,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
2586,GO:0005886,1.26046535485009e-15,1,385,2835,plasma membrane,CC,HTRA1;CEMIP;ADGRL1;APOE;MARVELD1;MARCKSL1;TSPAN1;PPL;PTPRS;FLNC;SEMA4B;NT5E;GAA;SYTL1;LTB4R;SHANK2;RAPGEF3;MRC2;GSN;CLCA2;NDRG1;CADM4;NOS1;PARVB;ARAP1;COL6A1;GRB7;EFS;ALOX15B;ARRDC1;EPN3;SCN8A;SLCO4A1;EPHB2;OBSCN;CNTN1;MYZAP;IGF2;MST1R;LRP1;KCNG1;RAB11FIP4;EGFR;NLGN2;SLC43A1;FHL1;ADGRF1;PKN1;SDK2;CRTC1;ARHGEF4;SYT8;SHC1;F2R;PTK6;GNAL;ABCA7;SLC9A3R2;CA12;BBS2;SLC16A5;PRSS8;SHC2;SLC16A3;CORO1B;DGKA;GJC2;IGSF9;MALL;KCNC4;ABCG1;RIN1;ANK3;S100A6;KCNJ15;DOCK4;ZP3;CSMD2;NISCH;LRP5;ANO8;TENM2;SLC2A9;BCAM;ERBB2;SLC13A3;EXOC2;MICALL2;BSG;PTPRU;PKD2;SCN4B;CPT1C;ABTB1;SLC7A8;ITGB4;ITPR3;PLXNB3;DNM1;SPRY4;FCHO1;RIMS3;LRP11;VIPR1;CD9;XPC;PTPRE;SIGMAR1;SERPINE2;VAMP2;LTB4R2;NTSR1;CD320;MINK1;RALGAPA2;ATP2B4;GGT1;SLC6A8;PHF7;RASA4;PLCD1;GM2A;SLC20A1;TNFRSF25;PRR7;RHOD;ARVCF;ASIC1;WNT7A;INSR;RAB3D;LCE1E;CELSR1;GRK6;RABGGTA;EPHA1;ITGA6;SYNGAP1;IL20RB;NBEAL2;LPAR3;TMEM173;PRNP;ATP7B;EFNB3;SPRY2;SLC12A7;NPDC1;SNX9;DLG4;REEP2;PLCD3;RAB25;CERCAM;SCART1;PLEKHH2;C1ORF210;TTYH3;ATP12A;PLXNB1;IGFBP2;MVB12B;CD81;SRMS;FCGRT;FZD8;ENTPD6;LRRC8A;ARL2;VANGL2;AP2A2;RHBDF2;GPRC5C;SHANK3;ACVR2B;ADAM15;S1PR2;TNFRSF6B;MAPK3;PLEKHG5;TUB;KCNAB2;ETV5;OLFM2;AMN;SLC22A18;CAPNS2;C19ORF33;RAB40B;DVL1;ENTPD2;GPSM1;ADCY6;L3MBTL1;SLC16A13;EPHB3;TMEM25;SSH1;FURIN;SLC48A1;SAMD3;EVC;SLC2A3;TRIM4;NRP2;GPR153;ABCA2;TNFRSF14;LRSAM1;LY6K;ADA;CDC42EP5;PAG1;AQP3;HTR7;RASL10B;CELSR2;IL6R;PCSK9;SLC28A2;RHOF;FGFR3;PRKACA;F12;PITPNM1;KIAA1549;PLCH2;SCNN1A;HBEGF;ITGB5;RAB3B;MAP2K2;PI4K2A;FGFR4;SPTB;TSPAN33;DMTN;BBS1;PSD4;MDGA1;HDAC11;TNFRSF1A;SEZ6L2;EHD4;MAPK8IP1;LDLR;PTOV1;ROBO3;ABHD17C;TRPV4;RHOBTB2;IFNGR2;CROCC;LRRC45;RHBDL1;MSLN;LDLRAP1;TM7SF2;AHNAK2;DGKQ;SEMA4C;SLC29A4;LLGL1;ADGRB2;TSPAN4;WNT7B;BLVRB;COMT;TTC7B;PTAFR;PLEKHG6;ANKRD13D;VAV3;VASN;BCR;NEO1;SDHA;GSDMC;MUC19;USP21;PRKCZ;BCORL1;INPP5D;TM7SF3;ABCD4;SLITRK6;GPC1;ICOSLG;NDE1;ARAP3;CDHR1;FGFR1;CTSZ;C5;TMEM204;PCDHGC3;C21ORF2;ASAP2;DLG3;KCNMA1;ESYT2;BIN1;YIPF3;TMEM8B;SERPINB6;OSCP1;PI4KAP2;SH3D19;GRB10;BFSP1;SYNC;CAPN2;TOLLIP;PROCR;SNPH;TMEM231;GUCA1B;ADGRE2;TMPRSS11D;CYBRD1;MADD;RTN4R;OR7D2;EPB41L3;SLC9A7;CD68;SDC1;FGFBP1;RTN2;PEAR1;EPS8L1;WNT3;SORL1;STK39;COL13A1;ACVR1B;ANO9;GSDMA;ADORA2B;TPCN1;HGSNAT;ERBB3;ABR;AKT1;NLRX1;ADAM19;LRCH4;GPD1L;EPS8L2;SLC5A5;SPPL2B;IL17RD;PKD1;EHD3;SLC22A17;SNTA1;HOMER2;PLPPR2;RGS14;SPIRE2;RILPL1;CBLC;ATXN10;RHBG;KCNN4;DDN;STK17A;RANBP9;SLC2A1;CPNE7;JAK3;LITAF;APBA1;EREG;PODXL2;ZFYVE19;SHISA6;GIPR;SEMA4F;AGPAT3;RGS12;RAB40C;SULF2;STXBP2;LZTS2
15514,GO:0071944,1.38809500297657e-14,1,388,2906,cell periphery,CC,HTRA1;CEMIP;ADGRL1;APOE;MARVELD1;MARCKSL1;TSPAN1;PPL;PTPRS;FLNC;SEMA4B;FAM110C;NT5E;GAA;SYTL1;LTB4R;SHANK2;RAPGEF3;MRC2;GSN;CLCA2;NDRG1;CADM4;NOS1;PARVB;ARAP1;COL6A1;GRB7;EFS;ALOX15B;ARRDC1;EPN3;SCN8A;SLCO4A1;EPHB2;OBSCN;CNTN1;MYZAP;IGF2;MST1R;LRP1;KCNG1;RAB11FIP4;EGFR;NLGN2;SLC43A1;FHL1;ADGRF1;PKN1;SDK2;CRTC1;ARHGEF4;SYT8;SHC1;F2R;PTK6;GNAL;ABCA7;SLC9A3R2;CA12;BBS2;SLC16A5;PRSS8;SHC2;SLC16A3;CORO1B;DGKA;GJC2;IGSF9;MALL;KCNC4;ABCG1;RIN1;ANK3;S100A6;KCNJ15;DOCK4;ZP3;CSMD2;NISCH;LRP5;ANO8;TENM2;SLC2A9;BCAM;ERBB2;SLC13A3;EXOC2;MICALL2;BSG;PTPRU;PKD2;SCN4B;CPT1C;ABTB1;SLC7A8;ITGB4;ITPR3;PLXNB3;DNM1;SPRY4;FCHO1;RIMS3;LRP11;VIPR1;CD9;XPC;PTPRE;SIGMAR1;SERPINE2;VAMP2;LTB4R2;NTSR1;CD320;MINK1;RALGAPA2;ATP2B4;GGT1;SLC6A8;PHF7;RASA4;PLCD1;GM2A;SLC20A1;TNFRSF25;PRR7;RHOD;ARVCF;ASIC1;WNT7A;INSR;RAB3D;LCE1E;CELSR1;GRK6;RABGGTA;EPHA1;ITGA6;SYNGAP1;IL20RB;NBEAL2;LPAR3;TMEM173;PRNP;ATP7B;EFNB3;SPRY2;SLC12A7;NPDC1;SNX9;DLG4;REEP2;PLCD3;RAB25;CERCAM;SCART1;PLEKHH2;C1ORF210;TTYH3;ATP12A;PLXNB1;IGFBP2;MVB12B;CD81;SRMS;FCGRT;FZD8;ENTPD6;LRRC8A;ARL2;VANGL2;AP2A2;RHBDF2;GPRC5C;SHANK3;ACVR2B;ADAM15;S1PR2;TNFRSF6B;MAPK3;PLEKHG5;TUB;KCNAB2;ETV5;OLFM2;AMN;SLC22A18;CAPNS2;C19ORF33;RAB40B;DVL1;ENTPD2;WIPF1;GPSM1;ADCY6;L3MBTL1;SLC16A13;EPHB3;TMEM25;SSH1;FURIN;SLC48A1;SAMD3;EVC;SLC2A3;TRIM4;NRP2;GPR153;ABCA2;TNFRSF14;LRSAM1;LY6K;ADA;CDC42EP5;PAG1;AQP3;HTR7;RASL10B;CELSR2;IL6R;PCSK9;SLC28A2;RHOF;FGFR3;PRKACA;F12;PITPNM1;KIAA1549;PLCH2;SCNN1A;HBEGF;ITGB5;RAB3B;MAP2K2;PI4K2A;FGFR4;SPTB;TSPAN33;DMTN;BBS1;PSD4;MDGA1;HDAC11;TNFRSF1A;SEZ6L2;EHD4;MAPK8IP1;LDLR;PTOV1;ROBO3;ABHD17C;TRPV4;RHOBTB2;IFNGR2;CROCC;LRRC45;RHBDL1;MSLN;LDLRAP1;TM7SF2;AHNAK2;DGKQ;SEMA4C;SLC29A4;LLGL1;ADGRB2;TSPAN4;WNT7B;BLVRB;COMT;TTC7B;PTAFR;PLEKHG6;ANKRD13D;VAV3;VASN;BCR;NEO1;SDHA;GSDMC;MUC19;USP21;PRKCZ;BCORL1;INPP5D;TM7SF3;ABCD4;SLITRK6;GPC1;ICOSLG;NDE1;ARAP3;CDHR1;FGFR1;CTSZ;C5;TMEM204;PCDHGC3;C21ORF2;ASAP2;DLG3;KCNMA1;ESYT2;BIN1;YIPF3;TMEM8B;SERPINB6;OSCP1;PI4KAP2;SH3D19;GRB10;BFSP1;SYNC;CAPN2;TOLLIP;PROCR;SNPH;TMEM231;GUCA1B;ADGRE2;TMPRSS11D;CYBRD1;MADD;RTN4R;OR7D2;EPB41L3;SLC9A7;CD68;SDC1;FGFBP1;RTN2;PEAR1;EPS8L1;WNT3;SORL1;STK39;COL13A1;ACVR1B;ANO9;GSDMA;ADORA2B;TPCN1;HGSNAT;ERBB3;ABR;AKT1;NLRX1;SEPT8;ADAM19;LRCH4;GPD1L;EPS8L2;SLC5A5;SPPL2B;IL17RD;PKD1;EHD3;SLC22A17;SNTA1;HOMER2;PLPPR2;RGS14;SPIRE2;RILPL1;CBLC;ATXN10;RHBG;KCNN4;DDN;STK17A;RANBP9;SLC2A1;CPNE7;JAK3;LITAF;APBA1;EREG;PODXL2;ZFYVE19;SHISA6;GIPR;SEMA4F;AGPAT3;RGS12;RAB40C;SULF2;STXBP2;LZTS2
10894,GO:0044459,2.49773470156395e-12,1,217,1451,plasma membrane part,CC,ADGRL1;TSPAN1;PTPRS;SYTL1;LTB4R;SHANK2;MRC2;CLCA2;CADM4;NOS1;EPN3;SCN8A;SLCO4A1;EPHB2;MYZAP;MST1R;LRP1;KCNG1;RAB11FIP4;EGFR;NLGN2;SLC43A1;PKN1;ARHGEF4;SHC1;F2R;PTK6;GNAL;ABCA7;SLC9A3R2;BBS2;SLC16A5;PRSS8;SLC16A3;GJC2;KCNC4;ABCG1;ANK3;S100A6;KCNJ15;LRP5;TENM2;SLC2A9;BCAM;ERBB2;SLC13A3;BSG;PTPRU;PKD2;SCN4B;CPT1C;SLC7A8;ITGB4;ITPR3;PLXNB3;DNM1;SPRY4;RIMS3;VIPR1;CD9;SIGMAR1;SERPINE2;VAMP2;LTB4R2;NTSR1;CD320;MINK1;ATP2B4;SLC6A8;RASA4;GM2A;SLC20A1;TNFRSF25;PRR7;ASIC1;INSR;CELSR1;EPHA1;ITGA6;SYNGAP1;LPAR3;PRNP;ATP7B;EFNB3;SPRY2;SLC12A7;SNX9;DLG4;REEP2;PLCD3;RAB25;SCART1;ATP12A;PLXNB1;IGFBP2;CD81;SRMS;FZD8;ARL2;VANGL2;AP2A2;GPRC5C;SHANK3;ACVR2B;TNFRSF6B;MAPK3;KCNAB2;OLFM2;AMN;SLC22A18;DVL1;ADCY6;SLC16A13;EPHB3;SSH1;EVC;SLC2A3;ABCA2;TNFRSF14;ADA;PAG1;AQP3;HTR7;IL6R;PCSK9;SLC28A2;FGFR3;PRKACA;PITPNM1;SCNN1A;HBEGF;ITGB5;MAP2K2;PI4K2A;FGFR4;SPTB;TSPAN33;DMTN;BBS1;PSD4;MDGA1;TNFRSF1A;LDLR;ABHD17C;TRPV4;IFNGR2;RHBDL1;LDLRAP1;TM7SF2;AHNAK2;SEMA4C;SLC29A4;TSPAN4;COMT;PTAFR;PLEKHG6;BCR;NEO1;SDHA;PRKCZ;ABCD4;SLITRK6;GPC1;ICOSLG;NDE1;CDHR1;FGFR1;C5;PCDHGC3;DLG3;KCNMA1;ESYT2;BIN1;OSCP1;TOLLIP;PROCR;SNPH;TMEM231;GUCA1B;ADGRE2;TMPRSS11D;CYBRD1;RTN4R;EPB41L3;SDC1;RTN2;PEAR1;EPS8L1;SORL1;STK39;COL13A1;ACVR1B;ADORA2B;ERBB3;LRCH4;EPS8L2;IL17RD;PKD1;EHD3;SLC22A17;SNTA1;HOMER2;PLPPR2;RGS14;SPIRE2;RHBG;KCNN4;DDN;SLC2A1;JAK3;LITAF;EREG;PODXL2;ZFYVE19;SHISA6;SEMA4F;STXBP2
7247,GO:0031226,2.14365833322386e-10,1,128,771,intrinsic component of plasma membrane,CC,TSPAN1;PTPRS;LTB4R;SHANK2;MRC2;CLCA2;CADM4;SCN8A;SLCO4A1;EPHB2;MST1R;LRP1;KCNG1;EGFR;NLGN2;SLC43A1;F2R;SLC16A5;PRSS8;SLC16A3;KCNC4;KCNJ15;TENM2;SLC2A9;BCAM;ERBB2;SLC13A3;BSG;PTPRU;PKD2;SCN4B;CPT1C;SLC7A8;ITGB4;ITPR3;PLXNB3;VIPR1;CD9;SIGMAR1;VAMP2;LTB4R2;NTSR1;CD320;ATP2B4;SLC6A8;RASA4;GM2A;SLC20A1;TNFRSF25;ASIC1;INSR;CELSR1;EPHA1;ITGA6;SYNGAP1;LPAR3;PRNP;ATP7B;EFNB3;SLC12A7;DLG4;REEP2;ATP12A;PLXNB1;CD81;GPRC5C;SHANK3;ACVR2B;TNFRSF6B;KCNAB2;OLFM2;ADCY6;SLC16A13;EPHB3;SLC2A3;TNFRSF14;PAG1;HTR7;IL6R;SLC28A2;FGFR3;SCNN1A;HBEGF;ITGB5;PI4K2A;FGFR4;SPTB;TSPAN33;MDGA1;TNFRSF1A;LDLR;TRPV4;IFNGR2;RHBDL1;TM7SF2;TSPAN4;PTAFR;NEO1;SLITRK6;GPC1;CDHR1;FGFR1;C5;PCDHGC3;DLG3;KCNMA1;ESYT2;TOLLIP;PROCR;TMPRSS11D;RTN4R;SDC1;SORL1;COL13A1;ACVR1B;ADORA2B;ERBB3;IL17RD;PKD1;SLC22A17;PLPPR2;RHBG;KCNN4;SLC2A1;EREG;PODXL2;SHISA6;SEMA4F
2587,GO:0005887,9.89282795739806e-10,1,121,733,integral component of plasma membrane,CC,TSPAN1;PTPRS;LTB4R;SHANK2;MRC2;CLCA2;CADM4;SCN8A;SLCO4A1;EPHB2;MST1R;LRP1;KCNG1;EGFR;NLGN2;SLC43A1;F2R;SLC16A5;SLC16A3;KCNC4;KCNJ15;TENM2;SLC2A9;BCAM;ERBB2;SLC13A3;BSG;PTPRU;PKD2;SCN4B;CPT1C;SLC7A8;ITGB4;ITPR3;PLXNB3;VIPR1;CD9;SIGMAR1;VAMP2;LTB4R2;NTSR1;CD320;ATP2B4;SLC6A8;GM2A;SLC20A1;TNFRSF25;ASIC1;INSR;CELSR1;EPHA1;ITGA6;LPAR3;ATP7B;EFNB3;SLC12A7;DLG4;REEP2;ATP12A;PLXNB1;CD81;GPRC5C;SHANK3;ACVR2B;TNFRSF6B;KCNAB2;OLFM2;SLC16A13;EPHB3;SLC2A3;TNFRSF14;PAG1;HTR7;IL6R;SLC28A2;FGFR3;SCNN1A;HBEGF;ITGB5;PI4K2A;FGFR4;TSPAN33;TNFRSF1A;LDLR;TRPV4;IFNGR2;RHBDL1;TM7SF2;TSPAN4;PTAFR;NEO1;SLITRK6;GPC1;CDHR1;FGFR1;C5;PCDHGC3;DLG3;KCNMA1;ESYT2;TOLLIP;PROCR;TMPRSS11D;RTN4R;SDC1;SORL1;COL13A1;ACVR1B;ADORA2B;ERBB3;IL17RD;PKD1;SLC22A17;PLPPR2;RHBG;KCNN4;SLC2A1;EREG;PODXL2;SHISA6;SEMA4F
6246,GO:0019838,2.44467838205415e-09,0.999999999519321,28,85,growth factor binding,MF,HTRA1;LTBP4;LTBP1;COL6A1;LTBP2;EGFR;RHBDF1;SHC1;ERBB2;ITGB4;INSR;ITGA6;IGFBP2;RHBDF2;ACVR2B;FURIN;NRP2;IL6R;FGFR3;FGFR4;LTBP3;VASN;IGFBP4;GPC1;FGFR1;FGFBP1;ACVR1B;ERBB3
2400,GO:0005576,4.31041250704775e-09,1,338,2779,extracellular region,CC,HTRA1;CEMIP;APOE;MARCKSL1;TSPAN1;PPL;IDH2;PTPRS;SEMA4B;NT5E;GAA;SYTL1;NAPRT;PYGB;CST3;LTBP4;RAPGEF3;PGM1;GSN;CLCA2;XDH;OAF;PRDX5;NDRG1;PGLS;PRSS3;PGF;CADM4;LTBP1;COL6A1;TCTN1;CGREF1;POSTN;ALOX15B;ARRDC1;EPN3;EPHB2;CNTN1;IGF2;GPX3;GAMT;APPL2;HEBP1;LTBP2;RAB11FIP4;THEM6;EGFR;TIMP2;SMOC2;MMP28;B3GAT3;CRYL1;FBXO2;ACOT7;TOM1L2;LOXL1;SERPING1;KDSR;ADGRF1;CMTM7;MXRA7;PYGL;DOPEY2;NAGLU;F2R;GNAL;BPHL;DEAF1;LAMA5;SLC9A3R2;GALE;ACTA2;PRSS8;S100A4;CTSB;CORO1B;THBS3;NXPH4;PLAT;MMP1;DHRS11;S100A6;ARHGAP23;PLD3;ZP3;CRTAP;HYAL1;PLTP;BCAM;SLC13A3;FBLN1;BSG;CTSF;PKD2;FUCA1;TST;SLC7A8;ITGB4;H2AFJ;VAT1;DNM1;PTHLH;CD9;XPC;NINL;HEXB;SERPINE2;VAMP2;FUZ;JADE2;THSD4;CD320;MINK1;RALGAPA2;GGT1;ACP5;PLCD1;ADAMTS7;GM2A;DHRS4L2;TNFRSF25;GLUL;TNXB;LAMB2;WNT7A;INSR;RAB3D;AKR7A2;B4GAT1;ITGA6;HAGH;DNPH1;PRNP;SERINC2;PAPLN;IAH1;RNASET2;BLMH;ECM1;CEP250;SNX9;REEP2;TALDO1;RAB25;FAM20C;FAM131A;TTYH3;PLXNB1;FAM213A;CHMP1B;IGFBP2;SEC14L2;MVB12B;CD81;VEGFA;ENTPD6;DNASE1L1;ARL2;DPP7;GPRC5C;HSD11B1L;SSC4D;ADAM15;ZDHHC1;TNFRSF6B;MAPK3;PDZD2;TUB;OLFM2;AMN;GLB1;ENTPD2;GALK1;LTA4H;PHGDH;ST3GAL3;EPHB3;TMEM25;FURIN;SLC2A3;NRP2;LY6K;ADA;TRIM45;ACY1;CKMT1A;PFKL;IL6R;SLIT3;PCSK9;GGACT;FCGBP;RHOF;FGFR3;PRKACA;F12;SPATA20;MAGEF1;CYFIP2;SCNN1A;HBEGF;ITGB5;RAB3B;MAP2K2;FGFR4;MXRA8;SLC37A2;GAREM2;PMVK;MYH3;MDGA1;HDAC11;VGF;TNFRSF1A;EHD4;SEMA3B;LDLR;LYPLAL1;ACOT11;CROCC;MSLN;SEMA3F;SEMA4C;MVB12A;FAM3A;GAS6;TKFC;WNT7B;BLVRB;COMT;ALDH16A1;RFNG;LTBP3;ZNF446;PCK2;PCSK1;VAV3;VASN;BCR;IGFBP4;MUC19;WDR60;PRKCZ;ADAMTS13;CLTCL1;MDH2;CAPG;TM7SF3;ETFB;SLITRK6;TWF2;TPP1;GPC1;ICOSLG;RFXANK;FGFR1;CTSZ;CHADL;MAN1B1;C5;IRF2BPL;CMBL;PCDHGC3;DLG3;GPR155;KCNMA1;MTMR11;SERPINB6;PPP1R13L;ASS1;GLRX;CES2;CAPN2;TOLLIP;WNT2B;TSTA3;CSTB;PROCR;MAN2B2;DUSP23;LCAT;GAL3ST4;TMPRSS11D;CYBRD1;RTN4R;ELFN2;TIMP1;SDC1;GRHPR;ACTR1B;FGFBP1;EPS8L1;PLEKHH3;WNT3;GSTT1;OLFML2A;SORL1;COL13A1;VEGFB;ACVR1B;TP73-AS1;GSS;ERBB3;CTSD;TRAP1;NDRG2;GPD1L;EPS8L2;SLC5A5;NAGA;PKD1;PCIF1;CTSH;ABHD14B;ROBO4;CBLC;ATXN10;PYCARD;PNPO;SNX29;PCSK1N;CKLF;CMTM4;SLC2A1;CPNE7;GALNS;EREG;FAM162A;PPCS;GSTM2;ABHD14A;KRT15;ADAMTSL4;TMED4;SEMA4F;MIF;SULF2;STXBP2
7245,GO:0031224,1.2125646424006e-08,1,341,2762,intrinsic component of membrane,CC,LMF1;ADGRL1;MARVELD1;TSPAN1;PTPRS;SEMA4B;NT5E;LTB4R;SHANK2;MRC2;CLCA2;CADM4;NOS1;MARCH9;C14ORF132;FAM210B;NYNRIN;SCN8A;SLCO4A1;EPHB2;CNTN1;MST1R;LRP1;KCNG1;ST6GALNAC2;EGFR;B3GAT3;NLGN2;REEP6;SLC43A1;KDSR;ADGRF1;RHBDF1;CMTM7;MXRA7;SDK2;SYT8;F2R;ABCA7;CA12;SLC16A5;PRSS8;TMCC3;LPCAT4;SLC16A3;GJC2;IGSF9;MALL;GRAMD4;CERS4;KCNC4;ABCG1;PLD3;KCNJ15;ZP3;CSMD2;LRP5;TMEM54;ANO8;TENM2;SLC2A9;LRP3;B4GALNT4;BCAM;ERBB2;SLC13A3;BSG;PTPRU;PKD2;TMEM129;SCN4B;CPT1C;EDEM1;SLC7A8;ITGB4;ITPR3;PLXNB3;PRAF2;VAT1;LRP11;VIPR1;CD9;PTPRE;CACFD1;SIGMAR1;DNAJC4;VAMP2;GALNT12;LTB4R2;KIAA1549L;NTSR1;CD320;ATP2B4;GGT1;SNN;SLC6A8;ACP5;RASA4;DIRC2;TMEM134;GM2A;SLC20A1;TNFRSF25;PRR7;PEX10;ARMCX2;ASIC1;INSR;CELSR1;B4GAT1;EPHA1;ITGA6;SYNGAP1;IL20RB;LPAR3;TMEM173;PRNP;SERINC2;SRD5A3;ATP7B;EFNB3;GRAMD1A;SLC12A7;NPDC1;DLG4;ABCD1;MARCH2;REEP2;TMEM107;SCART1;C1ORF210;TTYH3;ATP12A;PLXNB1;TMEM92;BNIP3;CD81;FCGRT;FZD8;ENTPD6;LRRC8A;VANGL2;TMEM63C;RHBDF2;GPRC5C;SHANK3;ACVR2B;ADAM15;ZDHHC1;S1PR2;TNFRSF6B;KCNAB2;OLFM2;CARD19;AMN;SLC22A18;ENTPD2;ADCY6;ST3GAL3;SLC16A13;EPHB3;TMEM25;COMTD1;FURIN;MBOAT7;SLC48A1;EVC;SLC2A3;NRP2;GPR153;ABCA2;TNFRSF14;LY6K;MCTP1;OSBPL5;PAG1;AQP3;HTR7;CELSR2;IL6R;TMEM9;SLC28A2;BTBD11;CTXN1;FGFR3;PRKACA;KIAA1549;SLC38A10;MFSD13A;SCNN1A;HBEGF;SLC25A37;ITGB5;RAB3B;PI4K2A;FGFR4;SPTB;MXRA8;SLC37A2;STX10;TSPAN33;RNF215;MDGA1;XYLT2;TNFRSF1A;SEZ6L2;LDLR;ROBO3;TRPV4;PIGZ;IFNGR2;RRNAD1;RHBDL1;TMTC4;MSLN;TM7SF2;SEMA4C;FAM171A2;SLC29A4;SLC35E2B;CHST6;C1ORF115;ADGRB2;TSPAN4;TMEM187;COMT;AIG1;PTAFR;RFNG;TMEM200A;REEP4;LRP10;VASN;TMEM175;NEO1;ZDHHC24;TM7SF3;TMCO6;ABCD4;SLITRK6;GPC1;TMX4;ICOSLG;CDHR1;FGFR1;MAN1B1;C5;TMEM204;PCDHGC3;DLG3;GPR155;KCNMA1;ESYT2;YIPF3;TMEM8B;SLC25A27;TMCO3;TOLLIP;ADCK5;TMEM161A;PROCR;SNPH;TMEM231;ADGRE2;GAL3ST4;SMDT1;TMPRSS11D;CYBRD1;MADD;PAQR4;RTN4R;ELFN2;OR7D2;PIGV;SLC9A7;CD68;SDC1;RTN2;PEAR1;PIGQ;SBF1;SORL1;COL13A1;ACVR1B;KRTCAP3;ANO9;FAM189B;TSNARE1;ADORA2B;TPCN1;HGSNAT;SLC25A29;ERBB3;TMBIM4;ADAM19;FAM8A1;SLC5A5;SUN1;TMEM120A;SPPL2B;IL17RD;UQCR11;ADCK2;PINK1;PKD1;SLC22A17;PLPPR2;SYNE3;ROBO4;AGPAT4;NRSN1;NINJ1;RHBG;POMT1;KCNN4;DNAJC22;ERN1;CKLF;TMEM229B;ORAI3;TMEM158;CMTM4;SLC2A1;TAZ;RNASEK;ORAI2;RARG;EREG;FAM162A;ABHD14A;PODXL2;SHISA6;GIPR;PQLC2;TP53I11;TMED4;SEMA4F;NDST2;AGPAT3;ALG12;APCDD1L
10867,GO:0044425,2.18435156196077e-08,1,435,3697,membrane part,CC,LMF1;CEMIP;ADGRL1;MARVELD1;TSPAN1;PTPRS;SEMA4B;NT5E;SYTL1;LTB4R;SHANK2;MRC2;CLCA2;CADM4;NOS1;MARCH9;C14ORF132;ALOX15B;EPN3;FAM210B;NYNRIN;SCN8A;SLCO4A1;EPHB2;CNTN1;MYZAP;MST1R;LRP1;KCNG1;ST6GALNAC2;RAB11FIP4;EGFR;B3GAT3;NLGN2;REEP6;SLC43A1;KDSR;ADGRF1;ULK1;RHBDF1;PKN1;CMTM7;MXRA7;SDK2;ARHGEF4;SYT8;SHC1;F2R;PTK6;GNAL;ABCA7;SLC9A3R2;CA12;BBS2;SLC16A5;PRSS8;TMCC3;LPCAT4;SLC16A3;GJC2;IGSF9;MALL;GRAMD4;CERS4;KCNC4;ABCG1;ANK3;PIK3R2;S100A6;PLD3;KCNJ15;ZP3;CSMD2;LRP5;TMEM54;ANO8;TENM2;SLC2A9;LRP3;B4GALNT4;BCAM;ERBB2;SLC13A3;BSG;PTPRU;PKD2;TMEM129;SCN4B;CPT1C;EDEM1;SLC7A8;ITGB4;ITPR3;PLXNB3;PRAF2;VAT1;DNM1;SPRY4;FCHO1;RIMS3;LRP11;VIPR1;CD9;PTPRE;CACFD1;SIGMAR1;DNAJC4;SERPINE2;VPS11;VAMP2;GALNT12;LTB4R2;KIAA1549L;NTSR1;CD320;MINK1;ATP2B4;GGT1;SNN;SLC6A8;ACP5;RASA4;DIRC2;TMEM134;GM2A;SLC20A1;TNFRSF25;PRR7;PEX10;ARMCX2;ASIC1;INSR;CELSR1;B4GAT1;NDUFS8;EPHA1;ITGA6;SYNGAP1;IL20RB;LPAR3;TMEM173;PRNP;SERINC2;SRD5A3;ATP7B;EFNB3;GRAMD1A;SNX33;SPRY2;SLC12A7;NPDC1;SNX9;STAT6;DLG4;ABCD1;MARCH2;REEP2;PLCD3;RAB25;TMEM107;SCART1;C1ORF210;TTYH3;ANKZF1;ATP12A;PLXNB1;CHMP1B;IGFBP2;MVB12B;TMEM92;BNIP3;CD81;SRMS;FCGRT;FZD8;ENTPD6;HOOK2;LRRC8A;ARL2;VANGL2;TMEM63C;AP2A2;RHBDF2;GPRC5C;SHANK3;ACVR2B;ADAM15;ZDHHC1;S1PR2;TNFRSF6B;MAPK3;KCNAB2;OLFM2;CARD19;AMN;SLC22A18;DVL1;ENTPD2;GPSM1;ADCY6;WIPI2;ST3GAL3;SLC16A13;EPHB3;TMEM25;SSH1;COMTD1;FURIN;MBOAT7;SLC48A1;EVC;SLC2A3;NRP2;GPR153;ABCA2;TNFRSF14;LY6K;ADA;MCTP1;OSBPL5;RETSAT;PAG1;AQP3;HTR7;CELSR2;IL6R;PCSK9;TMEM9;SLC28A2;BTBD11;CTXN1;FGFR3;PRKACA;PITPNM1;KIAA1549;SLC38A10;MFSD13A;SCNN1A;HBEGF;SLC25A37;ITGB5;RAB3B;MAP2K2;PI4K2A;FGFR4;SPTB;MXRA8;SLC37A2;STX10;TSPAN33;DMTN;RNF215;BBS1;PSD4;MDGA1;XYLT2;TNFRSF1A;SEZ6L2;MAPK8IP1;LDLR;CYP3A5;ROBO3;ABHD17C;TRPV4;PIGZ;IFNGR2;RRNAD1;RHBDL1;TMTC4;MSLN;LDLRAP1;TM7SF2;AHNAK2;SEMA4C;MVB12A;HK1;FAM171A2;SLC29A4;SLC35E2B;CHST6;C1ORF115;SDHAF4;ADGRB2;TSPAN4;TMEM187;COMT;AIG1;PTAFR;PLEKHG6;RFNG;TMEM200A;REEP4;ATG2A;LRP10;VASN;BCR;TMEM175;NEO1;SDHA;PRKCZ;ZDHHC24;CLTCL1;INPP5D;TM7SF3;TMCO6;ABCD4;SLITRK6;GPC1;TMX4;ICOSLG;NDE1;CDHR1;FGFR1;MAN1B1;C5;TMEM204;PCDHGC3;DLG3;GPR155;KCNMA1;ESYT2;BIN1;YIPF3;TMEM8B;OSCP1;SLC25A27;TMCO3;CAPN2;NDUFA4L2;TOLLIP;ADCK5;TMEM161A;PROCR;SNPH;TMEM231;GUCA1B;ADGRE2;GAL3ST4;SMDT1;TMPRSS11D;CYBRD1;MADD;PAQR4;RTN4R;ELFN2;OR7D2;EPB41L3;PIGV;SLC9A7;CD68;SDC1;RTN2;PEAR1;EPS8L1;PIGQ;SBF1;SORL1;STK39;COL13A1;ACVR1B;KRTCAP3;ANO9;FAM189B;TSNARE1;ADORA2B;TPCN1;HGSNAT;SLC25A29;ERBB3;CYP2S1;CTSD;TMBIM4;ADAM19;LRCH4;FAM8A1;VPS33B;EPS8L2;SLC5A5;SUN1;TMEM120A;SPPL2B;IL17RD;UQCR11;ADCK2;PINK1;PKD1;EHD3;SLC22A17;SNTA1;HOMER2;PLPPR2;RGS14;SYNE3;SPIRE2;ROBO4;AGPAT4;NRSN1;CBLC;EPN2;NINJ1;RHBG;POMT1;KCNN4;DDN;DNAJC22;NDUFV3;ERN1;CKLF;TMEM229B;ORAI3;TMEM158;CMTM4;SLC2A1;TAZ;RNASEK;JAK3;LITAF;ORAI2;RARG;EREG;FAM162A;ABHD14A;PODXL2;ZFYVE19;SHISA6;GIPR;PQLC2;TP53I11;TMED4;SEMA4F;NDST2;AGPAT3;ALG12;APCDD1L;STXBP2
10864,GO:0044421,2.27136738987662e-08,1,305,2501,extracellular region part,CC,HTRA1;APOE;MARCKSL1;TSPAN1;PPL;IDH2;PTPRS;SEMA4B;NT5E;GAA;SYTL1;NAPRT;PYGB;CST3;LTBP4;RAPGEF3;PGM1;GSN;XDH;OAF;PRDX5;NDRG1;PGLS;PRSS3;PGF;CADM4;LTBP1;COL6A1;TCTN1;POSTN;ALOX15B;ARRDC1;EPN3;CNTN1;IGF2;GPX3;GAMT;APPL2;HEBP1;LTBP2;RAB11FIP4;EGFR;TIMP2;SMOC2;MMP28;B3GAT3;CRYL1;FBXO2;ACOT7;TOM1L2;LOXL1;SERPING1;KDSR;CMTM7;MXRA7;PYGL;DOPEY2;NAGLU;GNAL;BPHL;LAMA5;SLC9A3R2;GALE;ACTA2;PRSS8;S100A4;CTSB;CORO1B;THBS3;PLAT;MMP1;S100A6;ARHGAP23;PLD3;ZP3;CRTAP;HYAL1;PLTP;BCAM;SLC13A3;FBLN1;BSG;CTSF;PKD2;FUCA1;TST;SLC7A8;ITGB4;H2AFJ;VAT1;DNM1;PTHLH;CD9;XPC;NINL;HEXB;SERPINE2;VAMP2;FUZ;JADE2;THSD4;CD320;MINK1;RALGAPA2;GGT1;ACP5;PLCD1;ADAMTS7;GM2A;GLUL;TNXB;LAMB2;WNT7A;INSR;RAB3D;AKR7A2;B4GAT1;ITGA6;HAGH;DNPH1;PRNP;SERINC2;IAH1;RNASET2;BLMH;ECM1;CEP250;SNX9;REEP2;TALDO1;RAB25;FAM20C;TTYH3;FAM213A;CHMP1B;IGFBP2;SEC14L2;MVB12B;CD81;VEGFA;ENTPD6;DNASE1L1;ARL2;DPP7;GPRC5C;SSC4D;ADAM15;ZDHHC1;TNFRSF6B;MAPK3;AMN;GLB1;ENTPD2;GALK1;LTA4H;PHGDH;FURIN;SLC2A3;ADA;TRIM45;ACY1;CKMT1A;PFKL;SLIT3;PCSK9;GGACT;FCGBP;RHOF;PRKACA;F12;MAGEF1;CYFIP2;SCNN1A;HBEGF;ITGB5;RAB3B;MXRA8;SLC37A2;GAREM2;PMVK;MYH3;MDGA1;HDAC11;VGF;TNFRSF1A;EHD4;SEMA3B;LDLR;LYPLAL1;ACOT11;CROCC;MSLN;SEMA3F;SEMA4C;MVB12A;FAM3A;GAS6;TKFC;WNT7B;BLVRB;COMT;ALDH16A1;RFNG;LTBP3;ZNF446;PCK2;PCSK1;VAV3;VASN;BCR;IGFBP4;MUC19;WDR60;PRKCZ;ADAMTS13;CLTCL1;MDH2;CAPG;TM7SF3;ETFB;SLITRK6;TWF2;TPP1;GPC1;ICOSLG;RFXANK;CTSZ;CHADL;MAN1B1;C5;IRF2BPL;CMBL;PCDHGC3;DLG3;GPR155;KCNMA1;MTMR11;SERPINB6;PPP1R13L;ASS1;GLRX;CES2;CAPN2;TOLLIP;WNT2B;TSTA3;CSTB;PROCR;MAN2B2;DUSP23;LCAT;GAL3ST4;TMPRSS11D;CYBRD1;RTN4R;ELFN2;TIMP1;SDC1;GRHPR;ACTR1B;FGFBP1;EPS8L1;PLEKHH3;WNT3;GSTT1;OLFML2A;SORL1;VEGFB;ACVR1B;GSS;ERBB3;CTSD;TRAP1;NDRG2;GPD1L;EPS8L2;SLC5A5;NAGA;PKD1;PCIF1;CTSH;ABHD14B;ROBO4;CBLC;ATXN10;PNPO;SNX29;PCSK1N;CKLF;CMTM4;SLC2A1;CPNE7;GALNS;EREG;FAM162A;PPCS;GSTM2;ABHD14A;KRT15;ADAMTSL4;TMED4;SEMA4F;MIF;SULF2;STXBP2
10783,GO:0044281,3.18580278734358e-08,1,201,1502,small molecule metabolic process,BP,H6PD;LMF1;CEMIP;APOE;TYSND1;IDH2;NT5E;GAA;NAPRT;RAPGEF3;PGM1;CYP27B1;XDH;PGLS;PRSS3;PRODH;NOS1;NR1D1;CRAT;ALOX15B;CPT2;IGF2;NME4;GAMT;TIMP2;ALDH4A1;B3GAT3;HADH;CRYL1;ACSF2;ACOT7;ISYNA1;UROS;MTHFR;KDSR;EGR1;BPHL;CA12;GALE;SLC16A3;D2HGDH;ABCG1;CRTAP;NMRK1;NISCH;LRP5;HYAL1;PLTP;SLC2A9;BSG;OGDHL;PKD2;CBS;FUCA1;TST;CPT1C;SLC7A8;PHLDA2;PTHLH;HEXB;LTB4R2;NTSR1;CD320;ATP2B4;GGT1;SLC6A8;ACP5;PLCD1;GLUL;INSR;AKR7A2;MVD;B4GAT1;NDUFS8;HAGH;DNPH1;SRD5A3;BLMH;DLG4;ABCD1;FGGY;PLCD3;TALDO1;FAM20C;UCKL1;PFKFB2;SEC14L2;VEGFA;ENTPD6;MAPK3;KCNAB2;AMN;GLB1;DHTKD1;ENTPD2;GALK1;LHPP;ADCY6;LTA4H;PHGDH;ST3GAL3;PC;ACAD10;MLXIPL;NAGS;SLC2A3;NADK;TK2;ADA;OSBPL5;PYCR2;RETSAT;ACY1;CKMT1A;PFKL;PCSK9;HLCS;NUDT10;PLCH2;DGUOK;FGFR4;PMVK;MYH3;XYLT2;TNFRSF1A;LDLR;ACOT11;SNX17;LDLRAP1;TM7SF2;DGKQ;PEX7;HK1;NMRAL1;CHST6;PPARA;HMGCL;TKFC;GUK1;COMT;AIG1;PTAFR;IMPA2;RXRA;PCK2;IGFBP4;SDHA;MDH2;INPP5D;ETFB;ABCD4;PDK2;FGFR1;PNPLA4;PHYH;PROX1;GTPBP1;DLG3;ASS1;GLRX;CES2;SESN2;TSTA3;MAN2B2;LCAT;GUCA1B;MACROD1;GRHPR;APOBEC3C;SORL1;GSS;AHCYL2;ADORA2B;CYP2S1;AKT1;HPDL;GPD1L;UQCR11;PINK1;LONP2;ABHD14B;PNPO;TRERF1;AS3MT;NDUFV3;APOBEC3F;ACADS;GCAT;MOCS1;SLC2A1;MLYCD;TAZ;BCKDHA;NEIL1;FUK;GALNS;PPCS;GSTM2;PODXL2;NDST2;MIF
5302,GO:0016021,4.10211648484968e-08,1,331,2697,integral component of membrane,CC,LMF1;ADGRL1;MARVELD1;TSPAN1;PTPRS;SEMA4B;LTB4R;SHANK2;MRC2;CLCA2;CADM4;NOS1;MARCH9;C14ORF132;FAM210B;NYNRIN;SCN8A;SLCO4A1;EPHB2;MST1R;LRP1;KCNG1;ST6GALNAC2;EGFR;B3GAT3;NLGN2;REEP6;SLC43A1;KDSR;ADGRF1;RHBDF1;CMTM7;MXRA7;SDK2;SYT8;F2R;ABCA7;CA12;SLC16A5;PRSS8;TMCC3;LPCAT4;SLC16A3;GJC2;IGSF9;MALL;GRAMD4;CERS4;KCNC4;ABCG1;PLD3;KCNJ15;ZP3;CSMD2;LRP5;TMEM54;ANO8;TENM2;SLC2A9;LRP3;B4GALNT4;BCAM;ERBB2;SLC13A3;BSG;PTPRU;PKD2;TMEM129;SCN4B;CPT1C;EDEM1;SLC7A8;ITGB4;ITPR3;PLXNB3;PRAF2;VAT1;LRP11;VIPR1;CD9;PTPRE;CACFD1;SIGMAR1;DNAJC4;VAMP2;GALNT12;LTB4R2;KIAA1549L;NTSR1;CD320;ATP2B4;GGT1;SNN;SLC6A8;ACP5;DIRC2;TMEM134;GM2A;SLC20A1;TNFRSF25;PRR7;PEX10;ARMCX2;ASIC1;INSR;CELSR1;B4GAT1;EPHA1;ITGA6;IL20RB;LPAR3;TMEM173;SERINC2;SRD5A3;ATP7B;EFNB3;GRAMD1A;SLC12A7;NPDC1;DLG4;ABCD1;MARCH2;REEP2;TMEM107;SCART1;C1ORF210;TTYH3;ATP12A;PLXNB1;TMEM92;BNIP3;CD81;FCGRT;FZD8;ENTPD6;LRRC8A;VANGL2;TMEM63C;RHBDF2;GPRC5C;SHANK3;ACVR2B;ADAM15;ZDHHC1;S1PR2;TNFRSF6B;KCNAB2;OLFM2;CARD19;AMN;SLC22A18;ENTPD2;ADCY6;ST3GAL3;SLC16A13;EPHB3;TMEM25;COMTD1;FURIN;MBOAT7;SLC48A1;EVC;SLC2A3;NRP2;GPR153;ABCA2;TNFRSF14;MCTP1;OSBPL5;PAG1;AQP3;HTR7;CELSR2;IL6R;TMEM9;SLC28A2;BTBD11;CTXN1;FGFR3;PRKACA;KIAA1549;SLC38A10;MFSD13A;SCNN1A;HBEGF;SLC25A37;ITGB5;PI4K2A;FGFR4;MXRA8;SLC37A2;STX10;TSPAN33;RNF215;XYLT2;TNFRSF1A;SEZ6L2;LDLR;ROBO3;TRPV4;PIGZ;IFNGR2;RRNAD1;RHBDL1;TMTC4;TM7SF2;SEMA4C;FAM171A2;SLC29A4;SLC35E2B;CHST6;C1ORF115;ADGRB2;TSPAN4;TMEM187;COMT;AIG1;PTAFR;RFNG;TMEM200A;REEP4;LRP10;VASN;TMEM175;NEO1;ZDHHC24;TM7SF3;TMCO6;ABCD4;SLITRK6;GPC1;TMX4;ICOSLG;CDHR1;FGFR1;MAN1B1;C5;TMEM204;PCDHGC3;DLG3;GPR155;KCNMA1;ESYT2;YIPF3;TMEM8B;SLC25A27;TMCO3;TOLLIP;ADCK5;TMEM161A;PROCR;SNPH;TMEM231;ADGRE2;GAL3ST4;SMDT1;TMPRSS11D;CYBRD1;MADD;PAQR4;RTN4R;ELFN2;OR7D2;PIGV;SLC9A7;CD68;SDC1;RTN2;PEAR1;PIGQ;SBF1;SORL1;COL13A1;ACVR1B;KRTCAP3;ANO9;FAM189B;TSNARE1;ADORA2B;TPCN1;HGSNAT;SLC25A29;ERBB3;TMBIM4;ADAM19;FAM8A1;SLC5A5;SUN1;TMEM120A;SPPL2B;IL17RD;UQCR11;ADCK2;PINK1;PKD1;SLC22A17;PLPPR2;SYNE3;ROBO4;AGPAT4;NRSN1;NINJ1;RHBG;POMT1;KCNN4;DNAJC22;ERN1;CKLF;TMEM229B;ORAI3;TMEM158;CMTM4;SLC2A1;TAZ;RNASEK;ORAI2;RARG;EREG;FAM162A;ABHD14A;PODXL2;SHISA6;GIPR;PQLC2;TP53I11;TMED4;SEMA4F;NDST2;AGPAT3;ALG12;APCDD1L
2426,GO:0005615,5.23434273117771e-08,1,291,2390,extracellular space,CC,HTRA1;APOE;MARCKSL1;TSPAN1;PPL;IDH2;PTPRS;SEMA4B;NT5E;GAA;SYTL1;NAPRT;PYGB;CST3;LTBP4;RAPGEF3;PGM1;GSN;XDH;OAF;PRDX5;NDRG1;PGLS;PRSS3;PGF;CADM4;LTBP1;COL6A1;TCTN1;POSTN;ALOX15B;ARRDC1;EPN3;CNTN1;IGF2;GPX3;GAMT;APPL2;HEBP1;LTBP2;RAB11FIP4;EGFR;TIMP2;B3GAT3;CRYL1;FBXO2;ACOT7;TOM1L2;LOXL1;SERPING1;KDSR;CMTM7;PYGL;DOPEY2;NAGLU;GNAL;BPHL;LAMA5;SLC9A3R2;GALE;ACTA2;PRSS8;S100A4;CTSB;CORO1B;PLAT;S100A6;ARHGAP23;PLD3;ZP3;CRTAP;HYAL1;PLTP;BCAM;SLC13A3;FBLN1;BSG;CTSF;PKD2;FUCA1;TST;SLC7A8;ITGB4;H2AFJ;VAT1;DNM1;PTHLH;CD9;XPC;HEXB;SERPINE2;VAMP2;FUZ;JADE2;THSD4;CD320;MINK1;RALGAPA2;GGT1;ACP5;PLCD1;ADAMTS7;GM2A;GLUL;TNXB;LAMB2;WNT7A;INSR;RAB3D;AKR7A2;B4GAT1;HAGH;DNPH1;PRNP;SERINC2;IAH1;RNASET2;BLMH;ECM1;CEP250;SNX9;REEP2;TALDO1;RAB25;FAM20C;TTYH3;FAM213A;CHMP1B;IGFBP2;SEC14L2;MVB12B;CD81;VEGFA;ENTPD6;DNASE1L1;ARL2;DPP7;GPRC5C;SSC4D;ADAM15;ZDHHC1;TNFRSF6B;MAPK3;AMN;GLB1;ENTPD2;GALK1;LTA4H;PHGDH;FURIN;SLC2A3;ADA;ACY1;CKMT1A;PFKL;SLIT3;PCSK9;GGACT;FCGBP;RHOF;PRKACA;F12;MAGEF1;CYFIP2;SCNN1A;HBEGF;ITGB5;RAB3B;MXRA8;SLC37A2;GAREM2;PMVK;MYH3;MDGA1;HDAC11;VGF;TNFRSF1A;EHD4;SEMA3B;LDLR;LYPLAL1;ACOT11;CROCC;MSLN;SEMA3F;SEMA4C;MVB12A;FAM3A;GAS6;TKFC;WNT7B;BLVRB;COMT;ALDH16A1;RFNG;LTBP3;ZNF446;PCK2;PCSK1;VAV3;VASN;BCR;IGFBP4;MUC19;WDR60;PRKCZ;ADAMTS13;CLTCL1;MDH2;CAPG;TM7SF3;ETFB;SLITRK6;TWF2;TPP1;GPC1;ICOSLG;CTSZ;C5;IRF2BPL;CMBL;PCDHGC3;DLG3;GPR155;KCNMA1;MTMR11;SERPINB6;ASS1;GLRX;CES2;CAPN2;TOLLIP;WNT2B;TSTA3;CSTB;PROCR;MAN2B2;DUSP23;LCAT;GAL3ST4;TMPRSS11D;CYBRD1;RTN4R;ELFN2;TIMP1;SDC1;GRHPR;ACTR1B;FGFBP1;EPS8L1;PLEKHH3;WNT3;GSTT1;SORL1;VEGFB;ACVR1B;GSS;ERBB3;CTSD;TRAP1;NDRG2;GPD1L;EPS8L2;SLC5A5;NAGA;PKD1;CTSH;ABHD14B;ROBO4;CBLC;ATXN10;PNPO;SNX29;PCSK1N;CKLF;CMTM4;SLC2A1;CPNE7;GALNS;EREG;FAM162A;PPCS;GSTM2;ABHD14A;KRT15;ADAMTSL4;TMED4;SEMA4F;MIF;SULF2;STXBP2
7914,GO:0032501,5.57763187497287e-08,1,480,4178,multicellular organismal process,BP,HTRA1;FOS;DUSP6;LMF1;CEMIP;ADGRL1;APOE;MARVELD1;ESPN;CTNNBIP1;PPL;IDH2;PTPRS;ERCC1;WWC3;SEMA4B;GAA;LTB4R;BTBD2;CST3;SHANK2;LTBP4;RAPGEF3;TCFL5;MRC2;CYP27B1;GSN;XDH;NDRG1;PRSS3;PGF;MEF2D;NOS1;LTBP1;ZFP36L1;COL6A1;TCTN1;POSTN;GRB7;NR1D1;ALOX15B;FAM210B;SCN8A;EPHB2;EPAS1;OBSCN;CNTN1;IGF2;NFATC4;MST1R;LRP1;GAMT;MAPK13;RAB11FIP4;OBSL1;EGFR;TIMP2;NLGN2;REEP6;DUSP5;FHL1;LOXL1;SERPING1;MTHFR;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;PKN1;CMTM7;SDK2;CRTC1;DOPEY2;NAGLU;SHC1;F2R;PTK6;GNAL;ABCA7;DEAF1;LAMA5;BBS2;ACTA2;PRSS8;S100A4;CTSB;DNAH1;CORO1B;ULK2;DGKA;GJC2;IGSF9;MALL;THBS3;ZMYND8;ASH2L;SOX12;PLAT;ABCG1;ANK3;S100A6;ZNF516;HDAC5;THRA;DOCK4;ZP3;CRTAP;NISCH;LRP5;DBNDD1;HYAL1;MARK4;TENM2;PLTP;ZFPM1;TFEB;ERBB2;FBLN1;BRSK1;MICALL2;BSG;SCMH1;PTPRU;PKD2;SCN4B;ITGB4;ITPR3;PLXNB3;PHLDA2;DNM1;SPRY4;PTHLH;LRP11;SALL2;IFT140;CD9;KIF13B;SIGMAR1;HEXB;SERPINE2;FUZ;FOXQ1;RNF135;NPHP4;LTB4R2;UNK;NTSR1;MINK1;ATP2B4;GGT1;TMOD2;SLC6A8;TFDP2;CSNK1E;ACP5;PLCD1;TRAPPC9;ADAMTS7;PDCD4;DOCK6;GM2A;TNFRSF25;ARVCF;ASIC1;LAMB2;WNT7A;ZMIZ1;INSR;RAB3D;LCE1E;SH3PXD2B;TBC1D8;FBXW8;ID1;CELSR1;B4GAT1;POLL;RABGGTA;EPHA1;ADARB1;ITGA6;TXNRD3;SYNGAP1;IL20RB;NBEAL2;DNMT3A;LPAR3;TMEM173;PRNP;ATP7B;EFNB3;SPRY2;MNT;ECM1;STAT6;DLG4;SPEG;REEP2;MKNK2;PLCD3;WWTR1;RAB25;FAM20C;TMEM107;MYCBPAP;PHC2;BCL6;PLXNB1;FAM213A;IGFBP2;DYRK1B;BNIP3;FZD8;VEGFA;ZSCAN2;LRRC8A;VANGL2;FBXW4;AP2A2;CEBPB;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;S1PR2;ENDOG;TNFRSF6B;MAPK3;PLEKHG5;TUB;KCNAB2;ETV5;OLFM2;AMN;SLC22A18;DHTKD1;TNNT1;DVL1;ENTPD2;MTA1;GPSM1;ADCY6;L3MBTL1;PKN3;PHGDH;EPHB3;HES1;SSH1;FURIN;MBOAT7;CUL7;MEFV;EVC;ARHGAP22;NRP2;TNFRSF14;ADA;TRIM45;PHF21A;SH2D2A;AQP3;HTR7;RASL10B;CELSR2;IL6R;SLIT3;PCSK9;ZFP36;BTBD11;MAPKBP1;FGFR3;PRKACA;F12;PITPNM1;ZMYM3;LRRK1;SPATA20;DGUOK;CYFIP2;SLC38A10;RPS6KA5;SCNN1A;HBEGF;ITGB5;FGFR4;SPTB;MXRA8;DMTN;RAPGEF5;BBS1;MYH3;MDGA1;HDAC11;VGF;TNFRSF1A;TCF25;SEMA3B;LDLR;ROBO3;SNX17;SOX13;TRPV4;BHLHE40;CROCC;RAG1;NHSL1;EEF2K;MSLN;HMGA2;LDLRAP1;SEMA3F;ELK3;AHNAK2;DGKQ;PEX7;SEMA4C;HK1;SDHAF4;GAS6;BTRC;POU6F1;LLGL1;ADGRB2;ZNF217;PPARA;HMGCL;TKFC;WNT7B;COMT;SUFU;PTAFR;RFNG;DMC1;LTBP3;RXRA;PCK2;VAV3;LRP10;VASN;BCR;NEO1;IGFBP4;SDHA;USP21;WDR60;PRKCZ;ADAMTS13;INPP5D;SPATA7;NYAP1;SLITRK6;TWF2;LSM14B;TPP1;GPC1;ICOSLG;SRSF5;ZNF160;TEF;NDE1;AGO4;CDHR1;FGFR1;CTSZ;CHADL;PIN1;MN1;C5;TMEM204;PROX1;PCDHGC3;DLG3;GPR155;KCNMA1;BIN1;UNC119B;SERPINB6;PPP1R13L;SLC25A27;GRB10;BFSP1;JARID2;CAPN2;WNT2B;CSTB;PROCR;SNPH;TMEM231;LCAT;GUCA1B;TMPRSS11D;RTN4R;OR7D2;EPB41L3;TIMP1;SDC1;GRHPR;SH2B3;WNT3;ZFP41;PPM1F;MICALCL;SBF1;SORL1;STK39;COL13A1;VEGFB;ACVR1B;MEF2B;GSS;ADORA2B;ERBB3;ABR;AKT1;NLRX1;ADAM19;ZNF385A;LRCH4;NDRG2;SMARCA1;VPS33B;SIX5;ERCC6;GPD1L;EPS8L2;TDRKH;SUN1;RPL39L;SSH3;GAS8;PKD1;EHD3;SNTA1;CAMTA2;HOMER2;RGS14;SPIRE2;CTSH;P3H4;ROBO4;NRSN1;ATXN10;EPN2;RFX2;PYCARD;NINJ1;MAP2K3;POMT1;TRERF1;PCSK1N;KCNN4;PMS2P5;RANBP9;FBXL20;ARHGEF19;SLC2A1;TAZ;JAK3;LITAF;APBA1;RARG;PBXIP1;EREG;GSTM2;ZFYVE19;SHISA6;GIPR;WDR18;KRT15;TRNP1;POLM;SEMA4F;PRR15;FAM50A;MIF;SULF2;KIF26B;LZTS2
4276,GO:0009653,8.85083108904622e-08,1,223,1694,anatomical structure morphogenesis,BP,HTRA1;DUSP6;APOE;CTNNBIP1;PTPRS;ERCC1;SEMA4B;GAA;CST3;SHANK2;RAPGEF3;XDH;PGF;MEF2D;NOS1;PARVB;ARAP1;ZFP36L1;COL6A1;TCTN1;POSTN;GRB7;EPHB2;EPAS1;OBSCN;IGF2;NFATC4;LRP1;GAMT;OBSL1;EGFR;DUSP5;FHL1;MDFI;ULK1;PKN1;SDK2;ARPIN;NAGLU;SHC1;F2R;DEAF1;LAMA5;BBS2;ACTA2;CORO1B;ULK2;THBS3;ANK3;S100A6;HDAC5;THRA;ZP3;LRP5;HYAL1;TENM2;ZFPM1;ERBB2;FBLN1;BRSK1;MICALL2;BSG;PKD2;ITGB4;PLXNB3;PHLDA2;VAT1;IFT140;CD9;KIF13B;HEXB;SERPINE2;FUZ;FOXQ1;UNK;MINK1;TMOD2;CSNK1E;ACP5;PLCD1;PDCD4;RHOD;LAMB2;WNT7A;ZMIZ1;INSR;SH3PXD2B;FBXW8;ID1;CELSR1;B4GAT1;EPHA1;ADARB1;ITGA6;SYNGAP1;NBEAL2;LPAR3;EFNB3;SPRY2;ECM1;STAT6;DLG4;PLCD3;STRADB;WWTR1;RAB25;FAM20C;TMEM107;BCL6;PLXNB1;DYRK1B;BNIP3;FZD8;VEGFA;VANGL2;FBXW4;AP2A2;CEBPB;SHANK3;ACVR2B;ADAM15;NAB2;MAPK3;ETV5;TNNT1;DVL1;WIPF1;EPHB3;HES1;SSH1;MLXIPL;MBOAT7;CUL7;ARHGAP22;NRP2;ADA;CDC42EP5;SH2D2A;AQP3;CELSR2;SLIT3;RHOF;FGFR3;ZMYM3;CYFIP2;RPS6KA5;HBEGF;ITGB5;FGFR4;SPTB;DMTN;MYH3;SEMA3B;ROBO3;SOX13;TRPV4;RHOBTB2;EEF2K;HMGA2;SEMA3F;ELK3;AHNAK2;PEX7;SEMA4C;BTRC;LLGL1;ADGRB2;PPARA;WNT7B;SUFU;RFNG;RXRA;VAV3;BCR;NEO1;WDR60;PRKCZ;CLTCL1;NYAP1;SLITRK6;TWF2;GPC1;AGO4;ARAP3;CDHR1;FGFR1;CTSZ;C5;PROX1;C21ORF2;DLG3;PPP1R13L;SH3D19;GRB10;CAPN2;WNT2B;TMEM231;RTN4R;EPB41L3;SDC1;WNT3;COL13A1;VEGFB;ABR;ZNF385A;SSH3;PINK1;PKD1;SYNE3;CTSH;ROBO4;RILPL1;EPN2;RFX2;NINJ1;RANBP9;ARHGEF19;RARG;EREG;TRNP1;SEMA4F;SULF2;KIF26B
1252,GO:0003008,1.36127459320806e-07,1,121,806,system process,BP,FOS;CEMIP;APOE;ESPN;CTNNBIP1;GAA;LTB4R;SHANK2;GSN;NOS1;POSTN;SCN8A;EPHB2;EPAS1;GAMT;OBSL1;EGFR;NLGN2;REEP6;SERPING1;MTHFR;ADGRF1;PKN1;CRTC1;DOPEY2;F2R;GNAL;ABCA7;DEAF1;BBS2;ACTA2;ANK3;THRA;DOCK4;NISCH;LRP5;SCN4B;ITPR3;DNM1;HEXB;SERPINE2;NTSR1;ATP2B4;TMOD2;SLC6A8;GM2A;ASIC1;LAMB2;INSR;TBC1D8;RABGGTA;ADARB1;SYNGAP1;PRNP;SPRY2;DLG4;REEP2;CEBPB;SHANK3;HSF4;MAPK3;TUB;KCNAB2;OLFM2;AMN;SLC22A18;TNNT1;DVL1;ADCY6;ADA;AQP3;HTR7;RASL10B;PRKACA;SCNN1A;HBEGF;ITGB5;BBS1;MYH3;LDLR;TRPV4;RAG1;AHNAK2;GAS6;PPARA;COMT;PTAFR;BCR;PRKCZ;SPATA7;SLITRK6;TPP1;FGFR1;CTSZ;PIN1;GPR155;KCNMA1;SERPINB6;PPP1R13L;JARID2;GUCA1B;OR7D2;GRHPR;STK39;VEGFB;ADORA2B;ABR;AKT1;ZNF385A;GPD1L;EPS8L2;EHD3;SNTA1;CAMTA2;HOMER2;RGS14;MAP2K3;KCNN4;TAZ;GSTM2;SULF2
2106,GO:0004888,1.58592203610749e-07,1,61,326,transmembrane signaling receptor activity,MF,ADGRL1;LTB4R;LTBP4;MRC2;LTBP1;EPHB2;MST1R;EGFR;ADGRF1;F2R;ABCA7;LRP5;BCAM;ERBB2;PTPRU;PLXNB3;VIPR1;PTPRE;SIGMAR1;LTB4R2;NTSR1;TNFRSF25;INSR;CELSR1;EPHA1;IL20RB;LPAR3;EFNB3;PLXNB1;FCGRT;FZD8;GPRC5C;ACVR2B;S1PR2;TNFRSF6B;EPHB3;NRP2;GPR153;TNFRSF14;HTR7;CELSR2;IL6R;FGFR3;FGFR4;TNFRSF1A;TRPV4;IFNGR2;ADGRB2;PTAFR;FGFR1;ADGRE2;RTN4R;OR7D2;SORL1;ACVR1B;ADORA2B;ERBB3;IL17RD;SLC22A17;CTSH;GIPR
12657,GO:0050896,2.77071202676264e-07,1,606,5525,response to stimulus,BP,TNIP1;HTRA1;FOS;DUSP6;ADGRL1;APOE;CTNNBIP1;TSPAN1;PPL;PTPRS;ERCC1;WWC3;SEMA4B;FAM110C;NT5E;GAA;LTB4R;CITED4;NAPRT;BTBD2;PYGB;CST3;SHANK2;LTBP4;RAPGEF3;MRC2;PGM1;CYP27B1;GSN;XDH;PRDX5;NDRG1;PCBP4;PRSS3;PRODH;PGF;NOS1;LTBP1;ARAP1;SH3BP2;ZFP36L1;COL6A1;TCTN1;POSTN;GRB7;NR1D1;EFS;ALOX15B;ARRDC1;FAM210B;POLD4;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;RHPN1;MYZAP;IGF2;NFATC4;GPX3;MST1R;LRP1;MAPK13;APPL2;HEBP1;RALGDS;LTBP2;EGFR;TIMP2;SMOC2;MMP28;HADH;NLGN2;REEP6;FBXO2;DUSP5;TOM1L2;PPP1R14A;UROS;LOXL1;DDB2;SERPING1;MTHFR;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CMTM7;CRTC1;PYGL;ARHGEF4;SHC1;RGL2;F2R;PTK6;GNAL;BPHL;ABCA7;DEAF1;LAMA5;BBS2;ACTA2;S100A4;CTSB;SHC2;PITPNC1;CORO1B;CXXC5;ULK2;DGKA;GJC2;D2HGDH;ZMYND8;ASH2L;NXPH4;PLAT;MMP1;ABCG1;RIN1;ANK3;PIK3R2;S100A6;ZNF516;INO80C;HDAC5;THRA;ARHGAP23;DOCK4;ZP3;RPS6KA2;NISCH;LRP5;HYAL1;TENM2;MAML3;ZFPM1;BCAM;TFEB;ERBB2;SLC13A3;FBLN1;BRSK1;BSG;PTPRU;PKD2;CBS;TMEM129;FUCA1;IQSEC2;EDEM1;ABTB1;SLC7A8;ITGB4;ITPR3;PLXNB3;PRAF2;PHLDA2;VAT1;DNM1;SPRY4;DDIT4L;PTHLH;CDKN1C;LRP11;SALL2;MSRB2;IFT140;VIPR1;CD9;KIF13B;XPC;PTPRE;SIGMAR1;PAK6;HEXB;DNAJC4;SERPINE2;VAMP2;FUZ;RNF135;NPHP4;LTB4R2;NTSR1;CD320;MINK1;RALGAPA2;ATP2B4;GGT1;SNN;TMOD2;SLC6A8;TFDP2;CSNK1E;ACP5;RASA4;PLCD1;AGAP1;ADAMTS7;PDCD4;DOCK6;GM2A;SLC20A1;ACAP3;TNFRSF25;GLUL;PRR7;RHOD;DTX3;USP20;ASIC1;LAMB2;SPATA18;PLEKHG4;WNT7A;ZMIZ1;INSR;RAB3D;ID1;CELSR1;AKR7A2;GRK6;B4GAT1;POLL;NDUFS8;EPHA1;ADARB1;ITGA6;TXNRD3;SYNGAP1;IL20RB;NBEAL2;DNMT3A;LPAR3;TMEM173;PRNP;ATP7B;EFNB3;RNASET2;SPRY2;MNT;BLMH;ECM1;NPDC1;STAT6;DLG4;MKNK2;PLCD3;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;ARHGAP27;DNAJB5;SCART1;BCL6;ANKZF1;PFKFB2;PLXNB1;FAM213A;IGFBP2;MVB12B;BNIP3;CD81;SRMS;FCGRT;FZD8;VEGFA;ENTPD6;DNASE1L1;LRRC8A;YPEL3;VANGL2;MAST4;FBXW4;AP2A2;CEBPB;RHBDF2;DPP7;GPRC5C;SHANK3;ACVR2B;HSF4;ADAM15;CALCOCO1;S1PR2;ENDOG;TNFRSF6B;MAPK3;PLEKHG5;TUB;KCNAB2;ETV5;CARD19;AMN;SLC22A18;GLB1;RAB40B;TNNT1;DVL1;ENTPD2;MTA1;WIPF1;ADCY6;L3MBTL1;LTA4H;WIPI2;PKN3;EPHB3;NSMCE4A;HES1;GIGYF1;SSH1;FURIN;MLXIPL;SAMD3;CUL7;MEFV;EVC;ARHGAP22;SLC2A3;TRIM4;NRP2;GPR153;PLEKHG2;ABCA2;TNFRSF14;LRSAM1;ADA;CDC42EP5;MCTP1;PYCR2;PIDD1;PAG1;PHF21A;SH2D2A;AQP3;HTR7;RASL10B;CELSR2;ACY1;PFKL;IL6R;SLIT3;PCSK9;ZFP36;RHOF;BTBD11;MAPKBP1;HLCS;FGFR3;PRKACA;F12;PITPNM1;LRRK1;PLCH2;MAGEF1;CYFIP2;RPS6KA5;SCNN1A;HBEGF;ITGB5;RAB3B;MAP2K2;PI4K2A;DAP;FGFR4;SPTB;TSPAN33;DMTN;RAPGEF5;PMVK;BBS1;PSD4;VGF;TNFRSF1A;EHD4;MAPK8IP1;SEMA3B;LDLR;CYP3A5;ACOT11;ROBO3;SNX17;TRPV4;MPG;RHOBTB2;IFNGR2;BHLHE40;RAG1;DUSP7;TNFAIP8L1;EEF2K;RHBDL1;HMGA2;LDLRAP1;SEMA3F;ELK3;DGKQ;SEMA4C;MVB12A;HK1;FAM3A;MIB2;SDHAF4;GAS6;BTRC;LLGL1;ADGRB2;ZNF217;PPARA;HMGCL;TKFC;TSPAN4;STK32C;WNT7B;GIT1;COMT;SUFU;PTAFR;PLEKHG6;RFNG;DMC1;IMPA2;ARHGEF37;RXRA;PCK2;VAV3;VASN;BCR;NEO1;IGFBP4;GSDMC;MUC19;PRKCZ;ADAMTS13;CLTCL1;INPP5D;TM7SF3;ABCD4;SPATA7;NYAP1;SLITRK6;TWF2;TPP1;PDK2;GPC1;TMX4;ICOSLG;SRSF5;RFXANK;MAPKAPK3;AGO4;RAD23A;ARAP3;FGFR1;CTSZ;CAMKK1;PIN1;MAN1B1;C5;TMEM204;CMBL;PROX1;WBP2;GTPBP1;C21ORF2;ASAP2;GPR155;KCNMA1;VSNL1;SERPINB6;PI4KAP2;PPP1R13L;ASS1;WDR83;CES2;SLC25A27;GRB10;JARID2;CAPN2;SESN2;TOLLIP;WNT2B;TMEM161A;RXRB;CSTB;PROCR;TMEM231;GUCA1B;MACROD1;ADGRE2;CYBRD1;MADD;RTN4R;OR7D2;TIMP1;CD68;SDC1;SH2B3;ACTR1B;APOBEC3C;FGFBP1;PEAR1;EPS8L1;PLEKHH3;WNT3;LYST;GSTT1;PPM1F;SORL1;STK39;VEGFB;ACVR1B;GSDMA;GSS;ADORA2B;HGSNAT;SLC25A29;ERBB3;ABR;PNMA1;CYP2S1;AKT1;CTSD;TRAP1;TMBIM4;NLRX1;ZNF385A;TP53INP1;LRCH4;NDRG2;VPS33B;ERCC6;GPD1L;EPS8L2;SLC5A5;SUN1;SPPL2B;IL17RD;PINK1;PKD1;EHD3;LONP2;SLC22A17;ARHGEF10L;CAMTA2;HOMER2;PLPPR2;RGS14;CTSH;MLST8;CBLC;EPN2;RFX2;PYCARD;NINJ1;MAP2K3;POMT1;PCSK1N;KCNN4;PMS2P5;AS3MT;STK17A;ERN1;CKLF;RANBP9;APOBEC3F;PRIMPOL;FBXL20;ARHGEF19;SIRT3;C12ORF66;CMTM4;SLC2A1;CPNE7;MLYCD;JAK3;MAST3;LITAF;NEIL1;RARG;ING4;GALNS;EREG;FAM162A;GSTM2;SHISA6;MORN4;GIPR;PQLC2;TMED4;POLM;SEMA4F;RPL13A;RGS12;RAB40C;MIF;SULF2;STXBP2;LZTS2
16751,GO:0098590,3.45386785117946e-07,1,98,622,plasma membrane region,CC,ADGRL1;PTPRS;SYTL1;SHANK2;CLCA2;NOS1;MST1R;LRP1;RAB11FIP4;EGFR;NLGN2;PKN1;ARHGEF4;F2R;ABCA7;SLC9A3R2;BBS2;KCNC4;ANK3;TENM2;SLC2A9;ERBB2;PKD2;SLC7A8;DNM1;SPRY4;RIMS3;CD9;SIGMAR1;MINK1;ATP2B4;PRR7;INSR;ITGA6;ATP7B;SPRY2;DLG4;PLCD3;RAB25;ATP12A;IGFBP2;CD81;VANGL2;SHANK3;MAPK3;OLFM2;AMN;SLC22A18;SSH1;EVC;AQP3;IL6R;PRKACA;PITPNM1;SCNN1A;PI4K2A;DMTN;BBS1;PSD4;LDLR;ABHD17C;TRPV4;LDLRAP1;SEMA4C;SLC29A4;COMT;PLEKHG6;BCR;PRKCZ;NDE1;CDHR1;DLG3;KCNMA1;OSCP1;SNPH;TMEM231;GUCA1B;ADGRE2;CYBRD1;EPB41L3;EPS8L1;STK39;COL13A1;ERBB3;LRCH4;EPS8L2;PKD1;EHD3;HOMER2;RGS14;SPIRE2;RHBG;DDN;SLC2A1;ZFYVE19;SHISA6;SEMA4F;STXBP2
9774,GO:0040011,3.97319088604219e-07,1,152,1090,locomotion,BP,CEMIP;APOE;TSPAN1;IDH2;SEMA4B;FAM110C;PRSS3;PGF;POSTN;GRB7;EFS;ALOX15B;EPHB2;LRP1;EGFR;MMP28;RHBDF1;PKN1;CMTM7;ARPIN;SHC1;F2R;PTK6;LAMA5;BBS2;DNAH1;SLC16A3;CORO1B;ZMYND8;PLAT;MMP1;PIK3R2;HDAC5;DOCK4;ZP3;NISCH;LRP5;HYAL1;PLTP;ERBB2;FBLN1;BSG;PTPRU;SLC7A8;ITGB4;PLXNB3;PHLDA2;PAK6;HEXB;SERPINE2;FUZ;NPHP4;LTB4R2;UNK;MINK1;ATP2B4;RHOD;LAMB2;WNT7A;INSR;ID1;CELSR1;B4GAT1;EPHA1;ADARB1;ITGA6;EFNB3;SPRY2;ECM1;RAB25;MYO18A;PLXNB1;CD81;VEGFA;VANGL2;ELMO3;SHANK3;ADAM15;MAPK3;PLEKHG5;DVL1;PKN3;EPHB3;HES1;PC;SSH1;MBOAT7;NRP2;ADA;MCTP1;IL6R;SLIT3;RHOF;CYFIP2;RPS6KA5;HBEGF;FGFR4;SPTB;DMTN;MDGA1;SEMA3B;ROBO3;TRPV4;RHOBTB2;NHSL1;SEMA3F;PEX7;SEMA4C;GAS6;PTAFR;VAV3;BCR;NEO1;PRKCZ;INPP5D;GPC1;NDE1;ARAP3;FGFR1;PIN1;C5;PROX1;GRB10;PROCR;ADGRE2;TIMP1;SDC1;WNT3;LYST;PPM1F;SORL1;VEGFB;ACVR1B;ERBB3;ABR;AKT1;TP53INP1;SUN1;GAS8;MAFIP;CTSH;ROBO4;PYCARD;MAP2K3;CKLF;RANBP9;CMTM4;JAK3;EREG;PODXL2;SEMA4F;MIF
10784,GO:0044282,8.76871933324659e-07,0.999999728764227,56,304,small molecule catabolic process,BP,CEMIP;APOE;TYSND1;NT5E;PGM1;CYP27B1;PRODH;NOS1;CRAT;CPT2;ALDH4A1;HADH;CRYL1;GALE;LRP5;HYAL1;CBS;CPT1C;HEXB;NTSR1;ATP2B4;GLUL;HAGH;SRD5A3;BLMH;ABCD1;PFKFB2;ENTPD6;GLB1;ENTPD2;GALK1;ACAD10;ADA;PFKL;SNX17;PEX7;HK1;PPARA;HMGCL;TKFC;AIG1;IMPA2;PCK2;ETFB;PHYH;SESN2;APOBEC3C;AKT1;HPDL;LONP2;TRERF1;APOBEC3F;ACADS;GCAT;MLYCD;BCKDHA
9647,GO:0038023,1.04114858127101e-06,0.999999658913324,67,386,signaling receptor activity,MF,ADGRL1;LTB4R;LTBP4;MRC2;LTBP1;NR1D1;EPHB2;MST1R;EGFR;ADGRF1;F2R;ABCA7;THRA;LRP5;BCAM;ERBB2;PTPRU;PLXNB3;VIPR1;PTPRE;SIGMAR1;LTB4R2;NTSR1;TNFRSF25;INSR;CELSR1;EPHA1;IL20RB;LPAR3;EFNB3;PLXNB1;FCGRT;FZD8;GPRC5C;ACVR2B;S1PR2;TNFRSF6B;EPHB3;NRP2;GPR153;TNFRSF14;HTR7;CELSR2;IL6R;FGFR3;FGFR4;TNFRSF1A;TRPV4;IFNGR2;ADGRB2;PPARA;PTAFR;RXRA;FGFR1;RXRB;ADGRE2;RTN4R;OR7D2;SORL1;ACVR1B;ADORA2B;ERBB3;IL17RD;SLC22A17;CTSH;RARG;GIPR
13589,GO:0060089,1.04114858127101e-06,0.999999658913324,67,386,molecular transducer activity,MF,ADGRL1;LTB4R;LTBP4;MRC2;LTBP1;NR1D1;EPHB2;MST1R;EGFR;ADGRF1;F2R;ABCA7;THRA;LRP5;BCAM;ERBB2;PTPRU;PLXNB3;VIPR1;PTPRE;SIGMAR1;LTB4R2;NTSR1;TNFRSF25;INSR;CELSR1;EPHA1;IL20RB;LPAR3;EFNB3;PLXNB1;FCGRT;FZD8;GPRC5C;ACVR2B;S1PR2;TNFRSF6B;EPHB3;NRP2;GPR153;TNFRSF14;HTR7;CELSR2;IL6R;FGFR3;FGFR4;TNFRSF1A;TRPV4;IFNGR2;ADGRB2;PPARA;PTAFR;RXRA;FGFR1;RXRB;ADGRE2;RTN4R;OR7D2;SORL1;ACVR1B;ADORA2B;ERBB3;IL17RD;SLC22A17;CTSH;RARG;GIPR
2099,GO:0004871,1.21853730809945e-06,0.999999557748836,103,679,signal transducer activity,MF,ADGRL1;LTB4R;LTBP4;MRC2;LTBP1;NR1D1;EPHB2;MST1R;MAPK13;EGFR;ADGRF1;SHC1;F2R;GNAL;ABCA7;CXXC5;THRA;LRP5;BCAM;ERBB2;PTPRU;PKD2;ITPR3;PLXNB3;VIPR1;PTPRE;SIGMAR1;LTB4R2;NTSR1;MINK1;PLCD1;SLC20A1;TNFRSF25;RHOD;INSR;CELSR1;EPHA1;IL20RB;LPAR3;PRNP;EFNB3;ECM1;STAT6;PLCD3;PLXNB1;FCGRT;FZD8;GPRC5C;ACVR2B;S1PR2;TNFRSF6B;MAPK3;PLEKHG5;EPHB3;NRP2;GPR153;TNFRSF14;PAG1;HTR7;CELSR2;IL6R;RHOF;FGFR3;LRRK1;PLCH2;MAP2K2;FGFR4;TNFRSF1A;TRPV4;RHOBTB2;IFNGR2;DGKQ;MIB2;ADGRB2;PPARA;SUFU;PTAFR;RXRA;CLTCL1;MAPKAPK3;FGFR1;TOLLIP;RXRB;ADGRE2;RTN4R;OR7D2;SH2B3;SORL1;ACVR1B;ADORA2B;TPCN1;ERBB3;IL17RD;SLC22A17;RGS14;CTSH;CBLC;MAP2K3;LITAF;RARG;GIPR;TMED4;RGS12
12399,GO:0048870,1.28686753980568e-06,0.999999510794689,134,946,cell motility,BP,CEMIP;APOE;TSPAN1;IDH2;SEMA4B;FAM110C;PRSS3;PGF;POSTN;GRB7;EFS;ALOX15B;LRP1;EGFR;MMP28;RHBDF1;PKN1;ARPIN;SHC1;F2R;PTK6;LAMA5;BBS2;DNAH1;SLC16A3;CORO1B;ZMYND8;PLAT;MMP1;PIK3R2;HDAC5;DOCK4;ZP3;NISCH;LRP5;HYAL1;PLTP;ERBB2;FBLN1;BSG;PTPRU;SLC7A8;ITGB4;PLXNB3;PHLDA2;PAK6;HEXB;SERPINE2;FUZ;NPHP4;LTB4R2;UNK;MINK1;ATP2B4;RHOD;WNT7A;INSR;ID1;CELSR1;EPHA1;ADARB1;ITGA6;SPRY2;ECM1;RAB25;MYO18A;PLXNB1;CD81;VEGFA;VANGL2;ELMO3;ADAM15;MAPK3;PLEKHG5;PKN3;EPHB3;HES1;SSH1;MBOAT7;NRP2;ADA;MCTP1;IL6R;RHOF;HBEGF;FGFR4;DMTN;MDGA1;SEMA3B;TRPV4;RHOBTB2;NHSL1;SEMA3F;PEX7;SEMA4C;GAS6;PTAFR;VAV3;BCR;PRKCZ;INPP5D;GPC1;NDE1;ARAP3;FGFR1;PIN1;C5;PROX1;PROCR;ADGRE2;TIMP1;SDC1;LYST;PPM1F;SORL1;VEGFB;ACVR1B;ERBB3;ABR;AKT1;TP53INP1;SUN1;GAS8;MAFIP;CTSH;ROBO4;PYCARD;MAP2K3;CKLF;JAK3;EREG;PODXL2;SEMA4F;MIF
13101,GO:0051674,1.28686753980568e-06,0.999999510794689,134,946,localization of cell,BP,CEMIP;APOE;TSPAN1;IDH2;SEMA4B;FAM110C;PRSS3;PGF;POSTN;GRB7;EFS;ALOX15B;LRP1;EGFR;MMP28;RHBDF1;PKN1;ARPIN;SHC1;F2R;PTK6;LAMA5;BBS2;DNAH1;SLC16A3;CORO1B;ZMYND8;PLAT;MMP1;PIK3R2;HDAC5;DOCK4;ZP3;NISCH;LRP5;HYAL1;PLTP;ERBB2;FBLN1;BSG;PTPRU;SLC7A8;ITGB4;PLXNB3;PHLDA2;PAK6;HEXB;SERPINE2;FUZ;NPHP4;LTB4R2;UNK;MINK1;ATP2B4;RHOD;WNT7A;INSR;ID1;CELSR1;EPHA1;ADARB1;ITGA6;SPRY2;ECM1;RAB25;MYO18A;PLXNB1;CD81;VEGFA;VANGL2;ELMO3;ADAM15;MAPK3;PLEKHG5;PKN3;EPHB3;HES1;SSH1;MBOAT7;NRP2;ADA;MCTP1;IL6R;RHOF;HBEGF;FGFR4;DMTN;MDGA1;SEMA3B;TRPV4;RHOBTB2;NHSL1;SEMA3F;PEX7;SEMA4C;GAS6;PTAFR;VAV3;BCR;PRKCZ;INPP5D;GPC1;NDE1;ARAP3;FGFR1;PIN1;C5;PROX1;PROCR;ADGRE2;TIMP1;SDC1;LYST;PPM1F;SORL1;VEGFB;ACVR1B;ERBB3;ABR;AKT1;TP53INP1;SUN1;GAS8;MAFIP;CTSH;ROBO4;PYCARD;MAP2K3;CKLF;JAK3;EREG;PODXL2;SEMA4F;MIF
12644,GO:0050877,1.65919176512236e-06,0.999999446046363,69,409,nervous system process,BP,FOS;CEMIP;APOE;ESPN;GAA;SHANK2;SCN8A;EPHB2;EPAS1;EGFR;NLGN2;REEP6;ADGRF1;CRTC1;DOPEY2;F2R;GNAL;ABCA7;DEAF1;BBS2;ANK3;THRA;ITPR3;DNM1;HEXB;SERPINE2;NTSR1;TMOD2;GM2A;ASIC1;LAMB2;INSR;RABGGTA;ADARB1;SYNGAP1;PRNP;SPRY2;DLG4;REEP2;CEBPB;SHANK3;HSF4;MAPK3;TUB;KCNAB2;OLFM2;DVL1;SCNN1A;BBS1;LDLR;RAG1;AHNAK2;COMT;PTAFR;BCR;PRKCZ;SPATA7;SLITRK6;TPP1;FGFR1;GPR155;SERPINB6;GUCA1B;OR7D2;ABR;ZNF385A;EPS8L2;HOMER2;RGS14
6043,GO:0019199,2.75017852898214e-06,0.999999468068954,17,50,transmembrane receptor protein kinase activity,MF,LTBP4;LTBP1;EPHB2;MST1R;EGFR;ERBB2;INSR;EPHA1;EFNB3;ACVR2B;EPHB3;NRP2;FGFR3;FGFR4;FGFR1;ACVR1B;ERBB3
17719,GO:1901681,2.96885051050955e-06,0.999998995299173,32,142,sulfur compound binding,MF,APOE;PTPRS;PGF;POSTN;LRP1;LTBP2;ACBD4;SMOC2;ACOT7;THBS3;OGDHL;CBS;SERPINE2;TNXB;VEGFA;DHTKD1;PC;NRP2;HLCS;HBEGF;FGFR4;HMGCL;GPC1;FGFR1;ADGRE2;GAL3ST4;RTN4R;FGFBP1;COL13A1;VEGFB;GSS;GSTM2
3252,GO:0006928,3.00929342227118e-06,0.999998272234895,168,1257,movement of cell or subcellular component,BP,CEMIP;APOE;TSPAN1;IDH2;SEMA4B;FAM110C;PRSS3;PGF;ARAP1;POSTN;GRB7;EFS;ALOX15B;EPHB2;LRP1;EGFR;MMP28;RHBDF1;PKN1;ARPIN;SHC1;F2R;PTK6;LAMA5;BBS2;DNAH1;SLC16A3;CORO1B;ZMYND8;PLAT;MMP1;PIK3R2;HDAC5;DOCK4;ZP3;NISCH;LRP5;HYAL1;PLTP;ERBB2;FBLN1;BSG;PTPRU;SCN4B;SLC7A8;ITGB4;PLXNB3;PHLDA2;IFT140;CD9;KIF13B;PAK6;HEXB;SERPINE2;FUZ;NPHP4;LTB4R2;UNK;MINK1;ATP2B4;RHOD;LAMB2;WNT7A;INSR;ID1;CELSR1;B4GAT1;EPHA1;ADARB1;ITGA6;EFNB3;SPRY2;ECM1;RAB25;MYO18A;BCL6;PLXNB1;CD81;VEGFA;VANGL2;ELMO3;AP2A2;SHANK3;ADAM15;MAPK3;PLEKHG5;TNNT1;DVL1;FYCO1;WIPF1;PKN3;EPHB3;HES1;SSH1;MBOAT7;NRP2;ADA;MCTP1;IL6R;SLIT3;RHOF;CYFIP2;RPS6KA5;HBEGF;FGFR4;SPTB;DMTN;MYH3;MDGA1;SEMA3B;ROBO3;TRPV4;RHOBTB2;NHSL1;SEMA3F;PEX7;SEMA4C;GAS6;PTAFR;VAV3;BCR;NEO1;WDR60;PRKCZ;INPP5D;GPC1;NDE1;ARAP3;FGFR1;PIN1;C5;PROX1;GRB10;PROCR;ADGRE2;TIMP1;SDC1;WNT3;LYST;PPM1F;SORL1;VEGFB;ACVR1B;ERBB3;ABR;AKT1;TP53INP1;GPD1L;SUN1;GAS8;SNTA1;MAFIP;CTSH;ROBO4;PYCARD;MAP2K3;DNAAF5;CKLF;RANBP9;WDR63;JAK3;KIFC2;APBA1;EREG;PODXL2;SEMA4F;MIF;KIF26B
6637,GO:0023052,3.16985205753345e-06,0.999997881053309,446,3925,signaling,BP,TNIP1;HTRA1;FOS;DUSP6;ADGRL1;APOE;CTNNBIP1;TSPAN1;PTPRS;WWC3;SEMA4B;FAM110C;SYTL1;LTB4R;SHANK2;LTBP4;RAPGEF3;MRC2;CYP27B1;GSN;XDH;NDRG1;PCBP4;PRODH;PGF;NOS1;LTBP1;ARAP1;SH3BP2;ZFP36L1;TCTN1;POSTN;GRB7;NR1D1;EFS;ALOX15B;ARRDC1;SCN8A;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;RHPN1;MYZAP;IGF2;NFATC4;MST1R;LRP1;MAPK13;APPL2;HEBP1;RALGDS;LTBP2;EGFR;TIMP2;SMOC2;HADH;NLGN2;DUSP5;TOM1L2;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CMTM7;CRTC1;ARHGEF4;SYT8;SHC1;RGL2;F2R;PTK6;GNAL;ABCA7;LAMA5;BBS2;S100A4;CTSB;SHC2;PITPNC1;CXXC5;ULK2;DGKA;GJC2;ZMYND8;NXPH4;PLAT;KCNC4;MMP1;RIN1;ANK3;PIK3R2;S100A6;ZNF516;THRA;ARHGAP23;DOCK4;ZP3;RPS6KA2;NISCH;LRP5;TENM2;MAML3;BCAM;ERBB2;FBLN1;BRSK1;BSG;PTPRU;PKD2;SCN4B;IQSEC2;EDEM1;ITGB4;ITPR3;PLXNB3;PHLDA2;DNM1;SPRY4;DDIT4L;PTHLH;CDKN1C;RIMS3;SALL2;IFT140;VIPR1;CD9;KIF13B;PTPRE;SIGMAR1;PAK6;SERPINE2;VAMP2;FUZ;NPHP4;LTB4R2;NTSR1;CD320;MINK1;RALGAPA2;ATP2B4;TMOD2;TFDP2;CSNK1E;RASA4;PLCD1;AGAP1;PDCD4;DOCK6;SLC20A1;ACAP3;TNFRSF25;GLUL;RHOD;DTX3;USP20;ASIC1;PLEKHG4;WNT7A;ZMIZ1;INSR;RAB3D;ID1;CELSR1;GRK6;EPHA1;ADARB1;ITGA6;SYNGAP1;IL20RB;LPAR3;PRNP;EFNB3;SPRY2;MNT;SLC12A7;ECM1;STAT6;DLG4;MKNK2;PLCD3;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;ARHGAP27;MYCBPAP;BCL6;PFKFB2;PLXNB1;IGFBP2;MVB12B;BNIP3;CD81;SRMS;FCGRT;FZD8;VEGFA;LRRC8A;ARL2;VANGL2;MAST4;FBXW4;AP2A2;CEBPB;RHBDF2;GPRC5C;SHANK3;ACVR2B;ADAM15;CALCOCO1;S1PR2;TNFRSF6B;MAPK3;PLEKHG5;ETV5;CARD19;RAB40B;DVL1;ENTPD2;MTA1;WIPF1;ADCY6;L3MBTL1;PKN3;EPHB3;HES1;GIGYF1;SSH1;FURIN;MLXIPL;SAMD3;CUL7;EVC;ARHGAP22;NRP2;GPR153;PLEKHG2;TNFRSF14;LRSAM1;ADA;CDC42EP5;MCTP1;PIDD1;PAG1;SH2D2A;HTR7;RASL10B;CELSR2;PFKL;IL6R;SLIT3;PCSK9;ZFP36;RHOF;BTBD11;MAPKBP1;FGFR3;PRKACA;PITPNM1;LRRK1;PLCH2;CYFIP2;RPS6KA5;HBEGF;ITGB5;RAB3B;MAP2K2;DAP;FGFR4;SPTB;TSPAN33;DMTN;RAPGEF5;PSD4;VGF;TNFRSF1A;MAPK8IP1;SEMA3B;ACOT11;ROBO3;SNX17;TRPV4;RHOBTB2;IFNGR2;DUSP7;TNFAIP8L1;RHBDL1;HMGA2;LDLRAP1;SEMA3F;ELK3;AHNAK2;DGKQ;SEMA4C;MVB12A;MIB2;GAS6;BTRC;LLGL1;ADGRB2;ZNF217;PPARA;TKFC;TSPAN4;STK32C;WNT7B;GIT1;SUFU;PTAFR;PLEKHG6;RFNG;IMPA2;ARHGEF37;RXRA;PCK2;PCSK1;VAV3;VASN;BCR;NEO1;IGFBP4;MUC19;TBC1D16;PRKCZ;ADAMTS13;CLTCL1;INPP5D;TM7SF3;NYAP1;TPP1;PDK2;GPC1;ICOSLG;RFXANK;MAPKAPK3;AGO4;ARAP3;FGFR1;CAMKK1;PIN1;C5;TMEM204;WBP2;GTPBP1;PCDHGC3;ASAP2;DLG3;GPR155;VSNL1;PI4KAP2;PPP1R13L;WDR83;GRB10;SESN2;TOLLIP;WNT2B;TMEM161A;RXRB;SNPH;TMEM231;GUCA1B;ADGRE2;GAL3ST4;MADD;RTN4R;OR7D2;TIMP1;SDC1;SH2B3;FGFBP1;PEAR1;EPS8L1;PLEKHH3;WNT3;PPM1F;SORL1;STK39;VEGFB;ACVR1B;ADORA2B;ERBB3;ABR;AKT1;TRAP1;TMBIM4;NLRX1;ZNF385A;TP53INP1;LRCH4;NDRG2;ERCC6;GPD1L;EPS8L2;SPPL2B;IL17RD;PINK1;PKD1;EHD3;SLC22A17;ARHGEF10L;HOMER2;PLPPR2;RGS14;CTSH;MLST8;CBLC;EPN2;PYCARD;MAP2K3;PCSK1N;KCNN4;STK17A;ERN1;CKLF;RANBP9;ARHGEF19;SIRT3;C12ORF66;CMTM4;SLC2A1;JAK3;MAST3;LITAF;APBA1;RARG;ING4;EREG;FAM162A;FCHSD1;GSTM2;SHISA6;GIPR;TMED4;SEMA4F;RGS12;RAB40C;MIF;SULF2;LZTS2
3369,GO:0007154,5.25122980552157e-06,0.99999635264567,447,3951,cell communication,BP,TNIP1;HTRA1;FOS;DUSP6;ADGRL1;APOE;CTNNBIP1;TSPAN1;PTPRS;WWC3;SEMA4B;FAM110C;SYTL1;LTB4R;SHANK2;LTBP4;RAPGEF3;MRC2;CYP27B1;GSN;XDH;NDRG1;PCBP4;PRODH;PGF;NOS1;LTBP1;ARAP1;SH3BP2;ZFP36L1;TCTN1;POSTN;GRB7;NR1D1;EFS;ALOX15B;ARRDC1;SCN8A;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;RHPN1;MYZAP;IGF2;NFATC4;MST1R;LRP1;MAPK13;APPL2;HEBP1;RALGDS;LTBP2;EGFR;TIMP2;SMOC2;HADH;NLGN2;DUSP5;TOM1L2;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CMTM7;CRTC1;ARHGEF4;SYT8;SHC1;RGL2;F2R;PTK6;GNAL;ABCA7;LAMA5;BBS2;S100A4;CTSB;SHC2;PITPNC1;CXXC5;ULK2;DGKA;GJC2;ZMYND8;NXPH4;PLAT;KCNC4;MMP1;RIN1;ANK3;PIK3R2;S100A6;ZNF516;THRA;ARHGAP23;DOCK4;ZP3;RPS6KA2;NISCH;LRP5;TENM2;MAML3;BCAM;ERBB2;FBLN1;BRSK1;BSG;PTPRU;PKD2;CBS;SCN4B;IQSEC2;EDEM1;ITGB4;ITPR3;PLXNB3;PHLDA2;DNM1;SPRY4;DDIT4L;PTHLH;CDKN1C;RIMS3;SALL2;IFT140;VIPR1;CD9;KIF13B;PTPRE;SIGMAR1;PAK6;SERPINE2;VAMP2;FUZ;NPHP4;LTB4R2;NTSR1;CD320;MINK1;RALGAPA2;ATP2B4;TMOD2;TFDP2;CSNK1E;RASA4;PLCD1;AGAP1;PDCD4;DOCK6;SLC20A1;ACAP3;TNFRSF25;GLUL;RHOD;DTX3;USP20;ASIC1;PLEKHG4;WNT7A;ZMIZ1;INSR;RAB3D;ID1;CELSR1;GRK6;EPHA1;ADARB1;ITGA6;SYNGAP1;IL20RB;LPAR3;PRNP;EFNB3;SPRY2;MNT;SLC12A7;ECM1;STAT6;DLG4;MKNK2;PLCD3;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;ARHGAP27;MYCBPAP;BCL6;PFKFB2;PLXNB1;IGFBP2;MVB12B;BNIP3;CD81;SRMS;FCGRT;FZD8;VEGFA;LRRC8A;ARL2;VANGL2;MAST4;FBXW4;AP2A2;CEBPB;RHBDF2;GPRC5C;SHANK3;ACVR2B;ADAM15;CALCOCO1;S1PR2;TNFRSF6B;MAPK3;PLEKHG5;ETV5;CARD19;RAB40B;DVL1;ENTPD2;MTA1;WIPF1;ADCY6;L3MBTL1;PKN3;EPHB3;HES1;GIGYF1;SSH1;FURIN;MLXIPL;SAMD3;CUL7;EVC;ARHGAP22;NRP2;GPR153;PLEKHG2;TNFRSF14;LRSAM1;ADA;CDC42EP5;MCTP1;PIDD1;PAG1;SH2D2A;AQP3;HTR7;RASL10B;CELSR2;PFKL;IL6R;SLIT3;PCSK9;ZFP36;RHOF;BTBD11;MAPKBP1;FGFR3;PRKACA;PITPNM1;LRRK1;PLCH2;CYFIP2;RPS6KA5;HBEGF;ITGB5;RAB3B;MAP2K2;DAP;FGFR4;SPTB;TSPAN33;DMTN;RAPGEF5;PSD4;VGF;TNFRSF1A;MAPK8IP1;SEMA3B;ACOT11;ROBO3;SNX17;TRPV4;RHOBTB2;IFNGR2;DUSP7;TNFAIP8L1;RHBDL1;HMGA2;LDLRAP1;SEMA3F;ELK3;AHNAK2;DGKQ;SEMA4C;MVB12A;MIB2;GAS6;BTRC;LLGL1;ADGRB2;ZNF217;PPARA;TKFC;TSPAN4;STK32C;WNT7B;GIT1;COMT;SUFU;PTAFR;PLEKHG6;RFNG;IMPA2;ARHGEF37;RXRA;PCK2;PCSK1;VAV3;VASN;BCR;NEO1;IGFBP4;MUC19;PRKCZ;ADAMTS13;CLTCL1;INPP5D;TM7SF3;NYAP1;TPP1;PDK2;GPC1;ICOSLG;RFXANK;MAPKAPK3;AGO4;ARAP3;FGFR1;CAMKK1;PIN1;C5;TMEM204;WBP2;GTPBP1;PCDHGC3;ASAP2;DLG3;GPR155;VSNL1;PI4KAP2;PPP1R13L;WDR83;GRB10;SESN2;TOLLIP;WNT2B;TMEM161A;RXRB;SNPH;TMEM231;GUCA1B;ADGRE2;GAL3ST4;MADD;RTN4R;OR7D2;TIMP1;SDC1;SH2B3;FGFBP1;PEAR1;EPS8L1;PLEKHH3;WNT3;PPM1F;SORL1;STK39;VEGFB;ACVR1B;ADORA2B;ERBB3;ABR;AKT1;TRAP1;TMBIM4;NLRX1;ZNF385A;TP53INP1;LRCH4;NDRG2;ERCC6;GPD1L;EPS8L2;SPPL2B;IL17RD;PINK1;PKD1;SLC22A17;ARHGEF10L;HOMER2;PLPPR2;RGS14;CTSH;MLST8;CBLC;EPN2;PYCARD;MAP2K3;PCSK1N;KCNN4;STK17A;ERN1;CKLF;RANBP9;ARHGEF19;SIRT3;C12ORF66;CMTM4;SLC2A1;JAK3;MAST3;LITAF;APBA1;RARG;ING4;EREG;FAM162A;FCHSD1;GSTM2;SHISA6;GIPR;TMED4;SEMA4F;RGS12;RAB40C;MIF;SULF2;LZTS2
2200,GO:0005088,7.19823435426859e-06,0.999997257722529,36,172,Ras guanyl-nucleotide exchange factor activity,MF,RAPGEF3;OBSCN;EGFR;ARHGEF4;SHC1;RGL2;SHC2;RIN1;ERBB2;TRAPPC9;PLEKHG4;DLG4;PLEKHG5;PLEKHG2;FGFR3;HBEGF;FGFR4;SPTB;RAPGEF5;PLEKHG6;ARHGEF37;VAV3;BCR;FGFR1;MADD;EPS8L1;SBF1;ALS2CL;ERBB3;ABR;EPS8L2;ARHGEF10L;RANBP9;ARHGEF19;JAK3;EREG
7590,GO:0031982,7.40650604884889e-06,0.999994814039806,349,3046,vesicle,CC,HTRA1;CEMIP;APOE;MARCKSL1;TSPAN1;PPL;IDH2;PTPRS;NT5E;GAA;SYTL1;NAPRT;PYGB;CST3;LTBP4;RAPGEF3;PGM1;GSN;OAF;PRDX5;NDRG1;PGLS;PRSS3;CADM4;NOS1;ARAP1;COL6A1;ALOX15B;ARRDC1;EPN3;SCN8A;CNTN1;IGF2;GPX3;LRP1;GAMT;APPL2;HEBP1;LTBP2;RAB11FIP4;EGFR;TIMP2;B3GAT3;CRYL1;FBXO2;ACOT7;TOM1L2;LOXL1;SERPING1;ULK1;PKN1;PYGL;DOPEY2;SYT8;NAGLU;F2R;GNAL;BPHL;ABCA7;LAMA5;SLC9A3R2;GALE;ACTA2;PRSS8;S100A4;CTSB;CORO1B;ULK2;MALL;TBC1D14;PLAT;ABCG1;S100A6;ARHGAP23;PLD3;NISCH;DBNDD1;HYAL1;BCAM;ERBB2;SLC13A3;FBLN1;BRSK1;MICALL2;BSG;CTSF;PKD2;FUCA1;TST;SLC7A8;ITGB4;ITPR3;H2AFJ;PRAF2;VAT1;DNM1;CD9;XPC;SIGMAR1;HEXB;SERPINE2;VPS11;VAMP2;FUZ;JADE2;THSD4;CD320;MINK1;GGT1;ACP5;PLCD1;ZFYVE21;GM2A;GLUL;RHOD;TNXB;LAMB2;WNT7A;INSR;RAB3D;AKR7A2;B4GAT1;NBEAL2;HAGH;DNPH1;TMEM173;PRNP;SERINC2;ATP7B;IAH1;RNASET2;SNX33;BLMH;ECM1;CEP250;SNX9;DLG4;MARCH2;REEP2;TALDO1;RAB25;FAM20C;C1ORF210;TTYH3;FAM213A;CHMP1B;IGFBP2;SEC14L2;MVB12B;CD81;VEGFA;ENTPD6;DNASE1L1;ARL2;VANGL2;AP2A2;DPP7;GPRC5C;SSC4D;ADAM15;ZDHHC1;MAPK3;PLEKHG5;KCNAB2;AMN;GLB1;RAB40B;DVL1;ENTPD2;GALK1;FYCO1;WIPF1;LTA4H;PHGDH;FURIN;SLC48A1;MEFV;SLC2A3;ABCA2;LY6K;ADA;MCTP1;ACY1;CKMT1A;PFKL;PCSK9;GGACT;FCGBP;TMEM9;RHOF;FGFR3;PRKACA;F12;MAGEF1;CYFIP2;SCNN1A;HBEGF;ITGB5;RAB3B;MAP2K2;PI4K2A;FGFR4;MXRA8;SLC37A2;STX10;GAREM2;DMTN;PMVK;MYH3;HDAC11;VGF;EHD4;SEMA3B;LDLR;LYPLAL1;ACOT11;SNX17;ABHD17C;TRPV4;RHOBTB2;IFNGR2;CROCC;PHLDA1;LDLRAP1;AHNAK2;DGKQ;SEMA4C;MVB12A;MIB2;GAS6;LLGL1;TKFC;TSPAN4;TMEM187;WNT7B;BLVRB;COMT;ALDH16A1;PTAFR;RFNG;ANKRD13D;LTBP3;PCK2;PCSK1;VAV3;VASN;BCR;TMEM175;MUC19;TBC1D16;WDR60;PRKCZ;CLTCL1;MDH2;CAPG;TM7SF3;ETFB;TWF2;TPP1;GPC1;ICOSLG;FGFR1;CTSZ;MAN1B1;C5;CMBL;PCDHGC3;GPR155;KCNMA1;MTMR11;YIPF3;SERPINB6;ASS1;WDR83;GLRX;CAPN2;TOLLIP;TSTA3;CSTB;PROCR;MAN2B2;DUSP23;LCAT;GAL3ST4;TMPRSS11D;CYBRD1;RTN4R;SLC9A7;TIMP1;CD68;SDC1;GRHPR;ACTR1B;EPS8L1;WNT3;GSTT1;SORL1;VEGFB;ACVR1B;TBC1D17;GSS;TPCN1;HGSNAT;AKT1;CTSD;TRAP1;TP53INP1;NDRG2;VPS33B;GPD1L;EPS8L2;SLC5A5;SUN1;NAGA;SPPL2B;PKD1;EHD3;SPIRE2;CTSH;EHBP1L1;ABHD14B;ROBO4;NRSN1;CBLC;EPN2;PYCARD;PNPO;SNX29;RHBG;POMT1;PCSK1N;KCNN4;SLC2A1;CPNE7;JAK3;LITAF;APBA1;GALNS;FAM162A;PPCS;FCHSD1;GSTM2;ABHD14A;KRT15;TMED4;RAB40C;MIF;STXBP2;LZTS2
16423,GO:0097113,7.93713495771752e-06,1,5,5,AMPA glutamate receptor clustering,BP,APOE;DLG4;SHANK3;SSH1;SHISA6
16680,GO:0097688,7.93713495771752e-06,1,5,5,glutamate receptor clustering,BP,APOE;DLG4;SHANK3;SSH1;SHISA6
8139,GO:0032879,9.13337163543682e-06,0.999994035669541,212,1684,regulation of localization,BP,CEMIP;APOE;TSPAN1;IDH2;SEMA4B;FAM110C;SYTL1;SHANK2;RAPGEF3;GSN;EVI5L;PGF;NOS1;ARAP1;ZFP36L1;POSTN;GRB7;NR1D1;ALOX15B;SCN8A;EPHB2;CNTN1;LRP1;KCNG1;EGFR;MMP28;B3GAT3;HADH;NLGN2;REEP6;FHL1;RHBDF1;PKN1;ARPIN;SYT8;F2R;ABCA7;LAMA5;BBS2;PRSS8;CORO1B;GJC2;ZMYND8;TBC1D14;KCNC4;ABCG1;ANK3;PIK3R2;HDAC5;KCNJ15;DOCK4;ZP3;NISCH;LRP5;HYAL1;PLTP;ERBB2;FBLN1;MICALL2;PTPRU;PKD2;SCN4B;EDEM1;ITPR3;PLXNB3;PHLDA2;DNM1;RIMS3;CD9;SERPINE2;VPS11;VAMP2;FUZ;NTSR1;MINK1;ATP2B4;TFDP2;CSNK1E;GLUL;RHOD;ASIC1;WNT7A;INSR;RAB3D;TBC1D8;EPHA1;ADARB1;ITGA6;LPAR3;TMEM173;PRNP;SNX33;SPRY2;ECM1;CEP250;DLG4;REEP2;RAB25;MYO18A;BCL6;PFKFB2;PLXNB1;CD81;VEGFA;ARL2;RHBDF2;SHANK3;ADAM15;MAPK3;TUB;KCNAB2;RAB40B;DVL1;HES1;SSH1;NRP2;ABCA2;LRSAM1;ADA;MCTP1;RASL10B;PFKL;IL6R;PCSK9;ZFP36;RHOF;MAPKBP1;PRKACA;HBEGF;RAB3B;MAP2K2;STX10;DMTN;EHD4;SEMA3B;LDLR;SNX17;ABHD17C;TRPV4;RHOBTB2;CROCC;EEF2K;LDLRAP1;SEMA3F;SEMA4C;HK1;GAS6;LLGL1;PPARA;COMT;PTAFR;PCK2;BCR;TBC1D16;PRKCZ;CLTCL1;TM7SF3;ARAP3;FGFR1;PIN1;C5;PROX1;KCNMA1;BIN1;VSNL1;OSCP1;GLRX;SLC25A27;GRB10;SESN2;TMEM231;ADGRE2;TIMP1;SDC1;RTN2;WNT3;PPM1F;SORL1;STK39;VEGFB;ACVR1B;TBC1D17;ANO9;ADORA2B;TPCN1;ERBB3;ABR;AKT1;STON1;TP53INP1;GPD1L;PINK1;EHD3;SNTA1;HOMER2;CTSH;ROBO4;PYCARD;MAP2K3;KCNN4;SIRT3;SLC2A1;EREG;GSTM2;SHISA6;GIPR;SEMA4F;RAB40C;MIF;STXBP2;UBL5;LZTS2
4343,GO:0009925,9.7563237197652e-06,0.999998972540064,10,21,basal plasma membrane,CC,CLCA2;MST1R;EGFR;ANK3;ERBB2;PKD2;ITGA6;LDLRAP1;OSCP1;ERBB3
12596,GO:0050806,1.0906441366538e-05,0.999996951543,22,84,positive regulation of synaptic transmission,BP,APOE;SHANK2;EPHB2;EGFR;NLGN2;CRTC1;ITPR3;RIMS3;SERPINE2;VAMP2;NTSR1;GLUL;WNT7A;PRNP;DLG4;SHANK3;DVL1;SSH1;RAB3B;PRKCZ;PINK1;RGS14
323,GO:0000904,1.30480729852271e-05,0.999993180963577,76,482,cell morphogenesis involved in differentiation,BP,APOE;PTPRS;SEMA4B;SHANK2;PARVB;TCTN1;POSTN;GRB7;EPHB2;NFATC4;OBSL1;ULK1;SHC1;LAMA5;ULK2;ANK3;S100A6;ZFPM1;ERBB2;FBLN1;BRSK1;MICALL2;PLXNB3;KIF13B;UNK;MINK1;LAMB2;WNT7A;FBXW8;ID1;B4GAT1;EPHA1;ADARB1;SYNGAP1;NBEAL2;LPAR3;EFNB3;DLG4;RAB25;PLXNB1;VEGFA;VANGL2;SHANK3;MAPK3;DVL1;EPHB3;HES1;SSH1;CUL7;NRP2;CELSR2;SLIT3;CYFIP2;RPS6KA5;SPTB;DMTN;SEMA3B;ROBO3;EEF2K;SEMA3F;SEMA4C;LLGL1;NEO1;SLITRK6;TWF2;GPC1;CDHR1;PROX1;GRB10;RTN4R;WNT3;ZNF385A;SSH3;RILPL1;RANBP9;SEMA4F
8213,GO:0032989,1.61817980907573e-05,0.99999052705079,107,745,cellular component morphogenesis,BP,APOE;PTPRS;SEMA4B;SHANK2;PARVB;ARAP1;TCTN1;POSTN;GRB7;EPHB2;OBSCN;NFATC4;OBSL1;EGFR;ULK1;ARPIN;SHC1;LAMA5;CORO1B;ULK2;ANK3;S100A6;TENM2;ZFPM1;ERBB2;FBLN1;BRSK1;MICALL2;PLXNB3;CD9;KIF13B;HEXB;UNK;MINK1;TMOD2;CSNK1E;RHOD;LAMB2;WNT7A;FBXW8;ID1;B4GAT1;EPHA1;ADARB1;SYNGAP1;NBEAL2;LPAR3;EFNB3;DLG4;STRADB;RAB25;BCL6;PLXNB1;VEGFA;VANGL2;SHANK3;MAPK3;TNNT1;DVL1;WIPF1;EPHB3;HES1;SSH1;CUL7;NRP2;CDC42EP5;CELSR2;SLIT3;RHOF;ZMYM3;CYFIP2;RPS6KA5;SPTB;DMTN;MYH3;SEMA3B;ROBO3;RHOBTB2;EEF2K;SEMA3F;AHNAK2;SEMA4C;LLGL1;WNT7B;NEO1;PRKCZ;NYAP1;SLITRK6;TWF2;GPC1;AGO4;ARAP3;CDHR1;PROX1;C21ORF2;SH3D19;GRB10;RTN4R;EPB41L3;WNT3;ZNF385A;SSH3;SYNE3;RILPL1;RFX2;RANBP9;SEMA4F
4252,GO:0009605,1.64601578720766e-05,0.999989306811555,170,1319,response to external stimulus,BP,TNIP1;HTRA1;FOS;APOE;PPL;PTPRS;ERCC1;SEMA4B;NT5E;CST3;CYP27B1;GSN;PRSS3;PGF;NOS1;POSTN;GRB7;NR1D1;EPHB2;IGF2;MST1R;MAPK13;EGFR;MMP28;REEP6;LOXL1;SERPING1;MTHFR;ULK1;CMTM7;CRTC1;SHC1;F2R;BBS2;ACTA2;CORO1B;ULK2;PLAT;HDAC5;DOCK4;ZP3;HYAL1;ERBB2;PKD2;CBS;PLXNB3;LRP11;CD9;XPC;SERPINE2;LTB4R2;NTSR1;GGT1;ACP5;PDCD4;TNFRSF25;GLUL;LAMB2;B4GAT1;ADARB1;ITGA6;IL20RB;DNMT3A;TMEM173;EFNB3;ISG20;BCL6;PLXNB1;IGFBP2;BNIP3;CD81;VEGFA;VANGL2;CEBPB;SHANK3;ENDOG;TNFRSF6B;MAPK3;PLEKHG5;DVL1;MTA1;WIPF1;WIPI2;EPHB3;SSH1;MEFV;NRP2;TNFRSF14;LRSAM1;ADA;AQP3;IL6R;SLIT3;PCSK9;ZFP36;MAPKBP1;HLCS;F12;PITPNM1;CYFIP2;RPS6KA5;HBEGF;DAP;SPTB;DMTN;VGF;TNFRSF1A;SEMA3B;LDLR;ROBO3;TRPV4;IFNGR2;BHLHE40;HMGA2;SEMA3F;DGKQ;SEMA4C;FAM3A;GAS6;PPARA;HMGCL;TKFC;COMT;PTAFR;PCK2;VAV3;BCR;NEO1;GSDMC;ADAMTS13;SLITRK6;PDK2;GPC1;MAPKAPK3;FGFR1;C5;PROX1;GRB10;SESN2;WNT2B;GUCA1B;ADGRE2;RTN4R;APOBEC3C;WNT3;LYST;PPM1F;STK39;VEGFB;GSDMA;GSS;ADORA2B;ABR;AKT1;NLRX1;VPS33B;SUN1;PKD1;PYCARD;PCSK1N;CKLF;RANBP9;APOBEC3F;C12ORF66;CMTM4;SLC2A1;LITAF;GIPR;SEMA4F;MIF
10384,GO:0043235,1.78301356225462e-05,0.999992769629263,37,185,receptor complex,CC,SHANK2;EPHB2;MST1R;LRP1;EGFR;LRP5;ERBB2;CPT1C;ITGB4;ITPR3;PLXNB3;VIPR1;INSR;EPHA1;ITGA6;DLG4;PLXNB1;GPRC5C;SHANK3;ACVR2B;OLFM2;EPHB3;NRP2;IL6R;FGFR3;ITGB5;FGFR4;TNFRSF1A;LDLR;TM7SF2;RXRA;FGFR1;DLG3;TOLLIP;ACVR1B;ERBB3;SHISA6
6795,GO:0030258,1.82246965438198e-05,0.999992492170582,38,194,lipid modification,BP,APOE;TYSND1;CRAT;CPT2;EGFR;HADH;DGKA;ABCG1;PIK3R2;ERBB2;CPT1C;ZFYVE21;ABCD1;ACAD10;FGFR3;HBEGF;PI4K2A;FGFR4;CYP3A5;DGKQ;PEX7;PPARA;TTC7B;IMPA2;INPP5D;ETFB;FGFR1;PHYH;PI4KAP2;SESN2;LCAT;ERBB3;AKT1;LONP2;PLPPR2;ACADS;MLYCD;EREG
12294,GO:0048667,1.84276302124882e-05,0.999990663727694,63,382,cell morphogenesis involved in neuron differentiation,BP,APOE;PTPRS;SEMA4B;SHANK2;TCTN1;GRB7;EPHB2;NFATC4;OBSL1;ULK1;SHC1;ULK2;ANK3;S100A6;ERBB2;BRSK1;PLXNB3;KIF13B;UNK;MINK1;LAMB2;WNT7A;FBXW8;ID1;B4GAT1;ADARB1;SYNGAP1;LPAR3;EFNB3;DLG4;PLXNB1;VEGFA;VANGL2;SHANK3;MAPK3;DVL1;EPHB3;HES1;SSH1;CUL7;NRP2;CELSR2;SLIT3;CYFIP2;RPS6KA5;SPTB;SEMA3B;ROBO3;EEF2K;SEMA3F;SEMA4C;LLGL1;NEO1;SLITRK6;TWF2;GPC1;CDHR1;GRB10;RTN4R;WNT3;SSH3;RANBP9;SEMA4F
322,GO:0000902,2.04735121751457e-05,0.999987990106254,100,688,cell morphogenesis,BP,APOE;PTPRS;SEMA4B;SHANK2;PARVB;ARAP1;TCTN1;POSTN;GRB7;EPHB2;NFATC4;OBSL1;EGFR;ULK1;ARPIN;SHC1;LAMA5;CORO1B;ULK2;ANK3;S100A6;TENM2;ZFPM1;ERBB2;FBLN1;BRSK1;MICALL2;PLXNB3;KIF13B;HEXB;UNK;MINK1;CSNK1E;RHOD;LAMB2;WNT7A;FBXW8;ID1;B4GAT1;EPHA1;ADARB1;SYNGAP1;NBEAL2;LPAR3;EFNB3;DLG4;STRADB;RAB25;BCL6;PLXNB1;VEGFA;VANGL2;SHANK3;MAPK3;DVL1;WIPF1;EPHB3;HES1;SSH1;CUL7;NRP2;CDC42EP5;CELSR2;SLIT3;RHOF;ZMYM3;CYFIP2;RPS6KA5;SPTB;DMTN;SEMA3B;ROBO3;RHOBTB2;EEF2K;SEMA3F;SEMA4C;LLGL1;WNT7B;NEO1;PRKCZ;NYAP1;SLITRK6;TWF2;GPC1;AGO4;ARAP3;CDHR1;PROX1;C21ORF2;SH3D19;GRB10;RTN4R;EPB41L3;WNT3;ZNF385A;SSH3;SYNE3;RILPL1;RANBP9;SEMA4F
7141,GO:0031012,2.39529160663908e-05,0.999989327854754,44,241,extracellular matrix,CC,HTRA1;APOE;CST3;LTBP4;LTBP1;COL6A1;POSTN;LTBP2;TIMP2;SMOC2;MMP28;LOXL1;MXRA7;LAMA5;THBS3;MMP1;ZP3;CRTAP;BCAM;FBLN1;SERPINE2;THSD4;ADAMTS7;TNXB;LAMB2;WNT7A;ITGA6;ECM1;VEGFA;ENTPD2;SLIT3;WNT7B;LTBP3;ADAMTS13;SLITRK6;GPC1;CHADL;WNT2B;TIMP1;FGFBP1;WNT3;OLFML2A;CTSD;ADAMTSL4
3380,GO:0007165,2.45541162350455e-05,0.999981651108536,413,3662,signal transduction,BP,TNIP1;HTRA1;FOS;DUSP6;ADGRL1;APOE;CTNNBIP1;TSPAN1;PTPRS;WWC3;SEMA4B;FAM110C;LTB4R;SHANK2;LTBP4;RAPGEF3;MRC2;CYP27B1;GSN;XDH;NDRG1;PCBP4;PRODH;PGF;NOS1;LTBP1;ARAP1;SH3BP2;ZFP36L1;TCTN1;POSTN;GRB7;NR1D1;EFS;ALOX15B;ARRDC1;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;RHPN1;MYZAP;IGF2;NFATC4;MST1R;LRP1;MAPK13;APPL2;HEBP1;RALGDS;LTBP2;EGFR;TIMP2;SMOC2;NLGN2;DUSP5;TOM1L2;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CMTM7;ARHGEF4;SHC1;RGL2;F2R;PTK6;GNAL;ABCA7;LAMA5;BBS2;S100A4;CTSB;SHC2;PITPNC1;CXXC5;ULK2;DGKA;ZMYND8;NXPH4;PLAT;MMP1;RIN1;ANK3;PIK3R2;S100A6;ZNF516;THRA;ARHGAP23;DOCK4;ZP3;RPS6KA2;NISCH;LRP5;TENM2;MAML3;BCAM;ERBB2;FBLN1;BRSK1;BSG;PTPRU;PKD2;IQSEC2;EDEM1;ITGB4;ITPR3;PLXNB3;PHLDA2;DNM1;SPRY4;DDIT4L;PTHLH;CDKN1C;SALL2;IFT140;VIPR1;CD9;KIF13B;PTPRE;SIGMAR1;PAK6;SERPINE2;FUZ;NPHP4;LTB4R2;NTSR1;CD320;MINK1;RALGAPA2;ATP2B4;TMOD2;TFDP2;CSNK1E;RASA4;PLCD1;AGAP1;PDCD4;DOCK6;SLC20A1;ACAP3;TNFRSF25;RHOD;DTX3;USP20;ASIC1;PLEKHG4;WNT7A;ZMIZ1;INSR;RAB3D;ID1;CELSR1;GRK6;EPHA1;ITGA6;SYNGAP1;IL20RB;LPAR3;PRNP;EFNB3;SPRY2;MNT;ECM1;STAT6;DLG4;MKNK2;PLCD3;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;ARHGAP27;BCL6;PLXNB1;IGFBP2;MVB12B;BNIP3;CD81;SRMS;FCGRT;FZD8;VEGFA;LRRC8A;VANGL2;MAST4;FBXW4;AP2A2;CEBPB;RHBDF2;GPRC5C;SHANK3;ACVR2B;ADAM15;CALCOCO1;S1PR2;TNFRSF6B;MAPK3;PLEKHG5;CARD19;RAB40B;DVL1;ENTPD2;MTA1;WIPF1;ADCY6;L3MBTL1;PKN3;EPHB3;HES1;GIGYF1;SSH1;FURIN;MLXIPL;SAMD3;CUL7;EVC;ARHGAP22;NRP2;GPR153;PLEKHG2;TNFRSF14;LRSAM1;ADA;CDC42EP5;MCTP1;PIDD1;PAG1;SH2D2A;HTR7;RASL10B;CELSR2;IL6R;SLIT3;PCSK9;ZFP36;RHOF;BTBD11;MAPKBP1;FGFR3;PRKACA;PITPNM1;LRRK1;PLCH2;CYFIP2;RPS6KA5;HBEGF;ITGB5;RAB3B;MAP2K2;DAP;FGFR4;SPTB;TSPAN33;DMTN;RAPGEF5;PSD4;VGF;TNFRSF1A;MAPK8IP1;SEMA3B;ACOT11;ROBO3;SNX17;TRPV4;RHOBTB2;IFNGR2;DUSP7;TNFAIP8L1;RHBDL1;LDLRAP1;SEMA3F;ELK3;DGKQ;SEMA4C;MVB12A;MIB2;GAS6;BTRC;LLGL1;ADGRB2;ZNF217;PPARA;TKFC;TSPAN4;STK32C;WNT7B;GIT1;SUFU;PTAFR;PLEKHG6;RFNG;IMPA2;ARHGEF37;RXRA;VAV3;VASN;BCR;NEO1;IGFBP4;MUC19;PRKCZ;ADAMTS13;CLTCL1;INPP5D;NYAP1;TPP1;PDK2;GPC1;ICOSLG;RFXANK;MAPKAPK3;AGO4;ARAP3;FGFR1;CAMKK1;PIN1;C5;TMEM204;WBP2;GTPBP1;ASAP2;GPR155;PI4KAP2;PPP1R13L;WDR83;GRB10;SESN2;TOLLIP;WNT2B;TMEM161A;RXRB;TMEM231;GUCA1B;ADGRE2;MADD;RTN4R;OR7D2;TIMP1;SDC1;SH2B3;FGFBP1;PEAR1;EPS8L1;PLEKHH3;WNT3;PPM1F;SORL1;STK39;VEGFB;ACVR1B;ADORA2B;ERBB3;ABR;AKT1;TRAP1;TMBIM4;NLRX1;ZNF385A;TP53INP1;LRCH4;NDRG2;ERCC6;GPD1L;EPS8L2;SPPL2B;IL17RD;PINK1;PKD1;SLC22A17;ARHGEF10L;HOMER2;PLPPR2;RGS14;CTSH;MLST8;CBLC;EPN2;PYCARD;MAP2K3;PCSK1N;KCNN4;STK17A;ERN1;CKLF;RANBP9;ARHGEF19;SIRT3;C12ORF66;CMTM4;JAK3;MAST3;LITAF;RARG;ING4;EREG;FAM162A;GSTM2;SHISA6;GIPR;TMED4;SEMA4F;RGS12;RAB40C;MIF;SULF2;LZTS2
5441,GO:0016323,2.46381732693643e-05,0.999991331992275,28,126,basolateral plasma membrane,CC,CLCA2;MST1R;LRP1;EGFR;ANK3;SLC2A9;ERBB2;PKD2;SLC7A8;ATP2B4;ITGA6;ATP7B;DLG4;ATP12A;CD81;VANGL2;AQP3;IL6R;LDLR;LDLRAP1;DLG3;OSCP1;STK39;ERBB3;LRCH4;PKD1;RHBG;SLC2A1
8482,GO:0033674,2.46616359898718e-05,0.999987177621613,66,412,positive regulation of kinase activity,BP,DUSP6;CEMIP;EPHB2;IGF2;MST1R;EGFR;DUSP5;EGR1;PKN1;SHC1;F2R;SHC2;ERBB2;PKD2;PAK6;MINK1;ATP2B4;INSR;EPHA1;LPAR3;PRNP;SPRY2;SNX9;DLG4;STRADB;PFKFB2;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;MAPK3;ADCY6;EPHB3;FGFR3;PRKACA;MAP2K2;FGFR4;DUSP7;DGKQ;GAS6;WNT7B;VAV3;PRKCZ;MAPKAPK3;FGFR1;CAMKK1;C5;PROX1;DLG3;MAPRE3;MADD;STK39;ADORA2B;ERBB3;AKT1;ERCC6;PINK1;PKD1;MLST8;MAP2K3;ERN1;EREG;MIF
16852,GO:0098815,2.72668008308641e-05,0.999996598605384,10,23,modulation of excitatory postsynaptic potential,BP,SHANK2;NLGN2;ZMYND8;WNT7A;DLG4;SHANK3;S1PR2;DVL1;SSH1;PRKCZ
11132,GO:0045202,2.79668773107348e-05,0.999984503605497,78,510,synapse,CC,ADGRL1;PTPRS;SYTL1;SHANK2;NOS1;POSTN;NR1D1;EPHB2;EGFR;NLGN2;FBXO2;MTHFR;SDK2;CRTC1;SYT8;F2R;LAMA5;IGSF9;ZMYND8;KCNC4;ANK3;DBNDD1;TENM2;BRSK1;CPT1C;DNM1;RIMS3;SIGMAR1;SERPINE2;VAMP2;NPHP4;NTSR1;MINK1;GLUL;PRR7;ASIC1;LAMB2;WNT7A;RAB3D;SYNGAP1;PRNP;DLG4;BNIP3;SHANK3;KCNAB2;OLFM2;RAB40B;DVL1;MCTP1;CYFIP2;RAB3B;PI4K2A;DMTN;MAPK8IP1;ABHD17C;EEF2K;SEMA4C;BLVRB;COMT;BCR;NDE1;DLG3;KCNMA1;SYNC;SNPH;EPB41L3;COL13A1;AKT1;SNTA1;HOMER2;RGS14;DDN;APBA1;FCHSD1;SHISA6;SEMA4F;RGS12;RAB40C
3583,GO:0008015,2.84055526075074e-05,0.999987120062824,45,250,blood circulation,BP,APOE;CTNNBIP1;GAA;NOS1;POSTN;EPAS1;EGFR;SERPING1;MTHFR;F2R;BBS2;THRA;DOCK4;NISCH;LRP5;SCN4B;ITPR3;NTSR1;ATP2B4;TBC1D8;TNNT1;ADCY6;ADA;HTR7;RASL10B;PRKACA;HBEGF;TRPV4;GAS6;PPARA;PTAFR;BCR;CTSZ;PPP1R13L;STK39;VEGFB;ADORA2B;ABR;AKT1;GPD1L;EHD3;SNTA1;MAP2K3;TAZ;GSTM2
10380,GO:0043230,2.85702197401345e-05,0.999979843735282,240,2039,extracellular organelle,CC,HTRA1;APOE;MARCKSL1;TSPAN1;PPL;IDH2;PTPRS;NT5E;GAA;SYTL1;NAPRT;PYGB;CST3;LTBP4;RAPGEF3;PGM1;GSN;OAF;PRDX5;NDRG1;PGLS;PRSS3;CADM4;COL6A1;ALOX15B;ARRDC1;EPN3;CNTN1;IGF2;GPX3;GAMT;APPL2;HEBP1;LTBP2;TIMP2;B3GAT3;CRYL1;FBXO2;ACOT7;TOM1L2;SERPING1;PYGL;DOPEY2;NAGLU;GNAL;BPHL;LAMA5;SLC9A3R2;GALE;ACTA2;PRSS8;S100A4;CTSB;CORO1B;PLAT;S100A6;ARHGAP23;PLD3;HYAL1;BCAM;SLC13A3;FBLN1;BSG;CTSF;PKD2;FUCA1;TST;SLC7A8;ITGB4;H2AFJ;VAT1;DNM1;CD9;XPC;HEXB;SERPINE2;VAMP2;FUZ;JADE2;THSD4;CD320;MINK1;GGT1;ACP5;PLCD1;GM2A;GLUL;TNXB;LAMB2;WNT7A;INSR;RAB3D;AKR7A2;B4GAT1;HAGH;DNPH1;PRNP;SERINC2;IAH1;RNASET2;BLMH;ECM1;CEP250;SNX9;REEP2;TALDO1;RAB25;FAM20C;TTYH3;FAM213A;CHMP1B;IGFBP2;SEC14L2;MVB12B;CD81;ENTPD6;DNASE1L1;ARL2;DPP7;GPRC5C;SSC4D;ADAM15;ZDHHC1;MAPK3;AMN;GLB1;ENTPD2;GALK1;LTA4H;PHGDH;FURIN;SLC2A3;ACY1;CKMT1A;PFKL;GGACT;FCGBP;RHOF;PRKACA;F12;MAGEF1;CYFIP2;SCNN1A;ITGB5;RAB3B;MXRA8;SLC37A2;GAREM2;PMVK;MYH3;HDAC11;EHD4;SEMA3B;LYPLAL1;ACOT11;CROCC;MVB12A;GAS6;TKFC;WNT7B;BLVRB;COMT;ALDH16A1;RFNG;LTBP3;PCK2;VAV3;VASN;BCR;MUC19;WDR60;PRKCZ;CLTCL1;MDH2;CAPG;TM7SF3;ETFB;TWF2;TPP1;GPC1;ICOSLG;CTSZ;MAN1B1;C5;CMBL;PCDHGC3;GPR155;KCNMA1;MTMR11;SERPINB6;ASS1;GLRX;CAPN2;TOLLIP;TSTA3;CSTB;PROCR;MAN2B2;DUSP23;LCAT;GAL3ST4;TMPRSS11D;CYBRD1;RTN4R;TIMP1;SDC1;GRHPR;ACTR1B;EPS8L1;WNT3;GSTT1;SORL1;ACVR1B;GSS;CTSD;TRAP1;NDRG2;GPD1L;EPS8L2;SLC5A5;NAGA;PKD1;CTSH;ABHD14B;ROBO4;CBLC;PNPO;SNX29;PCSK1N;SLC2A1;CPNE7;GALNS;FAM162A;PPCS;GSTM2;ABHD14A;KRT15;TMED4;MIF;STXBP2
18438,GO:1903561,2.85702197401345e-05,0.999979843735282,240,2039,extracellular vesicle,CC,HTRA1;APOE;MARCKSL1;TSPAN1;PPL;IDH2;PTPRS;NT5E;GAA;SYTL1;NAPRT;PYGB;CST3;LTBP4;RAPGEF3;PGM1;GSN;OAF;PRDX5;NDRG1;PGLS;PRSS3;CADM4;COL6A1;ALOX15B;ARRDC1;EPN3;CNTN1;IGF2;GPX3;GAMT;APPL2;HEBP1;LTBP2;TIMP2;B3GAT3;CRYL1;FBXO2;ACOT7;TOM1L2;SERPING1;PYGL;DOPEY2;NAGLU;GNAL;BPHL;LAMA5;SLC9A3R2;GALE;ACTA2;PRSS8;S100A4;CTSB;CORO1B;PLAT;S100A6;ARHGAP23;PLD3;HYAL1;BCAM;SLC13A3;FBLN1;BSG;CTSF;PKD2;FUCA1;TST;SLC7A8;ITGB4;H2AFJ;VAT1;DNM1;CD9;XPC;HEXB;SERPINE2;VAMP2;FUZ;JADE2;THSD4;CD320;MINK1;GGT1;ACP5;PLCD1;GM2A;GLUL;TNXB;LAMB2;WNT7A;INSR;RAB3D;AKR7A2;B4GAT1;HAGH;DNPH1;PRNP;SERINC2;IAH1;RNASET2;BLMH;ECM1;CEP250;SNX9;REEP2;TALDO1;RAB25;FAM20C;TTYH3;FAM213A;CHMP1B;IGFBP2;SEC14L2;MVB12B;CD81;ENTPD6;DNASE1L1;ARL2;DPP7;GPRC5C;SSC4D;ADAM15;ZDHHC1;MAPK3;AMN;GLB1;ENTPD2;GALK1;LTA4H;PHGDH;FURIN;SLC2A3;ACY1;CKMT1A;PFKL;GGACT;FCGBP;RHOF;PRKACA;F12;MAGEF1;CYFIP2;SCNN1A;ITGB5;RAB3B;MXRA8;SLC37A2;GAREM2;PMVK;MYH3;HDAC11;EHD4;SEMA3B;LYPLAL1;ACOT11;CROCC;MVB12A;GAS6;TKFC;WNT7B;BLVRB;COMT;ALDH16A1;RFNG;LTBP3;PCK2;VAV3;VASN;BCR;MUC19;WDR60;PRKCZ;CLTCL1;MDH2;CAPG;TM7SF3;ETFB;TWF2;TPP1;GPC1;ICOSLG;CTSZ;MAN1B1;C5;CMBL;PCDHGC3;GPR155;KCNMA1;MTMR11;SERPINB6;ASS1;GLRX;CAPN2;TOLLIP;TSTA3;CSTB;PROCR;MAN2B2;DUSP23;LCAT;GAL3ST4;TMPRSS11D;CYBRD1;RTN4R;TIMP1;SDC1;GRHPR;ACTR1B;EPS8L1;WNT3;GSTT1;SORL1;ACVR1B;GSS;CTSD;TRAP1;NDRG2;GPD1L;EPS8L2;SLC5A5;NAGA;PKD1;CTSH;ABHD14B;ROBO4;CBLC;PNPO;SNX29;PCSK1N;SLC2A1;CPNE7;GALNS;FAM162A;PPCS;GSTM2;ABHD14A;KRT15;TMED4;MIF;STXBP2
10282,GO:0043062,2.93566278825041e-05,0.999986803306203,44,241,extracellular structure organization,BP,HTRA1;APOE;CST3;COL6A1;POSTN;LRP1;TIMP2;SMOC2;LOXL1;ABCA7;LAMA5;THBS3;MMP1;ABCG1;HYAL1;PLTP;FBLN1;BSG;ITGB4;THSD4;TNXB;LAMB2;SH3PXD2B;ITGA6;ADAM15;CAPNS2;FURIN;PRKACA;ITGB5;FGFR4;GAS6;CHADL;CAPN2;LCAT;TIMP1;SDC1;OLFML2A;COL13A1;ADAM19;VPS33B;P3H4;POMT1;ADAMTSL4;SULF2
5505,GO:0016477,2.94469040189551e-05,0.999981832486404,120,873,cell migration,BP,CEMIP;APOE;TSPAN1;IDH2;SEMA4B;FAM110C;PRSS3;PGF;POSTN;GRB7;EFS;ALOX15B;LRP1;EGFR;MMP28;RHBDF1;PKN1;ARPIN;SHC1;F2R;PTK6;LAMA5;SLC16A3;CORO1B;ZMYND8;PLAT;MMP1;PIK3R2;HDAC5;DOCK4;ZP3;NISCH;LRP5;HYAL1;BSG;PTPRU;SLC7A8;PLXNB3;PHLDA2;PAK6;HEXB;SERPINE2;FUZ;LTB4R2;UNK;MINK1;RHOD;WNT7A;INSR;ID1;CELSR1;EPHA1;ADARB1;ITGA6;SPRY2;ECM1;RAB25;MYO18A;PLXNB1;VEGFA;VANGL2;ELMO3;ADAM15;MAPK3;PLEKHG5;PKN3;EPHB3;HES1;SSH1;MBOAT7;NRP2;ADA;MCTP1;IL6R;RHOF;HBEGF;FGFR4;DMTN;MDGA1;SEMA3B;TRPV4;RHOBTB2;NHSL1;SEMA3F;PEX7;SEMA4C;GAS6;PTAFR;VAV3;BCR;PRKCZ;INPP5D;GPC1;NDE1;ARAP3;FGFR1;C5;PROX1;PROCR;ADGRE2;TIMP1;SDC1;LYST;PPM1F;SORL1;VEGFB;ACVR1B;ABR;AKT1;TP53INP1;SUN1;CTSH;ROBO4;PYCARD;MAP2K3;CKLF;JAK3;PODXL2;SEMA4F;MIF
5892,GO:0018108,2.97345235683583e-05,0.999986844904732,42,227,peptidyl-tyrosine phosphorylation,BP,EPHB2;CNTN1;IGF2;MST1R;EGFR;SHC1;PTK6;ERBB2;INSR;EPHA1;PRNP;DLG4;DYRK1B;CD81;SRMS;VEGFA;MAPK3;EPHB3;HES1;IL6R;FGFR3;LRRK1;HBEGF;MAP2K2;FGFR4;DMTN;TNFRSF1A;EHD4;DGKQ;GAS6;BCR;PRKCZ;FGFR1;DLG3;ERBB3;ERCC6;MLST8;CBLC;MAP2K3;JAK3;EREG;MIF
2208,GO:0005102,3.04946263915602e-05,0.999981049710084,119,873,signaling receptor binding,MF,APOE;SEMA4B;SYTL1;SHANK2;LTBP4;PRDX5;PGF;CADM4;ARAP1;CRAT;EPHB2;IGF2;NFATC4;LRP1;EGFR;TIMP2;NLGN2;PKN1;CMTM7;SHC1;F2R;PTK6;GNAL;LAMA5;SLC9A3R2;S100A4;SHC2;NXPH4;PLAT;PIK3R2;DOCK4;ZP3;NISCH;ERBB2;PKD2;ITGB4;DNM1;PTHLH;CD9;SERPINE2;CD320;TNXB;USP20;LAMB2;WNT7A;INSR;ITGA6;PRNP;EFNB3;ECM1;DLG4;REEP2;PLXNB1;IGFBP2;CD81;SRMS;FZD8;VEGFA;CEBPB;SHANK3;ADAM15;S1PR2;AMN;DVL1;PIDD1;PAG1;IL6R;SLIT3;PCSK9;PITPNM1;HBEGF;DMTN;BBS1;VGF;SEMA3B;SNX17;LDLRAP1;SEMA3F;SEMA4C;GAS6;HMGCL;TSPAN4;WNT7B;RXRA;VAV3;IGFBP4;ADAMTS13;ICOSLG;FGFR1;C5;PROX1;WBP2;DLG3;GRB10;TOLLIP;WNT2B;PITPNM3;MADD;TIMP1;EPS8L1;WNT3;VEGFB;TRAP1;LONP2;HOMER2;CBLC;PYCARD;PCSK1N;ERN1;CKLF;CMTM4;MLYCD;JAK3;RARG;EREG;GSTM2;SHISA6;SEMA4F;MIF
4502,GO:0010562,3.24544853810041e-05,0.999980639364998,99,691,positive regulation of phosphorus metabolic process,BP,DUSP6;CEMIP;APOE;RAPGEF3;XDH;NOS1;EPHB2;CNTN1;IGF2;MST1R;EGFR;TIMP2;DUSP5;EGR1;PKN1;SHC1;F2R;PTK6;ABCA7;SHC2;ZP3;ERBB2;PKD2;PTHLH;PAK6;NTSR1;MINK1;ATP2B4;TNFRSF25;WNT7A;INSR;EPHA1;ITGA6;LPAR3;PRNP;SPRY2;SNX9;DLG4;STRADB;PFKFB2;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;MAPK3;DVL1;ADCY6;EPHB3;HES1;MLXIPL;IL6R;FGFR3;PRKACA;LRRK1;RPS6KA5;HBEGF;MAP2K2;FGFR4;TNFRSF1A;EHD4;MAPK8IP1;TRPV4;DUSP7;DGKQ;SEMA4C;GAS6;WNT7B;PTAFR;VAV3;IGFBP4;PRKCZ;MAPKAPK3;FGFR1;CAMKK1;PIN1;C5;PROX1;DLG3;MAPRE3;GUCA1B;MADD;STK39;ACVR1B;ADORA2B;ERBB3;AKT1;ERCC6;PINK1;PKD1;MLST8;PYCARD;MAP2K3;ERN1;TAZ;EREG;MIF
11458,GO:0045937,3.24544853810041e-05,0.999980639364998,99,691,positive regulation of phosphate metabolic process,BP,DUSP6;CEMIP;APOE;RAPGEF3;XDH;NOS1;EPHB2;CNTN1;IGF2;MST1R;EGFR;TIMP2;DUSP5;EGR1;PKN1;SHC1;F2R;PTK6;ABCA7;SHC2;ZP3;ERBB2;PKD2;PTHLH;PAK6;NTSR1;MINK1;ATP2B4;TNFRSF25;WNT7A;INSR;EPHA1;ITGA6;LPAR3;PRNP;SPRY2;SNX9;DLG4;STRADB;PFKFB2;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;MAPK3;DVL1;ADCY6;EPHB3;HES1;MLXIPL;IL6R;FGFR3;PRKACA;LRRK1;RPS6KA5;HBEGF;MAP2K2;FGFR4;TNFRSF1A;EHD4;MAPK8IP1;TRPV4;DUSP7;DGKQ;SEMA4C;GAS6;WNT7B;PTAFR;VAV3;IGFBP4;PRKCZ;MAPKAPK3;FGFR1;CAMKK1;PIN1;C5;PROX1;DLG3;MAPRE3;GUCA1B;MADD;STK39;ACVR1B;ADORA2B;ERBB3;AKT1;ERCC6;PINK1;PKD1;MLST8;PYCARD;MAP2K3;ERN1;TAZ;EREG;MIF
17986,GO:1902495,3.30121082788918e-05,0.9999887052763,26,115,transmembrane transporter complex,CC,SHANK2;NOS1;SCN8A;KCNG1;ABCA7;KCNC4;SCN4B;CPT1C;VAMP2;GM2A;DLG4;TTYH3;ATP12A;LRRC8A;SHANK3;KCNAB2;OLFM2;ABCA2;PRKACA;SCNN1A;ABCD4;DLG3;KCNMA1;SMDT1;KCNN4;SHISA6
2390,GO:0005539,3.44449938783267e-05,0.999988779380607,24,104,glycosaminoglycan binding,MF,CEMIP;APOE;PTPRS;LTBP4;PGF;POSTN;LTBP2;SMOC2;THBS3;SERPINE2;TNXB;PRNP;VEGFA;NRP2;HBEGF;FGFR4;HK1;FGFR1;ADGRE2;RTN4R;FGFBP1;COL13A1;VEGFB;PODXL2
1257,GO:0003013,3.49335662788876e-05,0.999984009846148,45,252,circulatory system process,BP,APOE;CTNNBIP1;GAA;NOS1;POSTN;EPAS1;EGFR;SERPING1;MTHFR;F2R;BBS2;THRA;DOCK4;NISCH;LRP5;SCN4B;ITPR3;NTSR1;ATP2B4;TBC1D8;TNNT1;ADCY6;ADA;HTR7;RASL10B;PRKACA;HBEGF;TRPV4;GAS6;PPARA;PTAFR;BCR;CTSZ;PPP1R13L;STK39;VEGFB;ADORA2B;ABR;AKT1;GPD1L;EHD3;SNTA1;MAP2K3;TAZ;GSTM2
17027,GO:0099537,3.55585992902531e-05,0.999982875750834,51,297,trans-synaptic signaling,BP,APOE;SYTL1;SHANK2;NOS1;EPHB2;NFATC4;EGFR;NLGN2;CRTC1;SYT8;F2R;ZMYND8;KCNC4;NISCH;BRSK1;ITPR3;DNM1;RIMS3;SERPINE2;VAMP2;NTSR1;MINK1;TMOD2;GLUL;ASIC1;WNT7A;ADARB1;SYNGAP1;LPAR3;PRNP;SLC12A7;DLG4;MYCBPAP;SHANK3;S1PR2;ETV5;DVL1;SSH1;MCTP1;HTR7;RAB3B;VGF;PRKCZ;DLG3;SNPH;AKT1;PINK1;RGS14;APBA1;FCHSD1;SHISA6
3491,GO:0007399,3.63790205111294e-05,0.999975145063405,186,1467,nervous system development,BP,FOS;ADGRL1;APOE;MARVELD1;IDH2;PTPRS;SEMA4B;BTBD2;CST3;SHANK2;GSN;NDRG1;MEF2D;NOS1;ZFP36L1;TCTN1;POSTN;GRB7;SCN8A;EPHB2;CNTN1;NFATC4;LRP1;OBSL1;EGFR;TIMP2;NLGN2;RAPGEFL1;ADGRF1;ULK1;SDK2;CRTC1;NAGLU;SHC1;PTK6;DEAF1;BBS2;ULK2;GJC2;IGSF9;MALL;ZMYND8;SOX12;ANK3;S100A6;HDAC5;THRA;DBNDD1;MARK4;TENM2;ERBB2;BRSK1;MICALL2;PKD2;PLXNB3;SALL2;IFT140;CD9;KIF13B;SIGMAR1;HEXB;SERPINE2;FUZ;NPHP4;UNK;MINK1;ATP2B4;TMOD2;CSNK1E;TRAPPC9;LAMB2;WNT7A;FBXW8;ID1;CELSR1;B4GAT1;ADARB1;SYNGAP1;DNMT3A;LPAR3;EFNB3;DLG4;TMEM107;BCL6;PLXNB1;BNIP3;FZD8;VEGFA;VANGL2;CEBPB;SHANK3;NAB2;MAPK3;ETV5;DVL1;GPSM1;ADCY6;PHGDH;EPHB3;HES1;SSH1;MBOAT7;CUL7;NRP2;CELSR2;SLIT3;PCSK9;BTBD11;PITPNM1;DGUOK;CYFIP2;RPS6KA5;FGFR4;SPTB;MXRA8;RAPGEF5;MDGA1;HDAC11;SEMA3B;LDLR;ROBO3;TRPV4;NHSL1;EEF2K;SEMA3F;AHNAK2;PEX7;SEMA4C;GAS6;POU6F1;LLGL1;ADGRB2;WNT7B;SUFU;RFNG;BCR;NEO1;SDHA;USP21;PRKCZ;NYAP1;SLITRK6;TWF2;TPP1;GPC1;NDE1;CDHR1;FGFR1;CTSZ;PIN1;PROX1;PCDHGC3;DLG3;BIN1;UNC119B;GRB10;JARID2;WNT2B;SNPH;RTN4R;EPB41L3;WNT3;SORL1;ACVR1B;GSS;ERBB3;ABR;AKT1;LRCH4;NDRG2;SMARCA1;SUN1;SSH3;GAS8;PKD1;RGS14;NRSN1;ATXN10;NINJ1;RANBP9;SLC2A1;APBA1;RARG;TRNP1;SEMA4F;SULF2
6551,GO:0022008,3.75985354702608e-05,0.999975757269776,136,1013,neurogenesis,BP,APOE;IDH2;PTPRS;SEMA4B;BTBD2;SHANK2;GSN;NDRG1;NOS1;TCTN1;POSTN;GRB7;EPHB2;CNTN1;NFATC4;LRP1;OBSL1;EGFR;TIMP2;ADGRF1;ULK1;SDK2;CRTC1;NAGLU;SHC1;PTK6;ULK2;GJC2;IGSF9;ZMYND8;ANK3;S100A6;HDAC5;DBNDD1;TENM2;ERBB2;BRSK1;MICALL2;PLXNB3;IFT140;CD9;KIF13B;HEXB;SERPINE2;NPHP4;UNK;MINK1;CSNK1E;TRAPPC9;LAMB2;WNT7A;FBXW8;ID1;CELSR1;B4GAT1;ADARB1;SYNGAP1;DNMT3A;LPAR3;EFNB3;DLG4;BCL6;PLXNB1;BNIP3;FZD8;VEGFA;VANGL2;CEBPB;SHANK3;NAB2;MAPK3;ETV5;DVL1;ADCY6;EPHB3;HES1;SSH1;MBOAT7;CUL7;NRP2;CELSR2;SLIT3;PCSK9;BTBD11;DGUOK;CYFIP2;RPS6KA5;SPTB;MXRA8;MDGA1;HDAC11;SEMA3B;LDLR;ROBO3;TRPV4;NHSL1;EEF2K;SEMA3F;AHNAK2;PEX7;SEMA4C;GAS6;LLGL1;WNT7B;SUFU;NEO1;USP21;PRKCZ;NYAP1;SLITRK6;TWF2;GPC1;NDE1;CDHR1;FGFR1;CTSZ;PIN1;PROX1;BIN1;UNC119B;GRB10;WNT2B;SNPH;RTN4R;EPB41L3;WNT3;SORL1;ERBB3;AKT1;SMARCA1;SUN1;SSH3;RGS14;ATXN10;RANBP9;SEMA4F
1989,GO:0004714,3.78419523581723e-05,0.999992885808981,13,38,transmembrane receptor protein tyrosine kinase activity,MF,EPHB2;MST1R;EGFR;ERBB2;INSR;EPHA1;EFNB3;EPHB3;NRP2;FGFR3;FGFR4;FGFR1;ERBB3
17026,GO:0099536,3.90192005513935e-05,0.99998113582873,51,298,synaptic signaling,BP,APOE;SYTL1;SHANK2;NOS1;EPHB2;NFATC4;EGFR;NLGN2;CRTC1;SYT8;F2R;ZMYND8;KCNC4;NISCH;BRSK1;ITPR3;DNM1;RIMS3;SERPINE2;VAMP2;NTSR1;MINK1;TMOD2;GLUL;ASIC1;WNT7A;ADARB1;SYNGAP1;LPAR3;PRNP;SLC12A7;DLG4;MYCBPAP;SHANK3;S1PR2;ETV5;DVL1;SSH1;MCTP1;HTR7;RAB3B;VGF;PRKCZ;DLG3;SNPH;AKT1;PINK1;RGS14;APBA1;FCHSD1;SHISA6
2197,GO:0005085,3.98611686887525e-05,0.999982114167565,42,229,guanyl-nucleotide exchange factor activity,MF,RAPGEF3;OBSCN;RALGDS;EGFR;RAPGEFL1;ARHGEF4;SHC1;RGL2;SHC2;RIN1;DOCK4;ERBB2;IQSEC2;TRAPPC9;DOCK6;PLEKHG4;DLG4;PLEKHG5;PLEKHG2;FGFR3;HBEGF;FGFR4;SPTB;RAPGEF5;PSD4;PLEKHG6;ARHGEF37;VAV3;BCR;FGFR1;MADD;EPS8L1;SBF1;ALS2CL;ERBB3;ABR;EPS8L2;ARHGEF10L;RANBP9;ARHGEF19;JAK3;EREG
14520,GO:0070062,4.05743372343206e-05,0.999971126776124,238,2030,extracellular exosome,CC,HTRA1;APOE;MARCKSL1;TSPAN1;PPL;IDH2;PTPRS;NT5E;GAA;SYTL1;NAPRT;PYGB;CST3;LTBP4;RAPGEF3;PGM1;GSN;OAF;PRDX5;NDRG1;PGLS;PRSS3;CADM4;COL6A1;ALOX15B;ARRDC1;EPN3;CNTN1;IGF2;GPX3;GAMT;APPL2;HEBP1;LTBP2;TIMP2;B3GAT3;CRYL1;FBXO2;ACOT7;TOM1L2;SERPING1;PYGL;DOPEY2;NAGLU;GNAL;BPHL;LAMA5;SLC9A3R2;GALE;ACTA2;PRSS8;S100A4;CTSB;CORO1B;PLAT;S100A6;ARHGAP23;PLD3;HYAL1;BCAM;SLC13A3;FBLN1;BSG;CTSF;PKD2;FUCA1;TST;SLC7A8;ITGB4;H2AFJ;VAT1;DNM1;CD9;XPC;HEXB;VAMP2;FUZ;JADE2;THSD4;CD320;MINK1;GGT1;ACP5;PLCD1;GM2A;GLUL;TNXB;LAMB2;WNT7A;INSR;RAB3D;AKR7A2;B4GAT1;HAGH;DNPH1;PRNP;SERINC2;IAH1;RNASET2;BLMH;ECM1;CEP250;SNX9;REEP2;TALDO1;RAB25;FAM20C;TTYH3;FAM213A;CHMP1B;IGFBP2;SEC14L2;MVB12B;CD81;ENTPD6;DNASE1L1;ARL2;DPP7;GPRC5C;SSC4D;ADAM15;ZDHHC1;MAPK3;AMN;GLB1;ENTPD2;GALK1;LTA4H;PHGDH;FURIN;SLC2A3;ACY1;CKMT1A;PFKL;GGACT;FCGBP;RHOF;PRKACA;F12;MAGEF1;CYFIP2;SCNN1A;ITGB5;RAB3B;MXRA8;SLC37A2;GAREM2;PMVK;MYH3;HDAC11;EHD4;SEMA3B;LYPLAL1;ACOT11;CROCC;MVB12A;GAS6;TKFC;WNT7B;BLVRB;COMT;ALDH16A1;RFNG;LTBP3;PCK2;VAV3;VASN;BCR;MUC19;WDR60;PRKCZ;CLTCL1;MDH2;CAPG;TM7SF3;ETFB;TWF2;TPP1;GPC1;ICOSLG;CTSZ;C5;CMBL;PCDHGC3;GPR155;KCNMA1;MTMR11;SERPINB6;ASS1;GLRX;CAPN2;TOLLIP;TSTA3;CSTB;PROCR;MAN2B2;DUSP23;LCAT;GAL3ST4;TMPRSS11D;CYBRD1;RTN4R;TIMP1;SDC1;GRHPR;ACTR1B;EPS8L1;WNT3;GSTT1;SORL1;ACVR1B;GSS;CTSD;TRAP1;NDRG2;GPD1L;EPS8L2;SLC5A5;NAGA;PKD1;CTSH;ABHD14B;ROBO4;CBLC;PNPO;SNX29;PCSK1N;SLC2A1;CPNE7;GALNS;FAM162A;PPCS;GSTM2;ABHD14A;KRT15;TMED4;MIF;STXBP2
5924,GO:0018212,4.097866079904e-05,0.99998158397861,42,230,peptidyl-tyrosine modification,BP,EPHB2;CNTN1;IGF2;MST1R;EGFR;SHC1;PTK6;ERBB2;INSR;EPHA1;PRNP;DLG4;DYRK1B;CD81;SRMS;VEGFA;MAPK3;EPHB3;HES1;IL6R;FGFR3;LRRK1;HBEGF;MAP2K2;FGFR4;DMTN;TNFRSF1A;EHD4;DGKQ;GAS6;BCR;PRKCZ;FGFR1;DLG3;ERBB3;ERCC6;MLST8;CBLC;MAP2K3;JAK3;EREG;MIF
5268,GO:0015929,4.28511586808591e-05,0.9999971699959,7,12,hexosaminidase activity,MF,CEMIP;NAGLU;HYAL1;HEXB;GM2A;NAGA;HEXDC
15832,GO:0072578,4.49773660634465e-05,0.999999219942152,5,6,neurotransmitter-gated ion channel clustering,BP,APOE;DLG4;SHANK3;SSH1;SHISA6
16060,GO:0090066,5.03399386152521e-05,0.999974713900369,54,326,regulation of anatomical structure size,BP,APOE;PTPRS;SEMA4B;GSN;NOS1;EGFR;ARPIN;F2R;BBS2;CORO1B;ULK2;DOCK4;TMOD2;WNT7A;LPAR3;SLC12A7;PLEKHH2;VEGFA;LRRC8A;SHANK3;WIPF1;ADCY6;SSH1;PLEKHG2;CDC42EP5;HTR7;RAB3B;SPTB;DMTN;SEMA3B;TRPV4;SEMA3F;SEMA4C;WNT7B;PTAFR;VAV3;CAPG;TWF2;KCNMA1;RTN4R;WHAMMP3;EPS8L1;WNT3;ADORA2B;AKT1;EPS8L2;SSH3;SPIRE2;MLST8;PYCARD;KCNN4;RARG;FCHSD1;SEMA4F
19904,GO:2000463,5.21707743781884e-05,0.999995098449698,8,16,positive regulation of excitatory postsynaptic potential,BP,SHANK2;NLGN2;WNT7A;DLG4;SHANK3;DVL1;SSH1;PRKCZ
19727,GO:2000145,5.36406664730401e-05,0.999968955639201,83,564,regulation of cell motility,BP,CEMIP;APOE;IDH2;SEMA4B;FAM110C;PGF;POSTN;GRB7;ALOX15B;LRP1;EGFR;MMP28;PKN1;ARPIN;F2R;LAMA5;BBS2;CORO1B;ZMYND8;HDAC5;DOCK4;ZP3;NISCH;HYAL1;ERBB2;FBLN1;PTPRU;PLXNB3;PHLDA2;SERPINE2;FUZ;MINK1;RHOD;WNT7A;INSR;EPHA1;ADARB1;ITGA6;SPRY2;ECM1;RAB25;PLXNB1;CD81;VEGFA;ADAM15;MAPK3;SSH1;NRP2;ADA;MCTP1;IL6R;RHOF;HBEGF;DMTN;SEMA3B;TRPV4;RHOBTB2;SEMA3F;SEMA4C;GAS6;PTAFR;BCR;ARAP3;FGFR1;PIN1;C5;PROX1;TIMP1;PPM1F;SORL1;VEGFB;ACVR1B;ERBB3;ABR;AKT1;TP53INP1;CTSH;ROBO4;PYCARD;MAP2K3;EREG;SEMA4F;MIF
9850,GO:0042127,5.65135839250354e-05,0.999963247254101,135,1026,regulation of cell proliferation,BP,HTRA1;APOE;CTNNBIP1;MARCKSL1;IDH2;CST3;TCFL5;CYP27B1;XDH;NDRG1;PGF;MEF2D;ZFP36L1;CGREF1;NR1D1;ALOX15B;IGF2;MST1R;EGFR;TIMP2;FBXO2;MXD4;EGR1;PKN1;SHC1;F2R;PTK6;DEAF1;LAMA5;GJC2;ASH2L;MXI1;S100A6;ZP3;RPS6KA2;LRP5;HYAL1;ERBB2;FBLN1;PTPRU;PKD2;PLXNB3;PHLDA2;PTHLH;CDKN1C;VIPR1;CD9;SERPINE2;FUZ;CD320;PLCD1;PDCD4;TNFRSF25;GLUL;WNT7A;ZMIZ1;INSR;TBC1D8;ID1;MVD;EPHA1;ADARB1;IL20RB;PRNP;SPRY2;MNT;ECM1;STAT6;SPEG;MTA3;PLCD3;WWTR1;RAB25;BCL6;PLXNB1;IGFBP2;CD81;SRMS;VEGFA;FBXW4;CEBPB;HSF4;S1PR2;TNFRSF6B;ETV5;HES1;MLXIPL;NRP2;TNFRSF14;ADA;IL6R;SLIT3;ZFP36;FGFR3;HBEGF;FGFR4;TNFRSF1A;HMGA2;GAS6;COMT;PTAFR;LTBP3;VAV3;PRKCZ;INPP5D;ICOSLG;FGFR1;CTSZ;PROX1;DLG3;SLC25A27;JARID2;TIMP1;FGFBP1;WNT3;VEGFB;ERBB3;AKT1;TP53INP1;NDRG2;SIX5;GAS8;CTSH;RNF187;PYCARD;ERN1;JAK3;RARG;ING4;EREG;TP53I11;TRNP1;MIF;SULF2;LZTS2
6180,GO:0019637,5.90936041788267e-05,0.999962811859749,114,848,organophosphate metabolic process,BP,H6PD;APOE;IDH2;NT5E;NAPRT;RAPGEF3;PGM1;XDH;PGLS;NOS1;NME4;EGFR;TIMP2;CRYL1;ACOT7;ISYNA1;PYGL;LPCAT4;DGKA;PIK3R2;ZP3;NMRK1;ERBB2;OGDHL;PKD2;PTHLH;HEXB;LTB4R2;NTSR1;PLCD1;ZFYVE21;INSR;MVD;NDUFS8;DNPH1;SERINC2;SRD5A3;DLG4;PLCD3;TALDO1;FAM20C;UCKL1;PFKFB2;CD81;VEGFA;KCNAB2;DHTKD1;ENTPD2;GALK1;LHPP;ADCY6;MLXIPL;MBOAT7;NADK;TK2;ADA;OSBPL5;PFKL;PCSK9;FGFR3;PITPNM1;NUDT10;PLCH2;DGUOK;HBEGF;PI4K2A;FGFR4;PMVK;MYH3;LDLR;PIGZ;DGKQ;HK1;PPARA;TKFC;GUK1;TTC7B;PTAFR;IMPA2;PCK2;VAV3;SDHA;MDH2;INPP5D;FGFR1;GTPBP1;DLG3;PI4KAP2;LCAT;GUCA1B;PITPNM3;PIGV;PIGQ;SBF1;ADORA2B;ERBB3;ACP6;GPD1L;UQCR11;PINK1;PLPPR2;ABHD14B;AGPAT4;PNPO;NDUFV3;MOCS1;CPNE7;TAZ;NEIL1;FUK;EREG;PPCS;PODXL2;AGPAT3
3448,GO:0007268,5.9939389246382e-05,0.999970532680706,50,295,chemical synaptic transmission,BP,APOE;SYTL1;SHANK2;EPHB2;NFATC4;EGFR;NLGN2;CRTC1;SYT8;F2R;ZMYND8;KCNC4;NISCH;BRSK1;ITPR3;DNM1;RIMS3;SERPINE2;VAMP2;NTSR1;MINK1;TMOD2;GLUL;ASIC1;WNT7A;ADARB1;SYNGAP1;LPAR3;PRNP;SLC12A7;DLG4;MYCBPAP;SHANK3;S1PR2;ETV5;DVL1;SSH1;MCTP1;HTR7;RAB3B;VGF;PRKCZ;DLG3;SNPH;AKT1;PINK1;RGS14;APBA1;FCHSD1;SHISA6
16909,GO:0098916,5.9939389246382e-05,0.999970532680706,50,295,anterograde trans-synaptic signaling,BP,APOE;SYTL1;SHANK2;EPHB2;NFATC4;EGFR;NLGN2;CRTC1;SYT8;F2R;ZMYND8;KCNC4;NISCH;BRSK1;ITPR3;DNM1;RIMS3;SERPINE2;VAMP2;NTSR1;MINK1;TMOD2;GLUL;ASIC1;WNT7A;ADARB1;SYNGAP1;LPAR3;PRNP;SLC12A7;DLG4;MYCBPAP;SHANK3;S1PR2;ETV5;DVL1;SSH1;MCTP1;HTR7;RAB3B;VGF;PRKCZ;DLG3;SNPH;AKT1;PINK1;RGS14;APBA1;FCHSD1;SHISA6
1704,GO:0004252,6.03885882602156e-05,0.999982707578346,19,75,serine-type endopeptidase activity,MF,HTRA1;TYSND1;PRSS3;RHBDF1;PRSS8;CTSB;PLAT;MMP1;RHBDF2;FURIN;PCSK9;F12;RHBDL1;PCSK1;TPP1;TMPRSS11D;CTSD;LONP2;CTSH
10408,GO:0043270,6.17637776720655e-05,0.999977874897649,26,122,positive regulation of ion transport,BP,CEMIP;APOE;NOS1;EPHB2;CNTN1;FHL1;F2R;ABCA7;PRSS8;GJC2;ANK3;PKD2;SCN4B;NTSR1;LPAR3;SHANK3;RAB3B;PTAFR;GLRX;STK39;AKT1;GPD1L;PINK1;EHD3;GSTM2;MIF
12748,GO:0051049,6.37625948144459e-05,0.999957713177665,145,1115,regulation of transport,BP,CEMIP;APOE;TSPAN1;IDH2;SYTL1;SHANK2;RAPGEF3;EVI5L;NOS1;POSTN;NR1D1;ALOX15B;SCN8A;EPHB2;CNTN1;LRP1;KCNG1;EGFR;B3GAT3;HADH;NLGN2;REEP6;FHL1;RHBDF1;SYT8;F2R;ABCA7;PRSS8;GJC2;TBC1D14;KCNC4;ABCG1;ANK3;PIK3R2;KCNJ15;ZP3;LRP5;PLTP;ERBB2;MICALL2;PKD2;SCN4B;EDEM1;ITPR3;DNM1;RIMS3;SERPINE2;VPS11;VAMP2;NTSR1;MINK1;ATP2B4;TFDP2;GLUL;ASIC1;INSR;RAB3D;TBC1D8;LPAR3;TMEM173;PRNP;SNX33;DLG4;REEP2;RAB25;MYO18A;PFKFB2;VEGFA;ARL2;RHBDF2;SHANK3;MAPK3;TUB;KCNAB2;RAB40B;HES1;ABCA2;LRSAM1;ADA;MCTP1;RASL10B;PFKL;PCSK9;MAPKBP1;PRKACA;RAB3B;MAP2K2;DMTN;EHD4;LDLR;SNX17;TRPV4;EEF2K;LDLRAP1;HK1;GAS6;LLGL1;PPARA;COMT;PTAFR;PCK2;BCR;TBC1D16;PRKCZ;CLTCL1;TM7SF3;ARAP3;FGFR1;C5;KCNMA1;BIN1;VSNL1;OSCP1;GLRX;SLC25A27;GRB10;ADGRE2;SDC1;RTN2;SORL1;STK39;TBC1D17;ANO9;ADORA2B;TPCN1;ERBB3;ABR;AKT1;STON1;GPD1L;PINK1;EHD3;SNTA1;HOMER2;PYCARD;KCNN4;SIRT3;SLC2A1;GSTM2;SHISA6;GIPR;RAB40C;MIF;STXBP2;UBL5
4555,GO:0010646,6.38598344701192e-05,0.999953268631263,272,2306,regulation of cell communication,BP,TNIP1;HTRA1;DUSP6;APOE;CTNNBIP1;PTPRS;WWC3;FAM110C;SHANK2;LTBP4;RAPGEF3;CYP27B1;GSN;XDH;PGF;NOS1;LTBP1;ARAP1;SH3BP2;TCTN1;POSTN;GRB7;NR1D1;ALOX15B;ARRDC1;RBCK1;EPHB2;OBSCN;IGF2;NFATC4;MST1R;LRP1;APPL2;EGFR;TIMP2;HADH;NLGN2;DUSP5;MDFI;EGR1;RHBDF1;PKN1;CMTM7;CRTC1;ARHGEF4;SHC1;RGL2;F2R;PTK6;ABCA7;S100A4;SHC2;CXXC5;ZMYND8;KCNC4;ANK3;PIK3R2;THRA;ARHGAP23;ZP3;NISCH;LRP5;MAML3;ERBB2;FBLN1;PKD2;IQSEC2;ITPR3;PHLDA2;DNM1;SPRY4;DDIT4L;PTHLH;CDKN1C;RIMS3;IFT140;PTPRE;PAK6;SERPINE2;VAMP2;FUZ;NPHP4;NTSR1;CD320;MINK1;RALGAPA2;ATP2B4;TMOD2;TFDP2;CSNK1E;RASA4;AGAP1;PDCD4;SLC20A1;ACAP3;TNFRSF25;GLUL;RHOD;USP20;ASIC1;PLEKHG4;WNT7A;ZMIZ1;INSR;ID1;GRK6;EPHA1;ITGA6;SYNGAP1;LPAR3;PRNP;SPRY2;MNT;ECM1;DLG4;STRADB;WWTR1;FAM20C;BCL6;PFKFB2;PLXNB1;IGFBP2;MVB12B;BNIP3;CD81;SRMS;FZD8;VEGFA;ARL2;VANGL2;RHBDF2;SHANK3;ACVR2B;S1PR2;MAPK3;PLEKHG5;CARD19;DVL1;L3MBTL1;EPHB3;HES1;SSH1;FURIN;EVC;ARHGAP22;PLEKHG2;ADA;MCTP1;PIDD1;PAG1;SH2D2A;RASL10B;PFKL;IL6R;SLIT3;PCSK9;RHOF;MAPKBP1;FGFR3;PRKACA;LRRK1;CYFIP2;HBEGF;RAB3B;MAP2K2;FGFR4;DMTN;PSD4;VGF;TNFRSF1A;MAPK8IP1;TRPV4;RHOBTB2;IFNGR2;DUSP7;TNFAIP8L1;LDLRAP1;DGKQ;SEMA4C;MVB12A;MIB2;GAS6;BTRC;LLGL1;TKFC;WNT7B;GIT1;SUFU;PLEKHG6;RFNG;ARHGEF37;PCK2;VAV3;VASN;BCR;NEO1;IGFBP4;PRKCZ;INPP5D;TM7SF3;GPC1;MAPKAPK3;ARAP3;FGFR1;PIN1;C5;TMEM204;WBP2;ASAP2;VSNL1;PPP1R13L;GRB10;SESN2;WNT2B;TMEM161A;GUCA1B;MADD;RTN4R;TIMP1;SH2B3;FGFBP1;PEAR1;EPS8L1;WNT3;SORL1;STK39;VEGFB;ACVR1B;ADORA2B;ERBB3;ABR;AKT1;TRAP1;TMBIM4;NLRX1;ZNF385A;TP53INP1;NDRG2;ERCC6;GPD1L;EPS8L2;SPPL2B;PINK1;ARHGEF10L;HOMER2;RGS14;CTSH;MLST8;CBLC;EPN2;PYCARD;MAP2K3;KCNN4;ERN1;CKLF;RANBP9;ARHGEF19;SIRT3;C12ORF66;CMTM4;SLC2A1;LITAF;EREG;FAM162A;GSTM2;SHISA6;GIPR;TMED4;RGS12;MIF;SULF2;LZTS2
11412,GO:0045860,6.75977082336148e-05,0.999964560825982,59,369,positive regulation of protein kinase activity,BP,DUSP6;CEMIP;IGF2;MST1R;EGFR;DUSP5;EGR1;PKN1;SHC1;F2R;SHC2;ERBB2;PKD2;PAK6;MINK1;ATP2B4;INSR;LPAR3;PRNP;SPRY2;SNX9;DLG4;STRADB;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;MAPK3;ADCY6;PRKACA;MAP2K2;DUSP7;DGKQ;GAS6;WNT7B;PRKCZ;MAPKAPK3;FGFR1;CAMKK1;C5;PROX1;DLG3;MAPRE3;MADD;STK39;ADORA2B;ERBB3;AKT1;ERCC6;PINK1;PKD1;MLST8;MAP2K3;ERN1;EREG;MIF
715,GO:0001941,6.85067928104534e-05,0.999991514023122,9,21,postsynaptic membrane organization,BP,APOE;NLGN2;ZMYND8;DLG4;SHANK3;ETV5;DVL1;SSH1;SHISA6
14480,GO:0062013,6.87343339933168e-05,0.999977816845691,22,94,positive regulation of small molecule metabolic process,BP,APOE;RAPGEF3;NOS1;NR1D1;IGF2;TIMP2;ABCG1;PTHLH;NTSR1;INSR;PFKFB2;MLXIPL;LDLRAP1;PPARA;COMT;PTAFR;GUCA1B;ADORA2B;AKT1;PINK1;MLYCD;TAZ
17229,GO:0120039,7.17402185090388e-05,0.999960409197781,68,440,plasma membrane bounded cell projection morphogenesis,BP,APOE;PTPRS;SEMA4B;SHANK2;TCTN1;POSTN;GRB7;EPHB2;NFATC4;OBSL1;EGFR;ULK1;ARPIN;SHC1;CORO1B;ULK2;ANK3;S100A6;ERBB2;BRSK1;PLXNB3;KIF13B;MINK1;LAMB2;WNT7A;FBXW8;ID1;B4GAT1;ADARB1;SYNGAP1;LPAR3;EFNB3;DLG4;PLXNB1;VEGFA;VANGL2;SHANK3;MAPK3;DVL1;EPHB3;SSH1;CUL7;NRP2;CELSR2;SLIT3;CYFIP2;RPS6KA5;SPTB;SEMA3B;ROBO3;EEF2K;SEMA3F;SEMA4C;LLGL1;WNT7B;NEO1;PRKCZ;NYAP1;SLITRK6;TWF2;GPC1;GRB10;RTN4R;EPB41L3;WNT3;SSH3;RANBP9;SEMA4F
12390,GO:0048858,7.70132639994564e-05,0.999957388377978,68,441,cell projection morphogenesis,BP,APOE;PTPRS;SEMA4B;SHANK2;TCTN1;POSTN;GRB7;EPHB2;NFATC4;OBSL1;EGFR;ULK1;ARPIN;SHC1;CORO1B;ULK2;ANK3;S100A6;ERBB2;BRSK1;PLXNB3;KIF13B;MINK1;LAMB2;WNT7A;FBXW8;ID1;B4GAT1;ADARB1;SYNGAP1;LPAR3;EFNB3;DLG4;PLXNB1;VEGFA;VANGL2;SHANK3;MAPK3;DVL1;EPHB3;SSH1;CUL7;NRP2;CELSR2;SLIT3;CYFIP2;RPS6KA5;SPTB;SEMA3B;ROBO3;EEF2K;SEMA3F;SEMA4C;LLGL1;WNT7B;NEO1;PRKCZ;NYAP1;SLITRK6;TWF2;GPC1;GRB10;RTN4R;EPB41L3;WNT3;SSH3;RANBP9;SEMA4F
8903,GO:0034762,7.70542557607356e-05,0.999962814839939,46,268,regulation of transmembrane transport,BP,CEMIP;SHANK2;NOS1;SCN8A;EPHB2;KCNG1;NLGN2;FHL1;F2R;GJC2;KCNC4;ANK3;PIK3R2;KCNJ15;PKD2;SCN4B;VAMP2;NTSR1;MINK1;ATP2B4;INSR;PRNP;DLG4;SHANK3;KCNAB2;PCSK9;PRKACA;PTAFR;PRKCZ;CLTCL1;KCNMA1;GLRX;SLC25A27;GRB10;RTN2;STK39;ANO9;TPCN1;AKT1;GPD1L;PINK1;EHD3;SNTA1;SLC2A1;GSTM2;SHISA6
12894,GO:0051270,8.10498508254771e-05,0.999951723746916,87,605,regulation of cellular component movement,BP,CEMIP;APOE;IDH2;SEMA4B;FAM110C;PGF;ARAP1;POSTN;GRB7;ALOX15B;LRP1;EGFR;MMP28;PKN1;ARPIN;F2R;LAMA5;BBS2;CORO1B;ZMYND8;HDAC5;DOCK4;ZP3;NISCH;HYAL1;ERBB2;FBLN1;PTPRU;PLXNB3;PHLDA2;CD9;SERPINE2;FUZ;MINK1;RHOD;WNT7A;INSR;EPHA1;ADARB1;ITGA6;SPRY2;ECM1;RAB25;BCL6;PLXNB1;CD81;VEGFA;ADAM15;MAPK3;SSH1;NRP2;ADA;MCTP1;IL6R;RHOF;HBEGF;DMTN;SEMA3B;TRPV4;RHOBTB2;SEMA3F;SEMA4C;GAS6;PTAFR;BCR;ARAP3;FGFR1;PIN1;C5;PROX1;TIMP1;WNT3;PPM1F;SORL1;VEGFB;ACVR1B;ERBB3;ABR;AKT1;TP53INP1;CTSH;ROBO4;PYCARD;MAP2K3;EREG;SEMA4F;MIF
6624,GO:0023014,8.29180761435813e-05,0.999950425212399,88,616,signal transduction by protein phosphorylation,BP,TNIP1;DUSP6;APOE;XDH;ZFP36L1;EPHB2;IGF2;MST1R;MAPK13;EGFR;TIMP2;DUSP5;PKN1;SHC1;F2R;ABCA7;SHC2;PIK3R2;ERBB2;FBLN1;SPRY4;PAK6;MINK1;RASA4;PDCD4;TNFRSF25;WNT7A;INSR;ID1;EPHA1;SYNGAP1;LPAR3;SPRY2;DLG4;STRADB;CD81;FZD8;VEGFA;VANGL2;SHANK3;ACVR2B;S1PR2;MAPK3;EPHB3;CDC42EP5;ZFP36;FGFR3;HBEGF;MAP2K2;FGFR4;SPTB;TNFRSF1A;MAPK8IP1;TRPV4;DUSP7;SEMA4C;GAS6;BTRC;WNT7B;IGFBP4;PRKCZ;MAPKAPK3;FGFR1;PIN1;C5;WDR83;MADD;SORL1;STK39;ACVR1B;ADORA2B;ERBB3;AKT1;NDRG2;ERCC6;IL17RD;PINK1;RGS14;CTSH;CBLC;PYCARD;MAP2K3;ERN1;RANBP9;SIRT3;JAK3;EREG;MIF
5301,GO:0016020,8.75043658649711e-05,0.999932011837795,610,5747,membrane,CC,HTRA1;FOS;LMF1;CEMIP;ADGRL1;APOE;TYSND1;MARVELD1;MARCKSL1;TSPAN1;PPL;IDH2;PTPRS;FLNC;SEMA4B;NT5E;GAA;SYTL1;LTB4R;PYGB;CST3;SHANK2;RAPGEF3;MRC2;CYP27B1;GSN;CLCA2;NDRG1;PRODH;PGF;CADM4;NOS1;MARCH9;PARVB;ARAP1;C14ORF132;COL6A1;TCTN1;GRB7;CRAT;EFS;ALOX15B;ARRDC1;EPN3;FAM210B;NYNRIN;SCN8A;SLCO4A1;EPHB2;OBSCN;CNTN1;CPT2;MYZAP;IGF2;NME4;MST1R;LRP1;APPL2;KCNG1;ST6GALNAC2;RAB11FIP4;EGFR;B3GAT3;HADH;NLGN2;REEP6;FBXO2;SLC43A1;FHL1;KDSR;RAPGEFL1;ADGRF1;ULK1;RHBDF1;PKN1;CMTM7;MXRA7;SDK2;CRTC1;ARHGEF4;DOPEY2;SYT8;SHC1;F2R;PTK6;GNAL;BPHL;ABCA7;SLC9A3R2;CA12;BBS2;SLC16A5;PRSS8;TMCC3;LPCAT4;SHC2;SLC16A3;CORO1B;ULK2;DGKA;GJC2;IGSF9;DHRS1;MALL;GRAMD4;CERS4;KCNC4;ABCG1;RIN1;ANK3;PIK3R2;S100A6;PLD3;KCNJ15;DOCK4;ZP3;CSMD2;NISCH;LRP5;DBNDD1;TMEM54;ANO8;TENM2;SLC2A9;LRP3;B4GALNT4;BCAM;ERBB2;SLC13A3;EXOC2;MICALL2;BSG;PTPRU;PKD2;TMEM129;TST;SCN4B;CPT1C;EDEM1;ABTB1;SLC7A8;ITGB4;ITPR3;PLXNB3;PRAF2;PHLDA2;VAT1;DNM1;SPRY4;FCHO1;RIMS3;LRP11;VIPR1;CD9;XPC;PTPRE;CACFD1;SIGMAR1;HEXB;DNAJC4;SERPINE2;VPS11;VAMP2;GALNT12;LTB4R2;KIAA1549L;NTSR1;CD320;MINK1;RALGAPA2;ATP2B4;GGT1;SNN;SLC6A8;PHF7;ACP5;RASA4;PLCD1;TRAPPC9;AGAP1;ZFYVE21;DIRC2;TMEM134;GM2A;SLC20A1;ACAP3;TNFRSF25;PRR7;RHOD;ARVCF;PEX10;ARMCX2;ASIC1;SPATA18;WNT7A;INSR;RAB3D;LCE1E;TBC1D8;CELSR1;GRK6;B4GAT1;NDUFS8;RABGGTA;EPHA1;ITGA6;SYNGAP1;IL20RB;NBEAL2;LPAR3;TMEM173;PRNP;SERINC2;SRD5A3;ATP7B;EFNB3;GRAMD1A;SNX33;SPRY2;SLC12A7;NPDC1;ATG16L2;SNX9;STAT6;DLG4;ABCD1;MARCH2;REEP2;PLCD3;RAB25;MYO18A;TMEM107;ARHGAP27;CERCAM;MYCBPAP;SCART1;PLEKHH2;C1ORF210;TTYH3;ANKZF1;ATP12A;PLXNB1;CHMP1B;IGFBP2;MVB12B;TMEM92;BNIP3;CD81;SRMS;FCGRT;FZD8;VEGFA;ENTPD6;HOOK2;LRRC8A;ARL2;VANGL2;TMEM63C;AP2A2;RHBDF2;GPRC5C;SHANK3;SSC4D;ACVR2B;ADAM15;ZDHHC1;S1PR2;TNFRSF6B;MAPK3;PLEKHG5;TUB;KCNAB2;ETV5;OLFM2;CARD19;AMN;SLC22A18;CAPNS2;C19ORF33;RAB40B;DVL1;ENTPD2;GALK1;FYCO1;GPSM1;ADCY6;L3MBTL1;WIPI2;ST3GAL3;SLC16A13;EPHB3;FHOD1;TMEM25;SSH1;COMTD1;FURIN;MBOAT7;SLC48A1;SAMD3;EVC;SLC2A3;TRIM4;NRP2;GPR153;ABCA2;TNFRSF14;LRSAM1;LY6K;ADA;CDC42EP5;MCTP1;OSBPL5;RETSAT;PAG1;AQP3;HTR7;RASL10B;CELSR2;CKMT1A;PFKL;IL6R;PCSK9;TMEM9;SLC28A2;RHOF;BTBD11;CTXN1;FGFR3;PRKACA;F12;PITPNM1;KIAA1549;PLCH2;CYFIP2;SLC38A10;MFSD13A;SCNN1A;HBEGF;SLC25A37;ITGB5;RAB3B;MAP2K2;PI4K2A;FGFR4;SPTB;MXRA8;SLC37A2;STX10;TSPAN33;DMTN;RNF215;PMVK;BBS1;PSD4;MDGA1;XYLT2;HDAC11;TNFRSF1A;SEZ6L2;EHD4;MAPK8IP1;LDLR;PTOV1;CYP3A5;ROBO3;SNX17;ABHD17C;TRPV4;RHOBTB2;PIGZ;IFNGR2;EIF4EBP3;RRNAD1;CROCC;NHSL1;LRRC45;RHBDL1;TMTC4;MSLN;LDLRAP1;TM7SF2;AHNAK2;DGKQ;KLHDC2;SEMA4C;MVB12A;HK1;FAM171A2;SLC29A4;SLC35E2B;CHST6;C1ORF115;SDHAF4;LLGL1;ADGRB2;HMGCL;TSPAN4;TMEM187;WNT7B;BLVRB;GIT1;COMT;ALDH16A1;TTC7B;AIG1;PTAFR;PLEKHG6;RFNG;ANKRD13D;TMEM200A;REEP4;ATG2A;VAV3;LRP10;VASN;BCR;TMEM175;NEO1;SDHA;GSDMC;MUC19;USP21;RNF123;PRKCZ;ZDHHC24;CLTCL1;HLTF;MDH2;BCORL1;INPP5D;TM7SF3;TMCO6;ABCD4;SLITRK6;GPC1;TMX4;ICOSLG;SMOX;NDE1;AGO4;ARAP3;CDHR1;FGFR1;CTSZ;MAN1B1;PNPLA4;C5;TMEM204;GTPBP1;PCDHGC3;C21ORF2;ASAP2;DLG3;GPR155;KCNMA1;ESYT2;BIN1;VSNL1;YIPF3;TMEM8B;SERPINB6;OSCP1;PI4KAP2;SH3D19;WDR83;SLC25A27;TMCO3;GRB10;BFSP1;SYNC;CAPN2;NDUFA4L2;TOLLIP;ADCK5;TMEM161A;PROCR;SNPH;MAN2B2;TMEM231;GUCA1B;ADGRE2;GAL3ST4;SMDT1;PITPNM3;TMPRSS11D;CYBRD1;MADD;LMLN;PAQR4;RTN4R;ELFN2;OR7D2;EPB41L3;PIGV;SLC9A7;CD68;SDC1;WHAMMP3;ACTR1B;FGFBP1;RTN2;PEAR1;EPS8L1;PIGQ;WNT3;SBF1;SORL1;STK39;COL13A1;VEGFB;ACVR1B;KRTCAP3;ANO9;FAM189B;GSDMA;TSNARE1;ADORA2B;TPCN1;HGSNAT;SLC25A29;ERBB3;ABR;CYP2S1;AKT1;CTSD;TRAP1;STON1;TMBIM4;NLRX1;ADAM19;LRCH4;FAM8A1;VPS33B;GPD1L;EPS8L2;SLC5A5;SUN1;TMEM120A;SPPL2B;IL17RD;UQCR11;ADCK2;PINK1;PKD1;EHD3;LONP2;SLC22A17;SNTA1;HOMER2;PLPPR2;RGS14;SYNE3;GOLGA2P5;SPIRE2;EHBP1L1;ROBO4;AGPAT4;RILPL1;NRSN1;CBLC;ATXN10;EPN2;NINJ1;MAP2K3;RHBG;POMT1;KCNN4;DDN;DNAJC22;NDUFV3;STK17A;ERN1;CKLF;RANBP9;TMEM229B;GCAT;ORAI3;TMEM158;C12ORF66;CMTM4;SLC2A1;CPNE7;TAZ;RNASEK;JAK3;LITAF;APBA1;ORAI2;RARG;EREG;FAM162A;ABHD14A;PODXL2;ZFYVE19;SHISA6;GIPR;PQLC2;TP53I11;TMED4;SEMA4F;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;APCDD1L;SULF2;STXBP2;LZTS2
3559,GO:0007610,9.22752582418194e-05,0.999953272085389,51,310,behavior,BP,FOS;APOE;ESPN;GAA;CST3;SHANK2;EPHB2;EGFR;NLGN2;ADGRF1;CRTC1;NAGLU;ABCA7;DEAF1;BBS2;THRA;ITPR3;DNM1;HEXB;SERPINE2;NPHP4;NTSR1;TMOD2;GM2A;ASIC1;INSR;CELSR1;ADARB1;SYNGAP1;PRNP;EFNB3;DLG4;CEBPB;SHANK3;ETV5;OLFM2;DVL1;MTA1;ADA;LDLR;RAG1;PPARA;COMT;PRKCZ;SLITRK6;CSTB;ZNF385A;HOMER2;RGS14;FBXL20;APBA1
6636,GO:0023051,9.2367860075149e-05,0.999931814644247,274,2337,regulation of signaling,BP,TNIP1;HTRA1;DUSP6;APOE;CTNNBIP1;PTPRS;WWC3;FAM110C;SHANK2;LTBP4;RAPGEF3;CYP27B1;GSN;XDH;PGF;NOS1;LTBP1;ARAP1;SH3BP2;TCTN1;POSTN;GRB7;NR1D1;ALOX15B;ARRDC1;RBCK1;EPHB2;OBSCN;IGF2;NFATC4;MST1R;LRP1;APPL2;EGFR;TIMP2;HADH;NLGN2;DUSP5;MDFI;EGR1;RHBDF1;PKN1;CMTM7;CRTC1;ARHGEF4;SHC1;RGL2;F2R;PTK6;ABCA7;S100A4;SHC2;CXXC5;ZMYND8;KCNC4;PIK3R2;THRA;ARHGAP23;ZP3;NISCH;LRP5;MAML3;ERBB2;FBLN1;PKD2;IQSEC2;ITPR3;PHLDA2;DNM1;SPRY4;DDIT4L;PTHLH;CDKN1C;RIMS3;IFT140;PTPRE;PAK6;SERPINE2;VAMP2;FUZ;NPHP4;NTSR1;CD320;MINK1;RALGAPA2;ATP2B4;TMOD2;TFDP2;CSNK1E;RASA4;AGAP1;PDCD4;SLC20A1;ACAP3;TNFRSF25;GLUL;RHOD;USP20;ASIC1;PLEKHG4;WNT7A;ZMIZ1;INSR;ID1;GRK6;EPHA1;ITGA6;SYNGAP1;LPAR3;PRNP;SPRY2;MNT;ECM1;DLG4;STRADB;WWTR1;FAM20C;BCL6;PFKFB2;PLXNB1;IGFBP2;MVB12B;BNIP3;CD81;SRMS;FZD8;VEGFA;ARL2;VANGL2;RHBDF2;SHANK3;ACVR2B;S1PR2;MAPK3;PLEKHG5;CARD19;DVL1;L3MBTL1;EPHB3;HES1;SSH1;FURIN;EVC;ARHGAP22;PLEKHG2;ADA;MCTP1;PIDD1;PAG1;SH2D2A;RASL10B;PFKL;IL6R;SLIT3;PCSK9;RHOF;MAPKBP1;FGFR3;PRKACA;LRRK1;CYFIP2;HBEGF;RAB3B;MAP2K2;FGFR4;DMTN;PSD4;VGF;TNFRSF1A;MAPK8IP1;TRPV4;RHOBTB2;IFNGR2;DUSP7;TNFAIP8L1;LDLRAP1;DGKQ;SEMA4C;MVB12A;MIB2;GAS6;BTRC;LLGL1;TKFC;WNT7B;GIT1;SUFU;PLEKHG6;RFNG;ARHGEF37;PCK2;VAV3;VASN;BCR;NEO1;IGFBP4;TBC1D16;PRKCZ;INPP5D;TM7SF3;GPC1;MAPKAPK3;ARAP3;FGFR1;PIN1;C5;TMEM204;WBP2;ASAP2;VSNL1;PPP1R13L;GRB10;SESN2;WNT2B;TMEM161A;GUCA1B;MADD;RTN4R;TIMP1;SH2B3;FGFBP1;PEAR1;EPS8L1;WNT3;SORL1;STK39;VEGFB;ACVR1B;ADORA2B;ERBB3;ABR;AKT1;TRAP1;TMBIM4;NLRX1;ZNF385A;TP53INP1;NDRG2;ERCC6;GPD1L;EPS8L2;SPPL2B;PINK1;EHD3;ARHGEF10L;HOMER2;RGS14;CTSH;MLST8;CBLC;EPN2;PYCARD;MAP2K3;KCNN4;ERN1;CKLF;RANBP9;ARHGEF19;SIRT3;C12ORF66;CMTM4;SLC2A1;LITAF;APBA1;EREG;FAM162A;GSTM2;SHISA6;GIPR;TMED4;RGS12;MIF;SULF2;LZTS2
7661,GO:0032102,9.28619803018332e-05,0.99995984357877,35,188,negative regulation of response to external stimulus,BP,HTRA1;APOE;PTPRS;SEMA4B;NT5E;MMP28;SERPING1;BBS2;CORO1B;PLAT;CD9;SERPINE2;ACP5;PDCD4;IL20RB;DVL1;MEFV;ADA;MAPKBP1;F12;TNFRSF1A;SEMA3B;SEMA3F;SEMA4C;FAM3A;PPARA;TKFC;BCR;C5;RTN4R;WNT3;ABR;NLRX1;SEMA4F;MIF
12257,GO:0048589,9.43227015432655e-05,0.999948798775121,62,395,developmental growth,BP,DUSP6;APOE;PTPRS;ERCC1;WWC3;SEMA4B;SHANK2;GSN;ZFP36L1;POSTN;GAMT;ULK1;BBS2;ULK2;THBS3;ZP3;PLXNB3;PHLDA2;LAMB2;WNT7A;ZMIZ1;INSR;SH3PXD2B;ADARB1;LPAR3;SPRY2;WWTR1;PLXNB1;VEGFA;VANGL2;SHANK3;ACVR2B;ADAM15;DVL1;EVC;NRP2;SLIT3;FGFR3;CYFIP2;SEMA3B;SEMA3F;SEMA4C;WNT7B;RXRA;PRKCZ;SLITRK6;TWF2;FGFR1;PIN1;PROX1;PPP1R13L;JARID2;RTN4R;WNT3;AKT1;ERCC6;NINJ1;APBA1;RARG;EREG;SEMA4F;KIF26B
4639,GO:0010771,9.50589043508709e-05,0.999974136121109,17,64,negative regulation of cell morphogenesis involved in differentiation,BP,PTPRS;SEMA4B;POSTN;EPHB2;NFATC4;ULK2;FBLN1;ID1;SYNGAP1;EFNB3;DMTN;SEMA3B;SEMA3F;SEMA4C;RTN4R;WNT3;SEMA4F
2402,GO:0005578,9.56966751616063e-05,0.999958581191499,35,186,proteinaceous extracellular matrix,CC,CST3;LTBP4;LTBP1;COL6A1;POSTN;LTBP2;TIMP2;SMOC2;MMP28;LOXL1;LAMA5;MMP1;ZP3;CRTAP;FBLN1;THSD4;ADAMTS7;TNXB;LAMB2;WNT7A;ITGA6;ECM1;VEGFA;ENTPD2;SLIT3;WNT7B;ADAMTS13;SLITRK6;GPC1;CHADL;WNT2B;TIMP1;WNT3;OLFML2A;ADAMTSL4
12366,GO:0048812,9.72375086815836e-05,0.999946218782718,66,428,neuron projection morphogenesis,BP,APOE;PTPRS;SEMA4B;SHANK2;TCTN1;POSTN;GRB7;EPHB2;NFATC4;OBSL1;EGFR;ULK1;SHC1;ULK2;ANK3;S100A6;ERBB2;BRSK1;PLXNB3;KIF13B;MINK1;LAMB2;WNT7A;FBXW8;ID1;B4GAT1;ADARB1;SYNGAP1;LPAR3;EFNB3;DLG4;PLXNB1;VEGFA;VANGL2;SHANK3;MAPK3;DVL1;EPHB3;SSH1;CUL7;NRP2;CELSR2;SLIT3;CYFIP2;RPS6KA5;SPTB;SEMA3B;ROBO3;EEF2K;SEMA3F;SEMA4C;LLGL1;WNT7B;NEO1;PRKCZ;NYAP1;SLITRK6;TWF2;GPC1;GRB10;RTN4R;EPB41L3;WNT3;SSH3;RANBP9;SEMA4F
6660,GO:0030030,9.72832035533918e-05,0.999935362854447,137,1045,cell projection organization,BP,APOE;ESPN;PTPRS;SEMA4B;FAM110C;SHANK2;GSN;EVI5L;PARVB;ARAP1;TCTN1;POSTN;GRB7;EPHB2;CNTN1;NFATC4;LRP1;OBSL1;EGFR;ADGRF1;ULK1;CRTC1;ARPIN;ARHGEF4;SHC1;PTK6;LAMA5;BBS2;DNAH1;CORO1B;ULK2;IGSF9;ZMYND8;ANK3;S100A6;DBNDD1;MARK4;TENM2;ERBB2;BRSK1;MICALL2;PLXNB3;IFT140;KIF13B;NINL;FUZ;NPHP4;MINK1;CSNK1E;RHOD;LAMB2;WNT7A;INSR;FBXW8;ID1;B4GAT1;ADARB1;ITGA6;SYNGAP1;LPAR3;PRNP;EFNB3;SPRY2;CEP250;DLG4;WWTR1;RAB25;TMEM107;PLXNB1;VEGFA;VANGL2;SHANK3;NUDCD3;S1PR2;MAPK3;DVL1;ADCY6;EPHB3;HES1;SSH1;FBF1;CUL7;NRP2;CDC42EP5;CELSR2;SLIT3;PRKACA;DGUOK;CYFIP2;RPS6KA5;SPTB;DMTN;BBS1;SEMA3B;ROBO3;TRPV4;CROCC;EEF2K;SEMA3F;SEMA4C;LLGL1;WNT7B;VAV3;NEO1;USP21;WDR60;PRKCZ;NYAP1;SLITRK6;TWF2;GPC1;NDE1;FGFR1;CTSZ;C21ORF2;UNC119B;GRB10;WRAP73;TMEM231;RTN4R;EPB41L3;EPS8L1;WNT3;AKT1;SEPT8;EPS8L2;SSH3;GAS8;EHD3;MAFIP;RILPL1;ATXN10;RFX2;DNAAF5;RANBP9;SFI1;SEMA4F
19473,GO:1990351,0.000101216325117209,0.999962528851384,26,123,transporter complex,CC,SHANK2;NOS1;SCN8A;KCNG1;ABCA7;KCNC4;SCN4B;CPT1C;VAMP2;GM2A;DLG4;TTYH3;ATP12A;LRRC8A;SHANK3;KCNAB2;OLFM2;ABCA2;PRKACA;SCNN1A;ABCD4;DLG3;KCNMA1;SMDT1;KCNN4;SHISA6
12551,GO:0050731,0.000104426736147869,0.999965132890971,22,97,positive regulation of peptidyl-tyrosine phosphorylation,BP,CNTN1;IGF2;PTK6;PRNP;DLG4;CD81;VEGFA;HES1;IL6R;FGFR3;LRRK1;HBEGF;TNFRSF1A;EHD4;DGKQ;GAS6;DLG3;ERBB3;ERCC6;MLST8;EREG;MIF
7932,GO:0032535,0.00010536258624359,0.999948831621731,45,264,regulation of cellular component size,BP,APOE;PTPRS;SEMA4B;GSN;ARPIN;CORO1B;ULK2;TMOD2;WNT7A;LPAR3;SLC12A7;PLEKHH2;VEGFA;LRRC8A;SHANK3;WIPF1;SSH1;PLEKHG2;CDC42EP5;RAB3B;SPTB;DMTN;SEMA3B;TRPV4;SEMA3F;SEMA4C;WNT7B;VAV3;CAPG;TWF2;KCNMA1;RTN4R;WHAMMP3;EPS8L1;WNT3;AKT1;EPS8L2;SSH3;SPIRE2;MLST8;PYCARD;KCNN4;RARG;FCHSD1;SEMA4F
7025,GO:0030810,0.00011298429170197,0.999979785514134,11,32,positive regulation of nucleotide biosynthetic process,BP,APOE;NOS1;TIMP2;PTHLH;INSR;PFKFB2;MLXIPL;GUCA1B;ADORA2B;PINK1;TAZ
17453,GO:1900373,0.00011298429170197,0.999979785514134,11,32,positive regulation of purine nucleotide biosynthetic process,BP,APOE;NOS1;TIMP2;PTHLH;INSR;PFKFB2;MLXIPL;GUCA1B;ADORA2B;PINK1;TAZ
12388,GO:0048856,0.000122112060502519,0.999906028584305,402,3610,anatomical structure development,BP,HTRA1;FOS;DUSP6;ADGRL1;APOE;MARVELD1;CTNNBIP1;PPL;IDH2;PTPRS;ERCC1;FLNC;SEMA4B;GAA;BTBD2;CST3;SHANK2;LTBP4;RAPGEF3;TCFL5;CYP27B1;GSN;XDH;NDRG1;PGF;MEF2D;NOS1;LTBP1;PARVB;ARAP1;ZFP36L1;COL6A1;TCTN1;POSTN;GRB7;NR1D1;ALOX15B;FAM210B;SCN8A;EPHB2;EPAS1;OBSCN;CNTN1;IGF2;NFATC4;MST1R;LRP1;GAMT;RAB11FIP4;OBSL1;EGFR;TIMP2;NLGN2;DUSP5;FHL1;LOXL1;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;PKN1;CMTM7;SDK2;CRTC1;ARPIN;DOPEY2;NAGLU;SHC1;F2R;PTK6;DEAF1;LAMA5;BBS2;ACTA2;PRSS8;S100A4;CTSB;DNAH1;CORO1B;ULK2;GJC2;IGSF9;MALL;THBS3;ZMYND8;ASH2L;SOX12;ANK3;S100A6;ZNF516;HDAC5;THRA;ZP3;LRP5;DBNDD1;HYAL1;MARK4;TENM2;ZFPM1;TFEB;ERBB2;FBLN1;BRSK1;MICALL2;BSG;SCMH1;PTPRU;PKD2;TST;ITGB4;PLXNB3;PHLDA2;VAT1;SPRY4;PTHLH;SALL2;IFT140;CD9;KIF13B;SIGMAR1;HEXB;SERPINE2;FUZ;FOXQ1;NPHP4;UNK;MINK1;ATP2B4;TMOD2;TFDP2;CSNK1E;ACP5;PLCD1;TRAPPC9;ADAMTS7;PDCD4;TNFRSF25;RHOD;ARVCF;LAMB2;WNT7A;ZMIZ1;INSR;LCE1E;SH3PXD2B;FBXW8;ID1;CELSR1;B4GAT1;POLL;EPHA1;ADARB1;ITGA6;TXNRD3;SYNGAP1;NBEAL2;DNMT3A;DNPH1;LPAR3;ATP7B;EFNB3;SPRY2;MNT;ECM1;STAT6;DLG4;SPEG;MKNK2;PLCD3;STRADB;WWTR1;RAB25;FAM20C;TMEM107;MYCBPAP;PHC2;BCL6;PLXNB1;FAM213A;DYRK1B;BNIP3;FZD8;VEGFA;ZSCAN2;LRRC8A;VANGL2;FBXW4;AP2A2;CEBPB;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;S1PR2;ENDOG;TNFRSF6B;MAPK3;TUB;KCNAB2;ETV5;OLFM2;AMN;DHTKD1;TNNT1;DVL1;WIPF1;GPSM1;ADCY6;L3MBTL1;PHGDH;EPHB3;HES1;SSH1;FURIN;MLXIPL;MBOAT7;CUL7;EVC;ARHGAP22;NRP2;TNFRSF14;ADA;CDC42EP5;TRIM45;SH2D2A;AQP3;CELSR2;IL6R;SLIT3;PCSK9;ZFP36;RHOF;BTBD11;FGFR3;PRKACA;PITPNM1;ZMYM3;LRRK1;SPATA20;DGUOK;CYFIP2;SLC38A10;RPS6KA5;HBEGF;ITGB5;FGFR4;SPTB;MXRA8;DMTN;RAPGEF5;MYH3;MDGA1;HDAC11;VGF;TNFRSF1A;TCF25;SEMA3B;LDLR;ROBO3;SNX17;SOX13;TRPV4;RHOBTB2;RAG1;NHSL1;EEF2K;MSLN;HMGA2;SEMA3F;ELK3;AHNAK2;PEX7;SEMA4C;SDHAF4;GAS6;BTRC;POU6F1;LLGL1;ADGRB2;ZNF217;PPARA;HMGCL;WNT7B;SUFU;RFNG;DMC1;RXRA;PCK2;VAV3;LRP10;VASN;BCR;NEO1;IGFBP4;SDHA;USP21;WDR60;PRKCZ;CLTCL1;INPP5D;NYAP1;SLITRK6;TWF2;LSM14B;TPP1;GPC1;SRSF5;ZNF160;TEF;NDE1;AGO4;ARAP3;CDHR1;FGFR1;CTSZ;CHADL;PIN1;MN1;C5;TMEM204;PROX1;PCDHGC3;C21ORF2;DLG3;BIN1;UNC119B;PPP1R13L;SH3D19;SLC25A27;GRB10;BFSP1;JARID2;CAPN2;TOLLIP;WNT2B;SNPH;TMEM231;RTN4R;EPB41L3;TIMP1;SDC1;SH2B3;WNT3;ZFP41;MICALCL;SORL1;COL13A1;VEGFB;ACVR1B;MEF2B;GSS;ERBB3;ABR;AKT1;ADAM19;ZNF385A;LRCH4;NDRG2;SMARCA1;VPS33B;SIX5;SUN1;SSH3;PINK1;GAS8;PKD1;RGS14;SYNE3;CTSH;ROBO4;RILPL1;NRSN1;ATXN10;EPN2;RFX2;NINJ1;POMT1;TRERF1;PMS2P5;RANBP9;ARHGEF19;SLC2A1;TAZ;JAK3;APBA1;RARG;PBXIP1;EREG;ZFYVE19;GIPR;WDR18;KRT15;ADAMTSL4;TRNP1;POLM;SEMA4F;PRR15;SULF2;KIF26B;LZTS2
7370,GO:0031434,0.000123614963058174,0.999973098790782,13,42,mitogen-activated protein kinase kinase binding,MF,EPHB2;MST1R;EGFR;ERBB2;INSR;EPHA1;EPHB3;FGFR3;FGFR4;MAPK8IP1;FGFR1;PIN1;ERBB3
17227,GO:0120036,0.00012775022615611,0.99991476761981,134,1024,plasma membrane bounded cell projection organization,BP,APOE;ESPN;PTPRS;SEMA4B;SHANK2;GSN;EVI5L;PARVB;ARAP1;TCTN1;POSTN;GRB7;EPHB2;CNTN1;NFATC4;LRP1;OBSL1;EGFR;ADGRF1;ULK1;CRTC1;ARPIN;ARHGEF4;SHC1;PTK6;LAMA5;BBS2;DNAH1;CORO1B;ULK2;IGSF9;ZMYND8;ANK3;S100A6;DBNDD1;MARK4;TENM2;ERBB2;BRSK1;MICALL2;PLXNB3;IFT140;KIF13B;NINL;FUZ;NPHP4;MINK1;CSNK1E;RHOD;LAMB2;WNT7A;INSR;FBXW8;ID1;B4GAT1;ADARB1;ITGA6;SYNGAP1;LPAR3;PRNP;EFNB3;CEP250;DLG4;WWTR1;RAB25;TMEM107;PLXNB1;VEGFA;VANGL2;SHANK3;NUDCD3;S1PR2;MAPK3;DVL1;ADCY6;EPHB3;HES1;SSH1;FBF1;CUL7;NRP2;CDC42EP5;CELSR2;SLIT3;PRKACA;DGUOK;CYFIP2;RPS6KA5;SPTB;DMTN;BBS1;SEMA3B;ROBO3;TRPV4;CROCC;EEF2K;SEMA3F;SEMA4C;LLGL1;WNT7B;VAV3;NEO1;USP21;WDR60;PRKCZ;NYAP1;SLITRK6;TWF2;GPC1;NDE1;FGFR1;CTSZ;UNC119B;GRB10;WRAP73;TMEM231;RTN4R;EPB41L3;EPS8L1;WNT3;AKT1;SEPT8;EPS8L2;SSH3;GAS8;EHD3;MAFIP;RILPL1;ATXN10;RFX2;DNAAF5;RANBP9;SFI1;SEMA4F
5428,GO:0016301,0.000129529900624331,0.999920881114241,90,632,kinase activity,MF,LTBP4;LTBP1;EPHB2;OBSCN;NME4;MST1R;MAPK13;CDK18;EGFR;ULK1;PKN1;PTK6;ULK2;DGKA;PIK3R2;NEK9;RPS6KA2;NMRK1;MARK4;ERBB2;BRSK1;PAK6;MINK1;CSNK1E;ZFYVE21;INSR;GRK6;EPHA1;EFNB3;DLG4;SPEG;FGGY;MKNK2;STRADB;FAM20C;UCKL1;PFKFB2;DYRK1B;SRMS;MAST4;ACVR2B;MAPK3;GALK1;PKN3;EPHB3;NAGS;NRP2;NADK;TK2;CKMT1A;PFKL;FGFR3;PRKACA;LRRK1;DGUOK;RPS6KA5;HBEGF;MAP2K2;PI4K2A;FGFR4;PMVK;EEF2K;HMGA2;DGKQ;HK1;TKFC;GUK1;STK32C;BCR;PRKCZ;PDK2;MAPKAPK3;FGFR1;CAMKK1;DLG3;PI4KAP2;ADCK5;STK39;ACVR1B;ERBB3;AKT1;ADCK2;PINK1;MAP2K3;STK17A;ERN1;JAK3;MAST3;FUK;EREG
9940,GO:0042327,0.000130276504308711,0.999920174914307,91,646,positive regulation of phosphorylation,BP,DUSP6;CEMIP;RAPGEF3;XDH;EPHB2;CNTN1;IGF2;MST1R;EGFR;TIMP2;DUSP5;EGR1;PKN1;SHC1;F2R;PTK6;ABCA7;SHC2;ERBB2;PKD2;PAK6;MINK1;ATP2B4;TNFRSF25;WNT7A;INSR;EPHA1;ITGA6;LPAR3;PRNP;SPRY2;SNX9;DLG4;STRADB;PFKFB2;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;MAPK3;DVL1;ADCY6;EPHB3;HES1;MLXIPL;IL6R;FGFR3;PRKACA;LRRK1;RPS6KA5;HBEGF;MAP2K2;FGFR4;TNFRSF1A;EHD4;MAPK8IP1;TRPV4;DUSP7;DGKQ;SEMA4C;GAS6;WNT7B;VAV3;IGFBP4;PRKCZ;MAPKAPK3;FGFR1;CAMKK1;PIN1;C5;PROX1;DLG3;MAPRE3;MADD;STK39;ACVR1B;ADORA2B;ERBB3;AKT1;ERCC6;PINK1;PKD1;MLST8;PYCARD;MAP2K3;ERN1;EREG;MIF
708,GO:0001934,0.000131116916969713,0.999920528970129,87,612,positive regulation of protein phosphorylation,BP,DUSP6;CEMIP;RAPGEF3;XDH;EPHB2;CNTN1;IGF2;MST1R;EGFR;TIMP2;DUSP5;EGR1;PKN1;SHC1;F2R;PTK6;ABCA7;SHC2;ERBB2;PKD2;PAK6;MINK1;ATP2B4;TNFRSF25;WNT7A;INSR;EPHA1;LPAR3;PRNP;SPRY2;SNX9;DLG4;STRADB;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;MAPK3;DVL1;ADCY6;EPHB3;HES1;IL6R;FGFR3;PRKACA;LRRK1;RPS6KA5;HBEGF;MAP2K2;FGFR4;TNFRSF1A;EHD4;MAPK8IP1;TRPV4;DUSP7;DGKQ;SEMA4C;GAS6;WNT7B;IGFBP4;PRKCZ;MAPKAPK3;FGFR1;CAMKK1;PIN1;C5;PROX1;DLG3;MAPRE3;MADD;STK39;ACVR1B;ADORA2B;ERBB3;AKT1;ERCC6;PINK1;PKD1;MLST8;PYCARD;MAP2K3;ERN1;EREG;MIF
8906,GO:0034765,0.000131442289748292,0.999939812817971,38,213,regulation of ion transmembrane transport,BP,CEMIP;SHANK2;NOS1;SCN8A;EPHB2;KCNG1;NLGN2;FHL1;F2R;GJC2;KCNC4;ANK3;KCNJ15;PKD2;SCN4B;VAMP2;NTSR1;MINK1;ATP2B4;PRNP;DLG4;SHANK3;KCNAB2;PCSK9;PRKACA;PTAFR;KCNMA1;GLRX;STK39;ANO9;TPCN1;AKT1;GPD1L;PINK1;EHD3;SNTA1;GSTM2;SHISA6
3454,GO:0007275,0.00013158173664955,0.999899205683243,371,3303,multicellular organism development,BP,HTRA1;FOS;DUSP6;ADGRL1;APOE;MARVELD1;CTNNBIP1;PPL;IDH2;PTPRS;ERCC1;SEMA4B;GAA;BTBD2;CST3;SHANK2;LTBP4;RAPGEF3;TCFL5;CYP27B1;GSN;XDH;NDRG1;PGF;MEF2D;NOS1;LTBP1;ZFP36L1;COL6A1;TCTN1;POSTN;GRB7;NR1D1;ALOX15B;FAM210B;SCN8A;EPHB2;EPAS1;OBSCN;CNTN1;IGF2;NFATC4;MST1R;LRP1;GAMT;RAB11FIP4;OBSL1;EGFR;TIMP2;NLGN2;DUSP5;FHL1;LOXL1;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;PKN1;CMTM7;SDK2;CRTC1;DOPEY2;NAGLU;SHC1;PTK6;DEAF1;LAMA5;BBS2;ACTA2;PRSS8;S100A4;CTSB;ULK2;GJC2;IGSF9;MALL;THBS3;ZMYND8;ASH2L;SOX12;ANK3;S100A6;ZNF516;HDAC5;THRA;ZP3;LRP5;DBNDD1;HYAL1;MARK4;TENM2;ZFPM1;TFEB;ERBB2;FBLN1;BRSK1;MICALL2;BSG;SCMH1;PTPRU;PKD2;ITGB4;PLXNB3;PHLDA2;SPRY4;PTHLH;SALL2;IFT140;CD9;KIF13B;SIGMAR1;HEXB;SERPINE2;FUZ;FOXQ1;NPHP4;UNK;MINK1;ATP2B4;TMOD2;TFDP2;CSNK1E;ACP5;PLCD1;TRAPPC9;ADAMTS7;PDCD4;TNFRSF25;ARVCF;LAMB2;WNT7A;ZMIZ1;INSR;LCE1E;SH3PXD2B;FBXW8;ID1;CELSR1;B4GAT1;POLL;EPHA1;ADARB1;ITGA6;TXNRD3;SYNGAP1;NBEAL2;DNMT3A;LPAR3;ATP7B;EFNB3;SPRY2;MNT;ECM1;STAT6;DLG4;SPEG;MKNK2;PLCD3;WWTR1;FAM20C;TMEM107;MYCBPAP;PHC2;BCL6;PLXNB1;FAM213A;DYRK1B;BNIP3;FZD8;VEGFA;ZSCAN2;LRRC8A;VANGL2;FBXW4;AP2A2;CEBPB;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;S1PR2;ENDOG;TNFRSF6B;MAPK3;TUB;KCNAB2;ETV5;AMN;DHTKD1;DVL1;GPSM1;ADCY6;L3MBTL1;PHGDH;EPHB3;HES1;SSH1;FURIN;MBOAT7;CUL7;EVC;ARHGAP22;NRP2;TNFRSF14;ADA;TRIM45;SH2D2A;AQP3;CELSR2;IL6R;SLIT3;PCSK9;ZFP36;BTBD11;FGFR3;PITPNM1;ZMYM3;LRRK1;SPATA20;DGUOK;CYFIP2;SLC38A10;RPS6KA5;HBEGF;ITGB5;FGFR4;SPTB;MXRA8;DMTN;RAPGEF5;MYH3;MDGA1;HDAC11;VGF;TNFRSF1A;TCF25;SEMA3B;LDLR;ROBO3;SNX17;SOX13;TRPV4;RAG1;NHSL1;EEF2K;MSLN;HMGA2;SEMA3F;ELK3;AHNAK2;PEX7;SEMA4C;SDHAF4;GAS6;BTRC;POU6F1;LLGL1;ADGRB2;ZNF217;PPARA;HMGCL;WNT7B;SUFU;RFNG;DMC1;RXRA;PCK2;VAV3;LRP10;VASN;BCR;NEO1;IGFBP4;SDHA;USP21;WDR60;PRKCZ;INPP5D;NYAP1;SLITRK6;TWF2;LSM14B;TPP1;GPC1;SRSF5;ZNF160;TEF;NDE1;AGO4;CDHR1;FGFR1;CTSZ;CHADL;PIN1;MN1;C5;TMEM204;PROX1;PCDHGC3;DLG3;BIN1;UNC119B;PPP1R13L;SLC25A27;GRB10;BFSP1;JARID2;CAPN2;WNT2B;SNPH;TMEM231;RTN4R;EPB41L3;TIMP1;SDC1;SH2B3;WNT3;ZFP41;MICALCL;SORL1;COL13A1;VEGFB;ACVR1B;MEF2B;GSS;ERBB3;ABR;AKT1;ADAM19;ZNF385A;LRCH4;NDRG2;SMARCA1;VPS33B;SIX5;SUN1;SSH3;GAS8;PKD1;RGS14;CTSH;ROBO4;NRSN1;ATXN10;EPN2;NINJ1;POMT1;TRERF1;PMS2P5;RANBP9;ARHGEF19;SLC2A1;TAZ;JAK3;APBA1;RARG;PBXIP1;EREG;ZFYVE19;GIPR;WDR18;KRT15;TRNP1;POLM;SEMA4F;PRR15;SULF2;KIF26B;LZTS2
81,GO:0000165,0.00013553672225655,0.999918225786298,85,599,MAPK cascade,BP,TNIP1;DUSP6;APOE;XDH;ZFP36L1;EPHB2;IGF2;MST1R;MAPK13;EGFR;TIMP2;DUSP5;PKN1;SHC1;F2R;ABCA7;SHC2;PIK3R2;ERBB2;FBLN1;SPRY4;PAK6;MINK1;RASA4;PDCD4;TNFRSF25;WNT7A;INSR;ID1;EPHA1;SYNGAP1;LPAR3;SPRY2;DLG4;CD81;FZD8;VEGFA;VANGL2;SHANK3;S1PR2;MAPK3;EPHB3;CDC42EP5;ZFP36;FGFR3;HBEGF;MAP2K2;FGFR4;SPTB;TNFRSF1A;MAPK8IP1;TRPV4;DUSP7;SEMA4C;GAS6;BTRC;WNT7B;IGFBP4;PRKCZ;MAPKAPK3;FGFR1;PIN1;C5;WDR83;MADD;SORL1;STK39;ADORA2B;ERBB3;AKT1;NDRG2;ERCC6;IL17RD;PINK1;RGS14;CTSH;CBLC;PYCARD;MAP2K3;ERN1;RANBP9;SIRT3;JAK3;EREG;MIF
4556,GO:0010647,0.00014692628674274,0.999900180409811,145,1137,positive regulation of cell communication,BP,DUSP6;APOE;FAM110C;SHANK2;CYP27B1;GSN;XDH;NOS1;ARAP1;SH3BP2;GRB7;ALOX15B;RBCK1;EPHB2;IGF2;NFATC4;MST1R;EGFR;TIMP2;NLGN2;DUSP5;PKN1;CRTC1;SHC1;RGL2;F2R;PTK6;ABCA7;S100A4;SHC2;CXXC5;ANK3;PIK3R2;MAML3;ERBB2;PKD2;ITPR3;CDKN1C;RIMS3;SERPINE2;VAMP2;NTSR1;MINK1;TMOD2;TFDP2;CSNK1E;PDCD4;SLC20A1;TNFRSF25;GLUL;WNT7A;ZMIZ1;INSR;EPHA1;LPAR3;PRNP;SPRY2;ECM1;DLG4;PFKFB2;PLXNB1;BNIP3;CD81;FZD8;VEGFA;VANGL2;SHANK3;ACVR2B;S1PR2;MAPK3;PLEKHG5;DVL1;EPHB3;HES1;SSH1;EVC;ADA;PIDD1;PAG1;SH2D2A;RASL10B;IL6R;FGFR3;LRRK1;CYFIP2;HBEGF;RAB3B;MAP2K2;FGFR4;DMTN;TNFRSF1A;MAPK8IP1;TRPV4;DUSP7;LDLRAP1;SEMA4C;MIB2;GAS6;WNT7B;RFNG;PCK2;VAV3;NEO1;IGFBP4;PRKCZ;TM7SF3;MAPKAPK3;FGFR1;PIN1;C5;WBP2;VSNL1;GRB10;WNT2B;MADD;RTN4R;SH2B3;FGFBP1;WNT3;STK39;ACVR1B;ADORA2B;ERBB3;AKT1;ZNF385A;TP53INP1;ERCC6;PINK1;RGS14;CTSH;MLST8;EPN2;PYCARD;MAP2K3;KCNN4;ERN1;SIRT3;LITAF;EREG;FAM162A;GSTM2;GIPR;TMED4;MIF;SULF2
10487,GO:0043408,0.000155231056904215,0.999910855638906,70,470,regulation of MAPK cascade,BP,TNIP1;DUSP6;APOE;XDH;EPHB2;IGF2;MST1R;EGFR;TIMP2;DUSP5;PKN1;SHC1;F2R;ABCA7;SHC2;PIK3R2;ERBB2;FBLN1;SPRY4;PAK6;MINK1;PDCD4;TNFRSF25;WNT7A;INSR;ID1;EPHA1;SYNGAP1;LPAR3;SPRY2;CD81;FZD8;VEGFA;VANGL2;S1PR2;MAPK3;EPHB3;FGFR3;MAP2K2;FGFR4;TNFRSF1A;MAPK8IP1;TRPV4;DUSP7;SEMA4C;GAS6;WNT7B;IGFBP4;PRKCZ;MAPKAPK3;FGFR1;PIN1;C5;MADD;SORL1;STK39;ADORA2B;ERBB3;AKT1;NDRG2;ERCC6;PINK1;RGS14;CBLC;PYCARD;MAP2K3;ERN1;RANBP9;SIRT3;MIF
3496,GO:0007409,0.000155278404873181,0.999920108799779,50,305,axonogenesis,BP,APOE;PTPRS;SEMA4B;TCTN1;GRB7;EPHB2;ULK1;SHC1;ULK2;ANK3;S100A6;ERBB2;BRSK1;PLXNB3;KIF13B;LAMB2;WNT7A;B4GAT1;ADARB1;SYNGAP1;LPAR3;EFNB3;PLXNB1;VEGFA;VANGL2;SHANK3;MAPK3;DVL1;EPHB3;SSH1;NRP2;SLIT3;CYFIP2;RPS6KA5;SPTB;SEMA3B;ROBO3;SEMA3F;SEMA4C;LLGL1;NEO1;SLITRK6;TWF2;GPC1;GRB10;RTN4R;WNT3;SSH3;RANBP9;SEMA4F
2373,GO:0005509,0.000155463327736636,0.99991615110314,57,365,calcium ion binding,MF,SYTL1;LTBP4;GSN;PRSS3;LTBP1;CGREF1;ALOX15B;LRP1;LTBP2;RAB11FIP4;SMOC2;FKBP9;SYT8;PPP2R3B;S100A4;DGKA;THBS3;S100A6;TENM2;FBLN1;PKD2;EDEM1;ITPR3;NINL;CD320;PLCD1;CELSR1;FAM20C;CAPNS2;TNNT1;FKBP10;MCTP1;CELSR2;SLIT3;F12;PITPNM1;PLCH2;EHD4;LDLR;EEF2K;PADI3;GAS6;LTBP3;ADAMTS13;CDHR1;MAN1B1;PCDHGC3;ESYT2;VSNL1;CAPN2;GUCA1B;ADGRE2;PITPNM3;EFCAB1;EHD3;CBLC;SULF2
3560,GO:0007611,0.00015592090556793,0.999939179565698,27,133,learning or memory,BP,FOS;APOE;SHANK2;EPHB2;EGFR;ADGRF1;CRTC1;ABCA7;DEAF1;THRA;ITPR3;NTSR1;TMOD2;GM2A;ASIC1;INSR;SYNGAP1;PRNP;DLG4;CEBPB;SHANK3;LDLR;RAG1;COMT;PRKCZ;ZNF385A;RGS14
4353,GO:0009966,0.000159915164614464,0.999881721696186,251,2134,regulation of signal transduction,BP,TNIP1;HTRA1;DUSP6;APOE;CTNNBIP1;PTPRS;WWC3;FAM110C;SHANK2;LTBP4;CYP27B1;GSN;XDH;PGF;NOS1;LTBP1;ARAP1;SH3BP2;TCTN1;POSTN;GRB7;NR1D1;ALOX15B;ARRDC1;RBCK1;EPHB2;OBSCN;IGF2;NFATC4;MST1R;LRP1;APPL2;EGFR;TIMP2;NLGN2;DUSP5;MDFI;EGR1;RHBDF1;PKN1;CMTM7;ARHGEF4;SHC1;RGL2;F2R;PTK6;ABCA7;S100A4;SHC2;CXXC5;ZMYND8;PIK3R2;THRA;ARHGAP23;ZP3;LRP5;MAML3;ERBB2;FBLN1;PKD2;IQSEC2;PHLDA2;DNM1;SPRY4;DDIT4L;PTHLH;CDKN1C;IFT140;PTPRE;PAK6;SERPINE2;FUZ;NPHP4;NTSR1;CD320;MINK1;RALGAPA2;ATP2B4;TMOD2;TFDP2;CSNK1E;RASA4;AGAP1;PDCD4;SLC20A1;ACAP3;TNFRSF25;RHOD;USP20;PLEKHG4;WNT7A;ZMIZ1;INSR;ID1;GRK6;EPHA1;ITGA6;SYNGAP1;LPAR3;PRNP;SPRY2;MNT;ECM1;DLG4;STRADB;WWTR1;FAM20C;BCL6;PLXNB1;IGFBP2;MVB12B;BNIP3;CD81;SRMS;FZD8;VEGFA;VANGL2;RHBDF2;SHANK3;ACVR2B;S1PR2;MAPK3;PLEKHG5;CARD19;DVL1;L3MBTL1;EPHB3;HES1;SSH1;FURIN;EVC;ARHGAP22;PLEKHG2;ADA;PIDD1;PAG1;SH2D2A;IL6R;SLIT3;PCSK9;RHOF;MAPKBP1;FGFR3;PRKACA;LRRK1;CYFIP2;HBEGF;MAP2K2;FGFR4;DMTN;PSD4;VGF;TNFRSF1A;MAPK8IP1;TRPV4;RHOBTB2;IFNGR2;DUSP7;TNFAIP8L1;LDLRAP1;DGKQ;SEMA4C;MVB12A;MIB2;GAS6;BTRC;LLGL1;TKFC;WNT7B;GIT1;SUFU;PLEKHG6;RFNG;ARHGEF37;VAV3;VASN;BCR;NEO1;IGFBP4;PRKCZ;INPP5D;GPC1;MAPKAPK3;ARAP3;FGFR1;PIN1;C5;TMEM204;WBP2;ASAP2;PPP1R13L;GRB10;SESN2;WNT2B;TMEM161A;GUCA1B;MADD;RTN4R;TIMP1;SH2B3;FGFBP1;PEAR1;EPS8L1;WNT3;SORL1;STK39;VEGFB;ACVR1B;ADORA2B;ERBB3;ABR;AKT1;TRAP1;TMBIM4;NLRX1;ZNF385A;TP53INP1;NDRG2;ERCC6;GPD1L;EPS8L2;SPPL2B;PINK1;ARHGEF10L;HOMER2;RGS14;CTSH;MLST8;CBLC;EPN2;PYCARD;MAP2K3;KCNN4;ERN1;CKLF;RANBP9;ARHGEF19;SIRT3;C12ORF66;CMTM4;LITAF;EREG;FAM162A;GSTM2;SHISA6;GIPR;TMED4;RGS12;MIF;SULF2;LZTS2
11719,GO:0046578,0.000160017797235542,0.99992867800123,35,189,regulation of Ras protein signal transduction,BP,APOE;ARAP1;EPHB2;OBSCN;APPL2;TIMP2;ARHGEF4;RGL2;F2R;IQSEC2;SPRY4;RASA4;AGAP1;ACAP3;PLEKHG4;SYNGAP1;SPRY2;BCL6;PLEKHG5;PLEKHG2;PSD4;GIT1;PLEKHG6;ARHGEF37;VAV3;BCR;ARAP3;ASAP2;MADD;RTN4R;EPS8L1;ABR;EPS8L2;ARHGEF10L;ARHGEF19
14284,GO:0061448,0.000173683109225631,0.999930398786068,28,140,connective tissue development,BP,MEF2D;EGR1;BBS2;ACTA2;THBS3;ZNF516;THRA;LRP5;HYAL1;PTHLH;ADAMTS7;WNT7A;SH3PXD2B;DYRK1B;FBXW4;MAPK3;EVC;FGFR3;TRPV4;HMGA2;WNT7B;FGFR1;CHADL;WNT2B;TIMP1;PKD1;RARG;SULF2
12398,GO:0048869,0.000176489160971099,0.999866367184495,306,2675,cellular developmental process,BP,HTRA1;FOS;DUSP6;APOE;CTNNBIP1;PPL;IDH2;PTPRS;ERCC1;FLNC;SEMA4B;BTBD2;CST3;SHANK2;LTBP4;RAPGEF3;TCFL5;MRC2;CYP27B1;GSN;XDH;NDRG1;PGF;MEF2D;NOS1;PARVB;ARAP1;ZFP36L1;COL6A1;TCTN1;POSTN;GRB7;NR1D1;ALOX15B;FAM210B;EPHB2;EPAS1;OBSCN;CNTN1;IGF2;NFATC4;MST1R;LRP1;OBSL1;EGFR;TIMP2;FHL1;MDFI;ADGRF1;EGR1;ULK1;CMTM7;SDK2;CRTC1;ARPIN;NAGLU;SHC1;PTK6;DEAF1;LAMA5;BBS2;ACTA2;PRSS8;S100A4;CTSB;DNAH1;CORO1B;ULK2;GJC2;IGSF9;ZMYND8;ASH2L;SOX12;ABCG1;ANK3;S100A6;ZNF516;HDAC5;THRA;ZP3;LRP5;DBNDD1;TENM2;ZFPM1;ERBB2;FBLN1;BRSK1;MICALL2;PTPRU;TST;ITGB4;PLXNB3;PTHLH;IFT140;CD9;KIF13B;HEXB;SERPINE2;FUZ;FOXQ1;NPHP4;UNK;MINK1;TMOD2;CSNK1E;TRAPPC9;ADAMTS7;PDCD4;RHOD;LAMB2;WNT7A;ZMIZ1;INSR;LCE1E;SH3PXD2B;FBXW8;ID1;CELSR1;B4GAT1;EPHA1;ADARB1;ITGA6;TXNRD3;SYNGAP1;NBEAL2;DNMT3A;DNPH1;LPAR3;EFNB3;SPRY2;MNT;STAT6;DLG4;SPEG;STRADB;WWTR1;RAB25;FAM20C;MYCBPAP;BCL6;PLXNB1;FAM213A;DYRK1B;BNIP3;SRMS;FZD8;VEGFA;ZSCAN2;LRRC8A;YPEL3;VANGL2;CEBPB;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;S1PR2;MAPK3;KCNAB2;ETV5;OLFM2;DHTKD1;TNNT1;DVL1;WIPF1;GPSM1;ADCY6;L3MBTL1;EPHB3;HES1;SSH1;FURIN;MBOAT7;CUL7;ARHGAP22;NRP2;ADA;CDC42EP5;SH2D2A;AQP3;CELSR2;IL6R;SLIT3;PCSK9;ZFP36;ETV4;RHOF;BTBD11;FGFR3;PRKACA;ZMYM3;LRRK1;SPATA20;DGUOK;CYFIP2;RPS6KA5;ITGB5;FGFR4;SPTB;MXRA8;DMTN;MYH3;MDGA1;HDAC11;TNFRSF1A;SEMA3B;LDLR;ROBO3;SOX13;TRPV4;RHOBTB2;RAG1;NHSL1;EEF2K;HMGA2;SEMA3F;ELK3;AHNAK2;PEX7;SEMA4C;GAS6;LLGL1;PPARA;WNT7B;SUFU;RFNG;DMC1;LTBP3;RXRA;PCK2;VASN;NEO1;USP21;PRKCZ;INPP5D;NYAP1;SLITRK6;TWF2;TPP1;GPC1;NDE1;AGO4;ARAP3;CDHR1;FGFR1;CTSZ;CHADL;PIN1;TMEM204;PROX1;C21ORF2;BIN1;UNC119B;YIPF3;PPP1R13L;SH3D19;GRB10;BFSP1;JARID2;CAPN2;TOLLIP;WNT2B;SNPH;TMEM231;RTN4R;EPB41L3;SDC1;SH2B3;WNT3;ZFP41;MICALCL;SORL1;COL13A1;ACVR1B;ERBB3;CCDC85B;CCDC71L;AKT1;ZNF385A;TP53INP1;NDRG2;SMARCA1;VPS33B;SIX5;TDRKH;SUN1;TMEM120A;SSH3;RGS14;SYNE3;ROBO4;RILPL1;ATXN10;RFX2;RANBP9;JAK3;RARG;PBXIP1;EREG;KRT15;ADAMTSL4;POLM;SEMA4F;MIF;SULF2
7840,GO:0032412,0.000182214032798942,0.999929604772118,26,128,regulation of ion transmembrane transporter activity,BP,SHANK2;NOS1;EPHB2;KCNG1;NLGN2;FHL1;ANK3;PKD2;SCN4B;VAMP2;NTSR1;MINK1;PRNP;DLG4;SHANK3;PCSK9;PRKACA;PTAFR;GLRX;STK39;ANO9;GPD1L;PINK1;EHD3;GSTM2;SHISA6
7270,GO:0031267,0.000186338776458322,0.999893615808396,67,445,small GTPase binding,MF,SYTL1;RAPGEF3;EVI5L;NDRG1;ARAP1;OBSCN;APPL2;RAB11FIP4;EGFR;ULK1;PKN1;ARHGEF4;SHC1;RGL2;SHC2;TBC1D14;RIN1;DOCK4;ERBB2;EXOC2;MICALL2;RIMS3;PAK6;TRAPPC9;AGAP1;ACAP3;PLEKHG4;TBC1D8;RABGGTA;DLG4;PLEKHG5;DVL1;PKN3;PLEKHG2;CDC42EP5;FGFR3;HBEGF;FGFR4;SPTB;RAPGEF5;LLGL1;GIT1;PLEKHG6;ARHGEF37;VAV3;BCR;TBC1D16;ARAP3;FGFR1;ASAP2;MADD;WHAMMP3;EPS8L1;SBF1;SORL1;TBC1D17;ALS2CL;ERBB3;ABR;EPS8L2;GAS8;ARHGEF10L;RILPL1;RANBP9;ARHGEF19;JAK3;EREG
3447,GO:0007267,0.000187221379680925,0.999876645142345,119,904,cell-cell signaling,BP,APOE;CTNNBIP1;SYTL1;SHANK2;LTBP4;RAPGEF3;PGF;NOS1;NR1D1;EPHB2;NFATC4;LRP1;EGFR;HADH;NLGN2;MDFI;EGR1;CRTC1;SYT8;F2R;GJC2;ZMYND8;KCNC4;NISCH;LRP5;BRSK1;PTPRU;SCN4B;ITPR3;DNM1;PTHLH;RIMS3;SERPINE2;VAMP2;FUZ;NPHP4;NTSR1;MINK1;TMOD2;CSNK1E;GLUL;ASIC1;WNT7A;CELSR1;GRK6;ADARB1;SYNGAP1;LPAR3;PRNP;EFNB3;SLC12A7;DLG4;WWTR1;MYCBPAP;PFKFB2;IGFBP2;FZD8;ARL2;VANGL2;FBXW4;AP2A2;SHANK3;ACVR2B;CALCOCO1;S1PR2;ETV5;DVL1;HES1;SSH1;MCTP1;HTR7;RASL10B;CELSR2;PFKL;FGFR3;LRRK1;RAB3B;VGF;SEMA3B;TRPV4;HMGA2;BTRC;WNT7B;PCK2;PCSK1;IGFBP4;PRKCZ;TM7SF3;AGO4;FGFR1;PIN1;PCDHGC3;DLG3;VSNL1;GRB10;TOLLIP;WNT2B;SNPH;GUCA1B;GAL3ST4;SDC1;FGFBP1;WNT3;AKT1;NDRG2;PINK1;RGS14;ARHGEF19;SIRT3;SLC2A1;APBA1;RARG;EREG;FCHSD1;SHISA6;GIPR;SEMA4F;SULF2;LZTS2
5309,GO:0016042,0.000199052849601548,0.999908855368496,36,203,lipid catabolic process,BP,APOE;TYSND1;CYP27B1;CRAT;CPT2;HADH;THRA;PLD3;FUCA1;CPT1C;HEXB;PLCD1;GM2A;SRD5A3;IAH1;ABCD1;PLCD3;ACAD10;PLCH2;LDLR;SNX17;PEX7;PPARA;AIG1;PCK2;ETFB;PNPLA4;PHYH;CES2;SESN2;AKT1;NAGA;LONP2;TRERF1;ACADS;MLYCD
8182,GO:0032940,0.000205687427306274,0.999863551009692,121,929,secretion by cell,BP,LMF1;IDH2;GAA;SYTL1;NAPRT;PYGB;CST3;LTBP4;RAPGEF3;PGM1;GSN;PRSS3;POSTN;NR1D1;ALOX15B;IGF2;LTBP2;EGFR;TIMP2;HADH;NLGN2;SERPING1;RHBDF1;PYGL;SYT8;F2R;CTSB;KCNC4;ZP3;NISCH;LRP5;EXOC2;BRSK1;FUCA1;ITPR3;VAT1;RIMS3;CD9;HEXB;SERPINE2;VPS11;VAMP2;NTSR1;GM2A;GLUL;ASIC1;WNT7A;RAB3D;NBEAL2;TMEM173;RNASET2;ECM1;RAB25;MYO18A;PFKFB2;VEGFA;DNASE1L1;ARL2;AP2A2;RHBDF2;DPP7;ACVR2B;MAPK3;KCNAB2;OLFM2;GLB1;RAB40B;DVL1;LTA4H;FURIN;SLC2A3;MCTP1;RASL10B;PFKL;RHOF;MAPKBP1;RAB3B;PI4K2A;DMTN;VGF;TRPV4;HK1;GAS6;LLGL1;PTAFR;PCK2;BCR;PRKCZ;TM7SF3;FGFR1;CTSZ;C5;VSNL1;SERPINB6;TOLLIP;CSTB;SNPH;ADGRE2;TIMP1;CD68;SDC1;ACTR1B;VEGFB;ADORA2B;HGSNAT;ABR;CTSD;VPS33B;PINK1;CTSH;PYCARD;KCNN4;CKLF;SIRT3;SLC2A1;APBA1;GALNS;GIPR;RAB40C;MIF;STXBP2
14694,GO:0070371,0.000208576556601985,0.999908028499097,33,179,ERK1 and ERK2 cascade,BP,TNIP1;DUSP6;ZFP36L1;EPHB2;MST1R;EGFR;SHC1;F2R;ABCA7;ERBB2;FBLN1;SPRY4;INSR;EPHA1;SPRY2;MAPK3;EPHB3;FGFR3;MAP2K2;FGFR4;TRPV4;GAS6;PRKCZ;FGFR1;PIN1;ERBB3;NDRG2;RGS14;CTSH;PYCARD;RANBP9;SIRT3;MIF
12333,GO:0048731,0.000214295635892898,0.999835831355033,332,2936,system development,BP,HTRA1;FOS;DUSP6;ADGRL1;APOE;MARVELD1;CTNNBIP1;PPL;IDH2;PTPRS;ERCC1;SEMA4B;GAA;BTBD2;CST3;SHANK2;RAPGEF3;CYP27B1;GSN;XDH;NDRG1;PGF;MEF2D;NOS1;LTBP1;ZFP36L1;TCTN1;POSTN;GRB7;ALOX15B;FAM210B;SCN8A;EPHB2;EPAS1;CNTN1;IGF2;NFATC4;LRP1;GAMT;RAB11FIP4;OBSL1;EGFR;TIMP2;NLGN2;FHL1;LOXL1;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;PKN1;CMTM7;SDK2;CRTC1;NAGLU;SHC1;PTK6;DEAF1;LAMA5;BBS2;ACTA2;PRSS8;S100A4;CTSB;ULK2;GJC2;IGSF9;MALL;THBS3;ZMYND8;ASH2L;SOX12;ANK3;S100A6;ZNF516;HDAC5;THRA;ZP3;LRP5;DBNDD1;HYAL1;MARK4;TENM2;ZFPM1;TFEB;ERBB2;BRSK1;MICALL2;BSG;PTPRU;PKD2;ITGB4;PLXNB3;PHLDA2;SPRY4;PTHLH;SALL2;IFT140;CD9;KIF13B;SIGMAR1;HEXB;SERPINE2;FUZ;FOXQ1;NPHP4;UNK;MINK1;ATP2B4;TMOD2;TFDP2;CSNK1E;ACP5;PLCD1;TRAPPC9;ADAMTS7;PDCD4;LAMB2;WNT7A;ZMIZ1;INSR;LCE1E;SH3PXD2B;FBXW8;ID1;CELSR1;B4GAT1;POLL;EPHA1;ADARB1;ITGA6;SYNGAP1;NBEAL2;DNMT3A;LPAR3;ATP7B;EFNB3;SPRY2;ECM1;STAT6;DLG4;SPEG;MKNK2;PLCD3;WWTR1;FAM20C;TMEM107;BCL6;PLXNB1;FAM213A;DYRK1B;BNIP3;FZD8;VEGFA;LRRC8A;VANGL2;FBXW4;AP2A2;CEBPB;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;MAPK3;TUB;KCNAB2;ETV5;DHTKD1;DVL1;GPSM1;ADCY6;L3MBTL1;PHGDH;EPHB3;HES1;SSH1;FURIN;MBOAT7;CUL7;EVC;ARHGAP22;NRP2;ADA;TRIM45;SH2D2A;AQP3;CELSR2;IL6R;SLIT3;PCSK9;ZFP36;BTBD11;FGFR3;PITPNM1;LRRK1;DGUOK;CYFIP2;SLC38A10;RPS6KA5;HBEGF;FGFR4;SPTB;MXRA8;DMTN;RAPGEF5;MYH3;MDGA1;HDAC11;VGF;TCF25;SEMA3B;LDLR;ROBO3;SNX17;SOX13;TRPV4;RAG1;NHSL1;EEF2K;MSLN;HMGA2;SEMA3F;ELK3;AHNAK2;PEX7;SEMA4C;SDHAF4;GAS6;BTRC;POU6F1;LLGL1;ADGRB2;PPARA;HMGCL;WNT7B;SUFU;RFNG;DMC1;RXRA;PCK2;VAV3;LRP10;VASN;BCR;NEO1;IGFBP4;SDHA;USP21;WDR60;PRKCZ;INPP5D;NYAP1;SLITRK6;TWF2;TPP1;GPC1;SRSF5;ZNF160;NDE1;AGO4;CDHR1;FGFR1;CTSZ;CHADL;PIN1;C5;TMEM204;PROX1;PCDHGC3;DLG3;BIN1;UNC119B;PPP1R13L;SLC25A27;GRB10;BFSP1;JARID2;WNT2B;SNPH;TMEM231;RTN4R;EPB41L3;TIMP1;SDC1;SH2B3;WNT3;SORL1;COL13A1;VEGFB;ACVR1B;MEF2B;GSS;ERBB3;ABR;AKT1;ADAM19;ZNF385A;LRCH4;NDRG2;SMARCA1;VPS33B;SIX5;SUN1;SSH3;GAS8;PKD1;RGS14;CTSH;ROBO4;NRSN1;ATXN10;EPN2;NINJ1;PMS2P5;RANBP9;ARHGEF19;SLC2A1;TAZ;JAK3;APBA1;RARG;EREG;GIPR;KRT15;TRNP1;POLM;SEMA4F;SULF2;KIF26B;LZTS2
11235,GO:0045494,0.000230294161751477,0.999970450900107,8,19,photoreceptor cell maintenance,BP,BBS2;NPHP4;TUB;BBS1;CROCC;SPATA7;CDHR1;ERCC6
11866,GO:0046903,0.000231554773902977,0.999844215721294,128,994,secretion,BP,LMF1;IDH2;GAA;SYTL1;NAPRT;PYGB;CST3;LTBP4;RAPGEF3;PGM1;GSN;XDH;PRSS3;POSTN;NR1D1;ALOX15B;IGF2;LTBP2;EGFR;TIMP2;HADH;NLGN2;SERPING1;RHBDF1;PYGL;SYT8;F2R;CTSB;KCNC4;ZP3;NISCH;LRP5;EXOC2;BRSK1;FUCA1;ITPR3;VAT1;RIMS3;CD9;HEXB;SERPINE2;VPS11;VAMP2;NTSR1;GM2A;GLUL;ASIC1;WNT7A;RAB3D;NBEAL2;TMEM173;ATP7B;RNASET2;ECM1;RAB25;MYO18A;PFKFB2;VEGFA;DNASE1L1;ARL2;AP2A2;RHBDF2;DPP7;ACVR2B;MAPK3;KCNAB2;OLFM2;GLB1;RAB40B;DVL1;LTA4H;FURIN;SLC2A3;ADA;MCTP1;RASL10B;PFKL;RHOF;MAPKBP1;RAB3B;PI4K2A;DMTN;VGF;TRPV4;HK1;GAS6;LLGL1;COMT;PTAFR;PCK2;BCR;PRKCZ;TM7SF3;FGFR1;CTSZ;C5;VSNL1;SERPINB6;TOLLIP;CSTB;SNPH;GUCA1B;ADGRE2;TIMP1;CD68;SDC1;ACTR1B;STK39;VEGFB;ADORA2B;HGSNAT;ERBB3;ABR;CTSD;VPS33B;PINK1;CTSH;PYCARD;KCNN4;CKLF;SIRT3;SLC2A1;APBA1;GALNS;GIPR;RAB40C;MIF;STXBP2
6726,GO:0030154,0.000234495413436877,0.999822439688175,289,2518,cell differentiation,BP,HTRA1;FOS;DUSP6;APOE;CTNNBIP1;PPL;IDH2;PTPRS;ERCC1;FLNC;SEMA4B;BTBD2;CST3;SHANK2;LTBP4;RAPGEF3;TCFL5;MRC2;CYP27B1;GSN;XDH;NDRG1;PGF;MEF2D;NOS1;PARVB;ZFP36L1;COL6A1;TCTN1;POSTN;GRB7;NR1D1;ALOX15B;FAM210B;EPHB2;EPAS1;OBSCN;CNTN1;IGF2;NFATC4;MST1R;LRP1;OBSL1;EGFR;TIMP2;FHL1;MDFI;ADGRF1;EGR1;ULK1;CMTM7;SDK2;CRTC1;NAGLU;SHC1;PTK6;DEAF1;LAMA5;BBS2;ACTA2;PRSS8;S100A4;CTSB;DNAH1;ULK2;GJC2;IGSF9;ZMYND8;ASH2L;SOX12;ABCG1;ANK3;S100A6;ZNF516;HDAC5;THRA;ZP3;LRP5;DBNDD1;TENM2;ZFPM1;ERBB2;FBLN1;BRSK1;MICALL2;PTPRU;TST;ITGB4;PLXNB3;PTHLH;IFT140;CD9;KIF13B;HEXB;SERPINE2;FUZ;FOXQ1;NPHP4;UNK;MINK1;TMOD2;CSNK1E;TRAPPC9;ADAMTS7;PDCD4;LAMB2;WNT7A;ZMIZ1;INSR;LCE1E;SH3PXD2B;FBXW8;ID1;CELSR1;B4GAT1;EPHA1;ADARB1;ITGA6;TXNRD3;SYNGAP1;NBEAL2;DNMT3A;DNPH1;LPAR3;EFNB3;SPRY2;STAT6;DLG4;SPEG;WWTR1;RAB25;FAM20C;MYCBPAP;BCL6;PLXNB1;FAM213A;DYRK1B;BNIP3;SRMS;FZD8;VEGFA;ZSCAN2;LRRC8A;VANGL2;CEBPB;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;S1PR2;MAPK3;KCNAB2;ETV5;OLFM2;DHTKD1;TNNT1;DVL1;GPSM1;ADCY6;L3MBTL1;EPHB3;HES1;SSH1;FURIN;MBOAT7;CUL7;ARHGAP22;NRP2;ADA;SH2D2A;AQP3;CELSR2;IL6R;SLIT3;PCSK9;ZFP36;ETV4;BTBD11;FGFR3;PRKACA;LRRK1;SPATA20;DGUOK;CYFIP2;RPS6KA5;ITGB5;FGFR4;SPTB;MXRA8;DMTN;MYH3;MDGA1;HDAC11;TNFRSF1A;SEMA3B;LDLR;ROBO3;SOX13;TRPV4;RAG1;NHSL1;EEF2K;HMGA2;SEMA3F;ELK3;AHNAK2;PEX7;SEMA4C;GAS6;LLGL1;PPARA;WNT7B;SUFU;RFNG;DMC1;LTBP3;RXRA;PCK2;VASN;NEO1;USP21;PRKCZ;INPP5D;NYAP1;SLITRK6;TWF2;TPP1;GPC1;NDE1;AGO4;CDHR1;FGFR1;CTSZ;CHADL;PIN1;TMEM204;PROX1;BIN1;UNC119B;YIPF3;PPP1R13L;GRB10;BFSP1;JARID2;CAPN2;TOLLIP;WNT2B;SNPH;TMEM231;RTN4R;EPB41L3;SDC1;SH2B3;WNT3;ZFP41;MICALCL;SORL1;COL13A1;ACVR1B;ERBB3;CCDC85B;CCDC71L;AKT1;ZNF385A;TP53INP1;NDRG2;SMARCA1;VPS33B;SIX5;TDRKH;SUN1;TMEM120A;SSH3;RGS14;ROBO4;RILPL1;ATXN10;RFX2;RANBP9;JAK3;RARG;PBXIP1;EREG;KRT15;ADAMTSL4;POLM;SEMA4F;SULF2
10407,GO:0043269,0.000241904233775628,0.999874484866091,48,299,regulation of ion transport,BP,CEMIP;APOE;SHANK2;NOS1;SCN8A;EPHB2;CNTN1;KCNG1;NLGN2;FHL1;F2R;ABCA7;PRSS8;GJC2;KCNC4;ANK3;KCNJ15;PKD2;SCN4B;SERPINE2;VAMP2;NTSR1;MINK1;ATP2B4;LPAR3;PRNP;DLG4;SHANK3;KCNAB2;PCSK9;PRKACA;RAB3B;PTAFR;FGFR1;KCNMA1;GLRX;STK39;ANO9;TPCN1;AKT1;GPD1L;PINK1;EHD3;SNTA1;HOMER2;GSTM2;SHISA6;MIF
8214,GO:0032990,0.000242772349784219,0.999859151510135,68,459,cell part morphogenesis,BP,APOE;PTPRS;SEMA4B;SHANK2;TCTN1;POSTN;GRB7;EPHB2;NFATC4;OBSL1;EGFR;ULK1;ARPIN;SHC1;CORO1B;ULK2;ANK3;S100A6;ERBB2;BRSK1;PLXNB3;KIF13B;MINK1;LAMB2;WNT7A;FBXW8;ID1;B4GAT1;ADARB1;SYNGAP1;LPAR3;EFNB3;DLG4;PLXNB1;VEGFA;VANGL2;SHANK3;MAPK3;DVL1;EPHB3;SSH1;CUL7;NRP2;CELSR2;SLIT3;CYFIP2;RPS6KA5;SPTB;SEMA3B;ROBO3;EEF2K;SEMA3F;SEMA4C;LLGL1;WNT7B;NEO1;PRKCZ;NYAP1;SLITRK6;TWF2;GPC1;GRB10;RTN4R;EPB41L3;WNT3;SSH3;RANBP9;SEMA4F
96,GO:0000187,0.000244417426660918,0.99991259813171,22,102,activation of MAPK activity,BP,DUSP6;IGF2;DUSP5;PKN1;SHC1;SHC2;INSR;LPAR3;CD81;S1PR2;MAPK3;MAP2K2;DUSP7;WNT7B;MAPKAPK3;C5;MADD;STK39;ADORA2B;ERCC6;MAP2K3;ERN1
18675,GO:1904062,0.00024687263955399,0.999894861927929,30,160,regulation of cation transmembrane transport,BP,CEMIP;SHANK2;NOS1;EPHB2;KCNG1;NLGN2;FHL1;F2R;GJC2;ANK3;PKD2;SCN4B;VAMP2;NTSR1;MINK1;ATP2B4;PRNP;DLG4;SHANK3;KCNAB2;PCSK9;PRKACA;GLRX;STK39;GPD1L;PINK1;EHD3;SNTA1;GSTM2;SHISA6
6621,GO:0022898,0.00026395553506943,0.999895229055351,26,131,regulation of transmembrane transporter activity,BP,SHANK2;NOS1;EPHB2;KCNG1;NLGN2;FHL1;ANK3;PKD2;SCN4B;VAMP2;NTSR1;MINK1;PRNP;DLG4;SHANK3;PCSK9;PRKACA;PTAFR;GLRX;STK39;ANO9;GPD1L;PINK1;EHD3;GSTM2;SHISA6
6580,GO:0022604,0.00027346848223205,0.999852299138191,53,337,regulation of cell morphogenesis,BP,APOE;PTPRS;SEMA4B;PARVB;ARAP1;POSTN;EPHB2;NFATC4;OBSL1;ARPIN;CORO1B;ULK2;FBLN1;PLXNB3;KIF13B;HEXB;CSNK1E;RHOD;WNT7A;FBXW8;ID1;SYNGAP1;LPAR3;EFNB3;DLG4;PLXNB1;VEGFA;SHANK3;DVL1;WIPF1;EPHB3;SSH1;CUL7;CDC42EP5;RHOF;ZMYM3;DMTN;SEMA3B;RHOBTB2;EEF2K;SEMA3F;SEMA4C;TWF2;AGO4;ARAP3;C21ORF2;SH3D19;RTN4R;EPB41L3;WNT3;SSH3;SYNE3;SEMA4F
6638,GO:0023056,0.000273757362131338,0.999810943808979,144,1143,positive regulation of signaling,BP,DUSP6;APOE;FAM110C;SHANK2;CYP27B1;GSN;XDH;NOS1;ARAP1;SH3BP2;GRB7;ALOX15B;RBCK1;EPHB2;IGF2;NFATC4;MST1R;EGFR;TIMP2;NLGN2;DUSP5;PKN1;CRTC1;SHC1;RGL2;F2R;PTK6;ABCA7;S100A4;SHC2;CXXC5;PIK3R2;MAML3;ERBB2;PKD2;ITPR3;CDKN1C;RIMS3;SERPINE2;VAMP2;NTSR1;MINK1;TMOD2;TFDP2;CSNK1E;PDCD4;SLC20A1;TNFRSF25;GLUL;WNT7A;ZMIZ1;INSR;EPHA1;LPAR3;PRNP;SPRY2;ECM1;DLG4;PFKFB2;PLXNB1;BNIP3;CD81;FZD8;VEGFA;VANGL2;SHANK3;ACVR2B;S1PR2;MAPK3;PLEKHG5;DVL1;EPHB3;HES1;SSH1;EVC;ADA;PIDD1;PAG1;SH2D2A;RASL10B;IL6R;FGFR3;LRRK1;CYFIP2;HBEGF;RAB3B;MAP2K2;FGFR4;DMTN;TNFRSF1A;MAPK8IP1;TRPV4;DUSP7;LDLRAP1;SEMA4C;MIB2;GAS6;WNT7B;RFNG;PCK2;VAV3;NEO1;IGFBP4;PRKCZ;TM7SF3;MAPKAPK3;FGFR1;PIN1;C5;WBP2;VSNL1;GRB10;WNT2B;MADD;RTN4R;SH2B3;FGFBP1;WNT3;STK39;ACVR1B;ADORA2B;ERBB3;AKT1;ZNF385A;TP53INP1;ERCC6;PINK1;RGS14;CTSH;MLST8;EPN2;PYCARD;MAP2K3;KCNN4;ERN1;SIRT3;LITAF;EREG;FAM162A;GSTM2;GIPR;TMED4;MIF;SULF2
10489,GO:0043410,0.000281417700031186,0.999848875542399,52,330,positive regulation of MAPK cascade,BP,DUSP6;XDH;EPHB2;IGF2;MST1R;EGFR;TIMP2;DUSP5;PKN1;SHC1;F2R;ABCA7;SHC2;ERBB2;MINK1;TNFRSF25;WNT7A;INSR;EPHA1;LPAR3;SPRY2;CD81;FZD8;VEGFA;VANGL2;S1PR2;MAPK3;EPHB3;FGFR3;MAP2K2;FGFR4;TNFRSF1A;MAPK8IP1;TRPV4;DUSP7;SEMA4C;GAS6;WNT7B;IGFBP4;PRKCZ;MAPKAPK3;FGFR1;C5;MADD;STK39;ADORA2B;ERBB3;ERCC6;PYCARD;MAP2K3;ERN1;MIF
7323,GO:0031345,0.000281802236942775,0.999890049735081,25,124,negative regulation of cell projection organization,BP,APOE;PTPRS;SEMA4B;EVI5L;EPHB2;NFATC4;LRP1;ARPIN;ULK2;PLXNB3;ID1;SYNGAP1;PRNP;EFNB3;SPRY2;ADCY6;DGUOK;SEMA3B;TRPV4;SEMA3F;SEMA4C;CTSZ;RTN4R;WNT3;SEMA4F
3397,GO:0007186,0.000294255827926642,0.999835766658376,58,384,G-protein coupled receptor signaling pathway,BP,ADGRL1;APOE;LTB4R;NOS1;OBSCN;LRP1;HEBP1;RAPGEFL1;ADGRF1;ARHGEF4;F2R;GNAL;DGKA;NXPH4;ITPR3;PTHLH;VIPR1;SIGMAR1;LTB4R2;NTSR1;ATP2B4;TMOD2;USP20;INSR;CELSR1;GRK6;LPAR3;PLXNB1;FZD8;GPRC5C;S1PR2;PLEKHG5;ENTPD2;ADCY6;GPR153;PLEKHG2;ADA;HTR7;CELSR2;DGKQ;ADGRB2;GIT1;PTAFR;VAV3;C5;GUCA1B;ADGRE2;OR7D2;ADORA2B;ABR;AKT1;HOMER2;RGS14;PCSK1N;ARHGEF19;EREG;GIPR;RGS12
11478,GO:0045981,0.000304931512933224,0.999930959515728,12,41,positive regulation of nucleotide metabolic process,BP,APOE;RAPGEF3;NOS1;TIMP2;PTHLH;INSR;PFKFB2;MLXIPL;GUCA1B;ADORA2B;PINK1;TAZ
17477,GO:1900544,0.000304931512933224,0.999930959515728,12,41,positive regulation of purine nucleotide metabolic process,BP,APOE;RAPGEF3;NOS1;TIMP2;PTHLH;INSR;PFKFB2;MLXIPL;GUCA1B;ADORA2B;PINK1;TAZ
9775,GO:0040012,0.000314613431475183,0.999804322141945,85,611,regulation of locomotion,BP,CEMIP;APOE;IDH2;SEMA4B;FAM110C;PGF;POSTN;GRB7;ALOX15B;LRP1;EGFR;MMP28;PKN1;ARPIN;F2R;LAMA5;BBS2;CORO1B;ZMYND8;HDAC5;DOCK4;ZP3;NISCH;HYAL1;ERBB2;FBLN1;PTPRU;PLXNB3;PHLDA2;SERPINE2;FUZ;MINK1;RHOD;WNT7A;INSR;EPHA1;ADARB1;ITGA6;SPRY2;ECM1;RAB25;PLXNB1;CD81;VEGFA;ADAM15;MAPK3;PC;SSH1;NRP2;ADA;MCTP1;IL6R;RHOF;HBEGF;DMTN;SEMA3B;TRPV4;RHOBTB2;SEMA3F;SEMA4C;GAS6;PTAFR;BCR;ARAP3;FGFR1;PIN1;C5;PROX1;TIMP1;WNT3;PPM1F;SORL1;VEGFB;ACVR1B;ERBB3;ABR;AKT1;TP53INP1;CTSH;ROBO4;PYCARD;MAP2K3;EREG;SEMA4F;MIF
12594,GO:0050804,0.000325999832098881,0.999852206117235,33,183,modulation of chemical synaptic transmission,BP,APOE;SHANK2;EPHB2;NFATC4;EGFR;NLGN2;CRTC1;F2R;ZMYND8;KCNC4;NISCH;ITPR3;RIMS3;SERPINE2;VAMP2;NTSR1;GLUL;ASIC1;WNT7A;SYNGAP1;PRNP;DLG4;SHANK3;S1PR2;DVL1;SSH1;MCTP1;RAB3B;VGF;PRKCZ;PINK1;RGS14;SHISA6
16996,GO:0099177,0.000325999832098881,0.999852206117235,33,183,regulation of trans-synaptic signaling,BP,APOE;SHANK2;EPHB2;NFATC4;EGFR;NLGN2;CRTC1;F2R;ZMYND8;KCNC4;NISCH;ITPR3;RIMS3;SERPINE2;VAMP2;NTSR1;GLUL;ASIC1;WNT7A;SYNGAP1;PRNP;DLG4;SHANK3;S1PR2;DVL1;SSH1;MCTP1;RAB3B;VGF;PRKCZ;PINK1;RGS14;SHISA6
3268,GO:0006954,0.000332912293089359,0.999817330824741,54,353,inflammatory response,BP,TNIP1;FOS;APOE;CTNNBIP1;NT5E;LTB4R;PRDX5;NFATC4;MAPK13;EGFR;SERPING1;F2R;HDAC5;ZP3;HYAL1;LTB4R2;GGT1;ACP5;PDCD4;TNFRSF25;IL20RB;ECM1;BCL6;CD81;CEBPB;TNFRSF6B;MEFV;TNFRSF14;ADA;IL6R;F12;RPS6KA5;TNFRSF1A;LDLR;TRPV4;PPARA;PTAFR;BCR;IGFBP4;PRKCZ;C5;TOLLIP;ADGRE2;SDC1;STK39;ADORA2B;ABR;PNMA1;AKT1;NLRX1;PYCARD;MAP2K3;JAK3;MIF
10305,GO:0043113,0.000333889746554326,0.999937412369597,10,30,receptor clustering,BP,APOE;GSN;SYNGAP1;DLG4;SHANK3;ETV5;DVL1;SSH1;DLG3;SHISA6
7915,GO:0032502,0.000350314723991127,0.999724293180592,426,3896,developmental process,BP,HTRA1;FOS;DUSP6;ADGRL1;APOE;MARVELD1;CTNNBIP1;PPL;IDH2;PTPRS;ERCC1;WWC3;FLNC;SEMA4B;GAA;CITED4;BTBD2;CST3;SHANK2;LTBP4;RAPGEF3;TCFL5;MRC2;CYP27B1;GSN;XDH;NDRG1;PGF;MEF2D;NOS1;LTBP1;PARVB;ARAP1;ZFP36L1;COL6A1;TCTN1;POSTN;GRB7;NR1D1;ALOX15B;FAM210B;SCN8A;EPHB2;EPAS1;OBSCN;CNTN1;IGF2;NFATC4;MST1R;LRP1;GAMT;RAB11FIP4;OBSL1;EGFR;TIMP2;NLGN2;DUSP5;FHL1;LOXL1;SERPING1;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;PKN1;CMTM7;SDK2;CRTC1;ARPIN;DOPEY2;NAGLU;SHC1;F2R;PTK6;DEAF1;LAMA5;BBS2;ACTA2;PRSS8;S100A4;CTSB;DNAH1;CORO1B;ULK2;GJC2;IGSF9;MALL;THBS3;ZMYND8;ASH2L;SOX12;ABCG1;ANK3;S100A6;ZNF516;HDAC5;THRA;ZP3;LRP5;DBNDD1;HYAL1;MARK4;TENM2;ZFPM1;TFEB;ERBB2;FBLN1;BRSK1;MICALL2;BSG;SCMH1;PTPRU;PKD2;TST;ITGB4;PLXNB3;PHLDA2;VAT1;SPRY4;PTHLH;SALL2;IFT140;CD9;KIF13B;SIGMAR1;HEXB;SERPINE2;FUZ;FOXQ1;NPHP4;UNK;MINK1;ATP2B4;TMOD2;TFDP2;CSNK1E;ACP5;PLCD1;TRAPPC9;ADAMTS7;PDCD4;TNFRSF25;RHOD;ARVCF;LAMB2;WNT7A;ZMIZ1;INSR;LCE1E;SH3PXD2B;FBXW8;ID1;CELSR1;B4GAT1;POLL;EPHA1;ADARB1;ITGA6;TXNRD3;SYNGAP1;NBEAL2;DNMT3A;DNPH1;LPAR3;PRNP;ATP7B;EFNB3;SPRY2;MNT;ECM1;STAT6;DLG4;SPEG;MKNK2;PLCD3;STRADB;WWTR1;RAB25;FAM20C;TMEM107;MYCBPAP;PHC2;BCL6;PLXNB1;FAM213A;IGFBP2;DYRK1B;BNIP3;SRMS;FZD8;VEGFA;ZSCAN2;LRRC8A;YPEL3;VANGL2;FBXW4;AP2A2;CEBPB;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;NUDCD3;S1PR2;ENDOG;TNFRSF6B;MAPK3;TUB;KCNAB2;ETV5;OLFM2;AMN;DHTKD1;TNNT1;DVL1;WIPF1;GPSM1;ADCY6;L3MBTL1;PHGDH;EPHB3;HES1;SSH1;FURIN;MLXIPL;MBOAT7;CUL7;EVC;ARHGAP22;NRP2;TNFRSF14;ADA;CDC42EP5;TRIM45;SH2D2A;AQP3;CELSR2;IL6R;SLIT3;PCSK9;ZFP36;ETV4;RHOF;BTBD11;FGFR3;PRKACA;PITPNM1;ZMYM3;LRRK1;SPATA20;DGUOK;CYFIP2;SLC38A10;RPS6KA5;HBEGF;ITGB5;FGFR4;SPTB;MXRA8;DMTN;RAPGEF5;MYH3;MDGA1;HDAC11;VGF;TNFRSF1A;TCF25;SEMA3B;LDLR;ROBO3;SNX17;SOX13;TRPV4;RHOBTB2;RAG1;NHSL1;EEF2K;MSLN;HMGA2;SEMA3F;ELK3;AHNAK2;PEX7;SEMA4C;SDHAF4;GAS6;BTRC;POU6F1;LLGL1;ADGRB2;ZNF217;PPARA;HMGCL;WNT7B;COMT;SUFU;RFNG;DMC1;LTBP3;RXRA;PCK2;VAV3;LRP10;VASN;BCR;NEO1;IGFBP4;SDHA;USP21;WDR60;PRKCZ;CLTCL1;INPP5D;NYAP1;SLITRK6;TWF2;LSM14B;TPP1;GPC1;SRSF5;ZNF160;TEF;NDE1;AGO4;ARAP3;CDHR1;FGFR1;CTSZ;CHADL;PIN1;MN1;C5;TMEM204;IRF2BPL;PROX1;PCDHGC3;C21ORF2;DLG3;BIN1;UNC119B;YIPF3;PPP1R13L;SH3D19;SLC25A27;GRB10;BFSP1;JARID2;CAPN2;TOLLIP;WNT2B;SNPH;TMEM231;RTN4R;EPB41L3;TIMP1;SDC1;SH2B3;WNT3;ZFP41;MICALCL;SORL1;COL13A1;VEGFB;ACVR1B;MEF2B;GSS;ERBB3;ABR;CCDC85B;CCDC71L;AKT1;ADAM19;ZNF385A;TP53INP1;LRCH4;NDRG2;SMARCA1;VPS33B;SIX5;ERCC6;TDRKH;SUN1;TMEM120A;SSH3;PINK1;GAS8;PKD1;RGS14;SYNE3;CTSH;ROBO4;RILPL1;NRSN1;ATXN10;EPN2;RFX2;NINJ1;POMT1;TRERF1;PMS2P5;RANBP9;ARHGEF19;SIRT3;SLC2A1;TAZ;JAK3;LITAF;APBA1;RARG;PBXIP1;EREG;ZFYVE19;GIPR;WDR18;KRT15;ADAMTSL4;TRNP1;POLM;SEMA4F;PRR15;MIF;SULF2;KIF26B;LZTS2
3058,GO:0006629,0.000353330324491421,0.999760405739987,125,973,lipid metabolic process,BP,LMF1;APOE;TYSND1;CYP27B1;NR1D1;CRAT;ALOX15B;CPT2;LRP1;EGFR;HADH;CRYL1;ACSF2;ACOT7;ISYNA1;KDSR;EGR1;LPCAT4;DGKA;CERS4;ABCG1;DHRS11;PIK3R2;THRA;PLD3;ZP3;LRP5;PLTP;ERBB2;FUCA1;CPT1C;HEXB;GGT1;PLCD1;ZFYVE21;GM2A;PLCXD1;MVD;SERINC2;SRD5A3;IAH1;HINT2;ABCD1;PLCD3;SEC14L2;CD81;MAPK3;GLB1;LTA4H;PC;ACAD10;MLXIPL;MBOAT7;ABCA2;OSBPL5;RETSAT;PCSK9;FGFR3;PITPNM1;PLCH2;HBEGF;PI4K2A;FGFR4;PMVK;TNFRSF1A;LDLR;CYP3A5;ACOT11;SNX17;PIGZ;LDLRAP1;TM7SF2;DGKQ;PEX7;PPARA;HMGCL;COMT;TTC7B;AIG1;IMPA2;RXRA;PCK2;VAV3;LRP10;INPP5D;ETFB;TPP1;PDK2;GPC1;FGFR1;PNPLA4;PHYH;PROX1;ESYT2;PI4KAP2;CES2;SESN2;LCAT;GAL3ST4;PITPNM3;PIGV;SDC1;PIGQ;SBF1;SORL1;ERBB3;CYP2S1;CCDC71L;AKT1;ACP6;GPD1L;NAGA;LONP2;PLPPR2;AGPAT4;TRERF1;ACADS;CPNE7;MLYCD;TAZ;EREG;GSTM2;AGPAT3;ALG12;MIF
3687,GO:0008201,0.00036263247417461,0.999882235905341,18,79,heparin binding,MF,APOE;PTPRS;PGF;POSTN;LTBP2;SMOC2;THBS3;SERPINE2;TNXB;VEGFA;NRP2;HBEGF;FGFR4;FGFR1;RTN4R;FGFBP1;COL13A1;VEGFB
17967,GO:1902430,0.000366180272463815,0.999980922081986,5,8,negative regulation of amyloid-beta formation,BP,APOE;ABCA7;PRNP;BIN1;SORL1
7660,GO:0032101,0.000371003687602962,0.999785504436472,63,429,regulation of response to external stimulus,BP,TNIP1;HTRA1;APOE;PTPRS;SEMA4B;NT5E;CYP27B1;PGF;MAPK13;EGFR;MMP28;SERPING1;F2R;BBS2;CORO1B;PLAT;ZP3;CD9;SERPINE2;GGT1;ACP5;PDCD4;IL20RB;TMEM173;BCL6;CD81;VEGFA;MAPK3;DVL1;MEFV;LRSAM1;ADA;IL6R;MAPKBP1;F12;DMTN;TNFRSF1A;SEMA3B;LDLR;TRPV4;SEMA3F;SEMA4C;FAM3A;GAS6;PPARA;TKFC;BCR;FGFR1;C5;GUCA1B;RTN4R;WNT3;PPM1F;STK39;VEGFB;ADORA2B;ABR;NLRX1;VPS33B;PYCARD;APOBEC3F;SEMA4F;MIF
12653,GO:0050890,0.000374655391639807,0.999838709472391,29,155,cognition,BP,FOS;APOE;SHANK2;EPHB2;EGFR;ADGRF1;CRTC1;DOPEY2;ABCA7;DEAF1;THRA;ITPR3;NTSR1;TMOD2;GM2A;ASIC1;INSR;SYNGAP1;PRNP;DLG4;CEBPB;SHANK3;LDLR;RAG1;COMT;PRKCZ;GPR155;ZNF385A;RGS14
3709,GO:0008236,0.000410366404881254,0.99985538899929,20,93,serine-type peptidase activity,MF,HTRA1;TYSND1;PRSS3;RHBDF1;PRSS8;CTSB;PLAT;MMP1;RHBDF2;DPP7;FURIN;PCSK9;F12;RHBDL1;PCSK1;TPP1;TMPRSS11D;CTSD;LONP2;CTSH
7462,GO:0031638,0.00041949218941997,0.999918306005327,10,31,zymogen activation,BP,PRSS3;PLAT;SERPINE2;GGT1;FURIN;F12;CYFIP2;CTSZ;CTSH;PYCARD
12855,GO:0051216,0.000431186952084148,0.999838502205893,22,105,cartilage development,BP,MEF2D;BBS2;THBS3;THRA;HYAL1;PTHLH;ADAMTS7;WNT7A;FBXW4;MAPK3;EVC;FGFR3;TRPV4;HMGA2;WNT7B;FGFR1;CHADL;WNT2B;TIMP1;PKD1;RARG;SULF2
7479,GO:0031659,0.000433571840546926,0.999990748103435,4,5,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,EGFR;PKD2;AKT1;PKD1
2201,GO:0005089,0.00045644763610005,0.999868051573159,15,59,Rho guanyl-nucleotide exchange factor activity,MF,OBSCN;ARHGEF4;RGL2;PLEKHG4;PLEKHG5;PLEKHG2;PLEKHG6;ARHGEF37;VAV3;BCR;EPS8L1;ABR;EPS8L2;ARHGEF10L;ARHGEF19
12939,GO:0051347,0.000457259486809669,0.999726469762451,69,480,positive regulation of transferase activity,BP,DUSP6;CEMIP;EPHB2;IGF2;MST1R;EGFR;DUSP5;EGR1;PKN1;SHC1;F2R;SHC2;ERBB2;PKD2;PAK6;MINK1;ATP2B4;INSR;EPHA1;LPAR3;PRNP;SERINC2;SPRY2;SNX9;DLG4;STRADB;PFKFB2;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;MAPK3;ADCY6;EPHB3;FGFR3;PRKACA;MAP2K2;FGFR4;DUSP7;DGKQ;GAS6;WNT7B;VAV3;PRKCZ;MAPKAPK3;FGFR1;CAMKK1;PIN1;C5;PROX1;DLG3;MAPRE3;MADD;SORL1;STK39;ADORA2B;ERBB3;AKT1;ERCC6;PINK1;PKD1;MLST8;MAP2K3;ERN1;EREG;MIF
3497,GO:0007411,0.000460192065044526,0.999792783844689,31,170,axon guidance,BP,SEMA4B;GRB7;EPHB2;SHC1;ERBB2;PLXNB3;LAMB2;B4GAT1;EFNB3;PLXNB1;VEGFA;VANGL2;SHANK3;MAPK3;DVL1;EPHB3;NRP2;SLIT3;CYFIP2;RPS6KA5;SPTB;SEMA3B;ROBO3;SEMA3F;SEMA4C;NEO1;GPC1;GRB10;WNT3;RANBP9;SEMA4F
3183,GO:0006814,0.000466589690011191,0.999815075314268,24,120,sodium ion transport,BP,NOS1;SCN8A;CNTN1;PRSS8;ANK3;SLC13A3;PKD2;SCN4B;SERPINE2;ATP2B4;SLC6A8;SLC20A1;ASIC1;ATP12A;PCSK9;SLC38A10;SCNN1A;GLRX;SLC9A7;STK39;AKT1;GPD1L;SLC5A5;SNTA1
12316,GO:0048699,0.000470116918316384,0.999679959426945,122,943,generation of neurons,BP,APOE;IDH2;PTPRS;SEMA4B;SHANK2;NOS1;TCTN1;POSTN;GRB7;EPHB2;CNTN1;NFATC4;LRP1;OBSL1;EGFR;TIMP2;ADGRF1;ULK1;SDK2;CRTC1;NAGLU;SHC1;PTK6;ULK2;GJC2;IGSF9;ZMYND8;ANK3;S100A6;HDAC5;DBNDD1;TENM2;ERBB2;BRSK1;MICALL2;PLXNB3;IFT140;KIF13B;SERPINE2;NPHP4;UNK;MINK1;CSNK1E;TRAPPC9;LAMB2;WNT7A;FBXW8;ID1;CELSR1;B4GAT1;ADARB1;SYNGAP1;DNMT3A;LPAR3;EFNB3;DLG4;BCL6;PLXNB1;FZD8;VEGFA;VANGL2;CEBPB;SHANK3;MAPK3;ETV5;DVL1;ADCY6;EPHB3;HES1;SSH1;CUL7;NRP2;CELSR2;SLIT3;PCSK9;DGUOK;CYFIP2;RPS6KA5;SPTB;MDGA1;SEMA3B;LDLR;ROBO3;TRPV4;NHSL1;EEF2K;SEMA3F;PEX7;SEMA4C;GAS6;LLGL1;WNT7B;SUFU;NEO1;USP21;PRKCZ;NYAP1;SLITRK6;TWF2;GPC1;NDE1;CDHR1;FGFR1;CTSZ;PIN1;PROX1;BIN1;UNC119B;GRB10;WNT2B;SNPH;RTN4R;EPB41L3;WNT3;SORL1;AKT1;SMARCA1;SSH3;RGS14;ATXN10;RANBP9;SEMA4F
3061,GO:0006635,0.000475026832743569,0.999861499509206,15,61,fatty acid beta-oxidation,BP,TYSND1;CRAT;CPT2;HADH;CPT1C;ABCD1;ACAD10;PEX7;PPARA;ETFB;SESN2;AKT1;LONP2;ACADS;MLYCD
6852,GO:0030334,0.000476080945525605,0.999708497253128,75,532,regulation of cell migration,BP,CEMIP;APOE;IDH2;SEMA4B;FAM110C;PGF;POSTN;GRB7;ALOX15B;LRP1;EGFR;MMP28;ARPIN;F2R;LAMA5;CORO1B;ZMYND8;HDAC5;DOCK4;ZP3;NISCH;HYAL1;PTPRU;PLXNB3;PHLDA2;SERPINE2;FUZ;MINK1;RHOD;WNT7A;INSR;EPHA1;ADARB1;ITGA6;SPRY2;ECM1;RAB25;PLXNB1;VEGFA;ADAM15;MAPK3;SSH1;NRP2;ADA;MCTP1;IL6R;RHOF;HBEGF;DMTN;SEMA3B;TRPV4;RHOBTB2;SEMA3F;SEMA4C;GAS6;PTAFR;BCR;ARAP3;FGFR1;C5;PROX1;TIMP1;PPM1F;SORL1;VEGFB;ACVR1B;ABR;AKT1;TP53INP1;CTSH;ROBO4;PYCARD;MAP2K3;SEMA4F;MIF
3257,GO:0006935,0.000493510882374167,0.999725727834967,53,350,chemotaxis,BP,SEMA4B;PGF;GRB7;EPHB2;MMP28;CMTM7;SHC1;CORO1B;DOCK4;ERBB2;PLXNB3;LTB4R2;LAMB2;B4GAT1;EFNB3;PLXNB1;VEGFA;VANGL2;SHANK3;MAPK3;PLEKHG5;DVL1;EPHB3;NRP2;IL6R;SLIT3;CYFIP2;RPS6KA5;HBEGF;SPTB;SEMA3B;ROBO3;TRPV4;SEMA3F;SEMA4C;GAS6;PTAFR;VAV3;NEO1;GPC1;FGFR1;C5;GRB10;ADGRE2;WNT3;LYST;PPM1F;VEGFB;CKLF;RANBP9;CMTM4;SEMA4F;MIF
9942,GO:0042330,0.000493510882374167,0.999725727834967,53,350,taxis,BP,SEMA4B;PGF;GRB7;EPHB2;MMP28;CMTM7;SHC1;CORO1B;DOCK4;ERBB2;PLXNB3;LTB4R2;LAMB2;B4GAT1;EFNB3;PLXNB1;VEGFA;VANGL2;SHANK3;MAPK3;PLEKHG5;DVL1;EPHB3;NRP2;IL6R;SLIT3;CYFIP2;RPS6KA5;HBEGF;SPTB;SEMA3B;ROBO3;TRPV4;SEMA3F;SEMA4C;GAS6;PTAFR;VAV3;NEO1;GPC1;FGFR1;C5;GRB10;ADGRE2;WNT3;LYST;PPM1F;VEGFB;CKLF;RANBP9;CMTM4;SEMA4F;MIF
9184,GO:0035584,0.000498135242132285,0.999968671261615,5,9,calcium-mediated signaling using intracellular calcium source,BP,ADGRL1;PRNP;PRKACA;DMTN;HOMER2
3180,GO:0006811,0.000507230043748934,0.999660037474926,111,858,ion transport,BP,CEMIP;APOE;SHANK2;CYP27B1;CLCA2;NOS1;SCN8A;SLCO4A1;EPHB2;CNTN1;CPT2;KCNG1;NLGN2;SLC43A1;FHL1;F2R;ABCA7;CA12;SLC16A5;PRSS8;PITPNC1;SLC16A3;GJC2;KCNC4;ABCG1;ANK3;S100A6;KCNJ15;ANO8;PLTP;SLC2A9;SLC13A3;BSG;PKD2;SCN4B;SLC7A8;ITPR3;PRAF2;SERPINE2;VAMP2;NTSR1;MINK1;ATP2B4;SLC6A8;SLC20A1;ASIC1;LPAR3;PRNP;SERINC2;ATP7B;SLC12A7;DLG4;ABCD1;TTYH3;ATP12A;LRRC8A;TMEM63C;SHANK3;KCNAB2;SLC22A18;SLC16A13;SLC2A3;ADA;OSBPL5;PCSK9;PRKACA;PITPNM1;SLC38A10;SCNN1A;SLC25A37;RAB3B;SLC37A2;LDLR;TRPV4;GAS6;PPARA;PTAFR;RXRA;TMEM175;FGFR1;DLG3;KCNMA1;GLRX;TMCO3;NDUFA4L2;SMDT1;PITPNM3;SLC9A7;STK39;ANO9;TPCN1;SLC25A29;AKT1;GPD1L;SLC5A5;PINK1;PKD1;EHD3;SLC22A17;SNTA1;HOMER2;RHBG;KCNN4;ORAI3;SLC2A1;APBA1;ORAI2;GSTM2;SHISA6;PQLC2;MIF
12745,GO:0051046,0.000511072966887366,0.999701744246581,62,425,regulation of secretion,BP,IDH2;SYTL1;RAPGEF3;POSTN;NR1D1;ALOX15B;EGFR;HADH;NLGN2;RHBDF1;SYT8;F2R;KCNC4;ZP3;LRP5;ITPR3;RIMS3;VAMP2;NTSR1;GLUL;ASIC1;RAB3D;MYO18A;PFKFB2;ARL2;RHBDF2;MAPK3;RAB40B;ADA;MCTP1;RASL10B;PFKL;MAPKBP1;RAB3B;TRPV4;HK1;GAS6;LLGL1;COMT;PTAFR;PCK2;BCR;PRKCZ;TM7SF3;FGFR1;C5;VSNL1;ADGRE2;SDC1;STK39;ADORA2B;ERBB3;ABR;PINK1;PYCARD;KCNN4;SIRT3;SLC2A1;GIPR;RAB40C;MIF;STXBP2
16600,GO:0097485,0.00051129743676266,0.99976815013889,31,171,neuron projection guidance,BP,SEMA4B;GRB7;EPHB2;SHC1;ERBB2;PLXNB3;LAMB2;B4GAT1;EFNB3;PLXNB1;VEGFA;VANGL2;SHANK3;MAPK3;DVL1;EPHB3;NRP2;SLIT3;CYFIP2;RPS6KA5;SPTB;SEMA3B;ROBO3;SEMA3F;SEMA4C;NEO1;GPC1;GRB10;WNT3;RANBP9;SEMA4F
4633,GO:0010765,0.000512184510985077,0.999922717184038,8,21,positive regulation of sodium ion transport,BP,NOS1;CNTN1;PRSS8;ANK3;SCN4B;GLRX;AKT1;GPD1L
12895,GO:0051271,0.000512620701395795,0.999757661739255,34,196,negative regulation of cellular component movement,BP,APOE;IDH2;SEMA4B;ALOX15B;LRP1;MMP28;ARPIN;CORO1B;ZMYND8;HDAC5;NISCH;FBLN1;PTPRU;PLXNB3;CD9;FUZ;EPHA1;ADARB1;ADAM15;ADA;MCTP1;SEMA3B;SEMA3F;SEMA4C;BCR;ARAP3;PIN1;C5;TIMP1;WNT3;ABR;TP53INP1;SEMA4F;MIF
17466,GO:1900449,0.00052345178977811,0.999920744660823,8,21,regulation of glutamate receptor signaling pathway,BP,SHANK2;EPHB2;NLGN2;MINK1;DLG4;SHANK3;PINK1;SHISA6
12550,GO:0050730,0.000546181850511941,0.999766824538124,27,144,regulation of peptidyl-tyrosine phosphorylation,BP,CNTN1;IGF2;EGFR;SHC1;PTK6;PRNP;DLG4;CD81;VEGFA;HES1;IL6R;FGFR3;LRRK1;HBEGF;DMTN;TNFRSF1A;EHD4;DGKQ;GAS6;PRKCZ;DLG3;ERBB3;ERCC6;MLST8;CBLC;EREG;MIF
679,GO:0001890,0.000546982408985223,0.999785418082441,23,115,placenta development,BP,HTRA1;CYP27B1;ZFP36L1;EPAS1;IGF2;EGFR;MDFI;CTSB;TFEB;BSG;PKD2;PHLDA2;PLCD1;FBXW8;PLCD3;CEBPB;HES1;CUL7;ADA;WNT7B;RXRA;AKT1;PKD1
16395,GO:0097060,0.000559925776049836,0.999752306030219,29,157,synaptic membrane,CC,ADGRL1;PTPRS;SHANK2;NLGN2;F2R;ANK3;TENM2;DNM1;RIMS3;SIGMAR1;MINK1;PRR7;DLG4;SHANK3;OLFM2;PI4K2A;ABHD17C;SEMA4C;COMT;BCR;DLG3;KCNMA1;SNPH;COL13A1;HOMER2;RGS14;DDN;SHISA6;SEMA4F
14695,GO:0070372,0.000560852786836503,0.999747744286553,30,166,regulation of ERK1 and ERK2 cascade,BP,TNIP1;DUSP6;EPHB2;MST1R;EGFR;SHC1;F2R;ABCA7;ERBB2;FBLN1;SPRY4;INSR;EPHA1;SPRY2;MAPK3;EPHB3;FGFR3;FGFR4;TRPV4;GAS6;PRKCZ;FGFR1;PIN1;ERBB3;NDRG2;RGS14;PYCARD;RANBP9;SIRT3;MIF
13505,GO:0055114,0.000574163654463899,0.999627196749442,93,714,oxidation-reduction process,BP,H6PD;TYSND1;IDH2;GAA;PYGB;PGM1;CYP27B1;XDH;PRDX5;PRODH;NOS1;NR1D1;CRAT;ALOX15B;CPT2;IGF2;NFATC4;GPX3;ALDH4A1;HADH;CRYL1;LOXL1;MTHFR;KDSR;PYGL;DHRS1;D2HGDH;DHRS11;OGDHL;CBS;CPT1C;PHLDA2;VAT1;MSRB2;DHRS4L2;INSR;SH3PXD2B;AKR7A2;NDUFS8;TXNRD3;SRD5A3;ABCD1;FAM213A;BNIP3;HSD11B1L;KCNAB2;DHTKD1;PHGDH;PHYHD1;ACAD10;PYCR2;RETSAT;PFKL;CYP3A5;TM7SF2;PEX7;HK1;SDHAF4;PPARA;BLVRB;ALDH16A1;PCK2;SDHA;MDH2;ETFB;TMX4;SMOX;PHYH;GLRX;SESN2;NDUFA4L2;TSTA3;CYBRD1;GRHPR;KIAA1191;CYP2S1;AKT1;HPDL;TRAP1;GPD1L;UQCR11;PINK1;LONP2;KDM4B;RSAD1;PNPO;NDUFV3;ACADS;SIRT3;ALKBH6;MLYCD;TAZ;BCKDHA
5318,GO:0016054,0.00059235597398071,0.999720864016918,33,191,organic acid catabolic process,BP,CEMIP;TYSND1;PRODH;NOS1;CRAT;CPT2;ALDH4A1;HADH;CRYL1;HYAL1;CBS;CPT1C;HEXB;ATP2B4;GLUL;BLMH;ABCD1;ACAD10;PEX7;PPARA;HMGCL;AIG1;PCK2;ETFB;PHYH;SESN2;AKT1;HPDL;LONP2;ACADS;GCAT;MLYCD;BCKDHA
11634,GO:0046395,0.00059235597398071,0.999720864016918,33,191,carboxylic acid catabolic process,BP,CEMIP;TYSND1;PRODH;NOS1;CRAT;CPT2;ALDH4A1;HADH;CRYL1;HYAL1;CBS;CPT1C;HEXB;ATP2B4;GLUL;BLMH;ABCD1;ACAD10;PEX7;PPARA;HMGCL;AIG1;PCK2;ETFB;PHYH;SESN2;AKT1;HPDL;LONP2;ACADS;GCAT;MLYCD;BCKDHA
11137,GO:0045211,0.000592530971329733,0.999766295693485,23,114,postsynaptic membrane,CC,PTPRS;SHANK2;NLGN2;F2R;ANK3;TENM2;DNM1;SIGMAR1;MINK1;PRR7;DLG4;SHANK3;ABHD17C;SEMA4C;COMT;BCR;DLG3;KCNMA1;COL13A1;HOMER2;RGS14;SHISA6;SEMA4F
13121,GO:0051716,0.000596015586363732,0.999523073121801,498,4658,cellular response to stimulus,BP,TNIP1;HTRA1;FOS;DUSP6;ADGRL1;APOE;CTNNBIP1;TSPAN1;PTPRS;ERCC1;WWC3;SEMA4B;FAM110C;LTB4R;CST3;SHANK2;LTBP4;RAPGEF3;MRC2;CYP27B1;GSN;XDH;PRDX5;NDRG1;PCBP4;PRODH;PGF;NOS1;LTBP1;ARAP1;SH3BP2;ZFP36L1;COL6A1;TCTN1;POSTN;GRB7;NR1D1;EFS;ALOX15B;ARRDC1;FAM210B;POLD4;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;RHPN1;MYZAP;IGF2;NFATC4;GPX3;MST1R;LRP1;MAPK13;APPL2;HEBP1;RALGDS;LTBP2;EGFR;TIMP2;SMOC2;MMP28;NLGN2;FBXO2;DUSP5;TOM1L2;PPP1R14A;UROS;DDB2;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CMTM7;ARHGEF4;SHC1;RGL2;F2R;PTK6;GNAL;BPHL;ABCA7;LAMA5;BBS2;S100A4;CTSB;SHC2;PITPNC1;CORO1B;CXXC5;ULK2;DGKA;ZMYND8;ASH2L;NXPH4;PLAT;MMP1;ABCG1;RIN1;ANK3;PIK3R2;S100A6;ZNF516;INO80C;HDAC5;THRA;ARHGAP23;DOCK4;ZP3;RPS6KA2;NISCH;LRP5;HYAL1;TENM2;MAML3;BCAM;ERBB2;FBLN1;BRSK1;BSG;PTPRU;PKD2;CBS;TMEM129;IQSEC2;EDEM1;ITGB4;ITPR3;PLXNB3;PHLDA2;DNM1;SPRY4;DDIT4L;PTHLH;CDKN1C;SALL2;IFT140;VIPR1;CD9;KIF13B;XPC;PTPRE;SIGMAR1;PAK6;SERPINE2;VAMP2;FUZ;NPHP4;LTB4R2;NTSR1;CD320;MINK1;RALGAPA2;ATP2B4;GGT1;TMOD2;TFDP2;CSNK1E;RASA4;PLCD1;AGAP1;ADAMTS7;PDCD4;DOCK6;SLC20A1;ACAP3;TNFRSF25;GLUL;RHOD;DTX3;USP20;ASIC1;LAMB2;SPATA18;PLEKHG4;WNT7A;ZMIZ1;INSR;RAB3D;ID1;CELSR1;AKR7A2;GRK6;POLL;EPHA1;ITGA6;TXNRD3;SYNGAP1;IL20RB;DNMT3A;LPAR3;TMEM173;PRNP;EFNB3;SPRY2;MNT;ECM1;STAT6;DLG4;MKNK2;PLCD3;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;ARHGAP27;BCL6;ANKZF1;PLXNB1;FAM213A;IGFBP2;MVB12B;BNIP3;CD81;SRMS;FCGRT;FZD8;VEGFA;LRRC8A;YPEL3;VANGL2;MAST4;FBXW4;AP2A2;CEBPB;RHBDF2;GPRC5C;SHANK3;ACVR2B;HSF4;ADAM15;CALCOCO1;S1PR2;ENDOG;TNFRSF6B;MAPK3;PLEKHG5;ETV5;CARD19;RAB40B;DVL1;ENTPD2;MTA1;WIPF1;ADCY6;L3MBTL1;PKN3;EPHB3;NSMCE4A;HES1;GIGYF1;SSH1;FURIN;MLXIPL;SAMD3;CUL7;EVC;ARHGAP22;NRP2;GPR153;PLEKHG2;TNFRSF14;LRSAM1;ADA;CDC42EP5;MCTP1;PYCR2;PIDD1;PAG1;SH2D2A;AQP3;HTR7;RASL10B;CELSR2;ACY1;IL6R;SLIT3;PCSK9;ZFP36;RHOF;BTBD11;MAPKBP1;FGFR3;PRKACA;PITPNM1;LRRK1;PLCH2;MAGEF1;CYFIP2;RPS6KA5;HBEGF;ITGB5;RAB3B;MAP2K2;DAP;FGFR4;SPTB;TSPAN33;DMTN;RAPGEF5;PSD4;VGF;TNFRSF1A;EHD4;MAPK8IP1;SEMA3B;LDLR;CYP3A5;ACOT11;ROBO3;SNX17;TRPV4;MPG;RHOBTB2;IFNGR2;DUSP7;TNFAIP8L1;EEF2K;RHBDL1;HMGA2;LDLRAP1;SEMA3F;ELK3;DGKQ;SEMA4C;MVB12A;MIB2;GAS6;BTRC;LLGL1;ADGRB2;ZNF217;PPARA;TKFC;TSPAN4;STK32C;WNT7B;GIT1;COMT;SUFU;PTAFR;PLEKHG6;RFNG;DMC1;IMPA2;ARHGEF37;RXRA;PCK2;VAV3;VASN;BCR;NEO1;IGFBP4;MUC19;PRKCZ;ADAMTS13;CLTCL1;INPP5D;TM7SF3;ABCD4;NYAP1;TWF2;TPP1;PDK2;GPC1;TMX4;ICOSLG;SRSF5;RFXANK;MAPKAPK3;AGO4;RAD23A;ARAP3;FGFR1;CAMKK1;PIN1;MAN1B1;C5;TMEM204;CMBL;WBP2;GTPBP1;C21ORF2;ASAP2;GPR155;VSNL1;SERPINB6;PI4KAP2;PPP1R13L;ASS1;WDR83;CES2;GRB10;JARID2;CAPN2;SESN2;TOLLIP;WNT2B;TMEM161A;RXRB;TMEM231;GUCA1B;MACROD1;ADGRE2;MADD;RTN4R;OR7D2;TIMP1;CD68;SDC1;SH2B3;FGFBP1;PEAR1;EPS8L1;PLEKHH3;WNT3;LYST;GSTT1;PPM1F;SORL1;STK39;VEGFB;ACVR1B;ADORA2B;ERBB3;ABR;CYP2S1;AKT1;TRAP1;TMBIM4;NLRX1;ZNF385A;TP53INP1;LRCH4;NDRG2;ERCC6;GPD1L;EPS8L2;SLC5A5;SPPL2B;IL17RD;PINK1;PKD1;SLC22A17;ARHGEF10L;HOMER2;PLPPR2;RGS14;CTSH;MLST8;CBLC;EPN2;RFX2;PYCARD;MAP2K3;POMT1;PCSK1N;KCNN4;PMS2P5;AS3MT;STK17A;ERN1;CKLF;RANBP9;PRIMPOL;ARHGEF19;SIRT3;C12ORF66;CMTM4;SLC2A1;CPNE7;JAK3;MAST3;LITAF;NEIL1;RARG;ING4;EREG;FAM162A;GSTM2;SHISA6;GIPR;TMED4;POLM;SEMA4F;RPL13A;RGS12;RAB40C;MIF;SULF2;STXBP2;LZTS2
6606,GO:0022839,0.000614814226276558,0.99976263972583,22,108,ion gated channel activity,MF,CLCA2;SCN8A;KCNG1;KCNC4;KCNJ15;ANO8;PKD2;SCN4B;ITPR3;ASIC1;DLG4;TTYH3;TMEM63C;KCNAB2;SCNN1A;TRPV4;GAS6;DLG3;KCNMA1;ANO9;TPCN1;KCNN4
12301,GO:0048675,0.000615908209904315,0.999782424263067,19,87,axon extension,BP,APOE;PTPRS;SEMA4B;ULK1;ULK2;PLXNB3;LAMB2;PLXNB1;VEGFA;DVL1;NRP2;SLIT3;SEMA3B;SEMA3F;SEMA4C;TWF2;RTN4R;WNT3;SEMA4F
16993,GO:0099173,0.00063900703671551,0.999798294306852,16,68,postsynapse organization,BP,APOE;SHANK2;EPHB2;NLGN2;ZMYND8;WNT7A;INSR;PRNP;DLG4;SHANK3;ETV5;DVL1;EPHB3;SSH1;EEF2K;SHISA6
5856,GO:0017171,0.000640851349565572,0.999764918721443,20,96,serine hydrolase activity,MF,HTRA1;TYSND1;PRSS3;RHBDF1;PRSS8;CTSB;PLAT;MMP1;RHBDF2;DPP7;FURIN;PCSK9;F12;RHBDL1;PCSK1;TPP1;TMPRSS11D;CTSD;LONP2;CTSH
6753,GO:0030198,0.000671572725424578,0.999669671124064,36,212,extracellular matrix organization,BP,HTRA1;CST3;COL6A1;POSTN;LRP1;TIMP2;SMOC2;LOXL1;LAMA5;THBS3;MMP1;FBLN1;BSG;ITGB4;THSD4;TNXB;LAMB2;SH3PXD2B;ITGA6;ADAM15;CAPNS2;FURIN;ITGB5;FGFR4;GAS6;CHADL;CAPN2;TIMP1;OLFML2A;COL13A1;ADAM19;VPS33B;P3H4;POMT1;ADAMTSL4;SULF2
12253,GO:0048583,0.000673413257406585,0.999476705817662,304,2701,regulation of response to stimulus,BP,TNIP1;HTRA1;FOS;DUSP6;APOE;CTNNBIP1;PTPRS;ERCC1;WWC3;SEMA4B;FAM110C;NT5E;SHANK2;LTBP4;CYP27B1;GSN;XDH;PGF;NOS1;LTBP1;ARAP1;SH3BP2;TCTN1;POSTN;GRB7;NR1D1;ALOX15B;ARRDC1;RBCK1;EPHB2;OBSCN;IGF2;NFATC4;MST1R;LRP1;MAPK13;APPL2;EGFR;TIMP2;MMP28;NLGN2;DUSP5;SERPING1;MDFI;EGR1;RHBDF1;PKN1;CMTM7;ARHGEF4;SHC1;RGL2;F2R;PTK6;ABCA7;BBS2;S100A4;CTSB;SHC2;CORO1B;CXXC5;ZMYND8;PLAT;PIK3R2;THRA;ARHGAP23;ZP3;LRP5;MAML3;ERBB2;FBLN1;PKD2;IQSEC2;EDEM1;PHLDA2;DNM1;SPRY4;DDIT4L;PTHLH;CDKN1C;IFT140;CD9;PTPRE;PAK6;SERPINE2;FUZ;RNF135;NPHP4;NTSR1;CD320;MINK1;RALGAPA2;ATP2B4;GGT1;TMOD2;TFDP2;CSNK1E;ACP5;RASA4;AGAP1;PDCD4;SLC20A1;ACAP3;TNFRSF25;RHOD;USP20;PLEKHG4;WNT7A;ZMIZ1;INSR;ID1;GRK6;EPHA1;ITGA6;SYNGAP1;IL20RB;LPAR3;TMEM173;PRNP;SPRY2;MNT;ECM1;NPDC1;STAT6;DLG4;STRADB;WWTR1;FAM20C;BCL6;PLXNB1;IGFBP2;MVB12B;BNIP3;CD81;SRMS;FCGRT;FZD8;VEGFA;YPEL3;VANGL2;RHBDF2;SHANK3;ACVR2B;S1PR2;ENDOG;MAPK3;PLEKHG5;CARD19;TNNT1;DVL1;WIPF1;L3MBTL1;EPHB3;NSMCE4A;HES1;SSH1;FURIN;MEFV;EVC;ARHGAP22;PLEKHG2;LRSAM1;ADA;MCTP1;PIDD1;PAG1;SH2D2A;IL6R;SLIT3;PCSK9;RHOF;MAPKBP1;FGFR3;PRKACA;F12;LRRK1;MAGEF1;CYFIP2;RPS6KA5;HBEGF;RAB3B;MAP2K2;FGFR4;DMTN;PSD4;VGF;TNFRSF1A;MAPK8IP1;SEMA3B;LDLR;TRPV4;RHOBTB2;IFNGR2;RAG1;DUSP7;TNFAIP8L1;HMGA2;LDLRAP1;SEMA3F;DGKQ;SEMA4C;MVB12A;HK1;FAM3A;MIB2;GAS6;BTRC;LLGL1;PPARA;TKFC;WNT7B;GIT1;SUFU;PTAFR;PLEKHG6;RFNG;ARHGEF37;VAV3;VASN;BCR;NEO1;IGFBP4;MUC19;PRKCZ;INPP5D;GPC1;ICOSLG;MAPKAPK3;ARAP3;FGFR1;PIN1;C5;TMEM204;WBP2;ASAP2;VSNL1;PPP1R13L;GRB10;JARID2;SESN2;WNT2B;TMEM161A;GUCA1B;ADGRE2;MADD;RTN4R;TIMP1;SH2B3;FGFBP1;PEAR1;EPS8L1;WNT3;PPM1F;SORL1;STK39;VEGFB;ACVR1B;ADORA2B;ERBB3;ABR;AKT1;TRAP1;TMBIM4;NLRX1;ZNF385A;TP53INP1;NDRG2;VPS33B;ERCC6;GPD1L;EPS8L2;SPPL2B;PINK1;ARHGEF10L;HOMER2;RGS14;CTSH;MLST8;CBLC;EPN2;PYCARD;MAP2K3;KCNN4;ERN1;CKLF;RANBP9;APOBEC3F;ARHGEF19;SIRT3;C12ORF66;CMTM4;JAK3;LITAF;EREG;FAM162A;GSTM2;SHISA6;GIPR;TMED4;SEMA4F;RGS12;MIF;SULF2;STXBP2;LZTS2
3445,GO:0007265,0.000673595364609252,0.999615960430706,55,366,Ras protein signal transduction,BP,APOE;RAPGEF3;ARAP1;EPHB2;OBSCN;APPL2;RALGDS;TIMP2;ARHGEF4;SHC1;RGL2;F2R;SHC2;NISCH;IQSEC2;SPRY4;PAK6;RASA4;AGAP1;ACAP3;RHOD;PLEKHG4;RAB3D;CELSR1;SYNGAP1;SPRY2;RAB25;BCL6;VANGL2;PLEKHG5;RAB40B;SAMD3;PLEKHG2;CDC42EP5;RHOF;RAB3B;PSD4;RHOBTB2;GIT1;PLEKHG6;ARHGEF37;VAV3;BCR;RFXANK;MAPKAPK3;ARAP3;ASAP2;MADD;RTN4R;EPS8L1;ABR;EPS8L2;ARHGEF10L;ARHGEF19;RAB40C
8869,GO:0034702,0.000693886640551945,0.999736448852643,21,102,ion channel complex,CC,SHANK2;NOS1;SCN8A;KCNG1;KCNC4;SCN4B;CPT1C;VAMP2;DLG4;TTYH3;LRRC8A;SHANK3;KCNAB2;OLFM2;PRKACA;SCNN1A;DLG3;KCNMA1;SMDT1;KCNN4;SHISA6
6604,GO:0022836,0.000702269326159855,0.999725786888907,22,109,gated channel activity,MF,CLCA2;SCN8A;KCNG1;KCNC4;KCNJ15;ANO8;PKD2;SCN4B;ITPR3;ASIC1;DLG4;TTYH3;TMEM63C;KCNAB2;SCNN1A;TRPV4;GAS6;DLG3;KCNMA1;ANO9;TPCN1;KCNN4
10892,GO:0044456,0.000704094346992333,0.999585324593854,61,418,synapse part,CC,ADGRL1;PTPRS;SYTL1;SHANK2;NOS1;NR1D1;EPHB2;NLGN2;FBXO2;SYT8;F2R;LAMA5;ZMYND8;KCNC4;ANK3;DBNDD1;TENM2;BRSK1;DNM1;RIMS3;SIGMAR1;VAMP2;NTSR1;MINK1;GLUL;PRR7;LAMB2;WNT7A;RAB3D;SYNGAP1;PRNP;DLG4;BNIP3;SHANK3;KCNAB2;OLFM2;RAB40B;DVL1;MCTP1;RAB3B;PI4K2A;DMTN;ABHD17C;EEF2K;SEMA4C;BLVRB;COMT;BCR;DLG3;KCNMA1;SNPH;EPB41L3;COL13A1;AKT1;HOMER2;RGS14;DDN;APBA1;SHISA6;SEMA4F;RAB40C
7596,GO:0031994,0.000706150709386984,0.999951879910752,5,9,insulin-like growth factor I binding,MF,ITGB4;INSR;ITGA6;IGFBP2;IGFBP4
12678,GO:0050922,0.000710747937101551,0.999849368299264,10,33,negative regulation of chemotaxis,BP,SEMA4B;MMP28;CORO1B;SEMA3B;SEMA3F;SEMA4C;C5;WNT3;SEMA4F;MIF
3171,GO:0006796,0.000715975569557635,0.999451213825213,260,2280,phosphate-containing compound metabolic process,BP,TNIP1;DUSP6;H6PD;CEMIP;APOE;IDH2;PTPRS;NT5E;NAPRT;RAPGEF3;PGM1;XDH;PGLS;NOS1;ZFP36L1;EPHB2;OBSCN;CNTN1;IGF2;NME4;MST1R;MAPK13;CDK18;EGFR;TIMP2;B3GAT3;CRYL1;ACOT7;DUSP5;PPP1R14A;ISYNA1;EGR1;ULK1;PKN1;PYGL;SHC1;F2R;PTK6;ABCA7;PPP2R3B;PPM1J;LPCAT4;SHC2;ULK2;DGKA;GJC2;PIK3R2;NEK9;ZP3;RPS6KA2;NMRK1;LRP5;MARK4;ERBB2;FBLN1;BRSK1;PTPRU;OGDHL;PKD2;SPRY4;PTHLH;CDKN1C;PTPRE;PAK6;HEXB;LTB4R2;NTSR1;MINK1;ATP2B4;CSNK1E;ACP5;RASA4;PLCD1;ZFYVE21;PDCD4;SLC20A1;TNFRSF25;WNT7A;INSR;ID1;GRK6;MVD;NDUFS8;EPHA1;ADARB1;ITGA6;SYNGAP1;PPP1R35;DNPH1;LPAR3;PRNP;SERINC2;SRD5A3;SPRY2;SNX9;DLG4;SPEG;FGGY;MKNK2;PLCD3;NT5DC1;STRADB;TALDO1;WWTR1;FAM20C;UCKL1;PFKFB2;DYRK1B;CD81;SRMS;FZD8;VEGFA;VANGL2;MAST4;SHANK3;ACVR2B;NAB2;S1PR2;MAPK3;KCNAB2;DHTKD1;DVL1;ENTPD2;GALK1;LHPP;ADCY6;PKN3;EPHB3;HES1;SSH1;MLXIPL;MBOAT7;NADK;TK2;ADA;CDC42EP5;OSBPL5;CKMT1A;PFKL;IL6R;PCSK9;ZFP36;FGFR3;PRKACA;PITPNM1;LRRK1;NUDT10;PLCH2;DGUOK;RPS6KA5;HBEGF;MAP2K2;PI4K2A;FGFR4;SPTB;DMTN;PMVK;MYH3;TNFRSF1A;EHD4;MAPK8IP1;LDLR;TRPV4;PIGZ;DUSP7;EEF2K;HMGA2;DGKQ;SEMA4C;HK1;GAS6;BTRC;PPARA;TKFC;GUK1;STK32C;WNT7B;TTC7B;PTAFR;IMPA2;PCK2;VAV3;BCR;IGFBP4;SDHA;PRKCZ;MDH2;INPP5D;PDK2;MAPKAPK3;FGFR1;CAMKK1;PIN1;C5;PROX1;GTPBP1;DLG3;PI4KAP2;WDR83;GRB10;SESN2;TOLLIP;ADCK5;MAPRE3;DUSP23;LCAT;GUCA1B;PITPNM3;MADD;RTN4R;ELFN2;PIGV;PIGQ;PPM1F;SBF1;SORL1;STK39;ACVR1B;ADORA2B;ERBB3;AKT1;NDRG2;ERCC6;ACP6;GPD1L;IL17RD;UQCR11;ADCK2;SSH3;PINK1;PKD1;PLPPR2;RGS14;PCIF1;CTSH;ABHD14B;MLST8;AGPAT4;CBLC;PYCARD;MAP2K3;PNPO;NDUFV3;STK17A;ERN1;RANBP9;MOCS1;SIRT3;CPNE7;TAZ;JAK3;MAST3;NEIL1;FUK;EREG;PPCS;PODXL2;SFI1;AGPAT3;MIF
17725,GO:1901700,0.000716404789299244,0.999502278726504,127,1012,response to oxygen-containing compound,BP,TNIP1;FOS;APOE;ERCC1;CST3;RAPGEF3;CYP27B1;GSN;PRDX5;NOS1;ZFP36L1;COL6A1;POSTN;NR1D1;FAM210B;IGF2;NFATC4;GPX3;LRP1;MAPK13;EGFR;HADH;LOXL1;MTHFR;EGR1;SHC1;F2R;PTK6;PIK3R2;HDAC5;LRP5;HYAL1;BSG;PKD2;EDEM1;LRP11;CD9;PTPRE;VAMP2;ATP2B4;ACP5;PDCD4;TNFRSF25;GLUL;WNT7A;INSR;ID1;TXNRD3;DNMT3A;PRNP;STAT6;ANKZF1;PFKFB2;IGFBP2;BNIP3;CEBPB;ACVR2B;ENDOG;TNFRSF6B;MAPK3;GLB1;ADCY6;SSH1;MLXIPL;ABCA2;TNFRSF14;ADA;AQP3;PFKL;SLIT3;PCSK9;ZFP36;HLCS;PRKACA;DMTN;PMVK;VGF;TNFRSF1A;LDLR;TRPV4;EEF2K;DGKQ;GAS6;PPARA;HMGCL;WNT7B;COMT;PTAFR;RXRA;PCK2;BCR;PRKCZ;ADAMTS13;TWF2;PDK2;SRSF5;MAPKAPK3;MAN1B1;WBP2;KCNMA1;VSNL1;GRB10;CAPN2;SESN2;TMEM161A;TIMP1;SDC1;WNT3;GSS;ABR;AKT1;TRAP1;TP53INP1;ERCC6;SLC5A5;PINK1;HOMER2;CTSH;PYCARD;ERN1;SLC2A1;JAK3;LITAF;RARG;EREG;GIPR;MIF
12839,GO:0051186,0.000717377345770293,0.999576774574254,61,429,cofactor metabolic process,BP,H6PD;IDH2;NT5E;NAPRT;PGM1;PRDX5;PGLS;PRSS3;GPX3;GAMT;EGFR;ACSF2;ACOT7;UROS;MTHFR;D2HGDH;OPLAH;NMRK1;OGDHL;CD320;GGT1;INSR;AKR7A2;MVD;HAGH;TALDO1;PFKFB2;KCNAB2;AMN;DHTKD1;GALK1;PC;MLXIPL;SLC2A3;NADK;PFKL;HLCS;PMVK;ACOT11;HK1;PPARA;HMGCL;BLVRB;PCK2;MDH2;ABCD4;PDK2;PHYH;GSTT1;GSS;AHCYL2;AKT1;GPD1L;PINK1;RSAD1;PNPO;MOCS1;SLC2A1;MLYCD;PPCS;GSTM2
13713,GO:0060313,0.000730744043282015,1,3,3,negative regulation of blood vessel remodeling,BP,CST3;BCR;ABR
3258,GO:0006936,0.000747585706461605,0.999656750411527,30,171,muscle contraction,BP,GAA;LTB4R;NOS1;GAMT;OBSL1;F2R;BBS2;ACTA2;DOCK4;SCN4B;TMOD2;SLC6A8;TNNT1;ADA;HTR7;PRKACA;ITGB5;MYH3;PTAFR;KCNMA1;PPP1R13L;VEGFB;ADORA2B;GPD1L;EHD3;SNTA1;MAP2K3;TAZ;GSTM2;SULF2
8942,GO:0035023,0.000754509687990035,0.999719660322606,20,95,regulation of Rho protein signal transduction,BP,APOE;ARAP1;OBSCN;ARHGEF4;F2R;PLEKHG4;BCL6;PLEKHG5;PLEKHG2;PLEKHG6;ARHGEF37;VAV3;BCR;ARAP3;RTN4R;EPS8L1;ABR;EPS8L2;ARHGEF10L;ARHGEF19
7277,GO:0031281,0.000761813446469139,0.999947167224717,5,9,positive regulation of cyclase activity,BP,NOS1;TIMP2;MAPK3;GUCA1B;ADORA2B
3186,GO:0006820,0.000765992039369257,0.999570443965708,51,336,anion transport,BP,APOE;CLCA2;SLCO4A1;CPT2;SLC43A1;ABCA7;CA12;SLC16A5;PITPNC1;SLC16A3;ABCG1;ANO8;PLTP;SLC2A9;SLC13A3;BSG;SLC7A8;PRAF2;VAMP2;NTSR1;SLC6A8;SLC20A1;PRNP;SERINC2;SLC12A7;ABCD1;TTYH3;LRRC8A;SLC16A13;SLC2A3;OSBPL5;PITPNM1;SLC38A10;SLC37A2;LDLR;PPARA;PTAFR;RXRA;FGFR1;PITPNM3;STK39;ANO9;SLC25A29;AKT1;SLC5A5;SLC22A17;KCNN4;SLC2A1;APBA1;PQLC2;MIF
12662,GO:0050905,0.000774560956415708,0.999801884571514,12,44,neuromuscular process,BP,GAA;NLGN2;HEXB;GM2A;ADARB1;DLG4;KCNAB2;DVL1;BCR;SLITRK6;TPP1;ABR
12569,GO:0050771,0.000787957844267298,0.999798044274109,12,44,negative regulation of axonogenesis,BP,PTPRS;SEMA4B;EPHB2;ULK2;SYNGAP1;EFNB3;SEMA3B;SEMA3F;SEMA4C;RTN4R;WNT3;SEMA4F
5654,GO:0016773,0.000792254609846382,0.999497409469141,80,578,phosphotransferase activity, alcohol group as acceptor,MF,LTBP4;LTBP1;EPHB2;OBSCN;MST1R;MAPK13;CDK18;EGFR;ULK1;PKN1;PTK6;ULK2;DGKA;PIK3R2;NEK9;RPS6KA2;NMRK1;MARK4;ERBB2;BRSK1;PAK6;MINK1;CSNK1E;ZFYVE21;INSR;GRK6;EPHA1;EFNB3;SPEG;FGGY;MKNK2;STRADB;FAM20C;PFKFB2;DYRK1B;SRMS;MAST4;ACVR2B;MAPK3;GALK1;PKN3;EPHB3;NRP2;NADK;PFKL;FGFR3;PRKACA;LRRK1;RPS6KA5;HBEGF;MAP2K2;PI4K2A;FGFR4;EEF2K;HMGA2;DGKQ;HK1;TKFC;STK32C;BCR;PRKCZ;PDK2;MAPKAPK3;FGFR1;CAMKK1;PI4KAP2;ADCK5;STK39;ACVR1B;ERBB3;AKT1;ADCK2;PINK1;MAP2K3;STK17A;ERN1;JAK3;MAST3;FUK;EREG
10769,GO:0044255,0.000800718820213864,0.999467594856467,99,755,cellular lipid metabolic process,BP,LMF1;APOE;TYSND1;CRAT;ALOX15B;CPT2;LRP1;EGFR;HADH;CRYL1;ACSF2;ACOT7;ISYNA1;KDSR;LPCAT4;DGKA;CERS4;ABCG1;PIK3R2;ZP3;ERBB2;FUCA1;CPT1C;HEXB;GGT1;PLCD1;ZFYVE21;GM2A;MVD;SERINC2;SRD5A3;ABCD1;CD81;MAPK3;GLB1;LTA4H;ACAD10;MLXIPL;MBOAT7;OSBPL5;RETSAT;PCSK9;FGFR3;PITPNM1;PLCH2;HBEGF;PI4K2A;FGFR4;PMVK;TNFRSF1A;LDLR;CYP3A5;ACOT11;PIGZ;DGKQ;PEX7;PPARA;TTC7B;AIG1;IMPA2;PCK2;VAV3;INPP5D;ETFB;PDK2;GPC1;FGFR1;PNPLA4;PHYH;ESYT2;PI4KAP2;CES2;SESN2;LCAT;GAL3ST4;PITPNM3;PIGV;SDC1;PIGQ;SBF1;ERBB3;CYP2S1;CCDC71L;AKT1;ACP6;GPD1L;NAGA;LONP2;PLPPR2;AGPAT4;ACADS;CPNE7;MLYCD;TAZ;EREG;GSTM2;AGPAT3;ALG12;MIF
9771,GO:0040007,0.000805769049070359,0.999478510634481,87,648,growth,BP,HTRA1;DUSP6;APOE;PTPRS;ERCC1;WWC3;SEMA4B;SHANK2;LTBP4;CYP27B1;GSN;ZFP36L1;POSTN;ALOX15B;GAMT;EGFR;FHL1;ULK1;SHC1;PTK6;BBS2;ULK2;THBS3;ZP3;HYAL1;ERBB2;PLXNB3;PHLDA2;SERPINE2;LAMB2;WNT7A;ZMIZ1;INSR;SH3PXD2B;ADARB1;DNPH1;LPAR3;SPRY2;WWTR1;BCL6;PLXNB1;IGFBP2;VEGFA;VANGL2;SHANK3;ACVR2B;ADAM15;DVL1;EVC;NRP2;SLIT3;FGFR3;CYFIP2;HBEGF;SEMA3B;HMGA2;SEMA3F;SEMA4C;GAS6;WNT7B;RXRA;IGFBP4;PRKCZ;SLITRK6;TWF2;FGFR1;PIN1;PROX1;TMEM8B;PPP1R13L;JARID2;SESN2;RTN4R;EPB41L3;WNT3;PPM1F;ACVR1B;CCDC85B;AKT1;ERCC6;NINJ1;APBA1;RARG;ING4;EREG;SEMA4F;KIF26B
14488,GO:0065008,0.000824236163002951,0.999364103106418,269,2380,regulation of biological quality,BP,CEMIP;ADGRL1;APOE;CTNNBIP1;TSPAN1;PTPRS;ERCC1;SEMA4B;GAA;SYTL1;SHANK2;LTBP4;RAPGEF3;CYP27B1;GSN;XDH;PRDX5;PCBP4;NOS1;LTBP1;PARVB;ARAP1;ZFP36L1;POSTN;NR1D1;FAM210B;POLD4;SCN8A;SLCO4A1;EPHB2;EPAS1;IGF2;NFATC4;EGFR;HADH;NLGN2;FHL1;SERPING1;MDFI;EGR1;PKN1;CRTC1;ARPIN;PYGL;SYT8;F2R;ABCA7;CA12;BBS2;CORO1B;ULK2;DGKA;IGSF9;MALL;ZMYND8;MXI1;PLAT;KCNC4;ABCG1;ANK3;DHRS11;PIK3R2;THRA;DOCK4;CRTAP;NISCH;LRP5;ZFPM1;FBLN1;BRSK1;PKD2;SCN4B;SLC7A8;ITPR3;PLXNB3;DNM1;RIMS3;CD9;HEXB;SERPINE2;VPS11;VAMP2;NPHP4;NTSR1;ATP2B4;TMOD2;TFDP2;CSNK1E;ACP5;DOCK6;GM2A;GLUL;RHOD;ASIC1;WNT7A;INSR;RAB3D;SH3PXD2B;ID1;TXNRD3;SYNGAP1;IL20RB;LPAR3;PRNP;SRD5A3;ATP7B;SLC12A7;DLG4;FGGY;PLEKHH2;BCL6;PFKFB2;ATP12A;PLXNB1;BNIP3;CD81;VEGFA;LRRC8A;ARL2;SHANK3;ACVR2B;S1PR2;ENDOG;MAPK3;TUB;ETV5;DVL1;ENTPD2;WIPF1;ADCY6;EPHB3;SSH1;FURIN;MLXIPL;PLEKHG2;ABCA2;ADA;CDC42EP5;MCTP1;RETSAT;PHF21A;AQP3;HTR7;RASL10B;PFKL;PCSK9;ZFP36;RHOF;PRKACA;F12;LRRK1;SCNN1A;SLC25A37;RAB3B;FGFR4;SPTB;DMTN;BBS1;VGF;SEMA3B;LDLR;TRPV4;RHOBTB2;CROCC;RAG1;EEF2K;LDLRAP1;SEMA3F;DGKQ;SEMA4C;HK1;GAS6;BTRC;ADGRB2;PPARA;WNT7B;COMT;SUFU;PTAFR;PCK2;PCSK1;VAV3;BCR;TMEM175;NEO1;PRKCZ;ADAMTS13;CAPG;INPP5D;TM7SF3;SPATA7;SLITRK6;TWF2;TPP1;PDK2;TMX4;RAD23A;ARAP3;CDHR1;FGFR1;CTSZ;PIN1;PNPLA4;C21ORF2;KCNMA1;VSNL1;PPP1R13L;ASS1;GLRX;SLC25A27;SESN2;PROCR;SNPH;LCAT;GUCA1B;SMDT1;CYBRD1;RTN4R;EPB41L3;SLC9A7;WHAMMP3;SH2B3;EPS8L1;WNT3;SORL1;STK39;ACVR1B;ANO9;ADORA2B;TPCN1;ABR;AKT1;ZNF385A;VPS33B;ERCC6;GPD1L;EPS8L2;SLC5A5;SUN1;SSH3;PINK1;PKD1;EHD3;SLC22A17;SNTA1;HOMER2;RGS14;SYNE3;SPIRE2;CTSH;MLST8;PYCARD;TRERF1;PCSK1N;KCNN4;ERN1;GCAT;SIRT3;SLC2A1;JAK3;APBA1;RARG;FCHSD1;GSTM2;SHISA6;GIPR;PQLC2;SEMA4F;MIF
6605,GO:0022838,0.000834058781447211,0.999626453239729,28,154,substrate-specific channel activity,MF,CLCA2;SCN8A;KCNG1;KCNC4;KCNJ15;ANO8;PKD2;SCN4B;ITPR3;ASIC1;DLG4;TTYH3;LRRC8A;TMEM63C;KCNAB2;AQP3;SCNN1A;TRPV4;GAS6;TMEM175;DLG3;KCNMA1;ANO9;TPCN1;PKD1;KCNN4;ORAI3;ORAI2
12726,GO:0051020,0.000840050374313461,0.999477459847884,73,521,GTPase binding,MF,SYTL1;RAPGEF3;EVI5L;NDRG1;ARAP1;OBSCN;APPL2;RALGDS;RAB11FIP4;EGFR;RAPGEFL1;ULK1;PKN1;ARHGEF4;SHC1;RGL2;SHC2;TBC1D14;RIN1;DOCK4;ERBB2;EXOC2;MICALL2;IQSEC2;RIMS3;PAK6;TRAPPC9;AGAP1;DOCK6;ACAP3;PLEKHG4;TBC1D8;RABGGTA;DLG4;BNIP3;PLEKHG5;DVL1;PKN3;PLEKHG2;CDC42EP5;FGFR3;HBEGF;FGFR4;SPTB;RAPGEF5;PSD4;LLGL1;GIT1;PLEKHG6;ARHGEF37;VAV3;BCR;TBC1D16;ARAP3;FGFR1;ASAP2;MADD;WHAMMP3;EPS8L1;SBF1;SORL1;TBC1D17;ALS2CL;ERBB3;ABR;EPS8L2;GAS8;ARHGEF10L;RILPL1;RANBP9;ARHGEF19;JAK3;EREG
18418,GO:1903530,0.000863033024325868,0.999494017625522,58,399,regulation of secretion by cell,BP,IDH2;SYTL1;RAPGEF3;POSTN;NR1D1;ALOX15B;EGFR;HADH;NLGN2;RHBDF1;SYT8;F2R;KCNC4;ZP3;LRP5;ITPR3;RIMS3;VAMP2;NTSR1;GLUL;ASIC1;RAB3D;MYO18A;PFKFB2;ARL2;RHBDF2;MAPK3;RAB40B;MCTP1;RASL10B;PFKL;MAPKBP1;RAB3B;TRPV4;HK1;GAS6;LLGL1;PTAFR;PCK2;BCR;PRKCZ;TM7SF3;FGFR1;C5;VSNL1;ADGRE2;SDC1;ADORA2B;ABR;PINK1;PYCARD;KCNN4;SIRT3;SLC2A1;GIPR;RAB40C;MIF;STXBP2
12749,GO:0051050,0.000865237552709616,0.999445838756171,82,608,positive regulation of transport,BP,CEMIP;APOE;TSPAN1;RAPGEF3;NOS1;POSTN;ALOX15B;EPHB2;CNTN1;LRP1;EGFR;B3GAT3;NLGN2;FHL1;F2R;ABCA7;PRSS8;GJC2;ABCG1;ANK3;PIK3R2;ZP3;PLTP;ERBB2;MICALL2;PKD2;SCN4B;EDEM1;DNM1;VPS11;VAMP2;NTSR1;TFDP2;GLUL;INSR;RAB3D;LPAR3;TMEM173;PRNP;MYO18A;PFKFB2;VEGFA;SHANK3;MAPK3;TUB;HES1;RASL10B;PCSK9;RAB3B;LDLR;TRPV4;EEF2K;LDLRAP1;HK1;GAS6;PTAFR;PCK2;BCR;PRKCZ;CLTCL1;TM7SF3;FGFR1;C5;VSNL1;OSCP1;GLRX;SDC1;SORL1;STK39;ADORA2B;ABR;AKT1;GPD1L;PINK1;EHD3;PYCARD;KCNN4;SIRT3;GSTM2;GIPR;MIF;UBL5
13819,GO:0060448,0.000876192756632401,1,3,3,dichotomous subdivision of terminal units involved in lung branching,BP,CELSR1;VANGL2;CTSH
7837,GO:0032409,0.000877616869607754,0.99961887192549,26,141,regulation of transporter activity,BP,SHANK2;NOS1;EPHB2;KCNG1;NLGN2;FHL1;ANK3;PKD2;SCN4B;VAMP2;NTSR1;MINK1;PRNP;DLG4;SHANK3;PCSK9;PRKACA;PTAFR;GLRX;STK39;ANO9;GPD1L;PINK1;EHD3;GSTM2;SHISA6
12742,GO:0051043,0.00088594228133161,0.999875679528746,7,18,regulation of membrane protein ectodomain proteolysis,BP,APOE;TIMP2;SNX33;SNX9;FURIN;SH3D19;TIMP1
13695,GO:0060291,0.000890801208046544,0.999785442425014,11,39,long-term synaptic potentiation,BP,APOE;SHANK2;EPHB2;CRTC1;ITPR3;SERPINE2;VAMP2;PRNP;SHANK3;PRKCZ;RGS14
681,GO:0001892,0.000893365333224862,0.999707587911942,16,70,embryonic placenta development,BP,ZFP36L1;EPAS1;IGF2;EGFR;MDFI;TFEB;PKD2;PHLDA2;PLCD1;FBXW8;PLCD3;CEBPB;HES1;WNT7B;AKT1;PKD1
6747,GO:0030182,0.000909379002389061,0.999380055151873,110,851,neuron differentiation,BP,APOE;PTPRS;SEMA4B;SHANK2;TCTN1;POSTN;GRB7;EPHB2;CNTN1;NFATC4;LRP1;OBSL1;EGFR;TIMP2;ADGRF1;ULK1;SDK2;CRTC1;NAGLU;SHC1;PTK6;ULK2;IGSF9;ZMYND8;ANK3;S100A6;HDAC5;DBNDD1;TENM2;ERBB2;BRSK1;MICALL2;PLXNB3;IFT140;KIF13B;NPHP4;UNK;MINK1;CSNK1E;TRAPPC9;LAMB2;WNT7A;FBXW8;ID1;B4GAT1;ADARB1;SYNGAP1;DNMT3A;LPAR3;EFNB3;DLG4;BCL6;PLXNB1;FZD8;VEGFA;VANGL2;CEBPB;SHANK3;MAPK3;ETV5;DVL1;ADCY6;EPHB3;HES1;SSH1;CUL7;NRP2;CELSR2;SLIT3;PCSK9;DGUOK;CYFIP2;RPS6KA5;SPTB;MDGA1;SEMA3B;ROBO3;TRPV4;EEF2K;SEMA3F;SEMA4C;LLGL1;WNT7B;SUFU;NEO1;USP21;PRKCZ;NYAP1;SLITRK6;TWF2;GPC1;CDHR1;FGFR1;CTSZ;PIN1;PROX1;BIN1;UNC119B;GRB10;WNT2B;SNPH;RTN4R;EPB41L3;WNT3;AKT1;SMARCA1;SSH3;ATXN10;RANBP9;SEMA4F
6732,GO:0030160,0.000929194417303627,1,3,3,GKAP/Homer scaffold activity,MF,SHANK2;SHANK3;HOMER2
3738,GO:0008284,0.000952257755409539,0.999404196380784,73,533,positive regulation of cell proliferation,BP,HTRA1;MARCKSL1;CST3;PGF;MEF2D;IGF2;MST1R;EGFR;EGR1;SHC1;F2R;GJC2;ASH2L;S100A6;ZP3;LRP5;HYAL1;ERBB2;PLXNB3;PTHLH;VIPR1;CD320;GLUL;WNT7A;ZMIZ1;INSR;TBC1D8;ID1;MVD;EPHA1;ECM1;MTA3;WWTR1;RAB25;BCL6;IGFBP2;CD81;VEGFA;FBXW4;HSF4;S1PR2;ETV5;HES1;MLXIPL;NRP2;ADA;IL6R;FGFR3;HBEGF;FGFR4;HMGA2;GAS6;PTAFR;LTBP3;VAV3;PRKCZ;ICOSLG;FGFR1;CTSZ;PROX1;SLC25A27;TIMP1;FGFBP1;VEGFB;AKT1;CTSH;RNF187;PYCARD;ERN1;JAK3;RARG;EREG;MIF
15672,GO:0072236,0.000956986569990423,1,3,3,metanephric loop of Henle development,BP,PKD2;WNT7B;PKD1
14322,GO:0061564,0.000968474001354759,0.999454017281618,50,330,axon development,BP,APOE;PTPRS;SEMA4B;TCTN1;GRB7;EPHB2;ULK1;SHC1;ULK2;ANK3;S100A6;ERBB2;BRSK1;PLXNB3;KIF13B;LAMB2;WNT7A;B4GAT1;ADARB1;SYNGAP1;LPAR3;EFNB3;PLXNB1;VEGFA;VANGL2;SHANK3;MAPK3;DVL1;EPHB3;SSH1;NRP2;SLIT3;CYFIP2;RPS6KA5;SPTB;SEMA3B;ROBO3;SEMA3F;SEMA4C;LLGL1;NEO1;SLITRK6;TWF2;GPC1;GRB10;RTN4R;WNT3;SSH3;RANBP9;SEMA4F
8870,GO:0034703,0.000972526621805783,0.99966536874998,17,77,cation channel complex,CC,NOS1;SCN8A;KCNG1;KCNC4;SCN4B;CPT1C;VAMP2;DLG4;KCNAB2;OLFM2;PRKACA;SCNN1A;DLG3;KCNMA1;SMDT1;KCNN4;SHISA6
1988,GO:0004713,0.00100636026486929,0.999594932625507,22,111,protein tyrosine kinase activity,MF,EPHB2;MST1R;EGFR;PTK6;ERBB2;INSR;EPHA1;EFNB3;DYRK1B;SRMS;EPHB3;NRP2;FGFR3;HBEGF;MAP2K2;FGFR4;BCR;FGFR1;ERBB3;MAP2K3;JAK3;EREG
10363,GO:0043202,0.00101233240037335,0.999663979977491,16,71,lysosomal lumen,CC,GAA;NAGLU;CTSB;HYAL1;CTSF;FUCA1;HEXB;GM2A;RNASET2;GLB1;TPP1;GPC1;MAN2B2;SDC1;CTSD;GALNS
12382,GO:0048846,0.00102128322800754,0.999796498545476,9,28,axon extension involved in axon guidance,BP,SEMA4B;VEGFA;NRP2;SLIT3;SEMA3B;SEMA3F;SEMA4C;WNT3;SEMA4F
17917,GO:1902284,0.00102128322800754,0.999796498545476,9,28,neuron projection extension involved in neuron projection guidance,BP,SEMA4B;VEGFA;NRP2;SLIT3;SEMA3B;SEMA3F;SEMA4C;WNT3;SEMA4F
16149,GO:0090197,0.00103096662356693,0.999957990097203,4,6,positive regulation of chemokine secretion,BP,POSTN;ALOX15B;C5;PYCARD
13881,GO:0060560,0.00104929727461834,0.999522109267758,28,156,developmental growth involved in morphogenesis,BP,APOE;PTPRS;SEMA4B;POSTN;ULK1;ULK2;PLXNB3;LAMB2;LPAR3;SPRY2;PLXNB1;VEGFA;VANGL2;DVL1;NRP2;SLIT3;CYFIP2;SEMA3B;SEMA3F;SEMA4C;WNT7B;PRKCZ;TWF2;RTN4R;WNT3;RARG;SEMA4F;KIF26B
10484,GO:0043405,0.00105118235996937,0.999442180101637,41,259,regulation of MAP kinase activity,BP,DUSP6;APOE;EPHB2;IGF2;MST1R;EGFR;DUSP5;PKN1;SHC1;F2R;SHC2;ERBB2;SPRY4;MINK1;PDCD4;INSR;LPAR3;SPRY2;CD81;FZD8;VEGFA;VANGL2;S1PR2;MAPK3;MAP2K2;MAPK8IP1;DUSP7;WNT7B;MAPKAPK3;FGFR1;C5;MADD;SORL1;STK39;ADORA2B;ERCC6;RGS14;CBLC;MAP2K3;ERN1;MIF
7041,GO:0030828,0.00106237598042999,0.999956343498316,4,6,positive regulation of cGMP biosynthetic process,BP,APOE;NOS1;GUCA1B;ADORA2B
17687,GO:1901626,0.00106863312993162,0.99995601378161,4,6,regulation of postsynaptic membrane organization,BP,APOE;ZMYND8;SSH1;SHISA6
17532,GO:1901136,0.00107315803570712,0.999544625527555,24,129,carbohydrate derivative catabolic process,BP,CEMIP;NT5E;CST3;RAPGEF3;FBXO2;NAGLU;HYAL1;FUCA1;EDEM1;HEXB;GM2A;GLB1;ADA;NUDT10;GPC1;MAN1B1;SDC1;APOBEC3C;HGSNAT;GPD1L;NAGA;APOBEC3F;NEIL1;GALNS
7682,GO:0032147,0.00109429130009722,0.999433654482029,38,235,activation of protein kinase activity,BP,DUSP6;IGF2;EGFR;DUSP5;PKN1;SHC1;F2R;SHC2;PAK6;MINK1;INSR;LPAR3;PRNP;STRADB;CD81;VEGFA;ACVR2B;S1PR2;MAPK3;ADCY6;PRKACA;MAP2K2;DUSP7;DGKQ;GAS6;WNT7B;PRKCZ;MAPKAPK3;C5;MADD;STK39;ADORA2B;AKT1;ERCC6;PINK1;MLST8;MAP2K3;ERN1
3446,GO:0007266,0.00109557955141093,0.999507688797903,27,149,Rho protein signal transduction,BP,APOE;ARAP1;OBSCN;ARHGEF4;F2R;PAK6;RHOD;PLEKHG4;CELSR1;BCL6;VANGL2;PLEKHG5;PLEKHG2;CDC42EP5;RHOF;RHOBTB2;PLEKHG6;ARHGEF37;VAV3;BCR;ARAP3;RTN4R;EPS8L1;ABR;EPS8L2;ARHGEF10L;ARHGEF19
19431,GO:1990138,0.00110215348309675,0.999552765484224,22,112,neuron projection extension,BP,APOE;PTPRS;SEMA4B;POSTN;ULK1;ULK2;PLXNB3;LAMB2;PLXNB1;VEGFA;DVL1;NRP2;SLIT3;CYFIP2;SEMA3B;SEMA3F;SEMA4C;PRKCZ;TWF2;RTN4R;WNT3;SEMA4F
12755,GO:0051056,0.00112481962743018,0.999396065352494,42,265,regulation of small GTPase mediated signal transduction,BP,APOE;ARAP1;EPHB2;OBSCN;APPL2;TIMP2;ARHGEF4;RGL2;F2R;PIK3R2;ARHGAP23;IQSEC2;SPRY4;RALGAPA2;RASA4;AGAP1;ACAP3;RHOD;PLEKHG4;SYNGAP1;SPRY2;BCL6;PLEKHG5;ARHGAP22;PLEKHG2;RHOF;PSD4;RHOBTB2;GIT1;PLEKHG6;ARHGEF37;VAV3;BCR;ARAP3;ASAP2;MADD;RTN4R;EPS8L1;ABR;EPS8L2;ARHGEF10L;ARHGEF19
12568,GO:0050770,0.00114125352494139,0.999524336140735,23,120,regulation of axonogenesis,BP,APOE;PTPRS;SEMA4B;EPHB2;ULK2;PLXNB3;KIF13B;WNT7A;SYNGAP1;LPAR3;EFNB3;PLXNB1;VEGFA;EPHB3;SSH1;SEMA3B;SEMA3F;SEMA4C;TWF2;RTN4R;WNT3;SSH3;SEMA4F
5048,GO:0015267,0.0011530834637487,0.999462750084725,29,165,channel activity,MF,CLCA2;SCN8A;KCNG1;GJC2;KCNC4;KCNJ15;ANO8;PKD2;SCN4B;ITPR3;ASIC1;DLG4;TTYH3;LRRC8A;TMEM63C;KCNAB2;AQP3;SCNN1A;TRPV4;GAS6;TMEM175;DLG3;KCNMA1;ANO9;TPCN1;PKD1;KCNN4;ORAI3;ORAI2
6596,GO:0022803,0.0011530834637487,0.999462750084725,29,165,passive transmembrane transporter activity,MF,CLCA2;SCN8A;KCNG1;GJC2;KCNC4;KCNJ15;ANO8;PKD2;SCN4B;ITPR3;ASIC1;DLG4;TTYH3;LRRC8A;TMEM63C;KCNAB2;AQP3;SCNN1A;TRPV4;GAS6;TMEM175;DLG3;KCNMA1;ANO9;TPCN1;PKD1;KCNN4;ORAI3;ORAI2
9166,GO:0035556,0.00115392186227935,0.999118473174728,228,1976,intracellular signal transduction,BP,TNIP1;DUSP6;ADGRL1;APOE;WWC3;FAM110C;RAPGEF3;GSN;XDH;NDRG1;PCBP4;PRODH;NOS1;ARAP1;ZFP36L1;EFS;RBCK1;EPHB2;OBSCN;MYZAP;IGF2;NFATC4;MST1R;MAPK13;APPL2;RALGDS;EGFR;TIMP2;DUSP5;RAPGEFL1;ADGRF1;PKN1;ARHGEF4;SHC1;RGL2;F2R;PTK6;GNAL;ABCA7;S100A4;SHC2;CXXC5;DGKA;PIK3R2;ARHGAP23;DOCK4;ZP3;RPS6KA2;NISCH;ERBB2;FBLN1;BRSK1;PKD2;IQSEC2;ITPR3;SPRY4;PTHLH;PAK6;SERPINE2;NPHP4;MINK1;RALGAPA2;ATP2B4;TFDP2;RASA4;PLCD1;AGAP1;PDCD4;DOCK6;SLC20A1;ACAP3;TNFRSF25;RHOD;PLEKHG4;WNT7A;INSR;RAB3D;ID1;CELSR1;EPHA1;SYNGAP1;LPAR3;PRNP;SPRY2;ECM1;DLG4;MKNK2;PLCD3;STRADB;WWTR1;RAB25;BCL6;PLXNB1;BNIP3;CD81;FZD8;VEGFA;VANGL2;MAST4;CEBPB;SHANK3;ADAM15;S1PR2;MAPK3;PLEKHG5;CARD19;RAB40B;DVL1;ADCY6;L3MBTL1;PKN3;EPHB3;HES1;MLXIPL;SAMD3;ARHGAP22;PLEKHG2;ADA;CDC42EP5;MCTP1;PIDD1;PAG1;IL6R;ZFP36;RHOF;MAPKBP1;FGFR3;PRKACA;LRRK1;PLCH2;RPS6KA5;HBEGF;RAB3B;MAP2K2;FGFR4;SPTB;DMTN;RAPGEF5;PSD4;TNFRSF1A;MAPK8IP1;ACOT11;TRPV4;RHOBTB2;DUSP7;TNFAIP8L1;DGKQ;SEMA4C;MIB2;GAS6;BTRC;ADGRB2;TKFC;STK32C;WNT7B;GIT1;PTAFR;PLEKHG6;ARHGEF37;VAV3;BCR;IGFBP4;PRKCZ;INPP5D;NYAP1;PDK2;RFXANK;MAPKAPK3;ARAP3;FGFR1;CAMKK1;PIN1;C5;ASAP2;GPR155;PI4KAP2;PPP1R13L;WDR83;SESN2;TOLLIP;TMEM161A;MADD;RTN4R;SH2B3;EPS8L1;PPM1F;SORL1;STK39;ADORA2B;ERBB3;ABR;AKT1;TRAP1;TMBIM4;NLRX1;ZNF385A;TP53INP1;NDRG2;ERCC6;GPD1L;EPS8L2;IL17RD;PINK1;PKD1;ARHGEF10L;HOMER2;RGS14;CTSH;MLST8;CBLC;PYCARD;MAP2K3;STK17A;ERN1;RANBP9;ARHGEF19;SIRT3;C12ORF66;JAK3;MAST3;LITAF;ING4;EREG;GSTM2;GIPR;TMED4;RAB40C;MIF
4860,GO:0014731,0.00117479709819991,0.999950336305165,4,6,spectrin-associated cytoskeleton,CC,ANK3;SPTB;DMTN;RHBG
5509,GO:0016485,0.00122619820003455,0.999443567034795,27,153,protein processing,BP,TYSND1;GSN;PRSS3;SERPING1;RHBDF1;PLAT;SERPINE2;GGT1;PRNP;CD81;RHBDF2;FURIN;PCSK9;F12;CYFIP2;RHBDL1;GAS6;PCSK1;ADAMTS13;CTSZ;C5;CAPN2;SPPL2B;LONP2;CTSH;PYCARD;PCSK1N
15452,GO:0071825,0.00123568108752783,0.999776672129633,8,24,protein-lipid complex subunit organization,BP,APOE;ABCA7;ABCG1;PLTP;SNX9;PRKACA;BIN1;LCAT
462,GO:0001501,0.0012516144078487,0.999298314239295,47,309,skeletal system development,BP,MEF2D;POSTN;IGF2;MDFI;DEAF1;BBS2;THBS3;THRA;LRP5;HYAL1;ZFPM1;PTHLH;IFT140;HEXB;FUZ;ACP5;ADAMTS7;WNT7A;SH3PXD2B;FAM20C;PLXNB1;FBXW4;ACVR2B;NAB2;MAPK3;EVC;TRIM45;FGFR3;LRRK1;SLC38A10;TRPV4;HMGA2;PEX7;WNT7B;SUFU;IGFBP4;WDR60;FGFR1;CHADL;WNT2B;TIMP1;COL13A1;ZNF385A;VPS33B;PKD1;RARG;SULF2
13920,GO:0060627,0.00125531196954457,0.999278242801353,51,344,regulation of vesicle-mediated transport,BP,APOE;TSPAN1;SYTL1;EVI5L;LRP1;SYT8;ABCA7;TBC1D14;ZP3;RIMS3;VPS11;VAMP2;RAB3D;TBC1D8;SNX33;DLG4;RAB25;MYO18A;VEGFA;MAPK3;TUB;RAB40B;LRSAM1;MCTP1;PCSK9;RAB3B;MAP2K2;EHD4;LDLR;SNX17;EEF2K;LDLRAP1;GAS6;LLGL1;PTAFR;BCR;TBC1D16;ARAP3;BIN1;VSNL1;ADGRE2;SDC1;SORL1;TBC1D17;ADORA2B;ABR;STON1;PINK1;PYCARD;RAB40C;STXBP2
3170,GO:0006793,0.00130708420088353,0.998982914363178,265,2352,phosphorus metabolic process,BP,TNIP1;DUSP6;H6PD;CEMIP;APOE;IDH2;PTPRS;NT5E;NAPRT;RAPGEF3;PGM1;XDH;PGLS;NOS1;ZFP36L1;EPHB2;OBSCN;CNTN1;IGF2;NME4;MST1R;MAPK13;CDK18;EGFR;TIMP2;B3GAT3;CRYL1;ACSF2;ACOT7;DUSP5;PPP1R14A;ISYNA1;EGR1;ULK1;PKN1;PYGL;SHC1;F2R;PTK6;ABCA7;PPP2R3B;PPM1J;LPCAT4;SHC2;ULK2;DGKA;GJC2;PIK3R2;NEK9;ZP3;RPS6KA2;NMRK1;LRP5;MARK4;ERBB2;FBLN1;BRSK1;PTPRU;OGDHL;PKD2;SPRY4;PTHLH;CDKN1C;PTPRE;PAK6;HEXB;LTB4R2;NTSR1;MINK1;ATP2B4;CSNK1E;ACP5;RASA4;PLCD1;ZFYVE21;PDCD4;SLC20A1;TNFRSF25;WNT7A;INSR;ID1;GRK6;MVD;NDUFS8;EPHA1;ADARB1;ITGA6;SYNGAP1;PPP1R35;DNPH1;LPAR3;PRNP;SERINC2;SRD5A3;SPRY2;SNX9;DLG4;SPEG;FGGY;MKNK2;PLCD3;NT5DC1;STRADB;TALDO1;WWTR1;FAM20C;UCKL1;PFKFB2;DYRK1B;CD81;SRMS;FZD8;VEGFA;VANGL2;MAST4;SHANK3;ACVR2B;NAB2;S1PR2;MAPK3;KCNAB2;DHTKD1;DVL1;ENTPD2;GALK1;LHPP;ADCY6;PKN3;EPHB3;HES1;SSH1;MLXIPL;MBOAT7;NADK;TK2;ADA;CDC42EP5;OSBPL5;CKMT1A;PFKL;IL6R;PCSK9;ZFP36;FGFR3;PRKACA;PITPNM1;LRRK1;NUDT10;PLCH2;DGUOK;RPS6KA5;HBEGF;MAP2K2;PI4K2A;FGFR4;SPTB;DMTN;PMVK;MYH3;TNFRSF1A;EHD4;MAPK8IP1;LDLR;ACOT11;TRPV4;PIGZ;DUSP7;EEF2K;HMGA2;DGKQ;SEMA4C;HK1;GAS6;BTRC;PPARA;HMGCL;TKFC;GUK1;STK32C;WNT7B;TTC7B;PTAFR;IMPA2;PCK2;VAV3;BCR;IGFBP4;SDHA;PRKCZ;MDH2;INPP5D;PDK2;MAPKAPK3;FGFR1;CAMKK1;PIN1;C5;PROX1;GTPBP1;DLG3;PI4KAP2;WDR83;GRB10;SESN2;TOLLIP;ADCK5;TSTA3;MAPRE3;DUSP23;LCAT;GUCA1B;PITPNM3;MADD;RTN4R;ELFN2;PIGV;PIGQ;PPM1F;SBF1;SORL1;STK39;ACVR1B;ADORA2B;ERBB3;AKT1;NDRG2;ERCC6;ACP6;GPD1L;IL17RD;UQCR11;ADCK2;SSH3;PINK1;PKD1;PLPPR2;RGS14;PCIF1;CTSH;ABHD14B;MLST8;AGPAT4;CBLC;PYCARD;MAP2K3;PNPO;NDUFV3;STK17A;ERN1;RANBP9;MOCS1;SIRT3;CPNE7;MLYCD;TAZ;JAK3;MAST3;NEIL1;FUK;EREG;PPCS;PODXL2;SFI1;AGPAT3;MIF
766,GO:0002020,0.00132491486979928,0.999510947748326,18,88,protease binding,MF,TYSND1;CST3;LRP1;TIMP2;PRNP;ECM1;FURIN;LDLR;RAD23A;BIN1;SERPINB6;CSTB;TIMP1;PINK1;LONP2;PYCARD;ADAMTSL4;MIF
2268,GO:0005216,0.00133756587317679,0.999389729263848,27,151,ion channel activity,MF,CLCA2;SCN8A;KCNG1;KCNC4;KCNJ15;ANO8;PKD2;SCN4B;ITPR3;ASIC1;DLG4;TTYH3;LRRC8A;TMEM63C;KCNAB2;SCNN1A;TRPV4;GAS6;TMEM175;DLG3;KCNMA1;ANO9;TPCN1;PKD1;KCNN4;ORAI3;ORAI2
12092,GO:0048167,0.00134555943216609,0.999487403353171,19,93,regulation of synaptic plasticity,BP,APOE;SHANK2;EPHB2;NFATC4;CRTC1;ITPR3;RIMS3;SERPINE2;VAMP2;SYNGAP1;PRNP;DLG4;SHANK3;SSH1;MCTP1;VGF;PRKCZ;RGS14;SHISA6
13630,GO:0060170,0.00136836780390741,0.999621191188206,12,47,ciliary membrane,CC,SHANK2;BBS2;PKD2;SHANK3;EVC;SCNN1A;BBS1;CDHR1;TMEM231;GUCA1B;PKD1;EHD3
7354,GO:0031410,0.00137378609947905,0.998969667596575,188,1604,cytoplasmic vesicle,CC,CEMIP;APOE;PTPRS;GAA;SYTL1;NAPRT;PYGB;CST3;PGM1;GSN;PRDX5;NDRG1;PRSS3;ARAP1;ARRDC1;EPN3;SCN8A;IGF2;LRP1;APPL2;RAB11FIP4;EGFR;TIMP2;LOXL1;SERPING1;ULK1;PKN1;PYGL;DOPEY2;SYT8;F2R;ABCA7;CTSB;ULK2;MALL;TBC1D14;PLAT;ABCG1;NISCH;DBNDD1;HYAL1;ERBB2;BRSK1;MICALL2;BSG;PKD2;FUCA1;ITPR3;PRAF2;VAT1;DNM1;CD9;SIGMAR1;HEXB;SERPINE2;VPS11;VAMP2;CD320;ZFYVE21;GM2A;RHOD;WNT7A;INSR;RAB3D;NBEAL2;TMEM173;ATP7B;RNASET2;SNX33;ECM1;SNX9;DLG4;MARCH2;RAB25;C1ORF210;CHMP1B;IGFBP2;MVB12B;VEGFA;DNASE1L1;VANGL2;AP2A2;DPP7;GPRC5C;ADAM15;MAPK3;PLEKHG5;KCNAB2;AMN;GLB1;RAB40B;DVL1;FYCO1;WIPF1;LTA4H;FURIN;SLC48A1;MEFV;SLC2A3;ABCA2;LY6K;ADA;MCTP1;PFKL;PCSK9;TMEM9;RHOF;FGFR3;PRKACA;HBEGF;ITGB5;RAB3B;MAP2K2;PI4K2A;FGFR4;DMTN;VGF;EHD4;LDLR;SNX17;ABHD17C;TRPV4;RHOBTB2;IFNGR2;PHLDA1;LDLRAP1;AHNAK2;DGKQ;SEMA4C;MVB12A;MIB2;GAS6;LLGL1;TMEM187;WNT7B;PTAFR;ANKRD13D;PCSK1;TMEM175;TBC1D16;PRKCZ;CLTCL1;CAPG;TPP1;GPC1;FGFR1;CTSZ;YIPF3;SERPINB6;WDR83;TOLLIP;CSTB;SLC9A7;TIMP1;CD68;ACTR1B;WNT3;SORL1;VEGFB;TBC1D17;TPCN1;HGSNAT;CTSD;TP53INP1;VPS33B;SUN1;SPPL2B;PKD1;EHD3;SPIRE2;CTSH;EHBP1L1;NRSN1;EPN2;PYCARD;RHBG;POMT1;PCSK1N;SLC2A1;JAK3;LITAF;APBA1;GALNS;FCHSD1;TMED4;RAB40C;MIF;STXBP2
4637,GO:0010769,0.00140368012508145,0.999300380901088,33,198,regulation of cell morphogenesis involved in differentiation,BP,APOE;PTPRS;SEMA4B;POSTN;EPHB2;NFATC4;OBSL1;ULK2;FBLN1;PLXNB3;KIF13B;WNT7A;FBXW8;ID1;SYNGAP1;LPAR3;EFNB3;PLXNB1;VEGFA;SHANK3;EPHB3;SSH1;CUL7;DMTN;SEMA3B;EEF2K;SEMA3F;SEMA4C;TWF2;RTN4R;WNT3;SSH3;SEMA4F
9790,GO:0040036,0.00141599396056705,0.999738329692123,8,24,regulation of fibroblast growth factor receptor signaling pathway,BP,DUSP6;SPRY4;FUZ;SPRY2;FAM20C;GPC1;FGFBP1;SULF2
5889,GO:0018105,0.00141719248282563,0.999284953244145,34,206,peptidyl-serine phosphorylation,BP,RAPGEF3;MAPK13;EGFR;ULK1;PKN1;ATP2B4;CSNK1E;SPRY2;MKNK2;VEGFA;MAST4;MAPK3;PKN3;MLXIPL;PRKACA;RPS6KA5;MAP2K2;DMTN;HMGA2;DGKQ;GAS6;STK32C;PRKCZ;MAPKAPK3;CAMKK1;PPM1F;STK39;AKT1;GPD1L;PINK1;PKD1;ERN1;MAST3;MIF
18177,GO:1902992,0.0014210397073667,0.99987677381836,5,10,negative regulation of amyloid precursor protein catabolic process,BP,APOE;ABCA7;PRNP;BIN1;SORL1
20255,GO:2001257,0.00142491025360492,0.999489366437083,17,80,regulation of cation channel activity,BP,SHANK2;NOS1;EPHB2;KCNG1;NLGN2;ANK3;PKD2;VAMP2;NTSR1;MINK1;DLG4;SHANK3;PRKACA;PINK1;EHD3;GSTM2;SHISA6
8190,GO:0032956,0.00144496200502418,0.999239042348646,38,240,regulation of actin cytoskeleton organization,BP,RAPGEF3;GSN;ARAP1;LRP1;ARPIN;CORO1B;TMOD2;RHOD;SH3PXD2B;ID1;CELSR1;EPHA1;PLEKHH2;VANGL2;SHANK3;WIPF1;FHOD1;SSH1;PLEKHG2;CDC42EP5;RHOF;SPTB;DMTN;RHOBTB2;CAPG;TWF2;PROX1;WHAMMP3;EPS8L1;PPM1F;EPS8L2;SSH3;ARHGEF10L;SPIRE2;MLST8;PYCARD;ARHGEF19;FCHSD1
19813,GO:2000311,0.00144695982921681,0.999873990893142,5,10,regulation of AMPA receptor activity,BP,SHANK2;NLGN2;MINK1;SHANK3;SHISA6
3765,GO:0008328,0.00144750111019497,0.99977409163279,7,19,ionotropic glutamate receptor complex,CC,SHANK2;CPT1C;DLG4;SHANK3;OLFM2;DLG3;SHISA6
16885,GO:0098878,0.00144750111019497,0.99977409163279,7,19,neurotransmitter receptor complex,CC,SHANK2;CPT1C;DLG4;SHANK3;OLFM2;DLG3;SHISA6
16688,GO:0097708,0.00146022223821917,0.998903058264054,188,1606,intracellular vesicle,CC,CEMIP;APOE;PTPRS;GAA;SYTL1;NAPRT;PYGB;CST3;PGM1;GSN;PRDX5;NDRG1;PRSS3;ARAP1;ARRDC1;EPN3;SCN8A;IGF2;LRP1;APPL2;RAB11FIP4;EGFR;TIMP2;LOXL1;SERPING1;ULK1;PKN1;PYGL;DOPEY2;SYT8;F2R;ABCA7;CTSB;ULK2;MALL;TBC1D14;PLAT;ABCG1;NISCH;DBNDD1;HYAL1;ERBB2;BRSK1;MICALL2;BSG;PKD2;FUCA1;ITPR3;PRAF2;VAT1;DNM1;CD9;SIGMAR1;HEXB;SERPINE2;VPS11;VAMP2;CD320;ZFYVE21;GM2A;RHOD;WNT7A;INSR;RAB3D;NBEAL2;TMEM173;ATP7B;RNASET2;SNX33;ECM1;SNX9;DLG4;MARCH2;RAB25;C1ORF210;CHMP1B;IGFBP2;MVB12B;VEGFA;DNASE1L1;VANGL2;AP2A2;DPP7;GPRC5C;ADAM15;MAPK3;PLEKHG5;KCNAB2;AMN;GLB1;RAB40B;DVL1;FYCO1;WIPF1;LTA4H;FURIN;SLC48A1;MEFV;SLC2A3;ABCA2;LY6K;ADA;MCTP1;PFKL;PCSK9;TMEM9;RHOF;FGFR3;PRKACA;HBEGF;ITGB5;RAB3B;MAP2K2;PI4K2A;FGFR4;DMTN;VGF;EHD4;LDLR;SNX17;ABHD17C;TRPV4;RHOBTB2;IFNGR2;PHLDA1;LDLRAP1;AHNAK2;DGKQ;SEMA4C;MVB12A;MIB2;GAS6;LLGL1;TMEM187;WNT7B;PTAFR;ANKRD13D;PCSK1;TMEM175;TBC1D16;PRKCZ;CLTCL1;CAPG;TPP1;GPC1;FGFR1;CTSZ;YIPF3;SERPINB6;WDR83;TOLLIP;CSTB;SLC9A7;TIMP1;CD68;ACTR1B;WNT3;SORL1;VEGFB;TBC1D17;TPCN1;HGSNAT;CTSD;TP53INP1;VPS33B;SUN1;SPPL2B;PKD1;EHD3;SPIRE2;CTSH;EHBP1L1;NRSN1;EPN2;PYCARD;RHBG;POMT1;PCSK1N;SLC2A1;JAK3;LITAF;APBA1;GALNS;FCHSD1;TMED4;RAB40C;MIF;STXBP2
10765,GO:0044242,0.00146702259974546,0.999336607511291,26,147,cellular lipid catabolic process,BP,APOE;TYSND1;CRAT;CPT2;HADH;FUCA1;CPT1C;HEXB;GM2A;SRD5A3;ABCD1;ACAD10;LDLR;PEX7;PPARA;AIG1;PCK2;ETFB;PNPLA4;PHYH;SESN2;AKT1;NAGA;LONP2;ACADS;MLYCD
17042,GO:0099565,0.00148133762633793,0.99958590686995,12,47,chemical synaptic transmission, postsynaptic,BP,SHANK2;NLGN2;ZMYND8;NTSR1;WNT7A;DLG4;SHANK3;S1PR2;DVL1;SSH1;PRKCZ;AKT1
10291,GO:0043085,0.00148230961910677,0.998948476649872,126,1018,positive regulation of catalytic activity,BP,DUSP6;LMF1;CEMIP;APOE;RAPGEF3;CYP27B1;GSN;EVI5L;XDH;NOS1;ARAP1;EPHB2;IGF2;MST1R;EGFR;TIMP2;B3GAT3;DUSP5;EGR1;PKN1;SHC1;F2R;SHC2;TBC1D14;GRAMD4;RIN1;PIK3R2;ARHGAP23;DOCK4;ERBB2;FBLN1;PKD2;PAK6;MINK1;RALGAPA2;ATP2B4;RASA4;AGAP1;GM2A;ACAP3;PLEKHG4;INSR;SH3PXD2B;TBC1D8;EPHA1;ITGA6;SYNGAP1;LPAR3;PRNP;SERINC2;SPRY2;SNX9;DLG4;STRADB;ARHGAP27;PFKFB2;PLXNB1;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;MAPK3;ADCY6;EPHB3;MEFV;ARHGAP22;CDC42EP5;PIDD1;FGFR3;PRKACA;CYFIP2;MAP2K2;DAP;FGFR4;DUSP7;DGKQ;GAS6;LLGL1;WNT7B;GIT1;PTAFR;PLEKHG6;ARHGEF37;VAV3;BCR;TBC1D16;PRKCZ;MAPKAPK3;ARAP3;FGFR1;CAMKK1;PIN1;C5;PROX1;ASAP2;DLG3;MAPRE3;GUCA1B;MADD;RTN4R;PPM1F;SORL1;STK39;TBC1D17;ALS2CL;ADORA2B;ERBB3;ABR;AKT1;ERCC6;PINK1;PKD1;RGS14;CTSH;MLST8;PYCARD;MAP2K3;ERN1;ARHGEF19;EREG;FAM162A;RGS12;MIF
4359,GO:0009986,0.00149315830569678,0.999119352209272,54,372,cell surface,CC,NT5E;MST1R;EGFR;TIMP2;NLGN2;F2R;ABCA7;PLAT;ABCG1;ANK3;BCAM;ITGB4;PLXNB3;CD9;SERPINE2;NTSR1;ADAMTS7;ASIC1;WNT7A;INSR;ITGA6;PRNP;MYO18A;SCART1;VEGFA;ENTPD6;LRRC8A;ADAM15;FURIN;ADA;PCSK9;FGFR3;HBEGF;ITGB5;MXRA8;TSPAN33;TNFRSF1A;LDLR;TRPV4;MSLN;VASN;ADAMTS13;SLITRK6;ICOSLG;CTSZ;TMEM8B;PROCR;RTN4R;SDC1;FGFBP1;ACVR1B;PKD1;MIF;SULF2
15495,GO:0071902,0.00151771479084369,0.999177132130434,41,264,positive regulation of protein serine/threonine kinase activity,BP,DUSP6;CEMIP;IGF2;MST1R;EGFR;DUSP5;PKN1;SHC1;F2R;SHC2;ERBB2;PKD2;MINK1;ATP2B4;INSR;LPAR3;SPRY2;CD81;FZD8;VEGFA;VANGL2;S1PR2;MAPK3;MAP2K2;DUSP7;WNT7B;MAPKAPK3;FGFR1;C5;PROX1;MAPRE3;MADD;STK39;ADORA2B;AKT1;ERCC6;PKD1;MLST8;MAP2K3;ERN1;MIF
10780,GO:0044273,0.00153009667502225,0.999671151453849,9,30,sulfur compound catabolic process,BP,ACOT7;HYAL1;CBS;HEXB;GGT1;BLMH;GLB1;MLYCD;GALNS
10239,GO:0042995,0.00155005080874224,0.998860462317667,158,1313,cell projection,CC,FOS;ADGRL1;APOE;ESPN;PTPRS;SYTL1;CST3;SHANK2;RAPGEF3;GSN;NOS1;PARVB;TCTN1;GRB7;NR1D1;SCN8A;EPHB2;LRP1;TIMP2;REEP6;FBXO2;ULK1;CRTC1;ARPIN;ARHGEF4;PTK6;ABCA7;BBS2;ACTA2;S100A4;DNAH1;CORO1B;GJC2;IGSF9;ZMYND8;KCNC4;ANK3;S100A6;DOCK4;MARK4;TENM2;MICALL2;PKD2;CPT1C;DNM1;SPRY4;IFT140;KIF13B;SIGMAR1;VAMP2;FUZ;NPHP4;NTSR1;MINK1;ATP2B4;TMOD2;GLUL;PRR7;INSR;SH3PXD2B;EPHA1;ITGA6;SYNGAP1;LPAR3;PRNP;SPRY2;CEP250;SNX9;DLG4;RAB25;TMEM107;PLEKHH2;BNIP3;SHANK3;ADAM15;MAPK3;PLEKHG5;TUB;KCNAB2;AMN;DVL1;WIPF1;ADCY6;EPHB3;FHOD1;SSH1;FBF1;MEFV;EVC;ADA;HTR7;RSPH3;PRKACA;CYFIP2;SCNN1A;PI4K2A;DMTN;BBS1;PSD4;MAPK8IP1;ROBO3;ABHD17C;TRPV4;CROCC;EEF2K;LDLRAP1;HK1;LLGL1;ANKS6;BLVRB;COMT;SUFU;PLEKHG6;WDR60;PRKCZ;SPATA7;TWF2;ARAP3;CDHR1;CTSZ;PIN1;C21ORF2;DLG3;BIN1;UNC119B;CAPN2;WRAP73;SNPH;TMEM231;GUCA1B;ADGRE2;PITPNM3;CYBRD1;RTN4R;EPB41L3;EPS8L1;AHCYL2;AKT1;ZNF385A;NDRG2;EPS8L2;PINK1;GAS8;PKD1;EHD3;HOMER2;RGS14;MAFIP;RILPL1;NRSN1;ATXN10;DDN;APBA1;ORAI2;SHISA6;MORN4;TTLL11;RGS12
11121,GO:0045185,0.00163051900925297,0.999385699368135,18,89,maintenance of protein location,BP,GSN;LTBP1;MDFI;MXI1;ANK3;THRA;PKD2;ARL2;HK1;SUFU;TWF2;EPB41L3;SORL1;AKT1;SUN1;PINK1;PKD1;SYNE3
6978,GO:0030669,0.00164160668364794,0.999686030416968,8,25,clathrin-coated endocytic vesicle membrane,CC,APOE;EGFR;CD9;AP2A2;HBEGF;LDLR;LDLRAP1;EPN2
5777,GO:0017016,0.0016606954310879,0.998996194626589,58,405,Ras GTPase binding,MF,SYTL1;RAPGEF3;EVI5L;NDRG1;OBSCN;RAB11FIP4;EGFR;ULK1;PKN1;ARHGEF4;SHC1;RGL2;SHC2;TBC1D14;RIN1;DOCK4;ERBB2;EXOC2;MICALL2;RIMS3;PAK6;TRAPPC9;PLEKHG4;TBC1D8;RABGGTA;DLG4;PLEKHG5;DVL1;PKN3;PLEKHG2;CDC42EP5;FGFR3;HBEGF;FGFR4;SPTB;RAPGEF5;LLGL1;PLEKHG6;ARHGEF37;VAV3;BCR;TBC1D16;FGFR1;MADD;WHAMMP3;EPS8L1;SBF1;TBC1D17;ALS2CL;ERBB3;ABR;EPS8L2;GAS8;ARHGEF10L;RANBP9;ARHGEF19;JAK3;EREG
7019,GO:0030804,0.00167825461021112,0.999782421545175,6,15,positive regulation of cyclic nucleotide biosynthetic process,BP,APOE;NOS1;TIMP2;PTHLH;GUCA1B;ADORA2B
4021,GO:0009062,0.00167915537384976,0.99936561975943,18,89,fatty acid catabolic process,BP,TYSND1;CRAT;CPT2;HADH;CPT1C;ABCD1;ACAD10;PEX7;PPARA;AIG1;PCK2;ETFB;PHYH;SESN2;AKT1;LONP2;ACADS;MLYCD
2382,GO:0005523,0.00172116720796869,0.999902568353091,4,7,tropomyosin binding,MF,S100A6;TMOD2;TNNT1;PYCARD
1961,GO:0004674,0.00172778001541036,0.998958577523657,57,395,protein serine/threonine kinase activity,MF,LTBP4;LTBP1;EPHB2;OBSCN;MST1R;MAPK13;CDK18;EGFR;ULK1;PKN1;ULK2;NEK9;RPS6KA2;MARK4;ERBB2;BRSK1;PAK6;MINK1;CSNK1E;INSR;GRK6;EPHA1;SPEG;MKNK2;STRADB;FAM20C;DYRK1B;MAST4;ACVR2B;MAPK3;PKN3;EPHB3;FGFR3;PRKACA;LRRK1;RPS6KA5;MAP2K2;FGFR4;EEF2K;HMGA2;STK32C;BCR;PRKCZ;MAPKAPK3;FGFR1;CAMKK1;ADCK5;STK39;ACVR1B;ERBB3;AKT1;ADCK2;PINK1;MAP2K3;STK17A;ERN1;MAST3
6665,GO:0030036,0.00174156331829908,0.998913420838791,65,468,actin cytoskeleton organization,BP,ESPN;RAPGEF3;GSN;PARVB;ARAP1;EFS;OBSCN;LRP1;OBSL1;ARPIN;SHC1;CORO1B;NISCH;MICALL2;IQSEC2;MSRB2;PAK6;NPHP4;MINK1;TMOD2;RHOD;TNXB;SH3PXD2B;ID1;CELSR1;EPHA1;MYO18A;PLEKHH2;BCL6;VANGL2;SHANK3;S1PR2;TNNT1;WIPF1;FHOD1;SSH1;PLEKHG2;CDC42EP5;RHOF;ITGB5;SPTB;DMTN;MYH3;TRPV4;RHOBTB2;LLGL1;BCR;PRKCZ;CAPG;TWF2;PROX1;PI4KAP2;EPB41L3;WHAMMP3;EPS8L1;PPM1F;ABR;EPS8L2;SSH3;ARHGEF10L;SPIRE2;MLST8;PYCARD;ARHGEF19;FCHSD1
11411,GO:0045859,0.00174384981377634,0.998864479509288,78,584,regulation of protein kinase activity,BP,DUSP6;CEMIP;APOE;EPHB2;IGF2;MST1R;EGFR;DUSP5;EGR1;PKN1;SHC1;F2R;PTK6;SHC2;LRP5;ERBB2;PKD2;SPRY4;CDKN1C;PAK6;MINK1;ATP2B4;PDCD4;INSR;EPHA1;ADARB1;LPAR3;PRNP;SPRY2;SNX9;DLG4;STRADB;WWTR1;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;MAPK3;DVL1;ADCY6;PRKACA;MAP2K2;MAPK8IP1;DUSP7;DGKQ;GAS6;WNT7B;PRKCZ;MAPKAPK3;FGFR1;CAMKK1;C5;PROX1;DLG3;SESN2;MAPRE3;MADD;RTN4R;PPM1F;SORL1;STK39;ADORA2B;ERBB3;AKT1;ERCC6;PINK1;PKD1;RGS14;MLST8;CBLC;PYCARD;MAP2K3;ERN1;EREG;MIF
2379,GO:0005520,0.00174419171242737,0.999772082329635,6,15,insulin-like growth factor binding,MF,HTRA1;ITGB4;INSR;ITGA6;IGFBP2;IGFBP4
7016,GO:0030801,0.00175112756514202,0.999712650488483,7,20,positive regulation of cyclic nucleotide metabolic process,BP,APOE;RAPGEF3;NOS1;TIMP2;PTHLH;GUCA1B;ADORA2B
4326,GO:0009887,0.00175635094282111,0.998837687382149,84,638,animal organ morphogenesis,BP,HTRA1;CTNNBIP1;GAA;SHANK2;PGF;MEF2D;EPHB2;GAMT;EGFR;FHL1;MDFI;SDK2;NAGLU;LAMA5;BBS2;ACTA2;THBS3;THRA;LRP5;HYAL1;ZFPM1;BSG;PKD2;ITGB4;PHLDA2;IFT140;FUZ;ACP5;PDCD4;WNT7A;ZMIZ1;INSR;SH3PXD2B;ID1;CELSR1;ADARB1;ITGA6;SPRY2;STAT6;WWTR1;FAM20C;VEGFA;VANGL2;AP2A2;CEBPB;SHANK3;ACVR2B;ADAM15;NAB2;MAPK3;ETV5;DVL1;HES1;NRP2;AQP3;CELSR2;SLIT3;FGFR3;TRPV4;PEX7;BTRC;PPARA;WNT7B;SUFU;RFNG;RXRA;BCR;WDR60;SLITRK6;FGFR1;CTSZ;PROX1;PPP1R13L;WNT2B;SDC1;COL13A1;ABR;PKD1;CTSH;ARHGEF19;RARG;EREG;SULF2;KIF26B
4778,GO:0010977,0.00176225704449824,0.999290358703748,20,103,negative regulation of neuron projection development,BP,APOE;PTPRS;SEMA4B;EPHB2;NFATC4;LRP1;ULK2;ID1;SYNGAP1;EFNB3;ADCY6;DGUOK;SEMA3B;TRPV4;SEMA3F;SEMA4C;CTSZ;RTN4R;WNT3;SEMA4F
7446,GO:0031594,0.00177140514438295,0.999567011745175,10,36,neuromuscular junction,CC,POSTN;F2R;KCNC4;ANK3;SERPINE2;DLG4;DLG3;SYNC;SNTA1;FCHSD1
16272,GO:0090407,0.00177534764423845,0.998878843321981,68,498,organophosphate biosynthetic process,BP,APOE;IDH2;NAPRT;PGM1;NOS1;NME4;TIMP2;CRYL1;ACOT7;ISYNA1;PYGL;LPCAT4;DGKA;PIK3R2;ZP3;NMRK1;OGDHL;PTHLH;HEXB;LTB4R2;NTSR1;INSR;MVD;SRD5A3;UCKL1;PFKFB2;DHTKD1;GALK1;LHPP;ADCY6;MLXIPL;MBOAT7;NADK;TK2;ADA;PFKL;FGFR3;PITPNM1;DGUOK;PI4K2A;FGFR4;PMVK;PIGZ;DGKQ;HK1;PPARA;GUK1;PTAFR;INPP5D;FGFR1;LCAT;GUCA1B;PITPNM3;PIGV;PIGQ;SBF1;ADORA2B;ACP6;GPD1L;PINK1;AGPAT4;PNPO;MOCS1;CPNE7;TAZ;FUK;PPCS;AGPAT3
3545,GO:0007588,0.00177538554935511,0.999707938914299,7,20,excretion,BP,AMN;SLC22A18;AQP3;COMT;KCNMA1;GRHPR;ADORA2B
3552,GO:0007600,0.00178913514426592,0.999082460608401,34,212,sensory perception,BP,CEMIP;ESPN;EPAS1;NLGN2;REEP6;F2R;GNAL;BBS2;ITPR3;DNM1;HEXB;SERPINE2;NTSR1;ASIC1;LAMB2;RABGGTA;SPRY2;REEP2;HSF4;MAPK3;TUB;OLFM2;SCNN1A;BBS1;COMT;PTAFR;SPATA7;SLITRK6;FGFR1;SERPINB6;GUCA1B;OR7D2;EPS8L2;HOMER2
11115,GO:0045178,0.0017939742146992,0.999560713172519,10,36,basal part of cell,CC,CLCA2;MST1R;EGFR;ANK3;ERBB2;PKD2;ITGA6;LDLRAP1;OSCP1;ERBB3
13580,GO:0060078,0.00180523494158611,0.999481328218701,12,48,regulation of postsynaptic membrane potential,BP,SHANK2;NLGN2;ZMYND8;NTSR1;WNT7A;DLG4;SHANK3;S1PR2;DVL1;SSH1;PRKCZ;AKT1
5673,GO:0016798,0.00182095805636601,0.999330016292889,17,82,hydrolase activity, acting on glycosyl bonds,MF,CEMIP;GAA;NAGLU;HYAL1;FUCA1;EDEM1;HEXB;GM2A;DNPH1;GLB1;MPG;MAN1B1;MAN2B2;MACROD1;NAGA;HEXDC;NEIL1
17531,GO:1901135,0.00183294019126186,0.998716011480069,112,909,carbohydrate derivative metabolic process,BP,TNIP1;H6PD;LMF1;CEMIP;APOE;NT5E;CST3;RAPGEF3;PGM1;PGLS;NOS1;NME4;GAMT;ST6GALNAC2;TIMP2;B3GAT3;CRYL1;FBXO2;ACOT7;PYGL;NAGLU;ABCA7;HYAL1;OGDHL;PKD2;FUCA1;EDEM1;PTHLH;HEXB;GALNT12;LTB4R2;ADAMTS7;GM2A;INSR;AKR7A2;MVD;B4GAT1;NDUFS8;SRD5A3;DLG4;TALDO1;FAM20C;UCKL1;PFKFB2;VEGFA;VANGL2;GLB1;DHTKD1;GALK1;ADCY6;ST3GAL3;MLXIPL;NADK;TK2;ADA;PFKL;NUDT10;DGUOK;HBEGF;MYH3;XYLT2;PIGZ;PHLDA1;HK1;CHST6;PPARA;TKFC;GUK1;RFNG;SDHA;MUC19;ADAMTS13;GPC1;MAN1B1;GTPBP1;DLG3;ESYT2;TSTA3;MAN2B2;GUCA1B;MACROD1;GAL3ST4;PIGV;SDC1;APOBEC3C;PIGQ;VEGFB;AHCYL2;ADORA2B;HGSNAT;AKT1;ACP6;GPD1L;NAGA;UQCR11;PINK1;ABHD14B;POMT1;NDUFV3;APOBEC3F;MOCS1;TAZ;JAK3;NEIL1;FUK;GALNS;PPCS;PODXL2;ADAMTSL4;NDST2;ALG12;SULF2
13581,GO:0060079,0.00183445637966517,0.999508715402955,11,42,excitatory postsynaptic potential,BP,SHANK2;NLGN2;ZMYND8;WNT7A;DLG4;SHANK3;S1PR2;DVL1;SSH1;PRKCZ;AKT1
16780,GO:0098655,0.00189606722699964,0.998845701789683,58,415,cation transmembrane transport,BP,CEMIP;SHANK2;NOS1;SCN8A;EPHB2;KCNG1;NLGN2;FHL1;F2R;GJC2;KCNC4;ANK3;KCNJ15;SLC2A9;PKD2;SCN4B;ITPR3;VAMP2;NTSR1;MINK1;ATP2B4;SLC20A1;ASIC1;PRNP;ATP7B;SLC12A7;DLG4;ATP12A;SHANK3;KCNAB2;PCSK9;PRKACA;SCNN1A;SLC25A37;TRPV4;GAS6;TMEM175;KCNMA1;GLRX;TMCO3;NDUFA4L2;SMDT1;SLC9A7;STK39;TPCN1;SLC25A29;GPD1L;PINK1;PKD1;EHD3;SNTA1;RHBG;KCNN4;ORAI3;ORAI2;GSTM2;SHISA6;PQLC2
17052,GO:0099601,0.00189795376736047,0.999628202925691,8,25,regulation of neurotransmitter receptor activity,BP,SHANK2;EPHB2;NLGN2;MINK1;DLG4;SHANK3;PINK1;SHISA6
15676,GO:0072243,0.00192097407143397,0.999743957391169,6,15,metanephric nephron epithelium development,BP,PKD2;LAMB2;WWTR1;HES1;WNT7B;PKD1
12651,GO:0050885,0.0019235382620117,0.999622354148874,8,25,neuromuscular process controlling balance,BP,GAA;NLGN2;HEXB;GM2A;DLG4;BCR;TPP1;ABR
11185,GO:0045334,0.00192394172540936,0.999521976427361,10,37,clathrin-coated endocytic vesicle,CC,CEMIP;APOE;EGFR;CD9;AP2A2;HBEGF;LDLR;LDLRAP1;CLTCL1;EPN2
16836,GO:0098794,0.00192448392182157,0.998950695558332,40,257,postsynapse,CC,PTPRS;SHANK2;NOS1;NR1D1;EPHB2;NLGN2;FBXO2;F2R;ZMYND8;ANK3;TENM2;DNM1;SIGMAR1;NTSR1;MINK1;PRR7;SYNGAP1;PRNP;DLG4;BNIP3;SHANK3;KCNAB2;DVL1;DMTN;ABHD17C;EEF2K;SEMA4C;COMT;BCR;DLG3;KCNMA1;EPB41L3;COL13A1;AKT1;HOMER2;RGS14;DDN;APBA1;SHISA6;SEMA4F
17221,GO:0120025,0.00195029877086077,0.998564602626481,152,1264,plasma membrane bounded cell projection,CC,FOS;ADGRL1;APOE;ESPN;PTPRS;SYTL1;CST3;SHANK2;RAPGEF3;GSN;NOS1;PARVB;TCTN1;NR1D1;SCN8A;EPHB2;LRP1;TIMP2;REEP6;FBXO2;ULK1;CRTC1;ARPIN;ARHGEF4;PTK6;ABCA7;BBS2;ACTA2;S100A4;DNAH1;CORO1B;GJC2;IGSF9;ZMYND8;KCNC4;ANK3;S100A6;DOCK4;MARK4;TENM2;MICALL2;PKD2;CPT1C;DNM1;SPRY4;IFT140;KIF13B;SIGMAR1;VAMP2;NPHP4;NTSR1;MINK1;ATP2B4;TMOD2;GLUL;PRR7;INSR;EPHA1;ITGA6;SYNGAP1;LPAR3;PRNP;SPRY2;CEP250;SNX9;DLG4;RAB25;TMEM107;PLEKHH2;BNIP3;SHANK3;MAPK3;PLEKHG5;TUB;KCNAB2;AMN;DVL1;WIPF1;ADCY6;EPHB3;FHOD1;SSH1;FBF1;MEFV;EVC;ADA;HTR7;PRKACA;CYFIP2;SCNN1A;PI4K2A;DMTN;BBS1;PSD4;MAPK8IP1;ROBO3;ABHD17C;TRPV4;CROCC;EEF2K;LDLRAP1;HK1;LLGL1;ANKS6;BLVRB;COMT;SUFU;PLEKHG6;WDR60;PRKCZ;SPATA7;TWF2;ARAP3;CDHR1;CTSZ;PIN1;C21ORF2;DLG3;BIN1;UNC119B;CAPN2;WRAP73;SNPH;TMEM231;GUCA1B;ADGRE2;CYBRD1;RTN4R;EPB41L3;EPS8L1;AHCYL2;AKT1;ZNF385A;NDRG2;EPS8L2;PINK1;GAS8;PKD1;EHD3;HOMER2;RGS14;MAFIP;RILPL1;NRSN1;ATXN10;DDN;APBA1;ORAI2;SHISA6;MORN4;TTLL11;RGS12
16589,GO:0097458,0.00195032011529653,0.998621228085909,117,938,neuron part,CC,FOS;ADGRL1;APOE;ESPN;PTPRS;SYTL1;CST3;SHANK2;NOS1;NR1D1;SCN8A;EPHB2;LRP1;TIMP2;NLGN2;REEP6;FBXO2;ULK1;CRTC1;SYT8;BBS2;S100A4;GJC2;IGSF9;ZMYND8;KCNC4;ANK3;DOCK4;DBNDD1;MARK4;TENM2;BRSK1;MICALL2;CPT1C;ITPR3;DNM1;RIMS3;IFT140;KIF13B;SIGMAR1;VAMP2;NPHP4;NTSR1;MINK1;ATP2B4;TMOD2;GLUL;PRR7;WNT7A;INSR;RAB3D;EPHA1;SYNGAP1;LPAR3;PRNP;DLG4;BNIP3;SHANK3;ENDOG;KCNAB2;RAB40B;DVL1;EPHB3;SSH1;ADA;MCTP1;HTR7;CYFIP2;RAB3B;PI4K2A;DMTN;MAPK8IP1;LDLR;ROBO3;ABHD17C;TRPV4;CROCC;EEF2K;LDLRAP1;SEMA4C;LLGL1;BLVRB;COMT;BCR;PRKCZ;SPATA7;TWF2;CDHR1;CTSZ;PIN1;C21ORF2;DLG3;BIN1;SLC25A27;CAPN2;SNPH;GUCA1B;RTN4R;EPB41L3;AHCYL2;ZNF385A;NDRG2;EPS8L2;PINK1;HOMER2;RGS14;NRSN1;ATXN10;PYCARD;KCNN4;DDN;APBA1;ORAI2;SHISA6;MORN4;RGS12;RAB40C
18045,GO:1902652,0.00195397045757315,0.999205302041283,20,104,secondary alcohol metabolic process,BP,LMF1;APOE;CYP27B1;ABCG1;LRP5;MVD;SEC14L2;OSBPL5;PCSK9;PMVK;LDLR;SNX17;LDLRAP1;TM7SF2;DGKQ;RXRA;FGFR1;LCAT;SORL1;TRERF1
7322,GO:0031344,0.00195555440666972,0.998792535700353,61,436,regulation of cell projection organization,BP,APOE;ESPN;PTPRS;SEMA4B;FAM110C;SHANK2;EVI5L;ARAP1;EPHB2;CNTN1;NFATC4;LRP1;OBSL1;CRTC1;ARPIN;PTK6;CORO1B;ULK2;ZMYND8;TENM2;PLXNB3;IFT140;KIF13B;FUZ;WNT7A;FBXW8;ID1;SYNGAP1;LPAR3;PRNP;EFNB3;SPRY2;DLG4;PLXNB1;VEGFA;SHANK3;DVL1;ADCY6;EPHB3;SSH1;CUL7;CDC42EP5;DGUOK;DMTN;SEMA3B;TRPV4;CROCC;EEF2K;SEMA3F;SEMA4C;TWF2;FGFR1;CTSZ;WRAP73;RTN4R;EPS8L1;WNT3;AKT1;EPS8L2;SSH3;SEMA4F
7806,GO:0032371,0.00196792521740657,0.999608666161302,8,26,regulation of sterol transport,BP,APOE;LRP1;ABCA7;ABCG1;PLTP;ABCA2;PCSK9;LDLRAP1
7809,GO:0032374,0.00196792521740657,0.999608666161302,8,26,regulation of cholesterol transport,BP,APOE;LRP1;ABCA7;ABCG1;PLTP;ABCA2;PCSK9;LDLRAP1
16839,GO:0098797,0.00197140834045885,0.99889754746631,43,284,plasma membrane protein complex,CC,SHANK2;NOS1;SCN8A;LRP1;KCNG1;EGFR;SHC1;GNAL;ABCA7;GJC2;KCNC4;LRP5;SCN4B;CPT1C;ITGB4;VAMP2;GM2A;INSR;ITGA6;DLG4;ATP12A;FZD8;AP2A2;SHANK3;KCNAB2;OLFM2;EVC;ABCA2;IL6R;ITGB5;LDLRAP1;NEO1;SDHA;ABCD4;C5;DLG3;KCNMA1;TOLLIP;COL13A1;ACVR1B;SNTA1;KCNN4;SHISA6
5071,GO:0015318,0.00198222852593334,0.998802161753465,56,396,inorganic molecular entity transmembrane transporter activity,MF,CLCA2;SCN8A;KCNG1;SLC43A1;SLC16A5;SLC16A3;KCNC4;ABCG1;KCNJ15;ANO8;SLC2A9;SLC13A3;BSG;PKD2;SCN4B;SLC7A8;ITPR3;ATP2B4;SLC6A8;SLC20A1;ASIC1;SERINC2;ATP7B;SLC12A7;DLG4;TTYH3;ATP12A;LRRC8A;TMEM63C;KCNAB2;SLC22A18;SLC16A13;AQP3;SLC28A2;SLC38A10;SCNN1A;SLC25A37;SLC37A2;TRPV4;GAS6;TMEM175;DLG3;KCNMA1;TMCO3;NDUFA4L2;SLC9A7;ANO9;TPCN1;SLC25A29;SLC5A5;PKD1;SLC22A17;KCNN4;ORAI3;ORAI2;PQLC2
12598,GO:0050808,0.0020073326076205,0.999012491899097,30,178,synapse organization,BP,ADGRL1;APOE;SHANK2;EPHB2;NFATC4;NLGN2;ADGRF1;SDK2;F2R;IGSF9;ZMYND8;ANK3;ERBB2;LAMB2;WNT7A;INSR;PRNP;DLG4;SHANK3;ETV5;DVL1;EPHB3;SSH1;EEF2K;ADGRB2;WNT7B;SLITRK6;PIN1;PCDHGC3;SHISA6
10485,GO:0043406,0.00203417122798466,0.998972197712615,32,195,positive regulation of MAP kinase activity,BP,DUSP6;IGF2;MST1R;EGFR;DUSP5;PKN1;SHC1;F2R;SHC2;ERBB2;MINK1;INSR;LPAR3;CD81;FZD8;VEGFA;VANGL2;S1PR2;MAPK3;MAP2K2;DUSP7;WNT7B;MAPKAPK3;FGFR1;C5;MADD;STK39;ADORA2B;ERCC6;MAP2K3;ERN1;MIF
8646,GO:0034220,0.00204526620229951,0.998662979879063,77,582,ion transmembrane transport,BP,CEMIP;SHANK2;CLCA2;NOS1;SCN8A;EPHB2;CPT2;KCNG1;NLGN2;SLC43A1;FHL1;F2R;SLC16A3;GJC2;KCNC4;ANK3;S100A6;KCNJ15;ANO8;SLC2A9;SLC13A3;PKD2;SCN4B;SLC7A8;ITPR3;PRAF2;VAMP2;NTSR1;MINK1;ATP2B4;SLC6A8;SLC20A1;ASIC1;PRNP;ATP7B;SLC12A7;DLG4;TTYH3;ATP12A;LRRC8A;TMEM63C;SHANK3;KCNAB2;PCSK9;PRKACA;SLC38A10;SCNN1A;SLC25A37;SLC37A2;TRPV4;GAS6;PTAFR;TMEM175;DLG3;KCNMA1;GLRX;TMCO3;NDUFA4L2;SMDT1;SLC9A7;STK39;ANO9;TPCN1;SLC25A29;AKT1;GPD1L;PINK1;PKD1;EHD3;SNTA1;RHBG;KCNN4;ORAI3;ORAI2;GSTM2;SHISA6;PQLC2
3382,GO:0007167,0.00205470012706132,0.99861268927028,90,693,enzyme linked receptor protein signaling pathway,BP,HTRA1;FOS;DUSP6;LTBP4;XDH;PGF;LTBP1;ARAP1;GRB7;EFS;EPHB2;IGF2;MST1R;LRP1;MAPK13;LTBP2;EGFR;EGR1;RHBDF1;SHC1;PTK6;SHC2;PLAT;PIK3R2;ERBB2;PTPRU;DNM1;SPRY4;CDKN1C;PTPRE;FUZ;PDCD4;INSR;ID1;EPHA1;EFNB3;SPRY2;WWTR1;FAM20C;IGFBP2;MVB12B;SRMS;VEGFA;AP2A2;RHBDF2;ACVR2B;MAPK3;EPHB3;HES1;GIGYF1;FURIN;NRP2;PAG1;SH2D2A;BTBD11;FGFR3;CYFIP2;RPS6KA5;HBEGF;ITGB5;FGFR4;DGKQ;MVB12A;GAS6;GIT1;VAV3;VASN;BCR;NEO1;IGFBP4;PRKCZ;PDK2;GPC1;MAPKAPK3;FGFR1;PIN1;TMEM204;GRB10;GUCA1B;FGFBP1;VEGFB;ACVR1B;ERBB3;AKT1;RGS14;CBLC;EPN2;JAK3;EREG;SULF2
4628,GO:0010760,0.00207814006850578,0.999954620435308,3,4,negative regulation of macrophage chemotaxis,BP,MMP28;C5;MIF
19261,GO:1905522,0.00207814006850578,0.999954620435308,3,4,negative regulation of macrophage migration,BP,MMP28;C5;MIF
16758,GO:0098609,0.00208563575416716,0.998708197706495,61,438,cell-cell adhesion,BP,TNIP1;ADGRL1;NT5E;CADM4;ZFP36L1;IGF2;EGFR;NLGN2;SDK2;SHC1;IGSF9;ANK3;ZP3;TENM2;ERBB2;PTPRU;PLXNB3;CD9;SERPINE2;NPHP4;MINK1;ARVCF;ZMIZ1;CELSR1;ITGA6;IL20RB;PRNP;EFNB3;CERCAM;BCL6;IGFBP2;CEBPB;EPHB3;HES1;TNFRSF14;ADA;PAG1;CELSR2;CYFIP2;ITGB5;DMTN;TRPV4;RAG1;GAS6;PPARA;WNT7B;PTAFR;PRKCZ;ICOSLG;CDHR1;PCDHGC3;ASS1;TSTA3;COL13A1;AKT1;VPS33B;PKD1;PYCARD;JAK3;PODXL2;KIF26B
11830,GO:0046834,0.00210539876645002,0.99924302745302,16,75,lipid phosphorylation,BP,EGFR;DGKA;PIK3R2;ERBB2;ZFYVE21;FGFR3;HBEGF;PI4K2A;FGFR4;DGKQ;TTC7B;IMPA2;FGFR1;PI4KAP2;ERBB3;EREG
1256,GO:0003012,0.00213154374877857,0.998882276875617,35,222,muscle system process,BP,GAA;LTB4R;GSN;NOS1;GAMT;OBSL1;F2R;BBS2;ACTA2;DOCK4;SCN4B;ATP2B4;TMOD2;SLC6A8;TNNT1;ADA;HTR7;PRKACA;ITGB5;MYH3;PTAFR;PIN1;KCNMA1;PPP1R13L;JARID2;VEGFB;ADORA2B;GPD1L;EHD3;SNTA1;CAMTA2;MAP2K3;TAZ;GSTM2;SULF2
10567,GO:0043549,0.00220882569348877,0.998524997161419,84,642,regulation of kinase activity,BP,DUSP6;CEMIP;APOE;EPHB2;IGF2;MST1R;EGFR;DUSP5;EGR1;PKN1;SHC1;F2R;PTK6;SHC2;PIK3R2;LRP5;ERBB2;PKD2;SPRY4;CDKN1C;PAK6;MINK1;ATP2B4;PDCD4;INSR;EPHA1;ADARB1;LPAR3;PRNP;SPRY2;SNX9;DLG4;STRADB;WWTR1;PFKFB2;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;MAPK3;DVL1;ADCY6;EPHB3;FGFR3;PRKACA;MAP2K2;FGFR4;MAPK8IP1;DUSP7;DGKQ;GAS6;WNT7B;VAV3;PRKCZ;MAPKAPK3;FGFR1;CAMKK1;C5;PROX1;DLG3;SESN2;MAPRE3;MADD;RTN4R;PPM1F;SORL1;STK39;ADORA2B;ERBB3;AKT1;ERCC6;PINK1;PKD1;RGS14;MLST8;CBLC;PYCARD;MAP2K3;ERN1;EREG;MIF
8905,GO:0034764,0.00221184744897002,0.999089724932223,20,105,positive regulation of transmembrane transport,BP,CEMIP;NOS1;EPHB2;F2R;GJC2;ANK3;PIK3R2;PKD2;NTSR1;INSR;SHANK3;PTAFR;PRKCZ;CLTCL1;GLRX;STK39;AKT1;PINK1;EHD3;GSTM2
12256,GO:0048588,0.00221877781041617,0.998982155913466,25,141,developmental cell growth,BP,APOE;PTPRS;SEMA4B;POSTN;ULK1;ULK2;PLXNB3;LAMB2;LPAR3;PLXNB1;VEGFA;DVL1;NRP2;SLIT3;CYFIP2;SEMA3B;SEMA3F;SEMA4C;PRKCZ;TWF2;PIN1;RTN4R;WNT3;RARG;SEMA4F
2645,GO:0005996,0.00222567282054897,0.998868034415934,32,197,monosaccharide metabolic process,BP,H6PD;GAA;PGM1;NR1D1;IGF2;CRYL1;GALE;NISCH;LRP5;FUCA1;PHLDA2;INSR;FGGY;TALDO1;PFKFB2;GLB1;GALK1;PC;SLC2A3;PFKL;DGKQ;HK1;PPARA;TKFC;PCK2;IGFBP4;MDH2;PDK2;MAN2B2;AKT1;SLC2A1;MLYCD
9269,GO:0035725,0.00224833964930468,0.999185068011229,16,76,sodium ion transmembrane transport,BP,NOS1;SCN8A;ANK3;PKD2;SCN4B;ATP2B4;SLC20A1;ASIC1;ATP12A;PCSK9;SCNN1A;GLRX;SLC9A7;STK39;GPD1L;SNTA1
14697,GO:0070374,0.00225309542819575,0.999047655892185,21,112,positive regulation of ERK1 and ERK2 cascade,BP,EPHB2;MST1R;EGFR;SHC1;F2R;ABCA7;ERBB2;INSR;EPHA1;SPRY2;MAPK3;EPHB3;FGFR3;FGFR4;TRPV4;GAS6;PRKCZ;FGFR1;ERBB3;PYCARD;MIF
16148,GO:0090196,0.00227344312416578,0.999860698440209,4,7,regulation of chemokine secretion,BP,POSTN;ALOX15B;C5;PYCARD
12743,GO:0051044,0.00229881585776535,0.999763866568287,5,11,positive regulation of membrane protein ectodomain proteolysis,BP,APOE;SNX33;SNX9;FURIN;SH3D19
12196,GO:0048468,0.00232807407991299,0.998272975030103,155,1293,cell development,BP,APOE;IDH2;PTPRS;ERCC1;FLNC;SEMA4B;CST3;SHANK2;RAPGEF3;GSN;NDRG1;NOS1;PARVB;TCTN1;POSTN;GRB7;FAM210B;EPHB2;EPAS1;OBSCN;CNTN1;NFATC4;LRP1;OBSL1;EGFR;TIMP2;ADGRF1;ULK1;CRTC1;NAGLU;SHC1;PTK6;DEAF1;LAMA5;BBS2;ACTA2;DNAH1;ULK2;GJC2;IGSF9;ZMYND8;ANK3;S100A6;ZP3;LRP5;DBNDD1;TENM2;ZFPM1;ERBB2;FBLN1;BRSK1;MICALL2;PLXNB3;PTHLH;IFT140;CD9;KIF13B;HEXB;SERPINE2;NPHP4;UNK;MINK1;TMOD2;CSNK1E;PDCD4;LAMB2;WNT7A;FBXW8;ID1;B4GAT1;EPHA1;ADARB1;SYNGAP1;NBEAL2;LPAR3;EFNB3;DLG4;RAB25;FAM20C;BCL6;PLXNB1;VEGFA;VANGL2;SHANK3;HSF4;S1PR2;MAPK3;ETV5;TNNT1;DVL1;ADCY6;EPHB3;HES1;SSH1;CUL7;NRP2;CELSR2;SLIT3;PRKACA;LRRK1;DGUOK;CYFIP2;RPS6KA5;SPTB;MXRA8;DMTN;MYH3;HDAC11;TNFRSF1A;SEMA3B;LDLR;ROBO3;TRPV4;EEF2K;SEMA3F;AHNAK2;SEMA4C;LLGL1;WNT7B;DMC1;NEO1;USP21;PRKCZ;NYAP1;SLITRK6;TWF2;GPC1;CDHR1;FGFR1;CTSZ;PIN1;PROX1;BIN1;GRB10;BFSP1;RTN4R;EPB41L3;SDC1;WNT3;SORL1;AKT1;ZNF385A;VPS33B;SIX5;SSH3;RGS14;RILPL1;ATXN10;RFX2;RANBP9;RARG;EREG;ADAMTSL4;SEMA4F;SULF2
7040,GO:0030826,0.00233106211633216,0.999856141190119,4,7,regulation of cGMP biosynthetic process,BP,APOE;NOS1;GUCA1B;ADORA2B
3562,GO:0007613,0.00233501574007009,0.99922055016479,14,63,memory,BP,APOE;ADGRF1;CRTC1;ABCA7;ITPR3;ASIC1;INSR;PRNP;CEBPB;SHANK3;LDLR;COMT;PRKCZ;RGS14
7753,GO:0032281,0.00235570010325185,0.999756606996099,5,11,AMPA glutamate receptor complex,CC,CPT1C;DLG4;OLFM2;DLG3;SHISA6
3384,GO:0007169,0.00235976660003297,0.998490958619969,68,501,transmembrane receptor protein tyrosine kinase signaling pathway,BP,DUSP6;XDH;PGF;ARAP1;GRB7;EFS;EPHB2;IGF2;MST1R;LRP1;MAPK13;EGFR;RHBDF1;SHC1;PTK6;SHC2;PLAT;PIK3R2;ERBB2;DNM1;SPRY4;PTPRE;FUZ;INSR;EPHA1;EFNB3;SPRY2;FAM20C;IGFBP2;MVB12B;SRMS;VEGFA;AP2A2;RHBDF2;MAPK3;EPHB3;GIGYF1;NRP2;PAG1;SH2D2A;FGFR3;CYFIP2;RPS6KA5;HBEGF;FGFR4;DGKQ;MVB12A;GIT1;VAV3;BCR;IGFBP4;PRKCZ;PDK2;GPC1;MAPKAPK3;FGFR1;TMEM204;GRB10;FGFBP1;VEGFB;ERBB3;AKT1;RGS14;CBLC;EPN2;JAK3;EREG;SULF2
4354,GO:0009967,0.0023656995523643,0.998292288376132,128,1053,positive regulation of signal transduction,BP,DUSP6;FAM110C;SHANK2;CYP27B1;GSN;XDH;NOS1;ARAP1;SH3BP2;GRB7;ALOX15B;RBCK1;EPHB2;IGF2;NFATC4;MST1R;EGFR;TIMP2;NLGN2;DUSP5;PKN1;SHC1;RGL2;F2R;PTK6;ABCA7;S100A4;SHC2;CXXC5;PIK3R2;MAML3;ERBB2;PKD2;CDKN1C;NTSR1;MINK1;TMOD2;TFDP2;CSNK1E;PDCD4;SLC20A1;TNFRSF25;WNT7A;ZMIZ1;INSR;EPHA1;LPAR3;SPRY2;ECM1;DLG4;PLXNB1;BNIP3;CD81;FZD8;VEGFA;VANGL2;SHANK3;ACVR2B;S1PR2;MAPK3;PLEKHG5;DVL1;EPHB3;HES1;SSH1;EVC;ADA;PIDD1;PAG1;SH2D2A;IL6R;FGFR3;LRRK1;CYFIP2;HBEGF;MAP2K2;FGFR4;DMTN;TNFRSF1A;MAPK8IP1;TRPV4;DUSP7;LDLRAP1;SEMA4C;MIB2;GAS6;WNT7B;RFNG;VAV3;NEO1;IGFBP4;PRKCZ;MAPKAPK3;FGFR1;PIN1;C5;WBP2;GRB10;WNT2B;MADD;RTN4R;SH2B3;FGFBP1;WNT3;STK39;ACVR1B;ADORA2B;ERBB3;AKT1;ZNF385A;TP53INP1;ERCC6;PINK1;CTSH;MLST8;EPN2;PYCARD;MAP2K3;KCNN4;ERN1;LITAF;EREG;FAM162A;GSTM2;GIPR;TMED4;MIF;SULF2
15717,GO:0072329,0.00236661527576387,0.999045600522339,19,99,monocarboxylic acid catabolic process,BP,TYSND1;CRAT;CPT2;HADH;CRYL1;CPT1C;ABCD1;ACAD10;PEX7;PPARA;AIG1;PCK2;ETFB;PHYH;SESN2;AKT1;LONP2;ACADS;MLYCD
8718,GO:0034382,0.00238880468593726,0.999945123062029,3,4,chylomicron remnant clearance,BP,LMF1;APOE;LDLR
15455,GO:0071830,0.00238880468593726,0.999945123062029,3,4,triglyceride-rich lipoprotein particle clearance,BP,LMF1;APOE;LDLR
6583,GO:0022610,0.00239670358074215,0.998336591063632,101,797,biological adhesion,BP,TNIP1;ADGRL1;PTPRS;NT5E;GSN;CLCA2;CADM4;PARVB;ZFP36L1;COL6A1;CGREF1;POSTN;EFS;CNTN1;IGF2;EGFR;SMOC2;NLGN2;SDK2;SHC1;LAMA5;IGSF9;THBS3;ANK3;ZP3;HYAL1;TENM2;BCAM;ERBB2;FBLN1;MICALL2;PTPRU;ITGB4;PLXNB3;CD9;SERPINE2;NPHP4;MINK1;RHOD;ARVCF;TNXB;LAMB2;ZMIZ1;ID1;CELSR1;EPHA1;ITGA6;IL20RB;PRNP;EFNB3;CERCAM;BCL6;PLXNB1;IGFBP2;CD81;VEGFA;ARL2;CEBPB;ADAM15;PDZD2;EPHB3;HES1;NRP2;TNFRSF14;ADA;PAG1;CELSR2;CYFIP2;ITGB5;DMTN;TRPV4;RAG1;MSLN;GAS6;PPARA;WNT7B;PTAFR;VAV3;NEO1;PRKCZ;ADAMTS13;ICOSLG;CDHR1;PCDHGC3;TMEM8B;ASS1;TSTA3;ADGRE2;LMLN;PPM1F;COL13A1;ERBB3;AKT1;VPS33B;PKD1;PYCARD;NINJ1;JAK3;APBA1;PODXL2;KIF26B
12404,GO:0048875,0.00242294505747403,0.999848805158151,4,7,chemical homeostasis within a tissue,BP,EPAS1;VEGFA;HOMER2;CTSH
18997,GO:1904861,0.00250536591368411,0.999842154206187,4,7,excitatory synapse assembly,BP,SHANK2;NLGN2;WNT7A;SHANK3
7853,GO:0032426,0.00250904667585875,0.99984185565902,4,7,stereocilium tip,CC,ESPN;EPS8L2;HOMER2;MORN4
16396,GO:0097061,0.00252812604123578,0.999238183107706,12,50,dendritic spine organization,BP,APOE;SHANK2;EPHB2;ZMYND8;WNT7A;INSR;PRNP;DLG4;SHANK3;DVL1;EPHB3;EEF2K
6579,GO:0022603,0.00254189353824817,0.998265684201973,91,710,regulation of anatomical structure morphogenesis,BP,DUSP6;APOE;PTPRS;SEMA4B;CST3;RAPGEF3;XDH;PGF;PARVB;ARAP1;POSTN;EPHB2;NFATC4;OBSL1;PKN1;ARPIN;CORO1B;ULK2;HDAC5;HYAL1;ERBB2;FBLN1;PLXNB3;VAT1;KIF13B;HEXB;FUZ;CSNK1E;RHOD;WNT7A;FBXW8;ID1;CELSR1;EPHA1;SYNGAP1;LPAR3;EFNB3;SPRY2;ECM1;DLG4;BCL6;PLXNB1;BNIP3;VEGFA;VANGL2;AP2A2;SHANK3;ETV5;DVL1;WIPF1;EPHB3;HES1;SSH1;CUL7;ADA;CDC42EP5;CELSR2;RHOF;ZMYM3;DMTN;SEMA3B;RHOBTB2;EEF2K;HMGA2;SEMA3F;SEMA4C;ADGRB2;RXRA;BCR;TWF2;AGO4;ARAP3;FGFR1;C5;PROX1;C21ORF2;SH3D19;WNT2B;RTN4R;EPB41L3;WNT3;VEGFB;ABR;SSH3;PINK1;SYNE3;CTSH;EPN2;ARHGEF19;SEMA4F;SULF2
16416,GO:0097106,0.00254359596409463,0.999839047059812,4,7,postsynaptic density organization,BP,SHANK2;NLGN2;ZMYND8;SHANK3
16972,GO:0099084,0.00254359596409463,0.999839047059812,4,7,postsynaptic specialization organization,BP,SHANK2;NLGN2;ZMYND8;SHANK3
7600,GO:0031998,0.00256149403932592,0.999729985810464,5,11,regulation of fatty acid beta-oxidation,BP,TYSND1;PPARA;AKT1;LONP2;MLYCD
6589,GO:0022617,0.00256846339729049,0.999176014878942,13,57,extracellular matrix disassembly,BP,HTRA1;CST3;LRP1;TIMP2;MMP1;BSG;SH3PXD2B;ADAM15;CAPNS2;FURIN;FGFR4;CAPN2;TIMP1
772,GO:0002028,0.00257563968466475,0.999173436879497,13,57,regulation of sodium ion transport,BP,NOS1;CNTN1;PRSS8;ANK3;SCN4B;SERPINE2;ATP2B4;PCSK9;GLRX;STK39;AKT1;GPD1L;SNTA1
7808,GO:0032373,0.0025760348907456,0.999626563230349,6,16,positive regulation of sterol transport,BP,APOE;LRP1;ABCA7;ABCG1;PLTP;LDLRAP1
7811,GO:0032376,0.0025760348907456,0.999626563230349,6,16,positive regulation of cholesterol transport,BP,APOE;LRP1;ABCA7;ABCG1;PLTP;LDLRAP1
6124,GO:0019395,0.00262660517211448,0.999030056607782,16,78,fatty acid oxidation,BP,TYSND1;CRAT;CPT2;HADH;CPT1C;ABCD1;ACAD10;PEX7;PPARA;ETFB;PHYH;SESN2;AKT1;LONP2;ACADS;MLYCD
12659,GO:0050900,0.00264386287248665,0.998607832108089,34,217,leukocyte migration,BP,PGF;GRB7;MMP28;SHC1;SLC16A3;MMP1;PIK3R2;ZP3;BSG;SLC7A8;ITGA6;ECM1;VEGFA;MAPK3;ADA;IL6R;TRPV4;GAS6;PTAFR;VAV3;BCR;INPP5D;GPC1;C5;PROCR;ADGRE2;SDC1;LYST;VEGFB;ABR;PYCARD;CKLF;PODXL2;MIF
7232,GO:0031175,0.00266412465028224,0.998207547700189,84,644,neuron projection development,BP,APOE;PTPRS;SEMA4B;SHANK2;TCTN1;POSTN;GRB7;EPHB2;CNTN1;NFATC4;LRP1;OBSL1;EGFR;ADGRF1;ULK1;CRTC1;SHC1;PTK6;ULK2;IGSF9;ZMYND8;ANK3;S100A6;DBNDD1;ERBB2;BRSK1;MICALL2;PLXNB3;KIF13B;MINK1;LAMB2;WNT7A;FBXW8;ID1;B4GAT1;ADARB1;SYNGAP1;LPAR3;EFNB3;DLG4;PLXNB1;VEGFA;VANGL2;SHANK3;MAPK3;DVL1;ADCY6;EPHB3;HES1;SSH1;CUL7;NRP2;CELSR2;SLIT3;DGUOK;CYFIP2;RPS6KA5;SPTB;SEMA3B;ROBO3;TRPV4;EEF2K;SEMA3F;SEMA4C;LLGL1;WNT7B;NEO1;USP21;PRKCZ;NYAP1;SLITRK6;TWF2;GPC1;FGFR1;CTSZ;GRB10;RTN4R;EPB41L3;WNT3;AKT1;SSH3;ATXN10;RANBP9;SEMA4F
3737,GO:0008283,0.00268005454119937,0.998001590887506,156,1321,cell proliferation,BP,HTRA1;APOE;CTNNBIP1;MARCKSL1;TSPAN1;IDH2;ERCC1;CST3;RAPGEF3;TCFL5;CYP27B1;XDH;NDRG1;PGF;MEF2D;ZFP36L1;CGREF1;NR1D1;ALOX15B;IGF2;MST1R;LRP1;APPL2;EGFR;TIMP2;FBXO2;MXD4;EGR1;RHBDF1;PKN1;SHC1;F2R;PTK6;DEAF1;LAMA5;GJC2;ASH2L;MXI1;S100A6;ZP3;RPS6KA2;LRP5;HYAL1;ERBB2;FBLN1;PTPRU;PKD2;PLXNB3;PHLDA2;PTHLH;CDKN1C;VIPR1;CD9;SERPINE2;FUZ;CD320;PLCD1;PDCD4;TNFRSF25;GLUL;WNT7A;ZMIZ1;INSR;TBC1D8;FBXW8;ID1;MVD;EPHA1;ADARB1;IL20RB;DNPH1;PRNP;SPRY2;MNT;ECM1;STAT6;SPEG;MTA3;PLCD3;WWTR1;ISG20;RAB25;BCL6;PLXNB1;IGFBP2;CD81;SRMS;VEGFA;FBXW4;CEBPB;HSF4;NAB2;S1PR2;TNFRSF6B;ETV5;HES1;FURIN;MLXIPL;NRP2;TNFRSF14;ADA;SH2D2A;IL6R;SLIT3;ZFP36;HLCS;FGFR3;HBEGF;FGFR4;TNFRSF1A;HMGA2;GAS6;BTRC;WNT7B;COMT;PTAFR;LTBP3;RXRA;VAV3;IGFBP4;PRKCZ;INPP5D;ICOSLG;NDE1;FGFR1;CTSZ;PROX1;DLG3;BIN1;SLC25A27;JARID2;WNT2B;TIMP1;FGFBP1;WNT3;VEGFB;ERBB3;AKT1;TP53INP1;NDRG2;SIX5;GAS8;CTSH;RNF187;PYCARD;ERN1;CKLF;JAK3;RARG;ING4;EREG;TP53I11;TRNP1;MIF;SULF2;LZTS2
3444,GO:0007264,0.0027201234019627,0.998280608350997,63,457,small GTPase mediated signal transduction,BP,APOE;RAPGEF3;ARAP1;EPHB2;OBSCN;APPL2;RALGDS;TIMP2;RAPGEFL1;ARHGEF4;SHC1;RGL2;F2R;SHC2;PIK3R2;ARHGAP23;DOCK4;NISCH;IQSEC2;SPRY4;PAK6;RALGAPA2;RASA4;AGAP1;DOCK6;ACAP3;RHOD;PLEKHG4;RAB3D;CELSR1;SYNGAP1;SPRY2;RAB25;BCL6;VANGL2;PLEKHG5;RAB40B;SAMD3;ARHGAP22;PLEKHG2;CDC42EP5;RHOF;RAB3B;RAPGEF5;PSD4;RHOBTB2;GIT1;PLEKHG6;ARHGEF37;VAV3;BCR;RFXANK;MAPKAPK3;ARAP3;ASAP2;MADD;RTN4R;EPS8L1;ABR;EPS8L2;ARHGEF10L;ARHGEF19;RAB40C
1959,GO:0004672,0.00272077088499529,0.998267540647068,65,472,protein kinase activity,MF,LTBP4;LTBP1;EPHB2;OBSCN;MST1R;MAPK13;CDK18;EGFR;ULK1;PKN1;PTK6;ULK2;NEK9;RPS6KA2;MARK4;ERBB2;BRSK1;PAK6;MINK1;CSNK1E;INSR;GRK6;EPHA1;EFNB3;SPEG;MKNK2;STRADB;FAM20C;DYRK1B;SRMS;MAST4;ACVR2B;MAPK3;PKN3;EPHB3;NRP2;FGFR3;PRKACA;LRRK1;RPS6KA5;HBEGF;MAP2K2;FGFR4;EEF2K;HMGA2;STK32C;BCR;PRKCZ;PDK2;MAPKAPK3;FGFR1;CAMKK1;ADCK5;STK39;ACVR1B;ERBB3;AKT1;ADCK2;PINK1;MAP2K3;STK17A;ERN1;JAK3;MAST3;EREG
8000,GO:0032642,0.00279207142270529,0.999201253340872,11,45,regulation of chemokine production,BP,POSTN;ALOX15B;EGR1;ZFPM1;MEFV;IL6R;TRPV4;C5;ADORA2B;PYCARD;MIF
8908,GO:0034767,0.00285413627527281,0.99897706300047,15,72,positive regulation of ion transmembrane transport,BP,CEMIP;NOS1;EPHB2;F2R;GJC2;ANK3;PKD2;NTSR1;SHANK3;PTAFR;GLRX;STK39;PINK1;EHD3;GSTM2
9776,GO:0040013,0.00293592898683256,0.998460169062911,33,208,negative regulation of locomotion,BP,APOE;IDH2;SEMA4B;ALOX15B;LRP1;MMP28;ARPIN;CORO1B;ZMYND8;HDAC5;NISCH;FBLN1;PTPRU;PLXNB3;FUZ;EPHA1;ADARB1;ADAM15;ADA;MCTP1;SEMA3B;SEMA3F;SEMA4C;BCR;ARAP3;PIN1;C5;TIMP1;WNT3;ABR;TP53INP1;SEMA4F;MIF
16363,GO:0097006,0.00296526034911208,0.999083719736113,12,52,regulation of plasma lipoprotein particle levels,BP,LMF1;APOE;ABCA7;ABCG1;PLTP;AP2A2;AMN;PCSK9;PRKACA;LDLR;LDLRAP1;LCAT
2291,GO:0005261,0.00299437661315965,0.998732520582201,20,106,cation channel activity,MF,SCN8A;KCNG1;KCNC4;KCNJ15;PKD2;SCN4B;ITPR3;ASIC1;TMEM63C;KCNAB2;SCNN1A;TRPV4;GAS6;TMEM175;KCNMA1;TPCN1;PKD1;KCNN4;ORAI3;ORAI2
8044,GO:0032722,0.00299532872588765,0.999273631762513,9,33,positive regulation of chemokine production,BP,POSTN;ALOX15B;EGR1;IL6R;TRPV4;C5;ADORA2B;PYCARD;MIF
8750,GO:0034440,0.00300296121341956,0.998874091676803,16,79,lipid oxidation,BP,TYSND1;CRAT;CPT2;HADH;CPT1C;ABCD1;ACAD10;PEX7;PPARA;ETFB;PHYH;SESN2;AKT1;LONP2;ACADS;MLYCD
3381,GO:0007166,0.00301317703360202,0.997662804502053,211,1855,cell surface receptor signaling pathway,BP,HTRA1;FOS;DUSP6;ADGRL1;APOE;CTNNBIP1;TSPAN1;SEMA4B;SHANK2;LTBP4;XDH;PGF;LTBP1;ARAP1;TCTN1;POSTN;GRB7;EFS;ARRDC1;RBCK1;EPHB2;CNTN1;IGF2;NFATC4;MST1R;LRP1;MAPK13;LTBP2;EGFR;NLGN2;MDFI;ADGRF1;EGR1;RHBDF1;SHC1;PTK6;ABCA7;LAMA5;BBS2;SHC2;ZMYND8;PLAT;MMP1;PIK3R2;LRP5;MAML3;ERBB2;BSG;PTPRU;ITGB4;PLXNB3;DNM1;SPRY4;CDKN1C;IFT140;VIPR1;CD9;PTPRE;SERPINE2;FUZ;NPHP4;NTSR1;MINK1;CSNK1E;PDCD4;TNFRSF25;DTX3;WNT7A;ZMIZ1;INSR;ID1;CELSR1;GRK6;EPHA1;ITGA6;IL20RB;PRNP;EFNB3;SPRY2;ECM1;STAT6;DLG4;MKNK2;STRADB;TALDO1;WWTR1;ISG20;FAM20C;BCL6;PLXNB1;IGFBP2;MVB12B;CD81;SRMS;FCGRT;FZD8;VEGFA;VANGL2;FBXW4;AP2A2;RHBDF2;SHANK3;ACVR2B;ADAM15;CALCOCO1;S1PR2;TNFRSF6B;MAPK3;DVL1;WIPF1;EPHB3;HES1;GIGYF1;SSH1;FURIN;EVC;NRP2;TNFRSF14;ADA;PIDD1;PAG1;SH2D2A;CELSR2;IL6R;SLIT3;BTBD11;FGFR3;PRKACA;LRRK1;CYFIP2;RPS6KA5;HBEGF;ITGB5;FGFR4;TSPAN33;DMTN;TNFRSF1A;SEMA3B;ROBO3;IFNGR2;SEMA3F;DGKQ;SEMA4C;MVB12A;MIB2;GAS6;BTRC;LLGL1;ADGRB2;TSPAN4;WNT7B;GIT1;SUFU;PTAFR;RFNG;VAV3;VASN;BCR;NEO1;IGFBP4;MUC19;PRKCZ;ADAMTS13;INPP5D;PDK2;GPC1;ICOSLG;MAPKAPK3;AGO4;FGFR1;PIN1;C5;TMEM204;GRB10;TOLLIP;WNT2B;TMEM231;GUCA1B;ADGRE2;MADD;RTN4R;TIMP1;SDC1;FGFBP1;PEAR1;WNT3;VEGFB;ACVR1B;ADORA2B;ERBB3;AKT1;NDRG2;SPPL2B;IL17RD;PINK1;HOMER2;RGS14;CBLC;EPN2;PYCARD;KCNN4;ARHGEF19;JAK3;RARG;EREG;SHISA6;GIPR;SEMA4F;MIF;SULF2;LZTS2
5135,GO:0015672,0.00301485172463562,0.998335800820747,38,254,monovalent inorganic cation transport,BP,NOS1;SCN8A;CNTN1;KCNG1;FHL1;PRSS8;KCNC4;ANK3;KCNJ15;SLC2A9;SLC13A3;PKD2;SCN4B;SERPINE2;VAMP2;ATP2B4;SLC6A8;SLC20A1;ASIC1;PRNP;SLC12A7;ATP12A;KCNAB2;PCSK9;SLC38A10;SCNN1A;TMEM175;KCNMA1;GLRX;TMCO3;NDUFA4L2;SLC9A7;STK39;AKT1;GPD1L;SLC5A5;SNTA1;KCNN4
1097,GO:0002686,0.00301813993371462,0.999538922763211,6,17,negative regulation of leukocyte migration,BP,MMP28;ADA;BCR;C5;ABR;MIF
5989,GO:0019005,0.00302893907803842,0.999061510361748,12,52,SCF ubiquitin ligase complex,CC,BTBD2;FBXO2;ABTB1;FBXW8;FBXO27;FBXW4;BTBD11;FBXW5;FBXO17;BTRC;SPSB3;FBXL20
3370,GO:0007155,0.00304610973301994,0.997870946459629,100,794,cell adhesion,BP,TNIP1;ADGRL1;PTPRS;NT5E;GSN;CLCA2;CADM4;PARVB;ZFP36L1;COL6A1;CGREF1;POSTN;EFS;CNTN1;IGF2;EGFR;SMOC2;NLGN2;SDK2;SHC1;LAMA5;IGSF9;THBS3;ANK3;ZP3;HYAL1;TENM2;BCAM;ERBB2;FBLN1;MICALL2;PTPRU;ITGB4;PLXNB3;CD9;SERPINE2;NPHP4;MINK1;RHOD;ARVCF;TNXB;LAMB2;ZMIZ1;ID1;CELSR1;EPHA1;ITGA6;IL20RB;PRNP;EFNB3;CERCAM;BCL6;PLXNB1;IGFBP2;VEGFA;ARL2;CEBPB;ADAM15;PDZD2;EPHB3;HES1;NRP2;TNFRSF14;ADA;PAG1;CELSR2;CYFIP2;ITGB5;DMTN;TRPV4;RAG1;MSLN;GAS6;PPARA;WNT7B;PTAFR;VAV3;NEO1;PRKCZ;ADAMTS13;ICOSLG;CDHR1;PCDHGC3;TMEM8B;ASS1;TSTA3;ADGRE2;LMLN;PPM1F;COL13A1;ERBB3;AKT1;VPS33B;PKD1;PYCARD;NINJ1;JAK3;APBA1;PODXL2;KIF26B
3181,GO:0006812,0.00308429795074057,0.99795948343711,75,575,cation transport,BP,CEMIP;SHANK2;CYP27B1;NOS1;SCN8A;EPHB2;CNTN1;KCNG1;NLGN2;FHL1;F2R;PRSS8;GJC2;KCNC4;ANK3;KCNJ15;SLC2A9;SLC13A3;PKD2;SCN4B;SLC7A8;ITPR3;SERPINE2;VAMP2;NTSR1;MINK1;ATP2B4;SLC6A8;SLC20A1;ASIC1;LPAR3;PRNP;SERINC2;ATP7B;SLC12A7;DLG4;ATP12A;TMEM63C;SHANK3;KCNAB2;SLC22A18;ADA;PCSK9;PRKACA;SLC38A10;SCNN1A;SLC25A37;RAB3B;TRPV4;GAS6;TMEM175;KCNMA1;GLRX;TMCO3;NDUFA4L2;SMDT1;SLC9A7;STK39;TPCN1;SLC25A29;AKT1;GPD1L;SLC5A5;PINK1;PKD1;EHD3;SNTA1;HOMER2;RHBG;KCNN4;ORAI3;ORAI2;GSTM2;SHISA6;PQLC2
10895,GO:0044463,0.0031127352629961,0.997783350936484,111,896,cell projection part,CC,ADGRL1;APOE;ESPN;SYTL1;SHANK2;NOS1;TCTN1;NR1D1;SCN8A;EPHB2;LRP1;TIMP2;FBXO2;CRTC1;ARHGEF4;ABCA7;BBS2;DNAH1;GJC2;IGSF9;ZMYND8;KCNC4;ANK3;MARK4;TENM2;PKD2;CPT1C;DNM1;SPRY4;IFT140;KIF13B;SIGMAR1;VAMP2;NPHP4;NTSR1;MINK1;ATP2B4;TMOD2;GLUL;PRR7;INSR;SYNGAP1;PRNP;SPRY2;DLG4;RAB25;TMEM107;BNIP3;SHANK3;KCNAB2;AMN;DVL1;EPHB3;SSH1;FBF1;EVC;ADA;HTR7;PRKACA;SCNN1A;PI4K2A;DMTN;BBS1;PSD4;MAPK8IP1;ABHD17C;TRPV4;CROCC;EEF2K;HK1;BLVRB;COMT;SUFU;WDR60;PRKCZ;SPATA7;TWF2;CDHR1;CTSZ;C21ORF2;DLG3;BIN1;UNC119B;CAPN2;WRAP73;TMEM231;GUCA1B;ADGRE2;CYBRD1;RTN4R;EPB41L3;EPS8L1;AKT1;ZNF385A;NDRG2;EPS8L2;PINK1;GAS8;PKD1;EHD3;HOMER2;RGS14;RILPL1;NRSN1;ATXN10;DDN;APBA1;ORAI2;SHISA6;MORN4;RGS12
17228,GO:0120038,0.0031127352629961,0.997783350936484,111,896,plasma membrane bounded cell projection part,CC,ADGRL1;APOE;ESPN;SYTL1;SHANK2;NOS1;TCTN1;NR1D1;SCN8A;EPHB2;LRP1;TIMP2;FBXO2;CRTC1;ARHGEF4;ABCA7;BBS2;DNAH1;GJC2;IGSF9;ZMYND8;KCNC4;ANK3;MARK4;TENM2;PKD2;CPT1C;DNM1;SPRY4;IFT140;KIF13B;SIGMAR1;VAMP2;NPHP4;NTSR1;MINK1;ATP2B4;TMOD2;GLUL;PRR7;INSR;SYNGAP1;PRNP;SPRY2;DLG4;RAB25;TMEM107;BNIP3;SHANK3;KCNAB2;AMN;DVL1;EPHB3;SSH1;FBF1;EVC;ADA;HTR7;PRKACA;SCNN1A;PI4K2A;DMTN;BBS1;PSD4;MAPK8IP1;ABHD17C;TRPV4;CROCC;EEF2K;HK1;BLVRB;COMT;SUFU;WDR60;PRKCZ;SPATA7;TWF2;CDHR1;CTSZ;C21ORF2;DLG3;BIN1;UNC119B;CAPN2;WRAP73;TMEM231;GUCA1B;ADGRE2;CYBRD1;RTN4R;EPB41L3;EPS8L1;AKT1;ZNF385A;NDRG2;EPS8L2;PINK1;GAS8;PKD1;EHD3;HOMER2;RGS14;RILPL1;NRSN1;ATXN10;DDN;APBA1;ORAI2;SHISA6;MORN4;RGS12
18832,GO:1904491,0.00319073846832901,0.999918495477256,3,4,protein localization to ciliary transition zone,BP,TCTN1;TMEM107;SPATA7
6913,GO:0030517,0.00329431756697143,0.999280045601848,8,27,negative regulation of axon extension,BP,PTPRS;SEMA4B;SEMA3B;SEMA3F;SEMA4C;RTN4R;WNT3;SEMA4F
18775,GO:1904352,0.00333667307785681,0.999913350637482,3,4,positive regulation of protein catabolic process in the vacuole,BP,LRP1;CD81;LDLR
17209,GO:0110053,0.00334306929785488,0.998291073351048,30,186,regulation of actin filament organization,BP,RAPGEF3;GSN;ARAP1;ARPIN;CORO1B;TMOD2;SH3PXD2B;ID1;EPHA1;PLEKHH2;SHANK3;WIPF1;FHOD1;SSH1;PLEKHG2;CDC42EP5;SPTB;DMTN;CAPG;TWF2;WHAMMP3;EPS8L1;PPM1F;EPS8L2;SSH3;ARHGEF10L;SPIRE2;MLST8;PYCARD;FCHSD1
3275,GO:0006970,0.00336616711803589,0.998942873958491,12,52,response to osmotic stress,BP,ZFP36L1;MAPK13;EGFR;PKN1;PKD2;LRRC8A;TRPV4;ICOSLG;KCNMA1;SERPINB6;STK39;SLC2A1
5921,GO:0018209,0.00337458593756677,0.998176054035034,35,225,peptidyl-serine modification,BP,RAPGEF3;MAPK13;EGFR;ULK1;PKN1;GALNT12;ATP2B4;CSNK1E;SPRY2;MKNK2;VEGFA;MAST4;MAPK3;PKN3;MLXIPL;PRKACA;RPS6KA5;MAP2K2;DMTN;HMGA2;DGKQ;GAS6;STK32C;PRKCZ;MAPKAPK3;CAMKK1;PPM1F;STK39;AKT1;GPD1L;PINK1;PKD1;ERN1;MAST3;MIF
5805,GO:0017080,0.00338144726481018,0.999357515008623,7,22,sodium channel regulator activity,MF,NOS1;PRSS8;SCN4B;ATP2B4;PCSK9;GPD1L;SNTA1
17226,GO:0120035,0.00339251387104373,0.997866067110022,59,429,regulation of plasma membrane bounded cell projection organization,BP,APOE;ESPN;PTPRS;SEMA4B;SHANK2;EVI5L;ARAP1;EPHB2;CNTN1;NFATC4;LRP1;OBSL1;CRTC1;ARPIN;PTK6;CORO1B;ULK2;ZMYND8;TENM2;PLXNB3;IFT140;KIF13B;FUZ;WNT7A;FBXW8;ID1;SYNGAP1;LPAR3;PRNP;EFNB3;DLG4;PLXNB1;VEGFA;SHANK3;DVL1;ADCY6;EPHB3;SSH1;CUL7;CDC42EP5;DGUOK;DMTN;SEMA3B;TRPV4;CROCC;EEF2K;SEMA3F;SEMA4C;TWF2;FGFR1;CTSZ;WRAP73;RTN4R;EPS8L1;WNT3;AKT1;EPS8L2;SSH3;SEMA4F
2667,GO:0006027,0.00344600827790842,0.999061474425771,10,39,glycosaminoglycan catabolic process,BP,CEMIP;NAGLU;HYAL1;FUCA1;HEXB;GLB1;GPC1;SDC1;HGSNAT;GALNS
16826,GO:0098772,0.00344708785786514,0.997463657792075,134,1125,molecular function regulator,MF,APOE;SEMA4B;CST3;RAPGEF3;EVI5L;PRDX5;PGF;NOS1;ARAP1;OBSCN;IGF2;APPL2;RALGDS;EGFR;TIMP2;B3GAT3;PPP1R14A;SERPING1;RAPGEFL1;CMTM7;ARHGEF4;SHC1;RGL2;PPP2R3B;PRSS8;SHC2;TBC1D14;RIN1;PIK3R2;ARHGAP23;DOCK4;ZP3;ERBB2;FBLN1;SCN4B;IQSEC2;PTHLH;CDKN1C;SERPINE2;CD320;RALGAPA2;ATP2B4;RASA4;TRAPPC9;AGAP1;DOCK6;GM2A;ACAP3;PLEKHG4;WNT7A;SH3PXD2B;TBC1D8;SYNGAP1;PPP1R35;PAPLN;SPRY2;DLG4;ARHGAP27;PLXNB1;VEGFA;ARL2;PLEKHG5;KCNAB2;GPSM1;FURIN;SAMD3;ARHGAP22;PLEKHG2;CDC42EP5;PCSK9;FGFR3;HBEGF;MAP2K2;FGFR4;SPTB;RAPGEF5;PSD4;VGF;MAPK8IP1;SEMA3B;SEMA3F;DGKQ;SEMA4C;GAS6;LLGL1;WNT7B;GIT1;PLEKHG6;ARHGEF37;VAV3;BCR;TBC1D16;PRKCZ;ARAP3;FGFR1;C5;ASAP2;SERPINB6;SESN2;CSTB;GUCA1B;MADD;RTN4R;ELFN2;TIMP1;EPS8L1;WNT3;SBF1;VEGFB;TBC1D17;ALS2CL;ERBB3;ABR;AKT1;ERCC6;GPD1L;EPS8L2;PINK1;SNTA1;ARHGEF10L;RGS14;CTSH;MLST8;PYCARD;PCSK1N;CKLF;RANBP9;ARHGEF19;CMTM4;JAK3;EREG;SEMA4F;RGS12;MIF
7278,GO:0031282,0.0034503189015411,0.999909284457929,3,4,regulation of guanylate cyclase activity,BP,NOS1;GUCA1B;ADORA2B
7279,GO:0031284,0.0034503189015411,0.999909284457929,3,4,positive regulation of guanylate cyclase activity,BP,NOS1;GUCA1B;ADORA2B
8712,GO:0034375,0.0034524251499773,0.999734616555367,4,8,high-density lipoprotein particle remodeling,BP,APOE;ABCG1;PLTP;LCAT
12293,GO:0048666,0.00350574274398652,0.997583074487688,90,704,neuron development,BP,APOE;PTPRS;SEMA4B;SHANK2;TCTN1;POSTN;GRB7;EPHB2;CNTN1;NFATC4;LRP1;OBSL1;EGFR;ADGRF1;ULK1;CRTC1;NAGLU;SHC1;PTK6;ULK2;IGSF9;ZMYND8;ANK3;S100A6;DBNDD1;TENM2;ERBB2;BRSK1;MICALL2;PLXNB3;IFT140;KIF13B;NPHP4;UNK;MINK1;LAMB2;WNT7A;FBXW8;ID1;B4GAT1;ADARB1;SYNGAP1;LPAR3;EFNB3;DLG4;PLXNB1;VEGFA;VANGL2;SHANK3;MAPK3;DVL1;ADCY6;EPHB3;HES1;SSH1;CUL7;NRP2;CELSR2;SLIT3;DGUOK;CYFIP2;RPS6KA5;SPTB;SEMA3B;ROBO3;TRPV4;EEF2K;SEMA3F;SEMA4C;LLGL1;WNT7B;NEO1;USP21;PRKCZ;NYAP1;SLITRK6;TWF2;GPC1;CDHR1;FGFR1;CTSZ;GRB10;RTN4R;EPB41L3;WNT3;AKT1;SSH3;ATXN10;RANBP9;SEMA4F
12255,GO:0048585,0.00351746459175614,0.997415901823909,132,1102,negative regulation of response to stimulus,BP,TNIP1;HTRA1;DUSP6;APOE;CTNNBIP1;PTPRS;ERCC1;WWC3;SEMA4B;NT5E;XDH;LTBP1;NR1D1;ARRDC1;EPHB2;NFATC4;MST1R;LRP1;EGFR;TIMP2;MMP28;DUSP5;SERPING1;MDFI;EGR1;PTK6;BBS2;CORO1B;PLAT;PIK3R2;ERBB2;FBLN1;PKD2;DNM1;SPRY4;DDIT4L;CD9;PTPRE;SERPINE2;FUZ;NPHP4;ATP2B4;ACP5;RASA4;PDCD4;INSR;EPHA1;ITGA6;SYNGAP1;IL20RB;PRNP;SPRY2;MNT;ECM1;STAT6;STRADB;WWTR1;BCL6;IGFBP2;SRMS;S1PR2;CARD19;DVL1;EPHB3;MEFV;ADA;MCTP1;SLIT3;MAPKBP1;FGFR3;F12;MAGEF1;HBEGF;FGFR4;TNFRSF1A;MAPK8IP1;SEMA3B;DUSP7;TNFAIP8L1;HMGA2;SEMA3F;SEMA4C;FAM3A;GAS6;BTRC;PPARA;TKFC;SUFU;VASN;BCR;IGFBP4;PRKCZ;INPP5D;GPC1;ARAP3;FGFR1;PIN1;C5;GRB10;SESN2;TMEM161A;RTN4R;PEAR1;WNT3;SORL1;STK39;ERBB3;ABR;AKT1;TRAP1;NLRX1;ZNF385A;NDRG2;GPD1L;PINK1;RGS14;CBLC;EPN2;PYCARD;RANBP9;SIRT3;C12ORF66;JAK3;EREG;GSTM2;SHISA6;GIPR;SEMA4F;RGS12;MIF;SULF2;LZTS2
11841,GO:0046854,0.00353289371143652,0.998759253718482,14,65,phosphatidylinositol phosphorylation,BP,EGFR;PIK3R2;ERBB2;ZFYVE21;FGFR3;HBEGF;PI4K2A;FGFR4;TTC7B;IMPA2;FGFR1;PI4KAP2;ERBB3;EREG
4703,GO:0010875,0.00354228409159555,0.999579247395286,5,12,positive regulation of cholesterol efflux,BP,APOE;LRP1;ABCA7;ABCG1;PLTP
18541,GO:1903795,0.00354541709467559,0.999905842552879,3,4,regulation of inorganic anion transmembrane transport,BP,PRNP;PTAFR;ANO9
9699,GO:0038132,0.00354546822607988,0.999905840692738,3,4,neuregulin binding,MF,ITGB4;ITGA6;ERBB3
1459,GO:0003708,0.00354546822608142,0.999905840692738,3,4,retinoic acid receptor activity,MF,RXRA;RXRB;RARG
10437,GO:0043313,0.00354546822608146,0.999905840692738,3,4,regulation of neutrophil degranulation,BP,PTAFR;BCR;ABR
16417,GO:0097107,0.00354546822608146,0.999905840692738,3,4,postsynaptic density assembly,BP,SHANK2;NLGN2;SHANK3
16792,GO:0098698,0.00354546822608146,0.999905840692738,3,4,postsynaptic specialization assembly,BP,SHANK2;NLGN2;SHANK3
18013,GO:1902563,0.00354546822608146,0.999905840692738,3,4,regulation of neutrophil activation,BP,PTAFR;BCR;ABR
13486,GO:0055085,0.00355804996996839,0.997468966348173,107,872,transmembrane transport,BP,CEMIP;SHANK2;CLCA2;NOS1;SCN8A;SLCO4A1;EPHB2;CPT2;KCNG1;NLGN2;SLC43A1;FHL1;F2R;ABCA7;SLC16A5;SLC16A3;GJC2;KCNC4;ABCG1;ANK3;PIK3R2;S100A6;KCNJ15;ANO8;SLC2A9;SLC13A3;PKD2;TST;SCN4B;SLC7A8;ITPR3;PRAF2;VAMP2;NTSR1;MINK1;ATP2B4;SLC6A8;SLC20A1;PEX10;ASIC1;INSR;PRNP;ATP7B;SLC12A7;DLG4;ABCD1;TTYH3;ATP12A;LRRC8A;TMEM63C;SHANK3;KCNAB2;SLC22A18;SLC16A13;SLC2A3;ABCA2;AQP3;PCSK9;SLC28A2;PRKACA;SLC38A10;SCNN1A;SLC25A37;SLC37A2;DMTN;TRPV4;PEX7;SLC29A4;GAS6;PTAFR;BCR;TMEM175;PRKCZ;CLTCL1;ABCD4;DLG3;GPR155;KCNMA1;GLRX;SLC25A27;TMCO3;GRB10;SESN2;NDUFA4L2;SMDT1;SLC9A7;RTN2;STK39;ANO9;TPCN1;SLC25A29;AKT1;GPD1L;SLC5A5;PINK1;PKD1;EHD3;SLC22A17;SNTA1;RHBG;KCNN4;ORAI3;SLC2A1;ORAI2;GSTM2;SHISA6;PQLC2
17171,GO:0106027,0.00359855923425003,0.998860169697085,12,52,neuron projection organization,BP,APOE;SHANK2;EPHB2;ZMYND8;WNT7A;INSR;PRNP;DLG4;SHANK3;DVL1;EPHB3;EEF2K
15795,GO:0072524,0.00363957580085258,0.998320976050736,23,132,pyridine-containing compound metabolic process,BP,H6PD;IDH2;NT5E;NAPRT;PGM1;PGLS;NMRK1;OGDHL;INSR;TALDO1;PFKFB2;KCNAB2;DHTKD1;GALK1;MLXIPL;NADK;PFKL;HK1;PPARA;PCK2;MDH2;GPD1L;PNPO
11883,GO:0046934,0.00369035356889343,0.999075468202121,9,33,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,EGFR;PIK3R2;ERBB2;FGFR3;HBEGF;FGFR4;FGFR1;ERBB3;EREG
2515,GO:0005775,0.00372705196582304,0.998311055051214,22,125,vacuolar lumen,CC,GAA;NAPRT;PYGB;NAGLU;CTSB;HYAL1;CTSF;FUCA1;VAT1;HEXB;GM2A;RNASET2;DPP7;GLB1;TPP1;GPC1;TOLLIP;MAN2B2;SDC1;CTSD;PYCARD;GALNS
12121,GO:0048246,0.00377321125424603,0.999385945543792,6,18,macrophage chemotaxis,BP,MMP28;MAPK3;TRPV4;C5;CKLF;MIF
10248,GO:0043005,0.00382369404926484,0.997328529406105,95,754,neuron projection,CC,FOS;ADGRL1;APOE;ESPN;PTPRS;CST3;SHANK2;NOS1;NR1D1;SCN8A;EPHB2;LRP1;TIMP2;REEP6;FBXO2;ULK1;CRTC1;BBS2;S100A4;GJC2;IGSF9;ZMYND8;KCNC4;ANK3;DOCK4;MARK4;TENM2;MICALL2;CPT1C;DNM1;IFT140;KIF13B;SIGMAR1;VAMP2;NPHP4;NTSR1;MINK1;ATP2B4;TMOD2;GLUL;PRR7;INSR;EPHA1;SYNGAP1;LPAR3;PRNP;DLG4;BNIP3;SHANK3;KCNAB2;DVL1;EPHB3;SSH1;ADA;HTR7;CYFIP2;PI4K2A;MAPK8IP1;ROBO3;ABHD17C;TRPV4;EEF2K;LDLRAP1;LLGL1;BLVRB;COMT;PRKCZ;SPATA7;TWF2;CDHR1;CTSZ;PIN1;C21ORF2;DLG3;BIN1;CAPN2;SNPH;GUCA1B;RTN4R;EPB41L3;AHCYL2;ZNF385A;NDRG2;EPS8L2;PINK1;HOMER2;RGS14;NRSN1;ATXN10;DDN;APBA1;ORAI2;SHISA6;MORN4;RGS12
13487,GO:0055086,0.0038568644337548,0.997458965584187,70,547,nucleobase-containing small molecule metabolic process,BP,H6PD;APOE;IDH2;NT5E;NAPRT;RAPGEF3;PGM1;XDH;PGLS;NOS1;NME4;GAMT;TIMP2;ACOT7;NMRK1;OGDHL;PKD2;PTHLH;LTB4R2;INSR;NDUFS8;DNPH1;DLG4;TALDO1;FAM20C;UCKL1;PFKFB2;VEGFA;ENTPD6;KCNAB2;DHTKD1;ENTPD2;GALK1;LHPP;ADCY6;MLXIPL;NADK;TK2;ADA;PFKL;NUDT10;DGUOK;MYH3;HK1;PPARA;GUK1;PCK2;SDHA;MDH2;GTPBP1;DLG3;GLRX;TSTA3;GUCA1B;MACROD1;APOBEC3C;AHCYL2;ADORA2B;GPD1L;UQCR11;PINK1;ABHD14B;NDUFV3;APOBEC3F;MOCS1;TAZ;NEIL1;FUK;PPCS;PODXL2
7803,GO:0032368,0.00390067954507271,0.998746050426037,12,54,regulation of lipid transport,BP,APOE;LRP1;ABCA7;ABCG1;PLTP;NTSR1;ABCA2;PCSK9;LDLRAP1;PPARA;AKT1;MIF
3785,GO:0008361,0.0039302039324795,0.998211645324938,22,124,regulation of cell size,BP,APOE;PTPRS;SEMA4B;ULK2;LPAR3;SLC12A7;VEGFA;LRRC8A;SHANK3;SEMA3B;TRPV4;SEMA3F;SEMA4C;VAV3;TWF2;KCNMA1;RTN4R;WNT3;AKT1;KCNN4;RARG;SEMA4F
15655,GO:0072207,0.00404468263744958,0.999342900636994,6,17,metanephric epithelium development,BP,PKD2;LAMB2;WWTR1;HES1;WNT7B;PKD1
6121,GO:0019388,0.00415590225013746,0.999662905253956,4,8,galactose catabolic process,BP,PGM1;GALE;GLB1;GALK1
12773,GO:0051093,0.00415780540518408,0.997228604273966,73,562,negative regulation of developmental process,BP,APOE;IDH2;PTPRS;WWC3;SEMA4B;CST3;RAPGEF3;XDH;ZFP36L1;POSTN;EPHB2;NFATC4;LRP1;EGFR;ARPIN;BBS2;ULK2;ABCG1;HDAC5;LRP5;ZFPM1;ERBB2;FBLN1;VAT1;PTHLH;FUZ;ADAMTS7;PDCD4;WNT7A;ID1;SYNGAP1;EFNB3;SPRY2;ECM1;WWTR1;BCL6;BNIP3;ADCY6;HES1;ZFP36;FGFR3;DGUOK;DMTN;SEMA3B;LDLR;TRPV4;HMGA2;SEMA3F;SEMA4C;GAS6;ADGRB2;PPARA;SUFU;VASN;BCR;INPP5D;CTSZ;CHADL;JARID2;RTN4R;TIMP1;WNT3;SORL1;ABR;CCDC85B;TP53INP1;PINK1;EPN2;JAK3;RARG;EREG;SEMA4F;MIF
12250,GO:0048568,0.00417375643522975,0.997611480229576,40,269,embryonic organ development,BP,ERCC1;ZFP36L1;EPHB2;EPAS1;IGF2;EGFR;MDFI;NAGLU;HYAL1;ZFPM1;TFEB;PKD2;PHLDA2;IFT140;FUZ;PLCD1;FBXW8;CELSR1;SPRY2;PLCD3;VEGFA;VANGL2;CEBPB;MAPK3;DVL1;HES1;ADA;WNT7B;SUFU;BCR;WDR60;SLITRK6;FGFR1;PROX1;PPP1R13L;SH2B3;ABR;AKT1;PKD1;RARG
6659,GO:0030029,0.00419721954844809,0.997243722120901,68,512,actin filament-based process,BP,ESPN;RAPGEF3;GSN;PARVB;ARAP1;EFS;OBSCN;LRP1;OBSL1;ARPIN;SHC1;CORO1B;NISCH;MICALL2;SCN4B;IQSEC2;MSRB2;PAK6;NPHP4;MINK1;TMOD2;RHOD;TNXB;SH3PXD2B;ID1;CELSR1;EPHA1;MYO18A;PLEKHH2;BCL6;VANGL2;SHANK3;S1PR2;TNNT1;WIPF1;FHOD1;SSH1;PLEKHG2;CDC42EP5;RHOF;ITGB5;SPTB;DMTN;MYH3;TRPV4;RHOBTB2;LLGL1;BCR;PRKCZ;CAPG;TWF2;PROX1;PI4KAP2;EPB41L3;WHAMMP3;EPS8L1;PPM1F;ABR;GPD1L;EPS8L2;SSH3;SNTA1;ARHGEF10L;SPIRE2;MLST8;PYCARD;ARHGEF19;FCHSD1
8217,GO:0032994,0.00423071531386069,0.999294672404597,6,18,protein-lipid complex,CC,APOE;PLTP;LDLR;BIN1;LCAT;SORL1
12941,GO:0051349,0.00423646195465465,0.999654445473053,4,8,positive regulation of lyase activity,BP,NOS1;TIMP2;GUCA1B;ADORA2B
487,GO:0001540,0.0042938469903052,0.998783606796695,10,41,amyloid-beta binding,MF,APOE;CST3;EPHB2;FBXO2;INSR;PRNP;LDLR;LDLRAP1;SORL1;APBA1
7039,GO:0030825,0.00431987555313908,0.999645634814718,4,8,positive regulation of cGMP metabolic process,BP,APOE;NOS1;GUCA1B;ADORA2B
6768,GO:0030215,0.00432191048658473,0.999287923696374,6,17,semaphorin receptor binding,MF,SEMA4B;PLXNB1;SEMA3B;SEMA3F;SEMA4C;SEMA4F
7591,GO:0031983,0.0043232983805816,0.997642387310242,34,228,vesicle lumen,CC,APOE;NAPRT;PYGB;GSN;IGF2;EGFR;TIMP2;SERPING1;PYGL;FUCA1;VAT1;HEXB;GM2A;RNASET2;ECM1;VEGFA;DNASE1L1;DPP7;GLB1;ADA;PFKL;GAS6;PCSK1;CTSZ;TOLLIP;CSTB;TIMP1;ACTR1B;VEGFB;CTSD;CTSH;PYCARD;GALNS;MIF
413,GO:0001101,0.00432996400204763,0.997641231385909,34,222,response to acid chemical,BP,GSN;COL6A1;NFATC4;EGFR;MTHFR;EGR1;PTK6;PKD2;LRP11;CD9;ATP2B4;DNMT3A;IGFBP2;VEGFA;CEBPB;ADCY6;AQP3;HLCS;LDLR;HMGCL;WNT7B;PTAFR;RXRA;TWF2;CAPN2;SESN2;TMEM161A;WNT3;GSS;AKT1;PINK1;CTSH;RARG;GIPR
6843,GO:0030324,0.00436316071016463,0.998082610832727,20,110,lung development,BP,EPAS1;EGFR;LAMA5;THRA;ID1;CELSR1;SPRY2;VEGFA;VANGL2;ACVR2B;MAPK3;HES1;ADA;WNT7B;FGFR1;CTSZ;PROX1;WNT2B;PKD1;CTSH
14034,GO:0060840,0.00439660531471193,0.998567621864784,12,53,artery development,BP,APOE;LTBP1;LRP1;LOXL1;PKD2;ZMIZ1;VEGFA;ACVR2B;HES1;SNX17;SUFU;PROX1
1872,GO:0004553,0.0045727889391146,0.998417459946653,13,60,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,CEMIP;GAA;NAGLU;HYAL1;FUCA1;EDEM1;HEXB;GM2A;GLB1;MAN1B1;MAN2B2;NAGA;HEXDC
14489,GO:0065009,0.00458942026534372,0.996344707368583,248,2236,regulation of molecular function,BP,FOS;DUSP6;LMF1;CEMIP;APOE;CTNNBIP1;CST3;SHANK2;RAPGEF3;CYP27B1;GSN;EVI5L;XDH;PRDX5;PGF;NOS1;ARAP1;RBCK1;EPHB2;OBSCN;IGF2;NFATC4;MST1R;LRP1;KCNG1;RALGDS;EGFR;TIMP2;B3GAT3;NLGN2;DUSP5;PPP1R14A;FHL1;SERPING1;MDFI;RAPGEFL1;ADGRF1;EGR1;PKN1;CMTM7;CRTC1;ARHGEF4;SHC1;RGL2;F2R;PTK6;GNAL;PPP2R3B;PRSS8;CTSB;SHC2;TBC1D14;GRAMD4;MXI1;RIN1;ANK3;PIK3R2;HDAC5;THRA;ARHGAP23;DOCK4;ZP3;LRP5;ZFPM1;ERBB2;FBLN1;PKD2;SCN4B;IQSEC2;PLXNB3;PHLDA2;SPRY4;PTHLH;CDKN1C;PAK6;SERPINE2;VAMP2;LTB4R2;NTSR1;CD320;MINK1;RALGAPA2;ATP2B4;CSNK1E;RASA4;TRAPPC9;AGAP1;PDCD4;DOCK6;GM2A;ACAP3;PLEKHG4;WNT7A;INSR;SH3PXD2B;TBC1D8;ID1;EPHA1;ADARB1;ITGA6;SYNGAP1;PPP1R35;LPAR3;TMEM173;PRNP;SERINC2;PAPLN;SPRY2;ECM1;SNX9;DLG4;STRADB;WWTR1;ARHGAP27;BCL6;PFKFB2;PLXNB1;CD81;FZD8;VEGFA;ARL2;VANGL2;SHANK3;ACVR2B;ADAM15;NAB2;S1PR2;TNFRSF6B;MAPK3;PLEKHG5;KCNAB2;DVL1;GPSM1;ADCY6;EPHB3;HES1;FURIN;MEFV;ARHGAP22;PLEKHG2;CDC42EP5;PIDD1;PCSK9;ZFP36;FGFR3;PRKACA;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;SPTB;RAPGEF5;PSD4;VGF;MAPK8IP1;BHLHE40;RAG1;DUSP7;HMGA2;LDLRAP1;DGKQ;GAS6;BTRC;LLGL1;PPARA;WNT7B;GIT1;SUFU;PTAFR;PLEKHG6;RFNG;ARHGEF37;VAV3;BCR;TBC1D16;PRKCZ;MAPKAPK3;NDE1;ARAP3;FGFR1;CTSZ;CAMKK1;PIN1;C5;PROX1;ASAP2;DLG3;BIN1;SERPINB6;GLRX;SESN2;CSTB;MAPRE3;GUCA1B;MADD;RTN4R;ELFN2;TIMP1;EPS8L1;WNT3;PPM1F;SBF1;SORL1;STK39;VEGFB;TBC1D17;ANO9;ALS2CL;ADORA2B;ERBB3;ABR;ZER1;AKT1;NLRX1;ERCC6;GPD1L;EPS8L2;PINK1;GAS8;PKD1;EHD3;SNTA1;ARHGEF10L;RGS14;PCIF1;CTSH;MLST8;CBLC;PYCARD;MAP2K3;PCSK1N;ERN1;CKLF;RANBP9;ARHGEF19;CMTM4;JAK3;NEIL1;EREG;FAM162A;GSTM2;SHISA6;GIPR;SFI1;RGS12;MIF
12635,GO:0050865,0.00460077092565441,0.997274925742879,44,307,regulation of cell activation,BP,APOE;GSN;ZFP36L1;IGF2;PKN1;ZP3;ERBB2;CD9;SERPINE2;CD320;ZMIZ1;IL20RB;PRNP;EFNB3;STAT6;MYO18A;BCL6;IGFBP2;CD81;CEBPB;HES1;TNFRSF14;ADA;PAG1;DMTN;LDLR;SOX13;RAG1;GAS6;PTAFR;VAV3;BCR;PRKCZ;INPP5D;ICOSLG;ADGRE2;ADORA2B;ABR;AKT1;VPS33B;PYCARD;JAK3;MIF;STXBP2
7014,GO:0030799,0.00462729022086829,0.998674639902119,10,41,regulation of cyclic nucleotide metabolic process,BP,APOE;RAPGEF3;NOS1;TIMP2;PKD2;PTHLH;LTB4R2;VEGFA;GUCA1B;ADORA2B
6281,GO:0019900,0.00464228703909542,0.996865470847004,76,585,kinase binding,MF,TNIP1;WWC3;GRB7;EPHB2;MST1R;EGFR;TOM1L2;PKN1;SHC1;ACTA2;SHC2;TBC1D14;PIK3R2;NEK9;HDAC5;DOCK4;ERBB2;EXOC2;BRSK1;DNM1;KIF13B;ATP2B4;RHOD;INSR;EPHA1;TMEM173;SPRY2;SLC12A7;CEP250;DLG4;PFKFB2;AP2A2;CEBPB;DVL1;ADCY6;EPHB3;PAG1;PFKL;ZFP36;RHOF;FGFR3;PRKACA;PITPNM1;FGFR4;FBXW5;MAPK8IP1;TRPV4;RHOBTB2;DGKQ;GAS6;LLGL1;SUFU;PTAFR;PRKCZ;TWF2;SRSF5;CEP68;MAPKAPK3;RAD23A;FGFR1;PIN1;DLG3;TOLLIP;MAPRE3;PITPNM3;MICALCL;STK39;ERBB3;AKT1;TRAP1;PINK1;PKD1;RGS14;CBLC;MAP2K3;SLC2A1
12593,GO:0050803,0.00465002919975137,0.997994595222694,19,103,regulation of synapse structure or activity,BP,ADGRL1;APOE;EPHB2;NFATC4;NLGN2;IGSF9;ZMYND8;DNM1;WNT7A;SYNGAP1;PRNP;SHANK3;ETV5;EPHB3;SSH1;EEF2K;ADGRB2;SLITRK6;SHISA6
6106,GO:0019362,0.0046872662475118,0.99783050533216,22,127,pyridine nucleotide metabolic process,BP,H6PD;IDH2;NT5E;NAPRT;PGM1;PGLS;NMRK1;OGDHL;INSR;TALDO1;PFKFB2;KCNAB2;DHTKD1;GALK1;MLXIPL;NADK;PFKL;HK1;PPARA;PCK2;MDH2;GPD1L
11682,GO:0046496,0.0046872662475118,0.99783050533216,22,127,nicotinamide nucleotide metabolic process,BP,H6PD;IDH2;NT5E;NAPRT;PGM1;PGLS;NMRK1;OGDHL;INSR;TALDO1;PFKFB2;KCNAB2;DHTKD1;GALK1;MLXIPL;NADK;PFKL;HK1;PPARA;PCK2;MDH2;GPD1L
10096,GO:0042632,0.00475464762721209,0.998748221380812,9,35,cholesterol homeostasis,BP,APOE;MALL;ABCG1;LRP5;ABCA2;PCSK9;LDLR;LDLRAP1;LCAT
13493,GO:0055092,0.00475464762721209,0.998748221380812,9,35,sterol homeostasis,BP,APOE;MALL;ABCG1;LRP5;ABCA2;PCSK9;LDLR;LDLRAP1;LCAT
2963,GO:0006509,0.00478984624226192,0.998737475686468,9,35,membrane protein ectodomain proteolysis,BP,APOE;TIMP2;SNX33;SNX9;FURIN;SH3D19;TIMP1;ADAM19;SPPL2B
12586,GO:0050793,0.0048377148003714,0.99624646341839,188,1649,regulation of developmental process,BP,FOS;DUSP6;ADGRL1;APOE;CTNNBIP1;IDH2;PTPRS;WWC3;SEMA4B;CST3;SHANK2;LTBP4;RAPGEF3;TCFL5;CYP27B1;XDH;PGF;NOS1;PARVB;ARAP1;ZFP36L1;POSTN;NR1D1;ALOX15B;FAM210B;EPHB2;CNTN1;IGF2;NFATC4;LRP1;GAMT;OBSL1;EGFR;TIMP2;NLGN2;EGR1;PKN1;CRTC1;ARPIN;PTK6;DEAF1;LAMA5;BBS2;CORO1B;ULK2;GJC2;ZMYND8;ASH2L;ABCG1;HDAC5;THRA;ZP3;LRP5;HYAL1;ZFPM1;ERBB2;FBLN1;PLXNB3;PHLDA2;VAT1;PTHLH;KIF13B;HEXB;SERPINE2;FUZ;CSNK1E;ADAMTS7;PDCD4;RHOD;WNT7A;ZMIZ1;INSR;SH3PXD2B;FBXW8;ID1;CELSR1;EPHA1;SYNGAP1;LPAR3;EFNB3;SPRY2;ECM1;STAT6;DLG4;WWTR1;FAM20C;BCL6;PLXNB1;FAM213A;BNIP3;VEGFA;YPEL3;VANGL2;AP2A2;CEBPB;SHANK3;ACVR2B;HSF4;NAB2;S1PR2;ETV5;OLFM2;DVL1;WIPF1;ADCY6;L3MBTL1;EPHB3;HES1;SSH1;CUL7;ADA;CDC42EP5;AQP3;CELSR2;IL6R;ZFP36;RHOF;FGFR3;PRKACA;ZMYM3;DGUOK;DMTN;TNFRSF1A;SEMA3B;LDLR;SOX13;TRPV4;RHOBTB2;RAG1;EEF2K;HMGA2;SEMA3F;SEMA4C;GAS6;ADGRB2;PPARA;WNT7B;SUFU;LTBP3;RXRA;VASN;BCR;PRKCZ;INPP5D;SLITRK6;TWF2;GPC1;AGO4;ARAP3;FGFR1;CTSZ;CHADL;PIN1;C5;PROX1;C21ORF2;BIN1;PPP1R13L;SH3D19;JARID2;WNT2B;RTN4R;EPB41L3;TIMP1;WNT3;SORL1;VEGFB;ACVR1B;ERBB3;ABR;CCDC85B;CCDC71L;AKT1;ZNF385A;TP53INP1;SSH3;PINK1;RGS14;SYNE3;CTSH;EPN2;ARHGEF19;JAK3;RARG;EREG;SEMA4F;MIF;SULF2
2693,GO:0006066,0.00484038345367839,0.997316702998841,35,232,alcohol metabolic process,BP,LMF1;APOE;CYP27B1;ISYNA1;ABCG1;LRP5;NTSR1;PLCD1;MVD;SRD5A3;PLCD3;SEC14L2;GALK1;OSBPL5;RETSAT;PCSK9;NUDT10;PLCH2;PMVK;LDLR;SNX17;LDLRAP1;TM7SF2;DGKQ;TKFC;PTAFR;IMPA2;RXRA;PCK2;INPP5D;FGFR1;PNPLA4;LCAT;SORL1;TRERF1
3304,GO:0007015,0.0048862697229639,0.997154068779233,41,281,actin filament organization,BP,ESPN;RAPGEF3;GSN;ARAP1;EFS;OBSL1;ARPIN;CORO1B;MICALL2;MSRB2;TMOD2;RHOD;SH3PXD2B;ID1;EPHA1;PLEKHH2;SHANK3;WIPF1;FHOD1;SSH1;PLEKHG2;CDC42EP5;RHOF;ITGB5;SPTB;DMTN;TRPV4;RHOBTB2;CAPG;TWF2;PROX1;WHAMMP3;EPS8L1;PPM1F;EPS8L2;SSH3;ARHGEF10L;SPIRE2;MLST8;PYCARD;FCHSD1
10238,GO:0042994,0.00489734127658912,0.999157772724509,6,18,cytoplasmic sequestering of transcription factor,BP,MDFI;MXI1;THRA;PKD2;SUFU;PKD1
17006,GO:0099503,0.00492746128136613,0.996653882183939,77,607,secretory vesicle,CC,PTPRS;GAA;SYTL1;NAPRT;PYGB;CST3;PGM1;GSN;PRSS3;IGF2;TIMP2;LOXL1;SERPING1;PYGL;SYT8;CTSB;PLAT;DBNDD1;BRSK1;BSG;FUCA1;ITPR3;VAT1;DNM1;CD9;HEXB;SERPINE2;VAMP2;GM2A;RAB3D;NBEAL2;TMEM173;RNASET2;ECM1;DLG4;VEGFA;DNASE1L1;AP2A2;DPP7;ADAM15;KCNAB2;GLB1;RAB40B;LTA4H;SLC2A3;LY6K;MCTP1;PFKL;RHOF;PRKACA;RAB3B;PI4K2A;SEMA4C;GAS6;PTAFR;PCSK1;CTSZ;SERPINB6;TOLLIP;CSTB;TIMP1;CD68;ACTR1B;VEGFB;HGSNAT;CTSD;VPS33B;SUN1;CTSH;PYCARD;POMT1;PCSK1N;APBA1;GALNS;RAB40C;MIF;STXBP2
14486,GO:0065005,0.0049545237916786,0.999145827160284,6,18,protein-lipid complex assembly,BP,APOE;ABCA7;SNX9;PRKACA;BIN1;LCAT
2633,GO:0005975,0.00496257052958746,0.99680485888431,60,446,carbohydrate metabolic process,BP,H6PD;IDH2;GAA;PYGB;PGM1;PGLS;NR1D1;IGF2;ST6GALNAC2;B3GAT3;CRYL1;ISYNA1;PYGL;GALE;NISCH;LRP5;HYAL1;OGDHL;FUCA1;PHLDA2;HEXB;GALNT12;NTSR1;GM2A;INSR;AKR7A2;FGGY;TALDO1;PFKFB2;GLB1;DHTKD1;GALK1;ST3GAL3;PC;MLXIPL;SLC2A3;PFKL;DGKQ;HK1;CHST6;PPARA;TKFC;PTAFR;IMPA2;PCK2;IGFBP4;MDH2;PDK2;MAN1B1;MAN2B2;GAL3ST4;PIGQ;AKT1;GPD1L;NAGA;HEXDC;POMT1;SLC2A1;MLYCD;FUK
5156,GO:0015711,0.00496394546492988,0.997148931134753,39,264,organic anion transport,BP,APOE;SLCO4A1;CPT2;SLC43A1;ABCA7;CA12;SLC16A5;PITPNC1;SLC16A3;ABCG1;PLTP;SLC2A9;SLC13A3;BSG;SLC7A8;PRAF2;VAMP2;NTSR1;SLC6A8;SERINC2;ABCD1;SLC16A13;SLC2A3;OSBPL5;PITPNM1;SLC38A10;LDLR;PPARA;RXRA;PITPNM3;STK39;SLC25A29;AKT1;SLC22A17;KCNN4;SLC2A1;APBA1;PQLC2;MIF
12833,GO:0051179,0.00506112498097916,0.995799647993895,452,4301,localization,BP,LMF1;CEMIP;APOE;MARVELD1;TSPAN1;IDH2;SEMA4B;FAM110C;GAA;SYTL1;NAPRT;PYGB;CST3;SHANK2;LTBP4;RAPGEF3;MRC2;PGM1;CYP27B1;GSN;CLCA2;EVI5L;XDH;PRSS3;PGF;NOS1;LTBP1;ARAP1;ZFP36L1;TCTN1;POSTN;GRB7;NR1D1;EFS;ALOX15B;ARRDC1;SCN8A;SLCO4A1;EPHB2;OBSCN;CNTN1;CPT2;IGF2;NME4;LRP1;APPL2;KCNG1;LTBP2;RAB11FIP4;OBSL1;EGFR;TIMP2;MMP28;B3GAT3;HADH;NLGN2;REEP6;TOM1L2;SLC43A1;FHL1;SERPING1;MDFI;ULK1;RHBDF1;PKN1;ARPIN;PYGL;DOPEY2;SYT8;SHC1;F2R;PTK6;ABCA7;LAMA5;CA12;BBS2;SLC16A5;PRSS8;CTSB;DNAH1;PITPNC1;SLC16A3;CORO1B;GJC2;MALL;ZMYND8;TBC1D14;PACS2;MXI1;PLAT;KCNC4;MMP1;ABCG1;RIN1;ANK3;PIK3R2;S100A6;HDAC5;THRA;KCNJ15;DOCK4;ZP3;NISCH;LRP5;HYAL1;ANO8;MARK4;PLTP;SLC2A9;LRP3;ERBB2;SLC13A3;EXOC2;FBLN1;BRSK1;MICALL2;BSG;PTPRU;PKD2;TMEM129;FUCA1;TST;SCN4B;EDEM1;SLC7A8;ITGB4;ITPR3;PLXNB3;PRAF2;PHLDA2;VAT1;DNM1;FCHO1;RIMS3;IFT140;CD9;KIF13B;CACFD1;NINL;SIGMAR1;PAK6;HEXB;SERPINE2;VPS11;VAMP2;FUZ;NPHP4;LTB4R2;UNK;NTSR1;CD320;MINK1;ATP2B4;SLC6A8;TFDP2;CSNK1E;TRAPPC9;AGAP1;ZFYVE21;GM2A;SLC20A1;ACAP3;GLUL;RHOD;USP20;PEX10;ASIC1;WNT7A;INSR;RAB3D;SH3PXD2B;TBC1D8;ID1;CELSR1;EPHA1;ADARB1;ITGA6;SYNGAP1;NBEAL2;LPAR3;TMEM173;PRNP;SERINC2;ATP7B;RNASET2;SNX33;SPRY2;SLC12A7;ECM1;CEP250;ATG16L2;SNX9;DLG4;ABCD1;MARCH2;REEP2;STRADB;RAB25;MYO18A;TMEM107;ARHGAP27;SCART1;BCL6;TTYH3;PFKFB2;ATP12A;PLXNB1;CHMP1B;MVB12B;BNIP3;CD81;FCGRT;VEGFA;DNASE1L1;HOOK2;LRRC8A;ARL2;VANGL2;ELMO3;TMEM63C;AP2A2;RHBDF2;DPP7;SHANK3;SSC4D;ACVR2B;ADAM15;NUDCD3;ZDHHC1;MAPK3;PLEKHG5;TUB;KCNAB2;ETV5;OLFM2;AMN;SLC22A18;GLB1;RAB40B;DVL1;FYCO1;WIPF1;LTA4H;WIPI2;PKN3;SLC16A13;EPHB3;FHOD1;HES1;SSH1;FURIN;FBF1;MBOAT7;SLC48A1;SLC2A3;NRP2;ABCA2;LRSAM1;ADA;MCTP1;OSBPL5;AQP3;RASL10B;PFKL;IL6R;PCSK9;SLC28A2;ZFP36;RHOF;MAPKBP1;PRKACA;PITPNM1;CYFIP2;SLC38A10;SCNN1A;HBEGF;SLC25A37;RAB3B;MAP2K2;PI4K2A;FGFR4;SPTB;SLC37A2;STX10;TSPAN33;DMTN;BBS1;MDGA1;VGF;TNFRSF1A;EHD4;MAPK8IP1;SEMA3B;LDLR;SNX17;ABHD17C;TRPV4;RHOBTB2;CROCC;NHSL1;EEF2K;LDLRAP1;SEMA3F;PEX7;SEMA4C;MVB12A;HK1;SLC29A4;GAS6;LLGL1;PPARA;GUK1;GIT1;COMT;TTC7B;SUFU;PTAFR;RXRA;PCK2;VAV3;LRP10;BCR;TMEM175;TBC1D16;WDR60;PRKCZ;ZDHHC24;CLTCL1;INPP5D;TM7SF3;TMCO6;ABCD4;SPATA7;TWF2;GPC1;SRSF5;CEP68;MAPKAPK3;NDE1;ARAP3;FGFR1;CTSZ;PIN1;C5;PROX1;WBP2;ASAP2;DLG3;GPR155;KCNMA1;ESYT2;BIN1;VSNL1;UNC119B;SERPINB6;OSCP1;GLRX;SLC25A27;TMCO3;GRB10;SESN2;NDUFA4L2;TOLLIP;CSTB;PROCR;SNPH;TMEM231;MAPRE3;LCAT;GUCA1B;ADGRE2;SMDT1;PITPNM3;EPB41L3;SLC9A7;TIMP1;CD68;SDC1;WHAMMP3;ACTR1B;RTN2;PEAR1;WNT3;LYST;PPM1F;SORL1;STK39;VEGFB;ACVR1B;TBC1D17;ANO9;TSNARE1;ADORA2B;TPCN1;HGSNAT;SLC25A29;ERBB3;ABR;AKT1;CTSD;STON1;SEPT8;ZNF385A;TP53INP1;VPS33B;GPD1L;SLC5A5;SUN1;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;SNTA1;HOMER2;RGS14;SYNE3;MAFIP;SPIRE2;CTSH;ROBO4;RILPL1;EPN2;PYCARD;MAP2K3;RHBG;KCNN4;CKLF;SIRT3;ORAI3;C12ORF66;SLC2A1;JAK3;APBA1;ORAI2;GALNS;EREG;GSTM2;PODXL2;SHISA6;GIPR;PQLC2;SFI1;TMED4;SEMA4F;RPL13A;RAB40C;MIF;STXBP2;UBL5;LZTS2
2666,GO:0006026,0.00509762007520053,0.998518865066086,10,41,aminoglycan catabolic process,BP,CEMIP;NAGLU;HYAL1;FUCA1;HEXB;GLB1;GPC1;SDC1;HGSNAT;GALNS
3146,GO:0006753,0.00512792210278187,0.996664892804403,62,481,nucleoside phosphate metabolic process,BP,H6PD;APOE;IDH2;NT5E;NAPRT;RAPGEF3;PGM1;XDH;PGLS;NOS1;NME4;TIMP2;ACOT7;NMRK1;OGDHL;PKD2;PTHLH;LTB4R2;INSR;NDUFS8;DNPH1;DLG4;TALDO1;FAM20C;UCKL1;PFKFB2;VEGFA;KCNAB2;DHTKD1;ENTPD2;GALK1;LHPP;ADCY6;MLXIPL;NADK;TK2;ADA;PFKL;NUDT10;DGUOK;MYH3;HK1;PPARA;GUK1;PCK2;SDHA;MDH2;GTPBP1;DLG3;GUCA1B;ADORA2B;GPD1L;UQCR11;PINK1;ABHD14B;NDUFV3;MOCS1;TAZ;NEIL1;FUK;PPCS;PODXL2
17679,GO:1901615,0.00513352399967853,0.996901242478995,46,326,organic hydroxy compound metabolic process,BP,LMF1;APOE;CYP27B1;NR1D1;EPAS1;ISYNA1;D2HGDH;ABCG1;LRP5;PLTP;NTSR1;PLCD1;MVD;HAGH;SRD5A3;PLCD3;PFKFB2;SEC14L2;GALK1;OSBPL5;RETSAT;PCSK9;NUDT10;PLCH2;FGFR4;PMVK;LDLR;SNX17;LDLRAP1;TM7SF2;DGKQ;TKFC;COMT;PTAFR;IMPA2;RXRA;PCK2;INPP5D;FGFR1;PNPLA4;PROX1;LCAT;SORL1;SLC5A5;PNPO;TRERF1
12868,GO:0051235,0.00517520360340925,0.997172031321111,33,218,maintenance of location,BP,CEMIP;APOE;GAA;GSN;NOS1;LTBP1;MDFI;F2R;MXI1;ABCG1;ANK3;THRA;PKD2;ITPR3;HEXB;NTSR1;GM2A;ATP7B;ARL2;PRKACA;HK1;PPARA;SUFU;TWF2;EPB41L3;SORL1;TPCN1;AKT1;SUN1;PINK1;PKD1;SYNE3;GSTM2
3419,GO:0007215,0.00530214833466917,0.998579615636335,9,35,glutamate receptor signaling pathway,BP,SHANK2;EPHB2;NLGN2;MINK1;DLG4;SHANK3;PINK1;HOMER2;SHISA6
6826,GO:0030301,0.00535007563528014,0.998308870712883,11,49,cholesterol transport,BP,APOE;LRP1;ABCA7;ABCG1;PLTP;ABCA2;OSBPL5;PCSK9;LDLR;LDLRAP1;LCAT
7275,GO:0031279,0.00537575507326986,0.999056899069904,6,18,regulation of cyclase activity,BP,NOS1;TIMP2;LTB4R2;MAPK3;GUCA1B;ADORA2B
4957,GO:0015075,0.00542776974784603,0.996502194838003,59,441,ion transmembrane transporter activity,MF,CLCA2;SCN8A;SLCO4A1;KCNG1;SLC43A1;SLC16A5;SLC16A3;KCNC4;S100A6;KCNJ15;ANO8;SLC2A9;SLC13A3;BSG;PKD2;SCN4B;SLC7A8;ITPR3;ATP2B4;SLC6A8;SLC20A1;ASIC1;SERINC2;ATP7B;SLC12A7;DLG4;TTYH3;ATP12A;LRRC8A;TMEM63C;KCNAB2;SLC22A18;SLC16A13;SLC2A3;SLC28A2;SLC38A10;SCNN1A;SLC25A37;SLC37A2;TRPV4;GAS6;TMEM175;DLG3;KCNMA1;TMCO3;NDUFA4L2;SLC9A7;ANO9;TPCN1;SLC25A29;SLC5A5;PKD1;SLC22A17;RHBG;KCNN4;ORAI3;SLC2A1;ORAI2;PQLC2
3223,GO:0006884,0.00548173393878512,0.999034273825769,6,18,cell volume homeostasis,BP,SLC12A7;LRRC8A;SHANK3;TRPV4;KCNMA1;KCNN4
5433,GO:0016310,0.00549580849593131,0.995725188949989,186,1638,phosphorylation,BP,TNIP1;DUSP6;CEMIP;APOE;RAPGEF3;PGM1;XDH;ZFP36L1;EPHB2;OBSCN;CNTN1;IGF2;NME4;MST1R;MAPK13;CDK18;EGFR;TIMP2;DUSP5;PPP1R14A;EGR1;ULK1;PKN1;SHC1;F2R;PTK6;ABCA7;SHC2;ULK2;DGKA;GJC2;PIK3R2;NEK9;RPS6KA2;NMRK1;LRP5;MARK4;ERBB2;FBLN1;BRSK1;OGDHL;PKD2;SPRY4;CDKN1C;PAK6;MINK1;ATP2B4;CSNK1E;RASA4;ZFYVE21;PDCD4;TNFRSF25;WNT7A;INSR;ID1;GRK6;NDUFS8;EPHA1;ADARB1;ITGA6;SYNGAP1;LPAR3;PRNP;SPRY2;SNX9;DLG4;SPEG;FGGY;MKNK2;STRADB;WWTR1;FAM20C;UCKL1;PFKFB2;DYRK1B;CD81;SRMS;FZD8;VEGFA;VANGL2;MAST4;SHANK3;ACVR2B;NAB2;S1PR2;MAPK3;DHTKD1;DVL1;GALK1;ADCY6;PKN3;EPHB3;HES1;MLXIPL;NADK;TK2;CDC42EP5;CKMT1A;PFKL;IL6R;ZFP36;FGFR3;PRKACA;LRRK1;DGUOK;RPS6KA5;HBEGF;MAP2K2;PI4K2A;FGFR4;SPTB;DMTN;PMVK;TNFRSF1A;EHD4;MAPK8IP1;TRPV4;DUSP7;EEF2K;HMGA2;DGKQ;SEMA4C;HK1;GAS6;BTRC;PPARA;TKFC;GUK1;STK32C;WNT7B;TTC7B;IMPA2;VAV3;BCR;IGFBP4;SDHA;PRKCZ;PDK2;MAPKAPK3;FGFR1;CAMKK1;PIN1;C5;PROX1;DLG3;PI4KAP2;WDR83;GRB10;SESN2;TOLLIP;ADCK5;MAPRE3;MADD;RTN4R;PPM1F;SORL1;STK39;ACVR1B;ADORA2B;ERBB3;AKT1;NDRG2;ERCC6;GPD1L;IL17RD;UQCR11;ADCK2;PINK1;PKD1;RGS14;CTSH;MLST8;CBLC;PYCARD;MAP2K3;NDUFV3;STK17A;ERN1;RANBP9;SIRT3;TAZ;JAK3;MAST3;FUK;EREG;MIF
3528,GO:0007528,0.00555348102792389,0.998654006274065,8,29,neuromuscular junction development,BP,SHANK2;F2R;ANK3;ERBB2;LAMB2;SHANK3;ETV5;DVL1
8017,GO:0032673,0.00561474527686665,0.999229424899988,5,13,regulation of interleukin-4 production,BP,ZP3;ZFPM1;IL20RB;CEBPB;PRKCZ
15289,GO:0071526,0.0056387307759374,0.998629710706427,8,29,semaphorin-plexin signaling pathway,BP,SEMA4B;PLXNB3;PLXNB1;NRP2;SEMA3B;SEMA3F;SEMA4C;SEMA4F
7038,GO:0030823,0.00564848201990559,0.999223648805399,5,13,regulation of cGMP metabolic process,BP,APOE;NOS1;VEGFA;GUCA1B;ADORA2B
13391,GO:0052813,0.00564968175545603,0.998471037991904,9,35,phosphatidylinositol bisphosphate kinase activity,MF,EGFR;PIK3R2;ERBB2;FGFR3;HBEGF;FGFR4;FGFR1;ERBB3;EREG
11398,GO:0045834,0.00566823379443351,0.997795822005599,15,76,positive regulation of lipid metabolic process,BP,APOE;NR1D1;ABCG1;ZP3;CD81;MLXIPL;FGFR3;TNFRSF1A;LDLR;LDLRAP1;PPARA;VAV3;AKT1;MLYCD;TAZ
6925,GO:0030545,0.00571520684072635,0.997066610983972,27,174,receptor regulator activity,MF,SEMA4B;PGF;IGF2;CMTM7;ZP3;PTHLH;CD320;WNT7A;VEGFA;PCSK9;HBEGF;VGF;SEMA3B;SEMA3F;DGKQ;SEMA4C;GAS6;WNT7B;C5;TIMP1;WNT3;VEGFB;CKLF;CMTM4;EREG;SEMA4F;MIF
706,GO:0001932,0.00573734589217441,0.995811420146307,113,932,regulation of protein phosphorylation,BP,TNIP1;DUSP6;CEMIP;APOE;RAPGEF3;XDH;EPHB2;CNTN1;IGF2;MST1R;EGFR;TIMP2;DUSP5;EGR1;PKN1;SHC1;F2R;PTK6;ABCA7;SHC2;GJC2;PIK3R2;LRP5;ERBB2;FBLN1;PKD2;SPRY4;CDKN1C;PAK6;MINK1;ATP2B4;PDCD4;TNFRSF25;WNT7A;INSR;ID1;EPHA1;ADARB1;SYNGAP1;LPAR3;PRNP;SPRY2;SNX9;DLG4;STRADB;WWTR1;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;MAPK3;DVL1;ADCY6;EPHB3;HES1;MLXIPL;IL6R;FGFR3;PRKACA;LRRK1;RPS6KA5;HBEGF;MAP2K2;FGFR4;DMTN;TNFRSF1A;EHD4;MAPK8IP1;TRPV4;DUSP7;EEF2K;DGKQ;SEMA4C;GAS6;WNT7B;IGFBP4;PRKCZ;MAPKAPK3;FGFR1;CAMKK1;PIN1;C5;PROX1;DLG3;SESN2;MAPRE3;MADD;RTN4R;PPM1F;SORL1;STK39;ACVR1B;ADORA2B;ERBB3;AKT1;NDRG2;ERCC6;GPD1L;PINK1;PKD1;RGS14;MLST8;CBLC;PYCARD;MAP2K3;ERN1;RANBP9;SIRT3;EREG;MIF
12379,GO:0048843,0.00581433615073116,0.998962634652708,6,18,negative regulation of axon extension involved in axon guidance,BP,SEMA4B;SEMA3B;SEMA3F;SEMA4C;WNT3;SEMA4F
12047,GO:0048018,0.00583786542033878,0.997086018218215,25,158,receptor ligand activity,MF,SEMA4B;PGF;IGF2;CMTM7;ZP3;PTHLH;CD320;WNT7A;VEGFA;HBEGF;VGF;SEMA3B;SEMA3F;SEMA4C;GAS6;WNT7B;C5;TIMP1;WNT3;VEGFB;CKLF;CMTM4;EREG;SEMA4F;MIF
13253,GO:0051968,0.00585975441733588,0.999187276327035,5,13,positive regulation of synaptic transmission, glutamatergic,BP,SHANK2;EGFR;NLGN2;GLUL;SHANK3
7650,GO:0032091,0.00587154620401772,0.997702513654418,15,78,negative regulation of protein binding,BP,CTNNBIP1;NFATC4;ZFPM1;CSNK1E;ID1;ADAM15;MAPK3;DVL1;GPSM1;PCSK9;PPARA;CTSZ;PIN1;SORL1;AKT1
16782,GO:0098657,0.00588175775229823,0.996099404378957,66,502,import into cell,BP,APOE;TSPAN1;MRC2;GSN;NOS1;LRP1;NLGN2;SYT8;ABCA7;RIN1;PIK3R2;LRP5;LRP3;DNM1;FCHO1;CD9;NTSR1;ATP2B4;CSNK1E;GLUL;USP20;PRNP;SNX33;SNX9;DLG4;MARCH2;MYO18A;ARHGAP27;SCART1;CD81;VEGFA;HOOK2;ELMO3;AP2A2;SSC4D;MAPK3;TUB;AMN;WIPF1;LRSAM1;MCTP1;PCSK9;CYFIP2;RAB3B;EHD4;LDLR;SNX17;EEF2K;LDLRAP1;GAS6;VAV3;LRP10;BCR;TMEM175;CLTCL1;MAPKAPK3;ARAP3;ESYT2;BIN1;SLC9A7;PEAR1;SORL1;ABR;STON1;EPN2;PYCARD
8706,GO:0034368,0.00588786699011684,0.999433018553714,4,9,protein-lipid complex remodeling,BP,APOE;ABCG1;PLTP;LCAT
8707,GO:0034369,0.00588786699011684,0.999433018553714,4,9,plasma lipoprotein particle remodeling,BP,APOE;ABCG1;PLTP;LCAT
7974,GO:0032602,0.00588949453676138,0.998108814870678,11,50,chemokine production,BP,POSTN;ALOX15B;EGR1;ZFPM1;MEFV;IL6R;TRPV4;C5;ADORA2B;PYCARD;MIF
9791,GO:0040037,0.00591343313711886,0.999177980634624,5,13,negative regulation of fibroblast growth factor receptor signaling pathway,BP,SPRY4;FUZ;SPRY2;GPC1;SULF2
4362,GO:0009991,0.0059159680003438,0.996377517842213,47,338,response to extracellular stimulus,BP,FOS;APOE;ERCC1;CST3;CYP27B1;GSN;POSTN;IGF2;EGFR;MTHFR;ULK1;BBS2;ULK2;CBS;LRP11;GLUL;ITGA6;DNMT3A;IGFBP2;MAPK3;SSH1;ADA;AQP3;PCSK9;ZFP36;HLCS;DAP;VGF;LDLR;TRPV4;DGKQ;GAS6;PPARA;HMGCL;COMT;PCK2;PDK2;PROX1;SESN2;WNT2B;GSS;ADORA2B;AKT1;PCSK1N;C12ORF66;SLC2A1;GIPR
16726,GO:0098533,0.00593126002533774,0.99917488867959,5,13,ATPase dependent transmembrane transport complex,CC,ABCA7;GM2A;ATP12A;ABCA2;ABCD4
6615,GO:0022857,0.00593821529871777,0.996022479873859,69,533,transmembrane transporter activity,MF,CLCA2;SCN8A;SLCO4A1;KCNG1;SLC43A1;ABCA7;SLC16A5;SLC16A3;GJC2;KCNC4;ABCG1;S100A6;KCNJ15;ANO8;SLC2A9;SLC13A3;BSG;PKD2;SCN4B;SLC7A8;ITPR3;ATP2B4;SLC6A8;SLC20A1;ASIC1;SERINC2;ATP7B;SLC12A7;DLG4;ABCD1;TTYH3;ATP12A;LRRC8A;TMEM63C;KCNAB2;SLC22A18;SLC16A13;SLC48A1;SLC2A3;ABCA2;AQP3;SLC28A2;SLC38A10;SCNN1A;SLC25A37;SLC37A2;TRPV4;SLC29A4;GAS6;TMEM175;ABCD4;DLG3;KCNMA1;SLC25A27;TMCO3;NDUFA4L2;SLC9A7;ANO9;TPCN1;SLC25A29;SLC5A5;PKD1;SLC22A17;RHBG;KCNN4;ORAI3;SLC2A1;ORAI2;PQLC2
7848,GO:0032420,0.0060030746394351,0.998703449276017,7,24,stereocilium,CC,ESPN;BBS2;DOCK4;TWF2;EPS8L2;HOMER2;MORN4
683,GO:0001894,0.00609933614015765,0.997164255855416,21,122,tissue homeostasis,BP,EPAS1;EGFR;F2R;BBS2;NPHP4;ACP5;RAB3D;IL20RB;VEGFA;TUB;LRRK1;BBS1;CROCC;INPP5D;SPATA7;TPP1;CDHR1;STK39;ERCC6;HOMER2;CTSH
10293,GO:0043087,0.00614740155978466,0.996168504777044,50,360,regulation of GTPase activity,BP,RAPGEF3;EVI5L;ARAP1;F2R;TBC1D14;RIN1;PIK3R2;ARHGAP23;DOCK4;ERBB2;PLXNB3;RALGAPA2;RASA4;AGAP1;ACAP3;PLEKHG4;TBC1D8;EPHA1;ITGA6;SYNGAP1;SPRY2;SNX9;ARHGAP27;BCL6;PLXNB1;ARL2;GPSM1;EPHB3;ARHGAP22;CDC42EP5;LLGL1;GIT1;PLEKHG6;ARHGEF37;VAV3;BCR;TBC1D16;ARAP3;PIN1;ASAP2;RTN4R;SBF1;TBC1D17;ALS2CL;ABR;RGS14;MLST8;PYCARD;ARHGEF19;RGS12
13206,GO:0051897,0.00615333964085939,0.997494767883275,16,84,positive regulation of protein kinase B signaling,BP,FAM110C;IGF2;MST1R;EGFR;PIK3R2;ERBB2;INSR;SPRY2;FGFR3;HBEGF;FGFR4;GAS6;FGFR1;ERBB3;PINK1;EREG
6294,GO:0019932,0.0061845824431562,0.996854612410293,26,162,second-messenger-mediated signaling,BP,ADGRL1;APOE;RAPGEF3;NOS1;NFATC4;EGFR;ADGRF1;GNAL;PKD2;ITPR3;PTHLH;ATP2B4;PRNP;ADCY6;ADA;MCTP1;PRKACA;DMTN;DGKQ;ADGRB2;ADORA2B;ERBB3;TMBIM4;HOMER2;GSTM2;GIPR
4464,GO:0010469,0.00625120501996732,0.996605832932148,31,207,regulation of signaling receptor activity,BP,SHANK2;PGF;EPHB2;IGF2;NLGN2;CMTM7;SHC1;ZP3;PHLDA2;PTHLH;CD320;MINK1;WNT7A;DLG4;VEGFA;SHANK3;PCSK9;HBEGF;VGF;GAS6;WNT7B;TIMP1;WNT3;VEGFB;PINK1;CBLC;CKLF;CMTM4;EREG;SHISA6;MIF
18003,GO:1902533,0.00629542261532495,0.995627398164959,82,652,positive regulation of intracellular signal transduction,BP,DUSP6;FAM110C;XDH;NOS1;RBCK1;EPHB2;IGF2;MST1R;EGFR;TIMP2;DUSP5;PKN1;SHC1;RGL2;F2R;PTK6;ABCA7;S100A4;SHC2;CXXC5;PIK3R2;ERBB2;PKD2;MINK1;PDCD4;SLC20A1;TNFRSF25;WNT7A;INSR;EPHA1;LPAR3;SPRY2;ECM1;PLXNB1;CD81;FZD8;VEGFA;VANGL2;S1PR2;MAPK3;PLEKHG5;EPHB3;HES1;ADA;IL6R;FGFR3;LRRK1;HBEGF;MAP2K2;FGFR4;TNFRSF1A;MAPK8IP1;TRPV4;DUSP7;SEMA4C;MIB2;GAS6;WNT7B;IGFBP4;PRKCZ;MAPKAPK3;FGFR1;C5;MADD;RTN4R;STK39;ADORA2B;ERBB3;AKT1;ZNF385A;ERCC6;PINK1;MLST8;PYCARD;MAP2K3;ERN1;LITAF;EREG;GSTM2;GIPR;TMED4;MIF
14303,GO:0061512,0.00631876482867432,0.998424309431507,8,30,protein localization to cilium,BP,TCTN1;BBS2;IFT140;TMEM107;TUB;BBS1;CROCC;SPATA7
1096,GO:0002685,0.00641137243138453,0.997287334732857,17,94,regulation of leukocyte migration,BP,PGF;MMP28;ZP3;ECM1;VEGFA;MAPK3;ADA;IL6R;TRPV4;GAS6;PTAFR;BCR;C5;VEGFB;ABR;PYCARD;MIF
14696,GO:0070373,0.00642131370415288,0.997917663336249,11,49,negative regulation of ERK1 and ERK2 cascade,BP,TNIP1;DUSP6;EPHB2;FBLN1;SPRY4;SPRY2;PIN1;NDRG2;RGS14;RANBP9;SIRT3
7045,GO:0030835,0.00652244272574521,0.998568562326888,7,24,negative regulation of actin filament depolymerization,BP,GSN;TMOD2;PLEKHH2;SPTB;DMTN;CAPG;TWF2
12873,GO:0051241,0.00652553967620563,0.995439850685778,84,676,negative regulation of multicellular organismal process,BP,APOE;IDH2;PTPRS;WWC3;SEMA4B;CST3;XDH;ZFP36L1;EPHB2;NFATC4;LRP1;EGFR;SERPING1;F2R;BBS2;ULK2;PLAT;HDAC5;DOCK4;LRP5;ZFPM1;ERBB2;PTHLH;CD9;SERPINE2;FUZ;RNF135;ATP2B4;ACP5;ADAMTS7;PDCD4;WNT7A;ID1;SYNGAP1;IL20RB;PRNP;EFNB3;SPRY2;ECM1;BCL6;TNNT1;ADCY6;HES1;FURIN;MEFV;ADA;PCSK9;ZFP36;MAPKBP1;F12;DGUOK;RPS6KA5;SEMA3B;LDLR;TRPV4;SEMA3F;SEMA4C;GAS6;ADGRB2;COMT;SUFU;VASN;BCR;INPP5D;FGFR1;CTSZ;CHADL;PIN1;JARID2;PROCR;RTN4R;TIMP1;WNT3;SORL1;STK39;ADORA2B;ABR;NLRX1;NDRG2;EPN2;PYCARD;JAK3;RARG;SEMA4F
1987,GO:0004712,0.00653629838105274,0.998181352930092,9,36,protein serine/threonine/tyrosine kinase activity,MF,RPS6KA2;DYRK1B;ACVR2B;MAPK3;PRKACA;MAP2K2;MAPKAPK3;AKT1;MAP2K3
15439,GO:0071804,0.00653899235349794,0.997319829841625,16,84,cellular potassium ion transport,BP,KCNG1;FHL1;KCNC4;ANK3;KCNJ15;PKD2;VAMP2;PRNP;SLC12A7;ATP12A;KCNAB2;TMEM175;KCNMA1;SLC9A7;STK39;KCNN4
15440,GO:0071805,0.00653899235349794,0.997319829841625,16,84,potassium ion transmembrane transport,BP,KCNG1;FHL1;KCNC4;ANK3;KCNJ15;PKD2;VAMP2;PRNP;SLC12A7;ATP12A;KCNAB2;TMEM175;KCNMA1;SLC9A7;STK39;KCNN4
12254,GO:0048584,0.00655458402659907,0.994950836988047,163,1420,positive regulation of response to stimulus,BP,TNIP1;DUSP6;PTPRS;FAM110C;SHANK2;CYP27B1;GSN;XDH;PGF;NOS1;ARAP1;SH3BP2;GRB7;NR1D1;ALOX15B;RBCK1;EPHB2;IGF2;NFATC4;MST1R;MAPK13;EGFR;TIMP2;NLGN2;DUSP5;SERPING1;PKN1;SHC1;RGL2;F2R;PTK6;ABCA7;S100A4;CTSB;SHC2;CXXC5;PIK3R2;ZP3;MAML3;ERBB2;PKD2;EDEM1;CDKN1C;NTSR1;MINK1;TMOD2;TFDP2;CSNK1E;PDCD4;SLC20A1;TNFRSF25;WNT7A;ZMIZ1;INSR;EPHA1;LPAR3;TMEM173;PRNP;SPRY2;ECM1;STAT6;DLG4;PLXNB1;BNIP3;CD81;FZD8;VEGFA;YPEL3;VANGL2;SHANK3;ACVR2B;S1PR2;ENDOG;MAPK3;PLEKHG5;DVL1;WIPF1;EPHB3;NSMCE4A;HES1;SSH1;EVC;LRSAM1;ADA;PIDD1;PAG1;SH2D2A;IL6R;FGFR3;PRKACA;F12;LRRK1;CYFIP2;RPS6KA5;HBEGF;RAB3B;MAP2K2;FGFR4;DMTN;TNFRSF1A;MAPK8IP1;LDLR;TRPV4;DUSP7;HMGA2;LDLRAP1;SEMA4C;HK1;MIB2;GAS6;BTRC;TKFC;WNT7B;PTAFR;RFNG;VAV3;NEO1;IGFBP4;MUC19;PRKCZ;INPP5D;ICOSLG;MAPKAPK3;FGFR1;PIN1;C5;WBP2;VSNL1;GRB10;WNT2B;TMEM161A;MADD;RTN4R;SH2B3;FGFBP1;WNT3;PPM1F;STK39;VEGFB;ACVR1B;ADORA2B;ERBB3;AKT1;NLRX1;ZNF385A;TP53INP1;ERCC6;PINK1;CTSH;MLST8;EPN2;PYCARD;MAP2K3;KCNN4;ERN1;LITAF;EREG;FAM162A;GSTM2;GIPR;TMED4;MIF;SULF2
16941,GO:0098984,0.00656817327609313,0.996695741546929,25,152,neuron to neuron synapse,CC,PTPRS;SHANK2;NOS1;NLGN2;DNM1;SIGMAR1;NTSR1;MINK1;SYNGAP1;PRNP;DLG4;BNIP3;SHANK3;KCNAB2;DVL1;DMTN;ABHD17C;EEF2K;SEMA4C;BCR;DLG3;EPB41L3;HOMER2;RGS14;SHISA6
10669,GO:0043954,0.00658178246646738,0.998553008447268,7,24,cellular component maintenance,BP,APOE;NLGN2;MTHFR;F2R;ZMYND8;INSR;PRNP
2393,GO:0005543,0.00659064236213182,0.996060333459045,42,294,phospholipid binding,MF,APOE;SYTL1;ARAP1;GRB7;NME4;HS1BP3;SYT8;SHC1;PITPNC1;DGKA;ABCG1;NISCH;PLTP;ITPR3;VAMP2;RASA4;PLCD1;AGAP1;SH3PXD2B;LPAR3;SNX33;SNX9;SEC14L2;TUB;WIPI2;MCTP1;OSBPL5;PITPNM1;PSD4;SNX17;LDLRAP1;GAS6;PTAFR;GSDMC;TWF2;ARAP3;ESYT2;GSDMA;AKT1;SNX29;ZCCHC14;ZFYVE19
3677,GO:0008188,0.00659797608811774,0.999679063307036,3,5,neuropeptide receptor activity,MF,LTB4R;LTB4R2;NTSR1
3689,GO:0008203,0.00660177151406069,0.997120173606507,18,100,cholesterol metabolic process,BP,LMF1;APOE;ABCG1;LRP5;MVD;SEC14L2;OSBPL5;PCSK9;PMVK;LDLR;SNX17;LDLRAP1;TM7SF2;DGKQ;RXRA;LCAT;SORL1;TRERF1
6842,GO:0030323,0.00661428155498802,0.996969051659041,20,114,respiratory tube development,BP,EPAS1;EGFR;LAMA5;THRA;ID1;CELSR1;SPRY2;VEGFA;VANGL2;ACVR2B;MAPK3;HES1;ADA;WNT7B;FGFR1;CTSZ;PROX1;WNT2B;PKD1;CTSH
15493,GO:0071900,0.00663028237932489,0.99578874219573,53,391,regulation of protein serine/threonine kinase activity,BP,DUSP6;CEMIP;APOE;EPHB2;IGF2;MST1R;EGFR;DUSP5;PKN1;SHC1;F2R;SHC2;LRP5;ERBB2;PKD2;SPRY4;CDKN1C;MINK1;ATP2B4;PDCD4;INSR;LPAR3;SPRY2;CD81;FZD8;VEGFA;VANGL2;S1PR2;MAPK3;MAP2K2;MAPK8IP1;DUSP7;WNT7B;MAPKAPK3;FGFR1;C5;PROX1;SESN2;MAPRE3;MADD;SORL1;STK39;ADORA2B;AKT1;ERCC6;PKD1;RGS14;MLST8;CBLC;PYCARD;MAP2K3;ERN1;MIF
4626,GO:0010758,0.00664034781801989,0.999025606248802,5,14,regulation of macrophage chemotaxis,BP,MMP28;MAPK3;TRPV4;C5;MIF
12547,GO:0050727,0.00664219066459687,0.996550670712565,27,173,regulation of inflammatory response,BP,TNIP1;APOE;NT5E;MAPK13;EGFR;SERPING1;ZP3;GGT1;ACP5;PDCD4;IL20RB;BCL6;CD81;MEFV;ADA;F12;TNFRSF1A;LDLR;TRPV4;PPARA;BCR;C5;STK39;ADORA2B;ABR;NLRX1;PYCARD
3574,GO:0007626,0.00667656314859651,0.99708417335509,18,100,locomotory behavior,BP,APOE;ESPN;GAA;NLGN2;NAGLU;DNM1;HEXB;NTSR1;CELSR1;EFNB3;DLG4;ETV5;OLFM2;MTA1;SLITRK6;CSTB;ZNF385A;APBA1
15737,GO:0072359,0.0066996394050613,0.995304511449269,85,675,circulatory system development,BP,DUSP6;APOE;GAA;RAPGEF3;XDH;PGF;MEF2D;LTBP1;ZFP36L1;EPHB2;EPAS1;NFATC4;LRP1;OBSL1;EGFR;LOXL1;EGR1;SHC1;LAMA5;ACTA2;HDAC5;LRP5;HYAL1;ZFPM1;ERBB2;PKD2;IFT140;TFDP2;PLCD1;PDCD4;WNT7A;ZMIZ1;INSR;SH3PXD2B;FBXW8;ID1;EPHA1;SPRY2;ECM1;PLCD3;FZD8;VEGFA;VANGL2;ACVR2B;ADAM15;MAPK3;DVL1;EPHB3;HES1;CUL7;ARHGAP22;NRP2;SH2D2A;FGFR4;TCF25;SNX17;HMGA2;ELK3;POU6F1;ADGRB2;PPARA;WNT7B;SUFU;RXRA;VAV3;FGFR1;PIN1;C5;TMEM204;PROX1;PPP1R13L;JARID2;TMEM231;VEGFB;MEF2B;ERBB3;AKT1;ADAM19;PKD1;CTSH;ROBO4;EPN2;TAZ;RARG;EREG
6569,GO:0022407,0.00671998604940554,0.996222162438446,34,228,regulation of cell-cell adhesion,BP,IGF2;ANK3;ZP3;ERBB2;CD9;SERPINE2;MINK1;ZMIZ1;ITGA6;IL20RB;PRNP;EFNB3;BCL6;IGFBP2;CEBPB;EPHB3;HES1;TNFRSF14;ADA;PAG1;CELSR2;DMTN;TRPV4;RAG1;PPARA;PTAFR;PRKCZ;ICOSLG;ASS1;AKT1;VPS33B;PYCARD;JAK3;KIF26B
13744,GO:0060350,0.00672089602858229,0.998305769446973,8,30,endochondral bone morphogenesis,BP,MEF2D;THBS3;NAB2;FGFR3;TRPV4;PEX7;COL13A1;RARG
14474,GO:0061971,0.00672089602858229,0.998305769446973,8,30,replacement bone morphogenesis,BP,MEF2D;THBS3;NAB2;FGFR3;TRPV4;PEX7;COL13A1;RARG
12377,GO:0048841,0.00672429685743421,0.998515536957101,7,24,regulation of axon extension involved in axon guidance,BP,SEMA4B;VEGFA;SEMA3B;SEMA3F;SEMA4C;WNT3;SEMA4F
1694,GO:0004175,0.00692229832086048,0.99609823144961,34,231,endopeptidase activity,MF,HTRA1;TYSND1;CLCA2;PRSS3;MMP28;RHBDF1;PRSS8;CTSB;PLAT;MMP1;CTSF;ADAMTS7;USP20;BLMH;RHBDF2;ADAM15;CAPNS2;FURIN;PCSK9;F12;RHBDL1;PCSK1;ADAMTS13;TPP1;CTSZ;CAPN2;TMPRSS11D;LMLN;CTSD;ADAM19;SPPL2B;LONP2;CTSH;PYCARD
3443,GO:0007263,0.0069598749005454,0.999295900512956,4,9,nitric oxide mediated signal transduction,BP,APOE;NOS1;EGFR;ATP2B4
13553,GO:0060048,0.00699218015909608,0.997431542092011,13,64,cardiac muscle contraction,BP,GAA;NOS1;SCN4B;TNNT1;PRKACA;PPP1R13L;VEGFB;GPD1L;EHD3;SNTA1;MAP2K3;TAZ;GSTM2
15862,GO:0072656,0.00704664905547485,0.9996486861777,3,5,maintenance of protein location in mitochondrion,BP,HK1;AKT1;PINK1
8716,GO:0034380,0.00706713587436399,0.999281803110385,4,9,high-density lipoprotein particle assembly,BP,APOE;ABCA7;PRKACA;LCAT
13649,GO:0060205,0.00716884677450719,0.995984336946662,33,227,cytoplasmic vesicle lumen,CC,APOE;NAPRT;PYGB;GSN;IGF2;TIMP2;SERPING1;PYGL;FUCA1;VAT1;HEXB;GM2A;RNASET2;ECM1;VEGFA;DNASE1L1;DPP7;GLB1;ADA;PFKL;GAS6;PCSK1;CTSZ;TOLLIP;CSTB;TIMP1;ACTR1B;VEGFB;CTSD;CTSH;PYCARD;GALNS;MIF
16147,GO:0090195,0.00719465934212864,0.999264956726584,4,9,chemokine secretion,BP,POSTN;ALOX15B;C5;PYCARD
14001,GO:0060754,0.00720369656177167,0.999637872820141,3,5,positive regulation of mast cell chemotaxis,BP,PGF;VEGFA;VEGFB
8061,GO:0032753,0.00721703031535384,0.999261991883447,4,9,positive regulation of interleukin-4 production,BP,ZP3;IL20RB;CEBPB;PRKCZ
17418,GO:1900221,0.00723179778323884,0.999260033185555,4,9,regulation of amyloid-beta clearance,BP,APOE;LRP1;ABCA7;LDLR
8103,GO:0032803,0.00727167724383415,0.999633163553183,3,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,APOE;FURIN;PCSK9
11548,GO:0046122,0.00728456776671421,1,2,2,purine deoxyribonucleoside metabolic process,BP,ADA;DGUOK
13813,GO:0060441,0.0073001858585209,0.998612772518783,6,19,epithelial tube branching involved in lung morphogenesis,BP,CELSR1;SPRY2;VANGL2;CTSZ;WNT2B;CTSH
4376,GO:0010038,0.00733853525906946,0.995925724715604,32,215,response to metal ion,BP,FOS;ERCC1;GSN;NDRG1;NFATC4;EGFR;UROS;D2HGDH;ANK3;BSG;PKD2;ITPR3;RASA4;DNMT3A;PRNP;ATP7B;IGFBP2;BNIP3;ENTPD6;ENDOG;MAPK3;AQP3;DMTN;EEF2K;ADAMTS13;KCNMA1;CYBRD1;SDC1;GSS;AKT1;CPNE7;GIPR
6060,GO:0019218,0.00734128043989742,0.99704947157117,15,79,regulation of steroid metabolic process,BP,LMF1;APOE;CYP27B1;NR1D1;EGR1;ABCG1;MVD;SEC14L2;FGFR4;PMVK;LDLR;LDLRAP1;TM7SF2;DGKQ;PROX1
8708,GO:0034370,0.00734435300380159,1,2,2,triglyceride-rich lipoprotein particle remodeling,BP,APOE;LCAT
8710,GO:0034372,0.00734435300380159,1,2,2,very-low-density lipoprotein particle remodeling,BP,APOE;LCAT
606,GO:0001775,0.00736568201230474,0.994647145081777,103,855,cell activation,BP,APOE;ERCC1;GAA;NAPRT;PYGB;CST3;PGM1;GSN;NDRG1;PRSS3;ZFP36L1;IGF2;LRP1;EGFR;TIMP2;EGR1;PKN1;CMTM7;PYGL;F2R;CTSB;DGKA;HDAC5;ZP3;ZFPM1;ERBB2;FUCA1;ITPR3;VAT1;CD9;KIF13B;HEXB;SERPINE2;VAMP2;CD320;GM2A;WNT7A;ZMIZ1;RAB3D;IL20RB;NBEAL2;TMEM173;PRNP;EFNB3;RNASET2;STAT6;MYO18A;BCL6;IGFBP2;CD81;FZD8;DNASE1L1;LRRC8A;AP2A2;CEBPB;DPP7;MAPK3;KCNAB2;GLB1;ENTPD2;LTA4H;HES1;SLC2A3;TNFRSF14;ADA;PAG1;PFKL;RHOF;PI4K2A;DMTN;LDLR;SOX13;RAG1;DGKQ;GAS6;PTAFR;VAV3;BCR;PRKCZ;ADAMTS13;INPP5D;ICOSLG;CTSZ;SERPINB6;TOLLIP;CSTB;ADGRE2;TIMP1;CD68;ACTR1B;ADORA2B;HGSNAT;ABR;AKT1;CTSD;VPS33B;CTSH;PYCARD;JAK3;GALNS;POLM;MIF;STXBP2
11215,GO:0045408,0.00741596380592822,0.999235503026005,4,9,regulation of interleukin-6 biosynthetic process,BP,CEBPB;PTAFR;INPP5D;EREG
13067,GO:0051604,0.00742762886019523,0.995913537169445,31,209,protein maturation,BP,LMF1;TYSND1;GSN;PRSS3;SERPING1;RHBDF1;PLAT;SERPINE2;GGT1;PRNP;CD81;RHBDF2;FURIN;PCSK9;F12;MAGEF1;CYFIP2;TSPAN33;RHBDL1;GAS6;PCSK1;ADAMTS13;CTSZ;C5;CAPN2;SORL1;SPPL2B;LONP2;CTSH;PYCARD;PCSK1N
3120,GO:0006707,0.00744921563989125,0.99962078439165,3,5,cholesterol catabolic process,BP,APOE;SNX17;TRERF1
5346,GO:0016127,0.00744921563989125,0.99962078439165,3,5,sterol catabolic process,BP,APOE;SNX17;TRERF1
3239,GO:0006904,0.00747177052115931,0.997867050408685,9,37,vesicle docking involved in exocytosis,BP,EXOC2;VPS11;RAB3D;RAB40B;RAB3B;SNPH;VPS33B;RAB40C;STXBP2
3262,GO:0006941,0.00749939393138666,0.996978451094027,15,79,striated muscle contraction,BP,GAA;NOS1;OBSL1;SCN4B;TNNT1;PRKACA;MYH3;PPP1R13L;VEGFB;GPD1L;EHD3;SNTA1;MAP2K3;TAZ;GSTM2
9696,GO:0038128,0.00752983130026934,0.998052950578205,8,31,ERBB2 signaling pathway,BP,GRB7;EGFR;SHC1;PTK6;ERBB2;HBEGF;ERBB3;EREG
20257,GO:2001259,0.00754551891529575,0.998048175170259,8,31,positive regulation of cation channel activity,BP,EPHB2;ANK3;PKD2;NTSR1;SHANK3;PINK1;EHD3;GSTM2
7842,GO:0032414,0.00756416354338146,0.997478160753803,11,51,positive regulation of ion transmembrane transporter activity,BP,EPHB2;ANK3;PKD2;NTSR1;SHANK3;PTAFR;GLRX;STK39;PINK1;EHD3;GSTM2
11449,GO:0045926,0.00760780997107757,0.996060602449617,26,165,negative regulation of growth,BP,PTPRS;WWC3;SEMA4B;CYP27B1;ALOX15B;FHL1;PTK6;BBS2;ULK2;HYAL1;SERPINE2;BCL6;ADAM15;SLIT3;FGFR3;SEMA3B;SEMA3F;SEMA4C;JARID2;SESN2;RTN4R;WNT3;ACVR1B;CCDC85B;ING4;SEMA4F
5224,GO:0015850,0.0076220136106877,0.996620840752439,18,102,organic hydroxy compound transport,BP,APOE;NOS1;LRP1;ABCA7;SLC16A3;ABCG1;NISCH;PLTP;ABCA2;OSBPL5;AQP3;PCSK9;RAB3B;LDLR;LDLRAP1;RXRA;LCAT;PINK1
8202,GO:0032970,0.0076722406856185,0.995496285800542,38,264,regulation of actin filament-based process,BP,RAPGEF3;GSN;ARAP1;LRP1;ARPIN;CORO1B;TMOD2;RHOD;SH3PXD2B;ID1;CELSR1;EPHA1;PLEKHH2;VANGL2;SHANK3;WIPF1;FHOD1;SSH1;PLEKHG2;CDC42EP5;RHOF;SPTB;DMTN;RHOBTB2;CAPG;TWF2;PROX1;WHAMMP3;EPS8L1;PPM1F;EPS8L2;SSH3;ARHGEF10L;SPIRE2;MLST8;PYCARD;ARHGEF19;FCHSD1
2600,GO:0005905,0.00767981322626218,0.997285014237026,12,57,clathrin-coated pit,CC,CEMIP;EPN3;LRP1;EGFR;LRP3;FCHO1;AP2A2;AMN;LDLR;LDLRAP1;LRP10;CLTCL1
4222,GO:0009409,0.0076856382144705,0.998005439956611,8,31,response to cold,BP,FOS;ZNF516;THRA;LRP11;VGF;ACOT11;SLC25A27;PCSK1N
10337,GO:0043168,0.0077260479152852,0.993820041627773,224,2001,anion binding,MF,CEMIP;APOE;PTPRS;SYTL1;PYGB;RAPGEF3;XDH;PRODH;PGF;NOS1;ARAP1;POSTN;GRB7;SCN8A;EPHB2;OBSCN;NME4;MST1R;LRP1;MAPK13;CDK18;LTBP2;ACBD4;EGFR;SMOC2;HADH;CRYL1;ACSF2;ACOT7;HS1BP3;MTHFR;ULK1;PKN1;PYGL;SYT8;SHC1;PTK6;GNAL;ABCA7;ACTA2;DNAH1;PITPNC1;ULK2;DGKA;THBS3;D2HGDH;ABCG1;OPLAH;NEK9;RPS6KA2;NMRK1;NISCH;TUBG2;MARK4;PLTP;ERBB2;BRSK1;OGDHL;CBS;ITPR3;DNM1;CUL9;KIF13B;PAK6;SERPINE2;VAMP2;MINK1;ATP2B4;CSNK1E;RASA4;PLCD1;AGAP1;GLUL;RHOD;TNXB;INSR;RAB3D;SH3PXD2B;GRK6;MVD;EPHA1;TXNRD3;LPAR3;TMEM173;DHX32;ATP7B;SNX33;SNX9;SPEG;ABCD1;MKNK2;STRADB;RAB25;FAM20C;MYO18A;UCKL1;PFKFB2;ATP12A;DYRK1B;SEC14L2;SRMS;VEGFA;ARL2;MAST4;ACVR2B;MAPK3;TUB;DHTKD1;ARL10;RAB40B;ENTPD2;GALK1;FYCO1;ADCY6;WIPI2;PKN3;EPHB3;PC;ACAD10;NAGS;NRP2;NADK;ABCA2;TK2;MCTP1;OSBPL5;RASL10B;CKMT1A;PFKL;RHOF;HLCS;FGFR3;PRKACA;PITPNM1;LRRK1;DGUOK;RPS6KA5;HBEGF;RAB3B;MAP2K2;PI4K2A;FGFR4;PMVK;MYH3;PSD4;EHD4;SNX17;TRPV4;RHOBTB2;EEF2K;LDLRAP1;DGKQ;HK1;GAS6;PPARA;HMGCL;TKFC;GUK1;STK32C;PTAFR;DMC1;RXRA;PCK2;BCR;SDHA;GSDMC;PRKCZ;HLTF;ABCD4;TWF2;PDK2;GPC1;MAPKAPK3;ARAP3;FGFR1;CAMKK1;PHYH;GTPBP1;ESYT2;ASS1;SESN2;ADGRE2;GAL3ST4;RTN4R;GRHPR;ACTR1B;FGFBP1;STK39;COL13A1;VEGFB;ACVR1B;GSDMA;GSS;ERBB3;AKT1;TRAP1;NLRX1;SEPT8;TUT1;SMARCA1;ERCC6;ADCK2;PINK1;EHD3;LONP2;MAP2K3;PNPO;SNX29;STK17A;ERN1;ACADS;GCAT;MOCS1;SIRT3;JAK3;MAST3;KIFC2;FUK;ZCCHC14;GSTM2;ZFYVE19;TTLL11;RAB40C;KIF26B
4702,GO:0010874,0.00775787199529776,0.998816693513289,5,14,regulation of cholesterol efflux,BP,APOE;LRP1;ABCA7;ABCG1;PLTP
16512,GO:0097283,0.00779797090826272,0.999596133102772,3,5,keratinocyte apoptotic process,BP,GSN;ZFP36L1;ZFP36
17863,GO:1902172,0.00779797090826272,0.999596133102772,3,5,regulation of keratinocyte apoptotic process,BP,GSN;ZFP36L1;ZFP36
2181,GO:0005041,0.00780944526262567,0.999182463751004,4,9,low-density lipoprotein particle receptor activity,MF,LRP1;LDLR;LRP10;SORL1
18051,GO:1902668,0.00781281906590599,0.998493244603536,6,19,negative regulation of axon guidance,BP,SEMA4B;SEMA3B;SEMA3F;SEMA4C;WNT3;SEMA4F
10317,GO:0043129,0.00781383344208215,0.999595001502674,3,5,surfactant homeostasis,BP,EPAS1;VEGFA;CTSH
1068,GO:0002634,0.00786504298860113,0.999591342217841,3,5,regulation of germinal center formation,BP,PKN1;BCL6;ADA
16296,GO:0090527,0.00790071582894691,0.999170040714514,4,9,actin filament reorganization,BP,GSN;ARAP1;EFS;DMTN
4327,GO:0009888,0.00793226388864551,0.993953866391616,142,1224,tissue development,BP,FOS;DUSP6;CTNNBIP1;PPL;PTPRS;SEMA4B;GAA;CST3;RAPGEF3;CYP27B1;GSN;XDH;PGF;MEF2D;ZFP36L1;COL6A1;TCTN1;POSTN;ALOX15B;NFATC4;OBSL1;EGFR;DUSP5;EGR1;PTK6;DEAF1;LAMA5;BBS2;ACTA2;PRSS8;S100A4;CTSB;THBS3;ZNF516;THRA;LRP5;HYAL1;ZFPM1;BSG;PKD2;TST;ITGB4;PHLDA2;PTHLH;SALL2;IFT140;SERPINE2;FUZ;FOXQ1;ADAMTS7;PDCD4;LAMB2;WNT7A;INSR;LCE1E;SH3PXD2B;FBXW8;ID1;CELSR1;ADARB1;ITGA6;DNPH1;SPRY2;ECM1;STAT6;WWTR1;RAB25;FAM20C;TMEM107;DYRK1B;VEGFA;VANGL2;FBXW4;AP2A2;CEBPB;ACVR2B;ADAM15;NAB2;S1PR2;MAPK3;ETV5;DVL1;HES1;FURIN;CUL7;EVC;NRP2;ADA;AQP3;CELSR2;ZFP36;FGFR3;HBEGF;ITGB5;TNFRSF1A;SEMA3B;TRPV4;HMGA2;SEMA3F;SEMA4C;GAS6;BTRC;PPARA;WNT7B;SUFU;RXRA;PCK2;VASN;SLITRK6;TPP1;GPC1;FGFR1;CTSZ;CHADL;PIN1;PROX1;DLG3;PPP1R13L;BFSP1;JARID2;TOLLIP;WNT2B;TMEM231;TIMP1;SDC1;WNT3;ACVR1B;ERBB3;AKT1;PKD1;CTSH;RILPL1;NINJ1;ARHGEF19;TAZ;RARG;EREG;KRT15;ADAMTSL4;SEMA4F;SULF2;KIF26B
16098,GO:0090118,0.00793797595568169,0.99958611460686,3,5,receptor-mediated endocytosis involved in cholesterol transport,BP,PCSK9;LDLR;LDLRAP1
20232,GO:2001225,0.00795835670888654,0.99958465042053,3,5,regulation of chloride transport,BP,PRNP;PTAFR;ANO9
10797,GO:0044304,0.007976488185557,0.997698510590722,9,37,main axon,CC,SCN8A;GJC2;ANK3;DNM1;KIF13B;DLG4;KCNAB2;BIN1;EPB41L3
5794,GO:0017057,0.00799049111556006,1,2,2,6-phosphogluconolactonase activity,MF,H6PD;PGLS
18151,GO:1902947,0.0080375543643991,0.999578946869053,3,5,regulation of tau-protein kinase activity,BP,EGR1;NAB2;SORL1
1879,GO:0004563,0.00804443987625508,0.999578449957996,3,5,beta-N-acetylhexosaminidase activity,MF,HEXB;GM2A;HEXDC
7805,GO:0032370,0.0080595403380618,0.997880272034724,8,32,positive regulation of lipid transport,BP,APOE;LRP1;ABCA7;ABCG1;PLTP;NTSR1;LDLRAP1;MIF
15670,GO:0072234,0.00809447170215346,0.998752159124118,5,14,metanephric nephron tubule development,BP,PKD2;WWTR1;HES1;WNT7B;PKD1
16500,GO:0097242,0.00810503944544744,0.998750121473828,5,14,amyloid-beta clearance,BP,APOE;LRP1;ABCA7;INSR;LDLR
2701,GO:0006082,0.00812028452177316,0.994112405409377,99,821,organic acid metabolic process,BP,CEMIP;TYSND1;IDH2;PGM1;PRODH;NOS1;NR1D1;CRAT;ALOX15B;CPT2;GAMT;ALDH4A1;B3GAT3;HADH;CRYL1;ACSF2;ACOT7;UROS;MTHFR;BPHL;SLC16A3;D2HGDH;CRTAP;HYAL1;SLC2A9;BSG;OGDHL;CBS;TST;CPT1C;SLC7A8;HEXB;ATP2B4;GGT1;SLC6A8;GLUL;INSR;B4GAT1;HAGH;BLMH;ABCD1;PFKFB2;MAPK3;GLB1;DHTKD1;GALK1;LTA4H;PHGDH;ST3GAL3;PC;ACAD10;MLXIPL;NAGS;SLC2A3;PYCR2;ACY1;CKMT1A;PFKL;HLCS;FGFR4;XYLT2;TNFRSF1A;ACOT11;PEX7;HK1;CHST6;PPARA;HMGCL;COMT;AIG1;PCK2;SDHA;MDH2;ETFB;PDK2;PHYH;PROX1;ASS1;CES2;SESN2;GRHPR;GSS;AHCYL2;CYP2S1;AKT1;HPDL;LONP2;ABHD14B;AS3MT;ACADS;GCAT;SLC2A1;MLYCD;BCKDHA;GALNS;GSTM2;PODXL2;NDST2;MIF
15532,GO:0072006,0.00812400476263054,0.996582408730741,16,86,nephron development,BP,CTNNBIP1;PGF;EGR1;LAMA5;ACTA2;PKD2;LAMB2;WWTR1;VEGFA;VANGL2;HES1;WNT7B;WNT2B;PKD1;SULF2;KIF26B
717,GO:0001944,0.00812477319280356,0.994633305225482,60,454,vasculature development,BP,APOE;RAPGEF3;XDH;PGF;LTBP1;ZFP36L1;EPHB2;EPAS1;NFATC4;LRP1;LOXL1;EGR1;SHC1;LAMA5;ACTA2;HDAC5;LRP5;HYAL1;ERBB2;PKD2;PLCD1;PDCD4;WNT7A;ZMIZ1;FBXW8;ID1;EPHA1;SPRY2;ECM1;PLCD3;FZD8;VEGFA;ACVR2B;ADAM15;EPHB3;HES1;CUL7;ARHGAP22;NRP2;SH2D2A;FGFR4;SNX17;HMGA2;ELK3;ADGRB2;WNT7B;SUFU;VAV3;FGFR1;C5;TMEM204;PROX1;TMEM231;VEGFB;AKT1;PKD1;CTSH;ROBO4;EPN2;EREG
17468,GO:1900451,0.00813271010474867,0.999572065034086,3,5,positive regulation of glutamate receptor signaling pathway,BP,EPHB2;SHANK3;PINK1
19483,GO:1990393,0.00813751943090484,0.999571716376975,3,5,3M complex,CC,OBSL1;FBXW8;CUL7
8094,GO:0032794,0.00815606460744148,0.998740273118035,5,14,GTPase activating protein binding,MF,PLCD1;PLXNB1;PIN1;AKT1;RGS14
18596,GO:1903909,0.00816539621122876,0.999569693837155,3,5,regulation of receptor clustering,BP,GSN;SSH1;SHISA6
2758,GO:0006182,0.00816820634200673,0.998737927260048,5,14,cGMP biosynthetic process,BP,APOE;NOS1;ADCY6;GUCA1B;ADORA2B
12218,GO:0048513,0.00817188109834553,0.993427216251018,234,2127,animal organ development,BP,HTRA1;FOS;DUSP6;CTNNBIP1;PPL;PTPRS;ERCC1;SEMA4B;GAA;CST3;SHANK2;CYP27B1;XDH;PGF;MEF2D;LTBP1;ZFP36L1;TCTN1;ALOX15B;FAM210B;EPHB2;EPAS1;CNTN1;IGF2;NFATC4;LRP1;GAMT;RAB11FIP4;OBSL1;EGFR;FHL1;MDFI;EGR1;PKN1;CMTM7;SDK2;NAGLU;SHC1;DEAF1;LAMA5;BBS2;ACTA2;PRSS8;S100A4;CTSB;GJC2;THBS3;ASH2L;SOX12;ZNF516;HDAC5;THRA;ZP3;LRP5;HYAL1;ZFPM1;TFEB;ERBB2;BSG;PTPRU;PKD2;ITGB4;PHLDA2;SPRY4;PTHLH;SALL2;IFT140;CD9;SERPINE2;FUZ;FOXQ1;NPHP4;ATP2B4;TFDP2;CSNK1E;ACP5;PLCD1;TRAPPC9;ADAMTS7;PDCD4;LAMB2;WNT7A;ZMIZ1;INSR;LCE1E;SH3PXD2B;FBXW8;ID1;CELSR1;ADARB1;ITGA6;NBEAL2;ATP7B;SPRY2;ECM1;STAT6;SPEG;MKNK2;PLCD3;WWTR1;FAM20C;BCL6;PLXNB1;FAM213A;DYRK1B;BNIP3;FZD8;VEGFA;LRRC8A;VANGL2;FBXW4;AP2A2;CEBPB;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;MAPK3;TUB;KCNAB2;ETV5;DHTKD1;DVL1;L3MBTL1;PHGDH;EPHB3;HES1;FURIN;MBOAT7;CUL7;EVC;NRP2;ADA;TRIM45;AQP3;CELSR2;IL6R;SLIT3;PCSK9;ZFP36;FGFR3;PITPNM1;LRRK1;SLC38A10;HBEGF;DMTN;MYH3;MDGA1;VGF;TCF25;SEMA3B;SNX17;SOX13;TRPV4;RAG1;MSLN;HMGA2;SEMA3F;PEX7;SEMA4C;SDHAF4;GAS6;BTRC;POU6F1;PPARA;HMGCL;WNT7B;SUFU;RFNG;DMC1;RXRA;PCK2;LRP10;VASN;BCR;WDR60;PRKCZ;INPP5D;SLITRK6;GPC1;SRSF5;ZNF160;NDE1;AGO4;FGFR1;CTSZ;CHADL;PIN1;PROX1;PPP1R13L;SLC25A27;BFSP1;JARID2;WNT2B;SNPH;TMEM231;RTN4R;TIMP1;SDC1;SH2B3;WNT3;COL13A1;VEGFB;ACVR1B;MEF2B;ERBB3;ABR;AKT1;ADAM19;ZNF385A;NDRG2;SMARCA1;VPS33B;SIX5;SUN1;GAS8;PKD1;CTSH;NINJ1;ARHGEF19;SLC2A1;TAZ;JAK3;RARG;EREG;GIPR;KRT15;TRNP1;POLM;SEMA4F;SULF2;KIF26B;LZTS2
10349,GO:0043183,0.00818680474315978,1,2,2,vascular endothelial growth factor receptor 1 binding,MF,VEGFA;VEGFB
10358,GO:0043197,0.00819011471188777,0.996344124736754,18,101,dendritic spine,CC,SHANK2;NOS1;NR1D1;FBXO2;ZMYND8;TENM2;DNM1;NTSR1;DLG4;SHANK3;DVL1;ABHD17C;EEF2K;COMT;RGS14;DDN;APBA1;SHISA6
2168,GO:0005007,0.00821301928840526,0.999566232409682,3,5,fibroblast growth factor-activated receptor activity,MF,FGFR3;FGFR4;FGFR1
6404,GO:0021675,0.00822825337545362,0.997407093707626,10,44,nerve development,BP,EPHB2;SERPINE2;ADARB1;HES1;NRP2;SEMA3F;AHNAK2;SLITRK6;ERBB3;SULF2
8105,GO:0032805,0.00831534587002124,1,2,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,APOE;PCSK9
16424,GO:0097114,0.00831534587002132,1,2,2,NMDA glutamate receptor clustering,BP,APOE;SHANK3
18156,GO:1902952,0.00831534587002132,1,2,2,positive regulation of dendritic spine maintenance,BP,APOE;ZMYND8
18179,GO:1902994,0.00831534587002132,1,2,2,regulation of phospholipid efflux,BP,APOE;ABCA7
18180,GO:1902995,0.00831534587002132,1,2,2,positive regulation of phospholipid efflux,BP,APOE;ABCA7
18130,GO:1902903,0.00842153309036607,0.995101961408446,36,249,regulation of supramolecular fiber organization,BP,APOE;RAPGEF3;GSN;ARAP1;ARPIN;CORO1B;TMOD2;SH3PXD2B;ID1;EPHA1;PLEKHH2;ARL2;SHANK3;WIPF1;FHOD1;SSH1;PLEKHG2;CDC42EP5;SPTB;DMTN;LDLR;TRPV4;CAPG;TWF2;CHADL;PROX1;WHAMMP3;EPS8L1;PPM1F;EPS8L2;SSH3;ARHGEF10L;SPIRE2;MLST8;PYCARD;FCHSD1
18677,GO:1904064,0.00843072819644809,0.996819318912131,13,66,positive regulation of cation transmembrane transport,BP,CEMIP;NOS1;EPHB2;F2R;GJC2;ANK3;PKD2;NTSR1;SHANK3;GLRX;PINK1;EHD3;GSTM2
6089,GO:0019318,0.00850320221528907,0.99549490907847,27,173,hexose metabolic process,BP,H6PD;GAA;PGM1;NR1D1;IGF2;GALE;NISCH;LRP5;FUCA1;PHLDA2;INSR;PFKFB2;GLB1;GALK1;PC;PFKL;DGKQ;HK1;PPARA;TKFC;PCK2;IGFBP4;MDH2;PDK2;MAN2B2;AKT1;MLYCD
6091,GO:0019320,0.0085600365122014,0.997492260638384,9,38,hexose catabolic process,BP,PGM1;GALE;LRP5;PFKFB2;GLB1;GALK1;PFKL;HK1;TKFC
623,GO:0001807,0.00858745744506715,1,2,2,regulation of type IV hypersensitivity,BP,ZP3;IL20RB
10718,GO:0044093,0.00861652346828181,0.993397048590064,145,1253,positive regulation of molecular function,BP,DUSP6;LMF1;CEMIP;APOE;RAPGEF3;CYP27B1;GSN;EVI5L;XDH;NOS1;ARAP1;RBCK1;EPHB2;IGF2;MST1R;LRP1;EGFR;TIMP2;B3GAT3;DUSP5;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;SHC2;TBC1D14;GRAMD4;RIN1;ANK3;PIK3R2;HDAC5;ARHGAP23;DOCK4;LRP5;ERBB2;FBLN1;PKD2;PAK6;NTSR1;MINK1;RALGAPA2;ATP2B4;RASA4;TRAPPC9;AGAP1;GM2A;ACAP3;PLEKHG4;INSR;SH3PXD2B;TBC1D8;EPHA1;ITGA6;SYNGAP1;LPAR3;TMEM173;PRNP;SERINC2;SPRY2;SNX9;DLG4;STRADB;ARHGAP27;PFKFB2;PLXNB1;CD81;FZD8;VEGFA;VANGL2;SHANK3;ACVR2B;NAB2;S1PR2;MAPK3;GPSM1;ADCY6;EPHB3;HES1;MEFV;ARHGAP22;CDC42EP5;PIDD1;FGFR3;PRKACA;CYFIP2;RPS6KA5;MAP2K2;DAP;FGFR4;DUSP7;HMGA2;DGKQ;GAS6;LLGL1;WNT7B;GIT1;PTAFR;PLEKHG6;RFNG;ARHGEF37;VAV3;BCR;TBC1D16;PRKCZ;MAPKAPK3;ARAP3;FGFR1;CAMKK1;PIN1;C5;PROX1;ASAP2;DLG3;GLRX;MAPRE3;GUCA1B;MADD;RTN4R;PPM1F;SORL1;STK39;TBC1D17;ALS2CL;ADORA2B;ERBB3;ABR;AKT1;ERCC6;PINK1;PKD1;EHD3;RGS14;CTSH;MLST8;PYCARD;MAP2K3;ERN1;ARHGEF19;EREG;FAM162A;GSTM2;RGS12;MIF
19728,GO:2000146,0.00864009241703952,0.995415141153323,27,174,negative regulation of cell motility,BP,APOE;IDH2;ALOX15B;LRP1;MMP28;ARPIN;CORO1B;ZMYND8;HDAC5;NISCH;FBLN1;PTPRU;PLXNB3;FUZ;EPHA1;ADARB1;ADAM15;ADA;MCTP1;BCR;ARAP3;PIN1;C5;TIMP1;ABR;TP53INP1;MIF
17680,GO:1901616,0.00884780826807229,0.997393809845653,9,38,organic hydroxy compound catabolic process,BP,APOE;CYP27B1;NTSR1;SRD5A3;SNX17;TKFC;COMT;IMPA2;TRERF1
11819,GO:0046813,0.00892522945324952,1,2,2,receptor-mediated virion attachment to host cell,BP,CD81;GAS6
3069,GO:0006644,0.00892930305671583,0.994395800245365,47,343,phospholipid metabolic process,BP,EGFR;ISYNA1;LPCAT4;DGKA;PIK3R2;ZP3;ERBB2;HEXB;PLCD1;ZFYVE21;MVD;SERINC2;SRD5A3;CD81;MBOAT7;OSBPL5;PCSK9;FGFR3;PITPNM1;PLCH2;HBEGF;PI4K2A;FGFR4;PMVK;LDLR;PIGZ;DGKQ;TTC7B;IMPA2;VAV3;INPP5D;FGFR1;PI4KAP2;LCAT;PITPNM3;PIGV;PIGQ;SBF1;ERBB3;ACP6;GPD1L;PLPPR2;AGPAT4;CPNE7;TAZ;EREG;AGPAT3
524,GO:0001631,0.00893669116790724,1,2,2,cysteinyl leukotriene receptor activity,MF,LTB4R;LTB4R2
525,GO:0001632,0.00893669116790724,1,2,2,leukotriene B4 receptor activity,MF,LTB4R;LTB4R2
2150,GO:0004974,0.00893669116790724,1,2,2,leukotriene receptor activity,MF,LTB4R;LTB4R2
14404,GO:0061737,0.00893669116790724,1,2,2,leukotriene signaling pathway,BP,LTB4R;LTB4R2
5594,GO:0016645,0.00897611242789377,0.998194098938825,6,20,oxidoreductase activity, acting on the CH-NH group of donors,MF,PRODH;ALDH4A1;MTHFR;PYCR2;BLVRB;SMOX
12279,GO:0048640,0.00902097986732159,0.996571500949811,13,65,negative regulation of developmental growth,BP,PTPRS;WWC3;SEMA4B;BBS2;ULK2;FGFR3;SEMA3B;SEMA3F;SEMA4C;JARID2;RTN4R;WNT3;SEMA4F
17545,GO:1901184,0.00908497979579574,0.996252725709168,15,80,regulation of ERBB signaling pathway,BP,ARAP1;EGFR;RHBDF1;SHC1;PTK6;ERBB2;SPRY2;MVB12B;RHBDF2;HBEGF;MVB12A;ERBB3;AKT1;CBLC;EREG
13800,GO:0060425,0.00908668809453102,0.997311658554065,9,38,lung morphogenesis,BP,ID1;CELSR1;SPRY2;VANGL2;MAPK3;WNT7B;CTSZ;WNT2B;CTSH
17581,GO:1901293,0.00911287315461927,0.994758491012659,34,235,nucleoside phosphate biosynthetic process,BP,APOE;IDH2;NAPRT;PGM1;NOS1;NME4;TIMP2;ACOT7;NMRK1;OGDHL;PTHLH;LTB4R2;INSR;UCKL1;PFKFB2;DHTKD1;GALK1;LHPP;ADCY6;MLXIPL;NADK;TK2;ADA;PFKL;DGUOK;HK1;PPARA;GUK1;GUCA1B;ADORA2B;PINK1;TAZ;FUK;PPCS
12400,GO:0048871,0.00918167509224265,0.994923559099771,30,199,multicellular organismal homeostasis,BP,NR1D1;EPAS1;EGFR;CRTC1;F2R;BBS2;NPHP4;NTSR1;ACP5;RAB3D;IL20RB;VEGFA;TUB;ADCY6;AQP3;PRKACA;LRRK1;SCNN1A;BBS1;TRPV4;CROCC;INPP5D;SPATA7;TPP1;CDHR1;PPP1R13L;STK39;ERCC6;HOMER2;CTSH
7261,GO:0031253,0.00919432869999415,0.994862713227436,31,206,cell projection membrane,CC,SYTL1;SHANK2;ARHGEF4;ABCA7;BBS2;KCNC4;PKD2;SPRY4;INSR;SPRY2;RAB25;SHANK3;AMN;EVC;SCNN1A;DMTN;BBS1;PSD4;TRPV4;CDHR1;TMEM231;GUCA1B;ADGRE2;CYBRD1;EPB41L3;EPS8L1;EPS8L2;PKD1;EHD3;DDN;SHISA6
12564,GO:0050766,0.00919686831291083,0.997808716810099,7,26,positive regulation of phagocytosis,BP,ABCA7;MYO18A;TUB;GAS6;BCR;ABR;PYCARD
5653,GO:0016772,0.00919989441062269,0.993340574531007,95,776,transferase activity, transferring phosphorus-containing groups,MF,LTBP4;LTBP1;POLD4;EPHB2;OBSCN;NME4;MST1R;MAPK13;CDK18;EGFR;ULK1;PKN1;PTK6;ULK2;DGKA;PIK3R2;NEK9;RPS6KA2;NMRK1;MARK4;ERBB2;BRSK1;PAK6;MINK1;CSNK1E;ZFYVE21;INSR;GRK6;POLL;EPHA1;EFNB3;DLG4;SPEG;FGGY;MKNK2;STRADB;FAM20C;UCKL1;PFKFB2;DYRK1B;SRMS;MAST4;ACVR2B;MAPK3;GALK1;PKN3;EPHB3;NAGS;NRP2;NADK;TK2;CKMT1A;PFKL;FGFR3;PRKACA;LRRK1;DGUOK;RPS6KA5;HBEGF;MAP2K2;PI4K2A;FGFR4;PMVK;EEF2K;HMGA2;DGKQ;HK1;TKFC;GUK1;STK32C;BCR;PRKCZ;PDK2;MAPKAPK3;FGFR1;CAMKK1;DLG3;PI4KAP2;ADCK5;STK39;ACVR1B;ERBB3;AKT1;TUT1;ADCK2;PINK1;MAP2K3;STK17A;ERN1;PRIMPOL;JAK3;MAST3;FUK;EREG;POLM
5316,GO:0016052,0.00920318711035165,0.995456896537649,22,134,carbohydrate catabolic process,BP,GAA;PYGB;PGM1;CRYL1;PYGL;GALE;LRP5;OGDHL;HEXB;GM2A;INSR;PFKFB2;GLB1;DHTKD1;GALK1;MLXIPL;PFKL;HK1;PPARA;TKFC;MAN2B2;NAGA
5511,GO:0016491,0.00921627586966551,0.993761838771908,65,525,oxidoreductase activity,MF,H6PD;IDH2;CYP27B1;XDH;PRDX5;PRODH;NOS1;ALOX15B;GPX3;ALDH4A1;HADH;CRYL1;LOXL1;MTHFR;KDSR;DHRS1;D2HGDH;DHRS11;OGDHL;CBS;VAT1;MSRB2;DHRS4L2;AKR7A2;NDUFS8;TXNRD3;SRD5A3;HSD11B1L;KCNAB2;DHTKD1;PHGDH;PHYHD1;ACAD10;PYCR2;RETSAT;CYP3A5;TM7SF2;SDHAF4;BLVRB;ALDH16A1;SDHA;MDH2;ETFB;SMOX;PHYH;GLRX;SESN2;NDUFA4L2;TSTA3;CYBRD1;GRHPR;GSTT1;KIAA1191;CYP2S1;HPDL;GPD1L;UQCR11;KDM4B;RSAD1;PNPO;NDUFV3;ACADS;ALKBH6;BCKDHA;GSTM2
19211,GO:1905384,0.00924936150211598,1,2,2,regulation of protein localization to presynapse,BP,WNT7A;DVL1
19212,GO:1905386,0.00924936150211598,1,2,2,positive regulation of protein localization to presynapse,BP,WNT7A;DVL1
12044,GO:0048015,0.00925665547933641,0.995811867101276,18,102,phosphatidylinositol-mediated signaling,BP,GSN;ZFP36L1;IGF2;EGFR;RGL2;F2R;PIK3R2;ZP3;ERBB2;SERPINE2;PLXNB1;MAPK3;PTAFR;NYAP1;FGFR1;PI4KAP2;ERBB3;AKT1
7017,GO:0030802,0.00926734804442613,0.997788604594111,7,26,regulation of cyclic nucleotide biosynthetic process,BP,APOE;NOS1;TIMP2;PTHLH;LTB4R2;GUCA1B;ADORA2B
4058,GO:0009117,0.00927103877021239,0.993826386380489,60,476,nucleotide metabolic process,BP,H6PD;APOE;IDH2;NT5E;NAPRT;RAPGEF3;PGM1;XDH;PGLS;NOS1;NME4;TIMP2;ACOT7;NMRK1;OGDHL;PKD2;PTHLH;LTB4R2;INSR;NDUFS8;DNPH1;DLG4;TALDO1;FAM20C;UCKL1;PFKFB2;VEGFA;KCNAB2;DHTKD1;GALK1;ADCY6;MLXIPL;NADK;TK2;ADA;PFKL;NUDT10;DGUOK;MYH3;HK1;PPARA;GUK1;PCK2;SDHA;MDH2;GTPBP1;DLG3;GUCA1B;ADORA2B;GPD1L;UQCR11;PINK1;ABHD14B;NDUFV3;MOCS1;TAZ;NEIL1;FUK;PPCS;PODXL2
18869,GO:1904580,0.00928514150630468,1,2,2,regulation of intracellular mRNA localization,BP,ZFP36L1;ZFP36
18870,GO:1904582,0.00928514150630468,1,2,2,positive regulation of intracellular mRNA localization,BP,ZFP36L1;ZFP36
12039,GO:0048010,0.00929988247205211,0.996293772126741,14,73,vascular endothelial growth factor receptor signaling pathway,BP,PGF;MAPK13;SHC2;PIK3R2;VEGFA;NRP2;SH2D2A;CYFIP2;VAV3;MAPKAPK3;TMEM204;GRB10;VEGFB;EPN2
19259,GO:1905517,0.00931988603119008,0.998089582580449,6,21,macrophage migration,BP,MMP28;MAPK3;TRPV4;C5;CKLF;MIF
19260,GO:1905521,0.00937976403769926,0.998468203481478,5,15,regulation of macrophage migration,BP,MMP28;MAPK3;TRPV4;C5;MIF
8705,GO:0034367,0.00939227699621267,0.998908927665433,4,10,protein-containing complex remodeling,BP,APOE;ABCG1;PLTP;LCAT
9698,GO:0038131,0.00946131541747093,1,2,2,neuregulin receptor activity,MF,RTN4R;ERBB3
3788,GO:0008374,0.00955676882988556,0.997148895658252,9,38,O-acyltransferase activity,MF,CRAT;CPT2;LPCAT4;CPT1C;MBOAT7;LCAT;AGPAT4;TAZ;AGPAT3
6641,GO:0023061,0.00959209541916464,0.994415525016528,35,242,signal release,BP,SYTL1;LTBP4;RAPGEF3;NR1D1;EGFR;HADH;NLGN2;SYT8;KCNC4;LRP5;BRSK1;ITPR3;RIMS3;VAMP2;GLUL;ASIC1;WNT7A;PFKFB2;ARL2;ACVR2B;DVL1;MCTP1;RASL10B;PFKL;VGF;TRPV4;PCK2;TM7SF3;FGFR1;VSNL1;SNPH;SIRT3;SLC2A1;APBA1;GIPR
1167,GO:0002790,0.00962838185713577,0.99392748285183,47,347,peptide secretion,BP,LMF1;IDH2;LTBP4;RAPGEF3;POSTN;NR1D1;ALOX15B;LTBP2;EGFR;HADH;NLGN2;RHBDF1;F2R;LRP5;ITPR3;GLUL;RAB3D;MYO18A;PFKFB2;ARL2;RHBDF2;ACVR2B;MAPK3;OLFM2;RAB40B;RASL10B;PFKL;MAPKBP1;RAB3B;DMTN;VGF;TRPV4;HK1;GAS6;LLGL1;PCK2;PRKCZ;TM7SF3;C5;VSNL1;PYCARD;KCNN4;SIRT3;SLC2A1;GIPR;RAB40C;MIF
5053,GO:0015276,0.00963056710464655,0.997123213518819,9,38,ligand-gated ion channel activity,MF,CLCA2;KCNJ15;PKD2;ITPR3;ASIC1;DLG4;SCNN1A;DLG3;TPCN1
6602,GO:0022834,0.00963056710464655,0.997123213518819,9,38,ligand-gated channel activity,MF,CLCA2;KCNJ15;PKD2;ITPR3;ASIC1;DLG4;SCNN1A;DLG3;TPCN1
3009,GO:0006562,0.00964424662978225,1,2,2,proline catabolic process,BP,PRODH;ALDH4A1
4392,GO:0010133,0.00964424662978225,1,2,2,proline catabolic process to glutamate,BP,PRODH;ALDH4A1
12597,GO:0050807,0.00965675427106441,0.995726496899499,17,95,regulation of synapse organization,BP,ADGRL1;APOE;EPHB2;NFATC4;NLGN2;IGSF9;ZMYND8;WNT7A;PRNP;SHANK3;ETV5;EPHB3;SSH1;EEF2K;ADGRB2;SLITRK6;SHISA6
7347,GO:0031401,0.00967577160406188,0.992980654811026,95,781,positive regulation of protein modification process,BP,TNIP1;DUSP6;CEMIP;RAPGEF3;XDH;NOS1;EPHB2;CNTN1;IGF2;MST1R;EGFR;TIMP2;DUSP5;EGR1;PKN1;SHC1;F2R;PTK6;ABCA7;SHC2;ERBB2;PKD2;PAK6;MINK1;ATP2B4;TNFRSF25;WNT7A;INSR;EPHA1;LPAR3;PRNP;SPRY2;SNX9;DLG4;STRADB;BCL6;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;MAPK3;DVL1;MTA1;ADCY6;EPHB3;HES1;IL6R;FGFR3;PRKACA;LRRK1;RPS6KA5;HBEGF;MAP2K2;FGFR4;TNFRSF1A;EHD4;MAPK8IP1;TRPV4;DUSP7;DGKQ;SEMA4C;GAS6;WNT7B;IGFBP4;PRKCZ;MAPKAPK3;FGFR1;CAMKK1;PIN1;C5;PROX1;WBP2;DLG3;JARID2;TOLLIP;MAPRE3;MADD;STK39;ACVR1B;ADORA2B;ERBB3;AKT1;ERCC6;PINK1;PKD1;MLST8;PYCARD;MAP2K3;POMT1;ERN1;EREG;MIF
18164,GO:1902960,0.00967640260530932,1,2,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,BIN1;SORL1
19153,GO:1905246,0.00967640260530932,1,2,2,negative regulation of aspartic-type peptidase activity,BP,BIN1;SORL1
14097,GO:0060988,0.00967640260530934,1,2,2,lipid tube assembly,BP,SNX9;BIN1
14953,GO:0070889,0.00967954643202229,1,2,2,platelet alpha granule organization,BP,ZNF385A;VPS33B
1985,GO:0004709,0.00968914585082044,0.996652731070591,11,51,MAP kinase kinase kinase activity,MF,EPHB2;MST1R;EGFR;ERBB2;INSR;EPHA1;EPHB3;FGFR3;FGFR4;FGFR1;ERBB3
17196,GO:0106104,0.00970117439860525,1,2,2,regulation of glutamate receptor clustering,BP,SSH1;SHISA6
18927,GO:1904717,0.00970117439860525,1,2,2,regulation of AMPA glutamate receptor clustering,BP,SSH1;SHISA6
16370,GO:0097017,0.0097083998225508,1,2,2,renal protein absorption,BP,GSN;GAS6
7954,GO:0032571,0.00970856156669158,1,2,2,response to vitamin K,BP,POSTN;GAS6
15147,GO:0071307,0.00970856156669158,1,2,2,cellular response to vitamin K,BP,POSTN;GAS6
14733,GO:0070435,0.00971312358134919,1,2,2,Shc-EGFR complex,CC,EGFR;SHC1
18962,GO:1904783,0.00971751184330482,1,2,2,positive regulation of NMDA glutamate receptor activity,BP,EPHB2;PINK1
18146,GO:1902938,0.00971853274848934,1,2,2,regulation of intracellular calcium activated chloride channel activity,BP,PRNP;ANO9
3674,GO:0008184,0.00971872469237889,1,2,2,glycogen phosphorylase activity,MF,PYGB;PYGL
17105,GO:0102250,0.00971872469237889,1,2,2,linear malto-oligosaccharide phosphorylase activity,MF,PYGB;PYGL
17127,GO:0102499,0.00971872469237889,1,2,2,SHG alpha-glucan phosphorylase activity,MF,PYGB;PYGL
6010,GO:0019075,0.00971872471197944,1,2,2,virus maturation,BP,MVB12B;MVB12A
19434,GO:1990164,0.00971872471198004,1,2,2,histone H2A phosphorylation,BP,RPS6KA5;HMGA2
2104,GO:0004886,0.00971872471198127,1,2,2,9-cis retinoic acid receptor activity,MF,RXRA;RXRB
4286,GO:0009726,0.00971872471198175,1,2,2,detection of endogenous stimulus,BP,ABCG1;PKD2
19745,GO:2000182,0.00971872471198226,1,2,2,regulation of progesterone biosynthetic process,BP,EGR1;DGKQ
13719,GO:0060319,0.00971872471198244,1,2,2,primitive erythrocyte differentiation,BP,ZFPM1;VEGFA
2588,GO:0005889,0.00971872471198294,1,2,2,potassium:proton exchanging ATPase complex,CC,GM2A;ATP12A
18950,GO:1904761,0.00971872471198306,1,2,2,negative regulation of myofibroblast differentiation,BP,PDCD4;TP53INP1
19558,GO:1990666,0.00971872471198306,1,2,2,PCSK9-LDLR complex,CC,PCSK9;LDLR
8375,GO:0033300,0.00971872471198308,1,2,2,dehydroascorbic acid transmembrane transporter activity,MF,SLC2A3;SLC2A1
14918,GO:0070837,0.00971872471198308,1,2,2,dehydroascorbic acid transport,BP,SLC2A3;SLC2A1
13843,GO:0060488,0.00971872471198313,1,2,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,CELSR1;VANGL2
13844,GO:0060489,0.00971872471198313,1,2,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,CELSR1;VANGL2
13845,GO:0060490,0.00971872471198313,1,2,2,lateral sprouting involved in lung morphogenesis,BP,CELSR1;VANGL2
832,GO:0002133,0.00971872471198316,1,2,2,polycystin complex,CC,PKD2;PKD1
10438,GO:0043314,0.00971872471198316,1,2,2,negative regulation of neutrophil degranulation,BP,BCR;ABR
11136,GO:0045210,0.00971872471198316,1,2,2,FasL biosynthetic process,BP,PHLDA1;JAK3
15542,GO:0072021,0.00971872471198316,1,2,2,ascending thin limb development,BP,PKD2;PKD1
15633,GO:0072177,0.00971872471198316,1,2,2,mesonephric duct development,BP,PKD2;PKD1
15664,GO:0072218,0.00971872471198316,1,2,2,metanephric ascending thin limb development,BP,PKD2;PKD1
16921,GO:0098936,0.00971872471198316,1,2,2,intrinsic component of postsynaptic membrane,CC,PTPRS;NLGN2
16958,GO:0099055,0.00971872471198316,1,2,2,integral component of postsynaptic membrane,CC,PTPRS;NLGN2
16999,GO:0099240,0.00971872471198316,1,2,2,intrinsic component of synaptic membrane,CC,PTPRS;NLGN2
17076,GO:0099699,0.00971872471198316,1,2,2,integral component of synaptic membrane,CC,PTPRS;NLGN2
17288,GO:0140192,0.00971872471198316,1,2,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1;ATP2B4
18014,GO:1902564,0.00971872471198316,1,2,2,negative regulation of neutrophil activation,BP,BCR;ABR
19128,GO:1905167,0.00971872471198316,1,2,2,positive regulation of lysosomal protein catabolic process,BP,LRP1;LDLR
4256,GO:0009611,0.00983517500441408,0.99358186366053,54,413,response to wounding,BP,APOE;PTPRS;CST3;GSN;ZFP36L1;POSTN;EGFR;SERPING1;F2R;CORO1B;DGKA;PLAT;ZFPM1;ERBB2;FBLN1;ITGB4;ITPR3;CD9;SERPINE2;DOCK6;LAMB2;WNT7A;CELSR1;VANGL2;ADAM15;MAPK3;ENTPD2;PHF21A;ZFP36;PRKACA;F12;HBEGF;DMTN;ELK3;DGKQ;GAS6;PPARA;VAV3;ADAMTS13;PROCR;RTN4R;TIMP1;SDC1;SH2B3;ERBB3;AKT1;VPS33B;EHD3;NINJ1;ARHGEF19;EREG;MORN4;GIPR;SULF2
17667,GO:1901575,0.00986190768450384,0.992216499149837,181,1629,organic substance catabolic process,BP,CEMIP;APOE;TYSND1;RNPEPL1;NT5E;GAA;BTBD2;PYGB;RNF44;CST3;RAPGEF3;PGM1;CYP27B1;XDH;PCBP4;PRODH;NOS1;ZFP36L1;NR1D1;CRAT;ARRDC1;RBCK1;CPT2;LRP1;EGFR;TIMP2;H1F0;ALDH4A1;HADH;CRYL1;FBXO2;ACOT7;RHBDF1;PYGL;NAGLU;GALE;CTSB;THRA;PLD3;LRP5;HYAL1;CTSF;OGDHL;CBS;GID4;TMEM129;FUCA1;TST;CPT1C;EDEM1;ABTB1;CUL9;HEXB;SERPINE2;VPS11;NTSR1;ATP2B4;GGT1;CSNK1E;PLCD1;ADAMTS7;GM2A;GLUL;USP20;SPATA18;INSR;HAGH;DNPH1;SRD5A3;IAH1;RNASET2;SNX33;BLMH;SNX9;ABCD1;PLCD3;WWTR1;ISG20;ANKZF1;PFKFB2;MVB12B;BNIP3;CD81;ENTPD6;DNASE1L1;FBXW4;AP2A2;ENDOG;GLB1;DHTKD1;DVL1;ENTPD2;GALK1;MTA1;LTA4H;ACAD10;FURIN;MLXIPL;CUL7;LRSAM1;ADA;PFKL;PCSK9;GGACT;ZFP36;BTBD11;PRKACA;NUDT10;PLCH2;MAGEF1;FBXW5;LDLR;LYPLAL1;CYP3A5;SNX17;ABHD17C;PEX7;MVB12A;HK1;BTRC;PPARA;HMGCL;TKFC;BLVRB;COMT;SUFU;AIG1;IMPA2;PAN2;PCK2;USP21;RNF123;ADAMTS13;ETFB;TPP1;GPC1;SMOX;AGO4;RAD23A;CTSZ;SPSB3;PIN1;MAN1B1;PNPLA4;PHYH;GTPBP1;SH3D19;CES2;CAPN2;SESN2;TOLLIP;MAN2B2;PNRC1;TIMP1;SDC1;APOBEC3C;SORL1;HGSNAT;AKT1;HPDL;CTSD;GPD1L;NAGA;PINK1;PKD1;LONP2;CTSH;CBLC;RNF187;POMT1;TRERF1;ERN1;APOBEC3F;ACADS;FBXL20;GCAT;MLYCD;BCKDHA;NEIL1;GALNS;RPL13A
1978,GO:0004702,0.00988287947098796,0.995745563138231,16,87,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,EPHB2;MST1R;MAPK13;EGFR;ERBB2;MINK1;INSR;EPHA1;ACVR2B;MAPK3;EPHB3;FGFR3;FGFR4;FGFR1;ACVR1B;ERBB3
11623,GO:0046365,0.00990837741825816,0.996770604484661,10,46,monosaccharide catabolic process,BP,PGM1;CRYL1;GALE;LRP5;PFKFB2;GLB1;GALK1;PFKL;HK1;TKFC
10474,GO:0043393,0.00997743213904772,0.994708631747559,26,169,regulation of protein binding,BP,APOE;CTNNBIP1;NFATC4;LRP1;HDAC5;ZFPM1;PHLDA2;CSNK1E;ID1;TMEM173;ADAM15;MAPK3;DVL1;GPSM1;PCSK9;PRKACA;LDLRAP1;PPARA;RFNG;CTSZ;PIN1;MAPRE3;SORL1;AKT1;GAS8;PKD1
17926,GO:1902305,0.00998854564296497,0.996988027606813,9,39,regulation of sodium ion transmembrane transport,BP,NOS1;ANK3;SCN4B;ATP2B4;PCSK9;GLRX;STK39;GPD1L;SNTA1
10009,GO:0042471,0.00999852151565788,0.996323882745743,12,59,ear morphogenesis,BP,EPHB2;NAGLU;CELSR1;SPRY2;VANGL2;MAPK3;DVL1;BCR;SLITRK6;FGFR1;PROX1;ABR
10802,GO:0044309,0.0100457344481441,0.995412426367041,18,103,neuron spine,CC,SHANK2;NOS1;NR1D1;FBXO2;ZMYND8;TENM2;DNM1;NTSR1;DLG4;SHANK3;DVL1;ABHD17C;EEF2K;COMT;RGS14;DDN;APBA1;SHISA6
2933,GO:0006468,0.0100801716508186,0.992197260223711,151,1312,protein phosphorylation,BP,TNIP1;DUSP6;CEMIP;APOE;RAPGEF3;XDH;ZFP36L1;EPHB2;OBSCN;CNTN1;IGF2;MST1R;MAPK13;CDK18;EGFR;TIMP2;DUSP5;EGR1;ULK1;PKN1;SHC1;F2R;PTK6;ABCA7;SHC2;ULK2;GJC2;PIK3R2;NEK9;RPS6KA2;LRP5;MARK4;ERBB2;FBLN1;BRSK1;PKD2;SPRY4;CDKN1C;PAK6;MINK1;ATP2B4;CSNK1E;RASA4;PDCD4;TNFRSF25;WNT7A;INSR;ID1;GRK6;EPHA1;ADARB1;SYNGAP1;LPAR3;PRNP;SPRY2;SNX9;DLG4;SPEG;MKNK2;STRADB;WWTR1;FAM20C;DYRK1B;CD81;SRMS;FZD8;VEGFA;VANGL2;MAST4;SHANK3;ACVR2B;NAB2;S1PR2;MAPK3;DVL1;ADCY6;PKN3;EPHB3;HES1;MLXIPL;CDC42EP5;IL6R;ZFP36;FGFR3;PRKACA;LRRK1;DGUOK;RPS6KA5;HBEGF;MAP2K2;FGFR4;SPTB;DMTN;TNFRSF1A;EHD4;MAPK8IP1;TRPV4;DUSP7;EEF2K;HMGA2;DGKQ;SEMA4C;GAS6;BTRC;STK32C;WNT7B;BCR;IGFBP4;PRKCZ;PDK2;MAPKAPK3;FGFR1;CAMKK1;PIN1;C5;PROX1;DLG3;WDR83;SESN2;ADCK5;MAPRE3;MADD;RTN4R;PPM1F;SORL1;STK39;ACVR1B;ADORA2B;ERBB3;AKT1;NDRG2;ERCC6;GPD1L;IL17RD;ADCK2;PINK1;PKD1;RGS14;CTSH;MLST8;CBLC;PYCARD;MAP2K3;STK17A;ERN1;RANBP9;SIRT3;JAK3;MAST3;EREG;MIF
13742,GO:0060348,0.0100982101459737,0.995166581647085,20,118,bone development,BP,MEF2D;THBS3;LRP5;ZFPM1;ACP5;SH3PXD2B;FAM20C;PLXNB1;NAB2;TRIM45;FGFR3;LRRK1;SLC38A10;TRPV4;PEX7;COL13A1;ZNF385A;VPS33B;RARG;SULF2
13939,GO:0060674,0.0101997463724444,0.997519602443631,7,26,placenta blood vessel development,BP,PKD2;PLCD1;FBXW8;PLCD3;HES1;AKT1;PKD1
12504,GO:0050671,0.0102014758541795,0.996044985304238,13,68,positive regulation of lymphocyte proliferation,BP,IGF2;ZP3;CD320;BCL6;IGFBP2;CD81;HES1;ADA;VAV3;ICOSLG;PYCARD;JAK3;MIF
4776,GO:0010975,0.0102099535740686,0.99364401620514,44,319,regulation of neuron projection development,BP,APOE;PTPRS;SEMA4B;SHANK2;EPHB2;CNTN1;NFATC4;LRP1;OBSL1;CRTC1;PTK6;ULK2;ZMYND8;PLXNB3;KIF13B;WNT7A;FBXW8;ID1;SYNGAP1;LPAR3;EFNB3;DLG4;PLXNB1;VEGFA;SHANK3;DVL1;ADCY6;EPHB3;SSH1;CUL7;DGUOK;SEMA3B;TRPV4;EEF2K;SEMA3F;SEMA4C;TWF2;FGFR1;CTSZ;RTN4R;WNT3;AKT1;SSH3;SEMA4F
684,GO:0001895,0.0104297761977354,0.997114318474154,8,33,retina homeostasis,BP,BBS2;NPHP4;TUB;BBS1;CROCC;SPATA7;CDHR1;ERCC6
17660,GO:1901565,0.010454798337227,0.992171995197034,115,980,organonitrogen compound catabolic process,BP,CEMIP;APOE;RNPEPL1;NT5E;BTBD2;RNF44;CST3;RAPGEF3;XDH;PRODH;NOS1;NR1D1;ARRDC1;RBCK1;LRP1;EGFR;TIMP2;ALDH4A1;FBXO2;RHBDF1;NAGLU;CTSB;HYAL1;CTSF;CBS;GID4;TMEM129;FUCA1;TST;EDEM1;ABTB1;CUL9;HEXB;SERPINE2;VPS11;ATP2B4;GGT1;CSNK1E;ADAMTS7;GM2A;GLUL;USP20;SPATA18;DNPH1;SNX33;BLMH;SNX9;WWTR1;ANKZF1;MVB12B;BNIP3;CD81;FBXW4;AP2A2;GLB1;DVL1;MTA1;LTA4H;FURIN;CUL7;LRSAM1;ADA;PCSK9;GGACT;BTBD11;PRKACA;NUDT10;MAGEF1;FBXW5;LDLR;LYPLAL1;CYP3A5;ABHD17C;MVB12A;BTRC;HMGCL;BLVRB;COMT;SUFU;USP21;RNF123;ADAMTS13;TPP1;GPC1;SMOX;RAD23A;CTSZ;SPSB3;PIN1;MAN1B1;SH3D19;CAPN2;TOLLIP;TIMP1;SDC1;APOBEC3C;SORL1;HGSNAT;AKT1;HPDL;CTSD;NAGA;PINK1;PKD1;LONP2;CTSH;CBLC;RNF187;POMT1;APOBEC3F;FBXL20;GCAT;BCKDHA;NEIL1;GALNS
2967,GO:0006516,0.010455087915641,0.998245126665382,5,15,glycoprotein catabolic process,BP,CST3;FBXO2;EDEM1;GPC1;MAN1B1
2526,GO:0005788,0.0104723133072253,0.994280377427708,28,184,endoplasmic reticulum lumen,CC,H6PD;APOE;CST3;LTBP1;COL6A1;CRTAP;ANO8;ADAMTS7;LAMB2;WNT7A;RNASET2;FAM20C;CERCAM;FKBP10;PCSK9;MXRA8;VGF;MSLN;GAS6;WNT7B;IGFBP4;ADAMTS13;CTSZ;CES2;TIMP1;WNT3;COL13A1;ADAMTSL4
15736,GO:0072358,0.0105207018198681,0.992953330761768,60,460,cardiovascular system development,BP,APOE;RAPGEF3;XDH;PGF;LTBP1;ZFP36L1;EPHB2;EPAS1;NFATC4;LRP1;LOXL1;EGR1;SHC1;LAMA5;ACTA2;HDAC5;LRP5;HYAL1;ERBB2;PKD2;PLCD1;PDCD4;WNT7A;ZMIZ1;FBXW8;ID1;EPHA1;SPRY2;ECM1;PLCD3;FZD8;VEGFA;ACVR2B;ADAM15;EPHB3;HES1;CUL7;ARHGAP22;NRP2;SH2D2A;FGFR4;SNX17;HMGA2;ELK3;ADGRB2;WNT7B;SUFU;VAV3;FGFR1;C5;TMEM204;PROX1;TMEM231;VEGFB;AKT1;PKD1;CTSH;ROBO4;EPN2;EREG
6997,GO:0030695,0.0105370895484909,0.99377475534261,36,249,GTPase regulator activity,MF,EVI5L;ARAP1;APPL2;RALGDS;TBC1D14;RIN1;PIK3R2;ARHGAP23;DOCK4;RALGAPA2;RASA4;AGAP1;ACAP3;TBC1D8;SYNGAP1;ARHGAP27;PLXNB1;ARL2;GPSM1;ARHGAP22;CDC42EP5;LLGL1;GIT1;PLEKHG6;VAV3;BCR;TBC1D16;ARAP3;ASAP2;SESN2;TBC1D17;ALS2CL;ABR;RGS14;ARHGEF19;RGS12
767,GO:0002021,0.0105419185234265,0.998732199689792,4,10,response to dietary excess,BP,APOE;VGF;TRPV4;PCSK1N
3374,GO:0007159,0.0107467564953061,0.99411527976691,28,186,leukocyte cell-cell adhesion,BP,TNIP1;NT5E;IGF2;ZP3;ERBB2;ZMIZ1;IL20RB;PRNP;EFNB3;CERCAM;BCL6;IGFBP2;CEBPB;HES1;TNFRSF14;ADA;PAG1;RAG1;PPARA;PTAFR;PRKCZ;ICOSLG;ASS1;TSTA3;AKT1;PYCARD;JAK3;PODXL2
4226,GO:0009415,0.0108598151795241,0.998682225193235,4,10,response to water,BP,PKD2;LRP11;CD9;ATP2B4
8196,GO:0032963,0.0109336774347345,0.995549255587623,14,74,collagen metabolic process,BP,CST3;MRC2;COL6A1;F2R;CTSB;MMP1;TNXB;ID1;ADAM15;FURIN;COL13A1;CTSD;VPS33B;P3H4
3688,GO:0008202,0.0109531403121038,0.993920392163193,29,196,steroid metabolic process,BP,LMF1;APOE;CYP27B1;NR1D1;EGR1;ABCG1;DHRS11;LRP5;MVD;SRD5A3;HINT2;SEC14L2;OSBPL5;PCSK9;FGFR4;PMVK;LDLR;CYP3A5;SNX17;LDLRAP1;TM7SF2;DGKQ;COMT;RXRA;FGFR1;PROX1;LCAT;SORL1;TRERF1
6199,GO:0019722,0.01102012550946,0.995184862673901,16,90,calcium-mediated signaling,BP,ADGRL1;NOS1;NFATC4;EGFR;PKD2;ATP2B4;PRNP;ADA;MCTP1;PRKACA;DMTN;ADGRB2;ERBB3;TMBIM4;HOMER2;GSTM2
12503,GO:0050670,0.0110369749247573,0.994775730774185,19,114,regulation of lymphocyte proliferation,BP,IGF2;PKN1;ZP3;ERBB2;CD320;IL20RB;PRNP;BCL6;IGFBP2;CD81;CEBPB;HES1;ADA;VAV3;INPP5D;ICOSLG;PYCARD;JAK3;MIF
505,GO:0001568,0.0111518397774036,0.992587189406971,57,434,blood vessel development,BP,APOE;RAPGEF3;XDH;PGF;LTBP1;ZFP36L1;EPHB2;EPAS1;NFATC4;LRP1;LOXL1;EGR1;SHC1;LAMA5;ACTA2;HDAC5;LRP5;HYAL1;ERBB2;PKD2;PLCD1;WNT7A;ZMIZ1;FBXW8;ID1;EPHA1;SPRY2;ECM1;PLCD3;FZD8;VEGFA;ACVR2B;ADAM15;EPHB3;HES1;CUL7;ARHGAP22;NRP2;SH2D2A;FGFR4;SNX17;HMGA2;ELK3;ADGRB2;WNT7B;SUFU;VAV3;FGFR1;C5;PROX1;VEGFB;AKT1;PKD1;CTSH;ROBO4;EPN2;EREG
10874,GO:0044433,0.011198512221328,0.991535112740029,121,1038,cytoplasmic vesicle part,CC,CEMIP;APOE;PTPRS;GAA;NAPRT;PYGB;CST3;PGM1;GSN;NDRG1;PRSS3;IGF2;LRP1;APPL2;RAB11FIP4;EGFR;TIMP2;SERPING1;PYGL;SYT8;ABCA7;CTSB;ULK2;DBNDD1;ERBB2;BSG;PKD2;FUCA1;ITPR3;PRAF2;VAT1;CD9;HEXB;VPS11;VAMP2;CD320;ZFYVE21;GM2A;RHOD;WNT7A;INSR;RAB3D;NBEAL2;TMEM173;RNASET2;SNX33;ECM1;SNX9;DLG4;MARCH2;CHMP1B;MVB12B;VEGFA;DNASE1L1;AP2A2;DPP7;GPRC5C;KCNAB2;AMN;GLB1;RAB40B;LTA4H;FURIN;SLC48A1;SLC2A3;ABCA2;ADA;MCTP1;PFKL;PCSK9;TMEM9;RHOF;HBEGF;RAB3B;PI4K2A;EHD4;LDLR;SNX17;ABHD17C;IFNGR2;LDLRAP1;AHNAK2;SEMA4C;MVB12A;GAS6;LLGL1;WNT7B;PTAFR;PCSK1;TMEM175;CLTCL1;CTSZ;SERPINB6;WDR83;TOLLIP;CSTB;SLC9A7;TIMP1;CD68;ACTR1B;WNT3;SORL1;VEGFB;TPCN1;HGSNAT;CTSD;VPS33B;SUN1;SPPL2B;PKD1;EHD3;SPIRE2;CTSH;EPN2;PYCARD;RHBG;LITAF;GALNS;RAB40C;MIF;STXBP2
15626,GO:0072170,0.0112369015771395,0.998079025928542,5,15,metanephric tubule development,BP,PKD2;WWTR1;HES1;WNT7B;PKD1
4190,GO:0009306,0.0112520203880677,0.992909839892255,45,332,protein secretion,BP,LMF1;IDH2;RAPGEF3;POSTN;NR1D1;ALOX15B;LTBP2;EGFR;HADH;NLGN2;RHBDF1;F2R;LRP5;ITPR3;GLUL;RAB3D;MYO18A;PFKFB2;ARL2;RHBDF2;ACVR2B;MAPK3;OLFM2;RAB40B;PFKL;MAPKBP1;RAB3B;DMTN;VGF;TRPV4;HK1;GAS6;LLGL1;PCK2;PRKCZ;TM7SF3;C5;VSNL1;PYCARD;KCNN4;SIRT3;SLC2A1;GIPR;RAB40C;MIF
6654,GO:0030018,0.0113698387891874,0.995529056759949,13,68,Z disc,CC,FLNC;NOS1;PARVB;SCN8A;OBSCN;MYZAP;OBSL1;ANK3;ATP2B4;AHNAK2;BIN1;SYNC;SLC2A1
6282,GO:0019901,0.0113735970604361,0.992179475856855,67,525,protein kinase binding,MF,TNIP1;GRB7;EPHB2;MST1R;EGFR;TOM1L2;PKN1;SHC1;ACTA2;SHC2;TBC1D14;PIK3R2;NEK9;HDAC5;DOCK4;ERBB2;EXOC2;BRSK1;DNM1;KIF13B;ATP2B4;RHOD;INSR;EPHA1;TMEM173;SPRY2;SLC12A7;CEP250;PFKFB2;AP2A2;DVL1;ADCY6;EPHB3;PAG1;ZFP36;RHOF;FGFR3;PRKACA;PITPNM1;FGFR4;FBXW5;MAPK8IP1;TRPV4;RHOBTB2;GAS6;LLGL1;SUFU;PTAFR;PRKCZ;TWF2;SRSF5;CEP68;MAPKAPK3;FGFR1;PIN1;MAPRE3;PITPNM3;MICALCL;STK39;ERBB3;AKT1;TRAP1;PINK1;PKD1;RGS14;CBLC;MAP2K3
4194,GO:0009311,0.011379229851971,0.995959623808957,11,53,oligosaccharide metabolic process,BP,GAA;ST6GALNAC2;HEXB;GALNT12;GM2A;ST3GAL3;MAN1B1;MAN2B2;GAL3ST4;NAGA;SLC2A1
12285,GO:0048646,0.0114129460748745,0.99181018734279,85,689,anatomical structure formation involved in morphogenesis,BP,HTRA1;DUSP6;ERCC1;RAPGEF3;PGF;NOS1;COL6A1;TCTN1;EPHB2;EPAS1;OBSCN;NFATC4;OBSL1;DUSP5;PKN1;SDK2;SHC1;DEAF1;LAMA5;THBS3;HDAC5;ZP3;HYAL1;ZFPM1;ERBB2;ITGB4;CD9;FUZ;TMOD2;PLCD1;WNT7A;ID1;CELSR1;EPHA1;ITGA6;NBEAL2;SPRY2;ECM1;PLCD3;FAM20C;BCL6;DYRK1B;FZD8;VEGFA;VANGL2;ACVR2B;ADAM15;MAPK3;TNNT1;DVL1;EPHB3;HES1;MBOAT7;ARHGAP22;NRP2;ADA;SH2D2A;ITGB5;FGFR4;MYH3;HMGA2;ELK3;AHNAK2;SEMA4C;ADGRB2;PPARA;SUFU;VAV3;GPC1;FGFR1;C5;PROX1;CAPN2;WNT2B;EPB41L3;WNT3;VEGFB;ZNF385A;CTSH;ROBO4;EPN2;RFX2;RARG;EREG;KIF26B
11846,GO:0046873,0.0114850662098506,0.993536427707252,30,200,metal ion transmembrane transporter activity,MF,SCN8A;KCNG1;KCNC4;KCNJ15;SLC13A3;PKD2;SCN4B;ITPR3;ATP2B4;SLC6A8;SLC20A1;ASIC1;ATP7B;SLC12A7;ATP12A;KCNAB2;SLC28A2;SCNN1A;SLC25A37;TRPV4;GAS6;TMEM175;KCNMA1;SLC9A7;TPCN1;SLC5A5;PKD1;KCNN4;ORAI3;ORAI2
9888,GO:0042226,0.0114934003389333,0.998581251396722,4,10,interleukin-6 biosynthetic process,BP,CEBPB;PTAFR;INPP5D;EREG
8187,GO:0032946,0.011571752492562,0.995433628302731,13,69,positive regulation of mononuclear cell proliferation,BP,IGF2;ZP3;CD320;BCL6;IGFBP2;CD81;HES1;ADA;VAV3;ICOSLG;PYCARD;JAK3;MIF
8391,GO:0033363,0.0115881416267359,0.99750739752655,6,21,secretory granule organization,BP,F2R;SERPINE2;LYST;ZNF385A;VPS33B;RFX2
3234,GO:0006897,0.0116202063528651,0.992200756680445,59,455,endocytosis,BP,APOE;TSPAN1;MRC2;GSN;LRP1;NLGN2;SYT8;ABCA7;RIN1;PIK3R2;LRP5;LRP3;DNM1;FCHO1;CD9;CSNK1E;USP20;SNX33;SNX9;DLG4;MARCH2;MYO18A;ARHGAP27;SCART1;CD81;VEGFA;HOOK2;ELMO3;AP2A2;SSC4D;MAPK3;TUB;AMN;WIPF1;LRSAM1;MCTP1;PCSK9;CYFIP2;EHD4;LDLR;SNX17;EEF2K;LDLRAP1;GAS6;VAV3;LRP10;BCR;TMEM175;CLTCL1;MAPKAPK3;ARAP3;ESYT2;BIN1;PEAR1;SORL1;ABR;STON1;EPN2;PYCARD
14664,GO:0070307,0.0116465906519048,0.998556568831809,4,10,lens fiber cell development,BP,WNT7A;WNT7B;PROX1;BFSP1
8698,GO:0034358,0.0116675821981435,0.997951550868886,5,16,plasma lipoprotein particle,CC,APOE;PLTP;LDLR;LCAT;SORL1
19595,GO:1990777,0.0116675821981435,0.997951550868886,5,16,lipoprotein particle,CC,APOE;PLTP;LDLR;LCAT;SORL1
11086,GO:0045121,0.0116686818057564,0.993423485379377,30,201,membrane raft,CC,MARVELD1;LTB4R;NOS1;CNTN1;EGFR;F2R;MALL;BSG;NTSR1;ATP2B4;INSR;PRNP;STAT6;MAPK3;FURIN;LY6K;PAG1;PRKACA;PI4K2A;TNFRSF1A;HK1;PRKCZ;INPP5D;GPC1;KCNMA1;CAPN2;RTN4R;CTSD;CBLC;SLC2A1
3609,GO:0008064,0.0117575915152224,0.994159632790059,21,130,regulation of actin polymerization or depolymerization,BP,GSN;ARPIN;CORO1B;TMOD2;PLEKHH2;WIPF1;SSH1;PLEKHG2;CDC42EP5;SPTB;DMTN;CAPG;TWF2;WHAMMP3;EPS8L1;EPS8L2;SSH3;SPIRE2;MLST8;PYCARD;FCHSD1
14099,GO:0060993,0.0117664103314846,0.995568686637958,12,60,kidney morphogenesis,BP,CTNNBIP1;PGF;LAMA5;PKD2;WWTR1;VEGFA;VANGL2;HES1;WNT7B;WNT2B;PKD1;KIF26B
11385,GO:0045807,0.0117735325313642,0.994977631672081,15,83,positive regulation of endocytosis,BP,APOE;TSPAN1;LRP1;ABCA7;MYO18A;VEGFA;TUB;PCSK9;LDLR;EEF2K;LDLRAP1;GAS6;BCR;ABR;PYCARD
17701,GO:1901657,0.0117803923888851,0.994380389029429,19,116,glycosyl compound metabolic process,BP,NT5E;NME4;GAMT;FUCA1;AKR7A2;DLG4;UCKL1;TK2;ADA;DGUOK;GUK1;GTPBP1;DLG3;MACROD1;APOBEC3C;AHCYL2;NAGA;APOBEC3F;MOCS1
12496,GO:0050662,0.0117847277778684,0.993215252444665,32,220,coenzyme binding,MF,H6PD;IDH2;PYGB;XDH;PRODH;NOS1;ACBD4;HADH;CRYL1;ACOT7;MTHFR;PYGL;D2HGDH;OGDHL;CBS;TXNRD3;DHTKD1;PHGDH;PC;ACAD10;HLCS;TM7SF2;HMGCL;SDHA;PHYH;TSTA3;GRHPR;GPD1L;PNPO;ACADS;GCAT;SIRT3
2294,GO:0005272,0.0118420624853667,0.997948305345514,5,15,sodium channel activity,MF,SCN8A;PKD2;SCN4B;ASIC1;SCNN1A
16961,GO:0099068,0.0119329422591434,0.998510155456885,4,10,postsynapse assembly,BP,SHANK2;NLGN2;WNT7A;SHANK3
8502,GO:0033700,0.011939607639932,0.999143310707662,3,6,phospholipid efflux,BP,APOE;ABCA7;ABCG1
7849,GO:0032421,0.0119426796825386,0.996983805840502,7,27,stereocilium bundle,CC,ESPN;BBS2;DOCK4;TWF2;EPS8L2;HOMER2;MORN4
9970,GO:0042391,0.011971269538063,0.993308967973373,29,195,regulation of membrane potential,BP,SHANK2;SCN8A;NLGN2;FHL1;CRTC1;ZMYND8;ANK3;SCN4B;RIMS3;NTSR1;ASIC1;WNT7A;DLG4;BNIP3;SHANK3;S1PR2;DVL1;SSH1;PRKCZ;KCNMA1;GLRX;SLC25A27;TPCN1;AKT1;GPD1L;PINK1;EHD3;SNTA1;KCNN4
10503,GO:0043436,0.0119994132208948,0.991185345067188,97,814,oxoacid metabolic process,BP,CEMIP;TYSND1;IDH2;PGM1;PRODH;NOS1;NR1D1;CRAT;ALOX15B;CPT2;GAMT;ALDH4A1;B3GAT3;HADH;CRYL1;ACSF2;ACOT7;UROS;MTHFR;BPHL;SLC16A3;D2HGDH;CRTAP;HYAL1;BSG;OGDHL;CBS;CPT1C;SLC7A8;HEXB;ATP2B4;GGT1;SLC6A8;GLUL;INSR;B4GAT1;HAGH;BLMH;ABCD1;PFKFB2;MAPK3;GLB1;DHTKD1;GALK1;LTA4H;PHGDH;ST3GAL3;PC;ACAD10;MLXIPL;NAGS;SLC2A3;PYCR2;ACY1;CKMT1A;PFKL;HLCS;FGFR4;XYLT2;TNFRSF1A;ACOT11;PEX7;HK1;CHST6;PPARA;HMGCL;COMT;AIG1;PCK2;SDHA;MDH2;ETFB;PDK2;PHYH;PROX1;ASS1;CES2;SESN2;GRHPR;GSS;AHCYL2;CYP2S1;AKT1;HPDL;LONP2;ABHD14B;AS3MT;ACADS;GCAT;SLC2A1;MLYCD;BCKDHA;GALNS;GSTM2;PODXL2;NDST2;MIF
6779,GO:0030228,0.0120270921147439,0.998494817487578,4,10,lipoprotein particle receptor activity,MF,LRP1;LDLR;LRP10;SORL1
6719,GO:0030141,0.0120719589076219,0.991669574942872,67,538,secretory granule,CC,GAA;NAPRT;PYGB;CST3;PGM1;GSN;PRSS3;IGF2;TIMP2;LOXL1;SERPING1;PYGL;SYT8;CTSB;PLAT;BSG;FUCA1;ITPR3;VAT1;CD9;HEXB;SERPINE2;VAMP2;GM2A;RAB3D;NBEAL2;TMEM173;RNASET2;ECM1;VEGFA;DNASE1L1;AP2A2;DPP7;ADAM15;KCNAB2;GLB1;RAB40B;LTA4H;SLC2A3;LY6K;PFKL;RHOF;PRKACA;RAB3B;GAS6;PTAFR;PCSK1;CTSZ;SERPINB6;TOLLIP;CSTB;TIMP1;CD68;ACTR1B;VEGFB;HGSNAT;CTSD;VPS33B;SUN1;CTSH;PYCARD;POMT1;PCSK1N;GALNS;RAB40C;MIF;STXBP2
8185,GO:0032944,0.0121133764679349,0.994207666035365,19,115,regulation of mononuclear cell proliferation,BP,IGF2;PKN1;ZP3;ERBB2;CD320;IL20RB;PRNP;BCL6;IGFBP2;CD81;CEBPB;HES1;ADA;VAV3;INPP5D;ICOSLG;PYCARD;JAK3;MIF
2274,GO:0005229,0.0121470182734682,0.998475225109083,4,10,intracellular calcium activated chloride channel activity,MF,CLCA2;ANO8;TTYH3;ANO9
14426,GO:0061778,0.0121470182734682,0.998475225109083,4,10,intracellular chloride channel activity,MF,CLCA2;ANO8;TTYH3;ANO9
14164,GO:0061098,0.0121678897847786,0.996915420592526,7,27,positive regulation of protein tyrosine kinase activity,BP,PRNP;DLG4;GAS6;DLG3;ERBB3;ERCC6;EREG
7484,GO:0031667,0.0121834252531702,0.99236950354924,43,316,response to nutrient levels,BP,APOE;ERCC1;CST3;CYP27B1;GSN;POSTN;IGF2;EGFR;MTHFR;ULK1;BBS2;ULK2;LRP11;GLUL;DNMT3A;IGFBP2;MAPK3;SSH1;ADA;AQP3;PCSK9;ZFP36;HLCS;DAP;VGF;LDLR;TRPV4;DGKQ;GAS6;PPARA;HMGCL;COMT;PCK2;PDK2;PROX1;SESN2;WNT2B;GSS;AKT1;PCSK1N;C12ORF66;SLC2A1;GIPR
5257,GO:0015914,0.0122883231748069,0.995848671609748,10,47,phospholipid transport,BP,APOE;ABCA7;PITPNC1;ABCG1;PLTP;OSBPL5;PITPNM1;LDLR;PITPNM3;KCNN4
12046,GO:0048017,0.0124392880190816,0.994180840803394,18,105,inositol lipid-mediated signaling,BP,GSN;ZFP36L1;IGF2;EGFR;RGL2;F2R;PIK3R2;ZP3;ERBB2;SERPINE2;PLXNB1;MAPK3;PTAFR;NYAP1;FGFR1;PI4KAP2;ERBB3;AKT1
16875,GO:0098857,0.0124820415539932,0.992925891919278,30,202,membrane microdomain,CC,MARVELD1;LTB4R;NOS1;CNTN1;EGFR;F2R;MALL;BSG;NTSR1;ATP2B4;INSR;PRNP;STAT6;MAPK3;FURIN;LY6K;PAG1;PRKACA;PI4K2A;TNFRSF1A;HK1;PRKCZ;INPP5D;GPC1;KCNMA1;CAPN2;RTN4R;CTSD;CBLC;SLC2A1
13250,GO:0051965,0.0126109298939024,0.996388352322568,8,33,positive regulation of synapse assembly,BP,ADGRL1;EPHB2;NLGN2;WNT7A;EPHB3;EEF2K;ADGRB2;SLITRK6
4060,GO:0009120,0.0126973874293448,0.999067295305489,3,6,deoxyribonucleoside metabolic process,BP,TK2;ADA;DGUOK
8700,GO:0034362,0.0127225459931536,0.999064740010906,3,6,low-density lipoprotein particle,CC,APOE;LDLR;SORL1
4764,GO:0010959,0.0127853651409794,0.992894813396432,28,188,regulation of metal ion transport,BP,CEMIP;NOS1;CNTN1;KCNG1;FHL1;F2R;PRSS8;GJC2;ANK3;PKD2;SCN4B;SERPINE2;VAMP2;NTSR1;ATP2B4;LPAR3;PRNP;KCNAB2;PCSK9;PRKACA;GLRX;STK39;AKT1;GPD1L;EHD3;SNTA1;HOMER2;GSTM2
3657,GO:0008154,0.0128039743949527,0.993355962532348,23,147,actin polymerization or depolymerization,BP,GSN;ARPIN;CORO1B;MICALL2;MSRB2;TMOD2;PLEKHH2;WIPF1;SSH1;PLEKHG2;CDC42EP5;SPTB;DMTN;CAPG;TWF2;WHAMMP3;EPS8L1;EPS8L2;SSH3;SPIRE2;MLST8;PYCARD;FCHSD1
7042,GO:0030832,0.0128102182611983,0.993580379001892,21,131,regulation of actin filament length,BP,GSN;ARPIN;CORO1B;TMOD2;PLEKHH2;WIPF1;SSH1;PLEKHG2;CDC42EP5;SPTB;DMTN;CAPG;TWF2;WHAMMP3;EPS8L1;EPS8L2;SSH3;SPIRE2;MLST8;PYCARD;FCHSD1
1105,GO:0002694,0.0128194064894703,0.992143274494012,39,282,regulation of leukocyte activation,BP,GSN;ZFP36L1;IGF2;PKN1;ZP3;ERBB2;CD320;ZMIZ1;IL20RB;PRNP;EFNB3;STAT6;MYO18A;BCL6;IGFBP2;CD81;CEBPB;HES1;TNFRSF14;ADA;PAG1;LDLR;SOX13;RAG1;GAS6;PTAFR;VAV3;BCR;PRKCZ;INPP5D;ICOSLG;ADGRE2;ADORA2B;ABR;AKT1;PYCARD;JAK3;MIF;STXBP2
13106,GO:0051693,0.0128213796651592,0.997179075473788,6,21,actin filament capping,BP,GSN;TMOD2;SPTB;DMTN;CAPG;TWF2
4101,GO:0009165,0.0128918119461029,0.992453641635593,33,232,nucleotide biosynthetic process,BP,APOE;IDH2;NAPRT;PGM1;NOS1;NME4;TIMP2;ACOT7;NMRK1;OGDHL;PTHLH;LTB4R2;INSR;UCKL1;PFKFB2;DHTKD1;GALK1;ADCY6;MLXIPL;NADK;TK2;ADA;PFKL;DGUOK;HK1;PPARA;GUK1;GUCA1B;ADORA2B;PINK1;TAZ;FUK;PPCS
13056,GO:0051591,0.0130395456444889,0.995010988845571,12,61,response to cAMP,BP,FOS;RAPGEF3;ZFP36L1;BSG;PKD2;DMTN;VGF;EEF2K;DGKQ;PTAFR;SDC1;SLC5A5
6936,GO:0030574,0.0130464121415669,0.995872960894198,9,40,collagen catabolic process,BP,CST3;MRC2;COL6A1;CTSB;MMP1;ADAM15;FURIN;COL13A1;CTSD
8911,GO:0034774,0.013056991249414,0.992485977724079,31,219,secretory granule lumen,CC,NAPRT;PYGB;GSN;IGF2;TIMP2;SERPING1;PYGL;FUCA1;VAT1;HEXB;GM2A;RNASET2;ECM1;VEGFA;DNASE1L1;DPP7;GLB1;PFKL;GAS6;PCSK1;CTSZ;TOLLIP;CSTB;TIMP1;ACTR1B;VEGFB;CTSD;CTSH;PYCARD;GALNS;MIF
14000,GO:0060753,0.0131231907979222,0.99902377874495,3,6,regulation of mast cell chemotaxis,BP,PGF;VEGFA;VEGFB
7597,GO:0031995,0.0131625138826335,0.999019731337752,3,6,insulin-like growth factor II binding,MF,INSR;IGFBP2;IGFBP4
3182,GO:0006813,0.0131804754042119,0.993949750708435,17,98,potassium ion transport,BP,NOS1;KCNG1;FHL1;KCNC4;ANK3;KCNJ15;PKD2;VAMP2;PRNP;SLC12A7;ATP12A;KCNAB2;TMEM175;KCNMA1;SLC9A7;STK39;KCNN4
6806,GO:0030276,0.0132595279109539,0.995466632667901,10,47,clathrin binding,MF,CEMIP;SYTL1;LRP1;TOM1L2;SYT8;AP2A2;LDLR;LDLRAP1;CLTCL1;BIN1
12676,GO:0050920,0.0132934537159512,0.993578132600273,19,116,regulation of chemotaxis,BP,SEMA4B;PGF;MMP28;CORO1B;VEGFA;MAPK3;IL6R;SEMA3B;TRPV4;SEMA3F;SEMA4C;GAS6;FGFR1;C5;WNT3;PPM1F;VEGFB;SEMA4F;MIF
10488,GO:0043409,0.0133407441322344,0.993290420105557,21,130,negative regulation of MAPK cascade,BP,TNIP1;DUSP6;APOE;EPHB2;DUSP5;PIK3R2;FBLN1;SPRY4;PDCD4;SPRY2;MAPK8IP1;DUSP7;PIN1;SORL1;AKT1;NDRG2;PINK1;RGS14;CBLC;RANBP9;SIRT3
13489,GO:0055088,0.0133554426029136,0.994628877511611,13,69,lipid homeostasis,BP,APOE;MALL;ABCG1;LRP5;MLXIPL;ABCA2;PCSK9;LDLR;LDLRAP1;PNPLA4;SLC25A27;SESN2;LCAT
2125,GO:0004930,0.0133786010292031,0.993141981837031,22,140,G-protein coupled receptor activity,MF,ADGRL1;LTB4R;ADGRF1;F2R;VIPR1;SIGMAR1;LTB4R2;NTSR1;CELSR1;LPAR3;FZD8;GPRC5C;S1PR2;GPR153;HTR7;CELSR2;ADGRB2;PTAFR;ADGRE2;OR7D2;ADORA2B;GIPR
13712,GO:0060312,0.0134083736433358,0.998994317003991,3,6,regulation of blood vessel remodeling,BP,CST3;BCR;ABR
598,GO:0001766,0.0136281811248502,0.998971438016739,3,6,membrane raft polarization,BP,MARVELD1;GSN;MALL
7434,GO:0031580,0.0136281811248502,0.998971438016739,3,6,membrane raft distribution,BP,MARVELD1;GSN;MALL
10834,GO:0044351,0.0137043770634508,0.998963472557497,3,6,macropinocytosis,BP,SNX33;MAPKAPK3;PYCARD
19088,GO:1905049,0.0137513417425581,0.998958554103206,3,6,negative regulation of metallopeptidase activity,BP,TIMP2;TIMP1;SORL1
10010,GO:0042472,0.0137938906212497,0.995254387031017,10,47,inner ear morphogenesis,BP,EPHB2;CELSR1;SPRY2;VANGL2;DVL1;BCR;SLITRK6;FGFR1;PROX1;ABR
13870,GO:0060541,0.0138140266232696,0.993028358841977,21,130,respiratory system development,BP,EPAS1;EGFR;LAMA5;THRA;ID1;CELSR1;SPRY2;VEGFA;VANGL2;ACVR2B;MAPK3;HES1;ADA;WNT7B;FGFR1;CTSZ;PROX1;WNT2B;PKD1;CTSH;RARG
6854,GO:0030336,0.0138970403632274,0.992511681238924,25,164,negative regulation of cell migration,BP,APOE;IDH2;ALOX15B;LRP1;MMP28;ARPIN;CORO1B;ZMYND8;HDAC5;NISCH;PTPRU;PLXNB3;FUZ;EPHA1;ADARB1;ADAM15;ADA;MCTP1;BCR;ARAP3;C5;TIMP1;ABR;TP53INP1;MIF
14627,GO:0070244,0.0139111830361335,0.998941764313472,3,6,negative regulation of thymocyte apoptotic process,BP,ADA;RAG1;JAK3
11676,GO:0046487,0.0139469800059082,0.998937993595807,3,6,glyoxylate metabolic process,BP,IDH2;ALDH4A1;GRHPR
8935,GO:0035004,0.0140194232844646,0.995510703540695,9,40,phosphatidylinositol 3-kinase activity,MF,EGFR;PIK3R2;ERBB2;FGFR3;HBEGF;FGFR4;FGFR1;ERBB3;EREG
7609,GO:0032011,0.0140653063391404,0.995493505543417,9,40,ARF protein signal transduction,BP,ARAP1;APPL2;IQSEC2;AGAP1;ACAP3;PSD4;GIT1;ARAP3;ASAP2
7610,GO:0032012,0.0140653063391404,0.995493505543417,9,40,regulation of ARF protein signal transduction,BP,ARAP1;APPL2;IQSEC2;AGAP1;ACAP3;PSD4;GIT1;ARAP3;ASAP2
18154,GO:1902950,0.0141006362753479,0.998921764197657,3,6,regulation of dendritic spine maintenance,BP,APOE;ZMYND8;PRNP
1262,GO:0003018,0.0141781978214451,0.993808746747874,15,84,vascular process in circulatory system,BP,APOE;CTNNBIP1;NOS1;EGFR;F2R;BBS2;DOCK4;ADCY6;HTR7;TRPV4;PTAFR;BCR;ADORA2B;ABR;AKT1
10710,GO:0044070,0.0142148408442183,0.995075390182818,10,48,regulation of anion transport,BP,APOE;ABCA7;NTSR1;PRNP;PTAFR;FGFR1;STK39;ANO9;AKT1;MIF
5529,GO:0016528,0.0142232105988002,0.995420957205048,9,41,sarcoplasm,CC,FLNC;GSN;XDH;NOS1;ANK3;ITPR3;RTN2;POMT1;GSTM2
4098,GO:0009162,0.0143656635253083,0.998032369127415,4,11,deoxyribonucleoside monophosphate metabolic process,BP,DNPH1;TK2;DGUOK;GUK1
15792,GO:0072521,0.0144086290327911,0.990538430501472,50,395,purine-containing compound metabolic process,BP,APOE;NT5E;RAPGEF3;PGM1;XDH;NOS1;NME4;GAMT;TIMP2;ACOT7;SLC2A9;OGDHL;PKD2;PTHLH;LTB4R2;INSR;NDUFS8;DNPH1;DLG4;FAM20C;PFKFB2;VEGFA;DHTKD1;GALK1;ADCY6;MLXIPL;NADK;ADA;PFKL;NUDT10;DGUOK;MYH3;HK1;PPARA;GUK1;SDHA;GTPBP1;DLG3;GUCA1B;MACROD1;AHCYL2;ADORA2B;UQCR11;PINK1;ABHD14B;NDUFV3;MOCS1;TAZ;PPCS;PODXL2
13099,GO:0051668,0.0144165008933529,0.993691842380441,15,84,localization within membrane,BP,APOE;MARVELD1;GSN;MALL;DNM1;SYNGAP1;DLG4;REEP2;SHANK3;ETV5;DVL1;SSH1;DLG3;RILPL1;SHISA6
12705,GO:0050994,0.0144554142383338,0.996184183823812,7,28,regulation of lipid catabolic process,BP,TYSND1;THRA;LDLR;PPARA;AKT1;LONP2;MLYCD
7933,GO:0032536,0.0144677494474154,0.99888270334268,3,6,regulation of cell projection size,BP,WNT7A;WNT7B;TWF2
3007,GO:0006560,0.0144736399550007,0.998882073328909,3,6,proline metabolic process,BP,PRODH;ALDH4A1;PYCR2
15454,GO:0071827,0.0145144325156388,0.996686379609953,6,22,plasma lipoprotein particle organization,BP,APOE;ABCA7;ABCG1;PLTP;PRKACA;LCAT
3131,GO:0006732,0.0145687609777806,0.990928657517243,40,295,coenzyme metabolic process,BP,H6PD;IDH2;NT5E;NAPRT;PGM1;PGLS;GAMT;ACSF2;ACOT7;MTHFR;NMRK1;OGDHL;INSR;MVD;TALDO1;PFKFB2;KCNAB2;DHTKD1;GALK1;PC;MLXIPL;SLC2A3;NADK;PFKL;HLCS;PMVK;ACOT11;HK1;PPARA;HMGCL;PCK2;MDH2;PDK2;AHCYL2;GPD1L;PNPO;MOCS1;SLC2A1;MLYCD;PPCS
18933,GO:1904724,0.0146481357315608,0.995638163187021,8,36,tertiary granule lumen,CC,CST3;PGM1;PRSS3;TIMP2;LTA4H;CSTB;CTSD;CTSH
6691,GO:0030100,0.0147326257404467,0.992130001340307,24,157,regulation of endocytosis,BP,APOE;TSPAN1;LRP1;ABCA7;SNX33;DLG4;MYO18A;VEGFA;TUB;LRSAM1;MCTP1;PCSK9;EHD4;LDLR;SNX17;EEF2K;LDLRAP1;GAS6;BCR;ARAP3;BIN1;ABR;STON1;PYCARD
17420,GO:1900223,0.0147427161251019,0.998853185499658,3,6,positive regulation of amyloid-beta clearance,BP,LRP1;ABCA7;LDLR
6410,GO:0021683,0.014843927051891,0.998842264583395,3,6,cerebellar granular layer morphogenesis,BP,SERPINE2;WNT7A;PROX1
3422,GO:0007218,0.0148697553379934,0.997181803287186,5,17,neuropeptide signaling pathway,BP,LTB4R;NXPH4;LTB4R2;NTSR1;PCSK1N
13973,GO:0060716,0.014872654778017,0.997221167559245,5,16,labyrinthine layer blood vessel development,BP,PLCD1;FBXW8;PLCD3;HES1;AKT1
17979,GO:1902474,0.0148864266360742,0.998837669853919,3,6,positive regulation of protein localization to synapse,BP,NLGN2;WNT7A;DVL1
9520,GO:0036289,0.0149009955243914,0.998836093565826,3,6,peptidyl-serine autophosphorylation,BP,MAP2K2;PINK1;ERN1
9914,GO:0042278,0.0149210649799519,0.994158063863481,12,64,purine nucleoside metabolic process,BP,NT5E;NME4;GAMT;DLG4;ADA;DGUOK;GUK1;GTPBP1;DLG3;MACROD1;AHCYL2;MOCS1
12321,GO:0048705,0.0149224673664456,0.992407812519097,21,131,skeletal system morphogenesis,BP,MEF2D;MDFI;THBS3;THRA;LRP5;HYAL1;IFT140;FUZ;ACP5;WNT7A;SH3PXD2B;ACVR2B;NAB2;FGFR3;TRPV4;PEX7;WDR60;FGFR1;COL13A1;PKD1;RARG
6668,GO:0030041,0.0149384939136832,0.992536880019372,20,125,actin filament polymerization,BP,GSN;ARPIN;CORO1B;MICALL2;MSRB2;TMOD2;WIPF1;PLEKHG2;CDC42EP5;SPTB;DMTN;CAPG;TWF2;WHAMMP3;EPS8L1;EPS8L2;SPIRE2;MLST8;PYCARD;FCHSD1
9359,GO:0035904,0.0149846945121374,0.995551932112466,8,34,aorta development,BP,LTBP1;LRP1;LOXL1;PKD2;HES1;SNX17;SUFU;PROX1
728,GO:0001958,0.0150134803093451,0.997188010758516,5,16,endochondral ossification,BP,MEF2D;NAB2;FGFR3;PEX7;COL13A1
9449,GO:0036075,0.0150134803093451,0.997188010758516,5,16,replacement ossification,BP,MEF2D;NAB2;FGFR3;PEX7;COL13A1
9087,GO:0035374,0.0150404912682879,0.998820969511287,3,6,chondroitin sulfate binding,MF,PTPRS;ADGRE2;RTN4R
17811,GO:1902003,0.0150555502470972,0.997178089055651,5,16,regulation of amyloid-beta formation,BP,APOE;ABCA7;PRNP;BIN1;SORL1
10757,GO:0044224,0.0150602098183344,0.99881882708179,3,6,juxtaparanode region of axon,CC,DLG4;KCNAB2;EPB41L3
7993,GO:0032633,0.015097408952717,0.997168209656888,5,16,interleukin-4 production,BP,ZP3;ZFPM1;IL20RB;CEBPB;PRKCZ
8582,GO:0034104,0.0151384568011489,0.997893049728436,4,11,negative regulation of tissue remodeling,BP,CST3;BCR;INPP5D;ABR
14934,GO:0070857,0.0151837412516985,0.998805379746201,3,6,regulation of bile acid biosynthetic process,BP,NR1D1;FGFR4;PROX1
10773,GO:0044262,0.0151927406978807,0.991432257475762,28,189,cellular carbohydrate metabolic process,BP,IDH2;GAA;PYGB;PGM1;NR1D1;IGF2;ISYNA1;PYGL;PHLDA2;NTSR1;INSR;FGGY;PFKFB2;GLB1;GALK1;DGKQ;HK1;PPARA;TKFC;PTAFR;IMPA2;PCK2;IGFBP4;PDK2;AKT1;SLC2A1;MLYCD;FUK
1991,GO:0004716,0.0152226860810619,0.998801131174893,3,6,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,EGFR;ERBB2;INSR
6739,GO:0030169,0.0152261842113956,0.99880074934285,3,6,low-density lipoprotein particle binding,MF,PCSK9;LDLR;SORL1
5463,GO:0016406,0.0152262919056463,0.998800737587121,3,6,carnitine O-acyltransferase activity,MF,CRAT;CPT2;CPT1C
4436,GO:0010359,0.0152265901569066,0.998800705030326,3,6,regulation of anion channel activity,BP,PRNP;PTAFR;ANO9
10354,GO:0043190,0.0152267286995174,0.998800689907073,3,6,ATP-binding cassette (ABC) transporter complex,CC,ABCA7;ABCA2;ABCD4
9818,GO:0042063,0.0153098376770894,0.991565553818811,26,173,gliogenesis,BP,IDH2;GSN;NDRG1;LRP1;EGFR;GJC2;ERBB2;CD9;HEXB;SERPINE2;LAMB2;BNIP3;NAB2;MAPK3;ETV5;HES1;MBOAT7;MXRA8;HDAC11;LDLR;AHNAK2;GPC1;BIN1;ERBB3;AKT1;SUN1
7081,GO:0030888,0.0153364719039023,0.995410553319119,8,35,regulation of B cell proliferation,BP,PKN1;CD320;BCL6;CD81;ADA;VAV3;INPP5D;MIF
5260,GO:0015918,0.0153602981053039,0.994268267961195,11,56,sterol transport,BP,APOE;LRP1;ABCA7;ABCG1;PLTP;ABCA2;OSBPL5;PCSK9;LDLR;LDLRAP1;LCAT
12225,GO:0048522,0.0154481935333859,0.986980514480186,366,3470,positive regulation of cellular process,BP,TNIP1;HTRA1;FOS;DUSP6;CEMIP;ADGRL1;APOE;ESPN;CTNNBIP1;MARCKSL1;TSPAN1;ERCC1;SEMA4B;FAM110C;CITED4;CST3;SHANK2;RAPGEF3;CYP27B1;GSN;XDH;NDRG1;PCBP4;PRODH;PGF;MEF2D;NOS1;ARAP1;SH3BP2;ZFP36L1;POSTN;GRB7;NR1D1;ALOX15B;FAM210B;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;IGF2;NFATC4;MST1R;LRP1;RAB11FIP4;OBSL1;EGFR;TIMP2;NLGN2;TCEA2;DUSP5;DDB2;EGR1;ULK1;PKN1;CRTC1;ARPIN;ARHGEF4;TRIM65;SHC1;RGL2;F2R;PTK6;ABCA7;DEAF1;S100A4;SHC2;CORO1B;CXXC5;GJC2;ZMYND8;ASH2L;GRAMD4;SOX12;MMP1;ANK3;PIK3R2;S100A6;ZNF516;PEG3;HDAC5;THRA;DOCK4;ZP3;RPS6KA2;LRP5;HYAL1;MARK4;TENM2;MAML3;ZFPM1;TFEB;ERBB2;FBLN1;MICALL2;PKD2;EDEM1;ITPR3;PLXNB3;PTHLH;CDKN1C;RIMS3;SALL2;VIPR1;PAK6;HEXB;SERPINE2;VPS11;VAMP2;FUZ;NPHP4;NTSR1;CD320;MINK1;ATP2B4;TMOD2;TFDP2;CSNK1E;PDCD4;SLC20A1;TNFRSF25;GLUL;RHOD;WNT7A;ZMIZ1;INSR;RAB3D;SH3PXD2B;TBC1D8;FBXW8;ID1;MVD;EPHA1;ITGA6;DNMT3A;DNPH1;LPAR3;TMEM173;PRNP;EFNB3;SNX33;SPRY2;ECM1;SNX9;STAT6;DLG4;MTA3;STRADB;WWTR1;RAB25;FAM20C;MYO18A;BCL6;PFKFB2;PLXNB1;IGFBP2;DYRK1B;SEC14L2;BNIP3;CD81;FZD8;VEGFA;ARL2;YPEL3;VANGL2;FBXW4;CEBPB;SHANK3;ACVR2B;HSF4;NAB2;CALCOCO1;S1PR2;ENDOG;MAPK3;PLEKHG5;TUB;ETV5;OLFM2;DVL1;MTA1;FYCO1;WIPF1;GPSM1;ADCY6;EPHB3;NSMCE4A;FHOD1;HES1;SSH1;FURIN;MLXIPL;CUL7;MEFV;EVC;NRP2;PLEKHG2;TNFRSF14;LRSAM1;ADA;CDC42EP5;PIDD1;PAG1;SH2D2A;RASL10B;IL6R;PCSK9;ZFP36;ETV4;FGFR3;PRKACA;F12;LRRK1;MAGEF1;CYFIP2;RPS6KA5;HBEGF;RAB3B;MAP2K2;DAP;FGFR4;DMTN;TNFRSF1A;EHD4;MAPK8IP1;SEMA3B;LDLR;TRPV4;CROCC;RAG1;DUSP7;EEF2K;HMGA2;LDLRAP1;SEMA3F;ELK3;DGKQ;SEMA4C;HK1;ZXDC;MIB2;GAS6;BTRC;ADGRB2;PPARA;WNT7B;COMT;PTAFR;RFNG;LTBP3;RXRA;PCK2;VAV3;BCR;NEO1;IGFBP4;USP21;PRKCZ;HLTF;INPP5D;TM7SF3;SLITRK6;TWF2;GPC1;ICOSLG;SRSF5;RFXANK;TEF;MAPKAPK3;RAD23A;FGFR1;CTSZ;CAMKK1;PIN1;C5;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;KCNMA1;BIN1;VSNL1;OSCP1;PPP1R13L;ASS1;SH3D19;SLC25A27;GRB10;JARID2;SESN2;TOLLIP;WNT2B;WRAP73;TMEM161A;RXRB;MAPRE3;GUCA1B;MADD;RTN4R;TIMP1;SDC1;WHAMMP3;SH2B3;FGFBP1;EPS8L1;WNT3;PPM1F;SORL1;STK39;VEGFB;ACVR1B;MEF2B;ADORA2B;TPCN1;ERBB3;ABR;PNMA1;CCDC71L;AKT1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;EPS8L2;SSBP2;PINK1;PKD1;ARHGEF10L;CAMTA2;RGS14;SPIRE2;CTSH;ABHD14B;MLST8;EPN2;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;KCNN4;DDN;STK17A;ERN1;ARHGEF19;SIRT3;MLYCD;TAZ;JAK3;LITAF;MZF1;RARG;ING4;EREG;FAM162A;GSTM2;GIPR;ADAMTSL4;TMED4;SEMA4F;MIF;SULF2;UBL5
12930,GO:0051338,0.0156838528043174,0.98851541900525,88,732,regulation of transferase activity,BP,DUSP6;CEMIP;APOE;EPHB2;IGF2;MST1R;EGFR;DUSP5;EGR1;PKN1;SHC1;F2R;PTK6;SHC2;PIK3R2;LRP5;ERBB2;PKD2;SPRY4;CDKN1C;PAK6;MINK1;ATP2B4;PDCD4;INSR;EPHA1;ADARB1;LPAR3;PRNP;SERINC2;SPRY2;SNX9;DLG4;STRADB;WWTR1;PFKFB2;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;MAPK3;DVL1;ADCY6;EPHB3;ZFP36;FGFR3;PRKACA;MAP2K2;FGFR4;MAPK8IP1;DUSP7;DGKQ;GAS6;WNT7B;VAV3;PRKCZ;MAPKAPK3;FGFR1;CAMKK1;PIN1;C5;PROX1;DLG3;SESN2;MAPRE3;MADD;RTN4R;PPM1F;SORL1;STK39;ADORA2B;ERBB3;ZER1;AKT1;ERCC6;PINK1;PKD1;RGS14;MLST8;CBLC;PYCARD;MAP2K3;ERN1;EREG;MIF
11595,GO:0046320,0.015811850094345,0.996998446204394,5,16,regulation of fatty acid oxidation,BP,TYSND1;PPARA;AKT1;LONP2;MLYCD
11810,GO:0046777,0.0158371637269189,0.991253335757691,26,171,protein autophosphorylation,BP,EGFR;ULK1;PTK6;ULK2;ERBB2;MINK1;INSR;EPHA1;MKNK2;SRMS;VEGFA;MAPK3;EPHB3;FGFR3;MAP2K2;FGFR4;EEF2K;BCR;MAPKAPK3;FGFR1;STK39;ACVR1B;AKT1;PINK1;ERN1;JAK3
2657,GO:0006012,0.0158428220302264,0.99776405965222,4,11,galactose metabolic process,BP,PGM1;GALE;GLB1;GALK1
4122,GO:0009190,0.0158804038677984,0.995216960240092,8,35,cyclic nucleotide biosynthetic process,BP,APOE;NOS1;TIMP2;PTHLH;LTB4R2;ADCY6;GUCA1B;ADORA2B
13355,GO:0052652,0.0158804038677984,0.995216960240092,8,35,cyclic purine nucleotide metabolic process,BP,APOE;NOS1;TIMP2;PTHLH;LTB4R2;ADCY6;GUCA1B;ADORA2B
5788,GO:0017048,0.016116721818016,0.991590872073058,22,139,Rho GTPase binding,MF,OBSCN;PKN1;ARHGEF4;RGL2;DOCK4;PAK6;PLEKHG4;PLEKHG5;DVL1;PKN3;PLEKHG2;CDC42EP5;PLEKHG6;ARHGEF37;VAV3;BCR;WHAMMP3;EPS8L1;ABR;EPS8L2;ARHGEF10L;ARHGEF19
696,GO:0001917,0.0161413830621958,0.996225140442161,6,22,photoreceptor inner segment,CC,SHANK2;NOS1;REEP6;DNM1;CROCC;GUCA1B
14852,GO:0070665,0.0162253001672874,0.993280013728736,13,72,positive regulation of leukocyte proliferation,BP,IGF2;ZP3;CD320;BCL6;IGFBP2;CD81;HES1;ADA;VAV3;ICOSLG;PYCARD;JAK3;MIF
6685,GO:0030072,0.0162326596464085,0.991515542774777,22,142,peptide hormone secretion,BP,LTBP4;RAPGEF3;NR1D1;EGFR;HADH;NLGN2;LRP5;ITPR3;GLUL;PFKFB2;ARL2;ACVR2B;RASL10B;PFKL;VGF;TRPV4;PCK2;TM7SF3;VSNL1;SIRT3;SLC2A1;GIPR
11517,GO:0046068,0.016249555534377,0.9961940618729,6,22,cGMP metabolic process,BP,APOE;NOS1;VEGFA;ADCY6;GUCA1B;ADORA2B
18050,GO:1902667,0.0163131766463036,0.995586615581218,7,28,regulation of axon guidance,BP,SEMA4B;VEGFA;SEMA3B;SEMA3F;SEMA4C;WNT3;SEMA4F
7684,GO:0032153,0.016418465744774,0.993203738891385,13,70,cell division site,CC,RAB11FIP4;PKN1;RHOD;PLCD3;SSH1;RHOF;PITPNM1;RHOBTB2;PLEKHG6;NDE1;SEPT8;SPIRE2;ZFYVE19
3132,GO:0006733,0.0164458136577892,0.991393147934719,22,142,oxidoreduction coenzyme metabolic process,BP,H6PD;IDH2;NT5E;NAPRT;PGM1;PGLS;NMRK1;OGDHL;INSR;TALDO1;PFKFB2;KCNAB2;DHTKD1;GALK1;MLXIPL;NADK;PFKL;HK1;PPARA;PCK2;MDH2;GPD1L
12141,GO:0048278,0.0164625687681173,0.993792653828007,11,56,vesicle docking,BP,EXOC2;VPS11;RAB3D;RAB40B;RAB3B;STX10;SNPH;TSNARE1;VPS33B;RAB40C;STXBP2
2164,GO:0005003,0.0165121140992631,0.997639767589894,4,11,ephrin receptor activity,MF,EPHB2;EPHA1;EFNB3;EPHB3
2166,GO:0005005,0.0165121140992631,0.997639767589894,4,11,transmembrane-ephrin receptor activity,MF,EPHB2;EPHA1;EFNB3;EPHB3
10565,GO:0043547,0.0165741159941311,0.989527868222858,41,300,positive regulation of GTPase activity,BP,RAPGEF3;EVI5L;ARAP1;F2R;TBC1D14;RIN1;PIK3R2;ARHGAP23;DOCK4;ERBB2;RALGAPA2;RASA4;AGAP1;ACAP3;PLEKHG4;TBC1D8;EPHA1;ITGA6;SYNGAP1;SNX9;ARHGAP27;PLXNB1;ARHGAP22;CDC42EP5;LLGL1;GIT1;PLEKHG6;ARHGEF37;VAV3;BCR;TBC1D16;ARAP3;PIN1;ASAP2;RTN4R;TBC1D17;ALS2CL;ABR;RGS14;ARHGEF19;RGS12
536,GO:0001655,0.0166838405297504,0.990217133162351,31,215,urogenital system development,BP,CTNNBIP1;PGF;ALOX15B;EPHB2;EGR1;LAMA5;ACTA2;PKD2;ITGB4;IFT140;LAMB2;ITGA6;WWTR1;VEGFA;VANGL2;ACVR2B;EPHB3;HES1;PCSK9;WNT7B;RXRA;FGFR1;PROX1;WNT2B;SDC1;PKD1;CTSH;RARG;SULF2;KIF26B;LZTS2
5344,GO:0016125,0.0167092367470294,0.991904758754064,18,110,sterol metabolic process,BP,LMF1;APOE;ABCG1;LRP5;MVD;SEC14L2;OSBPL5;PCSK9;PMVK;LDLR;SNX17;LDLRAP1;TM7SF2;DGKQ;RXRA;LCAT;SORL1;TRERF1
16784,GO:0098660,0.016719680346239,0.988832663136386,52,406,inorganic ion transmembrane transport,BP,CEMIP;CLCA2;NOS1;SCN8A;KCNG1;FHL1;F2R;GJC2;KCNC4;ANK3;KCNJ15;SLC2A9;PKD2;SCN4B;ITPR3;VAMP2;NTSR1;ATP2B4;SLC20A1;ASIC1;PRNP;ATP7B;SLC12A7;TTYH3;ATP12A;KCNAB2;PCSK9;PRKACA;SCNN1A;SLC25A37;SLC37A2;TRPV4;GAS6;PTAFR;TMEM175;KCNMA1;GLRX;TMCO3;NDUFA4L2;SMDT1;SLC9A7;STK39;ANO9;TPCN1;GPD1L;PKD1;EHD3;SNTA1;KCNN4;ORAI3;ORAI2;GSTM2
14850,GO:0070663,0.0167360511263335,0.991703602534665,19,119,regulation of leukocyte proliferation,BP,IGF2;PKN1;ZP3;ERBB2;CD320;IL20RB;PRNP;BCL6;IGFBP2;CD81;CEBPB;HES1;ADA;VAV3;INPP5D;ICOSLG;PYCARD;JAK3;MIF
6837,GO:0030317,0.0167830902175621,0.995409103686304,7,29,flagellated sperm motility,BP,BBS2;DNAH1;PLTP;NPHP4;ATP2B4;GAS8;MAFIP
6120,GO:0019377,0.0167945409395489,0.997586824946842,4,11,glycolipid catabolic process,BP,FUCA1;HEXB;GM2A;NAGA
8093,GO:0032793,0.0167994305167191,0.997585905812894,4,11,positive regulation of CREB transcription factor activity,BP,ADGRF1;CRTC1;VEGFA;RPS6KA5
6822,GO:0030296,0.016805837097874,0.997584701384211,4,11,protein tyrosine kinase activator activity,MF,DGKQ;GAS6;ERBB3;ERCC6
12501,GO:0050667,0.0168423140553483,0.997577840934112,4,11,homocysteine metabolic process,BP,MTHFR;CBS;BLMH;COMT
8019,GO:0032675,0.0168538465244006,0.993294959849491,12,63,regulation of interleukin-6 production,BP,MAPK13;F2R;CEBPB;IL6R;TRPV4;GAS6;PTAFR;INPP5D;ADORA2B;NLRX1;PYCARD;EREG
12605,GO:0050818,0.0168543017484211,0.993987569422242,10,49,regulation of coagulation,BP,APOE;SERPING1;F2R;PLAT;CD9;SERPINE2;F12;DMTN;PROCR;VPS33B
16133,GO:0090181,0.0169554952049556,0.993945647997792,10,49,regulation of cholesterol metabolic process,BP,LMF1;APOE;ABCG1;MVD;SEC14L2;PMVK;LDLR;LDLRAP1;TM7SF2;DGKQ
7779,GO:0032331,0.0169695926014116,0.997553865215199,4,11,negative regulation of chondrocyte differentiation,BP,PTHLH;ADAMTS7;CHADL;RARG
4847,GO:0014069,0.0170008112110045,0.990935708849816,23,148,postsynaptic density,CC,PTPRS;SHANK2;NOS1;DNM1;SIGMAR1;MINK1;SYNGAP1;PRNP;DLG4;BNIP3;SHANK3;KCNAB2;DVL1;DMTN;ABHD17C;EEF2K;SEMA4C;BCR;DLG3;EPB41L3;HOMER2;RGS14;SHISA6
7683,GO:0032148,0.0171090819417381,0.995912984918268,6,23,activation of protein kinase B activity,BP,INSR;GAS6;PRKCZ;AKT1;PINK1;MLST8
7083,GO:0030890,0.0171867554708923,0.995890186875262,6,23,positive regulation of B cell proliferation,BP,CD320;BCL6;CD81;ADA;VAV3;MIF
7839,GO:0032411,0.0173231583984594,0.993407363744463,11,57,positive regulation of transporter activity,BP,EPHB2;ANK3;PKD2;NTSR1;SHANK3;PTAFR;GLRX;STK39;PINK1;EHD3;GSTM2
7028,GO:0030813,0.0175389225408398,0.997445909105468,4,11,positive regulation of nucleotide catabolic process,BP,RAPGEF3;INSR;PFKFB2;MLXIPL
9648,GO:0038024,0.0175501012166028,0.994126536437817,9,42,cargo receptor activity,MF,LRP1;ABCA7;SCART1;AP2A2;SSC4D;LDLR;LDLRAP1;LRP10;SORL1
3733,GO:0008277,0.0175821226616393,0.992359074167589,14,79,regulation of G-protein coupled receptor protein signaling pathway,BP,NOS1;DNM1;ATP2B4;TMOD2;USP20;GRK6;ADA;DGKQ;GIT1;GUCA1B;HOMER2;RGS14;GIPR;RGS12
15793,GO:0072522,0.0176905626553342,0.989996802353447,27,186,purine-containing compound biosynthetic process,BP,APOE;NT5E;PGM1;NOS1;NME4;TIMP2;ACOT7;OGDHL;PTHLH;LTB4R2;INSR;PFKFB2;DHTKD1;GALK1;ADCY6;MLXIPL;ADA;PFKL;DGUOK;HK1;PPARA;GUK1;GUCA1B;ADORA2B;PINK1;TAZ;PPCS
4289,GO:0009743,0.0178328895992066,0.990586355420449,22,144,response to carbohydrate,BP,ERCC1;CST3;ZFP36L1;NR1D1;IGF2;MAPK13;EGR1;LRP5;VAMP2;GLUL;PFKFB2;ACVR2B;ENDOG;MLXIPL;PFKL;PRKACA;GAS6;PCK2;VSNL1;SESN2;ERN1;GIPR
4659,GO:0010817,0.017839123005029,0.988876463808173,38,280,regulation of hormone levels,BP,LTBP4;RAPGEF3;CYP27B1;NR1D1;SLCO4A1;EGFR;HADH;NLGN2;EGR1;DHRS11;LRP5;ITPR3;GLUL;SRD5A3;PFKFB2;ARL2;ACVR2B;FURIN;RETSAT;RASL10B;PFKL;VGF;TRPV4;DGKQ;COMT;PCK2;PCSK1;TM7SF3;FGFR1;CTSZ;PNPLA4;VSNL1;SLC5A5;TRERF1;PCSK1N;SIRT3;SLC2A1;GIPR
12618,GO:0050848,0.0179700727757233,0.993945938974693,9,43,regulation of calcium-mediated signaling,BP,NOS1;PKD2;ATP2B4;PRNP;ADA;PRKACA;ERBB3;TMBIM4;GSTM2
1100,GO:0002689,0.0181541996903801,0.998319766697663,3,7,negative regulation of leukocyte chemotaxis,BP,MMP28;C5;MIF
6661,GO:0030031,0.0181720187502297,0.987618363914707,56,438,cell projection assembly,BP,ESPN;FAM110C;GSN;EVI5L;PARVB;ARAP1;TCTN1;ARHGEF4;LAMA5;BBS2;DNAH1;ZMYND8;MARK4;TENM2;PLXNB3;IFT140;NINL;FUZ;NPHP4;CSNK1E;RHOD;ITGA6;LPAR3;CEP250;WWTR1;TMEM107;VANGL2;NUDCD3;S1PR2;SSH1;FBF1;CDC42EP5;PRKACA;CYFIP2;DMTN;BBS1;CROCC;VAV3;WDR60;TWF2;NDE1;UNC119B;WRAP73;TMEM231;EPS8L1;SEPT8;EPS8L2;SSH3;GAS8;EHD3;MAFIP;RILPL1;ATXN10;RFX2;DNAAF5;SFI1
17046,GO:0099572,0.0183199918652705,0.990158829063118,23,149,postsynaptic specialization,CC,PTPRS;SHANK2;NOS1;DNM1;SIGMAR1;MINK1;SYNGAP1;PRNP;DLG4;BNIP3;SHANK3;KCNAB2;DVL1;DMTN;ABHD17C;EEF2K;SEMA4C;BCR;DLG3;EPB41L3;HOMER2;RGS14;SHISA6
12295,GO:0048668,0.0183719486529132,0.996321493153999,5,17,collateral sprouting,BP,PTPRS;ULK2;LPAR3;DVL1;WNT3
4960,GO:0015079,0.0184246147786777,0.992933358039977,11,56,potassium ion transmembrane transporter activity,MF,KCNG1;KCNC4;KCNJ15;PKD2;SLC12A7;ATP12A;KCNAB2;TMEM175;KCNMA1;SLC9A7;KCNN4
8088,GO:0032787,0.0185350580768097,0.987493626954747,53,415,monocarboxylic acid metabolic process,BP,TYSND1;IDH2;PGM1;NR1D1;CRAT;ALOX15B;CPT2;ALDH4A1;HADH;CRYL1;ACSF2;ACOT7;SLC16A3;D2HGDH;BSG;OGDHL;CPT1C;GGT1;INSR;HAGH;ABCD1;PFKFB2;MAPK3;DHTKD1;GALK1;PC;ACAD10;MLXIPL;PFKL;HLCS;FGFR4;TNFRSF1A;ACOT11;PEX7;HK1;PPARA;AIG1;PCK2;ETFB;PDK2;PHYH;PROX1;CES2;SESN2;GRHPR;CYP2S1;AKT1;LONP2;AS3MT;ACADS;MLYCD;GSTM2;MIF
7801,GO:0032366,0.0185893539489128,0.99626648570342,5,17,intracellular sterol transport,BP,ABCG1;ABCA2;PCSK9;LDLR;LDLRAP1
7802,GO:0032367,0.0185893539489128,0.99626648570342,5,17,intracellular cholesterol transport,BP,ABCG1;ABCA2;PCSK9;LDLR;LDLRAP1
16576,GO:0097435,0.0187086816374433,0.987099490561101,59,466,supramolecular fiber organization,BP,APOE;ESPN;CST3;RAPGEF3;GSN;ARAP1;EFS;OBSCN;LTBP2;OBSL1;LOXL1;ARPIN;CORO1B;TUBG2;MICALL2;MSRB2;TMOD2;RHOD;TNXB;SH3PXD2B;ID1;EPHA1;PLEKHH2;HOOK2;ARL2;SHANK3;TNNT1;DVL1;WIPF1;FHOD1;SSH1;PLEKHG2;CDC42EP5;RHOF;ITGB5;SPTB;DMTN;MYH3;LDLR;TRPV4;RHOBTB2;CAPG;TWF2;NDE1;CHADL;PROX1;WHAMMP3;EPS8L1;PPM1F;VPS33B;EPS8L2;SSH3;ARHGEF10L;SPIRE2;P3H4;MLST8;PYCARD;RANBP9;FCHSD1
6327,GO:0021510,0.0187196815841094,0.993208004551793,10,49,spinal cord development,BP,PTPRS;TCTN1;SOX12;PKD2;ADARB1;MDGA1;SUFU;PROX1;AKT1;PKD1
3214,GO:0006869,0.0187243998424713,0.989127427422333,29,201,lipid transport,BP,APOE;CPT2;NME4;LRP1;ABCA7;PITPNC1;ABCG1;PLTP;SIGMAR1;NTSR1;GM2A;ABCD1;ABCA2;OSBPL5;PCSK9;PITPNM1;LDLR;LDLRAP1;PPARA;RXRA;LRP10;ESYT2;LCAT;PITPNM3;SORL1;ANO9;AKT1;KCNN4;MIF
12264,GO:0048608,0.0188491156956381,0.988049203577598,40,297,reproductive structure development,BP,HTRA1;ERCC1;CST3;CYP27B1;ZFP36L1;ALOX15B;EPAS1;IGF2;EGFR;MDFI;CTSB;ZP3;TFEB;BSG;PKD2;PHLDA2;SERPINE2;PLCD1;WNT7A;INSR;FBXW8;PLCD3;VEGFA;CEBPB;ADAM15;HES1;CUL7;ADA;SLIT3;VGF;WNT7B;DMC1;RXRA;AGO4;WNT2B;SDC1;AKT1;PKD1;RARG;EREG
20201,GO:2001171,0.0190608268913323,0.996146582814632,5,17,positive regulation of ATP biosynthetic process,BP,INSR;PFKFB2;MLXIPL;PINK1;TAZ
11677,GO:0046488,0.0192140712014454,0.989472652366038,24,159,phosphatidylinositol metabolic process,BP,EGFR;PIK3R2;ZP3;ERBB2;ZFYVE21;MBOAT7;FGFR3;PITPNM1;PLCH2;HBEGF;PI4K2A;FGFR4;PIGZ;TTC7B;IMPA2;INPP5D;FGFR1;PI4KAP2;PITPNM3;PIGV;PIGQ;SBF1;ERBB3;EREG
8745,GO:0034433,0.0192317317623757,0.998179821856246,3,7,steroid esterification,BP,APOE;ABCG1;LCAT
8746,GO:0034434,0.0192317317623757,0.998179821856246,3,7,sterol esterification,BP,APOE;ABCG1;LCAT
8747,GO:0034435,0.0192317317623757,0.998179821856246,3,7,cholesterol esterification,BP,APOE;ABCG1;LCAT
11263,GO:0045596,0.0192428618191062,0.986984392644403,53,418,negative regulation of cell differentiation,BP,APOE;IDH2;PTPRS;SEMA4B;XDH;ZFP36L1;POSTN;EPHB2;NFATC4;LRP1;EGFR;ULK2;ABCG1;HDAC5;LRP5;ZFPM1;ERBB2;FBLN1;PTHLH;FUZ;ADAMTS7;PDCD4;WNT7A;ID1;SYNGAP1;EFNB3;WWTR1;BCL6;ADCY6;HES1;ZFP36;DGUOK;DMTN;SEMA3B;LDLR;TRPV4;SEMA3F;SEMA4C;PPARA;SUFU;VASN;INPP5D;CTSZ;CHADL;RTN4R;WNT3;SORL1;CCDC85B;TP53INP1;JAK3;RARG;EREG;SEMA4F
14908,GO:0070820,0.0193535857828858,0.990678952969506,17,105,tertiary granule,CC,GAA;CST3;PGM1;PRSS3;TIMP2;NBEAL2;AP2A2;KCNAB2;LTA4H;SLC2A3;PTAFR;SERPINB6;CSTB;HGSNAT;CTSD;CTSH;STXBP2
16750,GO:0098589,0.0194062142020032,0.988584609110944,30,209,membrane region,CC,MARVELD1;LTB4R;NOS1;CNTN1;EGFR;F2R;MALL;BSG;NTSR1;ATP2B4;INSR;PRNP;STAT6;MAPK3;FURIN;LY6K;PAG1;PRKACA;PI4K2A;TNFRSF1A;HK1;PRKCZ;INPP5D;GPC1;KCNMA1;CAPN2;RTN4R;CTSD;CBLC;SLC2A1
7909,GO:0032496,0.0194733402787654,0.988766796023014,28,196,response to lipopolysaccharide,BP,TNIP1;FOS;CYP27B1;NOS1;NR1D1;LOXL1;F2R;HDAC5;ACP5;PDCD4;TNFRSF25;CEBPB;TNFRSF6B;MAPK3;TNFRSF14;ZFP36;TNFRSF1A;COMT;PTAFR;PCK2;BCR;ADAMTS13;MAPKAPK3;ABR;AKT1;PYCARD;LITAF;MIF
10620,GO:0043648,0.0195879101670198,0.991358982000547,14,80,dicarboxylic acid metabolic process,BP,IDH2;PRODH;ALDH4A1;MTHFR;D2HGDH;GGT1;GLUL;NAGS;PCK2;SDHA;MDH2;PHYH;ASS1;GRHPR
7751,GO:0032279,0.0197180965225088,0.989328803869998,23,150,asymmetric synapse,CC,PTPRS;SHANK2;NOS1;DNM1;SIGMAR1;MINK1;SYNGAP1;PRNP;DLG4;BNIP3;SHANK3;KCNAB2;DVL1;DMTN;ABHD17C;EEF2K;SEMA4C;BCR;DLG3;EPB41L3;HOMER2;RGS14;SHISA6
10340,GO:0043171,0.0198329112589619,0.99509905662579,6,23,peptide catabolic process,BP,RNPEPL1;GGT1;LTA4H;ADAMTS13;TPP1;CTSH
12619,GO:0050849,0.019846075413829,0.996912704831002,4,12,negative regulation of calcium-mediated signaling,BP,PKD2;ATP2B4;PRNP;GSTM2
6639,GO:0023057,0.019868546600609,0.984844414005659,109,940,negative regulation of signaling,BP,TNIP1;HTRA1;DUSP6;APOE;CTNNBIP1;PTPRS;WWC3;SHANK2;XDH;LTBP1;NR1D1;ARRDC1;EPHB2;NFATC4;MST1R;LRP1;EGFR;TIMP2;HADH;DUSP5;MDFI;EGR1;PTK6;PIK3R2;ERBB2;FBLN1;PKD2;DNM1;SPRY4;DDIT4L;PTPRE;SERPINE2;FUZ;NPHP4;ATP2B4;RASA4;PDCD4;ASIC1;INSR;EPHA1;ITGA6;SYNGAP1;PRNP;SPRY2;MNT;ECM1;STRADB;WWTR1;BCL6;IGFBP2;SRMS;SHANK3;S1PR2;CARD19;DVL1;EPHB3;ADA;PFKL;SLIT3;PCSK9;MAPKBP1;FGFR3;HBEGF;FGFR4;MAPK8IP1;DUSP7;TNFAIP8L1;GAS6;BTRC;TKFC;SUFU;VASN;IGFBP4;PRKCZ;INPP5D;GPC1;ARAP3;FGFR1;PIN1;VSNL1;GRB10;SESN2;TMEM161A;RTN4R;PEAR1;SORL1;ERBB3;AKT1;TRAP1;NLRX1;ZNF385A;NDRG2;GPD1L;PINK1;RGS14;CBLC;EPN2;PYCARD;RANBP9;SIRT3;C12ORF66;EREG;GSTM2;SHISA6;GIPR;RGS12;MIF;SULF2;LZTS2
12599,GO:0050810,0.0201505753227474,0.991753942991455,12,65,regulation of steroid biosynthetic process,BP,APOE;CYP27B1;NR1D1;EGR1;ABCG1;MVD;SEC14L2;FGFR4;PMVK;TM7SF2;DGKQ;PROX1
16694,GO:0097722,0.0202618358830253,0.994210910508772,7,30,sperm motility,BP,BBS2;DNAH1;PLTP;NPHP4;ATP2B4;GAS8;MAFIP
3071,GO:0006650,0.0202688296863295,0.987329607337597,37,271,glycerophospholipid metabolic process,BP,EGFR;LPCAT4;DGKA;PIK3R2;ZP3;ERBB2;ZFYVE21;SERINC2;MBOAT7;OSBPL5;FGFR3;PITPNM1;PLCH2;HBEGF;PI4K2A;FGFR4;LDLR;PIGZ;DGKQ;TTC7B;IMPA2;INPP5D;FGFR1;PI4KAP2;LCAT;PITPNM3;PIGV;PIGQ;SBF1;ERBB3;ACP6;GPD1L;AGPAT4;CPNE7;TAZ;EREG;AGPAT3
14103,GO:0060997,0.0202756218515905,0.993584512034132,8,36,dendritic spine morphogenesis,BP,SHANK2;EPHB2;WNT7A;DLG4;SHANK3;DVL1;EPHB3;EEF2K
18001,GO:1902531,0.0203352584683585,0.983916122653774,147,1302,regulation of intracellular signal transduction,BP,TNIP1;DUSP6;APOE;WWC3;FAM110C;XDH;NOS1;ARAP1;RBCK1;EPHB2;OBSCN;IGF2;MST1R;APPL2;EGFR;TIMP2;DUSP5;PKN1;ARHGEF4;SHC1;RGL2;F2R;PTK6;ABCA7;S100A4;SHC2;CXXC5;PIK3R2;ARHGAP23;ERBB2;FBLN1;PKD2;IQSEC2;SPRY4;PAK6;SERPINE2;MINK1;RALGAPA2;ATP2B4;RASA4;AGAP1;PDCD4;SLC20A1;ACAP3;TNFRSF25;RHOD;PLEKHG4;WNT7A;INSR;ID1;EPHA1;SYNGAP1;LPAR3;PRNP;SPRY2;ECM1;BCL6;PLXNB1;CD81;FZD8;VEGFA;VANGL2;S1PR2;MAPK3;PLEKHG5;CARD19;L3MBTL1;EPHB3;HES1;ARHGAP22;PLEKHG2;ADA;IL6R;RHOF;MAPKBP1;FGFR3;PRKACA;LRRK1;HBEGF;MAP2K2;FGFR4;PSD4;TNFRSF1A;MAPK8IP1;TRPV4;RHOBTB2;DUSP7;TNFAIP8L1;DGKQ;SEMA4C;MIB2;GAS6;BTRC;TKFC;WNT7B;GIT1;PLEKHG6;ARHGEF37;VAV3;BCR;IGFBP4;PRKCZ;MAPKAPK3;ARAP3;FGFR1;PIN1;C5;ASAP2;PPP1R13L;SESN2;TMEM161A;MADD;RTN4R;EPS8L1;SORL1;STK39;ADORA2B;ERBB3;ABR;AKT1;TRAP1;TMBIM4;NLRX1;ZNF385A;TP53INP1;NDRG2;ERCC6;GPD1L;EPS8L2;PINK1;ARHGEF10L;RGS14;MLST8;CBLC;PYCARD;MAP2K3;ERN1;RANBP9;ARHGEF19;SIRT3;C12ORF66;LITAF;EREG;GSTM2;GIPR;TMED4;MIF
12548,GO:0050728,0.0203457106742525,0.99165257322778,12,66,negative regulation of inflammatory response,BP,APOE;NT5E;ACP5;PDCD4;IL20RB;MEFV;ADA;TNFRSF1A;PPARA;BCR;ABR;NLRX1
11177,GO:0045309,0.0204412466023101,0.993522133029056,8,36,protein phosphorylated amino acid binding,MF,SH3BP2;SHC1;PIK3R2;MAPK3;LDLRAP1;BTRC;PIN1;CBLC
12871,GO:0051239,0.0205896278749939,0.983224005267481,199,1822,regulation of multicellular organismal process,BP,FOS;DUSP6;ADGRL1;APOE;CTNNBIP1;IDH2;PTPRS;WWC3;SEMA4B;GAA;CST3;SHANK2;RAPGEF3;CYP27B1;XDH;PGF;NOS1;ZFP36L1;POSTN;ALOX15B;FAM210B;EPHB2;EPAS1;CNTN1;NFATC4;LRP1;GAMT;MAPK13;OBSL1;EGFR;TIMP2;NLGN2;SERPING1;EGR1;CRTC1;F2R;PTK6;ABCA7;DEAF1;LAMA5;BBS2;ULK2;GJC2;ZMYND8;ASH2L;PLAT;HDAC5;THRA;DOCK4;ZP3;LRP5;HYAL1;ZFPM1;ERBB2;SCN4B;ITPR3;PLXNB3;PHLDA2;PTHLH;CD9;KIF13B;SERPINE2;FUZ;RNF135;NTSR1;ATP2B4;CSNK1E;ACP5;ADAMTS7;PDCD4;WNT7A;ZMIZ1;INSR;SH3PXD2B;FBXW8;ID1;CELSR1;EPHA1;SYNGAP1;IL20RB;LPAR3;TMEM173;PRNP;EFNB3;SPRY2;ECM1;STAT6;DLG4;WWTR1;RAB25;FAM20C;BCL6;PLXNB1;FAM213A;VEGFA;VANGL2;AP2A2;CEBPB;SHANK3;ACVR2B;S1PR2;MAPK3;ETV5;TNNT1;DVL1;ADCY6;L3MBTL1;EPHB3;HES1;SSH1;FURIN;CUL7;MEFV;NRP2;ADA;AQP3;CELSR2;IL6R;PCSK9;ZFP36;MAPKBP1;PRKACA;F12;DGUOK;RPS6KA5;HBEGF;DMTN;TNFRSF1A;SEMA3B;LDLR;SOX13;TRPV4;RAG1;EEF2K;HMGA2;SEMA3F;SEMA4C;HK1;GAS6;ADGRB2;TKFC;WNT7B;COMT;SUFU;PTAFR;RXRA;VASN;BCR;PRKCZ;INPP5D;SLITRK6;TWF2;GPC1;ICOSLG;AGO4;FGFR1;CTSZ;CHADL;PIN1;C5;PROX1;BIN1;JARID2;WNT2B;PROCR;LCAT;RTN4R;TIMP1;WNT3;PPM1F;SORL1;STK39;VEGFB;ACVR1B;ADORA2B;ERBB3;ABR;AKT1;NLRX1;NDRG2;VPS33B;GPD1L;SSH3;EHD3;SNTA1;RGS14;CTSH;EPN2;PYCARD;MAP2K3;ARHGEF19;JAK3;LITAF;RARG;EREG;GSTM2;SEMA4F;MIF;SULF2
13089,GO:0051651,0.0206036407438558,0.991166257590795,13,74,maintenance of location in cell,BP,APOE;GAA;GSN;ANK3;ARL2;HK1;TWF2;EPB41L3;SORL1;AKT1;SUN1;PINK1;SYNE3
2207,GO:0005096,0.0206358769873467,0.987573747235534,32,226,GTPase activator activity,MF,EVI5L;ARAP1;APPL2;TBC1D14;RIN1;PIK3R2;ARHGAP23;DOCK4;RALGAPA2;RASA4;AGAP1;ACAP3;TBC1D8;SYNGAP1;ARHGAP27;PLXNB1;ARHGAP22;CDC42EP5;LLGL1;GIT1;PLEKHG6;VAV3;BCR;TBC1D16;ARAP3;ASAP2;TBC1D17;ALS2CL;ABR;RGS14;ARHGEF19;RGS12
2293,GO:0005267,0.0206529240231017,0.993442259621838,8,36,potassium channel activity,MF,KCNG1;KCNC4;KCNJ15;PKD2;KCNAB2;TMEM175;KCNMA1;KCNN4
18195,GO:1903019,0.0207334901010809,0.996730510984974,4,12,negative regulation of glycoprotein metabolic process,BP,CST3;ABCA7;HBEGF;JAK3
18620,GO:1903959,0.0207875072624581,0.995700497422168,5,17,regulation of anion transmembrane transport,BP,PRNP;PTAFR;STK39;ANO9;AKT1
2654,GO:0006006,0.0208202883418922,0.989022635174742,21,136,glucose metabolic process,BP,H6PD;GAA;PGM1;NR1D1;IGF2;NISCH;LRP5;PHLDA2;INSR;PFKFB2;PC;PFKL;DGKQ;HK1;PPARA;PCK2;IGFBP4;MDH2;PDK2;AKT1;MLYCD
11237,GO:0045499,0.0208608296985336,0.995681318260269,5,17,chemorepellent activity,MF,SEMA4B;SEMA3B;SEMA3F;SEMA4C;SEMA4F
9719,GO:0038191,0.0208751857978815,0.995677560880625,5,17,neuropilin binding,MF,SEMA4B;SEMA3B;SEMA3F;SEMA4C;SEMA4F
12297,GO:0048670,0.0209392015563105,0.996687906664379,4,12,regulation of collateral sprouting,BP,PTPRS;ULK2;LPAR3;WNT3
9938,GO:0042325,0.0213612464251476,0.983476350233852,119,1033,regulation of phosphorylation,BP,TNIP1;DUSP6;CEMIP;APOE;RAPGEF3;XDH;EPHB2;CNTN1;IGF2;MST1R;EGFR;TIMP2;DUSP5;PPP1R14A;EGR1;PKN1;SHC1;F2R;PTK6;ABCA7;SHC2;GJC2;PIK3R2;LRP5;ERBB2;FBLN1;PKD2;SPRY4;CDKN1C;PAK6;MINK1;ATP2B4;PDCD4;TNFRSF25;WNT7A;INSR;ID1;EPHA1;ADARB1;ITGA6;SYNGAP1;LPAR3;PRNP;SPRY2;SNX9;DLG4;STRADB;WWTR1;PFKFB2;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;MAPK3;DVL1;ADCY6;EPHB3;HES1;MLXIPL;IL6R;FGFR3;PRKACA;LRRK1;RPS6KA5;HBEGF;MAP2K2;FGFR4;DMTN;TNFRSF1A;EHD4;MAPK8IP1;TRPV4;DUSP7;EEF2K;DGKQ;SEMA4C;GAS6;PPARA;WNT7B;VAV3;IGFBP4;PRKCZ;MAPKAPK3;FGFR1;CAMKK1;PIN1;C5;PROX1;DLG3;GRB10;SESN2;MAPRE3;MADD;RTN4R;PPM1F;SORL1;STK39;ACVR1B;ADORA2B;ERBB3;AKT1;NDRG2;ERCC6;GPD1L;PINK1;PKD1;RGS14;MLST8;CBLC;PYCARD;MAP2K3;ERN1;RANBP9;SIRT3;EREG;MIF
3505,GO:0007423,0.0213624364296932,0.986253043826528,41,307,sensory organ development,BP,CST3;EPHB2;RAB11FIP4;EGFR;SDK2;NAGLU;LRP5;SALL2;IFT140;NPHP4;ATP2B4;LAMB2;WNT7A;SH3PXD2B;CELSR1;SPRY2;VEGFA;VANGL2;ACVR2B;HSF4;MAPK3;TUB;DVL1;HES1;SDHAF4;WNT7B;RXRA;LRP10;BCR;SLITRK6;FGFR1;PROX1;PPP1R13L;SLC25A27;BFSP1;WNT2B;TMEM231;ABR;SIX5;NINJ1;RARG
13970,GO:0060712,0.0215720886938401,0.996555971917571,4,12,spongiotrophoblast layer development,BP,ZFP36L1;PHLDA2;FBXW8;AKT1
14286,GO:0061458,0.0215909016622233,0.986174264454437,40,300,reproductive system development,BP,HTRA1;ERCC1;CST3;CYP27B1;ZFP36L1;ALOX15B;EPAS1;IGF2;EGFR;MDFI;CTSB;ZP3;TFEB;BSG;PKD2;PHLDA2;SERPINE2;PLCD1;WNT7A;INSR;FBXW8;PLCD3;VEGFA;CEBPB;ADAM15;HES1;CUL7;ADA;SLIT3;VGF;WNT7B;DMC1;RXRA;AGO4;WNT2B;SDC1;AKT1;PKD1;RARG;EREG
2145,GO:0004966,0.0215982631832651,0.999332424308567,2,3,galanin receptor activity,MF,LTB4R;LTB4R2
7477,GO:0031657,0.0215985745709033,0.996550422490269,4,12,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,EGFR;PKD2;AKT1;PKD1
2517,GO:0005777,0.0216379319510375,0.989436567493197,17,106,peroxisome,CC,TYSND1;IDH2;XDH;PRDX5;CRAT;PEX10;TMEM173;ABCD1;MAP2K2;PMVK;PEX7;HMGCL;ABCD4;PHYH;GRHPR;LONP2;MLYCD
10062,GO:0042579,0.0216379319510375,0.989436567493197,17,106,microbody,CC,TYSND1;IDH2;XDH;PRDX5;CRAT;PEX10;TMEM173;ABCD1;MAP2K2;PMVK;PEX7;HMGCL;ABCD4;PHYH;GRHPR;LONP2;MLYCD
7310,GO:0031331,0.0216706642541366,0.986293222765232,38,281,positive regulation of cellular catabolic process,BP,APOE;RAPGEF3;ZFP36L1;LRP1;ULK1;TRIM65;TFEB;EDEM1;VPS11;CSNK1E;INSR;SNX33;SNX9;PFKFB2;BNIP3;CD81;ENDOG;MAPK3;DVL1;FYCO1;GPSM1;FURIN;MLXIPL;MEFV;LRSAM1;PCSK9;ZFP36;MAGEF1;LDLR;PPARA;RAD23A;GTPBP1;SH3D19;SESN2;TPCN1;AKT1;TP53INP1;PINK1
12798,GO:0051129,0.0218220264077697,0.98472098412832,61,490,negative regulation of cellular component organization,BP,APOE;ESPN;CTNNBIP1;PTPRS;ERCC1;SEMA4B;CST3;RAPGEF3;GSN;EVI5L;ARAP1;POSTN;EPHB2;NFATC4;LRP1;TOM1L2;ULK1;ARPIN;CORO1B;ULK2;THRA;FBLN1;PLXNB3;VAT1;TMOD2;ID1;SYNGAP1;PRNP;EFNB3;SNX33;SPRY2;DLG4;PLEKHH2;BNIP3;SHANK3;ADCY6;MEFV;LRSAM1;MCTP1;PCSK9;DGUOK;SPTB;DMTN;SEMA3B;LDLR;TRPV4;SEMA3F;SEMA4C;PRKCZ;CAPG;TWF2;CTSZ;CHADL;JARID2;RTN4R;WNT3;SORL1;AKT1;PINK1;SEMA4F;RPL13A
7628,GO:0032050,0.0218796150221893,0.997822469946593,3,7,clathrin heavy chain binding,MF,CEMIP;LRP1;LDLR
4375,GO:0010035,0.0219545624727628,0.985605759475524,44,340,response to inorganic substance,BP,FOS;ERCC1;CST3;GSN;NDRG1;NFATC4;MAPK13;EGFR;UROS;D2HGDH;ANK3;BSG;PKD2;ITPR3;LRP11;CD9;ATP2B4;RASA4;TXNRD3;DNMT3A;PRNP;ATP7B;STAT6;ANKZF1;IGFBP2;BNIP3;ENTPD6;ENDOG;MAPK3;ADA;AQP3;DMTN;EEF2K;ADAMTS13;KCNMA1;CYBRD1;SDC1;GSS;AKT1;TRAP1;ERCC6;PINK1;CPNE7;GIPR
11675,GO:0046486,0.0219864850835713,0.985741368532625,42,317,glycerolipid metabolic process,BP,LMF1;APOE;EGFR;LPCAT4;DGKA;PIK3R2;ZP3;ERBB2;ZFYVE21;SERINC2;MBOAT7;OSBPL5;PCSK9;FGFR3;PITPNM1;PLCH2;HBEGF;PI4K2A;FGFR4;LDLR;PIGZ;DGKQ;TTC7B;IMPA2;PCK2;INPP5D;FGFR1;PNPLA4;PI4KAP2;LCAT;PITPNM3;PIGV;PIGQ;SBF1;ERBB3;ACP6;GPD1L;AGPAT4;CPNE7;TAZ;EREG;AGPAT3
9230,GO:0035641,0.0220160664691702,0.997803553176855,3,7,locomotory exploration behavior,BP,APOE;NLGN2;DLG4
3504,GO:0007422,0.0220319751010049,0.991759685313194,10,51,peripheral nervous system development,BP,NDRG1;SCN8A;ERBB2;LAMB2;NAB2;AHNAK2;ADGRB2;GPC1;ERBB3;AKT1
20207,GO:2001181,0.0220385292130568,0.999311238280138,2,3,positive regulation of interleukin-10 secretion,BP,PRKCZ;PYCARD
2818,GO:0006290,0.0221046490521878,0.997791246927596,3,7,pyrimidine dimer repair,BP,ERCC1;DDB2;ERCC6
5507,GO:0016480,0.0221332617307782,0.999306648087813,2,3,negative regulation of transcription by RNA polymerase III,BP,PRDX5;NAB2
4822,GO:0014037,0.0221770898345516,0.993543545554307,7,30,Schwann cell differentiation,BP,NDRG1;LAMB2;NAB2;AHNAK2;GPC1;ERBB3;AKT1
6783,GO:0030235,0.0222255257654605,0.997774421670085,3,7,nitric-oxide synthase regulator activity,MF,EGFR;ATP2B4;AKT1
12093,GO:0048168,0.0222674931651436,0.993511716813913,7,30,regulation of neuronal synaptic plasticity,BP,APOE;EPHB2;SYNGAP1;DLG4;SHANK3;MCTP1;SHISA6
7490,GO:0031674,0.0222997228254676,0.990333781066972,13,74,I band,CC,FLNC;NOS1;PARVB;SCN8A;OBSCN;MYZAP;OBSL1;ANK3;ATP2B4;AHNAK2;BIN1;SYNC;SLC2A1
18897,GO:1904659,0.0223201548071013,0.990729051962551,12,65,glucose transmembrane transport,BP,PIK3R2;SLC2A9;INSR;SLC2A3;PRKCZ;CLTCL1;SLC25A27;GRB10;SESN2;RTN2;AKT1;SLC2A1
14609,GO:0070207,0.0223746626102818,0.995224105694855,5,18,protein homotrimerization,BP,SIGMAR1;ASIC1;HSF4;ATXN10;MIF
12830,GO:0051174,0.022393529712193,0.982374175125793,136,1198,regulation of phosphorus metabolic process,BP,TNIP1;DUSP6;CEMIP;APOE;RAPGEF3;XDH;NOS1;EPHB2;CNTN1;IGF2;MST1R;EGFR;TIMP2;B3GAT3;DUSP5;PPP1R14A;EGR1;PKN1;SHC1;F2R;PTK6;ABCA7;PPP2R3B;SHC2;GJC2;PIK3R2;ZP3;LRP5;ERBB2;FBLN1;PKD2;SPRY4;PTHLH;CDKN1C;PAK6;LTB4R2;NTSR1;MINK1;ATP2B4;PDCD4;TNFRSF25;WNT7A;INSR;ID1;EPHA1;ADARB1;ITGA6;SYNGAP1;PPP1R35;LPAR3;PRNP;SPRY2;SNX9;DLG4;STRADB;WWTR1;FAM20C;PFKFB2;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;MAPK3;DVL1;ADCY6;EPHB3;HES1;MLXIPL;IL6R;FGFR3;PRKACA;LRRK1;RPS6KA5;HBEGF;MAP2K2;FGFR4;DMTN;TNFRSF1A;EHD4;MAPK8IP1;LDLR;TRPV4;DUSP7;EEF2K;DGKQ;SEMA4C;GAS6;PPARA;WNT7B;PTAFR;VAV3;IGFBP4;PRKCZ;PDK2;MAPKAPK3;FGFR1;CAMKK1;PIN1;C5;PROX1;DLG3;GRB10;SESN2;MAPRE3;GUCA1B;MADD;RTN4R;ELFN2;PPM1F;SORL1;STK39;ACVR1B;ADORA2B;ERBB3;AKT1;NDRG2;ERCC6;GPD1L;PINK1;PKD1;RGS14;PCIF1;MLST8;CBLC;PYCARD;MAP2K3;ERN1;RANBP9;SIRT3;TAZ;EREG;SFI1;MIF
7812,GO:0032377,0.0224018626006771,0.997749809484632,3,7,regulation of intracellular lipid transport,BP,ABCA2;PCSK9;LDLRAP1
7815,GO:0032380,0.0224018626006771,0.997749809484632,3,7,regulation of intracellular sterol transport,BP,ABCA2;PCSK9;LDLRAP1
7818,GO:0032383,0.0224018626006771,0.997749809484632,3,7,regulation of intracellular cholesterol transport,BP,ABCA2;PCSK9;LDLRAP1
9817,GO:0042060,0.0224358811331327,0.98526851748526,44,340,wound healing,BP,APOE;GSN;POSTN;EGFR;SERPING1;F2R;CORO1B;DGKA;PLAT;ZFPM1;ERBB2;FBLN1;ITPR3;CD9;SERPINE2;DOCK6;WNT7A;CELSR1;VANGL2;ADAM15;MAPK3;ENTPD2;PHF21A;PRKACA;F12;HBEGF;DMTN;ELK3;DGKQ;GAS6;PPARA;VAV3;ADAMTS13;PROCR;TIMP1;SDC1;SH2B3;ERBB3;AKT1;VPS33B;EHD3;NINJ1;ARHGEF19;EREG
9867,GO:0042159,0.0225337428912625,0.996353058145147,4,12,lipoprotein catabolic process,BP,APOE;LDLR;LYPLAL1;ABHD17C
13097,GO:0051665,0.0225364026038735,0.997730977602255,3,7,membrane raft localization,BP,MARVELD1;GSN;MALL
12929,GO:0051336,0.0225709278934494,0.982814922501781,103,891,regulation of hydrolase activity,BP,LMF1;CST3;RAPGEF3;GSN;EVI5L;XDH;PRDX5;NOS1;ARAP1;LRP1;EGFR;TIMP2;B3GAT3;PPP1R14A;SERPING1;F2R;PPP2R3B;TBC1D14;GRAMD4;RIN1;PIK3R2;ARHGAP23;DOCK4;ERBB2;FBLN1;PLXNB3;SERPINE2;RALGAPA2;RASA4;AGAP1;GM2A;ACAP3;PLEKHG4;TBC1D8;EPHA1;ITGA6;SYNGAP1;PPP1R35;PAPLN;SPRY2;ECM1;SNX9;ARHGAP27;BCL6;PLXNB1;VEGFA;ARL2;TNFRSF6B;MAPK3;GPSM1;EPHB3;FURIN;MEFV;ARHGAP22;CDC42EP5;PIDD1;FGFR3;CYFIP2;DAP;RAG1;GAS6;LLGL1;GIT1;PTAFR;PLEKHG6;ARHGEF37;VAV3;BCR;TBC1D16;PRKCZ;NDE1;ARAP3;FGFR1;PIN1;C5;ASAP2;DLG3;BIN1;SERPINB6;CSTB;RTN4R;ELFN2;TIMP1;PPM1F;SBF1;SORL1;TBC1D17;ALS2CL;ABR;AKT1;PINK1;RGS14;PCIF1;CTSH;MLST8;PYCARD;PCSK1N;ERN1;ARHGEF19;NEIL1;FAM162A;SFI1;RGS12
19210,GO:1905383,0.0226592308060674,0.999280960470191,2,3,protein localization to presynapse,BP,WNT7A;DVL1
12857,GO:0051220,0.0226659935825586,0.994182212256102,6,24,cytoplasmic sequestering of protein,BP,MDFI;MXI1;THRA;PKD2;SUFU;PKD1
466,GO:0001505,0.0226887769000941,0.987360227710379,24,162,regulation of neurotransmitter levels,BP,SYTL1;NOS1;SYT8;KCNC4;BRSK1;PKD2;RIMS3;VAMP2;NTSR1;ATP2B4;ACP5;GLUL;ASIC1;WNT7A;INSR;DVL1;MCTP1;RAB3B;COMT;ASS1;SNPH;AKT1;GCAT;APBA1
7043,GO:0030833,0.0227084726418196,0.988590486004851,18,114,regulation of actin filament polymerization,BP,GSN;ARPIN;CORO1B;TMOD2;WIPF1;PLEKHG2;CDC42EP5;SPTB;DMTN;CAPG;TWF2;WHAMMP3;EPS8L1;EPS8L2;SPIRE2;MLST8;PYCARD;FCHSD1
6680,GO:0030060,0.0227398774029013,0.999276991617323,2,3,L-malate dehydrogenase activity,MF,PHGDH;MDH2
15748,GO:0072378,0.0227481528467246,0.997701245023001,3,7,blood coagulation, fibrin clot formation,BP,SERPING1;FBLN1;F12
10717,GO:0044092,0.0228253968226162,0.982986625982782,88,750,negative regulation of molecular function,BP,DUSP6;APOE;CTNNBIP1;CST3;CYP27B1;PRDX5;NOS1;RBCK1;EPHB2;NFATC4;TIMP2;DUSP5;PPP1R14A;SERPING1;MDFI;PKN1;PTK6;MXI1;ANK3;THRA;LRP5;ZFPM1;PKD2;PLXNB3;SPRY4;CDKN1C;SERPINE2;LTB4R2;ATP2B4;CSNK1E;RASA4;PDCD4;ID1;EPHA1;ADARB1;PPP1R35;PRNP;PAPLN;SPRY2;ECM1;WWTR1;VEGFA;ARL2;ADAM15;TNFRSF6B;MAPK3;DVL1;GPSM1;FURIN;PCSK9;ZFP36;DAP;MAPK8IP1;BHLHE40;RAG1;DUSP7;HMGA2;GAS6;BTRC;PPARA;SUFU;PRKCZ;CTSZ;PIN1;C5;PROX1;DLG3;BIN1;SERPINB6;CSTB;RTN4R;ELFN2;TIMP1;PPM1F;SORL1;STK39;ANO9;AKT1;NLRX1;PKD1;RGS14;PCIF1;CBLC;PYCARD;PCSK1N;NEIL1;GSTM2;SFI1
9325,GO:0035845,0.022839470730604,0.997688387629599,3,7,photoreceptor cell outer segment organization,BP,IFT140;NPHP4;CDHR1
10369,GO:0043217,0.0230532919172237,0.996242227376775,4,12,myelin maintenance,BP,NDRG1;AHNAK2;EPB41L3;AKT1
9022,GO:0035254,0.0231397598616841,0.993203138754906,7,30,glutamate receptor binding,MF,SHANK2;PRNP;DLG4;SHANK3;DLG3;HOMER2;SHISA6
9452,GO:0036089,0.023205850306608,0.997636590203463,3,7,cleavage furrow formation,BP,SNX33;SNX9;SPIRE2
2258,GO:0005178,0.0233261023240489,0.989835050129294,13,73,integrin binding,MF,LTBP4;EGFR;TIMP2;LAMA5;NISCH;CD9;TNXB;LAMB2;ITGA6;ADAM15;S1PR2;TSPAN4;ADAMTS13
3073,GO:0006654,0.0233428326189012,0.993130919366494,7,30,phosphatidic acid biosynthetic process,BP,LPCAT4;DGKA;DGKQ;ACP6;GPD1L;AGPAT4;AGPAT3
6853,GO:0030335,0.0233453390975784,0.984878164035003,41,310,positive regulation of cell migration,BP,CEMIP;SEMA4B;FAM110C;PGF;POSTN;GRB7;EGFR;F2R;DOCK4;ZP3;HYAL1;RHOD;WNT7A;INSR;EPHA1;ITGA6;SPRY2;RAB25;VEGFA;MAPK3;SSH1;NRP2;IL6R;HBEGF;DMTN;SEMA3B;TRPV4;SEMA3F;SEMA4C;GAS6;PTAFR;FGFR1;PROX1;PPM1F;VEGFB;ACVR1B;AKT1;CTSH;PYCARD;MAP2K3;SEMA4F
6831,GO:0030308,0.0233724180780552,0.987969467217544,19,122,negative regulation of cell growth,BP,PTPRS;SEMA4B;CYP27B1;FHL1;ULK2;HYAL1;SERPINE2;BCL6;ADAM15;SLIT3;SEMA3B;SEMA3F;SEMA4C;SESN2;RTN4R;WNT3;ACVR1B;CCDC85B;SEMA4F
15443,GO:0071813,0.0233788956330022,0.996172345491035,4,12,lipoprotein particle binding,MF,APOE;PCSK9;LDLR;SORL1
15444,GO:0071814,0.0233788956330022,0.996172345491035,4,12,protein-lipid complex binding,MF,APOE;PCSK9;LDLR;SORL1
2520,GO:0005782,0.0234004894861269,0.993080528201064,7,31,peroxisomal matrix,CC,PRDX5;CRAT;PEX7;PHYH;GRHPR;LONP2;MLYCD
7553,GO:0031907,0.0234004894861269,0.993080528201064,7,31,microbody lumen,CC,PRDX5;CRAT;PEX7;PHYH;GRHPR;LONP2;MLYCD
4623,GO:0010755,0.0234040495328902,0.997608428824886,3,7,regulation of plasminogen activation,BP,SERPINE2;F12;CTSZ
15156,GO:0071320,0.023440424512908,0.993096162081298,7,30,cellular response to cAMP,BP,RAPGEF3;ZFP36L1;PKD2;DMTN;EEF2K;PTAFR;SLC5A5
7463,GO:0031639,0.0234541184353547,0.996156154909856,4,12,plasminogen activation,BP,PLAT;SERPINE2;F12;CTSZ
14674,GO:0070326,0.023514917460811,0.999238443487469,2,3,very-low-density lipoprotein particle receptor binding,MF,APOE;PCSK9
20133,GO:2000977,0.0236301448906146,0.999232649918242,2,3,regulation of forebrain neuron differentiation,BP,HES1;PROX1
11831,GO:0046835,0.0236303851379574,0.99387548183774,6,24,carbohydrate phosphorylation,BP,FGGY;PFKFB2;GALK1;HK1;TKFC;FUK
1984,GO:0004708,0.0237195744791214,0.996098882029394,4,12,MAP kinase kinase activity,MF,MAPK3;MAP2K2;MAPKAPK3;MAP2K3
4557,GO:0010648,0.0237400933279159,0.981774317516319,108,937,negative regulation of cell communication,BP,TNIP1;HTRA1;DUSP6;APOE;CTNNBIP1;PTPRS;WWC3;SHANK2;XDH;LTBP1;NR1D1;ARRDC1;EPHB2;NFATC4;MST1R;LRP1;EGFR;TIMP2;HADH;DUSP5;MDFI;EGR1;PTK6;PIK3R2;ERBB2;FBLN1;PKD2;DNM1;SPRY4;DDIT4L;PTPRE;SERPINE2;FUZ;NPHP4;ATP2B4;RASA4;PDCD4;ASIC1;INSR;EPHA1;ITGA6;SYNGAP1;PRNP;SPRY2;MNT;ECM1;STRADB;WWTR1;BCL6;IGFBP2;SRMS;SHANK3;S1PR2;CARD19;DVL1;EPHB3;ADA;PFKL;SLIT3;MAPKBP1;FGFR3;HBEGF;FGFR4;MAPK8IP1;DUSP7;TNFAIP8L1;GAS6;BTRC;TKFC;SUFU;VASN;IGFBP4;PRKCZ;INPP5D;GPC1;ARAP3;FGFR1;PIN1;VSNL1;GRB10;SESN2;TMEM161A;RTN4R;PEAR1;SORL1;ERBB3;AKT1;TRAP1;NLRX1;ZNF385A;NDRG2;GPD1L;PINK1;RGS14;CBLC;EPN2;PYCARD;RANBP9;SIRT3;C12ORF66;EREG;GSTM2;SHISA6;GIPR;RGS12;MIF;SULF2;LZTS2
16866,GO:0098839,0.0237556299702622,0.997558232675772,3,7,postsynaptic density membrane,CC,PTPRS;DLG4;DLG3
17069,GO:0099634,0.0237556299702622,0.997558232675772,3,7,postsynaptic specialization membrane,CC,PTPRS;DLG4;DLG3
13251,GO:0051966,0.0238031487210943,0.993820199391902,6,24,regulation of synaptic transmission, glutamatergic,BP,SHANK2;EGFR;NLGN2;SERPINE2;GLUL;SHANK3
4057,GO:0009116,0.0238193038492439,0.988519906836549,16,100,nucleoside metabolic process,BP,NT5E;NME4;GAMT;DLG4;UCKL1;TK2;ADA;DGUOK;GUK1;GTPBP1;DLG3;MACROD1;APOBEC3C;AHCYL2;APOBEC3F;MOCS1
5827,GO:0017124,0.0238535447521805,0.988521410343751,16,97,SH3 domain binding,MF,ESPN;SHANK2;SH3BP2;EFS;DOCK4;SYNGAP1;ARHGAP27;ELMO3;SHANK3;ADAM15;WIPF1;SH2D2A;MVB12A;INPP5D;ADAM19;CBLC
8748,GO:0034436,0.023887440950553,0.999219655158265,2,3,glycoprotein transport,BP,ABCG1;GUK1
17036,GO:0099550,0.023904961786772,0.999218767355902,2,3,trans-synaptic signaling, modulating synaptic transmission,BP,EPHB2;F2R
8711,GO:0034374,0.0240361998550603,0.999212105582463,2,3,low-density lipoprotein particle remodeling,BP,APOE;ABCG1
1962,GO:0004675,0.0241428692916858,0.996007114627376,4,12,transmembrane receptor protein serine/threonine kinase activity,MF,LTBP4;LTBP1;ACVR2B;ACVR1B
4366,GO:0010001,0.024193978181325,0.987259024102236,20,130,glial cell differentiation,BP,GSN;NDRG1;LRP1;EGFR;ERBB2;CD9;SERPINE2;LAMB2;BNIP3;NAB2;MAPK3;HES1;MXRA8;HDAC11;LDLR;AHNAK2;GPC1;BIN1;ERBB3;AKT1
6085,GO:0019287,0.0242439453505917,0.999201517803931,2,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,MVD;PMVK
17978,GO:1902473,0.0242510867275769,0.997486974608948,3,7,regulation of protein localization to synapse,BP,NLGN2;WNT7A;DVL1
18736,GO:1904251,0.0242543655755309,0.997486501019994,3,7,regulation of bile acid metabolic process,BP,NR1D1;FGFR4;PROX1
4059,GO:0009119,0.0242592203774378,0.988955691399652,14,84,ribonucleoside metabolic process,BP,NT5E;NME4;GAMT;DLG4;UCKL1;ADA;DGUOK;GUK1;GTPBP1;DLG3;APOBEC3C;AHCYL2;APOBEC3F;MOCS1
14424,GO:0061771,0.024275980980904,0.999199880485691,2,3,response to caloric restriction,BP,APOE;LDLR
15509,GO:0071933,0.0243421164599112,0.997473816688028,3,7,Arp2/3 complex binding,MF,CORO1B;SNX9;WHAMMP3
15216,GO:0071402,0.0243815204485886,0.994675604459359,5,18,cellular response to lipoprotein particle stimulus,BP,APOE;ABCG1;CD9;CD81;LDLR
9945,GO:0042340,0.0243912962883364,0.997466699519091,3,7,keratan sulfate catabolic process,BP,HEXB;GLB1;GALNS
6983,GO:0030676,0.0243955975604124,0.995952068747147,4,12,Rac guanyl-nucleotide exchange factor activity,MF,ARHGEF4;VAV3;EPS8L1;EPS8L2
17918,GO:1902285,0.0244037050420889,0.995950299731074,4,12,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,PLXNB3;PLXNB1;NRP2;SEMA3F
8359,GO:0033270,0.0244208908104748,0.997462413826244,3,7,paranode region of axon,CC,GJC2;KIF13B;EPB41L3
14673,GO:0070325,0.0244462127756324,0.994657703985289,5,18,lipoprotein particle receptor binding,MF,APOE;LRP1;PCSK9;SNX17;LDLRAP1
9946,GO:0042350,0.0244633610140333,0.999190278961576,2,3,GDP-L-fucose biosynthetic process,BP,TSTA3;FUK
17688,GO:1901628,0.0246450484011929,0.999180928986682,2,3,positive regulation of postsynaptic membrane organization,BP,APOE;SSH1
18342,GO:1903365,0.0246754454612681,0.999179360844444,2,3,regulation of fear response,BP,APOE;RAG1
20102,GO:2000822,0.0246754454612681,0.999179360844444,2,3,regulation of behavioral fear response,BP,APOE;RAG1
7193,GO:0031094,0.024711894460569,0.997420158525678,3,7,platelet dense tubular network,CC,F2R;ITPR3;DMTN
14265,GO:0061387,0.0247552544178026,0.989111631406972,13,74,regulation of extent of cell growth,BP,APOE;PTPRS;SEMA4B;ULK2;LPAR3;VEGFA;SEMA3B;SEMA3F;SEMA4C;TWF2;RTN4R;WNT3;SEMA4F
12061,GO:0048037,0.0247554842657217,0.983551769379223,45,352,cofactor binding,MF,H6PD;IDH2;PYGB;CYP27B1;XDH;PRODH;NOS1;NR1D1;HEBP1;ACBD4;HADH;CRYL1;ACOT7;UROS;MTHFR;PYGL;D2HGDH;OGDHL;CBS;CD320;NDUFS8;TXNRD3;DHTKD1;PHGDH;PC;ACAD10;SLC48A1;HLCS;CYP3A5;TM7SF2;HMGCL;SDHA;PHYH;TSTA3;GRHPR;GSS;CYP2S1;GPD1L;RSAD1;PNPO;ACADS;GCAT;MOCS1;SIRT3;GSTM2
4119,GO:0009187,0.02489700773698,0.989952783404238,11,59,cyclic nucleotide metabolic process,BP,APOE;RAPGEF3;NOS1;TIMP2;PKD2;PTHLH;LTB4R2;VEGFA;ADCY6;GUCA1B;ADORA2B
12533,GO:0050708,0.0251035189078112,0.984260484902827,35,260,regulation of protein secretion,BP,IDH2;RAPGEF3;POSTN;NR1D1;ALOX15B;EGFR;HADH;NLGN2;RHBDF1;F2R;LRP5;ITPR3;GLUL;MYO18A;PFKFB2;ARL2;RHBDF2;MAPK3;PFKL;MAPKBP1;TRPV4;HK1;GAS6;LLGL1;PCK2;PRKCZ;TM7SF3;C5;VSNL1;PYCARD;KCNN4;SIRT3;SLC2A1;GIPR;MIF
10006,GO:0042461,0.0251385992737984,0.994465282138974,5,18,photoreceptor cell development,BP,NAGLU;IFT140;NPHP4;VEGFA;CDHR1
622,GO:0001806,0.0251791775331681,0.999153213777723,2,3,type IV hypersensitivity,BP,ZP3;IL20RB
1212,GO:0002883,0.0251791775331682,0.999153213777723,2,3,regulation of hypersensitivity,BP,ZP3;IL20RB
13057,GO:0051592,0.0252035067106495,0.98848461735907,14,82,response to calcium ion,BP,FOS;EGFR;PKD2;ITPR3;RASA4;ENTPD6;ENDOG;AQP3;DMTN;EEF2K;KCNMA1;SDC1;CPNE7;GIPR
17222,GO:0120031,0.0253121962806089,0.982524680069351,54,428,plasma membrane bounded cell projection assembly,BP,ESPN;GSN;EVI5L;PARVB;ARAP1;TCTN1;ARHGEF4;LAMA5;BBS2;DNAH1;ZMYND8;MARK4;TENM2;PLXNB3;IFT140;NINL;FUZ;NPHP4;CSNK1E;RHOD;ITGA6;LPAR3;CEP250;WWTR1;TMEM107;VANGL2;NUDCD3;S1PR2;SSH1;FBF1;CDC42EP5;PRKACA;DMTN;BBS1;CROCC;VAV3;WDR60;TWF2;NDE1;UNC119B;WRAP73;TMEM231;EPS8L1;SEPT8;EPS8L2;SSH3;GAS8;EHD3;MAFIP;RILPL1;ATXN10;RFX2;DNAAF5;SFI1
11566,GO:0046164,0.0253240744957166,0.992386375238698,7,31,alcohol catabolic process,BP,APOE;NTSR1;SRD5A3;SNX17;TKFC;IMPA2;TRERF1
7252,GO:0031232,0.025414387316279,0.999140901689162,2,3,extrinsic component of external side of plasma membrane,CC,SERPINE2;PCSK9
6790,GO:0030246,0.0254202393391507,0.986792710954247,19,122,carbohydrate binding,MF,ADGRL1;GAA;MRC2;CNTN1;FBXO2;PYGL;ZP3;BSG;GALNT12;LGALS9C;TALDO1;GALK1;SLC2A3;PFKL;HK1;PHYH;MAN2B2;PKD1;LGALS9B
5896,GO:0018125,0.0254455840150109,0.999139263780238,2,3,peptidyl-cysteine methylation,BP,RAB3D;RAB3B
10309,GO:0043120,0.0256593076406093,0.999128011849131,2,3,tumor necrosis factor binding,MF,TNFRSF25;TNFRSF1A
14177,GO:0061134,0.02568777697238,0.987170977764053,17,111,peptidase regulator activity,MF,CST3;PRDX5;TIMP2;SERPING1;FBLN1;SERPINE2;PAPLN;FURIN;GAS6;C5;SERPINB6;CSTB;TIMP1;PINK1;CTSH;PYCARD;PCSK1N
17674,GO:1901605,0.0257812946407935,0.985859353599744,22,148,alpha-amino acid metabolic process,BP,PRODH;NOS1;GAMT;ALDH4A1;MTHFR;CRTAP;CBS;ATP2B4;GGT1;SLC6A8;GLUL;BLMH;PHGDH;NAGS;PYCR2;CKMT1A;HMGCL;COMT;ASS1;AHCYL2;HPDL;GCAT
6004,GO:0019062,0.0257882070921674,0.99912119965908,2,3,virion attachment to host cell,BP,CD81;GAS6
10934,GO:0044650,0.0257882070921674,0.99912119965908,2,3,adhesion of symbiont to host cell,BP,CD81;GAS6
11542,GO:0046110,0.0259322878878275,0.99911356204305,2,3,xanthine metabolic process,BP,XDH;ADA
6062,GO:0019220,0.0259607523989559,0.979482074155969,134,1185,regulation of phosphate metabolic process,BP,TNIP1;DUSP6;CEMIP;APOE;RAPGEF3;XDH;NOS1;EPHB2;CNTN1;IGF2;MST1R;EGFR;TIMP2;B3GAT3;DUSP5;PPP1R14A;EGR1;PKN1;SHC1;F2R;PTK6;ABCA7;PPP2R3B;SHC2;GJC2;PIK3R2;ZP3;LRP5;ERBB2;FBLN1;PKD2;SPRY4;PTHLH;CDKN1C;PAK6;LTB4R2;NTSR1;MINK1;ATP2B4;PDCD4;TNFRSF25;WNT7A;INSR;ID1;EPHA1;ADARB1;ITGA6;SYNGAP1;PPP1R35;LPAR3;PRNP;SPRY2;SNX9;DLG4;STRADB;WWTR1;PFKFB2;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;MAPK3;DVL1;ADCY6;EPHB3;HES1;MLXIPL;IL6R;FGFR3;PRKACA;LRRK1;RPS6KA5;HBEGF;MAP2K2;FGFR4;DMTN;TNFRSF1A;EHD4;MAPK8IP1;LDLR;TRPV4;DUSP7;EEF2K;DGKQ;SEMA4C;GAS6;PPARA;WNT7B;PTAFR;VAV3;IGFBP4;PRKCZ;MAPKAPK3;FGFR1;CAMKK1;PIN1;C5;PROX1;DLG3;GRB10;SESN2;MAPRE3;GUCA1B;MADD;RTN4R;ELFN2;PPM1F;SORL1;STK39;ACVR1B;ADORA2B;ERBB3;AKT1;NDRG2;ERCC6;GPD1L;PINK1;PKD1;RGS14;PCIF1;MLST8;CBLC;PYCARD;MAP2K3;ERN1;RANBP9;SIRT3;TAZ;EREG;SFI1;MIF
7995,GO:0032635,0.0259888338861365,0.988935132933287,12,67,interleukin-6 production,BP,MAPK13;F2R;CEBPB;IL6R;TRPV4;GAS6;PTAFR;INPP5D;ADORA2B;NLRX1;PYCARD;EREG
14839,GO:0070640,0.0261299594338184,0.999103044013955,2,3,vitamin D3 metabolic process,BP,CYP27B1;FGFR1
19292,GO:1905600,0.0262074296790847,0.999098909377662,2,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,PCSK9;LDLRAP1
5579,GO:0016614,0.0262196022143174,0.987551825526576,15,93,oxidoreductase activity, acting on CH-OH group of donors,MF,H6PD;IDH2;XDH;HADH;CRYL1;KDSR;D2HGDH;DHRS11;AKR7A2;KCNAB2;PHGDH;MDH2;TSTA3;GRHPR;GPD1L
6098,GO:0019344,0.026399920197271,0.99908860569052,2,3,cysteine biosynthetic process,BP,CBS;GGT1
17100,GO:0102148,0.0266085021093899,0.999077391909968,2,3,N-acetyl-beta-D-galactosaminidase activity,MF,HEXB;HEXDC
7918,GO:0032507,0.0266390906809124,0.989106693202429,11,61,maintenance of protein location in cell,BP,GSN;ANK3;ARL2;HK1;TWF2;EPB41L3;SORL1;AKT1;SUN1;PINK1;SYNE3
3763,GO:0008324,0.0266790047409293,0.982643224437794,40,306,cation transmembrane transporter activity,MF,SCN8A;KCNG1;KCNC4;KCNJ15;SLC2A9;SLC13A3;PKD2;SCN4B;SLC7A8;ITPR3;ATP2B4;SLC6A8;SLC20A1;ASIC1;SERINC2;ATP7B;SLC12A7;ATP12A;TMEM63C;KCNAB2;SLC22A18;SLC28A2;SCNN1A;SLC25A37;TRPV4;GAS6;TMEM175;KCNMA1;TMCO3;NDUFA4L2;SLC9A7;TPCN1;SLC25A29;SLC5A5;PKD1;RHBG;KCNN4;ORAI3;ORAI2;PQLC2
17817,GO:1902022,0.0266790868832165,0.999073585672766,2,3,L-lysine transport,BP,SLC25A29;PQLC2
18361,GO:1903401,0.0266790868832165,0.999073585672766,2,3,L-lysine transmembrane transport,BP,SLC25A29;PQLC2
12520,GO:0050692,0.0266838900899704,0.999073326452715,2,3,DBD domain binding,MF,RXRA;PROX1
18392,GO:1903463,0.0267020334973692,0.999072347045382,2,3,regulation of mitotic cell cycle DNA replication,BP,BCL6;FGFR1
3567,GO:0007619,0.0267291227230432,0.999070884018656,2,3,courtship behavior,BP,THRA;HEXB
12221,GO:0048518,0.0267810065059423,0.977023982349507,402,3882,positive regulation of biological process,BP,TNIP1;HTRA1;FOS;DUSP6;CEMIP;ADGRL1;APOE;ESPN;CTNNBIP1;MARCKSL1;TSPAN1;PTPRS;ERCC1;SEMA4B;FAM110C;CITED4;CST3;SHANK2;RAPGEF3;CYP27B1;GSN;XDH;NDRG1;PCBP4;PRODH;PGF;MEF2D;NOS1;ARAP1;SH3BP2;ZFP36L1;POSTN;GRB7;NR1D1;ALOX15B;FAM210B;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;IGF2;NFATC4;MST1R;LRP1;MAPK13;RAB11FIP4;OBSL1;EGFR;TIMP2;SMOC2;B3GAT3;NLGN2;TCEA2;DUSP5;FHL1;DDB2;SERPING1;ADGRF1;EGR1;ULK1;PKN1;CRTC1;ARPIN;ARHGEF4;TRIM65;SHC1;RGL2;F2R;PTK6;ABCA7;DEAF1;BBS2;ACTA2;PRSS8;S100A4;CTSB;SHC2;CORO1B;CXXC5;GJC2;ZMYND8;ASH2L;GRAMD4;SOX12;MMP1;ABCG1;ANK3;PIK3R2;S100A6;ZNF516;PEG3;HDAC5;THRA;DOCK4;ZP3;RPS6KA2;LRP5;HYAL1;MARK4;TENM2;PLTP;MAML3;ZFPM1;TFEB;ERBB2;FBLN1;MICALL2;PKD2;SCN4B;EDEM1;ITPR3;PLXNB3;DNM1;PTHLH;CDKN1C;RIMS3;SALL2;VIPR1;PAK6;HEXB;SERPINE2;VPS11;VAMP2;FUZ;RNF135;NPHP4;NTSR1;CD320;MINK1;ATP2B4;TMOD2;TFDP2;CSNK1E;TRAPPC9;PDCD4;SLC20A1;TNFRSF25;GLUL;RHOD;WNT7A;ZMIZ1;INSR;RAB3D;SH3PXD2B;TBC1D8;FBXW8;ID1;MVD;EPHA1;ADARB1;ITGA6;IL20RB;DNMT3A;DNPH1;LPAR3;TMEM173;PRNP;EFNB3;SNX33;SPRY2;ECM1;CEP250;SNX9;STAT6;DLG4;MTA3;STRADB;WWTR1;RAB25;FAM20C;MYO18A;BCL6;PFKFB2;PLXNB1;IGFBP2;DYRK1B;SEC14L2;MVB12B;BNIP3;CD81;FZD8;VEGFA;ARL2;YPEL3;VANGL2;FBXW4;CEBPB;SHANK3;ACVR2B;HSF4;NAB2;CALCOCO1;S1PR2;ENDOG;MAPK3;PLEKHG5;TUB;ETV5;OLFM2;DVL1;MTA1;FYCO1;WIPF1;GPSM1;ADCY6;EPHB3;NSMCE4A;FHOD1;HES1;PC;SSH1;FURIN;MLXIPL;CUL7;MEFV;EVC;NRP2;PLEKHG2;TNFRSF14;LRSAM1;ADA;CDC42EP5;PIDD1;PAG1;SH2D2A;AQP3;RASL10B;IL6R;PCSK9;ZFP36;ETV4;FGFR3;PRKACA;F12;LRRK1;MAGEF1;CYFIP2;RPS6KA5;HBEGF;RAB3B;MAP2K2;DAP;FGFR4;DMTN;TNFRSF1A;EHD4;MAPK8IP1;SEMA3B;LDLR;ABHD17C;TRPV4;CROCC;RAG1;DUSP7;EEF2K;HMGA2;LDLRAP1;SEMA3F;ELK3;DGKQ;SEMA4C;MVB12A;HK1;ZXDC;MIB2;GAS6;BTRC;ADGRB2;PPARA;TKFC;WNT7B;COMT;PTAFR;RFNG;LTBP3;RXRA;PCK2;VAV3;BCR;NEO1;IGFBP4;MUC19;USP21;PRKCZ;CLTCL1;HLTF;INPP5D;TM7SF3;SLITRK6;TWF2;GPC1;ICOSLG;SRSF5;RFXANK;TEF;MAPKAPK3;RAD23A;FGFR1;CTSZ;CAMKK1;PIN1;C5;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;KCNMA1;BIN1;VSNL1;OSCP1;PPP1R13L;ASS1;SH3D19;GLRX;SLC25A27;GRB10;JARID2;SESN2;TOLLIP;WNT2B;WRAP73;TMEM161A;RXRB;MAPRE3;GUCA1B;ADGRE2;MADD;RTN4R;TIMP1;SDC1;WHAMMP3;SH2B3;FGFBP1;EPS8L1;WNT3;PPM1F;SORL1;STK39;VEGFB;ACVR1B;MEF2B;ADORA2B;TPCN1;ERBB3;ABR;PNMA1;CCDC71L;AKT1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;GPD1L;EPS8L2;SSBP2;PINK1;PKD1;EHD3;ARHGEF10L;CAMTA2;RGS14;SPIRE2;CTSH;ABHD14B;MLST8;EPN2;RFX2;RNF187;PYCARD;NINJ1;MAP2K3;POMT1;TRERF1;KCNN4;DDN;STK17A;ERN1;ARHGEF19;SIRT3;MLYCD;TAZ;JAK3;LITAF;MZF1;RARG;ING4;EREG;FAM162A;GSTM2;GIPR;ADAMTSL4;TMED4;SEMA4F;MIF;SULF2;STXBP2;KIF26B;UBL5
9624,GO:0036510,0.0267843749938691,0.999067897331172,2,3,trimming of terminal mannose on C branch,BP,EDEM1;MAN1B1
11770,GO:0046658,0.0269223024808105,0.992760242440857,6,25,anchored component of plasma membrane,CC,PRSS8;PRNP;MDGA1;GPC1;RTN4R;RHBG
14479,GO:0062012,0.0269465809925801,0.982166674818815,43,335,regulation of small molecule metabolic process,BP,LMF1;APOE;TYSND1;RAPGEF3;CYP27B1;NOS1;NR1D1;IGF2;TIMP2;EGR1;ABCG1;PKD2;PHLDA2;PTHLH;LTB4R2;NTSR1;CD320;ATP2B4;INSR;MVD;PFKFB2;SEC14L2;VEGFA;MLXIPL;FGFR4;PMVK;LDLR;LDLRAP1;TM7SF2;DGKQ;PPARA;COMT;PTAFR;IGFBP4;PDK2;PROX1;GUCA1B;ADORA2B;AKT1;PINK1;LONP2;MLYCD;TAZ
4488,GO:0010523,0.0269779288354497,0.995277076861205,4,13,negative regulation of calcium ion transport into cytosol,BP,NOS1;PKD2;NTSR1;GSTM2
12672,GO:0050916,0.0270003681507677,0.999056187773048,2,3,sensory perception of sweet taste,BP,ITPR3;REEP2
16464,GO:0097187,0.0270323796528202,0.999054447751214,2,3,dentinogenesis,BP,HTRA1;FAM20C
5834,GO:0017134,0.02706202375587,0.993859823020442,5,19,fibroblast growth factor binding,MF,FGFR3;FGFR4;GPC1;FGFR1;FGFBP1
7127,GO:0030971,0.0271165241833566,0.990132674672418,9,45,receptor tyrosine kinase binding,MF,SHC1;SHC2;PIK3R2;DOCK4;PAG1;PITPNM1;GAS6;PITPNM3;CBLC
2096,GO:0004866,0.0271757292836662,0.987836321595612,13,79,endopeptidase inhibitor activity,MF,CST3;PRDX5;TIMP2;SERPING1;SERPINE2;PAPLN;FURIN;GAS6;C5;SERPINB6;CSTB;TIMP1;PCSK1N
6876,GO:0030414,0.0271757292836662,0.987836321595612,13,79,peptidase inhibitor activity,MF,CST3;PRDX5;TIMP2;SERPING1;SERPINE2;PAPLN;FURIN;GAS6;C5;SERPINB6;CSTB;TIMP1;PCSK1N
12298,GO:0048671,0.0271863016096863,0.999046064614972,2,3,negative regulation of collateral sprouting,BP,PTPRS;ULK2
10495,GO:0043418,0.0271985132678848,0.999045398353774,2,3,homocysteine catabolic process,BP,CBS;BLMH
16596,GO:0097475,0.0272196200048631,0.999044246376521,2,3,motor neuron migration,BP,VEGFA;NHSL1
4618,GO:0010749,0.0272321002146618,0.999043564981802,2,3,regulation of nitric oxide mediated signal transduction,BP,EGFR;ATP2B4
14949,GO:0070885,0.0272418537348207,0.999043032333918,2,3,negative regulation of calcineurin-NFAT signaling cascade,BP,ATP2B4;PRNP
17180,GO:0106057,0.0272418537348207,0.999043032333918,2,3,negative regulation of calcineurin-mediated signaling,BP,ATP2B4;PRNP
6671,GO:0030046,0.0272421998546492,0.99904301343001,2,3,parallel actin filament bundle assembly,BP,ESPN;SPIRE2
4814,GO:0014022,0.0272421998546609,0.99904301343001,2,3,neural plate elongation,BP,VANGL2;DVL1
6550,GO:0022007,0.0272421998546609,0.99904301343001,2,3,convergent extension involved in neural plate elongation,BP,VANGL2;DVL1
19618,GO:1990851,0.0272421998546611,0.99904301343001,2,3,Wnt-Frizzled-LRP5/6 complex,CC,LRP5;FZD8
9576,GO:0036446,0.0272421998546612,0.99904301343001,2,3,myofibroblast differentiation,BP,PDCD4;TP53INP1
18949,GO:1904760,0.0272421998546612,0.99904301343001,2,3,regulation of myofibroblast differentiation,BP,PDCD4;TP53INP1
6778,GO:0030226,0.0272421998546612,0.99904301343001,2,3,apolipoprotein receptor activity,MF,LRP1;ABCA7
10402,GO:0043260,0.0272421998546612,0.99904301343001,2,3,laminin-11 complex,CC,LAMA5;LAMB2
15671,GO:0072235,0.0272421998546612,0.99904301343001,2,3,metanephric distal tubule development,BP,PKD2;PKD1
5056,GO:0015280,0.0272421998546848,0.99904301343001,2,3,ligand-gated sodium channel activity,MF,ASIC1;SCNN1A
13743,GO:0060349,0.0272731772786597,0.989413458088395,10,52,bone morphogenesis,BP,MEF2D;THBS3;LRP5;ACP5;NAB2;FGFR3;TRPV4;PEX7;COL13A1;RARG
10424,GO:0043299,0.0273001053603799,0.981566313317821,47,375,leukocyte degranulation,BP,GAA;NAPRT;PYGB;CST3;PGM1;GSN;PRSS3;TIMP2;PYGL;CTSB;FUCA1;VAT1;HEXB;VAMP2;GM2A;RAB3D;NBEAL2;TMEM173;RNASET2;DNASE1L1;AP2A2;DPP7;KCNAB2;GLB1;LTA4H;SLC2A3;PFKL;RHOF;PI4K2A;PTAFR;BCR;CTSZ;SERPINB6;TOLLIP;CSTB;ADGRE2;CD68;ACTR1B;ADORA2B;HGSNAT;ABR;CTSD;CTSH;PYCARD;GALNS;MIF;STXBP2
3600,GO:0008047,0.027395555213254,0.981273687771918,50,394,enzyme activator activity,MF,APOE;EVI5L;ARAP1;IGF2;APPL2;B3GAT3;TBC1D14;RIN1;PIK3R2;ARHGAP23;DOCK4;FBLN1;RALGAPA2;RASA4;AGAP1;GM2A;ACAP3;SH3PXD2B;TBC1D8;SYNGAP1;SPRY2;ARHGAP27;PLXNB1;ARHGAP22;CDC42EP5;MAP2K2;DGKQ;GAS6;LLGL1;GIT1;PLEKHG6;VAV3;BCR;TBC1D16;ARAP3;ASAP2;GUCA1B;MADD;TBC1D17;ALS2CL;ERBB3;ABR;ERCC6;PINK1;RGS14;CTSH;MLST8;PYCARD;ARHGEF19;RGS12
3226,GO:0006887,0.0274851335037689,0.979984062615867,71,596,exocytosis,BP,GAA;SYTL1;NAPRT;PYGB;CST3;PGM1;GSN;PRSS3;IGF2;TIMP2;SERPING1;PYGL;SYT8;CTSB;ZP3;EXOC2;FUCA1;VAT1;RIMS3;CD9;HEXB;VPS11;VAMP2;GM2A;RAB3D;NBEAL2;TMEM173;RNASET2;ECM1;RAB25;VEGFA;DNASE1L1;AP2A2;DPP7;KCNAB2;GLB1;RAB40B;LTA4H;SLC2A3;PFKL;RHOF;RAB3B;PI4K2A;DMTN;GAS6;LLGL1;PTAFR;BCR;CTSZ;VSNL1;SERPINB6;TOLLIP;CSTB;SNPH;ADGRE2;TIMP1;CD68;SDC1;ACTR1B;VEGFB;ADORA2B;HGSNAT;ABR;CTSD;VPS33B;CTSH;PYCARD;GALNS;RAB40C;MIF;STXBP2
9596,GO:0036477,0.0275271723844983,0.980577830781655,59,477,somatodendritic compartment,CC,APOE;PTPRS;CST3;SHANK2;NOS1;NR1D1;EPHB2;LRP1;TIMP2;FBXO2;CRTC1;GJC2;IGSF9;ZMYND8;KCNC4;ANK3;TENM2;CPT1C;ITPR3;DNM1;KIF13B;NTSR1;MINK1;GLUL;PRR7;INSR;SYNGAP1;PRNP;DLG4;BNIP3;SHANK3;ENDOG;DVL1;EPHB3;ADA;HTR7;PI4K2A;MAPK8IP1;LDLR;ABHD17C;EEF2K;COMT;PRKCZ;DLG3;SLC25A27;CAPN2;SNPH;RTN4R;ZNF385A;HOMER2;RGS14;NRSN1;ATXN10;PYCARD;KCNN4;DDN;APBA1;SHISA6;RGS12
2746,GO:0006164,0.0275660314210563,0.984128682601076,25,176,purine nucleotide biosynthetic process,BP,APOE;PGM1;NOS1;NME4;TIMP2;ACOT7;OGDHL;PTHLH;LTB4R2;INSR;PFKFB2;DHTKD1;GALK1;ADCY6;MLXIPL;ADA;PFKL;HK1;PPARA;GUK1;GUCA1B;ADORA2B;PINK1;TAZ;PPCS
8102,GO:0032802,0.0276901962852839,0.995112249021621,4,13,low-density lipoprotein particle receptor catabolic process,BP,APOE;AP2A2;FURIN;PCSK9
11666,GO:0046473,0.0277012281744469,0.991511950182099,7,31,phosphatidic acid metabolic process,BP,LPCAT4;DGKA;DGKQ;ACP6;GPD1L;AGPAT4;AGPAT3
16200,GO:0090277,0.027799152985318,0.989156928750166,10,53,positive regulation of peptide hormone secretion,BP,EGFR;NLGN2;GLUL;PFKFB2;RASL10B;PCK2;TM7SF3;VSNL1;SIRT3;GIPR
9885,GO:0042221,0.0278117743251206,0.976493866133024,291,2770,response to chemical,BP,TNIP1;HTRA1;FOS;DUSP6;APOE;ERCC1;SEMA4B;CST3;LTBP4;RAPGEF3;CYP27B1;GSN;XDH;PRDX5;NDRG1;PRODH;PGF;NOS1;LTBP1;ZFP36L1;COL6A1;POSTN;GRB7;NR1D1;FAM210B;RBCK1;EPHB2;EPAS1;IGF2;NFATC4;GPX3;MST1R;LRP1;MAPK13;LTBP2;EGFR;TIMP2;MMP28;HADH;FBXO2;PPP1R14A;UROS;LOXL1;MTHFR;EGR1;CMTM7;SHC1;F2R;PTK6;BPHL;LAMA5;BBS2;CTSB;CORO1B;GJC2;D2HGDH;MMP1;ABCG1;ANK3;PIK3R2;HDAC5;THRA;DOCK4;LRP5;HYAL1;ERBB2;SLC13A3;BSG;PTPRU;PKD2;TMEM129;EDEM1;SLC7A8;ITPR3;PLXNB3;PRAF2;SPRY4;CDKN1C;LRP11;CD9;XPC;PTPRE;DNAJC4;VAMP2;FUZ;LTB4R2;NTSR1;CD320;ATP2B4;GGT1;SNN;SLC6A8;ACP5;RASA4;ADAMTS7;PDCD4;TNFRSF25;GLUL;LAMB2;WNT7A;INSR;ID1;AKR7A2;B4GAT1;ITGA6;TXNRD3;IL20RB;DNMT3A;TMEM173;PRNP;ATP7B;EFNB3;SPRY2;BLMH;ECM1;STAT6;MKNK2;TALDO1;ISG20;FAM20C;DNAJB5;BCL6;ANKZF1;PFKFB2;PLXNB1;FAM213A;IGFBP2;BNIP3;CD81;VEGFA;ENTPD6;VANGL2;CEBPB;SHANK3;ACVR2B;CALCOCO1;ENDOG;TNFRSF6B;MAPK3;PLEKHG5;TUB;ETV5;AMN;SLC22A18;GLB1;DVL1;ADCY6;EPHB3;HES1;SSH1;FURIN;MLXIPL;CUL7;MEFV;NRP2;ABCA2;TNFRSF14;ADA;PYCR2;AQP3;ACY1;PFKL;IL6R;SLIT3;PCSK9;ZFP36;HLCS;FGFR3;PRKACA;F12;CYFIP2;RPS6KA5;HBEGF;ITGB5;RAB3B;MAP2K2;FGFR4;SPTB;DMTN;PMVK;VGF;TNFRSF1A;EHD4;SEMA3B;LDLR;CYP3A5;ROBO3;TRPV4;IFNGR2;EEF2K;HMGA2;SEMA3F;DGKQ;SEMA4C;GAS6;BTRC;PPARA;HMGCL;WNT7B;COMT;PTAFR;RXRA;PCK2;VAV3;VASN;BCR;NEO1;PRKCZ;ADAMTS13;INPP5D;TM7SF3;ABCD4;TWF2;TPP1;PDK2;GPC1;SRSF5;MAPKAPK3;AGO4;FGFR1;PIN1;MAN1B1;C5;TMEM204;CMBL;WBP2;KCNMA1;VSNL1;CES2;GRB10;JARID2;CAPN2;SESN2;TOLLIP;TMEM161A;RXRB;ADGRE2;CYBRD1;MADD;RTN4R;OR7D2;TIMP1;CD68;SDC1;FGFBP1;WNT3;LYST;GSTT1;PPM1F;STK39;VEGFB;GSS;SLC25A29;ABR;CYP2S1;AKT1;TRAP1;TP53INP1;ERCC6;SLC5A5;SPPL2B;IL17RD;PINK1;LONP2;HOMER2;CTSH;EPN2;RFX2;PYCARD;MAP2K3;POMT1;AS3MT;ERN1;CKLF;RANBP9;CMTM4;SLC2A1;CPNE7;JAK3;LITAF;RARG;EREG;FAM162A;GSTM2;GIPR;PQLC2;SEMA4F;RPL13A;MIF;SULF2;STXBP2
18420,GO:1903532,0.0279459034116199,0.983020279108443,30,218,positive regulation of secretion by cell,BP,POSTN;ALOX15B;EGFR;NLGN2;F2R;ZP3;NTSR1;GLUL;RAB3D;MYO18A;PFKFB2;MAPK3;RASL10B;TRPV4;HK1;PTAFR;PCK2;PRKCZ;TM7SF3;FGFR1;C5;VSNL1;SDC1;ADORA2B;PINK1;PYCARD;KCNN4;SIRT3;GIPR;MIF
3561,GO:0007612,0.0279506137079808,0.98748202924655,13,75,learning,BP,FOS;SHANK2;EPHB2;DEAF1;NTSR1;ASIC1;INSR;SYNGAP1;DLG4;SHANK3;RAG1;COMT;RGS14
11460,GO:0045940,0.027961187986848,0.9950491619322,4,13,positive regulation of steroid metabolic process,BP,APOE;NR1D1;ABCG1;LDLRAP1
16786,GO:0098662,0.0279706685680761,0.981085214160206,47,373,inorganic cation transmembrane transport,BP,CEMIP;NOS1;SCN8A;KCNG1;FHL1;F2R;GJC2;KCNC4;ANK3;KCNJ15;SLC2A9;PKD2;SCN4B;ITPR3;VAMP2;NTSR1;ATP2B4;SLC20A1;ASIC1;PRNP;ATP7B;SLC12A7;ATP12A;KCNAB2;PCSK9;PRKACA;SCNN1A;SLC25A37;TRPV4;GAS6;TMEM175;KCNMA1;GLRX;TMCO3;NDUFA4L2;SMDT1;SLC9A7;STK39;TPCN1;GPD1L;PKD1;EHD3;SNTA1;KCNN4;ORAI3;ORAI2;GSTM2
2745,GO:0006163,0.0279890431747677,0.981143441757329,46,374,purine nucleotide metabolic process,BP,APOE;NT5E;RAPGEF3;PGM1;XDH;NOS1;NME4;TIMP2;ACOT7;OGDHL;PKD2;PTHLH;LTB4R2;INSR;NDUFS8;DNPH1;DLG4;FAM20C;PFKFB2;VEGFA;DHTKD1;GALK1;ADCY6;MLXIPL;NADK;ADA;PFKL;NUDT10;DGUOK;MYH3;HK1;PPARA;GUK1;SDHA;GTPBP1;DLG3;GUCA1B;ADORA2B;UQCR11;PINK1;ABHD14B;NDUFV3;MOCS1;TAZ;PPCS;PODXL2
3151,GO:0006766,0.0281194985949175,0.986528319756808,15,93,vitamin metabolic process,BP,CYP27B1;PRSS3;MTHFR;PLTP;CD320;ACP5;AMN;PC;SLC2A3;HLCS;RXRA;ABCD4;FGFR1;PNPO;SLC2A1
6210,GO:0019752,0.0281264063203896,0.978855817433515,87,748,carboxylic acid metabolic process,BP,CEMIP;TYSND1;IDH2;PGM1;PRODH;NOS1;NR1D1;CRAT;ALOX15B;CPT2;GAMT;ALDH4A1;HADH;CRYL1;ACSF2;ACOT7;UROS;MTHFR;BPHL;SLC16A3;D2HGDH;CRTAP;HYAL1;BSG;OGDHL;CBS;CPT1C;SLC7A8;HEXB;ATP2B4;GGT1;SLC6A8;GLUL;INSR;HAGH;BLMH;ABCD1;PFKFB2;MAPK3;DHTKD1;GALK1;LTA4H;PHGDH;PC;ACAD10;MLXIPL;NAGS;SLC2A3;PYCR2;ACY1;CKMT1A;PFKL;HLCS;FGFR4;TNFRSF1A;ACOT11;PEX7;HK1;PPARA;HMGCL;COMT;AIG1;PCK2;SDHA;MDH2;ETFB;PDK2;PHYH;PROX1;ASS1;CES2;SESN2;GRHPR;GSS;AHCYL2;CYP2S1;AKT1;HPDL;LONP2;AS3MT;ACADS;GCAT;SLC2A1;MLYCD;BCKDHA;GSTM2;MIF
12858,GO:0051222,0.0282467360858342,0.981651333230228,39,298,positive regulation of protein transport,BP,CEMIP;RAPGEF3;POSTN;ALOX15B;LRP1;EGFR;B3GAT3;NLGN2;F2R;ANK3;ERBB2;MICALL2;EDEM1;VPS11;VAMP2;GLUL;TMEM173;PRNP;MYO18A;PFKFB2;MAPK3;HES1;TRPV4;HK1;GAS6;PCK2;PRKCZ;TM7SF3;C5;VSNL1;OSCP1;SORL1;PINK1;PYCARD;KCNN4;SIRT3;GIPR;MIF;UBL5
15572,GO:0072080,0.0282755139983727,0.98834336203397,11,60,nephron tubule development,BP,CTNNBIP1;PGF;LAMA5;PKD2;WWTR1;VEGFA;HES1;WNT7B;WNT2B;PKD1;KIF26B
15658,GO:0072210,0.0282889588609591,0.992303244480842,6,25,metanephric nephron development,BP,EGR1;PKD2;LAMB2;HES1;PKD1;KIF26B
9178,GO:0035578,0.0283492951421934,0.987747050797195,12,69,azurophil granule lumen,CC,NAPRT;PYGB;FUCA1;VAT1;HEXB;GM2A;RNASET2;DPP7;GLB1;TOLLIP;PYCARD;GALNS
11552,GO:0046128,0.0283509129560448,0.988278012387807,11,62,purine ribonucleoside metabolic process,BP,NT5E;NME4;GAMT;DLG4;ADA;DGUOK;GUK1;GTPBP1;DLG3;AHCYL2;MOCS1
8422,GO:0033555,0.0285155403556754,0.991173684564126,7,32,multicellular organismal response to stress,BP,APOE;NOS1;DEAF1;LRP11;RAG1;COMT;FBXL20
6715,GO:0030136,0.0285380887910779,0.98496700568022,19,124,clathrin-coated vesicle,CC,CEMIP;APOE;EPN3;LRP1;EGFR;MALL;CD9;VPS11;VAMP2;SNX9;AP2A2;DVL1;FURIN;HBEGF;LDLR;LDLRAP1;CLTCL1;VPS33B;EPN2
11265,GO:0045598,0.0285466983201258,0.986725457925031,14,83,regulation of fat cell differentiation,BP,ZFP36L1;NR1D1;LRP5;ZFPM1;SH3PXD2B;WWTR1;CEBPB;HES1;ZFP36;TRPV4;CCDC85B;CCDC71L;AKT1;ZNF385A
6562,GO:0022038,0.0285678630709424,0.994907183910753,4,13,corpus callosum development,BP,PTPRS;EPHB2;EPHB3;RTN4R
1258,GO:0003014,0.0285732822842064,0.988201071952134,11,60,renal system process,BP,GSN;PKN1;F2R;ADCY6;AQP3;PRKACA;GAS6;COMT;BCR;KCNMA1;SULF2
12896,GO:0051272,0.0285876903121338,0.98110184375101,42,324,positive regulation of cellular component movement,BP,CEMIP;SEMA4B;FAM110C;PGF;POSTN;GRB7;EGFR;F2R;DOCK4;ZP3;HYAL1;RHOD;WNT7A;INSR;EPHA1;ITGA6;SPRY2;RAB25;BCL6;VEGFA;MAPK3;SSH1;NRP2;IL6R;HBEGF;DMTN;SEMA3B;TRPV4;SEMA3F;SEMA4C;GAS6;PTAFR;FGFR1;PROX1;PPM1F;VEGFB;ACVR1B;AKT1;CTSH;PYCARD;MAP2K3;SEMA4F
4743,GO:0010927,0.0286088222190925,0.988184071888824,11,60,cellular component assembly involved in morphogenesis,BP,OBSCN;OBSL1;CD9;TMOD2;TNNT1;MYH3;AHNAK2;GPC1;PROX1;EPB41L3;RFX2
4257,GO:0009612,0.02862052089292,0.984639257250797,20,132,response to mechanical stimulus,BP,FOS;PPL;POSTN;EGFR;PKD2;LRP11;XPC;SERPINE2;IGFBP2;BNIP3;SHANK3;ENDOG;MAPK3;TNFRSF1A;TRPV4;SLITRK6;AKT1;SUN1;PKD1;SLC2A1
1168,GO:0002791,0.0286239368231396,0.981734957304285,36,272,regulation of peptide secretion,BP,IDH2;RAPGEF3;POSTN;NR1D1;ALOX15B;EGFR;HADH;NLGN2;RHBDF1;F2R;LRP5;ITPR3;GLUL;MYO18A;PFKFB2;ARL2;RHBDF2;MAPK3;RASL10B;PFKL;MAPKBP1;TRPV4;HK1;GAS6;LLGL1;PCK2;PRKCZ;TM7SF3;C5;VSNL1;PYCARD;KCNN4;SIRT3;SLC2A1;GIPR;MIF
4961,GO:0015081,0.028635152934603,0.987630893632967,12,67,sodium ion transmembrane transporter activity,MF,SCN8A;SLC13A3;PKD2;SCN4B;SLC6A8;SLC20A1;ASIC1;ATP12A;SLC28A2;SCNN1A;SLC9A7;SLC5A5
4596,GO:0010721,0.0287069508192436,0.982850872933759,28,200,negative regulation of cell development,BP,APOE;IDH2;PTPRS;SEMA4B;POSTN;EPHB2;NFATC4;LRP1;ULK2;FBLN1;WNT7A;ID1;SYNGAP1;EFNB3;ADCY6;HES1;DGUOK;DMTN;SEMA3B;LDLR;TRPV4;SEMA3F;SEMA4C;CTSZ;RTN4R;WNT3;SORL1;SEMA4F
4958,GO:0015077,0.0287606760807598,0.983575664718978,24,169,monovalent inorganic cation transmembrane transporter activity,MF,SCN8A;KCNG1;KCNC4;KCNJ15;SLC2A9;SLC13A3;PKD2;SCN4B;SLC6A8;SLC20A1;ASIC1;SLC12A7;ATP12A;KCNAB2;SLC22A18;SLC28A2;SCNN1A;TMEM175;KCNMA1;TMCO3;NDUFA4L2;SLC9A7;SLC5A5;KCNN4
12797,GO:0051128,0.0290992703637457,0.976053351415619,196,1799,regulation of cellular component organization,BP,HTRA1;ADGRL1;APOE;ESPN;CTNNBIP1;TSPAN1;PTPRS;ERCC1;SEMA4B;FAM110C;CST3;SHANK2;LTBP4;RAPGEF3;CYP27B1;GSN;EVI5L;NOS1;PARVB;ARAP1;POSTN;EPHB2;CNTN1;IGF2;NFATC4;LRP1;OBSL1;EGFR;NLGN2;TOM1L2;FHL1;DDB2;MTHFR;ULK1;CRTC1;ARPIN;PTK6;ABCA7;CORO1B;ULK2;IGSF9;ZMYND8;TBC1D14;MMP1;THRA;LRP5;HYAL1;TENM2;ERBB2;FBLN1;MICALL2;PLXNB3;VAT1;IFT140;CUL9;KIF13B;HEXB;SERPINE2;VPS11;FUZ;NPHP4;TMOD2;TFDP2;CSNK1E;RHOD;WNT7A;INSR;SH3PXD2B;TBC1D8;FBXW8;ID1;CELSR1;EPHA1;SYNGAP1;DNPH1;LPAR3;PRNP;EFNB3;SNX33;SPRY2;CEP250;SNX9;DLG4;MYO18A;PLEKHH2;BCL6;PLXNB1;CHMP1B;IGFBP2;BNIP3;VEGFA;ARL2;VANGL2;SHANK3;ADAM15;ENDOG;MAPK3;TUB;ETV5;DVL1;FYCO1;WIPF1;ADCY6;L3MBTL1;EPHB3;FHOD1;HES1;SSH1;CUL7;MEFV;PLEKHG2;LRSAM1;CDC42EP5;MCTP1;SLIT3;PCSK9;RHOF;PRKACA;ZMYM3;DGUOK;RPS6KA5;HBEGF;MAP2K2;FGFR4;SPTB;FBXW5;DMTN;EHD4;SEMA3B;LDLR;SNX17;TRPV4;RHOBTB2;CROCC;EEF2K;LDLRAP1;SEMA3F;SEMA4C;GAS6;ADGRB2;BCR;IGFBP4;TBC1D16;PRKCZ;CAPG;SLITRK6;TWF2;AGO4;ARAP3;FGFR1;CTSZ;CHADL;PIN1;PROX1;WBP2;C21ORF2;BIN1;OSCP1;SH3D19;JARID2;CAPN2;SESN2;WRAP73;LCAT;RTN4R;EPB41L3;SDC1;WHAMMP3;EPS8L1;WNT3;PPM1F;SORL1;ACVR1B;TBC1D17;ABR;CCDC85B;AKT1;STON1;EPS8L2;SSH3;PINK1;PKD1;EHD3;ARHGEF10L;SYNE3;SPIRE2;MLST8;PYCARD;ARHGEF19;EREG;FAM162A;FCHSD1;SHISA6;SEMA4F;RPL13A;UBL5
6188,GO:0019674,0.0291852281680703,0.989216113495277,9,46,NAD metabolic process,BP,NT5E;NAPRT;NMRK1;NADK;PFKL;HK1;PCK2;MDH2;GPD1L
19087,GO:1905048,0.0293951839661012,0.994711930733249,4,13,regulation of metallopeptidase activity,BP,TIMP2;MAPK3;TIMP1;SORL1
12931,GO:0051339,0.0294847610667672,0.993153945379082,5,19,regulation of lyase activity,BP,NOS1;TIMP2;LTB4R2;GUCA1B;ADORA2B
7742,GO:0032270,0.0295021056195957,0.976824859074917,121,1071,positive regulation of cellular protein metabolic process,BP,TNIP1;DUSP6;CEMIP;APOE;RAPGEF3;GSN;XDH;NOS1;EPHB2;CNTN1;IGF2;MST1R;LRP1;EGFR;TIMP2;DUSP5;EGR1;PKN1;SHC1;F2R;PTK6;ABCA7;SHC2;GRAMD4;ERBB2;FBLN1;PKD2;EDEM1;PAK6;VPS11;MINK1;ATP2B4;CSNK1E;TNFRSF25;WNT7A;INSR;EPHA1;LPAR3;PRNP;SNX33;SPRY2;SNX9;DLG4;STRADB;BCL6;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;MAPK3;DVL1;MTA1;ADCY6;EPHB3;HES1;FURIN;MEFV;PIDD1;IL6R;PCSK9;FGFR3;PRKACA;F12;LRRK1;MAGEF1;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;TNFRSF1A;EHD4;MAPK8IP1;LDLR;TRPV4;DUSP7;DGKQ;SEMA4C;GAS6;BTRC;WNT7B;PTAFR;RXRA;IGFBP4;PRKCZ;MAPKAPK3;RAD23A;FGFR1;CAMKK1;PIN1;C5;PROX1;WBP2;DLG3;SH3D19;JARID2;TOLLIP;MAPRE3;MADD;PPM1F;STK39;ACVR1B;ADORA2B;ERBB3;AKT1;ERCC6;PINK1;PKD1;CTSH;MLST8;PYCARD;MAP2K3;POMT1;ERN1;EREG;FAM162A;MIF
4355,GO:0009968,0.0295502214519192,0.977256879976858,102,888,negative regulation of signal transduction,BP,TNIP1;HTRA1;DUSP6;APOE;CTNNBIP1;PTPRS;WWC3;XDH;LTBP1;NR1D1;ARRDC1;EPHB2;NFATC4;MST1R;LRP1;EGFR;TIMP2;DUSP5;MDFI;EGR1;PTK6;PIK3R2;ERBB2;FBLN1;PKD2;DNM1;SPRY4;DDIT4L;PTPRE;SERPINE2;FUZ;NPHP4;ATP2B4;RASA4;PDCD4;INSR;EPHA1;ITGA6;SYNGAP1;PRNP;SPRY2;MNT;ECM1;STRADB;WWTR1;BCL6;IGFBP2;SRMS;S1PR2;CARD19;DVL1;EPHB3;ADA;SLIT3;MAPKBP1;FGFR3;HBEGF;FGFR4;MAPK8IP1;DUSP7;TNFAIP8L1;GAS6;BTRC;TKFC;SUFU;VASN;IGFBP4;PRKCZ;INPP5D;GPC1;ARAP3;FGFR1;PIN1;GRB10;SESN2;TMEM161A;RTN4R;PEAR1;SORL1;ERBB3;AKT1;TRAP1;NLRX1;ZNF385A;NDRG2;GPD1L;PINK1;RGS14;CBLC;EPN2;PYCARD;RANBP9;SIRT3;C12ORF66;EREG;GSTM2;SHISA6;GIPR;RGS12;MIF;SULF2;LZTS2
6750,GO:0030193,0.0297257446744329,0.988979934672365,9,46,regulation of blood coagulation,BP,APOE;SERPING1;F2R;PLAT;CD9;SERPINE2;F12;DMTN;VPS33B
17329,GO:1900046,0.0297257446744329,0.988979934672365,9,46,regulation of hemostasis,BP,APOE;SERPING1;F2R;PLAT;CD9;SERPINE2;F12;DMTN;VPS33B
3742,GO:0008289,0.0297833119334226,0.979081023914788,56,453,lipid binding,MF,APOE;SYTL1;ARAP1;GRB7;ALOX15B;EPN3;NME4;ACBD4;HS1BP3;SYT8;SHC1;PITPNC1;DGKA;ABCG1;NISCH;PLTP;ITPR3;VAMP2;RASA4;PLCD1;AGAP1;SH3PXD2B;LPAR3;SNX33;SNX9;SEC14L2;MVB12B;AP2A2;S1PR2;TUB;WIPI2;MCTP1;OSBPL5;PITPNM1;PSD4;ACOT11;SNX17;LDLRAP1;MVB12A;GAS6;PPARA;PTAFR;RXRA;GSDMC;TWF2;ARAP3;ESYT2;UNC119B;PITPNM3;RTN4R;GSDMA;AKT1;EPN2;SNX29;ZCCHC14;ZFYVE19
15535,GO:0072009,0.0298806723439901,0.986996276956851,12,68,nephron epithelium development,BP,CTNNBIP1;PGF;LAMA5;PKD2;LAMB2;WWTR1;VEGFA;HES1;WNT7B;WNT2B;PKD1;KIF26B
12606,GO:0050819,0.0299000475430862,0.990651059673027,7,32,negative regulation of coagulation,BP,APOE;SERPING1;PLAT;CD9;SERPINE2;F12;PROCR
6676,GO:0030054,0.0299050739561425,0.977028802894917,100,870,cell junction,CC,ADGRL1;TSPAN1;PPL;PTPRS;FLNC;SHANK2;MRC2;GSN;CLCA2;NDRG1;CADM4;PARVB;GRB7;MYZAP;LRP1;OBSL1;EGFR;NLGN2;FHL1;DDB2;SDK2;ABCA7;SLC9A3R2;CORO1B;GJC2;IGSF9;ANK3;TENM2;BRSK1;MICALL2;BSG;PTPRU;PKD2;SCN4B;CPT1C;ITGB4;SPRY4;MPRIP;RIMS3;CD9;SIGMAR1;PAK6;VAMP2;NPHP4;MINK1;ZFYVE21;PRR7;SH3PXD2B;ITGA6;DLG4;CD81;ARL2;VANGL2;SHANK3;ADAM15;MAPK3;PDZD2;PLEKHG5;KCNAB2;OLFM2;FHOD1;FBF1;ARHGAP22;ADA;MCTP1;AQP3;FGFR3;CYFIP2;ITGB5;MAP2K2;PI4K2A;FGFR4;ABHD17C;TRPV4;SEMA4C;TSPAN4;GIT1;PLEKHG6;BCR;PRKCZ;CEP68;TMEM204;DLG3;PPP1R13L;CAPN2;PROCR;SNPH;LMLN;EPB41L3;COL13A1;AKT1;NLRX1;EHD3;SNTA1;HOMER2;RGS14;ALKBH6;SLC2A1;RPL13A;RGS12
792,GO:0002062,0.0300878526888946,0.987473405288959,11,60,chondrocyte differentiation,BP,MEF2D;PTHLH;ADAMTS7;WNT7A;FGFR3;HMGA2;FGFR1;CHADL;WNT2B;RARG;SULF2
17439,GO:1900271,0.0300926248486922,0.992974149879802,5,19,regulation of long-term synaptic potentiation,BP,APOE;EPHB2;CRTC1;PRNP;SHANK3
19729,GO:2000147,0.0301002873256336,0.980131789700551,41,316,positive regulation of cell motility,BP,CEMIP;SEMA4B;FAM110C;PGF;POSTN;GRB7;EGFR;F2R;DOCK4;ZP3;HYAL1;RHOD;WNT7A;INSR;EPHA1;ITGA6;SPRY2;RAB25;VEGFA;MAPK3;SSH1;NRP2;IL6R;HBEGF;DMTN;SEMA3B;TRPV4;SEMA3F;SEMA4C;GAS6;PTAFR;FGFR1;PROX1;PPM1F;VEGFB;ACVR1B;AKT1;CTSH;PYCARD;MAP2K3;SEMA4F
5313,GO:0016049,0.0301544231161602,0.979785442957459,44,344,cell growth,BP,HTRA1;APOE;PTPRS;SEMA4B;LTBP4;CYP27B1;POSTN;EGFR;FHL1;ULK1;ULK2;HYAL1;ERBB2;PLXNB3;SERPINE2;LAMB2;DNPH1;LPAR3;BCL6;PLXNB1;IGFBP2;VEGFA;ADAM15;DVL1;NRP2;SLIT3;CYFIP2;HBEGF;SEMA3B;SEMA3F;SEMA4C;IGFBP4;PRKCZ;TWF2;PIN1;SESN2;RTN4R;EPB41L3;WNT3;ACVR1B;CCDC85B;AKT1;RARG;SEMA4F
6708,GO:0030128,0.0304554399476356,0.994458983784243,4,13,clathrin coat of endocytic vesicle,CC,EGFR;AP2A2;LDLRAP1;EPN2
6756,GO:0030201,0.0304845465613368,0.991557320094538,6,25,heparan sulfate proteoglycan metabolic process,BP,B3GAT3;VANGL2;XYLT2;GPC1;NDST2;SULF2
7419,GO:0031532,0.030646430401574,0.98606898585784,13,77,actin cytoskeleton reorganization,BP,RAPGEF3;GSN;PARVB;ARAP1;EFS;SHC1;MICALL2;MINK1;RHOD;S1PR2;DMTN;TRPV4;PRKCZ
4461,GO:0010466,0.0307938655797998,0.983306101695478,20,138,negative regulation of peptidase activity,BP,CST3;PRDX5;TIMP2;SERPING1;SERPINE2;PAPLN;ECM1;VEGFA;TNFRSF6B;FURIN;RAG1;GAS6;C5;BIN1;SERPINB6;CSTB;TIMP1;SORL1;AKT1;PCSK1N
3375,GO:0007160,0.0309487829941301,0.982696151602104,22,149,cell-matrix adhesion,BP,POSTN;LAMA5;THBS3;BCAM;ITGB4;MINK1;RHOD;EPHA1;ITGA6;BCL6;VEGFA;ADAM15;ITGB5;DMTN;MSLN;PRKCZ;ADAMTS13;TMEM8B;PPM1F;COL13A1;PKD1;NINJ1
6044,GO:0019200,0.0309527763705943,0.992717936012847,5,19,carbohydrate kinase activity,MF,FGGY;PFKFB2;GALK1;PFKL;HK1
2286,GO:0005249,0.0310117687551457,0.991376110820768,6,25,voltage-gated potassium channel activity,MF,KCNG1;KCNC4;KCNJ15;PKD2;KCNAB2;KCNMA1
1397,GO:0003333,0.0310203732231244,0.988410834477914,9,46,amino acid transmembrane transport,BP,SLC43A1;SLC7A8;PRAF2;NTSR1;SLC6A8;SLC38A10;STK39;SLC25A29;PQLC2
9507,GO:0036230,0.0310344994162738,0.979045038024279,45,360,granulocyte activation,BP,GAA;NAPRT;PYGB;CST3;PGM1;GSN;PRSS3;TIMP2;PYGL;CTSB;FUCA1;VAT1;HEXB;VAMP2;GM2A;RAB3D;NBEAL2;TMEM173;RNASET2;DNASE1L1;AP2A2;DPP7;KCNAB2;GLB1;LTA4H;SLC2A3;PFKL;RHOF;PI4K2A;PTAFR;BCR;CTSZ;SERPINB6;TOLLIP;CSTB;CD68;ACTR1B;HGSNAT;ABR;CTSD;CTSH;PYCARD;GALNS;MIF;STXBP2
16397,GO:0097062,0.0311502355659566,0.994291594739593,4,13,dendritic spine maintenance,BP,APOE;ZMYND8;INSR;PRNP
3195,GO:0006836,0.0312104100975234,0.983385080902649,19,125,neurotransmitter transport,BP,SYTL1;NOS1;SYT8;KCNC4;BRSK1;PRAF2;RIMS3;VAMP2;NTSR1;SLC6A8;GLUL;ASIC1;WNT7A;DVL1;ADA;MCTP1;RAB3B;SNPH;APBA1
7044,GO:0030834,0.0313128552162896,0.990111968722977,7,32,regulation of actin filament depolymerization,BP,GSN;TMOD2;PLEKHH2;SPTB;DMTN;CAPG;TWF2
13940,GO:0060675,0.0313542632425018,0.989112476057435,8,39,ureteric bud morphogenesis,BP,CTNNBIP1;PGF;LAMA5;PKD2;VEGFA;HES1;WNT2B;KIF26B
15627,GO:0072171,0.0313542632425018,0.989112476057435,8,39,mesonephric tubule morphogenesis,BP,CTNNBIP1;PGF;LAMA5;PKD2;VEGFA;HES1;WNT2B;KIF26B
14128,GO:0061037,0.0313590134816352,0.994241047040475,4,13,negative regulation of cartilage development,BP,PTHLH;ADAMTS7;CHADL;RARG
15109,GO:0071229,0.0313959259917517,0.982971126328394,20,133,cellular response to acid chemical,BP,COL6A1;NFATC4;EGFR;EGR1;PTK6;PKD2;DNMT3A;VEGFA;CEBPB;ADCY6;LDLR;WNT7B;PTAFR;TWF2;CAPN2;SESN2;WNT3;AKT1;PINK1;RARG
4843,GO:0014065,0.0315324160568117,0.985125288402355,14,84,phosphatidylinositol 3-kinase signaling,BP,ZFP36L1;IGF2;EGFR;RGL2;F2R;PIK3R2;ERBB2;SERPINE2;PLXNB1;MAPK3;NYAP1;FGFR1;ERBB3;AKT1
12566,GO:0050768,0.0315524359929707,0.981595288543708,25,176,negative regulation of neurogenesis,BP,APOE;IDH2;PTPRS;SEMA4B;EPHB2;NFATC4;LRP1;ULK2;WNT7A;ID1;SYNGAP1;EFNB3;ADCY6;HES1;DGUOK;SEMA3B;LDLR;TRPV4;SEMA3F;SEMA4C;CTSZ;RTN4R;WNT3;SORL1;SEMA4F
425,GO:0001133,0.031593146155514,0.994184224548569,4,13,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,NR1D1;THRA;PPARA;RARG
13552,GO:0060047,0.0315987845074933,0.98314829034385,19,126,heart contraction,BP,GAA;NOS1;EPAS1;THRA;SCN4B;ITPR3;ATP2B4;TNNT1;ADA;PRKACA;HBEGF;PPP1R13L;VEGFB;GPD1L;EHD3;SNTA1;MAP2K3;TAZ;GSTM2
14239,GO:0061326,0.0316247988740329,0.986711696814067,11,61,renal tubule development,BP,CTNNBIP1;PGF;LAMA5;PKD2;WWTR1;VEGFA;HES1;WNT7B;WNT2B;PKD1;KIF26B
8460,GO:0033619,0.0316909757803438,0.987342877002908,10,54,membrane protein proteolysis,BP,APOE;TIMP2;SNX33;SNX9;FURIN;SH3D19;TIMP1;ADAM19;SPPL2B;CTSH
13483,GO:0055081,0.0316930946406521,0.989965903862302,7,32,anion homeostasis,BP,APOE;CA12;ABCG1;SLC12A7;MLXIPL;FGFR4;PQLC2
6903,GO:0030506,0.0316961037485203,0.994159192002215,4,13,ankyrin binding,MF,FLNC;OBSCN;SPTB;RHBG
13724,GO:0060326,0.0318055740041881,0.982695947027813,20,138,cell chemotaxis,BP,PGF;MMP28;CORO1B;DOCK4;PLXNB3;VEGFA;MAPK3;PLEKHG5;IL6R;HBEGF;TRPV4;GAS6;VAV3;FGFR1;C5;ADGRE2;LYST;VEGFB;CKLF;MIF
3614,GO:0008076,0.031900373430662,0.989886108144243,7,32,voltage-gated potassium channel complex,CC,KCNG1;KCNC4;VAMP2;DLG4;KCNAB2;KCNMA1;KCNN4
16199,GO:0090276,0.0319992877164932,0.983241097329238,18,118,regulation of peptide hormone secretion,BP,RAPGEF3;NR1D1;EGFR;HADH;NLGN2;LRP5;ITPR3;GLUL;PFKFB2;ARL2;RASL10B;PFKL;PCK2;TM7SF3;VSNL1;SIRT3;SLC2A1;GIPR
2253,GO:0005172,0.0320683004643738,0.996058801835651,3,8,vascular endothelial growth factor receptor binding,MF,PGF;VEGFA;VEGFB
11631,GO:0046390,0.0321108409261997,0.981010368912259,26,187,ribose phosphate biosynthetic process,BP,APOE;PGM1;NOS1;NME4;TIMP2;ACOT7;PYGL;OGDHL;PTHLH;LTB4R2;INSR;UCKL1;PFKFB2;DHTKD1;GALK1;ADCY6;MLXIPL;PFKL;HK1;PPARA;GUK1;GUCA1B;ADORA2B;PINK1;TAZ;PPCS
1494,GO:0003841,0.0322206344465039,0.992336508399624,5,19,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,LPCAT4;MBOAT7;AGPAT4;TAZ;AGPAT3
6193,GO:0019693,0.0322854930169621,0.977936140116196,47,386,ribose phosphate metabolic process,BP,H6PD;APOE;NT5E;RAPGEF3;PGM1;PGLS;NOS1;NME4;TIMP2;ACOT7;PYGL;OGDHL;PKD2;PTHLH;LTB4R2;INSR;NDUFS8;DLG4;TALDO1;FAM20C;UCKL1;PFKFB2;VEGFA;DHTKD1;GALK1;ADCY6;MLXIPL;NADK;PFKL;NUDT10;MYH3;HK1;PPARA;GUK1;SDHA;GTPBP1;DLG3;GUCA1B;ADORA2B;UQCR11;PINK1;ABHD14B;NDUFV3;MOCS1;TAZ;PPCS;PODXL2
12686,GO:0050930,0.0323187392121115,0.996015675658157,3,8,induction of positive chemotaxis,BP,PGF;VEGFA;VEGFB
895,GO:0002275,0.0323990240385753,0.977862634820961,47,379,myeloid cell activation involved in immune response,BP,GAA;NAPRT;PYGB;CST3;PGM1;GSN;PRSS3;TIMP2;PYGL;CTSB;FUCA1;VAT1;HEXB;VAMP2;GM2A;RAB3D;NBEAL2;TMEM173;RNASET2;DNASE1L1;AP2A2;DPP7;KCNAB2;GLB1;LTA4H;SLC2A3;PFKL;RHOF;PI4K2A;PTAFR;BCR;CTSZ;SERPINB6;TOLLIP;CSTB;ADGRE2;CD68;ACTR1B;ADORA2B;HGSNAT;ABR;CTSD;CTSH;PYCARD;GALNS;MIF;STXBP2
14776,GO:0070528,0.0324126562804009,0.992278353782456,5,19,protein kinase C signaling,BP,VEGFA;ADAM15;DGKQ;PRKCZ;GPD1L
1435,GO:0003416,0.0324272295213899,0.993980637259201,4,13,endochondral bone growth,BP,THBS3;EVC;FGFR3;RARG
3038,GO:0006600,0.0324274958829898,0.995996903688789,3,8,creatine metabolic process,BP,GAMT;SLC6A8;CKMT1A
6758,GO:0030203,0.0325157750985275,0.983315312819607,17,108,glycosaminoglycan metabolic process,BP,CEMIP;B3GAT3;NAGLU;HYAL1;FUCA1;HEXB;B4GAT1;GLB1;ST3GAL3;XYLT2;CHST6;GPC1;SDC1;HGSNAT;AKT1;GALNS;NDST2
6731,GO:0030159,0.0326583051411884,0.992203811518441,5,19,receptor signaling complex scaffold activity,MF,SHANK2;SHANK3;LDLRAP1;HOMER2;RGS14
9672,GO:0038083,0.0327441280018181,0.98956005039254,7,32,peptidyl-tyrosine autophosphorylation,BP,EGFR;PTK6;INSR;SRMS;VEGFA;MAPK3;JAK3
16846,GO:0098805,0.032839829712454,0.973799542666108,134,1198,whole membrane,CC,CEMIP;APOE;MARVELD1;TSPAN1;PTPRS;GAA;LTB4R;CYP27B1;NDRG1;NOS1;MARCH9;COL6A1;FAM210B;CNTN1;LRP1;APPL2;RAB11FIP4;EGFR;ULK1;SYT8;F2R;BPHL;ABCA7;ULK2;MALL;DBNDD1;ERBB2;BSG;CPT1C;ITPR3;PRAF2;VAT1;CD9;SIGMAR1;VPS11;VAMP2;NTSR1;CD320;ATP2B4;SNN;ZFYVE21;DIRC2;RHOD;PEX10;ARMCX2;SPATA18;WNT7A;INSR;RAB3D;NBEAL2;TMEM173;PRNP;ATG16L2;STAT6;DLG4;ABCD1;MARCH2;ANKZF1;CHMP1B;MVB12B;BNIP3;AP2A2;MAPK3;KCNAB2;AMN;RAB40B;WIPI2;FURIN;SLC48A1;SLC2A3;ABCA2;LY6K;MCTP1;RETSAT;PAG1;PCSK9;TMEM9;RHOF;PRKACA;HBEGF;RAB3B;MAP2K2;PI4K2A;TNFRSF1A;EHD4;LDLR;SNX17;ABHD17C;LDLRAP1;SEMA4C;MVB12A;HK1;LLGL1;WNT7B;PTAFR;ATG2A;VASN;TMEM175;PRKCZ;CLTCL1;INPP5D;ABCD4;GPC1;KCNMA1;SERPINB6;WDR83;CAPN2;MAN2B2;CYBRD1;RTN4R;SLC9A7;CD68;WNT3;SORL1;TPCN1;HGSNAT;CTSD;NLRX1;VPS33B;SUN1;SPPL2B;PINK1;PKD1;EHD3;SLC22A17;SYNE3;CBLC;EPN2;C12ORF66;SLC2A1;LITAF;PQLC2;RAB40C;STXBP2
10139,GO:0042737,0.0328890986469707,0.985435034338179,12,71,drug catabolic process,BP,NT5E;PRDX5;NOS1;GPX3;ADA;CYP3A5;COMT;PCK2;SMOX;CYP2S1;CTSH;GCAT
1038,GO:0002551,0.0330041520669072,0.995896928728744,3,8,mast cell chemotaxis,BP,PGF;VEGFA;VEGFB
877,GO:0002237,0.0330703650115069,0.979971530418359,28,205,response to molecule of bacterial origin,BP,TNIP1;FOS;CYP27B1;NOS1;NR1D1;LOXL1;F2R;HDAC5;ACP5;PDCD4;TNFRSF25;CEBPB;TNFRSF6B;MAPK3;TNFRSF14;ZFP36;TNFRSF1A;COMT;PTAFR;PCK2;BCR;ADAMTS13;MAPKAPK3;ABR;AKT1;PYCARD;LITAF;MIF
9969,GO:0042383,0.0331787451768615,0.984744492046225,13,77,sarcolemma,CC,FLNC;NOS1;COL6A1;OBSCN;ANK3;BSG;ATP2B4;AHNAK2;BIN1;SYNC;RTN2;SNTA1;SLC2A1
9009,GO:0035239,0.0332287090770453,0.975895162203154,65,535,tube morphogenesis,BP,APOE;CTNNBIP1;RAPGEF3;XDH;PGF;ZFP36L1;TCTN1;EPHB2;EPAS1;NFATC4;LRP1;EGFR;SHC1;DEAF1;LAMA5;HDAC5;LRP5;HYAL1;ERBB2;PKD2;FUZ;PLCD1;WNT7A;ZMIZ1;ID1;CELSR1;EPHA1;SPRY2;ECM1;PLCD3;FZD8;VEGFA;VANGL2;ACVR2B;ADAM15;ETV5;DVL1;EPHB3;HES1;CUL7;ARHGAP22;NRP2;SH2D2A;FGFR4;HMGA2;ELK3;SEMA4C;BTRC;ADGRB2;WNT7B;SUFU;VAV3;FGFR1;CTSZ;C5;PROX1;WNT2B;VEGFB;PKD1;CTSH;ROBO4;EPN2;RARG;EREG;KIF26B
10884,GO:0044448,0.0332849452274145,0.982149672310045,19,125,cell cortex part,CC,RAPGEF3;GSN;MYZAP;EXOC2;PKD2;RIMS3;GM2A;DLG4;PLEKHH2;WIPF1;SPTB;DMTN;TRPV4;LLGL1;PRKCZ;CTSZ;CAPN2;SEPT8;SLC2A1
6408,GO:0021681,0.0334463033426211,0.995819772961441,3,8,cerebellar granular layer development,BP,SERPINE2;WNT7A;PROX1
12323,GO:0048708,0.0334516095707632,0.988204837741984,8,40,astrocyte differentiation,BP,LRP1;EGFR;SERPINE2;LAMB2;MAPK3;HES1;LDLR;BIN1
15258,GO:0071470,0.0334963623115277,0.990458679331367,6,26,cellular response to osmotic stress,BP,ZFP36L1;PKD2;TRPV4;SERPINB6;STK39;SLC2A1
10634,GO:0043691,0.0336438089287228,0.995785168685725,3,8,reverse cholesterol transport,BP,APOE;ABCG1;LCAT
11039,GO:0045055,0.0336955416014946,0.975783589673097,61,509,regulated exocytosis,BP,GAA;SYTL1;NAPRT;PYGB;CST3;PGM1;GSN;PRSS3;IGF2;TIMP2;SERPING1;PYGL;SYT8;CTSB;ZP3;FUCA1;VAT1;RIMS3;CD9;HEXB;VAMP2;GM2A;RAB3D;NBEAL2;TMEM173;RNASET2;ECM1;VEGFA;DNASE1L1;AP2A2;DPP7;KCNAB2;GLB1;LTA4H;SLC2A3;PFKL;RHOF;PI4K2A;DMTN;GAS6;PTAFR;BCR;CTSZ;SERPINB6;TOLLIP;CSTB;SNPH;ADGRE2;TIMP1;CD68;ACTR1B;VEGFB;ADORA2B;HGSNAT;ABR;CTSD;CTSH;PYCARD;GALNS;MIF;STXBP2
11319,GO:0045665,0.0337421586205106,0.981236086306383,21,143,negative regulation of neuron differentiation,BP,APOE;PTPRS;SEMA4B;EPHB2;NFATC4;LRP1;ULK2;ID1;SYNGAP1;EFNB3;ADCY6;HES1;DGUOK;SEMA3B;TRPV4;SEMA3F;SEMA4C;CTSZ;RTN4R;WNT3;SEMA4F
3302,GO:0007010,0.0337842461505085,0.973544632692277,112,981,cytoskeleton organization,BP,APOE;ESPN;PPL;RAPGEF3;GSN;PARVB;ARAP1;EFS;OBSCN;LRP1;OBSL1;ARPIN;SHC1;LAMA5;BBS2;DNAH1;CORO1B;ANK3;NISCH;TUBG2;MARK4;BRSK1;MICALL2;PKD2;IQSEC2;MSRB2;CUL9;NINL;PAK6;CCDC69;NPHP4;MINK1;TMOD2;RHOD;TNXB;SH3PXD2B;ID1;CELSR1;EPHA1;SPRY2;CEP250;MYO18A;PLEKHH2;BCL6;PLXNB1;CHMP1B;HOOK2;ARL2;VANGL2;MAST4;SHANK3;S1PR2;MAPK3;TNNT1;DVL1;WIPF1;FHOD1;SSH1;CUL7;PLEKHG2;CDC42EP5;RHOF;ZMYM3;ITGB5;SPTB;FBXW5;DMTN;MYH3;TRPV4;RHOBTB2;CROCC;LLGL1;BCR;PRKCZ;CAPG;TWF2;CEP68;NDE1;ARAP3;PROX1;C21ORF2;BIN1;PI4KAP2;SH3D19;BFSP1;CAPN2;WRAP73;EPB41L3;WHAMMP3;EPS8L1;PPM1F;ABR;SEPT8;EPS8L2;SUN1;SSH3;GAS8;PKD1;ARHGEF10L;RGS14;SYNE3;GOLGA2P5;SPIRE2;MLST8;PYCARD;DNAAF5;RANBP9;ARHGEF19;MAST3;FCHSD1;KRT15;TTLL11
5585,GO:0016624,0.0339370577381705,0.995733631497312,3,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,OGDHL;DHTKD1;BCKDHA
9188,GO:0035588,0.0341446801377933,0.995697028928374,3,8,G-protein coupled purinergic receptor signaling pathway,BP,ADA;PTAFR;ADORA2B
3938,GO:0008645,0.0342258880411046,0.984780296490878,12,69,hexose transmembrane transport,BP,PIK3R2;SLC2A9;INSR;SLC2A3;PRKCZ;CLTCL1;SLC25A27;GRB10;SESN2;RTN2;AKT1;SLC2A1
11415,GO:0045869,0.0342865791025525,0.995671958869996,3,8,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,HMGA2;APOBEC3C;APOBEC3F
7755,GO:0032287,0.0342868710956373,0.995671907236759,3,8,peripheral nervous system myelin maintenance,BP,NDRG1;AHNAK2;AKT1
6354,GO:0021545,0.0345570123315556,0.990082540925352,6,26,cranial nerve development,BP,EPHB2;ADARB1;HES1;SEMA3F;SLITRK6;ERBB3
15570,GO:0072078,0.0346790586436655,0.986751871098345,9,47,nephron tubule morphogenesis,BP,CTNNBIP1;PGF;LAMA5;PKD2;VEGFA;HES1;WNT2B;PKD1;KIF26B
9815,GO:0042058,0.0346791844328269,0.984532617755985,12,70,regulation of epidermal growth factor receptor signaling pathway,BP,ARAP1;EGFR;RHBDF1;SHC1;PTK6;SPRY2;MVB12B;RHBDF2;MVB12A;AKT1;CBLC;EREG
464,GO:0001503,0.0350349346659985,0.977918087774217,32,238,ossification,BP,CTNNBIP1;MRC2;CYP27B1;MEF2D;COL6A1;IGF2;EGFR;THBS3;THRA;LRP5;PTHLH;SH3PXD2B;ID1;ECM1;WWTR1;FAM20C;PLXNB1;CEBPB;ACVR2B;NAB2;MAPK3;IL6R;FGFR3;PRKACA;PEX7;WNT7B;SUFU;MN1;WNT3;COL13A1;AKT1;SUN1
987,GO:0002444,0.0350477842111266,0.975920160245593,47,381,myeloid leukocyte mediated immunity,BP,GAA;NAPRT;PYGB;CST3;PGM1;GSN;PRSS3;TIMP2;PYGL;CTSB;FUCA1;VAT1;HEXB;VAMP2;GM2A;RAB3D;NBEAL2;TMEM173;RNASET2;DNASE1L1;AP2A2;DPP7;KCNAB2;GLB1;LTA4H;SLC2A3;PFKL;RHOF;PI4K2A;PTAFR;BCR;CTSZ;SERPINB6;TOLLIP;CSTB;ADGRE2;CD68;ACTR1B;ADORA2B;HGSNAT;ABR;CTSD;CTSH;PYCARD;GALNS;MIF;STXBP2
6883,GO:0030427,0.0351144044499219,0.981045075670555,19,126,site of polarized growth,CC,ADGRL1;SHANK2;TIMP2;TENM2;SIGMAR1;TMOD2;DVL1;SSH1;PI4K2A;MAPK8IP1;TRPV4;TWF2;CTSZ;DLG3;RTN4R;NDRG2;PINK1;NRSN1;ORAI2
10341,GO:0043173,0.0352188011377382,0.993167369963031,4,14,nucleotide salvage,BP,NAPRT;UCKL1;ADA;FUK
535,GO:0001654,0.0352504292680505,0.978135667634106,30,220,eye development,BP,CST3;EPHB2;RAB11FIP4;EGFR;SDK2;NAGLU;LRP5;SALL2;IFT140;NPHP4;ATP2B4;LAMB2;WNT7A;SH3PXD2B;VEGFA;ACVR2B;HSF4;TUB;SDHAF4;WNT7B;RXRA;SLITRK6;PROX1;PPP1R13L;BFSP1;WNT2B;TMEM231;SIX5;NINJ1;RARG
1170,GO:0002793,0.0352653436896289,0.979987917516714,22,153,positive regulation of peptide secretion,BP,POSTN;ALOX15B;EGFR;NLGN2;F2R;GLUL;MYO18A;PFKFB2;MAPK3;RASL10B;TRPV4;HK1;PCK2;PRKCZ;TM7SF3;C5;VSNL1;PYCARD;KCNN4;SIRT3;GIPR;MIF
12081,GO:0048143,0.0353368593603348,0.995485042377031,3,8,astrocyte activation,BP,LRP1;EGFR;LDLR
3869,GO:0008509,0.0353463446276864,0.97891211078885,26,185,anion transmembrane transporter activity,MF,CLCA2;SLCO4A1;SLC43A1;SLC16A5;SLC16A3;ANO8;SLC2A9;SLC13A3;BSG;SLC7A8;SLC6A8;SLC20A1;SERINC2;SLC12A7;TTYH3;LRRC8A;SLC16A13;SLC2A3;SLC38A10;SLC37A2;ANO9;SLC25A29;SLC5A5;SLC22A17;SLC2A1;PQLC2
16781,GO:0098656,0.0354062647258894,0.97991018795021,22,151,anion transmembrane transport,BP,CLCA2;CPT2;SLC43A1;SLC16A3;SLC13A3;SLC7A8;PRAF2;NTSR1;SLC6A8;SLC20A1;PRNP;SLC12A7;TTYH3;LRRC8A;SLC38A10;SLC37A2;PTAFR;STK39;ANO9;SLC25A29;AKT1;PQLC2
4015,GO:0009056,0.0355043600009135,0.970413103827637,211,1987,catabolic process,BP,CEMIP;APOE;TYSND1;RNPEPL1;NT5E;GAA;BTBD2;PYGB;RNF44;CST3;RAPGEF3;MRC2;PGM1;CYP27B1;XDH;PRDX5;PCBP4;PRODH;NOS1;ZFP36L1;COL6A1;NR1D1;CRAT;ARRDC1;RBCK1;CPT2;GPX3;LRP1;EGFR;TIMP2;H1F0;ALDH4A1;HADH;CRYL1;FBXO2;ACOT7;ULK1;RHBDF1;PYGL;TRIM65;NAGLU;GALE;CTSB;ULK2;TBC1D14;PACS2;MMP1;PIK3R2;THRA;PLD3;LRP5;HYAL1;TFEB;CTSF;OGDHL;CBS;GID4;TMEM129;FUCA1;TST;CPT1C;EDEM1;ABTB1;ITGB4;CUL9;HEXB;SERPINE2;VPS11;NTSR1;ATP2B4;GGT1;CSNK1E;PLCD1;ADAMTS7;GM2A;GLUL;USP20;SPATA18;INSR;HAGH;DNPH1;SRD5A3;IAH1;RNASET2;SNX33;BLMH;ATG16L2;SNX9;ABCD1;PLCD3;WWTR1;ISG20;ANKZF1;PFKFB2;MVB12B;BNIP3;CD81;ENTPD6;DNASE1L1;FBXW4;AP2A2;ADAM15;ENDOG;MAPK3;GLB1;DHTKD1;DVL1;ENTPD2;GALK1;MTA1;FYCO1;GPSM1;LTA4H;WIPI2;ACAD10;FURIN;MLXIPL;CUL7;MEFV;LRSAM1;ADA;PFKL;PCSK9;GGACT;ZFP36;BTBD11;PRKACA;NUDT10;PLCH2;MAGEF1;DAP;FBXW5;LDLR;LYPLAL1;CYP3A5;SNX17;ABHD17C;PEX7;MVB12A;HK1;BTRC;PPARA;HMGCL;TKFC;BLVRB;COMT;SUFU;AIG1;IMPA2;PAN2;ATG2A;PCK2;USP21;RNF123;ADAMTS13;ETFB;TPP1;GPC1;SMOX;AGO4;RAD23A;CTSZ;SPSB3;PIN1;MAN1B1;PNPLA4;PHYH;GTPBP1;SH3D19;CES2;CAPN2;SESN2;TOLLIP;MAN2B2;PNRC1;TIMP1;SDC1;APOBEC3C;SORL1;COL13A1;TBC1D17;TPCN1;HGSNAT;CYP2S1;AKT1;HPDL;CTSD;TP53INP1;GPD1L;NAGA;PINK1;PKD1;LONP2;CTSH;MLST8;CBLC;RNF187;PYCARD;POMT1;TRERF1;ERN1;APOBEC3F;ACADS;FBXL20;GCAT;MLYCD;BCKDHA;NEIL1;GALNS;GSTM2;RPL13A
12405,GO:0048878,0.0355146457505344,0.973548733879576,75,641,chemical homeostasis,BP,CEMIP;APOE;CYP27B1;NOS1;NR1D1;EPAS1;IGF2;EGFR;FHL1;PYGL;F2R;CA12;MALL;ABCG1;ANK3;PIK3R2;LRP5;PKD2;SLC7A8;ITPR3;HEXB;NTSR1;ATP2B4;INSR;LPAR3;PRNP;ATP7B;SLC12A7;DLG4;ATP12A;BNIP3;VEGFA;ENDOG;MAPK3;ADCY6;MLXIPL;ABCA2;AQP3;PCSK9;PRKACA;SCNN1A;SLC25A37;FGFR4;VGF;LDLR;TRPV4;LDLRAP1;HK1;GAS6;WNT7B;COMT;PCK2;TMEM175;NEO1;PDK2;PNPLA4;KCNMA1;VSNL1;SLC25A27;SESN2;LCAT;SMDT1;CYBRD1;SLC9A7;TPCN1;AKT1;GPD1L;PKD1;SLC22A17;HOMER2;CTSH;ERN1;GSTM2;GIPR;PQLC2
18773,GO:1904350,0.0355960748871908,0.995438544599244,3,8,regulation of protein catabolic process in the vacuole,BP,LRP1;CD81;LDLR
3144,GO:0006750,0.0355984459460603,0.993069835540058,4,14,glutathione biosynthetic process,BP,OPLAH;GGT1;HAGH;GSS
12692,GO:0050954,0.0356633236702549,0.984010419174306,12,71,sensory perception of mechanical stimulus,BP,CEMIP;ESPN;DNM1;HEXB;SERPINE2;SPRY2;TUB;SLITRK6;FGFR1;SERPINB6;EPS8L2;HOMER2
19631,GO:1990909,0.0356989042859058,0.995420059332973,3,8,Wnt signalosome,CC,LRP5;DVL1;WNT3
9944,GO:0042339,0.0357107666969045,0.989669973506294,6,26,keratan sulfate metabolic process,BP,HEXB;B4GAT1;GLB1;ST3GAL3;CHST6;GALNS
17533,GO:1901137,0.0357129113684041,0.973912716303597,66,553,carbohydrate derivative biosynthetic process,BP,TNIP1;LMF1;CEMIP;APOE;NT5E;PGM1;NOS1;NME4;ST6GALNAC2;TIMP2;B3GAT3;CRYL1;ACOT7;PYGL;ABCA7;HYAL1;OGDHL;PTHLH;GALNT12;LTB4R2;ADAMTS7;INSR;MVD;B4GAT1;SRD5A3;UCKL1;PFKFB2;VANGL2;DHTKD1;GALK1;ADCY6;ST3GAL3;MLXIPL;TK2;ADA;PFKL;HBEGF;XYLT2;PIGZ;PHLDA1;HK1;CHST6;PPARA;GUK1;RFNG;MUC19;ADAMTS13;GPC1;MAN1B1;TSTA3;GUCA1B;GAL3ST4;PIGV;SDC1;PIGQ;VEGFB;ADORA2B;PINK1;POMT1;TAZ;JAK3;FUK;PPCS;ADAMTSL4;NDST2;ALG12
15623,GO:0072163,0.0358154518942728,0.984628077830754,11,62,mesonephric epithelium development,BP,CTNNBIP1;PGF;LAMA5;PKD2;VEGFA;HES1;FGFR1;WNT2B;SDC1;PKD1;KIF26B
15624,GO:0072164,0.0358154518942728,0.984628077830754,11,62,mesonephric tubule development,BP,CTNNBIP1;PGF;LAMA5;PKD2;VEGFA;HES1;FGFR1;WNT2B;SDC1;PKD1;KIF26B
7185,GO:0031086,0.0358190779319581,0.995398427530877,3,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,ZFP36L1;ZFP36;PNRC1
6727,GO:0030155,0.0358571928620638,0.974857030360687,52,419,regulation of cell adhesion,BP,GSN;POSTN;IGF2;SMOC2;LAMA5;ANK3;ZP3;HYAL1;ERBB2;FBLN1;PLXNB3;CD9;SERPINE2;MINK1;RHOD;ZMIZ1;EPHA1;ITGA6;IL20RB;PRNP;EFNB3;BCL6;PLXNB1;IGFBP2;VEGFA;ARL2;CEBPB;ADAM15;EPHB3;HES1;TNFRSF14;ADA;PAG1;CELSR2;DMTN;TRPV4;RAG1;PPARA;PTAFR;VAV3;PRKCZ;ICOSLG;ASS1;PPM1F;ERBB3;AKT1;VPS33B;PKD1;PYCARD;NINJ1;JAK3;KIF26B
3500,GO:0007416,0.0360133367284743,0.983242780972677,13,77,synapse assembly,BP,ADGRL1;SHANK2;EPHB2;NLGN2;ADGRF1;SDK2;WNT7A;SHANK3;DVL1;EPHB3;EEF2K;ADGRB2;SLITRK6
2707,GO:0006090,0.036048592740612,0.981678101453297,16,102,pyruvate metabolic process,BP,PGM1;SLC16A3;BSG;OGDHL;INSR;HAGH;PFKFB2;DHTKD1;GALK1;PC;MLXIPL;PFKL;HK1;PPARA;PCK2;PDK2
8717,GO:0034381,0.0360759969436254,0.988172189077793,7,34,plasma lipoprotein particle clearance,BP,LMF1;APOE;AP2A2;AMN;PCSK9;LDLR;LDLRAP1
13491,GO:0055090,0.0361226021944056,0.992934588065076,4,14,acylglycerol homeostasis,BP,APOE;MLXIPL;SLC25A27;SESN2
14676,GO:0070328,0.0361226021944056,0.992934588065076,4,14,triglyceride homeostasis,BP,APOE;MLXIPL;SLC25A27;SESN2
4689,GO:0010857,0.0363217860315694,0.995307604411536,3,8,calcium-dependent protein kinase activity,MF,MKNK2;MAPKAPK3;PINK1
15007,GO:0070977,0.036371102291897,0.995298665656852,3,8,bone maturation,BP,THBS3;PLXNB1;FGFR3
12124,GO:0048251,0.0364134147072868,0.995290992270032,3,8,elastic fiber assembly,BP,LOXL1;THSD4;TNXB
3882,GO:0008526,0.0364138716130639,0.995290909389165,3,8,phosphatidylinositol transporter activity,MF,PITPNC1;PITPNM1;PITPNM3
4089,GO:0009152,0.0364296410324774,0.978685470050518,24,172,purine ribonucleotide biosynthetic process,BP,APOE;PGM1;NOS1;NME4;TIMP2;ACOT7;OGDHL;PTHLH;LTB4R2;INSR;PFKFB2;DHTKD1;GALK1;ADCY6;MLXIPL;PFKL;HK1;PPARA;GUK1;GUCA1B;ADORA2B;PINK1;TAZ;PPCS
1259,GO:0003015,0.0365533449889555,0.980162166351094,19,128,heart process,BP,GAA;NOS1;EPAS1;THRA;SCN4B;ITPR3;ATP2B4;TNNT1;ADA;PRKACA;HBEGF;PPP1R13L;VEGFB;GPD1L;EHD3;SNTA1;MAP2K3;TAZ;GSTM2
9046,GO:0035295,0.0365968056253641,0.972600490855437,77,650,tube development,BP,APOE;CTNNBIP1;RAPGEF3;XDH;PGF;ZFP36L1;TCTN1;EPHB2;EPAS1;NFATC4;LRP1;EGFR;SHC1;PTK6;DEAF1;LAMA5;HDAC5;THRA;LRP5;HYAL1;ERBB2;PKD2;ITGB4;SALL2;IFT140;SERPINE2;FUZ;PLCD1;WNT7A;ZMIZ1;ID1;CELSR1;EPHA1;ITGA6;SPRY2;ECM1;PLCD3;WWTR1;TMEM107;FZD8;VEGFA;VANGL2;ACVR2B;ADAM15;MAPK3;ETV5;DVL1;EPHB3;HES1;CUL7;ARHGAP22;NRP2;ADA;SH2D2A;FGFR4;HMGA2;ELK3;SEMA4C;BTRC;ADGRB2;WNT7B;SUFU;VAV3;FGFR1;CTSZ;C5;PROX1;WNT2B;SDC1;VEGFB;PKD1;CTSH;ROBO4;EPN2;RARG;EREG;KIF26B
1402,GO:0003338,0.0366296381306878,0.990896208830001,5,20,metanephros morphogenesis,BP,PKD2;HES1;WNT7B;PKD1;KIF26B
8873,GO:0034706,0.0366841179163475,0.99524181047405,3,8,sodium channel complex,CC,SCN8A;SCN4B;SCNN1A
1480,GO:0003779,0.0366980161341562,0.975816635176586,38,292,actin binding,MF,ESPN;MARCKSL1;FLNC;GSN;PARVB;OBSL1;EGFR;S100A4;CORO1B;MICALL2;MPRIP;MSRB2;TMOD2;MYO18A;PLEKHH2;SHANK3;WIPF1;FHOD1;SSH1;MEFV;SPTB;DMTN;MYH3;TRPV4;CROCC;MIB2;CAPG;TWF2;KCNMA1;BIN1;EPB41L3;EPS8L1;EPS8L2;SSH3;SNTA1;HOMER2;SYNE3;SPIRE2
544,GO:0001664,0.0369004554677691,0.980313014714393,18,122,G-protein coupled receptor binding,MF,ARAP1;GNAL;ITGB4;DNM1;USP20;WNT7A;PRNP;DLG4;REEP2;S1PR2;DVL1;BBS1;WNT7B;C5;WNT2B;WNT3;HOMER2;CKLF
3520,GO:0007507,0.0369021759182336,0.974787372719801,45,354,heart development,BP,DUSP6;GAA;MEF2D;LTBP1;ZFP36L1;NFATC4;OBSL1;EGFR;SHC1;ZFPM1;ERBB2;PKD2;IFT140;TFDP2;PDCD4;ZMIZ1;INSR;SH3PXD2B;ID1;VEGFA;VANGL2;ACVR2B;ADAM15;MAPK3;DVL1;HES1;NRP2;TCF25;SNX17;POU6F1;PPARA;SUFU;RXRA;FGFR1;PIN1;PROX1;PPP1R13L;JARID2;VEGFB;MEF2B;ERBB3;ADAM19;PKD1;TAZ;RARG
4160,GO:0009235,0.0369519108265294,0.992719224561174,4,14,cobalamin metabolic process,BP,PRSS3;CD320;AMN;ABCD4
19385,GO:1905952,0.0370103186824067,0.98329672451674,12,72,regulation of lipid localization,BP,APOE;LRP1;ABCA7;ABCG1;PLTP;NTSR1;ABCA2;PCSK9;LDLRAP1;PPARA;AKT1;MIF
12637,GO:0050867,0.0370117943679489,0.978051939275479,25,180,positive regulation of cell activation,BP,IGF2;ZP3;CD320;ZMIZ1;EFNB3;STAT6;BCL6;IGFBP2;CD81;HES1;TNFRSF14;ADA;DMTN;RAG1;GAS6;PTAFR;VAV3;PRKCZ;INPP5D;ICOSLG;ADORA2B;AKT1;PYCARD;JAK3;MIF
3169,GO:0006790,0.0370476994521311,0.976005795738974,35,272,sulfur compound metabolic process,BP,GAMT;B3GAT3;ACSF2;ACOT7;MTHFR;OPLAH;HYAL1;CBS;HEXB;GGT1;MVD;B4GAT1;HAGH;BLMH;GLB1;ST3GAL3;PC;HLCS;PMVK;XYLT2;ACOT11;CHST6;HMGCL;COMT;PDK2;GAL3ST4;GSTT1;GSS;AHCYL2;ABHD14B;MLYCD;GALNS;GSTM2;PODXL2;NDST2
11267,GO:0045600,0.0371561727243246,0.986622625342757,8,40,positive regulation of fat cell differentiation,BP,ZFP36L1;LRP5;SH3PXD2B;CEBPB;ZFP36;CCDC71L;AKT1;ZNF385A
6653,GO:0030017,0.0372118476266713,0.980990449192953,16,104,sarcomere,CC,FLNC;NOS1;PARVB;SCN8A;OBSCN;MYZAP;OBSL1;ANK3;ATP2B4;TMOD2;TNNT1;MYH3;AHNAK2;BIN1;SYNC;SLC2A1
8872,GO:0034705,0.0372450029861538,0.987744671862297,7,33,potassium channel complex,CC,KCNG1;KCNC4;VAMP2;DLG4;KCNAB2;KCNMA1;KCNN4
986,GO:0002443,0.0372474000508277,0.973215192619472,59,494,leukocyte mediated immunity,BP,ERCC1;GAA;NAPRT;PYGB;CST3;PGM1;GSN;PRSS3;TIMP2;SERPING1;PYGL;CTSB;ZP3;FUCA1;VAT1;HEXB;VAMP2;GM2A;RAB3D;IL20RB;NBEAL2;TMEM173;RNASET2;STAT6;SCART1;BCL6;DNASE1L1;AP2A2;DPP7;KCNAB2;GLB1;LTA4H;SLC2A3;PFKL;RHOF;PI4K2A;PTAFR;BCR;PRKCZ;INPP5D;CTSZ;C5;SERPINB6;TOLLIP;CSTB;ADGRE2;CD68;ACTR1B;LYST;ADORA2B;HGSNAT;ABR;CTSD;CTSH;PYCARD;JAK3;GALNS;MIF;STXBP2
6619,GO:0022890,0.0373182365270131,0.975823694424844,35,269,inorganic cation transmembrane transporter activity,MF,SCN8A;KCNG1;KCNC4;KCNJ15;SLC2A9;SLC13A3;PKD2;SCN4B;ITPR3;ATP2B4;SLC6A8;SLC20A1;ASIC1;ATP7B;SLC12A7;ATP12A;TMEM63C;KCNAB2;SLC22A18;SLC28A2;SCNN1A;SLC25A37;TRPV4;GAS6;TMEM175;KCNMA1;TMCO3;NDUFA4L2;SLC9A7;TPCN1;SLC5A5;PKD1;KCNN4;ORAI3;ORAI2
13224,GO:0051930,0.0373237366502494,0.992622121391717,4,14,regulation of sensory perception of pain,BP,F2R;NTSR1;COMT;PTAFR
13225,GO:0051931,0.0373237366502494,0.992622121391717,4,14,regulation of sensory perception,BP,F2R;NTSR1;COMT;PTAFR
3119,GO:0006706,0.0373883224163113,0.992605220578024,4,14,steroid catabolic process,BP,APOE;CYP27B1;SNX17;TRERF1
6610,GO:0022843,0.0375993008601414,0.9864310002938,8,40,voltage-gated cation channel activity,MF,KCNG1;KCNC4;KCNJ15;PKD2;KCNAB2;GAS6;KCNMA1;TPCN1
1085,GO:0002673,0.0376418270363515,0.988916194045104,6,27,regulation of acute inflammatory response,BP,SERPING1;ZP3;IL20RB;CD81;F12;C5
12539,GO:0050714,0.0376700407891443,0.978786230212968,21,145,positive regulation of protein secretion,BP,POSTN;ALOX15B;EGFR;NLGN2;F2R;GLUL;MYO18A;PFKFB2;MAPK3;TRPV4;HK1;PCK2;PRKCZ;TM7SF3;C5;VSNL1;PYCARD;KCNN4;SIRT3;GIPR;MIF
5176,GO:0015749,0.0378037361202104,0.982914410247204,12,70,monosaccharide transmembrane transport,BP,PIK3R2;SLC2A9;INSR;SLC2A3;PRKCZ;CLTCL1;SLC25A27;GRB10;SESN2;RTN2;AKT1;SLC2A1
18176,GO:1902991,0.0378193867403014,0.990517484952101,5,20,regulation of amyloid precursor protein catabolic process,BP,APOE;ABCA7;PRNP;BIN1;SORL1
15747,GO:0072376,0.0378674754976217,0.990502102294063,5,20,protein activation cascade,BP,SERPING1;FBLN1;CD81;F12;C5
18553,GO:1903825,0.0380476271496158,0.982138864329934,13,78,organic acid transmembrane transport,BP,CPT2;SLC43A1;SLC16A3;SLC13A3;SLC7A8;PRAF2;NTSR1;SLC6A8;SLC38A10;STK39;SLC25A29;AKT1;PQLC2
19081,GO:1905039,0.0380476271496158,0.982138864329934,13,78,carboxylic acid transmembrane transport,BP,CPT2;SLC43A1;SLC16A3;SLC13A3;SLC7A8;PRAF2;NTSR1;SLC6A8;SLC38A10;STK39;SLC25A29;AKT1;PQLC2
7352,GO:0031406,0.0380541246716446,0.9804945793846,16,105,carboxylic acid binding,MF,CEMIP;NOS1;PYGL;GLUL;PC;NAGS;HLCS;PPARA;HMGCL;RXRA;PHYH;ASS1;SESN2;RTN4R;GRHPR;GSS
8339,GO:0033218,0.0381000739034041,0.976840256515118,27,199,amide binding,MF,CEMIP;APOE;RNPEPL1;CST3;EPHB2;FBXO2;PLTP;SLC7A8;VIPR1;INSR;PRNP;LTA4H;PC;FURIN;HLCS;LDLR;LDLRAP1;PEX7;RXRA;TPP1;RTN4R;SORL1;GSS;TMEM158;APBA1;GSTM2;GIPR
1099,GO:0002688,0.0381098971655637,0.984224235685463,10,57,regulation of leukocyte chemotaxis,BP,PGF;MMP28;VEGFA;MAPK3;IL6R;TRPV4;GAS6;C5;VEGFB;MIF
4024,GO:0009065,0.0381559091443405,0.990409716777226,5,20,glutamine family amino acid catabolic process,BP,PRODH;NOS1;ALDH4A1;ATP2B4;GLUL
13245,GO:0051960,0.0382357186034208,0.971963615968274,66,548,regulation of nervous system development,BP,ADGRL1;APOE;IDH2;PTPRS;SEMA4B;SHANK2;NOS1;EPHB2;CNTN1;NFATC4;LRP1;OBSL1;TIMP2;NLGN2;CRTC1;PTK6;ULK2;GJC2;ZMYND8;PLXNB3;KIF13B;SERPINE2;CSNK1E;WNT7A;FBXW8;ID1;CELSR1;SYNGAP1;LPAR3;EFNB3;DLG4;BCL6;PLXNB1;VEGFA;VANGL2;SHANK3;ETV5;DVL1;ADCY6;EPHB3;HES1;SSH1;CUL7;DGUOK;SEMA3B;LDLR;TRPV4;EEF2K;SEMA3F;SEMA4C;ADGRB2;SUFU;SLITRK6;TWF2;FGFR1;CTSZ;PROX1;BIN1;RTN4R;WNT3;SORL1;AKT1;SSH3;RGS14;RARG;SEMA4F
401,GO:0001078,0.0382559773109434,0.980406622301074,16,102,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,TCFL5;NR1D1;NFATC4;ZFPM1;FOXQ1;ZNF692;HES2;CEBPB;HES1;MLXIPL;BHLHE40;HMGA2;ZNF217;PPARA;PROX1;MZF1
718,GO:0001945,0.0383326176216384,0.990353014549729,5,20,lymph vessel development,BP,VEGFA;ACVR2B;TMEM204;PROX1;PKD1
7063,GO:0030863,0.0383506496967519,0.981975629755309,13,78,cortical cytoskeleton,CC,RAPGEF3;GSN;MYZAP;RIMS3;DLG4;PLEKHH2;WIPF1;SPTB;DMTN;TRPV4;LLGL1;CAPN2;SLC2A1
4023,GO:0009064,0.038454278082009,0.98499961938658,9,48,glutamine family amino acid metabolic process,BP,PRODH;NOS1;ALDH4A1;ATP2B4;GGT1;GLUL;NAGS;PYCR2;ASS1
12219,GO:0048514,0.0386481906713108,0.973276649268203,47,374,blood vessel morphogenesis,BP,APOE;RAPGEF3;XDH;PGF;ZFP36L1;EPHB2;EPAS1;NFATC4;LRP1;SHC1;LAMA5;HDAC5;LRP5;HYAL1;ERBB2;PKD2;PLCD1;WNT7A;ZMIZ1;ID1;EPHA1;SPRY2;ECM1;PLCD3;FZD8;VEGFA;ADAM15;EPHB3;HES1;CUL7;ARHGAP22;NRP2;SH2D2A;FGFR4;HMGA2;ELK3;ADGRB2;WNT7B;VAV3;FGFR1;C5;PROX1;VEGFB;CTSH;ROBO4;EPN2;EREG
3557,GO:0007606,0.038682910487552,0.98708340200233,7,35,sensory perception of chemical stimulus,BP,GNAL;ITPR3;ASIC1;REEP2;SCNN1A;BBS1;OR7D2
18412,GO:1903522,0.0388660695285869,0.978755740352034,19,128,regulation of blood circulation,BP,GAA;NOS1;EPAS1;EGFR;F2R;THRA;DOCK4;SCN4B;ITPR3;ATP2B4;ADA;PRKACA;HBEGF;PTAFR;AKT1;GPD1L;EHD3;SNTA1;GSTM2
13246,GO:0051961,0.0389792195221437,0.976509777962226,26,188,negative regulation of nervous system development,BP,APOE;IDH2;PTPRS;SEMA4B;EPHB2;NFATC4;LRP1;ULK2;WNT7A;ID1;SYNGAP1;EFNB3;ADCY6;HES1;DGUOK;SEMA3B;LDLR;TRPV4;SEMA3F;SEMA4C;SUFU;CTSZ;RTN4R;WNT3;SORL1;SEMA4F
7685,GO:0032154,0.0392110455054023,0.984649019454028,9,48,cleavage furrow,CC,RAB11FIP4;PKN1;PLCD3;SSH1;PITPNM1;PLEKHG6;NDE1;SPIRE2;ZFYVE19
8356,GO:0033267,0.0392300244543814,0.975022509203969,32,241,axon part,CC,ADGRL1;SHANK2;SCN8A;TIMP2;GJC2;KCNC4;ANK3;TENM2;DNM1;KIF13B;SIGMAR1;NTSR1;TMOD2;GLUL;DLG4;KCNAB2;DVL1;SSH1;MAPK8IP1;TRPV4;BLVRB;PRKCZ;TWF2;CTSZ;DLG3;BIN1;RTN4R;EPB41L3;NDRG2;PINK1;NRSN1;ORAI2
1223,GO:0002901,0.0392786878679134,0.997639170205804,2,4,mature B cell apoptotic process,BP,ADA;MIF
1227,GO:0002905,0.0392786878679134,0.997639170205804,2,4,regulation of mature B cell apoptotic process,BP,ADA;MIF
1228,GO:0002906,0.0392786878679134,0.997639170205804,2,4,negative regulation of mature B cell apoptotic process,BP,ADA;MIF
5586,GO:0016627,0.0394222245572153,0.984524149372659,9,49,oxidoreductase activity, acting on the CH-CH group of donors,MF,SRD5A3;ACAD10;RETSAT;TM7SF2;SDHAF4;BLVRB;SDHA;RSAD1;ACADS
9874,GO:0042171,0.0396705527846855,0.989921196740846,5,20,lysophosphatidic acid acyltransferase activity,MF,LPCAT4;MBOAT7;AGPAT4;TAZ;AGPAT3
15348,GO:0071617,0.0396705527846855,0.989921196740846,5,20,lysophospholipid acyltransferase activity,MF,LPCAT4;MBOAT7;AGPAT4;TAZ;AGPAT3
2533,GO:0005796,0.0396905255887048,0.984399185966782,9,49,Golgi lumen,CC,WNT7A;FURIN;GAS6;WNT7B;MUC19;GPC1;SDC1;WNT3;PODXL2
17252,GO:0140029,0.0397046828158381,0.983468972837243,10,56,exocytic process,BP,EXOC2;VPS11;RAB3D;RAB40B;RAB3B;DMTN;SNPH;VPS33B;RAB40C;STXBP2
1215,GO:0002886,0.0397227476482765,0.988149592441893,6,27,regulation of myeloid leukocyte mediated immunity,BP,PTAFR;BCR;ADGRE2;ADORA2B;ABR;STXBP2
16733,GO:0098552,0.0398298709136057,0.974232387664764,34,260,side of membrane,CC,MYZAP;PTK6;GNAL;ABCG1;S100A6;BCAM;PKD2;CD9;SERPINE2;NTSR1;RASA4;GM2A;INSR;ITGA6;SYNGAP1;PRNP;SNX9;DLG4;SCART1;SRMS;KCNAB2;ADA;PCSK9;MAP2K2;SPTB;LDLR;LDLRAP1;ICOSLG;ESYT2;RTN4R;SDC1;SPPL2B;JAK3;LITAF
14276,GO:0061437,0.039909206926018,0.99193778166824,4,14,renal system vasculature development,BP,EGR1;ACTA2;PKD2;HES1
14279,GO:0061440,0.039909206926018,0.99193778166824,4,14,kidney vasculature development,BP,EGR1;ACTA2;PKD2;HES1
12645,GO:0050878,0.0400079581374708,0.973289460603329,39,308,regulation of body fluid levels,BP,APOE;XDH;EPHB2;SERPING1;F2R;DGKA;PLAT;ZFPM1;FBLN1;ITPR3;CD9;SERPINE2;DOCK6;ATP7B;VEGFA;MAPK3;ENTPD2;ADCY6;ADA;PHF21A;AQP3;PRKACA;F12;SCNN1A;DMTN;TRPV4;DGKQ;GAS6;VAV3;ADAMTS13;PROCR;GUCA1B;SH2B3;STK39;AKT1;ZNF385A;VPS33B;EHD3;KCNN4
12723,GO:0051017,0.0400426800004826,0.978886976148388,17,111,actin filament bundle assembly,BP,ESPN;RAPGEF3;ARAP1;CORO1B;RHOD;SH3PXD2B;ID1;EPHA1;SHANK3;FHOD1;RHOF;ITGB5;DMTN;RHOBTB2;PPM1F;ARHGEF10L;SPIRE2
7144,GO:0031016,0.0402056118333369,0.985259127551148,8,41,pancreas development,BP,INSR;ACVR2B;HES1;IL6R;MSLN;PROX1;AKT1;GIPR
7326,GO:0031348,0.0402154846976757,0.978766224538158,17,113,negative regulation of defense response,BP,HTRA1;APOE;NT5E;SERPING1;ACP5;PDCD4;IL20RB;MEFV;ADA;MAPKBP1;TNFRSF1A;FAM3A;PPARA;TKFC;BCR;ABR;NLRX1
5368,GO:0016192,0.0402853650888398,0.967093664063023,157,1437,vesicle-mediated transport,BP,LMF1;APOE;TSPAN1;GAA;SYTL1;NAPRT;PYGB;CST3;MRC2;PGM1;GSN;EVI5L;PRSS3;ARAP1;IGF2;LRP1;APPL2;RAB11FIP4;TIMP2;NLGN2;SERPING1;PYGL;DOPEY2;SYT8;ABCA7;BBS2;CTSB;TBC1D14;RIN1;ANK3;PIK3R2;ZP3;LRP5;LRP3;EXOC2;MICALL2;FUCA1;VAT1;DNM1;FCHO1;RIMS3;CD9;CACFD1;HEXB;VPS11;VAMP2;CSNK1E;TRAPPC9;AGAP1;ZFYVE21;GM2A;ACAP3;USP20;RAB3D;TBC1D8;NBEAL2;TMEM173;RNASET2;SNX33;ECM1;SNX9;DLG4;MARCH2;RAB25;MYO18A;ARHGAP27;SCART1;MVB12B;CD81;FCGRT;VEGFA;DNASE1L1;HOOK2;ELMO3;AP2A2;DPP7;SSC4D;MAPK3;TUB;KCNAB2;AMN;GLB1;RAB40B;WIPF1;LTA4H;SLC2A3;LRSAM1;MCTP1;OSBPL5;PFKL;PCSK9;RHOF;CYFIP2;RAB3B;MAP2K2;PI4K2A;SPTB;STX10;DMTN;BBS1;EHD4;MAPK8IP1;LDLR;SNX17;EEF2K;LDLRAP1;MVB12A;GAS6;LLGL1;GIT1;PTAFR;VAV3;LRP10;BCR;TMEM175;TBC1D16;CLTCL1;MAPKAPK3;ARAP3;CTSZ;ASAP2;ESYT2;BIN1;VSNL1;SERPINB6;TOLLIP;CSTB;SNPH;ADGRE2;TIMP1;CD68;SDC1;WHAMMP3;ACTR1B;PEAR1;LYST;SORL1;VEGFB;TBC1D17;TSNARE1;ADORA2B;HGSNAT;ABR;CTSD;STON1;VPS33B;PINK1;EHD3;SPIRE2;CTSH;EPN2;PYCARD;GALNS;TMED4;RAB40C;MIF;STXBP2
10425,GO:0043300,0.0403030508886572,0.987933897584227,6,27,regulation of leukocyte degranulation,BP,PTAFR;BCR;ADGRE2;ADORA2B;ABR;STXBP2
6642,GO:0030001,0.0403557833866287,0.971187852992485,55,452,metal ion transport,BP,CEMIP;CYP27B1;NOS1;SCN8A;CNTN1;KCNG1;FHL1;F2R;PRSS8;GJC2;KCNC4;ANK3;KCNJ15;SLC13A3;PKD2;SCN4B;ITPR3;SERPINE2;VAMP2;NTSR1;ATP2B4;SLC6A8;SLC20A1;ASIC1;LPAR3;PRNP;ATP7B;SLC12A7;ATP12A;KCNAB2;PCSK9;PRKACA;SLC38A10;SCNN1A;SLC25A37;TRPV4;GAS6;TMEM175;KCNMA1;GLRX;SMDT1;SLC9A7;STK39;TPCN1;AKT1;GPD1L;SLC5A5;PKD1;EHD3;SNTA1;HOMER2;KCNN4;ORAI3;ORAI2;GSTM2
4038,GO:0009084,0.0405103374446474,0.991776418549496,4,14,glutamine family amino acid biosynthetic process,BP,GLUL;NAGS;PYCR2;ASS1
4144,GO:0009215,0.0405677272870551,0.99428720941553,3,9,purine deoxyribonucleoside triphosphate metabolic process,BP,ADA;DGUOK;GUK1
595,GO:0001763,0.0406022016126476,0.977309848885457,20,136,morphogenesis of a branching structure,BP,CTNNBIP1;PGF;NFATC4;LAMA5;LRP5;PKD2;CELSR1;SPRY2;VEGFA;VANGL2;ETV5;BTRC;RXRA;FGFR1;CTSZ;PROX1;WNT2B;COL13A1;PKD1;CTSH
1107,GO:0002696,0.0406137583185667,0.975967748306049,24,173,positive regulation of leukocyte activation,BP,IGF2;ZP3;CD320;ZMIZ1;EFNB3;STAT6;BCL6;IGFBP2;CD81;HES1;TNFRSF14;ADA;RAG1;GAS6;PTAFR;VAV3;PRKCZ;INPP5D;ICOSLG;ADORA2B;AKT1;PYCARD;JAK3;MIF
10486,GO:0043407,0.0406504709650842,0.982149110180311,11,64,negative regulation of MAP kinase activity,BP,DUSP6;APOE;DUSP5;SPRY4;PDCD4;SPRY2;MAPK8IP1;DUSP7;SORL1;RGS14;CBLC
12809,GO:0051145,0.0407784221955603,0.986267668376147,7,34,smooth muscle cell differentiation,BP,NFATC4;PDCD4;VEGFA;OLFM2;HES1;TMEM204;EREG
18540,GO:1903793,0.0409268102025877,0.989430033710671,5,21,positive regulation of anion transport,BP,APOE;ABCA7;NTSR1;PTAFR;MIF
377,GO:0001010,0.0409866115805355,0.991647977664113,4,14,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,NR1D1;THRA;PPARA;RARG
17262,GO:0140056,0.0410276299504779,0.976325754286739,22,155,organelle localization by membrane tethering,BP,TCTN1;MARK4;EXOC2;NINL;VPS11;NPHP4;CSNK1E;RAB3D;CEP250;RAB40B;FBF1;PRKACA;RAB3B;STX10;NDE1;ESYT2;SNPH;TSNARE1;VPS33B;SFI1;RAB40C;STXBP2
3277,GO:0006972,0.0410753894877838,0.991623978467786,4,14,hyperosmotic response,BP,PKN1;TRPV4;ICOSLG;SLC2A1
4704,GO:0010876,0.0411207041142287,0.974125341593808,30,224,lipid localization,BP,APOE;CPT2;NME4;LRP1;ABCA7;PITPNC1;ABCG1;PLTP;SIGMAR1;HEXB;NTSR1;GM2A;ABCD1;ABCA2;OSBPL5;PCSK9;PITPNM1;LDLR;LDLRAP1;PPARA;RXRA;LRP10;ESYT2;LCAT;PITPNM3;SORL1;ANO9;AKT1;KCNN4;MIF
10345,GO:0043177,0.0411636709015864,0.978674676924117,16,106,organic acid binding,MF,CEMIP;NOS1;PYGL;GLUL;PC;NAGS;HLCS;PPARA;HMGCL;RXRA;PHYH;ASS1;SESN2;RTN4R;GRHPR;GSS
2191,GO:0005057,0.041263703719322,0.977711515359152,18,119,signal transducer activity, downstream of receptor,MF,EPHB2;MST1R;MAPK13;EGFR;ERBB2;MINK1;INSR;EPHA1;ACVR2B;MAPK3;EPHB3;FGFR3;FGFR4;FGFR1;ACVR1B;ERBB3;RGS14;RGS12
3401,GO:0007190,0.041316483732716,0.991558712662105,4,14,activation of adenylate cyclase activity,BP,GNAL;ADCY6;ADORA2B;GIPR
5375,GO:0016209,0.0414141893933954,0.983491129224379,9,53,antioxidant activity,MF,APOE;PRDX5;GPX3;TXNRD3;FAM213A;SESN2;GSTT1;TP53INP1;GSTM2
14178,GO:0061135,0.041490965387729,0.98018642251963,13,84,endopeptidase regulator activity,MF,CST3;PRDX5;TIMP2;SERPING1;SERPINE2;PAPLN;FURIN;GAS6;C5;SERPINB6;CSTB;TIMP1;PCSK1N
9446,GO:0036066,0.0415160214576922,0.99150459592457,4,14,protein O-linked fucosylation,BP,ADAMTS7;RFNG;ADAMTS13;ADAMTSL4
15118,GO:0071248,0.0415626846713216,0.978979437088573,15,97,cellular response to metal ion,BP,FOS;GSN;NFATC4;EGFR;ANK3;PKD2;RASA4;PRNP;BNIP3;ENDOG;MAPK3;DMTN;EEF2K;AKT1;CPNE7
9530,GO:0036303,0.041609654263568,0.991479170396295,4,14,lymph vessel morphogenesis,BP,VEGFA;ACVR2B;PROX1;PKD1
7281,GO:0031290,0.041757048864981,0.991439105655032,4,14,retinal ganglion cell axon guidance,BP,EPHB2;VEGFA;EPHB3;SEMA4F
2700,GO:0006081,0.0418410513812174,0.982396439178695,10,57,cellular aldehyde metabolic process,BP,H6PD;IDH2;PGLS;ALDH4A1;AKR7A2;HAGH;TALDO1;TKFC;GRHPR;PNPO
11318,GO:0045664,0.0418438817749961,0.97045570645851,51,413,regulation of neuron differentiation,BP,APOE;PTPRS;SEMA4B;SHANK2;EPHB2;CNTN1;NFATC4;LRP1;OBSL1;TIMP2;CRTC1;PTK6;ULK2;ZMYND8;PLXNB3;KIF13B;CSNK1E;WNT7A;FBXW8;ID1;SYNGAP1;LPAR3;EFNB3;DLG4;BCL6;PLXNB1;VEGFA;SHANK3;ETV5;DVL1;ADCY6;EPHB3;HES1;SSH1;CUL7;DGUOK;SEMA3B;TRPV4;EEF2K;SEMA3F;SEMA4C;TWF2;FGFR1;CTSZ;PROX1;BIN1;RTN4R;WNT3;AKT1;SSH3;SEMA4F
17024,GO:0099531,0.0419254547847933,0.980004065888922,13,80,presynaptic process involved in chemical synaptic transmission,BP,SYTL1;SYT8;KCNC4;BRSK1;RIMS3;VAMP2;ASIC1;WNT7A;DVL1;MCTP1;RAB3B;SNPH;APBA1
16878,GO:0098868,0.0419654721169405,0.991382367828215,4,14,bone growth,BP,THBS3;EVC;FGFR3;RARG
10436,GO:0043312,0.0420386875887927,0.971241688719831,43,349,neutrophil degranulation,BP,GAA;NAPRT;PYGB;CST3;PGM1;GSN;PRSS3;TIMP2;PYGL;CTSB;FUCA1;VAT1;HEXB;GM2A;RAB3D;NBEAL2;TMEM173;RNASET2;DNASE1L1;AP2A2;DPP7;KCNAB2;GLB1;LTA4H;SLC2A3;PFKL;RHOF;PTAFR;BCR;CTSZ;SERPINB6;TOLLIP;CSTB;CD68;ACTR1B;HGSNAT;ABR;CTSD;CTSH;PYCARD;GALNS;MIF;STXBP2
13205,GO:0051896,0.0422039107506525,0.977123587269873,18,121,regulation of protein kinase B signaling,BP,FAM110C;XDH;IGF2;MST1R;EGFR;PIK3R2;ERBB2;INSR;SPRY2;FGFR3;HBEGF;FGFR4;GAS6;FGFR1;ERBB3;AKT1;PINK1;EREG
5848,GO:0017157,0.0423546686061942,0.977031884904769,18,121,regulation of exocytosis,BP,SYTL1;SYT8;ZP3;RIMS3;VAMP2;RAB3D;RAB40B;RAB3B;LLGL1;PTAFR;BCR;VSNL1;ADGRE2;SDC1;ADORA2B;ABR;RAB40C;STXBP2
14930,GO:0070851,0.0425390263860702,0.97966763638721,13,80,growth factor receptor binding,MF,PGF;SHC1;ECM1;VEGFA;IL6R;HBEGF;VAV3;TOLLIP;VEGFB;CBLC;PYCARD;ERN1;EREG
18078,GO:1902743,0.0427533574055481,0.985451688198076,7,34,regulation of lamellipodium organization,BP,ARPIN;CORO1B;PLXNB3;SSH1;DMTN;TWF2;SSH3
17702,GO:1901658,0.0429608832268428,0.986876199610047,6,28,glycosyl compound catabolic process,BP,NT5E;FUCA1;ADA;APOBEC3C;NAGA;APOBEC3F
10785,GO:0044283,0.0429736956161831,0.968409938493661,64,542,small molecule biosynthetic process,BP,CEMIP;APOE;NT5E;RAPGEF3;PGM1;CYP27B1;XDH;NR1D1;ALOX15B;NME4;GAMT;ACOT7;ISYNA1;UROS;EGR1;ABCG1;HYAL1;PLTP;OGDHL;CBS;NTSR1;ATP2B4;GGT1;GLUL;INSR;MVD;DNPH1;SRD5A3;TALDO1;UCKL1;PFKFB2;SEC14L2;DHTKD1;ENTPD2;GALK1;LTA4H;PHGDH;PC;MLXIPL;NAGS;TK2;ADA;PYCR2;PFKL;NUDT10;FGFR4;PMVK;TM7SF2;DGKQ;HK1;PPARA;HMGCL;GUK1;PTAFR;IMPA2;PCK2;MDH2;PDK2;PROX1;ASS1;PNPO;MLYCD;NEIL1;MIF
14330,GO:0061572,0.0431389475651083,0.97703014424582,17,112,actin filament bundle organization,BP,ESPN;RAPGEF3;ARAP1;CORO1B;RHOD;SH3PXD2B;ID1;EPHA1;SHANK3;FHOD1;RHOF;ITGB5;DMTN;RHOBTB2;PPM1F;ARHGEF10L;SPIRE2
6880,GO:0030424,0.0431424387598613,0.970178437709214,45,360,axon,CC,ADGRL1;PTPRS;CST3;SHANK2;SCN8A;EPHB2;TIMP2;ULK1;GJC2;IGSF9;KCNC4;ANK3;TENM2;CPT1C;DNM1;KIF13B;SIGMAR1;NTSR1;MINK1;TMOD2;GLUL;INSR;LPAR3;DLG4;KCNAB2;DVL1;SSH1;MAPK8IP1;ROBO3;TRPV4;LDLRAP1;LLGL1;BLVRB;COMT;PRKCZ;TWF2;CTSZ;DLG3;BIN1;RTN4R;EPB41L3;NDRG2;PINK1;NRSN1;ORAI2
10045,GO:0042552,0.0431917886433689,0.979308842687541,13,80,myelination,BP,MARVELD1;NDRG1;SCN8A;MALL;ERBB2;CD9;HEXB;NAB2;AHNAK2;GPC1;EPB41L3;AKT1;RARG
11721,GO:0046580,0.0431921494066798,0.983933511900564,8,41,negative regulation of Ras protein signal transduction,BP,EPHB2;TIMP2;SPRY4;RASA4;SYNGAP1;SPRY2;BCL6;ARAP3
9772,GO:0040008,0.0432271798930587,0.969093040561167,54,446,regulation of growth,BP,HTRA1;DUSP6;APOE;PTPRS;WWC3;SEMA4B;LTBP4;CYP27B1;ALOX15B;GAMT;EGFR;FHL1;SHC1;PTK6;BBS2;ULK2;ZP3;HYAL1;ERBB2;PHLDA2;SERPINE2;INSR;SH3PXD2B;DNPH1;LPAR3;BCL6;IGFBP2;VEGFA;ADAM15;SLIT3;FGFR3;HBEGF;SEMA3B;HMGA2;SEMA3F;SEMA4C;GAS6;IGFBP4;TWF2;FGFR1;PIN1;PROX1;TMEM8B;JARID2;SESN2;RTN4R;EPB41L3;WNT3;PPM1F;ACVR1B;CCDC85B;AKT1;ING4;SEMA4F
3136,GO:0006739,0.0432694512727287,0.986758725018635,6,28,NADP metabolic process,BP,H6PD;IDH2;PGLS;TALDO1;KCNAB2;NADK
9838,GO:0042104,0.0432933698582831,0.9908878719993,4,15,positive regulation of activated T cell proliferation,BP,IGF2;IGFBP2;ICOSLG;PYCARD
1204,GO:0002864,0.0433102971496507,0.997250098408392,2,4,regulation of acute inflammatory response to antigenic stimulus,BP,ZP3;IL20RB
615,GO:0001784,0.0433976236876185,0.986769973448755,6,27,phosphotyrosine residue binding,MF,SH3BP2;SHC1;PIK3R2;MAPK3;LDLRAP1;CBLC
12195,GO:0048408,0.0435396753167956,0.997227298280341,2,4,epidermal growth factor binding,MF,EGFR;SHC1
16177,GO:0090238,0.0435456604520414,0.997226702412985,2,4,positive regulation of arachidonic acid secretion,BP,NTSR1;MIF
12347,GO:0048754,0.043628293727405,0.977246617383186,16,104,branching morphogenesis of an epithelial tube,BP,CTNNBIP1;PGF;NFATC4;LAMA5;LRP5;PKD2;CELSR1;SPRY2;VEGFA;VANGL2;ETV5;BTRC;CTSZ;WNT2B;PKD1;CTSH
11835,GO:0046847,0.0437212465416375,0.983696505525051,8,41,filopodium assembly,BP,ESPN;ARAP1;ARHGEF4;ZMYND8;TENM2;ITGA6;S1PR2;DMTN
901,GO:0002283,0.0437994642356097,0.969943522675447,43,350,neutrophil activation involved in immune response,BP,GAA;NAPRT;PYGB;CST3;PGM1;GSN;PRSS3;TIMP2;PYGL;CTSB;FUCA1;VAT1;HEXB;GM2A;RAB3D;NBEAL2;TMEM173;RNASET2;DNASE1L1;AP2A2;DPP7;KCNAB2;GLB1;LTA4H;SLC2A3;PFKL;RHOF;PTAFR;BCR;CTSZ;SERPINB6;TOLLIP;CSTB;CD68;ACTR1B;HGSNAT;ABR;CTSD;CTSH;PYCARD;GALNS;MIF;STXBP2
633,GO:0001823,0.043837532635851,0.980508813512726,11,64,mesonephros development,BP,CTNNBIP1;PGF;LAMA5;PKD2;VEGFA;HES1;FGFR1;WNT2B;SDC1;PKD1;KIF26B
12856,GO:0051219,0.0439177600574512,0.980467235567771,11,64,phosphoprotein binding,MF,SH3BP2;SHC1;PLAT;PIK3R2;PKD2;LRP11;MAPK3;LDLRAP1;BTRC;PIN1;CBLC
11178,GO:0045321,0.0440161767498958,0.966149862821977,87,763,leukocyte activation,BP,ERCC1;GAA;NAPRT;PYGB;CST3;PGM1;GSN;NDRG1;PRSS3;ZFP36L1;IGF2;TIMP2;EGR1;PKN1;CMTM7;PYGL;CTSB;HDAC5;ZP3;ZFPM1;ERBB2;FUCA1;VAT1;KIF13B;HEXB;VAMP2;CD320;GM2A;ZMIZ1;RAB3D;IL20RB;NBEAL2;TMEM173;PRNP;EFNB3;RNASET2;STAT6;MYO18A;BCL6;IGFBP2;CD81;FZD8;DNASE1L1;LRRC8A;AP2A2;CEBPB;DPP7;KCNAB2;GLB1;LTA4H;HES1;SLC2A3;TNFRSF14;ADA;PAG1;PFKL;RHOF;PI4K2A;LDLR;SOX13;RAG1;GAS6;PTAFR;VAV3;BCR;PRKCZ;INPP5D;ICOSLG;CTSZ;SERPINB6;TOLLIP;CSTB;ADGRE2;CD68;ACTR1B;ADORA2B;HGSNAT;ABR;AKT1;CTSD;CTSH;PYCARD;JAK3;GALNS;POLM;MIF;STXBP2
18452,GO:1903580,0.0440222591139582,0.988397812118305,5,21,positive regulation of ATP metabolic process,BP,INSR;PFKFB2;MLXIPL;PINK1;TAZ
15188,GO:0071363,0.0440414183700402,0.968375657703028,55,453,cellular response to growth factor stimulus,BP,HTRA1;FOS;DUSP6;LTBP4;XDH;NOS1;LTBP1;ZFP36L1;POSTN;LTBP2;EGFR;EGR1;SHC1;CORO1B;HYAL1;ERBB2;SPRY4;CDKN1C;FUZ;ADAMTS7;PDCD4;WNT7A;INSR;ID1;SPRY2;FAM20C;VEGFA;ACVR2B;MAPK3;HES1;FURIN;NRP2;ZFP36;FGFR3;CYFIP2;ITGB5;FGFR4;EHD4;EEF2K;GAS6;VASN;NEO1;PRKCZ;TWF2;GPC1;FGFR1;PIN1;TMEM204;GRB10;FGFBP1;AKT1;EPN2;MAP2K3;ERN1;SULF2
12879,GO:0051251,0.0440527669997697,0.974370701663045,22,157,positive regulation of lymphocyte activation,BP,IGF2;ZP3;CD320;ZMIZ1;EFNB3;STAT6;BCL6;IGFBP2;CD81;HES1;TNFRSF14;ADA;RAG1;GAS6;VAV3;PRKCZ;INPP5D;ICOSLG;AKT1;PYCARD;JAK3;MIF
14240,GO:0061333,0.0441411646152532,0.982301769147698,9,49,renal tubule morphogenesis,BP,CTNNBIP1;PGF;LAMA5;PKD2;VEGFA;HES1;WNT2B;PKD1;KIF26B
15576,GO:0072088,0.0441411646152645,0.982301769147699,9,49,nephron epithelium morphogenesis,BP,CTNNBIP1;PGF;LAMA5;PKD2;VEGFA;HES1;WNT2B;PKD1;KIF26B
9191,GO:0035591,0.0442509126672811,0.981223701972679,10,56,signaling adaptor activity,MF,SH3BP2;GRB7;SHC1;PAG1;SH2D2A;MAPK8IP1;LDLRAP1;VAV3;GRB10;SH2B3
4174,GO:0009260,0.0442536501242151,0.973263263478549,25,184,ribonucleotide biosynthetic process,BP,APOE;PGM1;NOS1;NME4;TIMP2;ACOT7;OGDHL;PTHLH;LTB4R2;INSR;UCKL1;PFKFB2;DHTKD1;GALK1;ADCY6;MLXIPL;PFKL;HK1;PPARA;GUK1;GUCA1B;ADORA2B;PINK1;TAZ;PPCS
14180,GO:0061138,0.0442982021534596,0.975401867318899,19,129,morphogenesis of a branching epithelium,BP,CTNNBIP1;PGF;NFATC4;LAMA5;LRP5;PKD2;CELSR1;SPRY2;VEGFA;VANGL2;ETV5;BTRC;RXRA;FGFR1;CTSZ;PROX1;WNT2B;PKD1;CTSH
8585,GO:0034110,0.0443223911143974,0.988296540845525,5,21,regulation of homotypic cell-cell adhesion,BP,ANK3;CD9;SERPINE2;DMTN;VPS33B
3648,GO:0008138,0.0443602199663178,0.984734668770645,7,35,protein tyrosine/serine/threonine phosphatase activity,MF,DUSP6;DUSP5;SSH1;DUSP7;DUSP23;SBF1;SSH3
4337,GO:0009898,0.0443836306169468,0.97579345084823,18,121,cytoplasmic side of plasma membrane,CC,MYZAP;PTK6;GNAL;S100A6;NTSR1;RASA4;GM2A;SYNGAP1;SNX9;DLG4;SRMS;KCNAB2;MAP2K2;SPTB;LDLRAP1;ESYT2;JAK3;LITAF
16710,GO:0097755,0.0445670037227997,0.9846476918158,7,35,positive regulation of blood vessel diameter,BP,APOE;NOS1;EGFR;BBS2;DOCK4;PTAFR;ADORA2B
5581,GO:0016616,0.0448547397065368,0.978345191731086,13,83,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,H6PD;IDH2;HADH;CRYL1;KDSR;DHRS11;AKR7A2;KCNAB2;PHGDH;MDH2;TSTA3;GRHPR;GPD1L
6662,GO:0030032,0.0448656271648795,0.981956106173055,9,49,lamellipodium assembly,BP,PARVB;ARHGEF4;PLXNB3;RHOD;SSH1;DMTN;VAV3;TWF2;SSH3
8641,GO:0034205,0.0448831149638883,0.988106787040811,5,21,amyloid-beta formation,BP,APOE;ABCA7;PRNP;BIN1;SORL1
13025,GO:0051541,0.0449113290142669,0.997089485590033,2,4,elastin metabolic process,BP,CST3;HBEGF
3235,GO:0006898,0.044949818713255,0.973446887382692,23,165,receptor-mediated endocytosis,BP,APOE;LRP1;LRP3;DNM1;FCHO1;CD9;SNX9;DLG4;ARHGAP27;SCART1;CD81;VEGFA;AP2A2;SSC4D;AMN;PCSK9;LDLR;SNX17;LDLRAP1;LRP10;CLTCL1;ARAP3;SORL1
16877,GO:0098862,0.0449573806616533,0.978318278960404,13,81,cluster of actin-based cell projections,CC,ESPN;SHANK2;RALGDS;BBS2;DOCK4;ITPR3;SCART1;AMN;TWF2;CYBRD1;EPS8L2;HOMER2;MORN4
6031,GO:0019136,0.0449804028155167,0.997082479234375,2,4,deoxynucleoside kinase activity,MF,TK2;DGUOK
7441,GO:0031589,0.045086365395672,0.971387404789682,30,225,cell-substrate adhesion,BP,PARVB;POSTN;SMOC2;LAMA5;THBS3;BCAM;FBLN1;MICALL2;ITGB4;MINK1;RHOD;ID1;EPHA1;ITGA6;BCL6;VEGFA;ARL2;ADAM15;EPHB3;ITGB5;DMTN;MSLN;GAS6;PRKCZ;ADAMTS13;TMEM8B;PPM1F;COL13A1;PKD1;NINJ1
9047,GO:0035296,0.0450892363842977,0.979837474449439,11,65,regulation of tube diameter,BP,APOE;NOS1;EGFR;F2R;BBS2;DOCK4;ADCY6;HTR7;PTAFR;ADORA2B;AKT1
16705,GO:0097746,0.0450892363842977,0.979837474449439,11,65,regulation of blood vessel diameter,BP,APOE;NOS1;EGFR;F2R;BBS2;DOCK4;ADCY6;HTR7;PTAFR;ADORA2B;AKT1
14163,GO:0061097,0.0451707741342786,0.980738601541306,10,57,regulation of protein tyrosine kinase activity,BP,SHC1;PTK6;PRNP;DLG4;GAS6;DLG3;ERBB3;ERCC6;CBLC;EREG
1103,GO:0002692,0.0452500407680161,0.997055068406036,2,4,negative regulation of cellular extravasation,BP,BCR;ABR
5249,GO:0015889,0.0453852984340988,0.99704128205543,2,4,cobalamin transport,BP,CD320;AMN
17677,GO:1901611,0.0454033321433278,0.993307360439756,3,9,phosphatidylglycerol binding,MF,NME4;PITPNC1;PLTP
17585,GO:1901298,0.0455032224957262,0.993286624848248,3,9,regulation of hydrogen peroxide-mediated programmed cell death,BP,ENDOG;TRAP1;PINK1
14608,GO:0070206,0.0455828182918961,0.984219010652684,7,35,protein trimerization,BP,COL6A1;SIGMAR1;ASIC1;HSF4;TRIM4;ATXN10;MIF
11782,GO:0046686,0.0457174171474036,0.982688105257943,8,44,response to cadmium ion,BP,FOS;ERCC1;GSN;EGFR;PRNP;MAPK3;GSS;AKT1
8645,GO:0034219,0.0457336709404073,0.978669302166485,12,72,carbohydrate transmembrane transport,BP,PIK3R2;SLC2A9;INSR;SLC2A3;PRKCZ;CLTCL1;SLC25A27;GRB10;SESN2;RTN2;AKT1;SLC2A1
10714,GO:0044089,0.0457370689695104,0.967984065335626,47,380,positive regulation of cellular component biogenesis,BP,ADGRL1;ESPN;ERCC1;RAPGEF3;GSN;ARAP1;EPHB2;NLGN2;DDB2;ULK1;ARPIN;CORO1B;ZMYND8;MMP1;HYAL1;TENM2;FUZ;NPHP4;WNT7A;SH3PXD2B;ID1;EPHA1;SNX9;VEGFA;ARL2;WIPF1;EPHB3;FHOD1;LRSAM1;CDC42EP5;CROCC;EEF2K;ADGRB2;SLITRK6;TWF2;PROX1;WRAP73;SDC1;WHAMMP3;EPS8L1;PPM1F;EPS8L2;PINK1;ARHGEF10L;SPIRE2;MLST8;PYCARD
5530,GO:0016529,0.045809128338739,0.984123188815659,7,35,sarcoplasmic reticulum,CC,XDH;NOS1;ANK3;ITPR3;RTN2;POMT1;GSTM2
18516,GO:1903750,0.0459003549723799,0.996988562321685,2,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,TRAP1;PINK1
18517,GO:1903751,0.0459003549723799,0.996988562321685,2,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,TRAP1;PINK1
12277,GO:0048638,0.0459448702168441,0.971564029752953,27,199,regulation of developmental growth,BP,DUSP6;APOE;PTPRS;WWC3;SEMA4B;GAMT;BBS2;ULK2;ZP3;PHLDA2;INSR;SH3PXD2B;LPAR3;VEGFA;FGFR3;SEMA3B;SEMA3F;SEMA4C;TWF2;FGFR1;PIN1;PROX1;JARID2;RTN4R;WNT3;AKT1;SEMA4F
11139,GO:0045214,0.0461098613597763,0.987689155405788,5,21,sarcomere organization,BP,OBSCN;OBSL1;TNNT1;MYH3;PROX1
4292,GO:0009749,0.0464737158693964,0.974482151410818,18,124,response to glucose,BP,NR1D1;IGF2;EGR1;LRP5;VAMP2;GLUL;PFKFB2;ACVR2B;ENDOG;MLXIPL;PFKL;PRKACA;GAS6;PCK2;VSNL1;SESN2;ERN1;GIPR
5223,GO:0015849,0.0465206952835579,0.972083122565467,24,173,organic acid transport,BP,APOE;CPT2;SLC43A1;SLC16A5;SLC16A3;SLC13A3;BSG;SLC7A8;PRAF2;VAMP2;NTSR1;SLC6A8;SERINC2;ABCD1;SLC16A13;SLC38A10;PPARA;RXRA;STK39;SLC25A29;AKT1;APBA1;PQLC2;MIF
11887,GO:0046942,0.0465206952835579,0.972083122565467,24,173,carboxylic acid transport,BP,APOE;CPT2;SLC43A1;SLC16A5;SLC16A3;SLC13A3;BSG;SLC7A8;PRAF2;VAMP2;NTSR1;SLC6A8;SERINC2;ABCD1;SLC16A13;SLC38A10;PPARA;RXRA;STK39;SLC25A29;AKT1;APBA1;PQLC2;MIF
16628,GO:0097531,0.046630239472084,0.993051316202441,3,9,mast cell migration,BP,PGF;VEGFA;VEGFB
15796,GO:0072525,0.0466429312695064,0.976035399783513,15,97,pyridine-containing compound biosynthetic process,BP,IDH2;NAPRT;PGM1;NMRK1;OGDHL;INSR;PFKFB2;DHTKD1;GALK1;MLXIPL;NADK;PFKL;HK1;PPARA;PNPO
4063,GO:0009125,0.0467319068566647,0.993029966990163,3,9,nucleoside monophosphate catabolic process,BP,NT5E;DNPH1;NUDT10
16739,GO:0098562,0.0467949942533236,0.973386561173626,20,140,cytoplasmic side of membrane,CC,MYZAP;PTK6;GNAL;S100A6;PKD2;NTSR1;RASA4;GM2A;SYNGAP1;SNX9;DLG4;SRMS;KCNAB2;MAP2K2;SPTB;LDLRAP1;ESYT2;SPPL2B;JAK3;LITAF
12038,GO:0048009,0.046851464885041,0.987435044736651,5,21,insulin-like growth factor receptor signaling pathway,BP,IGFBP2;GIGYF1;IGFBP4;GRB10;AKT1
6571,GO:0022409,0.0468713096088695,0.973338118023507,20,140,positive regulation of cell-cell adhesion,BP,IGF2;ANK3;ZP3;ZMIZ1;ITGA6;EFNB3;BCL6;IGFBP2;HES1;TNFRSF14;ADA;DMTN;RAG1;PTAFR;PRKCZ;ICOSLG;AKT1;PYCARD;JAK3;KIF26B
4494,GO:0010543,0.0469304808854482,0.987407897623883,5,21,regulation of platelet activation,BP,APOE;CD9;SERPINE2;DMTN;VPS33B
15724,GO:0072341,0.0469549751007934,0.980892372191351,9,51,modified amino acid binding,MF,MTHFR;CBS;PLCD1;OSBPL5;GAS6;GSDMC;GSDMA;GSS;GSTM2
9369,GO:0035924,0.0470976280845044,0.98528306269607,6,28,cellular response to vascular endothelial growth factor stimulus,BP,XDH;VEGFA;NRP2;AKT1;MAP2K3;ERN1
11624,GO:0046368,0.0471521813828051,0.996858970694979,2,4,GDP-L-fucose metabolic process,BP,TSTA3;FUK
5595,GO:0016646,0.0471924864839298,0.989782265791545,4,15,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,ALDH4A1;MTHFR;PYCR2;BLVRB
3021,GO:0006575,0.0471993964268085,0.973549707294721,19,134,cellular modified amino acid metabolic process,BP,PRODH;GAMT;ALDH4A1;MTHFR;LPCAT4;OPLAH;CRTAP;GGT1;SLC6A8;HAGH;SERINC2;OSBPL5;CKMT1A;ASS1;GSTT1;GSS;AHCYL2;SLC5A5;GSTM2
10880,GO:0044444,0.0472088814602848,0.958712096232461,710,7173,cytoplasmic part,CC,TNIP1;HTRA1;FOS;DUSP6;H6PD;LMF1;CEMIP;APOE;TYSND1;CTNNBIP1;TSPAN1;PPL;IDH2;PTPRS;ERCC1;WWC3;FLNC;FAM110C;NT5E;GAA;SYTL1;CLIP2;NAPRT;BTBD2;PYGB;CST3;SHANK2;RAPGEF3;PGM1;CYP27B1;GSN;CLCA2;XDH;PRDX5;NDRG1;PGLS;PCBP4;PRSS3;PRODH;NOS1;LTBP1;MARCH9;PARVB;ARAP1;ZFP36L1;COL6A1;TCTN1;POSTN;GRB7;CRAT;ALOX15B;ARRDC1;EPN3;FAM210B;POLD4;SCN8A;RBCK1;EPHB2;EPAS1;OBSCN;CPT2;RHPN1;MYZAP;IGF2;NFATC4;NME4;MST1R;LRP1;GAMT;MAPK13;APPL2;RALGDS;ST6GALNAC2;RAB11FIP4;OBSL1;EGFR;TIMP2;H1F0;ALDH4A1;B3GAT3;HADH;CRYL1;SUGCT;ACSF2;REEP6;FBXO2;ACOT7;FKBP9;HS1BP3;PPP1R14A;ISYNA1;UROS;FHL1;JOSD2;LOXL1;SERPING1;MTHFR;KDSR;ULK1;RHBDF1;PKN1;CRTC1;PYGL;ARHGEF4;TRIM65;DOPEY2;SYT8;NAGLU;SHC1;F2R;PTK6;BPHL;ABCA7;GALE;BBS2;ACTA2;S100A4;CTSB;LPCAT4;DNAH1;RNF208;SHC2;PITPNC1;CORO1B;CXXC5;ULK2;DGKA;DHRS1;MALL;THBS3;D2HGDH;TBC1D14;PACS2;GRAMD4;MXI1;CERS4;PLAT;ABCG1;RIN1;ANK3;NOL4L;PIK3R2;OPLAH;S100A6;PEG3;NEK9;HDAC5;THRA;ARHGAP23;PLD3;DOCK4;CRTAP;RPS6KA2;NMRK1;NISCH;LRP5;DBNDD1;HYAL1;TUBG2;ANO8;MARK4;TENM2;B4GALNT4;ERBB2;EXOC2;BRSK1;MICALL2;BSG;CTSF;OGDHL;PKD2;CBS;TMEM129;FUCA1;TST;CPT1C;EDEM1;ABTB1;ITPR3;PRAF2;VAT1;DNM1;SPRY4;FCHO1;MPRIP;PTHLH;RIMS3;MSRB2;IFT140;CUL9;CD9;KIF13B;XPC;ANGEL1;NINL;SIGMAR1;HEXB;SERPINE2;VPS11;VAMP2;GALNT12;RNF135;NPHP4;NTSR1;CD320;MINK1;RALGAPA2;ATP2B4;SNN;TMOD2;TFDP2;PHF7;CSNK1E;ACP5;RASA4;PLCD1;TRAPPC9;AGAP1;ZFYVE21;DIRC2;ADAMTS7;ENKD1;PDCD4;DOCK6;TMEM134;GM2A;ACAP3;TNFRSF25;GLUL;PRR7;RHOD;USP20;PEX10;ARMCX2;ASIC1;LAMB2;SPATA18;WNT7A;INSR;RAB3D;FBXW8;ID1;AKR7A2;MVD;LGALS9C;MZT2A;B4GAT1;NDUFS8;RABGGTA;ADARB1;TXNRD3;SYNGAP1;NBEAL2;HAGH;FBXO27;DNPH1;TMEM173;PRNP;DHX32;SRD5A3;OXLD1;ATP7B;RNASET2;FBXL8;SNX33;FBXO41;SPRY2;HINT2;BLMH;ECM1;CEP250;ATG16L2;SNX9;STAT6;DLG4;ABCD1;MARCH2;REEP2;PLCD3;STRADB;TALDO1;WWTR1;RAB25;FAM20C;MYO18A;ARHGAP27;CERCAM;MZT2B;DNAJB5;PLEKHH2;C1ORF210;BCL6;ANKZF1;UCKL1;PFKFB2;CHMP1B;IGFBP2;SEC14L2;MVB12B;BNIP3;SRMS;FZD8;VEGFA;ENTPD6;DNASE1L1;HOOK2;ARL2;VANGL2;FBXW4;AP2A2;RHBDF2;DPP7;GPRC5C;SHANK3;ADAM15;CALCOCO1;ZDHHC1;ENDOG;MAPK3;PDZD2;FBXL16;PLEKHG5;TUB;KCNAB2;CARD19;AMN;GLB1;CAPNS2;DHTKD1;C19ORF33;RAB40B;TNNT1;DVL1;ENTPD2;GALK1;MTA1;LHPP;FYCO1;WIPF1;GPSM1;ADCY6;LTA4H;WIPI2;PKN3;PHGDH;ST3GAL3;SLC16A13;EPHB3;FHOD1;PC;ACAD10;SSH1;COMTD1;FURIN;MLXIPL;NAGS;FBF1;MBOAT7;SLC48A1;SAMD3;CUL7;MEFV;ARHGAP22;SLC2A3;TRIM4;NADK;PLEKHG2;ABCA2;TK2;LRSAM1;LY6K;ADA;FKBP10;CDC42EP5;TRIM45;MCTP1;OSBPL5;PYCR2;PIDD1;RETSAT;SH2D2A;ACY1;CKMT1A;PFKL;SLIT3;PCSK9;TMEM9;ZFP36;RHOF;BTBD11;HLCS;CYHR1;FGFR3;PRKACA;F12;PITPNM1;LRRK1;NUDT10;DGUOK;CYFIP2;SLC38A10;HBEGF;SLC25A37;ITGB5;RAB3B;MAP2K2;PI4K2A;FGFR4;SPTB;FBXW5;MXRA8;SLC37A2;STX10;DMTN;PMVK;BBS1;MYH3;XYLT2;VGF;TNFRSF1A;SEZ6L2;EHD4;MAPK8IP1;SEMA3B;LDLR;PTOV1;LYPLAL1;CYP3A5;ACOT11;SNX17;ABHD17C;TRPV4;MPG;RHOBTB2;PIGZ;IFNGR2;EIF4EBP3;CROCC;CCDC92;DUSP7;PHLDA1;LRRC45;EEF2K;MSLN;LDLRAP1;TM7SF2;ELK3;AHNAK2;DGKQ;PEX7;SEMA4C;MVB12A;HK1;NMRAL1;MIB2;FBXO17;CHST6;SDHAF4;PADI3;GAS6;BTRC;MEX3A;LLGL1;ZNF217;HMGCL;TKFC;GUK1;TMEM187;WNT7B;BLVRB;GIT1;COMT;TTC7B;SUFU;PTAFR;RFNG;ANKRD13D;IMPA2;PAN2;REEP4;ATG2A;PCK2;PCSK1;VAV3;VASN;BCR;TMEM175;NEO1;IGFBP4;SDHA;GSDMC;MUC19;TBC1D16;USP21;RNF123;WDR60;PRKCZ;ADAMTS13;ZDHHC24;CLTCL1;MDH2;CAPG;INPP5D;ETFB;ABCD4;SPATA7;TWF2;SH3GLB2;KLHDC8B;TPP1;PDK2;GPC1;TMX4;ICOSLG;SRSF5;RFXANK;SMOX;CEP68;MAPKAPK3;NDE1;AGO4;RAD23A;ARAP3;FGFR1;CTSZ;CAMKK1;SPSB3;PIN1;MAN1B1;PNPLA4;PHYH;CMBL;GTPBP1;C21ORF2;ASAP2;DLG3;ESYT2;BIN1;VSNL1;UNC119B;YIPF3;TMEM8B;SERPINB6;PPP1R13L;ASS1;SH3D19;WDR83;GLRX;CES2;SLC25A27;GRB10;BFSP1;JARID2;SYNC;CAPN2;SESN2;NDUFA4L2;TOLLIP;TSTA3;WRAP73;CSTB;SNPH;MAN2B2;PNRC1;DUSP23;MACROD1;GAL3ST4;SMDT1;PITPNM3;CYBRD1;MADD;LMLN;RTN4R;EPB41L3;PIGV;SLC9A7;TIMP1;CD68;SDC1;WHAMMP3;GRHPR;SH2B3;ACTR1B;APOBEC3C;RTN2;EPS8L1;PIGQ;WNT3;GSTT1;PPM1F;SBF1;SORL1;STK39;COL13A1;VEGFB;ACVR1B;TBC1D17;GSDMA;GSS;AHCYL2;ALS2CL;TSNARE1;TPCN1;HGSNAT;SLC25A29;ABR;CYP2S1;AKT1;CTSD;TRAP1;TMBIM4;NLRX1;SEPT8;ADAM19;TP53INP1;NDRG2;TUT1;VPS33B;ACP6;GPD1L;EPS8L2;TDRKH;SUN1;NAGA;SPPL2B;IL17RD;UQCR11;RPL39L;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;MPLKIP;ARHGEF10L;HOMER2;LGALS9B;SYNE3;GOLGA2P5;SPIRE2;CCDC106;EIF4G3;CTSH;EHBP1L1;ABHD14B;P3H4;MLST8;AGPAT4;RILPL1;NRSN1;RSAD1;ATXN10;EPN2;RNF187;PYCARD;MAP2K3;PNPO;RHBG;POMT1;TRERF1;PCSK1N;DDN;AS3MT;NDUFV3;ERN1;RANBP9;APOBEC3F;PRIMPOL;ACADS;FBXL20;GCAT;MOCS1;ARHGEF19;SIRT3;C12ORF66;SLC2A1;MLYCD;TAZ;JAK3;BCKDHA;LITAF;APBA1;FUK;ING4;EIF4E3;GALNS;PBXIP1;FAM162A;PPCS;FCHSD1;GSTM2;PODXL2;PQLC2;SFI1;KRT15;ADAMTSL4;TTLL11;TMED4;SEMA4F;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;STXBP2;LZTS2
4340,GO:0009914,0.0472777587245973,0.971569421947653,24,175,hormone transport,BP,LTBP4;RAPGEF3;NR1D1;SLCO4A1;EGFR;HADH;NLGN2;LRP5;ITPR3;GLUL;PFKFB2;ARL2;ACVR2B;RASL10B;PFKL;VGF;TRPV4;PCK2;TM7SF3;FGFR1;VSNL1;SIRT3;SLC2A1;GIPR
6882,GO:0030426,0.0472906291997792,0.97399613842674,18,122,growth cone,CC,ADGRL1;SHANK2;TIMP2;TENM2;SIGMAR1;TMOD2;DVL1;SSH1;MAPK8IP1;TRPV4;TWF2;CTSZ;DLG3;RTN4R;NDRG2;PINK1;NRSN1;ORAI2
5838,GO:0017144,0.0473469104679143,0.965233718101945,61,528,drug metabolic process,BP,IDH2;NT5E;PGM1;CYP27B1;PRDX5;PRSS3;NOS1;GPX3;GAMT;EGFR;MTHFR;EGR1;OGDHL;PKD2;CBS;CD320;ATP2B4;GGT1;SLC6A8;ACP5;INSR;AKR7A2;NDUFS8;ABCD1;FAM20C;PFKFB2;AMN;DHTKD1;GALK1;PC;MLXIPL;NADK;ADA;PYCR2;CKMT1A;PFKL;HLCS;MYH3;CYP3A5;DGKQ;HK1;PPARA;HMGCL;GUK1;COMT;PCK2;SDHA;MDH2;ABCD4;SMOX;ASS1;AHCYL2;CYP2S1;AKT1;UQCR11;PINK1;CTSH;PNPO;NDUFV3;GCAT;TAZ
2398,GO:0005548,0.0474313936772421,0.981977267396478,8,42,phospholipid transporter activity,MF,ABCA7;PITPNC1;ABCG1;PLTP;OSBPL5;PITPNM1;PITPNM3;ANO9
9671,GO:0038066,0.04748953817819,0.985130124067757,6,28,p38MAPK cascade,BP,XDH;ZFP36L1;MINK1;VEGFA;ZFP36;MAP2K3
6451,GO:0021782,0.0476289539214746,0.978485161945319,11,66,glial cell development,BP,GSN;NDRG1;LRP1;EGFR;CD9;LAMB2;MXRA8;HDAC11;LDLR;AHNAK2;AKT1
2211,GO:0005109,0.0477039556977283,0.987141428841187,5,21,frizzled binding,MF,WNT7A;DVL1;WNT7B;WNT2B;WNT3
4757,GO:0010951,0.0478602278566484,0.973118628947812,19,136,negative regulation of endopeptidase activity,BP,CST3;PRDX5;TIMP2;SERPING1;SERPINE2;PAPLN;VEGFA;TNFRSF6B;FURIN;RAG1;GAS6;C5;BIN1;SERPINB6;CSTB;TIMP1;SORL1;AKT1;PCSK1N
16995,GO:0099175,0.0479688442184256,0.983203014511654,7,35,regulation of postsynapse organization,BP,APOE;ZMYND8;PRNP;SHANK3;SSH1;EEF2K;SHISA6
19994,GO:2000644,0.0481121625720421,0.992738142066492,3,9,regulation of receptor catabolic process,BP,APOE;FURIN;PCSK9
1023,GO:0002524,0.0481333951386487,0.996755957758757,2,4,hypersensitivity,BP,ZP3;IL20RB
1901,GO:0004591,0.0482126888958829,0.996747578265265,2,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,OGDHL;DHTKD1
10070,GO:0042588,0.0482973502393022,0.99269870847486,3,9,zymogen granule,CC,VAMP2;RAB3D;STXBP2
8122,GO:0032835,0.0483003163396852,0.983060879236538,7,35,glomerulus development,BP,EGR1;ACTA2;LAMB2;WWTR1;VANGL2;HES1;SULF2
12589,GO:0050796,0.0483904542748218,0.974379893271081,16,107,regulation of insulin secretion,BP,RAPGEF3;NR1D1;HADH;NLGN2;LRP5;ITPR3;GLUL;PFKFB2;ARL2;PFKL;PCK2;TM7SF3;VSNL1;SIRT3;SLC2A1;GIPR
16646,GO:0097581,0.0484415643667242,0.978078132617878,11,65,lamellipodium organization,BP,PARVB;ARPIN;ARHGEF4;CORO1B;PLXNB3;RHOD;SSH1;DMTN;VAV3;TWF2;SSH3
10153,GO:0042758,0.0484912680026779,0.996718074169191,2,4,long-chain fatty acid catabolic process,BP,ABCD1;AIG1
17161,GO:0106003,0.0485711273230763,0.992640290245403,3,9,amyloid-beta complex,CC,APOE;INSR;PRNP
9023,GO:0035255,0.0485812627903522,0.986837596273028,5,21,ionotropic glutamate receptor binding,MF,SHANK2;DLG4;SHANK3;DLG3;SHISA6
6786,GO:0030239,0.0485871436820295,0.9846999907955,6,28,myofibril assembly,BP,OBSCN;OBSL1;TMOD2;TNNT1;MYH3;PROX1
2974,GO:0006525,0.0486193110412853,0.989369428796464,4,15,arginine metabolic process,BP,NOS1;ATP2B4;NAGS;ASS1
10355,GO:0043194,0.0486788902974035,0.992617256537457,3,9,axon initial segment,CC,SCN8A;ANK3;BIN1
16844,GO:0098802,0.0486883343336193,0.97550333614787,14,89,plasma membrane receptor complex,CC,SHANK2;CPT1C;ITGB4;INSR;ITGA6;DLG4;SHANK3;OLFM2;IL6R;ITGB5;DLG3;TOLLIP;ACVR1B;SHISA6
3114,GO:0006701,0.0487824294998306,0.996687129795905,2,4,progesterone biosynthetic process,BP,EGR1;DGKQ
15563,GO:0072070,0.0488253054614391,0.99258592556977,3,9,loop of Henle development,BP,PKD2;WNT7B;PKD1
11599,GO:0046324,0.0488263987435057,0.981336700500358,8,42,regulation of glucose import,BP,PIK3R2;INSR;PRKCZ;CLTCL1;SLC25A27;GRB10;RTN2;AKT1
6669,GO:0030042,0.048827707691832,0.982834242439019,7,35,actin filament depolymerization,BP,GSN;TMOD2;PLEKHH2;SPTB;DMTN;CAPG;TWF2
4625,GO:0010757,0.0488665626070442,0.996678167738903,2,4,negative regulation of plasminogen activation,BP,SERPINE2;CTSZ
2662,GO:0006021,0.0488760617403204,0.996677155292716,2,4,inositol biosynthetic process,BP,ISYNA1;IMPA2
6881,GO:0030425,0.0489630739358083,0.965832802148119,45,363,dendrite,CC,APOE;SHANK2;NOS1;NR1D1;EPHB2;LRP1;FBXO2;CRTC1;IGSF9;ZMYND8;KCNC4;ANK3;TENM2;CPT1C;DNM1;KIF13B;NTSR1;MINK1;PRR7;INSR;SYNGAP1;PRNP;DLG4;BNIP3;SHANK3;DVL1;EPHB3;ADA;HTR7;PI4K2A;MAPK8IP1;ABHD17C;EEF2K;COMT;DLG3;CAPN2;RTN4R;ZNF385A;HOMER2;RGS14;ATXN10;DDN;APBA1;SHISA6;RGS12
16582,GO:0097447,0.0489630739358083,0.965832802148119,45,363,dendritic tree,CC,APOE;SHANK2;NOS1;NR1D1;EPHB2;LRP1;FBXO2;CRTC1;IGSF9;ZMYND8;KCNC4;ANK3;TENM2;CPT1C;DNM1;KIF13B;NTSR1;MINK1;PRR7;INSR;SYNGAP1;PRNP;DLG4;BNIP3;SHANK3;DVL1;EPHB3;ADA;HTR7;PI4K2A;MAPK8IP1;ABHD17C;EEF2K;COMT;DLG3;CAPN2;RTN4R;ZNF385A;HOMER2;RGS14;ATXN10;DDN;APBA1;SHISA6;RGS12
10855,GO:0044406,0.04896318044708,0.996667864468905,2,4,adhesion of symbiont to host,BP,CD81;GAS6
4576,GO:0010676,0.0490714535554629,0.982729294158805,7,35,positive regulation of cellular carbohydrate metabolic process,BP,IGF2;NTSR1;INSR;PFKFB2;PPARA;PTAFR;AKT1
16126,GO:0090170,0.0491290250166509,0.996650150731956,2,4,regulation of Golgi inheritance,BP,MAPK3;MAP2K2
9254,GO:0035694,0.0491492755328659,0.996647985351804,2,4,mitochondrial protein catabolic process,BP,SPATA18;BNIP3
18501,GO:1903715,0.0491492755328866,0.996647985351805,2,4,regulation of aerobic respiration,BP,BNIP3;TRPV4
1216,GO:0002887,0.0492090020416552,0.996641595730641,2,4,negative regulation of myeloid leukocyte mediated immunity,BP,BCR;ABR
15544,GO:0072028,0.0494630043811898,0.979703449993464,9,50,nephron morphogenesis,BP,CTNNBIP1;PGF;LAMA5;PKD2;VEGFA;HES1;WNT2B;PKD1;KIF26B
1939,GO:0004645,0.0496170103851562,0.996597823216014,2,4,phosphorylase activity,MF,PYGB;PYGL
11702,GO:0046530,0.0497448344980047,0.984243459864569,6,28,photoreceptor cell differentiation,BP,SDK2;NAGLU;IFT140;NPHP4;VEGFA;CDHR1
2121,GO:0004920,0.04978236345887,0.996580022434448,2,4,interleukin-10 receptor activity,MF,IL20RB;IFNGR2
4829,GO:0014045,0.0497866736768241,0.996579557954774,2,4,establishment of endothelial blood-brain barrier,BP,WNT7A;WNT7B
6552,GO:0022009,0.0497866736768241,0.996579557954774,2,4,central nervous system vasculogenesis,BP,WNT7A;WNT7B
6411,GO:0021684,0.0497866736768242,0.996579557954774,2,4,cerebellar granular layer formation,BP,WNT7A;PROX1
6426,GO:0021707,0.0497866736768242,0.996579557954774,2,4,cerebellar granule cell differentiation,BP,WNT7A;PROX1
3138,GO:0006741,0.0498541524096286,0.996572283161736,2,4,NADP biosynthetic process,BP,IDH2;NADK
16486,GO:0097223,0.0498688399307438,0.974792838831469,14,91,sperm part,CC,LOXL1;SYT8;DNAH1;BSG;HEXB;ATP2B4;ADAM15;LY6K;PRKACA;HK1;SUN1;GAS8;MAFIP;POMT1
5705,GO:0016849,0.0498848518813605,0.992357979507923,3,9,phosphorus-oxygen lyase activity,MF,ADCY6;TKFC;MOCS1
3104,GO:0006689,0.0499432856369187,0.996562664841326,2,4,ganglioside catabolic process,BP,HEXB;GM2A
8702,GO:0034364,0.0499853739412561,0.992098708328736,3,10,high-density lipoprotein particle,CC,APOE;PLTP;LCAT
12746,GO:0051047,0.0499980810229322,0.967945527671837,30,230,positive regulation of secretion,BP,POSTN;ALOX15B;EGFR;NLGN2;F2R;ZP3;NTSR1;GLUL;RAB3D;MYO18A;PFKFB2;MAPK3;RASL10B;TRPV4;HK1;PTAFR;PCK2;PRKCZ;TM7SF3;FGFR1;C5;VSNL1;SDC1;ADORA2B;PINK1;PYCARD;KCNN4;SIRT3;GIPR;MIF
12146,GO:0048289,0.0500316278282491,0.996553121794707,2,4,isotype switching to IgE isotypes,BP,STAT6;BCL6
12149,GO:0048293,0.0500316278282491,0.996553121794707,2,4,regulation of isotype switching to IgE isotypes,BP,STAT6;BCL6
13063,GO:0051599,0.0500356321734686,0.996552688992886,2,4,response to hydrostatic pressure,BP,PKD2;ATP2B4
18153,GO:1902949,0.0500453799087376,0.996551635341783,2,4,positive regulation of tau-protein kinase activity,BP,EGR1;NAB2
14044,GO:0060856,0.0500608358188866,0.992319912932677,3,9,establishment of blood-brain barrier,BP,WNT7A;MXRA8;WNT7B
18554,GO:1903826,0.0501763070908798,0.99653747133694,2,4,arginine transmembrane transport,BP,SLC25A29;PQLC2
19606,GO:1990822,0.0501763070908798,0.99653747133694,2,4,basic amino acid transmembrane transport,BP,SLC25A29;PQLC2
4699,GO:0010871,0.050182751515325,0.996536773595362,2,4,negative regulation of receptor biosynthetic process,BP,NR1D1;PPARA
2330,GO:0005355,0.0502601495311683,0.992276729334754,3,9,glucose transmembrane transporter activity,MF,SLC2A9;SLC2A3;SLC2A1
8817,GO:0034618,0.0502943282265406,0.996524684662513,2,4,arginine binding,MF,NOS1;NAGS
16428,GO:0097119,0.0503152545279706,0.996522415593139,2,4,postsynaptic density protein 95 clustering,BP,NLGN2;ZMYND8
9396,GO:0035977,0.0503190741183132,0.996522001368714,2,4,protein deglycosylation involved in glycoprotein catabolic process,BP,EDEM1;MAN1B1
16591,GO:0097466,0.0503190741183132,0.996522001368714,2,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,EDEM1;MAN1B1
18789,GO:1904382,0.0503190741183132,0.996522001368714,2,4,mannose trimming involved in glycoprotein ERAD pathway,BP,EDEM1;MAN1B1
18873,GO:1904587,0.0503190741183132,0.996522001368714,2,4,response to glycoprotein,BP,EDEM1;MAN1B1
18431,GO:1903546,0.0503329774397311,0.996520493432304,2,4,protein localization to photoreceptor outer segment,BP,TUB;SPATA7
19860,GO:2000378,0.0503383951217786,0.982131664784648,7,36,negative regulation of reactive oxygen species metabolic process,BP,ATP2B4;ACP5;BNIP3;BCR;TRAP1;PINK1;SIRT3
15341,GO:0071608,0.0504394488730558,0.996508937452936,2,4,macrophage inflammatory protein-1 alpha production,BP,MEFV;TRPV4
15364,GO:0071640,0.0504394488730558,0.996508937452936,2,4,regulation of macrophage inflammatory protein 1 alpha production,BP,MEFV;TRPV4
8389,GO:0033344,0.0504478743530732,0.986091482251316,5,22,cholesterol efflux,BP,APOE;LRP1;ABCA7;ABCG1;PLTP
4196,GO:0009313,0.0504706806119513,0.992231034037767,3,9,oligosaccharide catabolic process,BP,HEXB;GM2A;MAN2B2
19812,GO:2000310,0.0506252658875856,0.992197428541352,3,9,regulation of NMDA receptor activity,BP,EPHB2;DLG4;PINK1
2388,GO:0005536,0.0506852480549112,0.99218437684357,3,9,glucose binding,MF,PYGL;SLC2A3;HK1
3706,GO:0008233,0.0507135571065856,0.964363341411306,46,377,peptidase activity,MF,HTRA1;TYSND1;RNPEPL1;CLCA2;PRSS3;MMP28;JOSD2;RHBDF1;NPEPL1;PRSS8;CTSB;PLAT;MMP1;CTSF;THSD4;GGT1;ADAMTS7;USP20;PAPLN;BLMH;ANKZF1;RHBDF2;DPP7;ADAM15;CAPNS2;LTA4H;FURIN;ACY1;PCSK9;F12;RHBDL1;PCSK1;USP21;ADAMTS13;TPP1;CTSZ;CAPN2;TMPRSS11D;LMLN;CTSD;ADAM19;SPPL2B;LONP2;CTSH;PYCARD;ADAMTSL4
6144,GO:0019470,0.0507164643166533,0.996478803201765,2,4,4-hydroxyproline catabolic process,BP,PRODH;ALDH4A1
2285,GO:0005248,0.0507192044245844,0.992176985180715,3,9,voltage-gated sodium channel activity,MF,SCN8A;PKD2;SCN4B
16937,GO:0098976,0.0507291339108301,0.996477422628537,2,4,excitatory chemical synaptic transmission,BP,SSH1;SHISA6
8346,GO:0033239,0.0507997045557854,0.996469728965294,2,4,negative regulation of cellular amine metabolic process,BP,ATP2B4;COMT
12095,GO:0048170,0.0508050193331021,0.996469149286231,2,4,positive regulation of long-term neuronal synaptic plasticity,BP,EPHB2;SHANK3
13924,GO:0060633,0.0508865560051291,0.996460251606608,2,4,negative regulation of transcription initiation from RNA polymerase II promoter,BP,CTNNBIP1;THRA
19725,GO:2000143,0.0508865560051291,0.996460251606608,2,4,negative regulation of DNA-templated transcription, initiation,BP,CTNNBIP1;THRA
16604,GO:0097490,0.0509083961313717,0.99645786686101,2,4,sympathetic neuron projection extension,BP,NRP2;SEMA3F
16605,GO:0097491,0.0509083961313717,0.99645786686101,2,4,sympathetic neuron projection guidance,BP,NRP2;SEMA3F
18644,GO:1904016,0.0509151099166684,0.996457133653342,2,4,response to Thyroglobulin triiodothyronine,BP,GLB1;SLC2A1
17311,GO:1900019,0.0509252742341945,0.996456023505806,2,4,regulation of protein kinase C activity,BP,CEMIP;EGFR
17312,GO:1900020,0.0509252742341945,0.996456023505806,2,4,positive regulation of protein kinase C activity,BP,CEMIP;EGFR
17734,GO:1901727,0.0509359747845301,0.996454854648093,2,4,positive regulation of histone deacetylase activity,BP,VEGFA;PINK1
1645,GO:0004095,0.0509374564095536,0.996454692793584,2,4,carnitine O-palmitoyltransferase activity,MF,CPT2;CPT1C
5472,GO:0016416,0.0509374564095536,0.996454692793584,2,4,O-palmitoyltransferase activity,MF,CPT2;CPT1C
6333,GO:0021516,0.0509380399927481,0.996454629041488,2,4,dorsal spinal cord development,BP,MDGA1;PROX1
19528,GO:1990535,0.050938464016984,0.996454582719724,2,4,neuron projection maintenance,BP,INSR;PRNP
6163,GO:0019534,0.0509389320658264,0.996454531588317,2,4,toxin transmembrane transporter activity,MF,ABCG1;SLC7A8
15984,GO:0086023,0.0509389320658267,0.996454531588316,2,4,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1;ATP2B4
12078,GO:0048104,0.0509389320658268,0.996454531588316,2,4,establishment of body hair or bristle planar orientation,BP,CELSR1;VANGL2
12079,GO:0048105,0.0509389320658268,0.996454531588316,2,4,establishment of body hair planar orientation,BP,CELSR1;VANGL2
13538,GO:0060029,0.0509389320658477,0.996454531588317,2,4,convergent extension involved in organogenesis,BP,VANGL2;DVL1
15918,GO:0075044,0.0509389320658482,0.996454531588316,2,4,autophagy of host cells involved in interaction with symbiont,BP,ULK1;ULK2
15919,GO:0075071,0.0509389320658482,0.996454531588316,2,4,autophagy involved in symbiotic interaction,BP,ULK1;ULK2
931,GO:0002329,0.0509389320658483,0.996454531588316,2,4,pre-B cell differentiation,BP,LRRC8A;RAG1
3599,GO:0008046,0.0509389320658483,0.996454531588316,2,4,axon guidance receptor activity,MF,EPHB2;EPHB3
11381,GO:0045794,0.0509389320658483,0.996454531588316,2,4,negative regulation of cell volume,BP,SHANK3;KCNMA1
18079,GO:1902744,0.0509389320658695,0.996454531588317,2,4,negative regulation of lamellipodium organization,BP,ARPIN;PLXNB3
10289,GO:0043083,0.0509389320658696,0.996454531588317,2,4,synaptic cleft,CC,LAMA5;LAMB2
12975,GO:0051425,0.0509389320658697,0.996454531588316,2,4,PTB domain binding,MF,INSR;INPP5D
6757,GO:0030202,0.0509389320658697,0.996454531588316,2,4,heparin metabolic process,BP,XYLT2;NDST2
6764,GO:0030210,0.0509389320658697,0.996454531588316,2,4,heparin biosynthetic process,BP,XYLT2;NDST2
7752,GO:0032280,0.0509389320658699,0.996454531588316,2,4,symmetric synapse,CC,NLGN2;NTSR1
7195,GO:0031098,0.0510105558961466,0.967243827547069,30,228,stress-activated protein kinase signaling cascade,BP,XDH;ZFP36L1;MAPK13;EGFR;PKN1;PAK6;MINK1;PDCD4;WNT7A;STRADB;FZD8;VEGFA;VANGL2;MAPK3;CDC42EP5;ZFP36;MAP2K2;MAPK8IP1;TRPV4;SEMA4C;BTRC;WNT7B;STK39;ADORA2B;AKT1;ERCC6;PINK1;PYCARD;MAP2K3;ERN1
8357,GO:0033268,0.0510130779609222,0.992112924067024,3,9,node of Ranvier,CC,SCN8A;ANK3;BIN1
3453,GO:0007274,0.051018688316106,0.992111699498311,3,9,neuromuscular synaptic transmission,BP,ADARB1;ETV5;FCHSD1
16463,GO:0097186,0.05102607220585,0.988663312694969,4,15,amelogenesis,BP,ITGB4;ITGA6;FAM20C;PPARA
11343,GO:0045725,0.0510757934684386,0.992099231839634,3,9,positive regulation of glycogen biosynthetic process,BP,IGF2;INSR;AKT1
3556,GO:0007605,0.0512103792914466,0.976562156211544,11,67,sensory perception of sound,BP,CEMIP;ESPN;DNM1;HEXB;SPRY2;TUB;SLITRK6;FGFR1;SERPINB6;EPS8L2;HOMER2
10619,GO:0043647,0.0512498308288575,0.978827405907844,9,50,inositol phosphate metabolic process,BP,ISYNA1;NTSR1;PLCD1;PLCD3;NUDT10;PLCH2;PTAFR;IMPA2;INPP5D
13846,GO:0060491,0.0512695642225343,0.971503708244926,18,124,regulation of cell projection assembly,BP,ESPN;FAM110C;EVI5L;ARAP1;ZMYND8;TENM2;PLXNB3;IFT140;FUZ;SSH1;CDC42EP5;DMTN;CROCC;TWF2;WRAP73;EPS8L1;EPS8L2;SSH3
19387,GO:1905954,0.0513105476375922,0.980105959366574,8,44,positive regulation of lipid localization,BP,APOE;LRP1;ABCA7;ABCG1;PLTP;NTSR1;LDLRAP1;MIF
13011,GO:0051493,0.051318030729632,0.963629657384218,48,394,regulation of cytoskeleton organization,BP,ESPN;RAPGEF3;GSN;ARAP1;LRP1;ARPIN;CORO1B;TMOD2;RHOD;SH3PXD2B;ID1;CELSR1;EPHA1;CEP250;PLEKHH2;PLXNB1;CHMP1B;ARL2;VANGL2;SHANK3;MAPK3;WIPF1;FHOD1;SSH1;PLEKHG2;CDC42EP5;RHOF;SPTB;FBXW5;DMTN;TRPV4;RHOBTB2;CAPG;TWF2;PROX1;CAPN2;WHAMMP3;EPS8L1;PPM1F;EPS8L2;SSH3;PKD1;ARHGEF10L;SPIRE2;MLST8;PYCARD;ARHGEF19;FCHSD1
7964,GO:0032590,0.0513210065165199,0.988575952810334,4,15,dendrite membrane,CC,KCNC4;INSR;DDN;SHISA6
3452,GO:0007272,0.0513454239126967,0.974719284178751,13,82,ensheathment of neurons,BP,MARVELD1;NDRG1;SCN8A;MALL;ERBB2;CD9;HEXB;NAB2;AHNAK2;GPC1;EPB41L3;AKT1;RARG
3786,GO:0008366,0.0513454239126967,0.974719284178751,13,82,axon ensheathment,BP,MARVELD1;NDRG1;SCN8A;MALL;ERBB2;CD9;HEXB;NAB2;AHNAK2;GPC1;EPB41L3;AKT1;RARG
8063,GO:0032755,0.0514204195149813,0.98009356159359,8,43,positive regulation of interleukin-6 production,BP,MAPK13;F2R;IL6R;TRPV4;PTAFR;ADORA2B;PYCARD;EREG
6686,GO:0030073,0.0514520217918676,0.971379852617741,18,125,insulin secretion,BP,RAPGEF3;NR1D1;HADH;NLGN2;LRP5;ITPR3;GLUL;PFKFB2;ARL2;ACVR2B;PFKL;VGF;PCK2;TM7SF3;VSNL1;SIRT3;SLC2A1;GIPR
10252,GO:0043010,0.0514942401170551,0.968075875676374,26,192,camera-type eye development,BP,EPHB2;RAB11FIP4;EGFR;SDK2;LRP5;IFT140;NPHP4;ATP2B4;LAMB2;WNT7A;VEGFA;ACVR2B;HSF4;TUB;SDHAF4;WNT7B;RXRA;SLITRK6;PROX1;PPP1R13L;BFSP1;WNT2B;TMEM231;SIX5;NINJ1;RARG
12675,GO:0050919,0.0515595823851447,0.983522024687604,6,28,negative chemotaxis,BP,SEMA4B;SLIT3;SEMA3B;SEMA3F;SEMA4C;SEMA4F
4669,GO:0010827,0.0516204857326736,0.978644867781231,9,50,regulation of glucose transmembrane transport,BP,PIK3R2;INSR;PRKCZ;CLTCL1;SLC25A27;GRB10;RTN2;AKT1;SLC2A1
8907,GO:0034766,0.0516695270172844,0.978587980919595,9,51,negative regulation of ion transmembrane transport,BP,EPHB2;ANK3;PKD2;NTSR1;PCSK9;STK39;ANO9;AKT1;GSTM2
2267,GO:0005215,0.0516888628729759,0.960474107518692,78,679,transporter activity,MF,APOE;CLCA2;SCN8A;SLCO4A1;LRP1;KCNG1;SLC43A1;ABCA7;SLC16A5;PITPNC1;SLC16A3;GJC2;KCNC4;ABCG1;S100A6;KCNJ15;ANO8;PLTP;SLC2A9;SLC13A3;BSG;PKD2;SCN4B;SLC7A8;ITPR3;ATP2B4;SLC6A8;GM2A;SLC20A1;ASIC1;SERINC2;ATP7B;SLC12A7;DLG4;ABCD1;TTYH3;ATP12A;LRRC8A;TMEM63C;KCNAB2;SLC22A18;SLC16A13;SLC48A1;SLC2A3;ABCA2;OSBPL5;AQP3;SLC28A2;PITPNM1;SLC38A10;SCNN1A;SLC25A37;SLC37A2;TRPV4;SLC29A4;GAS6;TMEM175;ABCD4;DLG3;KCNMA1;SLC25A27;TMCO3;NDUFA4L2;PITPNM3;SLC9A7;ANO9;TPCN1;SLC25A29;SLC5A5;PKD1;SLC22A17;RHBG;KCNN4;ORAI3;SLC2A1;CPNE7;ORAI2;PQLC2
7841,GO:0032413,0.0517241359645108,0.981527345044744,7,36,negative regulation of ion transmembrane transporter activity,BP,EPHB2;ANK3;PKD2;PCSK9;STK39;ANO9;GSTM2
11432,GO:0045907,0.0517441549301455,0.988450302760525,4,15,positive regulation of vasoconstriction,BP,EGFR;F2R;PTAFR;AKT1
4575,GO:0010675,0.0517754883203711,0.974475202810314,13,82,regulation of cellular carbohydrate metabolic process,BP,NR1D1;IGF2;PHLDA2;NTSR1;INSR;PFKFB2;DGKQ;PPARA;PTAFR;IGFBP4;PDK2;AKT1;MLYCD
11227,GO:0045446,0.0519702997719262,0.976178125208842,11,66,endothelial cell differentiation,BP,PTPRS;RAPGEF3;XDH;LAMA5;WNT7A;ID1;ACVR2B;S1PR2;TNFRSF1A;WNT7B;PROX1
8288,GO:0033135,0.0519839315503404,0.974339598782153,13,83,regulation of peptidyl-serine phosphorylation,BP,RAPGEF3;EGFR;ATP2B4;SPRY2;VEGFA;MLXIPL;DMTN;GAS6;PPM1F;AKT1;GPD1L;PINK1;MIF
18206,GO:1903037,0.0520885090944252,0.968718437249123,23,168,regulation of leukocyte cell-cell adhesion,BP,IGF2;ZP3;ERBB2;ZMIZ1;IL20RB;PRNP;EFNB3;BCL6;IGFBP2;CEBPB;HES1;TNFRSF14;ADA;PAG1;RAG1;PPARA;PTAFR;PRKCZ;ICOSLG;ASS1;AKT1;PYCARD;JAK3
12886,GO:0051258,0.0521591010138386,0.967287422261615,27,204,protein polymerization,BP,GSN;ARPIN;CORO1B;TUBG2;MICALL2;DNM1;MSRB2;TMOD2;ARL2;WIPF1;PLEKHG2;CDC42EP5;SPTB;DMTN;TRPV4;CAPG;TWF2;NDE1;WHAMMP3;EPS8L1;EPS8L2;PINK1;SPIRE2;MLST8;PYCARD;RANBP9;FCHSD1
6975,GO:0030665,0.0523361444623537,0.975959033403821,11,67,clathrin-coated vesicle membrane,CC,CEMIP;APOE;EGFR;CD9;VAMP2;AP2A2;HBEGF;LDLR;LDLRAP1;CLTCL1;EPN2
11349,GO:0045737,0.0523576557772949,0.983133766374182,6,29,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,EGFR;PKD2;PROX1;MAPRE3;AKT1;PKD1
7064,GO:0030864,0.0523694328777308,0.97704592625025,10,58,cortical actin cytoskeleton,CC,RAPGEF3;GSN;MYZAP;PLEKHH2;WIPF1;SPTB;TRPV4;LLGL1;CAPN2;SLC2A1
10606,GO:0043621,0.0524291565919876,0.979621472770446,8,43,protein self-association,MF,VAMP2;ID1;SHANK3;FHOD1;PCSK9;DMTN;MDH2;SLC2A1
3266,GO:0006952,0.0524881665891048,0.95857037943379,100,902,defense response,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;PTPRS;NT5E;LTB4R;CST3;CYP27B1;GSN;PRDX5;NR1D1;NFATC4;MST1R;MAPK13;EGFR;SERPING1;EGR1;SHC1;F2R;PTK6;DEAF1;CTSB;HDAC5;ZP3;HYAL1;RNF135;LTB4R2;GGT1;ACP5;PDCD4;TNFRSF25;ADARB1;IL20RB;TMEM173;ECM1;ISG20;BCL6;BNIP3;CD81;SRMS;CEBPB;ADAM15;TNFRSF6B;MAPK3;WIPI2;MEFV;TRIM4;TNFRSF14;LRSAM1;ADA;IL6R;MAPKBP1;PRKACA;F12;RPS6KA5;VGF;TNFRSF1A;LDLR;TRPV4;IFNGR2;RAG1;FAM3A;SDHAF4;BTRC;PPARA;TKFC;PTAFR;BCR;IGFBP4;GSDMC;MUC19;PRKCZ;ADAMTS13;ICOSLG;MAPKAPK3;C5;TOLLIP;ADGRE2;SDC1;APOBEC3C;LYST;STK39;GSDMA;ADORA2B;ABR;PNMA1;AKT1;NLRX1;PYCARD;MAP2K3;KCNN4;APOBEC3F;FBXL20;JAK3;EREG;RPL13A;MIF;STXBP2
11238,GO:0045503,0.0524997371553906,0.988225026561392,4,15,dynein light chain binding,MF,DNAH1;GLUL;WDR60;WDR63
3322,GO:0007040,0.0526867430307192,0.978084821974753,9,51,lysosome organization,BP,GAA;NAGLU;TFEB;HEXB;VPS11;HOOK2;TMEM175;TPP1;LYST
15957,GO:0080171,0.0526867430307192,0.978084821974753,9,51,lytic vacuole organization,BP,GAA;NAGLU;TFEB;HEXB;VPS11;HOOK2;TMEM175;TPP1;LYST
17081,GO:0101002,0.0527294937252956,0.969548440331755,20,145,ficolin-1-rich granule,CC,GAA;CST3;PGM1;GSN;TIMP2;PYGL;CTSB;NBEAL2;AP2A2;GLB1;LTA4H;SLC2A3;PFKL;CTSZ;SERPINB6;CSTB;ACTR1B;CTSD;CTSH;MIF
6733,GO:0030162,0.0527517529494844,0.961101715250125,60,517,regulation of proteolysis,BP,TNIP1;APOE;BTBD2;CST3;LTBP4;GSN;XDH;PRDX5;TIMP2;SERPING1;RHBDF1;F2R;GRAMD4;PLAT;FBLN1;EDEM1;ABTB1;SERPINE2;CSNK1E;PRNP;PAPLN;SNX33;ECM1;SNX9;CD81;VEGFA;TNFRSF6B;MAPK3;DVL1;FURIN;MEFV;PIDD1;BTBD11;PRKACA;F12;MAGEF1;CYFIP2;DAP;FGFR4;RAG1;GAS6;BTRC;SUFU;RAD23A;CTSZ;C5;BIN1;SERPINB6;SH3D19;CSTB;TIMP1;PPM1F;SORL1;AKT1;PINK1;PKD1;CTSH;PYCARD;PCSK1N;FAM162A
15565,GO:0072073,0.0530109962514221,0.972981391332123,14,90,kidney epithelium development,BP,CTNNBIP1;PGF;LAMA5;PKD2;LAMB2;WWTR1;VEGFA;HES1;WNT7B;FGFR1;WNT2B;SDC1;PKD1;KIF26B
12457,GO:0050431,0.053019333764516,0.988069433832479,4,15,transforming growth factor beta binding,MF,LTBP4;LTBP1;LTBP3;VASN
10116,GO:0042692,0.053165658553742,0.966603164747533,27,202,muscle cell differentiation,BP,FLNC;NOS1;OBSCN;IGF2;NFATC4;OBSL1;HDAC5;THRA;TMOD2;PDCD4;SPEG;DYRK1B;VEGFA;OLFM2;TNNT1;HES1;MYH3;SEMA4C;RXRA;PIN1;TMEM204;PROX1;BIN1;CAPN2;SDC1;AKT1;EREG
13334,GO:0052547,0.0531738794870928,0.964463317736466,35,284,regulation of peptidase activity,BP,CST3;GSN;XDH;PRDX5;TIMP2;SERPING1;F2R;GRAMD4;FBLN1;SERPINE2;PAPLN;ECM1;VEGFA;TNFRSF6B;MAPK3;FURIN;MEFV;PIDD1;CYFIP2;DAP;RAG1;GAS6;C5;BIN1;SERPINB6;CSTB;TIMP1;PPM1F;SORL1;AKT1;PINK1;CTSH;PYCARD;PCSK1N;FAM162A
4291,GO:0009746,0.053239891019454,0.970248541426233,18,126,response to hexose,BP,NR1D1;IGF2;EGR1;LRP5;VAMP2;GLUL;PFKFB2;ACVR2B;ENDOG;MLXIPL;PFKL;PRKACA;GAS6;PCK2;VSNL1;SESN2;ERN1;GIPR
6056,GO:0019213,0.0532614238403471,0.977799648850859,9,51,deacetylase activity,MF,HDAC5;MTA3;MTA1;PHF21A;HDAC11;CES2;MACROD1;SIRT3;NDST2
707,GO:0001933,0.0532776789073378,0.963239883652774,41,329,negative regulation of protein phosphorylation,BP,TNIP1;DUSP6;APOE;XDH;EPHB2;DUSP5;PKN1;PTK6;PIK3R2;LRP5;FBLN1;SPRY4;CDKN1C;PDCD4;EPHA1;ADARB1;PRNP;SPRY2;WWTR1;DVL1;MLXIPL;LRRK1;DMTN;MAPK8IP1;DUSP7;DGKQ;PRKCZ;PIN1;RTN4R;PPM1F;SORL1;STK39;AKT1;NDRG2;GPD1L;PINK1;RGS14;CBLC;PYCARD;RANBP9;SIRT3
5175,GO:0015748,0.0534340236074752,0.975368509456576,11,67,organophosphate ester transport,BP,APOE;ABCA7;PITPNC1;ABCG1;PLTP;OSBPL5;PITPNM1;SLC37A2;LDLR;PITPNM3;KCNN4
8967,GO:0035091,0.0537429106223302,0.96687681015756,25,184,phosphatidylinositol binding,MF,ARAP1;GRB7;HS1BP3;PITPNC1;NISCH;ITPR3;PLCD1;SH3PXD2B;SNX33;SNX9;TUB;WIPI2;OSBPL5;PITPNM1;SNX17;LDLRAP1;GSDMC;TWF2;ARAP3;ESYT2;GSDMA;AKT1;SNX29;ZCCHC14;ZFYVE19
10235,GO:0042987,0.0540383308077022,0.982454105243614,6,29,amyloid precursor protein catabolic process,BP,APOE;ABCA7;ABCG1;PRNP;BIN1;SORL1
12747,GO:0051048,0.054044009903774,0.970935434280192,16,109,negative regulation of secretion,BP,IDH2;HADH;RHBDF1;F2R;ASIC1;RHBDF2;ADA;PFKL;MAPKBP1;GAS6;COMT;BCR;VSNL1;STK39;ERBB3;ABR
3179,GO:0006810,0.0541435205073288,0.952959103897147,343,3347,transport,BP,LMF1;CEMIP;APOE;TSPAN1;IDH2;GAA;SYTL1;NAPRT;PYGB;CST3;SHANK2;LTBP4;RAPGEF3;MRC2;PGM1;CYP27B1;GSN;CLCA2;EVI5L;XDH;PRSS3;NOS1;ARAP1;ZFP36L1;POSTN;NR1D1;ALOX15B;ARRDC1;SCN8A;SLCO4A1;EPHB2;CNTN1;CPT2;IGF2;NME4;LRP1;APPL2;KCNG1;LTBP2;RAB11FIP4;EGFR;TIMP2;B3GAT3;HADH;NLGN2;REEP6;TOM1L2;SLC43A1;FHL1;SERPING1;RHBDF1;PYGL;DOPEY2;SYT8;F2R;ABCA7;CA12;BBS2;SLC16A5;PRSS8;CTSB;PITPNC1;SLC16A3;GJC2;TBC1D14;KCNC4;ABCG1;RIN1;ANK3;PIK3R2;S100A6;KCNJ15;ZP3;NISCH;LRP5;ANO8;PLTP;SLC2A9;LRP3;ERBB2;SLC13A3;EXOC2;BRSK1;MICALL2;BSG;PKD2;TMEM129;FUCA1;TST;SCN4B;EDEM1;SLC7A8;ITPR3;PRAF2;VAT1;DNM1;FCHO1;RIMS3;IFT140;CD9;KIF13B;CACFD1;SIGMAR1;HEXB;SERPINE2;VPS11;VAMP2;FUZ;NTSR1;CD320;MINK1;ATP2B4;SLC6A8;TFDP2;CSNK1E;TRAPPC9;AGAP1;ZFYVE21;GM2A;SLC20A1;ACAP3;GLUL;RHOD;USP20;PEX10;ASIC1;WNT7A;INSR;RAB3D;TBC1D8;NBEAL2;LPAR3;TMEM173;PRNP;SERINC2;ATP7B;RNASET2;SNX33;SLC12A7;ECM1;ATG16L2;SNX9;DLG4;ABCD1;MARCH2;REEP2;STRADB;RAB25;MYO18A;ARHGAP27;SCART1;BCL6;TTYH3;PFKFB2;ATP12A;CHMP1B;MVB12B;BNIP3;CD81;FCGRT;VEGFA;DNASE1L1;HOOK2;LRRC8A;ARL2;ELMO3;TMEM63C;AP2A2;RHBDF2;DPP7;SHANK3;SSC4D;ACVR2B;ZDHHC1;MAPK3;TUB;KCNAB2;OLFM2;AMN;SLC22A18;GLB1;RAB40B;DVL1;FYCO1;WIPF1;LTA4H;SLC16A13;FHOD1;HES1;FURIN;SLC48A1;SLC2A3;ABCA2;LRSAM1;ADA;MCTP1;OSBPL5;AQP3;RASL10B;PFKL;PCSK9;SLC28A2;ZFP36;RHOF;MAPKBP1;PRKACA;PITPNM1;CYFIP2;SLC38A10;SCNN1A;SLC25A37;RAB3B;MAP2K2;PI4K2A;SPTB;SLC37A2;STX10;DMTN;BBS1;VGF;EHD4;MAPK8IP1;LDLR;SNX17;TRPV4;EEF2K;LDLRAP1;PEX7;MVB12A;HK1;SLC29A4;GAS6;LLGL1;PPARA;GUK1;GIT1;COMT;PTAFR;RXRA;PCK2;VAV3;LRP10;BCR;TMEM175;TBC1D16;WDR60;PRKCZ;ZDHHC24;CLTCL1;TM7SF3;TMCO6;ABCD4;SRSF5;MAPKAPK3;NDE1;ARAP3;FGFR1;CTSZ;C5;ASAP2;DLG3;GPR155;KCNMA1;ESYT2;BIN1;VSNL1;UNC119B;SERPINB6;OSCP1;GLRX;SLC25A27;TMCO3;GRB10;SESN2;NDUFA4L2;TOLLIP;CSTB;SNPH;LCAT;GUCA1B;ADGRE2;SMDT1;PITPNM3;SLC9A7;TIMP1;CD68;SDC1;WHAMMP3;ACTR1B;RTN2;PEAR1;LYST;SORL1;STK39;VEGFB;TBC1D17;ANO9;TSNARE1;ADORA2B;TPCN1;HGSNAT;SLC25A29;ERBB3;ABR;AKT1;CTSD;STON1;VPS33B;GPD1L;SLC5A5;SUN1;PINK1;PKD1;EHD3;LONP2;SLC22A17;SNTA1;HOMER2;RGS14;SPIRE2;CTSH;RILPL1;EPN2;PYCARD;RHBG;KCNN4;CKLF;SIRT3;ORAI3;SLC2A1;APBA1;ORAI2;GALNS;GSTM2;SHISA6;GIPR;PQLC2;TMED4;RPL13A;RAB40C;MIF;STXBP2;UBL5
6301,GO:0019955,0.054180222108725,0.976078556518444,10,59,cytokine binding,MF,LTBP4;LTBP1;TNFRSF25;IL20RB;NRP2;IL6R;ZFP36;TNFRSF1A;LTBP3;VASN
4088,GO:0009151,0.0542662058864189,0.99112773377334,3,10,purine deoxyribonucleotide metabolic process,BP,ADA;DGUOK;GUK1
2663,GO:0006022,0.0543023269215256,0.970183141912769,17,115,aminoglycan metabolic process,BP,CEMIP;B3GAT3;NAGLU;HYAL1;FUCA1;HEXB;B4GAT1;GLB1;ST3GAL3;XYLT2;CHST6;GPC1;SDC1;HGSNAT;AKT1;GALNS;NDST2
1250,GO:0003006,0.0546050373889964,0.960846313938644,50,413,developmental process involved in reproduction,BP,HTRA1;ERCC1;CST3;CYP27B1;ZFP36L1;ALOX15B;EPAS1;IGF2;EGFR;MDFI;DEAF1;BBS2;CTSB;DNAH1;ZP3;TFEB;BSG;PKD2;PHLDA2;HEXB;SERPINE2;PLCD1;WNT7A;INSR;FBXW8;PLCD3;VEGFA;CEBPB;ADAM15;ETV5;HES1;CUL7;ADA;SLIT3;PRKACA;VGF;WNT7B;DMC1;RXRA;AGO4;IRF2BPL;WNT2B;SDC1;ACVR1B;AKT1;SIX5;PKD1;RFX2;RARG;EREG
15529,GO:0072001,0.0547232831448423,0.965858265748477,26,193,renal system development,BP,CTNNBIP1;PGF;EGR1;LAMA5;ACTA2;PKD2;ITGB4;IFT140;LAMB2;ITGA6;WWTR1;VEGFA;VANGL2;ACVR2B;HES1;PCSK9;WNT7B;FGFR1;PROX1;WNT2B;SDC1;PKD1;CTSH;SULF2;KIF26B;LZTS2
955,GO:0002376,0.0547812678370721,0.953939447340976,194,1841,immune system process,BP,TNIP1;HTRA1;FOS;CTNNBIP1;PTPRS;ERCC1;GAA;LTB4R;NAPRT;PYGB;CST3;PGM1;CYP27B1;GSN;NDRG1;PRSS3;PGF;ZFP36L1;GRB7;NR1D1;FAM210B;RBCK1;EPAS1;IGF2;MST1R;LRP1;TIMP2;MMP28;SERPING1;EGR1;PKN1;CMTM7;PYGL;SHC1;PTK6;CTSB;SLC16A3;ASH2L;MMP1;PIK3R2;HDAC5;THRA;ZP3;LRP5;ZFPM1;TFEB;ERBB2;BSG;CTSF;FUCA1;SLC7A8;VAT1;KIF13B;HEXB;VAMP2;RNF135;CD320;GGT1;GM2A;TNFRSF25;PRR7;ZMIZ1;RAB3D;POLL;ADARB1;ITGA6;IL20RB;NBEAL2;TMEM173;PRNP;EFNB3;RNASET2;ECM1;NPDC1;STAT6;MKNK2;ISG20;FAM20C;MYO18A;SCART1;BCL6;FAM213A;IGFBP2;BNIP3;CD81;SRMS;FCGRT;FZD8;VEGFA;DNASE1L1;LRRC8A;AP2A2;CEBPB;DPP7;ADAM15;TNFRSF6B;MAPK3;KCNAB2;GLB1;DHTKD1;WIPF1;L3MBTL1;LTA4H;EPHB3;HES1;MEFV;SLC2A3;TRIM4;TNFRSF14;ADA;PAG1;AQP3;PFKL;IL6R;ZFP36;RHOF;PRKACA;F12;LRRK1;CYFIP2;RPS6KA5;ITGB5;RAB3B;PI4K2A;DMTN;TNFRSF1A;LDLR;SOX13;TRPV4;IFNGR2;RAG1;HK1;FAM3A;SDHAF4;GAS6;BTRC;TKFC;PTAFR;VAV3;BCR;MUC19;PRKCZ;ADAMTS13;INPP5D;GPC1;ICOSLG;ZNF160;MAPKAPK3;AGO4;CTSZ;C5;GTPBP1;SERPINB6;JARID2;TOLLIP;WNT2B;CSTB;PROCR;ADGRE2;PTMS;CD68;SDC1;SH2B3;ACTR1B;APOBEC3C;LYST;VEGFB;ACVR1B;ADORA2B;HGSNAT;ABR;PNMA1;AKT1;CTSD;NLRX1;ZNF385A;VPS33B;SPPL2B;CTSH;PYCARD;KCNN4;PMS2P5;CKLF;APOBEC3F;TAZ;JAK3;RARG;GALNS;EREG;PODXL2;POLM;RPL13A;MIF;STXBP2
5775,GO:0017014,0.0549018303451306,0.990980618761807,3,10,protein nitrosylation,BP,NOS1;ATP2B4;SNTA1
5895,GO:0018119,0.0549018303451306,0.990980618761807,3,10,peptidyl-cysteine S-nitrosylation,BP,NOS1;ATP2B4;SNTA1
9848,GO:0042119,0.0549306057615401,0.961637655886855,43,356,neutrophil activation,BP,GAA;NAPRT;PYGB;CST3;PGM1;GSN;PRSS3;TIMP2;PYGL;CTSB;FUCA1;VAT1;HEXB;GM2A;RAB3D;NBEAL2;TMEM173;RNASET2;DNASE1L1;AP2A2;DPP7;KCNAB2;GLB1;LTA4H;SLC2A3;PFKL;RHOF;PTAFR;BCR;CTSZ;SERPINB6;TOLLIP;CSTB;CD68;ACTR1B;HGSNAT;ABR;CTSD;CTSH;PYCARD;GALNS;MIF;STXBP2
7246,GO:0031225,0.0550432510462841,0.974452710885687,11,69,anchored component of membrane,CC,NT5E;CNTN1;PRSS8;PRNP;LY6K;RAB3B;MDGA1;MSLN;GPC1;RTN4R;RHBG
147,GO:0000302,0.055178852051868,0.967044259773719,22,163,response to reactive oxygen species,BP,FOS;APOE;CST3;PRDX5;MAPK13;EGFR;HYAL1;PKD2;TXNRD3;STAT6;ANKZF1;BNIP3;ENDOG;MAPK3;ADA;PDK2;SESN2;SDC1;AKT1;TRAP1;ERCC6;PINK1
3564,GO:0007616,0.0554807225965609,0.984285632122089,5,22,long-term memory,BP,APOE;PRNP;LDLR;PRKCZ;RGS14
7800,GO:0032365,0.0555415443025584,0.981841284265807,6,29,intracellular lipid transport,BP,CPT2;ABCG1;ABCA2;PCSK9;LDLR;LDLRAP1
10939,GO:0044706,0.0557609630537429,0.968115546300112,19,134,multi-multicellular organism process,BP,FOS;CST3;CYP27B1;PGF;CTSB;FBLN1;BSG;PTHLH;HEXB;SERPINE2;SH3PXD2B;IGFBP2;COMT;PTAFR;RXRA;TIMP1;ACVR1B;AKT1;SLC2A1
9780,GO:0040017,0.0557690316287607,0.961196949790033,42,340,positive regulation of locomotion,BP,CEMIP;SEMA4B;FAM110C;PGF;POSTN;GRB7;EGFR;F2R;DOCK4;ZP3;HYAL1;RHOD;WNT7A;INSR;EPHA1;ITGA6;SPRY2;RAB25;VEGFA;MAPK3;PC;SSH1;NRP2;IL6R;HBEGF;DMTN;SEMA3B;TRPV4;SEMA3F;SEMA4C;GAS6;PTAFR;FGFR1;PROX1;PPM1F;VEGFB;ACVR1B;AKT1;CTSH;PYCARD;MAP2K3;SEMA4F
890,GO:0002263,0.0559693776067217,0.959138360602039,55,468,cell activation involved in immune response,BP,ERCC1;GAA;NAPRT;PYGB;CST3;PGM1;GSN;PRSS3;LRP1;TIMP2;PYGL;CTSB;ZFPM1;FUCA1;VAT1;HEXB;VAMP2;GM2A;RAB3D;NBEAL2;TMEM173;RNASET2;STAT6;BCL6;DNASE1L1;AP2A2;DPP7;KCNAB2;GLB1;LTA4H;SLC2A3;ADA;PFKL;RHOF;PI4K2A;PTAFR;BCR;PRKCZ;CTSZ;SERPINB6;TOLLIP;CSTB;ADGRE2;CD68;ACTR1B;ADORA2B;HGSNAT;ABR;CTSD;CTSH;PYCARD;JAK3;GALNS;MIF;STXBP2
12899,GO:0051280,0.0561846976704271,0.990681420798596,3,10,negative regulation of release of sequestered calcium ion into cytosol,BP,PKD2;NTSR1;GSTM2
12903,GO:0051284,0.0561846976704271,0.990681420798596,3,10,positive regulation of sequestering of calcium ion,BP,PKD2;NTSR1;GSTM2
3152,GO:0006767,0.0565810190126948,0.973639165939871,11,68,water-soluble vitamin metabolic process,BP,PRSS3;MTHFR;CD320;ACP5;AMN;PC;SLC2A3;HLCS;ABCD4;PNPO;SLC2A1
12937,GO:0051345,0.0567060384397489,0.957494805183425,65,557,positive regulation of hydrolase activity,BP,LMF1;RAPGEF3;GSN;EVI5L;XDH;ARAP1;EGFR;F2R;TBC1D14;GRAMD4;RIN1;PIK3R2;ARHGAP23;DOCK4;ERBB2;FBLN1;RALGAPA2;RASA4;AGAP1;GM2A;ACAP3;PLEKHG4;TBC1D8;EPHA1;ITGA6;SYNGAP1;SNX9;ARHGAP27;PLXNB1;VEGFA;MAPK3;MEFV;ARHGAP22;CDC42EP5;PIDD1;FGFR3;CYFIP2;DAP;LLGL1;GIT1;PTAFR;PLEKHG6;ARHGEF37;VAV3;BCR;TBC1D16;PRKCZ;ARAP3;FGFR1;PIN1;ASAP2;RTN4R;PPM1F;TBC1D17;ALS2CL;ABR;AKT1;PINK1;RGS14;CTSH;PYCARD;ERN1;ARHGEF19;FAM162A;RGS12
4729,GO:0010906,0.0567169224676476,0.973589226816054,11,67,regulation of glucose metabolic process,BP,NR1D1;IGF2;PHLDA2;INSR;PFKFB2;DGKQ;PPARA;IGFBP4;PDK2;AKT1;MLYCD
3449,GO:0007269,0.0568149076421983,0.972500554455154,12,75,neurotransmitter secretion,BP,SYTL1;SYT8;KCNC4;BRSK1;RIMS3;VAMP2;ASIC1;WNT7A;DVL1;MCTP1;SNPH;APBA1
17075,GO:0099643,0.0568149076421983,0.972500554455154,12,75,signal release from synapse,BP,SYTL1;SYT8;KCNC4;BRSK1;RIMS3;VAMP2;ASIC1;WNT7A;DVL1;MCTP1;SNPH;APBA1
11262,GO:0045595,0.0568924636017282,0.95381493038371,126,1152,regulation of cell differentiation,BP,FOS;DUSP6;APOE;CTNNBIP1;IDH2;PTPRS;SEMA4B;SHANK2;LTBP4;TCFL5;CYP27B1;XDH;NOS1;ZFP36L1;POSTN;NR1D1;ALOX15B;FAM210B;EPHB2;CNTN1;IGF2;NFATC4;LRP1;OBSL1;EGFR;TIMP2;CRTC1;PTK6;ULK2;GJC2;ZMYND8;ASH2L;ABCG1;HDAC5;THRA;LRP5;ZFPM1;ERBB2;FBLN1;PLXNB3;PTHLH;KIF13B;SERPINE2;FUZ;CSNK1E;ADAMTS7;PDCD4;WNT7A;ZMIZ1;SH3PXD2B;FBXW8;ID1;SYNGAP1;LPAR3;EFNB3;SPRY2;DLG4;WWTR1;FAM20C;BCL6;PLXNB1;FAM213A;VEGFA;CEBPB;SHANK3;ACVR2B;HSF4;S1PR2;ETV5;OLFM2;DVL1;ADCY6;L3MBTL1;EPHB3;HES1;SSH1;CUL7;ADA;AQP3;IL6R;ZFP36;PRKACA;DGUOK;DMTN;TNFRSF1A;SEMA3B;LDLR;SOX13;TRPV4;RAG1;EEF2K;SEMA3F;SEMA4C;GAS6;PPARA;WNT7B;SUFU;LTBP3;VASN;PRKCZ;INPP5D;TWF2;GPC1;AGO4;FGFR1;CTSZ;CHADL;PIN1;PROX1;BIN1;PPP1R13L;RTN4R;WNT3;SORL1;ACVR1B;CCDC85B;CCDC71L;AKT1;ZNF385A;TP53INP1;SSH3;RGS14;JAK3;RARG;EREG;SEMA4F
6039,GO:0019184,0.0569306538723159,0.986722780683459,4,16,nonribosomal peptide biosynthetic process,BP,OPLAH;GGT1;HAGH;GSS
6821,GO:0030295,0.0570868637595755,0.975850110571269,9,52,protein kinase activator activity,MF,IGF2;SPRY2;MAP2K2;DGKQ;GAS6;MADD;ERBB3;ERCC6;MLST8
11598,GO:0046323,0.0571874714250604,0.975834205869612,9,51,glucose import,BP,PIK3R2;INSR;PRKCZ;CLTCL1;SLC25A27;GRB10;SESN2;RTN2;AKT1
12584,GO:0050790,0.0572711244937929,0.952207275093175,172,1607,regulation of catalytic activity,BP,DUSP6;LMF1;CEMIP;APOE;CST3;RAPGEF3;CYP27B1;GSN;EVI5L;XDH;PRDX5;NOS1;ARAP1;EPHB2;IGF2;MST1R;LRP1;RALGDS;EGFR;TIMP2;B3GAT3;DUSP5;PPP1R14A;SERPING1;EGR1;PKN1;SHC1;F2R;PTK6;GNAL;PPP2R3B;CTSB;SHC2;TBC1D14;GRAMD4;RIN1;PIK3R2;ARHGAP23;DOCK4;LRP5;ERBB2;FBLN1;PKD2;PLXNB3;SPRY4;CDKN1C;PAK6;SERPINE2;LTB4R2;MINK1;RALGAPA2;ATP2B4;RASA4;AGAP1;PDCD4;GM2A;ACAP3;PLEKHG4;INSR;SH3PXD2B;TBC1D8;EPHA1;ADARB1;ITGA6;SYNGAP1;PPP1R35;LPAR3;PRNP;SERINC2;PAPLN;SPRY2;ECM1;SNX9;DLG4;STRADB;WWTR1;ARHGAP27;BCL6;PFKFB2;PLXNB1;CD81;FZD8;VEGFA;ARL2;VANGL2;ACVR2B;NAB2;S1PR2;TNFRSF6B;MAPK3;DVL1;GPSM1;ADCY6;EPHB3;FURIN;MEFV;ARHGAP22;CDC42EP5;PIDD1;ZFP36;FGFR3;PRKACA;CYFIP2;MAP2K2;DAP;FGFR4;MAPK8IP1;RAG1;DUSP7;DGKQ;GAS6;LLGL1;WNT7B;GIT1;PTAFR;PLEKHG6;ARHGEF37;VAV3;BCR;TBC1D16;PRKCZ;MAPKAPK3;NDE1;ARAP3;FGFR1;CAMKK1;PIN1;C5;PROX1;ASAP2;DLG3;BIN1;SERPINB6;SESN2;CSTB;MAPRE3;GUCA1B;MADD;RTN4R;ELFN2;TIMP1;PPM1F;SBF1;SORL1;STK39;TBC1D17;ALS2CL;ADORA2B;ERBB3;ABR;ZER1;AKT1;ERCC6;PINK1;PKD1;RGS14;PCIF1;CTSH;MLST8;CBLC;PYCARD;MAP2K3;PCSK1N;ERN1;ARHGEF19;NEIL1;EREG;FAM162A;GIPR;SFI1;RGS12;MIF
6297,GO:0019935,0.0573667562602108,0.973210217526255,11,68,cyclic-nucleotide-mediated signaling,BP,APOE;RAPGEF3;NOS1;ADGRF1;GNAL;PTHLH;ATP2B4;ADCY6;DGKQ;ADORA2B;GIPR
7196,GO:0031099,0.0574446885909522,0.9681893519633,17,118,regeneration,BP,APOE;PTPRS;GSN;PGF;POSTN;EGFR;ULK1;PTPRU;LAMB2;WNT7A;CEBPB;ADAM15;GAS6;SRSF5;RTN4R;NINJ1;SULF2
989,GO:0002446,0.0574790050763999,0.959714538713,43,357,neutrophil mediated immunity,BP,GAA;NAPRT;PYGB;CST3;PGM1;GSN;PRSS3;TIMP2;PYGL;CTSB;FUCA1;VAT1;HEXB;GM2A;RAB3D;NBEAL2;TMEM173;RNASET2;DNASE1L1;AP2A2;DPP7;KCNAB2;GLB1;LTA4H;SLC2A3;PFKL;RHOF;PTAFR;BCR;CTSZ;SERPINB6;TOLLIP;CSTB;CD68;ACTR1B;HGSNAT;ABR;CTSD;CTSH;PYCARD;GALNS;MIF;STXBP2
12549,GO:0050729,0.0575142276988195,0.974274432838829,10,61,positive regulation of inflammatory response,BP,TNIP1;MAPK13;EGFR;ZP3;PDCD4;F12;TNFRSF1A;LDLR;TRPV4;ADORA2B
10359,GO:0043198,0.0575260420437125,0.98353689412345,5,22,dendritic shaft,CC,ZMYND8;NTSR1;SYNGAP1;DLG3;RTN4R
4850,GO:0014074,0.0577030582211219,0.970188546873697,14,92,response to purine-containing compound,BP,FOS;RAPGEF3;ZFP36L1;BSG;PKD2;SSH1;DMTN;VGF;EEF2K;DGKQ;PTAFR;SDC1;SLC5A5;GSTM2
8713,GO:0034377,0.0577123328399698,0.986478900488445,4,16,plasma lipoprotein particle assembly,BP,APOE;ABCA7;PRKACA;LCAT
10404,GO:0043266,0.0580303180438551,0.976918684359767,8,44,regulation of potassium ion transport,BP,NOS1;KCNG1;FHL1;ANK3;VAMP2;PRNP;KCNAB2;STK39
3378,GO:0007163,0.0580639149042646,0.965152278644359,22,159,establishment or maintenance of cell polarity,BP,GSN;PARVB;MARK4;BRSK1;RHOD;WNT7A;SPRY2;DLG4;MYO18A;VANGL2;HES1;FBF1;RHOF;RHOBTB2;LLGL1;WNT7B;PRKCZ;NDE1;DLG3;LRCH4;PKD1;KIF26B
7190,GO:0031091,0.0581054449722613,0.97533491441191,9,52,platelet alpha granule,CC,IGF2;SERPING1;CD9;SERPINE2;VEGFA;GAS6;TIMP1;VEGFB;VPS33B
465,GO:0001504,0.0582584708430651,0.986307798062375,4,16,neurotransmitter uptake,BP,NOS1;NTSR1;GLUL;RAB3B
6912,GO:0030516,0.0583943173637721,0.972672482991595,11,67,regulation of axon extension,BP,APOE;PTPRS;SEMA4B;VEGFA;SEMA3B;SEMA3F;SEMA4C;TWF2;RTN4R;WNT3;SEMA4F
7662,GO:0032103,0.0584753065378575,0.96530629000426,21,155,positive regulation of response to external stimulus,BP,TNIP1;CYP27B1;PGF;MAPK13;EGFR;ZP3;PDCD4;VEGFA;MAPK3;LRSAM1;IL6R;F12;TNFRSF1A;LDLR;TRPV4;GAS6;FGFR1;PPM1F;VEGFB;ADORA2B;MIF
17675,GO:1901606,0.0585359394521158,0.97376224137313,10,60,alpha-amino acid catabolic process,BP,PRODH;NOS1;ALDH4A1;CBS;ATP2B4;GLUL;BLMH;HMGCL;HPDL;GCAT
18132,GO:1902905,0.0585427536313307,0.965778319864359,20,144,positive regulation of supramolecular fiber organization,BP,APOE;RAPGEF3;GSN;ARPIN;CORO1B;SH3PXD2B;ID1;EPHA1;ARL2;WIPF1;FHOD1;CDC42EP5;TRPV4;PROX1;WHAMMP3;PPM1F;ARHGEF10L;SPIRE2;MLST8;PYCARD
11779,GO:0046683,0.0585786837789523,0.970531340044425,13,84,response to organophosphorus,BP,FOS;RAPGEF3;ZFP36L1;BSG;PKD2;SSH1;DMTN;VGF;EEF2K;DGKQ;PTAFR;SDC1;SLC5A5
2708,GO:0006091,0.0587504648650329,0.95873160325394,43,366,generation of precursor metabolites and energy,BP,IDH2;GAA;PYGB;PGM1;XDH;NR1D1;IGF2;NFATC4;ALDH4A1;PYGL;D2HGDH;OGDHL;PHLDA2;INSR;AKR7A2;NDUFS8;TXNRD3;PFKFB2;BNIP3;DHTKD1;GALK1;PHGDH;MLXIPL;PFKL;VGF;HK1;SDHAF4;PPARA;HMGCL;SDHA;MDH2;ETFB;GLRX;NDUFA4L2;TSTA3;AKT1;TRAP1;UQCR11;PINK1;NDUFV3;SIRT3;TAZ;GIPR
11859,GO:0046889,0.0590092061554812,0.976447031478595,8,44,positive regulation of lipid biosynthetic process,BP,APOE;NR1D1;ABCG1;ZP3;MLXIPL;TNFRSF1A;LDLR;AKT1
9835,GO:0042100,0.0591330310052799,0.976344104874064,8,45,B cell proliferation,BP,PKN1;CD320;BCL6;CD81;ADA;VAV3;INPP5D;MIF
14199,GO:0061180,0.0592646476247308,0.974746232138574,9,52,mammary gland epithelium development,BP,DEAF1;LRP5;STAT6;CEBPB;ETV5;BTRC;WNT7B;WNT3;AKT1
4797,GO:0012505,0.059276057165396,0.948477610391446,326,3162,endomembrane system,CC,FOS;H6PD;LMF1;CEMIP;APOE;PTPRS;GAA;SYTL1;NAPRT;PYGB;CST3;RAPGEF3;PGM1;GSN;CLCA2;EVI5L;XDH;NDRG1;PRSS3;NOS1;LTBP1;MARCH9;ARAP1;COL6A1;POSTN;CRAT;EPN3;IGF2;LRP1;APPL2;ST6GALNAC2;RAB11FIP4;OBSL1;EGFR;TIMP2;H1F0;B3GAT3;REEP6;FBXO2;FKBP9;HS1BP3;LOXL1;SERPING1;KDSR;ULK1;RHBDF1;PKN1;PYGL;DOPEY2;SYT8;F2R;ABCA7;SLC9A3R2;TMCC3;CTSB;LPCAT4;SLC16A3;DHRS1;MALL;TBC1D14;PACS2;CERS4;PLAT;ABCG1;ANK3;S100A6;HDAC5;PLD3;DOCK4;CRTAP;NISCH;LRP5;DBNDD1;ANO8;TENM2;SLC2A9;LRP3;B4GALNT4;ERBB2;BRSK1;MICALL2;BSG;PKD2;TMEM129;FUCA1;CPT1C;EDEM1;ITPR3;PRAF2;VAT1;DNM1;FCHO1;PTHLH;CD9;ANGEL1;SIGMAR1;HEXB;SERPINE2;VPS11;VAMP2;GALNT12;NTSR1;CD320;MINK1;PHF7;TRAPPC9;ZFYVE21;ADAMTS7;GM2A;GLUL;RHOD;ASIC1;LAMB2;WNT7A;INSR;RAB3D;TBC1D8;FBXW8;ID1;AKR7A2;B4GAT1;TXNRD3;NBEAL2;TMEM173;PRNP;SRD5A3;ATP7B;RNASET2;SNX33;ECM1;SNX9;STAT6;DLG4;MARCH2;REEP2;RAB25;FAM20C;MYO18A;CERCAM;C1ORF210;BCL6;CHMP1B;MVB12B;BNIP3;FZD8;VEGFA;ENTPD6;DNASE1L1;ARL2;AP2A2;RHBDF2;DPP7;ADAM15;ZDHHC1;MAPK3;PDZD2;KCNAB2;CARD19;AMN;SLC22A18;GLB1;RAB40B;ENTPD2;MTA1;FYCO1;GPSM1;LTA4H;PKN3;ST3GAL3;SLC16A13;FURIN;MBOAT7;SLC48A1;CUL7;SLC2A3;ABCA2;LY6K;FKBP10;CDC42EP5;MCTP1;OSBPL5;PIDD1;RETSAT;PFKL;PCSK9;TMEM9;RHOF;FGFR3;PRKACA;F12;PITPNM1;SLC38A10;RAB3B;MAP2K2;PI4K2A;FGFR4;SPTB;MXRA8;SLC37A2;STX10;DMTN;XYLT2;VGF;TNFRSF1A;SEZ6L2;EHD4;MAPK8IP1;SEMA3B;LDLR;CYP3A5;SNX17;ABHD17C;PIGZ;IFNGR2;MSLN;LDLRAP1;TM7SF2;DGKQ;KLHDC2;SEMA4C;MVB12A;MIB2;CHST6;GAS6;LLGL1;TMEM187;WNT7B;AIG1;PTAFR;RFNG;ANKRD13D;REEP4;PCSK1;LRP10;TMEM175;NEO1;IGFBP4;MUC19;TBC1D16;RNF123;PRKCZ;ADAMTS13;ZDHHC24;CLTCL1;ABCD4;GPC1;TMX4;SMOX;CTSZ;MAN1B1;ASAP2;ESYT2;BIN1;YIPF3;TMEM8B;SERPINB6;WDR83;CES2;CAPN2;TOLLIP;CSTB;GAL3ST4;PITPNM3;RTN4R;PIGV;SLC9A7;TIMP1;CD68;SDC1;ACTR1B;RTN2;PIGQ;WNT3;SBF1;SORL1;COL13A1;VEGFB;TBC1D17;AHCYL2;TSNARE1;TPCN1;HGSNAT;CYP2S1;CTSD;TMBIM4;ADAM19;NDRG2;VPS33B;SUN1;TMEM120A;SPPL2B;IL17RD;GAS8;PKD1;EHD3;MPLKIP;SYNE3;GOLGA2P5;CTSH;EHBP1L1;P3H4;AGPAT4;NRSN1;PYCARD;POMT1;PCSK1N;DDN;ERN1;SLC2A1;JAK3;LITAF;APBA1;GALNS;FCHSD1;GSTM2;PODXL2;ADAMTSL4;TMED4;SEMA4F;NDST2;AGPAT3;ALG12;RAB40C;MIF;SULF2;STXBP2
10507,GO:0043457,0.0592993082863307,0.985980102620952,4,16,regulation of cellular respiration,BP,BNIP3;TRPV4;TRAP1;PINK1
18141,GO:1902930,0.0595369897053201,0.974607566293213,9,52,regulation of alcohol biosynthetic process,BP,APOE;CYP27B1;ABCG1;NTSR1;MVD;SEC14L2;PMVK;TM7SF2;PTAFR
9424,GO:0036019,0.0596558144354462,0.985867379144412,4,16,endolysosome,CC,CTSB;AP2A2;PCSK9;LDLR
12666,GO:0050909,0.0596901527658244,0.985711047360066,4,17,sensory perception of taste,BP,ITPR3;ASIC1;REEP2;SCNN1A
13899,GO:0060589,0.0597963490560091,0.959424258329632,36,284,nucleoside-triphosphatase regulator activity,MF,EVI5L;ARAP1;APPL2;RALGDS;TBC1D14;RIN1;PIK3R2;ARHGAP23;DOCK4;RALGAPA2;RASA4;AGAP1;ACAP3;TBC1D8;SYNGAP1;ARHGAP27;PLXNB1;ARL2;GPSM1;ARHGAP22;CDC42EP5;LLGL1;GIT1;PLEKHG6;VAV3;BCR;TBC1D16;ARAP3;ASAP2;SESN2;TBC1D17;ALS2CL;ABR;RGS14;ARHGEF19;RGS12
5913,GO:0018198,0.0601348059900875,0.977664439283644,7,38,peptidyl-cysteine modification,BP,NOS1;ATP2B4;RAB3D;ZDHHC1;RAB3B;ZDHHC24;SNTA1
12966,GO:0051403,0.0601435799592237,0.961732924209962,27,205,stress-activated MAPK cascade,BP,XDH;ZFP36L1;MAPK13;EGFR;PKN1;MINK1;PDCD4;WNT7A;FZD8;VEGFA;VANGL2;MAPK3;CDC42EP5;ZFP36;MAP2K2;MAPK8IP1;TRPV4;SEMA4C;BTRC;WNT7B;ADORA2B;AKT1;ERCC6;PINK1;PYCARD;MAP2K3;ERN1
12367,GO:0048813,0.060164500818167,0.967919738940729,15,100,dendrite morphogenesis,BP,SHANK2;EPHB2;NFATC4;OBSL1;MINK1;WNT7A;FBXW8;ID1;DLG4;SHANK3;DVL1;EPHB3;CUL7;CELSR2;EEF2K
10073,GO:0042592,0.0605281714333433,0.950995350619208,119,1093,homeostatic process,BP,CEMIP;APOE;ERCC1;GAA;CYP27B1;PRDX5;NOS1;ZFP36L1;NR1D1;FAM210B;POLD4;EPAS1;IGF2;EGFR;FHL1;PKN1;CRTC1;PYGL;F2R;CA12;BBS2;MALL;ABCG1;ANK3;PIK3R2;THRA;LRP5;ZFPM1;PKD2;SLC7A8;ITPR3;HEXB;NPHP4;NTSR1;ATP2B4;ACP5;INSR;RAB3D;TXNRD3;IL20RB;LPAR3;PRNP;ATP7B;SLC12A7;DLG4;FGGY;BCL6;ATP12A;BNIP3;VEGFA;LRRC8A;SHANK3;ENDOG;MAPK3;TUB;ADCY6;MLXIPL;ABCA2;ADA;AQP3;PCSK9;ZFP36;PRKACA;LRRK1;SCNN1A;SLC25A37;FGFR4;DMTN;BBS1;VGF;LDLR;TRPV4;CROCC;RAG1;LDLRAP1;HK1;GAS6;WNT7B;COMT;PCK2;BCR;TMEM175;NEO1;INPP5D;SPATA7;TPP1;PDK2;TMX4;CDHR1;PNPLA4;KCNMA1;VSNL1;PPP1R13L;GLRX;SLC25A27;SESN2;LCAT;SMDT1;CYBRD1;SLC9A7;STK39;ACVR1B;TPCN1;AKT1;ERCC6;GPD1L;PINK1;PKD1;SLC22A17;HOMER2;CTSH;TRERF1;KCNN4;ERN1;JAK3;GSTM2;GIPR;PQLC2;MIF
3387,GO:0007173,0.0605548088348068,0.966926956600074,16,109,epidermal growth factor receptor signaling pathway,BP,ARAP1;GRB7;EGFR;RHBDF1;SHC1;PTK6;SPRY2;MVB12B;RHBDF2;PAG1;RPS6KA5;HBEGF;MVB12A;AKT1;CBLC;EREG
13495,GO:0055094,0.0606254560164846,0.985559553514539,4,16,response to lipoprotein particle,BP,APOE;CD9;CD81;LDLR
6738,GO:0030168,0.0607047225959794,0.967575318567712,15,101,platelet activation,BP,APOE;F2R;DGKA;ITPR3;CD9;SERPINE2;MAPK3;ENTPD2;DMTN;DGKQ;GAS6;VAV3;ADAMTS13;AKT1;VPS33B
11686,GO:0046500,0.0607994147378416,0.989580368507282,3,10,S-adenosylmethionine metabolic process,BP,GAMT;MTHFR;AHCYL2
10830,GO:0044344,0.0609380376439459,0.966675377616991,16,110,cellular response to fibroblast growth factor stimulus,BP,DUSP6;ZFP36L1;POSTN;HYAL1;SPRY4;FUZ;SPRY2;FAM20C;MAPK3;ZFP36;FGFR3;FGFR4;GPC1;FGFR1;FGFBP1;SULF2
1108,GO:0002697,0.0609778177619366,0.961500338412086,26,198,regulation of immune effector process,BP,HTRA1;SERPING1;PKN1;ZP3;IL20RB;TMEM173;STAT6;MYO18A;BCL6;CD81;MAPK3;HK1;TKFC;PTAFR;BCR;PRKCZ;C5;ADGRE2;ADORA2B;ABR;NLRX1;PYCARD;APOBEC3F;JAK3;MIF;STXBP2
11402,GO:0045838,0.0610165594125067,0.989527617741801,3,10,positive regulation of membrane potential,BP,ANK3;GLRX;AKT1
17659,GO:1901564,0.0610293235438362,0.946192502449284,490,4903,organonitrogen compound metabolic process,BP,TNIP1;HTRA1;DUSP6;H6PD;LMF1;CEMIP;APOE;TYSND1;IDH2;RNPEPL1;PTPRS;NT5E;NAPRT;BTBD2;RNF44;CST3;LTBP4;RAPGEF3;PGM1;GSN;CLCA2;XDH;PRDX5;PGLS;PRSS3;PRODH;NOS1;LTBP1;MARCH9;ZFP36L1;GRB7;NR1D1;CRAT;ARRDC1;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;IGF2;NME4;MST1R;LRP1;GAMT;MAPK13;CDK18;ST6GALNAC2;OBSL1;EGFR;TIMP2;ALDH4A1;MMP28;B3GAT3;FBXO2;ACOT7;DUSP5;FKBP9;PPP1R14A;UROS;JOSD2;LOXL1;DDB2;SERPING1;MTHFR;KDSR;EGR1;ULK1;RHBDF1;PKN1;NAGLU;SHC1;F2R;PTK6;BPHL;NPEPL1;ABCA7;PPP2R3B;PRSS8;PPM1J;CTSB;LPCAT4;RNF208;SHC2;ULK2;GJC2;D2HGDH;ZMYND8;ASH2L;GRAMD4;CERS4;PLAT;MMP1;ABCG1;PIK3R2;OPLAH;INO80C;NEK9;HDAC5;CRTAP;RPS6KA2;NMRK1;LRP5;HYAL1;ANO8;MARK4;TENM2;SLC2A9;ZFPM1;ERBB2;FBLN1;BRSK1;CTSF;PTPRU;OGDHL;PKD2;CBS;GID4;TMEM129;FUCA1;TST;CPT1C;EDEM1;ABTB1;SLC7A8;SPRY4;PTHLH;CDKN1C;MSRB2;CUL9;PTPRE;PAK6;HEXB;SERPINE2;VPS11;GALNT12;RNF135;LTB4R2;UNK;JADE2;THSD4;CD320;MINK1;ATP2B4;GGT1;SLC6A8;CSNK1E;ACP5;RASA4;ADAMTS7;PDCD4;GM2A;TNFRSF25;GLUL;DTX3;USP20;PEX10;LAMB2;SPATA18;WNT7A;INSR;RAB3D;LCE1E;FBXW8;ID1;GRK6;MVD;B4GAT1;NDUFS8;RABGGTA;EPHA1;ADARB1;SYNGAP1;HAGH;FBXO27;PPP1R35;DNPH1;LPAR3;PRNP;SERINC2;PAPLN;SRD5A3;FBXL8;SNX33;FBXO41;SPRY2;HINT2;BLMH;ECM1;SNX9;DLG4;SPEG;MARCH2;MTA3;MKNK2;STRADB;TALDO1;WWTR1;FAM20C;BCL6;ANKZF1;UCKL1;PFKFB2;IGFBP2;DYRK1B;MVB12B;BNIP3;CD81;SRMS;FZD8;VEGFA;VANGL2;MAST4;FBXW4;AP2A2;CEBPB;RHBDF2;DPP7;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;ZDHHC1;S1PR2;TNFRSF6B;MAPK3;FBXL16;KCNAB2;AMN;GLB1;CAPNS2;DHTKD1;RAB40B;DVL1;GALK1;MTA1;LHPP;KLHL29;ADCY6;LTA4H;WIPI2;PKN3;PHGDH;ST3GAL3;EPHB3;HES1;PC;SSH1;FURIN;MLXIPL;NAGS;CUL7;MEFV;TRIM4;NADK;TK2;LRSAM1;LY6K;ADA;FKBP10;CDC42EP5;OSBPL5;PYCR2;PIDD1;PHF21A;ACY1;CKMT1A;PFKL;IL6R;PCSK9;GGACT;ZFP36;BTBD11;HLCS;FGFR3;PRKACA;F12;ZNF862;LRRK1;NUDT10;DGUOK;MAGEF1;CYFIP2;RPS6KA5;HBEGF;RAB3B;MAP2K2;DAP;FGFR4;SPTB;FBXW5;MXRA8;TSPAN33;DMTN;MYH3;MDGA1;XYLT2;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;LDLR;LYPLAL1;CYP3A5;ABHD17C;TRPV4;PIGZ;EIF4EBP3;RAG1;DUSP7;PHLDA1;EEF2K;RHBDL1;MSLN;HMGA2;LDLRAP1;DGKQ;SEMA4C;MVB12A;HK1;NMRAL1;MIB2;FBXO17;CHST6;PADI3;GAS6;BTRC;MEX3A;PPARA;HMGCL;GUK1;STK32C;WNT7B;BLVRB;COMT;SUFU;PTAFR;RFNG;RXRA;PCK2;PCSK1;BCR;IGFBP4;SDHA;MUC19;USP21;RNF123;PRKCZ;ADAMTS13;ZDHHC24;HLTF;MDH2;INPP5D;ETFB;ABCD4;LSM14B;KLHDC8B;TPP1;PDK2;GPC1;SMOX;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;CAMKK1;SPSB3;PIN1;MAN1B1;C5;KMT5C;PROX1;WBP2;GTPBP1;DLG3;ESYT2;BIN1;SERPINB6;ASS1;SH3D19;WDR83;GLRX;JARID2;CAPN2;SESN2;TOLLIP;ADCK5;CSTB;MAN2B2;MAPRE3;DUSP23;LCAT;GUCA1B;MACROD1;GAL3ST4;TMPRSS11D;MADD;LMLN;RTN4R;ELFN2;PIGV;TIMP1;SDC1;APOBEC3C;PIGQ;GSTT1;PPM1F;SBF1;SORL1;STK39;VEGFB;ACVR1B;GSS;AHCYL2;ADORA2B;HGSNAT;ERBB3;ZER1;AKT1;HPDL;CTSD;TRAP1;ADAM19;ZNF385A;NDRG2;VPS33B;ERCC6;PCMTD2;GPD1L;SLC5A5;NAGA;SPPL2B;IL17RD;UQCR11;RPL39L;ADCK2;SSH3;PINK1;PKD1;LONP2;SNTA1;KDM4B;RGS14;EIF4G3;CTSH;ABHD14B;P3H4;MLST8;RSAD1;CBLC;RNF187;PYCARD;MAP2K3;PNPO;POMT1;PCSK1N;NDUFV3;STK17A;ERN1;RANBP9;APOBEC3F;FBXL20;GCAT;MOCS1;SIRT3;TAZ;JAK3;BCKDHA;MAST3;NEIL1;ING4;EIF4E3;GALNS;EREG;FAM162A;PPCS;GSTM2;PODXL2;TRIM7;ADAMTSL4;TTLL11;NDST2;RPL13A;ALG12;RAB40C;MIF;SULF2;UBL5
12643,GO:0050873,0.0611707406328553,0.982075387850776,5,23,brown fat cell differentiation,BP,ZNF516;ITGA6;BNIP3;CEBPB;TRPV4
9695,GO:0038127,0.0611993436405383,0.965191846040867,18,126,ERBB signaling pathway,BP,ARAP1;GRB7;EGFR;RHBDF1;SHC1;PTK6;ERBB2;SPRY2;MVB12B;RHBDF2;PAG1;RPS6KA5;HBEGF;MVB12A;ERBB3;AKT1;CBLC;EREG
3241,GO:0006907,0.0615008423495436,0.985280108360027,4,16,pinocytosis,BP,SNX33;EHD4;MAPKAPK3;PYCARD
6568,GO:0022406,0.0616838306372487,0.962700340589727,22,162,membrane docking,BP,TCTN1;MARK4;EXOC2;NINL;VPS11;NPHP4;CSNK1E;RAB3D;CEP250;RAB40B;FBF1;PRKACA;RAB3B;STX10;NDE1;ESYT2;SNPH;TSNARE1;VPS33B;SFI1;RAB40C;STXBP2
13969,GO:0060711,0.0617888880018669,0.976962630436598,7,37,labyrinthine layer development,BP,ZFP36L1;PLCD1;FBXW8;PLCD3;HES1;WNT7B;AKT1
13248,GO:0051963,0.0621563736552768,0.974918453807573,8,44,regulation of synapse assembly,BP,ADGRL1;EPHB2;NLGN2;WNT7A;EPHB3;EEF2K;ADGRB2;SLITRK6
3211,GO:0006865,0.062410211766434,0.969304571659571,12,76,amino acid transport,BP,SLC43A1;SLC7A8;PRAF2;VAMP2;NTSR1;SLC6A8;SERINC2;SLC38A10;STK39;SLC25A29;APBA1;PQLC2
16835,GO:0098793,0.0625724105946276,0.960015939810475,27,207,presynapse,CC,ADGRL1;PTPRS;SYTL1;NLGN2;SYT8;KCNC4;DBNDD1;BRSK1;DNM1;RIMS3;VAMP2;NTSR1;GLUL;WNT7A;RAB3D;DLG4;KCNAB2;RAB40B;DVL1;MCTP1;RAB3B;PI4K2A;SEMA4C;BLVRB;SNPH;APBA1;RAB40C
7023,GO:0030808,0.0629300597205535,0.967968730592062,13,85,regulation of nucleotide biosynthetic process,BP,APOE;NOS1;TIMP2;PTHLH;LTB4R2;INSR;PFKFB2;MLXIPL;PPARA;GUCA1B;ADORA2B;PINK1;TAZ
17451,GO:1900371,0.0629300597205535,0.967968730592062,13,85,regulation of purine nucleotide biosynthetic process,BP,APOE;NOS1;TIMP2;PTHLH;LTB4R2;INSR;PFKFB2;MLXIPL;PPARA;GUCA1B;ADORA2B;PINK1;TAZ
26,GO:0000050,0.0629696935853449,0.98904940388393,3,10,urea cycle,BP,NAGS;NMRAL1;ASS1
6179,GO:0019627,0.0629696935853449,0.98904940388393,3,10,urea metabolic process,BP,NAGS;NMRAL1;ASS1
13769,GO:0060384,0.0629902333685858,0.98480132479293,4,16,innervation,BP,SERPINE2;ADARB1;SLITRK6;SULF2
17307,GO:1900006,0.0631329604267893,0.972763967690103,9,52,positive regulation of dendrite development,BP,APOE;SHANK2;OBSL1;CRTC1;ZMYND8;FBXW8;SHANK3;CUL7;EEF2K
9931,GO:0042310,0.0631756651794921,0.976325016170774,7,37,vasoconstriction,BP,EGFR;F2R;BBS2;DOCK4;HTR7;PTAFR;AKT1
548,GO:0001669,0.0632005713467078,0.97269189905593,9,53,acrosomal vesicle,CC,LOXL1;SYT8;BSG;HEXB;ADAM15;LY6K;PRKACA;SUN1;POMT1
7613,GO:0032024,0.0632355851580508,0.974343687388426,8,45,positive regulation of insulin secretion,BP,NLGN2;GLUL;PFKFB2;PCK2;TM7SF3;VSNL1;SIRT3;GIPR
9031,GO:0035265,0.0632419549637288,0.966879982106188,14,92,organ growth,BP,DUSP6;WWC3;THBS3;SPRY2;ACVR2B;EVC;FGFR3;RXRA;FGFR1;PIN1;PROX1;JARID2;AKT1;RARG
5537,GO:0016540,0.0632601735224197,0.988977709602297,3,10,protein autoprocessing,BP,PCSK9;F12;CAPN2
15131,GO:0071276,0.0633506630851882,0.981147406986879,5,24,cellular response to cadmium ion,BP,FOS;GSN;EGFR;MAPK3;AKT1
12380,GO:0048844,0.0636203332134574,0.976119809436073,7,37,artery morphogenesis,BP,APOE;LRP1;PKD2;ZMIZ1;VEGFA;HES1;PROX1
16242,GO:0090330,0.0636822186267585,0.984577460510058,4,16,regulation of platelet aggregation,BP,CD9;SERPINE2;DMTN;VPS33B
6452,GO:0021783,0.0639110102378187,0.988816540381204,3,10,preganglionic parasympathetic fiber development,BP,ADARB1;HES1;SEMA3F
9187,GO:0035587,0.0639151657392442,0.988815508970207,3,10,purinergic receptor signaling pathway,BP,ADA;PTAFR;ADORA2B
11512,GO:0046060,0.0639410192251839,0.994168349898163,2,5,dATP metabolic process,BP,ADA;GUK1
13908,GO:0060600,0.0639684884237151,0.988802271418099,3,10,dichotomous subdivision of an epithelial terminal unit,BP,CELSR1;VANGL2;CTSH
6752,GO:0030195,0.0640690924868,0.978200055678371,6,30,negative regulation of blood coagulation,BP,APOE;SERPING1;PLAT;CD9;SERPINE2;F12
17330,GO:1900047,0.0640690924868,0.978200055678371,6,30,negative regulation of hemostasis,BP,APOE;SERPING1;PLAT;CD9;SERPINE2;F12
8559,GO:0034045,0.0642524790196535,0.984392304618026,4,16,phagophore assembly site membrane,CC,ULK1;ULK2;WIPI2;ATG2A
17980,GO:1902475,0.0643745493314207,0.978069480389297,6,30,L-alpha-amino acid transmembrane transport,BP,SLC43A1;SLC7A8;PRAF2;NTSR1;SLC25A29;PQLC2
11071,GO:0045091,0.0643980504877291,0.988695451063533,3,10,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,HMGA2;APOBEC3C;APOBEC3F
14146,GO:0061061,0.0644050044120638,0.953918419708102,46,380,muscle structure development,BP,FOS;FLNC;MEF2D;NOS1;ZFP36L1;EPAS1;OBSCN;IGF2;NFATC4;OBSL1;FHL1;EGR1;LAMA5;HDAC5;THRA;ZFPM1;TMOD2;PDCD4;ADARB1;SPEG;DYRK1B;VEGFA;VANGL2;OLFM2;TNNT1;HES1;EVC;HBEGF;MYH3;SEMA4C;POU6F1;RXRA;GPC1;FGFR1;PIN1;TMEM204;PROX1;BIN1;JARID2;CAPN2;SDC1;MEF2B;ERBB3;AKT1;TAZ;EREG
3587,GO:0008021,0.0644051016141162,0.965275592758297,15,103,synaptic vesicle,CC,PTPRS;SYT8;DBNDD1;BRSK1;DNM1;VAMP2;RAB3D;DLG4;RAB40B;MCTP1;RAB3B;PI4K2A;SEMA4C;APBA1;RAB40C
486,GO:0001539,0.0644310960415244,0.98433418586474,4,16,cilium or flagellum-dependent cell motility,BP,BBS2;DNAH1;GAS8;MAFIP
13692,GO:0060285,0.0644310960415244,0.98433418586474,4,16,cilium-dependent cell motility,BP,BBS2;DNAH1;GAS8;MAFIP
11855,GO:0046885,0.0644356675977146,0.984332697586769,4,16,regulation of hormone biosynthetic process,BP,CYP27B1;EGR1;DGKQ;TRERF1
11849,GO:0046879,0.0644521535483537,0.960343607591701,23,172,hormone secretion,BP,LTBP4;RAPGEF3;NR1D1;EGFR;HADH;NLGN2;LRP5;ITPR3;GLUL;PFKFB2;ARL2;ACVR2B;RASL10B;PFKL;VGF;TRPV4;PCK2;TM7SF3;FGFR1;VSNL1;SIRT3;SLC2A1;GIPR
44,GO:0000096,0.0645224944712292,0.97800617492836,6,30,sulfur amino acid metabolic process,BP,MTHFR;CBS;GGT1;BLMH;COMT;AHCYL2
3231,GO:0006893,0.0646901010771594,0.973627062041217,8,45,Golgi to plasma membrane transport,BP,BBS2;ANK3;EXOC2;VAMP2;AMN;OSBPL5;BBS1;LLGL1
17905,GO:1902259,0.0648009197451452,0.988594978033195,3,10,regulation of delayed rectifier potassium channel activity,BP,KCNG1;ANK3;VAMP2
4087,GO:0009150,0.0651217444438037,0.954079215001645,42,358,purine ribonucleotide metabolic process,BP,APOE;NT5E;RAPGEF3;PGM1;NOS1;NME4;TIMP2;ACOT7;OGDHL;PKD2;PTHLH;LTB4R2;INSR;NDUFS8;DLG4;FAM20C;PFKFB2;VEGFA;DHTKD1;GALK1;ADCY6;MLXIPL;NADK;PFKL;NUDT10;MYH3;HK1;PPARA;GUK1;SDHA;GTPBP1;DLG3;GUCA1B;ADORA2B;UQCR11;PINK1;ABHD14B;NDUFV3;MOCS1;TAZ;PPCS;PODXL2
1024,GO:0002526,0.0651278043982307,0.9716560798565,9,54,acute inflammatory response,BP,CTNNBIP1;SERPING1;ZP3;IL20RB;CD81;CEBPB;IL6R;F12;C5
8989,GO:0035150,0.0652234415056986,0.968834259995454,11,69,regulation of tube size,BP,APOE;NOS1;EGFR;F2R;BBS2;DOCK4;ADCY6;HTR7;PTAFR;ADORA2B;AKT1
12647,GO:0050880,0.0652234415056986,0.968834259995454,11,69,regulation of blood vessel size,BP,APOE;NOS1;EGFR;F2R;BBS2;DOCK4;ADCY6;HTR7;PTAFR;ADORA2B;AKT1
9913,GO:0042277,0.0652884766299195,0.959763428568068,23,173,peptide binding,MF,CEMIP;APOE;RNPEPL1;CST3;EPHB2;FBXO2;SLC7A8;VIPR1;INSR;PRNP;LTA4H;FURIN;LDLR;LDLRAP1;PEX7;RXRA;TPP1;SORL1;GSS;TMEM158;APBA1;GSTM2;GIPR
17441,GO:1900273,0.0653372788965561,0.988460778463639,3,10,positive regulation of long-term synaptic potentiation,BP,EPHB2;CRTC1;SHANK3
9939,GO:0042326,0.065406725889012,0.953703164830235,43,353,negative regulation of phosphorylation,BP,TNIP1;DUSP6;APOE;XDH;EPHB2;DUSP5;PKN1;PTK6;PIK3R2;LRP5;FBLN1;SPRY4;CDKN1C;PDCD4;EPHA1;ADARB1;PRNP;SPRY2;WWTR1;DVL1;MLXIPL;LRRK1;DMTN;MAPK8IP1;DUSP7;DGKQ;PPARA;PRKCZ;PIN1;GRB10;RTN4R;PPM1F;SORL1;STK39;AKT1;NDRG2;GPD1L;PINK1;RGS14;CBLC;PYCARD;RANBP9;SIRT3
4700,GO:0010872,0.0654075169026286,0.993956375275627,2,5,regulation of cholesterol esterification,BP,APOE;ABCG1
11672,GO:0046479,0.0654119336221348,0.988442060198124,3,10,glycosphingolipid catabolic process,BP,HEXB;GM2A;NAGA
16785,GO:0098661,0.0654676075287511,0.973242435457216,8,45,inorganic anion transmembrane transport,BP,CLCA2;SLC20A1;PRNP;SLC12A7;TTYH3;SLC37A2;PTAFR;ANO9
10476,GO:0043395,0.0654869313135518,0.988423246283833,3,10,heparan sulfate proteoglycan binding,MF,PTPRS;LRP1;GPC1
15469,GO:0071868,0.0657797700193869,0.980316031607816,5,23,cellular response to monoamine stimulus,BP,ATP2B4;ID1;MAPK3;ADCY6;PRKACA
15471,GO:0071870,0.0657797700193869,0.980316031607816,5,23,cellular response to catecholamine stimulus,BP,ATP2B4;ID1;MAPK3;ADCY6;PRKACA
17676,GO:1901607,0.0658364584043423,0.971323915277593,9,53,alpha-amino acid biosynthetic process,BP,GAMT;CBS;ATP2B4;GGT1;GLUL;PHGDH;NAGS;PYCR2;ASS1
12057,GO:0048029,0.065876454641821,0.973039750215147,8,45,monosaccharide binding,MF,PYGL;BSG;TALDO1;GALK1;SLC2A3;PFKL;HK1;PHYH
894,GO:0002274,0.0659009842437342,0.952073422080051,50,426,myeloid leukocyte activation,BP,GAA;NAPRT;PYGB;CST3;PGM1;GSN;NDRG1;PRSS3;TIMP2;PYGL;CTSB;FUCA1;VAT1;HEXB;VAMP2;GM2A;RAB3D;NBEAL2;TMEM173;RNASET2;MYO18A;DNASE1L1;AP2A2;DPP7;KCNAB2;GLB1;LTA4H;SLC2A3;PFKL;RHOF;PI4K2A;LDLR;PTAFR;BCR;CTSZ;SERPINB6;TOLLIP;CSTB;ADGRE2;CD68;ACTR1B;ADORA2B;HGSNAT;ABR;CTSD;CTSH;PYCARD;GALNS;MIF;STXBP2
998,GO:0002467,0.0659910682348248,0.988296527688446,3,10,germinal center formation,BP,PKN1;BCL6;ADA
12045,GO:0048016,0.0661662597626513,0.977300080787887,6,30,inositol phosphate-mediated signaling,BP,NFATC4;ITPR3;ATP2B4;PRNP;ADGRB2;ERBB3
15485,GO:0071889,0.0661805471643515,0.980161159808219,5,23,14-3-3 protein binding,MF,ZFP36L1;KIF13B;ZFP36;PRKCZ;AKT1
15828,GO:0072574,0.0661868257314408,0.988247205049051,3,10,hepatocyte proliferation,BP,CEBPB;PROX1;SULF2
15829,GO:0072575,0.0661868257314408,0.988247205049051,3,10,epithelial cell proliferation involved in liver morphogenesis,BP,CEBPB;PROX1;SULF2
8314,GO:0033173,0.0662300262911325,0.980142018998527,5,23,calcineurin-NFAT signaling cascade,BP,NFATC4;ATP2B4;PRNP;ADGRB2;ERBB3
12562,GO:0050764,0.066300422370754,0.974815177442882,7,38,regulation of phagocytosis,BP,ABCA7;MYO18A;TUB;GAS6;BCR;ABR;PYCARD
13698,GO:0060294,0.0663503353095548,0.988205957228066,3,10,cilium movement involved in cell motility,BP,BBS2;GAS8;MAFIP
2984,GO:0006536,0.066394287654882,0.980078442626007,5,23,glutamate metabolic process,BP,PRODH;ALDH4A1;GGT1;GLUL;NAGS
14152,GO:0061078,0.0664170297355424,1,1,1,positive regulation of prostaglandin secretion involved in immune response,BP,MIF
16236,GO:0090323,0.0664170297355424,1,1,1,prostaglandin secretion involved in immune response,BP,MIF
10500,GO:0043433,0.0665524821662086,0.962394367618319,17,120,negative regulation of DNA binding transcription factor activity,BP,CTNNBIP1;RBCK1;MDFI;MXI1;THRA;PKD2;ID1;PRNP;DAP;BHLHE40;GAS6;BTRC;SUFU;PROX1;NLRX1;PKD1;PYCARD
8587,GO:0034112,0.0666582319102746,0.993773304143289,2,5,positive regulation of homotypic cell-cell adhesion,BP,ANK3;DMTN
11225,GO:0045444,0.0666991774937328,0.960382161201693,20,145,fat cell differentiation,BP,ZFP36L1;NR1D1;BBS2;ZNF516;LRP5;ZFPM1;SH3PXD2B;ITGA6;WWTR1;BNIP3;CEBPB;HES1;ZFP36;TRPV4;HMGA2;CCDC85B;CCDC71L;AKT1;ZNF385A;TMEM120A
18808,GO:1904427,0.0667702769163048,0.974595188798002,7,38,positive regulation of calcium ion transmembrane transport,BP,CEMIP;F2R;GJC2;PKD2;NTSR1;EHD3;GSTM2
4994,GO:0015149,0.0667839547006196,0.988096348693258,3,10,hexose transmembrane transporter activity,MF,SLC2A9;SLC2A3;SLC2A1
6285,GO:0019904,0.0668165524045048,0.949385614790312,65,564,protein domain specific binding,MF,ESPN;CTNNBIP1;ERCC1;SHANK2;RAPGEF3;SH3BP2;EFS;EPN3;ARHGEF4;THRA;DOCK4;PKD2;PLXNB3;ANGEL1;VPS11;ATP2B4;TFDP2;INSR;SH3PXD2B;SYNGAP1;CEP250;DLG4;ARHGAP27;CHMP1B;FZD8;ELMO3;AP2A2;SHANK3;ADAM15;CALCOCO1;CARD19;WIPF1;L3MBTL1;FHOD1;PAG1;SH2D2A;SCNN1A;MAP2K2;DAP;TRPV4;BHLHE40;HMGA2;MVB12A;ZXDC;PPARA;RXRA;PRKCZ;CAPG;INPP5D;CEP68;NDE1;PROX1;DLG3;WNT3;FAM189B;ADAM19;PINK1;PKD1;SNTA1;HOMER2;CBLC;PYCARD;WBP1;LITAF;SHISA6
6946,GO:0030595,0.0668385591286461,0.964616296386424,14,97,leukocyte chemotaxis,BP,PGF;MMP28;VEGFA;MAPK3;IL6R;TRPV4;GAS6;VAV3;C5;ADGRE2;LYST;VEGFB;CKLF;MIF
1485,GO:0003824,0.0668656542202468,0.941038414968613,441,4352,catalytic activity,MF,HTRA1;DUSP6;H6PD;CEMIP;TYSND1;IDH2;RNPEPL1;PTPRS;ERCC1;NT5E;GAA;NAPRT;PYGB;RNF44;LTBP4;PGM1;CYP27B1;CLCA2;XDH;PRDX5;PGLS;PRSS3;PRODH;NOS1;LTBP1;MARCH9;CRAT;ALOX15B;POLD4;RBCK1;EPHB2;OBSCN;CPT2;GPX3;NME4;MST1R;GAMT;MAPK13;CDK18;ST6GALNAC2;EGFR;ALDH4A1;MMP28;B3GAT3;HADH;NLGN2;CRYL1;SUGCT;ACSF2;FBXO2;ACOT7;DUSP5;FKBP9;ISYNA1;UROS;JOSD2;LOXL1;DDB2;MTHFR;KDSR;ULK1;RHBDF1;PKN1;PYGL;NAGLU;PTK6;GNAL;BPHL;NPEPL1;ABCA7;PPP2R3B;CA12;GALE;PRSS8;PPM1J;CTSB;LPCAT4;DNAH1;RNF208;ULK2;DGKA;DHRS1;D2HGDH;ASH2L;CERS4;PLAT;MMP1;ABCG1;DHRS11;PIK3R2;OPLAH;NEK9;HDAC5;PLD3;RPS6KA2;NMRK1;HYAL1;TUBG2;MARK4;B4GALNT4;ERBB2;NUDT8;BRSK1;CTSF;PTPRU;OGDHL;CBS;GID4;TMEM129;FUCA1;TST;CPT1C;EDEM1;VAT1;DNM1;MSRB2;KIF13B;PTPRE;PAK6;HEXB;GALNT12;RNF135;JADE2;THSD4;MINK1;ATP2B4;GGT1;CSNK1E;ACP5;PLCD1;AGAP1;ZFYVE21;ADAMTS7;GM2A;DHRS4L2;GLUL;RHOD;DTX3;USP20;INSR;RAB3D;PLCXD1;FBXW8;AKR7A2;GRK6;MVD;B4GAT1;POLL;NDUFS8;RABGGTA;EPHA1;ADARB1;TXNRD3;HAGH;FBXO27;DNMT3A;DNPH1;DHX32;PAPLN;SRD5A3;ATP7B;EFNB3;IAH1;RNASET2;FBXL8;FBXO41;HINT2;BLMH;DLG4;SPEG;ABCD1;MARCH2;FGGY;MTA3;MKNK2;PLCD3;NT5DC1;STRADB;TALDO1;ISG20;RAB25;FAM20C;ANKZF1;UCKL1;PFKFB2;ATP12A;DYRK1B;SRMS;ENTPD6;DNASE1L1;ARL2;MAST4;FBXW4;RHBDF2;DPP7;HSD11B1L;ACVR2B;ADAM15;ZDHHC1;ENDOG;MAPK3;FBXL16;KCNAB2;GLB1;CAPNS2;DHTKD1;EXD3;RAB40B;TNNT1;ENTPD2;GALK1;MTA1;LHPP;KLHL29;ADCY6;LTA4H;PKN3;PHGDH;ST3GAL3;EPHB3;PHYHD1;PC;ACAD10;SSH1;COMTD1;FURIN;NAGS;FAM86C2P;MBOAT7;TRIM4;NRP2;NADK;ABCA2;TK2;LRSAM1;ADA;FKBP10;PYCR2;RETSAT;PHF21A;RASL10B;MYH16;ACY1;CKMT1A;PFKL;PCSK9;GGACT;RHOF;HLCS;FGFR3;NSUN7;PRKACA;F12;ZNF862;LRRK1;NUDT10;SPATA20;PLCH2;DGUOK;RPS6KA5;HBEGF;RAB3B;MAP2K2;PI4K2A;FGFR4;FBXW5;PMVK;MYH3;XYLT2;HDAC11;LYPLAL1;CYP3A5;ACOT11;ABHD17C;MPG;RHOBTB2;PIGZ;RRNAD1;RAG1;DUSP7;EEF2K;RHBDL1;HMGA2;TM7SF2;DGKQ;HK1;MIB2;FBXO17;CHST6;SDHAF4;PADI3;BTRC;HMGCL;TKFC;GUK1;STK32C;BLVRB;COMT;ALDH16A1;AIG1;RFNG;DMC1;IMPA2;PAN2;PCK2;PCSK1;BCR;SDHA;USP21;RNF123;WDR60;PRKCZ;ADAMTS13;ZDHHC24;HAGHL;HLTF;MDH2;INPP5D;ETFB;ABCD4;KLHDC8B;TPP1;PDK2;TMX4;SMOX;MAPKAPK3;FGFR1;CTSZ;CAMKK1;SPSB3;PIN1;MAN1B1;PNPLA4;KMT5C;PHYH;CMBL;GTPBP1;DLG3;PI4KAP2;ASS1;GLRX;CES2;CAPN2;SESN2;NDUFA4L2;ADCK5;TSTA3;MAN2B2;DUSP23;LCAT;MACROD1;GAL3ST4;TMPRSS11D;CYBRD1;LMLN;PIGV;GRHPR;APOBEC3C;PIGQ;GSTT1;PPM1F;KIAA1191;SBF1;STK39;ACVR1B;GSS;AHCYL2;HGSNAT;ERBB3;ZER1;CYP2S1;AKT1;HPDL;CTSD;SEPT8;ADAM19;TUT1;SMARCA1;ERCC6;PCMTD2;ACP6;GPD1L;NAGA;SPPL2B;UQCR11;ADCK2;SSH3;PINK1;LONP2;KDM4B;PLPPR2;HEXDC;CTSH;ABHD14B;AGPAT4;RSAD1;CBLC;RNF187;PYCARD;MAP2K3;PNPO;POMT1;PMS2P5;AS3MT;NDUFV3;STK17A;ERN1;APOBEC3F;PRIMPOL;ACADS;FBXL20;GCAT;WDR63;MOCS1;SIRT3;ALKBH6;MLYCD;TAZ;RNASEK;JAK3;BCKDHA;MAST3;KIFC2;NEIL1;FUK;GALNS;EREG;PPCS;GSTM2;ABHD14A;TRIM7;ADAMTSL4;TTLL11;POLM;NDST2;AGPAT3;ALG12;RAB40C;MIF;SULF2;KIF26B
3937,GO:0008643,0.0669278446025079,0.964632336075371,14,93,carbohydrate transport,BP,PIK3R2;SLC2A9;INSR;SLC2A3;AQP3;SLC37A2;PRKCZ;CLTCL1;SLC25A27;GRB10;SESN2;RTN2;AKT1;SLC2A1
12357,GO:0048771,0.0669654299146126,0.964591257691559,14,94,tissue remodeling,BP,CST3;EPAS1;EGFR;F2R;LRP5;ACP5;RAB3D;ACVR2B;LRRK1;BCR;INPP5D;TPP1;ABR;P3H4
6209,GO:0019751,0.0671158517895077,0.965471592120778,13,86,polyol metabolic process,BP,CYP27B1;ISYNA1;NTSR1;PLCD1;PLCD3;GALK1;NUDT10;PLCH2;TKFC;PTAFR;IMPA2;PCK2;INPP5D
4072,GO:0009135,0.0671438658591556,0.964482707284419,14,94,purine nucleoside diphosphate metabolic process,BP,PGM1;OGDHL;INSR;DLG4;PFKFB2;DHTKD1;ENTPD2;GALK1;MLXIPL;PFKL;HK1;PPARA;GUK1;DLG3
4111,GO:0009179,0.0671438658591556,0.964482707284419,14,94,purine ribonucleoside diphosphate metabolic process,BP,PGM1;OGDHL;INSR;DLG4;PFKFB2;DHTKD1;ENTPD2;GALK1;MLXIPL;PFKL;HK1;PPARA;GUK1;DLG3
12938,GO:0051346,0.067143998317662,0.954471954912942,34,276,negative regulation of hydrolase activity,BP,CST3;PRDX5;NOS1;TIMP2;PPP1R14A;SERPING1;PLXNB3;SERPINE2;RASA4;PPP1R35;PAPLN;SPRY2;ECM1;VEGFA;ARL2;TNFRSF6B;GPSM1;FURIN;RAG1;GAS6;PRKCZ;C5;DLG3;BIN1;SERPINB6;CSTB;ELFN2;TIMP1;SORL1;AKT1;PCIF1;PCSK1N;NEIL1;SFI1
2101,GO:0004879,0.067182911182162,0.976860881859368,6,30,nuclear receptor activity,MF,NR1D1;THRA;PPARA;RXRA;RXRB;RARG
16724,GO:0098531,0.067182911182162,0.976860881859368,6,30,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,NR1D1;THRA;PPARA;RXRA;RXRB;RARG
16834,GO:0098792,0.0672534792571845,0.987977302516168,3,10,xenophagy,BP,MAPK3;WIPI2;LRSAM1
14702,GO:0070382,0.0674009584231697,0.962596041847884,16,112,exocytic vesicle,CC,PTPRS;SYTL1;SYT8;DBNDD1;BRSK1;DNM1;VAMP2;RAB3D;DLG4;RAB40B;MCTP1;RAB3B;PI4K2A;SEMA4C;APBA1;RAB40C
16626,GO:0097529,0.0674498770551522,0.966307075018326,12,80,myeloid leukocyte migration,BP,PGF;MMP28;VEGFA;MAPK3;IL6R;TRPV4;VAV3;C5;ADGRE2;VEGFB;CKLF;MIF
11391,GO:0045821,0.0674938709869772,0.98791620688556,3,10,positive regulation of glycolytic process,BP,INSR;PFKFB2;MLXIPL
12848,GO:0051197,0.0674938709869772,0.98791620688556,3,10,positive regulation of coenzyme metabolic process,BP,INSR;PFKFB2;MLXIPL
18621,GO:1903960,0.0675580301848076,0.9878998842057,3,10,negative regulation of anion transmembrane transport,BP,STK39;ANO9;AKT1
10419,GO:0043292,0.0675853415801274,0.961017234093416,18,130,contractile fiber,CC,FLNC;CST3;NOS1;PARVB;SCN8A;OBSCN;MYZAP;OBSL1;ANK3;ATP2B4;TMOD2;TNNT1;MYH3;AHNAK2;TWF2;BIN1;SYNC;SLC2A1
5468,GO:0016411,0.0676566174150711,0.979588205147463,5,23,acylglycerol O-acyltransferase activity,MF,LPCAT4;MBOAT7;AGPAT4;TAZ;AGPAT3
828,GO:0002116,0.067736351779899,0.98785448088128,3,10,semaphorin receptor complex,CC,PLXNB3;PLXNB1;NRP2
5846,GO:0017154,0.067736351779899,0.98785448088128,3,10,semaphorin receptor activity,MF,PLXNB3;PLXNB1;NRP2
14943,GO:0070875,0.0677578501456631,0.987849003434268,3,10,positive regulation of glycogen metabolic process,BP,IGF2;INSR;AKT1
8669,GO:0034284,0.0679179129563963,0.960800479290513,18,130,response to monosaccharide,BP,NR1D1;IGF2;EGR1;LRP5;VAMP2;GLUL;PFKFB2;ACVR2B;ENDOG;MLXIPL;PFKL;PRKACA;GAS6;PCK2;VSNL1;SESN2;ERN1;GIPR
13714,GO:0060314,0.0680210172775093,0.982982504798354,4,17,regulation of ryanodine-sensitive calcium-release channel activity,BP,NOS1;PKD2;PRKACA;GSTM2
4459,GO:0010464,0.0681619427258455,0.979391137959644,5,23,regulation of mesenchymal cell proliferation,BP,CTNNBIP1;LRP5;VEGFA;FBXW4;FGFR1
7392,GO:0031467,0.0682063416234128,0.993543804491022,2,5,Cul7-RING ubiquitin ligase complex,CC,FBXW8;CUL7
6652,GO:0030016,0.0682247459544789,0.961308058960357,17,121,myofibril,CC,FLNC;NOS1;PARVB;SCN8A;OBSCN;MYZAP;OBSL1;ANK3;ATP2B4;TMOD2;TNNT1;MYH3;AHNAK2;TWF2;BIN1;SYNC;SLC2A1
11489,GO:0046006,0.0684547594036156,0.979166179095804,5,24,regulation of activated T cell proliferation,BP,IGF2;PRNP;IGFBP2;ICOSLG;PYCARD
6835,GO:0030315,0.0684695011366238,0.976302372781216,6,30,T-tubule,CC,NOS1;ANK3;ATP2B4;AHNAK2;BIN1;RTN2
13640,GO:0060191,0.0684830357680169,0.971692511886013,8,46,regulation of lipase activity,BP,LMF1;LRP1;EGFR;FURIN;FGFR3;PTAFR;PRKCZ;FGFR1
12780,GO:0051100,0.0684939047352263,0.961122062278687,17,122,negative regulation of binding,BP,CTNNBIP1;NFATC4;MDFI;ZFPM1;CSNK1E;ID1;ADAM15;MAPK3;DVL1;GPSM1;PCSK9;HMGA2;PPARA;CTSZ;PIN1;SORL1;AKT1
947,GO:0002366,0.0684996826819474,0.949422166834841,54,465,leukocyte activation involved in immune response,BP,ERCC1;GAA;NAPRT;PYGB;CST3;PGM1;GSN;PRSS3;TIMP2;PYGL;CTSB;ZFPM1;FUCA1;VAT1;HEXB;VAMP2;GM2A;RAB3D;NBEAL2;TMEM173;RNASET2;STAT6;BCL6;DNASE1L1;AP2A2;DPP7;KCNAB2;GLB1;LTA4H;SLC2A3;ADA;PFKL;RHOF;PI4K2A;PTAFR;BCR;PRKCZ;CTSZ;SERPINB6;TOLLIP;CSTB;ADGRE2;CD68;ACTR1B;ADORA2B;HGSNAT;ABR;CTSD;CTSH;PYCARD;JAK3;GALNS;MIF;STXBP2
16640,GO:0097553,0.0685373377618039,0.966939649327047,11,70,calcium ion transmembrane import into cytosol,BP,CEMIP;NOS1;F2R;PKD2;ITPR3;NTSR1;ATP2B4;PRNP;PRKACA;TPCN1;GSTM2
19597,GO:1990782,0.0686244767804069,0.969863880913551,9,53,protein tyrosine kinase binding,MF,SHC1;SHC2;PIK3R2;DOCK4;PAG1;PITPNM1;GAS6;PITPNM3;CBLC
6105,GO:0019359,0.0688956924255247,0.963414415745153,14,94,nicotinamide nucleotide biosynthetic process,BP,IDH2;NAPRT;PGM1;NMRK1;OGDHL;INSR;PFKFB2;DHTKD1;GALK1;MLXIPL;NADK;PFKL;HK1;PPARA
6107,GO:0019363,0.0688956924255247,0.963414415745153,14,94,pyridine nucleotide biosynthetic process,BP,IDH2;NAPRT;PGM1;NMRK1;OGDHL;INSR;PFKFB2;DHTKD1;GALK1;MLXIPL;NADK;PFKL;HK1;PPARA
12636,GO:0050866,0.0690024085808538,0.962425596176549,15,103,negative regulation of cell activation,BP,APOE;PKN1;ERBB2;CD9;SERPINE2;IL20RB;PRNP;BCL6;CEBPB;PAG1;LDLR;BCR;INPP5D;ABR;JAK3
11857,GO:0046887,0.0690141777406694,0.966669325573284,11,70,positive regulation of hormone secretion,BP,EGFR;NLGN2;GLUL;PFKFB2;RASL10B;PCK2;TM7SF3;FGFR1;VSNL1;SIRT3;GIPR
4259,GO:0009617,0.0690613574731545,0.952758822936811,35,289,response to bacterium,BP,TNIP1;FOS;CYP27B1;NOS1;NR1D1;LOXL1;SHC1;F2R;HDAC5;ACP5;PDCD4;TNFRSF25;CEBPB;TNFRSF6B;MAPK3;TNFRSF14;IL6R;ZFP36;MAPKBP1;VGF;TNFRSF1A;COMT;PTAFR;PCK2;BCR;GSDMC;ADAMTS13;MAPKAPK3;LYST;GSDMA;ABR;AKT1;PYCARD;LITAF;MIF
16209,GO:0090287,0.0691998558457916,0.957081117591393,23,172,regulation of cellular response to growth factor stimulus,BP,HTRA1;DUSP6;LTBP4;XDH;LTBP1;SPRY4;CDKN1C;FUZ;SPRY2;FAM20C;VEGFA;HES1;CYFIP2;VASN;NEO1;GPC1;FGFR1;PIN1;TMEM204;GRB10;FGFBP1;EPN2;SULF2
538,GO:0001657,0.069440229054193,0.967849205408527,10,61,ureteric bud development,BP,CTNNBIP1;PGF;LAMA5;PKD2;VEGFA;HES1;FGFR1;WNT2B;SDC1;KIF26B
3400,GO:0007189,0.069461985548229,0.973327323139911,7,38,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1;ADGRF1;GNAL;PTHLH;ATP2B4;ADCY6;ADORA2B
18658,GO:1904031,0.0695995437147368,0.975727620858992,6,31,positive regulation of cyclin-dependent protein kinase activity,BP,EGFR;PKD2;PROX1;MAPRE3;AKT1;PKD1
18403,GO:1903510,0.0696187312723563,0.965112109534926,12,77,mucopolysaccharide metabolic process,BP,CEMIP;B3GAT3;HYAL1;HEXB;B4GAT1;GLB1;ST3GAL3;XYLT2;CHST6;AKT1;GALNS;NDST2
18002,GO:1902532,0.0698898076843609,0.949485585717589,47,393,negative regulation of intracellular signal transduction,BP,TNIP1;DUSP6;APOE;WWC3;XDH;EPHB2;TIMP2;DUSP5;PIK3R2;FBLN1;PKD2;SPRY4;SERPINE2;ATP2B4;RASA4;PDCD4;SYNGAP1;PRNP;SPRY2;BCL6;CARD19;MAPKBP1;MAPK8IP1;DUSP7;TNFAIP8L1;TKFC;ARAP3;PIN1;SESN2;TMEM161A;RTN4R;SORL1;AKT1;TRAP1;NLRX1;ZNF385A;NDRG2;GPD1L;PINK1;RGS14;CBLC;PYCARD;RANBP9;SIRT3;C12ORF66;GSTM2;MIF
20205,GO:2001179,0.0699588118915714,0.993280164945329,2,5,regulation of interleukin-10 secretion,BP,PRKCZ;PYCARD
10350,GO:0043184,0.069984679026999,0.993276243085874,2,5,vascular endothelial growth factor receptor 2 binding,MF,VEGFA;VEGFB
12877,GO:0051249,0.0701724703796184,0.953163879228416,31,246,regulation of lymphocyte activation,BP,GSN;ZFP36L1;IGF2;PKN1;ZP3;ERBB2;CD320;ZMIZ1;IL20RB;PRNP;EFNB3;STAT6;BCL6;IGFBP2;CD81;CEBPB;HES1;TNFRSF14;ADA;PAG1;SOX13;RAG1;GAS6;VAV3;PRKCZ;INPP5D;ICOSLG;AKT1;PYCARD;JAK3;MIF
16176,GO:0090237,0.0704532593249395,0.993205046179123,2,5,regulation of arachidonic acid secretion,BP,NTSR1;MIF
17274,GO:0140096,0.0705348289931221,0.940406878289315,182,1702,catalytic activity, acting on a protein,MF,HTRA1;DUSP6;TYSND1;RNPEPL1;PTPRS;RNF44;LTBP4;CLCA2;PRSS3;LTBP1;RBCK1;EPHB2;OBSCN;MST1R;MAPK13;CDK18;EGFR;MMP28;FBXO2;DUSP5;FKBP9;JOSD2;LOXL1;DDB2;ULK1;RHBDF1;PKN1;PTK6;NPEPL1;PPP2R3B;PRSS8;PPM1J;CTSB;RNF208;ULK2;ASH2L;PLAT;MMP1;NEK9;HDAC5;RPS6KA2;MARK4;B4GALNT4;ERBB2;BRSK1;CTSF;PTPRU;GID4;TMEM129;PTPRE;PAK6;GALNT12;RNF135;THSD4;MINK1;GGT1;CSNK1E;ADAMTS7;USP20;INSR;FBXW8;GRK6;RABGGTA;EPHA1;FBXO27;PAPLN;EFNB3;FBXL8;FBXO41;BLMH;SPEG;MARCH2;MTA3;MKNK2;STRADB;FAM20C;ANKZF1;DYRK1B;SRMS;MAST4;FBXW4;RHBDF2;DPP7;ACVR2B;ADAM15;ZDHHC1;MAPK3;FBXL16;CAPNS2;MTA1;LHPP;KLHL29;LTA4H;PKN3;EPHB3;SSH1;FURIN;NRP2;LRSAM1;FKBP10;PHF21A;ACY1;PCSK9;HLCS;FGFR3;PRKACA;F12;ZNF862;LRRK1;RPS6KA5;HBEGF;MAP2K2;FGFR4;FBXW5;MYH3;XYLT2;HDAC11;LYPLAL1;ABHD17C;RAG1;DUSP7;EEF2K;RHBDL1;HMGA2;MIB2;FBXO17;BTRC;STK32C;PCSK1;BCR;USP21;RNF123;PRKCZ;ADAMTS13;ZDHHC24;HLTF;KLHDC8B;TPP1;PDK2;TMX4;MAPKAPK3;FGFR1;CTSZ;CAMKK1;SPSB3;PIN1;KMT5C;CAPN2;ADCK5;DUSP23;TMPRSS11D;LMLN;PPM1F;SBF1;STK39;ACVR1B;ERBB3;ZER1;AKT1;CTSD;ADAM19;PCMTD2;SPPL2B;ADCK2;SSH3;PINK1;LONP2;KDM4B;CTSH;CBLC;RNF187;PYCARD;MAP2K3;STK17A;ERN1;FBXL20;SIRT3;JAK3;MAST3;EREG;ADAMTSL4;TTLL11
5158,GO:0015718,0.0708149086515912,0.963258971875165,13,86,monocarboxylic acid transport,BP,APOE;CPT2;SLC16A5;SLC16A3;BSG;NTSR1;ABCD1;SLC16A13;PPARA;RXRA;AKT1;APBA1;MIF
628,GO:0001818,0.070898376546921,0.956952167497168,21,157,negative regulation of cytokine production,BP,PTPRS;ZFPM1;RNF135;ACP5;PDCD4;IL20RB;PRNP;BCL6;FURIN;MEFV;ZFP36;MAPKBP1;RPS6KA5;GAS6;INPP5D;FGFR1;PIN1;NLRX1;NDRG2;PYCARD;JAK3
12900,GO:0051281,0.0711243317801932,0.978110892429684,5,24,positive regulation of release of sequestered calcium ion into cytosol,BP,CEMIP;F2R;PKD2;NTSR1;GSTM2
4163,GO:0009240,0.0711384886477917,0.993100410420111,2,5,isopentenyl diphosphate biosynthetic process,BP,MVD;PMVK
11678,GO:0046490,0.0711384886477917,0.993100410420111,2,5,isopentenyl diphosphate metabolic process,BP,MVD;PMVK
5220,GO:0015844,0.0711962464960409,0.978082286997765,5,24,monoamine transport,BP,NOS1;NISCH;RAB3B;SLC29A4;PINK1
11223,GO:0045428,0.0717076336313837,0.974799011528115,6,31,regulation of nitric oxide biosynthetic process,BP,PKD2;ATP2B4;ACP5;INSR;ASS1;AKT1
50,GO:0000104,0.0719016457785826,0.992983148576367,2,5,succinate dehydrogenase activity,MF,SDHAF4;SDHA
2494,GO:0005749,0.0719016457785826,0.992983148576367,2,5,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,SDHAF4;SDHA
3671,GO:0008177,0.0719016457785826,0.992983148576367,2,5,succinate dehydrogenase (ubiquinone) activity,MF,SDHAF4;SDHA
11158,GO:0045257,0.0719016457785826,0.992983148576367,2,5,succinate dehydrogenase complex (ubiquinone),CC,SDHAF4;SDHA
11163,GO:0045273,0.0719016457785826,0.992983148576367,2,5,respiratory chain complex II,CC,SDHAF4;SDHA
11167,GO:0045281,0.0719016457785826,0.992983148576367,2,5,succinate dehydrogenase complex,CC,SDHAF4;SDHA
11169,GO:0045283,0.0719016457785826,0.992983148576367,2,5,fumarate reductase complex,CC,SDHAF4;SDHA
3398,GO:0007187,0.0719561147350666,0.963717148021362,12,78,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,LTB4R;NOS1;ADGRF1;GNAL;PTHLH;VIPR1;LTB4R2;ATP2B4;LPAR3;ADCY6;HTR7;ADORA2B
15689,GO:0072273,0.0720031224345573,0.981633275237886,4,17,metanephric nephron morphogenesis,BP,PKD2;HES1;PKD1;KIF26B
13642,GO:0060193,0.0721061155380301,0.974622599071998,6,31,positive regulation of lipase activity,BP,LMF1;EGFR;FGFR3;PTAFR;PRKCZ;FGFR1
4892,GO:0014831,0.0723427391918712,0.992915024748479,2,5,gastro-intestinal system smooth muscle contraction,BP,PTAFR;SULF2
6597,GO:0022804,0.0724631151698625,0.953400621551263,26,200,active transmembrane transporter activity,MF,SLCO4A1;ABCA7;SLC16A5;SLC16A3;ABCG1;SLC2A9;SLC13A3;SLC7A8;ATP2B4;SLC6A8;SLC20A1;ATP7B;SLC12A7;ABCD1;ATP12A;SLC22A18;SLC16A13;ABCA2;SLC28A2;SLC37A2;SLC29A4;ABCD4;TMCO3;SLC9A7;SLC5A5;SLC22A17
11376,GO:0045785,0.0725060439703943,0.951799947655227,30,237,positive regulation of cell adhesion,BP,IGF2;SMOC2;ANK3;ZP3;HYAL1;ERBB2;RHOD;ZMIZ1;EPHA1;ITGA6;EFNB3;BCL6;IGFBP2;VEGFA;ARL2;HES1;TNFRSF14;ADA;DMTN;RAG1;PTAFR;VAV3;PRKCZ;ICOSLG;PPM1F;AKT1;PYCARD;NINJ1;JAK3;KIF26B
4586,GO:0010711,0.0729460214902079,1,1,1,negative regulation of collagen catabolic process,BP,CST3
13709,GO:0060309,0.0729460214902079,1,1,1,elastin catabolic process,BP,CST3
13710,GO:0060310,0.0729460214902079,1,1,1,regulation of elastin catabolic process,BP,CST3
13711,GO:0060311,0.0729460214902079,1,1,1,negative regulation of elastin catabolic process,BP,CST3
6705,GO:0030125,0.0729767794304228,0.977371110956958,5,24,clathrin vesicle coat,CC,EGFR;AP2A2;LDLRAP1;CLTCL1;EPN2
2229,GO:0005138,0.0731669003705191,0.992787056848848,2,5,interleukin-6 receptor binding,MF,IL6R;PYCARD
5510,GO:0016486,0.0733127278589143,0.981183392356009,4,17,peptide hormone processing,BP,FURIN;PCSK1;CTSZ;PCSK1N
17586,GO:1901299,0.0733289215529561,0.992761795438059,2,5,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,TRAP1;PINK1
19044,GO:1904951,0.0733415695718312,0.948273071400309,40,330,positive regulation of establishment of protein localization,BP,CEMIP;RAPGEF3;POSTN;ALOX15B;LRP1;EGFR;B3GAT3;NLGN2;F2R;ANK3;ERBB2;MICALL2;EDEM1;VPS11;VAMP2;TFDP2;GLUL;TMEM173;PRNP;MYO18A;PFKFB2;MAPK3;HES1;TRPV4;HK1;GAS6;PCK2;PRKCZ;TM7SF3;C5;VSNL1;OSCP1;SORL1;PINK1;PYCARD;KCNN4;SIRT3;GIPR;MIF;UBL5
13546,GO:0060041,0.07339904808462,0.962866781337646,12,78,retina development in camera-type eye,BP,RAB11FIP4;SDK2;LRP5;IFT140;NPHP4;ATP2B4;LAMB2;ACVR2B;TUB;SDHAF4;PROX1;RARG
10525,GO:0043491,0.0735674518291598,0.955752619585152,20,147,protein kinase B signaling,BP,FAM110C;XDH;ZFP36L1;IGF2;MST1R;EGFR;PIK3R2;ERBB2;INSR;SPRY2;FGFR3;HBEGF;FGFR4;GAS6;FGFR1;SESN2;ERBB3;AKT1;PINK1;EREG
3549,GO:0007597,0.073578702005984,0.992722784061225,2,5,blood coagulation, intrinsic pathway,BP,SERPING1;F12
13597,GO:0060119,0.0735828805794262,0.977127743642795,5,24,inner ear receptor cell development,BP,NAGLU;VANGL2;HES1;SLITRK6;FGFR1
12198,GO:0048471,0.0736823209688447,0.944590420585679,59,510,perinuclear region of cytoplasm,CC,TSPAN1;CST3;GSN;PRDX5;NDRG1;NOS1;EPN3;RAB11FIP4;OBSL1;EGFR;S100A4;CTSB;CORO1B;THBS3;S100A6;ERBB2;ANGEL1;VAMP2;DOCK6;TMEM134;PRR7;USP20;FBXW8;TMEM173;ATP7B;CEP250;ABCD1;PLEKHG5;GLB1;RAB40B;PKN3;CUL7;PCSK9;CYHR1;PRKACA;CYFIP2;RAB3B;MAP2K2;STX10;DMTN;EHD4;MAPK8IP1;PTOV1;NMRAL1;PRKCZ;TWF2;SYNC;CAPN2;TOLLIP;PPM1F;GSDMA;NDRG2;VPS33B;PINK1;EHD3;SPIRE2;ATXN10;APBA1;RAB40C
12325,GO:0048710,0.0737158848513415,0.981044291730953,4,17,regulation of astrocyte differentiation,BP,SERPINE2;HES1;LDLR;BIN1
2434,GO:0005640,0.0737223793373801,0.981042048622723,4,17,nuclear outer membrane,CC,ITPR3;SIGMAR1;RETSAT;SYNE3
12557,GO:0050750,0.0739613199191037,0.980959470558584,4,17,low-density lipoprotein particle receptor binding,MF,APOE;PCSK9;SNX17;LDLRAP1
10295,GO:0043094,0.0740259921349477,0.973687190841154,6,32,cellular metabolic compound salvage,BP,NAPRT;UCKL1;TK2;ADA;DGUOK;FUK
12641,GO:0050871,0.0741156557065331,0.968791175844959,8,47,positive regulation of B cell activation,BP,CD320;STAT6;BCL6;CD81;ADA;VAV3;INPP5D;MIF
9017,GO:0035249,0.0742117749890965,0.973685797793495,6,31,synaptic transmission, glutamatergic,BP,SHANK2;EGFR;NLGN2;SERPINE2;GLUL;SHANK3
15425,GO:0071774,0.0744065245723557,0.958117879114938,16,113,response to fibroblast growth factor,BP,DUSP6;ZFP36L1;POSTN;HYAL1;SPRY4;FUZ;SPRY2;FAM20C;MAPK3;ZFP36;FGFR3;FGFR4;GPC1;FGFR1;FGFBP1;SULF2
11269,GO:0045602,0.0746671348010306,0.992551842031267,2,5,negative regulation of endothelial cell differentiation,BP,XDH;ID1
14102,GO:0060996,0.0748267689913998,0.963345196841988,11,70,dendritic spine development,BP,APOE;PTPRS;SHANK2;EPHB2;ZMYND8;WNT7A;DLG4;SHANK3;DVL1;EPHB3;EEF2K
14496,GO:0070011,0.0750251031019471,0.946287005793224,43,360,peptidase activity, acting on L-amino acid peptides,MF,HTRA1;TYSND1;RNPEPL1;CLCA2;PRSS3;MMP28;JOSD2;RHBDF1;NPEPL1;PRSS8;CTSB;PLAT;MMP1;CTSF;GGT1;ADAMTS7;USP20;BLMH;ANKZF1;RHBDF2;DPP7;ADAM15;CAPNS2;LTA4H;FURIN;ACY1;PCSK9;F12;RHBDL1;PCSK1;USP21;ADAMTS13;TPP1;CTSZ;CAPN2;TMPRSS11D;LMLN;CTSD;ADAM19;SPPL2B;LONP2;CTSH;PYCARD
3551,GO:0007599,0.0750873628951204,0.951063312487894,27,214,hemostasis,BP,APOE;SERPING1;F2R;DGKA;PLAT;ZFPM1;FBLN1;ITPR3;CD9;SERPINE2;DOCK6;MAPK3;ENTPD2;PHF21A;PRKACA;F12;DMTN;DGKQ;GAS6;VAV3;ADAMTS13;PROCR;SH2B3;AKT1;ZNF385A;VPS33B;EHD3
8735,GO:0034404,0.075195730057496,0.953421122696337,22,168,nucleobase-containing small molecule biosynthetic process,BP,NT5E;RAPGEF3;PGM1;XDH;NME4;OGDHL;INSR;DNPH1;UCKL1;PFKFB2;DHTKD1;ENTPD2;GALK1;MLXIPL;TK2;ADA;PFKL;NUDT10;HK1;PPARA;GUK1;NEIL1
19996,GO:2000646,0.0752033494965967,0.992467062155363,2,5,positive regulation of receptor catabolic process,BP,APOE;PCSK9
12094,GO:0048169,0.075231163945107,0.98051894411996,4,17,regulation of long-term neuronal synaptic plasticity,BP,EPHB2;SYNGAP1;DLG4;SHANK3
11436,GO:0045913,0.0753291234847036,0.968219846062282,8,46,positive regulation of carbohydrate metabolic process,BP,IGF2;NTSR1;INSR;PFKFB2;MLXIPL;PPARA;PTAFR;AKT1
10079,GO:0042602,0.0753437431077118,1,1,1,riboflavin reductase (NADPH) activity,MF,BLVRB
6295,GO:0019933,0.0754352726120051,0.964459362188242,10,63,cAMP-mediated signaling,BP,RAPGEF3;NOS1;ADGRF1;GNAL;PTHLH;ATP2B4;ADCY6;DGKQ;ADORA2B;GIPR
741,GO:0001973,0.0755659578578599,0.992409519748402,2,5,adenosine receptor signaling pathway,BP,ADA;ADORA2B
7719,GO:0032226,0.0755862076596642,0.992406301286482,2,5,positive regulation of synaptic transmission, dopaminergic,BP,RAB3B;PINK1
9493,GO:0036159,0.0756879886760022,0.992390116389225,2,5,inner dynein arm assembly,BP,DNAH1;DNAAF5
13925,GO:0060638,0.0759619579501455,0.992346484119116,2,5,mesenchymal-epithelial cell signaling,BP,FGFR1;WNT2B
6278,GO:0019897,0.0759958414142227,0.958013017885698,15,104,extrinsic component of plasma membrane,CC,SYTL1;EPN3;MYZAP;PTK6;GNAL;PRSS8;S100A6;SERPINE2;SNX9;DLG4;SRMS;KCNAB2;PCSK9;ESYT2;JAK3
2137,GO:0004953,0.0760326468987225,0.992335210477699,2,5,icosanoid receptor activity,MF,LTB4R;LTB4R2
14928,GO:0070848,0.0761697526423162,0.943184536940812,55,470,response to growth factor,BP,HTRA1;FOS;DUSP6;LTBP4;XDH;NOS1;LTBP1;ZFP36L1;POSTN;LTBP2;EGFR;EGR1;SHC1;CORO1B;HYAL1;ERBB2;SPRY4;CDKN1C;FUZ;ADAMTS7;PDCD4;WNT7A;INSR;ID1;SPRY2;FAM20C;VEGFA;ACVR2B;MAPK3;HES1;FURIN;NRP2;ZFP36;FGFR3;CYFIP2;ITGB5;FGFR4;EHD4;EEF2K;GAS6;VASN;NEO1;PRKCZ;TWF2;GPC1;FGFR1;PIN1;TMEM204;GRB10;FGFBP1;AKT1;EPN2;MAP2K3;ERN1;SULF2
12721,GO:0051015,0.0761961603594851,0.956136382577087,17,121,actin filament binding,MF,ESPN;FLNC;GSN;OBSL1;EGFR;CORO1B;MICALL2;MYO18A;WIPF1;SPTB;DMTN;MYH3;TRPV4;CAPG;TWF2;BIN1;SYNE3
6920,GO:0030534,0.0763091297031971,0.963969892393761,10,63,adult behavior,BP,SHANK2;BBS2;DNM1;NTSR1;EFNB3;SHANK3;PPARA;SLITRK6;CSTB;HOMER2
897,GO:0002277,0.0764131844177846,1,1,1,myeloid dendritic cell activation involved in immune response,BP,PYCARD
1054,GO:0002582,0.0764131844177846,1,1,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,PYCARD
1057,GO:0002585,0.0764131844177846,1,1,1,positive regulation of antigen processing and presentation of peptide antigen,BP,PYCARD
1060,GO:0002588,0.0764131844177846,1,1,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,PYCARD
5782,GO:0017024,0.0764131844177846,1,1,1,myosin I binding,MF,PYCARD
4546,GO:0010637,0.076463557202065,0.992266348369899,2,5,negative regulation of mitochondrial fusion,BP,VAT1;BNIP3
16976,GO:0099094,0.0764637376585999,0.972675441569966,6,31,ligand-gated cation channel activity,MF,KCNJ15;PKD2;ITPR3;ASIC1;SCNN1A;TPCN1
16693,GO:0097720,0.0764975796342722,0.975948438504414,5,24,calcineurin-mediated signaling,BP,NFATC4;ATP2B4;PRNP;ADGRB2;ERBB3
494,GO:0001547,0.0765116556542403,0.992258647080905,2,5,antral ovarian follicle growth,BP,ZP3;EREG
8360,GO:0033273,0.0765196032300061,0.96385182382883,10,63,response to vitamin,BP,CYP27B1;GSN;POSTN;EGFR;MTHFR;DNMT3A;ADA;AQP3;HLCS;GAS6
10409,GO:0043271,0.0765741654564148,0.962305783626042,11,71,negative regulation of ion transport,BP,NOS1;EPHB2;ANK3;PKD2;SERPINE2;NTSR1;PCSK9;STK39;ANO9;AKT1;GSTM2
6549,GO:0021999,0.0766225567112675,0.992240878779287,2,5,neural plate anterior/posterior regionalization,BP,FUZ;CELSR2
4117,GO:0009185,0.0767158479860829,0.958549864305869,14,96,ribonucleoside diphosphate metabolic process,BP,PGM1;OGDHL;INSR;DLG4;PFKFB2;DHTKD1;ENTPD2;GALK1;MLXIPL;PFKL;HK1;PPARA;GUK1;DLG3
18511,GO:1903727,0.0767243535530998,0.975856067086785,5,24,positive regulation of phospholipid metabolic process,BP,ZP3;CD81;FGFR3;VAV3;TAZ
4446,GO:0010421,0.076786112640666,0.98514444219637,3,11,hydrogen peroxide-mediated programmed cell death,BP,ENDOG;TRAP1;PINK1
16592,GO:0097468,0.076786112640666,0.98514444219637,3,11,programmed cell death in response to reactive oxygen species,BP,ENDOG;TRAP1;PINK1
5055,GO:0015279,0.0768317601834469,0.992207317550372,2,5,store-operated calcium channel activity,MF,ORAI3;ORAI2
15468,GO:0071867,0.0768536568874734,0.97580335858572,5,24,response to monoamine,BP,ATP2B4;ID1;MAPK3;ADCY6;PRKACA
15470,GO:0071869,0.0768536568874734,0.97580335858572,5,24,response to catecholamine,BP,ATP2B4;ID1;MAPK3;ADCY6;PRKACA
14672,GO:0070324,0.0769010871017801,0.992196183421754,2,5,thyroid hormone binding,MF,THRA;CTSH
4173,GO:0009259,0.0769042191278556,0.944795257827934,43,372,ribonucleotide metabolic process,BP,APOE;NT5E;RAPGEF3;PGM1;NOS1;NME4;TIMP2;ACOT7;OGDHL;PKD2;PTHLH;LTB4R2;INSR;NDUFS8;DLG4;FAM20C;UCKL1;PFKFB2;VEGFA;DHTKD1;GALK1;ADCY6;MLXIPL;NADK;PFKL;NUDT10;MYH3;HK1;PPARA;GUK1;SDHA;GTPBP1;DLG3;GUCA1B;ADORA2B;UQCR11;PINK1;ABHD14B;NDUFV3;MOCS1;TAZ;PPCS;PODXL2
14120,GO:0061028,0.0769709443134958,0.972446687184543,6,31,establishment of endothelial barrier,BP,PTPRS;RAPGEF3;WNT7A;S1PR2;TNFRSF1A;WNT7B
12206,GO:0048486,0.077049629089706,0.985071760287489,3,11,parasympathetic nervous system development,BP,ADARB1;HES1;SEMA3F
10426,GO:0043301,0.0773392017057538,0.992125677718865,2,5,negative regulation of leukocyte degranulation,BP,BCR;ABR
453,GO:0001227,0.0773714774556097,0.951949938474961,22,164,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,TCFL5;NR1D1;NFATC4;DEAF1;MXI1;ZFPM1;FOXQ1;ZNF692;HES2;MNT;BCL6;CEBPB;HES1;MLXIPL;BHLHE40;HMGA2;POU6F1;ZNF217;PPARA;PROX1;JARID2;MZF1
12521,GO:0050693,0.0773979368932388,0.992116206707341,2,5,LBD domain binding,MF,RXRA;PROX1
17223,GO:0120032,0.0774201234632647,0.95532023349543,17,122,regulation of plasma membrane bounded cell projection assembly,BP,ESPN;EVI5L;ARAP1;ZMYND8;TENM2;PLXNB3;IFT140;FUZ;SSH1;CDC42EP5;DMTN;CROCC;TWF2;WRAP73;EPS8L1;EPS8L2;SSH3
2975,GO:0006526,0.0774290340997449,0.992111190507032,2,5,arginine biosynthetic process,BP,NAGS;ASS1
17617,GO:1901379,0.0776073907299525,0.969346781279069,7,39,regulation of potassium ion transmembrane transport,BP,KCNG1;FHL1;ANK3;VAMP2;PRNP;KCNAB2;STK39
1253,GO:0003009,0.0776330860881971,0.979501445563474,4,18,skeletal muscle contraction,BP,GAA;TNNT1;MYH3;GSTM2
11944,GO:0047184,0.07764503003022,0.992076314535439,2,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,LPCAT4;TAZ
15249,GO:0071458,0.0777281764385372,0.992062873251918,2,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,PKD2;SPPL2B
9355,GO:0035897,0.0778417620596609,0.992044496879002,2,5,proteolysis in other organism,BP,MAP2K2;MAP2K3
7555,GO:0031915,0.0778478532833657,0.992043510946571,2,5,positive regulation of synaptic plasticity,BP,EPHB2;SSH1
1783,GO:0004415,0.0779148416811065,0.992032664986305,2,5,hyalurononglucosaminidase activity,MF,CEMIP;HYAL1
9296,GO:0035771,0.0779228436562265,0.992031369017129,2,5,interleukin-4-mediated signaling pathway,BP,STAT6;JAK3
3980,GO:0008859,0.0780904650464778,1,1,1,exoribonuclease II activity,MF,ISG20
16547,GO:0097367,0.0782071563547117,0.933979813280688,170,1585,carbohydrate derivative binding,MF,CEMIP;APOE;PTPRS;LTBP4;RAPGEF3;PGF;NOS1;POSTN;SCN8A;EPHB2;OBSCN;NME4;MST1R;LRP1;MAPK13;CDK18;LTBP2;EGFR;SMOC2;ACSF2;ULK1;PKN1;PYGL;PTK6;GNAL;ABCA7;ACTA2;CTSB;DNAH1;ULK2;DGKA;THBS3;ABCG1;OPLAH;NEK9;RPS6KA2;NMRK1;TUBG2;MARK4;ERBB2;BRSK1;DNM1;CUL9;KIF13B;PAK6;SERPINE2;MINK1;ATP2B4;CSNK1E;AGAP1;GLUL;RHOD;TNXB;INSR;RAB3D;GRK6;MVD;EPHA1;TMEM173;PRNP;DHX32;ATP7B;SPEG;ABCD1;MKNK2;STRADB;RAB25;FAM20C;MYO18A;UCKL1;PFKFB2;ATP12A;DYRK1B;SRMS;VEGFA;ARL2;MAST4;ACVR2B;MAPK3;GLB1;ARL10;RAB40B;ENTPD2;GALK1;FYCO1;ADCY6;PKN3;EPHB3;PC;NRP2;NADK;ABCA2;TK2;ADA;RASL10B;CKMT1A;PFKL;RHOF;HLCS;FGFR3;PRKACA;LRRK1;DGUOK;RPS6KA5;HBEGF;RAB3B;MAP2K2;PI4K2A;FGFR4;PMVK;MYH3;EHD4;TRPV4;RHOBTB2;EEF2K;DGKQ;HK1;TKFC;GUK1;STK32C;PTAFR;DMC1;PCK2;BCR;PRKCZ;HLTF;ABCD4;TWF2;PDK2;GPC1;MAPKAPK3;FGFR1;CAMKK1;GTPBP1;ASS1;ADGRE2;GAL3ST4;RTN4R;ACTR1B;FGFBP1;STK39;COL13A1;VEGFB;ACVR1B;GSS;ERBB3;AKT1;TRAP1;NLRX1;SEPT8;TUT1;SMARCA1;ERCC6;ADCK2;PINK1;EHD3;LONP2;MAP2K3;PNPO;STK17A;ERN1;MOCS1;JAK3;MAST3;KIFC2;FUK;PODXL2;TTLL11;RAB40C;KIF26B
6049,GO:0019206,0.0782207882640425,0.984747364141045,3,11,nucleoside kinase activity,MF,UCKL1;TK2;DGUOK
17183,GO:0106070,0.0782770536312877,0.991973920238891,2,5,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1;ATP2B4
3260,GO:0006939,0.0782803334373094,0.964620067612073,9,55,smooth muscle contraction,BP,F2R;BBS2;DOCK4;ADA;HTR7;PTAFR;KCNMA1;ADORA2B;SULF2
15654,GO:0072205,0.0782837556870059,0.991972831691832,2,5,metanephric collecting duct development,BP,WNT7B;PKD1
5770,GO:0017002,0.0782903679333773,0.991971757675177,2,5,activin-activated receptor activity,MF,ACVR2B;ACVR1B
19707,GO:2000107,0.0783789393640727,0.971722366558498,6,32,negative regulation of leukocyte apoptotic process,BP,BCL6;ADA;RAG1;GAS6;JAK3;MIF
14968,GO:0070914,0.0783933618798214,0.984699374569094,3,11,UV-damage excision repair,BP,ERCC1;DDB2;XPC
5008,GO:0015181,0.0784142042702982,0.991951632784688,2,5,arginine transmembrane transporter activity,MF,SLC25A29;PQLC2
5015,GO:0015189,0.0784142042702982,0.991951632784688,2,5,L-lysine transmembrane transporter activity,MF,SLC25A29;PQLC2
15488,GO:0071895,0.0784303315154213,0.991949010467711,2,5,odontoblast differentiation,BP,FAM20C;CEBPB
12334,GO:0048732,0.0784375194042579,0.945450626539102,36,293,gland development,BP,CST3;XDH;ALOX15B;EGFR;DEAF1;LAMA5;THRA;LRP5;PKD2;SERPINE2;INSR;ATP7B;STAT6;VEGFA;CEBPB;MAPK3;ETV5;EPHB3;HES1;ADA;PCSK9;RAG1;BTRC;HMGCL;WNT7B;RXRA;PCK2;SRSF5;FGFR1;PROX1;JARID2;WNT3;AKT1;PKD1;RARG;SULF2
14567,GO:0070141,0.0784400882362147,0.991947423846832,2,5,response to UV-A,BP,EGFR;AKT1
11694,GO:0046514,0.0784454460545755,0.984684881402605,3,11,ceramide catabolic process,BP,HEXB;GM2A;NAGA
5784,GO:0017034,0.0785245773081352,0.991933679281639,2,5,Rap guanyl-nucleotide exchange factor activity,MF,RAPGEF3;RAPGEF5
648,GO:0001839,0.0785974931234123,0.991921810087903,2,5,neural plate morphogenesis,BP,VANGL2;DVL1
10667,GO:0043950,0.0786700661320969,0.991909989936128,2,5,positive regulation of cAMP-mediated signaling,BP,NOS1;GIPR
4440,GO:0010385,0.0786851385984207,0.991907534199345,2,5,double-stranded methylated DNA binding,MF,EGR1;MBD1
10398,GO:0043255,0.0787143192748554,0.964427456885952,9,54,regulation of carbohydrate biosynthetic process,BP,NR1D1;IGF2;NTSR1;INSR;DGKQ;PPARA;PTAFR;PDK2;AKT1
7129,GO:0030976,0.0788044173865755,0.991888090010017,2,5,thiamine pyrophosphate binding,MF,OGDHL;DHTKD1
3059,GO:0006631,0.0788714424138807,0.946385184130998,32,259,fatty acid metabolic process,BP,TYSND1;CRAT;ALOX15B;CPT2;HADH;CRYL1;ACSF2;ACOT7;CPT1C;GGT1;ABCD1;MAPK3;ACAD10;MLXIPL;TNFRSF1A;ACOT11;PEX7;PPARA;AIG1;PCK2;ETFB;PDK2;PHYH;CES2;SESN2;CYP2S1;AKT1;LONP2;ACADS;MLYCD;GSTM2;MIF
17580,GO:1901292,0.0789377339658018,0.953506621688599,18,132,nucleoside phosphate catabolic process,BP,NT5E;RAPGEF3;PGM1;XDH;OGDHL;INSR;DNPH1;PFKFB2;DHTKD1;ENTPD2;GALK1;MLXIPL;ADA;PFKL;NUDT10;HK1;PPARA;NEIL1
13467,GO:0055056,0.0790241120399278,0.991852228922908,2,5,D-glucose transmembrane transporter activity,MF,SLC2A3;SLC2A1
2320,GO:0005337,0.0790264997605688,0.991851838832592,2,5,nucleoside transmembrane transporter activity,MF,SLC28A2;SLC29A4
5228,GO:0015858,0.0790264997605688,0.991851838832592,2,5,nucleoside transport,BP,SLC28A2;SLC29A4
17695,GO:1901642,0.0790264997605688,0.991851838832592,2,5,nucleoside transmembrane transport,BP,SLC28A2;SLC29A4
2760,GO:0006185,0.0790299617399316,1,1,1,dGDP biosynthetic process,BP,GUK1
4106,GO:0009170,0.0790299617399316,1,1,1,purine deoxyribonucleoside monophosphate metabolic process,BP,GUK1
4115,GO:0009183,0.0790299617399316,1,1,1,purine deoxyribonucleoside diphosphate biosynthetic process,BP,GUK1
11508,GO:0046054,0.0790299617399316,1,1,1,dGMP metabolic process,BP,GUK1
11795,GO:0046711,0.0790299617399316,1,1,1,GDP biosynthetic process,BP,GUK1
7963,GO:0032589,0.0790561220414329,0.974901164969594,5,24,neuron projection membrane,CC,KCNC4;INSR;EPB41L3;DDN;SHISA6
11116,GO:0045179,0.0790787261384331,0.991843304602026,2,5,apical cortex,CC,GM2A;PRKCZ
13045,GO:0051575,0.0790959157464815,0.991840494912313,2,5,5'-deoxyribose-5-phosphate lyase activity,MF,POLL;HMGA2
11645,GO:0046439,0.0792657205890616,0.99181271954108,2,5,L-cysteine metabolic process,BP,CBS;AHCYL2
17836,GO:1902083,0.079314684449832,0.991804703564864,2,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,ATP2B4;SNTA1
19735,GO:2000169,0.079314684449832,0.991804703564864,2,5,regulation of peptidyl-cysteine S-nitrosylation,BP,ATP2B4;SNTA1
2706,GO:0006089,0.0793212930418631,0.984440505245788,3,11,lactate metabolic process,BP,D2HGDH;HAGH;PFKFB2
5050,GO:0015271,0.0793582117844909,0.991797575042175,2,5,outward rectifier potassium channel activity,MF,PKD2;KCNMA1
4206,GO:0009374,0.0793615255698907,0.991797032240501,2,5,biotin binding,MF,PC;HLCS
14666,GO:0070314,0.0793821666512461,0.991793650893069,2,5,G1 to G0 transition,BP,CYP27B1;RAB11FIP4
16580,GO:0097443,0.0793861685608452,0.991792995251723,2,5,sorting endosome,CC,LDLR;CLTCL1
13654,GO:0060215,0.079407609747014,0.991789482148198,2,5,primitive hemopoiesis,BP,ZFPM1;VEGFA
2640,GO:0005984,0.0794228743408771,0.991786980711476,2,5,disaccharide metabolic process,BP,GAA;SLC2A1
5370,GO:0016198,0.0794228743409316,0.991786980711486,2,5,axon choice point recognition,BP,EFNB3;ROBO3
4834,GO:0014051,0.0794228743409422,0.991786980711476,2,5,gamma-aminobutyric acid secretion,BP,NTSR1;APBA1
12948,GO:0051371,0.0794228743409642,0.991786980711486,2,5,muscle alpha-actinin binding,MF,OBSL1;PKD2
8932,GO:0034992,0.0794228743410064,0.991786980711476,2,5,microtubule organizing center attachment site,CC,SUN1;SYNE3
8933,GO:0034993,0.0794228743410064,0.991786980711476,2,5,meiotic nuclear membrane microtubule tethering complex,CC,SUN1;SYNE3
16208,GO:0090286,0.0794228743410064,0.991786980711476,2,5,cytoskeletal anchoring at nuclear membrane,BP,SUN1;SYNE3
17191,GO:0106083,0.0794228743410064,0.991786980711476,2,5,nuclear membrane protein complex,CC,SUN1;SYNE3
17194,GO:0106094,0.0794228743410064,0.991786980711476,2,5,nuclear membrane microtubule tethering complex,CC,SUN1;SYNE3
3039,GO:0006601,0.079453702635236,1,1,1,creatine biosynthetic process,BP,GAMT
7007,GO:0030731,0.079453702635236,1,1,1,guanidinoacetate N-methyltransferase activity,MF,GAMT
7091,GO:0030899,0.0795064129629561,1,1,1,calcium-dependent ATPase activity,MF,TNNT1
7380,GO:0031444,0.0795064129629561,1,1,1,slow-twitch skeletal muscle fiber contraction,BP,TNNT1
15865,GO:0072659,0.0795222732662905,0.949324084846006,24,184,protein localization to plasma membrane,BP,EPHB2;LRP1;EGFR;LAMA5;BBS2;PACS2;ANK3;BSG;VAMP2;PRNP;AMN;RAB40B;TSPAN33;BBS1;TNFRSF1A;LDLRAP1;GAS6;TTC7B;PRKCZ;EPB41L3;AKT1;EHD3;RILPL1;RAB40C
1671,GO:0004138,0.0795853706091038,1,1,1,deoxyguanosine kinase activity,MF,DGUOK
3926,GO:0008617,0.0795853706091038,1,1,1,guanosine metabolic process,BP,DGUOK
14929,GO:0070849,0.0795982746083479,0.968371556309166,7,39,response to epidermal growth factor,BP,ZFP36L1;EGFR;ERBB2;ID1;MAPK3;ZFP36;AKT1
17475,GO:1900542,0.0797288069510975,0.95466471947222,16,114,regulation of purine nucleotide metabolic process,BP,APOE;RAPGEF3;NOS1;TIMP2;PKD2;PTHLH;LTB4R2;INSR;PFKFB2;VEGFA;MLXIPL;PPARA;GUCA1B;ADORA2B;PINK1;TAZ
3124,GO:0006720,0.0797797211606127,0.960410421646599,11,72,isoprenoid metabolic process,BP,APOE;LRP1;EGFR;MVD;SRD5A3;RETSAT;PMVK;GPC1;PNPLA4;PHYH;SDC1
10813,GO:0044325,0.0798405130322719,0.958979345930611,12,80,ion channel binding,MF,NOS1;FHL1;PACS2;ANK3;PKD2;SCN4B;RIMS3;PRNP;GPD1L;PKD1;SNTA1;PYCARD
3175,GO:0006805,0.0800639533626243,0.961783779049581,10,65,xenobiotic metabolic process,BP,BPHL;GGT1;AKR7A2;ACY1;CYP3A5;CMBL;CES2;CYP2S1;AS3MT;GSTM2
16711,GO:0097756,0.0800762168867511,0.968136475570041,7,39,negative regulation of blood vessel diameter,BP,EGFR;F2R;BBS2;DOCK4;HTR7;PTAFR;AKT1
19663,GO:2000010,0.0801321760433132,0.984213148957209,3,11,positive regulation of protein localization to cell surface,BP,SNX33;AKT1;GPD1L
8032,GO:0032695,0.0802966956718004,0.984166891368503,3,11,negative regulation of interleukin-12 production,BP,ACP5;MEFV;JAK3
2635,GO:0005977,0.0806661879543065,0.963320336578338,9,55,glycogen metabolic process,BP,GAA;PYGB;PGM1;NR1D1;IGF2;PYGL;PHLDA2;INSR;AKT1
2699,GO:0006073,0.0806661879543065,0.963320336578338,9,55,cellular glucan metabolic process,BP,GAA;PYGB;PGM1;NR1D1;IGF2;PYGL;PHLDA2;INSR;AKT1
10702,GO:0044042,0.0806661879543065,0.963320336578338,9,55,glucan metabolic process,BP,GAA;PYGB;PGM1;NR1D1;IGF2;PYGL;PHLDA2;INSR;AKT1
19257,GO:1905515,0.080727018356534,0.965372703397091,8,47,non-motile cilium assembly,BP,BBS2;IFT140;FUZ;CEP250;TMEM107;VANGL2;BBS1;WRAP73
4501,GO:0010561,0.0807712482621508,0.984033218603167,3,11,negative regulation of glycoprotein biosynthetic process,BP,ABCA7;HBEGF;JAK3
12375,GO:0048839,0.0808670798908876,0.955951447224302,14,96,inner ear development,BP,EPHB2;NAGLU;CELSR1;SPRY2;VANGL2;DVL1;HES1;LRP10;BCR;SLITRK6;FGFR1;PROX1;SLC25A27;ABR
10237,GO:0042989,0.08089373605356,0.990862790325484,2,6,sequestering of actin monomers,BP,GSN;TWF2
16843,GO:0098801,0.0809588379537306,0.983980278243932,3,11,regulation of renal system process,BP,F2R;GAS6;COMT
4634,GO:0010766,0.0809831137769037,0.983973423149761,3,11,negative regulation of sodium ion transport,BP,SERPINE2;PCSK9;STK39
9932,GO:0042311,0.081051938388926,0.978277933807539,4,18,vasodilation,BP,APOE;NOS1;BBS2;ADORA2B
15512,GO:0071941,0.0810719207286699,0.983948337469014,3,11,nitrogen cycle metabolic process,BP,NAGS;NMRAL1;ASS1
3784,GO:0008360,0.0811219577174424,0.95288286164849,17,122,regulation of cell shape,BP,PARVB;ARAP1;PLXNB3;HEXB;CSNK1E;RHOD;PLXNB1;VEGFA;WIPF1;CDC42EP5;RHOF;DMTN;RHOBTB2;ARAP3;C21ORF2;EPB41L3;SYNE3
14626,GO:0070243,0.0811703068612976,0.983920531149445,3,11,regulation of thymocyte apoptotic process,BP,ADA;RAG1;JAK3
18676,GO:1904063,0.0813886973243332,0.967421877121985,7,40,negative regulation of cation transmembrane transport,BP,EPHB2;ANK3;PKD2;NTSR1;PCSK9;STK39;GSTM2
7265,GO:0031260,0.0814406814267394,1,1,1,pseudopodium membrane,CC,RAB25
1524,GO:0003905,0.0815162972563121,1,1,1,alkylbase DNA N-glycosylase activity,MF,MPG
3951,GO:0008725,0.0815162972563121,1,1,1,DNA-3-methyladenine glycosylase activity,MF,MPG
10637,GO:0043733,0.0815162972563121,1,1,1,DNA-3-methylbase glycosylase activity,MF,MPG
10656,GO:0043916,0.0815162972563121,1,1,1,DNA-7-methylguanine glycosylase activity,MF,MPG
13393,GO:0052821,0.0815162972563121,1,1,1,DNA-7-methyladenine glycosylase activity,MF,MPG
13394,GO:0052822,0.0815162972563121,1,1,1,DNA-3-methylguanine glycosylase activity,MF,MPG
19999,GO:2000649,0.0815627801288318,0.970265068420158,6,32,regulation of sodium ion transmembrane transporter activity,BP,ANK3;SCN4B;PCSK9;GLRX;STK39;GPD1L
12326,GO:0048711,0.0817921530428733,0.983744423628061,3,11,positive regulation of astrocyte differentiation,BP,SERPINE2;HES1;BIN1
9763,GO:0039692,0.081814094768569,0.983738198409497,3,11,single stranded viral RNA replication via double stranded DNA intermediate,BP,HMGA2;APOBEC3C;APOBEC3F
5286,GO:0015980,0.0818209623240042,0.946581326112215,26,216,energy derivation by oxidation of organic compounds,BP,IDH2;GAA;PYGB;PGM1;NR1D1;IGF2;NFATC4;PYGL;D2HGDH;OGDHL;PHLDA2;INSR;NDUFS8;BNIP3;DHTKD1;SDHAF4;SDHA;MDH2;ETFB;AKT1;TRAP1;UQCR11;PINK1;NDUFV3;SIRT3;TAZ
4534,GO:0010621,0.0818423674182689,1,1,1,negative regulation of transcription by transcription factor localization,BP,ID1
9494,GO:0036164,0.0818423674182689,1,1,1,cell-abiotic substrate adhesion,BP,ID1
6771,GO:0030218,0.0818769046874215,0.957753348770129,12,80,erythrocyte differentiation,BP,ZFP36L1;FAM210B;EPAS1;THRA;ZFPM1;BCL6;VEGFA;ZFP36;DMTN;INPP5D;ACVR1B;JAK3
19342,GO:1905809,0.082080629208316,0.983662516918658,3,11,negative regulation of synapse organization,BP,APOE;NFATC4;PRNP
17550,GO:1901193,0.0825357476626987,1,1,1,regulation of formation of translation preinitiation complex,BP,RPL13A
17551,GO:1901194,0.0825357476626987,1,1,1,negative regulation of formation of translation preinitiation complex,BP,RPL13A
18910,GO:1904689,0.0825357476626987,1,1,1,negative regulation of cytoplasmic translational initiation,BP,RPL13A
1773,GO:0004385,0.0825698517473844,0.983523309024093,3,11,guanylate kinase activity,MF,DLG4;GUK1;DLG3
12540,GO:0050715,0.0826989618062613,0.9603187655899,10,64,positive regulation of cytokine secretion,BP,POSTN;ALOX15B;F2R;MAPK3;TRPV4;HK1;PRKCZ;C5;PYCARD;MIF
14305,GO:0061515,0.0827843659964077,0.964294734016659,8,47,myeloid cell development,BP,FAM210B;ZFPM1;FAM20C;BCL6;LRRK1;DMTN;ZNF385A;VPS33B
8219,GO:0033002,0.082915678962451,0.952588142794977,16,114,muscle cell proliferation,BP,CTNNBIP1;MEF2D;EGFR;PDCD4;IL6R;HBEGF;COMT;PTAFR;RXRA;FGFR1;JARID2;AKT1;NDRG2;SIX5;ERN1;EREG
18976,GO:1904813,0.0831699870754705,0.953341395388714,15,109,ficolin-1-rich granule lumen,CC,CST3;PGM1;GSN;TIMP2;PYGL;CTSB;GLB1;LTA4H;PFKL;CTSZ;CSTB;ACTR1B;CTSD;CTSH;MIF
18131,GO:1902904,0.0831708531859143,0.955649076577544,13,89,negative regulation of supramolecular fiber organization,BP,GSN;ARAP1;ARPIN;CORO1B;TMOD2;PLEKHH2;SHANK3;SPTB;DMTN;LDLR;CAPG;TWF2;CHADL
11153,GO:0045240,0.0834065072639287,0.983284356696336,3,11,dihydrolipoyl dehydrogenase complex,CC,OGDHL;DHTKD1;BCKDHA
12709,GO:0050998,0.083572119238975,0.983236925454015,3,11,nitric-oxide synthase binding,MF,DNM1;ATP2B4;SNTA1
9293,GO:0035767,0.0836564943395795,0.977332640536878,4,18,endothelial cell chemotaxis,BP,CORO1B;VEGFA;PLEKHG5;FGFR1
8701,GO:0034363,0.0837666162575551,1,1,1,intermediate-density lipoprotein particle,CC,APOE
8703,GO:0034365,0.0837666162575551,1,1,1,discoidal high-density lipoprotein particle,CC,APOE
8709,GO:0034371,0.0837666162575551,1,1,1,chylomicron remodeling,BP,APOE
11869,GO:0046911,0.0837666162575551,1,1,1,metal chelating activity,MF,APOE
16354,GO:0090731,0.0837666162575551,1,1,1,cellular response to very-low-density lipoprotein particle stimulus,BP,APOE
17690,GO:1901630,0.0837666162575551,1,1,1,negative regulation of presynaptic membrane organization,BP,APOE
18184,GO:1903000,0.0837666162575551,1,1,1,regulation of lipid transport across blood brain barrier,BP,APOE
18185,GO:1903002,0.0837666162575551,1,1,1,positive regulation of lipid transport across blood brain barrier,BP,APOE
19350,GO:1905853,0.0837666162575551,1,1,1,regulation of heparan sulfate binding,BP,APOE
19351,GO:1905855,0.0837666162575551,1,1,1,positive regulation of heparan sulfate binding,BP,APOE
19352,GO:1905858,0.0837666162575551,1,1,1,regulation of heparan sulfate proteoglycan binding,BP,APOE
19353,GO:1905860,0.0837666162575551,1,1,1,positive regulation of heparan sulfate proteoglycan binding,BP,APOE
19361,GO:1905890,0.0837666162575551,1,1,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,APOE
4346,GO:0009950,0.0838377175852708,0.98316076739191,3,11,dorsal/ventral axis specification,BP,MDFI;LRP5;WNT3
2982,GO:0006534,0.0839366026588825,0.983132384407474,3,11,cysteine metabolic process,BP,CBS;GGT1;AHCYL2
7286,GO:0031296,0.0839912171817726,1,1,1,B cell costimulation,BP,CD320
12875,GO:0051247,0.0842678581487032,0.930478046116608,123,1139,positive regulation of protein metabolic process,BP,TNIP1;DUSP6;CEMIP;APOE;RAPGEF3;GSN;XDH;NOS1;EPHB2;CNTN1;IGF2;MST1R;LRP1;EGFR;TIMP2;DUSP5;EGR1;PKN1;SHC1;F2R;PTK6;ABCA7;SHC2;GRAMD4;ZFPM1;ERBB2;FBLN1;PKD2;EDEM1;PAK6;VPS11;MINK1;ATP2B4;CSNK1E;TNFRSF25;WNT7A;INSR;EPHA1;LPAR3;PRNP;SNX33;SPRY2;SNX9;DLG4;STRADB;BCL6;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;MAPK3;DVL1;MTA1;ADCY6;EPHB3;HES1;FURIN;MEFV;PIDD1;IL6R;PCSK9;FGFR3;PRKACA;F12;LRRK1;MAGEF1;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;TNFRSF1A;EHD4;MAPK8IP1;LDLR;TRPV4;DUSP7;DGKQ;SEMA4C;GAS6;BTRC;WNT7B;PTAFR;RXRA;IGFBP4;PRKCZ;MAPKAPK3;RAD23A;FGFR1;CAMKK1;PIN1;C5;PROX1;WBP2;DLG3;SH3D19;JARID2;TOLLIP;MAPRE3;MADD;PPM1F;SORL1;STK39;ACVR1B;ADORA2B;ERBB3;AKT1;ERCC6;PINK1;PKD1;CTSH;MLST8;PYCARD;MAP2K3;POMT1;ERN1;EREG;FAM162A;MIF
1098,GO:0002687,0.0844273623794226,0.959293685702105,10,65,positive regulation of leukocyte migration,BP,PGF;ZP3;VEGFA;MAPK3;IL6R;TRPV4;GAS6;PTAFR;VEGFB;PYCARD
463,GO:0001502,0.0847400627930677,0.982901194311382,3,11,cartilage condensation,BP,THRA;WNT7A;PKD1
16811,GO:0098743,0.0847400627930677,0.982901194311382,3,11,cell aggregation,BP,THRA;WNT7A;PKD1
15830,GO:0072576,0.0847853516382211,0.982888132427336,3,11,liver morphogenesis,BP,CEBPB;PROX1;SULF2
17225,GO:0120034,0.0849182353254748,0.957387207775111,11,72,positive regulation of plasma membrane bounded cell projection assembly,BP,ESPN;ARAP1;ZMYND8;TENM2;FUZ;CDC42EP5;CROCC;TWF2;WRAP73;EPS8L1;EPS8L2
13684,GO:0060271,0.0851797172226037,0.94062815569595,35,286,cilium assembly,BP,GSN;EVI5L;TCTN1;LAMA5;BBS2;DNAH1;MARK4;IFT140;NINL;FUZ;NPHP4;CSNK1E;CEP250;WWTR1;TMEM107;VANGL2;NUDCD3;FBF1;PRKACA;BBS1;CROCC;WDR60;NDE1;UNC119B;WRAP73;TMEM231;SEPT8;GAS8;EHD3;MAFIP;RILPL1;ATXN10;RFX2;DNAAF5;SFI1
3842,GO:0008465,0.0851825066941314,1,1,1,glycerate dehydrogenase activity,MF,GRHPR
12757,GO:0051058,0.0852179811638135,0.963011139924531,8,47,negative regulation of small GTPase mediated signal transduction,BP,EPHB2;TIMP2;SPRY4;RASA4;SYNGAP1;SPRY2;BCL6;ARAP3
3565,GO:0007617,0.0852855799558456,0.982743645266666,3,11,mating behavior,BP,THRA;HEXB;SERPINE2
2048,GO:0004801,0.0853183644907489,1,1,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,TALDO1
8535,GO:0033897,0.0854311047650404,1,1,1,ribonuclease T2 activity,MF,RNASET2
4993,GO:0015145,0.0854593213756846,0.982693369259431,3,11,monosaccharide transmembrane transporter activity,MF,SLC2A9;SLC2A3;SLC2A1
1181,GO:0002828,0.085478121658231,0.976664819042063,4,18,regulation of type 2 immune response,BP,ECM1;STAT6;BCL6;PRKCZ
12565,GO:0050767,0.0855226291489568,0.9351785177535,58,500,regulation of neurogenesis,BP,APOE;IDH2;PTPRS;SEMA4B;SHANK2;NOS1;EPHB2;CNTN1;NFATC4;LRP1;OBSL1;TIMP2;CRTC1;PTK6;ULK2;GJC2;ZMYND8;PLXNB3;KIF13B;SERPINE2;CSNK1E;WNT7A;FBXW8;ID1;SYNGAP1;LPAR3;EFNB3;DLG4;BCL6;PLXNB1;VEGFA;SHANK3;ETV5;DVL1;ADCY6;EPHB3;HES1;SSH1;CUL7;DGUOK;SEMA3B;LDLR;TRPV4;EEF2K;SEMA3F;SEMA4C;TWF2;FGFR1;CTSZ;PROX1;BIN1;RTN4R;WNT3;SORL1;AKT1;SSH3;RGS14;SEMA4F
742,GO:0001974,0.0856878367400494,0.972004279897393,5,25,blood vessel remodeling,BP,CST3;EPAS1;ACVR2B;BCR;ABR
1929,GO:0004632,0.0857333362383748,1,1,1,phosphopantothenate--cysteine ligase activity,MF,PPCS
12363,GO:0048799,0.0860654870303506,0.982517590341471,3,11,animal organ maturation,BP,THBS3;PLXNB1;FGFR3
19479,GO:1990384,0.0860764112580159,1,1,1,hyaloid vascular plexus regression,BP,NINJ1
4454,GO:0010457,0.0863409859378465,0.982437509389651,3,11,centriole-centriole cohesion,BP,CEP250;CROCC;CEP68
12834,GO:0051180,0.0863620856639339,0.976338788082012,4,18,vitamin transport,BP,CD320;AMN;SLC2A3;SLC2A1
15354,GO:0071625,0.0863942067018254,0.982422025689067,3,11,vocalization behavior,BP,SHANK2;DLG4;SHANK3
1928,GO:0004631,0.0864911581232556,1,1,1,phosphomevalonate kinase activity,MF,PMVK
2178,GO:0005031,0.0865315266303394,0.976276147659382,4,18,tumor necrosis factor-activated receptor activity,MF,TNFRSF25;TNFRSF6B;TNFRSF14;TNFRSF1A
2180,GO:0005035,0.0865315266303394,0.976276147659382,4,18,death receptor activity,MF,TNFRSF25;TNFRSF6B;TNFRSF14;TNFRSF1A
17919,GO:1902287,0.0865332536427497,0.982381551367919,3,11,semaphorin-plexin signaling pathway involved in axon guidance,BP,PLXNB3;PLXNB1;SEMA3F
7255,GO:0031235,0.0865518444109014,0.98237613760331,3,11,intrinsic component of the cytoplasmic side of the plasma membrane,CC,RASA4;SYNGAP1;SPTB
14657,GO:0070300,0.0866364615190202,0.976237330938939,4,18,phosphatidic acid binding,MF,PITPNC1;PLTP;PLCD1;PITPNM1
11715,GO:0046554,0.0866853665757784,1,1,1,malate dehydrogenase (NADP+) activity,MF,MDH2
9883,GO:0042219,0.086902915156956,0.976138685831159,4,18,cellular modified amino acid catabolic process,BP,PRODH;ALDH4A1;GGT1;GGACT
3942,GO:0008654,0.0869102296037577,0.94157690224983,29,231,phospholipid biosynthetic process,BP,ISYNA1;LPCAT4;DGKA;PIK3R2;ZP3;HEXB;MVD;SRD5A3;MBOAT7;FGFR3;PITPNM1;PI4K2A;FGFR4;PMVK;PIGZ;DGKQ;INPP5D;FGFR1;LCAT;PITPNM3;PIGV;PIGQ;SBF1;ACP6;GPD1L;AGPAT4;CPNE7;TAZ;AGPAT3
3566,GO:0007618,0.0873347369961224,0.975978573718245,4,18,mating,BP,THRA;HEXB;SERPINE2;ADA
4483,GO:0010518,0.0875279113409121,0.971220769665062,5,25,positive regulation of phospholipase activity,BP,EGFR;FGFR3;PTAFR;PRKCZ;FGFR1
12750,GO:0051051,0.0876898557177022,0.939760891182585,32,262,negative regulation of transport,BP,IDH2;NOS1;EPHB2;HADH;RHBDF1;F2R;ANK3;PKD2;SERPINE2;NTSR1;ASIC1;SNX33;DLG4;RHBDF2;LRSAM1;ADA;MCTP1;PFKL;PCSK9;MAPKBP1;DMTN;GAS6;COMT;BCR;VSNL1;GRB10;STK39;ANO9;ERBB3;ABR;AKT1;GSTM2
1910,GO:0004607,0.0876962908545171,1,1,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,LCAT
2084,GO:0004852,0.0877580652518141,1,1,1,uroporphyrinogen-III synthase activity,MF,UROS
15223,GO:0071418,0.0877580652518141,1,1,1,cellular response to amine stimulus,BP,UROS
15941,GO:0080058,0.0877991550650456,1,1,1,protein deglutathionylation,BP,GLRX
16641,GO:0097573,0.0877991550650456,1,1,1,glutathione oxidoreductase activity,MF,GLRX
6127,GO:0019402,0.0878606498656676,1,1,1,galactitol metabolic process,BP,GALK1
14355,GO:0061623,0.0878606498656676,1,1,1,glycolytic process from galactose,BP,GALK1
6028,GO:0019118,0.0878811107723906,1,1,1,phenanthrene-epoxide hydrolase activity,MF,AKR7A2
6029,GO:0019119,0.0878811107723906,1,1,1,phenanthrene-9,10-epoxide hydrolase activity,MF,AKR7A2
9951,GO:0042356,0.0878811107723906,1,1,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,TSTA3
12479,GO:0050577,0.0878811107723906,1,1,1,GDP-L-fucose synthase activity,MF,TSTA3
10806,GO:0044317,0.0880441238027364,1,1,1,rod spherule,CC,REEP6
625,GO:0001809,0.0884264469679404,1,1,1,positive regulation of type IV hypersensitivity,BP,ZP3
13832,GO:0060467,0.0884264469679404,1,1,1,negative regulation of fertilization,BP,ZP3
19848,GO:2000359,0.0884264469679404,1,1,1,regulation of binding of sperm to zona pellucida,BP,ZP3
19849,GO:2000360,0.0884264469679404,1,1,1,negative regulation of binding of sperm to zona pellucida,BP,ZP3
19868,GO:2000387,0.0884264469679404,1,1,1,regulation of antral ovarian follicle growth,BP,ZP3
19869,GO:2000388,0.0884264469679404,1,1,1,positive regulation of antral ovarian follicle growth,BP,ZP3
7743,GO:0032271,0.0886171509385758,0.945382125906427,20,152,regulation of protein polymerization,BP,GSN;ARPIN;CORO1B;TMOD2;ARL2;WIPF1;PLEKHG2;CDC42EP5;SPTB;DMTN;CAPG;TWF2;WHAMMP3;EPS8L1;EPS8L2;PINK1;SPIRE2;MLST8;PYCARD;FCHSD1
537,GO:0001656,0.0886262318622333,0.958874617829006,9,56,metanephros development,BP,EGR1;PKD2;LAMB2;WWTR1;HES1;WNT7B;PKD1;CTSH;KIF26B
4516,GO:0010591,0.0892090599479132,0.970500153233688,5,25,regulation of lamellipodium assembly,BP,PLXNB3;SSH1;DMTN;TWF2;SSH3
2513,GO:0005773,0.0892604720033397,0.930675145906652,68,601,vacuole,CC,TSPAN1;GAA;NAPRT;PYGB;CST3;MARCH9;COL6A1;MST1R;LRP1;ULK1;NAGLU;CTSB;TBC1D14;ANK3;PEG3;HYAL1;CTSF;FUCA1;VAT1;HEXB;VPS11;ACP5;DIRC2;GM2A;RAB3D;RNASET2;ATG16L2;MARCH2;AP2A2;DPP7;GLB1;FYCO1;SLC48A1;MEFV;ABCA2;ADA;PCSK9;TMEM9;PI4K2A;LDLR;VASN;TMEM175;ABCD4;TPP1;GPC1;CTSZ;CAPN2;TOLLIP;MAN2B2;CYBRD1;CD68;SDC1;TBC1D17;TPCN1;HGSNAT;CTSD;TP53INP1;VPS33B;NAGA;SPPL2B;SLC22A17;CTSH;PYCARD;C12ORF66;LITAF;GALNS;PQLC2;STXBP2
682,GO:0001893,0.0893355903626029,0.970445733221908,5,25,maternal placenta development,BP,CYP27B1;CTSB;BSG;RXRA;AKT1
10885,GO:0044449,0.0893921278771521,0.948275846644561,16,117,contractile fiber part,CC,FLNC;NOS1;PARVB;SCN8A;OBSCN;MYZAP;OBSL1;ANK3;ATP2B4;TMOD2;TNNT1;MYH3;AHNAK2;BIN1;SYNC;SLC2A1
4944,GO:0015018,0.0893995241692016,1,1,1,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,B3GAT3
1394,GO:0003310,0.0896070676493453,1,1,1,pancreatic A cell differentiation,BP,HES1
6363,GO:0021558,0.0896070676493453,1,1,1,trochlear nerve development,BP,HES1
11476,GO:0045977,0.0896070676493453,1,1,1,positive regulation of mitotic cell cycle, embryonic,BP,HES1
13626,GO:0060164,0.0896070676493453,1,1,1,regulation of timing of neuron differentiation,BP,HES1
14167,GO:0061102,0.0896070676493453,1,1,1,stomach neuroendocrine cell differentiation,BP,HES1
14168,GO:0061105,0.0896070676493453,1,1,1,regulation of stomach neuroendocrine cell differentiation,BP,HES1
14169,GO:0061106,0.0896070676493453,1,1,1,negative regulation of stomach neuroendocrine cell differentiation,BP,HES1
15449,GO:0071820,0.0896070676493453,1,1,1,N-box binding,MF,HES1
15564,GO:0072071,0.0896070676493453,1,1,1,kidney interstitial fibroblast differentiation,BP,HES1
15615,GO:0072141,0.0896070676493453,1,1,1,renal interstitial fibroblast development,BP,HES1
19764,GO:2000226,0.0896070676493453,1,1,1,regulation of pancreatic A cell differentiation,BP,HES1
19765,GO:2000227,0.0896070676493453,1,1,1,negative regulation of pancreatic A cell differentiation,BP,HES1
3282,GO:0006979,0.0897104440961277,0.936176162418237,38,321,response to oxidative stress,BP,FOS;APOE;ERCC1;NAPRT;CST3;PRDX5;PRODH;EPAS1;GPX3;MAPK13;EGFR;HYAL1;PKD2;MSRB2;NDUFS8;TXNRD3;PRNP;STAT6;ANKZF1;BNIP3;ENDOG;MAPK3;ETV5;ADA;MCTP1;PYCR2;PDK2;SESN2;TMEM161A;SDC1;GSS;AKT1;TRAP1;TP53INP1;ERCC6;PINK1;RGS14;NEIL1
3912,GO:0008593,0.0899911976070871,0.954332745483061,11,73,regulation of Notch signaling pathway,BP,POSTN;ARRDC1;EGFR;MAML3;ZMIZ1;BCL6;HES1;LLGL1;RFNG;PEAR1;EPN2
6695,GO:0030108,0.0900241223133444,1,1,1,HLA-A specific activating MHC class I receptor activity,MF,CTSH
7829,GO:0032397,0.0900241223133444,1,1,1,activating MHC class I receptor activity,MF,CTSH
8904,GO:0034763,0.0900597537165001,0.956038493175517,10,65,negative regulation of transmembrane transport,BP,EPHB2;ANK3;PKD2;NTSR1;PCSK9;GRB10;STK39;ANO9;AKT1;GSTM2
3318,GO:0007033,0.0902057075156533,0.945063757660441,19,142,vacuole organization,BP,GAA;ULK1;NAGLU;ULK2;TBC1D14;PACS2;TFEB;HEXB;VPS11;ATG16L2;HOOK2;WIPI2;LRSAM1;ATG2A;TMEM175;TPP1;LYST;TP53INP1;PINK1
2189,GO:0005053,0.0902333751531363,1,1,1,peroxisome matrix targeting signal-2 binding,MF,PEX7
12872,GO:0051240,0.0902721788542757,0.926294428280711,106,970,positive regulation of multicellular organismal process,BP,FOS;ADGRL1;APOE;CTNNBIP1;SHANK2;RAPGEF3;CYP27B1;PGF;NOS1;ZFP36L1;POSTN;ALOX15B;FAM210B;EPHB2;CNTN1;NFATC4;LRP1;MAPK13;OBSL1;EGFR;TIMP2;NLGN2;EGR1;CRTC1;F2R;PTK6;ABCA7;BBS2;GJC2;ZMYND8;ZP3;HYAL1;ZFPM1;PLXNB3;SERPINE2;RNF135;CSNK1E;WNT7A;ZMIZ1;SH3PXD2B;FBXW8;EPHA1;IL20RB;LPAR3;TMEM173;ECM1;STAT6;DLG4;WWTR1;RAB25;FAM20C;BCL6;PLXNB1;VEGFA;CEBPB;SHANK3;ACVR2B;MAPK3;ETV5;DVL1;EPHB3;HES1;CUL7;NRP2;ADA;IL6R;F12;HBEGF;DMTN;LDLR;TRPV4;RAG1;EEF2K;HMGA2;HK1;GAS6;ADGRB2;TKFC;WNT7B;PTAFR;PRKCZ;INPP5D;SLITRK6;TWF2;GPC1;FGFR1;PIN1;C5;PROX1;BIN1;WNT2B;WNT3;PPM1F;VEGFB;ACVR1B;ADORA2B;ERBB3;AKT1;NLRX1;RGS14;CTSH;PYCARD;MAP2K3;EREG;MIF;SULF2
15132,GO:0071277,0.0903397172640593,0.962925549079019,7,40,cellular response to calcium ion,BP,FOS;PKD2;RASA4;ENDOG;DMTN;EEF2K;CPNE7
12314,GO:0048696,0.0904131659271431,1,1,1,regulation of collateral sprouting in absence of injury,BP,WNT3
12315,GO:0048697,0.0904131659271431,1,1,1,positive regulation of collateral sprouting in absence of injury,BP,WNT3
13567,GO:0060064,0.0904131659271431,1,1,1,Spemann organizer formation at the anterior end of the primitive streak,BP,WNT3
19251,GO:1905474,0.0904131659271431,1,1,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,WNT3
10315,GO:0043126,0.0904845146110741,1,1,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,CD81
10316,GO:0043128,0.0904845146110741,1,1,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,CD81
12417,GO:0050104,0.0905023009498694,1,1,1,L-gulonate 3-dehydrogenase activity,MF,CRYL1
6280,GO:0019899,0.0905237513049918,0.922467987060199,192,1825,enzyme binding,MF,TNIP1;TYSND1;WWC3;SYTL1;BTBD2;CST3;RAPGEF3;EVI5L;NDRG1;MEF2D;ARAP1;GRB7;ARRDC1;EPHB2;EPAS1;OBSCN;MST1R;LRP1;APPL2;RALGDS;RAB11FIP4;EGFR;TIMP2;TOM1L2;RAPGEFL1;EGR1;ULK1;PKN1;ARHGEF4;SHC1;RGL2;SLC9A3R2;ACTA2;SHC2;TBC1D14;RIN1;PIK3R2;NEK9;HDAC5;DOCK4;ZP3;ERBB2;EXOC2;BRSK1;MICALL2;PKD2;CBS;IQSEC2;ABTB1;DNM1;RIMS3;CUL9;KIF13B;PAK6;ATP2B4;TRAPPC9;AGAP1;DOCK6;ACAP3;RHOD;PLEKHG4;INSR;TBC1D8;RABGGTA;EPHA1;PPP1R35;TMEM173;PRNP;SPRY2;SLC12A7;ECM1;CEP250;SNX9;STAT6;DLG4;ABCD1;PFKFB2;BNIP3;FZD8;AP2A2;CEBPB;MAPK3;PLEKHG5;SLC22A18;DVL1;ADCY6;PKN3;EPHB3;HES1;UHRF1BP1;FURIN;CUL7;PLEKHG2;TNFRSF14;CDC42EP5;PAG1;PFKL;IL6R;ZFP36;RHOF;BTBD11;HLCS;FGFR3;PRKACA;PITPNM1;HBEGF;FGFR4;SPTB;FBXW5;TSPAN33;RAPGEF5;PSD4;MAPK8IP1;LDLR;TRPV4;RHOBTB2;DGKQ;PEX7;GAS6;LLGL1;PPARA;GIT1;SUFU;PTAFR;PLEKHG6;ARHGEF37;RXRA;VAV3;BCR;TBC1D16;PRKCZ;HLTF;TWF2;SRSF5;RFXANK;CEP68;MAPKAPK3;RAD23A;ARAP3;FGFR1;PIN1;ASAP2;DLG3;BIN1;SERPINB6;TOLLIP;CSTB;MAPRE3;PITPNM3;MADD;TIMP1;WHAMMP3;EPS8L1;MICALCL;SBF1;SORL1;STK39;ACVR1B;MEF2B;TBC1D17;ALS2CL;ERBB3;ABR;AKT1;TRAP1;TUT1;EPS8L2;PINK1;GAS8;PKD1;LONP2;SNTA1;ARHGEF10L;CAMTA2;RGS14;RILPL1;CBLC;ATXN10;PYCARD;MAP2K3;KCNN4;ERN1;RANBP9;ARHGEF19;SIRT3;SLC2A1;JAK3;EREG;GSTM2;SFI1;ADAMTSL4;MIF
1786,GO:0004419,0.090546677708096,1,1,1,hydroxymethylglutaryl-CoA lyase activity,MF,HMGCL
12508,GO:0050679,0.090734735494987,0.947385449788953,16,117,positive regulation of epithelial cell proliferation,BP,HTRA1;PGF;EGFR;HYAL1;ERBB2;PLXNB3;GLUL;WNT7A;ID1;ECM1;VEGFA;NRP2;FGFR1;PROX1;VEGFB;AKT1
10652,GO:0043901,0.0909641843302156,0.947215994701363,16,118,negative regulation of multi-organism process,BP,TNIP1;HTRA1;GSN;ZP3;ISG20;ADA;ZFP36;MAPKBP1;HMGA2;FAM3A;TKFC;PROX1;TIMP1;APOBEC3C;NLRX1;APOBEC3F
9462,GO:0036114,0.0910177880416902,1,1,1,medium-chain fatty-acyl-CoA catabolic process,BP,ACOT7
9463,GO:0036115,0.0910177880416902,1,1,1,fatty-acyl-CoA catabolic process,BP,ACOT7
9464,GO:0036116,0.0910177880416902,1,1,1,long-chain fatty-acyl-CoA catabolic process,BP,ACOT7
17473,GO:1900533,0.0910177880416902,1,1,1,palmitic acid metabolic process,BP,ACOT7
17474,GO:1900535,0.0910177880416902,1,1,1,palmitic acid biosynthetic process,BP,ACOT7
10583,GO:0043574,0.0910366494767679,0.974593614942985,4,18,peroxisomal transport,BP,PEX10;ABCD1;PEX7;LONP2
1070,GO:0002636,0.0911459822835272,1,1,1,positive regulation of germinal center formation,BP,ADA
2744,GO:0006157,0.0911459822835272,1,1,1,deoxyadenosine catabolic process,BP,ADA
9936,GO:0042321,0.0911459822835272,1,1,1,negative regulation of circadian sleep/wake cycle, sleep,BP,ADA
9937,GO:0042323,0.0911459822835272,1,1,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,ADA
11532,GO:0046090,0.0911459822835272,1,1,1,deoxyadenosine metabolic process,BP,ADA
11543,GO:0046111,0.0911459822835272,1,1,1,xanthine biosynthetic process,BP,ADA
11549,GO:0046124,0.0911459822835272,1,1,1,purine deoxyribonucleoside catabolic process,BP,ADA
13628,GO:0060167,0.0911459822835272,1,1,1,regulation of adenosine receptor signaling pathway,BP,ADA
13629,GO:0060169,0.0911459822835272,1,1,1,negative regulation of adenosine receptor signaling pathway,BP,ADA
13788,GO:0060407,0.0911459822835272,1,1,1,negative regulation of penile erection,BP,ADA
14632,GO:0070256,0.0911459822835272,1,1,1,negative regulation of mucus secretion,BP,ADA
20151,GO:2001025,0.0911873392238965,0.980665227865472,3,12,positive regulation of response to drug,BP,ENDOG;RAB3B;PINK1
6058,GO:0019216,0.0912507182789953,0.937081736454374,32,260,regulation of lipid metabolic process,BP,LMF1;APOE;TYSND1;CYP27B1;NR1D1;CPT2;EGR1;ABCG1;PIK3R2;THRA;ZP3;MVD;SEC14L2;CD81;MLXIPL;FGFR3;FGFR4;PMVK;TNFRSF1A;LDLR;LDLRAP1;TM7SF2;DGKQ;PPARA;RXRA;VAV3;PDK2;PROX1;AKT1;LONP2;MLYCD;TAZ
13052,GO:0051586,0.0912982701283649,1,1,1,positive regulation of dopamine uptake involved in synaptic transmission,BP,RAB3B
13234,GO:0051944,0.0912982701283649,1,1,1,positive regulation of catecholamine uptake involved in synaptic transmission,BP,RAB3B
13464,GO:0055037,0.0917209341335269,0.944005206618337,19,143,recycling endosome,CC,NDRG1;RAB11FIP4;ULK1;TBC1D14;ABCG1;NISCH;MICALL2;RAB25;C1ORF210;MCTP1;EHD4;ABHD17C;LDLRAP1;SLC9A7;SORL1;TBC1D17;VPS33B;EHD3;FCHSD1
16103,GO:0090131,0.0918662691614782,1,1,1,mesenchyme migration,BP,ACTA2
3984,GO:0008890,0.0919064478457054,1,1,1,glycine C-acetyltransferase activity,MF,GCAT
6155,GO:0019518,0.0919064478457054,1,1,1,L-threonine catabolic process to glycine,BP,GCAT
13884,GO:0060563,0.0920302240607389,0.965261046173745,6,33,neuroepithelial cell differentiation,BP,FAM20C;CEBPB;HES1;SLITRK6;FGFR1;TMEM231
9340,GO:0035869,0.0920392672875477,0.959248179736307,8,49,ciliary transition zone,CC,TCTN1;IFT140;NPHP4;TMEM107;SPATA7;C21ORF2;UNC119B;TMEM231
794,GO:0002064,0.0921129339733626,0.943747689845404,19,142,epithelial cell development,BP,PTPRS;CST3;RAPGEF3;ACTA2;LAMB2;WNT7A;ID1;RAB25;S1PR2;TNFRSF1A;WNT7B;SLITRK6;FGFR1;PROX1;BFSP1;SDC1;RILPL1;RARG;ADAMTSL4
15815,GO:0072555,0.0921289756233559,1,1,1,17-beta-ketosteroid reductase activity,MF,DHRS11
15834,GO:0072582,0.0921289756233559,1,1,1,17-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,DHRS11
3359,GO:0007129,0.0921345264511014,0.974178660246625,4,18,synapsis,BP,DMC1;AGO4;SUN1;P3H4
12774,GO:0051094,0.0923107063142976,0.925693355341901,91,822,positive regulation of developmental process,BP,FOS;ADGRL1;APOE;CTNNBIP1;SHANK2;RAPGEF3;CYP27B1;PGF;ZFP36L1;ALOX15B;FAM210B;EPHB2;CNTN1;OBSL1;TIMP2;NLGN2;EGR1;CRTC1;PTK6;BBS2;CORO1B;GJC2;ZMYND8;THRA;ZP3;LRP5;HYAL1;PLXNB3;SERPINE2;CSNK1E;WNT7A;ZMIZ1;INSR;SH3PXD2B;FBXW8;EPHA1;LPAR3;ECM1;STAT6;DLG4;WWTR1;FAM20C;BCL6;PLXNB1;BNIP3;VEGFA;YPEL3;CEBPB;SHANK3;ACVR2B;HSF4;S1PR2;ETV5;OLFM2;DVL1;EPHB3;HES1;CUL7;ADA;IL6R;ZFP36;DMTN;RAG1;EEF2K;HMGA2;GAS6;ADGRB2;WNT7B;LTBP3;PRKCZ;INPP5D;SLITRK6;TWF2;GPC1;FGFR1;PIN1;C5;PROX1;BIN1;PPP1R13L;WNT2B;WNT3;VEGFB;ACVR1B;ERBB3;CCDC71L;AKT1;ZNF385A;PINK1;RGS14;CTSH
16816,GO:0098751,0.0923518691554111,0.969140916104871,5,25,bone cell development,BP,ZFPM1;FAM20C;LRRK1;ZNF385A;VPS33B
1564,GO:0003974,0.0923627138196921,1,1,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,GALE
1568,GO:0003978,0.0923627138196921,1,1,1,UDP-glucose 4-epimerase activity,MF,GALE
3178,GO:0006809,0.09239426222998,0.96180311348116,7,41,nitric oxide biosynthetic process,BP,NOS1;PKD2;ATP2B4;ACP5;INSR;ASS1;AKT1
10306,GO:0043114,0.0927146920831719,0.973958607919412,4,18,regulation of vascular permeability,BP,CTNNBIP1;TRPV4;BCR;ABR
4482,GO:0010517,0.0928010631097939,0.964891983649476,6,33,regulation of phospholipase activity,BP,LRP1;EGFR;FGFR3;PTAFR;PRKCZ;FGFR1
18314,GO:1903305,0.0928250045580463,0.952628517035046,11,73,regulation of regulated secretory pathway,BP,SYTL1;SYT8;ZP3;RIMS3;RAB3D;PTAFR;BCR;ADGRE2;ADORA2B;ABR;STXBP2
6517,GO:0021915,0.0928817071021494,0.944992568850426,17,124,neural tube development,BP,ZFP36L1;TCTN1;DEAF1;PKD2;SALL2;IFT140;FUZ;CELSR1;TMEM107;VANGL2;DVL1;HES1;SEMA4C;SUFU;PROX1;PKD1;RARG
788,GO:0002053,0.0929211990244422,0.973880152944184,4,18,positive regulation of mesenchymal cell proliferation,BP,LRP5;VEGFA;FBXW4;FGFR1
6575,GO:0022414,0.0930106369158664,0.925093415807655,91,826,reproductive process,BP,HTRA1;FOS;ERCC1;CST3;TCFL5;CYP27B1;PGF;ZFP36L1;ALOX15B;EPAS1;IGF2;MST1R;GAMT;EGFR;MDFI;EGR1;SYT8;DEAF1;BBS2;CTSB;DNAH1;THRA;ZP3;CRTAP;TUBG2;TFEB;FBLN1;BSG;SCMH1;PKD2;PHLDA2;PTHLH;CD9;HEXB;SERPINE2;ATP2B4;GGT1;PLCD1;WNT7A;ZMIZ1;INSR;SH3PXD2B;FBXW8;TXNRD3;DNMT3A;PLCD3;MYCBPAP;PHC2;BCL6;IGFBP2;VEGFA;ZSCAN2;CEBPB;ADAM15;ETV5;HES1;CUL7;ADA;SLIT3;PRKACA;SPATA20;VGF;WNT7B;COMT;PTAFR;DMC1;RXRA;AGO4;IRF2BPL;WNT2B;TIMP1;SDC1;WNT3;ZFP41;MICALCL;SBF1;ACVR1B;AKT1;SIX5;TDRKH;SUN1;RPL39L;PKD1;SPIRE2;P3H4;RFX2;SLC2A1;RARG;EREG;SHISA6;FAM50A
14617,GO:0070229,0.0930437060289719,0.968707501316188,5,26,negative regulation of lymphocyte apoptotic process,BP,BCL6;ADA;RAG1;JAK3;MIF
7240,GO:0031210,0.0930977007345124,0.980082706116523,3,12,phosphatidylcholine binding,MF,PLTP;PITPNM1;ESYT2
12708,GO:0050997,0.0930977007345124,0.980082706116523,3,12,quaternary ammonium group binding,MF,PLTP;PITPNM1;ESYT2
16218,GO:0090299,0.0931063220699937,1,1,1,regulation of neural crest formation,BP,FUZ
16219,GO:0090301,0.0931063220699937,1,1,1,negative regulation of neural crest formation,BP,FUZ
19816,GO:2000314,0.0931063220699937,1,1,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,FUZ
12119,GO:0048244,0.0931349156471703,1,1,1,phytanoyl-CoA dioxygenase activity,MF,PHYH
16407,GO:0097089,0.0931349156471703,1,1,1,methyl-branched fatty acid metabolic process,BP,PHYH
4407,GO:0010189,0.0933115962289002,1,1,1,vitamin E biosynthetic process,BP,PLTP
9954,GO:0042360,0.0933115962289002,1,1,1,vitamin E metabolic process,BP,PLTP
18685,GO:1904121,0.0933115962289002,1,1,1,phosphatidylethanolamine transporter activity,MF,PLTP
15103,GO:0071222,0.0934005281136166,0.947875420693544,14,100,cellular response to lipopolysaccharide,BP,TNIP1;NR1D1;HDAC5;PDCD4;CEBPB;MAPK3;ZFP36;PTAFR;BCR;ADAMTS13;AKT1;PYCARD;LITAF;MIF
1405,GO:0003341,0.0934745327724558,0.968518773264846,5,26,cilium movement,BP,BBS2;DNAH1;GAS8;MAFIP;DNAAF5
9109,GO:0035438,0.0934847608915877,1,1,1,cyclic-di-GMP binding,MF,TMEM173
14300,GO:0061507,0.0934847608915877,1,1,1,cyclic-GMP-AMP binding,MF,TMEM173
12002,GO:0047658,0.0935801884562881,1,1,1,alpha-amino-acid esterase activity,MF,BPHL
590,GO:0001755,0.0937257496428544,0.964448057649577,6,33,neural crest cell migration,BP,SEMA4B;LAMA5;SEMA3B;SEMA3F;SEMA4C;SEMA4F
9237,GO:0035659,0.0937941176619209,1,1,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,WNT7A
11109,GO:0045167,0.0937941176619209,1,1,1,asymmetric protein localization involved in cell fate determination,BP,WNT7A
19017,GO:1904889,0.0937941176619209,1,1,1,regulation of excitatory synapse assembly,BP,WNT7A
19018,GO:1904891,0.0937941176619209,1,1,1,positive regulation of excitatory synapse assembly,BP,WNT7A
4315,GO:0009822,0.0938072938020002,1,1,1,alkaloid catabolic process,BP,CYP3A5
5692,GO:0016830,0.0939086955576969,0.961024172845402,7,41,carbon-carbon lyase activity,MF,GLUL;MVD;HMGCL;PCK2;MOCS1;MLYCD;BCKDHA
3536,GO:0007566,0.093922622424877,0.964260302320764,6,34,embryo implantation,BP,CST3;FBLN1;BSG;RXRA;TIMP1;ACVR1B
3701,GO:0008217,0.0939624992985605,0.95029998791376,12,82,regulation of blood pressure,BP,NOS1;POSTN;F2R;NISCH;LRP5;NTSR1;RASL10B;GAS6;PPARA;PTAFR;CTSZ;STK39
1225,GO:0002903,0.0940705221449493,0.979783903949208,3,12,negative regulation of B cell apoptotic process,BP,BCL6;ADA;MIF
6048,GO:0019205,0.0940775442283046,0.960866608905992,7,42,nucleobase-containing compound kinase activity,MF,NME4;DLG4;UCKL1;TK2;DGUOK;GUK1;DLG3
18823,GO:1904464,0.0940786728487107,1,1,1,regulation of matrix metallopeptidase secretion,BP,IDH2
18824,GO:1904465,0.0940786728487107,1,1,1,negative regulation of matrix metallopeptidase secretion,BP,IDH2
19592,GO:1990773,0.0940786728487107,1,1,1,matrix metallopeptidase secretion,BP,IDH2
19671,GO:2000026,0.0941257206457129,0.921302975786253,135,1267,regulation of multicellular organismal development,BP,FOS;DUSP6;ADGRL1;APOE;CTNNBIP1;IDH2;PTPRS;SEMA4B;SHANK2;RAPGEF3;CYP27B1;XDH;PGF;NOS1;ZFP36L1;ALOX15B;FAM210B;EPHB2;CNTN1;NFATC4;LRP1;OBSL1;EGFR;TIMP2;NLGN2;EGR1;CRTC1;PTK6;DEAF1;LAMA5;ULK2;GJC2;ZMYND8;ASH2L;HDAC5;ZP3;HYAL1;ZFPM1;ERBB2;PLXNB3;PHLDA2;PTHLH;KIF13B;SERPINE2;FUZ;CSNK1E;ADAMTS7;PDCD4;WNT7A;ZMIZ1;INSR;SH3PXD2B;FBXW8;ID1;CELSR1;EPHA1;SYNGAP1;LPAR3;EFNB3;SPRY2;ECM1;STAT6;DLG4;WWTR1;FAM20C;BCL6;PLXNB1;FAM213A;VEGFA;VANGL2;AP2A2;CEBPB;SHANK3;ACVR2B;S1PR2;ETV5;DVL1;ADCY6;L3MBTL1;EPHB3;HES1;SSH1;CUL7;ADA;AQP3;CELSR2;ZFP36;DGUOK;TNFRSF1A;SEMA3B;LDLR;SOX13;TRPV4;RAG1;EEF2K;HMGA2;SEMA3F;SEMA4C;GAS6;ADGRB2;SUFU;RXRA;VASN;PRKCZ;INPP5D;SLITRK6;TWF2;GPC1;AGO4;FGFR1;CTSZ;CHADL;PIN1;C5;PROX1;BIN1;JARID2;WNT2B;RTN4R;TIMP1;WNT3;SORL1;VEGFB;ACVR1B;ERBB3;AKT1;SSH3;RGS14;CTSH;EPN2;ARHGEF19;JAK3;RARG;SEMA4F;SULF2
11066,GO:0045085,0.094166863994616,1,1,1,negative regulation of interleukin-2 biosynthetic process,BP,ZFP36
16812,GO:0098745,0.094166863994616,1,1,1,Dcp1-Dcp2 complex,CC,ZFP36
17749,GO:1901834,0.094166863994616,1,1,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,ZFP36
17750,GO:1901835,0.094166863994616,1,1,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,ZFP36
18734,GO:1904246,0.094166863994616,1,1,1,negative regulation of polynucleotide adenylyltransferase activity,BP,ZFP36
15522,GO:0071963,0.0942167467936448,1,1,1,establishment or maintenance of cell polarity regulating cell shape,BP,PARVB
11853,GO:0046883,0.0943122613547353,0.94219779648709,19,144,regulation of hormone secretion,BP,RAPGEF3;NR1D1;EGFR;HADH;NLGN2;LRP5;ITPR3;GLUL;PFKFB2;ARL2;RASL10B;PFKL;PCK2;TM7SF3;FGFR1;VSNL1;SIRT3;SLC2A1;GIPR
3821,GO:0008430,0.0943883967297313,1,1,1,selenium binding,MF,GPX3
969,GO:0002416,0.0944185691932449,1,1,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,FCGRT
6213,GO:0019770,0.0944185691932449,1,1,1,IgG receptor activity,MF,FCGRT
6261,GO:0019864,0.0944185691932449,1,1,1,IgG binding,MF,FCGRT
12867,GO:0051234,0.0946027725251325,0.91634495311404,347,3431,establishment of localization,BP,LMF1;CEMIP;APOE;TSPAN1;IDH2;GAA;SYTL1;NAPRT;PYGB;CST3;SHANK2;LTBP4;RAPGEF3;MRC2;PGM1;CYP27B1;GSN;CLCA2;EVI5L;XDH;PRSS3;NOS1;ARAP1;ZFP36L1;POSTN;NR1D1;ALOX15B;ARRDC1;SCN8A;SLCO4A1;EPHB2;CNTN1;CPT2;IGF2;NME4;LRP1;APPL2;KCNG1;LTBP2;RAB11FIP4;EGFR;TIMP2;B3GAT3;HADH;NLGN2;REEP6;TOM1L2;SLC43A1;FHL1;SERPING1;RHBDF1;PYGL;DOPEY2;SYT8;F2R;ABCA7;CA12;BBS2;SLC16A5;PRSS8;CTSB;PITPNC1;SLC16A3;GJC2;TBC1D14;KCNC4;ABCG1;RIN1;ANK3;PIK3R2;S100A6;KCNJ15;ZP3;NISCH;LRP5;ANO8;PLTP;SLC2A9;LRP3;ERBB2;SLC13A3;EXOC2;BRSK1;MICALL2;BSG;PKD2;TMEM129;FUCA1;TST;SCN4B;EDEM1;SLC7A8;ITPR3;PRAF2;VAT1;DNM1;FCHO1;RIMS3;IFT140;CD9;KIF13B;CACFD1;SIGMAR1;HEXB;SERPINE2;VPS11;VAMP2;FUZ;NTSR1;CD320;MINK1;ATP2B4;SLC6A8;TFDP2;CSNK1E;TRAPPC9;AGAP1;ZFYVE21;GM2A;SLC20A1;ACAP3;GLUL;RHOD;USP20;PEX10;ASIC1;WNT7A;INSR;RAB3D;TBC1D8;NBEAL2;LPAR3;TMEM173;PRNP;SERINC2;ATP7B;RNASET2;SNX33;SPRY2;SLC12A7;ECM1;ATG16L2;SNX9;DLG4;ABCD1;MARCH2;REEP2;STRADB;RAB25;MYO18A;ARHGAP27;SCART1;BCL6;TTYH3;PFKFB2;ATP12A;CHMP1B;MVB12B;BNIP3;CD81;FCGRT;VEGFA;DNASE1L1;HOOK2;LRRC8A;ARL2;ELMO3;TMEM63C;AP2A2;RHBDF2;DPP7;SHANK3;SSC4D;ACVR2B;ZDHHC1;MAPK3;TUB;KCNAB2;OLFM2;AMN;SLC22A18;GLB1;RAB40B;DVL1;FYCO1;WIPF1;LTA4H;SLC16A13;FHOD1;HES1;FURIN;SLC48A1;SLC2A3;ABCA2;LRSAM1;ADA;MCTP1;OSBPL5;AQP3;RASL10B;PFKL;PCSK9;SLC28A2;ZFP36;RHOF;MAPKBP1;PRKACA;PITPNM1;CYFIP2;SLC38A10;SCNN1A;SLC25A37;RAB3B;MAP2K2;PI4K2A;SPTB;SLC37A2;STX10;DMTN;BBS1;VGF;EHD4;MAPK8IP1;LDLR;SNX17;TRPV4;CROCC;EEF2K;LDLRAP1;PEX7;MVB12A;HK1;SLC29A4;GAS6;LLGL1;PPARA;GUK1;GIT1;COMT;PTAFR;RXRA;PCK2;VAV3;LRP10;BCR;TMEM175;TBC1D16;WDR60;PRKCZ;ZDHHC24;CLTCL1;TM7SF3;TMCO6;ABCD4;SRSF5;MAPKAPK3;NDE1;ARAP3;FGFR1;CTSZ;C5;WBP2;ASAP2;DLG3;GPR155;KCNMA1;ESYT2;BIN1;VSNL1;UNC119B;SERPINB6;OSCP1;GLRX;SLC25A27;TMCO3;GRB10;SESN2;NDUFA4L2;TOLLIP;CSTB;SNPH;LCAT;GUCA1B;ADGRE2;SMDT1;PITPNM3;SLC9A7;TIMP1;CD68;SDC1;WHAMMP3;ACTR1B;RTN2;PEAR1;LYST;SORL1;STK39;VEGFB;TBC1D17;ANO9;TSNARE1;ADORA2B;TPCN1;HGSNAT;SLC25A29;ERBB3;ABR;AKT1;CTSD;STON1;VPS33B;GPD1L;SLC5A5;SUN1;PINK1;PKD1;EHD3;LONP2;SLC22A17;SNTA1;HOMER2;RGS14;SYNE3;SPIRE2;CTSH;RILPL1;EPN2;PYCARD;RHBG;KCNN4;CKLF;SIRT3;ORAI3;SLC2A1;APBA1;ORAI2;GALNS;GSTM2;SHISA6;GIPR;PQLC2;TMED4;RPL13A;RAB40C;MIF;STXBP2;UBL5
1507,GO:0003868,0.0948090939191631,1,1,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,HPDL
1686,GO:0004163,0.0948540317420644,1,1,1,diphosphomevalonate decarboxylase activity,MF,MVD
13351,GO:0052642,0.0949976289802707,1,1,1,lysophosphatidic acid phosphatase activity,MF,ACP6
20281,GO:2001311,0.0949976289802707,1,1,1,lysobisphosphatidic acid metabolic process,BP,ACP6
2,GO:0000003,0.0950831642477835,0.923326844862228,91,827,reproduction,BP,HTRA1;FOS;ERCC1;CST3;TCFL5;CYP27B1;PGF;ZFP36L1;ALOX15B;EPAS1;IGF2;MST1R;GAMT;EGFR;MDFI;EGR1;SYT8;DEAF1;BBS2;CTSB;DNAH1;THRA;ZP3;CRTAP;TUBG2;TFEB;FBLN1;BSG;SCMH1;PKD2;PHLDA2;PTHLH;CD9;HEXB;SERPINE2;ATP2B4;GGT1;PLCD1;WNT7A;ZMIZ1;INSR;SH3PXD2B;FBXW8;TXNRD3;DNMT3A;PLCD3;MYCBPAP;PHC2;BCL6;IGFBP2;VEGFA;ZSCAN2;CEBPB;ADAM15;ETV5;HES1;CUL7;ADA;SLIT3;PRKACA;SPATA20;VGF;WNT7B;COMT;PTAFR;DMC1;RXRA;AGO4;IRF2BPL;WNT2B;TIMP1;SDC1;WNT3;ZFP41;MICALCL;SBF1;ACVR1B;AKT1;SIX5;TDRKH;SUN1;RPL39L;PKD1;SPIRE2;P3H4;RFX2;SLC2A1;RARG;EREG;SHISA6;FAM50A
28,GO:0000053,0.0951428232372904,1,1,1,argininosuccinate metabolic process,BP,ASS1
1618,GO:0004055,0.0951428232372904,1,1,1,argininosuccinate synthase activity,MF,ASS1
2281,GO:0005244,0.0951860450719419,0.953037034499712,10,65,voltage-gated ion channel activity,MF,SCN8A;KCNG1;KCNC4;KCNJ15;PKD2;SCN4B;KCNAB2;GAS6;KCNMA1;TPCN1
6601,GO:0022832,0.0951860450719419,0.953037034499712,10,65,voltage-gated channel activity,MF,SCN8A;KCNG1;KCNC4;KCNJ15;PKD2;SCN4B;KCNAB2;GAS6;KCNMA1;TPCN1
4022,GO:0009063,0.0952952048126797,0.951100115449204,11,74,cellular amino acid catabolic process,BP,PRODH;NOS1;ALDH4A1;CBS;ATP2B4;GLUL;BLMH;HMGCL;HPDL;GCAT;BCKDHA
12506,GO:0050673,0.0953513723664555,0.934370529177806,31,253,epithelial cell proliferation,BP,HTRA1;APOE;XDH;PGF;ZFP36L1;NR1D1;EGFR;DEAF1;HYAL1;ERBB2;PLXNB3;CDKN1C;GLUL;WNT7A;ID1;ECM1;STAT6;VEGFA;CEBPB;HES1;NRP2;ZFP36;BTRC;IGFBP4;FGFR1;PROX1;VEGFB;AKT1;ERN1;EREG;SULF2
12394,GO:0048864,0.0955372478702425,0.954927950692483,9,57,stem cell development,BP,SEMA4B;LAMA5;WNT7A;MAPK3;HES1;SEMA3B;SEMA3F;SEMA4C;SEMA4F
4991,GO:0015143,0.0955646973146737,1,1,1,urate transmembrane transporter activity,MF,SLC2A9
5174,GO:0015747,0.0955646973146737,1,1,1,urate transport,BP,SLC2A9
17727,GO:1901702,0.0955646973146737,1,1,1,salt transmembrane transporter activity,MF,SLC2A9
8408,GO:0033500,0.0956021984456391,0.941288374752055,19,145,carbohydrate homeostasis,BP,NR1D1;IGF2;PYGL;PIK3R2;LRP5;INSR;ENDOG;MLXIPL;PRKACA;FGFR4;VGF;TRPV4;HK1;GAS6;PCK2;PDK2;VSNL1;AKT1;ERN1
10074,GO:0042593,0.0956021984456391,0.941288374752055,19,145,glucose homeostasis,BP,NR1D1;IGF2;PYGL;PIK3R2;LRP5;INSR;ENDOG;MLXIPL;PRKACA;FGFR4;VGF;TRPV4;HK1;GAS6;PCK2;PDK2;VSNL1;AKT1;ERN1
20005,GO:2000656,0.0956704729009164,1,1,1,regulation of apolipoprotein binding,BP,MAPK3
20006,GO:2000657,0.0956704729009164,1,1,1,negative regulation of apolipoprotein binding,BP,MAPK3
1036,GO:0002545,0.0956988897860314,1,1,1,chronic inflammatory response to non-antigenic stimulus,BP,ADORA2B
1210,GO:0002880,0.0956988897860314,1,1,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,ADORA2B
1211,GO:0002882,0.0956988897860314,1,1,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,ADORA2B
5207,GO:0015819,0.0957551734538639,1,1,1,lysine transport,BP,PQLC2
664,GO:0001868,0.0957969072515933,1,1,1,regulation of complement activation, lectin pathway,BP,SERPING1
665,GO:0001869,0.0957969072515933,1,1,1,negative regulation of complement activation, lectin pathway,BP,SERPING1
15911,GO:0072740,0.095810727692234,1,1,1,cellular response to anisomycin,BP,MAPK13
1756,GO:0004363,0.095928615945538,1,1,1,glutathione synthase activity,MF,GSS
3602,GO:0008049,0.0959375447937853,1,1,1,male courtship behavior,BP,HEXB
11942,GO:0047166,0.0960082641733994,1,1,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,LPCAT4
1639,GO:0004085,0.0960518249391471,1,1,1,butyryl-CoA dehydrogenase activity,MF,ACADS
6176,GO:0019605,0.0960518249391471,1,1,1,butyrate metabolic process,BP,ACADS
11619,GO:0046359,0.0960518249391471,1,1,1,butyrate catabolic process,BP,ACADS
13420,GO:0052890,0.0960518249391471,1,1,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,ACADS
18467,GO:1903621,0.0962582702423535,1,1,1,protein localization to photoreceptor connecting cilium,BP,SPATA7
13239,GO:0051954,0.0962832697034449,0.979098860883285,3,12,positive regulation of amine transport,BP,NTSR1;RAB3B;PINK1
1115,GO:0002704,0.0962873699035802,0.967279468533593,5,26,negative regulation of leukocyte mediated immunity,BP,IL20RB;BCL6;BCR;ABR;JAK3
1914,GO:0004611,0.0964339343672657,1,1,1,phosphoenolpyruvate carboxykinase activity,MF,PCK2
1915,GO:0004613,0.0964339343672657,1,1,1,phosphoenolpyruvate carboxykinase (GTP) activity,MF,PCK2
6167,GO:0019543,0.0964339343672657,1,1,1,propionate catabolic process,BP,PCK2
11602,GO:0046327,0.0964339343672657,1,1,1,glycerol biosynthetic process from pyruvate,BP,PCK2
7031,GO:0030816,0.0965754494519439,0.979007847225694,3,12,positive regulation of cAMP metabolic process,BP,RAPGEF3;TIMP2;PTHLH
6534,GO:0021956,0.096662719967235,1,1,1,central nervous system interneuron axonogenesis,BP,TCTN1
1919,GO:0004617,0.09682425744901,1,1,1,phosphoglycerate dehydrogenase activity,MF,PHGDH
5525,GO:0016519,0.096904888766351,1,1,1,gastric inhibitory peptide receptor activity,MF,GIPR
9720,GO:0038192,0.096904888766351,1,1,1,gastric inhibitory peptide signaling pathway,BP,GIPR
10876,GO:0044438,0.0969481607907736,0.950061421092268,11,75,microbody part,CC,PRDX5;CRAT;PEX10;ABCD1;MAP2K2;PEX7;ABCD4;PHYH;GRHPR;LONP2;MLYCD
10877,GO:0044439,0.0969481607907736,0.950061421092268,11,75,peroxisomal part,CC,PRDX5;CRAT;PEX10;ABCD1;MAP2K2;PEX7;ABCD4;PHYH;GRHPR;LONP2;MLYCD
624,GO:0001808,0.0969637508953475,1,1,1,negative regulation of type IV hypersensitivity,BP,IL20RB
1205,GO:0002865,0.0969637508953475,1,1,1,negative regulation of acute inflammatory response to antigenic stimulus,BP,IL20RB
1213,GO:0002884,0.0969637508953475,1,1,1,negative regulation of hypersensitivity,BP,IL20RB
1033,GO:0002542,0.0970650390442218,1,1,1,Factor XII activation,BP,F12
13218,GO:0051919,0.0970650390442218,1,1,1,positive regulation of fibrinolysis,BP,F12
6034,GO:0019150,0.0970743171613591,1,1,1,D-ribulokinase activity,MF,FGGY
2509,GO:0005768,0.0970791272177893,0.923159030254786,76,682,endosome,CC,APOE;CST3;NDRG1;LRP1;APPL2;RAB11FIP4;EGFR;ULK1;PKN1;DOPEY2;F2R;ABCA7;CTSB;TBC1D14;ABCG1;NISCH;ERBB2;MICALL2;PRAF2;VPS11;CD320;ZFYVE21;RHOD;INSR;ATP7B;SNX33;SNX9;MARCH2;RAB25;C1ORF210;CHMP1B;MVB12B;AP2A2;MAPK3;AMN;RAB40B;FYCO1;FURIN;SLC48A1;ABCA2;MCTP1;PCSK9;TMEM9;MAP2K2;PI4K2A;FGFR4;EHD4;LDLR;SNX17;ABHD17C;LDLRAP1;DGKQ;MVB12A;MIB2;LLGL1;ANKRD13D;TMEM175;TBC1D16;PRKCZ;CLTCL1;GPC1;WDR83;SLC9A7;CD68;SORL1;TBC1D17;TPCN1;VPS33B;SPPL2B;EHD3;CTSH;EHBP1L1;JAK3;LITAF;FCHSD1;RAB40C
3133,GO:0006734,0.0971116387989049,0.966913983615715,5,26,NADH metabolic process,BP,PFKL;HK1;PCK2;MDH2;GPD1L
1578,GO:0003991,0.0971561643732566,1,1,1,acetylglutamate kinase activity,MF,NAGS
1610,GO:0004042,0.0971561643732566,1,1,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,NAGS
17151,GO:0103045,0.0971561643732566,1,1,1,methione N-acyltransferase activity,MF,NAGS
13421,GO:0052894,0.0971591389123501,1,1,1,norspermine:oxygen oxidoreductase activity,MF,SMOX
13422,GO:0052895,0.0971591389123501,1,1,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,SMOX
1809,GO:0004463,0.0971621094182122,1,1,1,leukotriene-A4 hydrolase activity,MF,LTA4H
7544,GO:0031883,0.0973166039439247,1,1,1,taste receptor binding,MF,REEP2
11114,GO:0045177,0.0974513833707796,0.934689850319593,27,215,apical part of cell,CC,SHANK2;EGFR;REEP6;SLC9A3R2;PLAT;SLC2A9;ERBB2;ITPR3;CD9;GM2A;IGFBP2;VANGL2;AMN;SLC22A18;IL6R;SCNN1A;LDLR;TRPV4;SLC29A4;PRKCZ;KCNMA1;SLC25A27;STK39;ERBB3;HOMER2;SLC2A1;STXBP2
20184,GO:2001138,0.09747722943517,0.987716923565982,2,6,regulation of phospholipid transport,BP,APOE;ABCA7
20185,GO:2001140,0.09747722943517,0.987716923565982,2,6,positive regulation of phospholipid transport,BP,APOE;ABCA7
8290,GO:0033138,0.0976000318690032,0.953702399519087,9,58,positive regulation of peptidyl-serine phosphorylation,BP,RAPGEF3;EGFR;ATP2B4;SPRY2;VEGFA;GAS6;AKT1;PINK1;MIF
4801,GO:0014002,0.0976643968219668,0.971852608573653,4,19,astrocyte development,BP,LRP1;EGFR;LAMB2;LDLR
12416,GO:0050080,0.0977606553349314,1,1,1,malonyl-CoA decarboxylase activity,MF,MLYCD
20273,GO:2001294,0.0977606553349314,1,1,1,malonyl-CoA catabolic process,BP,MLYCD
8099,GO:0032799,0.097808013534862,0.97179656709102,4,19,low-density lipoprotein receptor particle metabolic process,BP,APOE;AP2A2;FURIN;PCSK9
1949,GO:0004657,0.0978646957548417,1,1,1,proline dehydrogenase activity,MF,PRODH
3637,GO:0008118,0.0978855712216811,1,1,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,ST3GAL3
6620,GO:0022894,0.0979494328331982,1,1,1,Intermediate conductance calcium-activated potassium channel activity,MF,KCNN4
1582,GO:0003996,0.0979773521569479,1,1,1,acyl-CoA ligase activity,MF,ACSF2
3548,GO:0007596,0.097982225047107,0.934794493121461,26,211,blood coagulation,BP,APOE;SERPING1;F2R;DGKA;PLAT;ZFPM1;FBLN1;ITPR3;CD9;SERPINE2;DOCK6;MAPK3;ENTPD2;PHF21A;PRKACA;F12;DMTN;DGKQ;GAS6;VAV3;ADAMTS13;PROCR;SH2B3;AKT1;VPS33B;EHD3
10093,GO:0042628,0.0980161154074984,1,1,1,mating plug formation,BP,SERPINE2
11175,GO:0045297,0.0980161154074984,1,1,1,post-mating behavior,BP,SERPINE2
14170,GO:0061107,0.0980161154074984,1,1,1,seminal vesicle development,BP,SERPINE2
14171,GO:0061108,0.0980161154074984,1,1,1,seminal vesicle epithelium development,BP,SERPINE2
1845,GO:0004512,0.0980210537803346,1,1,1,inositol-3-phosphate synthase activity,MF,ISYNA1
5718,GO:0016872,0.0980210537803346,1,1,1,intramolecular lyase activity,MF,ISYNA1
10003,GO:0042451,0.0980214217768315,0.971528239010032,4,20,purine nucleoside biosynthetic process,BP,NT5E;NME4;ADA;GUK1
11553,GO:0046129,0.0980214217768315,0.971528239010032,4,20,purine ribonucleoside biosynthetic process,BP,NT5E;NME4;ADA;GUK1
3601,GO:0008048,0.0980373209857369,1,1,1,calcium sensitive guanylate cyclase activator activity,MF,GUCA1B
4686,GO:0010851,0.0980373209857369,1,1,1,cyclase regulator activity,MF,GUCA1B
4687,GO:0010853,0.0980373209857369,1,1,1,cyclase activator activity,MF,GUCA1B
6792,GO:0030249,0.0980373209857369,1,1,1,guanylate cyclase regulator activity,MF,GUCA1B
6793,GO:0030250,0.0980373209857369,1,1,1,guanylate cyclase activator activity,MF,GUCA1B
5308,GO:0016036,0.0980421432207245,1,1,1,cellular response to phosphate starvation,BP,COMT
7314,GO:0031335,0.0980421432207245,1,1,1,regulation of sulfur amino acid metabolic process,BP,COMT
7315,GO:0031337,0.0980421432207245,1,1,1,positive regulation of sulfur amino acid metabolic process,BP,COMT
9317,GO:0035814,0.0980421432207245,1,1,1,negative regulation of renal sodium excretion,BP,COMT
12500,GO:0050666,0.0980421432207245,1,1,1,regulation of homocysteine metabolic process,BP,COMT
12502,GO:0050668,0.0980421432207245,1,1,1,positive regulation of homocysteine metabolic process,BP,COMT
4102,GO:0009166,0.0980432755618701,0.941439663910406,17,127,nucleotide catabolic process,BP,NT5E;RAPGEF3;PGM1;XDH;OGDHL;INSR;DNPH1;PFKFB2;DHTKD1;GALK1;MLXIPL;ADA;PFKL;NUDT10;HK1;PPARA;NEIL1
14045,GO:0060857,0.0980658568125486,1,1,1,establishment of glial blood-brain barrier,BP,MXRA8
4210,GO:0009386,0.0981570172250277,1,1,1,translational attenuation,BP,TRAP1
14096,GO:0060987,0.0981920674482081,1,1,1,lipid tube,CC,BIN1
13027,GO:0051543,0.0982820920316436,1,1,1,regulation of elastin biosynthetic process,BP,HBEGF
13028,GO:0051545,0.0982820920316436,1,1,1,negative regulation of elastin biosynthetic process,BP,HBEGF
1896,GO:0004584,0.0982931946505297,1,1,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,PIGV
5935,GO:0018277,0.0982931946505297,1,1,1,protein deamination,BP,LOXL1
24,GO:0000048,0.0982986540975526,1,1,1,peptidyltransferase activity,MF,GGT1
1248,GO:0002951,0.0982986540975526,1,1,1,leukotriene-C(4) hydrolase,MF,GGT1
10649,GO:0043890,0.0983104513913537,1,1,1,N-acetylgalactosamine-6-sulfatase activity,MF,GALNS
3,GO:0000009,0.0983209239544748,1,1,1,alpha-1,6-mannosyltransferase activity,MF,ALG12
13432,GO:0052917,0.0983209239544748,1,1,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,ALG12
4020,GO:0009061,0.0983623478737952,1,1,1,anaerobic respiration,BP,SDHA
11164,GO:0045274,0.0983623478737952,1,1,1,plasma membrane respiratory chain complex II,CC,SDHA
11168,GO:0045282,0.0983623478737952,1,1,1,plasma membrane succinate dehydrogenase complex,CC,SDHA
4386,GO:0010070,0.0983946738750655,1,1,1,zygote asymmetric cell division,BP,RGS14
839,GO:0002153,0.0984039866392696,1,1,1,steroid receptor RNA activator RNA binding,MF,THRA
11448,GO:0045925,0.0984039866392696,1,1,1,positive regulation of female receptivity,BP,THRA
18928,GO:1904719,0.0984438514674445,1,1,1,positive regulation of AMPA glutamate receptor clustering,BP,SSH1
5974,GO:0018872,0.0984766304185384,1,1,1,arsonoacetate metabolic process,BP,AS3MT
7012,GO:0030791,0.0984766304185384,1,1,1,arsenite methyltransferase activity,MF,AS3MT
7013,GO:0030792,0.0984766304185384,1,1,1,methylarsonite methyltransferase activity,MF,AS3MT
5026,GO:0015211,0.0984841431187773,1,1,1,purine nucleoside transmembrane transporter activity,MF,SLC28A2
1838,GO:0004498,0.0985017827666796,1,1,1,calcidiol 1-monooxygenase activity,MF,CYP27B1
16371,GO:0097018,0.0985188666467358,1,1,1,renal albumin absorption,BP,GAS6
17378,GO:1900141,0.0985188666467358,1,1,1,regulation of oligodendrocyte apoptotic process,BP,GAS6
17379,GO:1900142,0.0985188666467358,1,1,1,negative regulation of oligodendrocyte apoptotic process,BP,GAS6
19932,GO:2000532,0.0985188666467358,1,1,1,regulation of renal albumin absorption,BP,GAS6
19933,GO:2000533,0.0985188666467358,1,1,1,negative regulation of renal albumin absorption,BP,GAS6
12970,GO:0051413,0.0985228684653016,1,1,1,response to cortisone,BP,GLB1
16766,GO:0098633,0.0985430412114531,1,1,1,collagen fibril binding,MF,CHADL
18654,GO:1904027,0.0985430412114531,1,1,1,negative regulation of collagen fibril organization,BP,CHADL
580,GO:0001733,0.0985472074928062,1,1,1,galactosylceramide sulfotransferase activity,MF,GAL3ST4
12522,GO:0050694,0.0985472074928062,1,1,1,galactose 3-O-sulfotransferase activity,MF,GAL3ST4
12523,GO:0050698,0.0985472074928062,1,1,1,proteoglycan sulfotransferase activity,MF,GAL3ST4
9516,GO:0036266,0.0985569765260647,1,1,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,ANKZF1
15872,GO:0072671,0.0985569765260647,1,1,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,ANKZF1
4619,GO:0010750,0.0985651771581832,1,1,1,positive regulation of nitric oxide mediated signal transduction,BP,EGFR
8442,GO:0033594,0.0985651771581832,1,1,1,response to hydroxyisoflavone,BP,EGFR
10249,GO:0043006,0.0985651771581832,1,1,1,activation of phospholipase A2 activity by calcium-mediated signaling,BP,EGFR
16603,GO:0097489,0.0985651771581832,1,1,1,multivesicular body, internal vesicle lumen,CC,EGFR
1805,GO:0004458,0.0985827342829022,1,1,1,D-lactate dehydrogenase (cytochrome) activity,MF,D2HGDH
5740,GO:0016898,0.0985827342829022,1,1,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,D2HGDH
6154,GO:0019516,0.0985827342829022,1,1,1,lactate oxidation,BP,D2HGDH
1660,GO:0004122,0.0985883062013778,1,1,1,cystathionine beta-synthase activity,MF,CBS
2983,GO:0006535,0.0985883062013778,1,1,1,cysteine biosynthetic process from serine,BP,CBS
4043,GO:0009093,0.0985883062013778,1,1,1,cysteine catabolic process,BP,CBS
5604,GO:0016662,0.0985883062013778,1,1,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,CBS
6142,GO:0019448,0.0985883062013778,1,1,1,L-cysteine catabolic process,BP,CBS
12454,GO:0050421,0.0985883062013778,1,1,1,nitrite reductase (NO-forming) activity,MF,CBS
14501,GO:0070025,0.0985883062013778,1,1,1,carbon monoxide binding,MF,CBS
16848,GO:0098809,0.0985883062013778,1,1,1,nitrite reductase activity,MF,CBS
19448,GO:1990188,0.0985983923585988,1,1,1,euchromatin binding,MF,ASH2L
9567,GO:0036403,0.0985989569857862,1,1,1,arachidonate 8(S)-lipoxygenase activity,MF,ALOX15B
5337,GO:0016095,0.0986092145927815,1,1,1,polyprenol catabolic process,BP,SRD5A3
17116,GO:0102389,0.0986092145927815,1,1,1,polyprenol reductase activity,MF,SRD5A3
18567,GO:1903850,0.0986097124649121,1,1,1,regulation of cristae formation,BP,PINK1
18568,GO:1903852,0.0986097124649121,1,1,1,positive regulation of cristae formation,BP,PINK1
18850,GO:1904542,0.0986097124649121,1,1,1,regulation of free ubiquitin chain polymerization,BP,PINK1
18851,GO:1904544,0.0986097124649121,1,1,1,positive regulation of free ubiquitin chain polymerization,BP,PINK1
19011,GO:1904881,0.0986097124649121,1,1,1,cellular response to hydrogen sulfide,BP,PINK1
11001,GO:0044855,0.0986203776276671,1,1,1,plasma membrane raft distribution,BP,GSN
11002,GO:0044856,0.0986203776276671,1,1,1,plasma membrane raft localization,BP,GSN
11004,GO:0044858,0.0986203776276671,1,1,1,plasma membrane raft polarization,BP,GSN
18595,GO:1903906,0.0986203776276671,1,1,1,regulation of plasma membrane raft polarization,BP,GSN
3987,GO:0008894,0.0986204719690303,1,1,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,ENTPD6
9496,GO:0036179,0.0986213727322669,1,1,1,osteoclast maturation,BP,FAM20C
15302,GO:0071547,0.0986216359959861,1,1,1,piP-body,CC,TDRKH
1878,GO:0004561,0.0986219084294543,1,1,1,alpha-N-acetylglucosaminidase activity,MF,NAGLU
2161,GO:0004999,0.0986220089799568,1,1,1,vasoactive intestinal polypeptide receptor activity,MF,VIPR1
1644,GO:0004092,0.0986220195794355,1,1,1,carnitine O-acetyltransferase activity,MF,CRAT
1296,GO:0003131,0.0986220195794356,1,1,1,mesodermal-endodermal cell signaling,BP,HMGA2
7157,GO:0031049,0.0986220195794356,1,1,1,programmed DNA elimination,BP,HMGA2
7159,GO:0031052,0.0986220195794356,1,1,1,chromosome breakage,BP,HMGA2
9133,GO:0035501,0.0986220195794356,1,1,1,MH1 domain binding,MF,HMGA2
9397,GO:0035978,0.0986220195794356,1,1,1,histone H2A-S139 phosphorylation,BP,HMGA2
20028,GO:2000685,0.0986220195794356,1,1,1,positive regulation of cellular response to X-ray,BP,HMGA2
17988,GO:1902499,0.0986220195794364,1,1,1,positive regulation of protein autoubiquitination,BP,MTA1
13967,GO:0060709,0.0986220195794372,1,1,1,glycogen cell differentiation involved in embryonic placenta development,BP,AKT1
17078,GO:0100002,0.0986220195794372,1,1,1,negative regulation of protein kinase activity by protein phosphorylation,BP,AKT1
193,GO:0000412,0.0986220195794384,1,1,1,histone peptidyl-prolyl isomerization,BP,FKBP10
1763,GO:0004371,0.0986220195794384,1,1,1,glycerone kinase activity,MF,TKFC
1849,GO:0004516,0.0986220195794384,1,1,1,nicotinate phosphoribosyltransferase activity,MF,NAPRT
4096,GO:0009159,0.0986220195794384,1,1,1,deoxyribonucleoside monophosphate catabolic process,BP,DNPH1
6103,GO:0019357,0.0986220195794384,1,1,1,nicotinate nucleotide biosynthetic process,BP,NAPRT
6104,GO:0019358,0.0986220195794384,1,1,1,nicotinate nucleotide salvage,BP,NAPRT
6109,GO:0019365,0.0986220195794384,1,1,1,pyridine nucleotide salvage,BP,NAPRT
7652,GO:0032093,0.0986220195794384,1,1,1,SAM domain binding,MF,L3MBTL1
8253,GO:0033058,0.0986220195794384,1,1,1,directional locomotion,BP,ARPIN
8454,GO:0033608,0.0986220195794384,1,1,1,formyl-CoA transferase activity,MF,SUGCT
8546,GO:0034012,0.0986220195794384,1,1,1,FAD-AMP lyase (cyclizing) activity,MF,TKFC
8696,GO:0034355,0.0986220195794384,1,1,1,NAD salvage,BP,NAPRT
9185,GO:0035585,0.0986220195794384,1,1,1,calcium-mediated signaling using extracellular calcium source,BP,DMTN
10952,GO:0044736,0.0986220195794384,1,1,1,acid-sensing ion channel activity,MF,ASIC1
11683,GO:0046497,0.0986220195794384,1,1,1,nicotinate nucleotide metabolic process,BP,NAPRT
11970,GO:0047369,0.0986220195794384,1,1,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,SUGCT
12423,GO:0050144,0.0986220195794384,1,1,1,nucleoside deoxyribosyltransferase activity,MF,DNPH1
12435,GO:0050262,0.0986220195794384,1,1,1,ribosylnicotinamide kinase activity,MF,NMRK1
12450,GO:0050354,0.0986220195794384,1,1,1,triokinase activity,MF,TKFC
12671,GO:0050915,0.0986220195794384,1,1,1,sensory perception of sour taste,BP,ASIC1
14422,GO:0061769,0.0986220195794384,1,1,1,ribosylnicotinate kinase activity,MF,NMRK1
14796,GO:0070560,0.0986220195794384,1,1,1,protein secretion by platelet,BP,DMTN
14867,GO:0070694,0.0986220195794384,1,1,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,DNPH1
18147,GO:1902939,0.0986220195794387,1,1,1,negative regulation of intracellular calcium activated chloride channel activity,BP,ANO9
14417,GO:0061760,0.0986220195794404,1,1,1,antifungal innate immune response,BP,FAM3A
19077,GO:1905034,0.0986220195794404,1,1,1,regulation of antifungal innate immune response,BP,FAM3A
19078,GO:1905035,0.0986220195794404,1,1,1,negative regulation of antifungal innate immune response,BP,FAM3A
4284,GO:0009720,0.098622019579443,1,1,1,detection of hormone stimulus,BP,ABCG1
8558,GO:0034041,0.098622019579443,1,1,1,sterol-transporting ATPase activity,MF,ABCG1
1406,GO:0003342,0.0986220195794445,1,1,1,proepicardium development,BP,ZFP36L1
1407,GO:0003343,0.0986220195794445,1,1,1,septum transversum development,BP,ZFP36L1
16563,GO:0097403,0.0986220195794445,1,1,1,cellular response to raffinose,BP,ZFP36L1
17651,GO:1901545,0.0986220195794445,1,1,1,response to raffinose,BP,ZFP36L1
2418,GO:0005600,0.0986220195794454,1,1,1,collagen type XIII trimer,CC,COL13A1
3822,GO:0008431,0.0986220195794454,1,1,1,vitamin E binding,MF,SEC14L2
7109,GO:0030936,0.0986220195794454,1,1,1,transmembrane collagen trimer,CC,COL13A1
861,GO:0002194,0.0986220195794459,1,1,1,hepatocyte cell migration,BP,PROX1
10280,GO:0043049,0.0986220195794459,1,1,1,otic placode formation,BP,PROX1
14174,GO:0061114,0.0986220195794459,1,1,1,branching involved in pancreas morphogenesis,BP,PROX1
14935,GO:0070858,0.0986220195794459,1,1,1,negative regulation of bile acid biosynthetic process,BP,PROX1
16277,GO:0090425,0.0986220195794459,1,1,1,acinar cell differentiation,BP,PROX1
18737,GO:1904252,0.0986220195794459,1,1,1,negative regulation of bile acid metabolic process,BP,PROX1
20135,GO:2000979,0.0986220195794459,1,1,1,positive regulation of forebrain neuron differentiation,BP,PROX1
10685,GO:0043990,0.0986220195794471,1,1,1,histone H2A-S1 phosphorylation,BP,RPS6KA5
9886,GO:0042222,0.0986220195794483,1,1,1,interleukin-1 biosynthetic process,BP,EGR1
11208,GO:0045360,0.0986220195794483,1,1,1,regulation of interleukin-1 biosynthetic process,BP,EGR1
11209,GO:0045362,0.0986220195794483,1,1,1,positive regulation of interleukin-1 biosynthetic process,BP,EGR1
12544,GO:0050720,0.0986220195794483,1,1,1,interleukin-1 beta biosynthetic process,BP,EGR1
12545,GO:0050722,0.0986220195794483,1,1,1,regulation of interleukin-1 beta biosynthetic process,BP,EGR1
12546,GO:0050725,0.0986220195794483,1,1,1,positive regulation of interleukin-1 beta biosynthetic process,BP,EGR1
15703,GO:0072303,0.0986220195794483,1,1,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,EGR1
2179,GO:0005034,0.098622019579449,1,1,1,osmosensor activity,MF,TRPV4
6693,GO:0030103,0.098622019579449,1,1,1,vasopressin secretion,BP,TRPV4
16608,GO:0097497,0.098622019579449,1,1,1,blood vessel endothelial cell delamination,BP,TRPV4
18387,GO:1903444,0.098622019579449,1,1,1,negative regulation of brown fat cell differentiation,BP,TRPV4
18522,GO:1903759,0.098622019579449,1,1,1,signal transduction involved in regulation of aerobic respiration,BP,TRPV4
15021,GO:0070995,0.0986220195794492,1,1,1,NADPH oxidation,BP,KCNAB2
19400,GO:1990031,0.0986220195794492,1,1,1,pinceau fiber,CC,KCNAB2
14539,GO:0070095,0.0986220195794492,1,1,1,fructose-6-phosphate binding,MF,PFKL
1266,GO:0003050,0.09862201957945,1,1,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,RASL10B
1957,GO:0004668,0.0986220195794504,1,1,1,protein-arginine deiminase activity,MF,PADI3
5887,GO:0018101,0.0986220195794504,1,1,1,protein citrullination,BP,PADI3
9569,GO:0036414,0.0986220195794504,1,1,1,histone citrullination,BP,PADI3
19527,GO:1990523,0.0986220195794506,1,1,1,bone regeneration,BP,POSTN
1335,GO:0003195,0.0986220195794511,1,1,1,tricuspid valve formation,BP,ZFPM1
9833,GO:0042097,0.0986220195794511,1,1,1,interleukin-4 biosynthetic process,BP,ZFPM1
11213,GO:0045402,0.0986220195794511,1,1,1,regulation of interleukin-4 biosynthetic process,BP,ZFPM1
11214,GO:0045403,0.0986220195794511,1,1,1,negative regulation of interleukin-4 biosynthetic process,BP,ZFPM1
13761,GO:0060375,0.0986220195794511,1,1,1,regulation of mast cell differentiation,BP,ZFPM1
13762,GO:0060377,0.0986220195794511,1,1,1,negative regulation of mast cell differentiation,BP,ZFPM1
1495,GO:0003842,0.0986220195794514,1,1,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,ALDH4A1
9157,GO:0035538,0.0986220195794516,1,1,1,carbohydrate response element binding,MF,MLXIPL
15962,GO:0085032,0.0986220195794519,1,1,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,TNIP1
19222,GO:1905407,0.0986220195794519,1,1,1,regulation of creatine transmembrane transporter activity,BP,STK39
19223,GO:1905408,0.0986220195794519,1,1,1,negative regulation of creatine transmembrane transporter activity,BP,STK39
2311,GO:0005316,0.0986220195794521,1,1,1,high-affinity inorganic phosphate:sodium symporter activity,MF,SLC20A1
13154,GO:0051786,0.0986220195794525,1,1,1,all-trans-retinol 13,14-reductase activity,MF,RETSAT
4911,GO:0014859,0.098622019579453,1,1,1,negative regulation of skeletal muscle cell proliferation,BP,SIX5
18067,GO:1902723,0.098622019579453,1,1,1,negative regulation of skeletal muscle satellite cell proliferation,BP,SIX5
2004,GO:0004733,0.098622019579455,1,1,1,pyridoxamine-phosphate oxidase activity,MF,PNPO
17813,GO:1902010,0.0986220195794553,1,1,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,SESN2
9675,GO:0038086,0.0986220195794555,1,1,1,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,VEGFA
9677,GO:0038091,0.0986220195794555,1,1,1,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,VEGFA
16629,GO:0097532,0.0986220195794555,1,1,1,stress response to acid chemical,BP,VEGFA
16630,GO:0097533,0.0986220195794555,1,1,1,cellular stress response to acid chemical,BP,VEGFA
18445,GO:1903570,0.0986220195794555,1,1,1,regulation of protein kinase D signaling,BP,VEGFA
18446,GO:1903572,0.0986220195794555,1,1,1,positive regulation of protein kinase D signaling,BP,VEGFA
2305,GO:0005308,0.0986220195794559,1,1,1,creatine transmembrane transporter activity,MF,SLC6A8
2306,GO:0005309,0.0986220195794559,1,1,1,creatine:sodium symporter activity,MF,SLC6A8
5243,GO:0015881,0.0986220195794559,1,1,1,creatine transmembrane transport,BP,SLC6A8
3989,GO:0008900,0.0986220195794559,1,1,1,potassium:proton exchanging ATPase activity,MF,ATP12A
6817,GO:0030290,0.0986220195794559,1,1,1,sphingolipid activator protein activity,MF,GM2A
7855,GO:0032428,0.0986220195794559,1,1,1,beta-N-acetylgalactosaminidase activity,MF,GM2A
3867,GO:0008507,0.0986220195794562,1,1,1,sodium:iodide symporter activity,MF,SLC5A5
812,GO:0002086,0.0986220195794564,1,1,1,diaphragm contraction,BP,GAA
1888,GO:0004574,0.0986220195794564,1,1,1,oligo-1,6-glucosidase activity,MF,GAA
2641,GO:0005985,0.0986220195794564,1,1,1,sucrose metabolic process,BP,GAA
10348,GO:0043181,0.0986220195794564,1,1,1,vacuolar sequestering,BP,GAA
11072,GO:0045092,0.0986220195794564,1,1,1,interleukin-18 receptor complex,CC,TOLLIP
54,GO:0000111,0.0986220195794565,1,1,1,nucleotide-excision repair factor 2 complex,CC,XPC
7813,GO:0032378,0.0986220195794565,1,1,1,negative regulation of intracellular lipid transport,BP,PCSK9
7816,GO:0032381,0.0986220195794565,1,1,1,negative regulation of intracellular sterol transport,BP,PCSK9
7819,GO:0032384,0.0986220195794565,1,1,1,negative regulation of intracellular cholesterol transport,BP,PCSK9
19288,GO:1905596,0.0986220195794565,1,1,1,negative regulation of low-density lipoprotein particle receptor binding,BP,PCSK9
19290,GO:1905598,0.0986220195794565,1,1,1,negative regulation of low-density lipoprotein receptor activity,BP,PCSK9
19293,GO:1905601,0.0986220195794565,1,1,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,PCSK9
3837,GO:0008456,0.0986220195794572,1,1,1,alpha-N-acetylgalactosaminidase activity,MF,NAGA
16186,GO:0090251,0.0986220195794572,1,1,1,protein localization involved in establishment of planar polarity,BP,CELSR1
17038,GO:0099552,0.0986220195794572,1,1,1,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,F2R
17039,GO:0099553,0.0986220195794572,1,1,1,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,F2R
17374,GO:1900134,0.0986220195794572,1,1,1,negative regulation of renin secretion into blood stream,BP,F2R
18389,GO:1903450,0.0986220195794572,1,1,1,regulation of G1 to G0 transition,BP,RAB11FIP4
18390,GO:1903452,0.0986220195794572,1,1,1,positive regulation of G1 to G0 transition,BP,RAB11FIP4
309,GO:0000821,0.0986220195794573,1,1,1,regulation of arginine metabolic process,BP,ATP2B4
960,GO:0002384,0.0986220195794573,1,1,1,hepatic immune response,BP,IL6R
1041,GO:0002560,0.0986220195794573,1,1,1,basophil mediated immunity,BP,PI4K2A
1042,GO:0002561,0.0986220195794573,1,1,1,basophil degranulation,BP,PI4K2A
1292,GO:0003127,0.0986220195794573,1,1,1,detection of nodal flow,BP,PKD2
1631,GO:0004077,0.0986220195794573,1,1,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,HLCS
1632,GO:0004078,0.0986220195794573,1,1,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,HLCS
1633,GO:0004079,0.0986220195794573,1,1,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,HLCS
1634,GO:0004080,0.0986220195794573,1,1,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,HLCS
1740,GO:0004344,0.0986220195794573,1,1,1,glucose dehydrogenase activity,MF,H6PD
1750,GO:0004356,0.0986220195794573,1,1,1,glutamate-ammonia ligase activity,MF,GLUL
1760,GO:0004367,0.0986220195794573,1,1,1,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,GPD1L
1830,GO:0004489,0.0986220195794573,1,1,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,MTHFR
1967,GO:0004686,0.0986220195794573,1,1,1,elongation factor-2 kinase activity,MF,EEF2K
2006,GO:0004736,0.0986220195794573,1,1,1,pyruvate carboxylase activity,MF,PC
2087,GO:0004855,0.0986220195794573,1,1,1,xanthine oxidase activity,MF,XDH
2157,GO:0004992,0.0986220195794573,1,1,1,platelet activating factor receptor activity,MF,PTAFR
2170,GO:0005009,0.0986220195794573,1,1,1,insulin-activated receptor activity,MF,INSR
2172,GO:0005011,0.0986220195794573,1,1,1,macrophage colony-stimulating factor receptor activity,MF,MST1R
2403,GO:0005579,0.0986220195794573,1,1,1,membrane attack complex,CC,C5
2989,GO:0006542,0.0986220195794573,1,1,1,glutamine biosynthetic process,BP,GLUL
3085,GO:0006666,0.0986220195794573,1,1,1,3-keto-sphinganine metabolic process,BP,KDSR
3862,GO:0008496,0.0986220195794573,1,1,1,mannan endo-1,6-alpha-mannosidase activity,MF,MAN2B2
4189,GO:0009305,0.0986220195794573,1,1,1,protein biotinylation,BP,HLCS
4559,GO:0010650,0.0986220195794573,1,1,1,positive regulation of cell communication by electrical coupling,BP,ANK3
4837,GO:0014054,0.0986220195794573,1,1,1,positive regulation of gamma-aminobutyric acid secretion,BP,NTSR1
4945,GO:0015019,0.0986220195794573,1,1,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,HGSNAT
5082,GO:0015362,0.0986220195794573,1,1,1,high-affinity sodium:dicarboxylate symporter activity,MF,SLC13A3
5376,GO:0016211,0.0986220195794573,1,1,1,ammonia ligase activity,MF,GLUL
5446,GO:0016332,0.0986220195794573,1,1,1,establishment or maintenance of polarity of embryonic epithelium,BP,WNT7B
5512,GO:0016492,0.0986220195794573,1,1,1,G-protein coupled neurotensin receptor activity,MF,NTSR1
5632,GO:0016727,0.0986220195794573,1,1,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,XDH
5759,GO:0016964,0.0986220195794573,1,1,1,alpha-2 macroglobulin receptor activity,MF,LRP1
5854,GO:0017168,0.0986220195794573,1,1,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,OPLAH
5933,GO:0018271,0.0986220195794573,1,1,1,biotin-protein ligase activity,MF,HLCS
5959,GO:0018400,0.0986220195794573,1,1,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,CRTAP
6015,GO:0019082,0.0986220195794573,1,1,1,viral protein processing,BP,FURIN
6189,GO:0019676,0.0986220195794573,1,1,1,ammonia assimilation cycle,BP,GLUL
6370,GO:0021566,0.0986220195794573,1,1,1,hypoglossal nerve development,BP,ADARB1
6392,GO:0021618,0.0986220195794573,1,1,1,hypoglossal nerve morphogenesis,BP,ADARB1
6666,GO:0030037,0.0986220195794573,1,1,1,actin filament reorganization involved in cell cycle,BP,ARAP1
7022,GO:0030807,0.0986220195794573,1,1,1,positive regulation of cyclic nucleotide catabolic process,BP,RAPGEF3
7037,GO:0030822,0.0986220195794573,1,1,1,positive regulation of cAMP catabolic process,BP,RAPGEF3
7529,GO:0031811,0.0986220195794573,1,1,1,G-protein coupled nucleotide receptor binding,MF,DLG4
7530,GO:0031812,0.0986220195794573,1,1,1,P2Y1 nucleotide receptor binding,MF,DLG4
8280,GO:0033123,0.0986220195794573,1,1,1,positive regulation of purine nucleotide catabolic process,BP,RAPGEF3
8348,GO:0033241,0.0986220195794573,1,1,1,regulation of cellular amine catabolic process,BP,ATP2B4
8349,GO:0033242,0.0986220195794573,1,1,1,negative regulation of cellular amine catabolic process,BP,ATP2B4
8361,GO:0033274,0.0986220195794573,1,1,1,response to vitamin B2,BP,MTHFR
8392,GO:0033364,0.0986220195794573,1,1,1,mast cell secretory granule organization,BP,LYST
8474,GO:0033644,0.0986220195794573,1,1,1,host cell membrane,CC,PI4K2A
8622,GO:0034164,0.0986220195794573,1,1,1,negative regulation of toll-like receptor 9 signaling pathway,BP,PTPRS
8854,GO:0034676,0.0986220195794573,1,1,1,integrin alpha6-beta4 complex,CC,ITGA6
9255,GO:0035695,0.0986220195794573,1,1,1,mitophagy by induced vacuole formation,BP,SPATA18
9314,GO:0035811,0.0986220195794573,1,1,1,negative regulation of urine volume,BP,ADCY6
9521,GO:0036290,0.0986220195794573,1,1,1,protein trans-autophosphorylation,BP,ERN1
9604,GO:0036487,0.0986220195794573,1,1,1,nitric-oxide synthase inhibitor activity,MF,ATP2B4
9948,GO:0042352,0.0986220195794573,1,1,1,GDP-L-fucose salvage,BP,FUK
10121,GO:0042700,0.0986220195794573,1,1,1,luteinizing hormone signaling pathway,BP,EREG
10439,GO:0043315,0.0986220195794573,1,1,1,positive regulation of neutrophil degranulation,BP,PTAFR
10754,GO:0044218,0.0986220195794573,1,1,1,other organism cell membrane,CC,PI4K2A
10756,GO:0044221,0.0986220195794573,1,1,1,host cell synapse,CC,PI4K2A
10759,GO:0044231,0.0986220195794573,1,1,1,host cell presynaptic membrane,CC,PI4K2A
10782,GO:0044279,0.0986220195794573,1,1,1,other organism membrane,CC,PI4K2A
11143,GO:0045219,0.0986220195794573,1,1,1,regulation of FasL biosynthetic process,BP,JAK3
11144,GO:0045221,0.0986220195794573,1,1,1,negative regulation of FasL biosynthetic process,BP,JAK3
11487,GO:0045994,0.0986220195794573,1,1,1,positive regulation of translational initiation by iron,BP,RXRA
11533,GO:0046092,0.0986220195794573,1,1,1,deoxycytidine metabolic process,BP,TK2
11570,GO:0046168,0.0986220195794573,1,1,1,glycerol-3-phosphate catabolic process,BP,GPD1L
11993,GO:0047560,0.0986220195794573,1,1,1,3-dehydrosphinganine reductase activity,MF,KDSR
12029,GO:0047936,0.0986220195794573,1,1,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,H6PD
12089,GO:0048160,0.0986220195794573,1,1,1,primary follicle stage,BP,EREG
12302,GO:0048677,0.0986220195794573,1,1,1,axon extension involved in regeneration,BP,LAMB2
12351,GO:0048763,0.0986220195794573,1,1,1,calcium-induced calcium release activity,MF,PKD2
12429,GO:0050201,0.0986220195794573,1,1,1,fucokinase activity,MF,FUK
13517,GO:0060005,0.0986220195794573,1,1,1,vestibular reflex,BP,SLITRK6
13518,GO:0060007,0.0986220195794573,1,1,1,linear vestibuloocular reflex,BP,SLITRK6
13574,GO:0060072,0.0986220195794573,1,1,1,large conductance calcium-activated potassium channel activity,MF,KCNMA1
13763,GO:0060378,0.0986220195794573,1,1,1,regulation of brood size,BP,SH3PXD2B
13931,GO:0060665,0.0986220195794573,1,1,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,FGFR1
14431,GO:0061798,0.0986220195794573,1,1,1,GTP 3',8'-cyclase activity,MF,MOCS1
14432,GO:0061799,0.0986220195794573,1,1,1,cyclic pyranopterin monophosphate synthase activity,MF,MOCS1
14457,GO:0061889,0.0986220195794573,1,1,1,negative regulation of astrocyte activation,BP,LDLR
14551,GO:0070119,0.0986220195794573,1,1,1,ciliary neurotrophic factor binding,MF,IL6R
14827,GO:0070615,0.0986220195794573,1,1,1,nucleosome-dependent ATPase activity,MF,SMARCA1
14901,GO:0070781,0.0986220195794573,1,1,1,response to biotin,BP,HLCS
15070,GO:0071110,0.0986220195794573,1,1,1,histone biotinylation,BP,HLCS
15122,GO:0071258,0.0986220195794573,1,1,1,cellular response to gravity,BP,PTAFR
15246,GO:0071454,0.0986220195794573,1,1,1,cellular response to anoxia,BP,EEF2K
15254,GO:0071464,0.0986220195794573,1,1,1,cellular response to hydrostatic pressure,BP,PKD2
15478,GO:0071878,0.0986220195794573,1,1,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,ATP2B4
15558,GO:0072055,0.0986220195794573,1,1,1,renal cortex development,BP,PKD2
15559,GO:0072059,0.0986220195794573,1,1,1,cortical collecting duct development,BP,PKD2
15560,GO:0072060,0.0986220195794573,1,1,1,outer medullary collecting duct development,BP,WNT7B
15645,GO:0072194,0.0986220195794573,1,1,1,kidney smooth muscle tissue development,BP,PKD2
15656,GO:0072208,0.0986220195794573,1,1,1,metanephric smooth muscle tissue development,BP,PKD2
15660,GO:0072214,0.0986220195794573,1,1,1,metanephric cortex development,BP,PKD2
15665,GO:0072219,0.0986220195794573,1,1,1,metanephric cortical collecting duct development,BP,PKD2
15677,GO:0072244,0.0986220195794573,1,1,1,metanephric glomerular epithelium development,BP,LAMB2
15678,GO:0072248,0.0986220195794573,1,1,1,metanephric glomerular visceral epithelial cell differentiation,BP,LAMB2
15679,GO:0072249,0.0986220195794573,1,1,1,metanephric glomerular visceral epithelial cell development,BP,LAMB2
15690,GO:0072274,0.0986220195794573,1,1,1,metanephric glomerular basement membrane development,BP,LAMB2
15696,GO:0072287,0.0986220195794573,1,1,1,metanephric distal tubule morphogenesis,BP,PKD1
15711,GO:0072312,0.0986220195794573,1,1,1,metanephric glomerular epithelial cell differentiation,BP,LAMB2
15712,GO:0072313,0.0986220195794573,1,1,1,metanephric glomerular epithelial cell development,BP,LAMB2
15740,GO:0072363,0.0986220195794573,1,1,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,PPARA
15743,GO:0072366,0.0986220195794573,1,1,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,PPARA
15816,GO:0072556,0.0986220195794573,1,1,1,other organism presynaptic membrane,CC,PI4K2A
15864,GO:0072658,0.0986220195794573,1,1,1,maintenance of protein location in membrane,BP,ANK3
15866,GO:0072660,0.0986220195794573,1,1,1,maintenance of protein location in plasma membrane,BP,ANK3
15891,GO:0072702,0.0986220195794573,1,1,1,response to methyl methanesulfonate,BP,TP53INP1
15892,GO:0072703,0.0986220195794573,1,1,1,cellular response to methyl methanesulfonate,BP,TP53INP1
16198,GO:0090272,0.0986220195794573,1,1,1,negative regulation of fibroblast growth factor production,BP,FGFR1
16281,GO:0090472,0.0986220195794573,1,1,1,dibasic protein processing,BP,FURIN
16299,GO:0090537,0.0986220195794573,1,1,1,CERF complex,CC,SMARCA1
16425,GO:0097116,0.0986220195794573,1,1,1,gephyrin clustering involved in postsynaptic density assembly,BP,NLGN2
16426,GO:0097117,0.0986220195794573,1,1,1,guanylate kinase-associated protein clustering,BP,SHANK3
16456,GO:0097168,0.0986220195794573,1,1,1,mesenchymal stem cell proliferation,BP,LTBP3
16808,GO:0098736,0.0986220195794573,1,1,1,negative regulation of the force of heart contraction,BP,ATP2B4
16914,GO:0098923,0.0986220195794573,1,1,1,retrograde trans-synaptic signaling by soluble gas,BP,NOS1
16915,GO:0098924,0.0986220195794573,1,1,1,retrograde trans-synaptic signaling by nitric oxide,BP,NOS1
16925,GO:0098948,0.0986220195794573,1,1,1,intrinsic component of postsynaptic specialization membrane,CC,PTPRS
16959,GO:0099060,0.0986220195794573,1,1,1,integral component of postsynaptic specialization membrane,CC,PTPRS
16960,GO:0099061,0.0986220195794573,1,1,1,integral component of postsynaptic density membrane,CC,PTPRS
16988,GO:0099146,0.0986220195794573,1,1,1,intrinsic component of postsynaptic density membrane,CC,PTPRS
16990,GO:0099163,0.0986220195794573,1,1,1,synaptic signaling by nitric oxide,BP,NOS1
17032,GO:0099543,0.0986220195794573,1,1,1,trans-synaptic signaling by soluble gas,BP,NOS1
17033,GO:0099545,0.0986220195794573,1,1,1,trans-synaptic signaling by trans-synaptic complex,BP,EPHB2
17035,GO:0099548,0.0986220195794573,1,1,1,trans-synaptic signaling by nitric oxide,BP,NOS1
17040,GO:0099557,0.0986220195794573,1,1,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,EPHB2
17172,GO:0106028,0.0986220195794573,1,1,1,neuron projection retraction,BP,EPHB2
17291,GO:0140196,0.0986220195794573,1,1,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1
17292,GO:0140199,0.0986220195794573,1,1,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,ATP2B4
17338,GO:1900081,0.0986220195794573,1,1,1,regulation of arginine catabolic process,BP,ATP2B4
17339,GO:1900082,0.0986220195794573,1,1,1,negative regulation of arginine catabolic process,BP,ATP2B4
17467,GO:1900450,0.0986220195794573,1,1,1,negative regulation of glutamate receptor signaling pathway,BP,EPHB2
17494,GO:1900827,0.0986220195794573,1,1,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,ANK3
17518,GO:1901074,0.0986220195794573,1,1,1,regulation of engulfment of apoptotic cell,BP,ABCA7
17519,GO:1901076,0.0986220195794573,1,1,1,positive regulation of engulfment of apoptotic cell,BP,ABCA7
17869,GO:1902178,0.0986220195794573,1,1,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,FGFR3
17973,GO:1902460,0.0986220195794573,1,1,1,regulation of mesenchymal stem cell proliferation,BP,LTBP3
17974,GO:1902462,0.0986220195794573,1,1,1,positive regulation of mesenchymal stem cell proliferation,BP,LTBP3
18015,GO:1902565,0.0986220195794573,1,1,1,positive regulation of neutrophil activation,BP,PTAFR
18042,GO:1902630,0.0986220195794573,1,1,1,regulation of membrane hyperpolarization,BP,CRTC1
18043,GO:1902631,0.0986220195794573,1,1,1,negative regulation of membrane hyperpolarization,BP,CRTC1
18087,GO:1902769,0.0986220195794573,1,1,1,regulation of choline O-acetyltransferase activity,BP,SORL1
18088,GO:1902771,0.0986220195794573,1,1,1,positive regulation of choline O-acetyltransferase activity,BP,SORL1
18148,GO:1902941,0.0986220195794573,1,1,1,regulation of voltage-gated chloride channel activity,BP,PTAFR
18149,GO:1902943,0.0986220195794573,1,1,1,positive regulation of voltage-gated chloride channel activity,BP,PTAFR
18152,GO:1902948,0.0986220195794573,1,1,1,negative regulation of tau-protein kinase activity,BP,SORL1
18159,GO:1902955,0.0986220195794573,1,1,1,positive regulation of early endosome to recycling endosome transport,BP,SORL1
18182,GO:1902997,0.0986220195794573,1,1,1,negative regulation of neurofibrillary tangle assembly,BP,SORL1
18199,GO:1903027,0.0986220195794573,1,1,1,regulation of opsonization,BP,MYO18A
18200,GO:1903028,0.0986220195794573,1,1,1,positive regulation of opsonization,BP,MYO18A
18291,GO:1903248,0.0986220195794573,1,1,1,regulation of citrulline biosynthetic process,BP,ATP2B4
18292,GO:1903249,0.0986220195794573,1,1,1,negative regulation of citrulline biosynthetic process,BP,ATP2B4
18394,GO:1903465,0.0986220195794573,1,1,1,positive regulation of mitotic cell cycle DNA replication,BP,FGFR1
18543,GO:1903797,0.0986220195794573,1,1,1,positive regulation of inorganic anion transmembrane transport,BP,PTAFR
18636,GO:1903979,0.0986220195794573,1,1,1,negative regulation of microglial cell activation,BP,LDLR
18756,GO:1904298,0.0986220195794573,1,1,1,regulation of transcytosis,BP,PTAFR
18757,GO:1904300,0.0986220195794573,1,1,1,positive regulation of transcytosis,BP,PTAFR
18758,GO:1904301,0.0986220195794573,1,1,1,regulation of maternal process involved in parturition,BP,PTAFR
18759,GO:1904303,0.0986220195794573,1,1,1,positive regulation of maternal process involved in parturition,BP,PTAFR
18764,GO:1904316,0.0986220195794573,1,1,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,PTAFR
18765,GO:1904317,0.0986220195794573,1,1,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,PTAFR
18961,GO:1904782,0.0986220195794573,1,1,1,negative regulation of NMDA glutamate receptor activity,BP,EPHB2
19444,GO:1990175,0.0986220195794573,1,1,1,EH domain binding,MF,EPN3
19472,GO:1990332,0.0986220195794573,1,1,1,Ire1 complex,CC,ERN1
19539,GO:1990579,0.0986220195794573,1,1,1,peptidyl-serine trans-autophosphorylation,BP,ERN1
19552,GO:1990630,0.0986220195794573,1,1,1,IRE1-RACK1-PP2A complex,CC,ERN1
19567,GO:1990715,0.0986220195794573,1,1,1,mRNA CDS binding,MF,UNK
19796,GO:2000283,0.0986220195794573,1,1,1,negative regulation of cellular amino acid biosynthetic process,BP,ATP2B4
19802,GO:2000297,0.0986220195794573,1,1,1,negative regulation of synapse maturation,BP,NFATC4
20108,GO:2000830,0.0986220195794573,1,1,1,positive regulation of parathyroid hormone secretion,BP,FGFR1
20227,GO:2001213,0.0986220195794573,1,1,1,negative regulation of vasculogenesis,BP,XDH
9425,GO:0036020,0.0987518410120058,0.97832583229559,3,12,endolysosome membrane,CC,AP2A2;PCSK9;LDLR
7312,GO:0031333,0.0989468305880469,0.945629915916328,13,92,negative regulation of protein complex assembly,BP,CTNNBIP1;GSN;ULK1;THRA;TMOD2;MEFV;SPTB;DMTN;PRKCZ;CAPG;TWF2;SORL1;RPL13A
10875,GO:0044437,0.0990020773554306,0.925302722466777,52,452,vacuolar part,CC,TSPAN1;GAA;NAPRT;PYGB;MARCH9;COL6A1;LRP1;ULK1;NAGLU;CTSB;HYAL1;CTSF;FUCA1;VAT1;HEXB;VPS11;DIRC2;GM2A;RAB3D;RNASET2;ATG16L2;MARCH2;AP2A2;DPP7;GLB1;SLC48A1;ABCA2;PCSK9;TMEM9;PI4K2A;LDLR;VASN;TMEM175;ABCD4;TPP1;GPC1;TOLLIP;MAN2B2;CYBRD1;CD68;SDC1;TPCN1;HGSNAT;CTSD;VPS33B;SPPL2B;SLC22A17;PYCARD;C12ORF66;LITAF;GALNS;PQLC2
11684,GO:0046498,0.0990940021580114,0.987390911069854,2,6,S-adenosylhomocysteine metabolic process,BP,GAMT;AHCYL2
2239,GO:0005154,0.0991074281651077,0.966024723092232,5,26,epidermal growth factor receptor binding,MF,SHC1;HBEGF;VAV3;CBLC;EREG
7655,GO:0032096,0.0994351029516783,0.987321698541504,2,6,negative regulation of response to food,BP,BBS2;PPARA
7658,GO:0032099,0.0994351029516783,0.987321698541504,2,6,negative regulation of appetite,BP,BBS2;PPARA
8416,GO:0033539,0.0996027805307275,0.978057229497295,3,12,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,ACAD10;ETFB;ACADS
15731,GO:0072350,0.0997019174910537,0.96144822960347,6,34,tricarboxylic acid metabolic process,BP,IDH2;OGDHL;DHTKD1;SDHA;MDH2;ASS1
5058,GO:0015291,0.0997233132265011,0.940326200490285,17,125,secondary active transmembrane transporter activity,MF,SLCO4A1;SLC16A5;SLC16A3;SLC2A9;SLC13A3;SLC7A8;SLC6A8;SLC20A1;SLC12A7;SLC22A18;SLC16A13;SLC28A2;SLC37A2;TMCO3;SLC9A7;SLC5A5;SLC22A17
12287,GO:0048660,0.0997801870191484,0.946638024561191,12,83,regulation of smooth muscle cell proliferation,BP,CTNNBIP1;MEF2D;EGFR;PDCD4;IL6R;HBEGF;COMT;PTAFR;AKT1;NDRG2;ERN1;EREG
543,GO:0001662,0.099843242469846,0.970998960842673,4,19,behavioral fear response,BP,APOE;DEAF1;RAG1;FBXL20
867,GO:0002209,0.099843242469846,0.970998960842673,4,19,behavioral defense response,BP,APOE;DEAF1;RAG1;FBXL20
10077,GO:0042596,0.099843242469846,0.970998960842673,4,19,fear response,BP,APOE;DEAF1;RAG1;FBXL20
9229,GO:0035640,0.100352431264292,0.977819697509182,3,12,exploration behavior,BP,APOE;NLGN2;DLG4
9599,GO:0036481,0.100390932654104,0.98712695239351,2,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,TRAP1;PINK1
13377,GO:0052742,0.100464419849773,0.961173861704402,6,33,phosphatidylinositol kinase activity,MF,PIK3R2;FGFR3;PI4K2A;FGFR4;FGFR1;PI4KAP2
4069,GO:0009132,0.100509161611302,0.941959635026207,15,110,nucleoside diphosphate metabolic process,BP,PGM1;NME4;OGDHL;INSR;DLG4;PFKFB2;DHTKD1;ENTPD2;GALK1;MLXIPL;PFKL;HK1;PPARA;GUK1;DLG3
14826,GO:0070613,0.100637129205579,0.954484469978574,8,50,regulation of protein processing,BP,GSN;SERPING1;SERPINE2;PRNP;CD81;F12;CTSZ;C5
5538,GO:0016553,0.100745554959743,0.977694796856035,3,12,base conversion or substitution editing,BP,ADARB1;APOBEC3C;APOBEC3F
15852,GO:0072608,0.100786570320478,0.987045998569136,2,6,interleukin-10 secretion,BP,PRKCZ;PYCARD
3748,GO:0008298,0.100859296196488,0.977658616600006,3,12,intracellular mRNA localization,BP,ZFP36L1;ZFP36;ZNF385A
7115,GO:0030950,0.10096988382095,0.977623420932895,3,12,establishment or maintenance of actin cytoskeleton polarity,BP,RHOD;RHOF;RHOBTB2
1102,GO:0002691,0.101001246647513,0.977613436057296,3,12,regulation of cellular extravasation,BP,PTAFR;BCR;ABR
6052,GO:0019209,0.101030246643317,0.951729532079378,9,58,kinase activator activity,MF,IGF2;SPRY2;MAP2K2;DGKQ;GAS6;MADD;ERBB3;ERCC6;MLST8
6888,GO:0030449,0.101038811849463,0.977601474617378,3,12,regulation of complement activation,BP,SERPING1;CD81;C5
19781,GO:2000257,0.101038811849463,0.977601474617378,3,12,regulation of protein activation cascade,BP,SERPING1;CD81;C5
14818,GO:0070588,0.101197180897313,0.936542587628065,20,153,calcium ion transmembrane transport,BP,CEMIP;NOS1;F2R;GJC2;PKD2;ITPR3;NTSR1;ATP2B4;ASIC1;PRNP;PRKACA;TRPV4;GAS6;SMDT1;TPCN1;PKD1;EHD3;ORAI3;ORAI2;GSTM2
11794,GO:0046710,0.101270371186747,0.977527695371921,3,12,GDP metabolic process,BP,DLG4;GUK1;DLG3
17303,GO:0150034,0.101330914163692,0.934209533961408,23,180,distal axon,CC,ADGRL1;SHANK2;TIMP2;KCNC4;TENM2;SIGMAR1;NTSR1;TMOD2;GLUL;KCNAB2;DVL1;SSH1;MAPK8IP1;TRPV4;BLVRB;TWF2;CTSZ;DLG3;RTN4R;NDRG2;PINK1;NRSN1;ORAI2
1231,GO:0002920,0.101413790704444,0.970379108581477,4,19,regulation of humoral immune response,BP,SERPING1;ZP3;CD81;C5
16879,GO:0098869,0.10159174295022,0.951222612612033,9,62,cellular oxidant detoxification,BP,APOE;PRDX5;GPX3;TXNRD3;FAM213A;SESN2;GSTT1;TP53INP1;GSTM2
4590,GO:0010715,0.101835382473013,0.977347335983531,3,12,regulation of extracellular matrix disassembly,BP,CST3;LRP1;FGFR4
6702,GO:0030122,0.101849786593746,0.977342731765673,3,12,AP-2 adaptor complex,CC,EGFR;AP2A2;LDLRAP1
14709,GO:0070403,0.101983522177461,0.977299968975333,3,12,NAD+ binding,MF,HADH;CRYL1;SIRT3
12022,GO:0047844,0.102123053819858,0.986771044542857,2,6,deoxycytidine deaminase activity,MF,APOBEC3C;APOBEC3F
15218,GO:0071404,0.102131856895125,0.977252506854284,3,12,cellular response to low-density lipoprotein particle stimulus,BP,CD9;CD81;LDLR
11860,GO:0046890,0.102213239166194,0.938585952318199,17,127,regulation of lipid biosynthetic process,BP,APOE;CYP27B1;NR1D1;EGR1;ABCG1;ZP3;MVD;SEC14L2;MLXIPL;FGFR4;PMVK;TNFRSF1A;LDLR;TM7SF2;DGKQ;PROX1;AKT1
3321,GO:0007039,0.102303722043575,0.977197474816722,3,12,protein catabolic process in the vacuole,BP,LRP1;CD81;LDLR
12604,GO:0050817,0.102307012205675,0.931578768304903,26,212,coagulation,BP,APOE;SERPING1;F2R;DGKA;PLAT;ZFPM1;FBLN1;ITPR3;CD9;SERPINE2;DOCK6;MAPK3;ENTPD2;PHF21A;PRKACA;F12;DMTN;DGKQ;GAS6;VAV3;ADAMTS13;PROCR;SH2B3;AKT1;VPS33B;EHD3
159,GO:0000323,0.102434657304743,0.921143324464787,59,520,lytic vacuole,CC,TSPAN1;GAA;NAPRT;PYGB;CST3;MARCH9;COL6A1;LRP1;NAGLU;CTSB;ANK3;HYAL1;CTSF;FUCA1;VAT1;HEXB;VPS11;ACP5;DIRC2;GM2A;RAB3D;RNASET2;MARCH2;AP2A2;DPP7;GLB1;FYCO1;SLC48A1;ABCA2;ADA;PCSK9;TMEM9;PI4K2A;LDLR;VASN;TMEM175;ABCD4;TPP1;GPC1;CTSZ;CAPN2;TOLLIP;MAN2B2;CYBRD1;CD68;SDC1;TPCN1;HGSNAT;CTSD;VPS33B;NAGA;SPPL2B;CTSH;PYCARD;C12ORF66;LITAF;GALNS;PQLC2;STXBP2
2505,GO:0005764,0.102434657304743,0.921143324464787,59,520,lysosome,CC,TSPAN1;GAA;NAPRT;PYGB;CST3;MARCH9;COL6A1;LRP1;NAGLU;CTSB;ANK3;HYAL1;CTSF;FUCA1;VAT1;HEXB;VPS11;ACP5;DIRC2;GM2A;RAB3D;RNASET2;MARCH2;AP2A2;DPP7;GLB1;FYCO1;SLC48A1;ABCA2;ADA;PCSK9;TMEM9;PI4K2A;LDLR;VASN;TMEM175;ABCD4;TPP1;GPC1;CTSZ;CAPN2;TOLLIP;MAN2B2;CYBRD1;CD68;SDC1;TPCN1;HGSNAT;CTSD;VPS33B;NAGA;SPPL2B;CTSH;PYCARD;C12ORF66;LITAF;GALNS;PQLC2;STXBP2
4335,GO:0009896,0.102440163648631,0.925924284437308,39,328,positive regulation of catabolic process,BP,APOE;RAPGEF3;ZFP36L1;LRP1;ULK1;TRIM65;TFEB;EDEM1;VPS11;CSNK1E;INSR;SNX33;SNX9;PFKFB2;BNIP3;CD81;ENDOG;MAPK3;DVL1;FYCO1;GPSM1;FURIN;MLXIPL;MEFV;LRSAM1;PCSK9;ZFP36;MAGEF1;LDLR;PPARA;RAD23A;GTPBP1;SH3D19;SESN2;SORL1;TPCN1;AKT1;TP53INP1;PINK1
15537,GO:0072012,0.102448569123229,0.977151059958327,3,12,glomerulus vasculature development,BP,EGR1;ACTA2;HES1
5589,GO:0016635,0.102528162820553,0.986687248874728,2,6,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,SDHAF4;SDHA
2242,GO:0005159,0.102542113859771,0.977121067858555,3,12,insulin-like growth factor receptor binding,MF,IGF2;SHC1;INSR
2484,GO:0005737,0.102604441874953,0.908988472984366,817,8367,cytoplasm,CC,TNIP1;HTRA1;FOS;DUSP6;H6PD;LMF1;CEMIP;APOE;TYSND1;MARVELD1;ESPN;CTNNBIP1;MARCKSL1;TSPAN1;PPL;IDH2;RNPEPL1;PTPRS;ERCC1;WWC3;FLNC;FAM110C;NT5E;GAA;SYTL1;CLIP2;CITED4;NAPRT;BTBD2;PYGB;CST3;SHANK2;RAPGEF3;PGM1;CYP27B1;GSN;CLCA2;XDH;PRDX5;NDRG1;PGLS;PCBP4;PRSS3;PRODH;MEF2D;NOS1;LTBP1;MARCH9;PARVB;ARAP1;ZFP36L1;COL6A1;TCTN1;POSTN;GRB7;NR1D1;CRAT;EFS;ALOX15B;ARRDC1;EPN3;FAM210B;POLD4;SCN8A;RBCK1;EPHB2;EPAS1;OBSCN;CPT2;RHPN1;MYZAP;IGF2;NFATC4;NME4;MST1R;LRP1;GAMT;MAPK13;APPL2;HEBP1;CDK18;RALGDS;ST6GALNAC2;RAB11FIP4;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;MMP28;B3GAT3;HADH;CRYL1;SUGCT;ACSF2;REEP6;FBXO2;ACOT7;DUSP5;FKBP9;HS1BP3;PPP1R14A;ISYNA1;UROS;FHL1;JOSD2;LOXL1;SERPING1;MTHFR;KDSR;MDFI;EGR1;ULK1;RHBDF1;PKN1;CRTC1;PYGL;ARHGEF4;TRIM65;DOPEY2;SYT8;NAGLU;SHC1;F2R;PTK6;BPHL;NPEPL1;ABCA7;DEAF1;GALE;BBS2;ACTA2;S100A4;CTSB;LPCAT4;DNAH1;RNF208;SHC2;PITPNC1;CORO1B;CXXC5;ULK2;DGKA;DHRS1;MALL;THBS3;D2HGDH;ZMYND8;TBC1D14;PACS2;GRAMD4;MXI1;CERS4;PLAT;ABCG1;RIN1;ANK3;NOL4L;PIK3R2;OPLAH;S100A6;PEG3;NEK9;HDAC5;THRA;ARHGAP23;PLD3;DOCK4;CRTAP;RPS6KA2;NMRK1;NISCH;LRP5;DBNDD1;HYAL1;TUBG2;ANO8;MARK4;TENM2;B4GALNT4;ZFPM1;TFEB;ERBB2;EXOC2;BRSK1;MICALL2;BSG;CTSF;OGDHL;PKD2;CBS;TMEM129;FUCA1;TST;IQSEC2;CPT1C;EDEM1;ABTB1;SLC7A8;ITPR3;PRAF2;PHLDA2;VAT1;DNM1;SPRY4;DDIT4L;FCHO1;MPRIP;PTHLH;CDKN1C;RIMS3;MSRB2;IFT140;CUL9;CD9;KIF13B;XPC;PTPRE;ANGEL1;NINL;SIGMAR1;PAK6;HEXB;SERPINE2;VPS11;VAMP2;CCDC69;FUZ;GALNT12;RNF135;NPHP4;UNK;NTSR1;CD320;MINK1;RALGAPA2;ATP2B4;SNN;TMOD2;TFDP2;PHF7;CSNK1E;ACP5;RASA4;PLCD1;TRAPPC9;AGAP1;ZFYVE21;DIRC2;ADAMTS7;ENKD1;PDCD4;DOCK6;TMEM134;GM2A;BEX2;ACAP3;TNFRSF25;GLUL;PRR7;RHOD;DTX3;ARVCF;USP20;PEX10;ARMCX2;ASIC1;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;RAB3D;PLCXD1;LCE1E;SH3PXD2B;FBXW8;ID1;AKR7A2;MVD;LGALS9C;MZT2A;B4GAT1;NDUFS8;RABGGTA;EPHA1;ADARB1;CCNG2;TXNRD3;SYNGAP1;NBEAL2;HAGH;FBXO27;DNMT3A;DNPH1;TMEM173;PRNP;DHX32;SRD5A3;OXLD1;ATP7B;RNASET2;FBXL8;SNX33;FBXO41;SPRY2;HINT2;BLMH;ECM1;CEP250;ATG16L2;SNX9;STAT6;DLG4;ABCD1;MARCH2;REEP2;MTA3;MKNK2;PLCD3;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;MYO18A;ARHGAP27;CERCAM;MZT2B;DNAJB5;MYCBPAP;SCART1;PLEKHH2;C1ORF210;BCL6;ANKZF1;UCKL1;PFKFB2;FAM213A;CHMP1B;IGFBP2;SEC14L2;MVB12B;BNIP3;SRMS;FZD8;VEGFA;ENTPD6;DNASE1L1;HOOK2;LRRC8A;ARL2;VANGL2;MAST4;FBXW4;ELMO3;AP2A2;CEBPB;RHBDF2;DPP7;GPRC5C;SHANK3;ACVR2B;ADAM15;NUDCD3;CALCOCO1;ZDHHC1;ENDOG;MAPK3;PDZD2;FBXL16;PLEKHG5;TUB;KCNAB2;OLFM2;CARD19;AMN;SLC22A18;GLB1;CAPNS2;DHTKD1;EXD3;C19ORF33;RAB40B;TNNT1;DVL1;ENTPD2;GALK1;MTA1;LHPP;FYCO1;WIPF1;GPSM1;ADCY6;LTA4H;WIPI2;PKN3;PHGDH;ST3GAL3;SLC16A13;EPHB3;FHOD1;HES1;PC;ACAD10;SSH1;COMTD1;FURIN;MLXIPL;NAGS;FBF1;MBOAT7;SLC48A1;SAMD3;CUL7;MEFV;EVC;ARHGAP22;SLC2A3;TRIM4;NADK;PLEKHG2;ABCA2;TK2;LRSAM1;LY6K;ADA;FKBP10;CDC42EP5;TRIM45;MCTP1;OSBPL5;PYCR2;PIDD1;RETSAT;SH2D2A;AQP3;CELSR2;ACY1;CKMT1A;PFKL;SLIT3;PCSK9;TMEM9;ZFP36;RHOF;BTBD11;MAPKBP1;HLCS;CYHR1;RSPH3;FGFR3;PRKACA;F12;PITPNM1;ZMYM3;LRRK1;NUDT10;PLCH2;DGUOK;CYFIP2;SLC38A10;RPS6KA5;SCNN1A;HBEGF;SLC25A37;ITGB5;RAB3B;MAP2K2;PI4K2A;FGFR4;SPTB;FBXW5;MXRA8;SLC37A2;STX10;DMTN;PMVK;BBS1;MYH3;XYLT2;VGF;TNFRSF1A;SEZ6L2;EHD4;MAPK8IP1;SEMA3B;LDLR;PTOV1;LYPLAL1;CYP3A5;ACOT11;SNX17;ABHD17C;TRPV4;MPG;RHOBTB2;PIGZ;IFNGR2;BHLHE40;EIF4EBP3;CROCC;CCDC92;DUSP7;PHLDA1;LRRC45;TNFAIP8L1;EEF2K;MSLN;LDLRAP1;TM7SF2;ELK3;AHNAK2;DGKQ;PEX7;SEMA4C;MVB12A;HK1;NMRAL1;MIB2;FBXO17;CHST6;SDHAF4;PADI3;GAS6;BTRC;MEX3A;LLGL1;ANKS6;ZNF217;HMGCL;TKFC;GUK1;TMEM187;WNT7B;BLVRB;GIT1;COMT;TTC7B;SUFU;PTAFR;PLEKHG6;RFNG;ANKRD13D;IMPA2;ARHGEF37;PAN2;REEP4;ATG2A;PCK2;PCSK1;VAV3;VASN;BCR;TMEM175;NEO1;IGFBP4;SDHA;GSDMC;MUC19;TBC1D16;USP21;RNF123;WDR60;PRKCZ;ADAMTS13;ZDHHC24;CLTCL1;HLTF;MDH2;CAPG;INPP5D;ETFB;ABCD4;SPATA7;TWF2;SH3GLB2;KLHDC8B;TPP1;PDK2;GPC1;TMX4;ICOSLG;SRSF5;RFXANK;SMOX;CEP68;MAPKAPK3;NDE1;AGO4;RAD23A;ARAP3;FGFR1;CTSZ;CAMKK1;SPSB3;PIN1;MAN1B1;PNPLA4;PHYH;CMBL;PROX1;WBP2;GTPBP1;C21ORF2;ASAP2;DLG3;GPR155;ESYT2;BIN1;VSNL1;MTMR11;UNC119B;YIPF3;TMEM8B;SERPINB6;PI4KAP2;PPP1R13L;ASS1;SH3D19;WDR83;GLRX;CES2;SLC25A27;GRB10;BFSP1;JARID2;SYNC;CAPN2;SESN2;NDUFA4L2;TOLLIP;TSTA3;WRAP73;CSTB;SNPH;MAN2B2;PNRC1;MAPRE3;DUSP23;MACROD1;GAL3ST4;SMDT1;PITPNM3;CYBRD1;MADD;LMLN;RTN4R;EPB41L3;PIGV;SLC9A7;TIMP1;CD68;SDC1;WHAMMP3;GRHPR;SH2B3;ACTR1B;APOBEC3C;RTN2;EPS8L1;PIGQ;WNT3;LYST;GSTT1;PPM1F;KIAA1191;MICALCL;SBF1;SORL1;STK39;COL13A1;VEGFB;ACVR1B;TBC1D17;GSDMA;GSS;AHCYL2;ALS2CL;TSNARE1;TPCN1;HGSNAT;SLC25A29;ERBB3;ABR;CCDC85B;PNMA1;CYP2S1;AKT1;CTSD;TRAP1;STON1;TMBIM4;NLRX1;SEPT8;ADAM19;ZNF385A;TP53INP1;LRCH4;NDRG2;TUT1;VPS33B;SIX5;PCMTD2;ACP6;GPD1L;EPS8L2;TDRKH;SUN1;NAGA;SPPL2B;IL17RD;UQCR11;SSBP2;RPL39L;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;MPLKIP;SNTA1;ARHGEF10L;HOMER2;LGALS9B;RGS14;SYNE3;GOLGA2P5;MAFIP;SPIRE2;CCDC106;HEXDC;EIF4G3;CTSH;EHBP1L1;ABHD14B;P3H4;MLST8;AGPAT4;RILPL1;NRSN1;RSAD1;ATXN10;EPN2;RFX2;RNF187;PYCARD;MAP2K3;PNPO;RHBG;POMT1;TRERF1;PCSK1N;DNAAF5;DDN;AS3MT;NDUFV3;ERN1;RANBP9;APOBEC3F;PRIMPOL;ACADS;FBXL20;GCAT;MOCS1;ARHGEF19;SIRT3;ALKBH6;C12ORF66;SLC2A1;CPNE7;MLYCD;TAZ;JAK3;BCKDHA;KIFC2;LITAF;APBA1;NEIL1;FUK;ING4;EIF4E3;GALNS;PBXIP1;FAM162A;PPCS;FCHSD1;GSTM2;ABHD14A;PODXL2;ZFYVE19;TRIM7;MORN4;WDR18;PQLC2;SFI1;KRT15;ADAMTSL4;TTLL11;TMED4;SEMA4F;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;STXBP2;KIF26B;UBL5;LZTS2
4225,GO:0009414,0.102741707381589,0.986642993106713,2,6,response to water deprivation,BP,LRP11;CD9
5580,GO:0016615,0.102851986356307,0.986620115606725,2,6,malate dehydrogenase activity,MF,PHGDH;MDH2
7224,GO:0031143,0.102933053400255,0.976995584950724,3,12,pseudopodium,CC,RAB25;MAPK3;CAPN2
18477,GO:1903649,0.102935630222872,0.969774887858275,4,19,regulation of cytoplasmic transport,BP,VPS11;MAPK3;MAP2K2;SORL1
18217,GO:1903054,0.10296114073153,0.986597456067614,2,6,negative regulation of extracellular matrix organization,BP,CST3;CHADL
7112,GO:0030947,0.103024310527391,0.969739570294949,4,19,regulation of vascular endothelial growth factor receptor signaling pathway,BP,VEGFA;TMEM204;GRB10;EPN2
12722,GO:0051016,0.103059533202786,0.976954939140479,3,12,barbed-end actin filament capping,BP,GSN;CAPG;TWF2
1579,GO:0003993,0.103065513599861,0.986575774860831,2,6,acid phosphatase activity,MF,ACP5;ACP6
6249,GO:0019842,0.103143293613112,0.94448761808235,12,84,vitamin binding,MF,PYGB;PYGL;OGDHL;CBS;CD320;SEC14L2;DHTKD1;PC;HLCS;PHYH;PNPO;GCAT
11765,GO:0046651,0.103162606125409,0.9359710821014,19,147,lymphocyte proliferation,BP,IGF2;PKN1;ZP3;ERBB2;CD320;IL20RB;PRNP;BCL6;IGFBP2;CD81;CEBPB;HES1;ADA;VAV3;INPP5D;ICOSLG;PYCARD;JAK3;MIF
17440,GO:1900272,0.103182427617089,0.986551471941414,2,6,negative regulation of long-term synaptic potentiation,BP,APOE;PRNP
15555,GO:0072050,0.103506742929678,0.98648396494922,2,6,S-shaped body morphogenesis,BP,PKD2;HES1
10712,GO:0044087,0.103549526169784,0.917953606425933,74,663,regulation of cellular component biogenesis,BP,ADGRL1;APOE;ESPN;CTNNBIP1;ERCC1;FAM110C;RAPGEF3;GSN;EVI5L;ARAP1;EPHB2;NLGN2;DDB2;ULK1;ARPIN;CORO1B;ZMYND8;TBC1D14;MMP1;THRA;HYAL1;TENM2;PLXNB3;IFT140;VPS11;FUZ;NPHP4;TMOD2;RHOD;WNT7A;SH3PXD2B;ID1;EPHA1;SNX9;CHMP1B;VEGFA;ARL2;SHANK3;WIPF1;EPHB3;FHOD1;SSH1;MEFV;PLEKHG2;LRSAM1;CDC42EP5;PRKACA;SPTB;DMTN;TNFRSF1A;CROCC;EEF2K;ADGRB2;PRKCZ;CAPG;SLITRK6;TWF2;PROX1;WRAP73;LCAT;SDC1;WHAMMP3;EPS8L1;PPM1F;SORL1;EPS8L2;SSH3;PINK1;ARHGEF10L;SPIRE2;MLST8;PYCARD;FCHSD1;RPL13A
6969,GO:0030656,0.103761882345442,0.986430762531411,2,6,regulation of vitamin metabolic process,BP,CYP27B1;CD320
7838,GO:0032410,0.103851074549625,0.955748391904197,7,42,negative regulation of transporter activity,BP,EPHB2;ANK3;PKD2;PCSK9;STK39;ANO9;GSTM2
5778,GO:0017017,0.103852337398892,0.97669962147833,3,12,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,DUSP6;DUSP5;DUSP7
3185,GO:0006817,0.104053075303787,0.97663482737003,3,12,phosphate ion transport,BP,SLC20A1;SLC37A2;FGFR1
13950,GO:0060688,0.104134354485965,0.959257861560149,6,34,regulation of morphogenesis of a branching structure,BP,PGF;VEGFA;ETV5;RXRA;FGFR1;WNT2B
13840,GO:0060485,0.10418029948648,0.93361011298268,21,162,mesenchyme development,BP,SEMA4B;ZFP36L1;LAMA5;ACTA2;S100A4;PKD2;FUZ;PDCD4;WWTR1;ADAM15;MAPK3;HES1;CUL7;SEMA3B;HMGA2;SEMA3F;SEMA4C;VASN;FGFR1;ERBB3;SEMA4F
3941,GO:0008652,0.104314991343171,0.94982541726157,9,58,cellular amino acid biosynthetic process,BP,GAMT;CBS;ATP2B4;GGT1;GLUL;PHGDH;NAGS;PYCR2;ASS1
8720,GO:0034384,0.104329606908029,0.986312080412868,2,6,high-density lipoprotein particle clearance,BP,APOE;AMN
10230,GO:0042982,0.104376830815498,0.95546917872216,7,42,amyloid precursor protein metabolic process,BP,APOE;ABCA7;ABCG1;PRNP;LDLRAP1;BIN1;SORL1
15850,GO:0072604,0.104416035324754,0.969183746549797,4,19,interleukin-6 secretion,BP,F2R;TRPV4;GAS6;PYCARD
19432,GO:1990144,0.104615097026039,0.986252243515832,2,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,BNIP3;PINK1
4792,GO:0010996,0.104713776698727,0.976421145657612,3,12,response to auditory stimulus,BP,XPC;SHANK3;SLITRK6
15692,GO:0072282,0.104769833777423,0.986219768217876,2,6,metanephric nephron tubule morphogenesis,BP,HES1;PKD1
12616,GO:0050840,0.104842678974342,0.958905172029788,6,34,extracellular matrix binding,MF,BCAM;ITGA6;ECM1;VEGFA;GPC1;OLFML2A
6533,GO:0021955,0.10486112627401,0.969005369995659,4,19,central nervous system neuron axonogenesis,BP,TCTN1;EPHB2;ADARB1;EPHB3
14653,GO:0070293,0.104873120370196,0.976369514800876,3,12,renal absorption,BP,GSN;AQP3;GAS6
8628,GO:0034185,0.104906854731066,0.976358579320428,3,12,apolipoprotein binding,MF,LRP1;PCSK9;LCAT
4458,GO:0010463,0.105018010924606,0.963355795008826,5,26,mesenchymal cell proliferation,BP,CTNNBIP1;LRP5;VEGFA;FBXW4;FGFR1
8175,GO:0032927,0.105125778164675,0.986144948638937,2,6,positive regulation of activin receptor signaling pathway,BP,ACVR2B;ACVR1B
9444,GO:0036064,0.105174261568346,0.941615366884028,13,92,ciliary basal body,CC,BBS2;MARK4;PKD2;IFT140;NPHP4;EVC;BBS1;SPATA7;C21ORF2;WRAP73;AKT1;GAS8;RILPL1
10180,GO:0042802,0.105299992373368,0.912153170901417,123,1157,identical protein binding,MF,TNIP1;HTRA1;APOE;CST3;XDH;PGF;CADM4;MEF2D;GRB7;ARRDC1;EPHB2;RAB11FIP4;EGFR;ALDH4A1;NLGN2;CRYL1;ACOT7;MDFI;ULK1;PYGL;PTK6;GALE;S100A4;CORO1B;ABCG1;S100A6;ZP3;NISCH;TENM2;ERBB2;FBLN1;PTPRU;PKD2;CBS;DNM1;MPRIP;HEXB;RNF135;NTSR1;GLUL;ID1;MVD;DNMT3A;DNPH1;TMEM173;PRNP;SNX33;BLMH;SNX9;STAT6;ABCD1;WWTR1;PHC2;PLEKHH2;BCL6;CHMP1B;SCAND1;BNIP3;VEGFA;HOOK2;LRRC8A;CEBPB;NAB2;MAPK3;DVL1;LHPP;L3MBTL1;FHOD1;HES1;UHRF1BP1;PC;MEFV;ACY1;PFKL;IL6R;HLCS;FGFR3;LRRK1;TNFRSF1A;LDLR;TRPV4;BHLHE40;RAG1;PEX7;NMRAL1;PADI3;HMGCL;IMPA2;PCSK1;SH3GLB2;PDK2;NDE1;FGFR1;ESYT2;BIN1;PPP1R13L;ASS1;TSTA3;MAPRE3;SLC9A7;SDC1;GRHPR;OLFML2A;VEGFB;GSS;ALS2CL;TPCN1;ERBB3;AKT1;GPD1L;NAGA;SPPL2B;HOMER2;ATXN10;PYCARD;PNPO;ERN1;APOBEC3F;SLC2A1;MLYCD;MZF1;GSTM2;MIF
11601,GO:0046326,0.105510745100592,0.963130943638442,5,26,positive regulation of glucose import,BP,PIK3R2;INSR;PRKCZ;CLTCL1;AKT1
18143,GO:1902932,0.105554960134526,0.976148160889757,3,12,positive regulation of alcohol biosynthetic process,BP,ABCG1;NTSR1;PTAFR
5066,GO:0015299,0.1055755831319,0.976141455126555,3,12,solute:proton antiporter activity,MF,SLC22A18;TMCO3;SLC9A7
11268,GO:0045601,0.105664959564401,0.968682467107033,4,19,regulation of endothelial cell differentiation,BP,XDH;ID1;S1PR2;TNFRSF1A
16405,GO:0097084,0.105698765914253,0.986024167288232,2,6,vascular smooth muscle cell development,BP,VEGFA;HES1
5570,GO:0016597,0.105706009196093,0.958474320753206,6,34,amino acid binding,MF,NOS1;GLUL;NAGS;ASS1;SESN2;GSS
8036,GO:0032703,0.105749204034283,0.97608497582852,3,12,negative regulation of interleukin-2 production,BP,IL20RB;PRNP;ZFP36
2737,GO:0006140,0.105866640502705,0.937164056008839,16,119,regulation of nucleotide metabolic process,BP,APOE;RAPGEF3;NOS1;TIMP2;PKD2;PTHLH;LTB4R2;INSR;PFKFB2;VEGFA;MLXIPL;PPARA;GUCA1B;ADORA2B;PINK1;TAZ
2651,GO:0006002,0.105932968106788,0.985974678906035,2,6,fructose 6-phosphate metabolic process,BP,TALDO1;PFKL
501,GO:0001558,0.106203805362129,0.924771073394522,34,285,regulation of cell growth,BP,HTRA1;APOE;PTPRS;SEMA4B;LTBP4;CYP27B1;EGFR;FHL1;ULK2;HYAL1;ERBB2;SERPINE2;DNPH1;LPAR3;BCL6;IGFBP2;VEGFA;ADAM15;SLIT3;HBEGF;SEMA3B;SEMA3F;SEMA4C;IGFBP4;TWF2;PIN1;SESN2;RTN4R;EPB41L3;WNT3;ACVR1B;CCDC85B;AKT1;SEMA4F
16957,GO:0099054,0.106205777286538,0.975936239891266,3,12,presynapse assembly,BP,NLGN2;WNT7A;DVL1
17314,GO:1900025,0.106262806005057,0.975917640366988,3,12,negative regulation of substrate adhesion-dependent cell spreading,BP,POSTN;FBLN1;DMTN
10967,GO:0044782,0.106311469180136,0.924302681484925,35,292,cilium organization,BP,GSN;EVI5L;TCTN1;LAMA5;BBS2;DNAH1;MARK4;IFT140;NINL;FUZ;NPHP4;CSNK1E;CEP250;WWTR1;TMEM107;VANGL2;NUDCD3;FBF1;PRKACA;BBS1;CROCC;WDR60;NDE1;UNC119B;WRAP73;TMEM231;SEPT8;GAS8;EHD3;MAFIP;RILPL1;ATXN10;RFX2;DNAAF5;SFI1
16054,GO:0090045,0.106349589234344,0.98588647173814,2,6,positive regulation of deacetylase activity,BP,VEGFA;PINK1
712,GO:0001938,0.106352868806715,0.948586365984271,9,59,positive regulation of endothelial cell proliferation,BP,PGF;PLXNB3;ECM1;VEGFA;NRP2;FGFR1;PROX1;VEGFB;AKT1
20069,GO:2000766,0.106363593071282,0.98588350300554,2,6,negative regulation of cytoplasmic translation,BP,UNK;RPL13A
10292,GO:0043086,0.106369686856487,0.917692213458041,60,537,negative regulation of catalytic activity,BP,DUSP6;APOE;CST3;CYP27B1;PRDX5;NOS1;EPHB2;TIMP2;DUSP5;PPP1R14A;SERPING1;PKN1;PTK6;LRP5;PLXNB3;SPRY4;CDKN1C;SERPINE2;LTB4R2;ATP2B4;RASA4;PDCD4;EPHA1;ADARB1;PPP1R35;PRNP;PAPLN;SPRY2;ECM1;WWTR1;VEGFA;ARL2;TNFRSF6B;DVL1;GPSM1;FURIN;ZFP36;MAPK8IP1;RAG1;DUSP7;GAS6;PRKCZ;C5;DLG3;BIN1;SERPINB6;CSTB;RTN4R;ELFN2;TIMP1;PPM1F;SORL1;AKT1;RGS14;PCIF1;CBLC;PYCARD;PCSK1N;NEIL1;SFI1
14035,GO:0060841,0.106414421981953,0.975868168633834,3,12,venous blood vessel development,BP,VEGFA;ACVR2B;PROX1
6926,GO:0030546,0.106443288872651,0.985866603208026,2,6,receptor activator activity,MF,IGF2;DGKQ
16408,GO:0097090,0.106664896851894,0.985819567949415,2,6,presynaptic membrane organization,BP,APOE;NLGN2
5200,GO:0015809,0.106698964008729,0.985812331818944,2,6,arginine transport,BP,SLC25A29;PQLC2
16132,GO:0090179,0.106831446864599,0.975731920970187,3,12,planar cell polarity pathway involved in neural tube closure,BP,CELSR1;VANGL2;DVL1
3501,GO:0007417,0.106833263975648,0.916322932119446,66,587,central nervous system development,BP,PTPRS;CST3;SHANK2;GSN;TCTN1;EPHB2;CNTN1;LRP1;EGFR;TIMP2;NAGLU;BBS2;GJC2;SOX12;THRA;ERBB2;PKD2;CD9;SERPINE2;ATP2B4;CSNK1E;TRAPPC9;LAMB2;WNT7A;ID1;CELSR1;ADARB1;BNIP3;SHANK3;MAPK3;PHGDH;EPHB3;HES1;MBOAT7;PITPNM1;FGFR4;MDGA1;HDAC11;LDLR;SEMA3F;SEMA4C;POU6F1;WNT7B;SUFU;BCR;TPP1;NDE1;FGFR1;PROX1;BIN1;JARID2;WNT2B;SNPH;RTN4R;WNT3;ACVR1B;ABR;AKT1;NDRG2;SMARCA1;SUN1;GAS8;PKD1;SLC2A1;RARG;TRNP1
12702,GO:0050982,0.106835511309814,0.975730591806077,3,12,detection of mechanical stimulus,BP,PKD2;SERPINE2;PKD1
7686,GO:0032155,0.106885516940941,0.948325314115723,9,58,cell division site part,CC,RAB11FIP4;PKN1;PLCD3;SSH1;PITPNM1;PLEKHG6;NDE1;SPIRE2;ZFYVE19
3799,GO:0008395,0.106931494594075,0.985762901119251,2,6,steroid hydroxylase activity,MF,CYP3A5;CYP2S1
12286,GO:0048659,0.106940275848358,0.942076368087058,12,84,smooth muscle cell proliferation,BP,CTNNBIP1;MEF2D;EGFR;PDCD4;IL6R;HBEGF;COMT;PTAFR;AKT1;NDRG2;ERN1;EREG
10011,GO:0042473,0.106972612169929,0.985754153313176,2,6,outer ear morphogenesis,BP,MAPK3;FGFR1
1975,GO:0004697,0.107022137690729,0.975669534746233,3,12,protein kinase C activity,MF,PKN1;PKN3;PRKCZ
9329,GO:0035855,0.107058613913561,0.975657595150597,3,12,megakaryocyte development,BP,ZFPM1;ZNF385A;VPS33B
1284,GO:0003094,0.107250825516723,0.975594647216005,3,12,glomerular filtration,BP,F2R;GAS6;SULF2
5198,GO:0015807,0.107264245203999,0.953928846690152,7,42,L-amino acid transport,BP,SLC43A1;SLC7A8;PRAF2;NTSR1;SERINC2;SLC25A29;PQLC2
16610,GO:0097499,0.107309979349751,0.985682297026974,2,6,protein localization to non-motile cilium,BP,TUB;SPATA7
13541,GO:0060033,0.107485359636861,0.985644885467495,2,6,anatomical structure regression,BP,LRP5;NINJ1
7756,GO:0032288,0.107497759571189,0.967942603819385,4,19,myelin assembly,BP,CD9;AHNAK2;GPC1;EPB41L3
11217,GO:0045410,0.10759345519076,0.985621807429469,2,6,positive regulation of interleukin-6 biosynthetic process,BP,PTAFR;EREG
11311,GO:0045657,0.107654177579984,0.985608836900615,2,6,positive regulation of monocyte differentiation,BP,CTNNBIP1;ZFP36L1
4715,GO:0010887,0.10772669815567,0.985593340106617,2,6,negative regulation of cholesterol storage,BP,ABCG1;PPARA
1308,GO:0003158,0.107830397163024,0.943352825442356,11,75,endothelium development,BP,PTPRS;RAPGEF3;XDH;LAMA5;WNT7A;ID1;ACVR2B;S1PR2;TNFRSF1A;WNT7B;PROX1
10698,GO:0044033,0.107839685499177,0.985569182748963,2,6,multi-organism metabolic process,BP,MAP2K2;MAP2K3
9024,GO:0035256,0.107937923967115,0.98554816563135,2,6,G-protein coupled glutamate receptor binding,MF,PRNP;HOMER2
10222,GO:0042953,0.107969114181487,0.985541490244244,2,6,lipoprotein transport,BP,LRP1;UNC119B
11008,GO:0044872,0.107969114181487,0.985541490244244,2,6,lipoprotein localization,BP,LRP1;UNC119B
4489,GO:0010524,0.108259477683209,0.961725327124695,5,27,positive regulation of calcium ion transport into cytosol,BP,CEMIP;F2R;PKD2;NTSR1;GSTM2
12795,GO:0051126,0.1083060708289,0.985469295548021,2,6,negative regulation of actin nucleation,BP,ARPIN;CORO1B
12215,GO:0048505,0.108306315686328,0.985469243033738,2,6,regulation of timing of cell differentiation,BP,SERPINE2;HES1
5265,GO:0015925,0.108350243433783,0.985459820673691,2,6,galactosidase activity,MF,GLB1;NAGA
14052,GO:0060897,0.108359509366576,0.985457832848785,2,6,neural plate regionalization,BP,FUZ;CELSR2
674,GO:0001885,0.108483234357191,0.953275073971469,7,42,endothelial cell development,BP,PTPRS;RAPGEF3;WNT7A;ID1;S1PR2;TNFRSF1A;WNT7B
16366,GO:0097011,0.108486057977659,0.985430673431041,2,6,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,ZFP36;AKT1
16367,GO:0097012,0.108486057977659,0.985430673431041,2,6,response to granulocyte macrophage colony-stimulating factor,BP,ZFP36;AKT1
8184,GO:0032943,0.108568326422783,0.932136253048994,19,148,mononuclear cell proliferation,BP,IGF2;PKN1;ZP3;ERBB2;CD320;IL20RB;PRNP;BCL6;IGFBP2;CD81;CEBPB;HES1;ADA;VAV3;INPP5D;ICOSLG;PYCARD;JAK3;MIF
11529,GO:0046085,0.108578855737097,0.985410744612705,2,6,adenosine metabolic process,BP,NT5E;ADA
15776,GO:0072497,0.108869609752318,0.985348233026484,2,6,mesenchymal stem cell differentiation,BP,LTBP3;WNT3
4992,GO:0015144,0.108883921808405,0.967379713260082,4,19,carbohydrate transmembrane transporter activity,MF,SLC2A9;SLC2A3;AQP3;SLC2A1
4263,GO:0009629,0.109008209494643,0.985318396674142,2,6,response to gravity,BP,FOS;PTAFR
1586,GO:0004000,0.109087367508682,0.985301345431636,2,6,adenosine deaminase activity,MF,ADARB1;ADA
12246,GO:0048562,0.109198278554941,0.929980629342571,21,163,embryonic organ morphogenesis,BP,EPHB2;MDFI;NAGLU;HYAL1;PKD2;IFT140;FUZ;CELSR1;SPRY2;VANGL2;MAPK3;DVL1;HES1;SUFU;BCR;WDR60;SLITRK6;FGFR1;PROX1;ABR;RARG
19111,GO:1905114,0.10931488052491,0.917577004095236,49,428,cell surface receptor signaling pathway involved in cell-cell signaling,BP,APOE;CTNNBIP1;SHANK2;NFATC4;LRP1;NLGN2;MDFI;EGR1;ZMYND8;LRP5;PTPRU;FUZ;NPHP4;NTSR1;CSNK1E;WNT7A;CELSR1;GRK6;DLG4;WWTR1;IGFBP2;FZD8;VANGL2;FBXW4;AP2A2;SHANK3;CALCOCO1;S1PR2;DVL1;SSH1;CELSR2;LRRK1;BTRC;WNT7B;IGFBP4;PRKCZ;AGO4;PIN1;GRB10;WNT2B;SDC1;WNT3;AKT1;NDRG2;ARHGEF19;RARG;SHISA6;SULF2;LZTS2
6366,GO:0021561,0.109374190699801,0.985239495131509,2,6,facial nerve development,BP,ADARB1;SEMA3F
6389,GO:0021610,0.109374190699801,0.985239495131509,2,6,facial nerve morphogenesis,BP,ADARB1;SEMA3F
15169,GO:0071340,0.109441156992422,0.985225039599551,2,6,skeletal muscle acetylcholine-gated channel clustering,BP,ETV5;DVL1
3881,GO:0008525,0.109471348712635,0.985218520475801,2,6,phosphatidylcholine transporter activity,MF,ABCA7;PLTP
530,GO:0001649,0.109490590709459,0.932487184034938,18,137,osteoblast differentiation,BP,CTNNBIP1;MRC2;MEF2D;COL6A1;LRP5;PTHLH;SH3PXD2B;ID1;WWTR1;FAM20C;CEBPB;ACVR2B;IL6R;PRKACA;WNT7B;SUFU;WNT3;AKT1
11643,GO:0046434,0.109500537647681,0.928945274773413,22,174,organophosphate catabolic process,BP,NT5E;RAPGEF3;PGM1;XDH;OGDHL;NTSR1;INSR;DNPH1;PFKFB2;DHTKD1;ENTPD2;GALK1;MLXIPL;ADA;PFKL;NUDT10;LDLR;HK1;PPARA;IMPA2;GPD1L;NEIL1
1696,GO:0004177,0.109726729650751,0.956453671864017,6,34,aminopeptidase activity,MF,RNPEPL1;NPEPL1;BLMH;DPP7;LTA4H;CTSH
17769,GO:1901880,0.109760410947147,0.952587892705551,7,42,negative regulation of protein depolymerization,BP,GSN;TMOD2;PLEKHH2;SPTB;DMTN;CAPG;TWF2
13208,GO:0051899,0.109798780895487,0.9492901959421,8,51,membrane depolarization,BP,SCN8A;FHL1;ANK3;SCN4B;NTSR1;PRKCZ;TPCN1;GPD1L
16100,GO:0090128,0.109802010379887,0.985147047207803,2,6,regulation of synapse maturation,BP,ADGRL1;NFATC4
18320,GO:1903317,0.110199376941258,0.94906300847764,8,51,regulation of protein maturation,BP,GSN;SERPING1;SERPINE2;PRNP;CD81;F12;CTSZ;C5
14030,GO:0060836,0.11021664306091,0.985057228221053,2,6,lymphatic endothelial cell differentiation,BP,ACVR2B;PROX1
18208,GO:1903039,0.110255431325716,0.934141101039181,16,120,positive regulation of leukocyte cell-cell adhesion,BP,IGF2;ZP3;ZMIZ1;EFNB3;BCL6;IGFBP2;HES1;TNFRSF14;ADA;RAG1;PTAFR;PRKCZ;ICOSLG;AKT1;PYCARD;JAK3
2668,GO:0006029,0.110270722058243,0.946336583177283,9,58,proteoglycan metabolic process,BP,B3GAT3;HYAL1;HEXB;VANGL2;XYLT2;GPC1;GAL3ST4;NDST2;SULF2
1447,GO:0003680,0.110366711377856,0.985024666468947,2,6,AT DNA binding,MF,H1F0;HMGA2
18804,GO:1904415,0.110549998248608,0.984984858416067,2,6,regulation of xenophagy,BP,MAPK3;LRSAM1
18805,GO:1904417,0.110549998248608,0.984984858416067,2,6,positive regulation of xenophagy,BP,MAPK3;LRSAM1
3243,GO:0006910,0.110588055896407,0.984976587365863,2,6,phagocytosis, recognition,BP,TUB;PEAR1
5469,GO:0016413,0.11067014746299,0.984958740224024,2,6,O-acetyltransferase activity,MF,CRAT;LPCAT4
13968,GO:0060710,0.11076881777556,0.984937277526353,2,6,chorio-allantoic fusion,BP,ZFP36L1;WNT7B
909,GO:0002295,0.110857072502343,0.984918070017112,2,6,T-helper cell lineage commitment,BP,ZFPM1;STAT6
10462,GO:0043373,0.110857072502343,0.984918070017112,2,6,CD4-positive, alpha-beta T cell lineage commitment,BP,ZFPM1;STAT6
5203,GO:0015812,0.110884402604108,0.98491211997932,2,6,gamma-aminobutyric acid transport,BP,NTSR1;APBA1
10051,GO:0042562,0.111029409241127,0.951822827738016,7,43,hormone binding,MF,EGFR;SHC1;THRA;VIPR1;INSR;CTSH;GIPR
6980,GO:0030672,0.11103892211338,0.948586191321014,8,51,synaptic vesicle membrane,CC,PTPRS;SYT8;DBNDD1;VAMP2;MCTP1;RAB3B;PI4K2A;SEMA4C
17005,GO:0099501,0.11103892211338,0.948586191321014,8,51,exocytic vesicle membrane,CC,PTPRS;SYT8;DBNDD1;VAMP2;MCTP1;RAB3B;PI4K2A;SEMA4C
16794,GO:0098703,0.111051548765091,0.984875710089361,2,6,calcium ion import across plasma membrane,BP,ATP2B4;PRNP
18047,GO:1902656,0.111051548765091,0.984875710089361,2,6,calcium ion import into cytosol,BP,ATP2B4;PRNP
16230,GO:0090313,0.111103632014316,0.960404594026227,5,27,regulation of protein targeting to membrane,BP,CEMIP;ANK3;ERBB2;PRNP;DMTN
19126,GO:1905165,0.111218446672396,0.98483931914009,2,6,regulation of lysosomal protein catabolic process,BP,LRP1;LDLR
1792,GO:0004430,0.111243014924787,0.984833959236356,2,6,1-phosphatidylinositol 4-kinase activity,MF,PI4K2A;PI4KAP2
14318,GO:0061549,0.111479584416678,0.984782309416359,2,6,sympathetic ganglion development,BP,NRP2;SEMA3F
16156,GO:0090205,0.111488032437481,0.984780463670428,2,6,positive regulation of cholesterol metabolic process,BP,ABCG1;LDLRAP1
3828,GO:0008443,0.111514033242453,0.98477478238171,2,6,phosphofructokinase activity,MF,PFKFB2;PFKL
17732,GO:1901725,0.111516942458418,0.984774146652424,2,6,regulation of histone deacetylase activity,BP,VEGFA;PINK1
20256,GO:2001258,0.111519130981734,0.966084961510981,4,20,negative regulation of cation channel activity,BP,EPHB2;ANK3;PKD2;GSTM2
6829,GO:0030306,0.111520948152695,0.984773271300478,2,6,ADP-ribosylation factor binding,MF,RAB11FIP4;SORL1
13983,GO:0060732,0.111520948152695,0.984773271300478,2,6,positive regulation of inositol phosphate biosynthetic process,BP,NTSR1;PTAFR
15668,GO:0072224,0.111520948152701,0.984773271300472,2,6,metanephric glomerulus development,BP,EGR1;LAMB2
7244,GO:0031223,0.111520948152702,0.984773271300471,2,6,auditory behavior,BP,SHANK3;SLITRK6
11141,GO:0045217,0.111520948152707,0.984773271300465,2,6,cell-cell junction maintenance,BP,NLGN2;F2R
7965,GO:0032591,0.111520948152783,0.984773271300478,2,6,dendritic spine membrane,CC,DDN;SHISA6
6678,GO:0030056,0.111520948152783,0.984773271300478,2,6,hemidesmosome,CC,ITGB4;ITGA6
12793,GO:0051124,0.111520948152783,0.984773271300477,2,6,synaptic growth at neuromuscular junction,BP,SHANK2;SHANK3
7194,GO:0031095,0.111520948152795,0.984773271300465,2,6,platelet dense tubular network membrane,CC,ITPR3;DMTN
474,GO:0001518,0.111520948152796,0.984773271300464,2,6,voltage-gated sodium channel complex,CC,SCN8A;SCN4B
929,GO:0002327,0.111520948152796,0.984773271300464,2,6,immature B cell differentiation,BP,LRRC8A;RAG1
13582,GO:0060080,0.111520948152796,0.984773271300464,2,6,inhibitory postsynaptic potential,BP,NLGN2;NTSR1
16441,GO:0097151,0.111520948152796,0.984773271300464,2,6,positive regulation of inhibitory postsynaptic potential,BP,NLGN2;NTSR1
16858,GO:0098828,0.111520948152796,0.984773271300464,2,6,modulation of inhibitory postsynaptic potential,BP,NLGN2;NTSR1
19914,GO:2000482,0.112066529384623,0.973624202469691,3,13,regulation of interleukin-8 secretion,BP,F2R;MAPKBP1;PYCARD
14909,GO:0070821,0.112203036636492,0.951186437937151,7,43,tertiary granule membrane,CC,GAA;NBEAL2;KCNAB2;SLC2A3;PTAFR;SERPINB6;HGSNAT
12852,GO:0051208,0.112260549222289,0.942652163241347,10,68,sequestering of calcium ion,BP,CEMIP;NOS1;F2R;PKD2;ITPR3;NTSR1;ATP7B;PRKACA;TPCN1;GSTM2
5060,GO:0015293,0.112652527451023,0.940332885857806,11,75,symporter activity,MF,SLC16A5;SLC16A3;SLC2A9;SLC13A3;SLC6A8;SLC20A1;SLC12A7;SLC22A18;SLC16A13;SLC28A2;SLC5A5
13335,GO:0052548,0.112795460039396,0.920932623920005,31,266,regulation of endopeptidase activity,BP,CST3;GSN;XDH;PRDX5;TIMP2;SERPING1;F2R;GRAMD4;SERPINE2;PAPLN;VEGFA;TNFRSF6B;FURIN;MEFV;PIDD1;CYFIP2;DAP;RAG1;GAS6;C5;BIN1;SERPINB6;CSTB;TIMP1;PPM1F;SORL1;AKT1;CTSH;PYCARD;PCSK1N;FAM162A
10863,GO:0044420,0.112907644146539,0.938251784513554,12,84,extracellular matrix component,CC,CST3;LTBP1;SMOC2;LOXL1;LAMA5;FBLN1;THSD4;TNXB;LAMB2;ITGA6;ENTPD2;TIMP1
6885,GO:0030431,0.113170174222881,0.973249076187524,3,13,sleep,BP,FOS;CST3;ADA
2196,GO:0005080,0.113688345408831,0.954332371129661,6,35,protein kinase C binding,MF,PKN1;HDAC5;ADCY6;TRPV4;TWF2;AKT1
3187,GO:0006821,0.113865951369144,0.950281535584194,7,43,chloride transport,BP,CLCA2;ANO8;PRNP;SLC12A7;TTYH3;PTAFR;ANO9
9865,GO:0042157,0.1139268155167,0.930395197884038,17,131,lipoprotein metabolic process,BP,APOE;LRP1;ZDHHC1;WIPI2;LY6K;PCSK9;MDGA1;LDLR;LYPLAL1;ABHD17C;PIGZ;MSLN;PPARA;ZDHHC24;LCAT;PIGV;PIGQ
9433,GO:0036038,0.115034325477952,0.972611447288204,3,13,MKS complex,CC,TCTN1;TMEM107;TMEM231
11108,GO:0045165,0.115199978089396,0.930752449112201,16,119,cell fate commitment,BP,DUSP6;EPAS1;SOX12;ZFPM1;WNT7A;SH3PXD2B;SPRY2;STAT6;CEBPB;HES1;WNT7B;SUFU;FGFR1;PROX1;WNT2B;WNT3
5723,GO:0016879,0.115517310435962,0.949379232288609,7,43,ligase activity, forming carbon-nitrogen bonds,MF,NAPRT;GLUL;HLCS;ASS1;GSS;PPCS;TTLL11
8843,GO:0034656,0.115766806209906,0.953161695025194,6,36,nucleobase-containing small molecule catabolic process,BP,NT5E;ENTPD6;ENTPD2;ADA;APOBEC3C;APOBEC3F
8227,GO:0033013,0.115797277470611,0.949146306303089,7,44,tetrapyrrole metabolic process,BP,PRSS3;UROS;CD320;AMN;BLVRB;ABCD4;RSAD1
5839,GO:0017145,0.115832738468583,0.958182715749224,5,27,stem cell division,BP,WNT7A;WWTR1;VANGL2;ETV5;FGFR1
2765,GO:0006195,0.115980501154848,0.953051415997249,6,36,purine nucleotide catabolic process,BP,NT5E;RAPGEF3;XDH;DNPH1;ADA;NUDT10
6375,GO:0021575,0.116016051447346,0.958095946798164,5,27,hindbrain morphogenesis,BP,SERPINE2;WNT7A;HES1;PROX1;TRNP1
710,GO:0001936,0.11619303933629,0.938020599596665,11,77,regulation of endothelial cell proliferation,BP,APOE;XDH;PGF;PLXNB3;ECM1;VEGFA;NRP2;FGFR1;PROX1;VEGFB;AKT1
1101,GO:0002690,0.116298749393852,0.948871019086156,7,44,positive regulation of leukocyte chemotaxis,BP,PGF;VEGFA;MAPK3;IL6R;TRPV4;GAS6;VEGFB
2507,GO:0005766,0.116313747319061,0.929919921138263,16,122,primary lysosome,CC,GAA;NAPRT;PYGB;FUCA1;VAT1;HEXB;GM2A;RAB3D;RNASET2;DPP7;GLB1;TOLLIP;CD68;PYCARD;GALNS;STXBP2
10064,GO:0042582,0.116313747319061,0.929919921138263,16,122,azurophil granule,CC,GAA;NAPRT;PYGB;FUCA1;VAT1;HEXB;GM2A;RAB3D;RNASET2;DPP7;GLB1;TOLLIP;CD68;PYCARD;GALNS;STXBP2
19391,GO:1990000,0.116316545686671,0.972169955854357,3,13,amyloid fibril formation,BP,APOE;GSN;LDLR
5150,GO:0015698,0.116487695484647,0.935903687323241,12,85,inorganic anion transport,BP,CLCA2;ANO8;SLC20A1;PRNP;SLC12A7;TTYH3;LRRC8A;SLC37A2;PTAFR;FGFR1;ANO9;SLC5A5
7726,GO:0032233,0.116795898282243,0.948678102900851,7,43,positive regulation of actin filament bundle assembly,BP,RAPGEF3;SH3PXD2B;ID1;EPHA1;FHOD1;PPM1F;ARHGEF10L
6068,GO:0019229,0.116798430516841,0.957725081781279,5,27,regulation of vasoconstriction,BP,EGFR;F2R;DOCK4;PTAFR;AKT1
6342,GO:0021532,0.117101260479413,0.957581301126594,5,27,neural tube patterning,BP,TCTN1;IFT140;TMEM107;HES1;SUFU
11837,GO:0046849,0.11712763813607,0.945100428278623,8,51,bone remodeling,BP,EGFR;LRP5;ACP5;RAB3D;LRRK1;INPP5D;TPP1;P3H4
4846,GO:0014068,0.117439160171565,0.952402078356974,6,35,positive regulation of phosphatidylinositol 3-kinase signaling,BP,IGF2;RGL2;F2R;PLXNB1;FGFR1;ERBB3
5351,GO:0016137,0.117582284327412,0.971731822258789,3,13,glycoside metabolic process,BP,FUCA1;AKR7A2;NAGA
11622,GO:0046364,0.118226435692779,0.941494448796246,9,60,monosaccharide biosynthetic process,BP,PGM1;NR1D1;TALDO1;PC;DGKQ;PPARA;PCK2;MDH2;PDK2
616,GO:0001786,0.118239471212443,0.957039732609084,5,27,phosphatidylserine binding,MF,PLCD1;OSBPL5;GAS6;GSDMC;GSDMA
7254,GO:0031234,0.118449533234696,0.938838533524892,10,68,extrinsic component of cytoplasmic side of plasma membrane,CC,MYZAP;PTK6;GNAL;S100A6;SNX9;DLG4;SRMS;KCNAB2;ESYT2;JAK3
5744,GO:0016903,0.118943208175369,0.951622613320365,6,35,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,XDH;ALDH4A1;OGDHL;DHTKD1;ALDH16A1;BCKDHA
7056,GO:0030855,0.11895874800504,0.909666980739695,49,434,epithelial cell differentiation,BP,PPL;PTPRS;CST3;RAPGEF3;CYP27B1;XDH;ZFP36L1;ALOX15B;PTK6;LAMA5;ACTA2;PRSS8;CTSB;THRA;TST;LAMB2;WNT7A;LCE1E;ID1;DNPH1;WWTR1;RAB25;FAM20C;VEGFA;CEBPB;ACVR2B;S1PR2;HES1;FURIN;AQP3;ZFP36;TNFRSF1A;WNT7B;RXRA;PCK2;SLITRK6;TPP1;FGFR1;PROX1;BFSP1;TOLLIP;TMEM231;SDC1;AKT1;RILPL1;RARG;EREG;KRT15;ADAMTSL4
16613,GO:0097502,0.119024103870882,0.956516542421159,5,28,mannosylation,BP,B4GAT1;PIGZ;PIGV;POMT1;ALG12
12590,GO:0050798,0.11908625473529,0.95648675956408,5,28,activated T cell proliferation,BP,IGF2;PRNP;IGFBP2;ICOSLG;PYCARD
539,GO:0001658,0.119124973114816,0.951528205499062,6,35,branching involved in ureteric bud morphogenesis,BP,CTNNBIP1;PGF;LAMA5;PKD2;VEGFA;WNT2B
678,GO:0001889,0.119207131031664,0.930727996724808,14,103,liver development,BP,EGFR;PKD2;CEBPB;HES1;ADA;PCSK9;HMGCL;PCK2;SRSF5;PROX1;JARID2;PKD1;RARG;SULF2
1201,GO:0002861,0.119417448382399,0.982163520296482,2,7,regulation of inflammatory response to antigenic stimulus,BP,ZP3;IL20RB
7395,GO:0031489,0.119418187675238,0.971092252628408,3,13,myosin V binding,MF,RAB3D;RAB25;RAB3B
11229,GO:0045453,0.119449775364014,0.951359392822952,6,35,bone resorption,BP,EGFR;ACP5;RAB3D;LRRK1;INPP5D;TPP1
3412,GO:0007205,0.119592412269601,0.962700110541981,4,20,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,LRP1;F2R;DGKA;DGKQ
2292,GO:0005262,0.119783684872963,0.943564821262869,8,51,calcium channel activity,MF,PKD2;ITPR3;TRPV4;GAS6;TPCN1;PKD1;ORAI3;ORAI2
6754,GO:0030199,0.119878354316119,0.956256741396462,5,27,collagen fibril organization,BP,LOXL1;TNXB;CHADL;VPS33B;P3H4
2203,GO:0005092,0.119890687083813,0.970926871187969,3,13,GDP-dissociation inhibitor activity,MF,GPSM1;SESN2;RGS14
632,GO:0001822,0.120276848613041,0.920222964865489,23,183,kidney development,BP,CTNNBIP1;PGF;EGR1;LAMA5;ACTA2;PKD2;LAMB2;WWTR1;VEGFA;VANGL2;ACVR2B;HES1;PCSK9;WNT7B;FGFR1;PROX1;WNT2B;SDC1;PKD1;CTSH;SULF2;KIF26B;LZTS2
2713,GO:0006099,0.120278684692725,0.955914295425063,5,28,tricarboxylic acid cycle,BP,IDH2;OGDHL;DHTKD1;SDHA;MDH2
8052,GO:0032733,0.120463364462776,0.970726000303432,3,13,positive regulation of interleukin-10 production,BP,IL20RB;PRKCZ;PYCARD
2775,GO:0006213,0.120646176559581,0.950526200872711,6,37,pyrimidine nucleoside metabolic process,BP,NT5E;NME4;UCKL1;TK2;APOBEC3C;APOBEC3F
13691,GO:0060284,0.120756660002999,0.904950573918245,64,571,regulation of cell development,BP,APOE;IDH2;PTPRS;SEMA4B;SHANK2;NOS1;POSTN;EPHB2;CNTN1;NFATC4;LRP1;OBSL1;TIMP2;CRTC1;PTK6;ULK2;GJC2;ZMYND8;FBLN1;PLXNB3;KIF13B;SERPINE2;CSNK1E;WNT7A;FBXW8;ID1;SYNGAP1;LPAR3;EFNB3;DLG4;BCL6;PLXNB1;VEGFA;SHANK3;S1PR2;ETV5;DVL1;ADCY6;EPHB3;HES1;SSH1;CUL7;DGUOK;DMTN;TNFRSF1A;SEMA3B;LDLR;TRPV4;EEF2K;SEMA3F;SEMA4C;TWF2;FGFR1;CTSZ;PIN1;PROX1;BIN1;RTN4R;WNT3;SORL1;AKT1;SSH3;RGS14;SEMA4F
6584,GO:0022612,0.120911551436049,0.933021946373497,12,85,gland morphogenesis,BP,EGFR;LAMA5;LRP5;STAT6;CEBPB;ETV5;BTRC;RXRA;FGFR1;PROX1;RARG;SULF2
12084,GO:0048146,0.120912156414748,0.950489007197673,6,36,positive regulation of fibroblast proliferation,BP,EGFR;S100A6;ZMIZ1;GAS6;EREG;MIF
8026,GO:0032688,0.12094451397815,0.97055687333579,3,13,negative regulation of interferon-beta production,BP,PTPRS;NLRX1;PYCARD
4303,GO:0009790,0.121552396466626,0.902665333751425,74,667,embryo development,BP,DUSP6;ERCC1;ZFP36L1;COL6A1;TCTN1;EPHB2;EPAS1;IGF2;EGFR;DUSP5;MDFI;NAGLU;DEAF1;LAMA5;ZP3;LRP5;HYAL1;ZFPM1;TFEB;PKD2;ITGB4;PHLDA2;SALL2;IFT140;FUZ;PLCD1;WNT7A;ZMIZ1;INSR;FBXW8;CELSR1;DNMT3A;SPRY2;DLG4;PLCD3;TMEM107;VEGFA;VANGL2;FBXW4;CEBPB;ACVR2B;ENDOG;MAPK3;DVL1;HES1;ADA;ITGB5;MYH3;HMGA2;SEMA3F;SEMA4C;WNT7B;SUFU;RXRA;BCR;WDR60;SLITRK6;FGFR1;C5;PROX1;DLG3;PPP1R13L;CAPN2;WNT2B;TMEM231;SH2B3;WNT3;ACVR1B;ABR;AKT1;PKD1;APBA1;RARG;SULF2
3884,GO:0008528,0.121755251369038,0.955202669193333,5,28,G-protein coupled peptide receptor activity,MF,LTB4R;F2R;SIGMAR1;LTB4R2;NTSR1
8006,GO:0032651,0.122097089927198,0.949868409638318,6,36,regulation of interleukin-1 beta production,BP,EGR1;F2R;ACP5;MEFV;HK1;PYCARD
5454,GO:0016358,0.122131765854053,0.920516754968991,21,165,dendrite development,BP,APOE;PTPRS;SHANK2;EPHB2;NFATC4;OBSL1;CRTC1;IGSF9;ZMYND8;MINK1;WNT7A;FBXW8;ID1;SYNGAP1;DLG4;SHANK3;DVL1;EPHB3;CUL7;CELSR2;EEF2K
1908,GO:0004602,0.122229345842553,0.969445234655424,3,15,glutathione peroxidase activity,MF,GPX3;GSTT1;GSTM2
5789,GO:0017049,0.122381503246587,0.961508929812382,4,20,GTP-Rho binding,MF,PKN1;PKN3;CDC42EP5;WHAMMP3
15972,GO:0086010,0.122613363630323,0.961409407485354,4,20,membrane depolarization during action potential,BP,SCN8A;ANK3;SCN4B;TPCN1
7559,GO:0031932,0.122772001886565,0.969911511063123,3,13,TORC2 complex,CC,SESN2;PINK1;MLST8
2725,GO:0006112,0.123292633988391,0.938435358614599,9,60,energy reserve metabolic process,BP,GAA;PYGB;PGM1;NR1D1;IGF2;PYGL;PHLDA2;INSR;AKT1
3301,GO:0007009,0.12354801418234,0.938280322304471,9,60,plasma membrane organization,BP,GSN;NDRG1;ANK3;SNX33;SNX9;AHNAK2;EPB41L3;ANO9;AKT1
2709,GO:0006094,0.123565745914111,0.941294205859842,8,52,gluconeogenesis,BP,PGM1;NR1D1;PC;DGKQ;PPARA;PCK2;MDH2;PDK2
6420,GO:0021696,0.123663888741631,0.96095753269411,4,20,cerebellar cortex morphogenesis,BP,SERPINE2;WNT7A;PROX1;TRNP1
5675,GO:0016801,0.123695577086113,0.96958356299443,3,13,hydrolase activity, acting on ether bonds,MF,AKR7A2;LTA4H;AHCYL2
2638,GO:0005980,0.124042997043111,0.96079407928059,4,20,glycogen catabolic process,BP,GAA;PYGB;PGM1;PYGL
4168,GO:0009251,0.124042997043111,0.96079407928059,4,20,glucan catabolic process,BP,GAA;PYGB;PGM1;PYGL
11581,GO:0046209,0.124361083394822,0.944399553531612,7,44,nitric oxide metabolic process,BP,NOS1;PKD2;ATP2B4;ACP5;INSR;ASS1;AKT1
10586,GO:0043583,0.124370923539644,0.92570297533805,15,112,ear development,BP,EPHB2;NAGLU;CELSR1;SPRY2;VANGL2;MAPK3;DVL1;HES1;LRP10;BCR;SLITRK6;FGFR1;PROX1;SLC25A27;ABR
9351,GO:0035886,0.124465804084867,0.969309147708179,3,13,vascular smooth muscle cell differentiation,BP,PDCD4;VEGFA;HES1
7192,GO:0031093,0.124644268283782,0.948527960830114,6,36,platelet alpha granule lumen,CC,IGF2;SERPING1;VEGFA;GAS6;TIMP1;VEGFB
12494,GO:0050660,0.124905081789519,0.93745514647344,9,60,flavin adenine dinucleotide binding,MF,XDH;PRODH;NOS1;MTHFR;D2HGDH;TXNRD3;ACAD10;SDHA;ACADS
3431,GO:0007229,0.124935554417375,0.937436591770516,9,60,integrin-mediated signaling pathway,BP,LAMA5;ITGB4;ITGA6;ADAM15;ITGB5;DMTN;VAV3;ADAMTS13;TIMP1
11152,GO:0045239,0.124974904737746,0.969127308213943,3,13,tricarboxylic acid cycle enzyme complex,CC,OGDHL;DHTKD1;BCKDHA
7029,GO:0030814,0.125172343173228,0.95354421562319,5,28,regulation of cAMP metabolic process,BP,RAPGEF3;TIMP2;PKD2;PTHLH;LTB4R2
17928,GO:1902307,0.125394094937496,0.968977309559317,3,13,positive regulation of sodium ion transmembrane transport,BP,NOS1;ANK3;GLRX
827,GO:0002115,0.12547376573822,0.968948773111003,3,13,store-operated calcium entry,BP,HOMER2;ORAI3;ORAI2
2282,GO:0005245,0.125478602111529,0.968947040534652,3,13,voltage-gated calcium channel activity,MF,PKD2;GAS6;TPCN1
14663,GO:0070306,0.125605180073156,0.960118403644202,4,20,lens fiber cell differentiation,BP,WNT7A;WNT7B;PROX1;BFSP1
8580,GO:0034101,0.125674230969267,0.929825435665526,12,87,erythrocyte homeostasis,BP,ZFP36L1;FAM210B;EPAS1;THRA;ZFPM1;BCL6;VEGFA;ZFP36;DMTN;INPP5D;ACVR1B;JAK3
13785,GO:0060402,0.1258526859833,0.931801248471216,11,78,calcium ion transport into cytosol,BP,CEMIP;NOS1;F2R;PKD2;ITPR3;NTSR1;ATP2B4;PRNP;PRKACA;TPCN1;GSTM2
13439,GO:0055001,0.125912145570178,0.929702760342649,12,86,muscle cell development,BP,FLNC;OBSCN;NFATC4;OBSL1;TMOD2;VEGFA;TNNT1;HES1;MYH3;PIN1;PROX1;SDC1
795,GO:0002065,0.125927985798083,0.934121357407936,10,69,columnar/cuboidal epithelial cell differentiation,BP,PTK6;FAM20C;CEBPB;HES1;RXRA;SLITRK6;FGFR1;PROX1;TMEM231;RARG
4940,GO:0015012,0.125956598997382,0.959965935158147,4,20,heparan sulfate proteoglycan biosynthetic process,BP,B3GAT3;VANGL2;XYLT2;NDST2
6187,GO:0019673,0.125969858575951,0.980568621546307,2,7,GDP-mannose metabolic process,BP,GUK1;TSTA3
8418,GO:0033549,0.12597837788162,0.968767824741344,3,13,MAP kinase phosphatase activity,MF,DUSP6;DUSP5;DUSP7
11309,GO:0045655,0.126008591857694,0.968756979021858,3,13,regulation of monocyte differentiation,BP,CTNNBIP1;ZFP36L1;INPP5D
3679,GO:0008191,0.126037706407157,0.9805518190197,2,7,metalloendopeptidase inhibitor activity,MF,TIMP2;TIMP1
3894,GO:0008543,0.126345460396009,0.929382331233974,12,87,fibroblast growth factor receptor signaling pathway,BP,DUSP6;SPRY4;FUZ;SPRY2;FAM20C;MAPK3;FGFR3;FGFR4;GPC1;FGFR1;FGFBP1;SULF2
4100,GO:0009164,0.126417705830306,0.959539406162956,4,21,nucleoside catabolic process,BP,NT5E;ADA;APOBEC3C;APOBEC3F
15100,GO:0071219,0.126420874230903,0.925765993854049,14,105,cellular response to molecule of bacterial origin,BP,TNIP1;NR1D1;HDAC5;PDCD4;CEBPB;MAPK3;ZFP36;PTAFR;BCR;ADAMTS13;AKT1;PYCARD;LITAF;MIF
17077,GO:0099738,0.126482490150657,0.952904083380574,5,28,cell cortex region,CC,PKD2;RIMS3;GM2A;PRKCZ;CTSZ
10938,GO:0044703,0.126519836560488,0.90063924503839,61,549,multi-organism reproductive process,BP,FOS;ERCC1;CST3;TCFL5;CYP27B1;PGF;MST1R;GAMT;SYT8;DEAF1;BBS2;CTSB;DNAH1;THRA;ZP3;CRTAP;FBLN1;BSG;SCMH1;PTHLH;CD9;HEXB;SERPINE2;ATP2B4;GGT1;ZMIZ1;SH3PXD2B;TXNRD3;DNMT3A;MYCBPAP;PHC2;BCL6;IGFBP2;ZSCAN2;ETV5;ADA;PRKACA;SPATA20;VGF;COMT;PTAFR;DMC1;RXRA;AGO4;TIMP1;WNT3;ZFP41;MICALCL;SBF1;ACVR1B;AKT1;SIX5;TDRKH;SUN1;RPL39L;SPIRE2;RFX2;SLC2A1;EREG;SHISA6;FAM50A
5693,GO:0016831,0.126568505381772,0.95286197446499,5,28,carboxy-lyase activity,MF,GLUL;MVD;PCK2;MLYCD;BCKDHA
6113,GO:0019370,0.12714560204719,0.98027661664194,2,7,leukotriene biosynthetic process,BP,GGT1;LTA4H
6767,GO:0030214,0.127552067271702,0.968201228854892,3,13,hyaluronan catabolic process,BP,CEMIP;HYAL1;HEXB
12461,GO:0050435,0.127596883401417,0.952357747432015,5,28,amyloid-beta metabolic process,BP,APOE;ABCA7;PRNP;BIN1;SORL1
709,GO:0001935,0.127835548947537,0.928396896840229,12,87,endothelial cell proliferation,BP,APOE;XDH;PGF;PLXNB3;ECM1;VEGFA;NRP2;FGFR1;PROX1;VEGFB;AKT1;ERN1
13481,GO:0055078,0.127863579951362,0.968088660831552,3,13,sodium ion homeostasis,BP,ATP12A;SCNN1A;COMT
11457,GO:0045936,0.127937147146628,0.902000672608772,50,441,negative regulation of phosphate metabolic process,BP,TNIP1;DUSP6;APOE;XDH;EPHB2;DUSP5;PPP1R14A;PKN1;PTK6;PIK3R2;LRP5;FBLN1;SPRY4;CDKN1C;LTB4R2;PDCD4;EPHA1;ADARB1;PPP1R35;PRNP;SPRY2;WWTR1;DVL1;MLXIPL;LRRK1;DMTN;MAPK8IP1;DUSP7;DGKQ;PPARA;PRKCZ;PIN1;DLG3;GRB10;RTN4R;ELFN2;PPM1F;SORL1;STK39;AKT1;NDRG2;GPD1L;PINK1;RGS14;PCIF1;CBLC;PYCARD;RANBP9;SIRT3;SFI1
12845,GO:0051194,0.128927887508734,0.967703043326149,3,13,positive regulation of cofactor metabolic process,BP,INSR;PFKFB2;MLXIPL
1549,GO:0003951,0.128983052573306,0.96768301307596,3,13,NAD+ kinase activity,MF,DGKA;NADK;DGKQ
2777,GO:0006216,0.1290867676484,0.979790654989035,2,7,cytidine catabolic process,BP,APOBEC3C;APOBEC3F
4356,GO:0009972,0.1290867676484,0.979790654989035,2,7,cytidine deamination,BP,APOBEC3C;APOBEC3F
11531,GO:0046087,0.1290867676484,0.979790654989035,2,7,cytidine metabolic process,BP,APOBEC3C;APOBEC3F
1876,GO:0004559,0.129095771673035,0.967642071994377,3,13,alpha-mannosidase activity,MF,EDEM1;MAN1B1;MAN2B2
19836,GO:2000343,0.129139408896181,0.979777409669154,2,7,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,POSTN;MIF
16130,GO:0090177,0.129205602767461,0.967602162888269,3,13,establishment of planar polarity involved in neural tube closure,BP,CELSR1;VANGL2;DVL1
16131,GO:0090178,0.129205602767461,0.967602162888269,3,13,regulation of establishment of planar polarity involved in neural tube closure,BP,CELSR1;VANGL2;DVL1
13745,GO:0060351,0.129284629261203,0.967573436819078,3,13,cartilage development involved in endochondral bone morphogenesis,BP,THBS3;TRPV4;RARG
18539,GO:1903792,0.129414301977688,0.967526282089252,3,13,negative regulation of anion transport,BP,STK39;ANO9;AKT1
16478,GO:0097205,0.129659371334932,0.967437100272958,3,13,renal filtration,BP,F2R;GAS6;SULF2
11488,GO:0045995,0.129668074072861,0.927216992037542,12,86,regulation of embryonic development,BP,DUSP6;LAMA5;PHLDA2;FUZ;INSR;CELSR1;VANGL2;DVL1;HES1;SUFU;FGFR1;WNT2B
7926,GO:0032526,0.129919150726276,0.931553385319751,10,70,response to retinoic acid,BP,PTK6;IGFBP2;AQP3;WNT7B;RXRA;TWF2;TMEM161A;WNT3;CTSH;RARG
3873,GO:0008514,0.130003973291833,0.919033595036426,17,130,organic anion transmembrane transporter activity,MF,SLCO4A1;SLC43A1;SLC16A5;SLC16A3;SLC2A9;SLC13A3;BSG;SLC7A8;SLC6A8;SERINC2;SLC16A13;SLC2A3;SLC38A10;SLC25A29;SLC22A17;SLC2A1;PQLC2
11300,GO:0045646,0.130111553212315,0.945621694272826,6,36,regulation of erythrocyte differentiation,BP,ZFP36L1;FAM210B;ZFPM1;ZFP36;INPP5D;ACVR1B
19370,GO:1905906,0.130716547923077,0.979378943982819,2,7,regulation of amyloid fibril formation,BP,APOE;LDLR
1689,GO:0004167,0.130870351653034,0.995416913040835,1,2,dopachrome isomerase activity,MF,MIF
5713,GO:0016862,0.130870351653034,0.995416913040835,1,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,MIF
12427,GO:0050178,0.130870351653034,0.995416913040835,1,2,phenylpyruvate tautomerase activity,MF,MIF
4503,GO:0010563,0.131433791366036,0.899094511706038,50,442,negative regulation of phosphorus metabolic process,BP,TNIP1;DUSP6;APOE;XDH;EPHB2;DUSP5;PPP1R14A;PKN1;PTK6;PIK3R2;LRP5;FBLN1;SPRY4;CDKN1C;LTB4R2;PDCD4;EPHA1;ADARB1;PPP1R35;PRNP;SPRY2;WWTR1;DVL1;MLXIPL;LRRK1;DMTN;MAPK8IP1;DUSP7;DGKQ;PPARA;PRKCZ;PIN1;DLG3;GRB10;RTN4R;ELFN2;PPM1F;SORL1;STK39;AKT1;NDRG2;GPD1L;PINK1;RGS14;PCIF1;CBLC;PYCARD;RANBP9;SIRT3;SFI1
6191,GO:0019682,0.131474442204418,0.957312030597814,4,21,glyceraldehyde-3-phosphate metabolic process,BP,H6PD;PGLS;TALDO1;TKFC
10879,GO:0044441,0.131670379939943,0.905685679199322,32,271,ciliary part,CC,SHANK2;TCTN1;BBS2;DNAH1;MARK4;PKD2;IFT140;NPHP4;ATP2B4;TMEM107;SHANK3;FBF1;EVC;PRKACA;SCNN1A;BBS1;CROCC;HK1;SUFU;WDR60;SPATA7;CDHR1;C21ORF2;UNC119B;WRAP73;TMEM231;GUCA1B;AKT1;GAS8;PKD1;EHD3;RILPL1
8545,GO:0033993,0.132048908561815,0.895367276386309,64,580,response to lipid,BP,TNIP1;FOS;CST3;CYP27B1;NOS1;ZFP36L1;POSTN;NR1D1;FAM210B;NFATC4;EGFR;LOXL1;F2R;PTK6;ABCG1;HDAC5;THRA;PTPRU;NTSR1;ACP5;PDCD4;TNFRSF25;WNT7A;DNMT3A;IGFBP2;CEBPB;CALCOCO1;ENDOG;TNFRSF6B;MAPK3;GLB1;ADCY6;ABCA2;TNFRSF14;AQP3;SLIT3;ZFP36;PMVK;TNFRSF1A;LDLR;PPARA;HMGCL;WNT7B;COMT;PTAFR;RXRA;PCK2;BCR;ADAMTS13;TWF2;MAPKAPK3;WBP2;TMEM161A;RXRB;SDC1;WNT3;ABR;AKT1;CTSH;PYCARD;LITAF;RARG;GIPR;MIF
15189,GO:0071364,0.132099657421661,0.944555137212281,6,36,cellular response to epidermal growth factor stimulus,BP,ZFP36L1;EGFR;ERBB2;ID1;ZFP36;AKT1
3570,GO:0007622,0.132317747086089,0.956937118969852,4,21,rhythmic behavior,BP,CST3;NAGLU;MTA1;ADA
12217,GO:0048512,0.132317747086089,0.956937118969852,4,21,circadian behavior,BP,CST3;NAGLU;MTA1;ADA
9998,GO:0042445,0.132371228093717,0.920056995454988,15,115,hormone metabolic process,BP,CYP27B1;EGR1;DHRS11;SRD5A3;FURIN;RETSAT;DGKQ;COMT;PCSK1;FGFR1;CTSZ;PNPLA4;SLC5A5;TRERF1;PCSK1N
19749,GO:2000194,0.132445302019407,0.978938544705601,2,7,regulation of female gonad development,BP,ZP3;INSR
13583,GO:0060081,0.132516636315719,0.978920290934158,2,7,membrane hyperpolarization,BP,CRTC1;PRKCZ
18142,GO:1902931,0.132562081710079,0.978908658526347,2,7,negative regulation of alcohol biosynthetic process,BP,APOE;CYP27B1
2567,GO:0005859,0.132632835444979,0.978890542874912,2,7,muscle myosin complex,CC,OBSL1;MYH3
12799,GO:0051130,0.132868555511248,0.890044236366971,97,903,positive regulation of cellular component organization,BP,ADGRL1;APOE;ESPN;TSPAN1;ERCC1;SHANK2;RAPGEF3;GSN;NOS1;ARAP1;EPHB2;CNTN1;IGF2;LRP1;OBSL1;NLGN2;DDB2;ULK1;CRTC1;ARPIN;PTK6;ABCA7;CORO1B;ZMYND8;MMP1;LRP5;HYAL1;TENM2;MICALL2;PLXNB3;VPS11;FUZ;NPHP4;TFDP2;WNT7A;INSR;SH3PXD2B;FBXW8;ID1;EPHA1;LPAR3;SNX9;DLG4;MYO18A;BCL6;PLXNB1;BNIP3;VEGFA;ARL2;SHANK3;ENDOG;MAPK3;TUB;DVL1;FYCO1;WIPF1;EPHB3;FHOD1;HES1;SSH1;CUL7;LRSAM1;CDC42EP5;PCSK9;RPS6KA5;DMTN;LDLR;TRPV4;CROCC;EEF2K;LDLRAP1;GAS6;ADGRB2;BCR;SLITRK6;TWF2;FGFR1;PROX1;WBP2;OSCP1;JARID2;WRAP73;SDC1;WHAMMP3;EPS8L1;WNT3;PPM1F;ABR;EPS8L2;PINK1;ARHGEF10L;SPIRE2;MLST8;PYCARD;EREG;FAM162A;UBL5
7047,GO:0030837,0.133008847629478,0.943952207096393,6,37,negative regulation of actin filament polymerization,BP,GSN;TMOD2;SPTB;DMTN;CAPG;TWF2
13510,GO:0055123,0.133256116270793,0.926991026488745,11,78,digestive system development,BP,EGFR;PTK6;ITGB4;INSR;ITGA6;VANGL2;ACVR2B;EPHB3;HES1;ADA;PKD1
12955,GO:0051384,0.133304360147657,0.924724165592424,12,88,response to glucocorticoid,BP,FOS;ZFP36L1;EGFR;PTPRU;IGFBP2;GLB1;SLIT3;ZFP36;WNT7B;PTAFR;PCK2;SDC1
4336,GO:0009897,0.133484650409501,0.920904042664588,14,105,external side of plasma membrane,CC,ABCG1;BCAM;CD9;SERPINE2;INSR;ITGA6;PRNP;SCART1;ADA;PCSK9;LDLR;ICOSLG;RTN4R;SDC1
981,GO:0002438,0.133683709865364,0.978620732868182,2,7,acute inflammatory response to antigenic stimulus,BP,ZP3;IL20RB
14112,GO:0061008,0.133775489432205,0.920702764971056,14,105,hepaticobiliary system development,BP,EGFR;PKD2;CEBPB;HES1;ADA;PCSK9;HMGCL;PCK2;SRSF5;PROX1;JARID2;PKD1;RARG;SULF2
13678,GO:0060263,0.134060736247178,0.978523591489877,2,7,regulation of respiratory burst,BP,INSR;BCR
4844,GO:0014066,0.13448365760169,0.931508590057132,9,61,regulation of phosphatidylinositol 3-kinase signaling,BP,IGF2;EGFR;RGL2;F2R;SERPINE2;PLXNB1;MAPK3;FGFR1;ERBB3
5668,GO:0016790,0.134594135878202,0.948730431324298,5,29,thiolester hydrolase activity,MF,ACOT7;HAGH;LYPLAL1;ACOT11;ABHD17C
15851,GO:0072606,0.134675733883734,0.965189453037377,3,14,interleukin-8 secretion,BP,F2R;MAPKBP1;PYCARD
11559,GO:0046135,0.134770179162565,0.965154032647771,3,14,pyrimidine nucleoside catabolic process,BP,NT5E;APOBEC3C;APOBEC3F
2655,GO:0006007,0.134782141011947,0.955835896968936,4,21,glucose catabolic process,BP,LRP5;PFKFB2;PFKL;HK1
8008,GO:0032653,0.134869935382425,0.9557965118989,4,21,regulation of interleukin-10 production,BP,IL20RB;PRKCZ;PYCARD;JAK3
10390,GO:0043244,0.134938121889265,0.925889711123761,11,78,regulation of protein complex disassembly,BP,GSN;TMOD2;INSR;PLEKHH2;BNIP3;FYCO1;SPTB;DMTN;TRPV4;CAPG;TWF2
12507,GO:0050678,0.134946025456999,0.906785322375899,26,216,regulation of epithelial cell proliferation,BP,HTRA1;APOE;XDH;PGF;ZFP36L1;NR1D1;EGFR;DEAF1;HYAL1;ERBB2;PLXNB3;CDKN1C;GLUL;WNT7A;ID1;ECM1;VEGFA;HES1;NRP2;ZFP36;FGFR1;PROX1;VEGFB;AKT1;EREG;SULF2
1458,GO:0003707,0.135076849250925,0.942948373717813,6,36,steroid hormone receptor activity,MF,NR1D1;THRA;PPARA;RXRA;RXRB;RARG
12640,GO:0050870,0.13525150310477,0.918033776249359,15,115,positive regulation of T cell activation,BP,IGF2;ZP3;ZMIZ1;EFNB3;BCL6;IGFBP2;HES1;TNFRSF14;ADA;RAG1;PRKCZ;ICOSLG;AKT1;PYCARD;JAK3
7856,GO:0032429,0.135336116184961,0.978193656327464,2,7,regulation of phospholipase A2 activity,BP,LRP1;EGFR
6178,GO:0019626,0.135401046667897,0.978176804142644,2,7,short-chain fatty acid catabolic process,BP,PCK2;ACADS
2193,GO:0005070,0.135452069414324,0.942745059480668,6,36,SH3/SH2 adaptor activity,MF,SH3BP2;GRB7;PAG1;SH2D2A;VAV3;GRB10
14703,GO:0070383,0.136037049764482,0.978011453366086,2,7,DNA cytosine deamination,BP,APOBEC3C;APOBEC3F
5539,GO:0016554,0.136037049764483,0.978011453366085,2,7,cytidine to uridine editing,BP,APOBEC3C;APOBEC3F
19581,GO:1990748,0.136119217490772,0.930219845340775,9,66,cellular detoxification,BP,APOE;PRDX5;GPX3;TXNRD3;FAM213A;SESN2;GSTT1;TP53INP1;GSTM2
12744,GO:0051045,0.136686581857479,0.977842058682668,2,7,negative regulation of membrane protein ectodomain proteolysis,BP,TIMP2;TIMP1
17512,GO:1901068,0.136690307292882,0.937223557411013,7,46,guanosine-containing compound metabolic process,BP,NME4;DLG4;DGUOK;GUK1;GTPBP1;DLG3;MOCS1
534,GO:0001653,0.13678597669354,0.947627374720978,5,29,peptide receptor activity,MF,LTB4R;F2R;SIGMAR1;LTB4R2;NTSR1
11288,GO:0045628,0.136880094050036,0.977791488859623,2,7,regulation of T-helper 2 cell differentiation,BP,BCL6;PRKCZ
8073,GO:0032769,0.137053829924138,0.977746046910399,2,7,negative regulation of monooxygenase activity,BP,CYP27B1;ATP2B4
10385,GO:0043236,0.137140866067579,0.954774096449181,4,21,laminin binding,MF,BCAM;ITGA6;ECM1;GPC1
15263,GO:0071476,0.137239322216393,0.977697488007791,2,7,cellular hypotonic response,BP,TRPV4;STK39
14154,GO:0061082,0.137906049636295,0.963970989081756,3,14,myeloid leukocyte cytokine production,BP,BCL6;GAS6;MIF
6289,GO:0019911,0.137922115596684,0.977518370381979,2,7,structural constituent of myelin sheath,MF,MARVELD1;MALL
13784,GO:0060401,0.138129403309012,0.921487171562223,12,88,cytosolic calcium ion transport,BP,CEMIP;NOS1;F2R;PKD2;ITPR3;NTSR1;ATP2B4;PRNP;PRKACA;SMDT1;TPCN1;GSTM2
9789,GO:0040034,0.138561877438474,0.97735000880495,2,7,regulation of development, heterochronic,BP,SERPINE2;HES1
3109,GO:0006694,0.138607355025739,0.914137226145563,16,125,steroid biosynthetic process,BP,APOE;CYP27B1;NR1D1;EGR1;ABCG1;DHRS11;MVD;SRD5A3;HINT2;SEC14L2;FGFR4;PMVK;TM7SF2;DGKQ;PROX1;TRERF1
1106,GO:0002695,0.138611418936819,0.921162450584271,12,88,negative regulation of leukocyte activation,BP,PKN1;ERBB2;IL20RB;PRNP;BCL6;CEBPB;PAG1;LDLR;BCR;INPP5D;ABR;JAK3
363,GO:0000982,0.138612210370734,0.900188505770829,32,269,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,FOS;TCFL5;MEF2D;NR1D1;EPAS1;NFATC4;EGR1;SOX12;ZFPM1;TFEB;FOXQ1;ZNF692;HES2;ZNF467;CEBPB;HES1;MLXIPL;ETV4;BHLHE40;HMGA2;ELK3;ZNF217;PPARA;HLTF;TEF;PROX1;MEF2B;SSBP2;CAMTA2;DDN;LITAF;MZF1
3595,GO:0008037,0.138629138940725,0.928866273115308,9,62,cell recognition,BP,CADM4;EPHB2;LAMA5;ZP3;EFNB3;TUB;EPHB3;ROBO3;PEAR1
1707,GO:0004301,0.138762729029583,0.977297045934488,2,7,epoxide hydrolase activity,MF,AKR7A2;LTA4H
16420,GO:0097110,0.138778783878059,0.936103728609916,7,45,scaffold protein binding,MF,NOS1;ATP2B4;DLG4;SHANK3;MAPK3;MAP2K2;KRT15
15629,GO:0072173,0.138920394697418,0.977255435291182,2,7,metanephric tubule morphogenesis,BP,HES1;PKD1
12076,GO:0048102,0.139068589345793,0.977216295719956,2,7,autophagic cell death,BP,BNIP3;TP53INP1
627,GO:0001817,0.139350594200685,0.893691005099888,46,409,regulation of cytokine production,BP,PTPRS;POSTN;ALOX15B;NFATC4;MAPK13;EGR1;F2R;ZP3;ZFPM1;RNF135;ACP5;PDCD4;IL20RB;TMEM173;PRNP;STAT6;BCL6;CEBPB;MAPK3;FURIN;MEFV;IL6R;ZFP36;MAPKBP1;RPS6KA5;TRPV4;HK1;GAS6;TKFC;PTAFR;PRKCZ;INPP5D;ICOSLG;FGFR1;PIN1;C5;ADORA2B;NLRX1;NDRG2;PYCARD;MAP2K3;JAK3;LITAF;EREG;MIF;SULF2
9837,GO:0042102,0.139620623840086,0.935528029692048,7,46,positive regulation of T cell proliferation,BP,IGF2;ZP3;IGFBP2;HES1;ICOSLG;PYCARD;JAK3
4627,GO:0010759,0.139915396561585,0.976992116755037,2,7,positive regulation of macrophage chemotaxis,BP,MAPK3;TRPV4
11453,GO:0045932,0.140076121817268,0.963144402274628,3,14,negative regulation of muscle contraction,BP,DOCK4;TNNT1;ADORA2B
4487,GO:0010522,0.140271611292253,0.931199726607568,8,54,regulation of calcium ion transport into cytosol,BP,CEMIP;NOS1;F2R;PKD2;NTSR1;PRNP;PRKACA;GSTM2
10071,GO:0042589,0.140514595770408,0.976832944075683,2,7,zymogen granule membrane,CC,VAMP2;STXBP2
11087,GO:0045123,0.140547471733283,0.953227221553264,4,21,cellular extravasation,BP,PTAFR;BCR;ABR;PODXL2
14941,GO:0070873,0.140611329907774,0.953198074762476,4,21,regulation of glycogen metabolic process,BP,IGF2;PHLDA2;INSR;AKT1
5444,GO:0016328,0.140807244220563,0.934927317894042,7,45,lateral plasma membrane,CC,ANK3;ARL2;VANGL2;DVL1;ERBB3;PKD1;SNTA1
5194,GO:0015802,0.141017623920571,0.976698970594799,2,7,basic amino acid transport,BP,SLC25A29;PQLC2
27,GO:0000052,0.141051040478023,0.976690059386995,2,7,citrulline metabolic process,BP,ATP2B4;ASS1
9186,GO:0035586,0.141109579254742,0.976674445450428,2,7,purinergic receptor activity,MF,PTAFR;ADORA2B
6125,GO:0019400,0.141239791600874,0.962698506914602,3,14,alditol metabolic process,BP,GALK1;TKFC;PCK2
10846,GO:0044387,0.141285599843107,0.976627469925443,2,7,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,ADARB1;PPM1F
7101,GO:0030913,0.141521827372557,0.97656436561,2,7,paranodal junction assembly,BP,CD9;EPB41L3
12634,GO:0050864,0.141618686303758,0.924006194783891,10,71,regulation of B cell activation,BP,ZFP36L1;PKN1;CD320;STAT6;BCL6;CD81;ADA;VAV3;INPP5D;MIF
13659,GO:0060228,0.141725874173973,0.994592387373483,1,2,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,APOE
12815,GO:0051151,0.14187912802476,0.976468785678296,2,7,negative regulation of smooth muscle cell differentiation,BP,PDCD4;EREG
5352,GO:0016139,0.141897745290539,0.976463801069709,2,7,glycoside catabolic process,BP,FUCA1;NAGA
8827,GO:0034637,0.141902360440459,0.926811442906435,9,62,cellular carbohydrate biosynthetic process,BP,PGM1;NR1D1;IGF2;ISYNA1;INSR;IMPA2;PCK2;AKT1;SLC2A1
8132,GO:0032872,0.142085729942516,0.906634577043541,20,160,regulation of stress-activated MAPK cascade,BP,XDH;EGFR;PKN1;MINK1;PDCD4;WNT7A;FZD8;VEGFA;VANGL2;MAPK3;MAP2K2;MAPK8IP1;TRPV4;SEMA4C;WNT7B;AKT1;ERCC6;PINK1;PYCARD;ERN1
14848,GO:0070661,0.142175524908857,0.907633381084545,19,154,leukocyte proliferation,BP,IGF2;PKN1;ZP3;ERBB2;CD320;IL20RB;PRNP;BCL6;IGFBP2;CD81;CEBPB;HES1;ADA;VAV3;INPP5D;ICOSLG;PYCARD;JAK3;MIF
11156,GO:0045252,0.142221767092825,0.976376977539972,2,7,oxoglutarate dehydrogenase complex,CC,OGDHL;DHTKD1
13864,GO:0060534,0.142243673164733,0.976371102933626,2,7,trachea cartilage development,BP,WNT7B;RARG
131,GO:0000272,0.142263616758911,0.952442010421998,4,21,polysaccharide catabolic process,BP,GAA;PYGB;PGM1;PYGL
10766,GO:0044247,0.142263616758911,0.952442010421998,4,21,cellular polysaccharide catabolic process,BP,GAA;PYGB;PGM1;PYGL
15260,GO:0071472,0.142382368170952,0.97633389479557,2,7,cellular response to salt stress,BP,ZFP36L1;TRPV4
16029,GO:0086103,0.142384768921626,0.976333250526573,2,7,G-protein coupled receptor signaling pathway involved in heart process,BP,NOS1;ATP2B4
10680,GO:0043983,0.142642466937331,0.976264052343531,2,7,histone H4-K12 acetylation,BP,JADE2;ING4
5254,GO:0015909,0.142878552516339,0.938561282981271,6,37,long-chain fatty acid transport,BP,APOE;CPT2;NTSR1;ABCD1;AKT1;MIF
4934,GO:0014909,0.142880105264389,0.933719978074437,7,45,smooth muscle cell migration,BP,POSTN;LRP1;CORO1B;PLAT;DOCK4;SSH1;SORL1
18546,GO:1903800,0.142917361892242,0.976190144707142,2,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,EGFR;MAP2K2
12174,GO:0048365,0.142934813642282,0.929653418363056,8,53,Rac GTPase binding,MF,PKN1;ARHGEF4;DOCK4;PAK6;DVL1;VAV3;EPS8L1;EPS8L2
15494,GO:0071901,0.14296850253384,0.912547579276912,15,116,negative regulation of protein serine/threonine kinase activity,BP,DUSP6;APOE;DUSP5;LRP5;SPRY4;CDKN1C;PDCD4;SPRY2;MAPK8IP1;DUSP7;SORL1;AKT1;RGS14;CBLC;PYCARD
7663,GO:0032104,0.143174179906473,0.961953208200998,3,14,regulation of response to extracellular stimulus,BP,CYP27B1;BBS2;PPARA
7666,GO:0032107,0.143174179906473,0.961953208200998,3,14,regulation of response to nutrient levels,BP,CYP27B1;BBS2;PPARA
10623,GO:0043651,0.143200661535684,0.961942969847019,3,14,linoleic acid metabolic process,BP,ALOX15B;ABCD1;GSTM2
19746,GO:2000191,0.143314249950464,0.96189904338834,3,14,regulation of fatty acid transport,BP,NTSR1;AKT1;MIF
12898,GO:0051279,0.143361090764019,0.933348490475953,7,46,regulation of release of sequestered calcium ion into cytosol,BP,CEMIP;NOS1;F2R;PKD2;NTSR1;PRKACA;GSTM2
7114,GO:0030949,0.143398012718612,0.976060690742067,2,7,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,VEGFA;GRB10
12288,GO:0048661,0.143431398829067,0.929277196149337,8,54,positive regulation of smooth muscle cell proliferation,BP,MEF2D;EGFR;IL6R;HBEGF;PTAFR;AKT1;ERN1;EREG
5614,GO:0016684,0.143435281346164,0.943800737828381,5,32,oxidoreductase activity, acting on peroxide as acceptor,MF,PRDX5;GPX3;SESN2;GSTT1;GSTM2
6751,GO:0030194,0.143557420567649,0.961804946586991,3,14,positive regulation of blood coagulation,BP,F2R;F12;DMTN
17331,GO:1900048,0.143557420567649,0.961804946586991,3,14,positive regulation of hemostasis,BP,F2R;F12;DMTN
14042,GO:0060850,0.143574311672857,0.976013135583121,2,7,regulation of transcription involved in cell fate commitment,BP,CEBPB;PROX1
7186,GO:0031087,0.143724986704619,0.97597246144757,2,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,ZFP36;PNRC1
2950,GO:0006489,0.143810258207821,0.975949430156726,2,7,dolichyl diphosphate biosynthetic process,BP,MVD;SRD5A3
11660,GO:0046465,0.143810258207821,0.975949430156726,2,7,dolichyl diphosphate metabolic process,BP,MVD;SRD5A3
16,GO:0000030,0.143825668272147,0.951485646007589,4,22,mannosyltransferase activity,MF,PIGZ;PIGV;POMT1;ALG12
14761,GO:0070493,0.144038616323779,0.975887707299914,2,7,thrombin-activated receptor signaling pathway,BP,F2R;DGKQ
9404,GO:0035988,0.144050552591513,0.97588447925599,2,7,chondrocyte proliferation,BP,FGFR3;HMGA2
16298,GO:0090533,0.144092339818323,0.97587317691594,2,7,cation-transporting ATPase complex,CC,GM2A;ATP12A
6646,GO:0030007,0.144092339818323,0.97587317691594,2,7,cellular potassium ion homeostasis,BP,ATP12A;KCNMA1
4476,GO:0010508,0.14421029976995,0.915279451376863,13,97,positive regulation of autophagy,BP,ULK1;TRIM65;TFEB;BNIP3;MAPK3;FYCO1;GPSM1;MEFV;LRSAM1;SESN2;TPCN1;TP53INP1;PINK1
7916,GO:0032504,0.1445598814471,0.887540933080458,52,466,multicellular organism reproduction,BP,ERCC1;TCFL5;CYP27B1;GAMT;EGFR;EGR1;DEAF1;BBS2;CTSB;DNAH1;THRA;ZP3;CRTAP;BSG;SCMH1;CD9;HEXB;SERPINE2;ATP2B4;GGT1;ZMIZ1;SH3PXD2B;TXNRD3;DNMT3A;MYCBPAP;PHC2;BCL6;ZSCAN2;ETV5;ADA;SLIT3;PRKACA;SPATA20;COMT;PTAFR;DMC1;RXRA;AGO4;WNT3;ZFP41;MICALCL;SBF1;AKT1;SIX5;TDRKH;SUN1;RPL39L;SPIRE2;RFX2;EREG;SHISA6;FAM50A
12683,GO:0050927,0.144569338109595,0.961412516573057,3,14,positive regulation of positive chemotaxis,BP,PGF;VEGFA;VEGFB
16496,GO:0097237,0.144570932455722,0.905803066780063,19,157,cellular response to toxic substance,BP,APOE;CST3;PRDX5;GPX3;MAPK13;EGR1;TXNRD3;DNMT3A;STAT6;ANKZF1;FAM213A;BNIP3;ENDOG;SESN2;GSTT1;TRAP1;TP53INP1;PINK1;GSTM2
46,GO:0000098,0.144583571107035,0.975740148186049,2,7,sulfur amino acid catabolic process,BP,CBS;BLMH
1145,GO:0002741,0.144767430577853,0.97569028024654,2,7,positive regulation of cytokine secretion involved in immune response,BP,MAPK3;HK1
15632,GO:0072176,0.144854169508417,0.975666739508262,2,7,nephric duct development,BP,PKD2;PKD1
2192,GO:0005068,0.144890288601717,0.975656934100823,2,7,transmembrane receptor protein tyrosine kinase adaptor activity,MF,SHC1;PAG1
10107,GO:0042659,0.14492077735883,0.97564865591675,2,7,regulation of cell fate specification,BP,DUSP6;FGFR1
5004,GO:0015174,0.145013521571536,0.97562346724456,2,7,basic amino acid transmembrane transporter activity,MF,SLC25A29;PQLC2
12620,GO:0050850,0.145164176837384,0.950864976077719,4,22,positive regulation of calcium-mediated signaling,BP,PKD2;ADA;ERBB3;GSTM2
4344,GO:0009931,0.145196200290667,0.975573821574075,2,7,calcium-dependent protein serine/threonine kinase activity,MF,MKNK2;MAPKAPK3
3360,GO:0007130,0.145226306807445,0.975565635678015,2,7,synaptonemal complex assembly,BP,AGO4;P3H4
1885,GO:0004571,0.145334875991995,0.97553610655323,2,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,EDEM1;MAN1B1
9092,GO:0035385,0.145335377980142,0.975535969986046,2,7,Roundabout signaling pathway,BP,SLIT3;ROBO3
10661,GO:0043931,0.145335377980325,0.975535969986027,2,7,ossification involved in bone maturation,BP,THBS3;PLXNB1
12591,GO:0050801,0.145354499137923,0.888356486037877,47,422,ion homeostasis,BP,CEMIP;APOE;CYP27B1;NOS1;EPAS1;EGFR;FHL1;F2R;CA12;ABCG1;ANK3;PKD2;SLC7A8;ITPR3;HEXB;NTSR1;ATP2B4;LPAR3;PRNP;ATP7B;SLC12A7;DLG4;ATP12A;BNIP3;MAPK3;MLXIPL;PRKACA;SCNN1A;SLC25A37;FGFR4;TRPV4;COMT;TMEM175;NEO1;PDK2;KCNMA1;SLC25A27;SMDT1;CYBRD1;SLC9A7;TPCN1;GPD1L;PKD1;SLC22A17;GSTM2;GIPR;PQLC2
14581,GO:0070168,0.145418564505154,0.975513334537252,2,7,negative regulation of biomineral tissue development,BP,ECM1;GAS6
7143,GO:0031014,0.145567425565378,0.994282937927153,1,2,troponin T binding,MF,TNNT1
10277,GO:0043046,0.145709199223383,0.975434183626288,2,7,DNA methylation involved in gamete generation,BP,DNMT3A;TDRKH
12957,GO:0051386,0.14571050743034,0.975433827113345,2,7,regulation of neurotrophin TRK receptor signaling pathway,BP,SPRY2;CYFIP2
9346,GO:0035878,0.145772632675773,0.975416894260896,2,7,nail development,BP,ITGB4;ITGA6
4977,GO:0015114,0.145796931122792,0.975410270167405,2,7,phosphate ion transmembrane transporter activity,MF,SLC20A1;SLC37A2
6530,GO:0021952,0.145820574835336,0.960925361157889,3,14,central nervous system projection neuron axonogenesis,BP,EPHB2;ADARB1;EPHB3
2288,GO:0005251,0.145829571707371,0.975401370731668,2,7,delayed rectifier potassium channel activity,MF,KCNG1;KCNC4
4014,GO:0009055,0.145908905045902,0.918232175533062,11,88,electron transfer activity,MF,XDH;ALDH4A1;AKR7A2;TXNRD3;PHGDH;SDHA;ETFB;GLRX;NDUFA4L2;TSTA3;UQCR11
18385,GO:1903441,0.146112902913003,0.975324064785846,2,7,protein localization to ciliary membrane,BP,BBS2;TUB
733,GO:0001964,0.146142182220635,0.975316070316486,2,7,startle response,BP,DVL1;SLITRK6
8109,GO:0032809,0.14615183205197,0.975313435276661,2,7,neuronal cell body membrane,CC,KCNC4;INSR
10792,GO:0044298,0.14615183205197,0.975313435276661,2,7,cell body membrane,CC,KCNC4;INSR
2583,GO:0005883,0.146199823337287,0.975300328767545,2,7,neurofilament,CC,SHANK2;LDLRAP1
4765,GO:0010960,0.146224557464219,0.97529357270943,2,7,magnesium ion homeostasis,BP,EGFR;ANK3
13536,GO:0060027,0.146232185382565,0.975291489010718,2,7,convergent extension involved in gastrulation,BP,VANGL2;DVL1
7615,GO:0032026,0.146244025973577,0.975288254403337,2,7,response to magnesium ion,BP,ANK3;ENTPD6
11233,GO:0045475,0.146244531753753,0.975288116230634,2,7,locomotor rhythm,BP,NAGLU;MTA1
2174,GO:0005024,0.146244570889816,0.975288105539132,2,7,transforming growth factor beta-activated receptor activity,MF,LTBP4;LTBP1
8681,GO:0034331,0.146244570889825,0.975288105539123,2,7,cell junction maintenance,BP,NLGN2;F2R
5063,GO:0015296,0.146244570889828,0.97528810553912,2,7,anion:cation symporter activity,MF,SLC12A7;SLC5A5
17296,GO:0150011,0.146244570889828,0.97528810553912,2,7,regulation of neuron projection arborization,BP,DLG4;DVL1
17297,GO:0150012,0.146244570889828,0.97528810553912,2,7,positive regulation of neuron projection arborization,BP,DLG4;DVL1
15186,GO:0071361,0.146244570889836,0.975288105539112,2,7,cellular response to ethanol,BP,DNMT3A;TP53INP1
4739,GO:0010919,0.146244570890049,0.97528810553912,2,7,regulation of inositol phosphate biosynthetic process,BP,NTSR1;PTAFR
14948,GO:0070884,0.146321023786253,0.960729924890469,3,14,regulation of calcineurin-NFAT signaling cascade,BP,ATP2B4;PRNP;ERBB3
17179,GO:0106056,0.146321023786253,0.960729924890469,3,14,regulation of calcineurin-mediated signaling,BP,ATP2B4;PRNP;ERBB3
11867,GO:0046906,0.146352688518708,0.923937705751182,9,63,tetrapyrrole binding,MF,CYP27B1;NOS1;NR1D1;HEBP1;CBS;CD320;SLC48A1;CYP3A5;CYP2S1
2614,GO:0005938,0.146493095298477,0.897072773765049,27,225,cell cortex,CC,FAM110C;RAPGEF3;GSN;MYZAP;EXOC2;PKD2;RIMS3;GM2A;RHOD;DLG4;PLEKHH2;WIPF1;GPSM1;SAMD3;RHOF;SPTB;DMTN;TRPV4;RHOBTB2;LLGL1;PRKCZ;CTSZ;BFSP1;CAPN2;SEPT8;SPIRE2;SLC2A1
4495,GO:0010544,0.146525349890117,0.960650033963894,3,14,negative regulation of platelet activation,BP,APOE;CD9;SERPINE2
3582,GO:0008013,0.146564477080606,0.92386378038196,9,62,beta-catenin binding,MF,CTNNBIP1;SLC9A3R2;ASH2L;PTPRU;CALCOCO1;DVL1;BTRC;SUFU;PIN1
13014,GO:0051496,0.146577147621891,0.93650936994036,6,37,positive regulation of stress fiber assembly,BP,RAPGEF3;SH3PXD2B;EPHA1;FHOD1;PPM1F;ARHGEF10L
11282,GO:0045622,0.146622578981571,0.960611997902815,3,14,regulation of T-helper cell differentiation,BP,BCL6;PRKCZ;JAK3
19788,GO:2000273,0.146742535184007,0.950130010284485,4,22,positive regulation of signaling receptor activity,BP,EPHB2;SHANK3;PINK1;EREG
2322,GO:0005342,0.146766854367981,0.915631808449391,12,88,organic acid transmembrane transporter activity,MF,SLC43A1;SLC16A5;SLC16A3;SLC13A3;BSG;SLC7A8;SLC6A8;SERINC2;SLC16A13;SLC38A10;SLC25A29;PQLC2
11888,GO:0046943,0.146766854367981,0.915631808449391,12,88,carboxylic acid transmembrane transporter activity,MF,SLC43A1;SLC16A5;SLC16A3;SLC13A3;BSG;SLC7A8;SLC6A8;SERINC2;SLC16A13;SLC38A10;SLC25A29;PQLC2
2312,GO:0005319,0.147167383161352,0.91770133861919,11,80,lipid transporter activity,MF,APOE;ABCA7;PITPNC1;ABCG1;PLTP;GM2A;ABCD1;OSBPL5;PITPNM1;PITPNM3;ANO9
4818,GO:0014032,0.147183221317745,0.926979342392804,8,54,neural crest cell development,BP,SEMA4B;LAMA5;MAPK3;HES1;SEMA3B;SEMA3F;SEMA4C;SEMA4F
614,GO:0001783,0.147321163575525,0.949859738990045,4,22,B cell apoptotic process,BP,PKN1;BCL6;ADA;MIF
10791,GO:0044297,0.147381019422417,0.891033765210236,36,313,cell body,CC,APOE;PTPRS;CST3;SHANK2;EPHB2;LRP1;TIMP2;CRTC1;ACTA2;GJC2;KCNC4;ITPR3;NTSR1;GLUL;INSR;ENDOG;DVL1;ADA;PITPNM1;PI4K2A;MAPK8IP1;COMT;PRKCZ;DLG3;SLC25A27;SNPH;PITPNM3;RTN4R;ZNF385A;PINK1;HOMER2;NRSN1;ATXN10;PYCARD;KCNN4;DDN
6773,GO:0030220,0.147557676810904,0.960245537096747,3,14,platelet formation,BP,ZFPM1;NBEAL2;ZNF385A
16992,GO:0099172,0.147936327806244,0.960096810668247,3,14,presynapse organization,BP,NLGN2;WNT7A;DVL1
770,GO:0002026,0.147973589814132,0.960082164487931,3,14,regulation of the force of heart contraction,BP,GAA;NOS1;ATP2B4
2273,GO:0005227,0.148190597079049,0.95999683067118,3,14,calcium activated cation channel activity,MF,TMEM63C;KCNMA1;KCNN4
14659,GO:0070302,0.148438716468226,0.901848488605559,20,161,regulation of stress-activated protein kinase signaling cascade,BP,XDH;EGFR;PKN1;MINK1;PDCD4;WNT7A;FZD8;VEGFA;VANGL2;MAPK3;MAP2K2;MAPK8IP1;TRPV4;SEMA4C;WNT7B;AKT1;ERCC6;PINK1;PYCARD;ERN1
2269,GO:0005217,0.148461435285095,0.959890240131264,3,14,intracellular ligand-gated ion channel activity,MF,PKD2;ITPR3;TPCN1
5054,GO:0015278,0.148461435285095,0.959890240131264,3,14,calcium-release channel activity,MF,PKD2;ITPR3;TPCN1
10405,GO:0043267,0.148554229437029,0.959853697589272,3,14,negative regulation of potassium ion transport,BP,NOS1;ANK3;STK39
4411,GO:0010224,0.148904566096304,0.959715630020658,3,14,response to UV-B,BP,HYAL1;XPC;ERCC6
18207,GO:1903038,0.148960749857387,0.922277664899327,9,63,negative regulation of leukocyte cell-cell adhesion,BP,ERBB2;IL20RB;PRNP;BCL6;CEBPB;PAG1;PPARA;ASS1;JAK3
12820,GO:0051156,0.148983270982829,0.949080911298431,4,22,glucose 6-phosphate metabolic process,BP,H6PD;PGLS;TALDO1;HK1
9805,GO:0042035,0.149020926550777,0.925847886595188,8,54,regulation of cytokine biosynthetic process,BP,EGR1;ZFPM1;CEBPB;ZFP36;PTAFR;INPP5D;MAP2K3;EREG
8990,GO:0035162,0.149179100183574,0.959607321109957,3,14,embryonic hemopoiesis,BP,ZFPM1;VEGFA;SH2B3
11661,GO:0046466,0.149733074913455,0.948728370512497,4,22,membrane lipid catabolic process,BP,FUCA1;HEXB;GM2A;NAGA
15113,GO:0071241,0.149905479426245,0.907562994213766,15,117,cellular response to inorganic substance,BP,FOS;GSN;NFATC4;EGFR;ANK3;PKD2;RASA4;PRNP;BNIP3;ENDOG;MAPK3;DMTN;EEF2K;AKT1;CPNE7
5493,GO:0016446,0.150061169660272,0.959258644003983,3,14,somatic hypermutation of immunoglobulin genes,BP,POLL;PMS2P5;POLM
19596,GO:1990778,0.150178888493614,0.895714190301539,25,208,protein localization to cell periphery,BP,EPHB2;LRP1;EGFR;LAMA5;BBS2;PACS2;ANK3;BSG;VAMP2;PRNP;TUB;AMN;RAB40B;TSPAN33;BBS1;TNFRSF1A;LDLRAP1;GAS6;TTC7B;PRKCZ;EPB41L3;AKT1;EHD3;RILPL1;RAB40C
4029,GO:0009070,0.150192473641832,0.959206651144189,3,14,serine family amino acid biosynthetic process,BP,CBS;GGT1;PHGDH
1793,GO:0004435,0.15026451002339,0.959178116860741,3,14,phosphatidylinositol phospholipase C activity,MF,PLCD1;PLCD3;PLCH2
12248,GO:0048565,0.150313090700209,0.918334004456277,10,71,digestive tract development,BP,EGFR;PTK6;ITGB4;ITGA6;VANGL2;ACVR2B;EPHB3;HES1;ADA;PKD1
4670,GO:0010828,0.150316889853917,0.940678453839352,5,29,positive regulation of glucose transmembrane transport,BP,PIK3R2;INSR;PRKCZ;CLTCL1;AKT1
1629,GO:0004074,0.150559960984796,0.993866813248823,1,2,biliverdin reductase activity,MF,BLVRB
13223,GO:0051928,0.150656114780737,0.924763556982507,8,55,positive regulation of calcium ion transport,BP,CEMIP;F2R;GJC2;PKD2;NTSR1;LPAR3;EHD3;GSTM2
8814,GO:0034614,0.150965626807291,0.906749846535484,15,119,cellular response to reactive oxygen species,BP,FOS;CST3;PRDX5;MAPK13;EGFR;PKD2;STAT6;ANKZF1;BNIP3;ENDOG;MAPK3;PDK2;AKT1;TRAP1;PINK1
358,GO:0000977,0.151025816429812,0.882994887604632,49,434,RNA polymerase II regulatory region sequence-specific DNA binding,MF,FOS;TCFL5;MEF2D;NR1D1;NFATC4;EGR1;DEAF1;ZMYND8;MXI1;THRA;ZFPM1;TFEB;SALL2;FOXQ1;TFDP2;ZC3H6;ZNF692;HES2;MNT;STAT6;BCL6;CEBPB;HSF4;ETV5;HES1;MLXIPL;PHF21A;ETV4;SOX13;BHLHE40;HMGA2;ELK3;ZNF217;PPARA;RXRA;HLTF;TEF;SMARCD2;WBP2;JARID2;RXRB;MEF2B;SIX5;SSBP2;RFX2;DDN;LITAF;MZF1;RARG
9457,GO:0036094,0.151062025207347,0.867938270969415,188,1813,small molecule binding,MF,H6PD;CEMIP;APOE;IDH2;NT5E;LTB4R;PYGB;RAPGEF3;XDH;PRODH;NOS1;SCN8A;EPHB2;OBSCN;NME4;MST1R;MAPK13;CDK18;EGFR;HADH;CRYL1;ACSF2;MTHFR;ULK1;PKN1;PYGL;PTK6;GNAL;ABCA7;ACTA2;DNAH1;ULK2;DGKA;D2HGDH;ABCG1;DHRS11;OPLAH;NEK9;RPS6KA2;NMRK1;TUBG2;MARK4;ERBB2;BRSK1;BSG;OGDHL;CBS;ITPR3;DNM1;CUL9;KIF13B;PAK6;VPS11;CD320;MINK1;ATP2B4;CSNK1E;AGAP1;GLUL;RHOD;INSR;RAB3D;GRK6;MVD;EPHA1;TXNRD3;TMEM173;DHX32;ATP7B;HINT2;SPEG;ABCD1;MKNK2;STRADB;TALDO1;RAB25;FAM20C;MYO18A;UCKL1;PFKFB2;ATP12A;DYRK1B;SEC14L2;SRMS;ARL2;MAST4;ACVR2B;MAPK3;DHTKD1;ARL10;RAB40B;ENTPD2;GALK1;FYCO1;ADCY6;MBD1;PKN3;PHGDH;EPHB3;PC;ACAD10;NAGS;SLC2A3;NADK;ABCA2;TK2;ADA;OSBPL5;RASL10B;CKMT1A;PFKL;RHOF;HLCS;FGFR3;PRKACA;LRRK1;DGUOK;RPS6KA5;RAB3B;MAP2K2;PI4K2A;FGFR4;PMVK;MYH3;EHD4;TRPV4;RHOBTB2;EEF2K;TM7SF2;DGKQ;HK1;PPARA;HMGCL;TKFC;GUK1;STK32C;DMC1;RXRA;PCK2;BCR;SDHA;PRKCZ;HLTF;ABCD4;TWF2;PDK2;MAPKAPK3;FGFR1;CAMKK1;PHYH;GTPBP1;ASS1;SESN2;GAL3ST4;RTN4R;GRHPR;ACTR1B;STK39;ACVR1B;GSS;ERBB3;AKT1;TRAP1;NLRX1;SEPT8;TUT1;SMARCA1;ERCC6;GPD1L;ADCK2;PINK1;EHD3;LONP2;MAP2K3;PNPO;STK17A;ERN1;ACADS;GCAT;MOCS1;SIRT3;JAK3;MAST3;KIFC2;FUK;TTLL11;RAB40C;KIF26B
2612,GO:0005929,0.15179804153639,0.886036234757278,39,342,cilium,CC,SHANK2;TCTN1;BBS2;DNAH1;MARK4;PKD2;IFT140;NPHP4;ATP2B4;CEP250;TMEM107;SHANK3;TUB;ADCY6;FBF1;EVC;PRKACA;SCNN1A;BBS1;TRPV4;CROCC;HK1;ANKS6;SUFU;WDR60;SPATA7;CDHR1;C21ORF2;UNC119B;WRAP73;TMEM231;GUCA1B;AKT1;GAS8;PKD1;EHD3;MAFIP;RILPL1;TTLL11
4062,GO:0009124,0.151976328031637,0.902948611445145,17,136,nucleoside monophosphate biosynthetic process,BP,PGM1;OGDHL;INSR;UCKL1;PFKFB2;DHTKD1;GALK1;LHPP;MLXIPL;TK2;ADA;PFKL;DGUOK;HK1;PPARA;PINK1;TAZ
12788,GO:0051119,0.152070962937496,0.958460295048208,3,14,sugar transmembrane transporter activity,MF,SLC2A9;SLC2A3;SLC2A1
13478,GO:0055075,0.152079637200943,0.9584568376807,3,14,potassium ion homeostasis,BP,SLC12A7;ATP12A;KCNMA1
15577,GO:0072089,0.152239623866,0.917066147554226,10,71,stem cell proliferation,BP,ZFP36L1;FBLN1;VEGFA;HMGA2;WNT7B;LTBP3;NDE1;FGFR1;WNT2B;WNT3
9844,GO:0042113,0.152313071342572,0.901351637491664,18,144,B cell activation,BP,ERCC1;ZFP36L1;PKN1;CMTM7;HDAC5;CD320;STAT6;BCL6;CD81;LRRC8A;ADA;RAG1;VAV3;INPP5D;ICOSLG;JAK3;POLM;MIF
5803,GO:0017075,0.152419779971171,0.958321185231405,3,14,syntaxin-1 binding,MF,VAMP2;SNPH;STXBP2
8007,GO:0032652,0.152521933617199,0.927847299210228,7,47,regulation of interleukin-1 production,BP,EGR1;F2R;ACP5;MEFV;HK1;GAS6;PYCARD
9829,GO:0042092,0.15253683515678,0.94740352771107,4,22,type 2 immune response,BP,ECM1;STAT6;BCL6;PRKCZ
5263,GO:0015923,0.152934071105828,0.958115787650405,3,14,mannosidase activity,MF,EDEM1;MAN1B1;MAN2B2
9895,GO:0042249,0.153051122272762,0.958068990517561,3,14,establishment of planar polarity of embryonic epithelium,BP,CELSR1;VANGL2;DVL1
7089,GO:0030897,0.153332276310449,0.957956510390179,3,14,HOPS complex,CC,VPS11;HOOK2;VPS33B
18509,GO:1903725,0.153517082924838,0.927345951210771,7,46,regulation of phospholipid metabolic process,BP,PIK3R2;ZP3;CD81;FGFR3;LDLR;VAV3;TAZ
18194,GO:1903018,0.15356195191716,0.938806064860383,5,30,regulation of glycoprotein metabolic process,BP,CST3;ABCA7;HBEGF;POMT1;JAK3
11019,GO:0045010,0.153633050137648,0.932422663272483,6,38,actin nucleation,BP,GSN;ARPIN;CORO1B;WIPF1;WHAMMP3;SPIRE2
3619,GO:0008083,0.153638908618242,0.919160516088921,9,65,growth factor activity,MF,PGF;IGF2;CD320;VEGFA;HBEGF;VGF;TIMP1;VEGFB;EREG
12835,GO:0051181,0.153656299272918,0.938756272938558,5,30,cofactor transport,BP,CD320;AMN;SLC48A1;SLC25A29;SLC22A17
7472,GO:0031648,0.1539212238822,0.932259317729914,6,38,protein destabilization,BP,GSN;ID1;PRNP;BTRC;RAD23A;CTSH
10031,GO:0042531,0.154151791121747,0.938494591605531,5,30,positive regulation of tyrosine phosphorylation of STAT protein,BP,PTK6;HES1;IL6R;FGFR3;TNFRSF1A
19859,GO:2000377,0.154561828891554,0.905979482640246,14,109,regulation of reactive oxygen species metabolic process,BP,XDH;EGFR;PKD2;ATP2B4;ACP5;INSR;BNIP3;BCR;ASS1;AKT1;TRAP1;PINK1;STK17A;SIRT3
12853,GO:0051209,0.154667432160189,0.918557392110445,9,64,release of sequestered calcium ion into cytosol,BP,CEMIP;NOS1;F2R;PKD2;ITPR3;NTSR1;PRKACA;TPCN1;GSTM2
12902,GO:0051283,0.154667432160189,0.918557392110445,9,64,negative regulation of sequestering of calcium ion,BP,CEMIP;NOS1;F2R;PKD2;ITPR3;NTSR1;PRKACA;TPCN1;GSTM2
3205,GO:0006855,0.155345667957392,0.926252243611785,7,46,drug transmembrane transport,BP,SLC13A3;PRAF2;NTSR1;SLC6A8;SLC22A18;SLC25A29;PQLC2
3261,GO:0006940,0.155548823932227,0.937755113997894,5,30,regulation of smooth muscle contraction,BP,F2R;DOCK4;ADA;PTAFR;ADORA2B
9414,GO:0036003,0.155557370874451,0.945964694709928,4,22,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,VEGFA;CEBPB;HSF4;SESN2
6090,GO:0019319,0.155713515387084,0.921617920848574,8,55,hexose biosynthetic process,BP,PGM1;NR1D1;PC;DGKQ;PPARA;PCK2;MDH2;PDK2
814,GO:0002088,0.156061849028787,0.925822819570748,7,46,lens development in camera-type eye,BP,WNT7A;WNT7B;SLITRK6;PROX1;BFSP1;WNT2B;SIX5
9893,GO:0042246,0.156508344327511,0.937245795173239,5,30,tissue regeneration,BP,GSN;POSTN;WNT7A;ADAM15;NINJ1
3584,GO:0008016,0.156828013222324,0.904390740887965,14,108,regulation of heart contraction,BP,GAA;NOS1;EPAS1;THRA;SCN4B;ITPR3;ATP2B4;ADA;PRKACA;HBEGF;GPD1L;EHD3;SNTA1;GSTM2
13715,GO:0060315,0.156951020083538,0.971362157787916,2,8,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,PKD2;GSTM2
9103,GO:0035418,0.157230260873715,0.945162682580553,4,22,protein localization to synapse,BP,NLGN2;WNT7A;DLG4;DVL1
7789,GO:0032350,0.157399429074806,0.945081377528618,4,22,regulation of hormone metabolic process,BP,CYP27B1;EGR1;DGKQ;TRERF1
18371,GO:1903426,0.157434995066337,0.924902450995427,7,47,regulation of reactive oxygen species biosynthetic process,BP,PKD2;ATP2B4;ACP5;INSR;ASS1;AKT1;TRAP1
10389,GO:0043243,0.157663123823923,0.944954567227407,4,22,positive regulation of protein complex disassembly,BP,INSR;BNIP3;FYCO1;TRPV4
1058,GO:0002586,0.157735017825843,0.993240882568213,1,2,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,PYCARD
19743,GO:2000179,0.157754073649306,0.944910808665238,4,22,positive regulation of neural precursor cell proliferation,BP,GJC2;VEGFA;CTSZ;PROX1
7324,GO:0031346,0.157888337295945,0.885912766928075,30,256,positive regulation of cell projection organization,BP,APOE;ESPN;SHANK2;ARAP1;CNTN1;OBSL1;CRTC1;PTK6;CORO1B;ZMYND8;TENM2;PLXNB3;FUZ;FBXW8;LPAR3;DLG4;PLXNB1;VEGFA;SHANK3;DVL1;CUL7;CDC42EP5;CROCC;EEF2K;TWF2;FGFR1;WRAP73;EPS8L1;WNT3;EPS8L2
8289,GO:0033137,0.157918478796549,0.944831681369704,4,22,negative regulation of peptidyl-serine phosphorylation,BP,MLXIPL;DMTN;PPM1F;GPD1L
4099,GO:0009163,0.158126737021268,0.929626763014405,6,40,nucleoside biosynthetic process,BP,NT5E;NME4;UCKL1;TK2;ADA;GUK1
18432,GO:1903547,0.15822319375158,0.993197091294845,1,2,regulation of growth hormone activity,BP,PHLDA2
16089,GO:0090102,0.158231957028415,0.944680708719761,4,22,cochlea development,BP,VANGL2;DVL1;HES1;SLITRK6
7150,GO:0031032,0.158481061647885,0.899720146622375,16,125,actomyosin structure organization,BP,RAPGEF3;ARAP1;OBSCN;OBSL1;TMOD2;SH3PXD2B;EPHA1;MYO18A;TNNT1;FHOD1;ITGB5;MYH3;PROX1;EPB41L3;PPM1F;ARHGEF10L
10704,GO:0044057,0.158660635006777,0.885956034455117,29,248,regulation of system process,BP,GAA;NOS1;EPAS1;EGFR;NLGN2;F2R;THRA;DOCK4;SCN4B;ITPR3;NTSR1;ATP2B4;TNNT1;ADA;PRKACA;HBEGF;GAS6;COMT;PTAFR;FGFR1;PIN1;JARID2;STK39;ADORA2B;AKT1;GPD1L;EHD3;SNTA1;GSTM2
17857,GO:1902162,0.158759201482545,0.993148831745374,1,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,ZNF385A
17858,GO:1902164,0.158759201482545,0.993148831745374,1,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,ZNF385A
4962,GO:0015085,0.158828121173161,0.915929431809685,9,63,calcium ion transmembrane transporter activity,MF,PKD2;ITPR3;ATP2B4;TRPV4;GAS6;TPCN1;PKD1;ORAI3;ORAI2
10004,GO:0042454,0.158968810228117,0.955250295185784,3,15,ribonucleoside catabolic process,BP,ADA;APOBEC3C;APOBEC3F
10013,GO:0042475,0.159099316134194,0.919495924023511,8,55,odontogenesis of dentin-containing tooth,BP,HTRA1;LAMA5;BSG;ITGB4;ITGA6;FAM20C;ACVR2B;PPARA
3264,GO:0006949,0.159160647494493,0.935831923260251,5,30,syncytium formation,BP,ERCC1;RAPGEF3;NOS1;DYRK1B;CAPN2
6279,GO:0019898,0.159591620138226,0.890145226977371,23,191,extrinsic component of membrane,CC,SYTL1;ALOX15B;EPN3;MYZAP;ULK1;PTK6;GNAL;PRSS8;PIK3R2;S100A6;SERPINE2;PRNP;SNX33;SNX9;DLG4;SRMS;KCNAB2;WIPI2;PCSK9;ATG2A;ESYT2;STK39;JAK3
16462,GO:0097180,0.159806359127678,0.993054013800179,1,2,serine protease inhibitor complex,CC,SERPINB6
12262,GO:0048598,0.160645196679449,0.877021374115767,43,380,embryonic morphogenesis,BP,DUSP6;ZFP36L1;COL6A1;TCTN1;EPHB2;IGF2;DUSP5;MDFI;NAGLU;DEAF1;LAMA5;LRP5;HYAL1;PKD2;ITGB4;IFT140;FUZ;WNT7A;CELSR1;SPRY2;TMEM107;VANGL2;FBXW4;ACVR2B;MAPK3;DVL1;HES1;ITGB5;MYH3;HMGA2;SEMA4C;WNT7B;SUFU;BCR;WDR60;SLITRK6;FGFR1;PROX1;WNT2B;TMEM231;WNT3;ABR;RARG
4921,GO:0014888,0.160647156559505,0.943513265036166,4,22,striated muscle adaptation,BP,GSN;ATP2B4;TNNT1;CAMTA2
11224,GO:0045429,0.160652873071988,0.943510492871275,4,22,positive regulation of nitric oxide biosynthetic process,BP,PKD2;INSR;ASS1;AKT1
18800,GO:1904407,0.160652873071988,0.943510492871275,4,22,positive regulation of nitric oxide metabolic process,BP,PKD2;INSR;ASS1;AKT1
885,GO:0002252,0.160815844264575,0.867823481485644,79,743,immune effector process,BP,HTRA1;ERCC1;GAA;NAPRT;PYGB;CST3;PGM1;GSN;PRSS3;LRP1;TIMP2;SERPING1;PKN1;PYGL;CTSB;PIK3R2;ZP3;ZFPM1;FUCA1;VAT1;HEXB;VAMP2;GM2A;RAB3D;ADARB1;IL20RB;NBEAL2;TMEM173;RNASET2;STAT6;ISG20;MYO18A;SCART1;BCL6;BNIP3;CD81;DNASE1L1;AP2A2;DPP7;MAPK3;KCNAB2;GLB1;WIPF1;LTA4H;SLC2A3;ADA;PFKL;RHOF;CYFIP2;PI4K2A;HK1;TKFC;PTAFR;VAV3;BCR;PRKCZ;INPP5D;CTSZ;C5;SERPINB6;TOLLIP;CSTB;ADGRE2;CD68;ACTR1B;APOBEC3C;LYST;ADORA2B;HGSNAT;ABR;CTSD;NLRX1;CTSH;PYCARD;APOBEC3F;JAK3;GALNS;MIF;STXBP2
6622,GO:0022900,0.161086070990488,0.897427777506904,16,142,electron transport chain,BP,XDH;ALDH4A1;D2HGDH;AKR7A2;NDUFS8;TXNRD3;PHGDH;SDHA;ETFB;GLRX;NDUFA4L2;TSTA3;UQCR11;PINK1;NDUFV3;TAZ
20172,GO:2001057,0.161155442196549,0.922653800177806,7,47,reactive nitrogen species metabolic process,BP,NOS1;PKD2;ATP2B4;ACP5;INSR;ASS1;AKT1
1966,GO:0004683,0.161288703527898,0.943201889954127,4,22,calmodulin-dependent protein kinase activity,MF,MKNK2;EEF2K;MAPKAPK3;CAMKK1
12633,GO:0050863,0.161632009187209,0.889546729143424,22,183,regulation of T cell activation,BP,GSN;IGF2;ZP3;ERBB2;ZMIZ1;IL20RB;PRNP;EFNB3;BCL6;IGFBP2;CEBPB;HES1;TNFRSF14;ADA;PAG1;SOX13;RAG1;PRKCZ;ICOSLG;AKT1;PYCARD;JAK3
16849,GO:0098810,0.161660111048787,0.96995674803496,2,8,neurotransmitter reuptake,BP,NOS1;RAB3B
6572,GO:0022410,0.161662757948337,0.96995595020541,2,8,circadian sleep/wake cycle process,BP,CST3;ADA
12592,GO:0050802,0.161662757948337,0.96995595020541,2,8,circadian sleep/wake cycle, sleep,BP,CST3;ADA
14105,GO:0060999,0.16171726508765,0.934460738083927,5,30,positive regulation of dendritic spine development,BP,APOE;SHANK2;ZMYND8;SHANK3;EEF2K
10245,GO:0043001,0.161891146188119,0.934367185392631,5,30,Golgi to plasma membrane protein transport,BP,BBS2;ANK3;VAMP2;AMN;BBS1
14285,GO:0061450,0.161931645193378,0.969874856069842,2,8,trophoblast cell migration,BP,TIMP1;ACVR1B
17541,GO:1901163,0.161931645193378,0.969874856069842,2,8,regulation of trophoblast cell migration,BP,TIMP1;ACVR1B
5691,GO:0016829,0.162128175777467,0.89693699338417,16,129,lyase activity,MF,UROS;CA12;CBS;GLUL;MVD;POLL;ADCY6;GGACT;HMGA2;HMGCL;TKFC;PCK2;MOCS1;MLYCD;BCKDHA;NEIL1
3820,GO:0008429,0.162174135774576,0.969801644775961,2,8,phosphatidylethanolamine binding,MF,PLTP;ESYT2
4061,GO:0009123,0.162178595496352,0.882326381875533,30,271,nucleoside monophosphate metabolic process,BP,NT5E;PGM1;OGDHL;INSR;NDUFS8;DNPH1;DLG4;FAM20C;UCKL1;PFKFB2;DHTKD1;GALK1;LHPP;MLXIPL;NADK;TK2;ADA;PFKL;NUDT10;DGUOK;MYH3;HK1;PPARA;GUK1;SDHA;DLG3;UQCR11;PINK1;NDUFV3;TAZ
17768,GO:1901879,0.162673370447871,0.91724211397494,8,55,regulation of protein depolymerization,BP,GSN;TMOD2;PLEKHH2;SPTB;DMTN;TRPV4;CAPG;TWF2
5339,GO:0016101,0.162875398778261,0.921608870954665,7,47,diterpenoid metabolic process,BP,APOE;LRP1;EGFR;RETSAT;GPC1;PNPLA4;SDC1
379,GO:0001012,0.163067508761685,0.872807638867381,49,437,RNA polymerase II regulatory region DNA binding,MF,FOS;TCFL5;MEF2D;NR1D1;NFATC4;EGR1;DEAF1;ZMYND8;MXI1;THRA;ZFPM1;TFEB;SALL2;FOXQ1;TFDP2;ZC3H6;ZNF692;HES2;MNT;STAT6;BCL6;CEBPB;HSF4;ETV5;HES1;MLXIPL;PHF21A;ETV4;SOX13;BHLHE40;HMGA2;ELK3;ZNF217;PPARA;RXRA;HLTF;TEF;SMARCD2;WBP2;JARID2;RXRB;MEF2B;SIX5;SSBP2;RFX2;DDN;LITAF;MZF1;RARG
8129,GO:0032868,0.163255215080707,0.88727381742495,23,192,response to insulin,BP,ZFP36L1;IGF2;HADH;EGR1;SHC1;PIK3R2;HDAC5;PTPRE;VAMP2;INSR;PCSK9;VGF;TRPV4;EEF2K;PPARA;PCK2;PRKCZ;PDK2;SRSF5;GRB10;SESN2;AKT1;SLC2A1
12794,GO:0051125,0.163377235858334,0.942184545226204,4,22,regulation of actin nucleation,BP,GSN;ARPIN;CORO1B;WIPF1
14090,GO:0060976,0.163379455235372,0.933564900881068,5,30,coronary vasculature development,BP,LTBP1;VEGFA;SNX17;SUFU;VEGFB
12265,GO:0048609,0.163726389338337,0.8715841939488,51,461,multicellular organismal reproductive process,BP,ERCC1;TCFL5;CYP27B1;GAMT;EGFR;EGR1;DEAF1;BBS2;CTSB;DNAH1;THRA;ZP3;CRTAP;BSG;SCMH1;HEXB;SERPINE2;ATP2B4;GGT1;ZMIZ1;SH3PXD2B;TXNRD3;DNMT3A;MYCBPAP;PHC2;BCL6;ZSCAN2;ETV5;ADA;SLIT3;PRKACA;SPATA20;COMT;PTAFR;DMC1;RXRA;AGO4;WNT3;ZFP41;MICALCL;SBF1;AKT1;SIX5;TDRKH;SUN1;RPL39L;SPIRE2;RFX2;EREG;SHISA6;FAM50A
3283,GO:0006982,0.164122878930276,0.992655637052399,1,2,response to lipid hydroperoxide,BP,GPX3
3678,GO:0008190,0.164132819014213,0.969207574724477,2,8,eukaryotic initiation factor 4E binding,MF,ANGEL1;EIF4EBP3
2724,GO:0006111,0.164133326616764,0.941814862995923,4,22,regulation of gluconeogenesis,BP,NR1D1;DGKQ;PPARA;PDK2
11321,GO:0045667,0.164224388928165,0.908980655810642,10,73,regulation of osteoblast differentiation,BP,CTNNBIP1;LRP5;ID1;FAM20C;CEBPB;ACVR2B;IL6R;PRKACA;WNT7B;SUFU
6322,GO:0020037,0.164476602199101,0.91602152577327,8,56,heme binding,MF,CYP27B1;NOS1;NR1D1;HEBP1;CBS;SLC48A1;CYP3A5;CYP2S1
1662,GO:0004126,0.164587048458278,0.96906911654055,2,8,cytidine deaminase activity,MF,APOBEC3C;APOBEC3F
9605,GO:0036488,0.164707220104714,0.99260077343185,1,2,CHOP-C/EBP complex,CC,CEBPB
5141,GO:0015688,0.164857976806886,0.992586582673702,1,2,iron chelate transport,BP,SLC22A17
5250,GO:0015891,0.164857976806886,0.992586582673702,1,2,siderophore transport,BP,SLC22A17
4232,GO:0009439,0.165090909322695,0.992564627433865,1,2,cyanate metabolic process,BP,TST
4233,GO:0009440,0.165090909322695,0.992564627433865,1,2,cyanate catabolic process,BP,TST
3596,GO:0008038,0.165117059853072,0.941332779722588,4,22,neuron recognition,BP,EPHB2;EFNB3;EPHB3;ROBO3
7345,GO:0031399,0.165351763950071,0.858071094896511,131,1254,regulation of protein modification process,BP,TNIP1;DUSP6;CEMIP;APOE;RAPGEF3;XDH;NOS1;EPHB2;CNTN1;IGF2;MST1R;EGFR;TIMP2;B3GAT3;FBXO2;DUSP5;PPP1R14A;MTHFR;EGR1;PKN1;SHC1;F2R;PTK6;ABCA7;PPP2R3B;SHC2;GJC2;PIK3R2;CRTAP;LRP5;ERBB2;FBLN1;PKD2;SPRY4;CDKN1C;PAK6;MINK1;ATP2B4;PDCD4;TNFRSF25;WNT7A;INSR;ID1;EPHA1;ADARB1;SYNGAP1;PPP1R35;LPAR3;PRNP;SPRY2;HINT2;SNX9;DLG4;STRADB;WWTR1;BCL6;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;MAPK3;DVL1;MTA1;ADCY6;EPHB3;HES1;MLXIPL;IL6R;FGFR3;PRKACA;LRRK1;RPS6KA5;HBEGF;MAP2K2;FGFR4;DMTN;TNFRSF1A;EHD4;MAPK8IP1;TRPV4;DUSP7;EEF2K;DGKQ;SEMA4C;GAS6;WNT7B;IGFBP4;PRKCZ;MAPKAPK3;FGFR1;CAMKK1;PIN1;C5;PROX1;WBP2;DLG3;JARID2;SESN2;TOLLIP;MAPRE3;MADD;RTN4R;ELFN2;PPM1F;SORL1;STK39;ACVR1B;ADORA2B;ERBB3;ZER1;AKT1;NDRG2;ERCC6;GPD1L;PINK1;PKD1;SNTA1;RGS14;MLST8;CBLC;PYCARD;MAP2K3;POMT1;ERN1;RANBP9;SIRT3;EREG;MIF
993,GO:0002455,0.165408895932512,0.952574249405685,3,15,humoral immune response mediated by circulating immunoglobulin,BP,SERPING1;ZP3;C5
18760,GO:1904304,0.165456727051365,0.992530075260336,1,2,regulation of gastro-intestinal system smooth muscle contraction,BP,PTAFR
18761,GO:1904306,0.165456727051365,0.992530075260336,1,2,positive regulation of gastro-intestinal system smooth muscle contraction,BP,PTAFR
20101,GO:2000821,0.165456727051365,0.992530075260336,1,2,regulation of grooming behavior,BP,DLG4
13009,GO:0051491,0.165530700820794,0.941129702725299,4,22,positive regulation of filopodium assembly,BP,ESPN;ARAP1;ZMYND8;TENM2
12901,GO:0051282,0.165643529278572,0.911353356625146,9,65,regulation of sequestering of calcium ion,BP,CEMIP;NOS1;F2R;PKD2;ITPR3;NTSR1;PRKACA;TPCN1;GSTM2
17486,GO:1900745,0.16567731365729,0.952461528818964,3,15,positive regulation of p38MAPK cascade,BP,XDH;MINK1;VEGFA
4131,GO:0009201,0.166222521702941,0.897538913528132,14,111,ribonucleoside triphosphate biosynthetic process,BP,PGM1;NME4;OGDHL;INSR;UCKL1;PFKFB2;DHTKD1;GALK1;MLXIPL;PFKL;HK1;PPARA;PINK1;TAZ
14621,GO:0070233,0.166692664709162,0.952034283059638,3,15,negative regulation of T cell apoptotic process,BP,ADA;RAG1;JAK3
13007,GO:0051489,0.166834379370029,0.931691944717848,5,30,regulation of filopodium assembly,BP,ESPN;ARAP1;ZMYND8;TENM2;DMTN
7769,GO:0032305,0.167030526978873,0.968319842658055,2,8,positive regulation of icosanoid secretion,BP,NTSR1;MIF
19748,GO:2000193,0.167030526978873,0.968319842658055,2,8,positive regulation of fatty acid transport,BP,NTSR1;MIF
5680,GO:0016810,0.167178018321214,0.896876923636023,14,110,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,OPLAH;HDAC5;ADARB1;MTA3;MTA1;ADA;PHF21A;ACY1;HDAC11;PADI3;APOBEC3C;APOBEC3F;SIRT3;NDST2
6531,GO:0021953,0.167201715430643,0.901355125777373,12,91,central nervous system neuron differentiation,BP,TCTN1;EPHB2;CSNK1E;WNT7A;ADARB1;SHANK3;EPHB3;HES1;MDGA1;SUFU;PROX1;WNT3
12524,GO:0050699,0.167441822165144,0.939929611574563,4,23,WW domain binding,MF,SCNN1A;FAM189B;WBP1;LITAF
3399,GO:0007188,0.167492439178762,0.906778218378601,10,73,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,LTB4R;NOS1;ADGRF1;GNAL;PTHLH;LTB4R2;ATP2B4;ADCY6;HTR7;ADORA2B
3558,GO:0007608,0.167496471373699,0.951695094643274,3,15,sensory perception of smell,BP,GNAL;BBS1;OR7D2
7649,GO:0032090,0.167505205100302,0.992334970412742,1,2,Pyrin domain binding,MF,PYCARD
560,GO:0001701,0.167645684530799,0.878725634414015,29,248,in utero embryonic development,BP,ZFP36L1;TCTN1;EPAS1;IGF2;EGFR;MDFI;ZP3;TFEB;PKD2;PHLDA2;PLCD1;ZMIZ1;FBXW8;PLCD3;VEGFA;CEBPB;ENDOG;HES1;ADA;WNT7B;RXRA;FGFR1;C5;CAPN2;TMEM231;ACVR1B;AKT1;PKD1;APBA1
7654,GO:0032095,0.16776151108807,0.968094233829636,2,8,regulation of response to food,BP,BBS2;PPARA
7657,GO:0032098,0.16776151108807,0.968094233829636,2,8,regulation of appetite,BP,BBS2;PPARA
11366,GO:0045764,0.167942084717382,0.992293003566194,1,2,positive regulation of cellular amino acid metabolic process,BP,COMT
7827,GO:0032393,0.168055675122635,0.992282071444968,1,2,MHC class I receptor activity,MF,CTSH
3568,GO:0007620,0.168069718938934,0.967998908333402,2,8,copulation,BP,SERPINE2;ADA
13976,GO:0060720,0.168080542982268,0.992279676989116,1,2,spongiotrophoblast cell proliferation,BP,PHLDA2
13977,GO:0060721,0.168080542982268,0.992279676989116,1,2,regulation of spongiotrophoblast cell proliferation,BP,PHLDA2
13978,GO:0060722,0.168080542982268,0.992279676989116,1,2,cell proliferation involved in embryonic placenta development,BP,PHLDA2
13979,GO:0060723,0.168080542982268,0.992279676989116,1,2,regulation of cell proliferation involved in embryonic placenta development,BP,PHLDA2
16163,GO:0090214,0.168080542982268,0.992279676989116,1,2,spongiotrophoblast layer developmental growth,BP,PHLDA2
12607,GO:0050820,0.168128627816858,0.951427744999697,3,15,positive regulation of coagulation,BP,F2R;F12;DMTN
14641,GO:0070269,0.168236890639643,0.967947153970097,2,8,pyroptosis,BP,GSDMC;GSDMA
19916,GO:2000484,0.168389609743165,0.967899843294464,2,8,positive regulation of interleukin-8 secretion,BP,F2R;PYCARD
7664,GO:0032105,0.168400656070284,0.967896420130113,2,8,negative regulation of response to extracellular stimulus,BP,BBS2;PPARA
7667,GO:0032108,0.168400656070284,0.967896420130113,2,8,negative regulation of response to nutrient levels,BP,BBS2;PPARA
4090,GO:0009153,0.168412881322403,0.992247637978633,1,2,purine deoxyribonucleotide biosynthetic process,BP,GUK1
4245,GO:0009581,0.168416182629068,0.9182197453663,7,47,detection of external stimulus,BP,REEP6;PKD2;SERPINE2;NTSR1;PITPNM1;GUCA1B;PKD1
10114,GO:0042668,0.168452579310962,0.992243806037489,1,2,auditory receptor cell fate determination,BP,HES1
20134,GO:2000978,0.168452579310962,0.992243806037489,1,2,negative regulation of forebrain neuron differentiation,BP,HES1
9600,GO:0036482,0.168465703727844,0.992242538944099,1,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,PINK1
18162,GO:1902958,0.168465703727844,0.992242538944099,1,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,PINK1
18352,GO:1903383,0.168465703727844,0.992242538944099,1,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,PINK1
18353,GO:1903384,0.168465703727844,0.992242538944099,1,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,PINK1
19795,GO:2000282,0.16847705782959,0.992241442673722,1,2,regulation of cellular amino acid biosynthetic process,BP,ATP2B4
1139,GO:0002731,0.168600334158038,0.992229534529928,1,2,negative regulation of dendritic cell cytokine production,BP,JAK3
722,GO:0001952,0.168640077213487,0.902996788263837,11,82,regulation of cell-matrix adhesion,BP,POSTN;MINK1;RHOD;EPHA1;BCL6;VEGFA;ADAM15;DMTN;PRKCZ;PPM1F;NINJ1
1131,GO:0002720,0.168752125787384,0.939279236315559,4,23,positive regulation of cytokine production involved in immune response,BP,MAPK3;HK1;PRKCZ;MIF
4737,GO:0010917,0.16877327268783,0.967780859642394,2,8,negative regulation of mitochondrial membrane potential,BP,BNIP3;SLC25A27
11401,GO:0045837,0.16877327268783,0.967780859642394,2,8,negative regulation of membrane potential,BP,BNIP3;SLC25A27
14913,GO:0070828,0.16899654902212,0.951059835769013,3,15,heterochromatin organization,BP,MTHFR;BAHCC1;HMGA2
12588,GO:0050795,0.169006822176738,0.939152562607561,4,23,regulation of behavior,BP,APOE;DLG4;ADA;RAG1
14502,GO:0070026,0.169083673642519,0.992182748662294,1,2,nitric oxide binding,MF,CBS
5001,GO:0015171,0.169119708252634,0.917786934318925,7,47,amino acid transmembrane transporter activity,MF,SLC43A1;SLC7A8;SLC6A8;SERINC2;SLC38A10;SLC25A29;PQLC2
12682,GO:0050926,0.169197582888263,0.950974477810292,3,15,regulation of positive chemotaxis,BP,PGF;VEGFA;VEGFB
3270,GO:0006956,0.1693521916043,0.950908795857345,3,15,complement activation,BP,SERPING1;CD81;C5
4073,GO:0009136,0.169374485535919,0.99215452466258,1,2,purine nucleoside diphosphate biosynthetic process,BP,GUK1
4112,GO:0009180,0.169374485535919,0.99215452466258,1,2,purine ribonucleoside diphosphate biosynthetic process,BP,GUK1
4120,GO:0009188,0.169374485535919,0.99215452466258,1,2,ribonucleoside diphosphate biosynthetic process,BP,GUK1
7858,GO:0032431,0.169498955331276,0.9921424275107,1,2,activation of phospholipase A2 activity,BP,EGFR
20162,GO:2001038,0.169547655027649,0.938883304626796,4,23,regulation of cellular response to drug,BP,ENDOG;HMGA2;TRAP1;PINK1
11264,GO:0045597,0.1695621699388,0.86285677698505,65,596,positive regulation of cell differentiation,BP,FOS;APOE;CTNNBIP1;SHANK2;CYP27B1;ZFP36L1;ALOX15B;FAM210B;EPHB2;CNTN1;OBSL1;TIMP2;CRTC1;PTK6;GJC2;ZMYND8;THRA;LRP5;PLXNB3;SERPINE2;CSNK1E;ZMIZ1;SH3PXD2B;FBXW8;LPAR3;DLG4;WWTR1;FAM20C;BCL6;PLXNB1;VEGFA;CEBPB;SHANK3;ACVR2B;HSF4;S1PR2;ETV5;OLFM2;DVL1;HES1;CUL7;ADA;IL6R;ZFP36;DMTN;RAG1;EEF2K;GAS6;WNT7B;LTBP3;PRKCZ;INPP5D;TWF2;GPC1;FGFR1;PIN1;PROX1;BIN1;PPP1R13L;WNT3;ACVR1B;CCDC71L;AKT1;ZNF385A;RGS14
3143,GO:0006749,0.169641611423699,0.922711738432162,6,42,glutathione metabolic process,BP,OPLAH;GGT1;HAGH;GSTT1;GSS;GSTM2
13472,GO:0055065,0.169820516056456,0.872550691166364,36,321,metal ion homeostasis,BP,CEMIP;APOE;CYP27B1;NOS1;EPAS1;EGFR;F2R;ANK3;PKD2;SLC7A8;ITPR3;HEXB;NTSR1;ATP2B4;LPAR3;PRNP;ATP7B;SLC12A7;DLG4;ATP12A;BNIP3;PRKACA;SCNN1A;SLC25A37;TRPV4;COMT;NEO1;KCNMA1;SLC25A27;SMDT1;CYBRD1;TPCN1;PKD1;SLC22A17;GSTM2;GIPR
7695,GO:0032190,0.169857636876552,0.992107510235732,1,2,acrosin binding,MF,ZP3
9311,GO:0035803,0.169857636876552,0.992107510235732,1,2,egg coat formation,BP,ZP3
4613,GO:0010743,0.1699751413466,0.950643834098705,3,15,regulation of macrophage derived foam cell differentiation,BP,ALOX15B;ABCG1;PPARA
10388,GO:0043242,0.170149715185854,0.917152266450581,7,47,negative regulation of protein complex disassembly,BP,GSN;TMOD2;PLEKHH2;SPTB;DMTN;CAPG;TWF2
1254,GO:0003010,0.170293590974891,0.992064956130694,1,2,voluntary skeletal muscle contraction,BP,TNNT1
4858,GO:0014721,0.170293590974891,0.992064956130694,1,2,twitch skeletal muscle contraction,BP,TNNT1
13810,GO:0060438,0.1703394473318,0.950488647904876,3,15,trachea development,BP,MAPK3;WNT7B;RARG
15794,GO:0072523,0.170574996367678,0.922392484548234,6,40,purine-containing compound catabolic process,BP,NT5E;RAPGEF3;XDH;DNPH1;ADA;NUDT10
4817,GO:0014031,0.170837380929154,0.911960116802122,8,56,mesenchymal cell development,BP,SEMA4B;LAMA5;MAPK3;HES1;SEMA3B;SEMA3F;SEMA4C;SEMA4F
13013,GO:0051495,0.170977348034582,0.885849579787295,19,157,positive regulation of cytoskeleton organization,BP,RAPGEF3;GSN;ARPIN;CORO1B;SH3PXD2B;ID1;EPHA1;ARL2;WIPF1;FHOD1;CDC42EP5;TRPV4;PROX1;WHAMMP3;PPM1F;ARHGEF10L;SPIRE2;MLST8;PYCARD
4254,GO:0009608,0.171000055842658,0.991995730253829,1,2,response to symbiont,BP,PTAFR
4255,GO:0009609,0.171000055842658,0.991995730253829,1,2,response to symbiotic bacterium,BP,PTAFR
12632,GO:0050862,0.171117295233582,0.967049908348939,2,8,positive regulation of T cell receptor signaling pathway,BP,ADA;KCNN4
17975,GO:1902463,0.171239435453573,0.991972198736777,1,2,protein localization to cell leading edge,BP,CORO1B
4130,GO:0009200,0.171285065465957,0.94967649851385,3,16,deoxyribonucleoside triphosphate metabolic process,BP,ADA;DGUOK;GUK1
9546,GO:0036344,0.171427845926125,0.950023984834056,3,15,platelet morphogenesis,BP,ZFPM1;NBEAL2;ZNF385A
4066,GO:0009128,0.171556723110122,0.966912112131806,2,8,purine nucleoside monophosphate catabolic process,BP,NT5E;NUDT10
4095,GO:0009158,0.171556723110122,0.966912112131806,2,8,ribonucleoside monophosphate catabolic process,BP,NT5E;NUDT10
4105,GO:0009169,0.171556723110122,0.966912112131806,2,8,purine ribonucleoside monophosphate catabolic process,BP,NT5E;NUDT10
3553,GO:0007601,0.171703384550754,0.900873658298563,11,82,visual perception,BP,EPAS1;REEP6;BBS2;LAMB2;RABGGTA;HSF4;OLFM2;BBS1;SPATA7;SLITRK6;GUCA1B
12691,GO:0050953,0.171703384550754,0.900873658298563,11,82,sensory perception of light stimulus,BP,EPAS1;REEP6;BBS2;LAMB2;RABGGTA;HSF4;OLFM2;BBS1;SPATA7;SLITRK6;GUCA1B
4693,GO:0010863,0.171732139008179,0.949893799180475,3,15,positive regulation of phospholipase C activity,BP,EGFR;PTAFR;FGFR1
16231,GO:0090314,0.171964866590151,0.93767533525869,4,23,positive regulation of protein targeting to membrane,BP,CEMIP;ANK3;ERBB2;PRNP
10134,GO:0042730,0.172229447541001,0.94968077659774,3,15,fibrinolysis,BP,SERPING1;PLAT;F12
3014,GO:0006567,0.172374674497641,0.991860085359542,1,2,threonine catabolic process,BP,GCAT
10001,GO:0042448,0.17237814374065,0.966653881549089,2,8,progesterone metabolic process,BP,EGR1;DGKQ
1283,GO:0003093,0.17248392844234,0.966620564518353,2,8,regulation of glomerular filtration,BP,F2R;GAS6
5787,GO:0017046,0.172511243482028,0.949559926376935,3,15,peptide hormone binding,MF,VIPR1;INSR;GIPR
2190,GO:0005055,0.172698864859037,0.991827912217518,1,2,laminin receptor activity,MF,BCAM
14472,GO:0061951,0.172882806424019,0.921158279812588,6,39,establishment of protein localization to plasma membrane,BP,BBS2;ANK3;VAMP2;AMN;BBS1;RILPL1
18414,GO:1903524,0.172935667391336,0.928166960536278,5,31,positive regulation of blood circulation,BP,EGFR;F2R;ADA;PTAFR;AKT1
9947,GO:0042351,0.172992492115124,0.991798711978159,1,2,'de novo' GDP-L-fucose biosynthetic process,BP,TSTA3
3276,GO:0006971,0.173268569319333,0.966373003488069,2,8,hypotonic response,BP,TRPV4;STK39
17008,GO:0099512,0.17327311414177,0.859839347545997,64,591,supramolecular fiber,CC,ESPN;FLNC;FAM110C;CLIP2;CST3;SHANK2;NDRG1;NOS1;LTBP1;PARVB;COL6A1;SCN8A;OBSCN;MYZAP;OBSL1;DNAH1;CORO1B;ANK3;TUBG2;PKD2;DNM1;KIF13B;NINL;THSD4;ATP2B4;TMOD2;ENKD1;TNXB;RAB3D;SPRY2;REEP2;HOOK2;KCNAB2;TNNT1;DVL1;MTA1;WIPF1;FBF1;MEFV;MAP2K2;DMTN;MYH3;TRPV4;LDLRAP1;AHNAK2;REEP4;PRKCZ;TWF2;NDE1;NICN1;BIN1;BFSP1;SYNC;SNPH;MAPRE3;GAS8;RGS14;SLC2A1;KIFC2;PBXIP1;KRT15;TTLL11;KIF26B;LZTS2
19476,GO:1990379,0.173331217273253,0.991764955752778,1,2,lipid transport across blood brain barrier,BP,APOE
17409,GO:1900208,0.173366130078703,0.991761472123443,1,2,regulation of cardiolipin metabolic process,BP,TAZ
17410,GO:1900210,0.173366130078703,0.991761472123443,1,2,positive regulation of cardiolipin metabolic process,BP,TAZ
7983,GO:0032613,0.173368874435796,0.936970302517222,4,23,interleukin-10 production,BP,IL20RB;PRKCZ;PYCARD;JAK3
11040,GO:0045056,0.173446603930988,0.949158051098189,3,15,transcytosis,BP,LRP1;FCGRT;PTAFR
4647,GO:0010801,0.173464891263528,0.949150182674264,3,15,negative regulation of peptidyl-threonine phosphorylation,BP,SPRY2;DMTN;DGKQ
4705,GO:0010877,0.173589277395104,0.991739187151093,1,2,lipid transport involved in lipid storage,BP,APOE
12859,GO:0051223,0.173795661052029,0.862637795611434,52,476,regulation of protein transport,BP,CEMIP;IDH2;RAPGEF3;POSTN;NR1D1;ALOX15B;LRP1;EGFR;B3GAT3;HADH;NLGN2;RHBDF1;F2R;ANK3;LRP5;ERBB2;MICALL2;EDEM1;ITPR3;VPS11;VAMP2;GLUL;TMEM173;PRNP;MYO18A;PFKFB2;ARL2;RHBDF2;MAPK3;HES1;PFKL;MAPKBP1;DMTN;TRPV4;HK1;GAS6;LLGL1;PCK2;PRKCZ;TM7SF3;C5;VSNL1;OSCP1;SORL1;PINK1;PYCARD;KCNN4;SIRT3;SLC2A1;GIPR;MIF;UBL5
19386,GO:1905953,0.173868744204765,0.936718687970345,4,23,negative regulation of lipid localization,BP,ABCG1;PCSK9;PPARA;AKT1
17682,GO:1901618,0.173893022368127,0.948965848313402,3,15,organic hydroxy compound transmembrane transporter activity,MF,SLC16A3;ABCG1;AQP3
3408,GO:0007198,0.173940898597133,0.991704004712685,1,2,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,HTR7
7171,GO:0031065,0.173947283575099,0.948942468860446,3,15,positive regulation of histone deacetylation,BP,BCL6;VEGFA;PINK1
17309,GO:1900016,0.174067067225078,0.96612027936193,2,8,negative regulation of cytokine production involved in inflammatory response,BP,PDCD4;MEFV
17689,GO:1901629,0.174133943040939,0.991684654129979,1,2,regulation of presynaptic membrane organization,BP,APOE
12350,GO:0048762,0.174352060211741,0.886224281773646,17,137,mesenchymal cell differentiation,BP,SEMA4B;LAMA5;S100A4;FUZ;PDCD4;WWTR1;ADAM15;MAPK3;HES1;CUL7;SEMA3B;HMGA2;SEMA3F;SEMA4C;VASN;FGFR1;SEMA4F
2648,GO:0005999,0.174383431797479,0.991659608873674,1,2,xylulose biosynthetic process,BP,TALDO1
5640,GO:0016744,0.174383431797479,0.991659608873674,1,2,transferase activity, transferring aldehyde or ketonic groups,MF,TALDO1
11972,GO:0047374,0.174516420926343,0.991646241647604,1,2,methylumbelliferyl-acetate deacetylase activity,MF,CES2
13058,GO:0051593,0.174530271319793,0.965973309943374,2,8,response to folic acid,BP,GSN;MTHFR
4874,GO:0014802,0.174534620231065,0.991644411452146,1,2,terminal cisterna,CC,RTN2
15255,GO:0071466,0.174566661335744,0.893609677175379,13,103,cellular response to xenobiotic stimulus,BP,EGFR;EGR1;BPHL;GGT1;AKR7A2;ACY1;CYP3A5;PCK2;CMBL;CES2;CYP2S1;AS3MT;GSTM2
1129,GO:0002718,0.174779357322363,0.919907959123822,6,40,regulation of cytokine production involved in immune response,BP,BCL6;MAPK3;HK1;PRKCZ;JAK3;MIF
16883,GO:0098876,0.174881202819771,0.905242013617811,9,65,vesicle-mediated transport to the plasma membrane,BP,BBS2;ANK3;EXOC2;VAMP2;AMN;OSBPL5;BBS1;SNX17;LLGL1
15252,GO:0071461,0.174956485579526,0.991601925115849,1,2,cellular response to redox state,BP,VASN
11111,GO:0045171,0.174986174078368,0.914054599329958,7,48,intercellular bridge,CC,NINL;TRIM45;PRKACA;RFXANK;PPP1R13L;PCIF1;GSTM2
1044,GO:0002566,0.174990097938293,0.948492411555437,3,15,somatic diversification of immune receptors via somatic mutation,BP,POLL;PMS2P5;POLM
9956,GO:0042362,0.174998633652009,0.96582443102387,2,8,fat-soluble vitamin biosynthetic process,BP,CYP27B1;PLTP
1182,GO:0002829,0.175044676337892,0.965809780569106,2,8,negative regulation of type 2 immune response,BP,STAT6;BCL6
6386,GO:0021602,0.175051350540473,0.948465932390922,3,15,cranial nerve morphogenesis,BP,EPHB2;ADARB1;SEMA3F
1926,GO:0004629,0.175204289405638,0.948399796553815,3,15,phospholipase C activity,MF,PLCD1;PLCD3;PLCH2
11789,GO:0046697,0.175383283530115,0.948322355108076,3,15,decidualization,BP,CYP27B1;CTSB;BSG
5049,GO:0015269,0.175435808435232,0.965685218224528,2,8,calcium-activated potassium channel activity,MF,KCNMA1;KCNN4
7057,GO:0030856,0.175446955488674,0.89548356198879,12,92,regulation of epithelial cell differentiation,BP,CYP27B1;XDH;ZFP36L1;ALOX15B;ID1;WWTR1;CEBPB;S1PR2;HES1;AQP3;ZFP36;TNFRSF1A
18337,GO:1903358,0.175534185478046,0.948257035475701,3,15,regulation of Golgi organization,BP,MAPK3;MAP2K2;EHD3
13053,GO:0051588,0.175546612914488,0.9137054051556,7,48,regulation of neurotransmitter transport,BP,NOS1;KCNC4;RIMS3;NTSR1;ASIC1;MCTP1;RAB3B
7825,GO:0032391,0.175567996582065,0.935860995812139,4,23,photoreceptor connecting cilium,CC,IFT140;NPHP4;SPATA7;C21ORF2
2934,GO:0006469,0.175643704431934,0.876487705078582,24,204,negative regulation of protein kinase activity,BP,DUSP6;APOE;EPHB2;DUSP5;PKN1;PTK6;LRP5;SPRY4;CDKN1C;PDCD4;EPHA1;ADARB1;SPRY2;WWTR1;DVL1;MAPK8IP1;DUSP7;RTN4R;PPM1F;SORL1;AKT1;RGS14;CBLC;PYCARD
8962,GO:0035082,0.175648822176826,0.935820108756923,4,23,axoneme assembly,BP,BBS2;DNAH1;GAS8;DNAAF5
11885,GO:0046939,0.175739011464397,0.895235072165438,12,93,nucleotide phosphorylation,BP,PGM1;NME4;OGDHL;INSR;PFKFB2;DHTKD1;GALK1;MLXIPL;PFKL;HK1;PPARA;GUK1
8123,GO:0032836,0.17578031957443,0.965575344664243,2,8,glomerular basement membrane development,BP,LAMB2;SULF2
13485,GO:0055083,0.175821153683035,0.948132736729563,3,15,monovalent inorganic anion homeostasis,BP,CA12;SLC12A7;FGFR4
8140,GO:0032880,0.175841652526911,0.855482569620603,74,692,regulation of protein localization,BP,CEMIP;IDH2;RAPGEF3;GSN;POSTN;NR1D1;ALOX15B;EPHB2;LRP1;EGFR;B3GAT3;HADH;NLGN2;RHBDF1;F2R;ZMYND8;ANK3;LRP5;ERBB2;MICALL2;EDEM1;ITPR3;VPS11;VAMP2;TFDP2;CSNK1E;GLUL;WNT7A;TMEM173;PRNP;SNX33;CEP250;MYO18A;PFKFB2;ARL2;RHBDF2;MAPK3;KCNAB2;DVL1;HES1;SSH1;PFKL;MAPKBP1;STX10;DMTN;ABHD17C;TRPV4;CROCC;LDLRAP1;HK1;GAS6;LLGL1;PCK2;PRKCZ;TM7SF3;PIN1;C5;VSNL1;OSCP1;SESN2;TMEM231;SORL1;AKT1;GPD1L;PINK1;PYCARD;KCNN4;SIRT3;SLC2A1;SHISA6;GIPR;MIF;UBL5;LZTS2
13127,GO:0051725,0.175876708068768,0.991508837069531,1,2,protein de-ADP-ribosylation,BP,MACROD1
9852,GO:0042129,0.175878928986648,0.897869832353011,11,84,regulation of T cell proliferation,BP,IGF2;ZP3;ERBB2;IL20RB;PRNP;IGFBP2;CEBPB;HES1;ICOSLG;PYCARD;JAK3
19501,GO:1990425,0.17589679894184,0.991506798408143,1,2,ryanodine receptor complex,CC,NOS1
1048,GO:0002576,0.175966480790451,0.900905532444431,10,75,platelet degranulation,BP,IGF2;SERPING1;CD9;ECM1;VEGFA;DMTN;GAS6;TIMP1;VEGFB;STXBP2
480,GO:0001527,0.176016805541252,0.965499837272832,2,8,microfibril,CC,LTBP1;THSD4
19262,GO:1905523,0.176095874116077,0.965474575947583,2,8,positive regulation of macrophage migration,BP,MAPK3;TRPV4
10304,GO:0043112,0.176103289868911,0.886537117521338,16,129,receptor metabolic process,BP,APOE;ARAP1;NR1D1;LRP1;DNM1;CD9;DLG4;CD81;VEGFA;AP2A2;FURIN;PCSK9;LDLRAP1;PPARA;TBC1D16;EHD3
13834,GO:0060478,0.176145877283491,0.991481501535245,1,2,acrosomal vesicle exocytosis,BP,ZP3
19852,GO:2000367,0.176145877283491,0.991481501535245,1,2,regulation of acrosomal vesicle exocytosis,BP,ZP3
19853,GO:2000368,0.176145877283491,0.991481501535245,1,2,positive regulation of acrosomal vesicle exocytosis,BP,ZP3
4028,GO:0009069,0.176279298620562,0.926311585915061,5,31,serine family amino acid metabolic process,BP,CBS;GGT1;PHGDH;AHCYL2;GCAT
17499,GO:1901016,0.176326867526603,0.926285092599274,5,31,regulation of potassium ion transmembrane transporter activity,BP,KCNG1;FHL1;ANK3;VAMP2;STK39
4511,GO:0010574,0.176394686583422,0.935442412361628,4,23,regulation of vascular endothelial growth factor production,BP,C5;ADORA2B;NDRG2;SULF2
12167,GO:0048333,0.176477163966566,0.947848189422049,3,15,mesodermal cell differentiation,BP,ITGB4;HMGA2;FGFR1
3535,GO:0007565,0.176520089669417,0.888040581136688,15,120,female pregnancy,BP,FOS;CST3;CYP27B1;PGF;CTSB;FBLN1;BSG;PTHLH;IGFBP2;COMT;RXRA;TIMP1;ACVR1B;AKT1;SLC2A1
11301,GO:0045647,0.176613318399955,0.96530906674508,2,8,negative regulation of erythrocyte differentiation,BP,ZFP36L1;ZFP36
14227,GO:0061307,0.176645278745307,0.96529883297177,2,8,cardiac neural crest cell differentiation involved in heart development,BP,MAPK3;HES1
14228,GO:0061308,0.176645278745307,0.96529883297177,2,8,cardiac neural crest cell development involved in heart development,BP,MAPK3;HES1
936,GO:0002337,0.176648477151149,0.991430330296081,1,2,B-1a B cell differentiation,BP,CMTM7
15237,GO:0071439,0.176748456228818,0.965265786603631,2,8,clathrin complex,CC,CLTCL1;VPS33B
11021,GO:0045017,0.176770984568451,0.874652201836636,25,212,glycerolipid biosynthetic process,BP,LPCAT4;DGKA;PIK3R2;ZP3;FGFR3;PITPNM1;PI4K2A;FGFR4;LDLR;PIGZ;DGKQ;PCK2;INPP5D;FGFR1;LCAT;PITPNM3;PIGV;PIGQ;SBF1;ACP6;GPD1L;AGPAT4;CPNE7;TAZ;AGPAT3
3161,GO:0006780,0.176851202360872,0.991409642413529,1,2,uroporphyrinogen III biosynthetic process,BP,UROS
11688,GO:0046502,0.176851202360872,0.991409642413529,1,2,uroporphyrinogen III metabolic process,BP,UROS
6070,GO:0019233,0.177099105090451,0.918528354270869,6,40,sensory perception of pain,BP,NLGN2;F2R;NTSR1;MAPK3;COMT;PTAFR
14007,GO:0060764,0.177187437272962,0.991375269389037,1,2,cell-cell signaling involved in mammary gland development,BP,LRP5
15150,GO:0071313,0.177433292467216,0.991350087911045,1,2,cellular response to caffeine,BP,GSTM2
15221,GO:0071415,0.177433292467216,0.991350087911045,1,2,cellular response to purine-containing compound,BP,GSTM2
4828,GO:0014044,0.177533676266556,0.934864293853197,4,23,Schwann cell development,BP,NDRG1;LAMB2;AHNAK2;AKT1
15551,GO:0072044,0.177644548706655,0.96497822092063,2,8,collecting duct development,BP,WNT7B;PKD1
4481,GO:0010513,0.177678471758084,0.991324935346122,1,2,positive regulation of phosphatidylinositol biosynthetic process,BP,ZP3
10182,GO:0042805,0.177680874536833,0.947324628732347,3,15,actinin binding,MF,OBSL1;MICALL2;PKD2
1734,GO:0004335,0.17782450032496,0.991309935363103,1,2,galactokinase activity,MF,GALK1
14354,GO:0061622,0.17782450032496,0.991309935363103,1,2,glycolytic process through glucose-1-phosphate,BP,GALK1
6762,GO:0030207,0.177923398157717,0.964888530563402,2,8,chondroitin sulfate catabolic process,BP,HYAL1;HEXB
3411,GO:0007204,0.177948137563992,0.885126149041601,16,130,positive regulation of cytosolic calcium ion concentration,BP,CEMIP;NOS1;F2R;PKD2;ITPR3;NTSR1;ATP2B4;LPAR3;PRNP;DLG4;PRKACA;TRPV4;TPCN1;PKD1;GSTM2;GIPR
4506,GO:0010566,0.17805472375601,0.964846256795655,2,8,regulation of ketone biosynthetic process,BP,EGR1;DGKQ
8283,GO:0033129,0.178126760839856,0.964823058881898,2,8,positive regulation of histone phosphorylation,BP,MAPK3;RPS6KA5
12123,GO:0048250,0.178197636468495,0.991271542074458,1,2,iron import into the mitochondrion,BP,SLC25A37
10140,GO:0042738,0.178276024562582,0.964774971256951,2,8,exogenous drug catabolic process,BP,NOS1;CYP2S1
18163,GO:1902959,0.178307074852502,0.964764964429498,2,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,BIN1;SORL1
19152,GO:1905245,0.178307074852502,0.964764964429498,2,8,regulation of aspartic-type peptidase activity,BP,BIN1;SORL1
12270,GO:0048627,0.178334536724854,0.991257432514748,1,2,myoblast development,BP,SDC1
1214,GO:0002885,0.178334536724854,0.991257432514747,1,2,positive regulation of hypersensitivity,BP,ZP3
19751,GO:2000196,0.178334536724854,0.991257432514747,1,2,positive regulation of female gonad development,BP,ZP3
19867,GO:2000386,0.178334536724854,0.991257432514747,1,2,positive regulation of ovarian follicle development,BP,ZP3
15561,GO:0072061,0.178549021335648,0.991235301479564,1,2,inner medullary collecting duct development,BP,WNT7B
1090,GO:0002678,0.178641397547443,0.991225760369934,1,2,positive regulation of chronic inflammatory response,BP,ADORA2B
1701,GO:0004197,0.178651244007405,0.899063719680106,10,75,cysteine-type endopeptidase activity,MF,CTSB;CTSF;USP20;BLMH;CAPNS2;CTSZ;CAPN2;CTSD;CTSH;PYCARD
6776,GO:0030224,0.17872449036856,0.934258131201775,4,23,monocyte differentiation,BP,CTNNBIP1;ZFP36L1;VEGFA;INPP5D
18241,GO:1903131,0.17872449036856,0.934258131201775,4,23,mononuclear cell differentiation,BP,CTNNBIP1;ZFP36L1;VEGFA;INPP5D
5754,GO:0016936,0.178758276770999,0.991213680249719,1,2,galactoside binding,MF,GLB1
16361,GO:0097001,0.178816107507795,0.964600742791141,2,8,ceramide binding,MF,PLTP;RTN4R
1874,GO:0004557,0.17884860997284,0.991204337525764,1,2,alpha-galactosidase activity,MF,NAGA
5990,GO:0019008,0.178918369763054,0.99119711886027,1,2,molybdopterin synthase complex,CC,MOCS1
4544,GO:0010635,0.178934048939755,0.964562646955177,2,8,regulation of mitochondrial fusion,BP,VAT1;BNIP3
14940,GO:0070863,0.179012656735925,0.964537246494318,2,8,positive regulation of protein exit from endoplasmic reticulum,BP,EDEM1;SORL1
19045,GO:1904953,0.17906420212403,0.964520586497217,2,8,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,CSNK1E;WNT3
908,GO:0002294,0.179136896653871,0.924715227967987,5,31,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,ZFPM1;STAT6;BCL6;PRKCZ;JAK3
9830,GO:0042093,0.179136896653871,0.924715227967987,5,31,T-helper cell differentiation,BP,ZFPM1;STAT6;BCL6;PRKCZ;JAK3
750,GO:0001991,0.17915354630364,0.964491701690155,2,8,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,F2R;CTSZ
14051,GO:0060896,0.179159501098814,0.964489776161862,2,8,neural plate pattern specification,BP,FUZ;CELSR2
8373,GO:0033293,0.179256768722076,0.924307252308175,5,33,monocarboxylic acid binding,MF,PYGL;PC;HLCS;PPARA;RXRA
17385,GO:1900150,0.179364947876925,0.991150830009785,1,2,regulation of defense response to fungus,BP,FAM3A
6362,GO:0021557,0.179398804233749,0.991147315255582,1,2,oculomotor nerve development,BP,HES1
11110,GO:0045168,0.179398804233749,0.991147315255582,1,2,cell-cell signaling involved in cell fate commitment,BP,HES1
11606,GO:0046331,0.179398804233749,0.991147315255582,1,2,lateral inhibition,BP,HES1
6361,GO:0021555,0.179398804233749,0.991147315255582,1,2,midbrain-hindbrain boundary morphogenesis,BP,HES1
14678,GO:0070330,0.179443260922656,0.964397968979083,2,8,aromatase activity,MF,CYP3A5;CYP2S1
17652,GO:1901550,0.179473016179468,0.964388336193051,2,8,regulation of endothelial cell development,BP,S1PR2;TNFRSF1A
18244,GO:1903140,0.179473016179468,0.964388336193051,2,8,regulation of establishment of endothelial barrier,BP,S1PR2;TNFRSF1A
4348,GO:0009953,0.179717664042675,0.911095627701441,7,48,dorsal/ventral pattern formation,BP,DUSP6;TCTN1;MDFI;LRP5;WNT7A;SUFU;WNT3
7552,GO:0031906,0.179774757071073,0.991108234404651,1,2,late endosome lumen,CC,CTSH
16601,GO:0097486,0.179774757071073,0.991108234404651,1,2,multivesicular body lumen,CC,CTSH
4655,GO:0010813,0.179774757071073,0.99110823440465,1,2,neuropeptide catabolic process,BP,CTSH
14026,GO:0060825,0.17995308559108,0.991089663654391,1,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,FUZ
19815,GO:2000313,0.17995308559108,0.991089663654391,1,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,FUZ
6782,GO:0030234,0.180049167683939,0.851021339292005,78,736,enzyme regulator activity,MF,APOE;CST3;EVI5L;PRDX5;ARAP1;IGF2;APPL2;RALGDS;EGFR;TIMP2;B3GAT3;PPP1R14A;SERPING1;PPP2R3B;TBC1D14;RIN1;PIK3R2;ARHGAP23;DOCK4;FBLN1;CDKN1C;SERPINE2;RALGAPA2;ATP2B4;RASA4;AGAP1;GM2A;ACAP3;SH3PXD2B;TBC1D8;SYNGAP1;PPP1R35;PAPLN;SPRY2;ARHGAP27;PLXNB1;ARL2;GPSM1;FURIN;SAMD3;ARHGAP22;CDC42EP5;MAP2K2;MAPK8IP1;DGKQ;GAS6;LLGL1;GIT1;PLEKHG6;VAV3;BCR;TBC1D16;ARAP3;C5;ASAP2;SERPINB6;SESN2;CSTB;GUCA1B;MADD;RTN4R;ELFN2;TIMP1;SBF1;TBC1D17;ALS2CL;ERBB3;ABR;AKT1;ERCC6;PINK1;RGS14;CTSH;MLST8;PYCARD;PCSK1N;ARHGEF19;RGS12
19046,GO:1904954,0.180125459407062,0.991071692677258,1,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3
10824,GO:0044338,0.180125459407063,0.991071692677258,1,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,WNT3
13566,GO:0060061,0.180125459407063,0.991071692677258,1,2,Spemann organizer formation,BP,WNT3
2005,GO:0004735,0.180361608131807,0.991047040326978,1,2,pyrroline-5-carboxylate reductase activity,MF,PYCR2
13048,GO:0051582,0.180383142724065,0.991044790391347,1,2,positive regulation of neurotransmitter uptake,BP,RAB3B
10365,GO:0043204,0.180407598302823,0.905684976365241,8,57,perikaryon,CC,PTPRS;GJC2;NTSR1;GLUL;ENDOG;PI4K2A;RTN4R;DDN
357,GO:0000976,0.180441858818605,0.856006119922835,55,499,transcription regulatory region sequence-specific DNA binding,MF,FOS;TCFL5;MEF2D;NR1D1;NFATC4;EGR1;DEAF1;BAHCC1;ZMYND8;SOX12;MXI1;ZNF516;THRA;ZFPM1;TFEB;SALL2;FOXQ1;TFDP2;ZC3H6;ZNF692;ZNF704;HES2;MNT;STAT6;BCL6;CEBPB;HSF4;ETV5;MTA1;HES1;MLXIPL;PHF21A;ETV4;SOX13;BHLHE40;HMGA2;ELK3;ZNF217;PPARA;RXRA;HLTF;TEF;SMARCD2;PROX1;WBP2;JARID2;RXRB;MEF2B;SIX5;SSBP2;RFX2;DDN;LITAF;MZF1;RARG
8177,GO:0032929,0.180472629002163,0.991035437514026,1,2,negative regulation of superoxide anion generation,BP,ACP5
14642,GO:0070273,0.180493827411885,0.933354205206572,4,23,phosphatidylinositol-4-phosphate binding,MF,SH3PXD2B;OSBPL5;GSDMC;GSDMA
919,GO:0002314,0.180497048961551,0.991032884265602,1,2,germinal center B cell differentiation,BP,ADA
18253,GO:1903169,0.180635662872487,0.897697797904088,10,75,regulation of calcium ion transmembrane transport,BP,CEMIP;NOS1;F2R;GJC2;PKD2;NTSR1;PRNP;PRKACA;EHD3;GSTM2
9461,GO:0036112,0.180664613453627,0.991015353591535,1,2,medium-chain fatty-acyl-CoA metabolic process,BP,ACOT7
2743,GO:0006154,0.180739187030601,0.991007545587412,1,2,adenosine catabolic process,BP,ADA
11539,GO:0046103,0.180739187030601,0.991007545587412,1,2,inosine biosynthetic process,BP,ADA
11124,GO:0045188,0.180786054737383,0.991002636526348,1,2,regulation of circadian sleep/wake cycle, non-REM sleep,BP,ADA
5068,GO:0015307,0.180900560123222,0.990990636670264,1,2,drug:proton antiporter activity,MF,SLC22A18
11738,GO:0046618,0.180900560123222,0.990990636670264,1,2,drug export,BP,SLC22A18
9688,GO:0038110,0.180938940318183,0.963912399403405,2,8,interleukin-2-mediated signaling pathway,BP,SHC1;JAK3
18457,GO:1903589,0.180968755054029,0.990983485826515,1,2,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,VEGFA
8069,GO:0032764,0.180968755054029,0.990983485826515,1,2,negative regulation of mast cell cytokine production,BP,BCL6
13653,GO:0060214,0.181029051737721,0.990977160572778,1,2,endocardium formation,BP,PROX1
946,GO:0002363,0.181053155139039,0.963875205123298,2,8,alpha-beta T cell lineage commitment,BP,ZFPM1;STAT6
16534,GO:0097344,0.181059086544318,0.990974008941478,1,2,Rix1 complex,CC,WDR18
2932,GO:0006465,0.181083761920671,0.945395011229927,3,16,signal peptide processing,BP,FURIN;GAS6;SPPL2B
17867,GO:1902176,0.181156333262597,0.945362837774777,3,16,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,AKT1;TRAP1;PINK1
10475,GO:0043394,0.181184736656565,0.933000169432497,4,23,proteoglycan binding,MF,PTPRS;LRP1;CTSB;GPC1
1784,GO:0004416,0.181185887697221,0.990960696658581,1,2,hydroxyacylglutathione hydrolase activity,MF,HAGH
6077,GO:0019243,0.181185887697221,0.990960696658581,1,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,HAGH
13060,GO:0051596,0.181185887697221,0.990960696658581,1,2,methylglyoxal catabolic process,BP,HAGH
14398,GO:0061727,0.181185887697221,0.990960696658581,1,2,methylglyoxal catabolic process to lactate,BP,HAGH
9107,GO:0035435,0.181241630265628,0.963813792267712,2,8,phosphate ion transmembrane transport,BP,SLC20A1;SLC37A2
11596,GO:0046321,0.1812784103501,0.963801802657381,2,8,positive regulation of fatty acid oxidation,BP,PPARA;MLYCD
13352,GO:0052646,0.181423516967551,0.963754484200769,2,8,alditol phosphate metabolic process,BP,ACP6;GPD1L
10357,GO:0043196,0.181536465025665,0.990923834683946,1,2,varicosity,CC,DNM1
12481,GO:0050613,0.181558008426941,0.990921566766715,1,2,delta14-sterol reductase activity,MF,TM7SF2
15473,GO:0071872,0.181650451363214,0.963680429543471,2,8,cellular response to epinephrine stimulus,BP,ATP2B4;PRKACA
5596,GO:0016647,0.181654283056106,0.990911427915292,1,2,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,SMOX
11726,GO:0046592,0.181654283056106,0.990911427915292,1,2,polyamine oxidase activity,MF,SMOX
13424,GO:0052901,0.181654283056106,0.990911427915292,1,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,SMOX
2045,GO:0004797,0.181657968821309,0.990911039636489,1,2,thymidine kinase activity,MF,TK2
649,GO:0001840,0.181705222507621,0.963662546664108,2,8,neural plate development,BP,VANGL2;DVL1
15480,GO:0071880,0.181804234530278,0.963630209567989,2,8,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,NOS1;ATP2B4
9558,GO:0036378,0.181815353514507,0.99089445131163,1,2,calcitriol biosynthetic process from calciol,BP,CYP27B1
11748,GO:0046628,0.181901803452589,0.963598331833105,2,8,positive regulation of insulin receptor signaling pathway,BP,IGF2;PRKCZ
12650,GO:0050884,0.181914808216177,0.963594082018449,2,8,neuromuscular process controlling posture,BP,GAA;ADARB1
4246,GO:0009582,0.181946234838849,0.909693393916839,7,48,detection of abiotic stimulus,BP,REEP6;PKD2;SERPINE2;NTSR1;PITPNM1;GUCA1B;PKD1
547,GO:0001667,0.181962570614877,0.86558795572299,31,271,ameboidal-type cell migration,BP,APOE;SEMA4B;PRSS3;PKN1;LAMA5;CORO1B;HDAC5;LRP5;HYAL1;LTB4R2;WNT7A;ID1;RAB25;VEGFA;PLEKHG5;PKN3;NRP2;HBEGF;DMTN;SEMA3B;SEMA3F;SEMA4C;FGFR1;PROX1;TIMP1;PPM1F;ACVR1B;AKT1;CTSH;MAP2K3;SEMA4F
15115,GO:0071243,0.181968454181966,0.945002332622805,3,16,cellular response to arsenic-containing substance,BP,MAPK13;UROS;MKNK2
20000,GO:2000650,0.182056056559585,0.963547910027255,2,8,negative regulation of sodium ion transmembrane transporter activity,BP,PCSK9;STK39
13247,GO:0051962,0.182057375353756,0.861847826764628,37,326,positive regulation of nervous system development,BP,ADGRL1;APOE;SHANK2;EPHB2;CNTN1;OBSL1;TIMP2;NLGN2;CRTC1;PTK6;GJC2;ZMYND8;PLXNB3;SERPINE2;CSNK1E;WNT7A;FBXW8;LPAR3;DLG4;BCL6;PLXNB1;VEGFA;SHANK3;ETV5;DVL1;EPHB3;HES1;CUL7;EEF2K;ADGRB2;SLITRK6;TWF2;FGFR1;PROX1;BIN1;WNT3;RGS14
5078,GO:0015347,0.182105751552233,0.963531659557968,2,8,sodium-independent organic anion transmembrane transporter activity,MF,SLCO4A1;SLC22A17
19294,GO:1905602,0.182217532623442,0.990851985709955,1,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,LDLRAP1
8104,GO:0032804,0.182217532623444,0.990851985709954,1,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,FURIN
19287,GO:1905595,0.182217532623444,0.990851985709954,1,2,regulation of low-density lipoprotein particle receptor binding,BP,PCSK9
19559,GO:1990667,0.182217532623444,0.990851985709954,1,2,PCSK9-AnxA2 complex,CC,PCSK9
8148,GO:0032891,0.182327095156563,0.963459241900118,2,8,negative regulation of organic acid transport,BP,STK39;AKT1
3432,GO:0007231,0.182390279732564,0.990833712007155,1,2,osmosensory signaling pathway,BP,TRPV4
1436,GO:0003417,0.182420691854095,0.963428601220184,2,8,growth plate cartilage development,BP,THBS3;RARG
9208,GO:0035612,0.182460384352177,0.963415603821194,2,8,AP-2 adaptor complex binding,MF,FCHO1;LDLRAP1
14317,GO:0061548,0.182696103924161,0.963338376468131,2,8,ganglion development,BP,NRP2;SEMA3F
15388,GO:0071679,0.182717660521315,0.96333131055816,2,8,commissural neuron axon guidance,BP,EPHB2;VEGFA
19471,GO:1990316,0.182719032627008,0.963330860784079,2,8,Atg1/ULK1 kinase complex,CC,ULK1;SESN2
5862,GO:0017185,0.182759695780471,0.963317530403061,2,8,peptidyl-lysine hydroxylation,BP,VPS33B;P3H4
1675,GO:0004143,0.18276441420385,0.963315983454511,2,8,diacylglycerol kinase activity,MF,DGKA;DGKQ
17459,GO:1900402,0.182764614425805,0.963315917810584,2,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,NR1D1;PPARA
2425,GO:0005614,0.182764723397065,0.963315882083673,2,8,interstitial matrix,CC,SMOC2;ADAMTSL4
3580,GO:0007638,0.182764723397066,0.963315882083671,2,8,mechanosensory behavior,BP,SHANK3;SLITRK6
2272,GO:0005225,0.182764723397115,0.96331588208369,2,8,volume-sensitive anion channel activity,MF,TTYH3;LRRC8A
3305,GO:0007016,0.182764723397133,0.963315882083671,2,8,cytoskeletal anchoring at plasma membrane,BP,ANK3;EPB41L3
15540,GO:0072017,0.182764723397198,0.963315882083673,2,8,distal tubule development,BP,PKD2;PKD1
335,GO:0000931,0.182764723397199,0.963315882083671,2,8,gamma-tubulin large complex,CC,MZT2A;MZT2B
3730,GO:0008274,0.182764723397199,0.963315882083671,2,8,gamma-tubulin ring complex,CC,MZT2A;MZT2B
10399,GO:0043256,0.1827647233972,0.963315882083671,2,8,laminin complex,CC,LAMA5;LAMB2
5086,GO:0015370,0.18286358338452,0.922618667131628,5,31,solute:sodium symporter activity,MF,SLC13A3;SLC6A8;SLC20A1;SLC28A2;SLC5A5
6338,GO:0021523,0.183023386553835,0.990766567630626,1,2,somatic motor neuron differentiation,BP,TCTN1
1801,GO:0004450,0.183068046739082,0.990761820941347,1,2,isocitrate dehydrogenase (NADP+) activity,MF,IDH2
2711,GO:0006097,0.183068046739082,0.990761820941347,1,2,glyoxylate cycle,BP,IDH2
1238,GO:0002933,0.183157483989941,0.990752311082249,1,2,lipid hydroxylation,BP,CYP3A5
17085,GO:0101020,0.183157483989941,0.990752311082249,1,2,estrogen 16-alpha-hydroxylase activity,MF,CYP3A5
13569,GO:0060066,0.183173208860263,0.990750638497883,1,2,oviduct development,BP,WNT7A
7222,GO:0031133,0.183173208860263,0.990750638497883,1,2,regulation of axon diameter,BP,WNT7A
4819,GO:0014033,0.183270159688717,0.903812516570059,8,57,neural crest cell differentiation,BP,SEMA4B;LAMA5;MAPK3;HES1;SEMA3B;SEMA3F;SEMA4C;SEMA4F
426,GO:0001134,0.183364419613908,0.931879359146849,4,23,transcription factor activity, transcription factor recruiting,MF,NR1D1;THRA;PPARA;RARG
11667,GO:0046474,0.183394019156966,0.871356398470827,23,194,glycerophospholipid biosynthetic process,BP,LPCAT4;DGKA;PIK3R2;ZP3;FGFR3;PITPNM1;PI4K2A;FGFR4;PIGZ;DGKQ;INPP5D;FGFR1;LCAT;PITPNM3;PIGV;PIGQ;SBF1;ACP6;GPD1L;AGPAT4;CPNE7;TAZ;AGPAT3
17865,GO:1902174,0.183496438280555,0.990716220941847,1,2,positive regulation of keratinocyte apoptotic process,BP,GSN
6097,GO:0019343,0.183506823672342,0.990715113929566,1,2,cysteine biosynthetic process via cystathionine,BP,CBS
18733,GO:1904245,0.183509219936378,0.990714858493695,1,2,regulation of polynucleotide adenylyltransferase activity,BP,ZFP36
6303,GO:0019957,0.183509219936537,0.990714858493694,1,2,C-C chemokine binding,MF,ZFP36
18204,GO:1903035,0.183568323078716,0.903616987563736,8,57,negative regulation of response to wounding,BP,APOE;PTPRS;SERPING1;PLAT;CD9;SERPINE2;F12;RTN4R
19649,GO:1990967,0.183698003897731,0.990694722364562,1,2,multi-organism toxin transport,BP,RAB40B
6212,GO:0019763,0.18373611883459,0.990690654009015,1,2,immunoglobulin receptor activity,MF,FCGRT
15844,GO:0072593,0.18379757491332,0.875880593925444,19,161,reactive oxygen species metabolic process,BP,XDH;PRDX5;NOS1;GPX3;EGFR;PKD2;ATP2B4;ACP5;INSR;SH3PXD2B;BNIP3;BCR;ASS1;SESN2;AKT1;TRAP1;PINK1;STK17A;SIRT3
13883,GO:0060562,0.18384681869662,0.868036144228205,26,222,epithelial tube morphogenesis,BP,CTNNBIP1;PGF;TCTN1;NFATC4;DEAF1;LAMA5;LRP5;PKD2;FUZ;CELSR1;SPRY2;VEGFA;VANGL2;ETV5;DVL1;HES1;SEMA4C;BTRC;SUFU;CTSZ;PROX1;WNT2B;PKD1;CTSH;RARG;KIF26B
1486,GO:0003826,0.18385762952964,0.990677677490983,1,2,alpha-ketoacid dehydrogenase activity,MF,BCKDHA
1504,GO:0003863,0.18385762952964,0.990677677490983,1,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,BCKDHA
479,GO:0001525,0.183919597622888,0.860830006869969,36,318,angiogenesis,BP,RAPGEF3;PGF;EPHB2;EPAS1;NFATC4;SHC1;LAMA5;HDAC5;HYAL1;ERBB2;PLCD1;WNT7A;ID1;EPHA1;SPRY2;ECM1;PLCD3;FZD8;VEGFA;ADAM15;EPHB3;ARHGAP22;NRP2;SH2D2A;FGFR4;HMGA2;ELK3;ADGRB2;VAV3;FGFR1;C5;VEGFB;CTSH;ROBO4;EPN2;EREG
2235,GO:0005150,0.183943828794774,0.9906684659276,1,2,interleukin-1, Type I receptor binding,MF,TOLLIP
8266,GO:0033084,0.183954269969711,0.990667349804189,1,2,regulation of immature T cell proliferation in thymus,BP,ERBB2
8269,GO:0033088,0.183954269969711,0.990667349804189,1,2,negative regulation of immature T cell proliferation in thymus,BP,ERBB2
15823,GO:0072566,0.18396469074306,0.990666235787931,1,2,chemokine (C-X-C motif) ligand 1 production,BP,TRPV4
19832,GO:2000338,0.18396469074306,0.990666235787931,1,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,TRPV4
19833,GO:2000340,0.18396469074306,0.990666235787931,1,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,TRPV4
5455,GO:0016361,0.183975091135521,0.990665123877065,1,2,activin receptor activity, type I,MF,ACVR1B
12097,GO:0048179,0.183975091135521,0.990665123877065,1,2,activin receptor complex,CC,ACVR1B
12151,GO:0048295,0.184103384752202,0.990651401915281,1,2,positive regulation of isotype switching to IgE isotypes,BP,STAT6
10111,GO:0042663,0.184125862230309,0.99064899663215,1,2,regulation of endodermal cell fate specification,BP,DUSP6
19498,GO:1990418,0.184193808710785,0.990641723692507,1,2,response to insulin-like growth factor stimulus,BP,AKT1
9445,GO:0036065,0.18420905510904,0.931443453010324,4,23,fucosylation,BP,ADAMTS7;RFNG;ADAMTS13;ADAMTSL4
18144,GO:1902936,0.184335045525071,0.898828068451448,9,66,phosphatidylinositol bisphosphate binding,MF,PLCD1;SH3PXD2B;WIPI2;LDLRAP1;GSDMC;TWF2;ARAP3;GSDMA;AKT1
7087,GO:0030895,0.18433514809073,0.990626584803078,1,2,apolipoprotein B mRNA editing enzyme complex,CC,APOBEC3F
5000,GO:0015168,0.184336104089499,0.990626482359742,1,2,glycerol transmembrane transporter activity,MF,AQP3
5046,GO:0015254,0.184336104089499,0.990626482359742,1,2,glycerol channel activity,MF,AQP3
5189,GO:0015793,0.184336104089499,0.990626482359742,1,2,glycerol transport,BP,AQP3
4730,GO:0010907,0.184352895282672,0.931369130604716,4,23,positive regulation of glucose metabolic process,BP,IGF2;INSR;PPARA;AKT1
12532,GO:0050707,0.184418200947104,0.888982136093438,12,94,regulation of cytokine secretion,BP,POSTN;ALOX15B;F2R;MAPK3;MAPKBP1;TRPV4;HK1;GAS6;PRKCZ;C5;PYCARD;MIF
17598,GO:1901329,0.184450742660416,0.990614193373297,1,2,regulation of odontoblast differentiation,BP,CEBPB
3200,GO:0006844,0.18450598127349,0.990608268740343,1,2,acyl carnitine transport,BP,SLC25A29
5034,GO:0015227,0.18450598127349,0.990608268740343,1,2,acyl carnitine transmembrane transporter activity,MF,SLC25A29
2714,GO:0006101,0.184518833863117,0.921500076671541,5,32,citrate metabolic process,BP,IDH2;OGDHL;DHTKD1;SDHA;MDH2
17365,GO:1900120,0.184605693180976,0.94382579210941,3,16,regulation of receptor binding,BP,PHLDA2;ADAM15;PCSK9
3797,GO:0008391,0.184676637167444,0.990589951915823,1,2,arachidonic acid monooxygenase activity,MF,CYP2S1
3798,GO:0008392,0.184676637167444,0.990589951915823,1,2,arachidonic acid epoxygenase activity,MF,CYP2S1
16344,GO:0090677,0.1847074400637,0.990586643676228,1,2,reversible differentiation,BP,OLFM2
16345,GO:0090678,0.1847074400637,0.990586643676228,1,2,cell dedifferentiation involved in phenotypic switching,BP,OLFM2
19133,GO:1905174,0.1847074400637,0.990586643676228,1,2,regulation of vascular smooth muscle cell dedifferentiation,BP,OLFM2
19643,GO:1990936,0.1847074400637,0.990586643676228,1,2,vascular smooth muscle cell dedifferentiation,BP,OLFM2
17185,GO:0106072,0.184742896757309,0.990582834820206,1,2,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,ATP2B4
18393,GO:1903464,0.184769292531972,0.990579998759021,1,2,negative regulation of mitotic cell cycle DNA replication,BP,BCL6
18201,GO:1903031,0.184773631135261,0.990579532557955,1,2,regulation of microtubule plus-end binding,BP,MAPRE3
18202,GO:1903033,0.184773631135261,0.990579532557955,1,2,positive regulation of microtubule plus-end binding,BP,MAPRE3
15952,GO:0080144,0.184940996655583,0.990561538677348,1,2,amino acid homeostasis,BP,PQLC2
20107,GO:2000828,0.184978617457441,0.990557491353967,1,2,regulation of parathyroid hormone secretion,BP,FGFR1
15910,GO:0072739,0.18499107585047,0.990556150842533,1,2,response to anisomycin,BP,MAPK13
15896,GO:0072709,0.184991075850471,0.990556150842532,1,2,cellular response to sorbitol,BP,MAPK13
6860,GO:0030348,0.185028206362463,0.990552155008987,1,2,syntaxin-3 binding,MF,STXBP2
19277,GO:1905573,0.185153313652414,0.990538684582531,1,2,ganglioside GM1 binding,MF,RTN4R
19280,GO:1905576,0.185153313652414,0.990538684582531,1,2,ganglioside GT1b binding,MF,RTN4R
18128,GO:1902897,0.18517703335438,0.990536129459679,1,2,regulation of postsynaptic density protein 95 clustering,BP,ZMYND8
19356,GO:1905874,0.18517703335438,0.990536129459679,1,2,regulation of postsynaptic density organization,BP,ZMYND8
9623,GO:0036509,0.185191467515694,0.990534574402529,1,2,trimming of terminal mannose on B branch,BP,MAN1B1
9625,GO:0036511,0.185191467515694,0.990534574402529,1,2,trimming of first mannose on A branch,BP,MAN1B1
9626,GO:0036512,0.185191467515694,0.990534574402529,1,2,trimming of second mannose on A branch,BP,MAN1B1
1877,GO:0004560,0.185227582606533,0.990530682941156,1,2,alpha-L-fucosidase activity,MF,FUCA1
5267,GO:0015928,0.185227582606533,0.990530682941156,1,2,fucosidase activity,MF,FUCA1
887,GO:0002254,0.185286028875297,0.990524383380646,1,2,kinin cascade,BP,F12
942,GO:0002353,0.185286028875297,0.990524383380646,1,2,plasma kallikrein-kinin cascade,BP,F12
14503,GO:0070032,0.185448339835332,0.990506876716069,1,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,VAMP2
14504,GO:0070033,0.185448339835332,0.990506876716069,1,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,VAMP2
8655,GO:0034242,0.185499796739583,0.990501322898557,1,2,negative regulation of syncytium formation by plasma membrane fusion,BP,RAPGEF3
2728,GO:0006116,0.185552863545727,0.990495593436852,1,2,NADH oxidation,BP,PCK2
16270,GO:0090402,0.185615307241843,0.990488849129245,1,2,oncogene-induced cell senescence,BP,HMGA2
15365,GO:0071641,0.185646027529221,0.99048553017424,1,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,MEFV
9465,GO:0036117,0.185676604024659,0.990482226117028,1,2,hyaluranon cable,CC,HYAL1
2113,GO:0004906,0.185776520906473,0.990471424792977,1,2,interferon-gamma receptor activity,MF,IFNGR2
1032,GO:0002541,0.185802489602644,0.990468616385019,1,2,activation of plasma proteins involved in acute inflammatory response,BP,F12
9315,GO:0035812,0.185807578401931,0.990468065998509,1,2,renal sodium excretion,BP,COMT
9316,GO:0035813,0.185807578401931,0.990468065998509,1,2,regulation of renal sodium excretion,BP,COMT
19227,GO:1905424,0.18586824612236,0.990461503036092,1,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,CSNK1E
19228,GO:1905426,0.18586824612236,0.990461503036092,1,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,CSNK1E
8030,GO:0032692,0.185999748445473,0.943200257802933,3,16,negative regulation of interleukin-1 production,BP,ACP5;MEFV;GAS6
11511,GO:0046058,0.18601519242249,0.913168314926937,6,40,cAMP metabolic process,BP,RAPGEF3;TIMP2;PKD2;PTHLH;LTB4R2;ADCY6
11530,GO:0046086,0.18610494306119,0.990435873500282,1,2,adenosine biosynthetic process,BP,NT5E
12958,GO:0051387,0.186159167587812,0.990429996703802,1,2,negative regulation of neurotrophin TRK receptor signaling pathway,BP,SPRY2
18155,GO:1902951,0.186223506256009,0.990423021151693,1,2,negative regulation of dendritic spine maintenance,BP,PRNP
19309,GO:1905664,0.186223506256009,0.990423021151693,1,2,regulation of calcium ion import across plasma membrane,BP,PRNP
13809,GO:0060437,0.186368298402665,0.990407312585899,1,2,lung growth,BP,SPRY2
14800,GO:0070564,0.186387361657037,0.990405243341562,1,2,positive regulation of vitamin D receptor signaling pathway,BP,CYP27B1
896,GO:0002276,0.186395098510359,0.990404403464734,1,2,basophil activation involved in immune response,BP,PI4K2A
11247,GO:0045575,0.186395098510359,0.990404403464734,1,2,basophil activation,BP,PI4K2A
10141,GO:0042742,0.18642477396864,0.890129953396556,11,91,defense response to bacterium,BP,SHC1;ACP5;CEBPB;IL6R;MAPKBP1;VGF;TNFRSF1A;GSDMC;LYST;GSDMA;PYCARD
13107,GO:0051694,0.186440407769618,0.990399484083955,1,2,pointed-end actin filament capping,BP,TMOD2
3923,GO:0008614,0.186442758273821,0.990399228843562,1,2,pyridoxine metabolic process,BP,PNPO
3924,GO:0008615,0.186442758273821,0.990399228843562,1,2,pyridoxine biosynthetic process,BP,PNPO
6358,GO:0021549,0.186500635561146,0.901689095466374,8,57,cerebellum development,BP,PTPRS;CNTN1;NAGLU;SERPINE2;WNT7A;SEMA4C;PROX1;TRNP1
15673,GO:0072237,0.186527356280298,0.990390039872521,1,2,metanephric proximal tubule development,BP,PKD1
542,GO:0001661,0.186596863149804,0.990382486442026,1,2,conditioned taste aversion,BP,FOS
13645,GO:0060199,0.186596863149804,0.990382486442026,1,2,clathrin-sculpted glutamate transport vesicle,CC,VAMP2
13648,GO:0060203,0.186596863149804,0.990382486442026,1,2,clathrin-sculpted glutamate transport vesicle membrane,CC,VAMP2
2345,GO:0005415,0.186731948927994,0.990367797026875,1,2,nucleoside:sodium symporter activity,MF,SLC28A2
5229,GO:0015860,0.186731948927994,0.990367797026875,1,2,purine nucleoside transmembrane transport,BP,SLC28A2
5419,GO:0016286,0.186827313488032,0.990357419466253,1,2,small conductance calcium-activated potassium channel activity,MF,KCNN4
14738,GO:0070447,0.186906152631523,0.990348835520489,1,2,positive regulation of oligodendrocyte progenitor proliferation,BP,GJC2
19590,GO:1990769,0.186906152631604,0.990348835520489,1,2,proximal neuron projection,CC,GJC2
11708,GO:0046541,0.186917916450342,0.990347554321705,1,2,saliva secretion,BP,KCNN4
13798,GO:0060423,0.186920598613506,0.990347262193837,1,2,foregut regionalization,BP,WNT2B
13799,GO:0060424,0.186920598613506,0.990347262193837,1,2,lung field specification,BP,WNT2B
13847,GO:0060492,0.186920598613506,0.990347262193837,1,2,lung induction,BP,WNT2B
11323,GO:0045669,0.186924423243001,0.912616636068019,6,40,positive regulation of osteoblast differentiation,BP,CTNNBIP1;FAM20C;CEBPB;ACVR2B;IL6R;WNT7B
16499,GO:0097241,0.186965232294368,0.990342400195462,1,2,hematopoietic stem cell migration to bone marrow,BP,GAS6
1505,GO:0003865,0.186969051364426,0.990341984116709,1,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,SRD5A3
8512,GO:0033765,0.186969051364426,0.990341984116709,1,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,SRD5A3
9245,GO:0035671,0.186969051364426,0.990341984116709,1,2,enone reductase activity,MF,SRD5A3
12015,GO:0047751,0.186969051364426,0.990341984116709,1,2,cholestenone 5-alpha-reductase activity,MF,SRD5A3
18712,GO:1904207,0.186983567194964,0.990340402560158,1,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
18713,GO:1904209,0.186983567194964,0.990340402560158,1,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
3383,GO:0007168,0.186998231213472,0.990338804712133,1,2,receptor guanylyl cyclase signaling pathway,BP,GUCA1B
5373,GO:0016206,0.187002578201009,0.990338331019413,1,2,catechol O-methyltransferase activity,MF,COMT
17094,GO:0102084,0.187002578201009,0.990338331019413,1,2,L-dopa O-methyltransferase activity,MF,COMT
17146,GO:0102938,0.187002578201009,0.990338331019413,1,2,orcinol O-methyltransferase activity,MF,COMT
11437,GO:0045914,0.18700257820109,0.990338331019413,1,2,negative regulation of catecholamine metabolic process,BP,COMT
11471,GO:0045963,0.18700257820109,0.990338331019413,1,2,negative regulation of dopamine metabolic process,BP,COMT
2710,GO:0006096,0.18701599056625,0.893280022583642,10,75,glycolytic process,BP,PGM1;OGDHL;INSR;PFKFB2;DHTKD1;GALK1;MLXIPL;PFKL;HK1;PPARA
15959,GO:0080184,0.187052364809173,0.99033290483743,1,2,response to phenylpropanoid,BP,EGFR
2313,GO:0005324,0.187089708358383,0.990328833700305,1,2,long-chain fatty acid transporter activity,MF,ABCD1
5255,GO:0015910,0.187089708358383,0.990328833700305,1,2,peroxisomal long-chain fatty acid import,BP,ABCD1
17758,GO:1901856,0.187106130991449,0.990327043028799,1,2,negative regulation of cellular respiration,BP,TRAP1
13266,GO:0051990,0.187130015578629,0.990324438401419,1,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,D2HGDH
4527,GO:0010609,0.187178112059678,0.99031919227354,1,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,ZNF385A
1741,GO:0004345,0.187182078516323,0.990318759561532,1,2,glucose-6-phosphate dehydrogenase activity,MF,H6PD
5297,GO:0016013,0.187187506918688,0.990318167344328,1,2,syntrophin complex,CC,SNTA1
5358,GO:0016165,0.187213989648053,0.990315277895366,1,2,linoleate 13S-lipoxygenase activity,MF,ALOX15B
13026,GO:0051542,0.187218879259726,0.990314744352595,1,2,elastin biosynthetic process,BP,HBEGF
16032,GO:0089709,0.187236625448899,0.990312807793818,1,2,L-histidine transmembrane transport,BP,SLC25A29
19537,GO:1990575,0.187236735597026,0.990312795773169,1,2,mitochondrial L-ornithine transmembrane transport,BP,SLC25A29
2298,GO:0005287,0.187236735597269,0.990312795773169,1,2,high-affinity basic amino acid transmembrane transporter activity,MF,SLC25A29
2299,GO:0005289,0.187236735597269,0.990312795773169,1,2,high-affinity arginine transmembrane transporter activity,MF,SLC25A29
2301,GO:0005292,0.187236735597269,0.990312795773169,1,2,high-affinity lysine transmembrane transporter activity,MF,SLC25A29
1747,GO:0004351,0.187242529719662,0.990312163440685,1,2,glutamate decarboxylase activity,MF,GLUL
1544,GO:0003943,0.187244443709761,0.990311954555327,1,2,N-acetylgalactosamine-4-sulfatase activity,MF,GALNS
11286,GO:0045626,0.187277433876704,0.990308353745843,1,2,negative regulation of T-helper 1 cell differentiation,BP,JAK3
18520,GO:1903756,0.187279186706243,0.990308162407308,1,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,ZMYND8
18521,GO:1903758,0.187279186706243,0.990308162407308,1,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,ZMYND8
14076,GO:0060940,0.187316472152258,0.990304091838808,1,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,PDCD4
5792,GO:0017055,0.187328760746917,0.990302750046868,1,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,THRA
3603,GO:0008050,0.187328760746917,0.990302750046868,1,2,female courtship behavior,BP,THRA
11447,GO:0045924,0.187328760746917,0.990302750046868,1,2,regulation of female receptivity,BP,THRA
12307,GO:0048682,0.187360717784773,0.990299260174929,1,2,sprouting of injured axon,BP,LAMB2
1850,GO:0004517,0.187388417215135,0.990296234691945,1,2,nitric-oxide synthase activity,MF,NOS1
19010,GO:1904880,0.187402758312559,0.990294668073401,1,2,response to hydrogen sulfide,BP,PINK1
16820,GO:0098758,0.187406479557546,0.990294261542413,1,2,response to interleukin-8,BP,EGR1
16821,GO:0098759,0.187406479557546,0.990294261542413,1,2,cellular response to interleukin-8,BP,EGR1
9718,GO:0038190,0.187410732100686,0.990293796957698,1,2,VEGF-activated neuropilin signaling pathway,BP,VEGFA
17935,GO:1902336,0.187410732100686,0.990293796957698,1,2,positive regulation of retinal ganglion cell axon guidance,BP,VEGFA
2173,GO:0005021,0.187410732100686,0.990293796957697,1,2,vascular endothelial growth factor-activated receptor activity,MF,NRP2
14280,GO:0061441,0.187410732100686,0.990293796957697,1,2,renal artery morphogenesis,BP,PKD2
4761,GO:0010956,0.187416918738601,0.990293121053684,1,2,negative regulation of calcidiol 1-monooxygenase activity,BP,CYP27B1
4779,GO:0010979,0.187416918738601,0.990293121053684,1,2,regulation of vitamin D 24-hydroxylase activity,BP,CYP27B1
4780,GO:0010980,0.187416918738601,0.990293121053684,1,2,positive regulation of vitamin D 24-hydroxylase activity,BP,CYP27B1
9961,GO:0042369,0.187416918738681,0.990293121053684,1,2,vitamin D catabolic process,BP,CYP27B1
1652,GO:0004109,0.187425013507609,0.990292236642645,1,2,coproporphyrinogen oxidase activity,MF,RSAD1
20017,GO:2000669,0.187432318945174,0.990291438433308,1,2,negative regulation of dendritic cell apoptotic process,BP,GAS6
18653,GO:1904026,0.187454111025378,0.990289057162917,1,2,regulation of collagen fibril organization,BP,CHADL
9551,GO:0036363,0.187462899298984,0.990288096756515,1,2,transforming growth factor beta activation,BP,LTBP3
16738,GO:0098560,0.187464634062242,0.990287907170652,1,2,cytoplasmic side of late endosome membrane,CC,LITAF
15518,GO:0071953,0.187468864644878,0.990287444817303,1,2,elastic fiber,CC,FBLN1
2167,GO:0005006,0.1874721766295,0.990287082847476,1,2,epidermal growth factor-activated receptor activity,MF,EGFR
12673,GO:0050917,0.187472200724567,0.990287080214087,1,2,sensory perception of umami taste,BP,ITPR3
7935,GO:0032542,0.187472827223745,0.990287011742567,1,2,sulfiredoxin activity,MF,SESN2
1979,GO:0004703,0.187477662767856,0.990286483245963,1,2,G-protein coupled receptor kinase activity,MF,GRK6
12007,GO:0047696,0.187477662767856,0.990286483245963,1,2,beta-adrenergic receptor kinase activity,MF,GRK6
14512,GO:0070051,0.187486168148447,0.990285553619037,1,2,fibrinogen binding,MF,FBLN1
1670,GO:0004137,0.187496197161489,0.990284457397682,1,2,deoxycytidine kinase activity,MF,TK2
6079,GO:0019254,0.187499826286012,0.990284060699287,1,2,carnitine metabolic process, CoA-linked,BP,CRAT
3801,GO:0008401,0.187503489909438,0.990283660220738,1,2,retinoic acid 4-hydroxylase activity,MF,CYP2S1
12465,GO:0050473,0.187504516112398,0.990283548042623,1,2,arachidonate 15-lipoxygenase activity,MF,ALOX15B
3750,GO:0008300,0.18751376279776,0.990282537220328,1,2,isoprenoid catabolic process,BP,SRD5A3
6131,GO:0019408,0.18751376279776,0.990282537220328,1,2,dolichol biosynthetic process,BP,SRD5A3
7211,GO:0031117,0.187513988683576,0.990282512526388,1,2,positive regulation of microtubule depolymerization,BP,TRPV4
16188,GO:0090258,0.187514211602827,0.990282488156695,1,2,negative regulation of mitochondrial fission,BP,PINK1
16964,GO:0099074,0.187514211602988,0.990282488156696,1,2,mitochondrion to lysosome transport,BP,PINK1
16965,GO:0099075,0.187514211602988,0.990282488156696,1,2,mitochondrion-derived vesicle mediated transport,BP,PINK1
16122,GO:0090164,0.187516848539233,0.990282199882548,1,2,asymmetric Golgi ribbon formation,BP,MYO18A
9095,GO:0035402,0.187518565135235,0.990282012218953,1,2,histone kinase activity (H3-T11 specific),MF,PKN1
9100,GO:0035407,0.187518565135235,0.990282012218953,1,2,histone H3-T11 phosphorylation,BP,PKN1
4509,GO:0010572,0.18752273646644,0.990281556187683,1,2,positive regulation of platelet activation,BP,DMTN
17735,GO:1901731,0.18752273646644,0.990281556187683,1,2,positive regulation of platelet aggregation,BP,DMTN
17030,GO:0099541,0.18752309424082,0.990281517073408,1,2,trans-synaptic signaling by lipid,BP,F2R
17031,GO:0099542,0.18752309424082,0.990281517073408,1,2,trans-synaptic signaling by endocannabinoid,BP,F2R
17492,GO:1900756,0.187523825678076,0.990281437107558,1,2,protein processing in phagocytic vesicle,BP,GSN
18603,GO:1903921,0.187523825678076,0.990281437107558,1,2,regulation of protein processing in phagocytic vesicle,BP,GSN
18604,GO:1903923,0.187523825678076,0.990281437107558,1,2,positive regulation of protein processing in phagocytic vesicle,BP,GSN
12434,GO:0050253,0.187524658336319,0.990281346075078,1,2,retinyl-palmitate esterase activity,MF,PNPLA4
15301,GO:0071546,0.187524960029954,0.990281313091515,1,2,pi-body,CC,TDRKH
13586,GO:0060086,0.187525040544753,0.990281304288976,1,2,circadian temperature homeostasis,BP,NR1D1
5079,GO:0015349,0.187525223620023,0.990281284273715,1,2,thyroid hormone transmembrane transporter activity,MF,SLCO4A1
15683,GO:0072262,0.187525305809737,0.990281275288019,1,2,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,EGR1
15701,GO:0072301,0.187525305809737,0.990281275288019,1,2,regulation of metanephric glomerular mesangial cell proliferation,BP,EGR1
9132,GO:0035500,0.187525305809737,0.990281275288019,1,2,MH2 domain binding,MF,HMGA2
7601,GO:0031999,0.187525305809738,0.990281275288019,1,2,negative regulation of fatty acid beta-oxidation,BP,AKT1
5110,GO:0015467,0.187525305809816,0.990281275288021,1,2,G-protein activated inward rectifier potassium channel activity,MF,KCNJ15
18181,GO:1902996,0.187525305809818,0.990281275288019,1,2,regulation of neurofibrillary tangle assembly,BP,SORL1
15366,GO:0071642,0.187525305809818,0.990281275288019,1,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,TRPV4
19094,GO:1905064,0.187525305809818,0.990281275288019,1,2,negative regulation of vascular smooth muscle cell differentiation,BP,PDCD4
2618,GO:0005945,0.187525305809819,0.990281275288018,1,2,6-phosphofructokinase complex,CC,PFKL
13035,GO:0051562,0.187525305809898,0.99028127528802,1,2,negative regulation of mitochondrial calcium ion concentration,BP,SLC25A27
5527,GO:0016524,0.187525305809898,0.990281275288021,1,2,latrotoxin receptor activity,MF,ADGRL1
6204,GO:0019732,0.187525305809898,0.99028127528802,1,2,antifungal humoral response,BP,FAM3A
1440,GO:0003430,0.187525305809899,0.990281275288019,1,2,growth plate cartilage chondrocyte growth,BP,RARG
17766,GO:1901873,0.187525305809899,0.990281275288019,1,2,regulation of post-translational protein modification,BP,CRTAP
17767,GO:1901874,0.187525305809899,0.990281275288019,1,2,negative regulation of post-translational protein modification,BP,CRTAP
18542,GO:1903796,0.187525305809899,0.990281275288019,1,2,negative regulation of inorganic anion transmembrane transport,BP,ANO9
5724,GO:0016880,0.1875253058099,0.990281275288019,1,2,acid-ammonia (or amide) ligase activity,MF,GLUL
7631,GO:0032053,0.1875253058099,0.990281275288019,1,2,ciliary basal body organization,BP,CROCC
16659,GO:0097632,0.1875253058099,0.990281275288019,1,2,extrinsic component of phagophore assembly site membrane,CC,ULK1
17643,GO:1901529,0.1875253058099,0.990281275288019,1,2,positive regulation of anion channel activity,BP,PTAFR
19873,GO:2000393,0.1875253058099,0.990281275288019,1,2,negative regulation of lamellipodium morphogenesis,BP,ARPIN
15217,GO:0071403,0.1875253058099,0.990281275288018,1,2,cellular response to high density lipoprotein particle stimulus,BP,ABCG1
15746,GO:0072369,0.1875253058099,0.990281275288018,1,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,PPARA
8749,GO:0034437,0.1875253058099,0.990281275288018,1,2,glycoprotein transporter activity,MF,ABCG1
1025,GO:0002528,0.1875253058099,0.990281275288018,1,2,regulation of vascular permeability involved in acute inflammatory response,BP,CTNNBIP1
12182,GO:0048382,0.1875253058099,0.990281275288018,1,2,mesendoderm development,BP,ZFP36L1
16050,GO:0090038,0.1875253058099,0.990281275288018,1,2,negative regulation of protein kinase C signaling,BP,GPD1L
10039,GO:0042539,0.1875253058099,0.990281275288018,1,2,hypotonic salinity response,BP,TRPV4
15264,GO:0071477,0.1875253058099,0.990281275288018,1,2,cellular hypotonic salinity response,BP,TRPV4
13072,GO:0051611,0.1875253058099,0.990281275288018,1,2,regulation of serotonin uptake,BP,NOS1
13073,GO:0051612,0.1875253058099,0.990281275288018,1,2,negative regulation of serotonin uptake,BP,NOS1
14173,GO:0061113,0.1875253058099,0.990281275288018,1,2,pancreas morphogenesis,BP,PROX1
6787,GO:0030240,0.1875253058099,0.990281275288018,1,2,skeletal muscle thin filament assembly,BP,PROX1
2642,GO:0005988,0.187525305809901,0.990281275288017,1,2,lactose metabolic process,BP,SLC2A1
2643,GO:0005989,0.187525305809901,0.990281275288017,1,2,lactose biosynthetic process,BP,SLC2A1
11616,GO:0046351,0.187525305809901,0.990281275288017,1,2,disaccharide biosynthetic process,BP,SLC2A1
3529,GO:0007529,0.187525305809901,0.990281275288017,1,2,establishment of synaptic specificity at neuromuscular junction,BP,F2R
5456,GO:0016362,0.187525305809901,0.990281275288017,1,2,activin receptor activity, type II,MF,ACVR2B
8630,GO:0034188,0.187525305809901,0.990281275288017,1,2,apolipoprotein A-I receptor activity,MF,ABCA7
9531,GO:0036309,0.187525305809901,0.990281275288017,1,2,protein localization to M-band,BP,OBSCN
15738,GO:0072361,0.187525305809901,0.990281275288017,1,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,PPARA
15741,GO:0072364,0.187525305809901,0.990281275288017,1,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,PPARA
16303,GO:0090554,0.187525305809901,0.990281275288017,1,2,phosphatidylcholine-translocating ATPase activity,MF,ABCA7
16304,GO:0090556,0.187525305809901,0.990281275288017,1,2,phosphatidylserine-translocating ATPase activity,MF,ABCA7
16788,GO:0098679,0.187525305809901,0.990281275288017,1,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,PPARA
18166,GO:1902962,0.187525305809901,0.990281275288017,1,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1
18167,GO:1902963,0.187525305809901,0.990281275288017,1,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1
19338,GO:1905793,0.187525305809901,0.990281275288017,1,2,protein localization to pericentriolar material,BP,NUDCD3
11739,GO:0046619,0.187525305809981,0.990281275288018,1,2,optic placode formation involved in camera-type eye formation,BP,PROX1
13442,GO:0055005,0.187525305809981,0.990281275288018,1,2,ventricular cardiac myofibril assembly,BP,PROX1
13792,GO:0060414,0.187525305809981,0.990281275288018,1,2,aorta smooth muscle tissue morphogenesis,BP,PROX1
14041,GO:0060849,0.187525305809981,0.990281275288018,1,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,PROX1
20027,GO:2000683,0.18752530581006,0.99028127528802,1,2,regulation of cellular response to X-ray,BP,HMGA2
15286,GO:0071505,0.18752530581006,0.99028127528802,1,2,response to mycophenolic acid,BP,EGR1
15287,GO:0071506,0.18752530581006,0.99028127528802,1,2,cellular response to mycophenolic acid,BP,EGR1
20233,GO:2001226,0.18752530581006,0.990281275288019,1,2,negative regulation of chloride transport,BP,ANO9
15700,GO:0072300,0.187525305810062,0.990281275288018,1,2,positive regulation of metanephric glomerulus development,BP,EGR1
5052,GO:0015275,0.187525305810062,0.990281275288018,1,2,stretch-activated, cation-selective, calcium channel activity,MF,TRPV4
17285,GO:0140135,0.187525305810062,0.990281275288018,1,2,mechanosensitive cation channel activity,MF,TRPV4
2118,GO:0004915,0.187525305810062,0.990281275288018,1,2,interleukin-6 receptor activity,MF,IL6R
2593,GO:0005896,0.187525305810062,0.990281275288018,1,2,interleukin-6 receptor complex,CC,IL6R
6312,GO:0019981,0.187525305810062,0.990281275288018,1,2,interleukin-6 binding,MF,IL6R
14550,GO:0070110,0.187525305810062,0.990281275288018,1,2,ciliary neurotrophic factor receptor complex,CC,IL6R
7517,GO:0031749,0.187525305810062,0.990281275288017,1,2,D2 dopamine receptor binding,MF,DNM1
1333,GO:0003192,0.187525305810062,0.990281275288017,1,2,mitral valve formation,BP,ZFPM1
2349,GO:0005436,0.187525305810062,0.990281275288017,1,2,sodium:phosphate symporter activity,MF,SLC20A1
5072,GO:0015319,0.187525305810062,0.990281275288017,1,2,sodium:inorganic phosphate symporter activity,MF,SLC20A1
5073,GO:0015321,0.187525305810062,0.990281275288017,1,2,sodium-dependent phosphate transmembrane transporter activity,MF,SLC20A1
11216,GO:0045409,0.187525305810062,0.990281275288017,1,2,negative regulation of interleukin-6 biosynthetic process,BP,INPP5D
9792,GO:0040038,0.187525305810062,0.990281275288017,1,2,polar body extrusion after meiotic divisions,BP,SPIRE2
10899,GO:0044501,0.187525305810062,0.990281275288017,1,2,modulation of signal transduction in other organism,BP,TNIP1
13269,GO:0052027,0.187525305810062,0.990281275288017,1,2,modulation by symbiont of host signal transduction pathway,BP,TNIP1
13303,GO:0052250,0.187525305810062,0.990281275288017,1,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,TNIP1
14844,GO:0070649,0.187525305810062,0.990281275288017,1,2,formin-nucleated actin cable assembly,BP,SPIRE2
17198,GO:0110009,0.187525305810062,0.990281275288017,1,2,formin-nucleated actin cable organization,BP,SPIRE2
6625,GO:0023016,0.187525305810062,0.990281275288017,1,2,signal transduction by trans-phosphorylation,BP,STK39
8154,GO:0032902,0.187525305810063,0.990281275288017,1,2,nerve growth factor production,BP,FURIN
8518,GO:0033842,0.187525305810063,0.990281275288017,1,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,B4GALNT4
10811,GO:0044323,0.187525305810063,0.990281275288017,1,2,retinoic acid-responsive element binding,MF,RXRA
2216,GO:0005119,0.187525305810063,0.990281275288017,1,2,smoothened binding,MF,BBS1
8860,GO:0034684,0.187525305810063,0.990281275288017,1,2,integrin alphav-beta5 complex,CC,ITGB5
15556,GO:0072053,0.187525305810063,0.990281275288017,1,2,renal inner medulla development,BP,WNT7B
15557,GO:0072054,0.187525305810063,0.990281275288017,1,2,renal outer medulla development,BP,WNT7B
10190,GO:0042823,0.187525305810063,0.990281275288017,1,2,pyridoxal phosphate biosynthetic process,BP,PNPO
12150,GO:0048294,0.187525305810063,0.990281275288017,1,2,negative regulation of isotype switching to IgE isotypes,BP,BCL6
1318,GO:0003169,0.187525305810063,0.990281275288017,1,2,coronary vein morphogenesis,BP,VEGFA
14078,GO:0060948,0.187525305810063,0.990281275288017,1,2,cardiac vascular smooth muscle cell development,BP,VEGFA
8631,GO:0034189,0.187525305810063,0.990281275288017,1,2,very-low-density lipoprotein particle binding,MF,PCSK9
3713,GO:0008240,0.187525305810063,0.990281275288017,1,2,tripeptidyl-peptidase activity,MF,TPP1
12,GO:0000023,0.187525305810063,0.990281275288017,1,2,maltose metabolic process,BP,GAA
1255,GO:0003011,0.187525305810063,0.990281275288017,1,2,involuntary skeletal muscle contraction,BP,GAA
1875,GO:0004558,0.187525305810063,0.990281275288017,1,2,alpha-1,4-glucosidase activity,MF,GAA
5087,GO:0015373,0.187525305810063,0.990281275288017,1,2,anion:sodium symporter activity,MF,SLC5A5
7871,GO:0032450,0.187525305810063,0.990281275288017,1,2,maltose alpha-glucosidase activity,MF,GAA
11313,GO:0045659,0.187525305810063,0.990281275288017,1,2,negative regulation of neutrophil differentiation,BP,INPP5D
12176,GO:0048369,0.187525305810063,0.990281275288017,1,2,lateral mesoderm morphogenesis,BP,FGFR1
12177,GO:0048370,0.187525305810063,0.990281275288017,1,2,lateral mesoderm formation,BP,FGFR1
12178,GO:0048371,0.187525305810063,0.990281275288017,1,2,lateral mesodermal cell differentiation,BP,FGFR1
12179,GO:0048372,0.187525305810063,0.990281275288017,1,2,lateral mesodermal cell fate commitment,BP,FGFR1
12180,GO:0048377,0.187525305810063,0.990281275288017,1,2,lateral mesodermal cell fate specification,BP,FGFR1
12181,GO:0048378,0.187525305810063,0.990281275288017,1,2,regulation of lateral mesodermal cell fate specification,BP,FGFR1
15253,GO:0071462,0.187525305810063,0.990281275288017,1,2,cellular response to water stimulus,BP,PKD2
17654,GO:1901552,0.187525305810063,0.990281275288017,1,2,positive regulation of endothelial cell development,BP,S1PR2
18246,GO:1903142,0.187525305810063,0.990281275288017,1,2,positive regulation of establishment of endothelial barrier,BP,S1PR2
11364,GO:0045762,0.187525305810063,0.990281275288017,1,2,positive regulation of adenylate cyclase activity,BP,TIMP2
14897,GO:0070777,0.187525305810063,0.990281275288017,1,2,D-aspartate transport,BP,NTSR1
14899,GO:0070779,0.187525305810063,0.990281275288017,1,2,D-aspartate import across plasma membrane,BP,NTSR1
9490,GO:0036156,0.187525305810063,0.990281275288017,1,2,inner dynein arm,CC,DNAH1
308,GO:0000820,0.187525305810063,0.990281275288017,1,2,regulation of glutamine family amino acid metabolic process,BP,ATP2B4
495,GO:0001550,0.187525305810063,0.990281275288017,1,2,ovarian cumulus expansion,BP,EREG
910,GO:0002296,0.187525305810063,0.990281275288017,1,2,T-helper 1 cell lineage commitment,BP,STAT6
932,GO:0002331,0.187525305810063,0.990281275288017,1,2,pre-B cell allelic exclusion,BP,RAG1
1468,GO:0003726,0.187525305810063,0.990281275288017,1,2,double-stranded RNA adenosine deaminase activity,MF,ADARB1
1590,GO:0004008,0.187525305810063,0.990281275288017,1,2,copper-exporting ATPase activity,MF,ATP7B
2086,GO:0004854,0.187525305810063,0.990281275288017,1,2,xanthine dehydrogenase activity,MF,XDH
2423,GO:0005608,0.187525305810063,0.990281275288017,1,2,laminin-3 complex,CC,LAMB2
2766,GO:0006196,0.187525305810063,0.990281275288017,1,2,AMP catabolic process,BP,NT5E
2922,GO:0006447,0.187525305810063,0.990281275288017,1,2,regulation of translational initiation by iron,BP,RXRA
3271,GO:0006957,0.187525305810063,0.990281275288017,1,2,complement activation, alternative pathway,BP,C5
3705,GO:0008228,0.187525305810063,0.990281275288017,1,2,opsonization,BP,MYO18A
3913,GO:0008594,0.187525305810063,0.990281275288017,1,2,photoreceptor cell morphogenesis,BP,CDHR1
4056,GO:0009115,0.187525305810063,0.990281275288017,1,2,xanthine catabolic process,BP,XDH
4200,GO:0009331,0.187525305810063,0.990281275288017,1,2,glycerol-3-phosphate dehydrogenase complex,CC,GPD1L
4518,GO:0010593,0.187525305810063,0.990281275288017,1,2,negative regulation of lamellipodium assembly,BP,PLXNB3
4620,GO:0010751,0.187525305810063,0.990281275288017,1,2,negative regulation of nitric oxide mediated signal transduction,BP,ATP2B4
4900,GO:0014846,0.187525305810063,0.990281275288017,1,2,esophagus smooth muscle contraction,BP,SULF2
4943,GO:0015016,0.187525305810063,0.990281275288017,1,2,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,NDST2
5436,GO:0016314,0.187525305810063,0.990281275288017,1,2,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,INPP5D
5631,GO:0016726,0.187525305810063,0.990281275288017,1,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,XDH
5779,GO:0017018,0.187525305810063,0.990281275288017,1,2,myosin phosphatase activity,MF,MYH3
6008,GO:0019072,0.187525305810063,0.990281275288017,1,2,viral genome packaging,BP,PC
6009,GO:0019074,0.187525305810063,0.990281275288017,1,2,viral RNA genome packaging,BP,PC
6341,GO:0021527,0.187525305810063,0.990281275288017,1,2,spinal cord association neuron differentiation,BP,MDGA1
6482,GO:0021847,0.187525305810063,0.990281275288017,1,2,ventricular zone neuroblast division,BP,FGFR1
6537,GO:0021965,0.187525305810063,0.990281275288017,1,2,spinal cord ventral commissure morphogenesis,BP,ADARB1
7259,GO:0031251,0.187525305810063,0.990281275288017,1,2,PAN complex,CC,PAN2
9203,GO:0035607,0.187525305810063,0.990281275288017,1,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,FGFR1
9322,GO:0035838,0.187525305810063,0.990281275288017,1,2,growing cell tip,CC,PI4K2A
9691,GO:0038113,0.187525305810063,0.990281275288017,1,2,interleukin-9-mediated signaling pathway,BP,JAK3
10631,GO:0043682,0.187525305810063,0.990281275288017,1,2,copper-transporting ATPase activity,MF,ATP7B
11365,GO:0045763,0.187525305810063,0.990281275288017,1,2,negative regulation of cellular amino acid metabolic process,BP,ATP2B4
12091,GO:0048165,0.187525305810063,0.990281275288017,1,2,fused antrum stage,BP,EREG
12419,GO:0050119,0.187525305810063,0.990281275288017,1,2,N-acetylglucosamine deacetylase activity,MF,NDST2
12462,GO:0050436,0.187525305810063,0.990281275288017,1,2,microfibril binding,MF,LTBP1
12960,GO:0051389,0.187525305810063,0.990281275288017,1,2,inactivation of MAPKK activity,BP,EPHB2
13019,GO:0051525,0.187525305810063,0.990281275288017,1,2,NFAT protein binding,MF,PPARA
13515,GO:0060003,0.187525305810063,0.990281275288017,1,2,copper ion export,BP,ATP7B
13584,GO:0060083,0.187525305810063,0.990281275288017,1,2,smooth muscle contraction involved in micturition,BP,KCNMA1
13639,GO:0060187,0.187525305810063,0.990281275288017,1,2,cell pole,CC,VANGL2
14243,GO:0061341,0.187525305810063,0.990281275288017,1,2,non-canonical Wnt signaling pathway involved in heart development,BP,VANGL2
14245,GO:0061346,0.187525305810063,0.990281275288017,1,2,planar cell polarity pathway involved in heart morphogenesis,BP,VANGL2
14914,GO:0070829,0.187525305810063,0.990281275288017,1,2,heterochromatin maintenance,BP,MTHFR
15064,GO:0071104,0.187525305810063,0.990281275288017,1,2,response to interleukin-9,BP,JAK3
15139,GO:0071286,0.187525305810063,0.990281275288017,1,2,cellular response to magnesium ion,BP,ANK3
15181,GO:0071355,0.187525305810063,0.990281275288017,1,2,cellular response to interleukin-9,BP,JAK3
15499,GO:0071910,0.187525305810063,0.990281275288017,1,2,determination of liver left/right asymmetry,BP,PKD2
15519,GO:0071955,0.187525305810063,0.990281275288017,1,2,recycling endosome to Golgi transport,BP,TBC1D14
15579,GO:0072092,0.187525305810063,0.990281275288017,1,2,ureteric bud invasion,BP,KIF26B
15968,GO:0086006,0.187525305810063,0.990281275288017,1,2,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,SCN4B
16071,GO:0090080,0.187525305810063,0.990281275288017,1,2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,FGFR1
16350,GO:0090722,0.187525305810063,0.990281275288017,1,2,receptor-receptor interaction,MF,FGFR1
16419,GO:0097109,0.187525305810063,0.990281275288017,1,2,neuroligin family protein binding,MF,DLG4
16660,GO:0097635,0.187525305810063,0.990281275288017,1,2,extrinsic component of autophagosome membrane,CC,ULK1
16938,GO:0098978,0.187525305810063,0.990281275288017,1,2,glutamatergic synapse,CC,SHISA6
16939,GO:0098982,0.187525305810063,0.990281275288017,1,2,GABA-ergic synapse,CC,NLGN2
16940,GO:0098983,0.187525305810063,0.990281275288017,1,2,symmetric, GABA-ergic, inhibitory synapse,CC,NLGN2
16942,GO:0098985,0.187525305810063,0.990281275288017,1,2,asymmetric, glutamatergic, excitatory synapse,CC,SHISA6
17417,GO:1900220,0.187525305810063,0.990281275288017,1,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,PLXNB1
18158,GO:1902954,0.187525305810063,0.990281275288017,1,2,regulation of early endosome to recycling endosome transport,BP,SORL1
18287,GO:1903238,0.187525305810063,0.990281275288017,1,2,positive regulation of leukocyte tethering or rolling,BP,PTAFR
18993,GO:1904849,0.187525305810063,0.990281275288017,1,2,positive regulation of cell chemotaxis to fibroblast growth factor,BP,FGFR1
18998,GO:1904862,0.187525305810063,0.990281275288017,1,2,inhibitory synapse assembly,BP,NLGN2
19035,GO:1904928,0.187525305810063,0.990281275288017,1,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,LRP5
19896,GO:2000427,0.187525305810063,0.990281275288017,1,2,positive regulation of apoptotic cell clearance,BP,ABCA7
19941,GO:2000546,0.187525305810063,0.990281275288017,1,2,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGFR1
20094,GO:2000809,0.187525305810063,0.990281275288017,1,2,positive regulation of synaptic vesicle clustering,BP,NLGN2
3753,GO:0008306,0.187806003939738,0.912080842296929,6,40,associative learning,BP,FOS;DEAF1;ASIC1;SYNGAP1;RAG1;RGS14
17703,GO:1901659,0.187918705501195,0.911756012784729,6,42,glycosyl compound biosynthetic process,BP,NT5E;NME4;UCKL1;TK2;ADA;GUK1
10611,GO:0043627,0.188703355797211,0.905303639631768,7,49,response to estrogen,BP,CITED4;CYP27B1;ASH2L;WNT7A;IGFBP2;COMT;WBP2
16078,GO:0090087,0.188708978317684,0.849428992535943,53,490,regulation of peptide transport,BP,CEMIP;IDH2;RAPGEF3;POSTN;NR1D1;ALOX15B;LRP1;EGFR;B3GAT3;HADH;NLGN2;RHBDF1;F2R;ANK3;LRP5;ERBB2;MICALL2;EDEM1;ITPR3;VPS11;VAMP2;GLUL;TMEM173;PRNP;MYO18A;PFKFB2;ARL2;RHBDF2;MAPK3;HES1;RASL10B;PFKL;MAPKBP1;DMTN;TRPV4;HK1;GAS6;LLGL1;PCK2;PRKCZ;TM7SF3;C5;VSNL1;OSCP1;SORL1;PINK1;PYCARD;KCNN4;SIRT3;SLC2A1;GIPR;MIF;UBL5
7724,GO:0032231,0.18871053432603,0.89585916195747,9,66,regulation of actin filament bundle assembly,BP,RAPGEF3;ARAP1;SH3PXD2B;ID1;EPHA1;SHANK3;FHOD1;PPM1F;ARHGEF10L
17681,GO:1901617,0.188726966747593,0.872081834367836,19,159,organic hydroxy compound biosynthetic process,BP,APOE;CYP27B1;NR1D1;ISYNA1;ABCG1;PLTP;NTSR1;MVD;SRD5A3;SEC14L2;FGFR4;PMVK;TM7SF2;DGKQ;PTAFR;IMPA2;PCK2;PROX1;PNPO
4935,GO:0014910,0.188896197201626,0.911417049180803,6,40,regulation of smooth muscle cell migration,BP,POSTN;LRP1;CORO1B;DOCK4;SSH1;SORL1
17546,GO:1901185,0.188999246436664,0.905114714432397,7,49,negative regulation of ERBB signaling pathway,BP,EGFR;ERBB2;SPRY2;HBEGF;ERBB3;CBLC;EREG
13737,GO:0060341,0.189674180863856,0.844981280077641,66,616,regulation of cellular localization,BP,CEMIP;RAPGEF3;GSN;NOS1;ZFP36L1;NR1D1;EPHB2;LRP1;EGFR;B3GAT3;NLGN2;REEP6;F2R;ZMYND8;KCNC4;ANK3;LRP5;ERBB2;MICALL2;PKD2;EDEM1;DNM1;RIMS3;VPS11;VAMP2;NTSR1;TFDP2;CSNK1E;ASIC1;TMEM173;PRNP;SNX33;CEP250;REEP2;MAPK3;KCNAB2;DVL1;HES1;SSH1;ABCA2;MCTP1;PCSK9;ZFP36;PRKACA;RAB3B;MAP2K2;DMTN;ABHD17C;CROCC;LDLRAP1;GAS6;PIN1;VSNL1;OSCP1;SESN2;ADGRE2;SORL1;ADORA2B;AKT1;GPD1L;PINK1;GSTM2;SHISA6;STXBP2;UBL5;LZTS2
11413,GO:0045861,0.189726392568732,0.865110493899061,24,212,negative regulation of proteolysis,BP,CST3;PRDX5;TIMP2;SERPING1;PLAT;SERPINE2;PRNP;PAPLN;ECM1;VEGFA;TNFRSF6B;FURIN;RAG1;GAS6;SUFU;CTSZ;C5;BIN1;SERPINB6;CSTB;TIMP1;SORL1;AKT1;PCSK1N
2097,GO:0004867,0.189781617896027,0.910617959794136,6,42,serine-type endopeptidase inhibitor activity,MF,SERPING1;SERPINE2;PAPLN;FURIN;SERPINB6;PCSK1N
3105,GO:0006690,0.190187700028178,0.89908795419048,8,59,icosanoid metabolic process,BP,ALOX15B;GGT1;MAPK3;LTA4H;TNFRSF1A;CES2;CYP2S1;MIF
3711,GO:0008238,0.190607116060052,0.8945663363848,9,66,exopeptidase activity,MF,RNPEPL1;NPEPL1;GGT1;BLMH;DPP7;LTA4H;TPP1;CTSZ;CTSH
14625,GO:0070242,0.19066931517498,0.941086821238991,3,16,thymocyte apoptotic process,BP,ADA;RAG1;JAK3
13595,GO:0060113,0.190869735569573,0.917869663446216,5,32,inner ear receptor cell differentiation,BP,NAGLU;VANGL2;HES1;SLITRK6;FGFR1
5657,GO:0016776,0.191061153301449,0.917582707833942,5,33,phosphotransferase activity, phosphate group as acceptor,MF,NME4;DLG4;PMVK;GUK1;DLG3
734,GO:0001965,0.191216737295046,0.940837234943374,3,16,G-protein alpha-subunit binding,MF,F2R;LPAR3;RGS14
5836,GO:0017137,0.192494622557967,0.869156878955428,19,158,Rab GTPase binding,MF,SYTL1;EVI5L;NDRG1;RAB11FIP4;ULK1;TBC1D14;RIN1;MICALL2;RIMS3;TRAPPC9;TBC1D8;RABGGTA;LLGL1;TBC1D16;MADD;SBF1;TBC1D17;ALS2CL;GAS8
6419,GO:0021695,0.192819720543288,0.91674545154382,5,32,cerebellar cortex development,BP,NAGLU;SERPINE2;WNT7A;PROX1;TRNP1
749,GO:0001990,0.193077253450548,0.939986115083853,3,16,regulation of systemic arterial blood pressure by hormone,BP,F2R;RASL10B;CTSZ
9973,GO:0042398,0.193407559558347,0.916226444097609,5,33,cellular modified amino acid biosynthetic process,BP,GAMT;OPLAH;GGT1;HAGH;GSS
5684,GO:0016814,0.193654565662044,0.926228526732839,4,24,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,ADARB1;ADA;APOBEC3C;APOBEC3F
4721,GO:0010894,0.194095994691928,0.939518210668059,3,16,negative regulation of steroid biosynthetic process,BP,APOE;CYP27B1;PROX1
11459,GO:0045939,0.194095994691928,0.939518210668059,3,16,negative regulation of steroid metabolic process,BP,APOE;CYP27B1;PROX1
4136,GO:0009206,0.194274240844032,0.879134258361022,13,105,purine ribonucleoside triphosphate biosynthetic process,BP,PGM1;NME4;OGDHL;INSR;PFKFB2;DHTKD1;GALK1;MLXIPL;PFKL;HK1;PPARA;PINK1;TAZ
12534,GO:0050709,0.194561319316643,0.891721581987962,9,68,negative regulation of protein secretion,BP,IDH2;HADH;RHBDF1;F2R;RHBDF2;PFKL;MAPKBP1;GAS6;VSNL1
488,GO:0001541,0.19460603314437,0.907782107033224,6,41,ovarian follicle development,BP,ZP3;VEGFA;CEBPB;VGF;DMC1;EREG
3269,GO:0006955,0.194693813027747,0.831962372169137,124,1213,immune response,BP,TNIP1;FOS;PTPRS;ERCC1;GAA;LTB4R;NAPRT;PYGB;CST3;PGM1;CYP27B1;GSN;PRSS3;NR1D1;RBCK1;MST1R;LRP1;TIMP2;SERPING1;EGR1;PKN1;PYGL;SHC1;PTK6;CTSB;PIK3R2;ZP3;ZFPM1;TFEB;FUCA1;VAT1;HEXB;VAMP2;RNF135;GM2A;TNFRSF25;PRR7;RAB3D;ADARB1;IL20RB;NBEAL2;TMEM173;PRNP;RNASET2;ECM1;NPDC1;STAT6;ISG20;SCART1;BCL6;CD81;SRMS;FCGRT;DNASE1L1;AP2A2;CEBPB;DPP7;ADAM15;TNFRSF6B;MAPK3;KCNAB2;GLB1;WIPF1;LTA4H;MEFV;SLC2A3;TRIM4;TNFRSF14;ADA;PAG1;PFKL;IL6R;RHOF;PRKACA;F12;CYFIP2;RPS6KA5;PI4K2A;TNFRSF1A;IFNGR2;RAG1;HK1;FAM3A;SDHAF4;GAS6;BTRC;TKFC;PTAFR;VAV3;BCR;MUC19;PRKCZ;ADAMTS13;INPP5D;ICOSLG;MAPKAPK3;CTSZ;C5;GTPBP1;SERPINB6;TOLLIP;CSTB;ADGRE2;CD68;ACTR1B;APOBEC3C;LYST;ADORA2B;HGSNAT;ABR;PNMA1;CTSD;NLRX1;SPPL2B;CTSH;PYCARD;KCNN4;APOBEC3F;JAK3;GALNS;EREG;RPL13A;MIF;STXBP2
3739,GO:0008285,0.194823286470152,0.844804863744291,51,470,negative regulation of cell proliferation,BP,APOE;CTNNBIP1;IDH2;CYP27B1;XDH;NDRG1;CGREF1;ALOX15B;TIMP2;FBXO2;MXD4;PKN1;F2R;MXI1;RPS6KA2;ERBB2;FBLN1;PTPRU;PKD2;PTHLH;CDKN1C;CD9;SERPINE2;FUZ;PDCD4;ADARB1;IL20RB;PRNP;SPRY2;MNT;SPEG;BCL6;PLXNB1;CEBPB;HES1;SLIT3;COMT;INPP5D;PROX1;DLG3;JARID2;FGFBP1;TP53INP1;NDRG2;SIX5;GAS8;RARG;ING4;EREG;TP53I11;LZTS2
20077,GO:2000778,0.195017234250703,0.939093952617618,3,16,positive regulation of interleukin-6 secretion,BP,F2R;TRPV4;PYCARD
6251,GO:0019852,0.195426137738411,0.958082657025028,2,9,L-ascorbic acid metabolic process,BP,SLC2A3;SLC2A1
11184,GO:0045333,0.195515967284269,0.869655554391488,17,154,cellular respiration,BP,IDH2;NFATC4;D2HGDH;OGDHL;NDUFS8;BNIP3;DHTKD1;SDHAF4;SDHA;MDH2;ETFB;TRAP1;UQCR11;PINK1;NDUFV3;SIRT3;TAZ
15297,GO:0071542,0.195623646156801,0.93881409375477,3,16,dopaminergic neuron differentiation,BP,CSNK1E;VEGFA;WNT3
12203,GO:0048483,0.196215104205637,0.924867494286368,4,24,autonomic nervous system development,BP,ADARB1;HES1;NRP2;SEMA3F
9724,GO:0038201,0.196218828062108,0.938538963722401,3,16,TOR complex,CC,SESN2;PINK1;MLST8
16825,GO:0098771,0.196231800138805,0.847248616083902,42,385,inorganic ion homeostasis,BP,CEMIP;APOE;CYP27B1;NOS1;EPAS1;EGFR;F2R;CA12;ANK3;PKD2;SLC7A8;ITPR3;HEXB;NTSR1;ATP2B4;LPAR3;PRNP;ATP7B;SLC12A7;DLG4;ATP12A;BNIP3;MAPK3;PRKACA;SCNN1A;SLC25A37;FGFR4;TRPV4;COMT;TMEM175;NEO1;PDK2;KCNMA1;SLC25A27;SMDT1;CYBRD1;SLC9A7;TPCN1;PKD1;SLC22A17;GSTM2;GIPR
16969,GO:0099081,0.196244489121734,0.839676653518607,64,597,supramolecular polymer,CC,ESPN;FLNC;FAM110C;CLIP2;CST3;SHANK2;NDRG1;NOS1;LTBP1;PARVB;COL6A1;SCN8A;OBSCN;MYZAP;OBSL1;DNAH1;CORO1B;ANK3;TUBG2;PKD2;DNM1;KIF13B;NINL;THSD4;ATP2B4;TMOD2;ENKD1;TNXB;RAB3D;SPRY2;REEP2;HOOK2;KCNAB2;TNNT1;DVL1;MTA1;WIPF1;FBF1;MEFV;MAP2K2;DMTN;MYH3;TRPV4;LDLRAP1;AHNAK2;REEP4;PRKCZ;TWF2;NDE1;NICN1;BIN1;BFSP1;SYNC;SNPH;MAPRE3;GAS8;RGS14;SLC2A1;KIFC2;PBXIP1;KRT15;TTLL11;KIF26B;LZTS2
3442,GO:0007260,0.196365315430063,0.906695553878904,6,41,tyrosine phosphorylation of STAT protein,BP,PTK6;HES1;IL6R;FGFR3;TNFRSF1A;JAK3
4052,GO:0009110,0.196674418494791,0.938328057927102,3,16,vitamin biosynthetic process,BP,CYP27B1;PLTP;PNPO
904,GO:0002287,0.196707592371907,0.91449073283606,5,32,alpha-beta T cell activation involved in immune response,BP,ZFPM1;STAT6;BCL6;PRKCZ;JAK3
907,GO:0002293,0.196707592371907,0.91449073283606,5,32,alpha-beta T cell differentiation involved in immune response,BP,ZFPM1;STAT6;BCL6;PRKCZ;JAK3
7117,GO:0030952,0.196789902053703,0.938274555486615,3,16,establishment or maintenance of cytoskeleton polarity,BP,RHOD;RHOF;RHOBTB2
19164,GO:1905276,0.196838418114094,0.938252073411605,3,16,regulation of epithelial tube formation,BP,CELSR1;VANGL2;DVL1
4510,GO:0010573,0.197036200354516,0.924429351677868,4,24,vascular endothelial growth factor production,BP,C5;ADORA2B;NDRG2;SULF2
8581,GO:0034103,0.197216244577138,0.906168776434255,6,41,regulation of tissue remodeling,BP,CST3;EGFR;LRP5;BCR;INPP5D;ABR
5391,GO:0016239,0.197495350483323,0.894294364208358,8,58,positive regulation of macroautophagy,BP,ULK1;BNIP3;MAPK3;FYCO1;GPSM1;LRSAM1;SESN2;PINK1
4415,GO:0010243,0.197629317285232,0.837245583551124,69,648,response to organonitrogen compound,BP,FOS;APOE;RAPGEF3;GSN;ZFP36L1;COL6A1;IGF2;LRP1;MAPK13;EGFR;HADH;FBXO2;UROS;MTHFR;EGR1;SHC1;PIK3R2;HDAC5;LRP5;BSG;PKD2;TMEM129;EDEM1;CD9;PTPRE;VAMP2;ATP2B4;INSR;ID1;DNMT3A;PRNP;ANKZF1;CD81;CEBPB;MAPK3;ADCY6;SSH1;ADA;PCSK9;HLCS;PRKACA;DMTN;VGF;LDLR;TRPV4;EEF2K;DGKQ;PPARA;PTAFR;PCK2;PRKCZ;ADAMTS13;PDK2;SRSF5;MAN1B1;GRB10;CAPN2;SESN2;TIMP1;SDC1;GSS;AKT1;SLC5A5;HOMER2;POMT1;SLC2A1;JAK3;EREG;GSTM2
14768,GO:0070509,0.19768931148878,0.913918613272806,5,32,calcium ion import,BP,PKD2;ATP2B4;PRNP;TRPV4;SMDT1
4853,GO:0014704,0.197751402700793,0.913882390522831,5,32,intercalated disc,CC,OBSL1;ANK3;SCN4B;FHOD1;SLC2A1
10767,GO:0044248,0.197835930632412,0.825177139003522,181,1801,cellular catabolic process,BP,CEMIP;APOE;TYSND1;RNPEPL1;NT5E;GAA;BTBD2;PYGB;RNF44;CST3;RAPGEF3;PGM1;CYP27B1;XDH;PRDX5;PCBP4;PRODH;NOS1;ZFP36L1;NR1D1;CRAT;ARRDC1;RBCK1;CPT2;GPX3;LRP1;TIMP2;H1F0;ALDH4A1;HADH;CRYL1;FBXO2;ACOT7;ULK1;RHBDF1;PYGL;TRIM65;CTSB;ULK2;TBC1D14;PACS2;PIK3R2;HYAL1;TFEB;CTSF;OGDHL;CBS;GID4;TMEM129;FUCA1;TST;CPT1C;EDEM1;ABTB1;ITGB4;CUL9;HEXB;VPS11;ATP2B4;GGT1;CSNK1E;ADAMTS7;GM2A;GLUL;USP20;SPATA18;INSR;HAGH;DNPH1;SRD5A3;RNASET2;SNX33;BLMH;ATG16L2;SNX9;ABCD1;WWTR1;ISG20;ANKZF1;PFKFB2;MVB12B;BNIP3;CD81;ENTPD6;DNASE1L1;FBXW4;AP2A2;ENDOG;MAPK3;GLB1;DHTKD1;DVL1;ENTPD2;GALK1;MTA1;FYCO1;GPSM1;LTA4H;WIPI2;ACAD10;FURIN;MLXIPL;CUL7;MEFV;LRSAM1;ADA;PFKL;PCSK9;ZFP36;BTBD11;PRKACA;NUDT10;MAGEF1;DAP;FBXW5;LDLR;CYP3A5;PEX7;MVB12A;HK1;BTRC;PPARA;HMGCL;TKFC;BLVRB;COMT;SUFU;AIG1;PAN2;ATG2A;PCK2;USP21;RNF123;ADAMTS13;ETFB;TPP1;GPC1;SMOX;AGO4;RAD23A;CTSZ;SPSB3;MAN1B1;PNPLA4;PHYH;GTPBP1;SH3D19;CAPN2;SESN2;TOLLIP;PNRC1;TIMP1;APOBEC3C;TBC1D17;TPCN1;CYP2S1;AKT1;HPDL;CTSD;TP53INP1;NAGA;PINK1;PKD1;LONP2;CTSH;MLST8;CBLC;RNF187;PYCARD;POMT1;ERN1;APOBEC3F;ACADS;FBXL20;GCAT;MLYCD;BCKDHA;NEIL1;GALNS;GSTM2;RPL13A
11352,GO:0045740,0.19787315557549,0.905761558992661,6,41,positive regulation of DNA replication,BP,CST3;EGFR;SHC1;INSR;FGFR1;EREG
3149,GO:0006757,0.198203031218617,0.885379711034744,10,76,ATP generation from ADP,BP,PGM1;OGDHL;INSR;PFKFB2;DHTKD1;GALK1;MLXIPL;PFKL;HK1;PPARA
11371,GO:0045776,0.198249291550776,0.923780533664164,4,24,negative regulation of blood pressure,BP,NOS1;NTSR1;PPARA;PTAFR
10005,GO:0042455,0.198351975166221,0.913174895920215,5,34,ribonucleoside biosynthetic process,BP,NT5E;NME4;UCKL1;ADA;GUK1
11242,GO:0045540,0.198387330124154,0.90544249005791,6,41,regulation of cholesterol biosynthetic process,BP,APOE;ABCG1;MVD;SEC14L2;PMVK;TM7SF2
20074,GO:2000774,0.198432416121129,0.957021236000335,2,9,positive regulation of cellular senescence,BP,YPEL3;HMGA2
2716,GO:0006103,0.198472371600434,0.937493166901471,3,16,2-oxoglutarate metabolic process,BP,IDH2;D2HGDH;PHYH
5908,GO:0018193,0.198694466299065,0.831232734689373,98,937,peptidyl-amino acid modification,BP,CEMIP;RAPGEF3;NOS1;EPHB2;CNTN1;IGF2;MST1R;MAPK13;ST6GALNAC2;EGFR;FKBP9;EGR1;ULK1;PKN1;SHC1;PTK6;ASH2L;CRTAP;ERBB2;GALNT12;JADE2;ATP2B4;CSNK1E;INSR;RAB3D;EPHA1;PRNP;SPRY2;HINT2;DLG4;MKNK2;DYRK1B;CD81;SRMS;VEGFA;MAST4;ZDHHC1;S1PR2;MAPK3;MTA1;PKN3;ST3GAL3;EPHB3;HES1;MLXIPL;FKBP10;IL6R;FGFR3;PRKACA;LRRK1;RPS6KA5;HBEGF;RAB3B;MAP2K2;FGFR4;DMTN;TNFRSF1A;EHD4;HMGA2;DGKQ;PADI3;GAS6;STK32C;BCR;PRKCZ;ZDHHC24;MAPKAPK3;FGFR1;CAMKK1;PIN1;KMT5C;WBP2;DLG3;JARID2;TOLLIP;PPM1F;STK39;ACVR1B;ERBB3;AKT1;VPS33B;ERCC6;GPD1L;PINK1;PKD1;SNTA1;P3H4;MLST8;CBLC;MAP2K3;ERN1;SIRT3;JAK3;MAST3;ING4;EREG;TTLL11;MIF
12401,GO:0048872,0.198699055903978,0.862789213209319,20,170,homeostasis of number of cells,BP,ZFP36L1;FAM210B;EPAS1;PKN1;F2R;THRA;ZFPM1;IL20RB;BCL6;VEGFA;ADA;ZFP36;DMTN;RAG1;BCR;INPP5D;ACVR1B;AKT1;JAK3;MIF
17054,GO:0099604,0.198754059288559,0.937361992540043,3,16,ligand-gated calcium channel activity,MF,PKD2;ITPR3;TPCN1
3184,GO:0006816,0.199071797076441,0.857623334065813,24,207,calcium ion transport,BP,CEMIP;CYP27B1;NOS1;F2R;GJC2;PKD2;ITPR3;NTSR1;ATP2B4;ASIC1;LPAR3;PRNP;PRKACA;TRPV4;GAS6;SMDT1;TPCN1;PKD1;EHD3;HOMER2;KCNN4;ORAI3;ORAI2;GSTM2
507,GO:0001570,0.199372855588363,0.898431976470039,7,49,vasculogenesis,BP,XDH;ZFP36L1;WNT7A;ZMIZ1;VEGFA;CUL7;WNT7B
5725,GO:0016881,0.199424721426291,0.93704927924574,3,16,acid-amino acid ligase activity,MF,GSS;PPCS;TTLL11
5835,GO:0017136,0.199649238181631,0.936944465506219,3,16,NAD-dependent histone deacetylase activity,MF,HDAC5;HDAC11;SIRT3
20154,GO:2001028,0.200154811886498,0.956407987363283,2,9,positive regulation of endothelial cell chemotaxis,BP,VEGFA;FGFR1
16968,GO:0099080,0.200228900967769,0.836154824955371,64,598,supramolecular complex,CC,ESPN;FLNC;FAM110C;CLIP2;CST3;SHANK2;NDRG1;NOS1;LTBP1;PARVB;COL6A1;SCN8A;OBSCN;MYZAP;OBSL1;DNAH1;CORO1B;ANK3;TUBG2;PKD2;DNM1;KIF13B;NINL;THSD4;ATP2B4;TMOD2;ENKD1;TNXB;RAB3D;SPRY2;REEP2;HOOK2;KCNAB2;TNNT1;DVL1;MTA1;WIPF1;FBF1;MEFV;MAP2K2;DMTN;MYH3;TRPV4;LDLRAP1;AHNAK2;REEP4;PRKCZ;TWF2;NDE1;NICN1;BIN1;BFSP1;SYNC;SNPH;MAPRE3;GAS8;RGS14;SLC2A1;KIFC2;PBXIP1;KRT15;TTLL11;KIF26B;LZTS2
11557,GO:0046133,0.200251603880998,0.956373414392344,2,9,pyrimidine ribonucleoside catabolic process,BP,APOBEC3C;APOBEC3F
1277,GO:0003073,0.200271249546461,0.904270933936822,6,41,regulation of systemic arterial blood pressure,BP,POSTN;F2R;NTSR1;RASL10B;GAS6;CTSZ
4971,GO:0015103,0.200274798207112,0.883914091239095,10,76,inorganic anion transmembrane transporter activity,MF,CLCA2;ANO8;SLC20A1;SLC12A7;TTYH3;LRRC8A;SLC37A2;ANO9;SLC5A5;SLC22A17
10148,GO:0042752,0.200355478936567,0.887793168086732,9,67,regulation of circadian rhythm,BP,NR1D1;CRTC1;CSNK1E;MTA1;ADA;BHLHE40;BTRC;PPARA;PROX1
12299,GO:0048672,0.200443338943054,0.956304894072345,2,9,positive regulation of collateral sprouting,BP,LPAR3;WNT3
2419,GO:0005604,0.200453669760238,0.887725163673741,9,67,basement membrane,CC,CST3;SMOC2;LOXL1;LAMA5;FBLN1;LAMB2;ITGA6;ENTPD2;TIMP1
5261,GO:0015919,0.200614953627432,0.936492903061375,3,16,peroxisomal membrane transport,BP,PEX10;ABCD1;PEX7
20149,GO:2001023,0.200628382742917,0.903914655484296,6,42,regulation of response to drug,BP,ENDOG;RAB3B;HMGA2;STK39;TRAP1;PINK1
1501,GO:0003857,0.200880984568142,0.956148319517023,2,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,HADH;CRYL1
18216,GO:1903053,0.200906406197623,0.922353128870987,4,24,regulation of extracellular matrix organization,BP,CST3;LRP1;FGFR4;CHADL
6721,GO:0030145,0.201329934757614,0.903610848710439,6,41,manganese ion binding,MF,NPEPL1;GLUL;FAM20C;HMGCL;PCK2;PRIMPOL
19834,GO:2000341,0.201562264079373,0.955904101776876,2,9,regulation of chemokine (C-X-C motif) ligand 2 production,BP,POSTN;MIF
7585,GO:0031968,0.201719277837369,0.861817105740004,19,162,organelle outer membrane,CC,CYP27B1;FAM210B;ULK1;BPHL;CPT1C;ITPR3;VAT1;SIGMAR1;SNN;ARMCX2;SPATA18;TMEM173;ANKZF1;BNIP3;RETSAT;HK1;NLRX1;PINK1;SYNE3
16876,GO:0098858,0.202122446058467,0.868696267104188,15,122,actin-based cell projection,CC,ESPN;SYTL1;RAPGEF3;BBS2;ACTA2;DOCK4;TENM2;KIF13B;ITGA6;TRPV4;PLEKHG6;TWF2;EPS8L2;HOMER2;MORN4
11022,GO:0045019,0.202129444455349,0.955700339849841,2,9,negative regulation of nitric oxide biosynthetic process,BP,ATP2B4;ACP5
18799,GO:1904406,0.202129444455349,0.955700339849841,2,9,negative regulation of nitric oxide metabolic process,BP,ATP2B4;ACP5
1703,GO:0004222,0.202786773610471,0.890731047552571,8,58,metalloendopeptidase activity,MF,CLCA2;MMP28;MMP1;ADAMTS7;ADAM15;ADAMTS13;LMLN;ADAM19
3259,GO:0006937,0.202998928071389,0.881863554361707,10,78,regulation of muscle contraction,BP,NOS1;F2R;DOCK4;TNNT1;ADA;PRKACA;PTAFR;ADORA2B;EHD3;GSTM2
12077,GO:0048103,0.203520430819398,0.935127221005004,3,16,somatic stem cell division,BP,WNT7A;VANGL2;FGFR1
4082,GO:0009145,0.203776343326284,0.872028882087437,13,106,purine nucleoside triphosphate biosynthetic process,BP,PGM1;NME4;OGDHL;INSR;PFKFB2;DHTKD1;GALK1;MLXIPL;PFKL;HK1;PPARA;PINK1;TAZ
20165,GO:2001044,0.20392106095798,0.955054037626696,2,9,regulation of integrin-mediated signaling pathway,BP,DMTN;TIMP1
4094,GO:0009157,0.203996919493428,0.955026583618887,2,9,deoxyribonucleoside monophosphate biosynthetic process,BP,TK2;DGUOK
7767,GO:0032303,0.204123766572584,0.954980660159186,2,9,regulation of icosanoid secretion,BP,NTSR1;MIF
3538,GO:0007568,0.204380734064817,0.853262041356712,24,210,aging,BP,FOS;ERCC1;GSN;LRP1;TIMP2;SERPING1;PDCD4;ZMIZ1;DNMT3A;PRNP;MNT;BCL6;IGFBP2;YPEL3;ENDOG;ADA;HMGA2;INPP5D;TIMP1;GSS;AKT1;SIRT3;LITAF;MIF
7034,GO:0030819,0.204877090880182,0.954707511522276,2,9,positive regulation of cAMP biosynthetic process,BP,TIMP2;PTHLH
13520,GO:0060009,0.204960293508648,0.954677299264484,2,9,Sertoli cell development,BP,CST3;SDC1
1169,GO:0002792,0.205261599982237,0.884243292754887,9,69,negative regulation of peptide secretion,BP,IDH2;HADH;RHBDF1;F2R;RHBDF2;PFKL;MAPKBP1;GAS6;VSNL1
10020,GO:0042490,0.20530458133459,0.909251157632179,5,33,mechanoreceptor differentiation,BP,NAGLU;VANGL2;HES1;SLITRK6;FGFR1
3147,GO:0006754,0.205328970839674,0.873644940049394,12,96,ATP biosynthetic process,BP,PGM1;OGDHL;INSR;PFKFB2;DHTKD1;GALK1;MLXIPL;PFKL;HK1;PPARA;PINK1;TAZ
13673,GO:0060253,0.205462850529308,0.954494627511549,2,9,negative regulation of glial cell proliferation,BP,IDH2;HES1
8425,GO:0033559,0.205569426163283,0.888674772714079,8,60,unsaturated fatty acid metabolic process,BP,ALOX15B;ABCD1;MAPK3;TNFRSF1A;CES2;CYP2S1;GSTM2;MIF
13046,GO:0051580,0.205773921116176,0.954381399136186,2,9,regulation of neurotransmitter uptake,BP,NOS1;RAB3B
7981,GO:0032611,0.205867971453651,0.900629987849623,6,42,interleukin-1 beta production,BP,EGR1;F2R;ACP5;MEFV;HK1;PYCARD
7453,GO:0031623,0.205876628440933,0.888549997066793,8,59,receptor internalization,BP,LRP1;DNM1;CD9;DLG4;CD81;VEGFA;PCSK9;LDLRAP1
14691,GO:0070365,0.206060144744575,0.954277107556829,2,9,hepatocyte differentiation,BP,PCK2;PROX1
10154,GO:0042759,0.206130989100083,0.95425127804116,2,9,long-chain fatty acid biosynthetic process,BP,ALOX15B;ACOT7
1224,GO:0002902,0.206143420722701,0.933431672282852,3,17,regulation of B cell apoptotic process,BP,BCL6;ADA;MIF
16315,GO:0090596,0.206181531230704,0.861653619518107,17,141,sensory organ morphogenesis,BP,EPHB2;SDK2;NAGLU;LRP5;CELSR1;SPRY2;VEGFA;VANGL2;MAPK3;DVL1;BCR;SLITRK6;FGFR1;PROX1;WNT2B;ABR;RARG
10633,GO:0043687,0.206696704706429,0.842157498804256,35,319,post-translational protein modification,BP,APOE;CST3;LTBP1;EPAS1;OBSL1;FBXO2;DDB2;CRTAP;ANO8;CUL9;LAMB2;FBXW8;RABGGTA;FBXO27;FBXL8;FBXO41;FAM20C;FBXW4;FBXL16;WIPI2;CUL7;LY6K;PCSK9;FBXW5;MXRA8;MDGA1;VGF;MSLN;FBXO17;GAS6;BTRC;IGFBP4;SPSB3;TIMP1;FBXL20
3542,GO:0007584,0.206918024603356,0.861027240894092,17,143,response to nutrient,BP,ERCC1;CYP27B1;GSN;POSTN;EGFR;MTHFR;DNMT3A;IGFBP2;SSH1;ADA;AQP3;HLCS;DGKQ;GAS6;HMGCL;PDK2;GIPR
5400,GO:0016254,0.20698117603821,0.93303076137853,3,17,preassembly of GPI anchor in ER membrane,BP,PIGZ;PIGV;PIGQ
948,GO:0002367,0.207018158566082,0.893217711708407,7,51,cytokine production involved in immune response,BP,BCL6;MAPK3;HK1;GAS6;PRKCZ;JAK3;MIF
17800,GO:1901985,0.207060816796372,0.908207628306687,5,33,positive regulation of protein acetylation,BP,RAPGEF3;NOS1;MAPK3;RPS6KA5;WBP2
11571,GO:0046173,0.207342192383451,0.899700387945003,6,42,polyol biosynthetic process,BP,CYP27B1;ISYNA1;NTSR1;PTAFR;IMPA2;PCK2
3653,GO:0008144,0.207370143747777,0.819659070862541,132,1268,drug binding,MF,PYGB;NOS1;SCN8A;EPHB2;OBSCN;NME4;MST1R;MAPK13;CDK18;EGFR;ACSF2;FKBP9;ULK1;PKN1;PYGL;PTK6;ABCA7;ACTA2;DNAH1;ULK2;DGKA;ABCG1;OPLAH;NEK9;RPS6KA2;NMRK1;MARK4;ERBB2;BRSK1;CBS;ITPR3;CUL9;KIF13B;SIGMAR1;PAK6;CD320;MINK1;ATP2B4;CSNK1E;GLUL;INSR;GRK6;MVD;EPHA1;TMEM173;DHX32;ATP7B;SPEG;ABCD1;MKNK2;STRADB;FAM20C;MYO18A;UCKL1;PFKFB2;ATP12A;DYRK1B;SRMS;MAST4;ACVR2B;MAPK3;ENTPD2;GALK1;FYCO1;ADCY6;PKN3;EPHB3;PC;NADK;ABCA2;TK2;FKBP10;CKMT1A;PFKL;HLCS;FGFR3;PRKACA;LRRK1;DGUOK;RPS6KA5;MAP2K2;PI4K2A;FGFR4;PMVK;MYH3;EHD4;CYP3A5;TRPV4;EEF2K;DGKQ;HK1;PPARA;TKFC;GUK1;STK32C;DMC1;BCR;PRKCZ;HLTF;ABCD4;TWF2;PDK2;MAPKAPK3;FGFR1;CAMKK1;ASS1;ACTR1B;STK39;ACVR1B;GSS;ERBB3;AKT1;TRAP1;NLRX1;TUT1;SMARCA1;ERCC6;ADCK2;PINK1;EHD3;LONP2;MAP2K3;PNPO;STK17A;ERN1;GCAT;JAK3;MAST3;KIFC2;FUK;TTLL11;KIF26B
5417,GO:0016281,0.207498148972592,0.953751583259208,2,9,eukaryotic translation initiation factor 4F complex,CC,EIF4EBP3;EIF4G3
2976,GO:0006527,0.207626938158944,0.953704390019608,2,9,arginine catabolic process,BP,NOS1;ATP2B4
17809,GO:1901998,0.207655144273726,0.907853686924967,5,33,toxin transport,BP,ABCG1;SLC7A8;DNM1;BNIP3;RAB40B
303,GO:0000813,0.207912200522322,0.953599784907842,2,9,ESCRT I complex,CC,MVB12B;MVB12A
745,GO:0001977,0.208659395817199,0.953325305558569,2,9,renal system process involved in regulation of blood volume,BP,F2R;GAS6
7263,GO:0031256,0.208823348767813,0.865821535754097,14,113,leading edge membrane,CC,ARHGEF4;ABCA7;KCNC4;SPRY4;INSR;SPRY2;PSD4;TRPV4;ADGRE2;EPB41L3;EPS8L1;EPS8L2;DDN;SHISA6
10579,GO:0043567,0.208885765348236,0.953242011200396,2,9,regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP2;IGFBP4
8719,GO:0034383,0.209025777192434,0.917658459056558,4,25,low-density lipoprotein particle clearance,BP,AP2A2;PCSK9;LDLR;LDLRAP1
11047,GO:0045064,0.209030714361184,0.953188642338471,2,9,T-helper 2 cell differentiation,BP,BCL6;PRKCZ
3371,GO:0007156,0.209088373132182,0.881708538313846,9,67,homophilic cell adhesion via plasma membrane adhesion molecules,BP,CADM4;SDK2;IGSF9;PLXNB3;CELSR1;CELSR2;CDHR1;PCDHGC3;PKD1
17927,GO:1902306,0.209331585713753,0.953077780128731,2,9,negative regulation of sodium ion transmembrane transport,BP,PCSK9;STK39
13237,GO:0051952,0.209352498851581,0.917478631843293,4,25,regulation of amine transport,BP,NTSR1;RAB3B;STK39;PINK1
2747,GO:0006165,0.209575787909195,0.873623652406738,11,87,nucleoside diphosphate phosphorylation,BP,PGM1;NME4;OGDHL;INSR;PFKFB2;DHTKD1;GALK1;MLXIPL;PFKL;HK1;PPARA
6074,GO:0019239,0.209603680528419,0.917340294526205,4,25,deaminase activity,MF,ADARB1;ADA;APOBEC3C;APOBEC3F
3684,GO:0008198,0.20960609944091,0.931768873433848,3,17,ferrous iron binding,MF,ACP5;PHYH;ALKBH6
10202,GO:0042866,0.209655569324979,0.877166442745851,10,77,pyruvate biosynthetic process,BP,PGM1;OGDHL;INSR;PFKFB2;DHTKD1;GALK1;MLXIPL;PFKL;HK1;PPARA
12572,GO:0050774,0.209699606217054,0.952942020902272,2,9,negative regulation of dendrite morphogenesis,BP,NFATC4;ID1
7328,GO:0031362,0.209720753182873,0.952934214823636,2,9,anchored component of external side of plasma membrane,CC,PRNP;RTN4R
7409,GO:0031514,0.2101150580649,0.876776985078822,10,78,motile cilium,CC,BBS2;DNAH1;PKD2;ATP2B4;PRKACA;SCNN1A;HK1;GAS8;PKD1;MAFIP
2712,GO:0006098,0.210198081416355,0.931483090683827,3,17,pentose-phosphate shunt,BP,H6PD;PGLS;TALDO1
13440,GO:0055002,0.21025105448795,0.876739083939434,10,77,striated muscle cell development,BP,FLNC;OBSCN;OBSL1;TMOD2;VEGFA;TNNT1;MYH3;PIN1;PROX1;SDC1
11354,GO:0045742,0.210633015772296,0.916772600702473,4,25,positive regulation of epidermal growth factor receptor signaling pathway,BP,ARAP1;PTK6;AKT1;EREG
18372,GO:1903427,0.210747399360035,0.931217510467603,3,17,negative regulation of reactive oxygen species biosynthetic process,BP,ATP2B4;ACP5;TRAP1
12660,GO:0050901,0.210819063188821,0.952528018724973,2,9,leukocyte tethering or rolling,BP,PTAFR;PODXL2
17716,GO:1901678,0.210846510191976,0.952517848402899,2,9,iron coordination entity transport,BP,SLC48A1;SLC22A17
8445,GO:0033598,0.210968954690433,0.916587050103968,4,25,mammary gland epithelial cell proliferation,BP,DEAF1;STAT6;CEBPB;BTRC
15863,GO:0072657,0.211545290706507,0.831701930157104,47,453,protein localization to membrane,BP,CEMIP;APOE;GSN;EPHB2;LRP1;EGFR;NLGN2;LAMA5;BBS2;ZMYND8;PACS2;ANK3;ERBB2;BSG;VAMP2;TFDP2;SH3PXD2B;SYNGAP1;PRNP;DLG4;REEP2;SHANK3;ZDHHC1;TUB;ETV5;AMN;RAB40B;DVL1;SSH1;TSPAN33;DMTN;BBS1;TNFRSF1A;LDLRAP1;GAS6;TTC7B;PRKCZ;ZDHHC24;DLG3;EPB41L3;AKT1;EHD3;SYNE3;RILPL1;SHISA6;RPL13A;RAB40C
3718,GO:0008253,0.211650189462635,0.95221963065514,2,9,5'-nucleotidase activity,MF,NT5E;NT5DC1
18170,GO:1902969,0.212394683079579,0.95194265132429,2,9,mitotic DNA replication,BP,BCL6;FGFR1
9097,GO:0035404,0.212676585689909,0.951837591492118,2,9,histone-serine phosphorylation,BP,RPS6KA5;HMGA2
6648,GO:0030010,0.212976210397283,0.865190981336379,13,104,establishment of cell polarity,BP,GSN;MARK4;BRSK1;WNT7A;SPRY2;MYO18A;HES1;FBF1;LLGL1;PRKCZ;NDE1;PKD1;KIF26B
4615,GO:0010745,0.213275224696692,0.951614159163947,2,9,negative regulation of macrophage derived foam cell differentiation,BP,ABCG1;PPARA
13811,GO:0060439,0.21340475345925,0.951565755466891,2,9,trachea morphogenesis,BP,MAPK3;WNT7B
478,GO:0001523,0.213441320785185,0.89582933483898,6,42,retinoid metabolic process,BP,APOE;LRP1;RETSAT;GPC1;PNPLA4;SDC1
2752,GO:0006171,0.21349306728778,0.915188569993164,4,25,cAMP biosynthetic process,BP,TIMP2;PTHLH;LTB4R2;ADCY6
10366,GO:0043207,0.213558590213795,0.827320786555545,54,513,response to external biotic stimulus,BP,TNIP1;HTRA1;FOS;CYP27B1;PRSS3;NOS1;NR1D1;MST1R;LOXL1;SHC1;F2R;ACTA2;HDAC5;HYAL1;ACP5;PDCD4;TNFRSF25;ADARB1;TMEM173;ISG20;BNIP3;CEBPB;TNFRSF6B;MAPK3;WIPF1;WIPI2;TNFRSF14;LRSAM1;IL6R;ZFP36;MAPKBP1;VGF;TNFRSF1A;IFNGR2;HMGA2;FAM3A;TKFC;COMT;PTAFR;PCK2;BCR;GSDMC;ADAMTS13;MAPKAPK3;APOBEC3C;LYST;GSDMA;ABR;AKT1;NLRX1;PYCARD;APOBEC3F;LITAF;MIF
13114,GO:0051707,0.213558590213795,0.827320786555545,54,513,response to other organism,BP,TNIP1;HTRA1;FOS;CYP27B1;PRSS3;NOS1;NR1D1;MST1R;LOXL1;SHC1;F2R;ACTA2;HDAC5;HYAL1;ACP5;PDCD4;TNFRSF25;ADARB1;TMEM173;ISG20;BNIP3;CEBPB;TNFRSF6B;MAPK3;WIPF1;WIPI2;TNFRSF14;LRSAM1;IL6R;ZFP36;MAPKBP1;VGF;TNFRSF1A;IFNGR2;HMGA2;FAM3A;TKFC;COMT;PTAFR;PCK2;BCR;GSDMC;ADAMTS13;MAPKAPK3;APOBEC3C;LYST;GSDMA;ABR;AKT1;NLRX1;PYCARD;APOBEC3F;LITAF;MIF
4046,GO:0009100,0.213634197052613,0.836953830756712,34,306,glycoprotein metabolic process,BP,TNIP1;LMF1;CST3;ST6GALNAC2;B3GAT3;FBXO2;ABCA7;HYAL1;EDEM1;HEXB;GALNT12;ADAMTS7;MVD;B4GAT1;SRD5A3;VANGL2;ST3GAL3;HBEGF;XYLT2;PHLDA1;RFNG;MUC19;ADAMTS13;GPC1;MAN1B1;MAN2B2;GAL3ST4;VEGFB;POMT1;JAK3;ADAMTSL4;NDST2;ALG12;SULF2
33,GO:0000062,0.213644154944817,0.929810745030088,3,17,fatty-acyl-CoA binding,MF,ACBD4;ACOT7;HMGCL
18419,GO:1903531,0.213839047040966,0.867281622489651,12,97,negative regulation of secretion by cell,BP,IDH2;HADH;RHBDF1;F2R;ASIC1;RHBDF2;PFKL;MAPKBP1;GAS6;BCR;VSNL1;ABR
16817,GO:0098754,0.213902644492422,0.8778484285529,9,74,detoxification,BP,APOE;PRDX5;GPX3;TXNRD3;FAM213A;SESN2;GSTT1;TP53INP1;GSTM2
14812,GO:0070578,0.213940364002418,0.951365379250715,2,9,RISC-loading complex,CC,ZFP36;AGO4
12840,GO:0051187,0.213977743883824,0.903699639685873,5,35,cofactor catabolic process,BP,PRDX5;GPX3;ACOT7;GGT1;BLVRB
19118,GO:1905146,0.214396235557456,0.951194550452761,2,9,lysosomal protein catabolic process,BP,LRP1;LDLR
5622,GO:0016712,0.214607735004122,0.951115206688507,2,9,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,CYP3A5;CYP2S1
2953,GO:0006493,0.214695435795117,0.86987004591149,11,87,protein O-linked glycosylation,BP,ST6GALNAC2;GALNT12;ADAMTS7;B4GAT1;ST3GAL3;RFNG;MUC19;ADAMTS13;VEGFB;POMT1;ADAMTSL4
4283,GO:0009719,0.21472489571022,0.815129820575935,110,1061,response to endogenous stimulus,BP,HTRA1;FOS;DUSP6;APOE;CST3;LTBP4;RAPGEF3;PGF;NOS1;LTBP1;ZFP36L1;COL6A1;POSTN;NR1D1;FAM210B;IGF2;LRP1;MAPK13;LTBP2;EGFR;TIMP2;HADH;UROS;EGR1;SHC1;BBS2;CTSB;CORO1B;ABCG1;PIK3R2;HDAC5;THRA;LRP5;HYAL1;ERBB2;BSG;PTPRU;PKD2;SPRY4;CDKN1C;CD9;PTPRE;VAMP2;FUZ;ATP2B4;ADAMTS7;PDCD4;WNT7A;INSR;ID1;DNMT3A;PRNP;SPRY2;FAM20C;IGFBP2;CD81;CEBPB;ACVR2B;CALCOCO1;ENDOG;MAPK3;TUB;GLB1;ADCY6;HES1;SSH1;FURIN;ABCA2;SLIT3;PCSK9;ZFP36;FGFR3;PRKACA;ITGB5;FGFR4;DMTN;VGF;LDLR;TRPV4;EEF2K;PPARA;WNT7B;PTAFR;RXRA;PCK2;VASN;NEO1;PRKCZ;PDK2;GPC1;SRSF5;FGFR1;PIN1;WBP2;GRB10;CAPN2;SESN2;RXRB;TIMP1;SDC1;FGFBP1;AKT1;SLC5A5;CTSH;SLC2A1;JAK3;RARG;EREG;GSTM2;SULF2
16243,GO:0090331,0.214908281223251,0.951002360588298,2,9,negative regulation of platelet aggregation,BP,CD9;SERPINE2
15594,GO:0072109,0.21497750615702,0.950976352641401,2,9,glomerular mesangium development,BP,EGR1;ACTA2
10999,GO:0044853,0.215176021195993,0.882187038608904,8,59,plasma membrane raft,CC,NOS1;F2R;ATP2B4;INSR;MAPK3;PRKACA;KCNMA1;SLC2A1
810,GO:0002084,0.215349483110258,0.950836497196499,2,9,protein depalmitoylation,BP,LYPLAL1;ABHD17C
6740,GO:0030170,0.215469363326045,0.903162578196524,5,33,pyridoxal phosphate binding,MF,PYGB;PYGL;CBS;PNPO;GCAT
14645,GO:0070279,0.215469363326045,0.903162578196524,5,33,vitamin B6 binding,MF,PYGB;PYGL;CBS;PNPO;GCAT
2581,GO:0005881,0.215809698709338,0.887385711318185,7,51,cytoplasmic microtubule,CC,CLIP2;TUBG2;ENKD1;RAB3D;REEP2;TRPV4;SNPH
8186,GO:0032945,0.215905067010966,0.894254203201384,6,42,negative regulation of mononuclear cell proliferation,BP,PKN1;ERBB2;IL20RB;PRNP;CEBPB;INPP5D
12505,GO:0050672,0.215905067010966,0.894254203201384,6,42,negative regulation of lymphocyte proliferation,BP,PKN1;ERBB2;IL20RB;PRNP;CEBPB;INPP5D
4713,GO:0010885,0.215923234479919,0.950620438464529,2,9,regulation of cholesterol storage,BP,ABCG1;PPARA
8767,GO:0034464,0.216007681715711,0.950588603128739,2,9,BBSome,CC,BBS2;BBS1
6711,GO:0030132,0.216389481117227,0.928467815919867,3,17,clathrin coat of coated pit,CC,EGFR;AP2A2;LDLRAP1
1143,GO:0002739,0.216503427897523,0.950401533865734,2,9,regulation of cytokine secretion involved in immune response,BP,MAPK3;HK1
11283,GO:0045623,0.216539566005242,0.950387885134822,2,9,negative regulation of T-helper cell differentiation,BP,BCL6;JAK3
16638,GO:0097546,0.216620702493763,0.913445139698203,4,25,ciliary base,CC,NPHP4;PRKACA;SUFU;WDR60
9268,GO:0035723,0.21677015580984,0.950300756822,2,9,interleukin-15-mediated signaling pathway,BP,SHC1;JAK3
15176,GO:0071350,0.21677015580984,0.950300756822,2,9,cellular response to interleukin-15,BP,SHC1;JAK3
13471,GO:0055064,0.216841502305005,0.950273785050654,2,9,chloride ion homeostasis,BP,CA12;SLC12A7
4645,GO:0010799,0.216879725572593,0.902308505375749,5,33,regulation of peptidyl-threonine phosphorylation,BP,CEMIP;SPRY2;S1PR2;DMTN;DGKQ
4065,GO:0009127,0.216993774759732,0.859469459391381,14,116,purine nucleoside monophosphate biosynthetic process,BP,PGM1;OGDHL;INSR;PFKFB2;DHTKD1;GALK1;LHPP;MLXIPL;ADA;PFKL;HK1;PPARA;PINK1;TAZ
4104,GO:0009168,0.216993774759732,0.859469459391381,14,116,purine ribonucleoside monophosphate biosynthetic process,BP,PGM1;OGDHL;INSR;PFKFB2;DHTKD1;GALK1;LHPP;MLXIPL;ADA;PFKL;HK1;PPARA;PINK1;TAZ
6748,GO:0030183,0.21709445192454,0.871742906866213,10,78,B cell differentiation,BP,ZFP36L1;CMTM7;HDAC5;BCL6;LRRC8A;ADA;RAG1;INPP5D;JAK3;POLM
14579,GO:0070166,0.217233567212473,0.950125455190535,2,9,enamel mineralization,BP,FAM20C;PPARA
14615,GO:0070227,0.217439132315478,0.886189536979882,7,52,lymphocyte apoptotic process,BP,PKN1;BCL6;ADA;RAG1;AKT1;JAK3;MIF
11113,GO:0045176,0.217441923227303,0.950046549423549,2,9,apical protein localization,BP,CELSR1;VANGL2
876,GO:0002230,0.217508214222147,0.927917862658451,3,17,positive regulation of defense response to virus by host,BP,TMEM173;PYCARD;APOBEC3F
6264,GO:0019867,0.217558690038888,0.849164956902869,19,164,outer membrane,CC,CYP27B1;FAM210B;ULK1;BPHL;CPT1C;ITPR3;VAT1;SIGMAR1;SNN;ARMCX2;SPATA18;TMEM173;ANKZF1;BNIP3;RETSAT;HK1;NLRX1;PINK1;SYNE3
18841,GO:1904526,0.217721447481118,0.949940606250847,2,9,regulation of microtubule binding,BP,MAPRE3;GAS8
13803,GO:0060429,0.217751349527305,0.816151705486461,84,808,epithelium development,BP,CTNNBIP1;PPL;PTPRS;CST3;RAPGEF3;CYP27B1;XDH;PGF;ZFP36L1;TCTN1;ALOX15B;NFATC4;EGFR;PTK6;DEAF1;LAMA5;ACTA2;PRSS8;CTSB;THRA;LRP5;PKD2;TST;SALL2;IFT140;SERPINE2;FUZ;FOXQ1;LAMB2;WNT7A;LCE1E;ID1;CELSR1;DNPH1;SPRY2;STAT6;WWTR1;RAB25;FAM20C;TMEM107;VEGFA;VANGL2;AP2A2;CEBPB;ACVR2B;S1PR2;ETV5;DVL1;HES1;FURIN;AQP3;CELSR2;ZFP36;HBEGF;TNFRSF1A;SEMA4C;BTRC;WNT7B;SUFU;RXRA;PCK2;SLITRK6;TPP1;FGFR1;CTSZ;PROX1;DLG3;BFSP1;TOLLIP;WNT2B;TMEM231;SDC1;WNT3;ACVR1B;AKT1;PKD1;CTSH;RILPL1;ARHGEF19;RARG;EREG;KRT15;ADAMTSL4;KIF26B
15158,GO:0071322,0.217932248364877,0.867382626662973,11,89,cellular response to carbohydrate stimulus,BP,ZFP36L1;NR1D1;MAPK13;LRP5;ENDOG;MLXIPL;PRKACA;GAS6;PCK2;VSNL1;ERN1
13576,GO:0060074,0.218371895428813,0.949693698994888,2,9,synapse maturation,BP,ADGRL1;NFATC4
9673,GO:0038084,0.218417248132216,0.927469843080452,3,17,vascular endothelial growth factor signaling pathway,BP,XDH;VEGFA;NRP2
14856,GO:0070669,0.218508383194901,0.949641821460389,2,9,response to interleukin-2,BP,SHC1;JAK3
15178,GO:0071352,0.218508383194901,0.949641821460389,2,9,cellular response to interleukin-2,BP,SHC1;JAK3
13579,GO:0060077,0.218528265860121,0.949634262322953,2,9,inhibitory synapse,CC,NLGN2;IGSF9
12381,GO:0048845,0.218829699954355,0.949519600154801,2,9,venous blood vessel morphogenesis,BP,VEGFA;PROX1
7146,GO:0031018,0.218976889696808,0.912124031941072,4,25,endocrine pancreas development,BP,HES1;IL6R;AKT1;GIPR
8027,GO:0032689,0.219046640272841,0.927159041158803,3,17,negative regulation of interferon-gamma production,BP,IL20RB;PRNP;GAS6
15472,GO:0071871,0.219054937901147,0.949433847754973,2,9,response to epinephrine,BP,ATP2B4;PRKACA
7221,GO:0031128,0.219071453352957,0.927146778011009,3,17,developmental induction,BP,FGFR1;WNT2B;WNT3
19991,GO:2000641,0.219091823667176,0.927136709997599,3,17,regulation of early endosome to late endosome transport,BP,VPS11;MAPK3;MAP2K2
11939,GO:0047144,0.219137590308739,0.949402364441188,2,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,LPCAT4;MBOAT7
5169,GO:0015740,0.219305356773991,0.949338433793596,2,9,C4-dicarboxylate transport,BP,SLC13A3;NTSR1
19872,GO:2000392,0.219383446288077,0.949308664237728,2,9,regulation of lamellipodium morphogenesis,BP,ARPIN;CORO1B
5264,GO:0015924,0.219403978819539,0.949300835484912,2,9,mannosyl-oligosaccharide mannosidase activity,MF,EDEM1;MAN1B1
10458,GO:0043369,0.219611461146522,0.949221695850247,2,9,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,ZFPM1;STAT6
4631,GO:0010763,0.21972802413508,0.949177211738318,2,9,positive regulation of fibroblast migration,BP,DMTN;AKT1
1781,GO:0004407,0.219815935382026,0.891740480210719,6,42,histone deacetylase activity,MF,HDAC5;MTA3;MTA1;PHF21A;HDAC11;SIRT3
9999,GO:0042446,0.220009094632141,0.891475925756616,6,43,hormone biosynthetic process,BP,CYP27B1;EGR1;DHRS11;SRD5A3;DGKQ;TRERF1
4357,GO:0009975,0.220028825087638,0.949062337879434,2,9,cyclase activity,MF,ADCY6;TKFC
18948,GO:1904754,0.220322166608565,0.948950203430515,2,9,positive regulation of vascular associated smooth muscle cell migration,BP,DOCK4;SSH1
14220,GO:0061298,0.22034164645405,0.948942753129248,2,9,retina vasculature development in camera-type eye,BP,LRP5;ACVR2B
18479,GO:1903651,0.220381476673731,0.948927518101045,2,9,positive regulation of cytoplasmic transport,BP,VPS11;SORL1
19310,GO:1905666,0.220390133699349,0.948924206532186,2,9,regulation of protein localization to endosome,BP,ABHD17C;SORL1
19311,GO:1905668,0.220390133699349,0.948924206532186,2,9,positive regulation of protein localization to endosome,BP,ABHD17C;SORL1
13441,GO:0055003,0.220390133699439,0.948924206532173,2,9,cardiac myofibril assembly,BP,OBSL1;PROX1
13915,GO:0060612,0.220853987022154,0.911066822754432,4,25,adipose tissue development,BP,ZNF516;LRP5;SH3PXD2B;DYRK1B
13012,GO:0051494,0.22096491449057,0.861941608558002,12,97,negative regulation of cytoskeleton organization,BP,ESPN;GSN;ARAP1;ARPIN;CORO1B;TMOD2;PLEKHH2;SHANK3;SPTB;DMTN;CAPG;TWF2
13671,GO:0060251,0.221044421748643,0.926169237142286,3,17,regulation of glial cell proliferation,BP,IDH2;ETV5;HES1
5442,GO:0016324,0.221088798226951,0.844827274471638,20,171,apical plasma membrane,CC,SHANK2;EGFR;SLC9A3R2;SLC2A9;ERBB2;CD9;IGFBP2;VANGL2;AMN;SLC22A18;IL6R;SCNN1A;TRPV4;SLC29A4;PRKCZ;KCNMA1;STK39;ERBB3;SLC2A1;STXBP2
4697,GO:0010869,0.221312068243537,0.9260362532945,3,17,regulation of receptor biosynthetic process,BP,NR1D1;FURIN;PPARA
10261,GO:0043025,0.221383068402696,0.833393455116436,30,269,neuronal cell body,CC,APOE;PTPRS;CST3;SHANK2;EPHB2;LRP1;TIMP2;CRTC1;GJC2;KCNC4;ITPR3;NTSR1;GLUL;INSR;ENDOG;DVL1;ADA;PI4K2A;PRKCZ;DLG3;SLC25A27;SNPH;RTN4R;ZNF385A;HOMER2;NRSN1;ATXN10;PYCARD;KCNN4;DDN
1907,GO:0004601,0.221592983916241,0.909888792071908,4,28,peroxidase activity,MF,PRDX5;GPX3;GSTT1;GSTM2
9764,GO:0039694,0.221740517545223,0.910566060968938,4,25,viral RNA genome replication,BP,ATG16L2;HMGA2;APOBEC3C;APOBEC3F
7048,GO:0030838,0.222017095717871,0.872342983705996,9,70,positive regulation of actin filament polymerization,BP,GSN;ARPIN;CORO1B;WIPF1;CDC42EP5;WHAMMP3;SPIRE2;MLST8;PYCARD
9826,GO:0042089,0.222222163586834,0.877218389143041,8,60,cytokine biosynthetic process,BP,EGR1;ZFPM1;CEBPB;ZFP36;PTAFR;INPP5D;MAP2K3;EREG
16699,GO:0097731,0.222335431036368,0.883005361912688,7,51,9+0 non-motile cilium,CC,SHANK2;IFT140;NPHP4;SPATA7;CDHR1;C21ORF2;GUCA1B
16701,GO:0097733,0.222335431036368,0.883005361912688,7,51,photoreceptor cell cilium,CC,SHANK2;IFT140;NPHP4;SPATA7;CDHR1;C21ORF2;GUCA1B
9358,GO:0035902,0.222385537707806,0.925501988448919,3,17,response to immobilization stress,BP,FOS;ERCC1;LRP11
3592,GO:0008028,0.22247116392871,0.910152650526119,4,25,monocarboxylic acid transmembrane transporter activity,MF,SLC16A5;SLC16A3;BSG;SLC16A13
7948,GO:0032559,0.222779546177889,0.806422078025816,122,1171,adenyl ribonucleotide binding,MF,RAPGEF3;SCN8A;EPHB2;OBSCN;NME4;MST1R;MAPK13;CDK18;EGFR;ACSF2;ULK1;PKN1;PYGL;PTK6;ABCA7;ACTA2;DNAH1;ULK2;DGKA;ABCG1;OPLAH;NEK9;RPS6KA2;NMRK1;MARK4;ERBB2;BRSK1;CUL9;KIF13B;PAK6;MINK1;ATP2B4;CSNK1E;GLUL;INSR;GRK6;MVD;EPHA1;TMEM173;DHX32;ATP7B;SPEG;ABCD1;MKNK2;STRADB;FAM20C;MYO18A;UCKL1;PFKFB2;ATP12A;DYRK1B;SRMS;MAST4;ACVR2B;MAPK3;ENTPD2;GALK1;FYCO1;ADCY6;PKN3;EPHB3;PC;NADK;ABCA2;TK2;CKMT1A;PFKL;HLCS;FGFR3;PRKACA;LRRK1;DGUOK;RPS6KA5;MAP2K2;PI4K2A;FGFR4;PMVK;MYH3;EHD4;TRPV4;EEF2K;DGKQ;HK1;TKFC;GUK1;STK32C;DMC1;BCR;PRKCZ;HLTF;ABCD4;TWF2;PDK2;MAPKAPK3;FGFR1;CAMKK1;ASS1;GAL3ST4;ACTR1B;STK39;ACVR1B;GSS;ERBB3;AKT1;TRAP1;NLRX1;TUT1;SMARCA1;ERCC6;ADCK2;PINK1;EHD3;LONP2;MAP2K3;STK17A;ERN1;JAK3;MAST3;KIFC2;FUK;TTLL11;KIF26B
6379,GO:0021587,0.223133936191291,0.90977709700269,4,25,cerebellum morphogenesis,BP,SERPINE2;WNT7A;PROX1;TRNP1
4223,GO:0009410,0.223162709875062,0.844638474342825,19,165,response to xenobiotic stimulus,BP,EGFR;EGR1;BPHL;HDAC5;GGT1;AKR7A2;DNMT3A;ADA;ACY1;CYP3A5;PTAFR;PCK2;CMBL;CES2;GSS;CYP2S1;HOMER2;AS3MT;GSTM2
14711,GO:0070405,0.223203970099226,0.909460213752273,4,26,ammonium ion binding,MF,PLTP;HTR7;PITPNM1;ESYT2
3571,GO:0007623,0.223241544963541,0.850132699773695,16,134,circadian rhythm,BP,CST3;NR1D1;HEBP1;EGFR;CRTC1;NAGLU;CSNK1E;ID1;MTA1;ADA;HTR7;BHLHE40;BTRC;PPARA;PROX1;ASS1
888,GO:0002260,0.223634829550373,0.889127668306011,6,43,lymphocyte homeostasis,BP,PKN1;ADA;RAG1;AKT1;JAK3;MIF
6765,GO:0030212,0.223767053183018,0.909417861492809,4,25,hyaluronan metabolic process,BP,CEMIP;HYAL1;HEXB;AKT1
10459,GO:0043370,0.223818744108878,0.924786446364744,3,17,regulation of CD4-positive, alpha-beta T cell differentiation,BP,BCL6;PRKCZ;JAK3
19736,GO:2000171,0.224068651481871,0.924661416010228,3,17,negative regulation of dendrite development,BP,PTPRS;NFATC4;ID1
5138,GO:0015680,0.224079935517174,0.981355019625611,1,3,intracellular copper ion transport,BP,ATP7B
16749,GO:0098588,0.22412833679982,0.802341243335851,155,1520,bounding membrane of organelle,CC,CEMIP;APOE;TSPAN1;PTPRS;GAA;SHANK2;CYP27B1;NDRG1;NOS1;MARCH9;ARAP1;COL6A1;FAM210B;LRP1;APPL2;ST6GALNAC2;RAB11FIP4;EGFR;B3GAT3;ULK1;RHBDF1;DOPEY2;SYT8;BPHL;ABCA7;BBS2;MALL;ABCG1;DBNDD1;B4GALNT4;ERBB2;BSG;PKD2;CPT1C;EDEM1;ITPR3;PRAF2;VAT1;CD9;SIGMAR1;VPS11;VAMP2;GALNT12;CD320;SNN;TRAPPC9;ZFYVE21;DIRC2;RHOD;PEX10;ARMCX2;SPATA18;WNT7A;INSR;RAB3D;B4GAT1;NBEAL2;TMEM173;ATP7B;ATG16L2;DLG4;ABCD1;MARCH2;MYO18A;ANKZF1;CHMP1B;MVB12B;BNIP3;ENTPD6;AP2A2;SHANK3;KCNAB2;AMN;RAB40B;GPSM1;ST3GAL3;SLC16A13;FURIN;SLC48A1;EVC;SLC2A3;ABCA2;MCTP1;RETSAT;PCSK9;TMEM9;RHOF;PITPNM1;SCNN1A;HBEGF;RAB3B;MAP2K2;PI4K2A;STX10;DMTN;BBS1;XYLT2;TNFRSF1A;EHD4;LDLR;SNX17;ABHD17C;IFNGR2;LDLRAP1;SEMA4C;MVB12A;HK1;CHST6;LLGL1;WNT7B;PTAFR;RFNG;VASN;TMEM175;CLTCL1;ABCD4;CDHR1;CTSZ;MAN1B1;ASAP2;SERPINB6;WDR83;MAN2B2;TMEM231;GUCA1B;GAL3ST4;CYBRD1;SLC9A7;CD68;WHAMMP3;WNT3;SORL1;TPCN1;HGSNAT;TMBIM4;NLRX1;VPS33B;SUN1;SPPL2B;IL17RD;PINK1;PKD1;EHD3;SLC22A17;SYNE3;GOLGA2P5;EPN2;C12ORF66;SLC2A1;LITAF;PQLC2;NDST2;AGPAT3;RAB40C;STXBP2
17442,GO:1900274,0.224252439284896,0.924569416155083,3,17,regulation of phospholipase C activity,BP,EGFR;PTAFR;FGFR1
1109,GO:0002698,0.224318559682109,0.87069694350638,9,70,negative regulation of immune effector process,BP,HTRA1;SERPING1;IL20RB;BCL6;TKFC;BCR;ABR;NLRX1;JAK3
13477,GO:0055074,0.224441190846329,0.837954570367939,23,202,calcium ion homeostasis,BP,CEMIP;APOE;CYP27B1;NOS1;F2R;PKD2;ITPR3;HEXB;NTSR1;ATP2B4;LPAR3;PRNP;ATP7B;DLG4;BNIP3;PRKACA;TRPV4;SLC25A27;SMDT1;TPCN1;PKD1;GSTM2;GIPR
10666,GO:0043949,0.224683496832427,0.924353474079728,3,17,regulation of cAMP-mediated signaling,BP,NOS1;ATP2B4;GIPR
11446,GO:0045923,0.225091696777575,0.924148769748417,3,17,positive regulation of fatty acid metabolic process,BP,MLXIPL;PPARA;MLYCD
12646,GO:0050879,0.225245532917847,0.908296961229884,4,26,multicellular organismal movement,BP,GAA;TNNT1;MYH3;GSTM2
12648,GO:0050881,0.225245532917847,0.908296961229884,4,26,musculoskeletal movement,BP,GAA;TNNT1;MYH3;GSTM2
16457,GO:0097169,0.225390704658149,0.981123058057133,1,3,AIM2 inflammasome complex,CC,PYCARD
10092,GO:0042627,0.225744401424629,0.981060190238035,1,3,chylomicron,CC,APOE
7778,GO:0032330,0.225841111395558,0.908237703234032,4,25,regulation of chondrocyte differentiation,BP,PTHLH;ADAMTS7;CHADL;RARG
7284,GO:0031294,0.225860238307979,0.896618304522884,5,34,lymphocyte costimulation,BP,CD320;EFNB3;TNFRSF14;ICOSLG;AKT1
4701,GO:0010873,0.225871165755604,0.981037629983638,1,3,positive regulation of cholesterol esterification,BP,APOE
2420,GO:0005605,0.225934384174434,0.923725523338335,3,17,basal lamina,CC,LAMA5;LAMB2;ENTPD2
3055,GO:0006625,0.225969484063259,0.923707874999708,3,17,protein targeting to peroxisome,BP,PEX10;PEX7;LONP2
15867,GO:0072662,0.225969484063259,0.923707874999708,3,17,protein localization to peroxisome,BP,PEX10;PEX7;LONP2
15868,GO:0072663,0.225969484063259,0.923707874999708,3,17,establishment of protein localization to peroxisome,BP,PEX10;PEX7;LONP2
12239,GO:0048546,0.226061853713246,0.908111799436352,4,25,digestive tract morphogenesis,BP,EGFR;VANGL2;ACVR2B;EPHB3
12905,GO:0051287,0.226136370598566,0.880323199196189,7,52,NAD binding,MF,IDH2;HADH;CRYL1;PHGDH;GRHPR;GPD1L;SIRT3
7073,GO:0030879,0.226324221825963,0.857897176061287,12,97,mammary gland development,BP,XDH;DEAF1;LRP5;ATP7B;STAT6;VEGFA;CEBPB;ETV5;BTRC;WNT7B;WNT3;AKT1
8925,GO:0034979,0.226402711282784,0.92348992091823,3,17,NAD-dependent protein deacetylase activity,MF,HDAC5;HDAC11;SIRT3
10269,GO:0043034,0.227309078885422,0.923033178741095,3,17,costamere,CC,FLNC;ANK3;AHNAK2
11359,GO:0045747,0.227361982658934,0.895689805544977,5,34,positive regulation of Notch signaling pathway,BP,MAML3;ZMIZ1;HES1;RFNG;EPN2
11281,GO:0045621,0.227458641273795,0.879424594828879,7,52,positive regulation of lymphocyte differentiation,BP,ZMIZ1;BCL6;ADA;RAG1;GAS6;PRKCZ;INPP5D
16952,GO:0099024,0.227760431101221,0.895443029698312,5,34,plasma membrane invagination,BP,GSN;ABCA7;SNX33;SNX9;SPIRE2
4760,GO:0010955,0.227803569429131,0.906832473917475,4,26,negative regulation of protein processing,BP,SERPING1;SERPINE2;PRNP;CTSZ
18321,GO:1903318,0.227803569429131,0.906832473917475,4,26,negative regulation of protein maturation,BP,SERPING1;SERPINE2;PRNP;CTSZ
12573,GO:0050775,0.22783510622072,0.907098310314585,4,25,positive regulation of dendrite morphogenesis,BP,OBSL1;FBXW8;CUL7;EEF2K
15961,GO:0085029,0.227893223504912,0.907065031032685,4,25,extracellular matrix assembly,BP,LOXL1;THSD4;TNXB;GAS6
14463,GO:0061900,0.228654627546195,0.922353241307517,3,17,glial cell activation,BP,LRP1;EGFR;LDLR
11711,GO:0046545,0.228827972568753,0.86745745567232,9,70,development of primary female sexual characteristics,BP,ZP3;INSR;VEGFA;CEBPB;SLIT3;VGF;DMC1;ACVR1B;EREG
12639,GO:0050869,0.228863032184437,0.922247728643175,3,17,negative regulation of B cell activation,BP,PKN1;BCL6;INPP5D
8041,GO:0032715,0.228866004123402,0.922246223598134,3,17,negative regulation of interleukin-6 production,BP,GAS6;INPP5D;NLRX1
6022,GO:0019098,0.229022779444879,0.92216681413157,3,17,reproductive behavior,BP,THRA;HEXB;SERPINE2
3317,GO:0007032,0.229101359125966,0.867260453070225,9,70,endosome organization,BP,DNM1;VPS11;SNX33;CHMP1B;HOOK2;PI4K2A;MVB12A;ALS2CL;VPS33B
12082,GO:0048144,0.229532254673789,0.871926378290248,8,62,fibroblast proliferation,BP,EGFR;S100A6;ZMIZ1;GAS6;WNT7B;TP53INP1;EREG;MIF
5830,GO:0017127,0.229669667948376,0.944339013991661,2,10,cholesterol transporter activity,MF,APOE;ABCG1
2568,GO:0005861,0.229844339112701,0.980322873114656,1,3,troponin complex,CC,TNNT1
11276,GO:0045616,0.230354160734551,0.893832295135272,5,34,regulation of keratinocyte differentiation,BP,CYP27B1;ZFP36L1;ALOX15B;AQP3;ZFP36
9857,GO:0042136,0.231190567433678,0.876878894409376,7,52,neurotransmitter biosynthetic process,BP,NOS1;PKD2;ATP2B4;ACP5;INSR;ASS1;AKT1
3752,GO:0008305,0.231642672198349,0.920835283702881,3,17,integrin complex,CC,ITGB4;ITGA6;ITGB5
16768,GO:0098636,0.231642672198349,0.920835283702881,3,17,protein complex involved in cell adhesion,CC,ITGB4;ITGA6;ITGB5
4093,GO:0009156,0.232044127246062,0.845319569385447,15,127,ribonucleoside monophosphate biosynthetic process,BP,PGM1;OGDHL;INSR;UCKL1;PFKFB2;DHTKD1;GALK1;LHPP;MLXIPL;ADA;PFKL;HK1;PPARA;PINK1;TAZ
2531,GO:0005794,0.232386410984356,0.797972433336107,118,1145,Golgi apparatus,CC,LMF1;APOE;MARCH9;ARAP1;POSTN;ST6GALNAC2;OBSL1;EGFR;H1F0;B3GAT3;RHBDF1;DOPEY2;F2R;ABCA7;MALL;TBC1D14;ABCG1;ANK3;HDAC5;DOCK4;TENM2;B4GALNT4;BSG;EDEM1;DNM1;PTHLH;ANGEL1;VAMP2;GALNT12;NTSR1;MINK1;PHF7;TRAPPC9;ASIC1;WNT7A;FBXW8;ID1;AKR7A2;B4GAT1;TMEM173;PRNP;ATP7B;SNX9;FAM20C;MYO18A;BCL6;FZD8;ENTPD6;ARL2;DPP7;ZDHHC1;MAPK3;GLB1;FYCO1;GPSM1;PKN3;ST3GAL3;SLC16A13;FURIN;CUL7;PIDD1;PCSK9;FGFR3;PITPNM1;SLC38A10;MAP2K2;PI4K2A;FGFR4;SPTB;STX10;XYLT2;VGF;TNFRSF1A;LDLR;SNX17;IFNGR2;MSLN;LDLRAP1;MVB12A;CHST6;GAS6;LLGL1;WNT7B;RFNG;NEO1;MUC19;ZDHHC24;CLTCL1;GPC1;CTSZ;MAN1B1;ASAP2;YIPF3;CAPN2;GAL3ST4;SLC9A7;SDC1;WNT3;SORL1;TMBIM4;ADAM19;NDRG2;VPS33B;SPPL2B;IL17RD;GAS8;PKD1;MPLKIP;GOLGA2P5;PCSK1N;SLC2A1;LITAF;APBA1;PODXL2;TMED4;NDST2;AGPAT3;SULF2
10142,GO:0042743,0.232545586847507,0.903829826681182,4,27,hydrogen peroxide metabolic process,BP,PRDX5;GPX3;EGFR;PINK1
12674,GO:0050918,0.232582879694497,0.892249269477085,5,35,positive chemotaxis,BP,PGF;PLXNB3;VEGFA;VEGFB;MIF
2154,GO:0004984,0.232694872909747,0.979800901714058,1,3,olfactory receptor activity,MF,OR7D2
12668,GO:0050911,0.232694872909747,0.979800901714058,1,3,detection of chemical stimulus involved in sensory perception of smell,BP,OR7D2
11555,GO:0046131,0.23303404856215,0.903545918128894,4,27,pyrimidine ribonucleoside metabolic process,BP,NME4;UCKL1;APOBEC3C;APOBEC3F
10014,GO:0042476,0.233160532371154,0.859923477503439,10,79,odontogenesis,BP,HTRA1;LAMA5;BSG;ITGB4;ITGA6;FAM20C;ACVR2B;AQP3;PPARA;SDC1
7877,GO:0032456,0.23320422203331,0.89205373989921,5,34,endocytic recycling,BP,RAB11FIP4;MICALL2;EHD4;SORL1;EHD3
2261,GO:0005184,0.233218053004499,0.979704264455519,1,3,neuropeptide hormone activity,MF,VGF
1521,GO:0003887,0.233314898924799,0.903651003202888,4,26,DNA-directed DNA polymerase activity,MF,POLD4;POLL;PRIMPOL;POLM
906,GO:0002292,0.233474596425075,0.891884546526039,5,34,T cell differentiation involved in immune response,BP,ZFPM1;STAT6;BCL6;PRKCZ;JAK3
6570,GO:0022408,0.233498201362046,0.85239866008666,12,98,negative regulation of cell-cell adhesion,BP,ERBB2;CD9;SERPINE2;IL20RB;PRNP;BCL6;CEBPB;PAG1;TRPV4;PPARA;ASS1;JAK3
17992,GO:1902512,0.233698156512756,0.979615355306794,1,3,positive regulation of apoptotic DNA fragmentation,BP,ENDOG
16152,GO:0090200,0.234157585072149,0.902891821528501,4,27,positive regulation of release of cytochrome c from mitochondria,BP,BNIP3;PINK1;PYCARD;FAM162A
523,GO:0001618,0.234172910188557,0.882223273141189,6,43,virus receptor activity,MF,EGFR;EFNB3;CD81;TNFRSF14;ITGB5;LDLR
17159,GO:0104005,0.234172910188557,0.882223273141189,6,43,hijacked molecular function,MF,EGFR;EFNB3;CD81;TNFRSF14;ITGB5;LDLR
15818,GO:0072558,0.235061647287251,0.979361659179024,1,3,NLRP1 inflammasome complex,CC,PYCARD
10144,GO:0042745,0.235075309543208,0.942155133186926,2,10,circadian sleep/wake cycle,BP,CST3;ADA
8147,GO:0032890,0.235266872103377,0.902515646398836,4,26,regulation of organic acid transport,BP,NTSR1;STK39;AKT1;MIF
14786,GO:0070542,0.235450464864029,0.873955941679746,7,52,response to fatty acid,BP,NFATC4;ADCY6;LDLR;HMGCL;PTAFR;AKT1;GIPR
8959,GO:0035066,0.235504907712951,0.902376888350597,4,26,positive regulation of histone acetylation,BP,NOS1;MAPK3;RPS6KA5;WBP2
9840,GO:0042107,0.235735613551108,0.867630263774599,8,61,cytokine metabolic process,BP,EGR1;ZFPM1;CEBPB;ZFP36;PTAFR;INPP5D;MAP2K3;EREG
18365,GO:1903409,0.23582544514855,0.867477160182718,8,62,reactive oxygen species biosynthetic process,BP,NOS1;PKD2;ATP2B4;ACP5;INSR;ASS1;AKT1;TRAP1
18254,GO:1903170,0.23613767989105,0.918055744115006,3,18,negative regulation of calcium ion transmembrane transport,BP,PKD2;NTSR1;GSTM2
16249,GO:0090343,0.236195730984327,0.94169784848748,2,10,positive regulation of cell aging,BP,YPEL3;HMGA2
17542,GO:1901164,0.23629899923304,0.979129900622924,1,3,negative regulation of trophoblast cell migration,BP,TIMP1
8424,GO:0033558,0.236388604509747,0.880756678002202,6,43,protein deacetylase activity,MF,HDAC5;MTA3;MTA1;PHF21A;HDAC11;SIRT3
8134,GO:0032874,0.236483908370872,0.847078003828684,13,107,positive regulation of stress-activated MAPK cascade,BP,XDH;PKN1;MINK1;WNT7A;FZD8;VEGFA;VANGL2;TRPV4;SEMA4C;WNT7B;ERCC6;PYCARD;ERN1
5253,GO:0015908,0.237069331003859,0.872840386582047,7,52,fatty acid transport,BP,APOE;CPT2;NTSR1;ABCD1;PPARA;AKT1;MIF
4879,GO:0014809,0.23766336293449,0.978872658462427,1,3,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,GSTM2
9373,GO:0035928,0.238018618852988,0.978805385152904,1,3,rRNA import into mitochondrion,BP,TST
2813,GO:0006285,0.238112525455946,0.940911844805146,2,10,base-excision repair, AP site formation,BP,MPG;NEIL1
4121,GO:0009189,0.238593824120364,0.978696204762639,1,3,deoxyribonucleoside diphosphate biosynthetic process,BP,GUK1
4725,GO:0010899,0.238919800907382,0.978634189995798,1,3,regulation of phosphatidylcholine catabolic process,BP,LDLR
11513,GO:0046061,0.239093777758303,0.97860105044216,1,3,dATP catabolic process,BP,ADA
3265,GO:0006950,0.240286604707907,0.782207943048785,262,2645,response to stress,BP,TNIP1;HTRA1;FOS;DUSP6;APOE;CTNNBIP1;PTPRS;ERCC1;NT5E;LTB4R;NAPRT;BTBD2;CST3;CYP27B1;GSN;XDH;PRDX5;NDRG1;PCBP4;PRODH;PGF;NOS1;ZFP36L1;POSTN;NR1D1;POLD4;EPAS1;NFATC4;GPX3;MST1R;MAPK13;EGFR;FBXO2;DDB2;SERPING1;MTHFR;EGR1;ULK1;PKN1;SHC1;F2R;PTK6;DEAF1;CTSB;CORO1B;ULK2;DGKA;ASH2L;PLAT;PIK3R2;ZNF516;INO80C;HDAC5;THRA;ZP3;RPS6KA2;HYAL1;ZFPM1;ERBB2;FBLN1;BRSK1;PKD2;CBS;TMEM129;EDEM1;ABTB1;ITGB4;ITPR3;LRP11;MSRB2;CD9;XPC;PAK6;DNAJC4;SERPINE2;RNF135;LTB4R2;MINK1;ATP2B4;GGT1;TFDP2;CSNK1E;ACP5;PDCD4;DOCK6;TNFRSF25;GLUL;LAMB2;SPATA18;WNT7A;CELSR1;POLL;NDUFS8;ADARB1;TXNRD3;IL20RB;DNMT3A;TMEM173;PRNP;ECM1;STAT6;STRADB;ISG20;DNAJB5;BCL6;ANKZF1;BNIP3;CD81;SRMS;FZD8;VEGFA;LRRC8A;YPEL3;VANGL2;CEBPB;HSF4;ADAM15;ENDOG;TNFRSF6B;MAPK3;ETV5;ENTPD2;MTA1;WIPI2;NSMCE4A;CUL7;MEFV;TRIM4;TNFRSF14;LRSAM1;ADA;CDC42EP5;MCTP1;PYCR2;PIDD1;PHF21A;AQP3;IL6R;PCSK9;ZFP36;BTBD11;MAPKBP1;PRKACA;F12;MAGEF1;RPS6KA5;HBEGF;MAP2K2;DAP;DMTN;VGF;TNFRSF1A;MAPK8IP1;LDLR;ACOT11;TRPV4;MPG;IFNGR2;RAG1;EEF2K;HMGA2;ELK3;DGKQ;SEMA4C;FAM3A;SDHAF4;GAS6;BTRC;PPARA;HMGCL;TKFC;WNT7B;COMT;PTAFR;DMC1;PCK2;VAV3;VASN;BCR;IGFBP4;GSDMC;MUC19;PRKCZ;ADAMTS13;TM7SF3;TPP1;PDK2;TMX4;ICOSLG;MAPKAPK3;RAD23A;MAN1B1;C5;C21ORF2;KCNMA1;SERPINB6;ASS1;SLC25A27;CAPN2;SESN2;TOLLIP;WNT2B;TMEM161A;PROCR;MACROD1;ADGRE2;RTN4R;TIMP1;SDC1;SH2B3;APOBEC3C;LYST;STK39;VEGFB;GSDMA;GSS;ADORA2B;ERBB3;ABR;PNMA1;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;VPS33B;ERCC6;PINK1;PKD1;EHD3;ARHGEF10L;CAMTA2;RGS14;MLST8;PYCARD;NINJ1;MAP2K3;POMT1;PCSK1N;KCNN4;PMS2P5;ERN1;APOBEC3F;PRIMPOL;FBXL20;ARHGEF19;C12ORF66;SLC2A1;MLYCD;JAK3;NEIL1;ING4;EREG;FAM162A;GSTM2;MORN4;GIPR;POLM;RPL13A;MIF;SULF2;STXBP2
12713,GO:0051004,0.240558185020868,0.93990221010969,2,10,regulation of lipoprotein lipase activity,BP,LMF1;FURIN
3581,GO:0008009,0.240590277994373,0.939042563850444,2,11,chemokine activity,MF,C5;CKLF
11384,GO:0045806,0.240811728806538,0.88706179758862,5,35,negative regulation of endocytosis,BP,SNX33;DLG4;LRSAM1;MCTP1;PCSK9
1052,GO:0002580,0.240812713092698,0.978272061520536,1,3,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,PYCARD
3230,GO:0006892,0.240923235873555,0.85017037557664,11,89,post-Golgi vesicle-mediated transport,BP,DOPEY2;BBS2;ANK3;EXOC2;VAMP2;AMN;OSBPL5;BBS1;LLGL1;SORL1;EHD3
555,GO:0001678,0.240949955623544,0.850043378148226,11,91,cellular glucose homeostasis,BP,NR1D1;PIK3R2;LRP5;ENDOG;MLXIPL;PRKACA;HK1;GAS6;PCK2;VSNL1;ERN1
14410,GO:0061744,0.241008766876502,0.978234358148695,1,3,motor behavior,BP,ADARB1
2597,GO:0005901,0.241096388284847,0.870054027654949,7,52,caveola,CC,NOS1;F2R;ATP2B4;INSR;MAPK3;KCNMA1;SLC2A1
20150,GO:2001024,0.241286610238344,0.915372166156265,3,18,negative regulation of response to drug,BP,STK39;TRAP1;PINK1
12677,GO:0050921,0.241370695316617,0.85819909769705,9,72,positive regulation of chemotaxis,BP,PGF;VEGFA;MAPK3;IL6R;TRPV4;GAS6;FGFR1;PPM1F;VEGFB
14131,GO:0061041,0.241581345539342,0.853603946513135,10,80,regulation of wound healing,BP,APOE;SERPING1;F2R;PLAT;CD9;SERPINE2;F12;HBEGF;DMTN;VPS33B
1203,GO:0002863,0.24201700883045,0.978039877247053,1,3,positive regulation of inflammatory response to antigenic stimulus,BP,ZP3
1206,GO:0002866,0.24201700883045,0.978039877247053,1,3,positive regulation of acute inflammatory response to antigenic stimulus,BP,ZP3
4227,GO:0009416,0.242137392764575,0.820774941396309,25,223,response to light stimulus,BP,FOS;ERCC1;NFATC4;MAPK13;EGFR;REEP6;DDB2;CRTC1;DEAF1;HYAL1;BRSK1;XPC;NPHP4;SYNGAP1;MTA1;PITPNM1;BHLHE40;RAG1;TMEM161A;GUCA1B;AKT1;TP53INP1;ERCC6;RGS14;PRIMPOL
11494,GO:0046031,0.242545160975946,0.852883794167925,10,80,ADP metabolic process,BP,PGM1;OGDHL;INSR;PFKFB2;DHTKD1;GALK1;MLXIPL;PFKL;HK1;PPARA
7346,GO:0031400,0.242716065898599,0.803482407631382,49,460,negative regulation of protein modification process,BP,TNIP1;DUSP6;APOE;XDH;EPHB2;DUSP5;PPP1R14A;PKN1;PTK6;PIK3R2;CRTAP;LRP5;FBLN1;SPRY4;CDKN1C;ATP2B4;PDCD4;EPHA1;ADARB1;PPP1R35;PRNP;SPRY2;HINT2;WWTR1;DVL1;MLXIPL;LRRK1;DMTN;MAPK8IP1;DUSP7;DGKQ;PRKCZ;PIN1;JARID2;RTN4R;ELFN2;PPM1F;SORL1;STK39;AKT1;NDRG2;GPD1L;PINK1;SNTA1;RGS14;CBLC;PYCARD;RANBP9;SIRT3
1087,GO:0002675,0.242817932859877,0.938962582476413,2,10,positive regulation of acute inflammatory response,BP,ZP3;F12
2720,GO:0006107,0.242879688096253,0.938936813057309,2,10,oxaloacetate metabolic process,BP,PCK2;MDH2
1278,GO:0003081,0.243030798402829,0.938873736871925,2,10,regulation of systemic arterial blood pressure by renin-angiotensin,BP,F2R;CTSZ
14349,GO:0061615,0.243470057509396,0.914224284079972,3,18,glycolytic process through fructose-6-phosphate,BP,GALK1;PFKL;HK1
14352,GO:0061620,0.243470057509396,0.914224284079972,3,18,glycolytic process through glucose-6-phosphate,BP,GALK1;PFKL;HK1
17366,GO:1900121,0.24352055157117,0.938669105927654,2,10,negative regulation of receptor binding,BP,ADAM15;PCSK9
7405,GO:0031507,0.243741271735131,0.938576784133583,2,10,heterochromatin assembly,BP,BAHCC1;HMGA2
7580,GO:0031960,0.243807505562246,0.844393913687741,12,100,response to corticosteroid,BP,FOS;ZFP36L1;EGFR;PTPRU;IGFBP2;GLB1;SLIT3;ZFP36;WNT7B;PTAFR;PCK2;SDC1
3909,GO:0008589,0.243929294535722,0.868084263812122,7,52,regulation of smoothened signaling pathway,BP,TCTN1;IFT140;SERPINE2;FUZ;EVC;BTRC;SUFU
11742,GO:0046622,0.243992035303013,0.897386192732021,4,26,positive regulation of organ growth,BP,FGFR1;PIN1;PROX1;AKT1
7982,GO:0032612,0.243993925280536,0.867814530461097,7,54,interleukin-1 production,BP,EGR1;F2R;ACP5;MEFV;HK1;GAS6;PYCARD
3216,GO:0006874,0.244131121733731,0.822903628273821,22,195,cellular calcium ion homeostasis,BP,CEMIP;APOE;NOS1;F2R;PKD2;ITPR3;HEXB;NTSR1;ATP2B4;LPAR3;PRNP;ATP7B;DLG4;BNIP3;PRKACA;TRPV4;SLC25A27;SMDT1;TPCN1;PKD1;GSTM2;GIPR
771,GO:0002027,0.244157221812038,0.875425627667676,6,44,regulation of heart rate,BP,EPAS1;SCN4B;ADA;PRKACA;GPD1L;SNTA1
7147,GO:0031021,0.244370343797989,0.977582123703066,1,3,interphase microtubule organizing center,CC,WDR60
8450,GO:0033603,0.244483691764857,0.977559940934251,1,3,positive regulation of dopamine secretion,BP,PINK1
1290,GO:0003105,0.244740711193497,0.977509594848343,1,3,negative regulation of glomerular filtration,BP,F2R
11479,GO:0045986,0.244750375562325,0.938153913671698,2,10,negative regulation of smooth muscle contraction,BP,DOCK4;ADORA2B
12725,GO:0051019,0.245224227367408,0.896654641052055,4,26,mitogen-activated protein kinase binding,MF,TNIP1;PTAFR;MAPKAPK3;MICALCL
5147,GO:0015695,0.245232390011713,0.896649789004596,4,26,organic cation transport,BP,SLC7A8;SLC22A18;SLC25A29;RHBG
567,GO:0001709,0.245249518641566,0.913284436149432,3,18,cell fate determination,BP,WNT7A;HES1;PROX1
4114,GO:0009182,0.245267861929453,0.977406134021443,1,3,purine deoxyribonucleoside diphosphate metabolic process,BP,GUK1
11515,GO:0046066,0.245267861929453,0.977406134021443,1,3,dGDP metabolic process,BP,GUK1
6759,GO:0030204,0.245399246024766,0.896550589297469,4,26,chondroitin sulfate metabolic process,BP,B3GAT3;HYAL1;HEXB;XYLT2
14739,GO:0070458,0.245416237918248,0.97737696454401,1,3,cellular detoxification of nitrogen compound,BP,GSTM2
5709,GO:0016857,0.245432641391582,0.93786727436658,2,10,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,GALE;TSTA3
9595,GO:0036476,0.245483116921731,0.977363809711288,1,3,neuron death in response to hydrogen peroxide,BP,PINK1
18274,GO:1903207,0.245483116921731,0.977363809711288,1,3,regulation of hydrogen peroxide-induced neuron death,BP,PINK1
18275,GO:1903208,0.245483116921731,0.977363809711288,1,3,negative regulation of hydrogen peroxide-induced neuron death,BP,PINK1
789,GO:0002054,0.245769691673867,0.977307392473493,1,3,nucleobase binding,MF,PYGL
791,GO:0002060,0.245769691673867,0.977307392473493,1,3,purine nucleobase binding,MF,PYGL
14851,GO:0070664,0.245773818308065,0.874338214896974,6,44,negative regulation of leukocyte proliferation,BP,PKN1;ERBB2;IL20RB;PRNP;CEBPB;INPP5D
19252,GO:1905475,0.245909081155322,0.834290205905691,15,128,regulation of protein localization to membrane,BP,CEMIP;GSN;EPHB2;LRP1;EGFR;ZMYND8;ANK3;ERBB2;TFDP2;PRNP;SSH1;DMTN;LDLRAP1;AKT1;SHISA6
4079,GO:0009142,0.245942751360525,0.836755470794039,14,120,nucleoside triphosphate biosynthetic process,BP,PGM1;NME4;OGDHL;INSR;UCKL1;PFKFB2;DHTKD1;GALK1;MLXIPL;PFKL;HK1;PPARA;PINK1;TAZ
2962,GO:0006508,0.246179385398793,0.784204580407792,127,1256,proteolysis,BP,TNIP1;HTRA1;APOE;TYSND1;RNPEPL1;BTBD2;RNF44;CST3;LTBP4;GSN;CLCA2;XDH;PRDX5;PRSS3;NR1D1;ARRDC1;RBCK1;TIMP2;MMP28;FBXO2;JOSD2;DDB2;SERPING1;RHBDF1;F2R;NPEPL1;PRSS8;CTSB;GRAMD4;PLAT;MMP1;INO80C;TENM2;FBLN1;CTSF;GID4;TMEM129;EDEM1;ABTB1;CUL9;SERPINE2;RNF135;THSD4;GGT1;CSNK1E;ADAMTS7;USP20;PRNP;PAPLN;SNX33;BLMH;ECM1;SNX9;WWTR1;ANKZF1;MVB12B;CD81;VEGFA;FBXW4;RHBDF2;DPP7;ADAM15;TNFRSF6B;MAPK3;CAPNS2;DVL1;MTA1;LTA4H;FURIN;CUL7;MEFV;PIDD1;ACY1;PCSK9;BTBD11;PRKACA;F12;MAGEF1;CYFIP2;MAP2K2;DAP;FGFR4;FBXW5;RAG1;RHBDL1;MVB12A;GAS6;BTRC;SUFU;PCSK1;USP21;RNF123;ADAMTS13;TPP1;RAD23A;CTSZ;SPSB3;MAN1B1;C5;BIN1;SERPINB6;SH3D19;CAPN2;TOLLIP;CSTB;TMPRSS11D;LMLN;TIMP1;PPM1F;SORL1;AKT1;CTSD;ADAM19;SPPL2B;PINK1;PKD1;LONP2;CTSH;CBLC;RNF187;PYCARD;MAP2K3;POMT1;PCSK1N;FBXL20;FAM162A;ADAMTSL4
12946,GO:0051354,0.246577128920594,0.937385116018809,2,10,negative regulation of oxidoreductase activity,BP,CYP27B1;ATP2B4
3577,GO:0007632,0.246779366915935,0.883253100431959,5,35,visual behavior,BP,DEAF1;NPHP4;SYNGAP1;RAG1;RGS14
4585,GO:0010710,0.24680252697064,0.977103399323853,1,3,regulation of collagen catabolic process,BP,CST3
13682,GO:0060267,0.246849769735477,0.977094043714334,1,3,positive regulation of respiratory burst,BP,INSR
8100,GO:0032800,0.246907901101372,0.912405023996355,3,18,receptor biosynthetic process,BP,NR1D1;FURIN;PPARA
7653,GO:0032094,0.246942441588888,0.912386671740032,3,18,response to food,BP,BBS2;PPARA;AKT1
14661,GO:0070304,0.246981779532064,0.838855627288635,13,108,positive regulation of stress-activated protein kinase signaling cascade,BP,XDH;PKN1;MINK1;WNT7A;FZD8;VEGFA;VANGL2;TRPV4;SEMA4C;WNT7B;ERCC6;PYCARD;ERN1
2041,GO:0004792,0.247304376426036,0.977003905813101,1,3,thiosulfate sulfurtransferase activity,MF,TST
3125,GO:0006721,0.247460179916141,0.865501795350912,7,53,terpenoid metabolic process,BP,APOE;LRP1;EGFR;RETSAT;GPC1;PNPLA4;SDC1
5274,GO:0015937,0.247498013359624,0.936995951907185,2,10,coenzyme A biosynthetic process,BP,ACOT7;PPCS
6205,GO:0019740,0.247679368724746,0.976929402237848,1,3,nitrogen utilization,BP,GLUL
1791,GO:0004427,0.247688805406071,0.976927525589531,1,3,inorganic diphosphatase activity,MF,LHPP
13033,GO:0051560,0.247695276288409,0.911986306124749,3,18,mitochondrial calcium ion homeostasis,BP,BNIP3;SLC25A27;SMDT1
18066,GO:1902722,0.247725932287676,0.976920141421311,1,3,positive regulation of prolactin secretion,BP,EGFR
18285,GO:1903236,0.247749888825481,0.976915375991261,1,3,regulation of leukocyte tethering or rolling,BP,PTAFR
18673,GO:1904058,0.247773376091148,0.976910703366103,1,3,positive regulation of sensory perception of pain,BP,PTAFR
9234,GO:0035651,0.247863902349989,0.976892688782186,1,3,AP-3 adaptor complex binding,MF,PI4K2A
3018,GO:0006572,0.247977841903507,0.9768700036431,1,3,tyrosine catabolic process,BP,HPDL
13683,GO:0060268,0.248005298429467,0.976864535212296,1,3,negative regulation of respiratory burst,BP,BCR
11480,GO:0045987,0.248065552843786,0.911789133008112,3,18,positive regulation of smooth muscle contraction,BP,F2R;ADA;PTAFR
52,GO:0000109,0.248239717010212,0.936681726621867,2,10,nucleotide-excision repair complex,CC,ERCC1;XPC
10313,GO:0043124,0.248302760189618,0.882274573425159,5,35,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,TNIP1;CARD19;MAPKBP1;NLRX1;PYCARD
11342,GO:0045724,0.248365754311316,0.911629151131002,3,18,positive regulation of cilium assembly,BP,FUZ;CROCC;WRAP73
5677,GO:0016803,0.248469224366481,0.936584353561783,2,10,ether hydrolase activity,MF,AKR7A2;LTA4H
15213,GO:0071398,0.248599784783923,0.8820834886073,5,35,cellular response to fatty acid,BP,NFATC4;ADCY6;LDLR;PTAFR;AKT1
3272,GO:0006958,0.24882020945749,0.9364353118216,2,10,complement activation, classical pathway,BP,SERPING1;C5
11016,GO:0045007,0.248849615336837,0.976696016506293,1,3,depurination,BP,MPG
15783,GO:0072507,0.248859999843424,0.815050786740388,25,226,divalent inorganic cation homeostasis,BP,CEMIP;APOE;CYP27B1;NOS1;EGFR;F2R;ANK3;PKD2;ITPR3;HEXB;NTSR1;ATP2B4;LPAR3;PRNP;ATP7B;DLG4;BNIP3;PRKACA;TRPV4;SLC25A27;SMDT1;TPCN1;PKD1;GSTM2;GIPR
15381,GO:0071672,0.248876923906926,0.976690554333362,1,3,negative regulation of smooth muscle cell chemotaxis,BP,CORO1B
10774,GO:0044264,0.248938407950493,0.852705051802749,9,71,cellular polysaccharide metabolic process,BP,GAA;PYGB;PGM1;NR1D1;IGF2;PYGL;PHLDA2;INSR;AKT1
11580,GO:0046208,0.249037187092831,0.976658484335244,1,3,spermine catabolic process,BP,SMOX
1114,GO:0002703,0.249328791403201,0.840120055102558,12,100,regulation of leukocyte mediated immunity,BP,ZP3;IL20RB;STAT6;BCL6;PTAFR;BCR;PRKCZ;ADGRE2;ADORA2B;ABR;JAK3;STXBP2
16229,GO:0090312,0.249484080278084,0.911032202061683,3,18,positive regulation of protein deacetylation,BP,BCL6;VEGFA;PINK1
9806,GO:0042036,0.249548321137156,0.91099786431017,3,18,negative regulation of cytokine biosynthetic process,BP,ZFPM1;ZFP36;INPP5D
9655,GO:0038033,0.24961995666327,0.976541655911452,1,3,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,VEGFA
12291,GO:0048664,0.249667242402286,0.976532161939765,1,3,neuron fate determination,BP,HES1
8981,GO:0035116,0.249837608119389,0.910843172939934,3,18,embryonic hindlimb morphogenesis,BP,WNT7A;WNT3;RARG
7176,GO:0031076,0.250065639346717,0.89376320927767,4,26,embryonic camera-type eye development,BP,IFT140;PROX1;PPP1R13L;RARG
10604,GO:0043619,0.250075116465171,0.935901150746364,2,10,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,EPAS1;SESN2
7386,GO:0031461,0.250197398502177,0.824384325667385,18,157,cullin-RING ubiquitin ligase complex,CC,BTBD2;FBXO2;DDB2;ABTB1;CUL9;FBXW8;FBXO27;FBXW4;KLHL29;CUL7;BTBD11;FBXW5;FBXO17;BTRC;KLHDC8B;SPSB3;ZER1;FBXL20
1367,GO:0003254,0.250254632116649,0.893358481092813,4,27,regulation of membrane depolarization,BP,FHL1;ANK3;NTSR1;GPD1L
4012,GO:0009051,0.250356911475467,0.976393442625518,1,3,pentose-phosphate shunt, oxidative branch,BP,PGLS
588,GO:0001750,0.250393400230566,0.880927552284495,5,35,photoreceptor outer segment,CC,SHANK2;IFT140;CDHR1;C21ORF2;GUCA1B
6262,GO:0019865,0.250413271886923,0.976382085790817,1,3,immunoglobulin binding,MF,FCGRT
10781,GO:0044275,0.250449268103859,0.880891490513268,5,35,cellular carbohydrate catabolic process,BP,GAA;PYGB;PGM1;PYGL;TKFC
19242,GO:1905457,0.250473957780747,0.97636985388012,1,3,negative regulation of lymphoid progenitor cell differentiation,BP,HES1
20132,GO:2000974,0.250473957780747,0.97636985388012,1,3,negative regulation of pro-B cell differentiation,BP,HES1
18160,GO:1902956,0.250485788656228,0.976367468817113,1,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,PINK1
18242,GO:1903135,0.250494403821876,0.976365731943599,1,3,cupric ion binding,MF,PRNP
16569,GO:0097421,0.2504960364393,0.89321321620248,4,27,liver regeneration,BP,EGFR;CEBPB;SRSF5;SULF2
2686,GO:0006059,0.250665542561662,0.976331214206847,1,3,hexitol metabolic process,BP,GALK1
12814,GO:0051150,0.250748710601432,0.910355303387385,3,18,regulation of smooth muscle cell differentiation,BP,PDCD4;OLFM2;EREG
4211,GO:0009394,0.250811294229314,0.892753983317366,4,28,2'-deoxyribonucleotide metabolic process,BP,ADA;DGUOK;GUK1;NEIL1
5429,GO:0016303,0.250842046803606,0.893296985367406,4,26,1-phosphatidylinositol-3-kinase activity,MF,PIK3R2;FGFR3;FGFR4;FGFR1
17848,GO:1902109,0.251021548579301,0.976259317899658,1,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,BNIP3
11572,GO:0046174,0.251055995514056,0.910190530769489,3,18,polyol catabolic process,BP,NTSR1;TKFC;IMPA2
7614,GO:0032025,0.251089123648244,0.935468069736362,2,10,response to cobalt ion,BP,D2HGDH;BNIP3
3010,GO:0006563,0.251375227303827,0.935345639055739,2,10,L-serine metabolic process,BP,CBS;PHGDH
18388,GO:1903445,0.251393423972954,0.976184084162197,1,3,protein transport from ciliary membrane to plasma membrane,BP,RILPL1
7857,GO:0032430,0.251417203004404,0.976179268840319,1,3,positive regulation of phospholipase A2 activity,BP,EGFR
1176,GO:0002823,0.251525679787361,0.909938451813722,3,18,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,IL20RB;BCL6;JAK3
17084,GO:0101006,0.251559313940895,0.976150479414303,1,3,protein histidine phosphatase activity,MF,LHPP
16602,GO:0097487,0.251690332562941,0.9761239195729,1,3,multivesicular body, internal vesicle,CC,EGFR
9750,GO:0039532,0.251698072275088,0.935207361013749,2,10,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,TKFC;NLRX1
3847,GO:0008474,0.25178904624993,0.935168371951089,2,10,palmitoyl-(protein) hydrolase activity,MF,LYPLAL1;ABHD17C
16757,GO:0098599,0.25178904624993,0.935168371951089,2,10,palmitoyl hydrolase activity,MF,LYPLAL1;ABHD17C
16806,GO:0098734,0.25178904624993,0.935168371951089,2,10,macromolecule depalmitoylation,BP,LYPLAL1;ABHD17C
16910,GO:0098917,0.251830678449793,0.976095450251615,1,3,retrograde trans-synaptic signaling,BP,NOS1
12603,GO:0050816,0.251875826282834,0.976086287855514,1,3,phosphothreonine residue binding,MF,PIN1
17814,GO:1902017,0.252066190502049,0.879648376061011,5,36,regulation of cilium assembly,BP,EVI5L;IFT140;FUZ;CROCC;WRAP73
4881,GO:0014812,0.252138546862057,0.862213040569294,7,53,muscle cell migration,BP,POSTN;LRP1;CORO1B;PLAT;DOCK4;SSH1;SORL1
11567,GO:0046165,0.252404953993488,0.834510558317723,13,110,alcohol biosynthetic process,BP,APOE;CYP27B1;ISYNA1;ABCG1;NTSR1;MVD;SRD5A3;SEC14L2;PMVK;TM7SF2;PTAFR;IMPA2;PCK2
17500,GO:1901017,0.25240732665972,0.934903114617478,2,10,negative regulation of potassium ion transmembrane transporter activity,BP,ANK3;STK39
17618,GO:1901380,0.25240732665972,0.934903114617478,2,10,negative regulation of potassium ion transmembrane transport,BP,ANK3;STK39
10456,GO:0043367,0.252513365016082,0.879556762806563,5,35,CD4-positive, alpha-beta T cell differentiation,BP,ZFPM1;STAT6;BCL6;PRKCZ;JAK3
17794,GO:1901978,0.252690733428451,0.934781363889145,2,10,positive regulation of cell cycle checkpoint,BP,NDRG1;PROX1
432,GO:0001161,0.252798328387097,0.934735114679896,2,10,intronic transcription regulatory region sequence-specific DNA binding,MF,ZC3H6;BCL6
10749,GO:0044213,0.252798328387097,0.934735114679896,2,10,intronic transcription regulatory region DNA binding,MF,ZC3H6;BCL6
10558,GO:0043539,0.252875594327132,0.891777705265252,4,27,protein serine/threonine kinase activator activity,MF,IGF2;SPRY2;MAP2K2;MLST8
9869,GO:0042165,0.252909536510184,0.909194160837709,3,18,neurotransmitter binding,MF,CBS;HTR7;GSS
3013,GO:0006566,0.252991542812654,0.975859226293423,1,3,threonine metabolic process,BP,GCAT
16698,GO:0097730,0.253019771304806,0.855129101406877,8,62,non-motile cilium,CC,SHANK2;PKD2;IFT140;NPHP4;SPATA7;CDHR1;C21ORF2;GUCA1B
11052,GO:0045071,0.253090872347906,0.869096455660255,6,46,negative regulation of viral genome replication,BP,TNIP1;ISG20;HMGA2;PROX1;APOBEC3C;APOBEC3F
10747,GO:0044211,0.253160134838775,0.975824809455999,1,3,CTP salvage,BP,UCKL1
19042,GO:1904949,0.253225964653829,0.844783830292043,10,81,ATPase complex,CC,APPL2;ABCA7;INO80C;SALL2;GM2A;ATP12A;ABCA2;ABCD4;SMARCD2;SMARCA1
16401,GO:0097067,0.253230735894483,0.934549097909478,2,10,cellular response to thyroid hormone stimulus,BP,CTSB;CTSH
19041,GO:1904948,0.253234731169763,0.934547378079914,2,10,midbrain dopaminergic neuron differentiation,BP,CSNK1E;WNT3
20001,GO:2000651,0.253248052226457,0.934541643673459,2,10,positive regulation of sodium ion transmembrane transporter activity,BP,ANK3;GLRX
11239,GO:0045504,0.253282423618073,0.934526846543752,2,10,dynein heavy chain binding,MF,WDR60;WDR63
9402,GO:0035986,0.253436589802715,0.975768312691268,1,3,senescence-associated heterochromatin focus assembly,BP,HMGA2
15513,GO:0071942,0.253602650756353,0.97573434007463,1,3,XPC complex,CC,XPC
10301,GO:0043103,0.253615075953525,0.975731797046691,1,3,hypoxanthine salvage,BP,ADA
7260,GO:0031252,0.253802687513307,0.803109217300024,33,301,cell leading edge,CC,RAPGEF3;GSN;PARVB;ARPIN;ARHGEF4;PTK6;ABCA7;ACTA2;CORO1B;KCNC4;S100A6;PKD2;ITGB4;SPRY4;INSR;SPRY2;SNX9;PLEKHH2;PLEKHG5;WIPF1;SSH1;MEFV;PSD4;TRPV4;PRKCZ;TWF2;ARAP3;ADGRE2;EPB41L3;EPS8L1;EPS8L2;DDN;SHISA6
11089,GO:0045125,0.253888143774342,0.934265833336212,2,10,bioactive lipid receptor activity,MF,LPAR3;S1PR2
19661,GO:2000008,0.253951031576448,0.89112677734161,4,27,regulation of protein localization to cell surface,BP,SNX33;KCNAB2;AKT1;GPD1L
9822,GO:0042078,0.253972879930396,0.975658501184523,1,3,germ-line stem cell division,BP,ETV5
12080,GO:0048133,0.253972879930396,0.975658501184523,1,3,male germ-line stem cell asymmetric division,BP,ETV5
16804,GO:0098728,0.253972879930396,0.975658501184523,1,3,germline stem cell asymmetric division,BP,ETV5
13801,GO:0060426,0.254031718817546,0.975646436017348,1,3,lung vasculature development,BP,ID1
13449,GO:0055012,0.254122109663428,0.934164889357617,2,10,ventricular cardiac muscle cell differentiation,BP,RXRA;PROX1
6561,GO:0022037,0.254158580040455,0.854301450839659,8,62,metencephalon development,BP,PTPRS;CNTN1;NAGLU;SERPINE2;WNT7A;SEMA4C;PROX1;TRNP1
509,GO:0001573,0.254380435021254,0.934053354734162,2,10,ganglioside metabolic process,BP,HEXB;GM2A
17547,GO:1901186,0.254415850257579,0.890845023249686,4,27,positive regulation of ERBB signaling pathway,BP,ARAP1;PTK6;AKT1;EREG
10460,GO:0043371,0.254640676592149,0.933940907001613,2,10,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,BCL6;JAK3
7325,GO:0031347,0.254651358126624,0.793730825833619,47,447,regulation of defense response,BP,TNIP1;HTRA1;APOE;PTPRS;NT5E;NR1D1;MAPK13;EGFR;SERPING1;CTSB;ZP3;RNF135;GGT1;ACP5;PDCD4;IL20RB;TMEM173;BCL6;CD81;MAPK3;MEFV;LRSAM1;ADA;MAPKBP1;PRKACA;F12;RPS6KA5;TNFRSF1A;LDLR;TRPV4;IFNGR2;RAG1;FAM3A;BTRC;PPARA;TKFC;BCR;MUC19;MAPKAPK3;C5;STK39;ADORA2B;ABR;NLRX1;PYCARD;APOBEC3F;EREG
2383,GO:0005524,0.254817940896386,0.777071356152668,119,1151,ATP binding,MF,SCN8A;EPHB2;OBSCN;NME4;MST1R;MAPK13;CDK18;EGFR;ACSF2;ULK1;PKN1;PYGL;PTK6;ABCA7;ACTA2;DNAH1;ULK2;DGKA;ABCG1;OPLAH;NEK9;RPS6KA2;NMRK1;MARK4;ERBB2;BRSK1;CUL9;KIF13B;PAK6;MINK1;ATP2B4;CSNK1E;GLUL;INSR;GRK6;MVD;EPHA1;DHX32;ATP7B;SPEG;ABCD1;MKNK2;STRADB;FAM20C;MYO18A;UCKL1;PFKFB2;ATP12A;DYRK1B;SRMS;MAST4;ACVR2B;MAPK3;ENTPD2;GALK1;FYCO1;ADCY6;PKN3;EPHB3;PC;NADK;ABCA2;TK2;CKMT1A;PFKL;HLCS;FGFR3;PRKACA;LRRK1;DGUOK;RPS6KA5;MAP2K2;PI4K2A;FGFR4;PMVK;MYH3;EHD4;TRPV4;EEF2K;DGKQ;HK1;TKFC;GUK1;STK32C;DMC1;BCR;PRKCZ;HLTF;ABCD4;TWF2;PDK2;MAPKAPK3;FGFR1;CAMKK1;ASS1;ACTR1B;STK39;ACVR1B;GSS;ERBB3;AKT1;TRAP1;NLRX1;TUT1;SMARCA1;ERCC6;ADCK2;PINK1;EHD3;LONP2;MAP2K3;STK17A;ERN1;JAK3;MAST3;KIFC2;FUK;TTLL11;KIF26B
2158,GO:0004993,0.254826784486563,0.975483069936352,1,3,G-protein coupled serotonin receptor activity,MF,HTR7
3415,GO:0007210,0.254826784486563,0.975483069936352,1,3,serotonin receptor signaling pathway,BP,HTR7
10344,GO:0043176,0.254826784486563,0.975483069936352,1,3,amine binding,MF,HTR7
12950,GO:0051378,0.254826784486563,0.975483069936352,1,3,serotonin binding,MF,HTR7
16787,GO:0098664,0.254826784486563,0.975483069936352,1,3,G-protein coupled serotonin receptor signaling pathway,BP,HTR7
17050,GO:0099589,0.254826784486563,0.975483069936352,1,3,serotonin receptor activity,MF,HTR7
7554,GO:0031914,0.254852705347157,0.975477733360035,1,3,negative regulation of synaptic plasticity,BP,RGS14
14859,GO:0070672,0.254874818549487,0.933839663077725,2,10,response to interleukin-15,BP,SHC1;JAK3
3460,GO:0007288,0.254887178930532,0.933834316462789,2,10,sperm axoneme assembly,BP,BBS2;DNAH1
7814,GO:0032379,0.25502550678238,0.975442140135358,1,3,positive regulation of intracellular lipid transport,BP,LDLRAP1
7817,GO:0032382,0.25502550678238,0.975442140135358,1,3,positive regulation of intracellular sterol transport,BP,LDLRAP1
7820,GO:0032385,0.25502550678238,0.975442140135358,1,3,positive regulation of intracellular cholesterol transport,BP,LDLRAP1
82,GO:0000166,0.255127898206748,0.772591693320111,166,1631,nucleotide binding,MF,H6PD;IDH2;NT5E;LTB4R;RAPGEF3;XDH;PRODH;NOS1;SCN8A;EPHB2;OBSCN;NME4;MST1R;MAPK13;CDK18;EGFR;HADH;CRYL1;ACSF2;MTHFR;ULK1;PKN1;PYGL;PTK6;GNAL;ABCA7;ACTA2;DNAH1;ULK2;DGKA;D2HGDH;ABCG1;DHRS11;OPLAH;NEK9;RPS6KA2;NMRK1;TUBG2;MARK4;ERBB2;BRSK1;DNM1;CUL9;KIF13B;PAK6;VPS11;MINK1;ATP2B4;CSNK1E;AGAP1;GLUL;RHOD;INSR;RAB3D;GRK6;MVD;EPHA1;TXNRD3;TMEM173;DHX32;ATP7B;HINT2;SPEG;ABCD1;MKNK2;STRADB;RAB25;FAM20C;MYO18A;UCKL1;PFKFB2;ATP12A;DYRK1B;SRMS;ARL2;MAST4;ACVR2B;MAPK3;ARL10;RAB40B;ENTPD2;GALK1;FYCO1;ADCY6;MBD1;PKN3;PHGDH;EPHB3;PC;ACAD10;NADK;ABCA2;TK2;RASL10B;CKMT1A;PFKL;RHOF;HLCS;FGFR3;PRKACA;LRRK1;DGUOK;RPS6KA5;RAB3B;MAP2K2;PI4K2A;FGFR4;PMVK;MYH3;EHD4;TRPV4;RHOBTB2;EEF2K;TM7SF2;DGKQ;HK1;TKFC;GUK1;STK32C;DMC1;PCK2;BCR;SDHA;PRKCZ;HLTF;ABCD4;TWF2;PDK2;MAPKAPK3;FGFR1;CAMKK1;GTPBP1;ASS1;GAL3ST4;GRHPR;ACTR1B;STK39;ACVR1B;GSS;ERBB3;AKT1;TRAP1;NLRX1;SEPT8;TUT1;SMARCA1;ERCC6;GPD1L;ADCK2;PINK1;EHD3;LONP2;MAP2K3;PNPO;STK17A;ERN1;ACADS;MOCS1;SIRT3;JAK3;MAST3;KIFC2;FUK;TTLL11;RAB40C;KIF26B
4720,GO:0010893,0.255140918154097,0.933724515933275,2,10,positive regulation of steroid biosynthetic process,BP,NR1D1;ABCG1
2661,GO:0006020,0.255202057823141,0.933698046738476,2,10,inositol metabolic process,BP,ISYNA1;IMPA2
6343,GO:0021533,0.255263086150901,0.933671621007679,2,10,cell differentiation in hindbrain,BP,WNT7A;PROX1
18203,GO:1903034,0.255307185989774,0.835464641784999,12,100,regulation of response to wounding,BP,APOE;PTPRS;SERPING1;F2R;PLAT;CD9;SERPINE2;F12;HBEGF;DMTN;RTN4R;VPS33B
7082,GO:0030889,0.255317235442291,0.933648169987616,2,10,negative regulation of B cell proliferation,BP,PKN1;INPP5D
4405,GO:0010181,0.255410315554228,0.933607850064464,2,10,FMN binding,MF,NOS1;PNPO
4857,GO:0014719,0.255414450216305,0.975361918712608,1,3,skeletal muscle satellite cell activation,BP,WNT7A
806,GO:0002080,0.255459582077953,0.933586504609054,2,10,acrosomal membrane,CC,BSG;SUN1
8714,GO:0034378,0.255559738531767,0.975331914002389,1,3,chylomicron assembly,BP,APOE
6332,GO:0021515,0.255662187038903,0.907706684340589,3,18,cell differentiation in spinal cord,BP,TCTN1;MDGA1;SUFU
12578,GO:0050780,0.255668903447677,0.933495778599093,2,10,dopamine receptor binding,MF,DNM1;DLG4
12361,GO:0048791,0.255685430656076,0.907694084336272,3,18,calcium ion-regulated exocytosis of neurotransmitter,BP,SYTL1;SYT8;RIMS3
13909,GO:0060601,0.255911505817615,0.933390557932686,2,10,lateral sprouting from an epithelium,BP,CELSR1;VANGL2
12810,GO:0051146,0.255942943313166,0.821680532044084,17,147,striated muscle cell differentiation,BP,FLNC;NOS1;OBSCN;OBSL1;HDAC5;THRA;TMOD2;DYRK1B;VEGFA;TNNT1;MYH3;RXRA;PIN1;PROX1;CAPN2;SDC1;AKT1
10479,GO:0043398,0.256035142012299,0.975233588713628,1,3,HLH domain binding,MF,PKD2
12495,GO:0050661,0.256102244166142,0.877023621684094,5,36,NADP binding,MF,H6PD;NOS1;MTHFR;TM7SF2;GRHPR
16164,GO:0090218,0.25627224345379,0.907375762448358,3,18,positive regulation of lipid kinase activity,BP,CD81;FGFR3;VAV3
3207,GO:0006858,0.256283695455901,0.975182092756877,1,3,extracellular transport,BP,ARRDC1
12575,GO:0050777,0.256514885817404,0.842224790346695,10,82,negative regulation of immune response,BP,SERPING1;IL20RB;STAT6;BCL6;FAM3A;BCR;INPP5D;ABR;NLRX1;JAK3
5582,GO:0016618,0.256520751640982,0.97513292192017,1,3,hydroxypyruvate reductase activity,MF,GRHPR
6802,GO:0030267,0.256520751640982,0.97513292192017,1,3,glyoxylate reductase (NADP) activity,MF,GRHPR
18504,GO:1903719,0.256538684941491,0.975129199884995,1,3,regulation of I-kappaB phosphorylation,BP,AKT1
18505,GO:1903721,0.256538684941491,0.975129199884995,1,3,positive regulation of I-kappaB phosphorylation,BP,AKT1
10396,GO:0043252,0.256661698738144,0.933064713332703,2,10,sodium-independent organic anion transport,BP,SLCO4A1;SLC22A17
10684,GO:0043988,0.256745918730347,0.975086165675713,1,3,histone H3-S28 phosphorylation,BP,RPS6KA5
8584,GO:0034109,0.25680916155374,0.8587925822586,7,54,homotypic cell-cell adhesion,BP,ANK3;PTPRU;CD9;SERPINE2;DMTN;GAS6;VPS33B
13482,GO:0055080,0.256914012808897,0.795468006933231,40,377,cation homeostasis,BP,CEMIP;APOE;CYP27B1;NOS1;EPAS1;EGFR;F2R;ANK3;PKD2;SLC7A8;ITPR3;HEXB;NTSR1;ATP2B4;LPAR3;PRNP;ATP7B;SLC12A7;DLG4;ATP12A;BNIP3;MAPK3;PRKACA;SCNN1A;SLC25A37;TRPV4;COMT;TMEM175;NEO1;PDK2;KCNMA1;SLC25A27;SMDT1;CYBRD1;SLC9A7;TPCN1;PKD1;SLC22A17;GSTM2;GIPR
14598,GO:0070193,0.257055244452996,0.932893491447311,2,10,synaptonemal complex organization,BP,AGO4;P3H4
9808,GO:0042043,0.257127926241383,0.932861847873542,2,10,neurexin family protein binding,MF,SYTL1;NLGN2
12289,GO:0048662,0.257220727253642,0.889139521006206,4,27,negative regulation of smooth muscle cell proliferation,BP,CTNNBIP1;PDCD4;COMT;NDRG2
13780,GO:0060397,0.257408095392969,0.93273980736451,2,10,JAK-STAT cascade involved in growth hormone signaling pathway,BP,MAPK3;JAK3
17576,GO:1901265,0.257460784636413,0.770397089707853,166,1632,nucleoside phosphate binding,MF,H6PD;IDH2;NT5E;LTB4R;RAPGEF3;XDH;PRODH;NOS1;SCN8A;EPHB2;OBSCN;NME4;MST1R;MAPK13;CDK18;EGFR;HADH;CRYL1;ACSF2;MTHFR;ULK1;PKN1;PYGL;PTK6;GNAL;ABCA7;ACTA2;DNAH1;ULK2;DGKA;D2HGDH;ABCG1;DHRS11;OPLAH;NEK9;RPS6KA2;NMRK1;TUBG2;MARK4;ERBB2;BRSK1;DNM1;CUL9;KIF13B;PAK6;VPS11;MINK1;ATP2B4;CSNK1E;AGAP1;GLUL;RHOD;INSR;RAB3D;GRK6;MVD;EPHA1;TXNRD3;TMEM173;DHX32;ATP7B;HINT2;SPEG;ABCD1;MKNK2;STRADB;RAB25;FAM20C;MYO18A;UCKL1;PFKFB2;ATP12A;DYRK1B;SRMS;ARL2;MAST4;ACVR2B;MAPK3;ARL10;RAB40B;ENTPD2;GALK1;FYCO1;ADCY6;MBD1;PKN3;PHGDH;EPHB3;PC;ACAD10;NADK;ABCA2;TK2;RASL10B;CKMT1A;PFKL;RHOF;HLCS;FGFR3;PRKACA;LRRK1;DGUOK;RPS6KA5;RAB3B;MAP2K2;PI4K2A;FGFR4;PMVK;MYH3;EHD4;TRPV4;RHOBTB2;EEF2K;TM7SF2;DGKQ;HK1;TKFC;GUK1;STK32C;DMC1;PCK2;BCR;SDHA;PRKCZ;HLTF;ABCD4;TWF2;PDK2;MAPKAPK3;FGFR1;CAMKK1;GTPBP1;ASS1;GAL3ST4;GRHPR;ACTR1B;STK39;ACVR1B;GSS;ERBB3;AKT1;TRAP1;NLRX1;SEPT8;TUT1;SMARCA1;ERCC6;GPD1L;ADCK2;PINK1;EHD3;LONP2;MAP2K3;PNPO;STK17A;ERN1;ACADS;MOCS1;SIRT3;JAK3;MAST3;KIFC2;FUK;TTLL11;RAB40C;KIF26B
4389,GO:0010107,0.257499646404929,0.906708579867109,3,18,potassium ion import,BP,KCNJ15;SLC12A7;ATP12A
589,GO:0001754,0.257506453311358,0.906704874663791,3,18,eye photoreceptor cell differentiation,BP,SDK2;NAGLU;VEGFA
16091,GO:0090107,0.257573220768615,0.974913944328874,1,3,regulation of high-density lipoprotein particle assembly,BP,LCAT
20065,GO:2000758,0.257784529517547,0.88879560485118,4,27,positive regulation of peptidyl-lysine acetylation,BP,NOS1;MAPK3;RPS6KA5;WBP2
11547,GO:0046121,0.257785598110436,0.974869623878454,1,3,deoxyribonucleoside catabolic process,BP,ADA
254,GO:0000720,0.257826922686238,0.974860994768318,1,3,pyrimidine dimer repair by nucleotide-excision repair,BP,ERCC1
702,GO:0001923,0.257862065391926,0.974853655181016,1,3,B-1 B cell differentiation,BP,CMTM7
5148,GO:0015696,0.257915080321014,0.86593560188242,6,45,ammonium transport,BP,NOS1;ADA;RAB3B;SLC25A29;PINK1;RHBG
3710,GO:0008237,0.257923313470292,0.833467594631421,12,99,metallopeptidase activity,MF,RNPEPL1;CLCA2;MMP28;NPEPL1;MMP1;ADAMTS7;ADAM15;LTA4H;ACY1;ADAMTS13;LMLN;ADAM19
13085,GO:0051647,0.257973850305343,0.90645032046586,3,18,nucleus localization,BP,FHOD1;BIN1;SUN1
6735,GO:0030165,0.258038069762116,0.851472881289752,8,62,PDZ domain binding,MF,DOCK4;ATP2B4;DLG4;FZD8;MAP2K2;DLG3;SNTA1;SHISA6
10575,GO:0043560,0.258086870312755,0.932443721891496,2,10,insulin receptor substrate binding,MF,INSR;PRKCZ
8481,GO:0033673,0.258139922810206,0.808411574076868,24,216,negative regulation of kinase activity,BP,DUSP6;APOE;EPHB2;DUSP5;PKN1;PTK6;LRP5;SPRY4;CDKN1C;PDCD4;EPHA1;ADARB1;SPRY2;WWTR1;DVL1;MAPK8IP1;DUSP7;RTN4R;PPM1F;SORL1;AKT1;RGS14;CBLC;PYCARD
5592,GO:0016641,0.25822158807958,0.932384887532944,2,10,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,LOXL1;PNPO
17082,GO:0101003,0.258303674060073,0.875584507186841,5,36,ficolin-1-rich granule membrane,CC,GAA;NBEAL2;AP2A2;SLC2A3;SERPINB6
2163,GO:0005001,0.258308060519764,0.932347110856043,2,10,transmembrane receptor protein tyrosine phosphatase activity,MF,PTPRU;PTPRE
6042,GO:0019198,0.258308060519764,0.932347110856043,2,10,transmembrane receptor protein phosphatase activity,MF,PTPRU;PTPRE
13838,GO:0060482,0.258347905217405,0.974752061547939,1,3,lobar bronchus development,BP,WNT7B
13865,GO:0060535,0.258347905217405,0.974752061547939,1,3,trachea cartilage morphogenesis,BP,WNT7B
8637,GO:0034199,0.258382799416643,0.932314452474968,2,10,activation of protein kinase A activity,BP,ADCY6;PRKACA
13708,GO:0060307,0.258403247631407,0.932305516055649,2,10,regulation of ventricular cardiac muscle cell membrane repolarization,BP,SCN4B;SNTA1
5891,GO:0018107,0.25843135449902,0.836705136794759,11,90,peptidyl-threonine phosphorylation,BP,CEMIP;ULK1;PKN1;SPRY2;S1PR2;DMTN;DGKQ;CAMKK1;STK39;ACVR1B;AKT1
18125,GO:1902894,0.25853321185397,0.932248705762896,2,10,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,NFATC4;PPARA
2244,GO:0005161,0.258548114769068,0.932242189989276,2,10,platelet-derived growth factor receptor binding,MF,VEGFA;ERN1
14499,GO:0070016,0.258548206562202,0.932242149855047,2,10,armadillo repeat domain binding,MF,CTNNBIP1;CALCOCO1
14456,GO:0061888,0.258552570378733,0.974709194040224,1,3,regulation of astrocyte activation,BP,LDLR
2241,GO:0005158,0.258658174579844,0.906077139583211,3,18,insulin receptor binding,MF,IGF2;SHC1;GRB10
15060,GO:0071073,0.258790542967984,0.974659297937654,1,3,positive regulation of phospholipid biosynthetic process,BP,ZP3
9419,GO:0036010,0.258824832608064,0.905986169368918,3,18,protein localization to endosome,BP,ABHD17C;TOLLIP;SORL1
14785,GO:0070541,0.258838818568908,0.974649169051408,1,3,response to platinum ion,BP,UROS
2387,GO:0005534,0.258922178843135,0.974631673467128,1,3,galactose binding,MF,GALK1
6825,GO:0030299,0.259011061542694,0.974613011236067,1,3,intestinal cholesterol absorption,BP,LDLR
10764,GO:0044241,0.259011061542694,0.974613011236067,1,3,lipid digestion,BP,LDLR
16874,GO:0098856,0.259011061542694,0.974613011236067,1,3,intestinal lipid absorption,BP,LDLR
1614,GO:0004046,0.259196102053882,0.974574134073415,1,3,aminoacylase activity,MF,ACY1
6976,GO:0030666,0.259243926169468,0.829020106810784,13,112,endocytic vesicle membrane,CC,APOE;LRP1;EGFR;CD9;WNT7A;DLG4;AP2A2;HBEGF;LDLR;LDLRAP1;WNT7B;WNT3;EPN2
135,GO:0000285,0.259268131903135,0.974558991341304,1,3,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,ZFYVE21
980,GO:0002437,0.259269450923175,0.905268869549751,3,19,inflammatory response to antigenic stimulus,BP,ZP3;IL20RB;PNMA1
3012,GO:0006565,0.259368112818465,0.9745379639483,1,3,L-serine catabolic process,BP,CBS
18691,GO:1904154,0.259374287677837,0.974536664962631,1,3,positive regulation of retrograde protein transport, ER to cytosol,BP,EDEM1
4499,GO:0010559,0.259388489697232,0.88781519229397,4,27,regulation of glycoprotein biosynthetic process,BP,ABCA7;HBEGF;POMT1;JAK3
5123,GO:0015629,0.259616609230867,0.795045932010307,37,343,actin cytoskeleton,CC,ESPN;RAPGEF3;PGM1;GSN;PARVB;MYZAP;MST1R;OBSL1;H1F0;CORO1B;MICALL2;PKD2;MPRIP;TMOD2;SH3PXD2B;MYO18A;PLEKHH2;VANGL2;TNNT1;WIPF1;FHOD1;MYH16;SPTB;DMTN;MYH3;TRPV4;CROCC;POU6F1;LLGL1;PRKCZ;CAPG;TWF2;BIN1;CAPN2;ACTR1B;SPPL2B;SLC2A1
11289,GO:0045629,0.259639241043124,0.974480891842,1,3,negative regulation of T-helper 2 cell differentiation,BP,BCL6
5061,GO:0015294,0.259670345111999,0.856873383546824,7,53,solute:cation symporter activity,MF,SLC2A9;SLC13A3;SLC6A8;SLC20A1;SLC12A7;SLC28A2;SLC5A5
2441,GO:0005656,0.25974697350464,0.974458194012919,1,3,nuclear pre-replicative complex,CC,WDR18
2800,GO:0006267,0.25974697350464,0.974458194012919,1,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,WDR18
9560,GO:0036387,0.25974697350464,0.974458194012919,1,3,pre-replicative complex,CC,WDR18
9561,GO:0036388,0.25974697350464,0.974458194012919,1,3,pre-replicative complex assembly,BP,WDR18
17923,GO:1902299,0.25974697350464,0.974458194012919,1,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,WDR18
663,GO:0001867,0.259767765294749,0.974453812123723,1,3,complement activation, lectin pathway,BP,SERPING1
16926,GO:0098953,0.259782215235436,0.97445076653184,1,3,receptor diffusion trapping,BP,DLG4
16932,GO:0098970,0.259782215235436,0.97445076653184,1,3,postsynaptic neurotransmitter receptor diffusion trapping,BP,DLG4
17065,GO:0099628,0.259782215235436,0.97445076653184,1,3,neurotransmitter receptor diffusion trapping,BP,DLG4
2155,GO:0004985,0.259800873337911,0.974446833684867,1,3,opioid receptor activity,MF,SIGMAR1
4505,GO:0010565,0.259859053415325,0.825561731194509,14,123,regulation of cellular ketone metabolic process,BP,TYSND1;NR1D1;EGR1;ATP2B4;MLXIPL;FGFR4;DGKQ;PPARA;COMT;PDK2;PROX1;AKT1;LONP2;MLYCD
6934,GO:0030554,0.260022466139956,0.771876322425055,122,1183,adenyl nucleotide binding,MF,RAPGEF3;SCN8A;EPHB2;OBSCN;NME4;MST1R;MAPK13;CDK18;EGFR;ACSF2;ULK1;PKN1;PYGL;PTK6;ABCA7;ACTA2;DNAH1;ULK2;DGKA;ABCG1;OPLAH;NEK9;RPS6KA2;NMRK1;MARK4;ERBB2;BRSK1;CUL9;KIF13B;PAK6;MINK1;ATP2B4;CSNK1E;GLUL;INSR;GRK6;MVD;EPHA1;TMEM173;DHX32;ATP7B;SPEG;ABCD1;MKNK2;STRADB;FAM20C;MYO18A;UCKL1;PFKFB2;ATP12A;DYRK1B;SRMS;MAST4;ACVR2B;MAPK3;ENTPD2;GALK1;FYCO1;ADCY6;PKN3;EPHB3;PC;NADK;ABCA2;TK2;CKMT1A;PFKL;HLCS;FGFR3;PRKACA;LRRK1;DGUOK;RPS6KA5;MAP2K2;PI4K2A;FGFR4;PMVK;MYH3;EHD4;TRPV4;EEF2K;DGKQ;HK1;TKFC;GUK1;STK32C;DMC1;BCR;PRKCZ;HLTF;ABCD4;TWF2;PDK2;MAPKAPK3;FGFR1;CAMKK1;ASS1;GAL3ST4;ACTR1B;STK39;ACVR1B;GSS;ERBB3;AKT1;TRAP1;NLRX1;TUT1;SMARCA1;ERCC6;ADCK2;PINK1;EHD3;LONP2;MAP2K3;STK17A;ERN1;JAK3;MAST3;KIFC2;FUK;TTLL11;KIF26B
13180,GO:0051835,0.260084081942453,0.974387095035629,1,3,positive regulation of synapse structural plasticity,BP,SHANK3
1522,GO:0003896,0.260101627229641,0.974383391491609,1,3,DNA primase activity,MF,PRIMPOL
14113,GO:0061009,0.260141021538673,0.974375074833731,1,3,common bile duct development,BP,HES1
4064,GO:0009126,0.260185155634787,0.80407671548431,26,248,purine nucleoside monophosphate metabolic process,BP,NT5E;PGM1;OGDHL;INSR;NDUFS8;DLG4;FAM20C;PFKFB2;DHTKD1;GALK1;LHPP;MLXIPL;NADK;ADA;PFKL;NUDT10;MYH3;HK1;PPARA;GUK1;SDHA;DLG3;UQCR11;PINK1;NDUFV3;TAZ
4103,GO:0009167,0.260185155634787,0.80407671548431,26,248,purine ribonucleoside monophosphate metabolic process,BP,NT5E;PGM1;OGDHL;INSR;NDUFS8;DLG4;FAM20C;PFKFB2;DHTKD1;GALK1;LHPP;MLXIPL;NADK;ADA;PFKL;NUDT10;MYH3;HK1;PPARA;GUK1;SDHA;DLG3;UQCR11;PINK1;NDUFV3;TAZ
18892,GO:1904636,0.260216114713578,0.974359217394801,1,3,response to ionomycin,BP,NFATC4
18893,GO:1904637,0.260216114713578,0.974359217394801,1,3,cellular response to ionomycin,BP,NFATC4
811,GO:0002085,0.260341317979642,0.97433276571245,1,3,inhibition of neuroepithelial cell differentiation,BP,HES1
11275,GO:0045608,0.260341317979642,0.97433276571245,1,3,negative regulation of inner ear auditory receptor cell differentiation,BP,HES1
9360,GO:0035905,0.260341317979642,0.97433276571245,1,3,ascending aorta development,BP,HES1
9363,GO:0035910,0.260341317979642,0.97433276571245,1,3,ascending aorta morphogenesis,BP,HES1
8268,GO:0033087,0.260496640176028,0.974299929106838,1,3,negative regulation of immature T cell proliferation,BP,ERBB2
1237,GO:0002931,0.260708861726937,0.887005895356482,4,27,response to ischemia,BP,EGR1;EEF2K;PINK1;MLYCD
1157,GO:0002765,0.260812989507954,0.974232975478692,1,3,immune response-inhibiting signal transduction,BP,IL20RB
10421,GO:0043295,0.260923914732369,0.930244819743938,2,11,glutathione binding,MF,GSS;GSTM2
17490,GO:1900750,0.260923914732369,0.930244819743938,2,11,oligopeptide binding,MF,GSS;GSTM2
2409,GO:0005589,0.260974543515119,0.97419874496608,1,3,collagen type VI trimer,CC,COL6A1
16776,GO:0098647,0.260974543515119,0.97419874496608,1,3,collagen beaded filament,CC,COL6A1
12296,GO:0048669,0.260996353304117,0.974194121853582,1,3,collateral sprouting in absence of injury,BP,WNT3
10825,GO:0044339,0.260996353304224,0.974194121853582,1,3,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,WNT3
15420,GO:0071733,0.261025375291397,0.974187969205578,1,3,transcriptional activation by promoter-enhancer looping,BP,ZFPM1
16154,GO:0090202,0.261025375291397,0.974187969205578,1,3,gene looping,BP,ZFPM1
16313,GO:0090579,0.261025375291397,0.974187969205578,1,3,dsDNA loop formation,BP,ZFPM1
11538,GO:0046102,0.261361898218249,0.974116565149704,1,3,inosine metabolic process,BP,ADA
11015,GO:0045006,0.261362855501217,0.930049064974725,2,11,DNA deamination,BP,APOBEC3C;APOBEC3F
3930,GO:0008626,0.261492921150952,0.974088733901591,1,3,granzyme-mediated apoptotic signaling pathway,BP,BNIP3
6019,GO:0019087,0.261569334679678,0.974072494604891,1,3,transformation of host cell by virus,BP,INSR
14519,GO:0070061,0.261578005107742,0.97407065160942,1,3,fructose binding,MF,PFKL
13786,GO:0060405,0.261591839665689,0.974067710765557,1,3,regulation of penile erection,BP,ADA
10146,GO:0042748,0.261591839665798,0.974067710765555,1,3,circadian sleep/wake cycle, non-REM sleep,BP,ADA
1847,GO:0004514,0.261729253764725,0.974038489959033,1,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,NAPRT
8067,GO:0032762,0.261756532840205,0.974032686880616,1,3,mast cell cytokine production,BP,BCL6
8068,GO:0032763,0.261756532840205,0.974032686880616,1,3,regulation of mast cell cytokine production,BP,BCL6
10413,GO:0043277,0.261897454033472,0.886275652246524,4,27,apoptotic cell clearance,BP,LRP1;ABCA7;GAS6;PEAR1
19585,GO:1990756,0.261950714284114,0.973991357184045,1,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,ARRDC1
414,GO:0001102,0.261966103125365,0.873178664941547,5,36,RNA polymerase II activating transcription factor binding,MF,FOS;MEF2D;ZFPM1;BHLHE40;MEF2B
10081,GO:0042608,0.261989339881401,0.97398313159762,1,3,T cell receptor binding,MF,EPS8L1
10075,GO:0042594,0.262012275417408,0.818901366771212,16,138,response to starvation,BP,ULK1;ULK2;LRP11;GLUL;MAPK3;PCSK9;ZFP36;DAP;GAS6;HMGCL;COMT;PCK2;SESN2;WNT2B;C12ORF66;SLC2A1
967,GO:0002414,0.262170503023835,0.973944531770413,1,3,immunoglobulin transcytosis in epithelial cells,BP,FCGRT
15533,GO:0072007,0.262177144496539,0.973943116070796,1,3,mesangial cell differentiation,BP,ACTA2
15534,GO:0072008,0.262177144496539,0.973943116070796,1,3,glomerular mesangial cell differentiation,BP,ACTA2
15616,GO:0072143,0.262177144496539,0.973943116070796,1,3,mesangial cell development,BP,ACTA2
15617,GO:0072144,0.262177144496539,0.973943116070796,1,3,glomerular mesangial cell development,BP,ACTA2
18730,GO:1904238,0.262177144496539,0.973943116070796,1,3,pericyte cell differentiation,BP,ACTA2
8438,GO:0033590,0.262183834593495,0.973941689961851,1,3,response to cobalamin,BP,EGFR
53,GO:0000110,0.262222822977942,0.973933378028821,1,3,nucleotide-excision repair factor 1 complex,CC,ERCC1
4081,GO:0009144,0.262262600927152,0.803445422119763,25,240,purine nucleoside triphosphate metabolic process,BP,PGM1;NME4;OGDHL;INSR;NDUFS8;FAM20C;PFKFB2;DHTKD1;GALK1;MLXIPL;NADK;ADA;PFKL;DGUOK;MYH3;HK1;PPARA;GUK1;SDHA;GTPBP1;UQCR11;PINK1;NDUFV3;MOCS1;TAZ
6347,GO:0021537,0.262312795059268,0.814379312088472,18,158,telencephalon development,BP,PTPRS;TCTN1;EPHB2;LRP1;EGFR;BBS2;ATP2B4;TRAPPC9;BNIP3;SHANK3;EPHB3;HES1;MBOAT7;NDE1;PROX1;RTN4R;SUN1;SLC2A1
11540,GO:0046104,0.262377816920051,0.973900319847681,1,3,thymidine metabolic process,BP,TK2
11550,GO:0046125,0.262377816920051,0.973900319847681,1,3,pyrimidine deoxyribonucleoside metabolic process,BP,TK2
1185,GO:0002832,0.262661756284069,0.872720050391334,5,36,negative regulation of response to biotic stimulus,BP,HTRA1;MAPKBP1;FAM3A;TKFC;NLRX1
7930,GO:0032532,0.262766520290559,0.973817308850277,1,3,regulation of microvillus length,BP,TWF2
19995,GO:2000645,0.262882229448589,0.973792568960275,1,3,negative regulation of receptor catabolic process,BP,FURIN
8517,GO:0033829,0.262917328550478,0.973785061738405,1,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,RFNG
19578,GO:1990743,0.263062465498383,0.973754005824205,1,3,protein sialylation,BP,ST6GALNAC2
18633,GO:1903976,0.263076853764319,0.973750925923075,1,3,negative regulation of glial cell migration,BP,IDH2
18772,GO:1904340,0.263132273678108,0.973739060996485,1,3,positive regulation of dopaminergic neuron differentiation,BP,CSNK1E
19049,GO:1904958,0.263132273678108,0.973739060996485,1,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,CSNK1E
14836,GO:0070634,0.263133963944744,0.973738699076655,1,3,transepithelial ammonium transport,BP,RHBG
8663,GO:0034260,0.263200376923398,0.872364601198228,5,36,negative regulation of GTPase activity,BP,PLXNB3;RASA4;SPRY2;ARL2;GPSM1
9214,GO:0035620,0.263351616458094,0.97369207142659,1,3,ceramide transporter activity,MF,PLTP
9700,GO:0038145,0.263479714109406,0.973664606918857,1,3,macrophage colony-stimulating factor signaling pathway,BP,MST1R
4624,GO:0010756,0.263504328417198,0.973659327657448,1,3,positive regulation of plasminogen activation,BP,F12
3473,GO:0007341,0.263528762991224,0.973654086344971,1,3,penetration of zona pellucida,BP,HEXB
521,GO:0001609,0.263529836934211,0.973653855966212,1,3,G-protein coupled adenosine receptor activity,MF,ADORA2B
6608,GO:0022841,0.263542719404615,0.973651092370855,1,3,potassium ion leak channel activity,MF,TMEM175
10651,GO:0043900,0.263587522077442,0.797106203672553,30,280,regulation of multi-organism process,BP,TNIP1;HTRA1;APOE;GSN;ZP3;EXOC2;ADARB1;TMEM173;ISG20;MVB12B;MAPK3;PC;LRSAM1;ADA;ZFP36;MAPKBP1;HMGA2;MVB12A;FAM3A;TKFC;PTAFR;RAD23A;PROX1;TIMP1;APOBEC3C;ACVR1B;NLRX1;PYCARD;APOBEC3F;MIF
8877,GO:0034711,0.263685906841971,0.973620364075424,1,3,inhibin binding,MF,ACVR1B
18679,GO:1904098,0.263700699067446,0.973617188465085,1,3,regulation of protein O-linked glycosylation,BP,POMT1
18680,GO:1904100,0.263700699067446,0.973617188465085,1,3,positive regulation of protein O-linked glycosylation,BP,POMT1
7399,GO:0031493,0.263711480480012,0.973614873761988,1,3,nucleosomal histone binding,MF,L3MBTL1
4894,GO:0014834,0.263726786093711,0.973611587540788,1,3,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,WNT7A
19554,GO:1990637,0.263732987472113,0.973610255994991,1,3,response to prolactin,BP,EEF2K
13559,GO:0060054,0.263743713031551,0.973607952936559,1,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,WNT7A
6635,GO:0023041,0.263767531842613,0.973602838001845,1,3,neuronal signal transduction,BP,RTN4R
11099,GO:0045143,0.263889302113977,0.885048261046562,4,27,homologous chromosome segregation,BP,DMC1;AGO4;SUN1;P3H4
14137,GO:0061047,0.263900291266975,0.97357431836184,1,3,positive regulation of branching involved in lung morphogenesis,BP,WNT2B
1992,GO:0004719,0.26398523672992,0.97355606094191,1,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,PCMTD2
11180,GO:0045323,0.26412737239239,0.97352549538986,1,3,interleukin-1 receptor complex,CC,TOLLIP
7665,GO:0032106,0.26412939337511,0.973525060641725,1,3,positive regulation of response to extracellular stimulus,BP,CYP27B1
7668,GO:0032109,0.26412939337511,0.973525060641725,1,3,positive regulation of response to nutrient levels,BP,CYP27B1
14655,GO:0070295,0.264140777298009,0.9735226116876,1,3,renal water absorption,BP,AQP3
18718,GO:1904217,0.264143938510442,0.973521931612148,1,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,SERINC2
18719,GO:1904219,0.264143938510442,0.973521931612148,1,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,SERINC2
18721,GO:1904222,0.264143938510442,0.973521931612148,1,3,positive regulation of serine C-palmitoyltransferase activity,BP,SERINC2
6737,GO:0030167,0.264275302432996,0.97349366226988,1,3,proteoglycan catabolic process,BP,GPC1
6755,GO:0030200,0.264275302432996,0.97349366226988,1,3,heparan sulfate proteoglycan catabolic process,BP,GPC1
8262,GO:0033080,0.264447791709904,0.973456516517294,1,3,immature T cell proliferation in thymus,BP,ERBB2
9134,GO:0035502,0.264475917674993,0.973450456729522,1,3,metanephric part of ureteric bud development,BP,PKD2
10707,GO:0044062,0.264557993397463,0.973432768834878,1,3,regulation of excretion,BP,COMT
14531,GO:0070081,0.264624195142536,0.973418496967831,1,3,clathrin-sculpted monoamine transport vesicle,CC,VAMP2
14532,GO:0070083,0.264624195142536,0.973418496967831,1,3,clathrin-sculpted monoamine transport vesicle membrane,CC,VAMP2
3519,GO:0007501,0.264632195785547,0.973416771879825,1,3,mesodermal cell fate specification,BP,FGFR1
10109,GO:0042661,0.264632195785547,0.973416771879825,1,3,regulation of mesodermal cell fate specification,BP,FGFR1
19330,GO:1905770,0.264632195785547,0.973416771879825,1,3,regulation of mesodermal cell differentiation,BP,FGFR1
19368,GO:1905902,0.264632195785547,0.973416771879825,1,3,regulation of mesoderm formation,BP,FGFR1
9482,GO:0036146,0.264686104590867,0.973405146459669,1,3,cellular response to mycotoxin,BP,EGR1
8505,GO:0033745,0.264695026593841,0.973403222150591,1,3,L-methionine-(R)-S-oxide reductase activity,MF,MSRB2
16105,GO:0090135,0.264730964430875,0.973395470222694,1,3,actin filament branching,BP,CORO1B
5023,GO:0015204,0.264791991725504,0.973382303432782,1,3,urea transmembrane transporter activity,MF,AQP3
5218,GO:0015840,0.264791991725504,0.973382303432782,1,3,urea transport,BP,AQP3
3808,GO:0008410,0.264826719757789,0.97337480910442,1,3,CoA-transferase activity,MF,SUGCT
2727,GO:0006114,0.264950382317893,0.97334811282172,1,3,glycerol biosynthetic process,BP,PCK2
13635,GO:0060179,0.265085814506963,0.973318858089016,1,3,male mating behavior,BP,HEXB
9495,GO:0036166,0.265126728294336,0.973310016670184,1,3,phenotypic switching,BP,OLFM2
17426,GO:1900239,0.265126728294336,0.973310016670184,1,3,regulation of phenotypic switching,BP,OLFM2
5554,GO:0016576,0.265184058446525,0.973297624865802,1,3,histone dephosphorylation,BP,PPM1F
10740,GO:0044194,0.265322487745622,0.973267690018489,1,3,cytolytic granule,CC,STXBP2
8816,GO:0034617,0.26534716636063,0.97326235133252,1,3,tetrahydrobiopterin binding,MF,NOS1
4989,GO:0015141,0.265352378643945,0.973261223689127,1,3,succinate transmembrane transporter activity,MF,SLC13A3
5172,GO:0015744,0.265352378643945,0.973261223689127,1,3,succinate transport,BP,SLC13A3
15226,GO:0071422,0.265352378643945,0.973261223689127,1,3,succinate transmembrane transport,BP,SLC13A3
11439,GO:0045916,0.265371178047555,0.973257156334458,1,3,negative regulation of complement activation,BP,SERPING1
19782,GO:2000258,0.265371178047555,0.973257156334458,1,3,negative regulation of protein activation cascade,BP,SERPING1
9356,GO:0035898,0.265371178047557,0.973257156334457,1,3,parathyroid hormone secretion,BP,FGFR1
16253,GO:0090360,0.265403446677259,0.973250174010164,1,3,platelet-derived growth factor production,BP,NDRG2
16254,GO:0090361,0.265403446677259,0.973250174010164,1,3,regulation of platelet-derived growth factor production,BP,NDRG2
9192,GO:0035594,0.265528655926362,0.973223071174095,1,3,ganglioside binding,MF,RTN4R
11947,GO:0047192,0.265542926455924,0.973219981169935,1,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,LPCAT4
15240,GO:0071442,0.265749407450547,0.973175248830135,1,3,positive regulation of histone H3-K14 acetylation,BP,WBP2
2225,GO:0005134,0.265803008584841,0.973163629592913,1,3,interleukin-2 receptor binding,MF,ECM1
18667,GO:1904047,0.265813525427218,0.973161349494483,1,3,S-adenosyl-L-methionine binding,MF,CBS
6165,GO:0019541,0.265888825578674,0.973145020834472,1,3,propionate metabolic process,BP,PCK2
15800,GO:0072529,0.265921588718299,0.883502982931187,4,28,pyrimidine-containing compound catabolic process,BP,NT5E;APOBEC3C;APOBEC3F;NEIL1
6441,GO:0021769,0.265966679215787,0.973128132459026,1,3,orbitofrontal cortex development,BP,FGFR1
12468,GO:0050501,0.266000370006014,0.973120822204492,1,3,hyaluronan synthase activity,MF,HYAL1
9466,GO:0036118,0.266000370006015,0.973120822204491,1,3,hyaluranon cable assembly,BP,HYAL1
17351,GO:1900104,0.266000370006015,0.973120822204491,1,3,regulation of hyaluranon cable assembly,BP,HYAL1
17352,GO:1900106,0.266000370006015,0.973120822204491,1,3,positive regulation of hyaluranon cable assembly,BP,HYAL1
10467,GO:0043380,0.266006247320401,0.973119546823099,1,3,regulation of memory T cell differentiation,BP,BCL6
2665,GO:0006024,0.266038207930484,0.835013354539163,10,81,glycosaminoglycan biosynthetic process,BP,CEMIP;B3GAT3;HYAL1;B4GAT1;ST3GAL3;XYLT2;CHST6;GPC1;SDC1;NDST2
11312,GO:0045658,0.266039243488651,0.973112385985856,1,3,regulation of neutrophil differentiation,BP,INPP5D
4974,GO:0015108,0.266068165243724,0.870466798551998,5,36,chloride transmembrane transporter activity,MF,CLCA2;ANO8;SLC12A7;TTYH3;ANO9
6286,GO:0019905,0.266068482126675,0.845476625518719,8,63,syntaxin binding,MF,SYTL1;SYT8;VPS11;VAMP2;STX10;LLGL1;SNPH;STXBP2
10189,GO:0042822,0.266098108866924,0.973099608284838,1,3,pyridoxal phosphate metabolic process,BP,PNPO
6714,GO:0030135,0.266155107625614,0.802900807300509,23,208,coated vesicle,CC,CEMIP;APOE;EPN3;LRP1;EGFR;MALL;CD9;VPS11;VAMP2;SNX9;VANGL2;AP2A2;DVL1;FURIN;PCSK9;HBEGF;LDLR;LDLRAP1;CLTCL1;CTSZ;VPS33B;EPN2;TMED4
8141,GO:0032881,0.266206459777836,0.883614669710357,4,27,regulation of polysaccharide metabolic process,BP,IGF2;PHLDA2;INSR;AKT1
6007,GO:0019068,0.266272204766396,0.870133759486931,5,37,virion assembly,BP,APOE;CHMP1B;PC;LRSAM1;MVB12A
9347,GO:0035879,0.266276892263085,0.973060779017867,1,3,plasma membrane lactate transport,BP,SLC16A3
4983,GO:0015129,0.266276892263193,0.973060779017867,1,3,lactate transmembrane transporter activity,MF,SLC16A3
6841,GO:0030322,0.266284637702098,0.973059096089103,1,3,stabilization of membrane potential,BP,KCNN4
20130,GO:2000969,0.266292918515501,0.973057296767362,1,3,positive regulation of AMPA receptor activity,BP,SHANK3
5655,GO:0016774,0.26630693518858,0.97305425095444,1,3,phosphotransferase activity, carboxyl group as acceptor,MF,NAGS
9796,GO:0042015,0.266319348365841,0.973051553414934,1,3,interleukin-20 binding,MF,IL20RB
14511,GO:0070050,0.266390729376842,0.973036038412246,1,3,neuron cellular homeostasis,BP,FGGY
6005,GO:0019064,0.266476814619322,0.973017320549463,1,3,fusion of virus membrane with host plasma membrane,BP,GAS6
9761,GO:0039663,0.266476814619322,0.973017320549463,1,3,membrane fusion involved in viral entry into host cell,BP,GAS6
10980,GO:0044800,0.266476814619322,0.973017320549463,1,3,multi-organism membrane fusion,BP,GAS6
4762,GO:0010957,0.266485689005512,0.973015390531446,1,3,negative regulation of vitamin D biosynthetic process,BP,CYP27B1
11561,GO:0046137,0.266485689005512,0.973015390531446,1,3,negative regulation of vitamin metabolic process,BP,CYP27B1
7528,GO:0031802,0.266493368696079,0.973013720273968,1,3,type 5 metabotropic glutamate receptor binding,MF,PRNP
3372,GO:0007157,0.266546580366173,0.901242478959834,3,19,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,ADGRL1;CADM4;TENM2
983,GO:0002440,0.266553951712016,0.823241013658184,13,111,production of molecular mediator of immune response,BP,ERCC1;PKN1;POLL;STAT6;BCL6;MAPK3;HK1;GAS6;PRKCZ;PMS2P5;JAK3;POLM;MIF
13702,GO:0060298,0.266590334166618,0.972992626124064,1,3,positive regulation of sarcomere organization,BP,PROX1
4980,GO:0015119,0.266632718607911,0.972983402714833,1,3,hexose phosphate transmembrane transporter activity,MF,SLC37A2
5069,GO:0015315,0.266632718607911,0.972983402714833,1,3,organophosphate:inorganic phosphate antiporter activity,MF,SLC37A2
5116,GO:0015526,0.266632718607911,0.972983402714833,1,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,SLC37A2
14304,GO:0061513,0.266632718607911,0.972983402714833,1,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,SLC37A2
14435,GO:0061819,0.266663226016361,0.972976762783264,1,3,telomeric DNA-containing double minutes formation,BP,ERCC1
19326,GO:1905764,0.266663226016361,0.972976762783264,1,3,regulation of protection from non-homologous end joining at telomere,BP,ERCC1
19327,GO:1905765,0.266663226016361,0.972976762783264,1,3,negative regulation of protection from non-homologous end joining at telomere,BP,ERCC1
19545,GO:1990599,0.266663226016361,0.972976762783264,1,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,ERCC1
10187,GO:0042819,0.266691010883476,0.972970714596478,1,3,vitamin B6 biosynthetic process,BP,PNPO
20012,GO:2000664,0.266697348996528,0.972969334812343,1,3,positive regulation of interleukin-5 secretion,BP,PRKCZ
20015,GO:2000667,0.266697348996528,0.972969334812343,1,3,positive regulation of interleukin-13 secretion,BP,PRKCZ
19944,GO:2000553,0.266697348996636,0.972969334812343,1,3,positive regulation of T-helper 2 cell cytokine production,BP,PRKCZ
13047,GO:0051581,0.266705756984929,0.972967504361416,1,3,negative regulation of neurotransmitter uptake,BP,NOS1
13241,GO:0051956,0.266705756984929,0.972967504361415,1,3,negative regulation of amino acid transport,BP,STK39
841,GO:0002155,0.266737434019247,0.972960607511255,1,3,regulation of thyroid hormone mediated signaling pathway,BP,THRA
7136,GO:0030997,0.266742990900525,0.972959397540721,1,3,regulation of centriole-centriole cohesion,BP,CEP250
11395,GO:0045829,0.266747067548965,0.972958509860321,1,3,negative regulation of isotype switching,BP,BCL6
286,GO:0000791,0.266768637554531,0.882976606528957,4,28,euchromatin,CC,H1F0;ASH2L;DNMT3A;TRNP1
2660,GO:0006015,0.266776353182771,0.972952132491739,1,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,PYGL
11632,GO:0046391,0.266776353182771,0.972952132491739,1,3,5-phosphoribose 1-diphosphate metabolic process,BP,PYGL
7850,GO:0032422,0.266789766750929,0.972949211205435,1,3,purine-rich negative regulatory element binding,MF,ELK3
14269,GO:0061408,0.266795429253663,0.972947977937656,1,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,HSF4
9762,GO:0039689,0.266833743162753,0.972939632490485,1,3,negative stranded viral RNA replication,BP,ATG16L2
18597,GO:1903911,0.266848793862075,0.972936353777213,1,3,positive regulation of receptor clustering,BP,SSH1
6444,GO:0021773,0.266889600826113,0.972927463052638,1,3,striatal medium spiny neuron differentiation,BP,SHANK3
15479,GO:0071879,0.266939426626968,0.972916605093664,1,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,NOS1
17184,GO:0106071,0.266939426626968,0.972916605093664,1,3,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1
19907,GO:2000467,0.266939426626968,0.972916605093664,1,3,positive regulation of glycogen (starch) synthase activity,BP,IGF2
8176,GO:0032928,0.266958217813718,0.927532036110353,2,11,regulation of superoxide anion generation,BP,EGFR;ACP5
20272,GO:2001293,0.266966917372361,0.972910613283056,1,3,malonyl-CoA metabolic process,BP,MLYCD
1179,GO:0002826,0.267096064693906,0.972882454475596,1,3,negative regulation of T-helper 1 type immune response,BP,JAK3
11603,GO:0046328,0.267098564295206,0.817173013527513,15,129,regulation of JNK cascade,BP,EGFR;PKN1;MINK1;PDCD4;WNT7A;FZD8;VANGL2;MAPK8IP1;TRPV4;WNT7B;AKT1;ERCC6;PINK1;PYCARD;ERN1
6698,GO:0030118,0.267101730919726,0.859584757980379,6,45,clathrin coat,CC,EGFR;AP2A2;LDLRAP1;CLTCL1;VPS33B;EPN2
8161,GO:0032911,0.267111643887243,0.97287905650894,1,3,negative regulation of transforming growth factor beta1 production,BP,FURIN
13805,GO:0060431,0.2671217544971,0.972876851160091,1,3,primary lung bud formation,BP,WNT2B
14225,GO:0061303,0.267121754497101,0.97287685116009,1,3,cornea development in camera-type eye,BP,WNT2B
9259,GO:0035701,0.267161989008392,0.972868074097288,1,3,hematopoietic stem cell migration,BP,GAS6
703,GO:0001927,0.267165054987108,0.972867405194401,1,3,exocyst assembly,BP,EXOC2
14936,GO:0070859,0.267175190357067,0.972865193898824,1,3,positive regulation of bile acid biosynthetic process,BP,NR1D1
18738,GO:1904253,0.267175190357067,0.972865193898824,1,3,positive regulation of bile acid metabolic process,BP,NR1D1
18622,GO:1903961,0.267183833320745,0.972863308128828,1,3,positive regulation of anion transmembrane transport,BP,PTAFR
12831,GO:0051176,0.267194493276607,0.972860982176448,1,3,positive regulation of sulfur metabolic process,BP,COMT
19544,GO:1990597,0.267227473542023,0.972853785311533,1,3,AIP1-IRE1 complex,CC,ERN1
19547,GO:1990604,0.267227473542023,0.972853785311533,1,3,IRE1-TRAF2-ASK1 complex,CC,ERN1
16250,GO:0090344,0.267237153375212,0.90085701463285,3,19,negative regulation of cell aging,BP,BCL6;HMGA2;MIF
1592,GO:0004013,0.267251871562648,0.9728484605351,1,3,adenosylhomocysteinase activity,MF,AHCYL2
5676,GO:0016802,0.267251871562648,0.9728484605351,1,3,trialkylsulfonium hydrolase activity,MF,AHCYL2
2629,GO:0005967,0.267259010601465,0.972846902353154,1,3,mitochondrial pyruvate dehydrogenase complex,CC,PDK2
2009,GO:0004740,0.267259010601465,0.972846902353154,1,3,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,PDK2
9556,GO:0036374,0.267353604857091,0.972826251154193,1,3,glutathione hydrolase activity,MF,GGT1
17147,GO:0102953,0.267353604857091,0.972826251154193,1,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,GGT1
17156,GO:0103068,0.267353604857091,0.972826251154193,1,3,leukotriene C4 gamma-glutamyl transferase activity,MF,GGT1
17739,GO:1901748,0.267353604857091,0.972826251154193,1,3,leukotriene D4 metabolic process,BP,GGT1
17740,GO:1901750,0.267353604857091,0.972826251154193,1,3,leukotriene D4 biosynthetic process,BP,GGT1
8564,GO:0034059,0.267358445342062,0.972825194168403,1,3,response to anoxia,BP,EEF2K
18360,GO:1903400,0.267406732490516,0.972814648718549,1,3,L-arginine transmembrane transport,BP,SLC25A29
18441,GO:1903566,0.267410222366612,0.972813886471873,1,3,positive regulation of protein localization to cilium,BP,CROCC
12269,GO:0048625,0.267411089929546,0.972813696979909,1,3,myoblast fate commitment,BP,EPAS1
6823,GO:0030297,0.267430507931661,0.972809455526042,1,3,transmembrane receptor protein tyrosine kinase activator activity,MF,DGKQ
13861,GO:0060528,0.267477902807651,0.972799101515448,1,3,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,RXRA
14072,GO:0060935,0.267478610075777,0.97279894698665,1,3,cardiac fibroblast cell differentiation,BP,PDCD4
14073,GO:0060936,0.267478610075777,0.97279894698665,1,3,cardiac fibroblast cell development,BP,PDCD4
14074,GO:0060938,0.267478610075777,0.97279894698665,1,3,epicardium-derived cardiac fibroblast cell differentiation,BP,PDCD4
14075,GO:0060939,0.267478610075777,0.97279894698665,1,3,epicardium-derived cardiac fibroblast cell development,BP,PDCD4
4290,GO:0009744,0.267486273853809,0.972797272519003,1,3,response to sucrose,BP,ERCC1
8670,GO:0034285,0.267486273853809,0.972797272519003,1,3,response to disaccharide,BP,ERCC1
13636,GO:0060180,0.267489687485623,0.972796526651604,1,3,female mating behavior,BP,THRA
7125,GO:0030969,0.267493057814864,0.972795790234066,1,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,ERN1
14515,GO:0070054,0.267493057814864,0.972795790234066,1,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,ERN1
14516,GO:0070055,0.267493057814864,0.972795790234066,1,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,ERN1
16737,GO:0098559,0.267525318404321,0.97278874071025,1,3,cytoplasmic side of early endosome membrane,CC,LITAF
11844,GO:0046870,0.267543464110754,0.972784775082831,1,3,cadmium ion binding,MF,NOS1
16501,GO:0097252,0.2675502385039,0.972783294497592,1,3,oligodendrocyte apoptotic process,BP,GAS6
9686,GO:0038108,0.267550264289125,0.972783288861986,1,3,negative regulation of appetite by leptin-mediated signaling pathway,BP,BBS2
9045,GO:0035290,0.267563579603245,0.97278037858301,1,3,trunk segmentation,BP,SEMA3F
9602,GO:0036484,0.267563579603245,0.97278037858301,1,3,trunk neural crest cell migration,BP,SEMA3F
9603,GO:0036486,0.267563579603245,0.97278037858301,1,3,ventral trunk neural crest cell migration,BP,SEMA3F
17544,GO:1901166,0.267563579603245,0.97278037858301,1,3,neural crest cell migration involved in autonomic nervous system development,BP,SEMA3F
16189,GO:0090259,0.267563579603245,0.97278037858301,1,3,regulation of retinal ganglion cell axon guidance,BP,VEGFA
4787,GO:0010989,0.26756732042716,0.972779560932715,1,3,negative regulation of low-density lipoprotein particle clearance,BP,PCSK9
4955,GO:0015057,0.267574528862881,0.972777985309814,1,3,thrombin-activated receptor activity,MF,F2R
11713,GO:0046548,0.26757876207444,0.97277705998809,1,3,retinal rod cell development,BP,NAGLU
17394,GO:1900165,0.267580325239371,0.97277671829726,1,3,negative regulation of interleukin-6 secretion,BP,GAS6
8307,GO:0033159,0.267583038811163,0.972776125134049,1,3,negative regulation of protein import into nucleus, translocation,BP,GAS6
13,GO:0000026,0.267599653166803,0.972772493218567,1,3,alpha-1,2-mannosyltransferase activity,MF,PIGZ
15356,GO:0071630,0.26761400684308,0.972769355265725,1,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,ANKZF1
16611,GO:0097500,0.267619554524732,0.972768142394304,1,3,receptor localization to non-motile cilium,BP,TUB
10218,GO:0042940,0.267630882084198,0.972765665790767,1,3,D-amino acid transport,BP,NTSR1
2401,GO:0005577,0.267631580545292,0.972765513078361,1,3,fibrinogen complex,CC,FBLN1
1509,GO:0003872,0.267649596603091,0.972761573853885,1,3,6-phosphofructokinase activity,MF,PFKL
18593,GO:1903903,0.267649659163546,0.972761560174518,1,3,regulation of establishment of T cell polarity,BP,GSN
5336,GO:0016094,0.267656455418728,0.972760074082758,1,3,polyprenol biosynthetic process,BP,SRD5A3
18332,GO:1903348,0.267659645933708,0.97275937641803,1,3,positive regulation of bicellular tight junction assembly,BP,NPHP4
667,GO:0001875,0.267660640104374,0.972759159022225,1,3,lipopolysaccharide receptor activity,MF,PTAFR
10626,GO:0043654,0.267660640104375,0.972759159022225,1,3,recognition of apoptotic cell,BP,PEAR1
141,GO:0000293,0.267661472660266,0.972758976966055,1,3,ferric-chelate reductase activity,MF,CYBRD1
14032,GO:0060838,0.267664544627202,0.97275830520874,1,3,lymphatic endothelial cell fate commitment,BP,PROX1
9299,GO:0035787,0.267666667949338,0.972757840889193,1,3,cell migration involved in kidney development,BP,VANGL2
14675,GO:0070327,0.267666786642396,0.972757814933698,1,3,thyroid hormone transport,BP,SLCO4A1
310,GO:0000822,0.267666860497397,0.972757798783277,1,3,inositol hexakisphosphate binding,MF,ITPR3
4437,GO:0010360,0.267666860731401,0.972757798732069,1,3,negative regulation of anion channel activity,BP,ANO9
14704,GO:0070384,0.267666860731404,0.972757798732066,1,3,Harderian gland development,BP,RARG
10949,GO:0044729,0.267666860731404,0.972757798732066,1,3,hemi-methylated DNA-binding,MF,EGR1
15698,GO:0072298,0.267666860731404,0.972757798732066,1,3,regulation of metanephric glomerulus development,BP,EGR1
699,GO:0001920,0.267666860731404,0.972757798732066,1,3,negative regulation of receptor recycling,BP,PCSK9
1964,GO:0004677,0.267666860731404,0.972757798732066,1,3,DNA-dependent protein kinase activity,MF,HMGA2
8991,GO:0035166,0.267666860731404,0.972757798732066,1,3,post-embryonic hemopoiesis,BP,ERCC1
7020,GO:0030805,0.267666860731405,0.972757798732065,1,3,regulation of cyclic nucleotide catabolic process,BP,RAPGEF3
7035,GO:0030820,0.267666860731405,0.972757798732065,1,3,regulation of cAMP catabolic process,BP,RAPGEF3
8278,GO:0033121,0.267666860731405,0.972757798732065,1,3,regulation of purine nucleotide catabolic process,BP,RAPGEF3
13607,GO:0060134,0.267666860731405,0.972757798732065,1,3,prepulse inhibition,BP,DVL1
2109,GO:0004897,0.267666860731407,0.972757798732063,1,3,ciliary neurotrophic factor receptor activity,MF,IL6R
14552,GO:0070120,0.267666860731407,0.972757798732063,1,3,ciliary neurotrophic factor-mediated signaling pathway,BP,IL6R
16030,GO:0089700,0.267666860731407,0.972757798732063,1,3,protein kinase D signaling,BP,VEGFA
12912,GO:0051295,0.267666860731407,0.972757798732063,1,3,establishment of meiotic spindle localization,BP,SPIRE2
19894,GO:2000425,0.267666860731408,0.972757798732062,1,3,regulation of apoptotic cell clearance,BP,ABCA7
891,GO:0002265,0.267666860731408,0.972757798732062,1,3,astrocyte activation involved in immune response,BP,LRP1
2271,GO:0005220,0.267666860731408,0.972757798732062,1,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,ITPR3
71,GO:0000147,0.267666860731408,0.972757798732062,1,3,actin cortical patch assembly,BP,WIPF1
1520,GO:0003886,0.267666860731408,0.972757798732062,1,3,DNA (cytosine-5-)-methyltransferase activity,MF,DNMT3A
3832,GO:0008449,0.267666860731408,0.972757798732062,1,3,N-acetylglucosamine-6-sulfatase activity,MF,SULF2
4835,GO:0014052,0.267666860731408,0.972757798732062,1,3,regulation of gamma-aminobutyric acid secretion,BP,NTSR1
6490,GO:0021869,0.267666860731408,0.972757798732062,1,3,forebrain ventricular zone progenitor cell division,BP,FGFR1
8079,GO:0032776,0.267666860731408,0.972757798732062,1,3,DNA methylation on cytosine,BP,DNMT3A
10853,GO:0044396,0.267666860731408,0.972757798732062,1,3,actin cortical patch organization,BP,WIPF1
11257,GO:0045586,0.267666860731408,0.972757798732062,1,3,regulation of gamma-delta T cell differentiation,BP,SOX13
11884,GO:0046935,0.267666860731408,0.972757798732062,1,3,1-phosphatidylinositol-3-kinase regulator activity,MF,PIK3R2
13098,GO:0051666,0.267666860731408,0.972757798732062,1,3,actin cortical patch localization,BP,WIPF1
14256,GO:0061364,0.267666860731408,0.972757798732062,1,3,apoptotic process involved in luteolysis,BP,SLIT3
14434,GO:0061817,0.267666860731408,0.972757798732062,1,3,endoplasmic reticulum-plasma membrane tethering,BP,ESYT2
14841,GO:0070644,0.267666860731408,0.972757798732062,1,3,vitamin D response element binding,MF,RXRA
16097,GO:0090116,0.267666860731408,0.972757798732062,1,3,C-5 methylation of cytosine,BP,DNMT3A
16195,GO:0090269,0.267666860731408,0.972757798732062,1,3,fibroblast growth factor production,BP,FGFR1
16196,GO:0090270,0.267666860731408,0.972757798732062,1,3,regulation of fibroblast growth factor production,BP,FGFR1
19066,GO:1904996,0.267666860731408,0.972757798732062,1,3,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,PTAFR
20092,GO:2000807,0.267666860731408,0.972757798732062,1,3,regulation of synaptic vesicle clustering,BP,NLGN2
3794,GO:0008381,0.267666860731512,0.972757798732067,1,3,mechanosensitive ion channel activity,MF,TRPV4
1737,GO:0004340,0.267666860731517,0.972757798732062,1,3,glucokinase activity,MF,HK1
1778,GO:0004396,0.267666860731517,0.972757798732062,1,3,hexokinase activity,MF,HK1
3981,GO:0008865,0.267666860731517,0.972757798732062,1,3,fructokinase activity,MF,HK1
6036,GO:0019158,0.267666860731517,0.972757798732062,1,3,mannokinase activity,MF,HK1
6467,GO:0021817,0.267666860731517,0.972757798732062,1,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,SUN1
15580,GO:0072093,0.267666860731517,0.972757798732062,1,3,metanephric renal vesicle formation,BP,KIF26B
1429,GO:0003406,0.26766686073162,0.972757798732069,1,3,retinal pigment epithelium development,BP,RARG
17373,GO:1900133,0.267666860731622,0.972757798732067,1,3,regulation of renin secretion into blood stream,BP,F2R
12436,GO:0050265,0.267666860731623,0.972757798732066,1,3,RNA uridylyltransferase activity,MF,TUT1
17987,GO:1902498,0.267666860731623,0.972757798732066,1,3,regulation of protein autoubiquitination,BP,MTA1
18174,GO:1902988,0.267666860731623,0.972757798732066,1,3,neurofibrillary tangle assembly,BP,SORL1
186,GO:0000404,0.267666860731626,0.972757798732063,1,3,heteroduplex DNA loop binding,MF,XPC
15667,GO:0072223,0.267666860731729,0.972757798732069,1,3,metanephric glomerular mesangium development,BP,EGR1
15674,GO:0072239,0.267666860731729,0.972757798732069,1,3,metanephric glomerulus vasculature development,BP,EGR1
4598,GO:0010724,0.267666860731731,0.972757798732066,1,3,regulation of definitive erythrocyte differentiation,BP,ZFPM1
18683,GO:1904116,0.267666860731732,0.972757798732066,1,3,response to vasopressin,BP,ADCY6
18684,GO:1904117,0.267666860731732,0.972757798732066,1,3,cellular response to vasopressin,BP,ADCY6
13760,GO:0060374,0.267666860731733,0.972757798732065,1,3,mast cell differentiation,BP,ZFPM1
6730,GO:0030158,0.267666860731733,0.972757798732065,1,3,protein xylosyltransferase activity,MF,XYLT2
18914,GO:1904694,0.267666860731733,0.972757798732065,1,3,negative regulation of vascular smooth muscle contraction,BP,DOCK4
8557,GO:0034040,0.267666860731733,0.972757798732065,1,3,lipid-transporting ATPase activity,MF,ABCG1
587,GO:0001743,0.267666860731734,0.972757798732064,1,3,optic placode formation,BP,PROX1
7099,GO:0030910,0.267666860731734,0.972757798732064,1,3,olfactory placode formation,BP,PROX1
15400,GO:0071698,0.267666860731734,0.972757798732064,1,3,olfactory placode development,BP,PROX1
15401,GO:0071699,0.267666860731734,0.972757798732064,1,3,olfactory placode morphogenesis,BP,PROX1
9331,GO:0035860,0.267666860731735,0.972757798732064,1,3,glial cell-derived neurotrophic factor receptor signaling pathway,BP,SULF2
14406,GO:0061739,0.267666860731735,0.972757798732063,1,3,protein lipidation involved in autophagosome assembly,BP,WIPI2
4893,GO:0014832,0.267666860731735,0.972757798732063,1,3,urinary bladder smooth muscle contraction,BP,KCNMA1
4902,GO:0014848,0.267666860731735,0.972757798732063,1,3,urinary tract smooth muscle contraction,BP,KCNMA1
7876,GO:0032455,0.267666860731735,0.972757798732063,1,3,nerve growth factor processing,BP,FURIN
13071,GO:0051610,0.267666860731735,0.972757798732063,1,3,serotonin uptake,BP,NOS1
2310,GO:0005315,0.267666860731736,0.972757798732063,1,3,inorganic phosphate transmembrane transporter activity,MF,SLC20A1
10827,GO:0044341,0.267666860731736,0.972757798732063,1,3,sodium-dependent phosphate transport,BP,SLC20A1
8621,GO:0034163,0.267666860731736,0.972757798732062,1,3,regulation of toll-like receptor 9 signaling pathway,BP,PTPRS
20183,GO:2001137,0.267666860731736,0.972757798732062,1,3,positive regulation of endocytic recycling,BP,SORL1
6318,GO:0020016,0.267666860731736,0.972757798732062,1,3,ciliary pocket,CC,EHD3
6319,GO:0020018,0.267666860731736,0.972757798732062,1,3,ciliary pocket membrane,CC,EHD3
1510,GO:0003873,0.267666860731736,0.972757798732062,1,3,6-phosphofructo-2-kinase activity,MF,PFKFB2
4975,GO:0015111,0.267666860731736,0.972757798732062,1,3,iodide transmembrane transporter activity,MF,SLC5A5
4770,GO:0010966,0.267666860731737,0.972757798732062,1,3,regulation of phosphate transport,BP,FGFR1
6396,GO:0021631,0.267666860731737,0.972757798732062,1,3,optic nerve morphogenesis,BP,EPHB2
15619,GO:0072156,0.267666860731737,0.972757798732062,1,3,distal tubule morphogenesis,BP,PKD1
16807,GO:0098735,0.267666860731737,0.972757798732062,1,3,positive regulation of the force of heart contraction,BP,NOS1
20056,GO:2000741,0.267666860731737,0.972757798732062,1,3,positive regulation of mesenchymal stem cell differentiation,BP,LTBP3
10796,GO:0044302,0.267666860731844,0.972757798732064,1,3,dentate gyrus mossy fiber,CC,MAPK8IP1
1332,GO:0003190,0.267666860731845,0.972757798732063,1,3,atrioventricular valve formation,BP,ZFPM1
7899,GO:0032484,0.267666860731845,0.972757798732063,1,3,Ral protein signal transduction,BP,RGL2
7900,GO:0032485,0.267666860731845,0.972757798732063,1,3,regulation of Ral protein signal transduction,BP,RGL2
8151,GO:0032898,0.267666860731845,0.972757798732063,1,3,neurotrophin production,BP,FURIN
15715,GO:0072320,0.267666860731845,0.972757798732062,1,3,volume-sensitive chloride channel activity,MF,TTYH3
17342,GO:1900086,0.267666860731845,0.972757798732062,1,3,positive regulation of peptidyl-tyrosine autophosphorylation,BP,VEGFA
6780,GO:0030229,0.267666860731846,0.972757798732062,1,3,very-low-density lipoprotein particle receptor activity,MF,LDLR
2424,GO:0005610,0.267666860731846,0.972757798732062,1,3,laminin-5 complex,CC,LAMA5
2595,GO:0005899,0.267666860731846,0.972757798732062,1,3,insulin receptor complex,CC,INSR
6336,GO:0021521,0.267666860731846,0.972757798732062,1,3,ventral spinal cord interneuron specification,BP,SUFU
6445,GO:0021775,0.267666860731846,0.972757798732062,1,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,SUFU
6446,GO:0021776,0.267666860731846,0.972757798732062,1,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,SUFU
7439,GO:0031587,0.267666860731846,0.972757798732062,1,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,PKD2
7758,GO:0032290,0.267666860731846,0.972757798732062,1,3,peripheral nervous system myelin formation,BP,AHNAK2
7902,GO:0032487,0.267666860731846,0.972757798732062,1,3,regulation of Rap protein signal transduction,BP,TIMP2
9183,GO:0035583,0.267666860731846,0.972757798732062,1,3,sequestering of TGFbeta in extracellular matrix,BP,LTBP1
9292,GO:0035766,0.267666860731846,0.972757798732062,1,3,cell chemotaxis to fibroblast growth factor,BP,FGFR1
9294,GO:0035768,0.267666860731846,0.972757798732062,1,3,endothelial cell chemotaxis to fibroblast growth factor,BP,FGFR1
10401,GO:0043259,0.267666860731846,0.972757798732062,1,3,laminin-10 complex,CC,LAMA5
10585,GO:0043578,0.267666860731846,0.972757798732062,1,3,nuclear matrix organization,BP,SUN1
10794,GO:0044300,0.267666860731846,0.972757798732062,1,3,cerebellar mossy fiber,CC,DLG4
13888,GO:0060573,0.267666860731846,0.972757798732062,1,3,cell fate specification involved in pattern specification,BP,SUFU
13894,GO:0060579,0.267666860731846,0.972757798732062,1,3,ventral spinal cord interneuron fate commitment,BP,SUFU
13895,GO:0060581,0.267666860731846,0.972757798732062,1,3,cell fate commitment involved in pattern specification,BP,SUFU
16214,GO:0090292,0.267666860731846,0.972757798732062,1,3,nuclear matrix anchoring at nuclear membrane,BP,SUN1
17623,GO:1901387,0.267666860731846,0.972757798732062,1,3,positive regulation of voltage-gated calcium channel activity,BP,EHD3
18698,GO:1904177,0.267666860731846,0.972757798732062,1,3,regulation of adipose tissue development,BP,SH3PXD2B
18699,GO:1904179,0.267666860731846,0.972757798732062,1,3,positive regulation of adipose tissue development,BP,SH3PXD2B
18992,GO:1904847,0.267666860731846,0.972757798732062,1,3,regulation of cell chemotaxis to fibroblast growth factor,BP,FGFR1
19940,GO:2000544,0.267666860731846,0.972757798732062,1,3,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGFR1
15393,GO:0071688,0.267666860731846,0.972757798732062,1,3,striated muscle myosin thick filament assembly,BP,OBSL1
4811,GO:0014015,0.267679456627654,0.869396607378642,5,36,positive regulation of gliogenesis,BP,GJC2;SERPINE2;ETV5;HES1;BIN1
6092,GO:0019321,0.26779799908635,0.927150798252863,2,11,pentose metabolic process,BP,FGGY;TALDO1
12488,GO:0050654,0.267890658004403,0.882568809477407,4,27,chondroitin sulfate proteoglycan metabolic process,BP,B3GAT3;HYAL1;HEXB;XYLT2
6544,GO:0021987,0.267923005526213,0.833497334606278,10,82,cerebral cortex development,BP,PTPRS;LRP1;EGFR;BBS2;TRAPPC9;BNIP3;MBOAT7;NDE1;SUN1;SLC2A1
723,GO:0001953,0.268754714792936,0.882030980059752,4,27,negative regulation of cell-matrix adhesion,BP,POSTN;BCL6;ADAM15;DMTN
4097,GO:0009161,0.268881950247261,0.795457201664301,27,259,ribonucleoside monophosphate metabolic process,BP,NT5E;PGM1;OGDHL;INSR;NDUFS8;DLG4;FAM20C;UCKL1;PFKFB2;DHTKD1;GALK1;LHPP;MLXIPL;NADK;ADA;PFKL;NUDT10;MYH3;HK1;PPARA;GUK1;SDHA;DLG3;UQCR11;PINK1;NDUFV3;TAZ
4193,GO:0009310,0.269628823246877,0.926316512866587,2,11,amine catabolic process,BP,ATP2B4;SMOX
3377,GO:0007162,0.269838749654267,0.806204194223016,19,168,negative regulation of cell adhesion,BP,POSTN;ERBB2;FBLN1;PLXNB3;CD9;SERPINE2;IL20RB;PRNP;BCL6;PLXNB1;CEBPB;ADAM15;PAG1;DMTN;TRPV4;PPARA;ASS1;ERBB3;JAK3
5397,GO:0016247,0.269930426616628,0.836755448389067,9,74,channel regulator activity,MF,NOS1;PRSS8;SCN4B;ATP2B4;KCNAB2;PCSK9;PRKCZ;GPD1L;SNTA1
7032,GO:0030817,0.269974608541878,0.899323270299555,3,19,regulation of cAMP biosynthetic process,BP,TIMP2;PTHLH;LTB4R2
4709,GO:0010881,0.270091994973032,0.92610476808805,2,11,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,PRKACA;GSTM2
2098,GO:0004869,0.270137899888647,0.88060310352052,4,29,cysteine-type endopeptidase inhibitor activity,MF,CST3;PRDX5;GAS6;CSTB
864,GO:0002200,0.270186214045436,0.849204299762888,7,54,somatic diversification of immune receptors,BP,ERCC1;POLL;STAT6;BCL6;RAG1;PMS2P5;POLM
8188,GO:0032947,0.270224240787252,0.836688538994894,9,72,protein-containing complex scaffold activity,MF,WWC3;SHANK2;SLC9A3R2;SHANK3;MAPK8IP1;LDLRAP1;SEPT8;HOMER2;RGS14
8004,GO:0032649,0.270588893967502,0.857002090626548,6,46,regulation of interferon-gamma production,BP,ZP3;ZFPM1;IL20RB;PRNP;GAS6;PYCARD
5492,GO:0016445,0.270857217408159,0.856963777216485,6,45,somatic diversification of immunoglobulins,BP,ERCC1;POLL;STAT6;BCL6;PMS2P5;POLM
6723,GO:0030149,0.271004221364372,0.898744021664825,3,19,sphingolipid catabolic process,BP,HEXB;GM2A;NAGA
15222,GO:0071417,0.271077993173818,0.782929330531786,40,374,cellular response to organonitrogen compound,BP,RAPGEF3;ZFP36L1;COL6A1;IGF2;LRP1;MAPK13;EGFR;UROS;EGR1;SHC1;PIK3R2;HDAC5;PKD2;PTPRE;VAMP2;ATP2B4;INSR;ID1;DNMT3A;PRNP;CEBPB;MAPK3;ADCY6;SSH1;PCSK9;PRKACA;DMTN;EEF2K;PTAFR;PCK2;PRKCZ;PDK2;SRSF5;GRB10;CAPN2;SESN2;AKT1;SLC5A5;JAK3;GSTM2
574,GO:0001726,0.271235707530721,0.81130790547952,16,139,ruffle,CC,GSN;ARHGEF4;PTK6;ABCA7;S100A6;SPRY4;SPRY2;SNX9;WIPF1;MEFV;PSD4;TRPV4;ARAP3;ADGRE2;EPS8L1;EPS8L2
3774,GO:0008344,0.271357642096692,0.866741419285029,5,37,adult locomotory behavior,BP,DNM1;NTSR1;EFNB3;SLITRK6;CSTB
2571,GO:0005865,0.271514927066996,0.92545253150376,2,11,striated muscle thin filament,CC,TMOD2;TNNT1
5315,GO:0016051,0.271989859109605,0.806310567747559,18,159,carbohydrate biosynthetic process,BP,PGM1;NR1D1;IGF2;ISYNA1;GALNT12;NTSR1;INSR;TALDO1;PC;DGKQ;PPARA;PTAFR;IMPA2;PCK2;MDH2;PDK2;AKT1;SLC2A1
13796,GO:0060420,0.2722653466032,0.866335435431199,5,36,regulation of heart growth,BP,DUSP6;FGFR1;PIN1;PROX1;JARID2
7433,GO:0031579,0.272466228099979,0.897919282253041,3,19,membrane raft organization,BP,MARVELD1;GSN;MALL
11414,GO:0045862,0.272608883344912,0.789246637616915,30,280,positive regulation of proteolysis,BP,TNIP1;APOE;GSN;XDH;F2R;GRAMD4;FBLN1;EDEM1;CSNK1E;SNX33;SNX9;MAPK3;DVL1;FURIN;MEFV;PIDD1;F12;MAGEF1;CYFIP2;DAP;FGFR4;BTRC;RAD23A;SH3D19;PPM1F;AKT1;PINK1;CTSH;PYCARD;FAM162A
4783,GO:0010984,0.272666304044912,0.924922862994569,2,11,regulation of lipoprotein particle clearance,BP,PCSK9;LDLR
365,GO:0000987,0.27297087025424,0.787177454288461,32,293,proximal promoter sequence-specific DNA binding,MF,FOS;TCFL5;MEF2D;NR1D1;NFATC4;ZNF516;ZFPM1;TFEB;FOXQ1;ZNF692;HES2;STAT6;CEBPB;HSF4;HES1;MLXIPL;ETV4;BHLHE40;HMGA2;ELK3;ZNF217;PPARA;RXRA;HLTF;SMARCD2;MEF2B;SIX5;SSBP2;RFX2;DDN;LITAF;MZF1
16158,GO:0090207,0.273003076769935,0.897615781027362,3,19,regulation of triglyceride metabolic process,BP,LMF1;APOE;LDLR
8223,GO:0033006,0.273465902120948,0.897353844788088,3,19,regulation of mast cell activation involved in immune response,BP,ADGRE2;ADORA2B;STXBP2
10429,GO:0043304,0.273465902120948,0.897353844788088,3,19,regulation of mast cell degranulation,BP,ADGRE2;ADORA2B;STXBP2
3316,GO:0007031,0.2741538075289,0.878352405991389,4,28,peroxisome organization,BP,PEX10;ABCD1;PEX7;LONP2
3546,GO:0007589,0.274283118755863,0.846114625206646,7,55,body fluid secretion,BP,XDH;ATP7B;VEGFA;ADA;GUCA1B;STK39;KCNN4
7745,GO:0032273,0.274312792907935,0.824147868420117,11,93,positive regulation of protein polymerization,BP,GSN;ARPIN;CORO1B;ARL2;WIPF1;CDC42EP5;WHAMMP3;PINK1;SPIRE2;MLST8;PYCARD
8029,GO:0032691,0.274896846742473,0.923891891950019,2,11,negative regulation of interleukin-1 beta production,BP,ACP5;MEFV
10012,GO:0042474,0.275002202801817,0.923843037308821,2,11,middle ear morphogenesis,BP,NAGLU;FGFR1
11500,GO:0046037,0.275386302489133,0.896264191835802,3,19,GMP metabolic process,BP,DLG4;GUK1;DLG3
8457,GO:0033613,0.275689006040149,0.845090759439858,7,55,activating transcription factor binding,MF,FOS;MEF2D;ZNF516;ZFPM1;BHLHE40;DGKQ;MEF2B
10298,GO:0043097,0.275915517616292,0.92341892520781,2,11,pyrimidine nucleoside salvage,BP,UCKL1;TK2
7961,GO:0032587,0.27598338380085,0.832226022997615,9,73,ruffle membrane,CC,ARHGEF4;ABCA7;SPRY4;SPRY2;PSD4;TRPV4;ADGRE2;EPS8L1;EPS8L2
13226,GO:0051932,0.276118881635101,0.895847330223418,3,19,synaptic transmission, GABAergic,BP,NLGN2;NISCH;DNM1
626,GO:0001816,0.276268128110644,0.774344432710266,47,449,cytokine production,BP,PTPRS;POSTN;ALOX15B;NFATC4;MAPK13;EGR1;F2R;ZP3;ZFPM1;RNF135;ACP5;PDCD4;IL20RB;TMEM173;PRNP;STAT6;BCL6;CEBPB;MAPK3;FURIN;MEFV;IL6R;ZFP36;MAPKBP1;RPS6KA5;TRPV4;HK1;GAS6;TKFC;PTAFR;LTBP3;PRKCZ;INPP5D;ICOSLG;FGFR1;PIN1;C5;ADORA2B;NLRX1;NDRG2;PYCARD;MAP2K3;JAK3;LITAF;EREG;MIF;SULF2
4553,GO:0010644,0.276350327294574,0.895715493508164,3,19,cell communication by electrical coupling,BP,GJC2;ANK3;PRKACA
12571,GO:0050773,0.27635139822347,0.818800198231689,12,101,regulation of dendrite development,BP,APOE;PTPRS;SHANK2;NFATC4;OBSL1;CRTC1;ZMYND8;FBXW8;ID1;SHANK3;CUL7;EEF2K
13004,GO:0051480,0.276357900463978,0.807019311915217,16,141,regulation of cytosolic calcium ion concentration,BP,CEMIP;NOS1;F2R;PKD2;ITPR3;NTSR1;ATP2B4;LPAR3;PRNP;DLG4;PRKACA;TRPV4;TPCN1;PKD1;GSTM2;GIPR
12670,GO:0050913,0.276367934810562,0.922354074320751,2,12,sensory perception of bitter taste,BP,ITPR3;REEP2
17509,GO:1901031,0.276543261680353,0.876842879320178,4,28,regulation of response to reactive oxygen species,BP,ENDOG;SESN2;TRAP1;PINK1
12216,GO:0048511,0.27657579815539,0.79704696003849,21,188,rhythmic process,BP,CST3;NR1D1;HEBP1;EGFR;EGR1;CRTC1;NAGLU;ZP3;CSNK1E;ID1;MTA1;ADA;HTR7;SLIT3;BHLHE40;BTRC;PPARA;TEF;PROX1;ASS1;EREG
334,GO:0000930,0.276673671279936,0.895531199653275,3,19,gamma-tubulin complex,CC,TUBG2;MZT2A;MZT2B
11642,GO:0046427,0.276922308220798,0.862997550337136,5,37,positive regulation of JAK-STAT cascade,BP,PTK6;HES1;IL6R;FGFR3;TNFRSF1A
4612,GO:0010742,0.277148265653226,0.895260467090823,3,19,macrophage derived foam cell differentiation,BP,ALOX15B;ABCG1;PPARA
16069,GO:0090077,0.277148265653226,0.895260467090823,3,19,foam cell differentiation,BP,ALOX15B;ABCG1;PPARA
15824,GO:0072567,0.277531387613673,0.92266593835793,2,11,chemokine (C-X-C motif) ligand 2 production,BP,POSTN;MIF
10251,GO:0043009,0.277619783160446,0.774736339881334,44,413,chordate embryonic development,BP,ZFP36L1;TCTN1;EPAS1;IGF2;EGFR;MDFI;DEAF1;ZP3;HYAL1;TFEB;PKD2;PHLDA2;SALL2;IFT140;FUZ;PLCD1;ZMIZ1;FBXW8;CELSR1;PLCD3;TMEM107;VEGFA;VANGL2;CEBPB;ENDOG;DVL1;HES1;ADA;SEMA4C;WNT7B;SUFU;RXRA;WDR60;FGFR1;C5;PROX1;CAPN2;TMEM231;ACVR1B;AKT1;PKD1;APBA1;RARG;SULF2
18316,GO:1903307,0.278646159540068,0.875508981610756,4,28,positive regulation of regulated secretory pathway,BP,ZP3;RAB3D;PTAFR;ADORA2B
18373,GO:1903428,0.27866559029279,0.875496632845611,4,28,positive regulation of reactive oxygen species biosynthetic process,BP,PKD2;INSR;ASS1;AKT1
2556,GO:0005845,0.278904034343117,0.922023648963473,2,11,mRNA cap binding complex,CC,ZFP36;EIF4E3
11356,GO:0045744,0.278941450448479,0.875321269773862,4,28,negative regulation of G-protein coupled receptor protein signaling pathway,BP,DNM1;ATP2B4;ADA;GIPR
3112,GO:0006699,0.278986100458032,0.894209473523409,3,19,bile acid biosynthetic process,BP,NR1D1;FGFR4;PROX1
6138,GO:0019433,0.279169829059365,0.921898997472234,2,11,triglyceride catabolic process,BP,APOE;PNPLA4
5322,GO:0016064,0.27924286540035,0.84249414866028,7,55,immunoglobulin mediated immune response,BP,ERCC1;SERPING1;ZP3;STAT6;BCL6;INPP5D;C5
6200,GO:0019724,0.27924286540035,0.84249414866028,7,55,B cell mediated immunity,BP,ERCC1;SERPING1;ZP3;STAT6;BCL6;INPP5D;C5
1173,GO:0002820,0.27929668497329,0.894031452917102,3,19,negative regulation of adaptive immune response,BP,IL20RB;BCL6;JAK3
19380,GO:1905939,0.279888380083073,0.92156155781475,2,11,regulation of gonad development,BP,ZP3;INSR
7718,GO:0032225,0.280177311134238,0.921425684810078,2,11,regulation of synaptic transmission, dopaminergic,BP,RAB3B;PINK1
6709,GO:0030130,0.280267376433518,0.921383308595874,2,11,clathrin coat of trans-Golgi network vesicle,CC,LDLRAP1;CLTCL1
4831,GO:0014047,0.280453360038781,0.893367432746319,3,19,glutamate secretion,BP,VAMP2;NTSR1;APBA1
10330,GO:0043153,0.280589465798867,0.893289189994457,3,19,entrainment of circadian clock by photoperiod,BP,CRTC1;MTA1;BHLHE40
56,GO:0000118,0.280651188243212,0.84146182302504,7,55,histone deacetylase complex,CC,APPL2;HDAC5;SALL2;PHF21A;HDAC11;ZNF217;TRERF1
9036,GO:0035272,0.280795623273959,0.860372022196222,5,37,exocrine system development,BP,CST3;EGFR;LAMA5;INSR;FGFR1
17318,GO:1900029,0.280933981647937,0.921069341831578,2,11,positive regulation of ruffle assembly,BP,EPS8L1;EPS8L2
5767,GO:0016999,0.281314738820165,0.81850767558794,11,95,antibiotic metabolic process,BP,IDH2;PRDX5;GPX3;EGFR;OGDHL;AKR7A2;DHTKD1;PCK2;SDHA;MDH2;PINK1
3242,GO:0006909,0.281462372701702,0.8004908722921,17,150,phagocytosis,BP,GSN;LRP1;ABCA7;PIK3R2;MYO18A;ELMO3;MAPK3;TUB;WIPF1;CYFIP2;GAS6;VAV3;BCR;TMEM175;PEAR1;ABR;PYCARD
594,GO:0001759,0.281873683775697,0.92062577425427,2,11,organ induction,BP,FGFR1;WNT2B
9180,GO:0035580,0.282105327151859,0.859282357480255,5,38,specific granule lumen,CC,TIMP2;DNASE1L1;CTSZ;TOLLIP;CTSD
9362,GO:0035909,0.282353502426616,0.892273053267746,3,19,aorta morphogenesis,BP,LRP1;HES1;PROX1
5669,GO:0016791,0.282635064296349,0.788796290643381,23,208,phosphatase activity,MF,DUSP6;PTPRS;NT5E;DUSP5;PPP2R3B;PPM1J;PTPRU;PTPRE;ACP5;NT5DC1;PFKFB2;LHPP;SSH1;MYH3;DUSP7;IMPA2;INPP5D;DUSP23;PPM1F;SBF1;ACP6;SSH3;PLPPR2
14648,GO:0070286,0.282804224764049,0.92018540774495,2,11,axonemal dynein complex assembly,BP,DNAH1;DNAAF5
5674,GO:0016799,0.282883323823174,0.891494563498852,3,20,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,DNPH1;MPG;NEIL1
19988,GO:2000637,0.282931449574893,0.891939311155392,3,19,positive regulation of gene silencing by miRNA,BP,EGFR;ZFP36;MAP2K2
12841,GO:0051188,0.283033751948049,0.784457269190062,26,240,cofactor biosynthetic process,BP,IDH2;NAPRT;PGM1;ACOT7;UROS;OPLAH;NMRK1;OGDHL;GGT1;INSR;HAGH;PFKFB2;DHTKD1;GALK1;MLXIPL;NADK;PFKL;HK1;PPARA;PDK2;GSS;RSAD1;PNPO;MOCS1;MLYCD;PPCS
17201,GO:0110020,0.283170020714658,0.832610635829147,8,64,regulation of actomyosin structure organization,BP,RAPGEF3;ARAP1;SH3PXD2B;EPHA1;FHOD1;PROX1;PPM1F;ARHGEF10L
16461,GO:0097179,0.283215895314473,0.965703660540574,1,4,protease inhibitor complex,CC,SERPINB6
18678,GO:1904090,0.283215895314473,0.965703660540574,1,4,peptidase inhibitor complex,CC,SERPINB6
10511,GO:0043467,0.283613253059589,0.816795352403069,11,93,regulation of generation of precursor metabolites and energy,BP,IGF2;PHLDA2;INSR;PFKFB2;BNIP3;MLXIPL;TRPV4;PPARA;AKT1;TRAP1;PINK1
269,GO:0000768,0.283638655011455,0.872321941851917,4,28,syncytium formation by plasma membrane fusion,BP,RAPGEF3;NOS1;DYRK1B;CAPN2
1275,GO:0003071,0.283806060450421,0.91971005196981,2,11,renal system process involved in regulation of systemic arterial blood pressure,BP,F2R;GAS6
336,GO:0000932,0.283840857880658,0.826040537666073,9,75,P-body,CC,BTBD2;ZFP36L1;ZFP36;MEX3A;PAN2;AGO4;PNRC1;APOBEC3C;APOBEC3F
13006,GO:0051482,0.284003151779137,0.919616382522268,2,11,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,F2R;LPAR3
16142,GO:0090190,0.284182132718032,0.919531276721864,2,11,positive regulation of branching involved in ureteric bud morphogenesis,BP,VEGFA;WNT2B
18334,GO:1903350,0.284229500143211,0.919508746488761,2,11,response to dopamine,BP,ID1;MAPK3
18335,GO:1903351,0.284229500143211,0.919508746488761,2,11,cellular response to dopamine,BP,ID1;MAPK3
11604,GO:0046329,0.284236311663162,0.871938511979422,4,28,negative regulation of JNK cascade,BP,PDCD4;MAPK8IP1;AKT1;PINK1
2637,GO:0005979,0.284408152009596,0.8910847176205,3,19,regulation of glycogen biosynthetic process,BP,IGF2;INSR;AKT1
4767,GO:0010962,0.284408152009596,0.8910847176205,3,19,regulation of glucan biosynthetic process,BP,IGF2;INSR;AKT1
670,GO:0001881,0.284553120083341,0.871735096642671,4,28,receptor recycling,BP,ARAP1;PCSK9;TBC1D16;EHD3
2636,GO:0005978,0.284648002215283,0.857744777291979,5,37,glycogen biosynthetic process,BP,PGM1;NR1D1;IGF2;INSR;AKT1
4167,GO:0009250,0.284648002215283,0.857744777291979,5,37,glucan biosynthetic process,BP,PGM1;NR1D1;IGF2;INSR;AKT1
2697,GO:0006071,0.284785304444917,0.919244162547438,2,11,glycerol metabolic process,BP,TKFC;PCK2
12099,GO:0048185,0.285016203351079,0.919134128532555,2,11,activin binding,MF,ACVR2B;ACVR1B
14481,GO:0062014,0.285084024988038,0.831068124046023,8,65,negative regulation of small molecule metabolic process,BP,APOE;CYP27B1;LTB4R2;ATP2B4;MLXIPL;PPARA;PROX1;AKT1
13926,GO:0060644,0.285337191922219,0.918981048140576,2,11,mammary gland epithelial cell differentiation,BP,CEBPB;AKT1
10496,GO:0043422,0.285346153347159,0.918976772499576,2,11,protein kinase B binding,MF,SRSF5;PINK1
2259,GO:0005179,0.285433197807037,0.890012011343182,3,20,hormone activity,MF,IGF2;PTHLH;VGF
6717,GO:0030139,0.285655143231011,0.786140127068806,23,211,endocytic vesicle,CC,CEMIP;APOE;GSN;LRP1;RAB11FIP4;EGFR;CD9;VPS11;WNT7A;DLG4;AP2A2;PLEKHG5;AMN;HBEGF;ITGB5;LDLR;LDLRAP1;WNT7B;CLTCL1;WNT3;EHD3;EPN2;STXBP2
7197,GO:0031100,0.285772627680795,0.837573200833961,7,56,animal organ regeneration,BP,PGF;EGFR;PTPRU;CEBPB;GAS6;SRSF5;SULF2
12306,GO:0048681,0.286170470454396,0.918583033465441,2,11,negative regulation of axon regeneration,BP,PTPRS;RTN4R
9211,GO:0035615,0.286354529267049,0.918494996898526,2,11,clathrin adaptor activity,MF,AP2A2;LDLRAP1
16814,GO:0098748,0.286354529267049,0.918494996898526,2,11,endocytic adaptor activity,MF,AP2A2;LDLRAP1
2789,GO:0006241,0.286444042631966,0.917551401848734,2,12,CTP biosynthetic process,BP,NME4;UCKL1
11499,GO:0046036,0.286444042631966,0.917551401848734,2,12,CTP metabolic process,BP,NME4;UCKL1
14135,GO:0061045,0.286510842562598,0.84572699648951,6,46,negative regulation of wound healing,BP,APOE;SERPING1;PLAT;CD9;SERPINE2;F12
5897,GO:0018126,0.286544097911712,0.889843891128174,3,19,protein hydroxylation,BP,CRTAP;VPS33B;P3H4
629,GO:0001819,0.286771948571648,0.780004109033094,27,251,positive regulation of cytokine production,BP,POSTN;ALOX15B;NFATC4;MAPK13;EGR1;F2R;ZP3;ZFPM1;RNF135;IL20RB;TMEM173;STAT6;CEBPB;MAPK3;IL6R;TRPV4;HK1;TKFC;PTAFR;PRKCZ;C5;ADORA2B;NLRX1;PYCARD;EREG;MIF;SULF2
14415,GO:0061756,0.287017870534711,0.91817735282534,2,11,leukocyte adhesion to vascular endothelial cell,BP,PTAFR;PODXL2
2649,GO:0006000,0.287229058128777,0.918076105210913,2,11,fructose metabolic process,BP,PFKFB2;TKFC
15974,GO:0086012,0.287550929177792,0.91792168272061,2,11,membrane depolarization during cardiac muscle cell action potential,BP,ANK3;SCN4B
6145,GO:0019471,0.287703089002816,0.917848635088946,2,11,4-hydroxyproline metabolic process,BP,PRODH;ALDH4A1
3717,GO:0008252,0.287806894852928,0.917798783643784,2,11,nucleotidase activity,MF,NT5E;NT5DC1
19614,GO:1990837,0.287985231899438,0.759768833763107,56,532,sequence-specific double-stranded DNA binding,MF,FOS;TCFL5;MEF2D;NR1D1;NFATC4;H1F0;EGR1;DEAF1;BAHCC1;ZMYND8;SOX12;MXI1;ZNF516;THRA;ZFPM1;TFEB;SALL2;FOXQ1;TFDP2;ZC3H6;ZNF692;ZNF704;HES2;MNT;STAT6;BCL6;CEBPB;HSF4;ETV5;MTA1;HES1;MLXIPL;PHF21A;ETV4;SOX13;BHLHE40;HMGA2;ELK3;ZNF217;PPARA;RXRA;HLTF;TEF;SMARCD2;PROX1;WBP2;JARID2;RXRB;MEF2B;SIX5;SSBP2;RFX2;DDN;LITAF;MZF1;RARG
13596,GO:0060117,0.288233392682121,0.917593817121554,2,11,auditory receptor cell development,BP,SLITRK6;FGFR1
12235,GO:0048538,0.288379855865138,0.855184629950452,5,37,thymus development,BP,MAPK3;EPHB3;HES1;RAG1;JARID2
7744,GO:0032272,0.288533088380559,0.844124631483288,6,47,negative regulation of protein polymerization,BP,GSN;TMOD2;SPTB;DMTN;CAPG;TWF2
1094,GO:0002683,0.288596054201023,0.777231718064677,28,265,negative regulation of immune system process,BP,HTRA1;PTPRS;ZFP36L1;NR1D1;MMP28;SERPING1;PKN1;ZFPM1;ERBB2;IL20RB;PRNP;STAT6;BCL6;CEBPB;HES1;ADA;PAG1;ZFP36;LDLR;FAM3A;TKFC;BCR;INPP5D;C5;ABR;NLRX1;JAK3;MIF
8736,GO:0034405,0.28870028228595,0.869061751158929,4,28,response to fluid shear stress,BP,PKD2;ASS1;AKT1;PKD1
17846,GO:1902107,0.289003784053138,0.816943735631697,10,84,positive regulation of leukocyte differentiation,BP,FOS;CTNNBIP1;ZFP36L1;ZMIZ1;BCL6;ADA;RAG1;GAS6;PRKCZ;INPP5D
11363,GO:0045761,0.28904819964077,0.917201582275415,2,11,regulation of adenylate cyclase activity,BP,TIMP2;LTB4R2
13490,GO:0055089,0.28911253319435,0.917170576538157,2,11,fatty acid homeostasis,BP,APOE;MLXIPL
5006,GO:0015179,0.289427178325695,0.854463473589368,5,37,L-amino acid transmembrane transporter activity,MF,SLC43A1;SLC7A8;SERINC2;SLC25A29;PQLC2
10828,GO:0044342,0.289493199092886,0.916987003871198,2,11,type B pancreatic cell proliferation,BP,NR1D1;IGFBP4
15098,GO:0071216,0.28955772594434,0.801415593076626,14,123,cellular response to biotic stimulus,BP,TNIP1;NR1D1;HDAC5;PDCD4;CEBPB;MAPK3;ZFP36;PTAFR;BCR;ADAMTS13;AKT1;PYCARD;LITAF;MIF
3153,GO:0006768,0.289641583322102,0.916915396099861,2,11,biotin metabolic process,BP,PC;HLCS
4543,GO:0010634,0.289779763688508,0.807912924128233,12,103,positive regulation of epithelial cell migration,BP,HYAL1;WNT7A;RAB25;VEGFA;NRP2;HBEGF;FGFR1;PROX1;PPM1F;AKT1;CTSH;MAP2K3
12088,GO:0048156,0.289783106721046,0.916847072685096,2,11,tau protein binding,MF,APOE;BIN1
1249,GO:0003002,0.289867789712687,0.784052125908457,22,199,regionalization,BP,DUSP6;CTNNBIP1;TCTN1;MDFI;LRP5;SCMH1;IFT140;FUZ;WNT7A;CELSR1;TMEM107;VANGL2;ACVR2B;HES1;CELSR2;SEMA3F;WNT7B;SUFU;FGFR1;WNT2B;WNT3;RARG
16151,GO:0090199,0.29002887831444,0.853651662068461,5,39,regulation of release of cytochrome c from mitochondria,BP,BNIP3;AKT1;PINK1;PYCARD;FAM162A
15112,GO:0071236,0.29011630421634,0.807590894451728,12,104,cellular response to antibiotic,BP,CST3;MAPK13;EGR1;DNMT3A;STAT6;ANKZF1;BNIP3;ENDOG;ADCY6;TRAP1;TP53INP1;PINK1
16513,GO:0097284,0.290523918776182,0.916489006686557,2,11,hepatocyte apoptotic process,BP,GSN;DNMT3A
15846,GO:0072595,0.290769072434981,0.853333076155688,5,38,maintenance of protein localization in organelle,BP,ARL2;HK1;AKT1;SUN1;PINK1
8586,GO:0034111,0.290819831918586,0.916345780560438,2,11,negative regulation of homotypic cell-cell adhesion,BP,CD9;SERPINE2
13230,GO:0051937,0.290827584393585,0.886849379635491,3,20,catecholamine transport,BP,NISCH;RAB3B;PINK1
359,GO:0000978,0.291102047791692,0.772073856684891,31,286,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,FOS;TCFL5;MEF2D;NR1D1;NFATC4;ZFPM1;TFEB;FOXQ1;ZNF692;HES2;STAT6;CEBPB;HSF4;HES1;MLXIPL;ETV4;BHLHE40;HMGA2;ELK3;ZNF217;PPARA;RXRA;HLTF;SMARCD2;MEF2B;SIX5;SSBP2;RFX2;DDN;LITAF;MZF1
15476,GO:0071875,0.291156495802036,0.916182692531011,2,11,adrenergic receptor signaling pathway,BP,NOS1;ATP2B4
400,GO:0001077,0.291231020158963,0.788112961949712,19,169,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,FOS;MEF2D;EPAS1;EGR1;SOX12;TFEB;ZNF467;CEBPB;ETV4;HMGA2;ELK3;PPARA;HLTF;TEF;MEF2B;SSBP2;CAMTA2;LITAF;MZF1
7435,GO:0031581,0.291290126809742,0.916117917758082,2,11,hemidesmosome assembly,BP,ITGB4;ITGA6
889,GO:0002262,0.29135676620253,0.806586767207698,12,104,myeloid cell homeostasis,BP,ZFP36L1;FAM210B;EPAS1;THRA;ZFPM1;BCL6;VEGFA;ZFP36;DMTN;INPP5D;ACVR1B;JAK3
9030,GO:0035264,0.291700373281849,0.806358501354115,12,103,multicellular organism growth,BP,ERCC1;ZFP36L1;GAMT;BBS2;SH3PXD2B;ADARB1;WWTR1;SLITRK6;PPP1R13L;ERCC6;APBA1;RARG
16557,GO:0097386,0.291852501498501,0.915845065006108,2,11,glial cell projection,CC,GLUL;PINK1
4706,GO:0010878,0.291994333425571,0.91577618630937,2,11,cholesterol storage,BP,ABCG1;PPARA
18272,GO:1903205,0.292042772817532,0.886132023593783,3,20,regulation of hydrogen peroxide-induced cell death,BP,ENDOG;TRAP1;PINK1
6239,GO:0019825,0.292076213474616,0.915736410532385,2,11,oxygen binding,MF,CBS;CYP3A5
23,GO:0000045,0.292278121629885,0.814359328308695,10,84,autophagosome assembly,BP,ULK1;ULK2;TBC1D14;PACS2;ATG16L2;WIPI2;LRSAM1;ATG2A;TP53INP1;PINK1
11745,GO:0046625,0.292417841484161,0.915570360326735,2,11,sphingolipid binding,MF,PLTP;RTN4R
18741,GO:1904262,0.292440802565477,0.915559194537601,2,11,negative regulation of TORC1 signaling,BP,SESN2;C12ORF66
6766,GO:0030213,0.292512175259419,0.915524482205693,2,11,hyaluronan biosynthetic process,BP,CEMIP;HYAL1
804,GO:0002076,0.292706973441462,0.915429707885739,2,11,osteoblast development,BP,LRP5;PTHLH
954,GO:0002374,0.292815685610825,0.915376795228482,2,11,cytokine secretion involved in immune response,BP,MAPK3;HK1
11758,GO:0046639,0.292852480011836,0.915358883094628,2,11,negative regulation of alpha-beta T cell differentiation,BP,BCL6;JAK3
18421,GO:1903533,0.293062137930729,0.809139244545478,11,95,regulation of protein targeting,BP,CEMIP;ANK3;ERBB2;MICALL2;VPS11;PRNP;HES1;DMTN;OSCP1;PINK1;UBL5
7009,GO:0030742,0.293661272701022,0.885173777668081,3,20,GTP-dependent protein binding,MF,RAB3D;RAB3B;RAPGEF5
16048,GO:0090036,0.29385129169632,0.914871973908539,2,11,regulation of protein kinase C signaling,BP,VEGFA;GPD1L
7402,GO:0031501,0.293978603491259,0.962836698697555,1,4,mannosyltransferase complex,CC,PIGV
8072,GO:0032768,0.294009719131997,0.851087237089385,5,38,regulation of monooxygenase activity,BP,APOE;CYP27B1;EGFR;ATP2B4;AKT1
66,GO:0000137,0.29404498146147,0.914777402552966,2,11,Golgi cis cisterna,CC,LLGL1;GOLGA2P5
7178,GO:0031078,0.294239399036658,0.914682426879512,2,11,histone deacetylase activity (H3-K14 specific),MF,HDAC5;HDAC11
7622,GO:0032041,0.294239399036658,0.914682426879512,2,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,HDAC5;HDAC11
14273,GO:0061430,0.294482160772032,0.914563765549973,2,11,bone trabecula morphogenesis,BP,THBS3;PLXNB1
2385,GO:0005527,0.294612119184714,0.913561326200435,2,12,macrolide binding,MF,FKBP9;FKBP10
2386,GO:0005528,0.294612119184714,0.913561326200435,2,12,FK506 binding,MF,FKBP9;FKBP10
3588,GO:0008022,0.294638717785814,0.787162344482552,18,162,protein C-terminus binding,MF,ERCC1;SLC9A3R2;BCAM;ERBB2;FBLN1;DNM1;ID1;ECM1;CEP250;DLG4;SHANK3;CALCOCO1;SNX17;DLG3;MAPRE3;SDC1;ERCC6;NEIL1
9370,GO:0035925,0.294650638785595,0.914481368956557,2,11,mRNA 3'-UTR AU-rich region binding,MF,ZFP36L1;ZFP36
14194,GO:0061158,0.294650787508615,0.914481296205226,2,11,3'-UTR-mediated mRNA destabilization,BP,ZFP36L1;ZFP36
719,GO:0001946,0.294663085039816,0.914475280475716,2,11,lymphangiogenesis,BP,ACVR2B;PROX1
8183,GO:0032941,0.294937174894564,0.884416110854679,3,20,secretion by tissue,BP,ADA;STK39;KCNN4
6192,GO:0019692,0.295058518777799,0.864346037066735,4,30,deoxyribose phosphate metabolic process,BP,ADA;DGUOK;GUK1;NEIL1
3920,GO:0008610,0.295227813975056,0.754344640964378,53,510,lipid biosynthetic process,BP,APOE;CYP27B1;NR1D1;ALOX15B;ACOT7;ISYNA1;KDSR;EGR1;LPCAT4;DGKA;CERS4;ABCG1;DHRS11;PIK3R2;ZP3;HEXB;MVD;SRD5A3;HINT2;SEC14L2;MLXIPL;MBOAT7;FGFR3;PITPNM1;PI4K2A;FGFR4;PMVK;TNFRSF1A;LDLR;PIGZ;TM7SF2;DGKQ;PEX7;PCK2;INPP5D;FGFR1;PROX1;LCAT;GAL3ST4;PITPNM3;PIGV;PIGQ;SBF1;AKT1;ACP6;GPD1L;AGPAT4;TRERF1;CPNE7;MLYCD;TAZ;AGPAT3;MIF
12963,GO:0051393,0.295275816155727,0.914175294941123,2,11,alpha-actinin binding,MF,OBSL1;PKD2
11009,GO:0044877,0.295479053688727,0.748738882700599,68,664,protein-containing complex binding,MF,APOE;ESPN;FLNC;LTBP4;MRC2;GSN;EPHB2;IGF2;LRP1;OBSL1;EGFR;TIMP2;DDB2;MTHFR;ULK1;SHC1;GNAL;LAMA5;CTSB;CORO1B;CRTAP;NISCH;FBLN1;MICALL2;FCHO1;CDKN1C;CD9;RNF135;TNXB;LAMB2;INSR;ID1;ITGA6;PRNP;SNX9;DLG4;MYO18A;CD81;FCGRT;ACVR2B;ADAM15;S1PR2;WIPF1;L3MBTL1;PCSK9;PI4K2A;SPTB;DMTN;MYH3;LDLR;TRPV4;HMGA2;LDLRAP1;TSPAN4;ADAMTS13;CAPG;TWF2;SMARCD2;CHADL;BIN1;GRB10;WHAMMP3;EPS8L1;SORL1;ACVR1B;SMARCA1;ERCC6;SYNE3
4253,GO:0009607,0.295632329255275,0.75308850437337,55,540,response to biotic stimulus,BP,TNIP1;HTRA1;FOS;CYP27B1;PRSS3;NOS1;NR1D1;MST1R;LOXL1;SHC1;F2R;ACTA2;HDAC5;HYAL1;ACP5;PDCD4;TNFRSF25;ADARB1;TMEM173;ISG20;BNIP3;CEBPB;ADAM15;TNFRSF6B;MAPK3;WIPF1;WIPI2;TNFRSF14;LRSAM1;IL6R;ZFP36;MAPKBP1;VGF;TNFRSF1A;IFNGR2;HMGA2;FAM3A;TKFC;COMT;PTAFR;PCK2;BCR;GSDMC;ADAMTS13;MAPKAPK3;APOBEC3C;LYST;GSDMA;ABR;AKT1;NLRX1;PYCARD;APOBEC3F;LITAF;MIF
9034,GO:0035269,0.29590207643737,0.912923236696775,2,12,protein O-linked mannosylation,BP,B4GAT1;POMT1
2051,GO:0004806,0.295926623894623,0.913856133720476,2,11,triglyceride lipase activity,MF,PNPLA4;CES2
19021,GO:1904894,0.295953730316047,0.849734642540684,5,38,positive regulation of STAT cascade,BP,PTK6;HES1;IL6R;FGFR3;TNFRSF1A
10285,GO:0043067,0.296113562598,0.739408161969482,111,1105,regulation of programmed cell death,BP,DUSP6;APOE;CST3;GSN;XDH;PRDX5;NDRG1;ZFP36L1;RBCK1;EPHB2;OBSCN;IGF2;NFATC4;NME4;MST1R;LRP1;EGFR;HS1BP3;EGR1;ARHGEF4;SHC1;RGL2;F2R;CTSB;GRAMD4;THRA;RPS6KA2;LRP5;MARK4;ERBB2;SIGMAR1;PAK6;NTSR1;MINK1;TFDP2;PDCD4;BEX2;TNFRSF25;WNT7A;INSR;ID1;RABGGTA;EPHA1;ITGA6;SYNGAP1;PRNP;SPRY2;MNT;STRADB;MYO18A;BCL6;BNIP3;VEGFA;CEBPB;ENDOG;TNFRSF6B;PLEKHG5;EPHB3;PLEKHG2;TNFRSF14;ADA;PIDD1;PCSK9;ZFP36;FGFR3;MAP2K2;DAP;FGFR4;TNFRSF1A;MAPK8IP1;RAG1;TNFAIP8L1;EEF2K;HMGA2;GAS6;VAV3;PRKCZ;INPP5D;TM7SF3;AGO4;FGFR1;CTSZ;PIN1;KCNMA1;BIN1;SLC25A27;TMEM161A;MADD;TIMP1;PPM1F;STK39;ERBB3;ABR;PNMA1;AKT1;TRAP1;TMBIM4;ZNF385A;TP53INP1;PINK1;CTSH;PYCARD;MAP2K3;STK17A;ARHGEF19;JAK3;RARG;ING4;FAM162A;ADAMTSL4;MIF
3439,GO:0007257,0.296117342472183,0.864231747415393,4,28,activation of JUN kinase activity,BP,PKN1;WNT7B;ERCC6;ERN1
20082,GO:2000786,0.296120990251569,0.913760708264201,2,11,positive regulation of autophagosome assembly,BP,ULK1;LRSAM1
4230,GO:0009437,0.296285391850609,0.913679955899371,2,11,carnitine metabolic process,BP,CRAT;CPT1C
10411,GO:0043274,0.296306273552481,0.913669696510503,2,11,phospholipase binding,MF,DGKQ;PRKCZ
17061,GO:0099623,0.296623173693796,0.913513930774759,2,11,regulation of cardiac muscle cell membrane repolarization,BP,SCN4B;SNTA1
17063,GO:0099625,0.296623173693803,0.913513930774752,2,11,ventricular cardiac muscle cell membrane repolarization,BP,SCN4B;SNTA1
10143,GO:0042744,0.296680641418978,0.912537061189107,2,12,hydrogen peroxide catabolic process,BP,PRDX5;GPX3
13535,GO:0060026,0.296739513139615,0.913456713775681,2,11,convergent extension,BP,VANGL2;DVL1
5216,GO:0015837,0.296862929067974,0.863440334568112,4,29,amine transport,BP,NTSR1;RAB3B;STK39;PINK1
8753,GO:0034447,0.297359625236734,0.961908491261077,1,4,very-low-density lipoprotein particle clearance,BP,APOE
11271,GO:0045604,0.297931644920996,0.837325530327908,6,47,regulation of epidermal cell differentiation,BP,CYP27B1;ZFP36L1;ALOX15B;HES1;AQP3;ZFP36
9066,GO:0035335,0.297935419001763,0.815088195813969,9,75,peptidyl-tyrosine dephosphorylation,BP,DUSP6;PTPRS;DUSP5;PTPRU;PTPRE;SSH1;DUSP7;DUSP23;SSH3
1095,GO:0002684,0.298319359659405,0.74802068845674,62,606,positive regulation of immune system process,BP,TNIP1;FOS;CTNNBIP1;PTPRS;PGF;ZFP36L1;NR1D1;FAM210B;RBCK1;IGF2;SERPING1;CTSB;PIK3R2;ZP3;CD320;ZMIZ1;TMEM173;PRNP;EFNB3;STAT6;MYO18A;BCL6;IGFBP2;CD81;VEGFA;MAPK3;WIPF1;HES1;TNFRSF14;ADA;PAG1;AQP3;IL6R;PRKACA;CYFIP2;RPS6KA5;TRPV4;RAG1;HK1;GAS6;BTRC;TKFC;PTAFR;VAV3;MUC19;PRKCZ;INPP5D;ICOSLG;MAPKAPK3;C5;ADGRE2;VEGFB;ACVR1B;ADORA2B;AKT1;NLRX1;PYCARD;KCNN4;JAK3;EREG;MIF;STXBP2
16841,GO:0098799,0.29876151095377,0.911501044897176,2,12,outer mitochondrial membrane protein complex,CC,ANKZF1;PINK1
13222,GO:0051926,0.298769585585718,0.862184800609861,4,29,negative regulation of calcium ion transport,BP,NOS1;PKD2;NTSR1;GSTM2
10336,GO:0043167,0.298921773303615,0.72293999402943,432,4380,ion binding,MF,CEMIP;APOE;IDH2;RNPEPL1;PTPRS;NT5E;SYTL1;PYGB;RNF44;LTBP4;RAPGEF3;PGM1;CYP27B1;GSN;CLCA2;XDH;PRSS3;PRODH;PGF;NOS1;LTBP1;MARCH9;ARAP1;ZFP36L1;CGREF1;POSTN;GRB7;NR1D1;ALOX15B;SCN8A;RBCK1;EPHB2;OBSCN;NME4;MST1R;LRP1;MAPK13;CDK18;LTBP2;RAB11FIP4;ACBD4;EGFR;TIMP2;SMOC2;MMP28;B3GAT3;HADH;CRYL1;ACSF2;ACOT7;TCEA2;FKBP9;HS1BP3;FHL1;LOXL1;MTHFR;EGR1;ULK1;PKN1;PYGL;TRIM65;SYT8;SHC1;PTK6;GNAL;NPEPL1;ABCA7;DEAF1;PPP2R3B;CA12;ACTA2;S100A4;DNAH1;RNF208;PITPNC1;CXXC5;ULK2;DGKA;THBS3;D2HGDH;ZMYND8;ASH2L;ZSCAN18;MMP1;ABCG1;OPLAH;S100A6;ZNF516;PEG3;NEK9;HDAC5;THRA;RPS6KA2;NMRK1;NISCH;TUBG2;MARK4;TENM2;PLTP;ZFPM1;ERBB2;NUDT8;FBLN1;BRSK1;MICALL2;OGDHL;PKD2;CBS;TMEM129;EDEM1;ITPR3;VAT1;DNM1;SALL2;MSRB2;CUL9;KIF13B;NINL;PAK6;SERPINE2;VPS11;VAMP2;GALNT12;RNF135;UNK;JADE2;CD320;MINK1;ATP2B4;SNN;PHF7;CSNK1E;ACP5;RASA4;PLCD1;AGAP1;ZFYVE21;ADAMTS7;ACAP3;GLUL;RHOD;DTX3;ZKSCAN1;TNXB;USP20;PEX10;ZMIZ1;INSR;RAB3D;SH3PXD2B;ZC3H6;CELSR1;GRK6;MVD;B4GAT1;POLL;NDUFS8;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;TXNRD3;HAGH;DNMT3A;LPAR3;TMEM173;PRNP;DHX32;ATP7B;SNX33;ZNF467;SNX9;SPEG;ABCD1;MARCH2;MTA3;MKNK2;PLCD3;NT5DC1;STRADB;ISG20;RAB25;FAM20C;MYO18A;PHC2;BCL6;ANKZF1;UCKL1;PFKFB2;ATP12A;DYRK1B;SEC14L2;SRMS;VEGFA;ZSCAN2;ARL2;YPEL3;MAST4;SHANK3;ACVR2B;ADAM15;ENDOG;MAPK3;TUB;CAPNS2;DHTKD1;EXD3;ARL10;RAB40B;TNNT1;ENTPD2;GALK1;MTA1;LHPP;FYCO1;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;EPHB3;PHYHD1;PC;ACAD10;YPEL2;FURIN;ZNF624;NAGS;MEFV;TRIM4;NRP2;NADK;ABCA2;TK2;LRSAM1;ZNF414;ADA;FKBP10;TRIM45;MCTP1;OSBPL5;PHF21A;HTR7;RASL10B;CELSR2;ACY1;CKMT1A;PFKL;SLIT3;ZFP36;RHOF;HLCS;CYHR1;FGFR3;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;LRRK1;NUDT10;PLCH2;DGUOK;RPS6KA5;HBEGF;RAB3B;MAP2K2;PI4K2A;FGFR4;RNF215;PMVK;MYH3;PSD4;EHD4;LDLR;CYP3A5;SNX17;TRPV4;RHOBTB2;RAG1;ZNF80;EEF2K;LDLRAP1;DGKQ;HK1;ZXDC;MIB2;PADI3;GAS6;MEX3A;ZNF217;PPARA;HMGCL;TKFC;GUK1;STK32C;GIT1;COMT;PTAFR;RFNG;DMC1;IMPA2;LTBP3;PAN2;ZNF446;RXRA;PCK2;VAV3;BCR;SDHA;GSDMC;USP21;RNF123;PRKCZ;ADAMTS13;HAGHL;HLTF;ABCD4;TWF2;ZNF485;TPP1;PDK2;GPC1;ZNF160;MAPKAPK3;ARAP3;CDHR1;FGFR1;CAMKK1;MAN1B1;ZNF563;ANKMY1;PHYH;IRF2BPL;GTPBP1;PCDHGC3;ASAP2;KCNMA1;ESYT2;VSNL1;ASS1;ZNF554;CAPN2;SESN2;RXRB;MAN2B2;GUCA1B;ADGRE2;GAL3ST4;PITPNM3;CYBRD1;LMLN;RTN4R;TIMP1;GRHPR;ACTR1B;APOBEC3C;FGFBP1;ZFP41;PPM1F;STK39;EFCAB1;COL13A1;VEGFB;ACVR1B;GSDMA;ZSCAN30;GSS;ERBB3;CYP2S1;AKT1;HPDL;TRAP1;NLRX1;SEPT8;ADAM19;ZNF385A;TUT1;SMARCA1;ERCC6;ADCK2;PINK1;EHD3;LONP2;KDM4B;LENG9;ZNF710;RSAD1;CBLC;RNF187;MAP2K3;PNPO;SNX29;POMT1;TRERF1;THAP8;STK17A;ERN1;ZNF319;APOBEC3F;PRIMPOL;ACADS;GCAT;MOCS1;SIRT3;ALKBH6;GLI4;JAK3;BCKDHA;MAST3;KIFC2;LITAF;MZF1;NEIL1;FUK;RARG;ING4;GALNS;ZCCHC14;GSTM2;ZNF514;ZFYVE19;TRIM7;TTLL11;ZNF837;POLM;RAB40C;SULF2;KIF26B
9854,GO:0042133,0.299334131009136,0.813991989270948,9,75,neurotransmitter metabolic process,BP,NOS1;PKD2;ATP2B4;ACP5;INSR;COMT;ASS1;AKT1;GCAT
7198,GO:0031102,0.299377893588456,0.847342445599732,5,38,neuron projection regeneration,BP,APOE;PTPRS;ULK1;LAMB2;RTN4R
3065,GO:0006639,0.299947779036963,0.819623205688306,8,66,acylglycerol metabolic process,BP,LMF1;APOE;DGKA;PCSK9;LDLR;DGKQ;PCK2;PNPLA4
724,GO:0001954,0.300413362117882,0.84661659697016,5,38,positive regulation of cell-matrix adhesion,BP,EPHA1;VEGFA;PRKCZ;PPM1F;NINJ1
11248,GO:0045576,0.300491074868953,0.861047653438088,4,29,mast cell activation,BP,NDRG1;ADGRE2;ADORA2B;STXBP2
16220,GO:0090303,0.300517126622944,0.861030418848673,4,29,positive regulation of wound healing,BP,F2R;F12;HBEGF;DMTN
10091,GO:0042626,0.300796500839924,0.818969032092985,8,66,ATPase activity, coupled to transmembrane movement of substances,MF,ABCA7;ABCG1;ATP2B4;ATP7B;ABCD1;ATP12A;ABCA2;ABCD4
2949,GO:0006488,0.301631574651896,0.880408154255304,3,20,dolichol-linked oligosaccharide biosynthetic process,BP,MVD;SRD5A3;ALG12
4753,GO:0010942,0.301709016765131,0.749276435257962,51,496,positive regulation of cell death,BP,FOS;DUSP6;GSN;XDH;PRODH;RBCK1;OBSCN;NFATC4;LRP1;EGR1;ARHGEF4;F2R;GRAMD4;RPS6KA2;MARK4;NTSR1;TFDP2;PDCD4;ITGA6;DNMT3A;PRNP;BCL6;BNIP3;ENDOG;PLEKHG5;SSH1;PLEKHG2;PIDD1;PCSK9;DAP;HMGA2;VAV3;INPP5D;CTSZ;PIN1;KCNMA1;BIN1;PPM1F;ABR;PNMA1;AKT1;TP53INP1;PINK1;CTSH;PYCARD;STK17A;ARHGEF19;RARG;ING4;FAM162A;ADAMTSL4
8807,GO:0034599,0.301901886265922,0.771975171366771,23,215,cellular response to oxidative stress,BP,FOS;CST3;PRDX5;PRODH;EPAS1;GPX3;MAPK13;EGFR;PKD2;STAT6;ANKZF1;BNIP3;ENDOG;MAPK3;ETV5;PYCR2;PDK2;SESN2;TMEM161A;AKT1;TRAP1;TP53INP1;PINK1
4368,GO:0010008,0.301957250070376,0.755843914972526,39,371,endosome membrane,CC,NDRG1;APPL2;RAB11FIP4;EGFR;ABCA7;ERBB2;PRAF2;VPS11;CD320;ZFYVE21;RHOD;INSR;MARCH2;CHMP1B;MVB12B;AP2A2;AMN;FURIN;SLC48A1;ABCA2;PCSK9;TMEM9;PI4K2A;EHD4;LDLR;SNX17;ABHD17C;MVB12A;LLGL1;TMEM175;WDR83;SLC9A7;CD68;SORL1;TPCN1;VPS33B;SPPL2B;EHD3;LITAF
1184,GO:0002831,0.302051618096655,0.801896080033812,11,95,regulation of response to biotic stimulus,BP,HTRA1;TMEM173;MAPK3;LRSAM1;MAPKBP1;FAM3A;TKFC;NLRX1;PYCARD;APOBEC3F;MIF
3526,GO:0007520,0.302234521130929,0.880044477322251,3,20,myoblast fusion,BP,NOS1;DYRK1B;CAPN2
5922,GO:0018210,0.302273127785781,0.797750926907082,12,103,peptidyl-threonine modification,BP,CEMIP;ULK1;PKN1;GALNT12;SPRY2;S1PR2;DMTN;DGKQ;CAMKK1;STK39;ACVR1B;AKT1
10021,GO:0042491,0.30287249196344,0.879659190626782,3,20,inner ear auditory receptor cell differentiation,BP,HES1;SLITRK6;FGFR1
6045,GO:0019201,0.303062742339405,0.879544197234598,3,20,nucleotide kinase activity,MF,DLG4;GUK1;DLG3
11253,GO:0045581,0.303690633968434,0.879164365273174,3,20,negative regulation of T cell differentiation,BP,ERBB2;BCL6;JAK3
2290,GO:0005254,0.30393597729683,0.858761989211992,4,29,chloride channel activity,MF,CLCA2;ANO8;TTYH3;ANO9
11519,GO:0046070,0.304035954896641,0.960036411601946,1,4,dGTP metabolic process,BP,DGUOK
18534,GO:1903779,0.304058214044995,0.844052576671188,5,38,regulation of cardiac conduction,BP,NOS1;ITPR3;ATP2B4;PRKACA;EHD3
17662,GO:1901567,0.304071352240258,0.878469603550043,3,21,fatty acid derivative binding,MF,ACBD4;ACOT7;HMGCL
12373,GO:0048821,0.304496819859235,0.878675970089348,3,20,erythrocyte development,BP,FAM210B;BCL6;DMTN
1202,GO:0002862,0.304686324688508,0.959851244953592,1,4,negative regulation of inflammatory response to antigenic stimulus,BP,IL20RB
3474,GO:0007342,0.304798952788122,0.959819127920815,1,4,fusion of sperm to egg plasma membrane involved in single fertilization,BP,CD9
14745,GO:0070470,0.305291412219527,0.959678522203064,1,4,plasma membrane respiratory chain,CC,SDHA
415,GO:0001103,0.306302942332699,0.857183725453557,4,29,RNA polymerase II repressing transcription factor binding,MF,BBS2;MTA1;BBS1;PPARA
9435,GO:0036042,0.30728032680067,0.95910773355789,1,4,long-chain fatty acyl-CoA binding,MF,ACOT7
122,GO:0000253,0.307608961521981,0.95901296908946,1,4,3-keto sterol reductase activity,MF,DHRS11
6554,GO:0022011,0.307737286408114,0.876704841567519,3,20,myelination in peripheral nervous system,BP,NDRG1;AHNAK2;AKT1
7760,GO:0032292,0.307737286408114,0.876704841567519,3,20,peripheral nervous system axon ensheathment,BP,NDRG1;AHNAK2;AKT1
13816,GO:0060444,0.308185327757663,0.876431293359209,3,20,branching involved in mammary gland duct morphogenesis,BP,LRP5;ETV5;BTRC
3106,GO:0006691,0.308232636618369,0.906714003244734,2,12,leukotriene metabolic process,BP,GGT1;LTA4H
11128,GO:0045197,0.308313604788955,0.855838050214392,4,29,establishment or maintenance of epithelial cell apical/basal polarity,BP,DLG4;VANGL2;DLG3;LRCH4
2703,GO:0006084,0.308513010851316,0.855704344032441,4,29,acetyl-CoA metabolic process,BP,MVD;PMVK;PDK2;MLYCD
11756,GO:0046637,0.308613593061232,0.855636884333873,4,29,regulation of alpha-beta T cell differentiation,BP,BCL6;ADA;PRKCZ;JAK3
17638,GO:1901522,0.309038560828951,0.875909679001225,3,20,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,VEGFA;RXRA;SESN2
797,GO:0002067,0.309220387987095,0.855229668510867,4,29,glandular epithelial cell differentiation,BP,HES1;RXRA;PROX1;RARG
4512,GO:0010575,0.309273207325191,0.875766074307101,3,20,positive regulation of vascular endothelial growth factor production,BP,C5;ADORA2B;SULF2
18470,GO:1903626,0.309289041269288,0.958526500310573,1,4,positive regulation of DNA catabolic process,BP,ENDOG
11801,GO:0046718,0.309482739971624,0.805826801693485,9,77,viral entry into host cell,BP,GSN;EGFR;CTSB;EFNB3;CD81;TNFRSF14;ITGB5;LDLR;GAS6
9559,GO:0036379,0.30955399005168,0.906036793205967,2,12,myofilament,CC,TMOD2;TNNT1
2475,GO:0005719,0.309812048007446,0.874960883971742,3,21,nuclear euchromatin,CC,H1F0;ASH2L;TRNP1
5587,GO:0016628,0.309977140784199,0.874859382109019,3,21,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,SRD5A3;TM7SF2;BLVRB
5550,GO:0016572,0.31006372730509,0.854663016455606,4,29,histone phosphorylation,BP,PKN1;MAPK3;RPS6KA5;HMGA2
3472,GO:0007340,0.310374024049968,0.905615361766691,2,12,acrosome reaction,BP,SYT8;ZP3
14580,GO:0070167,0.310738687137788,0.839316637645116,5,38,regulation of biomineral tissue development,BP,CYP27B1;ECM1;FAM20C;ACVR2B;GAS6
1282,GO:0003091,0.310937105519688,0.874745827801825,3,20,renal water homeostasis,BP,ADCY6;AQP3;PRKACA
13615,GO:0060148,0.310995198608981,0.874710145839102,3,20,positive regulation of posttranscriptional gene silencing,BP,EGFR;ZFP36;MAP2K2
698,GO:0001919,0.311077082554043,0.874659844030546,3,20,regulation of receptor recycling,BP,ARAP1;PCSK9;TBC1D16
1055,GO:0002583,0.311192492189224,0.957971293654346,1,4,regulation of antigen processing and presentation of peptide antigen,BP,PYCARD
2646,GO:0005997,0.31137251369493,0.957918560432005,1,4,xylulose metabolic process,BP,TALDO1
9473,GO:0036126,0.311375923525202,0.838654720425928,5,39,sperm flagellum,CC,DNAH1;ATP2B4;HK1;GAS8;MAFIP
16697,GO:0097729,0.311375923525202,0.838654720425928,5,39,9+2 motile cilium,CC,DNAH1;ATP2B4;HK1;GAS8;MAFIP
3943,GO:0008655,0.311541473228969,0.905013861376038,2,12,pyrimidine-containing compound salvage,BP,UCKL1;TK2
7879,GO:0032459,0.311553535633788,0.853363733199171,4,30,regulation of protein oligomerization,BP,APOE;MMP1;SNX9;SORL1
5978,GO:0018916,0.311914429789069,0.957759584590522,1,4,nitrobenzene metabolic process,BP,GSTM2
6867,GO:0030374,0.311915521688726,0.81780743447293,7,57,ligand-dependent nuclear receptor transcription coactivator activity,MF,NR1D1;PKN1;THRA;CALCOCO1;PPARA;TRERF1;RARG
1997,GO:0004725,0.311929821100907,0.803962709219522,9,76,protein tyrosine phosphatase activity,MF,DUSP6;PTPRS;DUSP5;PTPRU;PTPRE;SSH1;DUSP7;DUSP23;SSH3
15142,GO:0071295,0.312134765341155,0.874009365185984,3,20,cellular response to vitamin,BP,CYP27B1;POSTN;GAS6
10397,GO:0043254,0.312285564424475,0.749518006165292,35,333,regulation of protein complex assembly,BP,APOE;CTNNBIP1;ERCC1;GSN;DDB2;ULK1;ARPIN;CORO1B;MMP1;THRA;VPS11;TMOD2;SNX9;VEGFA;ARL2;WIPF1;MEFV;PLEKHG2;CDC42EP5;SPTB;DMTN;PRKCZ;CAPG;TWF2;LCAT;WHAMMP3;EPS8L1;SORL1;EPS8L2;PINK1;SPIRE2;MLST8;PYCARD;FCHSD1;RPL13A
14605,GO:0070201,0.312378443953444,0.738574795639841,53,515,regulation of establishment of protein localization,BP,CEMIP;IDH2;RAPGEF3;POSTN;NR1D1;ALOX15B;LRP1;EGFR;B3GAT3;HADH;NLGN2;RHBDF1;F2R;ANK3;LRP5;ERBB2;MICALL2;EDEM1;ITPR3;VPS11;VAMP2;TFDP2;GLUL;TMEM173;PRNP;MYO18A;PFKFB2;ARL2;RHBDF2;MAPK3;HES1;PFKL;MAPKBP1;DMTN;TRPV4;HK1;GAS6;LLGL1;PCK2;PRKCZ;TM7SF3;C5;VSNL1;OSCP1;SORL1;PINK1;PYCARD;KCNN4;SIRT3;SLC2A1;GIPR;MIF;UBL5
5065,GO:0015298,0.312468089395153,0.873804085806541,3,20,solute:cation antiporter activity,MF,SLC22A18;TMCO3;SLC9A7
13050,GO:0051584,0.312508720808426,0.957584840264299,1,4,regulation of dopamine uptake involved in synaptic transmission,BP,RAB3B
13232,GO:0051940,0.312508720808426,0.957584840264299,1,4,regulation of catecholamine uptake involved in synaptic transmission,BP,RAB3B
4078,GO:0009141,0.312535640593044,0.758309768059676,26,257,nucleoside triphosphate metabolic process,BP,PGM1;NME4;OGDHL;INSR;NDUFS8;FAM20C;UCKL1;PFKFB2;DHTKD1;GALK1;MLXIPL;NADK;ADA;PFKL;DGUOK;MYH3;HK1;PPARA;GUK1;SDHA;GTPBP1;UQCR11;PINK1;NDUFV3;MOCS1;TAZ
14973,GO:0070925,0.312539020661521,0.733848949603235,65,637,organelle assembly,BP,SHANK2;GSN;EVI5L;TCTN1;GRB7;OBSCN;OBSL1;NLGN2;ULK1;LAMA5;BBS2;DNAH1;ULK2;TBC1D14;PACS2;TUBG2;MARK4;IFT140;NINL;VPS11;CCDC69;FUZ;NPHP4;TMOD2;CSNK1E;SH3PXD2B;CEP250;ATG16L2;WWTR1;TMEM107;CHMP1B;VANGL2;SHANK3;NUDCD3;TNNT1;WIPI2;FBF1;LRSAM1;PRKACA;BBS1;MYH3;CROCC;MVB12A;ATG2A;TMEM175;WDR60;NDE1;PROX1;UNC119B;WRAP73;TMEM231;SDC1;SEPT8;TP53INP1;PINK1;GAS8;EHD3;GOLGA2P5;MAFIP;RILPL1;ATXN10;RFX2;DNAAF5;WDR18;SFI1
12663,GO:0050906,0.312644399536109,0.852349827165487,4,31,detection of stimulus involved in sensory perception,BP,REEP6;SERPINE2;NTSR1;OR7D2
4859,GO:0014722,0.312863409873864,0.957480346602511,1,4,regulation of skeletal muscle contraction by calcium ion signaling,BP,GSTM2
4266,GO:0009636,0.312933537709979,0.750595579278147,33,319,response to toxic substance,BP,FOS;APOE;CST3;GSN;PRDX5;GPX3;MAPK13;EGR1;BPHL;GJC2;SLC7A8;SNN;TXNRD3;DNMT3A;BLMH;STAT6;ANKZF1;FAM213A;BNIP3;ENDOG;MAPK3;ADA;PPARA;ADAMTS13;KCNMA1;SESN2;SDC1;GSTT1;TRAP1;TP53INP1;ERCC6;PINK1;GSTM2
1493,GO:0003839,0.313036604949601,0.957429267461493,1,4,gamma-glutamylcyclotransferase activity,MF,GGACT
4752,GO:0010941,0.313135463685127,0.72238393073863,118,1181,regulation of cell death,BP,FOS;DUSP6;APOE;CST3;GSN;XDH;PRDX5;NDRG1;PRODH;ZFP36L1;RBCK1;EPHB2;OBSCN;IGF2;NFATC4;NME4;MST1R;LRP1;EGFR;HS1BP3;EGR1;ARHGEF4;SHC1;RGL2;F2R;CTSB;GRAMD4;THRA;RPS6KA2;LRP5;MARK4;ERBB2;SIGMAR1;PAK6;NTSR1;MINK1;TFDP2;PDCD4;BEX2;TNFRSF25;WNT7A;INSR;ID1;RABGGTA;EPHA1;ITGA6;SYNGAP1;DNMT3A;PRNP;SPRY2;MNT;STRADB;MYO18A;BCL6;BNIP3;VEGFA;CEBPB;ENDOG;TNFRSF6B;PLEKHG5;EPHB3;SSH1;PLEKHG2;TNFRSF14;ADA;PIDD1;PCSK9;ZFP36;FGFR3;MAP2K2;DAP;FGFR4;TNFRSF1A;MAPK8IP1;RAG1;TNFAIP8L1;EEF2K;HMGA2;GAS6;PPARA;VAV3;PRKCZ;INPP5D;TM7SF3;AGO4;FGFR1;CTSZ;PIN1;KCNMA1;BIN1;SLC25A27;TMEM161A;MADD;TIMP1;PPM1F;SORL1;STK39;ERBB3;ABR;PNMA1;AKT1;TRAP1;TMBIM4;ZNF385A;TP53INP1;PINK1;CTSH;RILPL1;PYCARD;MAP2K3;STK17A;ARHGEF19;JAK3;RARG;ING4;FAM162A;ADAMTSL4;MIF
9372,GO:0035927,0.313183649265956,0.957385872551196,1,4,RNA import into mitochondrion,BP,TST
4070,GO:0009133,0.313297320002009,0.957352308904137,1,4,nucleoside diphosphate biosynthetic process,BP,GUK1
12303,GO:0048678,0.313452765995704,0.825596430030718,6,49,response to axon injury,BP,PTPRS;CST3;LAMB2;RTN4R;MORN4;GIPR
11420,GO:0045879,0.313539632247839,0.873143248805638,3,20,negative regulation of smoothened signaling pathway,BP,SERPINE2;BTRC;SUFU
6059,GO:0019217,0.313895741070086,0.81629272548065,7,57,regulation of fatty acid metabolic process,BP,TYSND1;MLXIPL;PPARA;PDK2;AKT1;LONP2;MLYCD
7807,GO:0032372,0.314001831779809,0.957143941439052,1,4,negative regulation of sterol transport,BP,PCSK9
7810,GO:0032375,0.314001831779809,0.957143941439052,1,4,negative regulation of cholesterol transport,BP,PCSK9
16735,GO:0098554,0.314073421416877,0.902841272648643,2,13,cytoplasmic side of endoplasmic reticulum membrane,CC,PKD2;SPPL2B
20152,GO:2001026,0.314108799455132,0.903684798252905,2,12,regulation of endothelial cell chemotaxis,BP,VEGFA;FGFR1
17337,GO:1900078,0.314314209163845,0.872664679692727,3,20,positive regulation of cellular response to insulin stimulus,BP,IGF2;PIK3R2;PRKCZ
13587,GO:0060087,0.314535926350298,0.956985579726553,1,4,relaxation of vascular smooth muscle,BP,ADORA2B
1051,GO:0002579,0.314779100719461,0.956913363749273,1,4,positive regulation of antigen processing and presentation,BP,PYCARD
2598,GO:0005902,0.314951268898424,0.824631029617006,6,48,microvillus,CC,ESPN;SYTL1;RAPGEF3;BBS2;KIF13B;PLEKHG6
3064,GO:0006638,0.314974120354464,0.807847311019832,8,67,neutral lipid metabolic process,BP,LMF1;APOE;DGKA;PCSK9;LDLR;DGKQ;PCK2;PNPLA4
16233,GO:0090316,0.31576469182243,0.771278316970624,17,155,positive regulation of intracellular protein transport,BP,CEMIP;RAPGEF3;B3GAT3;ANK3;ERBB2;MICALL2;EDEM1;VPS11;VAMP2;TMEM173;PRNP;HES1;GAS6;OSCP1;SORL1;PINK1;UBL5
7366,GO:0031430,0.315815096185782,0.902796672836016,2,12,M band,CC,OBSCN;OBSL1
7483,GO:0031666,0.316257356336593,0.956472832242427,1,4,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,MIF
10147,GO:0042749,0.316352043420759,0.956444525060221,1,4,regulation of circadian sleep/wake cycle,BP,ADA
11123,GO:0045187,0.316352043420759,0.956444525060221,1,4,regulation of circadian sleep/wake cycle, sleep,BP,ADA
12224,GO:0048521,0.316352043420759,0.956444525060221,1,4,negative regulation of behavior,BP,ADA
7253,GO:0031233,0.316731246876511,0.902318233355062,2,12,intrinsic component of external side of plasma membrane,CC,PRNP;RTN4R
17514,GO:1901070,0.316865146572634,0.90137509399343,2,13,guanosine-containing compound biosynthetic process,BP,NME4;GUK1
8793,GO:0034518,0.316917588425557,0.902220785061496,2,12,RNA cap binding complex,CC,ZFP36;EIF4E3
16477,GO:0097202,0.316966282427768,0.902195312724848,2,12,activation of cysteine-type endopeptidase activity,BP,CYFIP2;PYCARD
11996,GO:0047617,0.317179622861854,0.902083675243811,2,12,acyl-CoA hydrolase activity,MF,ACOT7;ACOT11
10138,GO:0042734,0.317284613423853,0.834630385020327,5,38,presynaptic membrane,CC,ADGRL1;NLGN2;RIMS3;PI4K2A;SNPH
2832,GO:0006308,0.317427710494353,0.849378276111078,4,30,DNA catabolic process,BP,H1F0;ISG20;DNASE1L1;ENDOG
8796,GO:0034552,0.317559171879614,0.956082699812668,1,4,respiratory chain complex II assembly,BP,SDHAF4
8797,GO:0034553,0.317559171879614,0.956082699812668,1,4,mitochondrial respiratory chain complex II assembly,BP,SDHAF4
2266,GO:0005212,0.317586867035372,0.956074377804215,1,4,structural constituent of eye lens,MF,BFSP1
19371,GO:1905907,0.317644609448235,0.956057024032446,1,4,negative regulation of amyloid fibril formation,BP,LDLR
8287,GO:0033133,0.317675759039331,0.956047660732615,1,4,positive regulation of glucokinase activity,BP,PFKFB2
10030,GO:0042509,0.317772200734002,0.834067385901375,5,39,regulation of tyrosine phosphorylation of STAT protein,BP,PTK6;HES1;IL6R;FGFR3;TNFRSF1A
7271,GO:0031268,0.317792122937309,0.901762830335621,2,12,pseudopodium organization,BP,RAB25;CDC42EP5
6581,GO:0022605,0.318036171068256,0.955939238660588,1,4,mammalian oogenesis stage,BP,EREG
7145,GO:0031017,0.318198355885802,0.955890397654376,1,4,exocrine pancreas development,BP,INSR
12466,GO:0050482,0.318660249717995,0.901307232237819,2,12,arachidonic acid secretion,BP,NTSR1;MIF
18623,GO:1903963,0.318660249717995,0.901307232237819,2,12,arachidonate transport,BP,NTSR1;MIF
12278,GO:0048639,0.318883266953363,0.783949778356898,12,105,positive regulation of developmental growth,BP,BBS2;ZP3;INSR;SH3PXD2B;LPAR3;VEGFA;TWF2;FGFR1;PIN1;PROX1;WNT3;AKT1
10181,GO:0042803,0.319121197717556,0.731889916719223,54,529,protein homodimerization activity,MF,APOE;XDH;PGF;CADM4;MEF2D;RAB11FIP4;CRYL1;ACOT7;PYGL;GALE;ABCG1;S100A6;TENM2;PKD2;CBS;HEXB;NTSR1;ID1;MVD;DNPH1;TMEM173;SNX9;ABCD1;WWTR1;BNIP3;VEGFA;CEBPB;LHPP;HES1;IL6R;HLCS;BHLHE40;RAG1;PEX7;HMGCL;IMPA2;PDK2;FGFR1;SLC9A7;GRHPR;OLFML2A;VEGFB;GSS;ERBB3;AKT1;GPD1L;NAGA;SPPL2B;HOMER2;PYCARD;PNPO;ERN1;MZF1;GSTM2
16586,GO:0097452,0.319338565196127,0.955546131410238,1,4,GAIT complex,CC,RPL13A
19238,GO:1905448,0.320103249841787,0.955314365415596,1,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,PINK1
3017,GO:0006570,0.320128559313952,0.955306682310361,1,4,tyrosine metabolic process,BP,HPDL
8938,GO:0035019,0.320178700681124,0.820566684635779,6,49,somatic stem cell population maintenance,BP,EPAS1;LRP5;WNT7A;EPHA1;VANGL2;HES1
16491,GO:0097228,0.320192579994318,0.900500626129275,2,12,sperm principal piece,CC,ATP2B4;HK1
7485,GO:0031668,0.320275277702465,0.761015799103191,20,184,cellular response to extracellular stimulus,BP,FOS;CYP27B1;POSTN;ULK1;CBS;GLUL;ITGA6;MAPK3;SSH1;AQP3;PCSK9;DAP;GAS6;COMT;PDK2;SESN2;WNT2B;ADORA2B;C12ORF66;SLC2A1
14534,GO:0070086,0.320292531449989,0.955256887035644,1,4,ubiquitin-dependent endocytosis,BP,LRSAM1
11740,GO:0046620,0.320426364526891,0.811271354698758,7,57,regulation of organ growth,BP,DUSP6;WWC3;FGFR1;PIN1;PROX1;JARID2;AKT1
12712,GO:0051001,0.320465984034897,0.955204177182521,1,4,negative regulation of nitric-oxide synthase activity,BP,ATP2B4
4591,GO:0010716,0.320477671916873,0.955200624081633,1,4,negative regulation of extracellular matrix disassembly,BP,CST3
8768,GO:0034465,0.320522963624075,0.955186853893968,1,4,response to carbon monoxide,BP,KCNMA1
10145,GO:0042747,0.320638744878367,0.955151641205312,1,4,circadian sleep/wake cycle, REM sleep,BP,CST3
10137,GO:0042733,0.320789778348863,0.820261561794878,6,48,embryonic digit morphogenesis,BP,LRP5;IFT140;WNT7A;TMEM107;FBXW4;TMEM231
10609,GO:0043625,0.32095733351438,0.955054664365546,1,4,delta DNA polymerase complex,CC,POLD4
2220,GO:0005126,0.32104252407248,0.77488059578682,14,129,cytokine receptor binding,MF,PGF;SHC1;ECM1;VEGFA;PIDD1;IL6R;C5;TOLLIP;MADD;VEGFB;TRAP1;PYCARD;CKLF;MIF
8729,GO:0034394,0.321103716559991,0.831660991735569,5,39,protein localization to cell surface,BP,PTPRU;SNX33;KCNAB2;AKT1;GPD1L
17908,GO:1902262,0.321244004490614,0.954967297609131,1,4,apoptotic process involved in blood vessel morphogenesis,BP,LRP5
2732,GO:0006121,0.321305102721884,0.954948664193676,1,4,mitochondrial electron transport, succinate to ubiquinone,BP,SDHA
1086,GO:0002674,0.321335232351724,0.954939473746377,1,4,negative regulation of acute inflammatory response,BP,IL20RB
15554,GO:0072049,0.32144145230775,0.954907064637496,1,4,comma-shaped body morphogenesis,BP,HES1
773,GO:0002029,0.321609378516991,0.899752072458767,2,12,desensitization of G-protein coupled receptor protein signaling pathway,BP,DNM1;GIPR
6564,GO:0022401,0.321609378516991,0.899752072458767,2,12,negative adaptation of signaling pathway,BP,DNM1;GIPR
1306,GO:0003156,0.321717174083365,0.867555778829603,3,21,regulation of animal organ formation,BP,HES1;FGFR1;WNT2B
16810,GO:0098742,0.321764543257271,0.78155228106364,12,105,cell-cell adhesion via plasma-membrane adhesion molecules,BP,ADGRL1;CADM4;SDK2;IGSF9;TENM2;PLXNB3;ARVCF;CELSR1;CELSR2;CDHR1;PCDHGC3;PKD1
12627,GO:0050857,0.321843839149662,0.899627941004677,2,12,positive regulation of antigen receptor-mediated signaling pathway,BP,ADA;KCNN4
10536,GO:0043508,0.321928758248804,0.899582963988284,2,12,negative regulation of JUN kinase activity,BP,PDCD4;MAPK8IP1
6808,GO:0030278,0.322106618739756,0.777504888590598,13,115,regulation of ossification,BP,CTNNBIP1;CYP27B1;LRP5;ID1;ECM1;FAM20C;CEBPB;ACVR2B;MAPK3;IL6R;PRKACA;WNT7B;SUFU
17493,GO:1900825,0.322272388809114,0.954653060837836,1,4,regulation of membrane depolarization during cardiac muscle cell action potential,BP,ANK3
14887,GO:0070742,0.32248197274946,0.899289722751289,2,12,C2H2 zinc finger domain binding,MF,HMGA2;ZXDC
7646,GO:0032079,0.322524245539745,0.954575906164211,1,4,positive regulation of endodeoxyribonuclease activity,BP,AKT1
11320,GO:0045666,0.322637024155068,0.750888255901432,25,232,positive regulation of neuron differentiation,BP,APOE;SHANK2;CNTN1;OBSL1;TIMP2;CRTC1;PTK6;ZMYND8;PLXNB3;CSNK1E;FBXW8;LPAR3;DLG4;BCL6;PLXNB1;VEGFA;SHANK3;ETV5;DVL1;CUL7;EEF2K;TWF2;FGFR1;PROX1;WNT3
16102,GO:0090130,0.322908588484043,0.755151451035672,22,204,tissue migration,BP,APOE;PRSS3;PKN1;ACTA2;CORO1B;HDAC5;HYAL1;LTB4R2;WNT7A;ID1;RAB25;VEGFA;PLEKHG5;PKN3;NRP2;HBEGF;FGFR1;PROX1;PPM1F;AKT1;CTSH;MAP2K3
14616,GO:0070228,0.322917109942537,0.830142242409532,5,40,regulation of lymphocyte apoptotic process,BP,BCL6;ADA;RAG1;JAK3;MIF
2219,GO:0005125,0.322927797317327,0.801298493177015,8,70,cytokine activity,MF,CMTM7;WNT7A;VEGFA;C5;TIMP1;CKLF;CMTM4;MIF
15380,GO:0071671,0.32297167708677,0.954438647598764,1,4,regulation of smooth muscle cell chemotaxis,BP,CORO1B
4490,GO:0010528,0.323415030127746,0.898794220744506,2,12,regulation of transposition,BP,APOBEC3C;APOBEC3F
4491,GO:0010529,0.323415030127746,0.898794220744506,2,12,negative regulation of transposition,BP,APOBEC3C;APOBEC3F
1265,GO:0003044,0.323470528369032,0.866450493797728,3,21,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,F2R;RASL10B;CTSZ
19837,GO:2000344,0.323756216066106,0.95419738460154,1,4,positive regulation of acrosome reaction,BP,ZP3
13159,GO:0051792,0.323903042184981,0.954152148793823,1,4,medium-chain fatty acid biosynthetic process,BP,ACOT7
16210,GO:0090288,0.324105084339656,0.783796969815382,11,96,negative regulation of cellular response to growth factor stimulus,BP,HTRA1;XDH;LTBP1;SPRY4;FUZ;SPRY2;VASN;GPC1;PIN1;EPN2;SULF2
4393,GO:0010138,0.324108954896491,0.954088664532009,1,4,pyrimidine ribonucleotide salvage,BP,UCKL1
10742,GO:0044206,0.324108954896491,0.954088664532009,1,4,UMP salvage,BP,UCKL1
12444,GO:0050321,0.324112900276356,0.898422861400293,2,12,tau-protein kinase activity,MF,MARK4;BRSK1
9038,GO:0035278,0.324200268020156,0.898376324725827,2,12,miRNA mediated inhibition of translation,BP,ZFP36;AGO4
9788,GO:0040033,0.324200268020156,0.898376324725827,2,12,negative regulation of translation, ncRNA-mediated,BP,ZFP36;AGO4
11474,GO:0045974,0.324200268020156,0.898376324725827,2,12,regulation of translation, ncRNA-mediated,BP,ZFP36;AGO4
11633,GO:0046394,0.324271780801575,0.743353848411512,30,285,carboxylic acid biosynthetic process,BP,CEMIP;PGM1;NR1D1;ALOX15B;GAMT;ACOT7;UROS;HYAL1;OGDHL;CBS;ATP2B4;GGT1;GLUL;INSR;PFKFB2;DHTKD1;GALK1;LTA4H;PHGDH;MLXIPL;NAGS;PYCR2;PFKL;FGFR4;HK1;PPARA;PROX1;ASS1;MLYCD;MIF
4139,GO:0009209,0.324285107742902,0.897427996986397,2,13,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,NME4;UCKL1
11292,GO:0045632,0.324411294124447,0.953995357348349,1,4,negative regulation of mechanoreceptor differentiation,BP,HES1
20137,GO:2000981,0.324411294124447,0.953995357348349,1,4,negative regulation of inner ear receptor cell differentiation,BP,HES1
18348,GO:1903377,0.324421958849547,0.953992063984907,1,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,PINK1
9401,GO:0035985,0.324511529451673,0.953964398280364,1,4,senescence-associated heterochromatin focus,CC,HMGA2
952,GO:0002371,0.32453135773491,0.953958272583749,1,4,dendritic cell cytokine production,BP,JAK3
1138,GO:0002730,0.32453135773491,0.953958272583749,1,4,regulation of dendritic cell cytokine production,BP,JAK3
267,GO:0000738,0.324783740533709,0.953880260063423,1,4,DNA catabolic process, exonucleolytic,BP,ISG20
11331,GO:0045686,0.324852659404205,0.898028506700063,2,12,negative regulation of glial cell differentiation,BP,HES1;LDLR
3757,GO:0008310,0.324870086845777,0.953853552169096,1,4,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,ISG20
12497,GO:0050663,0.324870704041511,0.778856846854271,12,107,cytokine secretion,BP,POSTN;ALOX15B;F2R;MAPK3;MAPKBP1;TRPV4;HK1;GAS6;PRKCZ;C5;PYCARD;MIF
4716,GO:0010888,0.325019033843241,0.897939714982668,2,12,negative regulation of lipid storage,BP,ABCG1;PPARA
12710,GO:0050999,0.325134535691774,0.844090183412953,4,30,regulation of nitric-oxide synthase activity,BP,APOE;EGFR;ATP2B4;AKT1
8050,GO:0032731,0.325371170583069,0.865248099619497,3,21,positive regulation of interleukin-1 beta production,BP,EGR1;HK1;PYCARD
10473,GO:0043392,0.325693998266199,0.828120436849278,5,40,negative regulation of DNA binding,BP,CTNNBIP1;MDFI;ID1;HMGA2;PPARA
4918,GO:0014883,0.325907275297123,0.953532023897219,1,4,transition between fast and slow fiber,BP,TNNT1
15813,GO:0072553,0.326386330079273,0.953383071422623,1,4,terminal button organization,BP,NLGN2
4810,GO:0014014,0.326421637734403,0.864581644892012,3,21,negative regulation of gliogenesis,BP,IDH2;HES1;LDLR
15618,GO:0072148,0.326436102552777,0.897181956754361,2,12,epithelial cell fate commitment,BP,HES1;PROX1
11537,GO:0046101,0.326480895479827,0.953353634900852,1,4,hypoxanthine biosynthetic process,BP,ADA
6424,GO:0021700,0.326493374082651,0.764567965354769,16,145,developmental maturation,BP,ADGRL1;FAM210B;EPAS1;NFATC4;THBS3;DLG4;FAM20C;PLXNB1;VEGFA;HES1;FGFR3;PRKACA;DMC1;FGFR1;BFSP1;EREG
15457,GO:0071838,0.326500308351203,0.95334759066132,1,4,cell proliferation in bone marrow,BP,HMGA2
11010,GO:0044878,0.326514926429739,0.953343038985225,1,4,mitotic cytokinesis checkpoint,BP,ZFYVE19
14166,GO:0061101,0.326553032384492,0.953331172582817,1,4,neuroendocrine cell differentiation,BP,HES1
17587,GO:1901300,0.326666375790876,0.953295866280538,1,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,ENDOG
11611,GO:0046339,0.32668095863086,0.897050753257432,2,12,diacylglycerol metabolic process,BP,DGKA;DGKQ
19925,GO:2000508,0.32675304789589,0.953268857396371,1,4,regulation of dendritic cell chemotaxis,BP,GAS6
19926,GO:2000510,0.32675304789589,0.953268857396371,1,4,positive regulation of dendritic cell chemotaxis,BP,GAS6
15300,GO:0071545,0.326819372960117,0.896976550209879,2,12,inositol phosphate catabolic process,BP,NTSR1;IMPA2
1983,GO:0004707,0.327040580307446,0.896857909531543,2,12,MAP kinase activity,MF,MAPK13;MAPK3
19846,GO:2000354,0.327067012744022,0.953170941908357,1,4,regulation of ovarian follicle development,BP,ZP3
3665,GO:0008171,0.327116938644006,0.864139775394354,3,21,O-methyltransferase activity,MF,COMTD1;COMT;PCMTD2
6093,GO:0019322,0.327177867214525,0.953136341025955,1,4,pentose biosynthetic process,BP,TALDO1
1653,GO:0004111,0.32717974849004,0.953135753695013,1,4,creatine kinase activity,MF,CKMT1A
1093,GO:0002682,0.327207791664607,0.713424295554101,91,916,regulation of immune system process,BP,TNIP1;HTRA1;FOS;CTNNBIP1;PTPRS;GSN;PGF;ZFP36L1;NR1D1;FAM210B;RBCK1;IGF2;MMP28;SERPING1;PKN1;SHC1;CTSB;ASH2L;PIK3R2;ZP3;ZFPM1;ERBB2;RNF135;CD320;GGT1;ZMIZ1;IL20RB;TMEM173;PRNP;EFNB3;ECM1;NPDC1;STAT6;MYO18A;BCL6;FAM213A;IGFBP2;CD81;FCGRT;VEGFA;CEBPB;MAPK3;WIPF1;L3MBTL1;HES1;TNFRSF14;ADA;PAG1;AQP3;IL6R;ZFP36;PRKACA;CYFIP2;RPS6KA5;LDLR;SOX13;TRPV4;IFNGR2;RAG1;HK1;FAM3A;GAS6;BTRC;TKFC;PTAFR;VAV3;BCR;MUC19;PRKCZ;INPP5D;ICOSLG;MAPKAPK3;AGO4;C5;ADGRE2;VEGFB;ACVR1B;ADORA2B;ABR;AKT1;NLRX1;SPPL2B;CTSH;PYCARD;KCNN4;APOBEC3F;JAK3;RARG;EREG;MIF;STXBP2
11290,GO:0045630,0.327371496675553,0.953075867412982,1,4,positive regulation of T-helper 2 cell differentiation,BP,PRKCZ
4074,GO:0009137,0.32751839740695,0.95302995715965,1,4,purine nucleoside diphosphate catabolic process,BP,ENTPD2
4113,GO:0009181,0.32751839740695,0.95302995715965,1,4,purine ribonucleoside diphosphate catabolic process,BP,ENTPD2
7316,GO:0031338,0.327531229725303,0.815174492245798,6,48,regulation of vesicle fusion,BP,EVI5L;TBC1D14;VPS11;TBC1D8;TBC1D16;TBC1D17
10119,GO:0042698,0.327671362420384,0.826882898168181,5,39,ovulation cycle,BP,EGFR;EGR1;ZP3;SLIT3;EREG
19911,GO:2000479,0.327714808816574,0.896495897977647,2,12,regulation of cAMP-dependent protein kinase activity,BP,ATP2B4;SESN2
12711,GO:0051000,0.327833569032081,0.896432069846084,2,12,positive regulation of nitric-oxide synthase activity,BP,APOE;AKT1
1804,GO:0004457,0.327869770108233,0.952920036392456,1,4,lactate dehydrogenase activity,MF,D2HGDH
90,GO:0000179,0.327899245358303,0.952910808667135,1,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,RRNAD1
4833,GO:0014049,0.327945914843155,0.952896195806962,1,4,positive regulation of glutamate secretion,BP,NTSR1
1955,GO:0004663,0.328164566138052,0.952827697330662,1,4,Rab geranylgeranyltransferase activity,MF,RABGGTA
17906,GO:1902260,0.328186298272064,0.952820885928812,1,4,negative regulation of delayed rectifier potassium channel activity,BP,ANK3
10314,GO:0043125,0.328311108667444,0.952781755914452,1,4,ErbB-3 class receptor binding,MF,ERBB2
8281,GO:0033127,0.328389388639196,0.896133093351826,2,12,regulation of histone phosphorylation,BP,MAPK3;RPS6KA5
5542,GO:0016558,0.328580927799104,0.896029968919935,2,12,protein import into peroxisome matrix,BP,PEX10;PEX7
16160,GO:0090209,0.328642136934532,0.952677880346751,1,4,negative regulation of triglyceride metabolic process,BP,APOE
3506,GO:0007431,0.328710181377991,0.841613905431222,4,30,salivary gland development,BP,CST3;EGFR;LAMA5;FGFR1
8353,GO:0033262,0.328729117877487,0.895950150113573,2,12,regulation of nuclear cell cycle DNA replication,BP,BCL6;FGFR1
9752,GO:0039534,0.328766002335802,0.952638977049625,1,4,negative regulation of MDA-5 signaling pathway,BP,TKFC
8944,GO:0035025,0.328798138994054,0.895912963683488,2,12,positive regulation of Rho protein signal transduction,BP,F2R;RTN4R
17860,GO:1902166,0.328798925361581,0.894991030180296,2,13,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,ZNF385A;MIF
5495,GO:0016453,0.32883646577545,0.952616837643636,1,4,C-acetyltransferase activity,MF,GCAT
8504,GO:0033743,0.328889013568914,0.952600323292946,1,4,peptide-methionine (R)-S-oxide reductase activity,MF,MSRB2
7904,GO:0032489,0.328933257351903,0.95258641602598,1,4,regulation of Cdc42 protein signal transduction,BP,APOE
15133,GO:0071279,0.328949053487304,0.952581450199065,1,4,cellular response to cobalt ion,BP,BNIP3
19372,GO:1905908,0.329027891604861,0.952556661276856,1,4,positive regulation of amyloid fibril formation,BP,APOE
4759,GO:0010954,0.329228601810489,0.895680900766151,2,12,positive regulation of protein processing,BP,GSN;F12
8220,GO:0033003,0.329314053109151,0.862739588329512,3,21,regulation of mast cell activation,BP,ADGRE2;ADORA2B;STXBP2
1380,GO:0003281,0.329635105744592,0.813577746554157,6,48,ventricular septum development,BP,LTBP1;ZFPM1;VANGL2;HES1;SUFU;PROX1
2951,GO:0006490,0.329712540124023,0.862485003390813,3,21,oligosaccharide-lipid intermediate biosynthetic process,BP,MVD;SRD5A3;ALG12
14544,GO:0070100,0.329831072296855,0.952303681238276,1,4,negative regulation of chemokine-mediated signaling pathway,BP,SLIT3
4272,GO:0009648,0.329861303870301,0.862389911357783,3,21,photoperiodism,BP,CRTC1;MTA1;BHLHE40
19928,GO:2000515,0.329981199235849,0.895274582661811,2,12,negative regulation of CD4-positive, alpha-beta T cell activation,BP,BCL6;JAK3
145,GO:0000298,0.330113253366268,0.952214612638336,1,4,endopolyphosphatase activity,MF,NUDT10
3856,GO:0008486,0.330113253366268,0.952214612638336,1,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,NUDT10
5283,GO:0015961,0.330113253366268,0.952214612638336,1,4,diadenosine polyphosphate catabolic process,BP,NUDT10
8743,GO:0034431,0.330113253366268,0.952214612638336,1,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,NUDT10
8744,GO:0034432,0.330113253366268,0.952214612638336,1,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,NUDT10
13408,GO:0052840,0.330113253366268,0.952214612638336,1,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,NUDT10
13409,GO:0052841,0.330113253366268,0.952214612638336,1,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,NUDT10
13410,GO:0052842,0.330113253366268,0.952214612638336,1,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,NUDT10
13411,GO:0052843,0.330113253366268,0.952214612638336,1,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,NUDT10
13412,GO:0052844,0.330113253366268,0.952214612638336,1,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,NUDT10
13413,GO:0052845,0.330113253366268,0.952214612638336,1,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,NUDT10
13414,GO:0052846,0.330113253366268,0.952214612638336,1,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,NUDT10
13415,GO:0052847,0.330113253366268,0.952214612638336,1,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,NUDT10
13416,GO:0052848,0.330113253366268,0.952214612638336,1,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,NUDT10
15298,GO:0071543,0.330113253366268,0.952214612638336,1,4,diphosphoinositol polyphosphate metabolic process,BP,NUDT10
17779,GO:1901906,0.330113253366268,0.952214612638336,1,4,diadenosine pentaphosphate metabolic process,BP,NUDT10
17780,GO:1901907,0.330113253366268,0.952214612638336,1,4,diadenosine pentaphosphate catabolic process,BP,NUDT10
17781,GO:1901908,0.330113253366268,0.952214612638336,1,4,diadenosine hexaphosphate metabolic process,BP,NUDT10
17782,GO:1901909,0.330113253366268,0.952214612638336,1,4,diadenosine hexaphosphate catabolic process,BP,NUDT10
17783,GO:1901910,0.330113253366268,0.952214612638336,1,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,NUDT10
17784,GO:1901911,0.330113253366268,0.952214612638336,1,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,NUDT10
6126,GO:0019401,0.330139767210371,0.952206238656641,1,4,alditol biosynthetic process,BP,PCK2
3908,GO:0008585,0.330142646191331,0.795752314702115,8,68,female gonad development,BP,ZP3;INSR;VEGFA;CEBPB;SLIT3;VGF;DMC1;EREG
6872,GO:0030388,0.330251154420794,0.952171049253475,1,4,fructose 1,6-bisphosphate metabolic process,BP,PFKL
4042,GO:0009092,0.330315049898091,0.952150856491626,1,4,homoserine metabolic process,BP,CBS
6099,GO:0019346,0.330315049898091,0.952150856491626,1,4,transsulfuration,BP,CBS
14904,GO:0070814,0.330315049898091,0.952150856491625,1,4,hydrogen sulfide biosynthetic process,BP,CBS
2664,GO:0006023,0.330342562377028,0.78352423175759,10,86,aminoglycan biosynthetic process,BP,CEMIP;B3GAT3;HYAL1;B4GAT1;ST3GAL3;XYLT2;CHST6;GPC1;SDC1;NDST2
13866,GO:0060536,0.3305201588887,0.952086002162647,1,4,cartilage morphogenesis,BP,WNT7B
2336,GO:0005372,0.330525134099089,0.952084428381709,1,4,water transmembrane transporter activity,MF,AQP3
5044,GO:0015250,0.330525134099089,0.952084428381709,1,4,water channel activity,MF,AQP3
11046,GO:0045063,0.330547482879136,0.894968356212579,2,12,T-helper 1 cell differentiation,BP,STAT6;JAK3
14658,GO:0070301,0.33057451726749,0.795310946035689,8,69,cellular response to hydrogen peroxide,BP,CST3;MAPK13;STAT6;ANKZF1;BNIP3;ENDOG;TRAP1;PINK1
18315,GO:1903306,0.330643629844686,0.894916320900919,2,12,negative regulation of regulated secretory pathway,BP,BCR;ABR
7740,GO:0032268,0.330712756310205,0.699350506549276,186,1892,regulation of cellular protein metabolic process,BP,TNIP1;DUSP6;CEMIP;APOE;CST3;RAPGEF3;GSN;XDH;PRDX5;NOS1;ZFP36L1;GRB7;EPHB2;CNTN1;IGF2;MST1R;LRP1;EGFR;TIMP2;B3GAT3;FBXO2;DUSP5;PPP1R14A;SERPING1;MTHFR;EGR1;RHBDF1;PKN1;SHC1;F2R;PTK6;ABCA7;PPP2R3B;SHC2;GJC2;GRAMD4;PLAT;PIK3R2;CRTAP;LRP5;ERBB2;FBLN1;PKD2;EDEM1;SPRY4;CDKN1C;PAK6;SERPINE2;VPS11;UNK;MINK1;ATP2B4;CSNK1E;PDCD4;TNFRSF25;WNT7A;INSR;ID1;EPHA1;ADARB1;SYNGAP1;PPP1R35;LPAR3;PRNP;PAPLN;SNX33;SPRY2;HINT2;ECM1;SNX9;DLG4;MKNK2;STRADB;WWTR1;BCL6;CD81;FZD8;VEGFA;VANGL2;ACVR2B;NAB2;S1PR2;TNFRSF6B;MAPK3;DVL1;MTA1;ADCY6;EPHB3;HES1;SSH1;FURIN;MLXIPL;MEFV;PIDD1;IL6R;PCSK9;ZFP36;FGFR3;PRKACA;F12;LRRK1;MAGEF1;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;DMTN;TNFRSF1A;EHD4;MAPK8IP1;LDLR;TRPV4;EIF4EBP3;RAG1;DUSP7;EEF2K;DGKQ;SEMA4C;GAS6;BTRC;MEX3A;WNT7B;SUFU;PTAFR;RXRA;IGFBP4;PRKCZ;LSM14B;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;CAMKK1;PIN1;C5;PROX1;WBP2;DLG3;BIN1;SERPINB6;SH3D19;JARID2;SESN2;TOLLIP;CSTB;MAPRE3;MADD;RTN4R;ELFN2;TIMP1;PPM1F;SORL1;STK39;ACVR1B;ADORA2B;ERBB3;ZER1;AKT1;TRAP1;ZNF385A;NDRG2;ERCC6;GPD1L;PINK1;PKD1;SNTA1;RGS14;EIF4G3;CTSH;MLST8;CBLC;PYCARD;MAP2K3;POMT1;PCSK1N;ERN1;RANBP9;SIRT3;EIF4E3;EREG;FAM162A;RPL13A;MIF
4451,GO:0010453,0.330784489873834,0.894840064391593,2,12,regulation of cell fate commitment,BP,DUSP6;FGFR1
16090,GO:0090103,0.330918093796794,0.894767711665498,2,12,cochlea morphogenesis,BP,VANGL2;DVL1
7169,GO:0031063,0.331055945506476,0.861625292239245,3,21,regulation of histone deacetylation,BP,BCL6;VEGFA;PINK1
11279,GO:0045619,0.33118094801403,0.777867621001292,11,97,regulation of lymphocyte differentiation,BP,ZFP36L1;ERBB2;ZMIZ1;BCL6;ADA;SOX13;RAG1;GAS6;PRKCZ;INPP5D;JAK3
8786,GO:0034505,0.331483958611746,0.894461006081903,2,12,tooth mineralization,BP,FAM20C;PPARA
8629,GO:0034186,0.331572123395091,0.951752557913585,1,4,apolipoprotein A-I binding,MF,LCAT
5317,GO:0016053,0.331632524868883,0.736699880813289,30,286,organic acid biosynthetic process,BP,CEMIP;PGM1;NR1D1;ALOX15B;GAMT;ACOT7;UROS;HYAL1;OGDHL;CBS;ATP2B4;GGT1;GLUL;INSR;PFKFB2;DHTKD1;GALK1;LTA4H;PHGDH;MLXIPL;NAGS;PYCR2;PFKL;FGFR4;HK1;PPARA;PROX1;ASS1;MLYCD;MIF
898,GO:0002278,0.331650682640783,0.951727601718096,1,4,eosinophil activation involved in immune response,BP,VAMP2
990,GO:0002447,0.331650682640783,0.951727601718096,1,4,eosinophil mediated immunity,BP,VAMP2
10432,GO:0043307,0.331650682640783,0.951727601718096,1,4,eosinophil activation,BP,VAMP2
10433,GO:0043308,0.331650682640783,0.951727601718096,1,4,eosinophil degranulation,BP,VAMP2
17469,GO:1900452,0.331693607974189,0.951713962240245,1,4,regulation of long term synaptic depression,BP,SHANK3
18635,GO:1903978,0.331693607974317,0.951713962240246,1,4,regulation of microglial cell activation,BP,LDLR
10715,GO:0044090,0.33176846537704,0.894306638856913,2,12,positive regulation of vacuole organization,BP,ULK1;LRSAM1
9841,GO:0042108,0.331904719859802,0.839389325210309,4,30,positive regulation of cytokine biosynthetic process,BP,EGR1;ZFPM1;PTAFR;EREG
4479,GO:0010511,0.331907947915716,0.95164582175067,1,4,regulation of phosphatidylinositol biosynthetic process,BP,ZP3
19079,GO:1905037,0.331954794815312,0.782127145340953,10,87,autophagosome organization,BP,ULK1;ULK2;TBC1D14;PACS2;ATG16L2;WIPI2;LRSAM1;ATG2A;TP53INP1;PINK1
12183,GO:0048384,0.331962833375133,0.861043675922857,3,21,retinoic acid receptor signaling pathway,BP,RXRA;RXRB;RARG
1110,GO:0002699,0.332005483463925,0.777122072905162,11,98,positive regulation of immune effector process,BP,ZP3;STAT6;MYO18A;MAPK3;HK1;PTAFR;PRKCZ;ADGRE2;ADORA2B;MIF;STXBP2
8780,GO:0034497,0.332119438542649,0.894116059832435,2,12,protein localization to phagophore assembly site,BP,PACS2;WIPI2
12665,GO:0050908,0.332161179602833,0.95156524376985,1,4,detection of light stimulus involved in visual perception,BP,REEP6
12697,GO:0050962,0.332161179602833,0.95156524376985,1,4,detection of light stimulus involved in sensory perception,BP,REEP6
7105,GO:0030917,0.332277818919227,0.951528102516121,1,4,midbrain-hindbrain boundary development,BP,HES1
10584,GO:0043576,0.332302997542333,0.894016321614949,2,12,regulation of respiratory gaseous exchange,BP,NLGN2;NTSR1
15538,GO:0072014,0.332334804072657,0.951509950689654,1,4,proximal tubule development,BP,PKD1
10007,GO:0042462,0.332338263239477,0.893997154580659,2,12,eye photoreceptor cell development,BP,NAGLU;VEGFA
19942,GO:2000551,0.332395809614045,0.95149051375459,1,4,regulation of T-helper 2 cell cytokine production,BP,PRKCZ
15483,GO:0071887,0.332407093038729,0.793846331400739,8,69,leukocyte apoptotic process,BP,PKN1;BCL6;ADA;RAG1;GAS6;AKT1;JAK3;MIF
14005,GO:0060762,0.33242223079596,0.951482094284646,1,4,regulation of branching involved in mammary gland duct morphogenesis,BP,ETV5
16284,GO:0090482,0.332447880614499,0.893937566556931,2,12,vitamin transmembrane transporter activity,MF,SLC2A3;SLC2A1
3008,GO:0006561,0.332556206735255,0.951439387676125,1,4,proline biosynthetic process,BP,PYCR2
13511,GO:0055129,0.332556206735255,0.951439387676125,1,4,L-proline biosynthetic process,BP,PYCR2
12515,GO:0050687,0.332593312745775,0.860638733428789,3,21,negative regulation of defense response to virus,BP,HTRA1;TKFC;NLRX1
759,GO:0002002,0.332716970923279,0.951388112518827,1,4,regulation of angiotensin levels in blood,BP,CTSZ
760,GO:0002003,0.332716970923279,0.951388112518827,1,4,angiotensin maturation,BP,CTSZ
12368,GO:0048814,0.332757686594118,0.801554834719702,7,58,regulation of dendrite morphogenesis,BP,NFATC4;OBSL1;FBXW8;ID1;SHANK3;CUL7;EEF2K
16607,GO:0097494,0.332781130181762,0.951367640187181,1,4,regulation of vesicle size,BP,RAB3B
9642,GO:0038003,0.332818866667862,0.951355596606677,1,4,opioid receptor signaling pathway,BP,SIGMAR1
3440,GO:0007258,0.332851858835856,0.951345065722442,1,4,JUN phosphorylation,BP,MAPK8IP1
945,GO:0002360,0.332887398246799,0.893698483845956,2,12,T cell lineage commitment,BP,ZFPM1;STAT6
6492,GO:0021871,0.332889519088397,0.893697329555551,2,12,forebrain regionalization,BP,WNT7B;WNT2B
2630,GO:0005968,0.332913025375007,0.951325538183028,1,4,Rab-protein geranylgeranyltransferase complex,CC,RABGGTA
2183,GO:0005044,0.332993287438284,0.860381585426336,3,21,scavenger receptor activity,MF,LRP1;SCART1;SSC4D
17818,GO:1902023,0.333041687808423,0.951284447260055,1,4,L-arginine transport,BP,SLC25A29
13175,GO:0051823,0.333074159594424,0.951274073491771,1,4,regulation of synapse structural plasticity,BP,SHANK3
18936,GO:1904738,0.333109788264643,0.893577413085523,2,12,vascular associated smooth muscle cell migration,BP,DOCK4;SSH1
18946,GO:1904752,0.333109788264643,0.893577413085523,2,12,regulation of vascular associated smooth muscle cell migration,BP,DOCK4;SSH1
4891,GO:0014829,0.333151394008737,0.89355475528986,2,12,vascular smooth muscle contraction,BP,BBS2;DOCK4
12910,GO:0051293,0.33316801252793,0.838506420639987,4,30,establishment of spindle localization,BP,SPRY2;LLGL1;NDE1;SPIRE2
15187,GO:0071362,0.333193177983335,0.951236039449265,1,4,cellular response to ether,BP,NFATC4
4306,GO:0009794,0.33327285505679,0.951210567644005,1,4,regulation of mitotic cell cycle, embryonic,BP,HES1
11228,GO:0045448,0.33327285505679,0.951210567644005,1,4,mitotic cell cycle, embryonic,BP,HES1
545,GO:0001665,0.333294951855915,0.951203502163155,1,4,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,ST6GALNAC2
6211,GO:0019755,0.333314352751442,0.951197298200314,1,4,one-carbon compound transport,BP,AQP3
8265,GO:0033083,0.33341659846752,0.951164594618629,1,4,regulation of immature T cell proliferation,BP,ERBB2
9485,GO:0036150,0.333450934633665,0.893391562318303,2,12,phosphatidylserine acyl-chain remodeling,BP,LPCAT4;OSBPL5
15199,GO:0071380,0.333454762048922,0.893389476326884,2,12,cellular response to prostaglandin E stimulus,BP,ADCY6;AKT1
14969,GO:0070915,0.333505272988601,0.951136221287083,1,4,lysophosphatidic acid receptor activity,MF,LPAR3
4657,GO:0010815,0.333514936898094,0.951133128518674,1,4,bradykinin catabolic process,BP,CTSH
10722,GO:0044107,0.333517166552512,0.951132414939628,1,4,cellular alcohol metabolic process,BP,CYP27B1
10723,GO:0044108,0.333517166552512,0.951132414939628,1,4,cellular alcohol biosynthetic process,BP,CYP27B1
12715,GO:0051006,0.333590906894415,0.951108811575945,1,4,positive regulation of lipoprotein lipase activity,BP,LMF1
14257,GO:0061365,0.333590906894415,0.951108811575945,1,4,positive regulation of triglyceride lipase activity,BP,LMF1
9986,GO:0042420,0.33360465253078,0.951104411020658,1,4,dopamine catabolic process,BP,COMT
4129,GO:0009199,0.33364294347262,0.742230700532682,24,239,ribonucleoside triphosphate metabolic process,BP,PGM1;NME4;OGDHL;INSR;NDUFS8;FAM20C;UCKL1;PFKFB2;DHTKD1;GALK1;MLXIPL;NADK;PFKL;MYH3;HK1;PPARA;GUK1;SDHA;GTPBP1;UQCR11;PINK1;NDUFV3;MOCS1;TAZ
128,GO:0000268,0.33376481178297,0.95105311998033,1,4,peroxisome targeting sequence binding,MF,PEX7
13879,GO:0060558,0.333859903780468,0.951022651630877,1,4,regulation of calcidiol 1-monooxygenase activity,BP,CYP27B1
17488,GO:1900747,0.333876848927233,0.951017221067836,1,4,negative regulation of vascular endothelial growth factor signaling pathway,BP,XDH
18007,GO:1902548,0.333876848927233,0.951017221067836,1,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,XDH
3218,GO:0006878,0.333964552860572,0.892168798114628,2,13,cellular copper ion homeostasis,BP,PRNP;ATP7B
3992,GO:0008934,0.333987812867552,0.950981650619431,1,4,inositol monophosphate 1-phosphatase activity,MF,IMPA2
13402,GO:0052832,0.333987812867552,0.950981650619431,1,4,inositol monophosphate 3-phosphatase activity,MF,IMPA2
13403,GO:0052833,0.333987812867552,0.950981650619431,1,4,inositol monophosphate 4-phosphatase activity,MF,IMPA2
13404,GO:0052834,0.333987812867552,0.950981650619431,1,4,inositol monophosphate phosphatase activity,MF,IMPA2
3023,GO:0006577,0.334188604840002,0.89298916133467,2,12,amino-acid betaine metabolic process,BP,CRAT;CPT1C
4314,GO:0009820,0.334258905220753,0.950894685099314,1,4,alkaloid metabolic process,BP,CYP3A5
5590,GO:0016638,0.334343125615191,0.892904777887905,2,12,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,LOXL1;PNPO
1310,GO:0003160,0.334380595279249,0.95085561754762,1,4,endocardium morphogenesis,BP,PROX1
20145,GO:2001016,0.334420827428313,0.950842697299517,1,4,positive regulation of skeletal muscle cell differentiation,BP,GPC1
10290,GO:0043084,0.334433298534073,0.950838691889249,1,4,penile erection,BP,ADA
10266,GO:0043031,0.334516454523412,0.950811979286536,1,4,negative regulation of macrophage activation,BP,LDLR
13797,GO:0060421,0.33460916119526,0.859340719826053,3,21,positive regulation of heart growth,BP,FGFR1;PIN1;PROX1
17263,GO:0140058,0.334618708209281,0.892754203761957,2,12,neuron projection arborization,BP,DLG4;DVL1
5157,GO:0015712,0.334652741132175,0.950768180626744,1,4,hexose phosphate transport,BP,SLC37A2
5177,GO:0015760,0.334652741132175,0.950768180626744,1,4,glucose-6-phosphate transport,BP,SLC37A2
1387,GO:0003299,0.334659585693106,0.892731860295366,2,12,muscle hypertrophy in response to stress,BP,ATP2B4;CAMTA2
4920,GO:0014887,0.334659585693106,0.892731860295366,2,12,cardiac muscle adaptation,BP,ATP2B4;CAMTA2
4928,GO:0014898,0.334659585693106,0.892731860295366,2,12,cardiac muscle hypertrophy in response to stress,BP,ATP2B4;CAMTA2
12796,GO:0051127,0.334666916922758,0.89272785283909,2,12,positive regulation of actin nucleation,BP,GSN;WIPF1
4923,GO:0014891,0.33467827327895,0.950759972740438,1,4,striated muscle atrophy,BP,GSN
14119,GO:0061025,0.334909437396991,0.750141183938041,19,176,membrane fusion,BP,SYTL1;EVI5L;SYT8;TBC1D14;VAT1;DNM1;CD9;VPS11;VAMP2;TBC1D8;BNIP3;STX10;GAS6;VAV3;TMEM175;TBC1D16;TBC1D17;TSNARE1;VPS33B
19108,GO:1905098,0.334949606019191,0.950672696440251,1,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,GPSM1
3198,GO:0006842,0.335210810190535,0.950588591264179,1,4,tricarboxylic acid transport,BP,SLC13A3
4987,GO:0015137,0.335210810190535,0.950588591264179,1,4,citrate transmembrane transporter activity,MF,SLC13A3
4990,GO:0015142,0.335210810190535,0.950588591264179,1,4,tricarboxylic acid transmembrane transporter activity,MF,SLC13A3
5173,GO:0015746,0.335210810190535,0.950588591264179,1,4,citrate transport,BP,SLC13A3
4785,GO:0010986,0.33521451397817,0.950587398068353,1,4,positive regulation of lipoprotein particle clearance,BP,LDLR
12236,GO:0048539,0.335233686344529,0.950581221310276,1,4,bone marrow development,BP,LRP5
9426,GO:0036021,0.335269514501267,0.95056967732852,1,4,endolysosome lumen,CC,CTSB
10683,GO:0043987,0.335341477205311,0.950546485800704,1,4,histone H3-S10 phosphorylation,BP,RPS6KA5
14298,GO:0061502,0.33545895227134,0.950508613037152,1,4,early endosome to recycling endosome transport,BP,SORL1
9080,GO:0035360,0.335551534925038,0.950478753185209,1,4,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B
9571,GO:0036438,0.335699343607803,0.950431059577317,1,4,maintenance of lens transparency,BP,STK39
19048,GO:1904956,0.33582189263508,0.950391495827386,1,4,regulation of midbrain dopaminergic neuron differentiation,BP,CSNK1E
14510,GO:0070044,0.335830620447915,0.950388677422555,1,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,VAMP2
3464,GO:0007296,0.33591107540665,0.950362692241904,1,4,vitellogenesis,BP,ZMIZ1
17248,GO:0140007,0.335925620402908,0.950357993664497,1,4,KICSTOR complex,CC,C12ORF66
6607,GO:0022840,0.336191615851236,0.950272020528581,1,4,leak channel activity,MF,TMEM175
6609,GO:0022842,0.336191615851236,0.950272020528581,1,4,narrow pore channel activity,MF,TMEM175
727,GO:0001957,0.336295246190945,0.95023850191685,1,4,intramembranous ossification,BP,MN1
9448,GO:0036072,0.336295246190945,0.95023850191685,1,4,direct ossification,BP,MN1
5899,GO:0018146,0.336297211489764,0.858249930901696,3,21,keratan sulfate biosynthetic process,BP,B4GAT1;ST3GAL3;CHST6
8996,GO:0035184,0.336338500286686,0.950224507664185,1,4,histone threonine kinase activity,MF,PKN1
9098,GO:0035405,0.336338500286686,0.950224507664185,1,4,histone-threonine phosphorylation,BP,PKN1
14129,GO:0061038,0.336373062608222,0.950213323829596,1,4,uterus morphogenesis,BP,WNT7A
9454,GO:0036091,0.336415310915181,0.950199650898,1,4,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,SESN2
4305,GO:0009792,0.336500858948904,0.72101843669938,44,423,embryo development ending in birth or egg hatching,BP,ZFP36L1;TCTN1;EPAS1;IGF2;EGFR;MDFI;DEAF1;ZP3;HYAL1;TFEB;PKD2;PHLDA2;SALL2;IFT140;FUZ;PLCD1;ZMIZ1;FBXW8;CELSR1;PLCD3;TMEM107;VEGFA;VANGL2;CEBPB;ENDOG;DVL1;HES1;ADA;SEMA4C;WNT7B;SUFU;RXRA;WDR60;FGFR1;C5;PROX1;CAPN2;TMEM231;ACVR1B;AKT1;PKD1;APBA1;RARG;SULF2
14136,GO:0061046,0.336514206971309,0.950167636169367,1,4,regulation of branching involved in lung morphogenesis,BP,WNT2B
4383,GO:0010046,0.336589046665759,0.950143400851465,1,4,response to mycotoxin,BP,EGR1
16266,GO:0090394,0.336627727856928,0.950130871983087,1,4,negative regulation of excitatory postsynaptic potential,BP,S1PR2
12878,GO:0051250,0.336636338976544,0.783886867838591,9,78,negative regulation of lymphocyte activation,BP,PKN1;ERBB2;IL20RB;PRNP;BCL6;CEBPB;PAG1;INPP5D;JAK3
1286,GO:0003097,0.336730988356964,0.95009741664901,1,4,renal water transport,BP,AQP3
18720,GO:1904220,0.3367338379693,0.950096493214726,1,4,regulation of serine C-palmitoyltransferase activity,BP,SERINC2
8833,GO:0034644,0.336834014471006,0.790296094910134,8,69,cellular response to UV,BP,ERCC1;NFATC4;MAPK13;DDB2;HYAL1;XPC;TMEM161A;TP53INP1
14277,GO:0061438,0.336914230783426,0.950038015122347,1,4,renal system vasculature morphogenesis,BP,PKD2
14278,GO:0061439,0.336914230783426,0.950038015122347,1,4,kidney vasculature morphogenesis,BP,PKD2
14665,GO:0070309,0.336965152660625,0.950021500356309,1,4,lens fiber cell morphogenesis,BP,PROX1
3651,GO:0008142,0.336990755171713,0.950013195831699,1,4,oxysterol binding,MF,OSBPL5
2105,GO:0004887,0.337005439322987,0.950008432455893,1,4,thyroid hormone receptor activity,MF,THRA
15694,GO:0072284,0.337007740429846,0.950007685977926,1,4,metanephric S-shaped body morphogenesis,BP,PKD2
12727,GO:0051021,0.337070861441235,0.949987206962707,1,4,GDP-dissociation inhibitor binding,MF,PLXNB3
12728,GO:0051022,0.337070861441235,0.949987206962707,1,4,Rho GDP-dissociation inhibitor binding,MF,PLXNB3
8678,GO:0034316,0.337076034853316,0.949985528276697,1,4,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,CORO1B
18280,GO:1903224,0.337147173554424,0.949962441552161,1,4,regulation of endodermal cell differentiation,BP,DUSP6
12211,GO:0048495,0.337222562858356,0.949937968452058,1,4,Roundabout binding,MF,SLIT3
15432,GO:0071797,0.337289953435495,0.949916085891796,1,4,LUBAC complex,CC,RBCK1
1355,GO:0003228,0.337296871781967,0.94991383909624,1,4,atrial cardiac muscle tissue development,BP,PROX1
13446,GO:0055009,0.337296871781967,0.94991383909624,1,4,atrial cardiac muscle tissue morphogenesis,BP,PROX1
4999,GO:0015166,0.337318012717691,0.949906973014337,1,4,polyol transmembrane transporter activity,MF,AQP3
15601,GO:0072126,0.337327090995705,0.949904024429872,1,4,positive regulation of glomerular mesangial cell proliferation,BP,EGR1
8752,GO:0034446,0.337389045034013,0.78994826649323,8,68,substrate adhesion-dependent cell spreading,BP,PARVB;POSTN;LAMA5;FBLN1;MICALL2;EPHA1;EPHB3;DMTN
16232,GO:0090315,0.337419816105539,0.949873901806835,1,4,negative regulation of protein targeting to membrane,BP,DMTN
13790,GO:0060412,0.337468487637323,0.835487318913531,4,30,ventricular septum morphogenesis,BP,ZFPM1;VANGL2;HES1;PROX1
18198,GO:1903026,0.337515326354901,0.946857889339716,1,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,ID1
18157,GO:1902953,0.337630154707695,0.949805531364613,1,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,SORL1
18021,GO:1902576,0.337670014675995,0.949792568649996,1,4,negative regulation of nuclear cell cycle DNA replication,BP,BCL6
14735,GO:0070444,0.337682617166118,0.949788469825625,1,4,oligodendrocyte progenitor proliferation,BP,GJC2
14736,GO:0070445,0.337682617166118,0.949788469825625,1,4,regulation of oligodendrocyte progenitor proliferation,BP,GJC2
15895,GO:0072708,0.337843923684473,0.94973598901472,1,4,response to sorbitol,BP,MAPK13
3865,GO:0008504,0.337923461111869,0.94971009962376,1,4,monoamine transmembrane transporter activity,MF,SLC29A4
11771,GO:0046660,0.337934975759886,0.782825724718533,9,78,female sex differentiation,BP,ZP3;INSR;VEGFA;CEBPB;SLIT3;VGF;DMC1;ACVR1B;EREG
10367,GO:0043208,0.337982064032759,0.94969101932311,1,4,glycosphingolipid binding,MF,RTN4R
9651,GO:0038027,0.338014115918817,0.949680581848451,1,4,apolipoprotein A-I-mediated signaling pathway,BP,ABCA7
14775,GO:0070527,0.338081363415825,0.819002740814936,5,40,platelet aggregation,BP,CD9;SERPINE2;DMTN;GAS6;VPS33B
4777,GO:0010976,0.338106020529074,0.745320969429564,20,185,positive regulation of neuron projection development,BP,APOE;SHANK2;CNTN1;OBSL1;CRTC1;PTK6;ZMYND8;PLXNB3;FBXW8;LPAR3;DLG4;PLXNB1;VEGFA;SHANK3;DVL1;CUL7;EEF2K;TWF2;FGFR1;WNT3
8632,GO:0034190,0.338115327115268,0.949647614657144,1,4,apolipoprotein receptor binding,MF,PCSK9
10499,GO:0043426,0.338156970988486,0.949634046399988,1,4,MRF binding,MF,BHLHE40
17423,GO:1900226,0.338187042608169,0.949624247218878,1,4,negative regulation of NLRP3 inflammasome complex assembly,BP,MEFV
13662,GO:0060232,0.338211624005356,0.949616236246066,1,4,delamination,BP,TRPV4
4912,GO:0014866,0.338263610568581,0.949599291546566,1,4,skeletal myofibril assembly,BP,PROX1
1713,GO:0004308,0.338275313159892,0.94959547669102,1,4,exo-alpha-sialidase activity,MF,GLB1
5765,GO:0016997,0.338275313159892,0.94959547669102,1,4,alpha-sialidase activity,MF,GLB1
17852,GO:1902117,0.338341641583289,0.797163874459611,7,58,positive regulation of organelle assembly,BP,ULK1;FUZ;LRSAM1;CROCC;PROX1;WRAP73;SDC1
1304,GO:0003150,0.338371374137322,0.94956415586472,1,4,muscular septum morphogenesis,BP,VANGL2
1916,GO:0004614,0.33838366538963,0.949560147446934,1,4,phosphoglucomutase activity,MF,PGM1
10466,GO:0043379,0.338412579280157,0.949550717313315,1,4,memory T cell differentiation,BP,BCL6
16348,GO:0090713,0.338412579280157,0.949550717313315,1,4,immunological memory process,BP,BCL6
16349,GO:0090715,0.338412579280157,0.949550717313315,1,4,immunological memory formation process,BP,BCL6
11104,GO:0045159,0.338504637101996,0.949520686078484,1,4,myosin II binding,MF,GSN
3437,GO:0007254,0.338578973771638,0.75148609608887,17,156,JNK cascade,BP,EGFR;PKN1;MINK1;PDCD4;WNT7A;FZD8;VANGL2;CDC42EP5;MAPK8IP1;TRPV4;WNT7B;ADORA2B;AKT1;ERCC6;PINK1;PYCARD;ERN1
1124,GO:0002713,0.33862500990288,0.94948140182463,1,4,negative regulation of B cell mediated immunity,BP,BCL6
1219,GO:0002890,0.33862500990288,0.94948140182463,1,4,negative regulation of immunoglobulin mediated immune response,BP,BCL6
5163,GO:0015727,0.338656546761346,0.949471106605749,1,4,lactate transport,BP,SLC16A3
9344,GO:0035873,0.338656546761346,0.949471106605749,1,4,lactate transmembrane transport,BP,SLC16A3
16187,GO:0090257,0.338667381679612,0.763341762577894,13,118,regulation of muscle system process,BP,NOS1;F2R;DOCK4;ATP2B4;TNNT1;ADA;PRKACA;PTAFR;PIN1;JARID2;ADORA2B;EHD3;GSTM2
19913,GO:2000481,0.33867099330623,0.94946639010851,1,4,positive regulation of cAMP-dependent protein kinase activity,BP,ATP2B4
12490,GO:0050656,0.338741146854295,0.949443482699897,1,4,3'-phosphoadenosine 5'-phosphosulfate binding,MF,GAL3ST4
11094,GO:0045134,0.33876333508611,0.949436236234824,1,4,uridine-diphosphatase activity,MF,ENTPD6
2650,GO:0006001,0.33879831708829,0.949424810189103,1,4,fructose catabolic process,BP,TKFC
14356,GO:0061624,0.33879831708829,0.949424810189103,1,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,TKFC
10981,GO:0044803,0.338836762773823,0.949412251038396,1,4,multi-organism membrane organization,BP,GAS6
4653,GO:0010811,0.33889975078132,0.782036471872412,9,78,positive regulation of cell-substrate adhesion,BP,SMOC2;EPHA1;ITGA6;VEGFA;ARL2;DMTN;PRKCZ;PPM1F;NINJ1
4887,GO:0014824,0.338913287759335,0.949387246893661,1,4,artery smooth muscle contraction,BP,BBS2
13701,GO:0060297,0.338939092698836,0.949378813602431,1,4,regulation of sarcomere organization,BP,PROX1
12118,GO:0048243,0.33897729930529,0.949366325794566,1,4,norepinephrine secretion,BP,NISCH
14772,GO:0070522,0.33900479959799,0.94935733620302,1,4,ERCC4-ERCC1 complex,CC,ERCC1
18838,GO:1904505,0.339004799598123,0.949357336203018,1,4,regulation of telomere maintenance in response to DNA damage,BP,ERCC1
18839,GO:1904506,0.339004799598123,0.949357336203018,1,4,negative regulation of telomere maintenance in response to DNA damage,BP,ERCC1
1767,GO:0004376,0.339010869785638,0.949355351786662,1,4,glycolipid mannosyltransferase activity,MF,PIGV
15849,GO:0072603,0.339035559075296,0.9493472800873,1,4,interleukin-5 secretion,BP,PRKCZ
20010,GO:2000662,0.339035559075296,0.9493472800873,1,4,regulation of interleukin-5 secretion,BP,PRKCZ
9717,GO:0038189,0.339105775572003,0.949324319931905,1,4,neuropilin signaling pathway,BP,VEGFA
18434,GO:1903553,0.339173654736883,0.949302118166593,1,4,positive regulation of extracellular exosome assembly,BP,SDC1
9290,GO:0035754,0.339184396268496,0.949298604319323,1,4,B cell chemotaxis,BP,GAS6
4936,GO:0014911,0.339214869342836,0.856356319889152,3,21,positive regulation of smooth muscle cell migration,BP,POSTN;DOCK4;SSH1
13575,GO:0060073,0.339245899948047,0.949278481996349,1,4,micturition,BP,KCNMA1
10308,GO:0043117,0.339260021744532,0.949273861058641,1,4,positive regulation of vascular permeability,BP,TRPV4
1437,GO:0003418,0.339302704142821,0.949259892988224,1,4,growth plate cartilage chondrocyte differentiation,BP,RARG
1441,GO:0003431,0.339302704142821,0.949259892988224,1,4,growth plate cartilage chondrocyte development,BP,RARG
11597,GO:0046322,0.339361193128236,0.949240748394168,1,4,negative regulation of fatty acid oxidation,BP,AKT1
10580,GO:0043568,0.339375702584197,0.94923599849762,1,4,positive regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP4
150,GO:0000306,0.33939313172293,0.949230292447103,1,4,extrinsic component of vacuolar membrane,CC,ULK1
18525,GO:1903763,0.339406392341477,0.9492259508544,1,4,gap junction channel activity involved in cell communication by electrical coupling,MF,GJC2
8779,GO:0034485,0.339416835743721,0.949222531476458,1,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,INPP5D
8940,GO:0035021,0.339449776324158,0.949211745174949,1,4,negative regulation of Rac protein signal transduction,BP,ARAP3
3469,GO:0007320,0.339465680776835,0.949206536817237,1,4,insemination,BP,SERPINE2
3077,GO:0006658,0.339482125859075,0.856182341589263,3,21,phosphatidylserine metabolic process,BP,LPCAT4;SERINC2;OSBPL5
8390,GO:0033353,0.339535422325237,0.949183694237288,1,4,S-adenosylmethionine cycle,BP,AHCYL2
12790,GO:0051121,0.339584600621071,0.949167583096453,1,4,hepoxilin metabolic process,BP,ALOX15B
12791,GO:0051122,0.339584600621071,0.949167583096453,1,4,hepoxilin biosynthetic process,BP,ALOX15B
5361,GO:0016176,0.339620735011149,0.949155743286329,1,4,superoxide-generating NADPH oxidase activator activity,MF,SH3PXD2B
8971,GO:0035095,0.339622753241751,0.949155081943591,1,4,behavioral response to nicotine,BP,PPARA
5681,GO:0016811,0.339655368144598,0.788024479527636,8,69,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,HDAC5;MTA3;MTA1;PHF21A;ACY1;HDAC11;SIRT3;NDST2
1695,GO:0004176,0.339662149793092,0.949142171278543,1,4,ATP-dependent peptidase activity,MF,LONP2
14554,GO:0070122,0.339672640557488,0.94913873301493,1,4,isopeptidase activity,MF,GGT1
5210,GO:0015822,0.339675018597932,0.949137953612063,1,4,ornithine transport,BP,SLC25A29
18336,GO:1903352,0.339675018597932,0.949137953612063,1,4,L-ornithine transmembrane transport,BP,SLC25A29
18439,GO:1903564,0.339678164477036,0.949136922539122,1,4,regulation of protein localization to cilium,BP,CROCC
13851,GO:0060509,0.339749796710916,0.949113441448521,1,4,Type I pneumocyte differentiation,BP,THRA
1880,GO:0004565,0.33975981487215,0.949110156974022,1,4,beta-galactosidase activity,MF,GLB1
7500,GO:0031697,0.339780063775129,0.949103517943997,1,4,beta-1 adrenergic receptor binding,MF,DLG4
8039,GO:0032713,0.339806242086404,0.949094934066769,1,4,negative regulation of interleukin-4 production,BP,ZFPM1
14912,GO:0070827,0.339815549252186,0.949091882036041,1,4,chromatin maintenance,BP,MTHFR
6397,GO:0021636,0.339816405274855,0.949091601321299,1,4,trigeminal nerve morphogenesis,BP,SEMA3F
6398,GO:0021637,0.339816405274855,0.949091601321299,1,4,trigeminal nerve structural organization,BP,SEMA3F
6367,GO:0021562,0.339816405274856,0.949091601321299,1,4,vestibulocochlear nerve development,BP,SLITRK6
9957,GO:0042363,0.339821432434199,0.949089952750903,1,4,fat-soluble vitamin catabolic process,BP,CYP27B1
16385,GO:0097048,0.339833946386299,0.949085848877282,1,4,dendritic cell apoptotic process,BP,GAS6
20016,GO:2000668,0.339833946386299,0.949085848877282,1,4,regulation of dendritic cell apoptotic process,BP,GAS6
1289,GO:0003104,0.339833946386425,0.949085848877289,1,4,positive regulation of glomerular filtration,BP,GAS6
14338,GO:0061588,0.339842853011275,0.949082927884341,1,4,calcium activated phospholipid scrambling,BP,ANO9
14339,GO:0061589,0.339842853011275,0.949082927884341,1,4,calcium activated phosphatidylserine scrambling,BP,ANO9
14340,GO:0061590,0.339842853011275,0.949082927884341,1,4,calcium activated phosphatidylcholine scrambling,BP,ANO9
14341,GO:0061591,0.339842853011275,0.949082927884341,1,4,calcium activated galactosylceramide scrambling,BP,ANO9
16742,GO:0098574,0.339860205115021,0.949077236847779,1,4,cytoplasmic side of lysosomal membrane,CC,LITAF
15110,GO:0071230,0.339862070007401,0.805591031148727,6,49,cellular response to amino acid stimulus,BP,COL6A1;EGFR;DNMT3A;CEBPB;CAPN2;SESN2
10988,GO:0044821,0.339898569215606,0.949064653078606,1,4,meiotic telomere tethering at nuclear periphery,BP,SUN1
14601,GO:0070197,0.339898569215606,0.949064653078606,1,4,meiotic attachment of telomere to nuclear envelope,BP,SUN1
16498,GO:0097240,0.339898569215606,0.949064653078606,1,4,chromosome attachment to the nuclear envelope,BP,SUN1
17340,GO:1900084,0.339902094664982,0.949063496606591,1,4,regulation of peptidyl-tyrosine autophosphorylation,BP,VEGFA
12959,GO:0051388,0.339907207897396,0.949061819257663,1,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,CYFIP2
8334,GO:0033206,0.339907349567092,0.949061772783784,1,4,meiotic cytokinesis,BP,SPIRE2
6891,GO:0030478,0.339908303239699,0.949061459936479,1,4,actin cap,CC,GSN
5845,GO:0017153,0.339909080877153,0.949061204835656,1,4,sodium:dicarboxylate symporter activity,MF,SLC13A3
8611,GO:0034144,0.339909290420012,0.949061136095817,1,4,negative regulation of toll-like receptor 4 signaling pathway,BP,NR1D1
6075,GO:0019240,0.33990950597015,0.949061065385324,1,4,citrulline biosynthetic process,BP,ATP2B4
9924,GO:0042297,0.339909505970151,0.949061065385323,1,4,vocal learning,BP,SHANK3
16754,GO:0098596,0.339909505970151,0.949061065385323,1,4,imitative learning,BP,SHANK3
16756,GO:0098598,0.339909505970151,0.949061065385323,1,4,learned vocalization behavior or vocal learning,BP,SHANK3
12360,GO:0048788,0.339909505970151,0.949061065385323,1,4,cytoskeleton of presynaptic active zone,CC,RIMS3
17044,GO:0099569,0.339909505970151,0.949061065385323,1,4,presynaptic cytoskeleton,CC,RIMS3
18907,GO:1904684,0.339909505970151,0.949061065385323,1,4,negative regulation of metalloendopeptidase activity,BP,SORL1
14292,GO:0061476,0.339909505970151,0.949061065385323,1,4,response to anticoagulant,BP,EGR1
15284,GO:0071503,0.339909505970151,0.949061065385323,1,4,response to heparin,BP,EGR1
15285,GO:0071504,0.339909505970151,0.949061065385323,1,4,cellular response to heparin,BP,EGR1
19455,GO:1990246,0.339909505970268,0.949061065385337,1,4,uniplex complex,CC,SMDT1
18812,GO:1904431,0.339909505970269,0.949061065385336,1,4,positive regulation of t-circle formation,BP,ERCC1
10178,GO:0042799,0.339909505970271,0.949061065385335,1,4,histone methyltransferase activity (H4-K20 specific),MF,KMT5C
18100,GO:1902816,0.339909505970271,0.949061065385335,1,4,regulation of protein localization to microtubule,BP,ABHD17C
18101,GO:1902817,0.339909505970271,0.949061065385335,1,4,negative regulation of protein localization to microtubule,BP,ABHD17C
9652,GO:0038028,0.339909505970276,0.949061065385329,1,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,IGF2
757,GO:0001999,0.339909505970277,0.949061065385328,1,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,F2R
758,GO:0002001,0.339909505970277,0.949061065385328,1,4,renin secretion into blood stream,BP,F2R
13759,GO:0060373,0.339909505970278,0.949061065385327,1,4,regulation of ventricular cardiac muscle cell membrane depolarization,BP,GPD1L
5364,GO:0016185,0.339909505970279,0.949061065385327,1,4,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,DNM1
16870,GO:0098844,0.339909505970279,0.949061065385327,1,4,postsynaptic endocytic zone membrane,CC,DNM1
16888,GO:0098884,0.339909505970279,0.949061065385327,1,4,postsynaptic neurotransmitter receptor internalization,BP,DNM1
13718,GO:0060318,0.339909505970279,0.949061065385327,1,4,definitive erythrocyte differentiation,BP,ZFPM1
1434,GO:0003415,0.339909505970279,0.949061065385326,1,4,chondrocyte hypertrophy,BP,RARG
1730,GO:0004331,0.33990950597028,0.949061065385326,1,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,PFKFB2
2652,GO:0006003,0.33990950597028,0.949061065385326,1,4,fructose 2,6-bisphosphate metabolic process,BP,PFKFB2
4616,GO:0010746,0.339909505970281,0.949061065385325,1,4,regulation of plasma membrane long-chain fatty acid transport,BP,AKT1
4617,GO:0010748,0.339909505970281,0.949061065385325,1,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,AKT1
15990,GO:0086036,0.339909505970281,0.949061065385325,1,4,regulation of cardiac muscle cell membrane potential,BP,EHD3
847,GO:0002175,0.339909505970281,0.949061065385325,1,4,protein localization to paranode region of axon,BP,EPB41L3
15744,GO:0072367,0.339909505970413,0.949061065385324,1,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,PPARA
7898,GO:0032483,0.339909505970414,0.949061065385324,1,4,regulation of Rab protein signal transduction,BP,MADD
13492,GO:0055091,0.339909505970414,0.949061065385324,1,4,phospholipid homeostasis,BP,ABCG1
2739,GO:0006145,0.339909505970415,0.949061065385323,1,4,purine nucleobase catabolic process,BP,XDH
14077,GO:0060947,0.339909505970543,0.949061065385325,1,4,cardiac vascular smooth muscle cell differentiation,BP,VEGFA
10607,GO:0043622,0.339909505970544,0.949061065385325,1,4,cortical microtubule organization,BP,TRPV4
3376,GO:0007161,0.339909505970545,0.949061065385324,1,4,calcium-independent cell-matrix adhesion,BP,PKD1
9105,GO:0035426,0.339909505970545,0.949061065385324,1,4,extracellular matrix-cell signaling,BP,LRP5
5371,GO:0016199,0.339909505970545,0.949061065385324,1,4,axon midline choice point recognition,BP,ROBO3
786,GO:0002051,0.339909505970545,0.949061065385324,1,4,osteoblast fate commitment,BP,SH3PXD2B
5153,GO:0015705,0.339909505970545,0.949061065385323,1,4,iodide transport,BP,SLC5A5
9692,GO:0038114,0.339909505970545,0.949061065385323,1,4,interleukin-21-mediated signaling pathway,BP,JAK3
16818,GO:0098756,0.339909505970545,0.949061065385323,1,4,response to interleukin-21,BP,JAK3
16819,GO:0098757,0.339909505970545,0.949061065385323,1,4,cellular response to interleukin-21,BP,JAK3
16316,GO:0090599,0.339909505970545,0.949061065385323,1,4,alpha-glucosidase activity,MF,GAA
20054,GO:2000739,0.339909505970545,0.949061065385323,1,4,regulation of mesenchymal stem cell differentiation,BP,LTBP3
1427,GO:0003402,0.339909505970545,0.949061065385323,1,4,planar cell polarity pathway involved in axis elongation,BP,VANGL2
6331,GO:0021514,0.339909505970545,0.949061065385323,1,4,ventral spinal cord interneuron differentiation,BP,SUFU
9629,GO:0036515,0.339909505970545,0.949061065385323,1,4,serotonergic neuron axon guidance,BP,VANGL2
11762,GO:0046643,0.339909505970545,0.949061065385323,1,4,regulation of gamma-delta T cell activation,BP,SOX13
14226,GO:0061304,0.339909505970545,0.949061065385323,1,4,retinal blood vessel morphogenesis,BP,LRP5
249,GO:0000710,0.339909505970545,0.949061065385324,1,4,meiotic mismatch repair,BP,ERCC1
3396,GO:0007185,0.339909505970546,0.949061065385323,1,4,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,PTPRU
7152,GO:0031034,0.339909505970546,0.949061065385323,1,4,myosin filament assembly,BP,OBSL1
7438,GO:0031585,0.339909505970546,0.949061065385323,1,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,PKD2
15091,GO:0071205,0.339909505970546,0.949061065385323,1,4,protein localization to juxtaparanode region of axon,BP,EPB41L3
7104,GO:0030916,0.339909505970546,0.949061065385323,1,4,otic vesicle formation,BP,PROX1
15335,GO:0071600,0.339909505970546,0.949061065385323,1,4,otic vesicle morphogenesis,BP,PROX1
1322,GO:0003175,0.339909505970546,0.949061065385322,1,4,tricuspid valve development,BP,ZFPM1
1330,GO:0003186,0.339909505970546,0.949061065385322,1,4,tricuspid valve morphogenesis,BP,ZFPM1
13094,GO:0051660,0.339909505970546,0.949061065385323,1,4,establishment of centrosome localization,BP,FHOD1
12193,GO:0048406,0.339909505970547,0.949061065385322,1,4,nerve growth factor binding,MF,FURIN
16409,GO:0097091,0.339909505970547,0.949061065385322,1,4,synaptic vesicle clustering,BP,NLGN2
2289,GO:0005253,0.340946107726974,0.816871219823255,5,40,anion channel activity,MF,CLCA2;ANO8;TTYH3;LRRC8A;ANO9
2599,GO:0005903,0.341017705042831,0.794924542688338,7,59,brush border,CC,ESPN;SHANK2;RALGDS;ITPR3;SCART1;AMN;CYBRD1
4176,GO:0009262,0.341281799354063,0.832203380931246,4,32,deoxyribonucleotide metabolic process,BP,ADA;DGUOK;GUK1;NEIL1
17726,GO:1901701,0.341694065606021,0.704665792686121,71,704,cellular response to oxygen-containing compound,BP,TNIP1;FOS;CST3;RAPGEF3;CYP27B1;PRDX5;ZFP36L1;COL6A1;NR1D1;FAM210B;IGF2;NFATC4;LRP1;MAPK13;EGFR;EGR1;SHC1;PTK6;PIK3R2;HDAC5;LRP5;PKD2;PTPRE;VAMP2;ATP2B4;PDCD4;INSR;ID1;DNMT3A;PRNP;STAT6;ANKZF1;BNIP3;CEBPB;ENDOG;MAPK3;ADCY6;SSH1;MLXIPL;PCSK9;ZFP36;PRKACA;DMTN;LDLR;EEF2K;GAS6;WNT7B;PTAFR;PCK2;BCR;PRKCZ;ADAMTS13;TWF2;PDK2;SRSF5;VSNL1;GRB10;CAPN2;SESN2;WNT3;AKT1;TRAP1;TP53INP1;SLC5A5;PINK1;PYCARD;ERN1;JAK3;LITAF;RARG;MIF
3792,GO:0008379,0.341737852900428,0.945397432696838,1,5,thioredoxin peroxidase activity,MF,PRDX5
12114,GO:0048232,0.342121016826306,0.72716416958163,30,288,male gamete generation,BP,ERCC1;TCFL5;GAMT;BBS2;DNAH1;CRTAP;SCMH1;ATP2B4;GGT1;TXNRD3;DNMT3A;MYCBPAP;PHC2;BCL6;ZSCAN2;ETV5;PRKACA;SPATA20;DMC1;AGO4;ZFP41;MICALCL;SBF1;SIX5;TDRKH;SUN1;RPL39L;RFX2;SHISA6;FAM50A
3457,GO:0007283,0.342207032619548,0.728197925127761,29,278,spermatogenesis,BP,ERCC1;TCFL5;GAMT;BBS2;DNAH1;CRTAP;SCMH1;ATP2B4;GGT1;TXNRD3;DNMT3A;MYCBPAP;PHC2;BCL6;ZSCAN2;ETV5;PRKACA;SPATA20;DMC1;ZFP41;MICALCL;SBF1;SIX5;TDRKH;SUN1;RPL39L;RFX2;SHISA6;FAM50A
3423,GO:0007219,0.342823882807534,0.75634911016622,14,127,Notch signaling pathway,BP,POSTN;ARRDC1;CNTN1;EGFR;MAML3;DTX3;ZMIZ1;BCL6;HES1;MIB2;LLGL1;RFNG;PEAR1;EPN2
12876,GO:0051248,0.342945919107185,0.699142248898528,88,889,negative regulation of protein metabolic process,BP,TNIP1;DUSP6;APOE;CST3;XDH;PRDX5;ZFP36L1;GRB7;EPHB2;EGFR;TIMP2;DUSP5;PPP1R14A;SERPING1;PKN1;PTK6;ABCA7;PLAT;PIK3R2;CRTAP;LRP5;ZFPM1;FBLN1;SPRY4;CDKN1C;SERPINE2;UNK;ATP2B4;PDCD4;EPHA1;ADARB1;PPP1R35;PRNP;PAPLN;SPRY2;HINT2;ECM1;WWTR1;VEGFA;TNFRSF6B;DVL1;FURIN;MLXIPL;ZFP36;LRRK1;HBEGF;MAP2K2;DMTN;MAPK8IP1;LDLR;EIF4EBP3;RAG1;DUSP7;DGKQ;GAS6;MEX3A;SUFU;PRKCZ;INPP5D;AGO4;CTSZ;PIN1;C5;BIN1;SERPINB6;JARID2;SESN2;CSTB;RTN4R;ELFN2;TIMP1;PPM1F;SORL1;STK39;AKT1;NDRG2;GPD1L;PINK1;SNTA1;RGS14;CBLC;PYCARD;PCSK1N;RANBP9;SIRT3;JAK3;RPL13A;MIF
7243,GO:0031214,0.342960025923302,0.785454761205735,8,68,biomineral tissue development,BP,CYP27B1;PTHLH;ECM1;FAM20C;ACVR2B;FGFR3;GAS6;PPARA
12638,GO:0050868,0.343406946103373,0.793030217934902,7,59,negative regulation of T cell activation,BP,ERBB2;IL20RB;PRNP;BCL6;CEBPB;PAG1;JAK3
2376,GO:0005516,0.343703775814861,0.755632206160596,14,126,calmodulin binding,MF,MARCKSL1;NOS1;OBSCN;EGFR;VAMP2;ATP2B4;MKNK2;MYH3;TRPV4;EEF2K;MAPKAPK3;CAMKK1;SNTA1;KCNN4
10878,GO:0044440,0.343708173158628,0.716260968277823,41,398,endosomal part,CC,NDRG1;APPL2;RAB11FIP4;EGFR;ABCA7;CTSB;ERBB2;PRAF2;VPS11;CD320;ZFYVE21;RHOD;INSR;MARCH2;CHMP1B;MVB12B;AP2A2;AMN;FURIN;SLC48A1;ABCA2;PCSK9;TMEM9;PI4K2A;EHD4;LDLR;SNX17;ABHD17C;MVB12A;LLGL1;TMEM175;WDR83;SLC9A7;CD68;SORL1;TPCN1;VPS33B;SPPL2B;EHD3;CTSH;LITAF
1525,GO:0003906,0.344176671182406,0.886484190068844,2,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,HMGA2;NEIL1
18228,GO:1903078,0.344310729107329,0.814356770109432,5,40,positive regulation of protein localization to plasma membrane,BP,EPHB2;LRP1;EGFR;PRNP;AKT1
9593,GO:0036474,0.34436763962464,0.852498095391999,3,22,cell death in response to hydrogen peroxide,BP,ENDOG;TRAP1;PINK1
3624,GO:0008092,0.344718203288671,0.702761171586297,68,669,cytoskeletal protein binding,MF,APOE;ESPN;MARCKSL1;FLNC;FAM110C;CLIP2;GSN;NDRG1;PARVB;OBSCN;OBSL1;EGFR;S100A4;CORO1B;ANK3;S100A6;MARK4;BRSK1;MICALL2;PKD2;DNM1;MPRIP;MSRB2;KIF13B;CCDC69;TMOD2;RAB3D;PRNP;RAB25;MYO18A;PLEKHH2;HOOK2;SHANK3;TNNT1;WIPF1;FHOD1;SSH1;MEFV;RAB3B;SPTB;DMTN;MYH3;MAPK8IP1;TRPV4;CROCC;MIB2;REEP4;CAPG;TWF2;NDE1;KCNMA1;BIN1;CAPN2;MAPRE3;EPB41L3;EPS8L1;EPS8L2;SSH3;GAS8;SNTA1;HOMER2;RGS14;SYNE3;SPIRE2;PYCARD;RHBG;KIFC2;KIF26B
10299,GO:0043101,0.345451682732737,0.88576459853087,2,13,purine-containing compound salvage,BP,ADA;DGUOK
10023,GO:0042493,0.345661773919667,0.704287699890993,61,604,response to drug,BP,FOS;DUSP6;CST3;GSN;PGF;NOS1;MAPK13;EGFR;TIMP2;HADH;PPP1R14A;MTHFR;EGR1;HDAC5;SLC13A3;PRAF2;XPC;NTSR1;CD320;SLC6A8;ID1;DNMT3A;PRNP;BLMH;STAT6;ANKZF1;IGFBP2;BNIP3;ENDOG;MAPK3;AMN;SLC22A18;ADCY6;SSH1;ABCA2;ADA;SLIT3;HLCS;RAB3B;HMGA2;DGKQ;GAS6;PPARA;COMT;PTAFR;PCK2;VAV3;WBP2;KCNMA1;SDC1;PPM1F;STK39;VEGFB;SLC25A29;CYP2S1;TRAP1;TP53INP1;PINK1;HOMER2;GSTM2;PQLC2
11346,GO:0045730,0.345740632651309,0.885601216013282,2,13,respiratory burst,BP,INSR;BCR
12552,GO:0050732,0.346197798860657,0.812941327218085,5,40,negative regulation of peptidyl-tyrosine phosphorylation,BP,PTK6;LRRK1;DMTN;PRKCZ;CBLC
6574,GO:0022412,0.346247471989283,0.738054248544073,20,187,cellular process involved in reproduction in multicellular organism,BP,ERCC1;DEAF1;BBS2;DNAH1;ZP3;CD9;HEXB;ZMIZ1;DNMT3A;ETV5;SLIT3;PRKACA;DMC1;AGO4;AKT1;SIX5;TDRKH;SPIRE2;RFX2;EREG
19451,GO:1990204,0.346907198732288,0.774717732685038,9,88,oxidoreductase complex,CC,OGDHL;NDUFS8;DHTKD1;SDHAF4;SDHA;PDK2;GPD1L;NDUFV3;BCKDHA
404,GO:0001085,0.346932695477683,0.760183705909447,12,108,RNA polymerase II transcription factor binding,MF,FOS;ERCC1;MEF2D;BBS2;HDAC5;ZFPM1;ID1;MTA1;BBS1;BHLHE40;PPARA;MEF2B
17510,GO:1901032,0.347799501999347,0.8844337946814,2,13,negative regulation of response to reactive oxygen species,BP,TRAP1;PINK1
18273,GO:1903206,0.347799501999347,0.8844337946814,2,13,negative regulation of hydrogen peroxide-induced cell death,BP,TRAP1;PINK1
20163,GO:2001039,0.347799501999347,0.8844337946814,2,13,negative regulation of cellular response to drug,BP,TRAP1;PINK1
8329,GO:0033194,0.347833717656119,0.884414345317572,2,13,response to hydroperoxide,BP,GPX3;TP53INP1
4648,GO:0010803,0.348224432512697,0.798801302854616,6,51,regulation of tumor necrosis factor-mediated signaling pathway,BP,RBCK1;TNFRSF1A;GAS6;MADD;SPPL2B;PYCARD
12940,GO:0051348,0.348245367920216,0.727820601090835,25,239,negative regulation of transferase activity,BP,DUSP6;APOE;EPHB2;DUSP5;PKN1;PTK6;LRP5;SPRY4;CDKN1C;PDCD4;EPHA1;ADARB1;SPRY2;WWTR1;DVL1;ZFP36;MAPK8IP1;DUSP7;RTN4R;PPM1F;SORL1;AKT1;RGS14;CBLC;PYCARD
9866,GO:0042158,0.34858035515308,0.758675131408053,12,110,lipoprotein biosynthetic process,BP,APOE;ZDHHC1;WIPI2;LY6K;MDGA1;ABHD17C;PIGZ;MSLN;ZDHHC24;LCAT;PIGV;PIGQ
613,GO:0001782,0.348757429986694,0.849593772176278,3,22,B cell homeostasis,BP,PKN1;ADA;MIF
2824,GO:0006298,0.348918386832122,0.827034575228227,4,31,mismatch repair,BP,ERCC1;POLD4;XPC;PMS2P5
6845,GO:0030326,0.349014757853544,0.767888967890911,10,88,embryonic limb morphogenesis,BP,LRP5;IFT140;WNT7A;TMEM107;FBXW4;MYH3;FGFR1;TMEM231;WNT3;RARG
8979,GO:0035113,0.349014757853544,0.767888967890911,10,88,embryonic appendage morphogenesis,BP,LRP5;IFT140;WNT7A;TMEM107;FBXW4;MYH3;FGFR1;TMEM231;WNT3;RARG
4800,GO:0012510,0.349021466333147,0.883738206537601,2,13,trans-Golgi network transport vesicle membrane,CC,LDLRAP1;CLTCL1
14951,GO:0070887,0.349072478120657,0.680455115048322,206,2106,cellular response to chemical stimulus,BP,TNIP1;HTRA1;FOS;DUSP6;APOE;CST3;LTBP4;RAPGEF3;CYP27B1;GSN;XDH;PRDX5;NDRG1;PRODH;PGF;NOS1;LTBP1;ZFP36L1;COL6A1;POSTN;NR1D1;FAM210B;RBCK1;EPAS1;IGF2;NFATC4;GPX3;MST1R;LRP1;MAPK13;LTBP2;EGFR;MMP28;PPP1R14A;UROS;EGR1;SHC1;PTK6;BPHL;LAMA5;BBS2;CTSB;CORO1B;MMP1;ANK3;PIK3R2;HDAC5;THRA;DOCK4;LRP5;HYAL1;ERBB2;PKD2;EDEM1;PLXNB3;SPRY4;CDKN1C;PTPRE;VAMP2;FUZ;ATP2B4;GGT1;RASA4;ADAMTS7;PDCD4;TNFRSF25;WNT7A;INSR;ID1;AKR7A2;ITGA6;TXNRD3;IL20RB;DNMT3A;TMEM173;PRNP;SPRY2;ECM1;STAT6;MKNK2;TALDO1;ISG20;FAM20C;BCL6;ANKZF1;FAM213A;IGFBP2;BNIP3;VEGFA;CEBPB;ACVR2B;CALCOCO1;ENDOG;TNFRSF6B;MAPK3;PLEKHG5;ETV5;ADCY6;HES1;SSH1;FURIN;MLXIPL;CUL7;NRP2;TNFRSF14;PYCR2;AQP3;ACY1;IL6R;SLIT3;PCSK9;ZFP36;FGFR3;PRKACA;CYFIP2;RPS6KA5;HBEGF;ITGB5;MAP2K2;FGFR4;DMTN;TNFRSF1A;EHD4;LDLR;CYP3A5;TRPV4;IFNGR2;EEF2K;HMGA2;GAS6;BTRC;PPARA;WNT7B;PTAFR;RXRA;PCK2;VAV3;VASN;BCR;NEO1;PRKCZ;ADAMTS13;INPP5D;TM7SF3;ABCD4;TWF2;TPP1;PDK2;GPC1;SRSF5;AGO4;FGFR1;PIN1;C5;TMEM204;CMBL;WBP2;VSNL1;CES2;GRB10;JARID2;CAPN2;SESN2;TOLLIP;TMEM161A;RXRB;ADGRE2;MADD;RTN4R;TIMP1;CD68;SDC1;FGFBP1;WNT3;LYST;GSTT1;PPM1F;VEGFB;CYP2S1;AKT1;TRAP1;TP53INP1;SLC5A5;SPPL2B;IL17RD;PINK1;CTSH;EPN2;RFX2;PYCARD;MAP2K3;POMT1;AS3MT;ERN1;CKLF;CPNE7;JAK3;LITAF;RARG;EREG;FAM162A;GSTM2;RPL13A;MIF;SULF2;STXBP2
8149,GO:0032892,0.349273354552016,0.883594571175498,2,13,positive regulation of organic acid transport,BP,NTSR1;MIF
3503,GO:0007420,0.349434095998683,0.707806239096678,46,447,brain development,BP,PTPRS;CST3;SHANK2;TCTN1;EPHB2;CNTN1;LRP1;EGFR;NAGLU;BBS2;GJC2;THRA;CD9;SERPINE2;ATP2B4;CSNK1E;TRAPPC9;WNT7A;ID1;BNIP3;SHANK3;PHGDH;EPHB3;HES1;MBOAT7;PITPNM1;MDGA1;SEMA4C;POU6F1;WNT7B;BCR;NDE1;FGFR1;PROX1;WNT2B;SNPH;RTN4R;WNT3;ABR;NDRG2;SMARCA1;SUN1;GAS8;SLC2A1;RARG;TRNP1
9879,GO:0042180,0.349436341010272,0.741783867834145,17,162,cellular ketone metabolic process,BP,TYSND1;NR1D1;KDSR;EGR1;ATP2B4;AKR7A2;HAGH;MLXIPL;FGFR4;DGKQ;PPARA;COMT;PDK2;PROX1;AKT1;LONP2;MLYCD
5707,GO:0016854,0.34955421321985,0.883434314616572,2,13,racemase and epimerase activity,MF,GALE;TSTA3
5499,GO:0016460,0.349567971162185,0.883426461660183,2,13,myosin II complex,CC,OBSL1;MYH3
13590,GO:0060090,0.34960654434869,0.744419206106741,16,147,molecular adaptor activity,MF,SH3BP2;GRB7;ARRDC1;OBSL1;SHC1;ANK3;VPS11;AP2A2;PAG1;SH2D2A;MAPK8IP1;LDLRAP1;GAS6;VAV3;GRB10;SH2B3
13010,GO:0051492,0.350554337042858,0.787331856053299,7,59,regulation of stress fiber assembly,BP,RAPGEF3;ARAP1;SH3PXD2B;EPHA1;FHOD1;PPM1F;ARHGEF10L
1172,GO:0002819,0.350628017549236,0.772296010465964,9,79,regulation of adaptive immune response,BP,PKN1;ZP3;IL20RB;STAT6;BCL6;ADA;PRKCZ;PYCARD;JAK3
3749,GO:0008299,0.350679408227741,0.848314680747756,3,22,isoprenoid biosynthetic process,BP,MVD;SRD5A3;PMVK
554,GO:0001676,0.351180774967769,0.78670668527144,7,60,long-chain fatty acid metabolic process,BP,ALOX15B;ACOT7;ABCD1;MAPK3;AIG1;CYP2S1;GSTM2
15578,GO:0072091,0.351253915617019,0.809130454009179,5,40,regulation of stem cell proliferation,BP,ZFP36L1;FBLN1;VEGFA;HMGA2;LTBP3
9953,GO:0042359,0.351310730411082,0.882429631699528,2,13,vitamin D metabolic process,BP,CYP27B1;FGFR1
266,GO:0000737,0.351674712723111,0.847650502662786,3,22,DNA catabolic process, endonucleolytic,BP,H1F0;DNASE1L1;ENDOG
12778,GO:0051098,0.351890005392949,0.719344827793716,29,281,regulation of binding,BP,APOE;CTNNBIP1;NFATC4;LRP1;MDFI;HDAC5;ZFPM1;PHLDA2;CSNK1E;ID1;TMEM173;ADAM15;MAPK3;DVL1;GPSM1;HES1;PCSK9;PRKACA;HMGA2;LDLRAP1;PPARA;RFNG;CTSZ;PIN1;MAPRE3;SORL1;AKT1;GAS8;PKD1
3409,GO:0007200,0.352270228361653,0.82462021183928,4,31,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,LTB4R;F2R;LTB4R2;LPAR3
9725,GO:0038202,0.352470732533068,0.824475383360175,4,31,TORC1 signaling,BP,DGKQ;SESN2;MLST8;C12ORF66
11654,GO:0046459,0.352622398111892,0.881676664259117,2,13,short-chain fatty acid metabolic process,BP,PCK2;ACADS
1217,GO:0002888,0.353409915078323,0.881223466070877,2,13,positive regulation of myeloid leukocyte mediated immunity,BP,PTAFR;ADORA2B
10976,GO:0044794,0.35374315721397,0.881031439275265,2,13,positive regulation by host of viral process,BP,APOE;PC
17504,GO:1901021,0.35408106338535,0.846039653088601,3,22,positive regulation of calcium ion transmembrane transporter activity,BP,PKD2;EHD3;GSTM2
12083,GO:0048145,0.354275759940702,0.784101713496912,7,61,regulation of fibroblast proliferation,BP,EGFR;S100A6;ZMIZ1;GAS6;TP53INP1;EREG;MIF
8964,GO:0035088,0.354786354990865,0.82279945843687,4,31,establishment or maintenance of apical/basal cell polarity,BP,DLG4;VANGL2;DLG3;LRCH4
14217,GO:0061245,0.354786354990865,0.82279945843687,4,31,establishment or maintenance of bipolar cell polarity,BP,DLG4;VANGL2;DLG3;LRCH4
3441,GO:0007259,0.354884835818218,0.762888668123477,10,89,JAK-STAT cascade,BP,PTK6;PKD2;MAPK3;HES1;IL6R;FGFR3;TNFRSF1A;RTN4R;PKD1;JAK3
10501,GO:0043434,0.355094859417601,0.714245334150754,31,298,response to peptide hormone,BP,ZFP36L1;IGF2;HADH;EGR1;SHC1;PIK3R2;HDAC5;LRP5;BSG;PTPRE;VAMP2;INSR;MAPK3;ADCY6;PCSK9;PRKACA;VGF;TRPV4;EEF2K;PPARA;PCK2;PRKCZ;PDK2;SRSF5;GRB10;SESN2;TIMP1;AKT1;SLC2A1;JAK3;EREG
16109,GO:0090141,0.355200779065321,0.880189729206584,2,13,positive regulation of mitochondrial fission,BP,BNIP3;PINK1
13156,GO:0051788,0.355721310269448,0.844937536619608,3,22,response to misfolded protein,BP,ANKZF1;F12;POMT1
6300,GO:0019953,0.356214679977685,0.702053683224503,45,441,sexual reproduction,BP,ERCC1;TCFL5;MST1R;GAMT;SYT8;DEAF1;BBS2;DNAH1;THRA;ZP3;CRTAP;SCMH1;CD9;HEXB;SERPINE2;ATP2B4;GGT1;ZMIZ1;TXNRD3;DNMT3A;MYCBPAP;PHC2;BCL6;ZSCAN2;ETV5;ADA;PRKACA;SPATA20;VGF;DMC1;AGO4;WNT3;ZFP41;MICALCL;SBF1;AKT1;SIX5;TDRKH;SUN1;RPL39L;SPIRE2;RFX2;EREG;SHISA6;FAM50A
13519,GO:0060008,0.35653092847653,0.879419108134908,2,13,Sertoli cell differentiation,BP,CST3;SDC1
5666,GO:0016787,0.356650720028444,0.674768822634363,180,1825,hydrolase activity,MF,HTRA1;DUSP6;H6PD;CEMIP;TYSND1;RNPEPL1;PTPRS;ERCC1;NT5E;GAA;CLCA2;PGLS;PRSS3;MMP28;NLGN2;ACOT7;DUSP5;JOSD2;RHBDF1;NAGLU;GNAL;BPHL;NPEPL1;ABCA7;PPP2R3B;PRSS8;PPM1J;CTSB;DNAH1;PLAT;MMP1;ABCG1;OPLAH;HDAC5;PLD3;HYAL1;TUBG2;NUDT8;CTSF;PTPRU;FUCA1;EDEM1;DNM1;KIF13B;PTPRE;HEXB;THSD4;ATP2B4;GGT1;ACP5;PLCD1;AGAP1;ADAMTS7;GM2A;RHOD;USP20;RAB3D;PLCXD1;AKR7A2;ADARB1;HAGH;DNPH1;DHX32;PAPLN;ATP7B;IAH1;RNASET2;HINT2;BLMH;ABCD1;MTA3;PLCD3;NT5DC1;ISG20;RAB25;ANKZF1;PFKFB2;ATP12A;ENTPD6;DNASE1L1;ARL2;RHBDF2;DPP7;ADAM15;ENDOG;GLB1;CAPNS2;EXD3;RAB40B;TNNT1;ENTPD2;MTA1;LHPP;LTA4H;ACAD10;SSH1;FURIN;ABCA2;ADA;PHF21A;RASL10B;MYH16;ACY1;PCSK9;RHOF;F12;NUDT10;PLCH2;RAB3B;MYH3;HDAC11;LYPLAL1;ACOT11;ABHD17C;MPG;RHOBTB2;RAG1;DUSP7;RHBDL1;PADI3;AIG1;DMC1;IMPA2;PAN2;PCSK1;USP21;WDR60;ADAMTS13;HAGHL;HLTF;INPP5D;ABCD4;TPP1;CTSZ;PIN1;MAN1B1;PNPLA4;CMBL;GTPBP1;CES2;CAPN2;MAN2B2;DUSP23;MACROD1;TMPRSS11D;LMLN;APOBEC3C;PPM1F;SBF1;AHCYL2;CTSD;SEPT8;ADAM19;SMARCA1;ERCC6;ACP6;NAGA;SPPL2B;SSH3;LONP2;PLPPR2;HEXDC;CTSH;ABHD14B;PYCARD;PMS2P5;ERN1;APOBEC3F;WDR63;SIRT3;RNASEK;KIFC2;NEIL1;GALNS;ABHD14A;ADAMTSL4;NDST2;RAB40C;SULF2;KIF26B
10427,GO:0043302,0.356821642752604,0.879250362485189,2,13,positive regulation of leukocyte degranulation,BP,PTAFR;ADORA2B
3893,GO:0008542,0.357044183941207,0.821159509566262,4,31,visual learning,BP,DEAF1;SYNGAP1;RAG1;RGS14
5192,GO:0015800,0.357048745885681,0.821156190198158,4,31,acidic amino acid transport,BP,PRAF2;VAMP2;NTSR1;APBA1
10534,GO:0043506,0.357368620567801,0.773603173214301,8,69,regulation of JUN kinase activity,BP,PKN1;PDCD4;FZD8;VANGL2;MAPK8IP1;WNT7B;ERCC6;ERN1
16141,GO:0090189,0.357552407439214,0.878825680632873,2,13,regulation of branching involved in ureteric bud morphogenesis,BP,VEGFA;WNT2B
17797,GO:1901981,0.357773323333906,0.750900709617003,12,108,phosphatidylinositol phosphate binding,MF,ARAP1;PLCD1;SH3PXD2B;WIPI2;OSBPL5;LDLRAP1;GSDMC;TWF2;ARAP3;GSDMA;AKT1;ZFYVE19
1423,GO:0003382,0.357773724047199,0.843553781024889,3,22,epithelial cell morphogenesis,BP,ID1;RAB25;RILPL1
8417,GO:0033540,0.357877164209567,0.878636715727476,2,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,CRAT;ABCD1
4883,GO:0014819,0.358102698800652,0.939513142250382,1,5,regulation of skeletal muscle contraction,BP,GSTM2
6667,GO:0030038,0.358115459379484,0.772989098499163,8,69,contractile actin filament bundle assembly,BP,RAPGEF3;ARAP1;SH3PXD2B;EPHA1;FHOD1;ITGB5;PPM1F;ARHGEF10L
10329,GO:0043149,0.358115459379484,0.772989098499163,8,69,stress fiber assembly,BP,RAPGEF3;ARAP1;SH3PXD2B;EPHA1;FHOD1;ITGB5;PPM1F;ARHGEF10L
12567,GO:0050769,0.358565978515539,0.711082776509873,31,296,positive regulation of neurogenesis,BP,APOE;SHANK2;EPHB2;CNTN1;OBSL1;TIMP2;CRTC1;PTK6;GJC2;ZMYND8;PLXNB3;SERPINE2;CSNK1E;FBXW8;LPAR3;DLG4;BCL6;PLXNB1;VEGFA;SHANK3;ETV5;DVL1;HES1;CUL7;EEF2K;TWF2;FGFR1;PROX1;BIN1;WNT3;RGS14
5820,GO:0017110,0.358973602836691,0.877997673744476,2,13,nucleoside-diphosphatase activity,MF,ENTPD6;ENTPD2
6640,GO:0023058,0.359059587900566,0.87794748940507,2,13,adaptation of signaling pathway,BP,DNM1;GIPR
10263,GO:0043028,0.359089070085605,0.819368665905968,4,32,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,PRDX5;GAS6;CTSH;PYCARD
8995,GO:0035176,0.359326122775485,0.819496175613212,4,31,social behavior,BP,SHANK2;DLG4;SHANK3;DVL1
13111,GO:0051703,0.359326122775485,0.819496175613212,4,31,intraspecies interaction between organisms,BP,SHANK2;DLG4;SHANK3;DVL1
9900,GO:0042262,0.359389614390294,0.93903509013102,1,5,DNA protection,BP,CBS
2634,GO:0005976,0.359589514757316,0.76483814244591,9,79,polysaccharide metabolic process,BP,GAA;PYGB;PGM1;NR1D1;IGF2;PYGL;PHLDA2;INSR;AKT1
11878,GO:0046928,0.359665431834243,0.819248344573722,4,31,regulation of neurotransmitter secretion,BP,KCNC4;RIMS3;ASIC1;MCTP1
4953,GO:0015038,0.359751887715085,0.938900108641095,1,5,glutathione disulfide oxidoreductase activity,MF,GLRX
5553,GO:0016575,0.360119030289819,0.764395380273355,9,79,histone deacetylation,BP,HDAC5;MTA3;BCL6;VEGFA;MTA1;PHF21A;HDAC11;PINK1;SIRT3
3130,GO:0006730,0.360479791677562,0.84172134158239,3,22,one-carbon metabolic process,BP,MTHFR;CA12;AHCYL2
1430,GO:0003407,0.360644787254496,0.818532291669761,4,31,neural retina development,BP,RAB11FIP4;SDK2;ATP2B4;SDHAF4
16917,GO:0098927,0.360766851426965,0.801671540795324,5,41,vesicle-mediated transport between endosomal compartments,BP,VPS11;HOOK2;MAPK3;MAP2K2;SORL1
12205,GO:0048485,0.3612440215562,0.876669182593208,2,13,sympathetic nervous system development,BP,NRP2;SEMA3F
13935,GO:0060669,0.361470414921869,0.841048259094464,3,22,embryonic placenta morphogenesis,BP,ZFP36L1;IGF2;WNT7B
14806,GO:0070571,0.361480461453949,0.876530429774314,2,13,negative regulation of neuron projection regeneration,BP,PTPRS;RTN4R
4138,GO:0009208,0.361599397819585,0.875564005195877,2,14,pyrimidine ribonucleoside triphosphate metabolic process,BP,NME4;UCKL1
13081,GO:0051642,0.361660869212961,0.840918714581773,3,22,centrosome localization,BP,FHOD1;NDE1;SUN1
13240,GO:0051955,0.361712812283288,0.876394002177433,2,13,regulation of amino acid transport,BP,NTSR1;STK39
8986,GO:0035137,0.36178228301582,0.840836106989327,3,22,hindlimb morphogenesis,BP,WNT7A;WNT3;RARG
3156,GO:0006775,0.361997400973513,0.84021929027304,3,23,fat-soluble vitamin metabolic process,BP,CYP27B1;PLTP;FGFR1
11764,GO:0046649,0.362373315049242,0.699628274051858,40,391,lymphocyte activation,BP,ERCC1;GSN;ZFP36L1;IGF2;EGR1;PKN1;CMTM7;HDAC5;ZP3;ZFPM1;ERBB2;KIF13B;CD320;ZMIZ1;IL20RB;PRNP;EFNB3;STAT6;BCL6;IGFBP2;CD81;FZD8;LRRC8A;CEBPB;HES1;TNFRSF14;ADA;PAG1;SOX13;RAG1;GAS6;VAV3;PRKCZ;INPP5D;ICOSLG;AKT1;PYCARD;JAK3;POLM;MIF
5131,GO:0015662,0.362531295030005,0.840326088827782,3,22,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,ATP2B4;ATP7B;ATP12A
13802,GO:0060428,0.362618396640076,0.840266734254685,3,22,lung epithelium development,BP,THRA;WNT7B;PKD1
1581,GO:0003995,0.362925222690968,0.875680923522902,2,13,acyl-CoA dehydrogenase activity,MF,ACAD10;ACADS
15096,GO:0071214,0.363121341184268,0.715830290445979,24,229,cellular response to abiotic stimulus,BP,ERCC1;ZFP36L1;NFATC4;MAPK13;EGFR;DDB2;EGR1;HYAL1;PKD2;XPC;ASIC1;BNIP3;MAPK3;TNFRSF1A;TRPV4;HMGA2;PTAFR;SERPINB6;TMEM161A;GUCA1B;STK39;AKT1;TP53INP1;SLC2A1
17158,GO:0104004,0.363121341184268,0.715830290445979,24,229,cellular response to environmental stimulus,BP,ERCC1;ZFP36L1;NFATC4;MAPK13;EGFR;DDB2;EGR1;HYAL1;PKD2;XPC;ASIC1;BNIP3;MAPK3;TNFRSF1A;TRPV4;HMGA2;PTAFR;SERPINB6;TMEM161A;GUCA1B;STK39;AKT1;TP53INP1;SLC2A1
13795,GO:0060419,0.363529936873398,0.786914057782131,6,50,heart growth,BP,DUSP6;RXRA;FGFR1;PIN1;PROX1;JARID2
13054,GO:0051589,0.363951340806207,0.875075841554436,2,13,negative regulation of neurotransmitter transport,BP,NOS1;ASIC1
6421,GO:0021697,0.363953558562888,0.87507453222548,2,13,cerebellar cortex formation,BP,WNT7A;PROX1
5251,GO:0015893,0.363992221667148,0.749956389118547,11,100,drug transport,BP,SLC13A3;PRAF2;NTSR1;CD320;SLC6A8;AMN;SLC22A18;RAB3B;SLC25A29;PINK1;PQLC2
11302,GO:0045648,0.364254919051569,0.839149788575575,3,22,positive regulation of erythrocyte differentiation,BP,FAM210B;INPP5D;ACVR1B
20025,GO:2000678,0.364795024879191,0.873669244912775,2,14,negative regulation of transcription regulatory region DNA binding,BP,ID1;PPARA
6674,GO:0030049,0.365595909865726,0.873192185711252,2,14,muscle filament sliding,BP,TNNT1;MYH3
8362,GO:0033275,0.365595909865726,0.873192185711252,2,14,actin-myosin filament sliding,BP,TNNT1;MYH3
1691,GO:0004169,0.36570012427632,0.936658105087392,1,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,POMT1
15256,GO:0071467,0.365753910717557,0.874009409673013,2,13,cellular response to pH,BP,HYAL1;ASIC1
6067,GO:0019228,0.365888524359515,0.873929591184955,2,13,neuronal action potential,BP,SCN8A;ANK3
3037,GO:0006598,0.366019152012544,0.936536481942046,1,5,polyamine catabolic process,BP,SMOX
18243,GO:1903136,0.366320016383496,0.936421654390381,1,5,cuprous ion binding,MF,PRNP
5204,GO:0015813,0.366382636077695,0.873636397067563,2,13,L-glutamate transmembrane transport,BP,PRAF2;NTSR1
9197,GO:0035601,0.366418596096446,0.747933379198141,11,99,protein deacylation,BP,HDAC5;MTA3;BCL6;VEGFA;MTA1;PHF21A;HDAC11;LYPLAL1;ABHD17C;PINK1;SIRT3
11450,GO:0045927,0.366549991600283,0.724201854741327,18,170,positive regulation of growth,BP,EGFR;BBS2;ZP3;HYAL1;ERBB2;INSR;SH3PXD2B;DNPH1;LPAR3;VEGFA;HBEGF;TWF2;FGFR1;PIN1;PROX1;WNT3;PPM1F;AKT1
18322,GO:1903319,0.366586152442145,0.873515537921879,2,13,positive regulation of protein maturation,BP,GSN;F12
13029,GO:0051546,0.366724594529356,0.873433290960444,2,13,keratinocyte migration,BP,LTB4R2;HBEGF
18591,GO:1903901,0.366924545215981,0.773731044510647,7,62,negative regulation of viral life cycle,BP,TNIP1;GSN;ISG20;HMGA2;PROX1;APOBEC3C;APOBEC3F
9843,GO:0042110,0.367026026757696,0.706696512989403,28,270,T cell activation,BP,GSN;ZFP36L1;IGF2;EGR1;ZP3;ZFPM1;ERBB2;KIF13B;ZMIZ1;IL20RB;PRNP;EFNB3;STAT6;BCL6;IGFBP2;FZD8;CEBPB;HES1;TNFRSF14;ADA;PAG1;SOX13;RAG1;PRKCZ;ICOSLG;AKT1;PYCARD;JAK3
2323,GO:0005343,0.367074061905638,0.873225559130094,2,13,organic acid:sodium symporter activity,MF,SLC13A3;SLC6A8
4135,GO:0009205,0.36709315717188,0.71357097603324,23,233,purine ribonucleoside triphosphate metabolic process,BP,PGM1;NME4;OGDHL;INSR;NDUFS8;FAM20C;PFKFB2;DHTKD1;GALK1;MLXIPL;NADK;PFKL;MYH3;HK1;PPARA;GUK1;SDHA;GTPBP1;UQCR11;PINK1;NDUFV3;MOCS1;TAZ
3751,GO:0008301,0.367498976726404,0.872972753666733,2,13,DNA binding, bending,MF,HMGA2;TRERF1
4946,GO:0015020,0.367546325916995,0.87294456764736,2,13,glucuronosyltransferase activity,MF,B3GAT3;B4GAT1
6734,GO:0030163,0.367553010249352,0.679267466080135,74,742,protein catabolic process,BP,APOE;BTBD2;RNF44;CST3;NR1D1;ARRDC1;RBCK1;LRP1;EGFR;TIMP2;FBXO2;RHBDF1;CTSB;CTSF;GID4;TMEM129;EDEM1;ABTB1;CUL9;SERPINE2;VPS11;CSNK1E;ADAMTS7;USP20;SPATA18;SNX33;SNX9;WWTR1;ANKZF1;MVB12B;BNIP3;CD81;FBXW4;AP2A2;DVL1;MTA1;FURIN;CUL7;LRSAM1;PCSK9;BTBD11;PRKACA;MAGEF1;FBXW5;LDLR;LYPLAL1;ABHD17C;MVB12A;BTRC;SUFU;USP21;RNF123;TPP1;GPC1;RAD23A;CTSZ;SPSB3;PIN1;MAN1B1;SH3D19;CAPN2;TOLLIP;TIMP1;SORL1;AKT1;CTSD;PINK1;PKD1;LONP2;CTSH;CBLC;RNF187;POMT1;FBXL20
17866,GO:1902175,0.367770507612067,0.836259627910916,3,23,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,AKT1;TRAP1;PINK1
6432,GO:0021756,0.367876833505172,0.872747737378097,2,13,striatum development,BP,BBS2;SHANK3
2812,GO:0006284,0.36795750433211,0.79592050407128,5,42,base-excision repair,BP,POLL;MPG;HMGA2;ERCC6;NEIL1
1111,GO:0002700,0.367957552649851,0.764648578996069,8,71,regulation of production of molecular mediator of immune response,BP,PKN1;STAT6;BCL6;MAPK3;HK1;PRKCZ;JAK3;MIF
16684,GO:0097696,0.367974619026338,0.751724470979376,10,90,STAT cascade,BP,PTK6;PKD2;MAPK3;HES1;IL6R;FGFR3;TNFRSF1A;RTN4R;PKD1;JAK3
10229,GO:0042981,0.368005807840751,0.671491573140168,108,1093,regulation of apoptotic process,BP,DUSP6;APOE;GSN;XDH;PRDX5;NDRG1;ZFP36L1;RBCK1;EPHB2;OBSCN;IGF2;NFATC4;NME4;MST1R;LRP1;EGFR;HS1BP3;EGR1;ARHGEF4;SHC1;RGL2;F2R;CTSB;GRAMD4;THRA;RPS6KA2;LRP5;ERBB2;SIGMAR1;PAK6;NTSR1;MINK1;TFDP2;PDCD4;BEX2;TNFRSF25;WNT7A;INSR;ID1;RABGGTA;EPHA1;ITGA6;SYNGAP1;PRNP;SPRY2;MNT;STRADB;MYO18A;BCL6;BNIP3;VEGFA;CEBPB;ENDOG;TNFRSF6B;PLEKHG5;EPHB3;PLEKHG2;TNFRSF14;ADA;PIDD1;PCSK9;ZFP36;FGFR3;MAP2K2;DAP;FGFR4;TNFRSF1A;MAPK8IP1;RAG1;TNFAIP8L1;EEF2K;HMGA2;GAS6;VAV3;PRKCZ;INPP5D;AGO4;FGFR1;CTSZ;PIN1;KCNMA1;BIN1;SLC25A27;TMEM161A;MADD;TIMP1;PPM1F;STK39;ERBB3;ABR;PNMA1;AKT1;TRAP1;TMBIM4;ZNF385A;TP53INP1;PINK1;CTSH;PYCARD;MAP2K3;STK17A;ARHGEF19;JAK3;RARG;ING4;FAM162A;ADAMTSL4;MIF
11358,GO:0045746,0.368219422063716,0.812648531380682,4,32,negative regulation of Notch signaling pathway,BP,ARRDC1;EGFR;BCL6;PEAR1
14464,GO:0061912,0.368310757308278,0.795855972796101,5,41,selective autophagy,BP,MAPK3;WIPI2;LRSAM1;SESN2;PINK1
5303,GO:0016024,0.36840556944014,0.872432542272506,2,13,CDP-diacylglycerol biosynthetic process,BP,AGPAT4;AGPAT3
9077,GO:0035357,0.368500494545821,0.872375913938259,2,13,peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B;RXRA
12197,GO:0048469,0.36868581197626,0.751117762113924,10,90,cell maturation,BP,FAM210B;EPAS1;FAM20C;VEGFA;HES1;PRKACA;DMC1;FGFR1;BFSP1;EREG
6712,GO:0030133,0.368733359279921,0.707740496924457,26,251,transport vesicle,CC,PTPRS;SYTL1;SYT8;DBNDD1;BRSK1;DNM1;VAMP2;RAB3D;DLG4;RAB40B;FURIN;MCTP1;FGFR3;RAB3B;PI4K2A;FGFR4;VGF;LDLRAP1;SEMA4C;TMEM187;PCSK1;CLTCL1;YIPF3;NRSN1;APBA1;RAB40C
3080,GO:0006661,0.369151974739216,0.736956259504121,13,119,phosphatidylinositol biosynthetic process,BP,PIK3R2;ZP3;FGFR3;PITPNM1;PI4K2A;FGFR4;PIGZ;INPP5D;FGFR1;PITPNM3;PIGV;PIGQ;SBF1
9431,GO:0036035,0.369230286945882,0.871940136734144,2,13,osteoclast development,BP,FAM20C;LRRK1
3166,GO:0006787,0.369619945230545,0.935153978540067,1,5,porphyrin-containing compound catabolic process,BP,BLVRB
8229,GO:0033015,0.369619945230545,0.935153978540067,1,5,tetrapyrrole catabolic process,BP,BLVRB
9871,GO:0042167,0.369619945230545,0.935153978540067,1,5,heme catabolic process,BP,BLVRB
11564,GO:0046149,0.369619945230545,0.935153978540067,1,5,pigment catabolic process,BP,BLVRB
9056,GO:0035313,0.369679503228377,0.871671534347035,2,13,wound healing, spreading of epidermal cells,BP,WNT7A;HBEGF
4050,GO:0009108,0.369955762847159,0.716734315240076,20,190,coenzyme biosynthetic process,BP,IDH2;NAPRT;PGM1;ACOT7;NMRK1;OGDHL;INSR;PFKFB2;DHTKD1;GALK1;MLXIPL;NADK;PFKL;HK1;PPARA;PDK2;PNPO;MOCS1;MLYCD;PPCS
7468,GO:0031644,0.369982464257969,0.811339991146341,4,32,regulation of neurological system process,BP,F2R;NTSR1;COMT;PTAFR
7901,GO:0032486,0.370281682935081,0.871311034137379,2,13,Rap protein signal transduction,BP,RAPGEF3;TIMP2
8101,GO:0032801,0.370310523696358,0.81109611369436,4,32,receptor catabolic process,BP,APOE;AP2A2;FURIN;PCSK9
2851,GO:0006349,0.370378077422417,0.871253280384301,2,13,regulation of gene expression by genetic imprinting,BP,IGF2;DNMT3A
12342,GO:0048745,0.37044302500257,0.871214360505706,2,13,smooth muscle tissue development,BP,PKD2;PROX1
3855,GO:0008484,0.370792786012739,0.871004666143642,2,13,sulfuric ester hydrolase activity,MF,GALNS;SULF2
9085,GO:0035372,0.370945023702493,0.87091334152882,2,13,protein localization to microtubule,BP,DVL1;ABHD17C
996,GO:0002460,0.371430112199345,0.731281064808145,14,130,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,ERCC1;SERPING1;PKN1;ZP3;IL20RB;STAT6;SCART1;BCL6;ADA;PRKCZ;INPP5D;C5;CTSH;JAK3
8312,GO:0033169,0.371917774514571,0.870329052246026,2,13,histone H3-K9 demethylation,BP,HSF4;KDM4B
4751,GO:0010940,0.37234553512014,0.934095517365249,1,5,positive regulation of necrotic cell death,BP,BNIP3
9306,GO:0035795,0.372596511912773,0.933997531019782,1,5,negative regulation of mitochondrial membrane permeability,BP,BNIP3
19319,GO:1905709,0.372596511912773,0.933997531019782,1,5,negative regulation of membrane permeability,BP,BNIP3
8897,GO:0034754,0.372647756395212,0.769042648927281,7,62,cellular hormone metabolic process,BP,EGR1;DHRS11;SRD5A3;RETSAT;DGKQ;COMT;PNPLA4
18499,GO:1903708,0.372656488003108,0.737906351946808,12,110,positive regulation of hemopoiesis,BP,FOS;CTNNBIP1;ZFP36L1;FAM210B;ZMIZ1;BCL6;ADA;RAG1;GAS6;PRKCZ;INPP5D;ACVR1B
10311,GO:0043122,0.372695287357597,0.716362408620092,19,181,regulation of I-kappaB kinase/NF-kappaB signaling,BP,TNIP1;RBCK1;F2R;S100A4;CXXC5;SLC20A1;ECM1;PLEKHG5;CARD19;MAPKBP1;TNFRSF1A;MIB2;BTRC;AKT1;NLRX1;PINK1;PYCARD;LITAF;TMED4
1606,GO:0004032,0.372714152024304,0.933951571642412,1,5,alditol:NADP+ 1-oxidoreductase activity,MF,AKR7A2
19773,GO:2000243,0.372755412199103,0.809274744028661,4,32,positive regulation of reproductive process,BP,ZP3;INSR;PTAFR;ACVR1B
12228,GO:0048525,0.373198567879369,0.760180246591032,8,72,negative regulation of viral process,BP,TNIP1;GSN;ISG20;ZFP36;HMGA2;PROX1;APOBEC3C;APOBEC3F
10061,GO:0042578,0.37356601006078,0.700692251802002,28,269,phosphoric ester hydrolase activity,MF,DUSP6;PTPRS;NT5E;DUSP5;PPP2R3B;PPM1J;PLD3;PTPRU;PTPRE;ACP5;PLCD1;PLCXD1;PLCD3;NT5DC1;PFKFB2;LHPP;SSH1;PLCH2;MYH3;DUSP7;IMPA2;INPP5D;DUSP23;PPM1F;SBF1;ACP6;SSH3;PLPPR2
10297,GO:0043096,0.373910271040846,0.933483174283225,1,5,purine nucleobase salvage,BP,ADA
5518,GO:0016504,0.373958558305729,0.808082470731964,4,33,peptidase activator activity,MF,FBLN1;PINK1;CTSH;PYCARD
3685,GO:0008199,0.374093691801196,0.933411169814629,1,5,ferric iron binding,MF,ACP5
12581,GO:0050786,0.374380182879335,0.930871306155985,1,6,RAGE receptor binding,MF,S100A4
4228,GO:0009435,0.374910411348558,0.807663695704625,4,32,NAD biosynthetic process,BP,NAPRT;NMRK1;PFKL;HK1
14104,GO:0060998,0.375394691681841,0.777259114801349,6,51,regulation of dendritic spine development,BP,APOE;PTPRS;SHANK2;ZMYND8;SHANK3;EEF2K
5656,GO:0016775,0.37541859456931,0.932889657149116,1,5,phosphotransferase activity, nitrogenous group as acceptor,MF,CKMT1A
14153,GO:0061081,0.375691168929526,0.932782059476116,1,5,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,MIF
2958,GO:0006501,0.375751846857015,0.806738246657036,4,33,C-terminal protein lipidation,BP,WIPI2;LY6K;MDGA1;MSLN
3240,GO:0006906,0.375875646221911,0.731009978088401,13,120,vesicle fusion,BP,SYTL1;EVI5L;SYT8;TBC1D14;VPS11;VAMP2;TBC1D8;STX10;VAV3;TMEM175;TBC1D16;TBC1D17;TSNARE1
4118,GO:0009186,0.376050541255758,0.932640038823314,1,5,deoxyribonucleoside diphosphate metabolic process,BP,GUK1
7770,GO:0032306,0.376100519490114,0.932620273478995,1,5,regulation of prostaglandin secretion,BP,MIF
7771,GO:0032308,0.376100519490114,0.932620273478995,1,5,positive regulation of prostaglandin secretion,BP,MIF
16325,GO:0090630,0.376764151266,0.757392749749995,8,70,activation of GTPase activity,BP,EVI5L;TBC1D14;RALGAPA2;PLEKHG4;TBC1D8;EPHA1;TBC1D16;TBC1D17
4784,GO:0010985,0.376862543406984,0.932318473032643,1,5,negative regulation of lipoprotein particle clearance,BP,PCSK9
11254,GO:0045582,0.3770987270497,0.788791834861611,5,42,positive regulation of T cell differentiation,BP,ZMIZ1;BCL6;ADA;RAG1;PRKCZ
17759,GO:1901857,0.377267095690399,0.932157916864453,1,5,positive regulation of cellular respiration,BP,PINK1
1175,GO:0002822,0.377523886358368,0.756653183057342,8,71,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,PKN1;ZP3;IL20RB;STAT6;BCL6;ADA;PRKCZ;JAK3
19915,GO:2000483,0.377674197584425,0.931996115599526,1,5,negative regulation of interleukin-8 secretion,BP,MAPKBP1
2691,GO:0006064,0.377747956407875,0.931966775357268,1,5,glucuronate catabolic process,BP,CRYL1
6181,GO:0019640,0.377747956407875,0.931966775357268,1,5,glucuronate catabolic process to xylulose 5-phosphate,BP,CRYL1
12823,GO:0051167,0.377747956407875,0.931966775357268,1,5,xylulose 5-phosphate metabolic process,BP,CRYL1
17538,GO:1901159,0.377747956407875,0.931966775357268,1,5,xylulose 5-phosphate biosynthetic process,BP,CRYL1
732,GO:0001963,0.377811033688707,0.865806477334213,2,14,synaptic transmission, dopaminergic,BP,RAB3B;PINK1
3944,GO:0008656,0.37784905559081,0.865783165595857,2,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,CTSH;PYCARD
10265,GO:0043030,0.378317155661147,0.828918628618787,3,23,regulation of macrophage activation,BP,MYO18A;LDLR;MIF
4431,GO:0010324,0.378332338433607,0.787823101709837,5,42,membrane invagination,BP,GSN;ABCA7;SNX33;SNX9;SPIRE2
4791,GO:0010994,0.378350320359778,0.931726875461346,1,5,free ubiquitin chain polymerization,BP,PINK1
12037,GO:0048008,0.378362909280328,0.788013996352245,5,41,platelet-derived growth factor receptor signaling pathway,BP,LRP1;PLAT;VEGFA;BCR;RGS14
11243,GO:0045541,0.378614755216781,0.931621398482115,1,5,negative regulation of cholesterol biosynthetic process,BP,APOE
16157,GO:0090206,0.378614755216781,0.931621398482115,1,5,negative regulation of cholesterol metabolic process,BP,APOE
6963,GO:0030638,0.378642873741954,0.931610176829059,1,5,polyketide metabolic process,BP,AKR7A2
6967,GO:0030647,0.378642873741954,0.931610176829059,1,5,aminoglycoside antibiotic metabolic process,BP,AKR7A2
10920,GO:0044597,0.378642873741954,0.931610176829059,1,5,daunorubicin metabolic process,BP,AKR7A2
10921,GO:0044598,0.378642873741954,0.931610176829059,1,5,doxorubicin metabolic process,BP,AKR7A2
16805,GO:0098732,0.378815044167365,0.737155158635764,11,100,macromolecule deacylation,BP,HDAC5;MTA3;BCL6;VEGFA;MTA1;PHF21A;HDAC11;LYPLAL1;ABHD17C;PINK1;SIRT3
2094,GO:0004864,0.379438838536588,0.828129701901891,3,23,protein phosphatase inhibitor activity,MF,PPP1R14A;PPP1R35;ELFN2
2396,GO:0005546,0.379588213929159,0.786835243139254,5,42,phosphatidylinositol-4,5-bisphosphate binding,MF,PLCD1;LDLRAP1;GSDMC;TWF2;GSDMA
4146,GO:0009217,0.380575486372825,0.930836217057863,1,5,purine deoxyribonucleoside triphosphate catabolic process,BP,ADA
7390,GO:0031465,0.380733477081179,0.930772711637404,1,5,Cul4B-RING E3 ubiquitin ligase complex,CC,DDB2
11558,GO:0046134,0.380998527186722,0.826574600926355,3,24,pyrimidine nucleoside biosynthetic process,BP,NME4;UCKL1;TK2
4652,GO:0010810,0.381084303747254,0.719414665772062,15,140,regulation of cell-substrate adhesion,BP,POSTN;SMOC2;FBLN1;MINK1;RHOD;EPHA1;ITGA6;BCL6;VEGFA;ARL2;ADAM15;DMTN;PRKCZ;PPM1F;NINJ1
4611,GO:0010739,0.381140000738258,0.930609143643887,1,5,positive regulation of protein kinase A signaling,BP,MIF
3390,GO:0007176,0.38117482390341,0.826905603294691,3,23,regulation of epidermal growth factor-activated receptor activity,BP,SHC1;CBLC;EREG
13956,GO:0060696,0.381398179908295,0.930505141194688,1,5,regulation of phospholipid catabolic process,BP,LDLR
3363,GO:0007140,0.381410037239726,0.826739456318633,3,23,male meiotic nuclear division,BP,DMC1;AGO4;TDRKH
15022,GO:0070997,0.381448800896245,0.69902261449265,24,232,neuron death,BP,FOS;APOE;LRP1;EGR1;F2R;SIGMAR1;ADARB1;SYNGAP1;PRNP;BNIP3;CEBPB;ENDOG;SSH1;PCSK9;PPARA;CTSZ;PIN1;SLC25A27;SORL1;ERBB3;AKT1;PINK1;RILPL1;FAM162A
7645,GO:0032077,0.381709192226499,0.93037972998472,1,5,positive regulation of deoxyribonuclease activity,BP,AKT1
8871,GO:0034704,0.381726288778012,0.82651595728168,3,23,calcium channel complex,CC,NOS1;PRKACA;SMDT1
15164,GO:0071333,0.381889320657148,0.745654837714092,9,83,cellular response to glucose stimulus,BP,NR1D1;LRP5;ENDOG;MLXIPL;PRKACA;GAS6;PCK2;VSNL1;ERN1
14740,GO:0070459,0.382127259212477,0.930210933520269,1,5,prolactin secretion,BP,EGFR
10914,GO:0044557,0.382158836074079,0.930198174103648,1,5,relaxation of smooth muscle,BP,ADORA2B
15350,GO:0071621,0.382199070536523,0.784374035254215,5,44,granulocyte chemotaxis,BP,MAPK3;TRPV4;VAV3;ADGRE2;CKLF
1370,GO:0003263,0.382553765565285,0.930038472967859,1,5,cardioblast proliferation,BP,HES1
1372,GO:0003266,0.382556583665335,0.930037332588549,1,5,regulation of secondary heart field cardioblast proliferation,BP,HES1
14903,GO:0070813,0.382791654780976,0.929942168260825,1,5,hydrogen sulfide metabolic process,BP,CBS
13244,GO:0051959,0.382843678327162,0.825725279095074,3,23,dynein light intermediate chain binding,MF,DNAH1;HOOK2;RILPL1
5421,GO:0016289,0.383486527165432,0.862304504421747,2,14,CoA hydrolase activity,MF,ACOT7;ACOT11
4848,GO:0014070,0.383705157605321,0.66751857523446,63,628,response to organic cyclic compound,BP,FOS;DUSP6;CST3;RAPGEF3;CYP27B1;GSN;ZFP36L1;POSTN;NR1D1;FAM210B;NFATC4;EGFR;MTHFR;EGR1;HDAC5;THRA;BSG;PTPRU;PKD2;ATP2B4;WNT7A;ID1;ITGA6;DNMT3A;TMEM173;IGFBP2;CEBPB;CALCOCO1;ENDOG;MAPK3;GLB1;ADCY6;SSH1;ABCA2;ADA;AQP3;SLIT3;ZFP36;HLCS;PRKACA;MAP2K2;DMTN;PMVK;VGF;EEF2K;DGKQ;BTRC;PPARA;WNT7B;COMT;PTAFR;RXRA;PCK2;AGO4;WBP2;RXRB;SDC1;AKT1;SLC5A5;LONP2;HOMER2;RARG;GSTM2
4231,GO:0009438,0.384269748982037,0.929341980321302,1,5,methylglyoxal metabolic process,BP,HAGH
4805,GO:0014009,0.384282996012554,0.824704491791062,3,23,glial cell proliferation,BP,IDH2;ETV5;HES1
17485,GO:1900744,0.384400029618565,0.824621375329827,3,23,regulation of p38MAPK cascade,BP,XDH;MINK1;VEGFA
7630,GO:0032052,0.38467170860417,0.929178222185999,1,5,bile acid binding,MF,PYGL
2722,GO:0006109,0.384760034752978,0.719464096932006,14,130,regulation of carbohydrate metabolic process,BP,NR1D1;IGF2;PHLDA2;NTSR1;INSR;PFKFB2;MLXIPL;DGKQ;PPARA;PTAFR;IGFBP4;PDK2;AKT1;MLYCD
18313,GO:1903301,0.384989157188153,0.929048730285965,1,5,positive regulation of hexokinase activity,BP,PFKFB2
3563,GO:0007614,0.3850192876884,0.929036432113999,1,5,short-term memory,BP,COMT
1088,GO:0002676,0.385263084904032,0.928936875119078,1,5,regulation of chronic inflammatory response,BP,ADORA2B
8452,GO:0033605,0.385326309160572,0.928911042957291,1,5,positive regulation of catecholamine secretion,BP,PINK1
4297,GO:0009757,0.385345651231288,0.928903139030662,1,5,hexose mediated signaling,BP,MLXIPL
4406,GO:0010182,0.385345651231288,0.928903139030662,1,5,sugar mediated signaling pathway,BP,MLXIPL
4417,GO:0010255,0.385345651231288,0.928903139030662,1,5,glucose mediated signaling pathway,BP,MLXIPL
9395,GO:0035976,0.38536712467054,0.928894363515036,1,5,transcription factor AP-1 complex,CC,FOS
189,GO:0000407,0.385681192347039,0.799532304156149,4,32,phagophore assembly site,CC,ULK1;ULK2;WIPI2;ATG2A
1130,GO:0002719,0.385841521907423,0.860838208120069,2,14,negative regulation of cytokine production involved in immune response,BP,BCL6;JAK3
97,GO:0000188,0.385846781864193,0.823592480836753,3,23,inactivation of MAPK activity,BP,DUSP6;DUSP5;DUSP7
10568,GO:0043550,0.38613935308403,0.799183481433476,4,32,regulation of lipid kinase activity,BP,PIK3R2;CD81;FGFR3;VAV3
7736,GO:0032262,0.386587568532506,0.928394519083274,1,5,pyrimidine nucleotide salvage,BP,UCKL1
2399,GO:0005575,0.38693481917876,0.68103864686935,1120,11707,cellular_component,CC,TNIP1;HTRA1;FOS;DUSP6;H6PD;LMF1;CEMIP;ADGRL1;APOE;TYSND1;MARVELD1;ESPN;CTNNBIP1;MARCKSL1;TSPAN1;PPL;IDH2;RNPEPL1;PTPRS;ERCC1;WWC3;FLNC;SEMA4B;FAM110C;NT5E;GAA;SYTL1;CLIP2;LTB4R;CITED4;NAPRT;BTBD2;PYGB;RNF44;CST3;SHANK2;LTBP4;RAPGEF3;TCFL5;MRC2;PGM1;CYP27B1;GSN;CLCA2;EVI5L;XDH;OAF;PRDX5;NDRG1;PGLS;PCBP4;PRSS3;PRODH;PGF;CADM4;MEF2D;NOS1;LTBP1;MARCH9;PARVB;ARAP1;C14ORF132;ZFP36L1;COL6A1;TCTN1;CGREF1;POSTN;GRB7;NR1D1;CRAT;EFS;ALOX15B;ARRDC1;EPN3;FAM210B;NYNRIN;POLD4;SCN8A;SLCO4A1;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;CPT2;RHPN1;MYZAP;IGF2;NFATC4;GPX3;NME4;MST1R;LRP1;GAMT;MAPK13;APPL2;HEBP1;KCNG1;CDK18;RALGDS;ST6GALNAC2;LTBP2;RAB11FIP4;THEM6;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;SMOC2;MMP28;B3GAT3;HADH;NLGN2;CRYL1;SUGCT;ACSF2;REEP6;FBXO2;ACOT7;TCEA2;DUSP5;TOM1L2;FKBP9;HS1BP3;PPP1R14A;ISYNA1;SLC43A1;UROS;FHL1;JOSD2;LOXL1;MXD4;DDB2;SERPING1;MTHFR;KDSR;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CMTM7;MXRA7;SDK2;CRTC1;ARPIN;PYGL;ARHGEF4;TRIM65;DOPEY2;SYT8;NAGLU;SHC1;RGL2;F2R;PTK6;GNAL;BPHL;NPEPL1;ABCA7;DEAF1;LAMA5;PPP2R3B;SLC9A3R2;CA12;BAHCC1;GALE;BBS2;SLC16A5;ACTA2;PRSS8;TMCC3;S100A4;CTSB;ESRG;LPCAT4;DNAH1;RNF208;SHC2;PITPNC1;SLC16A3;CORO1B;CXXC5;ULK2;DGKA;GJC2;IGSF9;DHRS1;MALL;THBS3;D2HGDH;ZMYND8;TBC1D14;ASH2L;ZSCAN18;PACS2;GRAMD4;NXPH4;SOX12;MXI1;CERS4;PLAT;KCNC4;MMP1;ABCG1;RIN1;ANK3;DHRS11;NOL4L;PIK3R2;OPLAH;S100A6;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;ARHGAP23;PLD3;KCNJ15;DOCK4;ZP3;CRTAP;CSMD2;RPS6KA2;NMRK1;NISCH;LRP5;DBNDD1;HYAL1;TMEM54;TUBG2;ANO8;MARK4;TENM2;PLTP;SLC2A9;LRP3;MAML3;KHNYN;B4GALNT4;ZFPM1;BCAM;TFEB;ERBB2;SLC13A3;EXOC2;FBLN1;BRSK1;MICALL2;BSG;CTSF;SCMH1;PTPRU;OGDHL;PKD2;CBS;SH3TC1;TMEM129;FUCA1;TST;SCN4B;IQSEC2;CPT1C;EDEM1;ABTB1;VWA5A;SLC7A8;ITGB4;ITPR3;PLXNB3;H2AFJ;PRAF2;PHLDA2;VAT1;DNM1;SPRY4;DDIT4L;FCHO1;MPRIP;PTHLH;CDKN1C;RIMS3;LRP11;SALL2;MSRB2;IFT140;VIPR1;CUL9;CD9;KIF13B;XPC;PTPRE;ANGEL1;CACFD1;NINL;SIGMAR1;PAK6;HEXB;DNAJC4;SERPINE2;VPS11;VAMP2;CCDC69;FUZ;GALNT12;FOXQ1;RNF135;NPHP4;LTB4R2;UNK;KIAA1549L;NTSR1;JADE2;THSD4;CD320;MINK1;RALGAPA2;ATP2B4;GGT1;SNN;TMOD2;SLC6A8;TFDP2;PHF7;CSNK1E;ACP5;RASA4;PLCD1;TRAPPC9;AGAP1;ZFYVE21;DIRC2;ADAMTS7;ENKD1;PDCD4;DOCK6;TMEM134;GM2A;DHRS4L2;SLC20A1;BEX2;ACAP3;TNFRSF25;GLUL;PRR7;RHOD;DTX3;ZKSCAN1;ARVCF;TNXB;USP20;PEX10;ARMCX2;ASIC1;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;RAB3D;PLCXD1;LCE1E;SH3PXD2B;TBC1D8;FBXW8;ZC3H6;ID1;CELSR1;AKR7A2;GRK6;MVD;LGALS9C;MZT2A;B4GAT1;POLL;WDR27;NDUFS8;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;CCNG2;TXNRD3;SYNGAP1;IL20RB;NBEAL2;HAGH;FBXO27;DNMT3A;DNPH1;LPAR3;TMEM173;PRNP;SERINC2;DHX32;PAPLN;SRD5A3;OXLD1;ATP7B;EFNB3;IAH1;RNASET2;GRAMD1A;FBXL8;SNX33;FBXO41;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;SLC12A7;ECM1;CEP250;NPDC1;ATG16L2;SNX9;STAT6;DLG4;SPEG;ABCD1;MARCH2;REEP2;FGGY;MTA3;MKNK2;PLCD3;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;MYO18A;TMEM107;ARHGAP27;CERCAM;MZT2B;DNAJB5;MYCBPAP;PHC2;SCART1;PLEKHH2;C1ORF210;BCL6;FAM131A;TTYH3;ANKZF1;UCKL1;PFKFB2;ATP12A;PLXNB1;FAM213A;CHMP1B;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;TMEM92;BNIP3;CD81;SRMS;FCGRT;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;HOOK2;LRRC8A;ARL2;YPEL3;C22ORF23;VANGL2;MAST4;FBXW4;ELMO3;TMEM63C;AP2A2;CEBPB;RHBDF2;DPP7;GPRC5C;SHANK3;HSD11B1L;SSC4D;ACVR2B;HSF4;ADAM15;NAB2;NUDCD3;CALCOCO1;ZDHHC1;S1PR2;ENDOG;TNFRSF6B;MAPK3;PDZD2;FBXL16;PLEKHG5;TUB;KCNAB2;ETV5;OLFM2;CARD19;AMN;SLC22A18;GLB1;CAPNS2;DHTKD1;EXD3;ARL10;C19ORF33;RAB40B;TNNT1;DVL1;ENTPD2;GALK1;MTA1;LHPP;FYCO1;KLHL29;WIPF1;GPSM1;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;PHGDH;ST3GAL3;SLC16A13;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;TMEM25;PC;ACAD10;YPEL2;GIGYF1;SSH1;COMTD1;FURIN;MLXIPL;ZNF624;NAGS;FBF1;MBOAT7;SLC48A1;SAMD3;CUL7;MEFV;EVC;ARHGAP22;SLC2A3;TRIM4;NRP2;GPR153;NADK;PLEKHG2;ABCA2;TNFRSF14;TK2;LRSAM1;ZNF414;LY6K;ADA;FKBP10;CDC42EP5;TRIM45;MCTP1;OSBPL5;PYCR2;PIDD1;RETSAT;PAG1;PHF21A;SH2D2A;AQP3;HTR7;RASL10B;MYH16;CELSR2;ACY1;CKMT1A;PFKL;IL6R;SLIT3;PCSK9;GGACT;FCGBP;TMEM9;SLC28A2;ZFP36;ETV4;RHOF;BTBD11;MAPKBP1;HLCS;CYHR1;RSPH3;CTXN1;FGFR3;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;KIAA1549;LRRK1;NUDT10;SPATA20;PLCH2;DGUOK;MAGEF1;CYFIP2;SLC38A10;RPS6KA5;MFSD13A;SCNN1A;HBEGF;SLC25A37;ITGB5;RAB3B;MAP2K2;PI4K2A;FGFR4;SPTB;FBXW5;MXRA8;SLC37A2;STX10;GAREM2;TSPAN33;DMTN;RAPGEF5;RNF215;PMVK;BBS1;MYH3;PSD4;MDGA1;XYLT2;HDAC11;VGF;TNFRSF1A;SEZ6L2;EHD4;MAPK8IP1;TCF25;SEMA3B;LDLR;PTOV1;FAM214B;LYPLAL1;CYP3A5;ACOT11;ROBO3;SNX17;SOX13;ABHD17C;TRPV4;MPG;RHOBTB2;PIGZ;IFNGR2;BHLHE40;EIF4EBP3;RRNAD1;CROCC;CCDC92;RAG1;ZNF80;DUSP7;PHLDA1;NHSL1;LRRC45;TNFAIP8L1;EEF2K;RHBDL1;TMTC4;MSLN;HMGA2;LDLRAP1;TM7SF2;SEMA3F;ELK3;AHNAK2;DGKQ;PEX7;KLHDC2;SEMA4C;MVB12A;HK1;FAM171A2;NMRAL1;FAM3A;ZXDC;SLC29A4;SLC35E2B;MIB2;FBXO17;CHST6;C1ORF115;SDHAF4;PADI3;GAS6;BTRC;MEX3A;POU6F1;LLGL1;ANKS6;ADGRB2;ZNF217;PPARA;HMGCL;TKFC;GUK1;TSPAN4;TMEM187;STK32C;WNT7B;BLVRB;GIT1;COMT;ALDH16A1;TTC7B;SUFU;AIG1;PTAFR;PLEKHG6;RFNG;ANKRD13D;DMC1;IMPA2;ARHGEF37;LTBP3;TMEM200A;PAN2;REEP4;ZNF446;ATG2A;RXRA;PCK2;PCSK1;VAV3;LRP10;VASN;BCR;TMEM175;NEO1;IGFBP4;SDHA;GSDMC;MUC19;TBC1D16;USP21;RNF123;WDR60;PRKCZ;ADAMTS13;ZDHHC24;CLTCL1;HLTF;MDH2;CAPG;BCORL1;INPP5D;TM7SF3;TMCO6;ETFB;ABCD4;SPATA7;NYAP1;SLITRK6;TWF2;ZNF485;SH3GLB2;KLHDC8B;TPP1;PDK2;GPC1;TMX4;ICOSLG;SRSF5;ZNF160;RFXANK;TEF;SMOX;CEP68;SMARCD2;MAPKAPK3;NDE1;AGO4;RAD23A;ARAP3;CDHR1;FGFR1;CTSZ;CAMKK1;CHADL;SPSB3;PIN1;MAN1B1;MN1;PNPLA4;ZNF563;C5;KMT5C;PHYH;TMEM204;IRF2BPL;CMBL;PROX1;WBP2;GTPBP1;PCDHGC3;C21ORF2;NICN1;ASAP2;DLG3;GPR155;KCNMA1;ESYT2;BIN1;VSNL1;MTMR11;UNC119B;YIPF3;TMEM8B;SERPINB6;OSCP1;PI4KAP2;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;CES2;SLC25A27;TMCO3;GRB10;BFSP1;JARID2;SYNC;CAPN2;SESN2;NDUFA4L2;TOLLIP;ADCK5;WNT2B;TSTA3;WRAP73;TMEM161A;RXRB;CSTB;PROCR;SNPH;MAN2B2;TMEM231;PNRC1;MAPRE3;DUSP23;LCAT;GUCA1B;MACROD1;ADGRE2;GAL3ST4;SMDT1;PTMS;PITPNM3;TMPRSS11D;CYBRD1;MADD;LMLN;PAQR4;RTN4R;ELFN2;OR7D2;EPB41L3;PIGV;SLC9A7;TIMP1;CD68;SDC1;WHAMMP3;GRHPR;SH2B3;ACTR1B;APOBEC3C;FGFBP1;RTN2;H1FX;PEAR1;EPS8L1;PLEKHH3;PIGQ;WNT3;LYST;GSTT1;ZFP41;PPM1F;KIAA1191;OLFML2A;MICALCL;SBF1;SORL1;STK39;COL13A1;VEGFB;ACVR1B;KRTCAP3;MEF2B;TBC1D17;ANO9;FAM189B;TP73-AS1;GSDMA;ZSCAN30;GSS;AHCYL2;ALS2CL;TSNARE1;ADORA2B;TPCN1;HGSNAT;SLC25A29;ERBB3;ABR;ZER1;CCDC85B;PNMA1;CYP2S1;AKT1;CTSD;TRAP1;STON1;TMBIM4;NLRX1;SEPT8;ADAM19;ZNF385A;TP53INP1;LRCH4;NDRG2;TUT1;FAM8A1;SMARCA1;VPS33B;SIX5;ERCC6;PCMTD2;ACP6;GPD1L;EPS8L2;TDRKH;SLC5A5;SUN1;NAGA;TMEM120A;SPPL2B;IL17RD;UQCR11;SSBP2;RPL39L;ADCK2;R3HDM2;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;MPLKIP;SNTA1;ARHGEF10L;KDM4B;CAMTA2;HOMER2;LGALS9B;PLPPR2;RGS14;SYNE3;PLEKHH1;GOLGA2P5;PCIF1;MAFIP;SPIRE2;CCDC106;R3HDM4;HEXDC;EIF4G3;ZNF710;CTSH;EHBP1L1;ABHD14B;P3H4;MLST8;ROBO4;AGPAT4;RILPL1;NRSN1;RSAD1;CBLC;ATXN10;EPN2;RFX2;RNF187;PYCARD;NINJ1;MAP2K3;PNPO;SNX29;RHBG;POMT1;TRERF1;PCSK1N;KCNN4;DNAAF5;DDN;DNAJC22;PMS2P5;AS3MT;NDUFV3;STK17A;ERN1;CKLF;RANBP9;ZNF319;APOBEC3F;PRIMPOL;ACADS;FBXL20;TMEM229B;GCAT;WDR63;MOCS1;ARHGEF19;SIRT3;ALKBH6;ORAI3;WBP1;GLI4;TMEM158;C12ORF66;CMTM4;SLC2A1;CPNE7;MLYCD;TAZ;RNASEK;JAK3;BCKDHA;MAST3;KIFC2;LITAF;APBA1;MZF1;NEIL1;FUK;ORAI2;RARG;ING4;EIF4E3;GALNS;PBXIP1;EREG;FAM162A;PPCS;FCHSD1;GSTM2;ABHD14A;ZNF514;PODXL2;ZFYVE19;TRIM7;SHISA6;MORN4;GIPR;WDR18;PQLC2;SFI1;TP53I11;KRT15;ADAMTSL4;TRNP1;TTLL11;ZNF837;TMED4;POLM;SEMA4F;FAM50A;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;MIF;APCDD1L;SULF2;STXBP2;KIF26B;UBL5;LZTS2
12968,GO:0051410,0.386950966481729,0.928245272542921,1,5,detoxification of nitrogen compound,BP,GSTM2
5696,GO:0016835,0.387044598347975,0.767484793940081,6,53,carbon-oxygen lyase activity,MF,UROS;CA12;CBS;POLL;HMGA2;NEIL1
18572,GO:1903862,0.387177355336165,0.928152199236979,1,5,positive regulation of oxidative phosphorylation,BP,PINK1
19236,GO:1905446,0.387177355336165,0.928152199236979,1,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,PINK1
19927,GO:2000514,0.387238471418926,0.822600263076727,3,23,regulation of CD4-positive, alpha-beta T cell activation,BP,BCL6;PRKCZ;JAK3
11785,GO:0046689,0.387312518996239,0.928096595400074,1,5,response to mercury ion,BP,BSG
9261,GO:0035710,0.387382574987644,0.780667212283901,5,42,CD4-positive, alpha-beta T cell activation,BP,ZFPM1;STAT6;BCL6;PRKCZ;JAK3
6100,GO:0019348,0.387452802238752,0.92803885765001,1,5,dolichol metabolic process,BP,SRD5A3
12042,GO:0048013,0.387684973537407,0.747972412577962,8,72,ephrin receptor signaling pathway,BP,EPHB2;DNM1;EPHA1;EFNB3;AP2A2;EPHB3;GIT1;VAV3
12911,GO:0051294,0.387732503664286,0.822247452451353,3,23,establishment of spindle orientation,BP,SPRY2;LLGL1;NDE1
12251,GO:0048569,0.387757486076356,0.85963954435035,2,14,post-embryonic animal organ development,BP,ERCC1;VEGFA
1233,GO:0002922,0.387931950603271,0.927841436131313,1,5,positive regulation of humoral immune response,BP,ZP3
8524,GO:0033865,0.388135477225148,0.797355653024324,4,33,nucleoside bisphosphate metabolic process,BP,ACOT7;ABHD14B;PPCS;PODXL2
8530,GO:0033875,0.388135477225148,0.797355653024324,4,33,ribonucleoside bisphosphate metabolic process,BP,ACOT7;ABHD14B;PPCS;PODXL2
8550,GO:0034032,0.388135477225148,0.797355653024324,4,33,purine nucleoside bisphosphate metabolic process,BP,ACOT7;ABHD14B;PPCS;PODXL2
17149,GO:0102991,0.388294753632905,0.927691731793387,1,5,myristoyl-CoA hydrolase activity,MF,ACOT7
12458,GO:0050432,0.388448165961699,0.859206180933851,2,14,catecholamine secretion,BP,NISCH;PINK1
17721,GO:1901685,0.388588695390667,0.857524872775536,2,16,glutathione derivative metabolic process,BP,GSTT1;GSTM2
17722,GO:1901687,0.388588695390667,0.857524872775536,2,16,glutathione derivative biosynthetic process,BP,GSTT1;GSTM2
11605,GO:0046330,0.388655894631746,0.733845083186338,10,91,positive regulation of JNK cascade,BP,PKN1;MINK1;WNT7A;FZD8;VANGL2;TRPV4;WNT7B;ERCC6;PYCARD;ERN1
7942,GO:0032553,0.388759830227338,0.646895181099137,143,1436,ribonucleotide binding,MF,RAPGEF3;NOS1;SCN8A;EPHB2;OBSCN;NME4;MST1R;MAPK13;CDK18;EGFR;ACSF2;ULK1;PKN1;PYGL;PTK6;GNAL;ABCA7;ACTA2;DNAH1;ULK2;DGKA;ABCG1;OPLAH;NEK9;RPS6KA2;NMRK1;TUBG2;MARK4;ERBB2;BRSK1;DNM1;CUL9;KIF13B;PAK6;MINK1;ATP2B4;CSNK1E;AGAP1;GLUL;RHOD;INSR;RAB3D;GRK6;MVD;EPHA1;TMEM173;DHX32;ATP7B;SPEG;ABCD1;MKNK2;STRADB;RAB25;FAM20C;MYO18A;UCKL1;PFKFB2;ATP12A;DYRK1B;SRMS;ARL2;MAST4;ACVR2B;MAPK3;ARL10;RAB40B;ENTPD2;GALK1;FYCO1;ADCY6;PKN3;EPHB3;PC;NADK;ABCA2;TK2;RASL10B;CKMT1A;PFKL;RHOF;HLCS;FGFR3;PRKACA;LRRK1;DGUOK;RPS6KA5;RAB3B;MAP2K2;PI4K2A;FGFR4;PMVK;MYH3;EHD4;TRPV4;RHOBTB2;EEF2K;DGKQ;HK1;TKFC;GUK1;STK32C;DMC1;PCK2;BCR;PRKCZ;HLTF;ABCD4;TWF2;PDK2;MAPKAPK3;FGFR1;CAMKK1;GTPBP1;ASS1;GAL3ST4;ACTR1B;STK39;ACVR1B;GSS;ERBB3;AKT1;TRAP1;NLRX1;SEPT8;TUT1;SMARCA1;ERCC6;ADCK2;PINK1;EHD3;LONP2;MAP2K3;PNPO;STK17A;ERN1;MOCS1;JAK3;MAST3;KIFC2;FUK;TTLL11;RAB40C;KIF26B
19064,GO:1904994,0.388847226270897,0.927463398904275,1,5,regulation of leukocyte adhesion to vascular endothelial cell,BP,PTAFR
9076,GO:0035356,0.3888663526933,0.927455486204337,1,5,cellular triglyceride homeostasis,BP,SLC25A27
16896,GO:0098902,0.389132668407818,0.927345255126978,1,5,regulation of membrane depolarization during action potential,BP,ANK3
9881,GO:0042182,0.389370955457129,0.927246538579637,1,5,ketone catabolic process,BP,HAGH
12131,GO:0048261,0.389500819417215,0.858544412409249,2,14,negative regulation of receptor-mediated endocytosis,BP,DLG4;PCSK9
15379,GO:0071670,0.389763023256055,0.927083935778136,1,5,smooth muscle cell chemotaxis,BP,CORO1B
4273,GO:0009649,0.389893107387403,0.820700858677239,3,23,entrainment of circadian clock,BP,CRTC1;MTA1;BHLHE40
5615,GO:0016701,0.3900320987312,0.858209824160668,2,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,ALOX15B;HPDL
5616,GO:0016702,0.3900320987312,0.858209824160668,2,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,ALOX15B;HPDL
18530,GO:1903772,0.390136792003544,0.926928715150554,1,5,regulation of viral budding via host ESCRT complex,BP,MVB12A
9676,GO:0038089,0.390366790631557,0.926833099630466,1,5,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,VEGFA
13551,GO:0060046,0.390470225018517,0.926790074696361,1,5,regulation of acrosome reaction,BP,ZP3
19258,GO:1905516,0.390470225018517,0.926790074696361,1,5,positive regulation of fertilization,BP,ZP3
15241,GO:0071447,0.390751728026234,0.926672901220248,1,5,cellular response to hydroperoxide,BP,TP53INP1
4338,GO:0009912,0.390831767890665,0.92663956427184,1,5,auditory receptor cell fate commitment,BP,HES1
13598,GO:0060120,0.390831767890665,0.92663956427184,1,5,inner ear receptor cell fate commitment,BP,HES1
3145,GO:0006751,0.390843056135699,0.9266348619221,1,5,glutathione catabolic process,BP,GGT1
17859,GO:1902165,0.390918658373545,0.85679034126968,2,15,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,ZNF385A;MIF
11274,GO:0045607,0.391060727628596,0.926544150274823,1,5,regulation of inner ear auditory receptor cell differentiation,BP,HES1
11291,GO:0045631,0.391060727628596,0.926544150274823,1,5,regulation of mechanoreceptor differentiation,BP,HES1
20136,GO:2000980,0.391060727628596,0.926544150274823,1,5,regulation of inner ear receptor cell differentiation,BP,HES1
18909,GO:1904688,0.391114664018893,0.926521662393721,1,5,regulation of cytoplasmic translational initiation,BP,RPL13A
11536,GO:0046100,0.391246732974956,0.926466580623864,1,5,hypoxanthine metabolic process,BP,ADA
14140,GO:0061051,0.391306244097015,0.92644175215447,1,5,positive regulation of cell growth involved in cardiac muscle cell development,BP,PIN1
5097,GO:0015399,0.391561509349828,0.744575854701922,8,73,primary active transmembrane transporter activity,MF,ABCA7;ABCG1;ATP2B4;ATP7B;ABCD1;ATP12A;ABCA2;ABCD4
5098,GO:0015405,0.391561509349828,0.744575854701922,8,73,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,ABCA7;ABCG1;ATP2B4;ATP7B;ABCD1;ATP12A;ABCA2;ABCD4
20068,GO:2000765,0.391575540039857,0.819492474769834,3,23,regulation of cytoplasmic translation,BP,UNK;ZNF385A;RPL13A
7799,GO:0032364,0.391766737323419,0.926249457304107,1,5,oxygen homeostasis,BP,WNT7B
18455,GO:1903587,0.392023849553677,0.92614195726483,1,5,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,VEGFA
7437,GO:0031584,0.39213060906318,0.926097292308591,1,5,activation of phospholipase D activity,BP,PRKCZ
15363,GO:0071639,0.392185205750672,0.926074444301716,1,5,positive regulation of monocyte chemotactic protein-1 production,BP,TRPV4
7917,GO:0032506,0.392215791087599,0.819031685853617,3,23,cytokinetic process,BP,SNX33;SNX9;SPIRE2
7804,GO:0032369,0.392270567786707,0.856795729044855,2,14,negative regulation of lipid transport,BP,PCSK9;AKT1
11877,GO:0046923,0.392316244521735,0.926019588594897,1,5,ER retention sequence binding,MF,CEMIP
13793,GO:0060415,0.39231758552818,0.776728870887764,5,42,muscle tissue morphogenesis,BP,ZFPM1;ADARB1;VANGL2;RXRA;PROX1
1799,GO:0004448,0.392350595310837,0.926005204470986,1,5,isocitrate dehydrogenase activity,MF,IDH2
2715,GO:0006102,0.392357128899153,0.926002468387898,1,5,isocitrate metabolic process,BP,IDH2
17543,GO:1901165,0.392357634429404,0.926002256683316,1,5,positive regulation of trophoblast cell migration,BP,ACVR1B
3247,GO:0006915,0.392390850736672,0.644116405992548,136,1389,apoptotic process,BP,DUSP6;APOE;CST3;GSN;XDH;PRDX5;NDRG1;PRODH;MEF2D;ZFP36L1;ALOX15B;RBCK1;EPHB2;OBSCN;IGF2;NFATC4;NME4;MST1R;LRP1;EGFR;H1F0;HS1BP3;EGR1;PKN1;ARHGEF4;SHC1;RGL2;F2R;CTSB;PACS2;GRAMD4;PEG3;THRA;RPS6KA2;NISCH;LRP5;ERBB2;PHLDA2;SIGMAR1;PAK6;NTSR1;MINK1;TFDP2;PDCD4;BEX2;TNFRSF25;WNT7A;INSR;ID1;RABGGTA;EPHA1;ADARB1;ITGA6;SYNGAP1;DNMT3A;TMEM173;PRNP;SPRY2;HINT2;MNT;MKNK2;STRADB;MYO18A;BCL6;BNIP3;VEGFA;ELMO3;CEBPB;ENDOG;TNFRSF6B;MAPK3;PLEKHG5;EPHB3;PLEKHG2;TNFRSF14;ADA;PIDD1;IL6R;SLIT3;PCSK9;ZFP36;FGFR3;CYFIP2;MAP2K2;DAP;FGFR4;TNFRSF1A;MAPK8IP1;RAG1;PHLDA1;TNFAIP8L1;EEF2K;HMGA2;GAS6;VAV3;PRKCZ;INPP5D;PDK2;AGO4;FGFR1;CTSZ;PIN1;KCNMA1;BIN1;PPP1R13L;SLC25A27;TMEM161A;MADD;EPB41L3;TIMP1;PPM1F;STK39;ACVR1B;GSDMA;ERBB3;ABR;PNMA1;AKT1;TRAP1;TMBIM4;ZNF385A;TP53INP1;ERCC6;PINK1;CTSH;PYCARD;MAP2K3;STK17A;ERN1;ARHGEF19;JAK3;RARG;ING4;FAM162A;ADAMTSL4;MIF
3489,GO:0007389,0.392436442874244,0.685880256093908,26,251,pattern specification process,BP,DUSP6;CTNNBIP1;TCTN1;MDFI;LRP5;SCMH1;PKD2;IFT140;FUZ;WNT7A;CELSR1;SYNGAP1;TMEM107;VANGL2;ACVR2B;HES1;CELSR2;SEMA3F;WNT7B;SUFU;RFNG;FGFR1;WNT2B;WNT3;GAS8;RARG
18659,GO:1904035,0.39246737124385,0.776608934681255,5,42,regulation of epithelial cell apoptotic process,BP,GSN;ZFP36L1;PDCD4;ZFP36;GAS6
13443,GO:0055006,0.392482778702632,0.776596596301647,5,42,cardiac cell development,BP,OBSL1;PDCD4;VEGFA;PIN1;PROX1
3921,GO:0008611,0.392492265853395,0.925945862912515,1,5,ether lipid biosynthetic process,BP,PEX7
11690,GO:0046504,0.392492265853395,0.925945862912515,1,5,glycerol ether biosynthetic process,BP,PEX7
17635,GO:1901503,0.392492265853395,0.925945862912515,1,5,ether biosynthetic process,BP,PEX7
20167,GO:2001046,0.392548077138454,0.925922477218541,1,5,positive regulation of integrin-mediated signaling pathway,BP,DMTN
8267,GO:0033085,0.392674224952457,0.92586960286154,1,5,negative regulation of T cell differentiation in thymus,BP,ERBB2
6797,GO:0030260,0.392691978872483,0.730188603232528,10,93,entry into host cell,BP,GSN;EGFR;CTSB;EXOC2;EFNB3;CD81;TNFRSF14;ITGB5;LDLR;GAS6
10856,GO:0044409,0.392691978872483,0.730188603232528,10,93,entry into host,BP,GSN;EGFR;CTSB;EXOC2;EFNB3;CD81;TNFRSF14;ITGB5;LDLR;GAS6
13169,GO:0051806,0.392691978872483,0.730188603232528,10,93,entry into cell of other organism involved in symbiotic interaction,BP,GSN;EGFR;CTSB;EXOC2;EFNB3;CD81;TNFRSF14;ITGB5;LDLR;GAS6
13176,GO:0051828,0.392691978872483,0.730188603232528,10,93,entry into other organism involved in symbiotic interaction,BP,GSN;EGFR;CTSB;EXOC2;EFNB3;CD81;TNFRSF14;ITGB5;LDLR;GAS6
11084,GO:0045117,0.392740918940083,0.856497700827932,2,14,azole transport,BP,ADA;SLC25A29
4013,GO:0009052,0.392814256356258,0.925810882140525,1,5,pentose-phosphate shunt, non-oxidative branch,BP,TALDO1
19998,GO:2000648,0.392840498327739,0.818581585360014,3,23,positive regulation of stem cell proliferation,BP,VEGFA;HMGA2;LTBP3
5365,GO:0016188,0.39284107071537,0.925799634561368,1,5,synaptic vesicle maturation,BP,DLG4
15464,GO:0071863,0.392943813352359,0.925756528341861,1,5,regulation of cell proliferation in bone marrow,BP,HMGA2
15465,GO:0071864,0.392943813352359,0.925756528341861,1,5,positive regulation of cell proliferation in bone marrow,BP,HMGA2
4317,GO:0009838,0.392956990424363,0.925750998719415,1,5,abscission,BP,ZFYVE19
5319,GO:0016055,0.392984408714526,0.671639111570522,39,387,Wnt signaling pathway,BP,APOE;CTNNBIP1;NFATC4;LRP1;MDFI;EGR1;LRP5;PTPRU;FUZ;NPHP4;CSNK1E;WNT7A;CELSR1;GRK6;WWTR1;IGFBP2;FZD8;VANGL2;FBXW4;AP2A2;CALCOCO1;DVL1;CELSR2;LRRK1;BTRC;WNT7B;IGFBP4;AGO4;PIN1;GRB10;WNT2B;SDC1;WNT3;NDRG2;ARHGEF19;RARG;SHISA6;SULF2;LZTS2
4540,GO:0010631,0.393041296559937,0.693649168819322,21,202,epithelial cell migration,BP,APOE;PRSS3;PKN1;CORO1B;HDAC5;HYAL1;LTB4R2;WNT7A;ID1;RAB25;VEGFA;PLEKHG5;PKN3;NRP2;HBEGF;FGFR1;PROX1;PPM1F;AKT1;CTSH;MAP2K3
19139,GO:1905206,0.393093510360674,0.925693694662902,1,5,positive regulation of hydrogen peroxide-induced cell death,BP,ENDOG
12543,GO:0050718,0.393131154407776,0.856250199840756,2,14,positive regulation of interleukin-1 beta secretion,BP,HK1;PYCARD
2082,GO:0004849,0.393194965959718,0.925651091237688,1,5,uridine kinase activity,MF,UCKL1
17723,GO:1901698,0.393335092121875,0.654914746470048,73,733,response to nitrogen compound,BP,FOS;APOE;RAPGEF3;GSN;ZFP36L1;COL6A1;IGF2;LRP1;MAPK13;EGFR;HADH;FBXO2;UROS;MTHFR;EGR1;SHC1;PIK3R2;HDAC5;LRP5;BSG;PKD2;TMEM129;EDEM1;CD9;PTPRE;VAMP2;ATP2B4;INSR;ID1;DNMT3A;TMEM173;PRNP;STAT6;ANKZF1;CD81;CEBPB;MAPK3;ADCY6;SSH1;ADA;PCSK9;HLCS;PRKACA;MAP2K2;DMTN;VGF;LDLR;TRPV4;EEF2K;DGKQ;PPARA;PTAFR;PCK2;PRKCZ;ADAMTS13;PDK2;SRSF5;AGO4;MAN1B1;GRB10;CAPN2;SESN2;TIMP1;SDC1;GSS;AKT1;SLC5A5;HOMER2;POMT1;SLC2A1;JAK3;EREG;GSTM2
564,GO:0001706,0.393744240233948,0.775585562201881,5,42,endoderm formation,BP,DUSP6;COL6A1;DUSP5;ITGB5;HMGA2
4275,GO:0009651,0.39387485807317,0.855777923001223,2,14,response to salt stress,BP,ZFP36L1;TRPV4
808,GO:0002082,0.393909810903745,0.855755707602358,2,14,regulation of oxidative phosphorylation,BP,MLXIPL;PINK1
2619,GO:0005947,0.393929046181057,0.92534238810846,1,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,BCKDHA
20073,GO:2000773,0.393932372882263,0.855741366694654,2,14,negative regulation of cellular senescence,BP,BCL6;HMGA2
16067,GO:0090074,0.393949201580521,0.925333901068213,1,5,negative regulation of protein homodimerization activity,BP,ID1
12971,GO:0051414,0.39409970594467,0.925270507923631,1,5,response to cortisol,BP,SLIT3
4832,GO:0014048,0.394246916175153,0.925208470314726,1,5,regulation of glutamate secretion,BP,NTSR1
1953,GO:0004661,0.394442655547333,0.925125932482578,1,5,protein geranylgeranyltransferase activity,MF,RABGGTA
18549,GO:1903817,0.394456804008286,0.925119964304021,1,5,negative regulation of voltage-gated potassium channel activity,BP,ANK3
11278,GO:0045618,0.394476296001413,0.855395419569596,2,14,positive regulation of keratinocyte differentiation,BP,CYP27B1;ALOX15B
5603,GO:0016661,0.394612704575058,0.925054182149162,1,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,CBS
5695,GO:0016833,0.394768177983122,0.924988544885303,1,5,oxo-acid-lyase activity,MF,HMGCL
7979,GO:0032609,0.394781501661948,0.761124321197163,6,53,interferon-gamma production,BP,ZP3;ZFPM1;IL20RB;PRNP;GAS6;PYCARD
14212,GO:0061213,0.394844199053961,0.855161188558391,2,14,positive regulation of mesonephros development,BP,VEGFA;WNT2B
571,GO:0001714,0.39500825446584,0.924887120802249,1,5,endodermal cell fate specification,BP,DUSP6
8025,GO:0032687,0.395148458875813,0.924827850286562,1,5,negative regulation of interferon-alpha production,BP,PTPRS
12327,GO:0048712,0.395174403143376,0.924816879363016,1,5,negative regulation of astrocyte differentiation,BP,LDLR
2380,GO:0005521,0.395198871445214,0.85493520026832,2,14,lamin binding,MF,PRNP;SUN1
6296,GO:0019934,0.395222234668591,0.924796650504264,1,5,cGMP-mediated signaling,BP,APOE
883,GO:0002250,0.395223737350125,0.693674535540292,20,192,adaptive immune response,BP,ERCC1;SERPING1;PKN1;ZP3;TFEB;PRR7;IL20RB;STAT6;SCART1;BCL6;ADA;PAG1;RAG1;PRKCZ;INPP5D;ICOSLG;C5;CTSH;PYCARD;JAK3
2999,GO:0006552,0.395254173493734,0.924783141106856,1,5,leucine catabolic process,BP,HMGCL
5781,GO:0017022,0.395623130726777,0.773863430250896,5,43,myosin binding,MF,GSN;RAB3D;RAB25;RAB3B;PYCARD
12162,GO:0048313,0.395640596792369,0.854653495787015,2,14,Golgi inheritance,BP,MAPK3;MAP2K2
18309,GO:1903297,0.395781222479315,0.924559995895725,1,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,PINK1
18310,GO:1903298,0.395781222479315,0.924559995895725,1,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,PINK1
8966,GO:0035090,0.396291545989675,0.924343544568873,1,5,maintenance of apical/basal cell polarity,BP,LRCH4
11130,GO:0045199,0.396291545989675,0.924343544568873,1,5,maintenance of epithelial cell apical/basal polarity,BP,LRCH4
4217,GO:0009403,0.396382508291925,0.924304923275082,1,5,toxin biosynthetic process,BP,CBS
15160,GO:0071326,0.396386862974078,0.733089312541175,9,84,cellular response to monosaccharide stimulus,BP,NR1D1;LRP5;ENDOG;MLXIPL;PRKACA;GAS6;PCK2;VSNL1;ERN1
15162,GO:0071331,0.396386862974078,0.733089312541175,9,84,cellular response to hexose stimulus,BP,NR1D1;LRP5;ENDOG;MLXIPL;PRKACA;GAS6;PCK2;VSNL1;ERN1
7725,GO:0032232,0.396418254111645,0.854156885642719,2,14,negative regulation of actin filament bundle assembly,BP,ARAP1;SHANK3
15651,GO:0072202,0.396457344775268,0.854131899885216,2,14,cell differentiation involved in metanephros development,BP,LAMB2;WWTR1
17386,GO:1900151,0.396481757749085,0.854116294638621,2,14,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L1;ZFP36
17388,GO:1900153,0.396481757749085,0.854116294638621,2,14,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L1;ZFP36
4005,GO:0009008,0.396542894418271,0.924236796077225,1,5,DNA-methyltransferase activity,MF,DNMT3A
20158,GO:2001033,0.396543819014493,0.924236403227234,1,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,HMGA2
2815,GO:0006287,0.396562679152571,0.924228389504981,1,5,base-excision repair, gap-filling,BP,POLL
9088,GO:0035376,0.39678921758424,0.924132091975264,1,5,sterol import,BP,LDLR
14767,GO:0070508,0.39678921758424,0.924132091975264,1,5,cholesterol import,BP,LDLR
6513,GO:0021903,0.397026840148937,0.924031001889303,1,5,rostrocaudal neural tube patterning,BP,HES1
881,GO:0002248,0.397071384001981,0.924012042692609,1,5,connective tissue replacement involved in inflammatory response wound healing,BP,F2R
2111,GO:0004904,0.397303822785985,0.923913062544752,1,5,interferon receptor activity,MF,IFNGR2
3522,GO:0007512,0.397454857821427,0.92384870429907,1,5,adult heart development,BP,MEF2D
13839,GO:0060484,0.397458866773737,0.923846995569339,1,5,lung-associated mesenchyme development,BP,FGFR1
12386,GO:0048854,0.397477915578829,0.815224923014627,3,23,brain morphogenesis,BP,SHANK2;BBS2;SHANK3
12234,GO:0048537,0.397533677671568,0.923815104700943,1,5,mucosal-associated lymphoid tissue development,BP,ADA
12237,GO:0048541,0.397533677671568,0.923815104700943,1,5,Peyer's patch development,BP,ADA
8270,GO:0033089,0.397623254956662,0.923776908307397,1,5,positive regulation of T cell differentiation in thymus,BP,ADA
19715,GO:2000116,0.397671774243065,0.693466148437626,19,188,regulation of cysteine-type endopeptidase activity,BP,CST3;GSN;XDH;PRDX5;F2R;GRAMD4;VEGFA;TNFRSF6B;MEFV;PIDD1;CYFIP2;DAP;RAG1;GAS6;PPM1F;AKT1;CTSH;PYCARD;FAM162A
10038,GO:0042538,0.397723723481241,0.923734053785921,1,5,hyperosmotic salinity response,BP,TRPV4
7285,GO:0031295,0.397795682025037,0.789914867309431,4,33,T cell costimulation,BP,EFNB3;TNFRSF14;ICOSLG;AKT1
45,GO:0000097,0.398082076574572,0.853091501758662,2,14,sulfur amino acid biosynthetic process,BP,CBS;GGT1
2516,GO:0005776,0.398092917365224,0.731772562157152,9,82,autophagosome,CC,ULK1;TBC1D14;PEG3;VPS11;ATG16L2;FYCO1;MEFV;TBC1D17;TP53INP1
11285,GO:0045625,0.398298027940226,0.92348880128213,1,5,regulation of T-helper 1 cell differentiation,BP,JAK3
4531,GO:0010614,0.398303611677977,0.852949352295115,2,14,negative regulation of cardiac muscle hypertrophy,BP,ATP2B4;JARID2
4869,GO:0014741,0.398303611677977,0.852949352295115,2,14,negative regulation of muscle hypertrophy,BP,ATP2B4;JARID2
3782,GO:0008356,0.398370748469981,0.852906259811712,2,14,asymmetric cell division,BP,ETV5;RGS14
520,GO:0001608,0.398388525665637,0.923450110653415,1,5,G-protein coupled nucleotide receptor activity,MF,PTAFR
9189,GO:0035589,0.398388525665637,0.923450110653415,1,5,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,PTAFR
11028,GO:0045028,0.398388525665637,0.923450110653415,1,5,G-protein coupled purinergic nucleotide receptor activity,MF,PTAFR
19588,GO:1990763,0.398413025092497,0.92343963430411,1,5,arrestin family protein binding,MF,ARRDC1
11809,GO:0046755,0.398589204790783,0.813936014127382,3,24,viral budding,BP,CHMP1B;LRSAM1;MVB12A
6543,GO:0021984,0.398613384005303,0.923353924456915,1,5,adenohypophysis development,BP,HES1
3420,GO:0007216,0.398648285795424,0.923338988071945,1,5,G-protein coupled glutamate receptor signaling pathway,BP,HOMER2
13877,GO:0060556,0.398689582946549,0.923321312446071,1,5,regulation of vitamin D biosynthetic process,BP,CYP27B1
5466,GO:0016409,0.398723966225184,0.789194224732524,4,33,palmitoyltransferase activity,MF,CPT2;CPT1C;ZDHHC1;ZDHHC24
13512,GO:0055131,0.398787753399644,0.923279284354668,1,5,C3HC4-type RING finger domain binding,MF,PINK1
11266,GO:0045599,0.398809337124929,0.789127900227961,4,33,negative regulation of fat cell differentiation,BP,ZFPM1;WWTR1;TRPV4;CCDC85B
3775,GO:0008347,0.398831538826537,0.789110650394011,4,33,glial cell migration,BP,IDH2;HEXB;MBOAT7;SUN1
16479,GO:0097208,0.398837419895006,0.923258016054072,1,5,alveolar lamellar body,CC,CTSH
2802,GO:0006269,0.398883888356046,0.923238113933442,1,5,DNA replication, synthesis of RNA primer,BP,PRIMPOL
4091,GO:0009154,0.399148578363771,0.81352770875602,3,24,purine ribonucleotide catabolic process,BP,NT5E;RAPGEF3;NUDT10
6174,GO:0019563,0.399177327817388,0.923112362376892,1,5,glycerol catabolic process,BP,TKFC
8261,GO:0033079,0.399178313598633,0.92311193971297,1,5,immature T cell proliferation,BP,ERBB2
17664,GO:1901569,0.399273001450097,0.923071334641491,1,5,fatty acid derivative catabolic process,BP,ACOT7
6095,GO:0019336,0.399347829705135,0.923039236629136,1,5,phenol-containing compound catabolic process,BP,COMT
6177,GO:0019614,0.399347829705135,0.923039236629136,1,5,catechol-containing compound catabolic process,BP,COMT
9989,GO:0042424,0.399347829705135,0.923039236629136,1,5,catecholamine catabolic process,BP,COMT
1927,GO:0004630,0.39955909339534,0.9229485692936,1,5,phospholipase D activity,MF,PLD3
8034,GO:0032700,0.399610442958015,0.922926521829359,1,5,negative regulation of interleukin-17 production,BP,PRNP
10826,GO:0044340,0.399610915539927,0.922926318903448,1,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,WNT3
15780,GO:0072503,0.399697966626935,0.685550302223161,22,215,cellular divalent inorganic cation homeostasis,BP,CEMIP;APOE;NOS1;F2R;PKD2;ITPR3;HEXB;NTSR1;ATP2B4;LPAR3;PRNP;ATP7B;DLG4;BNIP3;PRKACA;TRPV4;SLC25A27;SMDT1;TPCN1;PKD1;GSTM2;GIPR
7188,GO:0031089,0.399764189260594,0.922860486012729,1,5,platelet dense granule lumen,CC,ECM1
6775,GO:0030223,0.399963053708606,0.922775019698869,1,5,neutrophil differentiation,BP,INPP5D
14111,GO:0061005,0.400107346961343,0.788118448150091,4,33,cell differentiation involved in kidney development,BP,ACTA2;LAMB2;WWTR1;HES1
19784,GO:2000269,0.400229340463516,0.85171076718077,2,14,regulation of fibroblast apoptotic process,BP,GAS6;STK17A
11357,GO:0045745,0.400243158792997,0.851701860549463,2,14,positive regulation of G-protein coupled receptor protein signaling pathway,BP,NOS1;TMOD2
18610,GO:1903936,0.400330901429479,0.922616775289458,1,5,cellular response to sodium arsenite,BP,MAPK13
16140,GO:0090188,0.400338613578981,0.922613455461325,1,5,negative regulation of pancreatic juice secretion,BP,STK39
10022,GO:0042492,0.400354993677509,0.922606404073171,1,5,gamma-delta T cell differentiation,BP,SOX13
3598,GO:0008045,0.400404057485137,0.851598133046459,2,14,motor neuron axon guidance,BP,ERBB2;SEMA3F
10601,GO:0043615,0.400581501787158,0.922508855068277,1,5,astrocyte cell migration,BP,HEXB
6388,GO:0021604,0.40064892184459,0.92247980500061,1,5,cranial nerve structural organization,BP,SEMA3F
6390,GO:0021612,0.40064892184459,0.92247980500061,1,5,facial nerve structural organization,BP,SEMA3F
3066,GO:0006641,0.400768646823566,0.756162042918071,6,53,triglyceride metabolic process,BP,LMF1;APOE;PCSK9;LDLR;PCK2;PNPLA4
15395,GO:0071692,0.400856398537852,0.9223903649404,1,5,protein localization to extracellular region,BP,LTBP1
15396,GO:0071694,0.400856398537852,0.9223903649404,1,5,maintenance of protein location in extracellular region,BP,LTBP1
6815,GO:0030286,0.400874685581768,0.787225001900424,4,34,dynein complex,CC,DNAH1;NUDCD3;WDR60;WDR63
2342,GO:0005391,0.40097513921485,0.922339148996456,1,5,sodium:potassium-exchanging ATPase activity,MF,ATP12A
3899,GO:0008556,0.40097513921485,0.922339148996456,1,5,potassium-transporting ATPase activity,MF,ATP12A
14620,GO:0070232,0.400995115089181,0.812177045902349,3,24,regulation of T cell apoptotic process,BP,ADA;RAG1;JAK3
6047,GO:0019203,0.401138404754969,0.922268694271232,1,5,carbohydrate phosphatase activity,MF,PFKFB2
12441,GO:0050308,0.401138404754969,0.922268694271232,1,5,sugar-phosphatase activity,MF,PFKFB2
11776,GO:0046676,0.401293165024471,0.811958629938401,3,24,negative regulation of insulin secretion,BP,HADH;PFKL;VSNL1
16201,GO:0090278,0.401293165024471,0.811958629938401,3,24,negative regulation of peptide hormone secretion,BP,HADH;PFKL;VSNL1
7623,GO:0032042,0.401296384903761,0.851022204314819,2,14,mitochondrial DNA metabolic process,BP,SESN2;PRIMPOL
7516,GO:0031748,0.401369890584422,0.922168732531264,1,5,D1 dopamine receptor binding,MF,DLG4
1642,GO:0004089,0.401436278542544,0.922140049810771,1,5,carbonate dehydratase activity,MF,CA12
16101,GO:0090129,0.40152661667677,0.922101009007766,1,5,positive regulation of synapse maturation,BP,ADGRL1
7970,GO:0032596,0.401600819472886,0.922068932262764,1,5,protein transport into membrane raft,BP,REEP2
9416,GO:0036005,0.401628818179261,0.922056826727316,1,5,response to macrophage colony-stimulating factor,BP,MST1R
9417,GO:0036006,0.401628818179261,0.922056826727316,1,5,cellular response to macrophage colony-stimulating factor stimulus,BP,MST1R
8436,GO:0033578,0.401682447230732,0.922033636400659,1,5,protein glycosylation in Golgi,BP,LMF1
4413,GO:0010226,0.401700685566464,0.850760887215509,2,14,response to lithium ion,BP,NFATC4;IGFBP2
16472,GO:0097197,0.401744670354994,0.922006724478297,1,5,tetraspanin-enriched microdomain,CC,TSPAN33
19962,GO:2000587,0.401764196468157,0.921998278120145,1,5,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,LRP1
15383,GO:0071674,0.401810438067182,0.811579296152324,3,24,mononuclear cell migration,BP,MAPK3;IL6R;TRPV4
17464,GO:1900425,0.401814819489486,0.921976377625422,1,5,negative regulation of defense response to bacterium,BP,MAPKBP1
18836,GO:1904502,0.401965344688864,0.921911235093199,1,5,regulation of lipophagy,BP,SESN2
18837,GO:1904504,0.401965344688864,0.921911235093199,1,5,positive regulation of lipophagy,BP,SESN2
16656,GO:0097629,0.401980714476863,0.92190458164719,1,5,extrinsic component of omegasome membrane,CC,ULK1
4719,GO:0010891,0.401984725818298,0.921902845115287,1,5,negative regulation of sequestering of triglyceride,BP,PPARA
2217,GO:0005123,0.402008002434965,0.850562099642235,2,14,death receptor binding,MF,PIDD1;MADD
6245,GO:0019835,0.402051039294674,0.849639095340718,2,15,cytolysis,BP,C5;TSTA3
19093,GO:1905063,0.402110071925314,0.921848570072782,1,5,regulation of vascular smooth muscle cell differentiation,BP,PDCD4
4224,GO:0009411,0.402110803236753,0.707541367188267,13,123,response to UV,BP,ERCC1;NFATC4;MAPK13;EGFR;DDB2;HYAL1;BRSK1;XPC;TMEM161A;AKT1;TP53INP1;ERCC6;PRIMPOL
768,GO:0002024,0.402162375219897,0.921825915785454,1,5,diet induced thermogenesis,BP,TRPV4
16328,GO:0090649,0.40217252611819,0.921821518625568,1,5,response to oxygen-glucose deprivation,BP,AQP3
16329,GO:0090650,0.40217252611819,0.921821518625568,1,5,cellular response to oxygen-glucose deprivation,BP,AQP3
11638,GO:0046415,0.402184342724356,0.921816399722995,1,5,urate metabolic process,BP,SLC2A9
16104,GO:0090132,0.402279282473572,0.685110676959696,21,203,epithelium migration,BP,APOE;PRSS3;PKN1;CORO1B;HDAC5;HYAL1;LTB4R2;WNT7A;ID1;RAB25;VEGFA;PLEKHG5;PKN3;NRP2;HBEGF;FGFR1;PROX1;PPM1F;AKT1;CTSH;MAP2K3
10635,GO:0043696,0.402294014002851,0.921768880722873,1,5,dedifferentiation,BP,OLFM2
10636,GO:0043697,0.402294014002851,0.921768880722873,1,5,cell dedifferentiation,BP,OLFM2
13942,GO:0060677,0.402415447958224,0.921716244314081,1,5,ureteric bud elongation,BP,KIF26B
9389,GO:0035965,0.402429643128361,0.921710089889233,1,5,cardiolipin acyl-chain remodeling,BP,TAZ
3787,GO:0008373,0.402457909066932,0.850270835990398,2,14,sialyltransferase activity,MF,ST6GALNAC2;ST3GAL3
16614,GO:0097503,0.402457909066932,0.850270835990398,2,14,sialylation,BP,ST6GALNAC2;ST3GAL3
16383,GO:0097039,0.402669840906532,0.921605904973736,1,5,protein linear polyubiquitination,BP,RBCK1
15143,GO:0071300,0.402688021273387,0.768152423652006,5,43,cellular response to retinoic acid,BP,PTK6;WNT7B;TWF2;WNT3;RARG
1232,GO:0002921,0.402754515477577,0.921569157275702,1,5,negative regulation of humoral immune response,BP,SERPING1
16237,GO:0090324,0.402760485847455,0.921566565808478,1,5,negative regulation of oxidative phosphorylation,BP,MLXIPL
15854,GO:0072611,0.402865012030019,0.921521187157251,1,5,interleukin-13 secretion,BP,PRKCZ
20013,GO:2000665,0.402865012030019,0.921521187157251,1,5,regulation of interleukin-13 secretion,BP,PRKCZ
6267,GO:0019871,0.402887889955528,0.921511252846856,1,5,sodium channel inhibitor activity,MF,PCSK9
16386,GO:0097049,0.402894569758588,0.921508352120852,1,5,motor neuron apoptotic process,BP,ADARB1
19170,GO:1905288,0.402944224875644,0.921486787150347,1,5,vascular associated smooth muscle cell apoptotic process,BP,PDCD4
19244,GO:1905459,0.402944224875644,0.921486787150347,1,5,regulation of vascular associated smooth muscle cell apoptotic process,BP,PDCD4
19245,GO:1905461,0.402944224875644,0.921486787150347,1,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,PDCD4
13593,GO:0060099,0.402944224875964,0.921486787150323,1,5,regulation of phagocytosis, engulfment,BP,ABCA7
13594,GO:0060100,0.402944224875964,0.921486787150323,1,5,positive regulation of phagocytosis, engulfment,BP,ABCA7
19123,GO:1905155,0.402944224875964,0.921486787150323,1,5,positive regulation of membrane invagination,BP,ABCA7
10186,GO:0042816,0.402961801773708,0.921479152713694,1,5,vitamin B6 metabolic process,BP,PNPO
7491,GO:0031681,0.402993101971804,0.921465556494977,1,5,G-protein beta-subunit binding,MF,F2R
14208,GO:0061200,0.403012604123189,0.921457084390857,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,VAMP2
14209,GO:0061202,0.403012604123189,0.921457084390857,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,VAMP2
5567,GO:0016594,0.403164638313556,0.921391018490287,1,5,glycine binding,MF,GSS
19874,GO:2000394,0.403287907052366,0.921337427305265,1,5,positive regulation of lamellipodium morphogenesis,BP,CORO1B
1267,GO:0003056,0.403321817859157,0.921322680594509,1,5,regulation of vascular smooth muscle contraction,BP,DOCK4
15238,GO:0071440,0.403473100187793,0.921256871995084,1,5,regulation of histone H3-K14 acetylation,BP,WBP2
16202,GO:0090279,0.403480613936942,0.849607679596587,2,14,regulation of calcium ion import,BP,PKD2;PRNP
2873,GO:0006382,0.403547516573489,0.921224487998274,1,5,adenosine to inosine editing,BP,ADARB1
11310,GO:0045656,0.403574838890384,0.921212595999127,1,5,negative regulation of monocyte differentiation,BP,INPP5D
1700,GO:0004190,0.403627227468529,0.849512488483344,2,14,aspartic-type endopeptidase activity,MF,CTSD;SPPL2B
14491,GO:0070001,0.403627227468529,0.849512488483344,2,14,aspartic-type peptidase activity,MF,CTSD;SPPL2B
12701,GO:0050974,0.403654914697412,0.921177736726407,1,5,detection of mechanical stimulus involved in sensory perception,BP,SERPINE2
16523,GO:0097320,0.403674298666917,0.849481920288867,2,14,plasma membrane tubulation,BP,SNX33;SNX9
11613,GO:0046341,0.403775051601001,0.849416480395014,2,14,CDP-diacylglycerol metabolic process,BP,AGPAT4;AGPAT3
18538,GO:1903789,0.403857192159546,0.921089637135252,1,5,regulation of amino acid transmembrane transport,BP,STK39
1442,GO:0003433,0.403939374930907,0.921053825999931,1,5,chondrocyte development involved in endochondral bone morphogenesis,BP,RARG
2213,GO:0005113,0.404125620605498,0.920972632269582,1,5,patched binding,MF,BBS1
14147,GO:0061072,0.404127218863181,0.920971935286505,1,5,iris morphogenesis,BP,WNT2B
15198,GO:0071379,0.404133443990062,0.849183584339111,2,14,cellular response to prostaglandin stimulus,BP,ADCY6;AKT1
13954,GO:0060693,0.404150731267514,0.920961681336946,1,5,regulation of branching involved in salivary gland morphogenesis,BP,FGFR1
18370,GO:1903423,0.404183677085545,0.920947312015112,1,5,positive regulation of synaptic vesicle recycling,BP,DNM1
15727,GO:0072345,0.404187267213158,0.920945746083107,1,5,NAADP-sensitive calcium-release channel activity,MF,TPCN1
5238,GO:0015874,0.404190851017206,0.920944182889844,1,5,norepinephrine transport,BP,NISCH
7151,GO:0031033,0.40419442272997,0.920942624951933,1,5,myosin filament organization,BP,OBSL1
13975,GO:0060718,0.404250199695731,0.920918293247051,1,5,chorionic trophoblast cell differentiation,BP,HTRA1
13238,GO:0051953,0.404250199695731,0.920918293247051,1,5,negative regulation of amine transport,BP,STK39
840,GO:0002154,0.404275939453096,0.920907063175869,1,5,thyroid hormone mediated signaling pathway,BP,THRA
1072,GO:0002638,0.404283767354796,0.920903647723073,1,5,negative regulation of immunoglobulin production,BP,BCL6
10155,GO:0042760,0.404299476652274,0.920896793201832,1,5,very long-chain fatty acid catabolic process,BP,ABCD1
18544,GO:1903798,0.404384787452059,0.849020143351927,2,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,EGFR;MAP2K2
11545,GO:0046113,0.404440072260152,0.920835430010192,1,5,nucleobase catabolic process,BP,XDH
9834,GO:0042098,0.404458302295063,0.714365745069989,11,104,T cell proliferation,BP,IGF2;ZP3;ERBB2;IL20RB;PRNP;IGFBP2;CEBPB;HES1;ICOSLG;PYCARD;JAK3
8328,GO:0033192,0.404467905462139,0.920823278671352,1,5,calmodulin-dependent protein phosphatase activity,MF,PPM1F
12516,GO:0050688,0.404491762960768,0.753058501572214,6,53,regulation of defense response to virus,BP,HTRA1;TMEM173;TKFC;NLRX1;PYCARD;APOBEC3F
14868,GO:0070695,0.404496027919511,0.920810999878231,1,5,FHF complex,CC,HOOK2
1797,GO:0004445,0.404587058627807,0.920771246082686,1,5,inositol-polyphosphate 5-phosphatase activity,MF,INPP5D
8803,GO:0034594,0.40458705862784,0.920771246082653,1,5,phosphatidylinositol trisphosphate phosphatase activity,MF,INPP5D
3115,GO:0006702,0.404618658656636,0.920757443225785,1,5,androgen biosynthetic process,BP,SRD5A3
9371,GO:0035926,0.404634349358253,0.920750588992189,1,5,chemokine (C-C motif) ligand 2 secretion,BP,POSTN
16553,GO:0097381,0.404645090462076,0.920745896700295,1,5,photoreceptor disc membrane,CC,GUCA1B
14650,GO:0070290,0.404709275753822,0.920717853529493,1,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,PLD3
473,GO:0001517,0.404722294300781,0.92071216485237,1,5,N-acetylglucosamine 6-O-sulfotransferase activity,MF,CHST6
2620,GO:0005952,0.404748819631332,0.92070057337327,1,5,cAMP-dependent protein kinase complex,CC,PRKACA
10552,GO:0043533,0.404757045987827,0.92069697827049,1,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,ITPR3
14271,GO:0061419,0.404806508253894,0.920675360021283,1,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,VEGFA
1993,GO:0004720,0.404814041756858,0.920672067067344,1,5,protein-lysine 6-oxidase activity,MF,LOXL1
5256,GO:0015911,0.404824034281507,0.920667699124715,1,5,plasma membrane long-chain fatty acid transport,BP,AKT1
16414,GO:0097104,0.404850884797514,0.920655961462846,1,5,postsynaptic membrane assembly,BP,NLGN2
16415,GO:0097105,0.404850884797514,0.920655961462846,1,5,presynaptic membrane assembly,BP,NLGN2
1556,GO:0003958,0.40486410159899,0.9206501833635,1,5,NADPH-hemoprotein reductase activity,MF,NOS1
4369,GO:0010009,0.404916149352334,0.920627426681572,1,5,cytoplasmic side of endosome membrane,CC,LITAF
1413,GO:0003352,0.404936419586324,0.920618562895877,1,5,regulation of cilium movement,BP,BBS2
1414,GO:0003356,0.404936419586324,0.920618562895877,1,5,regulation of cilium beat frequency,BP,BBS2
13699,GO:0060295,0.404936419586324,0.920618562895877,1,5,regulation of cilium movement involved in cell motility,BP,BBS2
13700,GO:0060296,0.404936419586324,0.920618562895877,1,5,regulation of cilium beat frequency involved in ciliary motility,BP,BBS2
17816,GO:1902019,0.404936419586324,0.920618562895877,1,5,regulation of cilium-dependent cell motility,BP,BBS2
15978,GO:0086016,0.40493683593017,0.920618380830327,1,5,AV node cell action potential,BP,SCN4B
15987,GO:0086027,0.40493683593017,0.920618380830327,1,5,AV node cell to bundle of His cell signaling,BP,SCN4B
16033,GO:0089717,0.404956136208361,0.920609940606259,1,5,spanning component of membrane,CC,NLGN2
11244,GO:0045542,0.404964381019439,0.920606334890289,1,5,positive regulation of cholesterol biosynthetic process,BP,ABCG1
17684,GO:1901621,0.404986794254894,0.920596532363611,1,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,SUFU
13537,GO:0060028,0.405005222395443,0.920588472174329,1,5,convergent extension involved in axis elongation,BP,VANGL2
10223,GO:0042954,0.405014142281211,0.920584570569596,1,5,lipoprotein transporter activity,MF,LRP1
600,GO:0001768,0.405017184704503,0.920583239770883,1,5,establishment of T cell polarity,BP,GSN
8732,GO:0034398,0.405021303526592,0.920581438117578,1,5,telomere tethering at nuclear periphery,BP,SUN1
11037,GO:0045053,0.40502496736945,0.920579835460213,1,5,protein retention in Golgi apparatus,BP,SORL1
813,GO:0002087,0.405028710862037,0.92057819794116,1,5,regulation of respiratory gaseous exchange by neurological system process,BP,NLGN2
8838,GO:0034650,0.405030495726144,0.920577417179355,1,5,cortisol metabolic process,BP,DGKQ
8839,GO:0034651,0.405030495726144,0.920577417179355,1,5,cortisol biosynthetic process,BP,DGKQ
19691,GO:2000064,0.405030495726144,0.920577417179355,1,5,regulation of cortisol biosynthetic process,BP,DGKQ
9384,GO:0035947,0.405030967850821,0.920577210654762,1,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,NR1D1
9628,GO:0036514,0.405031162151832,0.920577125660104,1,5,dopaminergic neuron axon guidance,BP,VANGL2
19039,GO:1904938,0.405031162151832,0.920577125660104,1,5,planar cell polarity pathway involved in axon guidance,BP,VANGL2
4533,GO:0010616,0.405031162151897,0.920577125660039,1,5,negative regulation of cardiac muscle adaptation,BP,ATP2B4
18289,GO:1903243,0.405031162151897,0.920577125660039,1,5,negative regulation of cardiac muscle hypertrophy in response to stress,BP,ATP2B4
11059,GO:0045078,0.405031162152002,0.920577125660082,1,5,positive regulation of interferon-gamma biosynthetic process,BP,ZFPM1
16593,GO:0097470,0.405031162152041,0.920577125660043,1,5,ribbon synapse,CC,NPHP4
12439,GO:0050291,0.405031162152121,0.920577125660111,1,5,sphingosine N-acyltransferase activity,MF,CERS4
7629,GO:0032051,0.405031162152124,0.920577125660108,1,5,clathrin light chain binding,MF,CLTCL1
13082,GO:0051643,0.405031162152124,0.920577125660108,1,5,endoplasmic reticulum localization,BP,ESYT2
10973,GO:0044789,0.40503116215215,0.920577125660082,1,5,modulation by host of viral release from host cell,BP,PC
10974,GO:0044791,0.40503116215215,0.920577125660082,1,5,positive regulation by host of viral release from host cell,BP,PC
16861,GO:0098831,0.40503116215215,0.920577125660082,1,5,presynaptic active zone cytoplasmic component,CC,RIMS3
12904,GO:0051286,0.40503116215215,0.920577125660082,1,5,cell tip,CC,PI4K2A
6892,GO:0030479,0.405031162152151,0.920577125660082,1,5,actin cortical patch,CC,WIPF1
14368,GO:0061645,0.405031162152151,0.920577125660082,1,5,endocytic patch,CC,WIPF1
5682,GO:0016812,0.405031162152151,0.920577125660082,1,5,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,OPLAH
18960,GO:1904781,0.405031162152151,0.920577125660082,1,5,positive regulation of protein localization to centrosome,BP,CEP250
10574,GO:0043559,0.405031162152157,0.920577125660075,1,5,insulin binding,MF,INSR
10310,GO:0043121,0.405031162152158,0.920577125660075,1,5,neurotrophin binding,MF,FURIN
7054,GO:0030853,0.405031162152158,0.920577125660075,1,5,negative regulation of granulocyte differentiation,BP,INPP5D
4573,GO:0010668,0.40503116215216,0.920577125660072,1,5,ectodermal cell differentiation,BP,ITGA6
6465,GO:0021815,0.40503116215216,0.920577125660072,1,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,SUN1
7602,GO:0032000,0.405031162152161,0.920577125660071,1,5,positive regulation of fatty acid beta-oxidation,BP,PPARA
11117,GO:0045180,0.405031162152161,0.920577125660071,1,5,basal cortex,CC,PKD2
16755,GO:0098597,0.405031162152161,0.920577125660071,1,5,observational learning,BP,SHANK3
10820,GO:0044332,0.405031162152162,0.920577125660071,1,5,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,LRP5
13564,GO:0060059,0.405031162152182,0.92057712566005,1,5,embryonic retina morphogenesis in camera-type eye,BP,PROX1
19747,GO:2000192,0.405031162152189,0.920577125660043,1,5,negative regulation of fatty acid transport,BP,AKT1
498,GO:0001554,0.40503116215219,0.920577125660043,1,5,luteolysis,BP,SLIT3
6889,GO:0030473,0.405031162152227,0.920577125660006,1,5,nuclear migration along microtubule,BP,SUN1
12267,GO:0048617,0.405031162152305,0.920577125660075,1,5,embryonic foregut morphogenesis,BP,ACVR2B
15371,GO:0071651,0.405031162152337,0.920577125660043,1,5,positive regulation of chemokine (C-C motif) ligand 5 production,BP,TRPV4
6026,GO:0019104,0.405206999119231,0.847579765112289,2,15,DNA N-glycosylase activity,MF,MPG;NEIL1
8865,GO:0034695,0.405384100493244,0.848369430251138,2,14,response to prostaglandin E,BP,ADCY6;AKT1
4019,GO:0009060,0.405460724728544,0.740886050231796,7,68,aerobic respiration,BP,IDH2;OGDHL;BNIP3;DHTKD1;SDHA;MDH2;SIRT3
16831,GO:0098787,0.405595069608902,0.848231873532029,2,14,mRNA cleavage involved in mRNA processing,BP,TUT1;ERN1
8494,GO:0033688,0.405649682319309,0.848196254446181,2,14,regulation of osteoblast proliferation,BP,LRP5;PLXNB1
7978,GO:0032608,0.405979302243252,0.765473876133477,5,43,interferon-beta production,BP,PTPRS;RNF135;TMEM173;NLRX1;PYCARD
17304,GO:0198738,0.406239428302276,0.659078327901749,39,389,cell-cell signaling by wnt,BP,APOE;CTNNBIP1;NFATC4;LRP1;MDFI;EGR1;LRP5;PTPRU;FUZ;NPHP4;CSNK1E;WNT7A;CELSR1;GRK6;WWTR1;IGFBP2;FZD8;VANGL2;FBXW4;AP2A2;CALCOCO1;DVL1;CELSR2;LRRK1;BTRC;WNT7B;IGFBP4;AGO4;PIN1;GRB10;WNT2B;SDC1;WNT3;NDRG2;ARHGEF19;RARG;SHISA6;SULF2;LZTS2
6481,GO:0021846,0.406555574990244,0.847604799359679,2,14,cell proliferation in forebrain,BP,WNT7A;FGFR1
8565,GO:0034061,0.40677022699088,0.782606010303232,4,34,DNA polymerase activity,MF,POLD4;POLL;PRIMPOL;POLM
3329,GO:0007050,0.406841065321154,0.678927475026149,22,215,cell cycle arrest,BP,PCBP4;CGREF1;PPP2R3B;PKD2;CDKN1C;TFDP2;PRNP;STRADB;MLXIPL;PIDD1;PRKACA;HMGA2;GAS6;BIN1;WHAMMP3;ZNF385A;TP53INP1;PKD1;MLST8;ERN1;ING4;MIF
6055,GO:0019212,0.407112262366772,0.807671696894358,3,24,phosphatase inhibitor activity,MF,PPP1R14A;PPP1R35;ELFN2
3499,GO:0007413,0.407152345766598,0.847214529184396,2,14,axonal fasciculation,BP,EPHB2;EPHB3
17173,GO:0106030,0.407152345766598,0.847214529184396,2,14,neuron projection fasciculation,BP,EPHB2;EPHB3
10809,GO:0044321,0.407366509257449,0.847074348665491,2,14,response to leptin,BP,NR1D1;BBS2
1603,GO:0004029,0.407721886456447,0.84684159224278,2,14,aldehyde dehydrogenase (NAD) activity,MF,ALDH4A1;ALDH16A1
13655,GO:0060216,0.407748092030615,0.846824421599718,2,14,definitive hemopoiesis,BP,ZFPM1;BCR
4796,GO:0012501,0.407815285361815,0.628219421958442,144,1479,programmed cell death,BP,DUSP6;APOE;PPL;CST3;GSN;XDH;PRDX5;NDRG1;PRODH;MEF2D;ZFP36L1;ALOX15B;RBCK1;EPHB2;OBSCN;IGF2;NFATC4;NME4;MST1R;LRP1;EGFR;H1F0;HS1BP3;EGR1;PKN1;PYGL;ARHGEF4;SHC1;RGL2;F2R;PRSS8;CTSB;PACS2;GRAMD4;PEG3;THRA;RPS6KA2;NISCH;LRP5;MARK4;ERBB2;PHLDA2;SIGMAR1;PAK6;NTSR1;MINK1;TFDP2;PDCD4;BEX2;TNFRSF25;WNT7A;INSR;ID1;RABGGTA;EPHA1;ADARB1;ITGA6;SYNGAP1;DNMT3A;TMEM173;PRNP;SPRY2;HINT2;MNT;MKNK2;STRADB;MYO18A;BCL6;BNIP3;VEGFA;ELMO3;CEBPB;ENDOG;TNFRSF6B;MAPK3;PLEKHG5;EPHB3;FURIN;PLEKHG2;TNFRSF14;ADA;PIDD1;IL6R;SLIT3;PCSK9;ZFP36;FGFR3;CYFIP2;MAP2K2;DAP;FGFR4;TNFRSF1A;MAPK8IP1;RAG1;PHLDA1;TNFAIP8L1;EEF2K;HMGA2;GAS6;VAV3;GSDMC;PRKCZ;INPP5D;TM7SF3;PDK2;AGO4;FGFR1;CTSZ;PIN1;KCNMA1;BIN1;PPP1R13L;SLC25A27;TMEM161A;MADD;EPB41L3;TIMP1;PPM1F;STK39;ACVR1B;GSDMA;ERBB3;ABR;PNMA1;AKT1;TRAP1;TMBIM4;ZNF385A;TP53INP1;ERCC6;PINK1;CTSH;PYCARD;MAP2K3;STK17A;ERN1;ARHGEF19;JAK3;RARG;ING4;FAM162A;KRT15;ADAMTSL4;MIF
19861,GO:2000379,0.407853132915038,0.750089083484207,6,54,positive regulation of reactive oxygen species metabolic process,BP,XDH;EGFR;PKD2;INSR;ASS1;AKT1
13578,GO:0060076,0.407871171238687,0.846743763444949,2,14,excitatory synapse,CC,DLG4;SHISA6
15278,GO:0071496,0.408297423362094,0.674115968019081,24,234,cellular response to external stimulus,BP,FOS;CYP27B1;POSTN;EGFR;ULK1;CBS;GLUL;ITGA6;BNIP3;MAPK3;SSH1;AQP3;PCSK9;DAP;TNFRSF1A;GAS6;COMT;PDK2;SESN2;WNT2B;ADORA2B;AKT1;C12ORF66;SLC2A1
13186,GO:0051865,0.408591356267918,0.749625379702668,6,53,protein autoubiquitination,BP,DDB2;RNF208;MTA1;LRSAM1;RAG1;RNF187
7895,GO:0032480,0.408640958822908,0.763090340794205,5,44,negative regulation of type I interferon production,BP,PTPRS;RNF135;PIN1;NLRX1;PYCARD
13608,GO:0060135,0.409025369472654,0.762984685802472,5,43,maternal process involved in female pregnancy,BP,CYP27B1;CTSB;BSG;RXRA;AKT1
2966,GO:0006515,0.410941758377203,0.804826992082069,3,24,protein quality control for misfolded or incompletely synthesized proteins,BP,ANKZF1;LONP2;POMT1
3455,GO:0007276,0.411110921237016,0.655267334625356,38,378,gamete generation,BP,ERCC1;TCFL5;GAMT;DEAF1;BBS2;DNAH1;ZP3;CRTAP;SCMH1;HEXB;ATP2B4;GGT1;ZMIZ1;TXNRD3;DNMT3A;MYCBPAP;PHC2;BCL6;ZSCAN2;ETV5;PRKACA;SPATA20;DMC1;AGO4;WNT3;ZFP41;MICALCL;SBF1;AKT1;SIX5;TDRKH;SUN1;RPL39L;SPIRE2;RFX2;EREG;SHISA6;FAM50A
18205,GO:1903036,0.411678876050012,0.778729702937452,4,34,positive regulation of response to wounding,BP,F2R;F12;HBEGF;DMTN
18557,GO:1903829,0.412110245070593,0.663414034791624,29,286,positive regulation of cellular protein localization,BP,CEMIP;RAPGEF3;EPHB2;LRP1;EGFR;B3GAT3;ANK3;ERBB2;MICALL2;EDEM1;VPS11;VAMP2;TFDP2;TMEM173;PRNP;SNX33;CEP250;HES1;SSH1;ABHD17C;CROCC;GAS6;OSCP1;SESN2;SORL1;AKT1;GPD1L;PINK1;UBL5
9979,GO:0042407,0.412179512962038,0.842979585115644,2,15,cristae formation,BP,PINK1;TAZ
9455,GO:0036092,0.412469051935186,0.778407739570781,4,33,phosphatidylinositol-3-phosphate biosynthetic process,BP,PIK3R2;FGFR3;FGFR4;FGFR1
956,GO:0002377,0.412496170554636,0.735435980796857,7,63,immunoglobulin production,BP,ERCC1;PKN1;POLL;STAT6;BCL6;PMS2P5;POLM
18377,GO:1903432,0.412675317944179,0.803533081024669,3,24,regulation of TORC1 signaling,BP,DGKQ;SESN2;C12ORF66
5237,GO:0015872,0.413000975891997,0.842433024761784,2,15,dopamine transport,BP,RAB3B;PINK1
17503,GO:1901020,0.413699898902545,0.841967231829816,2,15,negative regulation of calcium ion transmembrane transporter activity,BP,PKD2;GSTM2
4809,GO:0014013,0.414179873562938,0.73398873743617,7,63,regulation of gliogenesis,BP,IDH2;GJC2;SERPINE2;ETV5;HES1;LDLR;BIN1
17559,GO:1901216,0.414473337209662,0.733612527006157,7,64,positive regulation of neuron death,BP,FOS;EGR1;PRNP;SSH1;PCSK9;CTSZ;PIN1
20171,GO:2001056,0.41486427417034,0.700095051003464,12,117,positive regulation of cysteine-type endopeptidase activity,BP,GSN;XDH;F2R;GRAMD4;MEFV;PIDD1;CYFIP2;DAP;PPM1F;CTSH;PYCARD;FAM162A
2512,GO:0005771,0.414884732249888,0.801418038038201,3,25,multivesicular body,CC,CST3;EGFR;CTSH
5005,GO:0015175,0.414913193461729,0.801857073108826,3,24,neutral amino acid transmembrane transporter activity,MF,SLC43A1;SLC7A8;SERINC2
10046,GO:0042554,0.415055466937198,0.841061816162172,2,15,superoxide anion generation,BP,EGFR;ACP5
3113,GO:0006700,0.415718531192537,0.840617975122876,2,15,C21-steroid hormone biosynthetic process,BP,EGR1;DGKQ
4047,GO:0009101,0.415794626890862,0.663987984013644,26,255,glycoprotein biosynthetic process,BP,TNIP1;LMF1;ST6GALNAC2;B3GAT3;ABCA7;GALNT12;ADAMTS7;MVD;B4GAT1;SRD5A3;VANGL2;ST3GAL3;HBEGF;XYLT2;PHLDA1;RFNG;MUC19;ADAMTS13;MAN1B1;GAL3ST4;VEGFB;POMT1;JAK3;ADAMTSL4;NDST2;ALG12
9814,GO:0042056,0.415912391253685,0.839673692044305,2,16,chemoattractant activity,MF,VEGFA;MIF
6736,GO:0030166,0.415937810475149,0.757299514566681,5,43,proteoglycan biosynthetic process,BP,B3GAT3;VANGL2;XYLT2;GAL3ST4;NDST2
2519,GO:0005779,0.416431966692813,0.840139708029133,2,15,integral component of peroxisomal membrane,CC,PEX10;ABCD1
7251,GO:0031231,0.416431966692813,0.840139708029133,2,15,intrinsic component of peroxisomal membrane,CC,PEX10;ABCD1
14443,GO:0061842,0.416520936568475,0.800649032014884,3,24,microtubule organizing center localization,BP,FHOD1;NDE1;SUN1
2371,GO:0005506,0.416580526446646,0.715406079650224,9,84,iron ion binding,MF,CYP27B1;XDH;NOS1;ALOX15B;ACP5;CYP3A5;PHYH;CYP2S1;ALKBH6
6112,GO:0019369,0.416833859615094,0.800413519912777,3,24,arachidonic acid metabolic process,BP,ALOX15B;MAPK3;CYP2S1
13460,GO:0055025,0.417020698112792,0.800272841695192,3,24,positive regulation of cardiac muscle tissue development,BP,FGFR1;PIN1;ERBB3
2431,GO:0005637,0.417098435552286,0.756126918770078,5,44,nuclear inner membrane,CC,SIGMAR1;TM7SF2;SUN1;TMEM120A;ERN1
4710,GO:0010882,0.417685042063275,0.839297901772258,2,15,regulation of cardiac muscle contraction by calcium ion signaling,BP,PRKACA;GSTM2
17502,GO:1901019,0.417929044636684,0.755438951588922,5,44,regulation of calcium ion transmembrane transporter activity,BP,NOS1;PKD2;PRKACA;EHD3;GSTM2
4708,GO:0010880,0.41806225772545,0.839044046693728,2,15,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,PRKACA;GSTM2
8949,GO:0035035,0.419536272444386,0.798374403897487,3,24,histone acetyltransferase binding,MF,EPAS1;EGR1;CEBPB
16690,GO:0097711,0.419827236250289,0.706141676879299,10,94,ciliary basal body-plasma membrane docking,BP,TCTN1;MARK4;NINL;NPHP4;CSNK1E;CEP250;FBF1;PRKACA;NDE1;SFI1
17696,GO:1901652,0.420171331042113,0.650251344523203,34,338,response to peptide,BP,ZFP36L1;IGF2;LRP1;HADH;EGR1;SHC1;PIK3R2;HDAC5;LRP5;BSG;PTPRE;VAMP2;INSR;ID1;PRNP;MAPK3;ADCY6;PCSK9;PRKACA;VGF;TRPV4;EEF2K;PPARA;PCK2;PRKCZ;PDK2;SRSF5;GRB10;SESN2;TIMP1;AKT1;SLC2A1;JAK3;EREG
8953,GO:0035051,0.420174226797837,0.712308097233116,9,83,cardiocyte differentiation,BP,OBSL1;EGFR;PDCD4;VEGFA;MAPK3;HES1;RXRA;PIN1;PROX1
9250,GO:0035690,0.420682053246355,0.662458630698139,24,237,cellular response to drug,BP,CST3;MAPK13;EGFR;PPP1R14A;EGR1;ID1;DNMT3A;PRNP;STAT6;ANKZF1;BNIP3;ENDOG;MAPK3;ADCY6;SSH1;HMGA2;GAS6;PTAFR;PCK2;PPM1F;TRAP1;TP53INP1;PINK1;GSTM2
13599,GO:0060122,0.420859724774414,0.837155003338449,2,15,inner ear receptor cell stereocilium organization,BP,VANGL2;HES1
4798,GO:0012506,0.420925802130187,0.636707418024745,52,523,vesicle membrane,CC,CEMIP;APOE;PTPRS;GAA;NOS1;LRP1;EGFR;SYT8;ULK2;DBNDD1;BSG;PKD2;ITPR3;CD9;VAMP2;WNT7A;RAB3D;NBEAL2;TMEM173;SNX33;SNX9;DLG4;AP2A2;GPRC5C;KCNAB2;RAB40B;SLC2A3;MCTP1;RHOF;HBEGF;RAB3B;PI4K2A;LDLR;SNX17;IFNGR2;LDLRAP1;AHNAK2;DGKQ;SEMA4C;WNT7B;PTAFR;CLTCL1;SERPINB6;CD68;WNT3;HGSNAT;SUN1;SPIRE2;EPN2;RHBG;RAB40C;STXBP2
13815,GO:0060443,0.420979077318306,0.771309136455245,4,34,mammary gland morphogenesis,BP,LRP5;STAT6;ETV5;BTRC
15798,GO:0072527,0.421639646257788,0.727181089241724,7,66,pyrimidine-containing compound metabolic process,BP,NT5E;NME4;UCKL1;TK2;APOBEC3C;APOBEC3F;NEIL1
7944,GO:0032555,0.42237616501383,0.614354165579194,141,1425,purine ribonucleotide binding,MF,RAPGEF3;SCN8A;EPHB2;OBSCN;NME4;MST1R;MAPK13;CDK18;EGFR;ACSF2;ULK1;PKN1;PYGL;PTK6;GNAL;ABCA7;ACTA2;DNAH1;ULK2;DGKA;ABCG1;OPLAH;NEK9;RPS6KA2;NMRK1;TUBG2;MARK4;ERBB2;BRSK1;DNM1;CUL9;KIF13B;PAK6;MINK1;ATP2B4;CSNK1E;AGAP1;GLUL;RHOD;INSR;RAB3D;GRK6;MVD;EPHA1;TMEM173;DHX32;ATP7B;SPEG;ABCD1;MKNK2;STRADB;RAB25;FAM20C;MYO18A;UCKL1;PFKFB2;ATP12A;DYRK1B;SRMS;ARL2;MAST4;ACVR2B;MAPK3;ARL10;RAB40B;ENTPD2;GALK1;FYCO1;ADCY6;PKN3;EPHB3;PC;NADK;ABCA2;TK2;RASL10B;CKMT1A;PFKL;RHOF;HLCS;FGFR3;PRKACA;LRRK1;DGUOK;RPS6KA5;RAB3B;MAP2K2;PI4K2A;FGFR4;PMVK;MYH3;EHD4;TRPV4;RHOBTB2;EEF2K;DGKQ;HK1;TKFC;GUK1;STK32C;DMC1;PCK2;BCR;PRKCZ;HLTF;ABCD4;TWF2;PDK2;MAPKAPK3;FGFR1;CAMKK1;GTPBP1;ASS1;GAL3ST4;ACTR1B;STK39;ACVR1B;GSS;ERBB3;AKT1;TRAP1;NLRX1;SEPT8;TUT1;SMARCA1;ERCC6;ADCK2;PINK1;EHD3;LONP2;MAP2K3;STK17A;ERN1;MOCS1;JAK3;MAST3;KIFC2;FUK;TTLL11;RAB40C;KIF26B
12529,GO:0050704,0.423143275643686,0.795167097544006,3,25,regulation of interleukin-1 secretion,BP,HK1;GAS6;PYCARD
1994,GO:0004721,0.423266950693302,0.680995782312407,15,144,phosphoprotein phosphatase activity,MF,DUSP6;PTPRS;DUSP5;PPP2R3B;PPM1J;PTPRU;PTPRE;LHPP;SSH1;MYH3;DUSP7;DUSP23;PPM1F;SBF1;SSH3
6954,GO:0030620,0.423296358701669,0.909222559649849,1,6,U2 snRNA binding,MF,ISG20
12143,GO:0048284,0.423487043803233,0.680754971875717,15,145,organelle fusion,BP,SYTL1;EVI5L;SYT8;TBC1D14;VAT1;VPS11;VAMP2;TBC1D8;BNIP3;STX10;VAV3;TMEM175;TBC1D16;TBC1D17;TSNARE1
20081,GO:2000785,0.423624605770489,0.7691799861187,4,34,regulation of autophagosome assembly,BP,ULK1;TBC1D14;LRSAM1;PINK1
11497,GO:0046034,0.423773112448369,0.666855279619049,20,208,ATP metabolic process,BP,PGM1;OGDHL;INSR;NDUFS8;FAM20C;PFKFB2;DHTKD1;GALK1;MLXIPL;NADK;PFKL;MYH3;HK1;PPARA;GUK1;SDHA;UQCR11;PINK1;NDUFV3;TAZ
14619,GO:0070231,0.423864651899918,0.768692405455523,4,35,T cell apoptotic process,BP,ADA;RAG1;AKT1;JAK3
19706,GO:2000106,0.424008507054217,0.736250662185178,6,55,regulation of leukocyte apoptotic process,BP,BCL6;ADA;RAG1;GAS6;JAK3;MIF
6352,GO:0021543,0.424066574144843,0.69191199723302,12,114,pallium development,BP,PTPRS;LRP1;EGFR;BBS2;ATP2B4;TRAPPC9;BNIP3;MBOAT7;NDE1;PROX1;SUN1;SLC2A1
12137,GO:0048268,0.424116359100522,0.834941590201343,2,15,clathrin coat assembly,BP,FCHO1;CLTCL1
3267,GO:0006953,0.424457718237516,0.834708687673528,2,15,acute-phase response,BP,CEBPB;IL6R
16838,GO:0098796,0.424757034018742,0.625158151068676,71,734,membrane protein complex,CC,SHANK2;NOS1;SCN8A;LRP1;KCNG1;EGFR;SHC1;GNAL;ABCA7;GJC2;KCNC4;PIK3R2;LRP5;SCN4B;CPT1C;ITGB4;DNM1;VPS11;VAMP2;GM2A;INSR;NDUFS8;ITGA6;DLG4;TTYH3;ANKZF1;ATP12A;CHMP1B;MVB12B;FZD8;HOOK2;LRRC8A;AP2A2;SHANK3;KCNAB2;OLFM2;EVC;ABCA2;IL6R;PRKACA;SCNN1A;ITGB5;STX10;LDLRAP1;MVB12A;SDHAF4;NEO1;SDHA;CLTCL1;ABCD4;C5;DLG3;KCNMA1;NDUFA4L2;TOLLIP;SMDT1;PIGQ;COL13A1;ACVR1B;TSNARE1;VPS33B;SUN1;PINK1;SNTA1;SYNE3;EPN2;KCNN4;NDUFV3;ERN1;SHISA6;STXBP2
14971,GO:0070920,0.424985438752163,0.83434830036695,2,15,regulation of production of small RNA involved in gene silencing by RNA,BP,EGFR;MAP2K2
8263,GO:0033081,0.42517298580757,0.834220124237953,2,15,regulation of T cell differentiation in thymus,BP,ERBB2;ADA
12734,GO:0051029,0.425202617218524,0.908304546671009,1,6,rRNA transport,BP,TST
11373,GO:0045778,0.425313976297809,0.735288432453452,6,54,positive regulation of ossification,BP,CTNNBIP1;FAM20C;CEBPB;ACVR2B;IL6R;WNT7B
13794,GO:0060416,0.425412795785825,0.793907843794769,3,24,response to growth hormone,BP,MAPK3;AKT1;JAK3
6977,GO:0030667,0.42555233553771,0.665463968473609,20,196,secretory granule membrane,CC,GAA;BSG;ITPR3;CD9;VAMP2;RAB3D;NBEAL2;TMEM173;AP2A2;KCNAB2;RAB40B;SLC2A3;RHOF;PTAFR;SERPINB6;CD68;HGSNAT;SUN1;RAB40C;STXBP2
18119,GO:1902883,0.425682507222135,0.767222881175485,4,35,negative regulation of response to oxidative stress,BP,MCTP1;AKT1;TRAP1;PINK1
13090,GO:0051653,0.425919792422697,0.767326210191643,4,34,spindle localization,BP,SPRY2;LLGL1;NDE1;SPIRE2
9873,GO:0042169,0.425995987412411,0.793462150962193,3,24,SH2 domain binding,MF,SH3PXD2B;PAG1;TRPV4
32,GO:0000060,0.426039024092712,0.766934228545631,4,35,protein import into nucleus, translocation,BP,TMEM173;BCL6;GAS6;AKT1
573,GO:0001725,0.42617200453627,0.748571827870303,5,44,stress fiber,CC,MST1R;CORO1B;MICALL2;VANGL2;FHOD1
16621,GO:0097517,0.42617200453627,0.748571827870303,5,44,contractile actin filament bundle,CC,MST1R;CORO1B;MICALL2;VANGL2;FHOD1
11050,GO:0045069,0.426475836759303,0.71397808261616,8,76,regulation of viral genome replication,BP,TNIP1;ADARB1;ISG20;HMGA2;RAD23A;PROX1;APOBEC3C;APOBEC3F
15964,GO:0086002,0.426519985798739,0.793061320929635,3,24,cardiac muscle cell action potential involved in contraction,BP,SCN4B;GPD1L;SNTA1
5273,GO:0015936,0.426539888439942,0.833284386022732,2,15,coenzyme A metabolic process,BP,ACOT7;PPCS
4175,GO:0009261,0.426548756905421,0.792563928445738,3,25,ribonucleotide catabolic process,BP,NT5E;RAPGEF3;NUDT10
3573,GO:0007625,0.426736429257926,0.907561703950204,1,6,grooming behavior,BP,DLG4
19771,GO:2000241,0.426975069400103,0.71363372627292,8,75,regulation of reproductive process,BP,ZP3;PHLDA2;INSR;ADA;PTAFR;RXRA;TIMP1;ACVR1B
13720,GO:0060322,0.427061349441952,0.633029980131279,48,480,head development,BP,PTPRS;CST3;SHANK2;TCTN1;EPHB2;CNTN1;LRP1;EGFR;NAGLU;BBS2;GJC2;THRA;CD9;SERPINE2;ATP2B4;CSNK1E;TRAPPC9;WNT7A;ID1;BNIP3;SHANK3;MAPK3;PHGDH;EPHB3;HES1;MBOAT7;PITPNM1;MYH3;MDGA1;SEMA4C;POU6F1;WNT7B;BCR;NDE1;FGFR1;PROX1;WNT2B;SNPH;RTN4R;WNT3;ABR;NDRG2;SMARCA1;SUN1;GAS8;SLC2A1;RARG;TRNP1
12874,GO:0051246,0.427156591475547,0.60509595883801,194,2006,regulation of protein metabolic process,BP,TNIP1;DUSP6;CEMIP;APOE;BTBD2;CST3;LTBP4;RAPGEF3;GSN;XDH;PRDX5;NOS1;ZFP36L1;GRB7;EPHB2;CNTN1;IGF2;MST1R;LRP1;EGFR;TIMP2;B3GAT3;FBXO2;DUSP5;PPP1R14A;SERPING1;MTHFR;EGR1;RHBDF1;PKN1;SHC1;F2R;PTK6;ABCA7;PPP2R3B;SHC2;GJC2;GRAMD4;PLAT;PIK3R2;CRTAP;LRP5;ZFPM1;ERBB2;FBLN1;PKD2;EDEM1;ABTB1;SPRY4;CDKN1C;PAK6;SERPINE2;VPS11;UNK;MINK1;ATP2B4;CSNK1E;PDCD4;TNFRSF25;WNT7A;INSR;ID1;EPHA1;ADARB1;SYNGAP1;PPP1R35;LPAR3;PRNP;PAPLN;SNX33;SPRY2;HINT2;ECM1;SNX9;DLG4;MKNK2;STRADB;WWTR1;BCL6;CD81;FZD8;VEGFA;VANGL2;CEBPB;ACVR2B;NAB2;S1PR2;TNFRSF6B;MAPK3;DVL1;MTA1;ADCY6;EPHB3;HES1;SSH1;FURIN;MLXIPL;MEFV;PIDD1;IL6R;PCSK9;ZFP36;BTBD11;FGFR3;PRKACA;F12;LRRK1;MAGEF1;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;DMTN;TNFRSF1A;EHD4;MAPK8IP1;LDLR;TRPV4;EIF4EBP3;RAG1;DUSP7;EEF2K;DGKQ;SEMA4C;GAS6;BTRC;MEX3A;WNT7B;SUFU;PTAFR;RXRA;IGFBP4;PRKCZ;INPP5D;LSM14B;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;CAMKK1;PIN1;C5;PROX1;WBP2;DLG3;BIN1;SERPINB6;SH3D19;JARID2;SESN2;TOLLIP;CSTB;MAPRE3;MADD;RTN4R;ELFN2;TIMP1;PPM1F;SORL1;STK39;ACVR1B;ADORA2B;ERBB3;ZER1;AKT1;TRAP1;ZNF385A;NDRG2;ERCC6;GPD1L;PINK1;PKD1;SNTA1;RGS14;EIF4G3;CTSH;MLST8;CBLC;PYCARD;MAP2K3;POMT1;PCSK1N;ERN1;RANBP9;SIRT3;JAK3;EIF4E3;EREG;FAM162A;RPL13A;MIF
7165,GO:0031058,0.427348137588703,0.713403687933423,8,74,positive regulation of histone modification,BP,NOS1;BCL6;VEGFA;MAPK3;RPS6KA5;WBP2;JARID2;PINK1
19254,GO:1905477,0.427662430337857,0.699038594918778,10,95,positive regulation of protein localization to membrane,BP,CEMIP;EPHB2;LRP1;EGFR;ANK3;ERBB2;TFDP2;PRNP;SSH1;AKT1
13049,GO:0051583,0.428369829491343,0.906766505318639,1,6,dopamine uptake involved in synaptic transmission,BP,RAB3B
13228,GO:0051934,0.428369829491343,0.906766505318639,1,6,catecholamine uptake involved in synaptic transmission,BP,RAB3B
16285,GO:0090493,0.428369829491343,0.906766505318639,1,6,catecholamine uptake,BP,RAB3B
16286,GO:0090494,0.428369829491343,0.906766505318639,1,6,dopamine uptake,BP,RAB3B
13221,GO:0051924,0.42906983660038,0.687298872697563,12,115,regulation of calcium ion transport,BP,CEMIP;NOS1;F2R;GJC2;PKD2;NTSR1;LPAR3;PRNP;PRKACA;EHD3;HOMER2;GSTM2
13475,GO:0055070,0.429095756736229,0.830676751569227,2,16,copper ion homeostasis,BP,PRNP;ATP7B
15078,GO:0071156,0.429152365723317,0.697626211159579,10,96,regulation of cell cycle arrest,BP,PCBP4;PKD2;TFDP2;MLXIPL;PIDD1;PRKACA;HMGA2;BIN1;ZNF385A;MIF
18451,GO:1903579,0.429455539251471,0.83127930114629,2,15,negative regulation of ATP metabolic process,BP,MLXIPL;PPARA
4937,GO:0014912,0.42969956455731,0.83111092133362,2,15,negative regulation of smooth muscle cell migration,BP,LRP1;CORO1B
2487,GO:0005741,0.429829610634427,0.674822550020746,15,147,mitochondrial outer membrane,CC,CYP27B1;FAM210B;ULK1;BPHL;CPT1C;VAT1;SNN;ARMCX2;SPATA18;TMEM173;ANKZF1;BNIP3;HK1;NLRX1;PINK1
5314,GO:0016050,0.429922928662784,0.643012376366582,32,319,vesicle organization,BP,SYTL1;EVI5L;SYT8;F2R;TBC1D14;DNM1;SERPINE2;VPS11;VAMP2;TRAPPC9;TBC1D8;SNX33;SNX9;DLG4;MYO18A;CHMP1B;HOOK2;PI4K2A;STX10;MVB12A;VAV3;TMEM175;TBC1D16;CTSZ;SDC1;LYST;TBC1D17;ALS2CL;TSNARE1;ZNF385A;VPS33B;RFX2
17575,GO:1901264,0.429950281661397,0.731151337518412,6,55,carbohydrate derivative transport,BP,ABCG1;ADA;SLC28A2;SLC37A2;SLC29A4;GUK1
2198,GO:0005086,0.430632104840669,0.83046665530859,2,15,ARF guanyl-nucleotide exchange factor activity,MF,IQSEC2;PSD4
2095,GO:0004865,0.431280697780316,0.905338799855904,1,6,protein serine/threonine phosphatase inhibitor activity,MF,PPP1R14A
4083,GO:0009146,0.431314300169364,0.905322239302529,1,6,purine nucleoside triphosphate catabolic process,BP,ADA
12159,GO:0048308,0.431332698576254,0.829981795401226,2,15,organelle inheritance,BP,MAPK3;MAP2K2
11454,GO:0045933,0.431535501415408,0.788725009483411,3,25,positive regulation of muscle contraction,BP,F2R;ADA;PTAFR
15819,GO:0072559,0.43172957933209,0.905117423707342,1,6,NLRP3 inflammasome complex,CC,PYCARD
16740,GO:0098563,0.432199855695862,0.829380663801501,2,15,intrinsic component of synaptic vesicle membrane,CC,PTPRS;RAB3B
10406,GO:0043268,0.432325902350983,0.829293193624912,2,15,positive regulation of potassium ion transport,BP,FHL1;STK39
8828,GO:0034638,0.432342658121937,0.904814545553594,1,6,phosphatidylcholine catabolic process,BP,LDLR
7052,GO:0030851,0.432499541193269,0.829172658563286,2,15,granulocyte differentiation,BP,ZFPM1;INPP5D
11096,GO:0045137,0.432569929939705,0.672320779378359,15,146,development of primary sexual characteristics,BP,ERCC1;CST3;ZP3;INSR;VEGFA;CEBPB;ADAM15;SLIT3;VGF;DMC1;AGO4;WNT2B;SDC1;ACVR1B;EREG
11751,GO:0046632,0.432680519692795,0.728953927090342,6,54,alpha-beta T cell differentiation,BP,ZFPM1;STAT6;BCL6;ADA;PRKCZ;JAK3
16400,GO:0097066,0.432947029426161,0.828861820816321,2,15,response to thyroid hormone,BP,CTSB;CTSH
7697,GO:0032196,0.433146878281353,0.828722905106236,2,15,transposition,BP,APOBEC3C;APOBEC3F
5498,GO:0016459,0.433190581708888,0.761112749348179,4,35,myosin complex,CC,OBSL1;MYO18A;MYH16;MYH3
11322,GO:0045668,0.433413011890151,0.787271311127142,3,25,negative regulation of osteoblast differentiation,BP,LRP5;ID1;SUFU
4285,GO:0009725,0.43355701555784,0.619142305392468,64,647,response to hormone,BP,FOS;CST3;PGF;NOS1;ZFP36L1;POSTN;NR1D1;FAM210B;IGF2;EGFR;TIMP2;HADH;EGR1;SHC1;BBS2;CTSB;ABCG1;PIK3R2;HDAC5;THRA;LRP5;BSG;PTPRU;PTPRE;VAMP2;WNT7A;INSR;DNMT3A;IGFBP2;CALCOCO1;ENDOG;MAPK3;TUB;GLB1;ADCY6;ABCA2;SLIT3;PCSK9;ZFP36;PRKACA;VGF;TRPV4;EEF2K;PPARA;WNT7B;PTAFR;RXRA;PCK2;PRKCZ;PDK2;SRSF5;WBP2;GRB10;SESN2;RXRB;TIMP1;SDC1;AKT1;SLC5A5;CTSH;SLC2A1;JAK3;RARG;EREG
6811,GO:0030282,0.433757293130273,0.728023505768646,6,54,bone mineralization,BP,CYP27B1;PTHLH;ECM1;FAM20C;ACVR2B;FGFR3
12626,GO:0050856,0.433832696273829,0.786945737021043,3,25,regulation of T cell receptor signaling pathway,BP,PRNP;ADA;KCNN4
16127,GO:0090174,0.433861028244086,0.678560473430864,13,125,organelle membrane fusion,BP,SYTL1;EVI5L;SYT8;TBC1D14;VPS11;VAMP2;TBC1D8;STX10;VAV3;TMEM175;TBC1D16;TBC1D17;TSNARE1
4566,GO:0010661,0.434055330143533,0.828090695759533,2,15,positive regulation of muscle cell apoptotic process,BP,PDCD4;BNIP3
3699,GO:0008215,0.434524732964943,0.903731615860094,1,6,spermine metabolic process,BP,SMOX
17043,GO:0099568,0.43459995489871,0.636467427142061,34,339,cytoplasmic region,CC,FAM110C;RAPGEF3;GSN;MYZAP;DNAH1;EXOC2;PKD2;RIMS3;IFT140;GM2A;RHOD;DLG4;PLEKHH2;WIPF1;GPSM1;SAMD3;ADA;RHOF;PRKACA;SPTB;DMTN;BBS1;TRPV4;RHOBTB2;LLGL1;PRKCZ;SPATA7;CTSZ;BFSP1;CAPN2;SEPT8;GAS8;SPIRE2;SLC2A1
818,GO:0002092,0.435225662684558,0.827274446565725,2,15,positive regulation of receptor internalization,BP,VEGFA;PCSK9
12226,GO:0048523,0.435371778700128,0.591787065842156,317,3284,negative regulation of cellular process,BP,TNIP1;HTRA1;DUSP6;CEMIP;APOE;ESPN;CTNNBIP1;IDH2;PTPRS;ERCC1;WWC3;SEMA4B;CST3;SHANK2;RAPGEF3;TCFL5;CYP27B1;GSN;EVI5L;XDH;PRDX5;NDRG1;PCBP4;NOS1;LTBP1;ARAP1;ZFP36L1;CGREF1;POSTN;GRB7;NR1D1;ALOX15B;ARRDC1;RBCK1;EPHB2;IGF2;NFATC4;MST1R;LRP1;EGFR;TIMP2;MMP28;HADH;FBXO2;DUSP5;TOM1L2;PPP1R14A;FHL1;MXD4;SERPING1;MDFI;EGR1;ULK1;RHBDF1;PKN1;ARPIN;SHC1;RGL2;F2R;PTK6;ABCA7;DEAF1;PPP2R3B;BAHCC1;CORO1B;CXXC5;ULK2;GJC2;ZMYND8;TBC1D14;MXI1;PLAT;ABCG1;ANK3;PIK3R2;PEG3;HDAC5;THRA;ZP3;CRTAP;RPS6KA2;NISCH;LRP5;HYAL1;TENM2;ZFPM1;ERBB2;FBLN1;BRSK1;SCMH1;PTPRU;PKD2;ITPR3;PLXNB3;H2AFJ;VAT1;DNM1;SPRY4;DDIT4L;PTHLH;CDKN1C;SALL2;CD9;XPC;PTPRE;SERPINE2;FUZ;FOXQ1;NPHP4;LTB4R2;UNK;NTSR1;ATP2B4;TMOD2;TFDP2;ACP5;RASA4;ADAMTS7;PDCD4;ASIC1;WNT7A;INSR;ZC3H6;ID1;EPHA1;ADARB1;ZNF692;ITGA6;SYNGAP1;IL20RB;PPP1R35;DNMT3A;PRNP;PAPLN;EFNB3;SNX33;HES2;SPRY2;HINT2;MNT;ECM1;STAT6;DLG4;SPEG;MTA3;STRADB;WWTR1;MYO18A;DNAJB5;PLEKHH2;BCL6;PLXNB1;IGFBP2;BNIP3;SRMS;FZD8;VEGFA;CEBPB;RHBDF2;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;S1PR2;TNFRSF6B;CARD19;DVL1;MTA1;ADCY6;L3MBTL1;MBD1;EPHB3;HES1;FURIN;MLXIPL;MEFV;LRSAM1;ADA;MCTP1;PIDD1;PAG1;PHF21A;PFKL;SLIT3;PCSK9;ZFP36;MAPKBP1;FGFR3;PRKACA;LRRK1;DGUOK;MAGEF1;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;SPTB;DMTN;MAPK8IP1;TCF25;SEMA3B;LDLR;TRPV4;BHLHE40;EIF4EBP3;RAG1;DUSP7;TNFAIP8L1;EEF2K;HMGA2;SEMA3F;ELK3;DGKQ;SEMA4C;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;TKFC;COMT;SUFU;RXRA;VASN;BCR;IGFBP4;PRKCZ;CAPG;INPP5D;TM7SF3;TWF2;GPC1;AGO4;ARAP3;FGFR1;CTSZ;CHADL;PIN1;C5;IRF2BPL;PROX1;DLG3;BIN1;VSNL1;SERPINB6;PPP1R13L;ASS1;SLC25A27;GRB10;JARID2;SESN2;TMEM161A;CSTB;RTN4R;ELFN2;TIMP1;WHAMMP3;APOBEC3C;FGFBP1;PEAR1;WNT3;PPM1F;SORL1;STK39;ACVR1B;TPCN1;ERBB3;ABR;CCDC85B;AKT1;TRAP1;TMBIM4;NLRX1;ZNF385A;TP53INP1;NDRG2;SIX5;GPD1L;PINK1;GAS8;PKD1;SNTA1;RGS14;PCIF1;CTSH;MLST8;CBLC;EPN2;PYCARD;PCSK1N;ERN1;RANBP9;APOBEC3F;SIRT3;C12ORF66;JAK3;MZF1;NEIL1;RARG;ING4;PBXIP1;EREG;GSTM2;ZFYVE19;SHISA6;GIPR;SFI1;TP53I11;SEMA4F;RPL13A;RGS12;MIF;SULF2;LZTS2
13696,GO:0060292,0.435412222390679,0.827144143756135,2,15,long term synaptic depression,BP,SHANK2;SHANK3
8285,GO:0033131,0.435573149437738,0.903208561940127,1,6,regulation of glucokinase activity,BP,PFKFB2
7072,GO:0030878,0.435731585582264,0.82692096502934,2,15,thyroid gland development,BP,THRA;MAPK3
2040,GO:0004791,0.435822383345356,0.903083957005216,1,6,thioredoxin-disulfide reductase activity,MF,TXNRD3
7721,GO:0032228,0.436014379947139,0.826723215823727,2,15,regulation of synaptic transmission, GABAergic,BP,NLGN2;NISCH
680,GO:0001891,0.436383441306854,0.826464965227172,2,15,phagocytic cup,CC,ABCA7;PEAR1
2372,GO:0005507,0.436594136301086,0.757768102199036,4,37,copper ion binding,MF,LOXL1;PRNP;ATP7B;GPC1
17891,GO:1902230,0.436686837378755,0.784277391247098,3,26,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,TMEM161A;ZNF385A;MIF
17400,GO:1900181,0.436844356939771,0.826142157100656,2,15,negative regulation of protein localization to nucleus,BP,GAS6;LZTS2
4092,GO:0009155,0.436853406918642,0.90256742232522,1,6,purine deoxyribonucleotide catabolic process,BP,ADA
596,GO:0001764,0.436969786301736,0.697208492169507,9,84,neuron migration,BP,UNK;CELSR1;VEGFA;MDGA1;NHSL1;PEX7;GAS6;NDE1;FGFR1
11652,GO:0046456,0.43702019588418,0.784016996132246,3,26,icosanoid biosynthetic process,BP,GGT1;LTA4H;MIF
8022,GO:0032680,0.437158637289774,0.713600228289848,7,66,regulation of tumor necrosis factor production,BP,NFATC4;ACP5;ZFP36;GAS6;PTAFR;PYCARD;MIF
17476,GO:1900543,0.437293941851621,0.784251914944403,3,25,negative regulation of purine nucleotide metabolic process,BP,LTB4R2;MLXIPL;PPARA
11280,GO:0045620,0.437543052876323,0.784057435272623,3,25,negative regulation of lymphocyte differentiation,BP,ERBB2;BCL6;JAK3
7773,GO:0032310,0.437654717839521,0.902164777058912,1,6,prostaglandin secretion,BP,MIF
9392,GO:0035970,0.437704977145337,0.825538570272663,2,15,peptidyl-threonine dephosphorylation,BP,DUSP5;PPM1F
15179,GO:0071353,0.438007959355113,0.783694269028998,3,25,cellular response to interleukin-4,BP,STAT6;ADAMTS13;JAK3
4758,GO:0010952,0.43830331785754,0.666844953031707,15,150,positive regulation of peptidase activity,BP,GSN;XDH;F2R;GRAMD4;FBLN1;MAPK3;MEFV;PIDD1;CYFIP2;DAP;PPM1F;PINK1;CTSH;PYCARD;FAM162A
11755,GO:0046636,0.438444179998897,0.825019263540701,2,15,negative regulation of alpha-beta T cell activation,BP,BCL6;JAK3
6291,GO:0019915,0.438703950282085,0.737780307409385,5,45,lipid storage,BP,APOE;ABCG1;HEXB;GM2A;PPARA
10678,GO:0043981,0.438835631046638,0.824743932710866,2,15,histone H4-K5 acetylation,BP,JADE2;ING4
10679,GO:0043982,0.438835631046638,0.824743932710866,2,15,histone H4-K8 acetylation,BP,JADE2;ING4
1607,GO:0004033,0.439777952208138,0.823200055288405,2,16,aldo-keto reductase (NADP) activity,MF,AKR7A2;KCNAB2
6971,GO:0030659,0.43987083760492,0.619476642091553,50,506,cytoplasmic vesicle membrane,CC,CEMIP;APOE;PTPRS;GAA;LRP1;EGFR;SYT8;ULK2;DBNDD1;BSG;PKD2;ITPR3;CD9;VAMP2;WNT7A;RAB3D;NBEAL2;TMEM173;SNX33;SNX9;DLG4;AP2A2;GPRC5C;KCNAB2;RAB40B;SLC2A3;MCTP1;RHOF;HBEGF;RAB3B;PI4K2A;LDLR;SNX17;IFNGR2;LDLRAP1;AHNAK2;SEMA4C;WNT7B;PTAFR;CLTCL1;SERPINB6;CD68;WNT3;HGSNAT;SUN1;SPIRE2;EPN2;RHBG;RAB40C;STXBP2
15874,GO:0072673,0.43992784981851,0.823974509664714,2,15,lamellipodium morphogenesis,BP,ARPIN;CORO1B
10255,GO:0043015,0.440026957805095,0.782113839981636,3,25,gamma-tubulin binding,MF,NDRG1;MARK4;BRSK1
17511,GO:1901033,0.440143315062316,0.900907616283988,1,6,positive regulation of response to reactive oxygen species,BP,ENDOG
10157,GO:0042762,0.440559593430963,0.823528664817405,2,15,regulation of sulfur metabolic process,BP,COMT;PDK2
2337,GO:0005375,0.44067243826529,0.9006390132221,1,6,copper ion transmembrane transporter activity,MF,ATP7B
9106,GO:0035434,0.44067243826529,0.9006390132221,1,6,copper ion transmembrane transport,BP,ATP7B
456,GO:0001302,0.440752071932318,0.900598548384276,1,6,replicative cell aging,BP,ERCC1
2537,GO:0005802,0.440768455427242,0.658548806543636,17,167,trans-Golgi network,CC,MARCH9;ARAP1;POSTN;DOPEY2;VAMP2;TRAPPC9;ATP7B;SNX9;MYO18A;FURIN;PI4K2A;STX10;LLGL1;CLTCL1;SLC9A7;SORL1;PCSK1N
2859,GO:0006359,0.440880872945847,0.781443812901475,3,25,regulation of transcription by RNA polymerase III,BP,PRDX5;ERBB2;NAB2
7487,GO:0031670,0.441032137780557,0.735795401548479,5,45,cellular response to nutrient,BP,CYP27B1;POSTN;SSH1;GAS6;PDK2
903,GO:0002286,0.441238153593464,0.73561948195813,5,45,T cell activation involved in immune response,BP,ZFPM1;STAT6;BCL6;PRKCZ;JAK3
9057,GO:0035315,0.441262911338065,0.781143736994676,3,25,hair cell differentiation,BP,HES1;SLITRK6;FGFR1
6859,GO:0030346,0.441360849944544,0.900288861567065,1,6,protein phosphatase 2B binding,MF,ATP2B4
1379,GO:0003279,0.441407127318378,0.700889144309304,8,74,cardiac septum development,BP,LTBP1;ZFPM1;VANGL2;HES1;NRP2;SNX17;SUFU;PROX1
7566,GO:0031941,0.441496374363912,0.780506512392162,3,26,filamentous actin,CC,ESPN;PKD2;PRKCZ
17810,GO:1902001,0.441781226914276,0.822664832068007,2,15,fatty acid transmembrane transport,BP,CPT2;AKT1
9492,GO:0036158,0.441882454057913,0.900023035926247,1,6,outer dynein arm assembly,BP,DNAAF5
5559,GO:0016581,0.442023761055063,0.822493069220199,2,15,NuRD complex,CC,APPL2;SALL2
16302,GO:0090545,0.442023761055063,0.822493069220199,2,15,CHD-type complex,CC,APPL2;SALL2
19409,GO:1990050,0.442138051469309,0.899892612221113,1,6,phosphatidic acid transporter activity,MF,PLTP
2849,GO:0006346,0.442400744573841,0.822225915580625,2,15,methylation-dependent chromatin silencing,BP,DNMT3A;MBD1
15435,GO:0071800,0.442441167728742,0.822197256705529,2,15,podosome assembly,BP,GSN;SH3PXD2B
816,GO:0002090,0.442488064233776,0.7801801415966,3,25,regulation of receptor internalization,BP,DLG4;VEGFA;PCSK9
14494,GO:0070006,0.442871570377287,0.821891962621437,2,15,metalloaminopeptidase activity,MF,RNPEPL1;LTA4H
4588,GO:0010713,0.443164489641646,0.899367768044782,1,6,negative regulation of collagen metabolic process,BP,CST3
3107,GO:0006692,0.443372452562545,0.779027403798129,3,26,prostanoid metabolic process,BP,TNFRSF1A;CES2;MIF
3108,GO:0006693,0.443372452562545,0.779027403798129,3,26,prostaglandin metabolic process,BP,TNFRSF1A;CES2;MIF
11183,GO:0045332,0.443425437996064,0.821498686364891,2,15,phospholipid translocation,BP,ABCA7;KCNN4
1371,GO:0003264,0.443471779464227,0.89921030506332,1,6,regulation of cardioblast proliferation,BP,HES1
15967,GO:0086005,0.443528478344716,0.821425471689216,2,15,ventricular cardiac muscle cell action potential,BP,GPD1L;SNTA1
17678,GO:1901612,0.443668997132181,0.899109163691733,1,6,cardiolipin binding,MF,NME4
17773,GO:1901890,0.444641691243168,0.77848153153163,3,25,positive regulation of cell junction assembly,BP,NPHP4;VEGFA;PPM1F
9853,GO:0042130,0.44467840599544,0.751636382667102,4,35,negative regulation of T cell proliferation,BP,ERBB2;IL20RB;PRNP;CEBPB
10342,GO:0043174,0.444758754478218,0.819656131384227,2,16,nucleoside salvage,BP,UCKL1;TK2
4416,GO:0010248,0.444807009406381,0.898524288751782,1,6,establishment or maintenance of transmembrane electrochemical gradient,BP,ATP12A
4123,GO:0009191,0.445083982503666,0.898381615874161,1,6,ribonucleoside diphosphate catabolic process,BP,ENTPD2
16869,GO:0098843,0.445318326852297,0.898260802480903,1,6,postsynaptic endocytic zone,CC,DNM1
5662,GO:0016782,0.445423335271161,0.731830494239688,5,46,transferase activity, transferring sulfur-containing groups,MF,SUGCT;TST;CHST6;GAL3ST4;NDST2
716,GO:0001942,0.445470566713374,0.706356973240216,7,65,hair follicle development,BP,EGFR;LAMA5;FUZ;FOXQ1;CELSR1;VANGL2;ACVR1B
10368,GO:0043209,0.445528525978723,0.663703707319118,14,138,myelin sheath,CC,GSN;NDRG1;CNTN1;GJC2;ERBB2;ITPR3;DNM1;GLUL;SDHA;PRKCZ;MDH2;ASS1;EHD3;MIF
7058,GO:0030857,0.445583327170704,0.777736934771189,3,25,negative regulation of epithelial cell differentiation,BP,XDH;ID1;HES1
4296,GO:0009756,0.445857927586122,0.897982271807463,1,6,carbohydrate mediated signaling,BP,MLXIPL
5636,GO:0016740,0.445989116221844,0.587200962560636,185,1895,transferase activity,MF,NAPRT;PYGB;RNF44;LTBP4;LTBP1;MARCH9;CRAT;POLD4;RBCK1;EPHB2;OBSCN;CPT2;NME4;MST1R;GAMT;MAPK13;CDK18;ST6GALNAC2;EGFR;B3GAT3;SUGCT;FBXO2;DDB2;ULK1;PKN1;PYGL;PTK6;LPCAT4;RNF208;ULK2;DGKA;ASH2L;CERS4;PIK3R2;NEK9;RPS6KA2;NMRK1;HYAL1;MARK4;B4GALNT4;ERBB2;BRSK1;GID4;TMEM129;TST;CPT1C;PAK6;HEXB;GALNT12;RNF135;JADE2;MINK1;GGT1;CSNK1E;ZFYVE21;DTX3;INSR;FBXW8;GRK6;B4GAT1;POLL;RABGGTA;EPHA1;FBXO27;DNMT3A;DNPH1;EFNB3;FBXL8;FBXO41;DLG4;SPEG;MARCH2;FGGY;MKNK2;STRADB;TALDO1;FAM20C;UCKL1;PFKFB2;DYRK1B;SRMS;MAST4;FBXW4;ACVR2B;ZDHHC1;MAPK3;FBXL16;GALK1;KLHL29;PKN3;ST3GAL3;EPHB3;COMTD1;NAGS;FAM86C2P;MBOAT7;TRIM4;NRP2;NADK;TK2;LRSAM1;CKMT1A;PFKL;FGFR3;NSUN7;PRKACA;ZNF862;LRRK1;DGUOK;RPS6KA5;HBEGF;MAP2K2;PI4K2A;FGFR4;FBXW5;PMVK;XYLT2;PIGZ;RRNAD1;RAG1;EEF2K;HMGA2;DGKQ;HK1;MIB2;FBXO17;CHST6;BTRC;TKFC;GUK1;STK32C;COMT;RFNG;BCR;RNF123;PRKCZ;ZDHHC24;HLTF;KLHDC8B;PDK2;MAPKAPK3;FGFR1;CAMKK1;SPSB3;KMT5C;DLG3;PI4KAP2;ADCK5;LCAT;GAL3ST4;PIGV;PIGQ;GSTT1;STK39;ACVR1B;HGSNAT;ERBB3;ZER1;AKT1;TUT1;PCMTD2;ADCK2;PINK1;AGPAT4;CBLC;RNF187;MAP2K3;POMT1;AS3MT;STK17A;ERN1;PRIMPOL;FBXL20;GCAT;TAZ;JAK3;MAST3;FUK;EREG;GSTM2;TRIM7;POLM;NDST2;AGPAT3;ALG12
4595,GO:0010720,0.446018557077582,0.625500881692381,34,339,positive regulation of cell development,BP,APOE;SHANK2;EPHB2;CNTN1;OBSL1;TIMP2;CRTC1;PTK6;GJC2;ZMYND8;PLXNB3;SERPINE2;CSNK1E;FBXW8;LPAR3;DLG4;BCL6;PLXNB1;VEGFA;SHANK3;S1PR2;ETV5;DVL1;HES1;CUL7;DMTN;EEF2K;TWF2;FGFR1;PIN1;PROX1;BIN1;WNT3;RGS14
2721,GO:0006108,0.446207594132657,0.897801523356532,1,6,malate metabolic process,BP,MDH2
17663,GO:1901568,0.446345802989023,0.681930226740136,10,97,fatty acid derivative metabolic process,BP,ALOX15B;ACOT7;GGT1;MAPK3;LTA4H;TNFRSF1A;HMGCL;CES2;CYP2S1;MIF
16121,GO:0090162,0.446367417530848,0.777116029548003,3,25,establishment of epithelial cell polarity,BP,MYO18A;HES1;FBF1
5519,GO:0016505,0.446558397412085,0.818366559659909,2,16,peptidase activator activity involved in apoptotic process,MF,CTSH;PYCARD
18341,GO:1903364,0.446703605593157,0.671028239446341,12,116,positive regulation of cellular protein catabolic process,BP,APOE;LRP1;EDEM1;VPS11;CSNK1E;CD81;DVL1;PCSK9;MAGEF1;LDLR;RAD23A;AKT1
13473,GO:0055067,0.446713456137099,0.688220367281175,9,86,monovalent inorganic cation homeostasis,BP,SLC12A7;ATP12A;MAPK3;SCNN1A;COMT;TMEM175;PDK2;KCNMA1;SLC9A7
13911,GO:0060603,0.446873633032401,0.776714739178033,3,25,mammary gland duct morphogenesis,BP,LRP5;ETV5;BTRC
8789,GO:0034511,0.447115786203112,0.897331115274867,1,6,U3 snoRNA binding,MF,ISG20
11297,GO:0045639,0.44715038628916,0.716192698557067,6,55,positive regulation of myeloid cell differentiation,BP,FOS;CTNNBIP1;ZFP36L1;FAM210B;INPP5D;ACVR1B
4418,GO:0010256,0.447614797584899,0.622032302380873,36,360,endomembrane system organization,BP,GSN;NDRG1;OBSL1;DOPEY2;F2R;ANK3;NEK9;DNM1;SERPINE2;VPS11;FBXW8;SNX33;SNX9;REEP2;MYO18A;CHMP1B;HOOK2;MAPK3;CUL7;MAP2K2;PI4K2A;AHNAK2;MVB12A;REEP4;EPB41L3;LYST;ANO9;ALS2CL;AKT1;ZNF385A;VPS33B;SUN1;EHD3;GOLGA2P5;RFX2;TMED4
6283,GO:0019902,0.447648737066175,0.658299549225167,15,145,phosphatase binding,MF,EGFR;SLC9A3R2;PIK3R2;ERBB2;ATP2B4;PPP1R35;STAT6;DLG4;MAPK3;PPARA;DLG3;AKT1;KCNN4;JAK3;SFI1
5735,GO:0016892,0.447760120837832,0.896996543359581,1,6,endoribonuclease activity, producing 3'-phosphomonoesters,MF,RNASET2
5335,GO:0016093,0.44788784784404,0.89693013879774,1,6,polyprenol metabolic process,BP,SRD5A3
9335,GO:0035864,0.448076511104753,0.896832004095558,1,6,response to potassium ion,BP,ADAMTS13
10364,GO:0043203,0.448219270581831,0.8967577071931,1,6,axon hillock,CC,PRKCZ
2742,GO:0006152,0.448254711138949,0.896739257448025,1,6,purine nucleoside catabolic process,BP,ADA
11554,GO:0046130,0.448254711138949,0.896739257448025,1,6,purine ribonucleoside catabolic process,BP,ADA
652,GO:0001843,0.448302724861307,0.694584273488532,8,75,neural tube closure,BP,DEAF1;FUZ;CELSR1;VANGL2;DVL1;SEMA4C;SUFU;RARG
13913,GO:0060606,0.448302724861307,0.694584273488532,8,75,tube closure,BP,DEAF1;FUZ;CELSR1;VANGL2;DVL1;SEMA4C;SUFU;RARG
4884,GO:0014820,0.448330548815671,0.896699770633751,1,6,tonic smooth muscle contraction,BP,BBS2
13068,GO:0051606,0.44853451415808,0.669174264296442,12,119,detection of stimulus,BP,POLD4;REEP6;ABCG1;PKD2;SERPINE2;NTSR1;PITPNM1;HMGA2;C21ORF2;GUCA1B;OR7D2;PKD1
9235,GO:0035655,0.448594615620512,0.896562202695824,1,6,interleukin-18-mediated signaling pathway,BP,AKT1
15177,GO:0071351,0.448594615620512,0.896562202695824,1,6,cellular response to interleukin-18,BP,AKT1
10103,GO:0042641,0.448811701895991,0.714732296178268,6,55,actomyosin,CC,MST1R;CORO1B;MICALL2;MYO18A;VANGL2;FHOD1
12770,GO:0051090,0.448942938661866,0.627047524877645,30,302,regulation of DNA binding transcription factor activity,BP,FOS;CTNNBIP1;RBCK1;MDFI;ADGRF1;CRTC1;MXI1;HDAC5;THRA;LRP5;PKD2;TRAPPC9;ID1;PRNP;VEGFA;MAPK3;PIDD1;RPS6KA5;DAP;BHLHE40;GAS6;BTRC;SUFU;PRKCZ;PROX1;AKT1;NLRX1;PINK1;PKD1;PYCARD
513,GO:0001578,0.448991296547898,0.728965818002271,5,45,microtubule bundle formation,BP,BBS2;DNAH1;MARK4;GAS8;DNAAF5
4654,GO:0010812,0.449082057134113,0.728887545157102,5,45,negative regulation of cell-substrate adhesion,BP,POSTN;FBLN1;BCL6;ADAM15;DMTN
6360,GO:0021554,0.44921357449996,0.896239294574177,1,6,optic nerve development,BP,EPHB2
4878,GO:0014808,0.449336623530522,0.816366246810051,2,16,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,PRKACA;GSTM2
18405,GO:1903514,0.449336623530522,0.816366246810051,2,16,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,PRKACA;GSTM2
16262,GO:0090385,0.449456567983735,0.896112351035023,1,6,phagosome-lysosome fusion,BP,TMEM175
1113,GO:0002702,0.449492295398713,0.728326632979918,5,46,positive regulation of production of molecular mediator of immune response,BP,STAT6;MAPK3;HK1;PRKCZ;MIF
12602,GO:0050815,0.44951893880445,0.896079751645936,1,6,phosphoserine residue binding,MF,PIN1
4262,GO:0009628,0.449655107418115,0.597177586203646,84,861,response to abiotic stimulus,BP,FOS;PPL;ERCC1;CST3;NDRG1;PGF;NOS1;ZFP36L1;POSTN;EPAS1;NFATC4;MAPK13;EGFR;REEP6;DDB2;MTHFR;EGR1;PKN1;CRTC1;DEAF1;PLAT;ZNF516;THRA;LRP5;HYAL1;BRSK1;PKD2;LRP11;CD9;XPC;SERPINE2;NPHP4;NTSR1;ATP2B4;ASIC1;SYNGAP1;DNMT3A;IGFBP2;BNIP3;VEGFA;LRRC8A;SHANK3;HSF4;ENDOG;MAPK3;MTA1;ADA;AQP3;PRKACA;PITPNM1;VGF;TNFRSF1A;ACOT11;TRPV4;BHLHE40;RAG1;EEF2K;HMGA2;PPARA;PTAFR;DMC1;VASN;SLITRK6;ICOSLG;KCNMA1;SERPINB6;SLC25A27;CAPN2;TMEM161A;GUCA1B;STK39;VEGFB;AKT1;TP53INP1;ERCC6;SUN1;PINK1;PKD1;RGS14;MLST8;PCSK1N;PRIMPOL;SLC2A1;FAM162A
11353,GO:0045741,0.449691744691228,0.895989397126441,1,6,positive regulation of epidermal growth factor-activated receptor activity,BP,EREG
5683,GO:0016813,0.449706821724372,0.895981511470438,1,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,PADI3
10196,GO:0042834,0.44984966094023,0.895906784252984,1,6,peptidoglycan binding,MF,HK1
13547,GO:0060042,0.449868639268263,0.774333629126687,3,25,retina morphogenesis in camera-type eye,BP,SDK2;LRP5;PROX1
7075,GO:0030881,0.450128833791303,0.895760634678424,1,6,beta-2-microglobulin binding,MF,FCGRT
7304,GO:0031325,0.450232683261687,0.581329290877273,211,2169,positive regulation of cellular metabolic process,BP,TNIP1;FOS;DUSP6;CEMIP;APOE;ERCC1;CITED4;CST3;RAPGEF3;GSN;XDH;MEF2D;NOS1;ARAP1;ZFP36L1;NR1D1;EPHB2;EPAS1;CNTN1;IGF2;NFATC4;MST1R;LRP1;EGFR;TIMP2;TCEA2;DUSP5;EGR1;ULK1;PKN1;CRTC1;TRIM65;SHC1;F2R;PTK6;ABCA7;DEAF1;SHC2;ASH2L;GRAMD4;SOX12;PIK3R2;ZNF516;PEG3;HDAC5;THRA;ZP3;LRP5;MAML3;ZFPM1;TFEB;ERBB2;FBLN1;PKD2;EDEM1;PTHLH;CDKN1C;SALL2;PAK6;HEXB;VPS11;NTSR1;MINK1;ATP2B4;TFDP2;CSNK1E;TNFRSF25;WNT7A;ZMIZ1;INSR;EPHA1;ITGA6;LPAR3;TMEM173;PRNP;SNX33;SPRY2;SNX9;STAT6;DLG4;STRADB;WWTR1;BCL6;PFKFB2;DYRK1B;SEC14L2;BNIP3;CD81;FZD8;VEGFA;VANGL2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;S1PR2;ENDOG;MAPK3;ETV5;DVL1;MTA1;FYCO1;GPSM1;ADCY6;EPHB3;FHOD1;HES1;FURIN;MLXIPL;MEFV;LRSAM1;PIDD1;IL6R;PCSK9;ZFP36;ETV4;FGFR3;PRKACA;F12;LRRK1;MAGEF1;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;TNFRSF1A;EHD4;MAPK8IP1;LDLR;TRPV4;DUSP7;HMGA2;ELK3;DGKQ;SEMA4C;ZXDC;GAS6;BTRC;PPARA;WNT7B;COMT;PTAFR;RXRA;VAV3;IGFBP4;USP21;PRKCZ;HLTF;SRSF5;RFXANK;TEF;MAPKAPK3;RAD23A;FGFR1;CAMKK1;PIN1;C5;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;ASS1;SH3D19;JARID2;SESN2;TOLLIP;TMEM161A;RXRB;MAPRE3;GUCA1B;MADD;PPM1F;STK39;ACVR1B;MEF2B;ADORA2B;TPCN1;ERBB3;AKT1;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;CAMTA2;CTSH;ABHD14B;MLST8;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;DDN;ERN1;MLYCD;TAZ;LITAF;MZF1;RARG;EREG;FAM162A;MIF
11261,GO:0045591,0.450376505117212,0.895630867262297,1,6,positive regulation of regulatory T cell differentiation,BP,BCL6
7881,GO:0032461,0.450479644556653,0.81553990232172,2,16,positive regulation of protein oligomerization,BP,MMP1;SNX9
15955,GO:0080154,0.450607798478553,0.895509588320451,1,6,regulation of fertilization,BP,ZP3
8142,GO:0032885,0.450792485181743,0.773596765047476,3,25,regulation of polysaccharide biosynthetic process,BP,IGF2;INSR;AKT1
8470,GO:0033632,0.451026348586201,0.895289893189258,1,6,regulation of cell-cell adhesion mediated by integrin,BP,ADA
17645,GO:1901533,0.451131868375644,0.895234459950006,1,6,negative regulation of hematopoietic progenitor cell differentiation,BP,HES1
20131,GO:2000973,0.45113823476233,0.895231114872131,1,6,regulation of pro-B cell differentiation,BP,HES1
7480,GO:0031663,0.451253054979069,0.745848884078497,4,36,lipopolysaccharide-mediated signaling pathway,BP,MAPK3;PTAFR;AKT1;MIF
3747,GO:0008297,0.451512881276135,0.895034145048654,1,6,single-stranded DNA exodeoxyribonuclease activity,MF,ISG20
12889,GO:0051261,0.451566846897471,0.691633568095414,8,75,protein depolymerization,BP,GSN;TMOD2;PLEKHH2;SPTB;DMTN;TRPV4;CAPG;TWF2
4786,GO:0010988,0.451704162611911,0.894933488336499,1,6,regulation of low-density lipoprotein particle clearance,BP,PCSK9
11444,GO:0045921,0.451712754818018,0.712018596404757,6,56,positive regulation of exocytosis,BP,ZP3;RAB3D;PTAFR;VSNL1;SDC1;ADORA2B
12654,GO:0050891,0.451843449135168,0.726501845863736,5,45,multicellular organismal water homeostasis,BP,ADCY6;AQP3;PRKACA;SCNN1A;TRPV4
7741,GO:0032269,0.451845384516635,0.595519214914095,82,852,negative regulation of cellular protein metabolic process,BP,TNIP1;DUSP6;APOE;CST3;XDH;PRDX5;ZFP36L1;GRB7;EPHB2;EGFR;TIMP2;DUSP5;PPP1R14A;SERPING1;PKN1;PTK6;PLAT;PIK3R2;CRTAP;LRP5;FBLN1;SPRY4;CDKN1C;SERPINE2;UNK;ATP2B4;PDCD4;EPHA1;ADARB1;PPP1R35;PRNP;PAPLN;SPRY2;HINT2;ECM1;WWTR1;VEGFA;TNFRSF6B;DVL1;FURIN;MLXIPL;ZFP36;LRRK1;MAP2K2;DMTN;MAPK8IP1;EIF4EBP3;RAG1;DUSP7;DGKQ;GAS6;MEX3A;SUFU;PRKCZ;AGO4;CTSZ;PIN1;C5;BIN1;SERPINB6;JARID2;SESN2;CSTB;RTN4R;ELFN2;TIMP1;PPM1F;SORL1;STK39;AKT1;NDRG2;GPD1L;PINK1;SNTA1;RGS14;CBLC;PYCARD;PCSK1N;RANBP9;SIRT3;RPL13A;MIF
5485,GO:0016433,0.451970083747625,0.894793452321939,1,6,rRNA (adenine) methyltransferase activity,MF,RRNAD1
11327,GO:0045682,0.452004805444852,0.700398823006244,7,66,regulation of epidermis development,BP,CYP27B1;ZFP36L1;ALOX15B;NAB2;HES1;AQP3;ZFP36
2970,GO:0006520,0.45215580685734,0.627836001655868,27,275,cellular amino acid metabolic process,BP,PRODH;NOS1;GAMT;ALDH4A1;MTHFR;BPHL;CRTAP;CBS;SLC7A8;ATP2B4;GGT1;SLC6A8;GLUL;BLMH;PHGDH;NAGS;PYCR2;ACY1;CKMT1A;HMGCL;COMT;ASS1;GSS;AHCYL2;HPDL;GCAT;BCKDHA
880,GO:0002246,0.45217122236616,0.89468745233339,1,6,wound healing involved in inflammatory response,BP,F2R
17844,GO:1902105,0.452216157399069,0.650708588134906,16,157,regulation of leukocyte differentiation,BP,FOS;CTNNBIP1;ZFP36L1;ZFPM1;ERBB2;ZMIZ1;BCL6;FAM213A;CEBPB;ADA;SOX13;RAG1;GAS6;PRKCZ;INPP5D;JAK3
607,GO:0001776,0.452519801698227,0.711305589582364,6,56,leukocyte homeostasis,BP,PKN1;ADA;RAG1;AKT1;JAK3;MIF
12283,GO:0048644,0.452736104420923,0.725728877823825,5,45,muscle organ morphogenesis,BP,ZFPM1;ADARB1;VANGL2;RXRA;PROX1
7886,GO:0032466,0.452849405666056,0.894329548522851,1,6,negative regulation of cytokinesis,BP,ZFYVE19
20164,GO:2001040,0.452972466732364,0.894264521429447,1,6,positive regulation of cellular response to drug,BP,ENDOG
1452,GO:0003690,0.453114384708769,0.601732359405909,60,604,double-stranded DNA binding,MF,FOS;TCFL5;MEF2D;NR1D1;NFATC4;EGFR;H1F0;EGR1;DEAF1;BAHCC1;ZMYND8;SOX12;MXI1;ZNF516;THRA;ZFPM1;TFEB;SALL2;XPC;FOXQ1;TFDP2;ZC3H6;ZNF692;ZNF704;HES2;MNT;STAT6;BCL6;CEBPB;HSF4;ETV5;MTA1;MBD1;HES1;MLXIPL;PHF21A;ETV4;SOX13;BHLHE40;HMGA2;ELK3;ZNF217;PPARA;DMC1;RXRA;HLTF;TEF;SMARCD2;PROX1;WBP2;JARID2;RXRB;MEF2B;SIX5;SSBP2;RFX2;DDN;LITAF;MZF1;RARG
3196,GO:0006837,0.453123130892629,0.89418487376798,1,6,serotonin transport,BP,NOS1
9403,GO:0035987,0.453163578821821,0.744537308796711,4,35,endodermal cell differentiation,BP,DUSP6;COL6A1;ITGB5;HMGA2
10787,GO:0044291,0.453388883231988,0.725163078719179,5,45,cell-cell contact zone,CC,OBSL1;ANK3;SCN4B;FHOD1;SLC2A1
6682,GO:0030062,0.453516800337712,0.89397658239116,1,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,BCKDHA
2521,GO:0005783,0.453599141242874,0.58524777922981,128,1324,endoplasmic reticulum,CC,FOS;H6PD;LMF1;CEMIP;APOE;CST3;XDH;NOS1;LTBP1;COL6A1;CRAT;EGFR;REEP6;FBXO2;FKBP9;HS1BP3;KDSR;ULK1;RHBDF1;LPCAT4;DHRS1;PACS2;CERS4;ABCG1;ANK3;PLD3;CRTAP;LRP5;ANO8;TENM2;PKD2;TMEM129;CPT1C;EDEM1;ITPR3;ANGEL1;SIGMAR1;NTSR1;CD320;TRAPPC9;ADAMTS7;GLUL;LAMB2;WNT7A;TXNRD3;NBEAL2;TMEM173;PRNP;SRD5A3;RNASET2;DLG4;MARCH2;REEP2;FAM20C;CERCAM;BNIP3;DNASE1L1;RHBDF2;ZDHHC1;PDZD2;CARD19;ENTPD2;GPSM1;FURIN;MBOAT7;FKBP10;MCTP1;OSBPL5;RETSAT;PCSK9;FGFR3;F12;PITPNM1;MAP2K2;FGFR4;MXRA8;SLC37A2;XYLT2;VGF;SEZ6L2;EHD4;MAPK8IP1;SEMA3B;CYP3A5;PIGZ;IFNGR2;MSLN;TM7SF2;GAS6;WNT7B;REEP4;IGFBP4;ADAMTS13;ZDHHC24;ABCD4;TMX4;CTSZ;MAN1B1;ESYT2;TMEM8B;CES2;CAPN2;RTN4R;PIGV;TIMP1;RTN2;PIGQ;WNT3;SBF1;SORL1;COL13A1;AHCYL2;CYP2S1;SPPL2B;SYNE3;P3H4;AGPAT4;PYCARD;POMT1;DDN;ERN1;GSTM2;ADAMTSL4;TMED4;SEMA4F;AGPAT3;ALG12;SULF2
13242,GO:0051957,0.453651957087211,0.893905010406268,1,6,positive regulation of amino acid transport,BP,NTSR1
7643,GO:0032075,0.453672977775523,0.813220905952978,2,16,positive regulation of nuclease activity,BP,AKT1;ERN1
11982,GO:0047484,0.453679011655992,0.893890680021602,1,6,regulation of response to osmotic stress,BP,TRPV4
3694,GO:0008210,0.453906219996386,0.813050923280525,2,16,estrogen metabolic process,BP,DHRS11;COMT
9140,GO:0035510,0.454005173325262,0.770557291887906,3,26,DNA dealkylation,BP,MPG;APOBEC3C;APOBEC3F
5950,GO:0018344,0.454188605827772,0.893620525113821,1,6,protein geranylgeranylation,BP,RABGGTA
4674,GO:0010832,0.454224814937312,0.893601312633972,1,6,negative regulation of myotube differentiation,BP,HDAC5
14357,GO:0061626,0.454255181598111,0.89358519843196,1,6,pharyngeal arch artery morphogenesis,BP,HES1
5445,GO:0016331,0.45427853230031,0.663991644903216,12,116,morphogenesis of embryonic epithelium,BP,TCTN1;DEAF1;LAMA5;FUZ;CELSR1;VANGL2;DVL1;SEMA4C;WNT7B;SUFU;WNT2B;RARG
9960,GO:0042368,0.454279416960273,0.893572336721459,1,6,vitamin D biosynthetic process,BP,CYP27B1
4614,GO:0010744,0.454296986313989,0.893563012038261,1,6,positive regulation of macrophage derived foam cell differentiation,BP,ALOX15B
11355,GO:0045743,0.454490388065119,0.893460332403505,1,6,positive regulation of fibroblast growth factor receptor signaling pathway,BP,FGFBP1
11061,GO:0045080,0.454518473958175,0.893445415962121,1,6,positive regulation of chemokine biosynthetic process,BP,EGR1
10526,GO:0043492,0.454522257374607,0.688852394674617,8,76,ATPase activity, coupled to movement of substances,MF,ABCA7;ABCG1;ATP2B4;ATP7B;ABCD1;ATP12A;ABCA2;ABCD4
9751,GO:0039533,0.454678530158093,0.893360384546129,1,6,regulation of MDA-5 signaling pathway,BP,TKFC
3766,GO:0008329,0.454715881287481,0.893340535166051,1,6,signaling pattern recognition receptor activity,MF,PTAFR
9716,GO:0038187,0.454715881287481,0.893340535166051,1,6,pattern recognition receptor activity,MF,PTAFR
14543,GO:0070099,0.454743414206266,0.893325901936413,1,6,regulation of chemokine-mediated signaling pathway,BP,SLIT3
16327,GO:0090647,0.454805772789917,0.893292754772346,1,6,modulation of age-related behavioral decline,BP,PRNP
1757,GO:0004364,0.454822613225312,0.810863022955953,2,18,glutathione transferase activity,MF,GSTT1;GSTM2
1358,GO:0003231,0.454994421484717,0.688524995805603,8,75,cardiac ventricle development,BP,LTBP1;ZFPM1;VANGL2;HES1;SUFU;RXRA;PROX1;PPP1R13L
13749,GO:0060359,0.455028504688467,0.6976849065864,7,66,response to ammonium ion,BP,HDAC5;ID1;DNMT3A;MAPK3;ADA;PTAFR;HOMER2
3743,GO:0008290,0.455213505584265,0.893075859361774,1,6,F-actin capping protein complex,CC,CAPG
19382,GO:1905941,0.455321903173922,0.893018149414186,1,6,positive regulation of gonad development,BP,ZP3
11334,GO:0045714,0.455338067933167,0.893009541735779,1,6,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,FURIN
17322,GO:1900038,0.45539520931597,0.892979110592443,1,6,negative regulation of cellular response to hypoxia,BP,PINK1
14229,GO:0061309,0.455564904636961,0.892888705276601,1,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,HES1
3450,GO:0007270,0.455971058942606,0.892672128195484,1,6,neuron-neuron synaptic transmission,BP,TMOD2
8171,GO:0032922,0.456037984600014,0.72286222899118,5,45,circadian regulation of gene expression,BP,NR1D1;CSNK1E;MTA1;BHLHE40;PPARA
4085,GO:0009148,0.456086196293215,0.810648187781629,2,17,pyrimidine nucleoside triphosphate biosynthetic process,BP,NME4;UCKL1
12284,GO:0048645,0.456148294373918,0.741722547398802,4,36,animal organ formation,BP,MAPK3;HES1;FGFR1;WNT2B
19785,GO:2000270,0.456216957100611,0.892540870006765,1,6,negative regulation of fibroblast apoptotic process,BP,GAS6
9678,GO:0038092,0.456288617088041,0.892502599272455,1,6,nodal signaling pathway,BP,ACVR1B
17605,GO:1901342,0.456486196591452,0.638495161376192,19,188,regulation of vasculature development,BP,RAPGEF3;XDH;PGF;EGR1;HDAC5;HYAL1;ERBB2;PDCD4;ID1;EPHA1;SPRY2;ECM1;VEGFA;HMGA2;ADGRB2;C5;VEGFB;CTSH;EPN2
6701,GO:0030121,0.456487170728239,0.892396514193641,1,6,AP-1 adaptor complex,CC,LDLRAP1
19516,GO:1990459,0.456552598671602,0.892361542093915,1,6,transferrin receptor binding,MF,CD81
16689,GO:0097709,0.456558179254439,0.8923585588644,1,6,connective tissue replacement,BP,F2R
13610,GO:0060137,0.456560520139702,0.892357307471578,1,6,maternal process involved in parturition,BP,PTAFR
522,GO:0001614,0.456712037475401,0.892276289532988,1,6,purinergic nucleotide receptor activity,MF,PTAFR
5516,GO:0016502,0.456712037475401,0.892276289532988,1,6,nucleotide receptor activity,MF,PTAFR
1186,GO:0002833,0.456726845396398,0.768365239846818,3,26,positive regulation of response to biotic stimulus,BP,MAPK3;LRSAM1;MIF
2338,GO:0005381,0.456805040188682,0.892226540688106,1,6,iron ion transmembrane transporter activity,MF,SLC25A37
7674,GO:0032135,0.457013810107759,0.892114812372586,1,6,DNA insertion or deletion binding,MF,XPC
503,GO:0001561,0.45732272554131,0.891949352915892,1,6,fatty acid alpha-oxidation,BP,PHYH
7632,GO:0032055,0.457420562589197,0.891896916191542,1,6,negative regulation of translation in response to stress,BP,SESN2
9283,GO:0035745,0.457428109122501,0.891892870879265,1,6,T-helper 2 cell cytokine production,BP,PRKCZ
11374,GO:0045779,0.457463576841518,0.891873857140464,1,6,negative regulation of bone resorption,BP,INPP5D
18186,GO:1903003,0.457543585638705,0.891830957699177,1,6,positive regulation of protein deubiquitination,BP,TNIP1
10233,GO:0042985,0.457610247220016,0.891795206515446,1,6,negative regulation of amyloid precursor protein biosynthetic process,BP,ABCA7
11390,GO:0045820,0.457623665619808,0.891788009193241,1,6,negative regulation of glycolytic process,BP,PPARA
12849,GO:0051198,0.457623665619808,0.891788009193241,1,6,negative regulation of coenzyme metabolic process,BP,PPARA
9767,GO:0039706,0.45772577845766,0.891733228195458,1,6,co-receptor binding,MF,NEO1
3158,GO:0006777,0.45777164706368,0.891708615059009,1,6,Mo-molybdopterin cofactor biosynthetic process,BP,MOCS1
6198,GO:0019720,0.45777164706368,0.891708615059009,1,6,Mo-molybdopterin cofactor metabolic process,BP,MOCS1
1474,GO:0003746,0.457796846034736,0.810203377197001,2,16,translation elongation factor activity,MF,ABTB1;GTPBP1
1702,GO:0004198,0.457798688368572,0.810202023364803,2,16,calcium-dependent cysteine-type endopeptidase activity,MF,CAPNS2;CAPN2
11670,GO:0046477,0.457855823297656,0.891663436696727,1,6,glycosylceramide catabolic process,BP,NAGA
18632,GO:1903975,0.457861927835844,0.891660159852557,1,6,regulation of glial cell migration,BP,IDH2
17051,GO:0099590,0.457958039044827,0.89160856011542,1,6,neurotransmitter receptor internalization,BP,DNM1
10206,GO:0042895,0.458047862583905,0.89156032185104,1,6,antibiotic transmembrane transporter activity,MF,SLC13A3
11893,GO:0046951,0.458073388753694,0.891546610937357,1,6,ketone body biosynthetic process,BP,HMGCL
899,GO:0002279,0.45829657126335,0.767096514145503,3,26,mast cell activation involved in immune response,BP,ADGRE2;ADORA2B;STXBP2
10428,GO:0043303,0.45829657126335,0.767096514145503,3,26,mast cell degranulation,BP,ADGRE2;ADORA2B;STXBP2
11431,GO:0045906,0.458322804707935,0.891412583317,1,6,negative regulation of vasoconstriction,BP,DOCK4
6128,GO:0019405,0.458406967768456,0.891367333052109,1,6,alditol catabolic process,BP,TKFC
3154,GO:0006771,0.458425506080664,0.891357364307079,1,6,riboflavin metabolic process,BP,ACP5
11477,GO:0045980,0.458531022042898,0.766906739725923,3,26,negative regulation of nucleotide metabolic process,BP,LTB4R2;MLXIPL;PPARA
16138,GO:0090186,0.45861679640323,0.891254466145917,1,6,regulation of pancreatic juice secretion,BP,STK39
15523,GO:0071971,0.45867049895261,0.891225567469673,1,6,extracellular exosome assembly,BP,SDC1
18433,GO:1903551,0.45867049895261,0.891225567469673,1,6,regulation of extracellular exosome assembly,BP,SDC1
9035,GO:0035270,0.45870920038553,0.694369755533507,7,66,endocrine system development,BP,THRA;INSR;MAPK3;HES1;IL6R;AKT1;GIPR
3011,GO:0006564,0.458797562058621,0.891157172061558,1,6,L-serine biosynthetic process,BP,PHGDH
11856,GO:0046886,0.458829074413028,0.891140205355762,1,6,positive regulation of hormone biosynthetic process,BP,EGR1
5588,GO:0016634,0.458950261805217,0.891074940572685,1,6,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,RSAD1
6742,GO:0030174,0.459039606724393,0.891026808318088,1,6,regulation of DNA-dependent DNA replication initiation,BP,WDR18
3402,GO:0007191,0.459060804411253,0.891015386622381,1,6,adenylate cyclase-activating dopamine receptor signaling pathway,BP,GNAL
12719,GO:0051013,0.459141026448392,0.89097215458647,1,6,microtubule severing,BP,TTLL11
568,GO:0001710,0.459142856061098,0.890971168467335,1,6,mesodermal cell fate commitment,BP,FGFR1
16049,GO:0090037,0.45923580371541,0.890921064512148,1,6,positive regulation of protein kinase C signaling,BP,VEGFA
4568,GO:0010663,0.459253082198844,0.890911748824883,1,6,positive regulation of striated muscle cell apoptotic process,BP,BNIP3
4571,GO:0010666,0.459253082198844,0.890911748824883,1,6,positive regulation of cardiac muscle cell apoptotic process,BP,BNIP3
9220,GO:0035627,0.459328857111325,0.890870888788953,1,6,ceramide transport,BP,PLTP
9020,GO:0035252,0.4593440585034,0.890862690575974,1,6,UDP-xylosyltransferase activity,MF,XYLT2
9918,GO:0042285,0.4593440585034,0.890862690575974,1,6,xylosyltransferase activity,MF,XYLT2
17835,GO:1902075,0.459465228611901,0.890797328610156,1,6,cellular response to salt,BP,MAPK13
18609,GO:1903935,0.459496353647039,0.890780534992242,1,6,response to sodium arsenite,BP,MAPK13
18843,GO:1904528,0.459551590583936,0.890750727652715,1,6,positive regulation of microtubule binding,BP,MAPRE3
13812,GO:0060440,0.459587363330447,0.890731420932514,1,6,trachea formation,BP,MAPK3
1492,GO:0003836,0.45961136771307,0.89071846443548,1,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,ST3GAL3
11744,GO:0046624,0.459655084598621,0.890694865470758,1,6,sphingolipid transporter activity,MF,PLTP
19107,GO:1905097,0.459703046977676,0.890668970971668,1,6,regulation of guanyl-nucleotide exchange factor activity,BP,GPSM1
16068,GO:0090075,0.459721206808884,0.808786458224424,2,16,relaxation of muscle,BP,ADORA2B;GSTM2
15269,GO:0071482,0.459772693135153,0.676190073045472,9,87,cellular response to light stimulus,BP,ERCC1;NFATC4;MAPK13;DDB2;HYAL1;XPC;TMEM161A;GUCA1B;TP53INP1
8054,GO:0032736,0.459870671775784,0.890578440844209,1,6,positive regulation of interleukin-13 production,BP,PRKCZ
16145,GO:0090193,0.459921874800587,0.890550777738603,1,6,positive regulation of glomerulus development,BP,EGR1
10028,GO:0042500,0.459933290770399,0.89054460949737,1,6,aspartic endopeptidase activity, intramembrane cleaving,MF,SPPL2B
9181,GO:0035581,0.45997004393264,0.890524749645919,1,6,sequestering of extracellular ligand from receptor,BP,LTBP1
389,GO:0001042,0.460035190673105,0.890489541429132,1,6,RNA polymerase I core binding,MF,ERBB2
8173,GO:0032925,0.460045615479255,0.808547039739831,2,16,regulation of activin receptor signaling pathway,BP,ACVR2B;ACVR1B
8130,GO:0032869,0.460093318014775,0.643224864821735,16,158,cellular response to insulin stimulus,BP,ZFP36L1;IGF2;SHC1;PIK3R2;HDAC5;PTPRE;VAMP2;INSR;PCSK9;EEF2K;PCK2;PRKCZ;PDK2;SRSF5;GRB10;AKT1
6335,GO:0021520,0.460110099179088,0.890449048547902,1,6,spinal cord motor neuron cell fate specification,BP,SUFU
15275,GO:0071493,0.460114954950794,0.890446423366064,1,6,cellular response to UV-B,BP,HYAL1
9078,GO:0035358,0.460192146769735,0.890404685528556,1,6,regulation of peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B
13644,GO:0060198,0.460294438191355,0.890349360571105,1,6,clathrin-sculpted vesicle,CC,VAMP2
18770,GO:1904338,0.460411827002468,0.890285848029116,1,6,regulation of dopaminergic neuron differentiation,BP,CSNK1E
13216,GO:0051917,0.460468672889349,0.890255083416996,1,6,regulation of fibrinolysis,BP,F12
13820,GO:0060449,0.460469412857923,0.890254682917579,1,6,bud elongation involved in lung branching,BP,SPRY2
11656,GO:0046461,0.460470172975977,0.808233468012325,2,16,neutral lipid catabolic process,BP,APOE;PNPLA4
11659,GO:0046464,0.460470172975977,0.808233468012325,2,16,acylglycerol catabolic process,BP,APOE;PNPLA4
12158,GO:0048306,0.460487300321247,0.737758594348337,4,37,calcium-dependent protein binding,MF,SYT8;S100A4;S100A6;VAMP2
14396,GO:0061724,0.460547920945633,0.890212185675851,1,6,lipophagy,BP,SESN2
12720,GO:0051014,0.460579826543303,0.890194911820941,1,6,actin filament severing,BP,GSN
5831,GO:0017128,0.460612056479474,0.890177460611562,1,6,phospholipid scramblase activity,MF,ANO9
6785,GO:0030238,0.460851826273346,0.890047579090793,1,6,male sex determination,BP,INSR
2979,GO:0006531,0.460872391888722,0.89003643426418,1,6,aspartate metabolic process,BP,ASS1
1971,GO:0004691,0.460905198875369,0.890018654148967,1,6,cAMP-dependent protein kinase activity,MF,PRKACA
8496,GO:0033690,0.460942092241351,0.889998657175048,1,6,positive regulation of osteoblast proliferation,BP,LRP5
18333,GO:1903349,0.460983517573048,0.889976201002074,1,6,omegasome membrane,CC,ULK1
19497,GO:1990416,0.461066611544732,0.889931147895769,1,6,cellular response to brain-derived neurotrophic factor stimulus,BP,EEF2K
3193,GO:0006833,0.461141752873191,0.889890396482327,1,6,water transport,BP,AQP3
6493,GO:0021872,0.461142534142006,0.737483488453307,4,36,forebrain generation of neurons,BP,SHANK3;HES1;FGFR1;PROX1
19617,GO:1990845,0.461147269024831,0.889887404522742,1,6,adaptive thermogenesis,BP,TRPV4
10276,GO:0043045,0.461176429964753,0.889871586785228,1,6,DNA methylation involved in embryo development,BP,DNMT3A
17650,GO:1901538,0.461176429964753,0.889871586785228,1,6,changes to DNA methylation involved in embryo development,BP,DNMT3A
9228,GO:0035639,0.461203007780813,0.576533532726818,138,1405,purine ribonucleoside triphosphate binding,MF,SCN8A;EPHB2;OBSCN;NME4;MST1R;MAPK13;CDK18;EGFR;ACSF2;ULK1;PKN1;PYGL;PTK6;GNAL;ABCA7;ACTA2;DNAH1;ULK2;DGKA;ABCG1;OPLAH;NEK9;RPS6KA2;NMRK1;TUBG2;MARK4;ERBB2;BRSK1;DNM1;CUL9;KIF13B;PAK6;MINK1;ATP2B4;CSNK1E;AGAP1;GLUL;RHOD;INSR;RAB3D;GRK6;MVD;EPHA1;DHX32;ATP7B;SPEG;ABCD1;MKNK2;STRADB;RAB25;FAM20C;MYO18A;UCKL1;PFKFB2;ATP12A;DYRK1B;SRMS;ARL2;MAST4;ACVR2B;MAPK3;ARL10;RAB40B;ENTPD2;GALK1;FYCO1;ADCY6;PKN3;EPHB3;PC;NADK;ABCA2;TK2;RASL10B;CKMT1A;PFKL;RHOF;HLCS;FGFR3;PRKACA;LRRK1;DGUOK;RPS6KA5;RAB3B;MAP2K2;PI4K2A;FGFR4;PMVK;MYH3;EHD4;TRPV4;RHOBTB2;EEF2K;DGKQ;HK1;TKFC;GUK1;STK32C;DMC1;PCK2;BCR;PRKCZ;HLTF;ABCD4;TWF2;PDK2;MAPKAPK3;FGFR1;CAMKK1;GTPBP1;ASS1;ACTR1B;STK39;ACVR1B;GSS;ERBB3;AKT1;TRAP1;NLRX1;SEPT8;TUT1;SMARCA1;ERCC6;ADCK2;PINK1;EHD3;LONP2;MAP2K3;STK17A;ERN1;MOCS1;JAK3;MAST3;KIFC2;FUK;TTLL11;RAB40C;KIF26B
5128,GO:0015651,0.461230056590005,0.889842494341221,1,6,quaternary ammonium group transmembrane transporter activity,MF,SLC25A29
713,GO:0001939,0.461271179576013,0.889820181778867,1,6,female pronucleus,CC,SLC2A1
12338,GO:0048739,0.461289991751032,0.889809973683464,1,6,cardiac muscle fiber development,BP,VEGFA
13529,GO:0060020,0.46129780211614,0.889805735343679,1,6,Bergmann glial cell differentiation,BP,MAPK3
1390,GO:0003306,0.461307969725315,0.889800217676395,1,6,Wnt signaling pathway involved in heart development,BP,VANGL2
6116,GO:0019373,0.461356164520952,0.88977406136072,1,6,epoxygenase P450 pathway,BP,CYP2S1
13949,GO:0060687,0.461375392192527,0.889763624994804,1,6,regulation of branching involved in prostate gland morphogenesis,BP,RXRA
15650,GO:0072201,0.461375392192527,0.889763624995123,1,6,negative regulation of mesenchymal cell proliferation,BP,CTNNBIP1
17731,GO:1901724,0.461437086218433,0.889730134515592,1,6,positive regulation of cell proliferation involved in kidney development,BP,EGR1
15280,GO:0071499,0.461467065517823,0.889713857959971,1,6,cellular response to laminar fluid shear stress,BP,ASS1
10087,GO:0042622,0.461530263134986,0.889679541242446,1,6,photoreceptor outer segment membrane,CC,CDHR1
8155,GO:0032905,0.461562258429856,0.889662164972205,1,6,transforming growth factor beta1 production,BP,FURIN
8158,GO:0032908,0.461562258429856,0.889662164972205,1,6,regulation of transforming growth factor beta1 production,BP,FURIN
8306,GO:0033158,0.461612260152212,0.80738857750237,2,16,regulation of protein import into nucleus, translocation,BP,TMEM173;GAS6
5188,GO:0015791,0.461619155233757,0.889631260662918,1,6,polyol transport,BP,AQP3
14884,GO:0070739,0.461668828174396,0.889604275549366,1,6,protein-glutamic acid ligase activity,MF,TTLL11
14885,GO:0070740,0.461668828174396,0.889604275549366,1,6,tubulin-glutamic acid ligase activity,MF,TTLL11
9657,GO:0038036,0.461738761029063,0.889566276943815,1,6,sphingosine-1-phosphate receptor activity,MF,S1PR2
17704,GO:1901660,0.461764865473806,0.889552090722714,1,6,calcium ion export,BP,ATP2B4
11368,GO:0045766,0.461786254475917,0.667695138779673,10,97,positive regulation of angiogenesis,BP,RAPGEF3;PGF;HYAL1;EPHA1;ECM1;VEGFA;HMGA2;C5;VEGFB;CTSH
7094,GO:0030902,0.461794337928969,0.674411152239707,9,86,hindbrain development,BP,PTPRS;CNTN1;NAGLU;SERPINE2;WNT7A;HES1;SEMA4C;PROX1;TRNP1
19121,GO:1905153,0.461852038797052,0.889504708708895,1,6,regulation of membrane invagination,BP,ABCA7
8910,GO:0034773,0.461884416596783,0.889487106821593,1,6,histone H4-K20 trimethylation,BP,KMT5C
7921,GO:0032510,0.461905758938191,0.889475503278341,1,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,LYST
8284,GO:0033130,0.462054481032809,0.889394623342032,1,6,acetylcholine receptor binding,MF,DLG4
7642,GO:0032074,0.462063375257898,0.889389785170702,1,6,negative regulation of nuclease activity,BP,NEIL1
14798,GO:0070562,0.462187282910436,0.889322369238665,1,6,regulation of vitamin D receptor signaling pathway,BP,CYP27B1
4802,GO:0014003,0.462268888596134,0.763871293124641,3,26,oligodendrocyte development,BP,GSN;CD9;HDAC11
10149,GO:0042753,0.462309203445563,0.889256008728535,1,6,positive regulation of circadian rhythm,BP,BTRC
8927,GO:0034983,0.46233363842369,0.889242705862333,1,6,peptidyl-lysine deacetylation,BP,SIRT3
6900,GO:0030502,0.462395853975385,0.889208829914916,1,6,negative regulation of bone mineralization,BP,ECM1
14759,GO:0070491,0.462423523726869,0.702502794727138,6,56,repressing transcription factor binding,MF,BBS2;ZMYND8;HDAC5;MTA1;BBS1;PPARA
14568,GO:0070142,0.462478907469083,0.889163597472825,1,6,synaptic vesicle budding,BP,DNM1
4387,GO:0010092,0.462487175176495,0.806739989993325,2,16,specification of animal organ identity,BP,FGFR1;WNT2B
14879,GO:0070728,0.462540792234713,0.889129886195219,1,6,leucine binding,MF,SESN2
3385,GO:0007171,0.462553430701425,0.889123000676498,1,6,activation of transmembrane receptor protein tyrosine kinase activity,BP,DGKQ
13470,GO:0055062,0.462592680270723,0.889101615500397,1,6,phosphate ion homeostasis,BP,FGFR4
15781,GO:0072505,0.462592680270723,0.889101615500397,1,6,divalent inorganic anion homeostasis,BP,FGFR4
15782,GO:0072506,0.462592680270723,0.889101615500397,1,6,trivalent inorganic anion homeostasis,BP,FGFR4
13231,GO:0051938,0.462674999676932,0.889056755051679,1,6,L-glutamate import,BP,NTSR1
16798,GO:0098712,0.462674999676932,0.889056755051679,1,6,L-glutamate import across plasma membrane,BP,NTSR1
17529,GO:1901098,0.46272687420884,0.889028479745297,1,6,positive regulation of autophagosome maturation,BP,FYCO1
15359,GO:0071635,0.462728765308731,0.889027448869014,1,6,negative regulation of transforming growth factor beta production,BP,FURIN
2986,GO:0006538,0.462759494623964,0.889010696921149,1,6,glutamate catabolic process,BP,GLUL
11871,GO:0046914,0.462845362207899,0.588017574110573,71,728,transition metal ion binding,MF,RNPEPL1;CYP27B1;XDH;NOS1;MARCH9;NR1D1;ALOX15B;TIMP2;MMP28;TCEA2;LOXL1;EGR1;TRIM65;NPEPL1;CA12;S100A4;CXXC5;MMP1;S100A6;THRA;VAT1;MSRB2;ACP5;GLUL;USP20;PEX10;ZMIZ1;RABGGTA;PRNP;ATP7B;MARCH2;MTA3;FAM20C;PHC2;SHANK3;MTA1;L3MBTL1;LTA4H;MBD1;MEFV;TRIM4;ADA;TRIM45;CYHR1;ZMYM3;CYP3A5;RAG1;MIB2;PPARA;HMGCL;RXRA;PCK2;ADAMTS13;HLTF;GPC1;PHYH;RXRB;TIMP1;APOBEC3C;CYP2S1;ZNF385A;CBLC;APOBEC3F;PRIMPOL;SIRT3;ALKBH6;LITAF;NEIL1;RARG;ZCCHC14;TRIM7
19934,GO:2000535,0.462933710139727,0.888915693412691,1,6,regulation of entry of bacterium into host cell,BP,EXOC2
5333,GO:0016081,0.462975764167475,0.888892752620759,1,6,synaptic vesicle docking,BP,SNPH
14289,GO:0061469,0.463022182398904,0.888867427583852,1,6,regulation of type B pancreatic cell proliferation,BP,NR1D1
8062,GO:0032754,0.463023103339275,0.88886692509286,1,6,positive regulation of interleukin-5 production,BP,PRKCZ
9285,GO:0035748,0.463023103339275,0.88886692509286,1,6,myelin sheath abaxonal region,CC,PRKCZ
11362,GO:0045760,0.463046998766188,0.888853886647869,1,6,positive regulation of action potential,BP,ANK3
5769,GO:0017001,0.463054636963374,0.762790041012773,3,27,antibiotic catabolic process,BP,PRDX5;GPX3;PCK2
11053,GO:0045072,0.463163920091087,0.888790074833236,1,6,regulation of interferon-gamma biosynthetic process,BP,ZFPM1
19905,GO:2000465,0.46320041548246,0.888770152032844,1,6,regulation of glycogen (starch) synthase activity,BP,IGF2
14214,GO:0061217,0.463201385063072,0.806209669551859,2,16,regulation of mesonephros development,BP,VEGFA;WNT2B
13032,GO:0051549,0.463307786685293,0.88871152487533,1,6,positive regulation of keratinocyte migration,BP,HBEGF
18906,GO:1904683,0.463375539425876,0.888674520113646,1,6,regulation of metalloendopeptidase activity,BP,SORL1
3533,GO:0007548,0.463411997455382,0.637078489320027,17,169,sex differentiation,BP,ERCC1;CST3;ZP3;WNT7A;INSR;VEGFA;CEBPB;ADAM15;SLIT3;VGF;DMC1;AGO4;WNT2B;SDC1;ACVR1B;PKD1;EREG
12201,GO:0048477,0.463415972835822,0.716201444754255,5,46,oogenesis,BP,ERCC1;ZP3;HEXB;DMC1;EREG
16583,GO:0097449,0.463479261369773,0.888617854591513,1,6,astrocyte projection,CC,PINK1
10564,GO:0043546,0.463497111711229,0.888608100703622,1,6,molybdopterin cofactor binding,MF,XDH
15652,GO:0072203,0.463536206569513,0.888586736330116,1,6,cell proliferation involved in metanephros development,BP,EGR1
5568,GO:0016595,0.463546523913902,0.888581097719074,1,6,glutamate binding,MF,GLUL
2027,GO:0004771,0.463560439475332,0.888573492331957,1,6,sterol esterase activity,MF,CES2
13657,GO:0060219,0.463576432197294,0.888564751277672,1,6,camera-type eye photoreceptor cell differentiation,BP,SDK2
18959,GO:1904779,0.463601963032436,0.88855079612438,1,6,regulation of protein localization to centrosome,BP,CEP250
17534,GO:1901142,0.463613616897596,0.888544425744555,1,6,insulin metabolic process,BP,ERN1
6864,GO:0030368,0.463627528189739,0.888536821079248,1,6,interleukin-17 receptor activity,MF,IL17RD
16009,GO:0086067,0.463648204810832,0.888525517492079,1,6,AV node cell to bundle of His cell communication,BP,SCN4B
6364,GO:0021559,0.463655405215299,0.888521580980055,1,6,trigeminal nerve development,BP,SEMA3F
6454,GO:0021785,0.463657582433737,0.888520390657752,1,6,branchiomotor neuron axon guidance,BP,SEMA3F
12378,GO:0048842,0.463657582433737,0.888520390657752,1,6,positive regulation of axon extension involved in axon guidance,BP,VEGFA
14221,GO:0061299,0.463657582433737,0.888520390657752,1,6,retina vasculature morphogenesis in camera-type eye,BP,LRP5
18052,GO:1902669,0.463657582433737,0.888520390657752,1,6,positive regulation of axon guidance,BP,VEGFA
9159,GO:0035542,0.463682600213581,0.888506712450821,1,6,regulation of SNARE complex assembly,BP,VPS11
6515,GO:0021910,0.463698581801555,0.888497974120495,1,6,smoothened signaling pathway involved in ventral spinal cord patterning,BP,SUFU
599,GO:0001767,0.463720632245077,0.888485916765987,1,6,establishment of lymphocyte polarity,BP,GSN
9821,GO:0042074,0.463730336585592,0.888480610098904,1,6,cell migration involved in gastrulation,BP,LRP5
8495,GO:0033689,0.463730783818357,0.888480365527529,1,6,negative regulation of osteoblast proliferation,BP,PLXNB1
7570,GO:0031946,0.463732630969226,0.888479355422554,1,6,regulation of glucocorticoid biosynthetic process,BP,DGKQ
2249,GO:0005168,0.463733231691243,0.888479026920365,1,6,neurotrophin TRKA receptor binding,MF,SHC1
5089,GO:0015377,0.463733231691243,0.888479026920205,1,6,cation:chloride symporter activity,MF,SLC12A7
5091,GO:0015379,0.463733231691243,0.888479026920205,1,6,potassium:chloride symporter activity,MF,SLC12A7
5630,GO:0016725,0.463733231691243,0.888479026920205,1,6,oxidoreductase activity, acting on CH or CH2 groups,MF,XDH
10210,GO:0042908,0.463733231691243,0.888479026920205,1,6,xenobiotic transport,BP,SLC2A1
10211,GO:0042910,0.463733231691243,0.888479026920205,1,6,xenobiotic transmembrane transporter activity,MF,SLC2A1
17058,GO:0099612,0.463733231691243,0.888479026920365,1,6,protein localization to axon,BP,EPB41L3
18168,GO:1902965,0.463733231691243,0.888479026920205,1,6,regulation of protein localization to early endosome,BP,SORL1
18169,GO:1902966,0.463733231691243,0.888479026920205,1,6,positive regulation of protein localization to early endosome,BP,SORL1
1594,GO:0004016,0.463733231691243,0.888479026920525,1,6,adenylate cyclase activity,MF,ADCY6
1772,GO:0004383,0.463733231691243,0.888479026920525,1,6,guanylate cyclase activity,MF,ADCY6
3438,GO:0007256,0.463733231691243,0.888479026920365,1,6,activation of JNKK activity,BP,ERCC6
3613,GO:0008074,0.463733231691243,0.888479026920525,1,6,guanylate cyclase complex, soluble,CC,ADCY6
3623,GO:0008091,0.463733231691243,0.888479026920525,1,6,spectrin,CC,SPTB
4508,GO:0010571,0.463733231691243,0.888479026919884,1,6,positive regulation of nuclear cell cycle DNA replication,BP,FGFR1
4529,GO:0010612,0.463733231691243,0.888479026920365,1,6,regulation of cardiac muscle adaptation,BP,ATP2B4
6494,GO:0021873,0.463733231691243,0.888479026920365,1,6,forebrain neuroblast division,BP,FGFR1
8937,GO:0035014,0.463733231691243,0.888479026920365,1,6,phosphatidylinositol 3-kinase regulator activity,MF,PIK3R2
14863,GO:0070679,0.463733231691243,0.888479026920525,1,6,inositol 1,4,5 trisphosphate binding,MF,ITPR3
15682,GO:0072257,0.463733231691243,0.888479026920525,1,6,metanephric nephron tubule epithelial cell differentiation,BP,WWTR1
15706,GO:0072307,0.463733231691243,0.888479026920525,1,6,regulation of metanephric nephron tubule epithelial cell differentiation,BP,WWTR1
16503,GO:0097264,0.463733231691243,0.888479026920365,1,6,self proteolysis,BP,TENM2
16606,GO:0097493,0.463733231691243,0.888479026920685,1,6,structural molecule activity conferring elasticity,MF,OBSL1
18288,GO:1903242,0.463733231691243,0.888479026920365,1,6,regulation of cardiac muscle hypertrophy in response to stress,BP,ATP2B4
3509,GO:0007440,0.463733231691243,0.888479026920525,1,6,foregut morphogenesis,BP,ACVR2B
8193,GO:0032959,0.463733231691243,0.888479026920685,1,6,inositol trisphosphate biosynthetic process,BP,PTAFR
15545,GO:0072033,0.463733231691243,0.888479026920685,1,6,renal vesicle formation,BP,KIF26B
14919,GO:0070838,0.464459518085833,0.620734740770499,24,240,divalent metal ion transport,BP,CEMIP;CYP27B1;NOS1;F2R;GJC2;PKD2;ITPR3;NTSR1;ATP2B4;ASIC1;LPAR3;PRNP;PRKACA;TRPV4;GAS6;SMDT1;TPCN1;PKD1;EHD3;HOMER2;KCNN4;ORAI3;ORAI2;GSTM2
14857,GO:0070670,0.464757608228969,0.761839934130831,3,26,response to interleukin-4,BP,STAT6;ADAMTS13;JAK3
3691,GO:0008206,0.464976000168411,0.761661283456403,3,26,bile acid metabolic process,BP,NR1D1;FGFR4;PROX1
2565,GO:0005856,0.465053474694944,0.571194232654146,152,1559,cytoskeleton,CC,MARVELD1;ESPN;PPL;FLNC;FAM110C;CLIP2;SHANK2;RAPGEF3;PGM1;GSN;NDRG1;NOS1;PARVB;TCTN1;ALOX15B;MYZAP;MST1R;RAB11FIP4;OBSL1;H1F0;BBS2;ACTA2;DNAH1;CORO1B;RIN1;ANK3;NEK9;TUBG2;MARK4;BRSK1;MICALL2;PKD2;DNM1;MPRIP;RIMS3;IFT140;KIF13B;NINL;CCDC69;FUZ;NPHP4;TMOD2;ENKD1;USP20;RAB3D;SH3PXD2B;ID1;MZT2A;SPRY2;CEP250;DLG4;REEP2;MYO18A;MZT2B;PLEKHH2;HOOK2;ARL2;VANGL2;NUDCD3;MAPK3;KCNAB2;TNNT1;DVL1;MTA1;WIPF1;FHOD1;SSH1;FBF1;CUL7;MEFV;EVC;ABCA2;CDC42EP5;MYH16;RHOF;MAPKBP1;RSPH3;PRKACA;PITPNM1;MAP2K2;SPTB;DMTN;BBS1;MYH3;TRPV4;CROCC;CCDC92;LRRC45;LDLRAP1;DGKQ;MVB12A;POU6F1;LLGL1;ADGRB2;PLEKHG6;REEP4;GSDMC;WDR60;PRKCZ;CLTCL1;CAPG;INPP5D;SPATA7;TWF2;CEP68;NDE1;RAD23A;ARAP3;C21ORF2;NICN1;BIN1;BFSP1;SYNC;CAPN2;WRAP73;PROCR;SNPH;MAPRE3;EPB41L3;ACTR1B;PLEKHH3;LYST;STK39;CCDC85B;AKT1;SEPT8;SPPL2B;SSH3;PINK1;GAS8;MPLKIP;SNTA1;RGS14;PLEKHH1;PCIF1;SPIRE2;RILPL1;RHBG;RANBP9;WDR63;SLC2A1;JAK3;KIFC2;NEIL1;ING4;PBXIP1;ZFYVE19;SFI1;KRT15;TTLL11;KIF26B;LZTS2
15661,GO:0072215,0.465147191963921,0.804760899003289,2,16,regulation of metanephros development,BP,EGR1;WWTR1
3640,GO:0008121,0.465158980049431,0.885039546886009,1,7,ubiquinol-cytochrome-c reductase activity,MF,UQCR11
5613,GO:0016681,0.465158980049431,0.885039546886009,1,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,UQCR11
18784,GO:1904377,0.465247167573887,0.714591141378219,5,46,positive regulation of protein localization to cell periphery,BP,EPHB2;LRP1;EGFR;PRNP;AKT1
15835,GO:0072583,0.465810411066191,0.733494612183079,4,36,clathrin-dependent endocytosis,BP,DNM1;FCHO1;AP2A2;ARAP3
6746,GO:0030178,0.465814281325651,0.640861392848402,15,153,negative regulation of Wnt signaling pathway,BP,APOE;CTNNBIP1;NFATC4;LRP1;MDFI;EGR1;FUZ;NPHP4;WWTR1;IGFBP2;DVL1;IGFBP4;GRB10;SHISA6;LZTS2
3194,GO:0006835,0.466520907721293,0.713468896437285,5,46,dicarboxylic acid transport,BP,SLC13A3;PRAF2;VAMP2;NTSR1;APBA1
11502,GO:0046039,0.466532778956521,0.759941501961371,3,27,GTP metabolic process,BP,NME4;GTPBP1;MOCS1
8525,GO:0033866,0.466714481541294,0.803589741819994,2,16,nucleoside bisphosphate biosynthetic process,BP,ACOT7;PPCS
8548,GO:0034030,0.466714481541294,0.803589741819994,2,16,ribonucleoside bisphosphate biosynthetic process,BP,ACOT7;PPCS
8551,GO:0034033,0.466714481541294,0.803589741819994,2,16,purine nucleoside bisphosphate biosynthetic process,BP,ACOT7;PPCS
11252,GO:0045580,0.466853517552652,0.677485654959972,8,77,regulation of T cell differentiation,BP,ERBB2;ZMIZ1;BCL6;ADA;SOX13;RAG1;PRKCZ;JAK3
2532,GO:0005795,0.466872344775029,0.652144930450833,12,117,Golgi stack,CC,MARCH9;ARAP1;B4GALNT4;ST3GAL3;PITPNM1;LLGL1;ASAP2;GAL3ST4;SORL1;TMBIM4;GOLGA2P5;SULF2
3310,GO:0007021,0.467323283636291,0.883821825126954,1,7,tubulin complex assembly,BP,ARL2
12595,GO:0050805,0.467577000818452,0.731978212060136,4,36,negative regulation of synaptic transmission,BP,SHANK2;ASIC1;SHANK3;S1PR2
645,GO:0001836,0.468056253063842,0.711526689144807,5,49,release of cytochrome c from mitochondria,BP,BNIP3;AKT1;PINK1;PYCARD;FAM162A
13886,GO:0060571,0.468143672369213,0.802518492966031,2,16,morphogenesis of an epithelial fold,BP,EGFR;WNT2B
9326,GO:0035850,0.468314327979142,0.758922506053912,3,26,epithelial cell differentiation involved in kidney development,BP,ACTA2;LAMB2;WWTR1
16301,GO:0090543,0.468548613899277,0.758729737052632,3,26,Flemming body,CC,EXOC2;CAPG;ZFYVE19
15279,GO:0071498,0.468596345595445,0.802178537479529,2,16,cellular response to fluid shear stress,BP,PKD2;ASS1
5196,GO:0015804,0.468755489624132,0.758559459862921,3,26,neutral amino acid transport,BP,SLC43A1;SLC7A8;SERINC2
18435,GO:1903555,0.468939970569171,0.684845620516294,7,68,regulation of tumor necrosis factor superfamily cytokine production,BP,NFATC4;ACP5;ZFP36;GAS6;PTAFR;PYCARD;MIF
9884,GO:0042220,0.469282096648139,0.758125756480418,3,26,response to cocaine,BP,HDAC5;DNMT3A;HOMER2
8066,GO:0032760,0.469302109970039,0.730205874870957,4,37,positive regulation of tumor necrosis factor production,BP,NFATC4;PTAFR;PYCARD;MIF
16135,GO:0090183,0.469709758542295,0.730142520512175,4,36,regulation of kidney development,BP,EGR1;WWTR1;VEGFA;WNT2B
16248,GO:0090342,0.469768559423176,0.729803626406908,4,37,regulation of cell aging,BP,BCL6;YPEL3;HMGA2;MIF
6012,GO:0019079,0.470047529678615,0.659860988782269,10,99,viral genome replication,BP,TNIP1;ADARB1;ATG16L2;ISG20;HMGA2;GAS6;RAD23A;PROX1;APOBEC3C;APOBEC3F
7413,GO:0031526,0.47100150836792,0.75670709262279,3,26,brush border membrane,CC,SHANK2;AMN;CYBRD1
10457,GO:0043368,0.471292030612439,0.800147555402503,2,16,positive T cell selection,BP,ZFPM1;STAT6
3309,GO:0007020,0.471298027246288,0.756462037645758,3,26,microtubule nucleation,BP,TUBG2;NDE1;RANBP9
11332,GO:0045687,0.471555192197774,0.756249410682044,3,26,positive regulation of glial cell differentiation,BP,SERPINE2;HES1;BIN1
9749,GO:0039531,0.471641975368709,0.799883078171667,2,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,TKFC;NLRX1
3507,GO:0007435,0.471829542807332,0.756022476448584,3,26,salivary gland morphogenesis,BP,EGFR;LAMA5;FGFR1
3063,GO:0006637,0.471988425048906,0.67265528396053,8,78,acyl-CoA metabolic process,BP,ACSF2;ACOT7;MVD;PMVK;ACOT11;HMGCL;PDK2;MLYCD
9090,GO:0035383,0.471988425048906,0.67265528396053,8,78,thioester metabolic process,BP,ACSF2;ACOT7;MVD;PMVK;ACOT11;HMGCL;PDK2;MLYCD
19482,GO:1990391,0.47199512135577,0.728169438340041,4,36,DNA repair complex,CC,ERCC1;XPC;PHF21A;PMS2P5
2952,GO:0006491,0.472141773970961,0.799505018062516,2,16,N-glycan processing,BP,EDEM1;MAN1B1
14597,GO:0070192,0.47222092667761,0.727974147745038,4,36,chromosome organization involved in meiotic cell cycle,BP,DMC1;AGO4;SUN1;P3H4
10535,GO:0043507,0.472301259053779,0.693624914364029,6,56,positive regulation of JUN kinase activity,BP,PKN1;FZD8;VANGL2;WNT7B;ERCC6;ERN1
17724,GO:1901699,0.472326479878503,0.591585506918598,44,447,cellular response to nitrogen compound,BP,RAPGEF3;ZFP36L1;COL6A1;IGF2;LRP1;MAPK13;EGFR;UROS;EGR1;SHC1;PIK3R2;HDAC5;PKD2;PTPRE;VAMP2;ATP2B4;INSR;ID1;DNMT3A;TMEM173;PRNP;STAT6;CEBPB;MAPK3;ADCY6;SSH1;PCSK9;PRKACA;MAP2K2;DMTN;EEF2K;PTAFR;PCK2;PRKCZ;PDK2;SRSF5;AGO4;GRB10;CAPN2;SESN2;AKT1;SLC5A5;JAK3;GSTM2
5804,GO:0017076,0.472831429237641,0.564686354680215,141,1439,purine nucleotide binding,MF,RAPGEF3;SCN8A;EPHB2;OBSCN;NME4;MST1R;MAPK13;CDK18;EGFR;ACSF2;ULK1;PKN1;PYGL;PTK6;GNAL;ABCA7;ACTA2;DNAH1;ULK2;DGKA;ABCG1;OPLAH;NEK9;RPS6KA2;NMRK1;TUBG2;MARK4;ERBB2;BRSK1;DNM1;CUL9;KIF13B;PAK6;MINK1;ATP2B4;CSNK1E;AGAP1;GLUL;RHOD;INSR;RAB3D;GRK6;MVD;EPHA1;TMEM173;DHX32;ATP7B;SPEG;ABCD1;MKNK2;STRADB;RAB25;FAM20C;MYO18A;UCKL1;PFKFB2;ATP12A;DYRK1B;SRMS;ARL2;MAST4;ACVR2B;MAPK3;ARL10;RAB40B;ENTPD2;GALK1;FYCO1;ADCY6;PKN3;EPHB3;PC;NADK;ABCA2;TK2;RASL10B;CKMT1A;PFKL;RHOF;HLCS;FGFR3;PRKACA;LRRK1;DGUOK;RPS6KA5;RAB3B;MAP2K2;PI4K2A;FGFR4;PMVK;MYH3;EHD4;TRPV4;RHOBTB2;EEF2K;DGKQ;HK1;TKFC;GUK1;STK32C;DMC1;PCK2;BCR;PRKCZ;HLTF;ABCD4;TWF2;PDK2;MAPKAPK3;FGFR1;CAMKK1;GTPBP1;ASS1;GAL3ST4;ACTR1B;STK39;ACVR1B;GSS;ERBB3;AKT1;TRAP1;NLRX1;SEPT8;TUT1;SMARCA1;ERCC6;ADCK2;PINK1;EHD3;LONP2;MAP2K3;STK17A;ERN1;MOCS1;JAK3;MAST3;KIFC2;FUK;TTLL11;RAB40C;KIF26B
17798,GO:1901983,0.473054089406151,0.692787618152047,6,57,regulation of protein acetylation,BP,RAPGEF3;NOS1;HINT2;MAPK3;RPS6KA5;WBP2
6337,GO:0021522,0.473378091239207,0.798568177358677,2,16,spinal cord motor neuron differentiation,BP,TCTN1;SUFU
15963,GO:0086001,0.473463754821864,0.726898175916321,4,36,cardiac muscle cell action potential,BP,ANK3;SCN4B;GPD1L;SNTA1
6353,GO:0021544,0.47370862859692,0.798317306181134,2,16,subpallium development,BP,BBS2;SHANK3
16962,GO:0099072,0.473918911461174,0.798157617651193,2,16,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,DNM1;DLG4
4970,GO:0015101,0.47399573102681,0.798099263888595,2,16,organic cation transmembrane transporter activity,MF,SLC7A8;SLC25A29
7593,GO:0031985,0.474091256670091,0.662924896676469,9,87,Golgi cisterna,CC,ARAP1;B4GALNT4;ST3GAL3;PITPNM1;LLGL1;ASAP2;GAL3ST4;SORL1;GOLGA2P5
650,GO:0001841,0.474313640251105,0.662717512257881,9,87,neural tube formation,BP,TCTN1;DEAF1;FUZ;CELSR1;VANGL2;DVL1;SEMA4C;SUFU;RARG
6578,GO:0022602,0.474574276423382,0.753746545235764,3,26,ovulation cycle process,BP,ZP3;SLIT3;EREG
6904,GO:0030507,0.475312357618185,0.797097704148492,2,16,spectrin binding,MF,ANK3;DMTN
17060,GO:0099622,0.475420397214995,0.797015398857558,2,16,cardiac muscle cell membrane repolarization,BP,SCN4B;SNTA1
9468,GO:0036120,0.475671217454174,0.796824252426655,2,16,cellular response to platelet-derived growth factor stimulus,BP,CORO1B;HYAL1
11324,GO:0045670,0.476313962827175,0.724423608896662,4,36,regulation of osteoclast differentiation,BP,FOS;FAM213A;CEBPB;INPP5D
13779,GO:0060396,0.476493547683509,0.796196881061486,2,16,growth hormone receptor signaling pathway,BP,MAPK3;JAK3
13707,GO:0060306,0.476513112442507,0.796181941932757,2,16,regulation of membrane repolarization,BP,SCN4B;SNTA1
3353,GO:0007097,0.476792515310514,0.795968532391126,2,16,nuclear migration,BP,FHOD1;SUN1
9579,GO:0036452,0.477003012288383,0.751268775464638,3,27,ESCRT complex,CC,CHMP1B;MVB12B;MVB12A
10185,GO:0042813,0.477064855033871,0.795760400844536,2,16,Wnt-activated receptor activity,MF,LRP5;FZD8
6687,GO:0030091,0.477209543104451,0.878154002073666,1,7,protein repair,BP,MSRB2
12837,GO:0051184,0.477216282799133,0.795644624518727,2,16,cofactor transmembrane transporter activity,MF,SLC6A8;SLC48A1
13817,GO:0060445,0.477285724538265,0.79559151987873,2,16,branching involved in salivary gland morphogenesis,BP,LAMA5;FGFR1
20095,GO:2000810,0.477303971374207,0.795577564608101,2,16,regulation of bicellular tight junction assembly,BP,NPHP4;PRKACA
12587,GO:0050794,0.477418438410721,0.547627178951317,685,7122,regulation of cellular process,BP,TNIP1;HTRA1;FOS;DUSP6;LMF1;CEMIP;ADGRL1;APOE;TYSND1;ESPN;CTNNBIP1;MARCKSL1;TSPAN1;IDH2;PTPRS;ERCC1;WWC3;SEMA4B;FAM110C;SYTL1;LTB4R;CITED4;CST3;SHANK2;LTBP4;RAPGEF3;TCFL5;MRC2;CYP27B1;GSN;EVI5L;XDH;PRDX5;NDRG1;PCBP4;PRODH;PGF;MEF2D;NOS1;LTBP1;PARVB;ARAP1;SH3BP2;ZFP36L1;TCTN1;CGREF1;POSTN;GRB7;NR1D1;EFS;ALOX15B;ARRDC1;FAM210B;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;RHPN1;MYZAP;IGF2;NFATC4;NME4;MST1R;LRP1;MAPK13;APPL2;HEBP1;KCNG1;RALGDS;LTBP2;RAB11FIP4;OBSL1;EGFR;TIMP2;TSC22D1;SMOC2;MMP28;B3GAT3;HADH;NLGN2;FBXO2;TCEA2;DUSP5;TOM1L2;HS1BP3;PPP1R14A;FHL1;MXD4;DDB2;SERPING1;MTHFR;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CMTM7;CRTC1;ARPIN;ARHGEF4;TRIM65;SYT8;SHC1;RGL2;F2R;PTK6;GNAL;ABCA7;DEAF1;LAMA5;PPP2R3B;BAHCC1;BBS2;S100A4;CTSB;SHC2;PITPNC1;CORO1B;CXXC5;ULK2;DGKA;GJC2;IGSF9;ZMYND8;TBC1D14;ASH2L;ZSCAN18;GRAMD4;NXPH4;SOX12;MXI1;PLAT;KCNC4;MMP1;ABCG1;RIN1;ANK3;PIK3R2;S100A6;ZNF516;INO80C;PEG3;HDAC5;THRA;ARHGAP23;DOCK4;ZP3;CRTAP;RPS6KA2;NISCH;LRP5;HYAL1;MARK4;TENM2;MAML3;ZFPM1;BCAM;TFEB;ERBB2;FBLN1;BRSK1;MICALL2;BSG;SCMH1;PTPRU;PKD2;IQSEC2;EDEM1;ITGB4;ITPR3;PLXNB3;H2AFJ;PHLDA2;VAT1;DNM1;SPRY4;DDIT4L;PTHLH;CDKN1C;RIMS3;SALL2;MSRB2;IFT140;VIPR1;CUL9;CD9;KIF13B;XPC;PTPRE;NINL;SIGMAR1;PAK6;HEXB;SERPINE2;VPS11;VAMP2;FUZ;FOXQ1;NPHP4;LTB4R2;UNK;NTSR1;CD320;MINK1;RALGAPA2;ATP2B4;TMOD2;TFDP2;CSNK1E;ACP5;RASA4;PLCD1;TRAPPC9;AGAP1;ADAMTS7;PDCD4;DOCK6;SLC20A1;BEX2;ACAP3;TNFRSF25;GLUL;RHOD;DTX3;ZKSCAN1;USP20;ASIC1;PLEKHG4;WNT7A;ZMIZ1;INSR;RAB3D;SH3PXD2B;TBC1D8;FBXW8;ZC3H6;ID1;CELSR1;GRK6;MVD;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;CCNG2;TXNRD3;SYNGAP1;IL20RB;PPP1R35;DNMT3A;DNPH1;LPAR3;TMEM173;PRNP;PAPLN;EFNB3;SNX33;HES2;SPRY2;HINT2;ZNF467;MNT;ECM1;CEP250;SNX9;STAT6;DLG4;SPEG;MTA3;MKNK2;PLCD3;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;MYO18A;ARHGAP27;DNAJB5;PLEKHH2;BCL6;PFKFB2;PLXNB1;FAM213A;CHMP1B;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;BNIP3;CD81;SRMS;FCGRT;FZD8;VEGFA;ZSCAN2;LRRC8A;ARL2;YPEL3;VANGL2;MAST4;FBXW4;AP2A2;CEBPB;RHBDF2;GPRC5C;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;CALCOCO1;S1PR2;ENDOG;TNFRSF6B;MAPK3;PLEKHG5;TUB;KCNAB2;ETV5;OLFM2;CARD19;RAB40B;DVL1;ENTPD2;MTA1;FYCO1;WIPF1;GPSM1;ADCY6;L3MBTL1;MBD1;PKN3;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;GIGYF1;SSH1;FURIN;MLXIPL;ZNF624;SAMD3;CUL7;MEFV;EVC;ARHGAP22;NRP2;GPR153;PLEKHG2;ABCA2;TNFRSF14;LRSAM1;ZNF414;ADA;CDC42EP5;MCTP1;PIDD1;PAG1;PHF21A;SH2D2A;AQP3;HTR7;RASL10B;CELSR2;PFKL;IL6R;SLIT3;PCSK9;ZFP36;ETV4;RHOF;BTBD11;MAPKBP1;FGFR3;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;KIAA1549;LRRK1;PLCH2;DGUOK;MAGEF1;CYFIP2;RPS6KA5;HBEGF;ITGB5;RAB3B;MAP2K2;DAP;FGFR4;SPTB;FBXW5;TSPAN33;DMTN;RAPGEF5;PSD4;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;TCF25;SEMA3B;LDLR;PTOV1;ACOT11;ROBO3;SNX17;SOX13;TRPV4;RHOBTB2;IFNGR2;BHLHE40;EIF4EBP3;CROCC;RAG1;ZNF80;DUSP7;TNFAIP8L1;EEF2K;RHBDL1;HMGA2;LDLRAP1;SEMA3F;ELK3;AHNAK2;DGKQ;SEMA4C;MVB12A;HK1;ZXDC;MIB2;GAS6;BTRC;MEX3A;POU6F1;LLGL1;ADGRB2;ZNF217;PPARA;TKFC;TSPAN4;STK32C;WNT7B;GIT1;COMT;SUFU;PTAFR;PLEKHG6;RFNG;IMPA2;ARHGEF37;LTBP3;ZNF446;RXRA;PCK2;VAV3;VASN;BCR;NEO1;IGFBP4;MUC19;TBC1D16;USP21;PRKCZ;ADAMTS13;CLTCL1;HLTF;CAPG;BCORL1;INPP5D;TM7SF3;NYAP1;SLITRK6;TWF2;ZNF485;LSM14B;TPP1;PDK2;GPC1;TMX4;ICOSLG;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;MAPKAPK3;NDE1;AGO4;RAD23A;ARAP3;FGFR1;CTSZ;CAMKK1;CHADL;PIN1;MN1;ZNF563;C5;KMT5C;TMEM204;IRF2BPL;PROX1;WBP2;GTPBP1;C21ORF2;ASAP2;DLG3;GPR155;KCNMA1;BIN1;VSNL1;TMEM8B;SERPINB6;OSCP1;PI4KAP2;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;SLC25A27;GRB10;JARID2;CAPN2;SESN2;TOLLIP;WNT2B;WRAP73;TMEM161A;RXRB;CSTB;TMEM231;PNRC1;MAPRE3;LCAT;GUCA1B;ADGRE2;MADD;RTN4R;ELFN2;OR7D2;EPB41L3;TIMP1;SDC1;WHAMMP3;SH2B3;APOBEC3C;FGFBP1;PEAR1;EPS8L1;PLEKHH3;WNT3;ZFP41;PPM1F;SORL1;STK39;VEGFB;ACVR1B;MEF2B;TBC1D17;ZSCAN30;ADORA2B;TPCN1;ERBB3;ABR;ZER1;CCDC85B;PNMA1;CCDC71L;AKT1;TRAP1;STON1;TMBIM4;NLRX1;ZNF385A;TP53INP1;LRCH4;NDRG2;SMARCA1;VPS33B;SIX5;ERCC6;GPD1L;EPS8L2;SPPL2B;IL17RD;SSBP2;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;SNTA1;ARHGEF10L;KDM4B;CAMTA2;HOMER2;PLPPR2;RGS14;SYNE3;PCIF1;MAFIP;SPIRE2;EIF4G3;ZNF710;CTSH;ABHD14B;MLST8;ROBO4;RILPL1;CBLC;EPN2;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;PCSK1N;KCNN4;THAP8;DDN;STK17A;ERN1;CKLF;RANBP9;ZNF319;APOBEC3F;ARHGEF19;SIRT3;GLI4;C12ORF66;CMTM4;SLC2A1;MLYCD;TAZ;JAK3;MAST3;LITAF;MZF1;NEIL1;RARG;ING4;EIF4E3;PBXIP1;EREG;FAM162A;FCHSD1;GSTM2;ZNF514;ZFYVE19;SHISA6;GIPR;WDR18;SFI1;TP53I11;ADAMTSL4;TRNP1;ZNF837;TMED4;SEMA4F;RPL13A;RGS12;RAB40C;MIF;SULF2;STXBP2;UBL5;LZTS2
14811,GO:0070577,0.477531912755884,0.795403190250033,2,16,lysine-acetylated histone binding,MF,ZMYND8;BRD3
17255,GO:0140033,0.477531912755884,0.795403190250033,2,16,acetylation-dependent protein binding,MF,ZMYND8;BRD3
8640,GO:0034204,0.477558200981534,0.795383074645488,2,16,lipid translocation,BP,ABCA7;KCNN4
5278,GO:0015949,0.477736429403133,0.750234325102091,3,28,nucleobase-containing small molecule interconversion,BP,NME4;GUK1;GLRX
12615,GO:0050839,0.477917025403677,0.590698996762943,38,390,cell adhesion molecule binding,MF,ADGRL1;PPL;LTBP4;NDRG1;CADM4;POSTN;EGFR;TIMP2;NLGN2;LAMA5;SLC9A3R2;CORO1B;ANK3;NISCH;TENM2;BSG;MPRIP;CD9;PAK6;TNXB;LAMB2;ITGA6;SNX9;ADAM15;S1PR2;EHD4;TSPAN4;VASN;ADAMTS13;CAPG;TWF2;SH3GLB2;ESYT2;PPP1R13L;H1FX;EPS8L1;EPS8L2;EPN2
16827,GO:0098773,0.478423356988985,0.676271584673843,7,67,skin epidermis development,BP,EGFR;LAMA5;FUZ;FOXQ1;CELSR1;VANGL2;ACVR1B
6566,GO:0022404,0.478423356989189,0.676271584673568,7,67,molting cycle process,BP,EGFR;LAMA5;FUZ;FOXQ1;CELSR1;VANGL2;ACVR1B
6567,GO:0022405,0.478423356989189,0.676271584673568,7,67,hair cycle process,BP,EGFR;LAMA5;FUZ;FOXQ1;CELSR1;VANGL2;ACVR1B
2577,GO:0005875,0.47855889067533,0.640989191718731,12,119,microtubule associated complex,CC,CLIP2;DNAH1;KIF13B;NUDCD3;MEFV;WDR60;NDE1;ACTR1B;RANBP9;WDR63;KIFC2;KIF26B
4373,GO:0010033,0.478724520899352,0.553336483634319,207,2155,response to organic substance,BP,TNIP1;HTRA1;FOS;DUSP6;APOE;ERCC1;CST3;LTBP4;RAPGEF3;CYP27B1;GSN;XDH;PGF;NOS1;LTBP1;ZFP36L1;COL6A1;POSTN;NR1D1;FAM210B;RBCK1;IGF2;NFATC4;GPX3;MST1R;LRP1;MAPK13;LTBP2;EGFR;TIMP2;HADH;FBXO2;UROS;LOXL1;MTHFR;EGR1;SHC1;F2R;PTK6;LAMA5;BBS2;CTSB;CORO1B;MMP1;ABCG1;PIK3R2;HDAC5;THRA;LRP5;HYAL1;ERBB2;BSG;PTPRU;PKD2;TMEM129;EDEM1;SPRY4;CDKN1C;CD9;PTPRE;DNAJC4;VAMP2;FUZ;NTSR1;ATP2B4;ACP5;ADAMTS7;PDCD4;TNFRSF25;GLUL;WNT7A;INSR;ID1;ITGA6;IL20RB;DNMT3A;TMEM173;PRNP;SPRY2;ECM1;STAT6;TALDO1;ISG20;FAM20C;DNAJB5;BCL6;ANKZF1;PFKFB2;IGFBP2;CD81;VEGFA;CEBPB;ACVR2B;CALCOCO1;ENDOG;TNFRSF6B;MAPK3;TUB;GLB1;ADCY6;HES1;SSH1;FURIN;MLXIPL;CUL7;MEFV;NRP2;ABCA2;TNFRSF14;ADA;AQP3;PFKL;IL6R;SLIT3;PCSK9;ZFP36;HLCS;FGFR3;PRKACA;F12;CYFIP2;RPS6KA5;ITGB5;MAP2K2;FGFR4;DMTN;PMVK;VGF;TNFRSF1A;EHD4;LDLR;TRPV4;IFNGR2;EEF2K;DGKQ;GAS6;BTRC;PPARA;HMGCL;WNT7B;COMT;PTAFR;RXRA;PCK2;VASN;BCR;NEO1;PRKCZ;ADAMTS13;INPP5D;TM7SF3;ABCD4;TWF2;TPP1;PDK2;GPC1;SRSF5;MAPKAPK3;AGO4;FGFR1;PIN1;MAN1B1;TMEM204;WBP2;KCNMA1;VSNL1;GRB10;JARID2;CAPN2;SESN2;TOLLIP;TMEM161A;RXRB;MADD;RTN4R;TIMP1;CD68;SDC1;FGFBP1;WNT3;GSS;ABR;AKT1;TP53INP1;SLC5A5;SPPL2B;IL17RD;LONP2;HOMER2;CTSH;EPN2;RFX2;PYCARD;MAP2K3;POMT1;ERN1;SLC2A1;JAK3;LITAF;RARG;EREG;GSTM2;GIPR;RPL13A;MIF;SULF2;STXBP2
8699,GO:0034361,0.478790099321164,0.877231667058561,1,7,very-low-density lipoprotein particle,CC,APOE
8721,GO:0034385,0.478790099321164,0.877231667058561,1,7,triglyceride-rich plasma lipoprotein particle,CC,APOE
2511,GO:0005770,0.478835698225455,0.616961988350919,19,192,late endosome,CC,CST3;EGFR;F2R;VPS11;ATP7B;CHMP1B;MVB12B;MAPK3;FYCO1;PCSK9;TMEM9;MAP2K2;LDLR;MVB12A;ANKRD13D;CLTCL1;VPS33B;CTSH;LITAF
10569,GO:0043551,0.479366751745442,0.749748266581574,3,26,regulation of phosphatidylinositol 3-kinase activity,BP,PIK3R2;FGFR3;VAV3
8051,GO:0032732,0.480541173749448,0.748304653807643,3,27,positive regulation of interleukin-1 production,BP,EGR1;HK1;PYCARD
5857,GO:0017176,0.480584932536595,0.876178823839349,1,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,PIGQ
15786,GO:0072511,0.481615225266158,0.604089438631308,24,242,divalent inorganic cation transport,BP,CEMIP;CYP27B1;NOS1;F2R;GJC2;PKD2;ITPR3;NTSR1;ATP2B4;ASIC1;LPAR3;PRNP;PRKACA;TRPV4;GAS6;SMDT1;TPCN1;PKD1;EHD3;HOMER2;KCNN4;ORAI3;ORAI2;GSTM2
3391,GO:0007178,0.482456751292252,0.608977787026265,21,211,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HTRA1;FOS;LTBP4;LTBP1;LTBP2;EGR1;CDKN1C;PDCD4;ID1;WWTR1;ACVR2B;MAPK3;HES1;FURIN;BTBD11;ITGB5;VASN;NEO1;PRKCZ;PIN1;ACVR1B
13572,GO:0060070,0.482517048910155,0.604906465819026,23,236,canonical Wnt signaling pathway,BP,APOE;EGR1;LRP5;PTPRU;FUZ;NPHP4;WNT7A;WWTR1;IGFBP2;FZD8;DVL1;LRRK1;BTRC;WNT7B;IGFBP4;PIN1;WNT2B;SDC1;WNT3;RARG;SHISA6;SULF2;LZTS2
14656,GO:0070296,0.483195356870643,0.790168709227303,2,17,sarcoplasmic reticulum calcium ion transport,BP,PRKACA;GSTM2
6982,GO:0030674,0.483227506113373,0.632033169981372,13,129,protein binding, bridging,MF,SH3BP2;GRB7;ARRDC1;OBSL1;SHC1;ANK3;VPS11;AP2A2;PAG1;SH2D2A;LDLRAP1;VAV3;GRB10
991,GO:0002448,0.484608453258753,0.744876291686352,3,27,mast cell mediated immunity,BP,ADGRE2;ADORA2B;STXBP2
441,GO:0001190,0.484978942097934,0.69679607860631,5,47,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,FOS;CITED4;SOX12;PPARA;WBP2
7998,GO:0032640,0.485013026676979,0.669939925403352,7,69,tumor necrosis factor production,BP,NFATC4;ACP5;ZFP36;GAS6;PTAFR;PYCARD;MIF
17990,GO:1902510,0.485194092816762,0.873448314531449,1,7,regulation of apoptotic DNA fragmentation,BP,ENDOG
8074,GO:0032770,0.485264225721279,0.788558952522379,2,17,positive regulation of monooxygenase activity,BP,APOE;AKT1
9523,GO:0036293,0.485754267072787,0.598271443584884,25,259,response to decreased oxygen levels,BP,CST3;NDRG1;PGF;NOS1;ZFP36L1;POSTN;EPAS1;MTHFR;EGR1;PLAT;DNMT3A;BNIP3;VEGFA;ENDOG;ADA;AQP3;EEF2K;PPARA;VASN;KCNMA1;CAPN2;VEGFB;AKT1;PINK1;FAM162A
4134,GO:0009204,0.485929264210728,0.873009207203807,1,7,deoxyribonucleoside triphosphate catabolic process,BP,ADA
4218,GO:0009404,0.486030130589468,0.787961305341765,2,17,toxin metabolic process,BP,CBS;AS3MT
18646,GO:1904018,0.486264915329767,0.6387578950584,11,109,positive regulation of vasculature development,BP,RAPGEF3;PGF;EGR1;HYAL1;EPHA1;ECM1;VEGFA;HMGA2;C5;VEGFB;CTSH
12541,GO:0050716,0.486293186621812,0.787755825519135,2,17,positive regulation of interleukin-1 secretion,BP,HK1;PYCARD
7550,GO:0031904,0.486300348370733,0.787750229768576,2,17,endosome lumen,CC,CTSB;CTSH
5962,GO:0018410,0.48666254284902,0.714777319171448,4,38,C-terminal protein amino acid modification,BP,WIPI2;LY6K;MDGA1;MSLN
6065,GO:0019226,0.487091436092805,0.742772288974185,3,27,transmission of nerve impulse,BP,SCN8A;ANK3;AHNAK2
9926,GO:0042303,0.487262281738063,0.658439133744434,8,78,molting cycle,BP,EGFR;LAMA5;FUZ;FOXQ1;CELSR1;VANGL2;PPP1R13L;ACVR1B
10097,GO:0042633,0.487262281738063,0.658439133744434,8,78,hair cycle,BP,EGFR;LAMA5;FUZ;FOXQ1;CELSR1;VANGL2;PPP1R13L;ACVR1B
13363,GO:0052689,0.487687063938684,0.650002388765998,9,89,carboxylic ester hydrolase activity,MF,H6PD;PGLS;NLGN2;ACOT7;BPHL;LYPLAL1;ACOT11;PNPLA4;CES2
2833,GO:0006309,0.487697119059596,0.786657332223461,2,17,apoptotic DNA fragmentation,BP,H1F0;ENDOG
13620,GO:0060155,0.487742437242043,0.871921986581002,1,7,platelet dense granule organization,BP,F2R
14390,GO:0061702,0.487799695905745,0.871887554529733,1,7,inflammasome complex,CC,PYCARD
324,GO:0000910,0.488081461674605,0.623296339747152,14,140,cytokinesis,BP,RAB11FIP4;ANK3;PAK6;RHOD;SNX33;SNX9;CUL7;RHOF;RHOBTB2;GIT1;PIN1;SEPT8;SPIRE2;ZFYVE19
18701,GO:1904181,0.488403095948914,0.871524337545188,1,7,positive regulation of membrane depolarization,BP,ANK3
6836,GO:0030316,0.488508488638201,0.67868362664295,6,57,osteoclast differentiation,BP,FOS;FAM20C;FAM213A;CEBPB;LRRK1;INPP5D
8133,GO:0032873,0.488644662124337,0.713305841225876,4,37,negative regulation of stress-activated MAPK cascade,BP,PDCD4;MAPK8IP1;AKT1;PINK1
14660,GO:0070303,0.488644662124337,0.713305841225876,4,37,negative regulation of stress-activated protein kinase signaling cascade,BP,PDCD4;MAPK8IP1;AKT1;PINK1
7103,GO:0030915,0.488687823631552,0.871352712561091,1,7,Smc5-Smc6 complex,CC,NSMCE4A
17182,GO:0106068,0.488687823631552,0.871352712561091,1,7,SUMO ligase complex,CC,NSMCE4A
1708,GO:0004303,0.488734503750016,0.871324560971922,1,7,estradiol 17-beta-dehydrogenase activity,MF,DHRS11
3083,GO:0006664,0.48880205623166,0.642116774637726,10,100,glycolipid metabolic process,BP,FUCA1;HEXB;GM2A;GLB1;PIGZ;ESYT2;GAL3ST4;PIGV;PIGQ;NAGA
18402,GO:1903509,0.48880205623166,0.642116774637726,10,100,liposaccharide metabolic process,BP,FUCA1;HEXB;GM2A;GLB1;PIGZ;ESYT2;GAL3ST4;PIGV;PIGQ;NAGA
18462,GO:1903599,0.489304135001111,0.785396116496814,2,17,positive regulation of autophagy of mitochondrion,BP,BNIP3;PINK1
13716,GO:0060316,0.489776151229994,0.870695323661082,1,7,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,GSTM2
163,GO:0000339,0.490194769456863,0.784695369931429,2,17,RNA cap binding,MF,CYFIP2;EIF4G3
10748,GO:0044212,0.49025417092895,0.565204454818328,60,610,transcription regulatory region DNA binding,MF,FOS;TCFL5;PRDX5;MEF2D;NR1D1;NFATC4;EGR1;DEAF1;BAHCC1;ZMYND8;ASH2L;SOX12;MXI1;ZNF516;HDAC5;THRA;ZFPM1;TFEB;SALL2;FOXQ1;TFDP2;ZC3H6;ZNF692;ZNF704;HES2;MNT;STAT6;BCL6;CEBPB;HSF4;CALCOCO1;ETV5;MTA1;HES1;MLXIPL;PHF21A;ETV4;SOX13;BHLHE40;HMGA2;ELK3;ZNF217;PPARA;RXRA;HLTF;TEF;SMARCD2;PROX1;WBP2;JARID2;RXRB;MEF2B;SIX5;SSBP2;RFX2;TRERF1;DDN;LITAF;MZF1;RARG
7735,GO:0032261,0.490500607975622,0.87025651205712,1,7,purine nucleotide salvage,BP,ADA
10530,GO:0043500,0.49057669510865,0.676622594716947,6,58,muscle adaptation,BP,GSN;ATP2B4;TNNT1;PIN1;JARID2;CAMTA2
1251,GO:0003007,0.490850279837565,0.617024962641905,15,149,heart morphogenesis,BP,GAA;ZFPM1;PKD2;PDCD4;ZMIZ1;INSR;VEGFA;VANGL2;ADAM15;HES1;NRP2;SUFU;RXRA;PROX1;PPP1R13L
5648,GO:0016758,0.490850288207015,0.616948839888452,15,151,transferase activity, transferring hexosyl groups,MF,PYGB;B3GAT3;PYGL;HYAL1;B4GALNT4;HEXB;GALNT12;B4GAT1;XYLT2;PIGZ;RFNG;PIGV;PIGQ;POMT1;ALG12
6696,GO:0030111,0.490963115386301,0.5931981966049,25,258,regulation of Wnt signaling pathway,BP,APOE;CTNNBIP1;NFATC4;LRP1;MDFI;EGR1;LRP5;FUZ;NPHP4;CSNK1E;WNT7A;WWTR1;IGFBP2;VANGL2;DVL1;LRRK1;BTRC;IGFBP4;PIN1;GRB10;WNT2B;WNT3;SHISA6;SULF2;LZTS2
15123,GO:0071260,0.490975586198079,0.676254400781259,6,58,cellular response to mechanical stimulus,BP,EGFR;BNIP3;MAPK3;TNFRSF1A;AKT1;SLC2A1
5951,GO:0018345,0.491039163690866,0.739409769576553,3,27,protein palmitoylation,BP,ZDHHC1;ABHD17C;ZDHHC24
5701,GO:0016842,0.491095865574464,0.869895230498134,1,7,amidine-lyase activity,MF,GGACT
18918,GO:1904705,0.491118620835454,0.739341872040224,3,27,regulation of vascular smooth muscle cell proliferation,BP,MEF2D;PDCD4;ERN1
19622,GO:1990874,0.491118620835454,0.739341872040224,3,27,vascular smooth muscle cell proliferation,BP,MEF2D;PDCD4;ERN1
12117,GO:0048240,0.491255011743807,0.869798528128687,1,7,sperm capacitation,BP,PRKACA
18311,GO:1903299,0.491264324035541,0.86979286822516,1,7,regulation of hexokinase activity,BP,PFKFB2
15877,GO:0072676,0.491438278292751,0.710543826842298,4,38,lymphocyte migration,BP,ECM1;GAS6;PYCARD;CKLF
18437,GO:1903557,0.491446457016034,0.710536552912757,4,38,positive regulation of tumor necrosis factor superfamily cytokine production,BP,NFATC4;PTAFR;PYCARD;MIF
10548,GO:0043525,0.491503952391811,0.710485415818064,4,38,positive regulation of neuron apoptotic process,BP,PRNP;PCSK9;CTSZ;PIN1
7823,GO:0032388,0.491625401775079,0.604538921772198,19,193,positive regulation of intracellular transport,BP,CEMIP;RAPGEF3;B3GAT3;ANK3;ERBB2;MICALL2;EDEM1;VPS11;VAMP2;TMEM173;PRNP;HES1;LDLRAP1;GAS6;OSCP1;SORL1;ADORA2B;PINK1;UBL5
11747,GO:0046627,0.492153580331662,0.738456689739499,3,27,negative regulation of insulin receptor signaling pathway,BP,PTPRE;PRKCZ;GRB10
7772,GO:0032309,0.49287942283977,0.78257548458634,2,17,icosanoid secretion,BP,NTSR1;MIF
6953,GO:0030619,0.493214708021887,0.868603896616576,1,7,U1 snRNA binding,MF,ISG20
6898,GO:0030500,0.493265477404071,0.709201415571293,4,37,regulation of bone mineralization,BP,CYP27B1;ECM1;FAM20C;ACVR2B
6224,GO:0019784,0.493587450258458,0.868375863824136,1,7,NEDD8-specific protease activity,MF,USP21
16136,GO:0090184,0.493858573376573,0.736995232129379,3,27,positive regulation of kidney development,BP,EGR1;VEGFA;WNT2B
16379,GO:0097035,0.493950870312927,0.736916004551553,3,27,regulation of membrane lipid distribution,BP,ABCA7;ANO9;KCNN4
1174,GO:0002821,0.493992482634534,0.688413067136928,5,48,positive regulation of adaptive immune response,BP,ZP3;STAT6;ADA;PRKCZ;PYCARD
13450,GO:0055013,0.494085792848809,0.708470046654332,4,37,cardiac muscle cell development,BP,OBSL1;VEGFA;PIN1;PROX1
11404,GO:0045840,0.494897575955248,0.70745993357602,4,38,positive regulation of mitotic nuclear division,BP,IGF2;LRP5;INSR;EREG
4790,GO:0010992,0.494968730295152,0.867528576354884,1,7,ubiquitin recycling,BP,PINK1
15339,GO:0071605,0.495016306602386,0.867499329172365,1,7,monocyte chemotactic protein-1 production,BP,TRPV4
15361,GO:0071637,0.495016306602386,0.867499329172365,1,7,regulation of monocyte chemotactic protein-1 production,BP,TRPV4
10262,GO:0043027,0.495049213006402,0.78085377257275,2,17,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,PRDX5;GAS6
12324,GO:0048709,0.495070027774179,0.672465630846034,6,58,oligodendrocyte differentiation,BP,GSN;ERBB2;CD9;BNIP3;HES1;HDAC11
3134,GO:0006735,0.495146725368037,0.780776220966637,2,17,NADH regeneration,BP,PFKL;HK1
14353,GO:0061621,0.495146725368037,0.780776220966637,2,17,canonical glycolysis,BP,PFKL;HK1
14394,GO:0061718,0.495146725368037,0.780776220966637,2,17,glucose catabolic process to pyruvate,BP,PFKL;HK1
12812,GO:0051148,0.495206929717941,0.73583663920664,3,27,negative regulation of muscle cell differentiation,BP,HDAC5;PDCD4;EREG
10447,GO:0043325,0.495343201967123,0.780619916965487,2,17,phosphatidylinositol-3,4-bisphosphate binding,MF,ARAP3;AKT1
9588,GO:0036465,0.495467778854246,0.707236045925662,4,37,synaptic vesicle recycling,BP,NLGN2;SYT8;DNM1;WNT7A
13055,GO:0051590,0.495573806135014,0.780436384648653,2,17,positive regulation of neurotransmitter transport,BP,NTSR1;RAB3B
8259,GO:0033077,0.49559610970545,0.686948020977843,5,48,T cell differentiation in thymus,BP,ZFP36L1;ERBB2;FZD8;ADA;RAG1
395,GO:0001067,0.495771123266752,0.559737028332057,60,611,regulatory region nucleic acid binding,MF,FOS;TCFL5;PRDX5;MEF2D;NR1D1;NFATC4;EGR1;DEAF1;BAHCC1;ZMYND8;ASH2L;SOX12;MXI1;ZNF516;HDAC5;THRA;ZFPM1;TFEB;SALL2;FOXQ1;TFDP2;ZC3H6;ZNF692;ZNF704;HES2;MNT;STAT6;BCL6;CEBPB;HSF4;CALCOCO1;ETV5;MTA1;HES1;MLXIPL;PHF21A;ETV4;SOX13;BHLHE40;HMGA2;ELK3;ZNF217;PPARA;RXRA;HLTF;TEF;SMARCD2;PROX1;WBP2;JARID2;RXRB;MEF2B;SIX5;SSBP2;RFX2;TRERF1;DDN;LITAF;MZF1;RARG
18590,GO:1903900,0.495950936095359,0.629321251065143,11,112,regulation of viral life cycle,BP,TNIP1;GSN;ADARB1;ISG20;PC;HMGA2;MVB12A;RAD23A;PROX1;APOBEC3C;APOBEC3F
3543,GO:0007585,0.496045098250218,0.706433708040639,4,38,respiratory gaseous exchange,BP,GAA;NLGN2;NTSR1;TMPRSS11D
18895,GO:1904646,0.496197807972358,0.779939330525242,2,17,cellular response to amyloid-beta,BP,LRP1;PRNP
7177,GO:0031077,0.496296244236998,0.866710906107605,1,7,post-embryonic camera-type eye development,BP,VEGFA
467,GO:0001508,0.496439771783764,0.65939652524725,7,68,action potential,BP,SCN8A;ANK3;SCN4B;NTSR1;TPCN1;GPD1L;SNTA1
7897,GO:0032482,0.4964952903272,0.670991954772693,6,59,Rab protein signal transduction,BP,RAB3D;RAB25;RAB40B;RAB3B;MADD;RAB40C
8347,GO:0033240,0.496872180548976,0.866355135443033,1,7,positive regulation of cellular amine metabolic process,BP,COMT
3002,GO:0006555,0.496907860434818,0.779372974664422,2,17,methionine metabolic process,BP,MTHFR;AHCYL2
631,GO:0001821,0.497000762230033,0.866275622167858,1,7,histamine secretion,BP,ADA
10527,GO:0043495,0.497264444953699,0.866112466915269,1,7,protein membrane anchor,MF,SUN1
14631,GO:0070255,0.497296401694958,0.86609268461328,1,7,regulation of mucus secretion,BP,ADA
6001,GO:0019058,0.497299459754692,0.5870042984882,25,257,viral life cycle,BP,TNIP1;APOE;GSN;EGFR;CTSB;ADARB1;EFNB3;ATG16L2;ISG20;CHMP1B;MVB12B;CD81;PC;FURIN;TNFRSF14;LRSAM1;ITGB5;LDLR;HMGA2;MVB12A;GAS6;RAD23A;PROX1;APOBEC3C;APOBEC3F
3789,GO:0008375,0.497705016416592,0.685017002285728,5,48,acetylglucosaminyltransferase activity,MF,HEXB;B4GAT1;XYLT2;RFNG;PIGQ
3163,GO:0006782,0.497811445073103,0.865773590328621,1,7,protoporphyrinogen IX biosynthetic process,BP,UROS
10361,GO:0043200,0.497818747917799,0.648392385815078,8,79,response to amino acid,BP,COL6A1;EGFR;MTHFR;DNMT3A;CEBPB;CAPN2;SESN2;GSS
7640,GO:0032071,0.498022484969728,0.865642696684979,1,7,regulation of endodeoxyribonuclease activity,BP,AKT1
14126,GO:0061035,0.498628087147489,0.704405346098307,4,37,regulation of cartilage development,BP,PTHLH;ADAMTS7;CHADL;RARG
10193,GO:0042826,0.498708209320743,0.63954470759738,9,89,histone deacetylase binding,MF,MEF2D;PKN1;HDAC5;CEBPB;HES1;UHRF1BP1;RFXANK;MEF2B;CAMTA2
381,GO:0001016,0.49901488512846,0.865026053086769,1,7,RNA polymerase III regulatory region DNA binding,MF,PRDX5
7957,GO:0032580,0.499409549343745,0.65660508222927,7,68,Golgi cisterna membrane,CC,ARAP1;B4GALNT4;ST3GAL3;PITPNM1;ASAP2;GAL3ST4;GOLGA2P5
4149,GO:0009220,0.49944103829208,0.776538144523302,2,18,pyrimidine ribonucleotide biosynthetic process,BP,NME4;UCKL1
11556,GO:0046132,0.49944103829208,0.776538144523302,2,18,pyrimidine ribonucleoside biosynthetic process,BP,NME4;UCKL1
13826,GO:0060457,0.499597019018661,0.86466346997769,1,7,negative regulation of digestive system process,BP,STK39
10352,GO:0043186,0.499622597380407,0.864647523764745,1,7,P granule,CC,TDRKH
11236,GO:0045495,0.499622597380407,0.864647523764745,1,7,pole plasm,CC,TDRKH
13697,GO:0060293,0.499622597380407,0.864647523764745,1,7,germ plasm,CC,TDRKH
7859,GO:0032432,0.49965406879068,0.68322794466058,5,48,actin filament bundle,CC,MST1R;CORO1B;MICALL2;VANGL2;FHOD1
18413,GO:1903523,0.499795838665677,0.777061124708559,2,17,negative regulation of blood circulation,BP,F2R;DOCK4
4071,GO:0009134,0.499837458589,0.86451352487408,1,7,nucleoside diphosphate catabolic process,BP,ENTPD2
4907,GO:0014855,0.49988920270834,0.703272334527678,4,37,striated muscle cell proliferation,BP,RXRA;FGFR1;JARID2;SIX5
4738,GO:0010918,0.500252447542049,0.86425446842087,1,7,positive regulation of mitochondrial membrane potential,BP,AKT1
16309,GO:0090568,0.500394971248561,0.731355351617578,3,27,nuclear transcriptional repressor complex,CC,APPL2;BAHCC1;SALL2
7024,GO:0030809,0.500515018963206,0.776483332174657,2,17,negative regulation of nucleotide biosynthetic process,BP,LTB4R2;PPARA
17452,GO:1900372,0.500515018963206,0.776483332174657,2,17,negative regulation of purine nucleotide biosynthetic process,BP,LTB4R2;PPARA
500,GO:0001556,0.50057615434256,0.776434177377047,2,17,oocyte maturation,BP,DMC1;EREG
11838,GO:0046850,0.501257822279256,0.730606432338265,3,27,regulation of bone remodeling,BP,EGFR;LRP5;INPP5D
6743,GO:0030175,0.501276951725577,0.654845479185302,7,68,filopodium,CC,RAPGEF3;ACTA2;TENM2;ITGA6;TRPV4;TWF2;MORN4
13458,GO:0055023,0.501688210674801,0.775538998165426,2,17,positive regulation of cardiac muscle tissue growth,BP,FGFR1;PIN1
6489,GO:0021861,0.501947628297408,0.863192863874265,1,7,forebrain radial glial cell differentiation,BP,HES1
6931,GO:0030551,0.50210564548317,0.775202458511745,2,17,cyclic nucleotide binding,MF,RAPGEF3;TMEM173
18111,GO:1902857,0.502189349521638,0.86304104185666,1,7,positive regulation of non-motile cilium assembly,BP,WRAP73
4178,GO:0009264,0.502276233408698,0.774251069807171,2,18,deoxyribonucleotide catabolic process,BP,ADA;NEIL1
4638,GO:0010770,0.502303889288743,0.623326869178151,11,110,positive regulation of cell morphogenesis involved in differentiation,BP,OBSL1;PLXNB3;FBXW8;LPAR3;PLXNB1;VEGFA;CUL7;DMTN;EEF2K;TWF2;WNT3
5562,GO:0016589,0.502335662229713,0.862949090723051,1,7,NURF complex,CC,SMARCA1
9876,GO:0042176,0.502393916984835,0.576139351397713,29,300,regulation of protein catabolic process,BP,APOE;CST3;LRP1;EGFR;TIMP2;RHBDF1;EDEM1;SERPINE2;VPS11;CSNK1E;SNX33;SNX9;CD81;DVL1;FURIN;PCSK9;PRKACA;MAGEF1;LDLR;BTRC;SUFU;RAD23A;PIN1;SH3D19;TIMP1;SORL1;AKT1;PINK1;PKD1
16566,GO:0097413,0.502436802157819,0.862885504900958,1,7,Lewy body,CC,PINK1
10832,GO:0044346,0.502883925420968,0.774574251607364,2,17,fibroblast apoptotic process,BP,GAS6;STK17A
10779,GO:0044272,0.502990799120746,0.608747197478428,14,143,sulfur compound biosynthetic process,BP,OPLAH;CBS;GGT1;B4GAT1;HAGH;ST3GAL3;XYLT2;CHST6;PDK2;GSTT1;GSS;MLYCD;GSTM2;NDST2
5450,GO:0016339,0.503018894479716,0.774465208668541,2,17,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,ARVCF;PCDHGC3
13044,GO:0051574,0.503061126076892,0.862492566631579,1,7,positive regulation of histone H3-K9 methylation,BP,JARID2
18920,GO:1904707,0.503477069151192,0.774094824950746,2,17,positive regulation of vascular smooth muscle cell proliferation,BP,MEF2D;ERN1
11443,GO:0045920,0.503585624286945,0.774007020376825,2,17,negative regulation of exocytosis,BP,BCR;ABR
13219,GO:0051920,0.503716307548315,0.859765487469619,1,8,peroxiredoxin activity,MF,PRDX5
1260,GO:0003016,0.503766567256994,0.773860622723513,2,17,respiratory system process,BP,GAA;NLGN2
11709,GO:0046543,0.503834811431796,0.862004592290282,1,7,development of secondary female sexual characteristics,BP,IRF2BPL
11674,GO:0046485,0.504059983718986,0.861862358345211,1,7,ether lipid metabolic process,BP,PEX7
546,GO:0001666,0.504067138061402,0.581952600080783,24,251,response to hypoxia,BP,CST3;NDRG1;PGF;NOS1;ZFP36L1;POSTN;EPAS1;MTHFR;EGR1;PLAT;DNMT3A;BNIP3;VEGFA;ENDOG;ADA;AQP3;PPARA;VASN;KCNMA1;CAPN2;VEGFB;AKT1;PINK1;FAM162A
8119,GO:0032825,0.504097992218872,0.861838340070901,1,7,positive regulation of natural killer cell differentiation,BP,GAS6
5312,GO:0016048,0.504338881042511,0.8616860537948,1,7,detection of temperature stimulus,BP,NTSR1
12696,GO:0050961,0.504338881042511,0.8616860537948,1,7,detection of temperature stimulus involved in sensory perception,BP,NTSR1
12698,GO:0050965,0.504338881042511,0.8616860537948,1,7,detection of temperature stimulus involved in sensory perception of pain,BP,NTSR1
10423,GO:0043297,0.504398002827862,0.67885568509427,5,48,apical junction assembly,BP,MICALL2;NPHP4;ARL2;FBF1;PRKACA
16597,GO:0097479,0.504469985636737,0.642072354048263,8,79,synaptic vesicle localization,BP,SYTL1;NLGN2;SYT8;DNM1;RIMS3;VAMP2;SNPH;PINK1
6718,GO:0030140,0.504484861530136,0.727349624137957,3,28,trans-Golgi network transport vesicle,CC,FURIN;LDLRAP1;CLTCL1
6462,GO:0021801,0.50461984053614,0.773169541126866,2,17,cerebral cortex radial glia guided migration,BP,MBOAT7;SUN1
6560,GO:0022030,0.50461984053614,0.773169541126866,2,17,telencephalon glial cell migration,BP,MBOAT7;SUN1
8256,GO:0033063,0.504661522297826,0.861481911117362,1,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,DMC1
15810,GO:0072542,0.504670264312198,0.861476377072635,1,7,protein phosphatase activator activity,MF,B3GAT3
819,GO:0002093,0.504697272839058,0.861459278663057,1,7,auditory receptor cell morphogenesis,BP,SLITRK6
14250,GO:0061351,0.504725835399833,0.641828444859843,8,79,neural precursor cell proliferation,BP,GJC2;WNT7A;VEGFA;NDE1;FGFR1;CTSZ;PROX1;TRNP1
12415,GO:0050072,0.504836281754506,0.861371253598854,1,7,m7G(5')pppN diphosphatase activity,MF,NUDT10
11023,GO:0045022,0.504845643052706,0.698509632750342,4,38,early endosome to late endosome transport,BP,VPS11;HOOK2;MAPK3;MAP2K2
13158,GO:0051791,0.504885899561425,0.86133982500434,1,7,medium-chain fatty acid metabolic process,BP,ACOT7
18661,GO:1904037,0.504949743006973,0.772902031169065,2,17,positive regulation of epithelial cell apoptotic process,BP,GSN;PDCD4
18124,GO:1902893,0.504959841689385,0.727381494143919,3,27,regulation of pri-miRNA transcription by RNA polymerase II,BP,FOS;NFATC4;PPARA
12086,GO:0048148,0.504960043573411,0.861292852392513,1,7,behavioral response to cocaine,BP,HOMER2
17901,GO:1902254,0.505127267304855,0.771938142973202,2,18,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,ZNF385A;MIF
16556,GO:0097384,0.505158149698837,0.861167294186697,1,7,cellular lipid biosynthetic process,BP,PEX7
17850,GO:1902115,0.505218568729723,0.60666117524547,14,141,regulation of organelle assembly,BP,GSN;EVI5L;ULK1;TBC1D14;IFT140;VPS11;FUZ;CHMP1B;LRSAM1;CROCC;PROX1;WRAP73;SDC1;PINK1
19241,GO:1905456,0.505294809020914,0.861080636714585,1,7,regulation of lymphoid progenitor cell differentiation,BP,HES1
3110,GO:0006695,0.505297053893976,0.662774081046242,6,59,cholesterol biosynthetic process,BP,APOE;ABCG1;MVD;SEC14L2;PMVK;TM7SF2
9598,GO:0036480,0.505304289351995,0.861074623789587,1,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,PINK1
18347,GO:1903376,0.505304289351995,0.861074623789587,1,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,PINK1
4030,GO:0009071,0.505326389219155,0.861060606208151,1,7,serine family amino acid catabolic process,BP,CBS
2998,GO:0006551,0.505353207765936,0.861043594394252,1,7,leucine metabolic process,BP,HMGCL
11054,GO:0045073,0.505424613942069,0.86099829258297,1,7,regulation of chemokine biosynthetic process,BP,EGR1
8192,GO:0032958,0.505551553696695,0.772413583149364,2,17,inositol phosphate biosynthetic process,BP,NTSR1;PTAFR
8493,GO:0033687,0.505805462619455,0.772207326756291,2,17,osteoblast proliferation,BP,LRP5;PLXNB1
14876,GO:0070723,0.505811955404205,0.772202051137293,2,17,response to cholesterol,BP,ABCA2;PMVK
3404,GO:0007194,0.505850086240901,0.860728160055182,1,7,negative regulation of adenylate cyclase activity,BP,LTB4R2
7276,GO:0031280,0.505850086240901,0.860728160055182,1,7,negative regulation of cyclase activity,BP,LTB4R2
4922,GO:0014889,0.505903975290917,0.860693921111542,1,7,muscle atrophy,BP,GSN
12122,GO:0048247,0.505949198532868,0.771268901089211,2,18,lymphocyte chemotaxis,BP,GAS6;CKLF
2246,GO:0005165,0.506193594275149,0.860509813385616,1,7,neurotrophin receptor binding,MF,SHC1
2248,GO:0005167,0.506193594275149,0.860509813385616,1,7,neurotrophin TRK receptor binding,MF,SHC1
16314,GO:0090594,0.506225950607604,0.86048923480993,1,7,inflammatory response to wounding,BP,F2R
3877,GO:0008519,0.506337024113948,0.771775187740848,2,17,ammonium transmembrane transporter activity,MF,SLC25A29;RHBG
6334,GO:0021517,0.506357834439629,0.771758260419247,2,17,ventral spinal cord development,BP,TCTN1;SUFU
8943,GO:0035024,0.506633096278269,0.771534293601092,2,17,negative regulation of Rho protein signal transduction,BP,BCL6;ARAP3
19089,GO:1905050,0.506781546058749,0.860135563354535,1,7,positive regulation of metallopeptidase activity,BP,MAPK3
11333,GO:0045713,0.507358320689867,0.859767782364672,1,7,low-density lipoprotein particle receptor biosynthetic process,BP,FURIN
7360,GO:0031419,0.507438801524904,0.859716412790375,1,7,cobalamin binding,MF,CD320
10286,GO:0043068,0.507518191983806,0.556105251860789,45,470,positive regulation of programmed cell death,BP,DUSP6;GSN;XDH;RBCK1;OBSCN;NFATC4;ARHGEF4;F2R;GRAMD4;RPS6KA2;MARK4;NTSR1;TFDP2;PDCD4;ITGA6;PRNP;BCL6;BNIP3;ENDOG;PLEKHG5;PLEKHG2;PIDD1;PCSK9;DAP;HMGA2;VAV3;INPP5D;CTSZ;PIN1;KCNMA1;BIN1;PPM1F;ABR;PNMA1;AKT1;TP53INP1;PINK1;CTSH;PYCARD;STK17A;ARHGEF19;RARG;ING4;FAM162A;ADAMTSL4
16801,GO:0098722,0.507606631778281,0.859609249417246,1,7,asymmetric stem cell division,BP,ETV5
4434,GO:0010340,0.507611780833714,0.85960596077286,1,7,carboxyl-O-methyltransferase activity,MF,PCMTD2
13268,GO:0051998,0.507611780833714,0.85960596077286,1,7,protein carboxyl O-methyltransferase activity,MF,PCMTD2
675,GO:0001886,0.507645479962694,0.859584436251489,1,7,endothelial cell morphogenesis,BP,ID1
9832,GO:0042095,0.50774407055831,0.859521451287961,1,7,interferon-gamma biosynthetic process,BP,ZFPM1
9754,GO:0039536,0.507857523309344,0.859448948407704,1,7,negative regulation of RIG-I signaling pathway,BP,NLRX1
3760,GO:0008318,0.508044432479873,0.859329448535085,1,7,protein prenyltransferase activity,MF,RABGGTA
7775,GO:0032324,0.508184048235816,0.859240141643076,1,7,molybdopterin cofactor biosynthetic process,BP,MOCS1
10563,GO:0043545,0.508184048235816,0.859240141643076,1,7,molybdopterin cofactor metabolic process,BP,MOCS1
12842,GO:0051189,0.508184048235816,0.859240141643076,1,7,prosthetic group metabolic process,BP,MOCS1
9467,GO:0036119,0.50856354075143,0.769960126563846,2,17,response to platelet-derived growth factor,BP,CORO1B;HYAL1
5822,GO:0017112,0.508602813862644,0.674758974894268,5,49,Rab guanyl-nucleotide exchange factor activity,MF,RIN1;TRAPPC9;MADD;SBF1;ALS2CL
736,GO:0001968,0.508745938928732,0.769811077683692,2,17,fibronectin binding,MF,FBLN1;VEGFA
5281,GO:0015959,0.508789896465071,0.858852167946627,1,7,diadenosine polyphosphate metabolic process,BP,NUDT10
11057,GO:0045076,0.508975176296279,0.858733376783882,1,7,regulation of interleukin-2 biosynthetic process,BP,ZFP36
10264,GO:0043029,0.509331823086957,0.723097123616655,3,28,T cell homeostasis,BP,RAG1;AKT1;JAK3
9033,GO:0035268,0.509349249922844,0.768488816999126,2,18,protein mannosylation,BP,B4GAT1;POMT1
15197,GO:0071378,0.509350929155658,0.769316314406059,2,17,cellular response to growth hormone stimulus,BP,MAPK3;JAK3
12519,GO:0050691,0.509356737979838,0.723075179640415,3,28,regulation of defense response to virus by host,BP,TMEM173;PYCARD;APOBEC3F
16235,GO:0090322,0.509418968146089,0.768431614371553,2,18,regulation of superoxide metabolic process,BP,EGFR;ACP5
2784,GO:0006228,0.509539776514421,0.856003991201318,1,8,UTP biosynthetic process,BP,NME4
11232,GO:0045472,0.509711874603925,0.858260390309467,1,7,response to ether,BP,NFATC4
9930,GO:0042308,0.509753956976676,0.858233340236574,1,7,negative regulation of protein import into nucleus,BP,GAS6
18875,GO:1904590,0.509753956976676,0.858233340236574,1,7,negative regulation of protein import,BP,GAS6
14804,GO:0070569,0.509788786316623,0.858210949739507,1,7,uridylyltransferase activity,MF,TUT1
10570,GO:0043552,0.509793561334031,0.768953950042602,2,17,positive regulation of phosphatidylinositol 3-kinase activity,BP,FGFR3;VAV3
9982,GO:0042415,0.509839742068195,0.858178187939408,1,7,norepinephrine metabolic process,BP,EPAS1
20226,GO:2001212,0.510079684287063,0.85802385046364,1,7,regulation of vasculogenesis,BP,XDH
8048,GO:0032729,0.510111643493322,0.722409878821101,3,28,positive regulation of interferon-gamma production,BP,ZP3;ZFPM1;PYCARD
9190,GO:0035590,0.510319068462189,0.85786976082276,1,7,purinergic nucleotide receptor signaling pathway,BP,PTAFR
6694,GO:0030104,0.51037708855794,0.67330906828668,5,48,water homeostasis,BP,ADCY6;AQP3;PRKACA;SCNN1A;TRPV4
12096,GO:0048172,0.510562966789823,0.857712651239746,1,7,regulation of short-term neuronal synaptic plasticity,BP,SHISA6
15261,GO:0071474,0.510710431553412,0.857617604371625,1,7,cellular hyperosmotic response,BP,SLC2A1
6496,GO:0021879,0.510793552108728,0.72180822395539,3,28,forebrain neuron differentiation,BP,SHANK3;HES1;PROX1
11839,GO:0046851,0.510996510266793,0.857433095036724,1,7,negative regulation of bone remodeling,BP,INPP5D
3279,GO:0006975,0.511134720525265,0.857343898039028,1,7,DNA damage induced protein phosphorylation,BP,MAPK3
10957,GO:0044764,0.511177724966922,0.721468977191699,3,28,multi-organism cellular process,BP,GAS6;TKFC;NLRX1
10713,GO:0044088,0.511438197232552,0.69251096380189,4,38,regulation of vacuole organization,BP,ULK1;TBC1D14;LRSAM1;PINK1
10205,GO:0042891,0.511523188656134,0.85709299301307,1,7,antibiotic transport,BP,SLC13A3
11892,GO:0046950,0.511546198077742,0.857078122422555,1,7,cellular ketone body metabolic process,BP,HMGCL
17886,GO:1902224,0.511546198077742,0.857078122422555,1,7,ketone body metabolic process,BP,HMGCL
15774,GO:0072488,0.511554951133928,0.857072465199539,1,7,ammonium transmembrane transport,BP,RHBG
17007,GO:0099504,0.511574073741027,0.635277724414526,8,79,synaptic vesicle cycle,BP,SYTL1;NLGN2;SYT8;DNM1;RIMS3;VAMP2;WNT7A;SNPH
11464,GO:0045947,0.511629238123827,0.766614012106409,2,18,negative regulation of translational initiation,BP,EIF4EBP3;RPL13A
9040,GO:0035280,0.51178112460332,0.856926234540458,1,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,AGO4
3805,GO:0008406,0.51180935598811,0.600141765124838,14,143,gonad development,BP,ERCC1;CST3;ZP3;INSR;VEGFA;CEBPB;ADAM15;SLIT3;VGF;DMC1;AGO4;WNT2B;SDC1;EREG
10131,GO:0042726,0.51186359854529,0.856872886922738,1,7,flavin-containing compound metabolic process,BP,ACP5
12829,GO:0051173,0.512065120868075,0.520494854674321,201,2085,positive regulation of nitrogen compound metabolic process,BP,TNIP1;FOS;DUSP6;CEMIP;APOE;ERCC1;CITED4;CST3;RAPGEF3;GSN;XDH;MEF2D;NOS1;ZFP36L1;NR1D1;EPHB2;EPAS1;CNTN1;IGF2;NFATC4;MST1R;LRP1;EGFR;TIMP2;TCEA2;DUSP5;EGR1;PKN1;CRTC1;SHC1;F2R;PTK6;ABCA7;DEAF1;SHC2;ASH2L;GRAMD4;SOX12;PIK3R2;ZNF516;PEG3;HDAC5;THRA;ZP3;LRP5;MAML3;ZFPM1;TFEB;ERBB2;FBLN1;PKD2;EDEM1;PTHLH;CDKN1C;SALL2;PAK6;HEXB;VPS11;MINK1;ATP2B4;TFDP2;CSNK1E;TNFRSF25;WNT7A;ZMIZ1;INSR;EPHA1;ITGA6;LPAR3;TMEM173;PRNP;SNX33;SPRY2;SNX9;STAT6;DLG4;STRADB;WWTR1;BCL6;PFKFB2;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;VANGL2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;S1PR2;ENDOG;MAPK3;ETV5;DVL1;MTA1;ADCY6;EPHB3;FHOD1;HES1;FURIN;MLXIPL;MEFV;PIDD1;IL6R;PCSK9;ZFP36;ETV4;FGFR3;PRKACA;F12;LRRK1;MAGEF1;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;TNFRSF1A;EHD4;MAPK8IP1;LDLR;TRPV4;DUSP7;HMGA2;ELK3;DGKQ;SEMA4C;ZXDC;GAS6;BTRC;PPARA;WNT7B;COMT;PTAFR;RXRA;IGFBP4;USP21;PRKCZ;HLTF;SRSF5;RFXANK;TEF;MAPKAPK3;RAD23A;FGFR1;CAMKK1;PIN1;C5;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;ASS1;SH3D19;JARID2;SESN2;TOLLIP;TMEM161A;RXRB;MAPRE3;GUCA1B;MADD;PPM1F;SORL1;STK39;ACVR1B;MEF2B;ADORA2B;ERBB3;AKT1;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;CAMTA2;CTSH;ABHD14B;MLST8;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;DDN;ERN1;TAZ;LITAF;MZF1;RARG;EREG;FAM162A;MIF
13789,GO:0060411,0.512067363732882,0.671733748818453,5,48,cardiac septum morphogenesis,BP,ZFPM1;VANGL2;HES1;NRP2;PROX1
15138,GO:0071285,0.5120845715337,0.856729887079222,1,7,cellular response to lithium ion,BP,NFATC4
19862,GO:2000380,0.512155520809179,0.85668395300847,1,7,regulation of mesoderm development,BP,FGFR1
11157,GO:0045254,0.512294894381281,0.856593691071902,1,7,pyruvate dehydrogenase complex,CC,PDK2
15307,GO:0071556,0.512313407298955,0.766049770994073,2,18,integral component of lumenal side of endoplasmic reticulum membrane,CC,PKD2;SPPL2B
16734,GO:0098553,0.512313407298955,0.766049770994073,2,18,lumenal side of endoplasmic reticulum membrane,CC,PKD2;SPPL2B
817,GO:0002091,0.512422788522767,0.856510830240594,1,7,negative regulation of receptor internalization,BP,DLG4
5019,GO:0015194,0.512431238910929,0.856505354229376,1,7,L-serine transmembrane transporter activity,MF,SERINC2
5212,GO:0015825,0.512431238910929,0.856505354229376,1,7,L-serine transport,BP,SERINC2
6618,GO:0022889,0.512431238910929,0.856505354229376,1,7,serine transmembrane transporter activity,MF,SERINC2
7558,GO:0031931,0.512543461168747,0.856432618904233,1,7,TORC1 complex,CC,MLST8
14094,GO:0060982,0.512559124635073,0.856422464891987,1,7,coronary artery morphogenesis,BP,VEGFA
1328,GO:0003183,0.512568238089659,0.856416556769512,1,7,mitral valve morphogenesis,BP,ZFPM1
1331,GO:0003188,0.512568238089659,0.856416556769512,1,7,heart valve formation,BP,ZFPM1
15595,GO:0072110,0.512622867947835,0.856381137664317,1,7,glomerular mesangial cell proliferation,BP,EGR1
15599,GO:0072124,0.512622867947835,0.856381137664317,1,7,regulation of glomerular mesangial cell proliferation,BP,EGR1
3712,GO:0008239,0.512877311527383,0.856216093279117,1,7,dipeptidyl-peptidase activity,MF,DPP7
5118,GO:0015556,0.512969002491822,0.856156587161593,1,7,C4-dicarboxylate transmembrane transporter activity,MF,SLC13A3
16115,GO:0090154,0.513138176174844,0.856046752851009,1,7,positive regulation of sphingolipid biosynthetic process,BP,TNFRSF1A
19809,GO:2000304,0.513138176174844,0.856046752851009,1,7,positive regulation of ceramide biosynthetic process,BP,TNFRSF1A
20199,GO:2001169,0.513236681524071,0.655292422082019,6,59,regulation of ATP biosynthetic process,BP,INSR;PFKFB2;MLXIPL;PPARA;PINK1;TAZ
7723,GO:0032230,0.513238042101428,0.855981889695327,1,7,positive regulation of synaptic transmission, GABAergic,BP,NLGN2
5826,GO:0017121,0.513281307582743,0.855953782620748,1,7,phospholipid scrambling,BP,ANO9
9557,GO:0036376,0.513352334568847,0.855907632584738,1,7,sodium ion export across plasma membrane,BP,ATP12A
12292,GO:0048665,0.513382099662738,0.855888289682879,1,7,neuron fate specification,BP,SUFU
19838,GO:2000345,0.513454747248748,0.85584107225203,1,7,regulation of hepatocyte proliferation,BP,SULF2
12617,GO:0050847,0.513519052847999,0.855799268115416,1,7,progesterone receptor signaling pathway,BP,WBP2
2089,GO:0004857,0.51368180381061,0.576128323781076,22,232,enzyme inhibitor activity,MF,CST3;PRDX5;TIMP2;PPP1R14A;SERPING1;CDKN1C;SERPINE2;ATP2B4;PPP1R35;PAPLN;SPRY2;ARL2;FURIN;MAPK8IP1;GAS6;C5;SERPINB6;CSTB;RTN4R;ELFN2;TIMP1;PCSK1N
7636,GO:0032059,0.513801156975083,0.855615780897336,1,7,bleb,CC,FHOD1
9726,GO:0038203,0.513964308458767,0.855509592338896,1,7,TORC2 signaling,BP,PINK1
19961,GO:2000586,0.513993474226212,0.85549060406122,1,7,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,LRP1
1153,GO:0002761,0.514074916775991,0.642572514282608,7,69,regulation of myeloid leukocyte differentiation,BP,FOS;CTNNBIP1;ZFP36L1;ZFPM1;FAM213A;CEBPB;INPP5D
1970,GO:0004690,0.514098806608851,0.855422013927559,1,7,cyclic nucleotide-dependent protein kinase activity,MF,PRKACA
19518,GO:1990462,0.514169403482029,0.855376030653555,1,7,omegasome,CC,ULK1
13113,GO:0051705,0.514235678361136,0.68994916212395,4,38,multi-organism behavior,BP,SHANK2;DLG4;SHANK3;DVL1
11379,GO:0045792,0.514273990084611,0.85530789025559,1,7,negative regulation of cell size,BP,AKT1
2435,GO:0005641,0.514359562840493,0.855252121874746,1,7,nuclear envelope lumen,CC,SORL1
1986,GO:0004711,0.514497711191221,0.855162059349086,1,7,ribosomal protein S6 kinase activity,MF,RPS6KA2
11270,GO:0045603,0.514522641205783,0.855145802848533,1,7,positive regulation of endothelial cell differentiation,BP,S1PR2
17994,GO:1902514,0.514657656645007,0.855057740074587,1,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,NOS1
1104,GO:0002693,0.514770099086109,0.854984373134972,1,7,positive regulation of cellular extravasation,BP,PTAFR
10737,GO:0044154,0.514815251692401,0.8549549047905,1,7,histone H3-K14 acetylation,BP,WBP2
15079,GO:0071157,0.514855949228227,0.763946186616482,2,18,negative regulation of cell cycle arrest,BP,MLXIPL;MIF
2280,GO:0005243,0.514955076942123,0.854863624089979,1,7,gap junction channel activity,MF,GJC2
13974,GO:0060717,0.515045826757939,0.854804360309117,1,7,chorion development,BP,HTRA1
16549,GO:0097371,0.515108045274046,0.854763719452341,1,7,MDM2/MDM4 family protein binding,MF,PPARA
3281,GO:0006978,0.51513026382369,0.763718596577455,2,18,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,ZNF385A;ING4
7505,GO:0031702,0.515193351531509,0.854707985449869,1,7,type 1 angiotensin receptor binding,MF,ARAP1
9484,GO:0036149,0.515198118727441,0.854704870428435,1,7,phosphatidylinositol acyl-chain remodeling,BP,MBOAT7
6814,GO:0030285,0.515426934714154,0.854555303162255,1,7,integral component of synaptic vesicle membrane,CC,PTPRS
7,GO:0000014,0.515430765831093,0.854552798051711,1,7,single-stranded DNA endodeoxyribonuclease activity,MF,ERCC1
4897,GO:0014841,0.515442490485381,0.854545131291501,1,7,skeletal muscle satellite cell proliferation,BP,SIX5
4898,GO:0014842,0.515442490485381,0.854545131291501,1,7,regulation of skeletal muscle satellite cell proliferation,BP,SIX5
4908,GO:0014856,0.515442490485381,0.854545131291501,1,7,skeletal muscle cell proliferation,BP,SIX5
4909,GO:0014857,0.515442490485381,0.854545131291501,1,7,regulation of skeletal muscle cell proliferation,BP,SIX5
3654,GO:0008146,0.515569159526483,0.717576349567132,3,28,sulfotransferase activity,MF,CHST6;GAL3ST4;NDST2
2297,GO:0005283,0.515596508536704,0.854444393732644,1,7,amino acid:sodium symporter activity,MF,SLC6A8
2940,GO:0006476,0.515613339371497,0.623218650653679,9,90,protein deacetylation,BP,HDAC5;MTA3;BCL6;VEGFA;MTA1;PHF21A;HDAC11;PINK1;SIRT3
1433,GO:0003413,0.51576089040957,0.854336826227623,1,7,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,RARG
8336,GO:0033210,0.515959602826394,0.854206722844672,1,7,leptin-mediated signaling pathway,BP,BBS2
5515,GO:0016500,0.516036682054195,0.854156235731752,1,7,protein-hormone receptor activity,MF,INSR
6464,GO:0021814,0.516058024648141,0.854142254214772,1,7,cell motility involved in cerebral cortex radial glia guided migration,BP,SUN1
2279,GO:0005242,0.516096668666134,0.854116936258364,1,7,inward rectifier potassium channel activity,MF,KCNJ15
1996,GO:0004723,0.5161903416237,0.854055553464757,1,7,calcium-dependent protein serine/threonine phosphatase activity,MF,PPM1F
19786,GO:2000271,0.516199185019958,0.85404975760067,1,7,positive regulation of fibroblast apoptotic process,BP,STK17A
10060,GO:0042577,0.516218664207733,0.854036990612416,1,7,lipid phosphatase activity,MF,PLPPR2
5093,GO:0015386,0.516227137383158,0.854031436915961,1,7,potassium:proton antiporter activity,MF,SLC9A7
8693,GO:0034350,0.516302510823928,0.853982027609476,1,7,regulation of glial cell apoptotic process,BP,GAS6
8694,GO:0034351,0.516302510823928,0.853982027609476,1,7,negative regulation of glial cell apoptotic process,BP,GAS6
18009,GO:1902555,0.516347603070381,0.716459470092627,3,29,endoribonuclease complex,CC,ZFP36;AGO4;ERN1
19197,GO:1905348,0.516347603070381,0.716459470092627,3,29,endonuclease complex,CC,ZFP36;AGO4;ERN1
3933,GO:0008631,0.516390619621319,0.687688740161005,4,39,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,PRODH;AKT1;TRAP1;PINK1
14033,GO:0060839,0.516396489258261,0.853920406598627,1,7,endothelial cell fate commitment,BP,PROX1
17683,GO:1901620,0.516457558614671,0.853880354532331,1,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,SUFU
3373,GO:0007158,0.516501526902789,0.85385151359141,1,7,neuron cell-cell adhesion,BP,NLGN2
5038,GO:0015232,0.516507683129361,0.853847475117141,1,7,heme transporter activity,MF,SLC48A1
5246,GO:0015886,0.516507683129361,0.853847475117141,1,7,heme transport,BP,SLC48A1
187,GO:0000405,0.516518516857323,0.853840368029793,1,7,bubble DNA binding,MF,XPC
10789,GO:0044294,0.516550051599002,0.853819679460228,1,7,dendritic growth cone,CC,MAPK8IP1
7824,GO:0032389,0.516569320359698,0.853807037107826,1,7,MutLalpha complex,CC,PMS2P5
7790,GO:0032351,0.516582959031068,0.853798088245356,1,7,negative regulation of hormone metabolic process,BP,CYP27B1
7792,GO:0032353,0.516582959031068,0.853798088245356,1,7,negative regulation of hormone biosynthetic process,BP,CYP27B1
16043,GO:0090030,0.51659320534546,0.853791365000269,1,7,regulation of steroid hormone biosynthetic process,BP,DGKQ
6794,GO:0030252,0.51660331950647,0.853784728267243,1,7,growth hormone secretion,BP,LTBP4
6330,GO:0021513,0.516616775547645,0.853775898337462,1,7,spinal cord dorsal/ventral patterning,BP,SUFU
3513,GO:0007494,0.516617512465919,0.853775414758606,1,7,midgut development,BP,EGFR
2698,GO:0006072,0.516644451680322,0.853757735991202,1,7,glycerol-3-phosphate metabolic process,BP,GPD1L
5266,GO:0015926,0.516646944673674,0.853756099905086,1,7,glucosidase activity,MF,GAA
12194,GO:0048407,0.51664788183761,0.853755484857545,1,7,platelet-derived growth factor binding,MF,COL6A1
2195,GO:0005078,0.516648009112377,0.853755401332623,1,7,MAP-kinase scaffold activity,MF,MAPK8IP1
8209,GO:0032982,0.516648009112377,0.853755401332623,1,7,myosin filament,CC,MYH3
15074,GO:0071141,0.516648009112377,0.853755401332624,1,7,SMAD protein complex,CC,HMGA2
15334,GO:0071599,0.516648009112377,0.853755401332624,1,7,otic vesicle development,BP,PROX1
15751,GO:0072383,0.516648009112377,0.853755401332624,1,7,plus-end-directed vesicle transport along microtubule,BP,FYCO1
16305,GO:0090557,0.516648009112377,0.853755401332623,1,7,establishment of endothelial intestinal barrier,BP,PTPRS
18810,GO:1904429,0.516648009112377,0.853755401332792,1,7,regulation of t-circle formation,BP,ERCC1
18118,GO:1902882,0.516880598735217,0.651687077185569,6,60,regulation of response to oxidative stress,BP,ENDOG;MCTP1;SESN2;AKT1;TRAP1;PINK1
3323,GO:0007041,0.517308346104823,0.621576294772301,9,90,lysosomal transport,BP,VPS11;HOOK2;PCSK9;BIN1;LYST;SORL1;HGSNAT;PINK1;EHD3
17336,GO:1900077,0.51765200894412,0.715720579495944,3,28,negative regulation of cellular response to insulin stimulus,BP,PTPRE;PRKCZ;GRB10
7794,GO:0032355,0.517826845199,0.629064108412479,8,81,response to estradiol,BP,CST3;POSTN;FAM210B;EGFR;WNT7A;DNMT3A;IGFBP2;ENDOG
19160,GO:1905269,0.517889205696019,0.629100169805939,8,80,positive regulation of chromatin organization,BP,NOS1;BCL6;VEGFA;MAPK3;RPS6KA5;WBP2;JARID2;PINK1
5612,GO:0016679,0.517917103032282,0.850476701890451,1,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,UQCR11
8240,GO:0033032,0.518009346626621,0.761322436229717,2,18,regulation of myeloid cell apoptotic process,BP,THRA;MIF
9680,GO:0038094,0.518507963592815,0.650288958044436,6,59,Fc-gamma receptor signaling pathway,BP,PIK3R2;FCGRT;MAPK3;WIPF1;CYFIP2;VAV3
6710,GO:0030131,0.519284817786419,0.714261494494166,3,28,clathrin adaptor complex,CC,EGFR;AP2A2;LDLRAP1
2488,GO:0005742,0.519333788163717,0.849528268006359,1,8,mitochondrial outer membrane translocase complex,CC,PINK1
10334,GO:0043162,0.519606111882024,0.759987603171845,2,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,MVB12B;MVB12A
12263,GO:0048599,0.520209546817986,0.713433476784431,3,28,oocyte development,BP,ZP3;DMC1;EREG
4813,GO:0014020,0.521032455186797,0.62606066735331,8,80,primary neural tube formation,BP,DEAF1;FUZ;CELSR1;VANGL2;DVL1;SEMA4C;SUFU;RARG
194,GO:0000413,0.521911403759089,0.711079402326851,3,30,protein peptidyl-prolyl isomerization,BP,FKBP9;FKBP10;PIN1
1476,GO:0003755,0.521911403759089,0.711079402326851,3,30,peptidyl-prolyl cis-trans isomerase activity,MF,FKBP9;FKBP10;PIN1
4247,GO:0009583,0.522011160439477,0.711816794987068,3,28,detection of light stimulus,BP,REEP6;PITPNM1;GUCA1B
18046,GO:1902653,0.522437720898918,0.646389172543701,6,60,secondary alcohol biosynthetic process,BP,APOE;ABCG1;MVD;SEC14L2;PMVK;TM7SF2
4594,GO:0010719,0.522826242714943,0.757282841172773,2,18,negative regulation of epithelial to mesenchymal transition,BP,FUZ;VASN
8812,GO:0034612,0.522955298832309,0.571167037840136,20,212,response to tumor necrosis factor,BP,ZFP36L1;POSTN;RBCK1;HYAL1;ADAMTS7;TNFRSF25;ENDOG;TNFRSF6B;MAPK3;TNFRSF14;ZFP36;TNFRSF1A;GAS6;PCK2;ADAMTS13;MADD;GSS;AKT1;SPPL2B;PYCARD
8331,GO:0033198,0.523037088553029,0.757105139026805,2,18,response to ATP,BP,SSH1;DGKQ
8553,GO:0034035,0.523971167780953,0.756317000356815,2,18,purine ribonucleoside bisphosphate metabolic process,BP,ABHD14B;PODXL2
12455,GO:0050427,0.523971167780953,0.756317000356815,2,18,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,ABHD14B;PODXL2
15821,GO:0072562,0.524511798808933,0.680170456489224,4,39,blood microparticle,CC,APOE;GSN;SERPING1;SLC2A1
3512,GO:0007492,0.525491150831792,0.643615762880231,6,59,endoderm development,BP,DUSP6;ZFP36L1;COL6A1;DUSP5;ITGB5;HMGA2
7488,GO:0031672,0.525609932274782,0.754930758266846,2,18,A band,CC,OBSCN;OBSL1
5928,GO:0018230,0.525614339321112,0.754927024265052,2,18,peptidyl-L-cysteine S-palmitoylation,BP,ZDHHC1;ZDHHC24
5929,GO:0018231,0.525614339321112,0.754927024265052,2,18,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,ZDHHC1;ZDHHC24
10041,GO:0042542,0.525681696522149,0.606250419629303,10,104,response to hydrogen peroxide,BP,CST3;MAPK13;STAT6;ANKZF1;BNIP3;ENDOG;ADA;SDC1;TRAP1;PINK1
11347,GO:0045732,0.525889738766735,0.576144523490238,17,175,positive regulation of protein catabolic process,BP,APOE;LRP1;EDEM1;VPS11;CSNK1E;SNX33;SNX9;CD81;DVL1;FURIN;PCSK9;MAGEF1;LDLR;RAD23A;SH3D19;SORL1;AKT1
10972,GO:0044788,0.526409470629644,0.754252793612743,2,18,modulation by host of viral process,BP,APOE;PC
3703,GO:0008219,0.526497547282599,0.510287691810794,149,1564,cell death,BP,FOS;DUSP6;APOE;PPL;CST3;GSN;XDH;PRDX5;NDRG1;PRODH;MEF2D;ZFP36L1;ALOX15B;RBCK1;EPHB2;OBSCN;IGF2;NFATC4;NME4;MST1R;LRP1;EGFR;H1F0;HS1BP3;EGR1;PKN1;PYGL;ARHGEF4;SHC1;RGL2;F2R;PRSS8;CTSB;PACS2;GRAMD4;PEG3;THRA;RPS6KA2;NISCH;LRP5;MARK4;ERBB2;PHLDA2;SIGMAR1;PAK6;NTSR1;MINK1;TFDP2;PDCD4;BEX2;TNFRSF25;WNT7A;INSR;ID1;RABGGTA;EPHA1;ADARB1;ITGA6;SYNGAP1;DNMT3A;TMEM173;PRNP;SPRY2;HINT2;MNT;MKNK2;STRADB;MYO18A;BCL6;BNIP3;VEGFA;ELMO3;CEBPB;ENDOG;TNFRSF6B;MAPK3;PLEKHG5;EPHB3;SSH1;FURIN;PLEKHG2;TNFRSF14;ADA;PIDD1;IL6R;SLIT3;PCSK9;ZFP36;FGFR3;CYFIP2;MAP2K2;DAP;FGFR4;TNFRSF1A;MAPK8IP1;RAG1;PHLDA1;TNFAIP8L1;EEF2K;HMGA2;GAS6;PPARA;VAV3;GSDMC;PRKCZ;INPP5D;TM7SF3;PDK2;AGO4;FGFR1;CTSZ;PIN1;KCNMA1;BIN1;PPP1R13L;SLC25A27;TMEM161A;MADD;EPB41L3;TIMP1;PPM1F;SORL1;STK39;ACVR1B;GSDMA;ERBB3;ABR;PNMA1;AKT1;TRAP1;TMBIM4;ZNF385A;TP53INP1;ERCC6;PINK1;CTSH;RILPL1;PYCARD;MAP2K3;STK17A;ERN1;ARHGEF19;JAK3;RARG;ING4;FAM162A;KRT15;ADAMTSL4;MIF
12304,GO:0048679,0.526709548337494,0.753998067934636,2,18,regulation of axon regeneration,BP,PTPRS;RTN4R
3365,GO:0007143,0.526805517162434,0.753916571449521,2,18,female meiotic nuclear division,BP,SPIRE2;EREG
7486,GO:0031669,0.527168919561864,0.577951873914041,16,164,cellular response to nutrient levels,BP,CYP27B1;POSTN;ULK1;GLUL;MAPK3;SSH1;AQP3;PCSK9;DAP;GAS6;COMT;PDK2;SESN2;WNT2B;C12ORF66;SLC2A1
19772,GO:2000242,0.527206218423561,0.706695956522923,3,29,negative regulation of reproductive process,BP,ZP3;ADA;TIMP1
6809,GO:0030279,0.527350143978989,0.677523231365432,4,39,negative regulation of ossification,BP,LRP5;ID1;ECM1;SUFU
10625,GO:0043653,0.527524817481662,0.84396568746705,1,8,mitochondrial fragmentation involved in apoptotic process,BP,BNIP3
18894,GO:1904645,0.527751193576519,0.753112679596214,2,18,response to amyloid-beta,BP,LRP1;PRNP
15277,GO:0071495,0.528050853932083,0.518680553703435,87,903,cellular response to endogenous stimulus,BP,HTRA1;FOS;DUSP6;LTBP4;RAPGEF3;PGF;LTBP1;ZFP36L1;COL6A1;POSTN;NR1D1;FAM210B;IGF2;LRP1;MAPK13;LTBP2;EGFR;UROS;EGR1;SHC1;BBS2;CTSB;CORO1B;PIK3R2;HDAC5;THRA;HYAL1;ERBB2;PKD2;SPRY4;CDKN1C;PTPRE;VAMP2;FUZ;ATP2B4;ADAMTS7;PDCD4;WNT7A;INSR;ID1;DNMT3A;PRNP;SPRY2;FAM20C;IGFBP2;CEBPB;ACVR2B;CALCOCO1;MAPK3;ADCY6;HES1;SSH1;FURIN;SLIT3;PCSK9;ZFP36;FGFR3;PRKACA;ITGB5;FGFR4;DMTN;EEF2K;PPARA;PTAFR;RXRA;PCK2;VASN;NEO1;PRKCZ;PDK2;GPC1;SRSF5;FGFR1;PIN1;WBP2;GRB10;CAPN2;SESN2;RXRB;FGFBP1;AKT1;SLC5A5;CTSH;JAK3;RARG;GSTM2;SULF2
9058,GO:0035325,0.528112047858855,0.843561685804756,1,8,Toll-like receptor binding,MF,TOLLIP
9365,GO:0035914,0.5284602255194,0.676485123898622,4,39,skeletal muscle cell differentiation,BP,FOS;MEF2D;EGR1;GPC1
6623,GO:0022904,0.528463305069472,0.61767587913295,8,94,respiratory electron transport chain,BP,D2HGDH;NDUFS8;SDHA;ETFB;UQCR11;PINK1;NDUFV3;TAZ
65,GO:0000132,0.528999697018819,0.75204906390161,2,18,establishment of mitotic spindle orientation,BP,SPRY2;NDE1
9226,GO:0035637,0.529348125635904,0.609756398788228,9,91,multicellular organismal signaling,BP,NOS1;SCN8A;ANK3;SCN4B;ITPR3;ATP2B4;PRKACA;AHNAK2;EHD3
15728,GO:0072347,0.529686950186683,0.675336118609675,4,39,response to anesthetic,BP,HDAC5;DNMT3A;ADA;HOMER2
8178,GO:0032930,0.529691714558348,0.84247142179279,1,8,positive regulation of superoxide anion generation,BP,EGFR
11781,GO:0046685,0.52994426712533,0.70420749715492,3,29,response to arsenic-containing substance,BP,MAPK13;UROS;MKNK2
10338,GO:0043169,0.530165505448344,0.498376818797847,287,2978,cation binding,MF,APOE;IDH2;RNPEPL1;NT5E;SYTL1;RNF44;LTBP4;PGM1;CYP27B1;GSN;CLCA2;XDH;PRSS3;NOS1;LTBP1;MARCH9;ARAP1;ZFP36L1;CGREF1;POSTN;NR1D1;ALOX15B;RBCK1;OBSCN;NME4;LRP1;LTBP2;RAB11FIP4;TIMP2;SMOC2;MMP28;B3GAT3;TCEA2;FKBP9;FHL1;LOXL1;EGR1;PYGL;TRIM65;SYT8;GNAL;NPEPL1;DEAF1;PPP2R3B;CA12;S100A4;RNF208;CXXC5;DGKA;THBS3;ZMYND8;ASH2L;ZSCAN18;MMP1;S100A6;ZNF516;PEG3;NEK9;HDAC5;THRA;RPS6KA2;NMRK1;TENM2;PLTP;ZFPM1;NUDT8;FBLN1;BRSK1;MICALL2;OGDHL;PKD2;CBS;TMEM129;EDEM1;ITPR3;VAT1;SALL2;MSRB2;CUL9;NINL;VPS11;GALNT12;RNF135;UNK;JADE2;CD320;ATP2B4;SNN;PHF7;ACP5;RASA4;PLCD1;AGAP1;ZFYVE21;ADAMTS7;ACAP3;GLUL;DTX3;ZKSCAN1;USP20;PEX10;ZMIZ1;ZC3H6;CELSR1;B4GAT1;POLL;NDUFS8;RABGGTA;ADARB1;ZNF692;ZNF704;ITGA6;HAGH;DNMT3A;PRNP;ATP7B;ZNF467;MARCH2;MTA3;MKNK2;PLCD3;NT5DC1;ISG20;FAM20C;PHC2;BCL6;ANKZF1;ATP12A;ZSCAN2;YPEL3;MAST4;SHANK3;ACVR2B;ADAM15;ENDOG;CAPNS2;DHTKD1;EXD3;TNNT1;MTA1;LHPP;FYCO1;ADCY6;L3MBTL1;LTA4H;MBD1;PHYHD1;PC;YPEL2;FURIN;ZNF624;NAGS;MEFV;TRIM4;NRP2;NADK;LRSAM1;ZNF414;ADA;FKBP10;TRIM45;MCTP1;PHF21A;HTR7;CELSR2;ACY1;PFKL;SLIT3;ZFP36;CYHR1;F12;PITPNM1;ZNF862;ZMYM3;LRRK1;NUDT10;PLCH2;RPS6KA5;MAP2K2;PI4K2A;RNF215;EHD4;LDLR;CYP3A5;RAG1;ZNF80;EEF2K;DGKQ;ZXDC;MIB2;PADI3;GAS6;MEX3A;ZNF217;PPARA;HMGCL;TKFC;STK32C;GIT1;COMT;RFNG;IMPA2;LTBP3;PAN2;ZNF446;RXRA;PCK2;VAV3;USP21;RNF123;PRKCZ;ADAMTS13;HAGHL;HLTF;ZNF485;TPP1;GPC1;ZNF160;ARAP3;CDHR1;MAN1B1;ZNF563;ANKMY1;PHYH;IRF2BPL;PCDHGC3;ASAP2;KCNMA1;ESYT2;VSNL1;ZNF554;CAPN2;SESN2;RXRB;MAN2B2;GUCA1B;ADGRE2;PITPNM3;CYBRD1;LMLN;TIMP1;APOBEC3C;ZFP41;PPM1F;EFCAB1;ACVR1B;ZSCAN30;GSS;CYP2S1;HPDL;ADAM19;ZNF385A;TUT1;PINK1;EHD3;KDM4B;LENG9;ZNF710;RSAD1;CBLC;RNF187;POMT1;TRERF1;THAP8;ERN1;ZNF319;APOBEC3F;PRIMPOL;MOCS1;SIRT3;ALKBH6;GLI4;BCKDHA;MAST3;LITAF;MZF1;NEIL1;RARG;ING4;GALNS;ZCCHC14;ZNF514;ZFYVE19;TRIM7;ZNF837;POLM;SULF2
8636,GO:0034198,0.530245213036237,0.674812592107704,4,39,cellular response to amino acid starvation,BP,MAPK3;DAP;SESN2;C12ORF66
11753,GO:0046634,0.53060325899575,0.674476616140611,4,39,regulation of alpha-beta T cell activation,BP,BCL6;ADA;PRKCZ;JAK3
13971,GO:0060713,0.53085253320414,0.75046577557385,2,18,labyrinthine layer morphogenesis,BP,ZFP36L1;WNT7B
12860,GO:0051224,0.530934487329047,0.601088394984745,10,104,negative regulation of protein transport,BP,IDH2;HADH;RHBDF1;F2R;RHBDF2;PFKL;MAPKBP1;DMTN;GAS6;VSNL1
562,GO:0001704,0.531184824020072,0.616181325100616,8,80,formation of primary germ layer,BP,DUSP6;COL6A1;DUSP5;ITGB4;ITGB5;HMGA2;FGFR1;WNT3
7638,GO:0032069,0.531782856301825,0.702530465215162,3,29,regulation of nuclease activity,BP,AKT1;ERN1;NEIL1
15406,GO:0071706,0.531905665277155,0.625021206244409,7,72,tumor necrosis factor superfamily cytokine production,BP,NFATC4;ACP5;ZFP36;GAS6;PTAFR;PYCARD;MIF
3456,GO:0007281,0.532093516729254,0.584205278174894,13,134,germ cell development,BP,ERCC1;DEAF1;BBS2;DNAH1;ZP3;HEXB;ETV5;PRKACA;DMC1;AKT1;SIX5;RFX2;EREG
12583,GO:0050789,0.532186587781192,0.493276220298979,719,7514,regulation of biological process,BP,TNIP1;HTRA1;FOS;DUSP6;LMF1;CEMIP;ADGRL1;APOE;TYSND1;ESPN;CTNNBIP1;MARCKSL1;TSPAN1;IDH2;PTPRS;ERCC1;WWC3;SEMA4B;FAM110C;NT5E;GAA;SYTL1;LTB4R;CITED4;BTBD2;CST3;SHANK2;LTBP4;RAPGEF3;TCFL5;MRC2;CYP27B1;GSN;EVI5L;XDH;PRDX5;NDRG1;PCBP4;PRODH;PGF;MEF2D;NOS1;LTBP1;PARVB;ARAP1;SH3BP2;ZFP36L1;TCTN1;CGREF1;POSTN;GRB7;NR1D1;EFS;ALOX15B;ARRDC1;FAM210B;SCN8A;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;CPT2;RHPN1;MYZAP;IGF2;NFATC4;NME4;MST1R;LRP1;GAMT;MAPK13;APPL2;HEBP1;KCNG1;RALGDS;LTBP2;RAB11FIP4;OBSL1;EGFR;TIMP2;TSC22D1;SMOC2;MMP28;B3GAT3;HADH;NLGN2;REEP6;FBXO2;TCEA2;DUSP5;TOM1L2;HS1BP3;PPP1R14A;FHL1;MXD4;DDB2;SERPING1;MTHFR;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CMTM7;CRTC1;ARPIN;ARHGEF4;TRIM65;SYT8;SHC1;RGL2;F2R;PTK6;GNAL;ABCA7;DEAF1;LAMA5;PPP2R3B;BAHCC1;BBS2;ACTA2;PRSS8;S100A4;CTSB;SHC2;PITPNC1;CORO1B;CXXC5;ULK2;DGKA;GJC2;IGSF9;ZMYND8;TBC1D14;ASH2L;ZSCAN18;GRAMD4;NXPH4;SOX12;MXI1;PLAT;KCNC4;MMP1;ABCG1;RIN1;ANK3;PIK3R2;S100A6;ZNF516;INO80C;PEG3;HDAC5;THRA;ARHGAP23;KCNJ15;DOCK4;ZP3;CRTAP;RPS6KA2;NISCH;LRP5;HYAL1;MARK4;TENM2;PLTP;MAML3;ZFPM1;BCAM;TFEB;ERBB2;EXOC2;FBLN1;BRSK1;MICALL2;BSG;SCMH1;PTPRU;PKD2;SCN4B;IQSEC2;EDEM1;ABTB1;ITGB4;ITPR3;PLXNB3;H2AFJ;PHLDA2;VAT1;DNM1;SPRY4;DDIT4L;PTHLH;CDKN1C;RIMS3;SALL2;MSRB2;IFT140;VIPR1;CUL9;CD9;KIF13B;XPC;PTPRE;NINL;SIGMAR1;PAK6;HEXB;SERPINE2;VPS11;VAMP2;FUZ;FOXQ1;RNF135;NPHP4;LTB4R2;UNK;NTSR1;CD320;MINK1;RALGAPA2;ATP2B4;GGT1;TMOD2;TFDP2;CSNK1E;ACP5;RASA4;PLCD1;TRAPPC9;AGAP1;ADAMTS7;PDCD4;DOCK6;SLC20A1;BEX2;ACAP3;TNFRSF25;GLUL;RHOD;DTX3;ZKSCAN1;USP20;ASIC1;PLEKHG4;WNT7A;ZMIZ1;INSR;RAB3D;SH3PXD2B;TBC1D8;FBXW8;ZC3H6;ID1;CELSR1;GRK6;MVD;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;CCNG2;TXNRD3;SYNGAP1;IL20RB;PPP1R35;DNMT3A;DNPH1;LPAR3;TMEM173;PRNP;PAPLN;EFNB3;SNX33;HES2;SPRY2;HINT2;ZNF467;MNT;ECM1;CEP250;NPDC1;SNX9;STAT6;DLG4;SPEG;REEP2;MTA3;MKNK2;PLCD3;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;MYO18A;ARHGAP27;DNAJB5;PLEKHH2;BCL6;PFKFB2;PLXNB1;FAM213A;CHMP1B;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;BNIP3;CD81;SRMS;FCGRT;FZD8;VEGFA;ZSCAN2;LRRC8A;ARL2;YPEL3;VANGL2;MAST4;FBXW4;AP2A2;CEBPB;RHBDF2;GPRC5C;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;CALCOCO1;S1PR2;ENDOG;TNFRSF6B;MAPK3;PLEKHG5;TUB;KCNAB2;ETV5;OLFM2;CARD19;AMN;RAB40B;TNNT1;DVL1;ENTPD2;MTA1;FYCO1;WIPF1;GPSM1;ADCY6;L3MBTL1;MBD1;PKN3;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;PC;GIGYF1;SSH1;FURIN;MLXIPL;ZNF624;SAMD3;CUL7;MEFV;EVC;ARHGAP22;NRP2;GPR153;PLEKHG2;ABCA2;TNFRSF14;LRSAM1;ZNF414;ADA;CDC42EP5;MCTP1;PIDD1;PAG1;PHF21A;SH2D2A;AQP3;HTR7;RASL10B;CELSR2;PFKL;IL6R;SLIT3;PCSK9;ZFP36;ETV4;RHOF;BTBD11;MAPKBP1;FGFR3;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;KIAA1549;LRRK1;PLCH2;DGUOK;MAGEF1;CYFIP2;RPS6KA5;HBEGF;ITGB5;RAB3B;MAP2K2;DAP;FGFR4;SPTB;FBXW5;STX10;TSPAN33;DMTN;RAPGEF5;PMVK;PSD4;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;TCF25;SEMA3B;LDLR;PTOV1;ACOT11;ROBO3;SNX17;SOX13;ABHD17C;TRPV4;RHOBTB2;IFNGR2;BHLHE40;EIF4EBP3;CROCC;RAG1;ZNF80;DUSP7;TNFAIP8L1;EEF2K;RHBDL1;HMGA2;LDLRAP1;TM7SF2;SEMA3F;ELK3;AHNAK2;DGKQ;SEMA4C;MVB12A;HK1;FAM3A;ZXDC;MIB2;GAS6;BTRC;MEX3A;POU6F1;LLGL1;ADGRB2;ZNF217;PPARA;TKFC;TSPAN4;STK32C;WNT7B;GIT1;COMT;SUFU;PTAFR;PLEKHG6;RFNG;IMPA2;ARHGEF37;LTBP3;PAN2;ZNF446;RXRA;PCK2;VAV3;VASN;BCR;NEO1;IGFBP4;MUC19;TBC1D16;USP21;PRKCZ;ADAMTS13;CLTCL1;HLTF;CAPG;BCORL1;INPP5D;TM7SF3;NYAP1;SLITRK6;TWF2;ZNF485;LSM14B;TPP1;PDK2;GPC1;TMX4;ICOSLG;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;MAPKAPK3;NDE1;AGO4;RAD23A;ARAP3;FGFR1;CTSZ;CAMKK1;CHADL;PIN1;MN1;ZNF563;C5;KMT5C;TMEM204;IRF2BPL;PROX1;WBP2;GTPBP1;C21ORF2;ASAP2;DLG3;GPR155;KCNMA1;BIN1;VSNL1;TMEM8B;SERPINB6;OSCP1;PI4KAP2;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;SLC25A27;GRB10;JARID2;CAPN2;SESN2;TOLLIP;WNT2B;WRAP73;TMEM161A;RXRB;CSTB;PROCR;TMEM231;PNRC1;MAPRE3;LCAT;GUCA1B;ADGRE2;MADD;RTN4R;ELFN2;OR7D2;EPB41L3;TIMP1;SDC1;WHAMMP3;SH2B3;APOBEC3C;FGFBP1;RTN2;PEAR1;EPS8L1;PLEKHH3;WNT3;ZFP41;PPM1F;SORL1;STK39;VEGFB;ACVR1B;MEF2B;TBC1D17;ANO9;ZSCAN30;ADORA2B;TPCN1;ERBB3;ABR;ZER1;CCDC85B;PNMA1;CCDC71L;AKT1;TRAP1;STON1;TMBIM4;NLRX1;ZNF385A;TP53INP1;LRCH4;NDRG2;SMARCA1;VPS33B;SIX5;ERCC6;GPD1L;EPS8L2;TDRKH;SPPL2B;IL17RD;SSBP2;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;SNTA1;ARHGEF10L;KDM4B;CAMTA2;HOMER2;PLPPR2;RGS14;SYNE3;PCIF1;MAFIP;SPIRE2;EIF4G3;ZNF710;CTSH;ABHD14B;MLST8;ROBO4;RILPL1;CBLC;EPN2;RFX2;RNF187;PYCARD;NINJ1;MAP2K3;POMT1;TRERF1;PCSK1N;KCNN4;THAP8;DDN;STK17A;ERN1;CKLF;RANBP9;ZNF319;APOBEC3F;ARHGEF19;SIRT3;GLI4;C12ORF66;CMTM4;SLC2A1;MLYCD;TAZ;JAK3;MAST3;LITAF;APBA1;MZF1;NEIL1;RARG;ING4;EIF4E3;PBXIP1;EREG;FAM162A;FCHSD1;GSTM2;ZNF514;ZFYVE19;SHISA6;GIPR;WDR18;SFI1;TP53I11;ADAMTSL4;TRNP1;ZNF837;TMED4;SEMA4F;RPL13A;RGS12;RAB40C;MIF;SULF2;STXBP2;KIF26B;UBL5;LZTS2
14629,GO:0070252,0.532486404973593,0.652040808678784,5,50,actin-mediated cell contraction,BP,SCN4B;TNNT1;MYH3;GPD1L;SNTA1
10056,GO:0042572,0.532883270226515,0.7487238139543,2,18,retinol metabolic process,BP,RETSAT;PNPLA4
10982,GO:0044804,0.532931147293472,0.748682660977711,2,18,autophagy of nucleus,BP,WIPI2;ATG2A
14630,GO:0070254,0.533482381513468,0.839834314063461,1,8,mucus secretion,BP,ADA
4032,GO:0009074,0.533709722926245,0.839675216776574,1,8,aromatic amino acid family catabolic process,BP,HPDL
11630,GO:0046386,0.534000272106053,0.746979569073029,2,19,deoxyribose phosphate catabolic process,BP,ADA;NEIL1
4570,GO:0010665,0.534072282508499,0.747700643210335,2,18,regulation of cardiac muscle cell apoptotic process,BP,RGL2;BNIP3
1697,GO:0004180,0.534136077426437,0.747645678568413,2,18,carboxypeptidase activity,MF,BLMH;CTSZ
1867,GO:0004536,0.534730778765918,0.634406344138168,6,61,deoxyribonuclease activity,MF,ERCC1;ISG20;DNASE1L1;ENDOG;DMC1;NEIL1
14018,GO:0060795,0.535251257741302,0.746683741966899,2,18,cell fate commitment involved in formation of primary germ layer,BP,DUSP6;FGFR1
16440,GO:0097150,0.535329230967253,0.746616404507906,2,18,neuronal stem cell population maintenance,BP,HES1;PROX1
4665,GO:0010823,0.535563348891528,0.669531630964312,4,40,negative regulation of mitochondrion organization,BP,VAT1;BNIP3;AKT1;PINK1
18468,GO:1903624,0.535993102882222,0.838071343899891,1,8,regulation of DNA catabolic process,BP,ENDOG
12331,GO:0048729,0.53627184141277,0.528785067385266,43,448,tissue morphogenesis,BP,CTNNBIP1;PGF;TCTN1;NFATC4;EGFR;DEAF1;LAMA5;ACTA2;LRP5;ZFPM1;PKD2;ITGB4;FUZ;FOXQ1;WNT7A;CELSR1;ADARB1;SPRY2;VEGFA;VANGL2;AP2A2;ETV5;DVL1;HES1;CELSR2;HBEGF;HMGA2;SEMA4C;BTRC;WNT7B;SUFU;RXRA;FGFR1;CTSZ;PROX1;DLG3;WNT2B;WNT3;PKD1;CTSH;ARHGEF19;RARG;KIF26B
8864,GO:0034694,0.536409903366233,0.745682074157335,2,18,response to prostaglandin,BP,ADCY6;AKT1
20063,GO:2000756,0.53656859874441,0.648125251893105,5,50,regulation of peptidyl-lysine acetylation,BP,NOS1;HINT2;MAPK3;RPS6KA5;WBP2
2496,GO:0005751,0.536573681162617,0.834034194027634,1,10,mitochondrial respiratory chain complex IV,CC,NDUFA4L2
360,GO:0000979,0.536737553362434,0.697986869455554,3,29,RNA polymerase II core promoter sequence-specific DNA binding,MF,FOS;CEBPB;WBP2
5920,GO:0018208,0.537201666939581,0.667720899125559,4,41,peptidyl-proline modification,BP,FKBP9;CRTAP;FKBP10;PIN1
5382,GO:0016229,0.537446349764261,0.743994561185064,2,19,steroid dehydrogenase activity,MF,DHRS11;SRD5A3
9967,GO:0042379,0.537557428270492,0.742555864230606,2,21,chemokine receptor binding,MF,C5;CKLF
19015,GO:1904886,0.538334586157253,0.74401310016836,2,18,beta-catenin destruction complex disassembly,BP,LRP5;DVL1
16627,GO:0097530,0.538378905674243,0.646007100583514,5,52,granulocyte migration,BP,MAPK3;TRPV4;VAV3;ADGRE2;CKLF
136,GO:0000287,0.538604010870409,0.569879626714709,15,155,magnesium ion binding,MF,IDH2;PGM1;RPS6KA2;BRSK1;GLUL;MAST4;LHPP;RPS6KA5;PI4K2A;HMGCL;COMT;GSS;PINK1;ERN1;MAST3
6514,GO:0021904,0.538714208074984,0.743683167376772,2,18,dorsal/ventral neural tube patterning,BP,TCTN1;SUFU
2704,GO:0006085,0.538818121867248,0.743592812034527,2,18,acetyl-CoA biosynthetic process,BP,PDK2;MLYCD
15288,GO:0071514,0.538885140811426,0.743534527785972,2,18,genetic imprinting,BP,IGF2;DNMT3A
11914,GO:0046983,0.538888328196387,0.509832264177827,79,850,protein dimerization activity,MF,FOS;APOE;TCFL5;XDH;PRDX5;PGF;CADM4;MEF2D;EPAS1;RAB11FIP4;EGFR;CRYL1;ACOT7;MXD4;PYGL;GALE;MXI1;ABCG1;PIK3R2;S100A6;TENM2;TFEB;ERBB2;PKD2;CBS;H2AFJ;DNM1;HEXB;NTSR1;RALGAPA2;ID1;CELSR1;MVD;RABGGTA;DNPH1;TMEM173;HES2;MNT;SNX9;ABCD1;WWTR1;BNIP3;VEGFA;CEBPB;LHPP;HES1;MLXIPL;IL6R;BTBD11;HLCS;ZNF862;BHLHE40;RAG1;PEX7;BTRC;HMGCL;IMPA2;RXRA;PDK2;FGFR1;CAPN2;SLC9A7;GRHPR;OLFML2A;VEGFB;MEF2B;GSS;ERBB3;AKT1;GPD1L;NAGA;SPPL2B;HOMER2;RILPL1;PYCARD;PNPO;ERN1;MZF1;GSTM2
4950,GO:0015035,0.539059953763099,0.741880936074532,2,20,protein disulfide oxidoreductase activity,MF,TXNRD3;GLRX
18647,GO:1904019,0.539162762438748,0.630247981191618,6,60,epithelial cell apoptotic process,BP,GSN;ZFP36L1;PDCD4;DNMT3A;ZFP36;GAS6
3116,GO:0006703,0.539179145710988,0.835815334859178,1,8,estrogen biosynthetic process,BP,DHRS11
1049,GO:0002577,0.539427192231292,0.835638806642734,1,8,regulation of antigen processing and presentation,BP,PYCARD
3325,GO:0007043,0.539740771087095,0.607682835548882,8,81,cell-cell junction assembly,BP,MICALL2;CD9;NPHP4;ARL2;FBF1;PRKACA;TRPV4;EPB41L3
13990,GO:0060740,0.539831614391565,0.742710589228596,2,18,prostate gland epithelium morphogenesis,BP,RXRA;RARG
15338,GO:0071604,0.540157757950566,0.742426314478018,2,18,transforming growth factor beta production,BP,FURIN;LTBP3
8241,GO:0033033,0.540216348478612,0.835076327973671,1,8,negative regulation of myeloid cell apoptotic process,BP,MIF
2500,GO:0005759,0.5404498932032,0.530222830164974,36,393,mitochondrial matrix,CC,IDH2;PRDX5;PRODH;NME4;ALDH4A1;HADH;ACSF2;SHC1;D2HGDH;OGDHL;TST;NDUFS8;HAGH;ARL2;DHTKD1;PC;ACAD10;NAGS;TK2;PYCR2;DGUOK;MPG;SDHAF4;HMGCL;PCK2;MDH2;ETFB;PDK2;SMDT1;TRAP1;ACP6;PRIMPOL;ACADS;SIRT3;MLYCD;BCKDHA
14771,GO:0070513,0.540593211248319,0.83480725488905,1,8,death domain binding,MF,DAP
1344,GO:0003209,0.54072609510055,0.741930502193926,2,18,cardiac atrium morphogenesis,BP,ZFPM1;PROX1
9084,GO:0035371,0.541051936814473,0.74164599092281,2,18,microtubule plus-end,CC,CLIP2;MAPRE3
793,GO:0002063,0.541239558642383,0.741482084775714,2,18,chondrocyte development,BP,RARG;SULF2
15391,GO:0071682,0.541262388382549,0.834328740016655,1,8,endocytic vesicle lumen,CC,APOE
10163,GO:0042772,0.541325732920764,0.74060999338811,2,19,DNA damage response, signal transduction resulting in transcription,BP,ZNF385A;ING4
2573,GO:0005869,0.541465228299998,0.834183507501162,1,8,dynactin complex,CC,ACTR1B
561,GO:0001702,0.54176680060853,0.741021163383679,2,18,gastrulation with mouth forming second,BP,LRP5;ACVR2B
6284,GO:0019903,0.541796152469216,0.590477101126371,10,102,protein phosphatase binding,MF,EGFR;PIK3R2;ERBB2;ATP2B4;STAT6;DLG4;DLG3;AKT1;KCNN4;JAK3
3692,GO:0008207,0.5420698552769,0.739957837247471,2,19,C21-steroid hormone metabolic process,BP,EGR1;DGKQ
2397,GO:0005547,0.542739900461377,0.692434847873343,3,29,phosphatidylinositol-3,4,5-trisphosphate binding,MF,ARAP1;ARAP3;AKT1
19955,GO:2000574,0.543099855747368,0.833009958958334,1,8,regulation of microtubule motor activity,BP,NDE1
5166,GO:0015732,0.543156149168471,0.83296944382888,1,8,prostaglandin transport,BP,MIF
5331,GO:0016079,0.54332861631615,0.641598722957616,5,50,synaptic vesicle exocytosis,BP,SYTL1;SYT8;RIMS3;VAMP2;SNPH
12965,GO:0051402,0.543396046819067,0.565012097413303,15,157,neuron apoptotic process,BP,APOE;LRP1;F2R;SIGMAR1;ADARB1;SYNGAP1;PRNP;BNIP3;CEBPB;PCSK9;CTSZ;PIN1;ERBB3;PINK1;FAM162A
5710,GO:0016859,0.54370860597039,0.690732335410745,3,31,cis-trans isomerase activity,MF,FKBP9;FKBP10;PIN1
4053,GO:0009111,0.544200758978292,0.832216408864261,1,8,vitamin catabolic process,BP,CYP27B1
18619,GO:1903955,0.544227680740076,0.625007423033334,6,62,positive regulation of protein targeting to mitochondrion,BP,MICALL2;VPS11;HES1;OSCP1;PINK1;UBL5
5422,GO:0016290,0.544281625259797,0.832158017957471,1,8,palmitoyl-CoA hydrolase activity,MF,ACOT7
10624,GO:0043652,0.544399881105723,0.83207260433176,1,8,engulfment of apoptotic cell,BP,ABCA7
8402,GO:0033483,0.544528295541568,0.831979819824744,1,8,gas homeostasis,BP,WNT7B
4717,GO:0010889,0.544541114475278,0.831970555721103,1,8,regulation of sequestering of triglyceride,BP,PPARA
10550,GO:0043531,0.544589687622561,0.690713242661397,3,29,ADP binding,MF,ABCG1;MYO18A;ERN1
12526,GO:0050701,0.544617157662698,0.690271951693515,3,30,interleukin-1 secretion,BP,HK1;GAS6;PYCARD
4364,GO:0009994,0.544929515044304,0.690396418705284,3,29,oocyte differentiation,BP,ZP3;DMC1;EREG
10416,GO:0043280,0.545184761616045,0.586774843641065,10,107,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,GSN;XDH;F2R;GRAMD4;PIDD1;DAP;PPM1F;CTSH;PYCARD;FAM162A
20147,GO:2001021,0.545282111394442,0.623973767135533,6,62,negative regulation of response to DNA damage stimulus,BP,ERCC1;MAGEF1;HMGA2;TMEM161A;ZNF385A;MIF
4180,GO:0009266,0.545629037509348,0.556371195910219,17,177,response to temperature stimulus,BP,FOS;NOS1;ZNF516;THRA;LRP11;NTSR1;HSF4;MAPK3;PRKACA;VGF;ACOT11;TRPV4;SLC25A27;AKT1;TP53INP1;MLST8;PCSK1N
3159,GO:0006778,0.545798106421407,0.689169282025978,3,30,porphyrin-containing compound metabolic process,BP,UROS;BLVRB;RSAD1
3823,GO:0008432,0.546313480139031,0.830686328809552,1,8,JUN kinase binding,MF,MAPK8IP1
3746,GO:0008296,0.546412983791129,0.830614032155034,1,8,3'-5'-exodeoxyribonuclease activity,MF,ISG20
16986,GO:0099132,0.546439505254356,0.688569540997033,3,30,ATP hydrolysis coupled cation transmembrane transport,BP,ATP2B4;ATP7B;ATP12A
1340,GO:0003205,0.54644801801531,0.585844717699749,10,102,cardiac chamber development,BP,LTBP1;ZFPM1;VANGL2;HES1;NRP2;SNX17;SUFU;RXRA;PROX1;PPP1R13L
9804,GO:0042033,0.546498186777288,0.830552109220196,1,8,chemokine biosynthetic process,BP,EGR1
12558,GO:0050755,0.546498186777288,0.830552109220196,1,8,chemokine metabolic process,BP,EGR1
12536,GO:0050711,0.546506849760419,0.830545812361302,1,8,negative regulation of interleukin-1 secretion,BP,GAS6
13070,GO:0051608,0.546635637129427,0.830452181907473,1,8,histamine transport,BP,ADA
4084,GO:0009147,0.546664788250474,0.735188081303175,2,20,pyrimidine nucleoside triphosphate metabolic process,BP,NME4;UCKL1
72,GO:0000149,0.547080225004719,0.59207518403236,9,93,SNARE binding,MF,SYTL1;SYT8;VPS11;VAMP2;STX10;LLGL1;SNPH;TSNARE1;STXBP2
15305,GO:0071550,0.547649297088324,0.829714000709004,1,8,death-inducing signaling complex assembly,BP,TNFRSF1A
15631,GO:0072175,0.547825412642009,0.584400759838197,10,103,epithelial tube formation,BP,TCTN1;DEAF1;FUZ;CELSR1;VANGL2;DVL1;SEMA4C;SUFU;PROX1;RARG
11017,GO:0045008,0.548277851785738,0.82925516423499,1,8,depyrimidination,BP,NEIL1
12652,GO:0050886,0.548378427937695,0.657311529168992,4,40,endocrine process,BP,F2R;RASL10B;FGFR1;CTSZ
3250,GO:0006924,0.548510789713258,0.82908490813495,1,8,activation-induced cell death of T cells,BP,AKT1
16828,GO:0098779,0.548549525233763,0.829056584788662,1,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,PINK1
17642,GO:1901526,0.548549525233763,0.829056584788662,1,8,positive regulation of mitophagy,BP,PINK1
7567,GO:0031943,0.548808801413244,0.828866919789663,1,8,regulation of glucocorticoid metabolic process,BP,DGKQ
12208,GO:0048488,0.548915323090009,0.686667749588421,3,29,synaptic vesicle endocytosis,BP,NLGN2;SYT8;DNM1
12574,GO:0050776,0.549112429771958,0.509101530105774,54,571,regulation of immune response,BP,TNIP1;FOS;PTPRS;NR1D1;RBCK1;SERPING1;PKN1;SHC1;CTSB;PIK3R2;ZP3;RNF135;IL20RB;TMEM173;PRNP;ECM1;NPDC1;STAT6;BCL6;CD81;FCGRT;MAPK3;WIPF1;ADA;PAG1;PRKACA;CYFIP2;RPS6KA5;IFNGR2;HK1;FAM3A;BTRC;TKFC;PTAFR;VAV3;BCR;MUC19;PRKCZ;INPP5D;ICOSLG;MAPKAPK3;C5;ADGRE2;ADORA2B;ABR;NLRX1;SPPL2B;CTSH;PYCARD;KCNN4;JAK3;EREG;MIF;STXBP2
4520,GO:0010595,0.549122245143842,0.608112965538225,7,72,positive regulation of endothelial cell migration,BP,WNT7A;VEGFA;NRP2;FGFR1;PROX1;AKT1;MAP2K3
7092,GO:0030900,0.549459546884373,0.540447916923759,22,229,forebrain development,BP,PTPRS;TCTN1;EPHB2;LRP1;EGFR;BBS2;ATP2B4;TRAPPC9;WNT7A;BNIP3;SHANK3;EPHB3;HES1;MBOAT7;WNT7B;NDE1;FGFR1;PROX1;WNT2B;RTN4R;SUN1;SLC2A1
9412,GO:0035999,0.549536551765994,0.828333788322073,1,8,tetrahydrofolate interconversion,BP,MTHFR
19880,GO:2000404,0.54965760723148,0.733253332685707,2,19,regulation of T cell migration,BP,ECM1;PYCARD
12402,GO:0048873,0.54978639335251,0.733138676547516,2,19,homeostasis of number of cells within a tissue,BP,F2R;IL20RB
8225,GO:0033008,0.549790783633585,0.828147276767547,1,8,positive regulation of mast cell activation involved in immune response,BP,ADORA2B
10431,GO:0043306,0.549790783633585,0.828147276767547,1,8,positive regulation of mast cell degranulation,BP,ADORA2B
16945,GO:0098993,0.549816133272296,0.828128671960789,1,8,anchored component of synaptic vesicle membrane,CC,RAB3B
3483,GO:0007369,0.549872543407803,0.571130210732296,12,123,gastrulation,BP,DUSP6;COL6A1;DUSP5;LRP5;ITGB4;VANGL2;ACVR2B;DVL1;ITGB5;HMGA2;FGFR1;WNT3
3523,GO:0007517,0.550013641806326,0.539888651735603,22,229,muscle organ development,BP,FOS;MEF2D;FHL1;EGR1;LAMA5;ZFPM1;ADARB1;SPEG;VANGL2;EVC;HBEGF;MYH3;POU6F1;RXRA;GPC1;FGFR1;PIN1;PROX1;JARID2;MEF2B;ERBB3;TAZ
11284,GO:0045624,0.550161520973154,0.82787504480677,1,8,positive regulation of T-helper cell differentiation,BP,PRKCZ
12135,GO:0048265,0.550281373372008,0.827786974174162,1,8,response to pain,BP,COMT
2566,GO:0005858,0.550627908753043,0.827532157297957,1,8,axonemal dynein complex,CC,DNAH1
935,GO:0002335,0.550733129520127,0.732294926184113,2,19,mature B cell differentiation,BP,CMTM7;ADA
5111,GO:0015485,0.550852680284085,0.684426584786443,3,30,cholesterol binding,MF,APOE;ABCG1;OSBPL5
14872,GO:0070700,0.551229841640657,0.827088925396477,1,8,BMP receptor binding,MF,PYCARD
13555,GO:0060050,0.551335398173232,0.827011118658938,1,8,positive regulation of protein glycosylation,BP,POMT1
11273,GO:0045606,0.55139357177929,0.731705401212482,2,19,positive regulation of epidermal cell differentiation,BP,CYP27B1;ALOX15B
3650,GO:0008140,0.551520034461174,0.826874963722254,1,8,cAMP response element binding protein binding,MF,CRTC1
9281,GO:0035743,0.551578396096139,0.826831911256268,1,8,CD4-positive, alpha-beta T cell cytokine production,BP,PRKCZ
18249,GO:1903147,0.551587931956354,0.826824876106355,1,8,negative regulation of autophagy of mitochondrion,BP,PINK1
5292,GO:0016004,0.55161945413702,0.826801618978842,1,8,phospholipase activator activity,MF,GM2A
13660,GO:0060229,0.55161945413702,0.826801618978842,1,8,lipase activator activity,MF,GM2A
1837,GO:0004497,0.551622485642198,0.654184401020713,4,40,monooxygenase activity,MF,CYP27B1;NOS1;CYP3A5;CYP2S1
13672,GO:0060252,0.551714608340681,0.826731401031061,1,8,positive regulation of glial cell proliferation,BP,ETV5
18787,GO:1904380,0.551774786409985,0.731364774184882,2,19,endoplasmic reticulum mannose trimming,BP,EDEM1;MAN1B1
3287,GO:0006987,0.551983410834781,0.826532935781353,1,8,activation of signaling protein activity involved in unfolded protein response,BP,ERN1
1121,GO:0002710,0.552013034369482,0.826511054260886,1,8,negative regulation of T cell mediated immunity,BP,IL20RB
14950,GO:0070886,0.552161274814635,0.826401527518335,1,8,positive regulation of calcineurin-NFAT signaling cascade,BP,ERBB3
17181,GO:0106058,0.552161274814635,0.826401527518335,1,8,positive regulation of calcineurin-mediated signaling,BP,ERBB3
3714,GO:0008242,0.552298487459398,0.82630010630947,1,8,omega peptidase activity,MF,GGT1
15965,GO:0086003,0.552655181891459,0.683147851882395,3,29,cardiac muscle cell contraction,BP,SCN4B;GPD1L;SNTA1
10283,GO:0043065,0.552755888916898,0.511390837807726,44,467,positive regulation of apoptotic process,BP,DUSP6;GSN;XDH;RBCK1;OBSCN;NFATC4;ARHGEF4;F2R;GRAMD4;RPS6KA2;NTSR1;TFDP2;PDCD4;ITGA6;PRNP;BCL6;BNIP3;ENDOG;PLEKHG5;PLEKHG2;PIDD1;PCSK9;DAP;HMGA2;VAV3;INPP5D;CTSZ;PIN1;KCNMA1;BIN1;PPM1F;ABR;PNMA1;AKT1;TP53INP1;PINK1;CTSH;PYCARD;STK17A;ARHGEF19;RARG;ING4;FAM162A;ADAMTSL4
1112,GO:0002701,0.553007275530521,0.730261768630483,2,19,negative regulation of production of molecular mediator of immune response,BP,BCL6;JAK3
14915,GO:0070830,0.553076053298005,0.652778777614935,4,40,bicellular tight junction assembly,BP,MICALL2;NPHP4;ARL2;PRKACA
11689,GO:0046503,0.553155101609372,0.682253725345789,3,30,glycerolipid catabolic process,BP,APOE;LDLR;PNPLA4
12690,GO:0050951,0.553250208203923,0.82559551825673,1,8,sensory perception of temperature stimulus,BP,NTSR1
12330,GO:0048715,0.553265564502428,0.825584133450966,1,8,negative regulation of oligodendrocyte differentiation,BP,HES1
17282,GO:0140112,0.553283818086967,0.730013914054575,2,19,extracellular vesicle biogenesis,BP,ARRDC1;SDC1
3248,GO:0006919,0.553287916353775,0.603645098688654,7,75,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,XDH;F2R;PIDD1;DAP;CTSH;PYCARD;FAM162A
7368,GO:0031432,0.553325986805036,0.825539332782167,1,8,titin binding,MF,OBSCN
73,GO:0000150,0.553373125957596,0.825504375533678,1,8,recombinase activity,MF,DMC1
9863,GO:0042148,0.553541036436348,0.825379818095947,1,8,strand invasion,BP,DMC1
248,GO:0000707,0.553541036436348,0.825379818095774,1,8,meiotic DNA recombinase assembly,BP,DMC1
4347,GO:0009952,0.553663207279392,0.567267022836314,12,124,anterior/posterior pattern specification,BP,CTNNBIP1;LRP5;SCMH1;FUZ;CELSR1;VANGL2;ACVR2B;HES1;CELSR2;WNT2B;WNT3;RARG
2510,GO:0005769,0.553804056431197,0.530609225470744,25,261,early endosome,CC,APOE;LRP1;APPL2;EGFR;F2R;ABCA7;NISCH;VPS11;RHOD;C1ORF210;MVB12B;MAPK3;PCSK9;MAP2K2;PI4K2A;EHD4;LDLR;SNX17;LDLRAP1;MIB2;LLGL1;TBC1D16;SORL1;VPS33B;LITAF
5408,GO:0016266,0.553908390017917,0.651972652017507,4,40,O-glycan processing,BP,ST6GALNAC2;GALNT12;ST3GAL3;MUC19
8988,GO:0035148,0.554015827536331,0.572146651674618,11,114,tube formation,BP,TCTN1;DEAF1;FUZ;CELSR1;VEGFA;VANGL2;DVL1;SEMA4C;SUFU;PROX1;RARG
9312,GO:0035809,0.554036218058398,0.8250121321805,1,8,regulation of urine volume,BP,ADCY6
3895,GO:0008544,0.554122496015436,0.530171812769649,25,268,epidermis development,BP,PPL;CYP27B1;ZFP36L1;ALOX15B;EGFR;LAMA5;PRSS8;PTHLH;FUZ;FOXQ1;INSR;LCE1E;CELSR1;VANGL2;NAB2;HES1;FURIN;AQP3;ZFP36;PPARA;SLITRK6;FGFR1;ACVR1B;EREG;KRT15
740,GO:0001972,0.55431180610065,0.824807270079726,1,8,retinoic acid binding,MF,RXRA
3470,GO:0007338,0.554423718479445,0.630387602030357,5,52,single fertilization,BP,MST1R;SYT8;ZP3;CD9;HEXB
2391,GO:0005540,0.554476112522945,0.824685052203693,1,8,hyaluronic acid binding,MF,CEMIP
7018,GO:0030803,0.554612405644143,0.824583627271735,1,8,negative regulation of cyclic nucleotide biosynthetic process,BP,LTB4R2
7033,GO:0030818,0.554612405644143,0.824583627271735,1,8,negative regulation of cAMP biosynthetic process,BP,LTB4R2
3273,GO:0006959,0.554824817114371,0.601618762361141,7,80,humoral immune response,BP,PRSS3;SERPING1;ZP3;TFEB;CD81;FAM3A;C5
15384,GO:0071675,0.554898962926073,0.728563642470677,2,19,regulation of mononuclear cell migration,BP,MAPK3;TRPV4
2613,GO:0005930,0.555013660702593,0.614377461305245,6,62,axoneme,CC,DNAH1;IFT140;PRKACA;BBS1;SPATA7;GAS8
4862,GO:0014733,0.555101065347503,0.824219650594195,1,8,regulation of skeletal muscle adaptation,BP,TNNT1
2759,GO:0006183,0.555403070663989,0.821833542800545,1,9,GTP biosynthetic process,BP,NME4
3704,GO:0008227,0.555424693745453,0.823978311014241,1,8,G-protein coupled amine receptor activity,MF,HTR7
15412,GO:0071715,0.555788380467089,0.72776306004818,2,19,icosanoid transport,BP,NTSR1;MIF
17666,GO:1901571,0.555788380467089,0.72776306004818,2,19,fatty acid derivative transport,BP,NTSR1;MIF
2991,GO:0006544,0.556045580659988,0.823514657979075,1,8,glycine metabolic process,BP,GCAT
2658,GO:0006013,0.556152426524389,0.823434785083113,1,8,mannose metabolic process,BP,MAN2B2
1122,GO:0002711,0.556189949547415,0.727401143678035,2,19,positive regulation of T cell mediated immunity,BP,ZP3;PRKCZ
11490,GO:0046007,0.556203333057267,0.823396721016749,1,8,negative regulation of activated T cell proliferation,BP,PRNP
11408,GO:0045844,0.556231018603001,0.649718370024629,4,40,positive regulation of striated muscle tissue development,BP,GPC1;FGFR1;PIN1;ERBB3
12276,GO:0048636,0.556231018603001,0.649718370024629,4,40,positive regulation of muscle organ development,BP,GPC1;FGFR1;PIN1;ERBB3
17765,GO:1901863,0.556231018603001,0.649718370024629,4,40,positive regulation of muscle tissue development,BP,GPC1;FGFR1;PIN1;ERBB3
18197,GO:1903025,0.556385123541036,0.82109245782291,1,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,ID1
578,GO:0001731,0.556520383986393,0.823159526930935,1,8,formation of translation preinitiation complex,BP,RPL13A
2738,GO:0006144,0.556557880710283,0.727069294357803,2,19,purine nucleobase metabolic process,BP,XDH;ADA
7113,GO:0030948,0.556672614870043,0.823045561035812,1,8,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,EPN2
9594,GO:0036475,0.556776282685085,0.726872197543301,2,19,neuron death in response to oxidative stress,BP,ENDOG;PINK1
13806,GO:0060433,0.556830716386879,0.822927146564975,1,8,bronchus development,BP,WNT7B
7625,GO:0032045,0.556909654818707,0.822868003016105,1,8,guanyl-nucleotide exchange factor complex,CC,ULK1
6315,GO:0019992,0.556930019974822,0.8228527424903,1,8,diacylglycerol binding,MF,PLTP
16172,GO:0090232,0.556961266666371,0.822829326173701,1,8,positive regulation of spindle checkpoint,BP,NDRG1
2584,GO:0005884,0.557095539304374,0.600067659051039,7,73,actin filament,CC,ESPN;CORO1B;PKD2;WIPF1;DMTN;PRKCZ;TWF2
433,GO:0001162,0.557098058287873,0.82272678921624,1,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,ZC3H6
13685,GO:0060272,0.557499800268822,0.822425412788116,1,8,embryonic skeletal joint morphogenesis,BP,HYAL1
12816,GO:0051152,0.557517440799762,0.822412171223087,1,8,positive regulation of smooth muscle cell differentiation,BP,OLFM2
10815,GO:0044327,0.557585905074572,0.822360773224604,1,8,dendritic spine head,CC,DNM1
8781,GO:0034498,0.55783048209024,0.822177078756474,1,8,early endosome to Golgi transport,BP,EHD3
11507,GO:0046051,0.5579296960459,0.819922598862607,1,9,UTP metabolic process,BP,NME4
16108,GO:0090140,0.558004278572033,0.725762426248108,2,19,regulation of mitochondrial fission,BP,BNIP3;PINK1
1301,GO:0003143,0.558030787441561,0.647966695879278,4,40,embryonic heart tube morphogenesis,BP,PKD2;VANGL2;HES1;SUFU
3117,GO:0006704,0.558162446733191,0.821927540369028,1,8,glucocorticoid biosynthetic process,BP,DGKQ
5064,GO:0015297,0.558443241838091,0.626615933724647,5,51,antiporter activity,MF,SLC7A8;SLC22A18;SLC37A2;TMCO3;SLC9A7
15836,GO:0072584,0.558503280286601,0.82167108377451,1,8,caveolin-mediated endocytosis,BP,MAPK3
5136,GO:0015677,0.558624788753807,0.821579594376399,1,8,copper ion import,BP,ATP7B
553,GO:0001675,0.558673615850358,0.821542821049207,1,8,acrosome assembly,BP,RFX2
970,GO:0002418,0.558774742679892,0.821466642381242,1,8,immune response to tumor cell,BP,ADAM15
13452,GO:0055015,0.558777506674454,0.821464559954266,1,8,ventricular cardiac muscle cell development,BP,PROX1
15058,GO:0071071,0.558867440993195,0.82139679317031,1,8,regulation of phospholipid biosynthetic process,BP,ZP3
7027,GO:0030812,0.559381455630427,0.821009134737575,1,8,negative regulation of nucleotide catabolic process,BP,PPARA
8300,GO:0033148,0.559450425871381,0.820957074705158,1,8,positive regulation of intracellular estrogen receptor signaling pathway,BP,WBP2
9532,GO:0036310,0.559568052087278,0.820868264084229,1,8,annealing helicase activity,MF,SMARCA1
9958,GO:0042364,0.55959914631795,0.820844782106165,1,8,water-soluble vitamin biosynthetic process,BP,PNPO
10417,GO:0043281,0.559641098788518,0.545091066431385,16,173,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,GSN;XDH;PRDX5;F2R;GRAMD4;VEGFA;TNFRSF6B;PIDD1;DAP;RAG1;GAS6;PPM1F;AKT1;CTSH;PYCARD;FAM162A
20254,GO:2001256,0.559671876911702,0.820789848548237,1,8,regulation of store-operated calcium entry,BP,HOMER2
2389,GO:0005537,0.559730819510482,0.820745320545767,1,8,mannose binding,MF,BSG
12175,GO:0048368,0.559741380126495,0.820737341755561,1,8,lateral mesoderm development,BP,FGFR1
12611,GO:0050829,0.559835651194791,0.722085509662219,2,22,defense response to Gram-negative bacterium,BP,IL6R;PYCARD
1303,GO:0003149,0.560014085953737,0.820531221065616,1,8,membranous septum morphogenesis,BP,VANGL2
6729,GO:0030157,0.560055100927041,0.820500206329104,1,8,pancreatic juice secretion,BP,STK39
18209,GO:1903044,0.560174973231135,0.820409539937811,1,8,protein localization to membrane raft,BP,REEP2
15369,GO:0071649,0.560340908931739,0.820283980859305,1,8,regulation of chemokine (C-C motif) ligand 5 production,BP,TRPV4
7791,GO:0032352,0.560360879402301,0.82026886564771,1,8,positive regulation of hormone metabolic process,BP,EGR1
13633,GO:0060174,0.560375727519333,0.82025762686213,1,8,limb bud formation,BP,WNT3
9782,GO:0040019,0.560424061549739,0.723567802587148,2,19,positive regulation of embryonic development,BP,HES1;WNT2B
9781,GO:0040018,0.560424888625302,0.72356705069686,2,19,positive regulation of multicellular organism growth,BP,BBS2;SH3PXD2B
565,GO:0001707,0.560507125492917,0.64554956664248,4,40,mesoderm formation,BP,ITGB4;HMGA2;FGFR1;WNT3
3516,GO:0007498,0.560508833713072,0.596767407848752,7,72,mesoderm development,BP,ZFP36L1;ITGB4;VEGFA;ACVR2B;HMGA2;FGFR1;WNT3
7777,GO:0032329,0.560523040715314,0.820146096739234,1,8,serine transport,BP,SERINC2
15408,GO:0071709,0.560563958463934,0.723440605676887,2,19,membrane assembly,BP,NLGN2;ANK3
14106,GO:0061000,0.560668115549333,0.820036214477967,1,8,negative regulation of dendritic spine development,BP,PTPRS
1321,GO:0003174,0.560668130323834,0.820036203288352,1,8,mitral valve development,BP,ZFPM1
11600,GO:0046325,0.560777517411908,0.819953320840436,1,8,negative regulation of glucose import,BP,GRB10
14938,GO:0070861,0.560856369887226,0.723174627489895,2,19,regulation of protein exit from endoplasmic reticulum,BP,EDEM1;SORL1
2572,GO:0005868,0.560858321524932,0.72242787505325,2,20,cytoplasmic dynein complex,CC,NUDCD3;WDR60
13506,GO:0055117,0.560919815409761,0.644876402325844,4,41,regulation of cardiac muscle contraction,BP,NOS1;PRKACA;EHD3;GSTM2
19845,GO:2000353,0.561132709959323,0.819684009755975,1,8,positive regulation of endothelial cell apoptotic process,BP,PDCD4
16730,GO:0098542,0.561164823868916,0.524679725927169,24,260,defense response to other organism,BP,HTRA1;SHC1;ACP5;ADARB1;TMEM173;ISG20;BNIP3;CEBPB;MAPK3;WIPI2;LRSAM1;IL6R;MAPKBP1;VGF;TNFRSF1A;FAM3A;TKFC;GSDMC;APOBEC3C;LYST;GSDMA;NLRX1;PYCARD;APOBEC3F
19487,GO:1990403,0.561245883919293,0.819598141403922,1,8,embryonic brain development,BP,IFT140
8778,GO:0034483,0.561275184239063,0.819575905792802,1,8,heparan sulfate sulfotransferase activity,MF,NDST2
10708,GO:0044065,0.561361300121641,0.819510542642361,1,8,regulation of respiratory system process,BP,NLGN2
3222,GO:0006883,0.561374912430803,0.819500209208637,1,8,cellular sodium ion homeostasis,BP,ATP12A
20181,GO:2001135,0.561414608964461,0.819470072275596,1,8,regulation of endocytic recycling,BP,SORL1
7627,GO:0032049,0.561474156470149,0.819424858284157,1,8,cardiolipin biosynthetic process,BP,TAZ
13740,GO:0060346,0.5614840515283,0.819417344276754,1,8,bone trabecula formation,BP,THBS3
3313,GO:0007028,0.561681311939031,0.819267505530279,1,8,cytoplasm organization,BP,ZMIZ1
4147,GO:0009218,0.561711607198177,0.721649455239559,2,20,pyrimidine ribonucleotide metabolic process,BP,NME4;UCKL1
11879,GO:0046929,0.561943829927394,0.819067963667272,1,8,negative regulation of neurotransmitter secretion,BP,ASIC1
5728,GO:0016885,0.562009453777252,0.819018058657474,1,8,ligase activity, forming carbon-carbon bonds,MF,PC
15801,GO:0072530,0.562060107306946,0.818979531615928,1,8,purine-containing compound transmembrane transport,BP,SLC28A2
1478,GO:0003774,0.562137074674459,0.576898632895325,9,94,motor activity,MF,DNAH1;KIF13B;MYH16;MYH3;WDR60;PIN1;WDR63;KIFC2;KIF26B
2329,GO:0005351,0.562196097404821,0.81887606952004,1,8,carbohydrate:proton symporter activity,MF,SLC2A9
8009,GO:0032655,0.562208064492683,0.673633698641764,3,30,regulation of interleukin-12 production,BP,ACP5;MEFV;JAK3
8179,GO:0032933,0.562228122705584,0.818851698517374,1,8,SREBP signaling pathway,BP,ARHGEF10L
15282,GO:0071501,0.562228122705584,0.818851698517374,1,8,cellular response to sterol depletion,BP,ARHGEF10L
15539,GO:0072015,0.562429455800703,0.818698433542872,1,8,glomerular visceral epithelial cell development,BP,LAMB2
15709,GO:0072310,0.562429455800703,0.818698433542872,1,8,glomerular epithelial cell development,BP,LAMB2
9656,GO:0038034,0.562448013019346,0.622462418366868,5,52,signal transduction in absence of ligand,BP,MKNK2;STRADB;FGFR1;ERBB3;AKT1
16467,GO:0097192,0.562448013019346,0.622462418366868,5,52,extrinsic apoptotic signaling pathway in absence of ligand,BP,MKNK2;STRADB;FGFR1;ERBB3;AKT1
14334,GO:0061577,0.562549411134723,0.818607074733692,1,8,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,NOS1
15202,GO:0071385,0.562562294842095,0.643267215720171,4,41,cellular response to glucocorticoid stimulus,BP,ZFP36L1;EGFR;ZFP36;PCK2
17224,GO:0120033,0.562585665891381,0.721598547867317,2,19,negative regulation of plasma membrane bounded cell projection assembly,BP,EVI5L;PLXNB3
7504,GO:0031701,0.562635524634912,0.818541470424964,1,8,angiotensin receptor binding,MF,ARAP1
5886,GO:0018095,0.56266824654191,0.818516537400851,1,8,protein polyglutamylation,BP,TTLL11
9606,GO:0036490,0.562687356101997,0.818501975449057,1,8,regulation of translation in response to endoplasmic reticulum stress,BP,SESN2
16119,GO:0090160,0.562690873579576,0.818499294954158,1,8,Golgi to lysosome transport,BP,EHD3
6700,GO:0030120,0.562867454637295,0.622046053418203,5,52,vesicle coat,CC,EGFR;AP2A2;LDLRAP1;CLTCL1;EPN2
18573,GO:1903867,0.562901420568066,0.818338797667213,1,8,extraembryonic membrane development,BP,HTRA1
18766,GO:1904321,0.562929681511219,0.818317247219529,1,8,response to forskolin,BP,ADCY6
18767,GO:1904322,0.562929681511219,0.818317247219529,1,8,cellular response to forskolin,BP,ADCY6
1625,GO:0004065,0.563030051986965,0.818240695158948,1,8,arylsulfatase activity,MF,SULF2
10393,GO:0043249,0.563123164268504,0.81816965888419,1,8,erythrocyte maturation,BP,FAM210B
15111,GO:0071233,0.563376737531688,0.817976107708996,1,8,cellular response to leucine,BP,SESN2
18080,GO:1902745,0.563466250586044,0.720793936984058,2,19,positive regulation of lamellipodium organization,BP,CORO1B;TWF2
2433,GO:0005639,0.563507965440333,0.817875886012725,1,8,integral component of nuclear inner membrane,CC,SUN1
7250,GO:0031229,0.563507965440333,0.817875886012725,1,8,intrinsic component of nuclear inner membrane,CC,SUN1
10889,GO:0044453,0.563507965440333,0.817875886012725,1,8,nuclear membrane part,CC,SUN1
12945,GO:0051353,0.563558091457881,0.671937562195836,3,31,positive regulation of oxidoreductase activity,BP,APOE;CYP27B1;AKT1
10250,GO:0043008,0.563621491990431,0.817789152352811,1,8,ATP-dependent protein binding,MF,PRNP
18339,GO:1903362,0.563645211387139,0.532647990298875,19,202,regulation of cellular protein catabolic process,BP,APOE;LRP1;RHBDF1;EDEM1;VPS11;CSNK1E;CD81;DVL1;FURIN;PCSK9;PRKACA;MAGEF1;LDLR;BTRC;SUFU;RAD23A;AKT1;PINK1;PKD1
18777,GO:1904354,0.563748318445428,0.817692223747247,1,8,negative regulation of telomere capping,BP,ERCC1
7994,GO:0032634,0.563768626411287,0.81767669982306,1,8,interleukin-5 production,BP,PRKCZ
8018,GO:0032674,0.563768626411287,0.81767669982306,1,8,regulation of interleukin-5 production,BP,PRKCZ
6201,GO:0019725,0.563811074810038,0.495793424331134,51,544,cellular homeostasis,BP,CEMIP;APOE;GAA;PRDX5;NOS1;NR1D1;POLD4;F2R;PIK3R2;LRP5;PKD2;ITPR3;HEXB;NTSR1;ATP2B4;TXNRD3;LPAR3;PRNP;ATP7B;SLC12A7;DLG4;FGGY;ATP12A;BNIP3;LRRC8A;SHANK3;ENDOG;MAPK3;MLXIPL;PRKACA;TRPV4;HK1;GAS6;PCK2;TMEM175;TMX4;KCNMA1;VSNL1;GLRX;SLC25A27;SMDT1;CYBRD1;SLC9A7;TPCN1;PINK1;PKD1;SLC22A17;KCNN4;ERN1;GSTM2;GIPR
994,GO:0002456,0.563869382548596,0.62105062539474,5,52,T cell mediated immunity,BP,ZP3;IL20RB;SCART1;PRKCZ;CTSH
8976,GO:0035107,0.56388838820263,0.568176322299269,10,104,appendage morphogenesis,BP,LRP5;IFT140;WNT7A;TMEM107;FBXW4;MYH3;FGFR1;TMEM231;WNT3;RARG
8977,GO:0035108,0.56388838820263,0.568176322299269,10,104,limb morphogenesis,BP,LRP5;IFT140;WNT7A;TMEM107;FBXW4;MYH3;FGFR1;TMEM231;WNT3;RARG
9063,GO:0035331,0.563954755021691,0.81753437564285,1,8,negative regulation of hippo signaling,BP,WWC3
5092,GO:0015385,0.563966249724585,0.81752558363304,1,8,sodium:proton antiporter activity,MF,SLC9A7
13030,GO:0051547,0.563999938143361,0.817499814511687,1,8,regulation of keratinocyte migration,BP,HBEGF
6532,GO:0021954,0.564020200252219,0.641835873808826,4,41,central nervous system neuron development,BP,TCTN1;EPHB2;ADARB1;EPHB3
1944,GO:0004652,0.56407514534212,0.817442277515567,1,8,polynucleotide adenylyltransferase activity,MF,TUT1
13991,GO:0060742,0.56420329666094,0.817344206797233,1,8,epithelial cell differentiation involved in prostate gland development,BP,RXRA
13858,GO:0060525,0.564233165467194,0.817321343756567,1,8,prostate glandular acinus development,BP,RXRA
11097,GO:0045141,0.564257022012485,0.817303081365449,1,8,meiotic telomere clustering,BP,SUN1
16166,GO:0090220,0.564257022012485,0.817303081365449,1,8,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,SUN1
18150,GO:1902946,0.564284155182101,0.817282309148762,1,8,protein localization to early endosome,BP,SORL1
7134,GO:0030991,0.564317468094108,0.817256803696156,1,8,intraciliary transport particle A,CC,IFT140
6328,GO:0021511,0.564317468094108,0.817256803696329,1,8,spinal cord patterning,BP,SUFU
8799,GO:0034587,0.564321111844148,0.817254013771339,1,8,piRNA metabolic process,BP,TDRKH
19993,GO:2000643,0.564334648220392,0.817243649062413,1,8,positive regulation of early endosome to late endosome transport,BP,VPS11
9168,GO:0035562,0.56434508757123,0.817235655448348,1,8,negative regulation of chromatin binding,BP,NFATC4
7239,GO:0031209,0.564345621924232,0.817235246274036,1,8,SCAR complex,CC,CYFIP2
14053,GO:0060900,0.564345621924232,0.817235246273862,1,8,embryonic camera-type eye formation,BP,PROX1
15511,GO:0071936,0.564345621924232,0.817235246274036,1,8,coreceptor activity involved in Wnt signaling pathway,MF,LRP5
8191,GO:0032957,0.564345621924232,0.817235246273689,1,8,inositol trisphosphate metabolic process,BP,PTAFR
13185,GO:0051864,0.564345621924232,0.817235246273689,1,8,histone demethylase activity (H3-K36 specific),MF,KDM4B
14787,GO:0070544,0.564345621924232,0.817235246273689,1,8,histone H3-K36 demethylation,BP,KDM4B
15754,GO:0072386,0.564345621924232,0.817235246273862,1,8,plus-end-directed organelle transport along microtubule,BP,FYCO1
1420,GO:0003373,0.564345621924232,0.817235246273689,1,8,dynamin family protein polymerization involved in membrane fission,BP,DNM1
1421,GO:0003374,0.564345621924232,0.817235246273689,1,8,dynamin family protein polymerization involved in mitochondrial fission,BP,DNM1
2341,GO:0005388,0.564345621924232,0.817235246273689,1,8,calcium-transporting ATPase activity,MF,ATP2B4
2405,GO:0005583,0.564345621924232,0.817235246273862,1,8,fibrillar collagen trimer,CC,TNXB
9574,GO:0036444,0.564345621924232,0.817235246273689,1,8,calcium import into the mitochondrion,BP,SMDT1
16772,GO:0098643,0.564345621924232,0.817235246273862,1,8,banded collagen fibril,CC,TNXB
10555,GO:0043536,0.564987801190302,0.640884348478036,4,41,positive regulation of blood vessel endothelial cell migration,BP,VEGFA;FGFR1;AKT1;MAP2K3
20079,GO:2000780,0.565615433061874,0.7188243636288,2,19,negative regulation of double-strand break repair,BP,MAGEF1;HMGA2
5750,GO:0016922,0.565676101781369,0.718768645094593,2,19,ligand-dependent nuclear receptor binding,MF,RXRA;PROX1
11166,GO:0045277,0.565816635423512,0.810639939390074,1,11,respiratory chain complex IV,CC,NDUFA4L2
6830,GO:0030307,0.566384326080393,0.55947074886169,11,117,positive regulation of cell growth,BP,EGFR;HYAL1;ERBB2;DNPH1;LPAR3;VEGFA;HBEGF;TWF2;PIN1;WNT3;AKT1
3217,GO:0006875,0.567404430978201,0.515093664257328,26,278,cellular metal ion homeostasis,BP,CEMIP;APOE;NOS1;F2R;PKD2;ITPR3;HEXB;NTSR1;ATP2B4;LPAR3;PRNP;ATP7B;DLG4;ATP12A;BNIP3;PRKACA;TRPV4;KCNMA1;SLC25A27;SMDT1;CYBRD1;TPCN1;PKD1;SLC22A17;GSTM2;GIPR
9535,GO:0036314,0.567636949734396,0.716964234220801,2,19,response to sterol,BP,ABCA2;PMVK
13717,GO:0060317,0.567949271485856,0.716676191814258,2,19,cardiac epithelial to mesenchymal transition,BP,PDCD4;ADAM15
3351,GO:0007095,0.567999923579945,0.71662946078479,2,19,mitotic G2 DNA damage checkpoint,BP,BRSK1;HMGA2
11784,GO:0046688,0.568234769483595,0.714974661616611,2,21,response to copper ion,BP,PRNP;ATP7B
3539,GO:0007569,0.568737000311588,0.578321874852129,8,85,cell aging,BP,ERCC1;PDCD4;ZMIZ1;MNT;BCL6;YPEL3;HMGA2;MIF
4025,GO:0009066,0.568911023997859,0.637013559525764,4,41,aspartate family amino acid metabolic process,BP,MTHFR;ASS1;AHCYL2;GCAT
13380,GO:0052745,0.56894590267613,0.715755862671736,2,19,inositol phosphate phosphatase activity,MF,IMPA2;INPP5D
113,GO:0000242,0.569744424005006,0.715017184039793,2,19,pericentriolar material,CC,TUBG2;WDR60
3605,GO:0008053,0.56985859917053,0.714151807635386,2,20,mitochondrial fusion,BP,VAT1;BNIP3
13853,GO:0060512,0.569917343276871,0.714857072067554,2,19,prostate gland morphogenesis,BP,RXRA;RARG
16368,GO:0097014,0.571569104864225,0.597671812390231,6,63,ciliary plasm,CC,DNAH1;IFT140;PRKACA;BBS1;SPATA7;GAS8
11746,GO:0046626,0.572112890005612,0.633839273570854,4,41,regulation of insulin receptor signaling pathway,BP,IGF2;PTPRE;PRKCZ;GRB10
8003,GO:0032648,0.572404273975124,0.633549718341483,4,41,regulation of interferon-beta production,BP,PTPRS;RNF135;NLRX1;PYCARD
5043,GO:0015248,0.5727947944351,0.711420371372323,2,20,sterol transporter activity,MF,APOE;ABCG1
6770,GO:0030217,0.573365376180958,0.542499935691305,13,137,T cell differentiation,BP,ZFP36L1;EGR1;ZFPM1;ERBB2;ZMIZ1;STAT6;BCL6;FZD8;ADA;SOX13;RAG1;PRKCZ;JAK3
6456,GO:0021795,0.574045754461234,0.662175908067708,3,30,cerebral cortex cell migration,BP,EGFR;MBOAT7;SUN1
241,GO:0000506,0.574591941766498,0.80696439988953,1,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,PIGQ
11330,GO:0045685,0.575054644173552,0.630910748854904,4,41,regulation of glial cell differentiation,BP,SERPINE2;HES1;LDLR;BIN1
20072,GO:2000772,0.575207593070865,0.660631982605494,3,31,regulation of cellular senescence,BP,BCL6;YPEL3;HMGA2
17557,GO:1901214,0.575309089608758,0.520740429353064,19,202,regulation of neuron death,BP,FOS;APOE;LRP1;EGR1;F2R;SIGMAR1;SYNGAP1;PRNP;CEBPB;SSH1;PCSK9;PPARA;CTSZ;PIN1;SORL1;ERBB3;AKT1;PINK1;RILPL1
17845,GO:1902106,0.575737497368031,0.609167871404876,5,52,negative regulation of leukocyte differentiation,BP,ZFPM1;ERBB2;BCL6;INPP5D;JAK3
8498,GO:0033692,0.576152873118738,0.608748904344726,5,52,cellular polysaccharide biosynthetic process,BP,PGM1;NR1D1;IGF2;INSR;AKT1
3081,GO:0006662,0.576720130866097,0.805263945422345,1,9,glycerol ether metabolic process,BP,PEX7
7065,GO:0030865,0.576757741946536,0.62920998923407,4,41,cortical cytoskeleton organization,BP,WIPF1;TRPV4;LLGL1;EPB41L3
5667,GO:0016788,0.577059021870485,0.48124891752994,53,560,hydrolase activity, acting on ester bonds,MF,DUSP6;H6PD;PTPRS;ERCC1;NT5E;PGLS;NLGN2;ACOT7;DUSP5;BPHL;PPP2R3B;PPM1J;PLD3;PTPRU;PTPRE;ACP5;PLCD1;PLCXD1;HAGH;RNASET2;PLCD3;NT5DC1;ISG20;PFKFB2;DNASE1L1;ENDOG;EXD3;LHPP;SSH1;PLCH2;MYH3;LYPLAL1;ACOT11;ABHD17C;RAG1;DUSP7;DMC1;IMPA2;PAN2;INPP5D;PNPLA4;CES2;DUSP23;PPM1F;SBF1;ACP6;SSH3;PLPPR2;ERN1;RNASEK;NEIL1;GALNS;SULF2
9878,GO:0042178,0.577119879468035,0.804943374878863,1,9,xenobiotic catabolic process,BP,GSTM2
12336,GO:0048736,0.577479548716186,0.542962505419439,12,126,appendage development,BP,LRP5;ITGB4;IFT140;WNT7A;ITGA6;TMEM107;FBXW4;MYH3;FGFR1;TMEM231;WNT3;RARG
13632,GO:0060173,0.577479548716186,0.542962505419439,12,126,limb development,BP,LRP5;ITGB4;IFT140;WNT7A;ITGA6;TMEM107;FBXW4;MYH3;FGFR1;TMEM231;WNT3;RARG
3427,GO:0007224,0.577711948340726,0.560987734354398,9,95,smoothened signaling pathway,BP,TCTN1;IFT140;SERPINE2;FUZ;HES1;EVC;BTRC;SUFU;TMEM231
540,GO:0001659,0.579377430943124,0.705239803913941,2,20,temperature homeostasis,BP,NR1D1;NTSR1
12531,GO:0050706,0.579995087387853,0.704655803722312,2,20,regulation of interleukin-1 beta secretion,BP,HK1;PYCARD
17530,GO:1901099,0.580644000129518,0.704041494361169,2,20,negative regulation of signal transduction in absence of ligand,BP,STRADB;AKT1
20243,GO:2001240,0.580644000129518,0.704041494361169,2,20,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,STRADB;AKT1
1120,GO:0002709,0.580678871087215,0.65525064208022,3,31,regulation of T cell mediated immunity,BP,ZP3;IL20RB;PRKCZ
15945,GO:0080111,0.581418609150976,0.703307175836122,2,20,DNA demethylation,BP,APOBEC3C;APOBEC3F
19043,GO:1904950,0.581447205367794,0.549999102928122,10,108,negative regulation of establishment of protein localization,BP,IDH2;HADH;RHBDF1;F2R;RHBDF2;PFKL;MAPKBP1;DMTN;GAS6;VSNL1
2954,GO:0006497,0.581749648131057,0.549688136800448,10,108,protein lipidation,BP,ZDHHC1;WIPI2;LY6K;MDGA1;ABHD17C;PIGZ;MSLN;ZDHHC24;PIGV;PIGQ
761,GO:0002009,0.58182891457925,0.487364913071418,37,393,morphogenesis of an epithelium,BP,CTNNBIP1;PGF;TCTN1;NFATC4;EGFR;DEAF1;LAMA5;LRP5;PKD2;FUZ;FOXQ1;WNT7A;CELSR1;SPRY2;VEGFA;VANGL2;AP2A2;ETV5;DVL1;HES1;CELSR2;HBEGF;SEMA4C;BTRC;WNT7B;SUFU;RXRA;FGFR1;CTSZ;PROX1;DLG3;WNT2B;PKD1;CTSH;ARHGEF19;RARG;KIF26B
6689,GO:0030098,0.581907378678646,0.513966278757088,19,202,lymphocyte differentiation,BP,ZFP36L1;EGR1;CMTM7;HDAC5;ZFPM1;ERBB2;ZMIZ1;STAT6;BCL6;FZD8;LRRC8A;ADA;SOX13;RAG1;GAS6;PRKCZ;INPP5D;JAK3;POLM
8342,GO:0033233,0.581919670211024,0.70283158746849,2,20,regulation of protein sumoylation,BP,EGR1;TOLLIP
5374,GO:0016208,0.582058014663083,0.800952732601996,1,9,AMP binding,MF,PYGL
15940,GO:0080025,0.582879666921326,0.701919099160393,2,20,phosphatidylinositol-3,5-bisphosphate binding,MF,SH3PXD2B;WIPI2
19716,GO:2000117,0.582887009164706,0.573635972677782,7,76,negative regulation of cysteine-type endopeptidase activity,BP,CST3;PRDX5;VEGFA;TNFRSF6B;RAG1;GAS6;AKT1
13112,GO:0051704,0.58330788520401,0.453118630585235,147,1577,multi-organism process,BP,TNIP1;HTRA1;FOS;APOE;ERCC1;CST3;SHANK2;TCFL5;CYP27B1;GSN;PRSS3;PGF;NOS1;NR1D1;RBCK1;MST1R;GAMT;RAB11FIP4;EGFR;LOXL1;ULK1;CRTC1;SYT8;SHC1;F2R;DEAF1;BBS2;ACTA2;CTSB;DNAH1;ULK2;PACS2;MMP1;HDAC5;THRA;ZP3;CRTAP;HYAL1;EXOC2;FBLN1;BSG;SCMH1;PTHLH;CD9;HEXB;SERPINE2;ATP2B4;GGT1;ACP5;PDCD4;TNFRSF25;ZMIZ1;INSR;SH3PXD2B;ADARB1;TXNRD3;DNMT3A;TMEM173;EFNB3;ATG16L2;DLG4;ISG20;MYCBPAP;PHC2;BCL6;UCKL1;CHMP1B;IGFBP2;MVB12B;BNIP3;CD81;ZSCAN2;AP2A2;CEBPB;SHANK3;TNFRSF6B;MAPK3;ETV5;RAB40B;DVL1;WIPF1;WIPI2;PC;FURIN;CUL7;TNFRSF14;LRSAM1;ADA;IL6R;ZFP36;MAPKBP1;PRKACA;SPATA20;ITGB5;MAP2K2;VGF;TNFRSF1A;LDLR;IFNGR2;HMGA2;MVB12A;FAM3A;GAS6;BTRC;TKFC;COMT;PTAFR;DMC1;RXRA;PCK2;BCR;GSDMC;ADAMTS13;MAPKAPK3;AGO4;RAD23A;PROX1;BIN1;TIMP1;APOBEC3C;WNT3;LYST;ZFP41;MICALCL;SBF1;ACVR1B;GSDMA;ABR;AKT1;NLRX1;SIX5;TDRKH;SUN1;RPL39L;SPIRE2;EIF4G3;RFX2;PYCARD;MAP2K3;APOBEC3F;SLC2A1;LITAF;EREG;SHISA6;FAM50A;RPL13A;MIF
14967,GO:0070911,0.583346280937403,0.652224612740517,3,32,global genome nucleotide-excision repair,BP,ERCC1;DDB2;XPC
4830,GO:0014046,0.583918063629184,0.799434802376398,1,9,dopamine secretion,BP,PINK1
4838,GO:0014059,0.583918063629184,0.799434802376398,1,9,regulation of dopamine secretion,BP,PINK1
4037,GO:0009083,0.584749346978229,0.700137049023496,2,20,branched-chain amino acid catabolic process,BP,HMGCL;BCKDHA
16520,GO:0097306,0.584752984701414,0.621173239163038,4,41,cellular response to alcohol,BP,DNMT3A;ADCY6;AKT1;TP53INP1
15099,GO:0071218,0.58488661696731,0.70000595723883,2,20,cellular response to misfolded protein,BP,ANKZF1;POMT1
12967,GO:0051409,0.584984409104482,0.798560918402916,1,9,response to nitrosative stress,BP,DUSP6
10871,GO:0044430,0.585259149312704,0.45562330826184,113,1188,cytoskeletal part,CC,ESPN;FAM110C;CLIP2;SHANK2;RAPGEF3;GSN;NDRG1;MYZAP;MST1R;RAB11FIP4;OBSL1;BBS2;DNAH1;CORO1B;NEK9;TUBG2;MARK4;BRSK1;MICALL2;PKD2;DNM1;IFT140;KIF13B;NINL;CCDC69;NPHP4;TMOD2;ENKD1;USP20;RAB3D;SH3PXD2B;ID1;MZT2A;SPRY2;CEP250;REEP2;MYO18A;MZT2B;PLEKHH2;HOOK2;ARL2;VANGL2;NUDCD3;KCNAB2;TNNT1;DVL1;MTA1;WIPF1;FHOD1;FBF1;CUL7;MEFV;EVC;ABCA2;MYH16;MAPKBP1;PRKACA;PITPNM1;MAP2K2;SPTB;DMTN;BBS1;MYH3;TRPV4;CROCC;CCDC92;LRRC45;LDLRAP1;MVB12A;LLGL1;ADGRB2;PLEKHG6;REEP4;GSDMC;WDR60;PRKCZ;CLTCL1;CAPG;SPATA7;TWF2;CEP68;NDE1;RAD23A;C21ORF2;NICN1;BFSP1;SYNC;CAPN2;WRAP73;PROCR;SNPH;MAPRE3;ACTR1B;CCDC85B;AKT1;SEPT8;SPPL2B;GAS8;MPLKIP;RGS14;RILPL1;RANBP9;WDR63;SLC2A1;KIFC2;NEIL1;PBXIP1;ZFYVE19;SFI1;KRT15;TTLL11;KIF26B;LZTS2
8150,GO:0032897,0.585457847431139,0.699460060564059,2,20,negative regulation of viral transcription,BP,ZFP36;HMGA2
1118,GO:0002707,0.585577728526468,0.69934541912755,2,20,negative regulation of lymphocyte mediated immunity,BP,IL20RB;BCL6
7984,GO:0032615,0.585594782058882,0.650376043629569,3,31,interleukin-12 production,BP,ACP5;MEFV;JAK3
11095,GO:0045136,0.585922747097857,0.797789717472495,1,9,development of secondary sexual characteristics,BP,IRF2BPL
8980,GO:0035115,0.585934266956541,0.699004305974833,2,20,embryonic forelimb morphogenesis,BP,WNT7A;WNT3
11826,GO:0046827,0.586055912456656,0.698887869219665,2,20,positive regulation of protein export from nucleus,BP,RAPGEF3;GAS6
5345,GO:0016126,0.586354852706712,0.582481113694399,6,64,sterol biosynthetic process,BP,APOE;ABCG1;MVD;SEC14L2;PMVK;TM7SF2
2960,GO:0006506,0.586383237145808,0.649203215403593,3,32,GPI anchor biosynthetic process,BP,PIGZ;PIGV;PIGQ
14805,GO:0070570,0.586546783350328,0.698417737002582,2,20,regulation of neuron projection regeneration,BP,PTPRS;RTN4R
7449,GO:0031616,0.586686113030333,0.797160785124771,1,9,spindle pole centrosome,CC,NDE1
11757,GO:0046638,0.586941548314798,0.698039324616725,2,20,positive regulation of alpha-beta T cell differentiation,BP,ADA;PRKCZ
3392,GO:0007179,0.587032536285201,0.533028072177665,12,128,transforming growth factor beta receptor signaling pathway,BP,HTRA1;FOS;LTBP4;LTBP1;LTBP2;CDKN1C;ID1;FURIN;ITGB5;VASN;PRKCZ;PIN1
7639,GO:0032070,0.587094232917596,0.796823970828562,1,9,regulation of deoxyribonuclease activity,BP,AKT1
6115,GO:0019372,0.587140457525508,0.796785797526134,1,9,lipoxygenase pathway,BP,ALOX15B
15182,GO:0071356,0.587280792305577,0.510841790750286,18,198,cellular response to tumor necrosis factor,BP,ZFP36L1;POSTN;RBCK1;HYAL1;ADAMTS7;TNFRSF25;TNFRSF6B;MAPK3;TNFRSF14;ZFP36;TNFRSF1A;GAS6;PCK2;ADAMTS13;MADD;AKT1;SPPL2B;PYCARD
12933,GO:0051341,0.587337805572023,0.597021392501768,5,54,regulation of oxidoreductase activity,BP,APOE;CYP27B1;EGFR;ATP2B4;AKT1
992,GO:0002449,0.58748543572542,0.532511020917197,12,129,lymphocyte mediated immunity,BP,ERCC1;SERPING1;ZP3;IL20RB;STAT6;SCART1;BCL6;PRKCZ;INPP5D;C5;LYST;CTSH
11845,GO:0046872,0.587582707827632,0.440669030051322,281,2936,metal ion binding,MF,APOE;IDH2;RNPEPL1;NT5E;SYTL1;RNF44;LTBP4;PGM1;CYP27B1;GSN;CLCA2;XDH;PRSS3;NOS1;LTBP1;MARCH9;ARAP1;ZFP36L1;CGREF1;POSTN;NR1D1;ALOX15B;RBCK1;OBSCN;NME4;LRP1;LTBP2;RAB11FIP4;TIMP2;SMOC2;MMP28;B3GAT3;TCEA2;FKBP9;FHL1;LOXL1;EGR1;TRIM65;SYT8;GNAL;NPEPL1;DEAF1;PPP2R3B;CA12;S100A4;RNF208;CXXC5;DGKA;THBS3;ZMYND8;ASH2L;ZSCAN18;MMP1;S100A6;ZNF516;PEG3;NEK9;HDAC5;THRA;RPS6KA2;NMRK1;TENM2;ZFPM1;NUDT8;FBLN1;BRSK1;MICALL2;OGDHL;PKD2;CBS;TMEM129;EDEM1;ITPR3;VAT1;SALL2;MSRB2;CUL9;NINL;VPS11;GALNT12;RNF135;UNK;JADE2;CD320;ATP2B4;SNN;PHF7;ACP5;RASA4;PLCD1;AGAP1;ZFYVE21;ADAMTS7;ACAP3;GLUL;DTX3;ZKSCAN1;USP20;PEX10;ZMIZ1;ZC3H6;CELSR1;B4GAT1;POLL;NDUFS8;RABGGTA;ADARB1;ZNF692;ZNF704;ITGA6;HAGH;DNMT3A;PRNP;ATP7B;ZNF467;MARCH2;MTA3;MKNK2;PLCD3;NT5DC1;ISG20;FAM20C;PHC2;BCL6;ANKZF1;ATP12A;ZSCAN2;YPEL3;MAST4;SHANK3;ACVR2B;ADAM15;ENDOG;CAPNS2;EXD3;TNNT1;MTA1;LHPP;FYCO1;ADCY6;L3MBTL1;LTA4H;MBD1;PHYHD1;PC;YPEL2;FURIN;ZNF624;MEFV;TRIM4;NRP2;NADK;LRSAM1;ZNF414;ADA;FKBP10;TRIM45;MCTP1;PHF21A;CELSR2;ACY1;PFKL;SLIT3;ZFP36;CYHR1;F12;PITPNM1;ZNF862;ZMYM3;LRRK1;NUDT10;PLCH2;RPS6KA5;MAP2K2;PI4K2A;RNF215;EHD4;LDLR;CYP3A5;RAG1;ZNF80;EEF2K;DGKQ;ZXDC;MIB2;PADI3;GAS6;MEX3A;ZNF217;PPARA;HMGCL;TKFC;STK32C;GIT1;COMT;RFNG;IMPA2;LTBP3;PAN2;ZNF446;RXRA;PCK2;VAV3;USP21;RNF123;PRKCZ;ADAMTS13;HAGHL;HLTF;ZNF485;TPP1;GPC1;ZNF160;ARAP3;CDHR1;MAN1B1;ZNF563;ANKMY1;PHYH;IRF2BPL;PCDHGC3;ASAP2;KCNMA1;ESYT2;VSNL1;ZNF554;CAPN2;RXRB;MAN2B2;GUCA1B;ADGRE2;PITPNM3;CYBRD1;LMLN;TIMP1;APOBEC3C;ZFP41;PPM1F;EFCAB1;ACVR1B;ZSCAN30;GSS;CYP2S1;HPDL;ADAM19;ZNF385A;TUT1;PINK1;EHD3;KDM4B;LENG9;ZNF710;RSAD1;CBLC;RNF187;POMT1;TRERF1;THAP8;ERN1;ZNF319;APOBEC3F;PRIMPOL;MOCS1;SIRT3;ALKBH6;GLI4;BCKDHA;MAST3;LITAF;MZF1;NEIL1;RARG;ING4;GALNS;ZCCHC14;ZNF514;ZFYVE19;TRIM7;ZNF837;POLM;SULF2
13528,GO:0060019,0.588443720542008,0.795707443196053,1,9,radial glial cell differentiation,BP,HES1
13034,GO:0051561,0.588866637074604,0.795356641528547,1,9,positive regulation of mitochondrial calcium ion concentration,BP,BNIP3
13465,GO:0055038,0.58910966976161,0.579649630635779,6,64,recycling endosome membrane,CC,NDRG1;RAB11FIP4;EHD4;ABHD17C;SLC9A7;EHD3
504,GO:0001562,0.589263934172545,0.795026701933309,1,9,response to protozoan,BP,LYST
10195,GO:0042832,0.589263934172545,0.795026701933309,1,9,defense response to protozoan,BP,LYST
15403,GO:0071702,0.589680043175873,0.443544058349447,182,1937,organic substance transport,BP,LMF1;CEMIP;APOE;IDH2;SYTL1;LTBP4;RAPGEF3;EVI5L;NOS1;ZFP36L1;POSTN;NR1D1;ALOX15B;ARRDC1;SLCO4A1;CPT2;NME4;LRP1;LTBP2;EGFR;B3GAT3;HADH;NLGN2;TOM1L2;SLC43A1;RHBDF1;DOPEY2;F2R;ABCA7;CA12;BBS2;SLC16A5;PITPNC1;SLC16A3;TBC1D14;ABCG1;ANK3;PIK3R2;NISCH;LRP5;PLTP;SLC2A9;ERBB2;SLC13A3;EXOC2;MICALL2;BSG;TMEM129;TST;EDEM1;SLC7A8;ITPR3;PRAF2;KIF13B;SIGMAR1;VPS11;VAMP2;FUZ;NTSR1;CD320;SLC6A8;AGAP1;GM2A;GLUL;RHOD;PEX10;INSR;RAB3D;TBC1D8;TMEM173;PRNP;SERINC2;SNX33;ATG16L2;SNX9;ABCD1;REEP2;STRADB;RAB25;MYO18A;BCL6;PFKFB2;CHMP1B;MVB12B;HOOK2;ARL2;AP2A2;RHBDF2;ACVR2B;ZDHHC1;MAPK3;OLFM2;AMN;SLC22A18;RAB40B;SLC16A13;HES1;SLC48A1;SLC2A3;ABCA2;LRSAM1;ADA;OSBPL5;AQP3;RASL10B;PFKL;PCSK9;SLC28A2;ZFP36;MAPKBP1;PITPNM1;SLC38A10;RAB3B;SLC37A2;STX10;DMTN;BBS1;VGF;LDLR;SNX17;TRPV4;LDLRAP1;PEX7;MVB12A;HK1;SLC29A4;GAS6;LLGL1;PPARA;GUK1;RXRA;PCK2;LRP10;BCR;TBC1D16;PRKCZ;ZDHHC24;CLTCL1;TM7SF3;TMCO6;SRSF5;C5;ESYT2;VSNL1;UNC119B;OSCP1;SLC25A27;GRB10;SESN2;LCAT;PITPNM3;RTN2;LYST;SORL1;STK39;TBC1D17;ANO9;TSNARE1;SLC25A29;AKT1;VPS33B;PINK1;PKD1;EHD3;LONP2;SLC22A17;SPIRE2;RILPL1;PYCARD;RHBG;KCNN4;SIRT3;SLC2A1;APBA1;GIPR;PQLC2;TMED4;RPL13A;RAB40C;MIF;STXBP2;UBL5
10706,GO:0044060,0.589725014463354,0.69536289707303,2,20,regulation of endocrine process,BP,F2R;FGFR1
8014,GO:0032663,0.589975377898156,0.646000500181941,3,31,regulation of interleukin-2 production,BP,IL20RB;PRNP;ZFP36
3627,GO:0008097,0.590220766559208,0.792302454199595,1,10,5S rRNA binding,MF,TST
8117,GO:0032823,0.590467350641501,0.794025009461485,1,9,regulation of natural killer cell differentiation,BP,GAS6
17308,GO:1900015,0.590665100798555,0.694455683509896,2,20,regulation of cytokine production involved in inflammatory response,BP,PDCD4;MEFV
6677,GO:0030055,0.591461300879209,0.481321241933993,33,360,cell-substrate junction,CC,FLNC;MRC2;GSN;PARVB;GRB7;LRP1;EGFR;FHL1;SLC9A3R2;CORO1B;BSG;ITGB4;SPRY4;MPRIP;CD9;ZFYVE21;ITGA6;CD81;ARL2;MAPK3;ARHGAP22;FGFR3;ITGB5;MAP2K2;TRPV4;TSPAN4;GIT1;CAPN2;PROCR;LMLN;EHD3;ALKBH6;RPL13A
1183,GO:0002830,0.591523949559086,0.793142663001126,1,9,positive regulation of type 2 immune response,BP,PRKCZ
12977,GO:0051428,0.591530046094785,0.79313756411773,1,9,peptide hormone receptor binding,MF,PTHLH
1155,GO:0002763,0.591561054099298,0.644409228444376,3,31,positive regulation of myeloid leukocyte differentiation,BP,FOS;CTNNBIP1;ZFP36L1
11249,GO:0045577,0.591614639831721,0.693537662077153,2,20,regulation of B cell differentiation,BP,ZFP36L1;INPP5D
12888,GO:0051260,0.591719794659385,0.501377783817768,20,216,protein homooligomerization,BP,APOE;TYSND1;GPX3;KCNG1;CRTC1;KCNC4;PKD2;ITPR3;SIGMAR1;GLUL;ASIC1;PRNP;HSF4;PFKL;EHD4;RXRA;TMEM120A;EHD3;ATXN10;MIF
10790,GO:0044295,0.591723838975734,0.693431978764556,2,20,axonal growth cone,CC,MAPK8IP1;RTN4R
711,GO:0001937,0.591749277501981,0.693407356045505,2,20,negative regulation of endothelial cell proliferation,BP,APOE;XDH
13203,GO:0051894,0.592007836911136,0.693157019423859,2,20,positive regulation of focal adhesion assembly,BP,VEGFA;PPM1F
11687,GO:0046501,0.592035156783536,0.792714800486378,1,9,protoporphyrinogen IX metabolic process,BP,UROS
12942,GO:0051350,0.592383723483012,0.792422701786186,1,9,negative regulation of lyase activity,BP,LTB4R2
654,GO:0001845,0.592541650290904,0.792290262875601,1,9,phagolysosome assembly,BP,TMEM175
11576,GO:0046185,0.592596775473534,0.792244020224447,1,9,aldehyde catabolic process,BP,HAGH
14346,GO:0061608,0.592685345886374,0.792169706161669,1,9,nuclear import signal receptor activity,MF,TMCO6
5620,GO:0016709,0.592715528313816,0.692471189873878,2,20,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,CYP27B1;NOS1
16573,GO:0097428,0.592849199921809,0.790087832333942,1,10,protein maturation by iron-sulfur cluster transfer,BP,MAGEF1
15693,GO:0072283,0.593127328156219,0.7917985828493,1,9,metanephric renal vesicle morphogenesis,BP,KIF26B
4567,GO:0010662,0.593310561730875,0.691893806870707,2,20,regulation of striated muscle cell apoptotic process,BP,RGL2;BNIP3
4564,GO:0010659,0.593326444475026,0.691878386093649,2,20,cardiac muscle cell apoptotic process,BP,RGL2;BNIP3
19507,GO:1990440,0.593349840142155,0.791611565735782,1,9,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,CEBPB
20242,GO:2001239,0.59340728247675,0.642159880325588,3,32,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,STRADB;FGFR1;AKT1
18512,GO:1903729,0.593506156136672,0.791480113586575,1,9,regulation of plasma membrane organization,BP,GSN
9812,GO:0042053,0.593546974678917,0.791445777974975,1,9,regulation of dopamine metabolic process,BP,COMT
9819,GO:0042069,0.593546974678917,0.791445777974975,1,9,regulation of catecholamine metabolic process,BP,COMT
3796,GO:0008385,0.593905908318588,0.79114367790721,1,9,IkappaB kinase complex,CC,PYCARD
11240,GO:0045505,0.594139199097298,0.69037030240227,2,21,dynein intermediate chain binding,MF,DNAH1;DNAAF5
445,GO:0001205,0.594194396903309,0.691034953981435,2,20,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,MEF2D;MEF2B
8222,GO:0033005,0.594211689681801,0.790886068133287,1,9,positive regulation of mast cell activation,BP,ADORA2B
19741,GO:2000177,0.594301836946338,0.611193136631441,4,42,regulation of neural precursor cell proliferation,BP,GJC2;VEGFA;CTSZ;PROX1
408,GO:0001094,0.594331922585038,0.790784714249676,1,9,TFIID-class transcription factor binding,MF,ERCC1
17009,GO:0099513,0.594401886871468,0.468897246410536,44,467,polymeric cytoskeletal fiber,CC,ESPN;FAM110C;CLIP2;SHANK2;NDRG1;DNAH1;CORO1B;TUBG2;PKD2;DNM1;KIF13B;NINL;ENKD1;RAB3D;SPRY2;REEP2;HOOK2;KCNAB2;DVL1;MTA1;WIPF1;FBF1;MEFV;MAP2K2;DMTN;TRPV4;LDLRAP1;REEP4;PRKCZ;TWF2;NDE1;NICN1;BFSP1;SYNC;SNPH;MAPRE3;GAS8;RGS14;KIFC2;PBXIP1;KRT15;TTLL11;KIF26B;LZTS2
10461,GO:0043372,0.594491211930421,0.790650382660311,1,9,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,PRKCZ
10997,GO:0044849,0.594513510092011,0.790631573311688,1,9,estrous cycle,BP,EGR1
3403,GO:0007193,0.594584412008314,0.641364209052303,3,31,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,GNAL;ADCY6;HTR7
13456,GO:0055021,0.594683725103277,0.641263939089271,3,31,regulation of cardiac muscle tissue growth,BP,FGFR1;PIN1;JARID2
8031,GO:0032693,0.594698362405494,0.790475596942571,1,9,negative regulation of interleukin-10 production,BP,JAK3
7739,GO:0032266,0.594813021819444,0.641133373189913,3,31,phosphatidylinositol-3-phosphate binding,MF,SH3PXD2B;WIPI2;ZFYVE19
14976,GO:0070932,0.594887838772178,0.690360077962575,2,20,histone H3 deacetylation,BP,HDAC5;HDAC11
12484,GO:0050650,0.594923809131666,0.690325045803878,2,20,chondroitin sulfate proteoglycan biosynthetic process,BP,B3GAT3;XYLT2
18483,GO:1903671,0.59499413598386,0.69025654617474,2,20,negative regulation of sprouting angiogenesis,BP,HDAC5;EPN2
5717,GO:0016868,0.595257933752411,0.790002931603738,1,9,intramolecular transferase activity, phosphotransferases,MF,PGM1
17487,GO:1900746,0.595433373878262,0.789854582260421,1,9,regulation of vascular endothelial growth factor signaling pathway,BP,XDH
18006,GO:1902547,0.595433373878262,0.789854582260421,1,9,regulation of cellular response to vascular endothelial growth factor stimulus,BP,XDH
5714,GO:0016863,0.59546671592436,0.787865807246574,1,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,MIF
18555,GO:1903827,0.595474918831755,0.471582394574841,39,416,regulation of cellular protein localization,BP,CEMIP;RAPGEF3;GSN;EPHB2;LRP1;EGFR;B3GAT3;ZMYND8;ANK3;ERBB2;MICALL2;EDEM1;VPS11;VAMP2;TFDP2;CSNK1E;TMEM173;PRNP;SNX33;CEP250;KCNAB2;DVL1;HES1;SSH1;DMTN;ABHD17C;CROCC;LDLRAP1;GAS6;PIN1;OSCP1;SESN2;SORL1;AKT1;GPD1L;PINK1;SHISA6;UBL5;LZTS2
7273,GO:0031272,0.595508480417227,0.78979105052771,1,9,regulation of pseudopodium assembly,BP,CDC42EP5
7274,GO:0031274,0.595508480417227,0.78979105052771,1,9,positive regulation of pseudopodium assembly,BP,CDC42EP5
784,GO:0002043,0.595512341385691,0.789787784211751,1,9,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,VEGFA
10560,GO:0043542,0.595588312171039,0.519449727016821,13,140,endothelial cell migration,BP,APOE;PRSS3;CORO1B;HDAC5;WNT7A;ID1;VEGFA;PLEKHG5;NRP2;FGFR1;PROX1;AKT1;MAP2K3
17890,GO:1902229,0.595596614332534,0.639581036810243,3,33,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,TMEM161A;ZNF385A;MIF
18656,GO:1904029,0.595633492295322,0.560479168333792,7,76,regulation of cyclin-dependent protein kinase activity,BP,EGFR;PKD2;CDKN1C;PROX1;MAPRE3;AKT1;PKD1
14860,GO:0070673,0.596226509475886,0.7891829859366,1,9,response to interleukin-18,BP,AKT1
11485,GO:0045992,0.596415675457405,0.688869929072454,2,20,negative regulation of embryonic development,BP,FUZ;SUFU
3102,GO:0006687,0.596777750216291,0.587490964200488,5,53,glycosphingolipid metabolic process,BP,HEXB;GM2A;GLB1;ESYT2;NAGA
4756,GO:0010950,0.596819882939173,0.522638373147751,12,133,positive regulation of endopeptidase activity,BP,GSN;XDH;F2R;GRAMD4;MEFV;PIDD1;CYFIP2;DAP;PPM1F;CTSH;PYCARD;FAM162A
9748,GO:0039530,0.597010253414946,0.788517837660175,1,9,MDA-5 signaling pathway,BP,TKFC
16429,GO:0097120,0.597036871790192,0.688262787866925,2,20,receptor localization to synapse,BP,DLG4;DLG3
10668,GO:0043951,0.597093216960244,0.788447340445213,1,9,negative regulation of cAMP-mediated signaling,BP,ATP2B4
7235,GO:0031201,0.59709461572869,0.60807292737701,4,43,SNARE complex,CC,VAMP2;STX10;TSNARE1;STXBP2
9524,GO:0036294,0.597210586308446,0.513461957753859,14,155,cellular response to decreased oxygen levels,BP,NDRG1;ZFP36L1;EPAS1;EGR1;DNMT3A;BNIP3;VEGFA;ENDOG;AQP3;EEF2K;VASN;AKT1;PINK1;FAM162A
2781,GO:0006222,0.597233680533183,0.788327945014838,1,9,UMP biosynthetic process,BP,UCKL1
4107,GO:0009173,0.597233680533183,0.788327945014838,1,9,pyrimidine ribonucleoside monophosphate metabolic process,BP,UCKL1
4108,GO:0009174,0.597233680533183,0.788327945014838,1,9,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,UCKL1
11506,GO:0046049,0.597233680533183,0.788327945014838,1,9,UMP metabolic process,BP,UCKL1
3463,GO:0007292,0.597358282052217,0.558794319881745,7,75,female gamete generation,BP,ERCC1;ZP3;HEXB;ZMIZ1;DMC1;SPIRE2;EREG
12040,GO:0048011,0.597472584392222,0.687836495408542,2,20,neurotrophin TRK receptor signaling pathway,BP,SPRY2;CYFIP2
1281,GO:0003085,0.597553699335874,0.788055745943109,1,9,negative regulation of systemic arterial blood pressure,BP,NTSR1
8255,GO:0033061,0.597600926422135,0.788015554714097,1,9,DNA recombinase mediator complex,CC,DMC1
18092,GO:1902803,0.597620327119105,0.687691864789917,2,20,regulation of synaptic vesicle transport,BP,RIMS3;PINK1
6351,GO:0021542,0.597681064211075,0.787947343325147,1,9,dentate gyrus development,BP,PROX1
14139,GO:0061050,0.597709719780941,0.787922948570903,1,9,regulation of cell growth involved in cardiac muscle cell development,BP,PIN1
1134,GO:0002726,0.597932311391187,0.787733385889954,1,9,positive regulation of T cell cytokine production,BP,PRKCZ
2506,GO:0005765,0.598084369538059,0.480650231373689,28,299,lysosomal membrane,CC,TSPAN1;GAA;MARCH9;COL6A1;LRP1;VPS11;DIRC2;RAB3D;MARCH2;AP2A2;SLC48A1;ABCA2;PCSK9;TMEM9;PI4K2A;LDLR;VASN;TMEM175;ABCD4;CYBRD1;CD68;TPCN1;HGSNAT;VPS33B;SPPL2B;C12ORF66;LITAF;PQLC2
16873,GO:0098852,0.598084369538059,0.480650231373689,28,299,lytic vacuole membrane,CC,TSPAN1;GAA;MARCH9;COL6A1;LRP1;VPS11;DIRC2;RAB3D;MARCH2;AP2A2;SLC48A1;ABCA2;PCSK9;TMEM9;PI4K2A;LDLR;VASN;TMEM175;ABCD4;CYBRD1;CD68;TPCN1;HGSNAT;VPS33B;SPPL2B;C12ORF66;LITAF;PQLC2
930,GO:0002328,0.598115478798734,0.787577306611061,1,9,pro-B cell differentiation,BP,HES1
11341,GO:0045723,0.598392730757118,0.787340900471703,1,9,positive regulation of fatty acid biosynthetic process,BP,MLXIPL
17770,GO:1901881,0.598422237162062,0.787315729981481,1,9,positive regulation of protein depolymerization,BP,TRPV4
10312,GO:0043123,0.598709499765585,0.516157391118736,13,141,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,RBCK1;F2R;S100A4;CXXC5;SLC20A1;ECM1;PLEKHG5;TNFRSF1A;MIB2;AKT1;PINK1;LITAF;TMED4
8728,GO:0034393,0.598878430380372,0.786926302079996,1,9,positive regulation of smooth muscle cell apoptotic process,BP,PDCD4
17815,GO:1902018,0.599034102093083,0.786793296644074,1,9,negative regulation of cilium assembly,BP,EVI5L
17022,GO:0099528,0.599082306206742,0.786752099138972,1,9,G-protein coupled neurotransmitter receptor activity,MF,HTR7
7053,GO:0030852,0.59917963587676,0.786668899243228,1,9,regulation of granulocyte differentiation,BP,INPP5D
2576,GO:0005874,0.599261699971762,0.475613948069923,31,330,microtubule,CC,FAM110C;CLIP2;NDRG1;DNAH1;TUBG2;DNM1;KIF13B;NINL;ENKD1;RAB3D;SPRY2;REEP2;HOOK2;KCNAB2;DVL1;MTA1;MEFV;MAP2K2;TRPV4;REEP4;NDE1;NICN1;SNPH;MAPRE3;GAS8;RGS14;KIFC2;PBXIP1;TTLL11;KIF26B;LZTS2
10591,GO:0043588,0.59927838186765,0.48922899269704,22,240,skin development,BP,PPL;CYP27B1;ZFP36L1;ALOX15B;EGFR;LAMA5;PRSS8;ITGB4;FUZ;FOXQ1;LCE1E;CELSR1;ITGA6;VANGL2;FURIN;AQP3;ZFP36;SUFU;ACVR1B;PKD1;EREG;KRT15
11749,GO:0046629,0.599465023349746,0.786424808649888,1,9,gamma-delta T cell activation,BP,SOX13
16783,GO:0098659,0.599583540297661,0.636297446499863,3,31,inorganic cation import across plasma membrane,BP,ATP2B4;PRNP;SLC9A7
17049,GO:0099587,0.599583540297661,0.636297446499863,3,31,inorganic ion import across plasma membrane,BP,ATP2B4;PRNP;SLC9A7
13543,GO:0060038,0.599773032749902,0.636104606547594,3,31,cardiac muscle cell proliferation,BP,RXRA;FGFR1;JARID2
3886,GO:0008532,0.600096147786967,0.785884300114897,1,9,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,B4GAT1
2234,GO:0005149,0.600120831586801,0.785863140469529,1,9,interleukin-1 receptor binding,MF,TOLLIP
8138,GO:0032878,0.600183191574187,0.68517635451269,2,20,regulation of establishment or maintenance of cell polarity,BP,GSN;LLGL1
10658,GO:0043922,0.600275750818584,0.785730305129627,1,9,negative regulation by host of viral transcription,BP,HMGA2
5948,GO:0018342,0.600349558714563,0.785666997841561,1,9,protein prenylation,BP,RABGGTA
16539,GO:0097354,0.600349558714563,0.785666997841561,1,9,prenylation,BP,RABGGTA
15423,GO:0071772,0.600402815784814,0.537443807320986,9,96,response to BMP,BP,HTRA1;EGR1;ADAMTS7;PDCD4;ID1;ACVR2B;MAPK3;HES1;NEO1
15424,GO:0071773,0.600402815784814,0.537443807320986,9,96,cellular response to BMP stimulus,BP,HTRA1;EGR1;ADAMTS7;PDCD4;ID1;ACVR2B;MAPK3;HES1;NEO1
12166,GO:0048332,0.600405237576622,0.604916836410383,4,42,mesoderm morphogenesis,BP,ITGB4;HMGA2;FGFR1;WNT3
3451,GO:0007271,0.600635447688193,0.78542165548938,1,9,synaptic transmission, cholinergic,BP,APOE
6649,GO:0030011,0.60064475028189,0.785413668867919,1,9,maintenance of cell polarity,BP,LRCH4
10231,GO:0042983,0.600955866167207,0.785146441427354,1,9,amyloid precursor protein biosynthetic process,BP,ABCA7
10232,GO:0042984,0.600955866167207,0.785146441427354,1,9,regulation of amyloid precursor protein biosynthetic process,BP,ABCA7
4558,GO:0010649,0.600976210701664,0.785128958537691,1,9,regulation of cell communication by electrical coupling,BP,ANK3
1178,GO:0002825,0.600998301921268,0.785109973493283,1,9,regulation of T-helper 1 type immune response,BP,JAK3
15777,GO:0072498,0.601169314058658,0.784962966082307,1,9,embryonic skeletal joint development,BP,HYAL1
9778,GO:0040015,0.601181073786629,0.784952854397427,1,9,negative regulation of multicellular organism growth,BP,BBS2
8243,GO:0033036,0.60119839528558,0.42976268886716,214,2273,macromolecule localization,BP,LMF1;CEMIP;APOE;MARVELD1;IDH2;SYTL1;RAPGEF3;GSN;EVI5L;LTBP1;ZFP36L1;TCTN1;POSTN;NR1D1;ALOX15B;ARRDC1;EPHB2;OBSCN;CPT2;NME4;LRP1;LTBP2;OBSL1;EGFR;B3GAT3;HADH;NLGN2;TOM1L2;MDFI;ULK1;RHBDF1;DOPEY2;F2R;ABCA7;LAMA5;BBS2;PITPNC1;CORO1B;MALL;ZMYND8;TBC1D14;PACS2;MXI1;ABCG1;ANK3;PIK3R2;THRA;LRP5;PLTP;ERBB2;EXOC2;MICALL2;BSG;PTPRU;PKD2;TMEM129;TST;EDEM1;ITPR3;PRAF2;IFT140;KIF13B;SIGMAR1;HEXB;VPS11;VAMP2;FUZ;NTSR1;TFDP2;CSNK1E;AGAP1;GM2A;GLUL;RHOD;PEX10;WNT7A;RAB3D;SH3PXD2B;TBC1D8;ID1;CELSR1;SYNGAP1;TMEM173;PRNP;SNX33;CEP250;ATG16L2;SNX9;DLG4;ABCD1;REEP2;STRADB;RAB25;MYO18A;TMEM107;BCL6;PFKFB2;CHMP1B;MVB12B;CD81;HOOK2;ARL2;VANGL2;AP2A2;RHBDF2;SHANK3;ACVR2B;NUDCD3;ZDHHC1;MAPK3;TUB;KCNAB2;ETV5;OLFM2;AMN;RAB40B;DVL1;WIPI2;HES1;SSH1;ABCA2;LRSAM1;OSBPL5;PFKL;PCSK9;ZFP36;MAPKBP1;PITPNM1;RAB3B;STX10;TSPAN33;DMTN;BBS1;VGF;TNFRSF1A;LDLR;SNX17;ABHD17C;TRPV4;CROCC;LDLRAP1;PEX7;MVB12A;HK1;GAS6;LLGL1;PPARA;GUK1;TTC7B;SUFU;RXRA;PCK2;LRP10;BCR;TBC1D16;PRKCZ;ZDHHC24;CLTCL1;TM7SF3;TMCO6;SPATA7;TWF2;SRSF5;CEP68;PIN1;C5;WBP2;DLG3;ESYT2;VSNL1;UNC119B;OSCP1;SESN2;TOLLIP;TMEM231;MAPRE3;LCAT;PITPNM3;EPB41L3;RTN2;LYST;SORL1;TBC1D17;ANO9;TSNARE1;AKT1;SEPT8;ZNF385A;VPS33B;GPD1L;SUN1;PINK1;GAS8;PKD1;EHD3;LONP2;SYNE3;SPIRE2;RILPL1;PYCARD;KCNN4;SIRT3;C12ORF66;SLC2A1;APBA1;SHISA6;GIPR;TMED4;RPL13A;RAB40C;MIF;STXBP2;UBL5;LZTS2
15342,GO:0071609,0.601409427520176,0.784756435163918,1,9,chemokine (C-C motif) ligand 5 production,BP,TRPV4
14972,GO:0070922,0.601451465183329,0.78472026229182,1,9,small RNA loading onto RISC,BP,AGO4
9766,GO:0039702,0.601652127041685,0.682999973644221,2,21,viral budding via host ESCRT complex,BP,CHMP1B;MVB12A
7295,GO:0031307,0.60168938978307,0.682963149497948,2,21,integral component of mitochondrial outer membrane,CC,BNIP3;PINK1
6703,GO:0030123,0.601937680573083,0.784301562804538,1,9,AP-3 adaptor complex,CC,VPS33B
3537,GO:0007567,0.601974936553054,0.784269456081419,1,9,parturition,BP,PTAFR
2438,GO:0005652,0.602013589019292,0.784236142257971,1,9,nuclear lamina,CC,HLCS
16244,GO:0090335,0.602043115948994,0.784210691068471,1,9,regulation of brown fat cell differentiation,BP,TRPV4
3544,GO:0007586,0.602273504171336,0.602728978242988,4,43,digestion,BP,PRSS3;LDLR;STK39;KCNN4
4429,GO:0010310,0.602367576832266,0.783930874914693,1,9,regulation of hydrogen peroxide metabolic process,BP,PINK1
12846,GO:0051195,0.602613276412527,0.783718809322908,1,9,negative regulation of cofactor metabolic process,BP,PPARA
14389,GO:0061700,0.602619334443547,0.783713578689822,1,9,GATOR2 complex,CC,SESN2
4873,GO:0014745,0.602741279191112,0.783608269667939,1,9,negative regulation of muscle adaptation,BP,ATP2B4
16144,GO:0090192,0.602809480327848,0.783549356470087,1,9,regulation of glomerulus development,BP,EGR1
20200,GO:2001170,0.602862559166495,0.783503498166539,1,9,negative regulation of ATP biosynthetic process,BP,PPARA
8111,GO:0032813,0.602933988135161,0.632482273411594,3,32,tumor necrosis factor receptor superfamily binding,MF,PIDD1;MADD;TRAP1
265,GO:0000733,0.603015826588988,0.783371041127386,1,9,DNA strand renaturation,BP,SMARCA1
164,GO:0000340,0.603025112809259,0.783363013901267,1,9,RNA 7-methylguanosine cap binding,MF,CYFIP2
11367,GO:0045765,0.603065286247681,0.500442382768503,16,172,regulation of angiogenesis,BP,RAPGEF3;PGF;HDAC5;HYAL1;ERBB2;ID1;EPHA1;SPRY2;ECM1;VEGFA;HMGA2;ADGRB2;C5;VEGFB;CTSH;EPN2
8308,GO:0033160,0.603144268812001,0.783259993681735,1,9,positive regulation of protein import into nucleus, translocation,BP,TMEM173
4695,GO:0010867,0.603288603574113,0.783135157146472,1,9,positive regulation of triglyceride biosynthetic process,BP,LDLR
15890,GO:0072698,0.603310733676603,0.601910753964587,4,42,protein localization to microtubule cytoskeleton,BP,CEP250;NUDCD3;DVL1;ABHD17C
8961,GO:0035068,0.603385674456735,0.783051170509426,1,9,micro-ribonucleoprotein complex,CC,AGO4
10554,GO:0043535,0.60353514063619,0.56454365953375,6,65,regulation of blood vessel endothelial cell migration,BP,APOE;HDAC5;VEGFA;FGFR1;AKT1;MAP2K3
15303,GO:0071548,0.603589081642049,0.631811472580265,3,32,response to dexamethasone,BP,EGFR;PTAFR;PCK2
8010,GO:0032656,0.603595802972926,0.782869285179632,1,9,regulation of interleukin-13 production,BP,PRKCZ
9021,GO:0035253,0.603804792722934,0.78268827672131,1,9,ciliary rootlet,CC,CROCC
1307,GO:0003157,0.603921875851837,0.782586822199217,1,9,endocardium development,BP,PROX1
2457,GO:0005677,0.603971613113558,0.782543713697522,1,9,chromatin silencing complex,CC,BAHCC1
2968,GO:0006517,0.6039760935735,0.631414856790855,3,32,protein deglycosylation,BP,EDEM1;MAN1B1;MAN2B2
10150,GO:0042754,0.60408013946392,0.782449629890734,1,9,negative regulation of circadian rhythm,BP,ADA
10225,GO:0042975,0.604120526198151,0.782414610287332,1,9,peroxisome proliferator activated receptor binding,MF,NFATC4
3160,GO:0006779,0.604142879173782,0.680532662151401,2,21,porphyrin-containing compound biosynthetic process,BP,UROS;RSAD1
5646,GO:0016755,0.604240779098409,0.782310314165734,1,9,transferase activity, transferring amino-acyl groups,MF,GGT1
2514,GO:0005774,0.604375381767548,0.46913656727624,32,343,vacuolar membrane,CC,TSPAN1;GAA;MARCH9;COL6A1;LRP1;ULK1;VPS11;DIRC2;RAB3D;ATG16L2;MARCH2;AP2A2;SLC48A1;ABCA2;PCSK9;TMEM9;PI4K2A;LDLR;VASN;TMEM175;ABCD4;MAN2B2;CYBRD1;CD68;TPCN1;HGSNAT;VPS33B;SPPL2B;SLC22A17;C12ORF66;LITAF;PQLC2
18806,GO:1904424,0.604388351264515,0.782182274669352,1,9,regulation of GTP binding,BP,GPSM1
14293,GO:0061478,0.604459518910577,0.782120507396895,1,9,response to platelet aggregation inhibitor,BP,ADCY6
17771,GO:1901888,0.604473718992779,0.563699638118398,6,64,regulation of cell junction assembly,BP,NPHP4;RHOD;VEGFA;PRKACA;DMTN;PPM1F
17283,GO:0140115,0.604564015909186,0.782029790307074,1,9,export across plasma membrane,BP,ATP12A
13149,GO:0051781,0.604633465207249,0.579142877365754,5,54,positive regulation of cell division,BP,PGF;IGF2;VEGFA;VEGFB;EREG
4851,GO:0014075,0.604640683428861,0.680038109224343,2,21,response to amine,BP,UROS;ADAMTS13
7929,GO:0032530,0.604711180096247,0.781901986361058,1,9,regulation of microvillus organization,BP,TWF2
5149,GO:0015697,0.604961158467417,0.781684770237684,1,9,quaternary ammonium group transport,BP,SLC25A29
19677,GO:2000042,0.605022081840411,0.781631807882079,1,9,negative regulation of double-strand break repair via homologous recombination,BP,MAGEF1
7440,GO:0031588,0.605057669380703,0.78160086637386,1,9,nucleotide-activated protein kinase complex,CC,SESN2
8236,GO:0033028,0.605091751645626,0.67958957367066,2,21,myeloid cell apoptotic process,BP,THRA;MIF
11340,GO:0045722,0.605110854861463,0.781554618484458,1,9,positive regulation of gluconeogenesis,BP,PPARA
9303,GO:0035791,0.605183227707762,0.781491674718286,1,9,platelet-derived growth factor receptor-beta signaling pathway,BP,LRP1
1422,GO:0003376,0.605208858200077,0.781469380354788,1,9,sphingosine-1-phosphate signaling pathway,BP,S1PR2
16294,GO:0090520,0.605208858200077,0.781469380354788,1,9,sphingolipid mediated signaling pathway,BP,S1PR2
8473,GO:0033643,0.605238166682518,0.781443884726998,1,9,host cell part,CC,PI4K2A
3289,GO:0006991,0.605431370075929,0.781275762244544,1,9,response to sterol depletion,BP,ARHGEF10L
15567,GO:0072075,0.605483339132772,0.781230523697732,1,9,metanephric mesenchyme development,BP,PKD2
12987,GO:0051446,0.605520490486333,0.781198179677576,1,9,positive regulation of meiotic cell cycle,BP,INSR
4845,GO:0014067,0.605565751864779,0.781158770398497,1,9,negative regulation of phosphatidylinositol 3-kinase signaling,BP,SERPINE2
15311,GO:0071560,0.605576102788099,0.50115478611167,15,162,cellular response to transforming growth factor beta stimulus,BP,HTRA1;FOS;LTBP4;LTBP1;ZFP36L1;POSTN;LTBP2;CDKN1C;WNT7A;ID1;FURIN;ITGB5;VASN;PRKCZ;PIN1
13814,GO:0060442,0.605586145574438,0.781141011834329,1,9,branching involved in prostate gland morphogenesis,BP,RXRA
13670,GO:0060249,0.605679602574164,0.475572743516414,26,285,anatomical structure homeostasis,BP,ERCC1;GAA;POLD4;EPAS1;EGFR;F2R;BBS2;NPHP4;ACP5;RAB3D;IL20RB;FGGY;VEGFA;MAPK3;TUB;LRRK1;BBS1;CROCC;INPP5D;SPATA7;TPP1;CDHR1;STK39;ERCC6;HOMER2;CTSH
13874,GO:0060546,0.605907052242769,0.780861433794658,1,9,negative regulation of necroptotic process,BP,RBCK1
8909,GO:0034770,0.605985989169775,0.780792623458583,1,9,histone H4-K20 methylation,BP,KMT5C
19457,GO:1990253,0.606045887563854,0.780740398855044,1,9,cellular response to leucine starvation,BP,SESN2
3031,GO:0006590,0.606069917245968,0.780719445174956,1,9,thyroid hormone generation,BP,SLC5A5
14797,GO:0070561,0.60620601007451,0.78060074611165,1,9,vitamin D receptor signaling pathway,BP,CYP27B1
3299,GO:0007007,0.606293727478086,0.677727451902422,2,22,inner mitochondrial membrane organization,BP,PINK1;TAZ
10909,GO:0044546,0.606313201148946,0.780507222282605,1,9,NLRP3 inflammasome complex assembly,BP,MEFV
17422,GO:1900225,0.606313201148946,0.780507222282605,1,9,regulation of NLRP3 inflammasome complex assembly,BP,MEFV
2346,GO:0005416,0.606485706123988,0.780356651895913,1,9,amino acid:cation symporter activity,MF,SLC6A8
15114,GO:0071242,0.606693746435496,0.628622962330805,3,32,cellular response to ammonium ion,BP,ID1;MAPK3;PTAFR
15080,GO:0071158,0.606881759315298,0.5486198937558,7,77,positive regulation of cell cycle arrest,BP,PCBP4;PKD2;TFDP2;PIDD1;PRKACA;HMGA2;ZNF385A
15636,GO:0072182,0.606932777598576,0.779966079994029,1,9,regulation of nephron tubule epithelial cell differentiation,BP,WWTR1
2350,GO:0005451,0.606998096979905,0.7799089735187,1,9,monovalent cation:proton antiporter activity,MF,SLC9A7
6598,GO:0022821,0.606998096979905,0.779908973518525,1,9,potassium ion antiporter activity,MF,SLC9A7
16800,GO:0098719,0.606998096979905,0.779908973518525,1,9,sodium ion import across plasma membrane,BP,SLC9A7
13361,GO:0052659,0.607046864283016,0.779866330974136,1,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,INPP5D
6981,GO:0030673,0.607098389804328,0.779821270136912,1,9,axolemma,CC,EPB41L3
9116,GO:0035457,0.607239620852032,0.779697724570319,1,9,cellular response to interferon-alpha,BP,GAS6
8731,GO:0034397,0.607260195604026,0.779679722087756,1,9,telomere localization,BP,SUN1
16228,GO:0090311,0.607280471945567,0.62801864197954,3,32,regulation of protein deacetylation,BP,BCL6;VEGFA;PINK1
2615,GO:0005940,0.607302390138639,0.779642799417477,1,9,septin ring,CC,SEPT8
7201,GO:0031105,0.607302390138639,0.779642799417477,1,9,septin complex,CC,SEPT8
7688,GO:0032160,0.607302390138639,0.779642799417477,1,9,septin filament array,CC,SEPT8
7199,GO:0031103,0.60731879961347,0.627979145537136,3,32,axon regeneration,BP,PTPRS;LAMB2;RTN4R
3772,GO:0008340,0.607322464700774,0.779625231438139,1,9,determination of adult lifespan,BP,INPP5D
3683,GO:0008195,0.607340058479842,0.779609833651492,1,9,phosphatidate phosphatase activity,MF,PLPPR2
15730,GO:0072349,0.607340058479843,0.779609833651316,1,9,modified amino acid transmembrane transporter activity,MF,SLC6A8
4155,GO:0009226,0.607888713494622,0.676799518083134,2,21,nucleotide-sugar biosynthetic process,BP,TSTA3;FUK
2819,GO:0006293,0.608109649683362,0.676578480105034,2,21,nucleotide-excision repair, preincision complex stabilization,BP,ERCC1;DDB2
2821,GO:0006295,0.608109649683362,0.676578480105034,2,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,ERCC1;DDB2
4931,GO:0014902,0.608156961550502,0.57545461585596,5,54,myotube differentiation,BP,NOS1;HDAC5;THRA;DYRK1B;CAPN2
2959,GO:0006505,0.608788042776313,0.626088746157228,3,33,GPI anchor metabolic process,BP,PIGZ;PIGV;PIGQ
17981,GO:1902476,0.608900396622245,0.626347241623667,3,32,chloride transmembrane transport,BP,CLCA2;SLC12A7;TTYH3
1471,GO:0003730,0.608953776353355,0.574618356354205,5,54,mRNA 3'-UTR binding,MF,PCBP4;ZFP36L1;ZFP36;ZNF385A;TUT1
16845,GO:0098803,0.609071679196719,0.572750780544198,5,66,respiratory chain complex,CC,NDUFS8;SDHAF4;SDHA;NDUFA4L2;NDUFV3
5812,GO:0017091,0.6094093803759,0.675276225871456,2,21,AU-rich element binding,MF,ZFP36L1;ZFP36
3547,GO:0007595,0.610305947230579,0.624893573243716,3,32,lactation,BP,XDH;ATP7B;VEGFA
20024,GO:2000677,0.610341989297775,0.624480899262811,3,33,regulation of transcription regulatory region DNA binding,BP,ID1;HMGA2;PPARA
6699,GO:0030119,0.611349833586168,0.593272468175526,4,43,AP-type membrane coat adaptor complex,CC,EGFR;AP2A2;LDLRAP1;VPS33B
17636,GO:1901505,0.611356744090768,0.623804701365,3,32,carbohydrate derivative transmembrane transporter activity,MF,SLC28A2;SLC37A2;SLC29A4
14744,GO:0070469,0.612198143439932,0.553974780003856,6,78,respiratory chain,CC,NDUFS8;SDHAF4;SDHA;NDUFA4L2;UQCR11;NDUFV3
12570,GO:0050772,0.612671601311863,0.554938740817229,6,65,positive regulation of axonogenesis,BP,PLXNB3;LPAR3;PLXNB1;VEGFA;TWF2;WNT3
3263,GO:0006942,0.613563764686477,0.590701183143703,4,44,regulation of striated muscle contraction,BP,NOS1;PRKACA;EHD3;GSTM2
5849,GO:0017158,0.613593726731857,0.59091657229298,4,43,regulation of calcium ion-dependent exocytosis,BP,SYTL1;SYT8;ZP3;RIMS3
149,GO:0000305,0.613640540346405,0.670339838791842,2,22,response to oxygen radical,BP,TXNRD3;ERCC6
3433,GO:0007249,0.613825330839859,0.480681596032659,19,207,I-kappaB kinase/NF-kappaB signaling,BP,TNIP1;RBCK1;F2R;S100A4;CXXC5;SLC20A1;ECM1;PLEKHG5;CARD19;MAPKBP1;TNFRSF1A;MIB2;BTRC;AKT1;NLRX1;PINK1;PYCARD;LITAF;TMED4
12209,GO:0048489,0.614073919889933,0.541140155763686,7,76,synaptic vesicle transport,BP,SYTL1;SYT8;DNM1;RIMS3;VAMP2;SNPH;PINK1
16598,GO:0097480,0.614073919889933,0.541140155763686,7,76,establishment of synaptic vesicle localization,BP,SYTL1;SYT8;DNM1;RIMS3;VAMP2;SNPH;PINK1
7026,GO:0030811,0.6141339332167,0.569162021741405,5,54,regulation of nucleotide catabolic process,BP,RAPGEF3;INSR;PFKFB2;MLXIPL;PPARA
14288,GO:0061462,0.614204280978954,0.620844915649946,3,32,protein localization to lysosome,BP,CD81;SORL1;C12ORF66
17461,GO:1900408,0.614222524801094,0.620448578077182,3,33,negative regulation of cellular response to oxidative stress,BP,AKT1;TRAP1;PINK1
18269,GO:1903202,0.614222524801094,0.620448578077182,3,33,negative regulation of oxidative stress-induced cell death,BP,AKT1;TRAP1;PINK1
5647,GO:0016757,0.614394352229565,0.480108192802052,19,206,transferase activity, transferring glycosyl groups,MF,NAPRT;PYGB;ST6GALNAC2;B3GAT3;PYGL;HYAL1;B4GALNT4;HEXB;GALNT12;B4GAT1;DNPH1;ST3GAL3;XYLT2;PIGZ;RFNG;PIGV;PIGQ;POMT1;ALG12
14533,GO:0070085,0.614491525895629,0.480006179596233,19,206,glycosylation,BP,LMF1;ST6GALNAC2;B3GAT3;GALNT12;ADAMTS7;MVD;B4GAT1;SRD5A3;ST3GAL3;PIGZ;RFNG;MUC19;ADAMTS13;MAN1B1;PIGV;VEGFB;POMT1;ADAMTSL4;ALG12
11230,GO:0045454,0.614908662961939,0.567831157326337,5,57,cell redox homeostasis,BP,PRDX5;NOS1;TXNRD3;TMX4;GLRX
7226,GO:0031146,0.615072577337902,0.551765532857681,6,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,FBXO2;WWTR1;FBXW4;FBXW5;BTRC;FBXL20
11350,GO:0045738,0.61529529764943,0.669337473738992,2,21,negative regulation of DNA repair,BP,MAGEF1;HMGA2
19189,GO:1905332,0.61589141465683,0.668732201391983,2,21,positive regulation of morphogenesis of an epithelium,BP,VEGFA;WNT2B
1412,GO:0003351,0.616108065989247,0.769748821993813,1,10,epithelial cilium movement,BP,GAS8
15516,GO:0071949,0.616138882782066,0.668480726038567,2,21,FAD binding,MF,PRODH;D2HGDH
4420,GO:0010259,0.616430262141944,0.668184472932368,2,21,multicellular organism aging,BP,ERCC1;INPP5D
12322,GO:0048706,0.616861609140199,0.538184735623072,7,76,embryonic skeletal system development,BP,MDFI;DEAF1;HYAL1;IFT140;FUZ;WDR60;SULF2
13153,GO:0051785,0.617082765126488,0.586991270473416,4,44,positive regulation of nuclear division,BP,IGF2;LRP5;INSR;EREG
9975,GO:0042402,0.617546414259833,0.7684461440437,1,10,cellular biogenic amine catabolic process,BP,SMOX
7968,GO:0032594,0.617603316927955,0.666990093948437,2,21,protein transport within lipid bilayer,BP,REEP2;RILPL1
15201,GO:0071384,0.617844510807953,0.586185859949612,4,44,cellular response to corticosteroid stimulus,BP,ZFP36L1;EGFR;ZFP36;PCK2
8180,GO:0032934,0.618785060359752,0.615675990580767,3,33,sterol binding,MF,APOE;ABCG1;OSBPL5
1356,GO:0003229,0.618910137214837,0.61592435428578,3,32,ventricular cardiac muscle tissue development,BP,RXRA;PROX1;PPP1R13L
4179,GO:0009265,0.619176426912903,0.766963400738413,1,10,2'-deoxyribonucleotide biosynthetic process,BP,GUK1
11629,GO:0046385,0.619176426912903,0.766963400738413,1,10,deoxyribose phosphate biosynthetic process,BP,GUK1
12906,GO:0051289,0.619254956533805,0.563385103718859,5,56,protein homotetramerization,BP,GPX3;CRTC1;PKD2;PFKL;RXRA
18226,GO:1903076,0.619925654828964,0.547107995661824,6,66,regulation of protein localization to plasma membrane,BP,EPHB2;LRP1;EGFR;PRNP;LDLRAP1;AKT1
12258,GO:0048592,0.619958219269191,0.524937616333703,8,87,eye morphogenesis,BP,EPHB2;SDK2;NAGLU;LRP5;VEGFA;PROX1;WNT2B;RARG
13147,GO:0051775,0.619967203451349,0.766241580526011,1,10,response to redox state,BP,VASN
481,GO:0001530,0.620067063973829,0.766150311986544,1,10,lipopolysaccharide binding,MF,PTAFR
252,GO:0000717,0.620232756833095,0.663620669307535,2,22,nucleotide-excision repair, DNA duplex unwinding,BP,DDB2;XPC
18277,GO:1903214,0.620273781040349,0.546606118799589,6,67,regulation of protein targeting to mitochondrion,BP,MICALL2;VPS11;HES1;OSCP1;PINK1;UBL5
9746,GO:0039528,0.620436856472084,0.664093754093172,2,21,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,TKFC;NLRX1
3708,GO:0008235,0.621144154019694,0.613575592829339,3,32,metalloexopeptidase activity,MF,RNPEPL1;NPEPL1;LTA4H
10287,GO:0043069,0.621397792923436,0.433147708939296,58,625,negative regulation of programmed cell death,BP,APOE;PRDX5;RBCK1;EPHB2;IGF2;MST1R;LRP1;EGFR;SHC1;RGL2;F2R;ERBB2;NTSR1;PDCD4;WNT7A;INSR;ID1;EPHA1;ITGA6;SYNGAP1;PRNP;SPRY2;MNT;STRADB;MYO18A;BCL6;BNIP3;VEGFA;CEBPB;TNFRSF6B;EPHB3;ADA;PIDD1;FGFR3;FGFR4;MAPK8IP1;RAG1;EEF2K;HMGA2;GAS6;PRKCZ;TM7SF3;AGO4;FGFR1;PIN1;SLC25A27;TMEM161A;TIMP1;ERBB3;AKT1;TRAP1;TMBIM4;ZNF385A;PINK1;CTSH;JAK3;RARG;MIF
1990,GO:0004715,0.621426577860156,0.613278072682153,3,32,non-membrane spanning protein tyrosine kinase activity,MF,PTK6;SRMS;JAK3
16809,GO:0098739,0.621433457017467,0.582628842740236,4,43,import across plasma membrane,BP,NTSR1;ATP2B4;PRNP;SLC9A7
12706,GO:0050995,0.621607475249516,0.7647391361909,1,10,negative regulation of lipid catabolic process,BP,AKT1
8569,GO:0034067,0.62164743355347,0.662851458760968,2,21,protein localization to Golgi apparatus,BP,OBSL1;SORL1
1341,GO:0003206,0.621988840881469,0.532726849419077,7,76,cardiac chamber morphogenesis,BP,ZFPM1;VANGL2;HES1;NRP2;RXRA;PROX1;PPP1R13L
4154,GO:0009225,0.622233010200098,0.612046479582058,3,33,nucleotide-sugar metabolic process,BP,GUK1;TSTA3;FUK
2831,GO:0006307,0.62228696930759,0.764114674214828,1,10,DNA dealkylation involved in DNA repair,BP,MPG
17272,GO:0140078,0.622538470237899,0.763883234943719,1,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,NEIL1
17273,GO:0140080,0.622538470237899,0.763883234943719,1,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,NEIL1
6460,GO:0021799,0.622611910947934,0.661859608859924,2,21,cerebral cortex radially oriented cell migration,BP,MBOAT7;SUN1
3326,GO:0007044,0.622663256628869,0.532006794928104,7,76,cell-substrate junction assembly,BP,LAMA5;ITGB4;RHOD;ITGA6;VEGFA;DMTN;PPM1F
11088,GO:0045124,0.622752043512986,0.661715343847302,2,21,regulation of bone resorption,BP,EGFR;INPP5D
4646,GO:0010800,0.622816985302687,0.661648473571302,2,21,positive regulation of peptidyl-threonine phosphorylation,BP,CEMIP;S1PR2
1177,GO:0002824,0.622836788642955,0.580886698185325,4,44,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,ZP3;STAT6;ADA;PRKCZ
11858,GO:0046888,0.622903872678859,0.61133799485033,3,33,negative regulation of hormone secretion,BP,HADH;PFKL;VSNL1
4244,GO:0009566,0.623193652970835,0.543489298985882,6,67,fertilization,BP,MST1R;SYT8;ZP3;CD9;HEXB;TDRKH
5508,GO:0016482,0.623265240186472,0.494908651398424,12,131,cytosolic transport,BP,DOPEY2;TBC1D14;VPS11;ZFYVE21;HOOK2;MAPK3;MAP2K2;STX10;CLTCL1;SORL1;TBC1D17;EHD3
20246,GO:2001243,0.624442547076813,0.529791235636004,7,79,negative regulation of intrinsic apoptotic signaling pathway,BP,MAPK8IP1;TMEM161A;AKT1;TRAP1;ZNF385A;PINK1;MIF
17321,GO:1900037,0.624689398951114,0.76189707759758,1,10,regulation of cellular response to hypoxia,BP,PINK1
15971,GO:0086009,0.624868111922457,0.659532069090631,2,21,membrane repolarization,BP,SCN4B;SNTA1
14193,GO:0061157,0.625161988005546,0.659228145435009,2,21,mRNA destabilization,BP,ZFP36L1;ZFP36
17900,GO:1902253,0.625235611146697,0.657838281404557,2,23,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,ZNF385A;MIF
11433,GO:0045910,0.625481246643104,0.658897773630234,2,21,negative regulation of DNA recombination,BP,BCL6;MAGEF1
10063,GO:0042581,0.625757436396406,0.510350752123134,9,100,specific granule,CC,TIMP2;DNASE1L1;KCNAB2;SLC2A3;CTSZ;TOLLIP;HGSNAT;CTSD;STXBP2
5841,GO:0017147,0.625901860597778,0.658462203740761,2,21,Wnt-protein binding,MF,LRP5;FZD8
4457,GO:0010460,0.626290514368285,0.760410674992431,1,10,positive regulation of heart rate,BP,ADA
7006,GO:0030730,0.626660895299299,0.760065861176358,1,10,sequestering of triglyceride,BP,PPARA
12819,GO:0051155,0.627688819710761,0.606262884708581,3,33,positive regulation of striated muscle cell differentiation,BP,THRA;PIN1;PROX1
12996,GO:0051457,0.628122382777218,0.655464960861405,2,22,maintenance of protein location in nucleus,BP,ARL2;SUN1
12130,GO:0048260,0.628307335322785,0.605604056892888,3,33,positive regulation of receptor-mediated endocytosis,BP,VEGFA;PCSK9;LDLRAP1
7294,GO:0031306,0.62867621723139,0.654887723625189,2,22,intrinsic component of mitochondrial outer membrane,CC,BNIP3;PINK1
2610,GO:0005925,0.628956888494013,0.443360928548878,32,355,focal adhesion,CC,FLNC;MRC2;GSN;PARVB;GRB7;LRP1;EGFR;FHL1;SLC9A3R2;CORO1B;BSG;SPRY4;MPRIP;CD9;ZFYVE21;ITGA6;CD81;ARL2;MAPK3;ARHGAP22;FGFR3;ITGB5;MAP2K2;TRPV4;TSPAN4;GIT1;CAPN2;PROCR;LMLN;EHD3;ALKBH6;RPL13A
11750,GO:0046631,0.629005983178593,0.537386435436779,6,66,alpha-beta T cell activation,BP,ZFPM1;STAT6;BCL6;ADA;PRKCZ;JAK3
19662,GO:2000009,0.629334136687955,0.757566304678564,1,10,negative regulation of protein localization to cell surface,BP,SNX33
14241,GO:0061337,0.630098971077273,0.536209618082897,6,66,cardiac conduction,BP,NOS1;SCN4B;ITPR3;ATP2B4;PRKACA;EHD3
417,GO:0001105,0.630229753730959,0.603552223749399,3,33,RNA polymerase II transcription coactivator activity,MF,CITED4;SOX12;WBP2
6631,GO:0023026,0.630664164559074,0.756315561898313,1,10,MHC class II protein complex binding,MF,CD81
3345,GO:0007084,0.630708021118285,0.756274238699955,1,10,mitotic nuclear envelope reassembly,BP,REEP4
647,GO:0001838,0.630711856657045,0.505113414374185,9,99,embryonic epithelial tube formation,BP,TCTN1;DEAF1;FUZ;CELSR1;VANGL2;DVL1;SEMA4C;SUFU;RARG
3682,GO:0008194,0.630834522552137,0.504981663066491,9,99,UDP-glycosyltransferase activity,MF,B3GAT3;HYAL1;B4GALNT4;HEXB;GALNT12;B4GAT1;XYLT2;RFNG;PIGQ
2108,GO:0004896,0.6309886836119,0.572155765713449,4,44,cytokine receptor activity,MF,IL20RB;IL6R;IFNGR2;IL17RD
10166,GO:0042775,0.631043738484849,0.533752360447546,6,79,mitochondrial ATP synthesis coupled electron transport,BP,NDUFS8;SDHA;UQCR11;PINK1;NDUFV3;TAZ
1071,GO:0002637,0.631401359592689,0.602298681951623,3,33,regulation of immunoglobulin production,BP,PKN1;STAT6;BCL6
17335,GO:1900076,0.631434078594364,0.550508682585998,5,55,regulation of cellular response to insulin stimulus,BP,IGF2;PIK3R2;PTPRE;PRKCZ;GRB10
11496,GO:0046033,0.631479373945318,0.755546595729445,1,10,AMP metabolic process,BP,NT5E
8344,GO:0033235,0.631770920482484,0.755271152188188,1,10,positive regulation of protein sumoylation,BP,TOLLIP
16382,GO:0097038,0.631930759049705,0.7551200445662,1,10,perinuclear endoplasmic reticulum,CC,CAPN2
13997,GO:0060749,0.632096505834877,0.754963278542594,1,10,mammary gland alveolus development,BP,VEGFA
14261,GO:0061377,0.632096505834877,0.754963278542594,1,10,mammary gland lobule development,BP,VEGFA
8023,GO:0032682,0.632441668645683,0.754636579478346,1,10,negative regulation of chemokine production,BP,MEFV
15662,GO:0072216,0.633162791627735,0.753952990550227,1,10,positive regulation of metanephros development,BP,EGR1
7637,GO:0032060,0.63319194404817,0.753925325856379,1,10,bleb assembly,BP,LPAR3
9831,GO:0042094,0.633297490003463,0.753825146913232,1,10,interleukin-2 biosynthetic process,BP,ZFP36
13202,GO:0051893,0.63335720849905,0.569600706425646,4,44,regulation of focal adhesion assembly,BP,RHOD;VEGFA;DMTN;PPM1F
16093,GO:0090109,0.63335720849905,0.569600706425646,4,44,regulation of cell-substrate junction assembly,BP,RHOD;VEGFA;DMTN;PPM1F
5426,GO:0016298,0.633405902052165,0.520361443107701,7,77,lipase activity,MF,PLD3;PLCD1;PLCD3;PLCH2;LYPLAL1;PNPLA4;CES2
762,GO:0002011,0.633644734962087,0.569289971138915,4,44,morphogenesis of an epithelial sheet,BP,WNT7A;VANGL2;DVL1;HBEGF
19023,GO:1904896,0.63381240060469,0.753335985921425,1,10,ESCRT complex disassembly,BP,CHMP1B
19025,GO:1904903,0.63381240060469,0.753335985921425,1,10,ESCRT III complex disassembly,BP,CHMP1B
2394,GO:0005544,0.633868062248139,0.599651854276041,3,33,calcium-dependent phospholipid binding,MF,SYTL1;SYT8;ESYT2
774,GO:0002031,0.633912438198041,0.753240867447463,1,10,G-protein coupled receptor internalization,BP,DNM1
10602,GO:0043616,0.634121670670842,0.599379139629293,3,33,keratinocyte proliferation,BP,ZFP36L1;ZFP36;EREG
15248,GO:0071456,0.634127146392135,0.478457650839575,13,148,cellular response to hypoxia,BP,NDRG1;ZFP36L1;EPAS1;EGR1;DNMT3A;BNIP3;VEGFA;ENDOG;AQP3;VASN;AKT1;PINK1;FAM162A
6243,GO:0019829,0.634415379900015,0.59870017261186,3,34,cation-transporting ATPase activity,MF,ATP2B4;ATP7B;ATP12A
15310,GO:0071559,0.634672306130065,0.470290156462717,15,165,response to transforming growth factor beta,BP,HTRA1;FOS;LTBP4;LTBP1;ZFP36L1;POSTN;LTBP2;CDKN1C;WNT7A;ID1;FURIN;ITGB5;VASN;PRKCZ;PIN1
11251,GO:0045579,0.63469267291613,0.752498064848603,1,10,positive regulation of B cell differentiation,BP,INPP5D
8012,GO:0032660,0.634703937131759,0.752487328902463,1,10,regulation of interleukin-17 production,BP,PRNP
2590,GO:0005891,0.634825395216177,0.752371544992628,1,10,voltage-gated calcium channel complex,CC,NOS1
14869,GO:0070696,0.635051060090307,0.752156315765809,1,10,transmembrane receptor protein serine/threonine kinase binding,MF,PYCARD
127,GO:0000266,0.635069096413974,0.598359366445545,3,33,mitochondrial fission,BP,DNM1;BNIP3;PINK1
4816,GO:0014029,0.635118279641301,0.752092177870473,1,10,neural crest formation,BP,FUZ
3410,GO:0007202,0.6351614122218,0.752051016194209,1,10,activation of phospholipase C activity,BP,EGFR
2609,GO:0005924,0.635236994501621,0.43674863604018,32,356,cell-substrate adherens junction,CC,FLNC;MRC2;GSN;PARVB;GRB7;LRP1;EGFR;FHL1;SLC9A3R2;CORO1B;BSG;SPRY4;MPRIP;CD9;ZFYVE21;ITGA6;CD81;ARL2;MAPK3;ARHGAP22;FGFR3;ITGB5;MAP2K2;TRPV4;TSPAN4;GIT1;CAPN2;PROCR;LMLN;EHD3;ALKBH6;RPL13A
551,GO:0001673,0.635257915027983,0.751958904611782,1,10,male germ cell nucleus,CC,TCFL5
4747,GO:0010934,0.635370732068793,0.751851188923216,1,10,macrophage cytokine production,BP,GAS6
18109,GO:1902855,0.635461641782086,0.751764364675327,1,10,regulation of non-motile cilium assembly,BP,WRAP73
1449,GO:0003684,0.635472975954024,0.530270267884285,6,67,damaged DNA binding,MF,ERCC1;DDB2;XPC;MPG;RAD23A;NEIL1
7139,GO:0031010,0.635528738345954,0.751700268942159,1,10,ISWI-type complex,CC,SMARCA1
865,GO:0002204,0.635891922317445,0.59747246341004,3,33,somatic recombination of immunoglobulin genes involved in immune response,BP,ERCC1;STAT6;BCL6
866,GO:0002208,0.635891922317445,0.59747246341004,3,33,somatic diversification of immunoglobulins involved in immune response,BP,ERCC1;STAT6;BCL6
11125,GO:0045190,0.635891922317445,0.59747246341004,3,33,isotype switching,BP,ERCC1;STAT6;BCL6
9621,GO:0036507,0.635913638081185,0.647286825813814,2,22,protein demannosylation,BP,EDEM1;MAN1B1
9622,GO:0036508,0.635913638081185,0.647286825813814,2,22,protein alpha-1,2-demannosylation,BP,EDEM1;MAN1B1
10788,GO:0044292,0.636063069306933,0.751189396309901,1,10,dendrite terminus,CC,MAPK8IP1
12129,GO:0048259,0.636261024409742,0.545110213162359,5,56,regulation of receptor-mediated endocytosis,BP,DLG4;VEGFA;PCSK9;LDLRAP1;ARAP3
17316,GO:1900027,0.636364989090024,0.646809236266377,2,22,regulation of ruffle assembly,BP,EPS8L1;EPS8L2
7985,GO:0032616,0.636522513125874,0.750749498544356,1,10,interleukin-13 production,BP,PRKCZ
4430,GO:0010314,0.636816250492359,0.750467954580377,1,10,phosphatidylinositol-5-phosphate binding,MF,SH3PXD2B
2362,GO:0005484,0.637267316520434,0.595623142310592,3,34,SNAP receptor activity,MF,VAMP2;STX10;TSNARE1
6054,GO:0019211,0.637298728140844,0.750004991584274,1,10,phosphatase activator activity,MF,B3GAT3
262,GO:0000730,0.637312666881416,0.749991607124363,1,10,DNA recombinase assembly,BP,DMC1
11012,GO:0045003,0.637312666881416,0.749991607124363,1,10,double-strand break repair via synthesis-dependent strand annealing,BP,DMC1
16356,GO:0090735,0.637312666881416,0.749991607124363,1,10,DNA repair complex assembly,BP,DMC1
7066,GO:0030866,0.63747912974877,0.59575837748722,3,33,cortical actin cytoskeleton organization,BP,WIPF1;LLGL1;EPB41L3
8469,GO:0033631,0.637705990324937,0.749613704304515,1,10,cell-cell adhesion mediated by integrin,BP,ADA
9825,GO:0042088,0.637764105944496,0.6453261011621,2,22,T-helper 1 type immune response,BP,STAT6;JAK3
4401,GO:0010165,0.63812030584758,0.595064720854366,3,33,response to X-ray,BP,ERCC1;HMGA2;ERCC6
7015,GO:0030800,0.638186529629235,0.749151427626241,1,10,negative regulation of cyclic nucleotide metabolic process,BP,LTB4R2
7030,GO:0030815,0.638186529629235,0.749151427626241,1,10,negative regulation of cAMP metabolic process,BP,LTB4R2
12485,GO:0050651,0.638245523187947,0.749094632279928,1,10,dermatan sulfate proteoglycan biosynthetic process,BP,B3GAT3
12489,GO:0050655,0.638245523187947,0.749094632279928,1,10,dermatan sulfate proteoglycan metabolic process,BP,B3GAT3
19787,GO:2000272,0.638371116312298,0.644681374916145,2,22,negative regulation of signaling receptor activity,BP,EPHB2;CBLC
8172,GO:0032924,0.638567444749037,0.644472683802709,2,22,activin receptor signaling pathway,BP,ACVR2B;ACVR1B
13965,GO:0060707,0.638689050501743,0.748667324588845,1,10,trophoblast giant cell differentiation,BP,MDFI
8680,GO:0034330,0.639045295699257,0.454028200369775,19,206,cell junction organization,BP,FLNC;NLGN2;SDK2;F2R;LAMA5;MICALL2;ITGB4;CD9;NPHP4;RHOD;ITGA6;VEGFA;ARL2;FBF1;PRKACA;DMTN;TRPV4;EPB41L3;PPM1F
6468,GO:0021819,0.639060211344021,0.748309320017473,1,10,layer formation in cerebral cortex,BP,MBOAT7
18077,GO:1902742,0.639162227221394,0.643839958316837,2,22,apoptotic process involved in development,BP,LRP5;SLIT3
16791,GO:0098693,0.639228081433224,0.593864606919484,3,33,regulation of synaptic vesicle cycle,BP,NLGN2;DNM1;RIMS3
2607,GO:0005922,0.639261857207468,0.748114662322303,1,10,connexin complex,CC,GJC2
1853,GO:0004520,0.639348441991346,0.562859305134205,4,45,endodeoxyribonuclease activity,MF,ERCC1;DNASE1L1;DMC1;NEIL1
13484,GO:0055082,0.639557976125302,0.425602250971114,39,428,cellular chemical homeostasis,BP,CEMIP;APOE;NOS1;NR1D1;F2R;PIK3R2;LRP5;PKD2;ITPR3;HEXB;NTSR1;ATP2B4;LPAR3;PRNP;ATP7B;DLG4;ATP12A;BNIP3;ENDOG;MAPK3;MLXIPL;PRKACA;TRPV4;HK1;GAS6;PCK2;TMEM175;KCNMA1;VSNL1;SLC25A27;SMDT1;CYBRD1;SLC9A7;TPCN1;PKD1;SLC22A17;ERN1;GSTM2;GIPR
2931,GO:0006464,0.640370030520279,0.386556985800299,291,3079,cellular protein modification process,BP,TNIP1;DUSP6;LMF1;CEMIP;APOE;PTPRS;RNF44;CST3;RAPGEF3;XDH;NOS1;LTBP1;MARCH9;ZFP36L1;ARRDC1;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;IGF2;MST1R;MAPK13;CDK18;ST6GALNAC2;OBSL1;EGFR;TIMP2;B3GAT3;FBXO2;DUSP5;FKBP9;PPP1R14A;JOSD2;LOXL1;DDB2;MTHFR;EGR1;ULK1;PKN1;SHC1;F2R;PTK6;ABCA7;PPP2R3B;PPM1J;RNF208;SHC2;ULK2;GJC2;ZMYND8;ASH2L;PLAT;PIK3R2;INO80C;NEK9;HDAC5;CRTAP;RPS6KA2;LRP5;ANO8;MARK4;ERBB2;FBLN1;BRSK1;PTPRU;PKD2;GID4;TMEM129;EDEM1;SPRY4;CDKN1C;CUL9;PTPRE;PAK6;GALNT12;RNF135;JADE2;MINK1;ATP2B4;CSNK1E;RASA4;ADAMTS7;PDCD4;TNFRSF25;DTX3;USP20;PEX10;LAMB2;WNT7A;INSR;RAB3D;LCE1E;FBXW8;ID1;GRK6;MVD;B4GAT1;RABGGTA;EPHA1;ADARB1;SYNGAP1;FBXO27;PPP1R35;LPAR3;PRNP;SRD5A3;FBXL8;FBXO41;SPRY2;HINT2;BLMH;SNX9;DLG4;SPEG;MARCH2;MTA3;MKNK2;STRADB;WWTR1;FAM20C;BCL6;DYRK1B;CD81;SRMS;FZD8;VEGFA;VANGL2;MAST4;FBXW4;SHANK3;ACVR2B;HSF4;NAB2;ZDHHC1;S1PR2;MAPK3;FBXL16;RAB40B;DVL1;MTA1;LHPP;KLHL29;ADCY6;WIPI2;PKN3;ST3GAL3;EPHB3;HES1;SSH1;MLXIPL;CUL7;TRIM4;LRSAM1;LY6K;FKBP10;CDC42EP5;PHF21A;IL6R;PCSK9;ZFP36;HLCS;FGFR3;PRKACA;ZNF862;LRRK1;DGUOK;MAGEF1;RPS6KA5;HBEGF;RAB3B;MAP2K2;FGFR4;SPTB;FBXW5;MXRA8;DMTN;MYH3;MDGA1;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;LYPLAL1;ABHD17C;TRPV4;PIGZ;RAG1;DUSP7;EEF2K;MSLN;HMGA2;DGKQ;SEMA4C;MIB2;FBXO17;PADI3;GAS6;BTRC;STK32C;WNT7B;RFNG;BCR;IGFBP4;MUC19;USP21;RNF123;PRKCZ;ADAMTS13;ZDHHC24;HLTF;MDH2;ETFB;KLHDC8B;PDK2;MAPKAPK3;RAD23A;FGFR1;CAMKK1;SPSB3;PIN1;MAN1B1;C5;KMT5C;PROX1;WBP2;DLG3;WDR83;GLRX;JARID2;SESN2;TOLLIP;ADCK5;MAN2B2;MAPRE3;DUSP23;MACROD1;MADD;RTN4R;ELFN2;PIGV;TIMP1;PIGQ;PPM1F;SBF1;SORL1;STK39;VEGFB;ACVR1B;ADORA2B;ERBB3;ZER1;AKT1;NDRG2;VPS33B;ERCC6;PCMTD2;GPD1L;IL17RD;ADCK2;SSH3;PINK1;PKD1;SNTA1;KDM4B;RGS14;CTSH;P3H4;MLST8;CBLC;RNF187;PYCARD;MAP2K3;POMT1;STK17A;ERN1;RANBP9;FBXL20;SIRT3;JAK3;MAST3;ING4;EREG;TRIM7;ADAMTSL4;TTLL11;ALG12;RAB40C;MIF;UBL5
9499,GO:0036211,0.640370030520279,0.386556985800299,291,3079,protein modification process,BP,TNIP1;DUSP6;LMF1;CEMIP;APOE;PTPRS;RNF44;CST3;RAPGEF3;XDH;NOS1;LTBP1;MARCH9;ZFP36L1;ARRDC1;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;IGF2;MST1R;MAPK13;CDK18;ST6GALNAC2;OBSL1;EGFR;TIMP2;B3GAT3;FBXO2;DUSP5;FKBP9;PPP1R14A;JOSD2;LOXL1;DDB2;MTHFR;EGR1;ULK1;PKN1;SHC1;F2R;PTK6;ABCA7;PPP2R3B;PPM1J;RNF208;SHC2;ULK2;GJC2;ZMYND8;ASH2L;PLAT;PIK3R2;INO80C;NEK9;HDAC5;CRTAP;RPS6KA2;LRP5;ANO8;MARK4;ERBB2;FBLN1;BRSK1;PTPRU;PKD2;GID4;TMEM129;EDEM1;SPRY4;CDKN1C;CUL9;PTPRE;PAK6;GALNT12;RNF135;JADE2;MINK1;ATP2B4;CSNK1E;RASA4;ADAMTS7;PDCD4;TNFRSF25;DTX3;USP20;PEX10;LAMB2;WNT7A;INSR;RAB3D;LCE1E;FBXW8;ID1;GRK6;MVD;B4GAT1;RABGGTA;EPHA1;ADARB1;SYNGAP1;FBXO27;PPP1R35;LPAR3;PRNP;SRD5A3;FBXL8;FBXO41;SPRY2;HINT2;BLMH;SNX9;DLG4;SPEG;MARCH2;MTA3;MKNK2;STRADB;WWTR1;FAM20C;BCL6;DYRK1B;CD81;SRMS;FZD8;VEGFA;VANGL2;MAST4;FBXW4;SHANK3;ACVR2B;HSF4;NAB2;ZDHHC1;S1PR2;MAPK3;FBXL16;RAB40B;DVL1;MTA1;LHPP;KLHL29;ADCY6;WIPI2;PKN3;ST3GAL3;EPHB3;HES1;SSH1;MLXIPL;CUL7;TRIM4;LRSAM1;LY6K;FKBP10;CDC42EP5;PHF21A;IL6R;PCSK9;ZFP36;HLCS;FGFR3;PRKACA;ZNF862;LRRK1;DGUOK;MAGEF1;RPS6KA5;HBEGF;RAB3B;MAP2K2;FGFR4;SPTB;FBXW5;MXRA8;DMTN;MYH3;MDGA1;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;LYPLAL1;ABHD17C;TRPV4;PIGZ;RAG1;DUSP7;EEF2K;MSLN;HMGA2;DGKQ;SEMA4C;MIB2;FBXO17;PADI3;GAS6;BTRC;STK32C;WNT7B;RFNG;BCR;IGFBP4;MUC19;USP21;RNF123;PRKCZ;ADAMTS13;ZDHHC24;HLTF;MDH2;ETFB;KLHDC8B;PDK2;MAPKAPK3;RAD23A;FGFR1;CAMKK1;SPSB3;PIN1;MAN1B1;C5;KMT5C;PROX1;WBP2;DLG3;WDR83;GLRX;JARID2;SESN2;TOLLIP;ADCK5;MAN2B2;MAPRE3;DUSP23;MACROD1;MADD;RTN4R;ELFN2;PIGV;TIMP1;PIGQ;PPM1F;SBF1;SORL1;STK39;VEGFB;ACVR1B;ADORA2B;ERBB3;ZER1;AKT1;NDRG2;VPS33B;ERCC6;PCMTD2;GPD1L;IL17RD;ADCK2;SSH3;PINK1;PKD1;SNTA1;KDM4B;RGS14;CTSH;P3H4;MLST8;CBLC;RNF187;PYCARD;MAP2K3;POMT1;STK17A;ERN1;RANBP9;FBXL20;SIRT3;JAK3;MAST3;ING4;EREG;TRIM7;ADAMTSL4;TTLL11;ALG12;RAB40C;MIF;UBL5
10546,GO:0043523,0.640417957975541,0.476410322892881,12,134,regulation of neuron apoptotic process,BP,APOE;LRP1;F2R;SIGMAR1;SYNGAP1;PRNP;CEBPB;PCSK9;CTSZ;PIN1;ERBB3;PINK1
11848,GO:0046875,0.640608493110669,0.642298351592743,2,22,ephrin receptor binding,MF,SHC1;EFNB3
13875,GO:0060547,0.640703238551644,0.746719957462508,1,10,negative regulation of necrotic cell death,BP,RBCK1
12883,GO:0051255,0.640729018312026,0.74669496013022,1,10,spindle midzone assembly,BP,CCDC69
2574,GO:0005871,0.641048845258856,0.561245839282773,4,44,kinesin complex,CC,KIF13B;NDE1;KIFC2;KIF26B
2797,GO:0006264,0.641149610883967,0.746286872126898,1,10,mitochondrial DNA replication,BP,PRIMPOL
251,GO:0000715,0.641245167146409,0.640975698600399,2,23,nucleotide-excision repair, DNA damage recognition,BP,DDB2;XPC
5628,GO:0016723,0.641443930747091,0.74600101033714,1,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,CYBRD1
11272,GO:0045605,0.641447756145227,0.745997293286606,1,10,negative regulation of epidermal cell differentiation,BP,HES1
11575,GO:0046184,0.641564530992133,0.745883806290445,1,10,aldehyde biosynthetic process,BP,PNPO
938,GO:0002347,0.641568254379977,0.745880187112469,1,10,response to tumor cell,BP,ADAM15
7059,GO:0030858,0.641622678876056,0.59089708554479,3,34,positive regulation of epithelial cell differentiation,BP,CYP27B1;ALOX15B;S1PR2
8610,GO:0034143,0.641737856922812,0.745715290481102,1,10,regulation of toll-like receptor 4 signaling pathway,BP,NR1D1
2836,GO:0006312,0.641843442614279,0.640978528853428,2,22,mitotic recombination,BP,ERCC1;DMC1
15207,GO:0071392,0.641973363313808,0.64083949335165,2,22,cellular response to estradiol stimulus,BP,FAM210B;EGFR
2549,GO:0005832,0.642061817274941,0.745400096371042,1,10,chaperonin-containing T-complex,CC,FYCO1
12969,GO:0051412,0.642142705560538,0.745321351276398,1,10,response to corticosterone,BP,FOS
12707,GO:0050996,0.642323092014602,0.745145678598349,1,10,positive regulation of lipid catabolic process,BP,PPARA
11833,GO:0046838,0.642379607900264,0.74509062089339,1,10,phosphorylated carbohydrate dephosphorylation,BP,IMPA2
11842,GO:0046855,0.642379607900264,0.74509062089339,1,10,inositol phosphate dephosphorylation,BP,IMPA2
19997,GO:2000647,0.642389212023158,0.745081263683221,1,10,negative regulation of stem cell proliferation,BP,FBLN1
14348,GO:0061614,0.642423365728008,0.590391112955823,3,33,pri-miRNA transcription by RNA polymerase II,BP,FOS;NFATC4;PPARA
9770,GO:0040001,0.64255218393537,0.640219633953813,2,22,establishment of mitotic spindle localization,BP,SPRY2;NDE1
3494,GO:0007405,0.642631795470008,0.590163921189695,3,33,neuroblast proliferation,BP,VEGFA;NDE1;FGFR1
20053,GO:2000738,0.642715079227972,0.74476362169845,1,10,positive regulation of stem cell differentiation,BP,LTBP3
4956,GO:0015074,0.642795856693921,0.744684837291925,1,10,DNA integration,BP,NYNRIN
14753,GO:0070482,0.642888258973948,0.437955233828203,25,279,response to oxygen levels,BP,CST3;NDRG1;PGF;NOS1;ZFP36L1;POSTN;EPAS1;MTHFR;EGR1;PLAT;DNMT3A;BNIP3;VEGFA;ENDOG;ADA;AQP3;EEF2K;PPARA;VASN;KCNMA1;CAPN2;VEGFB;AKT1;PINK1;FAM162A
100,GO:0000212,0.643037797746841,0.744448756713006,1,10,meiotic spindle organization,BP,TUBG2
8697,GO:0034356,0.643089415972727,0.74439836764959,1,10,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,NAPRT
14091,GO:0060977,0.643100098443,0.744387938626276,1,10,coronary vasculature morphogenesis,BP,VEGFA
14835,GO:0070633,0.643111797573117,0.744376516698495,1,10,transepithelial transport,BP,RHBG
6899,GO:0030501,0.643118735872002,0.639612231188204,2,22,positive regulation of bone mineralization,BP,FAM20C;ACVR2B
14582,GO:0070169,0.643118735872002,0.639612231188204,2,22,positive regulation of biomineral tissue development,BP,FAM20C;ACVR2B
7923,GO:0032515,0.643141679249063,0.589241094512926,3,34,negative regulation of phosphoprotein phosphatase activity,BP,PPP1R14A;PPP1R35;ELFN2
3625,GO:0008093,0.643166075416806,0.744323519919713,1,10,cytoskeletal adaptor activity,MF,OBSL1
8125,GO:0032839,0.643287491812538,0.639431176683586,2,22,dendrite cytoplasm,CC,DLG4;ADA
13964,GO:0060706,0.643375380263111,0.639336859371435,2,22,cell differentiation involved in embryonic placenta development,BP,MDFI;AKT1
7927,GO:0032527,0.643447677305347,0.588907015764591,3,34,protein exit from endoplasmic reticulum,BP,TMEM129;EDEM1;SORL1
5369,GO:0016197,0.643483289889637,0.457501887588376,16,177,endosomal transport,BP,RAB11FIP4;TBC1D14;MICALL2;ZFYVE21;SNX33;SNX9;MVB12B;STX10;EHD4;SNX17;MVB12A;CLTCL1;LYST;SORL1;TBC1D17;EHD3
12230,GO:0048532,0.643486901255307,0.744010097924157,1,10,anatomical structure arrangement,BP,SEMA3F
9544,GO:0036342,0.643506170191195,0.743991264498671,1,10,post-anal tail morphogenesis,BP,VANGL2
11463,GO:0045945,0.643587991287707,0.743911281119371,1,10,positive regulation of transcription by RNA polymerase III,BP,ERBB2
2381,GO:0005522,0.643608963426152,0.743890777001236,1,10,profilin binding,MF,WIPF1
454,GO:0001228,0.643750870288442,0.438819647141181,24,260,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,FOS;MEF2D;EPAS1;EGR1;SOX12;TFEB;SALL2;TFDP2;ZNF467;STAT6;CEBPB;ETV5;ETV4;HMGA2;ELK3;PPARA;HLTF;TEF;RXRB;MEF2B;SSBP2;CAMTA2;LITAF;MZF1
3074,GO:0006655,0.643760129046995,0.743742948406116,1,10,phosphatidylglycerol biosynthetic process,BP,TAZ
19275,GO:1905564,0.643778347719515,0.743725127595001,1,10,positive regulation of vascular endothelial cell proliferation,BP,FGFR1
19684,GO:2000052,0.643886487882201,0.743619329865377,1,10,positive regulation of non-canonical Wnt signaling pathway,BP,CSNK1E
4404,GO:0010172,0.643927252347415,0.743579439898788,1,10,embryonic body morphogenesis,BP,FUZ
12259,GO:0048593,0.643963724559276,0.52102300156341,6,67,camera-type eye morphogenesis,BP,EPHB2;SDK2;LRP5;VEGFA;PROX1;WNT2B
4182,GO:0009268,0.644045033139011,0.638617688347072,2,22,response to pH,BP,HYAL1;ASIC1
3204,GO:0006853,0.644146970982258,0.743364354555291,1,10,carnitine shuttle,BP,CPT2
16764,GO:0098631,0.644419348501259,0.587845097810793,3,34,cell adhesion mediator activity,MF,IGSF9;BCAM;PLXNB3
7535,GO:0031848,0.644522102210988,0.742996820904984,1,10,protection from non-homologous end joining at telomere,BP,ERCC1
16075,GO:0090084,0.644562059161275,0.742957649931254,1,10,negative regulation of inclusion body assembly,BP,SORL1
17527,GO:1901096,0.644762150026498,0.742761427520717,1,10,regulation of autophagosome maturation,BP,FYCO1
13549,GO:0060044,0.644863605973387,0.742661890093846,1,10,negative regulation of cardiac muscle cell proliferation,BP,JARID2
4547,GO:0010638,0.644877371446789,0.414399998031309,47,510,positive regulation of organelle organization,BP,ERCC1;RAPGEF3;GSN;NOS1;IGF2;ULK1;ARPIN;CORO1B;LRP5;MICALL2;VPS11;FUZ;TFDP2;INSR;SH3PXD2B;ID1;EPHA1;BCL6;BNIP3;VEGFA;ARL2;MAPK3;FYCO1;WIPF1;FHOD1;HES1;LRSAM1;CDC42EP5;RPS6KA5;TRPV4;CROCC;PROX1;WBP2;OSCP1;JARID2;WRAP73;SDC1;WHAMMP3;PPM1F;PINK1;ARHGEF10L;SPIRE2;MLST8;PYCARD;EREG;FAM162A;UBL5
7138,GO:0031005,0.644880918670274,0.742644901888956,1,10,filamin binding,MF,MICALL2
9976,GO:0042403,0.644949829845973,0.742577273962696,1,10,thyroid hormone metabolic process,BP,SLC5A5
15351,GO:0071622,0.644954086028334,0.63699337225531,2,23,regulation of granulocyte chemotaxis,BP,MAPK3;TRPV4
10362,GO:0043201,0.645307497769302,0.742226051913949,1,10,response to leucine,BP,SESN2
2315,GO:0005328,0.645324613459297,0.742209235657403,1,10,neurotransmitter:sodium symporter activity,MF,SLC6A8
6153,GO:0019511,0.645336792034829,0.742197269640392,1,10,peptidyl-proline hydroxylation,BP,CRTAP
7071,GO:0030877,0.645399219156134,0.742135925533811,1,10,beta-catenin destruction complex,CC,CTNNBIP1
18498,GO:1903707,0.645414945588834,0.496853004919725,8,95,negative regulation of hemopoiesis,BP,ZFP36L1;ZFPM1;ERBB2;BCL6;HES1;ZFP36;INPP5D;JAK3
18358,GO:1903393,0.645575900731616,0.636970063928888,2,22,positive regulation of adherens junction organization,BP,VEGFA;PPM1F
10808,GO:0044320,0.645589178286027,0.741949194404613,1,10,cellular response to leptin stimulus,BP,BBS2
3777,GO:0008349,0.64567504618742,0.741864752311441,1,10,MAP kinase kinase kinase kinase activity,MF,MINK1
6345,GO:0021535,0.645691857640535,0.741848217574334,1,10,cell migration in hindbrain,BP,SEMA4C
5847,GO:0017156,0.645716646325216,0.5191028840586,6,67,calcium ion regulated exocytosis,BP,SYTL1;SYT8;ZP3;RIMS3;VAMP2;SNPH
15620,GO:0072160,0.645727594551821,0.741813066246745,1,10,nephron tubule epithelial cell differentiation,BP,WWTR1
8563,GO:0034058,0.64573618535083,0.741804615680214,1,10,endosomal vesicle fusion,BP,VPS11
13516,GO:0060004,0.64573873617395,0.741802106455288,1,10,reflex,BP,SLITRK6
14610,GO:0070208,0.645761381005783,0.741779830106897,1,10,protein heterotrimerization,BP,COL6A1
13791,GO:0060413,0.645891444895117,0.741651854661463,1,10,atrial septum morphogenesis,BP,ZFPM1
10164,GO:0042773,0.645922072467208,0.517469077670115,6,80,ATP synthesis coupled electron transport,BP,NDUFS8;SDHA;UQCR11;PINK1;NDUFV3;TAZ
7821,GO:0032386,0.645989912831848,0.429006949156082,29,318,regulation of intracellular transport,BP,CEMIP;RAPGEF3;B3GAT3;REEP6;ANK3;ERBB2;MICALL2;EDEM1;RIMS3;VPS11;VAMP2;TMEM173;PRNP;REEP2;MAPK3;HES1;ABCA2;PCSK9;MAP2K2;DMTN;LDLRAP1;GAS6;OSCP1;ADGRE2;SORL1;ADORA2B;PINK1;STXBP2;UBL5
330,GO:0000921,0.646060755689838,0.741485191035766,1,10,septin ring assembly,BP,SEPT8
7687,GO:0032156,0.646060755689838,0.741485191035766,1,10,septin cytoskeleton,CC,SEPT8
2767,GO:0006198,0.646094709171046,0.741451758681845,1,10,cAMP catabolic process,BP,RAPGEF3
9575,GO:0036445,0.646094709171046,0.741451758682021,1,10,neuronal stem cell division,BP,FGFR1
13468,GO:0055057,0.646094709171046,0.741451758682021,1,10,neuroblast division,BP,FGFR1
16634,GO:0097539,0.646094709171046,0.741451758682021,1,10,ciliary transition fiber,CC,FBF1
1116,GO:0002705,0.646401501980844,0.533862643581768,5,57,positive regulation of leukocyte mediated immunity,BP,ZP3;STAT6;PTAFR;PRKCZ;ADORA2B
4248,GO:0009584,0.646707714629406,0.635748739216945,2,22,detection of visible light,BP,REEP6;GUCA1B
4563,GO:0010658,0.646747379469191,0.635705888156661,2,22,striated muscle cell apoptotic process,BP,RGL2;BNIP3
8366,GO:0033280,0.646841603910392,0.635604081405543,2,22,response to vitamin D,BP,CYP27B1;AQP3
3174,GO:0006801,0.646870628675845,0.584812865187577,3,35,superoxide metabolic process,BP,EGFR;ACP5;SH3PXD2B
15015,GO:0070988,0.647122495934551,0.533237621242842,5,56,demethylation,BP,HSF4;CYP3A5;APOBEC3C;KDM4B;APOBEC3F
11394,GO:0045824,0.647382062755545,0.584597052311121,3,34,negative regulation of innate immune response,BP,SERPING1;FAM3A;NLRX1
11140,GO:0045216,0.647901497770568,0.45281242902132,16,175,cell-cell junction organization,BP,NLGN2;SDK2;F2R;LAMA5;MICALL2;CD9;NPHP4;RHOD;VEGFA;ARL2;FBF1;PRKACA;DMTN;TRPV4;EPB41L3;PPM1F
3740,GO:0008286,0.647914945909473,0.486347825901948,9,101,insulin receptor signaling pathway,BP,IGF2;SHC1;PIK3R2;PTPRE;INSR;PRKCZ;PDK2;GRB10;AKT1
10799,GO:0044306,0.648409059255897,0.503822405226772,7,79,neuron projection terminus,CC,KCNC4;VAMP2;NTSR1;GLUL;DLG4;KCNAB2;BLVRB
6658,GO:0030027,0.648547723212573,0.459017513838662,14,155,lamellipodium,CC,RAPGEF3;GSN;PARVB;ARPIN;ACTA2;CORO1B;PKD2;PLEKHH2;PLEKHG5;SSH1;MEFV;TRPV4;TWF2;ARAP3
6896,GO:0030496,0.648627088712949,0.458931742163592,14,155,midbody,CC,RAB11FIP4;PKN1;EXOC2;CCDC69;CHMP1B;SSH1;PITPNM1;CAPG;KLHDC8B;PIN1;MAPRE3;MPLKIP;SLC2A1;ZFYVE19
7093,GO:0030901,0.648767076697328,0.531257783701051,5,57,midbrain development,BP,CSNK1E;HES1;FGFR1;WNT3;NDRG2
1043,GO:0002562,0.648878397282945,0.552406725159738,4,45,somatic diversification of immune receptors via germline recombination within a single locus,BP,ERCC1;STAT6;BCL6;RAG1
5491,GO:0016444,0.648878397282945,0.552406725159738,4,45,somatic cell DNA recombination,BP,ERCC1;STAT6;BCL6;RAG1
8596,GO:0034122,0.648925227892288,0.633347960337103,2,22,negative regulation of toll-like receptor signaling pathway,BP,PTPRS;NR1D1
19843,GO:2000351,0.649763097307953,0.632438116276934,2,22,regulation of endothelial cell apoptotic process,BP,PDCD4;GAS6
2264,GO:0005200,0.649776201796929,0.502321436671977,7,79,structural constituent of cytoskeleton,MF,PPL;ANK3;TUBG2;SPTB;BFSP1;EPB41L3;KRT15
13548,GO:0060043,0.650856754643963,0.631248251867464,2,22,regulation of cardiac muscle cell proliferation,BP,FGFR1;JARID2
12577,GO:0050779,0.650919897514797,0.631179476165598,2,22,RNA destabilization,BP,ZFP36L1;ZFP36
1357,GO:0003230,0.650994703093153,0.631097986284722,2,22,cardiac atrium development,BP,ZFPM1;PROX1
9862,GO:0042147,0.651759196464306,0.512325674378504,6,68,retrograde transport, endosome to Golgi,BP,TBC1D14;ZFYVE21;STX10;CLTCL1;TBC1D17;EHD3
14487,GO:0065007,0.651969654454649,0.372380375601723,752,7908,biological regulation,BP,TNIP1;HTRA1;FOS;DUSP6;LMF1;CEMIP;ADGRL1;APOE;TYSND1;ESPN;CTNNBIP1;MARCKSL1;TSPAN1;IDH2;PTPRS;ERCC1;WWC3;SEMA4B;FAM110C;NT5E;GAA;SYTL1;LTB4R;CITED4;BTBD2;CST3;SHANK2;LTBP4;RAPGEF3;TCFL5;MRC2;CYP27B1;GSN;EVI5L;XDH;PRDX5;NDRG1;PCBP4;PRODH;PGF;MEF2D;NOS1;LTBP1;PARVB;ARAP1;SH3BP2;ZFP36L1;TCTN1;CGREF1;POSTN;GRB7;NR1D1;EFS;ALOX15B;ARRDC1;FAM210B;POLD4;SCN8A;SLCO4A1;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;CPT2;RHPN1;MYZAP;IGF2;NFATC4;NME4;MST1R;LRP1;GAMT;MAPK13;APPL2;HEBP1;KCNG1;RALGDS;LTBP2;RAB11FIP4;OBSL1;EGFR;TIMP2;TSC22D1;SMOC2;MMP28;B3GAT3;HADH;NLGN2;REEP6;FBXO2;TCEA2;DUSP5;TOM1L2;HS1BP3;PPP1R14A;FHL1;MXD4;DDB2;SERPING1;MTHFR;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CMTM7;CRTC1;ARPIN;PYGL;ARHGEF4;TRIM65;SYT8;SHC1;RGL2;F2R;PTK6;GNAL;ABCA7;DEAF1;LAMA5;PPP2R3B;CA12;BAHCC1;BBS2;ACTA2;PRSS8;S100A4;CTSB;SHC2;PITPNC1;CORO1B;CXXC5;ULK2;DGKA;GJC2;IGSF9;MALL;ZMYND8;TBC1D14;ASH2L;ZSCAN18;GRAMD4;NXPH4;SOX12;MXI1;PLAT;KCNC4;MMP1;ABCG1;RIN1;ANK3;DHRS11;PIK3R2;S100A6;ZNF516;INO80C;PEG3;HDAC5;THRA;ARHGAP23;KCNJ15;DOCK4;ZP3;CRTAP;RPS6KA2;NISCH;LRP5;HYAL1;MARK4;TENM2;PLTP;MAML3;ZFPM1;BCAM;TFEB;ERBB2;EXOC2;FBLN1;BRSK1;MICALL2;BSG;SCMH1;PTPRU;PKD2;SCN4B;IQSEC2;EDEM1;ABTB1;SLC7A8;ITGB4;ITPR3;PLXNB3;H2AFJ;PHLDA2;VAT1;DNM1;SPRY4;DDIT4L;PTHLH;CDKN1C;RIMS3;SALL2;MSRB2;IFT140;VIPR1;CUL9;CD9;KIF13B;XPC;PTPRE;NINL;SIGMAR1;PAK6;HEXB;SERPINE2;VPS11;VAMP2;FUZ;FOXQ1;RNF135;NPHP4;LTB4R2;UNK;NTSR1;CD320;MINK1;RALGAPA2;ATP2B4;GGT1;TMOD2;TFDP2;CSNK1E;ACP5;RASA4;PLCD1;TRAPPC9;AGAP1;ADAMTS7;PDCD4;DOCK6;GM2A;SLC20A1;BEX2;ACAP3;TNFRSF25;GLUL;RHOD;DTX3;ZKSCAN1;USP20;ASIC1;PLEKHG4;WNT7A;ZMIZ1;INSR;RAB3D;SH3PXD2B;TBC1D8;FBXW8;ZC3H6;ID1;CELSR1;GRK6;MVD;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;CCNG2;TXNRD3;SYNGAP1;IL20RB;PPP1R35;DNMT3A;DNPH1;LPAR3;TMEM173;PRNP;SERINC2;PAPLN;SRD5A3;ATP7B;EFNB3;SNX33;HES2;SPRY2;HINT2;ZNF467;MNT;SLC12A7;ECM1;CEP250;NPDC1;SNX9;STAT6;DLG4;SPEG;REEP2;FGGY;MTA3;MKNK2;PLCD3;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;MYO18A;ARHGAP27;DNAJB5;PLEKHH2;BCL6;PFKFB2;ATP12A;PLXNB1;FAM213A;CHMP1B;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;BNIP3;CD81;SRMS;FCGRT;FZD8;VEGFA;ZSCAN2;LRRC8A;ARL2;YPEL3;VANGL2;MAST4;FBXW4;AP2A2;CEBPB;RHBDF2;GPRC5C;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;CALCOCO1;S1PR2;ENDOG;TNFRSF6B;MAPK3;PLEKHG5;TUB;KCNAB2;ETV5;OLFM2;CARD19;AMN;RAB40B;TNNT1;DVL1;ENTPD2;MTA1;FYCO1;WIPF1;GPSM1;ADCY6;L3MBTL1;MBD1;PKN3;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;PC;GIGYF1;SSH1;FURIN;MLXIPL;ZNF624;SAMD3;CUL7;MEFV;EVC;ARHGAP22;NRP2;GPR153;PLEKHG2;ABCA2;TNFRSF14;LRSAM1;ZNF414;ADA;CDC42EP5;MCTP1;PIDD1;RETSAT;PAG1;PHF21A;SH2D2A;AQP3;HTR7;RASL10B;CELSR2;PFKL;IL6R;SLIT3;PCSK9;ZFP36;ETV4;RHOF;BTBD11;MAPKBP1;FGFR3;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;KIAA1549;LRRK1;PLCH2;DGUOK;MAGEF1;CYFIP2;RPS6KA5;SCNN1A;HBEGF;SLC25A37;ITGB5;RAB3B;MAP2K2;DAP;FGFR4;SPTB;FBXW5;STX10;TSPAN33;DMTN;RAPGEF5;PMVK;BBS1;PSD4;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;TCF25;SEMA3B;LDLR;PTOV1;ACOT11;ROBO3;SNX17;SOX13;ABHD17C;TRPV4;RHOBTB2;IFNGR2;BHLHE40;EIF4EBP3;CROCC;RAG1;ZNF80;DUSP7;TNFAIP8L1;EEF2K;RHBDL1;HMGA2;LDLRAP1;TM7SF2;SEMA3F;ELK3;AHNAK2;DGKQ;SEMA4C;MVB12A;HK1;FAM3A;ZXDC;MIB2;GAS6;BTRC;MEX3A;POU6F1;LLGL1;ADGRB2;ZNF217;PPARA;TKFC;TSPAN4;STK32C;WNT7B;GIT1;COMT;SUFU;PTAFR;PLEKHG6;RFNG;IMPA2;ARHGEF37;LTBP3;PAN2;ZNF446;RXRA;PCK2;PCSK1;VAV3;VASN;BCR;TMEM175;NEO1;IGFBP4;MUC19;TBC1D16;USP21;PRKCZ;ADAMTS13;CLTCL1;HLTF;CAPG;BCORL1;INPP5D;TM7SF3;SPATA7;NYAP1;SLITRK6;TWF2;ZNF485;LSM14B;TPP1;PDK2;GPC1;TMX4;ICOSLG;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;MAPKAPK3;NDE1;AGO4;RAD23A;ARAP3;CDHR1;FGFR1;CTSZ;CAMKK1;CHADL;PIN1;MN1;PNPLA4;ZNF563;C5;KMT5C;TMEM204;IRF2BPL;PROX1;WBP2;GTPBP1;C21ORF2;ASAP2;DLG3;GPR155;KCNMA1;BIN1;VSNL1;TMEM8B;SERPINB6;OSCP1;PI4KAP2;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;SLC25A27;GRB10;JARID2;CAPN2;SESN2;TOLLIP;WNT2B;WRAP73;TMEM161A;RXRB;CSTB;PROCR;SNPH;TMEM231;PNRC1;MAPRE3;LCAT;GUCA1B;ADGRE2;SMDT1;CYBRD1;MADD;RTN4R;ELFN2;OR7D2;EPB41L3;SLC9A7;TIMP1;SDC1;WHAMMP3;SH2B3;APOBEC3C;FGFBP1;RTN2;PEAR1;EPS8L1;PLEKHH3;WNT3;ZFP41;PPM1F;SBF1;SORL1;STK39;VEGFB;ACVR1B;MEF2B;TBC1D17;ANO9;ZSCAN30;ALS2CL;ADORA2B;TPCN1;ERBB3;ABR;ZER1;CCDC85B;PNMA1;CCDC71L;AKT1;TRAP1;STON1;TMBIM4;NLRX1;ZNF385A;TP53INP1;LRCH4;NDRG2;SMARCA1;VPS33B;SIX5;ERCC6;GPD1L;EPS8L2;TDRKH;SLC5A5;SUN1;SPPL2B;IL17RD;SSBP2;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;SNTA1;ARHGEF10L;KDM4B;CAMTA2;HOMER2;PLPPR2;RGS14;SYNE3;PCIF1;MAFIP;SPIRE2;EIF4G3;ZNF710;CTSH;ABHD14B;MLST8;ROBO4;RILPL1;CBLC;EPN2;RFX2;RNF187;PYCARD;NINJ1;MAP2K3;POMT1;TRERF1;PCSK1N;KCNN4;THAP8;DDN;STK17A;ERN1;CKLF;RANBP9;ZNF319;APOBEC3F;GCAT;ARHGEF19;SIRT3;GLI4;C12ORF66;CMTM4;SLC2A1;MLYCD;TAZ;JAK3;MAST3;LITAF;APBA1;MZF1;NEIL1;RARG;ING4;EIF4E3;PBXIP1;EREG;FAM162A;FCHSD1;GSTM2;ZNF514;ZFYVE19;SHISA6;GIPR;WDR18;PQLC2;SFI1;TP53I11;ADAMTSL4;TRNP1;ZNF837;TMED4;SEMA4F;RPL13A;RGS12;RAB40C;MIF;SULF2;STXBP2;KIF26B;UBL5;LZTS2
11741,GO:0046621,0.652111530941548,0.629879934590421,2,22,negative regulation of organ growth,BP,WWC3;JARID2
19774,GO:2000249,0.652656067596461,0.628630549950492,2,23,regulation of actin cytoskeleton reorganization,BP,RAPGEF3;RHOD
4332,GO:0009893,0.652836597312994,0.376545915790598,221,2352,positive regulation of metabolic process,BP,TNIP1;FOS;DUSP6;CEMIP;APOE;ERCC1;CITED4;CST3;RAPGEF3;CYP27B1;GSN;XDH;MEF2D;NOS1;ARAP1;ZFP36L1;NR1D1;EPHB2;EPAS1;CNTN1;IGF2;NFATC4;MST1R;LRP1;EGFR;TIMP2;TCEA2;DUSP5;EGR1;ULK1;PKN1;CRTC1;TRIM65;SHC1;F2R;PTK6;ABCA7;DEAF1;ACTA2;SHC2;GJC2;ASH2L;GRAMD4;SOX12;ABCG1;ANK3;PIK3R2;ZNF516;PEG3;HDAC5;THRA;ZP3;LRP5;MAML3;ZFPM1;TFEB;ERBB2;FBLN1;PKD2;EDEM1;PTHLH;CDKN1C;SALL2;PAK6;HEXB;VPS11;NTSR1;MINK1;ATP2B4;TFDP2;CSNK1E;TNFRSF25;WNT7A;ZMIZ1;INSR;SH3PXD2B;ID1;EPHA1;ITGA6;LPAR3;TMEM173;PRNP;SNX33;SPRY2;SNX9;STAT6;DLG4;STRADB;WWTR1;BCL6;PFKFB2;DYRK1B;SEC14L2;BNIP3;CD81;FZD8;VEGFA;VANGL2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;S1PR2;ENDOG;MAPK3;ETV5;DVL1;MTA1;FYCO1;GPSM1;ADCY6;EPHB3;FHOD1;HES1;FURIN;MLXIPL;MEFV;LRSAM1;PIDD1;IL6R;PCSK9;ZFP36;ETV4;FGFR3;PRKACA;F12;LRRK1;MAGEF1;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;TNFRSF1A;EHD4;MAPK8IP1;LDLR;TRPV4;DUSP7;HMGA2;LDLRAP1;ELK3;DGKQ;SEMA4C;ZXDC;GAS6;BTRC;PPARA;WNT7B;COMT;PTAFR;RXRA;VAV3;IGFBP4;USP21;PRKCZ;HLTF;SRSF5;RFXANK;TEF;MAPKAPK3;RAD23A;FGFR1;CAMKK1;PIN1;C5;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;ASS1;SH3D19;JARID2;SESN2;TOLLIP;TMEM161A;RXRB;MAPRE3;GUCA1B;MADD;WNT3;PPM1F;SORL1;STK39;ACVR1B;MEF2B;ADORA2B;TPCN1;ERBB3;AKT1;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;CAMTA2;CTSH;ABHD14B;MLST8;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;DDN;ERN1;MLYCD;TAZ;LITAF;MZF1;RARG;EREG;FAM162A;MIF
10911,GO:0044548,0.653040871084917,0.732654140367251,1,11,S100 protein binding,MF,S100A6
6164,GO:0019538,0.653061904989426,0.371299765325244,394,4207,protein metabolic process,BP,TNIP1;HTRA1;DUSP6;LMF1;CEMIP;APOE;TYSND1;RNPEPL1;PTPRS;BTBD2;RNF44;CST3;LTBP4;RAPGEF3;GSN;CLCA2;XDH;PRDX5;PRSS3;NOS1;LTBP1;MARCH9;ZFP36L1;GRB7;NR1D1;ARRDC1;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;IGF2;MST1R;LRP1;MAPK13;CDK18;ST6GALNAC2;OBSL1;EGFR;TIMP2;MMP28;B3GAT3;FBXO2;DUSP5;FKBP9;PPP1R14A;JOSD2;LOXL1;DDB2;SERPING1;MTHFR;EGR1;ULK1;RHBDF1;PKN1;SHC1;F2R;PTK6;NPEPL1;ABCA7;PPP2R3B;PRSS8;PPM1J;CTSB;RNF208;SHC2;ULK2;GJC2;D2HGDH;ZMYND8;ASH2L;GRAMD4;PLAT;MMP1;ABCG1;PIK3R2;INO80C;NEK9;HDAC5;CRTAP;RPS6KA2;LRP5;HYAL1;ANO8;MARK4;TENM2;ZFPM1;ERBB2;FBLN1;BRSK1;CTSF;PTPRU;PKD2;GID4;TMEM129;EDEM1;ABTB1;SPRY4;CDKN1C;MSRB2;CUL9;PTPRE;PAK6;HEXB;SERPINE2;VPS11;GALNT12;RNF135;UNK;JADE2;THSD4;MINK1;ATP2B4;GGT1;CSNK1E;RASA4;ADAMTS7;PDCD4;TNFRSF25;DTX3;USP20;PEX10;LAMB2;SPATA18;WNT7A;INSR;RAB3D;LCE1E;FBXW8;ID1;GRK6;MVD;B4GAT1;RABGGTA;EPHA1;ADARB1;SYNGAP1;FBXO27;PPP1R35;LPAR3;PRNP;PAPLN;SRD5A3;FBXL8;SNX33;FBXO41;SPRY2;HINT2;BLMH;ECM1;SNX9;DLG4;SPEG;MARCH2;MTA3;MKNK2;STRADB;WWTR1;FAM20C;BCL6;ANKZF1;IGFBP2;DYRK1B;MVB12B;BNIP3;CD81;SRMS;FZD8;VEGFA;VANGL2;MAST4;FBXW4;AP2A2;CEBPB;RHBDF2;DPP7;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;ZDHHC1;S1PR2;TNFRSF6B;MAPK3;FBXL16;CAPNS2;RAB40B;DVL1;MTA1;LHPP;KLHL29;ADCY6;LTA4H;WIPI2;PKN3;ST3GAL3;EPHB3;HES1;SSH1;FURIN;MLXIPL;CUL7;MEFV;TRIM4;LRSAM1;LY6K;FKBP10;CDC42EP5;PIDD1;PHF21A;ACY1;IL6R;PCSK9;ZFP36;BTBD11;HLCS;FGFR3;PRKACA;F12;ZNF862;LRRK1;DGUOK;MAGEF1;CYFIP2;RPS6KA5;HBEGF;RAB3B;MAP2K2;DAP;FGFR4;SPTB;FBXW5;MXRA8;TSPAN33;DMTN;MYH3;MDGA1;XYLT2;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;LDLR;LYPLAL1;ABHD17C;TRPV4;PIGZ;EIF4EBP3;RAG1;DUSP7;PHLDA1;EEF2K;RHBDL1;MSLN;HMGA2;LDLRAP1;DGKQ;SEMA4C;MVB12A;MIB2;FBXO17;PADI3;GAS6;BTRC;MEX3A;PPARA;STK32C;WNT7B;SUFU;PTAFR;RFNG;RXRA;PCSK1;BCR;IGFBP4;MUC19;USP21;RNF123;PRKCZ;ADAMTS13;ZDHHC24;HLTF;MDH2;INPP5D;ETFB;LSM14B;KLHDC8B;TPP1;PDK2;GPC1;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;CAMKK1;SPSB3;PIN1;MAN1B1;C5;KMT5C;PROX1;WBP2;GTPBP1;DLG3;BIN1;SERPINB6;SH3D19;WDR83;GLRX;JARID2;CAPN2;SESN2;TOLLIP;ADCK5;CSTB;MAN2B2;MAPRE3;DUSP23;LCAT;MACROD1;GAL3ST4;TMPRSS11D;MADD;LMLN;RTN4R;ELFN2;PIGV;TIMP1;PIGQ;PPM1F;SBF1;SORL1;STK39;VEGFB;ACVR1B;ADORA2B;ERBB3;ZER1;AKT1;CTSD;TRAP1;ADAM19;ZNF385A;NDRG2;VPS33B;ERCC6;PCMTD2;GPD1L;SPPL2B;IL17RD;RPL39L;ADCK2;SSH3;PINK1;PKD1;LONP2;SNTA1;KDM4B;RGS14;EIF4G3;CTSH;P3H4;MLST8;CBLC;RNF187;PYCARD;MAP2K3;POMT1;PCSK1N;STK17A;ERN1;RANBP9;FBXL20;MOCS1;SIRT3;JAK3;MAST3;ING4;EIF4E3;EREG;FAM162A;TRIM7;ADAMTSL4;TTLL11;NDST2;RPL13A;ALG12;RAB40C;MIF;SULF2;UBL5
10691,GO:0044003,0.653126252461359,0.578255751453316,3,34,modification by symbiont of host morphology or physiology,BP,TNIP1;INSR;RXRA
19645,GO:1990939,0.653239996360933,0.578129595140477,3,34,ATP-dependent microtubule motor activity,MF,DNAH1;WDR60;WDR63
1305,GO:0003151,0.653256669918095,0.547558310704016,4,45,outflow tract morphogenesis,BP,ZFPM1;VEGFA;HES1;NRP2
13453,GO:0055017,0.653794737319856,0.546960435562813,4,45,cardiac muscle tissue growth,BP,RXRA;FGFR1;PIN1;JARID2
4080,GO:0009143,0.654114644010216,0.731568281202941,1,11,nucleoside triphosphate catabolic process,BP,ADA
5434,GO:0016311,0.654183210356431,0.415718354964707,33,359,dephosphorylation,BP,DUSP6;PTPRS;NT5E;B3GAT3;DUSP5;PPP1R14A;PPP2R3B;PPM1J;PTPRU;PTPRE;ACP5;PPP1R35;NT5DC1;PFKFB2;LHPP;SSH1;MYH3;DUSP7;BTRC;IMPA2;INPP5D;PIN1;DLG3;DUSP23;ELFN2;PPM1F;SBF1;ACP6;SSH3;PINK1;PLPPR2;PCIF1;SFI1
4152,GO:0009223,0.654272657250376,0.731408207942604,1,11,pyrimidine deoxyribonucleotide catabolic process,BP,NEIL1
10547,GO:0043524,0.654481724421865,0.487226105678624,8,91,negative regulation of neuron apoptotic process,BP,APOE;LRP1;F2R;SYNGAP1;CEBPB;PIN1;ERBB3;PINK1
6614,GO:0022853,0.655109632505979,0.575703558800564,3,35,active ion transmembrane transporter activity,MF,ATP2B4;ATP7B;ATP12A
10090,GO:0042625,0.655109632505979,0.575703558800564,3,35,ATPase coupled ion transmembrane transporter activity,MF,ATP2B4;ATP7B;ATP12A
1035,GO:0002544,0.655125294717561,0.730543205859049,1,11,chronic inflammatory response,BP,ADORA2B
4031,GO:0009072,0.655725739739233,0.72993278687754,1,11,aromatic amino acid family metabolic process,BP,HPDL
8679,GO:0034329,0.656315864731765,0.443695364810158,16,176,cell junction assembly,BP,FLNC;LAMA5;MICALL2;ITGB4;CD9;NPHP4;RHOD;ITGA6;VEGFA;ARL2;FBF1;PRKACA;DMTN;TRPV4;EPB41L3;PPM1F
17364,GO:1900119,0.656501226225378,0.729142866266617,1,11,positive regulation of execution phase of apoptosis,BP,ENDOG
6772,GO:0030219,0.656874502419475,0.505560984046388,6,78,megakaryocyte differentiation,BP,ASH2L;ZFPM1;L3MBTL1;AGO4;ZNF385A;VPS33B
15799,GO:0072528,0.657044206185051,0.573217977795545,3,36,pyrimidine-containing compound biosynthetic process,BP,NME4;UCKL1;TK2
2828,GO:0006304,0.657694869571104,0.493484896481906,7,80,DNA modification,BP,FOS;DNMT3A;MPG;APOBEC3C;TDRKH;APOBEC3F;NEIL1
16946,GO:0099003,0.657823900508181,0.483623154467835,8,90,vesicle-mediated transport in synapse,BP,SYTL1;NLGN2;SYT8;DNM1;RIMS3;VAMP2;SNPH;PINK1
2367,GO:0005501,0.657868817134838,0.727745543453849,1,11,retinoid binding,MF,RXRA
12320,GO:0048704,0.658008608760145,0.521008086845058,5,57,embryonic skeletal system morphogenesis,BP,MDFI;HYAL1;IFT140;FUZ;WDR60
15196,GO:0071377,0.658372951055314,0.622340753454074,2,23,cellular response to glucagon stimulus,BP,ADCY6;PRKACA
3459,GO:0007286,0.658997404570476,0.504176103721804,6,69,spermatid development,BP,BBS2;DNAH1;PRKACA;DMC1;SIX5;RFX2
7189,GO:0031090,0.659025826095771,0.370915361210149,207,2225,organelle membrane,CC,CEMIP;APOE;TSPAN1;IDH2;PTPRS;GAA;CST3;SHANK2;CYP27B1;CLCA2;NDRG1;PRODH;NOS1;MARCH9;ARAP1;COL6A1;CRAT;FAM210B;CPT2;NME4;LRP1;APPL2;ST6GALNAC2;RAB11FIP4;EGFR;B3GAT3;HADH;FBXO2;ULK1;RHBDF1;DOPEY2;SYT8;BPHL;ABCA7;BBS2;SLC16A3;ULK2;DHRS1;MALL;GRAMD4;CERS4;ABCG1;DBNDD1;B4GALNT4;ERBB2;BSG;PKD2;TST;CPT1C;EDEM1;ITPR3;PRAF2;VAT1;DNM1;CD9;SIGMAR1;VPS11;VAMP2;GALNT12;CD320;SNN;TRAPPC9;ZFYVE21;DIRC2;RHOD;PEX10;ARMCX2;SPATA18;WNT7A;INSR;RAB3D;B4GAT1;NDUFS8;NBEAL2;TMEM173;PRNP;ATP7B;SNX33;ATG16L2;SNX9;STAT6;DLG4;ABCD1;MARCH2;MYO18A;ANKZF1;CHMP1B;MVB12B;BNIP3;ENTPD6;AP2A2;GPRC5C;SHANK3;KCNAB2;CARD19;AMN;RAB40B;GPSM1;ST3GAL3;SLC16A13;FURIN;SLC48A1;EVC;SLC2A3;ABCA2;MCTP1;RETSAT;CKMT1A;PCSK9;TMEM9;RHOF;PITPNM1;SCNN1A;HBEGF;SLC25A37;RAB3B;MAP2K2;PI4K2A;STX10;DMTN;BBS1;XYLT2;TNFRSF1A;EHD4;MAPK8IP1;LDLR;CYP3A5;SNX17;ABHD17C;IFNGR2;LDLRAP1;TM7SF2;AHNAK2;DGKQ;KLHDC2;SEMA4C;MVB12A;HK1;CHST6;SDHAF4;LLGL1;HMGCL;WNT7B;PTAFR;RFNG;VASN;TMEM175;SDHA;RNF123;CLTCL1;MDH2;ABCD4;SMOX;CDHR1;CTSZ;MAN1B1;ASAP2;SERPINB6;WDR83;SLC25A27;NDUFA4L2;SNPH;MAN2B2;TMEM231;GUCA1B;GAL3ST4;SMDT1;CYBRD1;SLC9A7;CD68;WHAMMP3;WNT3;SORL1;TPCN1;HGSNAT;SLC25A29;CYP2S1;TRAP1;TMBIM4;NLRX1;VPS33B;SUN1;TMEM120A;SPPL2B;IL17RD;UQCR11;PINK1;PKD1;EHD3;SLC22A17;SYNE3;GOLGA2P5;SPIRE2;EPN2;RHBG;NDUFV3;ERN1;GCAT;C12ORF66;SLC2A1;TAZ;LITAF;PQLC2;NDST2;AGPAT3;RAB40C;STXBP2
9288,GO:0035751,0.659085014536518,0.726498303461996,1,11,regulation of lysosomal lumen pH,BP,TMEM175
13193,GO:0051881,0.659147725234095,0.540317918298735,4,48,regulation of mitochondrial membrane potential,BP,BNIP3;SLC25A27;AKT1;PINK1
17462,GO:1900409,0.659478228722634,0.7260941230176,1,11,positive regulation of cellular response to oxidative stress,BP,ENDOG
18120,GO:1902884,0.659478228722634,0.7260941230176,1,11,positive regulation of response to oxidative stress,BP,ENDOG
18276,GO:1903209,0.659478228722634,0.7260941230176,1,11,positive regulation of oxidative stress-induced cell death,BP,ENDOG
2485,GO:0005739,0.659615073436385,0.376833161249878,129,1425,mitochondrion,CC,PPL;IDH2;CYP27B1;PRDX5;PRODH;NOS1;CRAT;FAM210B;POLD4;CPT2;NME4;ALDH4A1;HADH;SUGCT;ACSF2;ACOT7;HS1BP3;UROS;ULK1;SHC1;BPHL;CTSB;DHRS1;D2HGDH;PACS2;GRAMD4;ABCG1;LRP5;BSG;OGDHL;TST;CPT1C;VAT1;DNM1;MSRB2;XPC;NTSR1;SNN;TFDP2;GM2A;TNFRSF25;GLUL;ARMCX2;SPATA18;RAB3D;NDUFS8;TXNRD3;HAGH;TMEM173;DHX32;OXLD1;ATP7B;HINT2;ABCD1;ANKZF1;BNIP3;ARL2;ENDOG;MAPK3;CARD19;DHTKD1;PC;ACAD10;COMTD1;NAGS;TK2;PYCR2;CKMT1A;SLIT3;HLCS;PRKACA;LRRK1;DGUOK;SLC25A37;MAP2K2;PI4K2A;TNFRSF1A;MAPK8IP1;MPG;ELK3;HK1;SDHAF4;ZNF217;HMGCL;COMT;PCK2;VASN;SDHA;GSDMC;MDH2;ETFB;SPATA7;TPP1;PDK2;PIN1;PNPLA4;PHYH;C21ORF2;TMEM8B;ASS1;GLRX;SLC25A27;JARID2;SESN2;NDUFA4L2;SNPH;MACROD1;SMDT1;SLC25A29;AKT1;TRAP1;NLRX1;ACP6;TDRKH;UQCR11;PINK1;RSAD1;PYCARD;AS3MT;NDUFV3;ERN1;PRIMPOL;ACADS;GCAT;SIRT3;MLYCD;TAZ;BCKDHA;FAM162A
13109,GO:0051701,0.66003645403244,0.446440982076725,14,158,interaction with host,BP,TNIP1;GSN;EGFR;CTSB;EXOC2;INSR;EFNB3;CD81;PC;TNFRSF14;ITGB5;LDLR;GAS6;RXRA
7336,GO:0031386,0.660063735030131,0.723896398400068,1,12,protein tag,MF,UBL5
10542,GO:0043517,0.660150374841271,0.725402176984865,1,11,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,ZNF385A
5699,GO:0016840,0.660373743862881,0.725171933016833,1,11,carbon-nitrogen lyase activity,MF,GGACT
635,GO:0001825,0.660747163972487,0.619707704233779,2,23,blastocyst formation,BP,ZP3;ADA
12525,GO:0050700,0.660797695218688,0.724734527812716,1,11,CARD domain binding,MF,CARD19
6559,GO:0022029,0.660938290972122,0.569537543653473,3,34,telencephalon cell migration,BP,EGFR;MBOAT7;SUN1
5606,GO:0016668,0.660955379297486,0.724571704155877,1,11,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,TXNRD3
2935,GO:0006470,0.661337131955245,0.42353798052252,22,243,protein dephosphorylation,BP,DUSP6;PTPRS;B3GAT3;DUSP5;PPP1R14A;PPP2R3B;PPM1J;PTPRU;PTPRE;PPP1R35;LHPP;SSH1;MYH3;DUSP7;BTRC;PIN1;DUSP23;ELFN2;PPM1F;SBF1;SSH3;PINK1
13676,GO:0060260,0.661386358305138,0.618996713239779,2,23,regulation of transcription initiation from RNA polymerase II promoter,BP,CTNNBIP1;THRA
10331,GO:0043154,0.661663173507694,0.501082298013388,6,70,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PRDX5;VEGFA;TNFRSF6B;RAG1;GAS6;AKT1
17697,GO:1901653,0.661674560956582,0.421295602863158,23,255,cellular response to peptide,BP,ZFP36L1;IGF2;LRP1;SHC1;PIK3R2;HDAC5;PTPRE;VAMP2;INSR;ID1;PRNP;MAPK3;ADCY6;PCSK9;PRKACA;EEF2K;PCK2;PRKCZ;PDK2;SRSF5;GRB10;AKT1;JAK3
2206,GO:0005095,0.661678458727431,0.723824113891711,1,11,GTPase inhibitor activity,MF,ARL2
11880,GO:0046930,0.66211813303637,0.723368777773096,1,11,pore complex,CC,C5
4587,GO:0010712,0.662165695566915,0.618128621944272,2,23,regulation of collagen metabolic process,BP,CST3;F2R
6844,GO:0030325,0.662212409194326,0.723271068649759,1,11,adrenal gland development,BP,INSR
2092,GO:0004861,0.662838003468875,0.722622024741411,1,11,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,CDKN1C
6196,GO:0019706,0.663602003204939,0.61652523287158,2,23,protein-cysteine S-palmitoyltransferase activity,MF,ZDHHC1;ZDHHC24
6197,GO:0019707,0.663602003204939,0.61652523287158,2,23,protein-cysteine S-acyltransferase activity,MF,ZDHHC1;ZDHHC24
10284,GO:0043066,0.663838949164968,0.389658291780267,56,612,negative regulation of apoptotic process,BP,APOE;PRDX5;EPHB2;IGF2;MST1R;LRP1;EGFR;SHC1;RGL2;F2R;ERBB2;NTSR1;PDCD4;WNT7A;INSR;ID1;EPHA1;ITGA6;SYNGAP1;PRNP;SPRY2;MNT;STRADB;MYO18A;BCL6;BNIP3;VEGFA;CEBPB;TNFRSF6B;EPHB3;ADA;PIDD1;FGFR3;FGFR4;MAPK8IP1;RAG1;EEF2K;HMGA2;GAS6;PRKCZ;AGO4;FGFR1;PIN1;SLC25A27;TMEM161A;TIMP1;ERBB3;AKT1;TRAP1;TMBIM4;ZNF385A;PINK1;CTSH;JAK3;RARG;MIF
4054,GO:0009112,0.664018426472897,0.565717653676436,3,35,nucleobase metabolic process,BP,XDH;UCKL1;ADA
4035,GO:0009081,0.664025581106628,0.616051510752064,2,23,branched-chain amino acid metabolic process,BP,HMGCL;BCKDHA
17606,GO:1901343,0.664066258277656,0.498643040973742,6,68,negative regulation of vasculature development,BP,XDH;HDAC5;PDCD4;SPRY2;ADGRB2;EPN2
10556,GO:0043537,0.664088622154467,0.615980972787974,2,23,negative regulation of blood vessel endothelial cell migration,BP,APOE;HDAC5
14061,GO:0060914,0.66409957681977,0.721309617041192,1,11,heart formation,BP,HES1
16076,GO:0090085,0.664346650114818,0.721052031646433,1,11,regulation of protein deubiquitination,BP,TNIP1
8958,GO:0035065,0.664635445281294,0.534584401779145,4,46,regulation of histone acetylation,BP,NOS1;MAPK3;RPS6KA5;WBP2
14364,GO:0061640,0.664866053346168,0.497621390932051,6,69,cytoskeleton-dependent cytokinesis,BP,ANK3;SNX33;SNX9;CUL7;SEPT8;SPIRE2
1457,GO:0003705,0.665119658759001,0.513040776120873,5,57,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,MEF2D;CEBPB;BHLHE40;PROX1;MEF2B
2690,GO:0006063,0.665485460920795,0.719862405681734,1,11,uronic acid metabolic process,BP,CRYL1
6175,GO:0019585,0.665485460920795,0.719862405681734,1,11,glucuronate metabolic process,BP,CRYL1
3904,GO:0008574,0.665971410911631,0.613870216630088,2,23,ATP-dependent microtubule motor activity, plus-end-directed,MF,WDR60;WDR63
15410,GO:0071712,0.666117151238047,0.719200850546978,1,11,ER-associated misfolded protein catabolic process,BP,POMT1
8330,GO:0033197,0.666163094549783,0.719152688341549,1,11,response to vitamin E,BP,ADA
18919,GO:1904706,0.66628303699855,0.719026923176399,1,11,negative regulation of vascular smooth muscle cell proliferation,BP,PDCD4
2582,GO:0005882,0.666514014020872,0.495772874946098,6,69,intermediate filament,CC,SHANK2;FBF1;LDLRAP1;BFSP1;SYNC;KRT15
10254,GO:0043014,0.666827286239801,0.612908105794371,2,23,alpha-tubulin binding,MF,FAM110C;TRPV4
8114,GO:0032816,0.667037802343008,0.718234522699643,1,11,positive regulation of natural killer cell activation,BP,GAS6
14236,GO:0061323,0.667131761339071,0.718135758358018,1,11,cell proliferation involved in heart morphogenesis,BP,HES1
11126,GO:0045191,0.667162801565598,0.612530498952385,2,23,regulation of isotype switching,BP,STAT6;BCL6
10194,GO:0042827,0.667286486082575,0.717973062448462,1,11,platelet dense granule,CC,ECM1
1027,GO:0002534,0.667328957715073,0.612343404911459,2,23,cytokine production involved in inflammatory response,BP,PDCD4;MEFV
19721,GO:2000136,0.667389414570701,0.717864791208553,1,11,regulation of cell proliferation involved in heart morphogenesis,BP,HES1
442,GO:0001191,0.667426779075528,0.561859240463685,3,35,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,ZMYND8;ID1;BHLHE40
10770,GO:0044257,0.667550283613691,0.384846102536722,58,635,cellular protein catabolic process,BP,APOE;BTBD2;RNF44;NR1D1;ARRDC1;RBCK1;LRP1;FBXO2;RHBDF1;CTSB;CTSF;GID4;TMEM129;EDEM1;ABTB1;CUL9;VPS11;CSNK1E;ADAMTS7;USP20;SPATA18;WWTR1;ANKZF1;MVB12B;BNIP3;CD81;FBXW4;AP2A2;DVL1;MTA1;FURIN;CUL7;PCSK9;BTBD11;PRKACA;MAGEF1;FBXW5;LDLR;MVB12A;BTRC;SUFU;USP21;RNF123;RAD23A;CTSZ;SPSB3;MAN1B1;CAPN2;TOLLIP;AKT1;PINK1;PKD1;LONP2;CTSH;CBLC;RNF187;POMT1;FBXL20
9872,GO:0042168,0.667784890293573,0.611218725095616,2,24,heme metabolic process,BP,UROS;BLVRB
9459,GO:0036109,0.667789617057926,0.717443510987484,1,11,alpha-linolenic acid metabolic process,BP,ABCD1
965,GO:0002407,0.668185834764801,0.717025948124096,1,11,dendritic cell chemotaxis,BP,GAS6
14197,GO:0061178,0.668315441766153,0.560516795639571,3,36,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,NR1D1;LRP5;VSNL1
1462,GO:0003714,0.668322408739626,0.430547287543811,16,179,transcription corepressor activity,MF,NR1D1;MXD4;ZMYND8;MXI1;MNT;WWTR1;HSF4;NAB2;MTA1;BHLHE40;ELK3;SUFU;PROX1;PPP1R13L;GRHPR;PBXIP1
15134,GO:0071280,0.668362397723201,0.715209150251966,1,12,cellular response to copper ion,BP,PRNP
7831,GO:0032400,0.668619883296585,0.61088770245784,2,23,melanosome localization,BP,BBS2;VPS33B
13189,GO:0051875,0.668619883296585,0.61088770245784,2,23,pigment granule localization,BP,BBS2;VPS33B
6909,GO:0030513,0.668698902712444,0.610798475617822,2,23,positive regulation of BMP signaling pathway,BP,HES1;NEO1
6697,GO:0030117,0.66888201138142,0.471179145675533,8,92,membrane coat,CC,EGFR;DNM1;CHMP1B;AP2A2;LDLRAP1;CLTCL1;VPS33B;EPN2
12199,GO:0048475,0.66888201138142,0.471179145675533,8,92,coated membrane,CC,EGFR;DNM1;CHMP1B;AP2A2;LDLRAP1;CLTCL1;VPS33B;EPN2
15155,GO:0071318,0.668995101671934,0.716171605975067,1,11,cellular response to ATP,BP,SSH1
14118,GO:0061024,0.66905656556184,0.382016376762887,61,665,membrane organization,BP,APOE;MARVELD1;SYTL1;GSN;EVI5L;NDRG1;EGFR;NLGN2;SYT8;ABCA7;MALL;ZMYND8;TBC1D14;ANK3;NEK9;VAT1;DNM1;FCHO1;CD9;VPS11;VAMP2;TFDP2;TRAPPC9;TBC1D8;SNX33;SNX9;DLG4;REEP2;MYO18A;BNIP3;AP2A2;SHANK3;ETV5;DVL1;SSH1;STX10;LDLR;LDLRAP1;AHNAK2;GAS6;REEP4;VAV3;TMEM175;TBC1D16;CLTCL1;CTSZ;BIN1;EPB41L3;TBC1D17;ANO9;TSNARE1;AKT1;VPS33B;SUN1;PINK1;SPIRE2;RILPL1;EPN2;KCNN4;TAZ;SHISA6
12290,GO:0048663,0.669132894596589,0.610308172674811,2,23,neuron fate commitment,BP,HES1;SUFU
6673,GO:0030048,0.669138578727289,0.492821699987585,6,69,actin filament-based movement,BP,SCN4B;TNNT1;WIPF1;MYH3;GPD1L;SNTA1
19034,GO:1904925,0.669307640051207,0.715841127436408,1,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,PINK1
15016,GO:0070989,0.669374516712039,0.715770373395551,1,11,oxidative demethylation,BP,CYP3A5
16514,GO:0097286,0.669432237767859,0.71570929485015,1,11,iron ion import,BP,SLC25A37
12624,GO:0050854,0.669453799777958,0.559554481031378,3,35,regulation of antigen receptor-mediated signaling pathway,BP,PRNP;ADA;KCNN4
15569,GO:0072077,0.669479787959837,0.715658971168993,1,11,renal vesicle morphogenesis,BP,KIF26B
15575,GO:0072087,0.669479787959837,0.715658971168993,1,11,renal vesicle development,BP,KIF26B
13650,GO:0060211,0.6695038355378,0.715633518334846,1,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,ZFP36
13652,GO:0060213,0.6695038355378,0.715633518334846,1,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,ZFP36
13554,GO:0060049,0.669660182782286,0.71546799179572,1,11,regulation of protein glycosylation,BP,POMT1
104,GO:0000217,0.669765575627234,0.609592642876117,2,23,DNA secondary structure binding,MF,XPC;DMC1
8456,GO:0033612,0.669891115893023,0.715223364261731,1,11,receptor serine/threonine kinase binding,MF,PYCARD
13459,GO:0055024,0.670191458946627,0.528289353494603,4,46,regulation of cardiac muscle tissue development,BP,FGFR1;PIN1;JARID2;ERBB3
7137,GO:0031000,0.670249307858372,0.71484360992814,1,11,response to caffeine,BP,GSTM2
9518,GO:0036270,0.670249307858372,0.71484360992814,1,11,response to diuretic,BP,GSTM2
20031,GO:2000696,0.670585853129601,0.714486448850901,1,11,regulation of epithelial cell differentiation involved in kidney development,BP,WWTR1
586,GO:0001741,0.670705232729917,0.714359673326045,1,11,XY body,CC,DNMT3A
20048,GO:2000727,0.670710719691088,0.714353845384847,1,11,positive regulation of cardiac muscle cell differentiation,BP,PIN1
18129,GO:1902902,0.67106857569482,0.713973552245928,1,11,negative regulation of autophagosome assembly,BP,PINK1
17360,GO:1900115,0.671203862075172,0.713829681591143,1,11,extracellular regulation of signal transduction,BP,LTBP1
17361,GO:1900116,0.671203862075172,0.713829681591143,1,11,extracellular negative regulation of signal transduction,BP,LTBP1
4750,GO:0010939,0.671241637259844,0.607305754668799,2,24,regulation of necrotic cell death,BP,RBCK1;BNIP3
3554,GO:0007602,0.671341585152738,0.607806340560104,2,23,phototransduction,BP,PITPNM1;GUCA1B
3482,GO:0007368,0.671343764343722,0.490335221645457,6,69,determination of left/right symmetry,BP,PKD2;IFT140;VANGL2;ACVR2B;SUFU;GAS8
13508,GO:0055119,0.671405110835025,0.713615559460635,1,11,relaxation of cardiac muscle,BP,GSTM2
7272,GO:0031269,0.671414430823697,0.713605640292863,1,11,pseudopodium assembly,BP,CDC42EP5
2718,GO:0006105,0.671620694492529,0.713386047907886,1,11,succinate metabolic process,BP,SDHA
10531,GO:0043501,0.671674575399523,0.713328663759687,1,11,skeletal muscle adaptation,BP,TNNT1
10936,GO:0044666,0.672204282047157,0.712764042658713,1,11,MLL3/4 complex,CC,ASH2L
566,GO:0001708,0.672342130209316,0.556257324693365,3,35,cell fate specification,BP,DUSP6;SUFU;FGFR1
1426,GO:0003401,0.672582074270884,0.606396385421247,2,23,axis elongation,BP,SPRY2;VANGL2
12066,GO:0048048,0.672648755295421,0.606320496330004,2,23,embryonic eye morphogenesis,BP,PROX1;RARG
506,GO:0001569,0.672705234646535,0.606256209794347,2,23,branching involved in blood vessel morphogenesis,BP,NFATC4;VEGFA
10553,GO:0043534,0.672844592228391,0.47646780872457,7,81,blood vessel endothelial cell migration,BP,APOE;HDAC5;ID1;VEGFA;FGFR1;AKT1;MAP2K3
639,GO:0001829,0.672866435021504,0.712057033884147,1,11,trophectodermal cell differentiation,BP,ADA
6274,GO:0019887,0.673009376471081,0.436196391282098,13,148,protein kinase regulator activity,MF,IGF2;CDKN1C;SPRY2;SAMD3;MAP2K2;MAPK8IP1;DGKQ;GAS6;MADD;RTN4R;ERBB3;ERCC6;MLST8
1386,GO:0003298,0.673202896002258,0.711697263607085,1,11,physiological muscle hypertrophy,BP,PIN1
1389,GO:0003301,0.673202896002258,0.711697263607085,1,11,physiological cardiac muscle hypertrophy,BP,PIN1
14138,GO:0061049,0.673202896002258,0.711697263607085,1,11,cell growth involved in cardiac muscle cell development,BP,PIN1
6905,GO:0030509,0.673494587367143,0.466097198501273,8,91,BMP signaling pathway,BP,HTRA1;EGR1;PDCD4;ID1;ACVR2B;MAPK3;HES1;NEO1
7903,GO:0032488,0.673573007687939,0.711301108653277,1,11,Cdc42 protein signal transduction,BP,APOE
959,GO:0002381,0.673586325513184,0.554832263447706,3,35,immunoglobulin production involved in immunoglobulin mediated immune response,BP,ERCC1;STAT6;BCL6
4465,GO:0010470,0.673844852845563,0.604957515385754,2,23,regulation of gastrulation,BP,DUSP6;FGFR1
8327,GO:0033189,0.673852791844869,0.711001356888496,1,11,response to vitamin A,BP,DNMT3A
4528,GO:0010611,0.673933680093657,0.554433901319926,3,35,regulation of cardiac muscle hypertrophy,BP,ATP2B4;PIN1;JARID2
4871,GO:0014743,0.673933680093657,0.554433901319926,3,35,regulation of muscle hypertrophy,BP,ATP2B4;PIN1;JARID2
14016,GO:0060788,0.673970943337584,0.710874700624903,1,11,ectodermal placode formation,BP,PROX1
15399,GO:0071697,0.673970943337584,0.710874700624903,1,11,ectodermal placode morphogenesis,BP,PROX1
7191,GO:0031092,0.674160812540461,0.710671073974167,1,11,platelet alpha granule membrane,CC,CD9
4449,GO:0010447,0.674182574315044,0.710647728282024,1,11,response to acidic pH,BP,ASIC1
4671,GO:0010829,0.674338997455089,0.710479876911229,1,11,negative regulation of glucose transmembrane transport,BP,GRB10
4541,GO:0010632,0.674873495033695,0.430177513272727,14,158,regulation of epithelial cell migration,BP,APOE;HDAC5;HYAL1;WNT7A;RAB25;VEGFA;NRP2;HBEGF;FGFR1;PROX1;PPM1F;AKT1;CTSH;MAP2K3
569,GO:0001711,0.674875925853492,0.709903144964551,1,11,endodermal cell fate commitment,BP,DUSP6
4952,GO:0015037,0.675158566359037,0.707939538547375,1,12,peptide disulfide oxidoreductase activity,MF,GLRX
9027,GO:0035259,0.675196704316434,0.709558160604979,1,11,glucocorticoid receptor binding,MF,CEBPB
17088,GO:0101031,0.675472372920846,0.709261435205826,1,11,chaperone complex,CC,FYCO1
3754,GO:0008307,0.675776467258742,0.60213153156979,2,24,structural constituent of muscle,MF,OBSCN;OBSL1
12041,GO:0048012,0.675936931635145,0.708760857724,1,11,hepatocyte growth factor receptor signaling pathway,BP,MST1R
20157,GO:2001032,0.676103954043785,0.708580721630987,1,11,regulation of double-strand break repair via nonhomologous end joining,BP,HMGA2
1870,GO:0004550,0.676122997919881,0.706896397077008,1,12,nucleoside diphosphate kinase activity,MF,NME4
3618,GO:0008081,0.676183765705898,0.50033814034724,5,58,phosphoric diester hydrolase activity,MF,PLD3;PLCD1;PLCXD1;PLCD3;PLCH2
3903,GO:0008569,0.676792702055026,0.707836979838298,1,11,ATP-dependent microtubule motor activity, minus-end-directed,MF,DNAH1
16159,GO:0090208,0.677217466784426,0.707377562364487,1,11,positive regulation of triglyceride metabolic process,BP,LDLR
9856,GO:0042135,0.677410085747314,0.707169043781749,1,11,neurotransmitter catabolic process,BP,COMT
10587,GO:0043584,0.677618286227055,0.706943527172478,1,11,nose development,BP,PROX1
3530,GO:0007530,0.677710641989566,0.706843446760192,1,11,sex determination,BP,INSR
17086,GO:0101023,0.677812702757647,0.706732818591119,1,11,vascular endothelial cell proliferation,BP,FGFR1
19273,GO:1905562,0.677812702757647,0.706732818591119,1,11,regulation of vascular endothelial cell proliferation,BP,FGFR1
5490,GO:0016442,0.67781449362977,0.706730877095279,1,11,RISC complex,CC,AGO4
7311,GO:0031332,0.67781449362977,0.706730877095279,1,11,RNAi effector complex,CC,AGO4
9130,GO:0035497,0.677857405776655,0.70668435275545,1,11,cAMP response element binding,MF,HMGA2
6973,GO:0030662,0.677882312534847,0.440321952182195,11,127,coated vesicle membrane,CC,CEMIP;APOE;EGFR;CD9;VAMP2;AP2A2;HBEGF;LDLR;LDLRAP1;CLTCL1;EPN2
14235,GO:0061318,0.677893310736644,0.70664542101746,1,11,renal filtration cell differentiation,BP,LAMB2
15597,GO:0072112,0.677893310736644,0.70664542101746,1,11,glomerular visceral epithelial cell differentiation,BP,LAMB2
15710,GO:0072311,0.677893310736644,0.70664542101746,1,11,glomerular epithelial cell differentiation,BP,LAMB2
14979,GO:0070935,0.678042217001119,0.706483918937785,1,11,3'-UTR-mediated mRNA stabilization,BP,ZFP36
979,GO:0002433,0.678104747283513,0.498143238752962,5,58,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,PIK3R2;MAPK3;WIPF1;CYFIP2;VAV3
9682,GO:0038096,0.678104747283513,0.498143238752962,5,58,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,PIK3R2;MAPK3;WIPF1;CYFIP2;VAV3
4478,GO:0010510,0.678153656735936,0.706363007229676,1,11,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,PDK2
11899,GO:0046965,0.678210127678434,0.706301721616453,1,11,retinoid X receptor binding,MF,RARG
17729,GO:1901722,0.678250864185708,0.706257505743006,1,11,regulation of cell proliferation involved in kidney development,BP,EGR1
13887,GO:0060572,0.678365073051362,0.706133514405898,1,11,morphogenesis of an epithelial bud,BP,WNT2B
20143,GO:2001014,0.678373477000447,0.70612438900859,1,11,regulation of skeletal muscle cell differentiation,BP,GPC1
11375,GO:0045780,0.678463261178412,0.706026883373976,1,11,positive regulation of bone resorption,BP,EGFR
11840,GO:0046852,0.678463261178412,0.706026883373976,1,11,positive regulation of bone remodeling,BP,EGFR
16832,GO:0098789,0.678467404014771,0.706022383643063,1,11,pre-mRNA cleavage required for polyadenylation,BP,TUT1
5697,GO:0016836,0.67848267778733,0.54886003310752,3,36,hydro-lyase activity,MF,UROS;CA12;CBS
6563,GO:0022400,0.678546820721294,0.705936114990393,1,11,regulation of rhodopsin mediated signaling pathway,BP,GUCA1B
4551,GO:0010642,0.67859254780599,0.705886433674587,1,11,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,LRP1
10160,GO:0042769,0.678910217256827,0.548048655579334,3,37,DNA damage response, detection of DNA damage,BP,POLD4;HMGA2;C21ORF2
14121,GO:0061029,0.678968667026066,0.705477540794908,1,11,eyelid development in camera-type eye,BP,EGFR
9809,GO:0042044,0.679008807846789,0.705433876023684,1,11,fluid transport,BP,AQP3
2343,GO:0005402,0.679033988310054,0.705406482391821,1,11,carbohydrate:cation symporter activity,MF,SLC2A9
16034,GO:0089718,0.679238935584131,0.705183447748638,1,11,amino acid import across plasma membrane,BP,NTSR1
720,GO:0001947,0.679449234022837,0.548078208549794,3,35,heart looping,BP,PKD2;VANGL2;SUFU
10346,GO:0043178,0.679711260452066,0.516946121752222,4,48,alcohol binding,MF,APOE;ABCG1;ITPR3;OSBPL5
4181,GO:0009267,0.679796642234641,0.444116985360421,10,114,cellular response to starvation,BP,GLUL;MAPK3;PCSK9;DAP;GAS6;COMT;SESN2;WNT2B;C12ORF66;SLC2A1
15206,GO:0071391,0.679906025703847,0.704456569698433,1,11,cellular response to estrogen stimulus,BP,WBP2
9483,GO:0036148,0.68008429987953,0.704262080448901,1,11,phosphatidylglycerol acyl-chain remodeling,BP,LPCAT4
15436,GO:0071801,0.680110247865762,0.704233763991634,1,11,regulation of podosome assembly,BP,GSN
2404,GO:0005581,0.680113366060463,0.547309060930883,3,35,collagen trimer,CC,COL6A1;TNXB;COL13A1
1484,GO:0003823,0.680234220832863,0.596999522467412,2,24,antigen binding,MF,SLC7A8;TSPAN4
11493,GO:0046030,0.680307636953835,0.704018288190751,1,11,inositol trisphosphate phosphatase activity,MF,INPP5D
18268,GO:1903201,0.680394546942916,0.516157895239139,4,48,regulation of oxidative stress-induced cell death,BP,ENDOG;AKT1;TRAP1;PINK1
8228,GO:0033014,0.680419712422964,0.596784983698509,2,24,tetrapyrrole biosynthetic process,BP,UROS;RSAD1
6690,GO:0030099,0.680422602127289,0.397538389625381,25,287,myeloid cell differentiation,BP,FOS;CTNNBIP1;ZFP36L1;FAM210B;EPAS1;ASH2L;THRA;ZFPM1;NBEAL2;FAM20C;BCL6;FAM213A;VEGFA;CEBPB;L3MBTL1;ZFP36;LRRK1;DMTN;INPP5D;AGO4;ACVR1B;ZNF385A;VPS33B;JAK3;RARG
14027,GO:0060828,0.680470043730973,0.41412855038197,17,196,regulation of canonical Wnt signaling pathway,BP,APOE;EGR1;LRP5;FUZ;NPHP4;WNT7A;WWTR1;IGFBP2;DVL1;LRRK1;BTRC;IGFBP4;PIN1;WNT2B;SHISA6;SULF2;LZTS2
16120,GO:0090161,0.680547574499783,0.703756199708692,1,11,Golgi ribbon formation,BP,MYO18A
15268,GO:0071481,0.680638738238382,0.703656572129789,1,11,cellular response to X-ray,BP,HMGA2
9062,GO:0035330,0.680741089288154,0.703544687307755,1,11,regulation of hippo signaling,BP,WWC3
13378,GO:0052743,0.680789129845496,0.703492160466975,1,11,inositol tetrakisphosphate phosphatase activity,MF,INPP5D
9587,GO:0036464,0.681456620387986,0.422799868707522,14,161,cytoplasmic ribonucleoprotein granule,CC,BTBD2;ZFP36L1;GRB7;ZFP36;PITPNM1;MEX3A;PAN2;ICOSLG;AGO4;PNRC1;APOBEC3C;TDRKH;CTSH;APOBEC3F
15879,GO:0072678,0.681517593484499,0.595513549932321,2,24,T cell migration,BP,ECM1;PYCARD
6799,GO:0030262,0.681629813955432,0.59538343245022,2,24,apoptotic nuclear changes,BP,H1F0;ENDOG
11728,GO:0046597,0.681632534325603,0.700881473976851,1,12,negative regulation of viral entry into host cell,BP,GSN
5663,GO:0016783,0.681995713382711,0.700481622036252,1,12,sulfurtransferase activity,MF,TST
16443,GO:0097153,0.682350981873543,0.700090074672785,1,12,cysteine-type endopeptidase activity involved in apoptotic process,MF,PYCARD
12527,GO:0050702,0.683774023560317,0.592891643248941,2,24,interleukin-1 beta secretion,BP,HK1;PYCARD
11462,GO:0045944,0.684015298789758,0.362098341984103,73,789,positive regulation of transcription by RNA polymerase II,BP,TNIP1;FOS;CITED4;MEF2D;NOS1;NR1D1;EPAS1;NFATC4;EGFR;TCEA2;EGR1;CRTC1;ASH2L;SOX12;PIK3R2;PEG3;HDAC5;THRA;LRP5;MAML3;ZFPM1;TFEB;PKD2;SALL2;HEXB;TFDP2;WNT7A;ZMIZ1;ITGA6;TMEM173;STAT6;WWTR1;CD81;FZD8;VEGFA;CEBPB;HSF4;CALCOCO1;MAPK3;ETV5;FHOD1;HES1;MLXIPL;ETV4;RPS6KA5;TNFRSF1A;HMGA2;ELK3;PPARA;RXRA;HLTF;RFXANK;TEF;PIN1;IRF2BPL;PROX1;WBP2;SESN2;RXRB;ACVR1B;MEF2B;AKT1;SIX5;SSBP2;PKD1;ARHGEF10L;CAMTA2;ABHD14B;RFX2;DDN;LITAF;MZF1;RARG
4959,GO:0015078,0.684036596434608,0.475216149581533,6,75,proton transmembrane transporter activity,MF,SLC2A9;ATP12A;SLC22A18;TMCO3;NDUFA4L2;SLC9A7
1871,GO:0004551,0.684280315513609,0.697956712533605,1,12,nucleotide diphosphatase activity,MF,NUDT10
1388,GO:0003300,0.684877445847333,0.511184414774835,4,47,cardiac muscle hypertrophy,BP,ATP2B4;PIN1;JARID2;CAMTA2
4927,GO:0014897,0.684877445847333,0.511184414774835,4,47,striated muscle hypertrophy,BP,ATP2B4;PIN1;JARID2;CAMTA2
12337,GO:0048738,0.685009827798915,0.432453884078974,11,125,cardiac muscle tissue development,BP,OBSL1;ZFPM1;VEGFA;RXRA;FGFR1;PIN1;PROX1;PPP1R13L;JARID2;ERBB3;TAZ
12585,GO:0050792,0.68512912936655,0.418659399409484,14,163,regulation of viral process,BP,TNIP1;APOE;GSN;ADARB1;ISG20;MVB12B;PC;ZFP36;HMGA2;MVB12A;RAD23A;PROX1;APOBEC3C;APOBEC3F
2822,GO:0006296,0.685409440951396,0.540488793848422,3,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,ERCC1;POLD4;DDB2
15194,GO:0071375,0.685455049535662,0.401345686721128,20,225,cellular response to peptide hormone stimulus,BP,ZFP36L1;IGF2;SHC1;PIK3R2;HDAC5;PTPRE;VAMP2;INSR;MAPK3;ADCY6;PCSK9;PRKACA;EEF2K;PCK2;PRKCZ;PDK2;SRSF5;GRB10;AKT1;JAK3
18356,GO:1903391,0.685769338306533,0.510147951656397,4,47,regulation of adherens junction organization,BP,RHOD;VEGFA;DMTN;PPM1F
12754,GO:0051055,0.68604221840385,0.54006737309614,3,36,negative regulation of lipid biosynthetic process,BP,APOE;CYP27B1;PROX1
7846,GO:0032418,0.686055231587249,0.509598478920628,4,48,lysosome localization,BP,ADGRE2;ADORA2B;VPS33B;STXBP2
7206,GO:0031112,0.686248952216911,0.590002188825814,2,24,positive regulation of microtubule polymerization or depolymerization,BP,ARL2;TRPV4
10716,GO:0044091,0.687116903213328,0.588985462626996,2,24,membrane biogenesis,BP,NLGN2;ANK3
5608,GO:0016671,0.687267078985692,0.694630599455432,1,12,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,MSRB2
8952,GO:0035050,0.687337083965511,0.508322898427687,4,47,embryonic heart tube development,BP,PKD2;VANGL2;HES1;SUFU
3629,GO:0008106,0.68765052782711,0.69420150332867,1,12,alcohol dehydrogenase (NADP+) activity,MF,AKR7A2
1,GO:0000002,0.6878920715416,0.588075923683699,2,24,mitochondrial genome maintenance,BP,SESN2;PRIMPOL
11754,GO:0046635,0.688097848025021,0.587834239106726,2,24,positive regulation of alpha-beta T cell activation,BP,ADA;PRKCZ
2790,GO:0006244,0.688398840726892,0.693362738213607,1,12,pyrimidine nucleotide catabolic process,BP,NEIL1
11985,GO:0047496,0.688496056266015,0.537189839638913,3,36,vesicle transport along microtubule,BP,FYCO1;PRKCZ;NDE1
12222,GO:0048519,0.688842517233416,0.335500531724661,339,3631,negative regulation of biological process,BP,TNIP1;HTRA1;DUSP6;CEMIP;APOE;ESPN;CTNNBIP1;IDH2;PTPRS;ERCC1;WWC3;SEMA4B;NT5E;CST3;SHANK2;RAPGEF3;TCFL5;CYP27B1;GSN;EVI5L;XDH;PRDX5;NDRG1;PCBP4;NOS1;LTBP1;ARAP1;ZFP36L1;CGREF1;POSTN;GRB7;NR1D1;ALOX15B;ARRDC1;RBCK1;EPHB2;IGF2;NFATC4;MST1R;LRP1;EGFR;TIMP2;MMP28;HADH;FBXO2;DUSP5;TOM1L2;PPP1R14A;FHL1;MXD4;SERPING1;MDFI;EGR1;ULK1;RHBDF1;PKN1;CRTC1;ARPIN;SHC1;RGL2;F2R;PTK6;ABCA7;DEAF1;PPP2R3B;BAHCC1;BBS2;CORO1B;CXXC5;ULK2;GJC2;ZMYND8;TBC1D14;MXI1;PLAT;ABCG1;ANK3;PIK3R2;PEG3;HDAC5;THRA;DOCK4;ZP3;CRTAP;RPS6KA2;NISCH;LRP5;HYAL1;TENM2;ZFPM1;ERBB2;FBLN1;BRSK1;SCMH1;PTPRU;PKD2;ITPR3;PLXNB3;H2AFJ;VAT1;DNM1;SPRY4;DDIT4L;PTHLH;CDKN1C;SALL2;CD9;XPC;PTPRE;SERPINE2;FUZ;FOXQ1;RNF135;NPHP4;LTB4R2;UNK;NTSR1;ATP2B4;TMOD2;TFDP2;ACP5;RASA4;ADAMTS7;PDCD4;ASIC1;WNT7A;INSR;ZC3H6;ID1;EPHA1;ADARB1;ZNF692;ITGA6;SYNGAP1;IL20RB;PPP1R35;DNMT3A;PRNP;PAPLN;EFNB3;SNX33;HES2;SPRY2;HINT2;MNT;ECM1;STAT6;DLG4;SPEG;MTA3;STRADB;WWTR1;ISG20;MYO18A;DNAJB5;PLEKHH2;BCL6;PLXNB1;IGFBP2;BNIP3;SRMS;FZD8;VEGFA;ARL2;CEBPB;RHBDF2;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;S1PR2;TNFRSF6B;CARD19;TNNT1;DVL1;MTA1;GPSM1;ADCY6;L3MBTL1;MBD1;EPHB3;HES1;PC;FURIN;MLXIPL;MEFV;LRSAM1;ADA;MCTP1;PIDD1;PAG1;PHF21A;PFKL;SLIT3;PCSK9;ZFP36;MAPKBP1;FGFR3;PRKACA;F12;LRRK1;DGUOK;MAGEF1;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;SPTB;DMTN;TNFRSF1A;MAPK8IP1;TCF25;SEMA3B;LDLR;ABHD17C;TRPV4;BHLHE40;EIF4EBP3;RAG1;DUSP7;TNFAIP8L1;EEF2K;HMGA2;SEMA3F;ELK3;DGKQ;SEMA4C;FAM3A;GAS6;BTRC;MEX3A;POU6F1;ADGRB2;ZNF217;PPARA;TKFC;COMT;SUFU;PAN2;RXRA;VASN;BCR;IGFBP4;PRKCZ;CAPG;INPP5D;TM7SF3;TWF2;GPC1;AGO4;ARAP3;FGFR1;CTSZ;CHADL;PIN1;C5;IRF2BPL;PROX1;GTPBP1;DLG3;BIN1;VSNL1;SERPINB6;PPP1R13L;ASS1;SLC25A27;GRB10;JARID2;SESN2;TMEM161A;CSTB;PROCR;PNRC1;RTN4R;ELFN2;TIMP1;WHAMMP3;APOBEC3C;FGFBP1;PEAR1;WNT3;PPM1F;SORL1;STK39;ACVR1B;ANO9;ADORA2B;TPCN1;ERBB3;ABR;CCDC85B;AKT1;TRAP1;TMBIM4;NLRX1;ZNF385A;TP53INP1;NDRG2;SIX5;GPD1L;TDRKH;PINK1;GAS8;PKD1;SNTA1;RGS14;PCIF1;CTSH;MLST8;CBLC;EPN2;PYCARD;PCSK1N;ERN1;RANBP9;APOBEC3F;SIRT3;C12ORF66;JAK3;MZF1;NEIL1;RARG;ING4;PBXIP1;EREG;GSTM2;ZFYVE19;SHISA6;GIPR;SFI1;TP53I11;SEMA4F;RPL13A;RGS12;MIF;SULF2;LZTS2
11814,GO:0046785,0.688975367094127,0.485462162985654,5,59,microtubule polymerization,BP,TUBG2;ARL2;TRPV4;NDE1;RANBP9
2541,GO:0005815,0.688989484554739,0.363020517870629,56,611,microtubule organizing center,CC,FAM110C;NDRG1;RAB11FIP4;OBSL1;BBS2;NEK9;TUBG2;MARK4;BRSK1;PKD2;IFT140;NINL;NPHP4;USP20;ID1;MZT2A;CEP250;MZT2B;HOOK2;ARL2;FBF1;CUL7;EVC;ABCA2;PRKACA;PITPNM1;BBS1;CROCC;CCDC92;LRRC45;MVB12A;ADGRB2;PLEKHG6;GSDMC;WDR60;PRKCZ;CAPG;SPATA7;CEP68;NDE1;RAD23A;C21ORF2;WRAP73;PROCR;ACTR1B;CCDC85B;AKT1;SPPL2B;GAS8;MPLKIP;RGS14;RILPL1;NEIL1;ZFYVE19;SFI1;LZTS2
7387,GO:0031462,0.689895994173192,0.691679161543914,1,12,Cul2-RING ubiquitin ligase complex,CC,ZER1
4051,GO:0009109,0.689925484491068,0.691645925891389,1,12,coenzyme catabolic process,BP,ACOT7
130,GO:0000271,0.690004792823831,0.484267309971498,5,59,polysaccharide biosynthetic process,BP,PGM1;NR1D1;IGF2;INSR;AKT1
14483,GO:0065002,0.690426707085317,0.504089579268842,4,50,intracellular protein transmembrane transport,BP,PEX10;PEX7;BCR;RTN2
9266,GO:0035721,0.691123231954971,0.69029366278908,1,12,intraciliary retrograde transport,BP,IFT140
13155,GO:0051787,0.691419799772512,0.583918730235268,2,24,misfolded protein binding,MF,EDEM1;F12
6247,GO:0019840,0.691639613715612,0.689709217499821,1,12,isoprenoid binding,MF,RXRA
10653,GO:0043902,0.692051449675597,0.419288849977707,12,141,positive regulation of multi-organism process,BP,APOE;ZP3;ADARB1;MVB12B;MAPK3;PC;LRSAM1;MVB12A;PTAFR;RAD23A;ACVR1B;MIF
3364,GO:0007141,0.692113671478233,0.689171905026667,1,12,male meiosis I,BP,DMC1
12233,GO:0048536,0.692254564245999,0.582930686969955,2,24,spleen development,BP,PKN1;JARID2
10844,GO:0044380,0.69231957192282,0.502495536977518,4,47,protein localization to cytoskeleton,BP,CEP250;NUDCD3;DVL1;ABHD17C
6208,GO:0019748,0.692419717129437,0.532244016398331,3,37,secondary metabolic process,BP,CBS;AKR7A2;AS3MT
3035,GO:0006596,0.692470121589709,0.688767406733107,1,12,polyamine biosynthetic process,BP,SMOX
2492,GO:0005746,0.693192799412556,0.478909404572189,5,72,mitochondrial respiratory chain,CC,NDUFS8;SDHAF4;SDHA;NDUFA4L2;NDUFV3
10078,GO:0042599,0.693441746667346,0.687662686513216,1,12,lamellar body,CC,CTSH
17743,GO:1901797,0.693500344208237,0.580873513543302,2,25,negative regulation of signal transduction by p53 class mediator,BP,ZNF385A;MIF
10037,GO:0042537,0.693580736735852,0.687504402830264,1,12,benzene-containing compound metabolic process,BP,GSTM2
7605,GO:0032007,0.693799580060328,0.530930840329796,3,36,negative regulation of TOR signaling,BP,TNFAIP8L1;SESN2;C12ORF66
5605,GO:0016667,0.694167237744336,0.499698209492831,4,50,oxidoreductase activity, acting on a sulfur group of donors,MF,MSRB2;TXNRD3;GLRX;SESN2
4678,GO:0010837,0.694495591706018,0.58026991824409,2,24,regulation of keratinocyte proliferation,BP,ZFP36L1;ZFP36
12100,GO:0048188,0.694591662425546,0.68635122641314,1,12,Set1C/COMPASS complex,CC,ASH2L
10543,GO:0043518,0.694924420272266,0.685970904854802,1,12,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,MIF
12459,GO:0050433,0.694931187119879,0.685963166958622,1,12,regulation of catecholamine secretion,BP,PINK1
6051,GO:0019208,0.695105190353265,0.462894601420024,6,71,phosphatase regulator activity,MF,B3GAT3;PPP1R14A;PPP2R3B;PPP1R35;ELFN2;SBF1
7051,GO:0030850,0.695117535368472,0.529366948948588,3,36,prostate gland development,BP,ALOX15B;RXRA;RARG
3707,GO:0008234,0.695195690780254,0.411422027269033,13,150,cysteine-type peptidase activity,MF,JOSD2;CTSB;CTSF;USP20;BLMH;ANKZF1;CAPNS2;USP21;CTSZ;CAPN2;CTSD;CTSH;PYCARD
12854,GO:0051213,0.695196203958057,0.462788963384403,6,71,dioxygenase activity,MF,ALOX15B;PHYHD1;PHYH;HPDL;KDM4B;ALKBH6
10541,GO:0043516,0.695578791865681,0.578398450520439,2,25,regulation of DNA damage response, signal transduction by p53 class mediator,BP,ZNF385A;MIF
8042,GO:0032717,0.695860897388333,0.684898596508454,1,12,negative regulation of interleukin-8 production,BP,MAPKBP1
3315,GO:0007030,0.696088988777717,0.42567770052613,10,115,Golgi organization,BP,OBSL1;FBXW8;MYO18A;MAPK3;CUL7;MAP2K2;PI4K2A;EHD3;GOLGA2P5;TMED4
11695,GO:0046519,0.696105375034788,0.684618178480957,1,12,sphingoid metabolic process,BP,KDSR
5642,GO:0016747,0.696135937727976,0.402927239206744,15,172,transferase activity, transferring acyl groups other than amino-acyl groups,MF,CRAT;CPT2;LPCAT4;CERS4;CPT1C;ZDHHC1;NAGS;MBOAT7;ZDHHC24;LCAT;HGSNAT;AGPAT4;GCAT;TAZ;AGPAT3
14116,GO:0061014,0.696374052813733,0.527872789198805,3,36,positive regulation of mRNA catabolic process,BP,ZFP36L1;ZFP36;GTPBP1
4926,GO:0014896,0.69654243733097,0.4973059390151,4,48,muscle hypertrophy,BP,ATP2B4;PIN1;JARID2;CAMTA2
9117,GO:0035458,0.696817565096906,0.683800154537099,1,12,cellular response to interferon-beta,BP,TMEM173
13778,GO:0060395,0.696888214780423,0.527260490113501,3,36,SMAD protein signal transduction,BP,FOS;WWTR1;BTBD11
9864,GO:0042149,0.697014256836842,0.5271103112043,3,36,cellular response to glucose starvation,BP,SESN2;C12ORF66;SLC2A1
2731,GO:0006120,0.697024666452173,0.524742341311696,3,45,mitochondrial electron transport, NADH to ubiquinone,BP,NDUFS8;PINK1;NDUFV3
8352,GO:0033260,0.697261122951379,0.496248078042947,4,49,nuclear DNA replication,BP,POLD4;BCL6;FGFR1;WDR18
305,GO:0000815,0.697618375821363,0.682878316849306,1,12,ESCRT III complex,CC,CHMP1B
3770,GO:0008333,0.697781202536383,0.495841718630709,4,48,endosome to lysosome transport,BP,VPS11;HOOK2;BIN1;LYST
13445,GO:0055008,0.697862845646336,0.52609840363802,3,36,cardiac muscle tissue morphogenesis,BP,ZFPM1;RXRA;PROX1
13613,GO:0060143,0.697992521285953,0.682446890659846,1,12,positive regulation of syncytium formation by plasma membrane fusion,BP,RAPGEF3
6275,GO:0019888,0.698097810478878,0.474664745450383,5,60,protein phosphatase regulator activity,MF,B3GAT3;PPP1R14A;PPP2R3B;PPP1R35;ELFN2
4630,GO:0010762,0.698367953746314,0.575643757896324,2,24,regulation of fibroblast migration,BP,DMTN;AKT1
4380,GO:0010042,0.698706137905759,0.681622718737913,1,12,response to manganese ion,BP,D2HGDH
7987,GO:0032620,0.699016706504761,0.681263501484696,1,12,interleukin-17 production,BP,PRNP
8874,GO:0034707,0.699181101948525,0.681073223096477,1,12,chloride channel complex,CC,TTYH3
1479,GO:0003777,0.699473097743461,0.445959935898542,7,82,microtubule motor activity,MF,DNAH1;KIF13B;MYH3;WDR60;WDR63;KIFC2;KIF26B
6628,GO:0023023,0.699705883115151,0.680465209270384,1,12,MHC protein complex binding,MF,CD81
6647,GO:0030008,0.699726885531506,0.67895636568749,1,13,TRAPP complex,CC,TRAPPC9
3346,GO:0007088,0.699963977706713,0.410406750995188,12,140,regulation of mitotic nuclear division,BP,IGF2;OBSL1;TOM1L2;LRP5;CUL9;INSR;CHMP1B;L3MBTL1;CUL7;FBXW5;PIN1;EREG
18689,GO:1904152,0.700669185947388,0.679346701969964,1,12,regulation of retrograde protein transport, ER to cytosol,BP,EDEM1
13890,GO:0060575,0.700862378208906,0.679122005149062,1,12,intestinal epithelial cell differentiation,BP,PTK6
9054,GO:0035308,0.700988323026582,0.522036531216177,3,37,negative regulation of protein dephosphorylation,BP,PPP1R14A;PPP1R35;ELFN2
134,GO:0000281,0.701147897713014,0.471078049778286,5,60,mitotic cytokinesis,BP,ANK3;SNX33;SNX9;CUL7;SEPT8
7556,GO:0031929,0.701488880483139,0.434007709114381,8,94,TOR signaling,BP,TNFAIP8L1;DGKQ;GAS6;SESN2;AKT1;PINK1;MLST8;C12ORF66
11470,GO:0045956,0.701530667657054,0.678343759161374,1,12,positive regulation of calcium ion-dependent exocytosis,BP,ZP3
19032,GO:1904923,0.701870702696597,0.677947194494566,1,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,PINK1
9880,GO:0042181,0.701999996767071,0.570685915831417,2,25,ketone biosynthetic process,BP,EGR1;DGKQ
15185,GO:0071360,0.702061078731107,0.677724997404425,1,12,cellular response to exogenous dsRNA,BP,TMEM173
2730,GO:0006119,0.702110347941478,0.441782443582651,7,96,oxidative phosphorylation,BP,NDUFS8;MLXIPL;SDHA;UQCR11;PINK1;NDUFV3;TAZ
8247,GO:0033043,0.702148409965037,0.338041147559638,93,1011,regulation of organelle organization,BP,ESPN;ERCC1;RAPGEF3;GSN;EVI5L;NOS1;ARAP1;IGF2;LRP1;OBSL1;TOM1L2;MTHFR;ULK1;ARPIN;CORO1B;ZMYND8;TBC1D14;LRP5;MICALL2;VAT1;IFT140;CUL9;VPS11;FUZ;TMOD2;TFDP2;RHOD;INSR;SH3PXD2B;TBC1D8;ID1;CELSR1;EPHA1;CEP250;PLEKHH2;BCL6;PLXNB1;CHMP1B;BNIP3;VEGFA;ARL2;VANGL2;SHANK3;MAPK3;FYCO1;WIPF1;L3MBTL1;FHOD1;HES1;SSH1;CUL7;PLEKHG2;LRSAM1;CDC42EP5;RHOF;RPS6KA5;MAP2K2;SPTB;FBXW5;DMTN;TRPV4;RHOBTB2;CROCC;TBC1D16;CAPG;TWF2;PIN1;PROX1;WBP2;OSCP1;JARID2;CAPN2;WRAP73;SDC1;WHAMMP3;EPS8L1;PPM1F;TBC1D17;AKT1;EPS8L2;SSH3;PINK1;PKD1;EHD3;ARHGEF10L;SPIRE2;MLST8;PYCARD;ARHGEF19;EREG;FAM162A;FCHSD1;UBL5
12811,GO:0051147,0.702754688213096,0.432545846074212,8,94,regulation of muscle cell differentiation,BP,IGF2;HDAC5;THRA;PDCD4;OLFM2;PIN1;PROX1;EREG
199,GO:0000421,0.70277986670066,0.569742355742216,2,25,autophagosome membrane,CC,ULK1;ATG16L2
884,GO:0002251,0.702816773321879,0.672969877750319,1,15,organ or tissue specific immune response,BP,IL6R
7493,GO:0031683,0.702946908605479,0.676689478517932,1,12,G-protein beta/gamma-subunit complex binding,MF,GNAL
19929,GO:2000516,0.703104878283458,0.676504533562414,1,12,positive regulation of CD4-positive, alpha-beta T cell activation,BP,PRKCZ
4274,GO:0009650,0.703310479965628,0.676263695133806,1,12,UV protection,BP,ERCC1
16114,GO:0090153,0.703330254621034,0.676240523808403,1,12,regulation of sphingolipid biosynthetic process,BP,TNFRSF1A
19080,GO:1905038,0.703330254621034,0.676240523808403,1,12,regulation of membrane lipid metabolic process,BP,TNFRSF1A
19808,GO:2000303,0.703330254621034,0.676240523808403,1,12,regulation of ceramide biosynthetic process,BP,TNFRSF1A
10288,GO:0043073,0.703481742400497,0.676062970784528,1,12,germ cell nucleus,CC,TCFL5
11799,GO:0046716,0.703583045591011,0.67594419338659,1,12,muscle cell cellular homeostasis,BP,GAA
7126,GO:0030970,0.704021989092747,0.568236427472888,2,25,retrograde protein transport, ER to cytosol,BP,TMEM129;EDEM1
18404,GO:1903513,0.704021989092747,0.568236427472888,2,25,endoplasmic reticulum to cytosol transport,BP,TMEM129;EDEM1
13842,GO:0060487,0.70416284495738,0.67526370576238,1,12,lung epithelial cell differentiation,BP,THRA
15722,GO:0072337,0.704355466181956,0.675037378775969,1,12,modified amino acid transport,BP,SLC6A8
6302,GO:0019956,0.704471622248998,0.674900835627651,1,12,chemokine binding,MF,ZFP36
15304,GO:0071549,0.704604335573173,0.567529089127284,2,25,cellular response to dexamethasone stimulus,BP,EGFR;PCK2
6582,GO:0022607,0.704778064967069,0.323668872218447,204,2214,cellular component assembly,BP,ADGRL1;APOE;TYSND1;ESPN;CTNNBIP1;ERCC1;FLNC;FAM110C;SHANK2;RAPGEF3;GSN;EVI5L;PARVB;ARAP1;COL6A1;TCTN1;GRB7;EPHB2;OBSCN;GPX3;KCNG1;OBSL1;H1F0;NLGN2;LOXL1;DDB2;ADGRF1;ULK1;SDK2;CRTC1;ARPIN;ARHGEF4;ABCA7;LAMA5;SLC9A3R2;BAHCC1;BBS2;DNAH1;CORO1B;ULK2;ZMYND8;TBC1D14;ASH2L;PACS2;SOX12;KCNC4;MMP1;ANK3;THRA;HYAL1;TUBG2;MARK4;TENM2;EXOC2;MICALL2;PKD2;ITGB4;ITPR3;PLXNB3;DNM1;FCHO1;MSRB2;IFT140;CD9;XPC;NINL;SIGMAR1;VPS11;VAMP2;CCDC69;FUZ;NPHP4;THSD4;TMOD2;CSNK1E;TRAPPC9;GLUL;RHOD;TNXB;ASIC1;WNT7A;INSR;SH3PXD2B;ID1;NDUFS8;RABGGTA;EPHA1;ITGA6;LPAR3;PRNP;CEP250;ATG16L2;SNX9;DLG4;WWTR1;TMEM107;CHMP1B;VEGFA;ARL2;VANGL2;SHANK3;HSF4;NUDCD3;S1PR2;MAPK3;TNNT1;DVL1;WIPF1;WIPI2;EPHB3;FHOD1;HES1;SSH1;FBF1;MEFV;TRIM4;PLEKHG2;LRSAM1;CDC42EP5;PFKL;RHOF;PRKACA;CYFIP2;ITGB5;SPTB;DMTN;BBS1;MYH3;TNFRSF1A;EHD4;TRPV4;RHOBTB2;CROCC;EEF2K;HMGA2;AHNAK2;DGKQ;MVB12A;SDHAF4;GAS6;LLGL1;ADGRB2;HMGCL;TSPAN4;DMC1;ATG2A;RXRA;VAV3;TMEM175;WDR60;PRKCZ;CLTCL1;CAPG;SLITRK6;TWF2;GPC1;SRSF5;NDE1;AGO4;CTSZ;PROX1;BIN1;UNC119B;WRAP73;TMEM231;LCAT;EPB41L3;SDC1;WHAMMP3;GRHPR;H1FX;EPS8L1;PPM1F;SORL1;HGSNAT;SEPT8;TP53INP1;EPS8L2;TMEM120A;SSH3;PINK1;GAS8;EHD3;ARHGEF10L;GOLGA2P5;MAFIP;SPIRE2;P3H4;MLST8;RILPL1;ATXN10;RFX2;PYCARD;DNAAF5;NDUFV3;RANBP9;SLC2A1;TAZ;APBA1;FCHSD1;WDR18;SFI1;RPL13A;MIF
3027,GO:0006584,0.704895638731946,0.567174947386531,2,25,catecholamine metabolic process,BP,EPAS1;COMT
4281,GO:0009712,0.704895638731946,0.567174947386531,2,25,catechol-containing compound metabolic process,BP,EPAS1;COMT
4027,GO:0009068,0.704901485404559,0.674395122054195,1,12,aspartate family amino acid catabolic process,BP,GCAT
3575,GO:0007628,0.705123975565659,0.674133123409239,1,12,adult walking behavior,BP,EFNB3
4197,GO:0009314,0.705152904907134,0.363976575524498,30,337,response to radiation,BP,FOS;ERCC1;NFATC4;MAPK13;EGFR;REEP6;DDB2;EGR1;CRTC1;DEAF1;LRP5;HYAL1;BRSK1;XPC;NPHP4;SYNGAP1;DNMT3A;MTA1;PITPNM1;BHLHE40;RAG1;HMGA2;DMC1;TMEM161A;GUCA1B;AKT1;TP53INP1;ERCC6;RGS14;PRIMPOL
8302,GO:0033151,0.705603515564781,0.673567849921928,1,12,V(D)J recombination,BP,RAG1
7860,GO:0032433,0.706059833654717,0.673029213725156,1,12,filopodium tip,CC,MORN4
7989,GO:0032623,0.706092666148813,0.515886700148116,3,37,interleukin-2 production,BP,IL20RB;PRNP;ZFP36
15398,GO:0071696,0.706112744555957,0.672966711378893,1,12,ectodermal placode development,BP,PROX1
4265,GO:0009635,0.706358810830103,0.672675912233834,1,12,response to herbicide,BP,MAPK13
17558,GO:1901215,0.706688510042321,0.407725085809157,11,129,negative regulation of neuron death,BP,APOE;LRP1;F2R;SYNGAP1;CEBPB;PPARA;PIN1;SORL1;ERBB3;AKT1;PINK1
39,GO:0000079,0.706803940913955,0.44899454945665,6,73,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,EGFR;PKD2;PROX1;MAPRE3;AKT1;PKD1
5600,GO:0016653,0.706817380938833,0.672133418926702,1,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,NOS1
5294,GO:0016010,0.706850951681439,0.672093675783254,1,12,dystrophin-associated glycoprotein complex,CC,SNTA1
16335,GO:0090665,0.706850951681439,0.672093675783254,1,12,glycoprotein complex,CC,SNTA1
4572,GO:0010667,0.706932021898905,0.671997683690895,1,12,negative regulation of cardiac muscle cell apoptotic process,BP,RGL2
19705,GO:2000105,0.706999304062673,0.671918000203411,1,12,positive regulation of DNA-dependent DNA replication,BP,FGFR1
11397,GO:0045833,0.707040109507049,0.484605054257592,4,49,negative regulation of lipid metabolic process,BP,APOE;CYP27B1;PROX1;AKT1
2733,GO:0006122,0.707095133376379,0.670293970420641,1,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,UQCR11
9845,GO:0042116,0.70757152311951,0.514095151814762,3,37,macrophage activation,BP,MYO18A;LDLR;MIF
7416,GO:0031529,0.707807678776938,0.513808653386225,3,37,ruffle organization,BP,CORO1B;EPS8L1;EPS8L2
8898,GO:0034755,0.708035539789236,0.670688783229585,1,12,iron ion transmembrane transport,BP,SLC25A37
8975,GO:0035102,0.708180251423782,0.670516824524088,1,12,PRC1 complex,CC,PHC2
8020,GO:0032677,0.708709778347605,0.512407001658884,3,38,regulation of interleukin-8 production,BP,F2R;MAPKBP1;PYCARD
5393,GO:0016241,0.708920481215428,0.39588389289988,13,151,regulation of macroautophagy,BP,ULK1;TBC1D14;BNIP3;MAPK3;FYCO1;GPSM1;LRSAM1;PRKACA;SESN2;AKT1;PINK1;MLST8;ERN1
11326,GO:0045672,0.70902933103354,0.669506405607593,1,12,positive regulation of osteoclast differentiation,BP,FOS
17834,GO:1902074,0.709046131607382,0.669486387267843,1,12,response to salt,BP,MAPK13
13184,GO:0051861,0.709262500734547,0.669228489449024,1,12,glycolipid binding,MF,RTN4R
730,GO:0001960,0.709517908334957,0.511424103296678,3,38,negative regulation of cytokine-mediated signaling pathway,BP,ECM1;SLIT3;GAS6
7004,GO:0030728,0.70958349862381,0.668845579494529,1,12,ovulation,BP,EREG
15566,GO:0072074,0.709689553704501,0.668718989941183,1,12,kidney mesenchyme development,BP,PKD2
15536,GO:0072010,0.709689696930164,0.668718818957607,1,12,glomerular epithelium development,BP,LAMB2
12601,GO:0050812,0.709924363257788,0.668438576236578,1,12,regulation of acyl-CoA biosynthetic process,BP,PDK2
6577,GO:0022600,0.709990345576061,0.511155333519226,3,37,digestive system process,BP,LDLR;STK39;KCNN4
3477,GO:0007350,0.710242243450001,0.668058650263946,1,12,blastoderm segmentation,BP,SEMA3F
4742,GO:0010923,0.710320754028368,0.444959614687715,6,72,negative regulation of phosphatase activity,BP,PPP1R14A;PPP1R35;DLG3;ELFN2;PCIF1;SFI1
11085,GO:0045120,0.710377960682374,0.667896334955997,1,12,pronucleus,CC,SLC2A1
12220,GO:0048515,0.710382484266951,0.444774329541547,6,73,spermatid differentiation,BP,BBS2;DNAH1;PRKACA;DMC1;SIX5;RFX2
787,GO:0002052,0.71041624755132,0.667850532876309,1,12,positive regulation of neuroblast proliferation,BP,VEGFA
10294,GO:0043090,0.710526197736696,0.667718972298782,1,12,amino acid import,BP,NTSR1
1852,GO:0004519,0.710527242041963,0.415519889304947,9,108,endonuclease activity,MF,ERCC1;RNASET2;DNASE1L1;ENDOG;RAG1;DMC1;ERN1;RNASEK;NEIL1
16110,GO:0090148,0.710546577179031,0.667694582670471,1,12,membrane fission,BP,DNM1
13550,GO:0060045,0.710565344773175,0.667672120775302,1,12,positive regulation of cardiac muscle cell proliferation,BP,FGFR1
8985,GO:0035136,0.710592210084245,0.560207067369408,2,25,forelimb morphogenesis,BP,WNT7A;WNT3
17862,GO:1902170,0.710681596542112,0.667532957891162,1,12,cellular response to reactive nitrogen species,BP,STAT6
13921,GO:0060628,0.710855926723723,0.667324181378006,1,12,regulation of ER to Golgi vesicle-mediated transport,BP,SORL1
14165,GO:0061099,0.710864150296925,0.559872404189005,2,25,negative regulation of protein tyrosine kinase activity,BP,PTK6;CBLC
1348,GO:0003215,0.710873399365761,0.667303250383171,1,12,cardiac right ventricle morphogenesis,BP,PPP1R13L
4565,GO:0010660,0.710910349883624,0.510034039414432,3,37,regulation of muscle cell apoptotic process,BP,RGL2;PDCD4;BNIP3
8815,GO:0034616,0.711033536052903,0.66711136788251,1,12,response to laminar fluid shear stress,BP,ASS1
5494,GO:0016447,0.71103457497747,0.509882502311839,3,37,somatic recombination of immunoglobulin gene segments,BP,ERCC1;STAT6;BCL6
3244,GO:0006911,0.711284714607476,0.559354469433567,2,25,phagocytosis, engulfment,BP,GSN;ABCA7
13204,GO:0051895,0.711470256179869,0.66658761274651,1,12,negative regulation of focal adhesion assembly,BP,DMTN
7465,GO:0031641,0.711859294508311,0.558646138727006,2,25,regulation of myelination,BP,AKT1;RARG
2351,GO:0005452,0.711941361040966,0.666021866548293,1,12,inorganic anion exchanger activity,MF,SLC22A17
7163,GO:0031056,0.712204307198983,0.407112229628892,10,117,regulation of histone modification,BP,NOS1;IGF2;MTHFR;BCL6;VEGFA;MAPK3;RPS6KA5;WBP2;JARID2;PINK1
16106,GO:0090136,0.712204933009515,0.665705003242352,1,12,epithelial cell-cell adhesion,BP,ITGB5
7202,GO:0031106,0.712221227974884,0.66568540555981,1,12,septin ring organization,BP,SEPT8
1866,GO:0004535,0.71222909503337,0.66567594364117,1,12,poly(A)-specific ribonuclease activity,MF,PAN2
6932,GO:0030552,0.71239326811365,0.665478438478992,1,12,cAMP binding,MF,RAPGEF3
7764,GO:0032300,0.712459736793452,0.665398447548501,1,12,mismatch repair complex,CC,PMS2P5
390,GO:0001046,0.71248328889714,0.442400734173749,6,72,core promoter sequence-specific DNA binding,MF,FOS;NR1D1;CEBPB;MTA1;PROX1;WBP2
10807,GO:0044319,0.712491451894721,0.557865862545067,2,25,wound healing, spreading of cells,BP,WNT7A;HBEGF
16293,GO:0090505,0.712491451894721,0.557865862545067,2,25,epiboly involved in wound healing,BP,WNT7A;HBEGF
2395,GO:0005545,0.712495281529914,0.665355665247435,1,12,1-phosphatidylinositol binding,MF,SNX9
14109,GO:0061003,0.712514597947979,0.665332413778403,1,12,positive regulation of dendritic spine morphogenesis,BP,EEF2K
4143,GO:0009214,0.712514597947979,0.665332413778059,1,12,cyclic nucleotide catabolic process,BP,RAPGEF3
7875,GO:0032454,0.712514597947979,0.66533241377823,1,12,histone demethylase activity (H3-K9 specific),MF,KDM4B
20266,GO:2001275,0.712514597947979,0.665332413778403,1,12,positive regulation of glucose import in response to insulin stimulus,BP,PIK3R2
11093,GO:0045132,0.713158317382527,0.477236349999855,4,49,meiotic chromosome segregation,BP,DMC1;AGO4;SUN1;P3H4
2370,GO:0005504,0.713382168804102,0.66144707738336,1,14,fatty acid binding,MF,PPARA
1995,GO:0004722,0.713625793562434,0.456107268390729,5,61,protein serine/threonine phosphatase activity,MF,PPP2R3B;PPM1J;MYH3;DUSP23;PPM1F
14107,GO:0061001,0.71378662452415,0.55626405586469,2,25,regulation of dendritic spine morphogenesis,BP,SHANK3;EEF2K
646,GO:0001837,0.714451248840621,0.418871486272479,8,95,epithelial to mesenchymal transition,BP,S100A4;FUZ;PDCD4;WWTR1;ADAM15;CUL7;HMGA2;VASN
6137,GO:0019432,0.714730406768241,0.555094143440005,2,25,triglyceride biosynthetic process,BP,LDLR;PCK2
59,GO:0000122,0.714918908878272,0.335690179511268,55,605,negative regulation of transcription by RNA polymerase II,BP,CTNNBIP1;WWC3;TCFL5;NR1D1;IGF2;NFATC4;MXD4;MDFI;EGR1;DEAF1;CXXC5;ZMYND8;MXI1;PEG3;HDAC5;THRA;TENM2;ZFPM1;SALL2;FOXQ1;ID1;ZNF692;DNMT3A;HES2;MNT;STAT6;WWTR1;DNAJB5;BCL6;FZD8;VEGFA;CEBPB;ACVR2B;HSF4;MBD1;HES1;MLXIPL;PHF21A;ZFP36;TCF25;TRPV4;BHLHE40;HMGA2;POU6F1;ZNF217;PPARA;SUFU;RXRA;FGFR1;IRF2BPL;PROX1;PPP1R13L;JARID2;MZF1;RARG
18776,GO:1904353,0.715363827819656,0.554307679903236,2,25,regulation of telomere capping,BP,ERCC1;MAPK3
14260,GO:0061371,0.715370192168223,0.5045738051468,3,37,determination of heart left/right asymmetry,BP,PKD2;VANGL2;SUFU
7651,GO:0032092,0.715823554213527,0.438322893538304,6,73,positive regulation of protein binding,BP,APOE;LRP1;TMEM173;RFNG;MAPRE3;PKD1
11041,GO:0045058,0.715966189226391,0.553558828344203,2,25,T cell selection,BP,ZFPM1;STAT6
9877,GO:0042177,0.716129224298896,0.416691619064955,8,98,negative regulation of protein catabolic process,BP,CST3;EGFR;TIMP2;SERPINE2;FURIN;SUFU;PIN1;TIMP1
6644,GO:0030003,0.716384571100908,0.352751288986755,29,332,cellular cation homeostasis,BP,CEMIP;APOE;NOS1;F2R;PKD2;ITPR3;HEXB;NTSR1;ATP2B4;LPAR3;PRNP;ATP7B;DLG4;ATP12A;BNIP3;MAPK3;PRKACA;TRPV4;TMEM175;KCNMA1;SLC25A27;SMDT1;CYBRD1;SLC9A7;TPCN1;PKD1;SLC22A17;GSTM2;GIPR
5737,GO:0016894,0.71653913167359,0.552298407422801,2,26,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,RNASET2;NEIL1
18450,GO:1903578,0.716550822346764,0.437457377809571,6,73,regulation of ATP metabolic process,BP,INSR;PFKFB2;MLXIPL;PPARA;PINK1;TAZ
11665,GO:0046471,0.716907611568452,0.552386595452514,2,25,phosphatidylglycerol metabolic process,BP,LPCAT4;TAZ
8277,GO:0033120,0.717077112505809,0.552175295773617,2,25,positive regulation of RNA splicing,BP,SRSF5;ERN1
3628,GO:0008104,0.717131012148731,0.31159071775157,190,2063,protein localization,BP,LMF1;CEMIP;APOE;MARVELD1;IDH2;SYTL1;RAPGEF3;GSN;EVI5L;LTBP1;TCTN1;POSTN;NR1D1;ALOX15B;ARRDC1;EPHB2;OBSCN;LRP1;LTBP2;OBSL1;EGFR;B3GAT3;HADH;NLGN2;TOM1L2;MDFI;ULK1;RHBDF1;DOPEY2;F2R;ABCA7;LAMA5;BBS2;CORO1B;MALL;ZMYND8;TBC1D14;PACS2;MXI1;ABCG1;ANK3;PIK3R2;THRA;LRP5;ERBB2;EXOC2;MICALL2;BSG;PTPRU;PKD2;TMEM129;EDEM1;ITPR3;PRAF2;IFT140;KIF13B;VPS11;VAMP2;FUZ;TFDP2;CSNK1E;AGAP1;GLUL;RHOD;PEX10;WNT7A;RAB3D;SH3PXD2B;TBC1D8;ID1;CELSR1;SYNGAP1;TMEM173;PRNP;SNX33;CEP250;ATG16L2;SNX9;DLG4;REEP2;STRADB;RAB25;MYO18A;TMEM107;BCL6;PFKFB2;CHMP1B;MVB12B;CD81;HOOK2;ARL2;VANGL2;AP2A2;RHBDF2;SHANK3;ACVR2B;NUDCD3;ZDHHC1;MAPK3;TUB;KCNAB2;ETV5;OLFM2;AMN;RAB40B;DVL1;WIPI2;HES1;SSH1;LRSAM1;PFKL;MAPKBP1;PITPNM1;RAB3B;STX10;TSPAN33;DMTN;BBS1;VGF;TNFRSF1A;SNX17;ABHD17C;TRPV4;CROCC;LDLRAP1;PEX7;MVB12A;HK1;GAS6;LLGL1;GUK1;TTC7B;SUFU;PCK2;BCR;TBC1D16;PRKCZ;ZDHHC24;CLTCL1;TM7SF3;TMCO6;SPATA7;TWF2;SRSF5;CEP68;PIN1;C5;WBP2;DLG3;VSNL1;UNC119B;OSCP1;SESN2;TOLLIP;TMEM231;MAPRE3;EPB41L3;RTN2;LYST;SORL1;TBC1D17;TSNARE1;AKT1;SEPT8;VPS33B;GPD1L;SUN1;PINK1;GAS8;PKD1;EHD3;LONP2;SYNE3;SPIRE2;RILPL1;PYCARD;KCNN4;SIRT3;C12ORF66;SLC2A1;APBA1;SHISA6;GIPR;TMED4;RPL13A;RAB40C;MIF;STXBP2;UBL5;LZTS2
6500,GO:0021885,0.717217027724672,0.502300672732439,3,37,forebrain cell migration,BP,EGFR;MBOAT7;SUN1
10654,GO:0043903,0.717247433473582,0.378975532800724,15,178,regulation of symbiosis, encompassing mutualism through parasitism,BP,TNIP1;APOE;GSN;EXOC2;ADARB1;ISG20;MVB12B;PC;ZFP36;HMGA2;MVB12A;RAD23A;PROX1;APOBEC3C;APOBEC3F
5977,GO:0018904,0.717774671319174,0.657403413210404,1,13,ether metabolic process,BP,PEX7
8064,GO:0032757,0.717872942164611,0.550634165516552,2,26,positive regulation of interleukin-8 production,BP,F2R;PYCARD
6050,GO:0019207,0.718123690035949,0.381494979893103,14,164,kinase regulator activity,MF,IGF2;PIK3R2;CDKN1C;SPRY2;SAMD3;MAP2K2;MAPK8IP1;DGKQ;GAS6;MADD;RTN4R;ERBB3;ERCC6;MLST8
7182,GO:0031083,0.718607744050464,0.65638078787683,1,13,BLOC-1 complex,CC,PI4K2A
9061,GO:0035329,0.719117650990936,0.499953921272732,3,37,hippo signaling,BP,WWC3;NPHP4;WWTR1
1922,GO:0004620,0.71934034238341,0.449237974080729,5,61,phospholipase activity,MF,PLD3;PLCD1;PLCD3;PLCH2;LYPLAL1
16153,GO:0090201,0.72014500504463,0.65448715092627,1,13,negative regulation of release of cytochrome c from mitochondria,BP,AKT1
12913,GO:0051298,0.720191584424055,0.448210285114813,5,61,centrosome duplication,BP,BRSK1;PKD2;CHMP1B;FBXW5;NDE1
8043,GO:0032720,0.720811520677667,0.546951408980917,2,26,negative regulation of tumor necrosis factor production,BP,ACP5;GAS6
19583,GO:1990752,0.721039230411222,0.54721498672005,2,25,microtubule end,CC,CLIP2;MAPRE3
8490,GO:0033683,0.721126745159394,0.49686485314374,3,39,nucleotide-excision repair, DNA incision,BP,ERCC1;POLD4;DDB2
4177,GO:0009263,0.721183144043636,0.653203483844672,1,13,deoxyribonucleotide biosynthetic process,BP,GUK1
977,GO:0002431,0.721295118257388,0.446876285246783,5,61,Fc receptor mediated stimulatory signaling pathway,BP,PIK3R2;MAPK3;WIPF1;CYFIP2;VAV3
5040,GO:0015238,0.72137214341664,0.446783101081241,5,61,drug transmembrane transporter activity,MF,SLC13A3;SLC6A8;SLC22A18;SLC25A29;PQLC2
8297,GO:0033145,0.721452901369756,0.652869282939849,1,13,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,WBP2
14527,GO:0070076,0.721688324581936,0.546398479208851,2,25,histone lysine demethylation,BP,HSF4;KDM4B
15173,GO:0071347,0.721718067674719,0.395780021409575,10,123,cellular response to interleukin-1,BP,MAPK13;EGR1;HYAL1;ADAMTS7;CEBPB;MAPK3;RPS6KA5;BTRC;TOLLIP;PYCARD
4192,GO:0009309,0.722828797937184,0.651160545769069,1,13,amine biosynthetic process,BP,SMOX
9974,GO:0042401,0.722828797937184,0.651160545769069,1,13,cellular biogenic amine biosynthetic process,BP,SMOX
14708,GO:0070402,0.723358394472676,0.650500982366595,1,13,NADPH binding,MF,GRHPR
796,GO:0002066,0.723835800093734,0.493786633395475,3,38,columnar/cuboidal epithelial cell development,BP,SLITRK6;FGFR1;RARG
11800,GO:0046717,0.723867078613652,0.463977396025919,4,50,acid secretion,BP,VAMP2;NTSR1;APBA1;MIF
3327,GO:0007045,0.724148010743042,0.443418526242422,5,61,cell-substrate adherens junction assembly,BP,LAMA5;RHOD;VEGFA;DMTN;PPM1F
12065,GO:0048041,0.724148010743042,0.443418526242422,5,61,focal adhesion assembly,BP,LAMA5;RHOD;VEGFA;DMTN;PPM1F
6439,GO:0021766,0.724194336345998,0.463575096368559,4,50,hippocampus development,BP,PTPRS;BBS2;ATP2B4;PROX1
3249,GO:0006921,0.724381299533277,0.542447391417191,2,26,cellular component disassembly involved in execution phase of apoptosis,BP,H1F0;ENDOG
3319,GO:0007034,0.724442090252731,0.392805098876664,10,119,vacuolar transport,BP,VPS11;CHMP1B;HOOK2;PCSK9;BIN1;LYST;SORL1;HGSNAT;PINK1;EHD3
917,GO:0002312,0.725075236131347,0.46249123266067,4,50,B cell activation involved in immune response,BP,ERCC1;STAT6;BCL6;ADA
604,GO:0001773,0.72585353916769,0.647379572157508,1,13,myeloid dendritic cell activation,BP,PYCARD
10810,GO:0044322,0.726058727994218,0.540319419192127,2,26,endoplasmic reticulum quality control compartment,CC,EDEM1;MAN1B1
19877,GO:2000401,0.72627470697002,0.540044890281306,2,26,regulation of lymphocyte migration,BP,ECM1;PYCARD
4610,GO:0010738,0.726292754462272,0.646827725532888,1,13,regulation of protein kinase A signaling,BP,MIF
11425,GO:0045898,0.72640082557161,0.646691830758099,1,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,THRA
1021,GO:0002521,0.72648188629176,0.345456980364404,26,296,leukocyte differentiation,BP,FOS;CTNNBIP1;ZFP36L1;EGR1;CMTM7;HDAC5;ZFPM1;ERBB2;ZMIZ1;STAT6;FAM20C;BCL6;FAM213A;FZD8;VEGFA;LRRC8A;CEBPB;ADA;LRRK1;SOX13;RAG1;GAS6;PRKCZ;INPP5D;JAK3;POLM
10449,GO:0043330,0.726492663174854,0.539767723016662,2,26,response to exogenous dsRNA,BP,TMEM173;MAPK3
3695,GO:0008211,0.72666209946149,0.646363110133193,1,13,glucocorticoid metabolic process,BP,DGKQ
16364,GO:0097009,0.726797755342553,0.646192334797888,1,13,energy homeostasis,BP,CRTC1
3354,GO:0007098,0.726803825808076,0.396518390589368,9,108,centrosome cycle,BP,BRSK1;PKD2;CEP250;CHMP1B;ARL2;FBXW5;CROCC;CEP68;NDE1
4055,GO:0009113,0.726930080858571,0.646025685803586,1,13,purine nucleobase biosynthetic process,BP,ADA
13612,GO:0060142,0.727127265243107,0.645777233020855,1,13,regulation of syncytium formation by plasma membrane fusion,BP,RAPGEF3
17463,GO:1900424,0.727195104899343,0.645691721287982,1,13,regulation of defense response to bacterium,BP,MAPKBP1
15245,GO:0071453,0.727552864317313,0.37055068866269,14,169,cellular response to oxygen levels,BP,NDRG1;ZFP36L1;EPAS1;EGR1;DNMT3A;BNIP3;VEGFA;ENDOG;AQP3;EEF2K;VASN;AKT1;PINK1;FAM162A
9267,GO:0035722,0.728138568654668,0.487832121814339,3,40,interleukin-12-mediated signaling pathway,BP,PDCD4;TALDO1;MIF
15175,GO:0071349,0.728138568654668,0.487832121814339,3,40,cellular response to interleukin-12,BP,PDCD4;TALDO1;MIF
3416,GO:0007212,0.728493944186092,0.537216872933608,2,26,dopamine receptor signaling pathway,BP,GNAL;ADCY6
7880,GO:0032460,0.72908749741795,0.643299410921868,1,13,negative regulation of protein oligomerization,BP,SORL1
7496,GO:0031690,0.72929281480238,0.643039044654805,1,13,adrenergic receptor binding,MF,DLG4
12613,GO:0050832,0.729494069179203,0.641429289391004,1,14,defense response to fungus,BP,FAM3A
10705,GO:0044058,0.72963614920149,0.642603301516317,1,13,regulation of digestive system process,BP,STK39
448,GO:0001222,0.729911703712881,0.642253259282304,1,13,transcription corepressor binding,MF,NR1D1
4016,GO:0009057,0.73052220700274,0.306440840588546,101,1126,macromolecule catabolic process,BP,CEMIP;APOE;GAA;BTBD2;PYGB;RNF44;CST3;PGM1;PCBP4;ZFP36L1;NR1D1;ARRDC1;RBCK1;LRP1;EGFR;TIMP2;H1F0;FBXO2;RHBDF1;PYGL;NAGLU;CTSB;HYAL1;CTSF;GID4;TMEM129;FUCA1;EDEM1;ABTB1;CUL9;HEXB;SERPINE2;VPS11;CSNK1E;ADAMTS7;USP20;SPATA18;RNASET2;SNX33;SNX9;WWTR1;ISG20;ANKZF1;MVB12B;BNIP3;CD81;DNASE1L1;FBXW4;AP2A2;ENDOG;GLB1;DVL1;MTA1;FURIN;CUL7;LRSAM1;PCSK9;ZFP36;BTBD11;PRKACA;MAGEF1;FBXW5;LDLR;LYPLAL1;ABHD17C;MVB12A;BTRC;SUFU;PAN2;USP21;RNF123;TPP1;GPC1;AGO4;RAD23A;CTSZ;SPSB3;PIN1;MAN1B1;GTPBP1;SH3D19;CAPN2;TOLLIP;PNRC1;TIMP1;SDC1;SORL1;HGSNAT;AKT1;CTSD;PINK1;PKD1;LONP2;CTSH;CBLC;RNF187;POMT1;ERN1;FBXL20;GALNS;RPL13A
3435,GO:0007252,0.73069436248023,0.641257465979669,1,13,I-kappaB phosphorylation,BP,AKT1
2807,GO:0006275,0.730792139958823,0.399446582237811,8,97,regulation of DNA replication,BP,CST3;EGFR;SHC1;INSR;BCL6;FGFR1;EREG;WDR18
5465,GO:0016408,0.730854028920376,0.641054033912756,1,13,C-acyltransferase activity,MF,GCAT
13876,GO:0060548,0.730872325567984,0.316007266794762,61,681,negative regulation of cell death,BP,APOE;CST3;PRDX5;RBCK1;EPHB2;IGF2;MST1R;LRP1;EGFR;SHC1;RGL2;F2R;ERBB2;NTSR1;PDCD4;WNT7A;INSR;ID1;EPHA1;ITGA6;SYNGAP1;PRNP;SPRY2;MNT;STRADB;MYO18A;BCL6;BNIP3;VEGFA;CEBPB;TNFRSF6B;EPHB3;ADA;PIDD1;FGFR3;FGFR4;MAPK8IP1;RAG1;EEF2K;HMGA2;GAS6;PPARA;PRKCZ;TM7SF3;AGO4;FGFR1;PIN1;SLC25A27;TMEM161A;TIMP1;SORL1;ERBB3;AKT1;TRAP1;TMBIM4;ZNF385A;PINK1;CTSH;JAK3;RARG;MIF
17350,GO:1900103,0.730892113870309,0.641005495339631,1,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,ERN1
18782,GO:1904375,0.730984792287157,0.420011923493992,6,74,regulation of protein localization to cell periphery,BP,EPHB2;LRP1;EGFR;PRNP;LDLRAP1;AKT1
5159,GO:0015721,0.73112968269715,0.640702593887281,1,13,bile acid and bile salt transport,BP,RXRA
10589,GO:0043586,0.73113364816359,0.640697536076025,1,13,tongue development,BP,EGFR
1132,GO:0002724,0.731316519195244,0.640464225791367,1,13,regulation of T cell cytokine production,BP,PRKCZ
13015,GO:0051497,0.731482932132254,0.640251802550823,1,13,negative regulation of stress fiber assembly,BP,ARAP1
3693,GO:0008209,0.731533153145914,0.640187675602152,1,13,androgen metabolic process,BP,SRD5A3
7431,GO:0031573,0.731875519365939,0.639750254135039,1,13,intra-S DNA damage checkpoint,BP,XPC
10948,GO:0044728,0.731913502881167,0.433795848921022,5,62,DNA methylation or demethylation,BP,FOS;DNMT3A;APOBEC3C;TDRKH;APOBEC3F
4694,GO:0010866,0.732252749623022,0.639267771681669,1,13,regulation of triglyceride biosynthetic process,BP,LDLR
4438,GO:0010369,0.732260625220839,0.639257692904275,1,13,chromocenter,CC,SCMH1
6600,GO:0022829,0.732404996646436,0.639072891963184,1,13,wide pore channel activity,MF,GJC2
4500,GO:0010560,0.732467669314102,0.638992643781866,1,13,positive regulation of glycoprotein biosynthetic process,BP,POMT1
9001,GO:0035196,0.732773605603555,0.482557329839174,3,38,production of miRNAs involved in gene silencing by miRNA,BP,EGFR;MAP2K2;AGO4
1123,GO:0002712,0.733131405311047,0.531264774673027,2,26,regulation of B cell mediated immunity,BP,STAT6;BCL6
1218,GO:0002889,0.733131405311047,0.531264774673027,2,26,regulation of immunoglobulin mediated immune response,BP,STAT6;BCL6
16292,GO:0090504,0.733187397007447,0.531192556435549,2,26,epiboly,BP,WNT7A;HBEGF
13835,GO:0060479,0.733368126224168,0.637838010405079,1,13,lung cell differentiation,BP,THRA
8305,GO:0033157,0.733442950713859,0.352159626654192,18,211,regulation of intracellular protein transport,BP,CEMIP;RAPGEF3;B3GAT3;ANK3;ERBB2;MICALL2;EDEM1;VPS11;VAMP2;TMEM173;PRNP;HES1;DMTN;GAS6;OSCP1;SORL1;PINK1;UBL5
1047,GO:0002573,0.733523517384613,0.382159288406494,10,119,myeloid leukocyte differentiation,BP,FOS;CTNNBIP1;ZFP36L1;ZFPM1;FAM20C;FAM213A;VEGFA;CEBPB;LRRK1;INPP5D
924,GO:0002320,0.733640231728641,0.637488485260909,1,13,lymphoid progenitor cell differentiation,BP,HES1
7470,GO:0031646,0.733692551368285,0.637421247043328,1,13,positive regulation of neurological system process,BP,PTAFR
19478,GO:1990381,0.73369603723266,0.637416766834768,1,13,ubiquitin-specific protease binding,MF,RAD23A
3356,GO:0007100,0.733808097488192,0.637272716522904,1,13,mitotic centrosome separation,BP,NDE1
4321,GO:0009855,0.734038718817257,0.416304527493835,6,74,determination of bilateral symmetry,BP,PKD2;IFT140;VANGL2;ACVR2B;SUFU;GAS8
8725,GO:0034390,0.734122951178529,0.636867722765272,1,13,smooth muscle cell apoptotic process,BP,PDCD4
8726,GO:0034391,0.734122951178529,0.636867722765272,1,13,regulation of smooth muscle cell apoptotic process,BP,PDCD4
16332,GO:0090659,0.734234447289119,0.636724214845161,1,13,walking behavior,BP,EFNB3
16466,GO:0097191,0.73488382011661,0.362163011153165,14,167,extrinsic apoptotic signaling pathway,BP,RBCK1;ITGA6;MKNK2;STRADB;PIDD1;IL6R;FGFR3;TNFRSF1A;FGFR1;MADD;ACVR1B;ERBB3;AKT1;PYCARD
16057,GO:0090051,0.735371491694876,0.635257977468082,1,13,negative regulation of cell migration involved in sprouting angiogenesis,BP,HDAC5
7161,GO:0031054,0.735990231832461,0.63445800403919,1,13,pre-miRNA processing,BP,AGO4
18368,GO:1903421,0.735997432832237,0.634448685093395,1,13,regulation of synaptic vesicle recycling,BP,DNM1
9330,GO:0035859,0.736093283538405,0.634324623774257,1,13,Seh1-associated complex,CC,SESN2
7131,GO:0030983,0.736109395795638,0.634303765886505,1,13,mismatched DNA binding,MF,XPC
9753,GO:0039535,0.736181382903674,0.634210563746515,1,13,regulation of RIG-I signaling pathway,BP,NLRX1
17621,GO:1901385,0.736879400634616,0.63330579301088,1,13,regulation of voltage-gated calcium channel activity,BP,EHD3
2674,GO:0006044,0.736913747758092,0.633261223395081,1,13,N-acetylglucosamine metabolic process,BP,CHST6
5523,GO:0016514,0.736973293640683,0.633183944420727,1,13,SWI/SNF complex,CC,SMARCD2
9128,GO:0035493,0.736980281036432,0.63317487523406,1,13,SNARE complex assembly,BP,VPS11
10986,GO:0044818,0.737011560427046,0.52623996424115,2,26,mitotic G2/M transition checkpoint,BP,BRSK1;HMGA2
2872,GO:0006379,0.737245647863633,0.525420397133757,2,27,mRNA cleavage,BP,TUT1;ERN1
4574,GO:0010669,0.737344135661238,0.632702353012271,1,13,epithelial structure maintenance,BP,CROCC
10391,GO:0043247,0.737345880094287,0.632700086351135,1,13,telomere maintenance in response to DNA damage,BP,ERCC1
11328,GO:0045683,0.737492978670406,0.632508908432262,1,13,negative regulation of epidermis development,BP,HES1
18755,GO:1904294,0.737559793960792,0.632422043511248,1,13,positive regulation of ERAD pathway,BP,EDEM1
605,GO:0001774,0.737668552181536,0.632280612383468,1,13,microglial cell activation,BP,LDLR
9409,GO:0035994,0.73778674307331,0.632126862518915,1,13,response to muscle stretch,BP,FOS
12655,GO:0050892,0.737824612413397,0.632077588254771,1,13,intestinal absorption,BP,LDLR
16650,GO:0097617,0.738026247831759,0.631815133008091,1,13,annealing activity,MF,SMARCA1
4649,GO:0010804,0.738048971892663,0.630406515389264,1,14,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,GAS6
19417,GO:1990089,0.738359580378664,0.475157096298003,3,39,response to nerve growth factor,BP,ID1;EEF2K;AKT1
19418,GO:1990090,0.738359580378664,0.475157096298003,3,39,cellular response to nerve growth factor stimulus,BP,ID1;EEF2K;AKT1
1327,GO:0003181,0.738558858827135,0.631121104811006,1,13,atrioventricular valve morphogenesis,BP,ZFPM1
2705,GO:0006086,0.738561303095943,0.631117917206302,1,13,acetyl-CoA biosynthetic process from pyruvate,BP,PDK2
5320,GO:0016056,0.738865022695806,0.630721649935276,1,13,rhodopsin mediated signaling pathway,BP,GUCA1B
13568,GO:0060065,0.738961883528301,0.630595198193015,1,13,uterus development,BP,WNT7A
700,GO:0001921,0.738965315104312,0.630590717594234,1,13,positive regulation of receptor recycling,BP,ARAP1
14637,GO:0070265,0.739031016937896,0.474019685723009,3,40,necrotic cell death,BP,RBCK1;PYGL;BNIP3
7415,GO:0031528,0.739207187087291,0.630274789945363,1,13,microvillus membrane,CC,SYTL1
15607,GO:0072132,0.739295446015338,0.52326304987118,2,26,mesenchyme morphogenesis,BP,ACTA2;FGFR1
9297,GO:0035773,0.7393003224279,0.473674889941199,3,40,insulin secretion involved in cellular response to glucose stimulus,BP,NR1D1;LRP5;VSNL1
19141,GO:1905208,0.739436188200518,0.629975462252234,1,13,negative regulation of cardiocyte differentiation,BP,EGFR
18436,GO:1903556,0.739464974665801,0.522525391037068,2,27,negative regulation of tumor necrosis factor superfamily cytokine production,BP,ACP5;GAS6
14546,GO:0070102,0.739471814121968,0.629928877037035,1,13,interleukin-6-mediated signaling pathway,BP,IL6R
8692,GO:0034349,0.739482314007913,0.629915146210894,1,13,glial cell apoptotic process,BP,GAS6
12664,GO:0050907,0.739786921644274,0.626938728693924,1,15,detection of chemical stimulus involved in sensory perception,BP,OR7D2
2780,GO:0006221,0.739880932114242,0.521503663078774,2,28,pyrimidine nucleotide biosynthetic process,BP,NME4;UCKL1
18357,GO:1903392,0.739954700867546,0.629296951666202,1,13,negative regulation of adherens junction organization,BP,DMTN
2653,GO:0006004,0.740162571272659,0.629024641295675,1,13,fucose metabolic process,BP,FUCA1
12231,GO:0048534,0.740264578703665,0.308608441481307,54,615,hematopoietic or lymphoid organ development,BP,FOS;CTNNBIP1;ERCC1;ZFP36L1;FAM210B;EPAS1;EGR1;PKN1;CMTM7;ASH2L;HDAC5;THRA;LRP5;ZFPM1;ERBB2;ZMIZ1;NBEAL2;STAT6;MKNK2;FAM20C;BCL6;FAM213A;FZD8;VEGFA;LRRC8A;CEBPB;MAPK3;KCNAB2;DHTKD1;L3MBTL1;EPHB3;HES1;ADA;ZFP36;LRRK1;DMTN;SOX13;RAG1;GAS6;BCR;PRKCZ;INPP5D;ZNF160;AGO4;JARID2;WNT2B;SH2B3;ACVR1B;ZNF385A;VPS33B;TAZ;JAK3;RARG;POLM
15294,GO:0071539,0.740294071622013,0.52195687261507,2,26,protein localization to centrosome,BP,CEP250;NUDCD3
3034,GO:0006595,0.740410310178067,0.627314118577815,1,14,polyamine metabolic process,BP,SMOX
10532,GO:0043502,0.740480043329679,0.443111352919992,4,51,regulation of muscle adaptation,BP,ATP2B4;TNNT1;PIN1;JARID2
15190,GO:0071371,0.740588675113298,0.628465912412995,1,13,cellular response to gonadotropin stimulus,BP,SLC5A5
8567,GO:0034063,0.740604692986118,0.628444894993633,1,13,stress granule assembly,BP,GRB7
7694,GO:0032185,0.740631592546461,0.628409597182132,1,13,septin cytoskeleton organization,BP,SEPT8
8804,GO:0034595,0.740690469884324,0.628332327914868,1,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,INPP5D
14029,GO:0060831,0.740793878117801,0.62819658417045,1,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,SUFU
7692,GO:0032183,0.740875931798844,0.628088842426945,1,13,SUMO binding,MF,TOLLIP
12716,GO:0051010,0.740889059009522,0.628071603088978,1,13,microtubule plus-end binding,MF,CLIP2
1945,GO:0004653,0.740894144389906,0.628064924517862,1,13,polypeptide N-acetylgalactosaminyltransferase activity,MF,GALNT12
5931,GO:0018243,0.740894144389906,0.628064924517862,1,13,protein O-linked glycosylation via threonine,BP,GALNT12
1591,GO:0004012,0.74089602280551,0.628062457589877,1,13,phospholipid-translocating ATPase activity,MF,ABCA7
825,GO:0002102,0.7410412488362,0.520977774094182,2,26,podosome,CC,GSN;SH3PXD2B
2779,GO:0006220,0.741052482475096,0.471163257804,3,41,pyrimidine nucleotide metabolic process,BP,NME4;UCKL1;NEIL1
2947,GO:0006486,0.741203497698515,0.345788814138584,17,200,protein glycosylation,BP,LMF1;ST6GALNAC2;B3GAT3;GALNT12;ADAMTS7;MVD;B4GAT1;SRD5A3;ST3GAL3;RFNG;MUC19;ADAMTS13;MAN1B1;VEGFB;POMT1;ADAMTSL4;ALG12
10491,GO:0043413,0.741203497698515,0.345788814138584,17,200,macromolecule glycosylation,BP,LMF1;ST6GALNAC2;B3GAT3;GALNT12;ADAMTS7;MVD;B4GAT1;SRD5A3;ST3GAL3;RFNG;MUC19;ADAMTS13;MAN1B1;VEGFB;POMT1;ADAMTSL4;ALG12
2548,GO:0005829,0.74162207350701,0.280035491643528,382,4109,cytosol,CC,TNIP1;HTRA1;FOS;DUSP6;CTNNBIP1;PPL;IDH2;ERCC1;WWC3;FLNC;NT5E;NAPRT;BTBD2;SHANK2;PGM1;GSN;CLCA2;XDH;PRDX5;NDRG1;PGLS;PCBP4;NOS1;PARVB;ARAP1;ZFP36L1;TCTN1;GRB7;ALOX15B;POLD4;RBCK1;EPHB2;EPAS1;OBSCN;RHPN1;NFATC4;GAMT;MAPK13;APPL2;RALGDS;OBSL1;CRYL1;FBXO2;ACOT7;PPP1R14A;ISYNA1;UROS;FHL1;JOSD2;MTHFR;ULK1;PKN1;CRTC1;PYGL;ARHGEF4;TRIM65;DOPEY2;SHC1;PTK6;GALE;BBS2;ACTA2;RNF208;SHC2;PITPNC1;CORO1B;CXXC5;ULK2;DGKA;TBC1D14;MXI1;RIN1;ANK3;NOL4L;PIK3R2;OPLAH;S100A6;NEK9;HDAC5;THRA;ARHGAP23;DOCK4;RPS6KA2;NMRK1;NISCH;TUBG2;MARK4;ERBB2;EXOC2;MICALL2;OGDHL;CBS;ABTB1;SPRY4;FCHO1;MPRIP;PTHLH;MSRB2;CUL9;KIF13B;ANGEL1;NINL;SERPINE2;VAMP2;RNF135;NPHP4;MINK1;RALGAPA2;PHF7;CSNK1E;ACP5;RASA4;PLCD1;TRAPPC9;AGAP1;ZFYVE21;PDCD4;DOCK6;ACAP3;TNFRSF25;GLUL;RHOD;USP20;FBXW8;AKR7A2;MVD;LGALS9C;MZT2A;RABGGTA;ADARB1;SYNGAP1;HAGH;FBXO27;DNPH1;PRNP;FBXL8;SNX33;FBXO41;SPRY2;BLMH;CEP250;SNX9;STAT6;DLG4;ABCD1;PLCD3;STRADB;TALDO1;WWTR1;ARHGAP27;MZT2B;DNAJB5;PLEKHH2;UCKL1;PFKFB2;CHMP1B;SEC14L2;MVB12B;SRMS;HOOK2;ARL2;FBXW4;AP2A2;DPP7;SHANK3;CALCOCO1;ENDOG;MAPK3;FBXL16;PLEKHG5;TUB;KCNAB2;CARD19;CAPNS2;DHTKD1;C19ORF33;TNNT1;DVL1;GALK1;MTA1;LHPP;FYCO1;WIPF1;GPSM1;ADCY6;LTA4H;WIPI2;PHGDH;EPHB3;FHOD1;PC;SSH1;MLXIPL;FBF1;CUL7;MEFV;ARHGAP22;TRIM4;NADK;PLEKHG2;LRSAM1;ADA;CDC42EP5;TRIM45;OSBPL5;PIDD1;SH2D2A;ACY1;PFKL;ZFP36;RHOF;BTBD11;HLCS;PRKACA;PITPNM1;LRRK1;NUDT10;DGUOK;CYFIP2;RAB3B;MAP2K2;PI4K2A;SPTB;FBXW5;STX10;DMTN;PMVK;BBS1;MYH3;MAPK8IP1;LYPLAL1;ACOT11;SNX17;RHOBTB2;CROCC;DUSP7;PHLDA1;LRRC45;EEF2K;LDLRAP1;AHNAK2;DGKQ;PEX7;MVB12A;HK1;NMRAL1;MIB2;FBXO17;PADI3;BTRC;MEX3A;TKFC;GUK1;BLVRB;GIT1;COMT;TTC7B;SUFU;IMPA2;PAN2;ATG2A;PCK2;VAV3;BCR;GSDMC;TBC1D16;USP21;RNF123;PRKCZ;CLTCL1;INPP5D;ETFB;SPATA7;SH3GLB2;KLHDC8B;PDK2;GPC1;SRSF5;RFXANK;SMOX;CEP68;MAPKAPK3;NDE1;AGO4;RAD23A;ARAP3;FGFR1;CAMKK1;SPSB3;PIN1;PNPLA4;CMBL;GTPBP1;ASAP2;DLG3;BIN1;VSNL1;UNC119B;SERPINB6;PPP1R13L;ASS1;SH3D19;GLRX;GRB10;SYNC;CAPN2;SESN2;TOLLIP;TSTA3;CSTB;DUSP23;PITPNM3;MADD;LMLN;EPB41L3;GRHPR;SH2B3;ACTR1B;EPS8L1;GSTT1;PPM1F;SBF1;STK39;ACVR1B;TBC1D17;GSDMA;GSS;AHCYL2;ALS2CL;ABR;AKT1;TP53INP1;NDRG2;TUT1;GPD1L;EPS8L2;RPL39L;PINK1;EHD3;ARHGEF10L;HOMER2;LGALS9B;SPIRE2;CCDC106;EIF4G3;CTSH;ABHD14B;MLST8;RILPL1;ATXN10;EPN2;RNF187;PYCARD;MAP2K3;PNPO;TRERF1;AS3MT;RANBP9;FBXL20;MOCS1;ARHGEF19;SLC2A1;MLYCD;TAZ;JAK3;LITAF;APBA1;FUK;ING4;EIF4E3;PBXIP1;FAM162A;PPCS;GSTM2;SFI1;KRT15;TTLL11;RPL13A;RGS12;MIF;STXBP2;LZTS2
7996,GO:0032637,0.742772754335601,0.469214613019002,3,40,interleukin-8 production,BP,F2R;MAPKBP1;PYCARD
7396,GO:0031490,0.743250462168598,0.393148345774291,7,92,chromatin DNA binding,MF,H1F0;THRA;BCL6;HMGA2;RXRA;SMARCD2;WBP2
2723,GO:0006110,0.743945271275595,0.43873377969467,4,51,regulation of glycolytic process,BP,INSR;PFKFB2;MLXIPL;PPARA
9592,GO:0036473,0.74403811903648,0.418523572874709,5,64,cell death in response to oxidative stress,BP,PRODH;ENDOG;AKT1;TRAP1;PINK1
7327,GO:0031349,0.745412999028122,0.325529075251793,25,294,positive regulation of defense response,BP,TNIP1;PTPRS;NR1D1;MAPK13;EGFR;CTSB;ZP3;PDCD4;TMEM173;MAPK3;LRSAM1;PRKACA;F12;RPS6KA5;TNFRSF1A;LDLR;TRPV4;BTRC;TKFC;MUC19;MAPKAPK3;ADORA2B;NLRX1;PYCARD;EREG
13476,GO:0055072,0.745561698332917,0.416491523784953,5,65,iron ion homeostasis,BP,EPAS1;SLC25A37;NEO1;CYBRD1;SLC22A17
4308,GO:0009799,0.745582163488068,0.40205815335517,6,75,specification of symmetry,BP,PKD2;IFT140;VANGL2;ACVR2B;SUFU;GAS8
2539,GO:0005813,0.745746314343119,0.311072848802195,39,441,centrosome,CC,NDRG1;RAB11FIP4;OBSL1;NEK9;TUBG2;MARK4;BRSK1;IFT140;NPHP4;USP20;ID1;MZT2A;CEP250;MZT2B;HOOK2;ARL2;FBF1;CUL7;PRKACA;BBS1;CROCC;CCDC92;LRRC45;MVB12A;ADGRB2;PLEKHG6;WDR60;CEP68;NDE1;WRAP73;PROCR;ACTR1B;CCDC85B;SPPL2B;MPLKIP;RGS14;RILPL1;ZFYVE19;SFI1
18095,GO:1902806,0.746113276451031,0.356907039425649,12,146,regulation of cell cycle G1/S phase transition,BP,PCBP4;EGFR;FHL1;GJC2;HYAL1;PKD2;ATP2B4;TFDP2;PIDD1;AKT1;ZNF385A;PKD1
4519,GO:0010594,0.746281733859318,0.373249344501043,9,110,regulation of endothelial cell migration,BP,APOE;HDAC5;WNT7A;VEGFA;NRP2;FGFR1;PROX1;AKT1;MAP2K3
4165,GO:0009247,0.74676842392483,0.434786240878823,4,53,glycolipid biosynthetic process,BP,PIGZ;GAL3ST4;PIGV;PIGQ
4195,GO:0009312,0.746810059462975,0.512846446972975,2,27,oligosaccharide biosynthetic process,BP,GALNT12;SLC2A1
2518,GO:0005778,0.747393183933958,0.434169393900706,4,52,peroxisomal membrane,CC,PEX10;ABCD1;MAP2K2;ABCD4
7549,GO:0031903,0.747393183933958,0.434169393900706,4,52,microbody membrane,CC,PEX10;ABCD1;MAP2K2;ABCD4
7215,GO:0031122,0.747871172178353,0.433746248362179,4,51,cytoplasmic microtubule organization,BP,TUBG2;HOOK2;DVL1;TRPV4
3726,GO:0008270,0.747979870785048,0.301593370027276,51,573,zinc ion binding,MF,RNPEPL1;MARCH9;NR1D1;TIMP2;MMP28;TCEA2;EGR1;TRIM65;CA12;CXXC5;MMP1;S100A6;THRA;VAT1;MSRB2;USP20;PEX10;ZMIZ1;RABGGTA;MARCH2;MTA3;PHC2;SHANK3;MTA1;L3MBTL1;LTA4H;MBD1;MEFV;TRIM4;ADA;TRIM45;CYHR1;ZMYM3;RAG1;MIB2;PPARA;RXRA;ADAMTS13;HLTF;RXRB;TIMP1;APOBEC3C;ZNF385A;CBLC;APOBEC3F;SIRT3;LITAF;NEIL1;RARG;ZCCHC14;TRIM7
11777,GO:0046677,0.748866702642399,0.334413031783816,18,215,response to antibiotic,BP,CST3;GSN;MAPK13;UROS;EGR1;HYAL1;ID1;DNMT3A;STAT6;ANKZF1;BNIP3;ENDOG;ADCY6;ADA;SDC1;TRAP1;TP53INP1;PINK1
11720,GO:0046579,0.749253067456794,0.509593479529998,2,27,positive regulation of Ras protein signal transduction,BP,F2R;RTN4R
5473,GO:0016417,0.749423018131122,0.509366549607398,2,27,S-acyltransferase activity,MF,ZDHHC1;ZDHHC24
10080,GO:0042605,0.749426413697085,0.615302702780818,1,14,peptide antigen binding,MF,SLC7A8
19744,GO:2000181,0.749830764296079,0.411403728451412,5,63,negative regulation of blood vessel morphogenesis,BP,XDH;HDAC5;SPRY2;ADGRB2;EPN2
11655,GO:0046460,0.750690735061998,0.507671193872292,2,27,neutral lipid biosynthetic process,BP,LDLR;PCK2
11658,GO:0046463,0.750690735061998,0.507671193872292,2,27,acylglycerol biosynthetic process,BP,LDLR;PCK2
13172,GO:0051817,0.750890401660797,0.395384441219474,6,76,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,TNIP1;APOE;INSR;PC;HMGA2;RXRA
19678,GO:2000045,0.751138795466491,0.355637765190525,11,135,regulation of G1/S transition of mitotic cell cycle,BP,PCBP4;EGFR;FHL1;GJC2;HYAL1;PKD2;TFDP2;PIDD1;AKT1;ZNF385A;PKD1
16951,GO:0099023,0.751503097136071,0.409164775878142,5,64,tethering complex,CC,EXOC2;VPS11;TRAPPC9;HOOK2;VPS33B
15718,GO:0072330,0.75155984817512,0.333797814458082,17,202,monocarboxylic acid biosynthetic process,BP,PGM1;NR1D1;ALOX15B;ACOT7;OGDHL;INSR;PFKFB2;DHTKD1;GALK1;MLXIPL;PFKL;FGFR4;HK1;PPARA;PROX1;MLYCD;MIF
11640,GO:0046425,0.751577338462839,0.394530811906459,6,76,regulation of JAK-STAT cascade,BP,PTK6;HES1;IL6R;FGFR3;TNFRSF1A;RTN4R
8197,GO:0032964,0.751837251761491,0.506133943060539,2,27,collagen biosynthetic process,BP,F2R;P3H4
5649,GO:0016763,0.75203892208923,0.457179029019799,3,40,transferase activity, transferring pentosyl groups,MF,NAPRT;DNPH1;XYLT2
12343,GO:0048747,0.75230144502624,0.505510473423269,2,27,muscle fiber development,BP,FLNC;VEGFA
10621,GO:0043649,0.752343088704367,0.611346449540549,1,14,dicarboxylic acid catabolic process,BP,GLUL
7330,GO:0031369,0.752344522211887,0.504970170216914,2,28,translation initiation factor binding,MF,ANGEL1;EIF4EBP3
9816,GO:0042059,0.752372098423495,0.456742608790761,3,40,negative regulation of epidermal growth factor receptor signaling pathway,BP,EGFR;SPRY2;CBLC
1665,GO:0004129,0.752501191157219,0.607070529755174,1,18,cytochrome-c oxidase activity,MF,NDUFA4L2
4939,GO:0015002,0.752501191157219,0.607070529755174,1,18,heme-copper terminal oxidase activity,MF,NDUFA4L2
5611,GO:0016676,0.752501191157219,0.607070529755174,1,18,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,NDUFA4L2
2538,GO:0005811,0.752512819463208,0.407891474112549,5,64,lipid droplet,CC,SIGMAR1;PITPNM1;ATG2A;PNPLA4;LMLN
5108,GO:0015459,0.752748112483778,0.50490995461069,2,27,potassium channel regulator activity,MF,KCNAB2;PRKCZ
5641,GO:0016746,0.752758360896182,0.335109068381474,16,190,transferase activity, transferring acyl groups,MF,CRAT;CPT2;LPCAT4;CERS4;CPT1C;GGT1;ZDHHC1;NAGS;MBOAT7;ZDHHC24;LCAT;HGSNAT;AGPAT4;GCAT;TAZ;AGPAT3
9711,GO:0038179,0.753136812474321,0.504386899281799,2,27,neurotrophin signaling pathway,BP,SPRY2;CYFIP2
17313,GO:1900024,0.753979613168338,0.454633339568872,3,40,regulation of substrate adhesion-dependent cell spreading,BP,POSTN;FBLN1;DMTN
18426,GO:1903541,0.754331383344787,0.608629295272882,1,14,regulation of exosomal secretion,BP,SDC1
18428,GO:1903543,0.754331383344787,0.608629295272882,1,14,positive regulation of exosomal secretion,BP,SDC1
10415,GO:0043279,0.75458350819755,0.405274658253593,5,64,response to alkaloid,BP,HDAC5;DNMT3A;ADA;HOMER2;GSTM2
19882,GO:2000406,0.754900485026571,0.607848539505366,1,14,positive regulation of T cell migration,BP,PYCARD
610,GO:0001779,0.755011787462322,0.607695684122267,1,14,natural killer cell differentiation,BP,GAS6
255,GO:0000722,0.755147930844946,0.607508643212831,1,14,telomere maintenance via recombination,BP,ERCC1
13150,GO:0051782,0.755250537945566,0.607367624822963,1,14,negative regulation of cell division,BP,ZFYVE19
10913,GO:0044550,0.755295016249629,0.607306482199971,1,14,secondary metabolite biosynthetic process,BP,CBS
4067,GO:0009129,0.755692370417991,0.606759885976411,1,14,pyrimidine nucleoside monophosphate metabolic process,BP,UCKL1
4068,GO:0009130,0.755692370417991,0.606759885976411,1,14,pyrimidine nucleoside monophosphate biosynthetic process,BP,UCKL1
12630,GO:0050860,0.755823329315232,0.606579594886236,1,14,negative regulation of T cell receptor signaling pathway,BP,PRNP
3389,GO:0007175,0.755914631220193,0.606453856882229,1,14,negative regulation of epidermal growth factor-activated receptor activity,BP,CBLC
13023,GO:0051539,0.756016177681006,0.451687034856796,3,41,4 iron, 4 sulfur cluster binding,MF,NDUFS8;RSAD1;MOCS1
13923,GO:0060632,0.756157137726504,0.606119714444744,1,14,regulation of microtubule-based movement,BP,BBS2
5583,GO:0016620,0.756242049013681,0.50019253173221,2,27,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,ALDH4A1;ALDH16A1
3062,GO:0006636,0.756621617099017,0.499193998985874,2,28,unsaturated fatty acid biosynthetic process,BP,ALOX15B;MIF
6849,GO:0030330,0.756780021235258,0.367810645476239,8,101,DNA damage response, signal transduction by p53 class mediator,BP,NDRG1;PCBP4;TFDP2;PIDD1;SESN2;ZNF385A;ING4;MIF
15831,GO:0072577,0.756980258311779,0.499191249985006,2,27,endothelial cell apoptotic process,BP,PDCD4;GAS6
15211,GO:0071396,0.75721528593377,0.303156299858119,33,378,cellular response to lipid,BP,TNIP1;CYP27B1;ZFP36L1;NR1D1;FAM210B;NFATC4;EGFR;PTK6;HDAC5;THRA;PDCD4;CEBPB;CALCOCO1;MAPK3;ADCY6;ZFP36;LDLR;PPARA;WNT7B;PTAFR;RXRA;PCK2;BCR;ADAMTS13;TWF2;WBP2;RXRB;WNT3;AKT1;PYCARD;LITAF;RARG;MIF
5850,GO:0017160,0.757509303619532,0.604252055570481,1,14,Ral GTPase binding,MF,EXOC2
18271,GO:1903204,0.757516023022319,0.604242755184778,1,14,negative regulation of oxidative stress-induced neuron death,BP,PINK1
3585,GO:0008017,0.75764919714978,0.324323419317097,18,212,microtubule binding,MF,CLIP2;NDRG1;MARK4;DNM1;KIF13B;CCDC69;PRNP;MYO18A;HOOK2;MYH3;TRPV4;REEP4;NDE1;MAPRE3;GAS8;RGS14;KIFC2;KIF26B
15441,GO:0071806,0.757685041992771,0.420446716242409,4,55,protein transmembrane transport,BP,PEX10;PEX7;BCR;RTN2
9295,GO:0035770,0.757704430968314,0.335447464524966,14,170,ribonucleoprotein granule,CC,BTBD2;ZFP36L1;GRB7;ZFP36;PITPNM1;MEX3A;PAN2;ICOSLG;AGO4;PNRC1;APOBEC3C;TDRKH;CTSH;APOBEC3F
17640,GO:1901524,0.757941068204691,0.603654057033911,1,14,regulation of mitophagy,BP,PINK1
16171,GO:0090231,0.758438790718604,0.602963723637282,1,14,regulation of spindle checkpoint,BP,NDRG1
19256,GO:1905508,0.759266061745075,0.496080669098756,2,27,protein localization to microtubule organizing center,BP,CEP250;NUDCD3
5627,GO:0016722,0.759705378454069,0.601202225191466,1,14,oxidoreductase activity, oxidizing metal ions,MF,CYBRD1
8992,GO:0035173,0.75977486250343,0.601105392389464,1,14,histone kinase activity,MF,PKN1
4517,GO:0010592,0.759826577739054,0.601033308745847,1,14,positive regulation of lamellipodium assembly,BP,TWF2
16074,GO:0090083,0.76004422533844,0.600729813545805,1,14,regulation of inclusion body assembly,BP,SORL1
12914,GO:0051299,0.760089052238883,0.600667280182391,1,14,centrosome separation,BP,NDE1
12844,GO:0051193,0.760319392539213,0.383601766538277,6,76,regulation of cofactor metabolic process,BP,INSR;PFKFB2;MLXIPL;PPARA;PDK2;PINK1
14858,GO:0070671,0.760362575384335,0.445680431343527,3,42,response to interleukin-12,BP,PDCD4;TALDO1;MIF
4562,GO:0010657,0.760529034378974,0.445977012722242,3,40,muscle cell apoptotic process,BP,RGL2;PDCD4;BNIP3
14794,GO:0070555,0.76061084822466,0.344156796344174,11,139,response to interleukin-1,BP,MAPK13;MTHFR;EGR1;HYAL1;ADAMTS7;CEBPB;MAPK3;RPS6KA5;BTRC;TOLLIP;PYCARD
11049,GO:0045066,0.760657388360048,0.599873705704337,1,14,regulatory T cell differentiation,BP,BCL6
11259,GO:0045589,0.760657388360048,0.599873705704337,1,14,regulation of regulatory T cell differentiation,BP,BCL6
5555,GO:0016577,0.760701580905525,0.49411925306297,2,27,histone demethylation,BP,HSF4;KDM4B
5430,GO:0016307,0.760780236188388,0.599701989452407,1,14,phosphatidylinositol phosphate kinase activity,MF,ZFYVE21
3092,GO:0006677,0.76095909330847,0.599451867563199,1,14,glycosylceramide metabolic process,BP,NAGA
19529,GO:1990542,0.760982433406372,0.396764967409165,5,67,mitochondrial transmembrane transport,BP,CPT2;TST;SLC25A37;SMDT1;SLC25A29
7626,GO:0032048,0.761434172087375,0.598786826997695,1,14,cardiolipin metabolic process,BP,TAZ
13773,GO:0060390,0.762146971882991,0.597787185098637,1,14,regulation of SMAD protein signal transduction,BP,WWTR1
3233,GO:0006896,0.762403910457771,0.59742631157444,1,14,Golgi to vacuole transport,BP,EHD3
12249,GO:0048566,0.762470228137458,0.597333121118726,1,14,embryonic digestive tract development,BP,ADA
19019,GO:1904892,0.762587225900523,0.380647753541771,6,77,regulation of STAT cascade,BP,PTK6;HES1;IL6R;FGFR3;TNFRSF1A;RTN4R
6435,GO:0021761,0.762711356073659,0.394800581781951,5,65,limbic system development,BP,PTPRS;BBS2;ATP2B4;FGFR1;PROX1
3215,GO:0006873,0.762797547742504,0.300829451677476,29,340,cellular ion homeostasis,BP,CEMIP;APOE;NOS1;F2R;PKD2;ITPR3;HEXB;NTSR1;ATP2B4;LPAR3;PRNP;ATP7B;DLG4;ATP12A;BNIP3;MAPK3;PRKACA;TRPV4;TMEM175;KCNMA1;SLC25A27;SMDT1;CYBRD1;SLC9A7;TPCN1;PKD1;SLC22A17;GSTM2;GIPR
12828,GO:0051172,0.762871113403697,0.265271923938598,162,1779,negative regulation of nitrogen compound metabolic process,BP,TNIP1;DUSP6;APOE;CTNNBIP1;ERCC1;WWC3;CST3;TCFL5;XDH;PRDX5;ZFP36L1;GRB7;NR1D1;EPHB2;IGF2;NFATC4;EGFR;TIMP2;DUSP5;PPP1R14A;MXD4;SERPING1;MDFI;EGR1;PKN1;SHC1;PTK6;ABCA7;DEAF1;BAHCC1;CXXC5;ZMYND8;MXI1;PLAT;PIK3R2;PEG3;HDAC5;THRA;ZP3;CRTAP;LRP5;TENM2;ZFPM1;FBLN1;SCMH1;H2AFJ;SPRY4;CDKN1C;SALL2;SERPINE2;FOXQ1;LTB4R2;UNK;ATP2B4;TFDP2;ACP5;PDCD4;ZC3H6;ID1;EPHA1;ADARB1;ZNF692;PPP1R35;DNMT3A;PRNP;PAPLN;HES2;SPRY2;HINT2;MNT;ECM1;STAT6;MTA3;WWTR1;DNAJB5;BCL6;FZD8;VEGFA;CEBPB;ACVR2B;HSF4;NAB2;TNFRSF6B;DVL1;MTA1;L3MBTL1;MBD1;HES1;FURIN;MLXIPL;PHF21A;ZFP36;LRRK1;MAGEF1;RPS6KA5;HBEGF;MAP2K2;DAP;DMTN;MAPK8IP1;TCF25;LDLR;TRPV4;BHLHE40;EIF4EBP3;RAG1;DUSP7;HMGA2;ELK3;DGKQ;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;COMT;SUFU;RXRA;PRKCZ;INPP5D;AGO4;FGFR1;CTSZ;PIN1;C5;IRF2BPL;PROX1;BIN1;SERPINB6;PPP1R13L;JARID2;SESN2;CSTB;RTN4R;ELFN2;TIMP1;PPM1F;SORL1;STK39;CCDC85B;AKT1;NDRG2;SIX5;GPD1L;PINK1;SNTA1;RGS14;CBLC;PYCARD;PCSK1N;RANBP9;SIRT3;JAK3;MZF1;NEIL1;RARG;ING4;PBXIP1;EREG;RPL13A;MIF
16636,GO:0097542,0.763028966466386,0.442380334770684,3,41,ciliary tip,CC,IFT140;SUFU;WDR60
16765,GO:0098632,0.76304527670658,0.490417743466941,2,28,cell-cell adhesion mediator activity,MF,IGSF9;PLXNB3
15229,GO:0071425,0.763142577256154,0.596387250368648,1,14,hematopoietic stem cell proliferation,BP,WNT2B
18515,GO:1903749,0.763374146723835,0.368513223081557,7,90,positive regulation of establishment of protein localization to mitochondrion,BP,MICALL2;VPS11;TFDP2;HES1;OSCP1;PINK1;UBL5
12282,GO:0048643,0.763650541921687,0.59567133534935,1,14,positive regulation of skeletal muscle tissue development,BP,GPC1
815,GO:0002089,0.764403172865933,0.594608525100713,1,14,lens morphogenesis in camera-type eye,BP,PROX1
15596,GO:0072111,0.764444525221361,0.594550058641325,1,14,cell proliferation involved in kidney development,BP,EGR1
15145,GO:0071305,0.764533445096174,0.594424313023124,1,14,cellular response to vitamin D,BP,CYP27B1
19844,GO:2000352,0.764713976287651,0.594168909291818,1,14,negative regulation of endothelial cell apoptotic process,BP,GAS6
8677,GO:0034315,0.764913825774943,0.593886008890558,1,14,regulation of Arp2/3 complex-mediated actin nucleation,BP,CORO1B
1381,GO:0003283,0.765144663850781,0.593559024218014,1,14,atrial septum development,BP,ZFPM1
13457,GO:0055022,0.765332936251248,0.593292161241529,1,14,negative regulation of cardiac muscle tissue growth,BP,JARID2
14175,GO:0061117,0.765332936251248,0.593292161241529,1,14,negative regulation of heart growth,BP,JARID2
8620,GO:0034162,0.765344932508566,0.593275152111474,1,14,toll-like receptor 9 signaling pathway,BP,PTPRS
12169,GO:0048339,0.76602616782308,0.592308211425054,1,14,paraxial mesoderm development,BP,FGFR1
5462,GO:0016405,0.766035538637944,0.592294896317089,1,14,CoA-ligase activity,MF,ACSF2
2820,GO:0006294,0.766085936278334,0.485768712215623,2,29,nucleotide-excision repair, preincision complex assembly,BP,DDB2;XPC
88,GO:0000177,0.766333043694192,0.590615367889622,1,15,cytoplasmic exosome (RNase complex),CC,GTPBP1
5930,GO:0018242,0.766476037859445,0.591668548841261,1,14,protein O-linked glycosylation via serine,BP,GALNT12
70,GO:0000146,0.766477730959102,0.591666139763966,1,14,microfilament motor activity,MF,MYH3
672,GO:0001883,0.767589256206163,0.301732512171452,24,283,purine nucleoside binding,MF,GNAL;TUBG2;DNM1;AGAP1;RHOD;INSR;RAB3D;RAB25;ARL2;ARL10;RAB40B;ADA;RASL10B;RHOF;LRRK1;RAB3B;EHD4;RHOBTB2;PCK2;GTPBP1;SEPT8;EHD3;MOCS1;RAB40C
16055,GO:0090049,0.768009833478724,0.483550076764021,2,28,regulation of cell migration involved in sprouting angiogenesis,BP,HDAC5;VEGFA
11872,GO:0046915,0.768333107679032,0.483100272725484,2,28,transition metal ion transmembrane transporter activity,MF,ATP7B;SLC25A37
4886,GO:0014823,0.768790502553545,0.434645834003076,3,41,response to activity,BP,POSTN;HADH;HDAC5
7140,GO:0031011,0.768838545264903,0.587032373906429,1,15,Ino80 complex,CC,INO80C
8332,GO:0033202,0.768838545264903,0.587032373906429,1,15,DNA helicase complex,CC,INO80C
3091,GO:0006672,0.769513072324492,0.386052043442416,5,65,ceramide metabolic process,BP,CERS4;HEXB;GM2A;TNFRSF1A;NAGA
17460,GO:1900407,0.769521419924077,0.40515660673695,4,54,regulation of cellular response to oxidative stress,BP,ENDOG;AKT1;TRAP1;PINK1
7822,GO:0032387,0.769607796181423,0.433289671083857,3,42,negative regulation of intracellular transport,BP,PCSK9;DMTN;GAS6
9051,GO:0035305,0.769851945075695,0.371444659400787,6,77,negative regulation of dephosphorylation,BP,PPP1R14A;PPP1R35;DLG3;ELFN2;PCIF1;SFI1
399,GO:0001076,0.770147703600979,0.328248169287286,12,147,transcription factor activity, RNA polymerase II transcription factor binding,MF,FOS;CITED4;NR1D1;ZMYND8;SOX12;THRA;ID1;BHLHE40;PPARA;WBP2;TRERF1;RARG
13444,GO:0055007,0.770929584137562,0.38421938286909,5,65,cardiac muscle cell differentiation,BP,OBSL1;VEGFA;RXRA;PIN1;PROX1
6970,GO:0030658,0.771601093979392,0.336187139960608,10,125,transport vesicle membrane,CC,PTPRS;SYT8;DBNDD1;VAMP2;MCTP1;RAB3B;PI4K2A;LDLRAP1;SEMA4C;CLTCL1
11295,GO:0045637,0.771710017601765,0.318609016011547,14,179,regulation of myeloid cell differentiation,BP,FOS;CTNNBIP1;ZFP36L1;FAM210B;ASH2L;ZFPM1;FAM213A;CEBPB;L3MBTL1;ZFP36;INPP5D;AGO4;ACVR1B;RARG
7481,GO:0031664,0.771734570610249,0.582856056329914,1,15,regulation of lipopolysaccharide-mediated signaling pathway,BP,MIF
19140,GO:1905207,0.772269247067932,0.477597649995678,2,28,regulation of cardiocyte differentiation,BP,EGFR;PIN1
3471,GO:0007339,0.772399244052567,0.581892217050384,1,15,binding of sperm to zona pellucida,BP,ZP3
7604,GO:0032006,0.772841747143918,0.367631578936208,6,77,regulation of TOR signaling,BP,TNFAIP8L1;DGKQ;GAS6;SESN2;MLST8;C12ORF66
7158,GO:0031050,0.773129876523834,0.428766778167614,3,41,dsRNA fragmentation,BP,EGFR;MAP2K2;AGO4
14970,GO:0070918,0.773129876523834,0.428766778167614,3,41,production of small RNA involved in gene silencing by RNA,BP,EGFR;MAP2K2;AGO4
16081,GO:0090090,0.773162189283667,0.334102965453965,10,129,negative regulation of canonical Wnt signaling pathway,BP,APOE;EGR1;FUZ;NPHP4;WWTR1;IGFBP2;DVL1;IGFBP4;SHISA6;LZTS2
14004,GO:0060761,0.773421251903691,0.428117903903328,3,42,negative regulation of response to cytokine stimulus,BP,ECM1;SLIT3;GAS6
4249,GO:0009593,0.773761050234066,0.474624091297568,2,30,detection of chemical stimulus,BP,ABCG1;OR7D2
1461,GO:0003713,0.774350844027019,0.297039273397714,22,261,transcription coactivator activity,MF,CITED4;NR1D1;NFATC4;PKN1;SOX12;THRA;MAML3;MNT;WWTR1;SCAND1;DYRK1B;CALCOCO1;MTA1;PPARA;RXRA;USP21;SMARCD2;WBP2;RXRB;TRERF1;RARG;ING4
10630,GO:0043679,0.774354340980882,0.379648860188065,5,66,axon terminus,CC,KCNC4;NTSR1;GLUL;KCNAB2;BLVRB
13447,GO:0055010,0.774361129602886,0.474653623587054,2,28,ventricular cardiac muscle tissue morphogenesis,BP,RXRA;PROX1
11668,GO:0046475,0.77487679711556,0.578281855795228,1,15,glycerophospholipid catabolic process,BP,LDLR
16234,GO:0090317,0.775225174910053,0.472979688070031,2,29,negative regulation of intracellular protein transport,BP,DMTN;GAS6
1443,GO:0003674,0.77538189904809,0.264020762525185,1076,11324,molecular_function,MF,TNIP1;HTRA1;FOS;DUSP6;H6PD;CEMIP;ADGRL1;APOE;TYSND1;MARVELD1;ESPN;CTNNBIP1;MARCKSL1;TSPAN1;PPL;IDH2;RNPEPL1;PTPRS;ERCC1;WWC3;FLNC;SEMA4B;FAM110C;NT5E;GAA;SYTL1;CLIP2;LTB4R;CITED4;NAPRT;BTBD2;PYGB;RNF44;CST3;SHANK2;LTBP4;RAPGEF3;TCFL5;MRC2;PGM1;CYP27B1;GSN;CLCA2;EVI5L;XDH;PRDX5;NDRG1;PGLS;PCBP4;PRSS3;PRODH;PGF;CADM4;MEF2D;NOS1;LTBP1;MARCH9;PARVB;ARAP1;SH3BP2;ZFP36L1;COL6A1;CGREF1;POSTN;GRB7;NR1D1;CRAT;EFS;ALOX15B;ARRDC1;EPN3;NYNRIN;POLD4;SCN8A;SLCO4A1;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;CPT2;RHPN1;MYZAP;IGF2;NFATC4;GPX3;NME4;MST1R;LRP1;GAMT;MAPK13;APPL2;HEBP1;KCNG1;CDK18;RALGDS;ST6GALNAC2;LTBP2;RAB11FIP4;FAM102A;ACBD4;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;SMOC2;MMP28;B3GAT3;HADH;NLGN2;CRYL1;SUGCT;ACSF2;REEP6;FBXO2;ACOT7;TCEA2;DUSP5;TOM1L2;FKBP9;HS1BP3;PPP1R14A;ISYNA1;SLC43A1;UROS;FHL1;JOSD2;LOXL1;MXD4;DDB2;SERPING1;MTHFR;KDSR;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CMTM7;CRTC1;ARPIN;PYGL;ARHGEF4;TRIM65;DOPEY2;SYT8;NAGLU;SHC1;RGL2;PCED1A;F2R;PTK6;GNAL;BPHL;NPEPL1;ABCA7;DEAF1;LAMA5;PPP2R3B;SLC9A3R2;CA12;BAHCC1;GALE;BBS2;SLC16A5;ACTA2;PRSS8;TMCC3;S100A4;PPM1J;CTSB;LPCAT4;DNAH1;RNF208;SHC2;PITPNC1;SLC16A3;CORO1B;CXXC5;ULK2;DGKA;GJC2;IGSF9;DHRS1;MALL;THBS3;D2HGDH;ZMYND8;TBC1D14;ASH2L;ZSCAN18;PACS2;GRAMD4;NXPH4;SOX12;MXI1;CERS4;PLAT;KCNC4;MMP1;ABCG1;RIN1;ANK3;DHRS11;KIAA0930;NOL4L;PIK3R2;OPLAH;S100A6;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;ARHGAP23;PLD3;KCNJ15;DOCK4;ZP3;CRTAP;RPS6KA2;NMRK1;NISCH;LRP5;HYAL1;TMEM54;TUBG2;ANO8;MARK4;TENM2;PLTP;SLC2A9;MAML3;KHNYN;B4GALNT4;ZFPM1;BCAM;TFEB;ERBB2;SLC13A3;EXOC2;NUDT8;FBLN1;BRSK1;MICALL2;BSG;CTSF;SCMH1;PTPRU;OGDHL;PKD2;CBS;LRRC20;GID4;TMEM129;FUCA1;TST;SCN4B;IQSEC2;CPT1C;EDEM1;ABTB1;SLC7A8;ITGB4;ITPR3;PLXNB3;H2AFJ;PRAF2;VAT1;DNM1;SPRY4;DDIT4L;FCHO1;MPRIP;PTHLH;CDKN1C;RIMS3;LRP11;SALL2;MSRB2;IFT140;VIPR1;CUL9;CD9;KIF13B;XPC;PTPRE;ANGEL1;CACFD1;NINL;SIGMAR1;PAK6;HEXB;DNAJC4;SERPINE2;VPS11;VAMP2;CCDC69;FUZ;GALNT12;FOXQ1;RNF135;NPHP4;LTB4R2;UNK;NTSR1;JADE2;THSD4;CD320;MINK1;RALGAPA2;ATP2B4;GGT1;SNN;TMOD2;SLC6A8;TFDP2;PHF7;CSNK1E;ACP5;RASA4;PLCD1;TRAPPC9;AGAP1;ZFYVE21;ADAMTS7;ENKD1;PDCD4;DOCK6;TMEM134;GM2A;DHRS4L2;SLC20A1;BEX2;ACAP3;TNFRSF25;GLUL;RHOD;DTX3;ZKSCAN1;ARVCF;TNXB;USP20;PEX10;ASIC1;LAMB2;SPATA18;PLEKHG4;WNT7A;ZMIZ1;INSR;RAB3D;PLCXD1;LCE1E;SH3PXD2B;TBC1D8;FBXW8;ZC3H6;ID1;CELSR1;AKR7A2;GRK6;MVD;LGALS9C;B4GAT1;POLL;WDR27;NDUFS8;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;TXNRD3;SYNGAP1;IL20RB;HAGH;FBXO27;PPP1R35;DNMT3A;DNPH1;LPAR3;TMEM173;PRNP;SERINC2;DHX32;PAPLN;SRD5A3;ATP7B;EFNB3;IAH1;RNASET2;GRAMD1A;FBXL8;SNX33;FBXO41;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;SLC12A7;ECM1;CEP250;NPDC1;SNX9;STAT6;DLG4;SPEG;ABCD1;MARCH2;REEP2;FGGY;MTA3;MKNK2;PLCD3;NT5DC1;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;MYO18A;TMEM107;ARHGAP27;MZT2B;DNAJB5;MYCBPAP;PHC2;SCART1;PLEKHH2;JMJD7;BCL6;TTYH3;ANKZF1;UCKL1;PFKFB2;ATP12A;PLXNB1;FAM213A;CHMP1B;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;BNIP3;CD81;SRMS;FCGRT;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;HOOK2;LRRC8A;ARL2;YPEL3;C22ORF23;VANGL2;MAST4;FBXW4;ELMO3;TMEM63C;AP2A2;CEBPB;RHBDF2;DPP7;GPRC5C;SHANK3;HSD11B1L;SSC4D;ACVR2B;HSF4;ADAM15;NAB2;NUDCD3;CALCOCO1;ZDHHC1;S1PR2;ENDOG;TNFRSF6B;MAPK3;FBXL16;PLEKHG5;TUB;KCNAB2;ETV5;OLFM2;CARD19;AMN;SLC22A18;GLB1;CAPNS2;DHTKD1;EXD3;ARL10;RAB40B;TNNT1;DVL1;ENTPD2;GALK1;MTA1;LHPP;FYCO1;KLHL29;WIPF1;GPSM1;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;PHGDH;ST3GAL3;SLC16A13;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;TMEM25;PHYHD1;UHRF1BP1;PC;ACAD10;YPEL2;GIGYF1;SSH1;COMTD1;FURIN;MLXIPL;ZNF624;NAGS;FBF1;FAM86C2P;MBOAT7;SLC48A1;SAMD3;CUL7;MEFV;ARHGAP22;SLC2A3;TRIM4;NRP2;GPR153;NADK;PLEKHG2;ABCA2;TNFRSF14;TK2;LRSAM1;ZNF414;ADA;FKBP10;CDC42EP5;TRIM45;MCTP1;OSBPL5;PYCR2;PIDD1;RETSAT;PAG1;PHF21A;SH2D2A;AQP3;HTR7;RASL10B;MYH16;CELSR2;ACY1;CKMT1A;PFKL;IL6R;SLIT3;PCSK9;GGACT;FCGBP;TMEM9;SLC28A2;ZFP36;ETV4;RHOF;BTBD11;MAPKBP1;HLCS;CYHR1;RSPH3;FGFR3;NSUN7;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;KIAA1549;LRRK1;NUDT10;SPATA20;PLCH2;DGUOK;MAGEF1;CYFIP2;SLC38A10;RPS6KA5;SCNN1A;HBEGF;SLC25A37;ITGB5;RAB3B;MAP2K2;PI4K2A;DAP;FGFR4;SPTB;FBXW5;GSE1;MXRA8;SLC37A2;STX10;TSPAN33;DMTN;RAPGEF5;RNF215;PMVK;BBS1;MYH3;PSD4;MDGA1;XYLT2;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;TCF25;SEMA3B;LDLR;FAM214B;LYPLAL1;CYP3A5;ACOT11;ROBO3;SNX17;SOX13;ABHD17C;TRPV4;MPG;RHOBTB2;PIGZ;IFNGR2;BHLHE40;EIF4EBP3;RRNAD1;CROCC;CCDC92;RAG1;ZNF80;DUSP7;PHLDA1;LRRC45;TNFAIP8L1;EEF2K;RHBDL1;MSLN;HMGA2;LDLRAP1;TM7SF2;SEMA3F;ELK3;AHNAK2;DGKQ;PEX7;SEMA4C;MVB12A;HK1;NMRAL1;FAM3A;ZXDC;SLC29A4;MIB2;FBXO17;CHST6;SDHAF4;PADI3;GAS6;BTRC;MEX3A;POU6F1;LLGL1;ANKS6;ADGRB2;ZNF217;PPARA;HMGCL;TKFC;GUK1;TSPAN4;TMEM187;STK32C;WNT7B;BLVRB;GIT1;COMT;ALDH16A1;TTC7B;SUFU;AIG1;PTAFR;PLEKHG6;RFNG;DMC1;IMPA2;ARHGEF37;LTBP3;PAN2;REEP4;ZNF446;ATG2A;TYMSOS;RXRA;PCK2;PCSK1;VAV3;LRP10;VASN;BCR;TMEM175;NEO1;IGFBP4;SDHA;GSDMC;TBC1D16;USP21;RNF123;WDR60;PRKCZ;ADAMTS13;ZDHHC24;HAGHL;CLTCL1;HLTF;MDH2;CAPG;INPP5D;TM7SF3;TMCO6;ETFB;ABCD4;SPATA7;TWF2;ZNF485;SH3GLB2;LSM14B;KLHDC8B;TPP1;PDK2;GPC1;TMX4;ICOSLG;SRSF5;ZNF160;RFXANK;TEF;SMOX;CEP68;SMARCD2;MAPKAPK3;NDE1;AGO4;RAD23A;ARAP3;CDHR1;FGFR1;CTSZ;CAMKK1;CHADL;SPSB3;PIN1;MAN1B1;MN1;PNPLA4;ZNF563;C5;KMT5C;ANKMY1;PHYH;IRF2BPL;CMBL;PROX1;WBP2;GTPBP1;PCDHGC3;C21ORF2;ASAP2;DLG3;GPR155;KCNMA1;ESYT2;BIN1;VSNL1;UNC119B;YIPF3;TMEM8B;SERPINB6;PI4KAP2;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;CES2;SLC25A27;TMCO3;GRB10;BFSP1;JARID2;SYNC;CAPN2;SESN2;NDUFA4L2;TOLLIP;ADCK5;WNT2B;NATD1;TSTA3;WRAP73;RXRB;CSTB;PROCR;SNPH;MAN2B2;TMEM231;PNRC1;MAPRE3;DUSP23;LCAT;GUCA1B;MACROD1;ADGRE2;GAL3ST4;SMDT1;PITPNM3;TMPRSS11D;CYBRD1;MADD;LMLN;RTN4R;ELFN2;OR7D2;EPB41L3;PIGV;SLC9A7;TIMP1;SDC1;WHAMMP3;GRHPR;SH2B3;ACTR1B;APOBEC3C;FGFBP1;RTN2;H1FX;EPS8L1;PIGQ;WNT3;LYST;GSTT1;ZFP41;PPM1F;KIAA1191;OLFML2A;MICALCL;SBF1;SORL1;STK39;EFCAB1;COL13A1;VEGFB;ACVR1B;MEF2B;TBC1D17;ANO9;FAM189B;GSDMA;ZSCAN30;GSS;AHCYL2;ALS2CL;TSNARE1;ADORA2B;TPCN1;HGSNAT;SLC25A29;ERBB3;ABR;ZER1;CCDC85B;PNMA1;CYP2S1;AKT1;HPDL;CTSD;TRAP1;TMBIM4;NLRX1;SEPT8;ADAM19;ZNF385A;TP53INP1;LRCH4;NDRG2;TUT1;SMARCA1;VPS33B;SIX5;ERCC6;PCMTD2;ACP6;GPD1L;EPS8L2;TDRKH;SLC5A5;SUN1;NAGA;TMEM120A;SPPL2B;IL17RD;UQCR11;SSBP2;RPL39L;ADCK2;R3HDM2;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;MPLKIP;SNTA1;ARHGEF10L;KDM4B;CAMTA2;HOMER2;LGALS9B;PLPPR2;RGS14;SYNE3;SPIRE2;CCDC106;R3HDM4;LENG9;HEXDC;EIF4G3;ZNF710;CTSH;EHBP1L1;ABHD14B;MLST8;AGPAT4;RILPL1;NRSN1;RSAD1;CBLC;ATXN10;EPN2;RFX2;RNF187;PYCARD;NINJ1;MAP2K3;PNPO;SNX29;RHBG;POMT1;TRERF1;PCSK1N;KCNN4;CCDC57;DNAAF5;THAP8;DDN;PMS2P5;AS3MT;NDUFV3;STK17A;ERN1;CKLF;RANBP9;ZNF319;APOBEC3F;PRIMPOL;ACADS;FBXL20;GCAT;WDR63;MOCS1;ARHGEF19;SIRT3;ALKBH6;ORAI3;WBP1;GLI4;TMEM158;CMTM4;SLC2A1;CPNE7;MLYCD;TAZ;RNASEK;JAK3;BCKDHA;MAST3;KIFC2;LITAF;APBA1;MZF1;KIAA1328;NEIL1;FUK;ORAI2;RARG;ING4;EIF4E3;GALNS;PBXIP1;EREG;FAM162A;ZCCHC14;PPCS;GSTM2;ABHD14A;ZNF514;PODXL2;ZFYVE19;TRIM7;SHISA6;MORN4;GIPR;WDR18;PQLC2;SFI1;KRT15;ADAMTSL4;TRNP1;TTLL11;ZNF837;TMED4;POLM;SEMA4F;FAM50A;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;STXBP2;KIF26B;UBL5;LZTS2
11456,GO:0045935,0.775636456218304,0.256024293641712,116,1273,positive regulation of nucleobase-containing compound metabolic process,BP,TNIP1;FOS;APOE;ERCC1;CITED4;CST3;RAPGEF3;MEF2D;NOS1;ZFP36L1;NR1D1;EPAS1;NFATC4;EGFR;TIMP2;TCEA2;EGR1;CRTC1;SHC1;F2R;DEAF1;ASH2L;SOX12;PIK3R2;ZNF516;PEG3;HDAC5;THRA;ZP3;LRP5;MAML3;ZFPM1;TFEB;ERBB2;PKD2;PTHLH;CDKN1C;SALL2;HEXB;TFDP2;WNT7A;ZMIZ1;INSR;ITGA6;TMEM173;STAT6;WWTR1;PFKFB2;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;CEBPB;HSF4;CALCOCO1;ENDOG;MAPK3;ETV5;DVL1;FHOD1;HES1;MLXIPL;ZFP36;ETV4;RPS6KA5;MAP2K2;FGFR4;TNFRSF1A;HMGA2;ELK3;ZXDC;BTRC;PPARA;RXRA;USP21;HLTF;SRSF5;RFXANK;TEF;FGFR1;PIN1;IRF2BPL;PROX1;WBP2;GTPBP1;SESN2;TMEM161A;RXRB;MAPRE3;GUCA1B;ACVR1B;MEF2B;ADORA2B;AKT1;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;CAMTA2;ABHD14B;RFX2;RNF187;MAP2K3;TRERF1;DDN;ERN1;TAZ;LITAF;MZF1;RARG;EREG
918,GO:0002313,0.775832316459362,0.576881949692648,1,15,mature B cell differentiation involved in immune response,BP,ADA
6927,GO:0030547,0.775903491142633,0.576777505636849,1,15,receptor inhibitor activity,MF,PCSK9
12535,GO:0050710,0.776036085758834,0.471832356933711,2,29,negative regulation of cytokine secretion,BP,MAPKBP1;GAS6
6908,GO:0030512,0.776266647882883,0.39621891585724,4,54,negative regulation of transforming growth factor beta receptor signaling pathway,BP,HTRA1;LTBP1;VASN;PIN1
5610,GO:0016675,0.776913421283237,0.571555488104424,1,19,oxidoreductase activity, acting on a heme group of donors,MF,NDUFA4L2
7454,GO:0031624,0.777098014790238,0.470781030662878,2,28,ubiquitin conjugating enzyme binding,MF,PPARA;TOLLIP
15219,GO:0071407,0.777356183496599,0.277948485251289,36,414,cellular response to organic cyclic compound,BP,RAPGEF3;CYP27B1;ZFP36L1;NR1D1;FAM210B;NFATC4;EGFR;EGR1;THRA;PKD2;ATP2B4;ID1;ITGA6;TMEM173;CEBPB;CALCOCO1;MAPK3;ADCY6;SSH1;ZFP36;PRKACA;MAP2K2;DMTN;EEF2K;BTRC;PPARA;PTAFR;RXRA;PCK2;AGO4;WBP2;RXRB;AKT1;SLC5A5;RARG;GSTM2
10162,GO:0042771,0.778076872333555,0.421514751284361,3,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,ZNF385A;PYCARD;MIF
5124,GO:0015630,0.778080505429049,0.257858281466813,87,965,microtubule cytoskeleton,CC,FAM110C;CLIP2;NDRG1;RAB11FIP4;OBSL1;BBS2;DNAH1;NEK9;TUBG2;MARK4;BRSK1;PKD2;DNM1;IFT140;KIF13B;NINL;CCDC69;NPHP4;ENKD1;USP20;RAB3D;ID1;MZT2A;SPRY2;CEP250;REEP2;MZT2B;HOOK2;ARL2;NUDCD3;KCNAB2;DVL1;MTA1;FBF1;CUL7;MEFV;EVC;ABCA2;MAPKBP1;PRKACA;PITPNM1;MAP2K2;BBS1;TRPV4;CROCC;CCDC92;LRRC45;MVB12A;ADGRB2;PLEKHG6;REEP4;GSDMC;WDR60;PRKCZ;CLTCL1;CAPG;SPATA7;CEP68;NDE1;RAD23A;C21ORF2;NICN1;WRAP73;PROCR;SNPH;MAPRE3;ACTR1B;LYST;CCDC85B;AKT1;SEPT8;SPPL2B;GAS8;MPLKIP;RGS14;PCIF1;RILPL1;RANBP9;WDR63;KIFC2;NEIL1;PBXIP1;ZFYVE19;SFI1;TTLL11;KIF26B;LZTS2
4903,GO:0014850,0.778303171912599,0.573242437181157,1,15,response to muscle activity,BP,POSTN
20260,GO:2001269,0.778407167895635,0.573088632395904,1,15,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,GSN
17744,GO:1901798,0.778997400015355,0.571095756206681,1,16,positive regulation of signal transduction by p53 class mediator,BP,ZNF385A
7950,GO:0032561,0.779524068837572,0.287950151687867,24,285,guanyl ribonucleotide binding,MF,GNAL;TUBG2;DNM1;AGAP1;RHOD;INSR;RAB3D;TMEM173;RAB25;ARL2;ARL10;RAB40B;RASL10B;RHOF;LRRK1;RAB3B;EHD4;RHOBTB2;PCK2;GTPBP1;SEPT8;EHD3;MOCS1;RAB40C
1343,GO:0003208,0.779542349201168,0.419992787031274,3,41,cardiac ventricle morphogenesis,BP,RXRA;PROX1;PPP1R13L
20026,GO:2000679,0.779829502614463,0.570980003393488,1,15,positive regulation of transcription regulatory region DNA binding,BP,HMGA2
16087,GO:0090100,0.779849868115064,0.372468184212246,5,66,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,CDKN1C;ACVR2B;HES1;NEO1;ACVR1B
11445,GO:0045922,0.779978339154819,0.570758803973751,1,15,negative regulation of fatty acid metabolic process,BP,AKT1
17872,GO:1902188,0.780194827662043,0.570436875187574,1,15,positive regulation of viral release from host cell,BP,PC
16056,GO:0090050,0.780520065428975,0.569952816961839,1,15,positive regulation of cell migration involved in sprouting angiogenesis,BP,VEGFA
7313,GO:0031334,0.780542212747408,0.302300597686799,16,195,positive regulation of protein complex assembly,BP,ERCC1;GSN;DDB2;ARPIN;CORO1B;MMP1;SNX9;VEGFA;ARL2;WIPF1;CDC42EP5;WHAMMP3;PINK1;SPIRE2;MLST8;PYCARD
4307,GO:0009798,0.780653110474842,0.390354421853222,4,54,axis specification,BP,MDFI;LRP5;WNT7A;WNT3
7953,GO:0032570,0.780762911163229,0.465102888984066,2,29,response to progesterone,BP,FOS;WBP2
9542,GO:0036336,0.780823767766511,0.569500360840789,1,15,dendritic cell migration,BP,GAS6
10935,GO:0044665,0.780882303446666,0.464931985402589,2,29,MLL1/2 complex,CC,ASH2L;INO80C
15168,GO:0071339,0.780882303446666,0.464931985402589,2,29,MLL1 complex,CC,ASH2L;INO80C
8676,GO:0034314,0.780909243535906,0.464893415760899,2,29,Arp2/3 complex-mediated actin nucleation,BP,CORO1B;WHAMMP3
8609,GO:0034142,0.780913628112316,0.569366403458448,1,15,toll-like receptor 4 signaling pathway,BP,NR1D1
4711,GO:0010883,0.781619255056868,0.463876059378729,2,29,regulation of lipid storage,BP,ABCG1;PPARA
1951,GO:0004659,0.782087441810486,0.567613062025829,1,15,prenyltransferase activity,MF,RABGGTA
18196,GO:1903020,0.782114278247113,0.567572899805865,1,15,positive regulation of glycoprotein metabolic process,BP,POMT1
10184,GO:0042809,0.782188044792868,0.567462486461543,1,15,vitamin D receptor binding,MF,RXRA
20148,GO:2001022,0.782465889578443,0.368910069043538,5,67,positive regulation of response to DNA damage stimulus,BP,EGFR;NSMCE4A;HMGA2;TMEM161A;ZNF385A
9613,GO:0036498,0.78252607005224,0.36883081753533,5,67,IRE1-mediated unfolded protein response,BP,SHC1;EDEM1;CUL7;TPP1;ERN1
8939,GO:0035020,0.782716320439928,0.566671011287754,1,15,regulation of Rac protein signal transduction,BP,ARAP3
19142,GO:1905209,0.78272621155416,0.566656179533881,1,15,positive regulation of cardiocyte differentiation,BP,PIN1
16083,GO:0090092,0.782945930712255,0.317116010361181,11,137,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HTRA1;LTBP4;LTBP1;CDKN1C;WWTR1;ACVR2B;HES1;VASN;NEO1;PIN1;ACVR1B
4589,GO:0010714,0.783070125292427,0.56614019021361,1,15,positive regulation of collagen metabolic process,BP,F2R
8200,GO:0032967,0.783070125292427,0.56614019021361,1,15,positive regulation of collagen biosynthetic process,BP,F2R
10490,GO:0043412,0.783729401093488,0.237431454891585,300,3238,macromolecule modification,BP,TNIP1;FOS;DUSP6;LMF1;CEMIP;APOE;PTPRS;RNF44;CST3;RAPGEF3;XDH;NOS1;LTBP1;MARCH9;ZFP36L1;ARRDC1;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;IGF2;MST1R;MAPK13;CDK18;ST6GALNAC2;OBSL1;EGFR;TIMP2;B3GAT3;FBXO2;DUSP5;FKBP9;PPP1R14A;JOSD2;LOXL1;DDB2;MTHFR;EGR1;ULK1;PKN1;SHC1;F2R;PTK6;ABCA7;PPP2R3B;PPM1J;RNF208;SHC2;ULK2;GJC2;ZMYND8;ASH2L;PLAT;PIK3R2;INO80C;NEK9;HDAC5;CRTAP;RPS6KA2;LRP5;ANO8;MARK4;ERBB2;FBLN1;BRSK1;PTPRU;PKD2;GID4;TMEM129;EDEM1;SPRY4;CDKN1C;CUL9;PTPRE;PAK6;GALNT12;RNF135;JADE2;MINK1;ATP2B4;CSNK1E;RASA4;ADAMTS7;PDCD4;TNFRSF25;DTX3;USP20;PEX10;LAMB2;WNT7A;INSR;RAB3D;LCE1E;FBXW8;ID1;GRK6;MVD;B4GAT1;RABGGTA;EPHA1;ADARB1;SYNGAP1;FBXO27;PPP1R35;DNMT3A;LPAR3;PRNP;SRD5A3;FBXL8;FBXO41;SPRY2;HINT2;BLMH;SNX9;DLG4;SPEG;MARCH2;MTA3;MKNK2;STRADB;WWTR1;FAM20C;BCL6;DYRK1B;CD81;SRMS;FZD8;VEGFA;VANGL2;MAST4;FBXW4;SHANK3;ACVR2B;HSF4;NAB2;ZDHHC1;S1PR2;MAPK3;FBXL16;RAB40B;DVL1;MTA1;LHPP;KLHL29;ADCY6;WIPI2;MBD1;PKN3;ST3GAL3;EPHB3;HES1;SSH1;MLXIPL;CUL7;TRIM4;LRSAM1;LY6K;FKBP10;CDC42EP5;PHF21A;IL6R;PCSK9;ZFP36;HLCS;FGFR3;PRKACA;ZNF862;LRRK1;DGUOK;MAGEF1;RPS6KA5;HBEGF;RAB3B;MAP2K2;FGFR4;SPTB;FBXW5;MXRA8;DMTN;MYH3;MDGA1;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;LYPLAL1;ABHD17C;TRPV4;MPG;PIGZ;RRNAD1;RAG1;DUSP7;EEF2K;MSLN;HMGA2;DGKQ;SEMA4C;MIB2;FBXO17;PADI3;GAS6;BTRC;STK32C;WNT7B;RFNG;BCR;IGFBP4;MUC19;USP21;RNF123;PRKCZ;ADAMTS13;ZDHHC24;HLTF;MDH2;ETFB;KLHDC8B;PDK2;MAPKAPK3;RAD23A;FGFR1;CAMKK1;SPSB3;PIN1;MAN1B1;C5;KMT5C;PROX1;WBP2;DLG3;WDR83;GLRX;JARID2;SESN2;TOLLIP;ADCK5;MAN2B2;MAPRE3;DUSP23;MACROD1;MADD;RTN4R;ELFN2;PIGV;TIMP1;APOBEC3C;PIGQ;PPM1F;SBF1;SORL1;STK39;VEGFB;ACVR1B;ADORA2B;ERBB3;ZER1;AKT1;NDRG2;VPS33B;ERCC6;PCMTD2;GPD1L;TDRKH;IL17RD;ADCK2;SSH3;PINK1;PKD1;SNTA1;KDM4B;RGS14;CTSH;P3H4;MLST8;CBLC;RNF187;PYCARD;MAP2K3;POMT1;STK17A;ERN1;RANBP9;APOBEC3F;FBXL20;SIRT3;JAK3;MAST3;NEIL1;ING4;EREG;TRIM7;ADAMTSL4;TTLL11;ALG12;RAB40C;MIF;UBL5
15981,GO:0086019,0.7838725852572,0.564934029423269,1,15,cell-cell signaling involved in cardiac conduction,BP,SCN4B
11423,GO:0045892,0.784119014598638,0.252903605493798,79,895,negative regulation of transcription, DNA-templated,BP,CTNNBIP1;WWC3;TCFL5;PRDX5;NR1D1;IGF2;NFATC4;MXD4;MDFI;EGR1;SHC1;DEAF1;BAHCC1;CXXC5;ZMYND8;MXI1;PEG3;HDAC5;THRA;ZP3;TENM2;ZFPM1;SCMH1;H2AFJ;CDKN1C;SALL2;FOXQ1;TFDP2;PDCD4;ZC3H6;ID1;ZNF692;DNMT3A;HES2;MNT;STAT6;MTA3;WWTR1;DNAJB5;BCL6;FZD8;VEGFA;CEBPB;ACVR2B;HSF4;NAB2;L3MBTL1;MBD1;HES1;MLXIPL;PHF21A;ZFP36;RPS6KA5;DAP;TCF25;TRPV4;BHLHE40;HMGA2;ELK3;GAS6;BTRC;POU6F1;ZNF217;PPARA;SUFU;RXRA;FGFR1;IRF2BPL;PROX1;PPP1R13L;JARID2;PPM1F;CCDC85B;SIX5;MZF1;RARG;ING4;PBXIP1;EREG
94,GO:0000185,0.784163080093194,0.564496633741188,1,15,activation of MAPKKK activity,BP,MINK1
3932,GO:0008630,0.784474471332488,0.341655225280393,7,93,intrinsic apoptotic signaling pathway in response to DNA damage,BP,NFATC4;TNFRSF1A;TMEM161A;ZNF385A;ERCC6;PYCARD;MIF
15427,GO:0071786,0.78468358133998,0.563711907536519,1,15,endoplasmic reticulum tubular network organization,BP,REEP2
13910,GO:0060602,0.78487905923342,0.563416862092058,1,15,branch elongation of an epithelium,BP,SPRY2
14823,GO:0070603,0.784953115591255,0.36562878708764,5,67,SWI/SNF superfamily-type complex,CC,APPL2;INO80C;SALL2;SMARCD2;SMARCA1
3307,GO:0007018,0.785068709841037,0.289964538577521,19,229,microtubule-based movement,BP,BBS2;DNAH1;IFT140;KIF13B;MYO18A;AP2A2;FYCO1;MYH3;WDR60;PRKCZ;NDE1;SUN1;GAS8;MAFIP;DNAAF5;WDR63;KIFC2;APBA1;KIF26B
5986,GO:0019001,0.785268317887171,0.281275817170727,24,286,guanyl nucleotide binding,MF,GNAL;TUBG2;DNM1;AGAP1;RHOD;INSR;RAB3D;TMEM173;RAB25;ARL2;ARL10;RAB40B;RASL10B;RHOF;LRRK1;RAB3B;EHD4;RHOBTB2;PCK2;GTPBP1;SEPT8;EHD3;MOCS1;RAB40C
4569,GO:0010664,0.785434789963034,0.562577063019789,1,15,negative regulation of striated muscle cell apoptotic process,BP,RGL2
9747,GO:0039529,0.785705430682222,0.562167542108026,1,15,RIG-I signaling pathway,BP,NLRX1
8511,GO:0033764,0.785773301375258,0.560933357860911,1,16,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,DHRS11
10059,GO:0042575,0.785802569303315,0.560888987431287,1,16,DNA polymerase complex,CC,POLD4
7303,GO:0031324,0.786425079006247,0.239505756655,172,1893,negative regulation of cellular metabolic process,BP,TNIP1;DUSP6;APOE;CTNNBIP1;ERCC1;WWC3;CST3;TCFL5;CYP27B1;XDH;PRDX5;ZFP36L1;GRB7;NR1D1;EPHB2;IGF2;NFATC4;EGFR;TIMP2;DUSP5;PPP1R14A;MXD4;SERPING1;MDFI;EGR1;PKN1;SHC1;PTK6;ABCA7;DEAF1;BAHCC1;CXXC5;ZMYND8;TBC1D14;MXI1;PLAT;PIK3R2;PEG3;HDAC5;THRA;ZP3;CRTAP;LRP5;TENM2;ZFPM1;FBLN1;SCMH1;H2AFJ;SPRY4;CDKN1C;SALL2;SERPINE2;FOXQ1;LTB4R2;UNK;ATP2B4;TFDP2;ACP5;PDCD4;ZC3H6;ID1;EPHA1;ADARB1;ZNF692;PPP1R35;DNMT3A;PRNP;PAPLN;HES2;SPRY2;HINT2;MNT;ECM1;STAT6;DLG4;MTA3;WWTR1;DNAJB5;BCL6;BNIP3;FZD8;VEGFA;CEBPB;ACVR2B;HSF4;NAB2;TNFRSF6B;DVL1;MTA1;L3MBTL1;MBD1;HES1;FURIN;MLXIPL;PHF21A;PCSK9;ZFP36;LRRK1;MAGEF1;RPS6KA5;HBEGF;MAP2K2;DAP;DMTN;MAPK8IP1;TCF25;TRPV4;BHLHE40;EIF4EBP3;RAG1;DUSP7;HMGA2;ELK3;DGKQ;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;COMT;SUFU;RXRA;BCR;PRKCZ;INPP5D;AGO4;FGFR1;CTSZ;PIN1;C5;IRF2BPL;PROX1;DLG3;BIN1;SERPINB6;PPP1R13L;GRB10;JARID2;SESN2;CSTB;RTN4R;ELFN2;TIMP1;PPM1F;SORL1;STK39;CCDC85B;AKT1;TRAP1;NDRG2;SIX5;GPD1L;PINK1;SNTA1;RGS14;PCIF1;CBLC;PYCARD;PCSK1N;RANBP9;SIRT3;JAK3;MZF1;NEIL1;RARG;ING4;PBXIP1;EREG;SFI1;RPL13A;MIF
17014,GO:0099518,0.786483267964647,0.410124983254206,3,42,vesicle cytoskeletal trafficking,BP,FYCO1;PRKCZ;NDE1
2601,GO:0005911,0.786561387607751,0.277174056685232,26,304,cell-cell junction,CC,PPL;NDRG1;CADM4;OBSL1;GJC2;ANK3;MICALL2;PTPRU;PKD2;SCN4B;NPHP4;ITGA6;VANGL2;PDZD2;PLEKHG5;FHOD1;FBF1;AQP3;MAP2K2;FGFR4;PRKCZ;DLG3;EPB41L3;COL13A1;AKT1;SLC2A1
4681,GO:0010842,0.786741697093353,0.560596238199512,1,15,retina layer formation,BP,SDK2
5809,GO:0017085,0.786902551257951,0.560351866350645,1,15,response to insecticide,BP,MAPK13
14151,GO:0061077,0.787131266464805,0.362629817879785,5,68,chaperone-mediated protein folding,BP,FKBP9;CRTAP;FYCO1;FKBP10;TRAP1
6407,GO:0021680,0.787465084634319,0.55949626891475,1,15,cerebellar Purkinje cell layer development,BP,NAGLU
1320,GO:0003171,0.787472370578508,0.559485177095467,1,15,atrioventricular valve development,BP,ZFPM1
472,GO:0001516,0.78748850854986,0.558326098559721,1,16,prostaglandin biosynthetic process,BP,MIF
11653,GO:0046457,0.78748850854986,0.558326098559721,1,16,prostanoid biosynthetic process,BP,MIF
6650,GO:0030014,0.787514588366104,0.559420901395912,1,15,CCR4-NOT complex,CC,ZFP36
4443,GO:0010390,0.787610876472256,0.455225304147556,2,29,histone monoubiquitination,BP,DDB2;RAG1
19854,GO:2000369,0.787703396190087,0.559133339147307,1,15,regulation of clathrin-dependent endocytosis,BP,ARAP3
17827,GO:1902043,0.787770727049893,0.559030749368748,1,15,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,PIDD1
9487,GO:0036152,0.788188942383118,0.558393033013359,1,15,phosphatidylethanolamine acyl-chain remodeling,BP,LPCAT4
69,GO:0000145,0.788278782584733,0.55825592851387,1,15,exocyst,CC,EXOC2
4403,GO:0010171,0.788477588051741,0.407338941774189,3,42,body morphogenesis,BP,FUZ;MYH3;WNT3
17772,GO:1901889,0.788770942368636,0.557504145920453,1,15,negative regulation of cell junction assembly,BP,DMTN
5394,GO:0016242,0.788931491941309,0.453302647360859,2,29,negative regulation of macroautophagy,BP,AKT1;PINK1
16894,GO:0098900,0.78912319021628,0.453023073996874,2,29,regulation of action potential,BP,ANK3;NTSR1
8651,GO:0034237,0.789148045877255,0.556927310241936,1,15,protein kinase A regulatory subunit binding,MF,PRKACA
14717,GO:0070412,0.789294863932158,0.556702541397142,1,15,R-SMAD binding,MF,FOS
3490,GO:0007398,0.789409679586232,0.55652669229791,1,15,ectoderm development,BP,ITGA6
3907,GO:0008584,0.789422662839396,0.3353759902826,7,92,male gonad development,BP,ERCC1;CST3;INSR;ADAM15;AGO4;WNT2B;SDC1
459,GO:0001325,0.78952824812812,0.556345027293403,1,15,formation of extrachromosomal circular DNA,BP,ERCC1
16330,GO:0090656,0.78952824812812,0.556345027293403,1,15,t-circle formation,BP,ERCC1
16357,GO:0090737,0.78952824812812,0.556345027293403,1,15,telomere maintenance via telomere trimming,BP,ERCC1
16773,GO:0098644,0.789530252993658,0.556341954938494,1,15,complex of collagen trimers,CC,TNXB
10845,GO:0044381,0.789534883263413,0.556334859214947,1,15,glucose import in response to insulin stimulus,BP,PIK3R2
20264,GO:2001273,0.789534883263413,0.556334859214947,1,15,regulation of glucose import in response to insulin stimulus,BP,PIK3R2
1154,GO:0002762,0.789600889508844,0.452325860649115,2,29,negative regulation of myeloid leukocyte differentiation,BP,ZFPM1;INPP5D
11329,GO:0045684,0.789636004463159,0.45184995182486,2,30,positive regulation of epidermis development,BP,CYP27B1;ALOX15B
362,GO:0000981,0.789992590616322,0.250383451284262,64,717,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,FOS;TCFL5;MEF2D;ZFP36L1;NR1D1;EPAS1;NFATC4;TSC22D1;MXD4;EGR1;DEAF1;ZSCAN18;SOX12;MXI1;PEG3;THRA;ZFPM1;TFEB;SALL2;FOXQ1;TFDP2;ID1;ZNF692;HES2;ZNF467;MNT;STAT6;BCL6;ZSCAN2;CEBPB;HSF4;ETV5;HES1;MLXIPL;ETV4;ZMYM3;KIAA1549;SOX13;BHLHE40;HMGA2;ELK3;POU6F1;ZNF217;PPARA;ZNF446;RXRA;HLTF;ZNF160;TEF;PROX1;JARID2;RXRB;MEF2B;ZNF385A;SIX5;SSBP2;CAMTA2;RFX2;TRERF1;THAP8;DDN;LITAF;MZF1;RARG
6818,GO:0030291,0.79016552311109,0.451076081624793,2,30,protein serine/threonine kinase inhibitor activity,MF,CDKN1C;SPRY2
11306,GO:0045652,0.790177383672836,0.375974927753742,4,65,regulation of megakaryocyte differentiation,BP,ASH2L;ZFPM1;L3MBTL1;AGO4
13722,GO:0060324,0.79083715764435,0.404029038923338,3,42,face development,BP,MAPK3;MYH3;RARG
12813,GO:0051149,0.790892583329565,0.376337465507182,4,55,positive regulation of muscle cell differentiation,BP,THRA;OLFM2;PIN1;PROX1
3939,GO:0008649,0.791101238713626,0.552787499623606,1,16,rRNA methyltransferase activity,MF,RRNAD1
17278,GO:0140102,0.791101238713626,0.552787499623606,1,16,catalytic activity, acting on a rRNA,MF,RRNAD1
86,GO:0000175,0.791155006056723,0.449627468304938,2,30,3'-5'-exoribonuclease activity,MF,ISG20;PAN2
9512,GO:0036258,0.791258981666901,0.449475055564112,2,30,multivesicular body assembly,BP,CHMP1B;MVB12A
12984,GO:0051443,0.791404730435407,0.44926134822558,2,30,positive regulation of ubiquitin-protein transferase activity,BP,PIN1;PINK1
5900,GO:0018149,0.791456980152168,0.447745941348588,2,34,peptide cross-linking,BP,ABCA7;LCE1E
2377,GO:0005518,0.791524854194385,0.403061571694308,3,42,collagen binding,MF,MRC2;CTSB;CHADL
3645,GO:0008134,0.792018436377178,0.256209216040257,44,507,transcription factor binding,MF,FOS;ERCC1;MEF2D;NR1D1;EPAS1;NFATC4;GPX3;MDFI;PKN1;CRTC1;BBS2;CXXC5;ZMYND8;ZNF516;HDAC5;THRA;HYAL1;ZFPM1;TFDP2;ID1;TMEM173;HES2;CEBPB;NAB2;MTA1;HES1;MLXIPL;BBS1;HDAC11;BHLHE40;HMGA2;DGKQ;PPARA;SUFU;RXRA;PROX1;WBP2;PPP1R13L;JARID2;MEF2B;SMARCA1;CAMTA2;TRERF1;RARG
11822,GO:0046823,0.792162626765789,0.551148078285903,1,16,negative regulation of nucleocytoplasmic transport,BP,GAS6
11424,GO:0045893,0.792213693368077,0.241049209703512,95,1054,positive regulation of transcription, DNA-templated,BP,TNIP1;FOS;CITED4;MEF2D;NOS1;NR1D1;EPAS1;NFATC4;EGFR;TCEA2;EGR1;CRTC1;SHC1;F2R;DEAF1;ASH2L;SOX12;PIK3R2;ZNF516;PEG3;HDAC5;THRA;ZP3;LRP5;MAML3;ZFPM1;TFEB;ERBB2;PKD2;CDKN1C;SALL2;HEXB;TFDP2;WNT7A;ZMIZ1;INSR;ITGA6;TMEM173;STAT6;WWTR1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;CEBPB;HSF4;CALCOCO1;MAPK3;ETV5;DVL1;FHOD1;HES1;MLXIPL;ETV4;RPS6KA5;MAP2K2;TNFRSF1A;HMGA2;ELK3;ZXDC;BTRC;PPARA;RXRA;USP21;HLTF;RFXANK;TEF;PIN1;IRF2BPL;PROX1;WBP2;SESN2;RXRB;MAPRE3;ACVR1B;MEF2B;AKT1;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PKD1;ARHGEF10L;CAMTA2;ABHD14B;RFX2;RNF187;MAP2K3;TRERF1;DDN;LITAF;MZF1;RARG
18401,GO:1903508,0.792213693368077,0.241049209703512,95,1054,positive regulation of nucleic acid-templated transcription,BP,TNIP1;FOS;CITED4;MEF2D;NOS1;NR1D1;EPAS1;NFATC4;EGFR;TCEA2;EGR1;CRTC1;SHC1;F2R;DEAF1;ASH2L;SOX12;PIK3R2;ZNF516;PEG3;HDAC5;THRA;ZP3;LRP5;MAML3;ZFPM1;TFEB;ERBB2;PKD2;CDKN1C;SALL2;HEXB;TFDP2;WNT7A;ZMIZ1;INSR;ITGA6;TMEM173;STAT6;WWTR1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;CEBPB;HSF4;CALCOCO1;MAPK3;ETV5;DVL1;FHOD1;HES1;MLXIPL;ETV4;RPS6KA5;MAP2K2;TNFRSF1A;HMGA2;ELK3;ZXDC;BTRC;PPARA;RXRA;USP21;HLTF;RFXANK;TEF;PIN1;IRF2BPL;PROX1;WBP2;SESN2;RXRB;MAPRE3;ACVR1B;MEF2B;AKT1;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PKD1;ARHGEF10L;CAMTA2;ABHD14B;RFX2;RNF187;MAP2K3;TRERF1;DDN;LITAF;MZF1;RARG
7149,GO:0031023,0.792871971397598,0.315637624191161,9,115,microtubule organizing center organization,BP,BRSK1;PKD2;CEP250;CHMP1B;ARL2;FBXW5;CROCC;CEP68;NDE1
11026,GO:0045026,0.793283731007225,0.549410327797766,1,16,plasma membrane fusion,BP,CD9
7290,GO:0031301,0.794486732047606,0.302751575168721,11,140,integral component of organelle membrane,CC,PTPRS;PEX10;B4GAT1;ABCD1;BNIP3;RFNG;SMDT1;SUN1;PINK1;SLC22A17;PQLC2
2946,GO:0006482,0.794594557344577,0.444991369147897,2,29,protein demethylation,BP,HSF4;KDM4B
3698,GO:0008214,0.794594557344577,0.444991369147897,2,29,protein dealkylation,BP,HSF4;KDM4B
11834,GO:0046839,0.794649115785182,0.444910767250596,2,29,phospholipid dephosphorylation,BP,INPP5D;PLPPR2
4523,GO:0010604,0.795221645752136,0.228492363018115,202,2208,positive regulation of macromolecule metabolic process,BP,TNIP1;FOS;DUSP6;CEMIP;APOE;ERCC1;CITED4;CST3;RAPGEF3;GSN;XDH;MEF2D;NOS1;ARAP1;ZFP36L1;NR1D1;EPHB2;EPAS1;CNTN1;IGF2;NFATC4;MST1R;LRP1;EGFR;TIMP2;TCEA2;DUSP5;EGR1;PKN1;CRTC1;SHC1;F2R;PTK6;ABCA7;DEAF1;ACTA2;SHC2;GJC2;ASH2L;GRAMD4;SOX12;ANK3;PIK3R2;ZNF516;PEG3;HDAC5;THRA;ZP3;LRP5;MAML3;ZFPM1;TFEB;ERBB2;FBLN1;PKD2;EDEM1;CDKN1C;SALL2;PAK6;HEXB;VPS11;MINK1;ATP2B4;TFDP2;CSNK1E;TNFRSF25;WNT7A;ZMIZ1;INSR;SH3PXD2B;ID1;EPHA1;ITGA6;LPAR3;TMEM173;PRNP;SNX33;SPRY2;SNX9;STAT6;DLG4;STRADB;WWTR1;BCL6;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;VANGL2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;S1PR2;ENDOG;MAPK3;ETV5;DVL1;MTA1;ADCY6;EPHB3;FHOD1;HES1;FURIN;MLXIPL;MEFV;PIDD1;IL6R;PCSK9;ZFP36;ETV4;FGFR3;PRKACA;F12;LRRK1;MAGEF1;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;TNFRSF1A;EHD4;MAPK8IP1;LDLR;TRPV4;DUSP7;HMGA2;ELK3;DGKQ;SEMA4C;ZXDC;GAS6;BTRC;PPARA;WNT7B;PTAFR;RXRA;IGFBP4;USP21;PRKCZ;HLTF;SRSF5;RFXANK;TEF;MAPKAPK3;RAD23A;FGFR1;CAMKK1;PIN1;C5;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;SH3D19;JARID2;SESN2;TOLLIP;TMEM161A;RXRB;MAPRE3;MADD;WNT3;PPM1F;SORL1;STK39;ACVR1B;MEF2B;ADORA2B;ERBB3;AKT1;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;CAMTA2;CTSH;ABHD14B;MLST8;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;DDN;ERN1;LITAF;MZF1;RARG;EREG;FAM162A;MIF
18054,GO:1902680,0.795241463393387,0.237746966060202,95,1055,positive regulation of RNA biosynthetic process,BP,TNIP1;FOS;CITED4;MEF2D;NOS1;NR1D1;EPAS1;NFATC4;EGFR;TCEA2;EGR1;CRTC1;SHC1;F2R;DEAF1;ASH2L;SOX12;PIK3R2;ZNF516;PEG3;HDAC5;THRA;ZP3;LRP5;MAML3;ZFPM1;TFEB;ERBB2;PKD2;CDKN1C;SALL2;HEXB;TFDP2;WNT7A;ZMIZ1;INSR;ITGA6;TMEM173;STAT6;WWTR1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;CEBPB;HSF4;CALCOCO1;MAPK3;ETV5;DVL1;FHOD1;HES1;MLXIPL;ETV4;RPS6KA5;MAP2K2;TNFRSF1A;HMGA2;ELK3;ZXDC;BTRC;PPARA;RXRA;USP21;HLTF;RFXANK;TEF;PIN1;IRF2BPL;PROX1;WBP2;SESN2;RXRB;MAPRE3;ACVR1B;MEF2B;AKT1;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PKD1;ARHGEF10L;CAMTA2;ABHD14B;RFX2;RNF187;MAP2K3;TRERF1;DDN;LITAF;MZF1;RARG
6887,GO:0030433,0.79541998026603,0.351571790223434,5,68,ubiquitin-dependent ERAD pathway,BP,FBXO2;TMEM129;EDEM1;ANKZF1;MAN1B1
6805,GO:0030275,0.795473827960275,0.545997411869805,1,16,LRR domain binding,MF,ZXDC
5915,GO:0018200,0.796812750637532,0.543898967727975,1,16,peptidyl-glutamic acid modification,BP,TTLL11
5776,GO:0017015,0.797300426791182,0.33558285300716,6,80,regulation of transforming growth factor beta receptor signaling pathway,BP,HTRA1;LTBP4;LTBP1;CDKN1C;VASN;PIN1
3647,GO:0008137,0.797502854894648,0.437688450003513,2,38,NADH dehydrogenase (ubiquinone) activity,MF,NDUFS8;NDUFV3
12422,GO:0050136,0.797502854894648,0.437688450003513,2,38,NADH dehydrogenase (quinone) activity,MF,NDUFS8;NDUFV3
12917,GO:0051302,0.797914715349199,0.309203051123935,9,116,regulation of cell division,BP,PGF;IGF2;RAB11FIP4;VEGFA;GIT1;PIN1;VEGFB;EREG;ZFYVE19
19720,GO:2000134,0.798001259127157,0.324203452220828,7,93,negative regulation of G1/S transition of mitotic cell cycle,BP,PCBP4;FHL1;GJC2;PKD2;TFDP2;PIDD1;ZNF385A
10008,GO:0042470,0.798311563306282,0.323799528977299,7,93,melanosome,CC,SYTL1;CTSB;BSG;CAPG;TPP1;CTSD;SLC2A1
12356,GO:0048770,0.798311563306282,0.323799528977299,7,93,pigment granule,CC,SYTL1;CTSB;BSG;CAPG;TPP1;CTSD;SLC2A1
11712,GO:0046546,0.798888350654991,0.323048289832604,7,93,development of primary male sexual characteristics,BP,ERCC1;CST3;INSR;ADAM15;AGO4;WNT2B;SDC1
10179,GO:0042800,0.798912884456226,0.540589064029055,1,16,histone methyltransferase activity (H3-K4 specific),MF,ASH2L
5547,GO:0016569,0.799051230144185,0.254786610201796,34,396,covalent chromatin modification,BP,NOS1;IGF2;DDB2;MTHFR;PKN1;ZMYND8;ASH2L;HDAC5;JADE2;DNMT3A;MTA3;BCL6;VEGFA;HSF4;MAPK3;MTA1;MBD1;FKBP10;PHF21A;HLCS;RPS6KA5;HDAC11;RAG1;HMGA2;PADI3;USP21;KMT5C;WBP2;JARID2;PPM1F;PINK1;KDM4B;SIRT3;ING4
11766,GO:0046653,0.79910400105326,0.540286730605244,1,16,tetrahydrofolate metabolic process,BP,MTHFR
19724,GO:2000142,0.799143371982353,0.437810261252432,2,30,regulation of DNA-templated transcription, initiation,BP,CTNNBIP1;THRA
17851,GO:1902116,0.799376551062787,0.437462007678587,2,30,negative regulation of organelle assembly,BP,EVI5L;PINK1
16241,GO:0090329,0.799779380249773,0.391110026395479,3,43,regulation of DNA-dependent DNA replication,BP,BCL6;FGFR1;WDR18
14638,GO:0070266,0.799797007641729,0.43683357365632,2,30,necroptotic process,BP,RBCK1;PYGL
4672,GO:0010830,0.799858842936034,0.436741099485116,2,30,regulation of myotube differentiation,BP,HDAC5;THRA
2844,GO:0006337,0.800279262005556,0.538423396256003,1,16,nucleosome disassembly,BP,SMARCD2
18563,GO:1903845,0.800422185968522,0.363075324961726,4,56,negative regulation of cellular response to transforming growth factor beta stimulus,BP,HTRA1;LTBP1;VASN;PIN1
19879,GO:2000403,0.800433673933682,0.538178049400323,1,16,positive regulation of lymphocyte migration,BP,PYCARD
6944,GO:0030593,0.800563423790204,0.434918540274336,2,32,neutrophil chemotaxis,BP,VAV3;CKLF
10883,GO:0044447,0.800998830454978,0.537279008069572,1,16,axoneme part,CC,DNAH1
12628,GO:0050858,0.801027276857396,0.537233712042623,1,16,negative regulation of antigen receptor-mediated signaling pathway,BP,PRNP
406,GO:0001091,0.801587580428403,0.536340663516302,1,16,RNA polymerase II basal transcription factor binding,MF,ERCC1
3224,GO:0006885,0.801812955658021,0.342837142700681,5,69,regulation of pH,BP,ATP12A;MAPK3;TMEM175;PDK2;SLC9A7
2384,GO:0005525,0.801938809362026,0.263148915098779,23,278,GTP binding,MF,GNAL;TUBG2;DNM1;AGAP1;RHOD;INSR;RAB3D;RAB25;ARL2;ARL10;RAB40B;RASL10B;RHOF;LRRK1;RAB3B;EHD4;RHOBTB2;PCK2;GTPBP1;SEPT8;EHD3;MOCS1;RAB40C
18482,GO:1903670,0.802035614459311,0.387876097415449,3,43,regulation of sprouting angiogenesis,BP,HDAC5;VEGFA;EPN2
3764,GO:0008327,0.802257600340936,0.535270585649908,1,16,methyl-CpG binding,MF,MBD1
16006,GO:0086064,0.802280432999411,0.535234078511053,1,16,cell communication by electrical coupling involved in cardiac conduction,BP,PRKACA
7606,GO:0032008,0.802739227797439,0.432418580147179,2,30,positive regulation of TOR signaling,BP,GAS6;MLST8
9053,GO:0035307,0.80277225763174,0.432368842831973,2,30,positive regulation of protein dephosphorylation,BP,PIN1;PINK1
18211,GO:1903046,0.802854378618719,0.302911837076213,9,116,meiotic cell cycle process,BP,ERCC1;TUBG2;DMC1;AGO4;TDRKH;SUN1;SPIRE2;P3H4;EREG
5997,GO:0019048,0.802861902742275,0.432233832980574,2,30,modulation by virus of host morphology or physiology,BP,INSR;RXRA
449,GO:0001223,0.802876265881502,0.534280432671082,1,16,transcription coactivator binding,MF,PPARA
12847,GO:0051196,0.802950702996539,0.341404012119111,5,68,regulation of coenzyme metabolic process,BP,INSR;PFKFB2;MLXIPL;PPARA;PDK2
11396,GO:0045830,0.802954072429503,0.534155763393142,1,16,positive regulation of isotype switching,BP,STAT6
1020,GO:0002520,0.803029057775594,0.238472179686461,56,652,immune system development,BP,FOS;CTNNBIP1;ERCC1;ZFP36L1;FAM210B;EPAS1;EGR1;PKN1;CMTM7;ASH2L;HDAC5;THRA;LRP5;ZFPM1;ERBB2;ZMIZ1;POLL;NBEAL2;STAT6;MKNK2;FAM20C;BCL6;FAM213A;FZD8;VEGFA;LRRC8A;CEBPB;MAPK3;KCNAB2;DHTKD1;L3MBTL1;EPHB3;HES1;ADA;ZFP36;LRRK1;DMTN;SOX13;RAG1;GAS6;BCR;PRKCZ;INPP5D;ZNF160;AGO4;JARID2;WNT2B;SH2B3;ACVR1B;ZNF385A;VPS33B;PMS2P5;TAZ;JAK3;RARG;POLM
9350,GO:0035883,0.803457315926102,0.533348646397822,1,16,enteroendocrine cell differentiation,BP,HES1
5706,GO:0016853,0.803495980074279,0.301907004315423,9,120,isomerase activity,MF,PGM1;FKBP9;ISYNA1;GALE;FKBP10;TMX4;PIN1;TSTA3;MIF
16377,GO:0097028,0.803589539708377,0.533136360122477,1,16,dendritic cell differentiation,BP,GAS6
13739,GO:0060343,0.803698230614684,0.532961786832985,1,16,trabecula formation,BP,THBS3
184,GO:0000400,0.803716332291728,0.532932706857718,1,16,four-way junction DNA binding,MF,DMC1
14476,GO:0061982,0.804311925198564,0.339443262741945,5,69,meiosis I cell cycle process,BP,ERCC1;DMC1;AGO4;SUN1;P3H4
18778,GO:1904355,0.804402365297606,0.531829329340047,1,16,positive regulation of telomere capping,BP,MAPK3
19425,GO:1990126,0.80494917849341,0.530948075702288,1,16,retrograde transport, endosome to plasma membrane,BP,SNX17
7167,GO:0031061,0.805788059824825,0.529593022597773,1,16,negative regulation of histone methylation,BP,JARID2
20052,GO:2000737,0.805857626837806,0.52948048148348,1,16,negative regulation of stem cell differentiation,BP,HES1
2558,GO:0005847,0.806338607553271,0.52870167207601,1,16,mRNA cleavage and polyadenylation specificity factor complex,CC,TUT1
2606,GO:0005921,0.80665452369414,0.528189461718098,1,16,gap junction,CC,GJC2
1119,GO:0002708,0.806676403151383,0.380952601825438,3,44,positive regulation of lymphocyte mediated immunity,BP,ZP3;STAT6;PRKCZ
10971,GO:0044786,0.80688229440149,0.353920783616173,4,57,cell cycle DNA replication,BP,POLD4;BCL6;FGFR1;WDR18
9511,GO:0036257,0.806906925833948,0.425714684237828,2,31,multivesicular body organization,BP,CHMP1B;MVB12A
582,GO:0001736,0.806982027196271,0.30408017063646,8,109,establishment of planar polarity,BP,FUZ;CELSR1;VANGL2;AP2A2;DVL1;CELSR2;DLG3;ARHGEF19
3379,GO:0007164,0.806982027196271,0.30408017063646,8,109,establishment of tissue polarity,BP,FUZ;CELSR1;VANGL2;AP2A2;DVL1;CELSR2;DLG3;ARHGEF19
17515,GO:1901071,0.806986542489976,0.527650565024807,1,16,glucosamine-containing compound metabolic process,BP,CHST6
15265,GO:0071478,0.807006494715324,0.287059495535685,11,141,cellular response to radiation,BP,ERCC1;NFATC4;MAPK13;DDB2;EGR1;HYAL1;XPC;HMGA2;TMEM161A;GUCA1B;TP53INP1
3555,GO:0007603,0.807242637951145,0.52723449325279,1,16,phototransduction, visible light,BP,GUCA1B
1924,GO:0004622,0.807497330651819,0.526820349663619,1,16,lysophospholipase activity,MF,LYPLAL1
14230,GO:0061311,0.807660819408085,0.526554323826774,1,16,cell surface receptor signaling pathway involved in heart development,BP,VANGL2
1302,GO:0003148,0.807696091285531,0.526496911145652,1,16,outflow tract septum morphogenesis,BP,NRP2
19187,GO:1905330,0.807767388698172,0.285999295975776,11,144,regulation of morphogenesis of an epithelium,BP,CELSR1;VEGFA;VANGL2;AP2A2;ETV5;DVL1;CELSR2;RXRA;FGFR1;WNT2B;ARHGEF19
9170,GO:0035567,0.808019965486802,0.290492223880603,10,132,non-canonical Wnt signaling pathway,BP,CSNK1E;WNT7A;CELSR1;FZD8;VANGL2;AP2A2;DVL1;CELSR2;AGO4;ARHGEF19
13151,GO:0051783,0.808238173853564,0.281319014777681,12,153,regulation of nuclear division,BP,IGF2;OBSL1;TOM1L2;LRP5;CUL9;INSR;CHMP1B;L3MBTL1;CUL7;FBXW5;PIN1;EREG
7172,GO:0031069,0.808403758909131,0.525343604338507,1,16,hair follicle morphogenesis,BP,FOXQ1
11378,GO:0045787,0.808497786413798,0.252707332131089,25,302,positive regulation of cell cycle,BP,PCBP4;IGF2;RAB11FIP4;EGFR;PTK6;LRP5;HYAL1;PKD2;TFDP2;INSR;MTA3;HES1;MLXIPL;PIDD1;PRKACA;HMGA2;RAD23A;FGFR1;PROX1;MAPRE3;AKT1;ZNF385A;PKD1;EREG;MIF
18060,GO:1902692,0.808757902012819,0.524765426893459,1,16,regulation of neuroblast proliferation,BP,VEGFA
4549,GO:0010640,0.808795104574041,0.524704650058955,1,16,regulation of platelet-derived growth factor receptor signaling pathway,BP,LRP1
8973,GO:0035098,0.808922217676206,0.524496931948531,1,16,ESC/E(Z) complex,CC,JARID2
19682,GO:2000050,0.809082793951447,0.524234405231701,1,16,regulation of non-canonical Wnt signaling pathway,BP,CSNK1E
2616,GO:0005942,0.809503623337027,0.523545722846959,1,16,phosphatidylinositol 3-kinase complex,CC,PIK3R2
7371,GO:0031435,0.809588975118644,0.523405927742775,1,16,mitogen-activated protein kinase kinase kinase binding,MF,MAPK8IP1
12260,GO:0048596,0.809749278851639,0.523143263484918,1,16,embryonic camera-type eye morphogenesis,BP,PROX1
181,GO:0000394,0.809760292430837,0.522095943549976,1,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,ERN1
9777,GO:0040014,0.8098948240033,0.376272567234451,3,44,regulation of multicellular organism growth,BP,GAMT;BBS2;SH3PXD2B
11325,GO:0045671,0.809899983623739,0.522896199350761,1,16,negative regulation of osteoclast differentiation,BP,INPP5D
12890,GO:0051262,0.809936486170944,0.299901594484177,8,116,protein tetramerization,BP,GPX3;CRTC1;PKD2;DNM1;INSR;PFKL;HMGCL;RXRA
3425,GO:0007221,0.810006582888841,0.522721366349543,1,16,positive regulation of transcription of Notch receptor target,BP,MAML3
8510,GO:0033762,0.810243435406383,0.420620382350352,2,31,response to glucagon,BP,ADCY6;PRKACA
583,GO:0001738,0.810270762585064,0.29317044800001,9,121,morphogenesis of a polarized epithelium,BP,LAMA5;FUZ;CELSR1;VANGL2;AP2A2;DVL1;CELSR2;DLG3;ARHGEF19
11051,GO:0045070,0.811009427889284,0.419445078571887,2,31,positive regulation of viral genome replication,BP,ADARB1;RAD23A
671,GO:0001882,0.811251436754839,0.250736813191346,24,291,nucleoside binding,MF,GNAL;TUBG2;DNM1;AGAP1;RHOD;INSR;RAB3D;RAB25;ARL2;ARL10;RAB40B;ADA;RASL10B;RHOF;LRRK1;RAB3B;EHD4;RHOBTB2;PCK2;GTPBP1;SEPT8;EHD3;MOCS1;RAB40C
7882,GO:0032462,0.81158341000434,0.519096254192934,1,17,regulation of protein homooligomerization,BP,APOE
7289,GO:0031300,0.811704871541068,0.276946144399906,12,154,intrinsic component of organelle membrane,CC,PTPRS;PEX10;B4GAT1;ABCD1;BNIP3;RAB3B;RFNG;SMDT1;SUN1;PINK1;SLC22A17;PQLC2
17665,GO:1901570,0.812002286693922,0.346569423217519,4,58,fatty acid derivative biosynthetic process,BP,GGT1;LTA4H;HMGCL;MIF
1037,GO:0002548,0.812476658184388,0.517619859466021,1,17,monocyte chemotaxis,BP,IL6R
74,GO:0000151,0.813184621998144,0.251276302430488,22,267,ubiquitin ligase complex,CC,BTBD2;RBCK1;FBXO2;DDB2;ABTB1;CUL9;FBXW8;FBXO27;PHC2;FBXW4;KLHL29;CUL7;BTBD11;FBXW5;MIB2;FBXO17;BTRC;KLHDC8B;SPSB3;ZER1;PINK1;FBXL20
6382,GO:0021591,0.813436471032332,0.516028515391888,1,17,ventricular system development,BP,MBOAT7
5650,GO:0016765,0.81385631205162,0.369853958108752,3,47,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,RABGGTA;GSTT1;GSTM2
3068,GO:0006643,0.813873223377157,0.267403511045246,14,177,membrane lipid metabolic process,BP,KDSR;CERS4;FUCA1;HEXB;GM2A;SERINC2;GLB1;TNFRSF1A;PIGZ;ESYT2;GAL3ST4;PIGV;PIGQ;NAGA
8254,GO:0033059,0.814064385516295,0.369949497108288,3,45,cellular pigmentation,BP,BBS2;LYST;VPS33B
329,GO:0000920,0.814250719805687,0.514674489477047,1,17,cell separation after cytokinesis,BP,CHMP1B
16311,GO:0090575,0.814501465188522,0.282257642071252,10,131,RNA polymerase II transcription factor complex,CC,FOS;ERCC1;NR1D1;MXI1;THRA;TFDP2;CEBPB;PPARA;RXRA;RARG
16460,GO:0097178,0.814849898161154,0.413519586680731,2,31,ruffle assembly,BP,EPS8L1;EPS8L2
8112,GO:0032814,0.815449459103212,0.512674330097394,1,17,regulation of natural killer cell activation,BP,GAS6
16007,GO:0086065,0.815549267256412,0.412434576318496,2,31,cell communication involved in cardiac conduction,BP,SCN4B;PRKACA
12756,GO:0051057,0.81594141609138,0.411825382884114,2,31,positive regulation of small GTPase mediated signal transduction,BP,F2R;RTN4R
12887,GO:0051259,0.816006662438946,0.237544481634985,31,380,protein complex oligomerization,BP,APOE;TYSND1;COL6A1;GPX3;KCNG1;CRTC1;KCNC4;MMP1;PKD2;ITPR3;DNM1;SIGMAR1;GLUL;ASIC1;INSR;PRNP;SNX9;HSF4;TRIM4;PFKL;EHD4;HMGCL;RXRA;PRKCZ;GRHPR;SORL1;HGSNAT;TMEM120A;EHD3;ATXN10;MIF
18562,GO:1903844,0.816267798024895,0.31002330871017,6,82,regulation of cellular response to transforming growth factor beta stimulus,BP,HTRA1;LTBP4;LTBP1;CDKN1C;VASN;PIN1
8446,GO:0033599,0.816319109664419,0.511218206572415,1,17,regulation of mammary gland epithelial cell proliferation,BP,DEAF1
5910,GO:0018195,0.816448099713482,0.511001864193459,1,17,peptidyl-arginine modification,BP,PADI3
13721,GO:0060323,0.816467288043057,0.411007539431106,2,31,head morphogenesis,BP,MYH3;WNT3
10872,GO:0044431,0.816784889236518,0.220821786673375,63,719,Golgi apparatus part,CC,MARCH9;ARAP1;POSTN;ST6GALNAC2;EGFR;B3GAT3;RHBDF1;DOPEY2;ABCA7;MALL;ABCG1;B4GALNT4;BSG;EDEM1;ANGEL1;VAMP2;GALNT12;TRAPPC9;WNT7A;B4GAT1;ATP7B;SNX9;MYO18A;ENTPD6;GPSM1;ST3GAL3;SLC16A13;FURIN;PITPNM1;PI4K2A;STX10;XYLT2;TNFRSF1A;IFNGR2;LDLRAP1;CHST6;GAS6;LLGL1;WNT7B;RFNG;MUC19;CLTCL1;GPC1;CTSZ;MAN1B1;ASAP2;GAL3ST4;SLC9A7;SDC1;WNT3;SORL1;TMBIM4;SPPL2B;IL17RD;PKD1;GOLGA2P5;PCSK1N;SLC2A1;LITAF;PODXL2;NDST2;AGPAT3;SULF2
17792,GO:1901976,0.816883128260487,0.410360075374408,2,31,regulation of cell cycle checkpoint,BP,NDRG1;PROX1
391,GO:0001047,0.816994870863144,0.284650864985335,9,117,core promoter binding,MF,FOS;NR1D1;HDAC5;CEBPB;CALCOCO1;MTA1;HMGA2;PROX1;WBP2
11393,GO:0045823,0.817004184750114,0.51006811655146,1,17,positive regulation of heart contraction,BP,ADA
12882,GO:0051254,0.817093852561035,0.213068430710244,100,1116,positive regulation of RNA metabolic process,BP,TNIP1;FOS;CITED4;MEF2D;NOS1;ZFP36L1;NR1D1;EPAS1;NFATC4;EGFR;TCEA2;EGR1;CRTC1;SHC1;F2R;DEAF1;ASH2L;SOX12;PIK3R2;ZNF516;PEG3;HDAC5;THRA;ZP3;LRP5;MAML3;ZFPM1;TFEB;ERBB2;PKD2;CDKN1C;SALL2;HEXB;TFDP2;WNT7A;ZMIZ1;INSR;ITGA6;TMEM173;STAT6;WWTR1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;CEBPB;HSF4;CALCOCO1;MAPK3;ETV5;DVL1;FHOD1;HES1;MLXIPL;ZFP36;ETV4;RPS6KA5;MAP2K2;TNFRSF1A;HMGA2;ELK3;ZXDC;BTRC;PPARA;RXRA;USP21;HLTF;SRSF5;RFXANK;TEF;PIN1;IRF2BPL;PROX1;WBP2;GTPBP1;SESN2;RXRB;MAPRE3;ACVR1B;MEF2B;AKT1;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PKD1;ARHGEF10L;CAMTA2;ABHD14B;RFX2;RNF187;MAP2K3;TRERF1;DDN;ERN1;LITAF;MZF1;RARG
3806,GO:0008408,0.817812568521544,0.36441551845456,3,45,3'-5' exonuclease activity,MF,ISG20;EXD3;PAN2
7939,GO:0032550,0.817925673647258,0.244137814679623,23,281,purine ribonucleoside binding,MF,GNAL;TUBG2;DNM1;AGAP1;RHOD;INSR;RAB3D;RAB25;ARL2;ARL10;RAB40B;RASL10B;RHOF;LRRK1;RAB3B;EHD4;RHOBTB2;PCK2;GTPBP1;SEPT8;EHD3;MOCS1;RAB40C
16702,GO:0097734,0.818437561914616,0.507653145461922,1,17,extracellular exosome biogenesis,BP,SDC1
19447,GO:1990182,0.818437561914616,0.507653145461922,1,17,exosomal secretion,BP,SDC1
2769,GO:0006206,0.818759367067355,0.507109348254475,1,17,pyrimidine nucleobase metabolic process,BP,UCKL1
2829,GO:0006305,0.818949279079269,0.362943396825385,3,44,DNA alkylation,BP,FOS;DNMT3A;TDRKH
2830,GO:0006306,0.818949279079269,0.362943396825385,3,44,DNA methylation,BP,FOS;DNMT3A;TDRKH
20064,GO:2000757,0.819883676522452,0.505204774245487,1,17,negative regulation of peptidyl-lysine acetylation,BP,HINT2
7401,GO:0031498,0.820002232290777,0.50500351617825,1,17,chromatin disassembly,BP,SMARCD2
14832,GO:0070628,0.82029363501408,0.503585449081036,1,18,proteasome binding,MF,ID1
11727,GO:0046596,0.82042587868197,0.503360497186269,1,18,regulation of viral entry into host cell,BP,GSN
9984,GO:0042417,0.820471497462644,0.50420610161916,1,17,dopamine metabolic process,BP,COMT
3189,GO:0006825,0.820475285145024,0.503276428795557,1,18,copper ion transport,BP,ATP7B
13530,GO:0060021,0.820491747231446,0.3346161091382,4,57,roof of mouth development,BP,EPHB2;WNT7A;ACVR2B;EPHB3
13040,GO:0051570,0.820654708699734,0.503894427109471,1,17,regulation of histone H3-K9 methylation,BP,JARID2
17275,GO:0140097,0.821261958361335,0.258183285483291,14,178,catalytic activity, acting on DNA,MF,ERCC1;POLD4;POLL;DNMT3A;ISG20;DNASE1L1;ENDOG;MPG;HMGA2;DMC1;SMARCA1;PRIMPOL;NEIL1;POLM
1861,GO:0004529,0.821289275471175,0.502813408758408,1,17,exodeoxyribonuclease activity,MF,ISG20
5738,GO:0016895,0.821289275471175,0.502813408758408,1,17,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,ISG20
18096,GO:1902807,0.821358392366943,0.293136567213461,7,96,negative regulation of cell cycle G1/S phase transition,BP,PCBP4;FHL1;GJC2;PKD2;TFDP2;PIDD1;ZNF385A
5739,GO:0016896,0.821411346233217,0.402895808529004,2,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,ISG20;PAN2
4849,GO:0014072,0.821718475728602,0.502080912509249,1,17,response to isoquinoline alkaloid,BP,ADA
10414,GO:0043278,0.821718475728602,0.502080912509249,1,17,response to morphine,BP,ADA
1481,GO:0003785,0.821744639672632,0.501111678673244,1,18,actin monomer binding,MF,TWF2
3280,GO:0006977,0.822048663347864,0.332099963235417,4,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,PCBP4;TFDP2;PIDD1;ZNF385A
13494,GO:0055093,0.822234899843072,0.501198127554524,1,17,response to hyperoxia,BP,BNIP3
10578,GO:0043565,0.822371404152266,0.213476220425571,67,758,sequence-specific DNA binding,MF,FOS;TCFL5;MEF2D;NR1D1;EPAS1;NFATC4;H1F0;EGR1;DEAF1;BAHCC1;CXXC5;ZMYND8;SOX12;MXI1;ZNF516;THRA;ZFPM1;TFEB;SALL2;FOXQ1;TFDP2;ZC3H6;ZNF692;ZNF704;HES2;MNT;STAT6;MTA3;BCL6;CEBPB;HSF4;CALCOCO1;ETV5;MTA1;MBD1;HES1;MLXIPL;PHF21A;ETV4;SOX13;BHLHE40;RAG1;ZNF80;HMGA2;ELK3;POU6F1;ZNF217;PPARA;RXRA;HLTF;TEF;SMARCD2;PROX1;WBP2;ZNF554;JARID2;RXRB;MEF2B;SIX5;SSBP2;CAMTA2;RFX2;DDN;SIRT3;LITAF;MZF1;RARG
16829,GO:0098780,0.822511480507051,0.50072469262386,1,17,response to mitochondrial depolarisation,BP,PINK1
9147,GO:0035518,0.822977149515083,0.499926571551496,1,17,histone H2A monoubiquitination,BP,DDB2
1117,GO:0002706,0.823802420643371,0.312304361778001,5,71,regulation of lymphocyte mediated immunity,BP,ZP3;IL20RB;STAT6;BCL6;PRKCZ
1477,GO:0003756,0.824026860835585,0.49812275610545,1,17,protein disulfide isomerase activity,MF,TMX4
5715,GO:0016864,0.824026860835585,0.49812275610545,1,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,TMX4
15184,GO:0071359,0.824138346527126,0.329222528901917,4,58,cellular response to dsRNA,BP,EGFR;TMEM173;MAP2K2;AGO4
290,GO:0000795,0.824509297281852,0.497291552924512,1,17,synaptonemal complex,CC,P3H4
16973,GO:0099086,0.824509297281852,0.497291552924512,1,17,synaptonemal structure,CC,P3H4
13542,GO:0060037,0.824577832730613,0.497173359147407,1,17,pharyngeal system development,BP,HES1
798,GO:0002068,0.824623108864722,0.497095262217918,1,17,glandular epithelial cell development,BP,RARG
17399,GO:1900180,0.824823013612488,0.298260878019584,6,83,regulation of protein localization to nucleus,BP,TMEM173;GAS6;PIN1;SESN2;AKT1;LZTS2
13479,GO:0055076,0.824921034438943,0.288163006063346,7,99,transition metal ion homeostasis,BP,EPAS1;PRNP;ATP7B;SLC25A37;NEO1;CYBRD1;SLC22A17
4148,GO:0009219,0.825014365330005,0.495492035892125,1,18,pyrimidine deoxyribonucleotide metabolic process,BP,NEIL1
10873,GO:0044432,0.825317937456954,0.206501942242505,84,957,endoplasmic reticulum part,CC,H6PD;LMF1;APOE;CST3;NOS1;LTBP1;COL6A1;EGFR;REEP6;KDSR;ULK1;RHBDF1;LPCAT4;CERS4;ABCG1;PLD3;CRTAP;ANO8;PKD2;TMEM129;CPT1C;EDEM1;ITPR3;SIGMAR1;ADAMTS7;LAMB2;WNT7A;TMEM173;SRD5A3;RNASET2;MARCH2;REEP2;FAM20C;CERCAM;RHBDF2;CARD19;ENTPD2;GPSM1;MBOAT7;FKBP10;MCTP1;OSBPL5;RETSAT;PCSK9;PITPNM1;MXRA8;SLC37A2;XYLT2;VGF;SEZ6L2;MAPK8IP1;CYP3A5;PIGZ;IFNGR2;MSLN;TM7SF2;GAS6;WNT7B;REEP4;IGFBP4;ADAMTS13;ABCD4;CTSZ;MAN1B1;ESYT2;CES2;CAPN2;PIGV;TIMP1;RTN2;PIGQ;WNT3;SBF1;COL13A1;CYP2S1;SPPL2B;AGPAT4;POMT1;DDN;ERN1;ADAMTSL4;TMED4;AGPAT3;ALG12
6542,GO:0021983,0.825708740478213,0.495218993699131,1,17,pituitary gland development,BP,HES1
7359,GO:0031418,0.825893528744177,0.494898927374123,1,17,L-ascorbic acid binding,MF,PHYH
1552,GO:0003954,0.8259380318515,0.393453532434287,2,40,NADH dehydrogenase activity,MF,NDUFS8;NDUFV3
16599,GO:0097484,0.826322744192442,0.494154705554652,1,17,dendrite extension,BP,CYFIP2
2988,GO:0006541,0.826511421569877,0.493827205380443,1,17,glutamine metabolic process,BP,GLUL
8950,GO:0035036,0.826646903472586,0.492662478283897,1,18,sperm-egg recognition,BP,ZP3
14444,GO:0061844,0.826861085006322,0.489439178318512,1,22,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,FAM3A
20241,GO:2001238,0.82703698042616,0.350411114011946,3,46,positive regulation of extrinsic apoptotic signaling pathway,BP,RBCK1;PIDD1;PYCARD
10512,GO:0043470,0.827580420817686,0.32423324013466,4,58,regulation of carbohydrate catabolic process,BP,INSR;PFKFB2;MLXIPL;PPARA
8683,GO:0034333,0.827612057817229,0.307042281989741,5,70,adherens junction assembly,BP,LAMA5;RHOD;VEGFA;DMTN;PPM1F
5457,GO:0016363,0.827651048899739,0.284711907719128,7,95,nuclear matrix,CC,DNMT3A;CEBPB;MBD1;HLCS;DGKQ;PRKCZ;RGS12
15358,GO:0071634,0.827935167308786,0.491348988110569,1,17,regulation of transforming growth factor beta production,BP,FURIN
16024,GO:0086091,0.828420996153201,0.490500528434017,1,17,regulation of heart rate by cardiac conduction,BP,SCN4B
5270,GO:0015932,0.828469256256226,0.391680304862851,2,32,nucleobase-containing compound transmembrane transporter activity,MF,SLC28A2;SLC29A4
15397,GO:0071695,0.828575922974076,0.283458138879506,7,95,anatomical structure maturation,BP,FAM210B;THBS3;FAM20C;PLXNB1;FGFR3;DMC1;EREG
4951,GO:0015036,0.829771956705661,0.388916487890663,2,34,disulfide oxidoreductase activity,MF,TXNRD3;GLRX
15936,GO:0080008,0.830765885085436,0.38798776271556,2,32,Cul4-RING E3 ubiquitin ligase complex,CC,DDB2;FBXW5
1854,GO:0004521,0.830833318418061,0.344461154012424,3,47,endoribonuclease activity,MF,RNASET2;ERN1;RNASEK
3164,GO:0006783,0.831150021751623,0.484774049811357,1,18,heme biosynthetic process,BP,UROS
8211,GO:0032986,0.832015061372217,0.483244460929477,1,18,protein-DNA complex disassembly,BP,SMARCD2
9996,GO:0042440,0.832018531262811,0.342654803820463,3,47,pigment metabolic process,BP,UROS;ADA;BLVRB
95,GO:0000186,0.832042387364176,0.34301420254635,3,45,activation of MAPKK activity,BP,EGFR;F2R;ERCC6
15770,GO:0072431,0.832436689290201,0.316875651693783,4,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,PCBP4;TFDP2;PIDD1;ZNF385A
17956,GO:1902400,0.832436689290201,0.316875651693783,4,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,PCBP4;TFDP2;PIDD1;ZNF385A
7181,GO:0031082,0.832671042683704,0.482081437414596,1,18,BLOC complex,CC,PI4K2A
5981,GO:0018958,0.832881157229481,0.34153045764934,3,46,phenol-containing compound metabolic process,BP,EPAS1;COMT;SLC5A5
13020,GO:0051536,0.833282578659609,0.315508632452041,4,61,iron-sulfur cluster binding,MF,XDH;NDUFS8;RSAD1;MOCS1
13024,GO:0051540,0.833282578659609,0.315508632452041,4,61,metal cluster binding,MF,XDH;NDUFS8;RSAD1;MOCS1
7393,GO:0031468,0.833575252996671,0.480473913406413,1,18,nuclear envelope reassembly,BP,REEP4
18513,GO:1903747,0.83382592753842,0.276130520191421,7,98,regulation of establishment of protein localization to mitochondrion,BP,MICALL2;VPS11;TFDP2;HES1;OSCP1;PINK1;UBL5
17799,GO:1901984,0.833861314989529,0.479964279732993,1,18,negative regulation of protein acetylation,BP,HINT2
853,GO:0002183,0.834350836842118,0.47909097856412,1,18,cytoplasmic translational initiation,BP,RPL13A
3655,GO:0008150,0.834645881546121,0.196692933881882,1066,11244,biological_process,BP,TNIP1;HTRA1;FOS;DUSP6;H6PD;LMF1;CEMIP;ADGRL1;APOE;TYSND1;MARVELD1;ESPN;CTNNBIP1;MARCKSL1;TSPAN1;PPL;IDH2;RNPEPL1;PTPRS;ERCC1;WWC3;FLNC;SEMA4B;FAM110C;NT5E;GAA;SYTL1;LTB4R;CITED4;NAPRT;BTBD2;PYGB;RNF44;CST3;SHANK2;LTBP4;RAPGEF3;TCFL5;MRC2;PGM1;CYP27B1;GSN;CLCA2;EVI5L;XDH;PRDX5;NDRG1;PGLS;PCBP4;PRSS3;PRODH;PGF;CADM4;MEF2D;NOS1;LTBP1;MARCH9;PARVB;ARAP1;SH3BP2;ZFP36L1;COL6A1;TCTN1;CGREF1;POSTN;GRB7;NR1D1;CRAT;EFS;ALOX15B;ARRDC1;FAM210B;NYNRIN;POLD4;SCN8A;SLCO4A1;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;CPT2;RHPN1;MYZAP;IGF2;NFATC4;GPX3;NME4;MST1R;LRP1;GAMT;MAPK13;APPL2;HEBP1;KCNG1;CDK18;RALGDS;ST6GALNAC2;LTBP2;RAB11FIP4;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;SMOC2;MMP28;B3GAT3;HADH;NLGN2;CRYL1;SUGCT;ACSF2;REEP6;FBXO2;ACOT7;TCEA2;DUSP5;TOM1L2;FKBP9;HS1BP3;PPP1R14A;ISYNA1;SLC43A1;UROS;FHL1;JOSD2;LOXL1;MXD4;DDB2;SERPING1;MTHFR;KDSR;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CMTM7;SDK2;CRTC1;ARPIN;PYGL;ARHGEF4;TRIM65;DOPEY2;SYT8;NAGLU;SHC1;RGL2;F2R;PTK6;GNAL;BPHL;NPEPL1;ABCA7;DEAF1;LAMA5;PPP2R3B;SLC9A3R2;CA12;BAHCC1;GALE;BBS2;SLC16A5;ACTA2;PRSS8;S100A4;PPM1J;CTSB;LPCAT4;DNAH1;RNF208;SHC2;PITPNC1;SLC16A3;CORO1B;CXXC5;ULK2;DGKA;GJC2;IGSF9;DHRS1;MALL;THBS3;D2HGDH;ZMYND8;TBC1D14;ASH2L;ZSCAN18;PACS2;GRAMD4;NXPH4;SOX12;MXI1;CERS4;PLAT;KCNC4;MMP1;ABCG1;RIN1;ANK3;DHRS11;PIK3R2;OPLAH;S100A6;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;ARHGAP23;PLD3;KCNJ15;DOCK4;ZP3;CRTAP;RPS6KA2;NMRK1;NISCH;LRP5;DBNDD1;HYAL1;TMEM54;TUBG2;ANO8;MARK4;TENM2;PLTP;SLC2A9;LRP3;MAML3;KHNYN;ZFPM1;BCAM;TFEB;ERBB2;SLC13A3;EXOC2;FBLN1;BRSK1;MICALL2;BSG;CTSF;SCMH1;PTPRU;OGDHL;PKD2;CBS;GID4;SH3TC1;TMEM129;FUCA1;TST;SCN4B;IQSEC2;CPT1C;EDEM1;ABTB1;SLC7A8;ITGB4;ITPR3;PLXNB3;H2AFJ;PRAF2;PHLDA2;VAT1;DNM1;SPRY4;DDIT4L;FCHO1;PTHLH;CDKN1C;RIMS3;LRP11;SALL2;MSRB2;IFT140;VIPR1;CUL9;CD9;KIF13B;XPC;PTPRE;CACFD1;NINL;SIGMAR1;PAK6;HEXB;DNAJC4;SERPINE2;VPS11;VAMP2;CCDC69;FUZ;GALNT12;FOXQ1;RNF135;NPHP4;LTB4R2;UNK;NTSR1;JADE2;THSD4;CD320;MINK1;RALGAPA2;ATP2B4;GGT1;SNN;TMOD2;SLC6A8;TFDP2;CSNK1E;ACP5;RASA4;PLCD1;TRAPPC9;AGAP1;ZFYVE21;ADAMTS7;PDCD4;DOCK6;GM2A;DHRS4L2;SLC20A1;BEX2;ACAP3;TNFRSF25;GLUL;PRR7;RHOD;DTX3;ZKSCAN1;ARVCF;TNXB;USP20;PEX10;ASIC1;LAMB2;SPATA18;PLEKHG4;WNT7A;ZMIZ1;INSR;RAB3D;PLCXD1;LCE1E;SH3PXD2B;TBC1D8;FBXW8;ZC3H6;ID1;CELSR1;AKR7A2;GRK6;MVD;B4GAT1;POLL;NDUFS8;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;CCNG2;TXNRD3;SYNGAP1;IL20RB;NBEAL2;HAGH;FBXO27;PPP1R35;DNMT3A;DNPH1;LPAR3;TMEM173;PRNP;SERINC2;DHX32;PAPLN;SRD5A3;ATP7B;EFNB3;IAH1;RNASET2;FBXL8;SNX33;FBXO41;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;SLC12A7;ECM1;CEP250;NPDC1;ATG16L2;SNX9;STAT6;DLG4;SPEG;ABCD1;MARCH2;REEP2;FGGY;MTA3;MKNK2;PLCD3;NT5DC1;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;MYO18A;TMEM107;ARHGAP27;CERCAM;DNAJB5;MYCBPAP;PHC2;SCART1;PLEKHH2;BCL6;TTYH3;ANKZF1;UCKL1;PFKFB2;ATP12A;PLXNB1;FAM213A;CHMP1B;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;BNIP3;CD81;SRMS;FCGRT;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;HOOK2;LRRC8A;ARL2;YPEL3;C22ORF23;VANGL2;MAST4;FBXW4;ELMO3;TMEM63C;AP2A2;CEBPB;RHBDF2;DPP7;GPRC5C;SHANK3;HSD11B1L;SSC4D;ACVR2B;HSF4;ADAM15;NAB2;NUDCD3;CALCOCO1;ZDHHC1;S1PR2;ENDOG;TNFRSF6B;MAPK3;PDZD2;FBXL16;PLEKHG5;TUB;KCNAB2;ETV5;OLFM2;CARD19;AMN;SLC22A18;GLB1;CAPNS2;DHTKD1;EXD3;C19ORF33;RAB40B;TNNT1;DVL1;ENTPD2;GALK1;MTA1;LHPP;FYCO1;KLHL29;WIPF1;GPSM1;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;PHGDH;ST3GAL3;SLC16A13;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;PHYHD1;PC;ACAD10;GIGYF1;SSH1;COMTD1;FURIN;MLXIPL;ZNF624;NAGS;FBF1;FAM86C2P;MBOAT7;SLC48A1;SAMD3;CUL7;MEFV;EVC;ARHGAP22;SLC2A3;TRIM4;NRP2;GPR153;NADK;PLEKHG2;ABCA2;TNFRSF14;TK2;LRSAM1;ZNF414;LY6K;ADA;FKBP10;CDC42EP5;TRIM45;MCTP1;OSBPL5;PYCR2;PIDD1;RETSAT;PAG1;PHF21A;SH2D2A;AQP3;HTR7;RASL10B;CELSR2;ACY1;CKMT1A;PFKL;IL6R;SLIT3;PCSK9;GGACT;TMEM9;SLC28A2;ZFP36;ETV4;RHOF;BTBD11;MAPKBP1;HLCS;FGFR3;NSUN7;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;KIAA1549;LRRK1;NUDT10;SPATA20;PLCH2;DGUOK;MAGEF1;CYFIP2;SLC38A10;RPS6KA5;SCNN1A;HBEGF;SLC25A37;ITGB5;RAB3B;MAP2K2;PI4K2A;DAP;FGFR4;SPTB;FBXW5;MXRA8;SLC37A2;STX10;TSPAN33;DMTN;RAPGEF5;PMVK;BBS1;MYH3;PSD4;MDGA1;XYLT2;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;TCF25;SEMA3B;LDLR;PTOV1;LYPLAL1;CYP3A5;ACOT11;ROBO3;SNX17;SOX13;ABHD17C;TRPV4;MPG;RHOBTB2;PIGZ;IFNGR2;BHLHE40;EIF4EBP3;RRNAD1;CROCC;RAG1;ZNF80;DUSP7;PHLDA1;NHSL1;TNFAIP8L1;EEF2K;RHBDL1;MSLN;HMGA2;LDLRAP1;TM7SF2;SEMA3F;ELK3;AHNAK2;DGKQ;PEX7;SEMA4C;MVB12A;HK1;NMRAL1;FAM3A;ZXDC;SLC29A4;MIB2;FBXO17;CHST6;SDHAF4;PADI3;GAS6;BTRC;MEX3A;POU6F1;LLGL1;ADGRB2;ZNF217;PPARA;HMGCL;TKFC;GUK1;TSPAN4;TMEM187;STK32C;WNT7B;BLVRB;GIT1;COMT;ALDH16A1;TTC7B;SUFU;AIG1;PTAFR;PLEKHG6;RFNG;DMC1;IMPA2;ARHGEF37;LTBP3;PAN2;REEP4;ZNF446;ATG2A;RXRA;PCK2;PCSK1;VAV3;LRP10;VASN;BCR;TMEM175;NEO1;IGFBP4;SDHA;GSDMC;MUC19;TBC1D16;USP21;RNF123;WDR60;PRKCZ;ADAMTS13;ZDHHC24;CLTCL1;HLTF;MDH2;CAPG;BCORL1;INPP5D;TM7SF3;TMCO6;ETFB;ABCD4;SPATA7;NYAP1;SLITRK6;TWF2;ZNF485;LSM14B;KLHDC8B;TPP1;PDK2;GPC1;TMX4;ICOSLG;SRSF5;ZNF160;RFXANK;TEF;SMOX;CEP68;SMARCD2;MAPKAPK3;NDE1;AGO4;RAD23A;ARAP3;CDHR1;FGFR1;CTSZ;CAMKK1;CHADL;SPSB3;PIN1;MAN1B1;MN1;PNPLA4;ZNF563;C5;KMT5C;PHYH;TMEM204;IRF2BPL;CMBL;PROX1;WBP2;GTPBP1;PCDHGC3;C21ORF2;ASAP2;DLG3;GPR155;KCNMA1;ESYT2;BIN1;VSNL1;UNC119B;YIPF3;TMEM8B;SERPINB6;OSCP1;PI4KAP2;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;CES2;SLC25A27;TMCO3;GRB10;BFSP1;JARID2;SYNC;CAPN2;SESN2;NDUFA4L2;TOLLIP;ADCK5;WNT2B;TSTA3;WRAP73;TMEM161A;RXRB;CSTB;PROCR;SNPH;MAN2B2;TMEM231;PNRC1;MAPRE3;DUSP23;LCAT;GUCA1B;MACROD1;ADGRE2;GAL3ST4;SMDT1;PTMS;PITPNM3;TMPRSS11D;CYBRD1;MADD;LMLN;RTN4R;ELFN2;OR7D2;EPB41L3;PIGV;SLC9A7;TIMP1;CD68;SDC1;WHAMMP3;GRHPR;SH2B3;ACTR1B;APOBEC3C;FGFBP1;RTN2;H1FX;PEAR1;EPS8L1;PLEKHH3;PIGQ;WNT3;LYST;GSTT1;ZFP41;PPM1F;KIAA1191;OLFML2A;MICALCL;SBF1;SORL1;STK39;COL13A1;VEGFB;ACVR1B;MEF2B;TBC1D17;ANO9;FAM189B;GSDMA;ZSCAN30;GSS;AHCYL2;ALS2CL;TSNARE1;ADORA2B;TPCN1;HGSNAT;SLC25A29;ERBB3;ABR;ZER1;CCDC85B;PNMA1;CYP2S1;CCDC71L;AKT1;HPDL;CTSD;TRAP1;STON1;TMBIM4;NLRX1;SEPT8;ADAM19;ZNF385A;TP53INP1;LRCH4;NDRG2;TUT1;SMARCA1;VPS33B;SIX5;ERCC6;PCMTD2;ACP6;GPD1L;EPS8L2;TDRKH;SLC5A5;SUN1;NAGA;TMEM120A;SPPL2B;IL17RD;UQCR11;SSBP2;RPL39L;ADCK2;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;MPLKIP;SNTA1;ARHGEF10L;KDM4B;CAMTA2;HOMER2;PLPPR2;RGS14;SYNE3;GOLGA2P5;PCIF1;MAFIP;SPIRE2;HEXDC;EIF4G3;ZNF710;CTSH;EHBP1L1;ABHD14B;P3H4;MLST8;ROBO4;AGPAT4;RILPL1;NRSN1;RSAD1;CBLC;ATXN10;EPN2;RFX2;RNF187;PYCARD;NINJ1;MAP2K3;PNPO;RHBG;POMT1;TRERF1;PCSK1N;KCNN4;DNAAF5;THAP8;DDN;PMS2P5;AS3MT;NDUFV3;STK17A;ERN1;CKLF;RANBP9;ZNF319;APOBEC3F;PRIMPOL;ACADS;FBXL20;GCAT;WDR63;MOCS1;ARHGEF19;SIRT3;ALKBH6;ORAI3;WBP1;GLI4;C12ORF66;CMTM4;SLC2A1;CPNE7;MLYCD;TAZ;RNASEK;JAK3;BCKDHA;MAST3;KIFC2;LITAF;APBA1;MZF1;NEIL1;FUK;ORAI2;RARG;ING4;EIF4E3;GALNS;PBXIP1;EREG;FAM162A;PPCS;FCHSD1;GSTM2;ABHD14A;ZNF514;PODXL2;ZFYVE19;TRIM7;SHISA6;MORN4;GIPR;WDR18;PQLC2;SFI1;TP53I11;KRT15;ADAMTSL4;TRNP1;TTLL11;ZNF837;TMED4;POLM;SEMA4F;PRR15;FAM50A;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;STXBP2;KIF26B;UBL5;LZTS2
4474,GO:0010506,0.835246580099077,0.22464927650125,22,271,regulation of autophagy,BP,ULK1;TRIM65;ULK2;TBC1D14;PIK3R2;TFEB;BNIP3;MAPK3;FYCO1;GPSM1;MEFV;LRSAM1;PRKACA;DAP;SESN2;TPCN1;AKT1;TP53INP1;PINK1;MLST8;PYCARD;ERN1
9177,GO:0035577,0.835610306258495,0.337152868299311,3,47,azurophil granule membrane,CC,GAA;RAB3D;CD68
12817,GO:0051153,0.835617060542212,0.312326122894125,4,59,regulation of striated muscle cell differentiation,BP,HDAC5;THRA;PIN1;PROX1
13021,GO:0051537,0.835670922989622,0.47589270526664,1,19,2 iron, 2 sulfur cluster binding,MF,XDH
17286,GO:0140142,0.836389527604758,0.47543767655256,1,18,nucleocytoplasmic carrier activity,MF,TMCO6
13882,GO:0060561,0.836519038945033,0.475204701051115,1,18,apoptotic process involved in morphogenesis,BP,LRP5
12983,GO:0051438,0.836559972675637,0.335507051899212,3,48,regulation of ubiquitin-protein transferase activity,BP,PIN1;ZER1;PINK1
8583,GO:0034105,0.83673944961327,0.474807961884171,1,18,positive regulation of tissue remodeling,BP,EGFR
4419,GO:0010257,0.83694833498288,0.333816518473587,3,55,NADH dehydrogenase complex assembly,BP,NDUFS8;NDUFV3;TAZ
8208,GO:0032981,0.83694833498288,0.333816518473587,3,55,mitochondrial respiratory chain complex I assembly,BP,NDUFS8;NDUFV3;TAZ
148,GO:0000303,0.837074245785311,0.473368009245864,1,19,response to superoxide,BP,ERCC6
6202,GO:0019730,0.837137523329375,0.375367430555757,2,40,antimicrobial humoral response,BP,PRSS3;FAM3A
2476,GO:0005720,0.83721266954913,0.377160699408916,2,33,nuclear heterochromatin,CC,DNMT3A;KMT5C
4339,GO:0009913,0.837264119852542,0.237876463073748,14,185,epidermal cell differentiation,BP,PPL;CYP27B1;ZFP36L1;ALOX15B;PRSS8;LCE1E;HES1;FURIN;AQP3;ZFP36;SLITRK6;FGFR1;EREG;KRT15
17661,GO:1901566,0.83733437709167,0.187364112562442,132,1521,organonitrogen compound biosynthetic process,BP,TNIP1;LMF1;CEMIP;APOE;IDH2;NT5E;NAPRT;PGM1;NOS1;ZFP36L1;GRB7;NME4;GAMT;ST6GALNAC2;EGFR;TIMP2;B3GAT3;ACOT7;UROS;KDSR;EGR1;ABCA7;CERS4;OPLAH;NMRK1;HYAL1;ZFPM1;ERBB2;OGDHL;CBS;ABTB1;PTHLH;GALNT12;LTB4R2;UNK;ATP2B4;GGT1;ADAMTS7;GLUL;INSR;MVD;B4GAT1;HAGH;SRD5A3;MKNK2;UCKL1;PFKFB2;VANGL2;CEBPB;ZDHHC1;MAPK3;DHTKD1;GALK1;ADCY6;WIPI2;PHGDH;ST3GAL3;FURIN;MLXIPL;NAGS;NADK;TK2;LY6K;ADA;PYCR2;PFKL;ZFP36;DGUOK;CYFIP2;HBEGF;MAP2K2;MDGA1;XYLT2;TNFRSF1A;ABHD17C;PIGZ;EIF4EBP3;PHLDA1;EEF2K;MSLN;HK1;NMRAL1;CHST6;MEX3A;PPARA;GUK1;PTAFR;RFNG;RXRA;PCSK1;MUC19;ADAMTS13;ZDHHC24;INPP5D;LSM14B;GPC1;SMOX;AGO4;MAN1B1;GTPBP1;ASS1;SESN2;LCAT;GUCA1B;GAL3ST4;PIGV;SDC1;PIGQ;GSTT1;VEGFB;GSS;ADORA2B;AKT1;TRAP1;ZNF385A;RPL39L;PINK1;EIF4G3;RSAD1;PNPO;POMT1;MOCS1;TAZ;JAK3;EIF4E3;EREG;PPCS;GSTM2;ADAMTSL4;NDST2;RPL13A;ALG12
4673,GO:0010831,0.837375567537265,0.473661204027943,1,18,positive regulation of myotube differentiation,BP,THRA
9225,GO:0035635,0.837449967835446,0.473526909613497,1,18,entry of bacterium into host cell,BP,EXOC2
2529,GO:0005791,0.837558769655759,0.309081596737212,4,62,rough endoplasmic reticulum,CC,GLUL;PCSK9;F12;SYNE3
7938,GO:0032549,0.837795032799263,0.220171797453298,23,285,ribonucleoside binding,MF,GNAL;TUBG2;DNM1;AGAP1;RHOD;INSR;RAB3D;RAB25;ARL2;ARL10;RAB40B;RASL10B;RHOF;LRRK1;RAB3B;EHD4;RHOBTB2;PCK2;GTPBP1;SEPT8;EHD3;MOCS1;RAB40C
6688,GO:0030097,0.837952863512043,0.201499682333021,49,586,hemopoiesis,BP,FOS;CTNNBIP1;ERCC1;ZFP36L1;FAM210B;EPAS1;EGR1;CMTM7;ASH2L;HDAC5;THRA;ZFPM1;ERBB2;ZMIZ1;NBEAL2;STAT6;MKNK2;FAM20C;BCL6;FAM213A;FZD8;VEGFA;LRRC8A;CEBPB;KCNAB2;DHTKD1;L3MBTL1;HES1;ADA;ZFP36;LRRK1;DMTN;SOX13;RAG1;GAS6;BCR;PRKCZ;INPP5D;ZNF160;AGO4;WNT2B;SH2B3;ACVR1B;ZNF385A;VPS33B;TAZ;JAK3;RARG;POLM
902,GO:0002285,0.838542386379485,0.269721502525037,7,97,lymphocyte activation involved in immune response,BP,ERCC1;ZFPM1;STAT6;BCL6;ADA;PRKCZ;JAK3
11768,GO:0046655,0.838657831258827,0.471341692644809,1,18,folic acid metabolic process,BP,MTHFR
10963,GO:0044773,0.839014199842398,0.269014273153919,7,98,mitotic DNA damage checkpoint,BP,PCBP4;BRSK1;XPC;TFDP2;PIDD1;HMGA2;ZNF385A
9486,GO:0036151,0.839584149701567,0.469659431305287,1,18,phosphatidylcholine acyl-chain remodeling,BP,LPCAT4
13182,GO:0051851,0.839814693926794,0.330658523819454,3,47,modification by host of symbiont morphology or physiology,BP,APOE;PC;HMGA2
10760,GO:0044232,0.839864055147353,0.469150003278777,1,18,organelle membrane contact site,CC,ESYT2
1125,GO:0002714,0.839948505726383,0.468996202704259,1,18,positive regulation of B cell mediated immunity,BP,STAT6
1220,GO:0002891,0.839948505726383,0.468996202704259,1,18,positive regulation of immunoglobulin mediated immune response,BP,STAT6
18270,GO:1903203,0.840020282135698,0.468865447543228,1,18,regulation of oxidative stress-induced neuron death,BP,PINK1
10572,GO:0043555,0.840144055533538,0.468639890254612,1,18,regulation of translation in response to stress,BP,SESN2
634,GO:0001824,0.840381780266702,0.32977804228494,3,47,blastocyst development,BP,ZP3;ADA;CAPN2
6645,GO:0030004,0.840672426001133,0.288105829325728,5,73,cellular monovalent inorganic cation homeostasis,BP,ATP12A;MAPK3;TMEM175;KCNMA1;SLC9A7
7928,GO:0032528,0.840794803915891,0.467452353389446,1,18,microvillus organization,BP,TWF2
13776,GO:0060393,0.840860807828832,0.371152261988751,2,33,regulation of pathway-restricted SMAD protein phosphorylation,BP,PIN1;ACVR1B
7547,GO:0031901,0.841049254976129,0.258853556225129,8,109,early endosome membrane,CC,APPL2;EGFR;ABCA7;PI4K2A;EHD4;LLGL1;VPS33B;LITAF
2536,GO:0005801,0.841465373230609,0.328092586233905,3,47,cis-Golgi network,CC,B3GAT3;ANGEL1;GOLGA2P5
5067,GO:0015301,0.841651890736987,0.465884023610812,1,18,anion:anion antiporter activity,MF,SLC37A2
14921,GO:0070841,0.841688841694125,0.465816300337067,1,18,inclusion body assembly,BP,SORL1
2559,GO:0005849,0.84193378987604,0.465367133767782,1,18,mRNA cleavage factor complex,CC,TUT1
15763,GO:0072413,0.842314469219492,0.30212777290748,4,61,signal transduction involved in mitotic cell cycle checkpoint,BP,PCBP4;TFDP2;PIDD1;ZNF385A
17957,GO:1902402,0.842314469219492,0.30212777290748,4,61,signal transduction involved in mitotic DNA damage checkpoint,BP,PCBP4;TFDP2;PIDD1;ZNF385A
17958,GO:1902403,0.842314469219492,0.30212777290748,4,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,PCBP4;TFDP2;PIDD1;ZNF385A
3274,GO:0006968,0.842575721361001,0.464188123245397,1,18,cellular defense response,BP,ADORA2B
9114,GO:0035455,0.842603280814016,0.463297006238678,1,19,response to interferon-alpha,BP,GAS6
5062,GO:0015295,0.842692068773699,0.463974139351471,1,18,solute:proton symporter activity,MF,SLC2A9
2477,GO:0005721,0.842921237566586,0.463552392885445,1,18,pericentric heterochromatin,CC,KMT5C
10849,GO:0044390,0.843893305770506,0.366113949641344,2,33,ubiquitin-like protein conjugating enzyme binding,MF,PPARA;TOLLIP
5722,GO:0016878,0.843898828112502,0.461749362393976,1,18,acid-thiol ligase activity,MF,ACSF2
6761,GO:0030206,0.844181547900707,0.461226730798133,1,18,chondroitin sulfate biosynthetic process,BP,XYLT2
12332,GO:0048730,0.844379163374587,0.460861102630417,1,18,epidermis morphogenesis,BP,FOXQ1
16526,GO:0097327,0.844821500371587,0.282095580248929,5,73,response to antineoplastic agent,BP,MAPK13;EGFR;EGR1;PTAFR;PCK2
20238,GO:2001235,0.844824709648779,0.238150837196491,11,150,positive regulation of apoptotic signaling pathway,BP,GSN;RBCK1;NFATC4;TFDP2;BNIP3;PIDD1;TP53INP1;PINK1;CTSH;PYCARD;FAM162A
9618,GO:0036503,0.845152315550097,0.269662239429124,6,86,ERAD pathway,BP,FBXO2;TMEM129;EDEM1;ANKZF1;MAN1B1;POMT1
10450,GO:0043331,0.84520879819499,0.281532323690124,5,73,response to dsRNA,BP,EGFR;TMEM173;MAPK3;MAP2K2;AGO4
2817,GO:0006289,0.845353179026361,0.252806195026947,8,113,nucleotide-excision repair,BP,ERCC1;POLD4;DDB2;XPC;POLL;RAD23A;ERCC6;NEIL1
5113,GO:0015491,0.845551878190815,0.458685922241583,1,18,cation:cation antiporter activity,MF,SLC9A7
2493,GO:0005747,0.845577853994013,0.360967121891289,2,42,mitochondrial respiratory chain complex I,CC,NDUFS8;NDUFV3
7123,GO:0030964,0.845577853994013,0.360967121891289,2,42,NADH dehydrogenase complex,CC,NDUFS8;NDUFV3
11161,GO:0045271,0.845577853994013,0.360967121891289,2,42,respiratory chain complex I,CC,NDUFS8;NDUFV3
19714,GO:2000114,0.845714711811292,0.458383157934154,1,18,regulation of establishment of cell polarity,BP,GSN
13080,GO:0051641,0.845822975610451,0.174366324336317,196,2184,cellular localization,BP,LMF1;CEMIP;APOE;MARVELD1;GAA;SYTL1;RAPGEF3;GSN;EVI5L;NOS1;ZFP36L1;TCTN1;NR1D1;EPHB2;OBSCN;CPT2;LRP1;LTBP2;RAB11FIP4;OBSL1;EGFR;B3GAT3;NLGN2;REEP6;TOM1L2;DOPEY2;SYT8;F2R;ABCA7;LAMA5;BBS2;CORO1B;MALL;ZMYND8;TBC1D14;PACS2;KCNC4;ABCG1;ANK3;LRP5;MARK4;ERBB2;EXOC2;BRSK1;MICALL2;BSG;PTPRU;PKD2;TMEM129;EDEM1;ITPR3;DNM1;RIMS3;IFT140;KIF13B;NINL;VPS11;VAMP2;NPHP4;NTSR1;ATP2B4;TFDP2;CSNK1E;TRAPPC9;ZFYVE21;RHOD;PEX10;ASIC1;WNT7A;RAB3D;SH3PXD2B;TBC1D8;ID1;CELSR1;SYNGAP1;TMEM173;PRNP;ATP7B;SNX33;SPRY2;CEP250;SNX9;DLG4;ABCD1;REEP2;STRADB;RAB25;TMEM107;BCL6;CHMP1B;MVB12B;CD81;HOOK2;ARL2;AP2A2;SHANK3;NUDCD3;ZDHHC1;MAPK3;TUB;KCNAB2;ETV5;AMN;RAB40B;DVL1;FYCO1;WIPF1;WIPI2;FHOD1;HES1;SSH1;FBF1;ABCA2;LRSAM1;MCTP1;PCSK9;ZFP36;PRKACA;RAB3B;MAP2K2;SPTB;STX10;TSPAN33;DMTN;BBS1;TNFRSF1A;EHD4;LDLR;SNX17;ABHD17C;CROCC;LDLRAP1;PEX7;MVB12A;HK1;GAS6;LLGL1;TTC7B;BCR;TBC1D16;WDR60;PRKCZ;ZDHHC24;CLTCL1;TMCO6;SPATA7;TWF2;SRSF5;CEP68;NDE1;CTSZ;PIN1;DLG3;ESYT2;BIN1;VSNL1;OSCP1;SESN2;TOLLIP;SNPH;ADGRE2;EPB41L3;WHAMMP3;RTN2;LYST;SORL1;TBC1D17;TSNARE1;ADORA2B;TPCN1;AKT1;SEPT8;ZNF385A;VPS33B;GPD1L;SUN1;PINK1;GAS8;PKD1;EHD3;LONP2;RGS14;SYNE3;SPIRE2;RILPL1;C12ORF66;APBA1;GSTM2;SHISA6;SFI1;TMED4;RPL13A;RAB40C;STXBP2;UBL5;LZTS2
19674,GO:2000036,0.845934575195108,0.457974069516195,1,18,regulation of stem cell population maintenance,BP,HMGA2
1864,GO:0004532,0.846581814691031,0.361290721528626,2,34,exoribonuclease activity,MF,ISG20;PAN2
4609,GO:0010737,0.846584359619241,0.455920300546407,1,19,protein kinase A signaling,BP,MIF
692,GO:0001913,0.846598265014938,0.455894346907959,1,19,T cell mediated cytotoxicity,BP,CTSH
15148,GO:0071310,0.846753341905165,0.175134948281088,160,1791,cellular response to organic substance,BP,TNIP1;HTRA1;FOS;DUSP6;LTBP4;RAPGEF3;CYP27B1;GSN;XDH;PGF;NOS1;LTBP1;ZFP36L1;COL6A1;POSTN;NR1D1;FAM210B;RBCK1;IGF2;NFATC4;MST1R;LRP1;MAPK13;LTBP2;EGFR;UROS;EGR1;SHC1;PTK6;LAMA5;BBS2;CTSB;CORO1B;MMP1;PIK3R2;HDAC5;THRA;LRP5;HYAL1;ERBB2;PKD2;EDEM1;SPRY4;CDKN1C;PTPRE;VAMP2;FUZ;ATP2B4;ADAMTS7;PDCD4;TNFRSF25;WNT7A;INSR;ID1;ITGA6;IL20RB;DNMT3A;TMEM173;PRNP;SPRY2;ECM1;STAT6;TALDO1;ISG20;FAM20C;BCL6;ANKZF1;IGFBP2;VEGFA;CEBPB;ACVR2B;CALCOCO1;ENDOG;TNFRSF6B;MAPK3;ADCY6;HES1;SSH1;FURIN;MLXIPL;CUL7;NRP2;TNFRSF14;IL6R;SLIT3;PCSK9;ZFP36;FGFR3;PRKACA;CYFIP2;RPS6KA5;ITGB5;MAP2K2;FGFR4;DMTN;TNFRSF1A;EHD4;LDLR;IFNGR2;EEF2K;GAS6;BTRC;PPARA;WNT7B;PTAFR;RXRA;PCK2;VASN;BCR;NEO1;PRKCZ;ADAMTS13;INPP5D;TM7SF3;ABCD4;TWF2;TPP1;PDK2;GPC1;SRSF5;AGO4;FGFR1;PIN1;TMEM204;WBP2;VSNL1;GRB10;JARID2;CAPN2;SESN2;TOLLIP;RXRB;MADD;RTN4R;TIMP1;CD68;SDC1;FGFBP1;WNT3;AKT1;TP53INP1;SLC5A5;SPPL2B;IL17RD;CTSH;EPN2;RFX2;PYCARD;MAP2K3;POMT1;ERN1;JAK3;LITAF;RARG;EREG;GSTM2;RPL13A;MIF;SULF2;STXBP2
11370,GO:0045773,0.846792840384927,0.361258616507506,2,33,positive regulation of axon extension,BP,VEGFA;TWF2
14523,GO:0070069,0.847549875824449,0.452058172278695,1,22,cytochrome complex,CC,NDUFA4L2
19607,GO:1990823,0.847930545613248,0.27756315462125,5,73,response to leukemia inhibitory factor,BP,SPRY2;ABCD4;JARID2;RFX2;RARG
19610,GO:1990830,0.847930545613248,0.27756315462125,5,73,cellular response to leukemia inhibitory factor,BP,SPRY2;ABCD4;JARID2;RFX2;RARG
16842,GO:0098800,0.848326431215725,0.264375431582662,6,99,inner mitochondrial membrane protein complex,CC,NDUFS8;SDHAF4;SDHA;NDUFA4L2;SMDT1;NDUFV3
4475,GO:0010507,0.848600236936627,0.292800070414034,4,60,negative regulation of autophagy,BP,TBC1D14;DAP;AKT1;PINK1
7573,GO:0031952,0.848689837507293,0.358061664150778,2,33,regulation of protein autophosphorylation,BP,VEGFA;EEF2K
7430,GO:0031572,0.848726466080136,0.357999774805929,2,33,G2 DNA damage checkpoint,BP,BRSK1;HMGA2
4629,GO:0010761,0.849015771435193,0.357510736562217,2,33,fibroblast migration,BP,DMTN;AKT1
13079,GO:0051640,0.849216193906924,0.190619790950372,44,522,organelle localization,BP,SYTL1;TCTN1;NLGN2;SYT8;BBS2;MARK4;EXOC2;DNM1;RIMS3;NINL;VPS11;VAMP2;NPHP4;CSNK1E;TRAPPC9;RAB3D;SPRY2;CEP250;CHMP1B;RAB40B;FYCO1;FHOD1;FBF1;PRKACA;RAB3B;STX10;CROCC;LLGL1;PRKCZ;NDE1;CTSZ;ESYT2;BIN1;SNPH;ADGRE2;TSNARE1;ADORA2B;VPS33B;SUN1;PINK1;SPIRE2;SFI1;RAB40C;STXBP2
6276,GO:0019894,0.849388473409292,0.356880163805714,2,33,kinesin binding,MF,MAPK8IP1;CROCC
18053,GO:1902679,0.849394050335062,0.180286541787063,80,928,negative regulation of RNA biosynthetic process,BP,CTNNBIP1;WWC3;TCFL5;PRDX5;NR1D1;IGF2;NFATC4;MXD4;MDFI;EGR1;SHC1;DEAF1;BAHCC1;CXXC5;ZMYND8;MXI1;PEG3;HDAC5;THRA;ZP3;TENM2;ZFPM1;SCMH1;H2AFJ;CDKN1C;SALL2;FOXQ1;TFDP2;PDCD4;ZC3H6;ID1;ZNF692;DNMT3A;HES2;MNT;STAT6;MTA3;WWTR1;DNAJB5;BCL6;FZD8;VEGFA;CEBPB;ACVR2B;HSF4;NAB2;MTA1;L3MBTL1;MBD1;HES1;MLXIPL;PHF21A;ZFP36;RPS6KA5;DAP;TCF25;TRPV4;BHLHE40;HMGA2;ELK3;GAS6;BTRC;POU6F1;ZNF217;PPARA;SUFU;RXRA;FGFR1;IRF2BPL;PROX1;PPP1R13L;JARID2;PPM1F;CCDC85B;SIX5;MZF1;RARG;ING4;PBXIP1;EREG
18400,GO:1903507,0.849394050335062,0.180286541787063,80,928,negative regulation of nucleic acid-templated transcription,BP,CTNNBIP1;WWC3;TCFL5;PRDX5;NR1D1;IGF2;NFATC4;MXD4;MDFI;EGR1;SHC1;DEAF1;BAHCC1;CXXC5;ZMYND8;MXI1;PEG3;HDAC5;THRA;ZP3;TENM2;ZFPM1;SCMH1;H2AFJ;CDKN1C;SALL2;FOXQ1;TFDP2;PDCD4;ZC3H6;ID1;ZNF692;DNMT3A;HES2;MNT;STAT6;MTA3;WWTR1;DNAJB5;BCL6;FZD8;VEGFA;CEBPB;ACVR2B;HSF4;NAB2;MTA1;L3MBTL1;MBD1;HES1;MLXIPL;PHF21A;ZFP36;RPS6KA5;DAP;TCF25;TRPV4;BHLHE40;HMGA2;ELK3;GAS6;BTRC;POU6F1;ZNF217;PPARA;SUFU;RXRA;FGFR1;IRF2BPL;PROX1;PPP1R13L;JARID2;PPM1F;CCDC85B;SIX5;MZF1;RARG;ING4;PBXIP1;EREG
9298,GO:0035774,0.849540576169086,0.450372821948085,1,19,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,VSNL1
9115,GO:0035456,0.850309130297928,0.448163031911052,1,20,response to interferon-beta,BP,TMEM173
7586,GO:0031970,0.850464249701922,0.2734315804133,5,78,organelle envelope lumen,CC,NME4;ARL2;SORL1;TRAP1;PINK1
13872,GO:0060544,0.850930728471367,0.447743179513553,1,19,regulation of necroptotic process,BP,RBCK1
16465,GO:0097190,0.851814090185244,0.190564527161489,38,464,apoptotic signaling pathway,BP,GSN;PRODH;RBCK1;NFATC4;TFDP2;TNFRSF25;ITGA6;MNT;MKNK2;STRADB;BNIP3;CEBPB;TNFRSF6B;TNFRSF14;PIDD1;IL6R;FGFR3;DAP;TNFRSF1A;MAPK8IP1;PDK2;FGFR1;TMEM161A;MADD;PPM1F;ACVR1B;ERBB3;AKT1;TRAP1;ZNF385A;TP53INP1;ERCC6;PINK1;CTSH;PYCARD;ERN1;FAM162A;MIF
950,GO:0002369,0.85229767212311,0.445144191613653,1,19,T cell cytokine production,BP,PRKCZ
15950,GO:0080134,0.852424591231985,0.176046745590667,85,978,regulation of response to stress,BP,TNIP1;HTRA1;APOE;PTPRS;ERCC1;NT5E;XDH;NR1D1;MAPK13;EGFR;SERPING1;PKN1;F2R;CTSB;PLAT;ZP3;EDEM1;CD9;SERPINE2;RNF135;MINK1;ATP2B4;GGT1;ACP5;PDCD4;WNT7A;IL20RB;TMEM173;BCL6;CD81;FZD8;VEGFA;YPEL3;VANGL2;ENDOG;MAPK3;NSMCE4A;MEFV;LRSAM1;ADA;MCTP1;MAPKBP1;PRKACA;F12;MAGEF1;RPS6KA5;HBEGF;MAP2K2;DMTN;TNFRSF1A;MAPK8IP1;LDLR;TRPV4;IFNGR2;RAG1;HMGA2;SEMA4C;FAM3A;BTRC;PPARA;TKFC;WNT7B;BCR;MUC19;MAPKAPK3;C5;SESN2;TMEM161A;RTN4R;STK39;ADORA2B;ABR;AKT1;TRAP1;NLRX1;ZNF385A;VPS33B;ERCC6;PINK1;MLST8;PYCARD;ERN1;APOBEC3F;EREG;MIF
19367,GO:1905898,0.853151339675851,0.350157123827484,2,34,positive regulation of response to endoplasmic reticulum stress,BP,EDEM1;ERN1
11544,GO:0046112,0.853419962372569,0.443000456161612,1,19,nucleobase biosynthetic process,BP,ADA
13207,GO:0051898,0.853420653422195,0.349696467114765,2,34,negative regulation of protein kinase B signaling,BP,XDH;AKT1
10483,GO:0043403,0.85342468505722,0.442991416163983,1,19,skeletal muscle tissue regeneration,BP,WNT7A
4521,GO:0010596,0.853763440389956,0.349109645002971,2,34,negative regulation of endothelial cell migration,BP,APOE;HDAC5
5573,GO:0016601,0.85392912263647,0.348825813759039,2,34,Rac protein signal transduction,BP,NISCH;ARAP3
4774,GO:0010971,0.854172665221774,0.441557640315453,1,19,positive regulation of G2/M transition of mitotic cell cycle,BP,MTA3
9050,GO:0035304,0.854399305799431,0.247530205079996,7,99,regulation of protein dephosphorylation,BP,B3GAT3;PPP1R14A;PPP2R3B;PPP1R35;PIN1;ELFN2;PINK1
8230,GO:0033017,0.854453085665465,0.441019076300968,1,19,sarcoplasmic reticulum membrane,CC,NOS1
15149,GO:0071312,0.854781711553933,0.440387209290819,1,19,cellular response to alkaloid,BP,GSTM2
4260,GO:0009620,0.854825808006535,0.439542875211376,1,20,response to fungus,BP,FAM3A
17712,GO:1901673,0.854826586965403,0.440300864357227,1,19,regulation of mitotic spindle assembly,BP,CHMP1B
5291,GO:0015991,0.854919628341849,0.439362273948501,1,20,ATP hydrolysis coupled proton transport,BP,ATP12A
603,GO:0001772,0.855339839749989,0.439312276247499,1,19,immunological synapse,CC,CD81
19704,GO:2000104,0.855498148853527,0.439006968013232,1,19,negative regulation of DNA-dependent DNA replication,BP,BCL6
7397,GO:0031491,0.855599655635856,0.281469920953459,4,66,nucleosome binding,MF,L3MBTL1;HMGA2;SMARCD2;SMARCA1
11434,GO:0045911,0.855756562222457,0.438508211688301,1,19,positive regulation of DNA recombination,BP,STAT6
9067,GO:0035336,0.855850507919687,0.438326769340307,1,19,long-chain fatty-acyl-CoA metabolic process,BP,ACOT7
201,GO:0000423,0.855905929518427,0.438219700502597,1,19,mitophagy,BP,PINK1
12818,GO:0051154,0.856737829480614,0.436609860812273,1,19,negative regulation of striated muscle cell differentiation,BP,HDAC5
13086,GO:0051648,0.856791021521281,0.2103554102352,15,195,vesicle localization,BP,SYTL1;NLGN2;SYT8;BBS2;DNM1;RIMS3;VAMP2;TRAPPC9;FYCO1;PRKCZ;NDE1;CTSZ;SNPH;VPS33B;PINK1
5719,GO:0016874,0.857165285112188,0.226026038627081,10,135,ligase activity,MF,NAPRT;ACSF2;GLUL;PC;HLCS;BTRC;ASS1;GSS;PPCS;TTLL11
16291,GO:0090503,0.857261736947602,0.342788579224566,2,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,ISG20;PAN2
5548,GO:0016570,0.857310520982677,0.187889716924695,32,388,histone modification,BP,NOS1;IGF2;DDB2;MTHFR;PKN1;ZMYND8;ASH2L;HDAC5;JADE2;MTA3;BCL6;VEGFA;HSF4;MAPK3;MTA1;FKBP10;PHF21A;HLCS;RPS6KA5;HDAC11;RAG1;HMGA2;PADI3;USP21;KMT5C;WBP2;JARID2;PPM1F;PINK1;KDM4B;SIRT3;ING4
16895,GO:0098901,0.857413398170636,0.435298811953824,1,19,regulation of cardiac muscle cell action potential,BP,ANK3
5152,GO:0015701,0.857599895333434,0.434936292910006,1,19,bicarbonate transport,BP,CA12
4530,GO:0010613,0.857613834664504,0.434909186899865,1,19,positive regulation of cardiac muscle hypertrophy,BP,PIN1
4870,GO:0014742,0.857613834664504,0.434909186899865,1,19,positive regulation of muscle hypertrophy,BP,PIN1
16518,GO:0097300,0.857952790918774,0.341592593524305,2,35,programmed necrotic cell death,BP,RBCK1;PYGL
8578,GO:0034097,0.858131682588328,0.172744782921018,68,803,response to cytokine,BP,FOS;CYP27B1;GSN;ZFP36L1;POSTN;RBCK1;MST1R;MAPK13;TIMP2;MTHFR;EGR1;SHC1;LAMA5;BBS2;MMP1;HYAL1;ACP5;ADAMTS7;PDCD4;TNFRSF25;IL20RB;TMEM173;SPRY2;ECM1;STAT6;TALDO1;ISG20;BCL6;VEGFA;CEBPB;ENDOG;TNFRSF6B;MAPK3;MEFV;TNFRSF14;IL6R;SLIT3;ZFP36;PRKACA;RPS6KA5;TNFRSF1A;IFNGR2;GAS6;BTRC;PTAFR;PCK2;ADAMTS13;INPP5D;ABCD4;MAPKAPK3;JARID2;TOLLIP;MADD;RTN4R;TIMP1;SDC1;GSS;AKT1;SPPL2B;IL17RD;RFX2;PYCARD;JAK3;RARG;EREG;RPL13A;MIF;STXBP2
14952,GO:0070888,0.858312169479859,0.433549387507013,1,19,E-box binding,MF,BHLHE40
12238,GO:0048545,0.858346993980945,0.197552698402199,21,265,response to steroid hormone,BP,FOS;ZFP36L1;NR1D1;EGFR;THRA;PTPRU;IGFBP2;CALCOCO1;GLB1;ABCA2;SLIT3;ZFP36;PPARA;WNT7B;PTAFR;RXRA;PCK2;WBP2;RXRB;SDC1;RARG
78,GO:0000159,0.859134313723856,0.431943868978099,1,19,protein phosphatase type 2A complex,CC,PPP2R3B
5528,GO:0016525,0.859185065938744,0.27649632136262,4,61,negative regulation of angiogenesis,BP,HDAC5;SPRY2;ADGRB2;EPN2
17279,GO:0140103,0.85940811382136,0.431408062323725,1,19,catalytic activity, acting on a glycoprotein,MF,B4GALNT4
5388,GO:0016235,0.859484147686404,0.339234025975895,2,34,aggresome,CC,EDEM1;STRADB
19805,GO:2000300,0.859584947360256,0.431061714233084,1,19,regulation of synaptic vesicle exocytosis,BP,RIMS3
10224,GO:0042974,0.859611923732131,0.431008857440628,1,19,retinoic acid receptor binding,MF,RARG
3790,GO:0008376,0.85987424183084,0.338554874742648,2,34,acetylgalactosaminyltransferase activity,MF,B4GALNT4;GALNT12
10776,GO:0044267,0.860208774907718,0.155156265985683,356,3918,cellular protein metabolic process,BP,TNIP1;DUSP6;LMF1;CEMIP;APOE;PTPRS;BTBD2;RNF44;CST3;RAPGEF3;GSN;XDH;PRDX5;NOS1;LTBP1;MARCH9;ZFP36L1;GRB7;NR1D1;ARRDC1;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;IGF2;MST1R;LRP1;MAPK13;CDK18;ST6GALNAC2;OBSL1;EGFR;TIMP2;B3GAT3;FBXO2;DUSP5;FKBP9;PPP1R14A;JOSD2;LOXL1;DDB2;SERPING1;MTHFR;EGR1;ULK1;RHBDF1;PKN1;SHC1;F2R;PTK6;ABCA7;PPP2R3B;PPM1J;CTSB;RNF208;SHC2;ULK2;GJC2;D2HGDH;ZMYND8;ASH2L;GRAMD4;PLAT;MMP1;PIK3R2;INO80C;NEK9;HDAC5;CRTAP;RPS6KA2;LRP5;ANO8;MARK4;ERBB2;FBLN1;BRSK1;CTSF;PTPRU;PKD2;GID4;TMEM129;EDEM1;ABTB1;SPRY4;CDKN1C;MSRB2;CUL9;PTPRE;PAK6;HEXB;SERPINE2;VPS11;GALNT12;RNF135;UNK;JADE2;MINK1;ATP2B4;GGT1;CSNK1E;RASA4;ADAMTS7;PDCD4;TNFRSF25;DTX3;USP20;PEX10;LAMB2;SPATA18;WNT7A;INSR;RAB3D;LCE1E;FBXW8;ID1;GRK6;MVD;B4GAT1;RABGGTA;EPHA1;ADARB1;SYNGAP1;FBXO27;PPP1R35;LPAR3;PRNP;PAPLN;SRD5A3;FBXL8;SNX33;FBXO41;SPRY2;HINT2;BLMH;ECM1;SNX9;DLG4;SPEG;MARCH2;MTA3;MKNK2;STRADB;WWTR1;FAM20C;BCL6;ANKZF1;IGFBP2;DYRK1B;MVB12B;BNIP3;CD81;SRMS;FZD8;VEGFA;VANGL2;MAST4;FBXW4;AP2A2;SHANK3;ACVR2B;HSF4;NAB2;ZDHHC1;S1PR2;TNFRSF6B;MAPK3;FBXL16;RAB40B;DVL1;MTA1;LHPP;KLHL29;ADCY6;LTA4H;WIPI2;PKN3;ST3GAL3;EPHB3;HES1;SSH1;FURIN;MLXIPL;CUL7;MEFV;TRIM4;LRSAM1;LY6K;FKBP10;CDC42EP5;PIDD1;PHF21A;IL6R;PCSK9;ZFP36;BTBD11;HLCS;FGFR3;PRKACA;F12;ZNF862;LRRK1;DGUOK;MAGEF1;CYFIP2;RPS6KA5;HBEGF;RAB3B;MAP2K2;DAP;FGFR4;SPTB;FBXW5;MXRA8;DMTN;MYH3;MDGA1;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;LDLR;LYPLAL1;ABHD17C;TRPV4;PIGZ;EIF4EBP3;RAG1;DUSP7;EEF2K;MSLN;HMGA2;DGKQ;SEMA4C;MVB12A;MIB2;FBXO17;PADI3;GAS6;BTRC;MEX3A;STK32C;WNT7B;SUFU;PTAFR;RFNG;RXRA;BCR;IGFBP4;MUC19;USP21;RNF123;PRKCZ;ADAMTS13;ZDHHC24;HLTF;MDH2;ETFB;LSM14B;KLHDC8B;PDK2;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;CAMKK1;SPSB3;PIN1;MAN1B1;C5;KMT5C;PROX1;WBP2;GTPBP1;DLG3;BIN1;SERPINB6;SH3D19;WDR83;GLRX;JARID2;CAPN2;SESN2;TOLLIP;ADCK5;CSTB;MAN2B2;MAPRE3;DUSP23;MACROD1;MADD;RTN4R;ELFN2;PIGV;TIMP1;PIGQ;PPM1F;SBF1;SORL1;STK39;VEGFB;ACVR1B;ADORA2B;ERBB3;ZER1;AKT1;TRAP1;ZNF385A;NDRG2;VPS33B;ERCC6;PCMTD2;GPD1L;SPPL2B;IL17RD;RPL39L;ADCK2;SSH3;PINK1;PKD1;LONP2;SNTA1;KDM4B;RGS14;EIF4G3;CTSH;P3H4;MLST8;CBLC;RNF187;PYCARD;MAP2K3;POMT1;PCSK1N;STK17A;ERN1;RANBP9;FBXL20;MOCS1;SIRT3;JAK3;MAST3;ING4;EIF4E3;EREG;FAM162A;TRIM7;ADAMTSL4;TTLL11;RPL13A;ALG12;RAB40C;MIF;UBL5
3232,GO:0006895,0.860309497815622,0.429640153413498,1,19,Golgi to endosome transport,BP,DOPEY2
4664,GO:0010822,0.860442590926439,0.221464931383701,10,139,positive regulation of mitochondrion organization,BP,MICALL2;VPS11;TFDP2;BNIP3;HES1;OSCP1;PINK1;PYCARD;FAM162A;UBL5
18126,GO:1902895,0.860603643313938,0.42906191613882,1,19,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,FOS
12358,GO:0048786,0.860907561755847,0.428463781277985,1,19,presynaptic active zone,CC,RIMS3
9319,GO:0035821,0.861164975931439,0.246334095039962,6,91,modification of morphology or physiology of other organism,BP,TNIP1;APOE;INSR;PC;HMGA2;RXRA
1156,GO:0002764,0.861236251136648,0.186275569602577,28,349,immune response-regulating signaling pathway,BP,TNIP1;FOS;PTPRS;NR1D1;RBCK1;SHC1;CTSB;PIK3R2;IL20RB;PRNP;FCGRT;MAPK3;WIPF1;ADA;PAG1;PRKACA;CYFIP2;RPS6KA5;BTRC;TKFC;VAV3;MUC19;INPP5D;ICOSLG;MAPKAPK3;NLRX1;CTSH;KCNN4
12781,GO:0051101,0.861300278832702,0.246197183750852,6,90,regulation of DNA binding,BP,CTNNBIP1;MDFI;ID1;HES1;HMGA2;PPARA
5732,GO:0016889,0.86130510163153,0.426918807496065,1,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,NEIL1
20258,GO:2001267,0.861710746670469,0.426118051945569,1,20,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,GSN
6769,GO:0030216,0.862080801427585,0.215122106759307,11,154,keratinocyte differentiation,BP,PPL;CYP27B1;ZFP36L1;ALOX15B;PRSS8;LCE1E;FURIN;AQP3;ZFP36;EREG;KRT15
10528,GO:0043496,0.862250871740011,0.425049889366395,1,20,regulation of protein homodimerization activity,BP,ID1
1026,GO:0002532,0.862445012324535,0.333761553385356,2,35,production of molecular mediator involved in inflammatory response,BP,PDCD4;MEFV
14542,GO:0070098,0.862514342324757,0.424528038175715,1,20,chemokine-mediated signaling pathway,BP,SLIT3
3221,GO:0006882,0.862551479065428,0.423767459381839,1,21,cellular zinc ion homeostasis,BP,ATP7B
13474,GO:0055069,0.862551479065428,0.423767459381839,1,21,zinc ion homeostasis,BP,ATP7B
17362,GO:1900117,0.862555828863382,0.424445818292522,1,20,regulation of execution phase of apoptosis,BP,ENDOG
1011,GO:0002495,0.862781486053943,0.255307276618092,5,76,antigen processing and presentation of peptide antigen via MHC class II,BP,CTSF;AP2A2;ACTR1B;CTSD;PYCARD
10886,GO:0044450,0.863319056473044,0.213615551431511,11,148,microtubule organizing center part,CC,TUBG2;MZT2A;CEP250;MZT2B;FBF1;CROCC;CCDC92;WDR60;CAPG;WRAP73;SFI1
12576,GO:0050778,0.863388148170589,0.177968497031489,36,442,positive regulation of immune response,BP,TNIP1;PTPRS;NR1D1;RBCK1;SERPING1;CTSB;PIK3R2;ZP3;TMEM173;PRNP;STAT6;CD81;MAPK3;WIPF1;ADA;PAG1;PRKACA;CYFIP2;RPS6KA5;HK1;BTRC;TKFC;PTAFR;VAV3;MUC19;PRKCZ;INPP5D;ICOSLG;MAPKAPK3;C5;ADORA2B;NLRX1;PYCARD;KCNN4;EREG;MIF
2551,GO:0005834,0.863425128561355,0.422719970497333,1,20,heterotrimeric G-protein complex,CC,GNAL
19202,GO:1905360,0.863425128561355,0.422719970497333,1,20,GTPase complex,CC,GNAL
2245,GO:0005164,0.863471537633645,0.422627670048703,1,20,tumor necrosis factor receptor binding,MF,TRAP1
2827,GO:0006303,0.863781705742162,0.268725566210099,4,67,double-strand break repair via nonhomologous end joining,BP,ERCC1;POLL;HMGA2;POLM
12956,GO:0051385,0.864364450708447,0.420848571068389,1,20,response to mineralocorticoid,BP,FOS
447,GO:0001221,0.864764747426159,0.329678686447034,2,35,transcription cofactor binding,MF,NR1D1;PPARA
17698,GO:1901654,0.864866788089654,0.220155207730724,9,126,response to ketone,BP,FOS;EGFR;GLB1;ADCY6;SLIT3;PTAFR;PCK2;WBP2;AKT1
11080,GO:0045111,0.864997278305678,0.232365945419773,7,101,intermediate filament cytoskeleton,CC,SHANK2;FBF1;LDLRAP1;BFSP1;SYNC;ING4;KRT15
6865,GO:0030371,0.865368376647623,0.418840904728199,1,20,translation repressor activity,MF,EIF4EBP3
5289,GO:0015988,0.865583896725658,0.417721363731436,1,21,energy coupled proton transmembrane transport, against electrochemical gradient,BP,ATP12A
5577,GO:0016605,0.866258294333262,0.239068230621402,6,88,PML body,CC,TENM2;MKNK2;ISG20;TP53INP1;LRCH4;RGS14
13726,GO:0060330,0.866768046049883,0.416028678158649,1,20,regulation of response to interferon-gamma,BP,IFNGR2
13730,GO:0060334,0.866768046049883,0.416028678158649,1,20,regulation of interferon-gamma-mediated signaling pathway,BP,IFNGR2
13664,GO:0060236,0.86712091357893,0.325503920640951,2,35,regulation of mitotic spindle organization,BP,CHMP1B;PKD1
200,GO:0000422,0.867610701599454,0.247944550314208,5,77,autophagy of mitochondrion,BP,SPATA18;BNIP3;WIPI2;ATG2A;PINK1
14397,GO:0061726,0.867610701599454,0.247944550314208,5,77,mitochondrion disassembly,BP,SPATA18;BNIP3;WIPI2;ATG2A;PINK1
4427,GO:0010288,0.867735093296733,0.414076656509611,1,20,response to lead ion,BP,DNMT3A
11452,GO:0045931,0.867962475456634,0.221362542031017,8,114,positive regulation of mitotic cell cycle,BP,IGF2;LRP5;HYAL1;INSR;MTA3;HES1;FGFR1;EREG
138,GO:0000289,0.8681018594421,0.323757469486835,2,35,nuclear-transcribed mRNA poly(A) tail shortening,BP,ZFP36;PAN2
11296,GO:0045638,0.868198919130882,0.261715701381263,4,68,negative regulation of myeloid cell differentiation,BP,ZFP36L1;ZFPM1;ZFP36;INPP5D
2458,GO:0005680,0.86844817992398,0.411944628312225,1,21,anaphase-promoting complex,CC,CUL7
14262,GO:0061383,0.868758533909013,0.322585568365008,2,35,trabecula morphogenesis,BP,THBS3;PLXNB1
4185,GO:0009299,0.868825844238614,0.411866004536926,1,20,mRNA transcription,BP,EREG
3203,GO:0006851,0.868966982919686,0.411579259507485,1,20,mitochondrial calcium ion transmembrane transport,BP,SMDT1
18027,GO:1902600,0.869162389422883,0.245230113746191,5,82,proton transmembrane transport,BP,SLC2A9;ATP12A;TMCO3;NDUFA4L2;SLC9A7
17699,GO:1901655,0.869186630493704,0.260657289035623,4,63,cellular response to ketone,BP,EGFR;ADCY6;PCK2;AKT1
16334,GO:0090662,0.869250527211012,0.41031476456787,1,21,ATP hydrolysis coupled transmembrane transport,BP,ATP12A
16985,GO:0099131,0.869250527211012,0.41031476456787,1,21,ATP hydrolysis coupled ion transmembrane transport,BP,ATP12A
729,GO:0001959,0.869659017170439,0.213466925946225,9,127,regulation of cytokine-mediated signaling pathway,BP,RBCK1;ECM1;SLIT3;TNFRSF1A;IFNGR2;GAS6;MADD;SPPL2B;PYCARD
8198,GO:0032965,0.869784533128887,0.409915126378037,1,20,regulation of collagen biosynthetic process,BP,F2R
5310,GO:0016043,0.869800475080763,0.144264562776576,421,4595,cellular component organization,BP,HTRA1;ADGRL1;APOE;TYSND1;MARVELD1;ESPN;CTNNBIP1;TSPAN1;PPL;IDH2;PTPRS;ERCC1;FLNC;SEMA4B;FAM110C;GAA;SYTL1;CST3;SHANK2;LTBP4;RAPGEF3;CYP27B1;GSN;EVI5L;NDRG1;NOS1;PARVB;ARAP1;COL6A1;TCTN1;POSTN;GRB7;EFS;POLD4;EPHB2;EPAS1;OBSCN;CNTN1;IGF2;NFATC4;GPX3;LRP1;KCNG1;LTBP2;OBSL1;EGFR;TIMP2;H1F0;SMOC2;NLGN2;TOM1L2;FHL1;LOXL1;DDB2;MTHFR;ADGRF1;ULK1;PKN1;SDK2;CRTC1;ARPIN;ARHGEF4;DOPEY2;SYT8;NAGLU;SHC1;F2R;PTK6;ABCA7;LAMA5;SLC9A3R2;BAHCC1;BBS2;DNAH1;CORO1B;ULK2;IGSF9;MALL;THBS3;ZMYND8;TBC1D14;ASH2L;PACS2;SOX12;KCNC4;MMP1;ABCG1;ANK3;S100A6;INO80C;NEK9;HDAC5;THRA;NISCH;LRP5;DBNDD1;HYAL1;TUBG2;MARK4;TENM2;PLTP;ZFPM1;TFEB;ERBB2;EXOC2;FBLN1;BRSK1;MICALL2;BSG;SCMH1;PKD2;IQSEC2;ITGB4;ITPR3;PLXNB3;H2AFJ;VAT1;DNM1;FCHO1;MSRB2;IFT140;CUL9;CD9;KIF13B;XPC;NINL;SIGMAR1;PAK6;HEXB;SERPINE2;VPS11;VAMP2;CCDC69;FUZ;NPHP4;UNK;JADE2;THSD4;MINK1;TMOD2;TFDP2;CSNK1E;TRAPPC9;GLUL;RHOD;TNXB;PEX10;ASIC1;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;SH3PXD2B;TBC1D8;FBXW8;ID1;CELSR1;B4GAT1;NDUFS8;RABGGTA;EPHA1;ADARB1;ITGA6;SYNGAP1;NBEAL2;DNMT3A;DNPH1;LPAR3;PRNP;EFNB3;SNX33;SPRY2;SLC12A7;CEP250;ATG16L2;SNX9;DLG4;ABCD1;REEP2;MTA3;STRADB;WWTR1;RAB25;MYO18A;TMEM107;PLEKHH2;BCL6;PLXNB1;CHMP1B;IGFBP2;BNIP3;VEGFA;HOOK2;LRRC8A;ARL2;VANGL2;MAST4;AP2A2;SHANK3;HSF4;ADAM15;NUDCD3;S1PR2;ENDOG;MAPK3;TUB;ETV5;CAPNS2;TNNT1;DVL1;MTA1;FYCO1;WIPF1;ADCY6;L3MBTL1;WIPI2;MBD1;EPHB3;FHOD1;HES1;BRD3;SSH1;FURIN;FBF1;CUL7;MEFV;TRIM4;NRP2;PLEKHG2;LRSAM1;FKBP10;CDC42EP5;MCTP1;PHF21A;CELSR2;PFKL;SLIT3;PCSK9;RHOF;HLCS;PRKACA;ZMYM3;DGUOK;CYFIP2;RPS6KA5;HBEGF;ITGB5;RAB3B;MAP2K2;PI4K2A;FGFR4;SPTB;FBXW5;STX10;DMTN;BBS1;MYH3;HDAC11;TNFRSF1A;EHD4;SEMA3B;LDLR;ROBO3;SNX17;TRPV4;RHOBTB2;CROCC;RAG1;EEF2K;HMGA2;LDLRAP1;SEMA3F;AHNAK2;DGKQ;PEX7;SEMA4C;MVB12A;SDHAF4;PADI3;GAS6;LLGL1;ADGRB2;HMGCL;TSPAN4;WNT7B;DMC1;REEP4;ATG2A;RXRA;VAV3;BCR;TMEM175;NEO1;IGFBP4;TBC1D16;USP21;WDR60;PRKCZ;CLTCL1;HLTF;CAPG;BCORL1;NYAP1;SLITRK6;TWF2;TPP1;GPC1;SRSF5;CEP68;SMARCD2;NDE1;AGO4;ARAP3;CDHR1;FGFR1;CTSZ;CHADL;PIN1;KMT5C;PROX1;WBP2;PCDHGC3;C21ORF2;KCNMA1;BIN1;UNC119B;OSCP1;PI4KAP2;SH3D19;GRB10;BFSP1;JARID2;CAPN2;SESN2;WRAP73;TMEM231;LCAT;RTN4R;EPB41L3;TIMP1;SDC1;WHAMMP3;GRHPR;H1FX;EPS8L1;WNT3;LYST;PPM1F;OLFML2A;SORL1;COL13A1;ACVR1B;TBC1D17;ANO9;ALS2CL;TSNARE1;HGSNAT;ABR;CCDC85B;AKT1;STON1;SEPT8;ADAM19;ZNF385A;TP53INP1;SMARCA1;VPS33B;EPS8L2;TDRKH;SUN1;TMEM120A;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;ARHGEF10L;KDM4B;RGS14;SYNE3;GOLGA2P5;MAFIP;SPIRE2;P3H4;MLST8;RILPL1;ATXN10;EPN2;RFX2;PYCARD;POMT1;KCNN4;DNAAF5;NDUFV3;RANBP9;PRIMPOL;ARHGEF19;SIRT3;SLC2A1;TAZ;MAST3;APBA1;RARG;ING4;EREG;FAM162A;FCHSD1;SHISA6;WDR18;SFI1;KRT15;ADAMTSL4;TTLL11;TMED4;SEMA4F;RPL13A;MIF;SULF2;UBL5
7833,GO:0032402,0.86982248717598,0.409837739462929,1,20,melanosome transport,BP,BBS2
13213,GO:0051904,0.86982248717598,0.409837739462929,1,20,pigment granule transport,BP,BBS2
2874,GO:0006383,0.870329502772874,0.280985157225121,3,51,transcription by RNA polymerase III,BP,PRDX5;ERBB2;NAB2
1014,GO:0002504,0.870445290483808,0.243637845230147,5,77,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,CTSF;AP2A2;ACTR1B;CTSD;PYCARD
277,GO:0000780,0.870448042865134,0.408560573160203,1,20,condensed nuclear chromosome, centromeric region,CC,KMT5C
4577,GO:0010677,0.870630786493261,0.408186874798405,1,20,negative regulation of cellular carbohydrate metabolic process,BP,PPARA
8970,GO:0035094,0.870698021176098,0.408049316025621,1,20,response to nicotine,BP,PPARA
688,GO:0001909,0.870718521395071,0.280337804411852,3,51,leukocyte mediated cytotoxicity,BP,LYST;CTSH;STXBP2
4947,GO:0015026,0.871472804791906,0.406461485600291,1,20,coreceptor activity,MF,LRP5
10605,GO:0043620,0.87173315559193,0.222424827940932,7,106,regulation of DNA-templated transcription in response to stress,BP,EPAS1;EGR1;VEGFA;CEBPB;HSF4;SESN2;RGS14
6924,GO:0030544,0.871972367285983,0.316539472987489,2,36,Hsp70 protein binding,MF,MVD;ERN1
7647,GO:0032088,0.872412806468816,0.255445488639122,4,64,negative regulation of NF-kappaB transcription factor activity,BP,RBCK1;DAP;NLRX1;PYCARD
7575,GO:0031954,0.872859250967341,0.403607820630097,1,20,positive regulation of protein autophosphorylation,BP,VEGFA
7231,GO:0031167,0.872908203536802,0.402818648800396,1,21,rRNA methylation,BP,RRNAD1
2948,GO:0006487,0.872986701876255,0.239681205010272,5,78,protein N-linked glycosylation,BP,ST6GALNAC2;MVD;SRD5A3;ST3GAL3;ALG12
11421,GO:0045880,0.873297855097738,0.402701749953683,1,20,positive regulation of smoothened signaling pathway,BP,EVC
14886,GO:0070741,0.873503032264146,0.402277344667557,1,20,response to interleukin-6,BP,IL6R
15180,GO:0071354,0.873503032264146,0.402277344667557,1,20,cellular response to interleukin-6,BP,IL6R
2307,GO:0005310,0.873912474732614,0.401429370839036,1,20,dicarboxylic acid transmembrane transporter activity,MF,SLC13A3
2602,GO:0005912,0.87422368253975,0.164940593311931,36,448,adherens junction,CC,FLNC;MRC2;GSN;NDRG1;CADM4;PARVB;GRB7;LRP1;EGFR;FHL1;SLC9A3R2;CORO1B;BSG;SPRY4;MPRIP;CD9;ZFYVE21;ITGA6;CD81;ARL2;ADAM15;MAPK3;ARHGAP22;FGFR3;ITGB5;MAP2K2;TRPV4;TSPAN4;GIT1;TMEM204;CAPN2;PROCR;LMLN;EHD3;ALKBH6;RPL13A
7308,GO:0031329,0.874284176922616,0.156551745555991,58,690,regulation of cellular catabolic process,BP,APOE;TYSND1;CST3;RAPGEF3;PCBP4;ZFP36L1;LRP1;TIMP2;ULK1;RHBDF1;TRIM65;ULK2;TBC1D14;PIK3R2;TFEB;EDEM1;VPS11;ATP2B4;CSNK1E;INSR;SNX33;SNX9;PFKFB2;BNIP3;CD81;ENDOG;MAPK3;DVL1;FYCO1;GPSM1;FURIN;MLXIPL;MEFV;LRSAM1;PCSK9;ZFP36;PRKACA;MAGEF1;DAP;LDLR;BTRC;PPARA;SUFU;RAD23A;GTPBP1;SH3D19;SESN2;TIMP1;TPCN1;AKT1;TP53INP1;PINK1;PKD1;LONP2;MLST8;PYCARD;ERN1;MLYCD
8671,GO:0034308,0.874302475081879,0.312324311501702,2,36,primary alcohol metabolic process,BP,RETSAT;PNPLA4
8867,GO:0034698,0.874520248479584,0.400168057041597,1,20,response to gonadotropin,BP,SLC5A5
6741,GO:0030173,0.874859248785705,0.311312788840146,2,36,integral component of Golgi membrane,CC,B4GAT1;RFNG
14878,GO:0070727,0.874882906637287,0.146227674348976,128,1471,cellular macromolecule localization,BP,CEMIP;APOE;SYTL1;RAPGEF3;GSN;EVI5L;ZFP36L1;TCTN1;EPHB2;OBSCN;LRP1;LTBP2;OBSL1;EGFR;B3GAT3;NLGN2;TOM1L2;ABCA7;LAMA5;BBS2;CORO1B;ZMYND8;TBC1D14;PACS2;ANK3;ERBB2;MICALL2;BSG;PTPRU;TMEM129;EDEM1;IFT140;KIF13B;VPS11;VAMP2;TFDP2;CSNK1E;RHOD;PEX10;RAB3D;SH3PXD2B;TBC1D8;ID1;CELSR1;SYNGAP1;TMEM173;PRNP;SNX33;CEP250;SNX9;DLG4;REEP2;STRADB;RAB25;TMEM107;BCL6;CD81;ARL2;AP2A2;SHANK3;NUDCD3;ZDHHC1;TUB;KCNAB2;ETV5;AMN;RAB40B;DVL1;WIPI2;HES1;SSH1;LRSAM1;ZFP36;RAB3B;STX10;TSPAN33;DMTN;BBS1;TNFRSF1A;SNX17;ABHD17C;CROCC;LDLRAP1;PEX7;HK1;GAS6;TTC7B;BCR;TBC1D16;PRKCZ;ZDHHC24;CLTCL1;TMCO6;SPATA7;TWF2;SRSF5;CEP68;PIN1;DLG3;OSCP1;SESN2;TOLLIP;EPB41L3;RTN2;SORL1;TBC1D17;TSNARE1;AKT1;SEPT8;ZNF385A;VPS33B;GPD1L;SUN1;PINK1;GAS8;PKD1;EHD3;LONP2;SYNE3;RILPL1;C12ORF66;APBA1;SHISA6;TMED4;RPL13A;RAB40C;UBL5;LZTS2
11735,GO:0046605,0.875004967656284,0.273315886646355,3,50,regulation of centrosome cycle,BP,CEP250;CHMP1B;FBXW5
13772,GO:0060389,0.875071950274678,0.310925918522252,2,36,pathway-restricted SMAD protein phosphorylation,BP,PIN1;ACVR1B
18556,GO:1903828,0.875181694796872,0.236388100400843,5,77,negative regulation of cellular protein localization,BP,SNX33;DMTN;ABHD17C;GAS6;LZTS2
18592,GO:1903902,0.875775645799382,0.271865688085218,3,51,positive regulation of viral life cycle,BP,ADARB1;PC;RAD23A
8131,GO:0032870,0.87600865506632,0.161278079016045,39,473,cellular response to hormone stimulus,BP,FOS;PGF;ZFP36L1;NR1D1;FAM210B;IGF2;EGFR;SHC1;BBS2;CTSB;PIK3R2;HDAC5;THRA;PTPRE;VAMP2;INSR;IGFBP2;CALCOCO1;MAPK3;ADCY6;SLIT3;PCSK9;ZFP36;PRKACA;EEF2K;PPARA;RXRA;PCK2;PRKCZ;PDK2;SRSF5;WBP2;GRB10;RXRB;AKT1;SLC5A5;CTSH;JAK3;RARG
11772,GO:0046661,0.876424566346503,0.215737812858062,7,103,male sex differentiation,BP,ERCC1;CST3;INSR;ADAM15;AGO4;WNT2B;SDC1
18135,GO:1902911,0.876769152561695,0.223358352543168,6,90,protein kinase complex,CC,ULK1;INSR;SESN2;ACVR1B;PYCARD;ERN1
13110,GO:0051702,0.8769736206892,0.269843056988008,3,51,interaction with symbiont,BP,APOE;PC;HMGA2
6945,GO:0030594,0.877142563250813,0.394002160960992,1,21,neurotransmitter receptor activity,MF,HTR7
4538,GO:0010628,0.877307595719589,0.144232891275372,119,1360,positive regulation of gene expression,BP,TNIP1;FOS;CITED4;GSN;MEF2D;NOS1;NR1D1;EPHB2;EPAS1;CNTN1;NFATC4;EGFR;TCEA2;EGR1;CRTC1;SHC1;F2R;DEAF1;ACTA2;GJC2;ASH2L;SOX12;ANK3;PIK3R2;ZNF516;PEG3;HDAC5;THRA;ZP3;LRP5;MAML3;ZFPM1;TFEB;ERBB2;PKD2;CDKN1C;SALL2;HEXB;TFDP2;WNT7A;ZMIZ1;INSR;SH3PXD2B;ID1;ITGA6;TMEM173;SPRY2;STAT6;WWTR1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;CEBPB;HSF4;CALCOCO1;MAPK3;ETV5;DVL1;FHOD1;HES1;MLXIPL;ZFP36;ETV4;F12;RPS6KA5;MAP2K2;FGFR4;TNFRSF1A;LDLR;TRPV4;HMGA2;ELK3;DGKQ;ZXDC;GAS6;BTRC;PPARA;PTAFR;RXRA;USP21;HLTF;SRSF5;RFXANK;TEF;PIN1;IRF2BPL;PROX1;WBP2;SESN2;RXRB;MAPRE3;WNT3;PPM1F;ACVR1B;MEF2B;ERBB3;AKT1;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;CAMTA2;CTSH;ABHD14B;RFX2;RNF187;MAP2K3;TRERF1;DDN;ERN1;LITAF;MZF1;RARG
11226,GO:0045445,0.877546502507738,0.268873658409416,3,51,myoblast differentiation,BP,ZFP36L1;EPAS1;SDC1
16267,GO:0090398,0.877758843929162,0.268513989512342,3,51,cellular senescence,BP,BCL6;YPEL3;HMGA2
10953,GO:0044743,0.877965539714316,0.305132460264686,2,38,protein transmembrane import into intracellular organelle,BP,PEX10;PEX7
16748,GO:0098586,0.878155607104277,0.305289425711781,2,36,cellular response to virus,BP,TKFC;NLRX1
7920,GO:0032509,0.878308021423388,0.391548777151357,1,21,endosome transport via multivesicular body sorting pathway,BP,LYST
10318,GO:0043130,0.878387332929328,0.245794325452887,4,65,ubiquitin binding,MF,RBCK1;MARK4;MVB12A;TOLLIP
12518,GO:0050690,0.878396785446853,0.391361441115974,1,21,regulation of defense response to virus by virus,BP,AP2A2
16452,GO:0097164,0.878575096674168,0.200894691230257,9,129,ammonium ion metabolic process,BP,CRAT;KDSR;LPCAT4;CPT1C;AKR7A2;LDLR;COMT;SMOX;LCAT
5556,GO:0016578,0.879166812956743,0.389733430558649,1,21,histone deubiquitination,BP,USP21
3084,GO:0006665,0.879168638897918,0.200120767657966,9,127,sphingolipid metabolic process,BP,KDSR;CERS4;HEXB;GM2A;SERINC2;GLB1;TNFRSF1A;ESYT2;NAGA
2430,GO:0005635,0.879199755068948,0.16269059526766,30,375,nuclear envelope,CC,CST3;CLCA2;EGFR;SLC16A3;CERS4;S100A6;SLC2A9;ITPR3;SIGMAR1;INSR;PRNP;STAT6;BNIP3;MAPK3;SLC22A18;RAB40B;MTA1;RETSAT;TM7SF2;KLHDC2;RNF123;PRKCZ;SMOX;BIN1;SORL1;SUN1;TMEM120A;SYNE3;ERN1;AGPAT3
17012,GO:0099516,0.880066282379153,0.301770514900953,2,36,ion antiporter activity,MF,SLC37A2;SLC9A7
1073,GO:0002639,0.880116393181431,0.387718678302676,1,21,positive regulation of immunoglobulin production,BP,STAT6
6063,GO:0019221,0.880158858390987,0.154890399542232,42,524,cytokine-mediated signaling pathway,BP,FOS;RBCK1;MST1R;EGR1;SHC1;LAMA5;BBS2;MMP1;PDCD4;TNFRSF25;IL20RB;ECM1;STAT6;TALDO1;ISG20;BCL6;VEGFA;TNFRSF6B;MAPK3;TNFRSF14;IL6R;SLIT3;PRKACA;RPS6KA5;TNFRSF1A;IFNGR2;GAS6;BTRC;PTAFR;INPP5D;TOLLIP;MADD;RTN4R;TIMP1;SDC1;AKT1;SPPL2B;IL17RD;PYCARD;JAK3;EREG;MIF
10964,GO:0044774,0.880436405579084,0.209812215886647,7,104,mitotic DNA integrity checkpoint,BP,PCBP4;BRSK1;XPC;TFDP2;PIDD1;HMGA2;ZNF385A
17250,GO:0140013,0.880778494819793,0.209354376243798,7,103,meiotic nuclear division,BP,DMC1;AGO4;TDRKH;SUN1;SPIRE2;P3H4;EREG
886,GO:0002253,0.880927007218806,0.16205201383799,28,355,activation of immune response,BP,TNIP1;PTPRS;NR1D1;RBCK1;SERPING1;CTSB;PIK3R2;TMEM173;PRNP;CD81;MAPK3;WIPF1;ADA;PAG1;PRKACA;CYFIP2;RPS6KA5;BTRC;TKFC;VAV3;MUC19;INPP5D;ICOSLG;MAPKAPK3;C5;NLRX1;PYCARD;KCNN4
18008,GO:1902554,0.881087071435663,0.22717900040521,5,78,serine/threonine protein kinase complex,CC,ULK1;SESN2;ACVR1B;PYCARD;ERN1
89,GO:0000178,0.881217745807583,0.384748987207356,1,22,exosome (RNase complex),CC,GTPBP1
19199,GO:1905354,0.881217745807583,0.384748987207356,1,22,exoribonuclease complex,CC,GTPBP1
4514,GO:0010586,0.88141801238397,0.384944092450825,1,21,miRNA metabolic process,BP,AGO4
5936,GO:0018279,0.881630847525271,0.298370953273176,2,38,protein N-linked glycosylation via asparagine,BP,ST6GALNAC2;ST3GAL3
5617,GO:0016705,0.882085967909071,0.215358197078821,6,90,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,CYP27B1;NOS1;CYP3A5;PHYH;CYP2S1;KDM4B
20239,GO:2001236,0.882090087896217,0.201063964545991,8,117,regulation of extrinsic apoptotic signaling pathway,BP,RBCK1;ITGA6;STRADB;PIDD1;FGFR1;MADD;AKT1;PYCARD
5121,GO:0015605,0.882225563846997,0.383215114766662,1,21,organophosphate ester transmembrane transporter activity,MF,SLC37A2
418,GO:0001106,0.882581356153335,0.382451506694352,1,21,RNA polymerase II transcription corepressor activity,MF,ZMYND8
7832,GO:0032401,0.882682385565931,0.382234468171071,1,21,establishment of melanosome localization,BP,BBS2
13214,GO:0051905,0.882682385565931,0.382234468171071,1,21,establishment of pigment granule localization,BP,BBS2
1159,GO:0002768,0.882726694895723,0.169362702223163,19,251,immune response-regulating cell surface receptor signaling pathway,BP,FOS;RBCK1;SHC1;PIK3R2;PRNP;FCGRT;MAPK3;WIPF1;ADA;PAG1;PRKACA;CYFIP2;RPS6KA5;BTRC;VAV3;MUC19;INPP5D;ICOSLG;KCNN4
6907,GO:0030511,0.882726712183329,0.382139213616185,1,21,positive regulation of transforming growth factor beta receptor signaling pathway,BP,CDKN1C
18564,GO:1903846,0.882726712183329,0.382139213616185,1,21,positive regulation of cellular response to transforming growth factor beta stimulus,BP,CDKN1C
2460,GO:0005682,0.883343283652302,0.380189812999698,1,22,U5 snRNP,CC,MAPKBP1
11461,GO:0045943,0.883345093455943,0.380808511082128,1,21,positive regulation of transcription by RNA polymerase I,BP,ERBB2
11823,GO:0046824,0.883865302207089,0.258086737526653,3,51,positive regulation of nucleocytoplasmic transport,BP,RAPGEF3;TMEM173;GAS6
8002,GO:0032647,0.884229072317752,0.378900249719985,1,21,regulation of interferon-alpha production,BP,PTPRS
3052,GO:0006622,0.884663391462327,0.377960068211545,1,21,protein targeting to lysosome,BP,SORL1
9003,GO:0035198,0.884671542953479,0.377942405976105,1,21,miRNA binding,MF,AGO4
10498,GO:0043425,0.884947895234668,0.377343259449713,1,21,bHLH transcription factor binding,MF,BHLHE40
9167,GO:0035561,0.885153029770177,0.376898063314357,1,21,regulation of chromatin binding,BP,NFATC4
7865,GO:0032438,0.885181852211739,0.376213290227353,1,22,melanosome organization,BP,LYST
7398,GO:0031492,0.885349172158427,0.290583257585221,2,42,nucleosomal DNA binding,MF,HMGA2;SMARCD2
19465,GO:1990266,0.885591965722298,0.290748060405255,2,39,neutrophil migration,BP,VAV3;CKLF
4666,GO:0010824,0.885896476056421,0.290647714904004,2,37,regulation of centrosome duplication,BP,CHMP1B;FBXW5
3476,GO:0007346,0.885929337011425,0.146129394906936,47,573,regulation of mitotic cell cycle,BP,PCBP4;ZFP36L1;IGF2;OBSL1;EGFR;TIMP2;TOM1L2;FHL1;GJC2;LRP5;HYAL1;BRSK1;PKD2;CDKN1C;CUL9;XPC;NINL;PAK6;MINK1;TFDP2;CSNK1E;INSR;CEP250;MTA3;STRADB;BCL6;CHMP1B;L3MBTL1;HES1;CUL7;PIDD1;PRKACA;MAP2K2;FBXW5;HMGA2;NDE1;FGFR1;PIN1;TMEM8B;STK39;AKT1;ZNF385A;PKD1;MAP2K3;EREG;ZFYVE19;SFI1
10566,GO:0043548,0.886111140870161,0.374813569364855,1,21,phosphatidylinositol 3-kinase binding,MF,INSR
17562,GO:1901224,0.886143304763007,0.290183420711296,2,37,positive regulation of NIK/NF-kappaB signaling,BP,EGFR;PDCD4
13461,GO:0055026,0.886206378370079,0.374605903521941,1,21,negative regulation of cardiac muscle tissue development,BP,JARID2
8595,GO:0034121,0.88621220203092,0.29005375787751,2,37,regulation of toll-like receptor signaling pathway,BP,PTPRS;NR1D1
5362,GO:0016180,0.886455579034526,0.373440257879347,1,22,snRNA processing,BP,TUT1
783,GO:0002042,0.886563164742354,0.289392817928059,2,37,cell migration involved in sprouting angiogenesis,BP,HDAC5;VEGFA
11843,GO:0046856,0.88714541116846,0.372553814110231,1,21,phosphatidylinositol dephosphorylation,BP,INPP5D
7445,GO:0031593,0.888105433268928,0.286479671221089,2,37,polyubiquitin modification-dependent protein binding,MF,TNIP1;RAD23A
5618,GO:0016706,0.888507545371654,0.285717783993401,2,37,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,PHYH;KDM4B
9689,GO:0038111,0.888682542813599,0.366562148554499,1,26,interleukin-7-mediated signaling pathway,BP,JAK3
16822,GO:0098760,0.888682542813599,0.366562148554499,1,26,response to interleukin-7,BP,JAK3
16823,GO:0098761,0.888682542813599,0.366562148554499,1,26,cellular response to interleukin-7,BP,JAK3
5711,GO:0016860,0.889364308982302,0.283622838552894,2,39,intramolecular oxidoreductase activity,MF,TMX4;MIF
1460,GO:0003712,0.88951650187444,0.145901363771714,37,458,transcription cofactor activity,MF,CITED4;NR1D1;NFATC4;MXD4;PKN1;ZMYND8;SOX12;MXI1;THRA;MAML3;TFDP2;MNT;WWTR1;SCAND1;DYRK1B;HSF4;NAB2;CALCOCO1;MTA1;PHF21A;BHLHE40;ELK3;PPARA;SUFU;RXRA;USP21;RFXANK;SMARCD2;PROX1;WBP2;PPP1R13L;RXRB;GRHPR;TRERF1;RARG;ING4;PBXIP1
289,GO:0000794,0.889705125934051,0.227347017441542,4,65,condensed nuclear chromosome,CC,DMC1;KMT5C;P3H4;RGS12
15869,GO:0072665,0.890063368688466,0.247190871535254,3,52,protein localization to vacuole,BP,CD81;SORL1;C12ORF66
4322,GO:0009880,0.890429817852594,0.28206205272663,2,37,embryonic pattern specification,BP,WNT7A;SEMA3F
5911,GO:0018196,0.89095452908057,0.28059347624013,2,39,peptidyl-asparagine modification,BP,ST6GALNAC2;ST3GAL3
17914,GO:1902275,0.890973845882403,0.179083139673017,10,141,regulation of chromatin organization,BP,NOS1;IGF2;MTHFR;BCL6;VEGFA;MAPK3;RPS6KA5;WBP2;JARID2;PINK1
17611,GO:1901361,0.891039274204233,0.140658226082939,45,573,organic cyclic compound catabolic process,BP,APOE;NT5E;RAPGEF3;PGM1;CYP27B1;XDH;PCBP4;PRODH;ZFP36L1;H1F0;ALDH4A1;OGDHL;INSR;DNPH1;RNASET2;ISG20;PFKFB2;ENTPD6;DNASE1L1;ENDOG;DHTKD1;ENTPD2;GALK1;MLXIPL;ADA;PFKL;ZFP36;NUDT10;SNX17;HK1;PPARA;BLVRB;COMT;PAN2;AGO4;GTPBP1;PNRC1;APOBEC3C;AKT1;HPDL;TRERF1;ERN1;APOBEC3F;NEIL1;RPL13A
287,GO:0000792,0.891099732213298,0.224946726465726,4,66,heterochromatin,CC,DNMT3A;PHC2;HMGA2;KMT5C
7210,GO:0031116,0.891430753168553,0.36246270468972,1,22,positive regulation of microtubule polymerization,BP,ARL2
7548,GO:0031902,0.891900288055394,0.192692263052551,7,106,late endosome membrane,CC,VPS11;CHMP1B;MVB12B;TMEM9;MVB12A;VPS33B;LITAF
8465,GO:0033627,0.892064529791595,0.278696107764438,2,38,cell adhesion mediated by integrin,BP,ITGA6;ADA
11465,GO:0045948,0.892093265206841,0.360982958181946,1,22,positive regulation of translational initiation,BP,RXRA
14574,GO:0070161,0.89238802488132,0.142373170893863,37,465,anchoring junction,CC,PPL;FLNC;MRC2;GSN;NDRG1;CADM4;PARVB;GRB7;LRP1;EGFR;FHL1;SLC9A3R2;CORO1B;BSG;SPRY4;MPRIP;CD9;ZFYVE21;ITGA6;CD81;ARL2;ADAM15;MAPK3;ARHGAP22;FGFR3;ITGB5;MAP2K2;TRPV4;TSPAN4;GIT1;TMEM204;CAPN2;PROCR;LMLN;EHD3;ALKBH6;RPL13A
12771,GO:0051091,0.893205018444544,0.16670191641709,13,181,positive regulation of DNA binding transcription factor activity,BP,RBCK1;ADGRF1;CRTC1;HDAC5;LRP5;TRAPPC9;VEGFA;PIDD1;RPS6KA5;PRKCZ;AKT1;PINK1;PYCARD
17705,GO:1901661,0.893244318219578,0.357837935503927,1,23,quinone metabolic process,BP,AKR7A2
7307,GO:0031328,0.893278048882398,0.126680695298261,114,1304,positive regulation of cellular biosynthetic process,BP,TNIP1;FOS;APOE;CITED4;CST3;RAPGEF3;MEF2D;NOS1;NR1D1;EPAS1;IGF2;NFATC4;EGFR;TIMP2;TCEA2;EGR1;CRTC1;SHC1;F2R;DEAF1;ASH2L;SOX12;PIK3R2;ZNF516;PEG3;HDAC5;THRA;ZP3;LRP5;MAML3;ZFPM1;TFEB;ERBB2;PKD2;PTHLH;CDKN1C;SALL2;HEXB;NTSR1;TFDP2;WNT7A;ZMIZ1;INSR;ITGA6;TMEM173;STAT6;WWTR1;PFKFB2;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;CEBPB;HSF4;CALCOCO1;MAPK3;ETV5;DVL1;FHOD1;HES1;MLXIPL;ETV4;RPS6KA5;MAP2K2;FGFR4;TNFRSF1A;LDLR;HMGA2;ELK3;ZXDC;BTRC;PPARA;PTAFR;RXRA;USP21;HLTF;RFXANK;TEF;FGFR1;PIN1;IRF2BPL;PROX1;WBP2;ASS1;SESN2;RXRB;MAPRE3;GUCA1B;ACVR1B;MEF2B;ADORA2B;AKT1;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;CAMTA2;ABHD14B;RFX2;RNF187;MAP2K3;POMT1;TRERF1;DDN;TAZ;LITAF;MZF1;RARG;EREG
6313,GO:0019985,0.893393984411612,0.275915963474861,2,39,translesion synthesis,BP,POLD4;PRIMPOL
10870,GO:0044429,0.893636446754489,0.131579247709924,69,851,mitochondrial part,CC,IDH2;CYP27B1;PRDX5;PRODH;CRAT;FAM210B;CPT2;NME4;ALDH4A1;HADH;ACSF2;ULK1;SHC1;BPHL;DHRS1;D2HGDH;GRAMD4;OGDHL;TST;CPT1C;VAT1;DNM1;SNN;ARMCX2;SPATA18;NDUFS8;HAGH;TMEM173;ANKZF1;BNIP3;ARL2;CARD19;DHTKD1;PC;ACAD10;NAGS;TK2;PYCR2;CKMT1A;DGUOK;SLC25A37;MAPK8IP1;MPG;HK1;SDHAF4;HMGCL;PCK2;SDHA;MDH2;ETFB;PDK2;SLC25A27;NDUFA4L2;SNPH;SMDT1;SLC25A29;TRAP1;NLRX1;ACP6;UQCR11;PINK1;NDUFV3;PRIMPOL;ACADS;GCAT;SIRT3;MLYCD;TAZ;BCKDHA
3646,GO:0008135,0.893818302471566,0.206900053633932,5,81,translation factor activity, RNA binding,MF,ABTB1;EEF2K;GTPBP1;EIF4G3;EIF4E3
12753,GO:0051054,0.894033068713515,0.165600062823051,13,179,positive regulation of DNA metabolic process,BP,ERCC1;CST3;EGFR;SHC1;INSR;STAT6;ENDOG;MAPK3;FGFR4;FGFR1;TMEM161A;AKT1;EREG
12364,GO:0048806,0.894297494345357,0.356028611879751,1,22,genitalia development,BP,PKD1
6906,GO:0030510,0.89435227059154,0.239644465423244,3,52,regulation of BMP signaling pathway,BP,HTRA1;HES1;NEO1
20046,GO:2000725,0.894496367795689,0.355579236127307,1,22,regulation of cardiac muscle cell differentiation,BP,PIN1
7977,GO:0032607,0.894610639612055,0.355320847335675,1,22,interferon-alpha production,BP,PTPRS
2499,GO:0005758,0.894871402192407,0.218250337331806,4,71,mitochondrial intermembrane space,CC,NME4;ARL2;TRAP1;PINK1
4561,GO:0010656,0.895045497976316,0.354336355204959,1,22,negative regulation of muscle cell apoptotic process,BP,RGL2
3358,GO:0007127,0.895469478058221,0.217579903828453,4,67,meiosis I,BP,DMC1;AGO4;SUN1;P3H4
4360,GO:0009987,0.895583548074024,0.121633209579345,989,10499,cellular process,BP,TNIP1;HTRA1;FOS;DUSP6;H6PD;LMF1;CEMIP;ADGRL1;APOE;TYSND1;MARVELD1;ESPN;CTNNBIP1;MARCKSL1;TSPAN1;PPL;IDH2;RNPEPL1;PTPRS;ERCC1;WWC3;FLNC;SEMA4B;FAM110C;NT5E;GAA;SYTL1;LTB4R;CITED4;NAPRT;BTBD2;PYGB;RNF44;CST3;SHANK2;LTBP4;RAPGEF3;TCFL5;MRC2;PGM1;CYP27B1;GSN;EVI5L;XDH;PRDX5;NDRG1;PGLS;PCBP4;PRSS3;PRODH;PGF;CADM4;MEF2D;NOS1;LTBP1;MARCH9;PARVB;ARAP1;SH3BP2;ZFP36L1;COL6A1;TCTN1;CGREF1;POSTN;GRB7;NR1D1;CRAT;EFS;ALOX15B;ARRDC1;FAM210B;NYNRIN;POLD4;SCN8A;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;CPT2;RHPN1;MYZAP;IGF2;NFATC4;GPX3;NME4;MST1R;LRP1;GAMT;MAPK13;APPL2;HEBP1;KCNG1;CDK18;RALGDS;ST6GALNAC2;LTBP2;RAB11FIP4;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;SMOC2;MMP28;B3GAT3;HADH;NLGN2;CRYL1;ACSF2;FBXO2;ACOT7;TCEA2;DUSP5;TOM1L2;FKBP9;HS1BP3;PPP1R14A;ISYNA1;UROS;FHL1;JOSD2;LOXL1;MXD4;DDB2;SERPING1;MTHFR;KDSR;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CMTM7;SDK2;CRTC1;ARPIN;PYGL;ARHGEF4;TRIM65;DOPEY2;SYT8;NAGLU;SHC1;RGL2;F2R;PTK6;GNAL;BPHL;ABCA7;DEAF1;LAMA5;PPP2R3B;SLC9A3R2;CA12;BAHCC1;BBS2;ACTA2;PRSS8;S100A4;PPM1J;CTSB;LPCAT4;DNAH1;RNF208;SHC2;PITPNC1;SLC16A3;CORO1B;CXXC5;ULK2;DGKA;GJC2;IGSF9;MALL;THBS3;D2HGDH;ZMYND8;TBC1D14;ASH2L;ZSCAN18;PACS2;GRAMD4;NXPH4;SOX12;MXI1;CERS4;PLAT;KCNC4;MMP1;ABCG1;RIN1;ANK3;DHRS11;PIK3R2;OPLAH;S100A6;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;ARHGAP23;KCNJ15;DOCK4;ZP3;CRTAP;RPS6KA2;NMRK1;NISCH;LRP5;DBNDD1;HYAL1;TUBG2;ANO8;MARK4;TENM2;PLTP;SLC2A9;MAML3;ZFPM1;BCAM;TFEB;ERBB2;EXOC2;FBLN1;BRSK1;MICALL2;BSG;CTSF;SCMH1;PTPRU;OGDHL;PKD2;CBS;GID4;TMEM129;FUCA1;TST;SCN4B;IQSEC2;CPT1C;EDEM1;ABTB1;SLC7A8;ITGB4;ITPR3;PLXNB3;H2AFJ;PHLDA2;VAT1;DNM1;SPRY4;DDIT4L;FCHO1;PTHLH;CDKN1C;RIMS3;SALL2;MSRB2;IFT140;VIPR1;CUL9;CD9;KIF13B;XPC;PTPRE;NINL;SIGMAR1;PAK6;HEXB;DNAJC4;SERPINE2;VPS11;VAMP2;CCDC69;FUZ;GALNT12;FOXQ1;RNF135;NPHP4;LTB4R2;UNK;NTSR1;JADE2;THSD4;CD320;MINK1;RALGAPA2;ATP2B4;GGT1;TMOD2;SLC6A8;TFDP2;CSNK1E;ACP5;RASA4;PLCD1;TRAPPC9;AGAP1;ZFYVE21;ADAMTS7;PDCD4;DOCK6;GM2A;SLC20A1;BEX2;ACAP3;TNFRSF25;GLUL;RHOD;DTX3;ZKSCAN1;TNXB;USP20;PEX10;ASIC1;LAMB2;SPATA18;PLEKHG4;WNT7A;ZMIZ1;INSR;RAB3D;LCE1E;SH3PXD2B;TBC1D8;FBXW8;ZC3H6;ID1;CELSR1;AKR7A2;GRK6;MVD;B4GAT1;POLL;NDUFS8;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;CCNG2;TXNRD3;SYNGAP1;IL20RB;NBEAL2;HAGH;FBXO27;PPP1R35;DNMT3A;DNPH1;LPAR3;TMEM173;PRNP;SERINC2;DHX32;PAPLN;SRD5A3;ATP7B;EFNB3;RNASET2;FBXL8;SNX33;FBXO41;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;SLC12A7;ECM1;CEP250;ATG16L2;SNX9;STAT6;DLG4;SPEG;ABCD1;MARCH2;REEP2;FGGY;MTA3;MKNK2;PLCD3;NT5DC1;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;MYO18A;TMEM107;ARHGAP27;DNAJB5;MYCBPAP;PLEKHH2;BCL6;ANKZF1;UCKL1;PFKFB2;ATP12A;PLXNB1;FAM213A;CHMP1B;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;BNIP3;CD81;SRMS;FCGRT;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;HOOK2;LRRC8A;ARL2;YPEL3;VANGL2;MAST4;FBXW4;ELMO3;AP2A2;CEBPB;RHBDF2;DPP7;GPRC5C;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;NUDCD3;CALCOCO1;ZDHHC1;S1PR2;ENDOG;TNFRSF6B;MAPK3;FBXL16;PLEKHG5;TUB;KCNAB2;ETV5;OLFM2;CARD19;AMN;GLB1;CAPNS2;DHTKD1;EXD3;RAB40B;TNNT1;DVL1;ENTPD2;GALK1;MTA1;LHPP;FYCO1;KLHL29;WIPF1;GPSM1;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;PHGDH;ST3GAL3;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;PC;ACAD10;GIGYF1;SSH1;FURIN;MLXIPL;ZNF624;NAGS;FBF1;MBOAT7;SAMD3;CUL7;MEFV;EVC;ARHGAP22;SLC2A3;TRIM4;NRP2;GPR153;NADK;PLEKHG2;ABCA2;TNFRSF14;TK2;LRSAM1;ZNF414;LY6K;ADA;FKBP10;CDC42EP5;MCTP1;OSBPL5;PYCR2;PIDD1;RETSAT;PAG1;PHF21A;SH2D2A;AQP3;HTR7;RASL10B;CELSR2;ACY1;CKMT1A;PFKL;IL6R;SLIT3;PCSK9;SLC28A2;ZFP36;ETV4;RHOF;BTBD11;MAPKBP1;HLCS;FGFR3;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;KIAA1549;LRRK1;NUDT10;SPATA20;PLCH2;DGUOK;MAGEF1;CYFIP2;RPS6KA5;HBEGF;ITGB5;RAB3B;MAP2K2;PI4K2A;DAP;FGFR4;SPTB;FBXW5;MXRA8;STX10;TSPAN33;DMTN;RAPGEF5;PMVK;BBS1;MYH3;PSD4;MDGA1;XYLT2;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;TCF25;SEMA3B;LDLR;PTOV1;LYPLAL1;CYP3A5;ACOT11;ROBO3;SNX17;SOX13;ABHD17C;TRPV4;MPG;RHOBTB2;PIGZ;IFNGR2;BHLHE40;EIF4EBP3;RRNAD1;CROCC;RAG1;ZNF80;DUSP7;PHLDA1;NHSL1;TNFAIP8L1;EEF2K;RHBDL1;MSLN;HMGA2;LDLRAP1;SEMA3F;ELK3;AHNAK2;DGKQ;PEX7;SEMA4C;MVB12A;HK1;NMRAL1;ZXDC;MIB2;FBXO17;CHST6;SDHAF4;PADI3;GAS6;BTRC;MEX3A;POU6F1;LLGL1;ADGRB2;ZNF217;PPARA;HMGCL;TKFC;GUK1;TSPAN4;STK32C;WNT7B;BLVRB;GIT1;COMT;TTC7B;SUFU;AIG1;PTAFR;PLEKHG6;RFNG;DMC1;IMPA2;ARHGEF37;LTBP3;PAN2;REEP4;ZNF446;ATG2A;RXRA;PCK2;PCSK1;VAV3;VASN;BCR;TMEM175;NEO1;IGFBP4;SDHA;GSDMC;MUC19;TBC1D16;USP21;RNF123;WDR60;PRKCZ;ADAMTS13;ZDHHC24;CLTCL1;HLTF;MDH2;CAPG;BCORL1;INPP5D;TM7SF3;ETFB;ABCD4;NYAP1;SLITRK6;TWF2;ZNF485;LSM14B;KLHDC8B;TPP1;PDK2;GPC1;TMX4;ICOSLG;SRSF5;ZNF160;RFXANK;TEF;SMOX;CEP68;SMARCD2;MAPKAPK3;NDE1;AGO4;RAD23A;ARAP3;CDHR1;FGFR1;CTSZ;CAMKK1;CHADL;SPSB3;PIN1;MAN1B1;MN1;PNPLA4;ZNF563;C5;KMT5C;PHYH;TMEM204;IRF2BPL;CMBL;PROX1;WBP2;GTPBP1;PCDHGC3;C21ORF2;ASAP2;DLG3;GPR155;KCNMA1;ESYT2;BIN1;VSNL1;UNC119B;YIPF3;TMEM8B;SERPINB6;OSCP1;PI4KAP2;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;CES2;SLC25A27;GRB10;BFSP1;JARID2;SYNC;CAPN2;SESN2;NDUFA4L2;TOLLIP;ADCK5;WNT2B;TSTA3;WRAP73;TMEM161A;RXRB;CSTB;PROCR;SNPH;MAN2B2;TMEM231;PNRC1;MAPRE3;DUSP23;LCAT;GUCA1B;MACROD1;ADGRE2;GAL3ST4;SMDT1;PTMS;PITPNM3;CYBRD1;MADD;LMLN;RTN4R;ELFN2;OR7D2;EPB41L3;PIGV;SLC9A7;TIMP1;CD68;SDC1;WHAMMP3;GRHPR;SH2B3;ACTR1B;APOBEC3C;FGFBP1;H1FX;PEAR1;EPS8L1;PLEKHH3;PIGQ;WNT3;LYST;GSTT1;ZFP41;PPM1F;OLFML2A;MICALCL;SBF1;SORL1;STK39;COL13A1;VEGFB;ACVR1B;MEF2B;TBC1D17;ANO9;GSDMA;ZSCAN30;GSS;AHCYL2;ALS2CL;TSNARE1;ADORA2B;TPCN1;HGSNAT;ERBB3;ABR;ZER1;CCDC85B;PNMA1;CYP2S1;CCDC71L;AKT1;HPDL;CTSD;TRAP1;STON1;TMBIM4;NLRX1;SEPT8;ADAM19;ZNF385A;TP53INP1;LRCH4;NDRG2;TUT1;SMARCA1;VPS33B;SIX5;ERCC6;PCMTD2;ACP6;GPD1L;EPS8L2;TDRKH;SLC5A5;SUN1;NAGA;TMEM120A;SPPL2B;IL17RD;UQCR11;SSBP2;RPL39L;ADCK2;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;MPLKIP;SNTA1;ARHGEF10L;KDM4B;CAMTA2;HOMER2;PLPPR2;RGS14;SYNE3;GOLGA2P5;PCIF1;MAFIP;SPIRE2;EIF4G3;ZNF710;CTSH;ABHD14B;P3H4;MLST8;ROBO4;AGPAT4;RILPL1;RSAD1;CBLC;ATXN10;EPN2;RFX2;RNF187;PYCARD;MAP2K3;PNPO;POMT1;TRERF1;PCSK1N;KCNN4;DNAAF5;THAP8;DDN;PMS2P5;AS3MT;NDUFV3;STK17A;ERN1;CKLF;RANBP9;ZNF319;APOBEC3F;PRIMPOL;ACADS;FBXL20;GCAT;WDR63;MOCS1;ARHGEF19;SIRT3;GLI4;C12ORF66;CMTM4;SLC2A1;CPNE7;MLYCD;TAZ;RNASEK;JAK3;BCKDHA;MAST3;KIFC2;LITAF;APBA1;MZF1;NEIL1;FUK;RARG;ING4;EIF4E3;GALNS;PBXIP1;EREG;FAM162A;PPCS;FCHSD1;GSTM2;ZNF514;PODXL2;ZFYVE19;TRIM7;SHISA6;GIPR;WDR18;SFI1;TP53I11;KRT15;ADAMTSL4;TRNP1;TTLL11;ZNF837;TMED4;POLM;SEMA4F;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;STXBP2;KIF26B;UBL5;LZTS2
7208,GO:0031114,0.895642403339533,0.352981890966936,1,22,regulation of microtubule depolymerization,BP,TRPV4
7894,GO:0032479,0.895748718996102,0.186852609823885,7,107,regulation of type I interferon production,BP,PTPRS;RNF135;TMEM173;STAT6;PIN1;NLRX1;PYCARD
11824,GO:0046825,0.895809453841617,0.271247518397739,2,39,regulation of protein export from nucleus,BP,RAPGEF3;GAS6
16536,GO:0097346,0.895950724386231,0.351718168895779,1,23,INO80-type complex,CC,INO80C
2823,GO:0006297,0.895971553963545,0.351670782872368,1,23,nucleotide-excision repair, DNA gap filling,BP,POLD4
16168,GO:0090224,0.896058978769916,0.270987421681659,2,38,regulation of spindle organization,BP,CHMP1B;PKD1
12227,GO:0048524,0.896294326608425,0.193313324278824,6,95,positive regulation of viral process,BP,APOE;ADARB1;MVB12B;PC;MVB12A;RAD23A
10979,GO:0044798,0.896449003865629,0.167778340846649,11,157,nuclear transcription factor complex,CC,FOS;ERCC1;NR1D1;NFATC4;MXI1;THRA;TFDP2;CEBPB;PPARA;RXRA;RARG
242,GO:0000578,0.896463645321159,0.351112461045265,1,22,embryonic axis specification,BP,WNT7A
14521,GO:0070063,0.896464539574239,0.235762486979585,3,53,RNA polymerase binding,MF,ERBB2;ZFP36;BIN1
18660,GO:1904036,0.896517791419589,0.350988963991223,1,22,negative regulation of epithelial cell apoptotic process,BP,GAS6
12346,GO:0048753,0.896525644836321,0.35040863912128,1,23,pigment granule organization,BP,LYST
8687,GO:0034341,0.896641683922931,0.179637297597535,8,121,response to interferon-gamma,BP,CYP27B1;GSN;MEFV;IFNGR2;PTAFR;ADAMTS13;RPL13A;STXBP2
7376,GO:0031440,0.896952463015396,0.349996470967598,1,22,regulation of mRNA 3'-end processing,BP,ZFP36L1
19690,GO:2000060,0.896967889750899,0.201912606684779,5,80,positive regulation of ubiquitin-dependent protein catabolic process,BP,CSNK1E;DVL1;MAGEF1;RAD23A;AKT1
19253,GO:1905476,0.896971575985279,0.349952785470673,1,22,negative regulation of protein localization to membrane,BP,DMTN
9278,GO:0035735,0.896996514892514,0.268939537764435,2,39,intraciliary transport involved in cilium assembly,BP,IFT140;WDR60
7429,GO:0031571,0.897060332974664,0.214825752225974,4,68,mitotic G1 DNA damage checkpoint,BP,PCBP4;TFDP2;PIDD1;ZNF385A
10987,GO:0044819,0.897060332974664,0.214825752225974,4,68,mitotic G1/S transition checkpoint,BP,PCBP4;TFDP2;PIDD1;ZNF385A
15405,GO:0071705,0.897917164517921,0.11927209434121,148,1705,nitrogen compound transport,BP,LMF1;CEMIP;APOE;IDH2;SYTL1;LTBP4;RAPGEF3;EVI5L;NOS1;ZFP36L1;POSTN;NR1D1;ALOX15B;ARRDC1;LRP1;LTBP2;EGFR;B3GAT3;HADH;NLGN2;TOM1L2;SLC43A1;RHBDF1;DOPEY2;F2R;BBS2;TBC1D14;ABCG1;ANK3;PIK3R2;NISCH;LRP5;PLTP;SLC2A9;ERBB2;EXOC2;MICALL2;TMEM129;TST;EDEM1;SLC7A8;ITPR3;PRAF2;KIF13B;VPS11;VAMP2;FUZ;NTSR1;CD320;SLC6A8;AGAP1;GLUL;RHOD;PEX10;RAB3D;TBC1D8;TMEM173;PRNP;SERINC2;SNX33;ATG16L2;SNX9;REEP2;STRADB;RAB25;MYO18A;BCL6;PFKFB2;CHMP1B;MVB12B;HOOK2;ARL2;AP2A2;RHBDF2;ACVR2B;ZDHHC1;MAPK3;OLFM2;AMN;RAB40B;HES1;SLC48A1;LRSAM1;ADA;AQP3;RASL10B;PFKL;SLC28A2;ZFP36;MAPKBP1;PITPNM1;SLC38A10;RAB3B;STX10;DMTN;BBS1;VGF;SNX17;TRPV4;PEX7;MVB12A;HK1;SLC29A4;GAS6;LLGL1;GUK1;PCK2;BCR;TBC1D16;PRKCZ;ZDHHC24;CLTCL1;TM7SF3;TMCO6;SRSF5;C5;VSNL1;UNC119B;OSCP1;RTN2;LYST;SORL1;STK39;TBC1D17;TSNARE1;SLC25A29;AKT1;VPS33B;PINK1;PKD1;EHD3;LONP2;SPIRE2;RILPL1;PYCARD;RHBG;KCNN4;SIRT3;SLC2A1;APBA1;GIPR;PQLC2;TMED4;RPL13A;RAB40C;MIF;STXBP2;UBL5
4330,GO:0009891,0.898252324355089,0.120969625700567,115,1318,positive regulation of biosynthetic process,BP,TNIP1;FOS;APOE;CITED4;CST3;RAPGEF3;MEF2D;NOS1;NR1D1;EPAS1;IGF2;NFATC4;EGFR;TIMP2;TCEA2;EGR1;CRTC1;SHC1;F2R;DEAF1;ASH2L;SOX12;ABCG1;PIK3R2;ZNF516;PEG3;HDAC5;THRA;ZP3;LRP5;MAML3;ZFPM1;TFEB;ERBB2;PKD2;PTHLH;CDKN1C;SALL2;HEXB;NTSR1;TFDP2;WNT7A;ZMIZ1;INSR;ITGA6;TMEM173;STAT6;WWTR1;PFKFB2;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;CEBPB;HSF4;CALCOCO1;MAPK3;ETV5;DVL1;FHOD1;HES1;MLXIPL;ETV4;RPS6KA5;MAP2K2;FGFR4;TNFRSF1A;LDLR;HMGA2;ELK3;ZXDC;BTRC;PPARA;PTAFR;RXRA;USP21;HLTF;RFXANK;TEF;FGFR1;PIN1;IRF2BPL;PROX1;WBP2;ASS1;SESN2;RXRB;MAPRE3;GUCA1B;ACVR1B;MEF2B;ADORA2B;AKT1;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;CAMTA2;ABHD14B;RFX2;RNF187;MAP2K3;POMT1;TRERF1;DDN;TAZ;LITAF;MZF1;RARG;EREG
5783,GO:0017025,0.89834746009052,0.346236591810513,1,23,TBP-class protein binding,MF,THRA
19672,GO:2000027,0.898771571793023,0.158987373474305,13,184,regulation of organ morphogenesis,BP,CELSR1;VEGFA;VANGL2;AP2A2;ETV5;DVL1;HES1;CELSR2;RXRA;FGFR1;WNT2B;ARHGEF19;SULF2
2799,GO:0006266,0.899388504886863,0.343837083431643,1,23,DNA ligation,BP,POLD4
416,GO:0001104,0.899466956311114,0.197815097504348,5,81,RNA polymerase II transcription cofactor activity,MF,CITED4;ZMYND8;SOX12;WBP2;TRERF1
75,GO:0000152,0.900455838882118,0.26195074019926,2,40,nuclear ubiquitin ligase complex,CC,PHC2;CUL7
16979,GO:0099106,0.900558934825111,0.228306818777007,3,54,ion channel regulator activity,MF,KCNAB2;PCSK9;PRKCZ
7976,GO:0032606,0.900603765984662,0.179436680945928,7,108,type I interferon production,BP,PTPRS;RNF135;TMEM173;STAT6;PIN1;NLRX1;PYCARD
2364,GO:0005496,0.900662330729734,0.228120646512605,3,54,steroid binding,MF,APOE;ABCG1;OSBPL5
8335,GO:0033209,0.900747816757914,0.168766200769812,9,138,tumor necrosis factor-mediated signaling pathway,BP,RBCK1;TNFRSF25;TNFRSF6B;TNFRSF14;TNFRSF1A;GAS6;MADD;SPPL2B;PYCARD
18497,GO:1903706,0.901368838131128,0.139530872352348,24,325,regulation of hemopoiesis,BP,FOS;CTNNBIP1;ZFP36L1;FAM210B;ASH2L;ZFPM1;ERBB2;ZMIZ1;BCL6;FAM213A;CEBPB;L3MBTL1;HES1;ADA;ZFP36;SOX13;RAG1;GAS6;PRKCZ;INPP5D;AGO4;ACVR1B;JAK3;RARG
10161,GO:0042770,0.90205316862395,0.17157900421748,8,121,signal transduction in response to DNA damage,BP,NDRG1;PCBP4;TFDP2;PIDD1;SESN2;ZNF385A;ING4;MIF
3150,GO:0006760,0.90208889311861,0.337559508109741,1,23,folic acid-containing compound metabolic process,BP,MTHFR
5372,GO:0016202,0.902107563455378,0.193590434014843,5,80,regulation of striated muscle tissue development,BP,GPC1;FGFR1;PIN1;JARID2;ERBB3
17763,GO:1901861,0.902107563455378,0.193590434014843,5,80,regulation of muscle tissue development,BP,GPC1;FGFR1;PIN1;JARID2;ERBB3
17343,GO:1900087,0.902256897579907,0.337166365195065,1,23,positive regulation of G1/S transition of mitotic cell cycle,BP,HYAL1
2921,GO:0006446,0.902293786941935,0.205892125873384,4,69,regulation of translational initiation,BP,EIF4EBP3;RXRA;EIF4G3;RPL13A
18084,GO:1902751,0.902463038742845,0.336683561492721,1,23,positive regulation of cell cycle G2/M phase transition,BP,MTA3
11563,GO:0046148,0.903262417128869,0.256393787148693,2,40,pigment biosynthetic process,BP,UROS;ADA
6713,GO:0030134,0.903311621367375,0.204157082635808,4,69,COPII-coated ER to Golgi transport vesicle,CC,VANGL2;PCSK9;CTSZ;TMED4
10968,GO:0044783,0.903539920221184,0.203767288634073,4,69,G1 DNA damage checkpoint,BP,PCBP4;TFDP2;PIDD1;ZNF385A
18484,GO:1903672,0.903848439918279,0.333426782623179,1,23,positive regulation of sprouting angiogenesis,BP,VEGFA
12851,GO:0051205,0.903869800265189,0.255184075180025,2,40,protein insertion into membrane,BP,EGFR;TFDP2
15752,GO:0072384,0.903906253624282,0.203222198942063,4,68,organelle transport along microtubule,BP,FYCO1;PRKCZ;NDE1;SUN1
10657,GO:0043921,0.904008623414391,0.333048866807193,1,23,modulation by host of viral transcription,BP,HMGA2
13309,GO:0052312,0.904008623414391,0.333048866807193,1,23,modulation of transcription in other organism involved in symbiotic interaction,BP,HMGA2
13327,GO:0052472,0.904008623414391,0.333048866807193,1,23,modulation by host of symbiont transcription,BP,HMGA2
7283,GO:0031293,0.904154757394533,0.332703850338315,1,23,membrane protein intracellular domain proteolysis,BP,SPPL2B
4334,GO:0009895,0.9042963681158,0.14719700676676,15,208,negative regulation of catabolic process,BP,CST3;EGFR;TIMP2;TBC1D14;SERPINE2;ATP2B4;FURIN;ZFP36;DAP;PPARA;SUFU;PIN1;TIMP1;AKT1;PINK1
9052,GO:0035306,0.904381428349094,0.254370994221405,2,39,positive regulation of dephosphorylation,BP,PIN1;PINK1
14095,GO:0060986,0.904498018183204,0.331892495398413,1,23,endocrine hormone secretion,BP,FGFR1
2079,GO:0004842,0.904701701787207,0.130927079947898,30,380,ubiquitin-protein transferase activity,MF,RNF44;RBCK1;FBXO2;DDB2;RNF208;GID4;TMEM129;RNF135;FBXW8;FBXO27;FBXL8;FBXO41;MARCH2;FBXW4;FBXL16;KLHL29;LRSAM1;FBXW5;RAG1;MIB2;FBXO17;BTRC;RNF123;HLTF;KLHDC8B;SPSB3;ZER1;CBLC;RNF187;FBXL20
11435,GO:0045912,0.905223755353673,0.330172778913323,1,23,negative regulation of carbohydrate metabolic process,BP,PPARA
12328,GO:0048713,0.905443005295803,0.329652083810857,1,23,regulation of oligodendrocyte differentiation,BP,HES1
4258,GO:0009615,0.905792505358038,0.143405519192478,16,221,response to virus,BP,HTRA1;MST1R;ACTA2;HYAL1;ADARB1;TMEM173;ISG20;BNIP3;IFNGR2;HMGA2;TKFC;APOBEC3C;LYST;NLRX1;PYCARD;APOBEC3F
12145,GO:0048286,0.906063035790684,0.3281766538376,1,23,lung alveolus development,BP,ADA
13066,GO:0051603,0.906130923885169,0.121565411483544,48,592,proteolysis involved in cellular protein catabolic process,BP,BTBD2;RNF44;NR1D1;ARRDC1;RBCK1;FBXO2;RHBDF1;CTSB;CTSF;GID4;TMEM129;EDEM1;ABTB1;CUL9;CSNK1E;ADAMTS7;USP20;WWTR1;ANKZF1;MVB12B;FBXW4;DVL1;MTA1;CUL7;BTBD11;PRKACA;MAGEF1;FBXW5;MVB12A;BTRC;SUFU;USP21;RNF123;RAD23A;CTSZ;SPSB3;MAN1B1;CAPN2;TOLLIP;AKT1;PINK1;PKD1;LONP2;CTSH;CBLC;RNF187;POMT1;FBXL20
7885,GO:0032465,0.906152376943008,0.199370387533751,4,68,regulation of cytokinesis,BP,RAB11FIP4;GIT1;PIN1;ZFYVE19
12085,GO:0048147,0.906287657732634,0.3271325085483,1,24,negative regulation of fibroblast proliferation,BP,TP53INP1
11983,GO:0047485,0.906490466267616,0.177244726531149,6,96,protein N-terminus binding,MF,ZMYND8;EXOC2;NTSR1;ID1;GLRX;ERCC6
6777,GO:0030225,0.906882142804949,0.326220835129098,1,23,macrophage differentiation,BP,VEGFA
13573,GO:0060071,0.907042796052354,0.176236111308486,6,99,Wnt signaling pathway, planar cell polarity pathway,BP,CELSR1;VANGL2;AP2A2;DVL1;CELSR2;ARHGEF19
14,GO:0000027,0.907121652611526,0.324244382574451,1,26,ribosomal large subunit assembly,BP,WDR18
8124,GO:0032838,0.90735506438768,0.163572911124786,8,122,plasma membrane bounded cell projection cytoplasm,CC,DNAH1;IFT140;DLG4;ADA;PRKACA;BBS1;SPATA7;GAS8
11664,GO:0046470,0.907372967970362,0.215798876947934,3,55,phosphatidylcholine metabolic process,BP,LPCAT4;LDLR;LCAT
1336,GO:0003197,0.907436038505869,0.324893941839809,1,23,endocardial cushion development,BP,ERBB3
2314,GO:0005326,0.90758557993797,0.324535103012763,1,23,neurotransmitter transporter activity,MF,SLC6A8
12274,GO:0048634,0.907839692962623,0.184129336205195,5,81,regulation of muscle organ development,BP,GPC1;FGFR1;PIN1;JARID2;ERBB3
15171,GO:0071345,0.908753669192044,0.11551057738216,60,737,cellular response to cytokine stimulus,BP,FOS;GSN;ZFP36L1;POSTN;RBCK1;MST1R;MAPK13;EGR1;SHC1;LAMA5;BBS2;MMP1;HYAL1;ADAMTS7;PDCD4;TNFRSF25;IL20RB;TMEM173;SPRY2;ECM1;STAT6;TALDO1;ISG20;BCL6;VEGFA;CEBPB;TNFRSF6B;MAPK3;TNFRSF14;IL6R;SLIT3;ZFP36;PRKACA;RPS6KA5;TNFRSF1A;IFNGR2;GAS6;BTRC;PTAFR;PCK2;ADAMTS13;INPP5D;ABCD4;JARID2;TOLLIP;MADD;RTN4R;TIMP1;SDC1;AKT1;SPPL2B;IL17RD;RFX2;PYCARD;JAK3;RARG;EREG;RPL13A;MIF;STXBP2
13069,GO:0051607,0.908768589381054,0.150164275732867,11,160,defense response to virus,BP,HTRA1;ADARB1;TMEM173;ISG20;BNIP3;TKFC;APOBEC3C;LYST;NLRX1;PYCARD;APOBEC3F
5387,GO:0016234,0.908975981464496,0.194495717558521,4,68,inclusion body,CC,EDEM1;PRNP;STRADB;PINK1
109,GO:0000226,0.909108383302296,0.123190596793819,34,427,microtubule cytoskeleton organization,BP,OBSL1;BBS2;DNAH1;TUBG2;MARK4;BRSK1;PKD2;CUL9;NINL;CCDC69;SPRY2;CEP250;CHMP1B;HOOK2;ARL2;DVL1;CUL7;FBXW5;TRPV4;CROCC;LLGL1;PRKCZ;CEP68;NDE1;WRAP73;SUN1;GAS8;PKD1;RGS14;GOLGA2P5;SPIRE2;DNAAF5;RANBP9;TTLL11
10472,GO:0043388,0.909110668057391,0.244443283649421,2,41,positive regulation of DNA binding,BP,HES1;HMGA2
10670,GO:0043966,0.909162654048948,0.212503610578316,3,55,histone H3 acetylation,BP,JADE2;WBP2;ING4
5601,GO:0016655,0.909281415323055,0.242837691678655,2,49,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,NDUFS8;NDUFV3
11351,GO:0045739,0.909572515630652,0.24369886793987,2,40,positive regulation of DNA repair,BP,EGFR;TMEM161A
7249,GO:0031228,0.909807922710903,0.243219704887098,2,40,intrinsic component of Golgi membrane,CC,B4GAT1;RFNG
14002,GO:0060759,0.909808549321461,0.155462813626859,9,135,regulation of response to cytokine stimulus,BP,RBCK1;ECM1;SLIT3;TNFRSF1A;IFNGR2;GAS6;MADD;SPPL2B;PYCARD
6241,GO:0019827,0.910222801193479,0.159224751523193,8,122,stem cell population maintenance,BP,EPAS1;LRP5;WNT7A;EPHA1;VANGL2;HES1;HMGA2;PROX1
8085,GO:0032784,0.910605631639889,0.241592943543633,2,40,regulation of DNA-templated transcription, elongation,BP,TCEA2;ERCC6
5876,GO:0018024,0.910863610218594,0.241065836594386,2,40,histone-lysine N-methyltransferase activity,MF,ASH2L;KMT5C
10594,GO:0043601,0.910885592049959,0.316045094834444,1,24,nuclear replisome,CC,POLD4
2186,GO:0005048,0.911156443432551,0.240466910884513,2,40,signal sequence binding,MF,CEMIP;PEX7
1455,GO:0003697,0.911208657174045,0.169709151920984,6,96,single-stranded DNA binding,MF,ERCC1;XPC;DMC1;RAD23A;SSBP2;PMS2P5
4377,GO:0010039,0.911249960861411,0.315155866731515,1,24,response to iron ion,BP,CYBRD1
9526,GO:0036296,0.911480732174655,0.314591857359881,1,24,response to increased oxygen levels,BP,BNIP3
11913,GO:0046982,0.911492577268577,0.125581024448051,25,347,protein heterodimerization activity,MF,FOS;PGF;MEF2D;EPAS1;EGFR;ABCG1;PIK3R2;TENM2;ERBB2;H2AFJ;HEXB;NTSR1;RALGAPA2;RABGGTA;BNIP3;VEGFA;CEBPB;MLXIPL;BTBD11;BHLHE40;RXRA;CAPN2;VEGFB;ERBB3;HOMER2
11073,GO:0045095,0.911527386215166,0.314477756471423,1,24,keratin filament,CC,FBF1
8087,GO:0032786,0.911835101073108,0.313724529300424,1,24,positive regulation of DNA-templated transcription, elongation,BP,ERCC6
9179,GO:0035579,0.911864401882455,0.207494778068648,3,55,specific granule membrane,CC,KCNAB2;SLC2A3;HGSNAT
8813,GO:0034613,0.911888279804002,0.104788883197977,125,1461,cellular protein localization,BP,CEMIP;APOE;SYTL1;RAPGEF3;GSN;EVI5L;TCTN1;EPHB2;OBSCN;LRP1;LTBP2;OBSL1;EGFR;B3GAT3;NLGN2;TOM1L2;ABCA7;LAMA5;BBS2;CORO1B;ZMYND8;TBC1D14;PACS2;ANK3;ERBB2;MICALL2;BSG;PTPRU;TMEM129;EDEM1;IFT140;KIF13B;VPS11;VAMP2;TFDP2;CSNK1E;RHOD;PEX10;RAB3D;SH3PXD2B;TBC1D8;ID1;CELSR1;SYNGAP1;TMEM173;PRNP;SNX33;CEP250;SNX9;DLG4;REEP2;STRADB;RAB25;TMEM107;BCL6;CD81;ARL2;AP2A2;SHANK3;NUDCD3;ZDHHC1;TUB;KCNAB2;ETV5;AMN;RAB40B;DVL1;WIPI2;HES1;SSH1;LRSAM1;RAB3B;STX10;TSPAN33;DMTN;BBS1;TNFRSF1A;SNX17;ABHD17C;CROCC;LDLRAP1;PEX7;HK1;GAS6;TTC7B;BCR;TBC1D16;PRKCZ;ZDHHC24;CLTCL1;TMCO6;SPATA7;TWF2;SRSF5;CEP68;PIN1;DLG3;OSCP1;SESN2;TOLLIP;EPB41L3;RTN2;SORL1;TBC1D17;TSNARE1;AKT1;SEPT8;VPS33B;GPD1L;SUN1;PINK1;GAS8;PKD1;EHD3;LONP2;SYNE3;RILPL1;C12ORF66;APBA1;SHISA6;TMED4;RPL13A;RAB40C;UBL5;LZTS2
11693,GO:0046513,0.912128726163578,0.238473696409504,2,40,ceramide biosynthetic process,BP,CERS4;TNFRSF1A
16469,GO:0097194,0.912367753604642,0.18843743615939,4,70,execution phase of apoptosis,BP,H1F0;ENDOG;MADD;AKT1
14640,GO:0070268,0.912368642597404,0.188222317324384,4,73,cornification,BP,PPL;PRSS8;FURIN;KRT15
1147,GO:0002755,0.912403915177051,0.312329175962888,1,24,MyD88-dependent toll-like receptor signaling pathway,BP,TNIP1
4470,GO:0010494,0.912927821491519,0.236830159839623,2,40,cytoplasmic stress granule,CC,GRB7;ZFP36
259,GO:0000726,0.912940544852998,0.187155288604553,4,74,non-recombinational repair,BP,ERCC1;POLL;HMGA2;POLM
10709,GO:0044068,0.913199695371396,0.3103704652417,1,24,modulation by symbiont of host cellular process,BP,TNIP1
21,GO:0000038,0.913246294156218,0.310255528810497,1,24,very long-chain fatty acid metabolic process,BP,ABCD1
20105,GO:2000826,0.913297664447324,0.310128792586982,1,24,regulation of heart morphogenesis,BP,HES1
8661,GO:0034249,0.913361755346182,0.132964763116153,16,231,negative regulation of cellular amide metabolic process,BP,APOE;ZFP36L1;GRB7;EGFR;ABCA7;UNK;PRNP;ZFP36;MAP2K2;EIF4EBP3;MEX3A;AGO4;BIN1;SESN2;SORL1;RPL13A
7362,GO:0031424,0.913666377444335,0.174017415401097,5,89,keratinization,BP,PPL;PRSS8;LCE1E;FURIN;KRT15
7455,GO:0031625,0.913823445305764,0.127222995985485,20,270,ubiquitin protein ligase binding,MF,BTBD2;ARRDC1;EGFR;CBS;ABTB1;CUL9;TMEM173;SNX9;FZD8;SLC22A18;CUL7;TNFRSF14;BTBD11;PRKACA;HLTF;DLG3;TOLLIP;ACVR1B;ERBB3;PINK1
41,GO:0000083,0.913824266565952,0.308827738192427,1,24,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,TFDP2
20245,GO:2001242,0.913990339744494,0.153334968149906,8,127,regulation of intrinsic apoptotic signaling pathway,BP,MAPK8IP1;TMEM161A;AKT1;TRAP1;ZNF385A;PINK1;PYCARD;MIF
3686,GO:0008200,0.914454013842663,0.306806841357214,1,25,ion channel inhibitor activity,MF,PCSK9
10603,GO:0043618,0.914456581139066,0.164269275190589,6,101,regulation of transcription from RNA polymerase II promoter in response to stress,BP,EPAS1;EGR1;VEGFA;CEBPB;HSF4;SESN2
16803,GO:0098727,0.914701534333821,0.152354695348576,8,123,maintenance of cell number,BP,EPAS1;LRP5;WNT7A;EPHA1;VANGL2;HES1;HMGA2;PROX1
2535,GO:0005798,0.914753620327451,0.148015123869,9,137,Golgi-associated vesicle,CC,VANGL2;FURIN;PCSK9;LDLRAP1;CLTCL1;CTSZ;SPPL2B;PKD1;TMED4
10356,GO:0043195,0.915064912741508,0.232220057509562,2,41,terminal bouton,CC,NTSR1;BLVRB
5389,GO:0016236,0.915143847538441,0.125451651585639,20,271,macroautophagy,BP,ULK1;ULK2;TBC1D14;PACS2;ATG16L2;BNIP3;MAPK3;FYCO1;GPSM1;WIPI2;LRSAM1;PRKACA;MVB12A;ATG2A;SESN2;AKT1;TP53INP1;PINK1;MLST8;ERN1
18213,GO:1903050,0.915544519246867,0.137714823021494,12,175,regulation of proteolysis involved in cellular protein catabolic process,BP,RHBDF1;EDEM1;CSNK1E;DVL1;PRKACA;MAGEF1;BTRC;SUFU;RAD23A;AKT1;PINK1;PKD1
4381,GO:0010043,0.915999679241718,0.30253468584468,1,26,response to zinc ion,BP,D2HGDH
1325,GO:0003179,0.916274343525679,0.302729109104668,1,24,heart valve morphogenesis,BP,ZFPM1
10848,GO:0044389,0.916371178333145,0.122780186152326,21,283,ubiquitin-like protein ligase binding,MF,BTBD2;ARRDC1;EGFR;CBS;ABTB1;CUL9;TMEM173;SNX9;FZD8;CEBPB;SLC22A18;CUL7;TNFRSF14;BTBD11;PRKACA;HLTF;DLG3;TOLLIP;ACVR1B;ERBB3;PINK1
9928,GO:0042306,0.916374651464394,0.229494766871177,2,41,regulation of protein import into nucleus,BP,TMEM173;GAS6
7583,GO:0031966,0.91642445910628,0.110148058462552,44,577,mitochondrial membrane,CC,IDH2;CYP27B1;PRODH;CRAT;FAM210B;CPT2;NME4;HADH;ULK1;BPHL;DHRS1;GRAMD4;TST;CPT1C;VAT1;DNM1;SNN;ARMCX2;SPATA18;NDUFS8;TMEM173;ANKZF1;BNIP3;CARD19;CKMT1A;SLC25A37;MAPK8IP1;HK1;SDHAF4;HMGCL;SDHA;MDH2;SLC25A27;NDUFA4L2;SNPH;SMDT1;SLC25A29;TRAP1;NLRX1;UQCR11;PINK1;NDUFV3;GCAT;TAZ
16128,GO:0090175,0.917046375361671,0.160069344879197,6,101,regulation of establishment of planar polarity,BP,CELSR1;VANGL2;AP2A2;DVL1;CELSR2;ARHGEF19
6679,GO:0030057,0.91745681035252,0.299758608794544,1,24,desmosome,CC,PPL
10629,GO:0043666,0.918176552433519,0.166677817881507,5,84,regulation of phosphoprotein phosphatase activity,BP,B3GAT3;PPP1R14A;PPP2R3B;PPP1R35;ELFN2
11174,GO:0045296,0.918176938394169,0.119413453747335,22,298,cadherin binding,MF,PPL;NDRG1;EGFR;SLC9A3R2;CORO1B;ANK3;BSG;MPRIP;PAK6;ITGA6;SNX9;EHD4;VASN;CAPG;TWF2;SH3GLB2;ESYT2;PPP1R13L;H1FX;EPS8L1;EPS8L2;EPN2
2080,GO:0004843,0.918204394872478,0.178149315204222,4,70,thiol-dependent ubiquitin-specific protease activity,MF,JOSD2;USP20;ANKZF1;USP21
16519,GO:0097305,0.918348505023765,0.151740042881956,7,111,response to alcohol,BP,GSN;DNMT3A;ADCY6;ABCA2;PMVK;AKT1;TP53INP1
17401,GO:1900182,0.918636701152912,0.194643063714041,3,56,positive regulation of protein localization to nucleus,BP,TMEM173;SESN2;AKT1
15720,GO:0072332,0.918690244062588,0.177078323344558,4,73,intrinsic apoptotic signaling pathway by p53 class mediator,BP,PDK2;ZNF385A;PYCARD;MIF
5716,GO:0016866,0.918785311544529,0.295943203376631,1,25,intramolecular transferase activity,MF,PGM1
8957,GO:0035064,0.919535095829987,0.192931967909864,3,56,methylated histone binding,MF,ZMYND8;L3MBTL1;ING4
17256,GO:0140034,0.919535095829987,0.192931967909864,3,56,methylation-dependent protein binding,MF,ZMYND8;L3MBTL1;ING4
18319,GO:1903313,0.920403035391447,0.19127405336147,3,56,positive regulation of mRNA metabolic process,BP,ZFP36L1;ZFP36;GTPBP1
781,GO:0002040,0.920444771424206,0.174154356805114,4,70,sprouting angiogenesis,BP,PGF;HDAC5;VEGFA;EPN2
4333,GO:0009894,0.921107498108002,0.100220953434543,63,768,regulation of catabolic process,BP,APOE;TYSND1;CST3;RAPGEF3;PCBP4;ZFP36L1;LRP1;EGFR;TIMP2;ULK1;RHBDF1;TRIM65;ULK2;TBC1D14;PIK3R2;THRA;TFEB;EDEM1;SERPINE2;VPS11;ATP2B4;CSNK1E;INSR;SNX33;SNX9;PFKFB2;BNIP3;CD81;ENDOG;MAPK3;DVL1;FYCO1;GPSM1;FURIN;MLXIPL;MEFV;LRSAM1;PCSK9;ZFP36;PRKACA;MAGEF1;DAP;LDLR;BTRC;PPARA;SUFU;RAD23A;PIN1;GTPBP1;SH3D19;SESN2;TIMP1;SORL1;TPCN1;AKT1;TP53INP1;PINK1;PKD1;LONP2;MLST8;PYCARD;ERN1;MLYCD
11607,GO:0046332,0.921130071310222,0.189881604431274,3,56,SMAD binding,MF,FOS;HMGA2;ACVR1B
17348,GO:1900101,0.921204403314253,0.289769689959607,1,25,regulation of endoplasmic reticulum unfolded protein response,BP,ERN1
7863,GO:0032436,0.921498256737885,0.172196798825599,4,71,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,CSNK1E;DVL1;RAD23A;AKT1
9390,GO:0035966,0.921670690115728,0.128863797390009,12,175,response to topologically incorrect protein,BP,SHC1;TMEM129;EDEM1;DNAJC4;DNAJB5;ANKZF1;CUL7;F12;TM7SF3;TPP1;POMT1;ERN1
12126,GO:0048255,0.921817206267903,0.28819337147563,1,25,mRNA stabilization,BP,ZFP36
12622,GO:0050852,0.921845345528395,0.137189663748923,9,141,T cell receptor signaling pathway,BP,RBCK1;PIK3R2;PRNP;ADA;PAG1;BTRC;INPP5D;ICOSLG;KCNN4
12393,GO:0048863,0.921900704987382,0.126215361153948,13,200,stem cell differentiation,BP,SEMA4B;LAMA5;WNT7A;MAPK3;HES1;SEMA3B;HMGA2;SEMA3F;SEMA4C;LTBP3;JARID2;WNT3;SEMA4F
1868,GO:0004540,0.921950611276423,0.16010437505307,5,87,ribonuclease activity,MF,RNASET2;ISG20;PAN2;ERN1;RNASEK
4692,GO:0010862,0.921963902277795,0.287815267122874,1,25,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,ACVR1B
15761,GO:0072401,0.921981650724289,0.171261176924033,4,72,signal transduction involved in DNA integrity checkpoint,BP,PCBP4;TFDP2;PIDD1;ZNF385A
15765,GO:0072422,0.921981650724289,0.171261176924033,4,72,signal transduction involved in DNA damage checkpoint,BP,PCBP4;TFDP2;PIDD1;ZNF385A
16125,GO:0090169,0.92222945645062,0.287130062490164,1,25,regulation of spindle assembly,BP,CHMP1B
2870,GO:0006376,0.922229844458907,0.287129060612688,1,25,mRNA splice site selection,BP,SRSF5
4507,GO:0010569,0.922364080728005,0.286782325342482,1,25,regulation of double-strand break repair via homologous recombination,BP,MAGEF1
297,GO:0000803,0.922397891506686,0.286694952406617,1,25,sex chromosome,CC,DNMT3A
17280,GO:0140104,0.922611497147478,0.285341352423967,1,27,molecular carrier activity,MF,TMCO6
8413,GO:0033522,0.922624115905549,0.286109945244912,1,25,histone H2A ubiquitination,BP,DDB2
15068,GO:0071108,0.922810722927639,0.28562685699205,1,25,protein K48-linked deubiquitination,BP,USP20
5398,GO:0016248,0.922907826420244,0.284959053640887,1,26,channel inhibitor activity,MF,PCSK9
1469,GO:0003727,0.92343471658412,0.168712299516228,4,71,single-stranded RNA binding,MF,THRA;ZFP36;MEX3A;AGO4
4361,GO:0009988,0.923578300907607,0.283219159994025,1,26,cell-cell recognition,BP,ZP3
14801,GO:0070566,0.923594026259294,0.283593786002871,1,25,adenylyltransferase activity,MF,TUT1
20236,GO:2001233,0.923683872631889,0.112056818730018,22,302,regulation of apoptotic signaling pathway,BP,GSN;RBCK1;NFATC4;TFDP2;ITGA6;MNT;STRADB;BNIP3;PIDD1;MAPK8IP1;FGFR1;TMEM161A;MADD;AKT1;TRAP1;ZNF385A;TP53INP1;PINK1;CTSH;PYCARD;FAM162A;MIF
1851,GO:0004518,0.923733554550084,0.125831740912958,12,177,nuclease activity,MF,ERCC1;RNASET2;ISG20;DNASE1L1;ENDOG;EXD3;RAG1;DMC1;PAN2;ERN1;RNASEK;NEIL1
15267,GO:0071480,0.923773576428099,0.282711243215978,1,26,cellular response to gamma radiation,BP,EGR1
16290,GO:0090502,0.92454368961272,0.1830058253362,3,59,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,RNASET2;ERN1;RNASEK
14781,GO:0070536,0.924898127043754,0.280189954751118,1,25,protein K63-linked deubiquitination,BP,USP20
2091,GO:0004860,0.924972690866604,0.165863770629406,4,72,protein kinase inhibitor activity,MF,CDKN1C;SPRY2;MAPK8IP1;RTN4R
12779,GO:0051099,0.92506378941362,0.132307966384529,9,139,positive regulation of binding,BP,APOE;LRP1;TMEM173;GPSM1;HES1;HMGA2;RFNG;MAPRE3;PKD1
3246,GO:0006914,0.925293199938699,0.103168400196312,33,427,autophagy,BP,ULK1;TRIM65;ULK2;TBC1D14;PACS2;PIK3R2;TFEB;ITGB4;VPS11;SPATA18;ATG16L2;BNIP3;MAPK3;FYCO1;GPSM1;WIPI2;MEFV;LRSAM1;PRKACA;DAP;MVB12A;ATG2A;SESN2;TOLLIP;TBC1D17;TPCN1;AKT1;CTSD;TP53INP1;PINK1;MLST8;PYCARD;ERN1
14465,GO:0061919,0.925293199938699,0.103168400196312,33,427,process utilizing autophagic mechanism,BP,ULK1;TRIM65;ULK2;TBC1D14;PACS2;PIK3R2;TFEB;ITGB4;VPS11;SPATA18;ATG16L2;BNIP3;MAPK3;FYCO1;GPSM1;WIPI2;MEFV;LRSAM1;PRKACA;DAP;MVB12A;ATG2A;SESN2;TOLLIP;TBC1D17;TPCN1;AKT1;CTSD;TP53INP1;PINK1;MLST8;PYCARD;ERN1
18215,GO:1903052,0.925334982757789,0.146521708362793,6,99,positive regulation of proteolysis involved in cellular protein catabolic process,BP,EDEM1;CSNK1E;DVL1;MAGEF1;RAD23A;AKT1
975,GO:0002429,0.925341115439619,0.116394066977303,16,228,immune response-activating cell surface receptor signaling pathway,BP,RBCK1;PIK3R2;PRNP;MAPK3;WIPF1;ADA;PAG1;PRKACA;CYFIP2;RPS6KA5;BTRC;VAV3;MUC19;INPP5D;ICOSLG;KCNN4
7873,GO:0032452,0.925619929357704,0.278295627228711,1,25,histone demethylase activity,MF,KDM4B
7248,GO:0031227,0.926581657724784,0.133813203142748,8,126,intrinsic component of endoplasmic reticulum membrane,CC,PKD2;EDEM1;SLC37A2;TM7SF2;ESYT2;RTN2;SPPL2B;ERN1
7086,GO:0030894,0.926643168551958,0.275185271110143,1,26,replisome,CC,POLD4
15759,GO:0072395,0.927039111004101,0.162042158537982,4,73,signal transduction involved in cell cycle checkpoint,BP,PCBP4;TFDP2;PIDD1;ZNF385A
2540,GO:0005814,0.927941172187668,0.136335891832567,7,112,centriole,CC,CEP250;FBF1;CROCC;CCDC92;CAPG;WRAP73;SFI1
2860,GO:0006360,0.928129780654184,0.176011253935225,3,59,transcription by RNA polymerase I,BP,ERBB2;MAPK3;ERCC6
7203,GO:0031109,0.928693665384625,0.148512514373543,5,86,microtubule polymerization or depolymerization,BP,TUBG2;ARL2;TRPV4;NDE1;RANBP9
13088,GO:0051650,0.928934945932107,0.116191021469332,13,189,establishment of vesicle localization,BP,SYTL1;SYT8;BBS2;DNM1;RIMS3;VAMP2;TRAPPC9;FYCO1;PRKCZ;NDE1;CTSZ;SNPH;PINK1
16468,GO:0097193,0.929041339411784,0.109879917129985,17,243,intrinsic apoptotic signaling pathway,BP,PRODH;NFATC4;BNIP3;CEBPB;TNFRSF1A;MAPK8IP1;PDK2;TMEM161A;PPM1F;AKT1;TRAP1;ZNF385A;ERCC6;PINK1;PYCARD;ERN1;MIF
18753,GO:1904292,0.929144766748611,0.268527063654267,1,26,regulation of ERAD pathway,BP,EDEM1
10412,GO:0043276,0.92947632958854,0.267637588715542,1,26,anoikis,BP,AKT1
16574,GO:0097431,0.929498156548901,0.26757897587711,1,26,mitotic spindle pole,CC,MAPKBP1
13723,GO:0060325,0.929611280795587,0.267275083158957,1,26,face morphogenesis,BP,MYH3
13037,GO:0051567,0.929666680325759,0.267126189247078,1,26,histone H3-K9 methylation,BP,JARID2
1537,GO:0003924,0.929695717292672,0.110277724510562,16,228,GTPase activity,MF,GNAL;TUBG2;DNM1;AGAP1;RHOD;RAB3D;RAB25;ARL2;RAB40B;RASL10B;RHOF;RAB3B;RHOBTB2;GTPBP1;SEPT8;RAB40C
9,GO:0000018,0.93014259978783,0.172137113269176,3,58,regulation of DNA recombination,BP,STAT6;BCL6;MAGEF1
9929,GO:0042307,0.930359615839318,0.265259885417974,1,26,positive regulation of protein import into nucleus,BP,TMEM173
9091,GO:0035384,0.930520580149909,0.198814221502415,2,43,thioester biosynthetic process,BP,PDK2;MLYCD
15347,GO:0071616,0.930520580149909,0.198814221502415,2,43,acyl-CoA biosynthetic process,BP,PDK2;MLYCD
8047,GO:0032728,0.930810380992443,0.264041882082001,1,26,positive regulation of interferon-beta production,BP,RNF135
7287,GO:0031297,0.931001197267182,0.263525338464412,1,26,replication fork processing,BP,PRIMPOL
13123,GO:0051721,0.931046386884912,0.263402926813635,1,26,protein phosphatase 2A binding,MF,AKT1
16088,GO:0090101,0.931065258205637,0.154651657880531,4,73,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HTRA1;LTBP1;VASN;PIN1
14179,GO:0061136,0.931396262480739,0.119408173881531,10,154,regulation of proteasomal protein catabolic process,BP,RHBDF1;EDEM1;CSNK1E;DVL1;PRKACA;BTRC;RAD23A;AKT1;PINK1;PKD1
3314,GO:0007029,0.93149956901338,0.196648971695095,2,43,endoplasmic reticulum organization,BP,DOPEY2;REEP2
6910,GO:0030514,0.931595597155062,0.261912668736024,1,26,negative regulation of BMP signaling pathway,BP,HTRA1
7700,GO:0032201,0.93177959360682,0.261037780937972,1,27,telomere maintenance via semi-conservative replication,BP,POLD4
5125,GO:0015631,0.932356968748135,0.102120794747061,20,275,tubulin binding,MF,FAM110C;CLIP2;NDRG1;MARK4;BRSK1;DNM1;KIF13B;CCDC69;PRNP;MYO18A;HOOK2;MYH3;TRPV4;REEP4;NDE1;MAPRE3;GAS8;RGS14;KIFC2;KIF26B
7582,GO:0031965,0.932463491273637,0.10398079139442,18,251,nuclear membrane,CC,CST3;CLCA2;EGFR;SLC16A3;CERS4;ITPR3;SIGMAR1;PRNP;STAT6;RETSAT;TM7SF2;KLHDC2;RNF123;SMOX;SUN1;TMEM120A;SYNE3;ERN1
6273,GO:0019886,0.932609750398297,0.151731270485596,4,74,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,CTSF;AP2A2;ACTR1B;CTSD
5464,GO:0016407,0.93273198257597,0.141343484948688,5,88,acetyltransferase activity,MF,CRAT;LPCAT4;NAGS;HGSNAT;GCAT
13419,GO:0052866,0.932891581686008,0.258377338986149,1,26,phosphatidylinositol phosphate phosphatase activity,MF,INPP5D
18248,GO:1903146,0.932906943531059,0.19336865663872,2,44,regulation of autophagy of mitochondrion,BP,BNIP3;PINK1
5598,GO:0016651,0.933048816089571,0.150447220192288,4,83,oxidoreductase activity, acting on NAD(P)H,MF,NOS1;NDUFS8;TXNRD3;NDUFV3
17315,GO:1900026,0.933130087302197,0.257350986038277,1,27,positive regulation of substrate adhesion-dependent cell spreading,BP,DMTN
13867,GO:0060537,0.933657795675791,0.104689418597186,16,226,muscle tissue development,BP,FOS;MEF2D;OBSL1;EGR1;ZFPM1;PKD2;VEGFA;RXRA;GPC1;FGFR1;PIN1;PROX1;PPP1R13L;JARID2;ERBB3;TAZ
6226,GO:0019787,0.933791433528968,0.0931194824077013,31,404,ubiquitin-like protein transferase activity,MF,RNF44;RBCK1;FBXO2;DDB2;RNF208;GID4;TMEM129;RNF135;FBXW8;FBXO27;FBXL8;FBXO41;MARCH2;FBXW4;FBXL16;KLHL29;LRSAM1;ZNF862;FBXW5;RAG1;MIB2;FBXO17;BTRC;RNF123;HLTF;KLHDC8B;SPSB3;ZER1;CBLC;RNF187;FBXL20
3935,GO:0008637,0.934088207461264,0.131641134402146,6,104,apoptotic mitochondrial changes,BP,TFDP2;BNIP3;AKT1;PINK1;PYCARD;FAM162A
17825,GO:1902041,0.93410449240349,0.19069195237811,2,44,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,PIDD1;MADD
4221,GO:0009408,0.934105871292041,0.11826325082748,9,140,response to heat,BP,NOS1;LRP11;HSF4;MAPK3;PRKACA;TRPV4;AKT1;TP53INP1;MLST8
11873,GO:0046916,0.934154799264974,0.148688032015723,4,77,cellular transition metal ion homeostasis,BP,PRNP;ATP7B;CYBRD1;SLC22A17
6053,GO:0019210,0.934449166032443,0.148306038536633,4,74,kinase inhibitor activity,MF,CDKN1C;SPRY2;MAPK8IP1;RTN4R
11662,GO:0046467,0.935418281533601,0.123988951043732,7,116,membrane lipid biosynthetic process,BP,KDSR;CERS4;TNFRSF1A;PIGZ;GAL3ST4;PIGV;PIGQ
2671,GO:0006040,0.935595136418801,0.250546083118286,1,27,amino sugar metabolic process,BP,CHST6
285,GO:0000790,0.936101940611725,0.0960244662383475,21,303,nuclear chromatin,CC,MEF2D;NR1D1;APPL2;H1F0;ASH2L;INO80C;H2AFJ;SALL2;DNMT3A;STAT6;CEBPB;CALCOCO1;RXRA;SMARCD2;KMT5C;WBP2;MEF2B;ZNF385A;SMARCA1;RARG;TRNP1
5536,GO:0016538,0.93643269780887,0.247870105811897,1,28,cyclin-dependent protein serine/threonine kinase regulator activity,MF,CDKN1C
12928,GO:0051321,0.936457302373587,0.111649986386159,10,153,meiotic cell cycle,BP,ERCC1;TUBG2;INSR;DMC1;AGO4;TDRKH;SUN1;SPIRE2;P3H4;EREG
16062,GO:0090068,0.936903953740489,0.101349383308909,15,218,positive regulation of cell cycle process,BP,PCBP4;IGF2;RAB11FIP4;LRP5;HYAL1;PKD2;TFDP2;INSR;MTA3;PIDD1;PRKACA;HMGA2;FGFR1;ZNF385A;EREG
3219,GO:0006879,0.937681048881022,0.182337123171428,2,46,cellular iron ion homeostasis,BP,CYBRD1;SLC22A17
7309,GO:0031330,0.937918598068116,0.104803037392857,12,181,negative regulation of cellular catabolic process,BP,CST3;TIMP2;TBC1D14;ATP2B4;FURIN;ZFP36;DAP;PPARA;SUFU;TIMP1;AKT1;PINK1
12986,GO:0051445,0.938029267706775,0.243727689500362,1,27,regulation of meiotic cell cycle,BP,INSR
12792,GO:0051123,0.93829420317176,0.242640915225293,1,28,RNA polymerase II transcriptional preinitiation complex assembly,BP,THRA
18874,GO:1904589,0.93855681663604,0.180473111973209,2,45,regulation of protein import,BP,TMEM173;GAS6
1319,GO:0003170,0.938678431040866,0.241892181878889,1,27,heart valve development,BP,ZFPM1
14764,GO:0070498,0.93883744614818,0.130281851627191,5,93,interleukin-1-mediated signaling pathway,BP,EGR1;MAPK3;RPS6KA5;BTRC;TOLLIP
5791,GO:0017053,0.938963855464804,0.139807766806218,4,74,transcriptional repressor complex,CC,APPL2;BAHCC1;ZFPM1;SALL2
17483,GO:1900739,0.939006129593904,0.24062529199071,1,28,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TFDP2
17484,GO:1900740,0.939006129593904,0.24062529199071,1,28,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TFDP2
482,GO:0001533,0.939370755934695,0.178000739901137,2,50,cornified envelope,CC,PPL;LCE1E
8466,GO:0033628,0.939529471085326,0.239137945061592,1,28,regulation of cell adhesion mediated by integrin,BP,ADA
16833,GO:0098791,0.940197445013258,0.0787202336909907,53,660,Golgi subcompartment,CC,MARCH9;ARAP1;POSTN;ST6GALNAC2;EGFR;B3GAT3;RHBDF1;DOPEY2;ABCA7;MALL;ABCG1;B4GALNT4;BSG;EDEM1;VAMP2;GALNT12;TRAPPC9;B4GAT1;ATP7B;SNX9;MYO18A;ENTPD6;GPSM1;ST3GAL3;SLC16A13;FURIN;PITPNM1;PI4K2A;STX10;XYLT2;TNFRSF1A;IFNGR2;CHST6;LLGL1;RFNG;CLTCL1;CTSZ;MAN1B1;ASAP2;GAL3ST4;SLC9A7;SORL1;TMBIM4;SPPL2B;IL17RD;PKD1;GOLGA2P5;PCSK1N;SLC2A1;LITAF;NDST2;AGPAT3;SULF2
2862,GO:0006362,0.940456058049626,0.236181162755652,1,29,transcription elongation from RNA polymerase I promoter,BP,ERCC6
9927,GO:0042304,0.940622380749813,0.23601622989311,1,28,regulation of fatty acid biosynthetic process,BP,MLXIPL
3075,GO:0006656,0.940667208122188,0.235887731907486,1,28,phosphatidylcholine biosynthetic process,BP,LCAT
11068,GO:0045087,0.940977820902361,0.0800848319101936,42,548,innate immune response,BP,TNIP1;PTPRS;CYP27B1;GSN;NR1D1;MST1R;SERPING1;EGR1;PTK6;CTSB;RNF135;ADARB1;TMEM173;ISG20;SRMS;ADAM15;MEFV;TRIM4;PRKACA;F12;RPS6KA5;IFNGR2;FAM3A;SDHAF4;BTRC;TKFC;PTAFR;MUC19;ADAMTS13;MAPKAPK3;C5;TOLLIP;APOBEC3C;LYST;NLRX1;PYCARD;APOBEC3F;JAK3;EREG;RPL13A;MIF;STXBP2
4212,GO:0009395,0.941402031336167,0.233776177291269,1,28,phospholipid catabolic process,BP,LDLR
18657,GO:1904030,0.941452259838078,0.233631484781368,1,28,negative regulation of cyclin-dependent protein kinase activity,BP,CDKN1C
4304,GO:0009791,0.941517490581408,0.134886643214309,4,75,post-embryonic development,BP,ERCC1;VEGFA;ACVR2B;PPP1R13L
5552,GO:0016574,0.942074761251731,0.172363274692807,2,45,histone ubiquitination,BP,DDB2;RAG1
12623,GO:0050853,0.942259632849293,0.231299348386595,1,28,B cell receptor signaling pathway,BP,VAV3
4548,GO:0010639,0.942314839500841,0.0883147862809492,20,280,negative regulation of organelle organization,BP,ESPN;ERCC1;GSN;EVI5L;ARAP1;TOM1L2;ARPIN;CORO1B;VAT1;TMOD2;PLEKHH2;BNIP3;SHANK3;SPTB;DMTN;CAPG;TWF2;JARID2;AKT1;PINK1
4345,GO:0009948,0.942626014237789,0.230237065925591,1,28,anterior/posterior axis specification,BP,WNT3
17746,GO:1901800,0.942663791649687,0.123480692855016,5,90,positive regulation of proteasomal protein catabolic process,BP,EDEM1;CSNK1E;DVL1;RAD23A;AKT1
9049,GO:0035303,0.942789475121302,0.101760136653627,10,155,regulation of dephosphorylation,BP,B3GAT3;PPP1R14A;PPP2R3B;PPP1R35;PIN1;DLG3;ELFN2;PINK1;PCIF1;SFI1
2608,GO:0005923,0.943069947395767,0.122780003443265,5,89,bicellular tight junction,CC,ANK3;MICALL2;NPHP4;PRKCZ;DLG3
7297,GO:0031312,0.943284103056876,0.228322714190646,1,28,extrinsic component of organelle membrane,CC,ULK1
12612,GO:0050830,0.943310143325363,0.226901705805382,1,33,defense response to Gram-positive bacterium,BP,ACP5
6911,GO:0030515,0.943471594652241,0.227182722800506,1,30,snoRNA binding,MF,ISG20
14475,GO:0061980,0.943634688398505,0.22729954685286,1,28,regulatory RNA binding,MF,AGO4
4854,GO:0014706,0.943867929662588,0.0912296488443307,15,218,striated muscle tissue development,BP,FOS;MEF2D;OBSL1;EGR1;ZFPM1;VEGFA;RXRA;GPC1;FGFR1;PIN1;PROX1;PPP1R13L;JARID2;ERBB3;TAZ
3022,GO:0006576,0.944150705613736,0.225483254178105,1,29,cellular biogenic amine metabolic process,BP,SMOX
10048,GO:0042558,0.944268808453492,0.225137071144637,1,29,pteridine-containing compound metabolic process,BP,MTHFR
3958,GO:0008757,0.944372258291166,0.105076950821359,8,131,S-adenosylmethionine-dependent methyltransferase activity,MF,GAMT;ASH2L;DNMT3A;RRNAD1;COMT;KMT5C;PCMTD2;AS3MT
5721,GO:0016877,0.944536388988604,0.224657217023366,1,28,ligase activity, forming carbon-sulfur bonds,MF,ACSF2
6798,GO:0030261,0.9446851012795,0.224219931637326,1,28,chromosome condensation,BP,HMGA2
5985,GO:0018995,0.944805307601047,0.142001272886847,3,62,host,CC,MVB12B;PI4K2A;MVB12A
10628,GO:0043657,0.944805307601047,0.142001272886847,3,62,host cell,CC,MVB12B;PI4K2A;MVB12A
10751,GO:0044215,0.944805307601047,0.142001272886847,3,62,other organism,CC,MVB12B;PI4K2A;MVB12A
10752,GO:0044216,0.944805307601047,0.142001272886847,3,62,other organism cell,CC,MVB12B;PI4K2A;MVB12A
10753,GO:0044217,0.944805307601047,0.142001272886847,3,62,other organism part,CC,MVB12B;PI4K2A;MVB12A
3060,GO:0006633,0.944987210250729,0.11916455463886,5,92,fatty acid biosynthetic process,BP,ALOX15B;ACOT7;MLXIPL;MLYCD;MIF
872,GO:0002224,0.945004280850037,0.119169436180698,5,91,toll-like receptor signaling pathway,BP,TNIP1;PTPRS;NR1D1;CTSB;MAPKAPK3
68,GO:0000139,0.945177429669805,0.0738501919249907,46,583,Golgi membrane,CC,MARCH9;ARAP1;ST6GALNAC2;EGFR;B3GAT3;RHBDF1;DOPEY2;ABCA7;MALL;ABCG1;B4GALNT4;BSG;EDEM1;GALNT12;TRAPPC9;B4GAT1;ATP7B;MYO18A;ENTPD6;GPSM1;ST3GAL3;SLC16A13;FURIN;PITPNM1;STX10;XYLT2;TNFRSF1A;IFNGR2;CHST6;LLGL1;RFNG;CTSZ;MAN1B1;ASAP2;GAL3ST4;SLC9A7;SORL1;TMBIM4;SPPL2B;IL17RD;PKD1;GOLGA2P5;SLC2A1;LITAF;NDST2;AGPAT3
16112,GO:0090150,0.945295684701637,0.086712843382539,17,266,establishment of protein localization to membrane,BP,CEMIP;EGFR;BBS2;ANK3;ERBB2;VAMP2;TFDP2;PRNP;REEP2;ZDHHC1;AMN;DMTN;BBS1;ZDHHC24;SYNE3;RILPL1;RPL13A
5386,GO:0016233,0.945372439443277,0.163948856980605,2,51,telomere capping,BP,ERCC1;MAPK3
3589,GO:0008023,0.945479781910899,0.164253477950783,2,46,transcription elongation factor complex,CC,TCEA2;ERCC6
11315,GO:0045661,0.945606621398605,0.221196862531676,1,29,regulation of myoblast differentiation,BP,ZFP36L1
15524,GO:0071985,0.945929348677294,0.220241112518061,1,29,multivesicular body sorting pathway,BP,LYST
686,GO:0001906,0.946547104353252,0.138075956451544,3,66,cell killing,BP,LYST;CTSH;STXBP2
10204,GO:0042887,0.94665175994034,0.217812968605183,1,30,amide transmembrane transporter activity,MF,AQP3
12908,GO:0051291,0.946658121048291,0.115835399682908,5,100,protein heterooligomerization,BP,COL6A1;ITPR3;INSR;PRKCZ;TMEM120A
3525,GO:0007519,0.946701577695645,0.116048643914087,5,91,skeletal muscle tissue development,BP,FOS;MEF2D;EGR1;GPC1;TAZ
18876,GO:1904591,0.947211481836415,0.21642362654981,1,29,positive regulation of protein import,BP,TMEM173
283,GO:0000786,0.947315442631892,0.135585163259971,3,84,nucleosome,CC,H1F0;H2AFJ;H1FX
4740,GO:0010921,0.947498993589598,0.0999055682644207,8,131,regulation of phosphatase activity,BP,B3GAT3;PPP1R14A;PPP2R3B;PPP1R35;DLG3;ELFN2;PCIF1;SFI1
367,GO:0000989,0.947544599853854,0.072215113198377,40,519,transcription factor activity, transcription factor binding,MF,FOS;CITED4;NR1D1;NFATC4;MXD4;PKN1;ZMYND8;SOX12;MXI1;THRA;MAML3;TFDP2;ID1;MNT;WWTR1;SCAND1;DYRK1B;HSF4;NAB2;CALCOCO1;MTA1;PHF21A;BHLHE40;HMGA2;ELK3;PPARA;SUFU;RXRA;USP21;RFXANK;SMARCD2;PROX1;WBP2;PPP1R13L;RXRB;GRHPR;TRERF1;RARG;ING4;PBXIP1
12621,GO:0050851,0.947799169791017,0.0937542464216661,10,162,antigen receptor-mediated signaling pathway,BP,RBCK1;PIK3R2;PRNP;ADA;PAG1;BTRC;VAV3;INPP5D;ICOSLG;KCNN4
2971,GO:0006521,0.947828270293315,0.158121808485378,2,51,regulation of cellular amino acid metabolic process,BP,ATP2B4;COMT
12767,GO:0051087,0.94791563952021,0.122300107191748,4,79,chaperone binding,MF,PRNP;DNAJB5;HES1;BIN1
19016,GO:1904888,0.947961096203341,0.158351619692655,2,46,cranial skeletal system development,BP,IFT140;SH3PXD2B
4524,GO:0010605,0.94807277828833,0.0616507943213255,172,2019,negative regulation of macromolecule metabolic process,BP,TNIP1;DUSP6;APOE;CTNNBIP1;ERCC1;WWC3;CST3;TCFL5;XDH;PRDX5;PCBP4;ZFP36L1;GRB7;NR1D1;EPHB2;IGF2;NFATC4;EGFR;TIMP2;DUSP5;PPP1R14A;MXD4;SERPING1;MDFI;EGR1;PKN1;SHC1;PTK6;ABCA7;DEAF1;BAHCC1;BBS2;CXXC5;ZMYND8;MXI1;PLAT;PIK3R2;PEG3;HDAC5;THRA;ZP3;CRTAP;LRP5;TENM2;ZFPM1;FBLN1;SCMH1;H2AFJ;SPRY4;CDKN1C;SALL2;SERPINE2;FOXQ1;UNK;ATP2B4;TFDP2;PDCD4;ZC3H6;ID1;EPHA1;ADARB1;ZNF692;PPP1R35;DNMT3A;PRNP;PAPLN;HES2;SPRY2;HINT2;MNT;ECM1;STAT6;DLG4;MTA3;WWTR1;DNAJB5;BCL6;FZD8;VEGFA;CEBPB;ACVR2B;HSF4;NAB2;TNFRSF6B;DVL1;MTA1;L3MBTL1;MBD1;HES1;PC;FURIN;MLXIPL;PHF21A;SLIT3;PCSK9;ZFP36;LRRK1;MAGEF1;RPS6KA5;HBEGF;MAP2K2;DAP;DMTN;MAPK8IP1;TCF25;LDLR;TRPV4;BHLHE40;EIF4EBP3;RAG1;DUSP7;HMGA2;ELK3;DGKQ;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;SUFU;PAN2;RXRA;PRKCZ;INPP5D;AGO4;FGFR1;CTSZ;PIN1;C5;IRF2BPL;PROX1;GTPBP1;BIN1;SERPINB6;PPP1R13L;JARID2;SESN2;CSTB;PNRC1;RTN4R;ELFN2;TIMP1;PPM1F;SORL1;STK39;ACVR1B;CCDC85B;AKT1;TP53INP1;NDRG2;SIX5;GPD1L;TDRKH;PINK1;SNTA1;RGS14;CBLC;PYCARD;PCSK1N;ERN1;RANBP9;SIRT3;JAK3;MZF1;NEIL1;RARG;ING4;PBXIP1;EREG;RPL13A;MIF
4592,GO:0010717,0.948087401066905,0.135084912879504,3,62,regulation of epithelial to mesenchymal transition,BP,FUZ;WWTR1;VASN
10422,GO:0043296,0.948143702335732,0.107243265794631,6,104,apical junction complex,CC,ANK3;MICALL2;NPHP4;FBF1;PRKCZ;DLG3
10523,GO:0043489,0.948202452172825,0.213450266854935,1,29,RNA stabilization,BP,ZFP36
15030,GO:0071011,0.948325090602094,0.212542263578366,1,31,precatalytic spliceosome,CC,MAPKBP1
7896,GO:0032481,0.948427841891142,0.134292819723727,3,63,positive regulation of type I interferon production,BP,RNF135;TMEM173;STAT6
17870,GO:1902186,0.948626632640756,0.21217135003884,1,29,regulation of viral release from host cell,BP,PC
15172,GO:0071346,0.948957720992759,0.105715373073491,6,107,cellular response to interferon-gamma,BP,GSN;IFNGR2;PTAFR;ADAMTS13;RPL13A;STXBP2
9681,GO:0038095,0.949010722283092,0.105569575010283,6,109,Fc-epsilon receptor signaling pathway,BP,FOS;SHC1;PIK3R2;MAPK3;BTRC;VAV3
6745,GO:0030177,0.949086006238708,0.0971727803091529,8,136,positive regulation of Wnt signaling pathway,BP,CSNK1E;WNT7A;DVL1;LRRK1;PIN1;WNT2B;WNT3;SULF2
653,GO:0001844,0.949101048301516,0.210459214277683,1,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TFDP2
6436,GO:0021762,0.949297464383681,0.209864116060804,1,30,substantia nigra development,BP,NDRG2
19713,GO:2000113,0.949307340824355,0.0633809582083674,92,1118,negative regulation of cellular macromolecule biosynthetic process,BP,CTNNBIP1;WWC3;TCFL5;PRDX5;ZFP36L1;GRB7;NR1D1;IGF2;NFATC4;EGFR;MXD4;MDFI;EGR1;SHC1;ABCA7;DEAF1;BAHCC1;CXXC5;ZMYND8;MXI1;PEG3;HDAC5;THRA;ZP3;TENM2;ZFPM1;SCMH1;H2AFJ;CDKN1C;SALL2;FOXQ1;UNK;TFDP2;PDCD4;ZC3H6;ID1;ZNF692;DNMT3A;HES2;MNT;STAT6;MTA3;WWTR1;DNAJB5;BCL6;FZD8;VEGFA;CEBPB;ACVR2B;HSF4;NAB2;L3MBTL1;MBD1;HES1;MLXIPL;PHF21A;ZFP36;RPS6KA5;HBEGF;MAP2K2;DAP;TCF25;TRPV4;BHLHE40;EIF4EBP3;HMGA2;ELK3;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;SUFU;RXRA;AGO4;FGFR1;IRF2BPL;PROX1;PPP1R13L;JARID2;SESN2;PPM1F;CCDC85B;SIX5;JAK3;MZF1;RARG;ING4;PBXIP1;EREG;RPL13A
17560,GO:1901222,0.949437821163329,0.154685098275112,2,47,regulation of NIK/NF-kappaB signaling,BP,EGFR;PDCD4
7471,GO:0031647,0.949774205512514,0.0837262369479592,14,212,regulation of protein stability,BP,TSPAN1;GSN;CRTAP;VPS11;ID1;PRNP;CD81;DVL1;BTRC;RAD23A;PIN1;PINK1;CTSH;PYCARD
14573,GO:0070160,0.949913347620269,0.110091034887235,5,91,occluding junction,CC,ANK3;MICALL2;NPHP4;PRKCZ;DLG3
12280,GO:0048641,0.949944822478502,0.208172871988968,1,29,regulation of skeletal muscle tissue development,BP,GPC1
2449,GO:0005667,0.950106962004364,0.0789506533750441,18,260,transcription factor complex,CC,FOS;ERCC1;NR1D1;EPAS1;NFATC4;DEAF1;MXI1;THRA;ZFPM1;TFDP2;WWTR1;CEBPB;MLXIPL;PPARA;RXRA;MEF2B;TRERF1;RARG
7411,GO:0031519,0.950139436631364,0.152989888874466,2,47,PcG protein complex,CC,PHC2;JARID2
2846,GO:0006342,0.950242934687223,0.109007755802506,5,107,chromatin silencing,BP,BAHCC1;HDAC5;H2AFJ;DNMT3A;MBD1
5416,GO:0016279,0.950709047594079,0.151608901006044,2,47,protein-lysine N-methyltransferase activity,MF,ASH2L;KMT5C
16192,GO:0090263,0.950881035175125,0.102208059886082,6,110,positive regulation of canonical Wnt signaling pathway,BP,WNT7A;DVL1;LRRK1;PIN1;WNT2B;SULF2
4663,GO:0010821,0.951088730597994,0.0846666952444848,12,188,regulation of mitochondrion organization,BP,MICALL2;VAT1;VPS11;TFDP2;BNIP3;HES1;OSCP1;AKT1;PINK1;PYCARD;FAM162A;UBL5
20237,GO:2001234,0.951118413106268,0.0884581100418871,10,162,negative regulation of apoptotic signaling pathway,BP,ITGA6;MNT;STRADB;MAPK8IP1;TMEM161A;AKT1;TRAP1;ZNF385A;PINK1;MIF
6964,GO:0030641,0.951309513967458,0.128063733863431,3,64,regulation of cellular pH,BP,MAPK3;TMEM175;SLC9A7
2857,GO:0006356,0.951544628906165,0.202996952386105,1,30,regulation of transcription by RNA polymerase I,BP,ERBB2
3929,GO:0008625,0.951545158394731,0.127556183014146,3,64,extrinsic apoptotic signaling pathway via death domain receptors,BP,PIDD1;TNFRSF1A;MADD
18097,GO:1902808,0.951564865242737,0.202934612366974,1,30,positive regulation of cell cycle G1/S phase transition,BP,HYAL1
11387,GO:0045814,0.951587767819743,0.100702195919396,6,121,negative regulation of gene expression, epigenetic,BP,BAHCC1;HDAC5;H2AFJ;DNMT3A;MBD1;JARID2
7966,GO:0032592,0.951756924233938,0.127037103236051,3,65,integral component of mitochondrial membrane,CC,BNIP3;SMDT1;PINK1
5672,GO:0016796,0.95180880785721,0.148820159992969,2,48,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,ISG20;PAN2
1973,GO:0004693,0.951988000500819,0.201629022159326,1,30,cyclin-dependent protein serine/threonine kinase activity,MF,CDK18
1473,GO:0003743,0.952097242812775,0.148009967748471,2,49,translation initiation factor activity,MF,EIF4G3;EIF4E3
7133,GO:0030990,0.952202971882971,0.200964196283417,1,30,intraciliary transport particle,CC,IFT140
20252,GO:2001252,0.952375017242941,0.0888589667551964,9,146,positive regulation of chromosome organization,BP,ERCC1;NOS1;BCL6;VEGFA;MAPK3;RPS6KA5;WBP2;JARID2;PINK1
12866,GO:0051233,0.952710956044332,0.199389065847704,1,30,spindle midzone,CC,CCDC69
8274,GO:0033108,0.952776232690532,0.11230233053879,4,89,mitochondrial respiratory chain complex assembly,BP,NDUFS8;SDHAF4;NDUFV3;TAZ
2825,GO:0006301,0.952967298834307,0.145877690495622,2,49,postreplication repair,BP,POLD4;PRIMPOL
1149,GO:0002757,0.953385765155539,0.0707657223470433,23,325,immune response-activating signal transduction,BP,TNIP1;PTPRS;NR1D1;RBCK1;CTSB;PIK3R2;PRNP;MAPK3;WIPF1;ADA;PAG1;PRKACA;CYFIP2;RPS6KA5;BTRC;TKFC;VAV3;MUC19;INPP5D;ICOSLG;MAPKAPK3;NLRX1;KCNN4
7168,GO:0031062,0.953636406804691,0.196504393405917,1,30,positive regulation of histone methylation,BP,JARID2
9820,GO:0042073,0.953785426034454,0.143863162039228,2,49,intraciliary transport,BP,IFT140;WDR60
8733,GO:0034399,0.953898617668546,0.0925458453557335,7,120,nuclear periphery,CC,DNMT3A;CEBPB;MBD1;HLCS;DGKQ;PRKCZ;RGS12
16692,GO:0097718,0.954007893201484,0.195340901877367,1,30,disordered domain specific binding,MF,AP2A2
2866,GO:0006367,0.954072956371688,0.0860034039507472,9,150,transcription initiation from RNA polymerase II promoter,BP,CTNNBIP1;NR1D1;THRA;MAML3;WWTR1;PPARA;RXRA;RXRB;RARG
6573,GO:0022411,0.954215587564843,0.0648328077386438,35,476,cellular component disassembly,BP,HTRA1;CST3;GSN;LRP1;TIMP2;H1F0;MMP1;NEK9;LRP5;BSG;TMOD2;SPATA18;INSR;SH3PXD2B;PLEKHH2;CHMP1B;BNIP3;ADAM15;ENDOG;CAPNS2;DVL1;FYCO1;WIPI2;FURIN;FGFR4;SPTB;DMTN;TRPV4;ATG2A;CAPG;TWF2;SMARCD2;CAPN2;TIMP1;PINK1
16535,GO:0097345,0.954220530643481,0.142787962421834,2,49,mitochondrial outer membrane permeabilization,BP,TFDP2;BNIP3
366,GO:0000988,0.95458472139566,0.0630918862137944,40,524,transcription factor activity, protein binding,MF,FOS;CITED4;NR1D1;NFATC4;MXD4;PKN1;ZMYND8;SOX12;MXI1;THRA;MAML3;TFDP2;ID1;MNT;WWTR1;SCAND1;DYRK1B;HSF4;NAB2;CALCOCO1;MTA1;PHF21A;BHLHE40;HMGA2;ELK3;PPARA;SUFU;RXRA;USP21;RFXANK;SMARCD2;PROX1;WBP2;PPP1R13L;RXRB;GRHPR;TRERF1;RARG;ING4;PBXIP1
5415,GO:0016278,0.954783467421924,0.141495560260993,2,48,lysine N-methyltransferase activity,MF,ASH2L;KMT5C
16741,GO:0098573,0.955312775861627,0.119244768570456,3,66,intrinsic component of mitochondrial membrane,CC,BNIP3;SMDT1;PINK1
14517,GO:0070059,0.95563617997398,0.139271036558382,2,49,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,CEBPB;ERN1
870,GO:0002221,0.9563989145687,0.0881231505474413,7,122,pattern recognition receptor signaling pathway,BP,TNIP1;PTPRS;NR1D1;CTSB;TKFC;MAPKAPK3;NLRX1
7962,GO:0032588,0.956654049625842,0.116350442315756,3,65,trans-Golgi network membrane,CC,ATP7B;STX10;LLGL1
16594,GO:0097472,0.956734874503237,0.186454089886054,1,31,cyclin-dependent protein kinase activity,MF,CDK18
12207,GO:0048487,0.957136011762151,0.184939453698635,1,32,beta-tubulin binding,MF,TRPV4
6744,GO:0030176,0.95771215726578,0.0857869973701162,7,123,integral component of endoplasmic reticulum membrane,CC,PKD2;EDEM1;SLC37A2;TM7SF2;RTN2;SPPL2B;ERN1
4542,GO:0010633,0.957841569959018,0.133733496199909,2,49,negative regulation of epithelial cell migration,BP,APOE;HDAC5
13191,GO:0051879,0.957929375759848,0.18261378275979,1,31,Hsp90 protein binding,MF,ERN1
4432,GO:0010332,0.958146122784574,0.132867998106565,2,50,response to gamma radiation,BP,EGR1;ERCC6
4442,GO:0010389,0.958167356005684,0.0751494386992614,11,180,regulation of G2/M transition of mitotic cell cycle,BP,FHL1;BRSK1;NINL;CSNK1E;CEP250;MTA3;PRKACA;HMGA2;NDE1;ZFYVE19;SFI1
18190,GO:1903008,0.958171804986387,0.0942829277924428,5,96,organelle disassembly,BP,SPATA18;BNIP3;WIPI2;ATG2A;PINK1
12850,GO:0051204,0.95818460421694,0.181561512723531,1,32,protein insertion into mitochondrial membrane,BP,TFDP2
8298,GO:0033146,0.958453428270763,0.180917527570795,1,31,regulation of intracellular estrogen receptor signaling pathway,BP,WBP2
20078,GO:2000779,0.958463142464616,0.132159458429696,2,49,regulation of double-strand break repair,BP,MAGEF1;HMGA2
12881,GO:0051253,0.958515839551193,0.0530836444202977,80,993,negative regulation of RNA metabolic process,BP,CTNNBIP1;WWC3;TCFL5;PRDX5;NR1D1;IGF2;NFATC4;MXD4;MDFI;EGR1;SHC1;DEAF1;BAHCC1;CXXC5;ZMYND8;MXI1;PEG3;HDAC5;THRA;ZP3;TENM2;ZFPM1;SCMH1;H2AFJ;CDKN1C;SALL2;FOXQ1;TFDP2;PDCD4;ZC3H6;ID1;ZNF692;DNMT3A;HES2;MNT;STAT6;MTA3;WWTR1;DNAJB5;BCL6;FZD8;VEGFA;CEBPB;ACVR2B;HSF4;NAB2;MTA1;L3MBTL1;MBD1;HES1;MLXIPL;PHF21A;ZFP36;RPS6KA5;DAP;TCF25;TRPV4;BHLHE40;HMGA2;ELK3;GAS6;BTRC;POU6F1;ZNF217;PPARA;SUFU;RXRA;FGFR1;IRF2BPL;PROX1;PPP1R13L;JARID2;PPM1F;CCDC85B;SIX5;MZF1;RARG;ING4;PBXIP1;EREG
12918,GO:0051303,0.958529897092311,0.112187089787635,3,65,establishment of chromosome localization,BP,CHMP1B;NDE1;SUN1
2486,GO:0005740,0.958781815429218,0.0565951412109163,45,617,mitochondrial envelope,CC,IDH2;CYP27B1;PRODH;CRAT;FAM210B;CPT2;NME4;HADH;ULK1;BPHL;DHRS1;GRAMD4;TST;CPT1C;VAT1;DNM1;SNN;ARMCX2;SPATA18;NDUFS8;TMEM173;ANKZF1;BNIP3;ARL2;CARD19;CKMT1A;SLC25A37;MAPK8IP1;HK1;SDHAF4;HMGCL;SDHA;MDH2;SLC25A27;NDUFA4L2;SNPH;SMDT1;SLC25A29;TRAP1;NLRX1;UQCR11;PINK1;NDUFV3;GCAT;TAZ
7705,GO:0032206,0.958793224229259,0.131321135862758,2,49,positive regulation of telomere maintenance,BP,ERCC1;MAPK3
13868,GO:0060538,0.958801388262187,0.0930968037180859,5,95,skeletal muscle organ development,BP,FOS;MEF2D;EGR1;GPC1;TAZ
3662,GO:0008168,0.958932696933272,0.0739577033707012,11,176,methyltransferase activity,MF,GAMT;ASH2L;DNMT3A;COMTD1;FAM86C2P;NSUN7;RRNAD1;COMT;KMT5C;PCMTD2;AS3MT
3306,GO:0007017,0.958934283058527,0.0561009490598421,47,606,microtubule-based process,BP,OBSL1;BBS2;DNAH1;TUBG2;MARK4;ERBB2;BRSK1;PKD2;IFT140;CUL9;KIF13B;NINL;CCDC69;SPRY2;CEP250;MYO18A;CHMP1B;HOOK2;ARL2;AP2A2;DVL1;FYCO1;CUL7;FBXW5;MYH3;TRPV4;CROCC;LLGL1;WDR60;PRKCZ;CEP68;NDE1;WRAP73;SUN1;GAS8;PKD1;RGS14;GOLGA2P5;MAFIP;SPIRE2;DNAAF5;RANBP9;WDR63;KIFC2;APBA1;TTLL11;KIF26B
14270,GO:0061418,0.959104369441653,0.110642129173288,3,70,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,EPAS1;EGR1;VEGFA
8682,GO:0034332,0.959432681807512,0.0919042081311128,5,94,adherens junction organization,BP,LAMA5;RHOD;VEGFA;DMTN;PPM1F
3889,GO:0008536,0.960208474763983,0.17496144873148,1,32,Ran GTPase binding,MF,RANBP9
7432,GO:0031577,0.960560799100245,0.173801346320638,1,32,spindle checkpoint,BP,NDRG1
16260,GO:0090382,0.960702065120355,0.173127071818865,1,33,phagosome maturation,BP,TMEM175
4331,GO:0009892,0.96075803246788,0.0468190371011316,184,2166,negative regulation of metabolic process,BP,TNIP1;DUSP6;APOE;CTNNBIP1;ERCC1;WWC3;CST3;TCFL5;CYP27B1;XDH;PRDX5;PCBP4;ZFP36L1;GRB7;NR1D1;EPHB2;IGF2;NFATC4;EGFR;TIMP2;DUSP5;PPP1R14A;MXD4;SERPING1;MDFI;EGR1;PKN1;SHC1;PTK6;ABCA7;DEAF1;BAHCC1;BBS2;CXXC5;ZMYND8;TBC1D14;MXI1;PLAT;PIK3R2;PEG3;HDAC5;THRA;ZP3;CRTAP;LRP5;TENM2;ZFPM1;FBLN1;SCMH1;H2AFJ;SPRY4;CDKN1C;SALL2;SERPINE2;FOXQ1;LTB4R2;UNK;ATP2B4;TFDP2;ACP5;PDCD4;ZC3H6;ID1;EPHA1;ADARB1;ZNF692;PPP1R35;DNMT3A;PRNP;PAPLN;HES2;SPRY2;HINT2;MNT;ECM1;STAT6;DLG4;MTA3;WWTR1;DNAJB5;BCL6;BNIP3;FZD8;VEGFA;CEBPB;ACVR2B;HSF4;NAB2;TNFRSF6B;DVL1;MTA1;L3MBTL1;MBD1;HES1;PC;FURIN;MLXIPL;PHF21A;SLIT3;PCSK9;ZFP36;LRRK1;MAGEF1;RPS6KA5;HBEGF;MAP2K2;DAP;DMTN;MAPK8IP1;TCF25;LDLR;TRPV4;BHLHE40;EIF4EBP3;RAG1;DUSP7;HMGA2;ELK3;DGKQ;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;COMT;SUFU;PAN2;RXRA;BCR;PRKCZ;INPP5D;AGO4;FGFR1;CTSZ;PIN1;C5;IRF2BPL;PROX1;GTPBP1;DLG3;BIN1;SERPINB6;PPP1R13L;GRB10;JARID2;SESN2;CSTB;PNRC1;RTN4R;ELFN2;TIMP1;PPM1F;SORL1;STK39;ACVR1B;CCDC85B;AKT1;TRAP1;TP53INP1;NDRG2;SIX5;GPD1L;TDRKH;PINK1;SNTA1;RGS14;PCIF1;CBLC;PYCARD;PCSK1N;ERN1;RANBP9;SIRT3;JAK3;MZF1;NEIL1;RARG;ING4;PBXIP1;EREG;SFI1;RPL13A;MIF
9813,GO:0042054,0.961130088525055,0.125244571979198,2,50,histone methyltransferase activity,MF,ASH2L;KMT5C
9068,GO:0035337,0.961200431431373,0.171686561958013,1,32,fatty-acyl-CoA metabolic process,BP,ACOT7
6346,GO:0021536,0.961222284641867,0.171614110728556,1,32,diencephalon development,BP,HES1
9679,GO:0038093,0.961273160894116,0.0739199903158854,9,154,Fc receptor signaling pathway,BP,FOS;SHC1;PIK3R2;FCGRT;MAPK3;WIPF1;CYFIP2;BTRC;VAV3
15200,GO:0071383,0.961311499069798,0.0686125007290829,12,189,cellular response to steroid hormone stimulus,BP,ZFP36L1;NR1D1;EGFR;THRA;CALCOCO1;ZFP36;PPARA;RXRA;PCK2;WBP2;RXRB;RARG
7691,GO:0032182,0.961353275968251,0.0950926688683646,4,82,ubiquitin-like protein binding,MF,RBCK1;MARK4;MVB12A;TOLLIP
10891,GO:0044455,0.961437282543428,0.0735134948444886,9,166,mitochondrial membrane part,CC,NDUFS8;ANKZF1;BNIP3;SDHAF4;SDHA;NDUFA4L2;SMDT1;PINK1;NDUFV3
1146,GO:0002753,0.961456947240996,0.124400724402873,2,50,cytoplasmic pattern recognition receptor signaling pathway,BP,TKFC;NLRX1
17849,GO:1902110,0.961465053429723,0.124292078480037,2,51,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,TFDP2;BNIP3
4329,GO:0009890,0.961478442915074,0.0483438869248755,100,1221,negative regulation of biosynthetic process,BP,APOE;CTNNBIP1;WWC3;TCFL5;CYP27B1;PRDX5;ZFP36L1;GRB7;NR1D1;IGF2;NFATC4;EGFR;MXD4;MDFI;EGR1;SHC1;ABCA7;DEAF1;BAHCC1;CXXC5;ZMYND8;MXI1;PEG3;HDAC5;THRA;ZP3;TENM2;ZFPM1;SCMH1;H2AFJ;CDKN1C;SALL2;FOXQ1;LTB4R2;UNK;ATP2B4;TFDP2;ACP5;PDCD4;ZC3H6;ID1;ZNF692;DNMT3A;HES2;MNT;STAT6;MTA3;WWTR1;DNAJB5;BCL6;FZD8;VEGFA;CEBPB;ACVR2B;HSF4;NAB2;MTA1;L3MBTL1;MBD1;HES1;MLXIPL;PHF21A;ZFP36;RPS6KA5;HBEGF;MAP2K2;DAP;TCF25;TRPV4;BHLHE40;EIF4EBP3;HMGA2;ELK3;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;SUFU;RXRA;INPP5D;AGO4;FGFR1;IRF2BPL;PROX1;PPP1R13L;JARID2;SESN2;PPM1F;CCDC85B;TRAP1;SIX5;JAK3;MZF1;RARG;ING4;PBXIP1;EREG;RPL13A
12410,GO:0050000,0.961616204063968,0.105192713140029,3,66,chromosome localization,BP,CHMP1B;NDE1;SUN1
7001,GO:0030705,0.961913454006452,0.0728592790502821,9,152,cytoskeleton-dependent intracellular transport,BP,IFT140;KIF13B;HOOK2;FYCO1;WDR60;PRKCZ;NDE1;SUN1;APBA1
17948,GO:1902373,0.962122392729688,0.168618342576334,1,32,negative regulation of mRNA catabolic process,BP,ZFP36
12772,GO:0051092,0.962158094052755,0.0815551304093005,6,112,positive regulation of NF-kappaB transcription factor activity,BP,RBCK1;TRAPPC9;PIDD1;RPS6KA5;PRKCZ;PYCARD
11014,GO:0045005,0.962263018964932,0.168148242812151,1,32,DNA-dependent DNA replication maintenance of fidelity,BP,PRIMPOL
8660,GO:0034248,0.962670958973094,0.0549345609955451,30,424,regulation of cellular amide metabolic process,BP,APOE;ZFP36L1;GRB7;EGFR;ABCA7;ERBB2;UNK;PRNP;MKNK2;MAPK3;ZFP36;CYFIP2;MAP2K2;TNFRSF1A;EIF4EBP3;MEX3A;PTAFR;RXRA;LSM14B;AGO4;BIN1;SESN2;SORL1;AKT1;TRAP1;ZNF385A;PINK1;EIF4G3;EIF4E3;RPL13A
11407,GO:0045843,0.96281115854707,0.166310466499729,1,32,negative regulation of striated muscle tissue development,BP,JARID2
17764,GO:1901862,0.96281115854707,0.166310466499729,1,32,negative regulation of muscle tissue development,BP,JARID2
3308,GO:0007019,0.962862641116819,0.166137413702646,1,32,microtubule depolymerization,BP,TRPV4
12317,GO:0048701,0.962866212455952,0.16612540620558,1,32,embryonic cranial skeleton morphogenesis,BP,IFT140
7164,GO:0031057,0.963085096115902,0.165388772430186,1,32,negative regulation of histone modification,BP,JARID2
77,GO:0000154,0.963432036990991,0.163825157197021,1,34,rRNA modification,BP,RRNAD1
15861,GO:0072655,0.963497551234129,0.0701100502160012,9,157,establishment of protein localization to mitochondrion,BP,MICALL2;VPS11;TFDP2;HES1;HK1;OSCP1;AKT1;PINK1;UBL5
4775,GO:0010972,0.9636256211124,0.0901832385665083,4,87,negative regulation of G2/M transition of mitotic cell cycle,BP,FHL1;BRSK1;HMGA2;ZFYVE19
10203,GO:0042886,0.963650133894968,0.0447346532648254,127,1538,amide transport,BP,LMF1;CEMIP;APOE;IDH2;SYTL1;LTBP4;RAPGEF3;EVI5L;POSTN;NR1D1;ALOX15B;ARRDC1;LRP1;LTBP2;EGFR;B3GAT3;HADH;NLGN2;TOM1L2;RHBDF1;DOPEY2;F2R;BBS2;TBC1D14;ABCG1;ANK3;PIK3R2;LRP5;PLTP;ERBB2;EXOC2;MICALL2;TMEM129;EDEM1;ITPR3;PRAF2;KIF13B;VPS11;VAMP2;FUZ;AGAP1;GLUL;RHOD;PEX10;RAB3D;TBC1D8;TMEM173;PRNP;SNX33;ATG16L2;SNX9;REEP2;STRADB;RAB25;MYO18A;BCL6;PFKFB2;CHMP1B;MVB12B;HOOK2;ARL2;AP2A2;RHBDF2;ACVR2B;ZDHHC1;MAPK3;OLFM2;AMN;RAB40B;HES1;LRSAM1;AQP3;RASL10B;PFKL;MAPKBP1;PITPNM1;RAB3B;STX10;DMTN;BBS1;VGF;SNX17;TRPV4;PEX7;MVB12A;HK1;GAS6;LLGL1;GUK1;PCK2;BCR;TBC1D16;PRKCZ;ZDHHC24;CLTCL1;TM7SF3;TMCO6;SRSF5;C5;VSNL1;UNC119B;OSCP1;RTN2;LYST;SORL1;TBC1D17;TSNARE1;AKT1;VPS33B;PINK1;PKD1;EHD3;LONP2;SPIRE2;RILPL1;PYCARD;KCNN4;SIRT3;SLC2A1;APBA1;GIPR;TMED4;RPL13A;RAB40C;MIF;STXBP2;UBL5
3426,GO:0007223,0.963873752378573,0.162722975014408,1,32,Wnt signaling pathway, calcium modulating pathway,BP,AGO4
6593,GO:0022625,0.963934440979753,0.117058379152001,2,63,cytosolic large ribosomal subunit,CC,RPL39L;RPL13A
7388,GO:0031463,0.964829212819843,0.115503364051059,2,51,Cul3-RING ubiquitin ligase complex,CC,KLHL29;KLHDC8B
2375,GO:0005515,0.964869230371408,0.0405652329037848,766,8306,protein binding,MF,TNIP1;HTRA1;FOS;CEMIP;ADGRL1;APOE;TYSND1;ESPN;CTNNBIP1;MARCKSL1;TSPAN1;PPL;PTPRS;ERCC1;WWC3;FLNC;SEMA4B;FAM110C;SYTL1;CLIP2;NAPRT;BTBD2;PYGB;CST3;SHANK2;LTBP4;RAPGEF3;TCFL5;MRC2;PGM1;GSN;EVI5L;XDH;PRDX5;NDRG1;PGLS;PRSS3;PGF;CADM4;MEF2D;NOS1;LTBP1;PARVB;ARAP1;SH3BP2;ZFP36L1;COL6A1;POSTN;GRB7;NR1D1;CRAT;EFS;ARRDC1;EPN3;POLD4;SCN8A;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;RHPN1;MYZAP;IGF2;NFATC4;GPX3;NME4;MST1R;LRP1;MAPK13;APPL2;CDK18;RALGDS;LTBP2;RAB11FIP4;FAM102A;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;B3GAT3;NLGN2;CRYL1;ACSF2;REEP6;FBXO2;ACOT7;TCEA2;DUSP5;TOM1L2;ISYNA1;FHL1;MXD4;DDB2;SERPING1;MDFI;RAPGEFL1;EGR1;ULK1;RHBDF1;PKN1;CMTM7;CRTC1;ARPIN;PYGL;ARHGEF4;SYT8;SHC1;RGL2;PCED1A;F2R;PTK6;GNAL;DEAF1;LAMA5;PPP2R3B;SLC9A3R2;GALE;BBS2;ACTA2;PRSS8;TMCC3;S100A4;CTSB;DNAH1;RNF208;SHC2;PITPNC1;SLC16A3;CORO1B;CXXC5;ULK2;IGSF9;DHRS1;MALL;ZMYND8;TBC1D14;ASH2L;PACS2;NXPH4;MXI1;PLAT;ABCG1;RIN1;ANK3;KIAA0930;NOL4L;PIK3R2;S100A6;ZNF516;NEK9;HDAC5;THRA;PLD3;KCNJ15;DOCK4;ZP3;RPS6KA2;NMRK1;NISCH;LRP5;HYAL1;MARK4;TENM2;ZFPM1;BCAM;TFEB;ERBB2;EXOC2;FBLN1;BRSK1;MICALL2;BSG;SCMH1;PTPRU;OGDHL;PKD2;CBS;LRRC20;SCN4B;IQSEC2;CPT1C;EDEM1;ABTB1;SLC7A8;ITGB4;ITPR3;PLXNB3;H2AFJ;PRAF2;DNM1;SPRY4;DDIT4L;FCHO1;MPRIP;PTHLH;CDKN1C;RIMS3;LRP11;SALL2;MSRB2;IFT140;VIPR1;CUL9;CD9;KIF13B;XPC;PTPRE;ANGEL1;CACFD1;NINL;PAK6;HEXB;DNAJC4;SERPINE2;VPS11;VAMP2;CCDC69;FUZ;RNF135;NPHP4;NTSR1;JADE2;CD320;MINK1;RALGAPA2;ATP2B4;GGT1;TMOD2;TFDP2;PHF7;CSNK1E;PLCD1;TRAPPC9;AGAP1;ZFYVE21;ADAMTS7;ENKD1;PDCD4;DOCK6;TMEM134;BEX2;ACAP3;TNFRSF25;GLUL;RHOD;DTX3;ZKSCAN1;ARVCF;TNXB;USP20;PEX10;ASIC1;LAMB2;SPATA18;PLEKHG4;WNT7A;INSR;RAB3D;SH3PXD2B;TBC1D8;FBXW8;ID1;CELSR1;AKR7A2;GRK6;MVD;LGALS9C;B4GAT1;WDR27;RABGGTA;EPHA1;ADARB1;ITGA6;SYNGAP1;IL20RB;HAGH;FBXO27;PPP1R35;DNMT3A;DNPH1;LPAR3;TMEM173;PRNP;DHX32;ATP7B;EFNB3;GRAMD1A;FBXL8;SNX33;HES2;SPRY2;MNT;BLMH;SLC12A7;ECM1;CEP250;NPDC1;SNX9;STAT6;DLG4;SPEG;ABCD1;MARCH2;REEP2;MTA3;MKNK2;STRADB;TALDO1;WWTR1;RAB25;FAM20C;MYO18A;TMEM107;ARHGAP27;MZT2B;DNAJB5;MYCBPAP;PHC2;PLEKHH2;JMJD7;BCL6;ANKZF1;UCKL1;PFKFB2;PLXNB1;CHMP1B;SCAND1;IGFBP2;DYRK1B;MVB12B;BNIP3;CD81;SRMS;FCGRT;FZD8;VEGFA;HOOK2;LRRC8A;ARL2;C22ORF23;VANGL2;FBXW4;ELMO3;AP2A2;CEBPB;RHBDF2;SHANK3;ACVR2B;ADAM15;NAB2;NUDCD3;CALCOCO1;S1PR2;ENDOG;TNFRSF6B;MAPK3;PLEKHG5;ETV5;OLFM2;CARD19;AMN;SLC22A18;GLB1;TNNT1;DVL1;MTA1;LHPP;FYCO1;WIPF1;GPSM1;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;TMEM25;PHYHD1;UHRF1BP1;PC;GIGYF1;SSH1;COMTD1;FURIN;MLXIPL;ZNF624;FBF1;MBOAT7;SLC48A1;SAMD3;CUL7;MEFV;ARHGAP22;NRP2;NADK;PLEKHG2;TNFRSF14;LRSAM1;ZNF414;ADA;CDC42EP5;PIDD1;PAG1;PHF21A;SH2D2A;ACY1;PFKL;IL6R;SLIT3;PCSK9;GGACT;FCGBP;ZFP36;ETV4;RHOF;BTBD11;MAPKBP1;HLCS;CYHR1;RSPH3;FGFR3;PRKACA;F12;PITPNM1;ZNF862;LRRK1;NUDT10;MAGEF1;CYFIP2;RPS6KA5;SCNN1A;HBEGF;ITGB5;RAB3B;MAP2K2;PI4K2A;DAP;FGFR4;SPTB;FBXW5;GSE1;STX10;TSPAN33;DMTN;RAPGEF5;BBS1;MYH3;PSD4;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;TCF25;SEMA3B;LDLR;FAM214B;ROBO3;SNX17;SOX13;TRPV4;MPG;RHOBTB2;BHLHE40;EIF4EBP3;CROCC;CCDC92;RAG1;DUSP7;PHLDA1;LRRC45;TNFAIP8L1;EEF2K;MSLN;HMGA2;LDLRAP1;SEMA3F;ELK3;AHNAK2;DGKQ;PEX7;SEMA4C;MVB12A;HK1;NMRAL1;ZXDC;MIB2;FBXO17;PADI3;GAS6;BTRC;LLGL1;ANKS6;ADGRB2;ZNF217;PPARA;HMGCL;TKFC;TSPAN4;WNT7B;GIT1;COMT;TTC7B;SUFU;AIG1;PTAFR;PLEKHG6;DMC1;IMPA2;ARHGEF37;LTBP3;PAN2;REEP4;ATG2A;TYMSOS;RXRA;PCK2;PCSK1;VAV3;VASN;BCR;NEO1;IGFBP4;SDHA;TBC1D16;USP21;WDR60;PRKCZ;ADAMTS13;ZDHHC24;CLTCL1;HLTF;MDH2;CAPG;INPP5D;TMCO6;ETFB;SPATA7;TWF2;SH3GLB2;TPP1;PDK2;GPC1;ICOSLG;SRSF5;RFXANK;TEF;CEP68;SMARCD2;MAPKAPK3;NDE1;AGO4;RAD23A;ARAP3;FGFR1;CTSZ;CAMKK1;SPSB3;PIN1;C5;KMT5C;PHYH;PROX1;WBP2;C21ORF2;ASAP2;DLG3;KCNMA1;ESYT2;BIN1;VSNL1;UNC119B;YIPF3;TMEM8B;SERPINB6;PPP1R13L;ASS1;SH3D19;WDR83;GLRX;GRB10;BFSP1;JARID2;CAPN2;SESN2;TOLLIP;ADCK5;WNT2B;NATD1;TSTA3;WRAP73;RXRB;CSTB;PROCR;SNPH;TMEM231;PNRC1;MAPRE3;DUSP23;LCAT;MACROD1;SMDT1;PITPNM3;CYBRD1;MADD;RTN4R;EPB41L3;SLC9A7;TIMP1;SDC1;WHAMMP3;GRHPR;SH2B3;ACTR1B;APOBEC3C;FGFBP1;RTN2;H1FX;EPS8L1;WNT3;LYST;GSTT1;PPM1F;KIAA1191;OLFML2A;MICALCL;SBF1;SORL1;STK39;COL13A1;VEGFB;ACVR1B;MEF2B;TBC1D17;ANO9;FAM189B;GSS;AHCYL2;ALS2CL;TSNARE1;TPCN1;ERBB3;ABR;CCDC85B;PNMA1;CYP2S1;AKT1;CTSD;TRAP1;TMBIM4;NLRX1;SEPT8;ADAM19;ZNF385A;TP53INP1;LRCH4;NDRG2;TUT1;SMARCA1;VPS33B;SIX5;ERCC6;GPD1L;EPS8L2;SUN1;NAGA;SPPL2B;SSBP2;RPL39L;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;MPLKIP;SNTA1;ARHGEF10L;CAMTA2;HOMER2;LGALS9B;RGS14;SYNE3;SPIRE2;CCDC106;EIF4G3;CTSH;ABHD14B;MLST8;AGPAT4;RILPL1;NRSN1;CBLC;ATXN10;EPN2;RFX2;RNF187;PYCARD;NINJ1;MAP2K3;PNPO;RHBG;TRERF1;PCSK1N;KCNN4;CCDC57;DNAAF5;THAP8;DDN;ERN1;CKLF;RANBP9;APOBEC3F;PRIMPOL;FBXL20;WDR63;ARHGEF19;SIRT3;ALKBH6;ORAI3;WBP1;CMTM4;SLC2A1;CPNE7;MLYCD;JAK3;BCKDHA;MAST3;KIFC2;LITAF;APBA1;MZF1;KIAA1328;NEIL1;ORAI2;RARG;ING4;PBXIP1;EREG;FAM162A;GSTM2;PODXL2;ZFYVE19;TRIM7;SHISA6;MORN4;GIPR;WDR18;SFI1;KRT15;ADAMTSL4;POLM;SEMA4F;MIF;STXBP2;KIF26B;UBL5;LZTS2
3658,GO:0008156,0.965092412273583,0.158367882217036,1,33,negative regulation of DNA replication,BP,BCL6
9903,GO:0042267,0.965118733439265,0.158090644408942,1,34,natural killer cell mediated cytotoxicity,BP,LYST
868,GO:0002218,0.965120712045083,0.06124248118317,13,209,activation of innate immune response,BP,TNIP1;PTPRS;NR1D1;CTSB;TMEM173;PRKACA;RPS6KA5;BTRC;TKFC;MUC19;MAPKAPK3;NLRX1;PYCARD
11231,GO:0045471,0.965183092512011,0.096879495900072,3,69,response to ethanol,BP,GSN;DNMT3A;TP53INP1
2442,GO:0005657,0.965204749774149,0.0968759928035062,3,68,replication fork,CC,POLD4;BCL6;DMC1
7166,GO:0031060,0.965275913803663,0.114321207388568,2,51,regulation of histone methylation,BP,MTHFR;JARID2
6850,GO:0030331,0.965356440853199,0.157462077268055,1,33,estrogen receptor binding,MF,WBP2
16538,GO:0097352,0.965592685815366,0.156463703703628,1,34,autophagosome maturation,BP,FYCO1
1859,GO:0004527,0.965662326462424,0.0958161862068221,3,68,exonuclease activity,MF,ISG20;EXD3;PAN2
5988,GO:0019003,0.965669989962453,0.113195607947121,2,52,GDP binding,MF,RAB3B;RAB40C
11075,GO:0045103,0.965711887603452,0.156239220912139,1,33,intermediate filament-based process,BP,SYNC
7710,GO:0032212,0.965733022132288,0.156166386530879,1,33,positive regulation of telomere maintenance via telomerase,BP,MAPK3
6011,GO:0019076,0.965950651546455,0.155415568562693,1,33,viral release from host cell,BP,PC
9353,GO:0035890,0.965950651546455,0.155415568562693,1,33,exit from host,BP,PC
9354,GO:0035891,0.965950651546455,0.155415568562693,1,33,exit from host cell,BP,PC
13283,GO:0052126,0.965950651546455,0.155415568562693,1,33,movement in host environment,BP,PC
13292,GO:0052192,0.965950651546455,0.155415568562693,1,33,movement in environment of other organism involved in symbiotic interaction,BP,PC
13257,GO:0051973,0.966099473644451,0.154901273214733,1,33,positive regulation of telomerase activity,BP,MAPK3
11641,GO:0046426,0.966100322619188,0.154898337338556,1,33,negative regulation of JAK-STAT cascade,BP,RTN4R
19020,GO:1904893,0.966100322619188,0.154898337338556,1,33,negative regulation of STAT cascade,BP,RTN4R
2810,GO:0006282,0.966119850408,0.0850365638834128,4,83,regulation of DNA repair,BP,EGFR;MAGEF1;HMGA2;TMEM161A
10958,GO:0044766,0.966308516335328,0.0942687550308682,3,69,multi-organism transport,BP,MVB12B;RAB40B;MVB12A
18022,GO:1902579,0.966308516335328,0.0942687550308682,3,69,multi-organism localization,BP,MVB12B;RAB40B;MVB12A
10777,GO:0044270,0.966331522168109,0.047780972767431,39,547,cellular nitrogen compound catabolic process,BP,NT5E;RAPGEF3;PGM1;XDH;PCBP4;ZFP36L1;H1F0;OGDHL;TST;INSR;DNPH1;RNASET2;ISG20;PFKFB2;ENTPD6;DNASE1L1;ENDOG;DHTKD1;ENTPD2;GALK1;MLXIPL;ADA;PFKL;ZFP36;NUDT10;CYP3A5;HK1;PPARA;BLVRB;PAN2;AGO4;GTPBP1;PNRC1;APOBEC3C;AKT1;ERN1;APOBEC3F;NEIL1;RPL13A
12275,GO:0048635,0.96648872778691,0.153552765271359,1,33,negative regulation of muscle organ development,BP,JARID2
11790,GO:0046700,0.966645948281684,0.0473615790064891,39,547,heterocycle catabolic process,BP,NT5E;RAPGEF3;PGM1;XDH;PCBP4;PRODH;ZFP36L1;H1F0;ALDH4A1;OGDHL;INSR;DNPH1;RNASET2;ISG20;PFKFB2;ENTPD6;DNASE1L1;ENDOG;DHTKD1;ENTPD2;GALK1;MLXIPL;ADA;PFKL;ZFP36;NUDT10;HK1;PPARA;BLVRB;PAN2;AGO4;GTPBP1;PNRC1;APOBEC3C;AKT1;ERN1;APOBEC3F;NEIL1;RPL13A
7306,GO:0031327,0.966875664932433,0.0419108688775269,98,1205,negative regulation of cellular biosynthetic process,BP,CTNNBIP1;WWC3;TCFL5;CYP27B1;PRDX5;ZFP36L1;GRB7;NR1D1;IGF2;NFATC4;EGFR;MXD4;MDFI;EGR1;SHC1;ABCA7;DEAF1;BAHCC1;CXXC5;ZMYND8;MXI1;PEG3;HDAC5;THRA;ZP3;TENM2;ZFPM1;SCMH1;H2AFJ;CDKN1C;SALL2;FOXQ1;LTB4R2;UNK;ATP2B4;TFDP2;ACP5;PDCD4;ZC3H6;ID1;ZNF692;DNMT3A;HES2;MNT;STAT6;MTA3;WWTR1;DNAJB5;BCL6;FZD8;VEGFA;CEBPB;ACVR2B;HSF4;NAB2;MTA1;L3MBTL1;MBD1;HES1;MLXIPL;PHF21A;ZFP36;RPS6KA5;HBEGF;MAP2K2;DAP;TCF25;TRPV4;BHLHE40;EIF4EBP3;HMGA2;ELK3;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;SUFU;RXRA;INPP5D;AGO4;FGFR1;IRF2BPL;PROX1;PPP1R13L;JARID2;SESN2;PPM1F;CCDC85B;SIX5;JAK3;MZF1;RARG;ING4;PBXIP1;EREG;RPL13A
4497,GO:0010557,0.966953804511561,0.041615932763648,103,1246,positive regulation of macromolecule biosynthetic process,BP,TNIP1;FOS;CITED4;CST3;MEF2D;NOS1;NR1D1;EPAS1;IGF2;NFATC4;EGFR;TCEA2;EGR1;CRTC1;SHC1;F2R;DEAF1;ASH2L;SOX12;PIK3R2;ZNF516;PEG3;HDAC5;THRA;ZP3;LRP5;MAML3;ZFPM1;TFEB;ERBB2;PKD2;CDKN1C;SALL2;HEXB;TFDP2;WNT7A;ZMIZ1;INSR;ITGA6;TMEM173;STAT6;WWTR1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;CEBPB;HSF4;CALCOCO1;MAPK3;ETV5;DVL1;FHOD1;HES1;MLXIPL;ETV4;RPS6KA5;MAP2K2;FGFR4;TNFRSF1A;HMGA2;ELK3;ZXDC;BTRC;PPARA;PTAFR;RXRA;USP21;HLTF;RFXANK;TEF;FGFR1;PIN1;IRF2BPL;PROX1;WBP2;SESN2;RXRB;MAPRE3;ACVR1B;MEF2B;AKT1;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;CAMTA2;ABHD14B;RFX2;RNF187;MAP2K3;POMT1;TRERF1;DDN;LITAF;MZF1;RARG;EREG
10738,GO:0044183,0.967041399790519,0.151446787659508,1,34,protein binding involved in protein folding,MF,FYCO1
19616,GO:1990841,0.967306603633965,0.150703430514199,1,33,promoter-specific chromatin binding,MF,EGR1
2861,GO:0006361,0.967358965025127,0.15016650935557,1,35,transcription initiation from RNA polymerase I promoter,BP,MAPK3
15935,GO:0075733,0.967523235363409,0.108164823475694,2,53,intracellular transport of virus,BP,MVB12B;MVB12A
18057,GO:1902686,0.967612958743879,0.107923275294869,2,53,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,TFDP2;BNIP3
8216,GO:0032993,0.967816678915867,0.0646295206940329,8,163,protein-DNA complex,CC,FOS;POLD4;H1F0;SOX12;H2AFJ;HMGA2;H1FX;WDR18
16222,GO:0090305,0.967941996024,0.0540363976429153,16,249,nucleic acid phosphodiester bond hydrolysis,BP,ERCC1;POLD4;H1F0;DDB2;RNASET2;ISG20;DNASE1L1;ENDOG;EXD3;ZFP36;RAG1;PAN2;PNRC1;TUT1;ERN1;RNASEK
12907,GO:0051290,0.968052276066253,0.146667691532166,1,43,protein heterotetramerization,BP,INSR
2451,GO:0005669,0.968094379581171,0.147587545478714,1,35,transcription factor TFIID complex,CC,ERCC1
731,GO:0001961,0.968663608081258,0.145747613953221,1,34,positive regulation of cytokine-mediated signaling pathway,BP,GAS6
5215,GO:0015833,0.96894113122223,0.0384977036738177,125,1524,peptide transport,BP,LMF1;CEMIP;APOE;IDH2;SYTL1;LTBP4;RAPGEF3;EVI5L;POSTN;NR1D1;ALOX15B;ARRDC1;LRP1;LTBP2;EGFR;B3GAT3;HADH;NLGN2;TOM1L2;RHBDF1;DOPEY2;F2R;BBS2;TBC1D14;ABCG1;ANK3;PIK3R2;LRP5;ERBB2;EXOC2;MICALL2;TMEM129;EDEM1;ITPR3;PRAF2;KIF13B;VPS11;VAMP2;FUZ;AGAP1;GLUL;RHOD;PEX10;RAB3D;TBC1D8;TMEM173;PRNP;SNX33;ATG16L2;SNX9;REEP2;STRADB;RAB25;MYO18A;BCL6;PFKFB2;CHMP1B;MVB12B;HOOK2;ARL2;AP2A2;RHBDF2;ACVR2B;ZDHHC1;MAPK3;OLFM2;AMN;RAB40B;HES1;LRSAM1;RASL10B;PFKL;MAPKBP1;PITPNM1;RAB3B;STX10;DMTN;BBS1;VGF;SNX17;TRPV4;PEX7;MVB12A;HK1;GAS6;LLGL1;GUK1;PCK2;BCR;TBC1D16;PRKCZ;ZDHHC24;CLTCL1;TM7SF3;TMCO6;SRSF5;C5;VSNL1;UNC119B;OSCP1;RTN2;LYST;SORL1;TBC1D17;TSNARE1;AKT1;VPS33B;PINK1;PKD1;EHD3;LONP2;SPIRE2;RILPL1;PYCARD;KCNN4;SIRT3;SLC2A1;APBA1;GIPR;TMED4;RPL13A;RAB40C;MIF;STXBP2;UBL5
14815,GO:0070585,0.969045110430401,0.0605251588314332,9,160,protein localization to mitochondrion,BP,MICALL2;VPS11;TFDP2;HES1;HK1;OSCP1;AKT1;PINK1;UBL5
3576,GO:0007631,0.969249719436381,0.143499035032882,1,35,feeding behavior,BP,FOS
10985,GO:0044815,0.969278395380376,0.0865841877005513,3,91,DNA packaging complex,CC,H1F0;H2AFJ;H1FX
4498,GO:0010558,0.969507531502604,0.0388753072349938,94,1164,negative regulation of macromolecule biosynthetic process,BP,CTNNBIP1;WWC3;TCFL5;PRDX5;ZFP36L1;GRB7;NR1D1;IGF2;NFATC4;EGFR;MXD4;MDFI;EGR1;SHC1;ABCA7;DEAF1;BAHCC1;CXXC5;ZMYND8;MXI1;PEG3;HDAC5;THRA;ZP3;TENM2;ZFPM1;SCMH1;H2AFJ;CDKN1C;SALL2;FOXQ1;UNK;TFDP2;PDCD4;ZC3H6;ID1;ZNF692;DNMT3A;HES2;MNT;STAT6;MTA3;WWTR1;DNAJB5;BCL6;FZD8;VEGFA;CEBPB;ACVR2B;HSF4;NAB2;MTA1;L3MBTL1;MBD1;HES1;MLXIPL;PHF21A;ZFP36;RPS6KA5;HBEGF;MAP2K2;DAP;TCF25;TRPV4;BHLHE40;EIF4EBP3;HMGA2;ELK3;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;SUFU;RXRA;INPP5D;AGO4;FGFR1;IRF2BPL;PROX1;PPP1R13L;JARID2;SESN2;PPM1F;CCDC85B;SIX5;JAK3;MZF1;RARG;ING4;PBXIP1;EREG;RPL13A
17508,GO:1901030,0.969645363864533,0.142088289974354,1,35,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,TFDP2
12787,GO:0051117,0.969751319038419,0.102049254247955,2,54,ATPase binding,MF,PKD2;SNTA1
3053,GO:0006623,0.969752352196001,0.14187217698469,1,34,protein targeting to vacuole,BP,SORL1
3236,GO:0006900,0.969939945371191,0.0767292837392564,4,86,vesicle budding from membrane,BP,DNM1;TRAPPC9;MYO18A;CTSZ
17847,GO:1902108,0.970048056166653,0.101236550252986,2,54,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,TFDP2;BNIP3
2265,GO:0005201,0.970183313478948,0.14032656303129,1,34,extracellular matrix structural constituent,MF,FBLN1
8972,GO:0035097,0.970853033087921,0.083495439032666,3,70,histone methyltransferase complex,CC,ASH2L;INO80C;JARID2
7292,GO:0031304,0.9709659514536,0.137184738230903,1,36,intrinsic component of mitochondrial inner membrane,CC,SMDT1
7293,GO:0031305,0.9709659514536,0.137184738230903,1,36,integral component of mitochondrial inner membrane,CC,SMDT1
137,GO:0000288,0.971091510245482,0.0828454263175832,3,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L1;ZFP36;PAN2
2811,GO:0006283,0.971350376370709,0.082186749591834,3,73,transcription-coupled nucleotide-excision repair,BP,ERCC1;POLD4;ERCC6
12102,GO:0048194,0.971358714240074,0.0822421546385799,3,71,Golgi vesicle budding,BP,TRAPPC9;MYO18A;CTSZ
98,GO:0000209,0.971399287059879,0.0474112374051984,18,276,protein polyubiquitination,BP,RBCK1;FBXO2;DDB2;TMEM129;FBXW8;FBXO27;FBXL8;FBXO41;BLMH;FBXW4;FBXL16;LRSAM1;FBXW5;MIB2;FBXO17;BTRC;RNF187;FBXL20
12861,GO:0051225,0.971528430985891,0.0676528107351482,5,100,spindle assembly,BP,TUBG2;CCDC69;CHMP1B;WRAP73;GOLGA2P5
4949,GO:0015031,0.971602724675122,0.035364335660746,123,1506,protein transport,BP,LMF1;CEMIP;APOE;IDH2;SYTL1;RAPGEF3;EVI5L;POSTN;NR1D1;ALOX15B;ARRDC1;LRP1;LTBP2;EGFR;B3GAT3;HADH;NLGN2;TOM1L2;RHBDF1;DOPEY2;F2R;BBS2;TBC1D14;ABCG1;ANK3;PIK3R2;LRP5;ERBB2;EXOC2;MICALL2;TMEM129;EDEM1;ITPR3;PRAF2;KIF13B;VPS11;VAMP2;FUZ;AGAP1;GLUL;RHOD;PEX10;RAB3D;TBC1D8;TMEM173;PRNP;SNX33;ATG16L2;SNX9;REEP2;STRADB;RAB25;MYO18A;BCL6;PFKFB2;CHMP1B;MVB12B;HOOK2;ARL2;AP2A2;RHBDF2;ACVR2B;ZDHHC1;MAPK3;OLFM2;AMN;RAB40B;HES1;LRSAM1;PFKL;MAPKBP1;PITPNM1;RAB3B;STX10;DMTN;BBS1;VGF;SNX17;TRPV4;PEX7;MVB12A;HK1;GAS6;LLGL1;GUK1;PCK2;BCR;TBC1D16;PRKCZ;ZDHHC24;CLTCL1;TM7SF3;TMCO6;SRSF5;C5;VSNL1;UNC119B;OSCP1;RTN2;LYST;SORL1;TBC1D17;TSNARE1;AKT1;VPS33B;PINK1;PKD1;EHD3;LONP2;SPIRE2;RILPL1;PYCARD;KCNN4;SIRT3;SLC2A1;APBA1;GIPR;TMED4;RPL13A;RAB40C;MIF;STXBP2;UBL5
875,GO:0002228,0.971677006638958,0.134602457783528,1,36,natural killer cell mediated immunity,BP,LYST
10343,GO:0043175,0.971754928969974,0.134470704336803,1,35,RNA polymerase core enzyme binding,MF,ERBB2
17253,GO:0140030,0.971822058368194,0.0630610555168405,6,114,modification-dependent protein binding,MF,TNIP1;ZMYND8;L3MBTL1;BRD3;RAD23A;ING4
18781,GO:1904358,0.972175858355067,0.132930812971022,1,35,positive regulation of telomere maintenance via telomere lengthening,BP,MAPK3
9305,GO:0035794,0.972515973233855,0.0943394650963561,2,55,positive regulation of mitochondrial membrane permeability,BP,TFDP2;BNIP3
19320,GO:1905710,0.972515973233855,0.0943394650963561,2,55,positive regulation of membrane permeability,BP,TFDP2;BNIP3
12762,GO:0051082,0.972523601030079,0.0655438314533323,5,103,unfolded protein binding,MF,DNAJC4;DNAJB5;NUDCD3;FYCO1;TRAP1
3056,GO:0006626,0.972545566901001,0.061553227564924,6,120,protein targeting to mitochondrion,BP,MICALL2;VPS11;HES1;OSCP1;PINK1;UBL5
4773,GO:0010970,0.972603182315313,0.0585280239336674,7,131,transport along microtubule,BP,IFT140;FYCO1;WDR60;PRKCZ;NDE1;SUN1;APBA1
16980,GO:0099111,0.972603182315313,0.0585280239336674,7,131,microtubule-based transport,BP,IFT140;FYCO1;WDR60;PRKCZ;NDE1;SUN1;APBA1
7872,GO:0032451,0.972873429638264,0.130363704432819,1,35,demethylase activity,MF,KDM4B
17806,GO:1901992,0.972874674409993,0.0933351266365466,2,55,positive regulation of mitotic cell cycle phase transition,BP,HYAL1;MTA3
7704,GO:0032205,0.972938771374555,0.130122258614193,1,35,negative regulation of telomere maintenance,BP,ERCC1
6263,GO:0019866,0.972972289580153,0.0406053840559572,30,450,organelle inner membrane,CC,IDH2;PRODH;CRAT;CPT2;NME4;HADH;DHRS1;TST;SIGMAR1;NDUFS8;CKMT1A;SLC25A37;TM7SF2;SDHAF4;HMGCL;SDHA;MDH2;SLC25A27;NDUFA4L2;SMDT1;SLC25A29;TRAP1;SUN1;TMEM120A;UQCR11;PINK1;NDUFV3;ERN1;GCAT;TAZ
19689,GO:2000059,0.973072087299795,0.129338779124789,1,37,negative regulation of ubiquitin-dependent protein catabolic process,BP,SUFU
10561,GO:0043543,0.973120895233672,0.0493556824035381,12,198,protein acylation,BP,RAPGEF3;NOS1;JADE2;HINT2;ZDHHC1;MAPK3;RPS6KA5;ABHD17C;ZDHHC24;MDH2;WBP2;ING4
3286,GO:0006986,0.973185118487239,0.0532677560732421,9,158,response to unfolded protein,BP,SHC1;TMEM129;EDEM1;DNAJC4;DNAJB5;CUL7;TM7SF3;TPP1;ERN1
6972,GO:0030660,0.973187671260882,0.0695466251313278,4,88,Golgi-associated vesicle membrane,CC,LDLRAP1;CLTCL1;SPPL2B;PKD1
12916,GO:0051301,0.973369042717795,0.0386698298716024,37,507,cell division,BP,PGF;IGF2;RAB11FIP4;ANK3;NEK9;MARK4;PAK6;RHOD;WNT7A;CCNG2;SNX33;SNX9;WWTR1;CHMP1B;VEGFA;VANGL2;ETV5;CUL7;RHOF;RHOBTB2;HMGA2;GIT1;REEP4;KLHDC8B;NDE1;FGFR1;PIN1;MAPRE3;LMLN;VEGFB;SEPT8;MPLKIP;RGS14;SPIRE2;EREG;ZFYVE19;LZTS2
8275,GO:0033116,0.973456115007128,0.0917006853530125,2,55,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,CTSZ;WHAMMP3
8345,GO:0033238,0.973645497781045,0.0909407698952614,2,59,regulation of cellular amine metabolic process,BP,ATP2B4;COMT
7207,GO:0031113,0.97382432742374,0.126685521049608,1,36,regulation of microtubule polymerization,BP,ARL2
20240,GO:2001237,0.974056985193972,0.0756571409120031,3,72,negative regulation of extrinsic apoptotic signaling pathway,BP,ITGA6;STRADB;AKT1
5637,GO:0016741,0.97411083658309,0.048816017794238,11,185,transferase activity, transferring one-carbon groups,MF,GAMT;ASH2L;DNMT3A;COMTD1;FAM86C2P;NSUN7;RRNAD1;COMT;KMT5C;PCMTD2;AS3MT
3361,GO:0007131,0.974155448871583,0.125448195866123,1,36,reciprocal meiotic recombination,BP,DMC1
9321,GO:0035825,0.974155448871583,0.125448195866123,1,36,homologous recombination,BP,DMC1
18987,GO:1904837,0.974202633264988,0.124648983853315,1,41,beta-catenin-TCF complex assembly,BP,ASH2L
3045,GO:0006612,0.974438666721572,0.0526642848922099,8,165,protein targeting to membrane,BP,CEMIP;ANK3;ERBB2;PRNP;ZDHHC1;DMTN;ZDHHC24;RPL13A
12107,GO:0048207,0.974448796465848,0.0888327184978924,2,56,vesicle targeting, rough ER to cis-Golgi,BP,TRAPPC9;CTSZ
12108,GO:0048208,0.974448796465848,0.0888327184978924,2,56,COPII vesicle coating,BP,TRAPPC9;CTSZ
9584,GO:0036459,0.974501539667858,0.0666450170844637,4,87,thiol-dependent ubiquitinyl hydrolase activity,MF,JOSD2;USP20;ANKZF1;USP21
17083,GO:0101005,0.974501539667858,0.0666450170844637,4,87,ubiquitinyl hydrolase activity,MF,JOSD2;USP20;ANKZF1;USP21
6140,GO:0019439,0.974534013400624,0.0367332451096714,39,556,aromatic compound catabolic process,BP,NT5E;RAPGEF3;PGM1;XDH;PCBP4;ZFP36L1;H1F0;OGDHL;INSR;DNPH1;RNASET2;ISG20;PFKFB2;ENTPD6;DNASE1L1;ENDOG;DHTKD1;ENTPD2;GALK1;MLXIPL;ADA;PFKL;ZFP36;NUDT10;HK1;PPARA;BLVRB;COMT;PAN2;AGO4;GTPBP1;PNRC1;APOBEC3C;AKT1;HPDL;ERN1;APOBEC3F;NEIL1;RPL13A
3732,GO:0008276,0.974904346689953,0.0735743322996748,3,72,protein methyltransferase activity,MF,ASH2L;KMT5C;PCMTD2
14370,GO:0061647,0.974922918223463,0.12256264034312,1,36,histone H3-K9 modification,BP,JARID2
11345,GO:0045727,0.975016296862395,0.0603398898726287,5,104,positive regulation of translation,BP,ERBB2;MAPK3;PTAFR;RXRA;PINK1
11817,GO:0046794,0.975058058412305,0.0870971051848033,2,56,transport of virus,BP,MVB12B;MVB12A
5801,GO:0017069,0.975135058445838,0.121495590271316,1,38,snRNA binding,MF,ISG20
4471,GO:0010498,0.975137919205136,0.0378192408812612,29,416,proteasomal protein catabolic process,BP,BTBD2;RNF44;NR1D1;RBCK1;FBXO2;RHBDF1;GID4;TMEM129;EDEM1;ABTB1;CSNK1E;WWTR1;ANKZF1;FBXW4;DVL1;MTA1;BTBD11;PRKACA;FBXW5;BTRC;RAD23A;SPSB3;MAN1B1;AKT1;PINK1;PKD1;RNF187;POMT1;FBXL20
12509,GO:0050680,0.975237411178603,0.0649944136949777,4,87,negative regulation of epithelial cell proliferation,BP,APOE;XDH;CDKN1C;EREG
5875,GO:0018023,0.975756769686993,0.119264042516859,1,37,peptidyl-lysine trimethylation,BP,KMT5C
17251,GO:0140014,0.976200471465047,0.0417769124809472,15,239,mitotic nuclear division,BP,IGF2;OBSL1;TOM1L2;LRP5;TUBG2;CUL9;INSR;CHMP1B;L3MBTL1;CUL7;FBXW5;NDE1;PIN1;WRAP73;EREG
13128,GO:0051726,0.976432947150503,0.0309591727426208,79,999,regulation of cell cycle,BP,NDRG1;PCBP4;ZFP36L1;CGREF1;ALOX15B;IGF2;RAB11FIP4;OBSL1;EGFR;TIMP2;TOM1L2;FHL1;PTK6;PPP2R3B;GJC2;RPS6KA2;LRP5;HYAL1;BRSK1;PKD2;CDKN1C;CUL9;XPC;NINL;PAK6;MINK1;ATP2B4;TFDP2;CSNK1E;PDCD4;BEX2;INSR;ID1;ADARB1;CCNG2;PRNP;MNT;CEP250;MTA3;STRADB;BCL6;CHMP1B;L3MBTL1;HES1;MLXIPL;CUL7;PIDD1;PRKACA;MAP2K2;FBXW5;HMGA2;GAS6;GIT1;BCR;SRSF5;NDE1;RAD23A;FGFR1;PIN1;PROX1;BIN1;TMEM8B;MAPRE3;MADD;WHAMMP3;STK39;AKT1;ZNF385A;TP53INP1;PKD1;MLST8;MAP2K3;ERN1;ING4;EREG;ZFYVE19;SFI1;TRNP1;MIF
8842,GO:0034655,0.976507898490889,0.0344958417687505,36,522,nucleobase-containing compound catabolic process,BP,NT5E;RAPGEF3;PGM1;XDH;PCBP4;ZFP36L1;H1F0;OGDHL;INSR;DNPH1;RNASET2;ISG20;PFKFB2;ENTPD6;DNASE1L1;ENDOG;DHTKD1;ENTPD2;GALK1;MLXIPL;ADA;PFKL;ZFP36;NUDT10;HK1;PPARA;PAN2;AGO4;GTPBP1;PNRC1;APOBEC3C;AKT1;ERN1;APOBEC3F;NEIL1;RPL13A
10775,GO:0044265,0.976924455941862,0.0305718636789269,74,962,cellular macromolecule catabolic process,BP,APOE;BTBD2;RNF44;CST3;PCBP4;ZFP36L1;NR1D1;ARRDC1;RBCK1;LRP1;H1F0;FBXO2;RHBDF1;CTSB;CTSF;GID4;TMEM129;EDEM1;ABTB1;CUL9;VPS11;CSNK1E;ADAMTS7;USP20;SPATA18;RNASET2;WWTR1;ISG20;ANKZF1;MVB12B;BNIP3;CD81;DNASE1L1;FBXW4;AP2A2;ENDOG;DVL1;MTA1;FURIN;CUL7;PCSK9;ZFP36;BTBD11;PRKACA;MAGEF1;FBXW5;LDLR;MVB12A;BTRC;SUFU;PAN2;USP21;RNF123;GPC1;AGO4;RAD23A;CTSZ;SPSB3;MAN1B1;GTPBP1;CAPN2;TOLLIP;PNRC1;AKT1;PINK1;PKD1;LONP2;CTSH;CBLC;RNF187;POMT1;ERN1;FBXL20;RPL13A
14669,GO:0070317,0.977121107287659,0.114023367653511,1,37,negative regulation of G0 to G1 transition,BP,TFDP2
6692,GO:0030101,0.977135961061455,0.113841777144052,1,38,natural killer cell activation,BP,GAS6
10514,GO:0043473,0.977159957744125,0.0678982976728165,3,74,pigmentation,BP,BBS2;LYST;VPS33B
7584,GO:0031967,0.977211130578498,0.0302048490279939,74,972,organelle envelope,CC,IDH2;CST3;CYP27B1;CLCA2;PRODH;CRAT;FAM210B;CPT2;NME4;EGFR;HADH;ULK1;BPHL;SLC16A3;DHRS1;GRAMD4;CERS4;S100A6;SLC2A9;TST;CPT1C;ITPR3;VAT1;DNM1;SIGMAR1;SNN;ARMCX2;SPATA18;INSR;NDUFS8;TMEM173;PRNP;STAT6;ANKZF1;BNIP3;ARL2;MAPK3;CARD19;SLC22A18;RAB40B;MTA1;RETSAT;CKMT1A;SLC25A37;MAPK8IP1;TM7SF2;KLHDC2;HK1;SDHAF4;HMGCL;SDHA;RNF123;PRKCZ;MDH2;SMOX;BIN1;SLC25A27;NDUFA4L2;SNPH;SMDT1;SORL1;SLC25A29;TRAP1;NLRX1;SUN1;TMEM120A;UQCR11;PINK1;SYNE3;NDUFV3;ERN1;GCAT;TAZ;AGPAT3
7588,GO:0031975,0.977211130578498,0.0302048490279939,74,972,envelope,CC,IDH2;CST3;CYP27B1;CLCA2;PRODH;CRAT;FAM210B;CPT2;NME4;EGFR;HADH;ULK1;BPHL;SLC16A3;DHRS1;GRAMD4;CERS4;S100A6;SLC2A9;TST;CPT1C;ITPR3;VAT1;DNM1;SIGMAR1;SNN;ARMCX2;SPATA18;INSR;NDUFS8;TMEM173;PRNP;STAT6;ANKZF1;BNIP3;ARL2;MAPK3;CARD19;SLC22A18;RAB40B;MTA1;RETSAT;CKMT1A;SLC25A37;MAPK8IP1;TM7SF2;KLHDC2;HK1;SDHAF4;HMGCL;SDHA;RNF123;PRKCZ;MDH2;SMOX;BIN1;SLC25A27;NDUFA4L2;SNPH;SMDT1;SORL1;SLC25A29;TRAP1;NLRX1;SUN1;TMEM120A;UQCR11;PINK1;SYNE3;NDUFV3;ERN1;GCAT;TAZ;AGPAT3
19954,GO:2000573,0.97727922659412,0.0806875801955743,2,56,positive regulation of DNA biosynthetic process,BP,MAPK3;FGFR4
9391,GO:0035967,0.97736935237002,0.0473903623926285,8,147,cellular response to topologically incorrect protein,BP,SHC1;EDEM1;ANKZF1;CUL7;TM7SF3;TPP1;POMT1;ERN1
12724,GO:0051018,0.977632829589902,0.112035363738349,1,37,protein kinase A binding,MF,PRKACA
2937,GO:0006473,0.978011533174934,0.0445722684738665,9,162,protein acetylation,BP,RAPGEF3;NOS1;JADE2;HINT2;MAPK3;RPS6KA5;MDH2;WBP2;ING4
12144,GO:0048285,0.978336852738549,0.0345023037688382,24,354,organelle fission,BP,IGF2;OBSL1;TOM1L2;LRP5;TUBG2;DNM1;CUL9;INSR;CHMP1B;BNIP3;L3MBTL1;CUL7;FBXW5;DMC1;NDE1;AGO4;PIN1;WRAP73;TDRKH;SUN1;PINK1;SPIRE2;P3H4;EREG
4409,GO:0010212,0.978418308485999,0.0473681665489011,7,134,response to ionizing radiation,BP,ERCC1;EGR1;DNMT3A;MTA1;HMGA2;DMC1;ERCC6
133,GO:0000280,0.978505773616334,0.0352208535618978,21,317,nuclear division,BP,IGF2;OBSL1;TOM1L2;LRP5;TUBG2;CUL9;INSR;CHMP1B;L3MBTL1;CUL7;FBXW5;DMC1;NDE1;AGO4;PIN1;WRAP73;TDRKH;SUN1;SPIRE2;P3H4;EREG
7204,GO:0031110,0.978530044251964,0.0769666866730451,2,57,regulation of microtubule polymerization or depolymerization,BP,ARL2;TRPV4
9026,GO:0035258,0.978793419545007,0.0637719745868879,3,74,steroid hormone receptor binding,MF,PKN1;CEBPB;WBP2
10481,GO:0043401,0.978905910527614,0.0445101405290395,8,147,steroid hormone mediated signaling pathway,BP,NR1D1;THRA;CALCOCO1;PPARA;RXRA;WBP2;RXRB;RARG
869,GO:0002220,0.978922966070581,0.0564529638340827,4,94,innate immune response activating cell surface receptor signaling pathway,BP,PRKACA;RPS6KA5;BTRC;MUC19
871,GO:0002223,0.978922966070581,0.0564529638340827,4,94,stimulatory C-type lectin receptor signaling pathway,BP,PRKACA;RPS6KA5;BTRC;MUC19
8662,GO:0034250,0.978975648732651,0.0486921039402394,6,121,positive regulation of cellular amide metabolic process,BP,ERBB2;MAPK3;TNFRSF1A;PTAFR;RXRA;PINK1
14003,GO:0060760,0.979012373707725,0.106492742989708,1,38,positive regulation of response to cytokine stimulus,BP,GAS6
2943,GO:0006479,0.979171134544593,0.0439939859874817,8,149,protein methylation,BP,MTHFR;ASH2L;RAB3D;RAB3B;ETFB;KMT5C;JARID2;PCMTD2
3697,GO:0008213,0.979171134544593,0.0439939859874817,8,149,protein alkylation,BP,MTHFR;ASH2L;RAB3D;RAB3B;ETFB;KMT5C;JARID2;PCMTD2
17947,GO:1902369,0.979630054601021,0.104034689487543,1,38,negative regulation of RNA catabolic process,BP,ZFP36
16289,GO:0090501,0.979641994795501,0.0472970020476732,6,124,RNA phosphodiester bond hydrolysis,BP,RNASET2;ISG20;PAN2;TUT1;ERN1;RNASEK
11812,GO:0046782,0.979751805286795,0.0732450149888789,2,59,regulation of viral transcription,BP,ZFP36;HMGA2
15719,GO:0072331,0.979819077115336,0.0358982321910968,15,246,signal transduction by p53 class mediator,BP,NDRG1;PCBP4;TFDP2;L3MBTL1;PIDD1;PDK2;PIN1;PPP1R13L;SESN2;AKT1;ZNF385A;TP53INP1;PYCARD;ING4;MIF
14958,GO:0070897,0.979912666829956,0.102792652203058,1,39,DNA-templated transcriptional preinitiation complex assembly,BP,THRA
18325,GO:1903322,0.97999490058855,0.0496843503048255,5,107,positive regulation of protein modification by small protein conjugation or removal,BP,TNIP1;MTA1;PIN1;TOLLIP;PINK1
5785,GO:0017038,0.980043129574917,0.0408389442459375,9,165,protein import,BP,APOE;PEX10;TMEM173;SNX33;BCL6;PEX7;GAS6;TMCO6;AKT1
4593,GO:0010718,0.980131016960644,0.102026267199775,1,38,positive regulation of epithelial to mesenchymal transition,BP,WWTR1
1150,GO:0002758,0.98017116726893,0.0383144297718978,11,194,innate immune response-activating signal transduction,BP,TNIP1;PTPRS;NR1D1;CTSB;PRKACA;RPS6KA5;BTRC;TKFC;MUC19;MAPKAPK3;NLRX1
8785,GO:0034504,0.980331547888632,0.037153855027234,12,204,protein localization to nucleus,BP,ABCA7;TMEM173;BCL6;ARL2;DVL1;GAS6;TMCO6;PIN1;SESN2;AKT1;SUN1;LZTS2
851,GO:0002181,0.980449531612684,0.0592562800901408,3,85,cytoplasmic translation,BP,UNK;ZNF385A;RPL13A
3664,GO:0008170,0.980476467418512,0.0594302070574128,3,75,N-methyltransferase activity,MF,ASH2L;RRNAD1;KMT5C
11069,GO:0045088,0.980617760425721,0.0331109258537643,18,286,regulation of innate immune response,BP,TNIP1;PTPRS;NR1D1;SERPING1;CTSB;RNF135;TMEM173;PRKACA;RPS6KA5;IFNGR2;FAM3A;BTRC;TKFC;MUC19;MAPKAPK3;NLRX1;PYCARD;EREG
17246,GO:0120111,0.980619243169834,0.0706436797659717,2,59,neuron projection cytoplasm,CC,DLG4;ADA
18082,GO:1902749,0.98067188889743,0.0374318962954212,11,195,regulation of cell cycle G2/M phase transition,BP,FHL1;BRSK1;NINL;CSNK1E;CEP250;MTA3;PRKACA;HMGA2;NDE1;ZFYVE19;SFI1
2858,GO:0006357,0.980736901700851,0.0241616282214653,132,1596,regulation of transcription by RNA polymerase II,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;WWC3;CITED4;TCFL5;MEF2D;NOS1;ZFP36L1;NR1D1;EPAS1;IGF2;NFATC4;EGFR;TSC22D1;TCEA2;MXD4;MDFI;EGR1;PKN1;CRTC1;DEAF1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;PIK3R2;PEG3;HDAC5;THRA;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;PKD2;SALL2;HEXB;FOXQ1;ATP2B4;TFDP2;PDCD4;WNT7A;ZMIZ1;ZC3H6;ID1;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;HES2;MNT;ECM1;STAT6;WWTR1;DNAJB5;BCL6;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;CALCOCO1;MAPK3;ETV5;MBD1;FHOD1;HES1;BRD3;MLXIPL;ABCA2;PHF21A;ZFP36;ETV4;ZMYM3;KIAA1549;RPS6KA5;TNFRSF1A;TCF25;SOX13;TRPV4;BHLHE40;HMGA2;ELK3;DGKQ;POU6F1;ZNF217;PPARA;SUFU;PTAFR;ZNF446;RXRA;NEO1;HLTF;ZNF160;RFXANK;TEF;SMARCD2;FGFR1;PIN1;IRF2BPL;PROX1;WBP2;PPP1R13L;JARID2;SESN2;RXRB;ACVR1B;MEF2B;AKT1;ZNF385A;SIX5;SSBP2;PKD1;ARHGEF10L;CAMTA2;ABHD14B;RFX2;TRERF1;THAP8;DDN;LITAF;MZF1;RARG
1523,GO:0003899,0.981205519377916,0.097366398433098,1,41,DNA-directed 5'-3' RNA polymerase activity,MF,PRIMPOL
12510,GO:0050681,0.981327764356859,0.0970654419881389,1,39,androgen receptor binding,MF,PKN1
11118,GO:0045182,0.981345205220589,0.0968928267750505,1,40,translation regulator activity,MF,EIF4EBP3
12101,GO:0048193,0.981410967862786,0.0311075222224208,20,309,Golgi vesicle transport,BP,LMF1;DOPEY2;BBS2;TBC1D14;ANK3;EXOC2;VAMP2;TRAPPC9;MYO18A;AMN;OSBPL5;SPTB;BBS1;GAS6;LLGL1;CTSZ;WHAMMP3;SORL1;EHD3;TMED4
2871,GO:0006378,0.981491461057222,0.0963956037844408,1,39,mRNA polyadenylation,BP,TUT1
3349,GO:0007093,0.981785246814782,0.0390030777373008,8,152,mitotic cell cycle checkpoint,BP,PCBP4;BRSK1;XPC;TFDP2;PIDD1;HMGA2;ZNF385A;ZFYVE19
3237,GO:0006901,0.981917071298973,0.0666634314746937,2,60,vesicle coating,BP,TRAPPC9;CTSZ
2603,GO:0005913,0.981926530550589,0.0556343663216229,3,76,cell-cell adherens junction,CC,NDRG1;CADM4;ITGA6
12389,GO:0048857,0.981960672807183,0.0943671888632298,1,40,neural nucleus development,BP,NDRG2
7734,GO:0032259,0.981996747451776,0.0309339182376389,18,284,methylation,BP,FOS;GAMT;MTHFR;ASH2L;RAB3D;DNMT3A;COMTD1;FAM86C2P;NSUN7;RAB3B;RRNAD1;COMT;ETFB;KMT5C;JARID2;PCMTD2;TDRKH;AS3MT
10671,GO:0043967,0.982158925820548,0.065965112687918,2,59,histone H4 acetylation,BP,JADE2;ING4
6722,GO:0030148,0.982165104710747,0.0550092408814056,3,76,sphingolipid biosynthetic process,BP,KDSR;CERS4;TNFRSF1A
18083,GO:1902750,0.982402642885827,0.0482621173394521,4,97,negative regulation of cell cycle G2/M phase transition,BP,FHL1;BRSK1;HMGA2;ZFYVE19
18108,GO:1902850,0.982502351349128,0.0414027648553292,6,122,microtubule cytoskeleton organization involved in mitosis,BP,TUBG2;SPRY2;CHMP1B;NDE1;WRAP73;PKD1
4183,GO:0009295,0.982542632185831,0.0919581897229081,1,40,nucleoid,CC,MPG
10105,GO:0042645,0.982542632185831,0.0919581897229081,1,40,mitochondrial nucleoid,CC,MPG
15459,GO:0071840,0.98259905357474,0.0203374287369152,424,4804,cellular component organization or biogenesis,BP,HTRA1;ADGRL1;APOE;TYSND1;MARVELD1;ESPN;CTNNBIP1;TSPAN1;PPL;IDH2;PTPRS;ERCC1;FLNC;SEMA4B;FAM110C;GAA;SYTL1;CST3;SHANK2;LTBP4;RAPGEF3;CYP27B1;GSN;EVI5L;NDRG1;NOS1;PARVB;ARAP1;COL6A1;TCTN1;POSTN;GRB7;EFS;ARRDC1;POLD4;EPHB2;EPAS1;OBSCN;CNTN1;IGF2;NFATC4;GPX3;LRP1;KCNG1;LTBP2;OBSL1;EGFR;TIMP2;H1F0;SMOC2;NLGN2;TOM1L2;FHL1;LOXL1;DDB2;MTHFR;ADGRF1;ULK1;PKN1;SDK2;CRTC1;ARPIN;ARHGEF4;DOPEY2;SYT8;NAGLU;SHC1;F2R;PTK6;ABCA7;LAMA5;SLC9A3R2;BAHCC1;BBS2;DNAH1;CORO1B;ULK2;IGSF9;MALL;THBS3;ZMYND8;TBC1D14;ASH2L;PACS2;SOX12;KCNC4;MMP1;ABCG1;ANK3;S100A6;INO80C;NEK9;HDAC5;THRA;NISCH;LRP5;DBNDD1;HYAL1;TUBG2;MARK4;TENM2;PLTP;ZFPM1;TFEB;ERBB2;EXOC2;FBLN1;BRSK1;MICALL2;BSG;SCMH1;PKD2;IQSEC2;ITGB4;ITPR3;PLXNB3;H2AFJ;VAT1;DNM1;FCHO1;MSRB2;IFT140;CUL9;CD9;KIF13B;XPC;NINL;SIGMAR1;PAK6;HEXB;SERPINE2;VPS11;VAMP2;CCDC69;FUZ;NPHP4;UNK;JADE2;THSD4;MINK1;TMOD2;TFDP2;CSNK1E;TRAPPC9;GLUL;RHOD;TNXB;PEX10;ASIC1;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;SH3PXD2B;TBC1D8;FBXW8;ID1;CELSR1;B4GAT1;NDUFS8;RABGGTA;EPHA1;ADARB1;ITGA6;SYNGAP1;NBEAL2;DNMT3A;DNPH1;LPAR3;PRNP;EFNB3;SNX33;SPRY2;SLC12A7;CEP250;ATG16L2;SNX9;DLG4;ABCD1;REEP2;MTA3;STRADB;WWTR1;ISG20;RAB25;MYO18A;TMEM107;PLEKHH2;BCL6;PLXNB1;CHMP1B;IGFBP2;BNIP3;VEGFA;HOOK2;LRRC8A;ARL2;VANGL2;MAST4;AP2A2;SHANK3;HSF4;ADAM15;NUDCD3;S1PR2;ENDOG;MAPK3;TUB;ETV5;CAPNS2;TNNT1;DVL1;MTA1;FYCO1;WIPF1;ADCY6;L3MBTL1;WIPI2;MBD1;EPHB3;FHOD1;HES1;BRD3;SSH1;FURIN;FBF1;CUL7;MEFV;TRIM4;NRP2;PLEKHG2;LRSAM1;FKBP10;CDC42EP5;MCTP1;PHF21A;CELSR2;PFKL;SLIT3;PCSK9;RHOF;HLCS;PRKACA;ZMYM3;DGUOK;CYFIP2;RPS6KA5;HBEGF;ITGB5;RAB3B;MAP2K2;PI4K2A;FGFR4;SPTB;FBXW5;STX10;DMTN;BBS1;MYH3;HDAC11;TNFRSF1A;EHD4;SEMA3B;LDLR;ROBO3;SNX17;TRPV4;RHOBTB2;RRNAD1;CROCC;RAG1;EEF2K;HMGA2;LDLRAP1;SEMA3F;AHNAK2;DGKQ;PEX7;SEMA4C;MVB12A;SDHAF4;PADI3;GAS6;LLGL1;ADGRB2;HMGCL;TSPAN4;WNT7B;DMC1;REEP4;ATG2A;RXRA;VAV3;BCR;TMEM175;NEO1;IGFBP4;TBC1D16;USP21;WDR60;PRKCZ;CLTCL1;HLTF;CAPG;BCORL1;NYAP1;SLITRK6;TWF2;TPP1;GPC1;SRSF5;CEP68;SMARCD2;NDE1;AGO4;ARAP3;CDHR1;FGFR1;CTSZ;CHADL;PIN1;KMT5C;PROX1;WBP2;PCDHGC3;C21ORF2;KCNMA1;BIN1;UNC119B;OSCP1;PI4KAP2;SH3D19;GRB10;BFSP1;JARID2;CAPN2;SESN2;WRAP73;TMEM231;LCAT;RTN4R;EPB41L3;TIMP1;SDC1;WHAMMP3;GRHPR;H1FX;EPS8L1;WNT3;LYST;PPM1F;OLFML2A;SORL1;COL13A1;ACVR1B;TBC1D17;ANO9;ALS2CL;TSNARE1;HGSNAT;ABR;CCDC85B;AKT1;STON1;SEPT8;ADAM19;ZNF385A;TP53INP1;SMARCA1;VPS33B;EPS8L2;TDRKH;SUN1;TMEM120A;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;ARHGEF10L;KDM4B;RGS14;SYNE3;GOLGA2P5;MAFIP;SPIRE2;P3H4;MLST8;RILPL1;ATXN10;EPN2;RFX2;PYCARD;POMT1;KCNN4;DNAAF5;NDUFV3;RANBP9;PRIMPOL;ARHGEF19;SIRT3;SLC2A1;TAZ;MAST3;APBA1;RARG;ING4;EREG;FAM162A;FCHSD1;SHISA6;WDR18;SFI1;KRT15;ADAMTSL4;TTLL11;TMED4;SEMA4F;RPL13A;MIF;SULF2;UBL5
15870,GO:0072666,0.982709741741885,0.0912625987872635,1,40,establishment of protein localization to vacuole,BP,SORL1
13092,GO:0051656,0.982884242440891,0.0279423786358603,23,348,establishment of organelle localization,BP,SYTL1;SYT8;BBS2;DNM1;RIMS3;VAMP2;TRAPPC9;SPRY2;CHMP1B;FYCO1;FHOD1;CROCC;LLGL1;PRKCZ;NDE1;CTSZ;SNPH;ADGRE2;ADORA2B;SUN1;PINK1;SPIRE2;STXBP2
10711,GO:0044085,0.983380826408902,0.0201784533799708,207,2477,cellular component biogenesis,BP,ADGRL1;APOE;TYSND1;ESPN;CTNNBIP1;ERCC1;FLNC;FAM110C;SHANK2;RAPGEF3;GSN;EVI5L;PARVB;ARAP1;COL6A1;TCTN1;GRB7;ARRDC1;EPHB2;OBSCN;GPX3;KCNG1;OBSL1;H1F0;NLGN2;LOXL1;DDB2;ADGRF1;ULK1;SDK2;CRTC1;ARPIN;ARHGEF4;ABCA7;LAMA5;SLC9A3R2;BAHCC1;BBS2;DNAH1;CORO1B;ULK2;ZMYND8;TBC1D14;ASH2L;PACS2;SOX12;KCNC4;MMP1;ANK3;THRA;HYAL1;TUBG2;MARK4;TENM2;EXOC2;MICALL2;PKD2;ITGB4;ITPR3;PLXNB3;DNM1;FCHO1;MSRB2;IFT140;CD9;XPC;NINL;SIGMAR1;VPS11;VAMP2;CCDC69;FUZ;NPHP4;THSD4;TMOD2;CSNK1E;TRAPPC9;GLUL;RHOD;TNXB;ASIC1;WNT7A;INSR;SH3PXD2B;ID1;NDUFS8;RABGGTA;EPHA1;ITGA6;LPAR3;PRNP;CEP250;ATG16L2;SNX9;DLG4;WWTR1;ISG20;TMEM107;CHMP1B;VEGFA;ARL2;VANGL2;SHANK3;HSF4;NUDCD3;S1PR2;MAPK3;TNNT1;DVL1;WIPF1;WIPI2;EPHB3;FHOD1;HES1;SSH1;FBF1;MEFV;TRIM4;PLEKHG2;LRSAM1;CDC42EP5;PFKL;RHOF;PRKACA;CYFIP2;ITGB5;SPTB;DMTN;BBS1;MYH3;TNFRSF1A;EHD4;TRPV4;RHOBTB2;RRNAD1;CROCC;EEF2K;HMGA2;AHNAK2;DGKQ;MVB12A;SDHAF4;GAS6;LLGL1;ADGRB2;HMGCL;TSPAN4;DMC1;ATG2A;RXRA;VAV3;TMEM175;WDR60;PRKCZ;CLTCL1;CAPG;SLITRK6;TWF2;GPC1;SRSF5;NDE1;AGO4;CTSZ;PROX1;BIN1;UNC119B;WRAP73;TMEM231;LCAT;EPB41L3;SDC1;WHAMMP3;GRHPR;H1FX;EPS8L1;PPM1F;SORL1;HGSNAT;SEPT8;TP53INP1;EPS8L2;TMEM120A;SSH3;PINK1;GAS8;EHD3;ARHGEF10L;GOLGA2P5;MAFIP;SPIRE2;P3H4;MLST8;RILPL1;ATXN10;RFX2;PYCARD;DNAAF5;NDUFV3;RANBP9;SLC2A1;TAZ;APBA1;FCHSD1;WDR18;SFI1;RPL13A;MIF
19688,GO:2000058,0.983452318306789,0.0393802566375804,6,125,regulation of ubiquitin-dependent protein catabolic process,BP,CSNK1E;DVL1;MAGEF1;SUFU;RAD23A;AKT1
3285,GO:0006984,0.983528118555812,0.0878305506568883,1,40,ER-nucleus signaling pathway,BP,ARHGEF10L
2939,GO:0006475,0.983654318878461,0.0369700868070083,7,138,internal protein amino acid acetylation,BP,NOS1;JADE2;MAPK3;RPS6KA5;MDH2;WBP2;ING4
42,GO:0000086,0.983702725402106,0.030607555805728,13,225,G2/M transition of mitotic cell cycle,BP,FHL1;BRSK1;NINL;CSNK1E;CEP250;MTA3;PRKACA;PHLDA1;HMGA2;BTRC;NDE1;ZFYVE19;SFI1
12992,GO:0051453,0.98374835177765,0.0609693947132564,2,61,regulation of intracellular pH,BP,TMEM175;SLC9A7
19159,GO:1905268,0.983916318232449,0.0861872777745784,1,40,negative regulation of chromatin organization,BP,JARID2
3190,GO:0006826,0.983991218297662,0.085694924200371,1,42,iron ion transport,BP,SLC25A37
8566,GO:0034062,0.98401859196433,0.0854979513992468,1,43,5'-3' RNA polymerase activity,MF,PRIMPOL
16706,GO:0097747,0.98401859196433,0.0854979513992468,1,43,RNA polymerase activity,MF,PRIMPOL
10593,GO:0043596,0.984069862802227,0.0854454809697977,1,41,nuclear replication fork,CC,POLD4
3656,GO:0008152,0.984160486850409,0.0186404129281905,757,8276,metabolic process,BP,TNIP1;HTRA1;FOS;DUSP6;H6PD;LMF1;CEMIP;APOE;TYSND1;CTNNBIP1;IDH2;RNPEPL1;PTPRS;ERCC1;WWC3;NT5E;GAA;CITED4;NAPRT;BTBD2;PYGB;RNF44;CST3;LTBP4;RAPGEF3;TCFL5;MRC2;PGM1;CYP27B1;GSN;CLCA2;XDH;PRDX5;PGLS;PCBP4;PRSS3;PRODH;MEF2D;NOS1;LTBP1;MARCH9;ARAP1;ZFP36L1;COL6A1;GRB7;NR1D1;CRAT;ALOX15B;ARRDC1;NYNRIN;POLD4;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;CPT2;IGF2;NFATC4;GPX3;NME4;MST1R;LRP1;GAMT;MAPK13;CDK18;ST6GALNAC2;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;MMP28;B3GAT3;HADH;CRYL1;SUGCT;ACSF2;FBXO2;ACOT7;TCEA2;DUSP5;FKBP9;PPP1R14A;ISYNA1;UROS;JOSD2;LOXL1;MXD4;DDB2;SERPING1;MTHFR;KDSR;MDFI;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CRTC1;PYGL;TRIM65;NAGLU;SHC1;F2R;PTK6;BPHL;NPEPL1;ABCA7;DEAF1;PPP2R3B;CA12;BAHCC1;GALE;BBS2;ACTA2;PRSS8;PPM1J;CTSB;LPCAT4;RNF208;SHC2;SLC16A3;CXXC5;ULK2;DGKA;GJC2;DHRS1;D2HGDH;ZMYND8;TBC1D14;ASH2L;ZSCAN18;PACS2;GRAMD4;SOX12;MXI1;CERS4;PLAT;MMP1;ABCG1;ANK3;DHRS11;PIK3R2;OPLAH;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;PLD3;ZP3;CRTAP;RPS6KA2;NMRK1;NISCH;LRP5;HYAL1;ANO8;MARK4;TENM2;PLTP;SLC2A9;MAML3;ZFPM1;TFEB;ERBB2;FBLN1;BRSK1;BSG;CTSF;SCMH1;PTPRU;OGDHL;PKD2;CBS;GID4;TMEM129;FUCA1;TST;CPT1C;EDEM1;ABTB1;SLC7A8;ITGB4;H2AFJ;PHLDA2;VAT1;DNM1;SPRY4;PTHLH;CDKN1C;SALL2;MSRB2;CUL9;CD9;XPC;PTPRE;PAK6;HEXB;SERPINE2;VPS11;GALNT12;FOXQ1;RNF135;LTB4R2;UNK;NTSR1;JADE2;THSD4;CD320;MINK1;ATP2B4;GGT1;SLC6A8;TFDP2;CSNK1E;ACP5;RASA4;PLCD1;TRAPPC9;ZFYVE21;ADAMTS7;PDCD4;GM2A;DHRS4L2;SLC20A1;TNFRSF25;GLUL;DTX3;ZKSCAN1;TNXB;USP20;PEX10;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;RAB3D;PLCXD1;LCE1E;SH3PXD2B;FBXW8;ZC3H6;ID1;AKR7A2;GRK6;MVD;B4GAT1;POLL;NDUFS8;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;TXNRD3;SYNGAP1;HAGH;FBXO27;PPP1R35;DNMT3A;DNPH1;LPAR3;TMEM173;PRNP;SERINC2;DHX32;PAPLN;SRD5A3;IAH1;RNASET2;FBXL8;SNX33;FBXO41;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;ECM1;ATG16L2;SNX9;STAT6;DLG4;SPEG;ABCD1;MARCH2;FGGY;MTA3;MKNK2;PLCD3;NT5DC1;STRADB;TALDO1;WWTR1;ISG20;FAM20C;MYO18A;DNAJB5;BCL6;ANKZF1;UCKL1;PFKFB2;FAM213A;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;BNIP3;CD81;SRMS;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;VANGL2;MAST4;FBXW4;AP2A2;CEBPB;RHBDF2;DPP7;SHANK3;HSD11B1L;ACVR2B;HSF4;ADAM15;NAB2;CALCOCO1;ZDHHC1;S1PR2;ENDOG;TNFRSF6B;MAPK3;FBXL16;KCNAB2;ETV5;AMN;GLB1;CAPNS2;DHTKD1;EXD3;RAB40B;DVL1;ENTPD2;GALK1;MTA1;LHPP;FYCO1;KLHL29;GPSM1;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;PHGDH;ST3GAL3;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;PHYHD1;PC;ACAD10;SSH1;COMTD1;FURIN;MLXIPL;ZNF624;NAGS;FAM86C2P;MBOAT7;CUL7;MEFV;ARHGAP22;SLC2A3;TRIM4;NADK;ABCA2;TK2;LRSAM1;ZNF414;LY6K;ADA;FKBP10;CDC42EP5;OSBPL5;PYCR2;PIDD1;RETSAT;PHF21A;CELSR2;ACY1;CKMT1A;PFKL;IL6R;SLIT3;PCSK9;GGACT;SLC28A2;ZFP36;ETV4;BTBD11;MAPKBP1;HLCS;FGFR3;NSUN7;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;KIAA1549;LRRK1;NUDT10;PLCH2;DGUOK;MAGEF1;CYFIP2;RPS6KA5;HBEGF;RAB3B;MAP2K2;PI4K2A;DAP;FGFR4;SPTB;FBXW5;MXRA8;TSPAN33;DMTN;PMVK;MYH3;MDGA1;XYLT2;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;TCF25;LDLR;PTOV1;LYPLAL1;CYP3A5;ACOT11;SNX17;SOX13;ABHD17C;TRPV4;MPG;PIGZ;BHLHE40;EIF4EBP3;RRNAD1;RAG1;ZNF80;DUSP7;PHLDA1;EEF2K;RHBDL1;MSLN;HMGA2;LDLRAP1;TM7SF2;ELK3;AHNAK2;DGKQ;PEX7;SEMA4C;MVB12A;HK1;NMRAL1;ZXDC;MIB2;FBXO17;CHST6;SDHAF4;PADI3;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;HMGCL;TKFC;GUK1;STK32C;WNT7B;BLVRB;COMT;ALDH16A1;TTC7B;SUFU;AIG1;PTAFR;RFNG;DMC1;IMPA2;PAN2;ZNF446;ATG2A;RXRA;PCK2;PCSK1;VAV3;LRP10;BCR;NEO1;IGFBP4;SDHA;MUC19;TBC1D16;USP21;RNF123;PRKCZ;ADAMTS13;ZDHHC24;HLTF;MDH2;BCORL1;INPP5D;ETFB;ABCD4;ZNF485;LSM14B;KLHDC8B;TPP1;PDK2;GPC1;TMX4;SRSF5;ZNF160;RFXANK;TEF;SMOX;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;CAMKK1;SPSB3;PIN1;MAN1B1;MN1;PNPLA4;ZNF563;C5;KMT5C;PHYH;IRF2BPL;CMBL;PROX1;WBP2;GTPBP1;DLG3;ESYT2;BIN1;SERPINB6;PI4KAP2;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;CES2;GRB10;JARID2;CAPN2;SESN2;NDUFA4L2;TOLLIP;ADCK5;TSTA3;TMEM161A;RXRB;CSTB;MAN2B2;PNRC1;MAPRE3;DUSP23;LCAT;GUCA1B;MACROD1;GAL3ST4;PTMS;PITPNM3;TMPRSS11D;CYBRD1;MADD;LMLN;RTN4R;ELFN2;OR7D2;PIGV;TIMP1;SDC1;GRHPR;APOBEC3C;PIGQ;WNT3;GSTT1;ZFP41;PPM1F;KIAA1191;SBF1;SORL1;STK39;COL13A1;VEGFB;ACVR1B;MEF2B;TBC1D17;ZSCAN30;GSS;AHCYL2;ADORA2B;TPCN1;HGSNAT;ERBB3;ZER1;CCDC85B;CYP2S1;CCDC71L;AKT1;HPDL;CTSD;TRAP1;NLRX1;ADAM19;ZNF385A;TP53INP1;NDRG2;TUT1;SMARCA1;VPS33B;SIX5;ERCC6;PCMTD2;ACP6;GPD1L;TDRKH;SLC5A5;NAGA;SPPL2B;IL17RD;UQCR11;SSBP2;RPL39L;ADCK2;SSH3;PINK1;PKD1;EHD3;LONP2;SNTA1;ARHGEF10L;KDM4B;CAMTA2;PLPPR2;RGS14;PCIF1;MAFIP;HEXDC;EIF4G3;ZNF710;CTSH;ABHD14B;P3H4;MLST8;AGPAT4;RSAD1;CBLC;RFX2;RNF187;PYCARD;MAP2K3;PNPO;POMT1;TRERF1;PCSK1N;THAP8;DDN;PMS2P5;AS3MT;NDUFV3;STK17A;ERN1;RANBP9;ZNF319;APOBEC3F;PRIMPOL;ACADS;FBXL20;GCAT;MOCS1;SIRT3;ALKBH6;GLI4;SLC2A1;CPNE7;MLYCD;TAZ;RNASEK;JAK3;BCKDHA;MAST3;LITAF;APBA1;MZF1;NEIL1;FUK;RARG;ING4;EIF4E3;GALNS;PBXIP1;EREG;FAM162A;PPCS;GSTM2;ABHD14A;ZNF514;PODXL2;TRIM7;GIPR;WDR18;SFI1;ADAMTSL4;TRNP1;TTLL11;ZNF837;POLM;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;UBL5
2803,GO:0006270,0.984624158817716,0.0830771432979643,1,41,DNA replication initiation,BP,WDR18
13729,GO:0060333,0.984650536654028,0.0581015205678055,2,62,interferon-gamma-mediated signaling pathway,BP,IFNGR2;PTAFR
1448,GO:0003682,0.984739598541878,0.0237721484181751,30,439,chromatin binding,MF,FOS;NFATC4;EGFR;H1F0;EGR1;PKN1;BAHCC1;ZMYND8;ASH2L;HDAC5;THRA;DNMT3A;MNT;MTA3;BCL6;CEBPB;CALCOCO1;MTA1;L3MBTL1;BRD3;PHF21A;HMGA2;RXRA;SMARCD2;WBP2;JARID2;SMARCA1;ERCC6;CAMTA2;PRIMPOL
14668,GO:0070316,0.984740791413197,0.0825760778481609,1,41,regulation of G0 to G1 transition,BP,TFDP2
11403,GO:0045839,0.984841259864536,0.0820611074419317,1,42,negative regulation of mitotic nuclear division,BP,TOM1L2
10615,GO:0043631,0.98497308415628,0.0815752398442347,1,41,RNA polyadenylation,BP,TUT1
17804,GO:1901990,0.985308949896521,0.0242204041055694,23,357,regulation of mitotic cell cycle phase transition,BP,PCBP4;ZFP36L1;EGFR;FHL1;GJC2;HYAL1;BRSK1;PKD2;XPC;NINL;TFDP2;CSNK1E;CEP250;MTA3;PIDD1;PRKACA;HMGA2;NDE1;AKT1;ZNF385A;PKD1;ZFYVE19;SFI1
5957,GO:0018394,0.98534370090523,0.0335271942004553,7,140,peptidyl-lysine acetylation,BP,NOS1;JADE2;HINT2;MAPK3;RPS6KA5;WBP2;ING4
15266,GO:0071479,0.985523749377199,0.0553296437197038,2,62,cellular response to ionizing radiation,BP,EGR1;HMGA2
2839,GO:0006325,0.985529563482577,0.0208745671965801,47,660,chromatin organization,BP,NOS1;IGF2;H1F0;DDB2;MTHFR;PKN1;BAHCC1;ZMYND8;ASH2L;INO80C;HDAC5;ZFPM1;SCMH1;H2AFJ;JADE2;DNMT3A;MTA3;BCL6;VEGFA;HSF4;MAPK3;MTA1;L3MBTL1;MBD1;BRD3;FKBP10;PHF21A;HLCS;RPS6KA5;HDAC11;RAG1;HMGA2;PADI3;USP21;HLTF;BCORL1;SMARCD2;KMT5C;WBP2;JARID2;H1FX;PPM1F;SMARCA1;PINK1;KDM4B;SIRT3;ING4
16224,GO:0090307,0.985535421732412,0.0553268232346754,2,61,mitotic spindle assembly,BP,CHMP1B;WRAP73
4473,GO:0010501,0.98554853227577,0.0790790138550706,1,41,RNA secondary structure unwinding,BP,AGO4
411,GO:0001098,0.985691120138171,0.0783764990716053,1,42,basal transcription machinery binding,MF,ERCC1
412,GO:0001099,0.985691120138171,0.0783764990716053,1,42,basal RNA polymerase II transcription machinery binding,MF,ERCC1
5730,GO:0016887,0.985770958349741,0.0235195785790328,23,349,ATPase activity,MF,ABCA7;DNAH1;ABCG1;KIF13B;ATP2B4;DHX32;ATP7B;ABCD1;ATP12A;TNNT1;ABCA2;MYH3;DMC1;WDR60;HLTF;ABCD4;SMARCA1;ERCC6;LONP2;PMS2P5;WDR63;KIFC2;KIF26B
11070,GO:0045089,0.985803896036913,0.0264361653201145,14,241,positive regulation of innate immune response,BP,TNIP1;PTPRS;NR1D1;CTSB;TMEM173;PRKACA;RPS6KA5;BTRC;TKFC;MUC19;MAPKAPK3;NLRX1;PYCARD;EREG
10721,GO:0044106,0.985847940603931,0.0449970993517604,3,84,cellular amine metabolic process,BP,ATP2B4;COMT;SMOX
3342,GO:0007077,0.986174761746588,0.0762554417846114,1,42,mitotic nuclear envelope disassembly,BP,NEK9
17805,GO:1901991,0.986185440452505,0.0275627438819486,11,202,negative regulation of mitotic cell cycle phase transition,BP,PCBP4;ZFP36L1;FHL1;GJC2;BRSK1;PKD2;TFDP2;PIDD1;HMGA2;ZNF385A;ZFYVE19
3227,GO:0006888,0.986195480814229,0.0292708900171392,9,171,ER to Golgi vesicle-mediated transport,BP,LMF1;ANK3;TRAPPC9;SPTB;GAS6;CTSZ;WHAMMP3;SORL1;TMED4
3626,GO:0008094,0.986233733077655,0.0440377349327861,3,79,DNA-dependent ATPase activity,MF,DMC1;SMARCA1;ERCC6
11024,GO:0045023,0.986250866766311,0.075920022236059,1,42,G0 to G1 transition,BP,TFDP2
3298,GO:0007006,0.986262016598855,0.0389029134646,4,99,mitochondrial membrane organization,BP,TFDP2;BNIP3;PINK1;TAZ
5467,GO:0016410,0.986273444246873,0.0439090891216177,3,80,N-acyltransferase activity,MF,CERS4;NAGS;HGSNAT
17506,GO:1901028,0.986279752361915,0.0757179018212033,1,43,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,TFDP2
16096,GO:0090114,0.986313323901324,0.0527625252635988,2,63,COPII-coated vesicle budding,BP,TRAPPC9;CTSZ
13256,GO:0051972,0.986409926775732,0.0752175152552239,1,42,regulation of telomerase activity,BP,MAPK3
2489,GO:0005743,0.98649577568131,0.0219634224390937,25,407,mitochondrial inner membrane,CC,IDH2;PRODH;CRAT;CPT2;NME4;HADH;DHRS1;TST;NDUFS8;CKMT1A;SLC25A37;SDHAF4;HMGCL;SDHA;MDH2;SLC25A27;NDUFA4L2;SMDT1;SLC25A29;TRAP1;UQCR11;PINK1;NDUFV3;GCAT;TAZ
3293,GO:0006998,0.986650044906482,0.0428741479385637,3,80,nuclear envelope organization,BP,NEK9;REEP4;SUN1
11120,GO:0045184,0.986931125455055,0.0166606184745133,127,1587,establishment of protein localization,BP,LMF1;CEMIP;APOE;IDH2;SYTL1;RAPGEF3;EVI5L;POSTN;NR1D1;ALOX15B;ARRDC1;LRP1;LTBP2;EGFR;B3GAT3;HADH;NLGN2;TOM1L2;RHBDF1;DOPEY2;F2R;BBS2;TBC1D14;ABCG1;ANK3;PIK3R2;LRP5;ERBB2;EXOC2;MICALL2;TMEM129;EDEM1;ITPR3;PRAF2;KIF13B;VPS11;VAMP2;FUZ;TFDP2;AGAP1;GLUL;RHOD;PEX10;RAB3D;TBC1D8;TMEM173;PRNP;SNX33;ATG16L2;SNX9;DLG4;REEP2;STRADB;RAB25;MYO18A;BCL6;PFKFB2;CHMP1B;MVB12B;HOOK2;ARL2;AP2A2;RHBDF2;ACVR2B;ZDHHC1;MAPK3;OLFM2;AMN;RAB40B;HES1;LRSAM1;PFKL;MAPKBP1;PITPNM1;RAB3B;STX10;DMTN;BBS1;VGF;SNX17;TRPV4;PEX7;MVB12A;HK1;GAS6;LLGL1;GUK1;PCK2;BCR;TBC1D16;PRKCZ;ZDHHC24;CLTCL1;TM7SF3;TMCO6;SRSF5;C5;WBP2;VSNL1;UNC119B;OSCP1;RTN2;LYST;SORL1;TBC1D17;TSNARE1;AKT1;VPS33B;PINK1;PKD1;EHD3;LONP2;SYNE3;SPIRE2;RILPL1;PYCARD;KCNN4;SIRT3;SLC2A1;APBA1;GIPR;TMED4;RPL13A;RAB40C;MIF;STXBP2;UBL5
331,GO:0000922,0.987168834045438,0.0297557537259173,7,142,spindle pole,CC,FAM110C;FBF1;MAPKBP1;PLEKHG6;WDR60;NDE1;RGS14
10275,GO:0043044,0.987230058683087,0.0496185386821212,2,69,ATP-dependent chromatin remodeling,BP,SMARCD2;SMARCA1
12103,GO:0048199,0.987340686534182,0.0493927617031616,2,64,vesicle targeting, to, from or within Golgi,BP,TRAPPC9;CTSZ
3344,GO:0007080,0.987358279871523,0.0709146708369548,1,43,mitotic metaphase plate congression,BP,CHMP1B
3041,GO:0006606,0.98748816831539,0.0328558545144653,5,113,protein import into nucleus,BP,TMEM173;BCL6;GAS6;TMCO6;AKT1
6223,GO:0019783,0.987612856042316,0.035571096381505,4,97,ubiquitin-like protein-specific protease activity,MF,JOSD2;USP20;ANKZF1;USP21
7826,GO:0032392,0.987623794596802,0.0401570027082794,3,81,DNA geometric change,BP,DDB2;XPC;SMARCA1
12976,GO:0051427,0.987753955745,0.0285316706292863,7,143,hormone receptor binding,MF,PKN1;PTHLH;CEBPB;RXRA;PROX1;WBP2;RARG
18340,GO:1903363,0.987758390125055,0.0479923961958219,2,65,negative regulation of cellular protein catabolic process,BP,FURIN;SUFU
10088,GO:0042623,0.987800966273627,0.0215637936169542,18,290,ATPase activity, coupled,MF,ABCA7;DNAH1;ABCG1;ATP2B4;DHX32;ATP7B;ABCD1;ATP12A;TNNT1;ABCA2;MYH3;DMC1;WDR60;ABCD4;SMARCA1;ERCC6;LONP2;WDR63
11377,GO:0045786,0.987862700352007,0.0184087188778655,37,533,negative regulation of cell cycle,BP,NDRG1;PCBP4;ZFP36L1;CGREF1;ALOX15B;EGFR;TIMP2;TOM1L2;FHL1;PPP2R3B;GJC2;RPS6KA2;BRSK1;PKD2;CDKN1C;XPC;TFDP2;PDCD4;PRNP;STRADB;BCL6;MLXIPL;PIDD1;PRKACA;HMGA2;GAS6;PROX1;BIN1;WHAMMP3;ZNF385A;TP53INP1;PKD1;MLST8;ERN1;ING4;ZFYVE19;MIF
11451,GO:0045930,0.988038208023369,0.0217952582725188,16,272,negative regulation of mitotic cell cycle,BP,PCBP4;ZFP36L1;EGFR;TIMP2;TOM1L2;FHL1;GJC2;BRSK1;PKD2;XPC;TFDP2;BCL6;PIDD1;HMGA2;ZNF385A;ZFYVE19
13038,GO:0051568,0.988919253474607,0.0636592360086656,1,45,histone H3-K4 methylation,BP,ASH2L
8811,GO:0034605,0.989043233058102,0.0292136327609075,5,114,cellular response to heat,BP,HSF4;MAPK3;PRKACA;TRPV4;MLST8
4295,GO:0009755,0.989048663015469,0.0246613889032666,8,158,hormone-mediated signaling pathway,BP,NR1D1;THRA;CALCOCO1;PPARA;RXRA;WBP2;RXRB;RARG
2965,GO:0006513,0.989064177634377,0.0436457616717348,2,65,protein monoubiquitination,BP,DDB2;RAG1
11865,GO:0046902,0.989076420173473,0.0435790335897036,2,66,regulation of mitochondrial membrane permeability,BP,TFDP2;BNIP3
8924,GO:0034976,0.989078363097736,0.0207668893599499,14,242,response to endoplasmic reticulum stress,BP,FBXO2;SHC1;PIK3R2;TMEM129;EDEM1;ANKZF1;CEBPB;CUL7;TPP1;TMX4;MAN1B1;SESN2;POMT1;ERN1
430,GO:0001158,0.989523818431617,0.0420930661265818,2,65,enhancer sequence-specific DNA binding,MF,ZNF704;SMARCD2
17803,GO:1901989,0.989596721702994,0.041820870817694,2,66,positive regulation of cell cycle phase transition,BP,HYAL1;MTA3
38,GO:0000077,0.989785243445198,0.0242315110366192,7,146,DNA damage checkpoint,BP,PCBP4;BRSK1;XPC;TFDP2;PIDD1;HMGA2;ZNF385A
9025,GO:0035257,0.989844188842901,0.0254796148273466,6,131,nuclear hormone receptor binding,MF,PKN1;CEBPB;RXRA;PROX1;WBP2;RARG
3197,GO:0006839,0.989913902209805,0.0192842441056776,14,249,mitochondrial transport,BP,CPT2;MICALL2;TST;VPS11;TFDP2;BNIP3;HES1;SLC25A37;OSCP1;SLC25A27;SMDT1;SLC25A29;PINK1;UBL5
13733,GO:0060337,0.990036156592693,0.0402772848566457,2,68,type I interferon signaling pathway,BP,EGR1;ISG20
15183,GO:0071357,0.990036156592693,0.0402772848566457,2,68,cellular response to type I interferon,BP,EGR1;ISG20
10854,GO:0044403,0.990110999298429,0.0143765264775116,50,715,symbiont process,BP,TNIP1;APOE;GSN;RBCK1;RAB11FIP4;EGFR;ULK1;CRTC1;SHC1;CTSB;ULK2;PACS2;MMP1;EXOC2;FBLN1;INSR;ADARB1;TMEM173;EFNB3;ATG16L2;ISG20;UCKL1;CHMP1B;MVB12B;BNIP3;CD81;AP2A2;MAPK3;PC;FURIN;CUL7;TNFRSF14;LRSAM1;ZFP36;ITGB5;TNFRSF1A;LDLR;HMGA2;MVB12A;GAS6;BTRC;RXRA;RAD23A;PROX1;BIN1;APOBEC3C;NLRX1;EIF4G3;APOBEC3F;RPL13A
17801,GO:1901987,0.990160344717837,0.0164833248056684,24,379,regulation of cell cycle phase transition,BP,PCBP4;ZFP36L1;EGFR;FHL1;GJC2;HYAL1;BRSK1;PKD2;XPC;NINL;ATP2B4;TFDP2;CSNK1E;CEP250;MTA3;PIDD1;PRKACA;HMGA2;NDE1;AKT1;ZNF385A;PKD1;ZFYVE19;SFI1
5551,GO:0016573,0.990166238335379,0.0247567948183889,6,131,histone acetylation,BP,NOS1;JADE2;MAPK3;RPS6KA5;WBP2;ING4
6565,GO:0022402,0.990192791895665,0.0131565608115918,88,1137,cell cycle process,BP,ERCC1;CYP27B1;PCBP4;ARAP1;ZFP36L1;CGREF1;POLD4;IGF2;RAB11FIP4;OBSL1;EGFR;TOM1L2;FHL1;PPP2R3B;GJC2;ANK3;NEK9;LRP5;HYAL1;TUBG2;BRSK1;PKD2;CDKN1C;CUL9;XPC;NINL;PAK6;CCDC69;ATP2B4;TFDP2;CSNK1E;RHOD;INSR;PRNP;SNX33;SPRY2;CEP250;SNX9;MTA3;STRADB;BCL6;CHMP1B;ARL2;L3MBTL1;MLXIPL;CUL7;PIDD1;RHOF;PRKACA;FBXW5;RHOBTB2;CROCC;PHLDA1;HMGA2;GAS6;BTRC;LLGL1;GIT1;DMC1;REEP4;CEP68;NDE1;AGO4;FGFR1;PIN1;BIN1;WRAP73;WHAMMP3;ACVR1B;AKT1;SEPT8;ZNF385A;TP53INP1;TDRKH;SUN1;PKD1;RGS14;GOLGA2P5;SPIRE2;P3H4;MLST8;ERN1;ING4;EREG;ZFYVE19;WDR18;SFI1;MIF
3741,GO:0008287,0.990198959598748,0.0576436275254297,1,45,protein serine/threonine phosphatase complex,CC,PPP2R3B
18306,GO:1903293,0.990198959598748,0.0576436275254297,1,45,phosphatase complex,CC,PPP2R3B
20146,GO:2001020,0.990203273348146,0.0222840368763412,8,162,regulation of response to DNA damage stimulus,BP,ERCC1;EGFR;NSMCE4A;MAGEF1;HMGA2;TMEM161A;ZNF385A;MIF
2899,GO:0006417,0.990274384403298,0.0162980713145061,24,386,regulation of translation,BP,ZFP36L1;GRB7;EGFR;ERBB2;UNK;MKNK2;MAPK3;ZFP36;CYFIP2;MAP2K2;EIF4EBP3;MEX3A;PTAFR;RXRA;LSM14B;AGO4;SESN2;AKT1;TRAP1;ZNF385A;PINK1;EIF4G3;EIF4E3;RPL13A
10995,GO:0044843,0.990291430734733,0.0190121766145006,13,233,cell cycle G1/S phase transition,BP,PCBP4;EGFR;FHL1;GJC2;HYAL1;PKD2;ATP2B4;TFDP2;PIDD1;ACVR1B;AKT1;ZNF385A;PKD1
6915,GO:0030520,0.990295135550226,0.0571844715469655,1,45,intracellular estrogen receptor signaling pathway,BP,WBP2
2964,GO:0006511,0.990450839305967,0.0148196783116149,35,515,ubiquitin-dependent protein catabolic process,BP,BTBD2;RNF44;ARRDC1;RBCK1;FBXO2;GID4;TMEM129;EDEM1;ABTB1;CUL9;CSNK1E;USP20;WWTR1;ANKZF1;MVB12B;FBXW4;DVL1;MTA1;CUL7;BTBD11;MAGEF1;FBXW5;MVB12A;BTRC;SUFU;USP21;RAD23A;SPSB3;MAN1B1;TOLLIP;AKT1;PINK1;CBLC;RNF187;FBXL20
4191,GO:0009308,0.99050080745567,0.0318575294279005,3,89,amine metabolic process,BP,ATP2B4;COMT;SMOX
5305,GO:0016032,0.990502887377265,0.0139747451626345,47,680,viral process,BP,TNIP1;APOE;GSN;RBCK1;RAB11FIP4;EGFR;CRTC1;SHC1;CTSB;PACS2;MMP1;FBLN1;INSR;ADARB1;TMEM173;EFNB3;ATG16L2;ISG20;UCKL1;CHMP1B;MVB12B;BNIP3;CD81;AP2A2;MAPK3;PC;FURIN;CUL7;TNFRSF14;LRSAM1;ZFP36;ITGB5;TNFRSF1A;LDLR;HMGA2;MVB12A;GAS6;BTRC;RXRA;RAD23A;PROX1;BIN1;APOBEC3C;NLRX1;EIF4G3;APOBEC3F;RPL13A
282,GO:0000785,0.990517249738594,0.0152748878046687,29,457,chromatin,CC,MEF2D;NR1D1;APPL2;H1F0;BAHCC1;ASH2L;INO80C;H2AFJ;SALL2;DNMT3A;STAT6;PHC2;CEBPB;CALCOCO1;L3MBTL1;HLCS;HMGA2;RXRA;SMARCD2;KMT5C;WBP2;CAPN2;H1FX;MEF2B;ZNF385A;SMARCA1;PINK1;RARG;TRNP1
11388,GO:0045815,0.990536804177667,0.0383868123013464,2,77,positive regulation of gene expression, epigenetic,BP,WBP2;ERCC6
8818,GO:0034620,0.99055408559796,0.0238766766949386,6,132,cellular response to unfolded protein,BP,SHC1;EDEM1;CUL7;TM7SF3;TPP1;ERN1
7124,GO:0030968,0.990568189550611,0.0255609220299953,5,117,endoplasmic reticulum unfolded protein response,BP,SHC1;EDEM1;CUL7;TPP1;ERN1
11455,GO:0045934,0.990587227813697,0.0127202187743351,84,1098,negative regulation of nucleobase-containing compound metabolic process,BP,CTNNBIP1;ERCC1;WWC3;TCFL5;PRDX5;NR1D1;IGF2;NFATC4;MXD4;MDFI;EGR1;SHC1;DEAF1;BAHCC1;CXXC5;ZMYND8;MXI1;PEG3;HDAC5;THRA;ZP3;TENM2;ZFPM1;SCMH1;H2AFJ;CDKN1C;SALL2;FOXQ1;LTB4R2;TFDP2;PDCD4;ZC3H6;ID1;ZNF692;DNMT3A;HES2;MNT;STAT6;MTA3;WWTR1;DNAJB5;BCL6;FZD8;VEGFA;CEBPB;ACVR2B;HSF4;NAB2;MTA1;L3MBTL1;MBD1;HES1;MLXIPL;PHF21A;ZFP36;MAGEF1;RPS6KA5;DAP;TCF25;TRPV4;BHLHE40;HMGA2;ELK3;GAS6;BTRC;POU6F1;ZNF217;PPARA;SUFU;RXRA;FGFR1;IRF2BPL;PROX1;PPP1R13L;JARID2;PPM1F;CCDC85B;SIX5;MZF1;NEIL1;RARG;ING4;PBXIP1;EREG
19366,GO:1905897,0.990793557927368,0.0376911745707927,2,67,regulation of response to endoplasmic reticulum stress,BP,EDEM1;ERN1
3291,GO:0006996,0.990832437717113,0.0111242490879294,262,3092,organelle organization,BP,APOE;ESPN;PPL;IDH2;ERCC1;GAA;SYTL1;SHANK2;RAPGEF3;GSN;EVI5L;NOS1;PARVB;ARAP1;TCTN1;GRB7;EFS;POLD4;EPAS1;OBSCN;IGF2;LRP1;OBSL1;H1F0;NLGN2;TOM1L2;DDB2;MTHFR;ULK1;PKN1;ARPIN;DOPEY2;SYT8;NAGLU;SHC1;F2R;LAMA5;BAHCC1;BBS2;DNAH1;CORO1B;ULK2;ZMYND8;TBC1D14;ASH2L;PACS2;ANK3;INO80C;NEK9;HDAC5;NISCH;LRP5;TUBG2;MARK4;ZFPM1;TFEB;BRSK1;MICALL2;SCMH1;PKD2;IQSEC2;H2AFJ;VAT1;DNM1;MSRB2;IFT140;CUL9;XPC;NINL;PAK6;HEXB;SERPINE2;VPS11;VAMP2;CCDC69;FUZ;NPHP4;JADE2;MINK1;TMOD2;TFDP2;CSNK1E;TRAPPC9;RHOD;TNXB;PEX10;SPATA18;INSR;SH3PXD2B;TBC1D8;FBXW8;ID1;CELSR1;NDUFS8;EPHA1;DNMT3A;SNX33;SPRY2;CEP250;ATG16L2;SNX9;DLG4;ABCD1;REEP2;MTA3;WWTR1;MYO18A;TMEM107;PLEKHH2;BCL6;PLXNB1;CHMP1B;BNIP3;VEGFA;HOOK2;ARL2;VANGL2;MAST4;SHANK3;HSF4;NUDCD3;S1PR2;MAPK3;TNNT1;DVL1;MTA1;FYCO1;WIPF1;L3MBTL1;WIPI2;MBD1;FHOD1;HES1;BRD3;SSH1;FBF1;CUL7;PLEKHG2;LRSAM1;FKBP10;CDC42EP5;PHF21A;RHOF;HLCS;PRKACA;ZMYM3;RPS6KA5;ITGB5;MAP2K2;PI4K2A;SPTB;FBXW5;STX10;DMTN;BBS1;MYH3;HDAC11;TRPV4;RHOBTB2;CROCC;RAG1;HMGA2;PEX7;MVB12A;SDHAF4;PADI3;LLGL1;HMGCL;DMC1;REEP4;ATG2A;VAV3;BCR;TMEM175;TBC1D16;USP21;WDR60;PRKCZ;HLTF;CAPG;BCORL1;TWF2;TPP1;CEP68;SMARCD2;NDE1;AGO4;ARAP3;CTSZ;PIN1;KMT5C;PROX1;WBP2;C21ORF2;BIN1;UNC119B;OSCP1;PI4KAP2;SH3D19;BFSP1;JARID2;CAPN2;SESN2;WRAP73;TMEM231;EPB41L3;SDC1;WHAMMP3;H1FX;EPS8L1;LYST;PPM1F;TBC1D17;ALS2CL;TSNARE1;ABR;AKT1;SEPT8;ZNF385A;TP53INP1;SMARCA1;VPS33B;EPS8L2;TDRKH;SUN1;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;ARHGEF10L;KDM4B;RGS14;SYNE3;GOLGA2P5;MAFIP;SPIRE2;P3H4;MLST8;RILPL1;ATXN10;RFX2;PYCARD;DNAAF5;NDUFV3;RANBP9;PRIMPOL;ARHGEF19;SIRT3;TAZ;MAST3;ING4;EREG;FAM162A;FCHSD1;WDR18;SFI1;KRT15;TTLL11;TMED4;UBL5
6875,GO:0030397,0.990873276667558,0.0543500715099868,1,46,membrane disassembly,BP,NEK9
12761,GO:0051081,0.990873276667558,0.0543500715099868,1,46,nuclear envelope disassembly,BP,NEK9
13152,GO:0051784,0.990988460181806,0.0537420096539707,1,47,negative regulation of nuclear division,BP,TOM1L2
5751,GO:0016925,0.991159816991324,0.0299830453726546,3,85,protein sumoylation,BP,EGR1;MTA1;TOLLIP
40,GO:0000082,0.991186490696738,0.0177981810387005,12,221,G1/S transition of mitotic cell cycle,BP,PCBP4;EGFR;FHL1;GJC2;HYAL1;PKD2;TFDP2;PIDD1;ACVR1B;AKT1;ZNF385A;PKD1
2428,GO:0005623,0.991204337912403,0.0117369598856629,1041,11117,cell,CC,TNIP1;HTRA1;FOS;DUSP6;H6PD;LMF1;CEMIP;ADGRL1;APOE;TYSND1;MARVELD1;ESPN;CTNNBIP1;MARCKSL1;TSPAN1;PPL;IDH2;RNPEPL1;PTPRS;ERCC1;WWC3;FLNC;SEMA4B;FAM110C;NT5E;GAA;SYTL1;CLIP2;LTB4R;CITED4;NAPRT;BTBD2;PYGB;RNF44;CST3;SHANK2;RAPGEF3;TCFL5;MRC2;PGM1;CYP27B1;GSN;CLCA2;EVI5L;XDH;PRDX5;NDRG1;PGLS;PCBP4;PRSS3;PRODH;CADM4;MEF2D;NOS1;LTBP1;MARCH9;PARVB;ARAP1;ZFP36L1;COL6A1;TCTN1;POSTN;GRB7;NR1D1;CRAT;EFS;ALOX15B;ARRDC1;EPN3;FAM210B;POLD4;SCN8A;SLCO4A1;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;CPT2;RHPN1;MYZAP;IGF2;NFATC4;NME4;MST1R;LRP1;GAMT;MAPK13;APPL2;HEBP1;KCNG1;CDK18;RALGDS;ST6GALNAC2;LTBP2;RAB11FIP4;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;MMP28;B3GAT3;HADH;NLGN2;CRYL1;SUGCT;ACSF2;REEP6;FBXO2;ACOT7;TCEA2;DUSP5;TOM1L2;FKBP9;HS1BP3;PPP1R14A;ISYNA1;SLC43A1;UROS;FHL1;JOSD2;LOXL1;MXD4;DDB2;SERPING1;MTHFR;KDSR;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;SDK2;CRTC1;ARPIN;PYGL;ARHGEF4;TRIM65;DOPEY2;SYT8;NAGLU;SHC1;RGL2;F2R;PTK6;GNAL;BPHL;NPEPL1;ABCA7;DEAF1;LAMA5;PPP2R3B;SLC9A3R2;CA12;BAHCC1;GALE;BBS2;SLC16A5;ACTA2;PRSS8;TMCC3;S100A4;CTSB;ESRG;LPCAT4;DNAH1;RNF208;SHC2;PITPNC1;SLC16A3;CORO1B;CXXC5;ULK2;DGKA;GJC2;IGSF9;DHRS1;MALL;THBS3;D2HGDH;ZMYND8;TBC1D14;ASH2L;ZSCAN18;PACS2;GRAMD4;SOX12;MXI1;CERS4;PLAT;KCNC4;ABCG1;RIN1;ANK3;NOL4L;PIK3R2;OPLAH;S100A6;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;ARHGAP23;PLD3;KCNJ15;DOCK4;ZP3;CRTAP;CSMD2;RPS6KA2;NMRK1;NISCH;LRP5;DBNDD1;HYAL1;TUBG2;ANO8;MARK4;TENM2;SLC2A9;LRP3;MAML3;B4GALNT4;ZFPM1;BCAM;TFEB;ERBB2;SLC13A3;EXOC2;BRSK1;MICALL2;BSG;CTSF;SCMH1;PTPRU;OGDHL;PKD2;CBS;TMEM129;FUCA1;TST;SCN4B;IQSEC2;CPT1C;EDEM1;ABTB1;VWA5A;SLC7A8;ITGB4;ITPR3;PLXNB3;H2AFJ;PRAF2;PHLDA2;VAT1;DNM1;SPRY4;DDIT4L;FCHO1;MPRIP;PTHLH;CDKN1C;RIMS3;LRP11;SALL2;MSRB2;IFT140;VIPR1;CUL9;CD9;KIF13B;XPC;PTPRE;ANGEL1;NINL;SIGMAR1;PAK6;HEXB;SERPINE2;VPS11;VAMP2;CCDC69;FUZ;GALNT12;FOXQ1;RNF135;NPHP4;LTB4R2;UNK;NTSR1;JADE2;CD320;MINK1;RALGAPA2;ATP2B4;GGT1;SNN;TMOD2;SLC6A8;TFDP2;PHF7;CSNK1E;ACP5;RASA4;PLCD1;TRAPPC9;AGAP1;ZFYVE21;DIRC2;ADAMTS7;ENKD1;PDCD4;DOCK6;TMEM134;GM2A;SLC20A1;BEX2;ACAP3;TNFRSF25;GLUL;PRR7;RHOD;DTX3;ZKSCAN1;ARVCF;TNXB;USP20;PEX10;ARMCX2;ASIC1;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;RAB3D;PLCXD1;LCE1E;SH3PXD2B;TBC1D8;FBXW8;ZC3H6;ID1;CELSR1;AKR7A2;GRK6;MVD;LGALS9C;MZT2A;B4GAT1;POLL;WDR27;NDUFS8;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;CCNG2;TXNRD3;SYNGAP1;IL20RB;NBEAL2;HAGH;FBXO27;DNMT3A;DNPH1;LPAR3;TMEM173;PRNP;DHX32;SRD5A3;OXLD1;ATP7B;EFNB3;RNASET2;FBXL8;SNX33;FBXO41;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;SLC12A7;ECM1;CEP250;NPDC1;ATG16L2;SNX9;STAT6;DLG4;SPEG;ABCD1;MARCH2;REEP2;FGGY;MTA3;MKNK2;PLCD3;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;MYO18A;TMEM107;ARHGAP27;CERCAM;MZT2B;DNAJB5;MYCBPAP;PHC2;SCART1;PLEKHH2;C1ORF210;BCL6;TTYH3;ANKZF1;UCKL1;PFKFB2;ATP12A;PLXNB1;FAM213A;CHMP1B;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;TMEM92;BNIP3;CD81;SRMS;FCGRT;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;HOOK2;LRRC8A;ARL2;YPEL3;VANGL2;MAST4;FBXW4;ELMO3;AP2A2;CEBPB;RHBDF2;DPP7;GPRC5C;SHANK3;HSD11B1L;ACVR2B;HSF4;ADAM15;NAB2;NUDCD3;CALCOCO1;ZDHHC1;S1PR2;ENDOG;TNFRSF6B;MAPK3;PDZD2;FBXL16;PLEKHG5;TUB;KCNAB2;ETV5;OLFM2;CARD19;AMN;SLC22A18;GLB1;CAPNS2;DHTKD1;EXD3;ARL10;C19ORF33;RAB40B;TNNT1;DVL1;ENTPD2;GALK1;MTA1;LHPP;FYCO1;KLHL29;WIPF1;GPSM1;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;PHGDH;ST3GAL3;SLC16A13;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;TMEM25;PC;ACAD10;YPEL2;SSH1;COMTD1;FURIN;MLXIPL;ZNF624;NAGS;FBF1;MBOAT7;SLC48A1;SAMD3;CUL7;MEFV;EVC;ARHGAP22;SLC2A3;TRIM4;NRP2;GPR153;NADK;PLEKHG2;ABCA2;TNFRSF14;TK2;LRSAM1;ZNF414;LY6K;ADA;FKBP10;CDC42EP5;TRIM45;MCTP1;OSBPL5;PYCR2;PIDD1;RETSAT;PAG1;PHF21A;SH2D2A;AQP3;HTR7;RASL10B;MYH16;CELSR2;ACY1;CKMT1A;PFKL;IL6R;SLIT3;PCSK9;TMEM9;SLC28A2;ZFP36;ETV4;RHOF;BTBD11;MAPKBP1;HLCS;CYHR1;RSPH3;FGFR3;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;KIAA1549;LRRK1;NUDT10;PLCH2;DGUOK;CYFIP2;SLC38A10;RPS6KA5;SCNN1A;HBEGF;SLC25A37;ITGB5;RAB3B;MAP2K2;PI4K2A;FGFR4;SPTB;FBXW5;MXRA8;SLC37A2;STX10;TSPAN33;DMTN;RAPGEF5;PMVK;BBS1;MYH3;PSD4;MDGA1;XYLT2;HDAC11;VGF;TNFRSF1A;SEZ6L2;EHD4;MAPK8IP1;TCF25;SEMA3B;LDLR;PTOV1;FAM214B;LYPLAL1;CYP3A5;ACOT11;ROBO3;SNX17;SOX13;ABHD17C;TRPV4;MPG;RHOBTB2;PIGZ;IFNGR2;BHLHE40;EIF4EBP3;CROCC;CCDC92;RAG1;ZNF80;DUSP7;PHLDA1;LRRC45;TNFAIP8L1;EEF2K;RHBDL1;MSLN;HMGA2;LDLRAP1;TM7SF2;ELK3;AHNAK2;DGKQ;PEX7;KLHDC2;SEMA4C;MVB12A;HK1;NMRAL1;ZXDC;SLC29A4;MIB2;FBXO17;CHST6;SDHAF4;PADI3;GAS6;BTRC;MEX3A;POU6F1;LLGL1;ANKS6;ADGRB2;ZNF217;PPARA;HMGCL;TKFC;GUK1;TSPAN4;TMEM187;STK32C;WNT7B;BLVRB;GIT1;COMT;TTC7B;SUFU;AIG1;PTAFR;PLEKHG6;RFNG;ANKRD13D;DMC1;IMPA2;ARHGEF37;PAN2;REEP4;ZNF446;ATG2A;RXRA;PCK2;PCSK1;VAV3;LRP10;VASN;BCR;TMEM175;NEO1;IGFBP4;SDHA;GSDMC;MUC19;TBC1D16;USP21;RNF123;WDR60;PRKCZ;ADAMTS13;ZDHHC24;CLTCL1;HLTF;MDH2;CAPG;BCORL1;INPP5D;TM7SF3;TMCO6;ETFB;ABCD4;SPATA7;NYAP1;SLITRK6;TWF2;ZNF485;SH3GLB2;KLHDC8B;TPP1;PDK2;GPC1;TMX4;ICOSLG;SRSF5;ZNF160;RFXANK;TEF;SMOX;CEP68;SMARCD2;MAPKAPK3;NDE1;AGO4;RAD23A;ARAP3;CDHR1;FGFR1;CTSZ;CAMKK1;SPSB3;PIN1;MAN1B1;PNPLA4;ZNF563;C5;KMT5C;PHYH;TMEM204;IRF2BPL;CMBL;PROX1;WBP2;GTPBP1;PCDHGC3;C21ORF2;NICN1;ASAP2;DLG3;GPR155;KCNMA1;ESYT2;BIN1;VSNL1;MTMR11;UNC119B;YIPF3;TMEM8B;SERPINB6;OSCP1;PI4KAP2;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;CES2;SLC25A27;GRB10;BFSP1;JARID2;SYNC;CAPN2;SESN2;NDUFA4L2;TOLLIP;WNT2B;TSTA3;WRAP73;RXRB;CSTB;PROCR;SNPH;MAN2B2;TMEM231;PNRC1;MAPRE3;DUSP23;GUCA1B;MACROD1;ADGRE2;GAL3ST4;SMDT1;PTMS;PITPNM3;TMPRSS11D;CYBRD1;MADD;LMLN;RTN4R;OR7D2;EPB41L3;PIGV;SLC9A7;TIMP1;CD68;SDC1;WHAMMP3;GRHPR;SH2B3;ACTR1B;APOBEC3C;FGFBP1;RTN2;H1FX;PEAR1;EPS8L1;PLEKHH3;PIGQ;WNT3;LYST;GSTT1;ZFP41;PPM1F;KIAA1191;MICALCL;SBF1;SORL1;STK39;COL13A1;VEGFB;ACVR1B;MEF2B;TBC1D17;ANO9;GSDMA;ZSCAN30;GSS;AHCYL2;ALS2CL;TSNARE1;ADORA2B;TPCN1;HGSNAT;SLC25A29;ERBB3;ABR;ZER1;CCDC85B;PNMA1;CYP2S1;AKT1;CTSD;TRAP1;STON1;TMBIM4;NLRX1;SEPT8;ADAM19;ZNF385A;TP53INP1;LRCH4;NDRG2;TUT1;SMARCA1;VPS33B;SIX5;ERCC6;PCMTD2;ACP6;GPD1L;EPS8L2;TDRKH;SLC5A5;SUN1;NAGA;TMEM120A;SPPL2B;IL17RD;UQCR11;SSBP2;RPL39L;R3HDM2;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;MPLKIP;SNTA1;ARHGEF10L;KDM4B;CAMTA2;HOMER2;LGALS9B;PLPPR2;RGS14;SYNE3;PLEKHH1;GOLGA2P5;PCIF1;MAFIP;SPIRE2;CCDC106;R3HDM4;HEXDC;EIF4G3;ZNF710;CTSH;EHBP1L1;ABHD14B;P3H4;MLST8;AGPAT4;RILPL1;NRSN1;RSAD1;CBLC;ATXN10;EPN2;RFX2;RNF187;PYCARD;MAP2K3;PNPO;RHBG;POMT1;TRERF1;PCSK1N;KCNN4;DNAAF5;DDN;PMS2P5;AS3MT;NDUFV3;STK17A;ERN1;RANBP9;ZNF319;APOBEC3F;PRIMPOL;ACADS;FBXL20;GCAT;WDR63;MOCS1;ARHGEF19;SIRT3;ALKBH6;GLI4;C12ORF66;SLC2A1;CPNE7;MLYCD;TAZ;JAK3;BCKDHA;MAST3;KIFC2;LITAF;APBA1;MZF1;NEIL1;FUK;ORAI2;RARG;ING4;EIF4E3;GALNS;PBXIP1;EREG;FAM162A;PPCS;FCHSD1;GSTM2;ABHD14A;ZNF514;PODXL2;ZFYVE19;TRIM7;SHISA6;MORN4;GIPR;WDR18;PQLC2;SFI1;KRT15;ADAMTSL4;TRNP1;TTLL11;ZNF837;TMED4;POLM;SEMA4F;FAM50A;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;STXBP2;KIF26B;UBL5;LZTS2
263,GO:0000731,0.991253830708802,0.0360661250370848,2,68,DNA synthesis involved in DNA repair,BP,POLD4;PRIMPOL
5842,GO:0017148,0.991476075851989,0.0176983194905304,11,216,negative regulation of translation,BP,ZFP36L1;GRB7;EGFR;UNK;ZFP36;MAP2K2;EIF4EBP3;MEX3A;AGO4;SESN2;RPL13A
2845,GO:0006338,0.99150022218529,0.0205008309798373,7,155,chromatin remodeling,BP,BAHCC1;INO80C;HDAC5;SCMH1;HMGA2;SMARCD2;SMARCA1
2530,GO:0005793,0.991524475292658,0.0254570693829223,4,103,endoplasmic reticulum-Golgi intermediate compartment,CC,MYO18A;CTSZ;WHAMMP3;TMED4
2929,GO:0006458,0.991583460575457,0.0508321437401725,1,47,'de novo' protein folding,BP,FYCO1
2262,GO:0005198,0.991880174386524,0.0129227468415627,32,510,structural molecule activity,MF,APOE;MARVELD1;PPL;WWC3;SHANK2;OBSCN;OBSL1;SLC9A3R2;MALL;ANK3;TUBG2;FBLN1;NPHP4;LAMB2;LCE1E;SHANK3;SPTB;MAPK8IP1;CROCC;LDLRAP1;LLGL1;CLTCL1;BFSP1;SYNC;EPB41L3;SEPT8;RPL39L;SNTA1;HOMER2;RGS14;KRT15;RPL13A
2928,GO:0006457,0.991904368773391,0.0168914183798088,11,211,protein folding,BP,LTBP4;FKBP9;CRTAP;DNAJC4;DNAJB5;NUDCD3;FYCO1;FKBP10;TMX4;TRAP1;ALG12
6269,GO:0019882,0.991944472903068,0.0186397845673213,8,170,antigen processing and presentation,BP,CTSF;AP2A2;ITGB5;RAB3B;ACTR1B;CTSD;CTSH;PYCARD
5956,GO:0018393,0.992003659454114,0.0205588999090287,6,134,internal peptidyl-lysine acetylation,BP,NOS1;JADE2;MAPK3;RPS6KA5;WBP2;ING4
15886,GO:0072686,0.992054898571287,0.0273186637400793,3,86,mitotic spindle,CC,PKD2;MAPKBP1;CAPG
3620,GO:0008088,0.992065738272282,0.0483961303219324,1,48,axo-dendritic transport,BP,APBA1
16840,GO:0098798,0.992068663062035,0.0170333494875982,10,218,mitochondrial protein complex,CC,NDUFS8;ANKZF1;SDHAF4;SDHA;PDK2;NDUFA4L2;SMDT1;PINK1;NDUFV3;BCKDHA
10994,GO:0044839,0.992207449010538,0.0155153173186881,13,239,cell cycle G2/M phase transition,BP,FHL1;BRSK1;NINL;CSNK1E;CEP250;MTA3;PRKACA;PHLDA1;HMGA2;BTRC;NDE1;ZFYVE19;SFI1
3328,GO:0007049,0.992266904257764,0.010057080006485,123,1542,cell cycle,BP,MARVELD1;ERCC1;CYP27B1;NDRG1;PCBP4;ARAP1;ZFP36L1;CGREF1;ALOX15B;POLD4;IGF2;MAPK13;APPL2;RAB11FIP4;OBSL1;EGFR;TIMP2;TOM1L2;FHL1;PTK6;PPP2R3B;GJC2;ANK3;NEK9;RPS6KA2;LRP5;HYAL1;TUBG2;MARK4;BRSK1;PKD2;CDKN1C;CUL9;XPC;NINL;PAK6;CCDC69;MINK1;ATP2B4;TFDP2;CSNK1E;PDCD4;BEX2;RHOD;INSR;ID1;ADARB1;CCNG2;DNMT3A;PRNP;SNX33;SPRY2;MNT;CEP250;SNX9;MTA3;STRADB;BCL6;CHMP1B;ARL2;MAPK3;L3MBTL1;HES1;MLXIPL;CUL7;PIDD1;RHOF;PRKACA;MAP2K2;FBXW5;RHOBTB2;CROCC;PHLDA1;HMGA2;GAS6;BTRC;LLGL1;GIT1;DMC1;REEP4;BCR;CLTCL1;KLHDC8B;SRSF5;CEP68;NDE1;AGO4;RAD23A;FGFR1;PIN1;PROX1;BIN1;TMEM8B;WRAP73;MAPRE3;MADD;LMLN;WHAMMP3;STK39;ACVR1B;AKT1;SEPT8;ZNF385A;TP53INP1;TDRKH;SUN1;PKD1;MPLKIP;RGS14;GOLGA2P5;SPIRE2;P3H4;MLST8;MAP2K3;ERN1;ING4;EREG;ZFYVE19;WDR18;SFI1;TRNP1;MIF;LZTS2
9898,GO:0042255,0.992282088843104,0.0470883600863837,1,54,ribosome assembly,BP,WDR18
10333,GO:0043161,0.992361384882794,0.013121727202845,23,371,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,BTBD2;RNF44;RBCK1;FBXO2;GID4;TMEM129;EDEM1;ABTB1;CSNK1E;WWTR1;ANKZF1;FBXW4;DVL1;MTA1;BTBD11;FBXW5;BTRC;RAD23A;SPSB3;MAN1B1;AKT1;RNF187;FBXL20
10896,GO:0044464,0.99239031211058,0.0101975853822015,1040,11112,cell part,CC,TNIP1;HTRA1;FOS;DUSP6;H6PD;LMF1;CEMIP;ADGRL1;APOE;TYSND1;MARVELD1;ESPN;CTNNBIP1;MARCKSL1;TSPAN1;PPL;IDH2;RNPEPL1;PTPRS;ERCC1;WWC3;FLNC;SEMA4B;FAM110C;NT5E;GAA;SYTL1;CLIP2;LTB4R;CITED4;NAPRT;BTBD2;PYGB;RNF44;CST3;SHANK2;RAPGEF3;TCFL5;MRC2;PGM1;CYP27B1;GSN;CLCA2;EVI5L;XDH;PRDX5;NDRG1;PGLS;PCBP4;PRSS3;PRODH;CADM4;MEF2D;NOS1;LTBP1;MARCH9;PARVB;ARAP1;ZFP36L1;COL6A1;TCTN1;POSTN;GRB7;NR1D1;CRAT;EFS;ALOX15B;ARRDC1;EPN3;FAM210B;POLD4;SCN8A;SLCO4A1;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;CPT2;RHPN1;MYZAP;IGF2;NFATC4;NME4;MST1R;LRP1;GAMT;MAPK13;APPL2;HEBP1;KCNG1;CDK18;RALGDS;ST6GALNAC2;LTBP2;RAB11FIP4;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;MMP28;B3GAT3;HADH;NLGN2;CRYL1;SUGCT;ACSF2;REEP6;FBXO2;ACOT7;TCEA2;DUSP5;TOM1L2;FKBP9;HS1BP3;PPP1R14A;ISYNA1;SLC43A1;UROS;FHL1;JOSD2;LOXL1;MXD4;DDB2;SERPING1;MTHFR;KDSR;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;SDK2;CRTC1;ARPIN;PYGL;ARHGEF4;TRIM65;DOPEY2;SYT8;NAGLU;SHC1;RGL2;F2R;PTK6;GNAL;BPHL;NPEPL1;ABCA7;DEAF1;LAMA5;PPP2R3B;SLC9A3R2;CA12;BAHCC1;GALE;BBS2;SLC16A5;ACTA2;PRSS8;TMCC3;S100A4;CTSB;ESRG;LPCAT4;DNAH1;RNF208;SHC2;PITPNC1;SLC16A3;CORO1B;CXXC5;ULK2;DGKA;GJC2;IGSF9;DHRS1;MALL;THBS3;D2HGDH;ZMYND8;TBC1D14;ASH2L;ZSCAN18;PACS2;GRAMD4;SOX12;MXI1;CERS4;PLAT;KCNC4;ABCG1;RIN1;ANK3;NOL4L;PIK3R2;OPLAH;S100A6;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;ARHGAP23;PLD3;KCNJ15;DOCK4;ZP3;CRTAP;CSMD2;RPS6KA2;NMRK1;NISCH;LRP5;DBNDD1;HYAL1;TUBG2;ANO8;MARK4;TENM2;SLC2A9;LRP3;MAML3;B4GALNT4;ZFPM1;BCAM;TFEB;ERBB2;SLC13A3;EXOC2;BRSK1;MICALL2;BSG;CTSF;SCMH1;PTPRU;OGDHL;PKD2;CBS;TMEM129;FUCA1;TST;SCN4B;IQSEC2;CPT1C;EDEM1;ABTB1;VWA5A;SLC7A8;ITGB4;ITPR3;PLXNB3;H2AFJ;PRAF2;PHLDA2;VAT1;DNM1;SPRY4;DDIT4L;FCHO1;MPRIP;PTHLH;CDKN1C;RIMS3;LRP11;SALL2;MSRB2;IFT140;VIPR1;CUL9;CD9;KIF13B;XPC;PTPRE;ANGEL1;NINL;SIGMAR1;PAK6;HEXB;SERPINE2;VPS11;VAMP2;CCDC69;FUZ;GALNT12;FOXQ1;RNF135;NPHP4;LTB4R2;UNK;NTSR1;JADE2;CD320;MINK1;RALGAPA2;ATP2B4;GGT1;SNN;TMOD2;SLC6A8;TFDP2;PHF7;CSNK1E;ACP5;RASA4;PLCD1;TRAPPC9;AGAP1;ZFYVE21;DIRC2;ADAMTS7;ENKD1;PDCD4;DOCK6;TMEM134;GM2A;SLC20A1;BEX2;ACAP3;TNFRSF25;GLUL;PRR7;RHOD;DTX3;ZKSCAN1;ARVCF;TNXB;USP20;PEX10;ARMCX2;ASIC1;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;RAB3D;PLCXD1;LCE1E;SH3PXD2B;TBC1D8;FBXW8;ZC3H6;ID1;CELSR1;AKR7A2;GRK6;MVD;LGALS9C;MZT2A;B4GAT1;POLL;WDR27;NDUFS8;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;CCNG2;TXNRD3;SYNGAP1;IL20RB;NBEAL2;HAGH;FBXO27;DNMT3A;DNPH1;LPAR3;TMEM173;PRNP;DHX32;SRD5A3;OXLD1;ATP7B;EFNB3;RNASET2;FBXL8;SNX33;FBXO41;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;SLC12A7;ECM1;CEP250;NPDC1;ATG16L2;SNX9;STAT6;DLG4;SPEG;ABCD1;MARCH2;REEP2;MTA3;MKNK2;PLCD3;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;MYO18A;TMEM107;ARHGAP27;CERCAM;MZT2B;DNAJB5;MYCBPAP;PHC2;SCART1;PLEKHH2;C1ORF210;BCL6;TTYH3;ANKZF1;UCKL1;PFKFB2;ATP12A;PLXNB1;FAM213A;CHMP1B;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;TMEM92;BNIP3;CD81;SRMS;FCGRT;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;HOOK2;LRRC8A;ARL2;YPEL3;VANGL2;MAST4;FBXW4;ELMO3;AP2A2;CEBPB;RHBDF2;DPP7;GPRC5C;SHANK3;HSD11B1L;ACVR2B;HSF4;ADAM15;NAB2;NUDCD3;CALCOCO1;ZDHHC1;S1PR2;ENDOG;TNFRSF6B;MAPK3;PDZD2;FBXL16;PLEKHG5;TUB;KCNAB2;ETV5;OLFM2;CARD19;AMN;SLC22A18;GLB1;CAPNS2;DHTKD1;EXD3;ARL10;C19ORF33;RAB40B;TNNT1;DVL1;ENTPD2;GALK1;MTA1;LHPP;FYCO1;KLHL29;WIPF1;GPSM1;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;PHGDH;ST3GAL3;SLC16A13;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;TMEM25;PC;ACAD10;YPEL2;SSH1;COMTD1;FURIN;MLXIPL;ZNF624;NAGS;FBF1;MBOAT7;SLC48A1;SAMD3;CUL7;MEFV;EVC;ARHGAP22;SLC2A3;TRIM4;NRP2;GPR153;NADK;PLEKHG2;ABCA2;TNFRSF14;TK2;LRSAM1;ZNF414;LY6K;ADA;FKBP10;CDC42EP5;TRIM45;MCTP1;OSBPL5;PYCR2;PIDD1;RETSAT;PAG1;PHF21A;SH2D2A;AQP3;HTR7;RASL10B;MYH16;CELSR2;ACY1;CKMT1A;PFKL;IL6R;SLIT3;PCSK9;TMEM9;SLC28A2;ZFP36;ETV4;RHOF;BTBD11;MAPKBP1;HLCS;CYHR1;RSPH3;FGFR3;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;KIAA1549;LRRK1;NUDT10;PLCH2;DGUOK;CYFIP2;SLC38A10;RPS6KA5;SCNN1A;HBEGF;SLC25A37;ITGB5;RAB3B;MAP2K2;PI4K2A;FGFR4;SPTB;FBXW5;MXRA8;SLC37A2;STX10;TSPAN33;DMTN;RAPGEF5;PMVK;BBS1;MYH3;PSD4;MDGA1;XYLT2;HDAC11;VGF;TNFRSF1A;SEZ6L2;EHD4;MAPK8IP1;TCF25;SEMA3B;LDLR;PTOV1;FAM214B;LYPLAL1;CYP3A5;ACOT11;ROBO3;SNX17;SOX13;ABHD17C;TRPV4;MPG;RHOBTB2;PIGZ;IFNGR2;BHLHE40;EIF4EBP3;CROCC;CCDC92;RAG1;ZNF80;DUSP7;PHLDA1;LRRC45;TNFAIP8L1;EEF2K;RHBDL1;MSLN;HMGA2;LDLRAP1;TM7SF2;ELK3;AHNAK2;DGKQ;PEX7;KLHDC2;SEMA4C;MVB12A;HK1;NMRAL1;ZXDC;SLC29A4;MIB2;FBXO17;CHST6;SDHAF4;PADI3;GAS6;BTRC;MEX3A;POU6F1;LLGL1;ANKS6;ADGRB2;ZNF217;PPARA;HMGCL;TKFC;GUK1;TSPAN4;TMEM187;STK32C;WNT7B;BLVRB;GIT1;COMT;TTC7B;SUFU;AIG1;PTAFR;PLEKHG6;RFNG;ANKRD13D;DMC1;IMPA2;ARHGEF37;PAN2;REEP4;ZNF446;ATG2A;RXRA;PCK2;PCSK1;VAV3;LRP10;VASN;BCR;TMEM175;NEO1;IGFBP4;SDHA;GSDMC;MUC19;TBC1D16;USP21;RNF123;WDR60;PRKCZ;ADAMTS13;ZDHHC24;CLTCL1;HLTF;MDH2;CAPG;BCORL1;INPP5D;TM7SF3;TMCO6;ETFB;ABCD4;SPATA7;NYAP1;SLITRK6;TWF2;ZNF485;SH3GLB2;KLHDC8B;TPP1;PDK2;GPC1;TMX4;ICOSLG;SRSF5;ZNF160;RFXANK;TEF;SMOX;CEP68;SMARCD2;MAPKAPK3;NDE1;AGO4;RAD23A;ARAP3;CDHR1;FGFR1;CTSZ;CAMKK1;SPSB3;PIN1;MAN1B1;PNPLA4;ZNF563;C5;KMT5C;PHYH;TMEM204;IRF2BPL;CMBL;PROX1;WBP2;GTPBP1;PCDHGC3;C21ORF2;NICN1;ASAP2;DLG3;GPR155;KCNMA1;ESYT2;BIN1;VSNL1;MTMR11;UNC119B;YIPF3;TMEM8B;SERPINB6;OSCP1;PI4KAP2;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;CES2;SLC25A27;GRB10;BFSP1;JARID2;SYNC;CAPN2;SESN2;NDUFA4L2;TOLLIP;WNT2B;TSTA3;WRAP73;RXRB;CSTB;PROCR;SNPH;MAN2B2;TMEM231;PNRC1;MAPRE3;DUSP23;GUCA1B;MACROD1;ADGRE2;GAL3ST4;SMDT1;PTMS;PITPNM3;TMPRSS11D;CYBRD1;MADD;LMLN;RTN4R;OR7D2;EPB41L3;PIGV;SLC9A7;TIMP1;CD68;SDC1;WHAMMP3;GRHPR;SH2B3;ACTR1B;APOBEC3C;FGFBP1;RTN2;H1FX;PEAR1;EPS8L1;PLEKHH3;PIGQ;WNT3;LYST;GSTT1;ZFP41;PPM1F;KIAA1191;MICALCL;SBF1;SORL1;STK39;COL13A1;VEGFB;ACVR1B;MEF2B;TBC1D17;ANO9;GSDMA;ZSCAN30;GSS;AHCYL2;ALS2CL;TSNARE1;ADORA2B;TPCN1;HGSNAT;SLC25A29;ERBB3;ABR;ZER1;CCDC85B;PNMA1;CYP2S1;AKT1;CTSD;TRAP1;STON1;TMBIM4;NLRX1;SEPT8;ADAM19;ZNF385A;TP53INP1;LRCH4;NDRG2;TUT1;SMARCA1;VPS33B;SIX5;ERCC6;PCMTD2;ACP6;GPD1L;EPS8L2;TDRKH;SLC5A5;SUN1;NAGA;TMEM120A;SPPL2B;IL17RD;UQCR11;SSBP2;RPL39L;R3HDM2;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;MPLKIP;SNTA1;ARHGEF10L;KDM4B;CAMTA2;HOMER2;LGALS9B;PLPPR2;RGS14;SYNE3;PLEKHH1;GOLGA2P5;PCIF1;MAFIP;SPIRE2;CCDC106;R3HDM4;HEXDC;EIF4G3;ZNF710;CTSH;EHBP1L1;ABHD14B;P3H4;MLST8;AGPAT4;RILPL1;NRSN1;RSAD1;CBLC;ATXN10;EPN2;RFX2;RNF187;PYCARD;MAP2K3;PNPO;RHBG;POMT1;TRERF1;PCSK1N;KCNN4;DNAAF5;DDN;PMS2P5;AS3MT;NDUFV3;STK17A;ERN1;RANBP9;ZNF319;APOBEC3F;PRIMPOL;ACADS;FBXL20;GCAT;WDR63;MOCS1;ARHGEF19;SIRT3;ALKBH6;GLI4;C12ORF66;SLC2A1;CPNE7;MLYCD;TAZ;JAK3;BCKDHA;MAST3;KIFC2;LITAF;APBA1;MZF1;NEIL1;FUK;ORAI2;RARG;ING4;EIF4E3;GALNS;PBXIP1;EREG;FAM162A;PPCS;FCHSD1;GSTM2;ABHD14A;ZNF514;PODXL2;ZFYVE19;TRIM7;SHISA6;MORN4;GIPR;WDR18;PQLC2;SFI1;KRT15;ADAMTSL4;TRNP1;TTLL11;ZNF837;TMED4;POLM;SEMA4F;FAM50A;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;STXBP2;KIF26B;UBL5;LZTS2
6917,GO:0030522,0.992442080871784,0.0154538423770539,12,220,intracellular receptor signaling pathway,BP,CYP27B1;NR1D1;ALOX15B;THRA;CALCOCO1;PPARA;TKFC;RXRA;WBP2;RXRB;NLRX1;RARG
9527,GO:0036297,0.992480403493976,0.0463153487973379,1,48,interstrand cross-link repair,BP,ERCC1
8210,GO:0032984,0.992532754873937,0.0143131058841891,15,274,protein-containing complex disassembly,BP,GSN;LRP5;TMOD2;INSR;PLEKHH2;CHMP1B;BNIP3;DVL1;FYCO1;SPTB;DMTN;TRPV4;CAPG;TWF2;SMARCD2
6298,GO:0019941,0.992869275092913,0.01123342739038,35,523,modification-dependent protein catabolic process,BP,BTBD2;RNF44;ARRDC1;RBCK1;FBXO2;GID4;TMEM129;EDEM1;ABTB1;CUL9;CSNK1E;USP20;WWTR1;ANKZF1;MVB12B;FBXW4;DVL1;MTA1;CUL7;BTBD11;MAGEF1;FBXW5;MVB12A;BTRC;SUFU;USP21;RAD23A;SPSB3;MAN1B1;TOLLIP;AKT1;PINK1;CBLC;RNF187;FBXL20
7217,GO:0031124,0.992913237669046,0.0247114635909229,3,88,mRNA 3'-end processing,BP,ZFP36L1;SRSF5;TUT1
4504,GO:0010564,0.992973479280207,0.010653800109703,43,621,regulation of cell cycle process,BP,PCBP4;ZFP36L1;IGF2;RAB11FIP4;OBSL1;EGFR;TOM1L2;FHL1;GJC2;LRP5;HYAL1;BRSK1;PKD2;CUL9;XPC;NINL;ATP2B4;TFDP2;CSNK1E;INSR;CEP250;MTA3;BCL6;CHMP1B;L3MBTL1;MLXIPL;CUL7;PIDD1;PRKACA;FBXW5;HMGA2;GIT1;NDE1;FGFR1;PIN1;BIN1;AKT1;ZNF385A;PKD1;EREG;ZFYVE19;SFI1;MIF
14980,GO:0070936,0.993033806523292,0.0434602678058686,1,49,protein K48-linked ubiquitination,BP,RNF187
16307,GO:0090559,0.993064163550775,0.0295535605590333,2,71,regulation of membrane permeability,BP,TFDP2;BNIP3
8143,GO:0032886,0.99309133248014,0.0162257321606047,8,166,regulation of microtubule-based process,BP,BBS2;ERBB2;CEP250;CHMP1B;ARL2;FBXW5;TRPV4;PKD1
3040,GO:0006605,0.993098055579857,0.0121775890939049,21,367,protein targeting,BP,CEMIP;LTBP2;ANK3;ERBB2;MICALL2;KIF13B;VPS11;RHOD;PEX10;PRNP;ZDHHC1;HES1;DMTN;PEX7;ZDHHC24;OSCP1;SORL1;PINK1;LONP2;RPL13A;UBL5
10862,GO:0044419,0.993120620378333,0.0101630663904733,50,728,interspecies interaction between organisms,BP,TNIP1;APOE;GSN;RBCK1;RAB11FIP4;EGFR;ULK1;CRTC1;SHC1;CTSB;ULK2;PACS2;MMP1;EXOC2;FBLN1;INSR;ADARB1;TMEM173;EFNB3;ATG16L2;ISG20;UCKL1;CHMP1B;MVB12B;BNIP3;CD81;AP2A2;MAPK3;PC;FURIN;CUL7;TNFRSF14;LRSAM1;ZFP36;ITGB5;TNFRSF1A;LDLR;HMGA2;MVB12A;GAS6;BTRC;RXRA;RAD23A;PROX1;BIN1;APOBEC3C;NLRX1;EIF4G3;APOBEC3F;RPL13A
7861,GO:0032434,0.993166388523683,0.0210348562262095,4,106,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,CSNK1E;DVL1;RAD23A;AKT1
8875,GO:0034708,0.993221951669849,0.0237510691182627,3,90,methyltransferase complex,CC,ASH2L;INO80C;JARID2
17802,GO:1901988,0.993254307444165,0.0142793151925843,11,215,negative regulation of cell cycle phase transition,BP,PCBP4;ZFP36L1;FHL1;GJC2;BRSK1;PKD2;TFDP2;PIDD1;HMGA2;ZNF385A;ZFYVE19
4539,GO:0010629,0.993319190525979,0.00883591067807513,110,1432,negative regulation of gene expression,BP,CTNNBIP1;WWC3;TCFL5;XDH;PRDX5;PCBP4;ZFP36L1;GRB7;NR1D1;IGF2;NFATC4;EGFR;MXD4;SERPING1;MDFI;EGR1;SHC1;DEAF1;BAHCC1;BBS2;CXXC5;ZMYND8;MXI1;PEG3;HDAC5;THRA;ZP3;TENM2;ZFPM1;SCMH1;H2AFJ;CDKN1C;SALL2;SERPINE2;FOXQ1;UNK;TFDP2;PDCD4;ZC3H6;ID1;ZNF692;DNMT3A;PRNP;HES2;MNT;STAT6;MTA3;WWTR1;DNAJB5;BCL6;FZD8;VEGFA;CEBPB;ACVR2B;HSF4;NAB2;L3MBTL1;MBD1;HES1;PC;MLXIPL;PHF21A;SLIT3;ZFP36;RPS6KA5;MAP2K2;DAP;TCF25;LDLR;TRPV4;BHLHE40;EIF4EBP3;HMGA2;ELK3;DGKQ;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;SUFU;PAN2;RXRA;AGO4;FGFR1;CTSZ;IRF2BPL;PROX1;GTPBP1;PPP1R13L;JARID2;SESN2;PNRC1;PPM1F;ACVR1B;CCDC85B;AKT1;TP53INP1;SIX5;TDRKH;PINK1;ERN1;MZF1;RARG;ING4;PBXIP1;EREG;RPL13A;MIF
4948,GO:0015030,0.993373643752152,0.041637310678081,1,51,Cajal body,CC,ISG20
9666,GO:0038061,0.993395777198159,0.0203837717755022,4,110,NIK/NF-kappaB signaling,BP,EGFR;PDCD4;BTRC;AKT1
8919,GO:0034968,0.993431543943588,0.0231186907919093,3,89,histone lysine methylation,BP,ASH2L;KMT5C;JARID2
3331,GO:0007052,0.993455420472054,0.0202534686295284,4,105,mitotic spindle organization,BP,TUBG2;CHMP1B;WRAP73;PKD1
6250,GO:0019843,0.993469360646144,0.0409871750828536,1,56,rRNA binding,MF,TST
7919,GO:0032508,0.993633287550369,0.0274672682908359,2,71,DNA duplex unwinding,BP,DDB2;XPC
2853,GO:0006352,0.993641919491761,0.013933059925467,10,205,DNA-templated transcription, initiation,BP,CTNNBIP1;NR1D1;THRA;MAML3;WWTR1;MAPK3;PPARA;RXRA;RXRB;RARG
8686,GO:0034340,0.993672075487945,0.0272942640727057,2,73,response to type I interferon,BP,EGR1;ISG20
10608,GO:0043624,0.993870604119158,0.0145207542165933,8,179,cellular protein complex disassembly,BP,GSN;TMOD2;PLEKHH2;SPTB;DMTN;TRPV4;CAPG;TWF2
3617,GO:0008080,0.99399720748816,0.0261022746443232,2,72,N-acetyltransferase activity,MF,NAGS;HGSNAT
7344,GO:0031398,0.994105720076344,0.0210148086934481,3,91,positive regulation of protein ubiquitination,BP,MTA1;PIN1;PINK1
5659,GO:0016779,0.994375176542183,0.0160843669677949,5,127,nucleotidyltransferase activity,MF,POLD4;POLL;TUT1;PRIMPOL;POLM
3292,GO:0006997,0.994387628293882,0.0160653237405443,5,124,nucleus organization,BP,NEK9;CHMP1B;REEP4;BIN1;SUN1
11821,GO:0046822,0.994412425015893,0.0200549302819249,3,91,regulation of nucleocytoplasmic transport,BP,RAPGEF3;TMEM173;GAS6
17319,GO:1900034,0.994532182168128,0.024092835516026,2,72,regulation of cellular response to heat,BP,MAPK3;MLST8
7708,GO:0032210,0.994632815644161,0.0349813073773476,1,51,regulation of telomere maintenance via telomerase,BP,MAPK3
18323,GO:1903320,0.994683717370586,0.0122531488122328,9,188,regulation of protein modification by small protein conjugation or removal,BP,TNIP1;FBXO2;EGR1;MTA1;PIN1;TOLLIP;ZER1;AKT1;PINK1
22,GO:0000041,0.994694540360091,0.0234387008803835,2,75,transition metal ion transport,BP,ATP7B;SLC25A37
7428,GO:0031570,0.994727311602262,0.0133089025137441,7,156,DNA integrity checkpoint,BP,PCBP4;BRSK1;XPC;TFDP2;PIDD1;HMGA2;ZNF385A
10616,GO:0043632,0.994910872412067,0.00815200626918897,35,532,modification-dependent macromolecule catabolic process,BP,BTBD2;RNF44;ARRDC1;RBCK1;FBXO2;GID4;TMEM129;EDEM1;ABTB1;CUL9;CSNK1E;USP20;WWTR1;ANKZF1;MVB12B;FBXW4;DVL1;MTA1;CUL7;BTBD11;MAGEF1;FBXW5;MVB12A;BTRC;SUFU;USP21;RAD23A;SPSB3;MAN1B1;TOLLIP;AKT1;PINK1;CBLC;RNF187;FBXL20
361,GO:0000980,0.995010691344523,0.0328958295462177,1,52,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,SMARCD2
116,GO:0000245,0.995033520062676,0.0327435391416419,1,53,spliceosomal complex assembly,BP,SRSF5
3330,GO:0007051,0.995036874735072,0.0125978036808105,7,156,spindle organization,BP,TUBG2;CCDC69;CHMP1B;WRAP73;PKD1;RGS14;GOLGA2P5
14081,GO:0060964,0.995096694244844,0.0178061502832321,3,103,regulation of gene silencing by miRNA,BP,EGFR;ZFP36;MAP2K2
2834,GO:0006310,0.995142244129096,0.0105541816547274,11,215,DNA recombination,BP,ERCC1;INO80C;POLL;STAT6;BCL6;ENDOG;NSMCE4A;MAGEF1;RAG1;DMC1;POLM
2363,GO:0005488,0.99517749219919,0.00609277863507294,939,10143,binding,MF,TNIP1;HTRA1;FOS;H6PD;CEMIP;ADGRL1;APOE;TYSND1;ESPN;CTNNBIP1;MARCKSL1;TSPAN1;PPL;IDH2;RNPEPL1;PTPRS;ERCC1;WWC3;FLNC;SEMA4B;FAM110C;NT5E;GAA;SYTL1;CLIP2;LTB4R;NAPRT;BTBD2;PYGB;RNF44;CST3;SHANK2;LTBP4;RAPGEF3;TCFL5;MRC2;PGM1;CYP27B1;GSN;CLCA2;EVI5L;XDH;PRDX5;NDRG1;PGLS;PCBP4;PRSS3;PRODH;PGF;CADM4;MEF2D;NOS1;LTBP1;MARCH9;PARVB;ARAP1;SH3BP2;ZFP36L1;COL6A1;CGREF1;POSTN;GRB7;NR1D1;CRAT;EFS;ALOX15B;ARRDC1;EPN3;NYNRIN;POLD4;SCN8A;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;RHPN1;MYZAP;IGF2;NFATC4;GPX3;NME4;MST1R;LRP1;MAPK13;APPL2;HEBP1;CDK18;RALGDS;LTBP2;RAB11FIP4;FAM102A;ACBD4;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;SMOC2;MMP28;B3GAT3;HADH;NLGN2;CRYL1;ACSF2;REEP6;FBXO2;ACOT7;TCEA2;DUSP5;TOM1L2;FKBP9;HS1BP3;ISYNA1;UROS;FHL1;LOXL1;MXD4;DDB2;SERPING1;MTHFR;MDFI;RAPGEFL1;EGR1;ULK1;RHBDF1;PKN1;CMTM7;CRTC1;ARPIN;PYGL;ARHGEF4;TRIM65;SYT8;SHC1;RGL2;PCED1A;F2R;PTK6;GNAL;NPEPL1;ABCA7;DEAF1;LAMA5;PPP2R3B;SLC9A3R2;CA12;BAHCC1;GALE;BBS2;ACTA2;PRSS8;TMCC3;S100A4;CTSB;DNAH1;RNF208;SHC2;PITPNC1;SLC16A3;CORO1B;CXXC5;ULK2;DGKA;IGSF9;DHRS1;MALL;THBS3;D2HGDH;ZMYND8;TBC1D14;ASH2L;ZSCAN18;PACS2;NXPH4;SOX12;MXI1;CERS4;PLAT;MMP1;ABCG1;RIN1;ANK3;DHRS11;KIAA0930;NOL4L;PIK3R2;OPLAH;S100A6;ZNF516;PEG3;NEK9;HDAC5;THRA;PLD3;KCNJ15;DOCK4;ZP3;CRTAP;RPS6KA2;NMRK1;NISCH;LRP5;HYAL1;TUBG2;MARK4;TENM2;PLTP;KHNYN;ZFPM1;BCAM;TFEB;ERBB2;EXOC2;NUDT8;FBLN1;BRSK1;MICALL2;BSG;SCMH1;PTPRU;OGDHL;PKD2;CBS;LRRC20;TMEM129;TST;SCN4B;IQSEC2;CPT1C;EDEM1;ABTB1;SLC7A8;ITGB4;ITPR3;PLXNB3;H2AFJ;PRAF2;VAT1;DNM1;SPRY4;DDIT4L;FCHO1;MPRIP;PTHLH;CDKN1C;RIMS3;LRP11;SALL2;MSRB2;IFT140;VIPR1;CUL9;CD9;KIF13B;XPC;PTPRE;ANGEL1;CACFD1;NINL;SIGMAR1;PAK6;HEXB;DNAJC4;SERPINE2;VPS11;VAMP2;CCDC69;FUZ;GALNT12;FOXQ1;RNF135;NPHP4;UNK;NTSR1;JADE2;CD320;MINK1;RALGAPA2;ATP2B4;GGT1;SNN;TMOD2;TFDP2;PHF7;CSNK1E;ACP5;RASA4;PLCD1;TRAPPC9;AGAP1;ZFYVE21;ADAMTS7;ENKD1;PDCD4;DOCK6;TMEM134;BEX2;ACAP3;TNFRSF25;GLUL;RHOD;DTX3;ZKSCAN1;ARVCF;TNXB;USP20;PEX10;ASIC1;LAMB2;SPATA18;PLEKHG4;WNT7A;ZMIZ1;INSR;RAB3D;SH3PXD2B;TBC1D8;FBXW8;ZC3H6;ID1;CELSR1;AKR7A2;GRK6;MVD;LGALS9C;B4GAT1;POLL;WDR27;NDUFS8;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;TXNRD3;SYNGAP1;IL20RB;HAGH;FBXO27;PPP1R35;DNMT3A;DNPH1;LPAR3;TMEM173;PRNP;DHX32;ATP7B;EFNB3;RNASET2;GRAMD1A;FBXL8;SNX33;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;SLC12A7;ECM1;CEP250;NPDC1;SNX9;STAT6;DLG4;SPEG;ABCD1;MARCH2;REEP2;MTA3;MKNK2;PLCD3;NT5DC1;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;MYO18A;TMEM107;ARHGAP27;MZT2B;DNAJB5;MYCBPAP;PHC2;PLEKHH2;JMJD7;BCL6;ANKZF1;UCKL1;PFKFB2;ATP12A;PLXNB1;CHMP1B;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;BNIP3;CD81;SRMS;FCGRT;FZD8;VEGFA;DNASE1L1;ZSCAN2;HOOK2;LRRC8A;ARL2;YPEL3;C22ORF23;VANGL2;MAST4;FBXW4;ELMO3;AP2A2;CEBPB;RHBDF2;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;NUDCD3;CALCOCO1;ZDHHC1;S1PR2;ENDOG;TNFRSF6B;MAPK3;PLEKHG5;TUB;ETV5;OLFM2;CARD19;AMN;SLC22A18;GLB1;CAPNS2;DHTKD1;EXD3;ARL10;RAB40B;TNNT1;DVL1;ENTPD2;GALK1;MTA1;LHPP;FYCO1;WIPF1;GPSM1;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;PHGDH;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;TMEM25;PHYHD1;UHRF1BP1;PC;ACAD10;YPEL2;GIGYF1;SSH1;COMTD1;FURIN;MLXIPL;ZNF624;NAGS;FBF1;MBOAT7;SLC48A1;SAMD3;CUL7;MEFV;ARHGAP22;SLC2A3;TRIM4;NRP2;NADK;PLEKHG2;ABCA2;TNFRSF14;TK2;LRSAM1;ZNF414;ADA;FKBP10;CDC42EP5;TRIM45;MCTP1;OSBPL5;PIDD1;PAG1;PHF21A;SH2D2A;HTR7;RASL10B;CELSR2;ACY1;CKMT1A;PFKL;IL6R;SLIT3;PCSK9;GGACT;FCGBP;ZFP36;ETV4;RHOF;BTBD11;MAPKBP1;HLCS;CYHR1;RSPH3;FGFR3;NSUN7;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;LRRK1;NUDT10;PLCH2;DGUOK;MAGEF1;CYFIP2;RPS6KA5;SCNN1A;HBEGF;ITGB5;RAB3B;MAP2K2;PI4K2A;DAP;FGFR4;SPTB;FBXW5;GSE1;STX10;TSPAN33;DMTN;RAPGEF5;RNF215;PMVK;BBS1;MYH3;PSD4;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;TCF25;SEMA3B;LDLR;FAM214B;CYP3A5;ACOT11;ROBO3;SNX17;SOX13;TRPV4;MPG;RHOBTB2;BHLHE40;EIF4EBP3;CROCC;CCDC92;RAG1;ZNF80;DUSP7;PHLDA1;LRRC45;TNFAIP8L1;EEF2K;MSLN;HMGA2;LDLRAP1;TM7SF2;SEMA3F;ELK3;AHNAK2;DGKQ;PEX7;SEMA4C;MVB12A;HK1;NMRAL1;ZXDC;MIB2;FBXO17;PADI3;GAS6;BTRC;MEX3A;POU6F1;LLGL1;ANKS6;ADGRB2;ZNF217;PPARA;HMGCL;TKFC;GUK1;TSPAN4;STK32C;WNT7B;GIT1;COMT;TTC7B;SUFU;AIG1;PTAFR;PLEKHG6;RFNG;DMC1;IMPA2;ARHGEF37;LTBP3;PAN2;REEP4;ZNF446;ATG2A;TYMSOS;RXRA;PCK2;PCSK1;VAV3;VASN;BCR;NEO1;IGFBP4;SDHA;GSDMC;TBC1D16;USP21;RNF123;WDR60;PRKCZ;ADAMTS13;ZDHHC24;HAGHL;CLTCL1;HLTF;MDH2;CAPG;INPP5D;TMCO6;ETFB;ABCD4;SPATA7;TWF2;ZNF485;SH3GLB2;LSM14B;TPP1;PDK2;GPC1;ICOSLG;SRSF5;ZNF160;RFXANK;TEF;CEP68;SMARCD2;MAPKAPK3;NDE1;AGO4;RAD23A;ARAP3;CDHR1;FGFR1;CTSZ;CAMKK1;CHADL;SPSB3;PIN1;MAN1B1;ZNF563;C5;KMT5C;ANKMY1;PHYH;IRF2BPL;PROX1;WBP2;GTPBP1;PCDHGC3;C21ORF2;ASAP2;DLG3;KCNMA1;ESYT2;BIN1;VSNL1;UNC119B;YIPF3;TMEM8B;SERPINB6;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;GRB10;BFSP1;JARID2;CAPN2;SESN2;TOLLIP;ADCK5;WNT2B;NATD1;TSTA3;WRAP73;RXRB;CSTB;PROCR;SNPH;MAN2B2;TMEM231;PNRC1;MAPRE3;DUSP23;LCAT;GUCA1B;MACROD1;ADGRE2;GAL3ST4;SMDT1;PITPNM3;CYBRD1;MADD;LMLN;RTN4R;EPB41L3;SLC9A7;TIMP1;SDC1;WHAMMP3;GRHPR;SH2B3;ACTR1B;APOBEC3C;FGFBP1;RTN2;H1FX;EPS8L1;WNT3;LYST;GSTT1;ZFP41;PPM1F;KIAA1191;OLFML2A;MICALCL;SBF1;SORL1;STK39;EFCAB1;COL13A1;VEGFB;ACVR1B;MEF2B;TBC1D17;ANO9;FAM189B;GSDMA;ZSCAN30;GSS;AHCYL2;ALS2CL;TSNARE1;TPCN1;ERBB3;ABR;CCDC85B;PNMA1;CYP2S1;AKT1;HPDL;CTSD;TRAP1;TMBIM4;NLRX1;SEPT8;ADAM19;ZNF385A;TP53INP1;LRCH4;NDRG2;TUT1;SMARCA1;VPS33B;SIX5;ERCC6;GPD1L;EPS8L2;TDRKH;SUN1;NAGA;SPPL2B;SSBP2;RPL39L;ADCK2;R3HDM2;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;MPLKIP;SNTA1;ARHGEF10L;KDM4B;CAMTA2;HOMER2;LGALS9B;RGS14;SYNE3;SPIRE2;CCDC106;R3HDM4;LENG9;EIF4G3;ZNF710;CTSH;ABHD14B;MLST8;AGPAT4;RILPL1;NRSN1;RSAD1;CBLC;ATXN10;EPN2;RFX2;RNF187;PYCARD;NINJ1;MAP2K3;PNPO;SNX29;RHBG;POMT1;TRERF1;PCSK1N;KCNN4;CCDC57;DNAAF5;THAP8;DDN;PMS2P5;NDUFV3;STK17A;ERN1;CKLF;RANBP9;ZNF319;APOBEC3F;PRIMPOL;ACADS;FBXL20;GCAT;WDR63;MOCS1;ARHGEF19;SIRT3;ALKBH6;ORAI3;WBP1;GLI4;TMEM158;CMTM4;SLC2A1;CPNE7;MLYCD;JAK3;BCKDHA;MAST3;KIFC2;LITAF;APBA1;MZF1;KIAA1328;NEIL1;FUK;ORAI2;RARG;ING4;EIF4E3;GALNS;PBXIP1;EREG;FAM162A;ZCCHC14;GSTM2;ZNF514;PODXL2;ZFYVE19;TRIM7;SHISA6;MORN4;GIPR;WDR18;SFI1;KRT15;ADAMTSL4;TRNP1;TTLL11;ZNF837;POLM;SEMA4F;FAM50A;RPL13A;RAB40C;MIF;SULF2;STXBP2;KIF26B;UBL5;LZTS2
12752,GO:0051053,0.995218035039534,0.0153152430247136,4,109,negative regulation of DNA metabolic process,BP,ERCC1;BCL6;MAGEF1;HMGA2
17742,GO:1901796,0.995510437620296,0.0114894221513942,7,161,regulation of signal transduction by p53 class mediator,BP,L3MBTL1;PIN1;PPP1R13L;AKT1;ZNF385A;TP53INP1;MIF
12924,GO:0051310,0.995519102543613,0.0300545332109192,1,53,metaphase plate congression,BP,CHMP1B
12033,GO:0048002,0.995544708660032,0.0121009049504454,6,149,antigen processing and presentation of peptide antigen,BP,CTSF;AP2A2;ITGB5;ACTR1B;CTSD;PYCARD
288,GO:0000793,0.995568855064008,0.0108111004387003,8,174,condensed chromosome,CC,CEBPB;L3MBTL1;NSMCE4A;DMC1;NDE1;KMT5C;P3H4;RGS12
5549,GO:0016571,0.995609387686326,0.0141859534145966,4,111,histone methylation,BP,MTHFR;ASH2L;KMT5C;JARID2
15404,GO:0071704,0.995639808288642,0.0052560218499014,715,7918,organic substance metabolic process,BP,TNIP1;HTRA1;FOS;DUSP6;H6PD;LMF1;CEMIP;APOE;TYSND1;CTNNBIP1;IDH2;RNPEPL1;PTPRS;ERCC1;WWC3;NT5E;GAA;CITED4;NAPRT;BTBD2;PYGB;RNF44;CST3;LTBP4;RAPGEF3;TCFL5;PGM1;CYP27B1;GSN;CLCA2;XDH;PRDX5;PGLS;PCBP4;PRSS3;PRODH;MEF2D;NOS1;LTBP1;MARCH9;ARAP1;ZFP36L1;GRB7;NR1D1;CRAT;ALOX15B;ARRDC1;NYNRIN;POLD4;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;CPT2;IGF2;NFATC4;NME4;MST1R;LRP1;GAMT;MAPK13;CDK18;ST6GALNAC2;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;MMP28;B3GAT3;HADH;CRYL1;ACSF2;FBXO2;ACOT7;TCEA2;DUSP5;FKBP9;PPP1R14A;ISYNA1;UROS;JOSD2;LOXL1;MXD4;DDB2;SERPING1;MTHFR;KDSR;MDFI;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CRTC1;PYGL;NAGLU;SHC1;F2R;PTK6;BPHL;NPEPL1;ABCA7;DEAF1;PPP2R3B;BAHCC1;GALE;BBS2;ACTA2;PRSS8;PPM1J;CTSB;LPCAT4;RNF208;SHC2;SLC16A3;CXXC5;ULK2;DGKA;GJC2;D2HGDH;ZMYND8;ASH2L;ZSCAN18;GRAMD4;SOX12;MXI1;CERS4;PLAT;MMP1;ABCG1;ANK3;DHRS11;PIK3R2;OPLAH;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;PLD3;ZP3;CRTAP;RPS6KA2;NMRK1;NISCH;LRP5;HYAL1;ANO8;MARK4;TENM2;PLTP;SLC2A9;MAML3;ZFPM1;TFEB;ERBB2;FBLN1;BRSK1;BSG;CTSF;SCMH1;PTPRU;OGDHL;PKD2;CBS;GID4;TMEM129;FUCA1;TST;CPT1C;EDEM1;ABTB1;SLC7A8;H2AFJ;PHLDA2;DNM1;SPRY4;PTHLH;CDKN1C;SALL2;MSRB2;CUL9;CD9;XPC;PTPRE;PAK6;HEXB;SERPINE2;VPS11;GALNT12;FOXQ1;RNF135;LTB4R2;UNK;NTSR1;JADE2;THSD4;CD320;MINK1;ATP2B4;GGT1;SLC6A8;TFDP2;CSNK1E;ACP5;RASA4;PLCD1;TRAPPC9;ZFYVE21;ADAMTS7;PDCD4;GM2A;TNFRSF25;GLUL;DTX3;ZKSCAN1;USP20;PEX10;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;RAB3D;PLCXD1;LCE1E;SH3PXD2B;FBXW8;ZC3H6;ID1;AKR7A2;GRK6;MVD;B4GAT1;POLL;NDUFS8;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;SYNGAP1;HAGH;FBXO27;PPP1R35;DNMT3A;DNPH1;LPAR3;TMEM173;PRNP;SERINC2;DHX32;PAPLN;SRD5A3;IAH1;RNASET2;FBXL8;SNX33;FBXO41;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;ECM1;SNX9;STAT6;DLG4;SPEG;ABCD1;MARCH2;FGGY;MTA3;MKNK2;PLCD3;STRADB;TALDO1;WWTR1;ISG20;FAM20C;MYO18A;DNAJB5;BCL6;ANKZF1;UCKL1;PFKFB2;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;BNIP3;CD81;SRMS;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;VANGL2;MAST4;FBXW4;AP2A2;CEBPB;RHBDF2;DPP7;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;CALCOCO1;ZDHHC1;S1PR2;ENDOG;TNFRSF6B;MAPK3;FBXL16;KCNAB2;ETV5;AMN;GLB1;CAPNS2;DHTKD1;EXD3;RAB40B;DVL1;ENTPD2;GALK1;MTA1;LHPP;KLHL29;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;PHGDH;ST3GAL3;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;PC;ACAD10;SSH1;FURIN;MLXIPL;ZNF624;NAGS;MBOAT7;CUL7;MEFV;ARHGAP22;SLC2A3;TRIM4;NADK;ABCA2;TK2;LRSAM1;ZNF414;LY6K;ADA;FKBP10;CDC42EP5;OSBPL5;PYCR2;PIDD1;RETSAT;PHF21A;CELSR2;ACY1;CKMT1A;PFKL;IL6R;SLIT3;PCSK9;GGACT;SLC28A2;ZFP36;ETV4;BTBD11;MAPKBP1;HLCS;FGFR3;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;KIAA1549;LRRK1;NUDT10;PLCH2;DGUOK;MAGEF1;CYFIP2;RPS6KA5;HBEGF;RAB3B;MAP2K2;PI4K2A;DAP;FGFR4;SPTB;FBXW5;MXRA8;TSPAN33;DMTN;PMVK;MYH3;MDGA1;XYLT2;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;TCF25;LDLR;PTOV1;LYPLAL1;CYP3A5;ACOT11;SNX17;SOX13;ABHD17C;TRPV4;MPG;PIGZ;BHLHE40;EIF4EBP3;RRNAD1;RAG1;ZNF80;DUSP7;PHLDA1;EEF2K;RHBDL1;MSLN;HMGA2;LDLRAP1;TM7SF2;ELK3;AHNAK2;DGKQ;PEX7;SEMA4C;MVB12A;HK1;NMRAL1;ZXDC;MIB2;FBXO17;CHST6;PADI3;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;HMGCL;TKFC;GUK1;STK32C;WNT7B;BLVRB;COMT;TTC7B;SUFU;AIG1;PTAFR;RFNG;DMC1;IMPA2;PAN2;ZNF446;RXRA;PCK2;PCSK1;VAV3;LRP10;BCR;NEO1;IGFBP4;SDHA;MUC19;TBC1D16;USP21;RNF123;PRKCZ;ADAMTS13;ZDHHC24;HLTF;MDH2;BCORL1;INPP5D;ETFB;ABCD4;ZNF485;LSM14B;KLHDC8B;TPP1;PDK2;GPC1;SRSF5;ZNF160;RFXANK;TEF;SMOX;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;CAMKK1;SPSB3;PIN1;MAN1B1;MN1;PNPLA4;ZNF563;C5;KMT5C;PHYH;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;ESYT2;BIN1;SERPINB6;PI4KAP2;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;CES2;JARID2;CAPN2;SESN2;TOLLIP;ADCK5;TSTA3;TMEM161A;RXRB;CSTB;MAN2B2;PNRC1;MAPRE3;DUSP23;LCAT;GUCA1B;MACROD1;GAL3ST4;PTMS;PITPNM3;TMPRSS11D;MADD;LMLN;RTN4R;ELFN2;OR7D2;PIGV;TIMP1;SDC1;GRHPR;APOBEC3C;PIGQ;WNT3;GSTT1;ZFP41;PPM1F;SBF1;SORL1;STK39;VEGFB;ACVR1B;MEF2B;ZSCAN30;GSS;AHCYL2;ADORA2B;HGSNAT;ERBB3;ZER1;CCDC85B;CYP2S1;CCDC71L;AKT1;HPDL;CTSD;TRAP1;NLRX1;ADAM19;ZNF385A;TP53INP1;NDRG2;TUT1;SMARCA1;VPS33B;SIX5;ERCC6;PCMTD2;ACP6;GPD1L;TDRKH;SLC5A5;NAGA;SPPL2B;IL17RD;UQCR11;SSBP2;RPL39L;ADCK2;SSH3;PINK1;PKD1;EHD3;LONP2;SNTA1;ARHGEF10L;KDM4B;CAMTA2;PLPPR2;RGS14;MAFIP;HEXDC;EIF4G3;ZNF710;CTSH;ABHD14B;P3H4;MLST8;AGPAT4;RSAD1;CBLC;RFX2;RNF187;PYCARD;MAP2K3;PNPO;POMT1;TRERF1;PCSK1N;THAP8;DDN;PMS2P5;AS3MT;NDUFV3;STK17A;ERN1;RANBP9;ZNF319;APOBEC3F;PRIMPOL;ACADS;FBXL20;GCAT;MOCS1;SIRT3;GLI4;SLC2A1;CPNE7;MLYCD;TAZ;RNASEK;JAK3;BCKDHA;MAST3;LITAF;APBA1;MZF1;NEIL1;FUK;RARG;ING4;EIF4E3;GALNS;PBXIP1;EREG;FAM162A;PPCS;GSTM2;ZNF514;PODXL2;TRIM7;WDR18;ADAMTSL4;TRNP1;TTLL11;ZNF837;POLM;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;UBL5
18214,GO:1903051,0.995654006248246,0.0292504120702631,1,55,negative regulation of proteolysis involved in cellular protein catabolic process,BP,SUFU
5546,GO:0016567,0.995718628357463,0.00647927605139532,49,711,protein ubiquitination,BP,RNF44;MARCH9;ARRDC1;RBCK1;EPAS1;FBXO2;DDB2;RNF208;GID4;TMEM129;CUL9;RNF135;JADE2;DTX3;PEX10;FBXW8;FBXO27;FBXL8;FBXO41;BLMH;MARCH2;WWTR1;FBXW4;FBXL16;RAB40B;MTA1;KLHL29;CUL7;TRIM4;LRSAM1;MAGEF1;FBXW5;RAG1;MIB2;FBXO17;BTRC;RNF123;HLTF;KLHDC8B;SPSB3;PIN1;ZER1;AKT1;PINK1;CBLC;RNF187;FBXL20;TRIM7;RAB40C
7592,GO:0031984,0.996030196534872,0.00542201171922568,97,1272,organelle subcompartment,CC,LMF1;NOS1;MARCH9;ARAP1;POSTN;ST6GALNAC2;EGFR;B3GAT3;REEP6;KDSR;ULK1;RHBDF1;DOPEY2;ABCA7;LPCAT4;MALL;CERS4;ABCG1;PLD3;B4GALNT4;BSG;PKD2;TMEM129;CPT1C;EDEM1;ITPR3;SIGMAR1;VAMP2;GALNT12;TRAPPC9;B4GAT1;TMEM173;SRD5A3;ATP7B;SNX9;MARCH2;REEP2;MYO18A;ENTPD6;RHBDF2;CARD19;ENTPD2;GPSM1;ST3GAL3;SLC16A13;FURIN;MBOAT7;MCTP1;OSBPL5;RETSAT;PITPNM1;PI4K2A;SLC37A2;STX10;XYLT2;TNFRSF1A;SEZ6L2;MAPK8IP1;CYP3A5;PIGZ;IFNGR2;TM7SF2;CHST6;LLGL1;RFNG;REEP4;CLTCL1;ABCD4;CTSZ;MAN1B1;ASAP2;ESYT2;GAL3ST4;PIGV;SLC9A7;RTN2;PIGQ;SBF1;SORL1;CYP2S1;TMBIM4;SPPL2B;IL17RD;PKD1;GOLGA2P5;AGPAT4;POMT1;PCSK1N;DDN;ERN1;SLC2A1;LITAF;TMED4;NDST2;AGPAT3;ALG12;SULF2
5874,GO:0018022,0.996034130887503,0.0148169725476256,3,95,peptidyl-lysine methylation,BP,ASH2L;KMT5C;JARID2
13614,GO:0060147,0.996053698441413,0.0146946882540132,3,106,regulation of posttranscriptional gene silencing,BP,EGFR;ZFP36;MAP2K2
14083,GO:0060966,0.996053698441413,0.0146946882540132,3,106,regulation of gene silencing by RNA,BP,EGFR;ZFP36;MAP2K2
3238,GO:0006903,0.99609886457939,0.0179573647620917,2,77,vesicle targeting,BP,TRAPPC9;CTSZ
9059,GO:0035326,0.996170550745179,0.0176805856682591,2,76,enhancer binding,MF,ZNF704;SMARCD2
10596,GO:0043603,0.996194668683171,0.0055538907887148,62,907,cellular amide metabolic process,BP,TNIP1;APOE;RNPEPL1;ZFP36L1;GRB7;EGFR;MTHFR;ABCA7;CERS4;OPLAH;ERBB2;ABTB1;HEXB;UNK;GGT1;GM2A;HAGH;PRNP;MKNK2;MAPK3;LTA4H;PC;FURIN;NAGS;ZFP36;HLCS;CYFIP2;MAP2K2;TNFRSF1A;EIF4EBP3;EEF2K;NMRAL1;GAS6;MEX3A;PTAFR;RXRA;PCSK1;ADAMTS13;LSM14B;TPP1;AGO4;CTSZ;GTPBP1;BIN1;ASS1;SESN2;GSTT1;SORL1;GSS;AKT1;TRAP1;ZNF385A;NAGA;SPPL2B;RPL39L;PINK1;EIF4G3;CTSH;PCSK1N;EIF4E3;GSTM2;RPL13A
3667,GO:0008173,0.996202846850017,0.0261257487144844,1,55,RNA methyltransferase activity,MF,RRNAD1
10492,GO:0043414,0.99620631281513,0.00816162522211616,12,234,macromolecule methylation,BP,FOS;MTHFR;ASH2L;RAB3D;DNMT3A;RAB3B;RRNAD1;ETFB;KMT5C;JARID2;PCMTD2;TDRKH
7703,GO:0032204,0.996285177944282,0.0172211247731403,2,76,regulation of telomere maintenance,BP,ERCC1;MAPK3
15951,GO:0080135,0.996312798389995,0.00599872091431931,35,536,regulation of cellular response to stress,BP,PTPRS;ERCC1;XDH;EGFR;PKN1;EDEM1;MINK1;PDCD4;WNT7A;BCL6;FZD8;VEGFA;YPEL3;VANGL2;ENDOG;MAPK3;NSMCE4A;MAGEF1;MAP2K2;MAPK8IP1;TRPV4;HMGA2;SEMA4C;WNT7B;TMEM161A;RTN4R;AKT1;TRAP1;ZNF385A;ERCC6;PINK1;MLST8;PYCARD;ERN1;MIF
1470,GO:0003729,0.996476533048013,0.00875726025219611,8,180,mRNA binding,MF,PCBP4;ZFP36L1;UNK;ADARB1;ZFP36;ZNF385A;TUT1;RPL13A
36,GO:0000075,0.996485953880617,0.008073967026772,10,207,cell cycle checkpoint,BP,NDRG1;PCBP4;BRSK1;XPC;TFDP2;PIDD1;HMGA2;PROX1;ZNF385A;ZFYVE19
7343,GO:0031397,0.99662083137313,0.0236335523551505,1,58,negative regulation of protein ubiquitination,BP,AKT1
5497,GO:0016458,0.996659566468004,0.00744714261117956,11,237,gene silencing,BP,EGFR;BAHCC1;HDAC5;SCMH1;H2AFJ;DNMT3A;MBD1;ZFP36;MAP2K2;AGO4;TDRKH
12608,GO:0050821,0.996675778828354,0.0100126828160202,5,133,protein stabilization,BP,TSPAN1;CRTAP;DVL1;PIN1;PINK1
12826,GO:0051170,0.996698036118336,0.00995221999444072,5,133,import into nucleus,BP,TMEM173;BCL6;GAS6;TMCO6;AKT1
14484,GO:0065003,0.996716802503291,0.00445772631891177,106,1416,protein-containing complex assembly,BP,APOE;TYSND1;CTNNBIP1;ERCC1;GSN;COL6A1;GRB7;GPX3;KCNG1;OBSL1;H1F0;DDB2;ULK1;CRTC1;ARPIN;ABCA7;SLC9A3R2;DNAH1;CORO1B;ASH2L;SOX12;KCNC4;MMP1;THRA;TUBG2;EXOC2;MICALL2;PKD2;ITPR3;DNM1;FCHO1;MSRB2;XPC;SIGMAR1;VPS11;VAMP2;TMOD2;TRAPPC9;GLUL;ASIC1;INSR;SH3PXD2B;NDUFS8;RABGGTA;PRNP;SNX9;DLG4;VEGFA;ARL2;HSF4;MAPK3;WIPF1;HES1;MEFV;TRIM4;PLEKHG2;CDC42EP5;PFKL;PRKACA;SPTB;DMTN;TNFRSF1A;EHD4;TRPV4;DGKQ;SDHAF4;LLGL1;HMGCL;TSPAN4;DMC1;RXRA;PRKCZ;CLTCL1;CAPG;TWF2;SRSF5;NDE1;AGO4;CTSZ;BIN1;LCAT;WHAMMP3;GRHPR;H1FX;EPS8L1;SORL1;HGSNAT;SEPT8;EPS8L2;TMEM120A;PINK1;EHD3;SPIRE2;MLST8;ATXN10;PYCARD;DNAAF5;NDUFV3;RANBP9;SLC2A1;TAZ;APBA1;FCHSD1;WDR18;RPL13A;MIF
2578,GO:0005876,0.996836330968468,0.022392098107018,1,56,spindle microtubule,CC,TUBG2
60,GO:0000123,0.996859048283422,0.0148627477934127,2,79,histone acetyltransferase complex,CC,JADE2;ING4
2969,GO:0006518,0.996931160730995,0.00466979829307788,51,782,peptide metabolic process,BP,TNIP1;APOE;RNPEPL1;ZFP36L1;GRB7;EGFR;ABCA7;OPLAH;ERBB2;ABTB1;UNK;GGT1;HAGH;PRNP;MKNK2;MAPK3;LTA4H;FURIN;ZFP36;CYFIP2;MAP2K2;EIF4EBP3;EEF2K;GAS6;MEX3A;PTAFR;RXRA;PCSK1;ADAMTS13;LSM14B;TPP1;AGO4;CTSZ;GTPBP1;BIN1;SESN2;GSTT1;SORL1;GSS;AKT1;TRAP1;ZNF385A;SPPL2B;RPL39L;PINK1;EIF4G3;CTSH;PCSK1N;EIF4E3;GSTM2;RPL13A
14766,GO:0070507,0.996979707373822,0.00850921116413964,6,148,regulation of microtubule cytoskeleton organization,BP,CEP250;CHMP1B;ARL2;FBXW5;TRPV4;PKD1
2527,GO:0005789,0.996982827713746,0.0045365578497621,55,791,endoplasmic reticulum membrane,CC,LMF1;NOS1;EGFR;REEP6;KDSR;ULK1;RHBDF1;LPCAT4;CERS4;ABCG1;PLD3;PKD2;TMEM129;CPT1C;EDEM1;ITPR3;SIGMAR1;TMEM173;SRD5A3;MARCH2;REEP2;RHBDF2;CARD19;ENTPD2;GPSM1;MBOAT7;MCTP1;OSBPL5;RETSAT;PITPNM1;SLC37A2;XYLT2;SEZ6L2;MAPK8IP1;CYP3A5;PIGZ;IFNGR2;TM7SF2;REEP4;ABCD4;MAN1B1;ESYT2;PIGV;RTN2;PIGQ;SBF1;CYP2S1;SPPL2B;AGPAT4;POMT1;DDN;ERN1;TMED4;AGPAT3;ALG12
1456,GO:0003700,0.99702760449156,0.00419464397880108,82,1094,DNA binding transcription factor activity,MF,FOS;TCFL5;MEF2D;ZFP36L1;NR1D1;EPAS1;NFATC4;TSC22D1;MXD4;EGR1;DEAF1;ZSCAN18;SOX12;MXI1;ZNF516;PEG3;THRA;ZFPM1;TFEB;SALL2;MSRB2;FOXQ1;TFDP2;ZKSCAN1;ZC3H6;ID1;ZNF692;HES2;ZNF467;MNT;STAT6;MTA3;BCL6;SCAND1;ZSCAN2;CEBPB;HSF4;ETV5;MTA1;L3MBTL1;HES1;MLXIPL;ZNF624;ETV4;ZMYM3;KIAA1549;TCF25;SOX13;BHLHE40;ZNF80;HMGA2;ELK3;ZXDC;POU6F1;ZNF217;PPARA;ZNF446;RXRA;HLTF;ZNF160;RFXANK;TEF;PROX1;ZNF554;JARID2;RXRB;MEF2B;ZSCAN30;ZNF385A;SIX5;SSBP2;CAMTA2;RFX2;TRERF1;THAP8;DDN;GLI4;LITAF;MZF1;RARG;ZNF514;ZNF837
240,GO:0000502,0.997255926661988,0.0197565223434478,1,63,proteasome complex,CC,RAD23A
9875,GO:0042175,0.997279952084058,0.00409296643303168,56,806,nuclear outer membrane-endoplasmic reticulum membrane network,CC,LMF1;NOS1;EGFR;REEP6;KDSR;ULK1;RHBDF1;LPCAT4;CERS4;ABCG1;PLD3;PKD2;TMEM129;CPT1C;EDEM1;ITPR3;SIGMAR1;TMEM173;SRD5A3;MARCH2;REEP2;RHBDF2;CARD19;ENTPD2;GPSM1;MBOAT7;MCTP1;OSBPL5;RETSAT;PITPNM1;SLC37A2;XYLT2;SEZ6L2;MAPK8IP1;CYP3A5;PIGZ;IFNGR2;TM7SF2;REEP4;ABCD4;MAN1B1;ESYT2;PIGV;RTN2;PIGQ;SBF1;CYP2S1;SPPL2B;SYNE3;AGPAT4;POMT1;DDN;ERN1;TMED4;AGPAT3;ALG12
7400,GO:0031497,0.997314616473927,0.00908330273854832,4,134,chromatin assembly,BP,H1F0;BAHCC1;HMGA2;H1FX
16857,GO:0098827,0.997373968345013,0.00396938270608903,55,795,endoplasmic reticulum subcompartment,CC,LMF1;NOS1;EGFR;REEP6;KDSR;ULK1;RHBDF1;LPCAT4;CERS4;ABCG1;PLD3;PKD2;TMEM129;CPT1C;EDEM1;ITPR3;SIGMAR1;TMEM173;SRD5A3;MARCH2;REEP2;RHBDF2;CARD19;ENTPD2;GPSM1;MBOAT7;MCTP1;OSBPL5;RETSAT;PITPNM1;SLC37A2;XYLT2;SEZ6L2;MAPK8IP1;CYP3A5;PIGZ;IFNGR2;TM7SF2;REEP4;ABCD4;MAN1B1;ESYT2;PIGV;RTN2;PIGQ;SBF1;CYP2S1;SPPL2B;AGPAT4;POMT1;DDN;ERN1;TMED4;AGPAT3;ALG12
18779,GO:1904356,0.997414304856292,0.0188530173095914,1,58,regulation of telomere maintenance via telomere lengthening,BP,MAPK3
10518,GO:0043484,0.997468402632929,0.00994225705121116,3,100,regulation of RNA splicing,BP,AHNAK2;SRSF5;ERN1
16623,GO:0097525,0.997481855599203,0.0183811752867261,1,62,spliceosomal snRNP complex,CC,MAPKBP1
19206,GO:1905369,0.99752720577278,0.0180759861244383,1,64,endopeptidase complex,CC,RAD23A
2544,GO:0005819,0.997562076459618,0.0049419190624937,16,297,spindle,CC,FAM110C;RAB11FIP4;TUBG2;PKD2;CCDC69;MZT2A;MZT2B;FBF1;MAPKBP1;PLEKHG6;WDR60;CLTCL1;CAPG;NDE1;AKT1;RGS14
1004,GO:0002478,0.997562176557176,0.00755104141764961,5,141,antigen processing and presentation of exogenous peptide antigen,BP,CTSF;AP2A2;ITGB5;ACTR1B;CTSD
14361,GO:0061630,0.997613776866128,0.00585868528358889,9,198,ubiquitin protein ligase activity,MF,RNF44;GID4;TMEM129;LRSAM1;RAG1;MIB2;BTRC;HLTF;CBLC
9972,GO:0042393,0.997630061549944,0.00640027633929045,7,172,histone binding,MF,PKN1;ZMYND8;L3MBTL1;BRD3;PHF21A;RAG1;ING4
257,GO:0000724,0.997779839831967,0.00884415155857461,3,101,double-strand break repair via homologous recombination,BP,POLL;MAGEF1;DMC1
1589,GO:0004004,0.997788426840006,0.0164977778528616,1,59,ATP-dependent RNA helicase activity,MF,DHX32
2795,GO:0006260,0.997819340342666,0.00474794706901552,13,257,DNA replication,BP,CST3;POLD4;EGFR;SHC1;INSR;POLL;BCL6;FGFR1;PTMS;PRIMPOL;ING4;EREG;WDR18
2796,GO:0006261,0.997850101428427,0.0067451664991125,5,137,DNA-dependent DNA replication,BP,POLD4;BCL6;FGFR1;PRIMPOL;WDR18
8421,GO:0033554,0.997868341736413,0.00287391680051677,124,1614,cellular response to stress,BP,FOS;APOE;PTPRS;ERCC1;CST3;XDH;PRDX5;NDRG1;PCBP4;PRODH;ZFP36L1;POLD4;EPAS1;NFATC4;GPX3;MAPK13;EGFR;FBXO2;DDB2;EGR1;ULK1;PKN1;SHC1;ASH2L;PIK3R2;INO80C;RPS6KA2;BRSK1;PKD2;CBS;TMEM129;EDEM1;XPC;PAK6;MINK1;TFDP2;CSNK1E;PDCD4;GLUL;LAMB2;SPATA18;WNT7A;POLL;DNMT3A;STAT6;STRADB;BCL6;ANKZF1;BNIP3;FZD8;VEGFA;YPEL3;VANGL2;CEBPB;HSF4;ENDOG;MAPK3;ETV5;MTA1;NSMCE4A;CUL7;CDC42EP5;PYCR2;PIDD1;AQP3;PCSK9;ZFP36;PRKACA;MAGEF1;MAP2K2;DAP;TNFRSF1A;MAPK8IP1;TRPV4;MPG;EEF2K;HMGA2;SEMA4C;GAS6;BTRC;WNT7B;COMT;DMC1;VAV3;VASN;TM7SF3;TPP1;PDK2;TMX4;RAD23A;MAN1B1;C21ORF2;SERPINB6;ASS1;SESN2;WNT2B;TMEM161A;MACROD1;RTN4R;STK39;ADORA2B;AKT1;TRAP1;ZNF385A;TP53INP1;ERCC6;PINK1;ARHGEF10L;RGS14;MLST8;PYCARD;MAP2K3;POMT1;PMS2P5;ERN1;PRIMPOL;C12ORF66;SLC2A1;NEIL1;ING4;FAM162A;GSTM2;POLM;MIF
18318,GO:1903312,0.997895281964952,0.0158048374686508,1,60,negative regulation of mRNA metabolic process,BP,ZFP36
468,GO:0001510,0.997911165945219,0.0156915644273776,1,61,RNA methylation,BP,RRNAD1
258,GO:0000725,0.997963426978683,0.00818699117264135,3,102,recombinational repair,BP,POLL;MAGEF1;DMC1
9042,GO:0035282,0.997967893097666,0.0153390862996873,1,60,segmentation,BP,SEMA3F
1005,GO:0002479,0.997979279008162,0.0152028979677214,1,66,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,ITGB5
9909,GO:0042273,0.997989782886994,0.0151261217078276,1,67,ribosomal large subunit biogenesis,BP,WDR18
5821,GO:0017111,0.997990970804804,0.0032166562001482,43,648,nucleoside-triphosphatase activity,MF,GNAL;ABCA7;DNAH1;ABCG1;TUBG2;DNM1;KIF13B;ATP2B4;AGAP1;RHOD;RAB3D;DHX32;ATP7B;ABCD1;RAB25;ATP12A;ENTPD6;ARL2;RAB40B;TNNT1;ENTPD2;ABCA2;RASL10B;MYH16;RHOF;RAB3B;MYH3;RHOBTB2;DMC1;WDR60;HLTF;ABCD4;PIN1;GTPBP1;SEPT8;SMARCA1;ERCC6;LONP2;PMS2P5;WDR63;KIFC2;RAB40C;KIF26B
276,GO:0000779,0.997993082620579,0.00807460523834532,3,104,condensed chromosome, centromeric region,CC,CEBPB;NDE1;KMT5C
3675,GO:0008186,0.998007634419187,0.0150829757865411,1,60,RNA-dependent ATPase activity,MF,DHX32
1466,GO:0003724,0.998007634419199,0.0150829757865173,1,60,RNA helicase activity,MF,DHX32
8295,GO:0033143,0.99803205892246,0.0149139707584156,1,61,regulation of intracellular steroid hormone receptor signaling pathway,BP,WBP2
6271,GO:0019884,0.998063930987641,0.00612309899308798,5,144,antigen processing and presentation of exogenous antigen,BP,CTSF;AP2A2;ITGB5;ACTR1B;CTSD
780,GO:0002039,0.998073116265513,0.0146480622853759,1,61,p53 binding,MF,ZNF385A
7174,GO:0031072,0.998089004687463,0.00773264597426852,3,103,heat shock protein binding,MF,MVD;ZFP36;ERN1
11186,GO:0045335,0.998091728863218,0.0077170482717329,3,105,phagocytic vesicle,CC,GSN;ITGB5;STXBP2
9784,GO:0040029,0.998176618501101,0.00391501327113399,14,290,regulation of gene expression, epigenetic,BP,IGF2;EGFR;BAHCC1;HDAC5;H2AFJ;DNMT3A;MTA1;MBD1;ZFP36;MAP2K2;AGO4;WBP2;JARID2;ERCC6
2555,GO:0005844,0.998178860312778,0.0138852949321851,1,69,polysome,CC,UNK
2840,GO:0006333,0.99818543131146,0.00575792323167622,5,156,chromatin assembly or disassembly,BP,H1F0;BAHCC1;HMGA2;SMARCD2;H1FX
4755,GO:0010948,0.998186393744355,0.00381490531582146,15,295,negative regulation of cell cycle process,BP,PCBP4;ZFP36L1;TOM1L2;FHL1;GJC2;BRSK1;PKD2;TFDP2;BCL6;MLXIPL;PIDD1;HMGA2;ZNF385A;ZFYVE19;MIF
19792,GO:2000278,0.998198020607479,0.00911987907640725,2,84,regulation of DNA biosynthetic process,BP,MAPK3;FGFR4
14374,GO:0061659,0.998277814696182,0.00433095129670392,9,203,ubiquitin-like protein ligase activity,MF,RNF44;GID4;TMEM129;LRSAM1;RAG1;MIB2;BTRC;HLTF;CBLC
13087,GO:0051649,0.998312772666674,0.00228203695658737,127,1670,establishment of localization in cell,BP,LMF1;CEMIP;APOE;SYTL1;RAPGEF3;EVI5L;NOS1;NR1D1;CPT2;LTBP2;RAB11FIP4;B3GAT3;NLGN2;REEP6;TOM1L2;DOPEY2;SYT8;F2R;BBS2;TBC1D14;KCNC4;ABCG1;ANK3;LRP5;ERBB2;BRSK1;MICALL2;PKD2;TMEM129;EDEM1;ITPR3;DNM1;RIMS3;IFT140;KIF13B;VPS11;VAMP2;NTSR1;ATP2B4;TFDP2;TRAPPC9;ZFYVE21;RHOD;PEX10;ASIC1;WNT7A;RAB3D;TBC1D8;TMEM173;PRNP;ATP7B;SNX33;SPRY2;SNX9;ABCD1;REEP2;STRADB;RAB25;BCL6;CHMP1B;MVB12B;HOOK2;AP2A2;ZDHHC1;MAPK3;RAB40B;DVL1;FYCO1;FHOD1;HES1;ABCA2;MCTP1;PCSK9;PRKACA;RAB3B;MAP2K2;SPTB;STX10;DMTN;EHD4;LDLR;SNX17;LDLRAP1;PEX7;MVB12A;GAS6;LLGL1;BCR;TBC1D16;WDR60;PRKCZ;ZDHHC24;CLTCL1;TMCO6;SRSF5;NDE1;CTSZ;BIN1;VSNL1;OSCP1;SNPH;ADGRE2;WHAMMP3;RTN2;LYST;SORL1;TBC1D17;TSNARE1;ADORA2B;TPCN1;AKT1;VPS33B;SUN1;PINK1;PKD1;EHD3;LONP2;RGS14;SPIRE2;RILPL1;APBA1;GSTM2;TMED4;RPL13A;RAB40C;STXBP2;UBL5
10072,GO:0042590,0.998326340326988,0.0129244028485963,1,68,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,ITGB5
9000,GO:0035195,0.99837205548459,0.00578839019464144,4,134,gene silencing by miRNA,BP,EGFR;ZFP36;MAP2K2;AGO4
3296,GO:0007004,0.998428900119965,0.0122743174226463,1,64,telomere maintenance via telomerase,BP,MAPK3
1467,GO:0003725,0.998500438505051,0.0118015925921726,1,63,double-stranded RNA binding,MF,AGO4
7257,GO:0031248,0.99858564508323,0.00735373166884789,2,88,protein acetyltransferase complex,CC,JADE2;ING4
17984,GO:1902493,0.99858564508323,0.00735373166884789,2,88,acetyltransferase complex,CC,JADE2;ING4
7342,GO:0031396,0.998599160859171,0.00420853940966637,6,162,regulation of protein ubiquitination,BP,FBXO2;MTA1;PIN1;ZER1;AKT1;PINK1
18324,GO:1903321,0.998665684646304,0.010645322848436,1,67,negative regulation of protein modification by small protein conjugation or removal,BP,AKT1
6594,GO:0022626,0.998722594711189,0.00666499217331285,2,110,cytosolic ribosome,CC,RPL39L;RPL13A
2808,GO:0006278,0.998724207629648,0.0102488092506528,1,66,RNA-dependent DNA biosynthetic process,BP,MAPK3
15490,GO:0071897,0.998750720894463,0.00355043624203204,7,178,DNA biosynthetic process,BP,POLD4;POLL;MAPK3;TK2;FGFR4;PRIMPOL;POLM
5501,GO:0016462,0.998750988106736,0.0020187079473513,45,686,pyrophosphatase activity,MF,GNAL;ABCA7;DNAH1;ABCG1;TUBG2;DNM1;KIF13B;ATP2B4;AGAP1;RHOD;RAB3D;DHX32;ATP7B;ABCD1;RAB25;ATP12A;ENTPD6;ARL2;RAB40B;TNNT1;ENTPD2;LHPP;ABCA2;RASL10B;MYH16;RHOF;NUDT10;RAB3B;MYH3;RHOBTB2;DMC1;WDR60;HLTF;ABCD4;PIN1;GTPBP1;SEPT8;SMARCA1;ERCC6;LONP2;PMS2P5;WDR63;KIFC2;RAB40C;KIF26B
6919,GO:0030532,0.998755538153335,0.0100119720559527,1,69,small nuclear ribonucleoprotein complex,CC,MAPKBP1
12751,GO:0051052,0.998765815937588,0.00255594899184416,17,322,regulation of DNA metabolic process,BP,ERCC1;CST3;EGFR;SHC1;INSR;STAT6;BCL6;ENDOG;MAPK3;MAGEF1;FGFR4;HMGA2;FGFR1;TMEM161A;AKT1;EREG;WDR18
7155,GO:0031047,0.998786373437081,0.00399279941276834,5,155,gene silencing by RNA,BP,EGFR;ZFP36;MAP2K2;AGO4;TDRKH
5686,GO:0016817,0.998827615850876,0.00189942277970957,45,688,hydrolase activity, acting on acid anhydrides,MF,GNAL;ABCA7;DNAH1;ABCG1;TUBG2;DNM1;KIF13B;ATP2B4;AGAP1;RHOD;RAB3D;DHX32;ATP7B;ABCD1;RAB25;ATP12A;ENTPD6;ARL2;RAB40B;TNNT1;ENTPD2;LHPP;ABCA2;RASL10B;MYH16;RHOF;NUDT10;RAB3B;MYH3;RHOBTB2;DMC1;WDR60;HLTF;ABCD4;PIN1;GTPBP1;SEPT8;SMARCA1;ERCC6;LONP2;PMS2P5;WDR63;KIFC2;RAB40C;KIF26B
5687,GO:0016818,0.998827615850876,0.00189942277970957,45,688,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,GNAL;ABCA7;DNAH1;ABCG1;TUBG2;DNM1;KIF13B;ATP2B4;AGAP1;RHOD;RAB3D;DHX32;ATP7B;ABCD1;RAB25;ATP12A;ENTPD6;ARL2;RAB40B;TNNT1;ENTPD2;LHPP;ABCA2;RASL10B;MYH16;RHOF;NUDT10;RAB3B;MYH3;RHOBTB2;DMC1;WDR60;HLTF;ABCD4;PIN1;GTPBP1;SEPT8;SMARCA1;ERCC6;LONP2;PMS2P5;WDR63;KIFC2;RAB40C;KIF26B
2865,GO:0006366,0.998855619509531,0.00155046487841557,136,1762,transcription by RNA polymerase II,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;WWC3;CITED4;TCFL5;MEF2D;NOS1;ZFP36L1;NR1D1;EPAS1;IGF2;NFATC4;EGFR;TSC22D1;TCEA2;MXD4;MDFI;EGR1;PKN1;CRTC1;DEAF1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;PIK3R2;ZNF516;PEG3;HDAC5;THRA;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;PKD2;SALL2;HEXB;FOXQ1;ATP2B4;TFDP2;PDCD4;WNT7A;ZMIZ1;ZC3H6;ID1;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;HES2;MNT;ECM1;STAT6;WWTR1;DNAJB5;BCL6;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;CALCOCO1;MAPK3;ETV5;DVL1;MBD1;FHOD1;HES1;BRD3;MLXIPL;ABCA2;PHF21A;ZFP36;ETV4;ZMYM3;KIAA1549;RPS6KA5;TNFRSF1A;TCF25;SOX13;TRPV4;BHLHE40;HMGA2;ELK3;DGKQ;POU6F1;ZNF217;PPARA;SUFU;PTAFR;ZNF446;RXRA;NEO1;HLTF;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;FGFR1;PIN1;IRF2BPL;PROX1;WBP2;PPP1R13L;JARID2;SESN2;RXRB;ACVR1B;MEF2B;AKT1;ZNF385A;SIX5;ERCC6;SSBP2;PKD1;ARHGEF10L;CAMTA2;ABHD14B;RFX2;TRERF1;THAP8;DDN;LITAF;MZF1;RARG
14485,GO:0065004,0.998920691313551,0.00292943620323673,8,213,protein-DNA complex assembly,BP,H1F0;DDB2;SOX12;THRA;XPC;DMC1;H1FX;WDR18
2868,GO:0006369,0.998937814782007,0.00873215837428288,1,69,termination of RNA polymerase II transcription,BP,SRSF5
8999,GO:0035194,0.998965312586709,0.00383433716472936,4,140,posttranscriptional gene silencing by RNA,BP,EGFR;ZFP36;MAP2K2;AGO4
132,GO:0000278,0.999047005311859,0.00146113118352602,62,906,mitotic cell cycle,BP,PCBP4;ZFP36L1;IGF2;OBSL1;EGFR;TIMP2;TOM1L2;FHL1;GJC2;ANK3;NEK9;LRP5;HYAL1;TUBG2;BRSK1;PKD2;CDKN1C;CUL9;XPC;NINL;PAK6;MINK1;TFDP2;CSNK1E;INSR;DNMT3A;SNX33;SPRY2;CEP250;SNX9;MTA3;STRADB;BCL6;CHMP1B;L3MBTL1;HES1;CUL7;PIDD1;PRKACA;MAP2K2;FBXW5;PHLDA1;HMGA2;BTRC;REEP4;CLTCL1;NDE1;FGFR1;PIN1;TMEM8B;WRAP73;STK39;ACVR1B;AKT1;SEPT8;ZNF385A;PKD1;RGS14;MAP2K3;EREG;ZFYVE19;SFI1
5489,GO:0016441,0.999047410062068,0.00355613404702667,4,141,posttranscriptional gene silencing,BP,EGFR;ZFP36;MAP2K2;AGO4
4242,GO:0009451,0.99906202486223,0.003514925838535,4,132,RNA modification,BP,ADARB1;RRNAD1;APOBEC3C;APOBEC3F
10881,GO:0044445,0.999074958209153,0.00267957225366313,7,203,cytosolic part,CC,FYCO1;ADCY6;PFKL;PI4K2A;RPL39L;PYCARD;RPL13A
2897,GO:0006414,0.999129781238227,0.00379194822583303,3,125,translational elongation,BP,ABTB1;EEF2K;GTPBP1
3901,GO:0008565,0.999148171278488,0.00719828597519945,1,72,protein transporter activity,MF,LRP1
15032,GO:0071013,0.999168962495005,0.00457398786847915,2,96,catalytic step 2 spliceosome,CC,MAPKBP1;WDR83
3047,GO:0006614,0.999251364257499,0.00637401017693835,1,91,SRP-dependent cotranslational protein targeting to membrane,BP,RPL13A
10762,GO:0044237,0.999303285807554,0.000868346814006521,704,7901,cellular metabolic process,BP,TNIP1;HTRA1;FOS;DUSP6;H6PD;LMF1;CEMIP;APOE;TYSND1;CTNNBIP1;IDH2;RNPEPL1;PTPRS;ERCC1;WWC3;NT5E;GAA;CITED4;NAPRT;BTBD2;PYGB;RNF44;CST3;RAPGEF3;TCFL5;PGM1;CYP27B1;GSN;XDH;PRDX5;PGLS;PCBP4;PRSS3;PRODH;MEF2D;NOS1;LTBP1;MARCH9;ARAP1;ZFP36L1;GRB7;NR1D1;CRAT;ALOX15B;ARRDC1;NYNRIN;POLD4;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;CPT2;IGF2;NFATC4;GPX3;NME4;MST1R;LRP1;GAMT;MAPK13;CDK18;ST6GALNAC2;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;B3GAT3;HADH;CRYL1;ACSF2;FBXO2;ACOT7;TCEA2;DUSP5;FKBP9;PPP1R14A;ISYNA1;UROS;JOSD2;LOXL1;MXD4;DDB2;SERPING1;MTHFR;KDSR;MDFI;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CRTC1;PYGL;TRIM65;SHC1;F2R;PTK6;BPHL;ABCA7;DEAF1;PPP2R3B;CA12;BAHCC1;PPM1J;CTSB;LPCAT4;RNF208;SHC2;SLC16A3;CXXC5;ULK2;DGKA;GJC2;D2HGDH;ZMYND8;TBC1D14;ASH2L;ZSCAN18;PACS2;GRAMD4;SOX12;MXI1;CERS4;PLAT;MMP1;ABCG1;DHRS11;PIK3R2;OPLAH;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;ZP3;CRTAP;RPS6KA2;NMRK1;LRP5;HYAL1;ANO8;MARK4;TENM2;PLTP;SLC2A9;MAML3;ZFPM1;TFEB;ERBB2;FBLN1;BRSK1;BSG;CTSF;SCMH1;PTPRU;OGDHL;PKD2;CBS;GID4;TMEM129;FUCA1;TST;CPT1C;EDEM1;ABTB1;SLC7A8;ITGB4;H2AFJ;PHLDA2;DNM1;SPRY4;PTHLH;CDKN1C;SALL2;MSRB2;CUL9;CD9;XPC;PTPRE;PAK6;HEXB;SERPINE2;VPS11;GALNT12;FOXQ1;RNF135;LTB4R2;UNK;NTSR1;JADE2;CD320;MINK1;ATP2B4;GGT1;SLC6A8;TFDP2;CSNK1E;ACP5;RASA4;PLCD1;TRAPPC9;ZFYVE21;ADAMTS7;PDCD4;GM2A;SLC20A1;TNFRSF25;GLUL;DTX3;ZKSCAN1;USP20;PEX10;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;RAB3D;LCE1E;SH3PXD2B;FBXW8;ZC3H6;ID1;AKR7A2;GRK6;MVD;B4GAT1;POLL;NDUFS8;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;TXNRD3;SYNGAP1;HAGH;FBXO27;PPP1R35;DNMT3A;DNPH1;LPAR3;TMEM173;PRNP;SERINC2;DHX32;PAPLN;SRD5A3;RNASET2;FBXL8;SNX33;FBXO41;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;ECM1;ATG16L2;SNX9;STAT6;DLG4;SPEG;ABCD1;MARCH2;FGGY;MTA3;MKNK2;PLCD3;NT5DC1;STRADB;TALDO1;WWTR1;ISG20;FAM20C;MYO18A;DNAJB5;BCL6;ANKZF1;UCKL1;PFKFB2;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;BNIP3;CD81;SRMS;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;VANGL2;MAST4;FBXW4;AP2A2;CEBPB;SHANK3;ACVR2B;HSF4;NAB2;CALCOCO1;ZDHHC1;S1PR2;ENDOG;TNFRSF6B;MAPK3;FBXL16;KCNAB2;ETV5;AMN;GLB1;DHTKD1;EXD3;RAB40B;DVL1;ENTPD2;GALK1;MTA1;LHPP;FYCO1;KLHL29;GPSM1;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;PHGDH;ST3GAL3;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;PC;ACAD10;SSH1;FURIN;MLXIPL;ZNF624;NAGS;MBOAT7;CUL7;MEFV;ARHGAP22;SLC2A3;TRIM4;NADK;ABCA2;TK2;LRSAM1;ZNF414;LY6K;ADA;FKBP10;CDC42EP5;OSBPL5;PYCR2;PIDD1;RETSAT;PHF21A;CELSR2;ACY1;CKMT1A;PFKL;IL6R;PCSK9;SLC28A2;ZFP36;ETV4;BTBD11;MAPKBP1;HLCS;FGFR3;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;KIAA1549;LRRK1;NUDT10;PLCH2;DGUOK;MAGEF1;CYFIP2;RPS6KA5;HBEGF;RAB3B;MAP2K2;PI4K2A;DAP;FGFR4;SPTB;FBXW5;MXRA8;DMTN;PMVK;MYH3;MDGA1;XYLT2;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;TCF25;LDLR;PTOV1;LYPLAL1;CYP3A5;ACOT11;SOX13;ABHD17C;TRPV4;MPG;PIGZ;BHLHE40;EIF4EBP3;RRNAD1;RAG1;ZNF80;DUSP7;PHLDA1;EEF2K;MSLN;HMGA2;LDLRAP1;ELK3;AHNAK2;DGKQ;PEX7;SEMA4C;MVB12A;HK1;NMRAL1;ZXDC;MIB2;FBXO17;CHST6;SDHAF4;PADI3;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;HMGCL;TKFC;GUK1;STK32C;WNT7B;BLVRB;COMT;TTC7B;SUFU;AIG1;PTAFR;RFNG;DMC1;IMPA2;PAN2;ZNF446;ATG2A;RXRA;PCK2;PCSK1;VAV3;BCR;NEO1;IGFBP4;SDHA;MUC19;TBC1D16;USP21;RNF123;PRKCZ;ADAMTS13;ZDHHC24;HLTF;MDH2;BCORL1;INPP5D;ETFB;ABCD4;ZNF485;LSM14B;KLHDC8B;TPP1;PDK2;GPC1;SRSF5;ZNF160;RFXANK;TEF;SMOX;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;CAMKK1;SPSB3;PIN1;MAN1B1;MN1;PNPLA4;ZNF563;C5;KMT5C;PHYH;IRF2BPL;CMBL;PROX1;WBP2;GTPBP1;DLG3;ESYT2;BIN1;SERPINB6;PI4KAP2;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;CES2;GRB10;JARID2;CAPN2;SESN2;NDUFA4L2;TOLLIP;ADCK5;TSTA3;TMEM161A;RXRB;CSTB;MAN2B2;PNRC1;MAPRE3;DUSP23;LCAT;GUCA1B;MACROD1;GAL3ST4;PTMS;PITPNM3;MADD;RTN4R;ELFN2;OR7D2;PIGV;TIMP1;SDC1;GRHPR;APOBEC3C;PIGQ;GSTT1;ZFP41;PPM1F;SBF1;SORL1;STK39;VEGFB;ACVR1B;MEF2B;TBC1D17;ZSCAN30;GSS;AHCYL2;ADORA2B;TPCN1;ERBB3;ZER1;CCDC85B;CYP2S1;CCDC71L;AKT1;HPDL;CTSD;TRAP1;NLRX1;ZNF385A;TP53INP1;NDRG2;TUT1;SMARCA1;VPS33B;SIX5;ERCC6;PCMTD2;ACP6;GPD1L;TDRKH;SLC5A5;NAGA;SPPL2B;IL17RD;UQCR11;SSBP2;RPL39L;ADCK2;SSH3;PINK1;PKD1;EHD3;LONP2;SNTA1;ARHGEF10L;KDM4B;CAMTA2;PLPPR2;RGS14;PCIF1;MAFIP;EIF4G3;ZNF710;CTSH;ABHD14B;P3H4;MLST8;AGPAT4;RSAD1;CBLC;RFX2;RNF187;PYCARD;MAP2K3;PNPO;POMT1;TRERF1;PCSK1N;THAP8;DDN;PMS2P5;AS3MT;NDUFV3;STK17A;ERN1;RANBP9;ZNF319;APOBEC3F;PRIMPOL;ACADS;FBXL20;GCAT;MOCS1;SIRT3;GLI4;SLC2A1;CPNE7;MLYCD;TAZ;RNASEK;JAK3;BCKDHA;MAST3;LITAF;MZF1;NEIL1;FUK;RARG;ING4;EIF4E3;GALNS;PBXIP1;EREG;FAM162A;PPCS;GSTM2;ZNF514;PODXL2;TRIM7;GIPR;WDR18;SFI1;ADAMTSL4;TRNP1;TTLL11;ZNF837;POLM;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;UBL5
18212,GO:1903047,0.999315534624128,0.00111102398989892,49,757,mitotic cell cycle process,BP,PCBP4;ZFP36L1;IGF2;OBSL1;EGFR;TOM1L2;FHL1;GJC2;ANK3;NEK9;LRP5;HYAL1;TUBG2;BRSK1;PKD2;CUL9;XPC;NINL;TFDP2;CSNK1E;INSR;SNX33;SPRY2;CEP250;SNX9;MTA3;BCL6;CHMP1B;L3MBTL1;CUL7;PIDD1;PRKACA;FBXW5;PHLDA1;HMGA2;BTRC;REEP4;NDE1;FGFR1;PIN1;WRAP73;ACVR1B;AKT1;SEPT8;ZNF385A;PKD1;EREG;ZFYVE19;SFI1
14085,GO:0060968,0.999354862962212,0.00289238873975521,3,127,regulation of gene silencing,BP,EGFR;ZFP36;MAP2K2
5271,GO:0015934,0.999355662679157,0.0036205009812066,2,115,large ribosomal subunit,CC,RPL39L;RPL13A
15451,GO:0071824,0.999364700972012,0.00170652827438076,9,237,protein-DNA complex subunit organization,BP,H1F0;DDB2;SOX12;THRA;XPC;DMC1;SMARCD2;H1FX;WDR18
7216,GO:0031123,0.999418631837238,0.00263902642425528,3,119,RNA 3'-end processing,BP,ZFP36L1;SRSF5;TUT1
10522,GO:0043488,0.99942063559896,0.00226100508535785,4,141,regulation of mRNA stability,BP,PCBP4;ZFP36L1;ZFP36;AKT1
531,GO:0001650,0.999421043263452,0.00263000577811508,3,118,fibrillar center,CC,DEAF1;INO80C;PAK6
4675,GO:0010833,0.999446561785546,0.00493623882578174,1,74,telomere maintenance via telomere lengthening,BP,MAPK3
3225,GO:0006886,0.999466934661516,0.000837618181452179,60,919,intracellular protein transport,BP,CEMIP;SYTL1;RAPGEF3;EVI5L;LTBP2;B3GAT3;TOM1L2;TBC1D14;ANK3;ERBB2;MICALL2;TMEM129;EDEM1;KIF13B;VPS11;VAMP2;RHOD;PEX10;RAB3D;TBC1D8;TMEM173;PRNP;SNX33;SNX9;REEP2;STRADB;RAB25;BCL6;AP2A2;ZDHHC1;RAB40B;HES1;RAB3B;STX10;DMTN;SNX17;PEX7;GAS6;BCR;TBC1D16;ZDHHC24;CLTCL1;TMCO6;SRSF5;OSCP1;RTN2;SORL1;TBC1D17;TSNARE1;AKT1;VPS33B;PINK1;PKD1;LONP2;RILPL1;APBA1;TMED4;RPL13A;RAB40C;UBL5
7868,GO:0032446,0.999472595069073,0.000856648597180582,51,791,protein modification by small protein conjugation,BP,RNF44;MARCH9;ARRDC1;RBCK1;EPAS1;FBXO2;DDB2;EGR1;RNF208;GID4;TMEM129;CUL9;RNF135;JADE2;DTX3;PEX10;FBXW8;FBXO27;FBXL8;FBXO41;BLMH;MARCH2;WWTR1;FBXW4;FBXL16;RAB40B;MTA1;KLHL29;CUL7;TRIM4;LRSAM1;MAGEF1;FBXW5;RAG1;MIB2;FBXO17;BTRC;RNF123;HLTF;KLHDC8B;SPSB3;PIN1;TOLLIP;ZER1;AKT1;PINK1;CBLC;RNF187;FBXL20;TRIM7;RAB40C
14115,GO:0061013,0.999479088930939,0.00183780924754225,5,160,regulation of mRNA catabolic process,BP,PCBP4;ZFP36L1;ZFP36;GTPBP1;AKT1
5578,GO:0016607,0.999483441438997,0.00112051531201015,17,340,nuclear speck,CC,EPAS1;NFATC4;HDAC5;MAML3;PHF7;ZMIZ1;HSF4;LHPP;MBD1;PRKACA;DGKQ;ZNF217;SRSF5;PIN1;TUT1;STK17A;GCAT
2826,GO:0006302,0.999502659448437,0.0015104797745103,7,194,double-strand break repair,BP,ERCC1;POLL;MTA1;MAGEF1;HMGA2;DMC1;POLM
14385,GO:0061695,0.999507255495812,0.0012933651783293,10,241,transferase complex, transferring phosphorus-containing groups,CC,ERCC1;POLD4;ULK1;PIK3R2;INSR;PFKL;SESN2;ACVR1B;PYCARD;ERN1
17247,GO:0120114,0.999523357504892,0.00431792900517385,1,79,Sm-like protein family complex,CC,MAPKBP1
2841,GO:0006334,0.99952466403179,0.00275647988930507,2,116,nucleosome assembly,BP,H1F0;H1FX
3046,GO:0006613,0.999547739415248,0.00409151718131527,1,96,cotranslational protein targeting to membrane,BP,RPL13A
93,GO:0000184,0.999554543501264,0.00259808801344712,2,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,PNRC1;RPL13A
110,GO:0000228,0.999567311673386,0.000824207933584707,27,493,nuclear chromosome,CC,ERCC1;MEF2D;NR1D1;POLD4;APPL2;H1F0;ASH2L;INO80C;H2AFJ;SALL2;DNMT3A;STAT6;CEBPB;CALCOCO1;HMGA2;DMC1;RXRA;SMARCD2;KMT5C;WBP2;MEF2B;ZNF385A;SMARCA1;P3H4;RARG;TRNP1;RGS12
8889,GO:0034728,0.999600254849,0.00186786141202583,3,139,nucleosome organization,BP,H1F0;SMARCD2;H1FX
3297,GO:0007005,0.999602825690473,0.000767133526971595,26,485,mitochondrion organization,BP,IDH2;EPAS1;MICALL2;VAT1;DNM1;VPS11;TFDP2;SPATA18;NDUFS8;BNIP3;WIPI2;HES1;SDHAF4;HMGCL;ATG2A;OSCP1;SESN2;AKT1;PINK1;PYCARD;NDUFV3;PRIMPOL;SIRT3;TAZ;FAM162A;UBL5
1000,GO:0002474,0.99963687476591,0.00339189542546547,1,83,antigen processing and presentation of peptide antigen via MHC class I,BP,ITGB5
10663,GO:0043933,0.999642608947242,0.000506083300804489,120,1665,protein-containing complex subunit organization,BP,APOE;TYSND1;CTNNBIP1;ERCC1;GSN;COL6A1;GRB7;GPX3;KCNG1;OBSL1;H1F0;LOXL1;DDB2;ULK1;CRTC1;ARPIN;ABCA7;SLC9A3R2;DNAH1;CORO1B;ASH2L;SOX12;KCNC4;MMP1;ABCG1;THRA;LRP5;TUBG2;PLTP;EXOC2;MICALL2;PKD2;ITPR3;DNM1;FCHO1;MSRB2;XPC;SIGMAR1;VPS11;VAMP2;TMOD2;TRAPPC9;GLUL;TNXB;ASIC1;INSR;SH3PXD2B;NDUFS8;RABGGTA;PRNP;SNX9;DLG4;PLEKHH2;CHMP1B;BNIP3;VEGFA;ARL2;HSF4;MAPK3;DVL1;FYCO1;WIPF1;HES1;MEFV;TRIM4;PLEKHG2;CDC42EP5;PFKL;PRKACA;SPTB;DMTN;TNFRSF1A;EHD4;TRPV4;DGKQ;SDHAF4;LLGL1;HMGCL;TSPAN4;DMC1;RXRA;PRKCZ;CLTCL1;CAPG;TWF2;SRSF5;SMARCD2;NDE1;AGO4;CTSZ;CHADL;BIN1;LCAT;WHAMMP3;GRHPR;H1FX;EPS8L1;SORL1;HGSNAT;SEPT8;VPS33B;EPS8L2;TMEM120A;PINK1;EHD3;SPIRE2;P3H4;MLST8;ATXN10;PYCARD;DNAAF5;NDUFV3;RANBP9;SLC2A1;TAZ;APBA1;FCHSD1;WDR18;RPL13A;MIF
11868,GO:0046907,0.999654562712333,0.00049998863369651,104,1459,intracellular transport,BP,LMF1;CEMIP;APOE;SYTL1;RAPGEF3;EVI5L;CPT2;LTBP2;RAB11FIP4;B3GAT3;REEP6;TOM1L2;DOPEY2;SYT8;BBS2;TBC1D14;ABCG1;ANK3;ERBB2;MICALL2;TMEM129;EDEM1;DNM1;RIMS3;IFT140;KIF13B;VPS11;VAMP2;TRAPPC9;ZFYVE21;RHOD;PEX10;RAB3D;TBC1D8;TMEM173;PRNP;ATP7B;SNX33;SNX9;ABCD1;REEP2;STRADB;RAB25;BCL6;MVB12B;HOOK2;AP2A2;ZDHHC1;MAPK3;RAB40B;FYCO1;FHOD1;HES1;ABCA2;PCSK9;RAB3B;MAP2K2;SPTB;STX10;DMTN;EHD4;LDLR;SNX17;LDLRAP1;PEX7;MVB12A;GAS6;BCR;TBC1D16;WDR60;PRKCZ;ZDHHC24;CLTCL1;TMCO6;SRSF5;NDE1;CTSZ;BIN1;OSCP1;SNPH;ADGRE2;WHAMMP3;RTN2;LYST;SORL1;TBC1D17;TSNARE1;ADORA2B;AKT1;VPS33B;SUN1;PINK1;PKD1;EHD3;LONP2;RGS14;SPIRE2;RILPL1;APBA1;TMED4;RPL13A;RAB40C;STXBP2;UBL5
8819,GO:0034622,0.999667968975957,0.000538779052484357,55,880,cellular protein-containing complex assembly,BP,GSN;GRB7;OBSL1;H1F0;DDB2;ARPIN;DNAH1;CORO1B;SOX12;THRA;TUBG2;EXOC2;MICALL2;DNM1;FCHO1;MSRB2;XPC;VPS11;TMOD2;NDUFS8;SNX9;ARL2;WIPF1;MEFV;PLEKHG2;CDC42EP5;SPTB;DMTN;TRPV4;DGKQ;SDHAF4;DMC1;CLTCL1;CAPG;TWF2;SRSF5;NDE1;AGO4;BIN1;WHAMMP3;H1FX;EPS8L1;SEPT8;EPS8L2;PINK1;SPIRE2;MLST8;PYCARD;DNAAF5;NDUFV3;RANBP9;TAZ;FCHSD1;WDR18;RPL13A
10521,GO:0043487,0.99967764134359,0.00131966261859376,4,148,regulation of RNA stability,BP,PCBP4;ZFP36L1;ZFP36;AKT1
19205,GO:1905368,0.999685565989669,0.00298418085801885,1,85,peptidase complex,CC,RAD23A
11035,GO:0045047,0.999712773587338,0.00273589175982586,1,101,protein targeting to ER,BP,RPL13A
10890,GO:0044454,0.999726306097763,0.000549670576282396,24,462,nuclear chromosome part,CC,ERCC1;MEF2D;NR1D1;POLD4;APPL2;H1F0;ASH2L;INO80C;H2AFJ;SALL2;DNMT3A;STAT6;CEBPB;CALCOCO1;RXRA;SMARCD2;KMT5C;WBP2;MEF2B;ZNF385A;SMARCA1;P3H4;RARG;TRNP1
2896,GO:0006413,0.999727086508793,0.00100754269349855,5,185,translational initiation,BP,EIF4EBP3;RXRA;EIF4G3;EIF4E3;RPL13A
5918,GO:0018205,0.999733359678564,0.000610230692914797,16,337,peptidyl-lysine modification,BP,NOS1;EGR1;ASH2L;JADE2;HINT2;MAPK3;MTA1;RPS6KA5;KMT5C;WBP2;JARID2;TOLLIP;VPS33B;P3H4;SIRT3;ING4
5326,GO:0016073,0.999738390014398,0.00253751163734275,1,84,snRNA metabolic process,BP,TUT1
10962,GO:0044772,0.999752673097541,0.000487606721006201,26,484,mitotic cell cycle phase transition,BP,PCBP4;ZFP36L1;EGFR;FHL1;GJC2;HYAL1;BRSK1;PKD2;XPC;NINL;TFDP2;CSNK1E;CEP250;MTA3;PIDD1;PRKACA;PHLDA1;HMGA2;BTRC;NDE1;ACVR1B;AKT1;ZNF385A;PKD1;ZFYVE19;SFI1
20051,GO:2000736,0.999766034923934,0.00145358621057093,2,121,regulation of stem cell differentiation,BP,HES1;LTBP3
15847,GO:0072599,0.999790124634301,0.00206885788574068,1,104,establishment of protein localization to endoplasmic reticulum,BP,RPL13A
3044,GO:0006611,0.999802015327638,0.000750888094878814,5,170,protein export from nucleus,BP,RAPGEF3;STRADB;GAS6;SRSF5;PKD1
2838,GO:0006323,0.999806177591594,0.000823080064143258,4,166,DNA packaging,BP,H1F0;BAHCC1;HMGA2;H1FX
8393,GO:0033365,0.999819915258217,0.000314883226989474,43,729,protein localization to organelle,BP,TCTN1;OBSCN;OBSL1;ABCA7;BBS2;MICALL2;IFT140;VPS11;TFDP2;PEX10;TMEM173;CEP250;TMEM107;BCL6;CD81;ARL2;NUDCD3;TUB;DVL1;HES1;LRSAM1;BBS1;ABHD17C;CROCC;PEX7;HK1;GAS6;TMCO6;SPATA7;CEP68;PIN1;OSCP1;SESN2;TOLLIP;SORL1;AKT1;SUN1;PINK1;LONP2;C12ORF66;RPL13A;UBL5;LZTS2
2794,GO:0006259,0.999820997766017,0.00029865076437464,53,843,DNA metabolic process,BP,FOS;ERCC1;NT5E;CST3;NYNRIN;POLD4;EGFR;H1F0;DDB2;SHC1;INO80C;CBS;XPC;CSNK1E;INSR;POLL;DNMT3A;STAT6;ISG20;MYO18A;BCL6;DNASE1L1;ENDOG;MAPK3;MTA1;MBD1;NSMCE4A;TK2;MAGEF1;FGFR4;MPG;RAG1;HMGA2;DMC1;IGFBP4;RAD23A;FGFR1;SESN2;TMEM161A;PTMS;APOBEC3C;AKT1;SMARCA1;ERCC6;TDRKH;PMS2P5;APOBEC3F;PRIMPOL;NEIL1;ING4;EREG;WDR18;POLM
19453,GO:1990234,0.999834640074872,0.000290097060004837,43,715,transferase complex,CC,ERCC1;BTBD2;POLD4;RBCK1;FBXO2;DDB2;ULK1;ASH2L;PIK3R2;INO80C;OGDHL;ABTB1;CUL9;JADE2;INSR;FBXW8;RABGGTA;FBXO27;PHC2;FBXW4;DHTKD1;KLHL29;NSMCE4A;CUL7;PFKL;BTBD11;FBXW5;MIB2;FBXO17;BTRC;KLHDC8B;SPSB3;JARID2;SESN2;PIGV;PIGQ;ACVR1B;ZER1;PINK1;PYCARD;ERN1;FBXL20;ING4
10763,GO:0044238,0.999841946999278,0.000201394210842422,679,7706,primary metabolic process,BP,TNIP1;HTRA1;FOS;DUSP6;H6PD;LMF1;CEMIP;APOE;TYSND1;CTNNBIP1;IDH2;RNPEPL1;PTPRS;ERCC1;WWC3;NT5E;GAA;CITED4;NAPRT;BTBD2;PYGB;RNF44;CST3;LTBP4;RAPGEF3;TCFL5;PGM1;CYP27B1;GSN;CLCA2;XDH;PRDX5;PGLS;PCBP4;PRSS3;PRODH;MEF2D;NOS1;LTBP1;MARCH9;ZFP36L1;GRB7;NR1D1;CRAT;ALOX15B;ARRDC1;NYNRIN;POLD4;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;CPT2;IGF2;NFATC4;NME4;MST1R;LRP1;GAMT;MAPK13;CDK18;ST6GALNAC2;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;MMP28;B3GAT3;HADH;CRYL1;ACSF2;FBXO2;ACOT7;TCEA2;DUSP5;FKBP9;PPP1R14A;ISYNA1;JOSD2;LOXL1;MXD4;DDB2;SERPING1;MTHFR;KDSR;MDFI;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CRTC1;PYGL;SHC1;F2R;PTK6;BPHL;NPEPL1;ABCA7;DEAF1;PPP2R3B;BAHCC1;GALE;PRSS8;PPM1J;CTSB;LPCAT4;RNF208;SHC2;CXXC5;ULK2;DGKA;GJC2;D2HGDH;ZMYND8;ASH2L;ZSCAN18;GRAMD4;SOX12;MXI1;CERS4;PLAT;MMP1;ABCG1;DHRS11;PIK3R2;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;PLD3;ZP3;CRTAP;RPS6KA2;NMRK1;NISCH;LRP5;HYAL1;ANO8;MARK4;TENM2;PLTP;MAML3;ZFPM1;TFEB;ERBB2;FBLN1;BRSK1;CTSF;SCMH1;PTPRU;OGDHL;PKD2;CBS;GID4;TMEM129;FUCA1;CPT1C;EDEM1;ABTB1;SLC7A8;H2AFJ;PHLDA2;SPRY4;PTHLH;CDKN1C;SALL2;MSRB2;CUL9;XPC;PTPRE;PAK6;HEXB;SERPINE2;VPS11;GALNT12;FOXQ1;RNF135;LTB4R2;UNK;NTSR1;JADE2;THSD4;MINK1;ATP2B4;GGT1;SLC6A8;TFDP2;CSNK1E;RASA4;PLCD1;TRAPPC9;ZFYVE21;ADAMTS7;PDCD4;GM2A;TNFRSF25;GLUL;DTX3;ZKSCAN1;USP20;PEX10;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;RAB3D;PLCXD1;LCE1E;FBXW8;ZC3H6;ID1;AKR7A2;GRK6;MVD;B4GAT1;POLL;NDUFS8;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;SYNGAP1;FBXO27;PPP1R35;DNMT3A;DNPH1;LPAR3;TMEM173;PRNP;SERINC2;DHX32;PAPLN;SRD5A3;IAH1;RNASET2;FBXL8;SNX33;FBXO41;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;ECM1;SNX9;STAT6;DLG4;SPEG;ABCD1;MARCH2;FGGY;MTA3;MKNK2;PLCD3;STRADB;TALDO1;WWTR1;ISG20;FAM20C;MYO18A;DNAJB5;BCL6;ANKZF1;UCKL1;PFKFB2;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;BNIP3;CD81;SRMS;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;VANGL2;MAST4;FBXW4;AP2A2;CEBPB;RHBDF2;DPP7;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;CALCOCO1;ZDHHC1;S1PR2;ENDOG;TNFRSF6B;MAPK3;FBXL16;KCNAB2;ETV5;GLB1;CAPNS2;DHTKD1;EXD3;RAB40B;DVL1;ENTPD2;GALK1;MTA1;LHPP;KLHL29;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;PHGDH;ST3GAL3;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;PC;ACAD10;SSH1;FURIN;MLXIPL;ZNF624;NAGS;MBOAT7;CUL7;MEFV;ARHGAP22;SLC2A3;TRIM4;NADK;ABCA2;TK2;LRSAM1;ZNF414;LY6K;ADA;FKBP10;CDC42EP5;OSBPL5;PYCR2;PIDD1;RETSAT;PHF21A;CELSR2;ACY1;CKMT1A;PFKL;IL6R;PCSK9;SLC28A2;ZFP36;ETV4;BTBD11;MAPKBP1;HLCS;FGFR3;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;KIAA1549;LRRK1;NUDT10;PLCH2;DGUOK;MAGEF1;CYFIP2;RPS6KA5;HBEGF;RAB3B;MAP2K2;PI4K2A;DAP;FGFR4;SPTB;FBXW5;MXRA8;TSPAN33;DMTN;PMVK;MYH3;MDGA1;XYLT2;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;TCF25;LDLR;PTOV1;LYPLAL1;CYP3A5;ACOT11;SNX17;SOX13;ABHD17C;TRPV4;MPG;PIGZ;BHLHE40;EIF4EBP3;RRNAD1;RAG1;ZNF80;DUSP7;PHLDA1;EEF2K;RHBDL1;MSLN;HMGA2;LDLRAP1;TM7SF2;ELK3;AHNAK2;DGKQ;PEX7;SEMA4C;MVB12A;HK1;ZXDC;MIB2;FBXO17;CHST6;PADI3;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;HMGCL;TKFC;GUK1;STK32C;WNT7B;COMT;TTC7B;SUFU;AIG1;PTAFR;RFNG;DMC1;IMPA2;PAN2;ZNF446;RXRA;PCK2;PCSK1;VAV3;LRP10;BCR;NEO1;IGFBP4;SDHA;MUC19;USP21;RNF123;PRKCZ;ADAMTS13;ZDHHC24;HLTF;MDH2;BCORL1;INPP5D;ETFB;ZNF485;LSM14B;KLHDC8B;TPP1;PDK2;GPC1;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;CAMKK1;SPSB3;PIN1;MAN1B1;MN1;PNPLA4;ZNF563;C5;KMT5C;PHYH;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;ESYT2;BIN1;SERPINB6;PI4KAP2;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;CES2;JARID2;CAPN2;SESN2;TOLLIP;ADCK5;TSTA3;TMEM161A;RXRB;CSTB;MAN2B2;PNRC1;MAPRE3;DUSP23;LCAT;GUCA1B;MACROD1;GAL3ST4;PTMS;PITPNM3;TMPRSS11D;MADD;LMLN;RTN4R;ELFN2;OR7D2;PIGV;TIMP1;SDC1;APOBEC3C;PIGQ;ZFP41;PPM1F;SBF1;SORL1;STK39;VEGFB;ACVR1B;MEF2B;ZSCAN30;GSS;AHCYL2;ADORA2B;ERBB3;ZER1;CCDC85B;CYP2S1;CCDC71L;AKT1;HPDL;CTSD;TRAP1;NLRX1;ADAM19;ZNF385A;TP53INP1;NDRG2;TUT1;SMARCA1;VPS33B;SIX5;ERCC6;PCMTD2;ACP6;GPD1L;TDRKH;NAGA;SPPL2B;IL17RD;UQCR11;SSBP2;RPL39L;ADCK2;SSH3;PINK1;PKD1;LONP2;SNTA1;ARHGEF10L;KDM4B;CAMTA2;PLPPR2;RGS14;MAFIP;HEXDC;EIF4G3;ZNF710;CTSH;ABHD14B;P3H4;MLST8;AGPAT4;CBLC;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;PCSK1N;THAP8;DDN;PMS2P5;NDUFV3;STK17A;ERN1;RANBP9;ZNF319;APOBEC3F;PRIMPOL;ACADS;FBXL20;GCAT;MOCS1;SIRT3;GLI4;SLC2A1;CPNE7;MLYCD;TAZ;RNASEK;JAK3;BCKDHA;MAST3;LITAF;MZF1;NEIL1;FUK;RARG;ING4;EIF4E3;PBXIP1;EREG;FAM162A;PPCS;GSTM2;ZNF514;PODXL2;TRIM7;WDR18;ADAMTSL4;TRNP1;TTLL11;ZNF837;POLM;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;UBL5
5557,GO:0016579,0.999845992250477,0.000452282824004833,9,243,protein deubiquitination,BP,TNIP1;JOSD2;DDB2;INO80C;RNF135;USP20;USP21;RNF123;RAD23A
20251,GO:2001251,0.999851724375185,0.000965081998581929,2,111,negative regulation of chromosome organization,BP,ERCC1;JARID2
12733,GO:0051028,0.999873484630125,0.000653649120698349,3,135,mRNA transport,BP,ZFP36L1;ZFP36;SRSF5
10960,GO:0044770,0.999877111220793,0.000246469938565176,27,511,cell cycle phase transition,BP,PCBP4;ZFP36L1;EGFR;FHL1;GJC2;HYAL1;BRSK1;PKD2;XPC;NINL;ATP2B4;TFDP2;CSNK1E;CEP250;MTA3;PIDD1;PRKACA;PHLDA1;HMGA2;BTRC;NDE1;ACVR1B;AKT1;ZNF385A;PKD1;ZFYVE19;SFI1
6914,GO:0030518,0.999877492094908,0.000810812878352741,2,113,intracellular steroid hormone receptor signaling pathway,BP,CALCOCO1;WBP2
3591,GO:0008026,0.999878923719555,0.0012763706330752,1,87,ATP-dependent helicase activity,MF,DHX32
14506,GO:0070035,0.999878923719555,0.0012763706330752,1,87,purine NTP-dependent helicase activity,MF,DHX32
5576,GO:0016604,0.999880811892709,0.000218008679562728,38,652,nuclear body,CC,NR1D1;EPAS1;OBSCN;NFATC4;H1F0;CRTC1;PTK6;HDAC5;TENM2;MAML3;PHF7;ZMIZ1;MKNK2;WWTR1;ISG20;PLEKHH2;HSF4;LHPP;MBD1;NSMCE4A;PRKACA;RAPGEF5;BHLHE40;DGKQ;KLHDC2;POU6F1;ZNF217;SRSF5;AGO4;PIN1;TOLLIP;SBF1;TP53INP1;LRCH4;TUT1;RGS14;STK17A;GCAT
17644,GO:1901532,0.999880822972899,0.00124920289270472,1,103,regulation of hematopoietic progenitor cell differentiation,BP,HES1
274,GO:0000777,0.999905771232037,0.00101708589435409,1,92,condensed chromosome kinetochore,CC,NDE1
1774,GO:0004386,0.999914167598217,0.000457306008713725,3,137,helicase activity,MF,DHX32;HLTF;SMARCA1
278,GO:0000781,0.999916947844588,0.000442482993487477,3,146,chromosome, telomeric region,CC,ERCC1;NSMCE4A;DMC1
2855,GO:0006354,0.999921766193084,0.000537270612792554,2,121,DNA-templated transcription, elongation,BP,TCEA2;ERCC6
342,GO:0000956,0.999922029789505,0.000314040911872185,5,200,nuclear-transcribed mRNA catabolic process,BP,ZFP36L1;ZFP36;PAN2;PNRC1;RPL13A
8248,GO:0033044,0.999922577914135,0.000217240240438026,11,279,regulation of chromosome organization,BP,ERCC1;NOS1;IGF2;MTHFR;BCL6;VEGFA;MAPK3;RPS6KA5;WBP2;JARID2;PINK1
4526,GO:0010608,0.999930818692024,0.000145106616711931,25,505,posttranscriptional regulation of gene expression,BP,PCBP4;ZFP36L1;GRB7;EGFR;ERBB2;UNK;MKNK2;MAPK3;ZFP36;CYFIP2;MAP2K2;EIF4EBP3;MEX3A;PTAFR;RXRA;LSM14B;AGO4;SESN2;AKT1;TRAP1;ZNF385A;PINK1;EIF4G3;EIF4E3;RPL13A
10597,GO:0043604,0.999931300227139,0.000126137564180555,40,733,amide biosynthetic process,BP,TNIP1;ZFP36L1;GRB7;EGFR;CERS4;OPLAH;ERBB2;ABTB1;UNK;GGT1;HAGH;MKNK2;MAPK3;FURIN;NAGS;ZFP36;CYFIP2;MAP2K2;TNFRSF1A;EIF4EBP3;EEF2K;NMRAL1;MEX3A;PTAFR;RXRA;PCSK1;LSM14B;AGO4;GTPBP1;ASS1;SESN2;GSS;AKT1;TRAP1;ZNF385A;RPL39L;PINK1;EIF4G3;EIF4E3;RPL13A
17281,GO:0140110,0.999936275342865,9.68366063169542e-05,99,1413,transcription regulator activity,MF,FOS;CITED4;TCFL5;MEF2D;ZFP36L1;NR1D1;EPAS1;NFATC4;TSC22D1;MXD4;EGR1;PKN1;DEAF1;ZMYND8;ZSCAN18;SOX12;MXI1;ZNF516;PEG3;THRA;MAML3;ZFPM1;TFEB;SALL2;MSRB2;FOXQ1;TFDP2;ZKSCAN1;ZC3H6;ID1;ZNF692;HES2;ZNF467;MNT;STAT6;MTA3;WWTR1;BCL6;SCAND1;DYRK1B;ZSCAN2;CEBPB;HSF4;NAB2;CALCOCO1;ETV5;MTA1;L3MBTL1;HES1;MLXIPL;ZNF624;PHF21A;ETV4;ZMYM3;KIAA1549;TCF25;SOX13;BHLHE40;ZNF80;HMGA2;ELK3;ZXDC;POU6F1;ZNF217;PPARA;SUFU;ZNF446;RXRA;USP21;HLTF;ZNF160;RFXANK;TEF;SMARCD2;PROX1;WBP2;PPP1R13L;ZNF554;JARID2;RXRB;GRHPR;MEF2B;ZSCAN30;ZNF385A;SIX5;SSBP2;CAMTA2;RFX2;TRERF1;THAP8;DDN;GLI4;LITAF;MZF1;RARG;ING4;PBXIP1;ZNF514;ZNF837
6013,GO:0019080,0.999940072109256,0.000276737539689357,4,184,viral gene expression,BP,FURIN;ZFP36;HMGA2;RPL13A
879,GO:0002244,0.999944943530353,0.000301905289368638,3,158,hematopoietic progenitor cell differentiation,BP,KCNAB2;DHTKD1;HES1
10274,GO:0043043,0.999946239347558,0.000103079108619815,35,672,peptide biosynthetic process,BP,TNIP1;ZFP36L1;GRB7;EGFR;OPLAH;ERBB2;ABTB1;UNK;GGT1;HAGH;MKNK2;MAPK3;FURIN;ZFP36;CYFIP2;MAP2K2;EIF4EBP3;EEF2K;MEX3A;PTAFR;RXRA;PCSK1;LSM14B;AGO4;GTPBP1;SESN2;GSS;AKT1;TRAP1;ZNF385A;RPL39L;PINK1;EIF4G3;EIF4E3;RPL13A
14842,GO:0070646,0.999947564599897,0.000163507838796956,9,258,protein modification by small protein removal,BP,TNIP1;JOSD2;DDB2;INO80C;RNF135;USP20;USP21;RNF123;RAD23A
12824,GO:0051168,0.999950446149583,0.000206251620302017,5,187,nuclear export,BP,RAPGEF3;STRADB;GAS6;SRSF5;PKD1
1472,GO:0003735,0.999955173547532,0.000319673896855736,2,154,structural constituent of ribosome,MF,RPL39L;RPL13A
6590,GO:0022618,0.999955313059306,0.000187035667603979,5,193,ribonucleoprotein complex assembly,BP,GRB7;SRSF5;AGO4;WDR18;RPL13A
256,GO:0000723,0.999956511276353,0.000243074692447055,3,153,telomere maintenance,BP,ERCC1;POLD4;MAPK3
5269,GO:0015931,0.999959275924374,0.000156193376779011,6,207,nucleobase-containing compound transport,BP,ZFP36L1;TST;SLC28A2;ZFP36;SLC29A4;SRSF5
12512,GO:0050684,0.999962829445054,0.000438373294001819,1,99,regulation of mRNA processing,BP,ZFP36L1
5564,GO:0016591,0.999964412895779,0.000420648405396567,1,103,DNA-directed RNA polymerase II, holoenzyme,CC,ERCC1
6016,GO:0019083,0.999965789990251,0.000193848012800105,3,170,viral transcription,BP,ZFP36;HMGA2;RPL13A
12491,GO:0050657,0.999969826874866,0.000146467594536404,4,173,nucleic acid transport,BP,ZFP36L1;TST;ZFP36;SRSF5
12492,GO:0050658,0.999969826874866,0.000146467594536404,4,173,RNA transport,BP,ZFP36L1;TST;ZFP36;SRSF5
3176,GO:0006807,0.999970990290045,3.77931524321673e-05,641,7390,nitrogen compound metabolic process,BP,TNIP1;HTRA1;FOS;DUSP6;H6PD;LMF1;CEMIP;APOE;TYSND1;CTNNBIP1;IDH2;RNPEPL1;PTPRS;ERCC1;WWC3;NT5E;CITED4;NAPRT;BTBD2;RNF44;CST3;LTBP4;RAPGEF3;TCFL5;PGM1;GSN;CLCA2;XDH;PRDX5;PGLS;PCBP4;PRSS3;PRODH;MEF2D;NOS1;LTBP1;MARCH9;ZFP36L1;GRB7;NR1D1;CRAT;ARRDC1;NYNRIN;POLD4;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;IGF2;NFATC4;NME4;MST1R;LRP1;GAMT;MAPK13;CDK18;ST6GALNAC2;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;MMP28;B3GAT3;FBXO2;ACOT7;TCEA2;DUSP5;FKBP9;PPP1R14A;UROS;JOSD2;LOXL1;MXD4;DDB2;SERPING1;MTHFR;KDSR;MDFI;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CRTC1;NAGLU;SHC1;F2R;PTK6;BPHL;NPEPL1;ABCA7;DEAF1;PPP2R3B;BAHCC1;PRSS8;PPM1J;CTSB;LPCAT4;RNF208;SHC2;CXXC5;ULK2;GJC2;D2HGDH;ZMYND8;ASH2L;ZSCAN18;GRAMD4;SOX12;MXI1;CERS4;PLAT;MMP1;ABCG1;PIK3R2;OPLAH;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;ZP3;CRTAP;RPS6KA2;NMRK1;LRP5;HYAL1;ANO8;MARK4;TENM2;SLC2A9;MAML3;ZFPM1;TFEB;ERBB2;FBLN1;BRSK1;CTSF;SCMH1;PTPRU;OGDHL;PKD2;CBS;GID4;TMEM129;FUCA1;TST;CPT1C;EDEM1;ABTB1;SLC7A8;H2AFJ;SPRY4;PTHLH;CDKN1C;SALL2;MSRB2;CUL9;XPC;PTPRE;PAK6;HEXB;SERPINE2;VPS11;GALNT12;FOXQ1;RNF135;LTB4R2;UNK;JADE2;THSD4;CD320;MINK1;ATP2B4;GGT1;SLC6A8;TFDP2;CSNK1E;ACP5;RASA4;TRAPPC9;ADAMTS7;PDCD4;GM2A;TNFRSF25;GLUL;DTX3;ZKSCAN1;USP20;PEX10;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;RAB3D;LCE1E;FBXW8;ZC3H6;ID1;AKR7A2;GRK6;MVD;B4GAT1;POLL;NDUFS8;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;SYNGAP1;HAGH;FBXO27;PPP1R35;DNMT3A;DNPH1;LPAR3;TMEM173;PRNP;SERINC2;DHX32;PAPLN;SRD5A3;RNASET2;FBXL8;SNX33;FBXO41;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;ECM1;SNX9;STAT6;DLG4;SPEG;MARCH2;MTA3;MKNK2;STRADB;TALDO1;WWTR1;ISG20;FAM20C;MYO18A;DNAJB5;BCL6;ANKZF1;UCKL1;PFKFB2;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;BNIP3;CD81;SRMS;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;VANGL2;MAST4;FBXW4;AP2A2;CEBPB;RHBDF2;DPP7;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;CALCOCO1;ZDHHC1;S1PR2;ENDOG;TNFRSF6B;MAPK3;FBXL16;KCNAB2;ETV5;AMN;GLB1;CAPNS2;DHTKD1;EXD3;RAB40B;DVL1;ENTPD2;GALK1;MTA1;LHPP;KLHL29;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;PHGDH;ST3GAL3;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;PC;SSH1;FURIN;MLXIPL;ZNF624;NAGS;CUL7;MEFV;ARHGAP22;TRIM4;NADK;ABCA2;TK2;LRSAM1;ZNF414;LY6K;ADA;FKBP10;CDC42EP5;OSBPL5;PYCR2;PIDD1;PHF21A;CELSR2;ACY1;CKMT1A;PFKL;IL6R;PCSK9;GGACT;SLC28A2;ZFP36;ETV4;BTBD11;MAPKBP1;HLCS;FGFR3;PRKACA;F12;ZNF862;ZMYM3;KIAA1549;LRRK1;NUDT10;DGUOK;MAGEF1;CYFIP2;RPS6KA5;HBEGF;RAB3B;MAP2K2;DAP;FGFR4;SPTB;FBXW5;MXRA8;TSPAN33;DMTN;MYH3;MDGA1;XYLT2;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;TCF25;LDLR;PTOV1;LYPLAL1;CYP3A5;SOX13;ABHD17C;TRPV4;MPG;PIGZ;BHLHE40;EIF4EBP3;RRNAD1;RAG1;ZNF80;DUSP7;PHLDA1;EEF2K;RHBDL1;MSLN;HMGA2;LDLRAP1;ELK3;AHNAK2;DGKQ;SEMA4C;MVB12A;HK1;NMRAL1;ZXDC;MIB2;FBXO17;CHST6;PADI3;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;HMGCL;GUK1;STK32C;WNT7B;BLVRB;COMT;SUFU;PTAFR;RFNG;DMC1;PAN2;ZNF446;RXRA;PCK2;PCSK1;BCR;NEO1;IGFBP4;SDHA;MUC19;USP21;RNF123;PRKCZ;ADAMTS13;ZDHHC24;HLTF;MDH2;BCORL1;INPP5D;ETFB;ABCD4;ZNF485;LSM14B;KLHDC8B;TPP1;PDK2;GPC1;SRSF5;ZNF160;RFXANK;TEF;SMOX;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;CAMKK1;SPSB3;PIN1;MAN1B1;MN1;ZNF563;C5;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;ESYT2;BIN1;SERPINB6;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;JARID2;CAPN2;SESN2;TOLLIP;ADCK5;TSTA3;TMEM161A;RXRB;CSTB;MAN2B2;PNRC1;MAPRE3;DUSP23;LCAT;GUCA1B;MACROD1;GAL3ST4;PTMS;TMPRSS11D;MADD;LMLN;RTN4R;ELFN2;OR7D2;PIGV;TIMP1;SDC1;GRHPR;APOBEC3C;PIGQ;GSTT1;ZFP41;PPM1F;SBF1;SORL1;STK39;VEGFB;ACVR1B;MEF2B;ZSCAN30;GSS;AHCYL2;ADORA2B;HGSNAT;ERBB3;ZER1;CCDC85B;AKT1;HPDL;CTSD;TRAP1;NLRX1;ADAM19;ZNF385A;TP53INP1;NDRG2;TUT1;SMARCA1;VPS33B;SIX5;ERCC6;PCMTD2;GPD1L;TDRKH;SLC5A5;NAGA;SPPL2B;IL17RD;UQCR11;SSBP2;RPL39L;ADCK2;SSH3;PINK1;PKD1;LONP2;SNTA1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;EIF4G3;ZNF710;CTSH;ABHD14B;P3H4;MLST8;RSAD1;CBLC;RFX2;RNF187;PYCARD;MAP2K3;PNPO;POMT1;TRERF1;PCSK1N;THAP8;DDN;PMS2P5;NDUFV3;STK17A;ERN1;RANBP9;ZNF319;APOBEC3F;PRIMPOL;FBXL20;GCAT;MOCS1;SIRT3;GLI4;TAZ;RNASEK;JAK3;BCKDHA;MAST3;LITAF;MZF1;NEIL1;FUK;RARG;ING4;EIF4E3;GALNS;PBXIP1;EREG;FAM162A;PPCS;GSTM2;ZNF514;PODXL2;TRIM7;WDR18;ADAMTSL4;TRNP1;TTLL11;ZNF837;POLM;NDST2;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;UBL5
2891,GO:0006406,0.999971339958321,0.000345690477142794,1,103,mRNA export from nucleus,BP,SRSF5
15231,GO:0071427,0.999971339958321,0.000345690477142794,1,103,mRNA-containing ribonucleoprotein complex export from nucleus,BP,SRSF5
272,GO:0000775,0.999972736035316,0.000133254363395723,4,173,chromosome, centromeric region,CC,DNMT3A;CEBPB;NDE1;KMT5C
15063,GO:0071103,0.999973429690581,9.65007983277463e-05,7,245,DNA conformation change,BP,H1F0;DDB2;BAHCC1;XPC;HMGA2;H1FX;SMARCA1
14843,GO:0070647,0.999974884890275,4.34374688152825e-05,58,951,protein modification by small protein conjugation or removal,BP,TNIP1;RNF44;MARCH9;ARRDC1;RBCK1;EPAS1;FBXO2;JOSD2;DDB2;EGR1;RNF208;INO80C;GID4;TMEM129;CUL9;RNF135;JADE2;DTX3;USP20;PEX10;FBXW8;FBXO27;FBXL8;FBXO41;BLMH;MARCH2;WWTR1;FBXW4;FBXL16;RAB40B;MTA1;KLHL29;CUL7;TRIM4;LRSAM1;ZNF862;MAGEF1;FBXW5;RAG1;MIB2;FBXO17;BTRC;USP21;RNF123;HLTF;KLHDC8B;RAD23A;SPSB3;PIN1;TOLLIP;ZER1;AKT1;PINK1;CBLC;RNF187;FBXL20;TRIM7;RAB40C
2854,GO:0006353,0.99997489818339,0.000305944770758536,1,107,DNA-templated transcription, termination,BP,SRSF5
15003,GO:0070972,0.999975610384483,0.000296079046866999,1,125,protein localization to endoplasmic reticulum,BP,RPL13A
12869,GO:0051236,0.999976848699536,0.000114316104065895,4,176,establishment of RNA localization,BP,ZFP36L1;TST;ZFP36;SRSF5
3278,GO:0006974,0.999980653580661,3.67418129042219e-05,41,738,cellular response to DNA damage stimulus,BP,ERCC1;NDRG1;PCBP4;POLD4;NFATC4;EGFR;DDB2;ASH2L;INO80C;BRSK1;XPC;TFDP2;CSNK1E;SPATA18;POLL;BCL6;MAPK3;MTA1;NSMCE4A;PIDD1;MAGEF1;TNFRSF1A;MPG;HMGA2;DMC1;VAV3;RAD23A;C21ORF2;SESN2;TMEM161A;MACROD1;AKT1;ZNF385A;ERCC6;PYCARD;PMS2P5;PRIMPOL;NEIL1;ING4;POLM;MIF
7699,GO:0032200,0.999981508319611,0.000109610045002128,3,166,telomere organization,BP,ERCC1;POLD4;MAPK3
15453,GO:0071826,0.999981837230577,8.03082653862266e-05,5,204,ribonucleoprotein complex subunit organization,BP,GRB7;SRSF5;AGO4;WDR18;RPL13A
10376,GO:0043226,0.999982246208814,2.45600880415607e-05,880,9782,organelle,CC,TNIP1;HTRA1;FOS;DUSP6;H6PD;LMF1;CEMIP;APOE;TYSND1;MARVELD1;ESPN;CTNNBIP1;MARCKSL1;TSPAN1;PPL;IDH2;PTPRS;ERCC1;FLNC;FAM110C;NT5E;GAA;SYTL1;CLIP2;CITED4;NAPRT;BTBD2;PYGB;RNF44;CST3;SHANK2;LTBP4;RAPGEF3;TCFL5;PGM1;CYP27B1;GSN;CLCA2;XDH;OAF;PRDX5;NDRG1;PGLS;PRSS3;PRODH;CADM4;MEF2D;NOS1;LTBP1;MARCH9;PARVB;ARAP1;ZFP36L1;COL6A1;TCTN1;POSTN;GRB7;NR1D1;CRAT;ALOX15B;ARRDC1;EPN3;FAM210B;POLD4;SCN8A;EPHB2;EPAS1;OBSCN;CNTN1;CPT2;MYZAP;IGF2;NFATC4;GPX3;NME4;MST1R;LRP1;GAMT;MAPK13;APPL2;HEBP1;CDK18;RALGDS;ST6GALNAC2;LTBP2;RAB11FIP4;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;B3GAT3;HADH;CRYL1;SUGCT;ACSF2;REEP6;FBXO2;ACOT7;TCEA2;DUSP5;TOM1L2;FKBP9;HS1BP3;UROS;FHL1;LOXL1;MXD4;DDB2;SERPING1;KDSR;MDFI;EGR1;ULK1;RHBDF1;PKN1;CRTC1;PYGL;TRIM65;DOPEY2;SYT8;NAGLU;SHC1;F2R;PTK6;GNAL;BPHL;NPEPL1;ABCA7;DEAF1;LAMA5;PPP2R3B;SLC9A3R2;BAHCC1;GALE;BBS2;ACTA2;PRSS8;S100A4;CTSB;ESRG;LPCAT4;DNAH1;RNF208;PITPNC1;SLC16A3;CORO1B;CXXC5;ULK2;DHRS1;MALL;D2HGDH;ZMYND8;TBC1D14;ASH2L;ZSCAN18;PACS2;GRAMD4;SOX12;MXI1;CERS4;PLAT;ABCG1;RIN1;ANK3;NOL4L;PIK3R2;S100A6;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;ARHGAP23;PLD3;DOCK4;CRTAP;RPS6KA2;NISCH;LRP5;DBNDD1;HYAL1;TUBG2;ANO8;MARK4;TENM2;SLC2A9;MAML3;B4GALNT4;ZFPM1;BCAM;TFEB;ERBB2;SLC13A3;FBLN1;BRSK1;MICALL2;BSG;CTSF;SCMH1;OGDHL;PKD2;CBS;TMEM129;FUCA1;TST;CPT1C;EDEM1;ABTB1;VWA5A;SLC7A8;ITGB4;ITPR3;H2AFJ;PRAF2;VAT1;DNM1;FCHO1;MPRIP;PTHLH;CDKN1C;RIMS3;SALL2;MSRB2;IFT140;CD9;KIF13B;XPC;PTPRE;ANGEL1;NINL;SIGMAR1;PAK6;HEXB;SERPINE2;VPS11;VAMP2;CCDC69;FUZ;GALNT12;FOXQ1;NPHP4;LTB4R2;NTSR1;JADE2;THSD4;CD320;MINK1;RALGAPA2;ATP2B4;GGT1;SNN;TMOD2;TFDP2;PHF7;CSNK1E;ACP5;PLCD1;TRAPPC9;AGAP1;ZFYVE21;DIRC2;ADAMTS7;ENKD1;PDCD4;GM2A;BEX2;ACAP3;TNFRSF25;GLUL;PRR7;RHOD;ZKSCAN1;ARVCF;TNXB;USP20;PEX10;ARMCX2;ASIC1;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;RAB3D;SH3PXD2B;FBXW8;ZC3H6;ID1;CELSR1;AKR7A2;MZT2A;B4GAT1;POLL;WDR27;NDUFS8;RABGGTA;ADARB1;ZNF692;ZNF704;TXNRD3;SYNGAP1;NBEAL2;HAGH;DNMT3A;DNPH1;TMEM173;PRNP;SERINC2;DHX32;SRD5A3;OXLD1;ATP7B;IAH1;RNASET2;SNX33;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;ECM1;CEP250;ATG16L2;SNX9;STAT6;DLG4;SPEG;ABCD1;MARCH2;REEP2;MTA3;MKNK2;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;MYO18A;TMEM107;ARHGAP27;CERCAM;MZT2B;DNAJB5;PHC2;PLEKHH2;C1ORF210;BCL6;TTYH3;ANKZF1;UCKL1;PFKFB2;FAM213A;CHMP1B;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;TMEM92;BNIP3;CD81;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;HOOK2;ARL2;YPEL3;VANGL2;AP2A2;CEBPB;RHBDF2;DPP7;GPRC5C;SHANK3;HSD11B1L;SSC4D;HSF4;ADAM15;NAB2;NUDCD3;CALCOCO1;ZDHHC1;ENDOG;MAPK3;PDZD2;PLEKHG5;TUB;KCNAB2;ETV5;OLFM2;CARD19;AMN;SLC22A18;GLB1;DHTKD1;EXD3;C19ORF33;RAB40B;TNNT1;DVL1;ENTPD2;GALK1;MTA1;LHPP;FYCO1;WIPF1;GPSM1;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;PHGDH;ST3GAL3;SLC16A13;NSMCE4A;FHOD1;HES1;BRD3;PC;ACAD10;YPEL2;SSH1;COMTD1;FURIN;MLXIPL;ZNF624;NAGS;FBF1;MBOAT7;SLC48A1;CUL7;MEFV;EVC;ARHGAP22;SLC2A3;ABCA2;TK2;ZNF414;LY6K;ADA;FKBP10;CDC42EP5;TRIM45;MCTP1;OSBPL5;PYCR2;PIDD1;RETSAT;PHF21A;AQP3;MYH16;ACY1;CKMT1A;PFKL;SLIT3;PCSK9;GGACT;FCGBP;TMEM9;ZFP36;ETV4;RHOF;MAPKBP1;HLCS;CYHR1;RSPH3;FGFR3;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;LRRK1;NUDT10;DGUOK;MAGEF1;CYFIP2;SLC38A10;RPS6KA5;SCNN1A;HBEGF;SLC25A37;ITGB5;RAB3B;MAP2K2;PI4K2A;FGFR4;SPTB;MXRA8;SLC37A2;STX10;GAREM2;DMTN;RAPGEF5;PMVK;BBS1;MYH3;XYLT2;HDAC11;VGF;TNFRSF1A;SEZ6L2;EHD4;MAPK8IP1;TCF25;SEMA3B;LDLR;PTOV1;FAM214B;LYPLAL1;CYP3A5;ACOT11;SNX17;SOX13;ABHD17C;TRPV4;MPG;RHOBTB2;PIGZ;IFNGR2;BHLHE40;CROCC;CCDC92;RAG1;ZNF80;DUSP7;PHLDA1;LRRC45;EEF2K;MSLN;HMGA2;LDLRAP1;TM7SF2;ELK3;AHNAK2;DGKQ;PEX7;KLHDC2;SEMA4C;MVB12A;HK1;NMRAL1;ZXDC;MIB2;CHST6;SDHAF4;PADI3;GAS6;BTRC;MEX3A;POU6F1;LLGL1;ANKS6;ADGRB2;ZNF217;PPARA;HMGCL;TKFC;TSPAN4;TMEM187;WNT7B;BLVRB;GIT1;COMT;ALDH16A1;SUFU;PTAFR;PLEKHG6;RFNG;ANKRD13D;DMC1;LTBP3;PAN2;REEP4;ZNF446;ATG2A;RXRA;PCK2;PCSK1;VAV3;VASN;BCR;TMEM175;NEO1;IGFBP4;SDHA;GSDMC;MUC19;TBC1D16;USP21;RNF123;WDR60;PRKCZ;ADAMTS13;ZDHHC24;CLTCL1;HLTF;MDH2;CAPG;BCORL1;INPP5D;TM7SF3;ETFB;ABCD4;SPATA7;TWF2;ZNF485;SH3GLB2;TPP1;PDK2;GPC1;TMX4;ICOSLG;SRSF5;ZNF160;RFXANK;TEF;SMOX;CEP68;SMARCD2;MAPKAPK3;NDE1;AGO4;RAD23A;ARAP3;CDHR1;FGFR1;CTSZ;CAMKK1;PIN1;MAN1B1;PNPLA4;ZNF563;C5;KMT5C;PHYH;IRF2BPL;CMBL;PROX1;WBP2;PCDHGC3;C21ORF2;NICN1;ASAP2;DLG3;GPR155;KCNMA1;ESYT2;BIN1;MTMR11;UNC119B;YIPF3;TMEM8B;SERPINB6;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;CES2;SLC25A27;BFSP1;JARID2;SYNC;CAPN2;SESN2;NDUFA4L2;TOLLIP;WNT2B;TSTA3;WRAP73;RXRB;CSTB;PROCR;SNPH;MAN2B2;TMEM231;PNRC1;MAPRE3;DUSP23;LCAT;GUCA1B;MACROD1;GAL3ST4;SMDT1;PTMS;TMPRSS11D;CYBRD1;LMLN;RTN4R;EPB41L3;PIGV;SLC9A7;TIMP1;CD68;SDC1;WHAMMP3;GRHPR;ACTR1B;APOBEC3C;RTN2;H1FX;EPS8L1;PLEKHH3;PIGQ;WNT3;LYST;GSTT1;ZFP41;SBF1;SORL1;STK39;COL13A1;VEGFB;ACVR1B;MEF2B;TBC1D17;ZSCAN30;GSS;AHCYL2;TPCN1;HGSNAT;SLC25A29;CCDC85B;PNMA1;CYP2S1;AKT1;CTSD;TRAP1;TMBIM4;NLRX1;SEPT8;ADAM19;ZNF385A;TP53INP1;LRCH4;NDRG2;TUT1;SMARCA1;VPS33B;SIX5;ERCC6;ACP6;GPD1L;EPS8L2;TDRKH;SLC5A5;SUN1;NAGA;TMEM120A;SPPL2B;IL17RD;UQCR11;SSBP2;RPL39L;R3HDM2;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;MPLKIP;SNTA1;KDM4B;CAMTA2;HOMER2;RGS14;SYNE3;PLEKHH1;GOLGA2P5;PCIF1;MAFIP;SPIRE2;CCDC106;R3HDM4;HEXDC;ZNF710;CTSH;EHBP1L1;ABHD14B;P3H4;MLST8;ROBO4;AGPAT4;RILPL1;NRSN1;RSAD1;CBLC;EPN2;RFX2;RNF187;PYCARD;MAP2K3;PNPO;SNX29;RHBG;POMT1;TRERF1;PCSK1N;KCNN4;DDN;PMS2P5;AS3MT;NDUFV3;STK17A;ERN1;RANBP9;ZNF319;APOBEC3F;PRIMPOL;ACADS;GCAT;WDR63;MOCS1;SIRT3;ALKBH6;GLI4;C12ORF66;SLC2A1;CPNE7;MLYCD;TAZ;JAK3;BCKDHA;KIFC2;LITAF;APBA1;MZF1;NEIL1;RARG;ING4;GALNS;PBXIP1;FAM162A;PPCS;FCHSD1;GSTM2;ABHD14A;ZNF514;PODXL2;ZFYVE19;TRIM7;SHISA6;MORN4;WDR18;PQLC2;SFI1;KRT15;ADAMTSL4;TRNP1;TTLL11;ZNF837;TMED4;POLM;SEMA4F;FAM50A;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;STXBP2;KIF26B;UBL5;LZTS2
7403,GO:0031503,0.999982868355426,6.90625345671105e-05,6,218,protein-containing complex localization,BP,DNM1;IFT140;DLG4;WDR60;SRSF5;DLG3
10257,GO:0043021,0.999984244905036,0.000199958482499225,1,110,ribonucleoprotein complex binding,MF,RNF135
281,GO:0000784,0.999984374042248,0.000198137264397686,1,114,nuclear chromosome, telomeric region,CC,ERCC1
10888,GO:0044452,0.99998672175889,8.05987893227932e-05,3,163,nucleolar part,CC,DEAF1;INO80C;PAK6
2886,GO:0006401,0.999986808483867,3.87430569655272e-05,12,346,RNA catabolic process,BP,PCBP4;ZFP36L1;RNASET2;ISG20;ZFP36;PAN2;AGO4;GTPBP1;PNRC1;AKT1;ERN1;RPL13A
15845,GO:0072594,0.999990150423002,2.4400549557769e-05,19,459,establishment of protein localization to organelle,BP,MICALL2;VPS11;TFDP2;PEX10;TMEM173;BCL6;HES1;LRSAM1;PEX7;HK1;GAS6;TMCO6;OSCP1;SORL1;AKT1;PINK1;LONP2;RPL13A;UBL5
35,GO:0000070,0.999991310229562,7.06108033771037e-05,2,142,mitotic sister chromatid segregation,BP,TUBG2;CHMP1B
17985,GO:1902494,0.999991440178769,1.42748164508477e-05,77,1231,catalytic complex,CC,ERCC1;BTBD2;POLD4;RBCK1;APPL2;FBXO2;DDB2;ULK1;GNAL;ABCA7;PPP2R3B;DNAH1;ASH2L;PIK3R2;INO80C;HDAC5;OGDHL;ABTB1;SALL2;CUL9;JADE2;GM2A;INSR;FBXW8;NDUFS8;RABGGTA;FBXO27;PHC2;ATP12A;FBXW4;NUDCD3;DHTKD1;KLHL29;NSMCE4A;CUL7;ABCA2;PHF21A;PFKL;ZFP36;BTBD11;MAPKBP1;FBXW5;HDAC11;MIB2;FBXO17;SDHAF4;BTRC;ZNF217;SDHA;WDR60;ABCD4;KLHDC8B;PDK2;SMARCD2;AGO4;RAD23A;SPSB3;GTPBP1;WDR83;JARID2;SESN2;PIGV;PIGQ;ACVR1B;ZER1;SMARCA1;GPD1L;PINK1;P3H4;PYCARD;TRERF1;NDUFV3;ERN1;FBXL20;WDR63;BCKDHA;ING4
2888,GO:0006403,0.999992090076481,3.67172587231522e-05,5,209,RNA localization,BP,ZFP36L1;TST;ZFP36;SRSF5;ZNF385A
10772,GO:0044260,0.99999226915048,1.02219939442667e-05,526,6238,cellular macromolecule metabolic process,BP,TNIP1;HTRA1;FOS;DUSP6;LMF1;CEMIP;APOE;CTNNBIP1;PTPRS;ERCC1;WWC3;NT5E;GAA;CITED4;BTBD2;PYGB;RNF44;CST3;RAPGEF3;TCFL5;PGM1;GSN;XDH;PRDX5;PCBP4;MEF2D;NOS1;LTBP1;MARCH9;ARAP1;ZFP36L1;GRB7;NR1D1;ARRDC1;NYNRIN;POLD4;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;IGF2;NFATC4;MST1R;LRP1;MAPK13;CDK18;ST6GALNAC2;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;B3GAT3;FBXO2;TCEA2;DUSP5;FKBP9;PPP1R14A;JOSD2;LOXL1;MXD4;DDB2;SERPING1;MTHFR;MDFI;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CRTC1;PYGL;SHC1;F2R;PTK6;ABCA7;DEAF1;PPP2R3B;BAHCC1;PPM1J;CTSB;RNF208;SHC2;CXXC5;ULK2;GJC2;D2HGDH;ZMYND8;ASH2L;ZSCAN18;GRAMD4;SOX12;MXI1;PLAT;MMP1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;ZP3;CRTAP;RPS6KA2;LRP5;HYAL1;ANO8;MARK4;TENM2;MAML3;ZFPM1;TFEB;ERBB2;FBLN1;BRSK1;CTSF;SCMH1;PTPRU;PKD2;CBS;GID4;TMEM129;EDEM1;ABTB1;H2AFJ;PHLDA2;DNM1;SPRY4;CDKN1C;SALL2;MSRB2;CUL9;CD9;XPC;PTPRE;PAK6;HEXB;SERPINE2;VPS11;GALNT12;FOXQ1;RNF135;UNK;JADE2;MINK1;ATP2B4;GGT1;TFDP2;CSNK1E;RASA4;TRAPPC9;ADAMTS7;PDCD4;TNFRSF25;DTX3;ZKSCAN1;USP20;PEX10;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;RAB3D;LCE1E;FBXW8;ZC3H6;ID1;GRK6;MVD;B4GAT1;POLL;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;SYNGAP1;FBXO27;PPP1R35;DNMT3A;LPAR3;TMEM173;PRNP;PAPLN;SRD5A3;RNASET2;FBXL8;SNX33;FBXO41;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;ECM1;SNX9;STAT6;DLG4;SPEG;MARCH2;MTA3;MKNK2;STRADB;WWTR1;ISG20;FAM20C;MYO18A;DNAJB5;BCL6;ANKZF1;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;BNIP3;CD81;SRMS;FZD8;VEGFA;DNASE1L1;ZSCAN2;VANGL2;MAST4;FBXW4;AP2A2;CEBPB;SHANK3;ACVR2B;HSF4;NAB2;CALCOCO1;ZDHHC1;S1PR2;ENDOG;TNFRSF6B;MAPK3;FBXL16;ETV5;RAB40B;DVL1;MTA1;LHPP;KLHL29;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;ST3GAL3;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;SSH1;FURIN;MLXIPL;ZNF624;CUL7;MEFV;ARHGAP22;TRIM4;ABCA2;TK2;LRSAM1;ZNF414;LY6K;FKBP10;CDC42EP5;PIDD1;PHF21A;CELSR2;IL6R;PCSK9;ZFP36;ETV4;BTBD11;HLCS;FGFR3;PRKACA;F12;ZNF862;ZMYM3;KIAA1549;LRRK1;DGUOK;MAGEF1;CYFIP2;RPS6KA5;HBEGF;RAB3B;MAP2K2;DAP;FGFR4;SPTB;FBXW5;MXRA8;DMTN;MYH3;MDGA1;XYLT2;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;TCF25;LDLR;PTOV1;LYPLAL1;SOX13;ABHD17C;TRPV4;MPG;PIGZ;BHLHE40;EIF4EBP3;RRNAD1;RAG1;ZNF80;DUSP7;PHLDA1;EEF2K;MSLN;HMGA2;LDLRAP1;ELK3;DGKQ;SEMA4C;MVB12A;ZXDC;MIB2;FBXO17;PADI3;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;STK32C;WNT7B;SUFU;PTAFR;RFNG;DMC1;PAN2;ZNF446;RXRA;BCR;NEO1;IGFBP4;MUC19;TBC1D16;USP21;RNF123;PRKCZ;ADAMTS13;ZDHHC24;HLTF;MDH2;BCORL1;ETFB;ZNF485;LSM14B;KLHDC8B;PDK2;GPC1;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;CAMKK1;SPSB3;PIN1;MAN1B1;MN1;ZNF563;C5;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;BIN1;SERPINB6;PPP1R13L;SH3D19;ZNF554;WDR83;GLRX;JARID2;CAPN2;SESN2;TOLLIP;ADCK5;TMEM161A;RXRB;CSTB;MAN2B2;PNRC1;MAPRE3;DUSP23;LCAT;MACROD1;GAL3ST4;PTMS;MADD;RTN4R;ELFN2;OR7D2;PIGV;TIMP1;APOBEC3C;PIGQ;ZFP41;PPM1F;SBF1;SORL1;STK39;VEGFB;ACVR1B;MEF2B;ZSCAN30;ADORA2B;ERBB3;ZER1;CCDC85B;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;NDRG2;SMARCA1;VPS33B;SIX5;ERCC6;PCMTD2;GPD1L;TDRKH;SPPL2B;IL17RD;SSBP2;RPL39L;ADCK2;SSH3;PINK1;PKD1;EHD3;LONP2;SNTA1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;EIF4G3;ZNF710;CTSH;ABHD14B;P3H4;MLST8;CBLC;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;PCSK1N;THAP8;DDN;PMS2P5;STK17A;ERN1;RANBP9;ZNF319;APOBEC3F;PRIMPOL;FBXL20;MOCS1;SIRT3;GLI4;JAK3;MAST3;LITAF;MZF1;NEIL1;RARG;ING4;EIF4E3;PBXIP1;EREG;FAM162A;ZNF514;TRIM7;WDR18;ADAMTSL4;TRNP1;TTLL11;ZNF837;POLM;NDST2;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;UBL5
2887,GO:0006402,0.999993065128693,2.27246572406271e-05,10,322,mRNA catabolic process,BP,PCBP4;ZFP36L1;ZFP36;PAN2;AGO4;GTPBP1;PNRC1;AKT1;ERN1;RPL13A
3245,GO:0006913,0.999993106780093,2.2646877559295e-05,10,301,nucleocytoplasmic transport,BP,RAPGEF3;TMEM173;STRADB;BCL6;GAS6;TMCO6;SRSF5;AKT1;PKD1;RGS14
10377,GO:0043227,0.999993432368188,9.02688995519659e-06,821,9247,membrane-bounded organelle,CC,TNIP1;HTRA1;FOS;DUSP6;H6PD;LMF1;CEMIP;APOE;TYSND1;MARVELD1;CTNNBIP1;MARCKSL1;TSPAN1;PPL;IDH2;PTPRS;ERCC1;FAM110C;NT5E;GAA;SYTL1;CITED4;NAPRT;PYGB;RNF44;CST3;SHANK2;LTBP4;RAPGEF3;TCFL5;PGM1;CYP27B1;GSN;CLCA2;XDH;OAF;PRDX5;NDRG1;PGLS;PRSS3;PRODH;CADM4;MEF2D;NOS1;LTBP1;MARCH9;ARAP1;ZFP36L1;COL6A1;POSTN;NR1D1;CRAT;ALOX15B;ARRDC1;EPN3;FAM210B;POLD4;SCN8A;EPHB2;EPAS1;OBSCN;CNTN1;CPT2;IGF2;NFATC4;GPX3;NME4;MST1R;LRP1;GAMT;MAPK13;APPL2;HEBP1;CDK18;RALGDS;ST6GALNAC2;LTBP2;RAB11FIP4;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;B3GAT3;HADH;CRYL1;SUGCT;ACSF2;REEP6;FBXO2;ACOT7;TCEA2;DUSP5;TOM1L2;FKBP9;HS1BP3;UROS;FHL1;LOXL1;MXD4;DDB2;SERPING1;KDSR;MDFI;EGR1;ULK1;RHBDF1;PKN1;CRTC1;PYGL;TRIM65;DOPEY2;SYT8;NAGLU;SHC1;F2R;PTK6;GNAL;BPHL;NPEPL1;ABCA7;DEAF1;LAMA5;PPP2R3B;SLC9A3R2;BAHCC1;GALE;BBS2;ACTA2;PRSS8;S100A4;CTSB;ESRG;LPCAT4;RNF208;PITPNC1;SLC16A3;CORO1B;CXXC5;ULK2;DHRS1;MALL;D2HGDH;ZMYND8;TBC1D14;ASH2L;ZSCAN18;PACS2;GRAMD4;SOX12;MXI1;CERS4;PLAT;ABCG1;ANK3;NOL4L;PIK3R2;S100A6;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;ARHGAP23;PLD3;DOCK4;CRTAP;RPS6KA2;NISCH;LRP5;DBNDD1;HYAL1;TUBG2;ANO8;TENM2;SLC2A9;MAML3;B4GALNT4;ZFPM1;BCAM;TFEB;ERBB2;SLC13A3;FBLN1;BRSK1;MICALL2;BSG;CTSF;SCMH1;OGDHL;PKD2;CBS;TMEM129;FUCA1;TST;CPT1C;EDEM1;ABTB1;VWA5A;SLC7A8;ITGB4;ITPR3;H2AFJ;PRAF2;VAT1;DNM1;FCHO1;PTHLH;CDKN1C;SALL2;MSRB2;CD9;XPC;PTPRE;ANGEL1;SIGMAR1;PAK6;HEXB;SERPINE2;VPS11;VAMP2;CCDC69;FUZ;GALNT12;FOXQ1;NPHP4;LTB4R2;NTSR1;JADE2;THSD4;CD320;MINK1;RALGAPA2;ATP2B4;GGT1;SNN;TFDP2;PHF7;CSNK1E;ACP5;PLCD1;TRAPPC9;AGAP1;ZFYVE21;DIRC2;ADAMTS7;PDCD4;GM2A;BEX2;ACAP3;TNFRSF25;GLUL;PRR7;RHOD;ZKSCAN1;ARVCF;TNXB;PEX10;ARMCX2;ASIC1;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;RAB3D;FBXW8;ZC3H6;ID1;CELSR1;AKR7A2;MZT2A;B4GAT1;POLL;WDR27;NDUFS8;RABGGTA;ADARB1;ZNF692;ZNF704;TXNRD3;NBEAL2;HAGH;DNMT3A;DNPH1;TMEM173;PRNP;SERINC2;DHX32;SRD5A3;OXLD1;ATP7B;IAH1;RNASET2;SNX33;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;ECM1;CEP250;ATG16L2;SNX9;STAT6;DLG4;SPEG;ABCD1;MARCH2;REEP2;MTA3;MKNK2;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;MYO18A;ARHGAP27;CERCAM;MZT2B;DNAJB5;PHC2;PLEKHH2;C1ORF210;BCL6;TTYH3;ANKZF1;UCKL1;PFKFB2;FAM213A;CHMP1B;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;TMEM92;BNIP3;CD81;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;HOOK2;ARL2;YPEL3;VANGL2;AP2A2;CEBPB;RHBDF2;DPP7;GPRC5C;SHANK3;HSD11B1L;SSC4D;HSF4;ADAM15;NAB2;CALCOCO1;ZDHHC1;ENDOG;MAPK3;PDZD2;PLEKHG5;TUB;KCNAB2;ETV5;OLFM2;CARD19;AMN;SLC22A18;GLB1;DHTKD1;EXD3;C19ORF33;RAB40B;DVL1;ENTPD2;GALK1;MTA1;LHPP;FYCO1;WIPF1;GPSM1;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;PHGDH;ST3GAL3;SLC16A13;NSMCE4A;FHOD1;HES1;BRD3;PC;ACAD10;YPEL2;COMTD1;FURIN;MLXIPL;ZNF624;NAGS;MBOAT7;SLC48A1;CUL7;MEFV;EVC;ARHGAP22;SLC2A3;ABCA2;TK2;ZNF414;LY6K;ADA;FKBP10;TRIM45;MCTP1;OSBPL5;PYCR2;PIDD1;RETSAT;PHF21A;AQP3;ACY1;CKMT1A;PFKL;SLIT3;PCSK9;GGACT;FCGBP;TMEM9;ZFP36;ETV4;RHOF;MAPKBP1;HLCS;CYHR1;FGFR3;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;LRRK1;NUDT10;DGUOK;MAGEF1;CYFIP2;SLC38A10;RPS6KA5;SCNN1A;HBEGF;SLC25A37;ITGB5;RAB3B;MAP2K2;PI4K2A;FGFR4;SPTB;MXRA8;SLC37A2;STX10;GAREM2;DMTN;RAPGEF5;PMVK;BBS1;MYH3;XYLT2;HDAC11;VGF;TNFRSF1A;SEZ6L2;EHD4;MAPK8IP1;TCF25;SEMA3B;LDLR;PTOV1;FAM214B;LYPLAL1;CYP3A5;ACOT11;SNX17;SOX13;ABHD17C;TRPV4;MPG;RHOBTB2;PIGZ;IFNGR2;BHLHE40;CROCC;CCDC92;RAG1;ZNF80;DUSP7;PHLDA1;LRRC45;MSLN;HMGA2;LDLRAP1;TM7SF2;ELK3;AHNAK2;DGKQ;PEX7;KLHDC2;SEMA4C;MVB12A;HK1;NMRAL1;ZXDC;MIB2;CHST6;SDHAF4;PADI3;GAS6;BTRC;MEX3A;POU6F1;LLGL1;ZNF217;PPARA;HMGCL;TKFC;TSPAN4;TMEM187;WNT7B;BLVRB;GIT1;COMT;ALDH16A1;SUFU;PTAFR;RFNG;ANKRD13D;DMC1;LTBP3;PAN2;REEP4;ZNF446;ATG2A;RXRA;PCK2;PCSK1;VAV3;VASN;BCR;TMEM175;NEO1;IGFBP4;SDHA;GSDMC;MUC19;TBC1D16;USP21;RNF123;WDR60;PRKCZ;ADAMTS13;ZDHHC24;CLTCL1;HLTF;MDH2;CAPG;BCORL1;TM7SF3;ETFB;ABCD4;SPATA7;TWF2;ZNF485;SH3GLB2;TPP1;PDK2;GPC1;TMX4;ICOSLG;SRSF5;ZNF160;RFXANK;TEF;SMOX;CEP68;SMARCD2;MAPKAPK3;AGO4;RAD23A;ARAP3;CDHR1;FGFR1;CTSZ;CAMKK1;PIN1;MAN1B1;PNPLA4;ZNF563;C5;KMT5C;PHYH;IRF2BPL;CMBL;PROX1;WBP2;PCDHGC3;C21ORF2;NICN1;ASAP2;GPR155;KCNMA1;ESYT2;BIN1;MTMR11;YIPF3;TMEM8B;SERPINB6;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;CES2;SLC25A27;JARID2;CAPN2;SESN2;NDUFA4L2;TOLLIP;WNT2B;TSTA3;RXRB;CSTB;PROCR;SNPH;MAN2B2;TMEM231;PNRC1;DUSP23;LCAT;GUCA1B;MACROD1;GAL3ST4;SMDT1;PTMS;TMPRSS11D;CYBRD1;RTN4R;PIGV;SLC9A7;TIMP1;CD68;SDC1;WHAMMP3;GRHPR;ACTR1B;APOBEC3C;RTN2;H1FX;EPS8L1;PIGQ;WNT3;GSTT1;ZFP41;SBF1;SORL1;STK39;COL13A1;VEGFB;ACVR1B;MEF2B;TBC1D17;ZSCAN30;GSS;AHCYL2;TPCN1;HGSNAT;SLC25A29;CCDC85B;PNMA1;CYP2S1;AKT1;CTSD;TRAP1;TMBIM4;NLRX1;ADAM19;ZNF385A;TP53INP1;LRCH4;NDRG2;TUT1;SMARCA1;VPS33B;SIX5;ERCC6;ACP6;GPD1L;EPS8L2;TDRKH;SLC5A5;SUN1;NAGA;TMEM120A;SPPL2B;IL17RD;UQCR11;SSBP2;R3HDM2;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;MPLKIP;KDM4B;CAMTA2;RGS14;SYNE3;GOLGA2P5;PCIF1;MAFIP;SPIRE2;CCDC106;R3HDM4;HEXDC;ZNF710;CTSH;EHBP1L1;ABHD14B;P3H4;MLST8;ROBO4;AGPAT4;RILPL1;NRSN1;RSAD1;CBLC;EPN2;RFX2;RNF187;PYCARD;MAP2K3;PNPO;SNX29;RHBG;POMT1;TRERF1;PCSK1N;KCNN4;DDN;PMS2P5;AS3MT;NDUFV3;STK17A;ERN1;RANBP9;ZNF319;APOBEC3F;PRIMPOL;ACADS;GCAT;MOCS1;SIRT3;ALKBH6;GLI4;C12ORF66;SLC2A1;CPNE7;MLYCD;TAZ;JAK3;BCKDHA;LITAF;APBA1;MZF1;NEIL1;RARG;ING4;GALNS;PBXIP1;FAM162A;PPCS;FCHSD1;GSTM2;ABHD14A;ZNF514;PODXL2;TRIM7;WDR18;PQLC2;KRT15;ADAMTSL4;TRNP1;ZNF837;TMED4;POLM;SEMA4F;FAM50A;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;STXBP2;UBL5;LZTS2
3336,GO:0007062,0.999994422295785,7.69577381002984e-05,1,120,sister chromatid cohesion,BP,NDE1
12825,GO:0051169,0.999994428828324,1.84794600556524e-05,10,304,nuclear transport,BP,RAPGEF3;TMEM173;STRADB;BCL6;GAS6;TMCO6;SRSF5;AKT1;PKD1;RGS14
15230,GO:0071426,0.999994915552906,7.06506489329031e-05,1,121,ribonucleoprotein complex export from nucleus,BP,SRSF5
273,GO:0000776,0.999995158594484,6.75385783993752e-05,1,121,kinetochore,CC,NDE1
2809,GO:0006281,0.999995183000553,1.18170590927963e-05,21,484,DNA repair,BP,ERCC1;POLD4;EGFR;DDB2;INO80C;XPC;CSNK1E;POLL;MTA1;NSMCE4A;MAGEF1;MPG;HMGA2;DMC1;RAD23A;TMEM161A;ERCC6;PMS2P5;PRIMPOL;NEIL1;POLM
16850,GO:0098813,0.999995230008289,1.89855490630585e-05,7,252,nuclear chromosome segregation,BP,TUBG2;CHMP1B;DMC1;NDE1;AGO4;SUN1;P3H4
15084,GO:0071166,0.999995417602065,6.41820851603734e-05,1,122,ribonucleoprotein complex localization,BP,SRSF5
2427,GO:0005622,0.999996007296077,5.95254013222208e-06,956,10534,intracellular,CC,TNIP1;HTRA1;FOS;DUSP6;H6PD;LMF1;CEMIP;ADGRL1;APOE;TYSND1;MARVELD1;ESPN;CTNNBIP1;MARCKSL1;TSPAN1;PPL;IDH2;RNPEPL1;PTPRS;ERCC1;WWC3;FLNC;FAM110C;NT5E;GAA;SYTL1;CLIP2;CITED4;NAPRT;BTBD2;PYGB;RNF44;CST3;SHANK2;RAPGEF3;TCFL5;PGM1;CYP27B1;GSN;CLCA2;EVI5L;XDH;PRDX5;NDRG1;PGLS;PCBP4;PRSS3;PRODH;MEF2D;NOS1;LTBP1;MARCH9;PARVB;ARAP1;ZFP36L1;COL6A1;TCTN1;POSTN;GRB7;NR1D1;CRAT;EFS;ALOX15B;ARRDC1;EPN3;FAM210B;POLD4;SCN8A;RBCK1;EPHB2;EPAS1;OBSCN;CPT2;RHPN1;MYZAP;IGF2;NFATC4;NME4;MST1R;LRP1;GAMT;MAPK13;APPL2;HEBP1;CDK18;RALGDS;ST6GALNAC2;LTBP2;RAB11FIP4;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;MMP28;B3GAT3;HADH;CRYL1;SUGCT;ACSF2;REEP6;FBXO2;ACOT7;TCEA2;DUSP5;TOM1L2;FKBP9;HS1BP3;PPP1R14A;ISYNA1;UROS;FHL1;JOSD2;LOXL1;MXD4;DDB2;SERPING1;MTHFR;KDSR;MDFI;RAPGEFL1;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CRTC1;PYGL;ARHGEF4;TRIM65;DOPEY2;SYT8;NAGLU;SHC1;RGL2;F2R;PTK6;GNAL;BPHL;NPEPL1;ABCA7;DEAF1;LAMA5;PPP2R3B;SLC9A3R2;BAHCC1;GALE;BBS2;ACTA2;S100A4;CTSB;ESRG;LPCAT4;DNAH1;RNF208;SHC2;PITPNC1;SLC16A3;CORO1B;CXXC5;ULK2;DGKA;DHRS1;MALL;THBS3;D2HGDH;ZMYND8;TBC1D14;ASH2L;ZSCAN18;PACS2;GRAMD4;SOX12;MXI1;CERS4;PLAT;ABCG1;RIN1;ANK3;NOL4L;PIK3R2;OPLAH;S100A6;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;ARHGAP23;PLD3;DOCK4;ZP3;CRTAP;RPS6KA2;NMRK1;NISCH;LRP5;DBNDD1;HYAL1;TUBG2;ANO8;MARK4;TENM2;SLC2A9;MAML3;B4GALNT4;ZFPM1;TFEB;ERBB2;EXOC2;BRSK1;MICALL2;BSG;CTSF;SCMH1;OGDHL;PKD2;CBS;TMEM129;FUCA1;TST;IQSEC2;CPT1C;EDEM1;ABTB1;VWA5A;SLC7A8;ITPR3;H2AFJ;PRAF2;PHLDA2;VAT1;DNM1;SPRY4;DDIT4L;FCHO1;MPRIP;PTHLH;CDKN1C;RIMS3;SALL2;MSRB2;IFT140;CUL9;CD9;KIF13B;XPC;PTPRE;ANGEL1;NINL;SIGMAR1;PAK6;HEXB;SERPINE2;VPS11;VAMP2;CCDC69;FUZ;GALNT12;FOXQ1;RNF135;NPHP4;LTB4R2;UNK;NTSR1;JADE2;CD320;MINK1;RALGAPA2;ATP2B4;SNN;TMOD2;TFDP2;PHF7;CSNK1E;ACP5;RASA4;PLCD1;TRAPPC9;AGAP1;ZFYVE21;DIRC2;ADAMTS7;ENKD1;PDCD4;DOCK6;TMEM134;GM2A;BEX2;ACAP3;TNFRSF25;GLUL;PRR7;RHOD;DTX3;ZKSCAN1;ARVCF;TNXB;USP20;PEX10;ARMCX2;ASIC1;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;RAB3D;PLCXD1;LCE1E;SH3PXD2B;TBC1D8;FBXW8;ZC3H6;ID1;CELSR1;AKR7A2;MVD;LGALS9C;MZT2A;B4GAT1;POLL;WDR27;NDUFS8;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;CCNG2;TXNRD3;SYNGAP1;NBEAL2;HAGH;FBXO27;DNMT3A;DNPH1;TMEM173;PRNP;DHX32;SRD5A3;OXLD1;ATP7B;RNASET2;FBXL8;SNX33;FBXO41;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;ECM1;CEP250;ATG16L2;SNX9;STAT6;DLG4;SPEG;ABCD1;MARCH2;REEP2;MTA3;MKNK2;PLCD3;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;MYO18A;ARHGAP27;CERCAM;MZT2B;DNAJB5;MYCBPAP;PHC2;SCART1;PLEKHH2;C1ORF210;BCL6;ANKZF1;UCKL1;PFKFB2;PLXNB1;FAM213A;CHMP1B;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;TMEM92;BNIP3;SRMS;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;HOOK2;LRRC8A;ARL2;YPEL3;VANGL2;MAST4;FBXW4;ELMO3;AP2A2;CEBPB;RHBDF2;DPP7;GPRC5C;SHANK3;HSD11B1L;ACVR2B;HSF4;ADAM15;NAB2;NUDCD3;CALCOCO1;ZDHHC1;ENDOG;MAPK3;PDZD2;FBXL16;PLEKHG5;TUB;KCNAB2;ETV5;OLFM2;CARD19;AMN;SLC22A18;GLB1;CAPNS2;DHTKD1;EXD3;ARL10;C19ORF33;RAB40B;TNNT1;DVL1;ENTPD2;GALK1;MTA1;LHPP;FYCO1;KLHL29;WIPF1;GPSM1;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;PHGDH;ST3GAL3;SLC16A13;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;PC;ACAD10;YPEL2;SSH1;COMTD1;FURIN;MLXIPL;ZNF624;NAGS;FBF1;MBOAT7;SLC48A1;SAMD3;CUL7;MEFV;EVC;ARHGAP22;SLC2A3;TRIM4;NADK;PLEKHG2;ABCA2;TK2;LRSAM1;ZNF414;LY6K;ADA;FKBP10;CDC42EP5;TRIM45;MCTP1;OSBPL5;PYCR2;PIDD1;RETSAT;PAG1;PHF21A;SH2D2A;AQP3;MYH16;CELSR2;ACY1;CKMT1A;PFKL;SLIT3;PCSK9;TMEM9;ZFP36;ETV4;RHOF;BTBD11;MAPKBP1;HLCS;CYHR1;RSPH3;FGFR3;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;LRRK1;NUDT10;PLCH2;DGUOK;CYFIP2;SLC38A10;RPS6KA5;SCNN1A;HBEGF;SLC25A37;ITGB5;RAB3B;MAP2K2;PI4K2A;FGFR4;SPTB;FBXW5;MXRA8;SLC37A2;STX10;DMTN;RAPGEF5;PMVK;BBS1;MYH3;XYLT2;HDAC11;VGF;TNFRSF1A;SEZ6L2;EHD4;MAPK8IP1;TCF25;SEMA3B;LDLR;PTOV1;FAM214B;LYPLAL1;CYP3A5;ACOT11;SNX17;SOX13;ABHD17C;TRPV4;MPG;RHOBTB2;PIGZ;IFNGR2;BHLHE40;EIF4EBP3;CROCC;CCDC92;RAG1;ZNF80;DUSP7;PHLDA1;LRRC45;TNFAIP8L1;EEF2K;MSLN;HMGA2;LDLRAP1;TM7SF2;ELK3;AHNAK2;DGKQ;PEX7;KLHDC2;SEMA4C;MVB12A;HK1;NMRAL1;ZXDC;MIB2;FBXO17;CHST6;SDHAF4;PADI3;GAS6;BTRC;MEX3A;POU6F1;LLGL1;ANKS6;ADGRB2;ZNF217;PPARA;HMGCL;TKFC;GUK1;TMEM187;STK32C;WNT7B;BLVRB;GIT1;COMT;TTC7B;SUFU;PTAFR;PLEKHG6;RFNG;ANKRD13D;DMC1;IMPA2;ARHGEF37;PAN2;REEP4;ZNF446;ATG2A;RXRA;PCK2;PCSK1;VAV3;VASN;BCR;TMEM175;NEO1;IGFBP4;SDHA;GSDMC;MUC19;TBC1D16;USP21;RNF123;WDR60;PRKCZ;ADAMTS13;ZDHHC24;CLTCL1;HLTF;MDH2;CAPG;BCORL1;INPP5D;TMCO6;ETFB;ABCD4;SPATA7;NYAP1;TWF2;ZNF485;SH3GLB2;KLHDC8B;TPP1;PDK2;GPC1;TMX4;ICOSLG;SRSF5;ZNF160;RFXANK;TEF;SMOX;CEP68;SMARCD2;MAPKAPK3;NDE1;AGO4;RAD23A;ARAP3;FGFR1;CTSZ;CAMKK1;SPSB3;PIN1;MAN1B1;PNPLA4;ZNF563;KMT5C;PHYH;IRF2BPL;CMBL;PROX1;WBP2;GTPBP1;C21ORF2;NICN1;ASAP2;DLG3;GPR155;ESYT2;BIN1;VSNL1;MTMR11;UNC119B;YIPF3;TMEM8B;SERPINB6;PI4KAP2;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;CES2;SLC25A27;GRB10;BFSP1;JARID2;SYNC;CAPN2;SESN2;NDUFA4L2;TOLLIP;WNT2B;TSTA3;WRAP73;RXRB;CSTB;PROCR;SNPH;MAN2B2;PNRC1;MAPRE3;DUSP23;MACROD1;GAL3ST4;SMDT1;PTMS;PITPNM3;CYBRD1;MADD;LMLN;RTN4R;EPB41L3;PIGV;SLC9A7;TIMP1;CD68;SDC1;WHAMMP3;GRHPR;SH2B3;ACTR1B;APOBEC3C;RTN2;H1FX;EPS8L1;PLEKHH3;PIGQ;WNT3;LYST;GSTT1;ZFP41;PPM1F;KIAA1191;MICALCL;SBF1;SORL1;STK39;COL13A1;VEGFB;ACVR1B;MEF2B;TBC1D17;ANO9;GSDMA;ZSCAN30;GSS;AHCYL2;ALS2CL;TSNARE1;ADORA2B;TPCN1;HGSNAT;SLC25A29;ERBB3;ABR;ZER1;CCDC85B;PNMA1;CYP2S1;AKT1;CTSD;TRAP1;STON1;TMBIM4;NLRX1;SEPT8;ADAM19;ZNF385A;TP53INP1;LRCH4;NDRG2;TUT1;SMARCA1;VPS33B;SIX5;ERCC6;PCMTD2;ACP6;GPD1L;EPS8L2;TDRKH;SLC5A5;SUN1;NAGA;TMEM120A;SPPL2B;IL17RD;UQCR11;SSBP2;RPL39L;R3HDM2;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;MPLKIP;SNTA1;ARHGEF10L;KDM4B;CAMTA2;HOMER2;LGALS9B;RGS14;SYNE3;PLEKHH1;GOLGA2P5;PCIF1;MAFIP;SPIRE2;CCDC106;R3HDM4;HEXDC;EIF4G3;ZNF710;CTSH;EHBP1L1;ABHD14B;P3H4;MLST8;AGPAT4;RILPL1;NRSN1;RSAD1;CBLC;ATXN10;EPN2;RFX2;RNF187;PYCARD;MAP2K3;PNPO;RHBG;POMT1;TRERF1;PCSK1N;DNAAF5;DDN;PMS2P5;AS3MT;NDUFV3;STK17A;ERN1;RANBP9;ZNF319;APOBEC3F;PRIMPOL;ACADS;FBXL20;GCAT;WDR63;MOCS1;ARHGEF19;SIRT3;ALKBH6;GLI4;C12ORF66;SLC2A1;CPNE7;MLYCD;TAZ;JAK3;BCKDHA;MAST3;KIFC2;LITAF;APBA1;MZF1;NEIL1;FUK;RARG;ING4;EIF4E3;GALNS;PBXIP1;EREG;FAM162A;PPCS;FCHSD1;GSTM2;ABHD14A;ZNF514;PODXL2;ZFYVE19;TRIM7;MORN4;WDR18;PQLC2;SFI1;KRT15;ADAMTSL4;TRNP1;TTLL11;ZNF837;TMED4;POLM;SEMA4F;FAM50A;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;STXBP2;KIF26B;UBL5;LZTS2
2895,GO:0006412,0.999996217490757,8.2618247900483e-06,30,653,translation,BP,TNIP1;ZFP36L1;GRB7;EGFR;ERBB2;ABTB1;UNK;GGT1;MKNK2;MAPK3;ZFP36;CYFIP2;MAP2K2;EIF4EBP3;EEF2K;MEX3A;PTAFR;RXRA;LSM14B;AGO4;GTPBP1;SESN2;AKT1;TRAP1;ZNF385A;RPL39L;PINK1;EIF4G3;EIF4E3;RPL13A
10850,GO:0044391,0.999996295502811,3.16467052866958e-05,2,182,ribosomal subunit,CC,RPL39L;RPL13A
13463,GO:0055029,0.999996796027596,4.60706475368839e-05,1,127,nuclear DNA-directed RNA polymerase complex,CC,ERCC1
7302,GO:0031323,0.9999970040056,4.06779516246113e-06,373,4616,regulation of cellular metabolic process,BP,TNIP1;HTRA1;FOS;DUSP6;LMF1;CEMIP;APOE;TYSND1;CTNNBIP1;ERCC1;WWC3;CITED4;CST3;RAPGEF3;TCFL5;CYP27B1;GSN;XDH;PRDX5;PCBP4;MEF2D;NOS1;ARAP1;ZFP36L1;GRB7;NR1D1;RBCK1;EPHB2;EPAS1;CNTN1;IGF2;NFATC4;MST1R;LRP1;MAPK13;EGFR;TIMP2;TSC22D1;B3GAT3;FBXO2;TCEA2;DUSP5;PPP1R14A;MXD4;SERPING1;MTHFR;MDFI;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CRTC1;TRIM65;SHC1;F2R;PTK6;ABCA7;DEAF1;PPP2R3B;BAHCC1;SHC2;CXXC5;ULK2;GJC2;ZMYND8;TBC1D14;ASH2L;ZSCAN18;GRAMD4;SOX12;MXI1;PLAT;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;CRTAP;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;FBLN1;SCMH1;PKD2;EDEM1;H2AFJ;PHLDA2;SPRY4;PTHLH;CDKN1C;SALL2;MSRB2;PAK6;HEXB;SERPINE2;VPS11;FOXQ1;LTB4R2;UNK;NTSR1;MINK1;ATP2B4;TFDP2;CSNK1E;ACP5;TRAPPC9;PDCD4;TNFRSF25;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;SYNGAP1;PPP1R35;DNMT3A;LPAR3;TMEM173;PRNP;PAPLN;SNX33;HES2;SPRY2;HINT2;ZNF467;MNT;ECM1;SNX9;STAT6;DLG4;MTA3;MKNK2;STRADB;WWTR1;FAM20C;DNAJB5;BCL6;PFKFB2;SCAND1;DYRK1B;SEC14L2;BNIP3;CD81;FZD8;VEGFA;ZSCAN2;VANGL2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;S1PR2;ENDOG;TNFRSF6B;MAPK3;ETV5;DVL1;MTA1;FYCO1;GPSM1;ADCY6;L3MBTL1;MBD1;EPHB3;FHOD1;HES1;BRD3;SSH1;FURIN;MLXIPL;ZNF624;MEFV;ARHGAP22;ABCA2;LRSAM1;ZNF414;PIDD1;PHF21A;CELSR2;IL6R;PCSK9;ZFP36;ETV4;FGFR3;PRKACA;F12;ZNF862;ZMYM3;KIAA1549;LRRK1;MAGEF1;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;DMTN;HDAC11;TNFRSF1A;EHD4;MAPK8IP1;TCF25;LDLR;PTOV1;SOX13;TRPV4;BHLHE40;EIF4EBP3;RAG1;ZNF80;DUSP7;EEF2K;HMGA2;ELK3;AHNAK2;DGKQ;SEMA4C;ZXDC;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;WNT7B;COMT;SUFU;PTAFR;ZNF446;RXRA;VAV3;BCR;NEO1;IGFBP4;TBC1D16;USP21;PRKCZ;HLTF;BCORL1;INPP5D;ZNF485;LSM14B;PDK2;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;CAMKK1;PIN1;MN1;ZNF563;C5;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;BIN1;SERPINB6;PPP1R13L;ASS1;SH3D19;ZNF554;GRB10;JARID2;SESN2;TOLLIP;TMEM161A;RXRB;CSTB;PNRC1;MAPRE3;GUCA1B;MADD;RTN4R;ELFN2;OR7D2;TIMP1;ZFP41;PPM1F;SORL1;STK39;ACVR1B;MEF2B;ZSCAN30;ADORA2B;TPCN1;ERBB3;ZER1;CCDC85B;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;NDRG2;SMARCA1;SIX5;ERCC6;GPD1L;SSBP2;PINK1;PKD1;LONP2;SNTA1;ARHGEF10L;KDM4B;CAMTA2;RGS14;PCIF1;MAFIP;EIF4G3;ZNF710;CTSH;ABHD14B;MLST8;CBLC;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;PCSK1N;THAP8;DDN;STK17A;ERN1;RANBP9;ZNF319;SIRT3;GLI4;MLYCD;TAZ;JAK3;LITAF;MZF1;NEIL1;RARG;ING4;EIF4E3;PBXIP1;EREG;FAM162A;ZNF514;WDR18;SFI1;TRNP1;ZNF837;RPL13A;MIF
15943,GO:0080090,0.999997028092209,4.04309872942215e-06,363,4508,regulation of primary metabolic process,BP,TNIP1;HTRA1;FOS;DUSP6;LMF1;CEMIP;APOE;TYSND1;CTNNBIP1;ERCC1;WWC3;CITED4;BTBD2;CST3;LTBP4;RAPGEF3;TCFL5;CYP27B1;GSN;XDH;PRDX5;PCBP4;MEF2D;NOS1;ZFP36L1;GRB7;NR1D1;RBCK1;EPHB2;EPAS1;CNTN1;CPT2;IGF2;NFATC4;MST1R;LRP1;MAPK13;EGFR;TIMP2;TSC22D1;B3GAT3;FBXO2;TCEA2;DUSP5;PPP1R14A;MXD4;SERPING1;MTHFR;MDFI;ADGRF1;EGR1;RHBDF1;PKN1;CRTC1;SHC1;F2R;PTK6;ABCA7;DEAF1;PPP2R3B;BAHCC1;SHC2;CXXC5;GJC2;ZMYND8;ASH2L;ZSCAN18;GRAMD4;SOX12;MXI1;PLAT;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;CRTAP;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;FBLN1;SCMH1;PKD2;EDEM1;ABTB1;H2AFJ;PHLDA2;SPRY4;PTHLH;CDKN1C;SALL2;MSRB2;PAK6;HEXB;SERPINE2;VPS11;FOXQ1;LTB4R2;UNK;NTSR1;MINK1;ATP2B4;TFDP2;CSNK1E;TRAPPC9;PDCD4;TNFRSF25;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;MVD;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;SYNGAP1;PPP1R35;DNMT3A;LPAR3;TMEM173;PRNP;PAPLN;SNX33;HES2;SPRY2;HINT2;ZNF467;MNT;ECM1;SNX9;STAT6;DLG4;MTA3;MKNK2;STRADB;WWTR1;DNAJB5;BCL6;PFKFB2;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;VANGL2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;S1PR2;ENDOG;TNFRSF6B;MAPK3;ETV5;DVL1;MTA1;ADCY6;L3MBTL1;MBD1;EPHB3;FHOD1;HES1;BRD3;SSH1;FURIN;MLXIPL;ZNF624;MEFV;ARHGAP22;ABCA2;ZNF414;PIDD1;PHF21A;CELSR2;IL6R;PCSK9;ZFP36;ETV4;BTBD11;FGFR3;PRKACA;F12;ZNF862;ZMYM3;KIAA1549;LRRK1;MAGEF1;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;DMTN;PMVK;HDAC11;TNFRSF1A;EHD4;MAPK8IP1;TCF25;LDLR;PTOV1;SOX13;TRPV4;BHLHE40;EIF4EBP3;RAG1;ZNF80;DUSP7;EEF2K;HMGA2;LDLRAP1;TM7SF2;ELK3;AHNAK2;DGKQ;SEMA4C;ZXDC;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;WNT7B;COMT;SUFU;PTAFR;ZNF446;RXRA;VAV3;NEO1;IGFBP4;USP21;PRKCZ;HLTF;BCORL1;INPP5D;ZNF485;LSM14B;PDK2;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;CAMKK1;PIN1;MN1;ZNF563;C5;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;BIN1;SERPINB6;PPP1R13L;SH3D19;ZNF554;JARID2;SESN2;TOLLIP;TMEM161A;RXRB;CSTB;PNRC1;MAPRE3;GUCA1B;MADD;RTN4R;ELFN2;OR7D2;TIMP1;ZFP41;PPM1F;SORL1;STK39;ACVR1B;MEF2B;ZSCAN30;ADORA2B;ERBB3;ZER1;CCDC85B;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;NDRG2;SMARCA1;SIX5;ERCC6;GPD1L;SSBP2;PINK1;PKD1;LONP2;SNTA1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;EIF4G3;ZNF710;CTSH;ABHD14B;MLST8;CBLC;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;PCSK1N;THAP8;DDN;ERN1;RANBP9;ZNF319;SIRT3;GLI4;MLYCD;TAZ;JAK3;LITAF;MZF1;NEIL1;RARG;ING4;EIF4E3;PBXIP1;EREG;FAM162A;ZNF514;WDR18;TRNP1;ZNF837;RPL13A;MIF
202,GO:0000428,0.999997115315911,4.18024725089461e-05,1,128,DNA-directed RNA polymerase complex,CC,ERCC1
2856,GO:0006355,0.999997117084084,4.13901170292833e-06,212,2836,regulation of transcription, DNA-templated,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;WWC3;CITED4;TCFL5;PRDX5;MEF2D;NOS1;ZFP36L1;NR1D1;RBCK1;EPAS1;IGF2;NFATC4;MAPK13;EGFR;TSC22D1;TCEA2;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;PKD2;H2AFJ;CDKN1C;SALL2;MSRB2;PAK6;HEXB;FOXQ1;ATP2B4;TFDP2;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;PRNP;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;WWTR1;DNAJB5;BCL6;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;MAPK3;ETV5;DVL1;MTA1;L3MBTL1;MBD1;FHOD1;HES1;BRD3;MLXIPL;ZNF624;ARHGAP22;ABCA2;ZNF414;PIDD1;PHF21A;CELSR2;ZFP36;ETV4;ZNF862;ZMYM3;KIAA1549;RPS6KA5;MAP2K2;DAP;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;BHLHE40;ZNF80;HMGA2;ELK3;DGKQ;ZXDC;GAS6;BTRC;POU6F1;ZNF217;PPARA;SUFU;PTAFR;ZNF446;RXRA;NEO1;USP21;PRKCZ;HLTF;BCORL1;ZNF485;ZNF160;RFXANK;TEF;SMARCD2;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;PPP1R13L;ZNF554;JARID2;SESN2;RXRB;PNRC1;MAPRE3;OR7D2;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;CCDC85B;AKT1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;ZNF710;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;TRERF1;THAP8;DDN;ERN1;ZNF319;GLI4;LITAF;MZF1;RARG;ING4;PBXIP1;EREG;ZNF514;TRNP1;ZNF837
12827,GO:0051171,0.999997131399449,3.91309579039862e-06,352,4391,regulation of nitrogen compound metabolic process,BP,TNIP1;HTRA1;FOS;DUSP6;CEMIP;APOE;CTNNBIP1;ERCC1;WWC3;CITED4;BTBD2;CST3;LTBP4;RAPGEF3;TCFL5;GSN;XDH;PRDX5;PCBP4;MEF2D;NOS1;ZFP36L1;GRB7;NR1D1;RBCK1;EPHB2;EPAS1;CNTN1;IGF2;NFATC4;MST1R;LRP1;MAPK13;EGFR;TIMP2;TSC22D1;B3GAT3;FBXO2;TCEA2;DUSP5;PPP1R14A;MXD4;SERPING1;MTHFR;MDFI;ADGRF1;EGR1;RHBDF1;PKN1;CRTC1;SHC1;F2R;PTK6;ABCA7;DEAF1;PPP2R3B;BAHCC1;SHC2;CXXC5;GJC2;ZMYND8;ASH2L;ZSCAN18;GRAMD4;SOX12;MXI1;PLAT;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;CRTAP;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;FBLN1;SCMH1;PKD2;EDEM1;ABTB1;H2AFJ;SPRY4;PTHLH;CDKN1C;SALL2;MSRB2;PAK6;HEXB;SERPINE2;VPS11;FOXQ1;LTB4R2;UNK;MINK1;ATP2B4;TFDP2;CSNK1E;ACP5;TRAPPC9;PDCD4;TNFRSF25;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;SYNGAP1;PPP1R35;DNMT3A;LPAR3;TMEM173;PRNP;PAPLN;SNX33;HES2;SPRY2;HINT2;ZNF467;MNT;ECM1;SNX9;STAT6;DLG4;MTA3;MKNK2;STRADB;WWTR1;DNAJB5;BCL6;PFKFB2;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;VANGL2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;S1PR2;ENDOG;TNFRSF6B;MAPK3;ETV5;DVL1;MTA1;ADCY6;L3MBTL1;MBD1;EPHB3;FHOD1;HES1;BRD3;SSH1;FURIN;MLXIPL;ZNF624;MEFV;ARHGAP22;ABCA2;ZNF414;PIDD1;PHF21A;CELSR2;IL6R;PCSK9;ZFP36;ETV4;BTBD11;FGFR3;PRKACA;F12;ZNF862;ZMYM3;KIAA1549;LRRK1;MAGEF1;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;DMTN;HDAC11;TNFRSF1A;EHD4;MAPK8IP1;TCF25;LDLR;PTOV1;SOX13;TRPV4;BHLHE40;EIF4EBP3;RAG1;ZNF80;DUSP7;EEF2K;HMGA2;ELK3;AHNAK2;DGKQ;SEMA4C;ZXDC;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;WNT7B;COMT;SUFU;PTAFR;ZNF446;RXRA;BCR;NEO1;IGFBP4;USP21;PRKCZ;HLTF;BCORL1;INPP5D;ZNF485;LSM14B;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;CAMKK1;PIN1;MN1;ZNF563;C5;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;BIN1;SERPINB6;PPP1R13L;ASS1;SH3D19;ZNF554;JARID2;SESN2;TOLLIP;TMEM161A;RXRB;CSTB;PNRC1;MAPRE3;GUCA1B;MADD;RTN4R;ELFN2;OR7D2;TIMP1;ZFP41;PPM1F;SORL1;STK39;ACVR1B;MEF2B;ZSCAN30;ADORA2B;ERBB3;ZER1;CCDC85B;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;NDRG2;SMARCA1;SIX5;ERCC6;GPD1L;SSBP2;PINK1;PKD1;SNTA1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;EIF4G3;ZNF710;CTSH;ABHD14B;MLST8;CBLC;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;PCSK1N;THAP8;DDN;ERN1;RANBP9;ZNF319;SIRT3;GLI4;TAZ;JAK3;LITAF;MZF1;NEIL1;RARG;ING4;EIF4E3;PBXIP1;EREG;FAM162A;ZNF514;WDR18;TRNP1;ZNF837;RPL13A;MIF
2459,GO:0005681,0.999997163749377,1.89519119326916e-05,3,181,spliceosomal complex,CC,DHX32;MAPKBP1;WDR83
7074,GO:0030880,0.999997551696339,3.59014436207401e-05,1,130,RNA polymerase complex,CC,ERCC1
18399,GO:1903506,0.999998326133977,2.42265441658744e-06,212,2853,regulation of nucleic acid-templated transcription,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;WWC3;CITED4;TCFL5;PRDX5;MEF2D;NOS1;ZFP36L1;NR1D1;RBCK1;EPAS1;IGF2;NFATC4;MAPK13;EGFR;TSC22D1;TCEA2;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;PKD2;H2AFJ;CDKN1C;SALL2;MSRB2;PAK6;HEXB;FOXQ1;ATP2B4;TFDP2;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;PRNP;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;WWTR1;DNAJB5;BCL6;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;MAPK3;ETV5;DVL1;MTA1;L3MBTL1;MBD1;FHOD1;HES1;BRD3;MLXIPL;ZNF624;ARHGAP22;ABCA2;ZNF414;PIDD1;PHF21A;CELSR2;ZFP36;ETV4;ZNF862;ZMYM3;KIAA1549;RPS6KA5;MAP2K2;DAP;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;BHLHE40;ZNF80;HMGA2;ELK3;DGKQ;ZXDC;GAS6;BTRC;POU6F1;ZNF217;PPARA;SUFU;PTAFR;ZNF446;RXRA;NEO1;USP21;PRKCZ;HLTF;BCORL1;ZNF485;ZNF160;RFXANK;TEF;SMARCD2;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;PPP1R13L;ZNF554;JARID2;SESN2;RXRB;PNRC1;MAPRE3;OR7D2;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;CCDC85B;AKT1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;ZNF710;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;TRERF1;THAP8;DDN;ERN1;ZNF319;GLI4;LITAF;MZF1;RARG;ING4;PBXIP1;EREG;ZNF514;TRNP1;ZNF837
20186,GO:2001141,0.999998427745879,2.27767529668318e-06,212,2855,regulation of RNA biosynthetic process,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;WWC3;CITED4;TCFL5;PRDX5;MEF2D;NOS1;ZFP36L1;NR1D1;RBCK1;EPAS1;IGF2;NFATC4;MAPK13;EGFR;TSC22D1;TCEA2;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;PKD2;H2AFJ;CDKN1C;SALL2;MSRB2;PAK6;HEXB;FOXQ1;ATP2B4;TFDP2;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;PRNP;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;WWTR1;DNAJB5;BCL6;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;MAPK3;ETV5;DVL1;MTA1;L3MBTL1;MBD1;FHOD1;HES1;BRD3;MLXIPL;ZNF624;ARHGAP22;ABCA2;ZNF414;PIDD1;PHF21A;CELSR2;ZFP36;ETV4;ZNF862;ZMYM3;KIAA1549;RPS6KA5;MAP2K2;DAP;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;BHLHE40;ZNF80;HMGA2;ELK3;DGKQ;ZXDC;GAS6;BTRC;POU6F1;ZNF217;PPARA;SUFU;PTAFR;ZNF446;RXRA;NEO1;USP21;PRKCZ;HLTF;BCORL1;ZNF485;ZNF160;RFXANK;TEF;SMARCD2;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;PPP1R13L;ZNF554;JARID2;SESN2;RXRB;PNRC1;MAPRE3;OR7D2;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;CCDC85B;AKT1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;ZNF710;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;TRERF1;THAP8;DDN;ERN1;ZNF319;GLI4;LITAF;MZF1;RARG;ING4;PBXIP1;EREG;ZNF514;TRNP1;ZNF837
2890,GO:0006405,0.999998508582109,2.26723355549447e-05,1,133,RNA export from nucleus,BP,SRSF5
10378,GO:0043228,0.999998815354132,1.69355961960196e-06,244,3268,non-membrane-bounded organelle,CC,MARVELD1;ESPN;PPL;ERCC1;FLNC;FAM110C;CLIP2;BTBD2;CST3;SHANK2;RAPGEF3;PGM1;GSN;NDRG1;MEF2D;NOS1;PARVB;ZFP36L1;TCTN1;GRB7;NR1D1;ALOX15B;POLD4;SCN8A;OBSCN;CPT2;MYZAP;MST1R;APPL2;RAB11FIP4;OBSL1;H1F0;DEAF1;BAHCC1;BBS2;ACTA2;CTSB;DNAH1;CORO1B;ASH2L;MXI1;RIN1;ANK3;INO80C;NEK9;DOCK4;TUBG2;MARK4;BRSK1;MICALL2;SCMH1;PKD2;ABTB1;ITPR3;H2AFJ;DNM1;MPRIP;RIMS3;SALL2;IFT140;KIF13B;XPC;NINL;SIGMAR1;PAK6;CCDC69;FUZ;NPHP4;ATP2B4;TMOD2;ENKD1;USP20;RAB3D;SH3PXD2B;ID1;MZT2A;ADARB1;ZNF692;DNMT3A;SPRY2;HINT2;CEP250;STAT6;DLG4;REEP2;ISG20;MYO18A;MZT2B;PHC2;PLEKHH2;BCL6;HOOK2;ARL2;YPEL3;VANGL2;CEBPB;NUDCD3;CALCOCO1;MAPK3;KCNAB2;TNNT1;DVL1;MTA1;WIPF1;L3MBTL1;MBD1;NSMCE4A;FHOD1;YPEL2;SSH1;FBF1;CUL7;MEFV;EVC;ABCA2;FKBP10;CDC42EP5;MYH16;ZFP36;ETV4;RHOF;MAPKBP1;HLCS;RSPH3;PRKACA;PITPNM1;MAP2K2;SPTB;DMTN;BBS1;MYH3;TRPV4;MPG;CROCC;CCDC92;PHLDA1;LRRC45;HMGA2;LDLRAP1;AHNAK2;DGKQ;MVB12A;MEX3A;POU6F1;LLGL1;ADGRB2;PLEKHG6;DMC1;PAN2;REEP4;ATG2A;RXRA;SDHA;GSDMC;WDR60;PRKCZ;CLTCL1;HLTF;CAPG;INPP5D;SPATA7;TWF2;ICOSLG;SRSF5;CEP68;SMARCD2;NDE1;AGO4;RAD23A;ARAP3;FGFR1;PNPLA4;KMT5C;WBP2;C21ORF2;NICN1;BIN1;ZNF554;BFSP1;SYNC;CAPN2;WRAP73;CSTB;PROCR;SNPH;PNRC1;MAPRE3;LMLN;EPB41L3;ACTR1B;APOBEC3C;H1FX;PLEKHH3;LYST;STK39;MEF2B;CCDC85B;PNMA1;AKT1;SEPT8;ZNF385A;TUT1;SMARCA1;ERCC6;TDRKH;SPPL2B;RPL39L;SSH3;PINK1;GAS8;MPLKIP;SNTA1;RGS14;PLEKHH1;PCIF1;MAFIP;SPIRE2;CTSH;ABHD14B;P3H4;RILPL1;PYCARD;RHBG;TRERF1;RANBP9;APOBEC3F;WDR63;SLC2A1;JAK3;KIFC2;NEIL1;RARG;ING4;PBXIP1;ZFYVE19;WDR18;SFI1;KRT15;TRNP1;TTLL11;RPL13A;RGS12;KIF26B;LZTS2
10382,GO:0043232,0.999998815354132,1.69355961960196e-06,244,3268,intracellular non-membrane-bounded organelle,CC,MARVELD1;ESPN;PPL;ERCC1;FLNC;FAM110C;CLIP2;BTBD2;CST3;SHANK2;RAPGEF3;PGM1;GSN;NDRG1;MEF2D;NOS1;PARVB;ZFP36L1;TCTN1;GRB7;NR1D1;ALOX15B;POLD4;SCN8A;OBSCN;CPT2;MYZAP;MST1R;APPL2;RAB11FIP4;OBSL1;H1F0;DEAF1;BAHCC1;BBS2;ACTA2;CTSB;DNAH1;CORO1B;ASH2L;MXI1;RIN1;ANK3;INO80C;NEK9;DOCK4;TUBG2;MARK4;BRSK1;MICALL2;SCMH1;PKD2;ABTB1;ITPR3;H2AFJ;DNM1;MPRIP;RIMS3;SALL2;IFT140;KIF13B;XPC;NINL;SIGMAR1;PAK6;CCDC69;FUZ;NPHP4;ATP2B4;TMOD2;ENKD1;USP20;RAB3D;SH3PXD2B;ID1;MZT2A;ADARB1;ZNF692;DNMT3A;SPRY2;HINT2;CEP250;STAT6;DLG4;REEP2;ISG20;MYO18A;MZT2B;PHC2;PLEKHH2;BCL6;HOOK2;ARL2;YPEL3;VANGL2;CEBPB;NUDCD3;CALCOCO1;MAPK3;KCNAB2;TNNT1;DVL1;MTA1;WIPF1;L3MBTL1;MBD1;NSMCE4A;FHOD1;YPEL2;SSH1;FBF1;CUL7;MEFV;EVC;ABCA2;FKBP10;CDC42EP5;MYH16;ZFP36;ETV4;RHOF;MAPKBP1;HLCS;RSPH3;PRKACA;PITPNM1;MAP2K2;SPTB;DMTN;BBS1;MYH3;TRPV4;MPG;CROCC;CCDC92;PHLDA1;LRRC45;HMGA2;LDLRAP1;AHNAK2;DGKQ;MVB12A;MEX3A;POU6F1;LLGL1;ADGRB2;PLEKHG6;DMC1;PAN2;REEP4;ATG2A;RXRA;SDHA;GSDMC;WDR60;PRKCZ;CLTCL1;HLTF;CAPG;INPP5D;SPATA7;TWF2;ICOSLG;SRSF5;CEP68;SMARCD2;NDE1;AGO4;RAD23A;ARAP3;FGFR1;PNPLA4;KMT5C;WBP2;C21ORF2;NICN1;BIN1;ZNF554;BFSP1;SYNC;CAPN2;WRAP73;CSTB;PROCR;SNPH;PNRC1;MAPRE3;LMLN;EPB41L3;ACTR1B;APOBEC3C;H1FX;PLEKHH3;LYST;STK39;MEF2B;CCDC85B;PNMA1;AKT1;SEPT8;ZNF385A;TUT1;SMARCA1;ERCC6;TDRKH;SPPL2B;RPL39L;SSH3;PINK1;GAS8;MPLKIP;SNTA1;RGS14;PLEKHH1;PCIF1;MAFIP;SPIRE2;CTSH;ABHD14B;P3H4;RILPL1;PYCARD;RHBG;TRERF1;RANBP9;APOBEC3F;WDR63;SLC2A1;JAK3;KIFC2;NEIL1;RARG;ING4;PBXIP1;ZFYVE19;WDR18;SFI1;KRT15;TRNP1;TTLL11;RPL13A;RGS12;KIF26B;LZTS2
2864,GO:0006364,0.999999030310879,5.00599225347068e-06,5,255,rRNA processing,BP,CSNK1E;ISG20;RRNAD1;WDR18;RPL13A
5898,GO:0018130,0.9999992813286,1.02667721559737e-06,261,3440,heterocycle biosynthetic process,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;IDH2;WWC3;NT5E;CITED4;NAPRT;RAPGEF3;TCFL5;PGM1;XDH;PRDX5;MEF2D;NOS1;ZFP36L1;NR1D1;POLD4;RBCK1;EPAS1;IGF2;NFATC4;NME4;MAPK13;EGFR;TIMP2;TSC22D1;ACOT7;TCEA2;UROS;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;NMRK1;LRP5;TENM2;PLTP;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;OGDHL;PKD2;H2AFJ;PTHLH;CDKN1C;SALL2;MSRB2;PAK6;HEXB;FOXQ1;LTB4R2;ATP2B4;TFDP2;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;POLL;ZNF692;ZNF704;ITGA6;DNMT3A;DNPH1;TMEM173;PRNP;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;WWTR1;DNAJB5;BCL6;UCKL1;PFKFB2;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;MAPK3;ETV5;DHTKD1;DVL1;ENTPD2;GALK1;MTA1;LHPP;ADCY6;L3MBTL1;MBD1;FHOD1;HES1;BRD3;MLXIPL;ZNF624;ARHGAP22;NADK;ABCA2;TK2;ZNF414;ADA;PYCR2;PIDD1;PHF21A;CELSR2;PFKL;ZFP36;ETV4;ZNF862;ZMYM3;KIAA1549;NUDT10;DGUOK;RPS6KA5;MAP2K2;DAP;FGFR4;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;BHLHE40;ZNF80;HMGA2;ELK3;DGKQ;HK1;ZXDC;GAS6;BTRC;POU6F1;ZNF217;PPARA;GUK1;SUFU;PTAFR;ZNF446;RXRA;NEO1;USP21;PRKCZ;HLTF;BCORL1;ZNF485;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;PPP1R13L;ZNF554;JARID2;SESN2;TSTA3;RXRB;PNRC1;MAPRE3;GUCA1B;OR7D2;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;ADORA2B;CCDC85B;AKT1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;ZNF710;ABHD14B;RSAD1;RFX2;RNF187;PYCARD;MAP2K3;PNPO;TRERF1;THAP8;DDN;ERN1;ZNF319;PRIMPOL;MOCS1;GLI4;TAZ;LITAF;MZF1;NEIL1;FUK;RARG;ING4;PBXIP1;EREG;PPCS;ZNF514;TRNP1;ZNF837;POLM;RGS12
17612,GO:1901362,0.999999522042156,6.84499761851976e-07,268,3532,organic cyclic compound biosynthetic process,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;IDH2;WWC3;NT5E;CITED4;NAPRT;RAPGEF3;TCFL5;PGM1;CYP27B1;XDH;PRDX5;MEF2D;NOS1;ZFP36L1;NR1D1;POLD4;RBCK1;EPAS1;IGF2;NFATC4;NME4;MAPK13;EGFR;TIMP2;TSC22D1;ACOT7;TCEA2;UROS;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;DHRS11;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;NMRK1;LRP5;TENM2;PLTP;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;OGDHL;PKD2;H2AFJ;PTHLH;CDKN1C;SALL2;MSRB2;PAK6;HEXB;FOXQ1;LTB4R2;ATP2B4;TFDP2;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;MVD;POLL;ZNF692;ZNF704;ITGA6;DNMT3A;DNPH1;TMEM173;PRNP;SRD5A3;HES2;HINT2;ZNF467;MNT;ECM1;STAT6;MTA3;WWTR1;DNAJB5;BCL6;UCKL1;PFKFB2;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;MAPK3;ETV5;DHTKD1;DVL1;ENTPD2;GALK1;MTA1;LHPP;ADCY6;L3MBTL1;MBD1;FHOD1;HES1;BRD3;MLXIPL;ZNF624;ARHGAP22;NADK;ABCA2;TK2;ZNF414;ADA;PYCR2;PIDD1;PHF21A;CELSR2;PFKL;ZFP36;ETV4;ZNF862;ZMYM3;KIAA1549;NUDT10;DGUOK;RPS6KA5;MAP2K2;DAP;FGFR4;PMVK;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;BHLHE40;ZNF80;HMGA2;TM7SF2;ELK3;DGKQ;HK1;ZXDC;GAS6;BTRC;POU6F1;ZNF217;PPARA;GUK1;SUFU;PTAFR;ZNF446;RXRA;NEO1;USP21;PRKCZ;HLTF;BCORL1;ZNF485;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;PPP1R13L;ZNF554;JARID2;SESN2;TSTA3;RXRB;PNRC1;MAPRE3;GUCA1B;OR7D2;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;ADORA2B;CCDC85B;AKT1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;ZNF710;ABHD14B;RSAD1;RFX2;RNF187;PYCARD;MAP2K3;PNPO;TRERF1;THAP8;DDN;ERN1;ZNF319;PRIMPOL;MOCS1;GLI4;TAZ;LITAF;MZF1;NEIL1;FUK;RARG;ING4;PBXIP1;EREG;PPCS;ZNF514;TRNP1;ZNF837;POLM;RGS12
6064,GO:0019222,0.999999523025944,6.60409605500575e-07,393,4908,regulation of metabolic process,BP,TNIP1;HTRA1;FOS;DUSP6;LMF1;CEMIP;APOE;TYSND1;CTNNBIP1;ERCC1;WWC3;CITED4;BTBD2;CST3;LTBP4;RAPGEF3;TCFL5;CYP27B1;GSN;XDH;PRDX5;PCBP4;MEF2D;NOS1;ARAP1;ZFP36L1;GRB7;NR1D1;RBCK1;EPHB2;EPAS1;CNTN1;CPT2;IGF2;NFATC4;MST1R;LRP1;MAPK13;EGFR;TIMP2;TSC22D1;B3GAT3;FBXO2;TCEA2;DUSP5;PPP1R14A;MXD4;SERPING1;MTHFR;MDFI;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CRTC1;TRIM65;SHC1;F2R;PTK6;ABCA7;DEAF1;PPP2R3B;BAHCC1;BBS2;ACTA2;SHC2;CXXC5;ULK2;GJC2;ZMYND8;TBC1D14;ASH2L;ZSCAN18;GRAMD4;SOX12;MXI1;PLAT;ABCG1;ANK3;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;CRTAP;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;FBLN1;SCMH1;PKD2;EDEM1;ABTB1;H2AFJ;PHLDA2;SPRY4;PTHLH;CDKN1C;SALL2;MSRB2;PAK6;HEXB;SERPINE2;VPS11;FOXQ1;LTB4R2;UNK;NTSR1;CD320;MINK1;ATP2B4;TFDP2;CSNK1E;ACP5;TRAPPC9;PDCD4;TNFRSF25;ZKSCAN1;WNT7A;ZMIZ1;INSR;SH3PXD2B;ZC3H6;ID1;MVD;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;SYNGAP1;PPP1R35;DNMT3A;LPAR3;TMEM173;PRNP;PAPLN;SNX33;HES2;SPRY2;HINT2;ZNF467;MNT;ECM1;SNX9;STAT6;DLG4;MTA3;MKNK2;STRADB;WWTR1;FAM20C;DNAJB5;BCL6;PFKFB2;SCAND1;DYRK1B;SEC14L2;BNIP3;CD81;FZD8;VEGFA;ZSCAN2;VANGL2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;S1PR2;ENDOG;TNFRSF6B;MAPK3;ETV5;DVL1;MTA1;FYCO1;GPSM1;ADCY6;L3MBTL1;MBD1;EPHB3;FHOD1;HES1;BRD3;PC;SSH1;FURIN;MLXIPL;ZNF624;MEFV;ARHGAP22;ABCA2;LRSAM1;ZNF414;PIDD1;PHF21A;CELSR2;IL6R;SLIT3;PCSK9;ZFP36;ETV4;BTBD11;FGFR3;PRKACA;F12;ZNF862;ZMYM3;KIAA1549;LRRK1;MAGEF1;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;DMTN;PMVK;HDAC11;TNFRSF1A;EHD4;MAPK8IP1;TCF25;LDLR;PTOV1;SOX13;TRPV4;BHLHE40;EIF4EBP3;RAG1;ZNF80;DUSP7;EEF2K;HMGA2;LDLRAP1;TM7SF2;ELK3;AHNAK2;DGKQ;SEMA4C;ZXDC;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;WNT7B;COMT;SUFU;PTAFR;PAN2;ZNF446;RXRA;VAV3;BCR;NEO1;IGFBP4;TBC1D16;USP21;PRKCZ;HLTF;BCORL1;INPP5D;ZNF485;LSM14B;PDK2;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;CAMKK1;PIN1;MN1;ZNF563;C5;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;BIN1;SERPINB6;PPP1R13L;ASS1;SH3D19;ZNF554;GRB10;JARID2;SESN2;TOLLIP;TMEM161A;RXRB;CSTB;PNRC1;MAPRE3;GUCA1B;MADD;RTN4R;ELFN2;OR7D2;TIMP1;WNT3;ZFP41;PPM1F;SORL1;STK39;ACVR1B;MEF2B;ZSCAN30;ADORA2B;TPCN1;ERBB3;ZER1;CCDC85B;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;NDRG2;SMARCA1;SIX5;ERCC6;GPD1L;TDRKH;SSBP2;PINK1;PKD1;LONP2;SNTA1;ARHGEF10L;KDM4B;CAMTA2;RGS14;PCIF1;MAFIP;EIF4G3;ZNF710;CTSH;ABHD14B;MLST8;CBLC;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;PCSK1N;THAP8;DDN;STK17A;ERN1;RANBP9;ZNF319;SIRT3;GLI4;MLYCD;TAZ;JAK3;LITAF;APBA1;MZF1;NEIL1;RARG;ING4;EIF4E3;PBXIP1;EREG;FAM162A;ZNF514;WDR18;SFI1;TRNP1;ZNF837;RPL13A;MIF
3334,GO:0007059,0.999999547468741,1.86856689486998e-06,8,300,chromosome segregation,BP,TUBG2;CHMP1B;DMC1;NDE1;AGO4;SUN1;RGS14;P3H4
8841,GO:0034654,0.999999613819993,5.57744514386108e-07,255,3391,nucleobase-containing compound biosynthetic process,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;IDH2;WWC3;NT5E;CITED4;NAPRT;RAPGEF3;TCFL5;PGM1;XDH;PRDX5;MEF2D;NOS1;ZFP36L1;NR1D1;POLD4;RBCK1;EPAS1;IGF2;NFATC4;NME4;MAPK13;EGFR;TIMP2;TSC22D1;ACOT7;TCEA2;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;NMRK1;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;OGDHL;PKD2;H2AFJ;PTHLH;CDKN1C;SALL2;MSRB2;PAK6;HEXB;FOXQ1;LTB4R2;ATP2B4;TFDP2;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;POLL;ZNF692;ZNF704;ITGA6;DNMT3A;DNPH1;TMEM173;PRNP;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;WWTR1;DNAJB5;BCL6;UCKL1;PFKFB2;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;MAPK3;ETV5;DHTKD1;DVL1;ENTPD2;GALK1;MTA1;LHPP;ADCY6;L3MBTL1;MBD1;FHOD1;HES1;BRD3;MLXIPL;ZNF624;ARHGAP22;NADK;ABCA2;TK2;ZNF414;ADA;PIDD1;PHF21A;CELSR2;PFKL;ZFP36;ETV4;ZNF862;ZMYM3;KIAA1549;NUDT10;DGUOK;RPS6KA5;MAP2K2;DAP;FGFR4;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;BHLHE40;ZNF80;HMGA2;ELK3;DGKQ;HK1;ZXDC;GAS6;BTRC;POU6F1;ZNF217;PPARA;GUK1;SUFU;PTAFR;ZNF446;RXRA;NEO1;USP21;PRKCZ;HLTF;BCORL1;ZNF485;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;PPP1R13L;ZNF554;JARID2;SESN2;TSTA3;RXRB;PNRC1;MAPRE3;GUCA1B;OR7D2;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;ADORA2B;CCDC85B;AKT1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;ZNF710;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;TRERF1;THAP8;DDN;ERN1;ZNF319;PRIMPOL;GLI4;TAZ;LITAF;MZF1;NEIL1;FUK;RARG;ING4;PBXIP1;EREG;PPCS;ZNF514;TRNP1;ZNF837;POLM;RGS12
10868,GO:0044427,0.999999650546831,7.62976464832879e-07,37,771,chromosomal part,CC,ERCC1;MEF2D;NR1D1;POLD4;APPL2;H1F0;BAHCC1;ASH2L;INO80C;SCMH1;H2AFJ;SALL2;DNMT3A;STAT6;PHC2;BCL6;CEBPB;CALCOCO1;L3MBTL1;NSMCE4A;HLCS;HMGA2;DMC1;RXRA;SMARCD2;NDE1;KMT5C;WBP2;CAPN2;H1FX;MEF2B;ZNF385A;SMARCA1;PINK1;P3H4;RARG;TRNP1
10887,GO:0044451,0.999999718295884,5.5552845462907e-07,53,975,nucleoplasm part,CC,ERCC1;NR1D1;EPAS1;OBSCN;NFATC4;APPL2;H1F0;TCEA2;CRTC1;PTK6;BAHCC1;ASH2L;INO80C;HDAC5;TENM2;MAML3;SALL2;JADE2;PHF7;ZMIZ1;MKNK2;WWTR1;ISG20;PLEKHH2;HSF4;LHPP;MBD1;NSMCE4A;PHF21A;PRKACA;RAPGEF5;HDAC11;BHLHE40;DGKQ;KLHDC2;POU6F1;ZNF217;SRSF5;AGO4;PIN1;JARID2;TOLLIP;SBF1;TP53INP1;LRCH4;TUT1;ERCC6;RGS14;TRERF1;STK17A;GCAT;ING4;WDR18
10865,GO:0044422,0.999999735162183,3.65589553481227e-07,602,7164,organelle part,CC,TNIP1;FOS;DUSP6;H6PD;LMF1;CEMIP;APOE;ESPN;CTNNBIP1;TSPAN1;IDH2;PTPRS;ERCC1;FLNC;FAM110C;NT5E;GAA;CLIP2;CITED4;NAPRT;PYGB;RNF44;CST3;SHANK2;RAPGEF3;PGM1;CYP27B1;GSN;CLCA2;PRDX5;NDRG1;PRSS3;PRODH;MEF2D;NOS1;LTBP1;MARCH9;PARVB;ARAP1;COL6A1;TCTN1;POSTN;NR1D1;CRAT;EPN3;FAM210B;POLD4;SCN8A;EPAS1;OBSCN;CPT2;MYZAP;IGF2;NFATC4;NME4;MST1R;LRP1;APPL2;ST6GALNAC2;RAB11FIP4;OBSL1;EGFR;TIMP2;H1F0;ALDH4A1;B3GAT3;HADH;ACSF2;REEP6;FBXO2;ACOT7;TCEA2;DUSP5;DDB2;SERPING1;KDSR;EGR1;ULK1;RHBDF1;PKN1;CRTC1;PYGL;TRIM65;DOPEY2;SYT8;NAGLU;SHC1;PTK6;BPHL;ABCA7;DEAF1;PPP2R3B;BAHCC1;BBS2;CTSB;LPCAT4;DNAH1;RNF208;PITPNC1;SLC16A3;CORO1B;CXXC5;ULK2;DHRS1;MALL;D2HGDH;TBC1D14;ASH2L;GRAMD4;SOX12;MXI1;CERS4;ABCG1;ANK3;NOL4L;S100A6;INO80C;NEK9;HDAC5;THRA;PLD3;DOCK4;CRTAP;RPS6KA2;DBNDD1;HYAL1;TUBG2;ANO8;MARK4;TENM2;SLC2A9;MAML3;B4GALNT4;ZFPM1;ERBB2;BRSK1;MICALL2;BSG;CTSF;SCMH1;OGDHL;PKD2;TMEM129;FUCA1;TST;CPT1C;EDEM1;ABTB1;VWA5A;ITPR3;H2AFJ;PRAF2;VAT1;DNM1;FCHO1;PTHLH;SALL2;IFT140;CD9;KIF13B;XPC;ANGEL1;NINL;SIGMAR1;PAK6;HEXB;VPS11;VAMP2;CCDC69;GALNT12;NPHP4;LTB4R2;JADE2;CD320;ATP2B4;SNN;TMOD2;TFDP2;PHF7;CSNK1E;TRAPPC9;ZFYVE21;DIRC2;ADAMTS7;ENKD1;GM2A;RHOD;USP20;PEX10;ARMCX2;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;RAB3D;SH3PXD2B;ID1;CELSR1;MZT2A;B4GAT1;POLL;WDR27;NDUFS8;RABGGTA;ADARB1;ZNF692;NBEAL2;HAGH;DNMT3A;TMEM173;PRNP;DHX32;SRD5A3;ATP7B;RNASET2;SNX33;SPRY2;HINT2;MNT;ECM1;CEP250;ATG16L2;SNX9;STAT6;DLG4;ABCD1;MARCH2;REEP2;MTA3;MKNK2;TALDO1;WWTR1;ISG20;FAM20C;MYO18A;TMEM107;ARHGAP27;CERCAM;MZT2B;PHC2;PLEKHH2;BCL6;ANKZF1;PFKFB2;CHMP1B;MVB12B;TMEM92;BNIP3;VEGFA;ENTPD6;DNASE1L1;HOOK2;ARL2;YPEL3;VANGL2;AP2A2;CEBPB;RHBDF2;DPP7;GPRC5C;SHANK3;HSD11B1L;HSF4;NUDCD3;CALCOCO1;MAPK3;KCNAB2;ETV5;OLFM2;CARD19;AMN;SLC22A18;GLB1;DHTKD1;RAB40B;TNNT1;DVL1;ENTPD2;MTA1;LHPP;WIPF1;GPSM1;L3MBTL1;LTA4H;WIPI2;MBD1;ST3GAL3;SLC16A13;NSMCE4A;FHOD1;HES1;PC;ACAD10;YPEL2;FURIN;MLXIPL;NAGS;FBF1;MBOAT7;SLC48A1;CUL7;MEFV;EVC;SLC2A3;ABCA2;TK2;ADA;FKBP10;TRIM45;MCTP1;OSBPL5;PYCR2;PIDD1;RETSAT;PHF21A;MYH16;CKMT1A;PFKL;PCSK9;TMEM9;ETV4;RHOF;MAPKBP1;HLCS;CYHR1;PRKACA;PITPNM1;ZMYM3;DGUOK;RPS6KA5;SCNN1A;HBEGF;SLC25A37;RAB3B;MAP2K2;PI4K2A;SPTB;MXRA8;SLC37A2;STX10;DMTN;RAPGEF5;BBS1;MYH3;XYLT2;HDAC11;VGF;TNFRSF1A;SEZ6L2;EHD4;MAPK8IP1;LDLR;CYP3A5;SNX17;SOX13;ABHD17C;TRPV4;MPG;PIGZ;IFNGR2;BHLHE40;CROCC;CCDC92;RAG1;DUSP7;PHLDA1;LRRC45;MSLN;HMGA2;LDLRAP1;TM7SF2;ELK3;AHNAK2;DGKQ;PEX7;KLHDC2;SEMA4C;MVB12A;HK1;CHST6;SDHAF4;GAS6;BTRC;POU6F1;LLGL1;ADGRB2;ZNF217;PPARA;HMGCL;WNT7B;BLVRB;SUFU;PTAFR;PLEKHG6;RFNG;DMC1;REEP4;RXRA;PCK2;PCSK1;VASN;TMEM175;NEO1;IGFBP4;SDHA;GSDMC;MUC19;USP21;RNF123;WDR60;PRKCZ;ADAMTS13;CLTCL1;HLTF;MDH2;CAPG;BCORL1;ETFB;ABCD4;SPATA7;TWF2;SH3GLB2;TPP1;PDK2;GPC1;SRSF5;RFXANK;SMOX;CEP68;SMARCD2;MAPKAPK3;NDE1;AGO4;RAD23A;CDHR1;FGFR1;CTSZ;PIN1;MAN1B1;KMT5C;PHYH;IRF2BPL;WBP2;C21ORF2;NICN1;ASAP2;DLG3;ESYT2;BIN1;UNC119B;SERPINB6;PPP1R13L;SH3D19;ZNF554;WDR83;CES2;SLC25A27;BFSP1;JARID2;SYNC;CAPN2;NDUFA4L2;TOLLIP;WRAP73;RXRB;CSTB;PROCR;SNPH;MAN2B2;TMEM231;MAPRE3;DUSP23;GUCA1B;MACROD1;GAL3ST4;SMDT1;CYBRD1;PIGV;SLC9A7;TIMP1;CD68;SDC1;WHAMMP3;GRHPR;ACTR1B;RTN2;H1FX;PIGQ;WNT3;SBF1;SORL1;STK39;COL13A1;VEGFB;MEF2B;TPCN1;HGSNAT;SLC25A29;CCDC85B;PNMA1;CYP2S1;AKT1;CTSD;TRAP1;TMBIM4;NLRX1;SEPT8;ZNF385A;TP53INP1;LRCH4;TUT1;SMARCA1;VPS33B;ERCC6;ACP6;EPS8L2;SUN1;TMEM120A;SPPL2B;IL17RD;UQCR11;RPL39L;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;MPLKIP;KDM4B;HOMER2;RGS14;SYNE3;GOLGA2P5;PCIF1;MAFIP;SPIRE2;CTSH;ABHD14B;P3H4;MLST8;AGPAT4;RILPL1;EPN2;RNF187;PYCARD;MAP2K3;PNPO;RHBG;POMT1;TRERF1;PCSK1N;DDN;PMS2P5;NDUFV3;STK17A;ERN1;RANBP9;APOBEC3F;PRIMPOL;ACADS;GCAT;WDR63;SIRT3;ALKBH6;C12ORF66;SLC2A1;MLYCD;TAZ;BCKDHA;KIFC2;LITAF;NEIL1;RARG;ING4;GALNS;PBXIP1;PODXL2;ZFYVE19;MORN4;WDR18;PQLC2;SFI1;KRT15;ADAMTSL4;TRNP1;TTLL11;TMED4;POLM;FAM50A;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;STXBP2;KIF26B;LZTS2
6139,GO:0019438,0.999999735751535,3.83033980023756e-07,258,3437,aromatic compound biosynthetic process,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;IDH2;WWC3;NT5E;CITED4;NAPRT;RAPGEF3;TCFL5;PGM1;XDH;PRDX5;MEF2D;NOS1;ZFP36L1;NR1D1;POLD4;RBCK1;EPAS1;IGF2;NFATC4;NME4;MAPK13;EGFR;TIMP2;TSC22D1;ACOT7;TCEA2;UROS;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;NMRK1;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;OGDHL;PKD2;H2AFJ;PTHLH;CDKN1C;SALL2;MSRB2;PAK6;HEXB;FOXQ1;LTB4R2;ATP2B4;TFDP2;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;POLL;ZNF692;ZNF704;ITGA6;DNMT3A;DNPH1;TMEM173;PRNP;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;WWTR1;DNAJB5;BCL6;UCKL1;PFKFB2;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;MAPK3;ETV5;DHTKD1;DVL1;ENTPD2;GALK1;MTA1;LHPP;ADCY6;L3MBTL1;MBD1;FHOD1;HES1;BRD3;MLXIPL;ZNF624;ARHGAP22;NADK;ABCA2;TK2;ZNF414;ADA;PIDD1;PHF21A;CELSR2;PFKL;ZFP36;ETV4;ZNF862;ZMYM3;KIAA1549;NUDT10;DGUOK;RPS6KA5;MAP2K2;DAP;FGFR4;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;BHLHE40;ZNF80;HMGA2;ELK3;DGKQ;HK1;ZXDC;GAS6;BTRC;POU6F1;ZNF217;PPARA;GUK1;SUFU;PTAFR;ZNF446;RXRA;NEO1;USP21;PRKCZ;HLTF;BCORL1;ZNF485;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;PPP1R13L;ZNF554;JARID2;SESN2;TSTA3;RXRB;PNRC1;MAPRE3;GUCA1B;OR7D2;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;ADORA2B;CCDC85B;AKT1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;ZNF710;ABHD14B;RSAD1;RFX2;RNF187;PYCARD;MAP2K3;PNPO;TRERF1;THAP8;DDN;ERN1;ZNF319;PRIMPOL;GLI4;TAZ;LITAF;MZF1;NEIL1;FUK;RARG;ING4;PBXIP1;EREG;PPCS;ZNF514;TRNP1;ZNF837;POLM;RGS12
18317,GO:1903311,0.999999738336704,1.44198204623367e-06,5,250,regulation of mRNA metabolic process,BP,PCBP4;ZFP36L1;ZFP36;GTPBP1;AKT1
16790,GO:0098687,0.99999975171007,1.05015689143805e-06,8,312,chromosomal region,CC,ERCC1;SCMH1;DNMT3A;CEBPB;NSMCE4A;DMC1;NDE1;KMT5C
12897,GO:0051276,0.999999756621828,4.71768899088695e-07,57,1047,chromosome organization,BP,ERCC1;NOS1;POLD4;IGF2;H1F0;DDB2;MTHFR;PKN1;BAHCC1;ZMYND8;ASH2L;INO80C;HDAC5;TUBG2;ZFPM1;SCMH1;H2AFJ;XPC;JADE2;DNMT3A;MTA3;BCL6;CHMP1B;VEGFA;HSF4;MAPK3;MTA1;L3MBTL1;MBD1;BRD3;FKBP10;PHF21A;HLCS;RPS6KA5;HDAC11;RAG1;HMGA2;PADI3;DMC1;USP21;HLTF;BCORL1;SMARCD2;NDE1;AGO4;KMT5C;WBP2;JARID2;H1FX;PPM1F;SMARCA1;SUN1;PINK1;KDM4B;P3H4;SIRT3;ING4
10866,GO:0044424,0.999999769976443,3.54271519492904e-07,936,10414,intracellular part,CC,TNIP1;HTRA1;FOS;DUSP6;H6PD;LMF1;CEMIP;APOE;TYSND1;MARVELD1;ESPN;CTNNBIP1;MARCKSL1;TSPAN1;PPL;IDH2;RNPEPL1;PTPRS;ERCC1;WWC3;FLNC;FAM110C;NT5E;GAA;SYTL1;CLIP2;CITED4;NAPRT;BTBD2;PYGB;RNF44;CST3;SHANK2;RAPGEF3;TCFL5;PGM1;CYP27B1;GSN;CLCA2;XDH;PRDX5;NDRG1;PGLS;PCBP4;PRSS3;PRODH;MEF2D;NOS1;LTBP1;MARCH9;PARVB;ARAP1;ZFP36L1;COL6A1;TCTN1;POSTN;GRB7;NR1D1;CRAT;EFS;ALOX15B;ARRDC1;EPN3;FAM210B;POLD4;SCN8A;RBCK1;EPHB2;EPAS1;OBSCN;CPT2;RHPN1;MYZAP;IGF2;NFATC4;NME4;MST1R;LRP1;GAMT;MAPK13;APPL2;HEBP1;CDK18;RALGDS;ST6GALNAC2;RAB11FIP4;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;MMP28;B3GAT3;HADH;CRYL1;SUGCT;ACSF2;REEP6;FBXO2;ACOT7;TCEA2;DUSP5;FKBP9;HS1BP3;PPP1R14A;ISYNA1;UROS;FHL1;JOSD2;LOXL1;MXD4;DDB2;SERPING1;MTHFR;KDSR;MDFI;EGR1;ULK1;RHBDF1;PKN1;CRTC1;PYGL;ARHGEF4;TRIM65;DOPEY2;SYT8;NAGLU;SHC1;F2R;PTK6;GNAL;BPHL;NPEPL1;ABCA7;DEAF1;LAMA5;PPP2R3B;SLC9A3R2;BAHCC1;GALE;BBS2;ACTA2;S100A4;CTSB;ESRG;LPCAT4;DNAH1;RNF208;SHC2;PITPNC1;SLC16A3;CORO1B;CXXC5;ULK2;DGKA;DHRS1;MALL;THBS3;D2HGDH;ZMYND8;TBC1D14;ASH2L;ZSCAN18;PACS2;GRAMD4;SOX12;MXI1;CERS4;PLAT;ABCG1;RIN1;ANK3;NOL4L;PIK3R2;OPLAH;S100A6;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;ARHGAP23;PLD3;DOCK4;CRTAP;RPS6KA2;NMRK1;NISCH;LRP5;DBNDD1;HYAL1;TUBG2;ANO8;MARK4;TENM2;SLC2A9;MAML3;B4GALNT4;ZFPM1;TFEB;ERBB2;EXOC2;BRSK1;MICALL2;BSG;CTSF;SCMH1;OGDHL;PKD2;CBS;TMEM129;FUCA1;TST;IQSEC2;CPT1C;EDEM1;ABTB1;VWA5A;SLC7A8;ITPR3;H2AFJ;PRAF2;PHLDA2;VAT1;DNM1;SPRY4;DDIT4L;FCHO1;MPRIP;PTHLH;CDKN1C;RIMS3;SALL2;MSRB2;IFT140;CUL9;CD9;KIF13B;XPC;PTPRE;ANGEL1;NINL;SIGMAR1;PAK6;HEXB;SERPINE2;VPS11;VAMP2;CCDC69;FUZ;GALNT12;FOXQ1;RNF135;NPHP4;LTB4R2;UNK;NTSR1;JADE2;CD320;MINK1;RALGAPA2;ATP2B4;SNN;TMOD2;TFDP2;PHF7;CSNK1E;ACP5;RASA4;PLCD1;TRAPPC9;AGAP1;ZFYVE21;DIRC2;ADAMTS7;ENKD1;PDCD4;DOCK6;TMEM134;GM2A;BEX2;ACAP3;TNFRSF25;GLUL;PRR7;RHOD;DTX3;ZKSCAN1;ARVCF;USP20;PEX10;ARMCX2;ASIC1;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;RAB3D;PLCXD1;LCE1E;SH3PXD2B;FBXW8;ZC3H6;ID1;CELSR1;AKR7A2;MVD;LGALS9C;MZT2A;B4GAT1;POLL;WDR27;NDUFS8;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;CCNG2;TXNRD3;SYNGAP1;NBEAL2;HAGH;FBXO27;DNMT3A;DNPH1;TMEM173;PRNP;DHX32;SRD5A3;OXLD1;ATP7B;RNASET2;FBXL8;SNX33;FBXO41;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;ECM1;CEP250;ATG16L2;SNX9;STAT6;DLG4;SPEG;ABCD1;MARCH2;REEP2;MTA3;MKNK2;PLCD3;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;MYO18A;ARHGAP27;CERCAM;MZT2B;DNAJB5;MYCBPAP;PHC2;SCART1;PLEKHH2;C1ORF210;BCL6;ANKZF1;UCKL1;PFKFB2;FAM213A;CHMP1B;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;TMEM92;BNIP3;SRMS;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;HOOK2;LRRC8A;ARL2;YPEL3;VANGL2;MAST4;FBXW4;ELMO3;AP2A2;CEBPB;RHBDF2;DPP7;GPRC5C;SHANK3;HSD11B1L;ACVR2B;HSF4;ADAM15;NAB2;NUDCD3;CALCOCO1;ZDHHC1;ENDOG;MAPK3;PDZD2;FBXL16;PLEKHG5;TUB;KCNAB2;ETV5;OLFM2;CARD19;AMN;SLC22A18;GLB1;CAPNS2;DHTKD1;EXD3;C19ORF33;RAB40B;TNNT1;DVL1;ENTPD2;GALK1;MTA1;LHPP;FYCO1;KLHL29;WIPF1;GPSM1;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;PHGDH;ST3GAL3;SLC16A13;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;PC;ACAD10;YPEL2;SSH1;COMTD1;FURIN;MLXIPL;ZNF624;NAGS;FBF1;MBOAT7;SLC48A1;SAMD3;CUL7;MEFV;EVC;ARHGAP22;SLC2A3;TRIM4;NADK;PLEKHG2;ABCA2;TK2;LRSAM1;ZNF414;LY6K;ADA;FKBP10;CDC42EP5;TRIM45;MCTP1;OSBPL5;PYCR2;PIDD1;RETSAT;PHF21A;SH2D2A;AQP3;MYH16;CELSR2;ACY1;CKMT1A;PFKL;SLIT3;PCSK9;TMEM9;ZFP36;ETV4;RHOF;BTBD11;MAPKBP1;HLCS;CYHR1;RSPH3;FGFR3;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;LRRK1;NUDT10;PLCH2;DGUOK;CYFIP2;SLC38A10;RPS6KA5;SCNN1A;HBEGF;SLC25A37;ITGB5;RAB3B;MAP2K2;PI4K2A;FGFR4;SPTB;FBXW5;MXRA8;SLC37A2;STX10;DMTN;RAPGEF5;PMVK;BBS1;MYH3;XYLT2;HDAC11;VGF;TNFRSF1A;SEZ6L2;EHD4;MAPK8IP1;TCF25;SEMA3B;LDLR;PTOV1;FAM214B;LYPLAL1;CYP3A5;ACOT11;SNX17;SOX13;ABHD17C;TRPV4;MPG;RHOBTB2;PIGZ;IFNGR2;BHLHE40;EIF4EBP3;CROCC;CCDC92;RAG1;ZNF80;DUSP7;PHLDA1;LRRC45;TNFAIP8L1;EEF2K;MSLN;HMGA2;LDLRAP1;TM7SF2;ELK3;AHNAK2;DGKQ;PEX7;KLHDC2;SEMA4C;MVB12A;HK1;NMRAL1;ZXDC;MIB2;FBXO17;CHST6;SDHAF4;PADI3;GAS6;BTRC;MEX3A;POU6F1;LLGL1;ANKS6;ADGRB2;ZNF217;PPARA;HMGCL;TKFC;GUK1;TMEM187;WNT7B;BLVRB;GIT1;COMT;TTC7B;SUFU;PTAFR;PLEKHG6;RFNG;ANKRD13D;DMC1;IMPA2;ARHGEF37;PAN2;REEP4;ZNF446;ATG2A;RXRA;PCK2;PCSK1;VAV3;VASN;BCR;TMEM175;NEO1;IGFBP4;SDHA;GSDMC;MUC19;TBC1D16;USP21;RNF123;WDR60;PRKCZ;ADAMTS13;ZDHHC24;CLTCL1;HLTF;MDH2;CAPG;BCORL1;INPP5D;ETFB;ABCD4;SPATA7;TWF2;ZNF485;SH3GLB2;KLHDC8B;TPP1;PDK2;GPC1;TMX4;ICOSLG;SRSF5;ZNF160;RFXANK;TEF;SMOX;CEP68;SMARCD2;MAPKAPK3;NDE1;AGO4;RAD23A;ARAP3;FGFR1;CTSZ;CAMKK1;SPSB3;PIN1;MAN1B1;PNPLA4;ZNF563;KMT5C;PHYH;IRF2BPL;CMBL;PROX1;WBP2;GTPBP1;C21ORF2;NICN1;ASAP2;DLG3;GPR155;ESYT2;BIN1;VSNL1;MTMR11;UNC119B;YIPF3;TMEM8B;SERPINB6;PI4KAP2;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;CES2;SLC25A27;GRB10;BFSP1;JARID2;SYNC;CAPN2;SESN2;NDUFA4L2;TOLLIP;WNT2B;TSTA3;WRAP73;RXRB;CSTB;PROCR;SNPH;MAN2B2;PNRC1;MAPRE3;DUSP23;MACROD1;GAL3ST4;SMDT1;PTMS;PITPNM3;CYBRD1;MADD;LMLN;RTN4R;EPB41L3;PIGV;SLC9A7;TIMP1;CD68;SDC1;WHAMMP3;GRHPR;SH2B3;ACTR1B;APOBEC3C;RTN2;H1FX;EPS8L1;PLEKHH3;PIGQ;WNT3;LYST;GSTT1;ZFP41;PPM1F;KIAA1191;MICALCL;SBF1;SORL1;STK39;COL13A1;VEGFB;ACVR1B;MEF2B;TBC1D17;GSDMA;ZSCAN30;GSS;AHCYL2;ALS2CL;TSNARE1;TPCN1;HGSNAT;SLC25A29;ERBB3;ABR;ZER1;CCDC85B;PNMA1;CYP2S1;AKT1;CTSD;TRAP1;STON1;TMBIM4;NLRX1;SEPT8;ADAM19;ZNF385A;TP53INP1;LRCH4;NDRG2;TUT1;SMARCA1;VPS33B;SIX5;ERCC6;PCMTD2;ACP6;GPD1L;EPS8L2;TDRKH;SLC5A5;SUN1;NAGA;TMEM120A;SPPL2B;IL17RD;UQCR11;SSBP2;RPL39L;R3HDM2;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;MPLKIP;SNTA1;ARHGEF10L;KDM4B;CAMTA2;HOMER2;LGALS9B;RGS14;SYNE3;PLEKHH1;GOLGA2P5;PCIF1;MAFIP;SPIRE2;CCDC106;R3HDM4;HEXDC;EIF4G3;ZNF710;CTSH;EHBP1L1;ABHD14B;P3H4;MLST8;AGPAT4;RILPL1;NRSN1;RSAD1;CBLC;ATXN10;EPN2;RFX2;RNF187;PYCARD;MAP2K3;PNPO;RHBG;POMT1;TRERF1;PCSK1N;DNAAF5;DDN;PMS2P5;AS3MT;NDUFV3;STK17A;ERN1;RANBP9;ZNF319;APOBEC3F;PRIMPOL;ACADS;FBXL20;GCAT;WDR63;MOCS1;ARHGEF19;SIRT3;ALKBH6;GLI4;C12ORF66;SLC2A1;CPNE7;MLYCD;TAZ;JAK3;BCKDHA;KIFC2;LITAF;APBA1;MZF1;NEIL1;FUK;RARG;ING4;EIF4E3;GALNS;PBXIP1;FAM162A;PPCS;FCHSD1;GSTM2;ABHD14A;ZNF514;PODXL2;ZFYVE19;TRIM7;MORN4;WDR18;PQLC2;SFI1;KRT15;ADAMTSL4;TRNP1;TTLL11;ZNF837;TMED4;POLM;SEMA4F;FAM50A;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;STXBP2;KIF26B;UBL5;LZTS2
17276,GO:0140098,0.999999820196292,7.24082283758429e-07,9,332,catalytic activity, acting on RNA,MF,DHX32;RNASET2;ISG20;RRNAD1;PAN2;TUT1;ERN1;PRIMPOL;RNASEK
2480,GO:0005730,0.999999838700715,3.47510776334136e-07,41,835,nucleolus,CC,POLD4;CPT2;DEAF1;CTSB;MXI1;INO80C;DOCK4;ABTB1;ITPR3;XPC;PAK6;ADARB1;ZNF692;HINT2;ISG20;ARL2;YPEL3;YPEL2;FKBP10;ETV4;PHLDA1;SDHA;HLTF;CAPG;SRSF5;FGFR1;ZNF554;CSTB;H1FX;PNMA1;ZNF385A;TUT1;ERCC6;MAFIP;ABHD14B;P3H4;PYCARD;TRERF1;WDR18;RPL13A;RGS12
307,GO:0000819,0.999999910493035,7.19969221361683e-07,3,216,sister chromatid segregation,BP,TUBG2;CHMP1B;NDE1
13674,GO:0060255,0.999999919665479,1.14434178198941e-07,357,4575,regulation of macromolecule metabolic process,BP,TNIP1;HTRA1;FOS;DUSP6;CEMIP;APOE;CTNNBIP1;ERCC1;WWC3;CITED4;BTBD2;CST3;LTBP4;RAPGEF3;TCFL5;GSN;XDH;PRDX5;PCBP4;MEF2D;NOS1;ARAP1;ZFP36L1;GRB7;NR1D1;RBCK1;EPHB2;EPAS1;CNTN1;IGF2;NFATC4;MST1R;LRP1;MAPK13;EGFR;TIMP2;TSC22D1;B3GAT3;FBXO2;TCEA2;DUSP5;PPP1R14A;MXD4;SERPING1;MTHFR;MDFI;ADGRF1;EGR1;RHBDF1;PKN1;CRTC1;SHC1;F2R;PTK6;ABCA7;DEAF1;PPP2R3B;BAHCC1;BBS2;ACTA2;SHC2;CXXC5;GJC2;ZMYND8;ASH2L;ZSCAN18;GRAMD4;SOX12;MXI1;PLAT;ABCG1;ANK3;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;CRTAP;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;FBLN1;SCMH1;PKD2;EDEM1;ABTB1;H2AFJ;PHLDA2;SPRY4;PTHLH;CDKN1C;SALL2;MSRB2;PAK6;HEXB;SERPINE2;VPS11;FOXQ1;UNK;MINK1;ATP2B4;TFDP2;CSNK1E;TRAPPC9;PDCD4;TNFRSF25;ZKSCAN1;WNT7A;ZMIZ1;INSR;SH3PXD2B;ZC3H6;ID1;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;SYNGAP1;PPP1R35;DNMT3A;LPAR3;TMEM173;PRNP;PAPLN;SNX33;HES2;SPRY2;HINT2;ZNF467;MNT;ECM1;SNX9;STAT6;DLG4;MTA3;MKNK2;STRADB;WWTR1;DNAJB5;BCL6;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;VANGL2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;S1PR2;ENDOG;TNFRSF6B;MAPK3;ETV5;DVL1;MTA1;ADCY6;L3MBTL1;MBD1;EPHB3;FHOD1;HES1;BRD3;PC;SSH1;FURIN;MLXIPL;ZNF624;MEFV;ARHGAP22;ABCA2;ZNF414;PIDD1;PHF21A;CELSR2;IL6R;SLIT3;PCSK9;ZFP36;ETV4;BTBD11;FGFR3;PRKACA;F12;ZNF862;ZMYM3;KIAA1549;LRRK1;MAGEF1;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;DMTN;HDAC11;TNFRSF1A;EHD4;MAPK8IP1;TCF25;LDLR;PTOV1;SOX13;TRPV4;BHLHE40;EIF4EBP3;RAG1;ZNF80;DUSP7;EEF2K;HMGA2;ELK3;AHNAK2;DGKQ;SEMA4C;ZXDC;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;WNT7B;SUFU;PTAFR;PAN2;ZNF446;RXRA;NEO1;IGFBP4;TBC1D16;USP21;PRKCZ;HLTF;BCORL1;INPP5D;ZNF485;LSM14B;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;CAMKK1;PIN1;MN1;ZNF563;C5;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;BIN1;SERPINB6;PPP1R13L;SH3D19;ZNF554;JARID2;SESN2;TOLLIP;TMEM161A;RXRB;CSTB;PNRC1;MAPRE3;MADD;RTN4R;ELFN2;OR7D2;TIMP1;WNT3;ZFP41;PPM1F;SORL1;STK39;ACVR1B;MEF2B;ZSCAN30;ADORA2B;ERBB3;ZER1;CCDC85B;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;NDRG2;SMARCA1;SIX5;ERCC6;GPD1L;TDRKH;SSBP2;PINK1;PKD1;SNTA1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;EIF4G3;ZNF710;CTSH;ABHD14B;MLST8;CBLC;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;PCSK1N;THAP8;DDN;ERN1;RANBP9;ZNF319;SIRT3;GLI4;JAK3;LITAF;APBA1;MZF1;NEIL1;RARG;ING4;EIF4E3;PBXIP1;EREG;FAM162A;ZNF514;WDR18;TRNP1;ZNF837;RPL13A;MIF
5325,GO:0016072,0.999999923126187,4.45976065947658e-07,5,284,rRNA metabolic process,BP,CSNK1E;ISG20;RRNAD1;WDR18;RPL13A
10339,GO:0043170,0.999999929629594,9.85423014124102e-08,571,6863,macromolecule metabolic process,BP,TNIP1;HTRA1;FOS;DUSP6;LMF1;CEMIP;APOE;TYSND1;CTNNBIP1;RNPEPL1;PTPRS;ERCC1;WWC3;NT5E;GAA;CITED4;BTBD2;PYGB;RNF44;CST3;LTBP4;RAPGEF3;TCFL5;PGM1;GSN;CLCA2;XDH;PRDX5;PCBP4;PRSS3;MEF2D;NOS1;LTBP1;MARCH9;ARAP1;ZFP36L1;GRB7;NR1D1;ARRDC1;NYNRIN;POLD4;RBCK1;EPHB2;EPAS1;OBSCN;CNTN1;IGF2;NFATC4;MST1R;LRP1;MAPK13;CDK18;ST6GALNAC2;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;MMP28;B3GAT3;FBXO2;TCEA2;DUSP5;FKBP9;PPP1R14A;JOSD2;LOXL1;MXD4;DDB2;SERPING1;MTHFR;MDFI;ADGRF1;EGR1;ULK1;RHBDF1;PKN1;CRTC1;PYGL;NAGLU;SHC1;F2R;PTK6;NPEPL1;ABCA7;DEAF1;PPP2R3B;BAHCC1;BBS2;ACTA2;PRSS8;PPM1J;CTSB;RNF208;SHC2;CXXC5;ULK2;GJC2;D2HGDH;ZMYND8;ASH2L;ZSCAN18;GRAMD4;SOX12;MXI1;PLAT;MMP1;ABCG1;ANK3;PIK3R2;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;ZP3;CRTAP;RPS6KA2;LRP5;HYAL1;ANO8;MARK4;TENM2;MAML3;ZFPM1;TFEB;ERBB2;FBLN1;BRSK1;CTSF;SCMH1;PTPRU;PKD2;CBS;GID4;TMEM129;FUCA1;EDEM1;ABTB1;H2AFJ;PHLDA2;DNM1;SPRY4;PTHLH;CDKN1C;SALL2;MSRB2;CUL9;CD9;XPC;PTPRE;PAK6;HEXB;SERPINE2;VPS11;GALNT12;FOXQ1;RNF135;UNK;JADE2;THSD4;MINK1;ATP2B4;GGT1;TFDP2;CSNK1E;RASA4;TRAPPC9;ADAMTS7;PDCD4;TNFRSF25;DTX3;ZKSCAN1;USP20;PEX10;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;RAB3D;LCE1E;SH3PXD2B;FBXW8;ZC3H6;ID1;GRK6;MVD;B4GAT1;POLL;RABGGTA;EPHA1;ADARB1;ZNF692;ZNF704;ITGA6;SYNGAP1;FBXO27;PPP1R35;DNMT3A;LPAR3;TMEM173;PRNP;DHX32;PAPLN;SRD5A3;RNASET2;FBXL8;SNX33;FBXO41;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;ECM1;SNX9;STAT6;DLG4;SPEG;MARCH2;MTA3;MKNK2;STRADB;WWTR1;ISG20;FAM20C;MYO18A;DNAJB5;BCL6;ANKZF1;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;BNIP3;CD81;SRMS;FZD8;VEGFA;DNASE1L1;ZSCAN2;VANGL2;MAST4;FBXW4;AP2A2;CEBPB;RHBDF2;DPP7;SHANK3;ACVR2B;HSF4;ADAM15;NAB2;CALCOCO1;ZDHHC1;S1PR2;ENDOG;TNFRSF6B;MAPK3;FBXL16;ETV5;GLB1;CAPNS2;EXD3;RAB40B;DVL1;MTA1;LHPP;KLHL29;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;ST3GAL3;EPHB3;NSMCE4A;FHOD1;HES1;BRD3;PC;SSH1;FURIN;MLXIPL;ZNF624;CUL7;MEFV;ARHGAP22;TRIM4;ABCA2;TK2;LRSAM1;ZNF414;LY6K;FKBP10;CDC42EP5;PIDD1;PHF21A;CELSR2;ACY1;IL6R;SLIT3;PCSK9;ZFP36;ETV4;BTBD11;MAPKBP1;HLCS;FGFR3;PRKACA;F12;ZNF862;ZMYM3;KIAA1549;LRRK1;DGUOK;MAGEF1;CYFIP2;RPS6KA5;HBEGF;RAB3B;MAP2K2;DAP;FGFR4;SPTB;FBXW5;MXRA8;TSPAN33;DMTN;MYH3;MDGA1;XYLT2;HDAC11;VGF;TNFRSF1A;EHD4;MAPK8IP1;TCF25;LDLR;PTOV1;LYPLAL1;SOX13;ABHD17C;TRPV4;MPG;PIGZ;BHLHE40;EIF4EBP3;RRNAD1;RAG1;ZNF80;DUSP7;PHLDA1;EEF2K;RHBDL1;MSLN;HMGA2;LDLRAP1;ELK3;AHNAK2;DGKQ;SEMA4C;MVB12A;ZXDC;MIB2;FBXO17;CHST6;PADI3;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;STK32C;WNT7B;SUFU;PTAFR;RFNG;DMC1;PAN2;ZNF446;RXRA;PCSK1;BCR;NEO1;IGFBP4;MUC19;TBC1D16;USP21;RNF123;PRKCZ;ADAMTS13;ZDHHC24;HLTF;MDH2;BCORL1;INPP5D;ETFB;ZNF485;LSM14B;KLHDC8B;TPP1;PDK2;GPC1;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;CAMKK1;SPSB3;PIN1;MAN1B1;MN1;ZNF563;C5;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;BIN1;SERPINB6;PPP1R13L;SH3D19;ZNF554;WDR83;GLRX;JARID2;CAPN2;SESN2;TOLLIP;ADCK5;TMEM161A;RXRB;CSTB;MAN2B2;PNRC1;MAPRE3;DUSP23;LCAT;MACROD1;GAL3ST4;PTMS;TMPRSS11D;MADD;LMLN;RTN4R;ELFN2;OR7D2;PIGV;TIMP1;SDC1;APOBEC3C;PIGQ;WNT3;ZFP41;PPM1F;SBF1;SORL1;STK39;VEGFB;ACVR1B;MEF2B;ZSCAN30;ADORA2B;HGSNAT;ERBB3;ZER1;CCDC85B;AKT1;CTSD;TRAP1;NLRX1;ADAM19;ZNF385A;TP53INP1;NDRG2;TUT1;SMARCA1;VPS33B;SIX5;ERCC6;PCMTD2;GPD1L;TDRKH;SPPL2B;IL17RD;SSBP2;RPL39L;ADCK2;SSH3;PINK1;PKD1;EHD3;LONP2;SNTA1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;EIF4G3;ZNF710;CTSH;ABHD14B;P3H4;MLST8;CBLC;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;PCSK1N;THAP8;DDN;PMS2P5;STK17A;ERN1;RANBP9;ZNF319;APOBEC3F;PRIMPOL;FBXL20;MOCS1;SIRT3;GLI4;RNASEK;JAK3;MAST3;LITAF;APBA1;MZF1;NEIL1;RARG;ING4;EIF4E3;GALNS;PBXIP1;EREG;FAM162A;ZNF514;TRIM7;WDR18;ADAMTSL4;TRNP1;TTLL11;ZNF837;POLM;NDST2;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;UBL5
2554,GO:0005840,0.999999938430426,6.6787479329793e-07,2,225,ribosome,CC,RPL39L;RPL13A
2852,GO:0006351,0.999999951383502,7.38288184465616e-08,214,2981,transcription, DNA-templated,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;WWC3;CITED4;TCFL5;PRDX5;MEF2D;NOS1;ZFP36L1;NR1D1;RBCK1;EPAS1;IGF2;NFATC4;MAPK13;EGFR;TSC22D1;TCEA2;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;PKD2;H2AFJ;CDKN1C;SALL2;MSRB2;PAK6;HEXB;FOXQ1;ATP2B4;TFDP2;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;PRNP;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;WWTR1;DNAJB5;BCL6;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;MAPK3;ETV5;DVL1;MTA1;L3MBTL1;MBD1;FHOD1;HES1;BRD3;MLXIPL;ZNF624;ARHGAP22;ABCA2;ZNF414;PIDD1;PHF21A;CELSR2;ZFP36;ETV4;ZNF862;ZMYM3;KIAA1549;RPS6KA5;MAP2K2;DAP;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;BHLHE40;ZNF80;HMGA2;ELK3;DGKQ;ZXDC;GAS6;BTRC;POU6F1;ZNF217;PPARA;SUFU;PTAFR;ZNF446;RXRA;NEO1;USP21;PRKCZ;HLTF;BCORL1;ZNF485;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;PPP1R13L;ZNF554;JARID2;SESN2;RXRB;PNRC1;MAPRE3;OR7D2;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;CCDC85B;AKT1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;ZNF710;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;TRERF1;THAP8;DDN;ERN1;ZNF319;GLI4;LITAF;MZF1;RARG;ING4;PBXIP1;EREG;ZNF514;TRNP1;ZNF837;RGS12
8077,GO:0032774,0.999999968576916,4.79762707274069e-08,215,3005,RNA biosynthetic process,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;WWC3;CITED4;TCFL5;PRDX5;MEF2D;NOS1;ZFP36L1;NR1D1;RBCK1;EPAS1;IGF2;NFATC4;MAPK13;EGFR;TSC22D1;TCEA2;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;PKD2;H2AFJ;CDKN1C;SALL2;MSRB2;PAK6;HEXB;FOXQ1;ATP2B4;TFDP2;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;PRNP;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;WWTR1;DNAJB5;BCL6;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;MAPK3;ETV5;DVL1;MTA1;L3MBTL1;MBD1;FHOD1;HES1;BRD3;MLXIPL;ZNF624;ARHGAP22;ABCA2;ZNF414;PIDD1;PHF21A;CELSR2;ZFP36;ETV4;ZNF862;ZMYM3;KIAA1549;RPS6KA5;MAP2K2;DAP;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;BHLHE40;ZNF80;HMGA2;ELK3;DGKQ;ZXDC;GAS6;BTRC;POU6F1;ZNF217;PPARA;SUFU;PTAFR;ZNF446;RXRA;NEO1;USP21;PRKCZ;HLTF;BCORL1;ZNF485;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;PPP1R13L;ZNF554;JARID2;SESN2;RXRB;PNRC1;MAPRE3;OR7D2;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;CCDC85B;AKT1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;ZNF710;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;TRERF1;THAP8;DDN;ERN1;ZNF319;PRIMPOL;GLI4;LITAF;MZF1;RARG;ING4;PBXIP1;EREG;ZNF514;TRNP1;ZNF837;RGS12
7587,GO:0031974,0.999999970211753,4.33022704517477e-08,326,4304,membrane-enclosed lumen,CC,TNIP1;FOS;DUSP6;H6PD;APOE;CTNNBIP1;TSPAN1;IDH2;ERCC1;NT5E;GAA;CITED4;NAPRT;PYGB;RNF44;CST3;PGM1;GSN;PRDX5;PRSS3;PRODH;MEF2D;NOS1;LTBP1;ARAP1;COL6A1;NR1D1;CRAT;EPN3;POLD4;EPAS1;OBSCN;CPT2;IGF2;NFATC4;NME4;APPL2;EGFR;TIMP2;H1F0;ALDH4A1;HADH;ACSF2;ACOT7;TCEA2;DUSP5;DDB2;SERPING1;EGR1;PKN1;CRTC1;PYGL;TRIM65;NAGLU;SHC1;PTK6;DEAF1;PPP2R3B;BAHCC1;CTSB;RNF208;PITPNC1;CXXC5;D2HGDH;TBC1D14;ASH2L;SOX12;MXI1;NOL4L;INO80C;HDAC5;THRA;DOCK4;CRTAP;RPS6KA2;HYAL1;ANO8;TENM2;MAML3;ZFPM1;BRSK1;CTSF;SCMH1;OGDHL;FUCA1;TST;ABTB1;VWA5A;ITPR3;H2AFJ;VAT1;DNM1;FCHO1;PTHLH;SALL2;XPC;PAK6;HEXB;LTB4R2;JADE2;TFDP2;PHF7;CSNK1E;ADAMTS7;GM2A;LAMB2;WNT7A;ZMIZ1;INSR;ID1;CELSR1;MZT2A;POLL;WDR27;NDUFS8;RABGGTA;ADARB1;ZNF692;HAGH;DNMT3A;RNASET2;HINT2;MNT;ECM1;ATG16L2;STAT6;MTA3;MKNK2;TALDO1;WWTR1;ISG20;FAM20C;ARHGAP27;CERCAM;MZT2B;PHC2;PLEKHH2;BCL6;PFKFB2;TMEM92;BNIP3;VEGFA;DNASE1L1;ARL2;YPEL3;CEBPB;DPP7;HSD11B1L;HSF4;CALCOCO1;MAPK3;ETV5;OLFM2;GLB1;DHTKD1;MTA1;LHPP;L3MBTL1;LTA4H;WIPI2;MBD1;NSMCE4A;HES1;PC;ACAD10;YPEL2;FURIN;MLXIPL;NAGS;TK2;ADA;FKBP10;TRIM45;PYCR2;PIDD1;PHF21A;PFKL;PCSK9;ETV4;HLCS;CYHR1;PRKACA;ZMYM3;DGUOK;RPS6KA5;MXRA8;RAPGEF5;HDAC11;VGF;SOX13;MPG;BHLHE40;CCDC92;RAG1;DUSP7;PHLDA1;LRRC45;MSLN;HMGA2;ELK3;DGKQ;PEX7;KLHDC2;MVB12A;SDHAF4;GAS6;BTRC;POU6F1;ZNF217;PPARA;HMGCL;WNT7B;BLVRB;DMC1;RXRA;PCK2;PCSK1;NEO1;IGFBP4;SDHA;MUC19;USP21;PRKCZ;ADAMTS13;HLTF;MDH2;CAPG;BCORL1;ETFB;SPATA7;SH3GLB2;TPP1;PDK2;GPC1;SRSF5;RFXANK;SMOX;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;PIN1;KMT5C;PHYH;IRF2BPL;WBP2;NICN1;PPP1R13L;SH3D19;ZNF554;CES2;JARID2;TOLLIP;RXRB;CSTB;MAN2B2;DUSP23;MACROD1;SMDT1;TIMP1;SDC1;GRHPR;ACTR1B;H1FX;WNT3;SBF1;SORL1;STK39;COL13A1;VEGFB;MEF2B;PNMA1;AKT1;CTSD;TRAP1;ZNF385A;TP53INP1;LRCH4;TUT1;SMARCA1;ERCC6;ACP6;SPPL2B;IL17RD;PINK1;LONP2;MPLKIP;KDM4B;RGS14;PCIF1;MAFIP;CTSH;ABHD14B;P3H4;MLST8;RILPL1;RNF187;PYCARD;MAP2K3;PNPO;TRERF1;NDUFV3;STK17A;PRIMPOL;ACADS;GCAT;SIRT3;ALKBH6;MLYCD;BCKDHA;LITAF;NEIL1;RARG;ING4;GALNS;PODXL2;WDR18;ADAMTSL4;TRNP1;POLM;FAM50A;RPL13A;RGS12;MIF
10383,GO:0043233,0.999999970211753,4.33022704517477e-08,326,4304,organelle lumen,CC,TNIP1;FOS;DUSP6;H6PD;APOE;CTNNBIP1;TSPAN1;IDH2;ERCC1;NT5E;GAA;CITED4;NAPRT;PYGB;RNF44;CST3;PGM1;GSN;PRDX5;PRSS3;PRODH;MEF2D;NOS1;LTBP1;ARAP1;COL6A1;NR1D1;CRAT;EPN3;POLD4;EPAS1;OBSCN;CPT2;IGF2;NFATC4;NME4;APPL2;EGFR;TIMP2;H1F0;ALDH4A1;HADH;ACSF2;ACOT7;TCEA2;DUSP5;DDB2;SERPING1;EGR1;PKN1;CRTC1;PYGL;TRIM65;NAGLU;SHC1;PTK6;DEAF1;PPP2R3B;BAHCC1;CTSB;RNF208;PITPNC1;CXXC5;D2HGDH;TBC1D14;ASH2L;SOX12;MXI1;NOL4L;INO80C;HDAC5;THRA;DOCK4;CRTAP;RPS6KA2;HYAL1;ANO8;TENM2;MAML3;ZFPM1;BRSK1;CTSF;SCMH1;OGDHL;FUCA1;TST;ABTB1;VWA5A;ITPR3;H2AFJ;VAT1;DNM1;FCHO1;PTHLH;SALL2;XPC;PAK6;HEXB;LTB4R2;JADE2;TFDP2;PHF7;CSNK1E;ADAMTS7;GM2A;LAMB2;WNT7A;ZMIZ1;INSR;ID1;CELSR1;MZT2A;POLL;WDR27;NDUFS8;RABGGTA;ADARB1;ZNF692;HAGH;DNMT3A;RNASET2;HINT2;MNT;ECM1;ATG16L2;STAT6;MTA3;MKNK2;TALDO1;WWTR1;ISG20;FAM20C;ARHGAP27;CERCAM;MZT2B;PHC2;PLEKHH2;BCL6;PFKFB2;TMEM92;BNIP3;VEGFA;DNASE1L1;ARL2;YPEL3;CEBPB;DPP7;HSD11B1L;HSF4;CALCOCO1;MAPK3;ETV5;OLFM2;GLB1;DHTKD1;MTA1;LHPP;L3MBTL1;LTA4H;WIPI2;MBD1;NSMCE4A;HES1;PC;ACAD10;YPEL2;FURIN;MLXIPL;NAGS;TK2;ADA;FKBP10;TRIM45;PYCR2;PIDD1;PHF21A;PFKL;PCSK9;ETV4;HLCS;CYHR1;PRKACA;ZMYM3;DGUOK;RPS6KA5;MXRA8;RAPGEF5;HDAC11;VGF;SOX13;MPG;BHLHE40;CCDC92;RAG1;DUSP7;PHLDA1;LRRC45;MSLN;HMGA2;ELK3;DGKQ;PEX7;KLHDC2;MVB12A;SDHAF4;GAS6;BTRC;POU6F1;ZNF217;PPARA;HMGCL;WNT7B;BLVRB;DMC1;RXRA;PCK2;PCSK1;NEO1;IGFBP4;SDHA;MUC19;USP21;PRKCZ;ADAMTS13;HLTF;MDH2;CAPG;BCORL1;ETFB;SPATA7;SH3GLB2;TPP1;PDK2;GPC1;SRSF5;RFXANK;SMOX;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;PIN1;KMT5C;PHYH;IRF2BPL;WBP2;NICN1;PPP1R13L;SH3D19;ZNF554;CES2;JARID2;TOLLIP;RXRB;CSTB;MAN2B2;DUSP23;MACROD1;SMDT1;TIMP1;SDC1;GRHPR;ACTR1B;H1FX;WNT3;SBF1;SORL1;STK39;COL13A1;VEGFB;MEF2B;PNMA1;AKT1;CTSD;TRAP1;ZNF385A;TP53INP1;LRCH4;TUT1;SMARCA1;ERCC6;ACP6;SPPL2B;IL17RD;PINK1;LONP2;MPLKIP;KDM4B;RGS14;PCIF1;MAFIP;CTSH;ABHD14B;P3H4;MLST8;RILPL1;RNF187;PYCARD;MAP2K3;PNPO;TRERF1;NDUFV3;STK17A;PRIMPOL;ACADS;GCAT;SIRT3;ALKBH6;MLYCD;BCKDHA;LITAF;NEIL1;RARG;ING4;GALNS;PODXL2;WDR18;ADAMTSL4;TRNP1;POLM;FAM50A;RPL13A;RGS12;MIF
14498,GO:0070013,0.999999970211753,4.33022704517477e-08,326,4304,intracellular organelle lumen,CC,TNIP1;FOS;DUSP6;H6PD;APOE;CTNNBIP1;TSPAN1;IDH2;ERCC1;NT5E;GAA;CITED4;NAPRT;PYGB;RNF44;CST3;PGM1;GSN;PRDX5;PRSS3;PRODH;MEF2D;NOS1;LTBP1;ARAP1;COL6A1;NR1D1;CRAT;EPN3;POLD4;EPAS1;OBSCN;CPT2;IGF2;NFATC4;NME4;APPL2;EGFR;TIMP2;H1F0;ALDH4A1;HADH;ACSF2;ACOT7;TCEA2;DUSP5;DDB2;SERPING1;EGR1;PKN1;CRTC1;PYGL;TRIM65;NAGLU;SHC1;PTK6;DEAF1;PPP2R3B;BAHCC1;CTSB;RNF208;PITPNC1;CXXC5;D2HGDH;TBC1D14;ASH2L;SOX12;MXI1;NOL4L;INO80C;HDAC5;THRA;DOCK4;CRTAP;RPS6KA2;HYAL1;ANO8;TENM2;MAML3;ZFPM1;BRSK1;CTSF;SCMH1;OGDHL;FUCA1;TST;ABTB1;VWA5A;ITPR3;H2AFJ;VAT1;DNM1;FCHO1;PTHLH;SALL2;XPC;PAK6;HEXB;LTB4R2;JADE2;TFDP2;PHF7;CSNK1E;ADAMTS7;GM2A;LAMB2;WNT7A;ZMIZ1;INSR;ID1;CELSR1;MZT2A;POLL;WDR27;NDUFS8;RABGGTA;ADARB1;ZNF692;HAGH;DNMT3A;RNASET2;HINT2;MNT;ECM1;ATG16L2;STAT6;MTA3;MKNK2;TALDO1;WWTR1;ISG20;FAM20C;ARHGAP27;CERCAM;MZT2B;PHC2;PLEKHH2;BCL6;PFKFB2;TMEM92;BNIP3;VEGFA;DNASE1L1;ARL2;YPEL3;CEBPB;DPP7;HSD11B1L;HSF4;CALCOCO1;MAPK3;ETV5;OLFM2;GLB1;DHTKD1;MTA1;LHPP;L3MBTL1;LTA4H;WIPI2;MBD1;NSMCE4A;HES1;PC;ACAD10;YPEL2;FURIN;MLXIPL;NAGS;TK2;ADA;FKBP10;TRIM45;PYCR2;PIDD1;PHF21A;PFKL;PCSK9;ETV4;HLCS;CYHR1;PRKACA;ZMYM3;DGUOK;RPS6KA5;MXRA8;RAPGEF5;HDAC11;VGF;SOX13;MPG;BHLHE40;CCDC92;RAG1;DUSP7;PHLDA1;LRRC45;MSLN;HMGA2;ELK3;DGKQ;PEX7;KLHDC2;MVB12A;SDHAF4;GAS6;BTRC;POU6F1;ZNF217;PPARA;HMGCL;WNT7B;BLVRB;DMC1;RXRA;PCK2;PCSK1;NEO1;IGFBP4;SDHA;MUC19;USP21;PRKCZ;ADAMTS13;HLTF;MDH2;CAPG;BCORL1;ETFB;SPATA7;SH3GLB2;TPP1;PDK2;GPC1;SRSF5;RFXANK;SMOX;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;CTSZ;PIN1;KMT5C;PHYH;IRF2BPL;WBP2;NICN1;PPP1R13L;SH3D19;ZNF554;CES2;JARID2;TOLLIP;RXRB;CSTB;MAN2B2;DUSP23;MACROD1;SMDT1;TIMP1;SDC1;GRHPR;ACTR1B;H1FX;WNT3;SBF1;SORL1;STK39;COL13A1;VEGFB;MEF2B;PNMA1;AKT1;CTSD;TRAP1;ZNF385A;TP53INP1;LRCH4;TUT1;SMARCA1;ERCC6;ACP6;SPPL2B;IL17RD;PINK1;LONP2;MPLKIP;KDM4B;RGS14;PCIF1;MAFIP;CTSH;ABHD14B;P3H4;MLST8;RILPL1;RNF187;PYCARD;MAP2K3;PNPO;TRERF1;NDUFV3;STK17A;PRIMPOL;ACADS;GCAT;SIRT3;ALKBH6;MLYCD;BCKDHA;LITAF;NEIL1;RARG;ING4;GALNS;PODXL2;WDR18;ADAMTSL4;TRNP1;POLM;FAM50A;RPL13A;RGS12;MIF
7305,GO:0031326,0.999999970313696,4.45509068025447e-08,246,3357,regulation of cellular biosynthetic process,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;WWC3;CITED4;CST3;RAPGEF3;TCFL5;CYP27B1;PRDX5;MEF2D;NOS1;ZFP36L1;GRB7;NR1D1;RBCK1;EPAS1;IGF2;NFATC4;MAPK13;EGFR;TIMP2;TSC22D1;TCEA2;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;ABCA7;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;PKD2;H2AFJ;PTHLH;CDKN1C;SALL2;MSRB2;PAK6;HEXB;FOXQ1;LTB4R2;UNK;NTSR1;ATP2B4;TFDP2;ACP5;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;PRNP;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;MKNK2;WWTR1;DNAJB5;BCL6;PFKFB2;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;MAPK3;ETV5;DVL1;MTA1;L3MBTL1;MBD1;FHOD1;HES1;BRD3;MLXIPL;ZNF624;ARHGAP22;ABCA2;ZNF414;PIDD1;PHF21A;CELSR2;ZFP36;ETV4;ZNF862;ZMYM3;KIAA1549;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;LDLR;PTOV1;SOX13;TRPV4;BHLHE40;EIF4EBP3;ZNF80;HMGA2;ELK3;DGKQ;ZXDC;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;SUFU;PTAFR;ZNF446;RXRA;NEO1;USP21;PRKCZ;HLTF;BCORL1;INPP5D;ZNF485;LSM14B;PDK2;ZNF160;RFXANK;TEF;SMARCD2;AGO4;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;PPP1R13L;ASS1;ZNF554;JARID2;SESN2;RXRB;PNRC1;MAPRE3;GUCA1B;OR7D2;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;ADORA2B;CCDC85B;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;EIF4G3;ZNF710;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;THAP8;DDN;ERN1;ZNF319;GLI4;TAZ;JAK3;LITAF;MZF1;RARG;ING4;EIF4E3;PBXIP1;EREG;ZNF514;WDR18;TRNP1;ZNF837;RPL13A
16674,GO:0097659,0.999999970314188,4.5385800607745e-08,214,2995,nucleic acid-templated transcription,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;WWC3;CITED4;TCFL5;PRDX5;MEF2D;NOS1;ZFP36L1;NR1D1;RBCK1;EPAS1;IGF2;NFATC4;MAPK13;EGFR;TSC22D1;TCEA2;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;PKD2;H2AFJ;CDKN1C;SALL2;MSRB2;PAK6;HEXB;FOXQ1;ATP2B4;TFDP2;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;PRNP;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;WWTR1;DNAJB5;BCL6;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;MAPK3;ETV5;DVL1;MTA1;L3MBTL1;MBD1;FHOD1;HES1;BRD3;MLXIPL;ZNF624;ARHGAP22;ABCA2;ZNF414;PIDD1;PHF21A;CELSR2;ZFP36;ETV4;ZNF862;ZMYM3;KIAA1549;RPS6KA5;MAP2K2;DAP;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;BHLHE40;ZNF80;HMGA2;ELK3;DGKQ;ZXDC;GAS6;BTRC;POU6F1;ZNF217;PPARA;SUFU;PTAFR;ZNF446;RXRA;NEO1;USP21;PRKCZ;HLTF;BCORL1;ZNF485;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;PPP1R13L;ZNF554;JARID2;SESN2;RXRB;PNRC1;MAPRE3;OR7D2;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;CCDC85B;AKT1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;ZNF710;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;TRERF1;THAP8;DDN;ERN1;ZNF319;GLI4;LITAF;MZF1;RARG;ING4;PBXIP1;EREG;ZNF514;TRNP1;ZNF837;RGS12
4328,GO:0009889,0.999999974410194,3.83935175374719e-08,250,3407,regulation of biosynthetic process,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;WWC3;CITED4;CST3;RAPGEF3;TCFL5;CYP27B1;PRDX5;MEF2D;NOS1;ZFP36L1;GRB7;NR1D1;RBCK1;EPAS1;IGF2;NFATC4;MAPK13;EGFR;TIMP2;TSC22D1;TCEA2;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;ABCA7;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;PKD2;H2AFJ;PTHLH;CDKN1C;SALL2;MSRB2;PAK6;HEXB;FOXQ1;LTB4R2;UNK;NTSR1;ATP2B4;TFDP2;ACP5;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;MVD;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;PRNP;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;MKNK2;WWTR1;DNAJB5;BCL6;PFKFB2;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;MAPK3;ETV5;DVL1;MTA1;L3MBTL1;MBD1;FHOD1;HES1;BRD3;FURIN;MLXIPL;ZNF624;ARHGAP22;ABCA2;ZNF414;PIDD1;PHF21A;CELSR2;ZFP36;ETV4;ZNF862;ZMYM3;KIAA1549;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;PMVK;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;LDLR;PTOV1;SOX13;TRPV4;BHLHE40;EIF4EBP3;ZNF80;HMGA2;TM7SF2;ELK3;DGKQ;ZXDC;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;SUFU;PTAFR;ZNF446;RXRA;NEO1;USP21;PRKCZ;HLTF;BCORL1;INPP5D;ZNF485;LSM14B;PDK2;ZNF160;RFXANK;TEF;SMARCD2;AGO4;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;PPP1R13L;ASS1;ZNF554;JARID2;SESN2;RXRB;PNRC1;MAPRE3;GUCA1B;OR7D2;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;ADORA2B;CCDC85B;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;EIF4G3;ZNF710;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;THAP8;DDN;ERN1;ZNF319;GLI4;TAZ;JAK3;LITAF;MZF1;RARG;ING4;EIF4E3;PBXIP1;EREG;ZNF514;WDR18;TRNP1;ZNF837;RPL13A
4463,GO:0010468,0.999999977479287,3.3707189660615e-08,258,3517,regulation of gene expression,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;WWC3;CITED4;TCFL5;GSN;XDH;PRDX5;PCBP4;MEF2D;NOS1;ZFP36L1;GRB7;NR1D1;RBCK1;EPHB2;EPAS1;CNTN1;IGF2;NFATC4;MAPK13;EGFR;TSC22D1;TCEA2;MXD4;SERPING1;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;BBS2;ACTA2;CXXC5;GJC2;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;ANK3;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;PKD2;H2AFJ;PHLDA2;PTHLH;CDKN1C;SALL2;MSRB2;PAK6;HEXB;SERPINE2;FOXQ1;UNK;ATP2B4;TFDP2;CSNK1E;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;SH3PXD2B;ZC3H6;ID1;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;PRNP;HES2;SPRY2;ZNF467;MNT;ECM1;STAT6;MTA3;MKNK2;WWTR1;DNAJB5;BCL6;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;MAPK3;ETV5;DVL1;MTA1;L3MBTL1;MBD1;FHOD1;HES1;BRD3;PC;MLXIPL;ZNF624;ARHGAP22;ABCA2;ZNF414;PIDD1;PHF21A;CELSR2;SLIT3;ZFP36;ETV4;F12;ZNF862;ZMYM3;KIAA1549;CYFIP2;RPS6KA5;MAP2K2;DAP;FGFR4;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;LDLR;PTOV1;SOX13;TRPV4;BHLHE40;EIF4EBP3;RAG1;ZNF80;HMGA2;ELK3;AHNAK2;DGKQ;ZXDC;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;SUFU;PTAFR;PAN2;ZNF446;RXRA;NEO1;USP21;PRKCZ;HLTF;BCORL1;ZNF485;LSM14B;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;AGO4;FGFR1;CTSZ;PIN1;MN1;ZNF563;C5;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;PPP1R13L;ZNF554;JARID2;SESN2;RXRB;PNRC1;MAPRE3;OR7D2;WNT3;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;ERBB3;CCDC85B;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;TDRKH;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;EIF4G3;ZNF710;CTSH;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;TRERF1;THAP8;DDN;ERN1;ZNF319;GLI4;LITAF;APBA1;MZF1;RARG;ING4;EIF4E3;PBXIP1;EREG;ZNF514;TRNP1;ZNF837;RPL13A;MIF
12880,GO:0051252,0.999999983741449,2.50303407959112e-08,216,3030,regulation of RNA metabolic process,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;WWC3;CITED4;TCFL5;PRDX5;PCBP4;MEF2D;NOS1;ZFP36L1;NR1D1;RBCK1;EPAS1;IGF2;NFATC4;MAPK13;EGFR;TSC22D1;TCEA2;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;PKD2;H2AFJ;CDKN1C;SALL2;MSRB2;PAK6;HEXB;FOXQ1;ATP2B4;TFDP2;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;PRNP;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;WWTR1;DNAJB5;BCL6;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;MAPK3;ETV5;DVL1;MTA1;L3MBTL1;MBD1;FHOD1;HES1;BRD3;MLXIPL;ZNF624;ARHGAP22;ABCA2;ZNF414;PIDD1;PHF21A;CELSR2;ZFP36;ETV4;ZNF862;ZMYM3;KIAA1549;RPS6KA5;MAP2K2;DAP;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;BHLHE40;ZNF80;HMGA2;ELK3;AHNAK2;DGKQ;ZXDC;GAS6;BTRC;POU6F1;ZNF217;PPARA;SUFU;PTAFR;ZNF446;RXRA;NEO1;USP21;PRKCZ;HLTF;BCORL1;ZNF485;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;PPP1R13L;ZNF554;JARID2;SESN2;RXRB;PNRC1;MAPRE3;OR7D2;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;CCDC85B;AKT1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;ZNF710;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;TRERF1;THAP8;DDN;ERN1;ZNF319;GLI4;LITAF;MZF1;RARG;ING4;PBXIP1;EREG;ZNF514;TRNP1;ZNF837
19712,GO:2000112,0.999999989586385,1.59901127877153e-08,231,3215,regulation of cellular macromolecule biosynthetic process,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;WWC3;CITED4;CST3;TCFL5;PRDX5;MEF2D;NOS1;ZFP36L1;GRB7;NR1D1;RBCK1;EPAS1;IGF2;NFATC4;MAPK13;EGFR;TSC22D1;TCEA2;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;ABCA7;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;PKD2;H2AFJ;CDKN1C;SALL2;MSRB2;PAK6;HEXB;FOXQ1;UNK;ATP2B4;TFDP2;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;PRNP;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;MKNK2;WWTR1;DNAJB5;BCL6;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;MAPK3;ETV5;DVL1;MTA1;L3MBTL1;MBD1;FHOD1;HES1;BRD3;MLXIPL;ZNF624;ARHGAP22;ABCA2;ZNF414;PIDD1;PHF21A;CELSR2;ZFP36;ETV4;ZNF862;ZMYM3;KIAA1549;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;BHLHE40;EIF4EBP3;ZNF80;HMGA2;ELK3;DGKQ;ZXDC;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;SUFU;PTAFR;ZNF446;RXRA;NEO1;USP21;PRKCZ;HLTF;BCORL1;ZNF485;LSM14B;ZNF160;RFXANK;TEF;SMARCD2;AGO4;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;PPP1R13L;ZNF554;JARID2;SESN2;RXRB;PNRC1;MAPRE3;OR7D2;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;CCDC85B;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;EIF4G3;ZNF710;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;THAP8;DDN;ERN1;ZNF319;GLI4;JAK3;LITAF;MZF1;RARG;ING4;EIF4E3;PBXIP1;EREG;ZNF514;WDR18;TRNP1;ZNF837;RPL13A
10882,GO:0044446,0.999999992849253,1.03274333723748e-08,582,7067,intracellular organelle part,CC,TNIP1;FOS;DUSP6;H6PD;LMF1;CEMIP;APOE;ESPN;CTNNBIP1;TSPAN1;IDH2;PTPRS;ERCC1;FAM110C;NT5E;GAA;CLIP2;CITED4;NAPRT;PYGB;RNF44;CST3;SHANK2;RAPGEF3;PGM1;CYP27B1;GSN;CLCA2;PRDX5;NDRG1;PRSS3;PRODH;MEF2D;NOS1;LTBP1;MARCH9;ARAP1;COL6A1;POSTN;NR1D1;CRAT;EPN3;FAM210B;POLD4;EPAS1;OBSCN;CPT2;MYZAP;IGF2;NFATC4;NME4;MST1R;LRP1;APPL2;ST6GALNAC2;RAB11FIP4;OBSL1;EGFR;TIMP2;H1F0;ALDH4A1;B3GAT3;HADH;ACSF2;REEP6;ACOT7;TCEA2;DUSP5;DDB2;SERPING1;KDSR;EGR1;ULK1;RHBDF1;PKN1;CRTC1;PYGL;TRIM65;DOPEY2;SYT8;NAGLU;SHC1;PTK6;BPHL;ABCA7;DEAF1;PPP2R3B;BAHCC1;BBS2;CTSB;LPCAT4;DNAH1;RNF208;PITPNC1;SLC16A3;CORO1B;CXXC5;ULK2;DHRS1;MALL;D2HGDH;TBC1D14;ASH2L;GRAMD4;SOX12;MXI1;CERS4;ABCG1;NOL4L;S100A6;INO80C;NEK9;HDAC5;THRA;PLD3;DOCK4;CRTAP;RPS6KA2;DBNDD1;HYAL1;TUBG2;ANO8;MARK4;TENM2;SLC2A9;MAML3;B4GALNT4;ZFPM1;ERBB2;BRSK1;MICALL2;BSG;CTSF;SCMH1;OGDHL;PKD2;TMEM129;FUCA1;TST;CPT1C;EDEM1;ABTB1;VWA5A;ITPR3;H2AFJ;PRAF2;VAT1;DNM1;FCHO1;PTHLH;SALL2;IFT140;CD9;KIF13B;XPC;ANGEL1;NINL;SIGMAR1;PAK6;HEXB;VPS11;VAMP2;CCDC69;GALNT12;NPHP4;LTB4R2;JADE2;CD320;SNN;TMOD2;TFDP2;PHF7;CSNK1E;TRAPPC9;ZFYVE21;DIRC2;ADAMTS7;ENKD1;GM2A;RHOD;USP20;PEX10;ARMCX2;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;RAB3D;SH3PXD2B;ID1;CELSR1;MZT2A;B4GAT1;POLL;WDR27;NDUFS8;RABGGTA;ADARB1;ZNF692;NBEAL2;HAGH;DNMT3A;TMEM173;PRNP;DHX32;SRD5A3;ATP7B;RNASET2;SNX33;SPRY2;HINT2;MNT;ECM1;CEP250;ATG16L2;SNX9;STAT6;DLG4;ABCD1;MARCH2;REEP2;MTA3;MKNK2;TALDO1;WWTR1;ISG20;FAM20C;MYO18A;ARHGAP27;CERCAM;MZT2B;PHC2;PLEKHH2;BCL6;ANKZF1;PFKFB2;CHMP1B;MVB12B;TMEM92;BNIP3;VEGFA;ENTPD6;DNASE1L1;HOOK2;ARL2;YPEL3;VANGL2;AP2A2;CEBPB;RHBDF2;DPP7;GPRC5C;HSD11B1L;HSF4;NUDCD3;CALCOCO1;MAPK3;KCNAB2;ETV5;OLFM2;CARD19;AMN;SLC22A18;GLB1;DHTKD1;RAB40B;TNNT1;DVL1;ENTPD2;MTA1;LHPP;WIPF1;GPSM1;L3MBTL1;LTA4H;WIPI2;MBD1;ST3GAL3;SLC16A13;NSMCE4A;FHOD1;HES1;PC;ACAD10;YPEL2;FURIN;MLXIPL;NAGS;FBF1;MBOAT7;SLC48A1;CUL7;MEFV;EVC;SLC2A3;ABCA2;TK2;ADA;FKBP10;TRIM45;MCTP1;OSBPL5;PYCR2;PIDD1;RETSAT;PHF21A;MYH16;CKMT1A;PFKL;PCSK9;TMEM9;ETV4;RHOF;MAPKBP1;HLCS;CYHR1;PRKACA;PITPNM1;ZMYM3;DGUOK;RPS6KA5;HBEGF;SLC25A37;RAB3B;MAP2K2;PI4K2A;SPTB;MXRA8;SLC37A2;STX10;DMTN;RAPGEF5;BBS1;MYH3;XYLT2;HDAC11;VGF;TNFRSF1A;SEZ6L2;EHD4;MAPK8IP1;LDLR;CYP3A5;SNX17;SOX13;ABHD17C;TRPV4;MPG;PIGZ;IFNGR2;BHLHE40;CROCC;CCDC92;RAG1;DUSP7;PHLDA1;LRRC45;MSLN;HMGA2;LDLRAP1;TM7SF2;ELK3;AHNAK2;DGKQ;PEX7;KLHDC2;SEMA4C;MVB12A;HK1;CHST6;SDHAF4;GAS6;BTRC;POU6F1;LLGL1;ADGRB2;ZNF217;PPARA;HMGCL;WNT7B;BLVRB;PTAFR;PLEKHG6;RFNG;DMC1;REEP4;RXRA;PCK2;PCSK1;VASN;TMEM175;NEO1;IGFBP4;SDHA;GSDMC;MUC19;USP21;RNF123;WDR60;PRKCZ;ADAMTS13;CLTCL1;HLTF;MDH2;CAPG;BCORL1;ETFB;ABCD4;SPATA7;TWF2;SH3GLB2;TPP1;PDK2;GPC1;SRSF5;RFXANK;SMOX;CEP68;SMARCD2;MAPKAPK3;NDE1;AGO4;RAD23A;FGFR1;CTSZ;PIN1;MAN1B1;KMT5C;PHYH;IRF2BPL;WBP2;C21ORF2;NICN1;ASAP2;ESYT2;BIN1;SERPINB6;PPP1R13L;SH3D19;ZNF554;WDR83;CES2;SLC25A27;BFSP1;JARID2;SYNC;CAPN2;NDUFA4L2;TOLLIP;WRAP73;RXRB;CSTB;PROCR;SNPH;MAN2B2;MAPRE3;DUSP23;MACROD1;GAL3ST4;SMDT1;CYBRD1;PIGV;SLC9A7;TIMP1;CD68;SDC1;GRHPR;ACTR1B;RTN2;H1FX;PIGQ;WNT3;SBF1;SORL1;STK39;COL13A1;VEGFB;MEF2B;TPCN1;HGSNAT;SLC25A29;CCDC85B;PNMA1;CYP2S1;AKT1;CTSD;TRAP1;TMBIM4;NLRX1;SEPT8;ZNF385A;TP53INP1;LRCH4;TUT1;SMARCA1;VPS33B;ERCC6;ACP6;SUN1;TMEM120A;SPPL2B;IL17RD;UQCR11;RPL39L;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;MPLKIP;KDM4B;RGS14;SYNE3;GOLGA2P5;PCIF1;MAFIP;SPIRE2;CTSH;ABHD14B;P3H4;MLST8;AGPAT4;RILPL1;EPN2;RNF187;PYCARD;MAP2K3;PNPO;RHBG;POMT1;TRERF1;PCSK1N;DDN;PMS2P5;NDUFV3;STK17A;ERN1;RANBP9;APOBEC3F;PRIMPOL;ACADS;GCAT;WDR63;SIRT3;ALKBH6;C12ORF66;SLC2A1;MLYCD;TAZ;BCKDHA;KIFC2;LITAF;NEIL1;RARG;ING4;GALNS;PBXIP1;PODXL2;ZFYVE19;WDR18;PQLC2;SFI1;KRT15;ADAMTSL4;TRNP1;TTLL11;TMED4;POLM;FAM50A;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;STXBP2;KIF26B;LZTS2
2470,GO:0005694,0.999999993715539,1.46983662102044e-08,40,881,chromosome,CC,ERCC1;MEF2D;NR1D1;POLD4;APPL2;H1F0;BAHCC1;ASH2L;INO80C;SCMH1;H2AFJ;SALL2;DNMT3A;STAT6;PHC2;BCL6;CEBPB;CALCOCO1;L3MBTL1;MBD1;NSMCE4A;HLCS;HMGA2;DMC1;RXRA;SMARCD2;NDE1;KMT5C;WBP2;CAPN2;H1FX;MEF2B;ZNF385A;SMARCA1;PINK1;P3H4;NEIL1;RARG;TRNP1;RGS12
9897,GO:0042254,0.9999999952308,3.0971030188753e-08,5,317,ribosome biogenesis,BP,CSNK1E;ISG20;RRNAD1;WDR18;RPL13A
4496,GO:0010556,0.999999996029526,6.19127047933386e-09,233,3263,regulation of macromolecule biosynthetic process,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;WWC3;CITED4;CST3;TCFL5;PRDX5;MEF2D;NOS1;ZFP36L1;GRB7;NR1D1;RBCK1;EPAS1;IGF2;NFATC4;MAPK13;EGFR;TSC22D1;TCEA2;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;ABCA7;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;PKD2;H2AFJ;CDKN1C;SALL2;MSRB2;PAK6;HEXB;FOXQ1;UNK;ATP2B4;TFDP2;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;PRNP;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;MKNK2;WWTR1;DNAJB5;BCL6;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;MAPK3;ETV5;DVL1;MTA1;L3MBTL1;MBD1;FHOD1;HES1;BRD3;FURIN;MLXIPL;ZNF624;ARHGAP22;ABCA2;ZNF414;PIDD1;PHF21A;CELSR2;ZFP36;ETV4;ZNF862;ZMYM3;KIAA1549;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;BHLHE40;EIF4EBP3;ZNF80;HMGA2;ELK3;DGKQ;ZXDC;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;SUFU;PTAFR;ZNF446;RXRA;NEO1;USP21;PRKCZ;HLTF;BCORL1;INPP5D;ZNF485;LSM14B;ZNF160;RFXANK;TEF;SMARCD2;AGO4;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;PPP1R13L;ZNF554;JARID2;SESN2;RXRB;PNRC1;MAPRE3;OR7D2;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;CCDC85B;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;EIF4G3;ZNF710;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;THAP8;DDN;ERN1;ZNF319;GLI4;JAK3;LITAF;MZF1;RARG;ING4;EIF4E3;PBXIP1;EREG;ZNF514;WDR18;TRNP1;ZNF837;RPL13A
1445,GO:0003677,0.999999996179022,6.7304093825684e-09,120,1924,DNA binding,MF,FOS;ERCC1;TCFL5;PRDX5;PCBP4;MEF2D;ZFP36L1;NR1D1;EPAS1;NFATC4;EGFR;H1F0;TCEA2;MXD4;DDB2;EGR1;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;CERS4;ZNF516;HDAC5;THRA;ZFPM1;TFEB;H2AFJ;SALL2;XPC;FOXQ1;TFDP2;ZKSCAN1;ZC3H6;POLL;ZNF692;ZNF704;DNMT3A;HES2;ZNF467;MNT;STAT6;MTA3;MYO18A;PHC2;BCL6;DNASE1L1;ZSCAN2;CEBPB;HSF4;CALCOCO1;ZDHHC1;ETV5;MTA1;MBD1;HES1;MLXIPL;ZNF624;ZNF414;PHF21A;ZFP36;ETV4;ZMYM3;TCF25;SOX13;MPG;BHLHE40;RAG1;ZNF80;HMGA2;ELK3;POU6F1;ZNF217;PPARA;DMC1;ZNF446;RXRA;HLTF;ZNF485;ZNF160;RFXANK;TEF;SMARCD2;RAD23A;ZNF563;PROX1;WBP2;ZNF554;JARID2;RXRB;H1FX;ZFP41;MEF2B;ZSCAN30;ZNF385A;SMARCA1;SIX5;ERCC6;SSBP2;CAMTA2;ZNF710;RFX2;TRERF1;THAP8;DDN;PMS2P5;ZNF319;SIRT3;GLI4;LITAF;MZF1;NEIL1;RARG;ZNF514;TRNP1;ZNF837;POLM
17668,GO:1901576,0.999999997545146,3.68564100800477e-09,376,4901,organic substance biosynthetic process,BP,TNIP1;HTRA1;FOS;LMF1;CEMIP;APOE;CTNNBIP1;IDH2;WWC3;NT5E;CITED4;NAPRT;CST3;RAPGEF3;TCFL5;PGM1;CYP27B1;XDH;PRDX5;MEF2D;NOS1;ZFP36L1;GRB7;NR1D1;ALOX15B;POLD4;RBCK1;EPAS1;IGF2;NFATC4;NME4;GAMT;MAPK13;ST6GALNAC2;EGFR;TIMP2;TSC22D1;B3GAT3;CRYL1;ACOT7;TCEA2;ISYNA1;UROS;MXD4;KDSR;MDFI;ADGRF1;EGR1;PKN1;CRTC1;PYGL;SHC1;F2R;ABCA7;DEAF1;BAHCC1;LPCAT4;CXXC5;DGKA;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;CERS4;ABCG1;DHRS11;PIK3R2;OPLAH;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;NMRK1;LRP5;HYAL1;TENM2;PLTP;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;OGDHL;PKD2;CBS;ABTB1;H2AFJ;PTHLH;CDKN1C;SALL2;MSRB2;PAK6;HEXB;GALNT12;FOXQ1;LTB4R2;UNK;NTSR1;ATP2B4;GGT1;TFDP2;TRAPPC9;ADAMTS7;PDCD4;GLUL;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;MVD;B4GAT1;POLL;ZNF692;ZNF704;ITGA6;HAGH;DNMT3A;DNPH1;TMEM173;PRNP;SRD5A3;HES2;HINT2;ZNF467;MNT;ECM1;STAT6;MTA3;MKNK2;TALDO1;WWTR1;DNAJB5;BCL6;UCKL1;PFKFB2;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;VANGL2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;ZDHHC1;MAPK3;ETV5;DHTKD1;DVL1;ENTPD2;GALK1;MTA1;LHPP;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PHGDH;ST3GAL3;FHOD1;HES1;BRD3;PC;FURIN;MLXIPL;ZNF624;NAGS;MBOAT7;ARHGAP22;NADK;ABCA2;TK2;ZNF414;LY6K;ADA;PYCR2;PIDD1;PHF21A;CELSR2;PFKL;ZFP36;ETV4;FGFR3;PITPNM1;ZNF862;ZMYM3;KIAA1549;NUDT10;DGUOK;CYFIP2;RPS6KA5;HBEGF;MAP2K2;PI4K2A;DAP;FGFR4;PMVK;MDGA1;XYLT2;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;LDLR;PTOV1;SOX13;ABHD17C;TRPV4;PIGZ;BHLHE40;EIF4EBP3;ZNF80;PHLDA1;EEF2K;MSLN;HMGA2;TM7SF2;ELK3;DGKQ;PEX7;HK1;NMRAL1;ZXDC;CHST6;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;HMGCL;GUK1;SUFU;PTAFR;RFNG;IMPA2;ZNF446;RXRA;PCK2;PCSK1;NEO1;MUC19;USP21;PRKCZ;ADAMTS13;ZDHHC24;HLTF;MDH2;BCORL1;INPP5D;ZNF485;LSM14B;PDK2;GPC1;SRSF5;ZNF160;RFXANK;TEF;SMOX;SMARCD2;AGO4;FGFR1;PIN1;MAN1B1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;PPP1R13L;ASS1;ZNF554;JARID2;SESN2;TSTA3;RXRB;PNRC1;MAPRE3;LCAT;GUCA1B;GAL3ST4;PTMS;PITPNM3;OR7D2;PIGV;SDC1;PIGQ;GSTT1;ZFP41;PPM1F;SBF1;VEGFB;ACVR1B;MEF2B;ZSCAN30;GSS;ADORA2B;CCDC85B;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;ACP6;GPD1L;SSBP2;RPL39L;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;EIF4G3;ZNF710;ABHD14B;AGPAT4;RSAD1;RFX2;RNF187;PYCARD;MAP2K3;PNPO;POMT1;TRERF1;THAP8;DDN;ERN1;ZNF319;PRIMPOL;MOCS1;GLI4;SLC2A1;CPNE7;MLYCD;TAZ;JAK3;LITAF;MZF1;NEIL1;FUK;RARG;ING4;EIF4E3;PBXIP1;EREG;PPCS;GSTM2;ZNF514;WDR18;ADAMTSL4;TRNP1;ZNF837;POLM;NDST2;AGPAT3;RPL13A;RGS12;ALG12;MIF
4017,GO:0009058,0.999999998229644,2.69347328276439e-09,379,4942,biosynthetic process,BP,TNIP1;HTRA1;FOS;LMF1;CEMIP;APOE;CTNNBIP1;IDH2;WWC3;NT5E;CITED4;NAPRT;CST3;RAPGEF3;TCFL5;PGM1;CYP27B1;XDH;PRDX5;MEF2D;NOS1;ZFP36L1;GRB7;NR1D1;ALOX15B;POLD4;RBCK1;EPAS1;IGF2;NFATC4;NME4;GAMT;MAPK13;ST6GALNAC2;EGFR;TIMP2;TSC22D1;B3GAT3;CRYL1;ACOT7;TCEA2;ISYNA1;UROS;MXD4;KDSR;MDFI;ADGRF1;EGR1;PKN1;CRTC1;PYGL;SHC1;F2R;ABCA7;DEAF1;BAHCC1;LPCAT4;CXXC5;DGKA;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;CERS4;ABCG1;DHRS11;PIK3R2;OPLAH;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;NMRK1;LRP5;HYAL1;TENM2;PLTP;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;OGDHL;PKD2;CBS;ABTB1;H2AFJ;PTHLH;CDKN1C;SALL2;MSRB2;PAK6;HEXB;GALNT12;FOXQ1;LTB4R2;UNK;NTSR1;ATP2B4;GGT1;TFDP2;ACP5;TRAPPC9;ADAMTS7;PDCD4;GLUL;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;MVD;B4GAT1;POLL;ZNF692;ZNF704;ITGA6;HAGH;DNMT3A;DNPH1;TMEM173;PRNP;SRD5A3;HES2;HINT2;ZNF467;MNT;ECM1;STAT6;MTA3;MKNK2;TALDO1;WWTR1;DNAJB5;BCL6;UCKL1;PFKFB2;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;VANGL2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;ZDHHC1;MAPK3;ETV5;DHTKD1;DVL1;ENTPD2;GALK1;MTA1;LHPP;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PHGDH;ST3GAL3;FHOD1;HES1;BRD3;PC;FURIN;MLXIPL;ZNF624;NAGS;MBOAT7;ARHGAP22;NADK;ABCA2;TK2;ZNF414;LY6K;ADA;PYCR2;PIDD1;PHF21A;CELSR2;PFKL;ZFP36;ETV4;FGFR3;PITPNM1;ZNF862;ZMYM3;KIAA1549;NUDT10;DGUOK;CYFIP2;RPS6KA5;HBEGF;MAP2K2;PI4K2A;DAP;FGFR4;PMVK;MDGA1;XYLT2;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;LDLR;PTOV1;SOX13;ABHD17C;TRPV4;PIGZ;BHLHE40;EIF4EBP3;ZNF80;PHLDA1;EEF2K;MSLN;HMGA2;TM7SF2;ELK3;DGKQ;PEX7;HK1;NMRAL1;ZXDC;CHST6;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;HMGCL;GUK1;SUFU;PTAFR;RFNG;IMPA2;ZNF446;RXRA;PCK2;PCSK1;NEO1;MUC19;USP21;PRKCZ;ADAMTS13;ZDHHC24;HLTF;MDH2;BCORL1;INPP5D;ZNF485;LSM14B;PDK2;GPC1;SRSF5;ZNF160;RFXANK;TEF;SMOX;SMARCD2;AGO4;FGFR1;PIN1;MAN1B1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;PPP1R13L;ASS1;ZNF554;JARID2;SESN2;TSTA3;RXRB;PNRC1;MAPRE3;LCAT;GUCA1B;GAL3ST4;PTMS;PITPNM3;OR7D2;PIGV;SDC1;PIGQ;GSTT1;ZFP41;PPM1F;SBF1;VEGFB;ACVR1B;MEF2B;ZSCAN30;GSS;ADORA2B;CCDC85B;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;ACP6;GPD1L;SSBP2;RPL39L;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;EIF4G3;ZNF710;ABHD14B;P3H4;AGPAT4;RSAD1;RFX2;RNF187;PYCARD;MAP2K3;PNPO;POMT1;TRERF1;THAP8;DDN;ERN1;ZNF319;PRIMPOL;GCAT;MOCS1;GLI4;SLC2A1;CPNE7;MLYCD;TAZ;JAK3;LITAF;MZF1;NEIL1;FUK;RARG;ING4;EIF4E3;PBXIP1;EREG;PPCS;GSTM2;ZNF514;WDR18;ADAMTSL4;TRNP1;ZNF837;POLM;NDST2;AGPAT3;RPL13A;RGS12;ALG12;MIF
6061,GO:0019219,0.999999998586804,2.29605802284272e-09,232,3274,regulation of nucleobase-containing compound metabolic process,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;ERCC1;WWC3;CITED4;CST3;RAPGEF3;TCFL5;PRDX5;PCBP4;MEF2D;NOS1;ZFP36L1;NR1D1;RBCK1;EPAS1;IGF2;NFATC4;MAPK13;EGFR;TIMP2;TSC22D1;TCEA2;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;PKD2;H2AFJ;PTHLH;CDKN1C;SALL2;MSRB2;PAK6;HEXB;FOXQ1;LTB4R2;ATP2B4;TFDP2;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;PRNP;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;WWTR1;DNAJB5;BCL6;PFKFB2;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;ENDOG;MAPK3;ETV5;DVL1;MTA1;L3MBTL1;MBD1;FHOD1;HES1;BRD3;MLXIPL;ZNF624;ARHGAP22;ABCA2;ZNF414;PIDD1;PHF21A;CELSR2;ZFP36;ETV4;ZNF862;ZMYM3;KIAA1549;MAGEF1;RPS6KA5;MAP2K2;DAP;FGFR4;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;BHLHE40;ZNF80;HMGA2;ELK3;AHNAK2;DGKQ;ZXDC;GAS6;BTRC;POU6F1;ZNF217;PPARA;SUFU;PTAFR;ZNF446;RXRA;NEO1;USP21;PRKCZ;HLTF;BCORL1;ZNF485;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;PPP1R13L;ZNF554;JARID2;SESN2;TMEM161A;RXRB;PNRC1;MAPRE3;GUCA1B;OR7D2;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;ADORA2B;CCDC85B;AKT1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;ZNF710;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;TRERF1;THAP8;DDN;ERN1;ZNF319;GLI4;TAZ;LITAF;MZF1;NEIL1;RARG;ING4;PBXIP1;EREG;ZNF514;WDR18;TRNP1;ZNF837
10768,GO:0044249,0.999999998962005,1.61748747591526e-09,368,4836,cellular biosynthetic process,BP,TNIP1;HTRA1;FOS;LMF1;CEMIP;APOE;CTNNBIP1;IDH2;WWC3;NT5E;CITED4;NAPRT;CST3;RAPGEF3;TCFL5;PGM1;CYP27B1;XDH;PRDX5;MEF2D;NOS1;ZFP36L1;GRB7;NR1D1;ALOX15B;POLD4;RBCK1;EPAS1;IGF2;NFATC4;NME4;GAMT;MAPK13;ST6GALNAC2;EGFR;TIMP2;TSC22D1;B3GAT3;ACOT7;TCEA2;ISYNA1;UROS;MXD4;KDSR;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;ABCA7;DEAF1;BAHCC1;LPCAT4;CXXC5;DGKA;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;CERS4;ABCG1;DHRS11;PIK3R2;OPLAH;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;NMRK1;LRP5;HYAL1;TENM2;PLTP;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;OGDHL;PKD2;CBS;ABTB1;H2AFJ;PTHLH;CDKN1C;SALL2;MSRB2;PAK6;HEXB;GALNT12;FOXQ1;LTB4R2;UNK;NTSR1;ATP2B4;GGT1;TFDP2;ACP5;TRAPPC9;ADAMTS7;PDCD4;GLUL;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;MVD;B4GAT1;POLL;ZNF692;ZNF704;ITGA6;HAGH;DNMT3A;DNPH1;TMEM173;PRNP;SRD5A3;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;MKNK2;WWTR1;DNAJB5;BCL6;UCKL1;PFKFB2;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;VANGL2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;ZDHHC1;MAPK3;ETV5;DHTKD1;DVL1;ENTPD2;GALK1;MTA1;LHPP;ADCY6;L3MBTL1;LTA4H;WIPI2;MBD1;PHGDH;ST3GAL3;FHOD1;HES1;BRD3;FURIN;MLXIPL;ZNF624;NAGS;MBOAT7;ARHGAP22;NADK;ABCA2;TK2;ZNF414;LY6K;ADA;PYCR2;PIDD1;PHF21A;CELSR2;PFKL;ZFP36;ETV4;FGFR3;PITPNM1;ZNF862;ZMYM3;KIAA1549;NUDT10;DGUOK;CYFIP2;RPS6KA5;HBEGF;MAP2K2;PI4K2A;DAP;FGFR4;PMVK;MDGA1;XYLT2;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;LDLR;PTOV1;SOX13;ABHD17C;TRPV4;PIGZ;BHLHE40;EIF4EBP3;ZNF80;PHLDA1;EEF2K;MSLN;HMGA2;ELK3;DGKQ;PEX7;HK1;NMRAL1;ZXDC;CHST6;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;HMGCL;GUK1;SUFU;PTAFR;RFNG;IMPA2;ZNF446;RXRA;PCK2;PCSK1;NEO1;MUC19;USP21;PRKCZ;ADAMTS13;ZDHHC24;HLTF;BCORL1;INPP5D;ZNF485;LSM14B;PDK2;SRSF5;ZNF160;RFXANK;TEF;SMOX;SMARCD2;AGO4;FGFR1;PIN1;MAN1B1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;PPP1R13L;ASS1;ZNF554;JARID2;SESN2;TSTA3;RXRB;PNRC1;MAPRE3;LCAT;GUCA1B;GAL3ST4;PTMS;PITPNM3;OR7D2;PIGV;PIGQ;GSTT1;ZFP41;PPM1F;SBF1;VEGFB;ACVR1B;MEF2B;ZSCAN30;GSS;ADORA2B;CCDC85B;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;ACP6;GPD1L;SSBP2;RPL39L;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;EIF4G3;ZNF710;ABHD14B;AGPAT4;RSAD1;RFX2;RNF187;PYCARD;MAP2K3;PNPO;POMT1;TRERF1;THAP8;DDN;ERN1;ZNF319;PRIMPOL;MOCS1;GLI4;SLC2A1;CPNE7;MLYCD;TAZ;JAK3;LITAF;MZF1;NEIL1;FUK;RARG;ING4;EIF4E3;PBXIP1;EREG;PPCS;GSTM2;ZNF514;WDR18;ADAMTSL4;TRNP1;ZNF837;POLM;NDST2;AGPAT3;RPL13A;RGS12;ALG12;MIF
171,GO:0000377,0.999999999467072,4.38311520090115e-09,4,298,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,DHX32;SRSF5;WDR83;UBL5
183,GO:0000398,0.999999999467072,4.38311520090115e-09,4,298,mRNA splicing, via spliceosome,BP,DHX32;SRSF5;WDR83;UBL5
170,GO:0000375,0.999999999591689,3.39041284242694e-09,4,301,RNA splicing, via transesterification reactions,BP,DHX32;SRSF5;WDR83;UBL5
10778,GO:0044271,0.999999999639382,6.25646763955389e-10,286,3956,cellular nitrogen compound biosynthetic process,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;IDH2;WWC3;NT5E;CITED4;NAPRT;RAPGEF3;TCFL5;PGM1;XDH;PRDX5;MEF2D;NOS1;ZFP36L1;GRB7;NR1D1;POLD4;RBCK1;EPAS1;IGF2;NFATC4;NME4;MAPK13;EGFR;TIMP2;TSC22D1;ACOT7;TCEA2;UROS;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;CERS4;ABCG1;PIK3R2;OPLAH;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;NMRK1;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;OGDHL;PKD2;ABTB1;H2AFJ;PTHLH;CDKN1C;SALL2;MSRB2;PAK6;HEXB;FOXQ1;LTB4R2;UNK;ATP2B4;GGT1;TFDP2;ACP5;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;POLL;ZNF692;ZNF704;ITGA6;HAGH;DNMT3A;DNPH1;TMEM173;PRNP;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;MKNK2;WWTR1;DNAJB5;BCL6;UCKL1;PFKFB2;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;MAPK3;ETV5;DHTKD1;DVL1;ENTPD2;GALK1;MTA1;LHPP;ADCY6;L3MBTL1;MBD1;FHOD1;HES1;BRD3;FURIN;MLXIPL;ZNF624;NAGS;ARHGAP22;NADK;ABCA2;TK2;ZNF414;ADA;PIDD1;PHF21A;CELSR2;PFKL;ZFP36;ETV4;ZNF862;ZMYM3;KIAA1549;NUDT10;DGUOK;CYFIP2;RPS6KA5;MAP2K2;DAP;FGFR4;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;BHLHE40;EIF4EBP3;ZNF80;EEF2K;HMGA2;ELK3;DGKQ;HK1;NMRAL1;ZXDC;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;GUK1;SUFU;PTAFR;ZNF446;RXRA;PCSK1;NEO1;USP21;PRKCZ;HLTF;BCORL1;ZNF485;LSM14B;SRSF5;ZNF160;RFXANK;TEF;SMOX;SMARCD2;AGO4;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;PPP1R13L;ASS1;ZNF554;JARID2;SESN2;TSTA3;RXRB;PNRC1;MAPRE3;GUCA1B;OR7D2;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;GSS;ADORA2B;CCDC85B;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;RPL39L;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;EIF4G3;ZNF710;ABHD14B;RSAD1;RFX2;RNF187;PYCARD;MAP2K3;PNPO;TRERF1;THAP8;DDN;ERN1;ZNF319;PRIMPOL;GLI4;TAZ;LITAF;MZF1;NEIL1;FUK;RARG;ING4;EIF4E3;PBXIP1;EREG;PPCS;ZNF514;TRNP1;ZNF837;POLM;RPL13A;RGS12
8769,GO:0034470,0.999999999834896,9.87623973648581e-10,7,396,ncRNA processing,BP,CSNK1E;ISG20;RRNAD1;AGO4;TUT1;WDR18;RPL13A
2882,GO:0006397,0.999999999860283,6.87989822538829e-10,10,439,mRNA processing,BP,ZFP36L1;ADARB1;DHX32;PRKACA;PAN2;SRSF5;WDR83;TUT1;ERN1;UBL5
3793,GO:0008380,0.999999999951513,3.36295310170465e-10,7,391,RNA splicing,BP,DHX32;MAPKBP1;AHNAK2;SRSF5;WDR83;ERN1;UBL5
15949,GO:0080129,0.999999999975162,0.91833288529412,0,1,proteasome core complex assembly,BP,
7843,GO:0032415,0.999999999975475,0.733890278533087,0,3,regulation of sodium:proton antiporter activity,BP,
2120,GO:0004918,0.999999999976627,0.901509797709047,0,1,interleukin-8 receptor activity,MF,
6305,GO:0019959,0.999999999976627,0.901509797709047,0,1,interleukin-8 binding,MF,
9690,GO:0038112,0.999999999976627,0.901509797709047,0,1,interleukin-8-mediated signaling pathway,BP,
7410,GO:0031515,0.999999999978298,0.735379759029187,0,3,tRNA (m1A) methyltransferase complex,CC,
14060,GO:0060913,0.999999999978575,0.901381637884177,0,1,cardiac cell fate determination,BP,
15374,GO:0071657,0.999999999978575,0.901381637884177,0,1,positive regulation of granulocyte colony-stimulating factor production,BP,
17574,GO:1901258,0.999999999978575,0.901381637884177,0,1,positive regulation of macrophage colony-stimulating factor production,BP,
18560,GO:1903837,0.999999999978969,0.901518331615068,0,1,regulation of mRNA 3'-UTR binding,BP,
18561,GO:1903839,0.999999999978969,0.901518331615068,0,1,positive regulation of mRNA 3'-UTR binding,BP,
834,GO:0002135,0.999999999979033,0.901447209710592,0,1,CTP binding,MF,
5814,GO:0017098,0.999999999979033,0.901447209710592,0,1,sulfonylurea receptor binding,MF,
17624,GO:1901388,0.999999999979033,0.901447209710592,0,1,regulation of transforming growth factor beta activation,BP,
17625,GO:1901389,0.999999999979033,0.901447209710592,0,1,negative regulation of transforming growth factor beta activation,BP,
18480,GO:1903659,0.999999999979033,0.901447209710592,0,1,regulation of complement-dependent cytotoxicity,BP,
18481,GO:1903660,0.999999999979033,0.901447209710592,0,1,negative regulation of complement-dependent cytotoxicity,BP,
19634,GO:1990913,0.999999999979033,0.901447209710592,0,1,sperm head plasma membrane,CC,
19635,GO:1990917,0.999999999979033,0.901447209710592,0,1,ooplasm,CC,
14644,GO:0070278,0.999999999979969,0.812816821642292,0,2,extracellular matrix constituent secretion,BP,
13666,GO:0060244,0.999999999980083,0.735260624115419,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
15044,GO:0071034,0.999999999980583,0.67220518889881,0,4,CUT catabolic process,BP,
15048,GO:0071043,0.999999999980583,0.67220518889881,0,4,CUT metabolic process,BP,
13503,GO:0055108,0.999999999980717,0.903485394444259,0,1,Golgi to transport vesicle transport,BP,
19480,GO:1990386,0.999999999980717,0.903485394444259,0,1,mitotic cleavage furrow ingression,BP,
19540,GO:1990583,0.999999999980717,0.903485394444259,0,1,phospholipase D activator activity,MF,
8485,GO:0033678,0.999999999980731,0.901389802738545,0,1,5'-3' DNA/RNA helicase activity,MF,
8489,GO:0033682,0.999999999980731,0.901389802738545,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
18230,GO:1903094,0.999999999980892,0.842854715873864,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19732,GO:2000157,0.999999999980892,0.842854715873864,0,2,negative regulation of ubiquitin-specific protease activity,BP,
19239,GO:1905449,0.99999999998163,0.815288101993262,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19240,GO:1905451,0.99999999998163,0.815288101993262,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
14332,GO:0061574,0.999999999981839,0.734441916474909,0,3,ASAP complex,CC,
17982,GO:1902480,0.999999999982084,0.901586958513356,0,1,protein localization to mitotic spindle,BP,
16881,GO:0098871,0.999999999982269,0.906460572875089,0,1,postsynaptic actin cytoskeleton,CC,
17045,GO:0099571,0.999999999982269,0.906460572875089,0,1,postsynaptic cytoskeleton,CC,
15433,GO:0071798,0.999999999982341,0.819906799754368,0,2,response to prostaglandin D,BP,
15434,GO:0071799,0.999999999982341,0.819906799754368,0,2,cellular response to prostaglandin D stimulus,BP,
6960,GO:0030627,0.999999999982432,0.825504691797898,0,2,pre-mRNA 5'-splice site binding,MF,
11081,GO:0045112,0.999999999982471,0.758119253649877,0,3,integrin biosynthetic process,BP,
7947,GO:0032558,0.999999999982473,0.753088417663179,0,3,adenyl deoxyribonucleotide binding,MF,
7951,GO:0032564,0.999999999982473,0.753088417663179,0,3,dATP binding,MF,
11882,GO:0046933,0.999999999982491,0.768922161523523,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
6349,GO:0021540,0.999999999982606,0.684124223858685,0,4,corpus callosum morphogenesis,BP,
17902,GO:1902255,0.999999999982756,0.798133051170677,0,3,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
8480,GO:0033668,0.999999999983026,0.672582219648692,0,4,negative regulation by symbiont of host apoptotic process,BP,
13274,GO:0052041,0.999999999983026,0.672582219648692,0,4,negative regulation by symbiont of host programmed cell death,BP,
13328,GO:0052490,0.999999999983026,0.672582219648692,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
1822,GO:0004479,0.999999999983229,0.901378899784941,0,1,methionyl-tRNA formyltransferase activity,MF,
6314,GO:0019988,0.999999999983229,0.901378899784941,0,1,charged-tRNA amino acid modification,BP,
15517,GO:0071951,0.999999999983229,0.901378899784941,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
17785,GO:1901917,0.999999999983229,0.901378899784941,0,1,regulation of exoribonuclease activity,BP,
17786,GO:1901919,0.999999999983229,0.901378899784941,0,1,positive regulation of exoribonuclease activity,BP,
19337,GO:1905779,0.999999999983229,0.901378899784941,0,1,positive regulation of exonuclease activity,BP,
848,GO:0002176,0.99999999998324,0.766346655865779,0,3,male germ cell proliferation,BP,
9456,GO:0036093,0.99999999998324,0.766346655865779,0,3,germ cell proliferation,BP,
2060,GO:0004817,0.999999999983277,0.815209523555857,0,2,cysteine-tRNA ligase activity,MF,
2905,GO:0006423,0.999999999983277,0.815209523555857,0,2,cysteinyl-tRNA aminoacylation,BP,
3036,GO:0006597,0.999999999983373,0.81706866084626,0,2,spermine biosynthetic process,BP,
1621,GO:0004060,0.999999999983475,0.903203171214426,0,1,arylamine N-acetyltransferase activity,MF,
3768,GO:0008331,0.999999999983509,0.73504071337064,0,3,high voltage-gated calcium channel activity,MF,
8371,GO:0033291,0.999999999983693,0.939604190129371,0,1,eukaryotic 80S initiation complex,CC,
8766,GO:0034463,0.999999999983693,0.939604190129371,0,1,90S preribosome assembly,BP,
8600,GO:0034128,0.999999999983919,0.660094340163777,0,4,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
11207,GO:0045359,0.999999999983919,0.660094340163777,0,4,positive regulation of interferon-beta biosynthetic process,BP,
15059,GO:0071072,0.999999999984017,0.660090652272207,0,4,negative regulation of phospholipid biosynthetic process,BP,
16481,GO:0097210,0.999999999984032,0.733360679814821,0,3,response to gonadotropin-releasing hormone,BP,
16482,GO:0097211,0.999999999984032,0.733360679814821,0,3,cellular response to gonadotropin-releasing hormone,BP,
1630,GO:0004075,0.999999999984209,0.732388128583976,0,3,biotin carboxylase activity,MF,
1028,GO:0002536,0.999999999984234,0.834285984700954,0,2,respiratory burst involved in inflammatory response,BP,
13679,GO:0060264,0.999999999984234,0.834285984700954,0,2,regulation of respiratory burst involved in inflammatory response,BP,
13681,GO:0060266,0.999999999984234,0.834285984700954,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
8396,GO:0033385,0.999999999984355,0.901377980428519,0,1,geranylgeranyl diphosphate metabolic process,BP,
8397,GO:0033386,0.999999999984355,0.901377980428519,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
12730,GO:0051024,0.999999999984444,0.675262132332188,0,4,positive regulation of immunoglobulin secretion,BP,
2560,GO:0005850,0.999999999984903,0.660118100459828,0,4,eukaryotic translation initiation factor 2 complex,CC,
15887,GO:0072687,0.999999999984987,0.662322976991489,0,4,meiotic spindle,CC,
1764,GO:0004372,0.999999999985223,0.813228397168094,0,2,glycine hydroxymethyltransferase activity,MF,
2042,GO:0004793,0.999999999985223,0.813228397168094,0,2,threonine aldolase activity,MF,
2992,GO:0006545,0.999999999985223,0.813228397168094,0,2,glycine biosynthetic process,BP,
3952,GO:0008732,0.999999999985223,0.813228397168094,0,2,L-allo-threonine aldolase activity,MF,
6082,GO:0019264,0.999999999985223,0.813228397168094,0,2,glycine biosynthetic process from serine,BP,
14828,GO:0070618,0.999999999985241,0.901384941737383,0,1,Grb2-Sos complex,CC,
2052,GO:0004807,0.999999999985315,0.910243492794286,0,1,triose-phosphate isomerase activity,MF,
17630,GO:1901474,0.999999999985334,0.664333074176523,0,4,azole transmembrane transporter activity,MF,
15322,GO:0071579,0.999999999985365,0.903216989761677,0,1,regulation of zinc ion transport,BP,
15323,GO:0071580,0.999999999985365,0.903216989761677,0,1,regulation of zinc ion transmembrane transport,BP,
15324,GO:0071581,0.999999999985365,0.903216989761677,0,1,regulation of zinc ion transmembrane import,BP,
15325,GO:0071582,0.999999999985365,0.903216989761677,0,1,negative regulation of zinc ion transport,BP,
15326,GO:0071583,0.999999999985365,0.903216989761677,0,1,negative regulation of zinc ion transmembrane transport,BP,
15327,GO:0071584,0.999999999985365,0.903216989761677,0,1,negative regulation of zinc ion transmembrane import,BP,
15328,GO:0071585,0.999999999985365,0.903216989761677,0,1,detoxification of cadmium ion,BP,
19440,GO:1990170,0.999999999985365,0.903216989761677,0,1,stress response to cadmium ion,BP,
14291,GO:0061474,0.999999999985387,0.901447989635504,0,1,phagolysosome membrane,CC,
1820,GO:0004477,0.999999999985399,0.66084081794047,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1829,GO:0004488,0.999999999985399,0.66084081794047,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
12732,GO:0051026,0.99999999998543,0.665348940991618,0,4,chiasma assembly,BP,
20262,GO:2001271,0.999999999985436,0.73367276943887,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
17685,GO:1901622,0.999999999985598,0.901421682190022,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
6655,GO:0030020,0.999999999985777,0.732413696389898,0,3,extracellular matrix structural constituent conferring tensile strength,MF,
20198,GO:2001168,0.999999999985782,0.660193285828947,0,4,positive regulation of histone H2B ubiquitination,BP,
10700,GO:0044036,0.999999999985803,0.742063886060951,0,3,cell wall macromolecule metabolic process,BP,
15306,GO:0071554,0.999999999985803,0.742063886060951,0,3,cell wall organization or biogenesis,BP,
3631,GO:0008108,0.999999999985847,0.912656915014172,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
5306,GO:0016034,0.999999999985847,0.912656915014172,0,1,maleylacetoacetate isomerase activity,MF,
17087,GO:0101030,0.999999999985847,0.912656915014172,0,1,tRNA-guanine transglycosylation,BP,
17971,GO:1902455,0.999999999985887,0.660091400958734,0,4,negative regulation of stem cell population maintenance,BP,
15491,GO:0071898,0.999999999985922,0.7389746120586,0,3,regulation of estrogen receptor binding,BP,
15492,GO:0071899,0.999999999985922,0.7389746120586,0,3,negative regulation of estrogen receptor binding,BP,
14978,GO:0070934,0.999999999985935,0.665467468368845,0,4,CRD-mediated mRNA stabilization,BP,
11960,GO:0047290,0.999999999985998,0.907125633136425,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
12699,GO:0050966,0.999999999986058,0.813774725587274,0,2,detection of mechanical stimulus involved in sensory perception of pain,BP,
10744,GO:0044208,0.999999999986082,0.820135091798597,0,2,'de novo' AMP biosynthetic process,BP,
17632,GO:1901490,0.999999999986237,0.66112971028506,0,4,regulation of lymphangiogenesis,BP,
19062,GO:1904990,0.999999999986318,0.90156580362969,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19063,GO:1904992,0.999999999986318,0.90156580362969,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
2892,GO:0006407,0.999999999986346,0.75439633352027,0,3,rRNA export from nucleus,BP,
14687,GO:0070345,0.999999999986394,0.660150146957569,0,4,negative regulation of fat cell proliferation,BP,
4875,GO:0014805,0.999999999986575,0.69256470382041,0,4,smooth muscle adaptation,BP,
1558,GO:0003962,0.999999999986616,0.905801915534724,0,1,cystathionine gamma-synthase activity,MF,
1661,GO:0004123,0.999999999986616,0.905801915534724,0,1,cystathionine gamma-lyase activity,MF,
5934,GO:0018272,0.999999999986616,0.905801915534724,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
9352,GO:0035887,0.999999999986616,0.905801915534724,0,1,aortic smooth muscle cell differentiation,BP,
10900,GO:0044524,0.999999999986616,0.905801915534724,0,1,protein sulfhydration,BP,
10907,GO:0044540,0.999999999986616,0.905801915534724,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
12032,GO:0047982,0.999999999986616,0.905801915534724,0,1,homocysteine desulfhydrase activity,MF,
15127,GO:0071266,0.999999999986616,0.905801915534724,0,1,'de novo' L-methionine biosynthetic process,BP,
15953,GO:0080146,0.999999999986616,0.905801915534724,0,1,L-cysteine desulfhydrase activity,MF,
18983,GO:1904829,0.999999999986616,0.905801915534724,0,1,regulation of aortic smooth muscle cell differentiation,BP,
18984,GO:1904831,0.999999999986616,0.905801915534724,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
12014,GO:0047750,0.999999999986711,0.844667262207924,0,2,cholestenol delta-isomerase activity,MF,
15688,GO:0072272,0.999999999986764,0.81534532663522,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
19161,GO:1905271,0.999999999986775,0.931489848778243,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
19162,GO:1905273,0.999999999986775,0.931489848778243,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
18222,GO:1903070,0.999999999986816,0.741050472966554,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
8358,GO:0033269,0.999999999986836,0.813016423273589,0,2,internode region of axon,CC,
9223,GO:0035633,0.999999999986836,0.813016423273589,0,2,maintenance of permeability of blood-brain barrier,BP,
18908,GO:1904685,0.999999999986836,0.813016423273589,0,2,positive regulation of metalloendopeptidase activity,BP,
19652,GO:1990983,0.999999999986883,0.901419989204677,0,1,tRNA demethylation,BP,
19653,GO:1990984,0.999999999986883,0.901419989204677,0,1,tRNA demethylase activity,MF,
218,GO:0000455,0.999999999986902,0.816965775525562,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
13022,GO:0051538,0.999999999986916,0.745028846577913,0,3,3 iron, 4 sulfur cluster binding,MF,
11501,GO:0046038,0.999999999986984,0.91106152103202,0,1,GMP catabolic process,BP,
13359,GO:0052657,0.999999999986984,0.91106152103202,0,1,guanine phosphoribosyltransferase activity,MF,
346,GO:0000960,0.999999999986999,0.660184435213906,0,4,regulation of mitochondrial RNA catabolic process,BP,
7391,GO:0031466,0.999999999987021,0.689608751675552,0,4,Cul5-RING ubiquitin ligase complex,CC,
3220,GO:0006880,0.999999999987024,0.764016489753461,0,3,intracellular sequestering of iron ion,BP,
16645,GO:0097577,0.999999999987024,0.764016489753461,0,3,sequestering of iron ion,BP,
2680,GO:0006050,0.999999999987093,0.908206388338455,0,1,mannosamine metabolic process,BP,
2681,GO:0006051,0.999999999987093,0.908206388338455,0,1,N-acetylmannosamine metabolic process,BP,
11090,GO:0045127,0.999999999987093,0.908206388338455,0,1,N-acetylglucosamine kinase activity,MF,
2223,GO:0005131,0.999999999987165,0.660676663516818,0,4,growth hormone receptor binding,MF,
3086,GO:0006667,0.999999999987203,0.815131066063951,0,2,sphinganine metabolic process,BP,
11006,GO:0044861,0.999999999987203,0.815131066063951,0,2,protein transport into plasma membrane raft,BP,
11691,GO:0046511,0.999999999987203,0.815131066063951,0,2,sphinganine biosynthetic process,BP,
18298,GO:1903279,0.999999999987203,0.815131066063951,0,2,regulation of calcium:sodium antiporter activity,BP,
18299,GO:1903281,0.999999999987203,0.815131066063951,0,2,positive regulation of calcium:sodium antiporter activity,BP,
7634,GO:0032057,0.999999999987243,0.663583622470108,0,4,negative regulation of translational initiation in response to stress,BP,
8420,GO:0033553,0.999999999987247,0.664017948229704,0,4,rDNA heterochromatin,CC,
1894,GO:0004582,0.999999999987251,0.783000689598077,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
8324,GO:0033185,0.999999999987251,0.783000689598077,0,3,dolichol-phosphate-mannose synthase complex,CC,
172,GO:0000379,0.999999999987271,0.735646883220874,0,3,tRNA-type intron splice site recognition and cleavage,BP,
19641,GO:1990930,0.999999999987334,0.908255066122379,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
8387,GO:0033342,0.999999999987433,0.901463941905003,0,1,negative regulation of collagen binding,BP,
11197,GO:0045349,0.99999999998745,0.670735872259728,0,4,interferon-alpha biosynthetic process,BP,
11202,GO:0045354,0.99999999998745,0.670735872259728,0,4,regulation of interferon-alpha biosynthetic process,BP,
13325,GO:0052428,0.999999999987461,0.680488524187981,0,4,modulation by host of symbiont molecular function,BP,
17405,GO:1900195,0.999999999987469,0.815221699468442,0,2,positive regulation of oocyte maturation,BP,
13889,GO:0060574,0.999999999987541,0.674075226144382,0,4,intestinal epithelial cell maturation,BP,
7098,GO:0030906,0.999999999987575,0.672498550686895,0,4,retromer, cargo-selective complex,CC,
3887,GO:0008534,0.999999999987582,0.695229432413705,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
17609,GO:1901355,0.999999999987639,0.813390465558866,0,2,response to rapamycin,BP,
19307,GO:1905661,0.999999999987639,0.813390465558866,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
19308,GO:1905663,0.999999999987639,0.813390465558866,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
14028,GO:0060830,0.999999999987653,0.749370645536651,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
15899,GO:0072714,0.999999999987735,0.905858217202629,0,1,response to selenite ion,BP,
15900,GO:0072715,0.999999999987735,0.905858217202629,0,1,cellular response to selenite ion,BP,
18860,GO:1904569,0.999999999987735,0.905858217202629,0,1,regulation of selenocysteine incorporation,BP,
18861,GO:1904570,0.999999999987735,0.905858217202629,0,1,negative regulation of selenocysteine incorporation,BP,
18862,GO:1904572,0.999999999987735,0.905858217202629,0,1,negative regulation of mRNA binding,BP,
18863,GO:1904573,0.999999999987735,0.905858217202629,0,1,regulation of selenocysteine insertion sequence binding,BP,
18864,GO:1904574,0.999999999987735,0.905858217202629,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
19144,GO:1905215,0.999999999987735,0.905858217202629,0,1,negative regulation of RNA binding,BP,
11722,GO:0046581,0.999999999987789,0.661573835905055,0,4,intercellular canaliculus,CC,
12027,GO:0047915,0.999999999987807,0.906625658213065,0,1,ganglioside galactosyltransferase activity,MF,
1898,GO:0004587,0.999999999987841,0.90345143854346,0,1,ornithine-oxo-acid transaminase activity,MF,
4390,GO:0010121,0.999999999987841,0.90345143854346,0,1,arginine catabolic process to proline via ornithine,BP,
6150,GO:0019493,0.999999999987841,0.90345143854346,0,1,arginine catabolic process to proline,BP,
6168,GO:0019544,0.999999999987841,0.90345143854346,0,1,arginine catabolic process to glutamate,BP,
11924,GO:0047021,0.999999999987859,0.914726852528129,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12432,GO:0050221,0.999999999987859,0.914726852528129,0,1,prostaglandin-E2 9-reductase activity,MF,
777,GO:0002036,0.999999999987929,0.661392832608188,0,4,regulation of L-glutamate import across plasma membrane,BP,
4763,GO:0010958,0.999999999987929,0.661392832608188,0,4,regulation of amino acid import across plasma membrane,BP,
19820,GO:2000319,0.999999999987963,0.661587405236603,0,4,regulation of T-helper 17 cell differentiation,BP,
6160,GO:0019530,0.999999999988074,0.660093667717354,0,4,taurine metabolic process,BP,
6194,GO:0019694,0.999999999988074,0.660093667717354,0,4,alkanesulfonate metabolic process,BP,
11060,GO:0045079,0.999999999988148,0.90672345937712,0,1,negative regulation of chemokine biosynthetic process,BP,
9182,GO:0035582,0.999999999988157,0.737470862648026,0,3,sequestering of BMP in extracellular matrix,BP,
6704,GO:0030124,0.999999999988179,0.66838267904549,0,4,AP-4 adaptor complex,CC,
1619,GO:0004056,0.999999999988197,0.903373633964946,0,1,argininosuccinate lyase activity,MF,
10002,GO:0042450,0.999999999988197,0.903373633964946,0,1,arginine biosynthetic process via ornithine,BP,
14046,GO:0060872,0.999999999988204,0.665716212776376,0,4,semicircular canal development,BP,
16548,GO:0097368,0.999999999988217,0.744831896219579,0,3,establishment of Sertoli cell barrier,BP,
8948,GO:0035034,0.999999999988252,0.813722362303014,0,2,histone acetyltransferase regulator activity,MF,
16295,GO:0090521,0.999999999988283,0.660091032159261,0,4,glomerular visceral epithelial cell migration,BP,
4768,GO:0010963,0.999999999988288,0.910430490123247,0,1,regulation of L-arginine import,BP,
14989,GO:0070947,0.999999999988288,0.910430490123247,0,1,neutrophil mediated killing of fungus,BP,
14994,GO:0070953,0.999999999988288,0.910430490123247,0,1,regulation of neutrophil mediated killing of fungus,BP,
14999,GO:0070965,0.999999999988288,0.910430490123247,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
19943,GO:2000552,0.999999999988288,0.910430490123247,0,1,negative regulation of T-helper 2 cell cytokine production,BP,
9236,GO:0035658,0.999999999988289,0.733993739819165,0,3,Mon1-Ccz1 complex,CC,
15809,GO:0072540,0.999999999988289,0.733993739819165,0,3,T-helper 17 cell lineage commitment,BP,
5609,GO:0016672,0.999999999988291,0.843007225294466,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
11112,GO:0045174,0.999999999988291,0.843007225294466,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
12480,GO:0050610,0.999999999988291,0.843007225294466,0,2,methylarsonate reductase activity,MF,
5914,GO:0018199,0.999999999988298,0.66528977397438,0,4,peptidyl-glutamine modification,BP,
2199,GO:0005087,0.999999999988318,0.68398818205597,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
9981,GO:0042414,0.999999999988322,0.814910711474818,0,2,epinephrine metabolic process,BP,
11780,GO:0046684,0.999999999988322,0.814910711474818,0,2,response to pyrethroid,BP,
11589,GO:0046294,0.999999999988331,0.825499115527425,0,2,formaldehyde catabolic process,BP,
1608,GO:0004034,0.999999999988334,0.901506248874538,0,1,aldose 1-epimerase activity,MF,
9382,GO:0035945,0.999999999988334,0.901506248874538,0,1,mitochondrial ncRNA surveillance,BP,
9383,GO:0035946,0.999999999988334,0.901506248874538,0,1,mitochondrial mRNA surveillance,BP,
15037,GO:0071026,0.999999999988334,0.901506248874538,0,1,cytoplasmic RNA surveillance,BP,
20106,GO:2000827,0.999999999988334,0.901506248874538,0,1,mitochondrial RNA surveillance,BP,
1796,GO:0004441,0.999999999988355,0.902736442348402,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
13399,GO:0052829,0.999999999988355,0.902736442348402,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
7079,GO:0030885,0.999999999988365,0.752552543985686,0,3,regulation of myeloid dendritic cell activation,BP,
1411,GO:0003350,0.999999999988375,0.813103595291462,0,2,pulmonary myocardium development,BP,
13603,GO:0060126,0.999999999988375,0.813103595291462,0,2,somatotropin secreting cell differentiation,BP,
5487,GO:0016435,0.999999999988376,0.685859832638212,0,4,rRNA (guanine) methyltransferase activity,MF,
10595,GO:0043602,0.999999999988497,0.901479119247716,0,1,nitrate catabolic process,BP,
11582,GO:0046210,0.999999999988497,0.901479119247716,0,1,nitric oxide catabolic process,BP,
12011,GO:0047726,0.999999999988497,0.901479119247716,0,1,iron-cytochrome-c reductase activity,MF,
16251,GO:0090345,0.999999999988497,0.901479119247716,0,1,cellular organohalogen metabolic process,BP,
16252,GO:0090346,0.999999999988497,0.901479119247716,0,1,cellular organofluorine metabolic process,BP,
11176,GO:0045298,0.999999999988516,0.677685526023787,0,4,tubulin complex,CC,
18344,GO:1903371,0.999999999988539,0.660528285725652,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
8931,GO:0034991,0.999999999988568,0.812929758095317,0,2,nuclear meiotic cohesin complex,CC,
3960,GO:0008768,0.999999999988578,0.924429588410909,0,1,UDP-sugar diphosphatase activity,MF,
3745,GO:0008295,0.999999999988616,0.673701236136048,0,4,spermidine biosynthetic process,BP,
17317,GO:1900028,0.999999999988617,0.66532493455432,0,4,negative regulation of ruffle assembly,BP,
3005,GO:0006558,0.99999999998868,0.693711888044414,0,4,L-phenylalanine metabolic process,BP,
3006,GO:0006559,0.99999999998868,0.693711888044414,0,4,L-phenylalanine catabolic process,BP,
17884,GO:1902221,0.99999999998868,0.693711888044414,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
17885,GO:1902222,0.99999999998868,0.693711888044414,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
15875,GO:0072674,0.999999999988768,0.660883453014983,0,4,multinuclear osteoclast differentiation,BP,
15876,GO:0072675,0.999999999988768,0.660883453014983,0,4,osteoclast fusion,BP,
15026,GO:0071006,0.99999999998878,0.732913513219994,0,3,U2-type catalytic step 1 spliceosome,CC,
8033,GO:0032696,0.999999999988844,0.734027179964109,0,3,negative regulation of interleukin-13 production,BP,
11761,GO:0046642,0.999999999988844,0.734027179964109,0,3,negative regulation of alpha-beta T cell proliferation,BP,
4808,GO:0014012,0.999999999988859,0.679221968427364,0,4,peripheral nervous system axon regeneration,BP,
12185,GO:0048386,0.999999999988998,0.660972048765222,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
11481,GO:0045988,0.999999999989081,0.733892997559579,0,3,negative regulation of striated muscle contraction,BP,
13507,GO:0055118,0.999999999989081,0.733892997559579,0,3,negative regulation of cardiac muscle contraction,BP,
16391,GO:0097056,0.999999999989092,0.666808923457191,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
15151,GO:0071314,0.999999999989137,0.90137798716576,0,1,cellular response to cocaine,BP,
17942,GO:1902362,0.999999999989137,0.90137798716576,0,1,melanocyte apoptotic process,BP,
19009,GO:1904879,0.999999999989176,0.81281791194268,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
5698,GO:0016838,0.999999999989221,0.832657494346846,0,2,carbon-oxygen lyase activity, acting on phosphates,MF,
16448,GO:0097158,0.999999999989306,0.907184509080781,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
9148,GO:0035519,0.999999999989332,0.694621015738306,0,4,protein K29-linked ubiquitination,BP,
10804,GO:0044314,0.999999999989332,0.694621015738306,0,4,protein K27-linked ubiquitination,BP,
12629,GO:0050859,0.999999999989355,0.735184042873965,0,3,negative regulation of B cell receptor signaling pathway,BP,
9142,GO:0035513,0.99999999998936,0.665158958938928,0,4,oxidative RNA demethylation,BP,
9144,GO:0035515,0.99999999998936,0.665158958938928,0,4,oxidative RNA demethylase activity,MF,
5688,GO:0016822,0.9999999999894,0.825336412375342,0,2,hydrolase activity, acting on acid carbon-carbon bonds,MF,
5689,GO:0016823,0.9999999999894,0.825336412375342,0,2,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
9104,GO:0035425,0.999999999989413,0.735599440162637,0,3,autocrine signaling,BP,
1499,GO:0003847,0.999999999989432,0.686512539855337,0,4,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
3634,GO:0008112,0.999999999989452,0.908222593004282,0,1,nicotinamide N-methyltransferase activity,MF,
7011,GO:0030760,0.999999999989452,0.908222593004282,0,1,pyridine N-methyltransferase activity,MF,
1942,GO:0004649,0.999999999989459,0.817093300216521,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
1626,GO:0004066,0.999999999989497,0.812975902687061,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
2978,GO:0006529,0.999999999989497,0.812975902687061,0,2,asparagine biosynthetic process,BP,
3864,GO:0008503,0.999999999989523,0.836018659522356,0,2,benzodiazepine receptor activity,MF,
3890,GO:0008537,0.999999999989534,0.766006450314667,0,3,proteasome activator complex,CC,
7358,GO:0031417,0.999999999989553,0.732340917840715,0,3,NatC complex,CC,
20103,GO:2000823,0.999999999989567,0.700539714334228,0,4,regulation of androgen receptor activity,BP,
20104,GO:2000825,0.999999999989567,0.700539714334228,0,4,positive regulation of androgen receptor activity,BP,
13751,GO:0060364,0.999999999989569,0.661295737374173,0,4,frontal suture morphogenesis,BP,
13951,GO:0060689,0.999999999989585,0.735336266016273,0,3,cell differentiation involved in salivary gland development,BP,
14133,GO:0061043,0.999999999989585,0.735336266016273,0,3,regulation of vascular wound healing,BP,
12735,GO:0051030,0.999999999989645,0.680927589797285,0,4,snRNA transport,BP,
16625,GO:0097527,0.999999999989673,0.662493274813557,0,4,necroptotic signaling pathway,BP,
1609,GO:0004040,0.999999999989704,0.813631692095318,0,2,amidase activity,MF,
17430,GO:1900244,0.999999999989704,0.813631692095318,0,2,positive regulation of synaptic vesicle endocytosis,BP,
16431,GO:0097124,0.999999999989714,0.813079397943085,0,2,cyclin A2-CDK2 complex,CC,
7673,GO:0032133,0.999999999989727,0.670815551238104,0,4,chromosome passenger complex,CC,
8333,GO:0033204,0.999999999989736,0.901506835866987,0,1,ribonuclease P RNA binding,MF,
11187,GO:0045337,0.999999999989759,0.739135048270508,0,3,farnesyl diphosphate biosynthetic process,BP,
6664,GO:0030035,0.999999999989768,0.732333267225443,0,3,microspike assembly,BP,
10851,GO:0044393,0.999999999989768,0.732333267225443,0,3,microspike,CC,
14141,GO:0061052,0.999999999989773,0.661025387044299,0,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,
2994,GO:0006547,0.999999999989796,0.660336200947272,0,4,histidine metabolic process,BP,
13386,GO:0052803,0.999999999989796,0.660336200947272,0,4,imidazole-containing compound metabolic process,BP,
3986,GO:0008893,0.99999999998993,0.919606389121932,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
5671,GO:0016794,0.99999999998993,0.919606389121932,0,1,diphosphoric monoester hydrolase activity,MF,
15291,GO:0071532,0.999999999989933,0.660124412019015,0,4,ankyrin repeat binding,MF,
974,GO:0002428,0.999999999989941,0.752754051757174,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
19633,GO:1990911,0.99999999998997,0.814912146129023,0,2,response to psychosocial stress,BP,
16950,GO:0099022,0.999999999989998,0.818020293890043,0,2,vesicle tethering,BP,
16954,GO:0099044,0.999999999989998,0.818020293890043,0,2,vesicle tethering to endoplasmic reticulum,BP,
9978,GO:0042406,0.999999999990004,0.665281629775856,0,4,extrinsic component of endoplasmic reticulum membrane,CC,
10322,GO:0043137,0.999999999990047,0.676458337241778,0,4,DNA replication, removal of RNA primer,BP,
14792,GO:0070552,0.999999999990053,0.732882550536724,0,3,BRISC complex,CC,
14824,GO:0070611,0.999999999990174,0.901397507027666,0,1,histone methyltransferase activity (H3-R2 specific),MF,
14825,GO:0070612,0.999999999990174,0.901397507027666,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
2750,GO:0006168,0.999999999990237,0.764248727951358,0,3,adenine salvage,BP,
11527,GO:0046083,0.999999999990237,0.764248727951358,0,3,adenine metabolic process,BP,
11528,GO:0046084,0.999999999990237,0.764248727951358,0,3,adenine biosynthetic process,BP,
1812,GO:0004466,0.999999999990251,0.671576610862768,0,4,long-chain-acyl-CoA dehydrogenase activity,MF,
5815,GO:0017099,0.999999999990251,0.671576610862768,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
10101,GO:0042637,0.99999999999027,0.679405569503218,0,4,catagen,BP,
12370,GO:0048818,0.99999999999027,0.679405569503218,0,4,positive regulation of hair follicle maturation,BP,
13161,GO:0051794,0.99999999999027,0.679405569503218,0,4,regulation of timing of catagen,BP,
2002,GO:0004730,0.99999999999029,0.906836580172759,0,1,pseudouridylate synthase activity,MF,
14963,GO:0070902,0.99999999999029,0.906836580172759,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
1391,GO:0003307,0.99999999999031,0.735644244807926,0,3,regulation of Wnt signaling pathway involved in heart development,BP,
14233,GO:0061316,0.99999999999031,0.735644244807926,0,3,canonical Wnt signaling pathway involved in heart development,BP,
18035,GO:1902617,0.999999999990311,0.679678317453294,0,4,response to fluoride,BP,
14671,GO:0070320,0.999999999990318,0.901388098235645,0,1,inward rectifier potassium channel inhibitor activity,MF,
17341,GO:1900085,0.999999999990318,0.901388098235645,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18460,GO:1903596,0.999999999990318,0.901388098235645,0,1,regulation of gap junction assembly,BP,
18461,GO:1903598,0.999999999990318,0.901388098235645,0,1,positive regulation of gap junction assembly,BP,
18464,GO:1903609,0.999999999990318,0.901388098235645,0,1,negative regulation of inward rectifier potassium channel activity,BP,
4603,GO:0010730,0.99999999999034,0.73279785015784,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
8741,GO:0034421,0.99999999999034,0.73279785015784,0,3,post-translational protein acetylation,BP,
10152,GO:0042756,0.999999999990368,0.744769318953035,0,3,drinking behavior,BP,
18809,GO:1904428,0.999999999990387,0.743653776046445,0,3,negative regulation of tubulin deacetylation,BP,
16444,GO:0097154,0.999999999990508,0.674595567395888,0,4,GABAergic neuron differentiation,BP,
14407,GO:0061740,0.999999999990619,0.733723094864826,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
19508,GO:1990441,0.99999999999062,0.662386884776367,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
9585,GO:0036461,0.999999999990631,0.834442840436543,0,2,BLOC-2 complex binding,MF,
4601,GO:0010728,0.999999999990656,0.661802246467782,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
6035,GO:0019153,0.999999999990656,0.907871024376662,0,1,protein-disulfide reductase (glutathione) activity,MF,
5733,GO:0016890,0.999999999990692,0.819955339330964,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
3809,GO:0008413,0.999999999990781,0.838903709566729,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
9158,GO:0035539,0.999999999990781,0.838903709566729,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
2569,GO:0005862,0.999999999990834,0.67373616766549,0,4,muscle thin filament tropomyosin,CC,
11162,GO:0045272,0.99999999999084,0.770514576896285,0,3,plasma membrane respiratory chain complex I,CC,
8084,GO:0032783,0.999999999990907,0.673861933391956,0,4,ELL-EAF complex,CC,
1615,GO:0004047,0.999999999990912,0.82106084760325,0,2,aminomethyltransferase activity,MF,
16927,GO:0098957,0.999999999990976,0.663734195833868,0,4,anterograde axonal transport of mitochondrion,BP,
10508,GO:0043461,0.999999999990988,0.669830105949049,0,4,proton-transporting ATP synthase complex assembly,BP,
12580,GO:0050785,0.999999999991008,0.912594196770448,0,1,advanced glycation end-product receptor activity,MF,
18879,GO:1904596,0.999999999991008,0.912594196770448,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18880,GO:1904597,0.999999999991008,0.912594196770448,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18881,GO:1904599,0.999999999991008,0.912594196770448,0,1,advanced glycation end-product binding,MF,
18882,GO:1904603,0.999999999991008,0.912594196770448,0,1,regulation of advanced glycation end-product receptor activity,BP,
18883,GO:1904604,0.999999999991008,0.912594196770448,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
19137,GO:1905204,0.999999999991008,0.912594196770448,0,1,negative regulation of connective tissue replacement,BP,
4086,GO:0009149,0.999999999991016,0.829981425609731,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4142,GO:0009213,0.999999999991016,0.829981425609731,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
7945,GO:0032556,0.999999999991016,0.829981425609731,0,2,pyrimidine deoxyribonucleotide binding,MF,
19430,GO:1990136,0.999999999991029,0.901476147520953,0,1,linoleate 9S-lipoxygenase activity,MF,
6630,GO:0023025,0.999999999991118,0.813210495606809,0,2,MHC class Ib protein complex binding,MF,
6633,GO:0023030,0.999999999991118,0.813210495606809,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
18380,GO:1903435,0.99999999999113,0.901377983832105,0,1,positive regulation of constitutive secretory pathway,BP,
593,GO:0001758,0.999999999991137,0.733384976105181,0,3,retinal dehydrogenase activity,MF,
7350,GO:0031404,0.999999999991183,0.745126874477462,0,3,chloride ion binding,MF,
5907,GO:0018192,0.999999999991268,0.901544726986077,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
7869,GO:0032447,0.999999999991268,0.901544726986077,0,1,protein urmylation,BP,
9922,GO:0042292,0.999999999991268,0.901544726986077,0,1,URM1 activating enzyme activity,MF,
14344,GO:0061604,0.999999999991268,0.901544726986077,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
14345,GO:0061605,0.999999999991268,0.901544726986077,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
16855,GO:0098822,0.999999999991268,0.901544726986077,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
10648,GO:0043874,0.999999999991288,0.903223925166867,0,1,acireductone synthase activity,MF,
4428,GO:0010309,0.999999999991317,0.906737520955074,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
19532,GO:1990565,0.999999999991317,0.906737520955074,0,1,HSP90-CDC37 chaperone complex,CC,
5193,GO:0015801,0.999999999991323,0.81314576925841,0,2,aromatic amino acid transport,BP,
5214,GO:0015827,0.999999999991323,0.81314576925841,0,2,tryptophan transport,BP,
15769,GO:0072429,0.999999999991325,0.732839798222232,0,3,response to intra-S DNA damage checkpoint signaling,BP,
7943,GO:0032554,0.999999999991414,0.678799940570002,0,4,purine deoxyribonucleotide binding,MF,
1572,GO:0003985,0.999999999991512,0.739109457977178,0,3,acetyl-CoA C-acetyltransferase activity,MF,
13131,GO:0051731,0.999999999991536,0.666727683231178,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
15081,GO:0071159,0.999999999991543,0.833912509463689,0,2,NF-kappaB complex,CC,
9539,GO:0036324,0.999999999991562,0.826777068469439,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
3756,GO:0008309,0.99999999999163,0.668228392669084,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
2454,GO:0005673,0.999999999991659,0.819213936028852,0,2,transcription factor TFIIE complex,CC,
7373,GO:0031437,0.999999999991665,0.73250692926186,0,3,regulation of mRNA cleavage,BP,
18303,GO:1903286,0.999999999991671,0.737324732713408,0,3,regulation of potassium ion import,BP,
8095,GO:0032795,0.999999999991685,0.918685650639512,0,1,heterotrimeric G-protein binding,MF,
10219,GO:0042942,0.9999999999917,0.901422256464396,0,1,D-serine transport,BP,
17458,GO:1900390,0.999999999991706,0.832429557021614,0,2,regulation of iron ion import,BP,
18813,GO:1904432,0.999999999991706,0.832429557021614,0,2,regulation of ferrous iron binding,BP,
18814,GO:1904434,0.999999999991706,0.832429557021614,0,2,positive regulation of ferrous iron binding,BP,
18815,GO:1904435,0.999999999991706,0.832429557021614,0,2,regulation of transferrin receptor binding,BP,
18816,GO:1904437,0.999999999991706,0.832429557021614,0,2,positive regulation of transferrin receptor binding,BP,
2328,GO:0005350,0.999999999991717,0.813143651018849,0,2,pyrimidine nucleobase transmembrane transporter activity,MF,
5227,GO:0015855,0.999999999991717,0.813143651018849,0,2,pyrimidine nucleobase transport,BP,
14442,GO:0061833,0.999999999991717,0.813143651018849,0,2,protein localization to tricellular tight junction,BP,
18980,GO:1904823,0.999999999991717,0.813143651018849,0,2,purine nucleobase transmembrane transport,BP,
4888,GO:0014825,0.999999999991769,0.925859244681417,0,1,stomach fundus smooth muscle contraction,BP,
4901,GO:0014847,0.999999999991769,0.925859244681417,0,1,proximal stomach smooth muscle contraction,BP,
7533,GO:0031839,0.999999999991769,0.925859244681417,0,1,type 1 neuromedin U receptor binding,MF,
7534,GO:0031840,0.999999999991769,0.925859244681417,0,1,type 2 neuromedin U receptor binding,MF,
9124,GO:0035483,0.999999999991769,0.925859244681417,0,1,gastric emptying,BP,
10213,GO:0042922,0.999999999991769,0.925859244681417,0,1,neuromedin U receptor binding,MF,
10897,GO:0044495,0.999999999991769,0.925859244681417,0,1,modulation of blood pressure in other organism,BP,
10898,GO:0044497,0.999999999991769,0.925859244681417,0,1,positive regulation of blood pressure in other organism,BP,
17234,GO:0120060,0.999999999991769,0.925859244681417,0,1,regulation of gastric emptying,BP,
17235,GO:0120061,0.999999999991769,0.925859244681417,0,1,negative regulation of gastric emptying,BP,
17236,GO:0120063,0.999999999991769,0.925859244681417,0,1,stomach smooth muscle contraction,BP,
17237,GO:0120068,0.999999999991769,0.925859244681417,0,1,regulation of stomach fundus smooth muscle contraction,BP,
17238,GO:0120069,0.999999999991769,0.925859244681417,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
11863,GO:0046900,0.999999999991782,0.820048523295166,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
16471,GO:0097196,0.999999999991801,0.814642614830626,0,2,Shu complex,CC,
8772,GO:0034473,0.999999999991806,0.758192566584422,0,3,U1 snRNA 3'-end processing,BP,
8775,GO:0034476,0.999999999991806,0.758192566584422,0,3,U5 snRNA 3'-end processing,BP,
5796,GO:0017060,0.999999999991826,0.813178302814695,0,2,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
10694,GO:0044020,0.999999999991842,0.667399331227317,0,4,histone methyltransferase activity (H4-R3 specific),MF,
19454,GO:1990239,0.999999999991926,0.670135338941099,0,4,steroid hormone binding,MF,
1378,GO:0003278,0.999999999992021,0.732750513596588,0,3,apoptotic process involved in heart morphogenesis,BP,
13901,GO:0060591,0.999999999992021,0.732750513596588,0,3,chondroblast differentiation,BP,
10066,GO:0042584,0.99999999999203,0.662168711654476,0,4,chromaffin granule membrane,CC,
8303,GO:0033152,0.999999999992123,0.669458186489123,0,4,immunoglobulin V(D)J recombination,BP,
19420,GO:1990111,0.999999999992207,0.696966117697898,0,4,spermatoproteasome complex,CC,
11440,GO:0045917,0.999999999992223,0.815596672818551,0,2,positive regulation of complement activation,BP,
19783,GO:2000259,0.999999999992223,0.815596672818551,0,2,positive regulation of protein activation cascade,BP,
9543,GO:0036337,0.999999999992247,0.660375223921118,0,4,Fas signaling pathway,BP,
16868,GO:0098842,0.999999999992259,0.813654495099531,0,2,postsynaptic early endosome,CC,
1624,GO:0004064,0.999999999992325,0.74155250614367,0,3,arylesterase activity,MF,
47,GO:0000099,0.999999999992356,0.660090567965275,0,4,sulfur amino acid transmembrane transporter activity,MF,
14898,GO:0070778,0.999999999992356,0.660090567965275,0,4,L-aspartate transmembrane transport,BP,
1241,GO:0002943,0.999999999992368,0.665944780312965,0,4,tRNA dihydrouridine synthesis,BP,
5843,GO:0017150,0.999999999992368,0.665944780312965,0,4,tRNA dihydrouridine synthase activity,MF,
2977,GO:0006528,0.999999999992382,0.743057442568671,0,3,asparagine metabolic process,BP,
10167,GO:0042776,0.999999999992447,0.713323471335722,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
18238,GO:1903121,0.999999999992501,0.676797462133788,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
5410,GO:0016269,0.999999999992504,0.901495985716244,0,1,O-glycan processing, core 3,BP,
11950,GO:0047224,0.999999999992504,0.901495985716244,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
14966,GO:0070905,0.999999999992528,0.813727579130196,0,2,serine binding,MF,
5321,GO:0016062,0.999999999992551,0.901432140913662,0,1,adaptation of rhodopsin mediated signaling,BP,
9552,GO:0036367,0.999999999992551,0.901432140913662,0,1,light adaption,BP,
5942,GO:0018312,0.999999999992557,0.815148217346438,0,2,peptidyl-serine ADP-ribosylation,BP,
19488,GO:1990404,0.999999999992557,0.815148217346438,0,2,protein ADP-ribosylase activity,MF,
19495,GO:1990414,0.999999999992602,0.661492434350229,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
7421,GO:0031536,0.999999999992616,0.686439108386688,0,4,positive regulation of exit from mitosis,BP,
16013,GO:0086072,0.999999999992672,0.901520835790481,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
16021,GO:0086082,0.999999999992672,0.901520835790481,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
12936,GO:0051344,0.999999999992716,0.743364969739665,0,3,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
10018,GO:0042487,0.999999999992741,0.663142438427359,0,4,regulation of odontogenesis of dentin-containing tooth,BP,
20193,GO:2001160,0.999999999992774,0.825525828466685,0,2,regulation of histone H3-K79 methylation,BP,
20194,GO:2001162,0.999999999992774,0.825525828466685,0,2,positive regulation of histone H3-K79 methylation,BP,
6541,GO:0021979,0.999999999992798,0.67498772868694,0,4,hypothalamus cell differentiation,BP,
13532,GO:0060023,0.999999999992827,0.665579157020691,0,4,soft palate development,BP,
16722,GO:0098528,0.999999999992827,0.665579157020691,0,4,skeletal muscle fiber differentiation,BP,
3311,GO:0007023,0.999999999992849,0.687128090284514,0,4,post-chaperonin tubulin folding pathway,BP,
6248,GO:0019841,0.999999999992852,0.707695104862919,0,4,retinol binding,MF,
11778,GO:0046680,0.999999999992858,0.902739273431247,0,1,response to DDT,BP,
20075,GO:2000775,0.999999999992858,0.902739273431247,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
16480,GO:0097209,0.999999999992871,0.668892105620391,0,4,epidermal lamellar body,CC,
6472,GO:0021825,0.999999999992896,0.660183579191076,0,4,substrate-dependent cerebral cortex tangential migration,BP,
14319,GO:0061550,0.999999999992896,0.660183579191076,0,4,cranial ganglion development,BP,
17264,GO:0140059,0.999999999992896,0.660183579191076,0,4,dendrite arborization,BP,
16212,GO:0090290,0.999999999992912,0.919683990500394,0,1,positive regulation of osteoclast proliferation,BP,
14865,GO:0070682,0.999999999992916,0.739159219735079,0,3,proteasome regulatory particle assembly,BP,
12978,GO:0051429,0.999999999992981,0.741525849592093,0,3,corticotropin-releasing hormone receptor binding,MF,
2250,GO:0005169,0.999999999992985,0.830040093321367,0,2,neurotrophin TRKB receptor binding,MF,
12391,GO:0048859,0.999999999992985,0.830040093321367,0,2,formation of anatomical boundary,BP,
14762,GO:0070494,0.999999999993016,0.737357000923283,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
14763,GO:0070495,0.999999999993016,0.737357000923283,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
18028,GO:1902603,0.999999999993035,0.735489368097986,0,3,carnitine transmembrane transport,BP,
12530,GO:0050705,0.999999999993038,0.681290336918858,0,4,regulation of interleukin-1 alpha secretion,BP,
1816,GO:0004471,0.999999999993045,0.732865414728145,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1817,GO:0004473,0.999999999993045,0.732865414728145,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
18286,GO:1903237,0.999999999993059,0.925888148448561,0,1,negative regulation of leukocyte tethering or rolling,BP,
2025,GO:0004768,0.999999999993086,0.732365266386368,0,3,stearoyl-CoA 9-desaturase activity,MF,
5379,GO:0016215,0.999999999993086,0.732365266386368,0,3,acyl-CoA desaturase activity,MF,
15768,GO:0072428,0.999999999993095,0.904435302685274,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
18606,GO:1903925,0.999999999993095,0.904435302685274,0,1,response to bisphenol A,BP,
18607,GO:1903926,0.999999999993095,0.904435302685274,0,1,cellular response to bisphenol A,BP,
15094,GO:0071209,0.999999999993097,0.760124026444703,0,3,U7 snRNA binding,MF,
6505,GO:0021892,0.999999999993098,0.74763082864951,0,3,cerebral cortex GABAergic interneuron differentiation,BP,
16245,GO:0090336,0.999999999993106,0.668492260539007,0,4,positive regulation of brown fat cell differentiation,BP,
7061,GO:0030860,0.999999999993116,0.812577111914208,0,2,regulation of polarized epithelial cell differentiation,BP,
10901,GO:0044528,0.99999999999315,0.662162104971026,0,4,regulation of mitochondrial mRNA stability,BP,
9697,GO:0038129,0.999999999993168,0.812901520957602,0,2,ERBB3 signaling pathway,BP,
4371,GO:0010025,0.999999999993173,0.813651447298562,0,2,wax biosynthetic process,BP,
4402,GO:0010166,0.999999999993173,0.813651447298562,0,2,wax metabolic process,BP,
15938,GO:0080019,0.999999999993173,0.813651447298562,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17148,GO:0102965,0.999999999993173,0.813651447298562,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
3487,GO:0007387,0.99999999999318,0.901381692855322,0,1,anterior compartment pattern formation,BP,
3488,GO:0007388,0.99999999999318,0.901381692855322,0,1,posterior compartment specification,BP,
5143,GO:0015691,0.999999999993182,0.733827502912811,0,3,cadmium ion transport,BP,
14809,GO:0070574,0.999999999993182,0.733827502912811,0,3,cadmium ion transmembrane transport,BP,
16204,GO:0090281,0.999999999993182,0.733827502912811,0,3,negative regulation of calcium ion import,BP,
17334,GO:1900063,0.999999999993182,0.733827502912811,0,3,regulation of peroxisome organization,BP,
2942,GO:0006478,0.99999999999322,0.816033828909739,0,2,peptidyl-tyrosine sulfation,BP,
3849,GO:0008476,0.99999999999322,0.816033828909739,0,2,protein-tyrosine sulfotransferase activity,MF,
19975,GO:2000616,0.999999999993255,0.815113988529703,0,2,negative regulation of histone H3-K9 acetylation,BP,
16856,GO:0098826,0.999999999993267,0.660673062084239,0,4,endoplasmic reticulum tubular network membrane,CC,
8899,GO:0034756,0.99999999999327,0.750321230875595,0,3,regulation of iron ion transport,BP,
1658,GO:0004117,0.999999999993297,0.901382334307769,0,1,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
2037,GO:0004782,0.999999999993297,0.901382334307769,0,1,sulfinoalanine decarboxylase activity,MF,
3836,GO:0008455,0.999999999993297,0.901382334307769,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
3885,GO:0008531,0.999999999993297,0.901382334307769,0,1,riboflavin kinase activity,MF,
4157,GO:0009231,0.999999999993297,0.901382334307769,0,1,riboflavin biosynthetic process,BP,
4215,GO:0009398,0.999999999993297,0.901382334307769,0,1,FMN biosynthetic process,BP,
9980,GO:0042412,0.999999999993297,0.901382334307769,0,1,taurine biosynthetic process,BP,
11591,GO:0046305,0.999999999993297,0.901382334307769,0,1,alkanesulfonate biosynthetic process,BP,
11648,GO:0046444,0.999999999993297,0.901382334307769,0,1,FMN metabolic process,BP,
14599,GO:0070194,0.999999999993305,0.813325270233818,0,2,synaptonemal complex disassembly,BP,
16082,GO:0090091,0.999999999993346,0.660092693298777,0,4,positive regulation of extracellular matrix disassembly,BP,
2413,GO:0005593,0.999999999993354,0.660163106744268,0,4,FACIT collagen trimer,CC,
3594,GO:0008035,0.999999999993357,0.660441147795102,0,4,high-density lipoprotein particle binding,MF,
15817,GO:0072557,0.999999999993366,0.838707158732348,0,2,IPAF inflammasome complex,CC,
9540,GO:0036333,0.999999999993381,0.90139870013992,0,1,hepatocyte homeostasis,BP,
18955,GO:1904772,0.999999999993381,0.90139870013992,0,1,response to tetrachloromethane,BP,
5975,GO:0018879,0.999999999993385,0.813381016464713,0,2,biphenyl metabolic process,BP,
2672,GO:0006041,0.999999999993408,0.663784082617302,0,4,glucosamine metabolic process,BP,
1533,GO:0003920,0.999999999993408,0.904301110213972,0,1,GMP reductase activity,MF,
5279,GO:0015950,0.999999999993408,0.904301110213972,0,1,purine nucleotide interconversion,BP,
5280,GO:0015951,0.999999999993408,0.904301110213972,0,1,purine ribonucleotide interconversion,BP,
5602,GO:0016657,0.999999999993408,0.904301110213972,0,1,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
18011,GO:1902560,0.999999999993408,0.904301110213972,0,1,GMP reductase complex,CC,
1247,GO:0002950,0.999999999993426,0.738902346231663,0,3,ceramide phosphoethanolamine synthase activity,MF,
8326,GO:0033188,0.999999999993426,0.738902346231663,0,3,sphingomyelin synthase activity,MF,
11984,GO:0047493,0.999999999993426,0.738902346231663,0,3,ceramide cholinephosphotransferase activity,MF,
11148,GO:0045226,0.999999999993431,0.812481189823542,0,2,extracellular polysaccharide biosynthetic process,BP,
11626,GO:0046379,0.999999999993431,0.812481189823542,0,2,extracellular polysaccharide metabolic process,BP,
179,GO:0000390,0.99999999999345,0.825420295364087,0,2,spliceosomal complex disassembly,BP,
14900,GO:0070780,0.99999999999345,0.825420295364087,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
7545,GO:0031893,0.999999999993473,0.902200292115518,0,1,vasopressin receptor binding,MF,
7546,GO:0031896,0.999999999993473,0.902200292115518,0,1,V2 vasopressin receptor binding,MF,
4880,GO:0014810,0.999999999993543,0.926790038648695,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
20261,GO:2001270,0.999999999993558,0.678715085701259,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
842,GO:0002158,0.999999999993622,0.747377845238387,0,3,osteoclast proliferation,BP,
20033,GO:2000698,0.999999999993626,0.681685224736096,0,4,positive regulation of epithelial cell differentiation involved in kidney development,BP,
8866,GO:0034696,0.999999999993633,0.813703903740123,0,2,response to prostaglandin F,BP,
12125,GO:0048254,0.999999999993634,0.682591838104115,0,4,snoRNA localization,BP,
6259,GO:0019862,0.999999999993654,0.908352994896716,0,1,IgA binding,MF,
8447,GO:0033600,0.999999999993662,0.666964637848668,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
4724,GO:0010898,0.999999999993669,0.813780041189849,0,2,positive regulation of triglyceride catabolic process,BP,
11287,GO:0045627,0.999999999993745,0.740393458686099,0,3,positive regulation of T-helper 1 cell differentiation,BP,
15496,GO:0071907,0.999999999993783,0.742997259002042,0,3,determination of digestive tract left/right asymmetry,BP,
17837,GO:1902093,0.999999999993806,0.765599662378668,0,3,positive regulation of flagellated sperm motility,BP,
1725,GO:0004322,0.999999999993867,0.743494986830057,0,3,ferroxidase activity,MF,
5629,GO:0016724,0.999999999993867,0.743494986830057,0,3,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
6195,GO:0019695,0.999999999993873,0.660227477571779,0,4,choline metabolic process,BP,
11816,GO:0046790,0.999999999993895,0.738882802298526,0,3,virion binding,MF,
4203,GO:0009360,0.999999999993935,0.901383113959281,0,1,DNA polymerase III complex,CC,
1375,GO:0003273,0.999999999993944,0.73341644943532,0,3,cell migration involved in endocardial cushion formation,BP,
10360,GO:0043199,0.999999999993965,0.738946048758125,0,3,sulfate binding,MF,
5438,GO:0016320,0.999999999993965,0.823953013483215,0,2,endoplasmic reticulum membrane fusion,BP,
7702,GO:0032203,0.999999999993971,0.904538607647927,0,1,telomere formation via telomerase,BP,
13955,GO:0060694,0.999999999993971,0.904538607647927,0,1,regulation of cholesterol transporter activity,BP,
15725,GO:0072343,0.999999999993971,0.904538607647927,0,1,pancreatic stellate cell proliferation,BP,
17656,GO:1901558,0.999999999993971,0.904538607647927,0,1,response to metformin,BP,
19274,GO:1905563,0.999999999993971,0.904538607647927,0,1,negative regulation of vascular endothelial cell proliferation,BP,
19766,GO:2000229,0.999999999993971,0.904538607647927,0,1,regulation of pancreatic stellate cell proliferation,BP,
19767,GO:2000230,0.999999999993971,0.904538607647927,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
12300,GO:0048674,0.999999999993984,0.901560562524549,0,1,collateral sprouting of injured axon,BP,
12308,GO:0048686,0.999999999993984,0.901560562524549,0,1,regulation of sprouting of injured axon,BP,
12309,GO:0048687,0.999999999993984,0.901560562524549,0,1,positive regulation of sprouting of injured axon,BP,
12310,GO:0048688,0.999999999993984,0.901560562524549,0,1,negative regulation of sprouting of injured axon,BP,
12311,GO:0048689,0.999999999993984,0.901560562524549,0,1,formation of growth cone in injured axon,BP,
12312,GO:0048693,0.999999999993984,0.901560562524549,0,1,regulation of collateral sprouting of injured axon,BP,
12313,GO:0048694,0.999999999993984,0.901560562524549,0,1,positive regulation of collateral sprouting of injured axon,BP,
19282,GO:1905578,0.999999999993984,0.901560562524549,0,1,regulation of ERBB3 signaling pathway,BP,
19283,GO:1905580,0.999999999993984,0.901560562524549,0,1,positive regulation of ERBB3 signaling pathway,BP,
19383,GO:1905942,0.999999999993984,0.901560562524549,0,1,regulation of formation of growth cone in injured axon,BP,
19384,GO:1905943,0.999999999993984,0.901560562524549,0,1,negative regulation of formation of growth cone in injured axon,BP,
552,GO:0001674,0.999999999993991,0.813100331494324,0,2,female germ cell nucleus,CC,
10067,GO:0042585,0.999999999993991,0.813100331494324,0,2,germinal vesicle,CC,
15106,GO:0071225,0.999999999994027,0.66011964687163,0,4,cellular response to muramyl dipeptide,BP,
1623,GO:0004062,0.999999999994033,0.684979268798635,0,4,aryl sulfotransferase activity,MF,
657,GO:0001849,0.999999999994037,0.828570732231393,0,2,complement component C1q binding,MF,
11048,GO:0045065,0.999999999994041,0.817446793148296,0,2,cytotoxic T cell differentiation,BP,
11255,GO:0045583,0.999999999994041,0.817446793148296,0,2,regulation of cytotoxic T cell differentiation,BP,
11256,GO:0045585,0.999999999994041,0.817446793148296,0,2,positive regulation of cytotoxic T cell differentiation,BP,
7905,GO:0032490,0.999999999994053,0.660096085951637,0,4,detection of molecule of bacterial origin,BP,
9660,GO:0038042,0.999999999994057,0.684580575732789,0,4,dimeric G-protein coupled receptor signaling pathway,BP,
16669,GO:0097646,0.999999999994057,0.684580575732789,0,4,calcitonin family receptor signaling pathway,BP,
7120,GO:0030956,0.999999999994064,0.762421959958461,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
12478,GO:0050567,0.999999999994064,0.762421959958461,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
14864,GO:0070681,0.999999999994064,0.762421959958461,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
2047,GO:0004799,0.99999999999407,0.908077518055946,0,1,thymidylate synthase activity,MF,
6020,GO:0019088,0.99999999999407,0.908077518055946,0,1,immortalization of host cell by virus,BP,
6320,GO:0020021,0.99999999999407,0.908077518055946,0,1,immortalization of host cell,BP,
9823,GO:0042083,0.99999999999407,0.908077518055946,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
7557,GO:0031930,0.999999999994107,0.910206331272451,0,1,mitochondria-nucleus signaling pathway,BP,
8035,GO:0032701,0.999999999994111,0.817897222912348,0,2,negative regulation of interleukin-18 production,BP,
4382,GO:0010044,0.999999999994114,0.665034437676628,0,4,response to aluminum ion,BP,
16490,GO:0097227,0.999999999994128,0.660153774671949,0,4,sperm annulus,CC,
3681,GO:0008193,0.999999999994161,0.823273737736059,0,2,tRNA guanylyltransferase activity,MF,
3725,GO:0008269,0.999999999994171,0.902178232264081,0,1,JAK pathway signal transduction adaptor activity,MF,
4310,GO:0009810,0.999999999994171,0.902178232264081,0,1,stilbene metabolic process,BP,
8534,GO:0033885,0.999999999994171,0.902178232264081,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
11586,GO:0046272,0.999999999994171,0.902178232264081,0,1,stilbene catabolic process,BP,
8107,GO:0032807,0.999999999994207,0.66514552385025,0,4,DNA ligase IV complex,CC,
9336,GO:0035865,0.99999999999422,0.749681597759523,0,3,cellular response to potassium ion,BP,
12832,GO:0051177,0.999999999994221,0.675735922730542,0,4,meiotic sister chromatid cohesion,BP,
2848,GO:0006344,0.999999999994274,0.660106301277678,0,4,maintenance of chromatin silencing,BP,
3928,GO:0008623,0.999999999994307,0.812661607882521,0,2,CHRAC,CC,
2138,GO:0004954,0.999999999994327,0.735374306148801,0,3,prostanoid receptor activity,MF,
9270,GO:0035726,0.999999999994335,0.679722088556792,0,4,common myeloid progenitor cell proliferation,BP,
5120,GO:0015578,0.999999999994338,0.901543334603769,0,1,mannose transmembrane transporter activity,MF,
5178,GO:0015761,0.999999999994338,0.901543334603769,0,1,mannose transmembrane transport,BP,
17260,GO:0140052,0.999999999994404,0.732340472129837,0,3,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
14813,GO:0070579,0.999999999994423,0.660121249952137,0,4,methylcytosine dioxygenase activity,MF,
19381,GO:1905940,0.999999999994423,0.734284016835698,0,3,negative regulation of gonad development,BP,
856,GO:0002189,0.999999999994431,0.901453202377683,0,1,ribose phosphate diphosphokinase complex,CC,
4049,GO:0009107,0.999999999994457,0.906716437014119,0,1,lipoate biosynthetic process,BP,
5764,GO:0016992,0.999999999994457,0.906716437014119,0,1,lipoate synthase activity,MF,
14647,GO:0070283,0.999999999994457,0.906716437014119,0,1,radical SAM enzyme activity,MF,
2256,GO:0005175,0.999999999994472,0.930108008599972,0,1,CD27 receptor binding,MF,
1895,GO:0004583,0.999999999994524,0.663617270438681,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
485,GO:0001537,0.999999999994548,0.813254927867087,0,2,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
8515,GO:0033814,0.999999999994551,0.910983902014333,0,1,propanoyl-CoA C-acyltransferase activity,MF,
12483,GO:0050632,0.999999999994551,0.910983902014333,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
14783,GO:0070538,0.999999999994551,0.910983902014333,0,1,oleic acid binding,MF,
17614,GO:1901373,0.999999999994551,0.910983902014333,0,1,lipid hydroperoxide transport,BP,
2473,GO:0005713,0.999999999994558,0.901524647637337,0,1,recombination nodule,CC,
2474,GO:0005715,0.999999999994558,0.901524647637337,0,1,late recombination nodule,CC,
5003,GO:0015173,0.999999999994558,0.901524647637337,0,1,aromatic amino acid transmembrane transporter activity,MF,
5021,GO:0015196,0.999999999994558,0.901524647637337,0,1,L-tryptophan transmembrane transporter activity,MF,
10281,GO:0043060,0.999999999994558,0.901524647637337,0,1,meiotic metaphase I plate congression,BP,
12885,GO:0051257,0.999999999994558,0.901524647637337,0,1,meiotic spindle midzone assembly,BP,
12925,GO:0051311,0.999999999994558,0.901524647637337,0,1,meiotic metaphase plate congression,BP,
18746,GO:1904271,0.999999999994558,0.901524647637337,0,1,L-proline import across plasma membrane,BP,
18853,GO:1904555,0.999999999994558,0.901524647637337,0,1,L-proline transmembrane transport,BP,
18854,GO:1904556,0.999999999994558,0.901524647637337,0,1,L-tryptophan transmembrane transport,BP,
19304,GO:1905647,0.999999999994558,0.901524647637337,0,1,proline import across plasma membrane,BP,
3812,GO:0008419,0.999999999994569,0.901392911131935,0,1,RNA lariat debranching enzyme activity,MF,
2491,GO:0005745,0.999999999994584,0.812479374331307,0,2,m-AAA complex,CC,
10610,GO:0043626,0.999999999994611,0.912667384151364,0,1,PCNA complex,CC,
10978,GO:0044796,0.999999999994611,0.912667384151364,0,1,DNA polymerase processivity factor complex,CC,
1857,GO:0004525,0.99999999999463,0.66332645466662,0,4,ribonuclease III activity,MF,
7761,GO:0032296,0.99999999999463,0.66332645466662,0,4,double-stranded RNA-specific ribonuclease activity,MF,
6146,GO:0019474,0.999999999994645,0.732931563243532,0,3,L-lysine catabolic process to acetyl-CoA,BP,
6147,GO:0019477,0.999999999994645,0.732931563243532,0,3,L-lysine catabolic process,BP,
8412,GO:0033512,0.999999999994645,0.732931563243532,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
11646,GO:0046440,0.999999999994645,0.732931563243532,0,3,L-lysine metabolic process,BP,
13623,GO:0060158,0.999999999994646,0.667824032516399,0,4,phospholipase C-activating dopamine receptor signaling pathway,BP,
1299,GO:0003139,0.999999999994647,0.667025214357141,0,4,secondary heart field specification,BP,
12133,GO:0048263,0.999999999994671,0.677344271732276,0,4,determination of dorsal identity,BP,
577,GO:0001730,0.999999999994675,0.668932713690385,0,4,2'-5'-oligoadenylate synthetase activity,MF,
19789,GO:2000275,0.999999999994688,0.832306099275259,0,2,regulation of oxidative phosphorylation uncoupler activity,BP,
17754,GO:1901841,0.999999999994707,0.667845887679002,0,4,regulation of high voltage-gated calcium channel activity,BP,
2030,GO:0004774,0.999999999994713,0.740597319737435,0,3,succinate-CoA ligase activity,MF,
20269,GO:2001286,0.999999999994756,0.665831761611936,0,4,regulation of caveolin-mediated endocytosis,BP,
4198,GO:0009328,0.999999999994762,0.662878243304028,0,4,phenylalanine-tRNA ligase complex,CC,
19115,GO:1905143,0.999999999994768,0.908584454525852,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
9164,GO:0035552,0.999999999994771,0.737955836367473,0,3,oxidative single-stranded DNA demethylation,BP,
10916,GO:0044571,0.999999999994771,0.698656635457385,0,4,[2Fe-2S] cluster assembly,BP,
14624,GO:0070236,0.999999999994774,0.664433936481777,0,4,negative regulation of activation-induced cell death of T cells,BP,
8405,GO:0033489,0.999999999994783,0.671385306158432,0,4,cholesterol biosynthetic process via desmosterol,BP,
8406,GO:0033490,0.999999999994783,0.671385306158432,0,4,cholesterol biosynthetic process via lathosterol,BP,
14405,GO:0061738,0.999999999994783,0.734465946690789,0,3,late endosomal microautophagy,BP,
5119,GO:0015562,0.999999999994795,0.660100714388254,0,4,efflux transmembrane transporter activity,MF,
8126,GO:0032847,0.999999999994843,0.817382505279663,0,2,regulation of cellular pH reduction,BP,
18427,GO:1903542,0.999999999994861,0.813110156925214,0,2,negative regulation of exosomal secretion,BP,
17622,GO:1901386,0.999999999994864,0.666428756485686,0,4,negative regulation of voltage-gated calcium channel activity,BP,
4214,GO:0009397,0.99999999999487,0.676604436315832,0,4,folic acid-containing compound catabolic process,BP,
10050,GO:0042560,0.99999999999487,0.676604436315832,0,4,pteridine-containing compound catabolic process,BP,
9081,GO:0035363,0.999999999994898,0.664732102845322,0,4,histone locus body,CC,
8765,GO:0034462,0.999999999994909,0.902022647842984,0,1,small-subunit processome assembly,BP,
16732,GO:0098547,0.999999999994909,0.902022647842984,0,1,lumenal side of Golgi membrane,CC,
13120,GO:0051715,0.999999999994959,0.85840014929901,0,2,cytolysis in other organism,BP,
5033,GO:0015226,0.999999999994959,0.66293560962431,0,4,carnitine transmembrane transporter activity,MF,
11897,GO:0046963,0.999999999994961,0.815338436022076,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
11898,GO:0046964,0.999999999994961,0.815338436022076,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
18010,GO:1902559,0.999999999994961,0.815338436022076,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
10942,GO:0044715,0.999999999994964,0.832375681504718,0,2,8-oxo-dGDP phosphatase activity,MF,
5949,GO:0018343,0.99999999999502,0.737545649595639,0,3,protein farnesylation,BP,
3332,GO:0007056,0.999999999995054,0.813963239119814,0,2,spindle assembly involved in female meiosis,BP,
3333,GO:0007057,0.999999999995054,0.813963239119814,0,2,spindle assembly involved in female meiosis I,BP,
19670,GO:2000020,0.999999999995058,0.662941685698051,0,4,positive regulation of male gonad development,BP,
3879,GO:0008521,0.999999999995058,0.901390785407146,0,1,acetyl-CoA transmembrane transporter activity,MF,
5239,GO:0015876,0.999999999995058,0.901390785407146,0,1,acetyl-CoA transport,BP,
5258,GO:0015916,0.999999999995058,0.901390785407146,0,1,fatty-acyl-CoA transport,BP,
17600,GO:1901337,0.999999999995058,0.901390785407146,0,1,thioester transport,BP,
15814,GO:0072554,0.99999999999506,0.901716786625671,0,1,blood vessel lumenization,BP,
17549,GO:1901189,0.99999999999506,0.901716786625671,0,1,positive regulation of ephrin receptor signaling pathway,BP,
17584,GO:1901297,0.99999999999506,0.901716786625671,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
19098,GO:1905068,0.99999999999506,0.901716786625671,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
6457,GO:0021796,0.999999999995081,0.660091709807885,0,4,cerebral cortex regionalization,BP,
15458,GO:0071839,0.999999999995082,0.673617659853308,0,4,apoptotic process in bone marrow,BP,
756,GO:0001998,0.999999999995092,0.903965540642851,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
776,GO:0002034,0.999999999995092,0.903965540642851,0,1,regulation of blood vessel diameter by renin-angiotensin,BP,
1276,GO:0003072,0.999999999995092,0.903965540642851,0,1,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
18485,GO:1903673,0.999999999995092,0.903965540642851,0,1,mitotic cleavage furrow formation,BP,
18915,GO:1904695,0.999999999995092,0.903965540642851,0,1,positive regulation of vascular smooth muscle contraction,BP,
49,GO:0000103,0.999999999995096,0.743531580803726,0,3,sulfate assimilation,BP,
5031,GO:0015220,0.999999999995096,0.660319479145953,0,4,choline transmembrane transporter activity,MF,
3818,GO:0008427,0.999999999995159,0.83076102893088,0,2,calcium-dependent protein kinase inhibitor activity,MF,
4690,GO:0010858,0.999999999995159,0.83076102893088,0,2,calcium-dependent protein kinase regulator activity,MF,
13366,GO:0052696,0.999999999995172,0.661871380380943,0,4,flavonoid glucuronidation,BP,
13367,GO:0052697,0.999999999995172,0.661871380380943,0,4,xenobiotic glucuronidation,BP,
2956,GO:0006499,0.99999999999518,0.660108776622045,0,4,N-terminal protein myristoylation,BP,
5955,GO:0018377,0.99999999999518,0.660108776622045,0,4,protein myristoylation,BP,
1053,GO:0002581,0.999999999995222,0.822010098445515,0,2,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
2985,GO:0006537,0.999999999995222,0.660105276913847,0,4,glutamate biosynthetic process,BP,
11203,GO:0045355,0.999999999995222,0.825575345154028,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
19549,GO:1990617,0.999999999995269,0.836546633275347,0,2,CHOP-ATF4 complex,CC,
9453,GO:0036090,0.999999999995269,0.815792450211048,0,2,cleavage furrow ingression,BP,
11915,GO:0046984,0.999999999995272,0.667665869225636,0,4,regulation of hemoglobin biosynthetic process,BP,
2240,GO:0005157,0.99999999999529,0.901582126917452,0,1,macrophage colony-stimulating factor receptor binding,MF,
10019,GO:0042488,0.99999999999529,0.901582126917452,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
13914,GO:0060611,0.99999999999529,0.901582126917452,0,1,mammary gland fat development,BP,
17889,GO:1902228,0.99999999999529,0.901582126917452,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
18628,GO:1903971,0.99999999999529,0.901582126917452,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
18631,GO:1903974,0.99999999999529,0.901582126917452,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18686,GO:1904124,0.99999999999529,0.901582126917452,0,1,microglial cell migration,BP,
18687,GO:1904139,0.99999999999529,0.901582126917452,0,1,regulation of microglial cell migration,BP,
18688,GO:1904141,0.99999999999529,0.901582126917452,0,1,positive regulation of microglial cell migration,BP,
19561,GO:1990682,0.99999999999529,0.901582126917452,0,1,CSF1-CSF1R complex,CC,
19841,GO:2000348,0.999999999995298,0.662705617899212,0,4,regulation of CD40 signaling pathway,BP,
7538,GO:0031859,0.999999999995299,0.904089301281187,0,1,platelet activating factor receptor binding,MF,
9858,GO:0042137,0.999999999995299,0.904089301281187,0,1,sequestering of neurotransmitter,BP,
13693,GO:0060287,0.999999999995315,0.669703452199736,0,4,epithelial cilium movement involved in determination of left/right asymmetry,BP,
10502,GO:0043435,0.999999999995327,0.901414917543239,0,1,response to corticotropin-releasing hormone,BP,
15195,GO:0071376,0.999999999995327,0.901414917543239,0,1,cellular response to corticotropin-releasing hormone stimulus,BP,
16633,GO:0097536,0.999999999995334,0.901383393150092,0,1,thymus epithelium morphogenesis,BP,
5514,GO:0016494,0.999999999995358,0.661891870964511,0,4,C-X-C chemokine receptor activity,MF,
6304,GO:0019958,0.999999999995358,0.661891870964511,0,4,C-X-C chemokine binding,MF,
6938,GO:0030576,0.999999999995367,0.733425555898327,0,3,Cajal body organization,BP,
16455,GO:0097167,0.999999999995403,0.665092707336785,0,4,circadian regulation of translation,BP,
2152,GO:0004979,0.999999999995408,0.904464584249096,0,1,beta-endorphin receptor activity,MF,
7461,GO:0031635,0.999999999995408,0.904464584249096,0,1,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7656,GO:0032097,0.999999999995408,0.904464584249096,0,1,positive regulation of response to food,BP,
7659,GO:0032100,0.999999999995408,0.904464584249096,0,1,positive regulation of appetite,BP,
9662,GO:0038047,0.999999999995408,0.904464584249096,0,1,morphine receptor activity,MF,
11697,GO:0046521,0.999999999995408,0.904464584249096,0,1,sphingoid catabolic process,BP,
14255,GO:0061358,0.999999999995408,0.904464584249096,0,1,negative regulation of Wnt protein secretion,BP,
167,GO:0000349,0.999999999995429,0.812807411054943,0,2,generation of catalytic spliceosome for first transesterification step,BP,
14333,GO:0061575,0.999999999995462,0.709174287511107,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
13217,GO:0051918,0.999999999995471,0.662962679417234,0,4,negative regulation of fibrinolysis,BP,
12759,GO:0051066,0.999999999995478,0.819688469387924,0,2,dihydrobiopterin metabolic process,BP,
15004,GO:0070973,0.999999999995502,0.665654301921997,0,4,protein localization to endoplasmic reticulum exit site,BP,
3608,GO:0008063,0.999999999995543,0.660175804562283,0,4,Toll signaling pathway,BP,
10571,GO:0043553,0.999999999995591,0.732493875430035,0,3,negative regulation of phosphatidylinositol 3-kinase activity,BP,
7084,GO:0030891,0.999999999995591,0.684610026464326,0,4,VCB complex,CC,
14730,GO:0070432,0.999999999995604,0.732582798927236,0,3,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
314,GO:0000827,0.999999999995624,0.668421457225917,0,4,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
315,GO:0000828,0.999999999995624,0.668421457225917,0,4,inositol hexakisphosphate kinase activity,MF,
316,GO:0000829,0.999999999995624,0.668421457225917,0,4,inositol heptakisphosphate kinase activity,MF,
317,GO:0000832,0.999999999995624,0.668421457225917,0,4,inositol hexakisphosphate 5-kinase activity,MF,
13370,GO:0052723,0.999999999995624,0.668421457225917,0,4,inositol hexakisphosphate 1-kinase activity,MF,
13371,GO:0052724,0.999999999995624,0.668421457225917,0,4,inositol hexakisphosphate 3-kinase activity,MF,
7991,GO:0032627,0.999999999995629,0.660930034102776,0,4,interleukin-23 production,BP,
8015,GO:0032667,0.999999999995629,0.660930034102776,0,4,regulation of interleukin-23 production,BP,
14536,GO:0070091,0.999999999995647,0.732368175730628,0,3,glucagon secretion,BP,
14537,GO:0070092,0.999999999995647,0.732368175730628,0,3,regulation of glucagon secretion,BP,
5800,GO:0017065,0.999999999995653,0.908336620440545,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
13703,GO:0060300,0.999999999995664,0.739670644420005,0,3,regulation of cytokine activity,BP,
13157,GO:0051790,0.999999999995667,0.670241977980012,0,4,short-chain fatty acid biosynthetic process,BP,
13808,GO:0060435,0.999999999995679,0.912846061278059,0,1,bronchiole development,BP,
13836,GO:0060480,0.999999999995679,0.912846061278059,0,1,lung goblet cell differentiation,BP,
2816,GO:0006288,0.999999999995682,0.743743039587484,0,3,base-excision repair, DNA ligation,BP,
5901,GO:0018153,0.999999999995683,0.813508653663963,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
5932,GO:0018262,0.999999999995683,0.813508653663963,0,2,isopeptide cross-linking,BP,
14272,GO:0061428,0.999999999995698,0.664671583321851,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
3670,GO:0008176,0.99999999999572,0.828286138027139,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
17162,GO:0106004,0.99999999999572,0.828286138027139,0,2,tRNA (guanine-N7)-methylation,BP,
121,GO:0000252,0.999999999995721,0.907839578452686,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
11920,GO:0047012,0.999999999995721,0.907839578452686,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
17154,GO:0103066,0.999999999995721,0.907839578452686,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
17155,GO:0103067,0.999999999995721,0.907839578452686,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
5275,GO:0015938,0.999999999995725,0.920414629390928,0,1,coenzyme A catabolic process,BP,
8527,GO:0033869,0.999999999995725,0.920414629390928,0,1,nucleoside bisphosphate catabolic process,BP,
8549,GO:0034031,0.999999999995725,0.920414629390928,0,1,ribonucleoside bisphosphate catabolic process,BP,
8552,GO:0034034,0.999999999995725,0.920414629390928,0,1,purine nucleoside bisphosphate catabolic process,BP,
8544,GO:0033989,0.999999999995768,0.901384449765392,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9460,GO:0036111,0.999999999995768,0.901384449765392,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10917,GO:0044594,0.999999999995768,0.901384449765392,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
7854,GO:0032427,0.99999999999578,0.813349092765261,0,2,GBD domain binding,MF,
12109,GO:0048209,0.99999999999578,0.813349092765261,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
18193,GO:1903012,0.999999999995794,0.661034639874422,0,4,positive regulation of bone development,BP,
13108,GO:0051697,0.999999999995838,0.665630633909112,0,4,protein delipidation,BP,
1685,GO:0004161,0.999999999995857,0.820020314107087,0,2,dimethylallyltranstransferase activity,MF,
1736,GO:0004337,0.999999999995857,0.820020314107087,0,2,geranyltranstransferase activity,MF,
8394,GO:0033383,0.999999999995857,0.820020314107087,0,2,geranyl diphosphate metabolic process,BP,
8395,GO:0033384,0.999999999995857,0.820020314107087,0,2,geranyl diphosphate biosynthetic process,BP,
17202,GO:0110021,0.999999999995885,0.813569018811574,0,2,cardiac muscle myoblast proliferation,BP,
17203,GO:0110022,0.999999999995885,0.813569018811574,0,2,regulation of cardiac muscle myoblast proliferation,BP,
17204,GO:0110024,0.999999999995885,0.813569018811574,0,2,positive regulation of cardiac muscle myoblast proliferation,BP,
9906,GO:0042270,0.999999999995897,0.740502495672123,0,3,protection from natural killer cell mediated cytotoxicity,BP,
8536,GO:0033906,0.999999999995899,0.815360391666273,0,2,hyaluronoglucuronidase activity,MF,
18947,GO:1904753,0.99999999999591,0.735487989856748,0,3,negative regulation of vascular associated smooth muscle cell migration,BP,
8532,GO:0033882,0.999999999995924,0.916711067482478,0,1,choloyl-CoA hydrolase activity,MF,
11145,GO:0045222,0.999999999995924,0.916711067482478,0,1,CD4 biosynthetic process,BP,
11146,GO:0045223,0.999999999995924,0.916711067482478,0,1,regulation of CD4 biosynthetic process,BP,
11147,GO:0045225,0.999999999995924,0.916711067482478,0,1,negative regulation of CD4 biosynthetic process,BP,
13392,GO:0052815,0.999999999995924,0.916711067482478,0,1,medium-chain acyl-CoA hydrolase activity,MF,
18029,GO:1902605,0.999999999995938,0.901379239759475,0,1,heterotrimeric G-protein complex assembly,BP,
943,GO:0002357,0.999999999995962,0.90137836400399,0,1,defense response to tumor cell,BP,
9773,GO:0040009,0.999999999995963,0.660466723844857,0,4,regulation of growth rate,BP,
16483,GO:0097212,0.999999999995964,0.814991768531634,0,2,lysosomal membrane organization,BP,
1137,GO:0002729,0.999999999995974,0.827438872019883,0,2,positive regulation of natural killer cell cytokine production,BP,
15047,GO:0071042,0.999999999995977,0.683400985206822,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
15052,GO:0071047,0.999999999995977,0.683400985206822,0,4,polyadenylation-dependent mRNA catabolic process,BP,
10975,GO:0044793,0.999999999995977,0.660508361346538,0,4,negative regulation by host of viral process,BP,
10990,GO:0044828,0.999999999995977,0.660508361346538,0,4,negative regulation by host of viral genome replication,BP,
18750,GO:1904288,0.999999999995986,0.660403499060672,0,4,BAT3 complex binding,MF,
18375,GO:1903430,0.999999999996007,0.68159534037487,0,4,negative regulation of cell maturation,BP,
16696,GO:0097726,0.999999999996015,0.917624119383217,0,1,LEM domain binding,MF,
2771,GO:0006208,0.99999999999603,0.813281655139783,0,2,pyrimidine nucleobase catabolic process,BP,
2772,GO:0006210,0.99999999999603,0.813281655139783,0,2,thymine catabolic process,BP,
6257,GO:0019859,0.99999999999603,0.813281655139783,0,2,thymine metabolic process,BP,
19696,GO:2000077,0.99999999999603,0.813281655139783,0,2,negative regulation of type B pancreatic cell development,BP,
12927,GO:0051316,0.999999999996042,0.813043499746312,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
3961,GO:0008775,0.999999999996072,0.904873113622097,0,1,acetate CoA-transferase activity,MF,
4319,GO:0009850,0.999999999996072,0.904873113622097,0,1,auxin metabolic process,BP,
4320,GO:0009852,0.999999999996072,0.904873113622097,0,1,auxin catabolic process,BP,
4391,GO:0010124,0.999999999996072,0.904873113622097,0,1,phenylacetate catabolic process,BP,
17287,GO:0140161,0.999999999996073,0.742849041297772,0,3,monocarboxylate:sodium symporter activity,MF,
9284,GO:0035747,0.99999999999608,0.745302777372717,0,3,natural killer cell chemotaxis,BP,
16165,GO:0090219,0.9999999999961,0.660235382527238,0,4,negative regulation of lipid kinase activity,BP,
12024,GO:0047874,0.999999999996104,0.902618390650242,0,1,dolichyldiphosphatase activity,MF,
937,GO:0002339,0.999999999996137,0.835445197739798,0,2,B cell selection,BP,
941,GO:0002352,0.999999999996137,0.835445197739798,0,2,B cell negative selection,BP,
3644,GO:0008131,0.999999999996162,0.732353585768962,0,3,primary amine oxidase activity,MF,
9849,GO:0042126,0.999999999996164,0.660455185536597,0,4,nitrate metabolic process,BP,
11965,GO:0047323,0.999999999996189,0.902519944637877,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
13318,GO:0052381,0.999999999996189,0.902519944637877,0,1,tRNA dimethylallyltransferase activity,MF,
15093,GO:0071208,0.999999999996234,0.701767862821014,0,4,histone pre-mRNA DCP binding,MF,
14987,GO:0070944,0.999999999996242,0.817230275345348,0,2,neutrophil mediated killing of bacterium,BP,
14988,GO:0070945,0.999999999996242,0.817230275345348,0,2,neutrophil mediated killing of gram-negative bacterium,BP,
9367,GO:0035921,0.99999999999625,0.902711139293906,0,1,desmosome disassembly,BP,
17457,GO:1900387,0.99999999999625,0.902711139293906,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
18945,GO:1904751,0.999999999996289,0.749652836902574,0,3,positive regulation of protein localization to nucleolus,BP,
19730,GO:2000152,0.9999999999963,0.692676475049276,0,4,regulation of ubiquitin-specific protease activity,BP,
6080,GO:0019255,0.999999999996302,0.815205865495841,0,2,glucose 1-phosphate metabolic process,BP,
7608,GO:0032010,0.999999999996303,0.732710388265695,0,3,phagolysosome,CC,
4855,GO:0014717,0.999999999996332,0.821665454159312,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4856,GO:0014718,0.999999999996332,0.821665454159312,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4930,GO:0014901,0.999999999996332,0.821665454159312,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
5383,GO:0016230,0.999999999996332,0.821665454159312,0,2,sphingomyelin phosphodiesterase activator activity,MF,
10434,GO:0043309,0.999999999996332,0.821665454159312,0,2,regulation of eosinophil degranulation,BP,
10435,GO:0043311,0.999999999996332,0.821665454159312,0,2,positive regulation of eosinophil degranulation,BP,
18016,GO:1902566,0.999999999996332,0.821665454159312,0,2,regulation of eosinophil activation,BP,
18017,GO:1902568,0.999999999996332,0.821665454159312,0,2,positive regulation of eosinophil activation,BP,
19169,GO:1905286,0.999999999996345,0.813011880288129,0,2,serine-type peptidase complex,CC,
12559,GO:0050757,0.999999999996369,0.901396683454112,0,1,thymidylate synthase biosynthetic process,BP,
12560,GO:0050758,0.999999999996369,0.901396683454112,0,1,regulation of thymidylate synthase biosynthetic process,BP,
12561,GO:0050760,0.999999999996369,0.901396683454112,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
16392,GO:0097057,0.999999999996441,0.831383704139352,0,2,TRAF2-GSTP1 complex,CC,
18943,GO:1904749,0.999999999996444,0.675702998646715,0,4,regulation of protein localization to nucleolus,BP,
12392,GO:0048861,0.999999999996497,0.664167544241918,0,4,leukemia inhibitory factor signaling pathway,BP,
14788,GO:0070545,0.999999999996513,0.661099121859439,0,4,PeBoW complex,CC,
369,GO:0000991,0.999999999996518,0.82056740150654,0,2,transcription factor activity, core RNA polymerase II binding,MF,
7110,GO:0030942,0.999999999996526,0.746047115981226,0,3,endoplasmic reticulum signal peptide binding,MF,
2522,GO:0005784,0.999999999996549,0.712666211750517,0,4,Sec61 translocon complex,CC,
15120,GO:0071256,0.999999999996549,0.712666211750517,0,4,translocon complex,CC,
5392,GO:0016240,0.999999999996556,0.679634700989249,0,4,autophagosome membrane docking,BP,
5132,GO:0015669,0.999999999996557,0.738930933681559,0,3,gas transport,BP,
10843,GO:0044378,0.999999999996571,0.82034954152427,0,2,non-sequence-specific DNA binding, bending,MF,
9709,GO:0038171,0.999999999996595,0.732549193047448,0,3,cannabinoid signaling pathway,BP,
15505,GO:0071926,0.999999999996595,0.732549193047448,0,3,endocannabinoid signaling pathway,BP,
1508,GO:0003870,0.999999999996605,0.901762375982546,0,1,5-aminolevulinate synthase activity,MF,
5644,GO:0016749,0.999999999996605,0.901762375982546,0,1,N-succinyltransferase activity,MF,
3118,GO:0006705,0.999999999996623,0.66009121779816,0,4,mineralocorticoid biosynthetic process,BP,
3696,GO:0008212,0.999999999996623,0.66009121779816,0,4,mineralocorticoid metabolic process,BP,
7568,GO:0031944,0.999999999996623,0.66009121779816,0,4,negative regulation of glucocorticoid metabolic process,BP,
7571,GO:0031947,0.999999999996623,0.66009121779816,0,4,negative regulation of glucocorticoid biosynthetic process,BP,
7781,GO:0032341,0.999999999996623,0.66009121779816,0,4,aldosterone metabolic process,BP,
7782,GO:0032342,0.999999999996623,0.66009121779816,0,4,aldosterone biosynthetic process,BP,
7783,GO:0032344,0.999999999996623,0.66009121779816,0,4,regulation of aldosterone metabolic process,BP,
7786,GO:0032347,0.999999999996623,0.66009121779816,0,4,regulation of aldosterone biosynthetic process,BP,
16045,GO:0090032,0.999999999996623,0.66009121779816,0,4,negative regulation of steroid hormone biosynthetic process,BP,
8994,GO:0035175,0.99999999999667,0.906245548325023,0,1,histone kinase activity (H3-S10 specific),MF,
15732,GO:0072354,0.99999999999667,0.906245548325023,0,1,histone kinase activity (H3-T3 specific),MF,
15733,GO:0072355,0.99999999999667,0.906245548325023,0,1,histone H3-T3 phosphorylation,BP,
12395,GO:0048865,0.999999999996675,0.748167272628691,0,3,stem cell fate commitment,BP,
11442,GO:0045919,0.999999999996713,0.749677506070444,0,3,positive regulation of cytolysis,BP,
9793,GO:0042000,0.999999999996732,0.901604468756976,0,1,translocation of peptides or proteins into host,BP,
10703,GO:0044053,0.999999999996732,0.901604468756976,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
13171,GO:0051808,0.999999999996732,0.901604468756976,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
3097,GO:0006682,0.999999999996759,0.734210963470659,0,3,galactosylceramide biosynthetic process,BP,
6118,GO:0019375,0.999999999996759,0.734210963470659,0,3,galactolipid biosynthetic process,BP,
5987,GO:0019002,0.999999999996763,0.817924434041325,0,2,GMP binding,MF,
13755,GO:0060369,0.99999999999677,0.6623909681418,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
18916,GO:1904700,0.999999999996776,0.90141315730498,0,1,granulosa cell apoptotic process,BP,
18921,GO:1904708,0.999999999996776,0.90141315730498,0,1,regulation of granulosa cell apoptotic process,BP,
8409,GO:0033503,0.999999999996781,0.66290761034787,0,4,HULC complex,CC,
5482,GO:0016428,0.999999999996793,0.667063211703578,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
10244,GO:0043000,0.999999999996828,0.820711479876403,0,2,Golgi to plasma membrane CFTR protein transport,BP,
6959,GO:0030626,0.999999999996841,0.815017215769176,0,2,U12 snRNA binding,MF,
1061,GO:0002589,0.999999999996852,0.817828509623444,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1062,GO:0002590,0.999999999996852,0.817828509623444,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1360,GO:0003245,0.999999999996866,0.817775751785213,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
7381,GO:0031445,0.999999999996866,0.817775751785213,0,2,regulation of heterochromatin assembly,BP,
7382,GO:0031453,0.999999999996866,0.817775751785213,0,2,positive regulation of heterochromatin assembly,BP,
7672,GO:0032129,0.999999999996866,0.817775751785213,0,2,histone deacetylase activity (H3-K9 specific),MF,
11383,GO:0045799,0.999999999996866,0.817775751785213,0,2,positive regulation of chromatin assembly or disassembly,BP,
11903,GO:0046969,0.999999999996866,0.817775751785213,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
19272,GO:1905555,0.999999999996866,0.817775751785213,0,2,positive regulation blood vessel branching,BP,
19550,GO:1990619,0.999999999996866,0.817775751785213,0,2,histone H3-K9 deacetylation,BP,
1158,GO:0002767,0.999999999996877,0.81857189359766,0,2,immune response-inhibiting cell surface receptor signaling pathway,BP,
8292,GO:0033140,0.999999999996914,0.815274851334553,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
13522,GO:0060011,0.999999999996936,0.752320619195672,0,3,Sertoli cell proliferation,BP,
13562,GO:0060057,0.999999999996936,0.752320619195672,0,3,apoptotic process involved in mammary gland involution,BP,
13563,GO:0060058,0.999999999996936,0.752320619195672,0,3,positive regulation of apoptotic process involved in mammary gland involution,BP,
17909,GO:1902263,0.999999999996936,0.752320619195672,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
17938,GO:1902339,0.999999999996936,0.752320619195672,0,3,positive regulation of apoptotic process involved in morphogenesis,BP,
18410,GO:1903519,0.999999999996936,0.752320619195672,0,3,regulation of mammary gland involution,BP,
18411,GO:1903521,0.999999999996936,0.752320619195672,0,3,positive regulation of mammary gland involution,BP,
18941,GO:1904747,0.999999999996936,0.752320619195672,0,3,positive regulation of apoptotic process involved in development,BP,
7906,GO:0032493,0.999999999996938,0.735542801807241,0,3,response to bacterial lipoprotein,BP,
14682,GO:0070339,0.999999999996938,0.735542801807241,0,3,response to bacterial lipopeptide,BP,
15101,GO:0071220,0.999999999996938,0.735542801807241,0,3,cellular response to bacterial lipoprotein,BP,
15102,GO:0071221,0.999999999996938,0.735542801807241,0,3,cellular response to bacterial lipopeptide,BP,
14726,GO:0070427,0.99999999999694,0.738046948496431,0,3,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
19092,GO:1905062,0.999999999996946,0.901382093151062,0,1,positive regulation of cardioblast proliferation,BP,
3481,GO:0007356,0.999999999996959,0.816014519444452,0,2,thorax and anterior abdomen determination,BP,
19562,GO:1990698,0.999999999996959,0.816014519444452,0,2,palmitoleoyltransferase activity,MF,
20175,GO:2001074,0.999999999996959,0.816014519444452,0,2,regulation of metanephric ureteric bud development,BP,
20176,GO:2001076,0.999999999996959,0.816014519444452,0,2,positive regulation of metanephric ureteric bud development,BP,
995,GO:0002457,0.999999999996967,0.734250579699817,0,3,T cell antigen processing and presentation,BP,
12431,GO:0050220,0.999999999996979,0.685882048120598,0,4,prostaglandin-E synthase activity,MF,
687,GO:0001907,0.999999999996996,0.755816921247811,0,3,killing by symbiont of host cells,BP,
10692,GO:0044004,0.999999999996996,0.755816921247811,0,3,disruption by symbiont of host cell,BP,
10905,GO:0044533,0.999999999996996,0.755816921247811,0,3,positive regulation of apoptotic process in other organism,BP,
13275,GO:0052042,0.999999999996996,0.755816921247811,0,3,positive regulation by symbiont of host programmed cell death,BP,
13311,GO:0052330,0.999999999996996,0.755816921247811,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13330,GO:0052501,0.999999999996996,0.755816921247811,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
4885,GO:0014821,0.999999999997002,0.682524922704333,0,4,phasic smooth muscle contraction,BP,
3915,GO:0008597,0.999999999997004,0.817244959308857,0,2,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
19711,GO:2000111,0.999999999997017,0.826318339546786,0,2,positive regulation of macrophage apoptotic process,BP,
3123,GO:0006713,0.999999999997027,0.905270408109619,0,1,glucocorticoid catabolic process,BP,
4184,GO:0009298,0.999999999997034,0.677263930886662,0,4,GDP-mannose biosynthetic process,BP,
8092,GO:0032792,0.99999999999704,0.676685710040373,0,4,negative regulation of CREB transcription factor activity,BP,
17970,GO:1902445,0.999999999997041,0.766841329865286,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
17305,GO:1900003,0.999999999997049,0.756726137569305,0,3,regulation of serine-type endopeptidase activity,BP,
17306,GO:1900004,0.999999999997049,0.756726137569305,0,3,negative regulation of serine-type endopeptidase activity,BP,
18019,GO:1902571,0.999999999997049,0.756726137569305,0,3,regulation of serine-type peptidase activity,BP,
18020,GO:1902572,0.999999999997049,0.756726137569305,0,3,negative regulation of serine-type peptidase activity,BP,
9152,GO:0035523,0.999999999997053,0.663903953517774,0,4,protein K29-linked deubiquitination,BP,
19193,GO:1905340,0.999999999997069,0.664118142142953,0,4,regulation of protein localization to kinetochore,BP,
19195,GO:1905342,0.999999999997069,0.664118142142953,0,4,positive regulation of protein localization to kinetochore,BP,
7088,GO:0030896,0.99999999999707,0.661795572680884,0,4,checkpoint clamp complex,CC,
16587,GO:0097454,0.999999999997072,0.740424696954165,0,3,Schwann cell microvillus,CC,
9238,GO:0035662,0.999999999997092,0.792836279832494,0,3,Toll-like receptor 4 binding,MF,
17922,GO:1902298,0.999999999997122,0.813085784208526,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19502,GO:1990426,0.999999999997122,0.813085784208526,0,2,mitotic recombination-dependent replication fork processing,BP,
19523,GO:1990505,0.999999999997122,0.813085784208526,0,2,mitotic DNA replication maintenance of fidelity,BP,
6399,GO:0021644,0.999999999997132,0.908871042776408,0,1,vagus nerve morphogenesis,BP,
19255,GO:1905502,0.999999999997132,0.915926411377567,0,1,acetyl-CoA binding,MF,
1613,GO:0004045,0.999999999997139,0.701648134829651,0,4,aminoacyl-tRNA hydrolase activity,MF,
11723,GO:0046586,0.999999999997192,0.832193829653908,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
1542,GO:0003939,0.999999999997236,0.901460401044989,0,1,L-iditol 2-dehydrogenase activity,MF,
2689,GO:0006062,0.999999999997236,0.901460401044989,0,1,sorbitol catabolic process,BP,
6130,GO:0019407,0.999999999997236,0.901460401044989,0,1,hexitol catabolic process,BP,
6156,GO:0019519,0.999999999997236,0.901460401044989,0,1,pentitol metabolic process,BP,
6159,GO:0019527,0.999999999997236,0.901460401044989,0,1,pentitol catabolic process,BP,
7301,GO:0031320,0.999999999997236,0.901460401044989,0,1,hexitol dehydrogenase activity,MF,
11700,GO:0046526,0.999999999997236,0.901460401044989,0,1,D-xylulose reductase activity,MF,
12821,GO:0051160,0.999999999997236,0.901460401044989,0,1,L-xylitol catabolic process,BP,
12822,GO:0051164,0.999999999997236,0.901460401044989,0,1,L-xylitol metabolic process,BP,
5380,GO:0016222,0.999999999997255,0.812513566265968,0,2,procollagen-proline 4-dioxygenase complex,CC,
5817,GO:0017102,0.999999999997255,0.812513566265968,0,2,methionyl glutamyl tRNA synthetase complex,CC,
1583,GO:0003997,0.999999999997273,0.735173267431351,0,3,acyl-CoA oxidase activity,MF,
1943,GO:0004651,0.999999999997276,0.817722280242695,0,2,polynucleotide 5'-phosphatase activity,MF,
6996,GO:0030692,0.999999999997276,0.817722280242695,0,2,Noc4p-Nop14p complex,CC,
16718,GO:0098507,0.999999999997276,0.817722280242695,0,2,polynucleotide 5' dephosphorylation,BP,
11314,GO:0045660,0.999999999997279,0.903380958413867,0,1,positive regulation of neutrophil differentiation,BP,
16390,GO:0097055,0.999999999997279,0.813232494450973,0,2,agmatine biosynthetic process,BP,
17540,GO:1901162,0.999999999997279,0.813232494450973,0,2,primary amino compound biosynthetic process,BP,
6516,GO:0021914,0.99999999999729,0.812527163221458,0,2,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
13807,GO:0060434,0.99999999999729,0.812527163221458,0,2,bronchus morphogenesis,BP,
17097,GO:0102121,0.99999999999729,0.812527163221458,0,2,ceramidase activity,MF,
243,GO:0000700,0.999999999997292,0.670914360413661,0,4,mismatch base pair DNA N-glycosylase activity,MF,
2073,GO:0004830,0.999999999997319,0.812480444582739,0,2,tryptophan-tRNA ligase activity,MF,
2918,GO:0006436,0.999999999997319,0.812480444582739,0,2,tryptophanyl-tRNA aminoacylation,BP,
5208,GO:0015820,0.999999999997328,0.813013468974752,0,2,leucine transport,BP,
2768,GO:0006203,0.999999999997332,0.756157293838469,0,3,dGTP catabolic process,BP,
2074,GO:0004831,0.999999999997338,0.813386270720014,0,2,tyrosine-tRNA ligase activity,MF,
2919,GO:0006437,0.999999999997338,0.813386270720014,0,2,tyrosyl-tRNA aminoacylation,BP,
7701,GO:0032202,0.999999999997347,0.664886690430139,0,4,telomere assembly,BP,
18969,GO:1904798,0.999999999997356,0.664311398398405,0,4,positive regulation of core promoter binding,BP,
19510,GO:1990446,0.999999999997362,0.679116433043289,0,4,U1 snRNP binding,MF,
7784,GO:0032345,0.999999999997373,0.732333946485876,0,3,negative regulation of aldosterone metabolic process,BP,
7787,GO:0032348,0.999999999997373,0.732333946485876,0,3,negative regulation of aldosterone biosynthetic process,BP,
19692,GO:2000065,0.999999999997373,0.732333946485876,0,3,negative regulation of cortisol biosynthetic process,BP,
6387,GO:0021603,0.999999999997396,0.660226404902674,0,4,cranial nerve formation,BP,
3511,GO:0007468,0.999999999997406,0.902978750193193,0,1,regulation of rhodopsin gene expression,BP,
11417,GO:0045872,0.999999999997406,0.902978750193193,0,1,positive regulation of rhodopsin gene expression,BP,
13382,GO:0052794,0.99999999999741,0.813807879771302,0,2,exo-alpha-(2->3)-sialidase activity,MF,
13383,GO:0052795,0.99999999999741,0.813807879771302,0,2,exo-alpha-(2->6)-sialidase activity,MF,
13384,GO:0052796,0.99999999999741,0.813807879771302,0,2,exo-alpha-(2->8)-sialidase activity,MF,
15988,GO:0086028,0.999999999997417,0.677727596301348,0,4,bundle of His cell to Purkinje myocyte signaling,BP,
15995,GO:0086043,0.999999999997417,0.677727596301348,0,4,bundle of His cell action potential,BP,
18583,GO:1903893,0.999999999997423,0.901490528106727,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
6400,GO:0021648,0.999999999997425,0.812589258347322,0,2,vestibulocochlear nerve morphogenesis,BP,
6471,GO:0021824,0.999999999997425,0.812589258347322,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6475,GO:0021828,0.999999999997425,0.812589258347322,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6486,GO:0021856,0.999999999997425,0.812589258347322,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
13770,GO:0060385,0.999999999997425,0.812589258347322,0,2,axonogenesis involved in innervation,BP,
14092,GO:0060978,0.999999999997425,0.812589258347322,0,2,angiogenesis involved in coronary vascular morphogenesis,BP,
16413,GO:0097102,0.999999999997425,0.812589258347322,0,2,endothelial tip cell fate specification,BP,
18346,GO:1903375,0.999999999997425,0.812589258347322,0,2,facioacoustic ganglion development,BP,
19601,GO:1990791,0.999999999997425,0.812589258347322,0,2,dorsal root ganglion development,BP,
14252,GO:0061355,0.999999999997429,0.662509232588837,0,4,Wnt protein secretion,BP,
14253,GO:0061356,0.999999999997429,0.662509232588837,0,4,regulation of Wnt protein secretion,BP,
4456,GO:0010459,0.999999999997464,0.677306747393697,0,4,negative regulation of heart rate,BP,
5039,GO:0015234,0.999999999997471,0.817695663791281,0,2,thiamine transmembrane transporter activity,MF,
15510,GO:0071934,0.999999999997471,0.817695663791281,0,2,thiamine transmembrane transport,BP,
7267,GO:0031262,0.999999999997474,0.69253893253264,0,4,Ndc80 complex,CC,
12116,GO:0048239,0.999999999997486,0.813588055035221,0,2,negative regulation of DNA recombination at telomere,BP,
15888,GO:0072695,0.999999999997486,0.813588055035221,0,2,regulation of DNA recombination at telomere,BP,
19005,GO:1904875,0.999999999997486,0.813588055035221,0,2,regulation of DNA ligase activity,BP,
16215,GO:0090296,0.999999999997497,0.669298837261749,0,4,regulation of mitochondrial DNA replication,BP,
17760,GO:1901858,0.999999999997497,0.669298837261749,0,4,regulation of mitochondrial DNA metabolic process,BP,
18040,GO:1902626,0.999999999997501,0.780317228314944,0,3,assembly of large subunit precursor of preribosome,BP,
1712,GO:0004307,0.999999999997506,0.828645867942797,0,2,ethanolaminephosphotransferase activity,MF,
15006,GO:0070976,0.999999999997559,0.901381748374486,0,1,TIR domain binding,MF,
9011,GO:0035241,0.999999999997571,0.732549514381395,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
3067,GO:0006642,0.999999999997591,0.732588031545969,0,3,triglyceride mobilization,BP,
4240,GO:0009449,0.999999999997591,0.732588031545969,0,3,gamma-aminobutyric acid biosynthetic process,BP,
18328,GO:1903335,0.999999999997613,0.675216804323565,0,4,regulation of vacuolar transport,BP,
4976,GO:0015112,0.999999999997626,0.901392633442174,0,1,nitrate transmembrane transporter activity,MF,
5154,GO:0015706,0.999999999997626,0.901392633442174,0,1,nitrate transport,BP,
18830,GO:1904481,0.999999999997637,0.901537842599558,0,1,response to tetrahydrofolate,BP,
18831,GO:1904482,0.999999999997637,0.901537842599558,0,1,cellular response to tetrahydrofolate,BP,
11725,GO:0046588,0.999999999997683,0.923252956643357,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
9563,GO:0036396,0.999999999997694,0.73897827508374,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
11171,GO:0045293,0.999999999997694,0.73897827508374,0,3,mRNA editing complex,CC,
19341,GO:1905799,0.999999999997717,0.930047063570514,0,1,regulation of intraciliary retrograde transport,BP,
34,GO:0000064,0.999999999997723,0.662308657624881,0,4,L-ornithine transmembrane transporter activity,MF,
15687,GO:0072268,0.999999999997726,0.735413583768721,0,3,pattern specification involved in metanephros development,BP,
5864,GO:0017187,0.999999999997734,0.687202803911642,0,4,peptidyl-glutamic acid carboxylation,BP,
5925,GO:0018214,0.999999999997734,0.687202803911642,0,4,protein carboxylation,BP,
17016,GO:0099522,0.999999999997788,0.903088503175547,0,1,region of cytosol,CC,
17017,GO:0099523,0.999999999997788,0.903088503175547,0,1,presynaptic cytosol,CC,
17018,GO:0099524,0.999999999997788,0.903088503175547,0,1,postsynaptic cytosol,CC,
18952,GO:1904764,0.999999999997788,0.903088503175547,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
19611,GO:1990832,0.999999999997788,0.903088503175547,0,1,slow axonal transport,BP,
19612,GO:1990833,0.999999999997788,0.903088503175547,0,1,clathrin-uncoating ATPase activity,MF,
19095,GO:1905065,0.99999999999779,0.735928011079463,0,3,positive regulation of vascular smooth muscle cell differentiation,BP,
5081,GO:0015355,0.999999999997797,0.669569844169337,0,4,secondary active monocarboxylate transmembrane transporter activity,MF,
3945,GO:0008670,0.999999999997821,0.830356208295615,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
15466,GO:0071865,0.999999999997842,0.673499699264075,0,4,regulation of apoptotic process in bone marrow,BP,
15467,GO:0071866,0.999999999997842,0.673499699264075,0,4,negative regulation of apoptotic process in bone marrow,BP,
5960,GO:0018401,0.999999999997845,0.661015204100713,0,4,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
204,GO:0000430,0.99999999999785,0.821676297091494,0,2,regulation of transcription from RNA polymerase II promoter by glucose,BP,
206,GO:0000432,0.99999999999785,0.821676297091494,0,2,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
12345,GO:0048752,0.999999999997882,0.738574024725563,0,3,semicircular canal morphogenesis,BP,
9251,GO:0035691,0.999999999997889,0.91318597107376,0,1,macrophage migration inhibitory factor signaling pathway,BP,
9253,GO:0035693,0.999999999997889,0.91318597107376,0,1,NOS2-CD74 complex,CC,
10106,GO:0042658,0.999999999997889,0.91318597107376,0,1,MHC class II protein binding, via antigen binding groove,MF,
7946,GO:0032557,0.999999999997907,0.733269134640574,0,3,pyrimidine ribonucleotide binding,MF,
15428,GO:0071787,0.999999999997921,0.660683568819546,0,4,endoplasmic reticulum tubular network formation,BP,
4839,GO:0014061,0.999999999997927,0.733367268505307,0,3,regulation of norepinephrine secretion,BP,
1893,GO:0004581,0.999999999997957,0.916411749351958,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
11196,GO:0045348,0.999999999997967,0.740244380187887,0,3,positive regulation of MHC class II biosynthetic process,BP,
5403,GO:0016259,0.999999999997999,0.662572054877324,0,4,selenocysteine metabolic process,BP,
6728,GO:0030156,0.999999999998005,0.928118934745782,0,1,benzodiazepine receptor binding,MF,
17887,GO:1902226,0.99999999999801,0.817119645778539,0,2,regulation of macrophage colony-stimulating factor signaling pathway,BP,
18626,GO:1903969,0.99999999999801,0.817119645778539,0,2,regulation of response to macrophage colony-stimulating factor,BP,
18629,GO:1903972,0.99999999999801,0.817119645778539,0,2,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
7864,GO:0032437,0.999999999998013,0.738270733555526,0,3,cuticular plate,CC,
14155,GO:0061083,0.999999999998026,0.661936255103517,0,4,regulation of protein refolding,BP,
14156,GO:0061084,0.999999999998026,0.661936255103517,0,4,negative regulation of protein refolding,BP,
6401,GO:0021649,0.999999999998045,0.901505080243791,0,1,vestibulocochlear nerve structural organization,BP,
9674,GO:0038085,0.999999999998045,0.901505080243791,0,1,vascular endothelial growth factor binding,MF,
13704,GO:0060301,0.999999999998045,0.901505080243791,0,1,positive regulation of cytokine activity,BP,
14321,GO:0061552,0.999999999998045,0.901505080243791,0,1,ganglion morphogenesis,BP,
16551,GO:0097374,0.999999999998045,0.901505080243791,0,1,sensory neuron axon guidance,BP,
17949,GO:1902378,0.999999999998045,0.901505080243791,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
18986,GO:1904835,0.999999999998045,0.901505080243791,0,1,dorsal root ganglion morphogenesis,BP,
19082,GO:1905040,0.999999999998045,0.901505080243791,0,1,otic placode development,BP,
6816,GO:0030289,0.999999999998051,0.675000535201629,0,4,protein phosphatase 4 complex,CC,
16255,GO:0090362,0.999999999998067,0.813624341365972,0,2,positive regulation of platelet-derived growth factor production,BP,
8293,GO:0033141,0.99999999999808,0.678228231945445,0,4,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
6003,GO:0019061,0.999999999998097,0.901940402301566,0,1,uncoating of virus,BP,
10234,GO:0042986,0.999999999998099,0.814565123120954,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
9277,GO:0035733,0.999999999998118,0.661795065572421,0,4,hepatic stellate cell activation,BP,
8071,GO:0032767,0.99999999999812,0.760366261214057,0,3,copper-dependent protein binding,MF,
15902,GO:0072717,0.999999999998154,0.758076659975523,0,3,cellular response to actinomycin D,BP,
9685,GO:0038107,0.999999999998158,0.739266390299369,0,3,nodal signaling pathway involved in determination of left/right asymmetry,BP,
17344,GO:1900094,0.999999999998158,0.739266390299369,0,3,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
17393,GO:1900164,0.999999999998158,0.739266390299369,0,3,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
1530,GO:0003917,0.999999999998183,0.662011481357675,0,4,DNA topoisomerase type I activity,MF,
10191,GO:0042824,0.999999999998183,0.662011481357675,0,4,MHC class I peptide loading complex,CC,
6670,GO:0030043,0.999999999998192,0.673623019142674,0,4,actin filament fragmentation,BP,
6632,GO:0023029,0.9999999999982,0.660688386316208,0,4,MHC class Ib protein binding,MF,
8322,GO:0033183,0.999999999998207,0.732540346892769,0,3,negative regulation of histone ubiquitination,BP,
17592,GO:1901314,0.999999999998207,0.732540346892769,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
17593,GO:1901315,0.999999999998207,0.732540346892769,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
5402,GO:0016256,0.999999999998223,0.824365598424029,0,2,N-glycan processing to lysosome,BP,
7175,GO:0031074,0.999999999998226,0.746541577089215,0,3,nucleocytoplasmic transport complex,CC,
4323,GO:0009881,0.999999999998248,0.660106564549823,0,4,photoreceptor activity,MF,
19798,GO:2000286,0.999999999998286,0.732409752269721,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
1240,GO:0002940,0.999999999998308,0.813270127017819,0,2,tRNA N2-guanine methylation,BP,
1860,GO:0004528,0.999999999998326,0.667732641045889,0,4,phosphodiesterase I activity,MF,
5941,GO:0018307,0.999999999998341,0.831676767932277,0,2,enzyme active site formation,BP,
9224,GO:0035634,0.99999999999835,0.849056696736015,0,2,response to stilbenoid,BP,
1541,GO:0003938,0.999999999998376,0.817132206901931,0,2,IMP dehydrogenase activity,MF,
7068,GO:0030868,0.999999999998377,0.742869113550303,0,3,smooth endoplasmic reticulum membrane,CC,
16571,GO:0097425,0.999999999998377,0.742869113550303,0,3,smooth endoplasmic reticulum part,CC,
11206,GO:0045358,0.999999999998384,0.825755298102541,0,2,negative regulation of interferon-beta biosynthetic process,BP,
11699,GO:0046525,0.999999999998389,0.90603638597805,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
13825,GO:0060456,0.999999999998399,0.733533979556924,0,3,positive regulation of digestive system process,BP,
6796,GO:0030259,0.999999999998407,0.665027117274828,0,4,lipid glycosylation,BP,
782,GO:0002041,0.999999999998424,0.901891625492842,0,1,intussusceptive angiogenesis,BP,
11854,GO:0046884,0.999999999998435,0.660791123851493,0,4,follicle-stimulating hormone secretion,BP,
350,GO:0000964,0.999999999998438,0.675241435044903,0,4,mitochondrial RNA 5'-end processing,BP,
6683,GO:0030070,0.999999999998465,0.732496431974096,0,3,insulin processing,BP,
3095,GO:0006680,0.999999999998491,0.732533673271743,0,3,glucosylceramide catabolic process,BP,
697,GO:0001918,0.999999999998492,0.901378020617301,0,1,farnesylated protein binding,MF,
7406,GO:0031508,0.999999999998506,0.826188452087826,0,2,pericentric heterochromatin assembly,BP,
18407,GO:1903516,0.999999999998513,0.733336761095402,0,3,regulation of single strand break repair,BP,
9923,GO:0042296,0.99999999999852,0.679623052037885,0,4,ISG15 transferase activity,MF,
18518,GO:1903753,0.99999999999852,0.660583148736514,0,4,negative regulation of p38MAPK cascade,BP,
4294,GO:0009753,0.99999999999853,0.82934554589405,0,2,response to jasmonic acid,BP,
5970,GO:0018636,0.99999999999853,0.82934554589405,0,2,phenanthrene 9,10-monooxygenase activity,MF,
11925,GO:0047023,0.99999999999853,0.82934554589405,0,2,androsterone dehydrogenase activity,MF,
11932,GO:0047086,0.99999999999853,0.82934554589405,0,2,ketosteroid monooxygenase activity,MF,
11934,GO:0047115,0.99999999999853,0.82934554589405,0,2,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
15210,GO:0071395,0.99999999999853,0.82934554589405,0,2,cellular response to jasmonic acid stimulus,BP,
3830,GO:0008446,0.999999999998538,0.906695403647488,0,1,GDP-mannose 4,6-dehydratase activity,MF,
14222,GO:0061300,0.999999999998541,0.819493044448668,0,2,cerebellum vasculature development,BP,
1550,GO:0003952,0.999999999998545,0.901559083187069,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1577,GO:0003990,0.999999999998545,0.901559083187069,0,1,acetylcholinesterase activity,MF,
4812,GO:0014016,0.999999999998545,0.901559083187069,0,1,neuroblast differentiation,BP,
11649,GO:0046448,0.999999999998545,0.901559083187069,0,1,tropane alkaloid metabolic process,BP,
12579,GO:0050783,0.999999999998545,0.901559083187069,0,1,cocaine metabolic process,BP,
8868,GO:0034699,0.999999999998555,0.73234152996792,0,3,response to luteinizing hormone,BP,
17402,GO:1900186,0.999999999998575,0.738702208574562,0,3,negative regulation of clathrin-dependent endocytosis,BP,
5786,GO:0017040,0.999999999998581,0.682078406285896,0,4,N-acylsphingosine amidohydrolase activity,MF,
16058,GO:0090063,0.999999999998589,0.660315540825871,0,4,positive regulation of microtubule nucleation,BP,
849,GO:0002177,0.999999999998597,0.747517046284819,0,3,manchette,CC,
11704,GO:0046533,0.9999999999986,0.660851945551477,0,4,negative regulation of photoreceptor cell differentiation,BP,
971,GO:0002420,0.999999999998607,0.660417809089603,0,4,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
972,GO:0002423,0.999999999998607,0.660417809089603,0,4,natural killer cell mediated immune response to tumor cell,BP,
1195,GO:0002855,0.999999999998607,0.660417809089603,0,4,regulation of natural killer cell mediated immune response to tumor cell,BP,
1198,GO:0002858,0.999999999998607,0.660417809089603,0,4,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
13619,GO:0060154,0.99999999999863,0.746190406040025,0,3,cellular process regulating host cell cycle in response to virus,BP,
5032,GO:0015222,0.999999999998631,0.814918796139758,0,2,serotonin transmembrane transporter activity,MF,
982,GO:0002439,0.999999999998634,0.81836065639545,0,2,chronic inflammatory response to antigenic stimulus,BP,
7357,GO:0031416,0.999999999998643,0.82837433495272,0,2,NatB complex,CC,
1782,GO:0004408,0.999999999998675,0.901900547047838,0,1,holocytochrome-c synthase activity,MF,
5771,GO:0017003,0.999999999998675,0.901900547047838,0,1,protein-heme linkage,BP,
5774,GO:0017006,0.999999999998675,0.901900547047838,0,1,protein-tetrapyrrole linkage,BP,
5882,GO:0018063,0.999999999998675,0.901900547047838,0,1,cytochrome c-heme linkage,BP,
660,GO:0001855,0.999999999998678,0.908085532433964,0,1,complement component C4b binding,MF,
15917,GO:0072757,0.999999999998679,0.660587047890736,0,4,cellular response to camptothecin,BP,
8110,GO:0032810,0.999999999998692,0.818881062099751,0,2,sterol response element binding,MF,
16719,GO:0098508,0.999999999998705,0.814500193800298,0,2,endothelial to hematopoietic transition,BP,
18937,GO:1904742,0.999999999998709,0.674450891124672,0,4,regulation of telomeric DNA binding,BP,
2237,GO:0005152,0.999999999998717,0.735561607573825,0,3,interleukin-1 receptor antagonist activity,MF,
15447,GO:0071818,0.999999999998781,0.733826813764368,0,3,BAT3 complex,CC,
15749,GO:0072379,0.999999999998781,0.733826813764368,0,3,ER membrane insertion complex,CC,
228,GO:0000472,0.999999999998798,0.73285698217935,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
353,GO:0000967,0.999999999998798,0.73285698217935,0,3,rRNA 5'-end processing,BP,
19519,GO:1990481,0.999999999998801,0.666560281039912,0,4,mRNA pseudouridine synthesis,BP,
7560,GO:0031933,0.999999999998804,0.737772759027107,0,3,telomeric heterochromatin,CC,
5290,GO:0015990,0.999999999998812,0.926614599249218,0,1,electron transport coupled proton transport,BP,
9125,GO:0035485,0.999999999998834,0.904679944598474,0,1,adenine/guanine mispair binding,MF,
9041,GO:0035281,0.999999999998838,0.828236650137765,0,2,pre-miRNA export from nucleus,BP,
10053,GO:0042565,0.999999999998838,0.828236650137765,0,2,RNA nuclear export complex,CC,
9422,GO:0036017,0.999999999998841,0.723329512855023,0,4,response to erythropoietin,BP,
9423,GO:0036018,0.999999999998841,0.723329512855023,0,4,cellular response to erythropoietin,BP,
4602,GO:0010729,0.999999999998843,0.903141845699939,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
12087,GO:0048149,0.999999999998874,0.662351418649317,0,4,behavioral response to ethanol,BP,
12440,GO:0050294,0.999999999998878,0.75757215041197,0,3,steroid sulfotransferase activity,MF,
9519,GO:0036284,0.999999999998883,0.819762169025232,0,2,tubulobulbar complex,CC,
19208,GO:1905371,0.999999999998883,0.819762169025232,0,2,ceramide phosphoethanolamine metabolic process,BP,
19209,GO:1905373,0.999999999998883,0.819762169025232,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
7363,GO:0031427,0.99999999999889,0.73266777948826,0,3,response to methotrexate,BP,
4208,GO:0009383,0.999999999998953,0.812478609429838,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
14148,GO:0061073,0.999999999998953,0.812478609429838,0,2,ciliary body morphogenesis,BP,
195,GO:0000414,0.999999999998963,0.660090478492283,0,4,regulation of histone H3-K36 methylation,BP,
337,GO:0000938,0.999999999998963,0.660090478492283,0,4,GARP complex,CC,
373,GO:0000995,0.999999999998963,0.660090478492283,0,4,transcription factor activity, core RNA polymerase III binding,MF,
609,GO:0001778,0.999999999998963,0.660090478492283,0,4,plasma membrane repair,BP,
843,GO:0002159,0.999999999998963,0.660090478492283,0,4,desmosome assembly,BP,
1382,GO:0003284,0.999999999998963,0.660090478492283,0,4,septum primum development,BP,
1814,GO:0004468,0.999999999998963,0.660090478492283,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
2339,GO:0005384,0.999999999998963,0.660090478492283,0,4,manganese ion transmembrane transporter activity,MF,
2479,GO:0005726,0.999999999998963,0.660090478492283,0,4,perichromatin fibrils,CC,
2623,GO:0005955,0.999999999998963,0.660090478492283,0,4,calcineurin complex,CC,
3510,GO:0007442,0.999999999998963,0.660090478492283,0,4,hindgut morphogenesis,BP,
3611,GO:0008066,0.999999999998963,0.660090478492283,0,4,glutamate receptor activity,MF,
3731,GO:0008275,0.999999999998963,0.660090478492283,0,4,gamma-tubulin small complex,CC,
3875,GO:0008517,0.999999999998963,0.660090478492283,0,4,folic acid transmembrane transporter activity,MF,
3900,GO:0008559,0.999999999998963,0.660090478492283,0,4,xenobiotic transmembrane transporting ATPase activity,MF,
4007,GO:0009019,0.999999999998963,0.660090478492283,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4468,GO:0010484,0.999999999998963,0.660090478492283,0,4,H3 histone acetyltransferase activity,MF,
4536,GO:0010624,0.999999999998963,0.660090478492283,0,4,regulation of Schwann cell proliferation,BP,
4537,GO:0010626,0.999999999998963,0.660090478492283,0,4,negative regulation of Schwann cell proliferation,BP,
4826,GO:0014042,0.999999999998963,0.660090478492283,0,4,positive regulation of neuron maturation,BP,
4941,GO:0015014,0.999999999998963,0.660090478492283,0,4,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
5106,GO:0015440,0.999999999998963,0.660090478492283,0,4,peptide-transporting ATPase activity,MF,
5122,GO:0015616,0.999999999998963,0.660090478492283,0,4,DNA translocase activity,MF,
5259,GO:0015917,0.999999999998963,0.660090478492283,0,4,aminophospholipid transport,BP,
5840,GO:0017146,0.999999999998963,0.660090478492283,0,4,NMDA selective glutamate receptor complex,CC,
5884,GO:0018076,0.999999999998963,0.660090478492283,0,4,N-terminal peptidyl-lysine acetylation,BP,
5947,GO:0018335,0.999999999998963,0.660090478492283,0,4,protein succinylation,BP,
5973,GO:0018812,0.999999999998963,0.660090478492283,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
6529,GO:0021943,0.999999999998963,0.660090478492283,0,4,formation of radial glial scaffolds,BP,
6535,GO:0021957,0.999999999998963,0.660090478492283,0,4,corticospinal tract morphogenesis,BP,
6557,GO:0022027,0.999999999998963,0.660090478492283,0,4,interkinetic nuclear migration,BP,
6558,GO:0022028,0.999999999998963,0.660090478492283,0,4,tangential migration from the subventricular zone to the olfactory bulb,BP,
6800,GO:0030263,0.999999999998963,0.660090478492283,0,4,apoptotic chromosome condensation,BP,
6952,GO:0030618,0.999999999998963,0.660090478492283,0,4,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
7116,GO:0030951,0.999999999998963,0.660090478492283,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7423,GO:0031544,0.999999999998963,0.660090478492283,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7576,GO:0031956,0.999999999998963,0.660090478492283,0,4,medium-chain fatty acid-CoA ligase activity,MF,
7612,GO:0032021,0.999999999998963,0.660090478492283,0,4,NELF complex,CC,
7676,GO:0032138,0.999999999998963,0.660090478492283,0,4,single base insertion or deletion binding,MF,
7693,GO:0032184,0.999999999998963,0.660090478492283,0,4,SUMO polymer binding,MF,
7727,GO:0032237,0.999999999998963,0.660090478492283,0,4,activation of store-operated calcium channel activity,BP,
8108,GO:0032808,0.999999999998963,0.660090478492283,0,4,lacrimal gland development,BP,
8136,GO:0032876,0.999999999998963,0.660090478492283,0,4,negative regulation of DNA endoreduplication,BP,
8194,GO:0032960,0.999999999998963,0.660090478492283,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
8340,GO:0033220,0.999999999998963,0.660090478492283,0,4,amide-transporting ATPase activity,MF,
8354,GO:0033263,0.999999999998963,0.660090478492283,0,4,CORVET complex,CC,
8365,GO:0033278,0.999999999998963,0.660090478492283,0,4,cell proliferation in midbrain,BP,
8684,GO:0034334,0.999999999998963,0.660090478492283,0,4,adherens junction maintenance,BP,
8836,GO:0034648,0.999999999998963,0.660090478492283,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
8955,GO:0035061,0.999999999998963,0.660090478492283,0,4,interchromatin granule,CC,
9161,GO:0035546,0.999999999998963,0.660090478492283,0,4,interferon-beta secretion,BP,
9162,GO:0035547,0.999999999998963,0.660090478492283,0,4,regulation of interferon-beta secretion,BP,
9163,GO:0035549,0.999999999998963,0.660090478492283,0,4,positive regulation of interferon-beta secretion,BP,
9247,GO:0035673,0.999999999998963,0.660090478492283,0,4,oligopeptide transmembrane transporter activity,MF,
9429,GO:0036033,0.999999999998963,0.660090478492283,0,4,mediator complex binding,MF,
9442,GO:0036056,0.999999999998963,0.660090478492283,0,4,filtration diaphragm,CC,
9443,GO:0036057,0.999999999998963,0.660090478492283,0,4,slit diaphragm,CC,
9582,GO:0036457,0.999999999998963,0.660090478492283,0,4,keratohyalin granule,CC,
10100,GO:0042636,0.999999999998963,0.660090478492283,0,4,negative regulation of hair cycle,BP,
10102,GO:0042640,0.999999999998963,0.660090478492283,0,4,anagen,BP,
10386,GO:0043237,0.999999999998963,0.660090478492283,0,4,laminin-1 binding,MF,
10582,GO:0043570,0.999999999998963,0.660090478492283,0,4,maintenance of DNA repeat elements,BP,
11106,GO:0045162,0.999999999998963,0.660090478492283,0,4,clustering of voltage-gated sodium channels,BP,
11190,GO:0045341,0.999999999998963,0.660090478492283,0,4,MHC class I biosynthetic process,BP,
11192,GO:0045343,0.999999999998963,0.660090478492283,0,4,regulation of MHC class I biosynthetic process,BP,
11193,GO:0045345,0.999999999998963,0.660090478492283,0,4,positive regulation of MHC class I biosynthetic process,BP,
11650,GO:0046449,0.999999999998963,0.660090478492283,0,4,creatinine metabolic process,BP,
11805,GO:0046726,0.999999999998963,0.660090478492283,0,4,positive regulation by virus of viral protein levels in host cell,BP,
11952,GO:0047238,0.999999999998963,0.660090478492283,0,4,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
11992,GO:0047555,0.999999999998963,0.660090478492283,0,4,3',5'-cyclic-GMP phosphodiesterase activity,MF,
12171,GO:0048341,0.999999999998963,0.660090478492283,0,4,paraxial mesoderm formation,BP,
12223,GO:0048520,0.999999999998963,0.660090478492283,0,4,positive regulation of behavior,BP,
12362,GO:0048793,0.999999999998963,0.660090478492283,0,4,pronephros development,BP,
12471,GO:0050510,0.999999999998963,0.660090478492283,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
13196,GO:0051884,0.999999999998963,0.660090478492283,0,4,regulation of timing of anagen,BP,
13249,GO:0051964,0.999999999998963,0.660090478492283,0,4,negative regulation of synapse assembly,BP,
13389,GO:0052811,0.999999999998963,0.660090478492283,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
13469,GO:0055059,0.999999999998963,0.660090478492283,0,4,asymmetric neuroblast division,BP,
13600,GO:0060123,0.999999999998963,0.660090478492283,0,4,regulation of growth hormone secretion,BP,
13859,GO:0060526,0.999999999998963,0.660090478492283,0,4,prostate glandular acinus morphogenesis,BP,
13860,GO:0060527,0.999999999998963,0.660090478492283,0,4,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
13994,GO:0060745,0.999999999998963,0.660090478492283,0,4,mammary gland branching involved in pregnancy,BP,
14063,GO:0060916,0.999999999998963,0.660090478492283,0,4,mesenchymal cell proliferation involved in lung development,BP,
14244,GO:0061343,0.999999999998963,0.660090478492283,0,4,cell adhesion involved in heart morphogenesis,BP,
14437,GO:0061821,0.999999999998963,0.660090478492283,0,4,telomeric D-loop binding,MF,
14500,GO:0070022,0.999999999998963,0.660090478492283,0,4,transforming growth factor beta receptor complex,CC,
14563,GO:0070137,0.999999999998963,0.660090478492283,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
14565,GO:0070139,0.999999999998963,0.660090478492283,0,4,SUMO-specific endopeptidase activity,MF,
14905,GO:0070815,0.999999999998963,0.660090478492283,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
14944,GO:0070876,0.999999999998963,0.660090478492283,0,4,SOSS complex,CC,
15137,GO:0071284,0.999999999998963,0.660090478492283,0,4,cellular response to lead ion,BP,
15377,GO:0071664,0.999999999998963,0.660090478492283,0,4,catenin-TCF7L2 complex,CC,
15489,GO:0071896,0.999999999998963,0.660090478492283,0,4,protein localization to adherens junction,BP,
15753,GO:0072385,0.999999999998963,0.660090478492283,0,4,minus-end-directed organelle transport along microtubule,BP,
15873,GO:0072672,0.999999999998963,0.660090478492283,0,4,neutrophil extravasation,BP,
16036,GO:0090009,0.999999999998963,0.660090478492283,0,4,primitive streak formation,BP,
16065,GO:0090071,0.999999999998963,0.660090478492283,0,4,negative regulation of ribosome biogenesis,BP,
16170,GO:0090230,0.999999999998963,0.660090478492283,0,4,regulation of centromere complex assembly,BP,
16226,GO:0090309,0.999999999998963,0.660090478492283,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
16767,GO:0098634,0.999999999998963,0.660090478492283,0,4,cell-matrix adhesion mediator activity,MF,
16769,GO:0098639,0.999999999998963,0.660090478492283,0,4,collagen binding involved in cell-matrix adhesion,MF,
16796,GO:0098706,0.999999999998963,0.660090478492283,0,4,ferric iron import across plasma membrane,BP,
17101,GO:0102158,0.999999999998963,0.660090478492283,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
17113,GO:0102343,0.999999999998963,0.660090478492283,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
17114,GO:0102344,0.999999999998963,0.660090478492283,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
17115,GO:0102345,0.999999999998963,0.660090478492283,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
17118,GO:0102391,0.999999999998963,0.660090478492283,0,4,decanoate-CoA ligase activity,MF,
17119,GO:0102420,0.999999999998963,0.660090478492283,0,4,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
17189,GO:0106077,0.999999999998963,0.660090478492283,0,4,histone succinylation,BP,
17424,GO:1900227,0.999999999998963,0.660090478492283,0,4,positive regulation of NLRP3 inflammasome complex assembly,BP,
17454,GO:1900376,0.999999999998963,0.660090478492283,0,4,regulation of secondary metabolite biosynthetic process,BP,
17604,GO:1901341,0.999999999998963,0.660090478492283,0,4,positive regulation of store-operated calcium channel activity,BP,
17882,GO:1902219,0.999999999998963,0.660090478492283,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
18491,GO:1903690,0.999999999998963,0.660090478492283,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
19346,GO:1905832,0.999999999998963,0.660090478492283,0,4,positive regulation of spindle assembly,BP,
19524,GO:1990511,0.999999999998963,0.660090478492283,0,4,piRNA biosynthetic process,BP,
19580,GO:1990745,0.999999999998963,0.660090478492283,0,4,EARP complex,CC,
19683,GO:2000051,0.999999999998963,0.660090478492283,0,4,negative regulation of non-canonical Wnt signaling pathway,BP,
19855,GO:2000370,0.999999999998963,0.660090478492283,0,4,positive regulation of clathrin-dependent endocytosis,BP,
19980,GO:2000622,0.999999999998963,0.660090478492283,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
19981,GO:2000623,0.999999999998963,0.660090478492283,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
20022,GO:2000675,0.999999999998963,0.660090478492283,0,4,negative regulation of type B pancreatic cell apoptotic process,BP,
16458,GO:0097176,0.999999999998983,0.666960308979354,0,4,epoxide metabolic process,BP,
6221,GO:0019781,0.999999999998984,0.816745636503515,0,2,NEDD8 activating enzyme activity,MF,
18032,GO:1902612,0.999999999999007,0.901378989710992,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
18033,GO:1902613,0.999999999999007,0.901378989710992,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19463,GO:1990262,0.999999999999007,0.901378989710992,0,1,anti-Mullerian hormone signaling pathway,BP,
1920,GO:0004618,0.999999999999014,0.901585339604302,0,1,phosphoglycerate kinase activity,MF,
15526,GO:0071987,0.999999999999058,0.660114131697846,0,4,WD40-repeat domain binding,MF,
3405,GO:0007195,0.999999999999062,0.81264399724288,0,2,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
6033,GO:0019145,0.999999999999067,0.901482150357679,0,1,aminobutyraldehyde dehydrogenase activity,MF,
8503,GO:0033737,0.999999999999067,0.901482150357679,0,1,1-pyrroline dehydrogenase activity,MF,
11933,GO:0047105,0.999999999999067,0.901482150357679,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
16435,GO:0097135,0.999999999999069,0.813081214659083,0,2,cyclin E2-CDK2 complex,CC,
10115,GO:0042670,0.999999999999069,0.732547198871996,0,3,retinal cone cell differentiation,BP,
11714,GO:0046549,0.999999999999069,0.732547198871996,0,3,retinal cone cell development,BP,
2257,GO:0005176,0.999999999999072,0.826748149380193,0,2,ErbB-2 class receptor binding,MF,
6216,GO:0019776,0.999999999999078,0.743088660831874,0,3,Atg8 ligase activity,MF,
17893,GO:1902232,0.999999999999087,0.816939515255115,0,2,regulation of positive thymic T cell selection,BP,
19436,GO:1990166,0.999999999999088,0.732603014633543,0,3,protein localization to site of double-strand break,BP,
2472,GO:0005712,0.999999999999139,0.812606897309425,0,2,chiasma,CC,
3335,GO:0007060,0.999999999999139,0.812606897309425,0,2,male meiosis chromosome segregation,BP,
11466,GO:0045950,0.999999999999139,0.812606897309425,0,2,negative regulation of mitotic recombination,BP,
5133,GO:0015670,0.999999999999139,0.906822361637259,0,1,carbon dioxide transport,BP,
8128,GO:0032849,0.999999999999139,0.906822361637259,0,1,positive regulation of cellular pH reduction,BP,
11102,GO:0045153,0.999999999999139,0.915459635524678,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
9430,GO:0036034,0.999999999999141,0.812813787996357,0,2,mediator complex assembly,BP,
20203,GO:2001176,0.999999999999141,0.812813787996357,0,2,regulation of mediator complex assembly,BP,
20204,GO:2001178,0.999999999999141,0.812813787996357,0,2,positive regulation of mediator complex assembly,BP,
4979,GO:0015117,0.999999999999145,0.904226227658408,0,1,thiosulfate transmembrane transporter activity,MF,
4985,GO:0015131,0.999999999999145,0.904226227658408,0,1,oxaloacetate transmembrane transporter activity,MF,
5155,GO:0015709,0.999999999999145,0.904226227658408,0,1,thiosulfate transport,BP,
5165,GO:0015729,0.999999999999145,0.904226227658408,0,1,oxaloacetate transport,BP,
5171,GO:0015743,0.999999999999145,0.904226227658408,0,1,malate transport,BP,
15227,GO:0071423,0.999999999999145,0.904226227658408,0,1,malate transmembrane transport,BP,
17939,GO:1902356,0.999999999999145,0.904226227658408,0,1,oxaloacetate(2-) transmembrane transport,BP,
320,GO:0000839,0.999999999999146,0.73746969473793,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
2411,GO:0005591,0.999999999999148,0.901401230212074,0,1,collagen type VIII trimer,CC,
2417,GO:0005598,0.999999999999148,0.901401230212074,0,1,short-chain collagen trimer,CC,
7108,GO:0030935,0.999999999999148,0.901401230212074,0,1,sheet-forming collagen trimer,CC,
16775,GO:0098646,0.999999999999148,0.901401230212074,0,1,collagen sheet,CC,
1263,GO:0003025,0.999999999999171,0.813291346645767,0,2,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
16470,GO:0097195,0.999999999999171,0.813291346645767,0,2,pilomotor reflex,BP,
1802,GO:0004452,0.999999999999185,0.823282064605877,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
12703,GO:0050992,0.999999999999185,0.823282064605877,0,2,dimethylallyl diphosphate biosynthetic process,BP,
12704,GO:0050993,0.999999999999185,0.823282064605877,0,2,dimethylallyl diphosphate metabolic process,BP,
2139,GO:0004955,0.999999999999187,0.815323821985925,0,2,prostaglandin receptor activity,MF,
15146,GO:0071306,0.999999999999187,0.815323821985925,0,2,cellular response to vitamin E,BP,
15283,GO:0071502,0.999999999999198,0.745173203127078,0,3,cellular response to temperature stimulus,BP,
4009,GO:0009032,0.999999999999204,0.906922360806737,0,1,thymidine phosphorylase activity,MF,
5355,GO:0016154,0.999999999999204,0.906922360806737,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
617,GO:0001787,0.999999999999206,0.675171375921409,0,4,natural killer cell proliferation,BP,
12801,GO:0051132,0.999999999999206,0.675171375921409,0,4,NK T cell activation,BP,
1977,GO:0004699,0.999999999999209,0.732333156853655,0,3,calcium-independent protein kinase C activity,MF,
3955,GO:0008747,0.999999999999212,0.908501316159216,0,1,N-acetylneuraminate lyase activity,MF,
4261,GO:0009624,0.999999999999261,0.901408438029495,0,1,response to nematode,BP,
4279,GO:0009692,0.999999999999261,0.901408438029495,0,1,ethylene metabolic process,BP,
4280,GO:0009698,0.999999999999261,0.901408438029495,0,1,phenylpropanoid metabolic process,BP,
4309,GO:0009804,0.999999999999261,0.901408438029495,0,1,coumarin metabolic process,BP,
5621,GO:0016711,0.999999999999261,0.901408438029495,0,1,flavonoid 3'-monooxygenase activity,MF,
6096,GO:0019341,0.999999999999261,0.901408438029495,0,1,dibenzo-p-dioxin catabolic process,BP,
10504,GO:0043449,0.999999999999261,0.901408438029495,0,1,cellular alkene metabolic process,BP,
14108,GO:0061002,0.999999999999273,0.738512318263059,0,3,negative regulation of dendritic spine morphogenesis,BP,
14320,GO:0061551,0.99999999999928,0.732436407470654,0,3,trigeminal ganglion development,BP,
17298,GO:0150018,0.99999999999928,0.732436407470654,0,3,basal dendrite development,BP,
17299,GO:0150019,0.99999999999928,0.732436407470654,0,3,basal dendrite morphogenesis,BP,
17300,GO:0150020,0.99999999999928,0.732436407470654,0,3,basal dendrite arborization,BP,
1540,GO:0003937,0.999999999999293,0.902699995245354,0,1,IMP cyclohydrolase activity,MF,
1937,GO:0004643,0.999999999999293,0.902699995245354,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
13385,GO:0052798,0.999999999999293,0.902699995245354,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
16459,GO:0097177,0.9999999999993,0.748546344145885,0,3,mitochondrial ribosome binding,MF,
8401,GO:0033477,0.999999999999307,0.903366327433384,0,1,S-methylmethionine metabolic process,BP,
11940,GO:0047150,0.999999999999307,0.903366327433384,0,1,betaine-homocysteine S-methyltransferase activity,MF,
14358,GO:0061627,0.999999999999307,0.903366327433384,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
11909,GO:0046977,0.999999999999308,0.669183714827679,0,4,TAP binding,MF,
11910,GO:0046978,0.999999999999308,0.669183714827679,0,4,TAP1 binding,MF,
8555,GO:0034038,0.999999999999308,0.916020566742634,0,1,deoxyhypusine synthase activity,MF,
12982,GO:0051434,0.999999999999309,0.678226589519948,0,4,BH3 domain binding,MF,
14205,GO:0061196,0.999999999999314,0.661050737989389,0,4,fungiform papilla development,BP,
14206,GO:0061197,0.999999999999314,0.661050737989389,0,4,fungiform papilla morphogenesis,BP,
8777,GO:0034481,0.999999999999322,0.661547168255942,0,4,chondroitin sulfotransferase activity,MF,
410,GO:0001097,0.99999999999936,0.738408147660371,0,3,TFIIH-class transcription factor binding,MF,
13016,GO:0051499,0.999999999999371,0.822120207860955,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13017,GO:0051500,0.999999999999371,0.822120207860955,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
9279,GO:0035739,0.999999999999376,0.66161754918807,0,4,CD4-positive, alpha-beta T cell proliferation,BP,
19945,GO:2000561,0.999999999999376,0.66161754918807,0,4,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
2782,GO:0006226,0.999999999999387,0.741267079731738,0,3,dUMP biosynthetic process,BP,
15726,GO:0072344,0.999999999999401,0.664607942792888,0,4,rescue of stalled ribosome,BP,
16578,GO:0097441,0.999999999999403,0.740162791012822,0,3,basal dendrite,CC,
1728,GO:0004326,0.999999999999415,0.901498217233375,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
3977,GO:0008841,0.999999999999415,0.901498217233375,0,1,dihydrofolate synthase activity,MF,
11864,GO:0046901,0.999999999999415,0.901498217233375,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
7317,GO:0031339,0.999999999999418,0.737270340772898,0,3,negative regulation of vesicle fusion,BP,
11150,GO:0045234,0.999999999999426,0.905304817387078,0,1,protein palmitoleylation,BP,
9082,GO:0035368,0.999999999999439,0.663935412128315,0,4,selenocysteine insertion sequence binding,MF,
16111,GO:0090149,0.999999999999483,0.812848233131522,0,2,mitochondrial membrane fission,BP,
2903,GO:0006421,0.999999999999491,0.732783797807266,0,3,asparaginyl-tRNA aminoacylation,BP,
11994,GO:0047578,0.999999999999494,0.901547535160626,0,1,4-hydroxyglutamate transaminase activity,MF,
11336,GO:0045716,0.999999999999497,0.743794709693887,0,3,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
16667,GO:0097643,0.999999999999512,0.923280706354884,0,1,amylin receptor activity,MF,
18384,GO:1903440,0.999999999999512,0.923280706354884,0,1,amylin receptor complex,CC,
19491,GO:1990407,0.999999999999512,0.923280706354884,0,1,calcitonin gene-related peptide binding,MF,
9620,GO:0036506,0.999999999999514,0.73343471332795,0,3,maintenance of unfolded protein,BP,
18785,GO:1904378,0.999999999999514,0.73343471332795,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
328,GO:0000917,0.999999999999543,0.904623925772258,0,1,division septum assembly,BP,
16297,GO:0090529,0.999999999999543,0.904623925772258,0,1,cell septum assembly,BP,
18638,GO:1903984,0.999999999999543,0.733664936318436,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
14266,GO:0061394,0.99999999999957,0.818258734241016,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
10036,GO:0042536,0.999999999999583,0.739730124325411,0,3,negative regulation of tumor necrosis factor biosynthetic process,BP,
1573,GO:0003986,0.99999999999961,0.764488684268825,0,3,acetyl-CoA hydrolase activity,MF,
158,GO:0000322,0.999999999999646,0.741415176985746,0,3,storage vacuole,CC,
18063,GO:1902713,0.999999999999651,0.660092924307503,0,4,regulation of interferon-gamma secretion,BP,
19512,GO:1990450,0.999999999999656,0.902744947409375,0,1,linear polyubiquitin binding,MF,
13972,GO:0060715,0.999999999999666,0.733797157666711,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
3421,GO:0007217,0.999999999999675,0.901430832181236,0,1,tachykinin receptor signaling pathway,BP,
8526,GO:0033867,0.999999999999681,0.907155026897737,0,1,Fas-activated serine/threonine kinase activity,MF,
4441,GO:0010387,0.999999999999683,0.901888674377449,0,1,COP9 signalosome assembly,BP,
6152,GO:0019510,0.999999999999683,0.901888674377449,0,1,S-adenosylhomocysteine catabolic process,BP,
15129,GO:0071268,0.999999999999683,0.901888674377449,0,1,homocysteine biosynthetic process,BP,
11612,GO:0046340,0.999999999999686,0.81247689620173,0,2,diacylglycerol catabolic process,BP,
10662,GO:0043932,0.999999999999699,0.813221440974449,0,2,ossification involved in bone remodeling,BP,
19946,GO:2000562,0.999999999999703,0.814353963003533,0,2,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
20014,GO:2000666,0.999999999999703,0.814353963003533,0,2,negative regulation of interleukin-13 secretion,BP,
16492,GO:0097229,0.999999999999715,0.912824971757076,0,1,sperm end piece,CC,
1733,GO:0004334,0.999999999999718,0.910318054072191,0,1,fumarylacetoacetase activity,MF,
8941,GO:0035022,0.999999999999721,0.680601605561179,0,4,positive regulation of Rac protein signal transduction,BP,
4823,GO:0014038,0.99999999999973,0.735940587253808,0,3,regulation of Schwann cell differentiation,BP,
311,GO:0000823,0.999999999999754,0.905213508922196,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
312,GO:0000824,0.999999999999754,0.905213508922196,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
313,GO:0000825,0.999999999999754,0.905213508922196,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
11967,GO:0047326,0.999999999999754,0.905213508922196,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
5480,GO:0016426,0.999999999999761,0.662512924050759,0,4,tRNA (adenine) methyltransferase activity,MF,
5513,GO:0016493,0.999999999999774,0.813597655489888,0,2,C-C chemokine receptor activity,MF,
19215,GO:1905395,0.999999999999782,0.836580259445374,0,2,response to flavonoid,BP,
14670,GO:0070318,0.999999999999785,0.667839910220661,0,4,positive regulation of G0 to G1 transition,BP,
4453,GO:0010455,0.999999999999789,0.734269677059373,0,3,positive regulation of cell fate commitment,BP,
15292,GO:0071535,0.999999999999796,0.670575664745094,0,4,RING-like zinc finger domain binding,MF,
17480,GO:1900673,0.999999999999813,0.813223549298108,0,2,olefin metabolic process,BP,
18714,GO:1904210,0.999999999999838,0.911673501844793,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18731,GO:1904239,0.999999999999838,0.911673501844793,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18732,GO:1904240,0.999999999999838,0.911673501844793,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
831,GO:0002127,0.999999999999845,0.910695599988481,0,1,tRNA wobble base cytosine methylation,BP,
1244,GO:0002946,0.999999999999845,0.910695599988481,0,1,tRNA C5-cytosine methylation,BP,
10228,GO:0042979,0.999999999999858,0.673499783097341,0,4,ornithine decarboxylase regulator activity,MF,
17910,GO:1902267,0.999999999999858,0.673499783097341,0,4,regulation of polyamine transmembrane transport,BP,
16124,GO:0090168,0.999999999999867,0.669912707620676,0,4,Golgi reassembly,BP,
4010,GO:0009041,0.99999999999987,0.745206030746538,0,3,uridylate kinase activity,MF,
4075,GO:0009138,0.99999999999987,0.745206030746538,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
5545,GO:0016561,0.999999999999904,0.814737342115346,0,2,protein import into peroxisome matrix, translocation,BP,
17523,GO:1901090,0.999999999999904,0.814737342115346,0,2,regulation of protein tetramerization,BP,
17524,GO:1901091,0.999999999999904,0.814737342115346,0,2,negative regulation of protein tetramerization,BP,
17525,GO:1901093,0.999999999999904,0.814737342115346,0,2,regulation of protein homotetramerization,BP,
17526,GO:1901094,0.999999999999904,0.814737342115346,0,2,negative regulation of protein homotetramerization,BP,
1065,GO:0002606,0.999999999999925,0.741928293057479,0,3,positive regulation of dendritic cell antigen processing and presentation,BP,
10469,GO:0043383,0.999999999999925,0.741928293057479,0,3,negative T cell selection,BP,
11043,GO:0045060,0.999999999999925,0.741928293057479,0,3,negative thymic T cell selection,BP,
14057,GO:0060907,0.999999999999925,0.741928293057479,0,3,positive regulation of macrophage cytokine production,BP,
18954,GO:1904768,0.999999999999928,0.832419388529435,0,2,all-trans-retinol binding,MF,
4981,GO:0015125,0.999999999999951,0.668117217398106,0,4,bile acid transmembrane transporter activity,MF,
18004,GO:1902544,0.999999999999952,0.833869650610066,0,2,regulation of DNA N-glycosylase activity,BP,
1269,GO:0003062,0.999999999999961,0.665366187269417,0,4,regulation of heart rate by chemical signal,BP,
803,GO:0002074,0.999999999999965,0.732900050498187,0,3,extraocular skeletal muscle development,BP,
3612,GO:0008073,0.999999999999966,0.828976721962016,0,2,ornithine decarboxylase inhibitor activity,MF,
17911,GO:1902268,0.999999999999966,0.828976721962016,0,2,negative regulation of polyamine transmembrane transport,BP,
16273,GO:0090409,0.999999999999976,0.901897561806183,0,1,malonyl-CoA synthetase activity,MF,
16274,GO:0090410,0.999999999999976,0.901897561806183,0,1,malonate catabolic process,BP,
6405,GO:0021678,0.999999999999993,0.779974453409005,0,3,third ventricle development,BP,
1899,GO:0004588,0.999999999999999,0.901391557112779,0,1,orotate phosphoribosyltransferase activity,MF,
1900,GO:0004590,0.999999999999999,0.901391557112779,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
6,GO:0000012,1,0.399782238641668,0,9,single strand break repair,BP,
11,GO:0000022,1,0.359212488266566,0,10,mitotic spindle elongation,BP,
15,GO:0000028,1,0.23029165457155,0,18,ribosomal small subunit assembly,BP,
25,GO:0000049,1,0.00422245378970216,0,54,tRNA binding,MF,
29,GO:0000054,1,0.294513283175094,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.466854139624196,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.519144993816034,0,7,ribosomal small subunit export from nucleus,BP,
37,GO:0000076,1,0.216725665969462,0,15,DNA replication checkpoint,BP,
57,GO:0000120,1,0.606218037505331,0,5,RNA polymerase I transcription factor complex,CC,
61,GO:0000124,1,0.278476153547745,0,13,SAGA complex,CC,
62,GO:0000125,1,0.625872083988658,0,5,PCAF complex,CC,
64,GO:0000127,1,0.548702542287289,0,6,transcription factor TFIIIC complex,CC,
67,GO:0000138,1,0.555042692199274,0,6,Golgi trans cisterna,CC,
76,GO:0000153,1,0.338046568008717,0,11,cytoplasmic ubiquitin ligase complex,CC,
80,GO:0000164,1,0.325136662039271,0,11,protein phosphatase type 1 complex,CC,
84,GO:0000172,1,0.565818521944916,0,6,ribonuclease MRP complex,CC,
87,GO:0000176,1,0.302758081030138,0,13,nuclear exosome (RNase complex),CC,
91,GO:0000182,1,0.356572769092234,0,10,rDNA binding,MF,
92,GO:0000183,1,0.0520769512748439,0,39,chromatin silencing at rDNA,BP,
105,GO:0000220,1,0.619247231652975,0,5,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
112,GO:0000235,1,0.436032244110036,0,8,astral microtubule,CC,
114,GO:0000243,1,0.462414469918696,0,8,commitment complex,CC,
115,GO:0000244,1,0.319456420561083,0,11,spliceosomal tri-snRNP complex assembly,BP,
139,GO:0000290,1,0.40670275102778,0,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
140,GO:0000291,1,0.0368047573706748,0,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
143,GO:0000295,1,0.327311009357796,0,11,adenine nucleotide transmembrane transporter activity,MF,
151,GO:0000307,1,0.0245218838977503,0,37,cyclin-dependent protein kinase holoenzyme complex,CC,
154,GO:0000313,1,0.000624743432522881,0,84,organellar ribosome,CC,
155,GO:0000314,1,0.084217271488217,0,28,organellar small ribosomal subunit,CC,
156,GO:0000315,1,0.011468542754293,0,51,organellar large ribosomal subunit,CC,
162,GO:0000338,1,0.368258722032211,0,10,protein deneddylation,BP,
165,GO:0000346,1,0.273768174144126,0,13,transcription export complex,CC,
166,GO:0000347,1,0.557059199119702,0,6,THO complex,CC,
173,GO:0000380,1,0.0100961548413567,0,45,alternative mRNA splicing, via spliceosome,BP,
174,GO:0000381,1,0.034249325890634,0,33,regulation of alternative mRNA splicing, via spliceosome,BP,
177,GO:0000387,1,0.0300095210550615,0,36,spliceosomal snRNP assembly,BP,
178,GO:0000389,1,0.542142362662319,0,6,mRNA 3'-splice site recognition,BP,
180,GO:0000393,1,0.601978263757929,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
182,GO:0000395,1,0.604513056751306,0,5,mRNA 5'-splice site recognition,BP,
185,GO:0000403,1,0.536266899255003,0,6,Y-form DNA binding,MF,
190,GO:0000408,1,0.620024165595919,0,5,EKC/KEOPS complex,CC,
210,GO:0000439,1,0.400148310214624,0,9,core TFIIH complex,CC,
212,GO:0000445,1,0.557059199119702,0,6,THO complex part of transcription export complex,CC,
213,GO:0000447,1,0.41953412910966,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
219,GO:0000459,1,0.509677245424772,0,7,exonucleolytic trimming involved in rRNA processing,BP,
220,GO:0000460,1,0.0402822636188512,0,33,maturation of 5.8S rRNA,BP,
222,GO:0000462,1,0.0289359267463497,0,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
223,GO:0000463,1,0.39220225756793,0,10,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
224,GO:0000466,1,0.114689267519411,0,22,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000467,1,0.509677245424772,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000469,1,0.0790055804436892,0,26,cleavage involved in rRNA processing,BP,
227,GO:0000470,1,0.104506833788187,0,24,maturation of LSU-rRNA,BP,
229,GO:0000478,1,0.224992450735932,0,15,endonucleolytic cleavage involved in rRNA processing,BP,
230,GO:0000479,1,0.249590855853218,0,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
231,GO:0000480,1,0.537359851584464,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
233,GO:0000491,1,0.412115135531441,0,9,small nucleolar ribonucleoprotein complex assembly,BP,
234,GO:0000492,1,0.505003906222301,0,7,box C/D snoRNP assembly,BP,
245,GO:0000702,1,0.631483051607589,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
250,GO:0000712,1,0.397925800605666,0,9,resolution of meiotic recombination intermediates,BP,
260,GO:0000727,1,0.606635529786353,0,5,double-strand break repair via break-induced replication,BP,
261,GO:0000729,1,0.10285053088609,0,22,DNA double-strand break processing,BP,
264,GO:0000732,1,0.0763019510680822,0,25,strand displacement,BP,
271,GO:0000774,1,0.333683833141707,0,11,adenyl-nucleotide exchange factor activity,MF,
275,GO:0000778,1,0.293030657969264,0,12,condensed nuclear chromosome kinetochore,CC,
279,GO:0000782,1,0.35615198976637,0,10,telomere cap complex,CC,
280,GO:0000783,1,0.35615198976637,0,10,nuclear telomere cap complex,CC,
284,GO:0000788,1,0.114057615325227,0,31,nuclear nucleosome,CC,
291,GO:0000796,1,0.483351990887623,0,7,condensin complex,CC,
295,GO:0000800,1,0.483986746572359,0,7,lateral element,CC,
298,GO:0000805,1,0.485576172523619,0,7,X chromosome,CC,
300,GO:0000808,1,0.393012264217186,0,9,origin recognition complex,CC,
302,GO:0000812,1,0.371020234497163,0,10,Swr1 complex,CC,
318,GO:0000835,1,0.540029385424852,0,6,ER ubiquitin ligase complex,CC,
319,GO:0000836,1,0.59914294688734,0,5,Hrd1p ubiquitin ligase complex,CC,
321,GO:0000900,1,0.356613084222129,0,10,translation repressor activity, mRNA regulatory element binding,MF,
325,GO:0000912,1,0.536762251870296,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
326,GO:0000915,1,0.536762251870296,0,6,actomyosin contractile ring assembly,BP,
332,GO:0000923,1,0.536266768308757,0,6,equatorial microtubule organizing center,CC,
339,GO:0000940,1,0.261010119123893,0,13,condensed chromosome outer kinetochore,CC,
343,GO:0000957,1,0.595053510700231,0,5,mitochondrial RNA catabolic process,BP,
345,GO:0000959,1,0.015358664474279,0,41,mitochondrial RNA metabolic process,BP,
349,GO:0000963,1,0.197758286859012,0,16,mitochondrial RNA processing,BP,
351,GO:0000965,1,0.609070694906815,0,5,mitochondrial RNA 3'-end processing,BP,
352,GO:0000966,1,0.132796464940245,0,21,RNA 5'-end processing,BP,
354,GO:0000972,1,0.488239762307215,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
356,GO:0000974,1,0.267881183947286,0,13,Prp19 complex,CC,
364,GO:0000983,1,0.216039612316149,0,15,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,
368,GO:0000990,1,0.399326721079491,0,9,transcription factor activity, core RNA polymerase binding,MF,
371,GO:0000993,1,0.0642288538547664,0,27,RNA polymerase II core binding,MF,
380,GO:0001013,1,0.444768492556184,0,8,RNA polymerase I regulatory region DNA binding,MF,
385,GO:0001030,1,0.597752057085432,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
386,GO:0001031,1,0.597752057085432,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
392,GO:0001054,1,0.360174527254455,0,11,RNA polymerase I activity,MF,
393,GO:0001055,1,0.356869551847725,0,11,RNA polymerase II activity,MF,
394,GO:0001056,1,0.23864210102769,0,15,RNA polymerase III activity,MF,
398,GO:0001075,1,0.544776672932625,0,6,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
402,GO:0001083,1,0.597450448286672,0,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
427,GO:0001135,1,0.483353422809819,0,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
434,GO:0001163,1,0.444768492556184,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
435,GO:0001164,1,0.444768492556184,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
440,GO:0001188,1,0.444768492556184,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
446,GO:0001206,1,0.536512648393429,0,6,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
461,GO:0001405,1,0.606758180271783,0,5,presequence translocase-associated import motor,CC,
470,GO:0001514,1,0.490117806005138,0,7,selenocysteine incorporation,BP,
477,GO:0001522,1,0.17957333168934,0,18,pseudouridine synthesis,BP,
489,GO:0001542,1,0.536357151360006,0,6,ovulation from ovarian follicle,BP,
497,GO:0001553,1,0.595600392888786,0,5,luteinization,BP,
515,GO:0001580,1,0.41754274334793,0,10,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
527,GO:0001637,1,0.485341581040253,0,7,G-protein coupled chemoattractant receptor activity,MF,
541,GO:0001660,1,0.543496259256431,0,6,fever generation,BP,
549,GO:0001671,1,0.108779150007361,0,22,ATPase activator activity,MF,
550,GO:0001672,1,0.486507020129065,0,7,regulation of chromatin assembly or disassembly,BP,
558,GO:0001682,1,0.326329957614764,0,12,tRNA 5'-leader removal,BP,
559,GO:0001696,1,0.550879140637247,0,6,gastric acid secretion,BP,
575,GO:0001727,1,0.597006876379756,0,5,lipid kinase activity,MF,
584,GO:0001739,1,0.540980746873621,0,6,sex chromatin,CC,
591,GO:0001756,1,0.0176269370834113,0,39,somitogenesis,BP,
597,GO:0001765,1,0.405194526426784,0,9,membrane raft assembly,BP,
602,GO:0001771,1,0.542707276385573,0,6,immunological synapse formation,BP,
611,GO:0001780,1,0.396966386824728,0,9,neutrophil homeostasis,BP,
612,GO:0001781,1,0.601491811259044,0,5,neutrophil apoptotic process,BP,
636,GO:0001826,1,0.594979238661798,0,5,inner cell mass cell differentiation,BP,
641,GO:0001832,1,0.236831354298082,0,14,blastocyst growth,BP,
642,GO:0001833,1,0.356665658149219,0,10,inner cell mass cell proliferation,BP,
651,GO:0001842,1,0.608446854177351,0,5,neural fold formation,BP,
655,GO:0001846,1,0.613624944568924,0,5,opsonin binding,MF,
656,GO:0001848,1,0.613624944568924,0,5,complement binding,MF,
661,GO:0001865,1,0.595241587936452,0,5,NK T cell differentiation,BP,
666,GO:0001871,1,0.536770626623101,0,6,pattern binding,MF,
689,GO:0001910,1,0.0607297432279487,0,28,regulation of leukocyte mediated cytotoxicity,BP,
690,GO:0001911,1,0.365022571890264,0,10,negative regulation of leukocyte mediated cytotoxicity,BP,
691,GO:0001912,1,0.20324646441938,0,16,positive regulation of leukocyte mediated cytotoxicity,BP,
693,GO:0001914,1,0.303311142295243,0,12,regulation of T cell mediated cytotoxicity,BP,
695,GO:0001916,1,0.500203057108507,0,7,positive regulation of T cell mediated cytotoxicity,BP,
705,GO:0001931,1,0.438796507487496,0,8,uropod,CC,
714,GO:0001940,1,0.597700140681869,0,5,male pronucleus,CC,
725,GO:0001955,1,0.609376122162031,0,5,blood vessel maturation,BP,
726,GO:0001956,1,0.397232391263137,0,9,positive regulation of neurotransmitter secretion,BP,
735,GO:0001967,1,0.491995682001693,0,7,suckling behavior,BP,
743,GO:0001975,1,0.33214229580648,0,11,response to amphetamine,BP,
799,GO:0002069,1,0.54763013853649,0,6,columnar/cuboidal epithelial cell maturation,BP,
800,GO:0002070,1,0.327376396007448,0,11,epithelial cell maturation,BP,
802,GO:0002072,1,0.536266768308757,0,6,optic cup morphogenesis involved in camera-type eye development,BP,
821,GO:0002097,1,0.19660262058131,0,16,tRNA wobble base modification,BP,
822,GO:0002098,1,0.294906629241927,0,12,tRNA wobble uridine modification,BP,
835,GO:0002138,1,0.609598565013223,0,5,retinoic acid biosynthetic process,BP,
838,GO:0002151,1,0.538171933678051,0,6,G-quadruplex RNA binding,MF,
844,GO:0002161,1,0.29188842692273,0,12,aminoacyl-tRNA editing activity,MF,
845,GO:0002162,1,0.483351990887623,0,7,dystroglycan binding,MF,
850,GO:0002178,1,0.325909338142675,0,11,palmitoyltransferase complex,CC,
852,GO:0002182,1,0.320996527404193,0,11,cytoplasmic translational elongation,BP,
857,GO:0002190,1,0.617614346272489,0,5,cap-independent translational initiation,BP,
863,GO:0002199,1,0.488841036214092,0,7,zona pellucida receptor complex,CC,
874,GO:0002227,1,0.498243828435479,0,10,innate immune response in mucosa,BP,
900,GO:0002281,1,0.595254462213297,0,5,macrophage activation involved in immune response,BP,
920,GO:0002315,1,0.438299116896442,0,8,marginal zone B cell differentiation,BP,
926,GO:0002323,1,0.412955128161629,0,9,natural killer cell activation involved in immune response,BP,
939,GO:0002349,1,0.613152770909973,0,5,histamine production involved in inflammatory response,BP,
961,GO:0002385,1,0.329732155470228,0,14,mucosal immune response,BP,
984,GO:0002441,1,0.613152770909973,0,5,histamine secretion involved in inflammatory response,BP,
1001,GO:0002475,1,0.551224324593591,0,6,antigen processing and presentation via MHC class Ib,BP,
1006,GO:0002480,1,0.424056405665373,0,9,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1008,GO:0002483,1,0.448980725070504,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1015,GO:0002507,1,0.29227419919478,0,12,tolerance induction,BP,
1018,GO:0002517,1,0.604031511789059,0,5,T cell tolerance induction,BP,
1022,GO:0002523,1,0.641320991537606,0,5,leukocyte migration involved in inflammatory response,BP,
1039,GO:0002553,1,0.613152770909973,0,5,histamine secretion by mast cell,BP,
1045,GO:0002568,1,0.594968816104133,0,5,somatic diversification of T cell receptor genes,BP,
1074,GO:0002643,1,0.398832206056722,0,9,regulation of tolerance induction,BP,
1075,GO:0002645,1,0.604031511789059,0,5,positive regulation of tolerance induction,BP,
1081,GO:0002664,1,0.604031511789059,0,5,regulation of T cell tolerance induction,BP,
1092,GO:0002681,1,0.594968816104133,0,5,somatic recombination of T cell receptor gene segments,BP,
1126,GO:0002715,1,0.165214036465923,0,18,regulation of natural killer cell mediated immunity,BP,
1127,GO:0002716,1,0.403331335258786,0,9,negative regulation of natural killer cell mediated immunity,BP,
1128,GO:0002717,1,0.371625592447953,0,10,positive regulation of natural killer cell mediated immunity,BP,
1148,GO:0002756,1,0.0653658708544749,0,27,MyD88-independent toll-like receptor signaling pathway,BP,
1180,GO:0002827,1,0.544501143136782,0,6,positive regulation of T-helper 1 type immune response,BP,
1187,GO:0002834,1,0.536796673052924,0,6,regulation of response to tumor cell,BP,
1190,GO:0002837,1,0.536796673052924,0,6,regulation of immune response to tumor cell,BP,
1239,GO:0002934,1,0.393241092641642,0,9,desmosome organization,BP,
1280,GO:0003084,1,0.557018180981363,0,6,positive regulation of systemic arterial blood pressure,BP,
1285,GO:0003096,1,0.597268496631528,0,5,renal sodium ion transport,BP,
1293,GO:0003128,1,0.603711699626806,0,5,heart field specification,BP,
1309,GO:0003159,1,0.328487586068321,0,11,morphogenesis of an endothelium,BP,
1311,GO:0003161,1,0.393209714955317,0,9,cardiac conduction system development,BP,
1324,GO:0003177,1,0.538624607807473,0,6,pulmonary valve development,BP,
1329,GO:0003184,1,0.538624607807473,0,6,pulmonary valve morphogenesis,BP,
1337,GO:0003198,1,0.320872809576891,0,11,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1339,GO:0003203,1,0.17196859953206,0,17,endocardial cushion morphogenesis,BP,
1347,GO:0003214,1,0.537121219220969,0,6,cardiac left ventricle morphogenesis,BP,
1352,GO:0003222,1,0.319195707613422,0,11,ventricular trabecula myocardium morphogenesis,BP,
1353,GO:0003223,1,0.537973103745462,0,6,ventricular compact myocardium morphogenesis,BP,
1374,GO:0003272,1,0.26064775145166,0,13,endocardial cushion formation,BP,
1393,GO:0003309,1,0.215914809893314,0,15,type B pancreatic cell differentiation,BP,
1396,GO:0003323,1,0.239569327285438,0,14,type B pancreatic cell development,BP,
1398,GO:0003334,1,0.323999078172426,0,11,keratinocyte development,BP,
1401,GO:0003337,1,0.500844365046642,0,7,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1403,GO:0003339,1,0.613798390852699,0,5,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1408,GO:0003344,1,0.536266768308757,0,6,pericardium morphogenesis,BP,
1444,GO:0003676,1,0,175,3243,nucleic acid binding,MF,FOS;ERCC1;TCFL5;PRDX5;PCBP4;MEF2D;ZFP36L1;GRB7;NR1D1;NYNRIN;EPAS1;NFATC4;LRP1;EGFR;H1F0;TCEA2;MXD4;DDB2;EGR1;DEAF1;BAHCC1;S100A4;SLC16A3;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;CERS4;ZNF516;PEG3;HDAC5;THRA;KHNYN;ZFPM1;TFEB;TST;ABTB1;H2AFJ;DNM1;SALL2;XPC;FOXQ1;UNK;TFDP2;CSNK1E;PDCD4;ZKSCAN1;ZC3H6;POLL;ADARB1;ZNF692;ZNF704;DNMT3A;DHX32;RNASET2;HES2;ZNF467;MNT;STAT6;MTA3;ISG20;MYO18A;PHC2;BCL6;ANKZF1;DNASE1L1;ZSCAN2;CEBPB;HSF4;CALCOCO1;ZDHHC1;ENDOG;ETV5;EXD3;MTA1;LTA4H;MBD1;HES1;MLXIPL;ZNF624;ZNF414;PHF21A;PCSK9;ZFP36;ETV4;MAPKBP1;NSUN7;ZNF862;ZMYM3;CYFIP2;EHD4;TCF25;SOX13;MPG;BHLHE40;RAG1;ZNF80;EEF2K;HMGA2;ELK3;AHNAK2;ZXDC;MEX3A;POU6F1;ZNF217;PPARA;DMC1;PAN2;ZNF446;RXRA;HLTF;MDH2;TWF2;ZNF485;LSM14B;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;AGO4;RAD23A;ZNF563;PROX1;WBP2;GTPBP1;ASS1;ZNF554;JARID2;RXRB;CSTB;APOBEC3C;H1FX;ZFP41;MEF2B;ZSCAN30;TRAP1;ZNF385A;TUT1;SMARCA1;SIX5;ERCC6;TDRKH;SSBP2;RPL39L;R3HDM2;EHD3;CAMTA2;R3HDM4;EIF4G3;ZNF710;RFX2;TRERF1;THAP8;DDN;PMS2P5;NDUFV3;ZNF319;APOBEC3F;SIRT3;GLI4;LITAF;MZF1;NEIL1;RARG;EIF4E3;ZCCHC14;ZNF514;TRNP1;ZNF837;POLM;FAM50A;RPL13A
1446,GO:0003678,1,0.00869229019981308,0,46,DNA helicase activity,MF,
1450,GO:0003688,1,0.234357682566183,0,14,DNA replication origin binding,MF,
1451,GO:0003689,1,0.444995976171353,0,8,DNA clamp loader activity,MF,
1453,GO:0003691,1,0.39693861215532,0,9,double-stranded telomeric DNA binding,MF,
1463,GO:0003720,1,0.457344757537519,0,8,telomerase activity,MF,
1465,GO:0003723,1,0,52,1482,RNA binding,MF,PCBP4;ZFP36L1;GRB7;LRP1;H1F0;S100A4;SLC16A3;THRA;KHNYN;TST;ABTB1;DNM1;UNK;CSNK1E;PDCD4;ADARB1;DHX32;RNASET2;ISG20;MYO18A;LTA4H;PCSK9;ZFP36;MAPKBP1;NSUN7;CYFIP2;EEF2K;AHNAK2;MEX3A;HLTF;MDH2;TWF2;LSM14B;SRSF5;AGO4;GTPBP1;ASS1;CSTB;APOBEC3C;H1FX;TRAP1;ZNF385A;TUT1;TDRKH;RPL39L;R3HDM2;EIF4G3;NDUFV3;APOBEC3F;EIF4E3;FAM50A;RPL13A
1475,GO:0003747,1,0.540492079815114,0,6,translation release factor activity,MF,
1490,GO:0003831,1,0.439900748902896,0,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1527,GO:0003909,1,0.485787037763283,0,7,DNA ligase activity,MF,
1528,GO:0003910,1,0.538230347601885,0,6,DNA ligase (ATP) activity,MF,
1529,GO:0003916,1,0.537827685494192,0,6,DNA topoisomerase activity,MF,
1536,GO:0003923,1,0.598621119941473,0,5,GPI-anchor transamidase activity,MF,
1548,GO:0003950,1,0.17279334399588,0,17,NAD+ ADP-ribosyltransferase activity,MF,
1560,GO:0003964,1,0.457344757537519,0,8,RNA-directed DNA polymerase activity,MF,
1575,GO:0003988,1,0.545300777920413,0,6,acetyl-CoA C-acyltransferase activity,MF,
1588,GO:0004003,1,0.03303355718637,0,33,ATP-dependent DNA helicase activity,MF,
1595,GO:0004017,1,0.59571039592665,0,5,adenylate kinase activity,MF,
1602,GO:0004028,1,0.484128135578777,0,7,3-chloroallyl aldehyde dehydrogenase activity,MF,
1604,GO:0004030,1,0.595160955167294,0,5,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1654,GO:0004112,1,0.263797843018953,0,13,cyclic-nucleotide phosphodiesterase activity,MF,
1656,GO:0004114,1,0.292692969071427,0,12,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1657,GO:0004115,1,0.483351990887623,0,7,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1664,GO:0004128,1,0.492843567485599,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1698,GO:0004181,1,0.396150950348633,0,9,metallocarboxypeptidase activity,MF,
1699,GO:0004185,1,0.43980890588867,0,8,serine-type carboxypeptidase activity,MF,
1705,GO:0004298,1,0.218080534808497,0,18,threonine-type endopeptidase activity,MF,
1706,GO:0004300,1,0.45276725834376,0,8,enoyl-CoA hydratase activity,MF,
1717,GO:0004312,1,0.404821778929055,0,9,fatty acid synthase activity,MF,
1759,GO:0004366,1,0.594973194273863,0,5,glycerol-3-phosphate O-acyltransferase activity,MF,
1780,GO:0004402,1,0.00546418839999548,0,51,histone acetyltransferase activity,MF,
1794,GO:0004438,1,0.23361370344876,0,14,phosphatidylinositol-3-phosphatase activity,MF,
1795,GO:0004439,1,0.435999844368918,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1813,GO:0004467,1,0.392895169191575,0,9,long-chain fatty acid-CoA ligase activity,MF,
1856,GO:0004523,1,0.558851441553835,0,6,RNA-DNA hybrid ribonuclease activity,MF,
1858,GO:0004526,1,0.359754431899868,0,11,ribonuclease P activity,MF,
1869,GO:0004549,1,0.215458714763265,0,16,tRNA-specific ribonuclease activity,MF,
1889,GO:0004576,1,0.381854922445513,0,10,oligosaccharyl transferase activity,MF,
1892,GO:0004579,1,0.416712781113189,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
1904,GO:0004596,1,0.371246948911813,0,10,peptide alpha-N-acetyltransferase activity,MF,
1925,GO:0004623,1,0.13152107586942,0,20,phospholipase A2 activity,MF,
1965,GO:0004679,1,0.486102840350049,0,7,AMP-activated protein kinase activity,MF,
1969,GO:0004689,1,0.601121174440268,0,5,phosphorylase kinase activity,MF,
1980,GO:0004704,1,0.604250681867205,0,5,NF-kappaB-inducing kinase activity,MF,
1998,GO:0004726,1,0.442465073760011,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2007,GO:0004738,1,0.599992039694227,0,5,pyruvate dehydrogenase activity,MF,
2013,GO:0004745,1,0.498279389750393,0,7,retinol dehydrogenase activity,MF,
2022,GO:0004758,1,0.596914563467742,0,5,serine C-palmitoyltransferase activity,MF,
2024,GO:0004767,1,0.601711104291593,0,5,sphingomyelin phosphodiesterase activity,MF,
2055,GO:0004812,1,0.0108803535043602,0,44,aminoacyl-tRNA ligase activity,MF,
2069,GO:0004826,1,0.599674628117829,0,5,phenylalanine-tRNA ligase activity,MF,
2078,GO:0004839,1,0.59506995298203,0,5,ubiquitin activating enzyme activity,MF,
2081,GO:0004844,1,0.612529128687913,0,5,uracil DNA N-glycosylase activity,MF,
2090,GO:0004859,1,0.518868041460257,0,7,phospholipase inhibitor activity,MF,
2093,GO:0004862,1,0.492013676973599,0,7,cAMP-dependent protein kinase inhibitor activity,MF,
2114,GO:0004908,1,0.602618543591345,0,5,interleukin-1 receptor activity,MF,
2135,GO:0004950,1,0.485341581040253,0,7,chemokine receptor activity,MF,
2185,GO:0005047,1,0.599789325174302,0,5,signal recognition particle binding,MF,
2187,GO:0005049,1,0.437487461565299,0,8,nuclear export signal receptor activity,MF,
2194,GO:0005072,1,0.435767679535832,0,8,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2209,GO:0005104,1,0.354505816410015,0,10,fibroblast growth factor receptor binding,MF,
2212,GO:0005112,1,0.21285399375419,0,15,Notch binding,MF,
2214,GO:0005114,1,0.486325810714514,0,7,type II transforming growth factor beta receptor binding,MF,
2243,GO:0005160,1,0.0862768022667665,0,24,transforming growth factor beta receptor binding,MF,
2275,GO:0005230,1,0.39357944911468,0,9,extracellular ligand-gated ion channel activity,MF,
2276,GO:0005231,1,0.484483681734395,0,7,excitatory extracellular ligand-gated ion channel activity,MF,
2283,GO:0005246,1,0.165694300699572,0,18,calcium channel regulator activity,MF,
2284,GO:0005247,1,0.491943043814309,0,7,voltage-gated chloride channel activity,MF,
2308,GO:0005313,1,0.536267186431625,0,6,L-glutamate transmembrane transporter activity,MF,
2321,GO:0005338,1,0.329682301995148,0,11,nucleotide-sugar transmembrane transporter activity,MF,
2325,GO:0005345,1,0.608422542581416,0,5,purine nucleobase transmembrane transporter activity,MF,
2326,GO:0005346,1,0.327311009357796,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2327,GO:0005347,1,0.445435192752552,0,8,ATP transmembrane transporter activity,MF,
2340,GO:0005385,1,0.211759722293753,0,15,zinc ion transmembrane transporter activity,MF,
2374,GO:0005513,1,0.44758958582741,0,8,detection of calcium ion,BP,
2392,GO:0005542,1,0.568271987047632,0,6,folic acid binding,MF,
2407,GO:0005587,1,0.594968816104133,0,5,collagen type IV trimer,CC,
2429,GO:0005634,1,0,414,5716,nucleus,CC,TNIP1;FOS;DUSP6;CEMIP;APOE;MARVELD1;CTNNBIP1;TSPAN1;PPL;ERCC1;FAM110C;NT5E;CITED4;RNF44;CST3;TCFL5;GSN;CLCA2;PRDX5;NDRG1;MEF2D;NOS1;ARAP1;ZFP36L1;NR1D1;ALOX15B;EPN3;POLD4;EPHB2;EPAS1;OBSCN;CPT2;NFATC4;LRP1;GAMT;MAPK13;APPL2;CDK18;RALGDS;EGFR;H1F0;TSC22D1;HADH;REEP6;ACOT7;TCEA2;DUSP5;FHL1;MXD4;DDB2;MDFI;EGR1;PKN1;CRTC1;TRIM65;PTK6;NPEPL1;DEAF1;LAMA5;PPP2R3B;SLC9A3R2;BAHCC1;S100A4;CTSB;ESRG;RNF208;PITPNC1;SLC16A3;CXXC5;ZMYND8;TBC1D14;ASH2L;ZSCAN18;SOX12;MXI1;CERS4;NOL4L;PIK3R2;S100A6;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;DOCK4;RPS6KA2;TUBG2;TENM2;SLC2A9;MAML3;ZFPM1;TFEB;ERBB2;BRSK1;SCMH1;CBS;ABTB1;VWA5A;ITPR3;H2AFJ;DNM1;FCHO1;PTHLH;CDKN1C;SALL2;XPC;PTPRE;ANGEL1;SIGMAR1;PAK6;CCDC69;FOXQ1;NPHP4;LTB4R2;JADE2;RALGAPA2;TFDP2;PHF7;CSNK1E;AGAP1;PDCD4;BEX2;GLUL;PRR7;ZKSCAN1;ARVCF;ZMIZ1;INSR;ZC3H6;ID1;CELSR1;MZT2A;POLL;WDR27;RABGGTA;ADARB1;ZNF692;ZNF704;TXNRD3;DNMT3A;DNPH1;PRNP;DHX32;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;ATG16L2;STAT6;SPEG;MTA3;MKNK2;STRADB;TALDO1;WWTR1;ISG20;ARHGAP27;MZT2B;DNAJB5;PHC2;PLEKHH2;BCL6;UCKL1;PFKFB2;CHMP1B;SCAND1;DYRK1B;SEC14L2;MVB12B;TMEM92;BNIP3;DNASE1L1;ZSCAN2;ARL2;YPEL3;CEBPB;HSD11B1L;HSF4;NAB2;CALCOCO1;ENDOG;MAPK3;PDZD2;TUB;ETV5;OLFM2;CARD19;SLC22A18;EXD3;C19ORF33;RAB40B;MTA1;LHPP;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;NSMCE4A;FHOD1;HES1;BRD3;YPEL2;MLXIPL;ZNF624;CUL7;MEFV;ARHGAP22;ZNF414;FKBP10;TRIM45;PIDD1;RETSAT;PHF21A;AQP3;ZFP36;ETV4;MAPKBP1;HLCS;CYHR1;FGFR3;PRKACA;ZNF862;ZMYM3;NUDT10;DGUOK;CYFIP2;RPS6KA5;MAP2K2;RAPGEF5;HDAC11;EHD4;MAPK8IP1;TCF25;PTOV1;FAM214B;SOX13;MPG;BHLHE40;CCDC92;RAG1;ZNF80;DUSP7;PHLDA1;LRRC45;HMGA2;TM7SF2;ELK3;AHNAK2;DGKQ;KLHDC2;MVB12A;NMRAL1;ZXDC;PADI3;BTRC;MEX3A;POU6F1;ZNF217;PPARA;TKFC;BLVRB;SUFU;DMC1;PAN2;ZNF446;ATG2A;RXRA;NEO1;SDHA;USP21;RNF123;PRKCZ;HLTF;MDH2;CAPG;BCORL1;SPATA7;ZNF485;SH3GLB2;PDK2;GPC1;SRSF5;ZNF160;RFXANK;TEF;SMOX;CEP68;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;CAMKK1;PIN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;NICN1;BIN1;TMEM8B;PPP1R13L;SH3D19;ZNF554;WDR83;GLRX;JARID2;CAPN2;SESN2;TOLLIP;RXRB;CSTB;PNRC1;DUSP23;MACROD1;SMDT1;PTMS;GRHPR;APOBEC3C;H1FX;ZFP41;SBF1;SORL1;STK39;MEF2B;ZSCAN30;CCDC85B;PNMA1;AKT1;TRAP1;ZNF385A;TP53INP1;LRCH4;NDRG2;TUT1;SMARCA1;SIX5;ERCC6;SLC5A5;SUN1;TMEM120A;SPPL2B;IL17RD;SSBP2;R3HDM2;SSH3;PINK1;PKD1;EHD3;LONP2;MPLKIP;KDM4B;CAMTA2;RGS14;SYNE3;PCIF1;MAFIP;CCDC106;R3HDM4;HEXDC;ZNF710;ABHD14B;P3H4;MLST8;RILPL1;CBLC;RFX2;RNF187;PYCARD;MAP2K3;PNPO;TRERF1;DDN;PMS2P5;NDUFV3;STK17A;ERN1;RANBP9;ZNF319;APOBEC3F;PRIMPOL;ACADS;GCAT;MOCS1;ALKBH6;GLI4;SLC2A1;CPNE7;TAZ;LITAF;APBA1;MZF1;NEIL1;RARG;ING4;PBXIP1;ZNF514;TRIM7;WDR18;KRT15;TRNP1;ZNF837;POLM;FAM50A;AGPAT3;RPL13A;RGS12;MIF;UBL5
2436,GO:0005642,1,0.602793823188021,0,5,annulate lamellae,CC,
2437,GO:0005643,1,0.000445063825109769,0,76,nuclear pore,CC,
2440,GO:0005655,1,0.49109991382837,0,8,nucleolar ribonuclease P complex,CC,
2443,GO:0005658,1,0.541881665956807,0,6,alpha DNA polymerase:primase complex,CC,
2444,GO:0005662,1,0.24253278576749,0,14,DNA replication factor A complex,CC,
2445,GO:0005663,1,0.55427532813556,0,6,DNA replication factor C complex,CC,
2446,GO:0005664,1,0.393012264217186,0,9,nuclear origin of replication recognition complex,CC,
2447,GO:0005665,1,0.201500452287217,0,17,DNA-directed RNA polymerase II, core complex,CC,
2448,GO:0005666,1,0.197090504487843,0,17,DNA-directed RNA polymerase III complex,CC,
2452,GO:0005671,1,0.242494464522258,0,14,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2456,GO:0005675,1,0.272547856804311,0,13,holo TFIIH complex,CC,
2461,GO:0005683,1,0.548525034822369,0,7,U7 snRNP,CC,
2462,GO:0005684,1,0.00348927908007362,0,58,U2-type spliceosomal complex,CC,
2463,GO:0005685,1,0.150868816790885,0,20,U1 snRNP,CC,
2464,GO:0005686,1,0.154740618695531,0,20,U2 snRNP,CC,
2465,GO:0005687,1,0.367846743423307,0,11,U4 snRNP,CC,
2466,GO:0005688,1,0.500148090771653,0,8,U6 snRNP,CC,
2467,GO:0005689,1,0.0918949941297228,0,26,U12-type spliceosomal complex,CC,
2471,GO:0005697,1,0.120646896222442,0,22,telomerase holoenzyme complex,CC,
2482,GO:0005732,1,0.120601906252368,0,24,small nucleolar ribonucleoprotein complex,CC,
2483,GO:0005736,1,0.32462342345445,0,12,DNA-directed RNA polymerase I complex,CC,
2490,GO:0005744,1,0.287409996584878,0,13,mitochondrial inner membrane presequence translocase complex,CC,
2495,GO:0005750,1,0.358878582271968,0,11,mitochondrial respiratory chain complex III,CC,
2502,GO:0005761,1,0.000624743432522881,0,84,mitochondrial ribosome,CC,
2503,GO:0005762,1,0.011468542754293,0,51,mitochondrial large ribosomal subunit,CC,
2504,GO:0005763,1,0.084217271488217,0,28,mitochondrial small ribosomal subunit,CC,
2508,GO:0005767,1,0.377129311701673,0,10,secondary lysosome,CC,
2523,GO:0005785,1,0.504899084290961,0,7,signal recognition particle receptor complex,CC,
2524,GO:0005786,1,0.564413952168384,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2525,GO:0005787,1,0.630640653523966,0,5,signal peptidase complex,CC,
2528,GO:0005790,1,0.112621020066995,0,22,smooth endoplasmic reticulum,CC,
2534,GO:0005797,1,0.500276757632219,0,7,Golgi medial cisterna,CC,
2542,GO:0005816,1,0.483351990887623,0,7,spindle pole body,CC,
2543,GO:0005818,1,0.436032244110036,0,8,aster,CC,
2545,GO:0005826,1,0.596279896417405,0,5,actomyosin contractile ring,CC,
2546,GO:0005827,1,0.596512893657879,0,5,polar microtubule,CC,
2547,GO:0005828,1,0.483496401415932,0,7,kinetochore microtubule,CC,
2552,GO:0005838,1,0.129362573665099,0,21,proteasome regulatory particle,CC,
2553,GO:0005839,1,0.177069445786486,0,20,proteasome core complex,CC,
2561,GO:0005851,1,0.547359237565579,0,6,eukaryotic translation initiation factor 2B complex,CC,
2562,GO:0005852,1,0.192381873877465,0,17,eukaryotic translation initiation factor 3 complex,CC,
2579,GO:0005879,1,0.601926542355798,0,5,axonemal microtubule,CC,
2585,GO:0005885,1,0.384663697134265,0,10,Arp2/3 protein complex,CC,
2604,GO:0005915,1,0.483351990887623,0,7,zonula adherens,CC,
2605,GO:0005916,1,0.536266768308757,0,6,fascia adherens,CC,
2627,GO:0005964,1,0.601121174440268,0,5,phosphorylase kinase complex,CC,
2656,GO:0006011,1,0.544172480905211,0,6,UDP-glucose metabolic process,BP,
2677,GO:0006047,1,0.264257475122455,0,13,UDP-N-acetylglucosamine metabolic process,BP,
2678,GO:0006048,1,0.399525465794939,0,9,UDP-N-acetylglucosamine biosynthetic process,BP,
2682,GO:0006054,1,0.363782680157525,0,10,N-acetylneuraminate metabolic process,BP,
2694,GO:0006067,1,0.328503159123814,0,11,ethanol metabolic process,BP,
2695,GO:0006068,1,0.497065382872073,0,7,ethanol catabolic process,BP,
2696,GO:0006069,1,0.537192255574565,0,6,ethanol oxidation,BP,
2717,GO:0006104,1,0.545949752580444,0,6,succinyl-CoA metabolic process,BP,
2734,GO:0006123,1,0.3358171308942,0,14,mitochondrial electron transport, cytochrome c to oxygen,BP,
2748,GO:0006166,1,0.621988215773207,0,5,purine ribonucleoside salvage,BP,
2749,GO:0006167,1,0.619516390751116,0,5,AMP biosynthetic process,BP,
2756,GO:0006177,1,0.606586502249205,0,5,GMP biosynthetic process,BP,
2762,GO:0006188,1,0.362615941217721,0,10,IMP biosynthetic process,BP,
2763,GO:0006189,1,0.54211871909019,0,6,'de novo' IMP biosynthetic process,BP,
2770,GO:0006207,1,0.537161583437861,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
2798,GO:0006265,1,0.39762258392985,0,9,DNA topological change,BP,
2801,GO:0006268,1,0.484869714486728,0,7,DNA unwinding involved in DNA replication,BP,
2804,GO:0006271,1,0.135092695944372,0,20,DNA strand elongation involved in DNA replication,BP,
2806,GO:0006273,1,0.328084234024568,0,11,lagging strand elongation,BP,
2842,GO:0006335,1,0.0944389500133551,0,32,DNA replication-dependent nucleosome assembly,BP,
2843,GO:0006336,1,0.0115478469658003,0,50,DNA replication-independent nucleosome assembly,BP,
2850,GO:0006348,1,0.469379153675589,0,8,chromatin silencing at telomere,BP,
2863,GO:0006363,1,0.0536579363116523,0,30,termination of RNA polymerase I transcription,BP,
2867,GO:0006368,1,6.41976689623802e-05,0,97,transcription elongation from RNA polymerase II promoter,BP,
2869,GO:0006370,1,0.0444533173148264,0,32,7-methylguanosine mRNA capping,BP,
2875,GO:0006384,1,0.496957396496985,0,7,transcription initiation from RNA polymerase III promoter,BP,
2877,GO:0006388,1,0.259805172846911,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
2878,GO:0006390,1,0.269158057377834,0,13,mitochondrial transcription,BP,
2881,GO:0006396,1,0,20,876,RNA processing,BP,ZFP36L1;EGFR;CSNK1E;ADARB1;DHX32;ISG20;MAPKBP1;PRKACA;MAP2K2;RRNAD1;AHNAK2;PAN2;SRSF5;AGO4;WDR83;TUT1;ERN1;WDR18;RPL13A;UBL5
2883,GO:0006398,1,0.598663385268737,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
2884,GO:0006399,1,9.42977301458572e-09,0,184,tRNA metabolic process,BP,
2885,GO:0006400,1,0.000566336670961877,0,74,tRNA modification,BP,
2894,GO:0006409,1,0.0381630490676553,0,32,tRNA export from nucleus,BP,
2898,GO:0006415,1,0.000124155354589122,0,100,translational termination,BP,
2900,GO:0006418,1,0.00687283272814603,0,49,tRNA aminoacylation for protein translation,BP,
2914,GO:0006432,1,0.599674628117829,0,5,phenylalanyl-tRNA aminoacylation,BP,
2923,GO:0006448,1,0.176578889280201,0,17,regulation of translational elongation,BP,
2924,GO:0006449,1,0.490213189534653,0,7,regulation of translational termination,BP,
2925,GO:0006450,1,0.159624728866992,0,19,regulation of translational fidelity,BP,
2926,GO:0006451,1,0.490117806005138,0,7,translational readthrough,BP,
2936,GO:0006471,1,0.0847878402899075,0,24,protein ADP-ribosylation,BP,
2938,GO:0006474,1,0.244969071478413,0,14,N-terminal protein amino acid acetylation,BP,
2941,GO:0006477,1,0.597575819964865,0,5,protein sulfation,BP,
2955,GO:0006498,1,0.595726129960954,0,5,N-terminal protein lipidation,BP,
2996,GO:0006549,1,0.599761788188317,0,5,isoleucine metabolic process,BP,
3000,GO:0006553,1,0.395093035695927,0,9,lysine metabolic process,BP,
3001,GO:0006554,1,0.438353652972157,0,8,lysine catabolic process,BP,
3015,GO:0006568,1,0.606620218883625,0,5,tryptophan metabolic process,BP,
3019,GO:0006573,1,0.39811209626655,0,9,valine metabolic process,BP,
3024,GO:0006578,1,0.595161835245525,0,5,amino-acid betaine biosynthetic process,BP,
3026,GO:0006582,1,0.405557867884104,0,9,melanin metabolic process,BP,
3029,GO:0006586,1,0.606620218883625,0,5,indolalkylamine metabolic process,BP,
3032,GO:0006591,1,0.491233421584946,0,7,ornithine metabolic process,BP,
3042,GO:0006607,1,0.126425231262422,0,20,NLS-bearing protein import into nucleus,BP,
3043,GO:0006610,1,0.450955297860068,0,8,ribosomal protein import into nucleus,BP,
3048,GO:0006616,1,0.582073112230642,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3050,GO:0006620,1,0.508318098981255,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3051,GO:0006621,1,0.445580565918754,0,8,protein retention in ER lumen,BP,
3057,GO:0006627,1,0.560141242064055,0,6,protein processing involved in protein targeting to mitochondrion,BP,
3070,GO:0006646,1,0.322459927986872,0,11,phosphatidylethanolamine biosynthetic process,BP,
3076,GO:0006657,1,0.494327220014264,0,7,CDP-choline pathway,BP,
3089,GO:0006670,1,0.374102103141233,0,10,sphingosine metabolic process,BP,
3093,GO:0006678,1,0.488147443789267,0,7,glucosylceramide metabolic process,BP,
3096,GO:0006681,1,0.539262792108681,0,6,galactosylceramide metabolic process,BP,
3099,GO:0006684,1,0.271825395704807,0,13,sphingomyelin metabolic process,BP,
3100,GO:0006685,1,0.598245477307305,0,5,sphingomyelin catabolic process,BP,
3101,GO:0006686,1,0.55460423133498,0,6,sphingomyelin biosynthetic process,BP,
3103,GO:0006688,1,0.26412910101797,0,13,glycosphingolipid biosynthetic process,BP,
3129,GO:0006729,1,0.514935478061205,0,7,tetrahydrobiopterin biosynthetic process,BP,
3140,GO:0006743,1,0.229409825497397,0,15,ubiquinone metabolic process,BP,
3141,GO:0006744,1,0.254541528210049,0,14,ubiquinone biosynthetic process,BP,
3172,GO:0006797,1,0.595367780920306,0,5,polyphosphate metabolic process,BP,
3192,GO:0006829,1,0.172001389028625,0,17,zinc ion transport,BP,
3206,GO:0006857,1,0.439226488528701,0,8,oligopeptide transport,BP,
3208,GO:0006862,1,0.197815308017678,0,16,nucleotide transport,BP,
3209,GO:0006863,1,0.554082706390843,0,6,purine nucleobase transport,BP,
3228,GO:0006890,1,0.000397082196178856,0,77,retrograde vesicle-mediated transport, Golgi to ER,BP,
3229,GO:0006891,1,0.0480068227271516,0,30,intra-Golgi vesicle-mediated transport,BP,
3251,GO:0006925,1,0.273059510130884,0,13,inflammatory cell apoptotic process,BP,
3253,GO:0006929,1,0.116352220849337,0,21,substrate-dependent cell migration,BP,
3254,GO:0006930,1,0.437469833422502,0,8,substrate-dependent cell migration, cell extension,BP,
3284,GO:0006983,1,0.362632855700902,0,10,ER overload response,BP,
3290,GO:0006995,1,0.387121871873468,0,10,cellular response to nitrogen starvation,BP,
3294,GO:0006999,1,0.216200548918364,0,15,nuclear pore organization,BP,
3295,GO:0007000,1,0.496315729260832,0,7,nucleolus organization,BP,
3312,GO:0007026,1,0.158200869496976,0,18,negative regulation of microtubule depolymerization,BP,
3320,GO:0007035,1,0.15547405640755,0,19,vacuolar acidification,BP,
3324,GO:0007042,1,0.462390353423934,0,8,lysosomal lumen acidification,BP,
3337,GO:0007063,1,0.118193074108304,0,21,regulation of sister chromatid cohesion,BP,
3338,GO:0007064,1,0.107188475856164,0,22,mitotic sister chromatid cohesion,BP,
3341,GO:0007076,1,0.190424261053262,0,16,mitotic chromosome condensation,BP,
3348,GO:0007091,1,0.0072608777089361,0,49,metaphase/anaphase transition of mitotic cell cycle,BP,
3350,GO:0007094,1,0.0531030856937129,0,29,mitotic spindle assembly checkpoint,BP,
3352,GO:0007096,1,0.221915061602142,0,15,regulation of exit from mitosis,BP,
3355,GO:0007099,1,0.0518772210581698,0,29,centriole replication,BP,
3362,GO:0007135,1,0.549364014004816,0,6,meiosis II,BP,
3366,GO:0007144,1,0.550757730665403,0,6,female meiosis I,BP,
3386,GO:0007172,1,0.485033969446953,0,7,signal complex assembly,BP,
3394,GO:0007182,1,0.539119832730069,0,6,common-partner SMAD protein phosphorylation,BP,
3395,GO:0007183,1,0.327541102418821,0,11,SMAD protein complex assembly,BP,
3417,GO:0007213,1,0.366668312004816,0,10,G-protein coupled acetylcholine receptor signaling pathway,BP,
3418,GO:0007214,1,0.539665487175316,0,6,gamma-aminobutyric acid signaling pathway,BP,
3424,GO:0007220,1,0.219554498565716,0,15,Notch receptor processing,BP,
3434,GO:0007250,1,0.192095592235014,0,16,activation of NF-kappaB-inducing kinase activity,BP,
3436,GO:0007253,1,0.511278723411042,0,7,cytoplasmic sequestering of NF-kappaB,BP,
3461,GO:0007289,1,0.330956865585272,0,11,spermatid nucleus differentiation,BP,
3478,GO:0007351,1,0.395706986014689,0,9,tripartite regional subdivision,BP,
3485,GO:0007379,1,0.324542243163399,0,11,segment specification,BP,
3486,GO:0007386,1,0.596120879324359,0,5,compartment pattern specification,BP,
3534,GO:0007549,1,0.292302979023717,0,12,dosage compensation,BP,
3579,GO:0007635,1,0.491733857212269,0,7,chemosensory behavior,BP,
3590,GO:0008024,1,0.436549169951571,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3593,GO:0008033,1,6.1904585608054e-06,0,120,tRNA processing,BP,
3616,GO:0008079,1,0.540492079815114,0,6,translation termination factor activity,MF,
3621,GO:0008089,1,0.033308690868544,0,34,anterograde axonal transport,BP,
3622,GO:0008090,1,0.504535699170585,0,7,retrograde axonal transport,BP,
3649,GO:0008139,1,0.0926096547376781,0,23,nuclear localization sequence binding,MF,
3652,GO:0008143,1,0.237854412936696,0,14,poly(A) binding,MF,
3659,GO:0008157,1,0.240852991814011,0,14,protein phosphatase 1 binding,MF,
3666,GO:0008172,1,0.604829173801421,0,5,S-methyltransferase activity,MF,
3668,GO:0008174,1,0.395633397569966,0,9,mRNA methyltransferase activity,MF,
3669,GO:0008175,1,0.0567217290808697,0,28,tRNA methyltransferase activity,MF,
3672,GO:0008179,1,0.359547744043191,0,10,adenylate cyclase binding,MF,
3673,GO:0008180,1,0.0595735359693772,0,28,COP9 signalosome,CC,
3676,GO:0008187,1,0.127001345092386,0,20,poly-pyrimidine tract binding,MF,
3700,GO:0008216,1,0.521900537197818,0,7,spermidine metabolic process,BP,
3715,GO:0008250,1,0.328328548795055,0,12,oligosaccharyltransferase complex,CC,
3723,GO:0008266,1,0.192514010178704,0,16,poly(U) RNA binding,MF,
3727,GO:0008271,1,0.594978042963808,0,5,secondary active sulfate transmembrane transporter activity,MF,
3728,GO:0008272,1,0.484887632089633,0,7,sulfate transport,BP,
3734,GO:0008278,1,0.435921367170316,0,8,cohesin complex,CC,
3755,GO:0008308,1,0.300568033998683,0,12,voltage-gated anion channel activity,MF,
3759,GO:0008312,1,0.509198729479851,0,7,7S RNA binding,MF,
3761,GO:0008320,1,0.280666387323201,0,14,protein transmembrane transporter activity,MF,
3771,GO:0008334,1,0.0996991260834244,0,24,histone mRNA metabolic process,BP,
3779,GO:0008353,1,0.201279301553126,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
3780,GO:0008354,1,0.483873150412859,0,7,germ cell migration,BP,
3791,GO:0008378,1,0.0695097672430033,0,26,galactosyltransferase activity,MF,
3807,GO:0008409,1,0.190391418626206,0,16,5'-3' exonuclease activity,MF,
3810,GO:0008417,1,0.354841524073098,0,10,fucosyltransferase activity,MF,
3813,GO:0008420,1,0.445109488395023,0,8,CTD phosphatase activity,MF,
3845,GO:0008469,1,0.440920897210289,0,8,histone-arginine N-methyltransferase activity,MF,
3854,GO:0008483,1,0.291640423967219,0,12,transaminase activity,MF,
3860,GO:0008494,1,0.50634721794195,0,7,translation activator activity,MF,
3863,GO:0008499,1,0.360432834389947,0,10,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
3870,GO:0008510,1,0.594968816104133,0,5,sodium:bicarbonate symporter activity,MF,
3883,GO:0008527,1,0.45673828402382,0,9,taste receptor activity,MF,
3888,GO:0008535,1,0.0974300047466146,0,24,respiratory chain complex IV assembly,BP,
3891,GO:0008540,1,0.310175510175306,0,12,proteasome regulatory particle, base subcomplex,CC,
3892,GO:0008541,1,0.504077932024054,0,7,proteasome regulatory particle, lid subcomplex,CC,
3897,GO:0008553,1,0.403680901872514,0,9,proton-exporting ATPase activity, phosphorylative mechanism,MF,
3902,GO:0008568,1,0.357290229184518,0,10,microtubule-severing ATPase activity,MF,
3914,GO:0008595,1,0.395706986014689,0,9,anterior/posterior axis specification, embryo,BP,
3916,GO:0008603,1,0.598326862536875,0,5,cAMP-dependent protein kinase regulator activity,MF,
3918,GO:0008608,1,0.0562406113667509,0,28,attachment of spindle microtubules to kinetochore,BP,
3927,GO:0008622,1,0.617264195709884,0,5,epsilon DNA polymerase complex,CC,
3931,GO:0008627,1,0.492436683116957,0,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
3934,GO:0008635,1,0.406133462483903,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
3936,GO:0008641,1,0.355896952508224,0,10,ubiquitin-like modifier activating enzyme activity,MF,
3973,GO:0008821,1,0.4071724452914,0,9,crossover junction endodeoxyribonuclease activity,MF,
3974,GO:0008823,1,0.602779681880316,0,5,cupric reductase activity,MF,
3999,GO:0008970,1,0.484197001380234,0,7,phosphatidylcholine 1-acylhydrolase activity,MF,
4011,GO:0009048,1,0.35845302443361,0,10,dosage compensation by inactivation of X chromosome,BP,
4026,GO:0009067,1,0.116580524737227,0,21,aspartate family amino acid biosynthetic process,BP,
4040,GO:0009086,1,0.328605926225188,0,11,methionine biosynthetic process,BP,
4109,GO:0009176,1,0.606813494078393,0,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4110,GO:0009177,1,0.606813494078393,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4132,GO:0009202,1,0.557853692212672,0,6,deoxyribonucleoside triphosphate biosynthetic process,BP,
4140,GO:0009211,1,0.568882976514151,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4150,GO:0009221,1,0.4580055070768,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4166,GO:0009249,1,0.543824989001845,0,7,protein lipoylation,BP,
4170,GO:0009256,1,0.595190315598949,0,5,10-formyltetrahydrofolate metabolic process,BP,
4186,GO:0009301,1,0.00129005649402722,0,67,snRNA transcription,BP,
4187,GO:0009303,1,0.0674776010426696,0,27,rRNA transcription,BP,
4188,GO:0009304,1,0.494561666390808,0,7,tRNA transcription,BP,
4207,GO:0009378,1,0.594968816104133,0,5,four-way junction helicase activity,MF,
4213,GO:0009396,1,0.4119948386226,0,9,folic acid-containing compound biosynthetic process,BP,
4236,GO:0009445,1,0.5073019564831,0,7,putrescine metabolic process,BP,
4237,GO:0009446,1,0.599846206041541,0,5,putrescine biosynthetic process,BP,
4243,GO:0009452,1,0.0400579839716846,0,33,7-methylguanosine RNA capping,BP,
4250,GO:0009595,1,0.442876848749747,0,8,detection of biotic stimulus,BP,
4251,GO:0009597,1,0.59720130320462,0,5,detection of virus,BP,
4268,GO:0009642,1,0.484378118249581,0,7,response to light intensity,BP,
4282,GO:0009713,1,0.404105619166516,0,9,catechol-containing compound biosynthetic process,BP,
4311,GO:0009812,1,0.447173092956613,0,8,flavonoid metabolic process,BP,
4325,GO:0009886,1,0.376922154525504,0,10,post-embryonic animal morphogenesis,BP,
4342,GO:0009922,1,0.600519722613827,0,5,fatty acid elongase activity,MF,
4349,GO:0009954,1,0.115628577886677,0,21,proximal/distal pattern formation,BP,
4358,GO:0009982,1,0.274020420570511,0,13,pseudouridine synthase activity,MF,
4367,GO:0010002,1,0.392936799425911,0,9,cardioblast differentiation,BP,
4372,GO:0010032,1,0.594968816104133,0,5,meiotic chromosome condensation,BP,
4379,GO:0010041,1,0.609189663084596,0,5,response to iron(III) ion,BP,
4396,GO:0010155,1,0.4340794889915,0,9,regulation of proton transport,BP,
4410,GO:0010216,1,0.536266768308757,0,6,maintenance of DNA methylation,BP,
4412,GO:0010225,1,0.271683661323353,0,13,response to UV-C,BP,
4422,GO:0010265,1,0.556404987436755,0,6,SCF complex assembly,BP,
4425,GO:0010273,1,0.684931130458471,0,5,detoxification of copper ion,BP,
4426,GO:0010286,1,0.615786979856818,0,5,heat acclimation,BP,
4450,GO:0010452,1,0.395772705773458,0,9,histone H3-K36 methylation,BP,
4455,GO:0010458,1,0.0747108785591535,0,26,exit from mitosis,BP,
4469,GO:0010485,1,0.155627066173709,0,18,H4 histone acetyltransferase activity,MF,
4472,GO:0010499,1,0.143826862843686,0,22,proteasomal ubiquitin-independent protein catabolic process,BP,
4484,GO:0010519,1,0.549789904037424,0,6,negative regulation of phospholipase activity,BP,
4515,GO:0010587,1,0.594971020816932,0,5,miRNA catabolic process,BP,
4522,GO:0010603,1,0.483351990887623,0,7,regulation of cytoplasmic mRNA processing body assembly,BP,
4525,GO:0010606,1,0.594968816104133,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4535,GO:0010623,1,0.501033628207274,0,7,programmed cell death involved in cell development,BP,
4578,GO:0010692,1,0.483629954116541,0,7,regulation of alkaline phosphatase activity,BP,
4580,GO:0010694,1,0.595310908695173,0,5,positive regulation of alkaline phosphatase activity,BP,
4632,GO:0010764,1,0.540082022269911,0,6,negative regulation of fibroblast migration,BP,
4640,GO:0010792,1,0.536271764250636,0,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4641,GO:0010793,1,0.59575318965582,0,5,regulation of mRNA export from nucleus,BP,
4650,GO:0010807,1,0.538964978866535,0,6,regulation of synaptic vesicle priming,BP,
4660,GO:0010818,1,0.402665569273965,0,9,T cell chemotaxis,BP,
4661,GO:0010819,1,0.545761867843912,0,6,regulation of T cell chemotaxis,BP,
4662,GO:0010820,1,0.545761867843912,0,6,positive regulation of T cell chemotaxis,BP,
4667,GO:0010825,1,0.536759827069767,0,6,positive regulation of centrosome duplication,BP,
4668,GO:0010826,1,0.30244753430954,0,12,negative regulation of centrosome duplication,BP,
4676,GO:0010835,1,0.487510729490906,0,7,regulation of protein ADP-ribosylation,BP,
4679,GO:0010838,1,0.594968864787708,0,5,positive regulation of keratinocyte proliferation,BP,
4680,GO:0010839,1,0.262902712050584,0,13,negative regulation of keratinocyte proliferation,BP,
4698,GO:0010870,1,0.367970883868045,0,10,positive regulation of receptor biosynthetic process,BP,
4712,GO:0010884,1,0.269952516449567,0,13,positive regulation of lipid storage,BP,
4733,GO:0010911,1,0.484325083467015,0,7,regulation of isomerase activity,BP,
4734,GO:0010912,1,0.484325083467015,0,7,positive regulation of isomerase activity,BP,
4741,GO:0010922,1,0.0934370289817645,0,23,positive regulation of phosphatase activity,BP,
4748,GO:0010935,1,0.448801818172678,0,8,regulation of macrophage cytokine production,BP,
4749,GO:0010936,1,0.604991491448114,0,5,negative regulation of macrophage cytokine production,BP,
4754,GO:0010944,1,0.559698695402306,0,6,negative regulation of transcription by competitive promoter binding,BP,
4769,GO:0010965,1,0.00674221906813151,0,50,regulation of mitotic sister chromatid separation,BP,
4772,GO:0010968,1,0.551159076386272,0,6,regulation of microtubule nucleation,BP,
4793,GO:0010997,1,0.599097042664778,0,5,anaphase-promoting complex binding,MF,
4794,GO:0010998,1,0.359357779678219,0,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
4799,GO:0012507,1,0.00996964730334922,0,46,ER to Golgi transport vesicle membrane,CC,
4806,GO:0014010,1,0.594968816104133,0,5,Schwann cell proliferation,BP,
4825,GO:0014041,1,0.494920518464686,0,7,regulation of neuron maturation,BP,
4877,GO:0014807,1,0.540086876834574,0,6,regulation of somitogenesis,BP,
4906,GO:0014854,1,0.444087952548944,0,8,response to inactivity,BP,
4913,GO:0014870,1,0.542739084036459,0,6,response to muscle inactivity,BP,
4914,GO:0014874,1,0.494831005091947,0,7,response to stimulus involved in regulation of muscle adaptation,BP,
4916,GO:0014877,1,0.602149000954882,0,5,response to muscle inactivity involved in regulation of muscle adaptation,BP,
4924,GO:0014894,1,0.602149000954882,0,5,response to denervation involved in regulation of muscle adaptation,BP,
4932,GO:0014904,1,0.217345327827722,0,15,myotube cell development,BP,
4968,GO:0015095,1,0.191629297841013,0,16,magnesium ion transmembrane transporter activity,MF,
4973,GO:0015106,1,0.318977605736652,0,11,bicarbonate transmembrane transporter activity,MF,
4978,GO:0015116,1,0.53797037722098,0,6,sulfate transmembrane transporter activity,MF,
4998,GO:0015165,1,0.405841375140701,0,9,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5002,GO:0015172,1,0.536267186431625,0,6,acidic amino acid transmembrane transporter activity,MF,
5007,GO:0015180,1,0.595065739926748,0,5,L-alanine transmembrane transporter activity,MF,
5014,GO:0015187,1,0.597028846465524,0,5,glycine transmembrane transporter activity,MF,
5018,GO:0015193,1,0.595065659256285,0,5,L-proline transmembrane transporter activity,MF,
5024,GO:0015205,1,0.548394144695461,0,6,nucleobase transmembrane transporter activity,MF,
5027,GO:0015215,1,0.219488734461908,0,15,nucleotide transmembrane transporter activity,MF,
5028,GO:0015216,1,0.327311009357796,0,11,purine nucleotide transmembrane transporter activity,MF,
5029,GO:0015217,1,0.401506767661736,0,9,ADP transmembrane transporter activity,MF,
5041,GO:0015245,1,0.595755863506067,0,5,fatty acid transmembrane transporter activity,MF,
5057,GO:0015288,1,0.55189712226386,0,6,porin activity,MF,
5084,GO:0015368,1,0.536622509942273,0,6,calcium:cation antiporter activity,MF,
5107,GO:0015450,1,0.543231764377779,0,7,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5109,GO:0015464,1,0.538531406941911,0,6,acetylcholine receptor activity,MF,
5126,GO:0015643,1,0.540748785488582,0,6,toxic substance binding,MF,
5127,GO:0015645,1,0.354321601322714,0,10,fatty acid ligase activity,MF,
5139,GO:0015682,1,0.0430727878353287,0,32,ferric iron transport,BP,
5145,GO:0015693,1,0.191629297841013,0,16,magnesium ion transport,BP,
5182,GO:0015780,1,0.297329492053821,0,12,nucleotide-sugar transmembrane transport,BP,
5199,GO:0015808,1,0.595065739926748,0,5,L-alanine transport,BP,
5205,GO:0015816,1,0.538123706863481,0,6,glycine transport,BP,
5211,GO:0015824,1,0.536354063990263,0,6,proline transport,BP,
5217,GO:0015838,1,0.486107113006237,0,7,amino-acid betaine transport,BP,
5221,GO:0015846,1,0.547476283909377,0,6,polyamine transport,BP,
5225,GO:0015851,1,0.499411382865295,0,7,nucleobase transport,BP,
5232,GO:0015865,1,0.295001289606489,0,12,purine nucleotide transport,BP,
5233,GO:0015866,1,0.401506767661736,0,9,ADP transport,BP,
5234,GO:0015867,1,0.401476257188499,0,9,ATP transport,BP,
5235,GO:0015868,1,0.295001289606489,0,12,purine ribonucleotide transport,BP,
5236,GO:0015871,1,0.536452843500586,0,6,choline transport,BP,
5241,GO:0015879,1,0.598359575712573,0,5,carnitine transport,BP,
5245,GO:0015884,1,0.61054599383278,0,5,folic acid transport,BP,
5272,GO:0015935,1,0.00357424412139277,0,68,small ribosomal subunit,CC,
5276,GO:0015939,1,0.606512593782974,0,5,pantothenate metabolic process,BP,
5287,GO:0015985,1,0.470823211530676,0,8,energy coupled proton transport, down electrochemical gradient,BP,
5288,GO:0015986,1,0.470823211530676,0,8,ATP synthesis coupled proton transport,BP,
5299,GO:0016018,1,0.376075709143021,0,10,cyclosporin A binding,MF,
5311,GO:0016045,1,0.545151069659637,0,6,detection of bacterium,BP,
5323,GO:0016070,1,0,237,3767,RNA metabolic process,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;WWC3;CITED4;TCFL5;PRDX5;PCBP4;MEF2D;NOS1;ZFP36L1;NR1D1;RBCK1;EPAS1;IGF2;NFATC4;MAPK13;EGFR;TSC22D1;TCEA2;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;PKD2;H2AFJ;CDKN1C;SALL2;MSRB2;PAK6;HEXB;FOXQ1;ATP2B4;TFDP2;CSNK1E;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;ADARB1;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;PRNP;DHX32;RNASET2;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;WWTR1;ISG20;DNAJB5;BCL6;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;MAPK3;ETV5;DVL1;MTA1;L3MBTL1;MBD1;FHOD1;HES1;BRD3;MLXIPL;ZNF624;ARHGAP22;ABCA2;ZNF414;PIDD1;PHF21A;CELSR2;ZFP36;ETV4;MAPKBP1;PRKACA;ZNF862;ZMYM3;KIAA1549;RPS6KA5;MAP2K2;DAP;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;BHLHE40;RRNAD1;ZNF80;HMGA2;ELK3;AHNAK2;DGKQ;ZXDC;GAS6;BTRC;POU6F1;ZNF217;PPARA;SUFU;PTAFR;PAN2;ZNF446;RXRA;NEO1;USP21;PRKCZ;HLTF;BCORL1;ZNF485;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;AGO4;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;PPP1R13L;ZNF554;WDR83;JARID2;SESN2;RXRB;PNRC1;MAPRE3;OR7D2;APOBEC3C;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;CCDC85B;AKT1;NLRX1;ZNF385A;TP53INP1;TUT1;SMARCA1;SIX5;ERCC6;TDRKH;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;ZNF710;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;TRERF1;THAP8;DDN;ERN1;ZNF319;APOBEC3F;PRIMPOL;GLI4;RNASEK;LITAF;MZF1;RARG;ING4;PBXIP1;EREG;ZNF514;WDR18;TRNP1;ZNF837;RPL13A;RGS12;UBL5
5327,GO:0016074,1,0.336662809530494,0,12,snoRNA metabolic process,BP,
5328,GO:0016075,1,0.234380015574005,0,15,rRNA catabolic process,BP,
5330,GO:0016078,1,0.565399081053068,0,6,tRNA catabolic process,BP,
5334,GO:0016082,1,0.320947136768255,0,11,synaptic vesicle priming,BP,
5340,GO:0016102,1,0.609598565013223,0,5,diterpenoid biosynthetic process,BP,
5342,GO:0016114,1,0.450517102709511,0,8,terpenoid biosynthetic process,BP,
5381,GO:0016226,1,0.151637954856751,0,20,iron-sulfur cluster assembly,BP,
5396,GO:0016246,1,0.225538339851369,0,15,RNA interference,BP,
5401,GO:0016255,1,0.491318484075748,0,7,attachment of GPI anchor to protein,BP,
5407,GO:0016264,1,0.483579745804159,0,7,gap junction assembly,BP,
5411,GO:0016272,1,0.557638466209516,0,7,prefoldin complex,CC,
5412,GO:0016273,1,0.322929705279411,0,11,arginine N-methyltransferase activity,MF,
5413,GO:0016274,1,0.322929705279411,0,11,protein-arginine N-methyltransferase activity,MF,
5431,GO:0016308,1,0.543111387392624,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5440,GO:0016322,1,0.53686040044432,0,6,neuron remodeling,BP,
5443,GO:0016327,1,0.265973166924901,0,13,apicolateral plasma membrane,CC,
5449,GO:0016338,1,0.454466377433336,0,8,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,
5452,GO:0016342,1,0.210990247269384,0,15,catenin complex,CC,
5477,GO:0016421,1,0.538480339176035,0,6,CoA carboxylase activity,MF,
5479,GO:0016423,1,0.265893042981161,0,13,tRNA (guanine) methyltransferase activity,MF,
5481,GO:0016427,1,0.44184154259651,0,8,tRNA (cytosine) methyltransferase activity,MF,
5496,GO:0016454,1,0.596914563467742,0,5,C-palmitoyltransferase activity,MF,
5500,GO:0016461,1,0.514800256996598,0,7,unconventional myosin complex,CC,
5502,GO:0016469,1,0.0997628255851966,0,24,proton-transporting two-sector ATPase complex,CC,
5503,GO:0016471,1,0.339274957952179,0,11,vacuolar proton-transporting V-type ATPase complex,CC,
5531,GO:0016530,1,0.605161881960779,0,6,metallochaperone activity,MF,
5532,GO:0016531,1,0.67139853926958,0,5,copper chaperone activity,MF,
5540,GO:0016556,1,0.215569871064685,0,15,mRNA modification,BP,
5543,GO:0016559,1,0.519480953671252,0,7,peroxisome fission,BP,
5558,GO:0016580,1,0.326297905275033,0,11,Sin3 complex,CC,
5560,GO:0016584,1,0.527187433133272,0,7,nucleosome positioning,BP,
5565,GO:0016592,1,0.0311649739854189,0,35,mediator complex,CC,
5566,GO:0016593,1,0.443713778770584,0,8,Cdc73/Paf1 complex,CC,
5572,GO:0016600,1,0.437298165701617,0,8,flotillin complex,CC,
5607,GO:0016670,1,0.483730631725143,0,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5625,GO:0016717,1,0.594994932085159,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
5638,GO:0016742,1,0.484511005858259,0,7,hydroxymethyl-, formyl- and related transferase activity,MF,
5652,GO:0016769,1,0.266289712674064,0,13,transferase activity, transferring nitrogenous groups,MF,
5660,GO:0016780,1,0.163032565038634,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
5678,GO:0016805,1,0.487618368896908,0,7,dipeptidase activity,MF,
5694,GO:0016832,1,0.493412484207695,0,7,aldehyde-lyase activity,MF,
5704,GO:0016846,1,0.525325168912384,0,7,carbon-sulfur lyase activity,MF,
5712,GO:0016861,1,0.4539636548023,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
5720,GO:0016875,1,0.0108803535043602,0,44,ligase activity, forming carbon-oxygen bonds,MF,
5727,GO:0016884,1,0.368818576510274,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
5729,GO:0016886,1,0.356062875027385,0,10,ligase activity, forming phosphoric ester bonds,MF,
5731,GO:0016888,1,0.325661359234764,0,11,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
5734,GO:0016891,1,0.0714188043877986,0,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
5736,GO:0016893,1,0.0316835582930437,0,35,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
5748,GO:0016918,1,0.63788077743277,0,5,retinal binding,MF,
5752,GO:0016926,1,0.48627848658808,0,7,protein desumoylation,BP,
5753,GO:0016929,1,0.536339677554437,0,6,SUMO-specific protease activity,MF,
5762,GO:0016973,1,0.368412857903049,0,10,poly(A)+ mRNA export from nucleus,BP,
5768,GO:0017000,1,0.246921382831442,0,14,antibiotic biosynthetic process,BP,
5772,GO:0017004,1,0.0366903818735707,0,34,cytochrome complex assembly,BP,
5793,GO:0017056,1,0.0767481273982557,0,25,structural constituent of nuclear pore,MF,
5795,GO:0017059,1,0.44380356686651,0,8,serine C-palmitoyltransferase complex,CC,
5798,GO:0017062,1,0.408889086358395,0,9,respiratory chain complex III assembly,BP,
5802,GO:0017070,1,0.349973294284677,0,11,U6 snRNA binding,MF,
5806,GO:0017081,1,0.307581660929299,0,12,chloride channel regulator activity,MF,
5816,GO:0017101,1,0.300560334620206,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
5818,GO:0017108,1,0.536664986133743,0,6,5'-flap endonuclease activity,MF,
5825,GO:0017119,1,0.288617817249889,0,12,Golgi transport complex,CC,
5844,GO:0017151,1,0.486636449301473,0,7,DEAD/H-box RNA helicase binding,MF,
5852,GO:0017162,1,0.444069141323762,0,8,aryl hydrocarbon receptor binding,MF,
5853,GO:0017166,1,0.353920727187864,0,10,vinculin binding,MF,
5855,GO:0017169,1,0.498998067431924,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
5860,GO:0017182,1,0.395150927889181,0,9,peptidyl-diphthamide metabolic process,BP,
5861,GO:0017183,1,0.395150927889181,0,9,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
5865,GO:0017196,1,0.548847294128947,0,6,N-terminal peptidyl-methionine acetylation,BP,
5878,GO:0018026,1,0.396018042176484,0,9,peptidyl-lysine monomethylation,BP,
5879,GO:0018027,1,0.240176764026438,0,14,peptidyl-lysine dimethylation,BP,
5883,GO:0018065,1,0.37000918782336,0,11,protein-cofactor linkage,BP,
5888,GO:0018103,1,0.557597836869544,0,6,protein C-linked glycosylation,BP,
5902,GO:0018158,1,0.41684719184346,0,9,protein oxidation,BP,
5917,GO:0018202,1,0.330602080585314,0,11,peptidyl-histidine modification,BP,
5919,GO:0018206,1,0.368405846406388,0,10,peptidyl-methionine modification,BP,
5923,GO:0018211,1,0.557597836869544,0,6,peptidyl-tryptophan modification,BP,
5926,GO:0018216,1,0.262318872636316,0,13,peptidyl-arginine methylation,BP,
5944,GO:0018317,1,0.557597836869544,0,6,protein C-linked glycosylation via tryptophan,BP,
5961,GO:0018406,1,0.557597836869544,0,6,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
5993,GO:0019042,1,0.328884336528697,0,11,viral latency,BP,
5994,GO:0019043,1,0.404859241648149,0,9,establishment of viral latency,BP,
6000,GO:0019054,1,0.129892442002704,0,20,modulation by virus of host process,BP,
6014,GO:0019081,1,0.243879435528358,0,14,viral translation,BP,
6025,GO:0019103,1,0.561274064482721,0,6,pyrimidine nucleotide binding,MF,
6057,GO:0019215,1,0.329106752903794,0,11,intermediate filament binding,MF,
6072,GO:0019237,1,0.536266768308757,0,6,centromeric DNA binding,MF,
6073,GO:0019238,1,0.539036022418574,0,6,cyclohydrolase activity,MF,
6081,GO:0019262,1,0.60856657546414,0,5,N-acetylneuraminate catabolic process,BP,
6088,GO:0019317,1,0.536266768308757,0,6,fucose catabolic process,BP,
6110,GO:0019367,1,0.600519722613827,0,5,fatty acid elongation, saturated fatty acid,BP,
6111,GO:0019368,1,0.600519722613827,0,5,fatty acid elongation, unsaturated fatty acid,BP,
6114,GO:0019371,1,0.55222493347938,0,6,cyclooxygenase pathway,BP,
6117,GO:0019374,1,0.539262792108681,0,6,galactolipid metabolic process,BP,
6136,GO:0019430,1,0.216082522880114,0,16,removal of superoxide radicals,BP,
6151,GO:0019509,1,0.608364151727006,0,5,L-methionine salvage from methylthioadenosine,BP,
6161,GO:0019531,1,0.594978042963808,0,5,oxalate transmembrane transporter activity,MF,
6162,GO:0019532,1,0.594978042963808,0,5,oxalate transport,BP,
6182,GO:0019646,1,0.3358171308942,0,14,aerobic electron transport chain,BP,
6203,GO:0019731,1,0.256145019851999,0,17,antibacterial humoral response,BP,
6214,GO:0019773,1,0.550032570283069,0,7,proteasome core complex, alpha-subunit complex,CC,
6215,GO:0019774,1,0.439950221198555,0,10,proteasome core complex, beta-subunit complex,CC,
6227,GO:0019788,1,0.572752774668738,0,6,NEDD8 transferase activity,MF,
6228,GO:0019789,1,0.199036986732627,0,16,SUMO transferase activity,MF,
6230,GO:0019798,1,0.536688581793972,0,6,procollagen-proline dioxygenase activity,MF,
6253,GO:0019855,1,0.46156436354136,0,8,calcium channel inhibitor activity,MF,
6254,GO:0019856,1,0.537161583437861,0,6,pyrimidine nucleobase biosynthetic process,BP,
6265,GO:0019869,1,0.465073323861036,0,8,chloride channel inhibitor activity,MF,
6266,GO:0019870,1,0.603574341105503,0,5,potassium channel inhibitor activity,MF,
6270,GO:0019883,1,0.333042319419337,0,11,antigen processing and presentation of endogenous antigen,BP,
6272,GO:0019885,1,0.49522855162288,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6277,GO:0019896,1,0.32646329817675,0,11,axonal transport of mitochondrion,BP,
6287,GO:0019907,1,0.496988550040427,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6288,GO:0019908,1,0.197419358499908,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6293,GO:0019919,1,0.489092646401015,0,7,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6310,GO:0019966,1,0.499627894857731,0,7,interleukin-1 binding,MF,
6321,GO:0020027,1,0.441352739592188,0,8,hemoglobin metabolic process,BP,
6344,GO:0021534,1,0.606579453837264,0,5,cell proliferation in hindbrain,BP,
6357,GO:0021548,1,0.5994136597844,0,5,pons development,BP,
6403,GO:0021670,1,0.450138578427982,0,8,lateral ventricle development,BP,
6416,GO:0021692,1,0.436048154514453,0,8,cerebellar Purkinje cell layer morphogenesis,BP,
6418,GO:0021694,1,0.595506454523405,0,5,cerebellar Purkinje cell layer formation,BP,
6425,GO:0021702,1,0.595506454523405,0,5,cerebellar Purkinje cell differentiation,BP,
6443,GO:0021772,1,0.172988935369038,0,17,olfactory bulb development,BP,
6450,GO:0021781,1,0.603101995556012,0,5,glial cell fate commitment,BP,
6455,GO:0021794,1,0.487290207885032,0,7,thalamus development,BP,
6461,GO:0021800,1,0.59505273907359,0,5,cerebral cortex tangential migration,BP,
6484,GO:0021854,1,0.338076741716971,0,11,hypothalamus development,BP,
6487,GO:0021859,1,0.5994136597844,0,5,pyramidal neuron differentiation,BP,
6488,GO:0021860,1,0.5994136597844,0,5,pyramidal neuron development,BP,
6495,GO:0021877,1,0.595655218886902,0,5,forebrain neuron fate commitment,BP,
6499,GO:0021884,1,0.199631075619255,0,16,forebrain neuron development,BP,
6503,GO:0021889,1,0.542367192126233,0,6,olfactory bulb interneuron differentiation,BP,
6504,GO:0021891,1,0.595376567535156,0,5,olfactory bulb interneuron development,BP,
6508,GO:0021895,1,0.329142218224134,0,11,cerebral cortex neuron differentiation,BP,
6518,GO:0021924,1,0.606579453837264,0,5,cell proliferation in external granule layer,BP,
6519,GO:0021930,1,0.606579453837264,0,5,cerebellar granule cell precursor proliferation,BP,
6520,GO:0021932,1,0.483902050650856,0,7,hindbrain radial glia guided cell migration,BP,
6540,GO:0021978,1,0.538625612697394,0,6,telencephalon regionalization,BP,
6545,GO:0021988,1,0.155903815057203,0,18,olfactory lobe development,BP,
6553,GO:0022010,1,0.441955261134817,0,8,central nervous system myelination,BP,
6576,GO:0022417,1,0.428075913406277,0,9,protein maturation by protein folding,BP,
6585,GO:0022613,1,6.5968365399013e-11,8,447,ribonucleoprotein complex biogenesis,BP,GRB7;CSNK1E;ISG20;RRNAD1;SRSF5;AGO4;WDR18;RPL13A
6588,GO:0022616,1,0.0803034812711179,0,25,DNA strand elongation,BP,
6592,GO:0022624,1,0.0990452634426253,0,24,proteasome accessory complex,CC,
6595,GO:0022627,1,0.0324918945839259,0,43,cytosolic small ribosomal subunit,CC,
6599,GO:0022824,1,0.483562019833828,0,7,transmitter-gated ion channel activity,MF,
6603,GO:0022835,1,0.483562019833828,0,7,transmitter-gated channel activity,MF,
6616,GO:0022858,1,0.595065739926748,0,5,alanine transmembrane transporter activity,MF,
6617,GO:0022884,1,0.252957409735867,0,15,macromolecule transmembrane transporter activity,MF,
6626,GO:0023019,1,0.398750005606749,0,9,signal transduction involved in regulation of gene expression,BP,
6634,GO:0023035,1,0.540436042333368,0,6,CD40 signaling pathway,BP,
6643,GO:0030002,1,0.542987701054116,0,6,cellular anion homeostasis,BP,
6651,GO:0030015,1,0.595384003486074,0,5,CCR4-NOT core complex,CC,
6663,GO:0030033,1,0.216037021927212,0,15,microvillus assembly,BP,
6675,GO:0030050,1,0.536266768308757,0,6,vesicle transport along actin filament,BP,
6681,GO:0030061,1,0.59867464997591,0,5,mitochondrial crista,CC,
6684,GO:0030071,1,0.00992710111266957,0,46,regulation of mitotic metaphase/anaphase transition,BP,
6706,GO:0030126,1,0.224629692073413,0,15,COPI vesicle coat,CC,
6707,GO:0030127,1,0.241640551969119,0,14,COPII vesicle coat,CC,
6716,GO:0030137,1,0.100537347599086,0,23,COPI-coated vesicle,CC,
6724,GO:0030150,1,0.177512397376314,0,18,protein import into mitochondrial matrix,BP,
6760,GO:0030205,1,0.440802221514257,0,8,dermatan sulfate metabolic process,BP,
6763,GO:0030208,1,0.440802221514257,0,8,dermatan sulfate biosynthetic process,BP,
6789,GO:0030242,1,0.594968816104133,0,5,autophagy of peroxisome,BP,
6791,GO:0030247,1,0.536770626623101,0,6,polysaccharide binding,MF,
6807,GO:0030277,1,0.441035659003407,0,8,maintenance of gastrointestinal epithelium,BP,
6810,GO:0030280,1,0.322793284023044,0,12,structural constituent of epidermis,MF,
6813,GO:0030284,1,0.595075270730624,0,5,estrogen receptor activity,MF,
6832,GO:0030309,1,0.443690769074856,0,8,poly-N-acetyllactosamine metabolic process,BP,
6833,GO:0030311,1,0.443690769074856,0,8,poly-N-acetyllactosamine biosynthetic process,BP,
6838,GO:0030318,1,0.26126207165986,0,13,melanocyte differentiation,BP,
6839,GO:0030320,1,0.542987701054116,0,6,cellular monovalent inorganic anion homeostasis,BP,
6851,GO:0030332,1,0.086524524859726,0,24,cyclin binding,MF,
6878,GO:0030422,1,0.41872641020999,0,9,production of siRNA involved in RNA interference,BP,
6894,GO:0030488,1,0.0396302180780717,0,32,tRNA methylation,BP,
6895,GO:0030490,1,0.00589320663983358,0,53,maturation of SSU-rRNA,BP,
6897,GO:0030497,1,0.363175626746037,0,10,fatty acid elongation,BP,
6916,GO:0030521,1,0.00274520498061363,0,58,androgen receptor signaling pathway,BP,
6922,GO:0030539,1,0.435946601913717,0,8,male genitalia development,BP,
6923,GO:0030540,1,0.364162090898785,0,10,female genitalia development,BP,
6928,GO:0030548,1,0.562789668916365,0,6,acetylcholine receptor regulator activity,MF,
6937,GO:0030575,1,0.397189845079487,0,9,nuclear body organization,BP,
6940,GO:0030579,1,0.601643620303269,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,
6955,GO:0030621,1,0.536782687638068,0,6,U4 snRNA binding,MF,
6961,GO:0030628,1,0.569410140580701,0,6,pre-mRNA 3'-splice site binding,MF,
6974,GO:0030663,1,0.167640940145089,0,18,COPI-coated vesicle membrane,CC,
6979,GO:0030670,1,0.00219415849028387,0,62,phagocytic vesicle membrane,CC,
6984,GO:0030677,1,0.298939806169701,0,13,ribonuclease P complex,CC,
6986,GO:0030681,1,0.399136113777891,0,10,multimeric ribonuclease P complex,CC,
6989,GO:0030684,1,0.000610824536687568,0,74,preribosome,CC,
6990,GO:0030686,1,0.0401241947280028,0,32,90S preribosome,CC,
6991,GO:0030687,1,0.0932135759861229,0,24,preribosome, large subunit precursor,CC,
6992,GO:0030688,1,0.294210058310598,0,12,preribosome, small subunit precursor,CC,
7046,GO:0030836,1,0.494320758894442,0,7,positive regulation of actin filament depolymerization,BP,
7055,GO:0030854,1,0.607329430246448,0,5,positive regulation of granulocyte differentiation,BP,
7060,GO:0030859,1,0.211782706893577,0,15,polarized epithelial cell differentiation,BP,
7067,GO:0030867,1,0.0977598245015461,0,25,rough endoplasmic reticulum membrane,CC,
7069,GO:0030870,1,0.595784337927168,0,5,Mre11 complex,CC,
7090,GO:0030898,1,0.448644341619564,0,8,actin-dependent ATPase activity,MF,
7095,GO:0030903,1,0.327493396332529,0,11,notochord development,BP,
7096,GO:0030904,1,0.13062339860764,0,20,retromer complex,CC,
7100,GO:0030911,1,0.438790263069104,0,8,TPR domain binding,MF,
7102,GO:0030914,1,0.306996469560704,0,12,STAGA complex,CC,
7118,GO:0030953,1,0.483496401415932,0,7,astral microtubule organization,BP,
7119,GO:0030955,1,0.393944511499571,0,9,potassium ion binding,MF,
7121,GO:0030957,1,0.36583282854448,0,10,Tat protein binding,MF,
7135,GO:0030992,1,0.148470042786345,0,19,intraciliary transport particle B,CC,
7154,GO:0031045,1,0.548358410391359,0,6,dense core granule,CC,
7160,GO:0031053,1,0.356528364101224,0,10,primary miRNA processing,BP,
7162,GO:0031055,1,0.0261825699208668,0,42,chromatin remodeling at centromere,BP,
7179,GO:0031080,1,0.36315864427779,0,10,nuclear pore outer ring,CC,
7187,GO:0031088,1,0.615140331385583,0,5,platelet dense granule membrane,CC,
7205,GO:0031111,1,0.0625436124248391,0,27,negative regulation of microtubule polymerization or depolymerization,BP,
7209,GO:0031115,1,0.395929172985536,0,9,negative regulation of microtubule polymerization,BP,
7212,GO:0031118,1,0.48277325498443,0,8,rRNA pseudouridine synthesis,BP,
7213,GO:0031119,1,0.504083616832406,0,7,tRNA pseudouridine synthesis,BP,
7218,GO:0031125,1,0.338440859877015,0,12,rRNA 3'-end processing,BP,
7219,GO:0031126,1,0.526928715118063,0,7,snoRNA 3'-end processing,BP,
7225,GO:0031145,1,0.000718345052360312,0,77,anaphase-promoting complex-dependent catabolic process,BP,
7229,GO:0031163,1,0.151637954856751,0,20,metallo-sulfur cluster assembly,BP,
7241,GO:0031211,1,0.44380356686651,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7262,GO:0031254,1,0.438796507487496,0,8,cell trailing edge,CC,
7264,GO:0031258,1,0.128593411216946,0,20,lamellipodium membrane,CC,
7266,GO:0031261,1,0.606475475730054,0,5,DNA replication preinitiation complex,CC,
7268,GO:0031264,1,0.398817831149122,0,9,death-inducing signaling complex,CC,
7269,GO:0031265,1,0.539583368260596,0,6,CD95 death-inducing signaling complex,CC,
7288,GO:0031298,1,0.406973596903536,0,9,replication fork protection complex,CC,
7298,GO:0031313,1,0.48935801150215,0,7,extrinsic component of endosome membrane,CC,
7299,GO:0031314,1,0.594968816095475,0,5,extrinsic component of mitochondrial inner membrane,CC,
7318,GO:0031340,1,0.545689631803216,0,6,positive regulation of vesicle fusion,BP,
7319,GO:0031341,1,0.0378681840565166,0,33,regulation of cell killing,BP,
7320,GO:0031342,1,0.32901875353728,0,11,negative regulation of cell killing,BP,
7321,GO:0031343,1,0.140685127648924,0,20,positive regulation of cell killing,BP,
7329,GO:0031365,1,0.0881810403309653,0,24,N-terminal protein amino acid modification,BP,
7332,GO:0031371,1,0.444678083390064,0,8,ubiquitin conjugating enzyme complex,CC,
7338,GO:0031390,1,0.444995976171353,0,8,Ctf18 RFC-like complex,CC,
7348,GO:0031402,1,0.437079480289545,0,8,sodium ion binding,MF,
7355,GO:0031414,1,0.411898923554646,0,9,N-terminal protein acetyltransferase complex,CC,
7361,GO:0031420,1,0.259951915416504,0,13,alkali metal ion binding,MF,
7364,GO:0031428,1,0.612400880668143,0,5,box C/D snoRNP complex,CC,
7365,GO:0031429,1,0.652713629859255,0,5,box H/ACA snoRNP complex,CC,
7377,GO:0031441,1,0.39275817556418,0,9,negative regulation of mRNA 3'-end processing,BP,
7378,GO:0031442,1,0.395235747514396,0,9,positive regulation of mRNA 3'-end processing,BP,
7389,GO:0031464,1,0.299904950158886,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7414,GO:0031527,1,0.319275699012859,0,11,filopodium membrane,CC,
7422,GO:0031543,1,0.393500782824654,0,9,peptidyl-proline dioxygenase activity,MF,
7424,GO:0031545,1,0.596242444752938,0,5,peptidyl-proline 4-dioxygenase activity,MF,
7447,GO:0031595,1,0.461974765327493,0,8,nuclear proteasome complex,CC,
7448,GO:0031597,1,0.306725006633477,0,12,cytosolic proteasome complex,CC,
7450,GO:0031618,1,0.442307383828769,0,8,nuclear pericentric heterochromatin,CC,
7459,GO:0031629,1,0.366184577095489,0,10,synaptic vesicle fusion to presynaptic active zone membrane,BP,
7464,GO:0031640,1,0.236375611647454,0,17,killing of cells of other organism,BP,
7466,GO:0031642,1,0.551053548427938,0,6,negative regulation of myelination,BP,
7467,GO:0031643,1,0.435795041119013,0,8,positive regulation of myelination,BP,
7469,GO:0031645,1,0.499997129680163,0,7,negative regulation of neurological system process,BP,
7473,GO:0031649,1,0.299845783129237,0,12,heat generation,BP,
7474,GO:0031650,1,0.451536110870977,0,8,regulation of heat generation,BP,
7476,GO:0031652,1,0.500970999787488,0,7,positive regulation of heat generation,BP,
7478,GO:0031658,1,0.5066158770304,0,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7482,GO:0031665,1,0.456130131326941,0,8,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
7514,GO:0031730,1,0.624385118706385,0,5,CCR5 chemokine receptor binding,MF,
7531,GO:0031821,1,0.542347094926096,0,6,G-protein coupled serotonin receptor binding,MF,
7561,GO:0031935,1,0.126619168587805,0,20,regulation of chromatin silencing,BP,
7562,GO:0031936,1,0.436730061766291,0,8,negative regulation of chromatin silencing,BP,
7563,GO:0031937,1,0.438498310351659,0,8,positive regulation of chromatin silencing,BP,
7574,GO:0031953,1,0.353944838084295,0,10,negative regulation of protein autophosphorylation,BP,
7577,GO:0031957,1,0.483920427735559,0,7,very long-chain fatty acid-CoA ligase activity,MF,
7578,GO:0031958,1,0.192110152267596,0,16,corticosteroid receptor signaling pathway,BP,
7594,GO:0031987,1,0.43597793913555,0,8,locomotion involved in locomotory behavior,BP,
7598,GO:0031996,1,0.355850177636671,0,10,thioesterase binding,MF,
7607,GO:0032009,1,0.488817085847615,0,7,early phagosome,CC,
7611,GO:0032020,1,0.56996845427569,0,6,ISG15-protein conjugation,BP,
7619,GO:0032036,1,0.613108557696149,0,5,myosin heavy chain binding,MF,
7620,GO:0032039,1,0.260681374128614,0,13,integrator complex,CC,
7621,GO:0032040,1,0.0371612613604218,0,33,small-subunit processome,CC,
7633,GO:0032056,1,0.538307653018176,0,6,positive regulation of translation in response to stress,BP,
7670,GO:0032119,1,0.471249212506475,0,8,sequestering of zinc ion,BP,
7709,GO:0032211,1,0.142675418133239,0,19,negative regulation of telomere maintenance via telomerase,BP,
7728,GO:0032239,1,0.190222099242466,0,16,regulation of nucleobase-containing compound transport,BP,
7730,GO:0032241,1,0.484090651256752,0,7,positive regulation of nucleobase-containing compound transport,BP,
7746,GO:0032274,1,0.484189705167792,0,7,gonadotropin secretion,BP,
7747,GO:0032275,1,0.595367800768937,0,5,luteinizing hormone secretion,BP,
7759,GO:0032291,1,0.441955261134817,0,8,axon ensheathment in central nervous system,BP,
7776,GO:0032328,1,0.536354136709256,0,6,alanine transport,BP,
7780,GO:0032332,1,0.319171223189426,0,11,positive regulation of chondrocyte differentiation,BP,
7793,GO:0032354,1,0.288151232594242,0,12,response to follicle-stimulating hormone,BP,
7795,GO:0032356,1,0.366127396175898,0,10,oxidized DNA binding,MF,
7796,GO:0032357,1,0.405663039313788,0,9,oxidized purine DNA binding,MF,
7834,GO:0032404,1,0.445595861680626,0,8,mismatch repair complex binding,MF,
7835,GO:0032405,1,0.606221776248636,0,5,MutLalpha complex binding,MF,
7836,GO:0032407,1,0.601012301174062,0,5,MutSalpha complex binding,MF,
7862,GO:0032435,1,0.0687625598575688,0,27,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
7870,GO:0032449,1,0.604683964598362,0,5,CBM complex,CC,
7874,GO:0032453,1,0.536266768308757,0,6,histone demethylase activity (H3-K4 specific),MF,
7883,GO:0032463,1,0.333507120057807,0,11,negative regulation of protein homooligomerization,BP,
7884,GO:0032464,1,0.556095100970022,0,6,positive regulation of protein homooligomerization,BP,
7887,GO:0032467,1,0.0793334013242832,0,25,positive regulation of cytokinesis,BP,
7889,GO:0032469,1,0.134906621639468,0,20,endoplasmic reticulum calcium ion homeostasis,BP,
7891,GO:0032471,1,0.516090423583458,0,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
7907,GO:0032494,1,0.59502569885514,0,5,response to peptidoglycan,BP,
7908,GO:0032495,1,0.289745065164479,0,12,response to muramyl dipeptide,BP,
7922,GO:0032511,1,0.462834023109195,0,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
7924,GO:0032516,1,0.237346382805991,0,14,positive regulation of phosphoprotein phosphatase activity,BP,
7925,GO:0032525,1,0.539224621226278,0,6,somite rostral/caudal axis specification,BP,
7931,GO:0032534,1,0.536266871505009,0,6,regulation of microvillus assembly,BP,
7934,GO:0032541,1,0.608620050438156,0,5,cortical endoplasmic reticulum,CC,
7936,GO:0032543,1,6.69957291152744e-06,0,129,mitochondrial translation,BP,
7941,GO:0032552,1,0.563355828604226,0,6,deoxyribonucleotide binding,MF,
7960,GO:0032585,1,0.370683278660524,0,10,multivesicular body membrane,CC,
7967,GO:0032593,1,0.556947164015247,0,6,insulin-responsive compartment,CC,
7975,GO:0032604,1,0.496177400713283,0,7,granulocyte macrophage colony-stimulating factor production,BP,
7980,GO:0032610,1,0.572374132987846,0,6,interleukin-1 alpha production,BP,
7988,GO:0032621,1,0.539847096213494,0,6,interleukin-18 production,BP,
8001,GO:0032645,1,0.496177400713283,0,7,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8005,GO:0032650,1,0.614081342028916,0,5,regulation of interleukin-1 alpha production,BP,
8013,GO:0032661,1,0.598940720934403,0,5,regulation of interleukin-18 production,BP,
8045,GO:0032725,1,0.550495001337668,0,6,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8046,GO:0032727,1,0.191541910226936,0,16,positive regulation of interferon-alpha production,BP,
8053,GO:0032735,1,0.177965681108476,0,17,positive regulation of interleukin-12 production,BP,
8056,GO:0032740,1,0.549027434263611,0,6,positive regulation of interleukin-17 production,BP,
8058,GO:0032743,1,0.145771986029115,0,19,positive regulation of interleukin-2 production,BP,
8081,GO:0032780,1,0.488040591730704,0,7,negative regulation of ATPase activity,BP,
8082,GO:0032781,1,0.0195333681288701,0,40,positive regulation of ATPase activity,BP,
8086,GO:0032785,1,0.326042177817133,0,11,negative regulation of DNA-templated transcription, elongation,BP,
8091,GO:0032790,1,0.445969533748216,0,8,ribosome disassembly,BP,
8097,GO:0032797,1,0.335090427305299,0,11,SMN complex,CC,
8106,GO:0032806,1,0.0789322187754772,0,25,carboxy-terminal domain protein kinase complex,CC,
8113,GO:0032815,1,0.615286476934255,0,5,negative regulation of natural killer cell activation,BP,
8135,GO:0032875,1,0.483351990887623,0,7,regulation of DNA endoreduplication,BP,
8156,GO:0032906,1,0.536989321373926,0,6,transforming growth factor beta2 production,BP,
8159,GO:0032909,1,0.536989321373926,0,6,regulation of transforming growth factor beta2 production,BP,
8174,GO:0032926,1,0.493193610931222,0,7,negative regulation of activin receptor signaling pathway,BP,
8199,GO:0032966,1,0.600671022994895,0,5,negative regulation of collagen biosynthetic process,BP,
8201,GO:0032968,1,0.219203309166985,0,15,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8212,GO:0032988,1,0.269733341305677,0,13,ribonucleoprotein complex disassembly,BP,
8226,GO:0033010,1,0.543608574658806,0,6,paranodal junction,CC,
8237,GO:0033029,1,0.601491811259044,0,5,regulation of neutrophil apoptotic process,BP,
8242,GO:0033034,1,0.551387363185349,0,6,positive regulation of myeloid cell apoptotic process,BP,
8245,GO:0033038,1,0.506709312096974,0,8,bitter taste receptor activity,MF,
8249,GO:0033045,1,0.000863995466936838,0,70,regulation of sister chromatid segregation,BP,
8250,GO:0033046,1,0.0270635175511311,0,36,negative regulation of sister chromatid segregation,BP,
8251,GO:0033047,1,0.00220237323177496,0,61,regulation of mitotic sister chromatid segregation,BP,
8252,GO:0033048,1,0.0333304154686508,0,34,negative regulation of mitotic sister chromatid segregation,BP,
8276,GO:0033119,1,0.111743922152608,0,22,negative regulation of RNA splicing,BP,
8291,GO:0033139,1,0.552904320015973,0,6,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8296,GO:0033144,1,0.084431148961814,0,24,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8299,GO:0033147,1,0.396752458695079,0,9,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8304,GO:0033153,1,0.594968816104133,0,5,T cell receptor V(D)J recombination,BP,
8309,GO:0033162,1,0.558503032868953,0,6,melanosome membrane,CC,
8313,GO:0033170,1,0.444995976171353,0,8,protein-DNA loading ATPase activity,MF,
8315,GO:0033176,1,0.147227717985474,0,20,proton-transporting V-type ATPase complex,CC,
8316,GO:0033177,1,0.426178920103229,0,9,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8317,GO:0033178,1,0.382257141880605,0,10,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8318,GO:0033179,1,0.467579492289187,0,8,proton-transporting V-type ATPase, V0 domain,CC,
8319,GO:0033180,1,0.4636729114718,0,8,proton-transporting V-type ATPase, V1 domain,CC,
8321,GO:0033182,1,0.354533629276993,0,10,regulation of histone ubiquitination,BP,
8323,GO:0033184,1,0.595061488843739,0,5,positive regulation of histone ubiquitination,BP,
8337,GO:0033211,1,0.606307637235763,0,5,adiponectin-activated signaling pathway,BP,
8338,GO:0033216,1,0.607993266403963,0,5,ferric iron import,BP,
8343,GO:0033234,1,0.36490831393693,0,10,negative regulation of protein sumoylation,BP,
8350,GO:0033256,1,0.489116027994097,0,7,I-kappaB/NF-kappaB complex,CC,
8363,GO:0033276,1,0.248851204050726,0,14,transcription factor TFTC complex,CC,
8374,GO:0033299,1,0.601291241817745,0,5,secretion of lysosomal enzymes,BP,
8378,GO:0033313,1,0.595734045446678,0,5,meiotic cell cycle checkpoint,BP,
8379,GO:0033314,1,0.440662495915823,0,8,mitotic DNA replication checkpoint,BP,
8384,GO:0033327,1,0.549138427596577,0,6,Leydig cell differentiation,BP,
8400,GO:0033391,1,0.536266768488243,0,6,chromatoid body,CC,
8414,GO:0033523,1,0.291567249632748,0,12,histone H2B ubiquitination,BP,
8427,GO:0033561,1,0.0944676444560934,0,23,regulation of water loss via skin,BP,
8431,GO:0033567,1,0.609723170839806,0,5,DNA replication, Okazaki fragment processing,BP,
8433,GO:0033572,1,0.0575976282912221,0,29,transferrin transport,BP,
8434,GO:0033574,1,0.0410729385277329,0,32,response to testosterone,BP,
8437,GO:0033588,1,0.599618729565998,0,5,Elongator holoenzyme complex,CC,
8440,GO:0033592,1,0.595030346291438,0,5,RNA strand annealing activity,MF,
8448,GO:0033601,1,0.436386801064044,0,8,positive regulation of mammary gland epithelial cell proliferation,BP,
8459,GO:0033617,1,0.145058642565245,0,20,mitochondrial respiratory chain complex IV assembly,BP,
8461,GO:0033622,1,0.320131329528349,0,11,integrin activation,BP,
8462,GO:0033623,1,0.536266847961216,0,6,regulation of integrin activation,BP,
8467,GO:0033629,1,0.494608518623488,0,7,negative regulation of cell adhesion mediated by integrin,BP,
8468,GO:0033630,1,0.304779783381746,0,12,positive regulation of cell adhesion mediated by integrin,BP,
8475,GO:0033646,1,0.485938909276675,0,7,host intracellular part,CC,
8476,GO:0033647,1,0.598152565602403,0,5,host intracellular organelle,CC,
8477,GO:0033648,1,0.598152565602403,0,5,host intracellular membrane-bounded organelle,CC,
8508,GO:0033750,1,0.294513283175094,0,13,ribosome localization,BP,
8540,GO:0033962,1,0.161706520097123,0,18,cytoplasmic mRNA processing body assembly,BP,
8554,GO:0034036,1,0.538197583788719,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
8560,GO:0034046,1,0.485446738791167,0,7,poly(G) binding,MF,
8570,GO:0034080,1,0.0317091517595965,0,40,CENP-A containing nucleosome assembly,BP,
8571,GO:0034085,1,0.484948238839369,0,7,establishment of sister chromatid cohesion,BP,
8572,GO:0034086,1,0.300274690013985,0,12,maintenance of sister chromatid cohesion,BP,
8574,GO:0034088,1,0.300274690013985,0,12,maintenance of mitotic sister chromatid cohesion,BP,
8575,GO:0034091,1,0.454739757442842,0,8,regulation of maintenance of sister chromatid cohesion,BP,
8577,GO:0034093,1,0.605923334860011,0,5,positive regulation of maintenance of sister chromatid cohesion,BP,
8579,GO:0034098,1,0.398034792225052,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
8588,GO:0034113,1,0.0511273164334007,0,29,heterotypic cell-cell adhesion,BP,
8589,GO:0034114,1,0.265696248273179,0,13,regulation of heterotypic cell-cell adhesion,BP,
8590,GO:0034115,1,0.48922784131285,0,7,negative regulation of heterotypic cell-cell adhesion,BP,
8591,GO:0034116,1,0.49296008397307,0,7,positive regulation of heterotypic cell-cell adhesion,BP,
8597,GO:0034123,1,0.271531094827252,0,13,positive regulation of toll-like receptor signaling pathway,BP,
8599,GO:0034127,1,0.596368829440599,0,5,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
8601,GO:0034134,1,0.368000572188765,0,10,toll-like receptor 2 signaling pathway,BP,
8602,GO:0034135,1,0.555483832360383,0,6,regulation of toll-like receptor 2 signaling pathway,BP,
8605,GO:0034138,1,0.173789128395374,0,17,toll-like receptor 3 signaling pathway,BP,
8606,GO:0034139,1,0.439210988706078,0,8,regulation of toll-like receptor 3 signaling pathway,BP,
8608,GO:0034141,1,0.540644009562895,0,6,positive regulation of toll-like receptor 3 signaling pathway,BP,
8612,GO:0034145,1,0.542866182650995,0,6,positive regulation of toll-like receptor 4 signaling pathway,BP,
8625,GO:0034182,1,0.454739757442842,0,8,regulation of maintenance of mitotic sister chromatid cohesion,BP,
8627,GO:0034184,1,0.605923334860011,0,5,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
8638,GO:0034201,1,0.606233877766802,0,5,response to oleic acid,BP,
8642,GO:0034212,1,0.00224165848338492,0,60,peptide N-acetyltransferase activity,MF,
8644,GO:0034214,1,0.484464620379601,0,7,protein hexamerization,BP,
8648,GO:0034227,1,0.605552815917264,0,5,tRNA thio-modification,BP,
8649,GO:0034235,1,0.598332868414406,0,5,GPI anchor binding,MF,
8650,GO:0034236,1,0.325363908079018,0,11,protein kinase A catalytic subunit binding,MF,
8656,GO:0034243,1,0.078229328591608,0,25,regulation of transcription elongation from RNA polymerase II promoter,BP,
8657,GO:0034244,1,0.361748359539517,0,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
8673,GO:0034310,1,0.497065382872073,0,7,primary alcohol catabolic process,BP,
8674,GO:0034311,1,0.192528843720202,0,17,diol metabolic process,BP,
8675,GO:0034312,1,0.233306278552766,0,15,diol biosynthetic process,BP,
8715,GO:0034379,1,0.558648464950954,0,6,very-low-density lipoprotein particle assembly,BP,
8723,GO:0034388,1,0.538831764723987,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
8724,GO:0034389,1,0.220756981313537,0,15,lipid particle organization,BP,
8742,GO:0034427,1,0.392848061090837,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
8755,GO:0034450,1,0.308057688463763,0,12,ubiquitin-ubiquitin ligase activity,MF,
8756,GO:0034451,1,0.103087037428296,0,22,centriolar satellite,CC,
8757,GO:0034452,1,0.354438445193302,0,10,dynactin binding,MF,
8758,GO:0034453,1,0.0931072948517119,0,23,microtubule anchoring,BP,
8759,GO:0034454,1,0.392707153773388,0,9,microtubule anchoring at centrosome,BP,
8770,GO:0034471,1,0.163500362736115,0,19,ncRNA 5'-end processing,BP,
8771,GO:0034472,1,0.259304078163699,0,14,snRNA 3'-end processing,BP,
8774,GO:0034475,1,0.483583952773098,0,8,U4 snRNA 3'-end processing,BP,
8783,GO:0034501,1,0.195240274116837,0,16,protein localization to kinetochore,BP,
8784,GO:0034502,1,0.000643359505618691,0,72,protein localization to chromosome,BP,
8788,GO:0034508,1,0.0113778161267343,0,50,centromere complex assembly,BP,
8791,GO:0034513,1,0.652713629859255,0,5,box H/ACA snoRNA binding,MF,
8795,GO:0034551,1,0.408889086358395,0,9,mitochondrial respiratory chain complex III assembly,BP,
8802,GO:0034593,1,0.0916955638474031,0,23,phosphatidylinositol bisphosphate phosphatase activity,MF,
8805,GO:0034596,1,0.435654378075768,0,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,
8809,GO:0034603,1,0.599992039694227,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
8810,GO:0034604,1,0.599992039694227,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
8820,GO:0034625,1,0.600519722613827,0,5,fatty acid elongation, monounsaturated fatty acid,BP,
8821,GO:0034626,1,0.600519722613827,0,5,fatty acid elongation, polyunsaturated fatty acid,BP,
8824,GO:0034629,1,0.118229860523803,0,21,cellular protein-containing complex localization,BP,
8832,GO:0034643,1,0.150093712528677,0,19,establishment of mitochondrion localization, microtubule-mediated,BP,
8846,GO:0034661,1,0.102002134548702,0,23,ncRNA catabolic process,BP,
8847,GO:0034663,1,0.456161505238034,0,8,endoplasmic reticulum chaperone complex,CC,
8876,GO:0034709,1,0.345813014947174,0,12,methylosome,CC,
8878,GO:0034713,1,0.442299240507095,0,8,type I transforming growth factor beta receptor binding,MF,
8880,GO:0034715,1,0.588464843435859,0,6,pICln-Sm protein complex,CC,
8882,GO:0034719,1,0.228048447311606,0,16,SMN-Sm protein complex,CC,
8883,GO:0034720,1,0.536266768308757,0,6,histone H3-K4 demethylation,BP,
8886,GO:0034723,1,0.0944389500133551,0,32,DNA replication-dependent nucleosome organization,BP,
8887,GO:0034724,1,0.0104047626335954,0,51,DNA replication-independent nucleosome organization,BP,
8920,GO:0034969,1,0.358184302168406,0,10,histone arginine methylation,BP,
8923,GO:0034975,1,0.234202457816866,0,14,protein folding in endoplasmic reticulum,BP,
8926,GO:0034982,1,0.375926876632409,0,10,mitochondrial protein processing,BP,
8936,GO:0035005,1,0.536266768308757,0,6,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
8946,GO:0035032,1,0.538569118027806,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
8960,GO:0035067,1,0.237922508330793,0,14,negative regulation of histone acetylation,BP,
8965,GO:0035089,1,0.260693937180439,0,13,establishment of apical/basal cell polarity,BP,
8978,GO:0035112,1,0.536266768308757,0,6,genitalia morphogenesis,BP,
8987,GO:0035145,1,0.118231713707435,0,21,exon-exon junction complex,CC,
8993,GO:0035174,1,0.547731701739154,0,6,histone serine kinase activity,MF,
9002,GO:0035197,1,0.39756751534653,0,9,siRNA binding,MF,
9007,GO:0035234,1,0.555882387112876,0,6,ectopic germ cell programmed cell death,BP,
9008,GO:0035235,1,0.39735143020819,0,9,ionotropic glutamate receptor signaling pathway,BP,
9012,GO:0035242,1,0.489092646401015,0,7,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9014,GO:0035246,1,0.322929705279411,0,11,peptidyl-arginine N-methylation,BP,
9015,GO:0035247,1,0.397407120197622,0,9,peptidyl-arginine omega-N-methylation,BP,
9018,GO:0035250,1,0.104674510144674,0,22,UDP-galactosyltransferase activity,MF,
9019,GO:0035251,1,0.496692321974915,0,7,UDP-glucosyltransferase activity,MF,
9032,GO:0035267,1,0.146447888994161,0,19,NuA4 histone acetyltransferase complex,CC,
9055,GO:0035312,1,0.537336788906883,0,6,5'-3' exodeoxyribonuclease activity,MF,
9060,GO:0035327,1,0.141244866569632,0,20,transcriptionally active chromatin,CC,
9065,GO:0035333,1,0.299898260002266,0,12,Notch receptor processing, ligand-dependent,BP,
9069,GO:0035338,1,0.266067389364457,0,13,long-chain fatty-acyl-CoA biosynthetic process,BP,
9108,GO:0035437,1,0.326243439051888,0,11,maintenance of protein localization in endoplasmic reticulum,BP,
9118,GO:0035459,1,0.126541972285233,0,20,cargo loading into vesicle,BP,
9119,GO:0035461,1,0.438459070363915,0,8,vitamin transmembrane transport,BP,
9137,GO:0035507,1,0.594968816104133,0,5,regulation of myosin-light-chain-phosphatase activity,BP,
9141,GO:0035511,1,0.613415460796937,0,5,oxidative DNA demethylation,BP,
9149,GO:0035520,1,0.39267422252269,0,9,monoubiquitinated protein deubiquitination,BP,
9153,GO:0035524,1,0.595065659256285,0,5,proline transmembrane transport,BP,
9156,GO:0035529,1,0.618360492238393,0,5,NADH pyrophosphatase activity,MF,
9169,GO:0035563,1,0.292775397318696,0,12,positive regulation of chromatin binding,BP,
9209,GO:0035613,1,0.219290158221692,0,15,RNA stem-loop binding,MF,
9222,GO:0035631,1,0.322027334623746,0,11,CD40 receptor complex,CC,
9232,GO:0035646,1,0.371245761173743,0,10,endosome to melanosome transport,BP,
9242,GO:0035666,1,0.0804893369619819,0,25,TRIF-dependent toll-like receptor signaling pathway,BP,
9246,GO:0035672,1,0.539515611784031,0,6,oligopeptide transmembrane transport,BP,
9272,GO:0035728,1,0.322169807070755,0,11,response to hepatocyte growth factor,BP,
9273,GO:0035729,1,0.396390374614227,0,9,cellular response to hepatocyte growth factor stimulus,BP,
9286,GO:0035749,1,0.605632679641689,0,5,myelin sheath adaxonal region,CC,
9313,GO:0035810,1,0.596371430569689,0,5,positive regulation of urine volume,BP,
9332,GO:0035861,1,0.0366259072173263,0,32,site of double-strand break,CC,
9342,GO:0035871,1,0.394929390411664,0,9,protein K11-linked deubiquitination,BP,
9343,GO:0035872,1,0.0382805176818685,0,32,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
9357,GO:0035900,1,0.566763011987883,0,6,response to isolation stress,BP,
9361,GO:0035907,1,0.595192527074111,0,5,dorsal aorta development,BP,
9374,GO:0035929,1,0.497578453029485,0,7,steroid hormone secretion,BP,
9388,GO:0035964,1,0.54306611209707,0,6,COPI-coated vesicle budding,BP,
9394,GO:0035973,1,0.491157432287679,0,7,aggrephagy,BP,
9413,GO:0036002,1,0.0409023506373965,0,32,pre-mRNA binding,MF,
9432,GO:0036037,1,0.442815116864408,0,8,CD8-positive, alpha-beta T cell activation,BP,
9434,GO:0036041,1,0.586261121690911,0,6,long-chain fatty acid binding,MF,
9470,GO:0036123,1,0.607098946202534,0,5,histone H3-K9 dimethylation,BP,
9471,GO:0036124,1,0.238287296298707,0,14,histone H3-K9 trimethylation,BP,
9489,GO:0036155,1,0.596034321440796,0,5,acylglycerol acyl-chain remodeling,BP,
9513,GO:0036260,1,0.0400579839716846,0,33,RNA capping,BP,
9525,GO:0036295,1,0.268170156131484,0,13,cellular response to increased oxygen levels,BP,
9529,GO:0036302,1,0.595192527074111,0,5,atrioventricular canal development,BP,
9533,GO:0036312,1,0.392718978618433,0,9,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
9536,GO:0036315,1,0.25952944330294,0,13,cellular response to sterol,BP,
9549,GO:0036353,1,0.446898239898503,0,8,histone H2A-K119 monoubiquitination,BP,
9566,GO:0036402,1,0.566086627039901,0,6,proteasome-activating ATPase activity,MF,
9573,GO:0036442,1,0.118662828105017,0,22,proton-exporting ATPase activity,MF,
9577,GO:0036449,1,0.483351990887623,0,7,microtubule minus-end,CC,
9586,GO:0036462,1,0.499746641837921,0,7,TRAIL-activated apoptotic signaling pathway,BP,
9607,GO:0036491,1,0.485191654151451,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
9608,GO:0036492,1,0.538132720869437,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
9614,GO:0036499,1,0.160653880326522,0,18,PERK-mediated unfolded protein response,BP,
9615,GO:0036500,1,0.365081620801888,0,10,ATF6-mediated unfolded protein response,BP,
9627,GO:0036513,1,0.359552828092602,0,10,Derlin-1 retrotranslocation complex,CC,
9653,GO:0038030,1,0.536290150750489,0,6,non-canonical Wnt signaling pathway via MAPK cascade,BP,
9654,GO:0038031,1,0.594994755862483,0,5,non-canonical Wnt signaling pathway via JNK cascade,BP,
9668,GO:0038063,1,0.483351990887623,0,7,collagen-activated tyrosine kinase receptor signaling pathway,BP,
9670,GO:0038065,1,0.435654378075768,0,8,collagen-activated signaling pathway,BP,
9702,GO:0038155,1,0.596346722692175,0,5,interleukin-23-mediated signaling pathway,BP,
9708,GO:0038166,1,0.608375738040231,0,5,angiotensin-activated signaling pathway,BP,
9712,GO:0038180,1,0.449632167564472,0,8,nerve growth factor signaling pathway,BP,
9779,GO:0040016,1,0.486269916428277,0,7,embryonic cleavage,BP,
9783,GO:0040020,1,0.192511142711179,0,16,regulation of meiotic nuclear division,BP,
9786,GO:0040031,1,0.578162518510319,0,6,snRNA modification,BP,
9800,GO:0042023,1,0.435654378075768,0,8,DNA endoreduplication,BP,
9802,GO:0042026,1,0.0795887416498508,0,25,protein refolding,BP,
9811,GO:0042048,1,0.594968816104133,0,5,olfactory behavior,BP,
9827,GO:0042090,1,0.595053254648682,0,5,interleukin-12 biosynthetic process,BP,
9836,GO:0042101,1,0.490432445898133,0,7,T cell receptor complex,CC,
9846,GO:0042117,1,0.595630820367348,0,5,monocyte activation,BP,
9847,GO:0042118,1,0.485228090647142,0,7,endothelial cell activation,BP,
9868,GO:0042162,1,0.0269651104420625,0,35,telomeric DNA binding,MF,
9889,GO:0042228,1,0.538286691760941,0,6,interleukin-8 biosynthetic process,BP,
9899,GO:0042256,1,0.620850302784191,0,5,mature ribosome assembly,BP,
9905,GO:0042269,1,0.199726588864081,0,16,regulation of natural killer cell mediated cytotoxicity,BP,
9910,GO:0042274,1,0.00140837531344715,0,70,ribosomal small subunit biogenesis,BP,
9912,GO:0042276,1,0.156630028182289,0,19,error-prone translesion synthesis,BP,
9919,GO:0042287,1,0.19666146934036,0,16,MHC protein binding,MF,
9920,GO:0042288,1,0.39835507689558,0,9,MHC class I protein binding,MF,
9925,GO:0042301,1,0.537356652135952,0,6,phosphate ion binding,MF,
9949,GO:0042354,1,0.536266768308757,0,6,L-fucose metabolic process,BP,
9950,GO:0042355,1,0.536266768308757,0,6,L-fucose catabolic process,BP,
9963,GO:0042373,1,0.628584433843205,0,5,vitamin K metabolic process,BP,
9968,GO:0042382,1,0.53814716694372,0,6,paraspeckles,CC,
9971,GO:0042392,1,0.604451237786167,0,5,sphingosine-1-phosphate phosphatase activity,MF,
9977,GO:0042405,1,0.289533204701571,0,12,nuclear inclusion body,CC,
9983,GO:0042416,1,0.497438812312671,0,7,dopamine biosynthetic process,BP,
9988,GO:0042423,1,0.404105619166516,0,9,catecholamine biosynthetic process,BP,
9992,GO:0042430,1,0.444486047256658,0,8,indole-containing compound metabolic process,BP,
9994,GO:0042438,1,0.449963322658146,0,8,melanin biosynthetic process,BP,
9995,GO:0042439,1,0.538621269487687,0,6,ethanolamine-containing compound metabolic process,BP,
10000,GO:0042447,1,0.544858928044614,0,6,hormone catabolic process,BP,
10015,GO:0042481,1,0.35639287583899,0,10,regulation of odontogenesis,BP,
10016,GO:0042482,1,0.596526473646463,0,5,positive regulation of odontogenesis,BP,
10029,GO:0042501,1,0.41182872877835,0,9,serine phosphorylation of STAT protein,BP,
10032,GO:0042532,1,0.325843530314963,0,11,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10033,GO:0042533,1,0.450905576455784,0,8,tumor necrosis factor biosynthetic process,BP,
10034,GO:0042534,1,0.450905576455784,0,8,regulation of tumor necrosis factor biosynthetic process,BP,
10040,GO:0042541,1,0.542998022556263,0,6,hemoglobin biosynthetic process,BP,
10044,GO:0042551,1,0.0767463043409258,0,25,neuron maturation,BP,
10047,GO:0042555,1,0.319047342825986,0,11,MCM complex,CC,
10049,GO:0042559,1,0.260381328000878,0,14,pteridine-containing compound biosynthetic process,BP,
10057,GO:0042573,1,0.371919159406707,0,10,retinoic acid metabolic process,BP,
10058,GO:0042574,1,0.440698740428375,0,8,retinal metabolic process,BP,
10065,GO:0042583,1,0.596842180331182,0,5,chromaffin granule,CC,
10069,GO:0042587,1,0.605163663056795,0,5,glycogen granule,CC,
10082,GO:0042609,1,0.607437995299013,0,5,CD4 receptor binding,MF,
10084,GO:0042611,1,0.32773404254968,0,12,MHC protein complex,CC,
10085,GO:0042612,1,0.430118504795515,0,9,MHC class I protein complex,CC,
10094,GO:0042629,1,0.374883804464226,0,10,mast cell granule,CC,
10098,GO:0042634,1,0.108500086089275,0,22,regulation of hair cycle,BP,
10099,GO:0042635,1,0.377795096369873,0,10,positive regulation of hair cycle,BP,
10117,GO:0042693,1,0.543172029831582,0,6,muscle cell fate commitment,BP,
10118,GO:0042695,1,0.610738134121787,0,5,thelarche,BP,
10125,GO:0042711,1,0.53815032335267,0,6,maternal behavior,BP,
10127,GO:0042719,1,0.641334340857826,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10129,GO:0042721,1,0.629471629606031,0,5,mitochondrial inner membrane protein insertion complex,CC,
10151,GO:0042755,1,0.250783131940273,0,14,eating behavior,BP,
10156,GO:0042761,1,0.363175626746037,0,10,very long-chain fatty acid biosynthetic process,BP,
10158,GO:0042765,1,0.598621119941473,0,5,GPI-anchor transamidase complex,CC,
10169,GO:0042780,1,0.498314056964063,0,7,tRNA 3'-end processing,BP,
10171,GO:0042788,1,0.0967331169200842,0,29,polysomal ribosome,CC,
10172,GO:0042789,1,0.244506703345111,0,14,mRNA transcription by RNA polymerase II,BP,
10173,GO:0042790,1,0.294683100463954,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10174,GO:0042791,1,0.548702542287289,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10175,GO:0042795,1,0.00129005649402722,0,67,snRNA transcription by RNA polymerase II,BP,
10176,GO:0042796,1,0.540046011757775,0,6,snRNA transcription by RNA polymerase III,BP,
10177,GO:0042797,1,0.548702542287289,0,6,tRNA transcription by RNA polymerase III,BP,
10212,GO:0042921,1,0.23651196018964,0,14,glucocorticoid receptor signaling pathway,BP,
10226,GO:0042976,1,0.552937314787091,0,6,activation of Janus kinase activity,BP,
10240,GO:0042996,1,0.595080884588587,0,5,regulation of Golgi to plasma membrane protein transport,BP,
10253,GO:0043011,1,0.437754021526314,0,8,myeloid dendritic cell differentiation,BP,
10258,GO:0043022,1,0.00920233854049153,0,47,ribosome binding,MF,
10259,GO:0043023,1,0.340926907642115,0,11,ribosomal large subunit binding,MF,
10260,GO:0043024,1,0.248157391336601,0,14,ribosomal small subunit binding,MF,
10267,GO:0043032,1,0.327207285315548,0,11,positive regulation of macrophage activation,BP,
10271,GO:0043038,1,0.00471541006229206,0,53,amino acid activation,BP,
10272,GO:0043039,1,0.00523381320086293,0,52,tRNA aminoacylation,BP,
10278,GO:0043047,1,0.322223197289554,0,11,single-stranded telomeric DNA binding,MF,
10300,GO:0043102,1,0.549551592209741,0,6,amino acid salvage,BP,
10307,GO:0043116,1,0.48822897701277,0,7,negative regulation of vascular permeability,BP,
10323,GO:0043138,1,0.293048884793778,0,12,3'-5' DNA helicase activity,MF,
10324,GO:0043139,1,0.490491214763889,0,7,5'-3' DNA helicase activity,MF,
10325,GO:0043140,1,0.483351990887623,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
10326,GO:0043141,1,0.603090668483404,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
10327,GO:0043142,1,0.26486499157628,0,13,single-stranded DNA-dependent ATPase activity,MF,
10328,GO:0043144,1,0.48140972973429,0,8,snoRNA processing,BP,
10353,GO:0043189,1,0.146447888994161,0,19,H4/H2A histone acetyltransferase complex,CC,
10370,GO:0043218,1,0.330030613003666,0,11,compact myelin,CC,
10372,GO:0043220,1,0.44450626012284,0,8,Schmidt-Lanterman incisure,CC,
10375,GO:0043225,1,0.435654378075768,0,8,ATPase-coupled anion transmembrane transporter activity,MF,
10387,GO:0043240,1,0.320624893800793,0,11,Fanconi anaemia nuclear complex,CC,
10392,GO:0043248,1,0.327424376813581,0,12,proteasome assembly,BP,
10443,GO:0043320,1,0.539947321806676,0,6,natural killer cell degranulation,BP,
10453,GO:0043353,1,0.536952476724194,0,6,enucleate erythrocyte differentiation,BP,
10463,GO:0043374,1,0.540482933591029,0,6,CD8-positive, alpha-beta T cell differentiation,BP,
10505,GO:0043455,1,0.441737202743866,0,8,regulation of secondary metabolic process,BP,
10509,GO:0043462,1,0.00638697263258178,0,51,regulation of ATPase activity,BP,
10513,GO:0043471,1,0.402362966796789,0,9,regulation of cellular carbohydrate catabolic process,BP,
10516,GO:0043476,1,0.301573934881221,0,12,pigment accumulation,BP,
10517,GO:0043482,1,0.301573934881221,0,12,cellular pigment accumulation,BP,
10519,GO:0043485,1,0.371245761173743,0,10,endosome to pigment granule transport,BP,
10520,GO:0043486,1,0.0145091254326915,0,48,histone exchange,BP,
10529,GO:0043497,1,0.406139446015152,0,9,regulation of protein heterodimerization activity,BP,
10540,GO:0043515,1,0.601689949856493,0,5,kinetochore binding,MF,
10545,GO:0043522,1,0.373301926697599,0,10,leucine zipper domain binding,MF,
10549,GO:0043527,1,0.609074169429149,0,5,tRNA methyltransferase complex,CC,
10573,GO:0043558,1,0.24074390821517,0,14,regulation of translational initiation in response to stress,BP,
10576,GO:0043562,1,0.387121871873468,0,10,cellular response to nitrogen levels,BP,
10590,GO:0043587,1,0.442462319428282,0,8,tongue morphogenesis,BP,
10592,GO:0043589,1,0.3927983783673,0,9,skin morphogenesis,BP,
10612,GO:0043628,1,0.0745863871893538,0,27,ncRNA 3'-end processing,BP,
10617,GO:0043633,1,0.459325183193613,0,8,polyadenylation-dependent RNA catabolic process,BP,
10618,GO:0043634,1,0.509612086161061,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
10622,GO:0043650,1,0.436303419482287,0,8,dicarboxylic acid biosynthetic process,BP,
10627,GO:0043656,1,0.485938909276675,0,7,intracellular region of host,CC,
10644,GO:0043813,1,0.594968816104133,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
10659,GO:0043923,1,0.194082764385577,0,16,positive regulation by host of viral transcription,BP,
10660,GO:0043928,1,0.0441565006332927,0,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
10672,GO:0043968,1,0.199085398284801,0,16,histone H2A acetylation,BP,
10674,GO:0043970,1,0.294318299792739,0,12,histone H3-K9 acetylation,BP,
10681,GO:0043984,1,0.141450646462969,0,19,histone H4-K16 acetylation,BP,
10682,GO:0043985,1,0.542205604717276,0,6,histone H4-R3 methylation,BP,
10687,GO:0043995,1,0.35516289767901,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
10688,GO:0043996,1,0.35516289767901,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
10697,GO:0044030,1,0.234147711416012,0,14,regulation of DNA methylation,BP,
10724,GO:0044110,1,0.611531366499331,0,5,growth involved in symbiotic interaction,BP,
10727,GO:0044116,1,0.611531366499331,0,5,growth of symbiont involved in interaction with host,BP,
10728,GO:0044117,1,0.611531366499331,0,5,growth of symbiont in host,BP,
10761,GO:0044233,1,0.296780066123987,0,12,ER-mitochondrion membrane contact site,CC,
10819,GO:0044331,1,0.240051762635313,0,14,cell-cell adhesion mediated by cadherin,BP,
10839,GO:0044359,1,0.552841606809109,0,6,modulation of molecular function in other organism,BP,
10840,GO:0044362,1,0.613356409499491,0,5,negative regulation of molecular function in other organism,BP,
10841,GO:0044364,1,0.236375611647454,0,17,disruption of cells of other organism,BP,
10847,GO:0044388,1,0.624908509609086,0,5,small protein activating enzyme binding,MF,
10861,GO:0044417,1,0.407990910440653,0,9,translocation of molecules into host,BP,
10893,GO:0044458,1,0.299822177236654,0,12,motile cilium assembly,BP,
10903,GO:0044531,1,0.553565023712132,0,6,modulation of programmed cell death in other organism,BP,
10904,GO:0044532,1,0.553565023712132,0,6,modulation of apoptotic process in other organism,BP,
10908,GO:0044545,1,0.597082138991548,0,5,NSL complex,CC,
10910,GO:0044547,1,0.595652030252147,0,5,DNA topoisomerase binding,MF,
10929,GO:0044613,1,0.30350773861221,0,12,nuclear pore central transport channel,CC,
10931,GO:0044615,1,0.395236414670159,0,9,nuclear pore nuclear basket,CC,
10956,GO:0044754,1,0.464034836072802,0,8,autolysosome,CC,
10959,GO:0044769,1,0.178621566655429,0,18,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
10969,GO:0044784,1,0.0072608777089361,0,49,metaphase/anaphase transition of cell cycle,BP,
10984,GO:0044806,1,0.483358333699327,0,7,G-quadruplex DNA unwinding,BP,
10989,GO:0044827,1,0.294172578988811,0,12,modulation by host of viral genome replication,BP,
10991,GO:0044829,1,0.494277353014423,0,7,positive regulation by host of viral genome replication,BP,
10993,GO:0044837,1,0.484288608097026,0,7,actomyosin contractile ring organization,BP,
10996,GO:0044848,1,0.448406609564532,0,8,biological phase,BP,
10998,GO:0044851,1,0.448406609564532,0,8,hair cycle phase,BP,
11011,GO:0045002,1,0.484765882387925,0,7,double-strand break repair via single-strand annealing,BP,
11018,GO:0045009,1,0.558503032868953,0,6,chitosome,CC,
11031,GO:0045039,1,0.589483261458014,0,6,protein import into mitochondrial inner membrane,BP,
11032,GO:0045040,1,0.581518474500018,0,6,protein import into mitochondrial outer membrane,BP,
11034,GO:0045046,1,0.538236265033412,0,6,protein import into peroxisome membrane,BP,
11036,GO:0045048,1,0.601368406261033,0,5,protein insertion into ER membrane,BP,
11042,GO:0045059,1,0.546281440469624,0,6,positive thymic T cell selection,BP,
11044,GO:0045061,1,0.324931979148623,0,11,thymic T cell selection,BP,
11056,GO:0045075,1,0.595053254648682,0,5,regulation of interleukin-12 biosynthetic process,BP,
11067,GO:0045086,1,0.542098342675182,0,6,positive regulation of interleukin-2 biosynthetic process,BP,
11076,GO:0045104,1,0.0380508582675776,0,32,intermediate filament cytoskeleton organization,BP,
11078,GO:0045109,1,0.193150355436248,0,16,intermediate filament organization,BP,
11079,GO:0045110,1,0.539775751837553,0,6,intermediate filament bundle assembly,BP,
11083,GO:0045116,1,0.273075096444067,0,14,protein neddylation,BP,
11100,GO:0045144,1,0.6094984837192,0,5,meiotic sister chromatid segregation,BP,
11105,GO:0045161,1,0.437743666725334,0,8,neuronal ion channel clustering,BP,
11129,GO:0045198,1,0.356076359567298,0,10,establishment of epithelial cell apical/basal polarity,BP,
11151,GO:0045236,1,0.564578621234774,0,6,CXCR chemokine receptor binding,MF,
11165,GO:0045275,1,0.358878582271968,0,11,respiratory chain complex III,CC,
11170,GO:0045292,1,0.199177043512548,0,16,mRNA cis splicing, via spliceosome,BP,
11172,GO:0045294,1,0.393175527792422,0,9,alpha-catenin binding,MF,
11173,GO:0045295,1,0.392659941520158,0,9,gamma-catenin binding,MF,
11181,GO:0045324,1,0.33927446294404,0,11,late endosome to vacuole transport,BP,
11191,GO:0045342,1,0.601397255607959,0,5,MHC class II biosynthetic process,BP,
11194,GO:0045346,1,0.601397255607959,0,5,regulation of MHC class II biosynthetic process,BP,
11198,GO:0045350,1,0.545038734438396,0,6,interferon-beta biosynthetic process,BP,
11199,GO:0045351,1,0.446784963292563,0,8,type I interferon biosynthetic process,BP,
11205,GO:0045357,1,0.545038734438396,0,6,regulation of interferon-beta biosynthetic process,BP,
11218,GO:0045414,1,0.597209656862379,0,5,regulation of interleukin-8 biosynthetic process,BP,
11245,GO:0045545,1,0.59837144972747,0,5,syndecan binding,MF,
11277,GO:0045617,1,0.537911186884634,0,6,negative regulation of keratinocyte differentiation,BP,
11293,GO:0045634,1,0.599909023509075,0,5,regulation of melanocyte differentiation,BP,
11303,GO:0045649,1,0.322292361336697,0,11,regulation of macrophage differentiation,BP,
11305,GO:0045651,1,0.394160031458295,0,9,positive regulation of macrophage differentiation,BP,
11307,GO:0045653,1,0.316375339980944,0,17,negative regulation of megakaryocyte differentiation,BP,
11316,GO:0045662,1,0.227316274505114,0,15,negative regulation of myoblast differentiation,BP,
11317,GO:0045663,1,0.362606560595855,0,10,positive regulation of myoblast differentiation,BP,
11337,GO:0045717,1,0.300481738543833,0,12,negative regulation of fatty acid biosynthetic process,BP,
11338,GO:0045719,1,0.595559906026501,0,5,negative regulation of glycogen biosynthetic process,BP,
11339,GO:0045721,1,0.484753185139684,0,7,negative regulation of gluconeogenesis,BP,
11348,GO:0045736,1,0.0717282833647123,0,26,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
11372,GO:0045777,1,0.277828991862678,0,13,positive regulation of blood pressure,BP,
11380,GO:0045793,1,0.397275698255259,0,9,positive regulation of cell size,BP,
11392,GO:0045822,1,0.363141884083783,0,10,negative regulation of heart contraction,BP,
11399,GO:0045835,1,0.536836079908913,0,6,negative regulation of meiotic nuclear division,BP,
11400,GO:0045836,1,0.538166362480729,0,6,positive regulation of meiotic nuclear division,BP,
11405,GO:0045841,1,0.0478532983792294,0,30,negative regulation of mitotic metaphase/anaphase transition,BP,
11406,GO:0045842,1,0.453728916780024,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
11409,GO:0045851,1,0.0237968165872194,0,38,pH reduction,BP,
11418,GO:0045875,1,0.609799333217591,0,5,negative regulation of sister chromatid cohesion,BP,
11419,GO:0045876,1,0.36069191115138,0,10,positive regulation of sister chromatid cohesion,BP,
11426,GO:0045899,1,0.373608348937917,0,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
11438,GO:0045915,1,0.61546511967567,0,5,positive regulation of catecholamine metabolic process,BP,
11467,GO:0045953,1,0.447493212765111,0,8,negative regulation of natural killer cell mediated cytotoxicity,BP,
11468,GO:0045954,1,0.446574492861969,0,8,positive regulation of natural killer cell mediated cytotoxicity,BP,
11469,GO:0045955,1,0.485081438160873,0,7,negative regulation of calcium ion-dependent exocytosis,BP,
11472,GO:0045964,1,0.61546511967567,0,5,positive regulation of dopamine metabolic process,BP,
11482,GO:0045989,1,0.503799434481808,0,7,positive regulation of striated muscle contraction,BP,
11503,GO:0046040,1,0.294562623625415,0,12,IMP metabolic process,BP,
11562,GO:0046146,1,0.514935478061205,0,7,tetrahydrobiopterin metabolic process,BP,
11577,GO:0046189,1,0.181718432164444,0,17,phenol-containing compound biosynthetic process,BP,
11609,GO:0046337,1,0.212766704116846,0,15,phosphatidylethanolamine metabolic process,BP,
11614,GO:0046348,1,0.445613659271572,0,8,amino sugar catabolic process,BP,
11615,GO:0046349,1,0.324550747168081,0,11,amino sugar biosynthetic process,BP,
11663,GO:0046469,1,0.602063608146514,0,5,platelet activating factor metabolic process,BP,
11669,GO:0046476,1,0.600436979195379,0,5,glycosylceramide biosynthetic process,BP,
11692,GO:0046512,1,0.453286133529457,0,8,sphingosine biosynthetic process,BP,
11696,GO:0046520,1,0.408553018363243,0,9,sphingoid biosynthetic process,BP,
11701,GO:0046527,1,0.241589745292552,0,14,glucosyltransferase activity,MF,
11703,GO:0046532,1,0.595655218886902,0,5,regulation of photoreceptor cell differentiation,BP,
11707,GO:0046540,1,0.100746651518844,0,24,U4/U6 x U5 tri-snRNP complex,CC,
11729,GO:0046598,1,0.564373437689666,0,6,positive regulation of viral entry into host cell,BP,
11730,GO:0046599,1,0.177199857704235,0,17,regulation of centriole replication,BP,
11731,GO:0046600,1,0.446271136763563,0,8,negative regulation of centriole replication,BP,
11733,GO:0046602,1,0.447083800791225,0,8,regulation of mitotic centrosome separation,BP,
11736,GO:0046606,1,0.272934352159864,0,13,negative regulation of centrosome cycle,BP,
11737,GO:0046607,1,0.402821102647901,0,9,positive regulation of centrosome cycle,BP,
11752,GO:0046633,1,0.296483076746556,0,12,alpha-beta T cell proliferation,BP,
11759,GO:0046640,1,0.363012697105376,0,10,regulation of alpha-beta T cell proliferation,BP,
11760,GO:0046641,1,0.548792498964661,0,6,positive regulation of alpha-beta T cell proliferation,BP,
11767,GO:0046654,1,0.494701501084567,0,7,tetrahydrofolate biosynthetic process,BP,
11791,GO:0046703,1,0.446975938597309,0,9,natural killer cell lectin-like receptor binding,MF,
11802,GO:0046719,1,0.500137375401291,0,7,regulation by virus of viral protein levels in host cell,BP,
11813,GO:0046784,1,0.452548756641813,0,8,viral mRNA export from host cell nucleus,BP,
11825,GO:0046826,1,0.52213379215345,0,7,negative regulation of protein export from nucleus,BP,
11827,GO:0046831,1,0.211064291254752,0,15,regulation of RNA export from nucleus,BP,
11829,GO:0046833,1,0.484090651256752,0,7,positive regulation of RNA export from nucleus,BP,
11832,GO:0046836,1,0.611236714502423,0,5,glycolipid transport,BP,
11874,GO:0046920,1,0.596542092789891,0,5,alpha-(1->3)-fucosyltransferase activity,MF,
11881,GO:0046931,1,0.220122069348407,0,15,pore complex assembly,BP,
11886,GO:0046940,1,0.605428944977101,0,5,nucleoside monophosphate phosphorylation,BP,
11891,GO:0046949,1,0.0795238520984629,0,25,fatty-acyl-CoA biosynthetic process,BP,
11896,GO:0046961,1,0.178621566655429,0,18,proton-transporting ATPase activity, rotational mechanism,MF,
11900,GO:0046966,1,0.0666668887414511,0,27,thyroid hormone receptor binding,MF,
11905,GO:0046972,1,0.35516289767901,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
11906,GO:0046974,1,0.594970249920631,0,5,histone methyltransferase activity (H3-K9 specific),MF,
11907,GO:0046975,1,0.540516862621472,0,6,histone methyltransferase activity (H3-K36 specific),MF,
11908,GO:0046976,1,0.595521476520898,0,5,histone methyltransferase activity (H3-K27 specific),MF,
11938,GO:0047134,1,0.625626255702658,0,5,protein-disulfide reductase activity,MF,
11971,GO:0047372,1,0.395846431067788,0,9,acylglycerol lipase activity,MF,
11978,GO:0047429,1,0.422514737456749,0,9,nucleoside-triphosphate diphosphatase activity,MF,
11986,GO:0047497,1,0.150093712528677,0,19,mitochondrion transport along microtubule,BP,
11987,GO:0047498,1,0.536295782345565,0,6,calcium-dependent phospholipase A2 activity,MF,
11988,GO:0047499,1,0.601053381792945,0,5,calcium-independent phospholipase A2 activity,MF,
12000,GO:0047631,1,0.636403069031132,0,5,ADP-ribose diphosphatase activity,MF,
12048,GO:0048019,1,0.369417314378952,0,10,receptor antagonist activity,MF,
12049,GO:0048020,1,0.516191787242688,0,8,CCR chemokine receptor binding,MF,
12053,GO:0048024,1,0.0015721059520672,0,63,regulation of mRNA splicing, via spliceosome,BP,
12054,GO:0048025,1,0.175718520839977,0,17,negative regulation of mRNA splicing, via spliceosome,BP,
12055,GO:0048026,1,0.294123426132435,0,12,positive regulation of mRNA splicing, via spliceosome,BP,
12056,GO:0048027,1,0.129589175925952,0,22,mRNA 5'-UTR binding,MF,
12062,GO:0048038,1,0.263773577596669,0,14,quinone binding,MF,
12063,GO:0048039,1,0.559206467012144,0,6,ubiquinone binding,MF,
12067,GO:0048050,1,0.569346383707542,0,6,post-embryonic eye morphogenesis,BP,
12069,GO:0048066,1,0.0481292236589461,0,30,developmental pigmentation,BP,
12070,GO:0048069,1,0.59608091971899,0,5,eye pigmentation,BP,
12071,GO:0048070,1,0.297801615213523,0,12,regulation of developmental pigmentation,BP,
12074,GO:0048087,1,0.496548644334029,0,7,positive regulation of developmental pigmentation,BP,
12075,GO:0048096,1,0.445322169359209,0,8,chromatin-mediated maintenance of transcription,BP,
12104,GO:0048200,1,0.54306611209707,0,6,Golgi transport vesicle coating,BP,
12106,GO:0048205,1,0.54306611209707,0,6,COPI coating of Golgi vesicle,BP,
12113,GO:0048227,1,0.451511975373578,0,8,plasma membrane to endosome transport,BP,
12127,GO:0048256,1,0.436093028639413,0,8,flap endonuclease activity,MF,
12132,GO:0048262,1,0.610521772928739,0,5,determination of dorsal/ventral asymmetry,BP,
12136,GO:0048266,1,0.612214372974808,0,5,behavioral response to pain,BP,
12140,GO:0048273,1,0.542353991346168,0,6,mitogen-activated protein kinase p38 binding,MF,
12142,GO:0048280,1,0.36534473885968,0,10,vesicle fusion with Golgi apparatus,BP,
12147,GO:0048290,1,0.537953194095958,0,6,isotype switching to IgA isotypes,BP,
12148,GO:0048291,1,0.439154701039665,0,8,isotype switching to IgG isotypes,BP,
12152,GO:0048296,1,0.59683968488828,0,5,regulation of isotype switching to IgA isotypes,BP,
12155,GO:0048302,1,0.486995630823854,0,7,regulation of isotype switching to IgG isotypes,BP,
12156,GO:0048304,1,0.599453083836995,0,5,positive regulation of isotype switching to IgG isotypes,BP,
12157,GO:0048305,1,0.364970787857656,0,10,immunoglobulin secretion,BP,
12160,GO:0048311,1,0.23356772602853,0,14,mitochondrion distribution,BP,
12161,GO:0048312,1,0.536266768308757,0,6,intracellular distribution of mitochondria,BP,
12163,GO:0048318,1,0.622182645590591,0,5,axial mesoderm development,BP,
12170,GO:0048340,1,0.483351990887623,0,7,paraxial mesoderm morphogenesis,BP,
12184,GO:0048385,1,0.329344853173843,0,11,regulation of retinoic acid receptor signaling pathway,BP,
12186,GO:0048387,1,0.59916523932098,0,5,negative regulation of retinoic acid receptor signaling pathway,BP,
12200,GO:0048476,1,0.616929095598515,0,5,Holliday junction resolvase complex,CC,
12202,GO:0048478,1,0.493646456162363,0,7,replication fork protection,BP,
12204,GO:0048484,1,0.613798390852699,0,5,enteric nervous system development,BP,
12210,GO:0048490,1,0.228246011010955,0,15,anterograde synaptic vesicle transport,BP,
12214,GO:0048500,1,0.420666518606542,0,9,signal recognition particle,CC,
12229,GO:0048531,1,0.294783266062137,0,12,beta-1,3-galactosyltransferase activity,MF,
12232,GO:0048535,1,0.296519739329856,0,12,lymph node development,BP,
12240,GO:0048548,1,0.396567269317547,0,9,regulation of pinocytosis,BP,
12242,GO:0048550,1,0.60065157458423,0,5,negative regulation of pinocytosis,BP,
12243,GO:0048557,1,0.487595658597614,0,7,embryonic digestive tract morphogenesis,BP,
12247,GO:0048563,1,0.513170187077031,0,7,post-embryonic animal organ morphogenesis,BP,
12252,GO:0048570,1,0.601898753049492,0,5,notochord morphogenesis,BP,
12281,GO:0048642,1,0.487092020245025,0,7,negative regulation of skeletal muscle tissue development,BP,
12318,GO:0048702,1,0.483482788716202,0,7,embryonic neurocranium morphogenesis,BP,
12319,GO:0048703,1,0.48737211804824,0,7,embryonic viscerocranium morphogenesis,BP,
12329,GO:0048714,1,0.28943556213602,0,12,positive regulation of oligodendrocyte differentiation,BP,
12339,GO:0048741,1,0.265459106714273,0,13,skeletal muscle fiber development,BP,
12340,GO:0048742,1,0.595253577822974,0,5,regulation of skeletal muscle fiber development,BP,
12348,GO:0048755,1,0.595409443001149,0,5,branching morphogenesis of a nerve,BP,
12349,GO:0048757,1,0.371245761173743,0,10,pigment granule maturation,BP,
12371,GO:0048819,1,0.448406609564532,0,8,regulation of hair follicle maturation,BP,
12372,GO:0048820,1,0.216949138760443,0,15,hair follicle maturation,BP,
12385,GO:0048853,1,0.486508344343396,0,7,forebrain morphogenesis,BP,
12407,GO:0048934,1,0.539928662713433,0,6,peripheral nervous system neuron differentiation,BP,
12408,GO:0048935,1,0.539928662713433,0,6,peripheral nervous system neuron development,BP,
12424,GO:0050145,1,0.605428944977101,0,5,nucleoside phosphate kinase activity,MF,
12456,GO:0050428,1,0.538197583788719,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
12460,GO:0050434,1,0.0189691148644412,0,40,positive regulation of viral transcription,BP,
12498,GO:0050664,1,0.554169111283891,0,6,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
12499,GO:0050665,1,0.374204630344794,0,10,hydrogen peroxide biosynthetic process,BP,
12513,GO:0050685,1,0.116161253234092,0,21,positive regulation of mRNA processing,BP,
12514,GO:0050686,1,0.0621059763865116,0,27,negative regulation of mRNA processing,BP,
12517,GO:0050689,1,0.607442590214973,0,5,negative regulation of defense response to virus by host,BP,
12528,GO:0050703,1,0.635022528801415,0,5,interleukin-1 alpha secretion,BP,
12538,GO:0050713,1,0.61286451792591,0,5,negative regulation of interleukin-1 beta secretion,BP,
12554,GO:0050746,1,0.450383555349983,0,8,regulation of lipoprotein metabolic process,BP,
12555,GO:0050747,1,0.614966207003606,0,5,positive regulation of lipoprotein metabolic process,BP,
12563,GO:0050765,1,0.403168390696925,0,9,negative regulation of phagocytosis,BP,
12600,GO:0050811,1,0.414284811116662,0,9,GABA receptor binding,MF,
12625,GO:0050855,1,0.289141026295647,0,12,regulation of B cell receptor signaling pathway,BP,
12642,GO:0050872,1,0.394759179360073,0,9,white fat cell differentiation,BP,
12649,GO:0050882,1,0.537001890370653,0,6,voluntary musculoskeletal movement,BP,
12669,GO:0050912,1,0.376358641151354,0,11,detection of chemical stimulus involved in sensory perception of taste,BP,
12687,GO:0050931,1,0.096880488481632,0,23,pigment cell differentiation,BP,
12688,GO:0050932,1,0.487366099596748,0,7,regulation of pigment cell differentiation,BP,
12689,GO:0050942,1,0.594968816104133,0,5,positive regulation of pigment cell differentiation,BP,
12717,GO:0051011,1,0.353905290828954,0,10,microtubule minus-end binding,MF,
12729,GO:0051023,1,0.449267881647994,0,8,regulation of immunoglobulin secretion,BP,
12736,GO:0051031,1,0.0343892176387928,0,33,tRNA transport,BP,
12739,GO:0051036,1,0.607046096868569,0,5,regulation of endosome size,BP,
12758,GO:0051059,1,0.06726151394737,0,27,NF-kappaB binding,MF,
12764,GO:0051084,1,0.0383200558062783,0,32,'de novo' posttranslational protein folding,BP,
12765,GO:0051085,1,0.0636614966788677,0,27,chaperone cofactor-dependent protein refolding,BP,
12775,GO:0051095,1,0.407185654838519,0,9,regulation of helicase activity,BP,
12776,GO:0051096,1,0.554115758766553,0,6,positive regulation of helicase activity,BP,
12783,GO:0051103,1,0.330322834909717,0,11,DNA ligation involved in DNA repair,BP,
12784,GO:0051105,1,0.537604033949894,0,6,regulation of DNA ligation,BP,
12785,GO:0051106,1,0.596452337434542,0,5,positive regulation of DNA ligation,BP,
12800,GO:0051131,1,0.181153845435226,0,17,chaperone-mediated protein complex assembly,BP,
12804,GO:0051136,1,0.595241587936452,0,5,regulation of NK T cell differentiation,BP,
12836,GO:0051182,1,0.484102918040042,0,7,coenzyme transport,BP,
12838,GO:0051185,1,0.537099831570231,0,6,coenzyme transmembrane transporter activity,MF,
12864,GO:0051231,1,0.323865398189059,0,11,spindle elongation,BP,
12870,GO:0051238,1,0.35997827327526,0,11,sequestering of metal ion,BP,
12884,GO:0051256,1,0.442186365918461,0,8,mitotic spindle midzone assembly,BP,
12909,GO:0051292,1,0.361040037483711,0,10,nuclear pore complex assembly,BP,
12919,GO:0051304,1,0.000946792343151383,0,69,chromosome separation,BP,
12920,GO:0051305,1,0.594970759926443,0,5,chromosome movement towards spindle pole,BP,
12921,GO:0051306,1,0.00547479185876798,0,52,mitotic sister chromatid separation,BP,
12922,GO:0051307,1,0.291341789996519,0,12,meiotic chromosome separation,BP,
12926,GO:0051315,1,0.261420162169625,0,13,attachment of mitotic spindle microtubules to kinetochore,BP,
12932,GO:0051340,1,0.448606320920804,0,8,regulation of ligase activity,BP,
12934,GO:0051342,1,0.551986851646507,0,6,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
12943,GO:0051351,1,0.49772072906671,0,7,positive regulation of ligase activity,BP,
12953,GO:0051382,1,0.240340800204499,0,14,kinetochore assembly,BP,
12954,GO:0051383,1,0.143451453750937,0,19,kinetochore organization,BP,
12964,GO:0051400,1,0.448073718799773,0,8,BH domain binding,MF,
12972,GO:0051415,1,0.536266768308757,0,6,microtubule nucleation by interphase microtubule organizing center,BP,
12974,GO:0051418,1,0.435654378075768,0,8,microtubule nucleation by microtubule organizing center,BP,
12985,GO:0051444,1,0.306726597058148,0,13,negative regulation of ubiquitin-protein transferase activity,BP,
12988,GO:0051447,1,0.354988276364077,0,10,negative regulation of meiotic cell cycle,BP,
12989,GO:0051450,1,0.410535024702662,0,9,myoblast proliferation,BP,
12990,GO:0051451,1,0.446752221172697,0,8,myoblast migration,BP,
12991,GO:0051452,1,0.0263713232622036,0,37,intracellular pH reduction,BP,
13018,GO:0051503,1,0.295001289606489,0,12,adenine nucleotide transport,BP,
13039,GO:0051569,1,0.116743238292589,0,21,regulation of histone H3-K4 methylation,BP,
13041,GO:0051571,1,0.237578267142472,0,14,positive regulation of histone H3-K4 methylation,BP,
13043,GO:0051573,1,0.400667233172845,0,9,negative regulation of histone H3-K9 methylation,BP,
13061,GO:0051597,1,0.54165719600185,0,6,response to methylmercury,BP,
13064,GO:0051601,1,0.539424454290457,0,6,exocyst localization,BP,
13065,GO:0051602,1,0.160294730303353,0,18,response to electrical stimulus,BP,
13078,GO:0051639,1,0.436666224844868,0,8,actin filament network formation,BP,
13083,GO:0051645,1,0.292701963998843,0,12,Golgi localization,BP,
13084,GO:0051646,1,0.0284029105398456,0,35,mitochondrion localization,BP,
13091,GO:0051654,1,0.135268055034105,0,20,establishment of mitochondrion localization,BP,
13093,GO:0051657,1,0.435654378075768,0,8,maintenance of organelle location,BP,
13095,GO:0051661,1,0.594968816104133,0,5,maintenance of centrosome location,BP,
13102,GO:0051683,1,0.492118860075284,0,7,establishment of Golgi localization,BP,
13116,GO:0051709,1,0.568289570485107,0,6,regulation of killing of cells of other organism,BP,
13118,GO:0051712,1,0.568289570485107,0,6,positive regulation of killing of cells of other organism,BP,
13140,GO:0051764,1,0.319340780423869,0,11,actin crosslink formation,BP,
13142,GO:0051766,1,0.597501385826518,0,5,inositol trisphosphate kinase activity,MF,
13143,GO:0051767,1,0.402154438990782,0,9,nitric-oxide synthase biosynthetic process,BP,
13144,GO:0051769,1,0.402154438990782,0,9,regulation of nitric-oxide synthase biosynthetic process,BP,
13145,GO:0051770,1,0.536266768308757,0,6,positive regulation of nitric-oxide synthase biosynthetic process,BP,
13164,GO:0051797,1,0.182502441436657,0,17,regulation of hair follicle development,BP,
13165,GO:0051798,1,0.377795096369873,0,10,positive regulation of hair follicle development,BP,
13173,GO:0051818,1,0.562301612445325,0,6,disruption of cells of other organism involved in symbiotic interaction,BP,
13181,GO:0051836,1,0.407990910440653,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
13192,GO:0051880,1,0.483351990887623,0,7,G-quadruplex DNA binding,MF,
13194,GO:0051882,1,0.233982210734219,0,15,mitochondrial depolarization,BP,
13195,GO:0051883,1,0.562301612445325,0,6,killing of cells in other organism involved in symbiotic interaction,BP,
13209,GO:0051900,1,0.282565202238854,0,13,regulation of mitochondrial depolarization,BP,
13210,GO:0051901,1,0.629729993356667,0,5,positive regulation of mitochondrial depolarization,BP,
13211,GO:0051902,1,0.610734671099147,0,5,negative regulation of mitochondrial depolarization,BP,
13220,GO:0051923,1,0.405441156943223,0,9,sulfation,BP,
13258,GO:0051974,1,0.445967606009733,0,8,negative regulation of telomerase activity,BP,
13261,GO:0051983,1,0.000121649083264021,0,89,regulation of chromosome segregation,BP,
13262,GO:0051984,1,0.070436973016743,0,26,positive regulation of chromosome segregation,BP,
13263,GO:0051985,1,0.0270635175511311,0,36,negative regulation of chromosome segregation,BP,
13264,GO:0051987,1,0.598121256474049,0,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,
13265,GO:0051988,1,0.289686133675149,0,12,regulation of attachment of spindle microtubules to kinetochore,BP,
13273,GO:0052040,1,0.553565023712132,0,6,modulation by symbiont of host programmed cell death,BP,
13285,GO:0052150,1,0.606229148780941,0,5,modulation by symbiont of host apoptotic process,BP,
13289,GO:0052173,1,0.544964439259649,0,6,response to defenses of other organism involved in symbiotic interaction,BP,
13294,GO:0052200,1,0.544964439259649,0,6,response to host defenses,BP,
13296,GO:0052204,1,0.613356409499491,0,5,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
13297,GO:0052205,1,0.552841606809109,0,6,modulation of molecular function in other organism involved in symbiotic interaction,BP,
13302,GO:0052248,1,0.553565023712132,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
13326,GO:0052433,1,0.553565023712132,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
13341,GO:0052564,1,0.604617738803351,0,5,response to immune response of other organism involved in symbiotic interaction,BP,
13343,GO:0052572,1,0.604617738803351,0,5,response to host immune response,BP,
13350,GO:0052629,1,0.319097516493164,0,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
13353,GO:0052650,1,0.49807920665811,0,7,NADP-retinol dehydrogenase activity,MF,
13360,GO:0052658,1,0.536667089049696,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
13365,GO:0052695,1,0.537724530447718,0,6,cellular glucuronidation,BP,
13379,GO:0052744,1,0.23361370344876,0,14,phosphatidylinositol monophosphate phosphatase activity,MF,
13417,GO:0052851,1,0.602779681880316,0,5,ferric-chelate reductase (NADPH) activity,MF,
13499,GO:0055102,1,0.467668510666461,0,8,lipase inhibitor activity,MF,
13501,GO:0055105,1,0.605036235971184,0,6,ubiquitin-protein transferase inhibitor activity,MF,
13502,GO:0055106,1,0.219804317392704,0,16,ubiquitin-protein transferase regulator activity,MF,
13524,GO:0060013,1,0.594968816104133,0,5,righting reflex,BP,
13526,GO:0060017,1,0.599916430497257,0,5,parathyroid gland development,BP,
13531,GO:0060022,1,0.596355321346219,0,5,hard palate development,BP,
13544,GO:0060039,1,0.234404160612348,0,14,pericardium development,BP,
13557,GO:0060052,1,0.494404461797434,0,7,neurofilament cytoskeleton organization,BP,
13560,GO:0060055,1,0.266968550581785,0,13,angiogenesis involved in wound healing,BP,
13561,GO:0060056,1,0.556448100514679,0,6,mammary gland involution,BP,
13571,GO:0060068,1,0.551433515924547,0,6,vagina development,BP,
13588,GO:0060088,1,0.609676697279619,0,5,auditory receptor cell stereocilium organization,BP,
13616,GO:0060149,1,0.250327215159408,0,14,negative regulation of posttranscriptional gene silencing,BP,
13641,GO:0060192,1,0.378488506834347,0,10,negative regulation of lipase activity,BP,
13656,GO:0060218,1,0.000158591497120885,0,100,hematopoietic stem cell differentiation,BP,
13661,GO:0060231,1,0.269656607034859,0,13,mesenchymal to epithelial transition,BP,
13665,GO:0060242,1,0.499353544379671,0,7,contact inhibition,BP,
13675,GO:0060259,1,0.496486576103947,0,7,regulation of feeding behavior,BP,
13677,GO:0060261,1,0.183438789990251,0,17,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
13688,GO:0060281,1,0.538261588898349,0,6,regulation of oocyte development,BP,
13706,GO:0060304,1,0.594969647621524,0,5,regulation of phosphatidylinositol dephosphorylation,BP,
13727,GO:0060331,1,0.551753975065766,0,6,negative regulation of response to interferon-gamma,BP,
13732,GO:0060336,1,0.551753975065766,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
13734,GO:0060338,1,0.0509720761899413,0,29,regulation of type I interferon-mediated signaling pathway,BP,
13735,GO:0060339,1,0.486365621740791,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
13736,GO:0060340,1,0.397720331878206,0,9,positive regulation of type I interferon-mediated signaling pathway,BP,
13741,GO:0060347,1,0.447907446059108,0,8,heart trabecula formation,BP,
13746,GO:0060352,1,0.602606513364842,0,5,cell adhesion molecule production,BP,
13750,GO:0060363,1,0.486389467728073,0,7,cranial suture morphogenesis,BP,
13754,GO:0060368,1,0.538675459485557,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
13764,GO:0060379,1,0.483691837000415,0,7,cardiac muscle cell myoblast differentiation,BP,
13774,GO:0060391,1,0.320670663017435,0,11,positive regulation of SMAD protein signal transduction,BP,
13777,GO:0060394,1,0.489820692309918,0,7,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
13821,GO:0060452,1,0.60312436233478,0,5,positive regulation of cardiac muscle contraction,BP,
13822,GO:0060453,1,0.611179315077801,0,5,regulation of gastric acid secretion,BP,
13829,GO:0060462,1,0.594968816104133,0,5,lung lobe development,BP,
13830,GO:0060463,1,0.594968816104133,0,5,lung lobe morphogenesis,BP,
13849,GO:0060502,1,0.438060445521097,0,8,epithelial cell proliferation involved in lung morphogenesis,BP,
13854,GO:0060513,1,0.487022215590436,0,7,prostatic bud formation,BP,
13869,GO:0060539,1,0.597561676156211,0,5,diaphragm development,BP,
13891,GO:0060576,1,0.408525460219879,0,9,intestinal epithelial cell development,BP,
13900,GO:0060590,1,0.0294111211780582,0,35,ATPase regulator activity,MF,
13916,GO:0060613,1,0.548460796386661,0,6,fat pad development,BP,
13932,GO:0060666,1,0.59505273907359,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
13936,GO:0060670,1,0.36185399631544,0,10,branching involved in labyrinthine layer morphogenesis,BP,
13960,GO:0060700,1,0.402744940317833,0,9,regulation of ribonuclease activity,BP,
13987,GO:0060736,1,0.483351990887623,0,7,prostate gland growth,BP,
13993,GO:0060744,1,0.610738134121787,0,5,mammary gland branching involved in thelarche,BP,
13995,GO:0060746,1,0.485049836416321,0,7,parental behavior,BP,
13999,GO:0060751,1,0.604443022256246,0,5,branch elongation involved in mammary gland duct branching,BP,
14008,GO:0060765,1,0.109004860873924,0,22,regulation of androgen receptor signaling pathway,BP,
14009,GO:0060766,1,0.43850390693696,0,8,negative regulation of androgen receptor signaling pathway,BP,
14010,GO:0060767,1,0.404346674616546,0,9,epithelial cell proliferation involved in prostate gland development,BP,
14011,GO:0060768,1,0.448619627926144,0,8,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14013,GO:0060770,1,0.552223511692077,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14017,GO:0060789,1,0.54812507626207,0,6,hair follicle placode formation,BP,
14031,GO:0060837,1,0.538568958023307,0,6,blood vessel endothelial cell differentiation,BP,
14058,GO:0060911,1,0.485540104888711,0,7,cardiac cell fate commitment,BP,
14067,GO:0060923,1,0.597659326846828,0,5,cardiac muscle cell fate commitment,BP,
14082,GO:0060965,1,0.294457432697662,0,12,negative regulation of gene silencing by miRNA,BP,
14084,GO:0060967,1,0.250327215159408,0,14,negative regulation of gene silencing by RNA,BP,
14086,GO:0060969,1,0.109216567578939,0,22,negative regulation of gene silencing,BP,
14088,GO:0060972,1,0.203049238754037,0,16,left/right pattern formation,BP,
14089,GO:0060973,1,0.356263749897395,0,10,cell migration involved in heart development,BP,
14098,GO:0060992,1,0.354208844231965,0,10,response to fungicide,BP,
14110,GO:0061004,1,0.494282623919119,0,7,pattern specification involved in kidney development,BP,
14127,GO:0061036,1,0.125832904321096,0,20,positive regulation of cartilage development,BP,
14132,GO:0061042,1,0.5409606341198,0,6,vascular wound healing,BP,
14142,GO:0061053,1,0.00456017573775308,0,52,somite development,BP,
14157,GO:0061085,1,0.394363411677979,0,9,regulation of histone H3-K27 methylation,BP,
14159,GO:0061087,1,0.537065758276527,0,6,positive regulation of histone H3-K27 methylation,BP,
14160,GO:0061088,1,0.538145424063168,0,6,regulation of sequestering of zinc ion,BP,
14176,GO:0061133,1,0.632455795125264,0,5,endopeptidase activator activity,MF,
14190,GO:0061154,1,0.328487586068321,0,11,endothelial tube morphogenesis,BP,
14195,GO:0061162,1,0.211756022369912,0,15,establishment of monopolar cell polarity,BP,
14198,GO:0061179,1,0.530662783977173,0,7,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
14231,GO:0061312,1,0.600028857548186,0,5,BMP signaling pathway involved in heart development,BP,
14232,GO:0061314,1,0.595193910986833,0,5,Notch signaling involved in heart development,BP,
14242,GO:0061339,1,0.211756022369912,0,15,establishment or maintenance of monopolar cell polarity,BP,
14263,GO:0061384,1,0.0945324085266426,0,23,heart trabecula morphogenesis,BP,
14275,GO:0061436,1,0.116284636040886,0,21,establishment of skin barrier,BP,
14309,GO:0061525,1,0.594968816104133,0,5,hindgut development,BP,
14335,GO:0061578,1,0.321812609578649,0,11,Lys63-specific deubiquitinase activity,MF,
14350,GO:0061617,1,0.469080830826296,0,8,MICOS complex,CC,
14362,GO:0061631,1,0.0761917733160864,0,26,ubiquitin conjugating enzyme activity,MF,
14363,GO:0061635,1,0.493144169749185,0,7,regulation of protein complex stability,BP,
14365,GO:0061641,1,0.0317091517595965,0,40,CENP-A containing chromatin organization,BP,
14372,GO:0061650,1,0.0697543598924511,0,27,ubiquitin-like protein conjugating enzyme activity,MF,
14376,GO:0061665,1,0.599002566299552,0,5,SUMO ligase activity,MF,
14377,GO:0061668,1,0.542782104680782,0,6,mitochondrial ribosome assembly,BP,
14379,GO:0061673,1,0.595484731420537,0,5,mitotic spindle astral microtubule,CC,
14380,GO:0061676,1,0.546673910475196,0,6,importin-alpha family protein binding,MF,
14381,GO:0061684,1,0.355952595104361,0,10,chaperone-mediated autophagy,BP,
14383,GO:0061687,1,0.557586423686375,0,7,detoxification of inorganic compound,BP,
14400,GO:0061732,1,0.540794769279261,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
14401,GO:0061733,1,0.00443534778437169,0,53,peptide-lysine-N-acetyltransferase activity,MF,
14402,GO:0061734,1,0.594968816104133,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
14436,GO:0061820,1,0.392659941520158,0,9,telomeric D-loop disassembly,BP,
14477,GO:0061983,1,0.549364014004816,0,6,meiosis II cell cycle process,BP,
14478,GO:0062009,1,0.440302049649872,0,8,secondary palate development,BP,
14492,GO:0070003,1,0.218080534808497,0,18,threonine-type peptidase activity,MF,
14495,GO:0070008,1,0.357280815980703,0,10,serine-type exopeptidase activity,MF,
14505,GO:0070034,1,0.129603314201298,0,21,telomerase RNA binding,MF,
14522,GO:0070064,1,0.146678251938361,0,19,proline-rich region binding,MF,
14524,GO:0070070,1,0.440062858569091,0,8,proton-transporting V-type ATPase complex assembly,BP,
14525,GO:0070071,1,0.294683235255085,0,12,proton-transporting two-sector ATPase complex assembly,BP,
14526,GO:0070072,1,0.440062858569091,0,8,vacuolar proton-transporting V-type ATPase complex assembly,BP,
14535,GO:0070087,1,0.536266768308757,0,6,chromo shadow domain binding,MF,
14549,GO:0070106,1,0.435654378075768,0,8,interleukin-27-mediated signaling pathway,BP,
14557,GO:0070125,1,0.000507747849324184,0,86,mitochondrial translational elongation,BP,
14558,GO:0070126,1,0.000415177572985143,0,88,mitochondrial translational termination,BP,
14559,GO:0070127,1,0.439449143293594,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
14560,GO:0070129,1,0.162494449982089,0,18,regulation of mitochondrial translation,BP,
14562,GO:0070131,1,0.329964396089763,0,11,positive regulation of mitochondrial translation,BP,
14575,GO:0070162,1,0.600341951907968,0,5,adiponectin secretion,BP,
14576,GO:0070163,1,0.600341951907968,0,5,regulation of adiponectin secretion,BP,
14590,GO:0070181,1,0.496405013917953,0,8,small ribosomal subunit rRNA binding,MF,
14591,GO:0070182,1,0.171875254861458,0,18,DNA polymerase binding,MF,
14594,GO:0070187,1,0.53901358668154,0,6,shelterin complex,CC,
14602,GO:0070198,1,0.0699792559634327,0,26,protein localization to chromosome, telomeric region,BP,
14603,GO:0070199,1,0.0983516188804208,0,23,establishment of protein localization to chromosome,BP,
14604,GO:0070200,1,0.23708502480235,0,14,establishment of protein localization to telomere,BP,
14606,GO:0070202,1,0.323289983135076,0,11,regulation of establishment of protein localization to chromosome,BP,
14607,GO:0070203,1,0.358695021300575,0,10,regulation of establishment of protein localization to telomere,BP,
14618,GO:0070230,1,0.315011508785583,0,12,positive regulation of lymphocyte apoptotic process,BP,
14622,GO:0070234,1,0.416032086754958,0,9,positive regulation of T cell apoptotic process,BP,
14623,GO:0070235,1,0.600569413834249,0,5,regulation of activation-induced cell death of T cells,BP,
14628,GO:0070245,1,0.601392466938659,0,5,positive regulation of thymocyte apoptotic process,BP,
14633,GO:0070257,1,0.553145359929059,0,6,positive regulation of mucus secretion,BP,
14636,GO:0070262,1,0.26586513098948,0,13,peptidyl-serine dephosphorylation,BP,
14684,GO:0070341,1,0.536317301559679,0,6,fat cell proliferation,BP,
14686,GO:0070344,1,0.536317301559679,0,6,regulation of fat cell proliferation,BP,
14690,GO:0070358,1,0.616139250795465,0,5,actin polymerization-dependent cell motility,BP,
14693,GO:0070370,1,0.615786979856818,0,5,cellular heat acclimation,BP,
14706,GO:0070391,1,0.597634029327857,0,5,response to lipoteichoic acid,BP,
14715,GO:0070410,1,0.487984548194723,0,7,co-SMAD binding,MF,
14716,GO:0070411,1,0.3942589760087,0,9,I-SMAD binding,MF,
14719,GO:0070417,1,0.487994322608067,0,7,cellular response to cold,BP,
14721,GO:0070419,1,0.487647680526908,0,7,nonhomologous end joining complex,CC,
14722,GO:0070423,1,0.0424032160382749,0,31,nucleotide-binding oligomerization domain containing signaling pathway,BP,
14723,GO:0070424,1,0.536449643410283,0,6,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14729,GO:0070431,1,0.439227243561086,0,8,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14742,GO:0070461,1,0.0746525015129551,0,26,SAGA-type complex,CC,
14749,GO:0070475,1,0.419884398290195,0,9,rRNA base methylation,BP,
14755,GO:0070486,1,0.388661092509949,0,10,leukocyte aggregation,BP,
14774,GO:0070525,1,0.272461381449219,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
14777,GO:0070530,1,0.139681662219954,0,19,K63-linked polyubiquitin modification-dependent protein binding,MF,
14778,GO:0070531,1,0.595010381907414,0,5,BRCA1-A complex,CC,
14779,GO:0070534,1,0.0172449901766611,0,40,protein K63-linked ubiquitination,BP,
14780,GO:0070535,1,0.595429931867454,0,5,histone H2A K63-linked ubiquitination,BP,
14802,GO:0070567,1,0.404882104707717,0,9,cytidylyltransferase activity,MF,
14803,GO:0070568,1,0.607149799351923,0,5,guanylyltransferase activity,MF,
14814,GO:0070584,1,0.130301685539586,0,21,mitochondrion morphogenesis,BP,
14816,GO:0070586,1,0.440953231181471,0,8,cell-cell adhesion involved in gastrulation,BP,
14817,GO:0070587,1,0.48922784131285,0,7,regulation of cell-cell adhesion involved in gastrulation,BP,
14821,GO:0070601,1,0.448352755055156,0,8,centromeric sister chromatid cohesion,BP,
14847,GO:0070652,1,0.451974679760007,0,8,HAUS complex,CC,
14875,GO:0070717,1,0.115361826132852,0,21,poly-purine tract binding,MF,
14881,GO:0070734,1,0.168577331130833,0,18,histone H3-K27 methylation,BP,
14888,GO:0070757,1,0.435654378075768,0,8,interleukin-35-mediated signaling pathway,BP,
14889,GO:0070761,1,0.55512047135251,0,6,pre-snoRNP complex,CC,
14891,GO:0070765,1,0.554596295414483,0,6,gamma-secretase complex,CC,
14895,GO:0070775,1,0.483917284091076,0,7,H3 histone acetyltransferase complex,CC,
14896,GO:0070776,1,0.483917284091076,0,7,MOZ/MORF histone acetyltransferase complex,CC,
14906,GO:0070816,1,0.216537281029439,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
14910,GO:0070822,1,0.241549892774623,0,14,Sin3-type complex,CC,
14916,GO:0070831,1,0.483351990887623,0,7,basement membrane assembly,BP,
14920,GO:0070840,1,0.154067358191408,0,18,dynein complex binding,MF,
14927,GO:0070847,1,0.461340690128689,0,8,core mediator complex,CC,
14939,GO:0070862,1,0.364358097340168,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
14942,GO:0070874,1,0.595559906026501,0,5,negative regulation of glycogen metabolic process,BP,
14946,GO:0070878,1,0.435664398337013,0,8,primary miRNA binding,MF,
14947,GO:0070883,1,0.61497462101198,0,5,pre-miRNA binding,MF,
14961,GO:0070900,1,0.407876468842856,0,9,mitochondrial tRNA modification,BP,
14977,GO:0070933,1,0.396342361280808,0,9,histone H4 deacetylation,BP,
14981,GO:0070937,1,0.599815751896814,0,5,CRD-mediated mRNA stability complex,CC,
14982,GO:0070938,1,0.320919429152187,0,11,contractile ring,CC,
14984,GO:0070940,1,0.60292163060414,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
15001,GO:0070970,1,0.435765157150691,0,8,interleukin-2 secretion,BP,
15002,GO:0070971,1,0.214974175767127,0,15,endoplasmic reticulum exit site,CC,
15008,GO:0070979,1,0.0727062435080781,0,27,protein K11-linked ubiquitination,BP,
15013,GO:0070986,1,0.299453755318312,0,12,left/right axis specification,BP,
15014,GO:0070987,1,0.169862157897731,0,18,error-free translesion synthesis,BP,
15017,GO:0070990,1,0.560577545175511,0,6,snRNP binding,MF,
15024,GO:0071004,1,0.19096396746789,0,17,U2-type prespliceosome,CC,
15027,GO:0071007,1,0.0606771019088759,0,29,U2-type catalytic step 2 spliceosome,CC,
15029,GO:0071010,1,0.117522854246156,0,22,prespliceosome,CC,
15031,GO:0071012,1,0.539191513104538,0,6,catalytic step 1 spliceosome,CC,
15033,GO:0071014,1,0.403422829795837,0,9,post-mRNA release spliceosomal complex,CC,
15036,GO:0071025,1,0.236193403157114,0,15,RNA surveillance,BP,
15038,GO:0071027,1,0.290732074300021,0,13,nuclear RNA surveillance,BP,
15039,GO:0071028,1,0.290732074300021,0,13,nuclear mRNA surveillance,BP,
15040,GO:0071029,1,0.565399117879984,0,6,nuclear ncRNA surveillance,BP,
15043,GO:0071033,1,0.612435031748902,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
15045,GO:0071035,1,0.565399117879984,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
15046,GO:0071038,1,0.627287236625497,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
15049,GO:0071044,1,0.336849291671777,0,11,histone mRNA catabolic process,BP,
15051,GO:0071046,1,0.565399117879984,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
15055,GO:0071051,1,0.637881145071095,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
15085,GO:0071168,1,0.107965998410235,0,22,protein localization to chromatin,BP,
15086,GO:0071169,1,0.460763660200601,0,8,establishment of protein localization to chromatin,BP,
15087,GO:0071173,1,0.0531030856937129,0,29,spindle assembly checkpoint,BP,
15088,GO:0071174,1,0.0531030856937129,0,29,mitotic spindle checkpoint,BP,
15089,GO:0071203,1,0.539168387232054,0,6,WASH complex,CC,
15090,GO:0071204,1,0.55382917641963,0,6,histone pre-mRNA 3'end processing complex,CC,
15104,GO:0071223,1,0.597634029327857,0,5,cellular response to lipoteichoic acid,BP,
15119,GO:0071253,1,0.595063142327722,0,5,connexin binding,MF,
15121,GO:0071257,1,0.594969085790236,0,5,cellular response to electrical stimulus,BP,
15126,GO:0071265,1,0.49775925979548,0,7,L-methionine biosynthetic process,BP,
15128,GO:0071267,1,0.549551592209741,0,6,L-methionine salvage,BP,
15135,GO:0071281,1,0.554714550820074,0,6,cellular response to iron ion,BP,
15140,GO:0071287,1,0.540722070232468,0,6,cellular response to manganese ion,BP,
15141,GO:0071294,1,0.504258482033151,0,8,cellular response to zinc ion,BP,
15153,GO:0071316,1,0.607971671687816,0,5,cellular response to nicotine,BP,
15191,GO:0071372,1,0.436170924319982,0,8,cellular response to follicle-stimulating hormone stimulus,BP,
15205,GO:0071389,1,0.547956760060041,0,6,cellular response to mineralocorticoid stimulus,BP,
15209,GO:0071394,1,0.491626207421533,0,7,cellular response to testosterone stimulus,BP,
15212,GO:0071397,1,0.319495119836264,0,11,cellular response to cholesterol,BP,
15232,GO:0071428,1,0.243551628661881,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
15233,GO:0071431,1,0.0381630490676553,0,32,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
15235,GO:0071437,1,0.235924885166867,0,14,invadopodium,CC,
15236,GO:0071438,1,0.60108345416061,0,5,invadopodium membrane,CC,
15243,GO:0071450,1,0.180779790587999,0,18,cellular response to oxygen radical,BP,
15244,GO:0071451,1,0.180779790587999,0,18,cellular response to superoxide,BP,
15247,GO:0071455,1,0.538180449973899,0,6,cellular response to hyperoxia,BP,
15250,GO:0071459,1,0.130763349026777,0,20,protein localization to chromosome, centromeric region,BP,
15257,GO:0071468,1,0.539874065738651,0,6,cellular response to acidic pH,BP,
15281,GO:0071500,1,0.628793510259904,0,5,cellular response to nitrosative stress,BP,
15296,GO:0071541,1,0.510802594846399,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
15308,GO:0071557,1,0.594968816104133,0,5,histone H3-K27 demethylation,BP,
15309,GO:0071558,1,0.594968816104133,0,5,histone demethylase activity (H3-K27 specific),MF,
15313,GO:0071564,1,0.293569420007159,0,12,npBAF complex,CC,
15314,GO:0071565,1,0.290980049521165,0,12,nBAF complex,CC,
15318,GO:0071569,1,0.555640128850737,0,6,protein ufmylation,BP,
15320,GO:0071577,1,0.211759722293753,0,15,zinc ion transmembrane transport,BP,
15321,GO:0071578,1,0.537758771572389,0,6,zinc ion import across plasma membrane,BP,
15333,GO:0071598,1,0.608116969009733,0,5,neuronal ribonucleoprotein granule,CC,
15353,GO:0071624,1,0.29198416374078,0,13,positive regulation of granulocyte chemotaxis,BP,
15360,GO:0071636,1,0.437675846114163,0,8,positive regulation of transforming growth factor beta production,BP,
15386,GO:0071677,1,0.373860284203221,0,10,positive regulation of mononuclear cell migration,BP,
15389,GO:0071680,1,0.594968816104133,0,5,response to indole-3-methanol,BP,
15390,GO:0071681,1,0.594968816104133,0,5,cellular response to indole-3-methanol,BP,
15409,GO:0071711,1,0.211581796697099,0,15,basement membrane organization,BP,
15418,GO:0071731,1,0.321006245388772,0,11,response to nitric oxide,BP,
15419,GO:0071732,1,0.356161396619347,0,10,cellular response to nitric oxide,BP,
15421,GO:0071763,1,0.537030877894939,0,6,nuclear membrane organization,BP,
15426,GO:0071782,1,0.157757095838098,0,18,endoplasmic reticulum tubular network,CC,
15438,GO:0071803,1,0.436905833215948,0,8,positive regulation of podosome assembly,BP,
15446,GO:0071817,1,0.620191777074741,0,5,MMXD complex,CC,
15456,GO:0071837,1,0.441331932512452,0,8,HMG box domain binding,MF,
15462,GO:0071850,1,0.24416786331835,0,14,mitotic cell cycle arrest,BP,
15463,GO:0071855,1,0.517726237473892,0,7,neuropeptide receptor binding,MF,
15484,GO:0071888,1,0.4541287349976,0,8,macrophage apoptotic process,BP,
15503,GO:0071921,1,0.538037613098931,0,6,cohesin loading,BP,
15504,GO:0071922,1,0.596933336712565,0,5,regulation of cohesin loading,BP,
15525,GO:0071986,1,0.536308437486021,0,6,Ragulator complex,CC,
15553,GO:0072048,1,0.494282623919119,0,7,renal system pattern specification,BP,
15571,GO:0072079,1,0.335884342395699,0,11,nephron tubule formation,BP,
15634,GO:0072178,1,0.597584530431826,0,5,nephric duct morphogenesis,BP,
15640,GO:0072189,1,0.485477358794217,0,7,ureter development,BP,
15663,GO:0072217,1,0.597584530431826,0,5,negative regulation of metanephros development,BP,
15713,GO:0072318,1,0.596215163867221,0,5,clathrin coat disassembly,BP,
15714,GO:0072319,1,0.537934458501766,0,6,vesicle uncoating,BP,
15716,GO:0072321,1,0.391052388967371,0,10,chaperone-mediated protein transport,BP,
15723,GO:0072338,1,0.594968816104133,0,5,cellular lactam metabolic process,BP,
15729,GO:0072348,1,0.114595981391699,0,21,sulfur compound transport,BP,
15735,GO:0072357,1,0.488058316782114,0,7,PTW/PP1 phosphatase complex,CC,
15758,GO:0072393,1,0.319011015408938,0,11,microtubule anchoring at microtubule organizing center,BP,
15760,GO:0072396,1,0.53663788504551,0,6,response to cell cycle checkpoint signaling,BP,
15762,GO:0072402,1,0.53663788504551,0,6,response to DNA integrity checkpoint signaling,BP,
15766,GO:0072423,1,0.53663788504551,0,6,response to DNA damage checkpoint signaling,BP,
15767,GO:0072425,1,0.319319367278824,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
15773,GO:0072487,1,0.595250117011736,0,5,MSL complex,CC,
15784,GO:0072509,1,0.155013726954986,0,18,divalent inorganic cation transmembrane transporter activity,MF,
15787,GO:0072512,1,0.0430727878353287,0,32,trivalent inorganic cation transport,BP,
15791,GO:0072520,1,0.36865317121162,0,10,seminiferous tubule development,BP,
15802,GO:0072531,1,0.545451256943072,0,6,pyrimidine-containing compound transmembrane transport,BP,
15806,GO:0072537,1,0.596505367655282,0,5,fibroblast activation,BP,
15807,GO:0072538,1,0.437527358113739,0,8,T-helper 17 type immune response,BP,
15808,GO:0072539,1,0.537483100972413,0,6,T-helper 17 cell differentiation,BP,
15812,GO:0072546,1,0.353905290834104,0,10,ER membrane protein complex,CC,
15839,GO:0072588,1,0.548086786216975,0,8,box H/ACA RNP complex,CC,
15858,GO:0072641,1,0.536266768308757,0,6,type I interferon secretion,BP,
15859,GO:0072642,1,0.536266768308757,0,6,interferon-alpha secretion,BP,
15860,GO:0072643,1,0.392661397055546,0,9,interferon-gamma secretion,BP,
15871,GO:0072669,1,0.524242412098965,0,7,tRNA-splicing ligase complex,CC,
15878,GO:0072677,1,0.61068942835821,0,5,eosinophil migration,BP,
15889,GO:0072697,1,0.324039914832093,0,11,protein localization to cell cortex,BP,
15897,GO:0072710,1,0.39295545615493,0,9,response to hydroxyurea,BP,
15898,GO:0072711,1,0.435982222107812,0,8,cellular response to hydroxyurea,BP,
15903,GO:0072718,1,0.396411958700962,0,9,response to cisplatin,BP,
15904,GO:0072719,1,0.541002593152714,0,6,cellular response to cisplatin,BP,
15924,GO:0075136,1,0.544964439259649,0,6,response to host,BP,
15929,GO:0075522,1,0.362243142609848,0,10,IRES-dependent viral translational initiation,BP,
15930,GO:0075525,1,0.608565297669625,0,5,viral translational termination-reinitiation,BP,
15933,GO:0075713,1,0.44813614617382,0,8,establishment of integrated proviral latency,BP,
15937,GO:0080009,1,0.358605096775518,0,10,mRNA methylation,BP,
15942,GO:0080084,1,0.597752057085432,0,5,5S rDNA binding,MF,
15958,GO:0080182,1,0.209966549757912,0,16,histone H3-K4 trimethylation,BP,
15960,GO:0085020,1,0.50866325572985,0,7,protein K6-linked ubiquitination,BP,
15966,GO:0086004,1,0.130047569664088,0,20,regulation of cardiac muscle cell contraction,BP,
15973,GO:0086011,1,0.321276484711468,0,11,membrane repolarization during action potential,BP,
15975,GO:0086013,1,0.438793097690052,0,8,membrane repolarization during cardiac muscle cell action potential,BP,
15976,GO:0086014,1,0.353905290828954,0,10,atrial cardiac muscle cell action potential,BP,
15986,GO:0086026,1,0.353905290828954,0,10,atrial cardiac muscle cell to AV node cell signaling,BP,
15994,GO:0086042,1,0.536351795189168,0,6,cardiac muscle cell-cardiac muscle cell adhesion,BP,
16008,GO:0086066,1,0.353905290828954,0,10,atrial cardiac muscle cell to AV node cell communication,BP,
16011,GO:0086069,1,0.403156067613981,0,9,bundle of His cell to Purkinje myocyte communication,BP,
16014,GO:0086073,1,0.594968816104133,0,5,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
16020,GO:0086080,1,0.435723464364864,0,8,protein binding involved in heterotypic cell-cell adhesion,MF,
16022,GO:0086083,1,0.594968816104133,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
16031,GO:0089701,1,0.63173696155982,0,5,U2AF,CC,
16035,GO:0089720,1,0.560801243529268,0,6,caspase binding,MF,
16037,GO:0090022,1,0.232901876587345,0,15,regulation of neutrophil chemotaxis,BP,
16038,GO:0090023,1,0.317509955001901,0,12,positive regulation of neutrophil chemotaxis,BP,
16040,GO:0090025,1,0.333616460065749,0,11,regulation of monocyte chemotaxis,BP,
16041,GO:0090026,1,0.454794465058997,0,8,positive regulation of monocyte chemotaxis,BP,
16051,GO:0090042,1,0.40286819937999,0,9,tubulin deacetylation,BP,
16052,GO:0090043,1,0.494624855335336,0,7,regulation of tubulin deacetylation,BP,
16063,GO:0090069,1,0.268540561817073,0,13,regulation of ribosome biogenesis,BP,
16064,GO:0090070,1,0.4515140282162,0,8,positive regulation of ribosome biogenesis,BP,
16066,GO:0090073,1,0.448115890593137,0,8,positive regulation of protein homodimerization activity,BP,
16070,GO:0090079,1,0.180459974177776,0,17,translation regulator activity, nucleic acid binding,MF,
16094,GO:0090110,1,0.261661533237616,0,13,cargo loading into COPII-coated vesicle,BP,
16113,GO:0090151,1,0.342709067858669,0,12,establishment of protein localization to mitochondrial membrane,BP,
16118,GO:0090158,1,0.596153995765883,0,5,endoplasmic reticulum membrane organization,BP,
16123,GO:0090166,1,0.544258475603908,0,6,Golgi disassembly,BP,
16137,GO:0090185,1,0.395048376142494,0,9,negative regulation of kidney development,BP,
16175,GO:0090235,1,0.483919077594802,0,7,regulation of metaphase plate congression,BP,
16178,GO:0090239,1,0.332973082893926,0,11,regulation of histone H4 acetylation,BP,
16179,GO:0090240,1,0.504407117811941,0,7,positive regulation of histone H4 acetylation,BP,
16193,GO:0090266,1,0.268022783986877,0,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16194,GO:0090267,1,0.491544115093463,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16203,GO:0090280,1,0.601504783309311,0,5,positive regulation of calcium ion import,BP,
16221,GO:0090304,1,0,265,4181,nucleic acid metabolic process,BP,TNIP1;HTRA1;FOS;APOE;CTNNBIP1;ERCC1;WWC3;NT5E;CITED4;CST3;TCFL5;PRDX5;PCBP4;MEF2D;NOS1;ZFP36L1;NR1D1;NYNRIN;POLD4;RBCK1;EPAS1;IGF2;NFATC4;MAPK13;EGFR;H1F0;TSC22D1;TCEA2;MXD4;DDB2;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;PKD2;CBS;H2AFJ;CDKN1C;SALL2;MSRB2;XPC;PAK6;HEXB;FOXQ1;ATP2B4;TFDP2;CSNK1E;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;POLL;ADARB1;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;PRNP;DHX32;RNASET2;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;WWTR1;ISG20;MYO18A;DNAJB5;BCL6;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;DNASE1L1;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;ENDOG;MAPK3;ETV5;EXD3;DVL1;MTA1;L3MBTL1;MBD1;NSMCE4A;FHOD1;HES1;BRD3;MLXIPL;ZNF624;ARHGAP22;ABCA2;TK2;ZNF414;PIDD1;PHF21A;CELSR2;ZFP36;ETV4;MAPKBP1;PRKACA;ZNF862;ZMYM3;KIAA1549;MAGEF1;RPS6KA5;MAP2K2;DAP;FGFR4;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;MPG;BHLHE40;RRNAD1;RAG1;ZNF80;HMGA2;ELK3;AHNAK2;DGKQ;ZXDC;GAS6;BTRC;POU6F1;ZNF217;PPARA;SUFU;PTAFR;DMC1;PAN2;ZNF446;RXRA;NEO1;IGFBP4;USP21;PRKCZ;HLTF;BCORL1;ZNF485;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;AGO4;RAD23A;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;PPP1R13L;ZNF554;WDR83;JARID2;SESN2;TMEM161A;RXRB;PNRC1;MAPRE3;PTMS;OR7D2;APOBEC3C;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;CCDC85B;AKT1;NLRX1;ZNF385A;TP53INP1;TUT1;SMARCA1;SIX5;ERCC6;TDRKH;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;ZNF710;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;TRERF1;THAP8;DDN;PMS2P5;ERN1;ZNF319;APOBEC3F;PRIMPOL;GLI4;RNASEK;LITAF;MZF1;NEIL1;RARG;ING4;PBXIP1;EREG;ZNF514;WDR18;TRNP1;ZNF837;POLM;RPL13A;RGS12;UBL5
16225,GO:0090308,1,0.435654388821399,0,8,regulation of methylation-dependent chromatin silencing,BP,
16261,GO:0090383,1,0.131208825402087,0,21,phagosome acidification,BP,
16268,GO:0090399,1,0.325827609958822,0,11,replicative senescence,BP,
16269,GO:0090400,1,0.484681298309889,0,7,stress-induced premature senescence,BP,
16279,GO:0090435,1,0.501080137445788,0,7,protein localization to nuclear envelope,BP,
16283,GO:0090481,1,0.366021624209023,0,10,pyrimidine nucleotide-sugar transmembrane transport,BP,
16312,GO:0090576,1,0.445758747357282,0,8,RNA polymerase III transcription factor complex,CC,
16319,GO:0090611,1,0.601570049425417,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
16326,GO:0090646,1,0.298824349698318,0,12,mitochondrial tRNA processing,BP,
16331,GO:0090657,1,0.318983928501619,0,11,telomeric loop disassembly,BP,
16333,GO:0090661,1,0.670628660440624,0,5,box H/ACA telomerase RNP complex,CC,
16340,GO:0090670,1,0.152892758870795,0,19,RNA localization to Cajal body,BP,
16341,GO:0090671,1,0.152892758870795,0,19,telomerase RNA localization to Cajal body,BP,
16342,GO:0090672,1,0.152892758870795,0,19,telomerase RNA localization,BP,
16346,GO:0090685,1,0.152892758870795,0,19,RNA localization to nucleus,BP,
16351,GO:0090723,1,0.328236580771479,0,11,growth cone part,CC,
16355,GO:0090734,1,0.0267984245110486,0,35,site of DNA damage,CC,
16358,GO:0090741,1,0.558503032868953,0,6,pigment granule membrane,CC,
16360,GO:0095500,1,0.33047689117025,0,11,acetylcholine receptor signaling pathway,BP,
16376,GO:0097027,1,0.496293041037215,0,7,ubiquitin-protein transferase activator activity,MF,
16387,GO:0097050,1,0.438491836808274,0,8,type B pancreatic cell apoptotic process,BP,
16398,GO:0097064,1,0.0235061668939051,0,37,ncRNA export from nucleus,BP,
16410,GO:0097094,1,0.320977835242242,0,11,craniofacial suture morphogenesis,BP,
16411,GO:0097100,1,0.616560251458061,0,5,supercoiled DNA binding,MF,
16436,GO:0097136,1,0.551530113097375,0,6,Bcl-2 family protein complex,CC,
16442,GO:0097152,1,0.487813688692385,0,7,mesenchymal cell apoptotic process,BP,
16447,GO:0097157,1,0.440767426296984,0,8,pre-mRNA intronic binding,MF,
16453,GO:0097165,1,0.601608125621073,0,5,nuclear stress granule,CC,
16474,GO:0097199,1,0.615715517473658,0,5,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
16475,GO:0097200,1,0.343955501493122,0,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
16476,GO:0097201,1,0.290806026571676,0,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,
16488,GO:0097225,1,0.378732521171289,0,10,sperm midpiece,CC,
16502,GO:0097255,1,0.612533886049207,0,5,R2TP complex,CC,
16516,GO:0097296,1,0.302232307413959,0,12,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
16524,GO:0097322,1,0.543207459723591,0,6,7SK snRNA binding,MF,
16527,GO:0097329,1,0.287833390169783,0,12,response to antimetabolite,BP,
16530,GO:0097340,1,0.333549020180346,0,11,inhibition of cysteine-type endopeptidase activity,BP,
16531,GO:0097341,1,0.333549020180346,0,11,zymogen inhibition,BP,
16532,GO:0097342,1,0.539538347978952,0,6,ripoptosome,CC,
16546,GO:0097366,1,0.106503938575316,0,22,response to bronchodilator,BP,
16568,GO:0097418,1,0.594968816104133,0,5,neurofibrillary tangle,CC,
16570,GO:0097422,1,0.595807417147483,0,5,tubular endosome,CC,
16572,GO:0097427,1,0.594968816104133,0,5,microtubule bundle,CC,
16575,GO:0097433,1,0.599100617259801,0,5,dense body,CC,
16577,GO:0097440,1,0.319289831963939,0,11,apical dendrite,CC,
16612,GO:0097501,1,0.557586423686375,0,7,stress response to metal ion,BP,
16615,GO:0097504,1,0.334080488297204,0,11,Gemini of coiled bodies,CC,
16617,GO:0097506,1,0.612529128687913,0,5,deaminated base DNA N-glycosylase activity,MF,
16624,GO:0097526,1,0.0666471273732312,0,29,spliceosomal tri-snRNP complex,CC,
16639,GO:0097550,1,0.55212687513908,0,6,transcriptional preinitiation complex,CC,
16648,GO:0097602,1,0.185335861399576,0,17,cullin family protein binding,MF,
16676,GO:0097677,1,0.561786109524965,0,6,STAT family protein binding,MF,
16712,GO:0098501,1,0.616064165948077,0,5,polynucleotide dephosphorylation,BP,
16716,GO:0098505,1,0.357511507772432,0,10,G-rich strand telomeric DNA binding,MF,
16721,GO:0098519,1,0.600095525698734,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
16725,GO:0098532,1,0.584192431927074,0,6,histone H3-K27 trimethylation,BP,
16727,GO:0098534,1,0.0468155425523657,0,30,centriole assembly,BP,
16731,GO:0098543,1,0.545151069659637,0,6,detection of other organism,BP,
16736,GO:0098556,1,0.693028139602665,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
16746,GO:0098581,1,0.491364522202775,0,7,detection of external biotic stimulus,BP,
16770,GO:0098641,1,0.168948433537511,0,18,cadherin binding involved in cell-cell adhesion,MF,
16771,GO:0098642,1,0.536280606483723,0,6,network-forming collagen trimer,CC,
16774,GO:0098645,1,0.536280606483723,0,6,collagen network,CC,
16778,GO:0098651,1,0.536280606483723,0,6,basement membrane collagen trimer,CC,
16797,GO:0098711,1,0.537671225935475,0,6,iron ion import across plasma membrane,BP,
16830,GO:0098781,1,8.56983113228821e-05,0,94,ncRNA transcription,BP,
16851,GO:0098814,1,0.602374807118233,0,5,spontaneous synaptic transmission,BP,
16871,GO:0098845,1,0.539165806318681,0,6,postsynaptic endosome,CC,
16872,GO:0098847,1,0.263328025511182,0,13,sequence-specific single stranded DNA binding,MF,
16884,GO:0098877,1,0.354500775419365,0,10,neurotransmitter receptor transport to plasma membrane,BP,
16891,GO:0098887,1,0.595146543832152,0,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
16897,GO:0098903,1,0.536275381838302,0,6,regulation of membrane repolarization during action potential,BP,
16903,GO:0098909,1,0.610874169784369,0,5,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
16904,GO:0098910,1,0.594968816104133,0,5,regulation of atrial cardiac muscle cell action potential,BP,
16905,GO:0098911,1,0.392664352077594,0,9,regulation of ventricular cardiac muscle cell action potential,BP,
16919,GO:0098930,1,0.0163580273732341,0,41,axonal transport,BP,
16931,GO:0098969,1,0.393320578456818,0,9,neurotransmitter receptor transport to postsynaptic membrane,BP,
16967,GO:0099078,1,0.461318930723543,0,8,BORC complex,CC,
16981,GO:0099116,1,0.22319049776979,0,16,tRNA 5'-end processing,BP,
16987,GO:0099133,1,0.435654378075768,0,8,ATP hydrolysis coupled anion transmembrane transport,BP,
17004,GO:0099500,1,0.366184577095489,0,10,vesicle fusion to plasma membrane,BP,
17010,GO:0099514,1,0.228246011010955,0,15,synaptic vesicle cytoskeletal transport,BP,
17011,GO:0099515,1,0.392659941520158,0,9,actin filament-based transport,BP,
17013,GO:0099517,1,0.228246011010955,0,15,synaptic vesicle transport along microtubule,BP,
17041,GO:0099563,1,0.288622111655343,0,12,modification of synaptic structure,BP,
17053,GO:0099602,1,0.562789668916365,0,6,neurotransmitter receptor regulator activity,MF,
17068,GO:0099632,1,0.262336793485674,0,13,protein transport within plasma membrane,BP,
17070,GO:0099637,1,0.262336793485674,0,13,neurotransmitter receptor transport,BP,
17071,GO:0099638,1,0.536426974410131,0,6,endosome to plasma membrane protein transport,BP,
17072,GO:0099639,1,0.536426974410131,0,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,
17106,GO:0102336,1,0.600519722613827,0,5,3-oxo-arachidoyl-CoA synthase activity,MF,
17107,GO:0102337,1,0.600519722613827,0,5,3-oxo-cerotoyl-CoA synthase activity,MF,
17108,GO:0102338,1,0.600519722613827,0,5,3-oxo-lignoceronyl-CoA synthase activity,MF,
17132,GO:0102567,1,0.289735630641807,0,12,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,
17133,GO:0102568,1,0.289735630641807,0,12,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,
17139,GO:0102756,1,0.600519722613827,0,5,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
17167,GO:0106018,1,0.23361370344876,0,14,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
17168,GO:0106019,1,0.354185979604706,0,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
17177,GO:0106049,1,0.606122650556591,0,5,regulation of cellular response to osmotic stress,BP,
17187,GO:0106074,1,0.29188842692273,0,12,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
17199,GO:0110011,1,0.594968816104133,0,5,regulation of basement membrane organization,BP,
17215,GO:0110096,1,0.626069135333151,0,5,cellular response to aldehyde,BP,
17216,GO:0120009,1,0.596569838687171,0,5,intermembrane lipid transfer,BP,
17218,GO:0120013,1,0.596569838687171,0,5,intermembrane lipid transfer activity,MF,
17244,GO:0120103,1,0.392659941520158,0,9,centriolar subdistal appendage,CC,
17257,GO:0140035,1,0.536915453267111,0,6,ubiquitination-like modification-dependent protein binding,MF,
17258,GO:0140036,1,0.536915453267111,0,6,ubiquitin-dependent protein binding,MF,
17261,GO:0140053,1,5.70449061843405e-07,0,153,mitochondrial gene expression,BP,
17277,GO:0140101,1,6.77687877730512e-06,0,118,catalytic activity, acting on a tRNA,MF,
17284,GO:0140131,1,0.444436735500315,0,8,positive regulation of lymphocyte chemotaxis,BP,
17295,GO:0150005,1,0.370169999113116,0,10,enzyme activator complex,CC,
17310,GO:1900017,1,0.39717340076235,0,9,positive regulation of cytokine production involved in inflammatory response,BP,
17324,GO:1900040,1,0.594968816104133,0,5,regulation of interleukin-2 secretion,BP,
17327,GO:1900044,1,0.435777703354277,0,8,regulation of protein K63-linked ubiquitination,BP,
17328,GO:1900045,1,0.595137196959178,0,5,negative regulation of protein K63-linked ubiquitination,BP,
17349,GO:1900102,1,0.320309723836329,0,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,
17357,GO:1900112,1,0.400667746867228,0,9,regulation of histone H3-K9 trimethylation,BP,
17358,GO:1900113,1,0.607097483165972,0,5,negative regulation of histone H3-K9 trimethylation,BP,
17363,GO:1900118,1,0.492533813055305,0,7,negative regulation of execution phase of apoptosis,BP,
17367,GO:1900122,1,0.553341007471816,0,6,positive regulation of receptor binding,BP,
17368,GO:1900125,1,0.536759827069767,0,6,regulation of hyaluronan biosynthetic process,BP,
17403,GO:1900193,1,0.597181808540815,0,5,regulation of oocyte maturation,BP,
17428,GO:1900242,1,0.537136030874439,0,6,regulation of synaptic vesicle endocytosis,BP,
17432,GO:1900246,1,0.594984292027943,0,5,positive regulation of RIG-I signaling pathway,BP,
17433,GO:1900247,1,0.320996527404193,0,11,regulation of cytoplasmic translational elongation,BP,
17437,GO:1900262,1,0.547763776830024,0,6,regulation of DNA-directed DNA polymerase activity,BP,
17438,GO:1900264,1,0.547763776830024,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
17445,GO:1900363,1,0.289909717780852,0,12,regulation of mRNA polyadenylation,BP,
17446,GO:1900364,1,0.435746581678816,0,8,negative regulation of mRNA polyadenylation,BP,
17465,GO:1900426,1,0.506400699198349,0,7,positive regulation of defense response to bacterium,BP,
17495,GO:1900864,1,0.407876468842856,0,9,mitochondrial RNA modification,BP,
17501,GO:1901018,1,0.406542358056705,0,9,positive regulation of potassium ion transmembrane transporter activity,BP,
17507,GO:1901029,1,0.50141781810702,0,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
17516,GO:1901072,1,0.599252200549569,0,5,glucosamine-containing compound catabolic process,BP,
17539,GO:1901160,1,0.484130691621192,0,7,primary amino compound metabolic process,BP,
17552,GO:1901201,1,0.319391397982766,0,11,regulation of extracellular matrix assembly,BP,
17554,GO:1901203,1,0.436054999554734,0,8,positive regulation of extracellular matrix assembly,BP,
17556,GO:1901213,1,0.439525693573552,0,8,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
17561,GO:1901223,1,0.452257211038032,0,8,negative regulation of NIK/NF-kappaB signaling,BP,
17602,GO:1901339,1,0.536266768308757,0,6,regulation of store-operated calcium channel activity,BP,
17619,GO:1901381,1,0.330251837967333,0,11,positive regulation of potassium ion transmembrane transport,BP,
17626,GO:1901407,1,0.398334742885144,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17627,GO:1901409,1,0.49026058772716,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17641,GO:1901525,1,0.53641095677258,0,6,negative regulation of mitophagy,BP,
17647,GO:1901535,1,0.594968816104133,0,5,regulation of DNA demethylation,BP,
17658,GO:1901563,1,0.595416434434353,0,5,response to camptothecin,BP,
17686,GO:1901623,1,0.40057625836522,0,9,regulation of lymphocyte chemotaxis,BP,
17707,GO:1901663,1,0.254541528210049,0,14,quinone biosynthetic process,BP,
17717,GO:1901679,1,0.441800143243993,0,8,nucleotide transmembrane transport,BP,
17720,GO:1901682,1,0.156226399044517,0,18,sulfur compound transmembrane transporter activity,MF,
17730,GO:1901723,1,0.597586546254853,0,5,negative regulation of cell proliferation involved in kidney development,BP,
17736,GO:1901739,1,0.369282373752298,0,10,regulation of myoblast fusion,BP,
17738,GO:1901741,1,0.408699938032609,0,9,positive regulation of myoblast fusion,BP,
17745,GO:1901799,1,0.0135753397408954,0,43,negative regulation of proteasomal protein catabolic process,BP,
17751,GO:1901836,1,0.326788270593845,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17753,GO:1901838,1,0.400734690999427,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17757,GO:1901844,1,0.491184334912448,0,7,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
17791,GO:1901970,1,0.453728916780024,0,8,positive regulation of mitotic sister chromatid separation,BP,
17793,GO:1901977,1,0.538799207836217,0,6,negative regulation of cell cycle checkpoint,BP,
17812,GO:1902004,1,0.439768446571142,0,8,positive regulation of amyloid-beta formation,BP,
17819,GO:1902031,1,0.543753103151067,0,6,regulation of NADP metabolic process,BP,
17820,GO:1902033,1,0.598485992138036,0,5,regulation of hematopoietic stem cell proliferation,BP,
17822,GO:1902036,1,0.000267258366100859,0,95,regulation of hematopoietic stem cell differentiation,BP,
17826,GO:1902042,1,0.0733002758598489,0,26,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
17830,GO:1902047,1,0.607056261546244,0,5,polyamine transmembrane transport,BP,
17831,GO:1902065,1,0.3985663209833,0,9,response to L-glutamate,BP,
17839,GO:1902099,1,0.00992710111266957,0,46,regulation of metaphase/anaphase transition of cell cycle,BP,
17840,GO:1902100,1,0.0478532983792294,0,30,negative regulation of metaphase/anaphase transition of cell cycle,BP,
17841,GO:1902101,1,0.453728916780024,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
17868,GO:1902177,1,0.622649724740325,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
17871,GO:1902187,1,0.234168673068058,0,14,negative regulation of viral release from host cell,BP,
17881,GO:1902218,1,0.606122650556591,0,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
17892,GO:1902231,1,0.574123460192197,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
17895,GO:1902235,1,0.0813955852454685,0,25,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
17896,GO:1902236,1,0.270275267502742,0,13,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
17897,GO:1902237,1,0.367156347137419,0,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
17936,GO:1902337,1,0.496548644334029,0,7,regulation of apoptotic process involved in morphogenesis,BP,
17940,GO:1902358,1,0.53797037722098,0,6,sulfate transmembrane transport,BP,
17959,GO:1902410,1,0.541006843764367,0,6,mitotic cytokinetic process,BP,
17961,GO:1902414,1,0.436916840445472,0,8,protein localization to cell junction,BP,
17962,GO:1902415,1,0.404465680808055,0,9,regulation of mRNA binding,BP,
17963,GO:1902416,1,0.495418296476786,0,7,positive regulation of mRNA binding,BP,
17972,GO:1902459,1,0.594968816104133,0,5,positive regulation of stem cell population maintenance,BP,
17993,GO:1902513,1,0.53926938251308,0,6,regulation of organelle transport along microtubule,BP,
17997,GO:1902525,1,0.623354493688344,0,5,regulation of protein monoubiquitination,BP,
18012,GO:1902562,1,0.0154524958547708,0,41,H4 histone acetyltransferase complex,CC,
18018,GO:1902570,1,0.421444694663835,0,9,protein localization to nucleolus,BP,
18023,GO:1902581,1,0.616108345693597,0,5,multi-organism cellular localization,BP,
18024,GO:1902583,1,0.616108345693597,0,5,multi-organism intracellular transport,BP,
18037,GO:1902622,1,0.170494513544903,0,18,regulation of neutrophil migration,BP,
18039,GO:1902624,1,0.232450827727319,0,15,positive regulation of neutrophil migration,BP,
18075,GO:1902739,1,0.536266768308757,0,6,regulation of interferon-alpha secretion,BP,
18076,GO:1902741,1,0.536266768308757,0,6,positive regulation of interferon-alpha secretion,BP,
18090,GO:1902774,1,0.548577238433588,0,6,late endosome to lysosome transport,BP,
18138,GO:1902914,1,0.215818032732585,0,15,regulation of protein polyubiquitination,BP,
18139,GO:1902915,1,0.536418549011566,0,6,negative regulation of protein polyubiquitination,BP,
18140,GO:1902916,1,0.446603263126787,0,8,positive regulation of protein polyubiquitination,BP,
18165,GO:1902961,1,0.543233565082874,0,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18178,GO:1902993,1,0.358860877644744,0,10,positive regulation of amyloid precursor protein catabolic process,BP,
18191,GO:1903010,1,0.319465045248367,0,11,regulation of bone development,BP,
18218,GO:1903055,1,0.288468806948314,0,12,positive regulation of extracellular matrix organization,BP,
18221,GO:1903069,1,0.401107644381076,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
18223,GO:1903071,1,0.488170339553294,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
18227,GO:1903077,1,0.172650764062291,0,17,negative regulation of protein localization to plasma membrane,BP,
18235,GO:1903115,1,0.117200869218082,0,21,regulation of actin filament-based movement,BP,
18283,GO:1903232,1,0.628042060316466,0,5,melanosome assembly,BP,
18293,GO:1903251,1,0.602082367681616,0,5,multi-ciliated epithelial cell differentiation,BP,
18295,GO:1903265,1,0.450860094353266,0,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
18326,GO:1903332,1,0.502065532097883,0,7,regulation of protein folding,BP,
18327,GO:1903333,1,0.617956876409248,0,5,negative regulation of protein folding,BP,
18338,GO:1903361,1,0.605705482932751,0,5,protein localization to basolateral plasma membrane,BP,
18362,GO:1903405,1,0.398527542332584,0,9,protein localization to nuclear body,BP,
18374,GO:1903429,1,0.222440966539934,0,15,regulation of cell maturation,BP,
18376,GO:1903431,1,0.48498692704178,0,7,positive regulation of cell maturation,BP,
18398,GO:1903504,1,0.268022783986877,0,13,regulation of mitotic spindle checkpoint,BP,
18415,GO:1903525,1,0.594968816104133,0,5,regulation of membrane tubulation,BP,
18424,GO:1903539,1,0.393320578456818,0,9,protein localization to postsynaptic membrane,BP,
18425,GO:1903540,1,0.393320578456818,0,9,establishment of protein localization to postsynaptic membrane,BP,
18447,GO:1903573,1,0.0258851541344274,0,36,negative regulation of response to endoplasmic reticulum stress,BP,
18463,GO:1903608,1,0.490424242914912,0,7,protein localization to cytoplasmic stress granule,BP,
18490,GO:1903689,1,0.536266768308757,0,6,regulation of wound healing, spreading of epidermal cells,BP,
18510,GO:1903726,1,0.452858742230283,0,8,negative regulation of phospholipid metabolic process,BP,
18545,GO:1903799,1,0.43664171119547,0,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
18558,GO:1903830,1,0.191629297841013,0,16,magnesium ion transmembrane transport,BP,
18559,GO:1903831,1,0.33047689117025,0,11,signal transduction involved in cellular response to ammonium ion,BP,
18569,GO:1903859,1,0.354042018431695,0,10,regulation of dendrite extension,BP,
18571,GO:1903861,1,0.435734345020751,0,8,positive regulation of dendrite extension,BP,
18584,GO:1903894,1,0.270770627027649,0,13,regulation of IRE1-mediated unfolded protein response,BP,
18586,GO:1903896,1,0.497141379301847,0,7,positive regulation of IRE1-mediated unfolded protein response,BP,
18587,GO:1903897,1,0.396335089857455,0,9,regulation of PERK-mediated unfolded protein response,BP,
18588,GO:1903898,1,0.597232910621852,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
18682,GO:1904115,1,0.0254155527923656,0,37,axon cytoplasm,CC,
18690,GO:1904153,1,0.404254837648063,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
18700,GO:1904180,1,0.610734671099147,0,5,negative regulation of membrane depolarization,BP,
18739,GO:1904259,1,0.594968816104133,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18740,GO:1904261,1,0.594968816104133,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18742,GO:1904263,1,0.449704839331115,0,8,positive regulation of TORC1 signaling,BP,
18754,GO:1904293,1,0.270524799966248,0,13,negative regulation of ERAD pathway,BP,
18780,GO:1904357,1,0.068877882001815,0,26,negative regulation of telomere maintenance via telomere lengthening,BP,
18783,GO:1904376,1,0.140230063051844,0,19,negative regulation of protein localization to cell periphery,BP,
18791,GO:1904385,1,0.246560634284822,0,14,cellular response to angiotensin,BP,
18825,GO:1904467,1,0.354894060816503,0,10,regulation of tumor necrosis factor secretion,BP,
18827,GO:1904469,1,0.483581259418436,0,7,positive regulation of tumor necrosis factor secretion,BP,
18898,GO:1904666,1,0.19250828577187,0,18,regulation of ubiquitin protein ligase activity,BP,
18899,GO:1904667,1,0.620222698684254,0,6,negative regulation of ubiquitin protein ligase activity,BP,
18900,GO:1904668,1,0.310538566850368,0,12,positive regulation of ubiquitin protein ligase activity,BP,
18904,GO:1904680,1,0.122161034077984,0,22,peptide transmembrane transporter activity,MF,
18924,GO:1904714,1,0.538345909049368,0,6,regulation of chaperone-mediated autophagy,BP,
18942,GO:1904748,1,0.496548644334029,0,7,regulation of apoptotic process involved in development,BP,
18956,GO:1904776,1,0.536266768308757,0,6,regulation of protein localization to cell cortex,BP,
18958,GO:1904778,1,0.594968816104133,0,5,positive regulation of protein localization to cell cortex,BP,
18967,GO:1904796,1,0.598773644949237,0,5,regulation of core promoter binding,BP,
18977,GO:1904814,1,0.263828657362898,0,13,regulation of protein localization to chromosome, telomeric region,BP,
18979,GO:1904816,1,0.323866873629218,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
18995,GO:1904851,1,0.39797371688367,0,9,positive regulation of establishment of protein localization to telomere,BP,
18999,GO:1904867,1,0.398527542332584,0,9,protein localization to Cajal body,BP,
19001,GO:1904869,1,0.440617978755555,0,8,regulation of protein localization to Cajal body,BP,
19002,GO:1904871,1,0.440617978755555,0,8,positive regulation of protein localization to Cajal body,BP,
19003,GO:1904872,1,0.169054662754765,0,18,regulation of telomerase RNA localization to Cajal body,BP,
19004,GO:1904874,1,0.230935474723156,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
19014,GO:1904885,1,0.594968816104133,0,5,beta-catenin destruction complex assembly,BP,
19036,GO:1904929,1,0.536266768308757,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
19070,GO:1905005,1,0.537973103745462,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
19072,GO:1905007,1,0.594968816104133,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
19116,GO:1905144,1,0.33047689117025,0,11,response to acetylcholine,BP,
19117,GO:1905145,1,0.33047689117025,0,11,cellular response to acetylcholine,BP,
19143,GO:1905214,1,0.328564575651263,0,11,regulation of RNA binding,BP,
19145,GO:1905216,1,0.446530912060024,0,8,positive regulation of RNA binding,BP,
19151,GO:1905244,1,0.436905901956667,0,8,regulation of modification of synaptic structure,BP,
19154,GO:1905247,1,0.543233565082874,0,6,positive regulation of aspartic-type peptidase activity,BP,
19181,GO:1905314,1,0.397716233930747,0,9,semi-lunar valve development,BP,
19186,GO:1905323,1,0.540300217820255,0,6,telomerase holoenzyme complex assembly,BP,
19188,GO:1905331,1,0.260691064757394,0,13,negative regulation of morphogenesis of an epithelium,BP,
19300,GO:1905634,1,0.538037613098931,0,6,regulation of protein localization to chromatin,BP,
19343,GO:1905818,1,0.00496134685687097,0,53,regulation of chromosome separation,BP,
19344,GO:1905819,1,0.0444405302657443,0,31,negative regulation of chromosome separation,BP,
19345,GO:1905820,1,0.408952139177633,0,9,positive regulation of chromosome separation,BP,
19358,GO:1905879,1,0.538261588898349,0,6,regulation of oogenesis,BP,
19390,GO:1905961,1,0.44380356686651,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
19392,GO:1990001,1,0.442253720913246,0,8,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
19397,GO:1990023,1,0.269184901330784,0,13,mitotic spindle midzone,CC,
19424,GO:1990124,1,0.494939758681824,0,7,messenger ribonucleoprotein complex,CC,
19427,GO:1990130,1,0.598793082657808,0,5,GATOR1 complex,CC,
19439,GO:1990169,1,0.684931130458471,0,5,stress response to copper ion,BP,
19442,GO:1990173,1,0.359194228788999,0,10,protein localization to nucleoplasm,BP,
19452,GO:1990226,1,0.598702693221583,0,5,histone methyltransferase binding,MF,
19456,GO:1990247,1,0.483351990887623,0,7,N6-methyladenosine-containing RNA binding,MF,
19470,GO:1990314,1,0.44055570767202,0,8,cellular response to insulin-like growth factor stimulus,BP,
19477,GO:1990380,1,0.392662627733488,0,9,Lys48-specific deubiquitinase activity,MF,
19531,GO:1990564,1,0.614531162444546,0,5,protein polyufmylation,BP,
19543,GO:1990592,1,0.614531162444546,0,5,protein K69-linked ufmylation,BP,
19560,GO:1990668,1,0.546049439342582,0,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
19566,GO:1990712,1,0.609585408947518,0,5,HFE-transferrin receptor complex,CC,
19570,GO:1990726,1,0.668701053093468,0,5,Lsm1-7-Pat1 complex,CC,
19593,GO:1990774,1,0.319863905210087,0,11,tumor necrosis factor secretion,BP,
19594,GO:1990776,1,0.200273755972279,0,16,response to angiotensin,BP,
19608,GO:1990825,1,0.363633144926797,0,10,sequence-specific mRNA binding,MF,
19620,GO:1990868,1,0.596679572688264,0,5,response to chemokine,BP,
19621,GO:1990869,1,0.596679572688264,0,5,cellular response to chemokine,BP,
19630,GO:1990907,1,0.319261041532892,0,11,beta-catenin-TCF complex,CC,
19646,GO:1990948,1,0.670035765529154,0,5,ubiquitin ligase inhibitor activity,MF,
19654,GO:2000001,1,0.194378146002067,0,16,regulation of DNA damage checkpoint,BP,
19655,GO:2000002,1,0.597772530599888,0,5,negative regulation of DNA damage checkpoint,BP,
19668,GO:2000018,1,0.59753895594979,0,5,regulation of male gonad development,BP,
19679,GO:2000047,1,0.610869277661989,0,5,regulation of cell-cell adhesion mediated by cadherin,BP,
19695,GO:2000074,1,0.49369000468402,0,7,regulation of type B pancreatic cell development,BP,
19700,GO:2000095,1,0.394411923234035,0,9,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
19701,GO:2000096,1,0.538513018392015,0,6,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
19708,GO:2000108,1,0.14099240627713,0,20,positive regulation of leukocyte apoptotic process,BP,
19709,GO:2000109,1,0.55517539133889,0,6,regulation of macrophage apoptotic process,BP,
19718,GO:2000121,1,0.495962556384924,0,7,regulation of removal of superoxide radicals,BP,
19723,GO:2000138,1,0.597811952706099,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
19726,GO:2000144,1,0.0988782323502999,0,23,positive regulation of DNA-templated transcription, initiation,BP,
19742,GO:2000178,1,0.262542522322014,0,13,negative regulation of neural precursor cell proliferation,BP,
19752,GO:2000197,1,0.536973812920306,0,6,regulation of ribonucleoprotein complex localization,BP,
19758,GO:2000209,1,0.145860132715575,0,19,regulation of anoikis,BP,
19759,GO:2000210,1,0.562481457378368,0,6,positive regulation of anoikis,BP,
19768,GO:2000232,1,0.330587637670162,0,11,regulation of rRNA processing,BP,
19770,GO:2000234,1,0.4515140282162,0,8,positive regulation of rRNA processing,BP,
19775,GO:2000251,1,0.373873836971041,0,10,positive regulation of actin cytoskeleton reorganization,BP,
19793,GO:2000279,1,0.062491142856345,0,27,negative regulation of DNA biosynthetic process,BP,
19799,GO:2000288,1,0.543486375840599,0,6,positive regulation of myoblast proliferation,BP,
19800,GO:2000291,1,0.446400901069573,0,8,regulation of myoblast proliferation,BP,
19817,GO:2000316,1,0.538571909085727,0,6,regulation of T-helper 17 type immune response,BP,
19823,GO:2000322,1,0.486015709791846,0,7,regulation of glucocorticoid receptor signaling pathway,BP,
19824,GO:2000323,1,0.538328116053075,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
19856,GO:2000371,1,0.537346297359871,0,6,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19857,GO:2000373,1,0.537346297359871,0,6,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19912,GO:2000480,1,0.492013676973599,0,7,negative regulation of cAMP-dependent protein kinase activity,BP,
19956,GO:2000576,1,0.623783260473376,0,5,positive regulation of microtubule motor activity,BP,
19968,GO:2000601,1,0.536266768308757,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
19974,GO:2000615,1,0.362299797659959,0,10,regulation of histone H3-K9 acetylation,BP,
19976,GO:2000617,1,0.547199716656845,0,6,positive regulation of histone H3-K9 acetylation,BP,
19977,GO:2000618,1,0.603678690249888,0,5,regulation of histone H4-K16 acetylation,BP,
19984,GO:2000628,1,0.491696041368644,0,7,regulation of miRNA metabolic process,BP,
19985,GO:2000630,1,0.605237922331847,0,5,positive regulation of miRNA metabolic process,BP,
20007,GO:2000659,1,0.546053788471795,0,6,regulation of interleukin-1-mediated signaling pathway,BP,
20021,GO:2000674,1,0.438491836808274,0,8,regulation of type B pancreatic cell apoptotic process,BP,
20047,GO:2000726,1,0.32074924836313,0,11,negative regulation of cardiac muscle cell differentiation,BP,
20070,GO:2000767,1,0.438025284326458,0,8,positive regulation of cytoplasmic translation,BP,
20080,GO:2000781,1,0.237128015998963,0,14,positive regulation of double-strand break repair,BP,
20086,GO:2000794,1,0.536844111377568,0,6,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
20096,GO:2000811,1,0.266712798323701,0,13,negative regulation of anoikis,BP,
20098,GO:2000816,1,0.0444405302657443,0,31,negative regulation of mitotic sister chromatid separation,BP,
20109,GO:2000831,1,0.611827988062593,0,5,regulation of steroid hormone secretion,BP,
20159,GO:2001034,1,0.595650436032182,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
20168,GO:2001053,1,0.541216483237136,0,6,regulation of mesenchymal cell apoptotic process,BP,
20169,GO:2001054,1,0.599916430497257,0,5,negative regulation of mesenchymal cell apoptotic process,BP,
20197,GO:2001166,1,0.595812313073725,0,5,regulation of histone H2B ubiquitination,BP,
20216,GO:2001197,1,0.594968816104133,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
20223,GO:2001204,1,0.48404353176364,0,7,regulation of osteoclast development,BP,
20228,GO:2001214,1,0.603052521545104,0,5,positive regulation of vasculogenesis,BP,
20229,GO:2001222,1,0.0921095186566689,0,23,regulation of neuron migration,BP,
20230,GO:2001223,1,0.598358441965123,0,5,negative regulation of neuron migration,BP,
20231,GO:2001224,1,0.233522269040898,0,14,positive regulation of neuron migration,BP,
20244,GO:2001241,1,0.309213547342457,0,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
20247,GO:2001244,1,0.0149971126807238,0,44,positive regulation of intrinsic apoptotic signaling pathway,BP,
20259,GO:2001268,1,0.624455245343082,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
7499,GO:0031694,1,0.917464252337243,0,1,alpha-2A adrenergic receptor binding,MF,
10381,GO:0043231,1,0,673,8309,intracellular membrane-bounded organelle,CC,TNIP1;FOS;DUSP6;H6PD;LMF1;CEMIP;APOE;TYSND1;MARVELD1;CTNNBIP1;TSPAN1;PPL;IDH2;ERCC1;FAM110C;NT5E;GAA;CITED4;NAPRT;PYGB;RNF44;CST3;TCFL5;CYP27B1;GSN;CLCA2;XDH;PRDX5;NDRG1;PRODH;MEF2D;NOS1;LTBP1;MARCH9;ARAP1;ZFP36L1;COL6A1;POSTN;NR1D1;CRAT;ALOX15B;EPN3;FAM210B;POLD4;EPHB2;EPAS1;OBSCN;CPT2;NFATC4;NME4;MST1R;LRP1;GAMT;MAPK13;APPL2;CDK18;RALGDS;ST6GALNAC2;OBSL1;EGFR;H1F0;TSC22D1;ALDH4A1;B3GAT3;HADH;SUGCT;ACSF2;REEP6;FBXO2;ACOT7;TCEA2;DUSP5;FKBP9;HS1BP3;UROS;FHL1;MXD4;DDB2;KDSR;MDFI;EGR1;ULK1;RHBDF1;PKN1;CRTC1;TRIM65;DOPEY2;NAGLU;SHC1;F2R;PTK6;BPHL;NPEPL1;ABCA7;DEAF1;LAMA5;PPP2R3B;SLC9A3R2;BAHCC1;S100A4;CTSB;ESRG;LPCAT4;RNF208;PITPNC1;SLC16A3;CXXC5;DHRS1;MALL;D2HGDH;ZMYND8;TBC1D14;ASH2L;ZSCAN18;PACS2;GRAMD4;SOX12;MXI1;CERS4;ABCG1;ANK3;NOL4L;PIK3R2;S100A6;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;PLD3;DOCK4;CRTAP;RPS6KA2;LRP5;HYAL1;TUBG2;ANO8;TENM2;SLC2A9;MAML3;B4GALNT4;ZFPM1;TFEB;ERBB2;BRSK1;BSG;CTSF;SCMH1;OGDHL;PKD2;CBS;TMEM129;FUCA1;TST;CPT1C;EDEM1;ABTB1;VWA5A;ITPR3;H2AFJ;VAT1;DNM1;FCHO1;PTHLH;CDKN1C;SALL2;MSRB2;XPC;PTPRE;ANGEL1;SIGMAR1;PAK6;HEXB;VPS11;VAMP2;CCDC69;GALNT12;FOXQ1;NPHP4;LTB4R2;NTSR1;JADE2;CD320;MINK1;RALGAPA2;ATP2B4;SNN;TFDP2;PHF7;CSNK1E;ACP5;TRAPPC9;AGAP1;DIRC2;ADAMTS7;PDCD4;GM2A;BEX2;ACAP3;TNFRSF25;GLUL;PRR7;RHOD;ZKSCAN1;ARVCF;PEX10;ARMCX2;ASIC1;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;RAB3D;FBXW8;ZC3H6;ID1;CELSR1;AKR7A2;MZT2A;B4GAT1;POLL;WDR27;NDUFS8;RABGGTA;ADARB1;ZNF692;ZNF704;TXNRD3;NBEAL2;HAGH;DNMT3A;DNPH1;TMEM173;PRNP;DHX32;SRD5A3;OXLD1;ATP7B;RNASET2;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;ATG16L2;SNX9;STAT6;DLG4;SPEG;ABCD1;MARCH2;REEP2;MTA3;MKNK2;STRADB;TALDO1;WWTR1;ISG20;FAM20C;MYO18A;ARHGAP27;CERCAM;MZT2B;DNAJB5;PHC2;PLEKHH2;BCL6;ANKZF1;UCKL1;PFKFB2;CHMP1B;SCAND1;DYRK1B;SEC14L2;MVB12B;TMEM92;BNIP3;FZD8;ENTPD6;DNASE1L1;ZSCAN2;HOOK2;ARL2;YPEL3;AP2A2;CEBPB;RHBDF2;DPP7;HSD11B1L;HSF4;NAB2;CALCOCO1;ZDHHC1;ENDOG;MAPK3;PDZD2;TUB;ETV5;OLFM2;CARD19;SLC22A18;GLB1;DHTKD1;EXD3;C19ORF33;RAB40B;ENTPD2;MTA1;LHPP;FYCO1;GPSM1;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;ST3GAL3;SLC16A13;NSMCE4A;FHOD1;HES1;BRD3;PC;ACAD10;YPEL2;COMTD1;FURIN;MLXIPL;ZNF624;NAGS;MBOAT7;SLC48A1;CUL7;MEFV;ARHGAP22;ABCA2;TK2;ZNF414;ADA;FKBP10;TRIM45;MCTP1;OSBPL5;PYCR2;PIDD1;RETSAT;PHF21A;AQP3;CKMT1A;SLIT3;PCSK9;TMEM9;ZFP36;ETV4;RHOF;MAPKBP1;HLCS;CYHR1;FGFR3;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;LRRK1;NUDT10;DGUOK;CYFIP2;SLC38A10;RPS6KA5;SLC25A37;MAP2K2;PI4K2A;FGFR4;SPTB;MXRA8;SLC37A2;STX10;DMTN;RAPGEF5;PMVK;XYLT2;HDAC11;VGF;TNFRSF1A;SEZ6L2;EHD4;MAPK8IP1;TCF25;SEMA3B;LDLR;PTOV1;FAM214B;CYP3A5;SNX17;SOX13;MPG;RHOBTB2;PIGZ;IFNGR2;BHLHE40;CCDC92;RAG1;ZNF80;DUSP7;PHLDA1;LRRC45;MSLN;HMGA2;LDLRAP1;TM7SF2;ELK3;AHNAK2;DGKQ;PEX7;KLHDC2;MVB12A;HK1;NMRAL1;ZXDC;CHST6;SDHAF4;PADI3;GAS6;BTRC;MEX3A;POU6F1;LLGL1;ZNF217;PPARA;HMGCL;TKFC;WNT7B;BLVRB;GIT1;COMT;SUFU;RFNG;DMC1;PAN2;REEP4;ZNF446;ATG2A;RXRA;PCK2;VASN;TMEM175;NEO1;IGFBP4;SDHA;GSDMC;MUC19;USP21;RNF123;PRKCZ;ADAMTS13;ZDHHC24;CLTCL1;HLTF;MDH2;CAPG;BCORL1;ETFB;ABCD4;SPATA7;ZNF485;SH3GLB2;TPP1;PDK2;GPC1;TMX4;SRSF5;ZNF160;RFXANK;TEF;SMOX;CEP68;SMARCD2;MAPKAPK3;AGO4;RAD23A;ARAP3;FGFR1;CTSZ;CAMKK1;PIN1;MAN1B1;PNPLA4;ZNF563;KMT5C;PHYH;IRF2BPL;PROX1;WBP2;C21ORF2;NICN1;ASAP2;ESYT2;BIN1;YIPF3;TMEM8B;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;CES2;SLC25A27;JARID2;CAPN2;SESN2;NDUFA4L2;TOLLIP;WNT2B;RXRB;CSTB;SNPH;MAN2B2;PNRC1;DUSP23;MACROD1;GAL3ST4;SMDT1;PTMS;CYBRD1;RTN4R;PIGV;SLC9A7;TIMP1;CD68;SDC1;WHAMMP3;GRHPR;APOBEC3C;RTN2;H1FX;PIGQ;WNT3;ZFP41;SBF1;SORL1;STK39;COL13A1;MEF2B;TBC1D17;ZSCAN30;AHCYL2;TPCN1;HGSNAT;SLC25A29;CCDC85B;PNMA1;CYP2S1;AKT1;CTSD;TRAP1;TMBIM4;NLRX1;ADAM19;ZNF385A;TP53INP1;LRCH4;NDRG2;TUT1;SMARCA1;VPS33B;SIX5;ERCC6;ACP6;TDRKH;SLC5A5;SUN1;NAGA;TMEM120A;SPPL2B;IL17RD;UQCR11;SSBP2;R3HDM2;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;MPLKIP;KDM4B;CAMTA2;RGS14;SYNE3;GOLGA2P5;PCIF1;MAFIP;CCDC106;R3HDM4;HEXDC;ZNF710;CTSH;ABHD14B;P3H4;MLST8;AGPAT4;RILPL1;RSAD1;CBLC;EPN2;RFX2;RNF187;PYCARD;MAP2K3;PNPO;POMT1;TRERF1;PCSK1N;DDN;PMS2P5;AS3MT;NDUFV3;STK17A;ERN1;RANBP9;ZNF319;APOBEC3F;PRIMPOL;ACADS;GCAT;MOCS1;SIRT3;ALKBH6;GLI4;C12ORF66;SLC2A1;CPNE7;MLYCD;TAZ;BCKDHA;LITAF;APBA1;MZF1;NEIL1;RARG;ING4;GALNS;PBXIP1;FAM162A;GSTM2;ZNF514;PODXL2;TRIM7;WDR18;PQLC2;KRT15;ADAMTSL4;TRNP1;ZNF837;TMED4;POLM;SEMA4F;FAM50A;NDST2;AGPAT3;RPL13A;RGS12;ALG12;MIF;SULF2;STXBP2;UBL5
2736,GO:0006139,1,0,321,4618,nucleobase-containing compound metabolic process,BP,TNIP1;HTRA1;FOS;H6PD;APOE;CTNNBIP1;IDH2;ERCC1;WWC3;NT5E;CITED4;NAPRT;CST3;RAPGEF3;TCFL5;PGM1;XDH;PRDX5;PGLS;PCBP4;MEF2D;NOS1;ZFP36L1;NR1D1;NYNRIN;POLD4;RBCK1;EPAS1;IGF2;NFATC4;NME4;GAMT;MAPK13;EGFR;TIMP2;H1F0;TSC22D1;ACOT7;TCEA2;MXD4;DDB2;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;NMRK1;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;OGDHL;PKD2;CBS;H2AFJ;PTHLH;CDKN1C;SALL2;MSRB2;XPC;PAK6;HEXB;FOXQ1;LTB4R2;ATP2B4;TFDP2;CSNK1E;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;POLL;NDUFS8;ADARB1;ZNF692;ZNF704;ITGA6;DNMT3A;DNPH1;TMEM173;PRNP;DHX32;RNASET2;HES2;ZNF467;MNT;ECM1;STAT6;DLG4;MTA3;TALDO1;WWTR1;ISG20;FAM20C;MYO18A;DNAJB5;BCL6;UCKL1;PFKFB2;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;ENDOG;MAPK3;KCNAB2;ETV5;DHTKD1;EXD3;DVL1;ENTPD2;GALK1;MTA1;LHPP;ADCY6;L3MBTL1;MBD1;NSMCE4A;FHOD1;HES1;BRD3;MLXIPL;ZNF624;ARHGAP22;NADK;ABCA2;TK2;ZNF414;ADA;PIDD1;PHF21A;CELSR2;PFKL;SLC28A2;ZFP36;ETV4;MAPKBP1;PRKACA;ZNF862;ZMYM3;KIAA1549;NUDT10;DGUOK;MAGEF1;RPS6KA5;MAP2K2;DAP;FGFR4;MYH3;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;MPG;BHLHE40;RRNAD1;RAG1;ZNF80;HMGA2;ELK3;AHNAK2;DGKQ;HK1;ZXDC;GAS6;BTRC;POU6F1;ZNF217;PPARA;GUK1;SUFU;PTAFR;DMC1;PAN2;ZNF446;RXRA;PCK2;NEO1;IGFBP4;SDHA;USP21;PRKCZ;HLTF;MDH2;BCORL1;ZNF485;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;AGO4;RAD23A;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;PPP1R13L;ZNF554;WDR83;GLRX;JARID2;SESN2;TSTA3;TMEM161A;RXRB;PNRC1;MAPRE3;GUCA1B;MACROD1;PTMS;OR7D2;APOBEC3C;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;AHCYL2;ADORA2B;CCDC85B;AKT1;NLRX1;ZNF385A;TP53INP1;TUT1;SMARCA1;SIX5;ERCC6;GPD1L;TDRKH;UQCR11;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;ZNF710;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;TRERF1;THAP8;DDN;PMS2P5;NDUFV3;ERN1;ZNF319;APOBEC3F;PRIMPOL;MOCS1;GLI4;TAZ;RNASEK;LITAF;MZF1;NEIL1;FUK;RARG;ING4;PBXIP1;EREG;PPCS;ZNF514;PODXL2;WDR18;TRNP1;ZNF837;POLM;RPL13A;RGS12;UBL5
7589,GO:0031981,1,0,225,3518,nuclear lumen,CC,TNIP1;FOS;DUSP6;CTNNBIP1;TSPAN1;ERCC1;NT5E;CITED4;RNF44;MEF2D;NOS1;ARAP1;NR1D1;EPN3;POLD4;EPAS1;OBSCN;CPT2;NFATC4;APPL2;H1F0;HADH;ACOT7;TCEA2;DUSP5;DDB2;EGR1;PKN1;CRTC1;TRIM65;PTK6;DEAF1;PPP2R3B;BAHCC1;CTSB;RNF208;PITPNC1;CXXC5;TBC1D14;ASH2L;SOX12;MXI1;NOL4L;INO80C;HDAC5;THRA;DOCK4;RPS6KA2;TENM2;MAML3;ZFPM1;BRSK1;SCMH1;ABTB1;VWA5A;ITPR3;H2AFJ;DNM1;FCHO1;PTHLH;SALL2;XPC;PAK6;LTB4R2;JADE2;TFDP2;PHF7;CSNK1E;ZMIZ1;INSR;ID1;CELSR1;MZT2A;POLL;WDR27;RABGGTA;ADARB1;ZNF692;DNMT3A;HINT2;MNT;ATG16L2;STAT6;MTA3;MKNK2;TALDO1;WWTR1;ISG20;ARHGAP27;MZT2B;PHC2;PLEKHH2;BCL6;PFKFB2;TMEM92;BNIP3;ARL2;YPEL3;CEBPB;HSD11B1L;HSF4;CALCOCO1;MAPK3;ETV5;OLFM2;MTA1;LHPP;L3MBTL1;LTA4H;WIPI2;MBD1;NSMCE4A;HES1;YPEL2;MLXIPL;FKBP10;TRIM45;PIDD1;PHF21A;ETV4;HLCS;CYHR1;PRKACA;ZMYM3;RPS6KA5;RAPGEF5;HDAC11;SOX13;MPG;BHLHE40;CCDC92;RAG1;DUSP7;PHLDA1;LRRC45;HMGA2;ELK3;DGKQ;KLHDC2;MVB12A;BTRC;POU6F1;ZNF217;PPARA;BLVRB;DMC1;RXRA;NEO1;SDHA;USP21;PRKCZ;HLTF;CAPG;BCORL1;SPATA7;SH3GLB2;PDK2;GPC1;SRSF5;RFXANK;SMOX;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;PIN1;KMT5C;IRF2BPL;WBP2;NICN1;PPP1R13L;SH3D19;ZNF554;JARID2;TOLLIP;RXRB;CSTB;DUSP23;MACROD1;H1FX;SBF1;STK39;MEF2B;PNMA1;AKT1;TRAP1;ZNF385A;TP53INP1;LRCH4;TUT1;SMARCA1;ERCC6;SPPL2B;IL17RD;MPLKIP;KDM4B;RGS14;PCIF1;MAFIP;ABHD14B;P3H4;MLST8;RILPL1;RNF187;PYCARD;MAP2K3;PNPO;TRERF1;NDUFV3;STK17A;ACADS;GCAT;ALKBH6;LITAF;NEIL1;RARG;ING4;WDR18;TRNP1;POLM;FAM50A;RPL13A;RGS12;MIF
4462,GO:0010467,1.00000000000001,0,291,4271,gene expression,BP,TNIP1;HTRA1;FOS;LMF1;APOE;TYSND1;CTNNBIP1;WWC3;CITED4;TCFL5;GSN;XDH;PRDX5;PCBP4;PRSS3;MEF2D;NOS1;ZFP36L1;GRB7;NR1D1;RBCK1;EPHB2;EPAS1;CNTN1;IGF2;NFATC4;MAPK13;EGFR;TSC22D1;TCEA2;MXD4;SERPING1;MDFI;ADGRF1;EGR1;RHBDF1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;BBS2;ACTA2;CXXC5;GJC2;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;PLAT;ABCG1;ANK3;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;PKD2;ABTB1;H2AFJ;PHLDA2;PTHLH;CDKN1C;SALL2;MSRB2;PAK6;HEXB;SERPINE2;FOXQ1;UNK;ATP2B4;GGT1;TFDP2;CSNK1E;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;SH3PXD2B;ZC3H6;ID1;ADARB1;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;PRNP;DHX32;HES2;SPRY2;ZNF467;MNT;ECM1;STAT6;MTA3;MKNK2;WWTR1;ISG20;DNAJB5;BCL6;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;CEBPB;RHBDF2;ACVR2B;HSF4;NAB2;CALCOCO1;MAPK3;ETV5;DVL1;MTA1;L3MBTL1;MBD1;FHOD1;HES1;BRD3;PC;FURIN;MLXIPL;ZNF624;ARHGAP22;ABCA2;ZNF414;PIDD1;PHF21A;CELSR2;SLIT3;PCSK9;ZFP36;ETV4;MAPKBP1;PRKACA;F12;ZNF862;ZMYM3;KIAA1549;MAGEF1;CYFIP2;RPS6KA5;MAP2K2;DAP;FGFR4;TSPAN33;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;LDLR;PTOV1;SOX13;TRPV4;BHLHE40;EIF4EBP3;RRNAD1;RAG1;ZNF80;EEF2K;RHBDL1;HMGA2;ELK3;AHNAK2;DGKQ;ZXDC;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;SUFU;PTAFR;PAN2;ZNF446;RXRA;PCSK1;NEO1;USP21;PRKCZ;ADAMTS13;HLTF;BCORL1;ZNF485;LSM14B;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;AGO4;FGFR1;CTSZ;PIN1;MN1;ZNF563;C5;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;PPP1R13L;ZNF554;WDR83;JARID2;CAPN2;SESN2;RXRB;PNRC1;MAPRE3;OR7D2;WNT3;ZFP41;PPM1F;SORL1;ACVR1B;MEF2B;ZSCAN30;ERBB3;CCDC85B;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;TUT1;SMARCA1;SIX5;ERCC6;TDRKH;SPPL2B;SSBP2;RPL39L;PINK1;PKD1;LONP2;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;EIF4G3;ZNF710;CTSH;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;TRERF1;PCSK1N;THAP8;DDN;ERN1;ZNF319;GLI4;LITAF;APBA1;MZF1;RARG;ING4;EIF4E3;PBXIP1;EREG;ZNF514;WDR18;TRNP1;ZNF837;RPL13A;RGS12;MIF;UBL5
8845,GO:0034660,1.00000000000001,0,8,546,ncRNA metabolic process,BP,CSNK1E;ISG20;RRNAD1;AGO4;TUT1;TDRKH;WDR18;RPL13A
5324,GO:0016071,1.00000000000001,0,18,737,mRNA metabolic process,BP,PCBP4;ZFP36L1;ADARB1;DHX32;ZFP36;PRKACA;PAN2;SRSF5;AGO4;GTPBP1;WDR83;PNRC1;AKT1;TUT1;ERN1;EREG;RPL13A;UBL5
10869,GO:0044428,1.00000000000002,0,252,3797,nuclear part,CC,TNIP1;FOS;DUSP6;CTNNBIP1;TSPAN1;ERCC1;NT5E;CITED4;RNF44;CST3;CLCA2;MEF2D;NOS1;ARAP1;NR1D1;EPN3;POLD4;EPAS1;OBSCN;CPT2;NFATC4;APPL2;EGFR;H1F0;HADH;ACOT7;TCEA2;DUSP5;DDB2;EGR1;PKN1;CRTC1;TRIM65;PTK6;DEAF1;PPP2R3B;BAHCC1;CTSB;RNF208;PITPNC1;SLC16A3;CXXC5;TBC1D14;ASH2L;SOX12;MXI1;CERS4;NOL4L;S100A6;INO80C;HDAC5;THRA;DOCK4;RPS6KA2;TENM2;SLC2A9;MAML3;ZFPM1;BRSK1;SCMH1;ABTB1;VWA5A;ITPR3;H2AFJ;DNM1;FCHO1;PTHLH;SALL2;XPC;SIGMAR1;PAK6;LTB4R2;JADE2;TFDP2;PHF7;CSNK1E;ZMIZ1;INSR;ID1;CELSR1;MZT2A;POLL;WDR27;RABGGTA;ADARB1;ZNF692;DNMT3A;PRNP;DHX32;HINT2;MNT;ATG16L2;STAT6;MTA3;MKNK2;TALDO1;WWTR1;ISG20;ARHGAP27;MZT2B;PHC2;PLEKHH2;BCL6;PFKFB2;TMEM92;BNIP3;ARL2;YPEL3;CEBPB;HSD11B1L;HSF4;CALCOCO1;MAPK3;ETV5;OLFM2;SLC22A18;RAB40B;MTA1;LHPP;L3MBTL1;LTA4H;WIPI2;MBD1;NSMCE4A;HES1;YPEL2;MLXIPL;CUL7;FKBP10;TRIM45;PIDD1;RETSAT;PHF21A;ETV4;MAPKBP1;HLCS;CYHR1;PRKACA;ZMYM3;RPS6KA5;RAPGEF5;HDAC11;SOX13;MPG;BHLHE40;CCDC92;RAG1;DUSP7;PHLDA1;LRRC45;HMGA2;TM7SF2;ELK3;DGKQ;KLHDC2;MVB12A;BTRC;POU6F1;ZNF217;PPARA;BLVRB;DMC1;RXRA;NEO1;SDHA;USP21;RNF123;PRKCZ;HLTF;CAPG;BCORL1;SPATA7;SH3GLB2;PDK2;GPC1;SRSF5;RFXANK;SMOX;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;PIN1;KMT5C;IRF2BPL;WBP2;NICN1;BIN1;PPP1R13L;SH3D19;ZNF554;WDR83;JARID2;TOLLIP;RXRB;CSTB;DUSP23;MACROD1;H1FX;SBF1;SORL1;STK39;MEF2B;PNMA1;AKT1;TRAP1;ZNF385A;TP53INP1;LRCH4;TUT1;SMARCA1;ERCC6;SUN1;TMEM120A;SPPL2B;IL17RD;MPLKIP;KDM4B;RGS14;SYNE3;PCIF1;MAFIP;ABHD14B;P3H4;MLST8;RILPL1;RNF187;PYCARD;MAP2K3;PNPO;TRERF1;PMS2P5;NDUFV3;STK17A;ERN1;APOBEC3F;ACADS;GCAT;ALKBH6;LITAF;NEIL1;RARG;ING4;WDR18;TRNP1;POLM;FAM50A;AGPAT3;RPL13A;RGS12;MIF
3127,GO:0006725,1.00000000000003,0,336,4735,cellular aromatic compound metabolic process,BP,TNIP1;HTRA1;FOS;H6PD;APOE;CTNNBIP1;IDH2;ERCC1;WWC3;NT5E;CITED4;NAPRT;CST3;RAPGEF3;TCFL5;PGM1;XDH;PRDX5;PGLS;PCBP4;PRSS3;MEF2D;NOS1;ZFP36L1;NR1D1;NYNRIN;POLD4;RBCK1;EPAS1;IGF2;NFATC4;NME4;GAMT;MAPK13;EGFR;TIMP2;H1F0;TSC22D1;ACOT7;TCEA2;UROS;MXD4;DDB2;MTHFR;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;NMRK1;LRP5;TENM2;SLC2A9;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;OGDHL;PKD2;CBS;H2AFJ;PTHLH;CDKN1C;SALL2;MSRB2;XPC;PAK6;HEXB;FOXQ1;LTB4R2;CD320;ATP2B4;TFDP2;CSNK1E;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;AKR7A2;POLL;NDUFS8;ADARB1;ZNF692;ZNF704;ITGA6;DNMT3A;DNPH1;TMEM173;PRNP;DHX32;RNASET2;HES2;ZNF467;MNT;ECM1;STAT6;DLG4;MTA3;TALDO1;WWTR1;ISG20;FAM20C;MYO18A;DNAJB5;BCL6;UCKL1;PFKFB2;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;ENDOG;MAPK3;KCNAB2;ETV5;AMN;DHTKD1;EXD3;DVL1;ENTPD2;GALK1;MTA1;LHPP;ADCY6;L3MBTL1;MBD1;NSMCE4A;FHOD1;HES1;BRD3;MLXIPL;ZNF624;ARHGAP22;NADK;ABCA2;TK2;ZNF414;ADA;PIDD1;PHF21A;CELSR2;PFKL;SLC28A2;ZFP36;ETV4;MAPKBP1;PRKACA;ZNF862;ZMYM3;KIAA1549;NUDT10;DGUOK;MAGEF1;RPS6KA5;MAP2K2;DAP;FGFR4;MYH3;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;MPG;BHLHE40;RRNAD1;RAG1;ZNF80;HMGA2;ELK3;AHNAK2;DGKQ;HK1;ZXDC;GAS6;BTRC;POU6F1;ZNF217;PPARA;GUK1;BLVRB;COMT;SUFU;PTAFR;DMC1;PAN2;ZNF446;RXRA;PCK2;NEO1;IGFBP4;SDHA;USP21;PRKCZ;HLTF;MDH2;BCORL1;ABCD4;ZNF485;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;AGO4;RAD23A;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;PPP1R13L;ZNF554;WDR83;GLRX;JARID2;SESN2;TSTA3;TMEM161A;RXRB;PNRC1;MAPRE3;GUCA1B;MACROD1;PTMS;OR7D2;APOBEC3C;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;AHCYL2;ADORA2B;CCDC85B;AKT1;HPDL;NLRX1;ZNF385A;TP53INP1;TUT1;SMARCA1;SIX5;ERCC6;GPD1L;TDRKH;SLC5A5;UQCR11;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;ZNF710;ABHD14B;RSAD1;RFX2;RNF187;PYCARD;MAP2K3;PNPO;TRERF1;THAP8;DDN;PMS2P5;NDUFV3;ERN1;ZNF319;APOBEC3F;PRIMPOL;MOCS1;GLI4;TAZ;RNASEK;LITAF;MZF1;NEIL1;FUK;RARG;ING4;PBXIP1;EREG;PPCS;GSTM2;ZNF514;PODXL2;WDR18;TRNP1;ZNF837;POLM;RPL13A;RGS12;UBL5
8633,GO:0034191,1.00000000000003,0.734323496044659,0,3,apolipoprotein A-I receptor binding,MF,
3922,GO:0008612,1.00000000000003,0.681810546202914,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
7333,GO:0031372,1.00000000000006,0.819537540268578,0,2,UBC13-MMS2 complex,CC,
237,GO:0000495,1.00000000000007,0.901424306015916,0,1,box H/ACA snoRNA 3'-end processing,BP,
2729,GO:0006117,1.00000000000007,0.901424306015916,0,1,acetaldehyde metabolic process,BP,
8542,GO:0033979,1.00000000000007,0.901424306015916,0,1,box H/ACA snoRNA metabolic process,BP,
8834,GO:0034645,1.00000000000007,0,277,4048,cellular macromolecule biosynthetic process,BP,TNIP1;HTRA1;FOS;LMF1;APOE;CTNNBIP1;WWC3;CITED4;CST3;TCFL5;PGM1;PRDX5;MEF2D;NOS1;ZFP36L1;GRB7;NR1D1;POLD4;RBCK1;EPAS1;IGF2;NFATC4;MAPK13;ST6GALNAC2;EGFR;TSC22D1;B3GAT3;TCEA2;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;ABCA7;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;LRP5;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;PKD2;ABTB1;H2AFJ;CDKN1C;SALL2;MSRB2;PAK6;HEXB;GALNT12;FOXQ1;UNK;ATP2B4;GGT1;TFDP2;TRAPPC9;ADAMTS7;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;MVD;B4GAT1;POLL;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;PRNP;SRD5A3;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;MKNK2;WWTR1;DNAJB5;BCL6;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;VANGL2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;ZDHHC1;MAPK3;ETV5;DVL1;MTA1;L3MBTL1;WIPI2;MBD1;ST3GAL3;FHOD1;HES1;BRD3;MLXIPL;ZNF624;ARHGAP22;ABCA2;TK2;ZNF414;LY6K;PIDD1;PHF21A;CELSR2;ZFP36;ETV4;ZNF862;ZMYM3;KIAA1549;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;MDGA1;XYLT2;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;ABHD17C;TRPV4;PIGZ;BHLHE40;EIF4EBP3;ZNF80;PHLDA1;EEF2K;MSLN;HMGA2;ELK3;DGKQ;ZXDC;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;SUFU;PTAFR;RFNG;ZNF446;RXRA;NEO1;MUC19;USP21;PRKCZ;ADAMTS13;ZDHHC24;HLTF;BCORL1;ZNF485;LSM14B;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;AGO4;FGFR1;PIN1;MAN1B1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;PPP1R13L;ZNF554;JARID2;SESN2;RXRB;PNRC1;MAPRE3;LCAT;GAL3ST4;PTMS;OR7D2;PIGV;PIGQ;ZFP41;PPM1F;VEGFB;ACVR1B;MEF2B;ZSCAN30;CCDC85B;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;RPL39L;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;EIF4G3;ZNF710;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;THAP8;DDN;ERN1;ZNF319;PRIMPOL;GLI4;JAK3;LITAF;MZF1;RARG;ING4;EIF4E3;PBXIP1;EREG;ZNF514;WDR18;ADAMTSL4;TRNP1;ZNF837;POLM;NDST2;RPL13A;RGS12;ALG12
8918,GO:0034964,1.00000000000007,0.901424306015916,0,1,box H/ACA snoRNA processing,BP,
9154,GO:0035525,1.00000000000007,0.901424306015916,0,1,NF-kappaB p50/p65 complex,CC,
8892,GO:0034739,1.00000000000009,0.818898529119713,0,2,histone deacetylase activity (H4-K16 specific),MF,
16399,GO:0097065,1.0000000000001,0.661108523272103,0,4,anterior head development,BP,
1151,GO:0002759,1.0000000000001,0.671362080745145,0,4,regulation of antimicrobial humoral response,BP,
516,GO:0001582,1.0000000000001,0.901436891378876,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
8246,GO:0033041,1.0000000000001,0.901436891378876,0,1,sweet taste receptor activity,MF,
10645,GO:0043843,1.0000000000001,0.901436891378876,0,1,ADP-specific glucokinase activity,MF,
18527,GO:1903767,1.0000000000001,0.901436891378876,0,1,sweet taste receptor complex,CC,
18528,GO:1903768,1.0000000000001,0.901436891378876,0,1,taste receptor complex,CC,
4018,GO:0009059,1.00000000000011,0,284,4118,macromolecule biosynthetic process,BP,TNIP1;HTRA1;FOS;LMF1;CEMIP;APOE;CTNNBIP1;WWC3;CITED4;CST3;TCFL5;PGM1;PRDX5;MEF2D;NOS1;ZFP36L1;GRB7;NR1D1;POLD4;RBCK1;EPAS1;IGF2;NFATC4;MAPK13;ST6GALNAC2;EGFR;TSC22D1;B3GAT3;TCEA2;MXD4;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;ABCA7;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;LRP5;HYAL1;TENM2;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;PKD2;ABTB1;H2AFJ;CDKN1C;SALL2;MSRB2;PAK6;HEXB;GALNT12;FOXQ1;UNK;ATP2B4;GGT1;TFDP2;TRAPPC9;ADAMTS7;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;MVD;B4GAT1;POLL;ZNF692;ZNF704;ITGA6;DNMT3A;TMEM173;PRNP;SRD5A3;HES2;ZNF467;MNT;ECM1;STAT6;MTA3;MKNK2;WWTR1;DNAJB5;BCL6;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ZSCAN2;VANGL2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;ZDHHC1;MAPK3;ETV5;DVL1;MTA1;L3MBTL1;WIPI2;MBD1;ST3GAL3;FHOD1;HES1;BRD3;FURIN;MLXIPL;ZNF624;ARHGAP22;ABCA2;TK2;ZNF414;LY6K;PIDD1;PHF21A;CELSR2;ZFP36;ETV4;ZNF862;ZMYM3;KIAA1549;CYFIP2;RPS6KA5;HBEGF;MAP2K2;DAP;FGFR4;MDGA1;XYLT2;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;ABHD17C;TRPV4;PIGZ;BHLHE40;EIF4EBP3;ZNF80;PHLDA1;EEF2K;MSLN;HMGA2;ELK3;DGKQ;ZXDC;CHST6;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;SUFU;PTAFR;RFNG;ZNF446;RXRA;NEO1;MUC19;USP21;PRKCZ;ADAMTS13;ZDHHC24;HLTF;BCORL1;INPP5D;ZNF485;LSM14B;GPC1;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;AGO4;FGFR1;PIN1;MAN1B1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;PPP1R13L;ZNF554;JARID2;SESN2;RXRB;PNRC1;MAPRE3;LCAT;GAL3ST4;PTMS;OR7D2;PIGV;SDC1;PIGQ;ZFP41;PPM1F;VEGFB;ACVR1B;MEF2B;ZSCAN30;CCDC85B;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;SMARCA1;SIX5;ERCC6;SSBP2;RPL39L;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;EIF4G3;ZNF710;ABHD14B;RFX2;RNF187;PYCARD;MAP2K3;POMT1;TRERF1;THAP8;DDN;ERN1;ZNF319;PRIMPOL;GLI4;JAK3;LITAF;MZF1;RARG;ING4;EIF4E3;PBXIP1;EREG;ZNF514;WDR18;ADAMTSL4;TRNP1;ZNF837;POLM;NDST2;RPL13A;RGS12;ALG12
16543,GO:0097361,1.00000000000011,0.679982270818842,0,4,CIA complex,CC,
2439,GO:0005654,1.00000000000012,0,192,3043,nucleoplasm,CC,TNIP1;FOS;DUSP6;CTNNBIP1;TSPAN1;ERCC1;NT5E;CITED4;RNF44;MEF2D;NOS1;ARAP1;NR1D1;EPN3;POLD4;EPAS1;OBSCN;CPT2;NFATC4;APPL2;H1F0;HADH;ACOT7;TCEA2;DUSP5;DDB2;EGR1;PKN1;CRTC1;TRIM65;PTK6;PPP2R3B;BAHCC1;RNF208;PITPNC1;CXXC5;TBC1D14;ASH2L;SOX12;NOL4L;INO80C;HDAC5;THRA;RPS6KA2;TENM2;MAML3;ZFPM1;BRSK1;SCMH1;VWA5A;ITPR3;DNM1;FCHO1;PTHLH;SALL2;XPC;LTB4R2;JADE2;TFDP2;PHF7;CSNK1E;ZMIZ1;ID1;CELSR1;MZT2A;POLL;WDR27;RABGGTA;ADARB1;DNMT3A;MNT;ATG16L2;STAT6;MTA3;MKNK2;TALDO1;WWTR1;ISG20;ARHGAP27;MZT2B;PHC2;PLEKHH2;BCL6;PFKFB2;TMEM92;BNIP3;CEBPB;HSD11B1L;HSF4;MAPK3;ETV5;OLFM2;MTA1;LHPP;L3MBTL1;LTA4H;WIPI2;MBD1;NSMCE4A;HES1;MLXIPL;TRIM45;PIDD1;PHF21A;ETV4;CYHR1;PRKACA;ZMYM3;RPS6KA5;RAPGEF5;HDAC11;SOX13;MPG;BHLHE40;CCDC92;RAG1;DUSP7;LRRC45;HMGA2;ELK3;DGKQ;KLHDC2;MVB12A;BTRC;POU6F1;ZNF217;PPARA;BLVRB;DMC1;RXRA;NEO1;USP21;HLTF;CAPG;BCORL1;SPATA7;SH3GLB2;PDK2;GPC1;SRSF5;RFXANK;SMOX;SMARCD2;MAPKAPK3;AGO4;RAD23A;PIN1;KMT5C;IRF2BPL;NICN1;PPP1R13L;SH3D19;JARID2;TOLLIP;RXRB;DUSP23;MACROD1;SBF1;STK39;AKT1;TRAP1;ZNF385A;TP53INP1;LRCH4;TUT1;SMARCA1;ERCC6;SPPL2B;IL17RD;MPLKIP;KDM4B;RGS14;PCIF1;MLST8;RILPL1;RNF187;MAP2K3;PNPO;TRERF1;NDUFV3;STK17A;ACADS;GCAT;ALKBH6;LITAF;NEIL1;RARG;ING4;WDR18;POLM;FAM50A;MIF
1500,GO:0003854,1.00000000000012,0.738309665937642,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
11568,GO:0046166,1.00000000000014,0.821610233263363,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
3078,GO:0006659,1.00000000000015,0.660859554767522,0,4,phosphatidylserine biosynthetic process,BP,
11673,GO:0046483,1.00000000000015,0,338,4721,heterocycle metabolic process,BP,TNIP1;HTRA1;FOS;H6PD;APOE;CTNNBIP1;IDH2;ERCC1;WWC3;NT5E;CITED4;NAPRT;CST3;RAPGEF3;TCFL5;PGM1;XDH;PRDX5;PGLS;PCBP4;PRSS3;PRODH;MEF2D;NOS1;ZFP36L1;NR1D1;NYNRIN;POLD4;RBCK1;EPAS1;IGF2;NFATC4;NME4;GAMT;MAPK13;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;ACOT7;TCEA2;UROS;MXD4;DDB2;MTHFR;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;NMRK1;LRP5;TENM2;PLTP;SLC2A9;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;OGDHL;PKD2;CBS;H2AFJ;PTHLH;CDKN1C;SALL2;MSRB2;XPC;PAK6;HEXB;FOXQ1;LTB4R2;CD320;ATP2B4;TFDP2;CSNK1E;ACP5;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;POLL;NDUFS8;ADARB1;ZNF692;ZNF704;ITGA6;DNMT3A;DNPH1;TMEM173;PRNP;DHX32;RNASET2;HES2;ZNF467;MNT;ECM1;STAT6;DLG4;MTA3;TALDO1;WWTR1;ISG20;FAM20C;MYO18A;DNAJB5;BCL6;UCKL1;PFKFB2;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;ENDOG;MAPK3;KCNAB2;ETV5;AMN;DHTKD1;EXD3;DVL1;ENTPD2;GALK1;MTA1;LHPP;ADCY6;L3MBTL1;MBD1;NSMCE4A;FHOD1;HES1;BRD3;PC;MLXIPL;ZNF624;ARHGAP22;NADK;ABCA2;TK2;ZNF414;ADA;PYCR2;PIDD1;PHF21A;CELSR2;PFKL;SLC28A2;ZFP36;ETV4;MAPKBP1;HLCS;PRKACA;ZNF862;ZMYM3;KIAA1549;NUDT10;DGUOK;MAGEF1;RPS6KA5;MAP2K2;DAP;FGFR4;MYH3;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;SOX13;TRPV4;MPG;BHLHE40;RRNAD1;RAG1;ZNF80;HMGA2;ELK3;AHNAK2;DGKQ;HK1;ZXDC;GAS6;BTRC;POU6F1;ZNF217;PPARA;GUK1;BLVRB;SUFU;PTAFR;DMC1;PAN2;ZNF446;RXRA;PCK2;NEO1;IGFBP4;SDHA;USP21;PRKCZ;HLTF;MDH2;BCORL1;ABCD4;ZNF485;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;AGO4;RAD23A;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;PPP1R13L;ZNF554;WDR83;GLRX;JARID2;SESN2;TSTA3;TMEM161A;RXRB;PNRC1;MAPRE3;GUCA1B;MACROD1;PTMS;OR7D2;APOBEC3C;ZFP41;PPM1F;ACVR1B;MEF2B;ZSCAN30;AHCYL2;ADORA2B;CCDC85B;AKT1;NLRX1;ZNF385A;TP53INP1;TUT1;SMARCA1;SIX5;ERCC6;GPD1L;TDRKH;UQCR11;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;ZNF710;ABHD14B;RSAD1;RFX2;RNF187;PYCARD;MAP2K3;PNPO;TRERF1;THAP8;DDN;PMS2P5;NDUFV3;ERN1;ZNF319;APOBEC3F;PRIMPOL;MOCS1;GLI4;TAZ;RNASEK;LITAF;MZF1;NEIL1;FUK;RARG;ING4;PBXIP1;EREG;PPCS;ZNF514;PODXL2;WDR18;TRNP1;ZNF837;POLM;RPL13A;RGS12;UBL5
10725,GO:0044111,1.00000000000017,0.817782458073843,0,2,development involved in symbiotic interaction,BP,
8830,GO:0034641,1.00000000000017,0,376,5148,cellular nitrogen compound metabolic process,BP,TNIP1;HTRA1;FOS;H6PD;APOE;CTNNBIP1;IDH2;RNPEPL1;ERCC1;WWC3;NT5E;CITED4;NAPRT;CST3;RAPGEF3;TCFL5;PGM1;XDH;PRDX5;PGLS;PCBP4;MEF2D;NOS1;ZFP36L1;GRB7;NR1D1;CRAT;NYNRIN;POLD4;RBCK1;EPAS1;IGF2;NFATC4;NME4;GAMT;MAPK13;EGFR;TIMP2;H1F0;TSC22D1;ACOT7;TCEA2;UROS;MXD4;DDB2;MTHFR;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;ABCA7;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;CERS4;ABCG1;PIK3R2;OPLAH;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;NMRK1;LRP5;TENM2;SLC2A9;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;OGDHL;PKD2;CBS;TST;CPT1C;ABTB1;H2AFJ;PTHLH;CDKN1C;SALL2;MSRB2;XPC;PAK6;HEXB;FOXQ1;LTB4R2;UNK;ATP2B4;GGT1;TFDP2;CSNK1E;ACP5;TRAPPC9;PDCD4;GM2A;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;POLL;NDUFS8;ADARB1;ZNF692;ZNF704;ITGA6;HAGH;DNMT3A;DNPH1;TMEM173;PRNP;DHX32;RNASET2;HES2;ZNF467;MNT;ECM1;STAT6;DLG4;MTA3;MKNK2;TALDO1;WWTR1;ISG20;FAM20C;MYO18A;DNAJB5;BCL6;UCKL1;PFKFB2;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;ENDOG;MAPK3;KCNAB2;ETV5;DHTKD1;EXD3;DVL1;ENTPD2;GALK1;MTA1;LHPP;ADCY6;L3MBTL1;LTA4H;MBD1;NSMCE4A;FHOD1;HES1;BRD3;PC;FURIN;MLXIPL;ZNF624;NAGS;ARHGAP22;NADK;ABCA2;TK2;ZNF414;ADA;PIDD1;PHF21A;CELSR2;PFKL;SLC28A2;ZFP36;ETV4;MAPKBP1;HLCS;PRKACA;ZNF862;ZMYM3;KIAA1549;NUDT10;DGUOK;MAGEF1;CYFIP2;RPS6KA5;MAP2K2;DAP;FGFR4;MYH3;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;PTOV1;CYP3A5;SOX13;TRPV4;MPG;BHLHE40;EIF4EBP3;RRNAD1;RAG1;ZNF80;EEF2K;HMGA2;ELK3;AHNAK2;DGKQ;HK1;NMRAL1;ZXDC;GAS6;BTRC;MEX3A;POU6F1;ZNF217;PPARA;GUK1;BLVRB;COMT;SUFU;PTAFR;DMC1;PAN2;ZNF446;RXRA;PCK2;PCSK1;NEO1;IGFBP4;SDHA;USP21;PRKCZ;ADAMTS13;HLTF;MDH2;BCORL1;ZNF485;LSM14B;TPP1;SRSF5;ZNF160;RFXANK;TEF;SMOX;SMARCD2;AGO4;RAD23A;FGFR1;CTSZ;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;BIN1;PPP1R13L;ASS1;ZNF554;WDR83;GLRX;JARID2;SESN2;TSTA3;TMEM161A;RXRB;PNRC1;MAPRE3;GUCA1B;MACROD1;PTMS;OR7D2;GRHPR;APOBEC3C;GSTT1;ZFP41;PPM1F;SORL1;ACVR1B;MEF2B;ZSCAN30;GSS;AHCYL2;ADORA2B;CCDC85B;AKT1;TRAP1;NLRX1;ZNF385A;TP53INP1;TUT1;SMARCA1;SIX5;ERCC6;GPD1L;TDRKH;NAGA;SPPL2B;UQCR11;SSBP2;RPL39L;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;EIF4G3;ZNF710;CTSH;ABHD14B;RSAD1;RFX2;RNF187;PYCARD;MAP2K3;PNPO;TRERF1;PCSK1N;THAP8;DDN;PMS2P5;NDUFV3;ERN1;ZNF319;APOBEC3F;PRIMPOL;MOCS1;GLI4;TAZ;RNASEK;BCKDHA;LITAF;MZF1;NEIL1;FUK;RARG;ING4;EIF4E3;PBXIP1;EREG;PPCS;GSTM2;ZNF514;PODXL2;WDR18;TRNP1;ZNF837;POLM;RPL13A;RGS12;UBL5
6217,GO:0019777,1.00000000000017,0.824719184576162,0,2,Atg12 transferase activity,MF,
1342,GO:0003207,1.00000000000018,0.663853526323659,0,4,cardiac chamber formation,BP,
1345,GO:0003211,1.00000000000018,0.663853526323659,0,4,cardiac ventricle formation,BP,
6340,GO:0021526,1.00000000000018,0.9044062075226,0,1,medial motor column neuron differentiation,BP,
18034,GO:1902616,1.00000000000018,0.9044062075226,0,1,acyl carnitine transmembrane transport,BP,
1678,GO:0004146,1.00000000000019,0.828213750390961,0,2,dihydrofolate reductase activity,MF,
10506,GO:0043456,1.00000000000021,0.669303816199523,0,4,regulation of pentose-phosphate shunt,BP,
3925,GO:0008616,1.00000000000021,0.752773259021501,0,3,queuosine biosynthetic process,BP,
11546,GO:0046116,1.00000000000021,0.752773259021501,0,3,queuosine metabolic process,BP,
102,GO:0000214,1.00000000000021,0.666309923430553,0,4,tRNA-intron endonuclease complex,CC,
215,GO:0000451,1.00000000000022,0.815558694064175,0,2,rRNA 2'-O-methylation,BP,
216,GO:0000453,1.00000000000022,0.815558694064175,0,2,enzyme-directed rRNA 2'-O-methylation,BP,
14508,GO:0070039,1.00000000000022,0.815558694064175,0,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
533,GO:0001652,1.00000000000022,0.671707120129075,0,4,granular component,CC,
1497,GO:0003845,1.00000000000023,0.823999128826351,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
8320,GO:0033181,1.00000000000023,0.906751604992071,0,1,plasma membrane proton-transporting V-type ATPase complex,CC,
16380,GO:0097036,1.00000000000024,0.910657491528774,0,1,regulation of plasma membrane sterol distribution,BP,
5761,GO:0016972,1.00000000000025,0.660269904967821,0,4,thiol oxidase activity,MF,
15914,GO:0072750,1.00000000000025,0.913791922897091,0,1,cellular response to leptomycin B,BP,
17607,GO:1901344,1.00000000000025,0.913791922897091,0,1,response to leptomycin B,BP,
17728,GO:1901707,1.00000000000025,0.913791922897091,0,1,leptomycin B binding,MF,
13624,GO:0060159,1.00000000000026,0.666971062784922,0,4,regulation of dopamine receptor signaling pathway,BP,
3347,GO:0007089,1.00000000000026,0.663372256724713,0,4,traversing start control point of mitotic cell cycle,BP,
9497,GO:0036194,1.00000000000026,0.750527392341154,0,3,muscle cell projection,CC,
9498,GO:0036195,1.00000000000026,0.750527392341154,0,3,muscle cell projection membrane,CC,
9233,GO:0035650,1.00000000000027,0.677941477960686,0,4,AP-1 adaptor complex binding,MF,
2021,GO:0004757,1.00000000000028,0.910299384003663,0,1,sepiapterin reductase activity,MF,
14931,GO:0070852,1.00000000000028,0.732824143141721,0,3,cell body fiber,CC,
15568,GO:0072076,1.00000000000028,0.732824143141721,0,3,nephrogenic mesenchyme development,BP,
214,GO:0000448,1.00000000000033,0.812731445696138,0,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
13625,GO:0060161,1.00000000000035,0.732485751207189,0,3,positive regulation of dopamine receptor signaling pathway,BP,
4239,GO:0009448,1.00000000000038,0.660320257664878,0,4,gamma-aminobutyric acid metabolic process,BP,
18598,GO:1903912,1.00000000000038,0.662386884776246,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
19957,GO:2000580,1.00000000000038,0.692055976022524,0,4,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
19958,GO:2000582,1.00000000000038,0.692055976022524,0,4,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
160,GO:0000332,1.00000000000039,0.937167758755289,0,1,template for synthesis of G-rich strand of telomere DNA activity,MF,
238,GO:0000496,1.00000000000039,0.937167758755289,0,1,base pairing,MF,
239,GO:0000497,1.00000000000039,0.937167758755289,0,1,base pairing with DNA,MF,
1464,GO:0003721,1.00000000000039,0.937167758755289,0,1,telomerase RNA reverse transcriptase activity,MF,
11082,GO:0045113,1.0000000000004,0.841080180516261,0,2,regulation of integrin biosynthetic process,BP,
15340,GO:0071606,1.00000000000042,0.903462716237965,0,1,chemokine (C-C motif) ligand 4 production,BP,
15367,GO:0071643,1.00000000000042,0.903462716237965,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
15368,GO:0071644,1.00000000000042,0.903462716237965,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
15855,GO:0072615,1.00000000000042,0.903462716237965,0,1,interleukin-17 secretion,BP,
19103,GO:1905076,1.00000000000042,0.903462716237965,0,1,regulation of interleukin-17 secretion,BP,
19104,GO:1905077,1.00000000000042,0.903462716237965,0,1,negative regulation of interleukin-17 secretion,BP,
19218,GO:1905403,1.00000000000042,0.903462716237965,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
10965,GO:0044778,1.00000000000043,0.813519394529253,0,2,meiotic DNA integrity checkpoint,BP,
13556,GO:0060051,1.00000000000044,0.817019627653587,0,2,negative regulation of protein glycosylation,BP,
16207,GO:0090285,1.00000000000044,0.817019627653587,0,2,negative regulation of protein glycosylation in Golgi,BP,
9474,GO:0036128,1.00000000000044,0.814684353887578,0,2,CatSper complex,CC,
7258,GO:0031249,1.00000000000045,0.901591865765973,0,1,denatured protein binding,MF,
17951,GO:1902380,1.00000000000045,0.901591865765973,0,1,positive regulation of endoribonuclease activity,BP,
18931,GO:1904722,1.00000000000045,0.901591865765973,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
1777,GO:0004395,1.00000000000047,0.914211043775347,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
3816,GO:0008425,1.00000000000047,0.914211043775347,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
3946,GO:0008689,1.00000000000047,0.914211043775347,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4445,GO:0010420,1.00000000000047,0.914211043775347,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4642,GO:0010795,1.00000000000047,0.914211043775347,0,1,regulation of ubiquinone biosynthetic process,BP,
6941,GO:0030580,1.00000000000047,0.914211043775347,0,1,quinone cofactor methyltransferase activity,MF,
10918,GO:0044595,1.00000000000047,0.914211043775347,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
10919,GO:0044596,1.00000000000047,0.914211043775347,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
13138,GO:0051750,1.00000000000047,0.914211043775347,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
14315,GO:0061542,1.00000000000047,0.914211043775347,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
18867,GO:1904578,1.00000000000047,0.754062841478536,0,3,response to thapsigargin,BP,
18868,GO:1904579,1.00000000000047,0.754062841478536,0,3,cellular response to thapsigargin,BP,
16223,GO:0090306,1.00000000000049,0.661300053336811,0,4,spindle assembly involved in meiosis,BP,
15009,GO:0070981,1.0000000000005,0.901789811255489,0,1,L-asparagine biosynthetic process,BP,
15010,GO:0070982,1.0000000000005,0.901789811255489,0,1,L-asparagine metabolic process,BP,
12979,GO:0051430,1.0000000000005,0.815021373107178,0,2,corticotropin-releasing hormone receptor 1 binding,MF,
14962,GO:0070901,1.00000000000053,0.67769720309172,0,4,mitochondrial tRNA methylation,BP,
14782,GO:0070537,1.00000000000053,0.732356094557276,0,3,histone H2A K63-linked deubiquitination,BP,
9611,GO:0036496,1.00000000000054,0.820533110587114,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
16365,GO:0097010,1.00000000000054,0.732408593353282,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
244,GO:0000701,1.00000000000055,0.825665284563792,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
19022,GO:1904895,1.00000000000055,0.906850821082066,0,1,ESCRT complex assembly,BP,
19024,GO:1904902,1.00000000000055,0.906850821082066,0,1,ESCRT III complex assembly,BP,
15552,GO:0072047,1.00000000000056,0.671609365821655,0,4,proximal/distal pattern formation involved in nephron development,BP,
15573,GO:0072081,1.00000000000056,0.671609365821655,0,4,specification of nephron tubule identity,BP,
15574,GO:0072086,1.00000000000056,0.671609365821655,0,4,specification of loop of Henle identity,BP,
268,GO:0000741,1.00000000000057,0.90577084082729,0,1,karyogamy,BP,
3475,GO:0007344,1.00000000000057,0.90577084082729,0,1,pronuclear fusion,BP,
13132,GO:0051732,1.00000000000057,0.90577084082729,0,1,polyribonucleotide kinase activity,MF,
13135,GO:0051736,1.00000000000057,0.90577084082729,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
16487,GO:0097224,1.00000000000057,0.90577084082729,0,1,sperm connecting piece,CC,
407,GO:0001093,1.0000000000006,0.735354253541181,0,3,TFIIB-class transcription factor binding,MF,
423,GO:0001129,1.0000000000006,0.735354253541181,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
424,GO:0001132,1.0000000000006,0.735354253541181,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
2204,GO:0005093,1.00000000000061,0.812914309158405,0,2,Rab GDP-dissociation inhibitor activity,MF,
10812,GO:0044324,1.00000000000062,0.923197496592915,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
19666,GO:2000016,1.00000000000062,0.923197496592915,0,1,negative regulation of determination of dorsal identity,BP,
17929,GO:1902308,1.00000000000063,0.735259336160375,0,3,regulation of peptidyl-serine dephosphorylation,BP,
15901,GO:0072716,1.00000000000067,0.683296503217795,0,4,response to actinomycin D,BP,
18506,GO:1903722,1.00000000000069,0.83224387134365,0,2,regulation of centriole elongation,BP,
15349,GO:0071619,1.0000000000007,0.901945127349543,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20195,GO:2001163,1.0000000000007,0.901945127349543,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20196,GO:2001165,1.0000000000007,0.901945127349543,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
7236,GO:0031204,1.0000000000007,0.758477304373633,0,3,posttranslational protein targeting to membrane, translocation,BP,
9515,GO:0036265,1.0000000000007,0.696564776945862,0,4,RNA (guanine-N7)-methylation,BP,
13124,GO:0051722,1.00000000000074,0.901535142807323,0,1,protein C-terminal methylesterase activity,MF,
13125,GO:0051723,1.00000000000074,0.901535142807323,0,1,protein methylesterase activity,MF,
15041,GO:0071030,1.00000000000075,0.816874552010103,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
15053,GO:0071048,1.00000000000075,0.816874552010103,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
3843,GO:0008466,1.00000000000075,0.905068182670911,0,1,glycogenin glucosyltransferase activity,MF,
17137,GO:0102751,1.00000000000075,0.905068182670911,0,1,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
4492,GO:0010533,1.0000000000008,0.837722736229243,0,2,regulation of activation of Janus kinase activity,BP,
12110,GO:0048210,1.00000000000081,0.745596793426917,0,3,Golgi vesicle fusion to target membrane,BP,
5982,GO:0018963,1.00000000000087,0.814920055773952,0,2,phthalate metabolic process,BP,
17471,GO:1900477,1.00000000000091,0.902814271399503,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
8403,GO:0033484,1.00000000000091,0.748937528406393,0,3,nitric oxide homeostasis,BP,
18664,GO:1904044,1.00000000000092,0.755919959105862,0,3,response to aldosterone,BP,
19475,GO:1990357,1.00000000000095,0.741307818316264,0,3,terminal web,CC,
422,GO:0001128,1.00000000000096,0.912490034968423,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
5643,GO:0016748,1.00000000000097,0.812821196742812,0,2,succinyltransferase activity,MF,
8484,GO:0033677,1.00000000000097,0.732344626312595,0,3,DNA/RNA helicase activity,MF,
14254,GO:0061357,1.00000000000098,0.732507599877007,0,3,positive regulation of Wnt protein secretion,BP,
10130,GO:0042723,1.00000000000098,0.740167026699654,0,3,thiamine-containing compound metabolic process,BP,
1918,GO:0004616,1.000000000001,0.735974727701472,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
19404,GO:1990037,1.00000000000102,0.738818623608487,0,3,Lewy body core,CC,
15487,GO:0071894,1.00000000000105,0.813499568801202,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
18532,GO:1903775,1.00000000000105,0.813499568801202,0,2,regulation of DNA double-strand break processing,BP,
129,GO:0000270,1.00000000000105,0.916304619247476,0,1,peptidoglycan metabolic process,BP,
927,GO:0002325,1.00000000000105,0.916304619247476,0,1,natural killer cell differentiation involved in immune response,BP,
3953,GO:0008745,1.00000000000105,0.916304619247476,0,1,N-acetylmuramoyl-L-alanine amidase activity,MF,
4169,GO:0009253,1.00000000000105,0.916304619247476,0,1,peptidoglycan catabolic process,BP,
5300,GO:0016019,1.00000000000105,0.916304619247476,0,1,peptidoglycan receptor activity,MF,
8118,GO:0032824,1.00000000000105,0.916304619247476,0,1,negative regulation of natural killer cell differentiation,BP,
8120,GO:0032826,1.00000000000105,0.916304619247476,0,1,regulation of natural killer cell differentiation involved in immune response,BP,
8121,GO:0032827,1.00000000000105,0.916304619247476,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
13117,GO:0051710,1.00000000000105,0.916304619247476,0,1,regulation of cytolysis in other organism,BP,
13119,GO:0051714,1.00000000000105,0.916304619247476,0,1,positive regulation of cytolysis in other organism,BP,
6453,GO:0021784,1.00000000000105,0.929894879872161,0,1,postganglionic parasympathetic fiber development,BP,
15370,GO:0071650,1.00000000000107,0.739062138660822,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
7214,GO:0031120,1.00000000000108,0.711649902018784,0,4,snRNA pseudouridine synthesis,BP,
19058,GO:1904978,1.00000000000109,0.732905965406391,0,3,regulation of endosome organization,BP,
16899,GO:0098905,1.00000000000109,0.834179629680101,0,2,regulation of bundle of His cell action potential,BP,
4550,GO:0010641,1.0000000000011,0.660349474081814,0,4,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
12241,GO:0048549,1.0000000000011,0.660349474081814,0,4,positive regulation of pinocytosis,BP,
2805,GO:0006272,1.00000000000111,0.741506889161688,0,3,leading strand elongation,BP,
7677,GO:0032139,1.00000000000111,0.741506889161688,0,3,dinucleotide insertion or deletion binding,MF,
18175,GO:1902990,1.00000000000111,0.741506889161688,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
9193,GO:0035596,1.00000000000113,0.814070795449057,0,2,methylthiotransferase activity,MF,
9196,GO:0035600,1.00000000000113,0.814070795449057,0,2,tRNA methylthiolation,BP,
12467,GO:0050497,1.00000000000113,0.814070795449057,0,2,transferase activity, transferring alkylthio groups,MF,
8164,GO:0032914,1.00000000000114,0.734740033997143,0,3,positive regulation of transforming growth factor beta1 production,BP,
9870,GO:0042166,1.00000000000114,0.660378115273179,0,4,acetylcholine binding,MF,
13183,GO:0051852,1.00000000000115,0.679395945952513,0,4,disruption by host of symbiont cells,BP,
13188,GO:0051873,1.00000000000115,0.679395945952513,0,4,killing by host of symbiont cells,BP,
9070,GO:0035339,1.00000000000116,0.672433620407858,0,4,SPOTS complex,CC,
19355,GO:1905867,1.00000000000119,0.742869096218793,0,3,epididymis development,BP,
2232,GO:0005143,1.00000000000121,0.814316866577457,0,2,interleukin-12 receptor binding,MF,
10468,GO:0043382,1.00000000000121,0.814316866577457,0,2,positive regulation of memory T cell differentiation,BP,
19828,GO:2000328,1.00000000000121,0.814316866577457,0,2,regulation of T-helper 17 cell lineage commitment,BP,
15329,GO:0071586,1.00000000000121,0.820266557011951,0,2,CAAX-box protein processing,BP,
15946,GO:0080120,1.00000000000121,0.820266557011951,0,2,CAAX-box protein maturation,BP,
2589,GO:0005890,1.00000000000124,0.664590062901122,0,4,sodium:potassium-exchanging ATPase complex,CC,
3979,GO:0008853,1.00000000000124,0.737904743201389,0,3,exodeoxyribonuclease III activity,MF,
2957,GO:0006500,1.00000000000125,0.902499906973778,0,1,N-terminal protein palmitoylation,BP,
5869,GO:0018009,1.00000000000125,0.902499906973778,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
12008,GO:0047708,1.00000000000127,0.90290417764118,0,1,biotinidase activity,MF,
13765,GO:0060380,1.00000000000127,0.90290417764118,0,1,regulation of single-stranded telomeric DNA binding,BP,
13766,GO:0060381,1.00000000000127,0.90290417764118,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
9393,GO:0035971,1.0000000000013,0.915251779330319,0,1,peptidyl-histidine dephosphorylation,BP,
10638,GO:0043734,1.00000000000131,0.680554402619354,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
17634,GO:1901492,1.00000000000131,0.813753607710058,0,2,positive regulation of lymphangiogenesis,BP,
11182,GO:0045329,1.00000000000132,0.660304606006984,0,4,carnitine biosynthetic process,BP,
1754,GO:0004361,1.00000000000137,0.906219081414145,0,1,glutaryl-CoA dehydrogenase activity,MF,
2260,GO:0005183,1.00000000000137,0.906219081414145,0,1,gonadotropin hormone-releasing hormone activity,MF,
7417,GO:0031530,1.00000000000137,0.906219081414145,0,1,gonadotropin-releasing hormone receptor binding,MF,
19395,GO:1990008,1.00000000000137,0.906219081414145,0,1,neurosecretory vesicle,CC,
1188,GO:0002835,1.00000000000139,0.812859901163727,0,2,negative regulation of response to tumor cell,BP,
1191,GO:0002838,1.00000000000139,0.812859901163727,0,2,negative regulation of immune response to tumor cell,BP,
1196,GO:0002856,1.00000000000139,0.812859901163727,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1199,GO:0002859,1.00000000000139,0.812859901163727,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
7992,GO:0032632,1.00000000000139,0.812859901163727,0,2,interleukin-3 production,BP,
8016,GO:0032672,1.00000000000139,0.812859901163727,0,2,regulation of interleukin-3 production,BP,
17828,GO:1902044,1.00000000000139,0.812785176832327,0,2,regulation of Fas signaling pathway,BP,
18366,GO:1903416,1.0000000000014,0.735370238556119,0,3,response to glycoside,BP,
438,GO:0001179,1.00000000000142,0.904503917340614,0,1,RNA polymerase I transcription factor binding,MF,
14450,GO:0061851,1.00000000000143,0.901380830665128,0,1,leading edge of lamellipodium,CC,
18769,GO:1904328,1.00000000000143,0.901380830665128,0,1,regulation of myofibroblast contraction,BP,
19589,GO:1990764,1.00000000000143,0.901380830665128,0,1,myofibroblast contraction,BP,
4424,GO:0010269,1.00000000000144,0.754735207306945,0,3,response to selenium ion,BP,
13992,GO:0060743,1.00000000000146,0.90143972666658,0,1,epithelial cell maturation involved in prostate gland development,BP,
16956,GO:0099053,1.00000000000147,0.733723116080007,0,3,activating signal cointegrator 1 complex,CC,
2318,GO:0005332,1.00000000000147,0.903337280032704,0,1,gamma-aminobutyric acid:sodium symporter activity,MF,
5012,GO:0015185,1.00000000000147,0.903337280032704,0,1,gamma-aminobutyric acid transmembrane transporter activity,MF,
12212,GO:0048496,1.00000000000147,0.732535119864655,0,3,maintenance of animal organ identity,BP,
16493,GO:0097231,1.00000000000149,0.906166422774664,0,1,cell motility in response to calcium ion,BP,
19568,GO:1990716,1.00000000000149,0.906166422774664,0,1,axonemal central apparatus,CC,
4896,GO:0014839,1.0000000000015,0.824338120316042,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
4929,GO:0014900,1.0000000000015,0.665530357162296,0,4,muscle hyperplasia,BP,
3803,GO:0008404,1.00000000000155,0.904513802728863,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
3804,GO:0008405,1.00000000000155,0.904513802728863,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
15345,GO:0071614,1.00000000000155,0.904513802728863,0,1,linoleic acid epoxygenase activity,MF,
12115,GO:0048237,1.00000000000155,0.819892036565367,0,2,rough endoplasmic reticulum lumen,CC,
973,GO:0002424,1.00000000000155,0.81287422060248,0,2,T cell mediated immune response to tumor cell,BP,
1193,GO:0002840,1.00000000000155,0.81287422060248,0,2,regulation of T cell mediated immune response to tumor cell,BP,
11788,GO:0046696,1.00000000000155,0.81287422060248,0,2,lipopolysaccharide receptor complex,CC,
859,GO:0002192,1.00000000000156,0.838828190671954,0,2,IRES-dependent translational initiation of linear mRNA,BP,
17200,GO:0110017,1.00000000000156,0.838828190671954,0,2,cap-independent translational initiation of linear mRNA,BP,
16059,GO:0090065,1.00000000000157,0.943314670685908,0,1,regulation of production of siRNA involved in RNA interference,BP,
16789,GO:0098680,1.00000000000157,0.943314670685908,0,1,template-free RNA nucleotidyltransferase,MF,
18496,GO:1903704,1.00000000000157,0.943314670685908,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19535,GO:1990572,1.00000000000157,0.943314670685908,0,1,TERT-RMRP complex,CC,
2236,GO:0005151,1.00000000000158,0.816056161819465,0,2,interleukin-1, Type II receptor binding,MF,
16622,GO:0097524,1.00000000000158,0.660141188989488,0,4,sperm plasma membrane,CC,
11657,GO:0046462,1.00000000000158,0.816056161819463,0,2,monoacylglycerol metabolic process,BP,
13354,GO:0052651,1.00000000000158,0.816056161819463,0,2,monoacylglycerol catabolic process,BP,
9364,GO:0035912,1.00000000000159,0.660338654253763,0,4,dorsal aorta morphogenesis,BP,
12335,GO:0048733,1.00000000000159,0.660338654253763,0,4,sebaceous gland development,BP,
15848,GO:0072602,1.00000000000159,0.660338654253763,0,4,interleukin-4 secretion,BP,
14373,GO:0061656,1.00000000000159,0.915692187084759,0,1,SUMO conjugating enzyme activity,MF,
18260,GO:1903182,1.00000000000159,0.915692187084759,0,1,regulation of SUMO transferase activity,BP,
18519,GO:1903755,1.00000000000159,0.915692187084759,0,1,positive regulation of SUMO transferase activity,BP,
19474,GO:1990356,1.00000000000159,0.915692187084759,0,1,sumoylated E2 ligase complex,CC,
13848,GO:0060501,1.00000000000161,0.660801008084597,0,4,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
873,GO:0002225,1.00000000000161,0.823306332462972,0,2,positive regulation of antimicrobial peptide production,BP,
1152,GO:0002760,1.00000000000161,0.823306332462972,0,2,positive regulation of antimicrobial humoral response,BP,
1171,GO:0002803,1.00000000000161,0.823306332462972,0,2,positive regulation of antibacterial peptide production,BP,
11038,GO:0045054,1.00000000000163,0.737258034523217,0,3,constitutive secretory pathway,BP,
14799,GO:0070563,1.00000000000164,0.813676456351419,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
19542,GO:1990590,1.00000000000164,0.816943019341481,0,2,ATF1-ATF4 transcription factor complex,CC,
1600,GO:0004022,1.00000000000164,0.901394953797181,0,1,alcohol dehydrogenase (NAD) activity,MF,
5966,GO:0018467,1.00000000000164,0.901394953797181,0,1,formaldehyde dehydrogenase activity,MF,
13212,GO:0051903,1.00000000000164,0.901394953797181,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
20206,GO:2001180,1.00000000000166,0.815075832881258,0,2,negative regulation of interleukin-10 secretion,BP,
3844,GO:0008467,1.00000000000171,0.737492303153775,0,3,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
397,GO:0001074,1.00000000000172,0.901418340519408,0,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,
403,GO:0001084,1.00000000000172,0.901418340519408,0,1,transcription factor activity, TFIID-class binding,MF,
8419,GO:0033552,1.00000000000172,0.901418340519408,0,1,response to vitamin B3,BP,
355,GO:0000973,1.00000000000175,0.736256274203377,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
8271,GO:0033091,1.00000000000177,0.901417800700676,0,1,positive regulation of immature T cell proliferation,BP,
2741,GO:0006148,1.00000000000179,0.901607047348279,0,1,inosine catabolic process,BP,
3135,GO:0006738,1.00000000000179,0.901607047348279,0,1,nicotinamide riboside catabolic process,BP,
11681,GO:0046495,1.00000000000179,0.901607047348279,0,1,nicotinamide riboside metabolic process,BP,
14837,GO:0070637,1.00000000000179,0.901607047348279,0,1,pyridine nucleoside metabolic process,BP,
14838,GO:0070638,1.00000000000179,0.901607047348279,0,1,pyridine nucleoside catabolic process,BP,
10729,GO:0044126,1.00000000000179,0.667409341727365,0,4,regulation of growth of symbiont in host,BP,
10732,GO:0044144,1.00000000000179,0.667409341727365,0,4,modulation of growth of symbiont involved in interaction with host,BP,
19897,GO:2000434,1.00000000000181,0.857330231866813,0,2,regulation of protein neddylation,BP,
19898,GO:2000435,1.00000000000181,0.857330231866813,0,2,negative regulation of protein neddylation,BP,
13254,GO:0051969,1.00000000000182,0.66433360636547,0,4,regulation of transmission of nerve impulse,BP,
913,GO:0002302,1.00000000000185,0.901379654650983,0,1,CD8-positive, alpha-beta T cell differentiation involved in immune response,BP,
8458,GO:0033615,1.00000000000186,0.73725608983175,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
2639,GO:0005981,1.00000000000187,0.666422029759182,0,4,regulation of glycogen catabolic process,BP,
3661,GO:0008160,1.00000000000187,0.901405398929729,0,1,protein tyrosine phosphatase activator activity,MF,
10054,GO:0042567,1.00000000000187,0.901405398929729,0,1,insulin-like growth factor ternary complex,CC,
2070,GO:0004827,1.00000000000189,0.745656949556013,0,3,proline-tRNA ligase activity,MF,
2915,GO:0006433,1.00000000000189,0.745656949556013,0,3,prolyl-tRNA aminoacylation,BP,
2151,GO:0004977,1.00000000000193,0.815257093818788,0,2,melanocortin receptor activity,MF,
3852,GO:0008481,1.00000000000193,0.815257093818788,0,2,sphinganine kinase activity,MF,
5790,GO:0017050,1.00000000000193,0.815257093818788,0,2,D-erythro-sphingosine kinase activity,MF,
17998,GO:1902527,1.00000000000193,0.691580321668501,0,4,positive regulation of protein monoubiquitination,BP,
14990,GO:0070948,1.00000000000194,0.739689188842791,0,3,regulation of neutrophil mediated cytotoxicity,BP,
8647,GO:0034224,1.00000000000195,0.902027822654461,0,1,cellular response to zinc ion starvation,BP,
12426,GO:0050152,1.00000000000195,0.914011719578432,0,1,omega-amidase activity,MF,
16912,GO:0098920,1.00000000000197,0.901380433776019,0,1,retrograde trans-synaptic signaling by lipid,BP,
16913,GO:0098921,1.00000000000197,0.901380433776019,0,1,retrograde trans-synaptic signaling by endocannabinoid,BP,
7624,GO:0032044,1.00000000000198,0.819987790275542,0,2,DSIF complex,CC,
15853,GO:0072610,1.000000000002,0.662399113006851,0,4,interleukin-12 secretion,BP,
20208,GO:2001182,1.000000000002,0.662399113006851,0,4,regulation of interleukin-12 secretion,BP,
8439,GO:0033591,1.00000000000201,0.675401022622112,0,4,response to L-ascorbic acid,BP,
8998,GO:0035189,1.00000000000202,0.733043941204363,0,3,Rb-E2F complex,CC,
3963,GO:0008783,1.00000000000204,0.902218639999528,0,1,agmatinase activity,MF,
8399,GO:0033388,1.00000000000204,0.902218639999528,0,1,putrescine biosynthetic process from arginine,BP,
5219,GO:0015842,1.00000000000213,0.817362145362328,0,2,aminergic neurotransmitter loading into synaptic vesicle,BP,
16793,GO:0098700,1.00000000000213,0.817362145362328,0,2,neurotransmitter loading into synaptic vesicle,BP,
13533,GO:0060024,1.00000000000213,0.813668916749355,0,2,rhythmic synaptic transmission,BP,
13896,GO:0060584,1.00000000000213,0.813668916749355,0,2,regulation of prostaglandin-endoperoxide synthase activity,BP,
13897,GO:0060585,1.00000000000213,0.813668916749355,0,2,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
14545,GO:0070101,1.00000000000213,0.813668916749355,0,2,positive regulation of chemokine-mediated signaling pathway,BP,
19269,GO:1905550,1.00000000000213,0.824492042601929,0,2,regulation of protein localization to endoplasmic reticulum,BP,
19270,GO:1905552,1.00000000000213,0.824492042601929,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
10303,GO:0043111,1.00000000000214,0.823704697868559,0,2,replication fork arrest,BP,
2039,GO:0004790,1.00000000000214,0.901438297916159,0,1,thioether S-methyltransferase activity,MF,
7010,GO:0030748,1.00000000000214,0.901438297916159,0,1,amine N-methyltransferase activity,MF,
17136,GO:0102707,1.00000000000214,0.901438297916159,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
9896,GO:0042253,1.00000000000217,0.826557829699258,0,2,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12802,GO:0051133,1.00000000000217,0.826557829699258,0,2,regulation of NK T cell activation,BP,
12803,GO:0051135,1.00000000000217,0.826557829699258,0,2,positive regulation of NK T cell activation,BP,
14654,GO:0070294,1.00000000000219,0.661235552626635,0,4,renal sodium ion absorption,BP,
3950,GO:0008721,1.00000000000222,0.901510995040586,0,1,D-serine ammonia-lyase activity,MF,
5708,GO:0016855,1.00000000000222,0.901510995040586,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
5893,GO:0018114,1.00000000000222,0.901510995040586,0,1,threonine racemase activity,MF,
6870,GO:0030378,1.00000000000222,0.901510995040586,0,1,serine racemase activity,MF,
9550,GO:0036361,1.00000000000222,0.901510995040586,0,1,racemase activity, acting on amino acids and derivatives,MF,
11639,GO:0046416,1.00000000000222,0.901510995040586,0,1,D-amino acid metabolic process,BP,
11644,GO:0046437,1.00000000000222,0.901510995040586,0,1,D-amino acid biosynthetic process,BP,
12003,GO:0047661,1.00000000000222,0.901510995040586,0,1,amino-acid racemase activity,MF,
14587,GO:0070178,1.00000000000222,0.901510995040586,0,1,D-serine metabolic process,BP,
14588,GO:0070179,1.00000000000222,0.901510995040586,0,1,D-serine biosynthetic process,BP,
16155,GO:0090204,1.00000000000223,0.758108097139025,0,3,protein localization to nuclear pore,BP,
6071,GO:0019236,1.00000000000224,0.823234946938699,0,2,response to pheromone,BP,
17528,GO:1901097,1.00000000000228,0.66133379428549,0,4,negative regulation of autophagosome maturation,BP,
8826,GO:0034635,1.0000000000023,0.814202093032589,0,2,glutathione transport,BP,
10217,GO:0042939,1.0000000000023,0.814202093032589,0,2,tripeptide transport,BP,
10814,GO:0044326,1.0000000000023,0.814202093032589,0,2,dendritic spine neck,CC,
6101,GO:0019353,1.00000000000231,0.901381975986128,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
8415,GO:0033526,1.00000000000231,0.901381975986128,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
2788,GO:0006238,1.00000000000233,0.914659052884679,0,1,CMP salvage,BP,
4153,GO:0009224,1.00000000000233,0.914659052884679,0,1,CMP biosynthetic process,BP,
11498,GO:0046035,1.00000000000233,0.914659052884679,0,1,CMP metabolic process,BP,
15023,GO:0071001,1.00000000000234,0.752462972297896,0,3,U4/U6 snRNP,CC,
18935,GO:1904734,1.00000000000235,0.938013723233435,0,1,positive regulation of electron transfer activity,BP,
19051,GO:1904960,1.00000000000235,0.938013723233435,0,1,positive regulation of cytochrome-c oxidase activity,BP,
16320,GO:0090615,1.00000000000238,0.814799396610618,0,2,mitochondrial mRNA processing,BP,
9859,GO:0042138,1.00000000000238,0.901772206653577,0,1,meiotic DNA double-strand break formation,BP,
12187,GO:0048388,1.00000000000239,0.820788276141737,0,2,endosomal lumen acidification,BP,
1643,GO:0004090,1.00000000000242,0.710085997480887,0,4,carbonyl reductase (NADPH) activity,MF,
341,GO:0000942,1.00000000000242,0.662443241417902,0,4,condensed nuclear chromosome outer kinetochore,CC,
2221,GO:0005127,1.00000000000244,0.735417777666529,0,3,ciliary neurotrophic factor receptor binding,MF,
1511,GO:0003874,1.00000000000245,0.922508714322857,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
4234,GO:0009441,1.00000000000245,0.922508714322857,0,1,glycolate metabolic process,BP,
5946,GO:0018323,1.00000000000245,0.922508714322857,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
8672,GO:0034309,1.00000000000245,0.922508714322857,0,1,primary alcohol biosynthetic process,BP,
9590,GO:0036470,1.00000000000245,0.922508714322857,0,1,tyrosine 3-monooxygenase activator activity,MF,
9591,GO:0036471,1.00000000000245,0.922508714322857,0,1,cellular response to glyoxal,BP,
9597,GO:0036478,1.00000000000245,0.922508714322857,0,1,L-dopa decarboxylase activator activity,MF,
9632,GO:0036524,1.00000000000245,0.922508714322857,0,1,protein deglycase activity,MF,
9633,GO:0036525,1.00000000000245,0.922508714322857,0,1,protein deglycation,BP,
9634,GO:0036526,1.00000000000245,0.922508714322857,0,1,peptidyl-cysteine deglycation,BP,
9635,GO:0036527,1.00000000000245,0.922508714322857,0,1,peptidyl-arginine deglycation,BP,
9636,GO:0036528,1.00000000000245,0.922508714322857,0,1,peptidyl-lysine deglycation,BP,
9637,GO:0036529,1.00000000000245,0.922508714322857,0,1,protein deglycation, glyoxal removal,BP,
9638,GO:0036530,1.00000000000245,0.922508714322857,0,1,protein deglycation, methylglyoxal removal,BP,
9639,GO:0036531,1.00000000000245,0.922508714322857,0,1,glutathione deglycation,BP,
11189,GO:0045340,1.00000000000245,0.922508714322857,0,1,mercury ion binding,MF,
11590,GO:0046295,1.00000000000245,0.922508714322857,0,1,glycolate biosynthetic process,BP,
17174,GO:0106044,1.00000000000245,0.922508714322857,0,1,guanine deglycation,BP,
17175,GO:0106045,1.00000000000245,0.922508714322857,0,1,guanine deglycation, methylglyoxal removal,BP,
17176,GO:0106046,1.00000000000245,0.922508714322857,0,1,guanine deglycation, glyoxal removal,BP,
17259,GO:0140041,1.00000000000245,0.922508714322857,0,1,cellular detoxification of methylglyoxal,BP,
17711,GO:1901671,1.00000000000245,0.922508714322857,0,1,positive regulation of superoxide dismutase activity,BP,
18224,GO:1903072,1.00000000000245,0.922508714322857,0,1,regulation of death-inducing signaling complex assembly,BP,
18225,GO:1903073,1.00000000000245,0.922508714322857,0,1,negative regulation of death-inducing signaling complex assembly,BP,
18239,GO:1903122,1.00000000000245,0.922508714322857,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
18251,GO:1903167,1.00000000000245,0.922508714322857,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
18252,GO:1903168,1.00000000000245,0.922508714322857,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
18256,GO:1903176,1.00000000000245,0.922508714322857,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
18257,GO:1903178,1.00000000000245,0.922508714322857,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
18261,GO:1903184,1.00000000000245,0.922508714322857,0,1,L-dopa metabolic process,BP,
18262,GO:1903185,1.00000000000245,0.922508714322857,0,1,L-dopa biosynthetic process,BP,
18263,GO:1903189,1.00000000000245,0.922508714322857,0,1,glyoxal metabolic process,BP,
18264,GO:1903195,1.00000000000245,0.922508714322857,0,1,regulation of L-dopa biosynthetic process,BP,
18265,GO:1903197,1.00000000000245,0.922508714322857,0,1,positive regulation of L-dopa biosynthetic process,BP,
18266,GO:1903198,1.00000000000245,0.922508714322857,0,1,regulation of L-dopa decarboxylase activity,BP,
18267,GO:1903200,1.00000000000245,0.922508714322857,0,1,positive regulation of L-dopa decarboxylase activity,BP,
18985,GO:1904833,1.00000000000245,0.922508714322857,0,1,positive regulation of removal of superoxide radicals,BP,
19791,GO:2000277,1.00000000000245,0.922508714322857,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
19797,GO:2000284,1.00000000000245,0.922508714322857,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
13146,GO:0051771,1.00000000000245,0.750031705415226,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
11246,GO:0045569,1.00000000000246,0.670837341751473,0,4,TRAIL binding,MF,
2270,GO:0005219,1.00000000000248,0.921491366749832,0,1,ryanodine-sensitive calcium-release channel activity,MF,
4452,GO:0010454,1.00000000000248,0.73536779141195,0,3,negative regulation of cell fate commitment,BP,
16181,GO:0090244,1.00000000000248,0.73536779141195,0,3,Wnt signaling pathway involved in somitogenesis,BP,
3495,GO:0007406,1.00000000000249,0.6606972803416,0,4,negative regulation of neuroblast proliferation,BP,
1082,GO:0002666,1.00000000000249,0.670144254841755,0,4,positive regulation of T cell tolerance induction,BP,
10086,GO:0042613,1.00000000000254,0.762115227014793,0,3,MHC class II protein complex,CC,
15913,GO:0072749,1.00000000000255,0.90504615734515,0,1,cellular response to cytochalasin B,BP,
16911,GO:0098918,1.00000000000255,0.90504615734515,0,1,structural constituent of synapse,MF,
16935,GO:0098973,1.00000000000255,0.90504615734515,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
16936,GO:0098974,1.00000000000255,0.90504615734515,0,1,postsynaptic actin cytoskeleton organization,BP,
16997,GO:0099186,1.00000000000255,0.90504615734515,0,1,structural constituent of postsynapse,MF,
16998,GO:0099188,1.00000000000255,0.90504615734515,0,1,postsynaptic cytoskeleton organization,BP,
17597,GO:1901328,1.00000000000255,0.90504615734515,0,1,response to cytochalasin B,BP,
16310,GO:0090571,1.00000000000256,0.739424911329571,0,3,RNA polymerase II transcription repressor complex,CC,
6134,GO:0019418,1.00000000000257,0.701023735106357,0,4,sulfide oxidation,BP,
14614,GO:0070221,1.00000000000257,0.701023735106357,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
16182,GO:0090245,1.00000000000257,0.660119254995828,0,4,axis elongation involved in somitogenesis,BP,
3524,GO:0007518,1.00000000000257,0.901692737082027,0,1,myoblast fate determination,BP,
1648,GO:0004103,1.00000000000258,0.817821440376205,0,2,choline kinase activity,MF,
2591,GO:0005892,1.0000000000026,0.660377231231462,0,4,acetylcholine-gated channel complex,CC,
16928,GO:0098960,1.0000000000026,0.660377231231462,0,4,postsynaptic neurotransmitter receptor activity,MF,
17023,GO:0099529,1.0000000000026,0.660377231231462,0,4,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18763,GO:1904315,1.0000000000026,0.660377231231462,0,4,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
2563,GO:0005853,1.0000000000026,0.758543272288608,0,3,eukaryotic translation elongation factor 1 complex,CC,
15234,GO:0071435,1.00000000000262,0.732515090862895,0,3,potassium ion export,BP,
11103,GO:0045155,1.00000000000262,0.825168554333149,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
1831,GO:0004490,1.00000000000262,0.907981762778309,0,1,methylglutaconyl-CoA hydratase activity,MF,
12411,GO:0050011,1.00000000000262,0.907981762778309,0,1,itaconyl-CoA hydratase activity,MF,
9684,GO:0038101,1.00000000000268,0.905997824737803,0,1,sequestering of nodal from receptor via nodal binding,BP,
17354,GO:1900108,1.00000000000268,0.905997824737803,0,1,negative regulation of nodal signaling pathway,BP,
17381,GO:1900146,1.00000000000268,0.905997824737803,0,1,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17398,GO:1900176,1.00000000000268,0.905997824737803,0,1,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
14087,GO:0060971,1.00000000000269,0.735496108579557,0,3,embryonic heart tube left/right pattern formation,BP,
14705,GO:0070390,1.00000000000269,0.906205882338064,0,1,transcription export complex 2,CC,
7616,GO:0032027,1.0000000000027,0.735902759796327,0,3,myosin light chain binding,MF,
8727,GO:0034392,1.00000000000271,0.735616105078544,0,3,negative regulation of smooth muscle cell apoptotic process,BP,
11651,GO:0046452,1.00000000000272,0.747615997601898,0,3,dihydrofolate metabolic process,BP,
4398,GO:0010159,1.00000000000272,0.735552195495289,0,3,specification of animal organ position,BP,
9324,GO:0035844,1.00000000000272,0.735552195495289,0,3,cloaca development,BP,
13663,GO:0060235,1.00000000000272,0.735552195495289,0,3,lens induction in camera-type eye,BP,
13944,GO:0060681,1.00000000000272,0.735552195495289,0,3,branch elongation involved in ureteric bud branching,BP,
14192,GO:0061156,1.00000000000272,0.735552195495289,0,3,pulmonary artery morphogenesis,BP,
14211,GO:0061209,1.00000000000272,0.735552195495289,0,3,cell proliferation involved in mesonephros development,BP,
15588,GO:0072102,1.00000000000272,0.735552195495289,0,3,glomerulus morphogenesis,BP,
15600,GO:0072125,1.00000000000272,0.735552195495289,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16146,GO:0090194,1.00000000000272,0.735552195495289,0,3,negative regulation of glomerulus development,BP,
19171,GO:1905292,1.00000000000272,0.735552195495289,0,3,regulation of neural crest cell differentiation,BP,
19172,GO:1905294,1.00000000000272,0.735552195495289,0,3,positive regulation of neural crest cell differentiation,BP,
19178,GO:1905310,1.00000000000272,0.735552195495289,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
19179,GO:1905312,1.00000000000272,0.735552195495289,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
15028,GO:0071008,1.00000000000273,0.670609881032856,0,4,U2-type post-mRNA release spliceosomal complex,CC,
16211,GO:0090289,1.00000000000273,0.828976590904665,0,2,regulation of osteoclast proliferation,BP,
8576,GO:0034092,1.00000000000274,0.750584499060707,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
8626,GO:0034183,1.00000000000274,0.750584499060707,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
11734,GO:0046604,1.00000000000274,0.750584499060707,0,3,positive regulation of mitotic centrosome separation,BP,
14822,GO:0070602,1.00000000000274,0.750584499060707,0,3,regulation of centromeric sister chromatid cohesion,BP,
752,GO:0001993,1.00000000000275,0.664844870803368,0,4,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
754,GO:0001996,1.00000000000277,0.736226163014305,0,3,positive regulation of heart rate by epinephrine-norepinephrine,BP,
1395,GO:0003321,1.00000000000277,0.736226163014305,0,3,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
9345,GO:0035877,1.00000000000279,0.670103459356324,0,4,death effector domain binding,MF,
19536,GO:1990573,1.0000000000028,0.734727690575749,0,3,potassium ion import across plasma membrane,BP,
14595,GO:0070189,1.0000000000028,0.669545817806694,0,4,kynurenine metabolic process,BP,
1752,GO:0004359,1.00000000000281,0.732496710090327,0,3,glutaminase activity,MF,
6611,GO:0022848,1.00000000000283,0.732651235092134,0,3,acetylcholine-gated cation-selective channel activity,MF,
18826,GO:1904468,1.00000000000283,0.73402989949744,0,3,negative regulation of tumor necrosis factor secretion,BP,
111,GO:0000229,1.00000000000285,0.907918354733571,0,1,cytoplasmic chromosome,CC,
126,GO:0000262,1.00000000000285,0.907918354733571,0,1,mitochondrial chromosome,CC,
8386,GO:0033341,1.00000000000286,0.812552174327983,0,2,regulation of collagen binding,BP,
16864,GO:0098837,1.00000000000286,0.735223352453783,0,3,postsynaptic recycling endosome,CC,
4866,GO:0014738,1.00000000000295,0.732456522964121,0,3,regulation of muscle hyperplasia,BP,
14862,GO:0070678,1.00000000000296,0.901386185305418,0,1,preprotein binding,MF,
953,GO:0002373,1.00000000000297,0.922371960709275,0,1,plasmacytoid dendritic cell cytokine production,BP,
1141,GO:0002736,1.00000000000297,0.922371960709275,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1142,GO:0002737,1.00000000000297,0.922371960709275,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
17569,GO:1901253,1.00000000000297,0.922371960709275,0,1,negative regulation of intracellular transport of viral material,BP,
14215,GO:0061218,1.00000000000301,0.736782914253843,0,3,negative regulation of mesonephros development,BP,
3072,GO:0006651,1.00000000000303,0.83044866289835,0,2,diacylglycerol biosynthetic process,BP,
3778,GO:0008352,1.00000000000303,0.901390534825874,0,1,katanin complex,CC,
1890,GO:0004577,1.00000000000304,0.828581778571172,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
7635,GO:0032058,1.00000000000306,0.660305019611725,0,4,positive regulation of translational initiation in response to stress,BP,
6993,GO:0030689,1.00000000000307,0.737063511192139,0,3,Noc complex,CC,
9375,GO:0035930,1.00000000000308,0.678793329886157,0,4,corticosteroid hormone secretion,BP,
20116,GO:2000846,1.00000000000308,0.678793329886157,0,4,regulation of corticosteroid hormone secretion,BP,
11926,GO:0047025,1.00000000000309,0.830064024925879,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
3962,GO:0008781,1.0000000000031,0.828633628080085,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
9348,GO:0035880,1.0000000000031,0.813210495606659,0,2,embryonic nail plate morphogenesis,BP,
17774,GO:1901894,1.00000000000313,0.739674277564522,0,3,regulation of calcium-transporting ATPase activity,BP,
19648,GO:1990966,1.00000000000314,0.670456294172107,0,4,ATP generation from poly-ADP-D-ribose,BP,
6369,GO:0021564,1.00000000000316,0.819229283223462,0,2,vagus nerve development,BP,
9398,GO:0035981,1.00000000000316,0.819229283223462,0,2,tongue muscle cell differentiation,BP,
18099,GO:1902811,1.00000000000316,0.819229283223462,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
20160,GO:2001035,1.00000000000316,0.819229283223462,0,2,regulation of tongue muscle cell differentiation,BP,
20161,GO:2001037,1.00000000000316,0.819229283223462,0,2,positive regulation of tongue muscle cell differentiation,BP,
8231,GO:0033018,1.00000000000316,0.814838752623376,0,2,sarcoplasmic reticulum lumen,CC,
1294,GO:0003129,1.00000000000317,0.738600189367764,0,3,heart induction,BP,
4238,GO:0009447,1.00000000000319,0.766623814530456,0,3,putrescine catabolic process,BP,
14917,GO:0070836,1.00000000000319,0.733349315033083,0,3,caveola assembly,BP,
3635,GO:0008113,1.0000000000032,0.830405328514244,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
1392,GO:0003308,1.00000000000321,0.815841154207844,0,2,negative regulation of Wnt signaling pathway involved in heart development,BP,
4365,GO:0009996,1.00000000000321,0.815841154207844,0,2,negative regulation of cell fate specification,BP,
118,GO:0000247,1.00000000000323,0.916783281501951,0,1,C-8 sterol isomerase activity,MF,
2026,GO:0004769,1.00000000000323,0.916783281501951,0,1,steroid delta-isomerase activity,MF,
10068,GO:0042586,1.00000000000323,0.916783281501951,0,1,peptide deformylase activity,MF,
4726,GO:0010900,1.00000000000326,0.936746615412169,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
3578,GO:0007634,1.00000000000329,0.901563545328194,0,1,optokinetic behavior,BP,
14049,GO:0060876,1.00000000000329,0.901563545328194,0,1,semicircular canal formation,BP,
51,GO:0000105,1.0000000000033,0.812777081222721,0,2,histidine biosynthetic process,BP,
9506,GO:0036228,1.0000000000033,0.812777081222721,0,2,protein localization to nuclear inner membrane,BP,
3831,GO:0008448,1.0000000000033,0.904762575738195,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
16677,GO:0097680,1.0000000000033,0.733224718718013,0,3,double-strand break repair via classical nonhomologous end joining,BP,
457,GO:0001306,1.0000000000033,0.920100099201142,0,1,age-dependent response to oxidative stress,BP,
458,GO:0001315,1.0000000000033,0.920100099201142,0,1,age-dependent response to reactive oxygen species,BP,
1272,GO:0003068,1.0000000000033,0.920100099201142,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1273,GO:0003069,1.0000000000033,0.920100099201142,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1274,GO:0003070,1.0000000000033,0.920100099201142,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
3540,GO:0007571,1.0000000000033,0.920100099201142,0,1,age-dependent general metabolic decline,BP,
18990,GO:1904844,1.00000000000331,0.838847606314445,0,2,response to L-glutamine,BP,
18991,GO:1904845,1.00000000000331,0.838847606314445,0,2,cellular response to L-glutamine,BP,
19407,GO:1990047,1.00000000000332,0.901924841910795,0,1,spindle matrix,CC,
8080,GO:0032777,1.00000000000332,0.664183099306708,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
951,GO:0002370,1.00000000000333,0.745822428204553,0,3,natural killer cell cytokine production,BP,
1135,GO:0002727,1.00000000000333,0.745822428204553,0,3,regulation of natural killer cell cytokine production,BP,
14538,GO:0070094,1.00000000000335,0.901421112903009,0,1,positive regulation of glucagon secretion,BP,
2083,GO:0004850,1.00000000000338,0.90502422018843,0,1,uridine phosphorylase activity,MF,
2778,GO:0006218,1.00000000000338,0.90502422018843,0,1,uridine catabolic process,BP,
11541,GO:0046108,1.00000000000338,0.90502422018843,0,1,uridine metabolic process,BP,
19938,GO:2000542,1.00000000000339,0.662826016728272,0,4,negative regulation of gastrulation,BP,
18641,GO:1903998,1.00000000000339,0.75222661182503,0,3,regulation of eating behavior,BP,
4439,GO:0010370,1.00000000000341,0.814138705544633,0,2,perinucleolar chromocenter,CC,
1738,GO:0004342,1.00000000000342,0.815260974180888,0,2,glucosamine-6-phosphate deaminase activity,MF,
2673,GO:0006043,1.00000000000342,0.815260974180888,0,2,glucosamine catabolic process,BP,
12511,GO:0050682,1.00000000000343,0.813077800771484,0,2,AF-2 domain binding,MF,
6886,GO:0030432,1.00000000000344,0.838181183418306,0,2,peristalsis,BP,
5998,GO:0019049,1.00000000000344,0.660700295686346,0,4,evasion or tolerance of host defenses by virus,BP,
10857,GO:0044413,1.00000000000344,0.660700295686346,0,4,avoidance of host defenses,BP,
10859,GO:0044415,1.00000000000344,0.660700295686346,0,4,evasion or tolerance of host defenses,BP,
13177,GO:0051832,1.00000000000344,0.660700295686346,0,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,
13179,GO:0051834,1.00000000000344,0.660700295686346,0,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
12188,GO:0048389,1.00000000000345,0.90533942973707,0,1,intermediate mesoderm development,BP,
12189,GO:0048390,1.00000000000345,0.90533942973707,0,1,intermediate mesoderm morphogenesis,BP,
12190,GO:0048391,1.00000000000345,0.90533942973707,0,1,intermediate mesoderm formation,BP,
12191,GO:0048392,1.00000000000345,0.90533942973707,0,1,intermediate mesodermal cell differentiation,BP,
13454,GO:0055018,1.00000000000345,0.90533942973707,0,1,regulation of cardiac muscle fiber development,BP,
13455,GO:0055020,1.00000000000345,0.90533942973707,0,1,positive regulation of cardiac muscle fiber development,BP,
13850,GO:0060503,1.00000000000345,0.90533942973707,0,1,bud dilation involved in lung branching,BP,
14185,GO:0061149,1.00000000000345,0.90533942973707,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
14186,GO:0061150,1.00000000000345,0.90533942973707,0,1,renal system segmentation,BP,
14187,GO:0061151,1.00000000000345,0.90533942973707,0,1,BMP signaling pathway involved in renal system segmentation,BP,
14191,GO:0061155,1.00000000000345,0.90533942973707,0,1,pulmonary artery endothelial tube morphogenesis,BP,
14213,GO:0061216,1.00000000000345,0.90533942973707,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
14216,GO:0061227,1.00000000000345,0.90533942973707,0,1,pattern specification involved in mesonephros development,BP,
15486,GO:0071893,1.00000000000345,0.90533942973707,0,1,BMP signaling pathway involved in nephric duct formation,BP,
15582,GO:0072096,1.00000000000345,0.90533942973707,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
15583,GO:0072097,1.00000000000345,0.90533942973707,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
15584,GO:0072098,1.00000000000345,0.90533942973707,0,1,anterior/posterior pattern specification involved in kidney development,BP,
15585,GO:0072099,1.00000000000345,0.90533942973707,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
15586,GO:0072100,1.00000000000345,0.90533942973707,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
15587,GO:0072101,1.00000000000345,0.90533942973707,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
15643,GO:0072192,1.00000000000345,0.90533942973707,0,1,ureter epithelial cell differentiation,BP,
15647,GO:0072198,1.00000000000345,0.90533942973707,0,1,mesenchymal cell proliferation involved in ureter development,BP,
15648,GO:0072199,1.00000000000345,0.90533942973707,0,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,
15649,GO:0072200,1.00000000000345,0.90533942973707,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
17790,GO:1901964,1.00000000000345,0.90533942973707,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19657,GO:2000004,1.00000000000345,0.90533942973707,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
19658,GO:2000005,1.00000000000345,0.90533942973707,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
19659,GO:2000006,1.00000000000345,0.90533942973707,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
19660,GO:2000007,1.00000000000345,0.90533942973707,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
13941,GO:0060676,1.00000000000345,0.683145576878335,0,4,ureteric bud formation,BP,
15628,GO:0072172,1.00000000000345,0.683145576878335,0,4,mesonephric tubule formation,BP,
4583,GO:0010701,1.00000000000345,0.813621898069165,0,2,positive regulation of norepinephrine secretion,BP,
19586,GO:1990758,1.00000000000345,0.904778221512397,0,1,mitotic sister chromatid biorientation,BP,
10632,GO:0043686,1.00000000000346,0.744951773648164,0,3,co-translational protein modification,BP,
6939,GO:0030578,1.00000000000346,0.666707693004098,0,4,PML body organization,BP,
9810,GO:0042045,1.00000000000347,0.661071142731172,0,4,epithelial fluid transport,BP,
790,GO:0002055,1.00000000000348,0.928089157148812,0,1,adenine binding,MF,
1585,GO:0003999,1.00000000000348,0.928089157148812,0,1,adenine phosphoribosyltransferase activity,MF,
19305,GO:1905651,1.00000000000351,0.73234481052728,0,3,regulation of artery morphogenesis,BP,
19306,GO:1905653,1.00000000000351,0.73234481052728,0,3,positive regulation of artery morphogenesis,BP,
892,GO:0002266,1.00000000000352,0.815239477937615,0,2,follicular dendritic cell activation,BP,
893,GO:0002268,1.00000000000352,0.815239477937615,0,2,follicular dendritic cell differentiation,BP,
8351,GO:0033257,1.00000000000352,0.815239477937615,0,2,Bcl3/NF-kappaB2 complex,CC,
9828,GO:0042091,1.00000000000352,0.815239477937615,0,2,interleukin-10 biosynthetic process,BP,
11055,GO:0045074,1.00000000000352,0.815239477937615,0,2,regulation of interleukin-10 biosynthetic process,BP,
9121,GO:0035470,1.00000000000354,0.905073702799996,0,1,positive regulation of vascular wound healing,BP,
13952,GO:0060690,1.00000000000354,0.905073702799996,0,1,epithelial cell differentiation involved in salivary gland development,BP,
13953,GO:0060691,1.00000000000354,0.905073702799996,0,1,epithelial cell maturation involved in salivary gland development,BP,
17346,GO:1900098,1.00000000000354,0.905073702799996,0,1,regulation of plasma cell differentiation,BP,
17347,GO:1900100,1.00000000000354,0.905073702799996,0,1,positive regulation of plasma cell differentiation,BP,
18396,GO:1903489,1.00000000000354,0.905073702799996,0,1,positive regulation of lactation,BP,
7501,GO:0031698,1.00000000000356,0.663567936501803,0,4,beta-2 adrenergic receptor binding,MF,
11717,GO:0046573,1.00000000000358,0.907243738322274,0,1,lactonohydrolase activity,MF,
17090,GO:0102007,1.00000000000358,0.907243738322274,0,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
9644,GO:0038016,1.00000000000358,0.812869408698604,0,2,insulin receptor internalization,BP,
5971,GO:0018738,1.00000000000359,0.915809090897684,0,1,S-formylglutathione hydrolase activity,MF,
517,GO:0001588,1.00000000000359,0.836853155770279,0,2,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
2136,GO:0004952,1.00000000000359,0.836853155770279,0,2,dopamine neurotransmitter receptor activity,MF,
12261,GO:0048597,1.0000000000036,0.763157588807357,0,3,post-embryonic camera-type eye morphogenesis,BP,
10124,GO:0042709,1.00000000000365,0.901722418090455,0,1,succinate-CoA ligase complex,CC,
11154,GO:0045244,1.00000000000365,0.901722418090455,0,1,succinate-CoA ligase complex (GDP-forming),CC,
17829,GO:1902045,1.00000000000365,0.901722418090455,0,1,negative regulation of Fas signaling pathway,BP,
19924,GO:2000504,1.00000000000365,0.901722418090455,0,1,positive regulation of blood vessel remodeling,BP,
10470,GO:0043385,1.00000000000365,0.901379407961549,0,1,mycotoxin metabolic process,BP,
10471,GO:0043387,1.00000000000365,0.901379407961549,0,1,mycotoxin catabolic process,BP,
11584,GO:0046222,1.00000000000365,0.901379407961549,0,1,aflatoxin metabolic process,BP,
11585,GO:0046223,1.00000000000365,0.901379407961549,0,1,aflatoxin catabolic process,BP,
17615,GO:1901376,1.00000000000365,0.901379407961549,0,1,organic heteropentacyclic compound metabolic process,BP,
17616,GO:1901377,1.00000000000365,0.901379407961549,0,1,organic heteropentacyclic compound catabolic process,BP,
18536,GO:1903786,1.00000000000365,0.901379407961549,0,1,regulation of glutathione biosynthetic process,BP,
18537,GO:1903788,1.00000000000365,0.901379407961549,0,1,positive regulation of glutathione biosynthetic process,BP,
3111,GO:0006696,1.00000000000367,0.814616373473052,0,2,ergosterol biosynthetic process,BP,
3690,GO:0008204,1.00000000000367,0.814616373473052,0,2,ergosterol metabolic process,BP,
3680,GO:0008192,1.00000000000368,0.742067811679051,0,3,RNA guanylyltransferase activity,MF,
7356,GO:0031415,1.00000000000369,0.679119138559254,0,4,NatA complex,CC,
376,GO:0001007,1.00000000000371,0.661650893125791,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
2453,GO:0005672,1.00000000000372,0.681903205201466,0,4,transcription factor TFIIA complex,CC,
20211,GO:2001185,1.00000000000373,0.665703599641725,0,4,regulation of CD8-positive, alpha-beta T cell activation,BP,
5359,GO:0016174,1.00000000000377,0.661125630986378,0,4,NAD(P)H oxidase activity,MF,
15343,GO:0071611,1.00000000000377,0.81286319973416,0,2,granulocyte colony-stimulating factor production,BP,
15372,GO:0071655,1.00000000000377,0.81286319973416,0,2,regulation of granulocyte colony-stimulating factor production,BP,
6820,GO:0030294,1.00000000000378,0.902176246635466,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
4008,GO:0009020,1.00000000000381,0.903632862310261,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
13362,GO:0052666,1.00000000000381,0.903632862310261,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
17178,GO:0106050,1.00000000000381,0.903632862310261,0,1,tRNA 2'-O-methyltransferase activity,MF,
17752,GO:1901837,1.00000000000381,0.815604711970752,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
744,GO:0001976,1.00000000000382,0.674481860246519,0,4,neurological system process involved in regulation of systemic arterial blood pressure,BP,
16675,GO:0097676,1.00000000000383,0.733171972654245,0,3,histone H3-K36 dimethylation,BP,
6965,GO:0030643,1.00000000000383,0.661494142125142,0,4,cellular phosphate ion homeostasis,BP,
15778,GO:0072501,1.00000000000383,0.661494142125142,0,4,cellular divalent inorganic anion homeostasis,BP,
15779,GO:0072502,1.00000000000383,0.661494142125142,0,4,cellular trivalent inorganic anion homeostasis,BP,
17520,GO:1901077,1.00000000000383,0.661494142125142,0,4,regulation of relaxation of muscle,BP,
16504,GO:0097267,1.00000000000385,0.660112788709278,0,4,omega-hydroxylase P450 pathway,BP,
15163,GO:0071332,1.00000000000385,0.815818830236113,0,2,cellular response to fructose stimulus,BP,
11716,GO:0046570,1.00000000000389,0.914344715288828,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
15095,GO:0071211,1.00000000000389,0.661343437746403,0,4,protein targeting to vacuole involved in autophagy,BP,
6948,GO:0030613,1.00000000000389,0.778206028225565,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
6949,GO:0030614,1.00000000000389,0.778206028225565,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
5799,GO:0017064,1.0000000000039,0.902661481059726,0,1,fatty acid amide hydrolase activity,MF,
17093,GO:0102077,1.0000000000039,0.902661481059726,0,1,oleamide hydrolase activity,MF,
17157,GO:0103073,1.0000000000039,0.902661481059726,0,1,anandamide amidohydrolase activity,MF,
19710,GO:2000110,1.00000000000391,0.745258488335634,0,3,negative regulation of macrophage apoptotic process,BP,
15448,GO:0071819,1.00000000000392,0.841250216546074,0,2,DUBm complex,CC,
12631,GO:0050861,1.00000000000392,0.661314656336967,0,4,positive regulation of B cell receptor signaling pathway,BP,
4942,GO:0015015,1.00000000000393,0.661367764692473,0,4,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
2020,GO:0004756,1.00000000000393,0.813050235431051,0,2,selenide, water dikinase activity,MF,
5404,GO:0016260,1.00000000000393,0.813050235431051,0,2,selenocysteine biosynthetic process,BP,
5661,GO:0016781,1.00000000000393,0.813050235431051,0,2,phosphotransferase activity, paired acceptors,MF,
14677,GO:0070329,1.00000000000393,0.813050235431051,0,2,tRNA seleno-modification,BP,
8272,GO:0033093,1.00000000000394,0.661060894301639,0,4,Weibel-Palade body,CC,
11195,GO:0045347,1.00000000000394,0.737221211299179,0,3,negative regulation of MHC class II biosynthetic process,BP,
7969,GO:0032595,1.00000000000394,0.902312281632928,0,1,B cell receptor transport within lipid bilayer,BP,
7971,GO:0032597,1.00000000000394,0.902312281632928,0,1,B cell receptor transport into membrane raft,BP,
7972,GO:0032599,1.00000000000394,0.902312281632928,0,1,protein transport out of membrane raft,BP,
7973,GO:0032600,1.00000000000394,0.902312281632928,0,1,chemokine receptor transport out of membrane raft,BP,
8163,GO:0032913,1.00000000000394,0.902312281632928,0,1,negative regulation of transforming growth factor beta3 production,BP,
8453,GO:0033606,1.00000000000394,0.902312281632928,0,1,chemokine receptor transport within lipid bilayer,BP,
15614,GO:0072139,1.00000000000394,0.902312281632928,0,1,glomerular parietal epithelial cell differentiation,BP,
20071,GO:2000768,1.00000000000394,0.902312281632928,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
9150,GO:0035521,1.00000000000396,0.660114475661995,0,4,monoubiquitinated histone deubiquitination,BP,
9151,GO:0035522,1.00000000000396,0.660114475661995,0,4,monoubiquitinated histone H2A deubiquitination,BP,
19863,GO:2000381,1.00000000000396,0.66622407077059,0,4,negative regulation of mesoderm development,BP,
19083,GO:1905041,1.00000000000396,0.813080985742669,0,2,regulation of epithelium regeneration,BP,
19464,GO:1990264,1.00000000000396,0.813080985742669,0,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
19484,GO:1990399,1.00000000000396,0.813080985742669,0,2,epithelium regeneration,BP,
16143,GO:0090191,1.000000000004,0.817411003480571,0,2,negative regulation of branching involved in ureteric bud morphogenesis,BP,
16565,GO:0097411,1.00000000000401,0.671006868067943,0,4,hypoxia-inducible factor-1alpha signaling pathway,BP,
16759,GO:0098619,1.00000000000401,0.904125374482668,0,1,selenocysteine-tRNA ligase activity,MF,
270,GO:0000773,1.00000000000401,0.920890309313475,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
1911,GO:0004608,1.00000000000401,0.920890309313475,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
11927,GO:0047035,1.00000000000401,0.920890309313475,0,1,testosterone dehydrogenase (NAD+) activity,MF,
15944,GO:0080101,1.00000000000401,0.920890309313475,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
6956,GO:0030622,1.00000000000405,0.733036467484791,0,3,U4atac snRNA binding,MF,
3825,GO:0008440,1.00000000000406,0.662900006963151,0,4,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
5231,GO:0015864,1.00000000000406,0.813508336453514,0,2,pyrimidine nucleoside transport,BP,
6478,GO:0021840,1.00000000000409,0.901668840901205,0,1,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6479,GO:0021842,1.00000000000409,0.901668840901205,0,1,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6323,GO:0021501,1.0000000000041,0.902767801227024,0,1,prechordal plate formation,BP,
6356,GO:0021547,1.0000000000041,0.902767801227024,0,1,midbrain-hindbrain boundary initiation,BP,
20057,GO:2000742,1.0000000000041,0.902767801227024,0,1,regulation of anterior head development,BP,
20058,GO:2000744,1.0000000000041,0.902767801227024,0,1,positive regulation of anterior head development,BP,
5905,GO:0018171,1.00000000000411,0.686762797463098,0,4,peptidyl-cysteine oxidation,BP,
14158,GO:0061086,1.00000000000412,0.662339796269636,0,4,negative regulation of histone H3-K27 methylation,BP,
3767,GO:0008330,1.00000000000412,0.665827293834979,0,4,protein tyrosine/threonine phosphatase activity,MF,
6485,GO:0021855,1.00000000000413,0.733003411521779,0,3,hypothalamus cell migration,BP,
1709,GO:0004304,1.00000000000414,0.90535101242032,0,1,estrone sulfotransferase activity,MF,
3079,GO:0006660,1.00000000000414,0.90535101242032,0,1,phosphatidylserine catabolic process,BP,
3122,GO:0006711,1.00000000000414,0.90535101242032,0,1,estrogen catabolic process,BP,
11200,GO:0045352,1.00000000000414,0.90535101242032,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11201,GO:0045353,1.00000000000414,0.90535101242032,0,1,interleukin-1 Type II receptor antagonist activity,MF,
14985,GO:0070942,1.00000000000417,0.67062456038034,0,4,neutrophil mediated cytotoxicity,BP,
7451,GO:0031620,1.00000000000417,0.738945656120803,0,3,regulation of fever generation,BP,
7452,GO:0031622,1.00000000000417,0.738945656120803,0,3,positive regulation of fever generation,BP,
1438,GO:0003419,1.00000000000418,0.812565855893258,0,2,growth plate cartilage chondrocyte proliferation,BP,
1439,GO:0003420,1.00000000000418,0.812565855893258,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
16044,GO:0090031,1.00000000000418,0.812565855893258,0,2,positive regulation of steroid hormone biosynthetic process,BP,
5837,GO:0017143,1.00000000000418,0.812511457245691,0,2,insecticide metabolic process,BP,
11027,GO:0045027,1.00000000000418,0.902683396056102,0,1,DNA end binding,MF,
1553,GO:0003955,1.00000000000418,0.745229095130313,0,3,NAD(P)H dehydrogenase (quinone) activity,MF,
19071,GO:1905006,1.00000000000419,0.81505899391083,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
999,GO:0002468,1.00000000000419,0.668739853232411,0,4,dendritic cell antigen processing and presentation,BP,
1063,GO:0002604,1.00000000000419,0.668739853232411,0,4,regulation of dendritic cell antigen processing and presentation,BP,
17823,GO:1902037,1.0000000000042,0.73234408882292,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
11948,GO:0047220,1.0000000000042,0.901378046359826,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
2580,GO:0005880,1.00000000000422,0.91027141607587,0,1,nuclear microtubule,CC,
7543,GO:0031871,1.00000000000423,0.735147406454223,0,3,proteinase activated receptor binding,MF,
1716,GO:0004311,1.00000000000424,0.733362872927999,0,3,farnesyltranstransferase activity,MF,
9415,GO:0036004,1.00000000000424,0.914953969868564,0,1,GAF domain binding,MF,
17067,GO:0099631,1.00000000000425,0.840364605032709,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
11949,GO:0047223,1.00000000000428,0.732431487544025,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
146,GO:0000301,1.00000000000429,0.732333126338014,0,3,retrograde transport, vesicle recycling within Golgi,BP,
721,GO:0001951,1.00000000000429,0.732333126338014,0,3,intestinal D-glucose absorption,BP,
855,GO:0002188,1.00000000000429,0.732333126338014,0,3,translation reinitiation,BP,
1376,GO:0003274,1.00000000000429,0.732333126338014,0,3,endocardial cushion fusion,BP,
1383,GO:0003289,1.00000000000429,0.732333126338014,0,3,atrial septum primum morphogenesis,BP,
1688,GO:0004165,1.00000000000429,0.732333126338014,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
2015,GO:0004748,1.00000000000429,0.732333126338014,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2124,GO:0004924,1.00000000000429,0.732333126338014,0,3,oncostatin-M receptor activity,MF,
2175,GO:0005025,1.00000000000429,0.732333126338014,0,3,transforming growth factor beta receptor activity, type I,MF,
2575,GO:0005873,1.00000000000429,0.732333126338014,0,3,plus-end kinesin complex,CC,
2632,GO:0005971,1.00000000000429,0.732333126338014,0,3,ribonucleoside-diphosphate reductase complex,CC,
2702,GO:0006083,1.00000000000429,0.732333126338014,0,3,acetate metabolic process,BP,
3201,GO:0006848,1.00000000000429,0.732333126338014,0,3,pyruvate transport,BP,
3343,GO:0007079,1.00000000000429,0.732333126338014,0,3,mitotic chromosome movement towards spindle pole,BP,
3848,GO:0008475,1.00000000000429,0.732333126338014,0,3,procollagen-lysine 5-dioxygenase activity,MF,
3983,GO:0008889,1.00000000000429,0.732333126338014,0,3,glycerophosphodiester phosphodiesterase activity,MF,
3993,GO:0008940,1.00000000000429,0.732333126338014,0,3,nitrate reductase activity,MF,
4161,GO:0009236,1.00000000000429,0.732333126338014,0,3,cobalamin biosynthetic process,BP,
4552,GO:0010643,1.00000000000429,0.732333126338014,0,3,cell communication by chemical coupling,BP,
4731,GO:0010908,1.00000000000429,0.732333126338014,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4732,GO:0010909,1.00000000000429,0.732333126338014,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4872,GO:0014744,1.00000000000429,0.732333126338014,0,3,positive regulation of muscle adaptation,BP,
5160,GO:0015722,1.00000000000429,0.732333126338014,0,3,canalicular bile acid transport,BP,
5427,GO:0016300,1.00000000000429,0.732333126338014,0,3,tRNA (uracil) methyltransferase activity,MF,
5432,GO:0016309,1.00000000000429,0.732333126338014,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5633,GO:0016728,1.00000000000429,0.732333126338014,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
5747,GO:0016917,1.00000000000429,0.732333126338014,0,3,GABA receptor activity,MF,
5756,GO:0016939,1.00000000000429,0.732333126338014,0,3,kinesin II complex,CC,
5881,GO:0018057,1.00000000000429,0.732333126338014,0,3,peptidyl-lysine oxidation,BP,
5916,GO:0018201,1.00000000000429,0.732333126338014,0,3,peptidyl-glycine modification,BP,
5964,GO:0018444,1.00000000000429,0.732333126338014,0,3,translation release factor complex,CC,
6229,GO:0019797,1.00000000000429,0.732333126338014,0,3,procollagen-proline 3-dioxygenase activity,MF,
6586,GO:0022614,1.00000000000429,0.732333126338014,0,3,membrane to membrane docking,BP,
6672,GO:0030047,1.00000000000429,0.732333126338014,0,3,actin modification,BP,
6868,GO:0030375,1.00000000000429,0.732333126338014,0,3,thyroid hormone receptor coactivator activity,MF,
7230,GO:0031166,1.00000000000429,0.732333126338014,0,3,integral component of vacuolar membrane,CC,
7296,GO:0031310,1.00000000000429,0.732333126338014,0,3,intrinsic component of vacuolar membrane,CC,
7457,GO:0031627,1.00000000000429,0.732333126338014,0,3,telomeric loop formation,BP,
7678,GO:0032142,1.00000000000429,0.732333126338014,0,3,single guanine insertion binding,MF,
7720,GO:0032227,1.00000000000429,0.732333126338014,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
7731,GO:0032252,1.00000000000429,0.732333126338014,0,3,secretory granule localization,BP,
7754,GO:0032286,1.00000000000429,0.732333126338014,0,3,central nervous system myelin maintenance,BP,
7959,GO:0032584,1.00000000000429,0.732333126338014,0,3,growth cone membrane,CC,
8195,GO:0032962,1.00000000000429,0.732333126338014,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
8423,GO:0033557,1.00000000000429,0.732333126338014,0,3,Slx1-Slx4 complex,CC,
8429,GO:0033565,1.00000000000429,0.732333126338014,0,3,ESCRT-0 complex,CC,
8499,GO:0033693,1.00000000000429,0.732333126338014,0,3,neurofilament bundle assembly,BP,
8603,GO:0034136,1.00000000000429,0.732333126338014,0,3,negative regulation of toll-like receptor 2 signaling pathway,BP,
8607,GO:0034140,1.00000000000429,0.732333126338014,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
8689,GO:0034343,1.00000000000429,0.732333126338014,0,3,type III interferon production,BP,
8690,GO:0034344,1.00000000000429,0.732333126338014,0,3,regulation of type III interferon production,BP,
8849,GO:0034666,1.00000000000429,0.732333126338014,0,3,integrin alpha2-beta1 complex,CC,
8974,GO:0035101,1.00000000000429,0.732333126338014,0,3,FACT complex,CC,
9212,GO:0035616,1.00000000000429,0.732333126338014,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9307,GO:0035799,1.00000000000429,0.732333126338014,0,3,ureter maturation,BP,
9385,GO:0035948,1.00000000000429,0.732333126338014,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
9643,GO:0038007,1.00000000000429,0.732333126338014,0,3,netrin-activated signaling pathway,BP,
9707,GO:0038165,1.00000000000429,0.732333126338014,0,3,oncostatin-M-mediated signaling pathway,BP,
10192,GO:0042825,1.00000000000429,0.732333126338014,0,3,TAP complex,CC,
10482,GO:0043402,1.00000000000429,0.732333126338014,0,3,glucocorticoid mediated signaling pathway,BP,
10533,GO:0043504,1.00000000000429,0.732333126338014,0,3,mitochondrial DNA repair,BP,
10581,GO:0043569,1.00000000000429,0.732333126338014,0,3,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
10643,GO:0043812,1.00000000000429,0.732333126338014,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
10677,GO:0043974,1.00000000000429,0.732333126338014,0,3,histone H3-K27 acetylation,BP,
10823,GO:0044336,1.00000000000429,0.732333126338014,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
10906,GO:0044539,1.00000000000429,0.732333126338014,0,3,long-chain fatty acid import,BP,
11142,GO:0045218,1.00000000000429,0.732333126338014,0,3,zonula adherens maintenance,BP,
11732,GO:0046601,1.00000000000429,0.732333126338014,0,3,positive regulation of centriole replication,BP,
11870,GO:0046912,1.00000000000429,0.732333126338014,0,3,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
11889,GO:0046946,1.00000000000429,0.732333126338014,0,3,hydroxylysine metabolic process,BP,
11890,GO:0046947,1.00000000000429,0.732333126338014,0,3,hydroxylysine biosynthetic process,BP,
12271,GO:0048630,1.00000000000429,0.732333126338014,0,3,skeletal muscle tissue growth,BP,
12272,GO:0048631,1.00000000000429,0.732333126338014,0,3,regulation of skeletal muscle tissue growth,BP,
12273,GO:0048633,1.00000000000429,0.732333126338014,0,3,positive regulation of skeletal muscle tissue growth,BP,
12614,GO:0050833,1.00000000000429,0.732333126338014,0,3,pyruvate transmembrane transporter activity,MF,
12949,GO:0051377,1.00000000000429,0.732333126338014,0,3,mannose-ethanolamine phosphotransferase activity,MF,
13103,GO:0051684,1.00000000000429,0.732333126338014,0,3,maintenance of Golgi location,BP,
13428,GO:0052905,1.00000000000429,0.732333126338014,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
13757,GO:0060371,1.00000000000429,0.732333126338014,0,3,regulation of atrial cardiac muscle cell membrane depolarization,BP,
14399,GO:0061731,1.00000000000429,0.732333126338014,0,3,ribonucleoside-diphosphate reductase activity,MF,
14564,GO:0070138,1.00000000000429,0.732333126338014,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
14566,GO:0070140,1.00000000000429,0.732333126338014,0,3,SUMO-specific isopeptidase activity,MF,
14746,GO:0070471,1.00000000000429,0.732333126338014,0,3,uterine smooth muscle contraction,BP,
14747,GO:0070472,1.00000000000429,0.732333126338014,0,3,regulation of uterine smooth muscle contraction,BP,
14748,GO:0070474,1.00000000000429,0.732333126338014,0,3,positive regulation of uterine smooth muscle contraction,BP,
14983,GO:0070939,1.00000000000429,0.732333126338014,0,3,Dsl1/NZR complex,CC,
15000,GO:0070966,1.00000000000429,0.732333126338014,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
15067,GO:0071107,1.00000000000429,0.732333126338014,0,3,response to parathyroid hormone,BP,
16012,GO:0086070,1.00000000000429,0.732333126338014,0,3,SA node cell to atrial cardiac muscle cell communication,BP,
16015,GO:0086075,1.00000000000429,0.732333126338014,0,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
16174,GO:0090234,1.00000000000429,0.732333126338014,0,3,regulation of kinetochore assembly,BP,
16282,GO:0090480,1.00000000000429,0.732333126338014,0,3,purine nucleotide-sugar transmembrane transport,BP,
16402,GO:0097068,1.00000000000429,0.732333126338014,0,3,response to thyroxine,BP,
16682,GO:0097694,1.00000000000429,0.732333126338014,0,3,establishment of RNA localization to telomere,BP,
16683,GO:0097695,1.00000000000429,0.732333126338014,0,3,establishment of protein-containing complex localization to telomere,BP,
16752,GO:0098592,1.00000000000429,0.732333126338014,0,3,cytoplasmic side of apical plasma membrane,CC,
16908,GO:0098915,1.00000000000429,0.732333126338014,0,3,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
16948,GO:0099010,1.00000000000429,0.732333126338014,0,3,modification of postsynaptic structure,BP,
16994,GO:0099174,1.00000000000429,0.732333126338014,0,3,regulation of presynapse organization,BP,
17160,GO:0106001,1.00000000000429,0.732333126338014,0,3,intestinal hexose absorption,BP,
17325,GO:1900041,1.00000000000429,0.732333126338014,0,3,negative regulation of interleukin-2 secretion,BP,
17370,GO:1900127,1.00000000000429,0.732333126338014,0,3,positive regulation of hyaluronan biosynthetic process,BP,
17631,GO:1901475,1.00000000000429,0.732333126338014,0,3,pyruvate transmembrane transport,BP,
17713,GO:1901674,1.00000000000429,0.732333126338014,0,3,regulation of histone H3-K27 acetylation,BP,
18071,GO:1902730,1.00000000000429,0.732333126338014,0,3,positive regulation of proteoglycan biosynthetic process,BP,
18792,GO:1904386,1.00000000000429,0.732333126338014,0,3,response to L-phenylalanine derivative,BP,
18811,GO:1904430,1.00000000000429,0.732333126338014,0,3,negative regulation of t-circle formation,BP,
18847,GO:1904533,1.00000000000429,0.732333126338014,0,3,regulation of telomeric loop disassembly,BP,
19295,GO:1905606,1.00000000000429,0.732333126338014,0,3,regulation of presynapse assembly,BP,
19415,GO:1990075,1.00000000000429,0.732333126338014,0,3,periciliary membrane compartment,CC,
19500,GO:1990423,1.00000000000429,0.732333126338014,0,3,RZZ complex,CC,
19818,GO:2000317,1.00000000000429,0.732333126338014,0,3,negative regulation of T-helper 17 type immune response,BP,
19821,GO:2000320,1.00000000000429,0.732333126338014,0,3,negative regulation of T-helper 17 cell differentiation,BP,
19870,GO:2000389,1.00000000000429,0.732333126338014,0,3,regulation of neutrophil extravasation,BP,
19871,GO:2000391,1.00000000000429,0.732333126338014,0,3,positive regulation of neutrophil extravasation,BP,
19878,GO:2000402,1.00000000000429,0.732333126338014,0,3,negative regulation of lymphocyte migration,BP,
20002,GO:2000653,1.00000000000429,0.732333126338014,0,3,regulation of genetic imprinting,BP,
20019,GO:2000671,1.00000000000429,0.732333126338014,0,3,regulation of motor neuron apoptotic process,BP,
20020,GO:2000672,1.00000000000429,0.732333126338014,0,3,negative regulation of motor neuron apoptotic process,BP,
16744,GO:0098576,1.00000000000429,0.662295077656981,0,4,lumenal side of membrane,CC,
124,GO:0000255,1.00000000000429,0.732333126338009,0,3,allantoin metabolic process,BP,
294,GO:0000799,1.00000000000429,0.732333126338009,0,3,nuclear condensin complex,CC,
383,GO:0001025,1.00000000000429,0.732333126338009,0,3,RNA polymerase III transcription factor binding,MF,
429,GO:0001156,1.00000000000429,0.732333126338009,0,3,TFIIIC-class transcription factor binding,MF,
450,GO:0001224,1.00000000000429,0.732333126338009,0,3,RNA polymerase II transcription cofactor binding,MF,
701,GO:0001922,1.00000000000429,0.732333126338009,0,3,B-1 B cell homeostasis,BP,
928,GO:0002326,1.00000000000429,0.732333126338009,0,3,B cell lineage commitment,BP,
1418,GO:0003365,1.00000000000429,0.732333126338009,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
1424,GO:0003383,1.00000000000429,0.732333126338009,0,3,apical constriction,BP,
1848,GO:0004515,1.00000000000429,0.732333126338009,0,3,nicotinate-nucleotide adenylyltransferase activity,MF,
1865,GO:0004534,1.00000000000429,0.732333126338009,0,3,5'-3' exoribonuclease activity,MF,
1982,GO:0004706,1.00000000000429,0.732333126338009,0,3,JUN kinase kinase kinase activity,MF,
2010,GO:0004741,1.00000000000429,0.732333126338009,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2075,GO:0004832,1.00000000000429,0.732333126338009,0,3,valine-tRNA ligase activity,MF,
2148,GO:0004970,1.00000000000429,0.732333126338009,0,3,ionotropic glutamate receptor activity,MF,
2149,GO:0004972,1.00000000000429,0.732333126338009,0,3,NMDA glutamate receptor activity,MF,
2171,GO:0005010,1.00000000000429,0.732333126338009,0,3,insulin-like growth factor-activated receptor activity,MF,
2254,GO:0005173,1.00000000000429,0.732333126338009,0,3,stem cell factor receptor binding,MF,
2408,GO:0005588,1.00000000000429,0.732333126338009,0,3,collagen type V trimer,CC,
2421,GO:0005606,1.00000000000429,0.732333126338009,0,3,laminin-1 complex,CC,
2773,GO:0006211,1.00000000000429,0.732333126338009,0,3,5-methylcytosine catabolic process,BP,
2920,GO:0006438,1.00000000000429,0.732333126338009,0,3,valyl-tRNA aminoacylation,BP,
3191,GO:0006828,1.00000000000429,0.732333126338009,0,3,manganese ion transport,BP,
3429,GO:0007227,1.00000000000429,0.732333126338009,0,3,signal transduction downstream of smoothened,BP,
3795,GO:0008384,1.00000000000429,0.732333126338009,0,3,IkappaB kinase activity,MF,
4607,GO:0010735,1.00000000000429,0.732333126338009,0,3,positive regulation of transcription via serum response element binding,BP,
4788,GO:0010990,1.00000000000429,0.732333126338009,0,3,regulation of SMAD protein complex assembly,BP,
4852,GO:0014701,1.00000000000429,0.732333126338009,0,3,junctional sarcoplasmic reticulum membrane,CC,
5042,GO:0015247,1.00000000000429,0.732333126338009,0,3,aminophospholipid transmembrane transporter activity,MF,
5099,GO:0015410,1.00000000000429,0.732333126338009,0,3,manganese-transporting ATPase activity,MF,
5191,GO:0015798,1.00000000000429,0.732333126338009,0,3,myo-inositol transport,BP,
5332,GO:0016080,1.00000000000429,0.732333126338009,0,3,synaptic vesicle targeting,BP,
5912,GO:0018197,1.00000000000429,0.732333126338009,0,3,peptidyl-aspartic acid modification,BP,
6255,GO:0019857,1.00000000000429,0.732333126338009,0,3,5-methylcytosine metabolic process,BP,
6306,GO:0019960,1.00000000000429,0.732333126338009,0,3,C-X3-C chemokine binding,MF,
6377,GO:0021578,1.00000000000429,0.732333126338009,0,3,hindbrain maturation,BP,
6395,GO:0021626,1.00000000000429,0.732333126338009,0,3,central nervous system maturation,BP,
6431,GO:0021747,1.00000000000429,0.732333126338009,0,3,cochlear nucleus development,BP,
6523,GO:0021936,1.00000000000429,0.732333126338009,0,3,regulation of cerebellar granule cell precursor proliferation,BP,
6657,GO:0030023,1.00000000000429,0.732333126338009,0,3,extracellular matrix constituent conferring elasticity,MF,
6933,GO:0030553,1.00000000000429,0.732333126338009,0,3,cGMP binding,MF,
7539,GO:0031860,1.00000000000429,0.732333126338009,0,3,telomeric 3' overhang formation,BP,
8410,GO:0033504,1.00000000000429,0.732333126338009,0,3,floor plate development,BP,
8443,GO:0033596,1.00000000000429,0.732333126338009,0,3,TSC1-TSC2 complex,CC,
8666,GO:0034274,1.00000000000429,0.732333126338009,0,3,Atg12-Atg5-Atg16 complex,CC,
8968,GO:0035092,1.00000000000429,0.732333126338009,0,3,sperm chromatin condensation,BP,
9139,GO:0035509,1.00000000000429,0.732333126338009,0,3,negative regulation of myosin-light-chain-phosphatase activity,BP,
9146,GO:0035517,1.00000000000429,0.732333126338009,0,3,PR-DUB complex,CC,
9650,GO:0038026,1.00000000000429,0.732333126338009,0,3,reelin-mediated signaling pathway,BP,
9941,GO:0042328,1.00000000000429,0.732333126338009,0,3,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10126,GO:0042713,1.00000000000429,0.732333126338009,0,3,sperm ejaculation,BP,
10803,GO:0044313,1.00000000000429,0.732333126338009,0,3,protein K6-linked deubiquitination,BP,
10928,GO:0044611,1.00000000000429,0.732333126338009,0,3,nuclear pore inner ring,CC,
11133,GO:0045204,1.00000000000429,0.732333126338009,0,3,MAPK export from nucleus,BP,
11294,GO:0045636,1.00000000000429,0.732333126338009,0,3,positive regulation of melanocyte differentiation,BP,
11763,GO:0046645,1.00000000000429,0.732333126338009,0,3,positive regulation of gamma-delta T cell activation,BP,
12034,GO:0048003,1.00000000000429,0.732333126338009,0,3,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12036,GO:0048007,1.00000000000429,0.732333126338009,0,3,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
12050,GO:0048021,1.00000000000429,0.732333126338009,0,3,regulation of melanin biosynthetic process,BP,
12376,GO:0048840,1.00000000000429,0.732333126338009,0,3,otolith development,BP,
12679,GO:0050923,1.00000000000429,0.732333126338009,0,3,regulation of negative chemotaxis,BP,
12768,GO:0051088,1.00000000000429,0.732333126338009,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
13005,GO:0051481,1.00000000000429,0.732333126338009,0,3,negative regulation of cytosolic calcium ion concentration,BP,
13166,GO:0051799,1.00000000000429,0.732333126338009,0,3,negative regulation of hair follicle development,BP,
13728,GO:0060332,1.00000000000429,0.732333126338009,0,3,positive regulation of response to interferon-gamma,BP,
13731,GO:0060335,1.00000000000429,0.732333126338009,0,3,positive regulation of interferon-gamma-mediated signaling pathway,BP,
13781,GO:0060398,1.00000000000429,0.732333126338009,0,3,regulation of growth hormone receptor signaling pathway,BP,
13988,GO:0060737,1.00000000000429,0.732333126338009,0,3,prostate gland morphogenetic growth,BP,
14064,GO:0060920,1.00000000000429,0.732333126338009,0,3,cardiac pacemaker cell differentiation,BP,
14068,GO:0060926,1.00000000000429,0.732333126338009,0,3,cardiac pacemaker cell development,BP,
14093,GO:0060979,1.00000000000429,0.732333126338009,0,3,vasculogenesis involved in coronary vascular morphogenesis,BP,
14312,GO:0061535,1.00000000000429,0.732333126338009,0,3,glutamate secretion, neurotransmission,BP,
14662,GO:0070305,1.00000000000429,0.732333126338009,0,3,response to cGMP,BP,
14692,GO:0070369,1.00000000000429,0.732333126338009,0,3,beta-catenin-TCF7L2 complex,CC,
14922,GO:0070842,1.00000000000429,0.732333126338009,0,3,aggresome assembly,BP,
15157,GO:0071321,1.00000000000429,0.732333126338009,0,3,cellular response to cGMP,BP,
15332,GO:0071596,1.00000000000429,0.732333126338009,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
15413,GO:0071723,1.00000000000429,0.732333126338009,0,3,lipopeptide binding,MF,
15515,GO:0071947,1.00000000000429,0.732333126338009,0,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
15630,GO:0072174,1.00000000000429,0.732333126338009,0,3,metanephric tubule formation,BP,
16374,GO:0097025,1.00000000000429,0.732333126338009,0,3,MPP7-DLG1-LIN7 complex,CC,
16388,GO:0097051,1.00000000000429,0.732333126338009,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
16439,GO:0097149,1.00000000000429,0.732333126338009,0,3,centralspindlin complex,CC,
16533,GO:0097343,1.00000000000429,0.732333126338009,0,3,ripoptosome assembly,BP,
16620,GO:0097513,1.00000000000429,0.732333126338009,0,3,myosin II filament,CC,
16703,GO:0097742,1.00000000000429,0.732333126338009,0,3,de novo centriole assembly,BP,
16728,GO:0098535,1.00000000000429,0.732333126338009,0,3,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
16729,GO:0098536,1.00000000000429,0.732333126338009,0,3,deuterosome,CC,
16854,GO:0098821,1.00000000000429,0.732333126338009,0,3,BMP receptor activity,MF,
16920,GO:0098935,1.00000000000429,0.732333126338009,0,3,dendritic transport,BP,
16922,GO:0098937,1.00000000000429,0.732333126338009,0,3,anterograde dendritic transport,BP,
17166,GO:0106017,1.00000000000429,0.732333126338009,0,3,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
17489,GO:1900748,1.00000000000429,0.732333126338009,0,3,positive regulation of vascular endothelial growth factor signaling pathway,BP,
17505,GO:1901026,1.00000000000429,0.732333126338009,0,3,ripoptosome assembly involved in necroptotic process,BP,
17649,GO:1901537,1.00000000000429,0.732333126338009,0,3,positive regulation of DNA demethylation,BP,
17777,GO:1901897,1.00000000000429,0.732333126338009,0,3,regulation of relaxation of cardiac muscle,BP,
17937,GO:1902338,1.00000000000429,0.732333126338009,0,3,negative regulation of apoptotic process involved in morphogenesis,BP,
17960,GO:1902412,1.00000000000429,0.732333126338009,0,3,regulation of mitotic cytokinesis,BP,
18192,GO:1903011,1.00000000000429,0.732333126338009,0,3,negative regulation of bone development,BP,
18279,GO:1903223,1.00000000000429,0.732333126338009,0,3,positive regulation of oxidative stress-induced neuron death,BP,
18331,GO:1903347,1.00000000000429,0.732333126338009,0,3,negative regulation of bicellular tight junction assembly,BP,
18369,GO:1903422,1.00000000000429,0.732333126338009,0,3,negative regulation of synaptic vesicle recycling,BP,
18417,GO:1903527,1.00000000000429,0.732333126338009,0,3,positive regulation of membrane tubulation,BP,
18550,GO:1903818,1.00000000000429,0.732333126338009,0,3,positive regulation of voltage-gated potassium channel activity,BP,
18796,GO:1904396,1.00000000000429,0.732333126338009,0,3,regulation of neuromuscular junction development,BP,
18901,GO:1904672,1.00000000000429,0.732333126338009,0,3,regulation of somatic stem cell population maintenance,BP,
18913,GO:1904693,1.00000000000429,0.732333126338009,0,3,midbrain morphogenesis,BP,
18940,GO:1904746,1.00000000000429,0.732333126338009,0,3,negative regulation of apoptotic process involved in development,BP,
19075,GO:1905031,1.00000000000429,0.732333126338009,0,3,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
19332,GO:1905773,1.00000000000429,0.732333126338009,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
19522,GO:1990504,1.00000000000429,0.732333126338009,0,3,dense core granule exocytosis,BP,
19599,GO:1990785,1.00000000000429,0.732333126338009,0,3,response to water-immersion restraint stress,BP,
20224,GO:2001205,1.00000000000429,0.732333126338009,0,3,negative regulation of osteoclast development,BP,
18581,GO:1903891,1.00000000000432,0.660191076282534,0,4,regulation of ATF6-mediated unfolded protein response,BP,
2683,GO:0006055,1.00000000000432,0.914794807299248,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
11628,GO:0046381,1.00000000000432,0.914794807299248,0,1,CMP-N-acetylneuraminate metabolic process,BP,
11979,GO:0047444,1.00000000000432,0.914794807299248,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12464,GO:0050462,1.00000000000432,0.914794807299248,0,1,N-acetylneuraminate synthase activity,MF,
11861,GO:0046898,1.00000000000432,0.732461382393796,0,3,response to cycloheximide,BP,
2296,GO:0005280,1.00000000000433,0.732333597914374,0,3,amino acid:proton symporter activity,MF,
510,GO:0001574,1.00000000000433,0.664460239108268,0,4,ganglioside biosynthetic process,BP,
4466,GO:0010481,1.00000000000434,0.741963084740592,0,3,epidermal cell division,BP,
4467,GO:0010482,1.00000000000434,0.741963084740592,0,3,regulation of epidermal cell division,BP,
11428,GO:0045901,1.00000000000434,0.741963084740592,0,3,positive regulation of translational elongation,BP,
1543,GO:0003941,1.00000000000438,0.821625595263804,0,2,L-serine ammonia-lyase activity,MF,
7937,GO:0032545,1.00000000000439,0.743945887063441,0,3,CURI complex,CC,
8761,GO:0034456,1.00000000000439,0.743945887063441,0,3,UTP-C complex,CC,
4644,GO:0010797,1.0000000000044,0.915390198052581,0,1,regulation of multivesicular body size involved in endosome transport,BP,
7341,GO:0031394,1.00000000000441,0.821380026767758,0,2,positive regulation of prostaglandin biosynthetic process,BP,
9522,GO:0036292,1.00000000000441,0.821380026767758,0,2,DNA rewinding,BP,
20268,GO:2001280,1.00000000000441,0.821380026767758,0,2,positive regulation of unsaturated fatty acid biosynthetic process,BP,
5571,GO:0016598,1.00000000000443,0.816239041339687,0,2,protein arginylation,BP,
8754,GO:0034448,1.00000000000444,0.674609667273021,0,4,EGO complex,CC,
4293,GO:0009750,1.00000000000447,0.662971332659957,0,4,response to fructose,BP,
13100,GO:0051673,1.00000000000449,0.82142269173338,0,2,membrane disruption in other organism,BP,
7757,GO:0032289,1.0000000000045,0.733139855016327,0,3,central nervous system myelin formation,BP,
8528,GO:0033871,1.0000000000045,0.903729463602566,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
11904,GO:0046970,1.0000000000045,0.903729463602566,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
14274,GO:0061433,1.0000000000045,0.903729463602566,0,1,cellular response to caloric restriction,BP,
14737,GO:0070446,1.0000000000045,0.903729463602566,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
5760,GO:0016971,1.00000000000451,0.732532172851633,0,3,flavin-linked sulfhydryl oxidase activity,MF,
4781,GO:0010982,1.00000000000451,0.812941717896005,0,2,regulation of high-density lipoprotein particle clearance,BP,
4782,GO:0010983,1.00000000000451,0.812941717896005,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
8617,GO:0034154,1.00000000000456,0.660718588505717,0,4,toll-like receptor 7 signaling pathway,BP,
17821,GO:1902035,1.00000000000458,0.663989257984805,0,4,positive regulation of hematopoietic stem cell proliferation,BP,
16528,GO:0097332,1.00000000000462,0.830787871977818,0,2,response to antipsychotic drug,BP,
11000,GO:0044854,1.00000000000464,0.663485340854158,0,4,plasma membrane raft assembly,BP,
11003,GO:0044857,1.00000000000464,0.663485340854158,0,4,plasma membrane raft organization,BP,
17920,GO:1902292,1.00000000000466,0.916209671454289,0,1,cell cycle DNA replication initiation,BP,
17933,GO:1902315,1.00000000000466,0.916209671454289,0,1,nuclear cell cycle DNA replication initiation,BP,
18171,GO:1902975,1.00000000000466,0.916209671454289,0,1,mitotic DNA replication initiation,BP,
5976,GO:0018894,1.00000000000466,0.732366274579015,0,3,dibenzo-p-dioxin metabolic process,BP,
4827,GO:0014043,1.00000000000471,0.815831137165182,0,2,negative regulation of neuron maturation,BP,
15445,GO:0071816,1.00000000000473,0.667189918070834,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
2059,GO:0004816,1.00000000000473,0.812974631737628,0,2,asparagine-tRNA ligase activity,MF,
1002,GO:0002476,1.00000000000475,0.817242849720701,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
9280,GO:0035740,1.00000000000475,0.817242849720701,0,2,CD8-positive, alpha-beta T cell proliferation,BP,
19948,GO:2000564,1.00000000000475,0.817242849720701,0,2,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
7458,GO:0031628,1.00000000000476,0.662317644144249,0,4,opioid receptor binding,MF,
7537,GO:0031852,1.00000000000476,0.662317644144249,0,4,mu-type opioid receptor binding,MF,
10750,GO:0044214,1.00000000000476,0.732425458210824,0,3,spanning component of plasma membrane,CC,
14773,GO:0070524,1.00000000000476,0.911188311601064,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
203,GO:0000429,1.00000000000482,0.740627816029179,0,3,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
208,GO:0000436,1.00000000000482,0.740627816029179,0,3,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
11492,GO:0046016,1.00000000000482,0.740627816029179,0,3,positive regulation of transcription by glucose,BP,
10,GO:0000019,1.00000000000482,0.73245230790654,0,3,regulation of mitotic recombination,BP,
7675,GO:0032137,1.00000000000482,0.73245230790654,0,3,guanine/thymine mispair binding,MF,
17708,GO:1901664,1.00000000000483,0.742855257242511,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
17709,GO:1901666,1.00000000000483,0.742855257242511,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
16117,GO:0090156,1.00000000000483,0.743594605452235,0,3,cellular sphingolipid homeostasis,BP,
9861,GO:0042144,1.00000000000483,0.812551367952097,0,2,vacuole fusion, non-autophagic,BP,
16644,GO:0097576,1.00000000000483,0.812551367952097,0,2,vacuole fusion,BP,
1940,GO:0004647,1.00000000000485,0.815306902432259,0,2,phosphoserine phosphatase activity,MF,
16339,GO:0090669,1.00000000000487,0.663120574652448,0,4,telomerase RNA stabilization,BP,
14302,GO:0061511,1.00000000000488,0.676154624446606,0,4,centriole elongation,BP,
4938,GO:0014916,1.00000000000488,0.734201145636131,0,3,regulation of lung blood pressure,BP,
1832,GO:0004491,1.00000000000491,0.902273175321352,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
4727,GO:0010904,1.00000000000491,0.902273175321352,0,1,regulation of UDP-glucose catabolic process,BP,
4728,GO:0010905,1.00000000000491,0.902273175321352,0,1,negative regulation of UDP-glucose catabolic process,BP,
5967,GO:0018478,1.00000000000491,0.902273175321352,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
18722,GO:1904226,1.00000000000491,0.902273175321352,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
18723,GO:1904227,1.00000000000491,0.902273175321352,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
5524,GO:0016517,1.00000000000492,0.903421564143779,0,1,interleukin-12 receptor activity,MF,
9797,GO:0042019,1.00000000000492,0.903421564143779,0,1,interleukin-23 binding,MF,
9798,GO:0042020,1.00000000000492,0.903421564143779,0,1,interleukin-23 receptor activity,MF,
9799,GO:0042022,1.00000000000492,0.903421564143779,0,1,interleukin-12 receptor complex,CC,
15805,GO:0072536,1.00000000000492,0.903421564143779,0,1,interleukin-23 receptor complex,CC,
19822,GO:2000321,1.00000000000492,0.903421564143779,0,1,positive regulation of T-helper 17 cell differentiation,BP,
19830,GO:2000330,1.00000000000492,0.903421564143779,0,1,positive regulation of T-helper 17 cell lineage commitment,BP,
8325,GO:0033186,1.00000000000493,0.732760198322461,0,3,CAF-1 complex,CC,
20225,GO:2001206,1.00000000000493,0.733380530415504,0,3,positive regulation of osteoclast development,BP,
5742,GO:0016900,1.00000000000495,0.845840160418716,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
11930,GO:0047057,1.00000000000495,0.845840160418716,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
3643,GO:0008127,1.00000000000495,0.913487191389945,0,1,quercetin 2,3-dioxygenase activity,MF,
5134,GO:0015671,1.00000000000495,0.814871594155675,0,2,oxygen transport,BP,
2348,GO:0005432,1.00000000000496,0.732818807181393,0,3,calcium:sodium antiporter activity,MF,
7130,GO:0030981,1.00000000000496,0.732352792026918,0,3,cortical microtubule cytoskeleton,CC,
18345,GO:1903373,1.00000000000496,0.732818807181393,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
18842,GO:1904527,1.00000000000496,0.732352792026918,0,3,negative regulation of microtubule binding,BP,
9202,GO:0035606,1.00000000000497,0.852078971072572,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
17737,GO:1901740,1.00000000000498,0.903624934114888,0,1,negative regulation of myoblast fusion,BP,
18613,GO:1903943,1.00000000000498,0.903624934114888,0,1,regulation of hepatocyte apoptotic process,BP,
18614,GO:1903944,1.00000000000498,0.903624934114888,0,1,negative regulation of hepatocyte apoptotic process,BP,
19571,GO:1990729,1.00000000000498,0.903624934114888,0,1,primary miRNA modification,BP,
19579,GO:1990744,1.00000000000498,0.903624934114888,0,1,primary miRNA methylation,BP,
9917,GO:0042284,1.00000000000499,0.904583586661288,0,1,sphingolipid delta-4 desaturase activity,MF,
5035,GO:0015228,1.00000000000501,0.73287181701003,0,3,coenzyme A transmembrane transporter activity,MF,
5242,GO:0015880,1.00000000000501,0.73287181701003,0,3,coenzyme A transport,BP,
9071,GO:0035349,1.00000000000501,0.73287181701003,0,3,coenzyme A transmembrane transport,BP,
15062,GO:0071077,1.00000000000501,0.73287181701003,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
15066,GO:0071106,1.00000000000501,0.73287181701003,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
15948,GO:0080122,1.00000000000501,0.73287181701003,0,3,AMP transmembrane transporter activity,MF,
8863,GO:0034693,1.00000000000501,0.901532473589332,0,1,U11/U12 snRNP,CC,
19458,GO:1990254,1.00000000000501,0.665217904862992,0,4,keratin filament binding,MF,
676,GO:0001887,1.00000000000502,0.660668514859639,0,4,selenium compound metabolic process,BP,
1300,GO:0003140,1.00000000000502,0.666340332265513,0,4,determination of left/right asymmetry in lateral mesoderm,BP,
6873,GO:0030389,1.00000000000505,0.929773317733989,0,1,fructosamine metabolic process,BP,
16287,GO:0090498,1.00000000000506,0.813055817959351,0,2,extrinsic component of Golgi membrane,CC,
12139,GO:0048270,1.00000000000507,0.902770675763982,0,1,methionine adenosyltransferase regulator activity,MF,
17594,GO:1901317,1.00000000000508,0.690077985215989,0,4,regulation of flagellated sperm motility,BP,
14893,GO:0070773,1.00000000000508,0.912427759582007,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
15299,GO:0071544,1.00000000000508,0.912427759582007,0,1,diphosphoinositol polyphosphate catabolic process,BP,
15477,GO:0071877,1.00000000000508,0.912427759582007,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
15481,GO:0071881,1.00000000000508,0.912427759582007,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16026,GO:0086096,1.00000000000508,0.912427759582007,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17289,GO:0140193,1.00000000000508,0.912427759582007,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17290,GO:0140194,1.00000000000508,0.912427759582007,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
348,GO:0000962,1.00000000000508,0.812590311805544,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
8763,GO:0034458,1.00000000000508,0.812590311805544,0,2,3'-5' RNA helicase activity,MF,
11025,GO:0045025,1.00000000000508,0.812590311805544,0,2,mitochondrial degradosome,CC,
12213,GO:0048499,1.00000000000509,0.74574274363527,0,3,synaptic vesicle membrane organization,BP,
19603,GO:1990809,1.00000000000511,0.660670669695208,0,4,endoplasmic reticulum tubular network membrane organization,BP,
3168,GO:0006789,1.00000000000513,0.90168323642782,0,1,bilirubin conjugation,BP,
15788,GO:0072513,1.00000000000513,0.926148819340551,0,1,positive regulation of secondary heart field cardioblast proliferation,BP,
3663,GO:0008169,1.00000000000513,0.742764855878286,0,3,C-methyltransferase activity,MF,
10122,GO:0042701,1.00000000000514,0.813336928806095,0,2,progesterone secretion,BP,
14870,GO:0070697,1.00000000000514,0.813336928806095,0,2,activin receptor binding,MF,
14871,GO:0070699,1.00000000000514,0.813336928806095,0,2,type II activin receptor binding,MF,
1567,GO:0003977,1.00000000000514,0.812839070278397,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
4220,GO:0009407,1.00000000000515,0.687558221297859,0,4,toxin catabolic process,BP,
9427,GO:0036022,1.00000000000516,0.815606216162891,0,2,limb joint morphogenesis,BP,
9428,GO:0036023,1.00000000000516,0.815606216162891,0,2,embryonic skeletal limb joint morphogenesis,BP,
17610,GO:1901360,1.00000000000518,0,359,4868,organic cyclic compound metabolic process,BP,TNIP1;HTRA1;FOS;H6PD;LMF1;APOE;CTNNBIP1;IDH2;ERCC1;WWC3;NT5E;CITED4;NAPRT;CST3;RAPGEF3;TCFL5;PGM1;CYP27B1;XDH;PRDX5;PGLS;PCBP4;PRSS3;PRODH;MEF2D;NOS1;ZFP36L1;NR1D1;NYNRIN;POLD4;RBCK1;EPAS1;IGF2;NFATC4;NME4;GAMT;MAPK13;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;ACOT7;TCEA2;UROS;MXD4;DDB2;MTHFR;MDFI;ADGRF1;EGR1;PKN1;CRTC1;SHC1;F2R;DEAF1;BAHCC1;CXXC5;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;ABCG1;DHRS11;PIK3R2;ZNF516;INO80C;PEG3;HDAC5;THRA;ZP3;NMRK1;LRP5;TENM2;PLTP;SLC2A9;MAML3;ZFPM1;TFEB;ERBB2;SCMH1;OGDHL;PKD2;CBS;H2AFJ;PTHLH;CDKN1C;SALL2;MSRB2;XPC;PAK6;HEXB;FOXQ1;LTB4R2;CD320;ATP2B4;TFDP2;CSNK1E;ACP5;TRAPPC9;PDCD4;ZKSCAN1;WNT7A;ZMIZ1;INSR;ZC3H6;ID1;AKR7A2;MVD;POLL;NDUFS8;ADARB1;ZNF692;ZNF704;ITGA6;DNMT3A;DNPH1;TMEM173;PRNP;DHX32;SRD5A3;RNASET2;HES2;HINT2;ZNF467;MNT;ECM1;STAT6;DLG4;MTA3;TALDO1;WWTR1;ISG20;FAM20C;MYO18A;DNAJB5;BCL6;UCKL1;PFKFB2;SCAND1;DYRK1B;SEC14L2;CD81;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;CEBPB;ACVR2B;HSF4;NAB2;CALCOCO1;ENDOG;MAPK3;KCNAB2;ETV5;AMN;DHTKD1;EXD3;DVL1;ENTPD2;GALK1;MTA1;LHPP;ADCY6;L3MBTL1;MBD1;NSMCE4A;FHOD1;HES1;BRD3;PC;MLXIPL;ZNF624;ARHGAP22;NADK;ABCA2;TK2;ZNF414;ADA;OSBPL5;PYCR2;PIDD1;PHF21A;CELSR2;PFKL;PCSK9;SLC28A2;ZFP36;ETV4;MAPKBP1;HLCS;PRKACA;ZNF862;ZMYM3;KIAA1549;NUDT10;DGUOK;MAGEF1;RPS6KA5;MAP2K2;DAP;FGFR4;PMVK;MYH3;HDAC11;TNFRSF1A;MAPK8IP1;TCF25;LDLR;PTOV1;CYP3A5;SNX17;SOX13;TRPV4;MPG;BHLHE40;RRNAD1;RAG1;ZNF80;HMGA2;LDLRAP1;TM7SF2;ELK3;AHNAK2;DGKQ;HK1;ZXDC;GAS6;BTRC;POU6F1;ZNF217;PPARA;GUK1;BLVRB;COMT;SUFU;PTAFR;DMC1;PAN2;ZNF446;RXRA;PCK2;NEO1;IGFBP4;SDHA;USP21;PRKCZ;HLTF;MDH2;BCORL1;ABCD4;ZNF485;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;AGO4;RAD23A;FGFR1;PIN1;MN1;ZNF563;KMT5C;IRF2BPL;PROX1;WBP2;GTPBP1;DLG3;PPP1R13L;ZNF554;WDR83;GLRX;JARID2;SESN2;TSTA3;TMEM161A;RXRB;PNRC1;MAPRE3;LCAT;GUCA1B;MACROD1;PTMS;OR7D2;APOBEC3C;ZFP41;PPM1F;SORL1;ACVR1B;MEF2B;ZSCAN30;AHCYL2;ADORA2B;CCDC85B;AKT1;HPDL;NLRX1;ZNF385A;TP53INP1;TUT1;SMARCA1;SIX5;ERCC6;GPD1L;TDRKH;SLC5A5;UQCR11;SSBP2;PINK1;PKD1;ARHGEF10L;KDM4B;CAMTA2;RGS14;MAFIP;ZNF710;ABHD14B;RSAD1;RFX2;RNF187;PYCARD;MAP2K3;PNPO;TRERF1;THAP8;DDN;PMS2P5;NDUFV3;ERN1;ZNF319;APOBEC3F;PRIMPOL;MOCS1;GLI4;TAZ;RNASEK;LITAF;MZF1;NEIL1;FUK;RARG;ING4;PBXIP1;EREG;PPCS;GSTM2;ZNF514;PODXL2;WDR18;TRNP1;ZNF837;POLM;RPL13A;RGS12;UBL5
19814,GO:2000312,1.00000000000518,0.732655492177272,0,3,regulation of kainate selective glutamate receptor activity,BP,
19377,GO:1905936,1.0000000000052,0.850171552924722,0,2,regulation of germ cell proliferation,BP,
19778,GO:2000254,1.0000000000052,0.850171552924722,0,2,regulation of male germ cell proliferation,BP,
5435,GO:0016312,1.00000000000521,0.661085552865679,0,4,inositol bisphosphate phosphatase activity,MF,
7532,GO:0031826,1.00000000000526,0.740634359099399,0,3,type 2A serotonin receptor binding,MF,
916,GO:0002309,1.00000000000527,0.925398421985761,0,1,T cell proliferation involved in immune response,BP,
1714,GO:0004309,1.00000000000528,0.66053307367967,0,4,exopolyphosphatase activity,MF,
3173,GO:0006798,1.00000000000528,0.66053307367967,0,4,polyphosphate catabolic process,BP,
13139,GO:0051754,1.0000000000053,0.732579482704704,0,3,meiotic sister chromatid cohesion, centromeric,BP,
6473,GO:0021826,1.00000000000534,0.812736879851471,0,2,substrate-independent telencephalic tangential migration,BP,
6476,GO:0021830,1.00000000000534,0.812736879851471,0,2,interneuron migration from the subpallium to the cortex,BP,
6480,GO:0021843,1.00000000000534,0.812736879851471,0,2,substrate-independent telencephalic tangential interneuron migration,BP,
11931,GO:0047066,1.00000000000536,0.922317353782983,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
16687,GO:0097707,1.00000000000536,0.922317353782983,0,1,ferroptosis,BP,
17212,GO:0110075,1.00000000000536,0.922317353782983,0,1,regulation of ferroptosis,BP,
17213,GO:0110076,1.00000000000536,0.922317353782983,0,1,negative regulation of ferroptosis,BP,
5,GO:0000011,1.00000000000537,0.901377980420617,0,1,vacuole inheritance,BP,
55,GO:0000117,1.00000000000537,0.901377980420617,0,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
58,GO:0000121,1.00000000000537,0.901377980420617,0,1,glycerol-1-phosphatase activity,MF,
79,GO:0000160,1.00000000000537,0.901377980420617,0,1,phosphorelay signal transduction system,BP,
99,GO:0000210,1.00000000000537,0.901377980420617,0,1,NAD+ diphosphatase activity,MF,
117,GO:0000246,1.00000000000537,0.901377980420617,0,1,delta24(24-1) sterol reductase activity,MF,
120,GO:0000250,1.00000000000537,0.901377980420617,0,1,lanosterol synthase activity,MF,
191,GO:0000409,1.00000000000537,0.901377980420617,0,1,regulation of transcription by galactose,BP,
192,GO:0000411,1.00000000000537,0.901377980420617,0,1,positive regulation of transcription by galactose,BP,
196,GO:0000415,1.00000000000537,0.901377980420617,0,1,negative regulation of histone H3-K36 methylation,BP,
197,GO:0000416,1.00000000000537,0.901377980420617,0,1,positive regulation of histone H3-K36 methylation,BP,
198,GO:0000417,1.00000000000537,0.901377980420617,0,1,HIR complex,CC,
205,GO:0000431,1.00000000000537,0.901377980420617,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
207,GO:0000435,1.00000000000537,0.901377980420617,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
232,GO:0000481,1.00000000000537,0.901377980420617,0,1,maturation of 5S rRNA,BP,
292,GO:0000797,1.00000000000537,0.901377980420617,0,1,condensin core heterodimer,CC,
296,GO:0000801,1.00000000000537,0.901377980420617,0,1,central element,CC,
333,GO:0000928,1.00000000000537,0.901377980420617,0,1,gamma-tubulin small complex, spindle pole body,CC,
378,GO:0001011,1.00000000000537,0.901377980420617,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
405,GO:0001087,1.00000000000537,0.901377980420617,0,1,transcription factor activity, TFIIB-class binding,MF,
409,GO:0001096,1.00000000000537,0.901377980420617,0,1,TFIIF-class transcription factor binding,MF,
419,GO:0001112,1.00000000000537,0.901377980420617,0,1,DNA-templated transcriptional open complex formation,BP,
420,GO:0001113,1.00000000000537,0.901377980420617,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
421,GO:0001120,1.00000000000537,0.901377980420617,0,1,protein-DNA complex remodeling,BP,
436,GO:0001165,1.00000000000537,0.901377980420617,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
452,GO:0001226,1.00000000000537,0.901377980420617,0,1,RNA polymerase II transcription corepressor binding,MF,
475,GO:0001519,1.00000000000537,0.901377980420617,0,1,peptide amidation,BP,
483,GO:0001534,1.00000000000537,0.901377980420617,0,1,radial spoke,CC,
484,GO:0001536,1.00000000000537,0.901377980420617,0,1,radial spoke stalk,CC,
490,GO:0001543,1.00000000000537,0.901377980420617,0,1,ovarian follicle rupture,BP,
491,GO:0001544,1.00000000000537,0.901377980420617,0,1,initiation of primordial ovarian follicle growth,BP,
492,GO:0001545,1.00000000000537,0.901377980420617,0,1,primary ovarian follicle growth,BP,
508,GO:0001572,1.00000000000537,0.901377980420617,0,1,lactosylceramide biosynthetic process,BP,
519,GO:0001605,1.00000000000537,0.901377980420617,0,1,adrenomedullin receptor activity,MF,
528,GO:0001640,1.00000000000537,0.901377980420617,0,1,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
529,GO:0001642,1.00000000000537,0.901377980420617,0,1,group III metabotropic glutamate receptor activity,MF,
557,GO:0001681,1.00000000000537,0.901377980420617,0,1,sialate O-acetylesterase activity,MF,
572,GO:0001715,1.00000000000537,0.901377980420617,0,1,ectodermal cell fate specification,BP,
601,GO:0001770,1.00000000000537,0.901377980420617,0,1,establishment of natural killer cell polarity,BP,
618,GO:0001792,1.00000000000537,0.901377980420617,0,1,polymeric immunoglobulin receptor activity,MF,
619,GO:0001794,1.00000000000537,0.901377980420617,0,1,type IIa hypersensitivity,BP,
620,GO:0001796,1.00000000000537,0.901377980420617,0,1,regulation of type IIa hypersensitivity,BP,
621,GO:0001798,1.00000000000537,0.901377980420617,0,1,positive regulation of type IIa hypersensitivity,BP,
640,GO:0001831,1.00000000000537,0.901377980420617,0,1,trophectodermal cellular morphogenesis,BP,
643,GO:0001834,1.00000000000537,0.901377980420617,0,1,trophectodermal cell proliferation,BP,
644,GO:0001835,1.00000000000537,0.901377980420617,0,1,blastocyst hatching,BP,
738,GO:0001970,1.00000000000537,0.901377980420617,0,1,positive regulation of activation of membrane attack complex,BP,
739,GO:0001971,1.00000000000537,0.901377980420617,0,1,negative regulation of activation of membrane attack complex,BP,
751,GO:0001992,1.00000000000537,0.901377980420617,0,1,regulation of systemic arterial blood pressure by vasopressin,BP,
807,GO:0002081,1.00000000000537,0.901377980420617,0,1,outer acrosomal membrane,CC,
823,GO:0002100,1.00000000000537,0.901377980420617,0,1,tRNA wobble adenosine to inosine editing,BP,
826,GO:0002114,1.00000000000537,0.901377980420617,0,1,interleukin-33 receptor activity,MF,
829,GO:0002118,1.00000000000537,0.901377980420617,0,1,aggressive behavior,BP,
830,GO:0002121,1.00000000000537,0.901377980420617,0,1,inter-male aggressive behavior,BP,
878,GO:0002238,1.00000000000537,0.901377980420617,0,1,response to molecule of fungal origin,BP,
921,GO:0002316,1.00000000000537,0.901377980420617,0,1,follicular B cell differentiation,BP,
933,GO:0002332,1.00000000000537,0.901377980420617,0,1,transitional stage B cell differentiation,BP,
934,GO:0002333,1.00000000000537,0.901377980420617,0,1,transitional one stage B cell differentiation,BP,
940,GO:0002351,1.00000000000537,0.901377980420617,0,1,serotonin production involved in inflammatory response,BP,
957,GO:0002378,1.00000000000537,0.901377980420617,0,1,immunoglobulin biosynthetic process,BP,
958,GO:0002380,1.00000000000537,0.901377980420617,0,1,immunoglobulin secretion involved in immune response,BP,
966,GO:0002408,1.00000000000537,0.901377980420617,0,1,myeloid dendritic cell chemotaxis,BP,
978,GO:0002432,1.00000000000537,0.901377980420617,0,1,granuloma formation,BP,
985,GO:0002442,1.00000000000537,0.901377980420617,0,1,serotonin secretion involved in inflammatory response,BP,
988,GO:0002445,1.00000000000537,0.901377980420617,0,1,type II hypersensitivity,BP,
1009,GO:0002488,1.00000000000537,0.901377980420617,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1010,GO:0002489,1.00000000000537,0.901377980420617,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1017,GO:0002514,1.00000000000537,0.901377980420617,0,1,B cell tolerance induction,BP,
1029,GO:0002537,1.00000000000537,0.901377980420617,0,1,nitric oxide production involved in inflammatory response,BP,
1030,GO:0002538,1.00000000000537,0.901377980420617,0,1,arachidonic acid metabolite production involved in inflammatory response,BP,
1031,GO:0002540,1.00000000000537,0.901377980420617,0,1,leukotriene production involved in inflammatory response,BP,
1040,GO:0002554,1.00000000000537,0.901377980420617,0,1,serotonin secretion by platelet,BP,
1064,GO:0002605,1.00000000000537,0.901377980420617,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
1069,GO:0002635,1.00000000000537,0.901377980420617,0,1,negative regulation of germinal center formation,BP,
1076,GO:0002649,1.00000000000537,0.901377980420617,0,1,regulation of tolerance induction to self antigen,BP,
1077,GO:0002651,1.00000000000537,0.901377980420617,0,1,positive regulation of tolerance induction to self antigen,BP,
1079,GO:0002661,1.00000000000537,0.901377980420617,0,1,regulation of B cell tolerance induction,BP,
1080,GO:0002663,1.00000000000537,0.901377980420617,0,1,positive regulation of B cell tolerance induction,BP,
1084,GO:0002669,1.00000000000537,0.901377980420617,0,1,positive regulation of T cell anergy,BP,
1136,GO:0002728,1.00000000000537,0.901377980420617,0,1,negative regulation of natural killer cell cytokine production,BP,
1140,GO:0002732,1.00000000000537,0.901377980420617,0,1,positive regulation of dendritic cell cytokine production,BP,
1160,GO:0002774,1.00000000000537,0.901377980420617,0,1,Fc receptor mediated inhibitory signaling pathway,BP,
1164,GO:0002785,1.00000000000537,0.901377980420617,0,1,negative regulation of antimicrobial peptide production,BP,
1166,GO:0002787,1.00000000000537,0.901377980420617,0,1,negative regulation of antibacterial peptide production,BP,
1221,GO:0002892,1.00000000000537,0.901377980420617,0,1,regulation of type II hypersensitivity,BP,
1222,GO:0002894,1.00000000000537,0.901377980420617,0,1,positive regulation of type II hypersensitivity,BP,
1230,GO:0002913,1.00000000000537,0.901377980420617,0,1,positive regulation of lymphocyte anergy,BP,
1236,GO:0002930,1.00000000000537,0.901377980420617,0,1,trabecular meshwork development,BP,
1245,GO:0002947,1.00000000000537,0.901377980420617,0,1,tumor necrosis factor receptor superfamily complex,CC,
1261,GO:0003017,1.00000000000537,0.901377980420617,0,1,lymph circulation,BP,
1315,GO:0003165,1.00000000000537,0.901377980420617,0,1,Purkinje myocyte development,BP,
1316,GO:0003166,1.00000000000537,0.901377980420617,0,1,bundle of His development,BP,
1317,GO:0003167,1.00000000000537,0.901377980420617,0,1,atrioventricular bundle cell differentiation,BP,
1334,GO:0003193,1.00000000000537,0.901377980420617,0,1,pulmonary valve formation,BP,
1350,GO:0003220,1.00000000000537,0.901377980420617,0,1,left ventricular cardiac muscle tissue morphogenesis,BP,
1351,GO:0003221,1.00000000000537,0.901377980420617,0,1,right ventricular cardiac muscle tissue morphogenesis,BP,
1354,GO:0003226,1.00000000000537,0.901377980420617,0,1,right ventricular compact myocardium morphogenesis,BP,
1364,GO:0003251,1.00000000000537,0.901377980420617,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1365,GO:0003252,1.00000000000537,0.901377980420617,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1369,GO:0003257,1.00000000000537,0.901377980420617,0,1,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1373,GO:0003270,1.00000000000537,0.901377980420617,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1384,GO:0003292,1.00000000000537,0.901377980420617,0,1,cardiac septum cell differentiation,BP,
1409,GO:0003345,1.00000000000537,0.901377980420617,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1417,GO:0003363,1.00000000000537,0.901377980420617,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
1419,GO:0003366,1.00000000000537,0.901377980420617,0,1,cell-matrix adhesion involved in ameboidal cell migration,BP,
1428,GO:0003404,1.00000000000537,0.901377980420617,0,1,optic vesicle morphogenesis,BP,
1432,GO:0003409,1.00000000000537,0.901377980420617,0,1,optic cup structural organization,BP,
1496,GO:0003844,1.00000000000537,0.901377980420617,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1506,GO:0003867,1.00000000000537,0.901377980420617,0,1,4-aminobutyrate transaminase activity,MF,
1512,GO:0003875,1.00000000000537,0.901377980420617,0,1,ADP-ribosylarginine hydrolase activity,MF,
1515,GO:0003878,1.00000000000537,0.901377980420617,0,1,ATP citrate synthase activity,MF,
1555,GO:0003957,1.00000000000537,0.901377980420617,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1562,GO:0003972,1.00000000000537,0.901377980420617,0,1,RNA ligase (ATP) activity,MF,
1563,GO:0003973,1.00000000000537,0.901377980420617,0,1,(S)-2-hydroxy-acid oxidase activity,MF,
1569,GO:0003979,1.00000000000537,0.901377980420617,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1593,GO:0004014,1.00000000000537,0.901377980420617,0,1,adenosylmethionine decarboxylase activity,MF,
1599,GO:0004021,1.00000000000537,0.901377980420617,0,1,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1605,GO:0004031,1.00000000000537,0.901377980420617,0,1,aldehyde oxidase activity,MF,
1611,GO:0004043,1.00000000000537,0.901377980420617,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1612,GO:0004044,1.00000000000537,0.901377980420617,0,1,amidophosphoribosyltransferase activity,MF,
1637,GO:0004083,1.00000000000537,0.901377980420617,0,1,bisphosphoglycerate 2-phosphatase activity,MF,
1651,GO:0004108,1.00000000000537,0.901377980420617,0,1,citrate (Si)-synthase activity,MF,
1655,GO:0004113,1.00000000000537,0.901377980420617,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1659,GO:0004118,1.00000000000537,0.901377980420617,0,1,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1667,GO:0004133,1.00000000000537,0.901377980420617,0,1,glycogen debranching enzyme activity,MF,
1668,GO:0004134,1.00000000000537,0.901377980420617,0,1,4-alpha-glucanotransferase activity,MF,
1669,GO:0004135,1.00000000000537,0.901377980420617,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1679,GO:0004148,1.00000000000537,0.901377980420617,0,1,dihydrolipoyl dehydrogenase activity,MF,
1680,GO:0004149,1.00000000000537,0.901377980420617,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1684,GO:0004157,1.00000000000537,0.901377980420617,0,1,dihydropyrimidinase activity,MF,
1718,GO:0004313,1.00000000000537,0.901377980420617,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1721,GO:0004316,1.00000000000537,0.901377980420617,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1722,GO:0004317,1.00000000000537,0.901377980420617,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1723,GO:0004319,1.00000000000537,0.901377980420617,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1727,GO:0004325,1.00000000000537,0.901377980420617,0,1,ferrochelatase activity,MF,
1735,GO:0004336,1.00000000000537,0.901377980420617,0,1,galactosylceramidase activity,MF,
1739,GO:0004343,1.00000000000537,0.901377980420617,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1745,GO:0004349,1.00000000000537,0.901377980420617,0,1,glutamate 5-kinase activity,MF,
1746,GO:0004350,1.00000000000537,0.901377980420617,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1748,GO:0004352,1.00000000000537,0.901377980420617,0,1,glutamate dehydrogenase (NAD+) activity,MF,
1749,GO:0004353,1.00000000000537,0.901377980420617,0,1,glutamate dehydrogenase [NAD(P)+] activity,MF,
1753,GO:0004360,1.00000000000537,0.901377980420617,0,1,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1761,GO:0004368,1.00000000000537,0.901377980420617,0,1,glycerol-3-phosphate dehydrogenase activity,MF,
1765,GO:0004373,1.00000000000537,0.901377980420617,0,1,glycogen (starch) synthase activity,MF,
1766,GO:0004375,1.00000000000537,0.901377980420617,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1769,GO:0004378,1.00000000000537,0.901377980420617,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1776,GO:0004394,1.00000000000537,0.901377980420617,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1779,GO:0004397,1.00000000000537,0.901377980420617,0,1,histidine ammonia-lyase activity,MF,
1787,GO:0004420,1.00000000000537,0.901377980420617,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1788,GO:0004421,1.00000000000537,0.901377980420617,0,1,hydroxymethylglutaryl-CoA synthase activity,MF,
1790,GO:0004423,1.00000000000537,0.901377980420617,0,1,iduronate-2-sulfatase activity,MF,
1798,GO:0004446,1.00000000000537,0.901377980420617,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1821,GO:0004478,1.00000000000537,0.901377980420617,0,1,methionine adenosyltransferase activity,MF,
1823,GO:0004482,1.00000000000537,0.901377980420617,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
1825,GO:0004484,1.00000000000537,0.901377980420617,0,1,mRNA guanylyltransferase activity,MF,
1827,GO:0004486,1.00000000000537,0.901377980420617,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
1835,GO:0004494,1.00000000000537,0.901377980420617,0,1,methylmalonyl-CoA mutase activity,MF,
1840,GO:0004500,1.00000000000537,0.901377980420617,0,1,dopamine beta-monooxygenase activity,MF,
1841,GO:0004504,1.00000000000537,0.901377980420617,0,1,peptidylglycine monooxygenase activity,MF,
1843,GO:0004506,1.00000000000537,0.901377980420617,0,1,squalene monooxygenase activity,MF,
1882,GO:0004567,1.00000000000537,0.901377980420617,0,1,beta-mannosidase activity,MF,
1884,GO:0004569,1.00000000000537,0.901377980420617,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
1891,GO:0004578,1.00000000000537,0.901377980420617,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
1905,GO:0004597,1.00000000000537,0.901377980420617,0,1,peptide-aspartate beta-dioxygenase activity,MF,
1906,GO:0004598,1.00000000000537,0.901377980420617,0,1,peptidylamidoglycolate lyase activity,MF,
1932,GO:0004637,1.00000000000537,0.901377980420617,0,1,phosphoribosylamine-glycine ligase activity,MF,
1933,GO:0004638,1.00000000000537,0.901377980420617,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
1934,GO:0004639,1.00000000000537,0.901377980420617,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
1935,GO:0004641,1.00000000000537,0.901377980420617,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
1936,GO:0004642,1.00000000000537,0.901377980420617,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
1938,GO:0004644,1.00000000000537,0.901377980420617,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
1946,GO:0004654,1.00000000000537,0.901377980420617,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
1947,GO:0004655,1.00000000000537,0.901377980420617,0,1,porphobilinogen synthase activity,MF,
1958,GO:0004671,1.00000000000537,0.901377980420617,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
1963,GO:0004676,1.00000000000537,0.901377980420617,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
1972,GO:0004692,1.00000000000537,0.901377980420617,0,1,cGMP-dependent protein kinase activity,MF,
1976,GO:0004698,1.00000000000537,0.901377980420617,0,1,calcium-dependent protein kinase C activity,MF,
2011,GO:0004742,1.00000000000537,0.901377980420617,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2012,GO:0004743,1.00000000000537,0.901377980420617,0,1,pyruvate kinase activity,MF,
2019,GO:0004753,1.00000000000537,0.901377980420617,0,1,saccharopine dehydrogenase activity,MF,
2028,GO:0004772,1.00000000000537,0.901377980420617,0,1,sterol O-acyltransferase activity,MF,
2029,GO:0004773,1.00000000000537,0.901377980420617,0,1,steryl-sulfatase activity,MF,
2033,GO:0004777,1.00000000000537,0.901377980420617,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2077,GO:0004835,1.00000000000537,0.901377980420617,0,1,tubulin-tyrosine ligase activity,MF,
2088,GO:0004856,1.00000000000537,0.901377980420617,0,1,xylulokinase activity,MF,
2102,GO:0004882,1.00000000000537,0.901377980420617,0,1,androgen receptor activity,MF,
2103,GO:0004883,1.00000000000537,0.901377980420617,0,1,glucocorticoid receptor activity,MF,
2107,GO:0004890,1.00000000000537,0.901377980420617,0,1,GABA-A receptor activity,MF,
2122,GO:0004921,1.00000000000537,0.901377980420617,0,1,interleukin-11 receptor activity,MF,
2134,GO:0004948,1.00000000000537,0.901377980420617,0,1,calcitonin receptor activity,MF,
2140,GO:0004957,1.00000000000537,0.901377980420617,0,1,prostaglandin E receptor activity,MF,
2143,GO:0004962,1.00000000000537,0.901377980420617,0,1,endothelin receptor activity,MF,
2153,GO:0004980,1.00000000000537,0.901377980420617,0,1,melanocyte-stimulating hormone receptor activity,MF,
2156,GO:0004990,1.00000000000537,0.901377980420617,0,1,oxytocin receptor activity,MF,
2159,GO:0004996,1.00000000000537,0.901377980420617,0,1,thyroid-stimulating hormone receptor activity,MF,
2160,GO:0004998,1.00000000000537,0.901377980420617,0,1,transferrin receptor activity,MF,
2165,GO:0005004,1.00000000000537,0.901377980420617,0,1,GPI-linked ephrin receptor activity,MF,
2169,GO:0005008,1.00000000000537,0.901377980420617,0,1,hepatocyte growth factor-activated receptor activity,MF,
2176,GO:0005026,1.00000000000537,0.901377980420617,0,1,transforming growth factor beta receptor activity, type II,MF,
2177,GO:0005030,1.00000000000537,0.901377980420617,0,1,neurotrophin receptor activity,MF,
2182,GO:0005042,1.00000000000537,0.901377980420617,0,1,netrin receptor activity,MF,
2215,GO:0005115,1.00000000000537,0.901377980420617,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2222,GO:0005128,1.00000000000537,0.901377980420617,0,1,erythropoietin receptor binding,MF,
2226,GO:0005135,1.00000000000537,0.901377980420617,0,1,interleukin-3 receptor binding,MF,
2227,GO:0005136,1.00000000000537,0.901377980420617,0,1,interleukin-4 receptor binding,MF,
2251,GO:0005170,1.00000000000537,0.901377980420617,0,1,neurotrophin TRKC receptor binding,MF,
2263,GO:0005199,1.00000000000537,0.901377980420617,0,1,structural constituent of cell wall,MF,
2278,GO:0005237,1.00000000000537,0.901377980420617,0,1,inhibitory extracellular ligand-gated ion channel activity,MF,
2295,GO:0005275,1.00000000000537,0.901377980420617,0,1,amine transmembrane transporter activity,MF,
2302,GO:0005294,1.00000000000537,0.901377980420617,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2303,GO:0005295,1.00000000000537,0.901377980420617,0,1,neutral amino acid:sodium symporter activity,MF,
2304,GO:0005298,1.00000000000537,0.901377980420617,0,1,proline:sodium symporter activity,MF,
2317,GO:0005330,1.00000000000537,0.901377980420617,0,1,dopamine:sodium symporter activity,MF,
2319,GO:0005335,1.00000000000537,0.901377980420617,0,1,serotonin:sodium symporter activity,MF,
2332,GO:0005366,1.00000000000537,0.901377980420617,0,1,myo-inositol:proton symporter activity,MF,
2333,GO:0005367,1.00000000000537,0.901377980420617,0,1,myo-inositol:sodium symporter activity,MF,
2334,GO:0005368,1.00000000000537,0.901377980420617,0,1,taurine transmembrane transporter activity,MF,
2335,GO:0005369,1.00000000000537,0.901377980420617,0,1,taurine:sodium symporter activity,MF,
2347,GO:0005427,1.00000000000537,0.901377980420617,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2355,GO:0005461,1.00000000000537,0.901377980420617,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2357,GO:0005464,1.00000000000537,0.901377980420617,0,1,UDP-xylose transmembrane transporter activity,MF,
2360,GO:0005477,1.00000000000537,0.901377980420617,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2368,GO:0005502,1.00000000000537,0.901377980420617,0,1,11-cis retinal binding,MF,
2369,GO:0005503,1.00000000000537,0.901377980420617,0,1,all-trans retinal binding,MF,
2378,GO:0005519,1.00000000000537,0.901377980420617,0,1,cytoskeletal regulatory protein binding,MF,
2410,GO:0005590,1.00000000000537,0.901377980420617,0,1,collagen type VII trimer,CC,
2412,GO:0005592,1.00000000000537,0.901377980420617,0,1,collagen type XI trimer,CC,
2415,GO:0005595,1.00000000000537,0.901377980420617,0,1,collagen type XII trimer,CC,
2416,GO:0005597,1.00000000000537,0.901377980420617,0,1,collagen type XVI trimer,CC,
2469,GO:0005691,1.00000000000537,0.901377980420617,0,1,U6atac snRNP,CC,
2550,GO:0005833,1.00000000000537,0.901377980420617,0,1,hemoglobin complex,CC,
2570,GO:0005863,1.00000000000537,0.901377980420617,0,1,striated muscle myosin thick filament,CC,
2594,GO:0005898,1.00000000000537,0.901377980420617,0,1,interleukin-13 receptor complex,CC,
2631,GO:0005969,1.00000000000537,0.901377980420617,0,1,serine-pyruvate aminotransferase complex,CC,
2644,GO:0005991,1.00000000000537,0.901377980420617,0,1,trehalose metabolic process,BP,
2647,GO:0005998,1.00000000000537,0.901377980420617,0,1,xylulose catabolic process,BP,
2679,GO:0006049,1.00000000000537,0.901377980420617,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2726,GO:0006113,1.00000000000537,0.901377980420617,0,1,fermentation,BP,
2735,GO:0006127,1.00000000000537,0.901377980420617,0,1,glycerophosphate shuttle,BP,
2740,GO:0006147,1.00000000000537,0.901377980420617,0,1,guanine catabolic process,BP,
2754,GO:0006174,1.00000000000537,0.901377980420617,0,1,dADP phosphorylation,BP,
2761,GO:0006186,1.00000000000537,0.901377980420617,0,1,dGDP phosphorylation,BP,
2774,GO:0006212,1.00000000000537,0.901377980420617,0,1,uracil catabolic process,BP,
2776,GO:0006214,1.00000000000537,0.901377980420617,0,1,thymidine catabolic process,BP,
2792,GO:0006256,1.00000000000537,0.901377980420617,0,1,UDP catabolic process,BP,
2835,GO:0006311,1.00000000000537,0.901377980420617,0,1,meiotic gene conversion,BP,
2837,GO:0006313,1.00000000000537,0.901377980420617,0,1,transposition, DNA-mediated,BP,
2847,GO:0006343,1.00000000000537,0.901377980420617,0,1,establishment of chromatin silencing,BP,
2930,GO:0006463,1.00000000000537,0.901377980420617,0,1,steroid hormone receptor complex assembly,BP,
2944,GO:0006480,1.00000000000537,0.901377980420617,0,1,N-terminal protein amino acid methylation,BP,
2972,GO:0006522,1.00000000000537,0.901377980420617,0,1,alanine metabolic process,BP,
2973,GO:0006524,1.00000000000537,0.901377980420617,0,1,alanine catabolic process,BP,
3004,GO:0006557,1.00000000000537,0.901377980420617,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3030,GO:0006589,1.00000000000537,0.901377980420617,0,1,octopamine biosynthetic process,BP,
3033,GO:0006592,1.00000000000537,0.901377980420617,0,1,ornithine biosynthetic process,BP,
3088,GO:0006669,1.00000000000537,0.901377980420617,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3090,GO:0006671,1.00000000000537,0.901377980420617,0,1,phytosphingosine metabolic process,BP,
3098,GO:0006683,1.00000000000537,0.901377980420617,0,1,galactosylceramide catabolic process,BP,
3128,GO:0006726,1.00000000000537,0.901377980420617,0,1,eye pigment biosynthetic process,BP,
3139,GO:0006742,1.00000000000537,0.901377980420617,0,1,NADP catabolic process,BP,
3148,GO:0006756,1.00000000000537,0.901377980420617,0,1,AMP phosphorylation,BP,
3300,GO:0007008,1.00000000000537,0.901377980420617,0,1,outer mitochondrial membrane organization,BP,
3303,GO:0007014,1.00000000000537,0.901377980420617,0,1,actin ubiquitination,BP,
3367,GO:0007146,1.00000000000537,0.901377980420617,0,1,meiotic recombination nodule assembly,BP,
3368,GO:0007147,1.00000000000537,0.901377980420617,0,1,female meiosis II,BP,
3406,GO:0007196,1.00000000000537,0.901377980420617,0,1,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3413,GO:0007206,1.00000000000537,0.901377980420617,0,1,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3428,GO:0007225,1.00000000000537,0.901377980420617,0,1,patched ligand maturation,BP,
3462,GO:0007290,1.00000000000537,0.901377980420617,0,1,spermatid nucleus elongation,BP,
3479,GO:0007352,1.00000000000537,0.901377980420617,0,1,zygotic specification of dorsal/ventral axis,BP,
3484,GO:0007371,1.00000000000537,0.901377980420617,0,1,ventral midline determination,BP,
3493,GO:0007403,1.00000000000537,0.901377980420617,0,1,glial cell fate determination,BP,
3508,GO:0007439,1.00000000000537,0.901377980420617,0,1,ectodermal digestive tract development,BP,
3514,GO:0007495,1.00000000000537,0.901377980420617,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3515,GO:0007497,1.00000000000537,0.901377980420617,0,1,posterior midgut development,BP,
3517,GO:0007499,1.00000000000537,0.901377980420617,0,1,ectoderm and mesoderm interaction,BP,
3521,GO:0007509,1.00000000000537,0.901377980420617,0,1,mesoderm migration involved in gastrulation,BP,
3569,GO:0007621,1.00000000000537,0.901377980420617,0,1,negative regulation of female receptivity,BP,
3572,GO:0007624,1.00000000000537,0.901377980420617,0,1,ultradian rhythm,BP,
3606,GO:0008057,1.00000000000537,0.901377980420617,0,1,eye pigment granule organization,BP,
3615,GO:0008078,1.00000000000537,0.901377980420617,0,1,mesodermal cell migration,BP,
3636,GO:0008117,1.00000000000537,0.901377980420617,0,1,sphinganine-1-phosphate aldolase activity,MF,
3638,GO:0008119,1.00000000000537,0.901377980420617,0,1,thiopurine S-methyltransferase activity,MF,
3642,GO:0008126,1.00000000000537,0.901377980420617,0,1,acetylesterase activity,MF,
3702,GO:0008218,1.00000000000537,0.901377980420617,0,1,bioluminescence,BP,
3719,GO:0008254,1.00000000000537,0.901377980420617,0,1,3'-nucleotidase activity,MF,
3720,GO:0008260,1.00000000000537,0.901377980420617,0,1,3-oxoacid CoA-transferase activity,MF,
3724,GO:0008267,1.00000000000537,0.901377980420617,0,1,poly-glutamine tract binding,MF,
3735,GO:0008281,1.00000000000537,0.901377980420617,0,1,sulfonylurea receptor activity,MF,
3744,GO:0008294,1.00000000000537,0.901377980420617,0,1,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
3773,GO:0008343,1.00000000000537,0.901377980420617,0,1,adult feeding behavior,BP,
3776,GO:0008348,1.00000000000537,0.901377980420617,0,1,negative regulation of antimicrobial humoral response,BP,
3781,GO:0008355,1.00000000000537,0.901377980420617,0,1,olfactory learning,BP,
3800,GO:0008398,1.00000000000537,0.901377980420617,0,1,sterol 14-demethylase activity,MF,
3802,GO:0008403,1.00000000000537,0.901377980420617,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
3815,GO:0008424,1.00000000000537,0.901377980420617,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
3824,GO:0008434,1.00000000000537,0.901377980420617,0,1,calcitriol receptor activity,MF,
3833,GO:0008452,1.00000000000537,0.901377980420617,0,1,RNA ligase activity,MF,
3834,GO:0008453,1.00000000000537,0.901377980420617,0,1,alanine-glyoxylate transaminase activity,MF,
3838,GO:0008457,1.00000000000537,0.901377980420617,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
3839,GO:0008458,1.00000000000537,0.901377980420617,0,1,carnitine O-octanoyltransferase activity,MF,
3846,GO:0008470,1.00000000000537,0.901377980420617,0,1,isovaleryl-CoA dehydrogenase activity,MF,
3850,GO:0008478,1.00000000000537,0.901377980420617,0,1,pyridoxal kinase activity,MF,
3857,GO:0008488,1.00000000000537,0.901377980420617,0,1,gamma-glutamyl carboxylase activity,MF,
3858,GO:0008489,1.00000000000537,0.901377980420617,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
3861,GO:0008495,1.00000000000537,0.901377980420617,0,1,protoheme IX farnesyltransferase activity,MF,
3871,GO:0008511,1.00000000000537,0.901377980420617,0,1,sodium:potassium:chloride symporter activity,MF,
3876,GO:0008518,1.00000000000537,0.901377980420617,0,1,reduced folate carrier activity,MF,
3878,GO:0008520,1.00000000000537,0.901377980420617,0,1,L-ascorbate:sodium symporter activity,MF,
3880,GO:0008523,1.00000000000537,0.901377980420617,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
3898,GO:0008555,1.00000000000537,0.901377980420617,0,1,chloride-transporting ATPase activity,MF,
3905,GO:0008579,1.00000000000537,0.901377980420617,0,1,JUN kinase phosphatase activity,MF,
3911,GO:0008592,1.00000000000537,0.901377980420617,0,1,regulation of Toll signaling pathway,BP,
3919,GO:0008609,1.00000000000537,0.901377980420617,0,1,alkylglycerone-phosphate synthase activity,MF,
3940,GO:0008650,1.00000000000537,0.901377980420617,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
3947,GO:0008700,1.00000000000537,0.901377980420617,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
3948,GO:0008705,1.00000000000537,0.901377980420617,0,1,methionine synthase activity,MF,
3954,GO:0008746,1.00000000000537,0.901377980420617,0,1,NAD(P)+ transhydrogenase activity,MF,
3956,GO:0008750,1.00000000000537,0.901377980420617,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
3957,GO:0008753,1.00000000000537,0.901377980420617,0,1,NADPH dehydrogenase (quinone) activity,MF,
3959,GO:0008761,1.00000000000537,0.901377980420617,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
3965,GO:0008792,1.00000000000537,0.901377980420617,0,1,arginine decarboxylase activity,MF,
3968,GO:0008798,1.00000000000537,0.901377980420617,0,1,beta-aspartyl-peptidase activity,MF,
3969,GO:0008802,1.00000000000537,0.901377980420617,0,1,betaine-aldehyde dehydrogenase activity,MF,
3971,GO:0008808,1.00000000000537,0.901377980420617,0,1,cardiolipin synthase activity,MF,
3972,GO:0008817,1.00000000000537,0.901377980420617,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
3976,GO:0008832,1.00000000000537,0.901377980420617,0,1,dGTPase activity,MF,
3978,GO:0008852,1.00000000000537,0.901377980420617,0,1,exodeoxyribonuclease I activity,MF,
3982,GO:0008887,1.00000000000537,0.901377980420617,0,1,glycerate kinase activity,MF,
3985,GO:0008892,1.00000000000537,0.901377980420617,0,1,guanine deaminase activity,MF,
3988,GO:0008897,1.00000000000537,0.901377980420617,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4000,GO:0008973,1.00000000000537,0.901377980420617,0,1,phosphopentomutase activity,MF,
4004,GO:0009007,1.00000000000537,0.901377980420617,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4006,GO:0009013,1.00000000000537,0.901377980420617,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4033,GO:0009078,1.00000000000537,0.901377980420617,0,1,pyruvate family amino acid metabolic process,BP,
4034,GO:0009080,1.00000000000537,0.901377980420617,0,1,pyruvate family amino acid catabolic process,BP,
4077,GO:0009140,1.00000000000537,0.901377980420617,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4125,GO:0009193,1.00000000000537,0.901377980420617,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4126,GO:0009195,1.00000000000537,0.901377980420617,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4151,GO:0009222,1.00000000000537,0.901377980420617,0,1,pyrimidine ribonucleotide catabolic process,BP,
4159,GO:0009234,1.00000000000537,0.901377980420617,0,1,menaquinone biosynthetic process,BP,
4162,GO:0009237,1.00000000000537,0.901377980420617,0,1,siderophore metabolic process,BP,
4201,GO:0009346,1.00000000000537,0.901377980420617,0,1,citrate lyase complex,CC,
4205,GO:0009372,1.00000000000537,0.901377980420617,0,1,quorum sensing,BP,
4209,GO:0009384,1.00000000000537,0.901377980420617,0,1,N-acylmannosamine kinase activity,MF,
4216,GO:0009400,1.00000000000537,0.901377980420617,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4229,GO:0009436,1.00000000000537,0.901377980420617,0,1,glyoxylate catabolic process,BP,
4235,GO:0009443,1.00000000000537,0.901377980420617,0,1,pyridoxal 5'-phosphate salvage,BP,
4264,GO:0009631,1.00000000000537,0.901377980420617,0,1,cold acclimation,BP,
4270,GO:0009645,1.00000000000537,0.901377980420617,0,1,response to low light intensity stimulus,BP,
4271,GO:0009646,1.00000000000537,0.901377980420617,0,1,response to absence of light,BP,
4278,GO:0009674,1.00000000000537,0.901377980420617,0,1,potassium:sodium symporter activity,MF,
4287,GO:0009737,1.00000000000537,0.901377980420617,0,1,response to abscisic acid,BP,
4288,GO:0009738,1.00000000000537,0.901377980420617,0,1,abscisic acid-activated signaling pathway,BP,
4298,GO:0009758,1.00000000000537,0.901377980420617,0,1,carbohydrate utilization,BP,
4301,GO:0009787,1.00000000000537,0.901377980420617,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4302,GO:0009789,1.00000000000537,0.901377980420617,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4351,GO:0009956,1.00000000000537,0.901377980420617,0,1,radial pattern formation,BP,
4374,GO:0010034,1.00000000000537,0.901377980420617,0,1,response to acetate,BP,
4395,GO:0010142,1.00000000000537,0.901377980420617,0,1,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
4397,GO:0010157,1.00000000000537,0.901377980420617,0,1,response to chlorate,BP,
4414,GO:0010232,1.00000000000537,0.901377980420617,0,1,vascular transport,BP,
4421,GO:0010260,1.00000000000537,0.901377980420617,0,1,animal organ senescence,BP,
4433,GO:0010335,1.00000000000537,0.901377980420617,0,1,response to non-ionic osmotic stress,BP,
4435,GO:0010348,1.00000000000537,0.901377980420617,0,1,lithium:proton antiporter activity,MF,
4444,GO:0010412,1.00000000000537,0.901377980420617,0,1,mannan metabolic process,BP,
4447,GO:0010428,1.00000000000537,0.901377980420617,0,1,methyl-CpNpG binding,MF,
4448,GO:0010430,1.00000000000537,0.901377980420617,0,1,fatty acid omega-oxidation,BP,
4460,GO:0010465,1.00000000000537,0.901377980420617,0,1,nerve growth factor receptor activity,MF,
4477,GO:0010509,1.00000000000537,0.901377980420617,0,1,polyamine homeostasis,BP,
4532,GO:0010615,1.00000000000537,0.901377980420617,0,1,positive regulation of cardiac muscle adaptation,BP,
4582,GO:0010700,1.00000000000537,0.901377980420617,0,1,negative regulation of norepinephrine secretion,BP,
4584,GO:0010705,1.00000000000537,0.901377980420617,0,1,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4597,GO:0010722,1.00000000000537,0.901377980420617,0,1,regulation of ferrochelatase activity,BP,
4608,GO:0010736,1.00000000000537,0.901377980420617,0,1,serum response element binding,MF,
4622,GO:0010754,1.00000000000537,0.901377980420617,0,1,negative regulation of cGMP-mediated signaling,BP,
4651,GO:0010808,1.00000000000537,0.901377980420617,0,1,positive regulation of synaptic vesicle priming,BP,
4656,GO:0010814,1.00000000000537,0.901377980420617,0,1,substance P catabolic process,BP,
4658,GO:0010816,1.00000000000537,0.901377980420617,0,1,calcitonin catabolic process,BP,
4684,GO:0010848,1.00000000000537,0.901377980420617,0,1,regulation of chromatin disassembly,BP,
4688,GO:0010856,1.00000000000537,0.901377980420617,0,1,adenylate cyclase activator activity,MF,
4691,GO:0010859,1.00000000000537,0.901377980420617,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
4744,GO:0010931,1.00000000000537,0.901377980420617,0,1,macrophage tolerance induction,BP,
4745,GO:0010932,1.00000000000537,0.901377980420617,0,1,regulation of macrophage tolerance induction,BP,
4746,GO:0010933,1.00000000000537,0.901377980420617,0,1,positive regulation of macrophage tolerance induction,BP,
4795,GO:0010999,1.00000000000537,0.901377980420617,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
4807,GO:0014011,1.00000000000537,0.901377980420617,0,1,Schwann cell proliferation involved in axon regeneration,BP,
4821,GO:0014036,1.00000000000537,0.901377980420617,0,1,neural crest cell fate specification,BP,
4836,GO:0014053,1.00000000000537,0.901377980420617,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
4842,GO:0014064,1.00000000000537,0.901377980420617,0,1,positive regulation of serotonin secretion,BP,
4863,GO:0014734,1.00000000000537,0.901377980420617,0,1,skeletal muscle hypertrophy,BP,
4867,GO:0014739,1.00000000000537,0.901377980420617,0,1,positive regulation of muscle hyperplasia,BP,
4895,GO:0014835,1.00000000000537,0.901377980420617,0,1,myoblast differentiation involved in skeletal muscle regeneration,BP,
4899,GO:0014843,1.00000000000537,0.901377980420617,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
4904,GO:0014852,1.00000000000537,0.901377980420617,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
4905,GO:0014853,1.00000000000537,0.901377980420617,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
4917,GO:0014878,1.00000000000537,0.901377980420617,0,1,response to electrical stimulus involved in regulation of muscle adaptation,BP,
4933,GO:0014908,1.00000000000537,0.901377980420617,0,1,myotube differentiation involved in skeletal muscle regeneration,BP,
4963,GO:0015086,1.00000000000537,0.901377980420617,0,1,cadmium ion transmembrane transporter activity,MF,
4964,GO:0015087,1.00000000000537,0.901377980420617,0,1,cobalt ion transmembrane transporter activity,MF,
4965,GO:0015091,1.00000000000537,0.901377980420617,0,1,ferric iron transmembrane transporter activity,MF,
4967,GO:0015094,1.00000000000537,0.901377980420617,0,1,lead ion transmembrane transporter activity,MF,
4982,GO:0015127,1.00000000000537,0.901377980420617,0,1,bilirubin transmembrane transporter activity,MF,
4984,GO:0015130,1.00000000000537,0.901377980420617,0,1,mevalonate transmembrane transporter activity,MF,
4986,GO:0015136,1.00000000000537,0.901377980420617,0,1,sialic acid transmembrane transporter activity,MF,
5020,GO:0015195,1.00000000000537,0.901377980420617,0,1,L-threonine transmembrane transporter activity,MF,
5022,GO:0015203,1.00000000000537,0.901377980420617,0,1,polyamine transmembrane transporter activity,MF,
5036,GO:0015229,1.00000000000537,0.901377980420617,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5045,GO:0015252,1.00000000000537,0.901377980420617,0,1,proton channel activity,MF,
5047,GO:0015265,1.00000000000537,0.901377980420617,0,1,urea channel activity,MF,
5051,GO:0015272,1.00000000000537,0.901377980420617,0,1,ATP-activated inward rectifier potassium channel activity,MF,
5059,GO:0015292,1.00000000000537,0.901377980420617,0,1,uniporter activity,MF,
5074,GO:0015322,1.00000000000537,0.901377980420617,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5075,GO:0015327,1.00000000000537,0.901377980420617,0,1,cystine:glutamate antiporter activity,MF,
5076,GO:0015328,1.00000000000537,0.901377980420617,0,1,cystine secondary active transmembrane transporter activity,MF,
5085,GO:0015369,1.00000000000537,0.901377980420617,0,1,calcium:proton antiporter activity,MF,
5088,GO:0015375,1.00000000000537,0.901377980420617,0,1,glycine:sodium symporter activity,MF,
5090,GO:0015378,1.00000000000537,0.901377980420617,0,1,sodium:chloride symporter activity,MF,
5100,GO:0015420,1.00000000000537,0.901377980420617,0,1,cobalamin-transporting ATPase activity,MF,
5101,GO:0015421,1.00000000000537,0.901377980420617,0,1,oligopeptide-transporting ATPase activity,MF,
5102,GO:0015431,1.00000000000537,0.901377980420617,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5103,GO:0015432,1.00000000000537,0.901377980420617,0,1,bile acid-exporting ATPase activity,MF,
5105,GO:0015439,1.00000000000537,0.901377980420617,0,1,heme-transporting ATPase activity,MF,
5112,GO:0015489,1.00000000000537,0.901377980420617,0,1,putrescine transmembrane transporter activity,MF,
5117,GO:0015538,1.00000000000537,0.901377980420617,0,1,sialic acid:proton symporter activity,MF,
5144,GO:0015692,1.00000000000537,0.901377980420617,0,1,lead ion transport,BP,
5146,GO:0015694,1.00000000000537,0.901377980420617,0,1,mercury ion transport,BP,
5161,GO:0015723,1.00000000000537,0.901377980420617,0,1,bilirubin transport,BP,
5164,GO:0015728,1.00000000000537,0.901377980420617,0,1,mevalonate transport,BP,
5167,GO:0015734,1.00000000000537,0.901377980420617,0,1,taurine transport,BP,
5168,GO:0015739,1.00000000000537,0.901377980420617,0,1,sialic acid transport,BP,
5186,GO:0015787,1.00000000000537,0.901377980420617,0,1,UDP-glucuronic acid transmembrane transport,BP,
5187,GO:0015790,1.00000000000537,0.901377980420617,0,1,UDP-xylose transmembrane transport,BP,
5213,GO:0015826,1.00000000000537,0.901377980420617,0,1,threonine transport,BP,
5222,GO:0015847,1.00000000000537,0.901377980420617,0,1,putrescine transport,BP,
5240,GO:0015878,1.00000000000537,0.901377980420617,0,1,biotin transport,BP,
5244,GO:0015882,1.00000000000537,0.901377980420617,0,1,L-ascorbic acid transmembrane transport,BP,
5247,GO:0015887,1.00000000000537,0.901377980420617,0,1,pantothenate transmembrane transport,BP,
5304,GO:0016031,1.00000000000537,0.901377980420617,0,1,tRNA import into mitochondrion,BP,
5329,GO:0016077,1.00000000000537,0.901377980420617,0,1,snoRNA catabolic process,BP,
5338,GO:0016098,1.00000000000537,0.901377980420617,0,1,monoterpenoid metabolic process,BP,
5341,GO:0016103,1.00000000000537,0.901377980420617,0,1,diterpenoid catabolic process,BP,
5343,GO:0016115,1.00000000000537,0.901377980420617,0,1,terpenoid catabolic process,BP,
5353,GO:0016149,1.00000000000537,0.901377980420617,0,1,translation release factor activity, codon specific,MF,
5363,GO:0016182,1.00000000000537,0.901377980420617,0,1,synaptic vesicle budding from endosome,BP,
5366,GO:0016189,1.00000000000537,0.901377980420617,0,1,synaptic vesicle to endosome fusion,BP,
5378,GO:0016213,1.00000000000537,0.901377980420617,0,1,linoleoyl-CoA desaturase activity,MF,
5384,GO:0016231,1.00000000000537,0.901377980420617,0,1,beta-N-acetylglucosaminidase activity,MF,
5385,GO:0016232,1.00000000000537,0.901377980420617,0,1,HNK-1 sulfotransferase activity,MF,
5390,GO:0016237,1.00000000000537,0.901377980420617,0,1,lysosomal microautophagy,BP,
5395,GO:0016243,1.00000000000537,0.901377980420617,0,1,regulation of autophagosome size,BP,
5418,GO:0016282,1.00000000000537,0.901377980420617,0,1,eukaryotic 43S preinitiation complex,CC,
5447,GO:0016333,1.00000000000537,0.901377980420617,0,1,morphogenesis of follicular epithelium,BP,
5448,GO:0016334,1.00000000000537,0.901377980420617,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5459,GO:0016402,1.00000000000537,0.901377980420617,0,1,pristanoyl-CoA oxidase activity,MF,
5461,GO:0016404,1.00000000000537,0.901377980420617,0,1,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5470,GO:0016414,1.00000000000537,0.901377980420617,0,1,O-octanoyltransferase activity,MF,
5471,GO:0016415,1.00000000000537,0.901377980420617,0,1,octanoyltransferase activity,MF,
5484,GO:0016430,1.00000000000537,0.901377980420617,0,1,tRNA (adenine-N6-)-methyltransferase activity,MF,
5520,GO:0016507,1.00000000000537,0.901377980420617,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5526,GO:0016520,1.00000000000537,0.901377980420617,0,1,growth hormone-releasing hormone receptor activity,MF,
5535,GO:0016534,1.00000000000537,0.901377980420617,0,1,cyclin-dependent protein kinase 5 activator activity,MF,
5563,GO:0016590,1.00000000000537,0.901377980420617,0,1,ACF complex,CC,
5569,GO:0016596,1.00000000000537,0.901377980420617,0,1,thienylcyclohexylpiperidine binding,MF,
5584,GO:0016623,1.00000000000537,0.901377980420617,0,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5591,GO:0016639,1.00000000000537,0.901377980420617,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5593,GO:0016642,1.00000000000537,0.901377980420617,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5599,GO:0016652,1.00000000000537,0.901377980420617,0,1,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5645,GO:0016751,1.00000000000537,0.901377980420617,0,1,S-succinyltransferase activity,MF,
5665,GO:0016785,1.00000000000537,0.901377980420617,0,1,transferase activity, transferring selenium-containing groups,MF,
5670,GO:0016793,1.00000000000537,0.901377980420617,0,1,triphosphoric monoester hydrolase activity,MF,
5679,GO:0016807,1.00000000000537,0.901377980420617,0,1,cysteine-type carboxypeptidase activity,MF,
5702,GO:0016843,1.00000000000537,0.901377980420617,0,1,amine-lyase activity,MF,
5703,GO:0016844,1.00000000000537,0.901377980420617,0,1,strictosidine synthase activity,MF,
5743,GO:0016901,1.00000000000537,0.901377980420617,0,1,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
5749,GO:0016920,1.00000000000537,0.901377980420617,0,1,pyroglutamyl-peptidase activity,MF,
5755,GO:0016938,1.00000000000537,0.901377980420617,0,1,kinesin I complex,CC,
5757,GO:0016941,1.00000000000537,0.901377980420617,0,1,natriuretic peptide receptor activity,MF,
5773,GO:0017005,1.00000000000537,0.901377980420617,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
5780,GO:0017020,1.00000000000537,0.901377980420617,0,1,myosin phosphatase regulator activity,MF,
5797,GO:0017061,1.00000000000537,0.901377980420617,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
5807,GO:0017082,1.00000000000537,0.901377980420617,0,1,mineralocorticoid receptor activity,MF,
5808,GO:0017084,1.00000000000537,0.901377980420617,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
5810,GO:0017087,1.00000000000537,0.901377980420617,0,1,mitochondrial processing peptidase complex,CC,
5823,GO:0017113,1.00000000000537,0.901377980420617,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
5828,GO:0017125,1.00000000000537,0.901377980420617,0,1,deoxycytidyl transferase activity,MF,
5829,GO:0017126,1.00000000000537,0.901377980420617,0,1,nucleologenesis,BP,
5832,GO:0017130,1.00000000000537,0.901377980420617,0,1,poly(C) RNA binding,MF,
5858,GO:0017177,1.00000000000537,0.901377980420617,0,1,glucosidase II complex,CC,
5859,GO:0017178,1.00000000000537,0.901377980420617,0,1,diphthine-ammonia ligase activity,MF,
5870,GO:0018011,1.00000000000537,0.901377980420617,0,1,N-terminal peptidyl-alanine methylation,BP,
5871,GO:0018012,1.00000000000537,0.901377980420617,0,1,N-terminal peptidyl-alanine trimethylation,BP,
5872,GO:0018013,1.00000000000537,0.901377980420617,0,1,N-terminal peptidyl-glycine methylation,BP,
5873,GO:0018016,1.00000000000537,0.901377980420617,0,1,N-terminal peptidyl-proline dimethylation,BP,
5877,GO:0018025,1.00000000000537,0.901377980420617,0,1,calmodulin-lysine N-methyltransferase activity,MF,
5880,GO:0018032,1.00000000000537,0.901377980420617,0,1,protein amidation,BP,
5885,GO:0018094,1.00000000000537,0.901377980420617,0,1,protein polyglycylation,BP,
5904,GO:0018166,1.00000000000537,0.901377980420617,0,1,C-terminal protein-tyrosinylation,BP,
5909,GO:0018194,1.00000000000537,0.901377980420617,0,1,peptidyl-alanine modification,BP,
5927,GO:0018217,1.00000000000537,0.901377980420617,0,1,peptidyl-aspartic acid phosphorylation,BP,
5943,GO:0018315,1.00000000000537,0.901377980420617,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
5945,GO:0018322,1.00000000000537,0.901377980420617,0,1,protein tyrosinylation,BP,
5958,GO:0018395,1.00000000000537,0.901377980420617,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
5984,GO:0018993,1.00000000000537,0.901377980420617,0,1,somatic sex determination,BP,
5992,GO:0019035,1.00000000000537,0.901377980420617,0,1,viral integration complex,CC,
6021,GO:0019089,1.00000000000537,0.901377980420617,0,1,transmission of virus,BP,
6024,GO:0019101,1.00000000000537,0.901377980420617,0,1,female somatic sex determination,BP,
6038,GO:0019171,1.00000000000537,0.901377980420617,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6041,GO:0019187,1.00000000000537,0.901377980420617,0,1,beta-1,4-mannosyltransferase activity,MF,
6046,GO:0019202,1.00000000000537,0.901377980420617,0,1,amino acid kinase activity,MF,
6083,GO:0019276,1.00000000000537,0.901377980420617,0,1,UDP-N-acetylgalactosamine metabolic process,BP,
6084,GO:0019285,1.00000000000537,0.901377980420617,0,1,glycine betaine biosynthetic process from choline,BP,
6086,GO:0019290,1.00000000000537,0.901377980420617,0,1,siderophore biosynthetic process,BP,
6108,GO:0019364,1.00000000000537,0.901377980420617,0,1,pyridine nucleotide catabolic process,BP,
6119,GO:0019376,1.00000000000537,0.901377980420617,0,1,galactolipid catabolic process,BP,
6149,GO:0019483,1.00000000000537,0.901377980420617,0,1,beta-alanine biosynthetic process,BP,
6172,GO:0019556,1.00000000000537,0.901377980420617,0,1,histidine catabolic process to glutamate and formamide,BP,
6173,GO:0019557,1.00000000000537,0.901377980420617,0,1,histidine catabolic process to glutamate and formate,BP,
6183,GO:0019659,1.00000000000537,0.901377980420617,0,1,glucose catabolic process to lactate,BP,
6184,GO:0019660,1.00000000000537,0.901377980420617,0,1,glycolytic fermentation,BP,
6185,GO:0019661,1.00000000000537,0.901377980420617,0,1,glucose catabolic process to lactate via pyruvate,BP,
6186,GO:0019666,1.00000000000537,0.901377980420617,0,1,nitrogenous compound fermentation,BP,
6190,GO:0019677,1.00000000000537,0.901377980420617,0,1,NAD catabolic process,BP,
6218,GO:0019778,1.00000000000537,0.901377980420617,0,1,Atg12 activating enzyme activity,MF,
6219,GO:0019779,1.00000000000537,0.901377980420617,0,1,Atg8 activating enzyme activity,MF,
6220,GO:0019780,1.00000000000537,0.901377980420617,0,1,FAT10 activating enzyme activity,MF,
6222,GO:0019782,1.00000000000537,0.901377980420617,0,1,ISG15 activating enzyme activity,MF,
6231,GO:0019799,1.00000000000537,0.901377980420617,0,1,tubulin N-acetyltransferase activity,MF,
6235,GO:0019810,1.00000000000537,0.901377980420617,0,1,putrescine binding,MF,
6236,GO:0019811,1.00000000000537,0.901377980420617,0,1,cocaine binding,MF,
6237,GO:0019814,1.00000000000537,0.901377980420617,0,1,immunoglobulin complex,CC,
6238,GO:0019815,1.00000000000537,0.901377980420617,0,1,B cell receptor complex,CC,
6308,GO:0019962,1.00000000000537,0.901377980420617,0,1,type I interferon binding,MF,
6309,GO:0019964,1.00000000000537,0.901377980420617,0,1,interferon-gamma binding,MF,
6311,GO:0019970,1.00000000000537,0.901377980420617,0,1,interleukin-11 binding,MF,
6316,GO:0020003,1.00000000000537,0.901377980420617,0,1,symbiont-containing vacuole,CC,
6325,GO:0021503,1.00000000000537,0.901377980420617,0,1,neural fold bending,BP,
6326,GO:0021508,1.00000000000537,0.901377980420617,0,1,floor plate formation,BP,
6329,GO:0021512,1.00000000000537,0.901377980420617,0,1,spinal cord anterior/posterior patterning,BP,
6350,GO:0021541,1.00000000000537,0.901377980420617,0,1,ammon gyrus development,BP,
6359,GO:0021553,1.00000000000537,0.901377980420617,0,1,olfactory nerve development,BP,
6373,GO:0021571,1.00000000000537,0.901377980420617,0,1,rhombomere 5 development,BP,
6374,GO:0021572,1.00000000000537,0.901377980420617,0,1,rhombomere 6 development,BP,
6376,GO:0021577,1.00000000000537,0.901377980420617,0,1,hindbrain structural organization,BP,
6378,GO:0021586,1.00000000000537,0.901377980420617,0,1,pons maturation,BP,
6380,GO:0021589,1.00000000000537,0.901377980420617,0,1,cerebellum structural organization,BP,
6383,GO:0021592,1.00000000000537,0.901377980420617,0,1,fourth ventricle development,BP,
6391,GO:0021615,1.00000000000537,0.901377980420617,0,1,glossopharyngeal nerve morphogenesis,BP,
6393,GO:0021622,1.00000000000537,0.901377980420617,0,1,oculomotor nerve morphogenesis,BP,
6394,GO:0021623,1.00000000000537,0.901377980420617,0,1,oculomotor nerve formation,BP,
6402,GO:0021650,1.00000000000537,0.901377980420617,0,1,vestibulocochlear nerve formation,BP,
6409,GO:0021682,1.00000000000537,0.901377980420617,0,1,nerve maturation,BP,
6412,GO:0021685,1.00000000000537,0.901377980420617,0,1,cerebellar granular layer structural organization,BP,
6414,GO:0021688,1.00000000000537,0.901377980420617,0,1,cerebellar molecular layer formation,BP,
6427,GO:0021718,1.00000000000537,0.901377980420617,0,1,superior olivary nucleus development,BP,
6428,GO:0021722,1.00000000000537,0.901377980420617,0,1,superior olivary nucleus maturation,BP,
6429,GO:0021730,1.00000000000537,0.901377980420617,0,1,trigeminal sensory nucleus development,BP,
6430,GO:0021740,1.00000000000537,0.901377980420617,0,1,principal sensory nucleus of trigeminal nerve development,BP,
6433,GO:0021757,1.00000000000537,0.901377980420617,0,1,caudate nucleus development,BP,
6434,GO:0021758,1.00000000000537,0.901377980420617,0,1,putamen development,BP,
6440,GO:0021768,1.00000000000537,0.901377980420617,0,1,nucleus accumbens development,BP,
6442,GO:0021771,1.00000000000537,0.901377980420617,0,1,lateral geniculate nucleus development,BP,
6447,GO:0021778,1.00000000000537,0.901377980420617,0,1,oligodendrocyte cell fate specification,BP,
6448,GO:0021779,1.00000000000537,0.901377980420617,0,1,oligodendrocyte cell fate commitment,BP,
6449,GO:0021780,1.00000000000537,0.901377980420617,0,1,glial cell fate specification,BP,
6458,GO:0021797,1.00000000000537,0.901377980420617,0,1,forebrain anterior/posterior pattern specification,BP,
6463,GO:0021812,1.00000000000537,0.901377980420617,0,1,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6491,GO:0021870,1.00000000000537,0.901377980420617,0,1,Cajal-Retzius cell differentiation,BP,
6497,GO:0021881,1.00000000000537,0.901377980420617,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
6527,GO:0021941,1.00000000000537,0.901377980420617,0,1,negative regulation of cerebellar granule cell precursor proliferation,BP,
6538,GO:0021966,1.00000000000537,0.901377980420617,0,1,corticospinal neuron axon guidance,BP,
6539,GO:0021972,1.00000000000537,0.901377980420617,0,1,corticospinal neuron axon guidance through spinal cord,BP,
6546,GO:0021993,1.00000000000537,0.901377980420617,0,1,initiation of neural tube closure,BP,
6548,GO:0021998,1.00000000000537,0.901377980420617,0,1,neural plate mediolateral regionalization,BP,
6555,GO:0022012,1.00000000000537,0.901377980420617,0,1,subpallium cell proliferation in forebrain,BP,
6556,GO:0022018,1.00000000000537,0.901377980420617,0,1,lateral ganglionic eminence cell proliferation,BP,
6612,GO:0022849,1.00000000000537,0.901377980420617,0,1,glutamate-gated calcium ion channel activity,MF,
6613,GO:0022851,1.00000000000537,0.901377980420617,0,1,GABA-gated chloride ion channel activity,MF,
6629,GO:0023024,1.00000000000537,0.901377980420617,0,1,MHC class I protein complex binding,MF,
6656,GO:0030021,1.00000000000537,0.901377980420617,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
6774,GO:0030222,1.00000000000537,0.901377980420617,0,1,eosinophil differentiation,BP,
6801,GO:0030264,1.00000000000537,0.901377980420617,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
6856,GO:0030342,1.00000000000537,0.901377980420617,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
6858,GO:0030345,1.00000000000537,0.901377980420617,0,1,structural constituent of tooth enamel,MF,
6862,GO:0030351,1.00000000000537,0.901377980420617,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
6866,GO:0030372,1.00000000000537,0.901377980420617,0,1,high molecular weight B cell growth factor receptor binding,MF,
6871,GO:0030379,1.00000000000537,0.901377980420617,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
6890,GO:0030474,1.00000000000537,0.901377980420617,0,1,spindle pole body duplication,BP,
6901,GO:0030504,1.00000000000537,0.901377980420617,0,1,inorganic diphosphate transmembrane transporter activity,MF,
6918,GO:0030523,1.00000000000537,0.901377980420617,0,1,dihydrolipoamide S-acyltransferase activity,MF,
6935,GO:0030572,1.00000000000537,0.901377980420617,0,1,phosphatidyltransferase activity,MF,
6943,GO:0030586,1.00000000000537,0.901377980420617,0,1,[methionine synthase] reductase activity,MF,
6950,GO:0030616,1.00000000000537,0.901377980420617,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
6951,GO:0030617,1.00000000000537,0.901377980420617,0,1,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
6957,GO:0030623,1.00000000000537,0.901377980420617,0,1,U5 snRNA binding,MF,
6958,GO:0030624,1.00000000000537,0.901377980420617,0,1,U6atac snRNA binding,MF,
6962,GO:0030629,1.00000000000537,0.901377980420617,0,1,U6 snRNA 3'-end binding,MF,
6968,GO:0030653,1.00000000000537,0.901377980420617,0,1,beta-lactam antibiotic metabolic process,BP,
6994,GO:0030690,1.00000000000537,0.901377980420617,0,1,Noc1p-Noc2p complex,CC,
6995,GO:0030691,1.00000000000537,0.901377980420617,0,1,Noc2p-Noc3p complex,CC,
6998,GO:0030696,1.00000000000537,0.901377980420617,0,1,tRNA (m5U54) methyltransferase activity,MF,
6999,GO:0030697,1.00000000000537,0.901377980420617,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7000,GO:0030702,1.00000000000537,0.901377980420617,0,1,chromatin silencing at centromere,BP,
7002,GO:0030718,1.00000000000537,0.901377980420617,0,1,germ-line stem cell population maintenance,BP,
7005,GO:0030729,1.00000000000537,0.901377980420617,0,1,acetoacetate-CoA ligase activity,MF,
7008,GO:0030735,1.00000000000537,0.901377980420617,0,1,carnosine N-methyltransferase activity,MF,
7049,GO:0030846,1.00000000000537,0.901377980420617,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7050,GO:0030849,1.00000000000537,0.901377980420617,0,1,autosome,CC,
7062,GO:0030862,1.00000000000537,0.901377980420617,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7076,GO:0030882,1.00000000000537,0.901377980420617,0,1,lipid antigen binding,MF,
7077,GO:0030883,1.00000000000537,0.901377980420617,0,1,endogenous lipid antigen binding,MF,
7078,GO:0030884,1.00000000000537,0.901377980420617,0,1,exogenous lipid antigen binding,MF,
7122,GO:0030961,1.00000000000537,0.901377980420617,0,1,peptidyl-arginine hydroxylation,BP,
7200,GO:0031104,1.00000000000537,0.901377980420617,0,1,dendrite regeneration,BP,
7227,GO:0031151,1.00000000000537,0.901377980420617,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7228,GO:0031161,1.00000000000537,0.901377980420617,0,1,phosphatidylinositol catabolic process,BP,
7234,GO:0031179,1.00000000000537,0.901377980420617,0,1,peptide modification,BP,
7280,GO:0031289,1.00000000000537,0.901377980420617,0,1,actin phosphorylation,BP,
7291,GO:0031302,1.00000000000537,0.901377980420617,0,1,intrinsic component of endosome membrane,CC,
7300,GO:0031315,1.00000000000537,0.901377980420617,0,1,extrinsic component of mitochondrial outer membrane,CC,
7331,GO:0031370,1.00000000000537,0.901377980420617,0,1,eukaryotic initiation factor 4G binding,MF,
7335,GO:0031380,1.00000000000537,0.901377980420617,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7337,GO:0031389,1.00000000000537,0.901377980420617,0,1,Rad17 RFC-like complex,CC,
7351,GO:0031405,1.00000000000537,0.901377980420617,0,1,lipoic acid binding,MF,
7369,GO:0031433,1.00000000000537,0.901377980420617,0,1,telethonin binding,MF,
7374,GO:0031438,1.00000000000537,0.901377980420617,0,1,negative regulation of mRNA cleavage,BP,
7379,GO:0031443,1.00000000000537,0.901377980420617,0,1,fast-twitch skeletal muscle fiber contraction,BP,
7383,GO:0031455,1.00000000000537,0.901377980420617,0,1,glycine betaine metabolic process,BP,
7384,GO:0031456,1.00000000000537,0.901377980420617,0,1,glycine betaine biosynthetic process,BP,
7385,GO:0031460,1.00000000000537,0.901377980420617,0,1,glycine betaine transport,BP,
7420,GO:0031533,1.00000000000537,0.901377980420617,0,1,mRNA cap methyltransferase complex,CC,
7426,GO:0031554,1.00000000000537,0.901377980420617,0,1,regulation of DNA-templated transcription, termination,BP,
7427,GO:0031559,1.00000000000537,0.901377980420617,0,1,oxidosqualene cyclase activity,MF,
7444,GO:0031592,1.00000000000537,0.901377980420617,0,1,centrosomal corona,CC,
7456,GO:0031626,1.00000000000537,0.901377980420617,0,1,beta-endorphin binding,MF,
7460,GO:0031630,1.00000000000537,0.901377980420617,0,1,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7475,GO:0031651,1.00000000000537,0.901377980420617,0,1,negative regulation of heat generation,BP,
7489,GO:0031673,1.00000000000537,0.901377980420617,0,1,H zone,CC,
7492,GO:0031682,1.00000000000537,0.901377980420617,0,1,G-protein gamma-subunit binding,MF,
7495,GO:0031686,1.00000000000537,0.901377980420617,0,1,A1 adenosine receptor binding,MF,
7502,GO:0031699,1.00000000000537,0.901377980420617,0,1,beta-3 adrenergic receptor binding,MF,
7506,GO:0031704,1.00000000000537,0.901377980420617,0,1,apelin receptor binding,MF,
7510,GO:0031714,1.00000000000537,0.901377980420617,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
7511,GO:0031715,1.00000000000537,0.901377980420617,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
7526,GO:0031775,1.00000000000537,0.901377980420617,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
7527,GO:0031798,1.00000000000537,0.901377980420617,0,1,type 1 metabotropic glutamate receptor binding,MF,
7536,GO:0031849,1.00000000000537,0.901377980420617,0,1,olfactory receptor binding,MF,
7541,GO:0031867,1.00000000000537,0.901377980420617,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
7542,GO:0031870,1.00000000000537,0.901377980420617,0,1,thromboxane A2 receptor binding,MF,
7569,GO:0031945,1.00000000000537,0.901377980420617,0,1,positive regulation of glucocorticoid metabolic process,BP,
7572,GO:0031948,1.00000000000537,0.901377980420617,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
7581,GO:0031962,1.00000000000537,0.901377980420617,0,1,mineralocorticoid receptor binding,MF,
7618,GO:0032029,1.00000000000537,0.901377980420617,0,1,myosin tail binding,MF,
7641,GO:0032072,1.00000000000537,0.901377980420617,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
7671,GO:0032127,1.00000000000537,0.901377980420617,0,1,dense core granule membrane,CC,
7680,GO:0032144,1.00000000000537,0.901377980420617,0,1,4-aminobutyrate transaminase complex,CC,
7681,GO:0032145,1.00000000000537,0.901377980420617,0,1,succinate-semialdehyde dehydrogenase binding,MF,
7689,GO:0032173,1.00000000000537,0.901377980420617,0,1,septin collar,CC,
7696,GO:0032194,1.00000000000537,0.901377980420617,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
7698,GO:0032197,1.00000000000537,0.901377980420617,0,1,transposition, RNA-mediated,BP,
7706,GO:0032207,1.00000000000537,0.901377980420617,0,1,regulation of telomere maintenance via recombination,BP,
7707,GO:0032208,1.00000000000537,0.901377980420617,0,1,negative regulation of telomere maintenance via recombination,BP,
7716,GO:0032222,1.00000000000537,0.901377980420617,0,1,regulation of synaptic transmission, cholinergic,BP,
7717,GO:0032224,1.00000000000537,0.901377980420617,0,1,positive regulation of synaptic transmission, cholinergic,BP,
7732,GO:0032253,1.00000000000537,0.901377980420617,0,1,dense core granule localization,BP,
7768,GO:0032304,1.00000000000537,0.901377980420617,0,1,negative regulation of icosanoid secretion,BP,
7785,GO:0032346,1.00000000000537,0.901377980420617,0,1,positive regulation of aldosterone metabolic process,BP,
7788,GO:0032349,1.00000000000537,0.901377980420617,0,1,positive regulation of aldosterone biosynthetic process,BP,
7851,GO:0032423,1.00000000000537,0.901377980420617,0,1,regulation of mismatch repair,BP,
7852,GO:0032425,1.00000000000537,0.901377980420617,0,1,positive regulation of mismatch repair,BP,
7878,GO:0032458,1.00000000000537,0.901377980420617,0,1,slow endocytic recycling,BP,
7888,GO:0032468,1.00000000000537,0.901377980420617,0,1,Golgi calcium ion homeostasis,BP,
7890,GO:0032470,1.00000000000537,0.901377980420617,0,1,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
7911,GO:0032498,1.00000000000537,0.901377980420617,0,1,detection of muramyl dipeptide,BP,
7912,GO:0032499,1.00000000000537,0.901377980420617,0,1,detection of peptidoglycan,BP,
7913,GO:0032500,1.00000000000537,0.901377980420617,0,1,muramyl dipeptide binding,MF,
7949,GO:0032560,1.00000000000537,0.901377980420617,0,1,guanyl deoxyribonucleotide binding,MF,
7952,GO:0032567,1.00000000000537,0.901377980420617,0,1,dGTP binding,MF,
7955,GO:0032574,1.00000000000537,0.901377980420617,0,1,5'-3' RNA helicase activity,MF,
7956,GO:0032575,1.00000000000537,0.901377980420617,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
7990,GO:0032625,1.00000000000537,0.901377980420617,0,1,interleukin-21 production,BP,
7999,GO:0032641,1.00000000000537,0.901377980420617,0,1,lymphotoxin A production,BP,
8024,GO:0032685,1.00000000000537,0.901377980420617,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8060,GO:0032752,1.00000000000537,0.901377980420617,0,1,positive regulation of interleukin-3 production,BP,
8070,GO:0032765,1.00000000000537,0.901377980420617,0,1,positive regulation of mast cell cytokine production,BP,
8075,GO:0032771,1.00000000000537,0.901377980420617,0,1,regulation of monophenol monooxygenase activity,BP,
8076,GO:0032773,1.00000000000537,0.901377980420617,0,1,positive regulation of monophenol monooxygenase activity,BP,
8078,GO:0032775,1.00000000000537,0.901377980420617,0,1,DNA methylation on adenine,BP,
8127,GO:0032848,1.00000000000537,0.901377980420617,0,1,negative regulation of cellular pH reduction,BP,
8144,GO:0032887,1.00000000000537,0.901377980420617,0,1,regulation of spindle elongation,BP,
8145,GO:0032888,1.00000000000537,0.901377980420617,0,1,regulation of mitotic spindle elongation,BP,
8152,GO:0032899,1.00000000000537,0.901377980420617,0,1,regulation of neurotrophin production,BP,
8153,GO:0032901,1.00000000000537,0.901377980420617,0,1,positive regulation of neurotrophin production,BP,
8162,GO:0032912,1.00000000000537,0.901377980420617,0,1,negative regulation of transforming growth factor beta2 production,BP,
8204,GO:0032977,1.00000000000537,0.901377980420617,0,1,membrane insertase activity,MF,
8205,GO:0032978,1.00000000000537,0.901377980420617,0,1,protein insertion into membrane from inner side,BP,
8206,GO:0032979,1.00000000000537,0.901377980420617,0,1,protein insertion into mitochondrial membrane from inner side,BP,
8235,GO:0033026,1.00000000000537,0.901377980420617,0,1,negative regulation of mast cell apoptotic process,BP,
8238,GO:0033030,1.00000000000537,0.901377980420617,0,1,negative regulation of neutrophil apoptotic process,BP,
8244,GO:0033037,1.00000000000537,0.901377980420617,0,1,polysaccharide localization,BP,
8264,GO:0033082,1.00000000000537,0.901377980420617,0,1,regulation of extrathymic T cell differentiation,BP,
8310,GO:0033167,1.00000000000537,0.901377980420617,0,1,ARC complex,CC,
8311,GO:0033168,1.00000000000537,0.901377980420617,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8367,GO:0033283,1.00000000000537,0.901377980420617,0,1,organic acid-transporting ATPase activity,MF,
8368,GO:0033284,1.00000000000537,0.901377980420617,0,1,carboxylic acid-transporting ATPase activity,MF,
8369,GO:0033285,1.00000000000537,0.901377980420617,0,1,monocarboxylic acid-transporting ATPase activity,MF,
8370,GO:0033290,1.00000000000537,0.901377980420617,0,1,eukaryotic 48S preinitiation complex,CC,
8376,GO:0033301,1.00000000000537,0.901377980420617,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8380,GO:0033316,1.00000000000537,0.901377980420617,0,1,meiotic spindle assembly checkpoint,BP,
8383,GO:0033326,1.00000000000537,0.901377980420617,0,1,cerebrospinal fluid secretion,BP,
8385,GO:0033328,1.00000000000537,0.901377980420617,0,1,peroxisome membrane targeting sequence binding,MF,
8388,GO:0033343,1.00000000000537,0.901377980420617,0,1,positive regulation of collagen binding,BP,
8404,GO:0033488,1.00000000000537,0.901377980420617,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
8411,GO:0033505,1.00000000000537,0.901377980420617,0,1,floor plate morphogenesis,BP,
8426,GO:0033560,1.00000000000537,0.901377980420617,0,1,folate reductase activity,MF,
8432,GO:0033570,1.00000000000537,0.901377980420617,0,1,transferrin transmembrane transporter activity,MF,
8441,GO:0033593,1.00000000000537,0.901377980420617,0,1,BRCA2-MAGE-D1 complex,CC,
8449,GO:0033602,1.00000000000537,0.901377980420617,0,1,negative regulation of dopamine secretion,BP,
8455,GO:0033609,1.00000000000537,0.901377980420617,0,1,oxalate metabolic process,BP,
8471,GO:0033633,1.00000000000537,0.901377980420617,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
8486,GO:0033679,1.00000000000537,0.901377980420617,0,1,3'-5' DNA/RNA helicase activity,MF,
8488,GO:0033681,1.00000000000537,0.901377980420617,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
8500,GO:0033695,1.00000000000537,0.901377980420617,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
8506,GO:0033746,1.00000000000537,0.901377980420617,0,1,histone demethylase activity (H3-R2 specific),MF,
8507,GO:0033749,1.00000000000537,0.901377980420617,0,1,histone demethylase activity (H4-R3 specific),MF,
8514,GO:0033787,1.00000000000537,0.901377980420617,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
8516,GO:0033823,1.00000000000537,0.901377980420617,0,1,procollagen glucosyltransferase activity,MF,
8520,GO:0033858,1.00000000000537,0.901377980420617,0,1,N-acetylgalactosamine kinase activity,MF,
8522,GO:0033862,1.00000000000537,0.901377980420617,0,1,UMP kinase activity,MF,
8531,GO:0033878,1.00000000000537,0.901377980420617,0,1,hormone-sensitive lipase activity,MF,
8537,GO:0033919,1.00000000000537,0.901377980420617,0,1,glucan 1,3-alpha-glucosidase activity,MF,
8538,GO:0033925,1.00000000000537,0.901377980420617,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
8613,GO:0034146,1.00000000000537,0.901377980420617,0,1,toll-like receptor 5 signaling pathway,BP,
8614,GO:0034147,1.00000000000537,0.901377980420617,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
8615,GO:0034148,1.00000000000537,0.901377980420617,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
8616,GO:0034150,1.00000000000537,0.901377980420617,0,1,toll-like receptor 6 signaling pathway,BP,
8618,GO:0034155,1.00000000000537,0.901377980420617,0,1,regulation of toll-like receptor 7 signaling pathway,BP,
8619,GO:0034157,1.00000000000537,0.901377980420617,0,1,positive regulation of toll-like receptor 7 signaling pathway,BP,
8624,GO:0034166,1.00000000000537,0.901377980420617,0,1,toll-like receptor 10 signaling pathway,BP,
8639,GO:0034203,1.00000000000537,0.901377980420617,0,1,glycolipid translocation,BP,
8652,GO:0034238,1.00000000000537,0.901377980420617,0,1,macrophage fusion,BP,
8653,GO:0034239,1.00000000000537,0.901377980420617,0,1,regulation of macrophage fusion,BP,
8654,GO:0034241,1.00000000000537,0.901377980420617,0,1,positive regulation of macrophage fusion,BP,
8658,GO:0034245,1.00000000000537,0.901377980420617,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
8691,GO:0034346,1.00000000000537,0.901377980420617,0,1,positive regulation of type III interferon production,BP,
8695,GO:0034353,1.00000000000537,0.901377980420617,0,1,RNA pyrophosphohydrolase activity,MF,
8704,GO:0034366,1.00000000000537,0.901377980420617,0,1,spherical high-density lipoprotein particle,CC,
8722,GO:0034386,1.00000000000537,0.901377980420617,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
8739,GO:0034417,1.00000000000537,0.901377980420617,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
8764,GO:0034459,1.00000000000537,0.901377980420617,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
8773,GO:0034474,1.00000000000537,0.901377980420617,0,1,U2 snRNA 3'-end processing,BP,
8776,GO:0034477,1.00000000000537,0.901377980420617,0,1,U6 snRNA 3'-end processing,BP,
8787,GO:0034506,1.00000000000537,0.901377980420617,0,1,chromosome, centromeric core domain,CC,
8790,GO:0034512,1.00000000000537,0.901377980420617,0,1,box C/D snoRNA binding,MF,
8798,GO:0034584,1.00000000000537,0.901377980420617,0,1,piRNA binding,MF,
8800,GO:0034589,1.00000000000537,0.901377980420617,0,1,hydroxyproline transport,BP,
8801,GO:0034590,1.00000000000537,0.901377980420617,0,1,L-hydroxyproline transmembrane transporter activity,MF,
8808,GO:0034602,1.00000000000537,0.901377980420617,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
8825,GO:0034634,1.00000000000537,0.901377980420617,0,1,glutathione transmembrane transporter activity,MF,
8829,GO:0034640,1.00000000000537,0.901377980420617,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
8831,GO:0034642,1.00000000000537,0.901377980420617,0,1,mitochondrion migration along actin filament,BP,
8837,GO:0034649,1.00000000000537,0.901377980420617,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
8840,GO:0034653,1.00000000000537,0.901377980420617,0,1,retinoic acid catabolic process,BP,
8851,GO:0034669,1.00000000000537,0.901377980420617,0,1,integrin alpha4-beta7 complex,CC,
8852,GO:0034670,1.00000000000537,0.901377980420617,0,1,chemotaxis to arachidonic acid,BP,
8855,GO:0034677,1.00000000000537,0.901377980420617,0,1,integrin alpha7-beta1 complex,CC,
8858,GO:0034681,1.00000000000537,0.901377980420617,0,1,integrin alpha11-beta1 complex,CC,
8859,GO:0034683,1.00000000000537,0.901377980420617,0,1,integrin alphav-beta3 complex,CC,
8881,GO:0034718,1.00000000000537,0.901377980420617,0,1,SMN-Gemin2 complex,CC,
8888,GO:0034727,1.00000000000537,0.901377980420617,0,1,piecemeal microautophagy of the nucleus,BP,
8891,GO:0034736,1.00000000000537,0.901377980420617,0,1,cholesterol O-acyltransferase activity,MF,
8895,GO:0034752,1.00000000000537,0.901377980420617,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
8896,GO:0034753,1.00000000000537,0.901377980420617,0,1,nuclear aryl hydrocarbon receptor complex,CC,
8900,GO:0034757,1.00000000000537,0.901377980420617,0,1,negative regulation of iron ion transport,BP,
8901,GO:0034759,1.00000000000537,0.901377980420617,0,1,regulation of iron ion transmembrane transport,BP,
8902,GO:0034760,1.00000000000537,0.901377980420617,0,1,negative regulation of iron ion transmembrane transport,BP,
8912,GO:0034775,1.00000000000537,0.901377980420617,0,1,glutathione transmembrane transport,BP,
8915,GO:0034875,1.00000000000537,0.901377980420617,0,1,caffeine oxidase activity,MF,
8916,GO:0034959,1.00000000000537,0.901377980420617,0,1,endothelin maturation,BP,
8922,GO:0034971,1.00000000000537,0.901377980420617,0,1,histone H3-R17 methylation,BP,
8928,GO:0034986,1.00000000000537,0.901377980420617,0,1,iron chaperone activity,MF,
8929,GO:0034987,1.00000000000537,0.901377980420617,0,1,immunoglobulin receptor binding,MF,
8930,GO:0034988,1.00000000000537,0.901377980420617,0,1,Fc-gamma receptor I complex binding,MF,
8934,GO:0034998,1.00000000000537,0.901377980420617,0,1,oligosaccharyltransferase I complex,CC,
8951,GO:0035037,1.00000000000537,0.901377980420617,0,1,sperm entry,BP,
8954,GO:0035054,1.00000000000537,0.901377980420617,0,1,embryonic heart tube anterior/posterior pattern specification,BP,
8956,GO:0035063,1.00000000000537,0.901377980420617,0,1,nuclear speck organization,BP,
8982,GO:0035120,1.00000000000537,0.901377980420617,0,1,post-embryonic appendage morphogenesis,BP,
8983,GO:0035127,1.00000000000537,0.901377980420617,0,1,post-embryonic limb morphogenesis,BP,
8984,GO:0035128,1.00000000000537,0.901377980420617,0,1,post-embryonic forelimb morphogenesis,BP,
8997,GO:0035188,1.00000000000537,0.901377980420617,0,1,hatching,BP,
9004,GO:0035226,1.00000000000537,0.901377980420617,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9005,GO:0035227,1.00000000000537,0.901377980420617,0,1,regulation of glutamate-cysteine ligase activity,BP,
9006,GO:0035229,1.00000000000537,0.901377980420617,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9016,GO:0035248,1.00000000000537,0.901377980420617,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9029,GO:0035262,1.00000000000537,0.901377980420617,0,1,gonad morphogenesis,BP,
9037,GO:0035276,1.00000000000537,0.901377980420617,0,1,ethanol binding,MF,
9043,GO:0035283,1.00000000000537,0.901377980420617,0,1,central nervous system segmentation,BP,
9044,GO:0035284,1.00000000000537,0.901377980420617,0,1,brain segmentation,BP,
9048,GO:0035299,1.00000000000537,0.901377980420617,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9074,GO:0035354,1.00000000000537,0.901377980420617,0,1,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9075,GO:0035355,1.00000000000537,0.901377980420617,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9079,GO:0035359,1.00000000000537,0.901377980420617,0,1,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9093,GO:0035400,1.00000000000537,0.901377980420617,0,1,histone tyrosine kinase activity,MF,
9094,GO:0035401,1.00000000000537,0.901377980420617,0,1,histone kinase activity (H3-Y41 specific),MF,
9096,GO:0035403,1.00000000000537,0.901377980420617,0,1,histone kinase activity (H3-T6 specific),MF,
9099,GO:0035406,1.00000000000537,0.901377980420617,0,1,histone-tyrosine phosphorylation,BP,
9101,GO:0035408,1.00000000000537,0.901377980420617,0,1,histone H3-T6 phosphorylation,BP,
9102,GO:0035409,1.00000000000537,0.901377980420617,0,1,histone H3-Y41 phosphorylation,BP,
9110,GO:0035441,1.00000000000537,0.901377980420617,0,1,cell migration involved in vasculogenesis,BP,
9112,GO:0035443,1.00000000000537,0.901377980420617,0,1,tripeptide transmembrane transport,BP,
9113,GO:0035445,1.00000000000537,0.901377980420617,0,1,borate transmembrane transport,BP,
9120,GO:0035469,1.00000000000537,0.901377980420617,0,1,determination of pancreatic left/right asymmetry,BP,
9126,GO:0035490,1.00000000000537,0.901377980420617,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9127,GO:0035491,1.00000000000537,0.901377980420617,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9131,GO:0035498,1.00000000000537,0.901377980420617,0,1,carnosine metabolic process,BP,
9138,GO:0035508,1.00000000000537,0.901377980420617,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9145,GO:0035516,1.00000000000537,0.901377980420617,0,1,oxidative DNA demethylase activity,MF,
9160,GO:0035544,1.00000000000537,0.901377980420617,0,1,negative regulation of SNARE complex assembly,BP,
9171,GO:0035568,1.00000000000537,0.901377980420617,0,1,N-terminal peptidyl-proline methylation,BP,
9172,GO:0035570,1.00000000000537,0.901377980420617,0,1,N-terminal peptidyl-serine methylation,BP,
9173,GO:0035572,1.00000000000537,0.901377980420617,0,1,N-terminal peptidyl-serine dimethylation,BP,
9174,GO:0035573,1.00000000000537,0.901377980420617,0,1,N-terminal peptidyl-serine trimethylation,BP,
9195,GO:0035598,1.00000000000537,0.901377980420617,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9198,GO:0035602,1.00000000000537,0.901377980420617,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9199,GO:0035603,1.00000000000537,0.901377980420617,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9200,GO:0035604,1.00000000000537,0.901377980420617,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9205,GO:0035609,1.00000000000537,0.901377980420617,0,1,C-terminal protein deglutamylation,BP,
9206,GO:0035610,1.00000000000537,0.901377980420617,0,1,protein side chain deglutamylation,BP,
9207,GO:0035611,1.00000000000537,0.901377980420617,0,1,protein branching point deglutamylation,BP,
9216,GO:0035622,1.00000000000537,0.901377980420617,0,1,intrahepatic bile duct development,BP,
9217,GO:0035623,1.00000000000537,0.901377980420617,0,1,renal glucose absorption,BP,
9219,GO:0035625,1.00000000000537,0.901377980420617,0,1,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
9227,GO:0035638,1.00000000000537,0.901377980420617,0,1,signal maturation,BP,
9231,GO:0035642,1.00000000000537,0.901377980420617,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9262,GO:0035711,1.00000000000537,0.901377980420617,0,1,T-helper 1 cell activation,BP,
9263,GO:0035712,1.00000000000537,0.901377980420617,0,1,T-helper 2 cell activation,BP,
9287,GO:0035750,1.00000000000537,0.901377980420617,0,1,protein localization to myelin sheath abaxonal region,BP,
9302,GO:0035790,1.00000000000537,0.901377980420617,0,1,platelet-derived growth factor receptor-alpha signaling pathway,BP,
9323,GO:0035841,1.00000000000537,0.901377980420617,0,1,new growing cell tip,CC,
9327,GO:0035851,1.00000000000537,0.901377980420617,0,1,Krueppel-associated box domain binding,MF,
9328,GO:0035853,1.00000000000537,0.901377980420617,0,1,chromosome passenger complex localization to spindle midzone,BP,
9333,GO:0035862,1.00000000000537,0.901377980420617,0,1,dITP metabolic process,BP,
9334,GO:0035863,1.00000000000537,0.901377980420617,0,1,dITP catabolic process,BP,
9368,GO:0035922,1.00000000000537,0.901377980420617,0,1,foramen ovale closure,BP,
9379,GO:0035935,1.00000000000537,0.901377980420617,0,1,androgen secretion,BP,
9380,GO:0035936,1.00000000000537,0.901377980420617,0,1,testosterone secretion,BP,
9381,GO:0035938,1.00000000000537,0.901377980420617,0,1,estradiol secretion,BP,
9386,GO:0035962,1.00000000000537,0.901377980420617,0,1,response to interleukin-13,BP,
9387,GO:0035963,1.00000000000537,0.901377980420617,0,1,cellular response to interleukin-13,BP,
9410,GO:0035995,1.00000000000537,0.901377980420617,0,1,detection of muscle stretch,BP,
9436,GO:0036046,1.00000000000537,0.901377980420617,0,1,protein demalonylation,BP,
9437,GO:0036047,1.00000000000537,0.901377980420617,0,1,peptidyl-lysine demalonylation,BP,
9438,GO:0036048,1.00000000000537,0.901377980420617,0,1,protein desuccinylation,BP,
9439,GO:0036049,1.00000000000537,0.901377980420617,0,1,peptidyl-lysine desuccinylation,BP,
9440,GO:0036054,1.00000000000537,0.901377980420617,0,1,protein-malonyllysine demalonylase activity,MF,
9441,GO:0036055,1.00000000000537,0.901377980420617,0,1,protein-succinyllysine desuccinylase activity,MF,
9447,GO:0036071,1.00000000000537,0.901377980420617,0,1,N-glycan fucosylation,BP,
9451,GO:0036085,1.00000000000537,0.901377980420617,0,1,GDP-fucose import into Golgi lumen,BP,
9458,GO:0036105,1.00000000000537,0.901377980420617,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
9472,GO:0036125,1.00000000000537,0.901377980420617,0,1,fatty acid beta-oxidation multienzyme complex,CC,
9478,GO:0036138,1.00000000000537,0.901377980420617,0,1,peptidyl-histidine hydroxylation,BP,
9479,GO:0036139,1.00000000000537,0.901377980420617,0,1,peptidyl-histidine dioxygenase activity,MF,
9480,GO:0036140,1.00000000000537,0.901377980420617,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
9501,GO:0036215,1.00000000000537,0.901377980420617,0,1,response to stem cell factor,BP,
9502,GO:0036216,1.00000000000537,0.901377980420617,0,1,cellular response to stem cell factor stimulus,BP,
9510,GO:0036255,1.00000000000537,0.901377980420617,0,1,response to methylamine,BP,
9514,GO:0036261,1.00000000000537,0.901377980420617,0,1,7-methylguanosine cap hypermethylation,BP,
9538,GO:0036317,1.00000000000537,0.901377980420617,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
9541,GO:0036335,1.00000000000537,0.901377980420617,0,1,intestinal stem cell homeostasis,BP,
9554,GO:0036371,1.00000000000537,0.901377980420617,0,1,protein localization to T-tubule,BP,
9562,GO:0036392,1.00000000000537,0.901377980420617,0,1,chemokine (C-C motif) ligand 20 production,BP,
9564,GO:0036398,1.00000000000537,0.901377980420617,0,1,TCR signalosome,CC,
9565,GO:0036399,1.00000000000537,0.901377980420617,0,1,TCR signalosome assembly,BP,
9568,GO:0036404,1.00000000000537,0.901377980420617,0,1,conversion of ds siRNA to ss siRNA,BP,
9572,GO:0036440,1.00000000000537,0.901377980420617,0,1,citrate synthase activity,MF,
9601,GO:0036483,1.00000000000537,0.901377980420617,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
9610,GO:0036494,1.00000000000537,0.901377980420617,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
9616,GO:0036501,1.00000000000537,0.901377980420617,0,1,UFD1-NPL4 complex,CC,
9617,GO:0036502,1.00000000000537,0.901377980420617,0,1,Derlin-1-VIMP complex,CC,
9619,GO:0036505,1.00000000000537,0.901377980420617,0,1,prosaposin receptor activity,MF,
9630,GO:0036517,1.00000000000537,0.901377980420617,0,1,chemoattraction of serotonergic neuron axon,BP,
9641,GO:0038002,1.00000000000537,0.901377980420617,0,1,endocrine signaling,BP,
9646,GO:0038021,1.00000000000537,0.901377980420617,0,1,leptin receptor activity,MF,
9659,GO:0038039,1.00000000000537,0.901377980420617,0,1,G-protein coupled receptor heterodimeric complex,CC,
9664,GO:0038051,1.00000000000537,0.901377980420617,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
9667,GO:0038062,1.00000000000537,0.901377980420617,0,1,protein tyrosine kinase collagen receptor activity,MF,
9687,GO:0038109,1.00000000000537,0.901377980420617,0,1,Kit signaling pathway,BP,
9693,GO:0038123,1.00000000000537,0.901377980420617,0,1,toll-like receptor TLR1:TLR2 signaling pathway,BP,
9701,GO:0038154,1.00000000000537,0.901377980420617,0,1,interleukin-11-mediated signaling pathway,BP,
9704,GO:0038161,1.00000000000537,0.901377980420617,0,1,prolactin signaling pathway,BP,
9710,GO:0038172,1.00000000000537,0.901377980420617,0,1,interleukin-33-mediated signaling pathway,BP,
9713,GO:0038181,1.00000000000537,0.901377980420617,0,1,bile acid receptor activity,MF,
9714,GO:0038183,1.00000000000537,0.901377980420617,0,1,bile acid signaling pathway,BP,
9715,GO:0038186,1.00000000000537,0.901377980420617,0,1,lithocholic acid receptor activity,MF,
9722,GO:0038194,1.00000000000537,0.901377980420617,0,1,thyroid-stimulating hormone signaling pathway,BP,
9727,GO:0039003,1.00000000000537,0.901377980420617,0,1,pronephric field specification,BP,
9728,GO:0039007,1.00000000000537,0.901377980420617,0,1,pronephric nephron morphogenesis,BP,
9729,GO:0039008,1.00000000000537,0.901377980420617,0,1,pronephric nephron tubule morphogenesis,BP,
9730,GO:0039017,1.00000000000537,0.901377980420617,0,1,pattern specification involved in pronephros development,BP,
9732,GO:0039020,1.00000000000537,0.901377980420617,0,1,pronephric nephron tubule development,BP,
9733,GO:0039022,1.00000000000537,0.901377980420617,0,1,pronephric duct development,BP,
9734,GO:0039023,1.00000000000537,0.901377980420617,0,1,pronephric duct morphogenesis,BP,
9735,GO:0039502,1.00000000000537,0.901377980420617,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
9736,GO:0039503,1.00000000000537,0.901377980420617,0,1,suppression by virus of host innate immune response,BP,
9740,GO:0039514,1.00000000000537,0.901377980420617,0,1,suppression by virus of host JAK-STAT cascade,BP,
9743,GO:0039520,1.00000000000537,0.901377980420617,0,1,induction by virus of host autophagy,BP,
9744,GO:0039521,1.00000000000537,0.901377980420617,0,1,suppression by virus of host autophagy,BP,
9755,GO:0039552,1.00000000000537,0.901377980420617,0,1,RIG-I binding,MF,
9756,GO:0039562,1.00000000000537,0.901377980420617,0,1,suppression by virus of host STAT activity,BP,
9757,GO:0039563,1.00000000000537,0.901377980420617,0,1,suppression by virus of host STAT1 activity,BP,
9758,GO:0039564,1.00000000000537,0.901377980420617,0,1,suppression by virus of host STAT2 activity,BP,
9765,GO:0039695,1.00000000000537,0.901377980420617,0,1,DNA-templated viral transcription,BP,
9768,GO:0039713,1.00000000000537,0.901377980420617,0,1,viral factory,CC,
9769,GO:0039714,1.00000000000537,0.901377980420617,0,1,cytoplasmic viral factory,CC,
9785,GO:0040030,1.00000000000537,0.901377980420617,0,1,regulation of molecular function, epigenetic,BP,
9795,GO:0042008,1.00000000000537,0.901377980420617,0,1,interleukin-18 receptor activity,MF,
9807,GO:0042040,1.00000000000537,0.901377980420617,0,1,metal incorporation into metallo-molybdopterin complex,BP,
9824,GO:0042084,1.00000000000537,0.901377980420617,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
9842,GO:0042109,1.00000000000537,0.901377980420617,0,1,lymphotoxin A biosynthetic process,BP,
9860,GO:0042140,1.00000000000537,0.901377980420617,0,1,late meiotic recombination nodule assembly,BP,
9887,GO:0042223,1.00000000000537,0.901377980420617,0,1,interleukin-3 biosynthetic process,BP,
9891,GO:0042241,1.00000000000537,0.901377980420617,0,1,interleukin-18 biosynthetic process,BP,
9894,GO:0042247,1.00000000000537,0.901377980420617,0,1,establishment of planar polarity of follicular epithelium,BP,
9902,GO:0042265,1.00000000000537,0.901377980420617,0,1,peptidyl-asparagine hydroxylation,BP,
9916,GO:0042282,1.00000000000537,0.901377980420617,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
9934,GO:0042316,1.00000000000537,0.901377980420617,0,1,penicillin metabolic process,BP,
9935,GO:0042320,1.00000000000537,0.901377980420617,0,1,regulation of circadian sleep/wake cycle, REM sleep,BP,
9955,GO:0042361,1.00000000000537,0.901377980420617,0,1,menaquinone catabolic process,BP,
9962,GO:0042371,1.00000000000537,0.901377980420617,0,1,vitamin K biosynthetic process,BP,
9966,GO:0042377,1.00000000000537,0.901377980420617,0,1,vitamin K catabolic process,BP,
9997,GO:0042441,1.00000000000537,0.901377980420617,0,1,eye pigment metabolic process,BP,
10017,GO:0042483,1.00000000000537,0.901377980420617,0,1,negative regulation of odontogenesis,BP,
10025,GO:0042495,1.00000000000537,0.901377980420617,0,1,detection of triacyl bacterial lipopeptide,BP,
10027,GO:0042497,1.00000000000537,0.901377980420617,0,1,triacyl lipopeptide binding,MF,
10052,GO:0042564,1.00000000000537,0.901377980420617,0,1,NLS-dependent protein nuclear import complex,CC,
10076,GO:0042595,1.00000000000537,0.901377980420617,0,1,behavioral response to starvation,BP,
10095,GO:0042631,1.00000000000537,0.901377980420617,0,1,cellular response to water deprivation,BP,
10104,GO:0042643,1.00000000000537,0.901377980420617,0,1,actomyosin, actin portion,CC,
10108,GO:0042660,1.00000000000537,0.901377980420617,0,1,positive regulation of cell fate specification,BP,
10112,GO:0042665,1.00000000000537,0.901377980420617,0,1,regulation of ectodermal cell fate specification,BP,
10113,GO:0042666,1.00000000000537,0.901377980420617,0,1,negative regulation of ectodermal cell fate specification,BP,
10133,GO:0042728,1.00000000000537,0.901377980420617,0,1,flavin-containing compound catabolic process,BP,
10159,GO:0042766,1.00000000000537,0.901377980420617,0,1,nucleosome mobilization,BP,
10165,GO:0042774,1.00000000000537,0.901377980420617,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10183,GO:0042806,1.00000000000537,0.901377980420617,0,1,fucose binding,MF,
10197,GO:0042835,1.00000000000537,0.901377980420617,0,1,BRE binding,MF,
10200,GO:0042851,1.00000000000537,0.901377980420617,0,1,L-alanine metabolic process,BP,
10201,GO:0042853,1.00000000000537,0.901377980420617,0,1,L-alanine catabolic process,BP,
10215,GO:0042937,1.00000000000537,0.901377980420617,0,1,tripeptide transmembrane transporter activity,MF,
10220,GO:0042946,1.00000000000537,0.901377980420617,0,1,glucoside transport,BP,
10221,GO:0042947,1.00000000000537,0.901377980420617,0,1,glucoside transmembrane transporter activity,MF,
10236,GO:0042988,1.00000000000537,0.901377980420617,0,1,X11-like protein binding,MF,
10243,GO:0042999,1.00000000000537,0.901377980420617,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10246,GO:0043002,1.00000000000537,0.901377980420617,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10247,GO:0043004,1.00000000000537,0.901377980420617,0,1,cytoplasmic sequestering of CFTR protein,BP,
10268,GO:0043033,1.00000000000537,0.901377980420617,0,1,isoamylase complex,CC,
10270,GO:0043035,1.00000000000537,0.901377980420617,0,1,chromatin insulator sequence binding,MF,
10273,GO:0043041,1.00000000000537,0.901377980420617,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
10319,GO:0043131,1.00000000000537,0.901377980420617,0,1,erythrocyte enucleation,BP,
10321,GO:0043136,1.00000000000537,0.901377980420617,0,1,glycerol-3-phosphatase activity,MF,
10332,GO:0043159,1.00000000000537,0.901377980420617,0,1,acrosomal matrix,CC,
10373,GO:0043221,1.00000000000537,0.901377980420617,0,1,SMC family protein binding,MF,
10400,GO:0043257,1.00000000000537,0.901377980420617,0,1,laminin-8 complex,CC,
10410,GO:0043273,1.00000000000537,0.901377980420617,0,1,CTPase activity,MF,
10441,GO:0043317,1.00000000000537,0.901377980420617,0,1,regulation of cytotoxic T cell degranulation,BP,
10442,GO:0043318,1.00000000000537,0.901377980420617,0,1,negative regulation of cytotoxic T cell degranulation,BP,
10446,GO:0043324,1.00000000000537,0.901377980420617,0,1,pigment metabolic process involved in developmental pigmentation,BP,
10452,GO:0043337,1.00000000000537,0.901377980420617,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
10454,GO:0043354,1.00000000000537,0.901377980420617,0,1,enucleate erythrocyte maturation,BP,
10464,GO:0043375,1.00000000000537,0.901377980420617,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
10465,GO:0043376,1.00000000000537,0.901377980420617,0,1,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
10477,GO:0043396,1.00000000000537,0.901377980420617,0,1,corticotropin-releasing hormone secretion,BP,
10478,GO:0043397,1.00000000000537,0.901377980420617,0,1,regulation of corticotropin-releasing hormone secretion,BP,
10497,GO:0043423,1.00000000000537,0.901377980420617,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
10510,GO:0043465,1.00000000000537,0.901377980420617,0,1,regulation of fermentation,BP,
10515,GO:0043474,1.00000000000537,0.901377980420617,0,1,pigment metabolic process involved in pigmentation,BP,
10551,GO:0043532,1.00000000000537,0.901377980420617,0,1,angiostatin binding,MF,
10557,GO:0043538,1.00000000000537,0.901377980420617,0,1,regulation of actin phosphorylation,BP,
10562,GO:0043544,1.00000000000537,0.901377980420617,0,1,lipoamide binding,MF,
10598,GO:0043606,1.00000000000537,0.901377980420617,0,1,formamide metabolic process,BP,
10599,GO:0043610,1.00000000000537,0.901377980420617,0,1,regulation of carbohydrate utilization,BP,
10613,GO:0043629,1.00000000000537,0.901377980420617,0,1,ncRNA polyadenylation,BP,
10614,GO:0043630,1.00000000000537,0.901377980420617,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
10639,GO:0043739,1.00000000000537,0.901377980420617,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
10640,GO:0043754,1.00000000000537,0.901377980420617,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
10646,GO:0043849,1.00000000000537,0.901377980420617,0,1,Ras palmitoyltransferase activity,MF,
10655,GO:0043914,1.00000000000537,0.901377980420617,0,1,NADPH:sulfur oxidoreductase activity,MF,
10673,GO:0043969,1.00000000000537,0.901377980420617,0,1,histone H2B acetylation,BP,
10675,GO:0043972,1.00000000000537,0.901377980420617,0,1,histone H3-K23 acetylation,BP,
10686,GO:0043994,1.00000000000537,0.901377980420617,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
10689,GO:0043997,1.00000000000537,0.901377980420617,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
10690,GO:0043998,1.00000000000537,0.901377980420617,0,1,H2A histone acetyltransferase activity,MF,
10693,GO:0044007,1.00000000000537,0.901377980420617,0,1,dissemination or transmission of symbiont from host,BP,
10730,GO:0044128,1.00000000000537,0.901377980420617,0,1,positive regulation of growth of symbiont in host,BP,
10736,GO:0044148,1.00000000000537,0.901377980420617,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
10743,GO:0044207,1.00000000000537,0.901377980420617,0,1,translation initiation ternary complex,CC,
10755,GO:0044220,1.00000000000537,0.901377980420617,0,1,host cell perinuclear region of cytoplasm,CC,
10758,GO:0044228,1.00000000000537,0.901377980420617,0,1,host cell surface,CC,
10793,GO:0044299,1.00000000000537,0.901377980420617,0,1,C-fiber,CC,
10795,GO:0044301,1.00000000000537,0.901377980420617,0,1,climbing fiber,CC,
10798,GO:0044305,1.00000000000537,0.901377980420617,0,1,calyx of Held,CC,
10800,GO:0044307,1.00000000000537,0.901377980420617,0,1,dendritic branch,CC,
10805,GO:0044316,1.00000000000537,0.901377980420617,0,1,cone cell pedicle,CC,
10816,GO:0044328,1.00000000000537,0.901377980420617,0,1,canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration,BP,
10817,GO:0044329,1.00000000000537,0.901377980420617,0,1,canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion,BP,
10818,GO:0044330,1.00000000000537,0.901377980420617,0,1,canonical Wnt signaling pathway involved in positive regulation of wound healing,BP,
10822,GO:0044335,1.00000000000537,0.901377980420617,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
10829,GO:0044343,1.00000000000537,0.901377980420617,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
10831,GO:0044345,1.00000000000537,0.901377980420617,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
10858,GO:0044414,1.00000000000537,0.901377980420617,0,1,suppression of host defenses,BP,
10922,GO:0044599,1.00000000000537,0.901377980420617,0,1,AP-5 adaptor complex,CC,
10933,GO:0044648,1.00000000000537,0.901377980420617,0,1,histone H3-K4 dimethylation,BP,
10946,GO:0044725,1.00000000000537,0.901377980420617,0,1,chromatin reprogramming in the zygote,BP,
10947,GO:0044727,1.00000000000537,0.901377980420617,0,1,DNA demethylation of male pronucleus,BP,
10951,GO:0044732,1.00000000000537,0.901377980420617,0,1,mitotic spindle pole body,CC,
10955,GO:0044753,1.00000000000537,0.901377980420617,0,1,amphisome,CC,
10966,GO:0044779,1.00000000000537,0.901377980420617,0,1,meiotic spindle checkpoint,BP,
10970,GO:0044785,1.00000000000537,0.901377980420617,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
11007,GO:0044868,1.00000000000537,0.901377980420617,0,1,modulation by host of viral molecular function,BP,
11020,GO:0045016,1.00000000000537,0.901377980420617,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11030,GO:0045032,1.00000000000537,0.901377980420617,0,1,ADP-activated adenosine receptor activity,MF,
11062,GO:0045081,1.00000000000537,0.901377980420617,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
11064,GO:0045083,1.00000000000537,0.901377980420617,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
11077,GO:0045105,1.00000000000537,0.901377980420617,0,1,intermediate filament polymerization or depolymerization,BP,
11091,GO:0045128,1.00000000000537,0.901377980420617,0,1,negative regulation of reciprocal meiotic recombination,BP,
11092,GO:0045131,1.00000000000537,0.901377980420617,0,1,pre-mRNA branch point binding,MF,
11119,GO:0045183,1.00000000000537,0.901377980420617,0,1,translation factor activity, non-nucleic acid binding,MF,
11122,GO:0045186,1.00000000000537,0.901377980420617,0,1,zonula adherens assembly,BP,
11134,GO:0045208,1.00000000000537,0.901377980420617,0,1,MAPK phosphatase export from nucleus,BP,
11135,GO:0045209,1.00000000000537,0.901377980420617,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11210,GO:0045381,1.00000000000537,0.901377980420617,0,1,regulation of interleukin-18 biosynthetic process,BP,
11211,GO:0045399,1.00000000000537,0.901377980420617,0,1,regulation of interleukin-3 biosynthetic process,BP,
11212,GO:0045401,1.00000000000537,0.901377980420617,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
11221,GO:0045423,1.00000000000537,0.901377980420617,0,1,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11222,GO:0045425,1.00000000000537,0.901377980420617,0,1,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11234,GO:0045485,1.00000000000537,0.901377980420617,0,1,omega-6 fatty acid desaturase activity,MF,
11260,GO:0045590,1.00000000000537,0.901377980420617,0,1,negative regulation of regulatory T cell differentiation,BP,
11298,GO:0045643,1.00000000000537,0.901377980420617,0,1,regulation of eosinophil differentiation,BP,
11299,GO:0045645,1.00000000000537,0.901377980420617,0,1,positive regulation of eosinophil differentiation,BP,
11335,GO:0045715,1.00000000000537,0.901377980420617,0,1,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
11344,GO:0045726,1.00000000000537,0.901377980420617,0,1,positive regulation of integrin biosynthetic process,BP,
11360,GO:0045751,1.00000000000537,0.901377980420617,0,1,negative regulation of Toll signaling pathway,BP,
11369,GO:0045769,1.00000000000537,0.901377980420617,0,1,negative regulation of asymmetric cell division,BP,
11382,GO:0045795,1.00000000000537,0.901377980420617,0,1,positive regulation of cell volume,BP,
11389,GO:0045819,1.00000000000537,0.901377980420617,0,1,positive regulation of glycogen catabolic process,BP,
11416,GO:0045870,1.00000000000537,0.901377980420617,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11422,GO:0045887,1.00000000000537,0.901377980420617,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
11486,GO:0045993,1.00000000000537,0.901377980420617,0,1,negative regulation of translational initiation by iron,BP,
11505,GO:0046048,1.00000000000537,0.901377980420617,0,1,UDP metabolic process,BP,
11551,GO:0046127,1.00000000000537,0.901377980420617,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
11573,GO:0046176,1.00000000000537,0.901377980420617,0,1,aldonic acid catabolic process,BP,
11574,GO:0046177,1.00000000000537,0.901377980420617,0,1,D-gluconate catabolic process,BP,
11588,GO:0046293,1.00000000000537,0.901377980420617,0,1,formaldehyde biosynthetic process,BP,
11592,GO:0046316,1.00000000000537,0.901377980420617,0,1,gluconokinase activity,MF,
11593,GO:0046317,1.00000000000537,0.901377980420617,0,1,regulation of glucosylceramide biosynthetic process,BP,
11594,GO:0046318,1.00000000000537,0.901377980420617,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
11608,GO:0046333,1.00000000000537,0.901377980420617,0,1,octopamine metabolic process,BP,
11617,GO:0046355,1.00000000000537,0.901377980420617,0,1,mannan catabolic process,BP,
11627,GO:0046380,1.00000000000537,0.901377980420617,0,1,N-acetylneuraminate biosynthetic process,BP,
11671,GO:0046478,1.00000000000537,0.901377980420617,0,1,lactosylceramide metabolic process,BP,
11685,GO:0046499,1.00000000000537,0.901377980420617,0,1,S-adenosylmethioninamine metabolic process,BP,
11698,GO:0046523,1.00000000000537,0.901377980420617,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
11705,GO:0046534,1.00000000000537,0.901377980420617,0,1,positive regulation of photoreceptor cell differentiation,BP,
11710,GO:0046544,1.00000000000537,0.901377980420617,0,1,development of secondary male sexual characteristics,BP,
11718,GO:0046577,1.00000000000537,0.901377980420617,0,1,long-chain-alcohol oxidase activity,MF,
11724,GO:0046587,1.00000000000537,0.901377980420617,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
11743,GO:0046623,1.00000000000537,0.901377980420617,0,1,sphingolipid-translocating ATPase activity,MF,
11774,GO:0046668,1.00000000000537,0.901377980420617,0,1,regulation of retinal cell programmed cell death,BP,
11775,GO:0046671,1.00000000000537,0.901377980420617,0,1,negative regulation of retinal cell programmed cell death,BP,
11786,GO:0046690,1.00000000000537,0.901377980420617,0,1,response to tellurium ion,BP,
11797,GO:0046713,1.00000000000537,0.901377980420617,0,1,borate transport,BP,
11798,GO:0046715,1.00000000000537,0.901377980420617,0,1,active borate transmembrane transporter activity,MF,
11804,GO:0046725,1.00000000000537,0.901377980420617,0,1,negative regulation by virus of viral protein levels in host cell,BP,
11808,GO:0046745,1.00000000000537,0.901377980420617,0,1,viral capsid secondary envelopment,BP,
11815,GO:0046786,1.00000000000537,0.901377980420617,0,1,viral replication complex formation and maintenance,BP,
11818,GO:0046811,1.00000000000537,0.901377980420617,0,1,histone deacetylase inhibitor activity,MF,
11875,GO:0046921,1.00000000000537,0.901377980420617,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
11895,GO:0046958,1.00000000000537,0.901377980420617,0,1,nonassociative learning,BP,
11902,GO:0046968,1.00000000000537,0.901377980420617,0,1,peptide antigen transport,BP,
11912,GO:0046980,1.00000000000537,0.901377980420617,0,1,tapasin binding,MF,
11917,GO:0046986,1.00000000000537,0.901377980420617,0,1,negative regulation of hemoglobin biosynthetic process,BP,
11918,GO:0046996,1.00000000000537,0.901377980420617,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
11923,GO:0047017,1.00000000000537,0.901377980420617,0,1,prostaglandin-F synthase activity,MF,
11935,GO:0047117,1.00000000000537,0.901377980420617,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
11936,GO:0047130,1.00000000000537,0.901377980420617,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
11937,GO:0047131,1.00000000000537,0.901377980420617,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
11941,GO:0047159,1.00000000000537,0.901377980420617,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
11945,GO:0047186,1.00000000000537,0.901377980420617,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
11946,GO:0047191,1.00000000000537,0.901377980420617,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
11953,GO:0047256,1.00000000000537,0.901377980420617,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
11954,GO:0047263,1.00000000000537,0.901377980420617,0,1,N-acylsphingosine galactosyltransferase activity,MF,
11955,GO:0047273,1.00000000000537,0.901377980420617,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
11956,GO:0047275,1.00000000000537,0.901377980420617,0,1,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
11958,GO:0047280,1.00000000000537,0.901377980420617,0,1,nicotinamide phosphoribosyltransferase activity,MF,
11963,GO:0047298,1.00000000000537,0.901377980420617,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
11966,GO:0047325,1.00000000000537,0.901377980420617,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
11968,GO:0047341,1.00000000000537,0.901377980420617,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
11969,GO:0047349,1.00000000000537,0.901377980420617,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
11975,GO:0047395,1.00000000000537,0.901377980420617,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
11980,GO:0047451,1.00000000000537,0.901377980420617,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
11981,GO:0047464,1.00000000000537,0.901377980420617,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
11991,GO:0047545,1.00000000000537,0.901377980420617,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
11997,GO:0047620,1.00000000000537,0.901377980420617,0,1,acylglycerol kinase activity,MF,
12001,GO:0047635,1.00000000000537,0.901377980420617,0,1,alanine-oxo-acid transaminase activity,MF,
12004,GO:0047676,1.00000000000537,0.901377980420617,0,1,arachidonate-CoA ligase activity,MF,
12012,GO:0047734,1.00000000000537,0.901377980420617,0,1,CDP-glycerol diphosphatase activity,MF,
12018,GO:0047760,1.00000000000537,0.901377980420617,0,1,butyrate-CoA ligase activity,MF,
12019,GO:0047800,1.00000000000537,0.901377980420617,0,1,cysteamine dioxygenase activity,MF,
12028,GO:0047933,1.00000000000537,0.901377980420617,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12035,GO:0048006,1.00000000000537,0.901377980420617,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12043,GO:0048014,1.00000000000537,0.901377980420617,0,1,Tie signaling pathway,BP,
12052,GO:0048023,1.00000000000537,0.901377980420617,0,1,positive regulation of melanin biosynthetic process,BP,
12059,GO:0048033,1.00000000000537,0.901377980420617,0,1,heme o metabolic process,BP,
12060,GO:0048034,1.00000000000537,0.901377980420617,0,1,heme O biosynthetic process,BP,
12068,GO:0048058,1.00000000000537,0.901377980420617,0,1,compound eye corneal lens development,BP,
12073,GO:0048075,1.00000000000537,0.901377980420617,0,1,positive regulation of eye pigmentation,BP,
12112,GO:0048213,1.00000000000537,0.901377980420617,0,1,Golgi vesicle prefusion complex stabilization,BP,
12134,GO:0048264,1.00000000000537,0.901377980420617,0,1,determination of ventral identity,BP,
12165,GO:0048320,1.00000000000537,0.901377980420617,0,1,axial mesoderm formation,BP,
12168,GO:0048338,1.00000000000537,0.901377980420617,0,1,mesoderm structural organization,BP,
12172,GO:0048352,1.00000000000537,0.901377980420617,0,1,paraxial mesoderm structural organization,BP,
12192,GO:0048403,1.00000000000537,0.901377980420617,0,1,brain-derived neurotrophic factor binding,MF,
12266,GO:0048611,1.00000000000537,0.901377980420617,0,1,embryonic ectodermal digestive tract development,BP,
12268,GO:0048619,1.00000000000537,0.901377980420617,0,1,embryonic hindgut morphogenesis,BP,
12344,GO:0048749,1.00000000000537,0.901377980420617,0,1,compound eye development,BP,
12365,GO:0048807,1.00000000000537,0.901377980420617,0,1,female genitalia morphogenesis,BP,
12387,GO:0048855,1.00000000000537,0.901377980420617,0,1,adenohypophysis morphogenesis,BP,
12396,GO:0048866,1.00000000000537,0.901377980420617,0,1,stem cell fate specification,BP,
12403,GO:0048874,1.00000000000537,0.901377980420617,0,1,homeostasis of number of cells in a free-living population,BP,
12414,GO:0050046,1.00000000000537,0.901377980420617,0,1,lathosterol oxidase activity,MF,
12418,GO:0050115,1.00000000000537,0.901377980420617,0,1,myosin-light-chain-phosphatase activity,MF,
12420,GO:0050124,1.00000000000537,0.901377980420617,0,1,N-acylneuraminate-9-phosphatase activity,MF,
12425,GO:0050146,1.00000000000537,0.901377980420617,0,1,nucleoside phosphotransferase activity,MF,
12428,GO:0050185,1.00000000000537,0.901377980420617,0,1,phosphatidylinositol deacylase activity,MF,
12437,GO:0050277,1.00000000000537,0.901377980420617,0,1,sedoheptulokinase activity,MF,
12438,GO:0050290,1.00000000000537,0.901377980420617,0,1,sphingomyelin phosphodiesterase D activity,MF,
12447,GO:0050346,1.00000000000537,0.901377980420617,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
12449,GO:0050353,1.00000000000537,0.901377980420617,0,1,trimethyllysine dioxygenase activity,MF,
12451,GO:0050355,1.00000000000537,0.901377980420617,0,1,triphosphatase activity,MF,
12452,GO:0050379,1.00000000000537,0.901377980420617,0,1,UDP-glucuronate 5'-epimerase activity,MF,
12463,GO:0050444,1.00000000000537,0.901377980420617,0,1,aquacobalamin reductase (NADPH) activity,MF,
12476,GO:0050560,1.00000000000537,0.901377980420617,0,1,aspartate-tRNA(Asn) ligase activity,MF,
12477,GO:0050561,1.00000000000537,0.901377980420617,0,1,glutamate-tRNA(Gln) ligase activity,MF,
12482,GO:0050614,1.00000000000537,0.901377980420617,0,1,delta24-sterol reductase activity,MF,
12486,GO:0050652,1.00000000000537,0.901377980420617,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12487,GO:0050653,1.00000000000537,0.901377980420617,0,1,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12556,GO:0050748,1.00000000000537,0.901377980420617,0,1,negative regulation of lipoprotein metabolic process,BP,
12609,GO:0050822,1.00000000000537,0.901377980420617,0,1,peptide stabilization,BP,
12610,GO:0050823,1.00000000000537,0.901377980420617,0,1,peptide antigen stabilization,BP,
12658,GO:0050897,1.00000000000537,0.901377980420617,0,1,cobalt ion binding,MF,
12680,GO:0050924,1.00000000000537,0.901377980420617,0,1,positive regulation of negative chemotaxis,BP,
12684,GO:0050928,1.00000000000537,0.901377980420617,0,1,negative regulation of positive chemotaxis,BP,
12685,GO:0050929,1.00000000000537,0.901377980420617,0,1,induction of negative chemotaxis,BP,
12693,GO:0050955,1.00000000000537,0.901377980420617,0,1,thermoception,BP,
12694,GO:0050957,1.00000000000537,0.901377980420617,0,1,equilibrioception,BP,
12695,GO:0050960,1.00000000000537,0.901377980420617,0,1,detection of temperature stimulus involved in thermoception,BP,
12700,GO:0050968,1.00000000000537,0.901377980420617,0,1,detection of chemical stimulus involved in sensory perception of pain,BP,
12731,GO:0051025,1.00000000000537,0.901377980420617,0,1,negative regulation of immunoglobulin secretion,BP,
12737,GO:0051032,1.00000000000537,0.901377980420617,0,1,nucleic acid transmembrane transporter activity,MF,
12738,GO:0051033,1.00000000000537,0.901377980420617,0,1,RNA transmembrane transporter activity,MF,
12740,GO:0051040,1.00000000000537,0.901377980420617,0,1,regulation of calcium-independent cell-cell adhesion,BP,
12741,GO:0051042,1.00000000000537,0.901377980420617,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
12760,GO:0051068,1.00000000000537,0.901377980420617,0,1,dihydrolipoamide metabolic process,BP,
12769,GO:0051089,1.00000000000537,0.901377980420617,0,1,constitutive protein ectodomain proteolysis,BP,
12782,GO:0051102,1.00000000000537,0.901377980420617,0,1,DNA ligation involved in DNA recombination,BP,
12786,GO:0051107,1.00000000000537,0.901377980420617,0,1,negative regulation of DNA ligation,BP,
12806,GO:0051139,1.00000000000537,0.901377980420617,0,1,metal ion:proton antiporter activity,MF,
12862,GO:0051228,1.00000000000537,0.901377980420617,0,1,mitotic spindle disassembly,BP,
12863,GO:0051230,1.00000000000537,0.901377980420617,0,1,spindle disassembly,BP,
12893,GO:0051267,1.00000000000537,0.901377980420617,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
12915,GO:0051300,1.00000000000537,0.901377980420617,0,1,spindle pole body organization,BP,
12923,GO:0051308,1.00000000000537,0.901377980420617,0,1,male meiosis chromosome separation,BP,
12944,GO:0051352,1.00000000000537,0.901377980420617,0,1,negative regulation of ligase activity,BP,
12947,GO:0051365,1.00000000000537,0.901377980420617,0,1,cellular response to potassium ion starvation,BP,
12961,GO:0051391,1.00000000000537,0.901377980420617,0,1,tRNA acetylation,BP,
12962,GO:0051392,1.00000000000537,0.901377980420617,0,1,tRNA N-acetyltransferase activity,MF,
12973,GO:0051417,1.00000000000537,0.901377980420617,0,1,microtubule nucleation by spindle pole body,BP,
12981,GO:0051433,1.00000000000537,0.901377980420617,0,1,BH2 domain binding,MF,
12994,GO:0051455,1.00000000000537,0.901377980420617,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13001,GO:0051463,1.00000000000537,0.901377980420617,0,1,negative regulation of cortisol secretion,BP,
13003,GO:0051466,1.00000000000537,0.901377980420617,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13051,GO:0051585,1.00000000000537,0.901377980420617,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13062,GO:0051598,1.00000000000537,0.901377980420617,0,1,meiotic recombination checkpoint,BP,
13074,GO:0051615,1.00000000000537,0.901377980420617,0,1,histamine uptake,BP,
13075,GO:0051620,1.00000000000537,0.901377980420617,0,1,norepinephrine uptake,BP,
13076,GO:0051621,1.00000000000537,0.901377980420617,0,1,regulation of norepinephrine uptake,BP,
13077,GO:0051622,1.00000000000537,0.901377980420617,0,1,negative regulation of norepinephrine uptake,BP,
13104,GO:0051685,1.00000000000537,0.901377980420617,0,1,maintenance of ER location,BP,
13105,GO:0051686,1.00000000000537,0.901377980420617,0,1,establishment of ER localization,BP,
13129,GO:0051728,1.00000000000537,0.901377980420617,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
13130,GO:0051729,1.00000000000537,0.901377980420617,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
13148,GO:0051780,1.00000000000537,0.901377980420617,0,1,behavioral response to nutrient,BP,
13163,GO:0051796,1.00000000000537,0.901377980420617,0,1,negative regulation of timing of catagen,BP,
13167,GO:0051800,1.00000000000537,0.901377980420617,0,1,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
13174,GO:0051821,1.00000000000537,0.901377980420617,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
13178,GO:0051833,1.00000000000537,0.901377980420617,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
13187,GO:0051870,1.00000000000537,0.901377980420617,0,1,methotrexate binding,MF,
13197,GO:0051885,1.00000000000537,0.901377980420617,0,1,positive regulation of timing of anagen,BP,
13198,GO:0051886,1.00000000000537,0.901377980420617,0,1,negative regulation of timing of anagen,BP,
13200,GO:0051891,1.00000000000537,0.901377980420617,0,1,positive regulation of cardioblast differentiation,BP,
13201,GO:0051892,1.00000000000537,0.901377980420617,0,1,negative regulation of cardioblast differentiation,BP,
13215,GO:0051908,1.00000000000537,0.901377980420617,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
13227,GO:0051933,1.00000000000537,0.901377980420617,0,1,amino acid neurotransmitter reuptake,BP,
13229,GO:0051935,1.00000000000537,0.901377980420617,0,1,glutamate reuptake,BP,
13233,GO:0051941,1.00000000000537,0.901377980420617,0,1,regulation of amino acid uptake involved in synaptic transmission,BP,
13235,GO:0051945,1.00000000000537,0.901377980420617,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
13236,GO:0051946,1.00000000000537,0.901377980420617,0,1,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
13270,GO:0052029,1.00000000000537,0.901377980420617,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
13272,GO:0052037,1.00000000000537,0.901377980420617,0,1,negative regulation by symbiont of host defense response,BP,
13276,GO:0052047,1.00000000000537,0.901377980420617,0,1,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
13280,GO:0052066,1.00000000000537,0.901377980420617,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
13281,GO:0052097,1.00000000000537,0.901377980420617,0,1,interspecies quorum sensing,BP,
13282,GO:0052106,1.00000000000537,0.901377980420617,0,1,quorum sensing involved in interaction with host,BP,
13287,GO:0052167,1.00000000000537,0.901377980420617,0,1,modulation by symbiont of host innate immune response,BP,
13288,GO:0052170,1.00000000000537,0.901377980420617,0,1,negative regulation by symbiont of host innate immune response,BP,
13290,GO:0052190,1.00000000000537,0.901377980420617,0,1,modulation by symbiont of host phagocytosis,BP,
13291,GO:0052191,1.00000000000537,0.901377980420617,0,1,positive regulation by symbiont of host phagocytosis,BP,
13301,GO:0052231,1.00000000000537,0.901377980420617,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
13306,GO:0052261,1.00000000000537,0.901377980420617,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
13307,GO:0052306,1.00000000000537,0.901377980420617,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13308,GO:0052309,1.00000000000537,0.901377980420617,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13317,GO:0052370,1.00000000000537,0.901377980420617,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
13329,GO:0052493,1.00000000000537,0.901377980420617,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
13333,GO:0052522,1.00000000000537,0.901377980420617,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
13339,GO:0052561,1.00000000000537,0.901377980420617,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13340,GO:0052562,1.00000000000537,0.901377980420617,0,1,negative regulation by symbiont of host immune response,BP,
13344,GO:0052590,1.00000000000537,0.901377980420617,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
13345,GO:0052591,1.00000000000537,0.901377980420617,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
13368,GO:0052717,1.00000000000537,0.901377980420617,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
13369,GO:0052718,1.00000000000537,0.901377980420617,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
13372,GO:0052725,1.00000000000537,0.901377980420617,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
13373,GO:0052726,1.00000000000537,0.901377980420617,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
13388,GO:0052810,1.00000000000537,0.901377980420617,0,1,1-phosphatidylinositol-5-kinase activity,MF,
13395,GO:0052825,1.00000000000537,0.901377980420617,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
13396,GO:0052826,1.00000000000537,0.901377980420617,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
13400,GO:0052830,1.00000000000537,0.901377980420617,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
13401,GO:0052831,1.00000000000537,0.901377980420617,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
13405,GO:0052835,1.00000000000537,0.901377980420617,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
13418,GO:0052858,1.00000000000537,0.901377980420617,0,1,peptidyl-lysine acetyltransferase activity,MF,
13429,GO:0052906,1.00000000000537,0.901377980420617,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
13430,GO:0052907,1.00000000000537,0.901377980420617,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
13431,GO:0052909,1.00000000000537,0.901377980420617,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
13433,GO:0052918,1.00000000000537,0.901377980420617,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13435,GO:0052926,1.00000000000537,0.901377980420617,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13462,GO:0055028,1.00000000000537,0.901377980420617,0,1,cortical microtubule,CC,
13466,GO:0055048,1.00000000000537,0.901377980420617,0,1,anastral spindle assembly,BP,
13496,GO:0055095,1.00000000000537,0.901377980420617,0,1,lipoprotein particle mediated signaling,BP,
13497,GO:0055096,1.00000000000537,0.901377980420617,0,1,low-density lipoprotein particle mediated signaling,BP,
13500,GO:0055103,1.00000000000537,0.901377980420617,0,1,ligase regulator activity,MF,
13504,GO:0055113,1.00000000000537,0.901377980420617,0,1,epiboly involved in gastrulation with mouth forming second,BP,
13513,GO:0060001,1.00000000000537,0.901377980420617,0,1,minus-end directed microfilament motor activity,MF,
13521,GO:0060010,1.00000000000537,0.901377980420617,0,1,Sertoli cell fate commitment,BP,
13523,GO:0060012,1.00000000000537,0.901377980420617,0,1,synaptic transmission, glycinergic,BP,
13525,GO:0060014,1.00000000000537,0.901377980420617,0,1,granulosa cell differentiation,BP,
13527,GO:0060018,1.00000000000537,0.901377980420617,0,1,astrocyte fate commitment,BP,
13539,GO:0060031,1.00000000000537,0.901377980420617,0,1,mediolateral intercalation,BP,
13540,GO:0060032,1.00000000000537,0.901377980420617,0,1,notochord regression,BP,
13565,GO:0060060,1.00000000000537,0.901377980420617,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
13570,GO:0060067,1.00000000000537,0.901377980420617,0,1,cervix development,BP,
13585,GO:0060084,1.00000000000537,0.901377980420617,0,1,synaptic transmission involved in micturition,BP,
13592,GO:0060092,1.00000000000537,0.901377980420617,0,1,regulation of synaptic transmission, glycinergic,BP,
13602,GO:0060125,1.00000000000537,0.901377980420617,0,1,negative regulation of growth hormone secretion,BP,
13605,GO:0060128,1.00000000000537,0.901377980420617,0,1,corticotropin hormone secreting cell differentiation,BP,
13621,GO:0060156,1.00000000000537,0.901377980420617,0,1,milk ejection reflex,BP,
13631,GO:0060171,1.00000000000537,0.901377980420617,0,1,stereocilium membrane,CC,
13637,GO:0060183,1.00000000000537,0.901377980420617,0,1,apelin receptor signaling pathway,BP,
13638,GO:0060184,1.00000000000537,0.901377980420617,0,1,cell cycle switching,BP,
13646,GO:0060200,1.00000000000537,0.901377980420617,0,1,clathrin-sculpted acetylcholine transport vesicle,CC,
13647,GO:0060201,1.00000000000537,0.901377980420617,0,1,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
13658,GO:0060221,1.00000000000537,0.901377980420617,0,1,retinal rod cell differentiation,BP,
13667,GO:0060245,1.00000000000537,0.901377980420617,0,1,detection of cell density,BP,
13668,GO:0060246,1.00000000000537,0.901377980420617,0,1,detection of cell density by contact stimulus,BP,
13669,GO:0060248,1.00000000000537,0.901377980420617,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
13690,GO:0060283,1.00000000000537,0.901377980420617,0,1,negative regulation of oocyte development,BP,
13694,GO:0060290,1.00000000000537,0.901377980420617,0,1,transdifferentiation,BP,
13725,GO:0060327,1.00000000000537,0.901377980420617,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
13752,GO:0060366,1.00000000000537,0.901377980420617,0,1,lambdoid suture morphogenesis,BP,
13753,GO:0060367,1.00000000000537,0.901377980420617,0,1,sagittal suture morphogenesis,BP,
13756,GO:0060370,1.00000000000537,0.901377980420617,0,1,susceptibility to T cell mediated cytotoxicity,BP,
13758,GO:0060372,1.00000000000537,0.901377980420617,0,1,regulation of atrial cardiac muscle cell membrane repolarization,BP,
13768,GO:0060383,1.00000000000537,0.901377980420617,0,1,positive regulation of DNA strand elongation,BP,
13771,GO:0060386,1.00000000000537,0.901377980420617,0,1,synapse assembly involved in innervation,BP,
13783,GO:0060400,1.00000000000537,0.901377980420617,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
13818,GO:0060447,1.00000000000537,0.901377980420617,0,1,bud outgrowth involved in lung branching,BP,
13823,GO:0060454,1.00000000000537,0.901377980420617,0,1,positive regulation of gastric acid secretion,BP,
13831,GO:0060465,1.00000000000537,0.901377980420617,0,1,pharynx development,BP,
13855,GO:0060516,1.00000000000537,0.901377980420617,0,1,primary prostatic bud elongation,BP,
13856,GO:0060517,1.00000000000537,0.901377980420617,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
13871,GO:0060542,1.00000000000537,0.901377980420617,0,1,regulation of strand invasion,BP,
13885,GO:0060566,1.00000000000537,0.901377980420617,0,1,positive regulation of DNA-templated transcription, termination,BP,
13904,GO:0060595,1.00000000000537,0.901377980420617,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
13905,GO:0060596,1.00000000000537,0.901377980420617,0,1,mammary placode formation,BP,
13907,GO:0060599,1.00000000000537,0.901377980420617,0,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,
13917,GO:0060615,1.00000000000537,0.901377980420617,0,1,mammary gland bud formation,BP,
13918,GO:0060620,1.00000000000537,0.901377980420617,0,1,regulation of cholesterol import,BP,
13927,GO:0060648,1.00000000000537,0.901377980420617,0,1,mammary gland bud morphogenesis,BP,
13933,GO:0060667,1.00000000000537,0.901377980420617,0,1,branch elongation involved in salivary gland morphogenesis,BP,
13934,GO:0060668,1.00000000000537,0.901377980420617,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
13981,GO:0060730,1.00000000000537,0.901377980420617,0,1,regulation of intestinal epithelial structure maintenance,BP,
13982,GO:0060731,1.00000000000537,0.901377980420617,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
13985,GO:0060734,1.00000000000537,0.901377980420617,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
13989,GO:0060739,1.00000000000537,0.901377980420617,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
13996,GO:0060748,1.00000000000537,0.901377980420617,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,
14012,GO:0060769,1.00000000000537,0.901377980420617,0,1,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14014,GO:0060775,1.00000000000537,0.901377980420617,0,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14015,GO:0060784,1.00000000000537,0.901377980420617,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
14020,GO:0060804,1.00000000000537,0.901377980420617,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
14024,GO:0060821,1.00000000000537,0.901377980420617,0,1,inactivation of X chromosome by DNA methylation,BP,
14025,GO:0060823,1.00000000000537,0.901377980420617,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14037,GO:0060843,1.00000000000537,0.901377980420617,0,1,venous endothelial cell differentiation,BP,
14043,GO:0060853,1.00000000000537,0.901377980420617,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
14047,GO:0060873,1.00000000000537,0.901377980420617,0,1,anterior semicircular canal development,BP,
14048,GO:0060875,1.00000000000537,0.901377980420617,0,1,lateral semicircular canal development,BP,
14050,GO:0060887,1.00000000000537,0.901377980420617,0,1,limb epidermis development,BP,
14054,GO:0060901,1.00000000000537,0.901377980420617,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
14056,GO:0060904,1.00000000000537,0.901377980420617,0,1,regulation of protein folding in endoplasmic reticulum,BP,
14059,GO:0060912,1.00000000000537,0.901377980420617,0,1,cardiac cell fate specification,BP,
14062,GO:0060915,1.00000000000537,0.901377980420617,0,1,mesenchymal cell differentiation involved in lung development,BP,
14066,GO:0060922,1.00000000000537,0.901377980420617,0,1,atrioventricular node cell differentiation,BP,
14069,GO:0060928,1.00000000000537,0.901377980420617,0,1,atrioventricular node cell development,BP,
14071,GO:0060932,1.00000000000537,0.901377980420617,0,1,His-Purkinje system cell differentiation,BP,
14080,GO:0060957,1.00000000000537,0.901377980420617,0,1,endocardial cell fate commitment,BP,
14114,GO:0061010,1.00000000000537,0.901377980420617,0,1,gall bladder development,BP,
14122,GO:0061030,1.00000000000537,0.901377980420617,0,1,epithelial cell differentiation involved in mammary gland alveolus development,BP,
14124,GO:0061032,1.00000000000537,0.901377980420617,0,1,visceral serous pericardium development,BP,
14125,GO:0061034,1.00000000000537,0.901377980420617,0,1,olfactory bulb mitral cell layer development,BP,
14130,GO:0061040,1.00000000000537,0.901377980420617,0,1,female gonad morphogenesis,BP,
14134,GO:0061044,1.00000000000537,0.901377980420617,0,1,negative regulation of vascular wound healing,BP,
14143,GO:0061054,1.00000000000537,0.901377980420617,0,1,dermatome development,BP,
14145,GO:0061056,1.00000000000537,0.901377980420617,0,1,sclerotome development,BP,
14161,GO:0061091,1.00000000000537,0.901377980420617,0,1,regulation of phospholipid translocation,BP,
14162,GO:0061092,1.00000000000537,0.901377980420617,0,1,positive regulation of phospholipid translocation,BP,
14182,GO:0061141,1.00000000000537,0.901377980420617,0,1,lung ciliated cell differentiation,BP,
14196,GO:0061163,1.00000000000537,0.901377980420617,0,1,endoplasmic reticulum polarization,BP,
14200,GO:0061183,1.00000000000537,0.901377980420617,0,1,regulation of dermatome development,BP,
14201,GO:0061184,1.00000000000537,0.901377980420617,0,1,positive regulation of dermatome development,BP,
14210,GO:0061205,1.00000000000537,0.901377980420617,0,1,paramesonephric duct development,BP,
14223,GO:0061301,1.00000000000537,0.901377980420617,0,1,cerebellum vasculature morphogenesis,BP,
14237,GO:0061324,1.00000000000537,0.901377980420617,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
14246,GO:0061347,1.00000000000537,0.901377980420617,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
14247,GO:0061348,1.00000000000537,0.901377980420617,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
14248,GO:0061349,1.00000000000537,0.901377980420617,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
14249,GO:0061350,1.00000000000537,0.901377980420617,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
14251,GO:0061354,1.00000000000537,0.901377980420617,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
14258,GO:0061369,1.00000000000537,0.901377980420617,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
14268,GO:0061400,1.00000000000537,0.901377980420617,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
14282,GO:0061444,1.00000000000537,0.901377980420617,0,1,endocardial cushion cell development,BP,
14283,GO:0061445,1.00000000000537,0.901377980420617,0,1,endocardial cushion cell fate commitment,BP,
14287,GO:0061459,1.00000000000537,0.901377980420617,0,1,L-arginine transmembrane transporter activity,MF,
14296,GO:0061485,1.00000000000537,0.901377980420617,0,1,memory T cell proliferation,BP,
14297,GO:0061495,1.00000000000537,0.901377980420617,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
14301,GO:0061508,1.00000000000537,0.901377980420617,0,1,CDP phosphorylation,BP,
14306,GO:0061517,1.00000000000537,0.901377980420617,0,1,macrophage proliferation,BP,
14307,GO:0061518,1.00000000000537,0.901377980420617,0,1,microglial cell proliferation,BP,
14308,GO:0061519,1.00000000000537,0.901377980420617,0,1,macrophage homeostasis,BP,
14310,GO:0061528,1.00000000000537,0.901377980420617,0,1,aspartate secretion,BP,
14311,GO:0061534,1.00000000000537,0.901377980420617,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
14313,GO:0061536,1.00000000000537,0.901377980420617,0,1,glycine secretion,BP,
14314,GO:0061537,1.00000000000537,0.901377980420617,0,1,glycine secretion, neurotransmission,BP,
14316,GO:0061547,1.00000000000537,0.901377980420617,0,1,glycogen synthase activity, transferring glucose-1-phosphate,MF,
14323,GO:0061565,1.00000000000537,0.901377980420617,0,1,dAMP phosphorylation,BP,
14324,GO:0061566,1.00000000000537,0.901377980420617,0,1,CMP phosphorylation,BP,
14325,GO:0061567,1.00000000000537,0.901377980420617,0,1,dCMP phosphorylation,BP,
14326,GO:0061568,1.00000000000537,0.901377980420617,0,1,GDP phosphorylation,BP,
14327,GO:0061569,1.00000000000537,0.901377980420617,0,1,UDP phosphorylation,BP,
14328,GO:0061570,1.00000000000537,0.901377980420617,0,1,dCDP phosphorylation,BP,
14329,GO:0061571,1.00000000000537,0.901377980420617,0,1,TDP phosphorylation,BP,
14331,GO:0061573,1.00000000000537,0.901377980420617,0,1,actin filament bundle retrograde transport,BP,
14336,GO:0061580,1.00000000000537,0.901377980420617,0,1,colon epithelial cell migration,BP,
14342,GO:0061598,1.00000000000537,0.901377980420617,0,1,molybdopterin adenylyltransferase activity,MF,
14343,GO:0061599,1.00000000000537,0.901377980420617,0,1,molybdopterin molybdotransferase activity,MF,
14351,GO:0061618,1.00000000000537,0.901377980420617,0,1,sublamina densa,CC,
14366,GO:0061642,1.00000000000537,0.901377980420617,0,1,chemoattraction of axon,BP,
14369,GO:0061646,1.00000000000537,0.901377980420617,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
14375,GO:0061663,1.00000000000537,0.901377980420617,0,1,NEDD8 ligase activity,MF,
14382,GO:0061685,1.00000000000537,0.901377980420617,0,1,diphthine methylesterase activity,MF,
14386,GO:0061697,1.00000000000537,0.901377980420617,0,1,protein-glutaryllysine deglutarylase activity,MF,
14387,GO:0061698,1.00000000000537,0.901377980420617,0,1,protein deglutarylation,BP,
14388,GO:0061699,1.00000000000537,0.901377980420617,0,1,peptidyl-lysine deglutarylation,BP,
14391,GO:0061709,1.00000000000537,0.901377980420617,0,1,reticulophagy,BP,
14393,GO:0061712,1.00000000000537,0.901377980420617,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
14403,GO:0061736,1.00000000000537,0.901377980420617,0,1,engulfment of target by autophagosome,BP,
14414,GO:0061753,1.00000000000537,0.901377980420617,0,1,substrate localization to autophagosome,BP,
14416,GO:0061757,1.00000000000537,0.901377980420617,0,1,leukocyte adhesion to arterial endothelial cell,BP,
14420,GO:0061767,1.00000000000537,0.901377980420617,0,1,negative regulation of lung blood pressure,BP,
14421,GO:0061768,1.00000000000537,0.901377980420617,0,1,magnesium:sodium antiporter activity,MF,
14425,GO:0061772,1.00000000000537,0.901377980420617,0,1,drug transport across blood-nerve barrier,BP,
14427,GO:0061780,1.00000000000537,0.901377980420617,0,1,mitotic cohesin loading,BP,
14429,GO:0061789,1.00000000000537,0.901377980420617,0,1,dense core granule priming,BP,
14430,GO:0061792,1.00000000000537,0.901377980420617,0,1,secretory granule maturation,BP,
14438,GO:0061825,1.00000000000537,0.901377980420617,0,1,podosome core,CC,
14440,GO:0061828,1.00000000000537,0.901377980420617,0,1,apical tubulobulbar complex,CC,
14441,GO:0061829,1.00000000000537,0.901377980420617,0,1,basal tubulobulbar complex,CC,
14445,GO:0061845,1.00000000000537,0.901377980420617,0,1,neuron projection branch point,CC,
14446,GO:0061846,1.00000000000537,0.901377980420617,0,1,dendritic spine cytoplasm,CC,
14459,GO:0061896,1.00000000000537,0.901377980420617,0,1,all-trans retinol 3,4-desaturase activity,MF,
14460,GO:0061897,1.00000000000537,0.901377980420617,0,1,all-trans retinal 3,4-desaturase activity,MF,
14461,GO:0061898,1.00000000000537,0.901377980420617,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
14462,GO:0061899,1.00000000000537,0.901377980420617,0,1,11-cis-retinal 3,4-desaturase activity,MF,
14466,GO:0061920,1.00000000000537,0.901377980420617,0,1,protein propionyltransferase activity,MF,
14467,GO:0061921,1.00000000000537,0.901377980420617,0,1,peptidyl-lysine propionylation,BP,
14468,GO:0061930,1.00000000000537,0.901377980420617,0,1,regulation of erythrocyte enucleation,BP,
14469,GO:0061931,1.00000000000537,0.901377980420617,0,1,positive regulation of erythrocyte enucleation,BP,
14470,GO:0061944,1.00000000000537,0.901377980420617,0,1,negative regulation of protein K48-linked ubiquitination,BP,
14490,GO:0065010,1.00000000000537,0.901377980420617,0,1,extracellular membrane-bounded organelle,CC,
14493,GO:0070004,1.00000000000537,0.901377980420617,0,1,cysteine-type exopeptidase activity,MF,
14509,GO:0070042,1.00000000000537,0.901377980420617,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
14518,GO:0070060,1.00000000000537,0.901377980420617,0,1,'de novo' actin filament nucleation,BP,
14528,GO:0070077,1.00000000000537,0.901377980420617,0,1,histone arginine demethylation,BP,
14529,GO:0070078,1.00000000000537,0.901377980420617,0,1,histone H3-R2 demethylation,BP,
14530,GO:0070079,1.00000000000537,0.901377980420617,0,1,histone H4-R3 demethylation,BP,
14540,GO:0070096,1.00000000000537,0.901377980420617,0,1,mitochondrial outer membrane translocase complex assembly,BP,
14553,GO:0070121,1.00000000000537,0.901377980420617,0,1,Kupffer's vesicle development,BP,
14555,GO:0070123,1.00000000000537,0.901377980420617,0,1,transforming growth factor beta receptor activity, type III,MF,
14561,GO:0070130,1.00000000000537,0.901377980420617,0,1,negative regulation of mitochondrial translation,BP,
14569,GO:0070143,1.00000000000537,0.901377980420617,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
14570,GO:0070145,1.00000000000537,0.901377980420617,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
14578,GO:0070165,1.00000000000537,0.901377980420617,0,1,positive regulation of adiponectin secretion,BP,
14584,GO:0070171,1.00000000000537,0.901377980420617,0,1,negative regulation of tooth mineralization,BP,
14585,GO:0070172,1.00000000000537,0.901377980420617,0,1,positive regulation of tooth mineralization,BP,
14592,GO:0070183,1.00000000000537,0.901377980420617,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
14600,GO:0070195,1.00000000000537,0.901377980420617,0,1,growth hormone receptor complex,CC,
14611,GO:0070209,1.00000000000537,0.901377980420617,0,1,ASTRA complex,CC,
14635,GO:0070260,1.00000000000537,0.901377980420617,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
14639,GO:0070267,1.00000000000537,0.901377980420617,0,1,oncosis,BP,
14646,GO:0070280,1.00000000000537,0.901377980420617,0,1,pyridoxal binding,MF,
14679,GO:0070335,1.00000000000537,0.901377980420617,0,1,aspartate binding,MF,
14681,GO:0070337,1.00000000000537,0.901377980420617,0,1,3'-flap-structured DNA binding,MF,
14685,GO:0070343,1.00000000000537,0.901377980420617,0,1,white fat cell proliferation,BP,
14689,GO:0070350,1.00000000000537,0.901377980420617,0,1,regulation of white fat cell proliferation,BP,
14699,GO:0070376,1.00000000000537,0.901377980420617,0,1,regulation of ERK5 cascade,BP,
14700,GO:0070377,1.00000000000537,0.901377980420617,0,1,negative regulation of ERK5 cascade,BP,
14712,GO:0070407,1.00000000000537,0.901377980420617,0,1,oxidation-dependent protein catabolic process,BP,
14713,GO:0070408,1.00000000000537,0.901377980420617,0,1,carbamoyl phosphate metabolic process,BP,
14714,GO:0070409,1.00000000000537,0.901377980420617,0,1,carbamoyl phosphate biosynthetic process,BP,
14718,GO:0070413,1.00000000000537,0.901377980420617,0,1,trehalose metabolism in response to stress,BP,
14720,GO:0070418,1.00000000000537,0.901377980420617,0,1,DNA-dependent protein kinase complex,CC,
14724,GO:0070425,1.00000000000537,0.901377980420617,0,1,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14727,GO:0070428,1.00000000000537,0.901377980420617,0,1,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14728,GO:0070429,1.00000000000537,0.901377980420617,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14731,GO:0070433,1.00000000000537,0.901377980420617,0,1,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14741,GO:0070460,1.00000000000537,0.901377980420617,0,1,thyroid-stimulating hormone secretion,BP,
14743,GO:0070463,1.00000000000537,0.901377980420617,0,1,tubulin-dependent ATPase activity,MF,
14751,GO:0070478,1.00000000000537,0.901377980420617,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
14752,GO:0070481,1.00000000000537,0.901377980420617,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
14754,GO:0070483,1.00000000000537,0.901377980420617,0,1,detection of hypoxia,BP,
14758,GO:0070489,1.00000000000537,0.901377980420617,0,1,T cell aggregation,BP,
14769,GO:0070510,1.00000000000537,0.901377980420617,0,1,regulation of histone H4-K20 methylation,BP,
14770,GO:0070512,1.00000000000537,0.901377980420617,0,1,positive regulation of histone H4-K20 methylation,BP,
14784,GO:0070539,1.00000000000537,0.901377980420617,0,1,linoleic acid binding,MF,
14789,GO:0070548,1.00000000000537,0.901377980420617,0,1,L-glutamine aminotransferase activity,MF,
14790,GO:0070550,1.00000000000537,0.901377980420617,0,1,rDNA condensation,BP,
14791,GO:0070551,1.00000000000537,0.901377980420617,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
14793,GO:0070553,1.00000000000537,0.901377980420617,0,1,nicotinic acid receptor activity,MF,
14808,GO:0070573,1.00000000000537,0.901377980420617,0,1,metallodipeptidase activity,MF,
14820,GO:0070593,1.00000000000537,0.901377980420617,0,1,dendrite self-avoidance,BP,
14831,GO:0070627,1.00000000000537,0.901377980420617,0,1,ferrous iron import,BP,
14833,GO:0070631,1.00000000000537,0.901377980420617,0,1,spindle pole body localization,BP,
14834,GO:0070632,1.00000000000537,0.901377980420617,0,1,establishment of spindle pole body localization,BP,
14845,GO:0070650,1.00000000000537,0.901377980420617,0,1,actin filament bundle distribution,BP,
14846,GO:0070651,1.00000000000537,0.901377980420617,0,1,nonfunctional rRNA decay,BP,
14854,GO:0070667,1.00000000000537,0.901377980420617,0,1,negative regulation of mast cell proliferation,BP,
14874,GO:0070715,1.00000000000537,0.901377980420617,0,1,sodium-dependent organic cation transport,BP,
14877,GO:0070724,1.00000000000537,0.901377980420617,0,1,BMP receptor complex,CC,
14882,GO:0070735,1.00000000000537,0.901377980420617,0,1,protein-glycine ligase activity,MF,
14883,GO:0070736,1.00000000000537,0.901377980420617,0,1,protein-glycine ligase activity, initiating,MF,
14890,GO:0070762,1.00000000000537,0.901377980420617,0,1,nuclear pore transmembrane ring,CC,
14892,GO:0070772,1.00000000000537,0.901377980420617,0,1,PAS complex,CC,
14894,GO:0070774,1.00000000000537,0.901377980420617,0,1,phytoceramidase activity,MF,
14911,GO:0070826,1.00000000000537,0.901377980420617,0,1,paraferritin complex,CC,
14923,GO:0070843,1.00000000000537,0.901377980420617,0,1,misfolded protein transport,BP,
14924,GO:0070844,1.00000000000537,0.901377980420617,0,1,polyubiquitinated protein transport,BP,
14925,GO:0070845,1.00000000000537,0.901377980420617,0,1,polyubiquitinated misfolded protein transport,BP,
14926,GO:0070846,1.00000000000537,0.901377980420617,0,1,Hsp90 deacetylation,BP,
14933,GO:0070856,1.00000000000537,0.901377980420617,0,1,myosin VI light chain binding,MF,
14954,GO:0070890,1.00000000000537,0.901377980420617,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
14959,GO:0070898,1.00000000000537,0.901377980420617,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
14960,GO:0070899,1.00000000000537,0.901377980420617,0,1,mitochondrial tRNA wobble uridine modification,BP,
14965,GO:0070904,1.00000000000537,0.901377980420617,0,1,transepithelial L-ascorbic acid transport,BP,
14974,GO:0070926,1.00000000000537,0.901377980420617,0,1,regulation of ATP:ADP antiporter activity,BP,
14975,GO:0070931,1.00000000000537,0.901377980420617,0,1,Golgi-associated vesicle lumen,CC,
14992,GO:0070950,1.00000000000537,0.901377980420617,0,1,regulation of neutrophil mediated killing of bacterium,BP,
14993,GO:0070951,1.00000000000537,0.901377980420617,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
14997,GO:0070962,1.00000000000537,0.901377980420617,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
14998,GO:0070963,1.00000000000537,0.901377980420617,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15005,GO:0070975,1.00000000000537,0.901377980420617,0,1,FHA domain binding,MF,
15011,GO:0070984,1.00000000000537,0.901377980420617,0,1,SET domain binding,MF,
15056,GO:0071062,1.00000000000537,0.901377980420617,0,1,alphav-beta3 integrin-vitronectin complex,CC,
15057,GO:0071065,1.00000000000537,0.901377980420617,0,1,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
15065,GO:0071105,1.00000000000537,0.901377980420617,0,1,response to interleukin-11,BP,
15071,GO:0071133,1.00000000000537,0.901377980420617,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
15083,GO:0071164,1.00000000000537,0.901377980420617,0,1,RNA trimethylguanosine synthase activity,MF,
15097,GO:0071215,1.00000000000537,0.901377980420617,0,1,cellular response to abscisic acid stimulus,BP,
15107,GO:0071226,1.00000000000537,0.901377980420617,0,1,cellular response to molecule of fungal origin,BP,
15108,GO:0071228,1.00000000000537,0.901377980420617,0,1,cellular response to tumor cell,BP,
15116,GO:0071245,1.00000000000537,0.901377980420617,0,1,cellular response to carbon monoxide,BP,
15144,GO:0071301,1.00000000000537,0.901377980420617,0,1,cellular response to vitamin B1,BP,
15159,GO:0071324,1.00000000000537,0.901377980420617,0,1,cellular response to disaccharide stimulus,BP,
15161,GO:0071329,1.00000000000537,0.901377980420617,0,1,cellular response to sucrose stimulus,BP,
15174,GO:0071348,1.00000000000537,0.901377980420617,0,1,cellular response to interleukin-11,BP,
15204,GO:0071387,1.00000000000537,0.901377980420617,0,1,cellular response to cortisol stimulus,BP,
15208,GO:0071393,1.00000000000537,0.901377980420617,0,1,cellular response to progesterone stimulus,BP,
15228,GO:0071424,1.00000000000537,0.901377980420617,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
15239,GO:0071441,1.00000000000537,0.901377980420617,0,1,negative regulation of histone H3-K14 acetylation,BP,
15259,GO:0071471,1.00000000000537,0.901377980420617,0,1,cellular response to non-ionic osmotic stress,BP,
15272,GO:0071485,1.00000000000537,0.901377980420617,0,1,cellular response to absence of light,BP,
15273,GO:0071486,1.00000000000537,0.901377980420617,0,1,cellular response to high light intensity,BP,
15290,GO:0071528,1.00000000000537,0.901377980420617,0,1,tRNA re-export from nucleus,BP,
15295,GO:0071540,1.00000000000537,0.901377980420617,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
15312,GO:0071561,1.00000000000537,0.901377980420617,0,1,nucleus-vacuole junction,CC,
15315,GO:0071566,1.00000000000537,0.901377980420617,0,1,UFM1 activating enzyme activity,MF,
15319,GO:0071573,1.00000000000537,0.901377980420617,0,1,shelterin complex assembly,BP,
15336,GO:0071602,1.00000000000537,0.901377980420617,0,1,phytosphingosine biosynthetic process,BP,
15344,GO:0071612,1.00000000000537,0.901377980420617,0,1,IP-10 production,BP,
15346,GO:0071615,1.00000000000537,0.901377980420617,0,1,oxidative deethylation,BP,
15352,GO:0071623,1.00000000000537,0.901377980420617,0,1,negative regulation of granulocyte chemotaxis,BP,
15357,GO:0071633,1.00000000000537,0.901377980420617,0,1,dihydroceramidase activity,MF,
15375,GO:0071658,1.00000000000537,0.901377980420617,0,1,regulation of IP-10 production,BP,
15376,GO:0071660,1.00000000000537,0.901377980420617,0,1,positive regulation of IP-10 production,BP,
15378,GO:0071665,1.00000000000537,0.901377980420617,0,1,gamma-catenin-TCF7L2 complex,CC,
15382,GO:0071673,1.00000000000537,0.901377980420617,0,1,positive regulation of smooth muscle cell chemotaxis,BP,
15387,GO:0071678,1.00000000000537,0.901377980420617,0,1,olfactory bulb axon guidance,BP,
15392,GO:0071684,1.00000000000537,0.901377980420617,0,1,organism emergence from protective structure,BP,
15394,GO:0071691,1.00000000000537,0.901377980420617,0,1,cardiac muscle thin filament assembly,BP,
15402,GO:0071701,1.00000000000537,0.901377980420617,0,1,regulation of MAPK export from nucleus,BP,
15411,GO:0071713,1.00000000000537,0.901377980420617,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
15415,GO:0071725,1.00000000000537,0.901377980420617,0,1,response to triacyl bacterial lipopeptide,BP,
15417,GO:0071727,1.00000000000537,0.901377980420617,0,1,cellular response to triacyl bacterial lipopeptide,BP,
15422,GO:0071765,1.00000000000537,0.901377980420617,0,1,nuclear inner membrane organization,BP,
15429,GO:0071789,1.00000000000537,0.901377980420617,0,1,spindle pole body localization to nuclear envelope,BP,
15430,GO:0071790,1.00000000000537,0.901377980420617,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
15437,GO:0071802,1.00000000000537,0.901377980420617,0,1,negative regulation of podosome assembly,BP,
15442,GO:0071812,1.00000000000537,0.901377980420617,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
15450,GO:0071821,1.00000000000537,0.901377980420617,0,1,FANCM-MHF complex,CC,
15461,GO:0071848,1.00000000000537,0.901377980420617,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
15474,GO:0071873,1.00000000000537,0.901377980420617,0,1,response to norepinephrine,BP,
15475,GO:0071874,1.00000000000537,0.901377980420617,0,1,cellular response to norepinephrine stimulus,BP,
15482,GO:0071885,1.00000000000537,0.901377980420617,0,1,N-terminal protein N-methyltransferase activity,MF,
15497,GO:0071908,1.00000000000537,0.901377980420617,0,1,determination of intestine left/right asymmetry,BP,
15498,GO:0071909,1.00000000000537,0.901377980420617,0,1,determination of stomach left/right asymmetry,BP,
15500,GO:0071914,1.00000000000537,0.901377980420617,0,1,prominosome,CC,
15508,GO:0071931,1.00000000000537,0.901377980420617,0,1,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15527,GO:0071988,1.00000000000537,0.901377980420617,0,1,protein localization to spindle pole body,BP,
15528,GO:0071997,1.00000000000537,0.901377980420617,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
15530,GO:0072003,1.00000000000537,0.901377980420617,0,1,kidney rudiment formation,BP,
15531,GO:0072004,1.00000000000537,0.901377980420617,0,1,kidney field specification,BP,
15543,GO:0072025,1.00000000000537,0.901377980420617,0,1,distal convoluted tubule development,BP,
15547,GO:0072036,1.00000000000537,0.901377980420617,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
15562,GO:0072069,1.00000000000537,0.901377980420617,0,1,DCT cell differentiation,BP,
15598,GO:0072114,1.00000000000537,0.901377980420617,0,1,pronephros morphogenesis,BP,
15612,GO:0072137,1.00000000000537,0.901377980420617,0,1,condensed mesenchymal cell proliferation,BP,
15625,GO:0072166,1.00000000000537,0.901377980420617,0,1,posterior mesonephric tubule development,BP,
15637,GO:0072183,1.00000000000537,0.901377980420617,0,1,negative regulation of nephron tubule epithelial cell differentiation,BP,
15657,GO:0072209,1.00000000000537,0.901377980420617,0,1,metanephric mesangial cell differentiation,BP,
15666,GO:0072221,1.00000000000537,0.901377980420617,0,1,metanephric distal convoluted tubule development,BP,
15675,GO:0072240,1.00000000000537,0.901377980420617,0,1,metanephric DCT cell differentiation,BP,
15680,GO:0072254,1.00000000000537,0.901377980420617,0,1,metanephric glomerular mesangial cell differentiation,BP,
15681,GO:0072255,1.00000000000537,0.901377980420617,0,1,metanephric glomerular mesangial cell development,BP,
15695,GO:0072285,1.00000000000537,0.901377980420617,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
15699,GO:0072299,1.00000000000537,0.901377980420617,0,1,negative regulation of metanephric glomerulus development,BP,
15702,GO:0072302,1.00000000000537,0.901377980420617,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
15704,GO:0072304,1.00000000000537,0.901377980420617,0,1,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15705,GO:0072305,1.00000000000537,0.901377980420617,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15707,GO:0072308,1.00000000000537,0.901377980420617,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
15708,GO:0072309,1.00000000000537,0.901377980420617,0,1,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
15734,GO:0072356,1.00000000000537,0.901377980420617,0,1,chromosome passenger complex localization to kinetochore,BP,
15739,GO:0072362,1.00000000000537,0.901377980420617,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15742,GO:0072365,1.00000000000537,0.901377980420617,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15750,GO:0072382,1.00000000000537,0.901377980420617,0,1,minus-end-directed vesicle transport along microtubule,BP,
15757,GO:0072389,1.00000000000537,0.901377980420617,0,1,flavin adenine dinucleotide catabolic process,BP,
15764,GO:0072414,1.00000000000537,0.901377980420617,0,1,response to mitotic cell cycle checkpoint signaling,BP,
15771,GO:0072432,1.00000000000537,0.901377980420617,0,1,response to G1 DNA damage checkpoint signaling,BP,
15785,GO:0072510,1.00000000000537,0.901377980420617,0,1,trivalent inorganic cation transmembrane transporter activity,MF,
15789,GO:0072517,1.00000000000537,0.901377980420617,0,1,host cell viral assembly compartment,CC,
15790,GO:0072518,1.00000000000537,0.901377980420617,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
15803,GO:0072534,1.00000000000537,0.901377980420617,0,1,perineuronal net,CC,
15804,GO:0072535,1.00000000000537,0.901377980420617,0,1,tumor necrosis factor (ligand) superfamily member 11 production,BP,
15820,GO:0072560,1.00000000000537,0.901377980420617,0,1,type B pancreatic cell maturation,BP,
15825,GO:0072570,1.00000000000537,0.901377980420617,0,1,ADP-D-ribose binding,MF,
15827,GO:0072573,1.00000000000537,0.901377980420617,0,1,tolerance induction to lipopolysaccharide,BP,
15833,GO:0072579,1.00000000000537,0.901377980420617,0,1,glycine receptor clustering,BP,
15837,GO:0072586,1.00000000000537,0.901377980420617,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
15838,GO:0072587,1.00000000000537,0.901377980420617,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
15841,GO:0072590,1.00000000000537,0.901377980420617,0,1,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
15842,GO:0072591,1.00000000000537,0.901377980420617,0,1,citrate-L-glutamate ligase activity,MF,
15856,GO:0072616,1.00000000000537,0.901377980420617,0,1,interleukin-18 secretion,BP,
15857,GO:0072619,1.00000000000537,0.901377980420617,0,1,interleukin-21 secretion,BP,
15881,GO:0072680,1.00000000000537,0.901377980420617,0,1,extracellular matrix-dependent thymocyte migration,BP,
15882,GO:0072681,1.00000000000537,0.901377980420617,0,1,fibronectin-dependent thymocyte migration,BP,
15883,GO:0072682,1.00000000000537,0.901377980420617,0,1,eosinophil extravasation,BP,
15885,GO:0072684,1.00000000000537,0.901377980420617,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
15905,GO:0072720,1.00000000000537,0.901377980420617,0,1,response to dithiothreitol,BP,
15915,GO:0072752,1.00000000000537,0.901377980420617,0,1,cellular response to rapamycin,BP,
15916,GO:0072755,1.00000000000537,0.901377980420617,0,1,cellular response to benomyl,BP,
15920,GO:0075109,1.00000000000537,0.901377980420617,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
15921,GO:0075111,1.00000000000537,0.901377980420617,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
15922,GO:0075112,1.00000000000537,0.901377980420617,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15923,GO:0075114,1.00000000000537,0.901377980420617,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15985,GO:0086024,1.00000000000537,0.901377980420617,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
15991,GO:0086038,1.00000000000537,0.901377980420617,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
15992,GO:0086039,1.00000000000537,0.901377980420617,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
15993,GO:0086040,1.00000000000537,0.901377980420617,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
15996,GO:0086044,1.00000000000537,0.901377980420617,0,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,
15998,GO:0086046,1.00000000000537,0.901377980420617,0,1,membrane depolarization during SA node cell action potential,BP,
15999,GO:0086047,1.00000000000537,0.901377980420617,0,1,membrane depolarization during Purkinje myocyte cell action potential,BP,
16002,GO:0086054,1.00000000000537,0.901377980420617,0,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,
16003,GO:0086055,1.00000000000537,0.901377980420617,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,
16004,GO:0086056,1.00000000000537,0.901377980420617,0,1,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
16005,GO:0086057,1.00000000000537,0.901377980420617,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
16016,GO:0086076,1.00000000000537,0.901377980420617,0,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,
16018,GO:0086078,1.00000000000537,0.901377980420617,0,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,
16019,GO:0086079,1.00000000000537,0.901377980420617,0,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,
16023,GO:0086089,1.00000000000537,0.901377980420617,0,1,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
16025,GO:0086092,1.00000000000537,0.901377980420617,0,1,regulation of the force of heart contraction by cardiac conduction,BP,
16028,GO:0086100,1.00000000000537,0.901377980420617,0,1,endothelin receptor signaling pathway,BP,
16039,GO:0090024,1.00000000000537,0.901377980420617,0,1,negative regulation of neutrophil chemotaxis,BP,
16061,GO:0090067,1.00000000000537,0.901377980420617,0,1,regulation of thalamus size,BP,
16099,GO:0090119,1.00000000000537,0.901377980420617,0,1,vesicle-mediated cholesterol transport,BP,
16107,GO:0090138,1.00000000000537,0.901377980420617,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
16129,GO:0090176,1.00000000000537,0.901377980420617,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
16150,GO:0090198,1.00000000000537,0.901377980420617,0,1,negative regulation of chemokine secretion,BP,
16162,GO:0090212,1.00000000000537,0.901377980420617,0,1,negative regulation of establishment of blood-brain barrier,BP,
16183,GO:0090246,1.00000000000537,0.901377980420617,0,1,convergent extension involved in somitogenesis,BP,
16190,GO:0090260,1.00000000000537,0.901377980420617,0,1,negative regulation of retinal ganglion cell axon guidance,BP,
16206,GO:0090284,1.00000000000537,0.901377980420617,0,1,positive regulation of protein glycosylation in Golgi,BP,
16213,GO:0090291,1.00000000000537,0.901377980420617,0,1,negative regulation of osteoclast proliferation,BP,
16239,GO:0090326,1.00000000000537,0.901377980420617,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
16240,GO:0090327,1.00000000000537,0.901377980420617,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
16258,GO:0090370,1.00000000000537,0.901377980420617,0,1,negative regulation of cholesterol efflux,BP,
16265,GO:0090389,1.00000000000537,0.901377980420617,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
16280,GO:0090461,1.00000000000537,0.901377980420617,0,1,glutamate homeostasis,BP,
16317,GO:0090600,1.00000000000537,0.901377980420617,0,1,alpha-1,3-glucosidase activity,MF,
16318,GO:0090601,1.00000000000537,0.901377980420617,0,1,enucleation,BP,
16321,GO:0090616,1.00000000000537,0.901377980420617,0,1,mitochondrial mRNA 3'-end processing,BP,
16322,GO:0090624,1.00000000000537,0.901377980420617,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
16323,GO:0090625,1.00000000000537,0.901377980420617,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
16337,GO:0090667,1.00000000000537,0.901377980420617,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
16338,GO:0090668,1.00000000000537,0.901377980420617,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
16343,GO:0090673,1.00000000000537,0.901377980420617,0,1,endothelial cell-matrix adhesion,BP,
16359,GO:0093001,1.00000000000537,0.901377980420617,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
16372,GO:0097020,1.00000000000537,0.901377980420617,0,1,COPII adaptor activity,MF,
16375,GO:0097026,1.00000000000537,0.901377980420617,0,1,dendritic cell dendrite assembly,BP,
16378,GO:0097029,1.00000000000537,0.901377980420617,0,1,mature conventional dendritic cell differentiation,BP,
16381,GO:0097037,1.00000000000537,0.901377980420617,0,1,heme export,BP,
16384,GO:0097045,1.00000000000537,0.901377980420617,0,1,phosphatidylserine exposure on blood platelet,BP,
16404,GO:0097070,1.00000000000537,0.901377980420617,0,1,ductus arteriosus closure,BP,
16406,GO:0097086,1.00000000000537,0.901377980420617,0,1,amniotic stem cell differentiation,BP,
16418,GO:0097108,1.00000000000537,0.901377980420617,0,1,hedgehog family protein binding,MF,
16422,GO:0097112,1.00000000000537,0.901377980420617,0,1,gamma-aminobutyric acid receptor clustering,BP,
16427,GO:0097118,1.00000000000537,0.901377980420617,0,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,
16446,GO:0097156,1.00000000000537,0.901377980420617,0,1,fasciculation of motor neuron axon,BP,
16450,GO:0097161,1.00000000000537,0.901377980420617,0,1,DH domain binding,MF,
16451,GO:0097162,1.00000000000537,0.901377980420617,0,1,MADS box domain binding,MF,
16454,GO:0097166,1.00000000000537,0.901377980420617,0,1,lens epithelial cell proliferation,BP,
16485,GO:0097222,1.00000000000537,0.901377980420617,0,1,mitochondrial mRNA polyadenylation,BP,
16494,GO:0097232,1.00000000000537,0.901377980420617,0,1,lamellar body membrane,CC,
16495,GO:0097233,1.00000000000537,0.901377980420617,0,1,alveolar lamellar body membrane,CC,
16505,GO:0097272,1.00000000000537,0.901377980420617,0,1,ammonia homeostasis,BP,
16506,GO:0097273,1.00000000000537,0.901377980420617,0,1,creatinine homeostasis,BP,
16508,GO:0097275,1.00000000000537,0.901377980420617,0,1,cellular ammonia homeostasis,BP,
16509,GO:0097276,1.00000000000537,0.901377980420617,0,1,cellular creatinine homeostasis,BP,
16510,GO:0097277,1.00000000000537,0.901377980420617,0,1,cellular urea homeostasis,BP,
16517,GO:0097298,1.00000000000537,0.901377980420617,0,1,regulation of nucleus size,BP,
16522,GO:0097310,1.00000000000537,0.901377980420617,0,1,cap2 mRNA methylation,BP,
16529,GO:0097338,1.00000000000537,0.901377980420617,0,1,response to clozapine,BP,
16540,GO:0097356,1.00000000000537,0.901377980420617,0,1,perinucleolar compartment,CC,
16554,GO:0097382,1.00000000000537,0.901377980420617,0,1,deoxynucleoside-diphosphatase activity,MF,
16555,GO:0097383,1.00000000000537,0.901377980420617,0,1,dIDP diphosphatase activity,MF,
16558,GO:0097393,1.00000000000537,0.901377980420617,0,1,telomeric repeat-containing RNA transcription,BP,
16559,GO:0097394,1.00000000000537,0.901377980420617,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
16579,GO:0097442,1.00000000000537,0.901377980420617,0,1,CA3 pyramidal cell dendrite,CC,
16581,GO:0097444,1.00000000000537,0.901377980420617,0,1,spine apparatus,CC,
16595,GO:0097473,1.00000000000537,0.901377980420617,0,1,retinal rod cell apoptotic process,BP,
16616,GO:0097505,1.00000000000537,0.901377980420617,0,1,Rad6-Rad18 complex,CC,
16635,GO:0097541,1.00000000000537,0.901377980420617,0,1,axonemal basal plate,CC,
16647,GO:0097598,1.00000000000537,0.901377980420617,0,1,sperm cytoplasmic droplet,CC,
16649,GO:0097603,1.00000000000537,0.901377980420617,0,1,temperature-gated ion channel activity,MF,
16653,GO:0097625,1.00000000000537,0.901377980420617,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
16654,GO:0097626,1.00000000000537,0.901377980420617,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
16655,GO:0097627,1.00000000000537,0.901377980420617,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
16657,GO:0097630,1.00000000000537,0.901377980420617,0,1,intrinsic component of omegasome membrane,CC,
16658,GO:0097631,1.00000000000537,0.901377980420617,0,1,integral component of omegasome membrane,CC,
16664,GO:0097639,1.00000000000537,0.901377980420617,0,1,L-lysine import across plasma membrane,BP,
16665,GO:0097640,1.00000000000537,0.901377980420617,0,1,L-ornithine import across plasma membrane,BP,
16673,GO:0097655,1.00000000000537,0.901377980420617,0,1,serpin family protein binding,MF,
16681,GO:0097692,1.00000000000537,0.901377980420617,0,1,histone H3-K4 monomethylation,BP,
16686,GO:0097699,1.00000000000537,0.901377980420617,0,1,vascular endothelial cell response to fluid shear stress,BP,
16691,GO:0097712,1.00000000000537,0.901377980420617,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
16707,GO:0097749,1.00000000000537,0.901377980420617,0,1,membrane tubulation,BP,
16709,GO:0097753,1.00000000000537,0.901377980420617,0,1,membrane bending,BP,
16723,GO:0098530,1.00000000000537,0.901377980420617,0,1,positive regulation of strand invasion,BP,
16745,GO:0098577,1.00000000000537,0.901377980420617,0,1,inactive sex chromosome,CC,
16760,GO:0098621,1.00000000000537,0.901377980420617,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
16761,GO:0098625,1.00000000000537,0.901377980420617,0,1,methylselenol reductase activity,MF,
16762,GO:0098626,1.00000000000537,0.901377980420617,0,1,methylseleninic acid reductase activity,MF,
16763,GO:0098629,1.00000000000537,0.901377980420617,0,1,trans-Golgi network membrane organization,BP,
16777,GO:0098648,1.00000000000537,0.901377980420617,0,1,collagen anchoring fibril,CC,
16779,GO:0098652,1.00000000000537,0.901377980420617,0,1,collagen type VII anchoring fibril,CC,
16795,GO:0098705,1.00000000000537,0.901377980420617,0,1,copper ion import across plasma membrane,BP,
16802,GO:0098725,1.00000000000537,0.901377980420617,0,1,symmetric cell division,BP,
16813,GO:0098746,1.00000000000537,0.901377980420617,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
16815,GO:0098749,1.00000000000537,0.901377980420617,0,1,cerebellar neuron development,BP,
16859,GO:0098829,1.00000000000537,0.901377980420617,0,1,intestinal folate absorption,BP,
16860,GO:0098830,1.00000000000537,0.901377980420617,0,1,presynaptic endosome,CC,
16862,GO:0098833,1.00000000000537,0.901377980420617,0,1,presynaptic endocytic zone,CC,
16863,GO:0098835,1.00000000000537,0.901377980420617,0,1,presynaptic endocytic zone membrane,CC,
16865,GO:0098838,1.00000000000537,0.901377980420617,0,1,reduced folate transmembrane transport,BP,
16882,GO:0098875,1.00000000000537,0.901377980420617,0,1,epididymosome,CC,
16889,GO:0098885,1.00000000000537,0.901377980420617,0,1,modification of postsynaptic actin cytoskeleton,BP,
16892,GO:0098888,1.00000000000537,0.901377980420617,0,1,extrinsic component of presynaptic membrane,CC,
16893,GO:0098890,1.00000000000537,0.901377980420617,0,1,extrinsic component of postsynaptic membrane,CC,
16900,GO:0098906,1.00000000000537,0.901377980420617,0,1,regulation of Purkinje myocyte action potential,BP,
16901,GO:0098907,1.00000000000537,0.901377980420617,0,1,regulation of SA node cell action potential,BP,
16906,GO:0098912,1.00000000000537,0.901377980420617,0,1,membrane depolarization during atrial cardiac muscle cell action potential,BP,
16916,GO:0098926,1.00000000000537,0.901377980420617,0,1,postsynaptic signal transduction,BP,
16923,GO:0098939,1.00000000000537,0.901377980420617,0,1,dendritic transport of mitochondrion,BP,
16930,GO:0098968,1.00000000000537,0.901377980420617,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
16934,GO:0098972,1.00000000000537,0.901377980420617,0,1,anterograde dendritic transport of mitochondrion,BP,
16943,GO:0098988,1.00000000000537,0.901377980420617,0,1,G-protein coupled glutamate receptor activity,MF,
16953,GO:0099039,1.00000000000537,0.901377980420617,0,1,sphingolipid translocation,BP,
16966,GO:0099077,1.00000000000537,0.901377980420617,0,1,histone-dependent DNA binding,MF,
16974,GO:0099089,1.00000000000537,0.901377980420617,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
16977,GO:0099095,1.00000000000537,0.901377980420617,0,1,ligand-gated anion channel activity,MF,
16978,GO:0099098,1.00000000000537,0.901377980420617,0,1,microtubule polymerization based movement,BP,
16989,GO:0099159,1.00000000000537,0.901377980420617,0,1,regulation of modification of postsynaptic structure,BP,
17000,GO:0099243,1.00000000000537,0.901377980420617,0,1,extrinsic component of synaptic membrane,CC,
17015,GO:0099519,1.00000000000537,0.901377980420617,0,1,dense core granule cytoskeletal transport,BP,
17021,GO:0099527,1.00000000000537,0.901377980420617,0,1,postsynapse to nucleus signaling pathway,BP,
17048,GO:0099580,1.00000000000537,0.901377980420617,0,1,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
17055,GO:0099606,1.00000000000537,0.901377980420617,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
17056,GO:0099607,1.00000000000537,0.901377980420617,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
17059,GO:0099617,1.00000000000537,0.901377980420617,0,1,matrix side of mitochondrial inner membrane,CC,
17064,GO:0099627,1.00000000000537,0.901377980420617,0,1,neurotransmitter receptor cycle,BP,
17066,GO:0099630,1.00000000000537,0.901377980420617,0,1,postsynaptic neurotransmitter receptor cycle,BP,
17080,GO:0100057,1.00000000000537,0.901377980420617,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
17091,GO:0102008,1.00000000000537,0.901377980420617,0,1,cytosolic dipeptidase activity,MF,
17096,GO:0102113,1.00000000000537,0.901377980420617,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
17098,GO:0102131,1.00000000000537,0.901377980420617,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
17099,GO:0102132,1.00000000000537,0.901377980420617,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
17102,GO:0102166,1.00000000000537,0.901377980420617,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17103,GO:0102167,1.00000000000537,0.901377980420617,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17104,GO:0102200,1.00000000000537,0.901377980420617,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
17128,GO:0102500,1.00000000000537,0.901377980420617,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
17131,GO:0102524,1.00000000000537,0.901377980420617,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
17134,GO:0102571,1.00000000000537,0.901377980420617,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17135,GO:0102704,1.00000000000537,0.901377980420617,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
17138,GO:0102752,1.00000000000537,0.901377980420617,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
17142,GO:0102773,1.00000000000537,0.901377980420617,0,1,dihydroceramide kinase activity,MF,
17143,GO:0102797,1.00000000000537,0.901377980420617,0,1,geranial:oxygen oxidoreductase activity,MF,
17144,GO:0102798,1.00000000000537,0.901377980420617,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
17152,GO:0103046,1.00000000000537,0.901377980420617,0,1,alanylglutamate dipeptidase activity,MF,
17163,GO:0106005,1.00000000000537,0.901377980420617,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
17170,GO:0106022,1.00000000000537,0.901377980420617,0,1,positive regulation of vesicle docking,BP,
17188,GO:0106075,1.00000000000537,0.901377980420617,0,1,peptide N-succinyltransferase activity,MF,
17190,GO:0106078,1.00000000000537,0.901377980420617,0,1,histone succinyltransferase activity,MF,
17192,GO:0106088,1.00000000000537,0.901377980420617,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
17193,GO:0106089,1.00000000000537,0.901377980420617,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
17197,GO:0110008,1.00000000000537,0.901377980420617,0,1,ncRNA deadenylation,BP,
17205,GO:0110025,1.00000000000537,0.901377980420617,0,1,DNA strand resection involved in replication fork processing,BP,
17206,GO:0110026,1.00000000000537,0.901377980420617,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
17207,GO:0110028,1.00000000000537,0.901377980420617,0,1,positive regulation of mitotic spindle organization,BP,
17208,GO:0110029,1.00000000000537,0.901377980420617,0,1,negative regulation of meiosis I,BP,
17210,GO:0110057,1.00000000000537,0.901377980420617,0,1,regulation of blood vessel endothelial cell differentiation,BP,
17211,GO:0110059,1.00000000000537,0.901377980420617,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
17217,GO:0120012,1.00000000000537,0.901377980420617,0,1,intermembrane sphingolipid transfer,BP,
17219,GO:0120016,1.00000000000537,0.901377980420617,0,1,intermembrane sphingolipid transfer activity,MF,
17220,GO:0120017,1.00000000000537,0.901377980420617,0,1,intermembrane ceramide transfer activity,MF,
17230,GO:0120043,1.00000000000537,0.901377980420617,0,1,stereocilium shaft,CC,
17231,GO:0120044,1.00000000000537,0.901377980420617,0,1,stereocilium base,CC,
17232,GO:0120048,1.00000000000537,0.901377980420617,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
17233,GO:0120049,1.00000000000537,0.901377980420617,0,1,snRNA (adenine-N6)-methylation,BP,
17239,GO:0120077,1.00000000000537,0.901377980420617,0,1,angiogenic sprout fusion,BP,
17240,GO:0120078,1.00000000000537,0.901377980420617,0,1,cell adhesion involved in sprouting angiogenesis,BP,
17241,GO:0120092,1.00000000000537,0.901377980420617,0,1,crotonyl-CoA hydratase activity,MF,
17242,GO:0120093,1.00000000000537,0.901377980420617,0,1,regulation of peptidyl-lysine crotonylation,BP,
17243,GO:0120094,1.00000000000537,0.901377980420617,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
17249,GO:0140009,1.00000000000537,0.901377980420617,0,1,L-aspartate import across plasma membrane,BP,
17265,GO:0140064,1.00000000000537,0.901377980420617,0,1,peptide crotonyltransferase activity,MF,
17266,GO:0140065,1.00000000000537,0.901377980420617,0,1,peptide butyryltransferase activity,MF,
17268,GO:0140067,1.00000000000537,0.901377980420617,0,1,peptidyl-lysine butyrylation,BP,
17269,GO:0140068,1.00000000000537,0.901377980420617,0,1,histone crotonyltransferase activity,MF,
17270,GO:0140069,1.00000000000537,0.901377980420617,0,1,histone butyryltransferase activity,MF,
17271,GO:0140074,1.00000000000537,0.901377980420617,0,1,cardiac endothelial to mesenchymal transition,BP,
17293,GO:0140200,1.00000000000537,0.901377980420617,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
17301,GO:0150031,1.00000000000537,0.901377980420617,0,1,regulation of protein localization to lysosome,BP,
17302,GO:0150033,1.00000000000537,0.901377980420617,0,1,negative regulation of protein localization to lysosome,BP,
17333,GO:1900062,1.00000000000537,0.901377980420617,0,1,regulation of replicative cell aging,BP,
17345,GO:1900095,1.00000000000537,0.901377980420617,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
17371,GO:1900130,1.00000000000537,0.901377980420617,0,1,regulation of lipid binding,BP,
17372,GO:1900131,1.00000000000537,0.901377980420617,0,1,negative regulation of lipid binding,BP,
17375,GO:1900135,1.00000000000537,0.901377980420617,0,1,positive regulation of renin secretion into blood stream,BP,
17377,GO:1900139,1.00000000000537,0.901377980420617,0,1,negative regulation of arachidonic acid secretion,BP,
17383,GO:1900148,1.00000000000537,0.901377980420617,0,1,negative regulation of Schwann cell migration,BP,
17384,GO:1900149,1.00000000000537,0.901377980420617,0,1,positive regulation of Schwann cell migration,BP,
17396,GO:1900170,1.00000000000537,0.901377980420617,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
17404,GO:1900194,1.00000000000537,0.901377980420617,0,1,negative regulation of oocyte maturation,BP,
17406,GO:1900200,1.00000000000537,0.901377980420617,0,1,mesenchymal cell apoptotic process involved in metanephros development,BP,
17407,GO:1900204,1.00000000000537,0.901377980420617,0,1,apoptotic process involved in metanephric collecting duct development,BP,
17408,GO:1900205,1.00000000000537,0.901377980420617,0,1,apoptotic process involved in metanephric nephron tubule development,BP,
17411,GO:1900211,1.00000000000537,0.901377980420617,0,1,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17412,GO:1900212,1.00000000000537,0.901377980420617,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17413,GO:1900214,1.00000000000537,0.901377980420617,0,1,regulation of apoptotic process involved in metanephric collecting duct development,BP,
17414,GO:1900215,1.00000000000537,0.901377980420617,0,1,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
17415,GO:1900217,1.00000000000537,0.901377980420617,0,1,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17416,GO:1900218,1.00000000000537,0.901377980420617,0,1,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17421,GO:1900224,1.00000000000537,0.901377980420617,0,1,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17427,GO:1900241,1.00000000000537,0.901377980420617,0,1,positive regulation of phenotypic switching,BP,
17429,GO:1900243,1.00000000000537,0.901377980420617,0,1,negative regulation of synaptic vesicle endocytosis,BP,
17444,GO:1900276,1.00000000000537,0.901377980420617,0,1,regulation of proteinase activated receptor activity,BP,
17450,GO:1900370,1.00000000000537,0.901377980420617,0,1,positive regulation of RNA interference,BP,
17481,GO:1900736,1.00000000000537,0.901377980420617,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17482,GO:1900737,1.00000000000537,0.901377980420617,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17491,GO:1900753,1.00000000000537,0.901377980420617,0,1,doxorubicin transport,BP,
17496,GO:1901003,1.00000000000537,0.901377980420617,0,1,negative regulation of fermentation,BP,
17521,GO:1901078,1.00000000000537,0.901377980420617,0,1,negative regulation of relaxation of muscle,BP,
17522,GO:1901086,1.00000000000537,0.901377980420617,0,1,benzylpenicillin metabolic process,BP,
17537,GO:1901147,1.00000000000537,0.901377980420617,0,1,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
17555,GO:1901207,1.00000000000537,0.901377980420617,0,1,regulation of heart looping,BP,
17563,GO:1901228,1.00000000000537,0.901377980420617,0,1,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
17570,GO:1901254,1.00000000000537,0.901377980420617,0,1,positive regulation of intracellular transport of viral material,BP,
17595,GO:1901318,1.00000000000537,0.901377980420617,0,1,negative regulation of flagellated sperm motility,BP,
17599,GO:1901331,1.00000000000537,0.901377980420617,0,1,positive regulation of odontoblast differentiation,BP,
17603,GO:1901340,1.00000000000537,0.901377980420617,0,1,negative regulation of store-operated calcium channel activity,BP,
17608,GO:1901350,1.00000000000537,0.901377980420617,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
17628,GO:1901419,1.00000000000537,0.901377980420617,0,1,regulation of response to alcohol,BP,
17629,GO:1901421,1.00000000000537,0.901377980420617,0,1,positive regulation of response to alcohol,BP,
17639,GO:1901523,1.00000000000537,0.901377980420617,0,1,icosanoid catabolic process,BP,
17653,GO:1901551,1.00000000000537,0.901377980420617,0,1,negative regulation of endothelial cell development,BP,
17655,GO:1901555,1.00000000000537,0.901377980420617,0,1,response to paclitaxel,BP,
17657,GO:1901561,1.00000000000537,0.901377980420617,0,1,response to benomyl,BP,
17669,GO:1901580,1.00000000000537,0.901377980420617,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17670,GO:1901581,1.00000000000537,0.901377980420617,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17671,GO:1901582,1.00000000000537,0.901377980420617,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17672,GO:1901585,1.00000000000537,0.901377980420617,0,1,regulation of acid-sensing ion channel activity,BP,
17673,GO:1901594,1.00000000000537,0.901377980420617,0,1,response to capsazepine,BP,
17691,GO:1901631,1.00000000000537,0.901377980420617,0,1,positive regulation of presynaptic membrane organization,BP,
17692,GO:1901639,1.00000000000537,0.901377980420617,0,1,XDP catabolic process,BP,
17693,GO:1901640,1.00000000000537,0.901377980420617,0,1,XTP binding,MF,
17694,GO:1901641,1.00000000000537,0.901377980420617,0,1,ITP binding,MF,
17714,GO:1901675,1.00000000000537,0.901377980420617,0,1,negative regulation of histone H3-K27 acetylation,BP,
17715,GO:1901676,1.00000000000537,0.901377980420617,0,1,positive regulation of histone H3-K27 acetylation,BP,
17718,GO:1901680,1.00000000000537,0.901377980420617,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
17733,GO:1901726,1.00000000000537,0.901377980420617,0,1,negative regulation of histone deacetylase activity,BP,
17775,GO:1901895,1.00000000000537,0.901377980420617,0,1,negative regulation of calcium-transporting ATPase activity,BP,
17778,GO:1901898,1.00000000000537,0.901377980420617,0,1,negative regulation of relaxation of cardiac muscle,BP,
17787,GO:1901950,1.00000000000537,0.901377980420617,0,1,dense core granule transport,BP,
17796,GO:1901980,1.00000000000537,0.901377980420617,0,1,positive regulation of inward rectifier potassium channel activity,BP,
17824,GO:1902038,1.00000000000537,0.901377980420617,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
17838,GO:1902098,1.00000000000537,0.901377980420617,0,1,calcitriol binding,MF,
17842,GO:1902102,1.00000000000537,0.901377980420617,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17843,GO:1902103,1.00000000000537,0.901377980420617,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17853,GO:1902121,1.00000000000537,0.901377980420617,0,1,lithocholic acid binding,MF,
17854,GO:1902145,1.00000000000537,0.901377980420617,0,1,regulation of response to cell cycle checkpoint signaling,BP,
17855,GO:1902151,1.00000000000537,0.901377980420617,0,1,regulation of response to DNA integrity checkpoint signaling,BP,
17856,GO:1902153,1.00000000000537,0.901377980420617,0,1,regulation of response to DNA damage checkpoint signaling,BP,
17864,GO:1902173,1.00000000000537,0.901377980420617,0,1,negative regulation of keratinocyte apoptotic process,BP,
17876,GO:1902211,1.00000000000537,0.901377980420617,0,1,regulation of prolactin signaling pathway,BP,
17877,GO:1902213,1.00000000000537,0.901377980420617,0,1,positive regulation of prolactin signaling pathway,BP,
17880,GO:1902216,1.00000000000537,0.901377980420617,0,1,positive regulation of interleukin-4-mediated signaling pathway,BP,
17898,GO:1902238,1.00000000000537,0.901377980420617,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17899,GO:1902239,1.00000000000537,0.901377980420617,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17904,GO:1902257,1.00000000000537,0.901377980420617,0,1,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
17913,GO:1902271,1.00000000000537,0.901377980420617,0,1,D3 vitamins binding,MF,
17915,GO:1902282,1.00000000000537,0.901377980420617,0,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
17916,GO:1902283,1.00000000000537,0.901377980420617,0,1,negative regulation of primary amine oxidase activity,BP,
17921,GO:1902296,1.00000000000537,0.901377980420617,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
17925,GO:1902304,1.00000000000537,0.901377980420617,0,1,positive regulation of potassium ion export,BP,
17934,GO:1902319,1.00000000000537,0.901377980420617,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
17943,GO:1902363,1.00000000000537,0.901377980420617,0,1,regulation of protein localization to spindle pole body,BP,
17944,GO:1902365,1.00000000000537,0.901377980420617,0,1,positive regulation of protein localization to spindle pole body,BP,
17950,GO:1902379,1.00000000000537,0.901377980420617,0,1,chemoattractant activity involved in axon guidance,MF,
17952,GO:1902387,1.00000000000537,0.901377980420617,0,1,ceramide 1-phosphate binding,MF,
17953,GO:1902388,1.00000000000537,0.901377980420617,0,1,ceramide 1-phosphate transporter activity,MF,
17954,GO:1902389,1.00000000000537,0.901377980420617,0,1,ceramide 1-phosphate transport,BP,
17955,GO:1902396,1.00000000000537,0.901377980420617,0,1,protein localization to bicellular tight junction,BP,
17968,GO:1902442,1.00000000000537,0.901377980420617,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
17969,GO:1902443,1.00000000000537,0.901377980420617,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
17976,GO:1902464,1.00000000000537,0.901377980420617,0,1,regulation of histone H3-K27 trimethylation,BP,
17977,GO:1902466,1.00000000000537,0.901377980420617,0,1,positive regulation of histone H3-K27 trimethylation,BP,
17983,GO:1902488,1.00000000000537,0.901377980420617,0,1,cholangiocyte apoptotic process,BP,
17989,GO:1902504,1.00000000000537,0.901377980420617,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
17999,GO:1902528,1.00000000000537,0.901377980420617,0,1,regulation of protein linear polyubiquitination,BP,
18000,GO:1902530,1.00000000000537,0.901377980420617,0,1,positive regulation of protein linear polyubiquitination,BP,
18036,GO:1902618,1.00000000000537,0.901377980420617,0,1,cellular response to fluoride,BP,
18038,GO:1902623,1.00000000000537,0.901377980420617,0,1,negative regulation of neutrophil migration,BP,
18056,GO:1902685,1.00000000000537,0.901377980420617,0,1,positive regulation of receptor localization to synapse,BP,
18058,GO:1902688,1.00000000000537,0.901377980420617,0,1,regulation of NAD metabolic process,BP,
18059,GO:1902689,1.00000000000537,0.901377980420617,0,1,negative regulation of NAD metabolic process,BP,
18061,GO:1902710,1.00000000000537,0.901377980420617,0,1,GABA receptor complex,CC,
18062,GO:1902711,1.00000000000537,0.901377980420617,0,1,GABA-A receptor complex,CC,
18069,GO:1902725,1.00000000000537,0.901377980420617,0,1,negative regulation of satellite cell differentiation,BP,
18074,GO:1902737,1.00000000000537,0.901377980420617,0,1,dendritic filopodium,CC,
18086,GO:1902767,1.00000000000537,0.901377980420617,0,1,isoprenoid biosynthetic process via mevalonate,BP,
18089,GO:1902773,1.00000000000537,0.901377980420617,0,1,GTPase activator complex,CC,
18103,GO:1902823,1.00000000000537,0.901377980420617,0,1,negative regulation of late endosome to lysosome transport,BP,
18105,GO:1902838,1.00000000000537,0.901377980420617,0,1,regulation of nuclear migration along microtubule,BP,
18106,GO:1902846,1.00000000000537,0.901377980420617,0,1,positive regulation of mitotic spindle elongation,BP,
18107,GO:1902847,1.00000000000537,0.901377980420617,0,1,regulation of neuronal signal transduction,BP,
18121,GO:1902889,1.00000000000537,0.901377980420617,0,1,protein localization to spindle microtubule,BP,
18133,GO:1902908,1.00000000000537,0.901377980420617,0,1,regulation of melanosome transport,BP,
18134,GO:1902910,1.00000000000537,0.901377980420617,0,1,positive regulation of melanosome transport,BP,
18136,GO:1902912,1.00000000000537,0.901377980420617,0,1,pyruvate kinase complex,CC,
18137,GO:1902913,1.00000000000537,0.901377980420617,0,1,positive regulation of neuroepithelial cell differentiation,BP,
18161,GO:1902957,1.00000000000537,0.901377980420617,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18173,GO:1902983,1.00000000000537,0.901377980420617,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
18183,GO:1902998,1.00000000000537,0.901377980420617,0,1,positive regulation of neurofibrillary tangle assembly,BP,
18187,GO:1903004,1.00000000000537,0.901377980420617,0,1,regulation of protein K63-linked deubiquitination,BP,
18188,GO:1903006,1.00000000000537,0.901377980420617,0,1,positive regulation of protein K63-linked deubiquitination,BP,
18189,GO:1903007,1.00000000000537,0.901377980420617,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
18210,GO:1903045,1.00000000000537,0.901377980420617,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
18232,GO:1903096,1.00000000000537,0.901377980420617,0,1,protein localization to meiotic spindle midzone,BP,
18233,GO:1903108,1.00000000000537,0.901377980420617,0,1,regulation of mitochondrial transcription,BP,
18234,GO:1903109,1.00000000000537,0.901377980420617,0,1,positive regulation of mitochondrial transcription,BP,
18245,GO:1903141,1.00000000000537,0.901377980420617,0,1,negative regulation of establishment of endothelial barrier,BP,
18247,GO:1903143,1.00000000000537,0.901377980420617,0,1,adrenomedullin receptor complex,CC,
18282,GO:1903231,1.00000000000537,0.901377980420617,0,1,mRNA binding involved in posttranscriptional gene silencing,MF,
18290,GO:1903244,1.00000000000537,0.901377980420617,0,1,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
18294,GO:1903259,1.00000000000537,0.901377980420617,0,1,exon-exon junction complex disassembly,BP,
18300,GO:1903282,1.00000000000537,0.901377980420617,0,1,regulation of glutathione peroxidase activity,BP,
18301,GO:1903284,1.00000000000537,0.901377980420617,0,1,positive regulation of glutathione peroxidase activity,BP,
18302,GO:1903285,1.00000000000537,0.901377980420617,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
18329,GO:1903336,1.00000000000537,0.901377980420617,0,1,negative regulation of vacuolar transport,BP,
18343,GO:1903367,1.00000000000537,0.901377980420617,0,1,positive regulation of fear response,BP,
18350,GO:1903381,1.00000000000537,0.901377980420617,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18351,GO:1903382,1.00000000000537,0.901377980420617,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18355,GO:1903387,1.00000000000537,0.901377980420617,0,1,positive regulation of homophilic cell adhesion,BP,
18363,GO:1903406,1.00000000000537,0.901377980420617,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
18364,GO:1903408,1.00000000000537,0.901377980420617,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
18367,GO:1903420,1.00000000000537,0.901377980420617,0,1,protein localization to endoplasmic reticulum tubular network,BP,
18379,GO:1903434,1.00000000000537,0.901377980420617,0,1,negative regulation of constitutive secretory pathway,BP,
18386,GO:1903442,1.00000000000537,0.901377980420617,0,1,response to lipoic acid,BP,
18391,GO:1903461,1.00000000000537,0.901377980420617,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
18406,GO:1903515,1.00000000000537,0.901377980420617,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
18408,GO:1903517,1.00000000000537,0.901377980420617,0,1,negative regulation of single strand break repair,BP,
18429,GO:1903544,1.00000000000537,0.901377980420617,0,1,response to butyrate,BP,
18430,GO:1903545,1.00000000000537,0.901377980420617,0,1,cellular response to butyrate,BP,
18440,GO:1903565,1.00000000000537,0.901377980420617,0,1,negative regulation of protein localization to cilium,BP,
18443,GO:1903568,1.00000000000537,0.901377980420617,0,1,negative regulation of protein localization to ciliary membrane,BP,
18453,GO:1903584,1.00000000000537,0.901377980420617,0,1,regulation of histone deubiquitination,BP,
18454,GO:1903586,1.00000000000537,0.901377980420617,0,1,positive regulation of histone deubiquitination,BP,
18465,GO:1903613,1.00000000000537,0.901377980420617,0,1,regulation of protein tyrosine phosphatase activity,BP,
18466,GO:1903615,1.00000000000537,0.901377980420617,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
18493,GO:1903697,1.00000000000537,0.901377980420617,0,1,negative regulation of microvillus assembly,BP,
18494,GO:1903699,1.00000000000537,0.901377980420617,0,1,tarsal gland development,BP,
18495,GO:1903701,1.00000000000537,0.901377980420617,0,1,substantia propria of cornea development,BP,
18500,GO:1903709,1.00000000000537,0.901377980420617,0,1,uterine gland development,BP,
18502,GO:1903717,1.00000000000537,0.901377980420617,0,1,response to ammonia,BP,
18503,GO:1903718,1.00000000000537,0.901377980420617,0,1,cellular response to ammonia,BP,
18508,GO:1903724,1.00000000000537,0.901377980420617,0,1,positive regulation of centriole elongation,BP,
18524,GO:1903762,1.00000000000537,0.901377980420617,0,1,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18526,GO:1903764,1.00000000000537,0.901377980420617,0,1,regulation of potassium ion export across plasma membrane,BP,
18529,GO:1903770,1.00000000000537,0.901377980420617,0,1,negative regulation of beta-galactosidase activity,BP,
18551,GO:1903823,1.00000000000537,0.901377980420617,0,1,telomere single strand break repair,BP,
18552,GO:1903824,1.00000000000537,0.901377980420617,0,1,negative regulation of telomere single strand break repair,BP,
18575,GO:1903881,1.00000000000537,0.901377980420617,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
18576,GO:1903883,1.00000000000537,0.901377980420617,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
18577,GO:1903884,1.00000000000537,0.901377980420617,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
18578,GO:1903886,1.00000000000537,0.901377980420617,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
18601,GO:1903918,1.00000000000537,0.901377980420617,0,1,regulation of actin filament severing,BP,
18602,GO:1903919,1.00000000000537,0.901377980420617,0,1,negative regulation of actin filament severing,BP,
18608,GO:1903929,1.00000000000537,0.901377980420617,0,1,primary palate development,BP,
18611,GO:1903937,1.00000000000537,0.901377980420617,0,1,response to acrylamide,BP,
18612,GO:1903939,1.00000000000537,0.901377980420617,0,1,regulation of TORC2 signaling,BP,
18615,GO:1903947,1.00000000000537,0.901377980420617,0,1,positive regulation of ventricular cardiac muscle cell action potential,BP,
18617,GO:1903952,1.00000000000537,0.901377980420617,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18618,GO:1903954,1.00000000000537,0.901377980420617,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18643,GO:1904000,1.00000000000537,0.901377980420617,0,1,positive regulation of eating behavior,BP,
18649,GO:1904021,1.00000000000537,0.901377980420617,0,1,negative regulation of G-protein coupled receptor internalization,BP,
18650,GO:1904022,1.00000000000537,0.901377980420617,0,1,positive regulation of G-protein coupled receptor internalization,BP,
18651,GO:1904023,1.00000000000537,0.901377980420617,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
18652,GO:1904024,1.00000000000537,0.901377980420617,0,1,negative regulation of glucose catabolic process to lactate via pyruvate,BP,
18655,GO:1904028,1.00000000000537,0.901377980420617,0,1,positive regulation of collagen fibril organization,BP,
18662,GO:1904041,1.00000000000537,0.901377980420617,0,1,regulation of cystathionine beta-synthase activity,BP,
18663,GO:1904042,1.00000000000537,0.901377980420617,0,1,negative regulation of cystathionine beta-synthase activity,BP,
18668,GO:1904048,1.00000000000537,0.901377980420617,0,1,regulation of spontaneous neurotransmitter secretion,BP,
18669,GO:1904050,1.00000000000537,0.901377980420617,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
18670,GO:1904054,1.00000000000537,0.901377980420617,0,1,regulation of cholangiocyte proliferation,BP,
18671,GO:1904056,1.00000000000537,0.901377980420617,0,1,positive regulation of cholangiocyte proliferation,BP,
18674,GO:1904059,1.00000000000537,0.901377980420617,0,1,regulation of locomotor rhythm,BP,
18681,GO:1904106,1.00000000000537,0.901377980420617,0,1,protein localization to microvillus,BP,
18692,GO:1904155,1.00000000000537,0.901377980420617,0,1,DN2 thymocyte differentiation,BP,
18693,GO:1904156,1.00000000000537,0.901377980420617,0,1,DN3 thymocyte differentiation,BP,
18694,GO:1904167,1.00000000000537,0.901377980420617,0,1,regulation of thyroid hormone receptor activity,BP,
18695,GO:1904168,1.00000000000537,0.901377980420617,0,1,negative regulation of thyroid hormone receptor activity,BP,
18696,GO:1904170,1.00000000000537,0.901377980420617,0,1,regulation of bleb assembly,BP,
18697,GO:1904172,1.00000000000537,0.901377980420617,0,1,positive regulation of bleb assembly,BP,
18702,GO:1904192,1.00000000000537,0.901377980420617,0,1,regulation of cholangiocyte apoptotic process,BP,
18703,GO:1904193,1.00000000000537,0.901377980420617,0,1,negative regulation of cholangiocyte apoptotic process,BP,
18704,GO:1904195,1.00000000000537,0.901377980420617,0,1,regulation of granulosa cell proliferation,BP,
18705,GO:1904197,1.00000000000537,0.901377980420617,0,1,positive regulation of granulosa cell proliferation,BP,
18706,GO:1904199,1.00000000000537,0.901377980420617,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
18707,GO:1904200,1.00000000000537,0.901377980420617,0,1,iodide transmembrane transport,BP,
18708,GO:1904201,1.00000000000537,0.901377980420617,0,1,regulation of iodide transport,BP,
18709,GO:1904202,1.00000000000537,0.901377980420617,0,1,negative regulation of iodide transport,BP,
18710,GO:1904204,1.00000000000537,0.901377980420617,0,1,regulation of skeletal muscle hypertrophy,BP,
18711,GO:1904206,1.00000000000537,0.901377980420617,0,1,positive regulation of skeletal muscle hypertrophy,BP,
18716,GO:1904212,1.00000000000537,0.901377980420617,0,1,regulation of iodide transmembrane transport,BP,
18717,GO:1904213,1.00000000000537,0.901377980420617,0,1,negative regulation of iodide transmembrane transport,BP,
18724,GO:1904229,1.00000000000537,0.901377980420617,0,1,regulation of succinate dehydrogenase activity,BP,
18725,GO:1904231,1.00000000000537,0.901377980420617,0,1,positive regulation of succinate dehydrogenase activity,BP,
18726,GO:1904232,1.00000000000537,0.901377980420617,0,1,regulation of aconitate hydratase activity,BP,
18727,GO:1904234,1.00000000000537,0.901377980420617,0,1,positive regulation of aconitate hydratase activity,BP,
18728,GO:1904235,1.00000000000537,0.901377980420617,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18729,GO:1904237,1.00000000000537,0.901377980420617,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18735,GO:1904247,1.00000000000537,0.901377980420617,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
18743,GO:1904265,1.00000000000537,0.901377980420617,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
18744,GO:1904266,1.00000000000537,0.901377980420617,0,1,regulation of Schwann cell chemotaxis,BP,
18745,GO:1904268,1.00000000000537,0.901377980420617,0,1,positive regulation of Schwann cell chemotaxis,BP,
18752,GO:1904290,1.00000000000537,0.901377980420617,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
18762,GO:1904313,1.00000000000537,0.901377980420617,0,1,response to methamphetamine hydrochloride,BP,
18771,GO:1904339,1.00000000000537,0.901377980420617,0,1,negative regulation of dopaminergic neuron differentiation,BP,
18794,GO:1904393,1.00000000000537,0.901377980420617,0,1,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18795,GO:1904395,1.00000000000537,0.901377980420617,0,1,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18798,GO:1904404,1.00000000000537,0.901377980420617,0,1,response to formaldehyde,BP,
18802,GO:1904412,1.00000000000537,0.901377980420617,0,1,regulation of cardiac ventricle development,BP,
18803,GO:1904414,1.00000000000537,0.901377980420617,0,1,positive regulation of cardiac ventricle development,BP,
18817,GO:1904447,1.00000000000537,0.901377980420617,0,1,folic acid import across plasma membrane,BP,
18818,GO:1904448,1.00000000000537,0.901377980420617,0,1,regulation of aspartate secretion,BP,
18819,GO:1904450,1.00000000000537,0.901377980420617,0,1,positive regulation of aspartate secretion,BP,
18820,GO:1904454,1.00000000000537,0.901377980420617,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
18829,GO:1904477,1.00000000000537,0.901377980420617,0,1,positive regulation of Ras GTPase binding,BP,
18834,GO:1904499,1.00000000000537,0.901377980420617,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
18835,GO:1904501,1.00000000000537,0.901377980420617,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
18840,GO:1904515,1.00000000000537,0.901377980420617,0,1,positive regulation of TORC2 signaling,BP,
18845,GO:1904530,1.00000000000537,0.901377980420617,0,1,negative regulation of actin filament binding,BP,
18846,GO:1904531,1.00000000000537,0.901377980420617,0,1,positive regulation of actin filament binding,BP,
18849,GO:1904535,1.00000000000537,0.901377980420617,0,1,positive regulation of telomeric loop disassembly,BP,
18856,GO:1904565,1.00000000000537,0.901377980420617,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18857,GO:1904566,1.00000000000537,0.901377980420617,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18858,GO:1904567,1.00000000000537,0.901377980420617,0,1,response to wortmannin,BP,
18859,GO:1904568,1.00000000000537,0.901377980420617,0,1,cellular response to wortmannin,BP,
18877,GO:1904594,1.00000000000537,0.901377980420617,0,1,regulation of termination of RNA polymerase II transcription,BP,
18878,GO:1904595,1.00000000000537,0.901377980420617,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
18887,GO:1904617,1.00000000000537,0.901377980420617,0,1,negative regulation of actin binding,BP,
18888,GO:1904618,1.00000000000537,0.901377980420617,0,1,positive regulation of actin binding,BP,
18896,GO:1904647,1.00000000000537,0.901377980420617,0,1,response to rotenone,BP,
18903,GO:1904674,1.00000000000537,0.901377980420617,0,1,positive regulation of somatic stem cell population maintenance,BP,
18923,GO:1904713,1.00000000000537,0.901377980420617,0,1,beta-catenin destruction complex binding,MF,
18930,GO:1904721,1.00000000000537,0.901377980420617,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18944,GO:1904750,1.00000000000537,0.901377980420617,0,1,negative regulation of protein localization to nucleolus,BP,
18951,GO:1904762,1.00000000000537,0.901377980420617,0,1,positive regulation of myofibroblast differentiation,BP,
18953,GO:1904766,1.00000000000537,0.901377980420617,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
18957,GO:1904777,1.00000000000537,0.901377980420617,0,1,negative regulation of protein localization to cell cortex,BP,
18963,GO:1904784,1.00000000000537,0.901377980420617,0,1,NLRP1 inflammasome complex assembly,BP,
18964,GO:1904790,1.00000000000537,0.901377980420617,0,1,regulation of shelterin complex assembly,BP,
18965,GO:1904792,1.00000000000537,0.901377980420617,0,1,positive regulation of shelterin complex assembly,BP,
18966,GO:1904793,1.00000000000537,0.901377980420617,0,1,regulation of euchromatin binding,BP,
18968,GO:1904797,1.00000000000537,0.901377980420617,0,1,negative regulation of core promoter binding,BP,
18970,GO:1904799,1.00000000000537,0.901377980420617,0,1,regulation of neuron remodeling,BP,
18971,GO:1904800,1.00000000000537,0.901377980420617,0,1,negative regulation of neuron remodeling,BP,
18973,GO:1904806,1.00000000000537,0.901377980420617,0,1,regulation of protein oxidation,BP,
18974,GO:1904808,1.00000000000537,0.901377980420617,0,1,positive regulation of protein oxidation,BP,
18975,GO:1904812,1.00000000000537,0.901377980420617,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
18981,GO:1904826,1.00000000000537,0.901377980420617,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
18982,GO:1904828,1.00000000000537,0.901377980420617,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
18994,GO:1904850,1.00000000000537,0.901377980420617,0,1,negative regulation of establishment of protein localization to telomere,BP,
18996,GO:1904854,1.00000000000537,0.901377980420617,0,1,proteasome core complex binding,MF,
19006,GO:1904876,1.00000000000537,0.901377980420617,0,1,negative regulation of DNA ligase activity,BP,
19008,GO:1904878,1.00000000000537,0.901377980420617,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19028,GO:1904910,1.00000000000537,0.901377980420617,0,1,regulation of establishment of RNA localization to telomere,BP,
19029,GO:1904911,1.00000000000537,0.901377980420617,0,1,negative regulation of establishment of RNA localization to telomere,BP,
19030,GO:1904913,1.00000000000537,0.901377980420617,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
19031,GO:1904914,1.00000000000537,0.901377980420617,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
19037,GO:1904933,1.00000000000537,0.901377980420617,0,1,regulation of cell proliferation in midbrain,BP,
19038,GO:1904934,1.00000000000537,0.901377980420617,0,1,negative regulation of cell proliferation in midbrain,BP,
19040,GO:1904947,1.00000000000537,0.901377980420617,0,1,folic acid import into mitochondrion,BP,
19047,GO:1904955,1.00000000000537,0.901377980420617,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
19052,GO:1904970,1.00000000000537,0.901377980420617,0,1,brush border assembly,BP,
19053,GO:1904971,1.00000000000537,0.901377980420617,0,1,regulation of viral translation,BP,
19054,GO:1904973,1.00000000000537,0.901377980420617,0,1,positive regulation of viral translation,BP,
19057,GO:1904977,1.00000000000537,0.901377980420617,0,1,lymphatic endothelial cell migration,BP,
19060,GO:1904980,1.00000000000537,0.901377980420617,0,1,positive regulation of endosome organization,BP,
19067,GO:1904997,1.00000000000537,0.901377980420617,0,1,regulation of leukocyte adhesion to arterial endothelial cell,BP,
19068,GO:1904998,1.00000000000537,0.901377980420617,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
19069,GO:1905000,1.00000000000537,0.901377980420617,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
19074,GO:1905026,1.00000000000537,0.901377980420617,0,1,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19076,GO:1905033,1.00000000000537,0.901377980420617,0,1,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
19085,GO:1905044,1.00000000000537,0.901377980420617,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
19086,GO:1905045,1.00000000000537,0.901377980420617,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
19099,GO:1905069,1.00000000000537,0.901377980420617,0,1,allantois development,BP,
19105,GO:1905089,1.00000000000537,0.901377980420617,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19106,GO:1905090,1.00000000000537,0.901377980420617,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19109,GO:1905099,1.00000000000537,0.901377980420617,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
19110,GO:1905103,1.00000000000537,0.901377980420617,0,1,integral component of lysosomal membrane,CC,
19113,GO:1905132,1.00000000000537,0.901377980420617,0,1,regulation of meiotic chromosome separation,BP,
19114,GO:1905133,1.00000000000537,0.901377980420617,0,1,negative regulation of meiotic chromosome separation,BP,
19120,GO:1905152,1.00000000000537,0.901377980420617,0,1,positive regulation of voltage-gated sodium channel activity,BP,
19122,GO:1905154,1.00000000000537,0.901377980420617,0,1,negative regulation of membrane invagination,BP,
19124,GO:1905161,1.00000000000537,0.901377980420617,0,1,protein localization to phagocytic vesicle,BP,
19125,GO:1905162,1.00000000000537,0.901377980420617,0,1,regulation of phagosome maturation,BP,
19129,GO:1905168,1.00000000000537,0.901377980420617,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
19130,GO:1905169,1.00000000000537,0.901377980420617,0,1,regulation of protein localization to phagocytic vesicle,BP,
19131,GO:1905171,1.00000000000537,0.901377980420617,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
19132,GO:1905172,1.00000000000537,0.901377980420617,0,1,RISC complex binding,MF,
19134,GO:1905176,1.00000000000537,0.901377980420617,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
19138,GO:1905205,1.00000000000537,0.901377980420617,0,1,positive regulation of connective tissue replacement,BP,
19146,GO:1905222,1.00000000000537,0.901377980420617,0,1,atrioventricular canal morphogenesis,BP,
19147,GO:1905223,1.00000000000537,0.901377980420617,0,1,epicardium morphogenesis,BP,
19150,GO:1905242,1.00000000000537,0.901377980420617,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
19155,GO:1905255,1.00000000000537,0.901377980420617,0,1,regulation of RNA binding transcription factor activity,BP,
19163,GO:1905274,1.00000000000537,0.901377980420617,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
19165,GO:1905277,1.00000000000537,0.901377980420617,0,1,negative regulation of epithelial tube formation,BP,
19167,GO:1905279,1.00000000000537,0.901377980420617,0,1,regulation of retrograde transport, endosome to Golgi,BP,
19168,GO:1905285,1.00000000000537,0.901377980420617,0,1,fibrous ring of heart morphogenesis,BP,
19173,GO:1905301,1.00000000000537,0.901377980420617,0,1,regulation of macropinocytosis,BP,
19174,GO:1905302,1.00000000000537,0.901377980420617,0,1,negative regulation of macropinocytosis,BP,
19175,GO:1905304,1.00000000000537,0.901377980420617,0,1,regulation of cardiac myofibril assembly,BP,
19176,GO:1905305,1.00000000000537,0.901377980420617,0,1,negative regulation of cardiac myofibril assembly,BP,
19177,GO:1905309,1.00000000000537,0.901377980420617,0,1,positive regulation of cohesin loading,BP,
19182,GO:1905317,1.00000000000537,0.901377980420617,0,1,inferior endocardial cushion morphogenesis,BP,
19183,GO:1905319,1.00000000000537,0.901377980420617,0,1,mesenchymal stem cell migration,BP,
19184,GO:1905320,1.00000000000537,0.901377980420617,0,1,regulation of mesenchymal stem cell migration,BP,
19185,GO:1905322,1.00000000000537,0.901377980420617,0,1,positive regulation of mesenchymal stem cell migration,BP,
19191,GO:1905335,1.00000000000537,0.901377980420617,0,1,regulation of aggrephagy,BP,
19192,GO:1905337,1.00000000000537,0.901377980420617,0,1,positive regulation of aggrephagy,BP,
19196,GO:1905344,1.00000000000537,0.901377980420617,0,1,prostaglandin catabolic process,BP,
19200,GO:1905355,1.00000000000537,0.901377980420617,0,1,spine apparatus assembly,BP,
19201,GO:1905359,1.00000000000537,0.901377980420617,0,1,protein localization to meiotic spindle,BP,
19220,GO:1905405,1.00000000000537,0.901377980420617,0,1,regulation of mitotic cohesin loading,BP,
19221,GO:1905406,1.00000000000537,0.901377980420617,0,1,positive regulation of mitotic cohesin loading,BP,
19231,GO:1905435,1.00000000000537,0.901377980420617,0,1,regulation of histone H3-K4 trimethylation,BP,
19232,GO:1905437,1.00000000000537,0.901377980420617,0,1,positive regulation of histone H3-K4 trimethylation,BP,
19233,GO:1905438,1.00000000000537,0.901377980420617,0,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
19234,GO:1905443,1.00000000000537,0.901377980420617,0,1,regulation of clathrin coat assembly,BP,
19235,GO:1905445,1.00000000000537,0.901377980420617,0,1,positive regulation of clathrin coat assembly,BP,
19237,GO:1905447,1.00000000000537,0.901377980420617,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19243,GO:1905458,1.00000000000537,0.901377980420617,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
19247,GO:1905463,1.00000000000537,0.901377980420617,0,1,negative regulation of DNA duplex unwinding,BP,
19248,GO:1905464,1.00000000000537,0.901377980420617,0,1,positive regulation of DNA duplex unwinding,BP,
19249,GO:1905468,1.00000000000537,0.901377980420617,0,1,regulation of clathrin-coated pit assembly,BP,
19250,GO:1905469,1.00000000000537,0.901377980420617,0,1,negative regulation of clathrin-coated pit assembly,BP,
19263,GO:1905524,1.00000000000537,0.901377980420617,0,1,negative regulation of protein autoubiquitination,BP,
19264,GO:1905535,1.00000000000537,0.901377980420617,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19265,GO:1905537,1.00000000000537,0.901377980420617,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19276,GO:1905572,1.00000000000537,0.901377980420617,0,1,ganglioside GM1 transport to membrane,BP,
19278,GO:1905574,1.00000000000537,0.901377980420617,0,1,ganglioside GM2 binding,MF,
19279,GO:1905575,1.00000000000537,0.901377980420617,0,1,ganglioside GM3 binding,MF,
19281,GO:1905577,1.00000000000537,0.901377980420617,0,1,ganglioside GP1c binding,MF,
19285,GO:1905590,1.00000000000537,0.901377980420617,0,1,fibronectin fibril organization,BP,
19296,GO:1905610,1.00000000000537,0.901377980420617,0,1,regulation of mRNA cap binding,BP,
19297,GO:1905612,1.00000000000537,0.901377980420617,0,1,positive regulation of mRNA cap binding,BP,
19302,GO:1905642,1.00000000000537,0.901377980420617,0,1,negative regulation of DNA methylation,BP,
19303,GO:1905643,1.00000000000537,0.901377980420617,0,1,positive regulation of DNA methylation,BP,
19314,GO:1905687,1.00000000000537,0.901377980420617,0,1,regulation of diacylglycerol kinase activity,BP,
19315,GO:1905689,1.00000000000537,0.901377980420617,0,1,positive regulation of diacylglycerol kinase activity,BP,
19317,GO:1905698,1.00000000000537,0.901377980420617,0,1,positive regulation of polysome binding,BP,
19318,GO:1905705,1.00000000000537,0.901377980420617,0,1,cellular response to paclitaxel,BP,
19321,GO:1905711,1.00000000000537,0.901377980420617,0,1,response to phosphatidylethanolamine,BP,
19325,GO:1905720,1.00000000000537,0.901377980420617,0,1,cytoplasmic microtubule bundle,CC,
19328,GO:1905767,1.00000000000537,0.901377980420617,0,1,regulation of double-stranded telomeric DNA binding,BP,
19329,GO:1905768,1.00000000000537,0.901377980420617,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
19333,GO:1905774,1.00000000000537,0.901377980420617,0,1,regulation of DNA helicase activity,BP,
19334,GO:1905776,1.00000000000537,0.901377980420617,0,1,positive regulation of DNA helicase activity,BP,
19339,GO:1905794,1.00000000000537,0.901377980420617,0,1,response to puromycin,BP,
19340,GO:1905795,1.00000000000537,0.901377980420617,0,1,cellular response to puromycin,BP,
19349,GO:1905843,1.00000000000537,0.901377980420617,0,1,regulation of cellular response to gamma radiation,BP,
19357,GO:1905878,1.00000000000537,0.901377980420617,0,1,invadopodium disassembly,BP,
19359,GO:1905880,1.00000000000537,0.901377980420617,0,1,negative regulation of oogenesis,BP,
19362,GO:1905891,1.00000000000537,0.901377980420617,0,1,regulation of cellular response to thapsigargin,BP,
19363,GO:1905892,1.00000000000537,0.901377980420617,0,1,negative regulation of cellular response to thapsigargin,BP,
19364,GO:1905894,1.00000000000537,0.901377980420617,0,1,regulation of cellular response to tunicamycin,BP,
19365,GO:1905895,1.00000000000537,0.901377980420617,0,1,negative regulation of cellular response to tunicamycin,BP,
19375,GO:1905927,1.00000000000537,0.901377980420617,0,1,regulation of invadopodium disassembly,BP,
19376,GO:1905929,1.00000000000537,0.901377980420617,0,1,positive regulation of invadopodium disassembly,BP,
19388,GO:1905957,1.00000000000537,0.901377980420617,0,1,regulation of cellular response to alcohol,BP,
19389,GO:1905959,1.00000000000537,0.901377980420617,0,1,positive regulation of cellular response to alcohol,BP,
19393,GO:1990003,1.00000000000537,0.901377980420617,0,1,IDP phosphatase activity,MF,
19396,GO:1990009,1.00000000000537,0.901377980420617,0,1,retinal cell apoptotic process,BP,
19398,GO:1990026,1.00000000000537,0.901377980420617,0,1,hippocampal mossy fiber expansion,CC,
19399,GO:1990029,1.00000000000537,0.901377980420617,0,1,vasomotion,BP,
19401,GO:1990032,1.00000000000537,0.901377980420617,0,1,parallel fiber,CC,
19403,GO:1990036,1.00000000000537,0.901377980420617,0,1,calcium ion import into sarcoplasmic reticulum,BP,
19408,GO:1990048,1.00000000000537,0.901377980420617,0,1,anterograde neuronal dense core vesicle transport,BP,
19410,GO:1990051,1.00000000000537,0.901377980420617,0,1,activation of protein kinase C activity,BP,
19414,GO:1990074,1.00000000000537,0.901377980420617,0,1,polyuridylation-dependent mRNA catabolic process,BP,
19426,GO:1990127,1.00000000000537,0.901377980420617,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19429,GO:1990134,1.00000000000537,0.901377980420617,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
19441,GO:1990172,1.00000000000537,0.901377980420617,0,1,G-protein coupled receptor catabolic process,BP,
19443,GO:1990174,1.00000000000537,0.901377980420617,0,1,phosphodiesterase decapping endonuclease activity,MF,
19459,GO:1990256,1.00000000000537,0.901377980420617,0,1,signal clustering,BP,
19462,GO:1990261,1.00000000000537,0.901377980420617,0,1,pre-mRNA catabolic process,BP,
19467,GO:1990275,1.00000000000537,0.901377980420617,0,1,preribosome binding,MF,
19468,GO:1990280,1.00000000000537,0.901377980420617,0,1,RNA localization to chromatin,BP,
19481,GO:1990390,1.00000000000537,0.901377980420617,0,1,protein K33-linked ubiquitination,BP,
19493,GO:1990409,1.00000000000537,0.901377980420617,0,1,adrenomedullin binding,MF,
19499,GO:1990421,1.00000000000537,0.901377980420617,0,1,subtelomeric heterochromatin,CC,
19506,GO:1990439,1.00000000000537,0.901377980420617,0,1,MAP kinase serine/threonine phosphatase activity,MF,
19511,GO:1990448,1.00000000000537,0.901377980420617,0,1,exon-exon junction complex binding,MF,
19515,GO:1990456,1.00000000000537,0.901377980420617,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
19521,GO:1990502,1.00000000000537,0.901377980420617,0,1,dense core granule maturation,BP,
19525,GO:1990518,1.00000000000537,0.901377980420617,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
19534,GO:1990570,1.00000000000537,0.901377980420617,0,1,GDP-mannose transmembrane transport,BP,
19538,GO:1990578,1.00000000000537,0.901377980420617,0,1,perinuclear endoplasmic reticulum membrane,CC,
19546,GO:1990603,1.00000000000537,0.901377980420617,0,1,dark adaptation,BP,
19548,GO:1990613,1.00000000000537,0.901377980420617,0,1,mitochondrial membrane fusion,BP,
19556,GO:1990646,1.00000000000537,0.901377980420617,0,1,cellular response to prolactin,BP,
19557,GO:1990654,1.00000000000537,0.901377980420617,0,1,sebum secreting cell proliferation,BP,
19563,GO:1990700,1.00000000000537,0.901377980420617,0,1,nucleolar chromatin organization,BP,
19564,GO:1990705,1.00000000000537,0.901377980420617,0,1,cholangiocyte proliferation,BP,
19565,GO:1990707,1.00000000000537,0.901377980420617,0,1,nuclear subtelomeric heterochromatin,CC,
19573,GO:1990736,1.00000000000537,0.901377980420617,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
19575,GO:1990738,1.00000000000537,0.901377980420617,0,1,pseudouridine 5'-phosphatase activity,MF,
19576,GO:1990739,1.00000000000537,0.901377980420617,0,1,granulosa cell proliferation,BP,
19582,GO:1990751,1.00000000000537,0.901377980420617,0,1,Schwann cell chemotaxis,BP,
19584,GO:1990755,1.00000000000537,0.901377980420617,0,1,mitotic spindle microtubule depolymerization,BP,
19591,GO:1990771,1.00000000000537,0.901377980420617,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
19598,GO:1990784,1.00000000000537,0.901377980420617,0,1,response to dsDNA,BP,
19600,GO:1990786,1.00000000000537,0.901377980420617,0,1,cellular response to dsDNA,BP,
19602,GO:1990796,1.00000000000537,0.901377980420617,0,1,photoreceptor cell terminal bouton,CC,
19623,GO:1990876,1.00000000000537,0.901377980420617,0,1,cytoplasmic side of nuclear pore,CC,
19625,GO:1990882,1.00000000000537,0.901377980420617,0,1,rRNA acetylation,BP,
19626,GO:1990883,1.00000000000537,0.901377980420617,0,1,rRNA cytidine N-acetyltransferase activity,MF,
19627,GO:1990884,1.00000000000537,0.901377980420617,0,1,RNA acetylation,BP,
19638,GO:1990926,1.00000000000537,0.901377980420617,0,1,short-term synaptic potentiation,BP,
19642,GO:1990931,1.00000000000537,0.901377980420617,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
19644,GO:1990938,1.00000000000537,0.901377980420617,0,1,peptidyl-aspartic acid autophosphorylation,BP,
19647,GO:1990955,1.00000000000537,0.901377980420617,0,1,G-rich single-stranded DNA binding,MF,
19650,GO:1990968,1.00000000000537,0.901377980420617,0,1,modulation by host of RNA binding by virus,BP,
19651,GO:1990969,1.00000000000537,0.901377980420617,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
19656,GO:2000003,1.00000000000537,0.901377980420617,0,1,positive regulation of DNA damage checkpoint,BP,
19669,GO:2000019,1.00000000000537,0.901377980420617,0,1,negative regulation of male gonad development,BP,
19675,GO:2000040,1.00000000000537,0.901377980420617,0,1,regulation of planar cell polarity pathway involved in axis elongation,BP,
19676,GO:2000041,1.00000000000537,0.901377980420617,0,1,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
19686,GO:2000054,1.00000000000537,0.901377980420617,0,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19687,GO:2000055,1.00000000000537,0.901377980420617,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19693,GO:2000066,1.00000000000537,0.901377980420617,0,1,positive regulation of cortisol biosynthetic process,BP,
19698,GO:2000079,1.00000000000537,0.901377980420617,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
19699,GO:2000080,1.00000000000537,0.901377980420617,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
19703,GO:2000098,1.00000000000537,0.901377980420617,0,1,negative regulation of smooth muscle cell-matrix adhesion,BP,
19717,GO:2000118,1.00000000000537,0.901377980420617,0,1,regulation of sodium-dependent phosphate transport,BP,
19734,GO:2000167,1.00000000000537,0.901377980420617,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
19738,GO:2000173,1.00000000000537,0.901377980420617,0,1,negative regulation of branching morphogenesis of a nerve,BP,
19739,GO:2000174,1.00000000000537,0.901377980420617,0,1,regulation of pro-T cell differentiation,BP,
19740,GO:2000176,1.00000000000537,0.901377980420617,0,1,positive regulation of pro-T cell differentiation,BP,
19753,GO:2000199,1.00000000000537,0.901377980420617,0,1,positive regulation of ribonucleoprotein complex localization,BP,
19754,GO:2000200,1.00000000000537,0.901377980420617,0,1,regulation of ribosomal subunit export from nucleus,BP,
19755,GO:2000202,1.00000000000537,0.901377980420617,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
19756,GO:2000206,1.00000000000537,0.901377980420617,0,1,regulation of ribosomal small subunit export from nucleus,BP,
19757,GO:2000208,1.00000000000537,0.901377980420617,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
19760,GO:2000211,1.00000000000537,0.901377980420617,0,1,regulation of glutamate metabolic process,BP,
19761,GO:2000212,1.00000000000537,0.901377980420617,0,1,negative regulation of glutamate metabolic process,BP,
19762,GO:2000224,1.00000000000537,0.901377980420617,0,1,regulation of testosterone biosynthetic process,BP,
19763,GO:2000225,1.00000000000537,0.901377980420617,0,1,negative regulation of testosterone biosynthetic process,BP,
19801,GO:2000295,1.00000000000537,0.901377980420617,0,1,regulation of hydrogen peroxide catabolic process,BP,
19804,GO:2000299,1.00000000000537,0.901377980420617,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
19810,GO:2000307,1.00000000000537,0.901377980420617,0,1,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
19811,GO:2000309,1.00000000000537,0.901377980420617,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
19826,GO:2000325,1.00000000000537,0.901377980420617,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19827,GO:2000327,1.00000000000537,0.901377980420617,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19829,GO:2000329,1.00000000000537,0.901377980420617,0,1,negative regulation of T-helper 17 cell lineage commitment,BP,
19831,GO:2000331,1.00000000000537,0.901377980420617,0,1,regulation of terminal button organization,BP,
19842,GO:2000349,1.00000000000537,0.901377980420617,0,1,negative regulation of CD40 signaling pathway,BP,
19850,GO:2000361,1.00000000000537,0.901377980420617,0,1,regulation of prostaglandin-E synthase activity,BP,
19851,GO:2000363,1.00000000000537,0.901377980420617,0,1,positive regulation of prostaglandin-E synthase activity,BP,
19864,GO:2000382,1.00000000000537,0.901377980420617,0,1,positive regulation of mesoderm development,BP,
19865,GO:2000383,1.00000000000537,0.901377980420617,0,1,regulation of ectoderm development,BP,
19866,GO:2000384,1.00000000000537,0.901377980420617,0,1,negative regulation of ectoderm development,BP,
19881,GO:2000405,1.00000000000537,0.901377980420617,0,1,negative regulation of T cell migration,BP,
19885,GO:2000410,1.00000000000537,0.901377980420617,0,1,regulation of thymocyte migration,BP,
19886,GO:2000412,1.00000000000537,0.901377980420617,0,1,positive regulation of thymocyte migration,BP,
19887,GO:2000413,1.00000000000537,0.901377980420617,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
19888,GO:2000415,1.00000000000537,0.901377980420617,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
19890,GO:2000417,1.00000000000537,0.901377980420617,0,1,negative regulation of eosinophil migration,BP,
19891,GO:2000418,1.00000000000537,0.901377980420617,0,1,positive regulation of eosinophil migration,BP,
19892,GO:2000419,1.00000000000537,0.901377980420617,0,1,regulation of eosinophil extravasation,BP,
19893,GO:2000420,1.00000000000537,0.901377980420617,0,1,negative regulation of eosinophil extravasation,BP,
19895,GO:2000426,1.00000000000537,0.901377980420617,0,1,negative regulation of apoptotic cell clearance,BP,
19908,GO:2000468,1.00000000000537,0.901377980420617,0,1,regulation of peroxidase activity,BP,
19909,GO:2000470,1.00000000000537,0.901377980420617,0,1,positive regulation of peroxidase activity,BP,
19910,GO:2000474,1.00000000000537,0.901377980420617,0,1,regulation of opioid receptor signaling pathway,BP,
19919,GO:2000491,1.00000000000537,0.901377980420617,0,1,positive regulation of hepatic stellate cell activation,BP,
19920,GO:2000492,1.00000000000537,0.901377980420617,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
19921,GO:2000494,1.00000000000537,0.901377980420617,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
19935,GO:2000536,1.00000000000537,0.901377980420617,0,1,negative regulation of entry of bacterium into host cell,BP,
19936,GO:2000537,1.00000000000537,0.901377980420617,0,1,regulation of B cell chemotaxis,BP,
19937,GO:2000538,1.00000000000537,0.901377980420617,0,1,positive regulation of B cell chemotaxis,BP,
19952,GO:2000569,1.00000000000537,0.901377980420617,0,1,regulation of T-helper 2 cell activation,BP,
19953,GO:2000570,1.00000000000537,0.901377980420617,0,1,positive regulation of T-helper 2 cell activation,BP,
19959,GO:2000583,1.00000000000537,0.901377980420617,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
19960,GO:2000584,1.00000000000537,0.901377980420617,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
19966,GO:2000592,1.00000000000537,0.901377980420617,0,1,regulation of metanephric DCT cell differentiation,BP,
19967,GO:2000594,1.00000000000537,0.901377980420617,0,1,positive regulation of metanephric DCT cell differentiation,BP,
19969,GO:2000606,1.00000000000537,0.901377980420617,0,1,regulation of cell proliferation involved in mesonephros development,BP,
19970,GO:2000607,1.00000000000537,0.901377980420617,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
19973,GO:2000612,1.00000000000537,0.901377980420617,0,1,regulation of thyroid-stimulating hormone secretion,BP,
19986,GO:2000631,1.00000000000537,0.901377980420617,0,1,regulation of pre-miRNA processing,BP,
19987,GO:2000632,1.00000000000537,0.901377980420617,0,1,negative regulation of pre-miRNA processing,BP,
20003,GO:2000654,1.00000000000537,0.901377980420617,0,1,regulation of cellular response to testosterone stimulus,BP,
20004,GO:2000655,1.00000000000537,0.901377980420617,0,1,negative regulation of cellular response to testosterone stimulus,BP,
20009,GO:2000661,1.00000000000537,0.901377980420617,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
20011,GO:2000663,1.00000000000537,0.901377980420617,0,1,negative regulation of interleukin-5 secretion,BP,
20029,GO:2000690,1.00000000000537,0.901377980420617,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
20030,GO:2000691,1.00000000000537,0.901377980420617,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
20034,GO:2000699,1.00000000000537,0.901377980420617,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20035,GO:2000701,1.00000000000537,0.901377980420617,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20036,GO:2000702,1.00000000000537,0.901377980420617,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20037,GO:2000703,1.00000000000537,0.901377980420617,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20039,GO:2000706,1.00000000000537,0.901377980420617,0,1,negative regulation of dense core granule biogenesis,BP,
20040,GO:2000707,1.00000000000537,0.901377980420617,0,1,positive regulation of dense core granule biogenesis,BP,
20043,GO:2000721,1.00000000000537,0.901377980420617,0,1,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
20044,GO:2000722,1.00000000000537,0.901377980420617,0,1,regulation of cardiac vascular smooth muscle cell differentiation,BP,
20045,GO:2000724,1.00000000000537,0.901377980420617,0,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
20049,GO:2000733,1.00000000000537,0.901377980420617,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20050,GO:2000734,1.00000000000537,0.901377980420617,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20055,GO:2000740,1.00000000000537,0.901377980420617,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
20066,GO:2000759,1.00000000000537,0.901377980420617,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
20067,GO:2000761,1.00000000000537,0.901377980420617,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
20087,GO:2000795,1.00000000000537,0.901377980420617,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
20088,GO:2000797,1.00000000000537,0.901377980420617,0,1,regulation of amniotic stem cell differentiation,BP,
20089,GO:2000798,1.00000000000537,0.901377980420617,0,1,negative regulation of amniotic stem cell differentiation,BP,
20090,GO:2000804,1.00000000000537,0.901377980420617,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20091,GO:2000806,1.00000000000537,0.901377980420617,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20093,GO:2000808,1.00000000000537,0.901377980420617,0,1,negative regulation of synaptic vesicle clustering,BP,
20097,GO:2000812,1.00000000000537,0.901377980420617,0,1,regulation of barbed-end actin filament capping,BP,
20100,GO:2000820,1.00000000000537,0.901377980420617,0,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
20112,GO:2000834,1.00000000000537,0.901377980420617,0,1,regulation of androgen secretion,BP,
20113,GO:2000836,1.00000000000537,0.901377980420617,0,1,positive regulation of androgen secretion,BP,
20114,GO:2000843,1.00000000000537,0.901377980420617,0,1,regulation of testosterone secretion,BP,
20115,GO:2000845,1.00000000000537,0.901377980420617,0,1,positive regulation of testosterone secretion,BP,
20126,GO:2000864,1.00000000000537,0.901377980420617,0,1,regulation of estradiol secretion,BP,
20129,GO:2000909,1.00000000000537,0.901377980420617,0,1,regulation of sterol import,BP,
20140,GO:2000987,1.00000000000537,0.901377980420617,0,1,positive regulation of behavioral fear response,BP,
20155,GO:2001029,1.00000000000537,0.901377980420617,0,1,regulation of cellular glucuronidation,BP,
20156,GO:2001031,1.00000000000537,0.901377980420617,0,1,positive regulation of cellular glucuronidation,BP,
20178,GO:2001108,1.00000000000537,0.901377980420617,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
20179,GO:2001109,1.00000000000537,0.901377980420617,0,1,regulation of lens epithelial cell proliferation,BP,
20180,GO:2001111,1.00000000000537,0.901377980420617,0,1,positive regulation of lens epithelial cell proliferation,BP,
20182,GO:2001136,1.00000000000537,0.901377980420617,0,1,negative regulation of endocytic recycling,BP,
20191,GO:2001151,1.00000000000537,0.901377980420617,0,1,regulation of renal water transport,BP,
20192,GO:2001153,1.00000000000537,0.901377980420617,0,1,positive regulation of renal water transport,BP,
20221,GO:2001202,1.00000000000537,0.901377980420617,0,1,negative regulation of transforming growth factor-beta secretion,BP,
20222,GO:2001203,1.00000000000537,0.901377980420617,0,1,positive regulation of transforming growth factor-beta secretion,BP,
20235,GO:2001229,1.00000000000537,0.901377980420617,0,1,negative regulation of response to gamma radiation,BP,
20249,GO:2001246,1.00000000000537,0.901377980420617,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
20250,GO:2001247,1.00000000000537,0.901377980420617,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
20253,GO:2001253,1.00000000000537,0.901377980420617,0,1,regulation of histone H3-K36 trimethylation,BP,
20271,GO:2001288,1.00000000000537,0.901377980420617,0,1,positive regulation of caveolin-mediated endocytosis,BP,
6804,GO:0030274,1.00000000000539,0.660746098351632,0,4,LIM domain binding,MF,
2053,GO:0004809,1.0000000000054,0.734897218442929,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
5295,GO:0016011,1.00000000000541,0.736245567281319,0,3,dystroglycan complex,CC,
3480,GO:0007354,1.00000000000541,0.735524069529001,0,3,zygotic determination of anterior/posterior axis, embryo,BP,
2072,GO:0004829,1.00000000000542,0.732564580592086,0,3,threonine-tRNA ligase activity,MF,
2917,GO:0006435,1.00000000000542,0.732564580592086,0,3,threonyl-tRNA aminoacylation,BP,
15638,GO:0072185,1.00000000000542,0.901709006225016,0,1,metanephric cap development,BP,
15639,GO:0072186,1.00000000000542,0.901709006225016,0,1,metanephric cap morphogenesis,BP,
16084,GO:0090094,1.00000000000542,0.901709006225016,0,1,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
16085,GO:0090095,1.00000000000542,0.901709006225016,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
16086,GO:0090096,1.00000000000542,0.901709006225016,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
6292,GO:0019918,1.00000000000542,0.660408848237821,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
9013,GO:0035243,1.00000000000542,0.660408848237821,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
15262,GO:0071475,1.00000000000543,0.741326132810092,0,3,cellular hyperosmotic salinity response,BP,
14613,GO:0070213,1.00000000000546,0.660147710997307,0,4,protein auto-ADP-ribosylation,BP,
8844,GO:0034657,1.00000000000546,0.663592633201378,0,4,GID complex,CC,
5277,GO:0015942,1.00000000000547,0.750652843495739,0,3,formate metabolic process,BP,
1597,GO:0004019,1.00000000000547,0.90137838885078,0,1,adenylosuccinate synthase activity,MF,
9991,GO:0042428,1.00000000000547,0.660533095719836,0,4,serotonin metabolic process,BP,
8556,GO:0034039,1.00000000000548,0.817827926253216,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
48,GO:0000101,1.00000000000548,0.732333225594721,0,3,sulfur amino acid transport,BP,
5010,GO:0015183,1.00000000000548,0.732333225594721,0,3,L-aspartate transmembrane transporter activity,MF,
1842,GO:0004505,1.0000000000055,0.830054890624537,0,2,phenylalanine 4-monooxygenase activity,MF,
3641,GO:0008124,1.0000000000055,0.830054890624537,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
9475,GO:0036132,1.00000000000551,0.743066417421462,0,3,13-prostaglandin reductase activity,MF,
11989,GO:0047522,1.00000000000551,0.743066417421462,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
5298,GO:0016015,1.00000000000551,0.818174170551786,0,2,morphogen activity,MF,
19090,GO:1905051,1.00000000000554,0.837675595905327,0,2,regulation of base-excision repair,BP,
19091,GO:1905053,1.00000000000554,0.837675595905327,0,2,positive regulation of base-excision repair,BP,
9794,GO:0042007,1.00000000000555,0.911022672792893,0,1,interleukin-18 binding,MF,
14577,GO:0070164,1.00000000000558,0.666051212668124,0,4,negative regulation of adiponectin secretion,BP,
14756,GO:0070487,1.00000000000558,0.666051212668124,0,4,monocyte aggregation,BP,
15591,GO:0072106,1.00000000000558,0.755505979352984,0,3,regulation of ureteric bud formation,BP,
15592,GO:0072107,1.00000000000558,0.755505979352984,0,3,positive regulation of ureteric bud formation,BP,
15593,GO:0072108,1.00000000000558,0.755505979352984,0,3,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
19166,GO:1905278,1.00000000000558,0.755505979352984,0,3,positive regulation of epithelial tube formation,BP,
13705,GO:0060302,1.00000000000558,0.820498766570462,0,2,negative regulation of cytokine activity,BP,
12409,GO:0048936,1.00000000000559,0.734253559525039,0,3,peripheral nervous system neuron axonogenesis,BP,
11929,GO:0047045,1.00000000000561,0.914772138492704,0,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
1771,GO:0004382,1.00000000000562,0.813883814053621,0,2,guanosine-diphosphatase activity,MF,
2889,GO:0006404,1.00000000000562,0.750684393675895,0,3,RNA import into nucleus,BP,
7738,GO:0032264,1.00000000000564,0.669029429803603,0,4,IMP salvage,BP,
11534,GO:0046098,1.00000000000564,0.669029429803603,0,4,guanine metabolic process,BP,
1873,GO:0004556,1.00000000000564,0.902277465467615,0,1,alpha-amylase activity,MF,
5357,GO:0016160,1.00000000000564,0.902277465467615,0,1,amylase activity,MF,
17150,GO:0103025,1.00000000000564,0.902277465467615,0,1,alpha-amylase activity (releasing maltohexaose),MF,
3998,GO:0008967,1.00000000000564,0.814095271478004,0,2,phosphoglycolate phosphatase activity,MF,
5037,GO:0015230,1.00000000000565,0.813010525443068,0,2,FAD transmembrane transporter activity,MF,
9072,GO:0035350,1.00000000000565,0.813010525443068,0,2,FAD transmembrane transport,BP,
15947,GO:0080121,1.00000000000565,0.813010525443068,0,2,AMP transport,BP,
4341,GO:0009918,1.00000000000566,0.901391954328519,0,1,sterol delta7 reductase activity,MF,
5114,GO:0015499,1.00000000000566,0.901391954328519,0,1,formate transmembrane transporter activity,MF,
5130,GO:0015660,1.00000000000566,0.901391954328519,0,1,formate efflux transmembrane transporter activity,MF,
5162,GO:0015724,1.00000000000566,0.901391954328519,0,1,formate transport,BP,
5190,GO:0015797,1.00000000000566,0.901391954328519,0,1,mannitol transport,BP,
5349,GO:0016131,1.00000000000566,0.901391954328519,0,1,brassinosteroid metabolic process,BP,
5350,GO:0016132,1.00000000000566,0.901391954328519,0,1,brassinosteroid biosynthetic process,BP,
11803,GO:0046724,1.00000000000566,0.901391954328519,0,1,oxalic acid secretion,BP,
11995,GO:0047598,1.00000000000566,0.901391954328519,0,1,7-dehydrocholesterol reductase activity,MF,
6884,GO:0030430,1.00000000000566,0.663254060277644,0,4,host cell cytoplasm,CC,
8479,GO:0033655,1.00000000000566,0.663254060277644,0,4,host cell cytoplasm part,CC,
6985,GO:0030678,1.00000000000567,0.749140802958771,0,3,mitochondrial ribonuclease P complex,CC,
16704,GO:0097745,1.00000000000567,0.749140802958771,0,3,mitochondrial tRNA 5'-end processing,BP,
2058,GO:0004815,1.0000000000057,0.81283454560953,0,2,aspartate-tRNA ligase activity,MF,
9111,GO:0035442,1.0000000000057,0.817395178044382,0,2,dipeptide transmembrane transport,BP,
10216,GO:0042938,1.0000000000057,0.817395178044382,0,2,dipeptide transport,BP,
16079,GO:0090088,1.0000000000057,0.817395178044382,0,2,regulation of oligopeptide transport,BP,
16080,GO:0090089,1.0000000000057,0.817395178044382,0,2,regulation of dipeptide transport,BP,
20127,GO:2000878,1.0000000000057,0.817395178044382,0,2,positive regulation of oligopeptide transport,BP,
20128,GO:2000880,1.0000000000057,0.817395178044382,0,2,positive regulation of dipeptide transport,BP,
20189,GO:2001148,1.0000000000057,0.817395178044382,0,2,regulation of dipeptide transmembrane transport,BP,
20190,GO:2001150,1.0000000000057,0.817395178044382,0,2,positive regulation of dipeptide transmembrane transport,BP,
19219,GO:1905404,1.0000000000057,0.908820030024772,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
4600,GO:0010727,1.00000000000571,0.660509394437459,0,4,negative regulation of hydrogen peroxide metabolic process,BP,
2228,GO:0005137,1.00000000000575,0.902352511768194,0,1,interleukin-5 receptor binding,MF,
2592,GO:0005895,1.00000000000575,0.902352511768194,0,1,interleukin-5 receptor complex,CC,
16708,GO:0097752,1.00000000000576,0.732333144389244,0,3,regulation of DNA stability,BP,
923,GO:0002318,1.00000000000578,0.732854191263855,0,3,myeloid progenitor cell differentiation,BP,
2557,GO:0005846,1.0000000000058,0.813709495292522,0,2,nuclear cap binding complex,CC,
253,GO:0000718,1.00000000000581,0.906023509119716,0,1,nucleotide-excision repair, DNA damage removal,BP,
1672,GO:0004139,1.00000000000581,0.906023509119716,0,1,deoxyribose-phosphate aldolase activity,MF,
10833,GO:0044349,1.00000000000581,0.906023509119716,0,1,DNA excision,BP,
11636,GO:0046403,1.00000000000581,0.906023509119716,0,1,polynucleotide 3'-phosphatase activity,MF,
16714,GO:0098503,1.00000000000581,0.906023509119716,0,1,DNA 3' dephosphorylation,BP,
16715,GO:0098504,1.00000000000581,0.906023509119716,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
16717,GO:0098506,1.00000000000581,0.906023509119716,0,1,polynucleotide 3' dephosphorylation,BP,
19411,GO:1990070,1.00000000000583,0.927230454985733,0,1,TRAPPI protein complex,CC,
4677,GO:0010836,1.00000000000583,0.738626684959318,0,3,negative regulation of protein ADP-ribosylation,BP,
3633,GO:0008111,1.00000000000585,0.903512059996095,0,1,alpha-methylacyl-CoA racemase activity,MF,
7733,GO:0032258,1.00000000000586,0.81342448902945,0,2,protein localization by the Cvt pathway,BP,
17964,GO:1902423,1.00000000000586,0.81342448902945,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
17965,GO:1902425,1.00000000000586,0.81342448902945,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
9683,GO:0038098,1.00000000000587,0.903072057387887,0,1,sequestering of BMP from receptor via BMP binding,BP,
2038,GO:0004784,1.00000000000591,0.703185870389927,0,4,superoxide dismutase activity,MF,
5626,GO:0016721,1.00000000000591,0.703185870389927,0,4,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
12009,GO:0047710,1.00000000000591,0.918445946543334,0,1,bis(5'-adenosyl)-triphosphatase activity,MF,
338,GO:0000939,1.00000000000595,0.741201579038883,0,3,condensed chromosome inner kinetochore,CC,
3817,GO:0008426,1.00000000000597,0.760247111722275,0,3,protein kinase C inhibitor activity,MF,
4312,GO:0009814,1.00000000000598,0.902206378070131,0,1,defense response, incompatible interaction,BP,
4313,GO:0009817,1.00000000000598,0.902206378070131,0,1,defense response to fungus, incompatible interaction,BP,
19180,GO:1905313,1.00000000000598,0.902206378070131,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
19486,GO:1990402,1.00000000000598,0.902206378070131,0,1,embryonic liver development,BP,
14471,GO:0061945,1.00000000000598,0.739208630778876,0,3,regulation of protein K48-linked ubiquitination,BP,
9911,GO:0042275,1.00000000000598,0.909146263368637,0,1,error-free postreplication DNA repair,BP,
6355,GO:0021546,1.00000000000598,0.818342021902733,0,2,rhombomere development,BP,
1189,GO:0002836,1.00000000000599,0.732709158452149,0,3,positive regulation of response to tumor cell,BP,
1192,GO:0002839,1.00000000000599,0.732709158452149,0,3,positive regulation of immune response to tumor cell,BP,
14991,GO:0070949,1.00000000000603,0.820635042957562,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
14995,GO:0070960,1.00000000000603,0.820635042957562,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
14996,GO:0070961,1.00000000000603,0.820635042957562,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
1636,GO:0004082,1.00000000000603,0.742553923886906,0,3,bisphosphoglycerate mutase activity,MF,
1921,GO:0004619,1.00000000000603,0.742553923886906,0,3,phosphoglycerate mutase activity,MF,
11706,GO:0046538,1.00000000000603,0.742553923886906,0,3,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
5094,GO:0015389,1.00000000000604,0.902120083504552,0,1,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5095,GO:0015390,1.00000000000604,0.902120083504552,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5096,GO:0015391,1.00000000000604,0.902120083504552,0,1,nucleobase:cation symporter activity,MF,
18747,GO:1904274,1.00000000000604,0.902120083504552,0,1,tricellular tight junction assembly,BP,
8533,GO:0033883,1.00000000000606,0.828857963202852,0,2,pyridoxal phosphatase activity,MF,
13591,GO:0060091,1.00000000000606,0.674881253057895,0,4,kinocilium,CC,
16700,GO:0097732,1.00000000000606,0.674881253057895,0,4,9+2 non-motile cilium,CC,
3853,GO:0008482,1.00000000000607,0.901774690246306,0,1,sulfite oxidase activity,MF,
9851,GO:0042128,1.00000000000607,0.901774690246306,0,1,nitrate assimilation,BP,
16434,GO:0097134,1.00000000000608,0.815815570537353,0,2,cyclin E1-CDK2 complex,CC,
5195,GO:0015803,1.0000000000061,0.732818906503987,0,3,branched-chain amino acid transport,BP,
16227,GO:0090310,1.00000000000611,0.812474704657565,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
12026,GO:0047894,1.00000000000613,0.827877475782432,0,2,flavonol 3-sulfotransferase activity,MF,
8762,GO:0034457,1.00000000000613,0.758231858911237,0,3,Mpp10 complex,CC,
1673,GO:0004140,1.00000000000614,0.814409135776231,0,2,dephospho-CoA kinase activity,MF,
1650,GO:0004105,1.00000000000615,0.818542889563561,0,2,choline-phosphate cytidylyltransferase activity,MF,
1089,GO:0002677,1.00000000000616,0.817897222912198,0,2,negative regulation of chronic inflammatory response,BP,
16560,GO:0097396,1.0000000000062,0.660220566598432,0,4,response to interleukin-17,BP,
16561,GO:0097398,1.0000000000062,0.660220566598432,0,4,cellular response to interleukin-17,BP,
16562,GO:0097400,1.0000000000062,0.660220566598432,0,4,interleukin-17-mediated signaling pathway,BP,
3210,GO:0006864,1.0000000000062,0.820432975534971,0,2,pyrimidine nucleotide transport,BP,
5030,GO:0015218,1.0000000000062,0.820432975534971,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
19526,GO:1990519,1.0000000000062,0.820432975534971,0,2,pyrimidine nucleotide import into mitochondrion,BP,
9341,GO:0035870,1.0000000000062,0.827566894110471,0,2,dITP diphosphatase activity,MF,
19084,GO:1905042,1.0000000000062,0.902050567166758,0,1,negative regulation of epithelium regeneration,BP,
1687,GO:0004164,1.00000000000621,0.905236201292071,0,1,diphthine synthase activity,MF,
1732,GO:0004333,1.00000000000621,0.905236201292071,0,1,fumarate hydratase activity,MF,
16886,GO:0098881,1.00000000000623,0.732593254590194,0,3,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
16929,GO:0098967,1.00000000000623,0.732593254590194,0,3,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
9581,GO:0036455,1.00000000000623,0.917550251706886,0,1,iron-sulfur transferase activity,MF,
1571,GO:0003983,1.00000000000624,0.902460538438266,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
13137,GO:0051748,1.00000000000624,0.902460538438266,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
6122,GO:0019389,1.00000000000626,0.901395883370223,0,1,glucuronoside metabolic process,BP,
6123,GO:0019391,1.00000000000626,0.901395883370223,0,1,glucuronoside catabolic process,BP,
17117,GO:0102390,1.00000000000626,0.901395883370223,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
6078,GO:0019249,1.00000000000627,0.749503964100747,0,3,lactate biosynthetic process,BP,
5574,GO:0016602,1.00000000000628,0.673137632612322,0,4,CCAAT-binding factor complex,CC,
8157,GO:0032907,1.00000000000631,0.733092338210852,0,3,transforming growth factor beta3 production,BP,
8160,GO:0032910,1.00000000000631,0.733092338210852,0,3,regulation of transforming growth factor beta3 production,BP,
11862,GO:0046899,1.00000000000634,0.812490823187225,0,2,nucleoside triphosphate adenylate kinase activity,MF,
2116,GO:0004910,1.00000000000635,0.910772051659179,0,1,interleukin-1, Type II, blocking receptor activity,MF,
8028,GO:0032690,1.00000000000635,0.910772051659179,0,1,negative regulation of interleukin-1 alpha production,BP,
12537,GO:0050712,1.00000000000635,0.910772051659179,0,1,negative regulation of interleukin-1 alpha secretion,BP,
3990,GO:0008903,1.00000000000635,0.917908589027657,0,1,hydroxypyruvate isomerase activity,MF,
17169,GO:0106020,1.00000000000636,0.813031356967401,0,2,regulation of vesicle docking,BP,
9488,GO:0036153,1.00000000000637,0.901377980550792,0,1,triglyceride acyl-chain remodeling,BP,
12891,GO:0051264,1.00000000000637,0.901377980550792,0,1,mono-olein transacylation activity,MF,
12892,GO:0051265,1.00000000000637,0.901377980550792,0,1,diolein transacylation activity,MF,
1059,GO:0002587,1.00000000000637,0.911955876197337,0,1,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
18048,GO:1902659,1.00000000000637,0.747259437144748,0,3,regulation of glucose mediated signaling pathway,BP,
18049,GO:1902661,1.00000000000637,0.747259437144748,0,3,positive regulation of glucose mediated signaling pathway,BP,
19312,GO:1905671,1.00000000000638,0.733745181898938,0,3,regulation of lysosome organization,BP,
15362,GO:0071638,1.0000000000064,0.830885238770008,0,2,negative regulation of monocyte chemotactic protein-1 production,BP,
1638,GO:0004084,1.0000000000064,0.818013414778043,0,2,branched-chain-amino-acid transaminase activity,MF,
4036,GO:0009082,1.0000000000064,0.818013414778043,0,2,branched-chain amino acid biosynthetic process,BP,
4044,GO:0009098,1.0000000000064,0.818013414778043,0,2,leucine biosynthetic process,BP,
4045,GO:0009099,1.0000000000064,0.818013414778043,0,2,valine biosynthetic process,BP,
13356,GO:0052654,1.0000000000064,0.818013414778043,0,2,L-leucine transaminase activity,MF,
13357,GO:0052655,1.0000000000064,0.818013414778043,0,2,L-valine transaminase activity,MF,
13358,GO:0052656,1.0000000000064,0.818013414778043,0,2,L-isoleucine transaminase activity,MF,
9215,GO:0035621,1.0000000000064,0.814347181414738,0,2,ER to Golgi ceramide transport,BP,
5940,GO:0018298,1.0000000000064,0.732350971383988,0,3,protein-chromophore linkage,BP,
2450,GO:0005668,1.0000000000064,0.824370654618847,0,2,RNA polymerase transcription factor SL1 complex,CC,
1050,GO:0002578,1.00000000000643,0.67224026312376,0,4,negative regulation of antigen processing and presentation,BP,
662,GO:0001866,1.00000000000643,0.749063083116,0,3,NK T cell proliferation,BP,
8115,GO:0032817,1.00000000000643,0.749063083116,0,3,regulation of natural killer cell proliferation,BP,
8116,GO:0032819,1.00000000000643,0.749063083116,0,3,positive regulation of natural killer cell proliferation,BP,
7763,GO:0032299,1.00000000000644,0.750719839866045,0,3,ribonuclease H2 complex,CC,
7774,GO:0032311,1.00000000000646,0.833013569625771,0,2,angiogenin-PRI complex,CC,
8529,GO:0033872,1.00000000000649,0.9031217139799,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
3910,GO:0008591,1.00000000000649,0.905112498554261,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
10110,GO:0042662,1.00000000000649,0.905112498554261,0,1,negative regulation of mesodermal cell fate specification,BP,
11386,GO:0045813,1.00000000000649,0.905112498554261,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
14409,GO:0061743,1.00000000000649,0.905112498554261,0,1,motor learning,BP,
16072,GO:0090081,1.00000000000649,0.905112498554261,0,1,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
16073,GO:0090082,1.00000000000649,0.905112498554261,0,1,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
16259,GO:0090381,1.00000000000649,0.905112498554261,0,1,regulation of heart induction,BP,
16887,GO:0098883,1.00000000000649,0.905112498554261,0,1,synapse disassembly,BP,
17079,GO:0100012,1.00000000000649,0.905112498554261,0,1,regulation of heart induction by canonical Wnt signaling pathway,BP,
17583,GO:1901296,1.00000000000649,0.905112498554261,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17596,GO:1901321,1.00000000000649,0.905112498554261,0,1,positive regulation of heart induction,BP,
18917,GO:1904701,1.00000000000649,0.905112498554261,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
18922,GO:1904711,1.00000000000649,0.905112498554261,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
18932,GO:1904723,1.00000000000649,0.905112498554261,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
19097,GO:1905067,1.00000000000649,0.905112498554261,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
19331,GO:1905771,1.00000000000649,0.905112498554261,0,1,negative regulation of mesodermal cell differentiation,BP,
19369,GO:1905903,1.00000000000649,0.905112498554261,0,1,negative regulation of mesoderm formation,BP,
161,GO:0000333,1.00000000000649,0.844737315595837,0,2,telomerase catalytic core complex,CC,
11524,GO:0046078,1.0000000000065,0.673111060120943,0,4,dUMP metabolic process,BP,
16618,GO:0097510,1.00000000000651,0.902975595455842,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
4683,GO:0010847,1.00000000000652,0.664398040020735,0,4,regulation of chromatin assembly,BP,
5296,GO:0016012,1.00000000000654,0.816814904197788,0,2,sarcoglycan complex,CC,
9915,GO:0042281,1.00000000000654,0.816814904197788,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
12805,GO:0051138,1.00000000000655,0.660393080361299,0,4,positive regulation of NK T cell differentiation,BP,
8760,GO:0034455,1.00000000000655,0.732454403225516,0,3,t-UTP complex,CC,
13946,GO:0060684,1.00000000000657,0.663706069507318,0,4,epithelial-mesenchymal cell signaling,BP,
1743,GO:0004347,1.00000000000659,0.902756342693058,0,1,glucose-6-phosphate isomerase activity,MF,
6076,GO:0019242,1.00000000000659,0.902756342693058,0,1,methylglyoxal biosynthetic process,BP,
19198,GO:1905349,1.00000000000659,0.915727214388489,0,1,ciliary transition zone assembly,BP,
9264,GO:0035718,1.0000000000066,0.83073042198052,0,2,macrophage migration inhibitory factor binding,MF,
14384,GO:0061689,1.0000000000066,0.733754800108197,0,3,tricellular tight junction,CC,
3339,GO:0007066,1.00000000000662,0.922426621695786,0,1,female meiosis sister chromatid cohesion,BP,
16619,GO:0097512,1.00000000000664,0.92956098189817,0,1,cardiac myofibril,CC,
14651,GO:0070291,1.00000000000664,0.662983776383936,0,4,N-acylethanolamine metabolic process,BP,
13945,GO:0060683,1.00000000000667,0.901378217662477,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
19485,GO:1990401,1.00000000000667,0.901378217662477,0,1,embryonic lung development,BP,
9249,GO:0035686,1.00000000000668,0.758978658514794,0,3,sperm fibrous sheath,CC,
1056,GO:0002584,1.00000000000669,0.745811462807004,0,3,negative regulation of antigen processing and presentation of peptide antigen,BP,
1518,GO:0003882,1.00000000000669,0.9015489509964,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
15276,GO:0071494,1.00000000000669,0.679940691464573,0,4,cellular response to UV-C,BP,
16713,GO:0098502,1.00000000000671,0.753427841509675,0,3,DNA dephosphorylation,BP,
15822,GO:0072563,1.00000000000671,0.818214898743933,0,2,endothelial microparticle,CC,
16484,GO:0097213,1.00000000000672,0.902061241343815,0,1,regulation of lysosomal membrane permeability,BP,
17353,GO:1900107,1.00000000000673,0.816639228873794,0,2,regulation of nodal signaling pathway,BP,
17380,GO:1900145,1.00000000000673,0.816639228873794,0,2,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17397,GO:1900175,1.00000000000673,0.816639228873794,0,2,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
5651,GO:0016768,1.00000000000674,0.906474205408772,0,1,spermine synthase activity,MF,
17389,GO:1900154,1.00000000000674,0.906474205408772,0,1,regulation of bone trabecula formation,BP,
17390,GO:1900155,1.00000000000674,0.906474205408772,0,1,negative regulation of bone trabecula formation,BP,
532,GO:0001651,1.00000000000674,0.826080615672677,0,2,dense fibrillar component,CC,
11427,GO:0045900,1.00000000000674,0.668683373934641,0,4,negative regulation of translational elongation,BP,
16205,GO:0090283,1.00000000000674,0.736430112926801,0,3,regulation of protein glycosylation in Golgi,BP,
4635,GO:0010767,1.00000000000675,0.732339202640623,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
16288,GO:0090500,1.00000000000675,0.819329496385095,0,2,endocardial cushion to mesenchymal transition,BP,
14295,GO:0061484,1.00000000000676,0.732345953032019,0,3,hematopoietic stem cell homeostasis,BP,
17588,GO:1901301,1.00000000000678,0.812477788318581,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
19989,GO:2000638,1.00000000000678,0.812477788318581,0,2,regulation of SREBP signaling pathway,BP,
19990,GO:2000639,1.00000000000678,0.812477788318581,0,2,negative regulation of SREBP signaling pathway,BP,
20265,GO:2001274,1.00000000000678,0.812477788318581,0,2,negative regulation of glucose import in response to insulin stimulus,BP,
20076,GO:2000777,1.00000000000678,0.814883744093751,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
8740,GO:0034418,1.00000000000681,0.813601398519076,0,2,urate biosynthetic process,BP,
3550,GO:0007598,1.00000000000681,0.901731557708396,0,1,blood coagulation, extrinsic pathway,BP,
17553,GO:1901202,1.00000000000681,0.901731557708396,0,1,negative regulation of extracellular matrix assembly,BP,
18359,GO:1903394,1.00000000000681,0.901731557708396,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
2432,GO:0005638,1.00000000000682,0.663808496525699,0,4,lamin filament,CC,
9959,GO:0042365,1.00000000000683,0.752260807502518,0,3,water-soluble vitamin catabolic process,BP,
18925,GO:1904715,1.00000000000684,0.734910655714753,0,3,negative regulation of chaperone-mediated autophagy,BP,
19574,GO:1990737,1.00000000000685,0.736208239970239,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
16271,GO:0090403,1.00000000000685,0.732365923130071,0,3,oxidative stress-induced premature senescence,BP,
5504,GO:0016476,1.00000000000686,0.732403343868215,0,3,regulation of embryonic cell shape,BP,
13775,GO:0060392,1.00000000000689,0.823148238228885,0,2,negative regulation of SMAD protein signal transduction,BP,
2205,GO:0005094,1.0000000000069,0.827895896268163,0,2,Rho GDP-dissociation inhibitor activity,MF,
1399,GO:0003335,1.0000000000069,0.90144877539647,0,1,corneocyte development,BP,
1400,GO:0003336,1.0000000000069,0.90144877539647,0,1,corneocyte desquamation,BP,
19322,GO:1905715,1.0000000000069,0.90144877539647,0,1,regulation of cornification,BP,
19323,GO:1905716,1.0000000000069,0.90144877539647,0,1,negative regulation of cornification,BP,
15507,GO:0071930,1.00000000000691,0.732337187394949,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
19416,GO:1990086,1.00000000000691,0.732337187394949,0,3,lens fiber cell apoptotic process,BP,
8634,GO:0034196,1.00000000000694,0.901415173699676,0,1,acylglycerol transport,BP,
8635,GO:0034197,1.00000000000694,0.901415173699676,0,1,triglyceride transport,BP,
10852,GO:0044395,1.00000000000694,0.901415173699676,0,1,protein targeting to vacuolar membrane,BP,
17472,GO:1900483,1.00000000000694,0.901415173699676,0,1,regulation of protein targeting to vacuolar membrane,BP,
4861,GO:0014732,1.00000000000695,0.738135040628768,0,3,skeletal muscle atrophy,BP,
176,GO:0000386,1.00000000000696,0.73629928816937,0,3,second spliceosomal transesterification activity,MF,
17323,GO:1900039,1.00000000000697,0.916280857651193,0,1,positive regulation of cellular response to hypoxia,BP,
17832,GO:1902071,1.00000000000697,0.916280857651193,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
17833,GO:1902073,1.00000000000697,0.916280857651193,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
10954,GO:0044752,1.00000000000701,0.732669857260285,0,3,response to human chorionic gonadotropin,BP,
6587,GO:0022615,1.00000000000702,0.670263150005833,0,4,protein to membrane docking,BP,
2117,GO:0004913,1.00000000000703,0.901652951693743,0,1,interleukin-4 receptor activity,MF,
4868,GO:0014740,1.00000000000704,0.812611573233987,0,2,negative regulation of muscle hyperplasia,BP,
1807,GO:0004461,1.00000000000705,0.813641541785435,0,2,lactose synthase activity,MF,
3498,GO:0007412,1.00000000000706,0.826975612070689,0,2,axon target recognition,BP,
3188,GO:0006824,1.00000000000706,0.734943186253273,0,3,cobalt ion transport,BP,
9210,GO:0035614,1.00000000000706,0.748630159176604,0,3,snRNA stem-loop binding,MF,
6498,GO:0021882,1.00000000000708,0.813411778586581,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6506,GO:0021893,1.00000000000708,0.813411778586581,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
9349,GO:0035881,1.00000000000708,0.813411778586581,0,2,amacrine cell differentiation,BP,
14149,GO:0061074,1.00000000000708,0.813411778586581,0,2,regulation of neural retina development,BP,
14150,GO:0061075,1.00000000000708,0.813411778586581,0,2,positive regulation of neural retina development,BP,
18114,GO:1902866,1.00000000000708,0.813411778586581,0,2,regulation of retina development in camera-type eye,BP,
18115,GO:1902868,1.00000000000708,0.813411778586581,0,2,positive regulation of retina development in camera-type eye,BP,
18116,GO:1902869,1.00000000000708,0.813411778586581,0,2,regulation of amacrine cell differentiation,BP,
18117,GO:1902871,1.00000000000708,0.813411778586581,0,2,positive regulation of amacrine cell differentiation,BP,
1909,GO:0004605,1.00000000000708,0.73233627974643,0,3,phosphatidate cytidylyltransferase activity,MF,
11029,GO:0045031,1.00000000000708,0.814422683755848,0,2,ATP-activated adenosine receptor activity,MF,
306,GO:0000818,1.0000000000071,0.813145998681206,0,2,nuclear MIS12/MIND complex,CC,
9658,GO:0038037,1.00000000000711,0.75013128623273,0,3,G-protein coupled receptor dimeric complex,CC,
16671,GO:0097648,1.00000000000711,0.75013128623273,0,3,G-protein coupled receptor complex,CC,
4718,GO:0010890,1.00000000000712,0.76171043894108,0,3,positive regulation of sequestering of triglyceride,BP,
5486,GO:0016434,1.00000000000713,0.732336664300552,0,3,rRNA (cytosine) methyltransferase activity,MF,
6536,GO:0021960,1.00000000000713,0.732336664300552,0,3,anterior commissure morphogenesis,BP,
19514,GO:1990454,1.00000000000713,0.732336664300552,0,3,L-type voltage-gated calcium channel complex,CC,
13980,GO:0060729,1.00000000000716,0.736956108275303,0,3,intestinal epithelial structure maintenance,BP,
20209,GO:2001183,1.00000000000716,0.904263506481561,0,1,negative regulation of interleukin-12 secretion,BP,
12718,GO:0051012,1.00000000000716,0.816791211082259,0,2,microtubule sliding,BP,
18422,GO:1903537,1.00000000000717,0.812747977179812,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
18423,GO:1903538,1.00000000000717,0.812747977179812,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
3465,GO:0007308,1.00000000000718,0.901428278309384,0,1,oocyte construction,BP,
3466,GO:0007309,1.00000000000718,0.901428278309384,0,1,oocyte axis specification,BP,
3467,GO:0007314,1.00000000000718,0.901428278309384,0,1,oocyte anterior/posterior axis specification,BP,
3468,GO:0007315,1.00000000000718,0.901428278309384,0,1,pole plasm assembly,BP,
3783,GO:0008358,1.00000000000718,0.901428278309384,0,1,maternal determination of anterior/posterior axis, embryo,BP,
7003,GO:0030719,1.00000000000718,0.901428278309384,0,1,P granule organization,BP,
9291,GO:0035755,1.00000000000718,0.901428278309384,0,1,cardiolipin hydrolase activity,MF,
8341,GO:0033227,1.00000000000718,0.735079215251012,0,3,dsRNA transport,BP,
19681,GO:2000049,1.00000000000718,0.735079215251012,0,3,positive regulation of cell-cell adhesion mediated by cadherin,BP,
11919,GO:0047006,1.0000000000072,0.911753802358419,0,1,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
11928,GO:0047042,1.0000000000072,0.911753802358419,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12010,GO:0047718,1.0000000000072,0.911753802358419,0,1,indanol dehydrogenase activity,MF,
17376,GO:1900138,1.00000000000722,0.741701881699006,0,3,negative regulation of phospholipase A2 activity,BP,
2000,GO:0004728,1.00000000000722,0.901417265717154,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
4002,GO:0008995,1.00000000000722,0.901417265717154,0,1,ribonuclease E activity,MF,
16184,GO:0090247,1.00000000000722,0.901417265717154,0,1,cell motility involved in somitogenic axis elongation,BP,
16185,GO:0090249,1.00000000000722,0.901417265717154,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17564,GO:1901229,1.00000000000722,0.901417265717154,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17565,GO:1901231,1.00000000000722,0.901417265717154,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17566,GO:1901232,1.00000000000722,0.901417265717154,0,1,regulation of convergent extension involved in axis elongation,BP,
17567,GO:1901233,1.00000000000722,0.901417265717154,0,1,negative regulation of convergent extension involved in axis elongation,BP,
13448,GO:0055011,1.00000000000723,0.906392751003232,0,1,atrial cardiac muscle cell differentiation,BP,
13451,GO:0055014,1.00000000000723,0.906392751003232,0,1,atrial cardiac muscle cell development,BP,
3758,GO:0008311,1.00000000000723,0.821879448611521,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
8260,GO:0033078,1.00000000000723,0.816874498808894,0,2,extrathymic T cell differentiation,BP,
175,GO:0000384,1.00000000000724,0.823173167250899,0,2,first spliceosomal transesterification activity,MF,
15136,GO:0071283,1.00000000000727,0.831509905441545,0,2,cellular response to iron(III) ion,BP,
2564,GO:0005854,1.00000000000728,0.827623185307786,0,2,nascent polypeptide-associated complex,CC,
2611,GO:0005927,1.00000000000729,0.908684913410512,0,1,muscle tendon junction,CC,
8643,GO:0034213,1.00000000000729,0.908684913410512,0,1,quinolinate catabolic process,BP,
11847,GO:0046874,1.00000000000729,0.908684913410512,0,1,quinolinate metabolic process,BP,
763,GO:0002016,1.0000000000073,0.929591284456981,0,1,regulation of blood volume by renin-angiotensin,BP,
765,GO:0002019,1.0000000000073,0.929591284456981,0,1,regulation of renal output by angiotensin,BP,
1279,GO:0003083,1.0000000000073,0.929591284456981,0,1,negative regulation of renal output by angiotensin,BP,
1291,GO:0003106,1.0000000000073,0.929591284456981,0,1,negative regulation of glomerular filtration by angiotensin,BP,
4925,GO:0014895,1.0000000000073,0.929591284456981,0,1,smooth muscle hypertrophy,BP,
10089,GO:0042624,1.0000000000073,0.929591284456981,0,1,ATPase activity, uncoupled,MF,
19428,GO:1990131,1.0000000000073,0.745486786383874,0,3,Gtr1-Gtr2 GTPase complex,CC,
15755,GO:0072387,1.00000000000731,0.814412270355749,0,2,flavin adenine dinucleotide metabolic process,BP,
14360,GO:0061629,1.00000000000732,0.668532585283272,0,4,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
13271,GO:0052031,1.00000000000733,0.739873337695202,0,3,modulation by symbiont of host defense response,BP,
13305,GO:0052255,1.00000000000733,0.739873337695202,0,3,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
13337,GO:0052552,1.00000000000733,0.739873337695202,0,3,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13338,GO:0052553,1.00000000000733,0.739873337695202,0,3,modulation by symbiont of host immune response,BP,
15931,GO:0075528,1.00000000000733,0.739873337695202,0,3,modulation by virus of host immune response,BP,
1974,GO:0004694,1.00000000000734,0.660093491069839,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
9640,GO:0038001,1.00000000000735,0.816098130943085,0,2,paracrine signaling,BP,
2001,GO:0004729,1.00000000000735,0.905789468149326,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
14907,GO:0070818,1.00000000000735,0.905789468149326,0,1,protoporphyrinogen oxidase activity,MF,
8286,GO:0033132,1.00000000000735,0.827264435576013,0,2,negative regulation of glucokinase activity,BP,
18312,GO:1903300,1.00000000000735,0.827264435576013,0,2,negative regulation of hexokinase activity,BP,
19541,GO:1990589,1.00000000000738,0.816773495601127,0,2,ATF4-CREB1 transcription factor complex,CC,
860,GO:0002193,1.00000000000739,0.732608439776137,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
1368,GO:0003256,1.00000000000739,0.732608439776137,0,3,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
14036,GO:0060842,1.00000000000739,0.732608439776137,0,3,arterial endothelial cell differentiation,BP,
2016,GO:0004749,1.00000000000739,0.663175102309263,0,4,ribose phosphate diphosphokinase activity,MF,
5658,GO:0016778,1.00000000000739,0.663175102309263,0,4,diphosphotransferase activity,MF,
19922,GO:2000501,1.0000000000074,0.826862404335707,0,2,regulation of natural killer cell chemotaxis,BP,
19923,GO:2000503,1.0000000000074,0.826862404335707,0,2,positive regulation of natural killer cell chemotaxis,BP,
9855,GO:0042134,1.0000000000074,0.830588684997035,0,2,rRNA primary transcript binding,MF,
17579,GO:1901291,1.00000000000741,0.904004899646909,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
8685,GO:0034338,1.00000000000741,0.733548630129575,0,3,short-chain carboxylesterase activity,MF,
19324,GO:1905719,1.00000000000743,0.812474784828437,0,2,protein localization to perinuclear region of cytoplasm,BP,
387,GO:0001032,1.00000000000744,0.664602201354089,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
8181,GO:0032937,1.00000000000746,0.732371436249329,0,3,SREBP-SCAP-Insig complex,CC,
1288,GO:0003100,1.00000000000746,0.663070782607282,0,4,regulation of systemic arterial blood pressure by endothelin,BP,
1133,GO:0002725,1.00000000000749,0.74162588727275,0,3,negative regulation of T cell cytokine production,BP,
18448,GO:1903575,1.0000000000075,0.820382861265026,0,2,cornified envelope assembly,BP,
630,GO:0001820,1.00000000000751,0.744578640277425,0,3,serotonin secretion,BP,
13252,GO:0051967,1.00000000000751,0.744578640277425,0,3,negative regulation of synaptic transmission, glutamatergic,BP,
905,GO:0002291,1.00000000000752,0.821787180364425,0,2,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
19930,GO:2000520,1.00000000000752,0.821787180364425,0,2,regulation of immunological synapse formation,BP,
19931,GO:2000521,1.00000000000752,0.821787180364425,0,2,negative regulation of immunological synapse formation,BP,
20214,GO:2001188,1.00000000000752,0.821787180364425,0,2,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
20215,GO:2001189,1.00000000000752,0.821787180364425,0,2,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
1410,GO:0003348,1.00000000000752,0.660303533978581,0,4,cardiac endothelial cell differentiation,BP,
14079,GO:0060956,1.00000000000752,0.660303533978581,0,4,endocardial cell differentiation,BP,
19840,GO:2000347,1.00000000000753,0.664450238987243,0,4,positive regulation of hepatocyte proliferation,BP,
14224,GO:0061302,1.00000000000754,0.73240444756555,0,3,smooth muscle cell-matrix adhesion,BP,
976,GO:0002430,1.00000000000756,0.901896073460653,0,1,complement receptor mediated signaling pathway,BP,
1923,GO:0004621,1.00000000000756,0.901896073460653,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2961,GO:0006507,1.00000000000756,0.901896073460653,0,1,GPI anchor release,BP,
4723,GO:0010897,1.00000000000756,0.901896073460653,0,1,negative regulation of triglyceride catabolic process,BP,
8547,GO:0034014,1.00000000000756,0.901896073460653,0,1,response to triglyceride,BP,
15215,GO:0071401,1.00000000000756,0.901896073460653,0,1,cellular response to triglyceride,BP,
8011,GO:0032658,1.00000000000757,0.905327869685647,0,1,regulation of interleukin-15 production,BP,
8055,GO:0032738,1.00000000000757,0.905327869685647,0,1,positive regulation of interleukin-15 production,BP,
9240,GO:0035664,1.00000000000757,0.905327869685647,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9241,GO:0035665,1.00000000000757,0.905327869685647,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
1711,GO:0004306,1.00000000000761,0.904533636201678,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
19335,GO:1905777,1.00000000000761,0.732333873412197,0,3,regulation of exonuclease activity,BP,
1690,GO:0004168,1.00000000000762,0.902214539327939,0,1,dolichol kinase activity,MF,
10279,GO:0043048,1.00000000000762,0.902214539327939,0,1,dolichyl monophosphate biosynthetic process,BP,
11304,GO:0045650,1.00000000000764,0.817801582787728,0,2,negative regulation of macrophage differentiation,BP,
11990,GO:0047536,1.00000000000764,0.902114428778371,0,1,2-aminoadipate transaminase activity,MF,
3393,GO:0007181,1.0000000000077,0.82175555277195,0,2,transforming growth factor beta receptor complex assembly,BP,
1674,GO:0004142,1.0000000000077,0.738542745240289,0,3,diacylglycerol cholinephosphotransferase activity,MF,
16362,GO:0097003,1.0000000000077,0.813501835000787,0,2,adipokinetic hormone receptor activity,MF,
1755,GO:0004362,1.0000000000077,0.901956255283299,0,1,glutathione-disulfide reductase activity,MF,
5185,GO:0015786,1.0000000000077,0.901956255283299,0,1,UDP-glucose transmembrane transport,BP,
15956,GO:0080163,1.00000000000771,0.901644273849521,0,1,regulation of protein serine/threonine phosphatase activity,BP,
13919,GO:0060623,1.00000000000772,0.73343931120009,0,3,regulation of chromosome condensation,BP,
18531,GO:1903774,1.00000000000773,0.739170534869653,0,3,positive regulation of viral budding via host ESCRT complex,BP,
19604,GO:1990812,1.00000000000774,0.732348324395952,0,3,growth cone filopodium,CC,
14413,GO:0061752,1.00000000000774,0.815387059751533,0,2,telomeric repeat-containing RNA binding,MF,
14423,GO:0061770,1.00000000000774,0.902389228297909,0,1,translation elongation factor binding,MF,
14593,GO:0070184,1.00000000000774,0.902389228297909,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15811,GO:0072545,1.00000000000774,0.902389228297909,0,1,tyrosine binding,MF,
18145,GO:1902937,1.00000000000774,0.902389228297909,0,1,inward rectifier potassium channel complex,CC,
18988,GO:1904842,1.00000000000774,0.902389228297909,0,1,response to nitroglycerin,BP,
18989,GO:1904843,1.00000000000774,0.902389228297909,0,1,cellular response to nitroglycerin,BP,
3388,GO:0007174,1.00000000000775,0.902082927572865,0,1,epidermal growth factor catabolic process,BP,
7847,GO:0032419,1.00000000000775,0.902082927572865,0,1,extrinsic component of lysosome membrane,CC,
19059,GO:1904979,1.00000000000775,0.902082927572865,0,1,negative regulation of endosome organization,BP,
19203,GO:1905365,1.00000000000775,0.902082927572865,0,1,regulation of intralumenal vesicle formation,BP,
19204,GO:1905366,1.00000000000775,0.902082927572865,0,1,negative regulation of intralumenal vesicle formation,BP,
18507,GO:1903723,1.00000000000775,0.923308469174484,0,1,negative regulation of centriole elongation,BP,
10455,GO:0043366,1.00000000000777,0.814807232495096,0,2,beta selection,BP,
16609,GO:0097498,1.00000000000777,0.814807232495096,0,2,endothelial tube lumen extension,BP,
5954,GO:0018364,1.0000000000078,0.855078432769554,0,2,peptidyl-glutamine methylation,BP,
5460,GO:0016403,1.0000000000078,0.822755569839966,0,2,dimethylargininase activity,MF,
1846,GO:0004513,1.00000000000783,0.901837470834718,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
11961,GO:0047291,1.00000000000783,0.901837470834718,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
12473,GO:0050542,1.00000000000783,0.714006880447695,0,4,icosanoid binding,MF,
12474,GO:0050543,1.00000000000783,0.714006880447695,0,4,icosatetraenoic acid binding,MF,
12475,GO:0050544,1.00000000000783,0.714006880447695,0,4,arachidonic acid binding,MF,
2043,GO:0004794,1.00000000000785,0.911394844861083,0,1,L-threonine ammonia-lyase activity,MF,
8562,GO:0034057,1.00000000000786,0.812558403082027,0,2,RNA strand-exchange activity,MF,
4202,GO:0009353,1.00000000000786,0.91290943945525,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
7418,GO:0031531,1.00000000000786,0.91290943945525,0,1,thyrotropin-releasing hormone receptor binding,MF,
13375,GO:0052739,1.00000000000787,0.902873803452991,0,1,phosphatidylserine 1-acylhydrolase activity,MF,
13376,GO:0052740,1.00000000000787,0.902873803452991,0,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
18852,GO:1904550,1.00000000000787,0.902873803452991,0,1,response to arachidonic acid,BP,
19825,GO:2000324,1.00000000000787,0.902873803452991,0,1,positive regulation of glucocorticoid receptor signaling pathway,BP,
9239,GO:0035663,1.00000000000787,0.816035299870336,0,2,Toll-like receptor 2 binding,MF,
11974,GO:0047391,1.00000000000787,0.816035299870336,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
11495,GO:0046032,1.00000000000789,0.908913696369765,0,1,ADP catabolic process,BP,
1682,GO:0004152,1.00000000000791,0.902867777467154,0,1,dihydroorotate dehydrogenase activity,MF,
18449,GO:1903576,1.00000000000791,0.902867777467154,0,1,response to L-arginine,BP,
16393,GO:0097058,1.00000000000793,0.905174012593722,0,1,CRLF-CLCF1 complex,CC,
16394,GO:0097059,1.00000000000793,0.905174012593722,0,1,CNTFR-CLCF1 complex,CC,
8364,GO:0033277,1.00000000000794,0.813034376284323,0,2,abortive mitotic cell cycle,BP,
17254,GO:0140031,1.00000000000794,0.813034376284323,0,2,phosphorylation-dependent protein binding,MF,
3094,GO:0006679,1.00000000000794,0.817843037756707,0,2,glucosylceramide biosynthetic process,BP,
2032,GO:0004776,1.00000000000795,0.820763253667237,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
6290,GO:0019912,1.00000000000795,0.813582951216755,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
7599,GO:0031997,1.00000000000798,0.742608584473236,0,3,N-terminal myristoylation domain binding,MF,
12935,GO:0051343,1.00000000000798,0.742608584473236,0,3,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13824,GO:0060455,1.000000000008,0.834543264456528,0,2,negative regulation of gastric acid secretion,BP,
18642,GO:1903999,1.000000000008,0.834543264456528,0,2,negative regulation of eating behavior,BP,
19776,GO:2000252,1.000000000008,0.834543264456528,0,2,negative regulation of feeding behavior,BP,
12777,GO:0051097,1.00000000000802,0.734954623425602,0,3,negative regulation of helicase activity,BP,
19697,GO:2000078,1.00000000000802,0.827702139422065,0,2,positive regulation of type B pancreatic cell development,BP,
7551,GO:0031905,1.00000000000802,0.748939661266659,0,3,early endosome lumen,CC,
2344,GO:0005412,1.00000000000803,0.813536230472973,0,2,glucose:sodium symporter activity,MF,
1649,GO:0004104,1.00000000000803,0.81264328157701,0,2,cholinesterase activity,MF,
8355,GO:0033265,1.00000000000803,0.81264328157701,0,2,choline binding,MF,
16924,GO:0098943,1.00000000000804,0.821221420160922,0,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
471,GO:0001515,1.00000000000805,0.903492990318234,0,1,opioid peptide activity,MF,
809,GO:0002083,1.00000000000808,0.9072140795881,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
11962,GO:0047293,1.00000000000808,0.9072140795881,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
18055,GO:1902683,1.0000000000081,0.812977442343486,0,2,regulation of receptor localization to synapse,BP,
11188,GO:0045338,1.00000000000811,0.667158796437948,0,4,farnesyl diphosphate metabolic process,BP,
14612,GO:0070212,1.00000000000811,0.660390279603071,0,4,protein poly-ADP-ribosylation,BP,
9534,GO:0036313,1.00000000000812,0.812653009754099,0,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
11894,GO:0046952,1.00000000000812,0.733232716334018,0,3,ketone body catabolic process,BP,
6874,GO:0030395,1.00000000000813,0.933709214394834,0,1,lactose binding,MF,
8592,GO:0034117,1.00000000000813,0.933709214394834,0,1,erythrocyte aggregation,BP,
8593,GO:0034118,1.00000000000813,0.933709214394834,0,1,regulation of erythrocyte aggregation,BP,
8594,GO:0034120,1.00000000000813,0.933709214394834,0,1,positive regulation of erythrocyte aggregation,BP,
12058,GO:0048030,1.00000000000813,0.933709214394834,0,1,disaccharide binding,MF,
6260,GO:0019863,1.00000000000814,0.911276566629747,0,1,IgE binding,MF,
1948,GO:0004656,1.00000000000814,0.732909012609144,0,3,procollagen-proline 4-dioxygenase activity,MF,
9528,GO:0036301,1.00000000000816,0.732683348729383,0,3,macrophage colony-stimulating factor production,BP,
17572,GO:1901256,1.00000000000816,0.732683348729383,0,3,regulation of macrophage colony-stimulating factor production,BP,
13286,GO:0052151,1.00000000000816,0.827702139421921,0,2,positive regulation by symbiont of host apoptotic process,BP,
13611,GO:0060139,1.00000000000816,0.827702139421921,0,2,positive regulation of apoptotic process by virus,BP,
18478,GO:1903650,1.00000000000819,0.848281342636254,0,2,negative regulation of cytoplasmic transport,BP,
19992,GO:2000642,1.00000000000819,0.848281342636254,0,2,negative regulation of early endosome to late endosome transport,BP,
15840,GO:0072589,1.00000000000819,0.715604824340904,0,4,box H/ACA scaRNP complex,CC,
963,GO:0002396,1.0000000000082,0.904000506793598,0,1,MHC protein complex assembly,BP,
964,GO:0002397,1.0000000000082,0.904000506793598,0,1,MHC class I protein complex assembly,BP,
1012,GO:0002501,1.0000000000082,0.904000506793598,0,1,peptide antigen assembly with MHC protein complex,BP,
1013,GO:0002502,1.0000000000082,0.904000506793598,0,1,peptide antigen assembly with MHC class I protein complex,BP,
125,GO:0000257,1.0000000000082,0.912118889227538,0,1,nitrilase activity,MF,
5685,GO:0016815,1.0000000000082,0.912118889227538,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
3826,GO:0008441,1.0000000000082,0.812613951987968,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
1887,GO:0004573,1.0000000000082,0.901379964397918,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
16743,GO:0098575,1.00000000000826,0.814605102273417,0,2,lumenal side of lysosomal membrane,CC,
18098,GO:1902809,1.00000000000828,0.73842198221877,0,3,regulation of skeletal muscle fiber differentiation,BP,
11922,GO:0047016,1.00000000000829,0.902264636036649,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
1913,GO:0004610,1.00000000000832,0.903322863257128,0,1,phosphoacetylglucosamine mutase activity,MF,
8688,GO:0034342,1.00000000000833,0.813531600657577,0,2,response to type III interferon,BP,
2893,GO:0006408,1.00000000000833,0.817630825744537,0,2,snRNA export from nucleus,BP,
1803,GO:0004454,1.00000000000835,0.901600214244117,0,1,ketohexokinase activity,MF,
7132,GO:0030984,1.00000000000835,0.826166855434906,0,2,kininogen binding,MF,
83,GO:0000171,1.00000000000835,0.812590840947977,0,2,ribonuclease MRP activity,MF,
19446,GO:1990180,1.00000000000836,0.749581108766563,0,3,mitochondrial tRNA 3'-end processing,BP,
18085,GO:1902766,1.00000000000836,0.825193839455116,0,2,skeletal muscle satellite cell migration,BP,
19629,GO:1990904,1.00000000000837,0,20,702,ribonucleoprotein complex,CC,BTBD2;ZFP36L1;GRB7;UNK;DHX32;ZFP36;MAPKBP1;PITPNM1;MEX3A;PAN2;ICOSLG;AGO4;WDR83;PNRC1;APOBEC3C;TDRKH;RPL39L;CTSH;APOBEC3F;RPL13A
4682,GO:0010845,1.00000000000838,0.901399581474908,0,1,positive regulation of reciprocal meiotic recombination,BP,
1912,GO:0004609,1.00000000000841,0.813520288606748,0,2,phosphatidylserine decarboxylase activity,MF,
17109,GO:0102339,1.00000000000842,0.901449567015551,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
17110,GO:0102340,1.00000000000842,0.901449567015551,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
17111,GO:0102341,1.00000000000842,0.901449567015551,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
17112,GO:0102342,1.00000000000842,0.901449567015551,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
18911,GO:1904690,1.00000000000844,0.663681571889371,0,4,positive regulation of cytoplasmic translational initiation,BP,
217,GO:0000454,1.00000000000848,0.776037954231168,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
382,GO:0001018,1.00000000000848,0.814668865789513,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
7603,GO:0032002,1.00000000000848,0.814668865789513,0,2,interleukin-28 receptor complex,CC,
5700,GO:0016841,1.0000000000085,0.740582111416984,0,3,ammonia-lyase activity,MF,
858,GO:0002191,1.0000000000085,0.736329837922372,0,3,cap-dependent translational initiation,BP,
17294,GO:0150003,1.00000000000851,0.741447417076254,0,3,regulation of spontaneous synaptic transmission,BP,
1454,GO:0003696,1.00000000000853,0.661780188641991,0,4,satellite DNA binding,MF,
3994,GO:0008941,1.00000000000854,0.814663828666232,0,2,nitric oxide dioxygenase activity,MF,
5619,GO:0016708,1.00000000000854,0.814663828666232,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
12542,GO:0050717,1.00000000000854,0.748053776059772,0,3,positive regulation of interleukin-1 alpha secretion,BP,
1646,GO:0004096,1.00000000000857,0.745801664338638,0,3,catalase activity,MF,
14267,GO:0061395,1.00000000000858,0.906146770504979,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
13141,GO:0051765,1.0000000000086,0.815932209701532,0,2,inositol tetrakisphosphate kinase activity,MF,
1197,GO:0002857,1.0000000000086,0.812492286827753,0,2,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1200,GO:0002860,1.0000000000086,0.812492286827753,0,2,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
8921,GO:0034970,1.0000000000086,0.812492286827753,0,2,histone H3-R2 methylation,BP,
18594,GO:1903905,1.0000000000086,0.812492286827753,0,2,positive regulation of establishment of T cell polarity,BP,
13374,GO:0052735,1.00000000000862,0.733131952489512,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
673,GO:0001884,1.00000000000863,0.812537091146603,0,2,pyrimidine nucleoside binding,MF,
833,GO:0002134,1.00000000000863,0.812537091146603,0,2,UTP binding,MF,
7940,GO:0032551,1.00000000000863,0.812537091146603,0,2,pyrimidine ribonucleoside binding,MF,
9943,GO:0042335,1.00000000000864,0.732965807840524,0,3,cuticle development,BP,
18939,GO:1904744,1.00000000000865,0.830147192157799,0,2,positive regulation of telomeric DNA binding,BP,
11578,GO:0046203,1.00000000000866,0.830292926679769,0,2,spermidine catabolic process,BP,
7394,GO:0031475,1.00000000000868,0.909163640264698,0,1,myosin V complex,CC,
8049,GO:0032730,1.00000000000868,0.674264291250012,0,4,positive regulation of interleukin-1 alpha production,BP,
15797,GO:0072526,1.00000000000872,0.667037907432989,0,4,pyridine-containing compound catabolic process,BP,
9787,GO:0040032,1.00000000000873,0.904203092748473,0,1,post-embryonic body morphogenesis,BP,
1720,GO:0004315,1.00000000000875,0.823843448472718,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
10930,GO:0044614,1.00000000000875,0.660090478703423,0,4,nuclear pore cytoplasmic filaments,CC,
9123,GO:0035482,1.00000000000876,0.839676876682976,0,2,gastric motility,BP,
19190,GO:1905333,1.00000000000876,0.839676876682976,0,2,regulation of gastric motility,BP,
17214,GO:0110095,1.00000000000878,0.761519755057514,0,3,cellular detoxification of aldehyde,BP,
3199,GO:0006843,1.00000000000878,0.907792571280799,0,1,mitochondrial citrate transmembrane transport,BP,
16053,GO:0090044,1.00000000000878,0.907792571280799,0,1,positive regulation of tubulin deacetylation,BP,
19530,GO:1990546,1.00000000000878,0.907792571280799,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
1836,GO:0004496,1.00000000000879,0.902840861087722,0,1,mevalonate kinase activity,MF,
8737,GO:0034414,1.00000000000881,0.81311676407639,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
10168,GO:0042779,1.00000000000881,0.81311676407639,0,2,tRNA 3'-trailer cleavage,BP,
10170,GO:0042781,1.00000000000881,0.81311676407639,0,2,3'-tRNA processing endoribonuclease activity,MF,
19158,GO:1905267,1.00000000000881,0.81311676407639,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
9491,GO:0036157,1.00000000000881,0.755382523121204,0,3,outer dynein arm,CC,
16720,GO:0098518,1.00000000000882,0.740862827199437,0,3,polynucleotide phosphatase activity,MF,
1692,GO:0004170,1.00000000000883,0.904386914003654,0,1,dUTP diphosphatase activity,MF,
11525,GO:0046080,1.00000000000883,0.904386914003654,0,1,dUTP metabolic process,BP,
11526,GO:0046081,1.00000000000883,0.904386914003654,0,1,dUTP catabolic process,BP,
2787,GO:0006235,1.00000000000884,0.685458690221244,0,4,dTTP biosynthetic process,BP,
4141,GO:0009212,1.00000000000884,0.685458690221244,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
11522,GO:0046075,1.00000000000884,0.685458690221244,0,4,dTTP metabolic process,BP,
1483,GO:0003810,1.00000000000884,0.732333186267587,0,3,protein-glutamine gamma-glutamyltransferase activity,MF,
1416,GO:0003360,1.00000000000885,0.733407393795363,0,3,brainstem development,BP,
18585,GO:1903895,1.00000000000886,0.660324965873179,0,4,negative regulation of IRE1-mediated unfolded protein response,BP,
11410,GO:0045852,1.00000000000889,0.734551381629718,0,3,pH elevation,BP,
12993,GO:0051454,1.00000000000889,0.734551381629718,0,3,intracellular pH elevation,BP,
9665,GO:0038052,1.0000000000089,0.81262001910851,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
1677,GO:0004145,1.0000000000089,0.845783461630786,0,2,diamine N-acetyltransferase activity,MF,
6234,GO:0019809,1.0000000000089,0.845783461630786,0,2,spermidine binding,MF,
8167,GO:0032917,1.0000000000089,0.845783461630786,0,2,polyamine acetylation,BP,
8168,GO:0032918,1.0000000000089,0.845783461630786,0,2,spermidine acetylation,BP,
5206,GO:0015817,1.00000000000891,0.901378010743066,0,1,histidine transport,BP,
7519,GO:0031753,1.00000000000891,0.901378010743066,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
7520,GO:0031755,1.00000000000891,0.901378010743066,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
17092,GO:0102009,1.00000000000894,0.90418008384445,0,1,proline dipeptidase activity,MF,
6037,GO:0019166,1.000000000009,0.740444086676783,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
11491,GO:0046015,1.00000000000901,0.671537867491324,0,4,regulation of transcription by glucose,BP,
4269,GO:0009644,1.00000000000904,0.813727534069403,0,2,response to high light intensity,BP,
12384,GO:0048852,1.00000000000904,0.733132419149636,0,3,diencephalon morphogenesis,BP,
14866,GO:0070685,1.00000000000904,0.902626395364321,0,1,macropinocytic cup,CC,
746,GO:0001978,1.00000000000905,0.902283926378881,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
747,GO:0001983,1.00000000000905,0.902283926378881,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
748,GO:0001985,1.00000000000905,0.902283926378881,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
753,GO:0001994,1.00000000000905,0.902283926378881,0,1,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
755,GO:0001997,1.00000000000905,0.902283926378881,0,1,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
1287,GO:0003099,1.00000000000905,0.902283926378881,0,1,positive regulation of the force of heart contraction by chemical signal,BP,
2128,GO:0004936,1.00000000000905,0.902283926378881,0,1,alpha-adrenergic receptor activity,MF,
2129,GO:0004937,1.00000000000905,0.902283926378881,0,1,alpha1-adrenergic receptor activity,MF,
18639,GO:1903995,1.00000000000905,0.902283926378881,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18640,GO:1903997,1.00000000000905,0.902283926378881,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
6240,GO:0019826,1.00000000000905,0.813573757331397,0,2,oxygen sensor activity,MF,
6317,GO:0020012,1.00000000000905,0.812478392039884,0,2,evasion or tolerance of host immune response,BP,
6987,GO:0030682,1.00000000000905,0.812478392039884,0,2,evasion or tolerance of host defense response,BP,
6988,GO:0030683,1.00000000000905,0.812478392039884,0,2,evasion or tolerance by virus of host immune response,BP,
13168,GO:0051805,1.00000000000905,0.812478392039884,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
13170,GO:0051807,1.00000000000905,0.812478392039884,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
19007,GO:1904877,1.00000000000906,0.902613073254943,0,1,positive regulation of DNA ligase activity,BP,
4480,GO:0010512,1.00000000000908,0.81247489849374,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
9300,GO:0035788,1.00000000000908,0.81247489849374,0,2,cell migration involved in metanephros development,BP,
9301,GO:0035789,1.00000000000908,0.81247489849374,0,2,metanephric mesenchymal cell migration,BP,
9304,GO:0035793,1.00000000000908,0.81247489849374,0,2,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
17425,GO:1900238,1.00000000000908,0.81247489849374,0,2,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
19964,GO:2000589,1.00000000000908,0.81247489849374,0,2,regulation of metanephric mesenchymal cell migration,BP,
19965,GO:2000591,1.00000000000908,0.81247489849374,0,2,positive regulation of metanephric mesenchymal cell migration,BP,
9801,GO:0042025,1.00000000000908,0.732739794668919,0,3,host cell nucleus,CC,
10719,GO:0044094,1.00000000000908,0.732739794668919,0,3,host cell nuclear part,CC,
10035,GO:0042535,1.00000000000909,0.676358514623181,0,4,positive regulation of tumor necrosis factor biosynthetic process,BP,
14188,GO:0061152,1.0000000000091,0.825748667163993,0,2,trachea submucosa development,BP,
14189,GO:0061153,1.0000000000091,0.825748667163993,0,2,trachea gland development,BP,
1034,GO:0002543,1.00000000000911,0.812793415710904,0,2,activation of blood coagulation via clotting cascade,BP,
16216,GO:0090297,1.00000000000912,0.913945594972943,0,1,positive regulation of mitochondrial DNA replication,BP,
17762,GO:1901860,1.00000000000912,0.913945594972943,0,1,positive regulation of mitochondrial DNA metabolic process,BP,
19406,GO:1990046,1.00000000000912,0.913945594972943,0,1,stress-induced mitochondrial fusion,BP,
13059,GO:0051595,1.00000000000915,0.757785104821877,0,3,response to methylglyoxal,BP,
1815,GO:0004470,1.00000000000916,0.669879846823671,0,4,malic enzyme activity,MF,
1834,GO:0004493,1.00000000000916,0.924316556180525,0,1,methylmalonyl-CoA epimerase activity,MF,
11679,GO:0046491,1.00000000000916,0.924316556180525,0,1,L-methylmalonyl-CoA metabolic process,BP,
16191,GO:0090261,1.00000000000916,0.676094831656304,0,4,positive regulation of inclusion body assembly,BP,
13042,GO:0051572,1.00000000000916,0.73441463144928,0,3,negative regulation of histone H3-K4 methylation,BP,
16449,GO:0097159,1.00000000000917,0,340,4623,organic cyclic compound binding,MF,FOS;H6PD;APOE;IDH2;ERCC1;NT5E;LTB4R;PYGB;RAPGEF3;TCFL5;CYP27B1;XDH;PRDX5;PCBP4;PRODH;MEF2D;NOS1;ZFP36L1;GRB7;NR1D1;NYNRIN;SCN8A;EPHB2;EPAS1;OBSCN;NFATC4;NME4;MST1R;LRP1;MAPK13;HEBP1;CDK18;EGFR;H1F0;HADH;CRYL1;ACSF2;TCEA2;FKBP9;MXD4;DDB2;MTHFR;EGR1;ULK1;PKN1;PYGL;PTK6;GNAL;ABCA7;DEAF1;BAHCC1;ACTA2;S100A4;DNAH1;SLC16A3;CXXC5;ULK2;DGKA;D2HGDH;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;CERS4;ABCG1;DHRS11;OPLAH;ZNF516;PEG3;NEK9;HDAC5;THRA;RPS6KA2;NMRK1;TUBG2;MARK4;KHNYN;ZFPM1;TFEB;ERBB2;BRSK1;OGDHL;CBS;TST;ABTB1;H2AFJ;DNM1;SALL2;CUL9;KIF13B;XPC;PAK6;VPS11;FOXQ1;UNK;CD320;MINK1;ATP2B4;TFDP2;CSNK1E;AGAP1;PDCD4;GLUL;RHOD;ZKSCAN1;INSR;RAB3D;ZC3H6;GRK6;MVD;POLL;EPHA1;ADARB1;ZNF692;ZNF704;TXNRD3;DNMT3A;TMEM173;DHX32;ATP7B;RNASET2;HES2;HINT2;ZNF467;MNT;STAT6;SPEG;ABCD1;MTA3;MKNK2;STRADB;ISG20;RAB25;FAM20C;MYO18A;PHC2;BCL6;ANKZF1;UCKL1;PFKFB2;ATP12A;DYRK1B;SEC14L2;SRMS;DNASE1L1;ZSCAN2;ARL2;MAST4;CEBPB;ACVR2B;HSF4;CALCOCO1;ZDHHC1;ENDOG;MAPK3;ETV5;DHTKD1;EXD3;ARL10;RAB40B;ENTPD2;GALK1;MTA1;FYCO1;ADCY6;LTA4H;MBD1;PKN3;PHGDH;EPHB3;HES1;PC;ACAD10;MLXIPL;ZNF624;SLC48A1;NADK;ABCA2;TK2;ZNF414;ADA;FKBP10;OSBPL5;PHF21A;HTR7;RASL10B;CKMT1A;PFKL;PCSK9;ZFP36;ETV4;RHOF;MAPKBP1;HLCS;FGFR3;NSUN7;PRKACA;ZNF862;ZMYM3;LRRK1;DGUOK;CYFIP2;RPS6KA5;RAB3B;MAP2K2;PI4K2A;FGFR4;PMVK;MYH3;EHD4;TCF25;CYP3A5;SOX13;TRPV4;MPG;RHOBTB2;BHLHE40;RAG1;ZNF80;EEF2K;HMGA2;TM7SF2;ELK3;AHNAK2;DGKQ;HK1;ZXDC;MEX3A;POU6F1;ZNF217;PPARA;TKFC;GUK1;STK32C;DMC1;PAN2;ZNF446;RXRA;PCK2;BCR;SDHA;PRKCZ;HLTF;MDH2;ABCD4;TWF2;ZNF485;LSM14B;PDK2;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;CAMKK1;ZNF563;PROX1;WBP2;GTPBP1;ASS1;ZNF554;JARID2;RXRB;CSTB;GAL3ST4;GRHPR;ACTR1B;APOBEC3C;H1FX;ZFP41;STK39;ACVR1B;MEF2B;ZSCAN30;GSS;ERBB3;CYP2S1;AKT1;TRAP1;NLRX1;SEPT8;ZNF385A;TUT1;SMARCA1;SIX5;ERCC6;GPD1L;TDRKH;SSBP2;RPL39L;ADCK2;R3HDM2;PINK1;EHD3;LONP2;CAMTA2;R3HDM4;EIF4G3;ZNF710;RFX2;MAP2K3;PNPO;TRERF1;THAP8;DDN;PMS2P5;NDUFV3;STK17A;ERN1;ZNF319;APOBEC3F;ACADS;GCAT;MOCS1;SIRT3;GLI4;JAK3;MAST3;KIFC2;LITAF;MZF1;NEIL1;FUK;RARG;EIF4E3;ZCCHC14;ZNF514;TRNP1;TTLL11;ZNF837;POLM;FAM50A;RPL13A;RAB40C;KIF26B
19061,GO:1904983,1.00000000000917,0.902550446843114,0,1,glycine import into mitochondrion,BP,
5282,GO:0015960,1.00000000000919,0.733352385188791,0,3,diadenosine polyphosphate biosynthetic process,BP,
5284,GO:0015965,1.00000000000919,0.733352385188791,0,3,diadenosine tetraphosphate metabolic process,BP,
5285,GO:0015966,1.00000000000919,0.733352385188791,0,3,diadenosine tetraphosphate biosynthetic process,BP,
7503,GO:0031700,1.00000000000922,0.910468126855603,0,1,adrenomedullin receptor binding,MF,
3121,GO:0006710,1.00000000000922,0.904367702879952,0,1,androgen catabolic process,BP,
2085,GO:0004853,1.00000000000923,0.911633465336537,0,1,uroporphyrinogen decarboxylase activity,MF,
18533,GO:1903778,1.00000000000923,0.812508212390748,0,2,protein localization to vacuolar membrane,BP,
4995,GO:0015152,1.00000000000927,0.90265061627399,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
7617,GO:0032028,1.00000000000927,0.90265061627399,0,1,myosin head/neck binding,MF,
12128,GO:0048257,1.00000000000929,0.812689051810194,0,2,3'-flap endonuclease activity,MF,
9469,GO:0036122,1.0000000000093,0.733709731037355,0,3,BMP binding,MF,
1960,GO:0004673,1.00000000000932,0.928327685654683,0,1,protein histidine kinase activity,MF,
5890,GO:0018106,1.00000000000932,0.928327685654683,0,1,peptidyl-histidine phosphorylation,BP,
2481,GO:0005731,1.00000000000933,0.906140231241901,0,1,nucleolus organizer region,CC,
3340,GO:0007072,1.00000000000933,0.906140231241901,0,1,positive regulation of transcription involved in exit from mitosis,BP,
7070,GO:0030874,1.00000000000933,0.906140231241901,0,1,nucleolar chromatin,CC,
16550,GO:0097372,1.00000000000933,0.906140231241901,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
1917,GO:0004615,1.0000000000094,0.824028855348296,0,2,phosphomannomutase activity,MF,
6032,GO:0019144,1.0000000000094,0.832130906510544,0,2,ADP-sugar diphosphatase activity,MF,
7713,GO:0032216,1.0000000000094,0.902015790960102,0,1,glucosaminyl-phosphotidylinositol O-acyltransferase activity,MF,
3541,GO:0007576,1.0000000000094,0.901446435600161,0,1,nucleolar fragmentation,BP,
6066,GO:0019227,1.0000000000094,0.748677265746182,0,3,neuronal action potential propagation,BP,
16880,GO:0098870,1.0000000000094,0.748677265746182,0,3,action potential propagation,BP,
9165,GO:0035553,1.00000000000941,0.737921439806706,0,3,oxidative single-stranded RNA demethylation,BP,
17431,GO:1900245,1.00000000000941,0.732352172022545,0,3,positive regulation of MDA-5 signaling pathway,BP,
18102,GO:1902822,1.00000000000943,0.749082565051865,0,3,regulation of late endosome to lysosome transport,BP,
5406,GO:0016263,1.00000000000945,0.818004581877041,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5409,GO:0016267,1.00000000000945,0.818004581877041,0,2,O-glycan processing, core 1,BP,
18409,GO:1903518,1.00000000000947,0.813588055035079,0,2,positive regulation of single strand break repair,BP,
20217,GO:2001198,1.00000000000947,0.747012026318006,0,3,regulation of dendritic cell differentiation,BP,
9252,GO:0035692,1.00000000000948,0.823118964560077,0,2,macrophage migration inhibitory factor receptor complex,CC,
19884,GO:2000409,1.00000000000951,0.904613809342473,0,1,positive regulation of T cell extravasation,BP,
19900,GO:2000451,1.00000000000951,0.904613809342473,0,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19902,GO:2000454,1.00000000000951,0.904613809342473,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
2356,GO:0005462,1.00000000000951,0.813415905424301,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
19466,GO:1990269,1.00000000000951,0.813415905424301,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
19533,GO:1990569,1.00000000000951,0.813415905424301,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
6819,GO:0030292,1.00000000000953,0.735520163457423,0,3,protein tyrosine kinase inhibitor activity,MF,
862,GO:0002196,1.00000000000953,0.904148082401857,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
4969,GO:0015098,1.00000000000953,0.904148082401857,0,1,molybdate ion transmembrane transporter activity,MF,
5142,GO:0015689,1.00000000000953,0.904148082401857,0,1,molybdate ion transport,BP,
2115,GO:0004909,1.00000000000953,0.814429646759034,0,2,interleukin-1, Type I, activating receptor activity,MF,
8221,GO:0033004,1.00000000000954,0.738243454478836,0,3,negative regulation of mast cell activation,BP,
8224,GO:0033007,1.00000000000954,0.738243454478836,0,3,negative regulation of mast cell activation involved in immune response,BP,
9509,GO:0036250,1.00000000000955,0.903888009309937,0,1,peroxisome transport along microtubule,BP,
10945,GO:0044721,1.00000000000955,0.903888009309937,0,1,protein import into peroxisome matrix, substrate release,BP,
19517,GO:1990460,1.00000000000958,0.73357479848625,0,3,leptin receptor binding,MF,
3769,GO:0008332,1.00000000000959,0.903828792494337,0,1,low voltage-gated calcium channel activity,MF,
12865,GO:0051232,1.00000000000962,0.901681151477309,0,1,meiotic spindle elongation,BP,
10420,GO:0043293,1.00000000000963,0.816247614947916,0,2,apoptosome,CC,
6627,GO:0023021,1.00000000000964,0.732872583263677,0,3,termination of signal transduction,BP,
14698,GO:0070375,1.00000000000967,0.732597661258745,0,3,ERK5 cascade,BP,
5766,GO:0016998,1.00000000000971,0.819571644389113,0,2,cell wall macromolecule catabolic process,BP,
5420,GO:0016287,1.00000000000971,0.901384611088965,0,1,glycerone-phosphate O-acyltransferase activity,MF,
11005,GO:0044860,1.00000000000972,0.662270796200458,0,4,protein localization to plasma membrane raft,BP,
17513,GO:1901069,1.00000000000975,0.828313440715314,0,2,guanosine-containing compound catabolic process,BP,
8751,GO:0034441,1.00000000000976,0.90515156599075,0,1,plasma lipoprotein particle oxidation,BP,
7183,GO:0031084,1.00000000000977,0.732347674248947,0,3,BLOC-2 complex,CC,
2046,GO:0004798,1.00000000000978,0.826755079759099,0,2,thymidylate kinase activity,MF,
2783,GO:0006227,1.00000000000978,0.826755079759099,0,2,dUDP biosynthetic process,BP,
2786,GO:0006233,1.00000000000978,0.826755079759099,0,2,dTDP biosynthetic process,BP,
4076,GO:0009139,1.00000000000978,0.826755079759099,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4127,GO:0009196,1.00000000000978,0.826755079759099,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4128,GO:0009197,1.00000000000978,0.826755079759099,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
11520,GO:0046072,1.00000000000978,0.826755079759099,0,2,dTDP metabolic process,BP,
11523,GO:0046077,1.00000000000978,0.826755079759099,0,2,dUDP metabolic process,BP,
8947,GO:0035033,1.00000000000979,0.821160120525988,0,2,histone deacetylase regulator activity,MF,
836,GO:0002143,1.00000000000979,0.666422071218698,0,4,tRNA wobble position uridine thiolation,BP,
20008,GO:2000660,1.0000000000098,0.67051007448775,0,4,negative regulation of interleukin-1-mediated signaling pathway,BP,
3660,GO:0008158,1.00000000000981,0.831621772963476,0,2,hedgehog receptor activity,MF,
2692,GO:0006065,1.00000000000983,0.73321281149804,0,3,UDP-glucuronate biosynthetic process,BP,
11635,GO:0046398,1.00000000000983,0.73321281149804,0,3,UDP-glucuronate metabolic process,BP,
5623,GO:0016714,1.00000000000983,0.750424021269777,0,3,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
1719,GO:0004314,1.00000000000986,0.814583402712086,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
5475,GO:0016419,1.00000000000986,0.814583402712086,0,2,S-malonyltransferase activity,MF,
5476,GO:0016420,1.00000000000986,0.814583402712086,0,2,malonyltransferase activity,MF,
1425,GO:0003400,1.00000000000987,0.902347985757692,0,1,regulation of COPII vesicle coating,BP,
2202,GO:0005090,1.00000000000987,0.902347985757692,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
13928,GO:0060661,1.00000000000987,0.902347985757692,0,1,submandibular salivary gland formation,BP,
15165,GO:0071335,1.00000000000987,0.902347985757692,0,1,hair follicle cell proliferation,BP,
15166,GO:0071336,1.00000000000987,0.902347985757692,0,1,regulation of hair follicle cell proliferation,BP,
15167,GO:0071338,1.00000000000987,0.902347985757692,0,1,positive regulation of hair follicle cell proliferation,BP,
16095,GO:0090113,1.00000000000987,0.902347985757692,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
101,GO:0000213,1.00000000000987,0.664760242256973,0,4,tRNA-intron endonuclease activity,MF,
6528,GO:0021942,1.00000000000992,0.73316624394204,0,3,radial glia guided migration of Purkinje cell,BP,
8096,GO:0032796,1.00000000000993,0.817951724087705,0,2,uropod organization,BP,
3995,GO:0008948,1.00000000000994,0.664437421899182,0,4,oxaloacetate decarboxylase activity,MF,
1981,GO:0004705,1.00000000000995,0.74016251427929,0,3,JUN kinase activity,MF,
5746,GO:0016909,1.00000000000995,0.74016251427929,0,3,SAP kinase activity,MF,
3949,GO:0008709,1.00000000000995,0.922031558253659,0,1,cholate 7-alpha-dehydrogenase activity,MF,
6812,GO:0030283,1.00000000000995,0.922031558253659,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
11921,GO:0047015,1.00000000000995,0.922031558253659,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
9892,GO:0042245,1.00000000000999,0.812512553311786,0,2,RNA repair,BP,
10207,GO:0042903,1.00000000001002,0.814594421580728,0,2,tubulin deacetylase activity,MF,
13609,GO:0060136,1.00000000001003,0.663505087338896,0,4,embryonic process involved in female pregnancy,BP,
1693,GO:0004174,1.00000000001009,0.812789278284244,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
5597,GO:0016649,1.00000000001009,0.812789278284244,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
211,GO:0000444,1.00000000001012,0.673287276179726,0,4,MIS12/MIND type complex,CC,
16497,GO:0097238,1.00000000001014,0.840709497515554,0,2,cellular response to methylglyoxal,BP,
15606,GO:0072131,1.00000000001014,0.73260211743337,0,3,kidney mesenchyme morphogenesis,BP,
15608,GO:0072133,1.00000000001014,0.73260211743337,0,3,metanephric mesenchyme morphogenesis,BP,
3137,GO:0006740,1.00000000001015,0.73296705398742,0,3,NADPH regeneration,BP,
10296,GO:0043095,1.00000000001016,0.928896981937558,0,1,regulation of GTP cyclohydrolase I activity,BP,
10302,GO:0043105,1.00000000001016,0.928896981937558,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
10912,GO:0044549,1.00000000001016,0.928896981937558,0,1,GTP cyclohydrolase binding,MF,
344,GO:0000958,1.00000000001017,0.732437357098267,0,3,mitochondrial mRNA catabolic process,BP,
107,GO:0000224,1.00000000001022,0.901452792507241,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
846,GO:0002169,1.00000000001023,0.812535700729994,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
1826,GO:0004485,1.00000000001023,0.812535700729994,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
19135,GO:1905202,1.00000000001023,0.812535700729994,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
8218,GO:0032996,1.00000000001023,0.90444504246531,0,1,Bcl3-Bcl10 complex,CC,
11063,GO:0045082,1.00000000001023,0.90444504246531,0,1,positive regulation of interleukin-10 biosynthetic process,BP,
3851,GO:0008479,1.00000000001025,0.687008118014689,0,4,queuine tRNA-ribosyltransferase activity,MF,
340,GO:0000941,1.00000000001027,0.902008982905901,0,1,condensed nuclear chromosome inner kinetochore,CC,
12995,GO:0051456,1.00000000001027,0.902008982905901,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
2324,GO:0005344,1.00000000001027,0.903705059073402,0,1,oxygen carrier activity,MF,
12025,GO:0047888,1.00000000001027,0.903705059073402,0,1,fatty acid peroxidase activity,MF,
2068,GO:0004825,1.00000000001029,0.812474684672405,0,2,methionine-tRNA ligase activity,MF,
2913,GO:0006431,1.00000000001029,0.812474684672405,0,2,methionyl-tRNA aminoacylation,BP,
13959,GO:0060699,1.00000000001029,0.668086808374494,0,4,regulation of endoribonuclease activity,BP,
658,GO:0001850,1.00000000001031,0.904841288608155,0,1,complement component C3a binding,MF,
659,GO:0001851,1.00000000001031,0.904841288608155,0,1,complement component C3b binding,MF,
824,GO:0002101,1.00000000001032,0.73993910603661,0,3,tRNA wobble cytosine modification,BP,
13364,GO:0052692,1.00000000001033,0.911003277715065,0,1,raffinose alpha-galactosidase activity,MF,
16552,GO:0097376,1.00000000001033,0.911003277715065,0,1,interneuron axon guidance,BP,
14902,GO:0070782,1.00000000001034,0.902403231485138,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
6348,GO:0021539,1.00000000001036,0.819176493735424,0,2,subthalamus development,BP,
16373,GO:0097021,1.00000000001037,0.815942427587727,0,2,lymphocyte migration into lymphoid organs,BP,
437,GO:0001172,1.00000000001037,0.850278448952077,0,2,transcription, RNA-templated,BP,
1561,GO:0003968,1.00000000001037,0.850278448952077,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
7334,GO:0031379,1.00000000001037,0.850278448952077,0,2,RNA-directed RNA polymerase complex,CC,
17449,GO:1900369,1.00000000001037,0.850278448952077,0,2,negative regulation of RNA interference,BP,
5439,GO:0016321,1.00000000001038,0.733218829685303,0,3,female meiosis chromosome segregation,BP,
20270,GO:2001287,1.0000000000104,0.819540148825394,0,2,negative regulation of caveolin-mediated endocytosis,BP,
769,GO:0002025,1.0000000000104,0.903068780955315,0,1,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
2130,GO:0004939,1.0000000000104,0.903068780955315,0,1,beta-adrenergic receptor activity,MF,
2131,GO:0004941,1.0000000000104,0.903068780955315,0,1,beta2-adrenergic receptor activity,MF,
12952,GO:0051380,1.0000000000104,0.903068780955315,0,1,norepinephrine binding,MF,
14454,GO:0061884,1.0000000000104,0.903068780955315,0,1,regulation of mini excitatory postsynaptic potential,BP,
14455,GO:0061885,1.0000000000104,0.903068780955315,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
16853,GO:0098816,1.0000000000104,0.903068780955315,0,1,mini excitatory postsynaptic potential,BP,
11618,GO:0046356,1.00000000001043,0.83065423497917,0,2,acetyl-CoA catabolic process,BP,
5226,GO:0015853,1.00000000001044,0.681455121853848,0,4,adenine transport,BP,
106,GO:0000221,1.00000000001047,0.733371676597647,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
5575,GO:0016603,1.00000000001047,0.817832374554541,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5863,GO:0017186,1.00000000001047,0.817832374554541,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
7408,GO:0031510,1.00000000001048,0.739807167757944,0,3,SUMO activating enzyme complex,CC,
518,GO:0001595,1.00000000001048,0.91613863340087,0,1,angiotensin receptor activity,MF,
2132,GO:0004945,1.00000000001048,0.91613863340087,0,1,angiotensin type II receptor activity,MF,
10741,GO:0044205,1.00000000001051,0.733554784044502,0,3,'de novo' UMP biosynthetic process,BP,
4316,GO:0009826,1.00000000001051,0.815400731749314,0,2,unidimensional cell growth,BP,
1627,GO:0004069,1.00000000001052,0.81366625596139,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
2980,GO:0006532,1.00000000001052,0.81366625596139,0,2,aspartate biosynthetic process,BP,
2981,GO:0006533,1.00000000001052,0.81366625596139,0,2,aspartate catabolic process,BP,
6170,GO:0019550,1.00000000001052,0.81366625596139,0,2,glutamate catabolic process to aspartate,BP,
6171,GO:0019551,1.00000000001052,0.81366625596139,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
16564,GO:0097409,1.00000000001054,0.903636833409182,0,1,glial cytoplasmic inclusion,CC,
16567,GO:0097414,1.00000000001054,0.903636833409182,0,1,classical Lewy body,CC,
16590,GO:0097462,1.00000000001054,0.903636833409182,0,1,Lewy neurite,CC,
19405,GO:1990038,1.00000000001054,0.903636833409182,0,1,Lewy body corona,CC,
10135,GO:0042731,1.00000000001054,0.671516474671867,0,4,PH domain binding,MF,
1758,GO:0004365,1.00000000001056,0.91316459057076,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
6242,GO:0019828,1.00000000001056,0.91316459057076,0,1,aspartic-type endopeptidase inhibitor activity,MF,
9201,GO:0035605,1.00000000001056,0.91316459057076,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
10650,GO:0043891,1.00000000001056,0.91316459057076,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
19835,GO:2000342,1.00000000001058,0.812768143345277,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
11308,GO:0045654,1.00000000001058,0.820396765303807,0,2,positive regulation of megakaryocyte differentiation,BP,
4,GO:0000010,1.0000000000106,0.817979092963311,0,2,trans-hexaprenyltranstransferase activity,MF,
12448,GO:0050347,1.0000000000106,0.817979092963311,0,2,trans-octaprenyltranstransferase activity,MF,
5478,GO:0016422,1.00000000001061,0.735178165445846,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
7798,GO:0032361,1.00000000001061,0.903308517527602,0,1,pyridoxal phosphate catabolic process,BP,
10188,GO:0042820,1.00000000001061,0.903308517527602,0,1,vitamin B6 catabolic process,BP,
10394,GO:0043250,1.00000000001062,0.909462187455863,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
10395,GO:0043251,1.00000000001062,0.909462187455863,0,1,sodium-dependent organic anion transport,BP,
12412,GO:0050023,1.00000000001063,0.904494052820901,0,1,L-fuconate dehydratase activity,MF,
15906,GO:0072733,1.00000000001063,0.738598938439125,0,3,response to staurosporine,BP,
15907,GO:0072734,1.00000000001063,0.738598938439125,0,3,cellular response to staurosporine,BP,
2008,GO:0004739,1.00000000001065,0.819321759632595,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
7097,GO:0030905,1.00000000001066,0.662067122877407,0,4,retromer, tubulation complex,CC,
14556,GO:0070124,1.00000000001067,0.828652055567999,0,2,mitochondrial translational initiation,BP,
11065,GO:0045084,1.00000000001068,0.732437041972567,0,3,positive regulation of interleukin-12 biosynthetic process,BP,
6781,GO:0030233,1.0000000000107,0.90716975694261,0,1,deoxynucleotide transmembrane transporter activity,MF,
6827,GO:0030302,1.0000000000107,0.90716975694261,0,1,deoxynucleotide transport,BP,
7128,GO:0030974,1.0000000000107,0.90716975694261,0,1,thiamine pyrophosphate transmembrane transport,BP,
15050,GO:0071045,1.0000000000107,0.90716975694261,0,1,nuclear histone mRNA catabolic process,BP,
15355,GO:0071629,1.0000000000107,0.90716975694261,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
16276,GO:0090422,1.0000000000107,0.90716975694261,0,1,thiamine pyrophosphate transmembrane transporter activity,MF,
10042,GO:0042543,1.00000000001071,0.933993771719913,0,1,protein N-linked glycosylation via arginine,BP,
11943,GO:0047179,1.00000000001072,0.841467719000429,0,2,platelet-activating factor acetyltransferase activity,MF,
19149,GO:1905232,1.00000000001075,0.661146870325974,0,4,cellular response to L-glutamate,BP,
8894,GO:0034751,1.00000000001077,0.743422072125305,0,3,aryl hydrocarbon receptor complex,CC,
2688,GO:0006061,1.00000000001077,0.911335619472876,0,1,sorbitol biosynthetic process,BP,
5980,GO:0018931,1.00000000001077,0.911335619472876,0,1,naphthalene metabolic process,BP,
6129,GO:0019406,1.00000000001077,0.911335619472876,0,1,hexitol biosynthetic process,BP,
10642,GO:0043795,1.00000000001077,0.911335619472876,0,1,glyceraldehyde oxidoreductase activity,MF,
16275,GO:0090420,1.00000000001077,0.911335619472876,0,1,naphthalene-containing compound metabolic process,BP,
1234,GO:0002923,1.00000000001081,0.901998861995134,0,1,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1235,GO:0002924,1.00000000001081,0.901998861995134,0,1,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
9839,GO:0042105,1.00000000001081,0.901998861995134,0,1,alpha-beta T cell receptor complex,CC,
18665,GO:1904045,1.00000000001081,0.902166367790529,0,1,cellular response to aldosterone,BP,
3155,GO:0006772,1.00000000001088,0.905202196321734,0,1,thiamine metabolic process,BP,
9952,GO:0042357,1.00000000001088,0.905202196321734,0,1,thiamine diphosphate metabolic process,BP,
12445,GO:0050333,1.00000000001088,0.905202196321734,0,1,thiamin-triphosphatase activity,MF,
85,GO:0000173,1.0000000000109,0.907074407112229,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
4003,GO:0009000,1.00000000001093,0.901528526707407,0,1,selenocysteine lyase activity,MF,
10430,GO:0043305,1.00000000001093,0.819031235703445,0,2,negative regulation of mast cell degranulation,BP,
14986,GO:0070943,1.00000000001094,0.744019087782665,0,3,neutrophil mediated killing of symbiont cell,BP,
16670,GO:0097647,1.00000000001095,0.759501139746626,0,3,amylin receptor signaling pathway,BP,
8169,GO:0032919,1.00000000001096,0.921666323232123,0,1,spermine acetylation,BP,
8170,GO:0032920,1.00000000001096,0.921666323232123,0,1,putrescine acetylation,BP,
11579,GO:0046204,1.00000000001096,0.921666323232123,0,1,nor-spermidine metabolic process,BP,
12443,GO:0050313,1.00000000001096,0.921666323232123,0,1,sulfur dioxygenase activity,MF,
6258,GO:0019860,1.00000000001096,0.81851396251771,0,2,uracil metabolic process,BP,
17571,GO:1901255,1.00000000001096,0.81851396251771,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
9405,GO:0035989,1.00000000001097,0.662992244138143,0,4,tendon development,BP,
13902,GO:0060592,1.00000000001097,0.662992244138143,0,4,mammary gland formation,BP,
13947,GO:0060685,1.00000000001097,0.662992244138143,0,4,regulation of prostatic bud formation,BP,
13948,GO:0060686,1.00000000001097,0.662992244138143,0,4,negative regulation of prostatic bud formation,BP,
15621,GO:0072161,1.00000000001097,0.662992244138143,0,4,mesenchymal cell differentiation involved in kidney development,BP,
20141,GO:2001012,1.00000000001097,0.662992244138143,0,4,mesenchymal cell differentiation involved in renal system development,BP,
18582,GO:1903892,1.00000000001098,0.812497026062874,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
10493,GO:0043415,1.00000000001099,0.667558752369692,0,4,positive regulation of skeletal muscle tissue regeneration,BP,
10494,GO:0043416,1.00000000001099,0.667558752369692,0,4,regulation of skeletal muscle tissue regeneration,BP,
14359,GO:0061628,1.000000000011,0.812940378797898,0,2,H3K27me3 modified histone binding,MF,
19553,GO:1990635,1.000000000011,0.66184298848864,0,4,proximal dendrite,CC,
5544,GO:0016560,1.000000000011,0.661929076823057,0,4,protein import into peroxisome matrix, docking,BP,
19819,GO:2000318,1.00000000001102,0.735480247956123,0,3,positive regulation of T-helper 17 type immune response,BP,
7282,GO:0031291,1.00000000001103,0.751898816773453,0,3,Ran protein signal transduction,BP,
12244,GO:0048560,1.00000000001103,0.813973685779238,0,2,establishment of anatomical structure orientation,BP,
7080,GO:0030886,1.00000000001104,0.818285008398756,0,2,negative regulation of myeloid dendritic cell activation,BP,
9904,GO:0042268,1.00000000001105,0.68839167691082,0,4,regulation of cytolysis,BP,
6002,GO:0019060,1.0000000000111,0.840677251099623,0,2,intracellular transport of viral protein in host cell,BP,
6942,GO:0030581,1.0000000000111,0.840677251099623,0,2,symbiont intracellular protein transport in host,BP,
13115,GO:0051708,1.0000000000111,0.840677251099623,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
13259,GO:0051977,1.00000000001111,0.902254038594237,0,1,lysophospholipid transport,BP,
13260,GO:0051978,1.00000000001111,0.902254038594237,0,1,lysophospholipid transporter activity,MF,
6855,GO:0030337,1.00000000001112,0.822651485590948,0,2,DNA polymerase processivity factor activity,MF,
13008,GO:0051490,1.00000000001114,0.736245597959866,0,3,negative regulation of filopodium assembly,BP,
1557,GO:0003960,1.00000000001115,0.744431795718225,0,3,NADPH:quinone reductase activity,MF,
19613,GO:1990834,1.00000000001116,0.732556567600383,0,3,response to odorant,BP,
10837,GO:0044355,1.00000000001116,0.910543636812875,0,1,clearance of foreign intracellular DNA,BP,
10838,GO:0044356,1.00000000001116,0.910543636812875,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
16955,GO:0099046,1.00000000001116,0.910543636812875,0,1,clearance of foreign intracellular nucleic acids,BP,
18889,GO:1904627,1.00000000001116,0.910543636812875,0,1,response to phorbol 13-acetate 12-myristate,BP,
18890,GO:1904628,1.00000000001116,0.910543636812875,0,1,cellular response to phorbol 13-acetate 12-myristate,BP,
5347,GO:0016128,1.00000000001117,0.734275111944556,0,3,phytosteroid metabolic process,BP,
5348,GO:0016129,1.00000000001117,0.734275111944556,0,3,phytosteroid biosynthetic process,BP,
15317,GO:0071568,1.00000000001117,0.827086413980894,0,2,UFM1 transferase activity,MF,
4048,GO:0009106,1.00000000001117,0.817287019830914,0,2,lipoate metabolic process,BP,
18229,GO:1903093,1.00000000001117,0.75971889262288,0,3,regulation of protein K48-linked deubiquitination,BP,
16525,GO:0097325,1.00000000001118,0.812474690713099,0,2,melanocyte proliferation,BP,
12374,GO:0048822,1.0000000000112,0.733269298483044,0,3,enucleate erythrocyte development,BP,
14707,GO:0070401,1.00000000001121,0.817937548136191,0,2,NADP+ binding,MF,
2455,GO:0005674,1.00000000001123,0.820621035135867,0,2,transcription factor TFIIF complex,CC,
2056,GO:0004813,1.00000000001123,0.73458410776749,0,3,alanine-tRNA ligase activity,MF,
2901,GO:0006419,1.00000000001123,0.73458410776749,0,3,alanyl-tRNA aminoacylation,BP,
5939,GO:0018293,1.00000000001123,0.915575701455043,0,1,protein-FAD linkage,BP,
2044,GO:0004795,1.00000000001125,0.902607771098556,0,1,threonine synthase activity,MF,
4041,GO:0009088,1.00000000001125,0.902607771098556,0,1,threonine biosynthetic process,BP,
11620,GO:0046360,1.00000000001125,0.902607771098556,0,1,2-oxobutyrate biosynthetic process,BP,
11621,GO:0046361,1.00000000001125,0.902607771098556,0,1,2-oxobutyrate metabolic process,BP,
16180,GO:0090241,1.00000000001125,0.669955767073119,0,4,negative regulation of histone H4 acetylation,BP,
1587,GO:0004001,1.00000000001127,0.902953628475284,0,1,adenosine kinase activity,MF,
1999,GO:0004727,1.00000000001127,0.902953628475284,0,1,prenylated protein tyrosine phosphatase activity,MF,
2751,GO:0006169,1.00000000001127,0.902953628475284,0,1,adenosine salvage,BP,
2755,GO:0006175,1.00000000001127,0.902953628475284,0,1,dATP biosynthetic process,BP,
704,GO:0001928,1.00000000001128,0.901995512582696,0,1,regulation of exocyst assembly,BP,
13634,GO:0060178,1.00000000001128,0.901995512582696,0,1,regulation of exocyst localization,BP,
19719,GO:2000124,1.00000000001128,0.812712163488848,0,2,regulation of endocannabinoid signaling pathway,BP,
19803,GO:2000298,1.00000000001128,0.812712163488848,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
6256,GO:0019858,1.00000000001128,0.830958394273737,0,2,cytosine metabolic process,BP,
14439,GO:0061827,1.00000000001129,0.819292208153347,0,2,sperm head,CC,
1833,GO:0004492,1.0000000000113,0.902602484159046,0,1,methylmalonyl-CoA decarboxylase activity,MF,
19437,GO:1990167,1.0000000000113,0.736563598613293,0,3,protein K27-linked deubiquitination,BP,
19438,GO:1990168,1.0000000000113,0.736563598613293,0,3,protein K33-linked deubiquitination,BP,
15061,GO:0071074,1.0000000000113,0.904026937724611,0,1,eukaryotic initiation factor eIF2 binding,MF,
18486,GO:1903674,1.0000000000113,0.904026937724611,0,1,regulation of cap-dependent translational initiation,BP,
18487,GO:1903676,1.0000000000113,0.904026937724611,0,1,positive regulation of cap-dependent translational initiation,BP,
19917,GO:2000489,1.00000000001136,0.734224107481709,0,3,regulation of hepatic stellate cell activation,BP,
13912,GO:0060605,1.00000000001137,0.744298810605618,0,3,tube lumen cavitation,BP,
13929,GO:0060662,1.00000000001137,0.744298810605618,0,3,salivary gland cavitation,BP,
14039,GO:0060846,1.00000000001142,0.732711759705941,0,3,blood vessel endothelial cell fate commitment,BP,
14040,GO:0060847,1.00000000001142,0.732711759705941,0,3,endothelial cell fate specification,BP,
16412,GO:0097101,1.00000000001142,0.732711759705941,0,3,blood vessel endothelial cell fate specification,BP,
8861,GO:0034685,1.00000000001143,0.812692257277406,0,2,integrin alphav-beta6 complex,CC,
18219,GO:1903059,1.00000000001143,0.667814780078942,0,4,regulation of protein lipidation,BP,
18220,GO:1903061,1.00000000001143,0.667814780078942,0,4,positive regulation of protein lipidation,BP,
2793,GO:0006258,1.00000000001143,0.823459109248506,0,2,UDP-glucose catabolic process,BP,
8604,GO:0034137,1.00000000001144,0.758569353227297,0,3,positive regulation of toll-like receptor 2 signaling pathway,BP,
14184,GO:0061146,1.00000000001146,0.735459083145864,0,3,Peyer's patch morphogenesis,BP,
14290,GO:0061470,1.00000000001146,0.663009229396513,0,4,T follicular helper cell differentiation,BP,
11836,GO:0046848,1.00000000001147,0.911794066170444,0,1,hydroxyapatite binding,MF,
512,GO:0001576,1.00000000001149,0.90275063715596,0,1,globoside biosynthetic process,BP,
1547,GO:0003948,1.00000000001149,0.90275063715596,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
12472,GO:0050512,1.00000000001149,0.90275063715596,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
1806,GO:0004459,1.00000000001149,0.745656877519227,0,3,L-lactate dehydrogenase activity,MF,
15042,GO:0071031,1.00000000001149,0.827383490105999,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
15054,GO:0071049,1.00000000001149,0.827383490105999,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
5483,GO:0016429,1.00000000001152,0.735020462593017,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
14473,GO:0061953,1.00000000001152,0.735020462593017,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
19402,GO:1990034,1.00000000001152,0.735020462593017,0,3,calcium ion export across plasma membrane,BP,
13873,GO:0060545,1.00000000001153,0.814760481066007,0,2,positive regulation of necroptotic process,BP,
2359,GO:0005476,1.00000000001155,0.815204470297097,0,2,carnitine:acyl carnitine antiporter activity,MF,
18514,GO:1903748,1.00000000001156,0.666187607746528,0,4,negative regulation of establishment of protein localization to mitochondrion,BP,
10577,GO:0043564,1.00000000001157,0.813463762149477,0,2,Ku70:Ku80 complex,CC,
388,GO:0001034,1.00000000001157,0.905095838591886,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
15105,GO:0071224,1.00000000001159,0.732403130013326,0,3,cellular response to peptidoglycan,BP,
12656,GO:0050893,1.0000000000116,0.81339492843399,0,2,sensory processing,BP,
15077,GO:0071149,1.00000000001161,0.813357265365941,0,2,TEAD-2-YAP complex,CC,
8483,GO:0033676,1.00000000001162,0.911256920748526,0,1,double-stranded DNA-dependent ATPase activity,MF,
6930,GO:0030550,1.00000000001168,0.744510838459909,0,3,acetylcholine receptor inhibitor activity,MF,
17497,GO:1901004,1.0000000000117,0.914055890788161,0,1,ubiquinone-6 metabolic process,BP,
17498,GO:1901006,1.0000000000117,0.914055890788161,0,1,ubiquinone-6 biosynthetic process,BP,
11637,GO:0046404,1.00000000001172,0.73969609720803,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
13133,GO:0051733,1.00000000001172,0.73969609720803,0,3,polydeoxyribonucleotide kinase activity,MF,
13134,GO:0051734,1.00000000001172,0.73969609720803,0,3,ATP-dependent polynucleotide kinase activity,MF,
14392,GO:0061711,1.00000000001174,0.819394130414164,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
1514,GO:0003877,1.00000000001175,0.902631750953396,0,1,ATP adenylyltransferase activity,MF,
2067,GO:0004824,1.00000000001175,0.902631750953396,0,1,lysine-tRNA ligase activity,MF,
2912,GO:0006430,1.00000000001175,0.902631750953396,0,1,lysyl-tRNA aminoacylation,BP,
3414,GO:0007207,1.0000000000118,0.813496135251723,0,2,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
7844,GO:0032416,1.00000000001181,0.903294242666405,0,1,negative regulation of sodium:proton antiporter activity,BP,
16515,GO:0097291,1.00000000001181,0.903294242666405,0,1,renal phosphate ion absorption,BP,
293,GO:0000798,1.00000000001182,0.732743346986409,0,3,nuclear cohesin complex,CC,
7085,GO:0030893,1.00000000001182,0.732743346986409,0,3,meiotic cohesin complex,CC,
8521,GO:0033860,1.00000000001182,0.772970960570718,0,3,regulation of NAD(P)H oxidase activity,BP,
8523,GO:0033864,1.00000000001182,0.772970960570718,0,3,positive regulation of NAD(P)H oxidase activity,BP,
5367,GO:0016191,1.00000000001183,0.660219920692262,0,4,synaptic vesicle uncoating,BP,
4116,GO:0009184,1.00000000001183,0.909181037748057,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,
4124,GO:0009192,1.00000000001183,0.909181037748057,0,1,deoxyribonucleoside diphosphate catabolic process,BP,
10943,GO:0044716,1.00000000001183,0.909181037748057,0,1,8-oxo-GDP phosphatase activity,MF,
10944,GO:0044717,1.00000000001183,0.909181037748057,0,1,8-hydroxy-dADP phosphatase activity,MF,
11510,GO:0046057,1.00000000001183,0.909181037748057,0,1,dADP catabolic process,BP,
11516,GO:0046067,1.00000000001183,0.909181037748057,0,1,dGDP catabolic process,BP,
11796,GO:0046712,1.00000000001183,0.909181037748057,0,1,GDP catabolic process,BP,
5999,GO:0019050,1.00000000001184,0.746190811211832,0,3,suppression by virus of host apoptotic process,BP,
9745,GO:0039526,1.00000000001184,0.746190811211832,0,3,modulation by virus of host apoptotic process,BP,
12359,GO:0048787,1.00000000001186,0.661022685190935,0,4,presynaptic active zone membrane,CC,
19214,GO:1905394,1.0000000000119,0.733040436997859,0,3,retromer complex binding,MF,
3256,GO:0006933,1.00000000001192,0.816629743929065,0,2,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
12553,GO:0050733,1.00000000001192,0.663099495199191,0,4,RS domain binding,MF,
6030,GO:0019135,1.00000000001194,0.904258828889738,0,1,deoxyhypusine monooxygenase activity,MF,
4408,GO:0010193,1.00000000001194,0.814091210108248,0,2,response to ozone,BP,
13480,GO:0055077,1.00000000001196,0.812475008941943,0,2,gap junction hemi-channel activity,MF,
9309,GO:0035801,1.00000000001197,0.815983501303984,0,2,adrenal cortex development,BP,
9310,GO:0035802,1.00000000001197,0.815983501303984,0,2,adrenal cortex formation,BP,
7866,GO:0032440,1.00000000001201,0.914523920288693,0,1,2-alkenal reductase [NAD(P)] activity,MF,
19301,GO:1905636,1.00000000001201,0.914523920288693,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
1323,GO:0003176,1.00000000001201,0.668586821322996,0,4,aortic valve development,BP,
1326,GO:0003180,1.00000000001201,0.668586821322996,0,4,aortic valve morphogenesis,BP,
1789,GO:0004422,1.00000000001201,0.823475329111304,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
2757,GO:0006178,1.00000000001201,0.823475329111304,0,2,guanine salvage,BP,
7737,GO:0032263,1.00000000001201,0.823475329111304,0,2,GMP salvage,BP,
11535,GO:0046099,1.00000000001201,0.823475329111304,0,2,guanine biosynthetic process,BP,
5083,GO:0015367,1.00000000001202,0.905374245772732,0,1,oxoglutarate:malate antiporter activity,MF,
5170,GO:0015742,1.00000000001202,0.905374245772732,0,1,alpha-ketoglutarate transport,BP,
8430,GO:0033566,1.00000000001202,0.81267349604464,0,2,gamma-tubulin complex localization,BP,
1264,GO:0003032,1.00000000001203,0.813037406506535,0,2,detection of oxygen,BP,
14760,GO:0070492,1.00000000001205,0.685326646689707,0,4,oligosaccharide binding,MF,
11957,GO:0047277,1.00000000001207,0.903713175012009,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
14395,GO:0061723,1.00000000001207,0.812631379372734,0,2,glycophagy,BP,
20173,GO:2001069,1.00000000001207,0.812631379372734,0,2,glycogen binding,MF,
20174,GO:2001070,1.00000000001207,0.812631379372734,0,2,starch binding,MF,
1091,GO:0002679,1.00000000001209,0.751994689476836,0,3,respiratory burst involved in defense response,BP,
6233,GO:0019808,1.0000000000121,0.762358984831939,0,3,polyamine binding,MF,
1952,GO:0004660,1.00000000001211,0.818257098033588,0,2,protein farnesyltransferase activity,MF,
2628,GO:0005965,1.00000000001211,0.818257098033588,0,2,protein farnesyltransferase complex,CC,
9248,GO:0035674,1.00000000001211,0.818257098033588,0,2,tricarboxylic acid transmembrane transport,BP,
16046,GO:0090034,1.00000000001211,0.818257098033588,0,2,regulation of chaperone-mediated protein complex assembly,BP,
16047,GO:0090035,1.00000000001211,0.818257098033588,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
5952,GO:0018350,1.00000000001211,0.90165100723093,0,1,protein esterification,BP,
10771,GO:0044258,1.00000000001211,0.90165100723093,0,1,intestinal lipid catabolic process,BP,
9964,GO:0042374,1.00000000001211,0.827398545365335,0,2,phylloquinone metabolic process,BP,
9965,GO:0042376,1.00000000001211,0.827398545365335,0,2,phylloquinone catabolic process,BP,
17706,GO:1901662,1.00000000001211,0.827398545365335,0,2,quinone catabolic process,BP,
14710,GO:0070404,1.00000000001213,0.753321487510198,0,3,NADH binding,MF,
13160,GO:0051793,1.00000000001213,0.733571636440951,0,3,medium-chain fatty acid catabolic process,BP,
16352,GO:0090724,1.00000000001213,0.662717958697855,0,4,central region of growth cone,CC,
2062,GO:0004819,1.00000000001214,0.812632676992234,0,2,glutamine-tRNA ligase activity,MF,
2907,GO:0006425,1.00000000001214,0.812632676992234,0,2,glutaminyl-tRNA aminoacylation,BP,
18442,GO:1903567,1.00000000001214,0.812759383405677,0,2,regulation of protein localization to ciliary membrane,BP,
5968,GO:0018479,1.00000000001216,0.902672407594897,0,1,benzaldehyde dehydrogenase (NAD+) activity,MF,
2064,GO:0004821,1.00000000001217,0.814525356425747,0,2,histidine-tRNA ligase activity,MF,
2909,GO:0006427,1.00000000001217,0.814525356425747,0,2,histidyl-tRNA aminoacylation,BP,
18395,GO:1903487,1.00000000001218,0.815806181891668,0,2,regulation of lactation,BP,
13747,GO:0060353,1.00000000001221,0.741724848032413,0,3,regulation of cell adhesion molecule production,BP,
13748,GO:0060355,1.00000000001221,0.741724848032413,0,3,positive regulation of cell adhesion molecule production,BP,
12446,GO:0050337,1.00000000001222,0.93282847653517,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
18458,GO:1903593,1.00000000001223,0.754112364308606,0,3,regulation of histamine secretion by mast cell,BP,
18459,GO:1903595,1.00000000001223,0.754112364308606,0,3,positive regulation of histamine secretion by mast cell,BP,
11361,GO:0045759,1.00000000001225,0.82061810587564,0,2,negative regulation of action potential,BP,
221,GO:0000461,1.00000000001225,0.861501880213055,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
19496,GO:1990415,1.00000000001228,0.734379612406024,0,3,Pex17p-Pex14p docking complex,CC,
19504,GO:1990429,1.00000000001228,0.734379612406024,0,3,peroxisomal importomer complex,CC,
2110,GO:0004900,1.00000000001228,0.904603714029137,0,1,erythropoietin receptor activity,MF,
9705,GO:0038162,1.00000000001228,0.904603714029137,0,1,erythropoietin-mediated signaling pathway,BP,
2224,GO:0005132,1.00000000001228,0.834795730575496,0,2,type I interferon receptor binding,MF,
13943,GO:0060678,1.00000000001229,0.901982235472117,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
15602,GO:0072127,1.00000000001229,0.901982235472117,0,1,renal capsule development,BP,
15603,GO:0072128,1.00000000001229,0.901982235472117,0,1,renal capsule morphogenesis,BP,
15604,GO:0072129,1.00000000001229,0.901982235472117,0,1,renal capsule formation,BP,
15605,GO:0072130,1.00000000001229,0.901982235472117,0,1,renal capsule specification,BP,
15659,GO:0072213,1.00000000001229,0.901982235472117,0,1,metanephric capsule development,BP,
15684,GO:0072265,1.00000000001229,0.901982235472117,0,1,metanephric capsule morphogenesis,BP,
15685,GO:0072266,1.00000000001229,0.901982235472117,0,1,metanephric capsule formation,BP,
15686,GO:0072267,1.00000000001229,0.901982235472117,0,1,metanephric capsule specification,BP,
3213,GO:0006868,1.00000000001231,0.661935419783805,0,4,glutamine transport,BP,
5013,GO:0015186,1.00000000001231,0.661935419783805,0,4,L-glutamine transmembrane transporter activity,MF,
14021,GO:0060809,1.00000000001232,0.812476193862091,0,2,mesodermal to mesenchymal transition involved in gastrulation,BP,
4643,GO:0010796,1.00000000001233,0.747126413887267,0,3,regulation of multivesicular body size,BP,
2785,GO:0006231,1.00000000001233,0.739327572352832,0,3,dTMP biosynthetic process,BP,
11521,GO:0046073,1.00000000001233,0.739327572352832,0,3,dTMP metabolic process,BP,
19702,GO:2000097,1.0000000000124,0.812553804000938,0,2,regulation of smooth muscle cell-matrix adhesion,BP,
1366,GO:0003253,1.0000000000124,0.663505531314945,0,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
4156,GO:0009227,1.00000000001242,0.742234912846257,0,3,nucleotide-sugar catabolic process,BP,
9545,GO:0036343,1.00000000001242,0.842047484747136,0,2,psychomotor behavior,BP,
2233,GO:0005146,1.00000000001244,0.817492094093624,0,2,leukemia inhibitory factor receptor binding,MF,
19918,GO:2000490,1.00000000001245,0.814572422193857,0,2,negative regulation of hepatic stellate cell activation,BP,
2676,GO:0006046,1.00000000001247,0.737604538174464,0,3,N-acetylglucosamine catabolic process,BP,
1498,GO:0003846,1.00000000001248,0.812623742613568,0,2,2-acylglycerol O-acyltransferase activity,MF,
1676,GO:0004144,1.00000000001248,0.812623742613568,0,2,diacylglycerol O-acyltransferase activity,MF,
12433,GO:0050252,1.00000000001248,0.812623742613568,0,2,retinol O-fatty-acyltransferase activity,MF,
15214,GO:0071400,1.00000000001248,0.812623742613568,0,2,cellular response to oleic acid,BP,
2993,GO:0006546,1.00000000001248,0.740073025785722,0,3,glycine catabolic process,BP,
6143,GO:0019464,1.00000000001248,0.740073025785722,0,3,glycine decarboxylation via glycine cleavage system,BP,
4864,GO:0014735,1.00000000001248,0.82184607881044,0,2,regulation of muscle atrophy,BP,
4865,GO:0014736,1.00000000001248,0.82184607881044,0,2,negative regulation of muscle atrophy,BP,
9308,GO:0035800,1.00000000001248,0.82184607881044,0,2,deubiquitinase activator activity,MF,
19733,GO:2000158,1.00000000001248,0.82184607881044,0,2,positive regulation of ubiquitin-specific protease activity,BP,
7173,GO:0031071,1.0000000000125,0.901672906643278,0,1,cysteine desulfurase activity,MF,
1897,GO:0004586,1.0000000000125,0.733543733420926,0,3,ornithine decarboxylase activity,MF,
8398,GO:0033387,1.0000000000125,0.733543733420926,0,3,putrescine biosynthetic process from ornithine,BP,
10902,GO:0044530,1.0000000000125,0.733543733420926,0,3,supraspliceosomal complex,CC,
16092,GO:0090108,1.00000000001252,0.902855774170689,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
16139,GO:0090187,1.00000000001252,0.902855774170689,0,1,positive regulation of pancreatic juice secretion,BP,
16246,GO:0090340,1.00000000001252,0.902855774170689,0,1,positive regulation of secretion of lysosomal enzymes,BP,
17130,GO:0102522,1.00000000001257,0.902158523707524,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
10699,GO:0044035,1.00000000001257,0.907266040212986,0,1,multi-organism catabolic process,BP,
10726,GO:0044115,1.00000000001257,0.907266040212986,0,1,development of symbiont involved in interaction with host,BP,
10733,GO:0044145,1.00000000001257,0.907266040212986,0,1,modulation of development of symbiont involved in interaction with host,BP,
10735,GO:0044147,1.00000000001257,0.907266040212986,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
10950,GO:0044730,1.00000000001257,0.907266040212986,0,1,bone sialoprotein binding,MF,
13298,GO:0052214,1.00000000001257,0.907266040212986,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
13299,GO:0052227,1.00000000001257,0.907266040212986,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
13300,GO:0052229,1.00000000001257,0.907266040212986,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
13312,GO:0052360,1.00000000001257,0.907266040212986,0,1,catabolism by host of symbiont macromolecule,BP,
13313,GO:0052361,1.00000000001257,0.907266040212986,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
13314,GO:0052362,1.00000000001257,0.907266040212986,0,1,catabolism by host of symbiont protein,BP,
13315,GO:0052363,1.00000000001257,0.907266040212986,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13316,GO:0052364,1.00000000001257,0.907266040212986,0,1,catabolism by host of substance in symbiont,BP,
13320,GO:0052416,1.00000000001257,0.907266040212986,0,1,metabolism by host of symbiont macromolecule,BP,
13321,GO:0052417,1.00000000001257,0.907266040212986,0,1,metabolism by host of symbiont protein,BP,
13322,GO:0052418,1.00000000001257,0.907266040212986,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13323,GO:0052419,1.00000000001257,0.907266040212986,0,1,metabolism by host of substance in symbiont,BP,
19284,GO:1905581,1.00000000001257,0.907266040212986,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
19289,GO:1905597,1.00000000001257,0.907266040212986,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
19291,GO:1905599,1.00000000001257,0.907266040212986,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
10128,GO:0042720,1.00000000001262,0.842200341008092,0,2,mitochondrial inner membrane peptidase complex,CC,
2366,GO:0005499,1.00000000001265,0.813878219673439,0,2,vitamin D binding,MF,
13545,GO:0060040,1.00000000001265,0.813878219673439,0,2,retinal bipolar neuron differentiation,BP,
7375,GO:0031439,1.00000000001265,0.812667490869479,0,2,positive regulation of mRNA cleavage,BP,
18929,GO:1904720,1.00000000001265,0.812667490869479,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
19271,GO:1905553,1.00000000001265,0.746336725577509,0,3,regulation of blood vessel branching,BP,
526,GO:0001635,1.00000000001265,0.750135559040224,0,3,calcitonin gene-related peptide receptor activity,MF,
16666,GO:0097642,1.00000000001265,0.750135559040224,0,3,calcitonin family receptor activity,MF,
18475,GO:1903644,1.00000000001265,0.841564132697079,0,2,regulation of chaperone-mediated protein folding,BP,
4581,GO:0010698,1.00000000001269,0.841505809679139,0,2,acetyltransferase activator activity,MF,
17120,GO:0102485,1.0000000000127,0.812474694187566,0,2,dATP phosphohydrolase activity,MF,
17121,GO:0102486,1.0000000000127,0.812474694187566,0,2,dCTP phosphohydrolase activity,MF,
17122,GO:0102487,1.0000000000127,0.812474694187566,0,2,dUTP phosphohydrolase activity,MF,
17123,GO:0102488,1.0000000000127,0.812474694187566,0,2,dTTP phosphohydrolase activity,MF,
17124,GO:0102489,1.0000000000127,0.812474694187566,0,2,GTP phosphohydrolase activity,MF,
17125,GO:0102490,1.0000000000127,0.812474694187566,0,2,8-oxo-dGTP phosphohydrolase activity,MF,
17126,GO:0102491,1.0000000000127,0.812474694187566,0,2,dGTP phosphohydrolase activity,MF,
18807,GO:1904426,1.0000000000127,0.812474694187566,0,2,positive regulation of GTP binding,BP,
5522,GO:0016509,1.00000000001271,0.73307447052588,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
19156,GO:1905258,1.00000000001272,0.838357424455182,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19157,GO:1905259,1.00000000001272,0.838357424455182,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
3840,GO:0008459,1.00000000001273,0.81289635867108,0,2,chondroitin 6-sulfotransferase activity,MF,
16134,GO:0090182,1.00000000001273,0.820223710252942,0,2,regulation of secretion of lysosomal enzymes,BP,
12305,GO:0048680,1.00000000001277,0.675169196010842,0,4,positive regulation of axon regeneration,BP,
14807,GO:0070572,1.00000000001277,0.675169196010842,0,4,positive regulation of neuron projection regeneration,BP,
7892,GO:0032472,1.00000000001277,0.814457665099029,0,2,Golgi calcium ion transport,BP,
4363,GO:0009992,1.00000000001277,0.90229694096336,0,1,cellular water homeostasis,BP,
103,GO:0000215,1.0000000000128,0.829742032169921,0,2,tRNA 2'-phosphotransferase activity,MF,
13833,GO:0060474,1.0000000000128,0.84435767607031,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
19577,GO:1990742,1.0000000000128,0.84435767607031,0,2,microvesicle,CC,
19494,GO:1990410,1.0000000000128,0.820668970494039,0,2,adrenomedullin receptor signaling pathway,BP,
2352,GO:0005456,1.00000000001285,0.904991479374287,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
5183,GO:0015782,1.00000000001285,0.904991479374287,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
16695,GO:0097724,1.00000000001285,0.904825449081947,0,1,sperm flagellum movement,BP,
19224,GO:1905419,1.00000000001285,0.904825449081947,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
3721,GO:0008263,1.00000000001286,0.812602329115161,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
1161,GO:0002775,1.00000000001289,0.742097193846847,0,3,antimicrobial peptide production,BP,
1162,GO:0002778,1.00000000001289,0.742097193846847,0,3,antibacterial peptide production,BP,
1163,GO:0002784,1.00000000001289,0.742097193846847,0,3,regulation of antimicrobial peptide production,BP,
1165,GO:0002786,1.00000000001289,0.742097193846847,0,3,regulation of antibacterial peptide production,BP,
5969,GO:0018585,1.00000000001289,0.902373053276538,0,1,fluorene oxygenase activity,MF,
5979,GO:0018917,1.00000000001289,0.902373053276538,0,1,fluorene metabolic process,BP,
15826,GO:0072572,1.00000000001289,0.902480105376894,0,1,poly-ADP-D-ribose binding,MF,
7367,GO:0031431,1.00000000001294,0.812474684634285,0,2,Dbf4-dependent protein kinase complex,CC,
4604,GO:0010731,1.00000000001295,0.901758732062106,0,1,protein glutathionylation,BP,
4605,GO:0010732,1.00000000001295,0.901758732062106,0,1,regulation of protein glutathionylation,BP,
4606,GO:0010734,1.00000000001295,0.901758732062106,0,1,negative regulation of protein glutathionylation,BP,
18044,GO:1902636,1.00000000001295,0.83052938357972,0,2,kinociliary basal body,CC,
3025,GO:0006580,1.00000000001296,0.901383905765531,0,1,ethanolamine metabolic process,BP,
18250,GO:1903165,1.00000000001296,0.901383905765531,0,1,response to polycyclic arene,BP,
18905,GO:1904681,1.00000000001296,0.901383905765531,0,1,response to 3-methylcholanthrene,BP,
7958,GO:0032581,1.00000000001296,0.904659499893457,0,1,ER-dependent peroxisome organization,BP,
17195,GO:0106101,1.00000000001296,0.904659499893457,0,1,ER-dependent peroxisome localization,BP,
16027,GO:0086098,1.00000000001297,0.812483805303451,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17795,GO:1901979,1.00000000001297,0.812483805303451,0,2,regulation of inward rectifier potassium channel activity,BP,
4876,GO:0014806,1.00000000001297,0.819169228107722,0,2,smooth muscle hyperplasia,BP,
1596,GO:0004018,1.00000000001299,0.909875468510371,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
14830,GO:0070626,1.00000000001299,0.909875468510371,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
2497,GO:0005753,1.000000000013,0.902226881538526,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
4685,GO:0010849,1.000000000013,0.902226881538526,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
19790,GO:2000276,1.000000000013,0.902226881538526,0,1,negative regulation of oxidative phosphorylation uncoupler activity,BP,
1503,GO:0003860,1.00000000001304,0.903875240368664,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
13136,GO:0051747,1.00000000001304,0.837619362227033,0,2,cytosine C-5 DNA demethylase activity,MF,
2625,GO:0005958,1.00000000001304,0.736873581553486,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
8294,GO:0033142,1.00000000001305,0.902247720884272,0,1,progesterone receptor binding,MF,
6087,GO:0019303,1.00000000001308,0.838379992482639,0,2,D-ribose catabolic process,BP,
2879,GO:0006391,1.00000000001308,0.737529382952175,0,3,transcription initiation from mitochondrial promoter,BP,
14117,GO:0061015,1.00000000001308,0.832832426578314,0,2,snRNA import into nucleus,BP,
17448,GO:1900368,1.0000000000131,0.766410953299044,0,3,regulation of RNA interference,BP,
6339,GO:0021524,1.00000000001312,0.815884733328886,0,2,visceral motor neuron differentiation,BP,
3003,GO:0006556,1.00000000001313,0.813730125311663,0,2,S-adenosylmethionine biosynthetic process,BP,
12138,GO:0048269,1.00000000001313,0.813730125311663,0,2,methionine adenosyltransferase complex,CC,
1226,GO:0002904,1.00000000001313,0.757342008011327,0,3,positive regulation of B cell apoptotic process,BP,
16116,GO:0090155,1.00000000001314,0.670241918818505,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17332,GO:1900060,1.00000000001314,0.670241918818505,0,4,negative regulation of ceramide biosynthetic process,BP,
19509,GO:1990442,1.00000000001314,0.773959824548565,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
11787,GO:0046695,1.00000000001315,0.744033775138613,0,3,SLIK (SAGA-like) complex,CC,
4486,GO:0010521,1.00000000001315,0.747008612716409,0,3,telomerase inhibitor activity,MF,
8165,GO:0032915,1.00000000001315,0.902591955842605,0,1,positive regulation of transforming growth factor beta2 production,BP,
1601,GO:0004027,1.00000000001315,0.91509106258058,0,1,alcohol sulfotransferase activity,MF,
4599,GO:0010726,1.00000000001316,0.814064715268879,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
17776,GO:1901896,1.00000000001317,0.820618501319737,0,2,positive regulation of calcium-transporting ATPase activity,BP,
7372,GO:0031436,1.00000000001318,0.812505950804824,0,2,BRCA1-BARD1 complex,CC,
2057,GO:0004814,1.00000000001322,0.736413678616837,0,3,arginine-tRNA ligase activity,MF,
2902,GO:0006420,1.00000000001322,0.736413678616837,0,3,arginyl-tRNA aminoacylation,BP,
3597,GO:0008043,1.00000000001323,0.845823933001511,0,2,intracellular ferritin complex,CC,
14649,GO:0070288,1.00000000001323,0.845823933001511,0,2,ferritin complex,CC,
18978,GO:1904815,1.00000000001324,0.814783777677823,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
3996,GO:0008962,1.00000000001324,0.814252659794082,0,2,phosphatidylglycerophosphatase activity,MF,
19750,GO:2000195,1.00000000001324,0.814638881919508,0,2,negative regulation of female gonad development,BP,
8282,GO:0033128,1.00000000001324,0.814803305174209,0,2,negative regulation of histone phosphorylation,BP,
19489,GO:1990405,1.00000000001326,0.660312551483714,0,4,protein antigen binding,MF,
8,GO:0000015,1.00000000001326,0.904937349631986,0,1,phosphopyruvate hydratase complex,CC,
1931,GO:0004634,1.00000000001326,0.904937349631986,0,1,phosphopyruvate hydratase activity,MF,
17129,GO:0102521,1.00000000001327,0.812723436105764,0,2,tRNA-4-demethylwyosine synthase activity,MF,
168,GO:0000350,1.00000000001327,0.740656067339397,0,3,generation of catalytic spliceosome for second transesterification step,BP,
1242,GO:0002944,1.00000000001327,0.812985937363661,0,2,cyclin K-CDK12 complex,CC,
1243,GO:0002945,1.00000000001327,0.812985937363661,0,2,cyclin K-CDK13 complex,CC,
10208,GO:0042904,1.00000000001328,0.812502140543196,0,2,9-cis-retinoic acid biosynthetic process,BP,
10209,GO:0042905,1.00000000001328,0.812502140543196,0,2,9-cis-retinoic acid metabolic process,BP,
14810,GO:0070576,1.00000000001328,0.812502140543196,0,2,vitamin D 24-hydroxylase activity,MF,
16169,GO:0090226,1.0000000000133,0.925455855376701,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
1565,GO:0003975,1.0000000000133,0.902455683203736,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
3997,GO:0008963,1.0000000000133,0.902455683203736,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
1710,GO:0004305,1.00000000001331,0.664456643222398,0,4,ethanolamine kinase activity,MF,
11976,GO:0047408,1.00000000001334,0.816423446842286,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
11977,GO:0047409,1.00000000001334,0.816423446842286,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
14964,GO:0070903,1.00000000001336,0.90355441700792,0,1,mitochondrial tRNA thio-modification,BP,
4423,GO:0010266,1.00000000001338,0.753556592560012,0,3,response to vitamin B1,BP,
6879,GO:0030423,1.00000000001342,0.669985373970544,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
8963,GO:0035087,1.00000000001342,0.669985373970544,0,4,siRNA loading onto RISC involved in RNA interference,BP,
16537,GO:0097350,1.00000000001342,0.740360746365553,0,3,neutrophil clearance,BP,
10444,GO:0043321,1.00000000001343,0.812537794207241,0,2,regulation of natural killer cell degranulation,BP,
10445,GO:0043323,1.00000000001343,0.812537794207241,0,2,positive regulation of natural killer cell degranulation,BP,
13966,GO:0060708,1.00000000001345,0.742529286286776,0,3,spongiotrophoblast differentiation,BP,
18091,GO:1902775,1.00000000001345,0.732366365498588,0,3,mitochondrial large ribosomal subunit assembly,BP,
10351,GO:0043185,1.00000000001348,0.902796725441293,0,1,vascular endothelial growth factor receptor 3 binding,MF,
14829,GO:0070625,1.00000000001348,0.902796725441293,0,1,zymogen granule exocytosis,BP,
7762,GO:0032298,1.00000000001349,0.902048799026243,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
16430,GO:0097123,1.00000000001349,0.902048799026243,0,1,cyclin A1-CDK2 complex,CC,
18093,GO:1902804,1.00000000001349,0.734869248814098,0,3,negative regulation of synaptic vesicle transport,BP,
19806,GO:2000301,1.00000000001349,0.734869248814098,0,3,negative regulation of synaptic vesicle exocytosis,BP,
6006,GO:0019065,1.0000000000135,0.732341348059806,0,3,receptor-mediated endocytosis of virus by host cell,BP,
15926,GO:0075509,1.0000000000135,0.732341348059806,0,3,endocytosis involved in viral entry into host cell,BP,
6846,GO:0030327,1.00000000001352,0.732385076902818,0,3,prenylated protein catabolic process,BP,
5521,GO:0016508,1.00000000001353,0.732338383318251,0,3,long-chain-enoyl-CoA hydratase activity,MF,
19216,GO:1905397,1.00000000001356,0.821078081305137,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19217,GO:1905402,1.00000000001356,0.821078081305137,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
5077,GO:0015333,1.00000000001356,0.732333150978039,0,3,peptide:proton symporter activity,MF,
3722,GO:0008265,1.00000000001359,0.901379590511208,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
17145,GO:0102867,1.00000000001359,0.901379590511208,0,1,molybdenum cofactor sulfurtransferase activity,MF,
1828,GO:0004487,1.00000000001359,0.733165514341011,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
7412,GO:0031523,1.00000000001363,0.812477090547663,0,2,Myb complex,CC,
11610,GO:0046338,1.00000000001363,0.812477090547663,0,2,phosphatidylethanolamine catabolic process,BP,
16217,GO:0090298,1.00000000001367,0.732335924119325,0,3,negative regulation of mitochondrial DNA replication,BP,
17761,GO:1901859,1.00000000001367,0.732335924119325,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
3859,GO:0008493,1.00000000001368,0.904479295120911,0,1,tetracycline transmembrane transporter activity,MF,
5252,GO:0015904,1.00000000001368,0.904479295120911,0,1,tetracycline transport,BP,
12667,GO:0050910,1.00000000001368,0.812506394718416,0,2,detection of mechanical stimulus involved in sensory perception of sound,BP,
13190,GO:0051877,1.00000000001368,0.812506394718416,0,2,pigment granule aggregation in cell center,BP,
16542,GO:0097360,1.00000000001368,0.812506394718416,0,2,chorionic trophoblast cell proliferation,BP,
17620,GO:1901382,1.00000000001368,0.812506394718416,0,2,regulation of chorionic trophoblast cell proliferation,BP,
16631,GO:0097534,1.00000000001369,0.812479563919777,0,2,lymphoid lineage cell migration,BP,
16632,GO:0097535,1.00000000001369,0.812479563919777,0,2,lymphoid lineage cell migration into thymus,BP,
5963,GO:0018423,1.0000000000137,0.823517646174532,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
15072,GO:0071139,1.00000000001377,0.812503374049993,0,2,resolution of recombination intermediates,BP,
15073,GO:0071140,1.00000000001377,0.812503374049993,0,2,resolution of mitotic recombination intermediates,BP,
5824,GO:0017116,1.00000000001377,0.732342733136473,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
3527,GO:0007525,1.00000000001378,0.812510098232884,0,2,somatic muscle development,BP,
19906,GO:2000466,1.00000000001379,0.733060560473442,0,3,negative regulation of glycogen (starch) synthase activity,BP,
10915,GO:0044565,1.00000000001379,0.820685960926951,0,2,dendritic cell proliferation,BP,
14006,GO:0060763,1.00000000001381,0.812658711816747,0,2,mammary duct terminal end bud growth,BP,
18634,GO:1903977,1.00000000001381,0.812658711816747,0,2,positive regulation of glial cell migration,BP,
209,GO:0000438,1.00000000001386,0.74445027647497,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
8207,GO:0032980,1.00000000001387,0.901601909594745,0,1,keratinocyte activation,BP,
14452,GO:0061880,1.00000000001389,0.906352330957854,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
14453,GO:0061881,1.00000000001389,0.906352330957854,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
8885,GO:0034722,1.00000000001393,0.909658507501732,0,1,gamma-glutamyl-peptidase activity,MF,
1559,GO:0003963,1.00000000001393,0.813328882563316,0,2,RNA-3'-phosphate cyclase activity,MF,
4352,GO:0009957,1.00000000001394,0.812780100366904,0,2,epidermal cell fate specification,BP,
13841,GO:0060486,1.00000000001394,0.812780100366904,0,2,Clara cell differentiation,BP,
14038,GO:0060844,1.00000000001394,0.812780100366904,0,2,arterial endothelial cell fate commitment,BP,
17548,GO:1901187,1.00000000001394,0.812780100366904,0,2,regulation of ephrin receptor signaling pathway,BP,
1863,GO:0004531,1.00000000001394,0.903258864396201,0,1,deoxyribonuclease II activity,MF,
15502,GO:0071920,1.00000000001397,0.814085106661228,0,2,cleavage body,CC,
18624,GO:1903964,1.00000000001398,0.812510338818893,0,2,monounsaturated fatty acid metabolic process,BP,
18625,GO:1903966,1.00000000001398,0.812510338818893,0,2,monounsaturated fatty acid biosynthetic process,BP,
15019,GO:0070992,1.00000000001398,0.846933636127518,0,2,translation initiation complex,CC,
4840,GO:0014062,1.00000000001399,0.826059092499128,0,2,regulation of serotonin secretion,BP,
7722,GO:0032229,1.00000000001399,0.826059092499128,0,2,negative regulation of synaptic transmission, GABAergic,BP,
5453,GO:0016344,1.00000000001403,0.812477338394904,0,2,meiotic chromosome movement towards spindle pole,BP,
14181,GO:0061140,1.00000000001404,0.753126163893154,0,3,lung secretory cell differentiation,BP,
1517,GO:0003881,1.00000000001404,0.904377298153556,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
5534,GO:0016533,1.00000000001406,0.826481437583593,0,2,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
18790,GO:1904383,1.00000000001409,0.902393881749618,0,1,response to sodium phosphate,BP,
18871,GO:1904585,1.00000000001409,0.902393881749618,0,1,response to putrescine,BP,
18872,GO:1904586,1.00000000001409,0.902393881749618,0,1,cellular response to putrescine,BP,
19609,GO:1990828,1.00000000001409,0.902393881749618,0,1,hepatocyte dedifferentiation,BP,
8083,GO:0032782,1.00000000001412,0.816031454111276,0,2,bile acid secretion,BP,
8568,GO:0034066,1.00000000001415,0.823370998287459,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
1349,GO:0003219,1.00000000001416,0.817105650556569,0,2,cardiac right ventricle formation,BP,
12763,GO:0051083,1.00000000001422,0.816728285853833,0,2,'de novo' cotranslational protein folding,BP,
5758,GO:0016942,1.00000000001422,0.830764534813065,0,2,insulin-like growth factor binding protein complex,CC,
9580,GO:0036454,1.00000000001422,0.830764534813065,0,2,growth factor complex,CC,
1534,GO:0003921,1.00000000001422,0.901529834770997,0,1,GMP synthase activity,MF,
1535,GO:0003922,1.00000000001422,0.901529834770997,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
11792,GO:0046707,1.00000000001423,0.819267733190968,0,2,IDP metabolic process,BP,
11793,GO:0046709,1.00000000001423,0.819267733190968,0,2,IDP catabolic process,BP,
7339,GO:0031392,1.00000000001427,0.667326818372303,0,4,regulation of prostaglandin biosynthetic process,BP,
8239,GO:0033031,1.00000000001427,0.667326818372303,0,4,positive regulation of neutrophil apoptotic process,BP,
20267,GO:2001279,1.00000000001427,0.667326818372303,0,4,regulation of unsaturated fatty acid biosynthetic process,BP,
6725,GO:0030151,1.00000000001427,0.66038224860646,0,4,molybdenum ion binding,MF,
15908,GO:0072737,1.0000000000143,0.813426488782198,0,2,response to diamide,BP,
15909,GO:0072738,1.0000000000143,0.813426488782198,0,2,cellular response to diamide,BP,
9143,GO:0035514,1.00000000001432,0.754999530891677,0,3,DNA demethylase activity,MF,
8561,GO:0034056,1.00000000001432,0.732464136398653,0,3,estrogen response element binding,MF,
9408,GO:0035993,1.00000000001433,0.736121609692347,0,3,deltoid tuberosity development,BP,
14238,GO:0061325,1.00000000001433,0.736121609692347,0,3,cell proliferation involved in outflow tract morphogenesis,BP,
5399,GO:0016250,1.00000000001433,0.901378274686573,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5690,GO:0016826,1.00000000001433,0.901378274686573,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
18471,GO:1903630,1.00000000001434,0.915320912545497,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
18472,GO:1903632,1.00000000001434,0.915320912545497,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
2626,GO:0005960,1.00000000001437,0.819722257590339,0,2,glycine cleavage complex,CC,
304,GO:0000814,1.00000000001443,0.757525216194163,0,3,ESCRT II complex,CC,
15893,GO:0072706,1.00000000001444,0.901429864590633,0,1,response to sodium dodecyl sulfate,BP,
15894,GO:0072707,1.00000000001444,0.901429864590633,0,1,cellular response to sodium dodecyl sulfate,BP,
6869,GO:0030377,1.00000000001444,0.910638466685126,0,1,urokinase plasminogen activator receptor activity,MF,
9723,GO:0038195,1.00000000001444,0.910638466685126,0,1,urokinase plasminogen activator signaling pathway,BP,
20111,GO:2000833,1.00000000001445,0.753081084127668,0,3,positive regulation of steroid hormone secretion,BP,
10241,GO:0042997,1.00000000001446,0.732471045191602,0,3,negative regulation of Golgi to plasma membrane protein transport,BP,
1903,GO:0004595,1.00000000001449,0.901871204886059,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
8539,GO:0033961,1.00000000001449,0.905752266048936,0,1,cis-stilbene-oxide hydrolase activity,MF,
3016,GO:0006569,1.0000000000145,0.74268266217012,0,3,tryptophan catabolic process,BP,
6141,GO:0019441,1.0000000000145,0.74268266217012,0,3,tryptophan catabolic process to kynurenine,BP,
9993,GO:0042436,1.0000000000145,0.74268266217012,0,3,indole-containing compound catabolic process,BP,
11583,GO:0046218,1.0000000000145,0.74268266217012,0,3,indolalkylamine catabolic process,BP,
18473,GO:1903636,1.0000000000145,0.933582970264484,0,1,regulation of protein import into mitochondrial outer membrane,BP,
18474,GO:1903638,1.0000000000145,0.933582970264484,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
18476,GO:1903645,1.0000000000145,0.933582970264484,0,1,negative regulation of chaperone-mediated protein folding,BP,
2354,GO:0005459,1.00000000001454,0.829901323713537,0,2,UDP-galactose transmembrane transporter activity,MF,
15721,GO:0072334,1.00000000001454,0.829901323713537,0,2,UDP-galactose transmembrane transport,BP,
1724,GO:0004320,1.00000000001456,0.816312923682188,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
5423,GO:0016295,1.00000000001456,0.816312923682188,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5424,GO:0016296,1.00000000001456,0.816312923682188,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5425,GO:0016297,1.00000000001456,0.816312923682188,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
63,GO:0000126,1.00000000001457,0.812474684632655,0,2,transcription factor TFIIIB complex,CC,
119,GO:0000248,1.00000000001457,0.812474684632655,0,2,C-5 sterol desaturase activity,MF,
123,GO:0000254,1.00000000001457,0.812474684632655,0,2,C-4 methylsterol oxidase activity,MF,
152,GO:0000308,1.00000000001457,0.812474684632655,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
153,GO:0000309,1.00000000001457,0.812474684632655,0,2,nicotinamide-nucleotide adenylyltransferase activity,MF,
157,GO:0000320,1.00000000001457,0.812474684632655,0,2,re-entry into mitotic cell cycle,BP,
169,GO:0000354,1.00000000001457,0.812474684632655,0,2,cis assembly of pre-catalytic spliceosome,BP,
188,GO:0000406,1.00000000001457,0.812474684632655,0,2,double-strand/single-strand DNA junction binding,MF,
247,GO:0000706,1.00000000001457,0.812474684632655,0,2,meiotic DNA double-strand break processing,BP,
347,GO:0000961,1.00000000001457,0.812474684632655,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
384,GO:0001026,1.00000000001457,0.812474684632655,0,2,TFIIIB-type transcription factor activity,MF,
396,GO:0001069,1.00000000001457,0.812474684632655,0,2,regulatory region RNA binding,MF,
428,GO:0001147,1.00000000001457,0.812474684632655,0,2,transcription termination site sequence-specific DNA binding,MF,
431,GO:0001160,1.00000000001457,0.812474684632655,0,2,transcription termination site DNA binding,MF,
451,GO:0001225,1.00000000001457,0.812474684632655,0,2,RNA polymerase II transcription coactivator binding,MF,
455,GO:0001300,1.00000000001457,0.812474684632655,0,2,chronological cell aging,BP,
476,GO:0001520,1.00000000001457,0.812474684632655,0,2,outer dense fiber,CC,
499,GO:0001555,1.00000000001457,0.812474684632655,0,2,oocyte growth,BP,
502,GO:0001560,1.00000000001457,0.812474684632655,0,2,regulation of cell growth by extracellular stimulus,BP,
514,GO:0001579,1.00000000001457,0.812474684632655,0,2,medium-chain fatty acid transport,BP,
563,GO:0001705,1.00000000001457,0.812474684632655,0,2,ectoderm formation,BP,
570,GO:0001712,1.00000000001457,0.812474684632655,0,2,ectodermal cell fate commitment,BP,
576,GO:0001729,1.00000000001457,0.812474684632655,0,2,ceramide kinase activity,MF,
592,GO:0001757,1.00000000001457,0.812474684632655,0,2,somite specification,BP,
637,GO:0001827,1.00000000001457,0.812474684632655,0,2,inner cell mass cell fate commitment,BP,
638,GO:0001828,1.00000000001457,0.812474684632655,0,2,inner cell mass cellular morphogenesis,BP,
669,GO:0001880,1.00000000001457,0.812474684632655,0,2,Mullerian duct regression,BP,
677,GO:0001888,1.00000000001457,0.812474684632655,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
685,GO:0001905,1.00000000001457,0.812474684632655,0,2,activation of membrane attack complex,BP,
737,GO:0001969,1.00000000001457,0.812474684632655,0,2,regulation of activation of membrane attack complex,BP,
801,GO:0002071,1.00000000001457,0.812474684632655,0,2,glandular epithelial cell maturation,BP,
805,GO:0002079,1.00000000001457,0.812474684632655,0,2,inner acrosomal membrane,CC,
854,GO:0002184,1.00000000001457,0.812474684632655,0,2,cytoplasmic translational termination,BP,
882,GO:0002249,1.00000000001457,0.812474684632655,0,2,lymphocyte anergy,BP,
925,GO:0002322,1.00000000001457,0.812474684632655,0,2,B cell proliferation involved in immune response,BP,
1046,GO:0002572,1.00000000001457,0.812474684632655,0,2,pro-T cell differentiation,BP,
1083,GO:0002667,1.00000000001457,0.812474684632655,0,2,regulation of T cell anergy,BP,
1207,GO:0002870,1.00000000001457,0.812474684632655,0,2,T cell anergy,BP,
1229,GO:0002911,1.00000000001457,0.812474684632655,0,2,regulation of lymphocyte anergy,BP,
1312,GO:0003162,1.00000000001457,0.812474684632655,0,2,atrioventricular node development,BP,
1313,GO:0003163,1.00000000001457,0.812474684632655,0,2,sinoatrial node development,BP,
1314,GO:0003164,1.00000000001457,0.812474684632655,0,2,His-Purkinje system development,BP,
1346,GO:0003213,1.00000000001457,0.812474684632655,0,2,cardiac right atrium morphogenesis,BP,
1362,GO:0003249,1.00000000001457,0.812474684632655,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1363,GO:0003250,1.00000000001457,0.812474684632655,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1377,GO:0003275,1.00000000001457,0.812474684632655,0,2,apoptotic process involved in outflow tract morphogenesis,BP,
1385,GO:0003294,1.00000000001457,0.812474684632655,0,2,atrial ventricular junction remodeling,BP,
1404,GO:0003340,1.00000000001457,0.812474684632655,0,2,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1415,GO:0003357,1.00000000001457,0.812474684632655,0,2,noradrenergic neuron differentiation,BP,
1431,GO:0003408,1.00000000001457,0.812474684632655,0,2,optic cup formation involved in camera-type eye development,BP,
1487,GO:0003827,1.00000000001457,0.812474684632655,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1488,GO:0003828,1.00000000001457,0.812474684632655,0,2,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
1489,GO:0003829,1.00000000001457,0.812474684632655,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1491,GO:0003835,1.00000000001457,0.812474684632655,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1502,GO:0003858,1.00000000001457,0.812474684632655,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1513,GO:0003876,1.00000000001457,0.812474684632655,0,2,AMP deaminase activity,MF,
1519,GO:0003883,1.00000000001457,0.812474684632655,0,2,CTP synthase activity,MF,
1531,GO:0003918,1.00000000001457,0.812474684632655,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
1570,GO:0003980,1.00000000001457,0.812474684632655,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1574,GO:0003987,1.00000000001457,0.812474684632655,0,2,acetate-CoA ligase activity,MF,
1576,GO:0003989,1.00000000001457,0.812474684632655,0,2,acetyl-CoA carboxylase activity,MF,
1628,GO:0004070,1.00000000001457,0.812474684632655,0,2,aspartate carbamoyltransferase activity,MF,
1640,GO:0004087,1.00000000001457,0.812474684632655,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1641,GO:0004088,1.00000000001457,0.812474684632655,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1663,GO:0004127,1.00000000001457,0.812474684632655,0,2,cytidylate kinase activity,MF,
1681,GO:0004151,1.00000000001457,0.812474684632655,0,2,dihydroorotase activity,MF,
1729,GO:0004329,1.00000000001457,0.812474684632655,0,2,formate-tetrahydrofolate ligase activity,MF,
1751,GO:0004357,1.00000000001457,0.812474684632655,0,2,glutamate-cysteine ligase activity,MF,
1762,GO:0004370,1.00000000001457,0.812474684632655,0,2,glycerol kinase activity,MF,
1770,GO:0004379,1.00000000001457,0.812474684632655,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1824,GO:0004483,1.00000000001457,0.812474684632655,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
1862,GO:0004530,1.00000000001457,0.812474684632655,0,2,deoxyribonuclease I activity,MF,
1883,GO:0004568,1.00000000001457,0.812474684632655,0,2,chitinase activity,MF,
1886,GO:0004572,1.00000000001457,0.812474684632655,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
1956,GO:0004666,1.00000000001457,0.812474684632655,0,2,prostaglandin-endoperoxide synthase activity,MF,
1968,GO:0004687,1.00000000001457,0.812474684632655,0,2,myosin light chain kinase activity,MF,
2050,GO:0004803,1.00000000001457,0.812474684632655,0,2,transposase activity,MF,
2061,GO:0004818,1.00000000001457,0.812474684632655,0,2,glutamate-tRNA ligase activity,MF,
2065,GO:0004822,1.00000000001457,0.812474684632655,0,2,isoleucine-tRNA ligase activity,MF,
2066,GO:0004823,1.00000000001457,0.812474684632655,0,2,leucine-tRNA ligase activity,MF,
2100,GO:0004874,1.00000000001457,0.812474684632655,0,2,aryl hydrocarbon receptor activity,MF,
2123,GO:0004923,1.00000000001457,0.812474684632655,0,2,leukemia inhibitory factor receptor activity,MF,
2144,GO:0004965,1.00000000001457,0.812474684632655,0,2,G-protein coupled GABA receptor activity,MF,
2146,GO:0004968,1.00000000001457,0.812474684632655,0,2,gonadotropin-releasing hormone receptor activity,MF,
2147,GO:0004969,1.00000000001457,0.812474684632655,0,2,histamine receptor activity,MF,
2162,GO:0005000,1.00000000001457,0.812474684632655,0,2,vasopressin receptor activity,MF,
2188,GO:0005052,1.00000000001457,0.812474684632655,0,2,peroxisome matrix targeting signal-1 binding,MF,
2238,GO:0005153,1.00000000001457,0.812474684632655,0,2,interleukin-8 receptor binding,MF,
2277,GO:0005234,1.00000000001457,0.812474684632655,0,2,extracellularly glutamate-gated ion channel activity,MF,
2316,GO:0005329,1.00000000001457,0.812474684632655,0,2,dopamine transmembrane transporter activity,MF,
2331,GO:0005365,1.00000000001457,0.812474684632655,0,2,myo-inositol transmembrane transporter activity,MF,
2353,GO:0005457,1.00000000001457,0.812474684632655,0,2,GDP-fucose transmembrane transporter activity,MF,
2406,GO:0005584,1.00000000001457,0.812474684632655,0,2,collagen type I trimer,CC,
2422,GO:0005607,1.00000000001457,0.812474684632655,0,2,laminin-2 complex,CC,
2501,GO:0005760,1.00000000001457,0.812474684632655,0,2,gamma DNA polymerase complex,CC,
2596,GO:0005900,1.00000000001457,0.812474684632655,0,2,oncostatin-M receptor complex,CC,
2617,GO:0005943,1.00000000001457,0.812474684632655,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
2669,GO:0006030,1.00000000001457,0.812474684632655,0,2,chitin metabolic process,BP,
2670,GO:0006032,1.00000000001457,0.812474684632655,0,2,chitin catabolic process,BP,
2675,GO:0006045,1.00000000001457,0.812474684632655,0,2,N-acetylglucosamine biosynthetic process,BP,
2880,GO:0006393,1.00000000001457,0.812474684632655,0,2,termination of mitochondrial transcription,BP,
2906,GO:0006424,1.00000000001457,0.812474684632655,0,2,glutamyl-tRNA aminoacylation,BP,
2910,GO:0006428,1.00000000001457,0.812474684632655,0,2,isoleucyl-tRNA aminoacylation,BP,
2911,GO:0006429,1.00000000001457,0.812474684632655,0,2,leucyl-tRNA aminoacylation,BP,
2995,GO:0006548,1.00000000001457,0.812474684632655,0,2,histidine catabolic process,BP,
3087,GO:0006668,1.00000000001457,0.812474684632655,0,2,sphinganine-1-phosphate metabolic process,BP,
3165,GO:0006784,1.00000000001457,0.812474684632655,0,2,heme a biosynthetic process,BP,
3202,GO:0006850,1.00000000001457,0.812474684632655,0,2,mitochondrial pyruvate transmembrane transport,BP,
3430,GO:0007228,1.00000000001457,0.812474684632655,0,2,positive regulation of hh target transcription factor activity,BP,
3458,GO:0007284,1.00000000001457,0.812474684632655,0,2,spermatogonial cell division,BP,
3502,GO:0007418,1.00000000001457,0.812474684632655,0,2,ventral midline development,BP,
3531,GO:0007538,1.00000000001457,0.812474684632655,0,2,primary sex determination,BP,
3532,GO:0007542,1.00000000001457,0.812474684632655,0,2,primary sex determination, germ-line,BP,
3607,GO:0008061,1.00000000001457,0.812474684632655,0,2,chitin binding,MF,
3610,GO:0008065,1.00000000001457,0.812474684632655,0,2,establishment of blood-nerve barrier,BP,
3630,GO:0008107,1.00000000001457,0.812474684632655,0,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3632,GO:0008109,1.00000000001457,0.812474684632655,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3729,GO:0008273,1.00000000001457,0.812474684632655,0,2,calcium, potassium:sodium antiporter activity,MF,
3736,GO:0008282,1.00000000001457,0.812474684632655,0,2,inward rectifying potassium channel,CC,
3762,GO:0008321,1.00000000001457,0.812474684632655,0,2,Ral guanyl-nucleotide exchange factor activity,MF,
3814,GO:0008422,1.00000000001457,0.812474684632655,0,2,beta-glucosidase activity,MF,
3866,GO:0008506,1.00000000001457,0.812474684632655,0,2,sucrose:proton symporter activity,MF,
3874,GO:0008515,1.00000000001457,0.812474684632655,0,2,sucrose transmembrane transporter activity,MF,
3896,GO:0008545,1.00000000001457,0.812474684632655,0,2,JUN kinase kinase activity,MF,
3906,GO:0008582,1.00000000001457,0.812474684632655,0,2,regulation of synaptic growth at neuromuscular junction,BP,
4001,GO:0008988,1.00000000001457,0.812474684632655,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
4039,GO:0009085,1.00000000001457,0.812474684632655,0,2,lysine biosynthetic process,BP,
4158,GO:0009233,1.00000000001457,0.812474684632655,0,2,menaquinone metabolic process,BP,
4171,GO:0009257,1.00000000001457,0.812474684632655,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4172,GO:0009258,1.00000000001457,0.812474684632655,0,2,10-formyltetrahydrofolate catabolic process,BP,
4199,GO:0009330,1.00000000001457,0.812474684632655,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
4219,GO:0009405,1.00000000001457,0.812474684632655,0,2,pathogenesis,BP,
4241,GO:0009450,1.00000000001457,0.812474684632655,0,2,gamma-aminobutyric acid catabolic process,BP,
4267,GO:0009637,1.00000000001457,0.812474684632655,0,2,response to blue light,BP,
4277,GO:0009669,1.00000000001457,0.812474684632655,0,2,sucrose:cation symporter activity,MF,
4299,GO:0009785,1.00000000001457,0.812474684632655,0,2,blue light signaling pathway,BP,
4324,GO:0009882,1.00000000001457,0.812474684632655,0,2,blue light photoreceptor activity,MF,
4554,GO:0010645,1.00000000001457,0.812474684632655,0,2,regulation of cell communication by chemical coupling,BP,
4560,GO:0010652,1.00000000001457,0.812474684632655,0,2,positive regulation of cell communication by chemical coupling,BP,
4579,GO:0010693,1.00000000001457,0.812474684632655,0,2,negative regulation of alkaline phosphatase activity,BP,
4621,GO:0010752,1.00000000001457,0.812474684632655,0,2,regulation of cGMP-mediated signaling,BP,
4636,GO:0010768,1.00000000001457,0.812474684632655,0,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4696,GO:0010868,1.00000000001457,0.812474684632655,0,2,negative regulation of triglyceride biosynthetic process,BP,
4766,GO:0010961,1.00000000001457,0.812474684632655,0,2,cellular magnesium ion homeostasis,BP,
4789,GO:0010991,1.00000000001457,0.812474684632655,0,2,negative regulation of SMAD protein complex assembly,BP,
4803,GO:0014004,1.00000000001457,0.812474684632655,0,2,microglia differentiation,BP,
4804,GO:0014005,1.00000000001457,0.812474684632655,0,2,microglia development,BP,
4820,GO:0014034,1.00000000001457,0.812474684632655,0,2,neural crest cell fate commitment,BP,
4882,GO:0014816,1.00000000001457,0.812474684632655,0,2,skeletal muscle satellite cell differentiation,BP,
4910,GO:0014858,1.00000000001457,0.812474684632655,0,2,positive regulation of skeletal muscle cell proliferation,BP,
4919,GO:0014886,1.00000000001457,0.812474684632655,0,2,transition between slow and fast fiber,BP,
4966,GO:0015093,1.00000000001457,0.812474684632655,0,2,ferrous iron transmembrane transporter activity,MF,
4996,GO:0015154,1.00000000001457,0.812474684632655,0,2,disaccharide transmembrane transporter activity,MF,
4997,GO:0015157,1.00000000001457,0.812474684632655,0,2,oligosaccharide transmembrane transporter activity,MF,
5011,GO:0015184,1.00000000001457,0.812474684632655,0,2,L-cystine transmembrane transporter activity,MF,
5080,GO:0015350,1.00000000001457,0.812474684632655,0,2,methotrexate transmembrane transporter activity,MF,
5104,GO:0015433,1.00000000001457,0.812474684632655,0,2,peptide antigen-transporting ATPase activity,MF,
5137,GO:0015679,1.00000000001457,0.812474684632655,0,2,plasma membrane copper ion transport,BP,
5140,GO:0015684,1.00000000001457,0.812474684632655,0,2,ferrous iron transport,BP,
5179,GO:0015766,1.00000000001457,0.812474684632655,0,2,disaccharide transport,BP,
5180,GO:0015770,1.00000000001457,0.812474684632655,0,2,sucrose transport,BP,
5181,GO:0015772,1.00000000001457,0.812474684632655,0,2,oligosaccharide transport,BP,
5184,GO:0015783,1.00000000001457,0.812474684632655,0,2,GDP-fucose transmembrane transport,BP,
5201,GO:0015810,1.00000000001457,0.812474684632655,0,2,aspartate transmembrane transport,BP,
5202,GO:0015811,1.00000000001457,0.812474684632655,0,2,L-cystine transport,BP,
5248,GO:0015888,1.00000000001457,0.812474684632655,0,2,thiamine transport,BP,
5356,GO:0016155,1.00000000001457,0.812474684632655,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5437,GO:0016316,1.00000000001457,0.812474684632655,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5451,GO:0016340,1.00000000001457,0.812474684632655,0,2,calcium-dependent cell-matrix adhesion,BP,
5474,GO:0016418,1.00000000001457,0.812474684632655,0,2,S-acetyltransferase activity,MF,
5488,GO:0016436,1.00000000001457,0.812474684632655,0,2,rRNA (uridine) methyltransferase activity,MF,
5561,GO:0016586,1.00000000001457,0.812474684632655,0,2,RSC-type complex,CC,
5624,GO:0016715,1.00000000001457,0.812474684632655,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
5639,GO:0016743,1.00000000001457,0.812474684632655,0,2,carboxyl- or carbamoyltransferase activity,MF,
5741,GO:0016899,1.00000000001457,0.812474684632655,0,2,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
5813,GO:0017095,1.00000000001457,0.812474684632655,0,2,heparan sulfate 6-O-sulfotransferase activity,MF,
5819,GO:0017109,1.00000000001457,0.812474684632655,0,2,glutamate-cysteine ligase complex,CC,
5851,GO:0017161,1.00000000001457,0.812474684632655,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
5868,GO:0018008,1.00000000001457,0.812474684632655,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
5983,GO:0018992,1.00000000001457,0.812474684632655,0,2,germ-line sex determination,BP,
5991,GO:0019034,1.00000000001457,0.812474684632655,0,2,viral replication complex,CC,
5995,GO:0019045,1.00000000001457,0.812474684632655,0,2,latent virus replication,BP,
5996,GO:0019046,1.00000000001457,0.812474684632655,0,2,release from viral latency,BP,
6017,GO:0019085,1.00000000001457,0.812474684632655,0,2,early viral transcription,BP,
6023,GO:0019100,1.00000000001457,0.812474684632655,0,2,male germ-line sex determination,BP,
6027,GO:0019107,1.00000000001457,0.812474684632655,0,2,myristoyltransferase activity,MF,
6069,GO:0019230,1.00000000001457,0.812474684632655,0,2,proprioception,BP,
6102,GO:0019355,1.00000000001457,0.812474684632655,0,2,nicotinamide nucleotide biosynthetic process from aspartate,BP,
6132,GO:0019413,1.00000000001457,0.812474684632655,0,2,acetate biosynthetic process,BP,
6133,GO:0019417,1.00000000001457,0.812474684632655,0,2,sulfur oxidation,BP,
6135,GO:0019427,1.00000000001457,0.812474684632655,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6148,GO:0019482,1.00000000001457,0.812474684632655,0,2,beta-alanine metabolic process,BP,
6166,GO:0019542,1.00000000001457,0.812474684632655,0,2,propionate biosynthetic process,BP,
6268,GO:0019878,1.00000000001457,0.812474684632655,0,2,lysine biosynthetic process via aminoadipic acid,BP,
6307,GO:0019961,1.00000000001457,0.812474684632655,0,2,interferon binding,MF,
6324,GO:0021502,1.00000000001457,0.812474684632655,0,2,neural fold elevation formation,BP,
6368,GO:0021563,1.00000000001457,0.812474684632655,0,2,glossopharyngeal nerve development,BP,
6381,GO:0021590,1.00000000001457,0.812474684632655,0,2,cerebellum maturation,BP,
6406,GO:0021679,1.00000000001457,0.812474684632655,0,2,cerebellar molecular layer development,BP,
6413,GO:0021687,1.00000000001457,0.812474684632655,0,2,cerebellar molecular layer morphogenesis,BP,
6415,GO:0021691,1.00000000001457,0.812474684632655,0,2,cerebellar Purkinje cell layer maturation,BP,
6417,GO:0021693,1.00000000001457,0.812474684632655,0,2,cerebellar Purkinje cell layer structural organization,BP,
6422,GO:0021698,1.00000000001457,0.812474684632655,0,2,cerebellar cortex structural organization,BP,
6423,GO:0021699,1.00000000001457,0.812474684632655,0,2,cerebellar cortex maturation,BP,
6438,GO:0021764,1.00000000001457,0.812474684632655,0,2,amygdala development,BP,
6459,GO:0021798,1.00000000001457,0.812474684632655,0,2,forebrain dorsal/ventral pattern formation,BP,
6466,GO:0021816,1.00000000001457,0.812474684632655,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
6470,GO:0021823,1.00000000001457,0.812474684632655,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6474,GO:0021827,1.00000000001457,0.812474684632655,0,2,postnatal olfactory bulb interneuron migration,BP,
6477,GO:0021836,1.00000000001457,0.812474684632655,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6483,GO:0021849,1.00000000001457,0.812474684632655,0,2,neuroblast division in subventricular zone,BP,
6509,GO:0021896,1.00000000001457,0.812474684632655,0,2,forebrain astrocyte differentiation,BP,
6510,GO:0021897,1.00000000001457,0.812474684632655,0,2,forebrain astrocyte development,BP,
6512,GO:0021902,1.00000000001457,0.812474684632655,0,2,commitment of neuronal cell to specific neuron type in forebrain,BP,
6521,GO:0021934,1.00000000001457,0.812474684632655,0,2,hindbrain tangential cell migration,BP,
6522,GO:0021935,1.00000000001457,0.812474684632655,0,2,cerebellar granule cell precursor tangential migration,BP,
6524,GO:0021937,1.00000000001457,0.812474684632655,0,2,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6525,GO:0021938,1.00000000001457,0.812474684632655,0,2,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6526,GO:0021940,1.00000000001457,0.812474684632655,0,2,positive regulation of cerebellar granule cell precursor proliferation,BP,
6547,GO:0021997,1.00000000001457,0.812474684632655,0,2,neural plate axis specification,BP,
6784,GO:0030237,1.00000000001457,0.812474684632655,0,2,female sex determination,BP,
6788,GO:0030241,1.00000000001457,0.812474684632655,0,2,skeletal muscle myosin thick filament assembly,BP,
6834,GO:0030314,1.00000000001457,0.812474684632655,0,2,junctional membrane complex,CC,
6861,GO:0030350,1.00000000001457,0.812474684632655,0,2,iron-responsive element binding,MF,
6902,GO:0030505,1.00000000001457,0.812474684632655,0,2,inorganic diphosphate transport,BP,
6921,GO:0030538,1.00000000001457,0.812474684632655,0,2,embryonic genitalia morphogenesis,BP,
7021,GO:0030806,1.00000000001457,0.812474684632655,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7036,GO:0030821,1.00000000001457,0.812474684632655,0,2,negative regulation of cAMP catabolic process,BP,
7107,GO:0030934,1.00000000001457,0.812474684632655,0,2,anchoring collagen complex,CC,
7148,GO:0031022,1.00000000001457,0.812474684632655,0,2,nuclear migration along microfilament,BP,
7156,GO:0031048,1.00000000001457,0.812474684632655,0,2,chromatin silencing by small RNA,BP,
7170,GO:0031064,1.00000000001457,0.812474684632655,0,2,negative regulation of histone deacetylation,BP,
7180,GO:0031081,1.00000000001457,0.812474684632655,0,2,nuclear pore distribution,BP,
7220,GO:0031127,1.00000000001457,0.812474684632655,0,2,alpha-(1,2)-fucosyltransferase activity,MF,
7242,GO:0031213,1.00000000001457,0.812474684632655,0,2,RSF complex,CC,
7340,GO:0031393,1.00000000001457,0.812474684632655,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7349,GO:0031403,1.00000000001457,0.812474684632655,0,2,lithium ion binding,MF,
7425,GO:0031547,1.00000000001457,0.812474684632655,0,2,brain-derived neurotrophic factor receptor signaling pathway,BP,
7442,GO:0031590,1.00000000001457,0.812474684632655,0,2,wybutosine metabolic process,BP,
7443,GO:0031591,1.00000000001457,0.812474684632655,0,2,wybutosine biosynthetic process,BP,
7494,GO:0031685,1.00000000001457,0.812474684632655,0,2,adenosine receptor binding,MF,
7518,GO:0031752,1.00000000001457,0.812474684632655,0,2,D5 dopamine receptor binding,MF,
7540,GO:0031862,1.00000000001457,0.812474684632655,0,2,prostanoid receptor binding,MF,
7579,GO:0031959,1.00000000001457,0.812474684632655,0,2,mineralocorticoid receptor signaling pathway,BP,
7648,GO:0032089,1.00000000001457,0.812474684632655,0,2,NACHT domain binding,MF,
7669,GO:0032116,1.00000000001457,0.812474684632655,0,2,SMC loading complex,CC,
7679,GO:0032143,1.00000000001457,0.812474684632655,0,2,single thymine insertion binding,MF,
7690,GO:0032181,1.00000000001457,0.812474684632655,0,2,dinucleotide repeat insertion binding,MF,
7711,GO:0032213,1.00000000001457,0.812474684632655,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
7712,GO:0032214,1.00000000001457,0.812474684632655,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
7714,GO:0032217,1.00000000001457,0.812474684632655,0,2,riboflavin transmembrane transporter activity,MF,
7715,GO:0032218,1.00000000001457,0.812474684632655,0,2,riboflavin transport,BP,
7729,GO:0032240,1.00000000001457,0.812474684632655,0,2,negative regulation of nucleobase-containing compound transport,BP,
7765,GO:0032301,1.00000000001457,0.812474684632655,0,2,MutSalpha complex,CC,
7766,GO:0032302,1.00000000001457,0.812474684632655,0,2,MutSbeta complex,CC,
7845,GO:0032417,1.00000000001457,0.812474684632655,0,2,positive regulation of sodium:proton antiporter activity,BP,
7867,GO:0032444,1.00000000001457,0.812474684632655,0,2,activin responsive factor complex,CC,
7893,GO:0032474,1.00000000001457,0.812474684632655,0,2,otolith morphogenesis,BP,
8040,GO:0032714,1.00000000001457,0.812474684632655,0,2,negative regulation of interleukin-5 production,BP,
8057,GO:0032741,1.00000000001457,0.812474684632655,0,2,positive regulation of interleukin-18 production,BP,
8098,GO:0032798,1.00000000001457,0.812474684632655,0,2,Swi5-Sfr1 complex,CC,
8137,GO:0032877,1.00000000001457,0.812474684632655,0,2,positive regulation of DNA endoreduplication,BP,
8166,GO:0032916,1.00000000001457,0.812474684632655,0,2,positive regulation of transforming growth factor beta3 production,BP,
8189,GO:0032954,1.00000000001457,0.812474684632655,0,2,regulation of cytokinetic process,BP,
8232,GO:0033023,1.00000000001457,0.812474684632655,0,2,mast cell homeostasis,BP,
8233,GO:0033024,1.00000000001457,0.812474684632655,0,2,mast cell apoptotic process,BP,
8234,GO:0033025,1.00000000001457,0.812474684632655,0,2,regulation of mast cell apoptotic process,BP,
8279,GO:0033122,1.00000000001457,0.812474684632655,0,2,negative regulation of purine nucleotide catabolic process,BP,
8301,GO:0033149,1.00000000001457,0.812474684632655,0,2,FFAT motif binding,MF,
8372,GO:0033292,1.00000000001457,0.812474684632655,0,2,T-tubule organization,BP,
8428,GO:0033564,1.00000000001457,0.812474684632655,0,2,anterior/posterior axon guidance,BP,
8451,GO:0033604,1.00000000001457,0.812474684632655,0,2,negative regulation of catecholamine secretion,BP,
8463,GO:0033624,1.00000000001457,0.812474684632655,0,2,negative regulation of integrin activation,BP,
8464,GO:0033625,1.00000000001457,0.812474684632655,0,2,positive regulation of integrin activation,BP,
8491,GO:0033684,1.00000000001457,0.812474684632655,0,2,regulation of luteinizing hormone secretion,BP,
8492,GO:0033686,1.00000000001457,0.812474684632655,0,2,positive regulation of luteinizing hormone secretion,BP,
8497,GO:0033691,1.00000000001457,0.812474684632655,0,2,sialic acid binding,MF,
8513,GO:0033768,1.00000000001457,0.812474684632655,0,2,SUMO-targeted ubiquitin ligase complex,CC,
8519,GO:0033857,1.00000000001457,0.812474684632655,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
8573,GO:0034087,1.00000000001457,0.812474684632655,0,2,establishment of mitotic sister chromatid cohesion,BP,
8623,GO:0034165,1.00000000001457,0.812474684632655,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
8738,GO:0034416,1.00000000001457,0.812474684632655,0,2,bisphosphoglycerate phosphatase activity,MF,
8782,GO:0034499,1.00000000001457,0.812474684632655,0,2,late endosome to Golgi transport,BP,
8792,GO:0034515,1.00000000001457,0.812474684632655,0,2,proteasome storage granule,CC,
8806,GO:0034597,1.00000000001457,0.812474684632655,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
8822,GO:0034627,1.00000000001457,0.812474684632655,0,2,'de novo' NAD biosynthetic process,BP,
8823,GO:0034628,1.00000000001457,0.812474684632655,0,2,'de novo' NAD biosynthetic process from aspartate,BP,
8835,GO:0034647,1.00000000001457,0.812474684632655,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
8848,GO:0034665,1.00000000001457,0.812474684632655,0,2,integrin alpha1-beta1 complex,CC,
8850,GO:0034667,1.00000000001457,0.812474684632655,0,2,integrin alpha3-beta1 complex,CC,
8853,GO:0034673,1.00000000001457,0.812474684632655,0,2,inhibin-betaglycan-ActRII complex,CC,
8856,GO:0034678,1.00000000001457,0.812474684632655,0,2,integrin alpha8-beta1 complex,CC,
8857,GO:0034680,1.00000000001457,0.812474684632655,0,2,integrin alpha10-beta1 complex,CC,
8862,GO:0034686,1.00000000001457,0.812474684632655,0,2,integrin alphav-beta8 complex,CC,
8884,GO:0034721,1.00000000001457,0.812474684632655,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
8893,GO:0034750,1.00000000001457,0.812474684632655,0,2,Scrib-APC-beta-catenin complex,CC,
8913,GO:0034776,1.00000000001457,0.812474684632655,0,2,response to histamine,BP,
8945,GO:0035026,1.00000000001457,0.812474684632655,0,2,leading edge cell differentiation,BP,
8969,GO:0035093,1.00000000001457,0.812474684632655,0,2,spermatogenesis, exchange of chromosomal proteins,BP,
9028,GO:0035261,1.00000000001457,0.812474684632655,0,2,external genitalia morphogenesis,BP,
9039,GO:0035279,1.00000000001457,0.812474684632655,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9064,GO:0035332,1.00000000001457,0.812474684632655,0,2,positive regulation of hippo signaling,BP,
9086,GO:0035373,1.00000000001457,0.812474684632655,0,2,chondroitin sulfate proteoglycan binding,MF,
9155,GO:0035526,1.00000000001457,0.812474684632655,0,2,retrograde transport, plasma membrane to Golgi,BP,
9175,GO:0035574,1.00000000001457,0.812474684632655,0,2,histone H4-K20 demethylation,BP,
9176,GO:0035575,1.00000000001457,0.812474684632655,0,2,histone demethylase activity (H4-K20 specific),MF,
9204,GO:0035608,1.00000000001457,0.812474684632655,0,2,protein deglutamylation,BP,
9218,GO:0035624,1.00000000001457,0.812474684632655,0,2,receptor transactivation,BP,
9221,GO:0035630,1.00000000001457,0.812474684632655,0,2,bone mineralization involved in bone maturation,BP,
9243,GO:0035668,1.00000000001457,0.812474684632655,0,2,TRAM-dependent toll-like receptor signaling pathway,BP,
9244,GO:0035669,1.00000000001457,0.812474684632655,0,2,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9320,GO:0035822,1.00000000001457,0.812474684632655,0,2,gene conversion,BP,
9337,GO:0035866,1.00000000001457,0.812474684632655,0,2,alphav-beta3 integrin-PKCalpha complex,CC,
9338,GO:0035867,1.00000000001457,0.812474684632655,0,2,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
9339,GO:0035868,1.00000000001457,0.812474684632655,0,2,alphav-beta3 integrin-HMGB1 complex,CC,
9450,GO:0036080,1.00000000001457,0.812474684632655,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
9476,GO:0036135,1.00000000001457,0.812474684632655,0,2,Schwann cell migration,BP,
9553,GO:0036369,1.00000000001457,0.812474684632655,0,2,transcription factor catabolic process,BP,
9578,GO:0036451,1.00000000001457,0.812474684632655,0,2,cap mRNA methylation,BP,
9589,GO:0036466,1.00000000001457,0.812474684632655,0,2,synaptic vesicle recycling via endosome,BP,
9631,GO:0036518,1.00000000001457,0.812474684632655,0,2,chemorepulsion of dopaminergic neuron axon,BP,
9645,GO:0038018,1.00000000001457,0.812474684632655,0,2,Wnt receptor catabolic process,BP,
9649,GO:0038025,1.00000000001457,0.812474684632655,0,2,reelin receptor activity,MF,
9663,GO:0038049,1.00000000001457,0.812474684632655,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
9669,GO:0038064,1.00000000001457,0.812474684632655,0,2,collagen receptor activity,MF,
9694,GO:0038124,1.00000000001457,0.812474684632655,0,2,toll-like receptor TLR6:TLR2 signaling pathway,BP,
9731,GO:0039019,1.00000000001457,0.812474684632655,0,2,pronephric nephron development,BP,
9742,GO:0039519,1.00000000001457,0.812474684632655,0,2,modulation by virus of host autophagy,BP,
9803,GO:0042030,1.00000000001457,0.812474684632655,0,2,ATPase inhibitor activity,MF,
9901,GO:0042264,1.00000000001457,0.812474684632655,0,2,peptidyl-aspartic acid hydroxylation,BP,
9907,GO:0042271,1.00000000001457,0.812474684632655,0,2,susceptibility to natural killer cell mediated cytotoxicity,BP,
9908,GO:0042272,1.00000000001457,0.812474684632655,0,2,nuclear RNA export factor complex,CC,
9990,GO:0042426,1.00000000001457,0.812474684632655,0,2,choline catabolic process,BP,
10024,GO:0042494,1.00000000001457,0.812474684632655,0,2,detection of bacterial lipoprotein,BP,
10026,GO:0042496,1.00000000001457,0.812474684632655,0,2,detection of diacyl bacterial lipopeptide,BP,
10123,GO:0042704,1.00000000001457,0.812474684632655,0,2,uterine wall breakdown,BP,
10227,GO:0042978,1.00000000001457,0.812474684632655,0,2,ornithine decarboxylase activator activity,MF,
10242,GO:0042998,1.00000000001457,0.812474684632655,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
10418,GO:0043291,1.00000000001457,0.812474684632655,0,2,RAVE complex,CC,
10524,GO:0043490,1.00000000001457,0.812474684632655,0,2,malate-aspartate shuttle,BP,
10559,GO:0043541,1.00000000001457,0.812474684632655,0,2,UDP-N-acetylglucosamine transferase complex,CC,
10588,GO:0043585,1.00000000001457,0.812474684632655,0,2,nose morphogenesis,BP,
10600,GO:0043614,1.00000000001457,0.812474684632655,0,2,multi-eIF complex,CC,
10695,GO:0044028,1.00000000001457,0.812474684632655,0,2,DNA hypomethylation,BP,
10696,GO:0044029,1.00000000001457,0.812474684632655,0,2,hypomethylation of CpG island,BP,
10746,GO:0044210,1.00000000001457,0.812474684632655,0,2,'de novo' CTP biosynthetic process,BP,
10801,GO:0044308,1.00000000001457,0.812474684632655,0,2,axonal spine,CC,
10821,GO:0044334,1.00000000001457,0.812474684632655,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
10937,GO:0044691,1.00000000001457,0.812474684632655,0,2,tooth eruption,BP,
10961,GO:0044771,1.00000000001457,0.812474684632655,0,2,meiotic cell cycle phase transition,BP,
10983,GO:0044805,1.00000000001457,0.812474684632655,0,2,late nucleophagy,BP,
10992,GO:0044830,1.00000000001457,0.812474684632655,0,2,modulation by host of viral RNA genome replication,BP,
11013,GO:0045004,1.00000000001457,0.812474684632655,0,2,DNA replication proofreading,BP,
11098,GO:0045142,1.00000000001457,0.812474684632655,0,2,triplex DNA binding,MF,
11101,GO:0045145,1.00000000001457,0.812474684632655,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11127,GO:0045196,1.00000000001457,0.812474684632655,0,2,establishment or maintenance of neuroblast polarity,BP,
11131,GO:0045200,1.00000000001457,0.812474684632655,0,2,establishment of neuroblast polarity,BP,
11179,GO:0045322,1.00000000001457,0.812474684632655,0,2,unmethylated CpG binding,MF,
11204,GO:0045356,1.00000000001457,0.812474684632655,0,2,positive regulation of interferon-alpha biosynthetic process,BP,
11220,GO:0045416,1.00000000001457,0.812474684632655,0,2,positive regulation of interleukin-8 biosynthetic process,BP,
11241,GO:0045509,1.00000000001457,0.812474684632655,0,2,interleukin-27 receptor activity,MF,
11258,GO:0045588,1.00000000001457,0.812474684632655,0,2,positive regulation of gamma-delta T cell differentiation,BP,
11473,GO:0045967,1.00000000001457,0.812474684632655,0,2,negative regulation of growth rate,BP,
11475,GO:0045976,1.00000000001457,0.812474684632655,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
11518,GO:0046069,1.00000000001457,0.812474684632655,0,2,cGMP catabolic process,BP,
11565,GO:0046160,1.00000000001457,0.812474684632655,0,2,heme a metabolic process,BP,
11569,GO:0046167,1.00000000001457,0.812474684632655,0,2,glycerol-3-phosphate biosynthetic process,BP,
11828,GO:0046832,1.00000000001457,0.812474684632655,0,2,negative regulation of RNA export from nucleus,BP,
11876,GO:0046922,1.00000000001457,0.812474684632655,0,2,peptide-O-fucosyltransferase activity,MF,
11901,GO:0046967,1.00000000001457,0.812474684632655,0,2,cytosol to ER transport,BP,
11951,GO:0047237,1.00000000001457,0.812474684632655,0,2,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
11964,GO:0047322,1.00000000001457,0.812474684632655,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
11973,GO:0047389,1.00000000001457,0.812474684632655,0,2,glycerophosphocholine phosphodiesterase activity,MF,
11999,GO:0047623,1.00000000001457,0.812474684632655,0,2,adenosine-phosphate deaminase activity,MF,
12017,GO:0047757,1.00000000001457,0.812474684632655,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
12051,GO:0048022,1.00000000001457,0.812474684632655,0,2,negative regulation of melanin biosynthetic process,BP,
12072,GO:0048073,1.00000000001457,0.812474684632655,0,2,regulation of eye pigmentation,BP,
12164,GO:0048319,1.00000000001457,0.812474684632655,0,2,axial mesoderm morphogenesis,BP,
12341,GO:0048743,1.00000000001457,0.812474684632655,0,2,positive regulation of skeletal muscle fiber development,BP,
12355,GO:0048769,1.00000000001457,0.812474684632655,0,2,sarcomerogenesis,BP,
12369,GO:0048817,1.00000000001457,0.812474684632655,0,2,negative regulation of hair follicle maturation,BP,
12383,GO:0048850,1.00000000001457,0.812474684632655,0,2,hypophysis morphogenesis,BP,
12430,GO:0050211,1.00000000001457,0.812474684632655,0,2,procollagen galactosyltransferase activity,MF,
12453,GO:0050405,1.00000000001457,0.812474684632655,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
12469,GO:0050508,1.00000000001457,0.812474684632655,0,2,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
12470,GO:0050509,1.00000000001457,0.812474684632655,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
12493,GO:0050659,1.00000000001457,0.812474684632655,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
12661,GO:0050904,1.00000000001457,0.812474684632655,0,2,diapedesis,BP,
12681,GO:0050925,1.00000000001457,0.812474684632655,0,2,negative regulation of negative chemotaxis,BP,
12997,GO:0051458,1.00000000001457,0.812474684632655,0,2,corticotropin secretion,BP,
12998,GO:0051459,1.00000000001457,0.812474684632655,0,2,regulation of corticotropin secretion,BP,
12999,GO:0051461,1.00000000001457,0.812474684632655,0,2,positive regulation of corticotropin secretion,BP,
13031,GO:0051548,1.00000000001457,0.812474684632655,0,2,negative regulation of keratinocyte migration,BP,
13036,GO:0051563,1.00000000001457,0.812474684632655,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13096,GO:0051664,1.00000000001457,0.812474684632655,0,2,nuclear pore localization,BP,
13122,GO:0051717,1.00000000001457,0.812474684632655,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
13199,GO:0051890,1.00000000001457,0.812474684632655,0,2,regulation of cardioblast differentiation,BP,
13243,GO:0051958,1.00000000001457,0.812474684632655,0,2,methotrexate transport,BP,
13381,GO:0052746,1.00000000001457,0.812474684632655,0,2,inositol phosphorylation,BP,
13387,GO:0052805,1.00000000001457,0.812474684632655,0,2,imidazole-containing compound catabolic process,BP,
13390,GO:0052812,1.00000000001457,0.812474684632655,0,2,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
13397,GO:0052827,1.00000000001457,0.812474684632655,0,2,inositol pentakisphosphate phosphatase activity,MF,
13398,GO:0052828,1.00000000001457,0.812474684632655,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
13514,GO:0060002,1.00000000001457,0.812474684632655,0,2,plus-end directed microfilament motor activity,MF,
13534,GO:0060025,1.00000000001457,0.812474684632655,0,2,regulation of synaptic activity,BP,
13601,GO:0060124,1.00000000001457,0.812474684632655,0,2,positive regulation of growth hormone secretion,BP,
13606,GO:0060129,1.00000000001457,0.812474684632655,0,2,thyroid-stimulating hormone-secreting cell differentiation,BP,
13617,GO:0060151,1.00000000001457,0.812474684632655,0,2,peroxisome localization,BP,
13618,GO:0060152,1.00000000001457,0.812474684632655,0,2,microtubule-based peroxisome localization,BP,
13622,GO:0060157,1.00000000001457,0.812474684632655,0,2,urinary bladder development,BP,
13767,GO:0060382,1.00000000001457,0.812474684632655,0,2,regulation of DNA strand elongation,BP,
13782,GO:0060399,1.00000000001457,0.812474684632655,0,2,positive regulation of growth hormone receptor signaling pathway,BP,
13787,GO:0060406,1.00000000001457,0.812474684632655,0,2,positive regulation of penile erection,BP,
13804,GO:0060430,1.00000000001457,0.812474684632655,0,2,lung saccule development,BP,
13857,GO:0060523,1.00000000001457,0.812474684632655,0,2,prostate epithelial cord elongation,BP,
13862,GO:0060529,1.00000000001457,0.812474684632655,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
13863,GO:0060532,1.00000000001457,0.812474684632655,0,2,bronchus cartilage development,BP,
13903,GO:0060594,1.00000000001457,0.812474684632655,0,2,mammary gland specification,BP,
13930,GO:0060664,1.00000000001457,0.812474684632655,0,2,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
13958,GO:0060698,1.00000000001457,0.812474684632655,0,2,endoribonuclease inhibitor activity,MF,
13961,GO:0060701,1.00000000001457,0.812474684632655,0,2,negative regulation of ribonuclease activity,BP,
13962,GO:0060702,1.00000000001457,0.812474684632655,0,2,negative regulation of endoribonuclease activity,BP,
13984,GO:0060733,1.00000000001457,0.812474684632655,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
14019,GO:0060800,1.00000000001457,0.812474684632655,0,2,regulation of cell differentiation involved in embryonic placenta development,BP,
14022,GO:0060816,1.00000000001457,0.812474684632655,0,2,random inactivation of X chromosome,BP,
14023,GO:0060819,1.00000000001457,0.812474684632655,0,2,inactivation of X chromosome by genetic imprinting,BP,
14065,GO:0060921,1.00000000001457,0.812474684632655,0,2,sinoatrial node cell differentiation,BP,
14070,GO:0060931,1.00000000001457,0.812474684632655,0,2,sinoatrial node cell development,BP,
14101,GO:0060995,1.00000000001457,0.812474684632655,0,2,cell-cell signaling involved in kidney development,BP,
14144,GO:0061055,1.00000000001457,0.812474684632655,0,2,myotome development,BP,
14172,GO:0061110,1.00000000001457,0.812474684632655,0,2,dense core granule biogenesis,BP,
14183,GO:0061145,1.00000000001457,0.812474684632655,0,2,lung smooth muscle development,BP,
14202,GO:0061187,1.00000000001457,0.812474684632655,0,2,regulation of chromatin silencing at rDNA,BP,
14203,GO:0061188,1.00000000001457,0.812474684632655,0,2,negative regulation of chromatin silencing at rDNA,BP,
14218,GO:0061289,1.00000000001457,0.812474684632655,0,2,Wnt signaling pathway involved in kidney development,BP,
14219,GO:0061290,1.00000000001457,0.812474684632655,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
14264,GO:0061386,1.00000000001457,0.812474684632655,0,2,closure of optic fissure,BP,
14281,GO:0061443,1.00000000001457,0.812474684632655,0,2,endocardial cushion cell differentiation,BP,
14299,GO:0061505,1.00000000001457,0.812474684632655,0,2,DNA topoisomerase II activity,MF,
14337,GO:0061582,1.00000000001457,0.812474684632655,0,2,intestinal epithelial cell migration,BP,
14367,GO:0061643,1.00000000001457,0.812474684632655,0,2,chemorepulsion of axon,BP,
14378,GO:0061669,1.00000000001457,0.812474684632655,0,2,spontaneous neurotransmitter secretion,BP,
14411,GO:0061749,1.00000000001457,0.812474684632655,0,2,forked DNA-dependent helicase activity,MF,
14418,GO:0061762,1.00000000001457,0.812474684632655,0,2,CAMKK-AMPK signaling cascade,BP,
14448,GO:0061849,1.00000000001457,0.812474684632655,0,2,telomeric G-quadruplex DNA binding,MF,
14451,GO:0061857,1.00000000001457,0.812474684632655,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
14482,GO:0065001,1.00000000001457,0.812474684632655,0,2,specification of axis polarity,BP,
14513,GO:0070052,1.00000000001457,0.812474684632655,0,2,collagen V binding,MF,
14541,GO:0070097,1.00000000001457,0.812474684632655,0,2,delta-catenin binding,MF,
14583,GO:0070170,1.00000000001457,0.812474684632655,0,2,regulation of tooth mineralization,BP,
14634,GO:0070259,1.00000000001457,0.812474684632655,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
14652,GO:0070292,1.00000000001457,0.812474684632655,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
14667,GO:0070315,1.00000000001457,0.812474684632655,0,2,G1 to G0 transition involved in cell differentiation,BP,
14680,GO:0070336,1.00000000001457,0.812474684632655,0,2,flap-structured DNA binding,MF,
14683,GO:0070340,1.00000000001457,0.812474684632655,0,2,detection of bacterial lipopeptide,BP,
14701,GO:0070381,1.00000000001457,0.812474684632655,0,2,endosome to plasma membrane transport vesicle,CC,
14734,GO:0070436,1.00000000001457,0.812474684632655,0,2,Grb2-EGFR complex,CC,
14849,GO:0070662,1.00000000001457,0.812474684632655,0,2,mast cell proliferation,BP,
14853,GO:0070666,1.00000000001457,0.812474684632655,0,2,regulation of mast cell proliferation,BP,
14855,GO:0070668,1.00000000001457,0.812474684632655,0,2,positive regulation of mast cell proliferation,BP,
14873,GO:0070704,1.00000000001457,0.812474684632655,0,2,sterol desaturase activity,MF,
14932,GO:0070853,1.00000000001457,0.812474684632655,0,2,myosin VI binding,MF,
14945,GO:0070877,1.00000000001457,0.812474684632655,0,2,microprocessor complex,CC,
15020,GO:0070993,1.00000000001457,0.812474684632655,0,2,translation preinitiation complex,CC,
15069,GO:0071109,1.00000000001457,0.812474684632655,0,2,superior temporal gyrus development,BP,
15075,GO:0071144,1.00000000001457,0.812474684632655,0,2,heteromeric SMAD protein complex,CC,
15076,GO:0071148,1.00000000001457,0.812474684632655,0,2,TEAD-1-YAP complex,CC,
15124,GO:0071262,1.00000000001457,0.812474684632655,0,2,regulation of translational initiation in response to starvation,BP,
15125,GO:0071264,1.00000000001457,0.812474684632655,0,2,positive regulation of translational initiation in response to starvation,BP,
15193,GO:0071374,1.00000000001457,0.812474684632655,0,2,cellular response to parathyroid hormone stimulus,BP,
15203,GO:0071386,1.00000000001457,0.812474684632655,0,2,cellular response to corticosterone stimulus,BP,
15220,GO:0071409,1.00000000001457,0.812474684632655,0,2,cellular response to cycloheximide,BP,
15224,GO:0071420,1.00000000001457,0.812474684632655,0,2,cellular response to histamine,BP,
15225,GO:0071421,1.00000000001457,0.812474684632655,0,2,manganese ion transmembrane transport,BP,
15270,GO:0071483,1.00000000001457,0.812474684632655,0,2,cellular response to blue light,BP,
15271,GO:0071484,1.00000000001457,0.812474684632655,0,2,cellular response to light intensity,BP,
15331,GO:0071595,1.00000000001457,0.812474684632655,0,2,Nem1-Spo7 phosphatase complex,CC,
15337,GO:0071603,1.00000000001457,0.812474684632655,0,2,endothelial cell-cell adhesion,BP,
15414,GO:0071724,1.00000000001457,0.812474684632655,0,2,response to diacyl bacterial lipopeptide,BP,
15416,GO:0071726,1.00000000001457,0.812474684632655,0,2,cellular response to diacyl bacterial lipopeptide,BP,
15460,GO:0071847,1.00000000001457,0.812474684632655,0,2,TNFSF11-mediated signaling pathway,BP,
15501,GO:0071918,1.00000000001457,0.812474684632655,0,2,urea transmembrane transport,BP,
15506,GO:0071929,1.00000000001457,0.812474684632655,0,2,alpha-tubulin acetylation,BP,
15546,GO:0072034,1.00000000001457,0.812474684632655,0,2,renal vesicle induction,BP,
15548,GO:0072038,1.00000000001457,0.812474684632655,0,2,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
15549,GO:0072039,1.00000000001457,0.812474684632655,0,2,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15550,GO:0072040,1.00000000001457,0.812474684632655,0,2,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15609,GO:0072134,1.00000000001457,0.812474684632655,0,2,nephrogenic mesenchyme morphogenesis,BP,
15610,GO:0072135,1.00000000001457,0.812474684632655,0,2,kidney mesenchymal cell proliferation,BP,
15611,GO:0072136,1.00000000001457,0.812474684632655,0,2,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
15622,GO:0072162,1.00000000001457,0.812474684632655,0,2,metanephric mesenchymal cell differentiation,BP,
15653,GO:0072204,1.00000000001457,0.812474684632655,0,2,cell-cell signaling involved in metanephros development,BP,
15697,GO:0072289,1.00000000001457,0.812474684632655,0,2,metanephric nephron tubule formation,BP,
15745,GO:0072368,1.00000000001457,0.812474684632655,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
15772,GO:0072434,1.00000000001457,0.812474684632655,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
15880,GO:0072679,1.00000000001457,0.812474684632655,0,2,thymocyte migration,BP,
15934,GO:0075732,1.00000000001457,0.812474684632655,0,2,viral penetration into host nucleus,BP,
15939,GO:0080023,1.00000000001457,0.812474684632655,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
15969,GO:0086007,1.00000000001457,0.812474684632655,0,2,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
15977,GO:0086015,1.00000000001457,0.812474684632655,0,2,SA node cell action potential,BP,
15979,GO:0086017,1.00000000001457,0.812474684632655,0,2,Purkinje myocyte action potential,BP,
15980,GO:0086018,1.00000000001457,0.812474684632655,0,2,SA node cell to atrial cardiac muscle cell signaling,BP,
15982,GO:0086020,1.00000000001457,0.812474684632655,0,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
15983,GO:0086021,1.00000000001457,0.812474684632655,0,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
15989,GO:0086029,1.00000000001457,0.812474684632655,0,2,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
15997,GO:0086045,1.00000000001457,0.812474684632655,0,2,membrane depolarization during AV node cell action potential,BP,
16000,GO:0086048,1.00000000001457,0.812474684632655,0,2,membrane depolarization during bundle of His cell action potential,BP,
16001,GO:0086053,1.00000000001457,0.812474684632655,0,2,AV node cell to bundle of His cell communication by electrical coupling,BP,
16010,GO:0086068,1.00000000001457,0.812474684632655,0,2,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
16017,GO:0086077,1.00000000001457,0.812474684632655,0,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
16161,GO:0090210,1.00000000001457,0.812474684632655,0,2,regulation of establishment of blood-brain barrier,BP,
16167,GO:0090222,1.00000000001457,0.812474684632655,0,2,centrosome-templated microtubule nucleation,BP,
16197,GO:0090271,1.00000000001457,0.812474684632655,0,2,positive regulation of fibroblast growth factor production,BP,
16238,GO:0090325,1.00000000001457,0.812474684632655,0,2,regulation of locomotion involved in locomotory behavior,BP,
16263,GO:0090386,1.00000000001457,0.812474684632655,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
16264,GO:0090387,1.00000000001457,0.812474684632655,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
16300,GO:0090541,1.00000000001457,0.812474684632655,0,2,MIT domain binding,MF,
16347,GO:0090694,1.00000000001457,0.812474684632655,0,2,Scc2-Scc4 cohesin loading complex,CC,
16369,GO:0097016,1.00000000001457,0.812474684632655,0,2,L27 domain binding,MF,
16403,GO:0097069,1.00000000001457,0.812474684632655,0,2,cellular response to thyroxine stimulus,BP,
16421,GO:0097111,1.00000000001457,0.812474684632655,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
16445,GO:0097155,1.00000000001457,0.812474684632655,0,2,fasciculation of sensory neuron axon,BP,
16473,GO:0097198,1.00000000001457,0.812474684632655,0,2,histone H3-K36 trimethylation,BP,
16507,GO:0097274,1.00000000001457,0.812474684632655,0,2,urea homeostasis,BP,
16521,GO:0097309,1.00000000001457,0.812474684632655,0,2,cap1 mRNA methylation,BP,
16541,GO:0097359,1.00000000001457,0.812474684632655,0,2,UDP-glucosylation,BP,
16545,GO:0097363,1.00000000001457,0.812474684632655,0,2,protein O-GlcNAc transferase activity,MF,
16584,GO:0097450,1.00000000001457,0.812474684632655,0,2,astrocyte end-foot,CC,
16585,GO:0097451,1.00000000001457,0.812474684632655,0,2,glial limiting end-foot,CC,
16588,GO:0097457,1.00000000001457,0.812474684632655,0,2,hippocampal mossy fiber,CC,
16637,GO:0097543,1.00000000001457,0.812474684632655,0,2,ciliary inversin compartment,CC,
16642,GO:0097574,1.00000000001457,0.812474684632655,0,2,lateral part of cell,CC,
16643,GO:0097575,1.00000000001457,0.812474684632655,0,2,lateral cell cortex,CC,
16661,GO:0097636,1.00000000001457,0.812474684632655,0,2,intrinsic component of autophagosome membrane,CC,
16662,GO:0097637,1.00000000001457,0.812474684632655,0,2,integral component of autophagosome membrane,CC,
16663,GO:0097638,1.00000000001457,0.812474684632655,0,2,L-arginine import across plasma membrane,BP,
16672,GO:0097651,1.00000000001457,0.812474684632655,0,2,phosphatidylinositol 3-kinase complex, class I,CC,
16678,GO:0097681,1.00000000001457,0.812474684632655,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
16747,GO:0098582,1.00000000001457,0.812474684632655,0,2,innate vocalization behavior,BP,
16824,GO:0098770,1.00000000001457,0.812474684632655,0,2,FBXO family protein binding,MF,
16837,GO:0098795,1.00000000001457,0.812474684632655,0,2,mRNA cleavage involved in gene silencing,BP,
16890,GO:0098886,1.00000000001457,0.812474684632655,0,2,modification of dendritic spine,BP,
16907,GO:0098914,1.00000000001457,0.812474684632655,0,2,membrane repolarization during atrial cardiac muscle cell action potential,BP,
16918,GO:0098928,1.00000000001457,0.812474684632655,0,2,presynaptic signal transduction,BP,
16933,GO:0098971,1.00000000001457,0.812474684632655,0,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,
16947,GO:0099004,1.00000000001457,0.812474684632655,0,2,calmodulin dependent kinase signaling pathway,BP,
16949,GO:0099011,1.00000000001457,0.812474684632655,0,2,neuronal dense core vesicle exocytosis,BP,
16963,GO:0099073,1.00000000001457,0.812474684632655,0,2,mitochondrion-derived vesicle,CC,
16975,GO:0099093,1.00000000001457,0.812474684632655,0,2,calcium export from the mitochondrion,BP,
17002,GO:0099403,1.00000000001457,0.812474684632655,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
17003,GO:0099404,1.00000000001457,0.812474684632655,0,2,mitotic sister chromatid cohesion, telomeric,BP,
17019,GO:0099525,1.00000000001457,0.812474684632655,0,2,presynaptic dense core vesicle exocytosis,BP,
17020,GO:0099526,1.00000000001457,0.812474684632655,0,2,presynapse to nucleus signaling pathway,BP,
17025,GO:0099532,1.00000000001457,0.812474684632655,0,2,synaptic vesicle endosomal processing,BP,
17057,GO:0099609,1.00000000001457,0.812474684632655,0,2,microtubule lateral binding,MF,
17062,GO:0099624,1.00000000001457,0.812474684632655,0,2,atrial cardiac muscle cell membrane repolarization,BP,
17095,GO:0102092,1.00000000001457,0.812474684632655,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
17186,GO:0106073,1.00000000001457,0.812474684632655,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
17267,GO:0140066,1.00000000001457,0.812474684632655,0,2,peptidyl-lysine crotonylation,BP,
17326,GO:1900042,1.00000000001457,0.812474684632655,0,2,positive regulation of interleukin-2 secretion,BP,
17359,GO:1900114,1.00000000001457,0.812474684632655,0,2,positive regulation of histone H3-K9 trimethylation,BP,
17382,GO:1900147,1.00000000001457,0.812474684632655,0,2,regulation of Schwann cell migration,BP,
17395,GO:1900169,1.00000000001457,0.812474684632655,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
17434,GO:1900248,1.00000000001457,0.812474684632655,0,2,negative regulation of cytoplasmic translational elongation,BP,
17443,GO:1900275,1.00000000001457,0.812474684632655,0,2,negative regulation of phospholipase C activity,BP,
17455,GO:1900377,1.00000000001457,0.812474684632655,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
17456,GO:1900378,1.00000000001457,0.812474684632655,0,2,positive regulation of secondary metabolite biosynthetic process,BP,
17478,GO:1900623,1.00000000001457,0.812474684632655,0,2,regulation of monocyte aggregation,BP,
17479,GO:1900625,1.00000000001457,0.812474684632655,0,2,positive regulation of monocyte aggregation,BP,
17517,GO:1901073,1.00000000001457,0.812474684632655,0,2,glucosamine-containing compound biosynthetic process,BP,
17535,GO:1901143,1.00000000001457,0.812474684632655,0,2,insulin catabolic process,BP,
17536,GO:1901145,1.00000000001457,0.812474684632655,0,2,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
17633,GO:1901491,1.00000000001457,0.812474684632655,0,2,negative regulation of lymphangiogenesis,BP,
17637,GO:1901509,1.00000000001457,0.812474684632655,0,2,regulation of endothelial tube morphogenesis,BP,
17646,GO:1901534,1.00000000001457,0.812474684632655,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
17648,GO:1901536,1.00000000001457,0.812474684632655,0,2,negative regulation of DNA demethylation,BP,
17700,GO:1901656,1.00000000001457,0.812474684632655,0,2,glycoside transport,BP,
17756,GO:1901843,1.00000000001457,0.812474684632655,0,2,positive regulation of high voltage-gated calcium channel activity,BP,
17807,GO:1901993,1.00000000001457,0.812474684632655,0,2,regulation of meiotic cell cycle phase transition,BP,
17808,GO:1901994,1.00000000001457,0.812474684632655,0,2,negative regulation of meiotic cell cycle phase transition,BP,
17903,GO:1902256,1.00000000001457,0.812474684632655,0,2,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
17907,GO:1902261,1.00000000001457,0.812474684632655,0,2,positive regulation of delayed rectifier potassium channel activity,BP,
17912,GO:1902269,1.00000000001457,0.812474684632655,0,2,positive regulation of polyamine transmembrane transport,BP,
17924,GO:1902302,1.00000000001457,0.812474684632655,0,2,regulation of potassium ion export,BP,
17995,GO:1902523,1.00000000001457,0.812474684632655,0,2,positive regulation of protein K63-linked ubiquitination,BP,
18025,GO:1902594,1.00000000001457,0.812474684632655,0,2,multi-organism nuclear import,BP,
18065,GO:1902715,1.00000000001457,0.812474684632655,0,2,positive regulation of interferon-gamma secretion,BP,
18068,GO:1902724,1.00000000001457,0.812474684632655,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
18070,GO:1902728,1.00000000001457,0.812474684632655,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
18072,GO:1902731,1.00000000001457,0.812474684632655,0,2,negative regulation of chondrocyte proliferation,BP,
18094,GO:1902805,1.00000000001457,0.812474684632655,0,2,positive regulation of synaptic vesicle transport,BP,
18110,GO:1902856,1.00000000001457,0.812474684632655,0,2,negative regulation of non-motile cilium assembly,BP,
18127,GO:1902896,1.00000000001457,0.812474684632655,0,2,terminal web assembly,BP,
18231,GO:1903095,1.00000000001457,0.812474684632655,0,2,ribonuclease III complex,CC,
18236,GO:1903116,1.00000000001457,0.812474684632655,0,2,positive regulation of actin filament-based movement,BP,
18281,GO:1903225,1.00000000001457,0.812474684632655,0,2,negative regulation of endodermal cell differentiation,BP,
18284,GO:1903233,1.00000000001457,0.812474684632655,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
18305,GO:1903292,1.00000000001457,0.812474684632655,0,2,protein localization to Golgi membrane,BP,
18307,GO:1903294,1.00000000001457,0.812474684632655,0,2,regulation of glutamate secretion, neurotransmission,BP,
18308,GO:1903296,1.00000000001457,0.812474684632655,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
18349,GO:1903378,1.00000000001457,0.812474684632655,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18354,GO:1903385,1.00000000001457,0.812474684632655,0,2,regulation of homophilic cell adhesion,BP,
18381,GO:1903436,1.00000000001457,0.812474684632655,0,2,regulation of mitotic cytokinetic process,BP,
18382,GO:1903438,1.00000000001457,0.812474684632655,0,2,positive regulation of mitotic cytokinetic process,BP,
18397,GO:1903490,1.00000000001457,0.812474684632655,0,2,positive regulation of mitotic cytokinesis,BP,
18416,GO:1903526,1.00000000001457,0.812474684632655,0,2,negative regulation of membrane tubulation,BP,
18492,GO:1903691,1.00000000001457,0.812474684632655,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
18523,GO:1903760,1.00000000001457,0.812474684632655,0,2,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18535,GO:1903781,1.00000000001457,0.812474684632655,0,2,positive regulation of cardiac conduction,BP,
18565,GO:1903847,1.00000000001457,0.812474684632655,0,2,regulation of aorta morphogenesis,BP,
18566,GO:1903849,1.00000000001457,0.812474684632655,0,2,positive regulation of aorta morphogenesis,BP,
18574,GO:1903874,1.00000000001457,0.812474684632655,0,2,ferrous iron transmembrane transport,BP,
18616,GO:1903949,1.00000000001457,0.812474684632655,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
18645,GO:1904017,1.00000000001457,0.812474684632655,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
18648,GO:1904020,1.00000000001457,0.812474684632655,0,2,regulation of G-protein coupled receptor internalization,BP,
18751,GO:1904289,1.00000000001457,0.812474684632655,0,2,regulation of mitotic DNA damage checkpoint,BP,
18768,GO:1904327,1.00000000001457,0.812474684632655,0,2,protein localization to cytosolic proteasome complex,BP,
18786,GO:1904379,1.00000000001457,0.812474684632655,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
18788,GO:1904381,1.00000000001457,0.812474684632655,0,2,Golgi apparatus mannose trimming,BP,
18793,GO:1904387,1.00000000001457,0.812474684632655,0,2,cellular response to L-phenylalanine derivative,BP,
18797,GO:1904398,1.00000000001457,0.812474684632655,0,2,positive regulation of neuromuscular junction development,BP,
18821,GO:1904455,1.00000000001457,0.812474684632655,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
18828,GO:1904475,1.00000000001457,0.812474684632655,0,2,regulation of Ras GTPase binding,BP,
18844,GO:1904529,1.00000000001457,0.812474684632655,0,2,regulation of actin filament binding,BP,
18848,GO:1904534,1.00000000001457,0.812474684632655,0,2,negative regulation of telomeric loop disassembly,BP,
18855,GO:1904562,1.00000000001457,0.812474684632655,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
18884,GO:1904612,1.00000000001457,0.812474684632655,0,2,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
18885,GO:1904613,1.00000000001457,0.812474684632655,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
18886,GO:1904616,1.00000000001457,0.812474684632655,0,2,regulation of actin binding,BP,
18902,GO:1904673,1.00000000001457,0.812474684632655,0,2,negative regulation of somatic stem cell population maintenance,BP,
18938,GO:1904743,1.00000000001457,0.812474684632655,0,2,negative regulation of telomeric DNA binding,BP,
19000,GO:1904868,1.00000000001457,0.812474684632655,0,2,telomerase catalytic core complex assembly,BP,
19012,GO:1904882,1.00000000001457,0.812474684632655,0,2,regulation of telomerase catalytic core complex assembly,BP,
19013,GO:1904884,1.00000000001457,0.812474684632655,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
19026,GO:1904907,1.00000000001457,0.812474684632655,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19027,GO:1904908,1.00000000001457,0.812474684632655,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19055,GO:1904975,1.00000000001457,0.812474684632655,0,2,response to bleomycin,BP,
19056,GO:1904976,1.00000000001457,0.812474684632655,0,2,cellular response to bleomycin,BP,
19073,GO:1905024,1.00000000001457,0.812474684632655,0,2,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19100,GO:1905071,1.00000000001457,0.812474684632655,0,2,occluding junction disassembly,BP,
19101,GO:1905073,1.00000000001457,0.812474684632655,0,2,regulation of occluding junction disassembly,BP,
19102,GO:1905075,1.00000000001457,0.812474684632655,0,2,positive regulation of occluding junction disassembly,BP,
19112,GO:1905123,1.00000000001457,0.812474684632655,0,2,regulation of glucosylceramidase activity,BP,
19119,GO:1905150,1.00000000001457,0.812474684632655,0,2,regulation of voltage-gated sodium channel activity,BP,
19148,GO:1905224,1.00000000001457,0.812474684632655,0,2,clathrin-coated pit assembly,BP,
19246,GO:1905462,1.00000000001457,0.812474684632655,0,2,regulation of DNA duplex unwinding,BP,
19266,GO:1905538,1.00000000001457,0.812474684632655,0,2,polysome binding,MF,
19298,GO:1905616,1.00000000001457,0.812474684632655,0,2,regulation of miRNA mediated inhibition of translation,BP,
19299,GO:1905618,1.00000000001457,0.812474684632655,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
19316,GO:1905696,1.00000000001457,0.812474684632655,0,2,regulation of polysome binding,BP,
19336,GO:1905778,1.00000000001457,0.812474684632655,0,2,negative regulation of exonuclease activity,BP,
19347,GO:1905838,1.00000000001457,0.812474684632655,0,2,regulation of telomeric D-loop disassembly,BP,
19348,GO:1905839,1.00000000001457,0.812474684632655,0,2,negative regulation of telomeric D-loop disassembly,BP,
19419,GO:1990108,1.00000000001457,0.812474684632655,0,2,protein linear deubiquitination,BP,
19421,GO:1990112,1.00000000001457,0.812474684632655,0,2,RQC complex,CC,
19422,GO:1990116,1.00000000001457,0.812474684632655,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
19433,GO:1990145,1.00000000001457,0.812474684632655,0,2,maintenance of translational fidelity,BP,
19503,GO:1990428,1.00000000001457,0.812474684632655,0,2,miRNA transport,BP,
19505,GO:1990430,1.00000000001457,0.812474684632655,0,2,extracellular matrix protein binding,MF,
19513,GO:1990452,1.00000000001457,0.812474684632655,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
19520,GO:1990498,1.00000000001457,0.812474684632655,0,2,mitotic spindle microtubule,CC,
19569,GO:1990723,1.00000000001457,0.812474684632655,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
19572,GO:1990730,1.00000000001457,0.812474684632655,0,2,VCP-NSFL1C complex,CC,
19624,GO:1990879,1.00000000001457,0.812474684632655,0,2,CST complex,CC,
19636,GO:1990918,1.00000000001457,0.812474684632655,0,2,double-strand break repair involved in meiotic recombination,BP,
19637,GO:1990923,1.00000000001457,0.812474684632655,0,2,PET complex,CC,
19639,GO:1990927,1.00000000001457,0.812474684632655,0,2,calcium ion regulated lysosome exocytosis,BP,
19640,GO:1990928,1.00000000001457,0.812474684632655,0,2,response to amino acid starvation,BP,
19667,GO:2000017,1.00000000001457,0.812474684632655,0,2,positive regulation of determination of dorsal identity,BP,
19685,GO:2000053,1.00000000001457,0.812474684632655,0,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19731,GO:2000156,1.00000000001457,0.812474684632655,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
19769,GO:2000233,1.00000000001457,0.812474684632655,0,2,negative regulation of rRNA processing,BP,
19777,GO:2000253,1.00000000001457,0.812474684632655,0,2,positive regulation of feeding behavior,BP,
19807,GO:2000302,1.00000000001457,0.812474684632655,0,2,positive regulation of synaptic vesicle exocytosis,BP,
19839,GO:2000346,1.00000000001457,0.812474684632655,0,2,negative regulation of hepatocyte proliferation,BP,
19889,GO:2000416,1.00000000001457,0.812474684632655,0,2,regulation of eosinophil migration,BP,
19939,GO:2000543,1.00000000001457,0.812474684632655,0,2,positive regulation of gastrulation,BP,
19947,GO:2000563,1.00000000001457,0.812474684632655,0,2,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
19963,GO:2000588,1.00000000001457,0.812474684632655,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
19972,GO:2000611,1.00000000001457,0.812474684632655,0,2,positive regulation of thyroid hormone generation,BP,
19979,GO:2000620,1.00000000001457,0.812474684632655,0,2,positive regulation of histone H4-K16 acetylation,BP,
20018,GO:2000670,1.00000000001457,0.812474684632655,0,2,positive regulation of dendritic cell apoptotic process,BP,
20032,GO:2000697,1.00000000001457,0.812474684632655,0,2,negative regulation of epithelial cell differentiation involved in kidney development,BP,
20038,GO:2000705,1.00000000001457,0.812474684632655,0,2,regulation of dense core granule biogenesis,BP,
20083,GO:2000790,1.00000000001457,0.812474684632655,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
20084,GO:2000791,1.00000000001457,0.812474684632655,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
20085,GO:2000793,1.00000000001457,0.812474684632655,0,2,cell proliferation involved in heart valve development,BP,
20110,GO:2000832,1.00000000001457,0.812474684632655,0,2,negative regulation of steroid hormone secretion,BP,
20117,GO:2000847,1.00000000001457,0.812474684632655,0,2,negative regulation of corticosteroid hormone secretion,BP,
20120,GO:2000850,1.00000000001457,0.812474684632655,0,2,negative regulation of glucocorticoid secretion,BP,
20142,GO:2001013,1.00000000001457,0.812474684632655,0,2,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
20144,GO:2001015,1.00000000001457,0.812474684632655,0,2,negative regulation of skeletal muscle cell differentiation,BP,
20153,GO:2001027,1.00000000001457,0.812474684632655,0,2,negative regulation of endothelial cell chemotaxis,BP,
20166,GO:2001045,1.00000000001457,0.812474684632655,0,2,negative regulation of integrin-mediated signaling pathway,BP,
20177,GO:2001106,1.00000000001457,0.812474684632655,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
20220,GO:2001201,1.00000000001457,0.812474684632655,0,2,regulation of transforming growth factor-beta secretion,BP,
20234,GO:2001228,1.00000000001457,0.812474684632655,0,2,regulation of response to gamma radiation,BP,
20248,GO:2001245,1.00000000001457,0.812474684632655,0,2,regulation of phosphatidylcholine biosynthetic process,BP,
20274,GO:2001295,1.00000000001457,0.812474684632655,0,2,malonyl-CoA biosynthetic process,BP,
11429,GO:0045903,1.00000000001458,0.76753030283147,0,3,positive regulation of translational fidelity,BP,
16668,GO:0097644,1.00000000001458,0.832218844590729,0,2,calcitonin family binding,MF,
18383,GO:1903439,1.00000000001458,0.832218844590729,0,2,calcitonin family receptor complex,CC,
19490,GO:1990406,1.00000000001458,0.832218844590729,0,2,CGRP receptor complex,CC,
19492,GO:1990408,1.00000000001458,0.832218844590729,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
2414,GO:0005594,1.00000000001462,0.812564064075931,0,2,collagen type IX trimer,CC,
1338,GO:0003199,1.00000000001464,0.908982211958271,0,1,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
4815,GO:0014028,1.00000000001464,0.908982211958271,0,1,notochord formation,BP,
13837,GO:0060481,1.00000000001465,0.82281255366663,0,2,lobar bronchus epithelium development,BP,
15843,GO:0072592,1.00000000001466,0.814552369011043,0,2,oxygen metabolic process,BP,
17873,GO:1902202,1.00000000001466,0.816934609205061,0,2,regulation of hepatocyte growth factor receptor signaling pathway,BP,
17878,GO:1902214,1.00000000001466,0.816934609205061,0,2,regulation of interleukin-4-mediated signaling pathway,BP,
6469,GO:0021822,1.00000000001467,0.902477646705564,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
3212,GO:0006867,1.00000000001472,0.901378102567816,0,1,asparagine transport,BP,
5009,GO:0015182,1.00000000001472,0.901378102567816,0,1,L-asparagine transmembrane transporter activity,MF,
5016,GO:0015190,1.00000000001472,0.901378102567816,0,1,L-leucine transmembrane transporter activity,MF,
5017,GO:0015191,1.00000000001472,0.901378102567816,0,1,L-methionine transmembrane transporter activity,MF,
5129,GO:0015658,1.00000000001472,0.901378102567816,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5209,GO:0015821,1.00000000001472,0.901378102567816,0,1,methionine transport,BP,
10647,GO:0043865,1.00000000001472,0.901378102567816,0,1,methionine transmembrane transporter activity,MF,
13162,GO:0051795,1.00000000001474,0.753760269663217,0,3,positive regulation of timing of catagen,BP,
1902,GO:0004594,1.00000000001474,0.663169873911338,0,4,pantothenate kinase activity,MF,
2126,GO:0004931,1.00000000001475,0.903095111233637,0,1,extracellularly ATP-gated cation channel activity,MF,
9089,GO:0035381,1.00000000001475,0.903095111233637,0,1,ATP-gated ion channel activity,MF,
17601,GO:1901338,1.00000000001476,0.736307515900446,0,3,catecholamine binding,MF,
10835,GO:0044352,1.00000000001476,0.664403489445475,0,4,pinosome,CC,
10836,GO:0044354,1.00000000001476,0.664403489445475,0,4,macropinosome,CC,
4513,GO:0010585,1.00000000001485,0.903896546140273,0,1,glutamine secretion,BP,
18548,GO:1903803,1.00000000001485,0.903896546140273,0,1,L-glutamine import across plasma membrane,BP,
5070,GO:0015317,1.00000000001487,0.906611776747709,0,1,phosphate:proton symporter activity,MF,
2031,GO:0004775,1.00000000001488,0.821328593306973,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
5293,GO:0016005,1.00000000001489,0.812510580492026,0,2,phospholipase A2 activator activity,MF,
14408,GO:0061741,1.00000000001491,0.814016629819349,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
3827,GO:0008442,1.00000000001492,0.903477816821099,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
5533,GO:0016532,1.00000000001495,0.764835735243301,0,3,superoxide dismutase copper chaperone activity,MF,
9213,GO:0035617,1.00000000001498,0.733043554719089,0,3,stress granule disassembly,BP,
16984,GO:0099130,1.00000000001501,0.902116310480894,0,1,estrogen binding,MF,
18605,GO:1903924,1.00000000001501,0.902116310480894,0,1,estradiol binding,MF,
11911,GO:0046979,1.00000000001501,0.742420689750785,0,3,TAP2 binding,MF,
14596,GO:0070191,1.00000000001502,0.814650093559718,0,2,methionine-R-sulfoxide reductase activity,MF,
235,GO:0000493,1.00000000001502,0.816161700149078,0,2,box H/ACA snoRNP assembly,BP,
8543,GO:0033981,1.00000000001503,0.930965469988161,0,1,D-dopachrome decarboxylase activity,MF,
20138,GO:2000983,1.00000000001503,0.851027414649564,0,2,regulation of ATP citrate synthase activity,BP,
20139,GO:2000984,1.00000000001503,0.851027414649564,0,2,negative regulation of ATP citrate synthase activity,BP,
1271,GO:0003065,1.00000000001505,0.905258983371809,0,1,positive regulation of heart rate by epinephrine,BP,
585,GO:0001740,1.00000000001506,0.73515465325627,0,3,Barr body,CC,
5506,GO:0016479,1.00000000001506,0.73515465325627,0,3,negative regulation of transcription by RNA polymerase I,BP,
16336,GO:0090666,1.00000000001506,0.664473227915997,0,4,scaRNA localization to Cajal body,BP,
4890,GO:0014827,1.00000000001506,0.902097637236259,0,1,intestine smooth muscle contraction,BP,
1800,GO:0004449,1.0000000000151,0.743857516172917,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
7233,GO:0031177,1.0000000000151,0.780615532981643,0,3,phosphopantetheine binding,MF,
2719,GO:0006106,1.00000000001512,0.736547035056332,0,3,fumarate metabolic process,BP,
16173,GO:0090233,1.00000000001512,0.901386565984998,0,1,negative regulation of spindle checkpoint,BP,
17966,GO:1902426,1.00000000001512,0.901386565984998,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19194,GO:1905341,1.00000000001512,0.901386565984998,0,1,negative regulation of protein localization to kinetochore,BP,
1546,GO:0003945,1.00000000001513,0.663094436148321,0,4,N-acetyllactosamine synthase activity,MF,
1811,GO:0004465,1.00000000001515,0.733509824892029,0,3,lipoprotein lipase activity,MF,
11138,GO:0045213,1.00000000001518,0.818521157840276,0,2,neurotransmitter receptor metabolic process,BP,
439,GO:0001181,1.00000000001522,0.818075503542687,0,2,transcription factor activity, core RNA polymerase I binding,MF,
1295,GO:0003130,1.00000000001523,0.816045720644273,0,2,BMP signaling pathway involved in heart induction,BP,
1297,GO:0003133,1.00000000001523,0.816045720644273,0,2,endodermal-mesodermal cell signaling,BP,
1298,GO:0003134,1.00000000001523,0.816045720644273,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
3518,GO:0007500,1.00000000001523,0.816045720644273,0,2,mesodermal cell fate determination,BP,
9406,GO:0035990,1.00000000001523,0.816045720644273,0,2,tendon cell differentiation,BP,
9407,GO:0035992,1.00000000001523,0.816045720644273,0,2,tendon formation,BP,
13643,GO:0060197,1.00000000001523,0.816045720644273,0,2,cloacal septation,BP,
14100,GO:0060994,1.00000000001523,0.816045720644273,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
15581,GO:0072095,1.00000000001523,0.816045720644273,0,2,regulation of branch elongation involved in ureteric bud branching,BP,
15589,GO:0072103,1.00000000001523,0.816045720644273,0,2,glomerulus vasculature morphogenesis,BP,
15590,GO:0072104,1.00000000001523,0.816045720644273,0,2,glomerular capillary formation,BP,
15613,GO:0072138,1.00000000001523,0.816045720644273,0,2,mesenchymal cell proliferation involved in ureteric bud development,BP,
15635,GO:0072179,1.00000000001523,0.816045720644273,0,2,nephric duct formation,BP,
15641,GO:0072190,1.00000000001523,0.816045720644273,0,2,ureter urothelium development,BP,
15642,GO:0072191,1.00000000001523,0.816045720644273,0,2,ureter smooth muscle development,BP,
15644,GO:0072193,1.00000000001523,0.816045720644273,0,2,ureter smooth muscle cell differentiation,BP,
15646,GO:0072197,1.00000000001523,0.816045720644273,0,2,ureter morphogenesis,BP,
15691,GO:0072278,1.00000000001523,0.816045720644273,0,2,metanephric comma-shaped body morphogenesis,BP,
17789,GO:1901963,1.00000000001523,0.816045720644273,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19722,GO:2000137,1.00000000001523,0.816045720644273,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
2659,GO:0006014,1.00000000001523,0.758510063842592,0,3,D-ribose metabolic process,BP,
9760,GO:0039656,1.00000000001528,0.815978349372564,0,2,modulation by virus of host gene expression,BP,
11811,GO:0046778,1.00000000001528,0.815978349372564,0,2,modification by virus of host mRNA processing,BP,
911,GO:0002299,1.00000000001529,0.908459944318242,0,1,alpha-beta intraepithelial T cell differentiation,BP,
912,GO:0002300,1.00000000001529,0.908459944318242,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
914,GO:0002304,1.00000000001529,0.908459944318242,0,1,gamma-delta intraepithelial T cell differentiation,BP,
915,GO:0002305,1.00000000001529,0.908459944318242,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
3082,GO:0006663,1.00000000001529,0.737974422148847,0,3,platelet activating factor biosynthetic process,BP,
3917,GO:0008607,1.00000000001529,0.737974422148847,0,3,phosphorylase kinase regulator activity,MF,
12980,GO:0051431,1.00000000001531,0.909839106748562,0,1,corticotropin-releasing hormone receptor 2 binding,MF,
10842,GO:0044375,1.00000000001532,0.832135394863033,0,2,regulation of peroxisome size,BP,
6863,GO:0030366,1.00000000001532,0.826271002307073,0,2,molybdopterin synthase activity,MF,
1954,GO:0004662,1.00000000001537,0.81825893243302,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2621,GO:0005953,1.00000000001537,0.81825893243302,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
10926,GO:0044609,1.00000000001544,0.813486041655068,0,2,DBIRD complex,CC,
12245,GO:0048561,1.00000000001544,0.90212766810163,0,1,establishment of animal organ orientation,BP,
16991,GO:0099170,1.00000000001545,0.732333382410988,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
17034,GO:0099547,1.00000000001545,0.732333382410988,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
17047,GO:0099578,1.00000000001545,0.732333382410988,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
7223,GO:0031134,1.00000000001548,0.735096158190886,0,3,sister chromatid biorientation,BP,
13998,GO:0060750,1.00000000001549,0.669984876750328,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
779,GO:0002038,1.00000000001549,0.901972403591894,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
4707,GO:0010879,1.00000000001549,0.901972403591894,0,1,cholesterol transport involved in cholesterol storage,BP,
9073,GO:0035352,1.00000000001549,0.901972403591894,0,1,NAD transmembrane transport,BP,
10320,GO:0043132,1.00000000001549,0.901972403591894,0,1,NAD transport,BP,
10927,GO:0044610,1.00000000001549,0.901972403591894,0,1,FMN transmembrane transporter activity,MF,
13126,GO:0051724,1.00000000001549,0.901972403591894,0,1,NAD transmembrane transporter activity,MF,
9083,GO:0035370,1.00000000001549,0.812929084143352,0,2,UBC13-UEV1A complex,CC,
14428,GO:0061783,1.0000000000155,0.833144664148173,0,2,peptidoglycan muralytic activity,MF,
7515,GO:0031731,1.00000000001553,0.826786564573754,0,3,CCR6 chemokine receptor binding,MF,
15012,GO:0070985,1.00000000001553,0.828897848783488,0,2,TFIIK complex,CC,
13986,GO:0060735,1.00000000001554,0.912078023526931,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
18041,GO:1902629,1.00000000001554,0.912078023526931,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
2018,GO:0004751,1.00000000001555,0.90474697821149,0,1,ribose-5-phosphate isomerase activity,MF,
14725,GO:0070426,1.00000000001556,0.812751655992264,0,2,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14732,GO:0070434,1.00000000001556,0.812751655992264,0,2,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
1616,GO:0004052,1.00000000001556,0.812853727708174,0,2,arachidonate 12-lipoxygenase activity,MF,
19,GO:0000035,1.00000000001557,0.866036059450884,0,2,acyl binding,MF,
20,GO:0000036,1.00000000001557,0.866036059450884,0,2,acyl carrier activity,MF,
4164,GO:0009245,1.00000000001557,0.866036059450884,0,2,lipid A biosynthetic process,BP,
10932,GO:0044620,1.00000000001557,0.866036059450884,0,2,ACP phosphopantetheine attachment site binding,MF,
11680,GO:0046493,1.00000000001557,0.866036059450884,0,2,lipid A metabolic process,BP,
12843,GO:0051192,1.00000000001557,0.866036059450884,0,2,prosthetic group binding,MF,
17577,GO:1901269,1.00000000001557,0.866036059450884,0,2,lipooligosaccharide metabolic process,BP,
17578,GO:1901271,1.00000000001557,0.866036059450884,0,2,lipooligosaccharide biosynthetic process,BP,
19673,GO:2000035,1.00000000001559,0.742509411477044,0,3,regulation of stem cell division,BP,
1731,GO:0004332,1.00000000001561,0.824360652238216,0,2,fructose-bisphosphate aldolase activity,MF,
5972,GO:0018773,1.00000000001562,0.906653488801831,0,1,acetylpyruvate hydrolase activity,MF,
8794,GO:0034545,1.00000000001562,0.906653488801831,0,1,fumarylpyruvate hydrolase activity,MF,
11998,GO:0047621,1.00000000001562,0.906653488801831,0,1,acylpyruvate hydrolase activity,MF,
13336,GO:0052550,1.00000000001562,0.906653488801831,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
13342,GO:0052567,1.00000000001562,0.906653488801831,0,1,response to defense-related host reactive oxygen species production,BP,
4145,GO:0009216,1.00000000001562,0.813895047449554,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
2076,GO:0004833,1.00000000001563,0.908287624208608,0,1,tryptophan 2,3-dioxygenase activity,MF,
8509,GO:0033754,1.00000000001563,0.908287624208608,0,1,indoleamine 2,3-dioxygenase activity,MF,
8667,GO:0034275,1.00000000001563,0.908287624208608,0,1,kynurenic acid metabolic process,BP,
8668,GO:0034276,1.00000000001563,0.908287624208608,0,1,kynurenic acid biosynthetic process,BP,
9517,GO:0036269,1.00000000001563,0.908287624208608,0,1,swimming behavior,BP,
2017,GO:0004750,1.00000000001565,0.901868332633546,0,1,ribulose-phosphate 3-epimerase activity,MF,
16651,GO:0097621,1.00000000001565,0.901868332633546,0,1,monoamine oxidase activity,MF,
12016,GO:0047756,1.00000000001566,0.813844964584886,0,2,chondroitin 4-sulfotransferase activity,MF,
16867,GO:0098840,1.00000000001569,0.832494786308202,0,2,protein transport along microtubule,BP,
16982,GO:0099118,1.00000000001569,0.832494786308202,0,2,microtubule-based protein transport,BP,
5541,GO:0016557,1.00000000001571,0.747544061577134,0,3,peroxisome membrane biogenesis,BP,
2210,GO:0005105,1.00000000001571,0.901935703586664,0,1,type 1 fibroblast growth factor receptor binding,MF,
15092,GO:0071207,1.00000000001571,0.816650795008719,0,2,histone pre-mRNA stem-loop binding,MF,
4493,GO:0010536,1.00000000001574,0.915136896621059,0,1,positive regulation of activation of Janus kinase activity,BP,
6824,GO:0030298,1.00000000001574,0.915136896621059,0,1,receptor signaling protein tyrosine kinase activator activity,MF,
7512,GO:0031726,1.00000000001574,0.915136896621059,0,1,CCR1 chemokine receptor binding,MF,
7513,GO:0031729,1.00000000001574,0.915136896621059,0,1,CCR4 chemokine receptor binding,MF,
11820,GO:0046817,1.00000000001574,0.915136896621059,0,1,chemokine receptor antagonist activity,MF,
8037,GO:0032707,1.00000000001574,0.901691671851549,0,1,negative regulation of interleukin-23 production,BP,
12013,GO:0047747,1.00000000001574,0.901691671851549,0,1,cholate-CoA ligase activity,MF,
4545,GO:0010636,1.00000000001574,0.812520025497781,0,2,positive regulation of mitochondrial fusion,BP,
17140,GO:0102758,1.00000000001574,0.916423673163578,0,1,very-long-chain enoyl-CoA reductase activity,MF,
9274,GO:0035730,1.00000000001577,0.921801303077864,0,1,S-nitrosoglutathione binding,MF,
9275,GO:0035731,1.00000000001577,0.921801303077864,0,1,dinitrosyl-iron complex binding,MF,
9276,GO:0035732,1.00000000001577,0.921801303077864,0,1,nitric oxide storage,BP,
12406,GO:0048880,1.00000000001579,0.81247798164105,0,2,sensory system development,BP,
3966,GO:0008794,1.0000000000158,0.923142089122314,0,1,arsenate reductase (glutaredoxin) activity,MF,
6947,GO:0030611,1.0000000000158,0.923142089122314,0,1,arsenate reductase activity,MF,
19354,GO:1905863,1.00000000001582,0.812477253976173,0,2,invadopodium organization,BP,
8890,GO:0034729,1.00000000001587,0.744097934998181,0,3,histone H3-K79 methylation,BP,
13488,GO:0055087,1.00000000001587,0.744097934998181,0,3,Ski complex,CC,
7644,GO:0032076,1.00000000001589,0.901381423426084,0,1,negative regulation of deoxyribonuclease activity,BP,
9376,GO:0035931,1.00000000001589,0.901381423426084,0,1,mineralocorticoid secretion,BP,
9377,GO:0035932,1.00000000001589,0.901381423426084,0,1,aldosterone secretion,BP,
9537,GO:0036316,1.00000000001589,0.901381423426084,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
13963,GO:0060703,1.00000000001589,0.901381423426084,0,1,deoxyribonuclease inhibitor activity,MF,
14688,GO:0070346,1.00000000001589,0.901381423426084,0,1,positive regulation of fat cell proliferation,BP,
17589,GO:1901303,1.00000000001589,0.901381423426084,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
17991,GO:1902511,1.00000000001589,0.901381423426084,0,1,negative regulation of apoptotic DNA fragmentation,BP,
18469,GO:1903625,1.00000000001589,0.901381423426084,0,1,negative regulation of DNA catabolic process,BP,
20122,GO:2000855,1.00000000001589,0.901381423426084,0,1,regulation of mineralocorticoid secretion,BP,
20123,GO:2000857,1.00000000001589,0.901381423426084,0,1,positive regulation of mineralocorticoid secretion,BP,
20124,GO:2000858,1.00000000001589,0.901381423426084,0,1,regulation of aldosterone secretion,BP,
20125,GO:2000860,1.00000000001589,0.901381423426084,0,1,positive regulation of aldosterone secretion,BP,
9289,GO:0035752,1.00000000001591,0.904093793006298,0,1,lysosomal lumen pH elevation,BP,
16433,GO:0097129,1.00000000001592,0.750269679539807,0,3,cyclin D2-CDK4 complex,CC,
1742,GO:0004346,1.00000000001594,0.907273485185731,0,1,glucose-6-phosphatase activity,MF,
12442,GO:0050309,1.00000000001594,0.907273485185731,0,1,sugar-terminal-phosphatase activity,MF,
1270,GO:0003064,1.00000000001595,0.904685069057003,0,1,regulation of heart rate by hormone,BP,
19373,GO:1905912,1.00000000001595,0.904685069057003,0,1,regulation of calcium ion export across plasma membrane,BP,
19374,GO:1905913,1.00000000001595,0.904685069057003,0,1,negative regulation of calcium ion export across plasma membrane,BP,
7748,GO:0032276,1.00000000001597,0.73311038627643,0,3,regulation of gonadotropin secretion,BP,
7750,GO:0032278,1.00000000001597,0.73311038627643,0,3,positive regulation of gonadotropin secretion,BP,
11850,GO:0046880,1.00000000001597,0.73311038627643,0,3,regulation of follicle-stimulating hormone secretion,BP,
11851,GO:0046881,1.00000000001597,0.73311038627643,0,3,positive regulation of follicle-stimulating hormone secretion,BP,
15912,GO:0072741,1.00000000001599,0.733009591606046,0,3,protein localization to cell division site,BP,
18237,GO:1903119,1.00000000001599,0.733009591606046,0,3,protein localization to actin cytoskeleton,BP,
18833,GO:1904498,1.00000000001599,0.733009591606046,0,3,protein localization to mitotic actomyosin contractile ring,BP,
19445,GO:1990179,1.00000000001599,0.733009591606046,0,3,protein localization to actomyosin contractile ring,BP,
2624,GO:0005956,1.000000000016,0.826911366041701,0,2,protein kinase CK2 complex,CC,
8381,GO:0033319,1.00000000001602,0.902727972691839,0,1,UDP-D-xylose metabolic process,BP,
8382,GO:0033320,1.00000000001602,0.902727972691839,0,1,UDP-D-xylose biosynthetic process,BP,
12064,GO:0048040,1.00000000001602,0.902727972691839,0,1,UDP-glucuronate decarboxylase activity,MF,
3054,GO:0006624,1.00000000001603,0.836330429472097,0,2,vacuolar protein processing,BP,
2014,GO:0004747,1.00000000001604,0.915738898512894,0,1,ribokinase activity,MF,
14419,GO:0061763,1.00000000001606,0.812495139555687,0,2,multivesicular body-lysosome fusion,BP,
1950,GO:0004658,1.00000000001607,0.815765957499524,0,2,propionyl-CoA carboxylase activity,MF,
8730,GO:0034395,1.00000000001607,0.908651343280102,0,1,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
12153,GO:0048297,1.00000000001612,0.902509896209279,0,1,negative regulation of isotype switching to IgA isotypes,BP,
7797,GO:0032358,1.00000000001612,0.925111987699542,0,1,oxidized pyrimidine DNA binding,MF,
14294,GO:0061481,1.00000000001612,0.925111987699542,0,1,response to TNF agonist,BP,
18005,GO:1902546,1.00000000001612,0.925111987699542,0,1,positive regulation of DNA N-glycosylase activity,BP,
20263,GO:2001272,1.00000000001612,0.925111987699542,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
19665,GO:2000015,1.00000000001614,0.750063669824302,0,3,regulation of determination of dorsal identity,BP,
7564,GO:0031938,1.00000000001616,0.820092065050819,0,2,regulation of chromatin silencing at telomere,BP,
1818,GO:0004475,1.00000000001616,0.907761341117355,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
3991,GO:0008905,1.00000000001616,0.907761341117355,0,1,mannose-phosphate guanylyltransferase activity,MF,
5377,GO:0016212,1.00000000001617,0.813291522933988,0,2,kynurenine-oxoglutarate transaminase activity,MF,
9477,GO:0036137,1.00000000001617,0.813291522933988,0,2,kynurenine aminotransferase activity,MF,
16389,GO:0097052,1.00000000001617,0.813291522933988,0,2,L-kynurenine metabolic process,BP,
15242,GO:0071449,1.00000000001621,0.92300380113042,0,1,cellular response to lipid hydroperoxide,BP,
7353,GO:0031407,1.00000000001624,0.901700261318446,0,1,oxylipin metabolic process,BP,
12031,GO:0047977,1.00000000001624,0.901700261318446,0,1,hepoxilin-epoxide hydrolase activity,MF,
17741,GO:1901751,1.00000000001624,0.901700261318446,0,1,leukotriene A4 metabolic process,BP,
20275,GO:2001300,1.00000000001624,0.901700261318446,0,1,lipoxin metabolic process,BP,
20276,GO:2001301,1.00000000001624,0.901700261318446,0,1,lipoxin biosynthetic process,BP,
20277,GO:2001302,1.00000000001624,0.901700261318446,0,1,lipoxin A4 metabolic process,BP,
20278,GO:2001303,1.00000000001624,0.901700261318446,0,1,lipoxin A4 biosynthetic process,BP,
20279,GO:2001304,1.00000000001624,0.901700261318446,0,1,lipoxin B4 metabolic process,BP,
20280,GO:2001306,1.00000000001624,0.901700261318446,0,1,lipoxin B4 biosynthetic process,BP,
4722,GO:0010896,1.00000000001626,0.733931502384402,0,3,regulation of triglyceride catabolic process,BP,
922,GO:0002317,1.00000000001626,0.765228419993364,0,3,plasma cell differentiation,BP,
17613,GO:1901363,1.00000000001627,0,338,4586,heterocyclic compound binding,MF,FOS;H6PD;IDH2;ERCC1;NT5E;LTB4R;PYGB;RAPGEF3;TCFL5;CYP27B1;XDH;PRDX5;PCBP4;PRODH;MEF2D;NOS1;ZFP36L1;GRB7;NR1D1;NYNRIN;SCN8A;EPHB2;EPAS1;OBSCN;NFATC4;NME4;MST1R;LRP1;MAPK13;HEBP1;CDK18;EGFR;H1F0;HADH;CRYL1;ACSF2;TCEA2;FKBP9;MXD4;DDB2;MTHFR;EGR1;ULK1;PKN1;PYGL;PTK6;GNAL;ABCA7;DEAF1;BAHCC1;ACTA2;S100A4;DNAH1;SLC16A3;CXXC5;ULK2;DGKA;D2HGDH;ZMYND8;ASH2L;ZSCAN18;SOX12;MXI1;CERS4;ABCG1;DHRS11;OPLAH;ZNF516;PEG3;NEK9;HDAC5;THRA;RPS6KA2;NMRK1;TUBG2;MARK4;KHNYN;ZFPM1;TFEB;ERBB2;BRSK1;OGDHL;CBS;TST;ABTB1;H2AFJ;DNM1;SALL2;CUL9;KIF13B;XPC;PAK6;VPS11;FOXQ1;UNK;CD320;MINK1;ATP2B4;TFDP2;CSNK1E;AGAP1;PDCD4;GLUL;RHOD;ZKSCAN1;INSR;RAB3D;ZC3H6;GRK6;MVD;POLL;EPHA1;ADARB1;ZNF692;ZNF704;TXNRD3;DNMT3A;TMEM173;DHX32;ATP7B;RNASET2;HES2;HINT2;ZNF467;MNT;STAT6;SPEG;ABCD1;MTA3;MKNK2;STRADB;ISG20;RAB25;FAM20C;MYO18A;PHC2;BCL6;ANKZF1;UCKL1;PFKFB2;ATP12A;DYRK1B;SEC14L2;SRMS;DNASE1L1;ZSCAN2;ARL2;MAST4;CEBPB;ACVR2B;HSF4;CALCOCO1;ZDHHC1;ENDOG;MAPK3;ETV5;DHTKD1;EXD3;ARL10;RAB40B;ENTPD2;GALK1;MTA1;FYCO1;ADCY6;LTA4H;MBD1;PKN3;PHGDH;EPHB3;HES1;PC;ACAD10;MLXIPL;ZNF624;SLC48A1;NADK;ABCA2;TK2;ZNF414;ADA;FKBP10;PHF21A;HTR7;RASL10B;CKMT1A;PFKL;PCSK9;ZFP36;ETV4;RHOF;MAPKBP1;HLCS;FGFR3;NSUN7;PRKACA;ZNF862;ZMYM3;LRRK1;DGUOK;CYFIP2;RPS6KA5;RAB3B;MAP2K2;PI4K2A;FGFR4;PMVK;MYH3;EHD4;TCF25;CYP3A5;SOX13;TRPV4;MPG;RHOBTB2;BHLHE40;RAG1;ZNF80;EEF2K;HMGA2;TM7SF2;ELK3;AHNAK2;DGKQ;HK1;ZXDC;MEX3A;POU6F1;ZNF217;PPARA;TKFC;GUK1;STK32C;DMC1;PAN2;ZNF446;RXRA;PCK2;BCR;SDHA;PRKCZ;HLTF;MDH2;ABCD4;TWF2;ZNF485;LSM14B;PDK2;SRSF5;ZNF160;RFXANK;TEF;SMARCD2;MAPKAPK3;AGO4;RAD23A;FGFR1;CAMKK1;ZNF563;PROX1;WBP2;GTPBP1;ASS1;ZNF554;JARID2;RXRB;CSTB;GAL3ST4;GRHPR;ACTR1B;APOBEC3C;H1FX;ZFP41;STK39;ACVR1B;MEF2B;ZSCAN30;GSS;ERBB3;CYP2S1;AKT1;TRAP1;NLRX1;SEPT8;ZNF385A;TUT1;SMARCA1;SIX5;ERCC6;GPD1L;TDRKH;SSBP2;RPL39L;ADCK2;R3HDM2;PINK1;EHD3;LONP2;CAMTA2;R3HDM4;EIF4G3;ZNF710;RFX2;MAP2K3;PNPO;TRERF1;THAP8;DDN;PMS2P5;NDUFV3;STK17A;ERN1;ZNF319;APOBEC3F;ACADS;GCAT;MOCS1;SIRT3;GLI4;JAK3;MAST3;KIFC2;LITAF;MZF1;NEIL1;FUK;RARG;EIF4E3;ZCCHC14;ZNF514;TRNP1;TTLL11;ZNF837;POLM;FAM50A;RPL13A;RAB40C;KIF26B
2049,GO:0004802,1.00000000001629,0.902634434490116,0,1,transketolase activity,MF,
1930,GO:0004633,1.00000000001632,0.902135304245083,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
10786,GO:0044284,1.00000000001634,0.92344747945717,0,1,mitochondrial crista junction,CC,
9282,GO:0035744,1.00000000001638,0.917000795366229,0,1,T-helper 1 cell cytokine production,BP,
9890,GO:0042231,1.00000000001638,0.917000795366229,0,1,interleukin-13 biosynthetic process,BP,
12807,GO:0051140,1.00000000001638,0.917000795366229,0,1,regulation of NK T cell proliferation,BP,
12808,GO:0051142,1.00000000001638,0.917000795366229,0,1,positive regulation of NK T cell proliferation,BP,
9609,GO:0036493,1.00000000001638,0.734880641138521,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
949,GO:0002368,1.00000000001639,0.901821196829717,0,1,B cell cytokine production,BP,
1194,GO:0002842,1.00000000001639,0.901821196829717,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
9547,GO:0036351,1.00000000001639,0.901821196829717,0,1,histone H2A-K13 ubiquitination,BP,
9548,GO:0036352,1.00000000001639,0.901821196829717,0,1,histone H2A-K15 ubiquitination,BP,
6244,GO:0019834,1.00000000001641,0.750246764784319,0,3,phospholipase A2 inhibitor activity,MF,
4394,GO:0010139,1.00000000001645,0.907591123556487,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4400,GO:0010164,1.00000000001645,0.907591123556487,0,1,response to cesium ion,BP,
6857,GO:0030343,1.00000000001645,0.907591123556487,0,1,vitamin D3 25-hydroxylase activity,MF,
14840,GO:0070643,1.00000000001645,0.907591123556487,0,1,vitamin D 25-hydroxylase activity,MF,
7256,GO:0031247,1.00000000001648,0.814214984601697,0,2,actin rod assembly,BP,
10371,GO:0043219,1.00000000001648,0.669300688418065,0,4,lateral loop,CC,
17996,GO:1902524,1.00000000001652,0.820101941936244,0,2,positive regulation of protein K48-linked ubiquitination,BP,
8273,GO:0033106,1.00000000001655,0.824195677836211,0,2,cis-Golgi network membrane,CC,
18666,GO:1904046,1.00000000001661,0.835259908293502,0,2,negative regulation of vascular endothelial growth factor production,BP,
493,GO:0001546,1.00000000001663,0.907067111269109,0,1,preantral ovarian follicle growth,BP,
1683,GO:0004155,1.00000000001663,0.907067111269109,0,1,6,7-dihydropteridine reductase activity,MF,
12090,GO:0048162,1.00000000001663,0.907067111269109,0,1,multi-layer follicle stage,BP,
1526,GO:0003908,1.00000000001664,0.914233278644248,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
14955,GO:0070893,1.00000000001666,0.812474708122991,0,2,transposon integration,BP,
14956,GO:0070894,1.00000000001666,0.812474708122991,0,2,regulation of transposon integration,BP,
14957,GO:0070895,1.00000000001666,0.812474708122991,0,2,negative regulation of transposon integration,BP,
1775,GO:0004392,1.00000000001676,0.823079705469872,0,2,heme oxygenase (decyclizing) activity,MF,
3167,GO:0006788,1.00000000001676,0.823079705469872,0,2,heme oxidation,BP,
299,GO:0000806,1.00000000001677,0.813079391858116,0,2,Y chromosome,CC,
14937,GO:0070860,1.0000000000168,0.901845755206935,0,1,RNA polymerase I core factor complex,CC,
8478,GO:0033650,1.00000000001685,0.905696857199739,0,1,host cell mitochondrion,CC,
10739,GO:0044190,1.00000000001685,0.905696857199739,0,1,host cell mitochondrial envelope,CC,
15775,GO:0072492,1.00000000001685,0.905696857199739,0,1,host cell mitochondrial intermembrane space,CC,
4889,GO:0014826,1.00000000001686,0.902702775403715,0,1,vein smooth muscle contraction,BP,
6749,GO:0030185,1.00000000001686,0.902702775403715,0,1,nitric oxide transport,BP,
7436,GO:0031583,1.00000000001686,0.902702775403715,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
7507,GO:0031705,1.00000000001686,0.902702775403715,0,1,bombesin receptor binding,MF,
7508,GO:0031707,1.00000000001686,0.902702775403715,0,1,endothelin A receptor binding,MF,
7509,GO:0031708,1.00000000001686,0.902702775403715,0,1,endothelin B receptor binding,MF,
9318,GO:0035815,1.00000000001686,0.902702775403715,0,1,positive regulation of renal sodium excretion,BP,
9933,GO:0042313,1.00000000001686,0.902702775403715,0,1,protein kinase C deactivation,BP,
10347,GO:0043179,1.00000000001686,0.902702775403715,0,1,rhythmic excitation,BP,
2133,GO:0004947,1.00000000001686,0.823665198443773,0,2,bradykinin receptor activity,MF,
10083,GO:0042610,1.00000000001688,0.902820152089547,0,1,CD8 receptor binding,MF,
19229,GO:1905429,1.00000000001688,0.902820152089547,0,1,response to glycine,BP,
19230,GO:1905430,1.00000000001688,0.902820152089547,0,1,cellular response to glycine,BP,
11959,GO:0047288,1.00000000001693,0.816434614893517,0,2,monosialoganglioside sialyltransferase activity,MF,
11074,GO:0045098,1.00000000001696,0.906865084352806,0,1,type III intermediate filament,CC,
15152,GO:0071315,1.00000000001697,0.734841296850454,0,3,cellular response to morphine,BP,
15154,GO:0071317,1.00000000001697,0.734841296850454,0,3,cellular response to isoquinoline alkaloid,BP,
18488,GO:1903677,1.00000000001698,0.736316899975186,0,3,regulation of cap-independent translational initiation,BP,
18489,GO:1903679,1.00000000001698,0.736316899975186,0,3,positive regulation of cap-independent translational initiation,BP,
12020,GO:0047801,1.000000000017,0.902530052435542,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
8472,GO:0033634,1.00000000001701,0.743513616134986,0,3,positive regulation of cell-cell adhesion mediated by integrin,BP,
16247,GO:0090341,1.00000000001701,0.90848475161727,0,1,negative regulation of secretion of lysosomal enzymes,BP,
460,GO:0001401,1.00000000001703,0.816236803045972,0,2,mitochondrial sorting and assembly machinery complex,CC,
6720,GO:0030144,1.00000000001704,0.732612286757104,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
7238,GO:0031208,1.00000000001705,0.812522915148453,0,2,POZ domain binding,MF,
9265,GO:0035720,1.00000000001705,0.736586103723764,0,3,intraciliary anterograde transport,BP,
1726,GO:0004324,1.00000000001706,0.904152638994231,0,1,ferredoxin-NADP+ reductase activity,MF,
4954,GO:0015039,1.00000000001706,0.904152638994231,0,1,NADPH-adrenodoxin reductase activity,MF,
5634,GO:0016730,1.00000000001706,0.904152638994231,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
5635,GO:0016731,1.00000000001706,0.904152638994231,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
1785,GO:0004418,1.00000000001707,0.910076892962246,0,1,hydroxymethylbilane synthase activity,MF,
5903,GO:0018160,1.00000000001707,0.910076892962246,0,1,peptidyl-pyrromethane cofactor linkage,BP,
2764,GO:0006193,1.00000000001709,0.918120177018748,0,1,ITP catabolic process,BP,
4133,GO:0009203,1.00000000001709,0.918120177018748,0,1,ribonucleoside triphosphate catabolic process,BP,
4137,GO:0009207,1.00000000001709,0.918120177018748,0,1,purine ribonucleoside triphosphate catabolic process,BP,
9504,GO:0036220,1.00000000001709,0.918120177018748,0,1,ITP diphosphatase activity,MF,
9505,GO:0036222,1.00000000001709,0.918120177018748,0,1,XTP diphosphatase activity,MF,
3868,GO:0008508,1.00000000001712,0.82235272382237,0,2,bile acid:sodium symporter activity,MF,
14259,GO:0061370,1.00000000001712,0.812484001020494,0,2,testosterone biosynthetic process,BP,
6501,GO:0021886,1.00000000001713,0.748859354698122,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6502,GO:0021888,1.00000000001713,0.748859354698122,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
7828,GO:0032395,1.00000000001716,0.757958807597937,0,3,MHC class II receptor activity,MF,
13689,GO:0060282,1.00000000001717,0.734809391019119,0,3,positive regulation of oocyte development,BP,
19360,GO:1905881,1.00000000001717,0.734809391019119,0,3,positive regulation of oogenesis,BP,
1941,GO:0004648,1.00000000001718,0.902578880649183,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
10720,GO:0044105,1.00000000001721,0.925369723551066,0,1,L-xylulose reductase (NAD+) activity,MF,
12413,GO:0050038,1.00000000001721,0.925369723551066,0,1,L-xylulose reductase (NADP+) activity,MF,
18589,GO:1903899,1.00000000001728,0.736382215492313,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
11916,GO:0046985,1.00000000001728,0.740736871608449,0,3,positive regulation of hemoglobin biosynthetic process,BP,
785,GO:0002046,1.00000000001728,0.921370587225544,0,1,opsin binding,MF,
9555,GO:0036372,1.00000000001728,0.921370587225544,0,1,opsin transport,BP,
4841,GO:0014063,1.0000000000173,0.916447533048678,0,1,negative regulation of serotonin secretion,BP,
8435,GO:0033577,1.00000000001731,0.812544360855166,0,2,protein glycosylation in endoplasmic reticulum,BP,
17568,GO:1901252,1.00000000001731,0.831399657196941,0,2,regulation of intracellular transport of viral material,BP,
837,GO:0002144,1.00000000001735,0.90266693659747,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
9122,GO:0035473,1.00000000001737,0.818688677865977,0,2,lipase binding,MF,
17419,GO:1900222,1.00000000001737,0.818688677865977,0,2,negative regulation of amyloid-beta clearance,BP,
15274,GO:0071492,1.00000000001737,0.81550230756354,0,2,cellular response to UV-A,BP,
1246,GO:0002949,1.00000000001737,0.741340041486477,0,3,tRNA threonylcarbamoyladenosine modification,BP,
668,GO:0001878,1.00000000001738,0.901842982774974,0,1,response to yeast,BP,
14447,GO:0061847,1.00000000001738,0.901842982774974,0,1,response to cholecystokinin,BP,
15293,GO:0071538,1.00000000001738,0.901842982774974,0,1,SH2 domain-mediated complex assembly,BP,
19615,GO:1990839,1.00000000001738,0.901842982774974,0,1,response to endothelin,BP,
19619,GO:1990859,1.00000000001738,0.901842982774974,0,1,cellular response to endothelin,BP,
1003,GO:0002477,1.00000000001739,0.921103202764735,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1007,GO:0002481,1.00000000001739,0.921103202764735,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
2023,GO:0004766,1.00000000001742,0.913989660403322,0,1,spermidine synthase activity,MF,
12005,GO:0047685,1.00000000001743,0.909400238394411,0,1,amine sulfotransferase activity,MF,
19978,GO:2000619,1.00000000001744,0.743052057864244,0,3,negative regulation of histone H4-K16 acetylation,BP,
12154,GO:0048298,1.00000000001747,0.66133525186384,0,4,positive regulation of isotype switching to IgA isotypes,BP,
6511,GO:0021898,1.0000000000175,0.733177858739937,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
6299,GO:0019948,1.00000000001753,0.812621034422082,0,2,SUMO activating enzyme activity,MF,
5866,GO:0017198,1.00000000001754,0.92383843679533,0,1,N-terminal peptidyl-serine acetylation,BP,
5867,GO:0018002,1.00000000001754,0.92383843679533,0,1,N-terminal peptidyl-glutamic acid acetylation,BP,
7106,GO:0030920,1.00000000001754,0.92383843679533,0,1,peptidyl-serine acetylation,BP,
14449,GO:0061850,1.00000000001754,0.92383843679533,0,1,growth cone leading edge,CC,
15520,GO:0071960,1.00000000001754,0.92383843679533,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
19450,GO:1990190,1.00000000001754,0.92383843679533,0,1,peptide-glutamate-N-acetyltransferase activity,MF,
20041,GO:2000718,1.00000000001754,0.92383843679533,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20042,GO:2000719,1.00000000001754,0.92383843679533,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
6507,GO:0021894,1.00000000001757,0.919143588010932,0,1,cerebral cortex GABAergic interneuron development,BP,
2987,GO:0006540,1.00000000001761,0.81275746073645,0,2,glutamate decarboxylation to succinate,BP,
9256,GO:0035697,1.00000000001766,0.817685608729353,0,2,CD8-positive, alpha-beta T cell extravasation,BP,
9257,GO:0035698,1.00000000001766,0.817685608729353,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
15884,GO:0072683,1.00000000001766,0.817685608729353,0,2,T cell extravasation,BP,
19883,GO:2000407,1.00000000001766,0.817685608729353,0,2,regulation of T cell extravasation,BP,
19899,GO:2000449,1.00000000001766,0.817685608729353,0,2,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19901,GO:2000452,1.00000000001766,0.817685608729353,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
1566,GO:0003976,1.00000000001769,0.743940605489213,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
15251,GO:0071460,1.0000000000177,0.838022495235353,0,2,cellular response to cell-matrix adhesion,BP,
15018,GO:0070991,1.00000000001774,0.732389781340668,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
5458,GO:0016401,1.00000000001776,0.815625361381263,0,2,palmitoyl-CoA oxidase activity,MF,
11504,GO:0046041,1.00000000001779,0.827583332211723,0,2,ITP metabolic process,BP,
5230,GO:0015862,1.00000000001779,0.901782203594357,0,1,uridine transport,BP,
17941,GO:1902359,1.0000000000178,0.813381632292539,0,2,Notch signaling pathway involved in somitogenesis,BP,
17945,GO:1902366,1.0000000000178,0.813381632292539,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
17946,GO:1902367,1.0000000000178,0.813381632292539,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
7830,GO:0032398,1.00000000001781,0.906667437900827,0,1,MHC class Ib protein complex,CC,
7997,GO:0032639,1.00000000001781,0.906667437900827,0,1,TRAIL production,BP,
8021,GO:0032679,1.00000000001781,0.906667437900827,0,1,regulation of TRAIL production,BP,
8065,GO:0032759,1.00000000001781,0.906667437900827,0,1,positive regulation of TRAIL production,BP,
19949,GO:2000566,1.00000000001781,0.906667437900827,0,1,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
20213,GO:2001187,1.00000000001781,0.906667437900827,0,1,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
8664,GO:0034271,1.00000000001783,0.733189316420784,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
8665,GO:0034272,1.00000000001783,0.733189316420784,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
10480,GO:0043400,1.0000000000179,0.835487969556077,0,2,cortisol secretion,BP,
13000,GO:0051462,1.0000000000179,0.835487969556077,0,2,regulation of cortisol secretion,BP,
16077,GO:0090086,1.0000000000179,0.7618132603145,0,3,negative regulation of protein deubiquitination,BP,
16353,GO:0090725,1.00000000001792,0.832721609890386,0,2,peripheral region of growth cone,CC,
19449,GO:1990189,1.00000000001792,0.832721609890386,0,2,peptide-serine-N-acetyltransferase activity,MF,
8146,GO:0032889,1.00000000001793,0.90146304736982,0,1,regulation of vacuole fusion, non-autophagic,BP,
2687,GO:0006060,1.00000000001799,0.821526087538887,0,2,sorbitol metabolic process,BP,
11625,GO:0046370,1.00000000001799,0.821526087538887,0,2,fructose biosynthetic process,BP,
6893,GO:0030485,1.00000000001799,0.81870336213376,0,2,smooth muscle contractile fiber,CC,
1482,GO:0003796,1.00000000001804,0.909250833311059,0,1,lysozyme activity,MF,
3829,GO:0008444,1.00000000001804,0.902235176817964,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
9583,GO:0036458,1.00000000001804,0.902235176817964,0,1,hepatocyte growth factor binding,MF,
10448,GO:0043328,1.00000000001805,0.697292953491811,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
3357,GO:0007113,1.00000000001806,0.749825825197426,0,3,endomitotic cell cycle,BP,
12789,GO:0051120,1.00000000001807,0.812765203683112,0,2,hepoxilin A3 synthase activity,MF,
2468,GO:0005690,1.00000000001807,0.813254927867235,0,2,U4atac snRNP,CC,
15025,GO:0071005,1.00000000001807,0.813254927867235,0,2,U2-type precatalytic spliceosome,CC,
7184,GO:0031085,1.00000000001809,0.812483049843785,0,2,BLOC-3 complex,CC,
12111,GO:0048211,1.00000000001813,0.812474716208496,0,2,Golgi vesicle docking,BP,
20023,GO:2000676,1.00000000001815,0.664388234895555,0,4,positive regulation of type B pancreatic cell apoptotic process,BP,
2071,GO:0004828,1.00000000001817,0.816274039838797,0,2,serine-tRNA ligase activity,MF,
2916,GO:0006434,1.00000000001817,0.816274039838797,0,2,seryl-tRNA aminoacylation,BP,
18774,GO:1904351,1.00000000001818,0.732888343205898,0,3,negative regulation of protein catabolic process in the vacuole,BP,
19127,GO:1905166,1.00000000001818,0.732888343205898,0,3,negative regulation of lysosomal protein catabolic process,BP,
14589,GO:0070180,1.0000000000182,0.933016617404805,0,1,large ribosomal subunit rRNA binding,MF,
14750,GO:0070476,1.0000000000182,0.933016617404805,0,1,rRNA (guanine-N7)-methylation,BP,
5811,GO:0017089,1.00000000001831,0.814660439591128,0,2,glycolipid transporter activity,MF,
9703,GO:0038158,1.00000000001832,0.817576876866299,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
18865,GO:1904576,1.00000000001832,0.817576876866299,0,2,response to tunicamycin,BP,
18866,GO:1904577,1.00000000001832,0.817576876866299,0,2,cellular response to tunicamycin,BP,
2034,GO:0004778,1.00000000001834,0.907408434059793,0,1,succinyl-CoA hydrolase activity,MF,
8089,GO:0032788,1.00000000001834,0.907408434059793,0,1,saturated monocarboxylic acid metabolic process,BP,
8090,GO:0032789,1.00000000001834,0.907408434059793,0,1,unsaturated monocarboxylic acid metabolic process,BP,
15521,GO:0071962,1.00000000001836,0.753416337174804,0,3,mitotic sister chromatid cohesion, centromeric,BP,
20218,GO:2001199,1.00000000001836,0.908141782581271,0,1,negative regulation of dendritic cell differentiation,BP,
5307,GO:0016035,1.00000000001838,0.82672212365611,0,2,zeta DNA polymerase complex,CC,
11159,GO:0045259,1.00000000001839,0.822385438790632,0,2,proton-transporting ATP synthase complex,CC,
19587,GO:1990761,1.0000000000184,0.812491544420275,0,2,growth cone lamellipodium,CC,
5953,GO:0018352,1.00000000001842,0.816746790087461,0,2,protein-pyridoxal-5-phosphate linkage,BP,
10136,GO:0042732,1.0000000000185,0.834101986257076,0,2,D-xylose metabolic process,BP,
327,GO:0000916,1.00000000001851,0.902290418185982,0,1,actomyosin contractile ring contraction,BP,
9500,GO:0036213,1.00000000001851,0.902290418185982,0,1,contractile ring contraction,BP,
15170,GO:0071344,1.00000000001854,0.829247171184072,0,2,diphosphate metabolic process,BP,
3288,GO:0006990,1.00000000001857,0.737943625920968,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
4485,GO:0010520,1.00000000001862,0.812494156831472,0,2,regulation of reciprocal meiotic recombination,BP,
14055,GO:0060903,1.00000000001862,0.812494156831472,0,2,positive regulation of meiosis I,BP,
1744,GO:0004348,1.00000000001865,0.812697125161596,0,2,glucosylceramidase activity,MF,
13255,GO:0051971,1.00000000001865,0.812697125161596,0,2,positive regulation of transmission of nerve impulse,BP,
16902,GO:0098908,1.00000000001865,0.812697125161596,0,2,regulation of neuronal action potential,BP,
1551,GO:0003953,1.00000000001868,0.909622630242608,0,1,NAD+ nucleosidase activity,MF,
12421,GO:0050135,1.00000000001868,0.909622630242608,0,1,NAD(P)+ nucleosidase activity,MF,
14433,GO:0061809,1.00000000001868,0.909622630242608,0,1,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
9399,GO:0035983,1.0000000000187,0.734729187698045,0,3,response to trichostatin A,BP,
9400,GO:0035984,1.0000000000187,0.734729187698045,0,3,cellular response to trichostatin A,BP,
18172,GO:1902977,1.00000000001871,0.903930887568989,0,1,mitotic DNA replication preinitiation complex assembly,BP,
1715,GO:0004310,1.00000000001872,0.902645206982268,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
7153,GO:0031038,1.00000000001872,0.902645206982268,0,1,myosin II filament organization,BP,
10544,GO:0043519,1.00000000001872,0.902645206982268,0,1,regulation of myosin II filament organization,BP,
13267,GO:0051996,1.00000000001872,0.902645206982268,0,1,squalene synthase activity,MF,
9378,GO:0035933,1.00000000001874,0.753078207155317,0,3,glucocorticoid secretion,BP,
20119,GO:2000849,1.00000000001874,0.753078207155317,0,3,regulation of glucocorticoid secretion,BP,
13957,GO:0060697,1.00000000001875,0.901378017973687,0,1,positive regulation of phospholipid catabolic process,BP,
17391,GO:1900161,1.00000000001875,0.901378017973687,0,1,regulation of phospholipid scramblase activity,BP,
17392,GO:1900163,1.00000000001875,0.901378017973687,0,1,positive regulation of phospholipid scramblase activity,BP,
20059,GO:2000752,1.00000000001875,0.901378017973687,0,1,regulation of glucosylceramide catabolic process,BP,
20060,GO:2000753,1.00000000001875,0.901378017973687,0,1,positive regulation of glucosylceramide catabolic process,BP,
20061,GO:2000754,1.00000000001875,0.901378017973687,0,1,regulation of sphingomyelin catabolic process,BP,
20062,GO:2000755,1.00000000001875,0.901378017973687,0,1,positive regulation of sphingomyelin catabolic process,BP,
694,GO:0001915,1.00000000001875,0.735349749917858,0,3,negative regulation of T cell mediated cytotoxicity,BP,
8598,GO:0034124,1.00000000001877,0.814381253477981,0,2,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
15316,GO:0071567,1.00000000001878,0.830418008746964,0,2,UFM1 hydrolase activity,MF,
3126,GO:0006722,1.0000000000188,0.901620234318384,0,1,triterpenoid metabolic process,BP,
6206,GO:0019742,1.0000000000188,0.901620234318384,0,1,pentacyclic triterpenoid metabolic process,BP,
19033,GO:1904924,1.0000000000188,0.901620234318384,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
19207,GO:1905370,1.0000000000188,0.901620234318384,0,1,serine-type endopeptidase complex,CC,
496,GO:0001552,1.00000000001881,0.90377878468807,0,1,ovarian follicle atresia,BP,
19847,GO:2000355,1.00000000001881,0.90377878468807,0,1,negative regulation of ovarian follicle development,BP,
15927,GO:0075519,1.00000000001881,0.929379385618328,0,1,microtubule-dependent intracellular transport of viral material,BP,
15928,GO:0075521,1.00000000001881,0.929379385618328,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
15932,GO:0075606,1.00000000001881,0.929379385618328,0,1,transport of viral material towards nucleus,BP,
10403,GO:0043262,1.00000000001885,0.73845664251602,0,3,adenosine-diphosphatase activity,MF,
20210,GO:2001184,1.00000000001886,0.812713875087792,0,2,positive regulation of interleukin-12 secretion,BP,
5937,GO:0018282,1.00000000001887,0.812740544901136,0,2,metal incorporation into metallo-sulfur cluster,BP,
5938,GO:0018283,1.00000000001887,0.812740544901136,0,2,iron incorporation into metallo-sulfur cluster,BP,
144,GO:0000296,1.00000000001891,0.901894587961784,0,1,spermine transport,BP,
20118,GO:2000848,1.00000000001891,0.835491161083851,0,2,positive regulation of corticosteroid hormone secretion,BP,
9661,GO:0038044,1.00000000001894,0.660267274414043,0,4,transforming growth factor-beta secretion,BP,
2112,GO:0004905,1.000000000019,0.821256544385635,0,2,type I interferon receptor activity,MF,
1584,GO:0003998,1.000000000019,0.85208443224699,0,2,acylphosphatase activity,MF,
16511,GO:0097278,1.000000000019,0.81253709422229,0,2,complement-dependent cytotoxicity,BP,
5664,GO:0016784,1.00000000001903,0.909975877686585,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6252,GO:0019853,1.00000000001903,0.909975877686585,0,1,L-ascorbic acid biosynthetic process,BP,
10198,GO:0042839,1.00000000001903,0.909975877686585,0,1,D-glucuronate metabolic process,BP,
10199,GO:0042840,1.00000000001903,0.909975877686585,0,1,D-glucuronate catabolic process,BP,
12030,GO:0047939,1.00000000001903,0.909975877686585,0,1,L-glucuronate reductase activity,MF,
8659,GO:0034247,1.00000000001905,0.913660895867169,0,1,snoRNA splicing,BP,
15431,GO:0071796,1.00000000001905,0.913660895867169,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
7111,GO:0030943,1.00000000001912,0.736740878821075,0,3,mitochondrion targeting sequence binding,MF,
7497,GO:0031691,1.00000000001913,0.815662294481283,0,2,alpha-1A adrenergic receptor binding,MF,
7498,GO:0031692,1.00000000001913,0.815662294481283,0,2,alpha-1B adrenergic receptor binding,MF,
7521,GO:0031762,1.00000000001913,0.815662294481283,0,2,follicle-stimulating hormone receptor binding,MF,
10120,GO:0042699,1.00000000001913,0.815662294481283,0,2,follicle-stimulating hormone signaling pathway,BP,
16847,GO:0098808,1.00000000001914,0.814514504327812,0,2,mRNA cap binding,MF,
579,GO:0001732,1.00000000001915,0.814514504327806,0,2,formation of cytoplasmic translation initiation complex,BP,
556,GO:0001680,1.00000000001915,0.901937266903576,0,1,tRNA 3'-terminal CCA addition,BP,
2054,GO:0004810,1.00000000001915,0.901937266903576,0,1,tRNA adenylyltransferase activity,MF,
13436,GO:0052927,1.00000000001915,0.901937266903576,0,1,CTP:tRNA cytidylyltransferase activity,MF,
13437,GO:0052928,1.00000000001915,0.901937266903576,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
13438,GO:0052929,1.00000000001915,0.901937266903576,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
19605,GO:1990817,1.00000000001915,0.901937266903576,0,1,RNA adenylyltransferase activity,MF,
1844,GO:0004511,1.00000000001918,0.904080332738679,0,1,tyrosine 3-monooxygenase activity,MF,
3028,GO:0006585,1.00000000001918,0.904080332738679,0,1,dopamine biosynthetic process from tyrosine,BP,
8258,GO:0033076,1.00000000001918,0.904080332738679,0,1,isoquinoline alkaloid metabolic process,BP,
9010,GO:0035240,1.00000000001918,0.904080332738679,0,1,dopamine binding,MF,
9882,GO:0042214,1.00000000001918,0.904080332738679,0,1,terpene metabolic process,BP,
9985,GO:0042418,1.00000000001918,0.904080332738679,0,1,epinephrine biosynthetic process,BP,
13310,GO:0052314,1.00000000001918,0.904080332738679,0,1,phytoalexin metabolic process,BP,
14586,GO:0070176,1.00000000001919,0.905157169287791,0,1,DRM complex,CC,
1361,GO:0003247,1.00000000001922,0.907258600743893,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1554,GO:0003956,1.00000000001922,0.907258600743893,0,1,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
2478,GO:0005724,1.00000000001922,0.907258600743893,0,1,nuclear telomeric heterochromatin,CC,
7407,GO:0031509,1.00000000001922,0.907258600743893,0,1,telomeric heterochromatin assembly,BP,
7565,GO:0031940,1.00000000001922,0.907258600743893,0,1,positive regulation of chromatin silencing at telomere,BP,
18073,GO:1902732,1.00000000001922,0.907258600743893,0,1,positive regulation of chondrocyte proliferation,BP,
19267,GO:1905547,1.00000000001922,0.907258600743893,0,1,regulation of telomeric heterochromatin assembly,BP,
19268,GO:1905549,1.00000000001922,0.907258600743893,0,1,positive regulation of telomeric heterochromatin assembly,BP,
11033,GO:0045041,1.00000000001924,0.819951027332432,0,2,protein import into mitochondrial intermembrane space,BP,
9739,GO:0039513,1.00000000001924,0.901378469780678,0,1,suppression by virus of host catalytic activity,BP,
9741,GO:0039516,1.00000000001924,0.901378469780678,0,1,modulation by virus of host catalytic activity,BP,
9759,GO:0039650,1.00000000001924,0.901378469780678,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
13277,GO:0052053,1.00000000001924,0.901378469780678,0,1,negative regulation by symbiont of host catalytic activity,BP,
13284,GO:0052148,1.00000000001924,0.901378469780678,0,1,modulation by symbiont of host catalytic activity,BP,
13293,GO:0052199,1.00000000001924,0.901378469780678,0,1,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
13577,GO:0060075,1.00000000001927,0.733168183661246,0,3,regulation of resting membrane potential,BP,
16898,GO:0098904,1.0000000000193,0.812603461132774,0,2,regulation of AV node cell action potential,BP,
1810,GO:0004464,1.00000000001931,0.86188746728889,0,2,leukotriene-C4 synthase activity,MF,
2184,GO:0005046,1.00000000001934,0.818927620505876,0,2,KDEL sequence binding,MF,
5517,GO:0016503,1.00000000001935,0.913314633424144,0,1,pheromone receptor activity,MF,
443,GO:0001192,1.00000000001938,0.924203726348714,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
444,GO:0001193,1.00000000001938,0.924203726348714,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
2990,GO:0006543,1.00000000001939,0.732349542946752,0,3,glutamine catabolic process,BP,
13498,GO:0055100,1.0000000000194,0.733259039047197,0,3,adiponectin binding,MF,
11509,GO:0046056,1.00000000001941,0.819508727363809,0,2,dADP metabolic process,BP,
1359,GO:0003241,1.00000000001942,0.737111712514086,0,3,growth involved in heart morphogenesis,BP,
2358,GO:0005471,1.00000000001945,0.748273988745077,0,3,ATP:ADP antiporter activity,MF,
5025,GO:0015207,1.00000000001945,0.748273988745077,0,3,adenine transmembrane transporter activity,MF,
15541,GO:0072019,1.00000000001945,0.902485033721769,0,1,proximal convoluted tubule development,BP,
15669,GO:0072229,1.00000000001945,0.902485033721769,0,1,metanephric proximal convoluted tubule development,BP,
18112,GO:1902858,1.00000000001945,0.902485033721769,0,1,propionyl-CoA metabolic process,BP,
18113,GO:1902860,1.00000000001945,0.902485033721769,0,1,propionyl-CoA biosynthetic process,BP,
13319,GO:0052405,1.00000000001945,0.754961640921752,0,3,negative regulation by host of symbiont molecular function,BP,
246,GO:0000703,1.00000000001945,0.834700403241034,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
18912,GO:1904691,1.00000000001948,0.9025351286528,0,1,negative regulation of type B pancreatic cell proliferation,BP,
3020,GO:0006574,1.00000000001949,0.664719784974078,0,4,valine catabolic process,BP,
4714,GO:0010886,1.00000000001951,0.73233934696545,0,3,positive regulation of cholesterol storage,BP,
1647,GO:0004098,1.00000000001951,0.904098289704368,0,1,cerebroside-sulfatase activity,MF,
2361,GO:0005483,1.00000000001952,0.734979015396705,0,3,soluble NSF attachment protein activity,MF,
13922,GO:0060631,1.00000000001956,0.732350679323464,0,3,regulation of meiosis I,BP,
18934,GO:1904732,1.00000000001958,0.845499910035074,0,2,regulation of electron transfer activity,BP,
19050,GO:1904959,1.00000000001958,0.845499910035074,0,2,regulation of cytochrome-c oxidase activity,BP,
2218,GO:0005124,1.00000000001959,0.813820403226713,0,2,scavenger receptor binding,MF,
4378,GO:0010040,1.0000000000196,0.676088465690795,0,4,response to iron(II) ion,BP,
15130,GO:0071275,1.00000000001962,0.902431624932749,0,1,cellular response to aluminum ion,BP,
19313,GO:1905672,1.00000000001962,0.902431624932749,0,1,negative regulation of lysosome organization,BP,
19555,GO:1990641,1.00000000001964,0.814601788832556,0,2,response to iron ion starvation,BP,
1538,GO:0003933,1.00000000001971,0.903676801780005,0,1,GTP cyclohydrolase activity,MF,
1539,GO:0003934,1.00000000001971,0.903676801780005,0,1,GTP cyclohydrolase I activity,MF,
9411,GO:0035998,1.00000000001971,0.903676801780005,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
15925,GO:0075341,1.00000000001974,0.901878434567578,0,1,host cell PML body,CC,
19551,GO:1990622,1.00000000001975,0.833657001579042,0,2,CHOP-ATF3 complex,CC,
11045,GO:0045062,1.00000000001977,0.906258816135345,0,1,extrathymic T cell selection,BP,
15035,GO:0071021,1.00000000001977,0.906258816135345,0,1,U2-type post-spliceosomal complex,CC,
3586,GO:0008020,1.00000000001986,0.812494480825455,0,2,G-protein coupled photoreceptor activity,MF,
17320,GO:1900036,1.00000000001986,0.901769733452645,0,1,positive regulation of cellular response to heat,BP,
2255,GO:0005174,1.00000000001992,0.901918699067182,0,1,CD40 receptor binding,MF,
1532,GO:0003919,1.00000000002008,0.903527398200662,0,1,FMN adenylyltransferase activity,MF,
3142,GO:0006747,1.00000000002008,0.903527398200662,0,1,FAD biosynthetic process,BP,
11647,GO:0046443,1.00000000002008,0.903527398200662,0,1,FAD metabolic process,BP,
15756,GO:0072388,1.00000000002008,0.903527398200662,0,1,flavin adenine dinucleotide biosynthetic process,BP,
13346,GO:0052593,1.0000000000201,0.812497381062871,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
13347,GO:0052594,1.0000000000201,0.812497381062871,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
13348,GO:0052595,1.0000000000201,0.812497381062871,0,2,aliphatic-amine oxidase activity,MF,
13349,GO:0052596,1.0000000000201,0.812497381062871,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
4824,GO:0014040,1.00000000002016,0.812516444686882,0,2,positive regulation of Schwann cell differentiation,BP,
6018,GO:0019086,1.00000000002021,0.667567563173255,0,4,late viral transcription,BP,
11483,GO:0045990,1.00000000002021,0.667567563173255,0,4,carbon catabolite regulation of transcription,BP,
11484,GO:0045991,1.00000000002021,0.667567563173255,0,4,carbon catabolite activation of transcription,BP,
2622,GO:0005954,1.00000000002022,0.901514630500387,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
5405,GO:0016262,1.00000000002022,0.734793859980099,0,3,protein N-acetylglucosaminyltransferase activity,MF,
4318,GO:0009841,1.00000000002022,0.901715667752677,0,1,mitochondrial endopeptidase Clp complex,CC,
13680,GO:0060265,1.00000000002024,0.924883725440784,0,1,positive regulation of respiratory burst involved in inflammatory response,BP,
4370,GO:0010015,1.00000000002028,0.926907230001908,0,1,root morphogenesis,BP,
4384,GO:0010053,1.00000000002028,0.926907230001908,0,1,root epidermal cell differentiation,BP,
4385,GO:0010054,1.00000000002028,0.926907230001908,0,1,trichoblast differentiation,BP,
6591,GO:0022622,1.00000000002028,0.926907230001908,0,1,root system development,BP,
7522,GO:0031763,1.00000000002028,0.926907230001908,0,1,galanin receptor binding,MF,
7523,GO:0031764,1.00000000002028,0.926907230001908,0,1,type 1 galanin receptor binding,MF,
7524,GO:0031765,1.00000000002028,0.926907230001908,0,1,type 2 galanin receptor binding,MF,
7525,GO:0031766,1.00000000002028,0.926907230001908,0,1,type 3 galanin receptor binding,MF,
12173,GO:0048364,1.00000000002028,0.926907230001908,0,1,root development,BP,
12352,GO:0048764,1.00000000002028,0.926907230001908,0,1,trichoblast maturation,BP,
12353,GO:0048765,1.00000000002028,0.926907230001908,0,1,root hair cell differentiation,BP,
12354,GO:0048767,1.00000000002028,0.926907230001908,0,1,root hair elongation,BP,
13002,GO:0051464,1.00000000002028,0.926907230001908,0,1,positive regulation of cortisol secretion,BP,
15954,GO:0080147,1.00000000002028,0.926907230001908,0,1,root hair cell development,BP,
16306,GO:0090558,1.00000000002028,0.926907230001908,0,1,plant epidermis development,BP,
16324,GO:0090627,1.00000000002028,0.926907230001908,0,1,plant epidermal cell differentiation,BP,
17001,GO:0099402,1.00000000002028,0.926907230001908,0,1,plant organ development,BP,
18030,GO:1902606,1.00000000002028,0.926907230001908,0,1,regulation of large conductance calcium-activated potassium channel activity,BP,
18031,GO:1902608,1.00000000002028,0.926907230001908,0,1,positive regulation of large conductance calcium-activated potassium channel activity,BP,
18122,GO:1902890,1.00000000002028,0.926907230001908,0,1,regulation of root hair elongation,BP,
18123,GO:1902891,1.00000000002028,0.926907230001908,0,1,negative regulation of root hair elongation,BP,
18579,GO:1903888,1.00000000002028,0.926907230001908,0,1,regulation of plant epidermal cell differentiation,BP,
18580,GO:1903889,1.00000000002028,0.926907230001908,0,1,negative regulation of plant epidermal cell differentiation,BP,
19213,GO:1905392,1.00000000002028,0.926907230001908,0,1,plant organ morphogenesis,BP,
19225,GO:1905421,1.00000000002028,0.926907230001908,0,1,regulation of plant organ morphogenesis,BP,
19226,GO:1905422,1.00000000002028,0.926907230001908,0,1,negative regulation of plant organ morphogenesis,BP,
19694,GO:2000067,1.00000000002028,0.926907230001908,0,1,regulation of root morphogenesis,BP,
19794,GO:2000280,1.00000000002028,0.926907230001908,0,1,regulation of root development,BP,
20121,GO:2000851,1.00000000002028,0.926907230001908,0,1,positive regulation of glucocorticoid secretion,BP,
9129,GO:0035494,1.00000000002033,0.734979043963189,0,3,SNARE complex disassembly,BP,
16679,GO:0097682,1.00000000002034,0.902656040959134,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
19875,GO:2000395,1.00000000002035,0.836616115624143,0,2,regulation of ubiquitin-dependent endocytosis,BP,
19876,GO:2000397,1.00000000002035,0.836616115624143,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
14497,GO:0070012,1.00000000002039,0.812726087172124,0,2,oligopeptidase activity,MF,
9987,GO:0042421,1.00000000002039,0.734529054461219,0,3,norepinephrine biosynthetic process,BP,
1016,GO:0002513,1.00000000002041,0.733006281115456,0,3,tolerance induction to self antigen,BP,
8879,GO:0034714,1.00000000002041,0.733006281115456,0,3,type III transforming growth factor beta receptor binding,MF,
17369,GO:1900126,1.00000000002041,0.733006281115456,0,3,negative regulation of hyaluronan biosynthetic process,BP,
1617,GO:0004053,1.00000000002043,0.822533181622996,0,2,arginase activity,MF,
6169,GO:0019547,1.00000000002043,0.822533181622996,0,2,arginine catabolic process to ornithine,BP,
3157,GO:0006776,1.00000000002044,0.750312064588584,0,3,vitamin A metabolic process,BP,
1598,GO:0004020,1.00000000002045,0.812535013334692,0,2,adenylylsulfate kinase activity,MF,
2035,GO:0004779,1.00000000002045,0.812535013334692,0,2,sulfate adenylyltransferase activity,MF,
2036,GO:0004781,1.00000000002045,0.812535013334692,0,2,sulfate adenylyltransferase (ATP) activity,MF,
18081,GO:1902746,1.00000000002047,0.901612263112947,0,1,regulation of lens fiber cell differentiation,BP,
18715,GO:1904211,1.00000000002047,0.816108674432043,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
3177,GO:0006808,1.00000000002048,0.834647550193084,0,2,regulation of nitrogen utilization,BP,
11773,GO:0046666,1.00000000002048,0.834647550193084,0,2,retinal cell programmed cell death,BP,
4735,GO:0010915,1.00000000002049,0.850815322525982,0,2,regulation of very-low-density lipoprotein particle clearance,BP,
4736,GO:0010916,1.00000000002049,0.850815322525982,0,2,negative regulation of very-low-density lipoprotein particle clearance,BP,
13558,GO:0060053,1.00000000002054,0.812726087171975,0,2,neurofilament cytoskeleton,CC,
14861,GO:0070676,1.00000000002064,0.744007952895722,0,3,intralumenal vesicle formation,BP,
13406,GO:0052836,1.00000000002066,0.822727133624589,0,2,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
13407,GO:0052839,1.00000000002066,0.822727133624589,0,2,inositol diphosphate tetrakisphosphate kinase activity,MF,
14572,GO:0070159,1.00000000002071,0.901662812641064,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
2791,GO:0006253,1.00000000002074,0.917735186563844,0,1,dCTP catabolic process,BP,
11514,GO:0046065,1.00000000002074,0.917735186563844,0,1,dCTP metabolic process,BP,
12021,GO:0047840,1.00000000002074,0.917735186563844,0,1,dCTP diphosphatase activity,MF,
13906,GO:0060598,1.00000000002077,0.914885654405034,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
8914,GO:0034777,1.0000000000208,0.902073836688051,0,1,recycling endosome lumen,CC,
18891,GO:1904631,1.00000000002081,0.902055890238711,0,1,response to glucoside,BP,
14795,GO:0070557,1.00000000002085,0.823402033371095,0,2,PCNA-p21 complex,CC,
14412,GO:0061750,1.00000000002088,0.901794935717163,0,1,acid sphingomyelin phosphodiesterase activity,MF,
2119,GO:0004917,1.00000000002089,0.905090296346791,0,1,interleukin-7 receptor activity,MF,
17355,GO:1900109,1.00000000002091,0.829032998445264,0,2,regulation of histone H3-K9 dimethylation,BP,
17356,GO:1900110,1.00000000002091,0.829032998445264,0,2,negative regulation of histone H3-K9 dimethylation,BP,
10977,GO:0044795,1.00000000002091,0.91675919397705,0,1,trans-Golgi network to recycling endosome transport,BP,
9570,GO:0036435,1.00000000002092,0.7423142171293,0,3,K48-linked polyubiquitin modification-dependent protein binding,MF,
14234,GO:0061317,1.00000000002099,0.816147834432648,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17582,GO:1901295,1.00000000002099,0.816147834432648,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
19096,GO:1905066,1.00000000002099,0.816147834432648,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
6437,GO:0021763,1.00000000002099,0.902075648569713,0,1,subthalamic nucleus development,BP,
13604,GO:0060127,1.00000000002099,0.902075648569713,0,1,prolactin secreting cell differentiation,BP,
13827,GO:0060459,1.00000000002099,0.902075648569713,0,1,left lung development,BP,
13828,GO:0060460,1.00000000002099,0.902075648569713,0,1,left lung morphogenesis,BP,
13892,GO:0060577,1.00000000002099,0.902075648569713,0,1,pulmonary vein morphogenesis,BP,
13893,GO:0060578,1.00000000002099,0.902075648569713,0,1,superior vena cava morphogenesis,BP,
14123,GO:0061031,1.00000000002099,0.902075648569713,0,1,endodermal digestive tract morphogenesis,BP,
10731,GO:0044130,1.00000000002105,0.740452293451121,0,3,negative regulation of growth of symbiont in host,BP,
10734,GO:0044146,1.00000000002105,0.740452293451121,0,3,negative regulation of growth of symbiont involved in interaction with host,BP,
16256,GO:0090365,1.00000000002106,0.902286086877984,0,1,regulation of mRNA modification,BP,
16257,GO:0090367,1.00000000002106,0.902286086877984,0,1,negative regulation of mRNA modification,BP,
18278,GO:1903215,1.00000000002106,0.902286086877984,0,1,negative regulation of protein targeting to mitochondrion,BP,
20187,GO:2001144,1.00000000002106,0.902286086877984,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20188,GO:2001145,1.00000000002106,0.902286086877984,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
8444,GO:0033597,1.00000000002106,0.902414999191614,0,1,mitotic checkpoint complex,CC,
19469,GO:1990298,1.00000000002106,0.902414999191614,0,1,bub1-bub3 complex,CC,
3407,GO:0007197,1.00000000002111,0.812475772100333,0,2,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
5745,GO:0016907,1.00000000002111,0.812475772100333,0,2,G-protein coupled acetylcholine receptor activity,MF,
17932,GO:1902311,1.00000000002111,0.905468088994671,0,1,regulation of copper ion transmembrane transport,BP,
1635,GO:0004081,1.00000000002114,0.830184380159086,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
3255,GO:0006931,1.00000000002114,0.747419563590569,0,3,substrate-dependent cell migration, cell attachment to substrate,BP,
3967,GO:0008796,1.00000000002114,0.830184380159086,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
12766,GO:0051086,1.00000000002121,0.903585572467466,0,1,chaperone mediated protein folding independent of cofactor,BP,
19378,GO:1905937,1.00000000002133,0.922810754004628,0,1,negative regulation of germ cell proliferation,BP,
19779,GO:2000255,1.00000000002133,0.922810754004628,0,1,negative regulation of male germ cell proliferation,BP,
301,GO:0000811,1.00000000002143,0.74438535374853,0,3,GINS complex,CC,
16438,GO:0097145,1.00000000002145,0.902239344665147,0,1,BAK complex,CC,
18296,GO:1903276,1.00000000002146,0.818012063115197,0,2,regulation of sodium ion export across plasma membrane,BP,
18297,GO:1903278,1.00000000002146,0.818012063115197,0,2,positive regulation of sodium ion export across plasma membrane,BP,
18304,GO:1903288,1.00000000002146,0.818012063115197,0,2,positive regulation of potassium ion import,BP,
16983,GO:0099122,1.0000000000215,0.733181578829813,0,3,RNA polymerase II C-terminal domain binding,MF,
13627,GO:0060166,1.00000000002151,0.821151380886589,0,2,olfactory pit development,BP,
7749,GO:0032277,1.00000000002152,0.902334491938919,0,1,negative regulation of gonadotropin secretion,BP,
10537,GO:0043509,1.00000000002152,0.902334491938919,0,1,activin A complex,CC,
10538,GO:0043511,1.00000000002152,0.902334491938919,0,1,inhibin complex,CC,
10539,GO:0043512,1.00000000002152,0.902334491938919,0,1,inhibin A complex,CC,
11058,GO:0045077,1.00000000002152,0.902334491938919,0,1,negative regulation of interferon-gamma biosynthetic process,BP,
11852,GO:0046882,1.00000000002152,0.902334491938919,0,1,negative regulation of follicle-stimulating hormone secretion,BP,
12098,GO:0048180,1.00000000002152,0.902334491938919,0,1,activin complex,CC,
13686,GO:0060278,1.00000000002152,0.902334491938919,0,1,regulation of ovulation,BP,
13687,GO:0060279,1.00000000002152,0.902334491938919,0,1,positive regulation of ovulation,BP,
14207,GO:0061198,1.00000000002152,0.733398388835045,0,3,fungiform papilla formation,BP,
18444,GO:1903569,1.00000000002152,0.901693804722228,0,1,positive regulation of protein localization to ciliary membrane,BP,
17930,GO:1902309,1.00000000002157,0.815455849177384,0,2,negative regulation of peptidyl-serine dephosphorylation,BP,
2498,GO:0005757,1.0000000000216,0.681505090869355,0,4,mitochondrial permeability transition pore complex,CC,
19632,GO:1990910,1.0000000000216,0.754908943288548,0,3,response to hypobaric hypoxia,BP,
9508,GO:0036245,1.0000000000217,0.820151136448008,0,2,cellular response to menadione,BP,
3975,GO:0008829,1.00000000002171,0.904915850605565,0,1,dCTP deaminase activity,MF,
13651,GO:0060212,1.00000000002171,0.904915850605565,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
17387,GO:1900152,1.00000000002171,0.904915850605565,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
17861,GO:1902167,1.00000000002171,0.932891154037589,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
18972,GO:1904803,1.00000000002171,0.932891154037589,0,1,regulation of translation involved in cellular response to UV,BP,
17089,GO:0102005,1.00000000002181,0.909338539522978,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
16308,GO:0090560,1.00000000002183,0.902400888690319,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
3811,GO:0008418,1.00000000002186,0.917784651835162,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
2365,GO:0005497,1.00000000002186,0.837219303126374,0,2,androgen binding,MF,
3841,GO:0008460,1.00000000002195,0.90406245520629,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
6828,GO:0030305,1.00000000002195,0.905551402704704,0,1,heparanase activity,MF,
14757,GO:0070488,1.00000000002195,0.875755206754709,0,2,neutrophil aggregation,BP,
2231,GO:0005142,1.00000000002195,0.901726967945591,0,1,interleukin-11 receptor binding,MF,
5833,GO:0017133,1.00000000002195,0.901726967945591,0,1,mitochondrial electron transfer flavoprotein complex,CC,
10641,GO:0043783,1.00000000002195,0.901726967945591,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11155,GO:0045251,1.00000000002195,0.901726967945591,0,1,electron transfer flavoprotein complex,CC,
14547,GO:0070103,1.00000000002195,0.906325498246912,0,1,regulation of interleukin-6-mediated signaling pathway,BP,
14548,GO:0070104,1.00000000002195,0.906325498246912,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
17874,GO:1902205,1.00000000002195,0.906325498246912,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
17875,GO:1902206,1.00000000002195,0.906325498246912,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
17879,GO:1902215,1.00000000002195,0.906325498246912,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
17888,GO:1902227,1.00000000002195,0.906325498246912,0,1,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
17894,GO:1902233,1.00000000002195,0.906325498246912,0,1,negative regulation of positive thymic T cell selection,BP,
18627,GO:1903970,1.00000000002195,0.906325498246912,0,1,negative regulation of response to macrophage colony-stimulating factor,BP,
18630,GO:1903973,1.00000000002195,0.906325498246912,0,1,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19412,GO:1990071,1.00000000002199,0.835779340345102,0,2,TRAPPII protein complex,CC,
19413,GO:1990072,1.00000000002199,0.835779340345102,0,2,TRAPPIII protein complex,CC,
1268,GO:0003057,1.00000000002204,0.733201048706429,0,3,regulation of the force of heart contraction by chemical signal,BP,
13738,GO:0060342,1.00000000002206,0.904310562082422,0,1,photoreceptor inner segment membrane,CC,
16544,GO:0097362,1.00000000002206,0.81261039408449,0,2,MCM8-MCM9 complex,CC,
142,GO:0000294,1.00000000002209,0.812477694557854,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
18064,GO:1902714,1.00000000002209,0.812477694557854,0,2,negative regulation of interferon-gamma secretion,BP,
19982,GO:2000625,1.00000000002209,0.812477694557854,0,2,regulation of miRNA catabolic process,BP,
19983,GO:2000627,1.00000000002209,0.812477694557854,0,2,positive regulation of miRNA catabolic process,BP,
997,GO:0002461,1.00000000002209,0.90180531187674,0,1,tolerance induction dependent upon immune response,BP,
1019,GO:0002519,1.00000000002209,0.90180531187674,0,1,natural killer cell tolerance induction,BP,
1078,GO:0002652,1.00000000002209,0.90180531187674,0,1,regulation of tolerance induction dependent upon immune response,BP,
8038,GO:0032712,1.00000000002209,0.90180531187674,0,1,negative regulation of interleukin-3 production,BP,
15373,GO:0071656,1.00000000002209,0.90180531187674,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
17573,GO:1901257,1.00000000002209,0.90180531187674,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
13898,GO:0060586,1.00000000002214,0.662405188895499,0,4,multicellular organismal iron ion homeostasis,BP,
2904,GO:0006422,1.00000000002214,0.901777184252828,0,1,aspartyl-tRNA aminoacylation,BP,
2927,GO:0006452,1.00000000002223,0.823157560263531,0,2,translational frameshifting,BP,
11430,GO:0045905,1.00000000002223,0.823157560263531,0,2,positive regulation of translational termination,BP,
1666,GO:0004132,1.00000000002228,0.903111705930162,0,1,dCMP deaminase activity,MF,
7595,GO:0031990,1.00000000002232,0.81285754838858,0,2,mRNA export from nucleus in response to heat stress,BP,
8734,GO:0034402,1.00000000002232,0.81285754838858,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
4972,GO:0015105,1.00000000002232,0.913835740661682,0,1,arsenite transmembrane transporter activity,MF,
5151,GO:0015700,1.00000000002232,0.913835740661682,0,1,arsenite transport,BP,
5262,GO:0015920,1.00000000002236,0.901385635648921,0,1,lipopolysaccharide transport,BP,
7910,GO:0032497,1.00000000002236,0.901385635648921,0,1,detection of lipopolysaccharide,BP,
14765,GO:0070506,1.00000000002236,0.901385635648921,0,1,high-density lipoprotein particle receptor activity,MF,
16944,GO:0098989,1.0000000000224,0.81970632520679,0,2,NMDA selective glutamate receptor signaling pathway,BP,
5763,GO:0016979,1.0000000000225,0.911139449504559,0,1,lipoate-protein ligase activity,MF,
764,GO:0002017,1.00000000002252,0.904320034369939,0,1,regulation of blood volume by renal aldosterone,BP,
10132,GO:0042727,1.00000000002254,0.814416204505588,0,2,flavin-containing compound biosynthetic process,BP,
6040,GO:0019185,1.00000000002267,0.812486227645468,0,2,snRNA-activating protein complex,CC,
1768,GO:0004377,1.00000000002268,0.901455274201408,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
2141,GO:0004960,1.00000000002271,0.901957856779261,0,1,thromboxane receptor activity,MF,
2142,GO:0004961,1.00000000002271,0.901957856779261,0,1,thromboxane A2 receptor activity,MF,
9721,GO:0038193,1.00000000002271,0.901957856779261,0,1,thromboxane A2 signaling pathway,BP,
13434,GO:0052925,1.00000000002281,0.909189744206072,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
15385,GO:0071676,1.00000000002285,0.814001804816253,0,2,negative regulation of mononuclear cell migration,BP,
16042,GO:0090027,1.00000000002285,0.814001804816253,0,2,negative regulation of monocyte chemotaxis,BP,
3049,GO:0006617,1.00000000002291,0.833338115975689,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
12714,GO:0051005,1.00000000002291,0.763827654603742,0,3,negative regulation of lipoprotein lipase activity,BP,
1808,GO:0004462,1.00000000002292,0.903016932129518,0,1,lactoylglutathione lyase activity,MF,
20099,GO:2000819,1.00000000002294,0.812482251183216,0,2,regulation of nucleotide-excision repair,BP,
6365,GO:0021560,1.00000000002297,0.812641961504428,0,2,abducens nerve development,BP,
6384,GO:0021598,1.00000000002297,0.812641961504428,0,2,abducens nerve morphogenesis,BP,
6385,GO:0021599,1.00000000002297,0.812641961504428,0,2,abducens nerve formation,BP,
12105,GO:0048203,1.00000000002301,0.814714360281721,0,2,vesicle targeting, trans-Golgi to endosome,BP,
775,GO:0002032,1.00000000002318,0.816447544242649,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
10745,GO:0044209,1.0000000000232,0.838015840109473,0,2,AMP salvage,BP,
2063,GO:0004820,1.00000000002323,0.818370983530672,0,2,glycine-tRNA ligase activity,MF,
2908,GO:0006426,1.00000000002323,0.818370983530672,0,2,glycyl-tRNA aminoacylation,BP,
14571,GO:0070150,1.00000000002323,0.818370983530672,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
8377,GO:0033306,1.00000000002324,0.815152516709165,0,2,phytol metabolic process,BP,
18255,GO:1903173,1.00000000002324,0.815152516709165,0,2,fatty alcohol metabolic process,BP,
10055,GO:0042568,1.00000000002328,0.921639368719155,0,1,insulin-like growth factor binary complex,CC,
16799,GO:0098713,1.00000000002329,0.90197566893347,0,1,leucine import across plasma membrane,BP,
18547,GO:1903801,1.00000000002329,0.90197566893347,0,1,L-leucine import across plasma membrane,BP,
10664,GO:0043946,1.00000000002331,0.905777044098403,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
10665,GO:0043947,1.00000000002331,0.905777044098403,0,1,positive regulation by host of symbiont catalytic activity,BP,
13324,GO:0052422,1.00000000002331,0.905777044098403,0,1,modulation by host of symbiont catalytic activity,BP,
17447,GO:1900365,1.00000000002342,0.73315486497032,0,3,positive regulation of mRNA polyadenylation,BP,
2876,GO:0006386,1.00000000002348,0.926439579406022,0,1,termination of RNA polymerase III transcription,BP,
19394,GO:1990005,1.00000000002348,0.81683868005978,0,2,granular vesicle,CC,
3162,GO:0006781,1.00000000002349,0.902343473797231,0,1,succinyl-CoA pathway,BP,
1580,GO:0003994,1.00000000002351,0.812475365998931,0,2,aconitate hydratase activity,MF,
9420,GO:0036015,1.00000000002353,0.762993136655862,0,3,response to interleukin-3,BP,
9421,GO:0036016,1.00000000002353,0.762993136655862,0,3,cellular response to interleukin-3,BP,
4204,GO:0009368,1.00000000002358,0.826736611086594,0,2,endopeptidase Clp complex,CC,
17153,GO:0103053,1.00000000002364,0.831315429771288,0,2,1-ethyladenine demethylase activity,MF,
14371,GO:0061649,1.00000000002364,0.733218751750943,0,3,ubiquitin modification-dependent histone binding,MF,
6207,GO:0019747,1.00000000002365,0.923531042130105,0,1,regulation of isoprenoid metabolic process,BP,
6877,GO:0030421,1.00000000002365,0.923531042130105,0,1,defecation,BP,
15407,GO:0071707,1.00000000002366,0.914166626594234,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
9194,GO:0035597,1.00000000002366,0.903148590612628,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
6232,GO:0019800,1.00000000002369,0.909613673594149,0,1,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
17073,GO:0099640,1.00000000002377,0.92358681558221,0,1,axo-dendritic protein transport,BP,
17074,GO:0099641,1.00000000002377,0.92358681558221,0,1,anterograde axonal protein transport,BP,
12023,GO:0047860,1.00000000002388,0.914078002798412,0,1,diiodophenylpyruvate reductase activity,MF,
18026,GO:1902595,1.0000000000239,0.821167942624873,0,2,regulation of DNA replication origin binding,BP,
17435,GO:1900259,1.0000000000239,0.904189272307835,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17436,GO:1900260,1.0000000000239,0.904189272307835,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
6094,GO:0019323,1.00000000002395,0.681511386773739,0,4,pentose catabolic process,BP,
11219,GO:0045415,1.00000000002397,0.735090851701799,0,3,negative regulation of interleukin-8 biosynthetic process,BP,
18926,GO:1904716,1.00000000002398,0.901698099433721,0,1,positive regulation of chaperone-mediated autophagy,BP,
15082,GO:0071163,1.00000000002398,0.745814437729115,0,3,DNA replication preinitiation complex assembly,BP,
2309,GO:0005314,1.00000000002399,0.812475207770285,0,2,high-affinity glutamate transmembrane transporter activity,MF,
5115,GO:0015501,1.00000000002399,0.812475207770285,0,2,glutamate:sodium symporter activity,MF,
10214,GO:0042923,1.00000000002407,0.815672717319373,0,2,neuropeptide binding,MF,
5726,GO:0016882,1.00000000002409,0.832797426829348,0,2,cyclo-ligase activity,MF,
11769,GO:0046657,1.00000000002409,0.832797426829348,0,2,folic acid catabolic process,BP,
8059,GO:0032747,1.00000000002429,0.812478081242266,0,2,positive regulation of interleukin-23 production,BP,
370,GO:0000992,1.00000000002444,0.812650203443092,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
374,GO:0001002,1.00000000002444,0.812650203443092,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
375,GO:0001003,1.00000000002444,0.812650203443092,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
19628,GO:1990889,1.00000000002449,0.904484209147392,0,1,H4K20me3 modified histone binding,MF,
16753,GO:0098594,1.00000000002449,0.928059390579947,0,1,mucin granule,CC,
18104,GO:1902824,1.00000000002449,0.831055460345263,0,2,positive regulation of late endosome to lysosome transport,BP,
18330,GO:1903337,1.00000000002449,0.831055460345263,0,2,positive regulation of vacuolar transport,BP,
962,GO:0002386,1.00000000002455,0.814772109630271,0,2,immune response in mucosal-associated lymphoid tissue,BP,
968,GO:0002415,1.00000000002455,0.814772109630271,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
1839,GO:0004499,1.00000000002463,0.902465408250638,0,1,N,N-dimethylaniline monooxygenase activity,MF,
8407,GO:0033499,1.00000000002468,0.822759121211814,0,2,galactose catabolic process via UDP-galactose,BP,
9737,GO:0039506,1.00000000002471,0.812475125764756,0,2,modulation by virus of host molecular function,BP,
9738,GO:0039507,1.00000000002471,0.812475125764756,0,2,suppression by virus of host molecular function,BP,
13278,GO:0052055,1.00000000002471,0.812475125764756,0,2,modulation by symbiont of host molecular function,BP,
13279,GO:0052056,1.00000000002471,0.812475125764756,0,2,negative regulation by symbiont of host molecular function,BP,
9135,GO:0035504,1.00000000002475,0.909515485388879,0,1,regulation of myosin light chain kinase activity,BP,
9136,GO:0035505,1.00000000002475,0.909515485388879,0,1,positive regulation of myosin light chain kinase activity,BP,
11560,GO:0046136,1.00000000002475,0.909515485388879,0,1,positive regulation of vitamin metabolic process,BP,
13878,GO:0060557,1.00000000002475,0.909515485388879,0,1,positive regulation of vitamin D biosynthetic process,BP,
13880,GO:0060559,1.00000000002475,0.909515485388879,0,1,positive regulation of calcidiol 1-monooxygenase activity,BP,
4988,GO:0015140,1.00000000002476,0.818656024079347,0,2,malate transmembrane transporter activity,MF,
5414,GO:0016277,1.00000000002486,0.901624739913738,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
17747,GO:1901804,1.00000000002486,0.901624739913738,0,1,beta-glucoside metabolic process,BP,
17748,GO:1901805,1.00000000002486,0.901624739913738,0,1,beta-glucoside catabolic process,BP,
18822,GO:1904457,1.00000000002486,0.901624739913738,0,1,positive regulation of neuronal action potential,BP,
236,GO:0000494,1.00000000002487,0.916471409272619,0,1,box C/D snoRNA 3'-end processing,BP,
8541,GO:0033967,1.00000000002487,0.916471409272619,0,1,box C/D snoRNA metabolic process,BP,
8917,GO:0034963,1.00000000002487,0.916471409272619,0,1,box C/D snoRNA processing,BP,
9418,GO:0036009,1.00000000002487,0.916471409272619,0,1,protein-glutamine N-methyltransferase activity,MF,
19460,GO:1990258,1.00000000002487,0.916471409272619,0,1,histone glutamine methylation,BP,
19461,GO:1990259,1.00000000002487,0.916471409272619,0,1,histone-glutamine methyltransferase activity,MF,
6840,GO:0030321,1.00000000002499,0.812487281365617,0,2,transepithelial chloride transport,BP,
5965,GO:0018455,1.00000000002501,0.913923588742031,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
581,GO:0001735,1.00000000002505,0.812532315383272,0,2,prenylcysteine oxidase activity,MF,
6847,GO:0030328,1.00000000002505,0.812532315383272,0,2,prenylcysteine catabolic process,BP,
6848,GO:0030329,1.00000000002505,0.812532315383272,0,2,prenylcysteine metabolic process,BP,
10440,GO:0043316,1.00000000002509,0.812474687707958,0,2,cytotoxic T cell degranulation,BP,
18378,GO:1903433,1.00000000002509,0.812474687707958,0,2,regulation of constitutive secretory pathway,BP,
13937,GO:0060671,1.00000000002512,0.736213558441288,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,
13938,GO:0060672,1.00000000002512,0.736213558441288,0,3,epithelial cell morphogenesis involved in placental branching,BP,
8215,GO:0032991,1.00000000002513,0,268,3847,protein-containing complex,CC,FOS;APOE;ESPN;CTNNBIP1;ERCC1;CLIP2;BTBD2;SHANK2;GSN;NOS1;LTBP1;ZFP36L1;COL6A1;TCTN1;GRB7;NR1D1;POLD4;SCN8A;RBCK1;EPHB2;EPAS1;NFATC4;MST1R;LRP1;APPL2;KCNG1;OBSL1;EGFR;H1F0;FBXO2;TCEA2;DDB2;ULK1;SHC1;GNAL;ABCA7;DEAF1;LAMA5;PPP2R3B;BAHCC1;BBS2;DNAH1;GJC2;ASH2L;SOX12;MXI1;KCNC4;PIK3R2;INO80C;HDAC5;THRA;CRTAP;LRP5;TUBG2;PLTP;ZFPM1;ERBB2;EXOC2;FBLN1;OGDHL;PKD2;SCN4B;CPT1C;ABTB1;ITGB4;ITPR3;PLXNB3;H2AFJ;DNM1;SALL2;IFT140;VIPR1;CUL9;KIF13B;XPC;VPS11;VAMP2;UNK;JADE2;ATP2B4;TFDP2;TRAPPC9;GM2A;TNXB;LAMB2;INSR;SH3PXD2B;FBXW8;MZT2A;NDUFS8;RABGGTA;EPHA1;ITGA6;FBXO27;PRNP;DHX32;CEP250;DLG4;WWTR1;MYO18A;TMEM107;MZT2B;PHC2;TTYH3;ANKZF1;ATP12A;PLXNB1;CHMP1B;MVB12B;FZD8;HOOK2;LRRC8A;FBXW4;AP2A2;CEBPB;GPRC5C;SHANK3;ACVR2B;NUDCD3;KCNAB2;OLFM2;DHTKD1;TNNT1;DVL1;FYCO1;KLHL29;GPSM1;ADCY6;WIPI2;EPHB3;NSMCE4A;GIGYF1;MLXIPL;FBF1;CUL7;MEFV;EVC;NRP2;ABCA2;PHF21A;MYH16;PFKL;IL6R;PCSK9;ZFP36;BTBD11;MAPKBP1;FGFR3;PRKACA;PITPNM1;CYFIP2;SCNN1A;ITGB5;PI4K2A;FGFR4;SPTB;FBXW5;STX10;BBS1;MYH3;HDAC11;TNFRSF1A;LDLR;EIF4EBP3;HMGA2;LDLRAP1;TM7SF2;MVB12A;MIB2;FBXO17;SDHAF4;BTRC;MEX3A;ZNF217;PPARA;DMC1;PAN2;RXRA;NEO1;SDHA;WDR60;PRKCZ;CLTCL1;CAPG;ABCD4;KLHDC8B;PDK2;ICOSLG;SMARCD2;NDE1;AGO4;RAD23A;FGFR1;SPSB3;C5;GTPBP1;DLG3;KCNMA1;BIN1;SERPINB6;WDR83;GRB10;JARID2;SESN2;NDUFA4L2;TOLLIP;TMEM231;PNRC1;LCAT;SMDT1;PIGV;ACTR1B;APOBEC3C;H1FX;EPS8L1;PIGQ;WNT3;PPM1F;SORL1;COL13A1;ACVR1B;MEF2B;TSNARE1;ERBB3;ZER1;AKT1;SEPT8;TUT1;SMARCA1;VPS33B;ERCC6;GPD1L;EPS8L2;TDRKH;SUN1;RPL39L;PINK1;PKD1;SNTA1;SYNE3;EIF4G3;CTSH;P3H4;MLST8;EPN2;PYCARD;TRERF1;KCNN4;PMS2P5;NDUFV3;ERN1;RANBP9;APOBEC3F;FBXL20;WDR63;MOCS1;SIRT3;C12ORF66;BCKDHA;KIFC2;RARG;ING4;EIF4E3;SHISA6;WDR18;RPL13A;STXBP2;KIF26B
6157,GO:0019520,1.00000000002517,0.814616574641544,0,2,aldonic acid metabolic process,BP,
6158,GO:0019521,1.00000000002517,0.814616574641544,0,2,D-gluconate metabolic process,BP,
8501,GO:0033699,1.00000000002528,0.903175742550955,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
17245,GO:0120108,1.00000000002528,0.903175742550955,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
19435,GO:1990165,1.00000000002528,0.903175742550955,0,1,single-strand break-containing DNA binding,MF,
19680,GO:2000048,1.0000000000253,0.831066320610413,0,2,negative regulation of cell-cell adhesion mediated by cadherin,BP,
4915,GO:0014876,1.00000000002532,0.911773924811525,0,1,response to injury involved in regulation of muscle adaptation,BP,
8257,GO:0033065,1.00000000002537,0.831478290148492,0,2,Rad51C-XRCC3 complex,CC,
11587,GO:0046292,1.00000000002537,0.744073854899417,0,3,formaldehyde metabolic process,BP,
3872,GO:0008513,1.00000000002542,0.902231022449793,0,1,secondary active organic cation transmembrane transporter activity,MF,
6929,GO:0030549,1.00000000002549,0.916916051581367,0,1,acetylcholine receptor activator activity,MF,
10335,GO:0043163,1.00000000002551,0.81247475111463,0,2,cell envelope organization,BP,
11149,GO:0045229,1.00000000002551,0.81247475111463,0,2,external encapsulating structure organization,BP,
17755,GO:1901842,1.00000000002554,0.910030901920133,0,1,negative regulation of high voltage-gated calcium channel activity,BP,
15192,GO:0071373,1.00000000002556,0.812484007101004,0,2,cellular response to luteinizing hormone stimulus,BP,
9366,GO:0035915,1.00000000002565,0.903026571720864,0,1,pore formation in membrane of other organism,BP,
19858,GO:2000374,1.00000000002565,0.903026571720864,0,1,regulation of oxygen metabolic process,BP,
2003,GO:0004731,1.00000000002574,0.812681176256829,0,2,purine-nucleoside phosphorylase activity,MF,
608,GO:0001777,1.00000000002583,0.925974931498107,0,1,T cell homeostatic proliferation,BP,
944,GO:0002358,1.00000000002583,0.925974931498107,0,1,B cell homeostatic proliferation,BP,
8203,GO:0032976,1.00000000002583,0.925974931498107,0,1,release of matrix enzymes from mitochondria,BP,
16437,GO:0097144,1.00000000002583,0.925974931498107,0,1,BAX complex,CC,
19423,GO:1990117,1.00000000002583,0.925974931498107,0,1,B cell receptor apoptotic signaling pathway,BP,
2814,GO:0006286,1.00000000002598,0.831589688731904,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
778,GO:0002037,1.00000000002602,0.90256073380558,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
2300,GO:0005290,1.00000000002611,0.812474822076059,0,2,L-histidine transmembrane transporter activity,MF,
1516,GO:0003880,1.00000000002621,0.742287680332748,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
2945,GO:0006481,1.00000000002621,0.742287680332748,0,3,C-terminal protein methylation,BP,
3716,GO:0008251,1.00000000002633,0.812476314065216,0,2,tRNA-specific adenosine deaminase activity,MF,
6803,GO:0030272,1.00000000002646,0.923922542467689,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
8487,GO:0033680,1.00000000002661,0.812485341821921,0,2,ATP-dependent DNA/RNA helicase activity,MF,
2247,GO:0005166,1.00000000002665,0.92086376136424,0,1,neurotrophin p75 receptor binding,MF,
3492,GO:0007402,1.00000000002665,0.92086376136424,0,1,ganglion mother cell fate determination,BP,
3604,GO:0008052,1.00000000002665,0.92086376136424,0,1,sensory organ boundary specification,BP,
4399,GO:0010160,1.00000000002665,0.92086376136424,0,1,formation of animal organ boundary,BP,
12397,GO:0048867,1.00000000002665,0.92086376136424,0,1,stem cell fate determination,BP,
14204,GO:0061193,1.00000000002665,0.92086376136424,0,1,taste bud development,BP,
16970,GO:0099082,1.00000000002665,0.92086376136424,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
16971,GO:0099083,1.00000000002665,0.92086376136424,0,1,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
17028,GO:0099538,1.00000000002665,0.92086376136424,0,1,synaptic signaling via neuropeptide,BP,
17029,GO:0099540,1.00000000002665,0.92086376136424,0,1,trans-synaptic signaling by neuropeptide,BP,
17037,GO:0099551,1.00000000002665,0.92086376136424,0,1,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
9503,GO:0036219,1.00000000002667,0.928836872811139,0,1,GTP diphosphatase activity,MF,
10940,GO:0044713,1.00000000002667,0.928836872811139,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
10941,GO:0044714,1.00000000002667,0.928836872811139,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
12006,GO:0047693,1.00000000002667,0.928836872811139,0,1,ATP diphosphatase activity,MF,
2753,GO:0006172,1.00000000002669,0.901909571375746,0,1,ADP biosynthetic process,BP,
16489,GO:0097226,1.00000000002669,0.901909571375746,0,1,sperm mitochondrial sheath,CC,
11441,GO:0045918,1.00000000002674,0.918270208185882,0,1,negative regulation of cytolysis,BP,
11783,GO:0046687,1.00000000002674,0.918270208185882,0,1,response to chromate,BP,
15117,GO:0071247,1.00000000002674,0.918270208185882,0,1,cellular response to chromate,BP,
17883,GO:1902220,1.00000000002674,0.918270208185882,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
11250,GO:0045578,1.00000000002677,0.733110386276298,0,3,negative regulation of B cell differentiation,BP,
5894,GO:0018117,1.00000000002693,0.907096327894445,0,1,protein adenylylation,BP,
5906,GO:0018175,1.00000000002693,0.907096327894445,0,1,protein nucleotidylation,BP,
10923,GO:0044601,1.00000000002693,0.907096327894445,0,1,protein denucleotidylation,BP,
10924,GO:0044602,1.00000000002693,0.907096327894445,0,1,protein deadenylylation,BP,
10925,GO:0044603,1.00000000002693,0.907096327894445,0,1,protein adenylylhydrolase activity,MF,
14880,GO:0070733,1.00000000002693,0.907096327894445,0,1,protein adenylyltransferase activity,MF,
13852,GO:0060510,1.00000000002702,0.825043502798916,0,2,Type II pneumocyte differentiation,BP,
19065,GO:1904995,1.00000000002707,0.83456931972132,0,2,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
9271,GO:0035727,1.00000000002715,0.812474684750135,0,2,lysophosphatidic acid binding,MF,
511,GO:0001575,1.00000000002718,0.816163947689724,0,2,globoside metabolic process,BP,
43,GO:0000095,1.00000000002721,0.902101346375143,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
5197,GO:0015805,1.00000000002721,0.902101346375143,0,1,S-adenosyl-L-methionine transport,BP,
17788,GO:1901962,1.00000000002721,0.902101346375143,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
10676,GO:0043973,1.00000000002728,0.902192224019961,0,1,histone H3-K4 acetylation,BP,
2997,GO:0006550,1.00000000002728,0.819018162144154,0,2,isoleucine catabolic process,BP,
1881,GO:0004566,1.00000000002729,0.816670570992589,0,2,beta-glucuronidase activity,MF,
14507,GO:0070037,1.00000000002748,0.919400103838691,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
9258,GO:0035700,1.00000000002749,0.905362617757931,0,1,astrocyte chemotaxis,BP,
9481,GO:0036145,1.00000000002749,0.905362617757931,0,1,dendritic cell homeostasis,BP,
19903,GO:2000458,1.00000000002749,0.905362617757931,0,1,regulation of astrocyte chemotaxis,BP,
5360,GO:0016175,1.0000000000275,0.83827399694838,0,2,superoxide-generating NADPH oxidase activity,MF,
10256,GO:0043020,1.0000000000275,0.83827399694838,0,2,NADPH oxidase complex,CC,
14643,GO:0070274,1.00000000002751,0.821084541859527,0,2,RES complex,CC,
7986,GO:0032618,1.00000000002772,0.820811715246845,0,2,interleukin-15 production,BP,
14514,GO:0070053,1.00000000002772,0.812501737372436,0,2,thrombospondin receptor activity,MF,
372,GO:0000994,1.00000000002776,0.905397569924566,0,1,RNA polymerase III core binding,MF,
3819,GO:0008428,1.00000000002786,0.734595228028701,0,3,ribonuclease inhibitor activity,MF,
16685,GO:0097698,1.00000000002788,0.909676476509487,0,1,telomere maintenance via base-excision repair,BP,
15330,GO:0071593,1.00000000002796,0.739416833155706,0,3,lymphocyte aggregation,BP,
108,GO:0000225,1.00000000002801,0.91683150504607,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
3970,GO:0008803,1.00000000002807,0.921023261684261,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
10860,GO:0044416,1.00000000002813,0.820839326154292,0,2,induction by symbiont of host defense response,BP,
11806,GO:0046730,1.00000000002813,0.820839326154292,0,2,induction of host immune response by virus,BP,
11807,GO:0046732,1.00000000002813,0.820839326154292,0,2,active induction of host immune response by virus,BP,
13304,GO:0052251,1.00000000002813,0.820839326154292,0,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
13331,GO:0052509,1.00000000002813,0.820839326154292,0,2,positive regulation by symbiont of host defense response,BP,
13332,GO:0052510,1.00000000002813,0.820839326154292,0,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
820,GO:0002094,1.00000000002822,0.817735618314957,0,2,polyprenyltransferase activity,MF,
5354,GO:0016150,1.00000000002836,0.90754515670402,0,1,translation release factor activity, codon nonspecific,MF,
4300,GO:0009786,1.0000000000284,0.821504358118013,0,2,regulation of asymmetric cell division,BP,
10451,GO:0043335,1.0000000000284,0.821504358118013,0,2,protein unfolding,BP,
6225,GO:0019785,1.00000000002862,0.813987075319688,0,2,ISG15-specific protease activity,MF,
16432,GO:0097125,1.00000000002865,0.817667724284839,0,2,cyclin B1-CDK1 complex,CC,
1622,GO:0004061,1.00000000002871,0.906419811543718,0,1,arylformamidase activity,MF,
4771,GO:0010967,1.00000000002871,0.906419811543718,0,1,regulation of polyamine biosynthetic process,BP,
7142,GO:0031013,1.00000000002871,0.906419811543718,0,1,troponin I binding,MF,
13423,GO:0052899,1.00000000002871,0.906419811543718,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13425,GO:0052902,1.00000000002871,0.906419811543718,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
13426,GO:0052903,1.00000000002871,0.906419811543718,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13427,GO:0052904,1.00000000002871,0.906419811543718,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
17590,GO:1901304,1.00000000002871,0.906419811543718,0,1,regulation of spermidine biosynthetic process,BP,
17591,GO:1901307,1.00000000002871,0.906419811543718,0,1,positive regulation of spermidine biosynthetic process,BP,
1855,GO:0004522,1.00000000002893,0.908402245231781,0,1,ribonuclease A activity,MF,
3964,GO:0008785,1.00000000002893,0.908402245231781,0,1,alkyl hydroperoxide reductase activity,MF,
6371,GO:0021569,1.00000000002906,0.907886779644954,0,1,rhombomere 3 development,BP,
6372,GO:0021570,1.00000000002906,0.907886779644954,0,1,rhombomere 4 development,BP,
17,GO:0000032,1.00000000002918,0.905444491353743,0,1,cell wall mannoprotein biosynthetic process,BP,
1819,GO:0004476,1.00000000002918,0.905444491353743,0,1,mannose-6-phosphate isomerase activity,MF,
2684,GO:0006056,1.00000000002918,0.905444491353743,0,1,mannoprotein metabolic process,BP,
2685,GO:0006057,1.00000000002918,0.905444491353743,0,1,mannoprotein biosynthetic process,BP,
7404,GO:0031506,1.00000000002918,0.905444491353743,0,1,cell wall glycoprotein biosynthetic process,BP,
10043,GO:0042546,1.00000000002918,0.905444491353743,0,1,cell wall biogenesis,BP,
10701,GO:0044038,1.00000000002918,0.905444491353743,0,1,cell wall macromolecule biosynthetic process,BP,
14347,GO:0061611,1.00000000002918,0.905444491353743,0,1,mannose to fructose-6-phosphate metabolic process,BP,
14819,GO:0070589,1.00000000002918,0.905444491353743,0,1,cellular component macromolecule biosynthetic process,BP,
13509,GO:0055120,1.00000000002942,0.91950312775642,0,1,striated muscle dense body,CC,
7237,GO:0031205,1.00000000002975,0.841477378711653,0,2,endoplasmic reticulum Sec complex,CC,
18456,GO:1903588,1.00000000002996,0.742349650193841,0,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
12120,GO:0048245,1.0000000000301,0.751679904026335,0,3,eosinophil chemotaxis,BP,
2127,GO:0004935,1.00000000003011,0.814817044121109,0,2,adrenergic receptor activity,MF,
3835,GO:0008454,1.00000000003019,0.812480588815911,0,2,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
19971,GO:2000609,1.00000000003029,0.734700794007443,0,3,regulation of thyroid hormone generation,BP,
1066,GO:0002625,1.00000000003031,0.903737636299273,0,1,regulation of T cell antigen processing and presentation,BP,
1067,GO:0002626,1.00000000003031,0.903737636299273,0,1,negative regulation of T cell antigen processing and presentation,BP,
4388,GO:0010106,1.00000000003031,0.903737636299273,0,1,cellular response to iron ion starvation,BP,
18748,GO:1904282,1.00000000003031,0.903737636299273,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
18749,GO:1904283,1.00000000003031,0.903737636299273,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20212,GO:2001186,1.00000000003031,0.903737636299273,0,1,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
1144,GO:0002740,1.00000000003048,0.907393351984546,0,1,negative regulation of cytokine secretion involved in immune response,BP,
1208,GO:0002874,1.00000000003048,0.907393351984546,0,1,regulation of chronic inflammatory response to antigenic stimulus,BP,
1209,GO:0002875,1.00000000003048,0.907393351984546,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
2230,GO:0005141,1.00000000003048,0.907393351984546,0,1,interleukin-10 receptor binding,MF,
18672,GO:1904057,1.00000000003048,0.907393351984546,0,1,negative regulation of sensory perception of pain,BP,
15034,GO:0071020,1.00000000003056,0.820667844699821,0,2,post-spliceosomal complex,CC,
2287,GO:0005250,1.00000000003077,0.812676544845805,0,2,A-type (transient outward) potassium channel activity,MF,
11107,GO:0045163,1.00000000003077,0.812676544845805,0,2,clustering of voltage-gated potassium channels,BP,
15970,GO:0086008,1.00000000003077,0.812676544845805,0,2,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
16652,GO:0097623,1.00000000003077,0.812676544845805,0,2,potassium ion export across plasma membrane,BP,
11160,GO:0045263,1.00000000003099,0.911513811967001,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
1620,GO:0004057,1.00000000003144,0.902150731872611,0,1,arginyltransferase activity,MF,
18,GO:0000033,1.00000000003154,0.742627286006973,0,3,alpha-1,3-mannosyltransferase activity,MF,
1545,GO:0003944,1.00000000003166,0.902182213402831,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
18570,GO:1903860,1.00000000003178,0.812639272665873,0,2,negative regulation of dendrite extension,BP,
19737,GO:2000172,1.00000000003178,0.812639272665873,0,2,regulation of branching morphogenesis of a nerve,BP,
9706,GO:0038163,1.00000000003245,0.921290224639814,0,1,thrombopoietin-mediated signaling pathway,BP,
19379,GO:1905938,1.00000000003245,0.921290224639814,0,1,positive regulation of germ cell proliferation,BP,
19780,GO:2000256,1.00000000003245,0.921290224639814,0,1,positive regulation of male germ cell proliferation,BP,
9612,GO:0036497,1.00000000003305,0.901670869067549,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
17931,GO:1902310,1.00000000003305,0.901670869067549,0,1,positive regulation of peptidyl-serine dephosphorylation,BP,
18599,GO:1903916,1.00000000003305,0.901670869067549,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
18600,GO:1903917,1.00000000003305,0.901670869067549,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
6966,GO:0030644,1.00000000003312,0.82090844891556,0,2,cellular chloride ion homeostasis,BP,
13295,GO:0052203,1.00000000003426,0.816440650097551,0,2,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
4350,GO:0009955,1.00000000003432,0.902194236068804,0,1,adaxial/abaxial pattern specification,BP,
9260,GO:0035709,1.00000000003432,0.902194236068804,0,1,memory T cell activation,BP,
16278,GO:0090427,1.00000000003432,0.902194236068804,0,1,activation of meiosis,BP,
19664,GO:2000011,1.00000000003432,0.902194236068804,0,1,regulation of adaxial/abaxial pattern formation,BP,
19950,GO:2000567,1.00000000003432,0.902194236068804,0,1,regulation of memory T cell activation,BP,
19951,GO:2000568,1.00000000003432,0.902194236068804,0,1,positive regulation of memory T cell activation,BP,
20170,GO:2001055,1.00000000003432,0.902194236068804,0,1,positive regulation of mesenchymal cell apoptotic process,BP,
18240,GO:1903126,1.00000000003449,0.902514913013463,0,1,negative regulation of centriole-centriole cohesion,BP,
20202,GO:2001173,1.00000000003449,0.902514913013463,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
17710,GO:1901668,1.00000000003459,0.831522933531666,0,2,regulation of superoxide dismutase activity,BP,
12582,GO:0050787,1.00000000003459,0.831522933531664,0,2,detoxification of mercury ion,BP,
18258,GO:1903179,1.00000000003459,0.831522933531664,0,2,regulation of dopamine biosynthetic process,BP,
18259,GO:1903181,1.00000000003459,0.831522933531664,0,2,positive regulation of dopamine biosynthetic process,BP,
12951,GO:0051379,1.00000000003564,0.814441706244447,0,2,epinephrine binding,MF,
14458,GO:0061890,1.00000000003713,0.822585510999203,0,2,positive regulation of astrocyte activation,BP,
17164,GO:0106014,1.00000000003713,0.822585510999203,0,2,regulation of inflammatory response to wounding,BP,
17165,GO:0106015,1.00000000003713,0.822585510999203,0,2,negative regulation of inflammatory response to wounding,BP,
17470,GO:1900453,1.00000000003713,0.822585510999203,0,2,negative regulation of long term synaptic depression,BP,
18637,GO:1903980,1.00000000003713,0.822585510999203,0,2,positive regulation of microglial cell activation,BP,
19136,GO:1905203,1.00000000003713,0.822585510999203,0,2,regulation of connective tissue replacement,BP,
20219,GO:2001200,1.00000000003713,0.822585510999203,0,2,positive regulation of dendritic cell differentiation,BP,
10374,GO:0043224,1.00000000003724,0.848801001743453,0,2,nuclear SCF ubiquitin ligase complex,CC,
469,GO:0001512,1.00000000003788,0.917122199050532,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
18801,GO:1904408,1.00000000003788,0.917122199050532,0,1,melatonin binding,MF,
19286,GO:1905594,1.00000000003788,0.917122199050532,0,1,resveratrol binding,MF,
2252,GO:0005171,1.00000000003874,0.903023354328328,0,1,hepatocyte growth factor receptor binding,MF,
3639,GO:0008120,1.00000000003987,0.907333242911019,0,1,ceramide glucosyltransferase activity,MF,
17141,GO:0102769,1.00000000003987,0.907333242911019,0,1,dihydroceramide glucosyltransferase activity,MF,
9921,GO:0042289,1.00000000004655,0.829354991350993,0,2,MHC class II protein binding,MF,
10379,GO:0043229,1.00000000005141,0,799,9306,intracellular organelle,CC,TNIP1;FOS;DUSP6;H6PD;LMF1;CEMIP;APOE;TYSND1;MARVELD1;ESPN;CTNNBIP1;TSPAN1;PPL;IDH2;PTPRS;ERCC1;FLNC;FAM110C;NT5E;GAA;SYTL1;CLIP2;CITED4;NAPRT;BTBD2;PYGB;RNF44;CST3;SHANK2;RAPGEF3;TCFL5;PGM1;CYP27B1;GSN;CLCA2;XDH;PRDX5;NDRG1;PRSS3;PRODH;MEF2D;NOS1;LTBP1;MARCH9;PARVB;ARAP1;ZFP36L1;COL6A1;TCTN1;POSTN;GRB7;NR1D1;CRAT;ALOX15B;ARRDC1;EPN3;FAM210B;POLD4;SCN8A;EPHB2;EPAS1;OBSCN;CPT2;MYZAP;IGF2;NFATC4;NME4;MST1R;LRP1;GAMT;MAPK13;APPL2;CDK18;RALGDS;ST6GALNAC2;RAB11FIP4;OBSL1;EGFR;TIMP2;H1F0;TSC22D1;ALDH4A1;B3GAT3;HADH;SUGCT;ACSF2;REEP6;FBXO2;ACOT7;TCEA2;DUSP5;FKBP9;HS1BP3;UROS;FHL1;LOXL1;MXD4;DDB2;SERPING1;KDSR;MDFI;EGR1;ULK1;RHBDF1;PKN1;CRTC1;PYGL;TRIM65;DOPEY2;SYT8;NAGLU;SHC1;F2R;PTK6;BPHL;NPEPL1;ABCA7;DEAF1;LAMA5;PPP2R3B;SLC9A3R2;BAHCC1;BBS2;ACTA2;S100A4;CTSB;ESRG;LPCAT4;DNAH1;RNF208;PITPNC1;SLC16A3;CORO1B;CXXC5;ULK2;DHRS1;MALL;D2HGDH;ZMYND8;TBC1D14;ASH2L;ZSCAN18;PACS2;GRAMD4;SOX12;MXI1;CERS4;PLAT;ABCG1;RIN1;ANK3;NOL4L;PIK3R2;S100A6;ZNF516;INO80C;PEG3;NEK9;HDAC5;THRA;PLD3;DOCK4;CRTAP;RPS6KA2;NISCH;LRP5;DBNDD1;HYAL1;TUBG2;ANO8;MARK4;TENM2;SLC2A9;MAML3;B4GALNT4;ZFPM1;TFEB;ERBB2;BRSK1;MICALL2;BSG;CTSF;SCMH1;OGDHL;PKD2;CBS;TMEM129;FUCA1;TST;CPT1C;EDEM1;ABTB1;VWA5A;ITPR3;H2AFJ;PRAF2;VAT1;DNM1;FCHO1;MPRIP;PTHLH;CDKN1C;RIMS3;SALL2;MSRB2;IFT140;CD9;KIF13B;XPC;PTPRE;ANGEL1;NINL;SIGMAR1;PAK6;HEXB;SERPINE2;VPS11;VAMP2;CCDC69;FUZ;GALNT12;FOXQ1;NPHP4;LTB4R2;NTSR1;JADE2;CD320;MINK1;RALGAPA2;ATP2B4;SNN;TMOD2;TFDP2;PHF7;CSNK1E;ACP5;TRAPPC9;AGAP1;ZFYVE21;DIRC2;ADAMTS7;ENKD1;PDCD4;GM2A;BEX2;ACAP3;TNFRSF25;GLUL;PRR7;RHOD;ZKSCAN1;ARVCF;USP20;PEX10;ARMCX2;ASIC1;LAMB2;SPATA18;WNT7A;ZMIZ1;INSR;RAB3D;SH3PXD2B;FBXW8;ZC3H6;ID1;CELSR1;AKR7A2;MZT2A;B4GAT1;POLL;WDR27;NDUFS8;RABGGTA;ADARB1;ZNF692;ZNF704;TXNRD3;NBEAL2;HAGH;DNMT3A;DNPH1;TMEM173;PRNP;DHX32;SRD5A3;OXLD1;ATP7B;RNASET2;SNX33;HES2;SPRY2;HINT2;ZNF467;MNT;BLMH;ECM1;CEP250;ATG16L2;SNX9;STAT6;DLG4;SPEG;ABCD1;MARCH2;REEP2;MTA3;MKNK2;STRADB;TALDO1;WWTR1;ISG20;RAB25;FAM20C;MYO18A;ARHGAP27;CERCAM;MZT2B;DNAJB5;PHC2;PLEKHH2;C1ORF210;BCL6;ANKZF1;UCKL1;PFKFB2;CHMP1B;SCAND1;IGFBP2;DYRK1B;SEC14L2;MVB12B;TMEM92;BNIP3;FZD8;VEGFA;ENTPD6;DNASE1L1;ZSCAN2;HOOK2;ARL2;YPEL3;VANGL2;AP2A2;CEBPB;RHBDF2;DPP7;GPRC5C;HSD11B1L;HSF4;ADAM15;NAB2;NUDCD3;CALCOCO1;ZDHHC1;ENDOG;MAPK3;PDZD2;PLEKHG5;TUB;KCNAB2;ETV5;OLFM2;CARD19;AMN;SLC22A18;GLB1;DHTKD1;EXD3;C19ORF33;RAB40B;TNNT1;DVL1;ENTPD2;MTA1;LHPP;FYCO1;WIPF1;GPSM1;L3MBTL1;LTA4H;WIPI2;MBD1;PKN3;ST3GAL3;SLC16A13;NSMCE4A;FHOD1;HES1;BRD3;PC;ACAD10;YPEL2;SSH1;COMTD1;FURIN;MLXIPL;ZNF624;NAGS;FBF1;MBOAT7;SLC48A1;CUL7;MEFV;EVC;ARHGAP22;SLC2A3;ABCA2;TK2;ZNF414;LY6K;ADA;FKBP10;CDC42EP5;TRIM45;MCTP1;OSBPL5;PYCR2;PIDD1;RETSAT;PHF21A;AQP3;MYH16;CKMT1A;PFKL;SLIT3;PCSK9;TMEM9;ZFP36;ETV4;RHOF;MAPKBP1;HLCS;CYHR1;RSPH3;FGFR3;PRKACA;F12;PITPNM1;ZNF862;ZMYM3;LRRK1;NUDT10;DGUOK;CYFIP2;SLC38A10;RPS6KA5;HBEGF;SLC25A37;ITGB5;RAB3B;MAP2K2;PI4K2A;FGFR4;SPTB;MXRA8;SLC37A2;STX10;DMTN;RAPGEF5;PMVK;BBS1;MYH3;XYLT2;HDAC11;VGF;TNFRSF1A;SEZ6L2;EHD4;MAPK8IP1;TCF25;SEMA3B;LDLR;PTOV1;FAM214B;CYP3A5;SNX17;SOX13;ABHD17C;TRPV4;MPG;RHOBTB2;PIGZ;IFNGR2;BHLHE40;CROCC;CCDC92;RAG1;ZNF80;DUSP7;PHLDA1;LRRC45;MSLN;HMGA2;LDLRAP1;TM7SF2;ELK3;AHNAK2;DGKQ;PEX7;KLHDC2;SEMA4C;MVB12A;HK1;NMRAL1;ZXDC;MIB2;CHST6;SDHAF4;PADI3;GAS6;BTRC;MEX3A;POU6F1;LLGL1;ADGRB2;ZNF217;PPARA;HMGCL;TKFC;TMEM187;WNT7B;BLVRB;GIT1;COMT;SUFU;PTAFR;PLEKHG6;RFNG;ANKRD13D;DMC1;PAN2;REEP4;ZNF446;ATG2A;RXRA;PCK2;PCSK1;VASN;TMEM175;NEO1;IGFBP4;SDHA;GSDMC;MUC19;TBC1D16;USP21;RNF123;WDR60;PRKCZ;ADAMTS13;ZDHHC24;CLTCL1;HLTF;MDH2;CAPG;BCORL1;INPP5D;ETFB;ABCD4;SPATA7;TWF2;ZNF485;SH3GLB2;TPP1;PDK2;GPC1;TMX4;ICOSLG;SRSF5;ZNF160;RFXANK;TEF;SMOX;CEP68;SMARCD2;MAPKAPK3;NDE1;AGO4;RAD23A;ARAP3;FGFR1;CTSZ;CAMKK1;PIN1;MAN1B1;PNPLA4;ZNF563;KMT5C;PHYH;IRF2BPL;PROX1;WBP2;C21ORF2;NICN1;ASAP2;ESYT2;BIN1;YIPF3;TMEM8B;SERPINB6;PPP1R13L;ASS1;SH3D19;ZNF554;WDR83;GLRX;CES2;SLC25A27;BFSP1;JARID2;SYNC;CAPN2;SESN2;NDUFA4L2;TOLLIP;WNT2B;WRAP73;RXRB;CSTB;PROCR;SNPH;MAN2B2;PNRC1;MAPRE3;DUSP23;MACROD1;GAL3ST4;SMDT1;PTMS;CYBRD1;LMLN;RTN4R;EPB41L3;PIGV;SLC9A7;TIMP1;CD68;SDC1;WHAMMP3;GRHPR;ACTR1B;APOBEC3C;RTN2;H1FX;PLEKHH3;PIGQ;WNT3;LYST;ZFP41;SBF1;SORL1;STK39;COL13A1;VEGFB;MEF2B;TBC1D17;ZSCAN30;AHCYL2;TPCN1;HGSNAT;SLC25A29;CCDC85B;PNMA1;CYP2S1;AKT1;CTSD;TRAP1;TMBIM4;NLRX1;SEPT8;ADAM19;ZNF385A;TP53INP1;LRCH4;NDRG2;TUT1;SMARCA1;VPS33B;SIX5;ERCC6;ACP6;TDRKH;SLC5A5;SUN1;NAGA;TMEM120A;SPPL2B;IL17RD;UQCR11;SSBP2;RPL39L;R3HDM2;SSH3;PINK1;GAS8;PKD1;EHD3;LONP2;SLC22A17;MPLKIP;SNTA1;KDM4B;CAMTA2;RGS14;SYNE3;PLEKHH1;GOLGA2P5;PCIF1;MAFIP;SPIRE2;CCDC106;R3HDM4;HEXDC;ZNF710;CTSH;EHBP1L1;ABHD14B;P3H4;MLST8;AGPAT4;RILPL1;NRSN1;RSAD1;CBLC;EPN2;RFX2;RNF187;PYCARD;MAP2K3;PNPO;RHBG;POMT1;TRERF1;PCSK1N;DDN;PMS2P5;AS3MT;NDUFV3;STK17A;ERN1;RANBP9;ZNF319;APOBEC3F;PRIMPOL;ACADS;GCAT;WDR63;MOCS1;SIRT3;ALKBH6;GLI4;C12ORF66;SLC2A1;CPNE7;MLYCD;TAZ;JAK3;BCKDHA;KIFC2;LITAF;APBA1;MZF1;NEIL1;RARG;ING4;GALNS;PBXIP1;FAM162A;FCHSD1;GSTM2;ZNF514;PODXL2;ZFYVE19;TRIM7;WDR18;PQLC2;SFI1;KRT15;ADAMTSL4;TRNP1;TTLL11;ZNF837;TMED4;POLM;SEMA4F;FAM50A;NDST2;AGPAT3;RPL13A;RGS12;ALG12;RAB40C;MIF;SULF2;STXBP2;KIF26B;UBL5;LZTS2
